id|nct_id|result_group_id|ctgov_group_code|period|reason|count
2811862|NCT04348851|9591240|P4|Post-Test 2|Stroke survivor death|1
2811863|NCT04348851|9591241|P3|Post-Test 2|Stroke survivor death|0
2811864|NCT04348851|9591242|P2|Post-Test 2|Stroke survivor death|1
2811865|NCT04348851|9591243|P1|Post-Test 2|Stroke survivor death|0
2811866|NCT04348851|9591240|P4|Post-Test 1|Lost to Follow-up|0
2811867|NCT04348851|9591241|P3|Post-Test 1|Lost to Follow-up|0
2811868|NCT04348851|9591242|P2|Post-Test 1|Lost to Follow-up|1
2811869|NCT04348851|9591243|P1|Post-Test 1|Lost to Follow-up|0
2811870|NCT04348851|9591240|P4|Post-Test 1|Withdrawal by Subject|0
2811871|NCT04348851|9591241|P3|Post-Test 1|Withdrawal by Subject|0
2811872|NCT04348851|9591242|P2|Post-Test 1|Withdrawal by Subject|1
2811873|NCT04348851|9591243|P1|Post-Test 1|Withdrawal by Subject|0
2811874|NCT04336475|9591323|P2|Overall Study|Lost to Follow-up|2
2811875|NCT04336475|9591324|P1|Overall Study|Lost to Follow-up|0
2811876|NCT04336475|9591323|P2|Overall Study|upper respiratory infection|0
2811877|NCT04336475|9591324|P1|Overall Study|upper respiratory infection|1
2811878|NCT04336475|9591323|P2|Overall Study|pain|0
2811879|NCT04336475|9591324|P1|Overall Study|pain|1
2811880|NCT04322526|9591332|P2|Washout (1 Week)|Lost to Follow-up|2
2811881|NCT04322526|9591333|P1|Washout (1 Week)|Lost to Follow-up|1
2811882|NCT04322526|9591332|P2|First Intervention (1 Day)|Withdrawal by Subject|1
2811883|NCT04322526|9591333|P1|First Intervention (1 Day)|Withdrawal by Subject|1
2811884|NCT04308239|9591352|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
2811885|NCT04308239|9591353|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
2811886|NCT04308239|9591352|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
2811887|NCT04308239|9591353|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
2811888|NCT04308239|9591352|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
2811889|NCT04308239|9591353|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
2811890|NCT04308239|9591352|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
2811891|NCT04308239|9591353|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
2811892|NCT04287517|9591385|P2|Overall Study|Withdrawal by Subject|1
2811893|NCT04287517|9591386|P1|Overall Study|Withdrawal by Subject|1
2811894|NCT04272775|9591408|P2|Overall Study|Progressive Disease|1
2811895|NCT04272775|9591409|P1|Overall Study|Progressive Disease|3
2811896|NCT04272775|9591408|P2|Overall Study|Adverse Event|2
2811897|NCT04272775|9591409|P1|Overall Study|Adverse Event|1
2811898|NCT04272775|9591408|P2|Overall Study|Withdrawal by Subject|2
2811899|NCT04272775|9591409|P1|Overall Study|Withdrawal by Subject|1
2811900|NCT04272775|9591408|P2|Overall Study|Symptomatic Deterioration|1
2811901|NCT04272775|9591409|P1|Overall Study|Symptomatic Deterioration|1
2811902|NCT04272775|9591408|P2|Overall Study|Protocol Violation|1
2811903|NCT04272775|9591409|P1|Overall Study|Protocol Violation|0
2811904|NCT04272775|9591408|P2|Overall Study|Study Terminated by Sponsor|0
2811905|NCT04272775|9591409|P1|Overall Study|Study Terminated by Sponsor|1
2811906|NCT04222699|9591499|P1|Overall Study|Lost to Follow-up|2
2811907|NCT04179838|9591587|P2|Second Intervention (1 Day)|Protocol Violation|1
2811908|NCT04179838|9591588|P1|Second Intervention (1 Day)|Protocol Violation|0
2811909|NCT04179838|9591587|P2|First Intervention (1 Day)|Withdrawal by Subject|3
2811910|NCT04179838|9591588|P1|First Intervention (1 Day)|Withdrawal by Subject|0
2811911|NCT04149353|9591735|P1|Overall Study|Study terminated|1
2811912|NCT04142216|9591763|P2|Overall Study|Use of clove|1
2811913|NCT04142216|9591764|P1|Overall Study|Use of clove|0
2811914|NCT04142216|9591763|P2|Overall Study|Referral to another hemodialysis unit|2
2811915|NCT04142216|9591764|P1|Overall Study|Referral to another hemodialysis unit|3
2811916|NCT04142216|9591763|P2|Overall Study|Death|1
2811917|NCT04142216|9591764|P1|Overall Study|Death|3
2811918|NCT04142216|9591763|P2|Overall Study|Hospitalization|2
2811919|NCT04142216|9591764|P1|Overall Study|Hospitalization|0
2811920|NCT04123665|9591803|P2|Overall Study|Lost to Follow-up|0
2811921|NCT04123665|9591804|P1|Overall Study|Lost to Follow-up|1
2811922|NCT04123665|9591803|P2|Overall Study|Withdrawal by Subject|0
2811923|NCT04123665|9591804|P1|Overall Study|Withdrawal by Subject|7
2811924|NCT04106817|9591868|P3|Overall Study|Lost to Follow-up|0
2811925|NCT04106817|9591869|P2|Overall Study|Lost to Follow-up|0
2811926|NCT04106817|9591870|P1|Overall Study|Lost to Follow-up|1
2811927|NCT04098809|9591886|P2|Overall Study|Physician Decision|1
2811928|NCT04098809|9591887|P1|Overall Study|Physician Decision|2
2811929|NCT04098809|9591886|P2|Overall Study|Withdrawal by Subject|3
2811930|NCT04098809|9591887|P1|Overall Study|Withdrawal by Subject|1
2811931|NCT04091659|9591915|P2|Overall Study|Lost to Follow-up|1
2811932|NCT04091659|9591916|P1|Overall Study|Lost to Follow-up|0
2811933|NCT04091659|9591915|P2|Overall Study|Protocol Violation|0
2811934|NCT04091659|9591916|P1|Overall Study|Protocol Violation|3
2811935|NCT04080297|9591966|P2|Overall Study|concurrent illness|0
2811936|NCT04080297|9591967|P1|Overall Study|concurrent illness|1
2811937|NCT04080297|9591966|P2|Overall Study|Adverse Event|3
2811938|NCT04080297|9591967|P1|Overall Study|Adverse Event|1
2811939|NCT04053465|9592087|P2|Overall Study|Withdrawal by Subject|4
2811940|NCT04053465|9592088|P1|Overall Study|Withdrawal by Subject|4
2811941|NCT04048681|9592130|P5|Overall Study|family emergency|0
2811942|NCT04048681|9592131|P4|Overall Study|family emergency|1
2811943|NCT04048681|9592132|P3|Overall Study|family emergency|0
2811944|NCT04048681|9592133|P2|Overall Study|family emergency|0
2811945|NCT04048681|9592134|P1|Overall Study|family emergency|0
2811946|NCT04035564|9592208|P2|Overall Study|Guardian declined consent|2
2811947|NCT04035564|9592209|P1|Overall Study|Guardian declined consent|1
2811948|NCT04035564|9592208|P2|Overall Study|No laboratory available|2
2811949|NCT04035564|9592209|P1|Overall Study|No laboratory available|2
2811950|NCT04035564|9592208|P2|Overall Study|Protocol Violation|2
2811951|NCT04035564|9592209|P1|Overall Study|Protocol Violation|1
2811952|NCT04032652|9592240|P2|Overall Study|The study was terminated and the PI has|1
2811953|NCT04032652|9592241|P1|Overall Study|The study was terminated and the PI has|1
2811954|NCT04015232|9592384|P2|Overall Study|Medical Grounds|3
2811955|NCT04015232|9592385|P1|Overall Study|Medical Grounds|3
2811956|NCT04015232|9592384|P2|Overall Study|Protocol Violation|0
2811957|NCT04015232|9592385|P1|Overall Study|Protocol Violation|1
2811958|NCT04015232|9592384|P2|Overall Study|Withdrawal by Subject|4
2811959|NCT04015232|9592385|P1|Overall Study|Withdrawal by Subject|7
2811960|NCT04014062|9592457|P2|Period I: Dosing|Withdrawal by Subject|1
2811961|NCT04014062|9592458|P1|Period I: Dosing|Withdrawal by Subject|3
2811962|NCT04014062|9592457|P2|Period I: Dosing|Medical Grounds|5
2811963|NCT04014062|9592458|P1|Period I: Dosing|Medical Grounds|4
2811964|NCT04002648|9592513|P2|Overall Study|Lost to Follow-up|0
2811965|NCT04002648|9592514|P1|Overall Study|Lost to Follow-up|2
2811966|NCT04000815|9592525|P3|Overall Study|Hypertension occured on follow up|2
2811967|NCT04000815|9592526|P2|Overall Study|Hypertension occured on follow up|0
2811968|NCT04000815|9592527|P1|Overall Study|Hypertension occured on follow up|0
2811969|NCT04000815|9592525|P3|Overall Study|Right ovarian cyst occured|0
2811970|NCT04000815|9592526|P2|Overall Study|Right ovarian cyst occured|0
2811971|NCT04000815|9592527|P1|Overall Study|Right ovarian cyst occured|1
2811972|NCT04000815|9592525|P3|Overall Study|Withdrawal by Subject|2
2811973|NCT04000815|9592526|P2|Overall Study|Withdrawal by Subject|3
2811974|NCT04000815|9592527|P1|Overall Study|Withdrawal by Subject|4
2811975|NCT04000815|9592525|P3|Overall Study|Lost to Follow-up|3
2811976|NCT04000815|9592526|P2|Overall Study|Lost to Follow-up|2
2811977|NCT04000815|9592527|P1|Overall Study|Lost to Follow-up|9
2811978|NCT03982433|9592610|P1|Overall Study|Lost to Follow-up|1
2811979|NCT03966365|9592914|P2|Overall Study|Protocol Violation|0
2811980|NCT03966365|9592915|P1|Overall Study|Protocol Violation|1
2811981|NCT03965403|9592933|P1|Overall Study|Subject not meeting eligibility criteria|1
2811982|NCT03965052|9592946|P2|Overall Study|Protocol Violation|0
2811983|NCT03965052|9592947|P1|Overall Study|Protocol Violation|1
2811984|NCT03961308|9592967|P2|Overall Study|Adverse Event|1
2811985|NCT03961308|9592968|P1|Overall Study|Adverse Event|0
2811986|NCT03961308|9592967|P2|Overall Study|Lost to Follow-up|1
2811987|NCT03961308|9592968|P1|Overall Study|Lost to Follow-up|0
2811988|NCT03961308|9592967|P2|Overall Study|Other|0
2811989|NCT03961308|9592968|P1|Overall Study|Other|1
2811990|NCT03961308|9592967|P2|Overall Study|Withdrawal by Subject|0
2811991|NCT03961308|9592968|P1|Overall Study|Withdrawal by Subject|1
2811992|NCT03948581|9593006|P2|Overall Study|Lost to Follow-up|1
2811993|NCT03948581|9593007|P1|Overall Study|Lost to Follow-up|0
2811994|NCT03946124|9593017|P1|Overall Study|Withdrawal by Subject|19
2811995|NCT03933449|9593282|P2|Overall Study|Ongoing in Study|6
2811996|NCT03933449|9593283|P1|Overall Study|Ongoing in Study|20
2811997|NCT03933449|9593282|P2|Overall Study|Death|51
2811998|NCT03933449|9593283|P1|Overall Study|Death|36
2811999|NCT03933449|9593282|P2|Overall Study|Adverse Event|4
2812000|NCT03933449|9593283|P1|Overall Study|Adverse Event|6
2812001|NCT03927950|9593305|P1|Overall Study|Adverse Event|9
2812002|NCT03923933|9593312|P2|Overall Study|Withdrawal by Subject|1
2812003|NCT03923933|9593313|P1|Overall Study|Withdrawal by Subject|0
2812004|NCT03923933|9593312|P2|Overall Study|Lost to Follow-up|0
2812005|NCT03923933|9593313|P1|Overall Study|Lost to Follow-up|1
2812006|NCT03923530|9593331|P1|Overall Study|screen failure|3
2812007|NCT03923530|9593331|P1|Overall Study|Withdrawal by Subject|1
2812008|NCT03914950|9593341|P1|Overall Study|Physician Decision|54
2812009|NCT03905642|9593373|P1|Overall Study|Completed study but not 24 of 28 days|2
2812010|NCT03905642|9593373|P1|Overall Study|Lack of Efficacy|1
2812011|NCT03905642|9593373|P1|Overall Study|Adverse Event|1
2812012|NCT03905642|9593373|P1|Overall Study|Pregnancy|1
2812013|NCT03905642|9593373|P1|Overall Study|Withdrawal by Subject|3
2812014|NCT03902392|9593384|P2|Overall Study|Lost to Follow-up|7
2812015|NCT03902392|9593385|P1|Overall Study|Lost to Follow-up|7
2812016|NCT03899064|9593425|P1|Overall Study|Other|2
2812017|NCT03899064|9593425|P1|Overall Study|Withdrawal by Subject|2
2812018|NCT03899064|9593425|P1|Overall Study|Protocol Violation|2
2812019|NCT03899064|9593425|P1|Overall Study|Lost to Follow-up|1
2812020|NCT03897179|9593440|P1|Overall Study|Withdrawal by Subject|1
2812021|NCT03892564|9593565|P1|Overall Study|Withdrawal by Subject|2
2812022|NCT03888391|9593592|P1|Overall Study|Lost to Follow-up|15
2812023|NCT03882047|9593623|P3|Overall Study|Did Not Meet Eligibility|1
2812024|NCT03882047|9593624|P2|Overall Study|Did Not Meet Eligibility|0
2812025|NCT03882047|9593625|P1|Overall Study|Did Not Meet Eligibility|0
2812026|NCT03882047|9593623|P3|Overall Study|Noncompliance With Protocol|0
2812027|NCT03882047|9593624|P2|Overall Study|Noncompliance With Protocol|0
2812028|NCT03882047|9593625|P1|Overall Study|Noncompliance With Protocol|2
2812029|NCT03882047|9593623|P3|Overall Study|Did Not Wish to Continue|1
2812030|NCT03882047|9593624|P2|Overall Study|Did Not Wish to Continue|4
2812031|NCT03882047|9593625|P1|Overall Study|Did Not Wish to Continue|1
2812032|NCT03882047|9593623|P3|Overall Study|Lost to Follow-up|0
2812033|NCT03882047|9593624|P2|Overall Study|Lost to Follow-up|1
2812034|NCT03882047|9593625|P1|Overall Study|Lost to Follow-up|0
2812035|NCT03882047|9593623|P3|Overall Study|Treatment Failure|12
2812036|NCT03882047|9593624|P2|Overall Study|Treatment Failure|3
2812037|NCT03882047|9593625|P1|Overall Study|Treatment Failure|3
2812038|NCT03882047|9593623|P3|Overall Study|Adverse Event|2
2812039|NCT03882047|9593624|P2|Overall Study|Adverse Event|2
2812040|NCT03882047|9593625|P1|Overall Study|Adverse Event|0
2812041|NCT03879772|9593681|P5|Overall Study|Did Not Meet Entry Requirements|0
2812042|NCT03879772|9593682|P4|Overall Study|Did Not Meet Entry Requirements|0
2812043|NCT03879772|9593683|P3|Overall Study|Did Not Meet Entry Requirements|1
2812044|NCT03879772|9593684|P2|Overall Study|Did Not Meet Entry Requirements|0
2812045|NCT03879772|9593685|P1|Overall Study|Did Not Meet Entry Requirements|1
2812046|NCT03879772|9593681|P5|Overall Study|Protocol Violation|2
2812047|NCT03879772|9593682|P4|Overall Study|Protocol Violation|1
2812048|NCT03879772|9593683|P3|Overall Study|Protocol Violation|3
2812049|NCT03879772|9593684|P2|Overall Study|Protocol Violation|0
2812050|NCT03879772|9593685|P1|Overall Study|Protocol Violation|0
2812051|NCT03879772|9593681|P5|Overall Study|Withdrawal by Subject|1
2812052|NCT03879772|9593682|P4|Overall Study|Withdrawal by Subject|1
2812053|NCT03879772|9593683|P3|Overall Study|Withdrawal by Subject|3
2812054|NCT03879772|9593684|P2|Overall Study|Withdrawal by Subject|1
2812055|NCT03879772|9593685|P1|Overall Study|Withdrawal by Subject|0
2812056|NCT03879772|9593681|P5|Overall Study|Lost to Follow-up|1
2812057|NCT03879772|9593682|P4|Overall Study|Lost to Follow-up|0
2812058|NCT03879772|9593683|P3|Overall Study|Lost to Follow-up|0
2812059|NCT03879772|9593684|P2|Overall Study|Lost to Follow-up|0
2812060|NCT03879772|9593685|P1|Overall Study|Lost to Follow-up|0
2812061|NCT03879772|9593681|P5|Overall Study|Treatment Failure|1
2812062|NCT03879772|9593682|P4|Overall Study|Treatment Failure|2
2812063|NCT03879772|9593683|P3|Overall Study|Treatment Failure|0
2812064|NCT03879772|9593684|P2|Overall Study|Treatment Failure|0
2812065|NCT03879772|9593685|P1|Overall Study|Treatment Failure|1
2812066|NCT03879772|9593681|P5|Overall Study|Adverse Event|3
2812067|NCT03879772|9593682|P4|Overall Study|Adverse Event|4
2812068|NCT03879772|9593683|P3|Overall Study|Adverse Event|3
2812069|NCT03879772|9593684|P2|Overall Study|Adverse Event|2
2812070|NCT03879772|9593685|P1|Overall Study|Adverse Event|2
2812071|NCT03878758|9593722|P1|Overall Study|Improper consent documentation|1
2812072|NCT03878758|9593722|P1|Overall Study|Protocol defined|2
2812073|NCT03878758|9593722|P1|Overall Study|Withdrawal by Subject|1
2812074|NCT03868631|9593817|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2812075|NCT03868631|9593818|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2812076|NCT03868631|9593817|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
2812077|NCT03868631|9593818|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
2812078|NCT03868631|9593817|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
2812079|NCT03868631|9593818|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
2812080|NCT03868631|9593817|P2|Baseline to Week 6|Withdrawal by Subject|0
2812081|NCT03868631|9593818|P1|Baseline to Week 6|Withdrawal by Subject|3
2812082|NCT03868631|9593817|P2|Baseline to Week 6|Protocol Violation|1
2812083|NCT03868631|9593818|P1|Baseline to Week 6|Protocol Violation|1
2812084|NCT03868631|9593817|P2|Baseline to Week 6|Adverse Event|3
2812085|NCT03868631|9593818|P1|Baseline to Week 6|Adverse Event|0
2812086|NCT03861559|9593848|P2|Overall Study|Did not meet eligibility requirements|0
2812087|NCT03861559|9593849|P1|Overall Study|Did not meet eligibility requirements|1
2812088|NCT03861559|9593848|P2|Overall Study|Noncompliance|1
2812089|NCT03861559|9593849|P1|Overall Study|Noncompliance|1
2812090|NCT03861559|9593848|P2|Overall Study|Treatment failure|2
2812091|NCT03861559|9593849|P1|Overall Study|Treatment failure|0
2812092|NCT03861559|9593848|P2|Overall Study|Adverse Event|2
2812093|NCT03861559|9593849|P1|Overall Study|Adverse Event|0
2812094|NCT03855228|9593937|P4|Overall Study|Did Not Meet Entry Requirements|1
2812095|NCT03855228|9593938|P3|Overall Study|Did Not Meet Entry Requirements|1
2812096|NCT03855228|9593939|P2|Overall Study|Did Not Meet Entry Requirements|2
2812097|NCT03855228|9593940|P1|Overall Study|Did Not Meet Entry Requirements|0
2812098|NCT03855228|9593937|P4|Overall Study|Protocol Violation|1
2812099|NCT03855228|9593938|P3|Overall Study|Protocol Violation|2
2812100|NCT03855228|9593939|P2|Overall Study|Protocol Violation|1
2812101|NCT03855228|9593940|P1|Overall Study|Protocol Violation|0
2812102|NCT03855228|9593937|P4|Overall Study|Lost to Follow-up|1
2812103|NCT03855228|9593938|P3|Overall Study|Lost to Follow-up|0
2812104|NCT03855228|9593939|P2|Overall Study|Lost to Follow-up|0
2812105|NCT03855228|9593940|P1|Overall Study|Lost to Follow-up|0
2812106|NCT03855228|9593937|P4|Overall Study|Treatment Failure|8
2812107|NCT03855228|9593938|P3|Overall Study|Treatment Failure|1
2812108|NCT03855228|9593939|P2|Overall Study|Treatment Failure|2
2812109|NCT03855228|9593940|P1|Overall Study|Treatment Failure|1
2812110|NCT03855228|9593937|P4|Overall Study|Adverse Event|8
2812111|NCT03855228|9593938|P3|Overall Study|Adverse Event|4
2812112|NCT03855228|9593939|P2|Overall Study|Adverse Event|4
2812113|NCT03855228|9593940|P1|Overall Study|Adverse Event|2
2812114|NCT03855189|9593989|P3|Overall Study|Did Not Return|0
2812115|NCT03855189|9593990|P2|Overall Study|Did Not Return|3
2812116|NCT03855189|9593991|P1|Overall Study|Did Not Return|4
2812117|NCT03855189|9593989|P3|Overall Study|Noncompliance with Protocol|0
2812118|NCT03855189|9593990|P2|Overall Study|Noncompliance with Protocol|1
2812119|NCT03855189|9593991|P1|Overall Study|Noncompliance with Protocol|0
2812120|NCT03855189|9593989|P3|Overall Study|Treatment Failure|2
2812121|NCT03855189|9593990|P2|Overall Study|Treatment Failure|1
2812122|NCT03855189|9593991|P1|Overall Study|Treatment Failure|1
2812123|NCT03855189|9593989|P3|Overall Study|Adverse Event|4
2812124|NCT03855189|9593990|P2|Overall Study|Adverse Event|2
2812125|NCT03855189|9593991|P1|Overall Study|Adverse Event|5
2812126|NCT03850496|9594110|P3|Overall Study|Lost to Follow-up|4
2812127|NCT03850496|9594111|P2|Overall Study|Lost to Follow-up|1
2812128|NCT03850496|9594112|P1|Overall Study|Lost to Follow-up|0
2812129|NCT03850496|9594110|P3|Overall Study|Withdrawal by Subject|0
2812130|NCT03850496|9594111|P2|Overall Study|Withdrawal by Subject|0
2812131|NCT03850496|9594112|P1|Overall Study|Withdrawal by Subject|1
2812132|NCT03850444|9594122|P2|Overall Study|Ongoing in Study|59
2812133|NCT03850444|9594123|P1|Overall Study|Ongoing in Study|78
2812134|NCT03850444|9594122|P2|Overall Study|Withdrawal by Subject|1
2812135|NCT03850444|9594123|P1|Overall Study|Withdrawal by Subject|0
2812136|NCT03850444|9594122|P2|Overall Study|Lost to Follow-up|1
2812137|NCT03850444|9594123|P1|Overall Study|Lost to Follow-up|0
2812138|NCT03850444|9594122|P2|Overall Study|Death|64
2812139|NCT03850444|9594123|P1|Overall Study|Death|38
2812140|NCT03850444|9594122|P2|Overall Study|Adverse Event|9
2812141|NCT03850444|9594123|P1|Overall Study|Adverse Event|12
2812142|NCT03850093|9594152|P3|Overall Study|Withdrawal by Subject|2
2812143|NCT03850093|9594153|P2|Overall Study|Withdrawal by Subject|0
2812144|NCT03850093|9594154|P1|Overall Study|Withdrawal by Subject|1
2812145|NCT03849300|9594216|P4|Overall Study|scheduling/transportation conflict|2
2812146|NCT03849300|9594217|P3|Overall Study|scheduling/transportation conflict|3
2812147|NCT03849300|9594218|P2|Overall Study|scheduling/transportation conflict|4
2812148|NCT03849300|9594219|P1|Overall Study|scheduling/transportation conflict|4
2812149|NCT03849300|9594216|P4|Overall Study|move out to different area|4
2812150|NCT03849300|9594217|P3|Overall Study|move out to different area|1
2812151|NCT03849300|9594218|P2|Overall Study|move out to different area|3
2812152|NCT03849300|9594219|P1|Overall Study|move out to different area|1
2812153|NCT03847987|9594327|P2|Overall Study|Adverse Event|0
2812154|NCT03847987|9594328|P1|Overall Study|Adverse Event|2
2812155|NCT03847987|9594327|P2|Overall Study|Lost to Follow-up|0
2812156|NCT03847987|9594328|P1|Overall Study|Lost to Follow-up|1
2812157|NCT03836729|9594384|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
2812158|NCT03836664|9594498|P2|Overall Study|Didn't complete forms and lost drug|3
2812159|NCT03836664|9594499|P1|Overall Study|Didn't complete forms and lost drug|3
2812160|NCT03832387|9594511|P2|Overall Study|EXCLUSION CRITERIA|1
2812161|NCT03832387|9594512|P1|Overall Study|EXCLUSION CRITERIA|3
2812162|NCT03832387|9594511|P2|Overall Study|Protocol Violation|6
2812163|NCT03832387|9594512|P1|Overall Study|Protocol Violation|2
2812164|NCT03832322|9594542|P2|Overall Study|Failed cecal intubation in 2nd exam|1
2812165|NCT03832322|9594543|P1|Overall Study|Failed cecal intubation in 2nd exam|3
2812166|NCT03831282|9594560|P1|Overall Study|Could not place sensor|1
2812167|NCT03824912|9594610|P3|Overall Study|Participation in another study|0
2812168|NCT03824912|9594611|P2|Overall Study|Participation in another study|1
2812169|NCT03824912|9594612|P1|Overall Study|Participation in another study|0
2812170|NCT03824912|9594610|P3|Overall Study|Withdrawal by Subject|1
2812171|NCT03824912|9594611|P2|Overall Study|Withdrawal by Subject|2
2812172|NCT03824912|9594612|P1|Overall Study|Withdrawal by Subject|3
2812173|NCT03824912|9594610|P3|Overall Study|Protocol Violation|1
2812174|NCT03824912|9594611|P2|Overall Study|Protocol Violation|4
2812175|NCT03824912|9594612|P1|Overall Study|Protocol Violation|1
2812176|NCT03824912|9594610|P3|Overall Study|Non-Compliance with Study Drug|1
2812177|NCT03824912|9594611|P2|Overall Study|Non-Compliance with Study Drug|0
2812178|NCT03824912|9594612|P1|Overall Study|Non-Compliance with Study Drug|0
2812179|NCT03824912|9594610|P3|Overall Study|Negative Baseline Culture Result|57
2812180|NCT03824912|9594611|P2|Overall Study|Negative Baseline Culture Result|112
2812181|NCT03824912|9594612|P1|Overall Study|Negative Baseline Culture Result|118
2812182|NCT03824912|9594610|P3|Overall Study|Lost to Follow-up|8
2812183|NCT03824912|9594611|P2|Overall Study|Lost to Follow-up|15
2812184|NCT03824912|9594612|P1|Overall Study|Lost to Follow-up|18
2812185|NCT03824236|9594635|P3|Overall Study|Lost to Follow-up|1
2812186|NCT03824236|9594636|P2|Overall Study|Lost to Follow-up|0
2812187|NCT03824236|9594637|P1|Overall Study|Lost to Follow-up|0
2812188|NCT03822884|9594676|P6|Overall Study|Withdrawal by Subject|0
2812189|NCT03822884|9594677|P5|Overall Study|Withdrawal by Subject|1
2812190|NCT03822884|9594678|P4|Overall Study|Withdrawal by Subject|0
2812191|NCT03822884|9594679|P3|Overall Study|Withdrawal by Subject|0
2812192|NCT03822884|9594680|P2|Overall Study|Withdrawal by Subject|0
2812193|NCT03822884|9594681|P1|Overall Study|Withdrawal by Subject|0
2812194|NCT03817879|9594806|P2|Overall Study|Withdrawal by Subject|1
2812195|NCT03817879|9594807|P1|Overall Study|Withdrawal by Subject|0
2812196|NCT03817879|9594806|P2|Overall Study|Drop out|12
2812197|NCT03817879|9594807|P1|Overall Study|Drop out|5
2812198|NCT03811093|9595041|P2|Overall Study|Unable to measure body fat percentage|0
2812199|NCT03811093|9595042|P1|Overall Study|Unable to measure body fat percentage|2
2812200|NCT03811093|9595041|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
2812201|NCT03811093|9595042|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
2812202|NCT03809104|9595052|P1|Overall Study|Withdrawal by Subject|3
2812203|NCT03807700|9595100|P2|Overall Study|Withdrawal by Subject|1
2812204|NCT03807700|9595101|P1|Overall Study|Withdrawal by Subject|2
2812205|NCT03805971|9595177|P1|Overall Study|Protocol Violation|2
2812206|NCT03805971|9595177|P1|Overall Study|Withdrawal by Subject|1
2812207|NCT03801148|9595203|P4|Follow-Up (12 Days)|Lost to Follow-up|0
2812208|NCT03801148|9595204|P3|Follow-Up (12 Days)|Lost to Follow-up|1
2812209|NCT03801148|9595205|P2|Follow-Up (12 Days)|Lost to Follow-up|1
2812210|NCT03801148|9595206|P1|Follow-Up (12 Days)|Lost to Follow-up|0
2812211|NCT03801148|9595203|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2812212|NCT03801148|9595204|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2812213|NCT03801148|9595205|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2812214|NCT03801148|9595206|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2812215|NCT03801148|9595203|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
2812216|NCT03801148|9595204|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2812217|NCT03801148|9595205|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2812218|NCT03801148|9595206|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2812219|NCT03801148|9595203|P4|Period 1 (2 Days)|Adverse Event|0
2812220|NCT03801148|9595204|P3|Period 1 (2 Days)|Adverse Event|0
2812221|NCT03801148|9595205|P2|Period 1 (2 Days)|Adverse Event|1
2812222|NCT03801148|9595206|P1|Period 1 (2 Days)|Adverse Event|1
2812223|NCT03793556|9595355|P2|Overall Study|Lost to Follow-up|1
2812224|NCT03793556|9595356|P1|Overall Study|Lost to Follow-up|1
2812225|NCT03793556|9595355|P2|Overall Study|Withdrawal by Subject|1
2812226|NCT03793556|9595356|P1|Overall Study|Withdrawal by Subject|12
2812227|NCT03787212|9595411|P2|Period 1|Study Termination|2
2812228|NCT03787212|9595412|P1|Period 1|Study Termination|2
2812229|NCT03783780|9595418|P1|Overall Study|Withdrawn prior to completion|1
2812230|NCT03782571|9595423|P4|Period 3|Adverse Event|0
2812231|NCT03782571|9595424|P3|Period 3|Adverse Event|0
2812232|NCT03782571|9595425|P2|Period 3|Adverse Event|0
2812233|NCT03782571|9595426|P1|Period 3|Adverse Event|1
2812234|NCT03782571|9595423|P4|Period 3|Subject Unable to Attend V5|0
2812235|NCT03782571|9595424|P3|Period 3|Subject Unable to Attend V5|0
2812236|NCT03782571|9595425|P2|Period 3|Subject Unable to Attend V5|0
2812237|NCT03782571|9595426|P1|Period 3|Subject Unable to Attend V5|1
2812238|NCT03782571|9595423|P4|Period 1|Withdrawal by Subject|0
2812239|NCT03782571|9595424|P3|Period 1|Withdrawal by Subject|0
2812240|NCT03782571|9595425|P2|Period 1|Withdrawal by Subject|0
2812241|NCT03782571|9595426|P1|Period 1|Withdrawal by Subject|1
2812242|NCT03781375|9595479|P2|Open-label Phase|Other|2
2812243|NCT03781375|9595480|P1|Open-label Phase|Other|2
2812244|NCT03781375|9595479|P2|Open-label Phase|Suboptimal Clinical Response|0
2812245|NCT03781375|9595480|P1|Open-label Phase|Suboptimal Clinical Response|1
2812246|NCT03781375|9595479|P2|Open-label Phase|Protocol Issues|1
2812247|NCT03781375|9595480|P1|Open-label Phase|Protocol Issues|0
2812248|NCT03781375|9595479|P2|Double-blind Phase|Other|3
2812249|NCT03781375|9595480|P1|Double-blind Phase|Other|1
2812250|NCT03781375|9595479|P2|Double-blind Phase|Lack of Response|2
2812251|NCT03781375|9595480|P1|Double-blind Phase|Lack of Response|6
2812252|NCT03781375|9595479|P2|Double-blind Phase|Adverse Event|1
2812253|NCT03781375|9595480|P1|Double-blind Phase|Adverse Event|0
2812254|NCT03780959|9595494|P3|Part 2|Response Status|6
2812255|NCT03780959|9595495|P2|Part 2|Response Status|18
2812256|NCT03780959|9595496|P1|Part 2|Response Status|0
2812257|NCT03780959|9595494|P3|Part 2|Withdrawal by Parent/Guardian|0
2812258|NCT03780959|9595495|P2|Part 2|Withdrawal by Parent/Guardian|1
2812259|NCT03780959|9595496|P1|Part 2|Withdrawal by Parent/Guardian|0
2812260|NCT03780959|9595494|P3|Part 1|Response Status|0
2812261|NCT03780959|9595495|P2|Part 1|Response Status|0
2812262|NCT03780959|9595496|P1|Part 1|Response Status|2
2812263|NCT03780959|9595494|P3|Part 1|Withdrawal by Parent/Guardian|0
2812264|NCT03780959|9595495|P2|Part 1|Withdrawal by Parent/Guardian|0
2812265|NCT03780959|9595496|P1|Part 1|Withdrawal by Parent/Guardian|1
2812266|NCT03780959|9595494|P3|Part 1|Withdrawal by Subject|0
2812267|NCT03780959|9595495|P2|Part 1|Withdrawal by Subject|0
2812268|NCT03780959|9595496|P1|Part 1|Withdrawal by Subject|1
2812269|NCT03780959|9595494|P3|Part 1|Adverse Event|0
2812270|NCT03780959|9595495|P2|Part 1|Adverse Event|0
2812271|NCT03780959|9595496|P1|Part 1|Adverse Event|1
2812272|NCT03774576|9595586|P1|Period 2|Adverse Event|1
2812273|NCT03772522|9595601|P2|Post-intervention Follow-up|Lost to Follow-up|0
2812274|NCT03772522|9595602|P1|Post-intervention Follow-up|Lost to Follow-up|1
2812275|NCT03772522|9595601|P2|Intervention|Withdrawal by Subject|0
2812276|NCT03772522|9595602|P1|Intervention|Withdrawal by Subject|1
2812277|NCT03772522|9595601|P2|Pre-intervention|Withdrawal by Subject|4
2812278|NCT03772522|9595602|P1|Pre-intervention|Withdrawal by Subject|3
2812279|NCT03772327|9595625|P2|Overall Study|Withdrawal by Subject|3
2812280|NCT03772327|9595626|P1|Overall Study|Withdrawal by Subject|2
2812281|NCT03772327|9595625|P2|Overall Study|Lost to Follow-up|4
2812282|NCT03772327|9595626|P1|Overall Study|Lost to Follow-up|3
2812283|NCT03765138|9595706|P1|Overall Study|Lost to Follow-up|1
2812284|NCT03764813|9595716|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2812285|NCT03764813|9595717|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2812286|NCT03764813|9595718|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2812287|NCT03764813|9595719|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2812288|NCT03762668|9595840|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
2812289|NCT03762668|9595841|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
2812290|NCT03760510|9595849|P2|Overall Study|Not ventilated for 24 hours|97
2996695|NCT00966875|10312492|P3|Part B|Death|1
2812291|NCT03760510|9595850|P1|Overall Study|Not ventilated for 24 hours|105
2812292|NCT03759587|9595862|P1|Overall Study|Ongoing|19
2812293|NCT03755882|9595910|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
2812294|NCT03755882|9595911|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
2812295|NCT03755882|9595910|P2|Period 1|Protocol Violation|0
2812296|NCT03755882|9595911|P1|Period 1|Protocol Violation|1
2812297|NCT03742271|9596033|P1|Overall Study|Protocol Violation|1
2812298|NCT03742271|9596033|P1|Overall Study|Failed Insertion & removal|3
2812299|NCT03742271|9596033|P1|Overall Study|Lost to Follow-up|4
2812300|NCT03742271|9596033|P1|Overall Study|Withdrawal by Subject|3
2812301|NCT03742271|9596033|P1|Overall Study|Unsatisfactory Visual Response|1
2812302|NCT03739242|9596052|P2|Overall Study|Protocol Violation|1
2812303|NCT03739242|9596053|P1|Overall Study|Protocol Violation|0
2812304|NCT03739242|9596052|P2|Overall Study|Withdrawal by Subject|1
2812305|NCT03739242|9596053|P1|Overall Study|Withdrawal by Subject|1
2812306|NCT03738865|9596091|P2|Overall Study|Physician Decision|1
2812307|NCT03738865|9596092|P1|Overall Study|Physician Decision|0
2812308|NCT03738865|9596091|P2|Overall Study|Adverse Event|0
2812309|NCT03738865|9596092|P1|Overall Study|Adverse Event|2
2812310|NCT03738865|9596091|P2|Overall Study|Withdrawal by Subject|3
2812311|NCT03738865|9596092|P1|Overall Study|Withdrawal by Subject|3
2812312|NCT03733899|9596125|P6|Period 3|Withdrawal by Subject|0
2812313|NCT03733899|9596126|P5|Period 3|Withdrawal by Subject|0
2812314|NCT03733899|9596127|P4|Period 3|Withdrawal by Subject|0
2812315|NCT03733899|9596128|P3|Period 3|Withdrawal by Subject|0
2812316|NCT03733899|9596129|P2|Period 3|Withdrawal by Subject|0
2812317|NCT03733899|9596130|P1|Period 3|Withdrawal by Subject|1
2812318|NCT03733899|9596125|P6|Period 2|Unscuccessful Treatment|0
2812319|NCT03733899|9596126|P5|Period 2|Unscuccessful Treatment|0
2812320|NCT03733899|9596127|P4|Period 2|Unscuccessful Treatment|0
2812321|NCT03733899|9596128|P3|Period 2|Unscuccessful Treatment|0
2812322|NCT03733899|9596129|P2|Period 2|Unscuccessful Treatment|1
2812323|NCT03733899|9596130|P1|Period 2|Unscuccessful Treatment|0
2812324|NCT03733899|9596125|P6|Period 1|Protocol Violation|1
2812325|NCT03733899|9596126|P5|Period 1|Protocol Violation|0
2812326|NCT03733899|9596127|P4|Period 1|Protocol Violation|0
2812327|NCT03733899|9596128|P3|Period 1|Protocol Violation|0
2812328|NCT03733899|9596129|P2|Period 1|Protocol Violation|0
2812329|NCT03733899|9596130|P1|Period 1|Protocol Violation|0
2812330|NCT03733470|9596158|P2|Overall Study|PI Decision|1
2812331|NCT03733470|9596159|P1|Overall Study|PI Decision|1
2812332|NCT03728140|9596167|P2|Overall Study|Abnormal embryo transfer operation|7
2812333|NCT03728140|9596168|P1|Overall Study|Abnormal embryo transfer operation|10
2812334|NCT03725982|9596214|P2|First Intervention|Physician Decision|1
2812335|NCT03725982|9596215|P1|First Intervention|Physician Decision|1
2812336|NCT03725982|9596214|P2|First Intervention|Withdrawal by Subject|1
2812337|NCT03725982|9596215|P1|First Intervention|Withdrawal by Subject|0
2812338|NCT03725085|9596232|P1|Overall Study|Lost to Follow-up|2
2812339|NCT03724981|9596240|P2|First Device|Protocol Violation|1
2812340|NCT03724981|9596241|P1|First Device|Protocol Violation|1
2812341|NCT03722264|9596289|P1|Overall Study|Physician Decision|3
2812342|NCT03720847|9596357|P2|Washout|Physician Decision|2
2812343|NCT03720847|9596358|P1|Washout|Physician Decision|1
2812344|NCT03718000|9596384|P2|Overall Study|Pregnancy|1
2812345|NCT03718000|9596385|P1|Overall Study|Pregnancy|0
2812346|NCT03718000|9596384|P2|Overall Study|Relocation|4
2812347|NCT03718000|9596385|P1|Overall Study|Relocation|2
2812348|NCT03717064|9596407|P1|Period 2|Adverse Event|1
2812349|NCT03716050|9596439|P8|Overall Study|Protocol Violation|2
2812350|NCT03716050|9596440|P7|Overall Study|Protocol Violation|0
2812351|NCT03716050|9596441|P6|Overall Study|Protocol Violation|0
2812352|NCT03716050|9596442|P5|Overall Study|Protocol Violation|0
2812353|NCT03716050|9596443|P4|Overall Study|Protocol Violation|1
2812354|NCT03716050|9596444|P3|Overall Study|Protocol Violation|0
2812355|NCT03716050|9596445|P2|Overall Study|Protocol Violation|0
2812356|NCT03716050|9596446|P1|Overall Study|Protocol Violation|0
2812357|NCT03716050|9596439|P8|Overall Study|Physician Decision|0
2812358|NCT03716050|9596440|P7|Overall Study|Physician Decision|0
2812359|NCT03716050|9596441|P6|Overall Study|Physician Decision|0
2812360|NCT03716050|9596442|P5|Overall Study|Physician Decision|0
2812361|NCT03716050|9596443|P4|Overall Study|Physician Decision|1
2812362|NCT03716050|9596444|P3|Overall Study|Physician Decision|0
2812363|NCT03716050|9596445|P2|Overall Study|Physician Decision|0
2812364|NCT03716050|9596446|P1|Overall Study|Physician Decision|0
2812365|NCT03716050|9596439|P8|Overall Study|Lost to Follow-up|0
2812366|NCT03716050|9596440|P7|Overall Study|Lost to Follow-up|0
2812367|NCT03716050|9596441|P6|Overall Study|Lost to Follow-up|0
2812368|NCT03716050|9596442|P5|Overall Study|Lost to Follow-up|0
2812369|NCT03716050|9596443|P4|Overall Study|Lost to Follow-up|0
2812370|NCT03716050|9596444|P3|Overall Study|Lost to Follow-up|1
2812371|NCT03716050|9596445|P2|Overall Study|Lost to Follow-up|0
2812372|NCT03716050|9596446|P1|Overall Study|Lost to Follow-up|0
2812373|NCT03715530|9596520|P3|Overall Study|Lost to Follow-up|2
2812374|NCT03715530|9596521|P2|Overall Study|Lost to Follow-up|1
2812375|NCT03715530|9596522|P1|Overall Study|Lost to Follow-up|3
2812376|NCT03714672|9596577|P4|Overall Study|Lost to Follow-up|0
2812377|NCT03714672|9596578|P3|Overall Study|Lost to Follow-up|0
2812378|NCT03714672|9596579|P2|Overall Study|Lost to Follow-up|1
2812379|NCT03714672|9596580|P1|Overall Study|Lost to Follow-up|1
2812380|NCT03714672|9596577|P4|Overall Study|Other Reason|1
2812381|NCT03714672|9596578|P3|Overall Study|Other Reason|1
2812382|NCT03714672|9596579|P2|Overall Study|Other Reason|2
2812383|NCT03714672|9596580|P1|Overall Study|Other Reason|1
2812384|NCT03714672|9596577|P4|Overall Study|Physician Decision|0
2812385|NCT03714672|9596578|P3|Overall Study|Physician Decision|0
2812386|NCT03714672|9596579|P2|Overall Study|Physician Decision|1
2812387|NCT03714672|9596580|P1|Overall Study|Physician Decision|0
2812388|NCT03714672|9596577|P4|Overall Study|Adverse Event|0
2812389|NCT03714672|9596578|P3|Overall Study|Adverse Event|3
2812390|NCT03714672|9596579|P2|Overall Study|Adverse Event|0
2812391|NCT03714672|9596580|P1|Overall Study|Adverse Event|0
2812392|NCT03712917|9596634|P3|Overall Study|Lost to Follow-up|5
2812393|NCT03712917|9596635|P2|Overall Study|Lost to Follow-up|4
2812394|NCT03712917|9596636|P1|Overall Study|Lost to Follow-up|9
2812395|NCT03712917|9596634|P3|Overall Study|Adverse Event|3
2812396|NCT03712917|9596635|P2|Overall Study|Adverse Event|4
2812397|NCT03712917|9596636|P1|Overall Study|Adverse Event|0
2812398|NCT03712917|9596634|P3|Overall Study|Pregnancy|1
2812399|NCT03712917|9596635|P2|Overall Study|Pregnancy|0
2812400|NCT03712917|9596636|P1|Overall Study|Pregnancy|0
2812401|NCT03709823|9596653|P6|Overall Study|Other, Not Specified|0
2812402|NCT03709823|9596654|P5|Overall Study|Other, Not Specified|0
2812403|NCT03709823|9596655|P4|Overall Study|Other, Not Specified|1
2812404|NCT03709823|9596656|P3|Overall Study|Other, Not Specified|0
2812405|NCT03709823|9596657|P2|Overall Study|Other, Not Specified|0
2812406|NCT03709823|9596658|P1|Overall Study|Other, Not Specified|0
2812407|NCT03709823|9596653|P6|Overall Study|Withdrawal by Subject|0
2812408|NCT03709823|9596654|P5|Overall Study|Withdrawal by Subject|0
2812409|NCT03709823|9596655|P4|Overall Study|Withdrawal by Subject|0
2812410|NCT03709823|9596656|P3|Overall Study|Withdrawal by Subject|0
2812411|NCT03709823|9596657|P2|Overall Study|Withdrawal by Subject|3
2812412|NCT03709823|9596658|P1|Overall Study|Withdrawal by Subject|1
2812413|NCT03709823|9596653|P6|Overall Study|Lost to Follow-up|0
2812414|NCT03709823|9596654|P5|Overall Study|Lost to Follow-up|1
2812415|NCT03709823|9596655|P4|Overall Study|Lost to Follow-up|1
2812416|NCT03709823|9596656|P3|Overall Study|Lost to Follow-up|2
2812417|NCT03709823|9596657|P2|Overall Study|Lost to Follow-up|2
2812418|NCT03709823|9596658|P1|Overall Study|Lost to Follow-up|2
2812419|NCT03709823|9596653|P6|Overall Study|Adverse Event|0
2812420|NCT03709823|9596654|P5|Overall Study|Adverse Event|0
2812421|NCT03709823|9596655|P4|Overall Study|Adverse Event|0
2812422|NCT03709823|9596656|P3|Overall Study|Adverse Event|1
2812423|NCT03709823|9596657|P2|Overall Study|Adverse Event|0
2812424|NCT03709823|9596658|P1|Overall Study|Adverse Event|0
2812425|NCT03708744|9596704|P4|Overall Study|Withdrawal by Subject|0
2812426|NCT03708744|9596705|P3|Overall Study|Withdrawal by Subject|1
2812427|NCT03708744|9596706|P2|Overall Study|Withdrawal by Subject|0
2812428|NCT03708744|9596707|P1|Overall Study|Withdrawal by Subject|0
2812429|NCT03707821|9596741|P2|Overall Study|Unsatisfactory Lens Fitting|0
2812430|NCT03707821|9596742|P1|Overall Study|Unsatisfactory Lens Fitting|1
2812431|NCT03707821|9596741|P2|Overall Study|Unsatisfactory Visual Response|0
2812432|NCT03707821|9596742|P1|Overall Study|Unsatisfactory Visual Response|1
2812433|NCT03707821|9596741|P2|Overall Study|Protocol Violation|1
2812434|NCT03707821|9596742|P1|Overall Study|Protocol Violation|0
2812435|NCT03707522|9596764|P4|Overall Study|Lost to Follow-up|36
2812436|NCT03707522|9596765|P3|Overall Study|Lost to Follow-up|41
2812437|NCT03707522|9596766|P2|Overall Study|Lost to Follow-up|27
2812438|NCT03707522|9596767|P1|Overall Study|Lost to Follow-up|24
2812439|NCT03700671|9596896|P2|Overall Study|Lack of Efficacy|2
2812440|NCT03700671|9596897|P1|Overall Study|Lack of Efficacy|1
2812441|NCT03698591|9596911|P2|Overall Study|Could not establish TMS dosage|1
2812442|NCT03698591|9596912|P1|Overall Study|Could not establish TMS dosage|0
2812443|NCT03698591|9596911|P2|Overall Study|Equipment Error|0
2812444|NCT03698591|9596912|P1|Overall Study|Equipment Error|1
2812445|NCT03698591|9596911|P2|Overall Study|Ineligible for financial compensation|0
2812446|NCT03698591|9596912|P1|Overall Study|Ineligible for financial compensation|1
2812447|NCT03698591|9596911|P2|Overall Study|Failed health screen|1
2812448|NCT03698591|9596912|P1|Overall Study|Failed health screen|0
2812449|NCT03698591|9596911|P2|Overall Study|Failed drug screen|1
2812450|NCT03698591|9596912|P1|Overall Study|Failed drug screen|1
2812451|NCT03698591|9596911|P2|Overall Study|Withdrawal by Subject|2
2812452|NCT03698591|9596912|P1|Overall Study|Withdrawal by Subject|2
2812453|NCT03694821|9596955|P3|Overall Study|Study terminated|4
2812454|NCT03694821|9596956|P2|Overall Study|Study terminated|8
2812455|NCT03694821|9596957|P1|Overall Study|Study terminated|4
2812456|NCT03693989|9596988|P2|Overall Study|Protocol Violation|4
2812457|NCT03693989|9596989|P1|Overall Study|Protocol Violation|3
2812458|NCT03693950|9597013|P2|Overall Study|Withdrawal by Subject|0
2812459|NCT03693950|9597014|P1|Overall Study|Withdrawal by Subject|1
2812460|NCT03688620|9597039|P3|Overall Study|Withdrawal by Subject|6
2812461|NCT03688620|9597040|P2|Overall Study|Withdrawal by Subject|0
2812462|NCT03688620|9597041|P1|Overall Study|Withdrawal by Subject|0
2812463|NCT03688620|9597039|P3|Overall Study|Lost to Follow-up|1
2812464|NCT03688620|9597040|P2|Overall Study|Lost to Follow-up|0
2812465|NCT03688620|9597041|P1|Overall Study|Lost to Follow-up|16
2812466|NCT03688620|9597039|P3|Overall Study|Unwilling to attend the scheduled visit|0
2812467|NCT03688620|9597040|P2|Overall Study|Unwilling to attend the scheduled visit|1
2812549|NCT03669081|9597934|P1|Overall Study|Data could not be validated|1
2812468|NCT03688620|9597041|P1|Overall Study|Unwilling to attend the scheduled visit|0
2812469|NCT03688620|9597039|P3|Overall Study|Other|1
2812470|NCT03688620|9597040|P2|Overall Study|Other|0
2812471|NCT03688620|9597041|P1|Overall Study|Other|0
2812472|NCT03687736|9597522|P1|Overall Study|Withdrawal by Subject|3
2812473|NCT03687736|9597522|P1|Overall Study|Lost to Follow-up|7
2812474|NCT03685643|9597553|P2|Overall Study|Lost to Follow-up|22
2812475|NCT03685643|9597554|P1|Overall Study|Lost to Follow-up|14
2812476|NCT03683758|9597603|P2|Overall Study|Adverse Event|0
2812477|NCT03683758|9597604|P1|Overall Study|Adverse Event|1
2812478|NCT03683758|9597603|P2|Overall Study|Illness preventing participation|0
2812479|NCT03683758|9597604|P1|Overall Study|Illness preventing participation|1
2812480|NCT03683758|9597603|P2|Overall Study|Non-study commitment conflict|3
2812481|NCT03683758|9597604|P1|Overall Study|Non-study commitment conflict|1
2812482|NCT03679741|9597696|P2|Period 2|Withdrawal by Subject|1
2812483|NCT03679741|9597697|P1|Period 2|Withdrawal by Subject|1
2812484|NCT03679741|9597696|P2|Period 2|Adverse Event|1
2812485|NCT03679741|9597697|P1|Period 2|Adverse Event|2
2812486|NCT03679741|9597696|P2|Period 1|Withdrawal by Subject|1
2812487|NCT03679741|9597697|P1|Period 1|Withdrawal by Subject|0
2812488|NCT03679741|9597696|P2|Period 1|Adverse Event|1
2812489|NCT03679741|9597697|P1|Period 1|Adverse Event|1
2812490|NCT03679741|9597696|P2|Period 1|Lost to Follow-up|1
2812491|NCT03679741|9597697|P1|Period 1|Lost to Follow-up|0
2812492|NCT03679741|9597696|P2|Period 1|No longer meet eligibility criteria|0
2812493|NCT03679741|9597697|P1|Period 1|No longer meet eligibility criteria|1
2812494|NCT03678870|9597740|P2|Overall Study|Lost to Follow-up|2
2812495|NCT03678870|9597741|P1|Overall Study|Lost to Follow-up|3
2812496|NCT03678870|9597740|P2|Overall Study|prescribed non- protocol medications|6
2812497|NCT03678870|9597741|P1|Overall Study|prescribed non- protocol medications|10
2812498|NCT03677375|9597753|P1|Overall Study|Physician Decision|1
2812499|NCT03677375|9597753|P1|Overall Study|Adverse Event|3
2812500|NCT03677375|9597753|P1|Overall Study|Incomplete procedure|8
2812501|NCT03674177|9597808|P4|Overall Study|Lost to Follow-up|2
2812502|NCT03674177|9597809|P3|Overall Study|Lost to Follow-up|0
2812503|NCT03674177|9597810|P2|Overall Study|Lost to Follow-up|1
2812504|NCT03674177|9597811|P1|Overall Study|Lost to Follow-up|2
2812505|NCT03673670|9597875|P6|Treatment Period 3 (3 Days)|Adverse Event|0
2812506|NCT03673670|9597876|P5|Treatment Period 3 (3 Days)|Adverse Event|1
2812507|NCT03673670|9597877|P4|Treatment Period 3 (3 Days)|Adverse Event|0
2812508|NCT03673670|9597878|P3|Treatment Period 3 (3 Days)|Adverse Event|0
2812509|NCT03673670|9597879|P2|Treatment Period 3 (3 Days)|Adverse Event|0
2812510|NCT03673670|9597880|P1|Treatment Period 3 (3 Days)|Adverse Event|0
2812511|NCT03673670|9597875|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2812512|NCT03673670|9597876|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
2812513|NCT03673670|9597877|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2812514|NCT03673670|9597878|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2812515|NCT03673670|9597879|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2812516|NCT03673670|9597880|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2812517|NCT03673670|9597875|P6|Treatment Period 2 (3 Days)|Adverse Event|0
2812518|NCT03673670|9597876|P5|Treatment Period 2 (3 Days)|Adverse Event|1
2812519|NCT03673670|9597877|P4|Treatment Period 2 (3 Days)|Adverse Event|0
2812520|NCT03673670|9597878|P3|Treatment Period 2 (3 Days)|Adverse Event|1
2812521|NCT03673670|9597879|P2|Treatment Period 2 (3 Days)|Adverse Event|0
2812522|NCT03673670|9597880|P1|Treatment Period 2 (3 Days)|Adverse Event|0
2812523|NCT03673670|9597875|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
2812524|NCT03673670|9597876|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2812525|NCT03673670|9597877|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2812526|NCT03673670|9597878|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2812527|NCT03673670|9597879|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2812528|NCT03673670|9597880|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2812529|NCT03673670|9597875|P6|Treatment Period 1 (3 Days)|Adverse Event|1
2812530|NCT03673670|9597876|P5|Treatment Period 1 (3 Days)|Adverse Event|0
2812531|NCT03673670|9597877|P4|Treatment Period 1 (3 Days)|Adverse Event|0
2812532|NCT03673670|9597878|P3|Treatment Period 1 (3 Days)|Adverse Event|0
2812533|NCT03673670|9597879|P2|Treatment Period 1 (3 Days)|Adverse Event|0
2812534|NCT03673670|9597880|P1|Treatment Period 1 (3 Days)|Adverse Event|0
2812535|NCT03673670|9597875|P6|Treatment Period 1 (3 Days)|Physician Decision|0
2812536|NCT03673670|9597876|P5|Treatment Period 1 (3 Days)|Physician Decision|0
2812537|NCT03673670|9597877|P4|Treatment Period 1 (3 Days)|Physician Decision|0
2812538|NCT03673670|9597878|P3|Treatment Period 1 (3 Days)|Physician Decision|1
2812539|NCT03673670|9597879|P2|Treatment Period 1 (3 Days)|Physician Decision|0
2812540|NCT03673670|9597880|P1|Treatment Period 1 (3 Days)|Physician Decision|0
2812541|NCT03673670|9597875|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2812542|NCT03673670|9597876|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2812543|NCT03673670|9597877|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2812544|NCT03673670|9597878|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2812545|NCT03673670|9597879|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2812546|NCT03673670|9597880|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
2812547|NCT03670537|9597927|P1|Overall Study|Protocol Violation|1
2812548|NCT03669081|9597933|P2|Overall Study|Data could not be validated|1
2996696|NCT00966875|10312493|P2|Part B|Death|0
2812550|NCT03663179|9597999|P2|Overall Study|Revealed exclusionary condition|0
2812551|NCT03663179|9598000|P1|Overall Study|Revealed exclusionary condition|1
2812552|NCT03663179|9597999|P2|Overall Study|Lost to Follow-up|1
2812553|NCT03663179|9598000|P1|Overall Study|Lost to Follow-up|1
2812554|NCT03663179|9597999|P2|Overall Study|Withdrawal by Subject|0
2812555|NCT03663179|9598000|P1|Overall Study|Withdrawal by Subject|2
2812556|NCT03662334|9598010|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
2812557|NCT03662334|9598011|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
2812558|NCT03658889|9598114|P1|Overall Study|Protocol Violation|2
2812559|NCT03658876|9598146|P2|Overall Study|Transplantation/other operation|5
2812560|NCT03658876|9598147|P1|Overall Study|Transplantation/other operation|1
2812561|NCT03658876|9598146|P2|Overall Study|Intercurrent illness|4
2812562|NCT03658876|9598147|P1|Overall Study|Intercurrent illness|6
2812563|NCT03658876|9598146|P2|Overall Study|Death|1
2812564|NCT03658876|9598147|P1|Overall Study|Death|0
2812565|NCT03658876|9598146|P2|Overall Study|Withdrawal by Subject|0
2812566|NCT03658876|9598147|P1|Overall Study|Withdrawal by Subject|2
2812567|NCT03658876|9598146|P2|Overall Study|Protocol Violation|2
2812568|NCT03658876|9598147|P1|Overall Study|Protocol Violation|3
2812569|NCT03658811|9598153|P1|Overall Study|Lost to Follow-up|3
2812570|NCT03655106|9598207|P2|Overall Study|Protocol Violation|0
2812571|NCT03655106|9598208|P1|Overall Study|Protocol Violation|3
2812572|NCT03655106|9598207|P2|Overall Study|Duplicate Enrollment|1
2812573|NCT03655106|9598208|P1|Overall Study|Duplicate Enrollment|1
2812574|NCT03655106|9598207|P2|Overall Study|Lost to Follow-up|1
2812575|NCT03655106|9598208|P1|Overall Study|Lost to Follow-up|2
2812576|NCT03655106|9598207|P2|Overall Study|Withdrawal by Subject|2
2812577|NCT03655106|9598208|P1|Overall Study|Withdrawal by Subject|3
2812578|NCT03653429|9598245|P2|Overall Study|Physician Decision|10
2812579|NCT03653429|9598246|P1|Overall Study|Physician Decision|4
2812580|NCT03649412|9598314|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
2812581|NCT03649412|9598315|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
2812582|NCT03649412|9598314|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
2812583|NCT03649412|9598315|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
2812584|NCT03649412|9598314|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
2812585|NCT03649412|9598315|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
2812586|NCT03649412|9598314|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
2812587|NCT03649412|9598315|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
2812588|NCT03649412|9598314|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
2812589|NCT03649412|9598315|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
2812590|NCT03649412|9598314|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
2812591|NCT03649412|9598315|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
2812592|NCT03648983|9598473|P1|Overall Study|Study was terminated due to PI departure|95
2812593|NCT03647709|9598483|P1|Overall Study|Withdrawal by Subject|3
2812594|NCT03647709|9598483|P1|Overall Study|Physician Decision|6
2812595|NCT03647709|9598483|P1|Overall Study|Lost to Follow-up|5
2812596|NCT03646656|9598516|P2|Overall Study|Withdrawal by Subject|0
2812597|NCT03646656|9598517|P1|Overall Study|Withdrawal by Subject|2
2812598|NCT03646656|9598516|P2|Overall Study|Lost to Follow-up|0
2812599|NCT03646656|9598517|P1|Overall Study|Lost to Follow-up|1
2812600|NCT03645421|9598551|P4|Overall Study|Study specific withdrawal criteria|0
2812601|NCT03645421|9598552|P3|Overall Study|Study specific withdrawal criteria|1
2812602|NCT03645421|9598553|P2|Overall Study|Study specific withdrawal criteria|0
2812603|NCT03645421|9598554|P1|Overall Study|Study specific withdrawal criteria|0
2812604|NCT03645421|9598551|P4|Overall Study|Withdrawal by patient|3
2812605|NCT03645421|9598552|P3|Overall Study|Withdrawal by patient|0
2812606|NCT03645421|9598553|P2|Overall Study|Withdrawal by patient|0
2812607|NCT03645421|9598554|P1|Overall Study|Withdrawal by patient|0
2812608|NCT03645421|9598551|P4|Overall Study|Adverse Event|1
2812609|NCT03645421|9598552|P3|Overall Study|Adverse Event|4
2812610|NCT03645421|9598553|P2|Overall Study|Adverse Event|0
2812611|NCT03645421|9598554|P1|Overall Study|Adverse Event|0
2812612|NCT03643575|9598659|P6|Washout: 7 Days|Non compliance check in|0
2812613|NCT03643575|9598660|P5|Washout: 7 Days|Non compliance check in|0
2812614|NCT03643575|9598661|P4|Washout: 7 Days|Non compliance check in|0
2812615|NCT03643575|9598662|P3|Washout: 7 Days|Non compliance check in|0
2812616|NCT03643575|9598663|P2|Washout: 7 Days|Non compliance check in|1
2812617|NCT03643575|9598664|P1|Washout: 7 Days|Non compliance check in|0
2812618|NCT03643575|9598659|P6|Washout: 7 Days|Adverse Event|0
2812619|NCT03643575|9598660|P5|Washout: 7 Days|Adverse Event|0
2812620|NCT03643575|9598661|P4|Washout: 7 Days|Adverse Event|0
2812621|NCT03643575|9598662|P3|Washout: 7 Days|Adverse Event|0
2812622|NCT03643575|9598663|P2|Washout: 7 Days|Adverse Event|0
2812623|NCT03643575|9598664|P1|Washout: 7 Days|Adverse Event|1
2812624|NCT03643575|9598659|P6|Washout: 7 Days|Withdrew consent due to illness|0
2812625|NCT03643575|9598660|P5|Washout: 7 Days|Withdrew consent due to illness|0
2812626|NCT03643575|9598661|P4|Washout: 7 Days|Withdrew consent due to illness|1
2812627|NCT03643575|9598662|P3|Washout: 7 Days|Withdrew consent due to illness|0
2812628|NCT03643575|9598663|P2|Washout: 7 Days|Withdrew consent due to illness|0
2812629|NCT03643575|9598664|P1|Washout: 7 Days|Withdrew consent due to illness|0
2812630|NCT03643159|9598722|P1|Overall Study|Withdrawal by Subject|1
2812631|NCT03643159|9598722|P1|Overall Study|Adverse Event|1
2812632|NCT03642873|9598729|P6|Third Intervention (1 Day)|Screen failure|0
2812633|NCT03642873|9598730|P5|Third Intervention (1 Day)|Screen failure|1
2812634|NCT03642873|9598731|P4|Third Intervention (1 Day)|Screen failure|0
2812635|NCT03642873|9598732|P3|Third Intervention (1 Day)|Screen failure|0
2812636|NCT03642873|9598733|P2|Third Intervention (1 Day)|Screen failure|0
2812637|NCT03642873|9598734|P1|Third Intervention (1 Day)|Screen failure|0
2812638|NCT03642262|9598766|P2|Period 1|Adverse Event|1
2812639|NCT03642262|9598767|P1|Period 1|Adverse Event|0
2812640|NCT03642262|9598766|P2|Period 1|Withdrawal by Subject|1
2812641|NCT03642262|9598767|P1|Period 1|Withdrawal by Subject|1
2812642|NCT03641508|9598788|P2|First Injection|Lost to Follow-up|0
2812643|NCT03641508|9598789|P1|First Injection|Lost to Follow-up|2
2812644|NCT03640559|9598816|P2|Overall Study|Withdrawal by Subject|0
2812645|NCT03640559|9598817|P1|Overall Study|Withdrawal by Subject|1
2812646|NCT03640559|9598816|P2|Overall Study|Physician Decision|1
2812647|NCT03640559|9598817|P1|Overall Study|Physician Decision|1
2812648|NCT03640052|9598823|P5|Overall Study|Lost to Follow-up|0
2812649|NCT03640052|9598824|P4|Overall Study|Lost to Follow-up|0
2812650|NCT03640052|9598825|P3|Overall Study|Lost to Follow-up|0
2812651|NCT03640052|9598826|P2|Overall Study|Lost to Follow-up|1
2812652|NCT03640052|9598827|P1|Overall Study|Lost to Follow-up|0
2812653|NCT03639675|9598844|P1|Overall Study|Withdrawal by Subject|1
2812654|NCT03638635|9598866|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
2812655|NCT03638635|9598867|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
2812656|NCT03638635|9598866|P2|Initial Hospitalization|Withdrawal by study personnel|1
2812657|NCT03638635|9598867|P1|Initial Hospitalization|Withdrawal by study personnel|0
2812658|NCT03638635|9598866|P2|Initial Hospitalization|Study terminated prematurely|1
2812659|NCT03638635|9598867|P1|Initial Hospitalization|Study terminated prematurely|0
2812660|NCT03634579|9598960|P1|Overall Study|study termination|9
2812661|NCT03633825|9599058|P2|Follow up|Lost to Follow-up|450
2812662|NCT03633825|9599059|P1|Follow up|Lost to Follow-up|478
2812663|NCT03633825|9599058|P2|Enrollment|Post not classified as crisis|13757
2812664|NCT03633825|9599059|P1|Enrollment|Post not classified as crisis|13967
2812665|NCT03633825|9599058|P2|Enrollment|Did not post on network|5080
2812666|NCT03633825|9599059|P1|Enrollment|Did not post on network|5066
2812667|NCT03630016|9599192|P1|Overall Study|Poor Sensor Placement|1
2812668|NCT03629184|9599198|P2|Overall Study|Physician Decision|0
2812669|NCT03629184|9599199|P1|Overall Study|Physician Decision|1
2812670|NCT03629184|9599198|P2|Overall Study|Withdrawal by Subject|1
2812671|NCT03629184|9599199|P1|Overall Study|Withdrawal by Subject|2
2812672|NCT03629054|9599249|P2|Period 2 (4 Days)|Not treated|1
2812673|NCT03629054|9599250|P1|Period 2 (4 Days)|Not treated|0
2812674|NCT03629041|9599274|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2812675|NCT03629041|9599275|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2812676|NCT03629041|9599276|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
2812677|NCT03629041|9599277|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2812678|NCT03629028|9599305|P2|Overall Study|intolerance to examination|0
2812679|NCT03629028|9599306|P1|Overall Study|intolerance to examination|2
2812680|NCT03629028|9599305|P2|Overall Study|Pregnancy|2
2812681|NCT03629028|9599306|P1|Overall Study|Pregnancy|4
2812682|NCT03629028|9599305|P2|Overall Study|Lost to Follow-up|23
2812683|NCT03629028|9599306|P1|Overall Study|Lost to Follow-up|26
2812684|NCT03628599|9599337|P2|Overall Study|Adverse Event|1
2812685|NCT03628599|9599338|P1|Overall Study|Adverse Event|0
2812686|NCT03628417|9599368|P2|Overall Study|Death|1
2812687|NCT03628417|9599369|P1|Overall Study|Death|1
2812688|NCT03627195|9599385|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
2812689|NCT03627195|9599386|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
2812690|NCT03627195|9599387|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
2812691|NCT03627195|9599388|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
2812692|NCT03627195|9599389|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
2812693|NCT03627195|9599390|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
2812694|NCT03620708|9599493|P3|Overall Study|Withdrawal by Subject|1
2812695|NCT03620708|9599494|P2|Overall Study|Withdrawal by Subject|0
2812696|NCT03620708|9599495|P1|Overall Study|Withdrawal by Subject|0
2812697|NCT03620708|9599493|P3|Overall Study|Lost to Follow-up|2
2812698|NCT03620708|9599494|P2|Overall Study|Lost to Follow-up|1
2812699|NCT03620708|9599495|P1|Overall Study|Lost to Follow-up|1
2812700|NCT03618628|9599576|P1|Overall Study|Lost to Follow-up|1
2812701|NCT03618628|9599576|P1|Overall Study|Death|1
2812702|NCT03616977|9599634|P2|Period 3|Adverse Event|1
2812703|NCT03616977|9599635|P1|Period 3|Adverse Event|1
2812704|NCT03616977|9599634|P2|Period 1|Physician Decision|1
2812705|NCT03616977|9599635|P1|Period 1|Physician Decision|0
2812706|NCT03616600|9599645|P2|Overall Study|Withdrawal by Subject|0
2812707|NCT03616600|9599646|P1|Overall Study|Withdrawal by Subject|1
2812708|NCT03614975|9599729|P2|Overall Study|Specimens not in lab batch shipment|1
2812709|NCT03614975|9599730|P1|Overall Study|Specimens not in lab batch shipment|1
2812710|NCT03614975|9599729|P2|Overall Study|Withdrawal by Subject|2
2812711|NCT03614975|9599730|P1|Overall Study|Withdrawal by Subject|2
2812712|NCT03614975|9599729|P2|Overall Study|Physician Decision|5
2812713|NCT03614975|9599730|P1|Overall Study|Physician Decision|7
2812714|NCT03614078|9599743|P3|Overall Study|Dizziness and Rash|0
2812715|NCT03614078|9599744|P2|Overall Study|Dizziness and Rash|1
2812716|NCT03614078|9599745|P1|Overall Study|Dizziness and Rash|0
2812717|NCT03614078|9599743|P3|Overall Study|Adverse Event|0
2996697|NCT00966875|10312494|P1|Part B|Death|0
2812718|NCT03614078|9599744|P2|Overall Study|Adverse Event|2
2812719|NCT03614078|9599745|P1|Overall Study|Adverse Event|0
2812720|NCT03614078|9599743|P3|Overall Study|Exacerbation of Psoriasis|0
2812721|NCT03614078|9599744|P2|Overall Study|Exacerbation of Psoriasis|1
2812722|NCT03614078|9599745|P1|Overall Study|Exacerbation of Psoriasis|0
2812723|NCT03614078|9599743|P3|Overall Study|Patient Did Not Meet Eligibility|0
2812724|NCT03614078|9599744|P2|Overall Study|Patient Did Not Meet Eligibility|0
2812725|NCT03614078|9599745|P1|Overall Study|Patient Did Not Meet Eligibility|1
2812726|NCT03614078|9599743|P3|Overall Study|High Neutrophils|2
2812727|NCT03614078|9599744|P2|Overall Study|High Neutrophils|0
2812728|NCT03614078|9599745|P1|Overall Study|High Neutrophils|0
2812729|NCT03614078|9599743|P3|Overall Study|Participant Did Not Return for Visit|0
2812730|NCT03614078|9599744|P2|Overall Study|Participant Did Not Return for Visit|1
2812731|NCT03614078|9599745|P1|Overall Study|Participant Did Not Return for Visit|0
2812732|NCT03614078|9599743|P3|Overall Study|Withdrawal by Subject|3
2812733|NCT03614078|9599744|P2|Overall Study|Withdrawal by Subject|2
2812734|NCT03614078|9599745|P1|Overall Study|Withdrawal by Subject|2
2812735|NCT03613649|9599774|P12|Fourth Treatment|Physician Decision|0
2812736|NCT03613649|9599775|P11|Fourth Treatment|Physician Decision|0
2812737|NCT03613649|9599776|P10|Fourth Treatment|Physician Decision|0
2812738|NCT03613649|9599777|P9|Fourth Treatment|Physician Decision|0
2812739|NCT03613649|9599778|P8|Fourth Treatment|Physician Decision|0
2812740|NCT03613649|9599779|P7|Fourth Treatment|Physician Decision|1
2812741|NCT03613649|9599780|P6|Fourth Treatment|Physician Decision|0
2812742|NCT03613649|9599781|P5|Fourth Treatment|Physician Decision|0
2812743|NCT03613649|9599782|P4|Fourth Treatment|Physician Decision|0
2812744|NCT03613649|9599783|P3|Fourth Treatment|Physician Decision|0
2812745|NCT03613649|9599784|P2|Fourth Treatment|Physician Decision|0
2812746|NCT03613649|9599785|P1|Fourth Treatment|Physician Decision|0
2812747|NCT03613649|9599774|P12|Fourth Treatment|Protocol Violation|0
2812748|NCT03613649|9599775|P11|Fourth Treatment|Protocol Violation|0
2812749|NCT03613649|9599776|P10|Fourth Treatment|Protocol Violation|0
2812750|NCT03613649|9599777|P9|Fourth Treatment|Protocol Violation|0
2812751|NCT03613649|9599778|P8|Fourth Treatment|Protocol Violation|0
2812752|NCT03613649|9599779|P7|Fourth Treatment|Protocol Violation|0
2812753|NCT03613649|9599780|P6|Fourth Treatment|Protocol Violation|0
2812754|NCT03613649|9599781|P5|Fourth Treatment|Protocol Violation|1
2812755|NCT03613649|9599782|P4|Fourth Treatment|Protocol Violation|0
2812756|NCT03613649|9599783|P3|Fourth Treatment|Protocol Violation|0
2812757|NCT03613649|9599784|P2|Fourth Treatment|Protocol Violation|0
2812758|NCT03613649|9599785|P1|Fourth Treatment|Protocol Violation|1
2812759|NCT03613649|9599774|P12|Third Treatment|Protocol Violation|1
2812760|NCT03613649|9599775|P11|Third Treatment|Protocol Violation|0
2812761|NCT03613649|9599776|P10|Third Treatment|Protocol Violation|0
2812762|NCT03613649|9599777|P9|Third Treatment|Protocol Violation|0
2812763|NCT03613649|9599778|P8|Third Treatment|Protocol Violation|0
2812764|NCT03613649|9599779|P7|Third Treatment|Protocol Violation|1
2812765|NCT03613649|9599780|P6|Third Treatment|Protocol Violation|0
2812766|NCT03613649|9599781|P5|Third Treatment|Protocol Violation|0
2812767|NCT03613649|9599782|P4|Third Treatment|Protocol Violation|0
2812768|NCT03613649|9599783|P3|Third Treatment|Protocol Violation|0
2812769|NCT03613649|9599784|P2|Third Treatment|Protocol Violation|0
2812770|NCT03613649|9599785|P1|Third Treatment|Protocol Violation|0
2812771|NCT03613649|9599774|P12|Third Treatment|Lost to Follow-up|1
2812772|NCT03613649|9599775|P11|Third Treatment|Lost to Follow-up|0
2812773|NCT03613649|9599776|P10|Third Treatment|Lost to Follow-up|0
2812774|NCT03613649|9599777|P9|Third Treatment|Lost to Follow-up|0
2812775|NCT03613649|9599778|P8|Third Treatment|Lost to Follow-up|0
2812776|NCT03613649|9599779|P7|Third Treatment|Lost to Follow-up|0
2812777|NCT03613649|9599780|P6|Third Treatment|Lost to Follow-up|0
2812778|NCT03613649|9599781|P5|Third Treatment|Lost to Follow-up|1
2812779|NCT03613649|9599782|P4|Third Treatment|Lost to Follow-up|0
2812780|NCT03613649|9599783|P3|Third Treatment|Lost to Follow-up|0
2812781|NCT03613649|9599784|P2|Third Treatment|Lost to Follow-up|0
2812782|NCT03613649|9599785|P1|Third Treatment|Lost to Follow-up|0
2812783|NCT03613649|9599774|P12|Second Treatment|Withdrawal by Subject|0
2812784|NCT03613649|9599775|P11|Second Treatment|Withdrawal by Subject|0
2812785|NCT03613649|9599776|P10|Second Treatment|Withdrawal by Subject|0
2812786|NCT03613649|9599777|P9|Second Treatment|Withdrawal by Subject|0
2812787|NCT03613649|9599778|P8|Second Treatment|Withdrawal by Subject|0
2812788|NCT03613649|9599779|P7|Second Treatment|Withdrawal by Subject|0
2812789|NCT03613649|9599780|P6|Second Treatment|Withdrawal by Subject|0
2812790|NCT03613649|9599781|P5|Second Treatment|Withdrawal by Subject|1
2812791|NCT03613649|9599782|P4|Second Treatment|Withdrawal by Subject|0
2812792|NCT03613649|9599783|P3|Second Treatment|Withdrawal by Subject|0
2812793|NCT03613649|9599784|P2|Second Treatment|Withdrawal by Subject|0
2812794|NCT03613649|9599785|P1|Second Treatment|Withdrawal by Subject|0
2812795|NCT03613649|9599774|P12|Second Treatment|Lost to Follow-up|0
2812796|NCT03613649|9599775|P11|Second Treatment|Lost to Follow-up|0
2812797|NCT03613649|9599776|P10|Second Treatment|Lost to Follow-up|0
2812798|NCT03613649|9599777|P9|Second Treatment|Lost to Follow-up|0
2812799|NCT03613649|9599778|P8|Second Treatment|Lost to Follow-up|0
2812800|NCT03613649|9599779|P7|Second Treatment|Lost to Follow-up|0
2812801|NCT03613649|9599780|P6|Second Treatment|Lost to Follow-up|0
2812802|NCT03613649|9599781|P5|Second Treatment|Lost to Follow-up|0
2812803|NCT03613649|9599782|P4|Second Treatment|Lost to Follow-up|0
2812804|NCT03613649|9599783|P3|Second Treatment|Lost to Follow-up|1
2812805|NCT03613649|9599784|P2|Second Treatment|Lost to Follow-up|0
2812806|NCT03613649|9599785|P1|Second Treatment|Lost to Follow-up|0
2812807|NCT03613129|9599930|P5|Pre-treatment Assessment|Withdrawal by Subject|0
2812808|NCT03613129|9599931|P4|Pre-treatment Assessment|Withdrawal by Subject|0
2812809|NCT03613129|9599932|P3|Pre-treatment Assessment|Withdrawal by Subject|0
2812810|NCT03613129|9599933|P2|Pre-treatment Assessment|Withdrawal by Subject|0
2812811|NCT03613129|9599934|P1|Pre-treatment Assessment|Withdrawal by Subject|1
2812812|NCT03613129|9599930|P5|Pre-treatment Assessment|Protocol Violation|0
2812813|NCT03613129|9599931|P4|Pre-treatment Assessment|Protocol Violation|0
2812814|NCT03613129|9599932|P3|Pre-treatment Assessment|Protocol Violation|0
2812815|NCT03613129|9599933|P2|Pre-treatment Assessment|Protocol Violation|0
2812816|NCT03613129|9599934|P1|Pre-treatment Assessment|Protocol Violation|2
2812817|NCT03610269|9600004|P1|Overall Study|Screen fail|4
2812818|NCT03610269|9600004|P1|Overall Study|Unable to draw blood|1
2812819|NCT03610269|9600004|P1|Overall Study|Protocol Violation|1
2812820|NCT03610269|9600004|P1|Overall Study|Physician Decision|10
2812821|NCT03609619|9600010|P2|Overall Study|Lost to Follow-up|1
2812822|NCT03609619|9600011|P1|Overall Study|Lost to Follow-up|1
2812823|NCT03609619|9600010|P2|Overall Study|Withdrawal by Subject|3
2812824|NCT03609619|9600011|P1|Overall Study|Withdrawal by Subject|2
2812825|NCT03609619|9600010|P2|Overall Study|Protocol Violation|0
2812826|NCT03609619|9600011|P1|Overall Study|Protocol Violation|5
2812827|NCT03609619|9600010|P2|Overall Study|Lack of Efficacy|2
2812828|NCT03609619|9600011|P1|Overall Study|Lack of Efficacy|1
2812829|NCT03609619|9600010|P2|Overall Study|Adverse Event|0
2812830|NCT03609619|9600011|P1|Overall Study|Adverse Event|1
2812831|NCT03605303|9600092|P2|Period 1|Study Terminated|1
2812832|NCT03605303|9600093|P1|Period 1|Study Terminated|2
2812833|NCT03604341|9600103|P2|Overall Study|Protocol Violation|1
2812834|NCT03604341|9600104|P1|Overall Study|Protocol Violation|0
2812835|NCT03604341|9600103|P2|Overall Study|Adverse Event|0
2812836|NCT03604341|9600104|P1|Overall Study|Adverse Event|1
2812837|NCT03604341|9600103|P2|Overall Study|Withdrawal by Subject|1
2812838|NCT03604341|9600104|P1|Overall Study|Withdrawal by Subject|1
2812839|NCT03603028|9600188|P1|Overall Study|Withdrawal by Subject|1
2812840|NCT03601715|9600196|P3|Second Intervention|Lost to Follow-up|0
2812841|NCT03601715|9600197|P2|Second Intervention|Lost to Follow-up|1
2812842|NCT03601715|9600198|P1|Second Intervention|Lost to Follow-up|1
2812843|NCT03599349|9600212|P1|Overall Study|Lost to Follow-up|1
2812844|NCT03591406|9600285|P2|Overall Study|Withdrawal by Subject|5
2812845|NCT03591406|9600286|P1|Overall Study|Withdrawal by Subject|0
2812846|NCT03591406|9600285|P2|Overall Study|Protocol Violation|1
2812847|NCT03591406|9600286|P1|Overall Study|Protocol Violation|2
2812848|NCT03591406|9600285|P2|Overall Study|Adverse Event|3
2812849|NCT03591406|9600286|P1|Overall Study|Adverse Event|5
2812850|NCT03590743|9600316|P2|Overall Study|Withdrawal by Subject|1
2812851|NCT03590743|9600317|P1|Overall Study|Withdrawal by Subject|0
2812852|NCT03590613|9600329|P4|Period 2, 4 Days|Physician Decision|1
2812853|NCT03590613|9600330|P3|Period 2, 4 Days|Physician Decision|0
2812854|NCT03590613|9600331|P2|Period 2, 4 Days|Physician Decision|0
2812855|NCT03590613|9600332|P1|Period 2, 4 Days|Physician Decision|0
2812856|NCT03588572|9600452|P2|Visitation 3|Withdrawal by Subject|0
2812857|NCT03588572|9600453|P1|Visitation 3|Withdrawal by Subject|1
2812858|NCT03588572|9600452|P2|Visitation 3|Physician Decision|1
2812859|NCT03588572|9600453|P1|Visitation 3|Physician Decision|1
2812860|NCT03588572|9600452|P2|Visitation 3|Lost to Follow-up|1
2812861|NCT03588572|9600453|P1|Visitation 3|Lost to Follow-up|1
2812862|NCT03588572|9600452|P2|Visitation 2|Withdrawal by Subject|0
2812863|NCT03588572|9600453|P1|Visitation 2|Withdrawal by Subject|1
2812864|NCT03588572|9600452|P2|Visitation 2|Lack of Efficacy|1
2812865|NCT03588572|9600453|P1|Visitation 2|Lack of Efficacy|0
2812866|NCT03588572|9600452|P2|Visitation 2|Lost to Follow-up|1
2812867|NCT03588572|9600453|P1|Visitation 2|Lost to Follow-up|1
2812868|NCT03588572|9600452|P2|Visitation 1|Lack of Efficacy|1
2812869|NCT03588572|9600453|P1|Visitation 1|Lack of Efficacy|1
2812870|NCT03586830|9600575|P4|Overall Study|Withdrawal by Subject|1
2812871|NCT03586830|9600576|P3|Overall Study|Withdrawal by Subject|3
2812872|NCT03586830|9600577|P2|Overall Study|Withdrawal by Subject|0
2812873|NCT03586830|9600578|P1|Overall Study|Withdrawal by Subject|1
2812874|NCT03586830|9600575|P4|Overall Study|Lost to Follow-up|1
2812875|NCT03586830|9600576|P3|Overall Study|Lost to Follow-up|2
2812876|NCT03586830|9600577|P2|Overall Study|Lost to Follow-up|2
2812877|NCT03586830|9600578|P1|Overall Study|Lost to Follow-up|0
2812878|NCT03586830|9600575|P4|Overall Study|Site terminated by Sponsor|3
2812879|NCT03586830|9600576|P3|Overall Study|Site terminated by Sponsor|3
2812880|NCT03586830|9600577|P2|Overall Study|Site terminated by Sponsor|4
2812881|NCT03586830|9600578|P1|Overall Study|Site terminated by Sponsor|1
2812882|NCT03586726|9600600|P1|Overall Study|Withdrawal by Subject|1
2812883|NCT03586648|9600617|P2|Period 2|Adverse Event|0
2812884|NCT03586648|9600618|P1|Period 2|Adverse Event|1
2812885|NCT03586648|9600617|P2|Period 1|Physician Decision|1
2812886|NCT03586648|9600618|P1|Period 1|Physician Decision|0
2812887|NCT03586648|9600617|P2|Period 1|Study related symptoms or complaints|1
2812888|NCT03586648|9600618|P1|Period 1|Study related symptoms or complaints|2
2812889|NCT03586648|9600617|P2|Period 1|Adverse Event|0
2812890|NCT03586648|9600618|P1|Period 1|Adverse Event|1
2812891|NCT03586648|9600617|P2|Period 1|Lost to Follow-up|1
2812892|NCT03586648|9600618|P1|Period 1|Lost to Follow-up|1
2812893|NCT03586648|9600617|P2|Period 1|Withdrawal by Subject|1
2812894|NCT03586648|9600618|P1|Period 1|Withdrawal by Subject|0
2812895|NCT03585959|9600631|P1|Overall Study|Unsuccessful Procedure|2
2812896|NCT03585959|9600631|P1|Overall Study|Physician Decision|1
2812897|NCT03585504|9600672|P2|Overall Study|Lost to Follow-up|29
2812898|NCT03585504|9600673|P1|Overall Study|Lost to Follow-up|26
2812899|NCT03585296|9600683|P1|Overall Study|Withdrawal by Subject|2
2812900|NCT03585296|9600683|P1|Overall Study|Lost to Follow-up|2
2812901|NCT03585296|9600683|P1|Overall Study|Adverse Event|1
2812902|NCT03583385|9600687|P2|Treatment Period 2|Adverse Event|0
2812903|NCT03583385|9600688|P1|Treatment Period 2|Adverse Event|1
2812904|NCT03583385|9600687|P2|Treatment Period 1|Withdrawal by Subject|1
2812905|NCT03583385|9600688|P1|Treatment Period 1|Withdrawal by Subject|1
2812906|NCT03582943|9600706|P2|Analyzed|Protocol Violation|1
2812907|NCT03582943|9600707|P1|Analyzed|Protocol Violation|4
2812908|NCT03582943|9600706|P2|Intervention and Follow up|Withdrawal by Subject|2
2812909|NCT03582943|9600707|P1|Intervention and Follow up|Withdrawal by Subject|4
2812910|NCT03582943|9600706|P2|Allocated to Groups|Withdrawal by Subject|1
2812911|NCT03582943|9600707|P1|Allocated to Groups|Withdrawal by Subject|1
2812912|NCT03582813|9600715|P2|Overall Study|Withdrawal by Subject|0
2812913|NCT03582813|9600716|P1|Overall Study|Withdrawal by Subject|1
2812914|NCT03582813|9600715|P2|Overall Study|Lost to Follow-up|21
2812915|NCT03582813|9600716|P1|Overall Study|Lost to Follow-up|18
2812916|NCT03582215|9600783|P8|Overall Study|Adverse Event|2
2812917|NCT03582215|9600784|P7|Overall Study|Adverse Event|2
2812918|NCT03582215|9600785|P6|Overall Study|Adverse Event|0
2812919|NCT03582215|9600786|P5|Overall Study|Adverse Event|0
2812920|NCT03582215|9600787|P4|Overall Study|Adverse Event|0
2812921|NCT03582215|9600788|P3|Overall Study|Adverse Event|0
2812922|NCT03582215|9600789|P2|Overall Study|Adverse Event|0
2812923|NCT03582215|9600790|P1|Overall Study|Adverse Event|1
2812924|NCT03581825|9600831|P2|Period 2|Unsatisfactory Vision to Test|1
2812925|NCT03581825|9600832|P1|Period 2|Unsatisfactory Vision to Test|0
2812926|NCT03581825|9600831|P2|Period 1|Lens Discomfort|0
2812927|NCT03581825|9600832|P1|Period 1|Lens Discomfort|1
2812928|NCT03580382|9600868|P2|Overall Study|Early Termination of Study|3
2812929|NCT03580382|9600869|P1|Overall Study|Early Termination of Study|0
2812930|NCT03579940|9600887|P11|Period 2|Withdrawal by Subject|0
2812931|NCT03579940|9600888|P10|Period 2|Withdrawal by Subject|0
2812932|NCT03579940|9600889|P9|Period 2|Withdrawal by Subject|0
2812933|NCT03579940|9600890|P8|Period 2|Withdrawal by Subject|0
2812934|NCT03579940|9600891|P7|Period 2|Withdrawal by Subject|0
2812935|NCT03579940|9600892|P6|Period 2|Withdrawal by Subject|0
2812936|NCT03579940|9600893|P5|Period 2|Withdrawal by Subject|0
2812937|NCT03579940|9600894|P4|Period 2|Withdrawal by Subject|0
2812938|NCT03579940|9600895|P3|Period 2|Withdrawal by Subject|1
2812939|NCT03579940|9600896|P2|Period 2|Withdrawal by Subject|0
2812940|NCT03579940|9600897|P1|Period 2|Withdrawal by Subject|0
2812941|NCT03579719|9600937|P1|Overall Study|Protocol deviation, pre-existent disease|1
2812942|NCT03578146|9600989|P6|Overall Study|Lost to Follow-up|1
2812943|NCT03578146|9600990|P5|Overall Study|Lost to Follow-up|0
2812944|NCT03578146|9600991|P4|Overall Study|Lost to Follow-up|0
2812945|NCT03578146|9600992|P3|Overall Study|Lost to Follow-up|1
2812946|NCT03578146|9600993|P2|Overall Study|Lost to Follow-up|1
2812947|NCT03578146|9600994|P1|Overall Study|Lost to Follow-up|0
2812948|NCT03578146|9600989|P6|Overall Study|Did Not Receive Treatment|2
2812949|NCT03578146|9600990|P5|Overall Study|Did Not Receive Treatment|0
2812950|NCT03578146|9600991|P4|Overall Study|Did Not Receive Treatment|0
2812951|NCT03578146|9600992|P3|Overall Study|Did Not Receive Treatment|0
2812952|NCT03578146|9600993|P2|Overall Study|Did Not Receive Treatment|0
2812953|NCT03578146|9600994|P1|Overall Study|Did Not Receive Treatment|1
2812954|NCT03575871|9601126|P3|Overall Study|Other than specified|0
2812955|NCT03575871|9601127|P2|Overall Study|Other than specified|2
2812956|NCT03575871|9601128|P1|Overall Study|Other than specified|2
2812957|NCT03575871|9601126|P3|Overall Study|Withdrawal by Subject|9
2812958|NCT03575871|9601127|P2|Overall Study|Withdrawal by Subject|1
2812959|NCT03575871|9601128|P1|Overall Study|Withdrawal by Subject|6
2812960|NCT03575871|9601126|P3|Overall Study|Protocol Deviation|1
2812961|NCT03575871|9601127|P2|Overall Study|Protocol Deviation|1
2812962|NCT03575871|9601128|P1|Overall Study|Protocol Deviation|1
2812963|NCT03575871|9601126|P3|Overall Study|Lost to Follow-up|1
2812964|NCT03575871|9601127|P2|Overall Study|Lost to Follow-up|1
2812965|NCT03575871|9601128|P1|Overall Study|Lost to Follow-up|1
2812966|NCT03575871|9601126|P3|Overall Study|Lack of Efficacy|7
2812967|NCT03575871|9601127|P2|Overall Study|Lack of Efficacy|4
2812968|NCT03575871|9601128|P1|Overall Study|Lack of Efficacy|5
2812969|NCT03575871|9601126|P3|Overall Study|Death|0
2812970|NCT03575871|9601127|P2|Overall Study|Death|0
2812971|NCT03575871|9601128|P1|Overall Study|Death|1
2812972|NCT03575871|9601126|P3|Overall Study|Adverse Event|8
2812973|NCT03575871|9601127|P2|Overall Study|Adverse Event|5
2812974|NCT03575871|9601128|P1|Overall Study|Adverse Event|5
2812975|NCT03575806|9601192|P2|Overall Study|Protocol Violation|2
2812976|NCT03575806|9601193|P1|Overall Study|Protocol Violation|0
2812977|NCT03575806|9601192|P2|Overall Study|Withdrawal by Subject|2
2812978|NCT03575806|9601193|P1|Overall Study|Withdrawal by Subject|0
2812979|NCT03575702|9601203|P2|Overall Study|Patient non compliance|0
2812980|NCT03575702|9601204|P1|Overall Study|Patient non compliance|4
2812981|NCT03575702|9601203|P2|Overall Study|Protocol Violation|1
2812982|NCT03575702|9601204|P1|Overall Study|Protocol Violation|0
2812983|NCT03575702|9601203|P2|Overall Study|Lost to Follow-up|2
2812984|NCT03575702|9601204|P1|Overall Study|Lost to Follow-up|1
2812985|NCT03575702|9601203|P2|Overall Study|Withdrawal by Subject|1
2812986|NCT03575702|9601204|P1|Overall Study|Withdrawal by Subject|1
2812987|NCT03573817|9601260|P2|Overall Study|Withdrawal by Subject|1
2812988|NCT03573817|9601261|P1|Overall Study|Withdrawal by Subject|1
2812989|NCT03573817|9601260|P2|Overall Study|Protocol Violation|1
2812990|NCT03573817|9601261|P1|Overall Study|Protocol Violation|0
2812991|NCT03573817|9601260|P2|Overall Study|Adverse Event|2
2812992|NCT03573817|9601261|P1|Overall Study|Adverse Event|0
2812993|NCT03569371|9601553|P1|Overall Study|Adverse Event|1
2812994|NCT03569371|9601553|P1|Overall Study|Lost to Follow-up|1
2812995|NCT03569371|9601553|P1|Overall Study|Lack of Efficacy|1
2812996|NCT03569202|9601574|P2|Part 3|Other|1
2812997|NCT03569202|9601575|P1|Part 3|Other|1
2812998|NCT03569202|9601574|P2|Part 3|Physician Decision|0
2812999|NCT03569202|9601575|P1|Part 3|Physician Decision|1
2813000|NCT03568942|9601624|P1|Overall Study|Lost to Follow-up|1
2813001|NCT03568942|9601624|P1|Overall Study|Family emergency|1
2813002|NCT03566979|9601672|P4|Overall Study|Adverse Event|0
2813003|NCT03566979|9601673|P3|Overall Study|Adverse Event|0
2813004|NCT03566979|9601674|P2|Overall Study|Adverse Event|0
2813005|NCT03566979|9601675|P1|Overall Study|Adverse Event|1
2813006|NCT03566979|9601672|P4|Overall Study|Lost to Follow-up|5
2813007|NCT03566979|9601673|P3|Overall Study|Lost to Follow-up|9
2813008|NCT03566979|9601674|P2|Overall Study|Lost to Follow-up|7
2813009|NCT03566979|9601675|P1|Overall Study|Lost to Follow-up|2
2813010|NCT03566979|9601672|P4|Overall Study|Withdrawal by Subject|1
2813011|NCT03566979|9601673|P3|Overall Study|Withdrawal by Subject|1
2813012|NCT03566979|9601674|P2|Overall Study|Withdrawal by Subject|0
2813013|NCT03566979|9601675|P1|Overall Study|Withdrawal by Subject|2
2813014|NCT03566810|9601691|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2813015|NCT03566810|9601692|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2813016|NCT03566810|9601693|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
2813017|NCT03566810|9601694|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2813018|NCT03566680|9601756|P1|Overall Study|Withdrawal by Subject|3
2813019|NCT03566680|9601756|P1|Overall Study|Lost to Follow-up|13
2813020|NCT03566680|9601756|P1|Overall Study|Pregnancy|1
2813021|NCT03562117|9602068|P3|Part 1, Up to 3 Days|Adverse Event|0
2813022|NCT03562117|9602069|P2|Part 1, Up to 3 Days|Adverse Event|0
2813023|NCT03562117|9602070|P1|Part 1, Up to 3 Days|Adverse Event|1
2813024|NCT03559062|9602218|P3|Overall Study|Other|0
2813025|NCT03559062|9602219|P2|Overall Study|Other|1
2813026|NCT03559062|9602220|P1|Overall Study|Other|0
2813027|NCT03558997|9602235|P4|Overall Study|Lost to Follow-up|0
2813028|NCT03558997|9602236|P3|Overall Study|Lost to Follow-up|1
2813029|NCT03558997|9602237|P2|Overall Study|Lost to Follow-up|0
2813030|NCT03558997|9602238|P1|Overall Study|Lost to Follow-up|0
2813031|NCT03558997|9602235|P4|Overall Study|Withdrawal by Subject|1
2813032|NCT03558997|9602236|P3|Overall Study|Withdrawal by Subject|1
2813033|NCT03558997|9602237|P2|Overall Study|Withdrawal by Subject|0
2813034|NCT03558997|9602238|P1|Overall Study|Withdrawal by Subject|1
2813035|NCT03558997|9602235|P4|Overall Study|Physician Decision|0
2813036|NCT03558997|9602236|P3|Overall Study|Physician Decision|1
2813037|NCT03558997|9602237|P2|Overall Study|Physician Decision|0
2813038|NCT03558997|9602238|P1|Overall Study|Physician Decision|0
2813039|NCT03558997|9602235|P4|Overall Study|Adverse Event|1
2813040|NCT03558997|9602236|P3|Overall Study|Adverse Event|5
2813041|NCT03558997|9602237|P2|Overall Study|Adverse Event|2
2813042|NCT03558997|9602238|P1|Overall Study|Adverse Event|0
2813043|NCT03558555|9602272|P2|Overall Study|Lost to Follow-up|1
2813044|NCT03558555|9602273|P1|Overall Study|Lost to Follow-up|2
2813045|NCT03557801|9602301|P3|Overall Study|Lost to Follow-up|0
2813046|NCT03557801|9602302|P2|Overall Study|Lost to Follow-up|1
2813047|NCT03557801|9602303|P1|Overall Study|Lost to Follow-up|0
2813048|NCT03557801|9602301|P3|Overall Study|Withdrawal by Subject|3
2813049|NCT03557801|9602302|P2|Overall Study|Withdrawal by Subject|0
2813050|NCT03557801|9602303|P1|Overall Study|Withdrawal by Subject|1
2813051|NCT03557801|9602301|P3|Overall Study|Protocol Violation|0
2813052|NCT03557801|9602302|P2|Overall Study|Protocol Violation|0
2813053|NCT03557801|9602303|P1|Overall Study|Protocol Violation|1
2813054|NCT03555890|9602369|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2813055|NCT03555890|9602370|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813056|NCT03555890|9602371|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813057|NCT03555890|9602372|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813058|NCT03554005|9602531|P6|Overall Study|Other|1
2813059|NCT03554005|9602532|P5|Overall Study|Other|0
2813060|NCT03554005|9602533|P4|Overall Study|Other|0
2813061|NCT03554005|9602534|P3|Overall Study|Other|0
2813062|NCT03554005|9602535|P2|Overall Study|Other|0
2813063|NCT03554005|9602536|P1|Overall Study|Other|0
2813064|NCT03554005|9602531|P6|Overall Study|Physician Decision|0
2813065|NCT03554005|9602532|P5|Overall Study|Physician Decision|1
2813066|NCT03554005|9602533|P4|Overall Study|Physician Decision|0
2813067|NCT03554005|9602534|P3|Overall Study|Physician Decision|0
2813068|NCT03554005|9602535|P2|Overall Study|Physician Decision|0
2813069|NCT03554005|9602536|P1|Overall Study|Physician Decision|0
2813070|NCT03554005|9602531|P6|Overall Study|Adverse Event|3
2813071|NCT03554005|9602532|P5|Overall Study|Adverse Event|0
2813072|NCT03554005|9602533|P4|Overall Study|Adverse Event|0
2813073|NCT03554005|9602534|P3|Overall Study|Adverse Event|0
2813074|NCT03554005|9602535|P2|Overall Study|Adverse Event|0
2813075|NCT03554005|9602536|P1|Overall Study|Adverse Event|0
2813076|NCT03554005|9602531|P6|Overall Study|Disease Progression|6
2813077|NCT03554005|9602532|P5|Overall Study|Disease Progression|5
2813078|NCT03554005|9602533|P4|Overall Study|Disease Progression|1
2813079|NCT03554005|9602534|P3|Overall Study|Disease Progression|1
2813080|NCT03554005|9602535|P2|Overall Study|Disease Progression|1
2813081|NCT03554005|9602536|P1|Overall Study|Disease Progression|1
2813082|NCT03554005|9602531|P6|Overall Study|Not in participant's best interest|1
2813083|NCT03554005|9602532|P5|Overall Study|Not in participant's best interest|0
2813084|NCT03554005|9602533|P4|Overall Study|Not in participant's best interest|0
2813085|NCT03554005|9602534|P3|Overall Study|Not in participant's best interest|0
2813086|NCT03554005|9602535|P2|Overall Study|Not in participant's best interest|0
2813087|NCT03554005|9602536|P1|Overall Study|Not in participant's best interest|0
2813088|NCT03552549|9602564|P2|Overall Study|Administrative|14
2813089|NCT03552549|9602565|P1|Overall Study|Administrative|0
2813090|NCT03552549|9602564|P2|Overall Study|Did not meet eligibility criteria|0
2813091|NCT03552549|9602565|P1|Overall Study|Did not meet eligibility criteria|1
2813092|NCT03552549|9602564|P2|Overall Study|Did not complete study treatment|3
2813093|NCT03552549|9602565|P1|Overall Study|Did not complete study treatment|2
2813094|NCT03552549|9602564|P2|Overall Study|Not in participant's best interest|1
2813095|NCT03552549|9602565|P1|Overall Study|Not in participant's best interest|2
2813096|NCT03552549|9602564|P2|Overall Study|Unknown (no reason provided)|2
2813097|NCT03552549|9602565|P1|Overall Study|Unknown (no reason provided)|4
2813098|NCT03552549|9602564|P2|Overall Study|Withdrawal by Subject|7
2813099|NCT03552549|9602565|P1|Overall Study|Withdrawal by Subject|7
2813100|NCT03552549|9602564|P2|Overall Study|Adverse event in first 12 months|8
2813101|NCT03552549|9602565|P1|Overall Study|Adverse event in first 12 months|12
2813102|NCT03552549|9602564|P2|Overall Study|Disease progression|17
2813103|NCT03552549|9602565|P1|Overall Study|Disease progression|25
2813104|NCT03552523|9602603|P2|Overall Study|Withdrawal by Subject|1
2813105|NCT03552523|9602604|P1|Overall Study|Withdrawal by Subject|1
2813106|NCT03551743|9602621|P4|Overall Study|Withdrawal by Subject|0
2813107|NCT03551743|9602622|P3|Overall Study|Withdrawal by Subject|0
2813108|NCT03551743|9602623|P2|Overall Study|Withdrawal by Subject|0
2813109|NCT03551743|9602624|P1|Overall Study|Withdrawal by Subject|1
2813110|NCT03551743|9602621|P4|Overall Study|Adverse Event|0
2813111|NCT03551743|9602622|P3|Overall Study|Adverse Event|0
2813112|NCT03551743|9602623|P2|Overall Study|Adverse Event|0
2813113|NCT03551743|9602624|P1|Overall Study|Adverse Event|1
2813114|NCT03551730|9602670|P4|Overall Study|Adverse Event|0
2813115|NCT03551730|9602671|P3|Overall Study|Adverse Event|0
2813116|NCT03551730|9602672|P2|Overall Study|Adverse Event|0
2813117|NCT03551730|9602673|P1|Overall Study|Adverse Event|1
2813118|NCT03550378|9602795|P2|Overall Study|Death|1
2813119|NCT03550378|9602796|P1|Overall Study|Death|0
2813120|NCT03549429|9602849|P2|Overall Study|Protocol Violation|3
2813121|NCT03549429|9602850|P1|Overall Study|Protocol Violation|5
2813122|NCT03549338|9602863|P3|Overall Study|Clinical Progression|0
2813123|NCT03549338|9602864|P2|Overall Study|Clinical Progression|1
2813124|NCT03549338|9602865|P1|Overall Study|Clinical Progression|0
2813125|NCT03549338|9602863|P3|Overall Study|Progressive Disease|0
2813126|NCT03549338|9602864|P2|Overall Study|Progressive Disease|0
2813127|NCT03549338|9602865|P1|Overall Study|Progressive Disease|1
2813128|NCT03549130|9602873|P2|Overall Study|Lost to Follow-up|1
2813129|NCT03549130|9602874|P1|Overall Study|Lost to Follow-up|0
2813130|NCT03549130|9602873|P2|Overall Study|Adverse Event|1
2813131|NCT03549130|9602874|P1|Overall Study|Adverse Event|0
2813132|NCT03549117|9602892|P2|Overall Study|Withdrawal by Subject|0
2813133|NCT03549117|9602893|P1|Overall Study|Withdrawal by Subject|1
2813134|NCT03547531|9602921|P2|Overall Study|having family occasion|2
2813135|NCT03547531|9602922|P1|Overall Study|having family occasion|0
2813136|NCT03547531|9602921|P2|Overall Study|not coming in data collection : sick|2
2813137|NCT03547531|9602922|P1|Overall Study|not coming in data collection : sick|2
2813138|NCT03547154|9602936|P2|Overall Study|Continued treatment beyond 12 mo.|50
2813139|NCT03547154|9602937|P1|Overall Study|Continued treatment beyond 12 mo.|58
2813140|NCT03547154|9602936|P2|Overall Study|Not Selected|1
2813141|NCT03547154|9602937|P1|Overall Study|Not Selected|0
2813142|NCT03547154|9602936|P2|Overall Study|Withdrawal by Subject|6
2813143|NCT03547154|9602937|P1|Overall Study|Withdrawal by Subject|10
2813144|NCT03547154|9602936|P2|Overall Study|Insufficient Therapeutic Response|10
2813145|NCT03547154|9602937|P1|Overall Study|Insufficient Therapeutic Response|13
2813146|NCT03547154|9602936|P2|Overall Study|Physician Decision|3
2813147|NCT03547154|9602937|P1|Overall Study|Physician Decision|4
2813148|NCT03547154|9602936|P2|Overall Study|Protocol Violation|1
2813149|NCT03547154|9602937|P1|Overall Study|Protocol Violation|6
2813150|NCT03547154|9602936|P2|Overall Study|Adverse Event|31
2813151|NCT03547154|9602937|P1|Overall Study|Adverse Event|26
2813152|NCT03547154|9602936|P2|Overall Study|Disease Progression/Recurrence|14
2813153|NCT03547154|9602937|P1|Overall Study|Disease Progression/Recurrence|6
2813154|NCT03546842|9602949|P1|Overall Study|Withdrawal by Subject|2
2813155|NCT03546842|9602949|P1|Overall Study|Protocol Violation|1
2813156|NCT03546621|9602962|P4|Overall Study|Progressive disease|1
2813157|NCT03546621|9602963|P3|Overall Study|Progressive disease|0
2813158|NCT03546621|9602964|P2|Overall Study|Progressive disease|0
2813159|NCT03546621|9602965|P1|Overall Study|Progressive disease|0
2813160|NCT03546621|9602962|P4|Overall Study|Adverse Event|1
2813161|NCT03546621|9602963|P3|Overall Study|Adverse Event|0
2813162|NCT03546621|9602964|P2|Overall Study|Adverse Event|1
2813163|NCT03546621|9602965|P1|Overall Study|Adverse Event|0
2813164|NCT03546621|9602962|P4|Overall Study|Lost to Follow-up|0
2813165|NCT03546621|9602963|P3|Overall Study|Lost to Follow-up|0
2813166|NCT03546621|9602964|P2|Overall Study|Lost to Follow-up|1
2813167|NCT03546621|9602965|P1|Overall Study|Lost to Follow-up|0
2813168|NCT03546621|9602962|P4|Overall Study|Withdrawal by Subject|1
2813169|NCT03546621|9602963|P3|Overall Study|Withdrawal by Subject|2
2813170|NCT03546621|9602964|P2|Overall Study|Withdrawal by Subject|1
2813171|NCT03546621|9602965|P1|Overall Study|Withdrawal by Subject|0
2813172|NCT03545984|9603055|P2|Overall Study|CSF cases not present during rotation|9
2813173|NCT03545984|9603056|P1|Overall Study|CSF cases not present during rotation|11
2813174|NCT03543137|9603141|P2|Study Period 2: Up to Day 8|Adverse Event|1
2813175|NCT03543137|9603142|P1|Study Period 2: Up to Day 8|Adverse Event|0
2813176|NCT03543137|9603141|P2|Study Period 2: Up to Day 8|Protocol Violation|0
2813177|NCT03543137|9603142|P1|Study Period 2: Up to Day 8|Protocol Violation|1
2813178|NCT03543137|9603141|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2813179|NCT03543137|9603142|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2813180|NCT03541044|9603162|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2813181|NCT03541044|9603163|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2813182|NCT03541044|9603162|P2|Study Period 2: Up to Day 8|Protocol Violation|0
2813183|NCT03541044|9603163|P1|Study Period 2: Up to Day 8|Protocol Violation|1
2813184|NCT03535974|9603325|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
2813185|NCT03535974|9603326|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
2813186|NCT03535974|9603327|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
2813187|NCT03535974|9603325|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
2813188|NCT03535974|9603326|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
2813189|NCT03535974|9603327|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
2813190|NCT03535844|9603337|P2|Overall Study|Withdrawal by Subject|1
2813191|NCT03535844|9603338|P1|Overall Study|Withdrawal by Subject|0
2813192|NCT03531905|9603595|P3|Overall Study|Could not speak with the participant|0
2813193|NCT03531905|9603596|P2|Overall Study|Could not speak with the participant|0
2813194|NCT03531905|9603597|P1|Overall Study|Could not speak with the participant|1
2813195|NCT03531905|9603595|P3|Overall Study|Participant was out of town|0
2813196|NCT03531905|9603596|P2|Overall Study|Participant was out of town|0
2813197|NCT03531905|9603597|P1|Overall Study|Participant was out of town|1
2813198|NCT03531905|9603595|P3|Overall Study|Lost to Follow-up|1
2813199|NCT03531905|9603596|P2|Overall Study|Lost to Follow-up|2
2813200|NCT03531905|9603597|P1|Overall Study|Lost to Follow-up|2
2813201|NCT03531905|9603595|P3|Overall Study|Withdrawal by Subject|2
2813202|NCT03531905|9603596|P2|Overall Study|Withdrawal by Subject|3
2813203|NCT03531905|9603597|P1|Overall Study|Withdrawal by Subject|3
2813204|NCT03528369|9603674|P3|Overall Study|Adverse Event|0
2813205|NCT03528369|9603675|P2|Overall Study|Adverse Event|1
2813206|NCT03528369|9603676|P1|Overall Study|Adverse Event|0
2813207|NCT03528369|9603674|P3|Overall Study|Lost to Follow-up|0
2813208|NCT03528369|9603675|P2|Overall Study|Lost to Follow-up|0
2813209|NCT03528369|9603676|P1|Overall Study|Lost to Follow-up|1
2813210|NCT03528369|9603674|P3|Overall Study|Withdrawal by Subject|0
2813211|NCT03528369|9603675|P2|Overall Study|Withdrawal by Subject|0
2813212|NCT03528369|9603676|P1|Overall Study|Withdrawal by Subject|2
2813213|NCT03528174|9603705|P1|Overall Study|sensors dislodged|1
2813214|NCT03528174|9603705|P1|Overall Study|Adverse Event|1
2813215|NCT03527966|9603725|P2|Overall Study|Lost to Follow-up|0
2813216|NCT03527966|9603726|P1|Overall Study|Lost to Follow-up|3
2813217|NCT03527173|9603740|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
2813218|NCT03527173|9603741|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
2813219|NCT03527173|9603740|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
2813220|NCT03527173|9603741|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
2813221|NCT03527173|9603740|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
2813222|NCT03527173|9603741|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
2813223|NCT03527173|9603740|P2|Overall Study|Lost to Follow-up|2
2813224|NCT03527173|9603741|P1|Overall Study|Lost to Follow-up|4
2813225|NCT03525678|9603801|P3|Overall Study|Death|4
2813226|NCT03525678|9603802|P2|Overall Study|Death|31
2813227|NCT03525678|9603803|P1|Overall Study|Death|32
2813228|NCT03525678|9603801|P3|Overall Study|Lost to Follow-up|0
2813229|NCT03525678|9603802|P2|Overall Study|Lost to Follow-up|0
2813230|NCT03525678|9603803|P1|Overall Study|Lost to Follow-up|1
2813231|NCT03525678|9603801|P3|Overall Study|Physician Decision|0
2813232|NCT03525678|9603802|P2|Overall Study|Physician Decision|2
2813233|NCT03525678|9603803|P1|Overall Study|Physician Decision|1
2813234|NCT03525678|9603801|P3|Overall Study|Withdrawal by Subject|0
2813235|NCT03525678|9603802|P2|Overall Study|Withdrawal by Subject|1
2813236|NCT03525678|9603803|P1|Overall Study|Withdrawal by Subject|3
2813237|NCT03525678|9603801|P3|Overall Study|Ongoing at the time of interim analysis|21
2813238|NCT03525678|9603802|P2|Overall Study|Ongoing at the time of interim analysis|65
2813239|NCT03525678|9603803|P1|Overall Study|Ongoing at the time of interim analysis|60
2813240|NCT03525444|9604005|P2|Overall Study|Other|1
2813241|NCT03525444|9604006|P1|Overall Study|Other|0
2813242|NCT03525444|9604005|P2|Overall Study|Withdrawal of consent (not due to AE)|1
2813243|NCT03525444|9604006|P1|Overall Study|Withdrawal of consent (not due to AE)|0
2813244|NCT03525444|9604005|P2|Overall Study|Adverse Event|1
2813245|NCT03525444|9604006|P1|Overall Study|Adverse Event|0
2813246|NCT03524157|9604038|P3|Overall Study|cytology not readable|1
2813247|NCT03524157|9604039|P2|Overall Study|cytology not readable|0
2813248|NCT03524157|9604040|P1|Overall Study|cytology not readable|0
2813249|NCT03522675|9604094|P1|Overall Study|Non-reactive to histamine|1
2813250|NCT03522675|9604094|P1|Overall Study|Screen fail|1
2813251|NCT03522506|9604112|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
2813252|NCT03522506|9604113|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2813253|NCT03522506|9604114|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2813254|NCT03522506|9604115|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2813255|NCT03522506|9604112|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2813256|NCT03522506|9604113|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2813257|NCT03522506|9604114|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2813258|NCT03522506|9604115|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2813259|NCT03521791|9604177|P2|Overall Study|Protocol Violation|17
2813260|NCT03521791|9604178|P1|Overall Study|Protocol Violation|7
2813261|NCT03520959|9604225|P2|Overall Study|Study terminated by Sponsor|1
2813262|NCT03520959|9604226|P1|Overall Study|Study terminated by Sponsor|0
2813263|NCT03519932|9604273|P2|First Intervention|Adverse Event|3
2813264|NCT03519932|9604274|P1|First Intervention|Adverse Event|1
2813265|NCT03519919|9604300|P1|Overall Study|Screen Failure|1
2813266|NCT03519919|9604300|P1|Overall Study|Lack of Efficacy|1
2813267|NCT03519919|9604300|P1|Overall Study|Withdrawal by Subject|1
2813268|NCT03519867|9604352|P10|Overall Study|Reason not provided|0
2813269|NCT03519867|9604353|P9|Overall Study|Reason not provided|1
2813270|NCT03519867|9604354|P8|Overall Study|Reason not provided|1
2813271|NCT03519867|9604355|P7|Overall Study|Reason not provided|0
2813272|NCT03519867|9604356|P6|Overall Study|Reason not provided|1
2813273|NCT03519867|9604357|P5|Overall Study|Reason not provided|0
2813274|NCT03519867|9604358|P4|Overall Study|Reason not provided|1
2813275|NCT03519867|9604359|P3|Overall Study|Reason not provided|1
2813276|NCT03519867|9604360|P2|Overall Study|Reason not provided|1
2813277|NCT03519867|9604361|P1|Overall Study|Reason not provided|1
2813278|NCT03519867|9604352|P10|Overall Study|Admin. of other reversal agent|0
2813279|NCT03519867|9604353|P9|Overall Study|Admin. of other reversal agent|0
2813280|NCT03519867|9604354|P8|Overall Study|Admin. of other reversal agent|0
2813281|NCT03519867|9604355|P7|Overall Study|Admin. of other reversal agent|0
2813282|NCT03519867|9604356|P6|Overall Study|Admin. of other reversal agent|1
2813283|NCT03519867|9604357|P5|Overall Study|Admin. of other reversal agent|0
2813284|NCT03519867|9604358|P4|Overall Study|Admin. of other reversal agent|0
2813285|NCT03519867|9604359|P3|Overall Study|Admin. of other reversal agent|0
2813286|NCT03519867|9604360|P2|Overall Study|Admin. of other reversal agent|1
2813287|NCT03519867|9604361|P1|Overall Study|Admin. of other reversal agent|1
2813288|NCT03519867|9604352|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
2813289|NCT03519867|9604353|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
2813290|NCT03519867|9604354|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
2813291|NCT03519867|9604355|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
2813292|NCT03519867|9604356|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
2813293|NCT03519867|9604357|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
2813294|NCT03519867|9604358|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
2813295|NCT03519867|9604359|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
2813296|NCT03519867|9604360|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
2813297|NCT03519867|9604361|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
2813298|NCT03519867|9604352|P10|Overall Study|Protocol Violation|0
2813299|NCT03519867|9604353|P9|Overall Study|Protocol Violation|0
2813300|NCT03519867|9604354|P8|Overall Study|Protocol Violation|0
2813301|NCT03519867|9604355|P7|Overall Study|Protocol Violation|0
2813302|NCT03519867|9604356|P6|Overall Study|Protocol Violation|1
2813303|NCT03519867|9604357|P5|Overall Study|Protocol Violation|0
2813304|NCT03519867|9604358|P4|Overall Study|Protocol Violation|0
2813305|NCT03519867|9604359|P3|Overall Study|Protocol Violation|0
2813306|NCT03519867|9604360|P2|Overall Study|Protocol Violation|0
2813307|NCT03519867|9604361|P1|Overall Study|Protocol Violation|0
2813308|NCT03519867|9604352|P10|Overall Study|Adverse Event|0
2813309|NCT03519867|9604353|P9|Overall Study|Adverse Event|0
2813310|NCT03519867|9604354|P8|Overall Study|Adverse Event|0
2813311|NCT03519867|9604355|P7|Overall Study|Adverse Event|0
2813312|NCT03519867|9604356|P6|Overall Study|Adverse Event|0
2813313|NCT03519867|9604357|P5|Overall Study|Adverse Event|0
2813314|NCT03519867|9604358|P4|Overall Study|Adverse Event|0
2813315|NCT03519867|9604359|P3|Overall Study|Adverse Event|0
2813316|NCT03519867|9604360|P2|Overall Study|Adverse Event|1
2813317|NCT03519867|9604361|P1|Overall Study|Adverse Event|1
2813318|NCT03519854|9604411|P18|Overall Study|Technical Error|0
2813319|NCT03519854|9604412|P17|Overall Study|Technical Error|0
2813320|NCT03519854|9604413|P16|Overall Study|Technical Error|0
2813321|NCT03519854|9604414|P15|Overall Study|Technical Error|0
2813322|NCT03519854|9604415|P14|Overall Study|Technical Error|0
2813323|NCT03519854|9604416|P13|Overall Study|Technical Error|0
2813324|NCT03519854|9604417|P12|Overall Study|Technical Error|0
2813325|NCT03519854|9604418|P11|Overall Study|Technical Error|0
2813326|NCT03519854|9604419|P10|Overall Study|Technical Error|0
2813327|NCT03519854|9604420|P9|Overall Study|Technical Error|0
2813328|NCT03519854|9604421|P8|Overall Study|Technical Error|0
2813329|NCT03519854|9604422|P7|Overall Study|Technical Error|0
2813330|NCT03519854|9604423|P6|Overall Study|Technical Error|0
2813331|NCT03519854|9604424|P5|Overall Study|Technical Error|0
2813332|NCT03519854|9604425|P4|Overall Study|Technical Error|0
2813333|NCT03519854|9604426|P3|Overall Study|Technical Error|1
2813334|NCT03519854|9604427|P2|Overall Study|Technical Error|0
2813335|NCT03519854|9604428|P1|Overall Study|Technical Error|0
2813336|NCT03519516|9604594|P2|Overall Study|Adverse Event|1
2813337|NCT03519516|9604595|P1|Overall Study|Adverse Event|0
2813338|NCT03519204|9604669|P2|Overall Study|Other Miscellaneous Reasons|0
2813339|NCT03519204|9604670|P1|Overall Study|Other Miscellaneous Reasons|1
2813340|NCT03519204|9604669|P2|Overall Study|Withdrawal by Subject|7
2813341|NCT03519204|9604670|P1|Overall Study|Withdrawal by Subject|9
2813342|NCT03519204|9604669|P2|Overall Study|Lost to Follow-up|8
2813343|NCT03519204|9604670|P1|Overall Study|Lost to Follow-up|3
2813344|NCT03519087|9604689|P5|Laboratory Testing|Protocol Violation|0
2813345|NCT03519087|9604690|P4|Laboratory Testing|Protocol Violation|1
2813346|NCT03519087|9604691|P3|Laboratory Testing|Protocol Violation|0
2813347|NCT03519087|9604692|P2|Laboratory Testing|Protocol Violation|0
2813348|NCT03519087|9604693|P1|Laboratory Testing|Protocol Violation|0
2813349|NCT03519087|9604689|P5|Laboratory Testing|Lost to Follow-up|6
2813350|NCT03519087|9604690|P4|Laboratory Testing|Lost to Follow-up|3
2813351|NCT03519087|9604691|P3|Laboratory Testing|Lost to Follow-up|2
2813352|NCT03519087|9604692|P2|Laboratory Testing|Lost to Follow-up|0
2813353|NCT03519087|9604693|P1|Laboratory Testing|Lost to Follow-up|0
2813354|NCT03519087|9604689|P5|Re-randomization for Treatment|Not appropriate|0
2813355|NCT03519087|9604690|P4|Re-randomization for Treatment|Not appropriate|0
2813356|NCT03519087|9604691|P3|Re-randomization for Treatment|Not appropriate|0
2813357|NCT03519087|9604692|P2|Re-randomization for Treatment|Not appropriate|3
2813358|NCT03519087|9604693|P1|Re-randomization for Treatment|Not appropriate|2
2813359|NCT03519087|9604689|P5|Re-randomization for Treatment|Withdrawal by Subject|0
2813360|NCT03519087|9604690|P4|Re-randomization for Treatment|Withdrawal by Subject|0
2813361|NCT03519087|9604691|P3|Re-randomization for Treatment|Withdrawal by Subject|0
2813362|NCT03519087|9604692|P2|Re-randomization for Treatment|Withdrawal by Subject|29
2813363|NCT03519087|9604693|P1|Re-randomization for Treatment|Withdrawal by Subject|25
2813364|NCT03519087|9604689|P5|Clinic Evaluation|Protocol Violation|0
2813365|NCT03519087|9604690|P4|Clinic Evaluation|Protocol Violation|0
2813366|NCT03519087|9604691|P3|Clinic Evaluation|Protocol Violation|0
2813367|NCT03519087|9604692|P2|Clinic Evaluation|Protocol Violation|0
2813368|NCT03519087|9604693|P1|Clinic Evaluation|Protocol Violation|1
2813369|NCT03519087|9604689|P5|Clinic Evaluation|Physician Decision|0
2813370|NCT03519087|9604690|P4|Clinic Evaluation|Physician Decision|0
2813371|NCT03519087|9604691|P3|Clinic Evaluation|Physician Decision|0
2813372|NCT03519087|9604692|P2|Clinic Evaluation|Physician Decision|18
2813373|NCT03519087|9604693|P1|Clinic Evaluation|Physician Decision|15
2813374|NCT03518008|9604729|P2|Period 2, Second Week of Wear|Family emergency|1
2813375|NCT03518008|9604730|P1|Period 2, Second Week of Wear|Family emergency|0
2813376|NCT03513588|9604813|P3|Overall Study|Death|1
2813377|NCT03513588|9604814|P2|Overall Study|Death|0
2813378|NCT03513588|9604815|P1|Overall Study|Death|0
2813379|NCT03513588|9604813|P3|Overall Study|Study dosing paused by sponsor|0
2813380|NCT03513588|9604814|P2|Overall Study|Study dosing paused by sponsor|1
2813381|NCT03513588|9604815|P1|Overall Study|Study dosing paused by sponsor|1
2813382|NCT03513588|9604813|P3|Overall Study|Lost to Follow-up|1
2813383|NCT03513588|9604814|P2|Overall Study|Lost to Follow-up|1
2813384|NCT03513588|9604815|P1|Overall Study|Lost to Follow-up|0
2813385|NCT03512028|9604890|P2|Overall Study|Protocol Violation|0
2813386|NCT03512028|9604891|P1|Overall Study|Protocol Violation|2
2813387|NCT03512028|9604890|P2|Overall Study|Withdrawal by Subject|0
2813388|NCT03512028|9604891|P1|Overall Study|Withdrawal by Subject|2
2813389|NCT03511105|9604899|P2|Overall Study|Withdrew consent|0
2813390|NCT03511105|9604900|P1|Overall Study|Withdrew consent|1
2813391|NCT03511105|9604899|P2|Overall Study|Adverse Event|0
2813392|NCT03511105|9604900|P1|Overall Study|Adverse Event|1
2813393|NCT03510273|9604954|P1|Overall Study|Moved away from study area|4
2813394|NCT03510273|9604954|P1|Overall Study|Care outside study, ineligible to cont.|3
2813395|NCT03510273|9604954|P1|Overall Study|Withdrawal by Subject|2
2813396|NCT03509948|9604959|P2|Overall Study|Protocol Violation|1
2813397|NCT03509948|9604960|P1|Overall Study|Protocol Violation|0
2813398|NCT03509675|9605028|P2|Second Intervention )7 Days)|Lost Rinse B|0
2813399|NCT03509675|9605029|P1|Second Intervention )7 Days)|Lost Rinse B|1
2813400|NCT03509675|9605028|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
2813401|NCT03509675|9605029|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
2813402|NCT03509675|9605028|P2|First Intervention (7 Days)|Lack of Efficacy|1
2813403|NCT03509675|9605029|P1|First Intervention (7 Days)|Lack of Efficacy|2
2813404|NCT03509675|9605028|P2|First Intervention (7 Days)|Lost to Follow-up|3
2813405|NCT03509675|9605029|P1|First Intervention (7 Days)|Lost to Follow-up|3
2813406|NCT03508843|9605035|P1|Overall Study|technical difficulties|2
2813407|NCT03508843|9605035|P1|Overall Study|Withdrawal by Subject|1
2813408|NCT03508050|9605057|P2|Overall Study|Sustained desaturation|1
2813409|NCT03508050|9605058|P1|Overall Study|Sustained desaturation|0
2813410|NCT03508050|9605057|P2|Overall Study|Negative biopsy, surgery cancelled|1
2813411|NCT03508050|9605058|P1|Overall Study|Negative biopsy, surgery cancelled|3
2813412|NCT03508050|9605057|P2|Overall Study|Mucus plug|0
2813413|NCT03508050|9605058|P1|Overall Study|Mucus plug|1
2813414|NCT03508050|9605057|P2|Overall Study|Pleural adhesions|0
2813415|NCT03508050|9605058|P1|Overall Study|Pleural adhesions|1
2813416|NCT03506425|9605116|P3|Overall Study|Withdrawal by Subject|1
2813417|NCT03506425|9605117|P2|Overall Study|Withdrawal by Subject|0
2813418|NCT03506425|9605118|P1|Overall Study|Withdrawal by Subject|0
2813419|NCT03506425|9605116|P3|Overall Study|Death|0
2813420|NCT03506425|9605117|P2|Overall Study|Death|0
2813421|NCT03506425|9605118|P1|Overall Study|Death|1
2813422|NCT03506425|9605116|P3|Overall Study|Adverse Event|0
2813423|NCT03506425|9605117|P2|Overall Study|Adverse Event|3
2813424|NCT03506425|9605118|P1|Overall Study|Adverse Event|1
2813425|NCT03504189|9605158|P1|Overall Study|Device Failure|2
2813426|NCT03504189|9605158|P1|Overall Study|Screening Failure|1
2813427|NCT03504189|9605158|P1|Overall Study|Withdrawal by Subject|1
2813428|NCT03503188|9605173|P2|Overall Study|Non eligible in the sub study|1
2813429|NCT03503188|9605174|P1|Overall Study|Non eligible in the sub study|0
2813430|NCT03501277|9605211|P4|Intervention Period 3 (4 Days)|Adverse Event|1
2813431|NCT03501277|9605212|P3|Intervention Period 3 (4 Days)|Adverse Event|0
2813432|NCT03501277|9605213|P2|Intervention Period 3 (4 Days)|Adverse Event|0
2813433|NCT03501277|9605214|P1|Intervention Period 3 (4 Days)|Adverse Event|0
2813434|NCT03501277|9605211|P4|Intervention Period 2 (4 Days)|Adverse Event|1
2813435|NCT03501277|9605212|P3|Intervention Period 2 (4 Days)|Adverse Event|0
2813436|NCT03501277|9605213|P2|Intervention Period 2 (4 Days)|Adverse Event|0
2813437|NCT03501277|9605214|P1|Intervention Period 2 (4 Days)|Adverse Event|0
2813438|NCT03501277|9605211|P4|Intervention Period 1 (4 Days)|Adverse Event|1
2813439|NCT03501277|9605212|P3|Intervention Period 1 (4 Days)|Adverse Event|0
2813440|NCT03501277|9605213|P2|Intervention Period 1 (4 Days)|Adverse Event|0
2813441|NCT03501277|9605214|P1|Intervention Period 1 (4 Days)|Adverse Event|0
2813442|NCT03501277|9605211|P4|Intervention Period 1 (4 Days)|Other|0
2813443|NCT03501277|9605212|P3|Intervention Period 1 (4 Days)|Other|1
2813444|NCT03501277|9605213|P2|Intervention Period 1 (4 Days)|Other|0
2813445|NCT03501277|9605214|P1|Intervention Period 1 (4 Days)|Other|0
2813446|NCT03500679|9605254|P2|Overall Study|Withdrawal by Subject|0
2813447|NCT03500679|9605255|P1|Overall Study|Withdrawal by Subject|3
2813448|NCT03500679|9605254|P2|Overall Study|Lost to Follow-up|3
2813449|NCT03500679|9605255|P1|Overall Study|Lost to Follow-up|6
2813450|NCT03500224|9605322|P1|Overall Study|Withdrawal by Subject|2
2813451|NCT03500211|9605361|P2|Overall Study|Withdrawal by Subject|1
2813452|NCT03500211|9605362|P1|Overall Study|Withdrawal by Subject|1
2813453|NCT03500159|9605378|P2|Overall Study|Study Terminated|1
2813454|NCT03500159|9605379|P1|Overall Study|Study Terminated|2
2813455|NCT03497130|9605397|P2|Overall Study|Lost to Follow-up|1
2813456|NCT03497130|9605398|P1|Overall Study|Lost to Follow-up|1
2813457|NCT03497039|9605410|P2|Overall Study|Protocol Violation|1
2813458|NCT03497039|9605411|P1|Overall Study|Protocol Violation|0
2813459|NCT03497039|9605410|P2|Overall Study|Withdrawal by Subject|0
2813460|NCT03497039|9605411|P1|Overall Study|Withdrawal by Subject|1
2813461|NCT03494985|9605549|P4|Overall Study|Other (Not specified)|0
2813462|NCT03494985|9605550|P3|Overall Study|Other (Not specified)|1
2813463|NCT03494985|9605551|P2|Overall Study|Other (Not specified)|1
2813464|NCT03494985|9605552|P1|Overall Study|Other (Not specified)|0
2813465|NCT03494985|9605549|P4|Overall Study|Other (Withdrawal of consent)|5
2813466|NCT03494985|9605550|P3|Overall Study|Other (Withdrawal of consent)|2
2813467|NCT03494985|9605551|P2|Overall Study|Other (Withdrawal of consent)|3
2813468|NCT03494985|9605552|P1|Overall Study|Other (Withdrawal of consent)|2
2813469|NCT03494985|9605549|P4|Overall Study|Adverse Event|0
2813470|NCT03494985|9605550|P3|Overall Study|Adverse Event|3
2813471|NCT03494985|9605551|P2|Overall Study|Adverse Event|2
2813472|NCT03494985|9605552|P1|Overall Study|Adverse Event|3
2813473|NCT03493542|9605616|P2|Overall Study|Withdrawal by Subject|6
2813474|NCT03493542|9605617|P1|Overall Study|Withdrawal by Subject|2
2813475|NCT03493542|9605616|P2|Overall Study|Withdrawal by parent or guardian|0
2813476|NCT03493542|9605617|P1|Overall Study|Withdrawal by parent or guardian|3
2813477|NCT03493542|9605616|P2|Overall Study|Ongoing|3
2813478|NCT03493542|9605617|P1|Overall Study|Ongoing|2
2813479|NCT03493386|9605641|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813480|NCT03493386|9605642|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813481|NCT03493386|9605643|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2813482|NCT03493386|9605644|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2813483|NCT03492554|9605764|P2|Overall Study|Protocol Violation|14
2813484|NCT03492554|9605765|P1|Overall Study|Protocol Violation|0
2813485|NCT03491553|9605792|P6|Overall Study|Withdrew Consent|0
2813486|NCT03491553|9605793|P5|Overall Study|Withdrew Consent|0
2813487|NCT03491553|9605794|P4|Overall Study|Withdrew Consent|0
2813488|NCT03491553|9605795|P3|Overall Study|Withdrew Consent|0
2813489|NCT03491553|9605796|P2|Overall Study|Withdrew Consent|1
2813490|NCT03491553|9605797|P1|Overall Study|Withdrew Consent|1
2813491|NCT03491553|9605792|P6|Overall Study|Adverse Event|0
2813492|NCT03491553|9605793|P5|Overall Study|Adverse Event|0
2813493|NCT03491553|9605794|P4|Overall Study|Adverse Event|1
2813494|NCT03491553|9605795|P3|Overall Study|Adverse Event|0
2813495|NCT03491553|9605796|P2|Overall Study|Adverse Event|0
2813496|NCT03491553|9605797|P1|Overall Study|Adverse Event|0
2813497|NCT03489720|9605940|P2|Overall Study|Withdrawal by Subject|0
2813498|NCT03489720|9605941|P1|Overall Study|Withdrawal by Subject|2
2813499|NCT03489551|9605966|P1|Overall Study|Withdrawal by Subject|2
2813500|NCT03489304|9605970|P1|Overall Study|Lost to Follow-up|4
2813501|NCT03488108|9605978|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
2813502|NCT03488108|9605979|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
2813503|NCT03488108|9605978|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
2813504|NCT03488108|9605979|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
2813505|NCT03486392|9606006|P5|Overall Study|Death|1
2813506|NCT03486392|9606007|P4|Overall Study|Death|0
2813507|NCT03486392|9606008|P3|Overall Study|Death|0
2813508|NCT03486392|9606009|P2|Overall Study|Death|0
2813509|NCT03486392|9606010|P1|Overall Study|Death|0
2813510|NCT03486392|9606006|P5|Overall Study|Withdrawal by Subject|1
2813511|NCT03486392|9606007|P4|Overall Study|Withdrawal by Subject|4
2813512|NCT03486392|9606008|P3|Overall Study|Withdrawal by Subject|6
2813513|NCT03486392|9606009|P2|Overall Study|Withdrawal by Subject|0
2813514|NCT03486392|9606010|P1|Overall Study|Withdrawal by Subject|3
2813515|NCT03486392|9606006|P5|Overall Study|Lost to Follow-up|2
2813516|NCT03486392|9606007|P4|Overall Study|Lost to Follow-up|5
2813517|NCT03486392|9606008|P3|Overall Study|Lost to Follow-up|8
2813518|NCT03486392|9606009|P2|Overall Study|Lost to Follow-up|0
2813519|NCT03486392|9606010|P1|Overall Study|Lost to Follow-up|0
2813520|NCT03483623|9606053|P1|Overall Study|43 complete sets achieved|1
2813521|NCT03482453|9606123|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813522|NCT03482453|9606124|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
2813523|NCT03482453|9606125|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813524|NCT03482453|9606126|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813525|NCT03482453|9606127|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813526|NCT03482453|9606128|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813527|NCT03482453|9606129|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813528|NCT03482453|9606130|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813529|NCT03482453|9606131|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813530|NCT03482453|9606132|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813531|NCT03482453|9606133|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813532|NCT03482453|9606134|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2813533|NCT03481309|9606257|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
2813534|NCT03481309|9606258|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
2813535|NCT03481309|9606259|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
2813536|NCT03481309|9606260|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
2813537|NCT03481309|9606261|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
2813538|NCT03481309|9606262|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
2813539|NCT03480841|9606304|P1|Overall Study|Lost to Follow-up|2
2813540|NCT03480425|9606313|P1|Overall Study|Force transducer technical failure|1
2813541|NCT03480152|9606319|P3|Phase I|Signed consent. Died before treatment.|0
2813542|NCT03480152|9606320|P2|Phase I|Signed consent. Died before treatment.|0
2813543|NCT03480152|9606321|P1|Phase I|Signed consent. Died before treatment.|1
2813544|NCT03479216|9606360|P2|Overall Study|Physician Decision|3
2813545|NCT03479216|9606361|P1|Overall Study|Physician Decision|2
2813546|NCT03479216|9606360|P2|Overall Study|Withdrawal by Subject|2
2813547|NCT03479216|9606361|P1|Overall Study|Withdrawal by Subject|3
2813548|NCT03478891|9606382|P3|Overall Study|Lost to Follow-up|1
2813549|NCT03478891|9606383|P2|Overall Study|Lost to Follow-up|0
2813550|NCT03478891|9606384|P1|Overall Study|Lost to Follow-up|1
2813551|NCT03478891|9606382|P3|Overall Study|Moved from area|1
2813552|NCT03478891|9606383|P2|Overall Study|Moved from area|0
2813553|NCT03478891|9606384|P1|Overall Study|Moved from area|0
2813554|NCT03478891|9606382|P3|Overall Study|Enrolled, but product never administered|1
2813555|NCT03478891|9606383|P2|Overall Study|Enrolled, but product never administered|0
2813556|NCT03478891|9606384|P1|Overall Study|Enrolled, but product never administered|0
2813557|NCT03478696|9606435|P2|Overall Study|Withdrawal by Subject|4
2813558|NCT03478696|9606436|P1|Overall Study|Withdrawal by Subject|9
2813559|NCT03478696|9606435|P2|Overall Study|Physician Decision|3
2813560|NCT03478696|9606436|P1|Overall Study|Physician Decision|6
2813561|NCT03478696|9606435|P2|Overall Study|Lost to Follow-up|0
2813562|NCT03478696|9606436|P1|Overall Study|Lost to Follow-up|1
2813563|NCT03478696|9606435|P2|Overall Study|Adverse Event|5
2813564|NCT03478696|9606436|P1|Overall Study|Adverse Event|1
2813565|NCT03478683|9606450|P2|Overall Study|Withdrawal by Subject|7
2813566|NCT03478683|9606451|P1|Overall Study|Withdrawal by Subject|7
2813567|NCT03478683|9606450|P2|Overall Study|Physician Decision|3
2813568|NCT03478683|9606451|P1|Overall Study|Physician Decision|1
2813569|NCT03478683|9606450|P2|Overall Study|Lost to Follow-up|5
2813570|NCT03478683|9606451|P1|Overall Study|Lost to Follow-up|0
2813571|NCT03478683|9606450|P2|Overall Study|Adverse Event|3
2813572|NCT03478683|9606451|P1|Overall Study|Adverse Event|5
2813573|NCT03478657|9606465|P2|Overall Study|Withdrawal by Subject|1
2813574|NCT03478657|9606466|P1|Overall Study|Withdrawal by Subject|0
2813575|NCT03478644|9606481|P2|Phase 2|Lost to Follow-up|0
2813576|NCT03478644|9606482|P1|Phase 2|Lost to Follow-up|1
2813577|NCT03478644|9606481|P2|Phase 2|Withdrawal by Subject|1
2813578|NCT03478644|9606482|P1|Phase 2|Withdrawal by Subject|2
2813579|NCT03478371|9606494|P1|Overall Study|Lost to Follow-up|4
2813580|NCT03478371|9606494|P1|Overall Study|non-compliance|1
2813581|NCT03477903|9606516|P1|Overall Study|Study Terminated by Sponsor|1
2813582|NCT03475875|9606573|P2|Period 2|Protocol Violation|1
2813583|NCT03475875|9606574|P1|Period 2|Protocol Violation|0
2813584|NCT03475875|9606573|P2|Period 2|Adverse Event|0
2813585|NCT03475875|9606574|P1|Period 2|Adverse Event|3
2813586|NCT03475875|9606573|P2|Period 1|Adverse Event|1
2813587|NCT03475875|9606574|P1|Period 1|Adverse Event|2
2813588|NCT03475875|9606573|P2|Period 1|Lost to Follow-up|0
2813589|NCT03475875|9606574|P1|Period 1|Lost to Follow-up|1
2813590|NCT03474081|9606612|P2|Overall Study|Investigator site closed|0
2813591|NCT03474081|9606613|P1|Overall Study|Investigator site closed|1
2813592|NCT03474081|9606612|P2|Overall Study|Withdrawal by Subject|7
2813593|NCT03474081|9606613|P1|Overall Study|Withdrawal by Subject|5
2813594|NCT03474081|9606612|P2|Overall Study|Physician Decision|2
2813595|NCT03474081|9606613|P1|Overall Study|Physician Decision|3
2813596|NCT03474081|9606612|P2|Overall Study|Lost to Follow-up|1
2813597|NCT03474081|9606613|P1|Overall Study|Lost to Follow-up|2
2813598|NCT03474081|9606612|P2|Overall Study|Adverse Event|3
2813599|NCT03474081|9606613|P1|Overall Study|Adverse Event|6
2813600|NCT03473808|9606654|P1|Overall Study|Withdrawal by Subject|1
2813601|NCT03473236|9606671|P10|Overall Study|Withdrawal by Subject|0
2813602|NCT03473236|9606672|P9|Overall Study|Withdrawal by Subject|1
2813603|NCT03473236|9606673|P8|Overall Study|Withdrawal by Subject|0
2813604|NCT03473236|9606674|P7|Overall Study|Withdrawal by Subject|0
2813605|NCT03473236|9606675|P6|Overall Study|Withdrawal by Subject|1
2813606|NCT03473236|9606676|P5|Overall Study|Withdrawal by Subject|0
2813607|NCT03473236|9606677|P4|Overall Study|Withdrawal by Subject|0
2813608|NCT03473236|9606678|P3|Overall Study|Withdrawal by Subject|0
2813609|NCT03473236|9606679|P2|Overall Study|Withdrawal by Subject|0
2813610|NCT03473236|9606680|P1|Overall Study|Withdrawal by Subject|0
2813611|NCT03473197|9606800|P1|Overall Study|Withdrawal by Subject|5
2813612|NCT03473197|9606800|P1|Overall Study|Lost to Follow-up|1
2813613|NCT03473197|9606800|P1|Overall Study|Adverse Event|4
2813614|NCT03472547|9606812|P1|Overall Study|Withdrawal by Subject|30
2813615|NCT03472534|9606816|P1|Overall Study|Adverse Event|2
2813616|NCT03472534|9606816|P1|Overall Study|Withdrawal by Subject|9
2813617|NCT03471871|9606842|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2813618|NCT03471871|9606843|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
2813619|NCT03471871|9606844|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2813620|NCT03471871|9606845|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2813621|NCT03471871|9606846|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2813622|NCT03471871|9606842|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
2813623|NCT03471871|9606843|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2813624|NCT03471871|9606844|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2813625|NCT03471871|9606845|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2813626|NCT03471871|9606846|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2813627|NCT03471871|9606842|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
2813628|NCT03471871|9606843|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2813629|NCT03471871|9606844|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2813630|NCT03471871|9606845|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2813631|NCT03471871|9606846|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2813632|NCT03471871|9606842|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2813633|NCT03471871|9606843|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2813634|NCT03471871|9606844|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2813635|NCT03471871|9606845|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2813636|NCT03471871|9606846|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2813637|NCT03471871|9606842|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2813638|NCT03471871|9606843|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2813639|NCT03471871|9606844|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
2813640|NCT03471871|9606845|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2813641|NCT03471871|9606846|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2813642|NCT03468543|9606974|P1|Overall Study|Protocol stopping rules met|3
2813643|NCT03467971|9606986|P2|Treatment Period 2|Withdrawal by Subject|1
2813644|NCT03467971|9606987|P1|Treatment Period 2|Withdrawal by Subject|0
2813645|NCT03467945|9607011|P4|Treatment Period 3|Withdrawal by Subject|1
2813646|NCT03467945|9607012|P3|Treatment Period 3|Withdrawal by Subject|2
2813647|NCT03467945|9607013|P2|Treatment Period 3|Withdrawal by Subject|0
2813648|NCT03467945|9607014|P1|Treatment Period 3|Withdrawal by Subject|1
2813649|NCT03467945|9607011|P4|Treatment Period 2|Withdrawal by Subject|0
2813650|NCT03467945|9607012|P3|Treatment Period 2|Withdrawal by Subject|0
2813651|NCT03467945|9607013|P2|Treatment Period 2|Withdrawal by Subject|1
2813652|NCT03467945|9607014|P1|Treatment Period 2|Withdrawal by Subject|0
2813653|NCT03466658|9607066|P1|Overall Study|Withdrawal by Subject|3
2813654|NCT03466086|9607072|P2|Period 1|Withdrawal by Subject|0
2813655|NCT03466086|9607073|P1|Period 1|Withdrawal by Subject|1
2813656|NCT03466086|9607072|P2|Period 1|Sponsor decision due to study timeline|0
2813657|NCT03466086|9607073|P1|Period 1|Sponsor decision due to study timeline|1
2813658|NCT03466073|9607087|P6|Overall Study|Death|1
2813659|NCT03466073|9607088|P5|Overall Study|Death|0
2813660|NCT03466073|9607089|P4|Overall Study|Death|0
2813661|NCT03466073|9607090|P3|Overall Study|Death|0
2813662|NCT03466073|9607091|P2|Overall Study|Death|0
2813663|NCT03466073|9607092|P1|Overall Study|Death|1
2813664|NCT03466060|9607125|P6|Period 2|Lens Handling Difficulties|0
2813665|NCT03466060|9607126|P5|Period 2|Lens Handling Difficulties|0
2813666|NCT03466060|9607127|P4|Period 2|Lens Handling Difficulties|0
2813667|NCT03466060|9607128|P3|Period 2|Lens Handling Difficulties|1
2813668|NCT03466060|9607129|P2|Period 2|Lens Handling Difficulties|0
2813669|NCT03466060|9607130|P1|Period 2|Lens Handling Difficulties|0
2813670|NCT03466060|9607125|P6|Period 1|Grade 2 Conjunctivitis|0
2813671|NCT03466060|9607126|P5|Period 1|Grade 2 Conjunctivitis|0
2813672|NCT03466060|9607127|P4|Period 1|Grade 2 Conjunctivitis|0
2813673|NCT03466060|9607128|P3|Period 1|Grade 2 Conjunctivitis|1
2813674|NCT03466060|9607129|P2|Period 1|Grade 2 Conjunctivitis|0
2813675|NCT03466060|9607130|P1|Period 1|Grade 2 Conjunctivitis|0
2813676|NCT03466060|9607125|P6|Period 1|Lost to Follow-up|0
2813677|NCT03466060|9607126|P5|Period 1|Lost to Follow-up|0
2813678|NCT03466060|9607127|P4|Period 1|Lost to Follow-up|1
2813679|NCT03466060|9607128|P3|Period 1|Lost to Follow-up|0
2813680|NCT03466060|9607129|P2|Period 1|Lost to Follow-up|0
2813681|NCT03466060|9607130|P1|Period 1|Lost to Follow-up|0
2813682|NCT03466060|9607125|P6|Period 1|Withdrawal by Subject|0
2813683|NCT03466060|9607126|P5|Period 1|Withdrawal by Subject|0
2813684|NCT03466060|9607127|P4|Period 1|Withdrawal by Subject|0
2813685|NCT03466060|9607128|P3|Period 1|Withdrawal by Subject|2
2813686|NCT03466060|9607129|P2|Period 1|Withdrawal by Subject|0
2813687|NCT03466060|9607130|P1|Period 1|Withdrawal by Subject|0
2813688|NCT03466060|9607125|P6|Period 1|Test Lens Damage|0
2813689|NCT03466060|9607126|P5|Period 1|Test Lens Damage|0
2813690|NCT03466060|9607127|P4|Period 1|Test Lens Damage|0
2813691|NCT03466060|9607128|P3|Period 1|Test Lens Damage|0
2813692|NCT03466060|9607129|P2|Period 1|Test Lens Damage|2
2813693|NCT03466060|9607130|P1|Period 1|Test Lens Damage|0
2813694|NCT03465904|9607146|P2|Overall Study|Ineligible for mITT analysis|47
2813695|NCT03465904|9607147|P1|Overall Study|Ineligible for mITT analysis|62
2813696|NCT03465904|9607146|P2|Overall Study|Protocol Violation|5
2813697|NCT03465904|9607147|P1|Overall Study|Protocol Violation|8
2813698|NCT03465904|9607146|P2|Overall Study|Lost to Follow-up|9
2813699|NCT03465904|9607147|P1|Overall Study|Lost to Follow-up|10
2813700|NCT03465904|9607146|P2|Overall Study|Withdrawal by Subject|5
2813701|NCT03465904|9607147|P1|Overall Study|Withdrawal by Subject|9
2813702|NCT03465436|9607169|P4|Period 4|Protocol Violation|0
2813703|NCT03465436|9607170|P3|Period 4|Protocol Violation|1
2813704|NCT03465436|9607171|P2|Period 4|Protocol Violation|0
2813705|NCT03465436|9607172|P1|Period 4|Protocol Violation|0
2813706|NCT03465436|9607169|P4|Period 3|Protocol Violation|0
2813707|NCT03465436|9607170|P3|Period 3|Protocol Violation|0
2813708|NCT03465436|9607171|P2|Period 3|Protocol Violation|1
2813709|NCT03465436|9607172|P1|Period 3|Protocol Violation|1
2813710|NCT03465436|9607169|P4|Period 2|Protocol Violation|0
2813711|NCT03465436|9607170|P3|Period 2|Protocol Violation|0
2813712|NCT03465436|9607171|P2|Period 2|Protocol Violation|1
2813713|NCT03465436|9607172|P1|Period 2|Protocol Violation|0
2813714|NCT03465436|9607169|P4|Period 1|Protocol Violation|0
2813715|NCT03465436|9607170|P3|Period 1|Protocol Violation|1
2813716|NCT03465436|9607171|P2|Period 1|Protocol Violation|0
2813717|NCT03465436|9607172|P1|Period 1|Protocol Violation|0
2813718|NCT03463031|9607228|P2|Overall Study|Use of prohibited medication by subject|0
2813719|NCT03463031|9607229|P1|Overall Study|Use of prohibited medication by subject|1
2813720|NCT03463031|9607228|P2|Overall Study|Adverse Event|1
2813721|NCT03463031|9607229|P1|Overall Study|Adverse Event|4
2813722|NCT03463031|9607228|P2|Overall Study|Lost to Follow-up|1
2813723|NCT03463031|9607229|P1|Overall Study|Lost to Follow-up|1
2813724|NCT03463031|9607228|P2|Overall Study|Investigator/Sponsor Decision|1
2813725|NCT03463031|9607229|P1|Overall Study|Investigator/Sponsor Decision|0
2813726|NCT03463031|9607228|P2|Overall Study|Withdrawal by Subject|2
2813727|NCT03463031|9607229|P1|Overall Study|Withdrawal by Subject|4
2813728|NCT03461757|9607279|P2|Overall Study|Other Reasons|4
2813729|NCT03461757|9607280|P1|Overall Study|Other Reasons|1
2813730|NCT03461757|9607279|P2|Overall Study|Withdrawal by Subject|7
2813731|NCT03461757|9607280|P1|Overall Study|Withdrawal by Subject|7
2813732|NCT03461757|9607279|P2|Overall Study|Protocol Violation|1
2813733|NCT03461757|9607280|P1|Overall Study|Protocol Violation|1
2813734|NCT03461757|9607279|P2|Overall Study|Pregnancy|0
2813735|NCT03461757|9607280|P1|Overall Study|Pregnancy|2
2813736|NCT03461757|9607279|P2|Overall Study|Non-compliance with study treatment|1
2813737|NCT03461757|9607280|P1|Overall Study|Non-compliance with study treatment|0
2813738|NCT03461757|9607279|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
2813739|NCT03461757|9607280|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
2813740|NCT03461757|9607279|P2|Overall Study|Lost to Follow-up|7
2813741|NCT03461757|9607280|P1|Overall Study|Lost to Follow-up|13
2813742|NCT03461757|9607279|P2|Overall Study|Adverse Event|0
2813743|NCT03461757|9607280|P1|Overall Study|Adverse Event|1
2813744|NCT03459196|9607449|P1|Overall Study|Subject didn't receive study catheter|2
2813745|NCT03458702|9607493|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
2813746|NCT03458702|9607494|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
2813747|NCT03458702|9607493|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
2813748|NCT03458702|9607494|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
2813749|NCT03457727|9607523|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
2813750|NCT03457727|9607524|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2813751|NCT03457727|9607525|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2813752|NCT03457727|9607526|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2813753|NCT03457636|9607723|P1|Overall Study|Lost to Follow-up|2
2813754|NCT03456960|9607736|P6|Period 2 (1 Day)|Adverse Event|0
2813755|NCT03456960|9607737|P5|Period 2 (1 Day)|Adverse Event|0
2813756|NCT03456960|9607738|P4|Period 2 (1 Day)|Adverse Event|1
2813757|NCT03456960|9607739|P3|Period 2 (1 Day)|Adverse Event|0
2813758|NCT03456960|9607740|P2|Period 2 (1 Day)|Adverse Event|0
2813759|NCT03456960|9607741|P1|Period 2 (1 Day)|Adverse Event|1
2813760|NCT03456960|9607736|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2813761|NCT03456960|9607737|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2813762|NCT03456960|9607738|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
2813763|NCT03456960|9607739|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2813764|NCT03456960|9607740|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2813765|NCT03456960|9607741|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2813766|NCT03456856|9607833|P1|Overall Study|Withdrawal by Subject|1
2813767|NCT03456856|9607833|P1|Overall Study|Lost to Follow-up|2
2813768|NCT03455543|9607861|P2|Overall Study|Physician Decision|0
2813769|NCT03455543|9607862|P1|Overall Study|Physician Decision|2
2813770|NCT03455543|9607861|P2|Overall Study|Withdrawal by Subject|2
2813771|NCT03455543|9607862|P1|Overall Study|Withdrawal by Subject|7
2813772|NCT03455543|9607861|P2|Overall Study|Adverse Event|5
2813773|NCT03455543|9607862|P1|Overall Study|Adverse Event|2
2813774|NCT03451721|9608229|P1|Overall Study|Death|1
2813775|NCT03450070|9608238|P1|Overall Study|Withdrawal by Subject|8
2813776|NCT03448536|9608283|P2|Overall Study|Physician Decision|0
2813777|NCT03448536|9608284|P1|Overall Study|Physician Decision|1
2813778|NCT03448536|9608283|P2|Overall Study|Other|0
2813779|NCT03448536|9608284|P1|Overall Study|Other|3
2813780|NCT03448536|9608283|P2|Overall Study|Inadequate pain reporter|0
2813781|NCT03448536|9608284|P1|Overall Study|Inadequate pain reporter|1
2813782|NCT03448536|9608283|P2|Overall Study|Lost to Follow-up|2
2813783|NCT03448536|9608284|P1|Overall Study|Lost to Follow-up|3
2813784|NCT03448536|9608283|P2|Overall Study|Withdrawal by Subject|2
2813785|NCT03448536|9608284|P1|Overall Study|Withdrawal by Subject|1
2813786|NCT03448536|9608283|P2|Overall Study|Pregnancy|0
2813787|NCT03448536|9608284|P1|Overall Study|Pregnancy|1
2813788|NCT03448536|9608283|P2|Overall Study|Protocol Violation|0
2813789|NCT03448536|9608284|P1|Overall Study|Protocol Violation|2
2813790|NCT03447821|9608311|P3|Overall Study|Lost to Follow-up|1
2813791|NCT03447821|9608312|P2|Overall Study|Lost to Follow-up|0
2813792|NCT03447821|9608313|P1|Overall Study|Lost to Follow-up|0
2813793|NCT03447821|9608311|P3|Overall Study|Withdrawal by Subject|0
2813794|NCT03447821|9608312|P2|Overall Study|Withdrawal by Subject|1
2813795|NCT03447821|9608313|P1|Overall Study|Withdrawal by Subject|1
2813796|NCT03447353|9608349|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
2813797|NCT03447353|9608349|P1|Overall Study|Scheduling Conflicts|3
2813798|NCT03447353|9608349|P1|Overall Study|Lost to Follow-up|4
2813799|NCT03447353|9608349|P1|Overall Study|Failure at Screening Visit|2
2813800|NCT03447249|9608365|P2|Overall Study|Other|0
2813801|NCT03447249|9608366|P1|Overall Study|Other|3
2813802|NCT03447249|9608365|P2|Overall Study|Withdrawal of consent (not due to AE)|0
2813803|NCT03447249|9608366|P1|Overall Study|Withdrawal of consent (not due to AE)|1
2813804|NCT03447249|9608365|P2|Overall Study|Adverse Event|0
2813805|NCT03447249|9608366|P1|Overall Study|Adverse Event|1
2813806|NCT03444584|9608473|P2|Overall Study|Other|1
2813807|NCT03444584|9608474|P1|Overall Study|Other|0
2813808|NCT03444584|9608473|P2|Overall Study|Withdrawal by Subject|1
2813809|NCT03444584|9608474|P1|Overall Study|Withdrawal by Subject|0
2813810|NCT03443713|9608544|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
2813811|NCT03443713|9608545|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2813812|NCT03443713|9608546|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2813813|NCT03443414|9608580|P5|Overall Study|Reason not specified|1
2813814|NCT03443414|9608581|P4|Overall Study|Reason not specified|0
2813815|NCT03443414|9608582|P3|Overall Study|Reason not specified|0
2813816|NCT03443414|9608583|P2|Overall Study|Reason not specified|0
2813817|NCT03443414|9608584|P1|Overall Study|Reason not specified|2
2813818|NCT03443414|9608580|P5|Overall Study|Death|0
2813819|NCT03443414|9608581|P4|Overall Study|Death|1
2813820|NCT03443414|9608582|P3|Overall Study|Death|0
2813821|NCT03443414|9608583|P2|Overall Study|Death|1
2813822|NCT03443414|9608584|P1|Overall Study|Death|0
2813823|NCT03443414|9608580|P5|Overall Study|Withdrawal by Subject|1
2813824|NCT03443414|9608581|P4|Overall Study|Withdrawal by Subject|2
2813825|NCT03443414|9608582|P3|Overall Study|Withdrawal by Subject|2
2813826|NCT03443414|9608583|P2|Overall Study|Withdrawal by Subject|2
2813827|NCT03443414|9608584|P1|Overall Study|Withdrawal by Subject|3
2813828|NCT03443414|9608580|P5|Overall Study|Adverse Event|3
2813829|NCT03443414|9608581|P4|Overall Study|Adverse Event|2
2813830|NCT03443414|9608582|P3|Overall Study|Adverse Event|4
2813831|NCT03443414|9608583|P2|Overall Study|Adverse Event|0
2813832|NCT03443414|9608584|P1|Overall Study|Adverse Event|6
2813833|NCT03441984|9608744|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813834|NCT03441984|9608745|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813835|NCT03441984|9608746|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813836|NCT03441984|9608747|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813837|NCT03441984|9608748|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813838|NCT03441984|9608749|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813839|NCT03441984|9608750|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813840|NCT03441984|9608751|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813841|NCT03441984|9608752|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813842|NCT03441984|9608753|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
2813843|NCT03441984|9608754|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813844|NCT03441984|9608755|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2813845|NCT03441789|9609116|P2|Overall Study|Lost to Follow-up|1
2813846|NCT03441789|9609117|P1|Overall Study|Lost to Follow-up|0
2813847|NCT03441789|9609116|P2|Overall Study|Protocol Violation|1
2813848|NCT03441789|9609117|P1|Overall Study|Protocol Violation|0
2813849|NCT03441789|9609116|P2|Overall Study|Adverse Event|1
2813850|NCT03441789|9609117|P1|Overall Study|Adverse Event|0
2813851|NCT03441789|9609116|P2|Overall Study|Withdrawal by Subject|1
2813852|NCT03441789|9609117|P1|Overall Study|Withdrawal by Subject|1
2813853|NCT03440918|9609299|P2|Overall Study|Protocol Violation|16
2813854|NCT03440918|9609300|P1|Overall Study|Protocol Violation|0
2813855|NCT03439072|9609396|P2|Overall Study|Physician Decision|1
2813856|NCT03439072|9609397|P1|Overall Study|Physician Decision|0
2813857|NCT03439072|9609396|P2|Overall Study|Withdrawal by Subject|3
2813858|NCT03439072|9609397|P1|Overall Study|Withdrawal by Subject|2
2813859|NCT03438539|9609435|P6|Overall Study|Lost to Follow-up|8
2813860|NCT03438539|9609436|P5|Overall Study|Lost to Follow-up|3
2813861|NCT03438539|9609437|P4|Overall Study|Lost to Follow-up|9
2813862|NCT03438539|9609438|P3|Overall Study|Lost to Follow-up|10
2813863|NCT03438539|9609439|P2|Overall Study|Lost to Follow-up|4
2813864|NCT03438539|9609440|P1|Overall Study|Lost to Follow-up|8
2813865|NCT03438383|9609468|P2|Overall Study|Protocol Violation|3
2813866|NCT03438383|9609469|P1|Overall Study|Protocol Violation|9
2813867|NCT03437733|9609500|P2|Overall Study|Eligibility criteria not met|3
2813868|NCT03437733|9609501|P1|Overall Study|Eligibility criteria not met|0
2813869|NCT03437447|9609541|P3|Treatment Period 1|Withdrawal by Subject|1
2813870|NCT03437447|9609542|P2|Treatment Period 1|Withdrawal by Subject|0
2813871|NCT03437447|9609543|P1|Treatment Period 1|Withdrawal by Subject|0
2813872|NCT03436732|9609598|P2|Overall Study|Death|1
2813873|NCT03436732|9609599|P1|Overall Study|Death|0
2813874|NCT03436732|9609598|P2|Overall Study|Adverse Event|0
2813875|NCT03436732|9609599|P1|Overall Study|Adverse Event|2
2813876|NCT03436732|9609598|P2|Overall Study|Off study after cycle 1|0
2813877|NCT03436732|9609599|P1|Overall Study|Off study after cycle 1|1
2813878|NCT03436732|9609598|P2|Overall Study|Not treated-enrolled in different study|0
2813879|NCT03436732|9609599|P1|Overall Study|Not treated-enrolled in different study|1
2813880|NCT03434977|9609642|P2|Washout Period (at Least 6 Days)|Adverse Event|1
2813881|NCT03434977|9609643|P1|Washout Period (at Least 6 Days)|Adverse Event|0
2813882|NCT03434249|9609710|P2|Overall Study|Difficulties in completing daily diary|1
2813883|NCT03434249|9609711|P1|Overall Study|Difficulties in completing daily diary|2
2813884|NCT03434249|9609710|P2|Overall Study|Non-compliance of family|1
2813885|NCT03434249|9609711|P1|Overall Study|Non-compliance of family|2
2813886|NCT03434249|9609710|P2|Overall Study|Lost to Follow-up|1
2813887|NCT03434249|9609711|P1|Overall Study|Lost to Follow-up|0
2813888|NCT03434249|9609710|P2|Overall Study|Adverse Event|0
2813889|NCT03434249|9609711|P1|Overall Study|Adverse Event|1
2813890|NCT03434119|9609745|P2|Overall Study|Other than specified|5
2813891|NCT03434119|9609746|P1|Overall Study|Other than specified|7
2813892|NCT03434119|9609745|P2|Overall Study|Withdrawal by Subject|5
2813893|NCT03434119|9609746|P1|Overall Study|Withdrawal by Subject|7
2813894|NCT03434119|9609745|P2|Overall Study|Study Terminated by Sponsor|102
2813895|NCT03434119|9609746|P1|Overall Study|Study Terminated by Sponsor|91
2813896|NCT03434119|9609745|P2|Overall Study|Poor Compliance to Protocol|1
2813897|NCT03434119|9609746|P1|Overall Study|Poor Compliance to Protocol|0
2813898|NCT03434119|9609745|P2|Overall Study|Adverse Event|0
2813899|NCT03434119|9609746|P1|Overall Study|Adverse Event|1
2813900|NCT03434119|9609745|P2|Overall Study|Randomized but not treated|0
2813901|NCT03434119|9609746|P1|Overall Study|Randomized but not treated|1
2813902|NCT03433703|9609764|P1|Overall Study|Study terminated by Sponsor|2
2813903|NCT03433677|9609773|P2|Period 2|Withdrawal by Subject|1
2813904|NCT03433677|9609774|P1|Period 2|Withdrawal by Subject|1
2813905|NCT03433677|9609773|P2|Period 1|Protocol Violation|0
2813906|NCT03433677|9609774|P1|Period 1|Protocol Violation|1
2813907|NCT03432533|9609794|P2|Overall Study|Withdrawal by Subject|9
2813908|NCT03432533|9609795|P1|Overall Study|Withdrawal by Subject|14
2813909|NCT03432533|9609794|P2|Overall Study|Lost to Follow-up|2
2813910|NCT03432533|9609795|P1|Overall Study|Lost to Follow-up|1
2813911|NCT03432390|9609811|P2|Apnea Period|Protocol Violation|2
2813912|NCT03432390|9609812|P1|Apnea Period|Protocol Violation|2
2813913|NCT03431441|9609822|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
2813914|NCT03431441|9609822|P1|Overall Study|Adverse Event|2
2813915|NCT03431441|9609822|P1|Overall Study|Withdrawal by Subject|2
2813916|NCT03430856|9609858|P3|Overall Study|Voluntary withdrawal of consent|1
2813917|NCT03430856|9609859|P2|Overall Study|Voluntary withdrawal of consent|1
2813918|NCT03430856|9609860|P1|Overall Study|Voluntary withdrawal of consent|1
2813919|NCT03430856|9609858|P3|Overall Study|Rescue criteria|0
2813920|NCT03430856|9609859|P2|Overall Study|Rescue criteria|1
2813921|NCT03430856|9609860|P1|Overall Study|Rescue criteria|1
2813922|NCT03430856|9609858|P3|Overall Study|Adverse Event|0
2813923|NCT03430856|9609859|P2|Overall Study|Adverse Event|1
2813924|NCT03430856|9609860|P1|Overall Study|Adverse Event|0
2813925|NCT03430245|9609898|P1|Overall Study|Lost to Follow-up|1
2813926|NCT03430245|9609898|P1|Overall Study|Withdrawal by Subject|6
2813927|NCT03429556|9609924|P4|Overall Study|Lost to Follow-up|0
2813928|NCT03429556|9609925|P3|Overall Study|Lost to Follow-up|0
2813929|NCT03429556|9609926|P2|Overall Study|Lost to Follow-up|1
2813930|NCT03429556|9609927|P1|Overall Study|Lost to Follow-up|0
2813931|NCT03428997|9609973|P1|Overall Study|Lost to Follow-up|4
2813932|NCT03428997|9609973|P1|Overall Study|Withdrawal by Subject|3
2813933|NCT03428997|9609973|P1|Overall Study|Sponsor decision.|1
2813934|NCT03428152|9609981|P2|Overall Study|Lack of Efficacy|4
2813935|NCT03428152|9609982|P1|Overall Study|Lack of Efficacy|0
2813936|NCT03428152|9609981|P2|Overall Study|Protocol Violation|5
2813937|NCT03428152|9609982|P1|Overall Study|Protocol Violation|3
2813938|NCT03428152|9609981|P2|Overall Study|Physician Decision|2
2813939|NCT03428152|9609982|P1|Overall Study|Physician Decision|4
2813940|NCT03427892|9609998|P1|Overall Study|Lost to Follow-up|2
2813941|NCT03427073|9610022|P8|Overall Study|Physician Decision|1
2813942|NCT03427073|9610023|P7|Overall Study|Physician Decision|1
2813943|NCT03427073|9610024|P6|Overall Study|Physician Decision|0
2813944|NCT03427073|9610025|P5|Overall Study|Physician Decision|0
2813945|NCT03427073|9610026|P4|Overall Study|Physician Decision|0
2813946|NCT03427073|9610027|P3|Overall Study|Physician Decision|0
2813947|NCT03427073|9610028|P2|Overall Study|Physician Decision|0
2813948|NCT03427073|9610029|P1|Overall Study|Physician Decision|0
2813949|NCT03427073|9610022|P8|Overall Study|Disease Progression|3
2813950|NCT03427073|9610023|P7|Overall Study|Disease Progression|2
2813951|NCT03427073|9610024|P6|Overall Study|Disease Progression|4
2813952|NCT03427073|9610025|P5|Overall Study|Disease Progression|3
2813953|NCT03427073|9610026|P4|Overall Study|Disease Progression|3
2813954|NCT03427073|9610027|P3|Overall Study|Disease Progression|1
2813955|NCT03427073|9610028|P2|Overall Study|Disease Progression|1
2813956|NCT03427073|9610029|P1|Overall Study|Disease Progression|1
2813957|NCT03426787|9610079|P1|Overall Study|Unrelated to intervention death|1
2813958|NCT03426787|9610079|P1|Overall Study|Lost to Follow-up|7
2813959|NCT03426787|9610079|P1|Overall Study|Withdrawal by Subject|6
2813960|NCT03426631|9610089|P2|Overall Study|Lost to Follow-up|1
2813961|NCT03426631|9610090|P1|Overall Study|Lost to Follow-up|0
2813962|NCT03426436|9610102|P1|Overall Study|ECGs not saved|4
2813963|NCT03426436|9610102|P1|Overall Study|Consent issue|1
2813964|NCT03426436|9610102|P1|Overall Study|Withdrawal by Subject|2
2813965|NCT03426436|9610102|P1|Overall Study|Incorrect lead placement|12
2813966|NCT03426137|9610110|P3|Overall Study|Withdrawal by Subject|0
2813967|NCT03426137|9610111|P2|Overall Study|Withdrawal by Subject|0
2813968|NCT03426137|9610112|P1|Overall Study|Withdrawal by Subject|3
2813969|NCT03424044|9610135|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813970|NCT03424044|9610136|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813971|NCT03424044|9610137|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813972|NCT03424044|9610138|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813973|NCT03424044|9610139|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813974|NCT03424044|9610140|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
2813975|NCT03424044|9610141|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813976|NCT03424044|9610142|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813977|NCT03424044|9610143|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
2813978|NCT03424044|9610135|P9|Third Intervention (76 Hours)|Adverse Event|0
2813979|NCT03424044|9610136|P8|Third Intervention (76 Hours)|Adverse Event|0
2813980|NCT03424044|9610137|P7|Third Intervention (76 Hours)|Adverse Event|1
2813981|NCT03424044|9610138|P6|Third Intervention (76 Hours)|Adverse Event|0
2813982|NCT03424044|9610139|P5|Third Intervention (76 Hours)|Adverse Event|0
2813983|NCT03424044|9610140|P4|Third Intervention (76 Hours)|Adverse Event|0
2813984|NCT03424044|9610141|P3|Third Intervention (76 Hours)|Adverse Event|0
2813985|NCT03424044|9610142|P2|Third Intervention (76 Hours)|Adverse Event|0
2813986|NCT03424044|9610143|P1|Third Intervention (76 Hours)|Adverse Event|1
2813987|NCT03424044|9610135|P9|First Intervention (76 Hours)|device issues|1
2813988|NCT03424044|9610136|P8|First Intervention (76 Hours)|device issues|1
2813989|NCT03424044|9610137|P7|First Intervention (76 Hours)|device issues|1
2813990|NCT03424044|9610138|P6|First Intervention (76 Hours)|device issues|0
2813991|NCT03424044|9610139|P5|First Intervention (76 Hours)|device issues|0
2813992|NCT03424044|9610140|P4|First Intervention (76 Hours)|device issues|0
2813993|NCT03424044|9610141|P3|First Intervention (76 Hours)|device issues|0
2813994|NCT03424044|9610142|P2|First Intervention (76 Hours)|device issues|0
2813995|NCT03424044|9610143|P1|First Intervention (76 Hours)|device issues|0
2813996|NCT03424044|9610135|P9|First Intervention (76 Hours)|Adverse Event|0
2813997|NCT03424044|9610136|P8|First Intervention (76 Hours)|Adverse Event|0
2813998|NCT03424044|9610137|P7|First Intervention (76 Hours)|Adverse Event|0
2813999|NCT03424044|9610138|P6|First Intervention (76 Hours)|Adverse Event|0
2814000|NCT03424044|9610139|P5|First Intervention (76 Hours)|Adverse Event|1
2814001|NCT03424044|9610140|P4|First Intervention (76 Hours)|Adverse Event|0
2814002|NCT03424044|9610141|P3|First Intervention (76 Hours)|Adverse Event|0
2814003|NCT03424044|9610142|P2|First Intervention (76 Hours)|Adverse Event|0
2814004|NCT03424044|9610143|P1|First Intervention (76 Hours)|Adverse Event|0
2814005|NCT03424044|9610135|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814006|NCT03424044|9610136|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814007|NCT03424044|9610137|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814008|NCT03424044|9610138|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814009|NCT03424044|9610139|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814010|NCT03424044|9610140|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814011|NCT03424044|9610141|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
2814012|NCT03424044|9610142|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814013|NCT03424044|9610143|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
2814014|NCT03421730|9610202|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814015|NCT03421730|9610203|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814016|NCT03421730|9610204|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814017|NCT03421730|9610205|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814018|NCT03421730|9610206|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814019|NCT03421730|9610207|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814020|NCT03421730|9610208|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814021|NCT03421730|9610209|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
2814022|NCT03421730|9610210|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814023|NCT03421730|9610211|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814024|NCT03421730|9610212|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814025|NCT03421730|9610213|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2814026|NCT03421730|9610202|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814027|NCT03421730|9610203|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814028|NCT03421730|9610204|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814029|NCT03421730|9610205|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814030|NCT03421730|9610206|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814031|NCT03421730|9610207|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814032|NCT03421730|9610208|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814033|NCT03421730|9610209|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814034|NCT03421730|9610210|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814035|NCT03421730|9610211|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814036|NCT03421730|9610212|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
2814037|NCT03421730|9610213|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2814038|NCT03421379|9610286|P2|Period 1|Did not receive treatment|2
2814039|NCT03421379|9610287|P1|Period 1|Did not receive treatment|1
2814040|NCT03421379|9610286|P2|Period 1|Physician Decision|1
2814041|NCT03421379|9610287|P1|Period 1|Physician Decision|1
2814042|NCT03421379|9610286|P2|Period 1|Withdrawal by Subject|1
2814043|NCT03421379|9610287|P1|Period 1|Withdrawal by Subject|0
2814044|NCT03420300|9610333|P1|Overall Study|Death|2
2814045|NCT03419962|9610342|P1|Overall Study|Missing completion data|31
2814046|NCT03419962|9610342|P1|Overall Study|Difficulty in inhaling the doses|1
2814047|NCT03419962|9610342|P1|Overall Study|Lost to Follow-up|3
2814048|NCT03419962|9610342|P1|Overall Study|Refusal of continuing with trial drug|1
2814049|NCT03419962|9610342|P1|Overall Study|Change to other medication|1
2814050|NCT03418571|9610401|P2|Overall Study|Consent withdrawn by legal guardian|0
2814051|NCT03418571|9610402|P1|Overall Study|Consent withdrawn by legal guardian|1
2814052|NCT03418376|9610414|P4|Overall Study|Exacerbation|0
2814053|NCT03418376|9610415|P3|Overall Study|Exacerbation|0
2814054|NCT03418376|9610416|P2|Overall Study|Exacerbation|1
2814055|NCT03418376|9610417|P1|Overall Study|Exacerbation|0
2814056|NCT03418376|9610414|P4|Overall Study|Personal reasons|1
2814057|NCT03418376|9610415|P3|Overall Study|Personal reasons|2
2814058|NCT03418376|9610416|P2|Overall Study|Personal reasons|2
2814059|NCT03418376|9610417|P1|Overall Study|Personal reasons|0
2814060|NCT03418376|9610414|P4|Overall Study|Musculoskeletal injury|0
2814061|NCT03418376|9610415|P3|Overall Study|Musculoskeletal injury|1
2814062|NCT03418376|9610416|P2|Overall Study|Musculoskeletal injury|2
2814063|NCT03418376|9610417|P1|Overall Study|Musculoskeletal injury|1
2814064|NCT03417830|9610475|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
2814065|NCT03417830|9610476|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
2814066|NCT03417505|9610588|P2|First Lens Type (30 Days)|Lost to Follow-up|1
2814067|NCT03417505|9610589|P1|First Lens Type (30 Days)|Lost to Follow-up|1
2814068|NCT03417219|9610620|P2|Overall Study|Lost to Follow-up|3
2814069|NCT03417219|9610621|P1|Overall Study|Lost to Follow-up|0
2814070|NCT03417024|9610631|P1|Overall Study|Physician Decision|2
2814071|NCT03417024|9610631|P1|Overall Study|Study Termination prior to follow-up|11
2814072|NCT03415178|9610720|P2|Single Arm Period (up to Week 16)|Adverse Event|1
2814073|NCT03415178|9610721|P1|Single Arm Period (up to Week 16)|Adverse Event|0
2814074|NCT03415178|9610720|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
2814075|NCT03415178|9610721|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
2814076|NCT03414359|9610758|P2|Overall Study|Protocol Violation|1
2814077|NCT03414359|9610759|P1|Overall Study|Protocol Violation|0
2814078|NCT03414359|9610758|P2|Overall Study|Lack of Efficacy|1
2814079|NCT03414359|9610759|P1|Overall Study|Lack of Efficacy|1
2814080|NCT03412929|9610796|P1|Overall Study|Protocol Violation|3
2814081|NCT03412019|9610807|P2|Overall Study|Withdrawal by Subject|1
2814082|NCT03412019|9610808|P1|Overall Study|Withdrawal by Subject|1
2814083|NCT03408639|9610857|P2|Overall Study|Physician Decision|6
2814084|NCT03408639|9610858|P1|Overall Study|Physician Decision|3
2814085|NCT03408639|9610857|P2|Overall Study|Withdrawal by Subject|7
2814086|NCT03408639|9610858|P1|Overall Study|Withdrawal by Subject|2
2814087|NCT03408639|9610857|P2|Overall Study|Lost to Follow-up|4
2814088|NCT03408639|9610858|P1|Overall Study|Lost to Follow-up|1
2814089|NCT03408639|9610857|P2|Overall Study|Death|5
2814090|NCT03408639|9610858|P1|Overall Study|Death|5
2814091|NCT03407430|9610983|P2|Washout|Protocol Violation|0
2814092|NCT03407430|9610984|P1|Washout|Protocol Violation|1
2814093|NCT03407118|9611016|P2|Period 2|Withdrawal by Subject|0
2814094|NCT03407118|9611017|P1|Period 2|Withdrawal by Subject|1
2814095|NCT03406260|9611094|P6|Period 1|Adverse Event|0
2814096|NCT03406260|9611095|P5|Period 1|Adverse Event|1
2814097|NCT03406260|9611096|P4|Period 1|Adverse Event|0
2814098|NCT03406260|9611097|P3|Period 1|Adverse Event|0
2814099|NCT03406260|9611098|P2|Period 1|Adverse Event|0
2814100|NCT03406260|9611099|P1|Period 1|Adverse Event|0
2814101|NCT03405935|9611111|P1|Overall Study|Still on Study|83
2814102|NCT03405935|9611111|P1|Overall Study|Adverse Event|3
2814103|NCT03405818|9611122|P1|Overall Study|Lost to Follow-up|4
2814104|NCT03405818|9611122|P1|Overall Study|Withdrawal by Subject|4
2814105|NCT03404843|9611176|P2|Overall Study|Study difficulties unrelated to Tx|1
2814106|NCT03404843|9611177|P1|Overall Study|Study difficulties unrelated to Tx|4
2814107|NCT03404206|9611206|P3|Overall Study|Lost to Follow-up|0
2814108|NCT03404206|9611207|P2|Overall Study|Lost to Follow-up|1
2814109|NCT03404206|9611208|P1|Overall Study|Lost to Follow-up|3
2814110|NCT03404206|9611206|P3|Overall Study|Withdrawal by Subject|0
2814111|NCT03404206|9611207|P2|Overall Study|Withdrawal by Subject|1
2814112|NCT03404206|9611208|P1|Overall Study|Withdrawal by Subject|1
2814113|NCT03403413|9611303|P1|Overall Study|Lack of Efficacy|2
2814114|NCT03403036|9611318|P1|Overall Study|Lack of Efficacy|5
2814115|NCT03402893|9611345|P1|Overall Study|Withdrawal by Subject|1
2814116|NCT03402750|9611356|P2|Overall Study|Lost to Follow-up|1
2814117|NCT03402750|9611357|P1|Overall Study|Lost to Follow-up|2
2814118|NCT03400787|9611416|P2|Overall Study|Unblinded before 3-month follow-upa-|6
2814119|NCT03400787|9611417|P1|Overall Study|Unblinded before 3-month follow-upa-|0
2814120|NCT03400787|9611416|P2|Overall Study|Protocol Violation|2
2814121|NCT03400787|9611417|P1|Overall Study|Protocol Violation|0
2814122|NCT03400787|9611416|P2|Overall Study|Death|0
2814123|NCT03400787|9611417|P1|Overall Study|Death|1
2814124|NCT03400787|9611416|P2|Overall Study|Lost to Follow-up|0
2814125|NCT03400787|9611417|P1|Overall Study|Lost to Follow-up|1
2814126|NCT03396835|9611663|P1|Overall Study|Did not meet criteria for data analysis|1
2814127|NCT03396835|9611663|P1|Overall Study|Withdrawn prior to completion|1
2814128|NCT03394391|9611680|P2|Overall Study|Lost to Follow-up|2
2814129|NCT03394391|9611681|P1|Overall Study|Lost to Follow-up|1
2814130|NCT03392194|9611767|P2|Overall Study|Conflicts with personal schedule|0
2814131|NCT03392194|9611768|P1|Overall Study|Conflicts with personal schedule|1
2814132|NCT03392194|9611767|P2|Overall Study|Withdrawal by Subject|2
2814133|NCT03392194|9611768|P1|Overall Study|Withdrawal by Subject|1
2814134|NCT03390426|9611803|P2|Overall Study|Protocol Violation|1
2814135|NCT03390426|9611804|P1|Overall Study|Protocol Violation|0
2814136|NCT03390166|9611818|P2|Overall Study|Move to work oversea|1
2814137|NCT03390166|9611819|P1|Overall Study|Move to work oversea|0
2814138|NCT03390166|9611818|P2|Overall Study|To drug therapy course|1
2814139|NCT03390166|9611819|P1|Overall Study|To drug therapy course|0
2814140|NCT03390166|9611818|P2|Overall Study|To militarycamp for conscript|0
2814141|NCT03390166|9611819|P1|Overall Study|To militarycamp for conscript|1
2814142|NCT03390166|9611818|P2|Overall Study|Move from study area|2
2814143|NCT03390166|9611819|P1|Overall Study|Move from study area|3
2814144|NCT03390166|9611818|P2|Overall Study|Physician Decision|1
2814145|NCT03390166|9611819|P1|Overall Study|Physician Decision|2
2814146|NCT03390166|9611818|P2|Overall Study|Lost to Follow-up|4
2814147|NCT03390166|9611819|P1|Overall Study|Lost to Follow-up|6
2814148|NCT03390166|9611818|P2|Overall Study|Death|1
2814149|NCT03390166|9611819|P1|Overall Study|Death|0
2814150|NCT03387683|9611833|P2|Overall Study|Did not receive treatment|0
2814151|NCT03387683|9611834|P1|Overall Study|Did not receive treatment|1
2814152|NCT03387683|9611833|P2|Overall Study|In receipt of disallowed medication|0
2814153|NCT03387683|9611834|P1|Overall Study|In receipt of disallowed medication|1
2814154|NCT03387462|9611842|P1|Overall Study|Lost to Follow-up|1
2814155|NCT03387059|9611872|P2|Overall Study|Study termination|4
2814156|NCT03387059|9611873|P1|Overall Study|Study termination|5
2814157|NCT03387046|9611887|P2|Overall Study|Adverse Event|1
2814158|NCT03387046|9611888|P1|Overall Study|Adverse Event|1
2814159|NCT03386474|9611914|P2|Overall Study|Adverse Event|1
2814160|NCT03386474|9611915|P1|Overall Study|Adverse Event|0
2814161|NCT03386474|9611914|P2|Overall Study|Death|0
2814162|NCT03386474|9611915|P1|Overall Study|Death|1
2814163|NCT03386448|9611937|P2|Overall Study|Adverse Event|2
2814164|NCT03386448|9611938|P1|Overall Study|Adverse Event|0
2814165|NCT03386435|9611946|P2|Overall Study|Protocol Violation|7
2814166|NCT03386435|9611947|P1|Overall Study|Protocol Violation|5
2814167|NCT03384316|9611970|P2|Overall Study|Screen failure|1
2814168|NCT03384316|9611971|P1|Overall Study|Screen failure|0
2814169|NCT03383887|9611994|P2|Overall Study|Lost to Follow-up|1
2814170|NCT03383887|9611995|P1|Overall Study|Lost to Follow-up|0
2814171|NCT03383783|9612003|P1|Overall Study|Withdrawal by Subject|2
2814172|NCT03383614|9612081|P4|Overall Study|Withdrawal by Subject|0
2814173|NCT03383614|9612082|P3|Overall Study|Withdrawal by Subject|0
2814174|NCT03383614|9612083|P2|Overall Study|Withdrawal by Subject|1
2814175|NCT03383614|9612084|P1|Overall Study|Withdrawal by Subject|0
2814176|NCT03382834|9612341|P2|Overall Study|Withdrawal by Subject|1
2814177|NCT03382834|9612342|P1|Overall Study|Withdrawal by Subject|0
2814178|NCT03382834|9612341|P2|Overall Study|Lost to Follow-up|0
2814179|NCT03382834|9612342|P1|Overall Study|Lost to Follow-up|1
2814180|NCT03382262|9612358|P4|Overall Study|Withdrawal by Subject|1
2814181|NCT03382262|9612359|P3|Overall Study|Withdrawal by Subject|0
2814182|NCT03382262|9612360|P2|Overall Study|Withdrawal by Subject|0
2814183|NCT03382262|9612361|P1|Overall Study|Withdrawal by Subject|0
2814184|NCT03382262|9612358|P4|Overall Study|Physician Decision|0
2814185|NCT03382262|9612359|P3|Overall Study|Physician Decision|1
2814186|NCT03382262|9612360|P2|Overall Study|Physician Decision|0
2814187|NCT03382262|9612361|P1|Overall Study|Physician Decision|0
2814188|NCT03381248|9612419|P2|Overall Study|Protocol Violation|1
2814189|NCT03381248|9612420|P1|Overall Study|Protocol Violation|2
2814190|NCT03381248|9612419|P2|Overall Study|Adverse Event|0
2814191|NCT03381248|9612420|P1|Overall Study|Adverse Event|2
2814192|NCT03381248|9612419|P2|Overall Study|Lack of Efficacy|0
2814193|NCT03381248|9612420|P1|Overall Study|Lack of Efficacy|1
2814194|NCT03381248|9612419|P2|Overall Study|Lost to Follow-up|2
2814195|NCT03381248|9612420|P1|Overall Study|Lost to Follow-up|3
2814196|NCT03381248|9612419|P2|Overall Study|Withdrawal by Subject|3
2814197|NCT03381248|9612420|P1|Overall Study|Withdrawal by Subject|5
2814198|NCT03380429|9612527|P5|Overall Study|Adverse Event|0
2814199|NCT03380429|9612528|P4|Overall Study|Adverse Event|2
2814200|NCT03380429|9612529|P3|Overall Study|Adverse Event|1
2814201|NCT03380429|9612530|P2|Overall Study|Adverse Event|1
2814202|NCT03380429|9612531|P1|Overall Study|Adverse Event|1
2814203|NCT03380429|9612527|P5|Overall Study|Lack of Efficacy|1
2814204|NCT03380429|9612528|P4|Overall Study|Lack of Efficacy|2
2814205|NCT03380429|9612529|P3|Overall Study|Lack of Efficacy|0
2814206|NCT03380429|9612530|P2|Overall Study|Lack of Efficacy|0
2814207|NCT03380429|9612531|P1|Overall Study|Lack of Efficacy|0
2814208|NCT03380429|9612527|P5|Overall Study|Protocol Violation|1
2814209|NCT03380429|9612528|P4|Overall Study|Protocol Violation|0
2814210|NCT03380429|9612529|P3|Overall Study|Protocol Violation|1
2814211|NCT03380429|9612530|P2|Overall Study|Protocol Violation|0
2814212|NCT03380429|9612531|P1|Overall Study|Protocol Violation|1
2814213|NCT03380429|9612527|P5|Overall Study|Lost to Follow-up|1
2814214|NCT03380429|9612528|P4|Overall Study|Lost to Follow-up|3
2814215|NCT03380429|9612529|P3|Overall Study|Lost to Follow-up|4
2814216|NCT03380429|9612530|P2|Overall Study|Lost to Follow-up|2
2814217|NCT03380429|9612531|P1|Overall Study|Lost to Follow-up|0
2814218|NCT03380429|9612527|P5|Overall Study|Withdrawal by Subject|1
2814219|NCT03380429|9612528|P4|Overall Study|Withdrawal by Subject|2
2814220|NCT03380429|9612529|P3|Overall Study|Withdrawal by Subject|5
2814221|NCT03380429|9612530|P2|Overall Study|Withdrawal by Subject|3
2814222|NCT03380429|9612531|P1|Overall Study|Withdrawal by Subject|3
2814223|NCT03380429|9612527|P5|Overall Study|Physician Decision|1
2814224|NCT03380429|9612528|P4|Overall Study|Physician Decision|1
2814225|NCT03380429|9612529|P3|Overall Study|Physician Decision|0
2814226|NCT03380429|9612530|P2|Overall Study|Physician Decision|1
2814227|NCT03380429|9612531|P1|Overall Study|Physician Decision|0
2814228|NCT03380390|9612584|P1|Overall Study|Adverse Event|3
2814229|NCT03379376|9612676|P1|Overall Study|Death|1
2814230|NCT03379376|9612676|P1|Overall Study|Overwhelmed, didn't want to continue|1
2814231|NCT03379376|9612676|P1|Overall Study|Did not wish to complete follow up|1
2814232|NCT03379376|9612676|P1|Overall Study|Lost to Follow-up|2
2814233|NCT03379233|9612686|P2|Overall Study|Technical issues with Concept 2 inhalers|6
2814234|NCT03379233|9612687|P1|Overall Study|Technical issues with Concept 2 inhalers|1
2814235|NCT03376516|9612719|P1|Overall Study|Consent withdrawn|1
2814236|NCT03376516|9612719|P1|Overall Study|Not treated|1
2814237|NCT03374995|9612785|P2|Overall Study|Withdrawal by Subject|1
2814238|NCT03374995|9612786|P1|Overall Study|Withdrawal by Subject|0
2814239|NCT03374488|9612800|P2|Overall Study|On-going at clinical cut off date|28
2814240|NCT03374488|9612801|P1|Overall Study|On-going at clinical cut off date|30
2814241|NCT03374488|9612800|P2|Overall Study|Withdrawal by Subject|1
2814242|NCT03374488|9612801|P1|Overall Study|Withdrawal by Subject|1
2814243|NCT03374488|9612800|P2|Overall Study|Death|8
2814244|NCT03374488|9612801|P1|Overall Study|Death|10
2814245|NCT03374189|9612813|P2|Overall Study|Lost to Follow-up|0
2814246|NCT03374189|9612814|P1|Overall Study|Lost to Follow-up|1
2814247|NCT03372603|9612895|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
2814248|NCT03372603|9612896|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
2814249|NCT03372603|9612895|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
2814250|NCT03372603|9612896|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
2814251|NCT03372551|9612938|P2|First Intervention (1 Week)|Withdrawal by Subject|0
2814252|NCT03372551|9612939|P1|First Intervention (1 Week)|Withdrawal by Subject|1
2814253|NCT03372369|9612969|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
2814342|NCT03357952|9613831|P2|Overall Study|Sponsor Decision|0
2814254|NCT03372369|9612970|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
2814255|NCT03372369|9612969|P2|Qualification Period|Inconsistent Eligibility Results|9
2814256|NCT03372369|9612970|P1|Qualification Period|Inconsistent Eligibility Results|10
2814257|NCT03372369|9612969|P2|Qualification Period|Withdrawal by Subject|13
2814258|NCT03372369|9612970|P1|Qualification Period|Withdrawal by Subject|16
2814259|NCT03371459|9612982|P2|Washout|Lost to Follow-up|1
2814260|NCT03371459|9612983|P1|Washout|Lost to Follow-up|0
2814261|NCT03371381|9612991|P1|Overall Study|Other|4
2814262|NCT03371381|9612991|P1|Overall Study|Study terminated by sponsor|3
2814263|NCT03371381|9612991|P1|Overall Study|Death|5
2814264|NCT03370419|9613012|P1|Overall Study|Lost to Follow-up|16
2814265|NCT03370289|9613016|P1|Overall Study|Sample Size Sufficient|4
2814266|NCT03370289|9613016|P1|Overall Study|Screen Failure|1
2814267|NCT03369704|9613052|P2|Follow-up Epoch|Lost to Follow-up|0
2814268|NCT03369704|9613053|P1|Follow-up Epoch|Lost to Follow-up|1
2814269|NCT03369704|9613052|P2|Treatment Epoch|Adverse Event|0
2814270|NCT03369704|9613053|P1|Treatment Epoch|Adverse Event|2
2814271|NCT03369704|9613052|P2|Treatment Epoch|Lack of Efficacy|2
2814272|NCT03369704|9613053|P1|Treatment Epoch|Lack of Efficacy|0
2814273|NCT03369704|9613052|P2|Treatment Epoch|Lost to Follow-up|1
2814274|NCT03369704|9613053|P1|Treatment Epoch|Lost to Follow-up|0
2814275|NCT03369704|9613052|P2|Treatment Epoch|Protocol Violation|0
2814276|NCT03369704|9613053|P1|Treatment Epoch|Protocol Violation|1
2814277|NCT03369704|9613052|P2|Treatment Epoch|technical problems|0
2814278|NCT03369704|9613053|P1|Treatment Epoch|technical problems|1
2814279|NCT03368807|9613173|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
2814280|NCT03368807|9613173|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
2814281|NCT03368807|9613173|P1|Period 1 (Blinded CGM)|Protocol Violation|1
2814282|NCT03368807|9613173|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
2814283|NCT03368170|9613189|P2|Overall Study|Adverse Event|1
2814284|NCT03368170|9613190|P1|Overall Study|Adverse Event|2
2814285|NCT03365934|9613222|P1|Overall Study|Withdrawal by Subject|1
2814286|NCT03365934|9613222|P1|Overall Study|Adverse Event|1
2814287|NCT03365011|9613512|P2|Overall Study|Withdrawal by Subject|2
2814288|NCT03365011|9613513|P1|Overall Study|Withdrawal by Subject|1
2814289|NCT03364608|9613523|P1|Overall Study|Lost to Follow-up|2
2814290|NCT03364608|9613523|P1|Overall Study|Protocol Violation|2
2814291|NCT03364608|9613523|P1|Overall Study|Withdrawal by Subject|4
2814292|NCT03364335|9613550|P5|Overall Study|Lost to Follow-up|11
2814293|NCT03364335|9613551|P4|Overall Study|Lost to Follow-up|11
2814294|NCT03364335|9613552|P3|Overall Study|Lost to Follow-up|10
2814295|NCT03364335|9613553|P2|Overall Study|Lost to Follow-up|7
2814296|NCT03364335|9613554|P1|Overall Study|Lost to Follow-up|7
2814297|NCT03364335|9613550|P5|Overall Study|Adverse Event|0
2814298|NCT03364335|9613551|P4|Overall Study|Adverse Event|2
2814299|NCT03364335|9613552|P3|Overall Study|Adverse Event|1
2814300|NCT03364335|9613553|P2|Overall Study|Adverse Event|4
2814301|NCT03364335|9613554|P1|Overall Study|Adverse Event|3
2814302|NCT03363906|9613626|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
2814303|NCT03363906|9613627|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
2814304|NCT03363906|9613626|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
2814305|NCT03363906|9613627|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
2814306|NCT03363906|9613626|P2|Period 2 (Test or Reference)|Adverse Event|0
2814307|NCT03363906|9613627|P1|Period 2 (Test or Reference)|Adverse Event|2
2814308|NCT03363906|9613626|P2|Period 1 (Reference or Test)|Adverse Event|2
2814309|NCT03363906|9613627|P1|Period 1 (Reference or Test)|Adverse Event|1
2814310|NCT03361865|9613697|P2|Overall Study|On-going at clinical cut off date|39
2814311|NCT03361865|9613698|P1|Overall Study|On-going at clinical cut off date|29
2814312|NCT03361865|9613697|P2|Overall Study|Physician Decision|0
2814313|NCT03361865|9613698|P1|Overall Study|Physician Decision|1
2814314|NCT03361865|9613697|P2|Overall Study|Death|10
2814315|NCT03361865|9613698|P1|Overall Study|Death|13
2814316|NCT03361228|9613710|P2|Overall Study|Death|0
2814317|NCT03361228|9613711|P1|Overall Study|Death|3
2814318|NCT03361228|9613710|P2|Overall Study|Other|1
2814319|NCT03361228|9613711|P1|Overall Study|Other|1
2814320|NCT03361176|9613733|P2|Overall Study|Withdrawal by Subject|1
2814321|NCT03361176|9613734|P1|Overall Study|Withdrawal by Subject|0
2814322|NCT03361176|9613733|P2|Overall Study|Adverse Event|2
2814323|NCT03361176|9613734|P1|Overall Study|Adverse Event|0
2814324|NCT03361176|9613733|P2|Overall Study|Lost to Follow-up|2
2814325|NCT03361176|9613734|P1|Overall Study|Lost to Follow-up|1
2814326|NCT03360071|9613767|P2|Overall Study|Lost to Follow-up|0
2814327|NCT03360071|9613768|P1|Overall Study|Lost to Follow-up|1
2814328|NCT03358472|9613792|P3|Overall Study|On-going at clinical cut off date|5
2814329|NCT03358472|9613793|P2|Overall Study|On-going at clinical cut off date|6
2814330|NCT03358472|9613794|P1|Overall Study|On-going at clinical cut off date|9
2814331|NCT03358472|9613792|P3|Overall Study|Withdrawal by Subject|1
2814332|NCT03358472|9613793|P2|Overall Study|Withdrawal by Subject|0
2814333|NCT03358472|9613794|P1|Overall Study|Withdrawal by Subject|0
2814334|NCT03358472|9613792|P3|Overall Study|Physician Decision|0
2814335|NCT03358472|9613793|P2|Overall Study|Physician Decision|1
2814336|NCT03358472|9613794|P1|Overall Study|Physician Decision|0
2814337|NCT03358472|9613792|P3|Overall Study|Death|10
2814338|NCT03358472|9613793|P2|Overall Study|Death|3
2814339|NCT03358472|9613794|P1|Overall Study|Death|6
2814340|NCT03358329|9613823|P1|Overall Study|Withdrawal by Subject|2
2814341|NCT03358329|9613823|P1|Overall Study|Lost to Follow-up|2
2814343|NCT03357952|9613832|P1|Overall Study|Sponsor Decision|9
2814344|NCT03357952|9613831|P2|Overall Study|Withdrawal by Subject|1
2814345|NCT03357952|9613832|P1|Overall Study|Withdrawal by Subject|0
2814346|NCT03357471|9613841|P2|Overall Study|Lost to Follow-up|0
2814347|NCT03357471|9613842|P1|Overall Study|Lost to Follow-up|1
2814348|NCT03357471|9613841|P2|Overall Study|Adverse Event|0
2814349|NCT03357471|9613842|P1|Overall Study|Adverse Event|1
2814350|NCT03356977|9613866|P1|Overall Study|Withdrawal by parent/guardian|2
2814351|NCT03356977|9613866|P1|Overall Study|Lost to Follow-up|3
2814352|NCT03354663|9613914|P1|Completed 30-day Visit|Missed Visit|1
2814353|NCT03354663|9613914|P1|Completed 30-day Visit|Withdrawal by Subject|1
2814354|NCT03354663|9613914|P1|Enrollment to Catheter Insertion|Adverse Event|1
2814355|NCT03354663|9613914|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
2814356|NCT03352713|9613988|P1|Overall Study|Device incompatible/stolen|5
2814357|NCT03352713|9613988|P1|Overall Study|Completed 0 EMAs|8
2814358|NCT03352713|9613988|P1|Overall Study|Withdrawn by investigator|5
2814359|NCT03352713|9613988|P1|Overall Study|Lost to Follow-up|8
2814360|NCT03351738|9614017|P6|Overall Study|Withdrawal by Subject|0
2814361|NCT03351738|9614018|P5|Overall Study|Withdrawal by Subject|0
2814362|NCT03351738|9614019|P4|Overall Study|Withdrawal by Subject|1
2814363|NCT03351738|9614020|P3|Overall Study|Withdrawal by Subject|0
2814364|NCT03351738|9614021|P2|Overall Study|Withdrawal by Subject|1
2814365|NCT03351738|9614022|P1|Overall Study|Withdrawal by Subject|0
2814366|NCT03351335|9614174|P3|Overall Study|Failure to maintain inclusion/exclusion|4
2814367|NCT03351335|9614175|P2|Overall Study|Failure to maintain inclusion/exclusion|0
2814368|NCT03351335|9614176|P1|Overall Study|Failure to maintain inclusion/exclusion|0
2814369|NCT03351231|9614196|P1|Safety Follow-Up Period|Other reason|2
2814370|NCT03351231|9614196|P1|Safety Follow-Up Period|Participant withdrew consent|1
2814371|NCT03351231|9614196|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
2814372|NCT03351231|9614196|P1|Combination Therapy Period|Study drug toxicity|1
2814373|NCT03351231|9614196|P1|Combination Therapy Period|Disease progression|2
2814374|NCT03351231|9614196|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
2814375|NCT03350984|9614220|P2|Overall Study|Physician Decision|0
2814376|NCT03350984|9614221|P1|Overall Study|Physician Decision|1
2814377|NCT03350984|9614220|P2|Overall Study|Protocol Violation|2
2814378|NCT03350984|9614221|P1|Overall Study|Protocol Violation|1
2814379|NCT03350984|9614220|P2|Overall Study|Lost to Follow-up|6
2814380|NCT03350984|9614221|P1|Overall Study|Lost to Follow-up|5
2814381|NCT03350984|9614220|P2|Overall Study|Death|0
2814382|NCT03350984|9614221|P1|Overall Study|Death|1
2814383|NCT03350503|9614288|P1|Overall Study|Subject Wishes|2
2814384|NCT03350503|9614288|P1|Overall Study|Hospital Transfer or Removal|2
2814385|NCT03350503|9614288|P1|Overall Study|Adverse Event|1
2814386|NCT03350256|9614292|P1|Overall Study|Lack of Efficacy|2
2814387|NCT03350256|9614292|P1|Overall Study|Lost to Follow-up|1
2814388|NCT03350256|9614292|P1|Overall Study|Subject moving out of state|1
2814389|NCT03350256|9614292|P1|Overall Study|Withdrawal by Subject|3
2814390|NCT03350256|9614292|P1|Overall Study|Did not proceed to permanent implant|3
2814391|NCT03350256|9614292|P1|Overall Study|Trial failure|12
2814392|NCT03350256|9614292|P1|Overall Study|Adverse Event|2
2814393|NCT03350256|9614292|P1|Overall Study|Denial by insurance|1
2814394|NCT03350256|9614292|P1|Overall Study|Non compliance|2
2814395|NCT03350256|9614292|P1|Overall Study|Protocol Violation|3
2814396|NCT03350256|9614292|P1|Overall Study|Recommended for other therapies|2
2814397|NCT03350256|9614292|P1|Overall Study|Inclusion/exclusion violation|4
2814398|NCT03349515|9614366|P2|Overall Study|Physician Decision|1
2814399|NCT03349515|9614367|P1|Overall Study|Physician Decision|3
2814400|NCT03349515|9614366|P2|Overall Study|Lack of Efficacy|0
2814401|NCT03349515|9614367|P1|Overall Study|Lack of Efficacy|2
2814402|NCT03349437|9614373|P3|Screening|Withdrawn|0
2814403|NCT03349437|9614374|P2|Screening|Withdrawn|0
2814404|NCT03349437|9614375|P1|Screening|Withdrawn|1
2814405|NCT03349437|9614373|P3|Screening|Screen Fail|0
2814406|NCT03349437|9614374|P2|Screening|Screen Fail|0
2814407|NCT03349437|9614375|P1|Screening|Screen Fail|4
2814408|NCT03349333|9614382|P1|Overall Study|Patients in treatment less than 24 month|8
2814409|NCT03349333|9614382|P1|Overall Study|3-week lapse between pralatrexate doses|1
2814410|NCT03349333|9614382|P1|Overall Study|Physician Decision|2
2814411|NCT03349333|9614382|P1|Overall Study|Conditions interfere with participation|2
2814412|NCT03349333|9614382|P1|Overall Study|Withdrawal by Subject|5
2814413|NCT03349333|9614382|P1|Overall Study|Other|6
2814414|NCT03349333|9614382|P1|Overall Study|Adverse Event|11
2814415|NCT03349333|9614382|P1|Overall Study|Progression of Disease|36
2814416|NCT03349099|9614405|P2|Overall Study|Stone migrated from the kidney|0
2814417|NCT03349099|9614406|P1|Overall Study|Stone migrated from the kidney|1
2814418|NCT03349099|9614405|P2|Overall Study|Physician Decision|4
2814419|NCT03349099|9614406|P1|Overall Study|Physician Decision|3
2814420|NCT03349060|9614419|P3|Overall Study|Other|0
2814421|NCT03349060|9614420|P2|Overall Study|Other|1
2814422|NCT03349060|9614421|P1|Overall Study|Other|2
2814423|NCT03349060|9614419|P3|Overall Study|Withdrawal By Parent/Guardian|0
2814424|NCT03349060|9614420|P2|Overall Study|Withdrawal By Parent/Guardian|1
2814425|NCT03349060|9614421|P1|Overall Study|Withdrawal By Parent/Guardian|0
2814426|NCT03349060|9614419|P3|Overall Study|Medication error,no linked adverse event|1
2814427|NCT03349060|9614420|P2|Overall Study|Medication error,no linked adverse event|0
2814599|NCT03340961|9615307|P1|Overall Study|Lost to Follow-up|0
2814428|NCT03349060|9614421|P1|Overall Study|Medication error,no linked adverse event|0
2814429|NCT03349060|9614419|P3|Overall Study|Withdrawal by Subject|4
2814430|NCT03349060|9614420|P2|Overall Study|Withdrawal by Subject|3
2814431|NCT03349060|9614421|P1|Overall Study|Withdrawal by Subject|5
2814432|NCT03349060|9614419|P3|Overall Study|Protocol Violation|1
2814433|NCT03349060|9614420|P2|Overall Study|Protocol Violation|2
2814434|NCT03349060|9614421|P1|Overall Study|Protocol Violation|2
2814435|NCT03349060|9614419|P3|Overall Study|Lost to Follow-up|1
2814436|NCT03349060|9614420|P2|Overall Study|Lost to Follow-up|1
2814437|NCT03349060|9614421|P1|Overall Study|Lost to Follow-up|2
2814438|NCT03349060|9614419|P3|Overall Study|Lack of Efficacy|2
2814439|NCT03349060|9614420|P2|Overall Study|Lack of Efficacy|0
2814440|NCT03349060|9614421|P1|Overall Study|Lack of Efficacy|1
2814441|NCT03349060|9614419|P3|Overall Study|Adverse Event|7
2814442|NCT03349060|9614420|P2|Overall Study|Adverse Event|9
2814443|NCT03349060|9614421|P1|Overall Study|Adverse Event|9
2814444|NCT03348904|9614563|P3|Overall Study|Administrative reason by the sponsor|0
2814445|NCT03348904|9614564|P2|Overall Study|Administrative reason by the sponsor|1
2814446|NCT03348904|9614565|P1|Overall Study|Administrative reason by the sponsor|0
2814447|NCT03346759|9614641|P2|Second Menstrual Cycle|Lost to Follow-up|0
2814448|NCT03346759|9614642|P1|Second Menstrual Cycle|Lost to Follow-up|1
2814449|NCT03346759|9614641|P2|First Menstrual Cycle|Withdrawal by Subject|0
2814450|NCT03346759|9614642|P1|First Menstrual Cycle|Withdrawal by Subject|1
2814451|NCT03346759|9614641|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
2814452|NCT03346759|9614642|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
2814453|NCT03346070|9614687|P5|Overall Study|Screen Failure|1
2814454|NCT03346070|9614688|P4|Overall Study|Screen Failure|1
2814455|NCT03346070|9614689|P3|Overall Study|Screen Failure|0
2814456|NCT03346070|9614690|P2|Overall Study|Screen Failure|0
2814457|NCT03346070|9614691|P1|Overall Study|Screen Failure|0
2814458|NCT03346070|9614687|P5|Overall Study|Study medication not received as planned|2
2814459|NCT03346070|9614688|P4|Overall Study|Study medication not received as planned|3
2814460|NCT03346070|9614689|P3|Overall Study|Study medication not received as planned|2
2814461|NCT03346070|9614690|P2|Overall Study|Study medication not received as planned|3
2814462|NCT03346070|9614691|P1|Overall Study|Study medication not received as planned|2
2814463|NCT03346070|9614687|P5|Overall Study|Withdrawal by Subject|0
2814464|NCT03346070|9614688|P4|Overall Study|Withdrawal by Subject|1
2814465|NCT03346070|9614689|P3|Overall Study|Withdrawal by Subject|0
2814466|NCT03346070|9614690|P2|Overall Study|Withdrawal by Subject|0
2814467|NCT03346070|9614691|P1|Overall Study|Withdrawal by Subject|1
2814468|NCT03346070|9614687|P5|Overall Study|Physician Decision|1
2814469|NCT03346070|9614688|P4|Overall Study|Physician Decision|1
2814470|NCT03346070|9614689|P3|Overall Study|Physician Decision|0
2814471|NCT03346070|9614690|P2|Overall Study|Physician Decision|0
2814472|NCT03346070|9614691|P1|Overall Study|Physician Decision|0
2814473|NCT03346070|9614687|P5|Overall Study|Lost to Follow-up|0
2814474|NCT03346070|9614688|P4|Overall Study|Lost to Follow-up|0
2814475|NCT03346070|9614689|P3|Overall Study|Lost to Follow-up|2
2814476|NCT03346070|9614690|P2|Overall Study|Lost to Follow-up|1
2814477|NCT03346070|9614691|P1|Overall Study|Lost to Follow-up|0
2814478|NCT03346070|9614687|P5|Overall Study|Death|1
2814479|NCT03346070|9614688|P4|Overall Study|Death|0
2814480|NCT03346070|9614689|P3|Overall Study|Death|0
2814481|NCT03346070|9614690|P2|Overall Study|Death|0
2814482|NCT03346070|9614691|P1|Overall Study|Death|0
2814483|NCT03345472|9614775|P1|3 Months to 12 Months|Death|1
2814484|NCT03345472|9614775|P1|3 Months to 12 Months|Adverse Event|1
2814485|NCT03345472|9614775|P1|3 Months to 12 Months|Withdrawal by Subject|1
2814486|NCT03345472|9614775|P1|3 Months to 12 Months|Lost to Follow-up|2
2814487|NCT03345472|9614775|P1|3 Months to 12 Months|Physician Decision|3
2814488|NCT03345472|9614775|P1|Implant to 3 Months|Adverse Event|1
2814489|NCT03345472|9614775|P1|Implant to 3 Months|Physician Decision|1
2814490|NCT03345472|9614775|P1|Implant to 3 Months|Withdrawal by Subject|2
2814491|NCT03345407|9614789|P7|Overall Study|Adverse Event|16
2814492|NCT03345407|9614790|P6|Overall Study|Adverse Event|5
2814493|NCT03345407|9614791|P5|Overall Study|Adverse Event|6
2814494|NCT03345407|9614792|P4|Overall Study|Adverse Event|4
2814495|NCT03345407|9614793|P3|Overall Study|Adverse Event|5
2814496|NCT03345407|9614794|P2|Overall Study|Adverse Event|0
2814497|NCT03345407|9614795|P1|Overall Study|Adverse Event|4
2814498|NCT03345407|9614789|P7|Overall Study|Lack of Efficacy|3
2814499|NCT03345407|9614790|P6|Overall Study|Lack of Efficacy|0
2814500|NCT03345407|9614791|P5|Overall Study|Lack of Efficacy|1
2814501|NCT03345407|9614792|P4|Overall Study|Lack of Efficacy|1
2814502|NCT03345407|9614793|P3|Overall Study|Lack of Efficacy|1
2814503|NCT03345407|9614794|P2|Overall Study|Lack of Efficacy|1
2814504|NCT03345407|9614795|P1|Overall Study|Lack of Efficacy|1
2814505|NCT03345407|9614789|P7|Overall Study|Protocol Violation|3
2814506|NCT03345407|9614790|P6|Overall Study|Protocol Violation|0
2814507|NCT03345407|9614791|P5|Overall Study|Protocol Violation|1
2814508|NCT03345407|9614792|P4|Overall Study|Protocol Violation|0
2814509|NCT03345407|9614793|P3|Overall Study|Protocol Violation|0
2814510|NCT03345407|9614794|P2|Overall Study|Protocol Violation|0
2814511|NCT03345407|9614795|P1|Overall Study|Protocol Violation|2
2814512|NCT03345407|9614789|P7|Overall Study|Protocol-defined stopping criteria|1
2814513|NCT03345407|9614790|P6|Overall Study|Protocol-defined stopping criteria|1
2814514|NCT03345407|9614791|P5|Overall Study|Protocol-defined stopping criteria|2
2814515|NCT03345407|9614792|P4|Overall Study|Protocol-defined stopping criteria|0
2814516|NCT03345407|9614793|P3|Overall Study|Protocol-defined stopping criteria|0
2814517|NCT03345407|9614794|P2|Overall Study|Protocol-defined stopping criteria|0
2814518|NCT03345407|9614795|P1|Overall Study|Protocol-defined stopping criteria|9
2814519|NCT03345407|9614789|P7|Overall Study|Lost to Follow-up|3
2814520|NCT03345407|9614790|P6|Overall Study|Lost to Follow-up|2
2814521|NCT03345407|9614791|P5|Overall Study|Lost to Follow-up|1
2814522|NCT03345407|9614792|P4|Overall Study|Lost to Follow-up|0
2814523|NCT03345407|9614793|P3|Overall Study|Lost to Follow-up|1
2814524|NCT03345407|9614794|P2|Overall Study|Lost to Follow-up|0
2814525|NCT03345407|9614795|P1|Overall Study|Lost to Follow-up|2
2814526|NCT03345407|9614789|P7|Overall Study|Physician Decision|3
2814527|NCT03345407|9614790|P6|Overall Study|Physician Decision|2
2814528|NCT03345407|9614791|P5|Overall Study|Physician Decision|1
2814529|NCT03345407|9614792|P4|Overall Study|Physician Decision|0
2814530|NCT03345407|9614793|P3|Overall Study|Physician Decision|0
2814531|NCT03345407|9614794|P2|Overall Study|Physician Decision|1
2814532|NCT03345407|9614795|P1|Overall Study|Physician Decision|3
2814533|NCT03345407|9614789|P7|Overall Study|Withdrawal by Subject|16
2814534|NCT03345407|9614790|P6|Overall Study|Withdrawal by Subject|6
2814535|NCT03345407|9614791|P5|Overall Study|Withdrawal by Subject|3
2814536|NCT03345407|9614792|P4|Overall Study|Withdrawal by Subject|6
2814537|NCT03345407|9614793|P3|Overall Study|Withdrawal by Subject|5
2814538|NCT03345407|9614794|P2|Overall Study|Withdrawal by Subject|1
2814539|NCT03345407|9614795|P1|Overall Study|Withdrawal by Subject|11
2814540|NCT03344172|9615032|P2|Overall Study|Received <1 dose of treatment|0
2814541|NCT03344172|9615033|P1|Overall Study|Received <1 dose of treatment|1
2814542|NCT03343639|9615051|P2|Overall Study|Protocol Violation|1
2814543|NCT03343639|9615052|P1|Overall Study|Protocol Violation|0
2814544|NCT03343639|9615051|P2|Overall Study|Lost to Follow-up|5
2814545|NCT03343639|9615052|P1|Overall Study|Lost to Follow-up|4
2814546|NCT03343639|9615051|P2|Overall Study|Withdrawal by Subject|6
2814547|NCT03343639|9615052|P1|Overall Study|Withdrawal by Subject|10
2814548|NCT03343067|9615080|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
2814549|NCT03343067|9615081|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
2814550|NCT03343067|9615082|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
2814551|NCT03342560|9615207|P1|Overall Study|Lost to Follow-up|2
2814552|NCT03341923|9615215|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
2814553|NCT03341923|9615216|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
2814554|NCT03341637|9615243|P2|Overall Study|Reason not Specified|1
2814555|NCT03341637|9615244|P1|Overall Study|Reason not Specified|1
2814556|NCT03341637|9615243|P2|Overall Study|Withdrawal by Subject|3
2814557|NCT03341637|9615244|P1|Overall Study|Withdrawal by Subject|3
2814558|NCT03341637|9615243|P2|Overall Study|Lost to Follow-up|0
2814559|NCT03341637|9615244|P1|Overall Study|Lost to Follow-up|1
2814560|NCT03341533|9615272|P2|Overall Study|Not eligible after randomization|1
2814561|NCT03341533|9615273|P1|Overall Study|Not eligible after randomization|2
2814562|NCT03341533|9615272|P2|Overall Study|Withdrawal by Subject|1
2814563|NCT03341533|9615273|P1|Overall Study|Withdrawal by Subject|1
2814564|NCT03341299|9615285|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
2814565|NCT03341299|9615286|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
2814566|NCT03341299|9615287|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
2814567|NCT03341299|9615288|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
2814568|NCT03340961|9615304|P4|Overall Study|Other|3
2814569|NCT03340961|9615305|P3|Overall Study|Other|1
2814570|NCT03340961|9615306|P2|Overall Study|Other|2
2814571|NCT03340961|9615307|P1|Overall Study|Other|0
2814572|NCT03340961|9615304|P4|Overall Study|Adverse Event|0
2814573|NCT03340961|9615305|P3|Overall Study|Adverse Event|0
2814574|NCT03340961|9615306|P2|Overall Study|Adverse Event|1
2814575|NCT03340961|9615307|P1|Overall Study|Adverse Event|1
2814576|NCT03340961|9615304|P4|Overall Study|Protocol Violation|0
2814577|NCT03340961|9615305|P3|Overall Study|Protocol Violation|1
2814578|NCT03340961|9615306|P2|Overall Study|Protocol Violation|0
2814579|NCT03340961|9615307|P1|Overall Study|Protocol Violation|1
2814580|NCT03340961|9615304|P4|Overall Study|Subject developed an exclusion criterion|0
2814581|NCT03340961|9615305|P3|Overall Study|Subject developed an exclusion criterion|0
2814582|NCT03340961|9615306|P2|Overall Study|Subject developed an exclusion criterion|1
2814583|NCT03340961|9615307|P1|Overall Study|Subject developed an exclusion criterion|0
2814584|NCT03340961|9615304|P4|Overall Study|rongful enrollment (I/E criteria not me|1
2814585|NCT03340961|9615305|P3|Overall Study|rongful enrollment (I/E criteria not me|0
2814586|NCT03340961|9615306|P2|Overall Study|rongful enrollment (I/E criteria not me|0
2814587|NCT03340961|9615307|P1|Overall Study|rongful enrollment (I/E criteria not me|0
2814588|NCT03340961|9615304|P4|Overall Study|Use of prohibited treatment|3
2814589|NCT03340961|9615305|P3|Overall Study|Use of prohibited treatment|2
2814590|NCT03340961|9615306|P2|Overall Study|Use of prohibited treatment|3
2814591|NCT03340961|9615307|P1|Overall Study|Use of prohibited treatment|0
2814592|NCT03340961|9615304|P4|Overall Study|Withdrawal by Subject|6
2814593|NCT03340961|9615305|P3|Overall Study|Withdrawal by Subject|3
2814594|NCT03340961|9615306|P2|Overall Study|Withdrawal by Subject|1
2814595|NCT03340961|9615307|P1|Overall Study|Withdrawal by Subject|3
2814596|NCT03340961|9615304|P4|Overall Study|Lost to Follow-up|1
2814597|NCT03340961|9615305|P3|Overall Study|Lost to Follow-up|0
2814598|NCT03340961|9615306|P2|Overall Study|Lost to Follow-up|1
2814600|NCT03340961|9615304|P4|Overall Study|Adverse Event|4
2814601|NCT03340961|9615305|P3|Overall Study|Adverse Event|2
2814602|NCT03340961|9615306|P2|Overall Study|Adverse Event|3
2814603|NCT03340961|9615307|P1|Overall Study|Adverse Event|1
2814604|NCT03339726|9615355|P3|Overall Study|Lost to Follow-up|0
2814605|NCT03339726|9615356|P2|Overall Study|Lost to Follow-up|1
2814606|NCT03339726|9615357|P1|Overall Study|Lost to Follow-up|0
2814607|NCT03339726|9615355|P3|Overall Study|Withdrawal by Subject|0
2814608|NCT03339726|9615356|P2|Overall Study|Withdrawal by Subject|0
2814609|NCT03339726|9615357|P1|Overall Study|Withdrawal by Subject|1
2814610|NCT03339583|9615415|P2|Follow-up (14 Days)|Physician Decision|3
2814611|NCT03339583|9615416|P1|Follow-up (14 Days)|Physician Decision|6
2814612|NCT03339583|9615415|P2|Second Intervention (14 Days)|Adverse Event|1
2814613|NCT03339583|9615416|P1|Second Intervention (14 Days)|Adverse Event|0
2814614|NCT03339583|9615415|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
2814615|NCT03339583|9615416|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
2814616|NCT03339583|9615415|P2|First Intervention (14 Days)|Adverse Event|0
2814617|NCT03339583|9615416|P1|First Intervention (14 Days)|Adverse Event|1
2814618|NCT03339453|9615454|P2|First Visit of Glucagon Treatment|Adverse Event|1
2814619|NCT03339453|9615455|P1|First Visit of Glucagon Treatment|Adverse Event|0
2814620|NCT03338816|9615473|P2|Open-Label Extension Period|Ongoing in Study|47
2814621|NCT03338816|9615474|P1|Open-Label Extension Period|Ongoing in Study|46
2814622|NCT03338816|9615473|P2|6-Month Double-blind Period|Adverse Event|1
2814623|NCT03338816|9615474|P1|6-Month Double-blind Period|Adverse Event|0
2814624|NCT03338400|9615536|P2|Overall Study|Lost to Follow-up|2
2814625|NCT03338400|9615537|P1|Overall Study|Lost to Follow-up|1
2814626|NCT03337477|9615545|P2|Overall Study|Lost to Follow-up|2
2814627|NCT03337477|9615546|P1|Overall Study|Lost to Follow-up|0
2814628|NCT03337477|9615545|P2|Overall Study|Death|1
2814629|NCT03337477|9615546|P1|Overall Study|Death|0
2814630|NCT03337477|9615545|P2|Overall Study|Withdrawal by Subject|1
2814631|NCT03337477|9615546|P1|Overall Study|Withdrawal by Subject|0
2814632|NCT03337477|9615545|P2|Overall Study|not categorized into the listed ones|9
2814633|NCT03337477|9615546|P1|Overall Study|not categorized into the listed ones|11
2814634|NCT03337308|9615570|P4|Overall Study|Protocol Violation|0
2814635|NCT03337308|9615571|P3|Overall Study|Protocol Violation|0
2814636|NCT03337308|9615572|P2|Overall Study|Protocol Violation|1
2814637|NCT03337308|9615573|P1|Overall Study|Protocol Violation|0
2814638|NCT03337308|9615570|P4|Overall Study|Withdrawal by Subject|1
2814639|NCT03337308|9615571|P3|Overall Study|Withdrawal by Subject|2
2814640|NCT03337308|9615572|P2|Overall Study|Withdrawal by Subject|1
2814641|NCT03337308|9615573|P1|Overall Study|Withdrawal by Subject|2
2814642|NCT03337308|9615570|P4|Overall Study|Lost to Follow-up|0
2814643|NCT03337308|9615571|P3|Overall Study|Lost to Follow-up|0
2814644|NCT03337308|9615572|P2|Overall Study|Lost to Follow-up|2
2814645|NCT03337308|9615573|P1|Overall Study|Lost to Follow-up|1
2814646|NCT03337308|9615570|P4|Overall Study|Adverse Event|1
2814647|NCT03337308|9615571|P3|Overall Study|Adverse Event|3
2814648|NCT03337308|9615572|P2|Overall Study|Adverse Event|3
2814649|NCT03337308|9615573|P1|Overall Study|Adverse Event|2
2814650|NCT03336502|9615618|P2|Overall Study|Adverse Event|5
2814651|NCT03336502|9615619|P1|Overall Study|Adverse Event|2
2814652|NCT03336502|9615618|P2|Overall Study|Death|2
2814653|NCT03336502|9615619|P1|Overall Study|Death|1
2814654|NCT03336502|9615618|P2|Overall Study|Prohibited Drugs|1
2814655|NCT03336502|9615619|P1|Overall Study|Prohibited Drugs|1
2814656|NCT03336502|9615618|P2|Overall Study|Physician Decision|1
2814657|NCT03336502|9615619|P1|Overall Study|Physician Decision|0
2814658|NCT03335566|9615655|P2|Overall Study|Other than specified above|2
2814659|NCT03335566|9615656|P1|Overall Study|Other than specified above|1
2814660|NCT03335566|9615655|P2|Overall Study|Protocol Violation|0
2814661|NCT03335566|9615656|P1|Overall Study|Protocol Violation|1
2814662|NCT03335566|9615655|P2|Overall Study|Technical Problems|0
2814663|NCT03335566|9615656|P1|Overall Study|Technical Problems|1
2814664|NCT03335566|9615655|P2|Overall Study|Lost to Follow-up|0
2814665|NCT03335566|9615656|P1|Overall Study|Lost to Follow-up|1
2814666|NCT03335566|9615655|P2|Overall Study|Adverse Event|1
2814667|NCT03335566|9615656|P1|Overall Study|Adverse Event|0
2814668|NCT03334448|9615876|P4|Washout|Protocol Violation|1
2814669|NCT03334448|9615877|P3|Washout|Protocol Violation|0
2814670|NCT03334448|9615878|P2|Washout|Protocol Violation|0
2814671|NCT03334448|9615879|P1|Washout|Protocol Violation|0
2814672|NCT03334448|9615876|P4|Washout|Personal Reason|0
2814673|NCT03334448|9615877|P3|Washout|Personal Reason|0
2814674|NCT03334448|9615878|P2|Washout|Personal Reason|1
2814675|NCT03334448|9615879|P1|Washout|Personal Reason|0
2814676|NCT03334422|9615891|P4|Overall Study|Pregnancy|0
2814677|NCT03334422|9615892|P3|Overall Study|Pregnancy|0
2814678|NCT03334422|9615893|P2|Overall Study|Pregnancy|1
2814679|NCT03334422|9615894|P1|Overall Study|Pregnancy|0
2814680|NCT03334422|9615891|P4|Overall Study|Inability to obtain laboratory samples|0
2814681|NCT03334422|9615892|P3|Overall Study|Inability to obtain laboratory samples|0
2814682|NCT03334422|9615893|P2|Overall Study|Inability to obtain laboratory samples|1
2814683|NCT03334422|9615894|P1|Overall Study|Inability to obtain laboratory samples|0
2814684|NCT03334422|9615891|P4|Overall Study|Lost to Follow-up|1
2814685|NCT03334422|9615892|P3|Overall Study|Lost to Follow-up|0
2814686|NCT03334422|9615893|P2|Overall Study|Lost to Follow-up|0
2814687|NCT03334422|9615894|P1|Overall Study|Lost to Follow-up|0
2814688|NCT03334422|9615891|P4|Overall Study|Withdrawal by Subject|0
2814689|NCT03334422|9615892|P3|Overall Study|Withdrawal by Subject|1
2814690|NCT03334422|9615893|P2|Overall Study|Withdrawal by Subject|3
2814691|NCT03334422|9615894|P1|Overall Study|Withdrawal by Subject|8
2814692|NCT03334422|9615891|P4|Overall Study|Lack of Efficacy|3
2814693|NCT03334422|9615892|P3|Overall Study|Lack of Efficacy|7
2814694|NCT03334422|9615893|P2|Overall Study|Lack of Efficacy|2
2814695|NCT03334422|9615894|P1|Overall Study|Lack of Efficacy|10
2814696|NCT03334422|9615891|P4|Overall Study|Adverse Event|2
2814697|NCT03334422|9615892|P3|Overall Study|Adverse Event|2
2814698|NCT03334422|9615893|P2|Overall Study|Adverse Event|3
2814699|NCT03334422|9615894|P1|Overall Study|Adverse Event|1
2814700|NCT03334396|9615997|P4|Overall Study|Started New Job|0
2814701|NCT03334396|9615998|P3|Overall Study|Started New Job|0
2814702|NCT03334396|9615999|P2|Overall Study|Started New Job|0
2814703|NCT03334396|9616000|P1|Overall Study|Started New Job|1
2814704|NCT03334396|9615997|P4|Overall Study|Ineligible|0
2814705|NCT03334396|9615998|P3|Overall Study|Ineligible|0
2814706|NCT03334396|9615999|P2|Overall Study|Ineligible|1
2814707|NCT03334396|9616000|P1|Overall Study|Ineligible|0
2814708|NCT03334396|9615997|P4|Overall Study|Pregnancy|0
2814709|NCT03334396|9615998|P3|Overall Study|Pregnancy|0
2814710|NCT03334396|9615999|P2|Overall Study|Pregnancy|1
2814711|NCT03334396|9616000|P1|Overall Study|Pregnancy|0
2814712|NCT03334396|9615997|P4|Overall Study|Withdrawal by Subject|2
2814713|NCT03334396|9615998|P3|Overall Study|Withdrawal by Subject|7
2814714|NCT03334396|9615999|P2|Overall Study|Withdrawal by Subject|5
2814715|NCT03334396|9616000|P1|Overall Study|Withdrawal by Subject|10
2814716|NCT03334396|9615997|P4|Overall Study|Physician Decision|0
2814717|NCT03334396|9615998|P3|Overall Study|Physician Decision|0
2814718|NCT03334396|9615999|P2|Overall Study|Physician Decision|0
2814719|NCT03334396|9616000|P1|Overall Study|Physician Decision|1
2814720|NCT03334396|9615997|P4|Overall Study|Lost to Follow-up|0
2814721|NCT03334396|9615998|P3|Overall Study|Lost to Follow-up|1
2814722|NCT03334396|9615999|P2|Overall Study|Lost to Follow-up|0
2814723|NCT03334396|9616000|P1|Overall Study|Lost to Follow-up|0
2814724|NCT03334396|9615997|P4|Overall Study|Lack of Efficacy|3
2814725|NCT03334396|9615998|P3|Overall Study|Lack of Efficacy|1
2814726|NCT03334396|9615999|P2|Overall Study|Lack of Efficacy|4
2814727|NCT03334396|9616000|P1|Overall Study|Lack of Efficacy|10
2814728|NCT03334396|9615997|P4|Overall Study|Adverse Event|0
2814729|NCT03334396|9615998|P3|Overall Study|Adverse Event|1
2814730|NCT03334396|9615999|P2|Overall Study|Adverse Event|0
2814731|NCT03334396|9616000|P1|Overall Study|Adverse Event|1
2814732|NCT03334214|9616101|P2|Overall Study|Other|0
2814733|NCT03334214|9616102|P1|Overall Study|Other|1
2814734|NCT03334214|9616101|P2|Overall Study|Withdrawal by Subject|1
2814735|NCT03334214|9616102|P1|Overall Study|Withdrawal by Subject|0
2814736|NCT03334214|9616101|P2|Overall Study|Adverse Event or Serious Adverse Event|1
2814737|NCT03334214|9616102|P1|Overall Study|Adverse Event or Serious Adverse Event|0
2814738|NCT03333876|9616128|P1|Mandibular Advancement|Product Damage|2
2814739|NCT03333876|9616128|P1|Mandibular Advancement|Adverse Event|2
2814740|NCT03333876|9616128|P1|Nasal Dilator|Bed Partner Lost to follow up|6
2814741|NCT03333876|9616128|P1|Screening Period|Screen Failure|4
2814742|NCT03331315|9616325|P2|Overall Study|Physician Decision|14
2814743|NCT03331315|9616326|P1|Overall Study|Physician Decision|18
2814744|NCT03331042|9616363|P4|Overall Study|Lost to Follow-up|1
2814745|NCT03331042|9616364|P3|Overall Study|Lost to Follow-up|0
2814746|NCT03331042|9616365|P2|Overall Study|Lost to Follow-up|0
2814747|NCT03331042|9616366|P1|Overall Study|Lost to Follow-up|0
2814748|NCT03331042|9616363|P4|Overall Study|Physician Decision|0
2814749|NCT03331042|9616364|P3|Overall Study|Physician Decision|1
2814750|NCT03331042|9616365|P2|Overall Study|Physician Decision|0
2814751|NCT03331042|9616366|P1|Overall Study|Physician Decision|0
2814752|NCT03331042|9616363|P4|Overall Study|Protocol Violation|0
2814753|NCT03331042|9616364|P3|Overall Study|Protocol Violation|0
2814754|NCT03331042|9616365|P2|Overall Study|Protocol Violation|0
2814755|NCT03331042|9616366|P1|Overall Study|Protocol Violation|1
2814756|NCT03329885|9616463|P9|Overall Study|Sponsor discontinued the study early|0
2814757|NCT03329885|9616464|P8|Overall Study|Sponsor discontinued the study early|1
2814758|NCT03329885|9616465|P7|Overall Study|Sponsor discontinued the study early|1
2814759|NCT03329885|9616466|P6|Overall Study|Sponsor discontinued the study early|0
2814760|NCT03329885|9616467|P5|Overall Study|Sponsor discontinued the study early|0
2814761|NCT03329885|9616468|P4|Overall Study|Sponsor discontinued the study early|0
2814762|NCT03329885|9616469|P3|Overall Study|Sponsor discontinued the study early|0
2814763|NCT03329885|9616470|P2|Overall Study|Sponsor discontinued the study early|0
2814764|NCT03329885|9616471|P1|Overall Study|Sponsor discontinued the study early|0
2814765|NCT03329573|9616639|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2814766|NCT03329573|9616640|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2814767|NCT03329573|9616641|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
2814768|NCT03329573|9616642|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2814769|NCT03329573|9616639|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2814770|NCT03329573|9616640|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2814771|NCT03329573|9616641|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2814772|NCT03329573|9616642|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
2814773|NCT03329573|9616639|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2814774|NCT03329573|9616640|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2814775|NCT03329573|9616641|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
2814776|NCT03329573|9616642|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
2814777|NCT03329573|9616639|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2814778|NCT03329573|9616640|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2814779|NCT03329573|9616641|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
2814780|NCT03329573|9616642|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2814781|NCT03328182|9616756|P1|Overall Study|No Product Evaluated|1
2814782|NCT03328182|9616756|P1|Overall Study|Protocol Violation|2
2814783|NCT03328182|9616756|P1|Overall Study|Withdrawal by Subject|1
2814784|NCT03327402|9616761|P1|Overall Study|Other (Visit Out-Of-Window)|1
2814785|NCT03327402|9616761|P1|Overall Study|Withdrawal by Subject|1
2814786|NCT03326323|9617059|P1|Overall Study|Unable to receive ANH protocol|3
2814787|NCT03325894|9617066|P2|Overall Study|Other (Not received Treatment)|0
2814788|NCT03325894|9617067|P1|Overall Study|Other (Not received Treatment)|1
2814789|NCT03325894|9617066|P2|Overall Study|Study Terminated by Sponsor|43
2814790|NCT03325894|9617067|P1|Overall Study|Study Terminated by Sponsor|38
2814791|NCT03325894|9617066|P2|Overall Study|Lack of Efficacy|14
2814792|NCT03325894|9617067|P1|Overall Study|Lack of Efficacy|8
2814793|NCT03325894|9617066|P2|Overall Study|Lost to Follow-up|9
2814794|NCT03325894|9617067|P1|Overall Study|Lost to Follow-up|4
2814795|NCT03325894|9617066|P2|Overall Study|Withdrawal by Subject|6
2814796|NCT03325894|9617067|P1|Overall Study|Withdrawal by Subject|10
2814797|NCT03325894|9617066|P2|Overall Study|Protocol Violation|2
2814798|NCT03325894|9617067|P1|Overall Study|Protocol Violation|1
2814799|NCT03325894|9617066|P2|Overall Study|Adverse Event|3
2814800|NCT03325894|9617067|P1|Overall Study|Adverse Event|2
2814801|NCT03325881|9617135|P2|Overall Study|Not treated|0
2814802|NCT03325881|9617136|P1|Overall Study|Not treated|1
2814803|NCT03325881|9617135|P2|Overall Study|Lack of Efficacy|0
2814804|NCT03325881|9617136|P1|Overall Study|Lack of Efficacy|2
2814805|NCT03325881|9617135|P2|Overall Study|Withdrawal by Subject|2
2814806|NCT03325881|9617136|P1|Overall Study|Withdrawal by Subject|0
2814807|NCT03325881|9617135|P2|Overall Study|Protocol Violation|1
2814808|NCT03325881|9617136|P1|Overall Study|Protocol Violation|0
2814809|NCT03325673|9617164|P2|Overall Study|Adverse Event|0
2814810|NCT03325673|9617165|P1|Overall Study|Adverse Event|4
2814811|NCT03323736|9617180|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
2814812|NCT03323736|9617181|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
2814813|NCT03323736|9617182|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
2814814|NCT03323736|9617180|P3|Overall Study|Withdrawal Before Treatment|1
2814815|NCT03323736|9617181|P2|Overall Study|Withdrawal Before Treatment|1
2814816|NCT03323736|9617182|P1|Overall Study|Withdrawal Before Treatment|3
2814817|NCT03323736|9617180|P3|Overall Study|Screen Failure|1
2814818|NCT03323736|9617181|P2|Overall Study|Screen Failure|9
2814819|NCT03323736|9617182|P1|Overall Study|Screen Failure|14
2814820|NCT03323086|9617209|P2|Overall Study|Lost to Follow-up|2
2814821|NCT03323086|9617210|P1|Overall Study|Lost to Follow-up|3
2814822|NCT03322566|9617238|P3|Overall Study|On-going at clinical cut off date|36
2814823|NCT03322566|9617239|P2|Overall Study|On-going at clinical cut off date|74
2814824|NCT03322566|9617240|P1|Overall Study|On-going at clinical cut off date|68
2814825|NCT03322566|9617238|P3|Overall Study|Withdrawal by Subject|5
2814826|NCT03322566|9617239|P2|Overall Study|Withdrawal by Subject|1
2814827|NCT03322566|9617240|P1|Overall Study|Withdrawal by Subject|3
2814828|NCT03322566|9617238|P3|Overall Study|Physician Decision|1
2814829|NCT03322566|9617239|P2|Overall Study|Physician Decision|0
2814830|NCT03322566|9617240|P1|Overall Study|Physician Decision|0
2814831|NCT03322566|9617238|P3|Overall Study|Death|13
2814832|NCT03322566|9617239|P2|Overall Study|Death|12
2814833|NCT03322566|9617240|P1|Overall Study|Death|20
2814834|NCT03322540|9617259|P2|Overall Study|Participants Ongoing|59
2814835|NCT03322540|9617260|P1|Overall Study|Participants Ongoing|63
2814836|NCT03322540|9617259|P2|Overall Study|Withdrawal by Subject|1
2814837|NCT03322540|9617260|P1|Overall Study|Withdrawal by Subject|2
2814838|NCT03322540|9617259|P2|Overall Study|Physician Decision|1
2814839|NCT03322540|9617260|P1|Overall Study|Physician Decision|0
2814840|NCT03322540|9617259|P2|Overall Study|Lost to Follow-up|1
2814841|NCT03322540|9617260|P1|Overall Study|Lost to Follow-up|0
2814842|NCT03322540|9617259|P2|Overall Study|Death|15
2814843|NCT03322540|9617260|P1|Overall Study|Death|12
2814844|NCT03322514|9617268|P2|Overall Study|Withdrawal by Subject|1
2814845|NCT03322514|9617269|P1|Overall Study|Withdrawal by Subject|1
2814846|NCT03322423|9617279|P2|Period 2|Subject not eligible for Pytergiumectomy|1
2814847|NCT03322423|9617280|P1|Period 2|Subject not eligible for Pytergiumectomy|0
2814848|NCT03322423|9617279|P2|Period 2|Protocol Violation|0
2814849|NCT03322423|9617280|P1|Period 2|Protocol Violation|1
2814850|NCT03322423|9617279|P2|Period 2|Dispensed incorrect lens in left eye|1
2814851|NCT03322423|9617280|P1|Period 2|Dispensed incorrect lens in left eye|0
2814852|NCT03322423|9617279|P2|Period 1|Unsatisfactory Lens Fitting|0
2814853|NCT03322423|9617280|P1|Period 1|Unsatisfactory Lens Fitting|1
2814854|NCT03322423|9617279|P2|Period 1|Incorrect Lens Dispensed|0
2814855|NCT03322423|9617280|P1|Period 1|Incorrect Lens Dispensed|1
2814856|NCT03322423|9617279|P2|Period 1|Withdrawal by Subject|1
2814857|NCT03322423|9617280|P1|Period 1|Withdrawal by Subject|0
2814858|NCT03322423|9617279|P2|Period 1|Subject no longer eligible|1
2814859|NCT03322423|9617280|P1|Period 1|Subject no longer eligible|0
2814860|NCT03322293|9617293|P3|Overall Study|Lost to Follow-up|1
2814861|NCT03322293|9617294|P2|Overall Study|Lost to Follow-up|0
2814862|NCT03322293|9617295|P1|Overall Study|Lost to Follow-up|0
2814863|NCT03321396|9617315|P1|Overall Study|Physician Decision|1
2814864|NCT03320941|9617334|P5|Overall Study|subject/guardian decision|0
2814865|NCT03320941|9617335|P4|Overall Study|subject/guardian decision|1
2814866|NCT03320941|9617336|P3|Overall Study|subject/guardian decision|0
2814867|NCT03320941|9617337|P2|Overall Study|subject/guardian decision|0
2814868|NCT03320941|9617338|P1|Overall Study|subject/guardian decision|0
2814869|NCT03320564|9617439|P1|Overall Study|Protocol Violation|1
2814870|NCT03319719|9617455|P1|Overall Study|Lost to Follow-up|1
2814871|NCT03319212|9617488|P2|Overall Study|Physician Decision|0
2814872|NCT03319212|9617489|P1|Overall Study|Physician Decision|1
2814873|NCT03319212|9617488|P2|Overall Study|Lost to Follow-up|1
2814874|NCT03319212|9617489|P1|Overall Study|Lost to Follow-up|0
2814875|NCT03319212|9617488|P2|Overall Study|Withdrawal by Subject|1
2814876|NCT03319212|9617489|P1|Overall Study|Withdrawal by Subject|0
2814877|NCT03319212|9617488|P2|Overall Study|Adverse Event|2
2814878|NCT03319212|9617489|P1|Overall Study|Adverse Event|2
2814879|NCT03319212|9617488|P2|Overall Study|Discontinued as moving out of local area|1
2814880|NCT03319212|9617489|P1|Overall Study|Discontinued as moving out of local area|0
2814881|NCT03318861|9617558|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
2814882|NCT03318861|9617559|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
2814883|NCT03318861|9617560|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
2814884|NCT03318861|9617561|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
2814885|NCT03318861|9617562|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
2814886|NCT03318861|9617558|P5|Overall Study|Still on Study|1
2814887|NCT03318861|9617559|P4|Overall Study|Still on Study|2
2814888|NCT03318861|9617560|P3|Overall Study|Still on Study|1
2814889|NCT03318861|9617561|P2|Overall Study|Still on Study|1
2814890|NCT03318861|9617562|P1|Overall Study|Still on Study|2
2814891|NCT03318861|9617558|P5|Overall Study|Death|1
2814892|NCT03318861|9617559|P4|Overall Study|Death|1
2814893|NCT03318861|9617560|P3|Overall Study|Death|2
2814894|NCT03318861|9617561|P2|Overall Study|Death|2
2814895|NCT03318861|9617562|P1|Overall Study|Death|1
2814896|NCT03316911|9617644|P2|Overall Study|Lost to Follow-up|29
2814897|NCT03316911|9617645|P1|Overall Study|Lost to Follow-up|33
2814898|NCT03316131|9617690|P2|Treatment Period 2|Protocol deviation|0
2814899|NCT03316131|9617691|P1|Treatment Period 2|Protocol deviation|1
2814900|NCT03315286|9617812|P2|Overall Study|Protocol Violation|1
2814901|NCT03315286|9617813|P1|Overall Study|Protocol Violation|0
2814902|NCT03315286|9617812|P2|Overall Study|Withdrawal by Subject|0
2814903|NCT03315286|9617813|P1|Overall Study|Withdrawal by Subject|1
2814904|NCT03315286|9617812|P2|Overall Study|Lost to Follow-up|3
2814905|NCT03315286|9617813|P1|Overall Study|Lost to Follow-up|0
2814906|NCT03314519|9617856|P2|Overall Study|Protocol Violation|2
2814907|NCT03314519|9617857|P1|Overall Study|Protocol Violation|3
2814908|NCT03314233|9617867|P1|Overall Study|No longer eligible at time of delivery|1
2814909|NCT03313037|9617880|P2|Overall Study|Randomized but not treated|0
2814910|NCT03313037|9617881|P1|Overall Study|Randomized but not treated|1
2814911|NCT03313037|9617880|P2|Overall Study|Lost to Follow-up|8
2814912|NCT03313037|9617881|P1|Overall Study|Lost to Follow-up|9
2814913|NCT03313037|9617880|P2|Overall Study|No longer meets eligibility criteria|7
2814914|NCT03313037|9617881|P1|Overall Study|No longer meets eligibility criteria|1
2814915|NCT03313037|9617880|P2|Overall Study|Withdrawal by Subject|3
2814916|NCT03313037|9617881|P1|Overall Study|Withdrawal by Subject|4
2814917|NCT03313037|9617880|P2|Overall Study|Other|1
2814918|NCT03313037|9617881|P1|Overall Study|Other|1
2814919|NCT03313037|9617880|P2|Overall Study|Protocol Violation|1
2814920|NCT03313037|9617881|P1|Overall Study|Protocol Violation|4
2814921|NCT03312933|9617903|P1|Overall Study|Withdrawal by Subject|3
2814922|NCT03312933|9617903|P1|Overall Study|Lost to Follow-up|36
2814923|NCT03312933|9617903|P1|Overall Study|Protocol Violation|15
2814924|NCT03312543|9617909|P2|Regression (Week 12 to Week 24)|Death|1
2814925|NCT03312543|9617910|P1|Regression (Week 12 to Week 24)|Death|0
2814926|NCT03312543|9617909|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
2814927|NCT03312543|9617910|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
2814928|NCT03312543|9617909|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
2814929|NCT03312543|9617910|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
2814930|NCT03312543|9617909|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
2814931|NCT03312543|9617910|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
2814932|NCT03312543|9617909|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
2814933|NCT03312543|9617910|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
2814934|NCT03312543|9617909|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
2814935|NCT03312543|9617910|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
2814936|NCT03311841|9618006|P5|14-day Wash-out|Non-Compliance With Study Drug|0
2814937|NCT03311841|9618007|P4|14-day Wash-out|Non-Compliance With Study Drug|1
2814938|NCT03311841|9618008|P3|14-day Wash-out|Non-Compliance With Study Drug|0
2814939|NCT03311841|9618009|P2|14-day Wash-out|Non-Compliance With Study Drug|0
2814940|NCT03311841|9618010|P1|14-day Wash-out|Non-Compliance With Study Drug|0
2814941|NCT03311841|9618006|P5|14-day Wash-out|Adverse Event|0
2814942|NCT03311841|9618007|P4|14-day Wash-out|Adverse Event|0
2814943|NCT03311841|9618008|P3|14-day Wash-out|Adverse Event|0
2814944|NCT03311841|9618009|P2|14-day Wash-out|Adverse Event|1
2814945|NCT03311841|9618010|P1|14-day Wash-out|Adverse Event|0
2814946|NCT03311659|9618111|P1|Overall Study|Protocol Violation|1
2814947|NCT03311646|9618126|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
2814948|NCT03311646|9618126|P1|Overall Study|Lost to Follow-up|5
2814949|NCT03311646|9618126|P1|Overall Study|Withdrawal by Subject|5
2814950|NCT03311646|9618126|P1|Overall Study|Physician Decision|1
2814951|NCT03311230|9618137|P4|Overall Study|Unrelated injury|0
2814952|NCT03311230|9618138|P3|Overall Study|Unrelated injury|0
2814953|NCT03311230|9618139|P2|Overall Study|Unrelated injury|1
2814954|NCT03311230|9618140|P1|Overall Study|Unrelated injury|0
2814955|NCT03311230|9618137|P4|Overall Study|Withdrawal by Subject|7
2814956|NCT03311230|9618138|P3|Overall Study|Withdrawal by Subject|2
2814957|NCT03311230|9618139|P2|Overall Study|Withdrawal by Subject|4
2814958|NCT03311230|9618140|P1|Overall Study|Withdrawal by Subject|1
2814959|NCT03310580|9618165|P3|Overall Study|Adverse Event|0
2814960|NCT03310580|9618166|P2|Overall Study|Adverse Event|1
2814961|NCT03310580|9618167|P1|Overall Study|Adverse Event|0
2814962|NCT03310411|9618200|P4|Period 1|Adverse Event|1
2814963|NCT03310411|9618201|P3|Period 1|Adverse Event|0
2814964|NCT03310411|9618202|P2|Period 1|Adverse Event|0
2814965|NCT03310411|9618203|P1|Period 1|Adverse Event|0
2814966|NCT03310268|9618224|P3|Overall Study|(Not specified)|0
2814967|NCT03310268|9618225|P2|Overall Study|(Not specified)|5
2814968|NCT03310268|9618226|P1|Overall Study|(Not specified)|1
2814969|NCT03309202|9618241|P4|Overall Study|Lost to Follow-up|0
2814970|NCT03309202|9618242|P3|Overall Study|Lost to Follow-up|0
2814971|NCT03309202|9618243|P2|Overall Study|Lost to Follow-up|0
2814972|NCT03309202|9618244|P1|Overall Study|Lost to Follow-up|1
2814973|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
2814974|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
2814975|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
2814976|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2814977|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2814978|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
2814979|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
2814980|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2814981|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2814982|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
2814983|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
2814984|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
2814985|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
2814986|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2814987|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2814988|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Adverse Event|1
2814989|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Adverse Event|1
2814990|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Adverse Event|4
2814991|NCT03308968|9618329|P3|Open-Label Period (12 Weeks)|Other than specified|1
2814992|NCT03308968|9618330|P2|Open-Label Period (12 Weeks)|Other than specified|2
2814993|NCT03308968|9618331|P1|Open-Label Period (12 Weeks)|Other than specified|1
2814994|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Other than specified|2
2814995|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Other than specified|0
2814996|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Other than specified|1
2814997|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
2814998|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2814999|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2815000|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2815001|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2815002|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
2815003|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
2815004|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2815005|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2815006|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
2815007|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
2815008|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
2815009|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
2815010|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2815011|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2815012|NCT03308968|9618329|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
2815013|NCT03308968|9618330|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
2815014|NCT03308968|9618331|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
2815015|NCT03308825|9618409|P4|Overall Study|Protocol Violation|0
2815016|NCT03308825|9618410|P3|Overall Study|Protocol Violation|0
2815017|NCT03308825|9618411|P2|Overall Study|Protocol Violation|2
2815018|NCT03308825|9618412|P1|Overall Study|Protocol Violation|0
2815019|NCT03308825|9618409|P4|Overall Study|Lost to Follow-up|0
2815020|NCT03308825|9618410|P3|Overall Study|Lost to Follow-up|1
2815021|NCT03308825|9618411|P2|Overall Study|Lost to Follow-up|2
2815022|NCT03308825|9618412|P1|Overall Study|Lost to Follow-up|2
2815023|NCT03307252|9618500|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
2815024|NCT03307252|9618501|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815025|NCT03307252|9618502|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815026|NCT03307252|9618503|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815027|NCT03307252|9618504|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815028|NCT03307252|9618505|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815029|NCT03307252|9618506|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815030|NCT03307252|9618507|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815031|NCT03307252|9618508|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815032|NCT03307252|9618509|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815033|NCT03307252|9618510|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2815034|NCT03307252|9618500|P11|Part 2, Period 4|Other than listed|0
2815035|NCT03307252|9618501|P10|Part 2, Period 4|Other than listed|0
2815036|NCT03307252|9618502|P9|Part 2, Period 4|Other than listed|0
2815037|NCT03307252|9618503|P8|Part 2, Period 4|Other than listed|0
2815038|NCT03307252|9618504|P7|Part 2, Period 4|Other than listed|1
2815039|NCT03307252|9618505|P6|Part 2, Period 4|Other than listed|0
2815040|NCT03307252|9618506|P5|Part 2, Period 4|Other than listed|0
2815041|NCT03307252|9618507|P4|Part 2, Period 4|Other than listed|0
2815042|NCT03307252|9618508|P3|Part 2, Period 4|Other than listed|0
2815043|NCT03307252|9618509|P2|Part 2, Period 4|Other than listed|0
2815044|NCT03307252|9618510|P1|Part 2, Period 4|Other than listed|0
2815045|NCT03307252|9618500|P11|Part 2, Period 3|Other than listed|0
2815046|NCT03307252|9618501|P10|Part 2, Period 3|Other than listed|0
2815047|NCT03307252|9618502|P9|Part 2, Period 3|Other than listed|0
2815048|NCT03307252|9618503|P8|Part 2, Period 3|Other than listed|0
2815049|NCT03307252|9618504|P7|Part 2, Period 3|Other than listed|0
2815050|NCT03307252|9618505|P6|Part 2, Period 3|Other than listed|0
2815051|NCT03307252|9618506|P5|Part 2, Period 3|Other than listed|1
2815052|NCT03307252|9618507|P4|Part 2, Period 3|Other than listed|0
2815053|NCT03307252|9618508|P3|Part 2, Period 3|Other than listed|0
2815054|NCT03307252|9618509|P2|Part 2, Period 3|Other than listed|0
2815055|NCT03307252|9618510|P1|Part 2, Period 3|Other than listed|0
2815056|NCT03307252|9618500|P11|Part 2, Period 1|Treatment not received|0
2815057|NCT03307252|9618501|P10|Part 2, Period 1|Treatment not received|0
2815058|NCT03307252|9618502|P9|Part 2, Period 1|Treatment not received|0
2815059|NCT03307252|9618503|P8|Part 2, Period 1|Treatment not received|0
2815060|NCT03307252|9618504|P7|Part 2, Period 1|Treatment not received|0
2815061|NCT03307252|9618505|P6|Part 2, Period 1|Treatment not received|1
2815062|NCT03307252|9618506|P5|Part 2, Period 1|Treatment not received|0
2815063|NCT03307252|9618507|P4|Part 2, Period 1|Treatment not received|0
2815064|NCT03307252|9618508|P3|Part 2, Period 1|Treatment not received|0
2815065|NCT03307252|9618509|P2|Part 2, Period 1|Treatment not received|0
2815066|NCT03307252|9618510|P1|Part 2, Period 1|Treatment not received|0
2815067|NCT03307174|9618547|P2|Overall Study|Intrathecal catheter placement|1
2815068|NCT03307174|9618548|P1|Overall Study|Intrathecal catheter placement|0
2815069|NCT03307174|9618547|P2|Overall Study|Planned epidural removal|0
2815070|NCT03307174|9618548|P1|Overall Study|Planned epidural removal|1
2815071|NCT03307174|9618547|P2|Overall Study|Nonfunctional epidural|1
2815072|NCT03307174|9618548|P1|Overall Study|Nonfunctional epidural|1
2815073|NCT03307174|9618547|P2|Overall Study|Hypotension|0
2815074|NCT03307174|9618548|P1|Overall Study|Hypotension|6
2815075|NCT03307174|9618547|P2|Overall Study|Aborted Surgery|2
2815076|NCT03307174|9618548|P1|Overall Study|Aborted Surgery|1
2815077|NCT03307174|9618547|P2|Overall Study|Unplanned ICU Administrion|3
2815078|NCT03307174|9618548|P1|Overall Study|Unplanned ICU Administrion|5
2815079|NCT03305770|9618844|P2|Overall Study|Subject moved|0
2815080|NCT03305770|9618845|P1|Overall Study|Subject moved|1
2815081|NCT03305770|9618844|P2|Overall Study|Physician Decision - prior to dispense|1
2815082|NCT03305770|9618845|P1|Overall Study|Physician Decision - prior to dispense|0
2815083|NCT03305731|9618853|P1|Overall Study|Protocol Violation|1
2815084|NCT03305419|9618870|P8|Part B (14 Days)|Physician Decision|0
2815085|NCT03305419|9618871|P7|Part B (14 Days)|Physician Decision|1
2815086|NCT03305419|9618872|P6|Part B (14 Days)|Physician Decision|8
2815087|NCT03305419|9618873|P5|Part B (14 Days)|Physician Decision|2
2815088|NCT03305419|9618874|P4|Part B (14 Days)|Physician Decision|0
2815089|NCT03305419|9618875|P3|Part B (14 Days)|Physician Decision|0
2815090|NCT03305419|9618876|P2|Part B (14 Days)|Physician Decision|0
2815091|NCT03305419|9618877|P1|Part B (14 Days)|Physician Decision|0
2815092|NCT03305419|9618870|P8|Part B (14 Days)|Adverse Event|0
2815093|NCT03305419|9618871|P7|Part B (14 Days)|Adverse Event|4
2815094|NCT03305419|9618872|P6|Part B (14 Days)|Adverse Event|2
2815095|NCT03305419|9618873|P5|Part B (14 Days)|Adverse Event|1
2815096|NCT03305419|9618874|P4|Part B (14 Days)|Adverse Event|0
2815097|NCT03305419|9618875|P3|Part B (14 Days)|Adverse Event|0
2815098|NCT03305419|9618876|P2|Part B (14 Days)|Adverse Event|0
2815099|NCT03305419|9618877|P1|Part B (14 Days)|Adverse Event|0
2815100|NCT03305419|9618870|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815101|NCT03305419|9618871|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815102|NCT03305419|9618872|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815103|NCT03305419|9618873|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815104|NCT03305419|9618874|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815105|NCT03305419|9618875|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815106|NCT03305419|9618876|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2815107|NCT03305419|9618877|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
2815108|NCT03305419|9618870|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815109|NCT03305419|9618871|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815110|NCT03305419|9618872|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815111|NCT03305419|9618873|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815112|NCT03305419|9618874|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815113|NCT03305419|9618875|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815114|NCT03305419|9618876|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2815115|NCT03305419|9618877|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
2815116|NCT03305419|9618870|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815117|NCT03305419|9618871|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815118|NCT03305419|9618872|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815119|NCT03305419|9618873|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815120|NCT03305419|9618874|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815121|NCT03305419|9618875|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815122|NCT03305419|9618876|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
2815123|NCT03305419|9618877|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2815124|NCT03305055|9619018|P2|Overall Study|Adverse Event|1
2815125|NCT03305055|9619019|P1|Overall Study|Adverse Event|1
2815126|NCT03305055|9619018|P2|Overall Study|Withdrawal by Subject|1
2815127|NCT03305055|9619019|P1|Overall Study|Withdrawal by Subject|0
2815128|NCT03304873|9619037|P2|Overall Study|Lost to Follow-up|8
2815129|NCT03304873|9619038|P1|Overall Study|Lost to Follow-up|1
2815130|NCT03303521|9619135|P2|Overall Study|Adverse Event|0
2815131|NCT03303521|9619136|P1|Overall Study|Adverse Event|1
2815132|NCT03303521|9619135|P2|Overall Study|Non-comliance to study protocol|1
2815133|NCT03303521|9619136|P1|Overall Study|Non-comliance to study protocol|0
2815134|NCT03303521|9619135|P2|Overall Study|Transferred to non-study dialysis center|0
2815135|NCT03303521|9619136|P1|Overall Study|Transferred to non-study dialysis center|1
2815136|NCT03303521|9619135|P2|Overall Study|Investigational product discontinuation|1
2815137|NCT03303521|9619136|P1|Overall Study|Investigational product discontinuation|0
2815138|NCT03303521|9619135|P2|Overall Study|Kidney transplantation|1
2815139|NCT03303521|9619136|P1|Overall Study|Kidney transplantation|0
2815140|NCT03303521|9619135|P2|Overall Study|Death|0
2815141|NCT03303521|9619136|P1|Overall Study|Death|1
2815142|NCT03303521|9619135|P2|Overall Study|Withdrawal by Subject|0
2815143|NCT03303521|9619136|P1|Overall Study|Withdrawal by Subject|2
2815144|NCT03303417|9619146|P2|Overall Study|Withdrawal by Subject|1
2815145|NCT03303417|9619147|P1|Overall Study|Withdrawal by Subject|1
2815146|NCT03302975|9619161|P1|Overall Study|Lost to Follow-up|4
2815147|NCT03302936|9619169|P2|Overall Study|Protocol Violation|4
2815148|NCT03302936|9619170|P1|Overall Study|Protocol Violation|3
2815149|NCT03302559|9619191|P1|Overall Study|Withdrew Consent|3
2815150|NCT03302559|9619191|P1|Overall Study|Lost to Follow-up|1
2815151|NCT03302559|9619191|P1|Overall Study|Adverse Event|2
2815152|NCT03301844|9619207|P2|Overall Study|suspected colon cancer|1
2815153|NCT03301844|9619208|P1|Overall Study|suspected colon cancer|1
2815154|NCT03301740|9619235|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
2815155|NCT03301740|9619236|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
2815156|NCT03301740|9619235|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
2815157|NCT03301740|9619236|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
2815158|NCT03301714|9619279|P3|Overall Study|Did not receive allocated intervention|3
2815159|NCT03301714|9619280|P2|Overall Study|Did not receive allocated intervention|2
2815160|NCT03301714|9619281|P1|Overall Study|Did not receive allocated intervention|0
2815161|NCT03301714|9619279|P3|Overall Study|Lost to Follow-up|4
2815162|NCT03301714|9619280|P2|Overall Study|Lost to Follow-up|4
2815163|NCT03301714|9619281|P1|Overall Study|Lost to Follow-up|10
2815164|NCT03301649|9619298|P3|Overall Study|Other than specified|0
2815165|NCT03301649|9619299|P2|Overall Study|Other than specified|3
2815166|NCT03301649|9619300|P1|Overall Study|Other than specified|5
2815167|NCT03301649|9619298|P3|Overall Study|Withdrawal by Subject|0
2815168|NCT03301649|9619299|P2|Overall Study|Withdrawal by Subject|4
2815169|NCT03301649|9619300|P1|Overall Study|Withdrawal by Subject|10
2815170|NCT03301649|9619298|P3|Overall Study|Protocol Violation|1
2815171|NCT03301649|9619299|P2|Overall Study|Protocol Violation|1
2815172|NCT03301649|9619300|P1|Overall Study|Protocol Violation|0
2815173|NCT03301649|9619298|P3|Overall Study|Lost to Follow-up|3
2815174|NCT03301649|9619299|P2|Overall Study|Lost to Follow-up|11
2815175|NCT03301649|9619300|P1|Overall Study|Lost to Follow-up|11
2815176|NCT03301649|9619298|P3|Overall Study|Need alternate therapy due to live lice|81
2815177|NCT03301649|9619299|P2|Overall Study|Need alternate therapy due to live lice|25
2815178|NCT03301649|9619300|P1|Overall Study|Need alternate therapy due to live lice|17
2815179|NCT03301155|9619366|P2|Overall Study|Сompliance with exclusion criteria|7
2815180|NCT03301155|9619367|P1|Overall Study|Сompliance with exclusion criteria|8
2815181|NCT03300570|9619402|P2|Overall Study|Inadequate bowel prep|0
2815182|NCT03300570|9619403|P1|Overall Study|Inadequate bowel prep|1
2815183|NCT03300570|9619402|P2|Overall Study|Withdrawal by Subject|0
2815184|NCT03300570|9619403|P1|Overall Study|Withdrawal by Subject|1
2815185|NCT03300570|9619402|P2|Overall Study|Adverse Event|1
2815186|NCT03300570|9619403|P1|Overall Study|Adverse Event|0
2815187|NCT03300024|9619426|P2|Overall Study|Physician Decision|6
2815188|NCT03300024|9619427|P1|Overall Study|Physician Decision|4
2815189|NCT03298867|9619481|P2|Overall Study|Continued in the Follow-Up Period|1
2815190|NCT03298867|9619482|P1|Overall Study|Continued in the Follow-Up Period|0
2815191|NCT03298867|9619481|P2|Overall Study|Did not Continue in the Follow-Up Period|1
2815192|NCT03298867|9619482|P1|Overall Study|Did not Continue in the Follow-Up Period|2
2815193|NCT03296566|9619606|P2|Overall Study|Withdrawal by Subject|3
2815194|NCT03296566|9619607|P1|Overall Study|Withdrawal by Subject|0
2815195|NCT03296566|9619606|P2|Overall Study|Lost to Follow-up|46
2815196|NCT03296566|9619607|P1|Overall Study|Lost to Follow-up|19
2815197|NCT03295201|9619704|P2|Overall Study|Hospital admission|1
2815198|NCT03295201|9619705|P1|Overall Study|Hospital admission|0
2815199|NCT03295201|9619704|P2|Overall Study|Lost to Follow-up|1
2815200|NCT03295201|9619705|P1|Overall Study|Lost to Follow-up|1
2815201|NCT03294538|9619791|P3|Overall Study|Outside of Visit Window|1
2815202|NCT03294538|9619792|P2|Overall Study|Outside of Visit Window|4
2815203|NCT03294538|9619793|P1|Overall Study|Outside of Visit Window|4
2815204|NCT03294538|9619791|P3|Overall Study|Lost to Follow-up|0
2815205|NCT03294538|9619792|P2|Overall Study|Lost to Follow-up|0
2815206|NCT03294538|9619793|P1|Overall Study|Lost to Follow-up|1
2815207|NCT03294538|9619791|P3|Overall Study|Adverse Event|1
2815208|NCT03294538|9619792|P2|Overall Study|Adverse Event|1
2815209|NCT03294538|9619793|P1|Overall Study|Adverse Event|0
2815210|NCT03293485|9619808|P1|Overall Study|Withdrawal by Subject|2
2815211|NCT03293485|9619808|P1|Overall Study|Screen Failure|2
2815212|NCT03293485|9619808|P1|Overall Study|Death|1
2815213|NCT03293394|9619819|P2|Follow-up (6 Months)|Adverse Event|2
2815214|NCT03293394|9619820|P1|Follow-up (6 Months)|Adverse Event|4
2815215|NCT03291288|9619911|P2|Pexidartinib Only|Ongoing|13
2815216|NCT03291288|9619912|P1|Pexidartinib Only|Ongoing|0
2815217|NCT03291288|9619911|P2|Pexidartinib Only|Other|2
2815218|NCT03291288|9619912|P1|Pexidartinib Only|Other|0
2815219|NCT03291288|9619911|P2|Pexidartinib Only|Patient request|1
2815220|NCT03291288|9619912|P1|Pexidartinib Only|Patient request|0
2815221|NCT03291288|9619911|P2|Pexidartinib Only|Disease progression|8
2815222|NCT03291288|9619912|P1|Pexidartinib Only|Disease progression|0
2815223|NCT03291288|9619911|P2|Pexidartinib Only|Adverse Event|1
2815224|NCT03291288|9619912|P1|Pexidartinib Only|Adverse Event|0
2815225|NCT03291288|9619911|P2|Drug-drug Interaction Phase|Did not receive treatment|0
2815226|NCT03291288|9619912|P1|Drug-drug Interaction Phase|Did not receive treatment|2
2815227|NCT03291288|9619911|P2|Drug-drug Interaction Phase|Disease progression|0
2815228|NCT03291288|9619912|P1|Drug-drug Interaction Phase|Disease progression|2
2815229|NCT03291288|9619911|P2|Drug-drug Interaction Phase|Adverse Event|0
2815230|NCT03291288|9619912|P1|Drug-drug Interaction Phase|Adverse Event|3
2815231|NCT03290300|9619986|P1|Overall Study|Lost to Follow-up|3
2815232|NCT03289676|9620019|P2|Overall Study|Lost to Follow-up|1
2815233|NCT03289676|9620020|P1|Overall Study|Lost to Follow-up|0
2815234|NCT03289676|9620019|P2|Overall Study|Protocol Violation|0
2815235|NCT03289676|9620020|P1|Overall Study|Protocol Violation|2
2815236|NCT03289676|9620019|P2|Overall Study|Withdrawal by Subject|0
2815237|NCT03289676|9620020|P1|Overall Study|Withdrawal by Subject|2
2815238|NCT03289208|9620070|P3|Overall Study|Adverse Event|0
2815239|NCT03289208|9620071|P2|Overall Study|Adverse Event|0
2815240|NCT03289208|9620072|P1|Overall Study|Adverse Event|1
2815241|NCT03288779|9620089|P1|Overall Study|Withdrawal by Subject|3
2815242|NCT03287791|9620112|P3|Overall Study|Did not meet inclusion criteria|0
2815243|NCT03287791|9620113|P2|Overall Study|Did not meet inclusion criteria|0
2815244|NCT03287791|9620114|P1|Overall Study|Did not meet inclusion criteria|1
2815245|NCT03287791|9620112|P3|Overall Study|Non-compliance|0
2815246|NCT03287791|9620113|P2|Overall Study|Non-compliance|1
2815247|NCT03287791|9620114|P1|Overall Study|Non-compliance|0
2815248|NCT03287791|9620112|P3|Overall Study|Too much time between 2 visits|0
2815249|NCT03287791|9620113|P2|Overall Study|Too much time between 2 visits|1
2815250|NCT03287791|9620114|P1|Overall Study|Too much time between 2 visits|0
2815251|NCT03287791|9620112|P3|Overall Study|Participant was enrolled at 2 sites|1
2815252|NCT03287791|9620113|P2|Overall Study|Participant was enrolled at 2 sites|0
2815253|NCT03287791|9620114|P1|Overall Study|Participant was enrolled at 2 sites|1
2815254|NCT03287791|9620112|P3|Overall Study|Protocol Violation|1
2815255|NCT03287791|9620113|P2|Overall Study|Protocol Violation|2
2815256|NCT03287791|9620114|P1|Overall Study|Protocol Violation|7
2815257|NCT03287791|9620112|P3|Overall Study|Lost to Follow-up|11
2815258|NCT03287791|9620113|P2|Overall Study|Lost to Follow-up|14
2815259|NCT03287791|9620114|P1|Overall Study|Lost to Follow-up|8
2815260|NCT03287791|9620112|P3|Overall Study|Missed more than 6 consecutive doses|2
2815261|NCT03287791|9620113|P2|Overall Study|Missed more than 6 consecutive doses|2
2815262|NCT03287791|9620114|P1|Overall Study|Missed more than 6 consecutive doses|3
2815263|NCT03287791|9620112|P3|Overall Study|Withdrawal by Subject|17
2815264|NCT03287791|9620113|P2|Overall Study|Withdrawal by Subject|12
2815265|NCT03287791|9620114|P1|Overall Study|Withdrawal by Subject|12
2815266|NCT03287791|9620112|P3|Overall Study|Adverse Event|3
2815267|NCT03287791|9620113|P2|Overall Study|Adverse Event|4
2815268|NCT03287791|9620114|P1|Overall Study|Adverse Event|0
2815269|NCT03287791|9620112|P3|Overall Study|Insufficient Therapeutic Response|1
2815270|NCT03287791|9620113|P2|Overall Study|Insufficient Therapeutic Response|0
2815271|NCT03287791|9620114|P1|Overall Study|Insufficient Therapeutic Response|0
2815272|NCT03286751|9620150|P6|Washout Period 5|Adverse Event|0
2815273|NCT03286751|9620151|P5|Washout Period 5|Adverse Event|1
2815274|NCT03286751|9620152|P4|Washout Period 5|Adverse Event|0
2815275|NCT03286751|9620153|P3|Washout Period 5|Adverse Event|0
2815276|NCT03286751|9620154|P2|Washout Period 5|Adverse Event|0
2815277|NCT03286751|9620155|P1|Washout Period 5|Adverse Event|0
2815278|NCT03286751|9620150|P6|Washout Period 2|Personal Reasons|0
2815279|NCT03286751|9620151|P5|Washout Period 2|Personal Reasons|0
2815280|NCT03286751|9620152|P4|Washout Period 2|Personal Reasons|0
2815281|NCT03286751|9620153|P3|Washout Period 2|Personal Reasons|0
2815282|NCT03286751|9620154|P2|Washout Period 2|Personal Reasons|1
2815283|NCT03286751|9620155|P1|Washout Period 2|Personal Reasons|0
2815284|NCT03286751|9620150|P6|Washout Period 1|Withdrawal by Subject|0
2815285|NCT03286751|9620151|P5|Washout Period 1|Withdrawal by Subject|1
2815286|NCT03286751|9620152|P4|Washout Period 1|Withdrawal by Subject|0
2815287|NCT03286751|9620153|P3|Washout Period 1|Withdrawal by Subject|0
2815288|NCT03286751|9620154|P2|Washout Period 1|Withdrawal by Subject|0
2815289|NCT03286751|9620155|P1|Washout Period 1|Withdrawal by Subject|0
2815290|NCT03286218|9620191|P12|Treatment Phase Period 4|Withdrawal by Subject|1
2815291|NCT03286218|9620192|P11|Treatment Phase Period 4|Withdrawal by Subject|0
2815292|NCT03286218|9620193|P10|Treatment Phase Period 4|Withdrawal by Subject|0
2815293|NCT03286218|9620194|P9|Treatment Phase Period 4|Withdrawal by Subject|0
2815294|NCT03286218|9620195|P8|Treatment Phase Period 4|Withdrawal by Subject|0
2815295|NCT03286218|9620196|P7|Treatment Phase Period 4|Withdrawal by Subject|0
2815296|NCT03286218|9620197|P6|Treatment Phase Period 4|Withdrawal by Subject|0
2815297|NCT03286218|9620198|P5|Treatment Phase Period 4|Withdrawal by Subject|0
2815298|NCT03286218|9620199|P4|Treatment Phase Period 4|Withdrawal by Subject|0
2815299|NCT03286218|9620200|P3|Treatment Phase Period 4|Withdrawal by Subject|0
2815300|NCT03286218|9620201|P2|Treatment Phase Period 4|Withdrawal by Subject|0
2815301|NCT03286218|9620202|P1|Treatment Phase Period 4|Withdrawal by Subject|0
2815302|NCT03286218|9620191|P12|Treatment Phase Period 1|Withdrawal by Subject|1
2815303|NCT03286218|9620192|P11|Treatment Phase Period 1|Withdrawal by Subject|0
2815304|NCT03286218|9620193|P10|Treatment Phase Period 1|Withdrawal by Subject|0
2815305|NCT03286218|9620194|P9|Treatment Phase Period 1|Withdrawal by Subject|0
2815306|NCT03286218|9620195|P8|Treatment Phase Period 1|Withdrawal by Subject|0
2815307|NCT03286218|9620196|P7|Treatment Phase Period 1|Withdrawal by Subject|0
2815308|NCT03286218|9620197|P6|Treatment Phase Period 1|Withdrawal by Subject|1
2815309|NCT03286218|9620198|P5|Treatment Phase Period 1|Withdrawal by Subject|0
2815310|NCT03286218|9620199|P4|Treatment Phase Period 1|Withdrawal by Subject|1
2815311|NCT03286218|9620200|P3|Treatment Phase Period 1|Withdrawal by Subject|1
2815312|NCT03286218|9620201|P2|Treatment Phase Period 1|Withdrawal by Subject|0
2815313|NCT03286218|9620202|P1|Treatment Phase Period 1|Withdrawal by Subject|0
2815314|NCT03286218|9620191|P12|Qualification Phase Period 2|Withdrawal by Subject|0
2815315|NCT03286218|9620192|P11|Qualification Phase Period 2|Withdrawal by Subject|0
2815316|NCT03286218|9620193|P10|Qualification Phase Period 2|Withdrawal by Subject|0
2815317|NCT03286218|9620194|P9|Qualification Phase Period 2|Withdrawal by Subject|0
2815318|NCT03286218|9620195|P8|Qualification Phase Period 2|Withdrawal by Subject|0
2815319|NCT03286218|9620196|P7|Qualification Phase Period 2|Withdrawal by Subject|0
2815320|NCT03286218|9620197|P6|Qualification Phase Period 2|Withdrawal by Subject|0
2815321|NCT03286218|9620198|P5|Qualification Phase Period 2|Withdrawal by Subject|0
2815322|NCT03286218|9620199|P4|Qualification Phase Period 2|Withdrawal by Subject|0
2815323|NCT03286218|9620200|P3|Qualification Phase Period 2|Withdrawal by Subject|0
2815324|NCT03286218|9620201|P2|Qualification Phase Period 2|Withdrawal by Subject|2
2815325|NCT03286218|9620202|P1|Qualification Phase Period 2|Withdrawal by Subject|1
2815326|NCT03286218|9620191|P12|Qualification Phase Period 2|Protocol Violation|0
2815327|NCT03286218|9620192|P11|Qualification Phase Period 2|Protocol Violation|0
2815328|NCT03286218|9620193|P10|Qualification Phase Period 2|Protocol Violation|0
2815329|NCT03286218|9620194|P9|Qualification Phase Period 2|Protocol Violation|0
2815330|NCT03286218|9620195|P8|Qualification Phase Period 2|Protocol Violation|0
2815331|NCT03286218|9620196|P7|Qualification Phase Period 2|Protocol Violation|0
2815332|NCT03286218|9620197|P6|Qualification Phase Period 2|Protocol Violation|0
2815333|NCT03286218|9620198|P5|Qualification Phase Period 2|Protocol Violation|0
2815334|NCT03286218|9620199|P4|Qualification Phase Period 2|Protocol Violation|0
2815335|NCT03286218|9620200|P3|Qualification Phase Period 2|Protocol Violation|0
2815336|NCT03286218|9620201|P2|Qualification Phase Period 2|Protocol Violation|0
2815337|NCT03286218|9620202|P1|Qualification Phase Period 2|Protocol Violation|2
2815338|NCT03286218|9620191|P12|Qualification Phase Period 2|Lost to Follow-up|0
2815339|NCT03286218|9620192|P11|Qualification Phase Period 2|Lost to Follow-up|0
2815340|NCT03286218|9620193|P10|Qualification Phase Period 2|Lost to Follow-up|0
2815341|NCT03286218|9620194|P9|Qualification Phase Period 2|Lost to Follow-up|0
2815342|NCT03286218|9620195|P8|Qualification Phase Period 2|Lost to Follow-up|0
2815343|NCT03286218|9620196|P7|Qualification Phase Period 2|Lost to Follow-up|0
2815344|NCT03286218|9620197|P6|Qualification Phase Period 2|Lost to Follow-up|0
2815345|NCT03286218|9620198|P5|Qualification Phase Period 2|Lost to Follow-up|0
2815346|NCT03286218|9620199|P4|Qualification Phase Period 2|Lost to Follow-up|0
2815347|NCT03286218|9620200|P3|Qualification Phase Period 2|Lost to Follow-up|0
2815348|NCT03286218|9620201|P2|Qualification Phase Period 2|Lost to Follow-up|1
2815349|NCT03286218|9620202|P1|Qualification Phase Period 2|Lost to Follow-up|0
2815350|NCT03286218|9620191|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815351|NCT03286218|9620192|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815352|NCT03286218|9620193|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815353|NCT03286218|9620194|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815354|NCT03286218|9620195|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815355|NCT03286218|9620196|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815356|NCT03286218|9620197|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815357|NCT03286218|9620198|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815358|NCT03286218|9620199|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815359|NCT03286218|9620200|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
2815360|NCT03286218|9620201|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
2815361|NCT03286218|9620202|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
2815362|NCT03286218|9620191|P12|Qualification Phase Period 2|Adverse Event|0
2815363|NCT03286218|9620192|P11|Qualification Phase Period 2|Adverse Event|0
2815364|NCT03286218|9620193|P10|Qualification Phase Period 2|Adverse Event|0
2815365|NCT03286218|9620194|P9|Qualification Phase Period 2|Adverse Event|0
2815366|NCT03286218|9620195|P8|Qualification Phase Period 2|Adverse Event|0
2815367|NCT03286218|9620196|P7|Qualification Phase Period 2|Adverse Event|0
2815368|NCT03286218|9620197|P6|Qualification Phase Period 2|Adverse Event|0
2815369|NCT03286218|9620198|P5|Qualification Phase Period 2|Adverse Event|0
2815370|NCT03286218|9620199|P4|Qualification Phase Period 2|Adverse Event|0
2815371|NCT03286218|9620200|P3|Qualification Phase Period 2|Adverse Event|0
2815372|NCT03286218|9620201|P2|Qualification Phase Period 2|Adverse Event|1
2815373|NCT03286218|9620202|P1|Qualification Phase Period 2|Adverse Event|0
2815374|NCT03286218|9620191|P12|Qualification Phase Period 1|Withdrawal by Subject|0
2815375|NCT03286218|9620192|P11|Qualification Phase Period 1|Withdrawal by Subject|0
2815376|NCT03286218|9620193|P10|Qualification Phase Period 1|Withdrawal by Subject|0
2815377|NCT03286218|9620194|P9|Qualification Phase Period 1|Withdrawal by Subject|0
2815378|NCT03286218|9620195|P8|Qualification Phase Period 1|Withdrawal by Subject|0
2815379|NCT03286218|9620196|P7|Qualification Phase Period 1|Withdrawal by Subject|0
2815380|NCT03286218|9620197|P6|Qualification Phase Period 1|Withdrawal by Subject|0
2815381|NCT03286218|9620198|P5|Qualification Phase Period 1|Withdrawal by Subject|0
2815382|NCT03286218|9620199|P4|Qualification Phase Period 1|Withdrawal by Subject|0
2815383|NCT03286218|9620200|P3|Qualification Phase Period 1|Withdrawal by Subject|0
2815384|NCT03286218|9620201|P2|Qualification Phase Period 1|Withdrawal by Subject|1
2815385|NCT03286218|9620202|P1|Qualification Phase Period 1|Withdrawal by Subject|0
2815386|NCT03286218|9620191|P12|Qualification Phase Period 1|Adverse Event|0
2815387|NCT03286218|9620192|P11|Qualification Phase Period 1|Adverse Event|0
2815388|NCT03286218|9620193|P10|Qualification Phase Period 1|Adverse Event|0
2815389|NCT03286218|9620194|P9|Qualification Phase Period 1|Adverse Event|0
2815390|NCT03286218|9620195|P8|Qualification Phase Period 1|Adverse Event|0
2815391|NCT03286218|9620196|P7|Qualification Phase Period 1|Adverse Event|0
2815392|NCT03286218|9620197|P6|Qualification Phase Period 1|Adverse Event|0
2815393|NCT03286218|9620198|P5|Qualification Phase Period 1|Adverse Event|0
2815394|NCT03286218|9620199|P4|Qualification Phase Period 1|Adverse Event|0
2815395|NCT03286218|9620200|P3|Qualification Phase Period 1|Adverse Event|0
2815396|NCT03286218|9620201|P2|Qualification Phase Period 1|Adverse Event|0
2815397|NCT03286218|9620202|P1|Qualification Phase Period 1|Adverse Event|1
2815398|NCT03285711|9620265|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2815399|NCT03285711|9620266|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2815400|NCT03285711|9620267|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
2815401|NCT03285711|9620268|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
2815402|NCT03285711|9620265|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2815403|NCT03285711|9620266|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
2815404|NCT03285711|9620267|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2815405|NCT03285711|9620268|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
2815406|NCT03285711|9620265|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
2815407|NCT03285711|9620266|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
2815408|NCT03285711|9620267|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
2815409|NCT03285711|9620268|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
2815410|NCT03285711|9620265|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
2815411|NCT03285711|9620266|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
2815412|NCT03285711|9620267|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
2815413|NCT03285711|9620268|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
2815414|NCT03285295|9620341|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2815415|NCT03285295|9620342|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2815416|NCT03285295|9620343|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2815417|NCT03285295|9620344|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2815418|NCT03285295|9620345|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
2815419|NCT03285295|9620341|P5|Alinity s Chagas|No Results Generated|0
2815420|NCT03285295|9620342|P4|Alinity s Chagas|No Results Generated|0
2815421|NCT03285295|9620343|P3|Alinity s Chagas|No Results Generated|0
2815422|NCT03285295|9620344|P2|Alinity s Chagas|No Results Generated|0
2815423|NCT03285295|9620345|P1|Alinity s Chagas|No Results Generated|105
2815424|NCT03285295|9620341|P5|Alinity s Chagas|No Results on Comparator Assay|0
2815425|NCT03285295|9620342|P4|Alinity s Chagas|No Results on Comparator Assay|0
2815426|NCT03285295|9620343|P3|Alinity s Chagas|No Results on Comparator Assay|0
2815427|NCT03285295|9620344|P2|Alinity s Chagas|No Results on Comparator Assay|0
2815428|NCT03285295|9620345|P1|Alinity s Chagas|No Results on Comparator Assay|38
2815429|NCT03285295|9620341|P5|Alinity s Chagas|Protocol Violation|0
2815430|NCT03285295|9620342|P4|Alinity s Chagas|Protocol Violation|0
2815431|NCT03285295|9620343|P3|Alinity s Chagas|Protocol Violation|0
2815432|NCT03285295|9620344|P2|Alinity s Chagas|Protocol Violation|0
2815433|NCT03285295|9620345|P1|Alinity s Chagas|Protocol Violation|76
2815434|NCT03285295|9620341|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2815435|NCT03285295|9620342|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2815436|NCT03285295|9620343|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2815437|NCT03285295|9620344|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2815438|NCT03285295|9620345|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
2815439|NCT03285295|9620341|P5|Alinity s Anti-HBc|No Results Generated|0
2815440|NCT03285295|9620342|P4|Alinity s Anti-HBc|No Results Generated|0
2815441|NCT03285295|9620343|P3|Alinity s Anti-HBc|No Results Generated|0
2815442|NCT03285295|9620344|P2|Alinity s Anti-HBc|No Results Generated|0
2815443|NCT03285295|9620345|P1|Alinity s Anti-HBc|No Results Generated|70
2815444|NCT03285295|9620341|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
2815445|NCT03285295|9620342|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
2815446|NCT03285295|9620343|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
2815447|NCT03285295|9620344|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
2815448|NCT03285295|9620345|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
2815449|NCT03285295|9620341|P5|Alinity s Anti-HBc|Protocol Violation|0
2815450|NCT03285295|9620342|P4|Alinity s Anti-HBc|Protocol Violation|0
2815451|NCT03285295|9620343|P3|Alinity s Anti-HBc|Protocol Violation|0
2815452|NCT03285295|9620344|P2|Alinity s Anti-HBc|Protocol Violation|0
2815453|NCT03285295|9620345|P1|Alinity s Anti-HBc|Protocol Violation|8
2815454|NCT03285295|9620341|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2815455|NCT03285295|9620342|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2815456|NCT03285295|9620343|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2815457|NCT03285295|9620344|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2815458|NCT03285295|9620345|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
2815459|NCT03285295|9620341|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2815460|NCT03285295|9620342|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2815461|NCT03285295|9620343|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2815462|NCT03285295|9620344|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2815463|NCT03285295|9620345|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
2815464|NCT03285295|9620341|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2815465|NCT03285295|9620342|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2815466|NCT03285295|9620343|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2815467|NCT03285295|9620344|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2815468|NCT03285295|9620345|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
2815469|NCT03285295|9620341|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2815470|NCT03285295|9620342|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2815471|NCT03285295|9620343|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2815472|NCT03285295|9620344|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2815473|NCT03285295|9620345|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
2815474|NCT03285295|9620341|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2815475|NCT03285295|9620342|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2815476|NCT03285295|9620343|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2815477|NCT03285295|9620344|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2815478|NCT03285295|9620345|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
2815479|NCT03285295|9620341|P5|Alinity s Anti-HCV|No Results Generated|0
2815480|NCT03285295|9620342|P4|Alinity s Anti-HCV|No Results Generated|0
2815481|NCT03285295|9620343|P3|Alinity s Anti-HCV|No Results Generated|0
2815482|NCT03285295|9620344|P2|Alinity s Anti-HCV|No Results Generated|0
2815483|NCT03285295|9620345|P1|Alinity s Anti-HCV|No Results Generated|71
2815484|NCT03285295|9620341|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
2815485|NCT03285295|9620342|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
2815486|NCT03285295|9620343|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
2815487|NCT03285295|9620344|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
2815488|NCT03285295|9620345|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
2815489|NCT03285295|9620341|P5|Alinity s Anti-HCV|Protocol Violation|0
2815490|NCT03285295|9620342|P4|Alinity s Anti-HCV|Protocol Violation|0
2815491|NCT03285295|9620343|P3|Alinity s Anti-HCV|Protocol Violation|0
2815492|NCT03285295|9620344|P2|Alinity s Anti-HCV|Protocol Violation|0
2815493|NCT03285295|9620345|P1|Alinity s Anti-HCV|Protocol Violation|12
2815494|NCT03285295|9620341|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2815495|NCT03285295|9620342|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2815496|NCT03285295|9620343|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2815497|NCT03285295|9620344|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2815498|NCT03285295|9620345|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
2815499|NCT03285295|9620341|P5|Alinity s HTLV I/II|No Results Generated|0
2815500|NCT03285295|9620342|P4|Alinity s HTLV I/II|No Results Generated|0
2815501|NCT03285295|9620343|P3|Alinity s HTLV I/II|No Results Generated|0
2815502|NCT03285295|9620344|P2|Alinity s HTLV I/II|No Results Generated|0
2815503|NCT03285295|9620345|P1|Alinity s HTLV I/II|No Results Generated|70
2815504|NCT03285295|9620341|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
2815505|NCT03285295|9620342|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
2815506|NCT03285295|9620343|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
2815507|NCT03285295|9620344|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
2815508|NCT03285295|9620345|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
2815509|NCT03285295|9620341|P5|Alinity s HTLV I/II|Protocol Violation|0
2815510|NCT03285295|9620342|P4|Alinity s HTLV I/II|Protocol Violation|0
2815511|NCT03285295|9620343|P3|Alinity s HTLV I/II|Protocol Violation|0
2815512|NCT03285295|9620344|P2|Alinity s HTLV I/II|Protocol Violation|0
2815513|NCT03285295|9620345|P1|Alinity s HTLV I/II|Protocol Violation|6
2815514|NCT03285295|9620341|P5|Alinity s HBsAg|No Results Generated|0
2815515|NCT03285295|9620342|P4|Alinity s HBsAg|No Results Generated|0
2815516|NCT03285295|9620343|P3|Alinity s HBsAg|No Results Generated|0
2815517|NCT03285295|9620344|P2|Alinity s HBsAg|No Results Generated|6
2815518|NCT03285295|9620345|P1|Alinity s HBsAg|No Results Generated|74
2815519|NCT03285295|9620341|P5|Alinity s HBsAg|No Result on Comparator Assay|0
2815520|NCT03285295|9620342|P4|Alinity s HBsAg|No Result on Comparator Assay|0
2815521|NCT03285295|9620343|P3|Alinity s HBsAg|No Result on Comparator Assay|0
2815522|NCT03285295|9620344|P2|Alinity s HBsAg|No Result on Comparator Assay|0
2815523|NCT03285295|9620345|P1|Alinity s HBsAg|No Result on Comparator Assay|17
2815524|NCT03285295|9620341|P5|Alinity s HBsAg|Protocol Violation|0
2815525|NCT03285295|9620342|P4|Alinity s HBsAg|Protocol Violation|0
2815526|NCT03285295|9620343|P3|Alinity s HBsAg|Protocol Violation|0
2815527|NCT03285295|9620344|P2|Alinity s HBsAg|Protocol Violation|0
2815528|NCT03285295|9620345|P1|Alinity s HBsAg|Protocol Violation|11
2815529|NCT03283709|9620381|P2|Overall Study|trial terminated|1
2815530|NCT03283709|9620382|P1|Overall Study|trial terminated|0
2815531|NCT03283319|9620418|P6|Overall Study|BARDA regulatory agency or IRB decision|0
2815532|NCT03283319|9620419|P5|Overall Study|BARDA regulatory agency or IRB decision|0
2815533|NCT03283319|9620420|P4|Overall Study|BARDA regulatory agency or IRB decision|1
2815534|NCT03283319|9620421|P3|Overall Study|BARDA regulatory agency or IRB decision|0
2815535|NCT03283319|9620422|P2|Overall Study|BARDA regulatory agency or IRB decision|0
2815536|NCT03283319|9620423|P1|Overall Study|BARDA regulatory agency or IRB decision|0
2815537|NCT03283319|9620418|P6|Overall Study|Withdrawal by Subject|1
2815538|NCT03283319|9620419|P5|Overall Study|Withdrawal by Subject|0
2815539|NCT03283319|9620420|P4|Overall Study|Withdrawal by Subject|1
2815540|NCT03283319|9620421|P3|Overall Study|Withdrawal by Subject|2
2815541|NCT03283319|9620422|P2|Overall Study|Withdrawal by Subject|2
2815542|NCT03283319|9620423|P1|Overall Study|Withdrawal by Subject|2
2815543|NCT03283319|9620418|P6|Overall Study|Lost to Follow-up|3
2815544|NCT03283319|9620419|P5|Overall Study|Lost to Follow-up|4
2815545|NCT03283319|9620420|P4|Overall Study|Lost to Follow-up|5
2815546|NCT03283319|9620421|P3|Overall Study|Lost to Follow-up|5
2815547|NCT03283319|9620422|P2|Overall Study|Lost to Follow-up|4
2815548|NCT03283319|9620423|P1|Overall Study|Lost to Follow-up|5
2815549|NCT03283098|9620565|P2|Overall Study|Withdrawal by Subject|1
2815550|NCT03283098|9620566|P1|Overall Study|Withdrawal by Subject|0
2815551|NCT03282240|9620686|P3|Overall Study|Withdrawal by Subject|1
2815552|NCT03282240|9620687|P2|Overall Study|Withdrawal by Subject|0
2815553|NCT03282240|9620688|P1|Overall Study|Withdrawal by Subject|1
2815554|NCT03282240|9620686|P3|Overall Study|Protocol Deviation|2
2815555|NCT03282240|9620687|P2|Overall Study|Protocol Deviation|1
2815556|NCT03282240|9620688|P1|Overall Study|Protocol Deviation|4
2815557|NCT03282240|9620686|P3|Overall Study|Lost to Follow-up|0
2815558|NCT03282240|9620687|P2|Overall Study|Lost to Follow-up|0
2815559|NCT03282240|9620688|P1|Overall Study|Lost to Follow-up|3
2815560|NCT03282240|9620686|P3|Overall Study|Adverse Event|0
2815561|NCT03282240|9620687|P2|Overall Study|Adverse Event|2
2815562|NCT03282240|9620688|P1|Overall Study|Adverse Event|2
2815563|NCT03281668|9620740|P1|Overall Study|Lost to Follow-up|1
2815564|NCT03281668|9620740|P1|Overall Study|Withdrawal by Subject|4
2815565|NCT03281668|9620740|P1|Overall Study|scheduling conflict, family circumstance|2
2815566|NCT03281668|9620740|P1|Overall Study|Physician Decision|1
2815567|NCT03280615|9620788|P2|Overall Study|Withdrawal by Subject|2
2815568|NCT03280615|9620789|P1|Overall Study|Withdrawal by Subject|2
2815569|NCT03280615|9620788|P2|Overall Study|Adverse Event|1
2815570|NCT03280615|9620789|P1|Overall Study|Adverse Event|1
2815571|NCT03280615|9620788|P2|Overall Study|Lost to Follow-up|2
2815572|NCT03280615|9620789|P1|Overall Study|Lost to Follow-up|1
2815573|NCT03280550|9620801|P2|Overall Study|Physician Decision|1
2815574|NCT03280550|9620802|P1|Overall Study|Physician Decision|0
2815575|NCT03280550|9620801|P2|Overall Study|Withdrawal by Subject|2
2815576|NCT03280550|9620802|P1|Overall Study|Withdrawal by Subject|2
2815577|NCT03280537|9620854|P2|Overall Study|Withdrawal by Subject|4
2815578|NCT03280537|9620855|P1|Overall Study|Withdrawal by Subject|2
2815579|NCT03280381|9620907|P2|Overall Study|Physician Decision|2
2815580|NCT03280381|9620908|P1|Overall Study|Physician Decision|0
2815581|NCT03280108|9620918|P2|Overall Study|Lost to Follow-up|0
2815582|NCT03280108|9620919|P1|Overall Study|Lost to Follow-up|2
2815583|NCT03278106|9620963|P1|Overall Study|No protocol treatment|1
2815584|NCT03278028|9621379|P2|Overall Study|Pregnancy|1
2815585|NCT03278028|9621380|P1|Overall Study|Pregnancy|0
2815586|NCT03278028|9621379|P2|Overall Study|Withdrawal by Subject|1
2815587|NCT03278028|9621380|P1|Overall Study|Withdrawal by Subject|3
2815588|NCT03278028|9621379|P2|Overall Study|Lost to Follow-up|0
2815589|NCT03278028|9621380|P1|Overall Study|Lost to Follow-up|1
2815590|NCT03277846|9621388|P2|Overall Study|Inpatient stay too brief|11
2815591|NCT03277846|9621389|P1|Overall Study|Inpatient stay too brief|12
2815592|NCT03276078|9621434|P1|Overall Study|Adverse Event|1
2815593|NCT03276026|9621463|P2|Overall Study|Protocol Violation|0
2815594|NCT03276026|9621464|P1|Overall Study|Protocol Violation|1
2815595|NCT03274986|9621492|P2|Overall Study|Lost to Follow-up|1
2815596|NCT03274986|9621493|P1|Overall Study|Lost to Follow-up|0
2815597|NCT03274986|9621492|P2|Overall Study|Withdrawal by Subject|1
2815598|NCT03274986|9621493|P1|Overall Study|Withdrawal by Subject|0
2815599|NCT03274453|9621560|P4|Overall Study|Surgery Cancelled|0
2815600|NCT03274453|9621561|P3|Overall Study|Surgery Cancelled|0
2815601|NCT03274453|9621562|P2|Overall Study|Surgery Cancelled|1
2815602|NCT03274453|9621563|P1|Overall Study|Surgery Cancelled|0
2815603|NCT03274453|9621560|P4|Overall Study|Physician Decision|3
2815604|NCT03274453|9621561|P3|Overall Study|Physician Decision|0
2815605|NCT03274453|9621562|P2|Overall Study|Physician Decision|0
2815606|NCT03274453|9621563|P1|Overall Study|Physician Decision|2
2815607|NCT03274453|9621560|P4|Overall Study|Lost to Follow-up|1
2815608|NCT03274453|9621561|P3|Overall Study|Lost to Follow-up|4
2815609|NCT03274453|9621562|P2|Overall Study|Lost to Follow-up|5
2815610|NCT03274453|9621563|P1|Overall Study|Lost to Follow-up|2
2815611|NCT03274076|9621575|P4|24 Weeks Open Label|Withdrawal by Subject|1
2815612|NCT03274076|9621576|P3|24 Weeks Open Label|Withdrawal by Subject|0
2815613|NCT03274076|9621577|P2|24 Weeks Open Label|Withdrawal by Subject|0
2815614|NCT03274076|9621578|P1|24 Weeks Open Label|Withdrawal by Subject|0
2815615|NCT03274076|9621575|P4|24 Weeks Open Label|Adverse Event|0
2815616|NCT03274076|9621576|P3|24 Weeks Open Label|Adverse Event|2
2815617|NCT03274076|9621577|P2|24 Weeks Open Label|Adverse Event|0
2815618|NCT03274076|9621578|P1|24 Weeks Open Label|Adverse Event|0
2815619|NCT03274076|9621575|P4|24 Weeks Double Blind|Withdrawal by Subject|0
2815620|NCT03274076|9621576|P3|24 Weeks Double Blind|Withdrawal by Subject|0
2815621|NCT03274076|9621577|P2|24 Weeks Double Blind|Withdrawal by Subject|1
2815622|NCT03274076|9621578|P1|24 Weeks Double Blind|Withdrawal by Subject|0
2815623|NCT03273946|9621606|P1|Overall Study|Participant relative refused to use drug|1
2815624|NCT03273946|9621606|P1|Overall Study|Participant refused to use the drug|2
2815625|NCT03273946|9621606|P1|Overall Study|Unwillingness of the guardian|1
2815626|NCT03273946|9621606|P1|Overall Study|Withdrawal by Subject|5
2815627|NCT03273387|9621626|P2|Overall Study|Withdrawal by Subject|1
2815628|NCT03273387|9621627|P1|Overall Study|Withdrawal by Subject|1
2815629|NCT03273387|9621626|P2|Overall Study|Death|2
2815630|NCT03273387|9621627|P1|Overall Study|Death|2
2815631|NCT03271021|9621691|P2|Overall Study|Miscellaneous|8
2815632|NCT03271021|9621692|P1|Overall Study|Miscellaneous|9
2815633|NCT03271021|9621691|P2|Overall Study|Abnormal Lab Results|0
2815634|NCT03271021|9621692|P1|Overall Study|Abnormal Lab Results|1
2815635|NCT03271021|9621691|P2|Overall Study|Protocol Violation|4
2815636|NCT03271021|9621692|P1|Overall Study|Protocol Violation|6
2815637|NCT03271021|9621691|P2|Overall Study|Lost to Follow-up|39
2815638|NCT03271021|9621692|P1|Overall Study|Lost to Follow-up|34
2815639|NCT03271021|9621691|P2|Overall Study|Withdrawal by Subject|53
2815640|NCT03271021|9621692|P1|Overall Study|Withdrawal by Subject|36
2815641|NCT03271021|9621691|P2|Overall Study|Adverse Event|2
2815642|NCT03271021|9621692|P1|Overall Study|Adverse Event|3
2815643|NCT03270657|9621710|P1|Overall Study|Withdrawal by Subject|1
2815644|NCT03270644|9621716|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
2815645|NCT03270644|9621716|P1|Day 1 Lasmiditan Reference|Physician Decision|1
2815646|NCT03270085|9621739|P2|Overall Study|Withdrawal by Subject|0
2815647|NCT03270085|9621740|P1|Overall Study|Withdrawal by Subject|1
2815648|NCT03269552|9621750|P1|Overall Study|Adverse Event|2
2815649|NCT03268941|9621761|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
2815650|NCT03268941|9621762|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815651|NCT03268941|9621763|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815652|NCT03268941|9621764|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815653|NCT03268941|9621765|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815654|NCT03268941|9621766|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815655|NCT03268941|9621767|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
2815656|NCT03268941|9621761|P7|Part 2: Days 17 to 25|Reason not specified|1
2815657|NCT03268941|9621762|P6|Part 2: Days 17 to 25|Reason not specified|0
2815658|NCT03268941|9621763|P5|Part 2: Days 17 to 25|Reason not specified|0
2815659|NCT03268941|9621764|P4|Part 2: Days 17 to 25|Reason not specified|0
2815660|NCT03268941|9621765|P3|Part 2: Days 17 to 25|Reason not specified|0
2815661|NCT03268941|9621766|P2|Part 2: Days 17 to 25|Reason not specified|0
2815662|NCT03268941|9621767|P1|Part 2: Days 17 to 25|Reason not specified|0
2815663|NCT03268941|9621761|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815664|NCT03268941|9621762|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815665|NCT03268941|9621763|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815666|NCT03268941|9621764|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815667|NCT03268941|9621765|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815668|NCT03268941|9621766|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
2815669|NCT03268941|9621767|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
2815670|NCT03268941|9621761|P7|Part 1 (Days 1 to 9)|Adverse Event|0
2815671|NCT03268941|9621762|P6|Part 1 (Days 1 to 9)|Adverse Event|0
2815672|NCT03268941|9621763|P5|Part 1 (Days 1 to 9)|Adverse Event|0
2815673|NCT03268941|9621764|P4|Part 1 (Days 1 to 9)|Adverse Event|1
2815674|NCT03268941|9621765|P3|Part 1 (Days 1 to 9)|Adverse Event|0
2815675|NCT03268941|9621766|P2|Part 1 (Days 1 to 9)|Adverse Event|0
2815676|NCT03268941|9621767|P1|Part 1 (Days 1 to 9)|Adverse Event|0
2815677|NCT03268941|9621761|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815678|NCT03268941|9621762|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815679|NCT03268941|9621763|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815680|NCT03268941|9621764|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
2815681|NCT03268941|9621765|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815682|NCT03268941|9621766|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815683|NCT03268941|9621767|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2815684|NCT03268746|9621829|P1|Overall Study|Withdrawal by Subject|1
2815685|NCT03268590|9621851|P1|Overall Study|Previously unknown exclusion criteria|1
2815686|NCT03268005|9621886|P2|Overall Study|Withdrawal by Subject|11
2815687|NCT03268005|9621887|P1|Overall Study|Withdrawal by Subject|11
2815688|NCT03268005|9621886|P2|Overall Study|Lost to Follow-up|2
2815689|NCT03268005|9621887|P1|Overall Study|Lost to Follow-up|2
2815690|NCT03268005|9621886|P2|Overall Study|Death|1
2815691|NCT03268005|9621887|P1|Overall Study|Death|2
2815692|NCT03267940|9622001|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
2815693|NCT03267940|9622002|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
2815694|NCT03267940|9622003|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
2815695|NCT03267940|9622004|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
2815696|NCT03267940|9622005|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
2815697|NCT03267940|9622006|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
2815698|NCT03267940|9622001|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
2815699|NCT03267940|9622002|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
2815700|NCT03267940|9622003|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
2815701|NCT03267940|9622004|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
2815702|NCT03267940|9622005|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2815703|NCT03267940|9622006|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2815704|NCT03267940|9622001|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2815705|NCT03267940|9622002|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2815706|NCT03267940|9622003|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2815707|NCT03267940|9622004|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
2815708|NCT03267940|9622005|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2815709|NCT03267940|9622006|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2815710|NCT03267940|9622001|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2815711|NCT03267940|9622002|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2815712|NCT03267940|9622003|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
2815713|NCT03267940|9622004|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2815714|NCT03267940|9622005|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2815715|NCT03267940|9622006|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2815716|NCT03267940|9622001|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2815717|NCT03267940|9622002|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
2815718|NCT03267940|9622003|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
2815719|NCT03267940|9622004|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2815720|NCT03267940|9622005|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2815721|NCT03267940|9622006|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2815722|NCT03267940|9622001|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2815723|NCT03267940|9622002|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2815724|NCT03267940|9622003|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2815725|NCT03267940|9622004|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2815726|NCT03267940|9622005|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
2815727|NCT03267940|9622006|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
2815728|NCT03267940|9622001|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2815729|NCT03267940|9622002|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2815730|NCT03267940|9622003|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2815731|NCT03267940|9622004|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2815732|NCT03267940|9622005|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
2815733|NCT03267940|9622006|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2815734|NCT03267940|9622001|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2815735|NCT03267940|9622002|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2815736|NCT03267940|9622003|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2815737|NCT03267940|9622004|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2815738|NCT03267940|9622005|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
2815739|NCT03267940|9622006|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2815740|NCT03267940|9622001|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2815741|NCT03267940|9622002|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2815742|NCT03267940|9622003|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2815743|NCT03267940|9622004|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2815744|NCT03267940|9622005|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
2815745|NCT03267940|9622006|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
2815746|NCT03267576|9622108|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
2815747|NCT03267576|9622109|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
2815748|NCT03267576|9622108|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
2815749|NCT03267576|9622109|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
2815750|NCT03267511|9622147|P4|Overall Study|Lost to Follow-up|1
2815751|NCT03267511|9622148|P3|Overall Study|Lost to Follow-up|0
2815752|NCT03267511|9622149|P2|Overall Study|Lost to Follow-up|0
2815753|NCT03267511|9622150|P1|Overall Study|Lost to Follow-up|0
2815754|NCT03267264|9622166|P4|Overall Study|Withdrawal by Subject|4
2815755|NCT03267264|9622167|P3|Overall Study|Withdrawal by Subject|2
2815756|NCT03267264|9622168|P2|Overall Study|Withdrawal by Subject|0
2815757|NCT03267264|9622169|P1|Overall Study|Withdrawal by Subject|1
2815758|NCT03267212|9622186|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
2815759|NCT03267212|9622187|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
2815760|NCT03267212|9622186|P2|First Intervention|Withdrawal by Subject|1
2815761|NCT03267212|9622187|P1|First Intervention|Withdrawal by Subject|1
2815762|NCT03267212|9622186|P2|First Intervention|Lost to Follow-up|2
2815763|NCT03267212|9622187|P1|First Intervention|Lost to Follow-up|0
2815764|NCT03266172|9622213|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2815765|NCT03266172|9622214|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2815766|NCT03266172|9622215|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2815767|NCT03266172|9622213|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2815768|NCT03266172|9622214|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2815769|NCT03266172|9622215|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2815770|NCT03266172|9622213|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
2815771|NCT03266172|9622214|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
2815772|NCT03266172|9622215|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
2815773|NCT03266172|9622213|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2815774|NCT03266172|9622214|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2815775|NCT03266172|9622215|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
2815776|NCT03266172|9622213|P3|Part A: Washout Period (7 Days)|Adverse Event|0
2815777|NCT03266172|9622214|P2|Part A: Washout Period (7 Days)|Adverse Event|0
2815778|NCT03266172|9622215|P1|Part A: Washout Period (7 Days)|Adverse Event|1
2815779|NCT03266172|9622213|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2815780|NCT03266172|9622214|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2815781|NCT03266172|9622215|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
2815782|NCT03266094|9622460|P1|Overall Study|Withdrawal by Subject|1
2815783|NCT03266094|9622460|P1|Overall Study|Lost to Follow-up|1
2815784|NCT03265600|9622480|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
2815785|NCT03265600|9622481|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
2815786|NCT03265600|9622480|P2|Overall Study|Withdrawal by Subject|2
2815787|NCT03265600|9622481|P1|Overall Study|Withdrawal by Subject|4
2815788|NCT03265600|9622480|P2|Overall Study|Lost to Follow-up|5
2815789|NCT03265600|9622481|P1|Overall Study|Lost to Follow-up|17
2815790|NCT03265132|9622507|P2|Overall Study|Withdrawal by Subject|1
2815791|NCT03265132|9622508|P1|Overall Study|Withdrawal by Subject|0
2815792|NCT03265132|9622507|P2|Overall Study|Progressive disease|2
2815793|NCT03265132|9622508|P1|Overall Study|Progressive disease|0
2815794|NCT03265132|9622507|P2|Overall Study|Lack of Efficacy|2
2815795|NCT03265132|9622508|P1|Overall Study|Lack of Efficacy|0
2815796|NCT03265132|9622507|P2|Overall Study|Adverse Event|1
2815797|NCT03265132|9622508|P1|Overall Study|Adverse Event|0
2815798|NCT03265119|9622606|P2|Overall Study|Lack of Compliance|0
2815799|NCT03265119|9622607|P1|Overall Study|Lack of Compliance|1
2815800|NCT03265119|9622606|P2|Overall Study|Lost to Follow-up|0
2815801|NCT03265119|9622607|P1|Overall Study|Lost to Follow-up|1
2815802|NCT03265119|9622606|P2|Overall Study|Withdrawal by Subject|4
2815803|NCT03265119|9622607|P1|Overall Study|Withdrawal by Subject|2
2815804|NCT03265119|9622606|P2|Overall Study|Protocol Violation|2
2815805|NCT03265119|9622607|P1|Overall Study|Protocol Violation|1
2815806|NCT03265119|9622606|P2|Overall Study|Lack of Efficacy|0
2815807|NCT03265119|9622607|P1|Overall Study|Lack of Efficacy|3
2815808|NCT03265119|9622606|P2|Overall Study|Adverse Event|1
2815809|NCT03265119|9622607|P1|Overall Study|Adverse Event|2
2815810|NCT03264456|9622615|P1|Overall Study|Lost to Follow-up|1
2815811|NCT03264456|9622615|P1|Overall Study|Withdrawal by Subject|3
2815812|NCT03263806|9622650|P2|Overall Study|Study Termination|6
2815813|NCT03263806|9622651|P1|Overall Study|Study Termination|5
2815814|NCT03263806|9622650|P2|Overall Study|Withdrawal by Subject|1
2815815|NCT03263806|9622651|P1|Overall Study|Withdrawal by Subject|0
2815816|NCT03263806|9622650|P2|Overall Study|Elevated Troponin (failed screen)|0
2815817|NCT03263806|9622651|P1|Overall Study|Elevated Troponin (failed screen)|1
2815818|NCT03263702|9622665|P2|Overall Study|Withdrawal by Subject|2
2815819|NCT03263702|9622666|P1|Overall Study|Withdrawal by Subject|1
2815820|NCT03263702|9622665|P2|Overall Study|Lost to Follow-up|2
2815821|NCT03263702|9622666|P1|Overall Study|Lost to Follow-up|2
2815822|NCT03262233|9622696|P4|Overall Study|data collection artifact|0
2815823|NCT03262233|9622697|P3|Overall Study|data collection artifact|0
2815824|NCT03262233|9622698|P2|Overall Study|data collection artifact|1
2815825|NCT03262233|9622699|P1|Overall Study|data collection artifact|0
2815826|NCT03262233|9622696|P4|Overall Study|Protocol Violation|13
2815827|NCT03262233|9622697|P3|Overall Study|Protocol Violation|2
2815828|NCT03262233|9622698|P2|Overall Study|Protocol Violation|10
2815829|NCT03262233|9622699|P1|Overall Study|Protocol Violation|5
2815830|NCT03262233|9622696|P4|Overall Study|Declined due to shock|3
2815831|NCT03262233|9622697|P3|Overall Study|Declined due to shock|2
2815832|NCT03262233|9622698|P2|Overall Study|Declined due to shock|2
2815833|NCT03262233|9622699|P1|Overall Study|Declined due to shock|1
2815834|NCT03262233|9622696|P4|Overall Study|Withdrawal by Subject|13
2815835|NCT03262233|9622697|P3|Overall Study|Withdrawal by Subject|21
2815836|NCT03262233|9622698|P2|Overall Study|Withdrawal by Subject|8
2815837|NCT03262233|9622699|P1|Overall Study|Withdrawal by Subject|12
2815838|NCT03262012|9622725|P4|Overall Study|Protocol Discontinuation Criteria|0
2815839|NCT03262012|9622726|P3|Overall Study|Protocol Discontinuation Criteria|0
2815840|NCT03262012|9622727|P2|Overall Study|Protocol Discontinuation Criteria|1
2815841|NCT03262012|9622728|P1|Overall Study|Protocol Discontinuation Criteria|0
2815842|NCT03262012|9622725|P4|Overall Study|Lack of Efficacy|2
2815843|NCT03262012|9622726|P3|Overall Study|Lack of Efficacy|1
2815844|NCT03262012|9622727|P2|Overall Study|Lack of Efficacy|5
2815845|NCT03262012|9622728|P1|Overall Study|Lack of Efficacy|0
2815846|NCT03262012|9622725|P4|Overall Study|Physician Decision|0
2815847|NCT03262012|9622726|P3|Overall Study|Physician Decision|1
2815848|NCT03262012|9622727|P2|Overall Study|Physician Decision|5
2815849|NCT03262012|9622728|P1|Overall Study|Physician Decision|2
2815850|NCT03262012|9622725|P4|Overall Study|Adverse Event|6
2815851|NCT03262012|9622726|P3|Overall Study|Adverse Event|4
2815852|NCT03262012|9622727|P2|Overall Study|Adverse Event|12
2815853|NCT03262012|9622728|P1|Overall Study|Adverse Event|10
2815854|NCT03262012|9622725|P4|Overall Study|Withdrawal by Subject|7
2815855|NCT03262012|9622726|P3|Overall Study|Withdrawal by Subject|8
2815856|NCT03262012|9622727|P2|Overall Study|Withdrawal by Subject|13
2815857|NCT03262012|9622728|P1|Overall Study|Withdrawal by Subject|15
2815858|NCT03261531|9622751|P1|Overall Study|Withdrawal by Subject|4
2815859|NCT03261167|9622769|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2815860|NCT03261167|9622770|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2815861|NCT03261167|9622769|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
2815862|NCT03261167|9622770|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
2815863|NCT03261167|9622769|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
2815864|NCT03261167|9622770|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
2815865|NCT03261167|9622769|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
2815866|NCT03261167|9622770|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
2815867|NCT03261167|9622769|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
2815868|NCT03261167|9622770|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
2815869|NCT03260894|9622808|P2|Overall Study|On-going at clinical cut off date|31
2815870|NCT03260894|9622809|P1|Overall Study|On-going at clinical cut off date|36
2815871|NCT03260894|9622808|P2|Overall Study|Withdrawal by Subject|11
2815872|NCT03260894|9622809|P1|Overall Study|Withdrawal by Subject|4
2815873|NCT03260894|9622808|P2|Overall Study|Death|8
2815874|NCT03260894|9622809|P1|Overall Study|Death|6
2815875|NCT03260868|9622821|P2|Overall Study|Other than specified above|0
2815876|NCT03260868|9622822|P1|Overall Study|Other than specified above|1
2815877|NCT03260868|9622821|P2|Overall Study|Study Terminated By Sponsor|1
2815878|NCT03260868|9622822|P1|Overall Study|Study Terminated By Sponsor|2
2815879|NCT03260868|9622821|P2|Overall Study|Poor Compliance to Protocol|2
2815880|NCT03260868|9622822|P1|Overall Study|Poor Compliance to Protocol|0
2815881|NCT03260205|9622944|P5|Overall Study|Participant Who Did Not Received AnyDose|1
2815882|NCT03260205|9622945|P4|Overall Study|Participant Who Did Not Received AnyDose|3
2815883|NCT03260205|9622946|P3|Overall Study|Participant Who Did Not Received AnyDose|2
2815884|NCT03260205|9622947|P2|Overall Study|Participant Who Did Not Received AnyDose|1
2815885|NCT03260205|9622948|P1|Overall Study|Participant Who Did Not Received AnyDose|1
2815886|NCT03260205|9622944|P5|Overall Study|Other: Unspecified|1
2815887|NCT03260205|9622945|P4|Overall Study|Other: Unspecified|1
2815888|NCT03260205|9622946|P3|Overall Study|Other: Unspecified|3
2815889|NCT03260205|9622947|P2|Overall Study|Other: Unspecified|0
2815890|NCT03260205|9622948|P1|Overall Study|Other: Unspecified|0
2815891|NCT03260205|9622944|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
2815892|NCT03260205|9622945|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
2815893|NCT03260205|9622946|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
2815894|NCT03260205|9622947|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
2815895|NCT03260205|9622948|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
2815896|NCT03260205|9622944|P5|Overall Study|Protocol Violation|1
2815897|NCT03260205|9622945|P4|Overall Study|Protocol Violation|0
2815898|NCT03260205|9622946|P3|Overall Study|Protocol Violation|2
2815899|NCT03260205|9622947|P2|Overall Study|Protocol Violation|0
2815900|NCT03260205|9622948|P1|Overall Study|Protocol Violation|0
2815901|NCT03260205|9622944|P5|Overall Study|Lost to Follow-up|5
2815902|NCT03260205|9622945|P4|Overall Study|Lost to Follow-up|1
2815903|NCT03260205|9622946|P3|Overall Study|Lost to Follow-up|1
2815904|NCT03260205|9622947|P2|Overall Study|Lost to Follow-up|2
2815905|NCT03260205|9622948|P1|Overall Study|Lost to Follow-up|2
2815906|NCT03260205|9622944|P5|Overall Study|Adverse Event|4
2815907|NCT03260205|9622945|P4|Overall Study|Adverse Event|2
2815908|NCT03260205|9622946|P3|Overall Study|Adverse Event|2
2815909|NCT03260205|9622947|P2|Overall Study|Adverse Event|0
2815910|NCT03260205|9622948|P1|Overall Study|Adverse Event|2
2815911|NCT03259555|9623011|P2|Overall Study|Other|0
2815912|NCT03259555|9623012|P1|Overall Study|Other|1
2815913|NCT03259555|9623011|P2|Overall Study|Physician Decision|2
2815914|NCT03259555|9623012|P1|Overall Study|Physician Decision|1
2815915|NCT03259555|9623011|P2|Overall Study|Withdrawal by Subject|16
2815916|NCT03259555|9623012|P1|Overall Study|Withdrawal by Subject|19
2815917|NCT03259555|9623011|P2|Overall Study|Progressive Disease|2
2815918|NCT03259555|9623012|P1|Overall Study|Progressive Disease|0
2815919|NCT03259555|9623011|P2|Overall Study|Non-Compliance With Study Drug|0
2815920|NCT03259555|9623012|P1|Overall Study|Non-Compliance With Study Drug|1
2815921|NCT03259555|9623011|P2|Overall Study|Lost to Follow-up|2
2815922|NCT03259555|9623012|P1|Overall Study|Lost to Follow-up|0
2815923|NCT03259555|9623011|P2|Overall Study|Lack of Efficacy|4
2815924|NCT03259555|9623012|P1|Overall Study|Lack of Efficacy|6
2815925|NCT03259555|9623011|P2|Overall Study|Adverse Event|4
2815926|NCT03259555|9623012|P1|Overall Study|Adverse Event|6
2815927|NCT03259490|9623022|P2|Period 2|Protocol Violation|0
2815928|NCT03259490|9623023|P1|Period 2|Protocol Violation|1
2815929|NCT03259490|9623022|P2|Period 1|Withdrawal by Subject|1
2815930|NCT03259490|9623023|P1|Period 1|Withdrawal by Subject|0
2815931|NCT03259087|9623091|P5|Period 2 of Part 2|Adverse Event|1
2815932|NCT03259087|9623092|P4|Period 2 of Part 2|Adverse Event|0
2815933|NCT03259087|9623093|P3|Period 2 of Part 2|Adverse Event|0
2815934|NCT03259087|9623094|P2|Period 2 of Part 2|Adverse Event|0
2815935|NCT03259087|9623095|P1|Period 2 of Part 2|Adverse Event|0
2815936|NCT03259087|9623091|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
2815937|NCT03259087|9623092|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
2815938|NCT03259087|9623093|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
2815939|NCT03259087|9623094|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
2815940|NCT03259087|9623095|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
2815941|NCT03258814|9623223|P3|Overall Study|Early Termination|10
2815942|NCT03258814|9623224|P2|Overall Study|Early Termination|3
2815943|NCT03258814|9623225|P1|Overall Study|Early Termination|4
2815944|NCT03258762|9623280|P2|Overall Study|Lost to Follow-up|1
2815945|NCT03258762|9623281|P1|Overall Study|Lost to Follow-up|0
2815946|NCT03258710|9623341|P1|Overall Study|Protocol-defined stopping criteria|1
2815947|NCT03258710|9623341|P1|Overall Study|Adverse Event|1
2815948|NCT03257995|9623379|P6|Overall Study|Protocol deviation|2
2815949|NCT03257995|9623380|P5|Overall Study|Protocol deviation|0
2815950|NCT03257995|9623381|P4|Overall Study|Protocol deviation|0
2815951|NCT03257995|9623382|P3|Overall Study|Protocol deviation|0
2815952|NCT03257995|9623383|P2|Overall Study|Protocol deviation|0
2815953|NCT03257995|9623384|P1|Overall Study|Protocol deviation|0
2815954|NCT03257995|9623379|P6|Overall Study|Adverse Event|0
2815955|NCT03257995|9623380|P5|Overall Study|Adverse Event|0
2815956|NCT03257995|9623381|P4|Overall Study|Adverse Event|0
2815957|NCT03257995|9623382|P3|Overall Study|Adverse Event|0
2815958|NCT03257995|9623383|P2|Overall Study|Adverse Event|1
2815959|NCT03257995|9623384|P1|Overall Study|Adverse Event|0
2815960|NCT03257865|9623434|P2|Overall Study|Lost to Follow-up|4
2815961|NCT03257865|9623435|P1|Overall Study|Lost to Follow-up|4
2815962|NCT03257865|9623434|P2|Overall Study|Other|1
2815963|NCT03257865|9623435|P1|Overall Study|Other|0
2815964|NCT03257865|9623434|P2|Overall Study|Physician Decision|1
2815965|NCT03257865|9623435|P1|Overall Study|Physician Decision|3
2815966|NCT03257865|9623434|P2|Overall Study|Withdrawal by Subject|17
2815967|NCT03257865|9623435|P1|Overall Study|Withdrawal by Subject|23
2815968|NCT03257865|9623434|P2|Overall Study|Non-compliance with Study Drug|2
2815969|NCT03257865|9623435|P1|Overall Study|Non-compliance with Study Drug|0
2815970|NCT03257865|9623434|P2|Overall Study|Lack of Efficacy|2
2815971|NCT03257865|9623435|P1|Overall Study|Lack of Efficacy|1
2815972|NCT03257865|9623434|P2|Overall Study|Adverse Event|8
2815973|NCT03257865|9623435|P1|Overall Study|Adverse Event|4
2815974|NCT03257813|9623445|P2|Overall Study|Protocol Violation|3
2815975|NCT03257813|9623446|P1|Overall Study|Protocol Violation|6
2815976|NCT03257657|9623468|P2|Overall Study|Noted not eligible right after enrolled|1
2815977|NCT03257657|9623469|P1|Overall Study|Noted not eligible right after enrolled|0
2815978|NCT03257657|9623468|P2|Overall Study|Withdrawn|1
2815979|NCT03257657|9623469|P1|Overall Study|Withdrawn|0
2815980|NCT03257657|9623468|P2|Overall Study|Lost to Follow-up|3
2815981|NCT03257657|9623469|P1|Overall Study|Lost to Follow-up|0
2815982|NCT03257631|9623500|P4|Overall Study|Still on Study|4
2815983|NCT03257631|9623501|P3|Overall Study|Still on Study|4
2815984|NCT03257631|9623502|P2|Overall Study|Still on Study|2
2815985|NCT03257631|9623503|P1|Overall Study|Still on Study|3
2815986|NCT03257631|9623500|P4|Overall Study|Lost to Follow-up|0
2815987|NCT03257631|9623501|P3|Overall Study|Lost to Follow-up|1
2815988|NCT03257631|9623502|P2|Overall Study|Lost to Follow-up|0
2815989|NCT03257631|9623503|P1|Overall Study|Lost to Follow-up|0
2815990|NCT03257631|9623500|P4|Overall Study|Withdrawal by Parent/Guardian|1
2815991|NCT03257631|9623501|P3|Overall Study|Withdrawal by Parent/Guardian|4
2815992|NCT03257631|9623502|P2|Overall Study|Withdrawal by Parent/Guardian|2
2815993|NCT03257631|9623503|P1|Overall Study|Withdrawal by Parent/Guardian|0
2815994|NCT03257631|9623500|P4|Overall Study|Progressive Disease|0
2815995|NCT03257631|9623501|P3|Overall Study|Progressive Disease|1
2815996|NCT03257631|9623502|P2|Overall Study|Progressive Disease|0
2815997|NCT03257631|9623503|P1|Overall Study|Progressive Disease|0
2815998|NCT03257631|9623500|P4|Overall Study|Death|5
2815999|NCT03257631|9623501|P3|Overall Study|Death|13
2816000|NCT03257631|9623502|P2|Overall Study|Death|5
2816001|NCT03257631|9623503|P1|Overall Study|Death|8
2816002|NCT03256851|9623565|P2|Overall Study|Withdrawal by Subject|0
2816003|NCT03256851|9623566|P1|Overall Study|Withdrawal by Subject|1
2816004|NCT03256695|9623578|P1|Overall Study|Other than specified|3
2816005|NCT03256695|9623578|P1|Overall Study|Protocol Violation|5
2816006|NCT03256695|9623578|P1|Overall Study|Lack of Efficacy|3
2816007|NCT03256695|9623578|P1|Overall Study|Lost to Follow-up|3
2816008|NCT03256695|9623578|P1|Overall Study|Non-compliance with study drug|1
2816009|NCT03256695|9623578|P1|Overall Study|Withdrawal by Subject|14
2816010|NCT03256695|9623578|P1|Overall Study|Death|2
2816011|NCT03256695|9623578|P1|Overall Study|Adverse Event|8
2816012|NCT03256552|9623586|P1|Overall Study|Withdrawal by Subject|2
2816013|NCT03256552|9623586|P1|Overall Study|Adverse Event|1
2816014|NCT03256552|9623586|P1|Overall Study|Physician Decision|1
2816015|NCT03256552|9623586|P1|Overall Study|Protocol Violation|1
2816016|NCT03256526|9623611|P3|Overall Study|Lost to Follow-up|2
2816017|NCT03256526|9623612|P2|Overall Study|Lost to Follow-up|0
2816018|NCT03256526|9623613|P1|Overall Study|Lost to Follow-up|1
2816019|NCT03256526|9623611|P3|Overall Study|Adverse Event|1
2816020|NCT03256526|9623612|P2|Overall Study|Adverse Event|0
2816021|NCT03256526|9623613|P1|Overall Study|Adverse Event|1
2816022|NCT03255824|9623661|P2|Overall Study|Under-sedation|1
2816023|NCT03255824|9623662|P1|Overall Study|Under-sedation|2
2816024|NCT03255733|9623690|P1|Overall Study|Lost to Follow-up|4
2816025|NCT03255655|9623697|P2|Overall Study|Lost to Follow-up|4
2816026|NCT03255655|9623698|P1|Overall Study|Lost to Follow-up|7
2816027|NCT03255382|9623708|P2|Overall Study|Other|0
2816028|NCT03255382|9623709|P1|Overall Study|Other|6
2816029|NCT03255382|9623708|P2|Overall Study|Withdrawal by Subject|0
2816030|NCT03255382|9623709|P1|Overall Study|Withdrawal by Subject|2
2816031|NCT03255382|9623708|P2|Overall Study|Lost to Follow-up|0
2816032|NCT03255382|9623709|P1|Overall Study|Lost to Follow-up|2
2816033|NCT03255382|9623708|P2|Overall Study|Adverse Event|0
2816034|NCT03255382|9623709|P1|Overall Study|Adverse Event|3
2816035|NCT03255291|9623883|P6|Overall Study|Baseline data collection issues|0
2816036|NCT03255291|9623884|P5|Overall Study|Baseline data collection issues|2
2816037|NCT03255291|9623885|P4|Overall Study|Baseline data collection issues|0
2816038|NCT03255291|9623886|P3|Overall Study|Baseline data collection issues|0
2816039|NCT03255291|9623887|P2|Overall Study|Baseline data collection issues|0
2816040|NCT03255291|9623888|P1|Overall Study|Baseline data collection issues|3
2816041|NCT03255291|9623883|P6|Overall Study|Determined to be ineligible|10
2816042|NCT03255291|9623884|P5|Overall Study|Determined to be ineligible|5
2816043|NCT03255291|9623885|P4|Overall Study|Determined to be ineligible|6
2816044|NCT03255291|9623886|P3|Overall Study|Determined to be ineligible|6
2816045|NCT03255291|9623887|P2|Overall Study|Determined to be ineligible|12
2816046|NCT03255291|9623888|P1|Overall Study|Determined to be ineligible|10
2816047|NCT03255187|9623921|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
2816048|NCT03255187|9623922|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
2816049|NCT03255187|9623921|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
2816050|NCT03255187|9623922|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
2816051|NCT03254602|9623981|P1|Overall Study|Lost to Follow-up|4
2816052|NCT03254459|9623989|P2|Overall Study|Miscellaneous|1
2816053|NCT03254459|9623990|P1|Overall Study|Miscellaneous|0
2816054|NCT03254459|9623989|P2|Overall Study|Lost to Follow-up|1
2816055|NCT03254459|9623990|P1|Overall Study|Lost to Follow-up|0
2816056|NCT03254459|9623989|P2|Overall Study|Withdrawal by Subject Consent|1
2816057|NCT03254459|9623990|P1|Overall Study|Withdrawal by Subject Consent|3
2816058|NCT03254459|9623989|P2|Overall Study|Adverse Event|20
2816059|NCT03254459|9623990|P1|Overall Study|Adverse Event|7
2816060|NCT03254134|9624015|P2|Overall Study|Not eligible patients|3630
2816061|NCT03254134|9624016|P1|Overall Study|Not eligible patients|599
2816062|NCT03252015|9624042|P4|Overall Study|Adverse Event|1
2816063|NCT03252015|9624043|P3|Overall Study|Adverse Event|0
2816064|NCT03252015|9624044|P2|Overall Study|Adverse Event|0
2816065|NCT03252015|9624045|P1|Overall Study|Adverse Event|1
2816066|NCT03252015|9624042|P4|Overall Study|Withdrawal by Subject|0
2816067|NCT03252015|9624043|P3|Overall Study|Withdrawal by Subject|1
2816068|NCT03252015|9624044|P2|Overall Study|Withdrawal by Subject|1
2816069|NCT03252015|9624045|P1|Overall Study|Withdrawal by Subject|0
2816070|NCT03251482|9624090|P5|Overall Study|Withdrawal by Subject|0
2816071|NCT03251482|9624091|P4|Overall Study|Withdrawal by Subject|0
2816072|NCT03251482|9624092|P3|Overall Study|Withdrawal by Subject|0
2816073|NCT03251482|9624093|P2|Overall Study|Withdrawal by Subject|1
2816074|NCT03251482|9624094|P1|Overall Study|Withdrawal by Subject|0
2816075|NCT03250182|9624238|P1|Overall Study|Withdrawal by Subject|1
2816076|NCT03249935|9624262|P1|Overall Study|Protocol Violation|5
2816077|NCT03249935|9624262|P1|Overall Study|Negative for chlamydia at enrollment|4
2816078|NCT03249935|9624262|P1|Overall Study|Discharged from facility early|36
2816079|NCT03249454|9624273|P11|Overall Study|Withdrawal by Subject|1
2816080|NCT03249454|9624274|P10|Overall Study|Withdrawal by Subject|1
2816081|NCT03249454|9624275|P9|Overall Study|Withdrawal by Subject|0
2816082|NCT03249454|9624276|P8|Overall Study|Withdrawal by Subject|0
2816083|NCT03249454|9624277|P7|Overall Study|Withdrawal by Subject|0
2816084|NCT03249454|9624278|P6|Overall Study|Withdrawal by Subject|0
2816085|NCT03249454|9624279|P5|Overall Study|Withdrawal by Subject|0
2816086|NCT03249454|9624280|P4|Overall Study|Withdrawal by Subject|0
2816087|NCT03249454|9624281|P3|Overall Study|Withdrawal by Subject|0
2816088|NCT03249454|9624282|P2|Overall Study|Withdrawal by Subject|0
2816089|NCT03249454|9624283|P1|Overall Study|Withdrawal by Subject|0
2816090|NCT03248882|9624308|P5|Overall Study|Withdrawal by Subject|2
2816091|NCT03248882|9624309|P4|Overall Study|Withdrawal by Subject|4
2816092|NCT03248882|9624310|P3|Overall Study|Withdrawal by Subject|3
2816093|NCT03248882|9624311|P2|Overall Study|Withdrawal by Subject|2
2816094|NCT03248882|9624312|P1|Overall Study|Withdrawal by Subject|2
2816095|NCT03248882|9624308|P5|Overall Study|Protocol Violation|1
2816096|NCT03248882|9624309|P4|Overall Study|Protocol Violation|0
2816097|NCT03248882|9624310|P3|Overall Study|Protocol Violation|2
2816098|NCT03248882|9624311|P2|Overall Study|Protocol Violation|0
2816099|NCT03248882|9624312|P1|Overall Study|Protocol Violation|2
2816100|NCT03248882|9624308|P5|Overall Study|Lost to Follow-up|1
2816101|NCT03248882|9624309|P4|Overall Study|Lost to Follow-up|0
2816102|NCT03248882|9624310|P3|Overall Study|Lost to Follow-up|0
2816103|NCT03248882|9624311|P2|Overall Study|Lost to Follow-up|0
2816104|NCT03248882|9624312|P1|Overall Study|Lost to Follow-up|0
2816105|NCT03248882|9624308|P5|Overall Study|Adverse Event|9
2816106|NCT03248882|9624309|P4|Overall Study|Adverse Event|6
2816107|NCT03248882|9624310|P3|Overall Study|Adverse Event|2
2816108|NCT03248882|9624311|P2|Overall Study|Adverse Event|3
2816109|NCT03248882|9624312|P1|Overall Study|Adverse Event|3
2816110|NCT03248492|9624354|P5|Overall Study|Other|0
2816111|NCT03248492|9624355|P4|Overall Study|Other|4
2816112|NCT03248492|9624356|P3|Overall Study|Other|0
2816113|NCT03248492|9624357|P2|Overall Study|Other|1
2816114|NCT03248492|9624358|P1|Overall Study|Other|0
2816115|NCT03248492|9624354|P5|Overall Study|Death|0
2816116|NCT03248492|9624355|P4|Overall Study|Death|6
2816117|NCT03248492|9624356|P3|Overall Study|Death|0
2816118|NCT03248492|9624357|P2|Overall Study|Death|0
2816119|NCT03248492|9624358|P1|Overall Study|Death|1
2816120|NCT03248492|9624354|P5|Overall Study|Physician Decision|0
2816121|NCT03248492|9624355|P4|Overall Study|Physician Decision|2
2816122|NCT03248492|9624356|P3|Overall Study|Physician Decision|1
2816123|NCT03248492|9624357|P2|Overall Study|Physician Decision|0
2816124|NCT03248492|9624358|P1|Overall Study|Physician Decision|1
2816125|NCT03248492|9624354|P5|Overall Study|Withdrawal by Subject|1
2816126|NCT03248492|9624355|P4|Overall Study|Withdrawal by Subject|3
2816127|NCT03248492|9624356|P3|Overall Study|Withdrawal by Subject|0
2816128|NCT03248492|9624357|P2|Overall Study|Withdrawal by Subject|3
2816129|NCT03248492|9624358|P1|Overall Study|Withdrawal by Subject|3
2816130|NCT03248492|9624354|P5|Overall Study|Adverse Event|1
2816131|NCT03248492|9624355|P4|Overall Study|Adverse Event|8
2816132|NCT03248492|9624356|P3|Overall Study|Adverse Event|8
2816133|NCT03248492|9624357|P2|Overall Study|Adverse Event|6
2816134|NCT03248492|9624358|P1|Overall Study|Adverse Event|6
2816135|NCT03248492|9624354|P5|Overall Study|Progressive disease per RECIST v1.1|0
2816136|NCT03248492|9624355|P4|Overall Study|Progressive disease per RECIST v1.1|22
2816137|NCT03248492|9624356|P3|Overall Study|Progressive disease per RECIST v1.1|9
2816138|NCT03248492|9624357|P2|Overall Study|Progressive disease per RECIST v1.1|12
2816139|NCT03248492|9624358|P1|Overall Study|Progressive disease per RECIST v1.1|16
2816140|NCT03248492|9624354|P5|Overall Study|Ongoing|2
2816141|NCT03248492|9624355|P4|Overall Study|Ongoing|85
2816142|NCT03248492|9624356|P3|Overall Study|Ongoing|3
2816143|NCT03248492|9624357|P2|Overall Study|Ongoing|26
2816144|NCT03248492|9624358|P1|Overall Study|Ongoing|23
2816145|NCT03247673|9624450|P3|Overall Study|Lost to Follow-up|1
2816146|NCT03247673|9624451|P2|Overall Study|Lost to Follow-up|0
2816147|NCT03247673|9624452|P1|Overall Study|Lost to Follow-up|0
2816148|NCT03247673|9624450|P3|Overall Study|Withdrawal by Subject|3
2816149|NCT03247673|9624451|P2|Overall Study|Withdrawal by Subject|0
2816150|NCT03247673|9624452|P1|Overall Study|Withdrawal by Subject|1
2816151|NCT03246672|9624472|P1|Overall Study|Lost to Follow-up|2
2816152|NCT03246152|9624478|P1|Overall Study|Protocol Violation|1
2816153|NCT03246152|9624478|P1|Overall Study|Lost to Follow-up|2
2816154|NCT03245619|9624510|P17|Part A (Up to Day 22)|Physician Decision|0
2816155|NCT03245619|9624511|P16|Part A (Up to Day 22)|Physician Decision|0
2816156|NCT03245619|9624512|P15|Part A (Up to Day 22)|Physician Decision|0
2816157|NCT03245619|9624513|P14|Part A (Up to Day 22)|Physician Decision|0
2816158|NCT03245619|9624514|P13|Part A (Up to Day 22)|Physician Decision|0
2816159|NCT03245619|9624515|P12|Part A (Up to Day 22)|Physician Decision|0
2816160|NCT03245619|9624516|P11|Part A (Up to Day 22)|Physician Decision|0
2816161|NCT03245619|9624517|P10|Part A (Up to Day 22)|Physician Decision|0
2816162|NCT03245619|9624518|P9|Part A (Up to Day 22)|Physician Decision|0
2816163|NCT03245619|9624519|P8|Part A (Up to Day 22)|Physician Decision|0
2816164|NCT03245619|9624520|P7|Part A (Up to Day 22)|Physician Decision|0
2816165|NCT03245619|9624521|P6|Part A (Up to Day 22)|Physician Decision|0
2816166|NCT03245619|9624522|P5|Part A (Up to Day 22)|Physician Decision|0
2816167|NCT03245619|9624523|P4|Part A (Up to Day 22)|Physician Decision|0
2816168|NCT03245619|9624524|P3|Part A (Up to Day 22)|Physician Decision|6
2816169|NCT03245619|9624525|P2|Part A (Up to Day 22)|Physician Decision|6
2816170|NCT03245619|9624526|P1|Part A (Up to Day 22)|Physician Decision|4
2816171|NCT03245398|9624800|P2|Overall Study|Travelled to another island|0
2816172|NCT03245398|9624801|P1|Overall Study|Travelled to another island|1
2816173|NCT03244800|9624831|P4|Overall Study|Withdrew treatment|1
2816174|NCT03244800|9624832|P3|Overall Study|Withdrew treatment|0
2816175|NCT03244800|9624833|P2|Overall Study|Withdrew treatment|0
2816176|NCT03244800|9624834|P1|Overall Study|Withdrew treatment|0
2816177|NCT03244800|9624831|P4|Overall Study|Adverse Event|1
2816178|NCT03244800|9624832|P3|Overall Study|Adverse Event|0
2816179|NCT03244800|9624833|P2|Overall Study|Adverse Event|1
2816180|NCT03244800|9624834|P1|Overall Study|Adverse Event|0
2816181|NCT03243084|9624913|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
2816182|NCT03243084|9624914|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
2816183|NCT03242434|9624936|P2|Overall Study|Death|2
2816184|NCT03242434|9624937|P1|Overall Study|Death|0
2816185|NCT03240575|9624953|P4|Overall Study|Other|0
2816186|NCT03240575|9624954|P3|Overall Study|Other|0
2816187|NCT03240575|9624955|P2|Overall Study|Other|1
2816188|NCT03240575|9624956|P1|Overall Study|Other|0
2816189|NCT03240575|9624953|P4|Overall Study|Withdrawal by Subject|1
2816190|NCT03240575|9624954|P3|Overall Study|Withdrawal by Subject|0
2816191|NCT03240575|9624955|P2|Overall Study|Withdrawal by Subject|11
2816192|NCT03240575|9624956|P1|Overall Study|Withdrawal by Subject|2
2816193|NCT03240575|9624953|P4|Overall Study|Adverse Event|1
2816194|NCT03240575|9624954|P3|Overall Study|Adverse Event|0
2816195|NCT03240575|9624955|P2|Overall Study|Adverse Event|2
2816196|NCT03240575|9624956|P1|Overall Study|Adverse Event|0
2816197|NCT03239873|9624978|P2|Overall Study|Protocol Violation|0
2816198|NCT03239873|9624979|P1|Overall Study|Protocol Violation|1
2816199|NCT03239873|9624978|P2|Overall Study|Contraindication to study medication|0
2816200|NCT03239873|9624979|P1|Overall Study|Contraindication to study medication|1
2816201|NCT03239873|9624978|P2|Overall Study|Withdrawal by Subject|0
2816202|NCT03239873|9624979|P1|Overall Study|Withdrawal by Subject|2
2816203|NCT03239873|9624978|P2|Overall Study|Withdrawal by Parent/Guardian|11
2816204|NCT03239873|9624979|P1|Overall Study|Withdrawal by Parent/Guardian|12
2816205|NCT03239873|9624978|P2|Overall Study|Physician Decision|0
2816206|NCT03239873|9624979|P1|Overall Study|Physician Decision|1
2816207|NCT03239873|9624978|P2|Overall Study|Lost to Follow-up|16
2816208|NCT03239873|9624979|P1|Overall Study|Lost to Follow-up|15
2816209|NCT03239483|9625115|P2|Overall Study|Withdrawal by Subject|0
2816210|NCT03239483|9625116|P1|Overall Study|Withdrawal by Subject|1
2816211|NCT03239483|9625115|P2|Overall Study|Lost to Follow-up|0
2816212|NCT03239483|9625116|P1|Overall Study|Lost to Follow-up|1
2816213|NCT03238924|9625137|P2|Overall Study|Withdrawal by Subject|2
2816214|NCT03238924|9625138|P1|Overall Study|Withdrawal by Subject|2
2816215|NCT03238911|9625150|P2|Overall Study|Lost to Follow-up|1
2816216|NCT03238911|9625151|P1|Overall Study|Lost to Follow-up|2
2816217|NCT03238911|9625150|P2|Overall Study|Withdrawal by Subject|2
2816218|NCT03238911|9625151|P1|Overall Study|Withdrawal by Subject|1
2816219|NCT03238781|9625194|P3|Overall Study|Decision by sponsor|0
2816220|NCT03238781|9625195|P2|Overall Study|Decision by sponsor|1
2816221|NCT03238781|9625196|P1|Overall Study|Decision by sponsor|0
2816222|NCT03238781|9625194|P3|Overall Study|Withdrawal by Subject|16
2816223|NCT03238781|9625195|P2|Overall Study|Withdrawal by Subject|14
2816224|NCT03238781|9625196|P1|Overall Study|Withdrawal by Subject|23
2816225|NCT03238781|9625194|P3|Overall Study|Lost to Follow-up|2
2816226|NCT03238781|9625195|P2|Overall Study|Lost to Follow-up|1
2816227|NCT03238781|9625196|P1|Overall Study|Lost to Follow-up|2
2816228|NCT03238781|9625194|P3|Overall Study|Adverse Event|2
2816229|NCT03238781|9625195|P2|Overall Study|Adverse Event|1
2816230|NCT03238781|9625196|P1|Overall Study|Adverse Event|1
2816231|NCT03238352|9625246|P3|Overall Study|Withdrawal by Subject|0
2816232|NCT03238352|9625247|P2|Overall Study|Withdrawal by Subject|1
2816233|NCT03238352|9625248|P1|Overall Study|Withdrawal by Subject|0
2816234|NCT03238352|9625246|P3|Overall Study|Lost to Follow-up|1
2816235|NCT03238352|9625247|P2|Overall Study|Lost to Follow-up|2
2816236|NCT03238352|9625248|P1|Overall Study|Lost to Follow-up|0
2816237|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
2816238|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
2816239|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
2816240|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
2816241|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
2816242|NCT03238001|9625259|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
2816243|NCT03238001|9625259|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
2816244|NCT03238001|9625259|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
2816245|NCT03237065|9625388|P2|Overall Study|Unable to obtain venous access|1
2816246|NCT03237065|9625389|P1|Overall Study|Unable to obtain venous access|0
2816247|NCT03237065|9625388|P2|Overall Study|Lost to Follow-up|0
2816248|NCT03237065|9625389|P1|Overall Study|Lost to Follow-up|1
2816249|NCT03237065|9625388|P2|Overall Study|Withdrawal by Subject|0
2816250|NCT03237065|9625389|P1|Overall Study|Withdrawal by Subject|3
2816251|NCT03237065|9625388|P2|Overall Study|Protocol Violation|1
2816252|NCT03237065|9625389|P1|Overall Study|Protocol Violation|0
2816253|NCT03237065|9625388|P2|Overall Study|Adverse Event|2
2816254|NCT03237065|9625389|P1|Overall Study|Adverse Event|0
2816255|NCT03237013|9625432|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
2816256|NCT03237013|9625433|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
2816257|NCT03237013|9625434|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
2816258|NCT03236311|9625483|P2|Overall Study|Adverse Event|1
2816259|NCT03236311|9625484|P1|Overall Study|Adverse Event|0
2816260|NCT03236311|9625483|P2|Overall Study|Study terminated by sponsor|2
2816261|NCT03236311|9625484|P1|Overall Study|Study terminated by sponsor|0
2816341|NCT03231943|9626223|P3|Part 2|Withdrawal by Subject|0
2816262|NCT03235726|9625528|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816263|NCT03235726|9625529|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816264|NCT03235726|9625530|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816265|NCT03235726|9625531|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816266|NCT03235726|9625532|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816267|NCT03235726|9625533|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
2816268|NCT03235726|9625534|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816269|NCT03235726|9625535|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816270|NCT03235726|9625536|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816271|NCT03235726|9625537|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2816272|NCT03235726|9625528|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816273|NCT03235726|9625529|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816274|NCT03235726|9625530|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816275|NCT03235726|9625531|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816276|NCT03235726|9625532|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816277|NCT03235726|9625533|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
2816278|NCT03235726|9625534|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816279|NCT03235726|9625535|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816280|NCT03235726|9625536|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816281|NCT03235726|9625537|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2816282|NCT03235349|9625689|P1|Overall Study|Other|1
2816283|NCT03235349|9625689|P1|Overall Study|Adverse Event|1
2816284|NCT03235284|9625699|P3|Overall Study|Adverse Event|1
2816285|NCT03235284|9625700|P2|Overall Study|Adverse Event|2
2816286|NCT03235284|9625701|P1|Overall Study|Adverse Event|1
2816287|NCT03235115|9625718|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
2816288|NCT03235115|9625719|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2816289|NCT03235115|9625720|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2816290|NCT03235115|9625721|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2816291|NCT03235115|9625722|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2816292|NCT03235115|9625723|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2816293|NCT03234036|9625746|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2816294|NCT03234036|9625747|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2816295|NCT03234036|9625748|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2816296|NCT03234036|9625749|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2816297|NCT03233529|9625920|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
2816298|NCT03233529|9625920|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
2816299|NCT03233438|9625964|P2|Overall Study|No recording of dalbavancin|1
2816300|NCT03233438|9625965|P1|Overall Study|No recording of dalbavancin|0
2816301|NCT03233438|9625964|P2|Overall Study|Withdrawal by Subject|1
2816302|NCT03233438|9625965|P1|Overall Study|Withdrawal by Subject|2
2816303|NCT03233438|9625964|P2|Overall Study|Lost to Follow-up|9
2816304|NCT03233438|9625965|P1|Overall Study|Lost to Follow-up|4
2816305|NCT03233308|9626031|P1|Overall Study|Protocol Violation|1
2816306|NCT03233308|9626031|P1|Overall Study|Adverse Event|1
2816307|NCT03233009|9626081|P1|Overall Study|Lost to Follow-up|1
2816308|NCT03232983|9626124|P4|Period 4|Withdrawal by Subject|0
2816309|NCT03232983|9626125|P3|Period 4|Withdrawal by Subject|0
2816310|NCT03232983|9626126|P2|Period 4|Withdrawal by Subject|0
2816311|NCT03232983|9626127|P1|Period 4|Withdrawal by Subject|1
2816312|NCT03232983|9626124|P4|Washout Period 2|Withdrawal by Subject|1
2816313|NCT03232983|9626125|P3|Washout Period 2|Withdrawal by Subject|0
2816314|NCT03232983|9626126|P2|Washout Period 2|Withdrawal by Subject|0
2816315|NCT03232983|9626127|P1|Washout Period 2|Withdrawal by Subject|0
2816316|NCT03232983|9626124|P4|Washout Period 2|Physician Decision|0
2816317|NCT03232983|9626125|P3|Washout Period 2|Physician Decision|1
2816318|NCT03232983|9626126|P2|Washout Period 2|Physician Decision|0
2816319|NCT03232983|9626127|P1|Washout Period 2|Physician Decision|0
2816320|NCT03232983|9626124|P4|Period 1|Physician Decision|0
2816321|NCT03232983|9626125|P3|Period 1|Physician Decision|1
2816322|NCT03232983|9626126|P2|Period 1|Physician Decision|0
2816323|NCT03232983|9626127|P1|Period 1|Physician Decision|0
2816324|NCT03232567|9626171|P4|Overall Study|Withdrawal by Subject|0
2816325|NCT03232567|9626172|P3|Overall Study|Withdrawal by Subject|0
2816326|NCT03232567|9626173|P2|Overall Study|Withdrawal by Subject|1
2816327|NCT03232567|9626174|P1|Overall Study|Withdrawal by Subject|0
2816328|NCT03232333|9626196|P1|Overall Study|Withdrawal by Subject|2
2816329|NCT03232333|9626196|P1|Overall Study|Lost to Follow-up|4
2816330|NCT03232333|9626196|P1|Overall Study|Infection or Osteomyelitis|9
2816331|NCT03231943|9626213|P13|Part 2|Withdrawal by Subject|0
2816332|NCT03231943|9626214|P12|Part 2|Withdrawal by Subject|1
2816333|NCT03231943|9626215|P11|Part 2|Withdrawal by Subject|0
2816334|NCT03231943|9626216|P10|Part 2|Withdrawal by Subject|0
2816335|NCT03231943|9626217|P9|Part 2|Withdrawal by Subject|0
2816336|NCT03231943|9626218|P8|Part 2|Withdrawal by Subject|0
2816337|NCT03231943|9626219|P7|Part 2|Withdrawal by Subject|0
2816338|NCT03231943|9626220|P6|Part 2|Withdrawal by Subject|0
2816339|NCT03231943|9626221|P5|Part 2|Withdrawal by Subject|0
2816340|NCT03231943|9626222|P4|Part 2|Withdrawal by Subject|0
2816342|NCT03231943|9626224|P2|Part 2|Withdrawal by Subject|0
2816343|NCT03231943|9626225|P1|Part 2|Withdrawal by Subject|0
2816344|NCT03231943|9626213|P13|Part 2|Adverse Event|0
2816345|NCT03231943|9626214|P12|Part 2|Adverse Event|0
2816346|NCT03231943|9626215|P11|Part 2|Adverse Event|1
2816347|NCT03231943|9626216|P10|Part 2|Adverse Event|0
2816348|NCT03231943|9626217|P9|Part 2|Adverse Event|0
2816349|NCT03231943|9626218|P8|Part 2|Adverse Event|0
2816350|NCT03231943|9626219|P7|Part 2|Adverse Event|0
2816351|NCT03231943|9626220|P6|Part 2|Adverse Event|0
2816352|NCT03231943|9626221|P5|Part 2|Adverse Event|0
2816353|NCT03231943|9626222|P4|Part 2|Adverse Event|0
2816354|NCT03231943|9626223|P3|Part 2|Adverse Event|0
2816355|NCT03231943|9626224|P2|Part 2|Adverse Event|0
2816356|NCT03231943|9626225|P1|Part 2|Adverse Event|0
2816357|NCT03231943|9626213|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816358|NCT03231943|9626214|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816359|NCT03231943|9626215|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816360|NCT03231943|9626216|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816361|NCT03231943|9626217|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816362|NCT03231943|9626218|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816363|NCT03231943|9626219|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816364|NCT03231943|9626220|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816365|NCT03231943|9626221|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816366|NCT03231943|9626222|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816367|NCT03231943|9626223|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816368|NCT03231943|9626224|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2816369|NCT03231943|9626225|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
2816370|NCT03231943|9626213|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816371|NCT03231943|9626214|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816372|NCT03231943|9626215|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816373|NCT03231943|9626216|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816374|NCT03231943|9626217|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816375|NCT03231943|9626218|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816376|NCT03231943|9626219|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816377|NCT03231943|9626220|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816378|NCT03231943|9626221|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816379|NCT03231943|9626222|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816380|NCT03231943|9626223|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816381|NCT03231943|9626224|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
2816382|NCT03231943|9626225|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2816383|NCT03231943|9626213|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816384|NCT03231943|9626214|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816385|NCT03231943|9626215|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816386|NCT03231943|9626216|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816387|NCT03231943|9626217|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816388|NCT03231943|9626218|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816389|NCT03231943|9626219|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816390|NCT03231943|9626220|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816391|NCT03231943|9626221|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816392|NCT03231943|9626222|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816393|NCT03231943|9626223|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2816394|NCT03231943|9626224|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2816395|NCT03231943|9626225|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2816396|NCT03231709|9626688|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
2816397|NCT03231709|9626689|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
2816398|NCT03231709|9626688|P2|Treatment Period 1|Reason not Specified|1
2816399|NCT03231709|9626689|P1|Treatment Period 1|Reason not Specified|0
2816400|NCT03231371|9626707|P1|Overall Study|chose or were ineligible to have MRI|12
2816401|NCT03231371|9626707|P1|Overall Study|Withdrawal by Subject|1
2816402|NCT03231228|9626720|P2|Overall Study|Physician Decision|0
2816403|NCT03231228|9626721|P1|Overall Study|Physician Decision|1
2816404|NCT03231228|9626720|P2|Overall Study|Lost to Follow-up|0
2816405|NCT03231228|9626721|P1|Overall Study|Lost to Follow-up|2
2816406|NCT03230864|9626732|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2816407|NCT03230864|9626733|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
2816408|NCT03230864|9626734|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2816409|NCT03230864|9626735|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2816410|NCT03230864|9626732|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2816411|NCT03230864|9626733|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2816412|NCT03230864|9626734|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2816413|NCT03230864|9626735|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2816414|NCT03230864|9626732|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
2816415|NCT03230864|9626733|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
2816416|NCT03230864|9626734|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
2816417|NCT03230864|9626735|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
2816418|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2816419|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2816500|NCT03227445|9626970|P1|Period 1 (28 Days)|Protocol Violation|1
2816420|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2816421|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
2816422|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
2816423|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
2816424|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
2816425|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
2816426|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2816427|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2816428|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
2816429|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
2816430|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2816431|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2816432|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
2816433|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
2816434|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
2816435|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
2816436|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
2816437|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
2816438|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2816439|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2816440|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2816441|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2816442|NCT03230864|9626732|P4|Prospective Confirmation (PC) Period|Adverse Event|0
2816443|NCT03230864|9626733|P3|Prospective Confirmation (PC) Period|Adverse Event|0
2816444|NCT03230864|9626734|P2|Prospective Confirmation (PC) Period|Adverse Event|0
2816445|NCT03230864|9626735|P1|Prospective Confirmation (PC) Period|Adverse Event|3
2816446|NCT03229486|9626753|P2|Overall Study|Protocol Violation|1
2816447|NCT03229486|9626754|P1|Overall Study|Protocol Violation|0
2816448|NCT03229109|9626795|P4|Overall Study|Withdrawal by Subject|1
2816449|NCT03229109|9626796|P3|Overall Study|Withdrawal by Subject|0
2816450|NCT03229109|9626797|P2|Overall Study|Withdrawal by Subject|0
2816451|NCT03229109|9626798|P1|Overall Study|Withdrawal by Subject|0
2816452|NCT03228433|9626814|P6|Overall Study|Positive alcohol test|0
2816453|NCT03228433|9626815|P5|Overall Study|Positive alcohol test|0
2816454|NCT03228433|9626816|P4|Overall Study|Positive alcohol test|1
2816455|NCT03228433|9626817|P3|Overall Study|Positive alcohol test|0
2816456|NCT03228433|9626818|P2|Overall Study|Positive alcohol test|0
2816457|NCT03228433|9626819|P1|Overall Study|Positive alcohol test|0
2816458|NCT03228433|9626814|P6|Overall Study|Lost to Follow-up|0
2816459|NCT03228433|9626815|P5|Overall Study|Lost to Follow-up|0
2816460|NCT03228433|9626816|P4|Overall Study|Lost to Follow-up|0
2816461|NCT03228433|9626817|P3|Overall Study|Lost to Follow-up|0
2816462|NCT03228433|9626818|P2|Overall Study|Lost to Follow-up|0
2816463|NCT03228433|9626819|P1|Overall Study|Lost to Follow-up|1
2816464|NCT03228212|9626894|P2|Period 2|Lost to Follow-up|0
2816465|NCT03228212|9626895|P1|Period 2|Lost to Follow-up|1
2816466|NCT03228212|9626894|P2|Period 1|no longer meets eligibility criteria|1
2816467|NCT03228212|9626895|P1|Period 1|no longer meets eligibility criteria|0
2816468|NCT03228212|9626894|P2|Period 1|Adverse Event|0
2816469|NCT03228212|9626895|P1|Period 1|Adverse Event|1
2816470|NCT03227861|9626911|P1|Overall Study|Other|5
2816471|NCT03227861|9626911|P1|Overall Study|Protocol Violation|1
2816472|NCT03227861|9626911|P1|Overall Study|Adverse Event|1
2816473|NCT03227861|9626911|P1|Overall Study|Withdrawal by Subject|1
2816474|NCT03227861|9626911|P1|Overall Study|Lost to Follow-up|4
2816475|NCT03227692|9626938|P2|Overall Study|Adverse Event|2
2816476|NCT03227692|9626939|P1|Overall Study|Adverse Event|0
2816477|NCT03227692|9626938|P2|Overall Study|Lost to Follow-up|2
2816478|NCT03227692|9626939|P1|Overall Study|Lost to Follow-up|4
2816479|NCT03227692|9626938|P2|Overall Study|Protocol Violation|1
2816480|NCT03227692|9626939|P1|Overall Study|Protocol Violation|1
2816481|NCT03227445|9626967|P4|Period 2 (28 Days)|Withdrawal by Subject|1
2816482|NCT03227445|9626968|P3|Period 2 (28 Days)|Withdrawal by Subject|0
2816483|NCT03227445|9626969|P2|Period 2 (28 Days)|Withdrawal by Subject|1
2816484|NCT03227445|9626970|P1|Period 2 (28 Days)|Withdrawal by Subject|0
2816485|NCT03227445|9626967|P4|Period 2 (28 Days)|Protocol Violation|1
2816486|NCT03227445|9626968|P3|Period 2 (28 Days)|Protocol Violation|0
2816487|NCT03227445|9626969|P2|Period 2 (28 Days)|Protocol Violation|0
2816488|NCT03227445|9626970|P1|Period 2 (28 Days)|Protocol Violation|0
2816489|NCT03227445|9626967|P4|Period 2 (28 Days)|Adverse Event|1
2816490|NCT03227445|9626968|P3|Period 2 (28 Days)|Adverse Event|2
2816491|NCT03227445|9626969|P2|Period 2 (28 Days)|Adverse Event|0
2816492|NCT03227445|9626970|P1|Period 2 (28 Days)|Adverse Event|1
2816493|NCT03227445|9626967|P4|Period 1 (28 Days)|Withdrawal by Subject|1
2816494|NCT03227445|9626968|P3|Period 1 (28 Days)|Withdrawal by Subject|1
2816495|NCT03227445|9626969|P2|Period 1 (28 Days)|Withdrawal by Subject|0
2816496|NCT03227445|9626970|P1|Period 1 (28 Days)|Withdrawal by Subject|0
2816497|NCT03227445|9626967|P4|Period 1 (28 Days)|Protocol Violation|0
2816498|NCT03227445|9626968|P3|Period 1 (28 Days)|Protocol Violation|0
2816499|NCT03227445|9626969|P2|Period 1 (28 Days)|Protocol Violation|0
2816501|NCT03227445|9626967|P4|Period 1 (28 Days)|Adverse Event|1
2816502|NCT03227445|9626968|P3|Period 1 (28 Days)|Adverse Event|0
2816503|NCT03227445|9626969|P2|Period 1 (28 Days)|Adverse Event|2
2816504|NCT03227445|9626970|P1|Period 1 (28 Days)|Adverse Event|1
2816505|NCT03226392|9627000|P2|Overall Study|Subject/Guardian Decision|6
2816506|NCT03226392|9627001|P1|Overall Study|Subject/Guardian Decision|7
2816507|NCT03226392|9627000|P2|Overall Study|Technical Problems|2
2816508|NCT03226392|9627001|P1|Overall Study|Technical Problems|0
2816509|NCT03226392|9627000|P2|Overall Study|Adverse Event|0
2816510|NCT03226392|9627001|P1|Overall Study|Adverse Event|1
2816511|NCT03226392|9627000|P2|Overall Study|Lost to Follow-up|0
2816512|NCT03226392|9627001|P1|Overall Study|Lost to Follow-up|1
2816513|NCT03226392|9627000|P2|Overall Study|Physician Decision|0
2816514|NCT03226392|9627001|P1|Overall Study|Physician Decision|1
2816515|NCT03226392|9627000|P2|Overall Study|Protocol Deviation|0
2816516|NCT03226392|9627001|P1|Overall Study|Protocol Deviation|1
2816517|NCT03226353|9627013|P1|Overall Study|Screen Failure|5
2816518|NCT03226353|9627013|P1|Overall Study|Withdrawal by Subject|1
2816519|NCT03226275|9627037|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
2816520|NCT03226275|9627038|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2816521|NCT03226275|9627039|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2816522|NCT03226275|9627040|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2816523|NCT03226275|9627037|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2816524|NCT03226275|9627038|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
2816525|NCT03226275|9627039|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2816526|NCT03226275|9627040|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2816527|NCT03224598|9627139|P3|Overall Study|Other|0
2816528|NCT03224598|9627140|P2|Overall Study|Other|1
2816529|NCT03224598|9627141|P1|Overall Study|Other|0
2816530|NCT03224598|9627139|P3|Overall Study|Lost to Follow-up|0
2816531|NCT03224598|9627140|P2|Overall Study|Lost to Follow-up|2
2816532|NCT03224598|9627141|P1|Overall Study|Lost to Follow-up|0
2816533|NCT03224325|9627167|P7|Overall Study|Withdrawal by Subject|0
2816534|NCT03224325|9627168|P6|Overall Study|Withdrawal by Subject|0
2816535|NCT03224325|9627169|P5|Overall Study|Withdrawal by Subject|0
2816536|NCT03224325|9627170|P4|Overall Study|Withdrawal by Subject|1
2816537|NCT03224325|9627171|P3|Overall Study|Withdrawal by Subject|0
2816538|NCT03224325|9627172|P2|Overall Study|Withdrawal by Subject|0
2816539|NCT03224325|9627173|P1|Overall Study|Withdrawal by Subject|0
2816540|NCT03224325|9627167|P7|Overall Study|Adverse Event|1
2816541|NCT03224325|9627168|P6|Overall Study|Adverse Event|0
2816542|NCT03224325|9627169|P5|Overall Study|Adverse Event|0
2816543|NCT03224325|9627170|P4|Overall Study|Adverse Event|0
2816544|NCT03224325|9627171|P3|Overall Study|Adverse Event|0
2816545|NCT03224325|9627172|P2|Overall Study|Adverse Event|0
2816546|NCT03224325|9627173|P1|Overall Study|Adverse Event|1
2816547|NCT03224130|9627236|P2|Overall Study|consent issue|1
2816548|NCT03224130|9627237|P1|Overall Study|consent issue|0
2816549|NCT03223909|9627258|P3|Overall Study|Protocol Violation|16
2816550|NCT03223909|9627259|P2|Overall Study|Protocol Violation|45
2816551|NCT03223909|9627260|P1|Overall Study|Protocol Violation|48
2816552|NCT03223662|9627289|P1|Overall Study|Study closure|1
2816553|NCT03223662|9627289|P1|Overall Study|Physician Decision|1
2816554|NCT03222583|9627374|P2|Overall Study|Other|3
2816555|NCT03222583|9627375|P1|Overall Study|Other|1
2816556|NCT03222583|9627374|P2|Overall Study|Lost to Follow-up|0
2816557|NCT03222583|9627375|P1|Overall Study|Lost to Follow-up|1
2816558|NCT03222583|9627374|P2|Overall Study|Withdrawal by Subject|3
2816559|NCT03222583|9627375|P1|Overall Study|Withdrawal by Subject|3
2816560|NCT03222141|9627425|P1|Overall Study|Lost to Follow-up|3
2816561|NCT03222141|9627425|P1|Overall Study|Death|15
2816562|NCT03219723|9627591|P1|Overall Study|Protocol Deviation|4
2816563|NCT03219723|9627591|P1|Overall Study|Case Report Forms Uncollected|6
2816564|NCT03219216|9627609|P2|Overall Study|Lost to Follow-up|1
2816565|NCT03219216|9627610|P1|Overall Study|Lost to Follow-up|0
2816566|NCT03218397|9627643|P2|Overall Study|Randomized during laboratory off hours|1
2816567|NCT03218397|9627644|P1|Overall Study|Randomized during laboratory off hours|2
2816568|NCT03218397|9627643|P2|Overall Study|No gram-negative bacilli (GNB)|2
2816569|NCT03218397|9627644|P1|Overall Study|No gram-negative bacilli (GNB)|0
2816570|NCT03218397|9627643|P2|Overall Study|Inaccessible hospital records|5
2816571|NCT03218397|9627644|P1|Overall Study|Inaccessible hospital records|2
2816572|NCT03218397|9627643|P2|Overall Study|Mixed culture|2
2816573|NCT03218397|9627644|P1|Overall Study|Mixed culture|2
2816574|NCT03218397|9627643|P2|Overall Study|Comfort care and mixed culture|1
2816575|NCT03218397|9627644|P1|Overall Study|Comfort care and mixed culture|0
2816576|NCT03218397|9627643|P2|Overall Study|Comfort care and positive blood culture|0
2816577|NCT03218397|9627644|P1|Overall Study|Comfort care and positive blood culture|1
2816578|NCT03218397|9627643|P2|Overall Study|Comfort care|5
2816579|NCT03218397|9627644|P1|Overall Study|Comfort care|8
2816580|NCT03218397|9627643|P2|Overall Study|Prior positive blood culture|13
2816581|NCT03218397|9627644|P1|Overall Study|Prior positive blood culture|8
2816582|NCT03217968|9627676|P1|Overall Study|Protocol Violation|6
2816583|NCT03217968|9627676|P1|Overall Study|Lost to Follow-up|1
2816584|NCT03217968|9627676|P1|Overall Study|Withdrawal by Subject|4
2816585|NCT03217175|9627685|P2|Overall Study|Physician Decision|1
2816586|NCT03217175|9627686|P1|Overall Study|Physician Decision|4
2816587|NCT03216850|9627700|P1|Overall Study|Pre-analytical error|6
2816588|NCT03216746|9627708|P4|Overall Study|Lost to Follow-up|6
2816589|NCT03216746|9627709|P3|Overall Study|Lost to Follow-up|5
2816590|NCT03216746|9627710|P2|Overall Study|Lost to Follow-up|8
2816591|NCT03216746|9627711|P1|Overall Study|Lost to Follow-up|6
2816592|NCT03216265|9627745|P3|Overall Study|Withdrawal by Subject|1
2816593|NCT03216265|9627746|P2|Overall Study|Withdrawal by Subject|0
2816594|NCT03216265|9627747|P1|Overall Study|Withdrawal by Subject|0
2816595|NCT03216265|9627745|P3|Overall Study|Lost to Follow-up|0
2816596|NCT03216265|9627746|P2|Overall Study|Lost to Follow-up|1
2816597|NCT03216265|9627747|P1|Overall Study|Lost to Follow-up|0
2816598|NCT03216265|9627745|P3|Overall Study|Adverse Event|2
2816599|NCT03216265|9627746|P2|Overall Study|Adverse Event|0
2816600|NCT03216265|9627747|P1|Overall Study|Adverse Event|2
2816601|NCT03215758|9627804|P2|Overall Study|Subject/Guardian Decision|3
2816602|NCT03215758|9627805|P1|Overall Study|Subject/Guardian Decision|3
2816603|NCT03215758|9627804|P2|Overall Study|Adverse Event|2
2816604|NCT03215758|9627805|P1|Overall Study|Adverse Event|1
2816605|NCT03215758|9627804|P2|Overall Study|Death|1
2816606|NCT03215758|9627805|P1|Overall Study|Death|0
2816607|NCT03215758|9627804|P2|Overall Study|Physician Decision|1
2816608|NCT03215758|9627805|P1|Overall Study|Physician Decision|0
2816609|NCT03215758|9627804|P2|Overall Study|Protocol deviation|1
2816610|NCT03215758|9627805|P1|Overall Study|Protocol deviation|0
2816611|NCT03215758|9627804|P2|Overall Study|Technical Problems|0
2816612|NCT03215758|9627805|P1|Overall Study|Technical Problems|1
2816613|NCT03214952|9627817|P1|Overall Study|Case Report Forms Uncollected|13
2816614|NCT03214952|9627817|P1|Overall Study|Protocol Deviation|45
2816615|NCT03214588|9627832|P3|Overall Study|Reason Not Specified|0
2816616|NCT03214588|9627833|P2|Overall Study|Reason Not Specified|1
2816617|NCT03214588|9627834|P1|Overall Study|Reason Not Specified|0
2816618|NCT03214588|9627832|P3|Overall Study|Adverse Event|2
2816619|NCT03214588|9627833|P2|Overall Study|Adverse Event|0
2816620|NCT03214588|9627834|P1|Overall Study|Adverse Event|1
2816621|NCT03214406|9627901|P2|Overall Study|Lost to Follow-up|2
2816622|NCT03214406|9627902|P1|Overall Study|Lost to Follow-up|0
2816623|NCT03214406|9627901|P2|Overall Study|Withdrawal by Subject|0
2816624|NCT03214406|9627902|P1|Overall Study|Withdrawal by Subject|1
2816625|NCT03214406|9627901|P2|Overall Study|did not meet enrollment criteria|13
2816626|NCT03214406|9627902|P1|Overall Study|did not meet enrollment criteria|9
2816627|NCT03214380|9627916|P6|Treatment Period|Treatment Interruption|0
2816628|NCT03214380|9627917|P5|Treatment Period|Treatment Interruption|0
2816629|NCT03214380|9627918|P4|Treatment Period|Treatment Interruption|0
2816630|NCT03214380|9627919|P3|Treatment Period|Treatment Interruption|1
2816631|NCT03214380|9627920|P2|Treatment Period|Treatment Interruption|0
2816632|NCT03214380|9627921|P1|Treatment Period|Treatment Interruption|0
2816633|NCT03214380|9627916|P6|Treatment Period|Participant schedule|0
2816634|NCT03214380|9627917|P5|Treatment Period|Participant schedule|0
2816635|NCT03214380|9627918|P4|Treatment Period|Participant schedule|0
2816636|NCT03214380|9627919|P3|Treatment Period|Participant schedule|1
2816637|NCT03214380|9627920|P2|Treatment Period|Participant schedule|0
2816638|NCT03214380|9627921|P1|Treatment Period|Participant schedule|0
2816639|NCT03214380|9627916|P6|Treatment Period|Lost to Follow-up|0
2816640|NCT03214380|9627917|P5|Treatment Period|Lost to Follow-up|0
2816641|NCT03214380|9627918|P4|Treatment Period|Lost to Follow-up|0
2816642|NCT03214380|9627919|P3|Treatment Period|Lost to Follow-up|3
2816643|NCT03214380|9627920|P2|Treatment Period|Lost to Follow-up|6
2816644|NCT03214380|9627921|P1|Treatment Period|Lost to Follow-up|0
2816645|NCT03214380|9627916|P6|Treatment Period|Death|0
2816646|NCT03214380|9627917|P5|Treatment Period|Death|0
2816647|NCT03214380|9627918|P4|Treatment Period|Death|0
2816648|NCT03214380|9627919|P3|Treatment Period|Death|2
2816649|NCT03214380|9627920|P2|Treatment Period|Death|1
2816650|NCT03214380|9627921|P1|Treatment Period|Death|0
2816651|NCT03214380|9627916|P6|Treatment Period|Withdrawal by Subject|11
2816652|NCT03214380|9627917|P5|Treatment Period|Withdrawal by Subject|7
2816653|NCT03214380|9627918|P4|Treatment Period|Withdrawal by Subject|0
2816654|NCT03214380|9627919|P3|Treatment Period|Withdrawal by Subject|8
2816655|NCT03214380|9627920|P2|Treatment Period|Withdrawal by Subject|10
2816656|NCT03214380|9627921|P1|Treatment Period|Withdrawal by Subject|0
2816657|NCT03214380|9627916|P6|Treatment Period|Non-Compliance with Study Drug|0
2816658|NCT03214380|9627917|P5|Treatment Period|Non-Compliance with Study Drug|1
2816659|NCT03214380|9627918|P4|Treatment Period|Non-Compliance with Study Drug|0
2816660|NCT03214380|9627919|P3|Treatment Period|Non-Compliance with Study Drug|0
2816661|NCT03214380|9627920|P2|Treatment Period|Non-Compliance with Study Drug|0
2816662|NCT03214380|9627921|P1|Treatment Period|Non-Compliance with Study Drug|0
2816663|NCT03214380|9627916|P6|Treatment Period|Adverse Event|0
2816664|NCT03214380|9627917|P5|Treatment Period|Adverse Event|1
2816665|NCT03214380|9627918|P4|Treatment Period|Adverse Event|0
2816666|NCT03214380|9627919|P3|Treatment Period|Adverse Event|1
2816667|NCT03214380|9627920|P2|Treatment Period|Adverse Event|1
2816668|NCT03214380|9627921|P1|Treatment Period|Adverse Event|0
2816669|NCT03214380|9627916|P6|Lead-in|Participant Schedule|0
2816670|NCT03214380|9627917|P5|Lead-in|Participant Schedule|0
2816671|NCT03214380|9627918|P4|Lead-in|Participant Schedule|0
2816672|NCT03214380|9627919|P3|Lead-in|Participant Schedule|0
2816673|NCT03214380|9627920|P2|Lead-in|Participant Schedule|0
2816674|NCT03214380|9627921|P1|Lead-in|Participant Schedule|2
2816675|NCT03214380|9627916|P6|Lead-in|Non Compliance|0
2816676|NCT03214380|9627917|P5|Lead-in|Non Compliance|0
2816677|NCT03214380|9627918|P4|Lead-in|Non Compliance|0
2816678|NCT03214380|9627919|P3|Lead-in|Non Compliance|0
2816679|NCT03214380|9627920|P2|Lead-in|Non Compliance|0
2816680|NCT03214380|9627921|P1|Lead-in|Non Compliance|1
2816681|NCT03214380|9627916|P6|Lead-in|Natural Disaster|0
2816682|NCT03214380|9627917|P5|Lead-in|Natural Disaster|0
2816683|NCT03214380|9627918|P4|Lead-in|Natural Disaster|0
2816684|NCT03214380|9627919|P3|Lead-in|Natural Disaster|0
2816685|NCT03214380|9627920|P2|Lead-in|Natural Disaster|0
2816686|NCT03214380|9627921|P1|Lead-in|Natural Disaster|9
2816687|NCT03214380|9627916|P6|Lead-in|Family Emergency|0
2816688|NCT03214380|9627917|P5|Lead-in|Family Emergency|0
2816689|NCT03214380|9627918|P4|Lead-in|Family Emergency|0
2816690|NCT03214380|9627919|P3|Lead-in|Family Emergency|0
2816691|NCT03214380|9627920|P2|Lead-in|Family Emergency|0
2816692|NCT03214380|9627921|P1|Lead-in|Family Emergency|1
2816693|NCT03214380|9627916|P6|Lead-in|Withdrawal by Subject|0
2816694|NCT03214380|9627917|P5|Lead-in|Withdrawal by Subject|0
2816695|NCT03214380|9627918|P4|Lead-in|Withdrawal by Subject|14
2816696|NCT03214380|9627919|P3|Lead-in|Withdrawal by Subject|0
2816697|NCT03214380|9627920|P2|Lead-in|Withdrawal by Subject|0
2816698|NCT03214380|9627921|P1|Lead-in|Withdrawal by Subject|41
2816699|NCT03214380|9627916|P6|Lead-in|Protocol Deviation|0
2816700|NCT03214380|9627917|P5|Lead-in|Protocol Deviation|0
2816701|NCT03214380|9627918|P4|Lead-in|Protocol Deviation|3
2816702|NCT03214380|9627919|P3|Lead-in|Protocol Deviation|0
2816703|NCT03214380|9627920|P2|Lead-in|Protocol Deviation|0
2816704|NCT03214380|9627921|P1|Lead-in|Protocol Deviation|7
2816705|NCT03214380|9627916|P6|Lead-in|Physician Decision|0
2816706|NCT03214380|9627917|P5|Lead-in|Physician Decision|0
2816707|NCT03214380|9627918|P4|Lead-in|Physician Decision|0
2816708|NCT03214380|9627919|P3|Lead-in|Physician Decision|0
2816709|NCT03214380|9627920|P2|Lead-in|Physician Decision|0
2816710|NCT03214380|9627921|P1|Lead-in|Physician Decision|6
2816711|NCT03214380|9627916|P6|Lead-in|Eligibility Criteria|0
2816712|NCT03214380|9627917|P5|Lead-in|Eligibility Criteria|0
2816713|NCT03214380|9627918|P4|Lead-in|Eligibility Criteria|0
2816714|NCT03214380|9627919|P3|Lead-in|Eligibility Criteria|0
2816715|NCT03214380|9627920|P2|Lead-in|Eligibility Criteria|0
2816716|NCT03214380|9627921|P1|Lead-in|Eligibility Criteria|3
2816717|NCT03214380|9627916|P6|Lead-in|Lost to Follow-up|0
2816718|NCT03214380|9627917|P5|Lead-in|Lost to Follow-up|0
2816719|NCT03214380|9627918|P4|Lead-in|Lost to Follow-up|1
2816720|NCT03214380|9627919|P3|Lead-in|Lost to Follow-up|0
2816721|NCT03214380|9627920|P2|Lead-in|Lost to Follow-up|0
2816722|NCT03214380|9627921|P1|Lead-in|Lost to Follow-up|4
2816723|NCT03214380|9627916|P6|Lead-in|Adverse Event|0
2816724|NCT03214380|9627917|P5|Lead-in|Adverse Event|0
2816725|NCT03214380|9627918|P4|Lead-in|Adverse Event|1
2816726|NCT03214380|9627919|P3|Lead-in|Adverse Event|0
2816727|NCT03214380|9627920|P2|Lead-in|Adverse Event|0
2816728|NCT03214380|9627921|P1|Lead-in|Adverse Event|3
2816729|NCT03214367|9627957|P8|Treatment Period|Withdrawal by Subject|1
2816730|NCT03214367|9627958|P7|Treatment Period|Withdrawal by Subject|1
2816731|NCT03214367|9627959|P6|Treatment Period|Withdrawal by Subject|1
2816732|NCT03214367|9627960|P5|Treatment Period|Withdrawal by Subject|0
2816733|NCT03214367|9627961|P4|Treatment Period|Withdrawal by Subject|14
2816734|NCT03214367|9627962|P3|Treatment Period|Withdrawal by Subject|23
2816735|NCT03214367|9627963|P2|Treatment Period|Withdrawal by Subject|20
2816736|NCT03214367|9627964|P1|Treatment Period|Withdrawal by Subject|0
2816737|NCT03214367|9627957|P8|Treatment Period|Protocol Violation|0
2816738|NCT03214367|9627958|P7|Treatment Period|Protocol Violation|0
2816739|NCT03214367|9627959|P6|Treatment Period|Protocol Violation|0
2816740|NCT03214367|9627960|P5|Treatment Period|Protocol Violation|0
2816741|NCT03214367|9627961|P4|Treatment Period|Protocol Violation|0
2816742|NCT03214367|9627962|P3|Treatment Period|Protocol Violation|0
2816743|NCT03214367|9627963|P2|Treatment Period|Protocol Violation|3
2816744|NCT03214367|9627964|P1|Treatment Period|Protocol Violation|0
2816745|NCT03214367|9627957|P8|Treatment Period|Physician Decision|0
2816746|NCT03214367|9627958|P7|Treatment Period|Physician Decision|0
2816747|NCT03214367|9627959|P6|Treatment Period|Physician Decision|0
2816748|NCT03214367|9627960|P5|Treatment Period|Physician Decision|0
2816749|NCT03214367|9627961|P4|Treatment Period|Physician Decision|0
2816750|NCT03214367|9627962|P3|Treatment Period|Physician Decision|2
2816751|NCT03214367|9627963|P2|Treatment Period|Physician Decision|1
2816752|NCT03214367|9627964|P1|Treatment Period|Physician Decision|0
2816753|NCT03214367|9627957|P8|Treatment Period|Sponsor Decision|0
2816754|NCT03214367|9627958|P7|Treatment Period|Sponsor Decision|0
2816755|NCT03214367|9627959|P6|Treatment Period|Sponsor Decision|0
2816756|NCT03214367|9627960|P5|Treatment Period|Sponsor Decision|0
2816757|NCT03214367|9627961|P4|Treatment Period|Sponsor Decision|0
2816758|NCT03214367|9627962|P3|Treatment Period|Sponsor Decision|0
2816759|NCT03214367|9627963|P2|Treatment Period|Sponsor Decision|3
2816760|NCT03214367|9627964|P1|Treatment Period|Sponsor Decision|0
2816761|NCT03214367|9627957|P8|Treatment Period|Lost to Follow-up|0
2816762|NCT03214367|9627958|P7|Treatment Period|Lost to Follow-up|1
2816763|NCT03214367|9627959|P6|Treatment Period|Lost to Follow-up|2
2816764|NCT03214367|9627960|P5|Treatment Period|Lost to Follow-up|0
2816765|NCT03214367|9627961|P4|Treatment Period|Lost to Follow-up|2
2816766|NCT03214367|9627962|P3|Treatment Period|Lost to Follow-up|3
2816767|NCT03214367|9627963|P2|Treatment Period|Lost to Follow-up|5
2816768|NCT03214367|9627964|P1|Treatment Period|Lost to Follow-up|0
2816769|NCT03214367|9627957|P8|Treatment Period|Death|0
2816770|NCT03214367|9627958|P7|Treatment Period|Death|0
2816771|NCT03214367|9627959|P6|Treatment Period|Death|0
2816772|NCT03214367|9627960|P5|Treatment Period|Death|0
2816773|NCT03214367|9627961|P4|Treatment Period|Death|1
2816774|NCT03214367|9627962|P3|Treatment Period|Death|1
2816775|NCT03214367|9627963|P2|Treatment Period|Death|1
2816776|NCT03214367|9627964|P1|Treatment Period|Death|0
2816777|NCT03214367|9627957|P8|Treatment Period|Adverse Event|0
2816778|NCT03214367|9627958|P7|Treatment Period|Adverse Event|0
2816779|NCT03214367|9627959|P6|Treatment Period|Adverse Event|0
2816780|NCT03214367|9627960|P5|Treatment Period|Adverse Event|0
2816781|NCT03214367|9627961|P4|Treatment Period|Adverse Event|2
2816782|NCT03214367|9627962|P3|Treatment Period|Adverse Event|4
2816783|NCT03214367|9627963|P2|Treatment Period|Adverse Event|1
2816784|NCT03214367|9627964|P1|Treatment Period|Adverse Event|0
2816785|NCT03214367|9627957|P8|Lead-in Period|Treatment Interruption|0
2816786|NCT03214367|9627958|P7|Lead-in Period|Treatment Interruption|0
2816787|NCT03214367|9627959|P6|Lead-in Period|Treatment Interruption|0
2816788|NCT03214367|9627960|P5|Lead-in Period|Treatment Interruption|0
2816789|NCT03214367|9627961|P4|Lead-in Period|Treatment Interruption|0
2816790|NCT03214367|9627962|P3|Lead-in Period|Treatment Interruption|0
2816791|NCT03214367|9627963|P2|Lead-in Period|Treatment Interruption|0
2816792|NCT03214367|9627964|P1|Lead-in Period|Treatment Interruption|1
2816793|NCT03214367|9627957|P8|Lead-in Period|Protocol Violation|0
2816794|NCT03214367|9627958|P7|Lead-in Period|Protocol Violation|0
2816795|NCT03214367|9627959|P6|Lead-in Period|Protocol Violation|0
2816796|NCT03214367|9627960|P5|Lead-in Period|Protocol Violation|0
2816797|NCT03214367|9627961|P4|Lead-in Period|Protocol Violation|0
2816798|NCT03214367|9627962|P3|Lead-in Period|Protocol Violation|0
2816799|NCT03214367|9627963|P2|Lead-in Period|Protocol Violation|0
2816800|NCT03214367|9627964|P1|Lead-in Period|Protocol Violation|5
2816801|NCT03214367|9627957|P8|Lead-in Period|Physician Decision|0
2816802|NCT03214367|9627958|P7|Lead-in Period|Physician Decision|0
2816803|NCT03214367|9627959|P6|Lead-in Period|Physician Decision|0
2816804|NCT03214367|9627960|P5|Lead-in Period|Physician Decision|0
2816805|NCT03214367|9627961|P4|Lead-in Period|Physician Decision|0
2816806|NCT03214367|9627962|P3|Lead-in Period|Physician Decision|0
2816807|NCT03214367|9627963|P2|Lead-in Period|Physician Decision|0
2816808|NCT03214367|9627964|P1|Lead-in Period|Physician Decision|12
2816809|NCT03214367|9627957|P8|Lead-in Period|Sponsor Decision|0
2816810|NCT03214367|9627958|P7|Lead-in Period|Sponsor Decision|0
2816811|NCT03214367|9627959|P6|Lead-in Period|Sponsor Decision|0
2816812|NCT03214367|9627960|P5|Lead-in Period|Sponsor Decision|0
2816813|NCT03214367|9627961|P4|Lead-in Period|Sponsor Decision|0
2816814|NCT03214367|9627962|P3|Lead-in Period|Sponsor Decision|0
2816815|NCT03214367|9627963|P2|Lead-in Period|Sponsor Decision|0
2816816|NCT03214367|9627964|P1|Lead-in Period|Sponsor Decision|11
2816817|NCT03214367|9627957|P8|Lead-in Period|Lost to Follow-up|0
2816818|NCT03214367|9627958|P7|Lead-in Period|Lost to Follow-up|0
2816819|NCT03214367|9627959|P6|Lead-in Period|Lost to Follow-up|0
2816820|NCT03214367|9627960|P5|Lead-in Period|Lost to Follow-up|0
2816821|NCT03214367|9627961|P4|Lead-in Period|Lost to Follow-up|0
2816822|NCT03214367|9627962|P3|Lead-in Period|Lost to Follow-up|0
2816823|NCT03214367|9627963|P2|Lead-in Period|Lost to Follow-up|0
2816824|NCT03214367|9627964|P1|Lead-in Period|Lost to Follow-up|12
2816825|NCT03214367|9627957|P8|Lead-in Period|Adverse Event|0
2816826|NCT03214367|9627958|P7|Lead-in Period|Adverse Event|0
2816827|NCT03214367|9627959|P6|Lead-in Period|Adverse Event|0
2816828|NCT03214367|9627960|P5|Lead-in Period|Adverse Event|0
2816829|NCT03214367|9627961|P4|Lead-in Period|Adverse Event|0
2816830|NCT03214367|9627962|P3|Lead-in Period|Adverse Event|0
2816831|NCT03214367|9627963|P2|Lead-in Period|Adverse Event|0
2816832|NCT03214367|9627964|P1|Lead-in Period|Adverse Event|3
2816833|NCT03214367|9627957|P8|Lead-in Period|Withdrawal by Subject|0
2816834|NCT03214367|9627958|P7|Lead-in Period|Withdrawal by Subject|0
2816835|NCT03214367|9627959|P6|Lead-in Period|Withdrawal by Subject|0
2816836|NCT03214367|9627960|P5|Lead-in Period|Withdrawal by Subject|2
2816837|NCT03214367|9627961|P4|Lead-in Period|Withdrawal by Subject|0
2816838|NCT03214367|9627962|P3|Lead-in Period|Withdrawal by Subject|0
2816839|NCT03214367|9627963|P2|Lead-in Period|Withdrawal by Subject|0
2816840|NCT03214367|9627964|P1|Lead-in Period|Withdrawal by Subject|50
2816841|NCT03214224|9628012|P3|Validation Study|Practice controls or therapists|6
2816842|NCT03214224|9628013|P2|Validation Study|Practice controls or therapists|0
2816843|NCT03214224|9628014|P1|Validation Study|Practice controls or therapists|0
2816844|NCT03214224|9628012|P3|Validation Study|Withdrawal by Subject|2
2816845|NCT03214224|9628013|P2|Validation Study|Withdrawal by Subject|0
2816846|NCT03214224|9628014|P1|Validation Study|Withdrawal by Subject|0
2816847|NCT03214224|9628012|P3|Validation Study|Protocol Violation|1
2816848|NCT03214224|9628013|P2|Validation Study|Protocol Violation|0
2816849|NCT03214224|9628014|P1|Validation Study|Protocol Violation|0
2816850|NCT03214094|9628023|P1|Overall Study|Protocol Deviation|46
2816851|NCT03214094|9628023|P1|Overall Study|Case Report Forms Uncollected|14
2816852|NCT03214081|9628031|P1|Overall Study|Protocol Deviation|54
2816853|NCT03214081|9628031|P1|Overall Study|Case Report Forms Uncollected|9
2816854|NCT03213509|9628048|P2|Overall Study|Did not consent for verbal autopsy|5
2816855|NCT03213509|9628049|P1|Overall Study|Did not consent for verbal autopsy|4
2816856|NCT03213366|9628062|P2|Overall Study|Lost to Follow-up|4
2816857|NCT03213366|9628063|P1|Overall Study|Lost to Follow-up|9
2816858|NCT03212690|9628089|P1|Overall Study|Protocol Violation|1
2816859|NCT03212521|9628137|P1|Overall Study|Other|1
2816860|NCT03212521|9628137|P1|Overall Study|Withdrawal by Subject|1
2816861|NCT03212521|9628137|P1|Overall Study|Lost to Follow-up|4
2816862|NCT03212521|9628137|P1|Overall Study|Adverse Event|1
2816863|NCT03212326|9628144|P1|Overall Study|Physician Decision|4
2816864|NCT03212261|9628149|P1|Overall Study|Too busy/ No time|5
2816865|NCT03212261|9628149|P1|Overall Study|Family Emergency|1
2816866|NCT03212261|9628149|P1|Overall Study|Lost to Follow-up|7
2816867|NCT03212261|9628149|P1|Overall Study|Tech Trouble- No first study visit|1
2816868|NCT03212261|9628149|P1|Overall Study|Became ineligible d/t tech|2
2816869|NCT03212144|9628157|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
2816870|NCT03212144|9628158|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
2816871|NCT03212144|9628157|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
2816872|NCT03212144|9628158|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
2816873|NCT03211858|9628166|P2|Overall Study|Other than specified above|21
2816874|NCT03211858|9628167|P1|Overall Study|Other than specified above|22
2816875|NCT03211858|9628166|P2|Overall Study|Non-serious Hypoglycemia|0
2816876|NCT03211858|9628167|P1|Overall Study|Non-serious Hypoglycemia|1
2816877|NCT03211858|9628166|P2|Overall Study|Poor compliance to protocol|2
2816878|NCT03211858|9628167|P1|Overall Study|Poor compliance to protocol|6
2816879|NCT03211858|9628166|P2|Overall Study|Lack of Efficacy|4
2816880|NCT03211858|9628167|P1|Overall Study|Lack of Efficacy|0
2816881|NCT03211858|9628166|P2|Overall Study|Adverse Event|6
2816882|NCT03211858|9628167|P1|Overall Study|Adverse Event|8
2816883|NCT03210961|9628218|P15|Overall Study|Other|0
2816884|NCT03210961|9628219|P14|Overall Study|Other|2
2816885|NCT03210961|9628220|P13|Overall Study|Other|2
2816886|NCT03210961|9628221|P12|Overall Study|Other|0
2816887|NCT03210961|9628222|P11|Overall Study|Other|1
2816888|NCT03210961|9628223|P10|Overall Study|Other|0
2816889|NCT03210961|9628224|P9|Overall Study|Other|0
2816890|NCT03210961|9628225|P8|Overall Study|Other|0
2816891|NCT03210961|9628226|P7|Overall Study|Other|1
2816892|NCT03210961|9628227|P6|Overall Study|Other|0
2816893|NCT03210961|9628228|P5|Overall Study|Other|0
2816894|NCT03210961|9628229|P4|Overall Study|Other|1
2816895|NCT03210961|9628230|P3|Overall Study|Other|0
2816896|NCT03210961|9628231|P2|Overall Study|Other|0
2816897|NCT03210961|9628232|P1|Overall Study|Other|0
2816898|NCT03210961|9628218|P15|Overall Study|No Longer Meets Eligibility Criteria|0
2816899|NCT03210961|9628219|P14|Overall Study|No Longer Meets Eligibility Criteria|1
2816900|NCT03210961|9628220|P13|Overall Study|No Longer Meets Eligibility Criteria|0
2816901|NCT03210961|9628221|P12|Overall Study|No Longer Meets Eligibility Criteria|0
2816902|NCT03210961|9628222|P11|Overall Study|No Longer Meets Eligibility Criteria|0
2816903|NCT03210961|9628223|P10|Overall Study|No Longer Meets Eligibility Criteria|0
2816904|NCT03210961|9628224|P9|Overall Study|No Longer Meets Eligibility Criteria|0
2816905|NCT03210961|9628225|P8|Overall Study|No Longer Meets Eligibility Criteria|0
2816906|NCT03210961|9628226|P7|Overall Study|No Longer Meets Eligibility Criteria|0
2816907|NCT03210961|9628227|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2816908|NCT03210961|9628228|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2816909|NCT03210961|9628229|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2816910|NCT03210961|9628230|P3|Overall Study|No Longer Meets Eligibility Criteria|0
2816911|NCT03210961|9628231|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2816912|NCT03210961|9628232|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2816913|NCT03210961|9628218|P15|Overall Study|Withdrawal by Subject|1
2816914|NCT03210961|9628219|P14|Overall Study|Withdrawal by Subject|0
2816915|NCT03210961|9628220|P13|Overall Study|Withdrawal by Subject|0
2816916|NCT03210961|9628221|P12|Overall Study|Withdrawal by Subject|0
2816917|NCT03210961|9628222|P11|Overall Study|Withdrawal by Subject|0
2816918|NCT03210961|9628223|P10|Overall Study|Withdrawal by Subject|0
2816919|NCT03210961|9628224|P9|Overall Study|Withdrawal by Subject|0
2816920|NCT03210961|9628225|P8|Overall Study|Withdrawal by Subject|0
2816921|NCT03210961|9628226|P7|Overall Study|Withdrawal by Subject|0
2816922|NCT03210961|9628227|P6|Overall Study|Withdrawal by Subject|0
2816923|NCT03210961|9628228|P5|Overall Study|Withdrawal by Subject|0
2816924|NCT03210961|9628229|P4|Overall Study|Withdrawal by Subject|0
2816925|NCT03210961|9628230|P3|Overall Study|Withdrawal by Subject|0
2816926|NCT03210961|9628231|P2|Overall Study|Withdrawal by Subject|0
2816927|NCT03210961|9628232|P1|Overall Study|Withdrawal by Subject|0
2816928|NCT03210961|9628218|P15|Overall Study|Lost to Follow-up|1
2816929|NCT03210961|9628219|P14|Overall Study|Lost to Follow-up|0
2816930|NCT03210961|9628220|P13|Overall Study|Lost to Follow-up|0
2816931|NCT03210961|9628221|P12|Overall Study|Lost to Follow-up|0
2816932|NCT03210961|9628222|P11|Overall Study|Lost to Follow-up|0
2816933|NCT03210961|9628223|P10|Overall Study|Lost to Follow-up|0
2816934|NCT03210961|9628224|P9|Overall Study|Lost to Follow-up|0
2816935|NCT03210961|9628225|P8|Overall Study|Lost to Follow-up|0
2816936|NCT03210961|9628226|P7|Overall Study|Lost to Follow-up|0
2816937|NCT03210961|9628227|P6|Overall Study|Lost to Follow-up|0
2816938|NCT03210961|9628228|P5|Overall Study|Lost to Follow-up|0
2816939|NCT03210961|9628229|P4|Overall Study|Lost to Follow-up|0
2816940|NCT03210961|9628230|P3|Overall Study|Lost to Follow-up|0
2816941|NCT03210961|9628231|P2|Overall Study|Lost to Follow-up|0
2816942|NCT03210961|9628232|P1|Overall Study|Lost to Follow-up|0
2816943|NCT03210961|9628218|P15|Overall Study|Adverse Event|0
2816944|NCT03210961|9628219|P14|Overall Study|Adverse Event|1
2816945|NCT03210961|9628220|P13|Overall Study|Adverse Event|0
2816946|NCT03210961|9628221|P12|Overall Study|Adverse Event|0
2816947|NCT03210961|9628222|P11|Overall Study|Adverse Event|0
2816948|NCT03210961|9628223|P10|Overall Study|Adverse Event|0
2816949|NCT03210961|9628224|P9|Overall Study|Adverse Event|0
2816950|NCT03210961|9628225|P8|Overall Study|Adverse Event|0
2816951|NCT03210961|9628226|P7|Overall Study|Adverse Event|0
2816952|NCT03210961|9628227|P6|Overall Study|Adverse Event|0
2816953|NCT03210961|9628228|P5|Overall Study|Adverse Event|0
2816954|NCT03210961|9628229|P4|Overall Study|Adverse Event|0
2816955|NCT03210961|9628230|P3|Overall Study|Adverse Event|0
2816956|NCT03210961|9628231|P2|Overall Study|Adverse Event|0
2816957|NCT03210961|9628232|P1|Overall Study|Adverse Event|0
2816958|NCT03210519|9628591|P2|Overall Study|Adverse Event|0
2816959|NCT03210519|9628592|P1|Overall Study|Adverse Event|2
2816960|NCT03210220|9628648|P2|Overall Study|Physician Decision|0
2816961|NCT03210220|9628649|P1|Overall Study|Physician Decision|1
2816962|NCT03209570|9628657|P2|Overall Study|Withdrawal by Subject|3
2816963|NCT03209570|9628658|P1|Overall Study|Withdrawal by Subject|0
2816964|NCT03209570|9628657|P2|Overall Study|Protocol Violation|0
2816965|NCT03209570|9628658|P1|Overall Study|Protocol Violation|1
2816966|NCT03209570|9628657|P2|Overall Study|Incomplete Data|10
2816967|NCT03209570|9628658|P1|Overall Study|Incomplete Data|8
2816968|NCT03209570|9628657|P2|Overall Study|Death|0
2816969|NCT03209570|9628658|P1|Overall Study|Death|1
2816970|NCT03209518|9628668|P1|Overall Study|Protocol Deviation|1
2816971|NCT03209518|9628668|P1|Overall Study|Case Report Forms Uncollected|1
2816972|NCT03209492|9628673|P1|Overall Study|Case Report Forms Uncollected|5
2816973|NCT03207750|9628712|P2|Overall Study|OTHER, NOT SPECIFIED|4
2816974|NCT03207750|9628713|P1|Overall Study|OTHER, NOT SPECIFIED|5
2816975|NCT03207750|9628712|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
2816976|NCT03207750|9628713|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
2816977|NCT03207750|9628712|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
2816978|NCT03207750|9628713|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
2816979|NCT03207750|9628712|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
2816980|NCT03207750|9628713|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
2816981|NCT03207750|9628712|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
2816982|NCT03207750|9628713|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
2816983|NCT03207750|9628712|P2|Overall Study|Protocol Violation|1
2816984|NCT03207750|9628713|P1|Overall Study|Protocol Violation|0
2816985|NCT03207750|9628712|P2|Overall Study|Lost to Follow-up|29
2816986|NCT03207750|9628713|P1|Overall Study|Lost to Follow-up|21
2816987|NCT03207750|9628712|P2|Overall Study|Adverse Event|2
2816988|NCT03207750|9628713|P1|Overall Study|Adverse Event|3
2816989|NCT03207243|9628793|P2|Overall Study|Protocol Violation|3
2816990|NCT03207243|9628794|P1|Overall Study|Protocol Violation|0
2816991|NCT03207243|9628793|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
2816992|NCT03207243|9628794|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
2816993|NCT03207243|9628793|P2|Overall Study|Lost to Follow-up|1
2816994|NCT03207243|9628794|P1|Overall Study|Lost to Follow-up|0
2816995|NCT03207243|9628793|P2|Overall Study|Physician Decision|1
2816996|NCT03207243|9628794|P1|Overall Study|Physician Decision|1
2816997|NCT03207243|9628793|P2|Overall Study|Withdrawal by Subject|4
2816998|NCT03207243|9628794|P1|Overall Study|Withdrawal by Subject|2
2816999|NCT03207243|9628793|P2|Overall Study|Loss of Asthma Control|31
2817000|NCT03207243|9628794|P1|Overall Study|Loss of Asthma Control|47
2817001|NCT03207243|9628793|P2|Overall Study|Adverse Event|2
2817002|NCT03207243|9628794|P1|Overall Study|Adverse Event|2
2817003|NCT03206970|9628901|P1|Overall Study|Lost to Follow-up|3
2817004|NCT03206970|9628901|P1|Overall Study|Withdrawal by Subject|9
2817005|NCT03206970|9628901|P1|Overall Study|Death|14
2817006|NCT03206216|9628907|P2|Overall Study|Withdrawal by Subject|1
2817007|NCT03206216|9628908|P1|Overall Study|Withdrawal by Subject|0
2817008|NCT03205163|9628918|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
2817009|NCT03205163|9628919|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
2817010|NCT03204539|9628984|P2|Overall Study|Loss of funding|1
2817011|NCT03204539|9628985|P1|Overall Study|Loss of funding|0
2817012|NCT03203291|9629123|P1|Overall Study|Withdrawal by Subject|1
2817013|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
2817014|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
2817015|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
2817016|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
2817017|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
2817018|NCT03201900|9629158|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
2817019|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
2817020|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
2817021|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
2817022|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
2817023|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
2817024|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
2817025|NCT03201900|9629158|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
2817026|NCT03200912|9629180|P3|Overall Study|Non-compliance with study drug|0
2817027|NCT03200912|9629181|P2|Overall Study|Non-compliance with study drug|1
2817028|NCT03200912|9629182|P1|Overall Study|Non-compliance with study drug|0
2817029|NCT03200912|9629180|P3|Overall Study|Withdrawal by Subject|4
2817030|NCT03200912|9629181|P2|Overall Study|Withdrawal by Subject|2
2817031|NCT03200912|9629182|P1|Overall Study|Withdrawal by Subject|1
2817032|NCT03200912|9629180|P3|Overall Study|Adverse Event|0
2817033|NCT03200912|9629181|P2|Overall Study|Adverse Event|0
2817034|NCT03200912|9629182|P1|Overall Study|Adverse Event|3
2817035|NCT03200860|9629192|P2|Overall Study|Withdrawal by Subject|0
2817036|NCT03200860|9629193|P1|Overall Study|Withdrawal by Subject|1
2817037|NCT03198767|9629252|P7|Overall Study|Protocol Violation|0
2817038|NCT03198767|9629253|P6|Overall Study|Protocol Violation|0
2817039|NCT03198767|9629254|P5|Overall Study|Protocol Violation|0
2817040|NCT03198767|9629255|P4|Overall Study|Protocol Violation|6
2817041|NCT03198767|9629256|P3|Overall Study|Protocol Violation|0
2817042|NCT03198767|9629257|P2|Overall Study|Protocol Violation|0
2817043|NCT03198767|9629258|P1|Overall Study|Protocol Violation|0
2817044|NCT03198507|9629299|P2|Overall Study|Withdrawal by Subject|0
2817045|NCT03198507|9629300|P1|Overall Study|Withdrawal by Subject|1
2817046|NCT03197883|9629426|P2|Overall Study|Other (Not Specified)|5
2817047|NCT03197883|9629427|P1|Overall Study|Other (Not Specified)|0
2817048|NCT03197883|9629426|P2|Overall Study|Protocol Violation|0
2817049|NCT03197883|9629427|P1|Overall Study|Protocol Violation|1
2817050|NCT03197883|9629426|P2|Overall Study|Lost to Follow-up|0
2817051|NCT03197883|9629427|P1|Overall Study|Lost to Follow-up|1
2817052|NCT03197883|9629426|P2|Overall Study|Adverse Event|1
2817053|NCT03197883|9629427|P1|Overall Study|Adverse Event|1
2817054|NCT03197558|9629457|P1|Overall Study|Tubes not placed|1
2817055|NCT03197376|9629465|P4|Overall Study|Not vaccine related|6
2817056|NCT03197376|9629466|P3|Overall Study|Not vaccine related|0
2817057|NCT03197376|9629467|P2|Overall Study|Not vaccine related|2
2817058|NCT03197376|9629468|P1|Overall Study|Not vaccine related|1
2817059|NCT03197376|9629465|P4|Overall Study|Ineligibility criteria|2
2817060|NCT03197376|9629466|P3|Overall Study|Ineligibility criteria|4
2817061|NCT03197376|9629467|P2|Overall Study|Ineligibility criteria|1
2817062|NCT03197376|9629468|P1|Overall Study|Ineligibility criteria|1
2817063|NCT03197376|9629465|P4|Overall Study|Withdrawal by subject's parents|11
2817064|NCT03197376|9629466|P3|Overall Study|Withdrawal by subject's parents|14
2817065|NCT03197376|9629467|P2|Overall Study|Withdrawal by subject's parents|10
2817066|NCT03197376|9629468|P1|Overall Study|Withdrawal by subject's parents|11
2817067|NCT03197376|9629465|P4|Overall Study|Physician Decision|3
2817068|NCT03197376|9629466|P3|Overall Study|Physician Decision|1
2817069|NCT03197376|9629467|P2|Overall Study|Physician Decision|0
2817070|NCT03197376|9629468|P1|Overall Study|Physician Decision|1
2817071|NCT03197376|9629465|P4|Overall Study|Lost to Follow-up|0
2817072|NCT03197376|9629466|P3|Overall Study|Lost to Follow-up|1
2817073|NCT03197376|9629467|P2|Overall Study|Lost to Follow-up|0
2817074|NCT03197376|9629468|P1|Overall Study|Lost to Follow-up|0
2817075|NCT03197376|9629465|P4|Overall Study|Death|2
2817076|NCT03197376|9629466|P3|Overall Study|Death|0
2817077|NCT03197376|9629467|P2|Overall Study|Death|0
2817078|NCT03197376|9629468|P1|Overall Study|Death|1
2817079|NCT03197376|9629465|P4|Overall Study|Adverse Event|1
2817080|NCT03197376|9629466|P3|Overall Study|Adverse Event|0
2817081|NCT03197376|9629467|P2|Overall Study|Adverse Event|0
2817082|NCT03197376|9629468|P1|Overall Study|Adverse Event|0
2817083|NCT03196635|9629526|P1|Overall Study|Withdrawal by Subject|1
2817084|NCT03196349|9629547|P3|Overall Study|Study Terminated early|11
2817085|NCT03196349|9629548|P2|Overall Study|Study Terminated early|9
2817086|NCT03196349|9629549|P1|Overall Study|Study Terminated early|15
2817087|NCT03196349|9629547|P3|Overall Study|No data entered|0
2817088|NCT03196349|9629548|P2|Overall Study|No data entered|4
2817089|NCT03196349|9629549|P1|Overall Study|No data entered|2
2817090|NCT03196349|9629547|P3|Overall Study|Did not receive study drug|2
2817091|NCT03196349|9629548|P2|Overall Study|Did not receive study drug|1
2817092|NCT03196349|9629549|P1|Overall Study|Did not receive study drug|0
2817093|NCT03194490|9629650|P2|Overall Study|participant developed specific neck pain|0
2817094|NCT03194490|9629651|P1|Overall Study|participant developed specific neck pain|1
2817095|NCT03194490|9629650|P2|Overall Study|Lost to Follow-up|3
2817096|NCT03194490|9629651|P1|Overall Study|Lost to Follow-up|1
2817097|NCT03193047|9629804|P2|Overall Study|Participant Left State|0
2817098|NCT03193047|9629805|P1|Overall Study|Participant Left State|1
2817099|NCT03193047|9629804|P2|Overall Study|Physician Decision|0
2817100|NCT03193047|9629805|P1|Overall Study|Physician Decision|1
2817101|NCT03193021|9629825|P2|Overall Study|Lost to Follow-up|1
2817102|NCT03193021|9629826|P1|Overall Study|Lost to Follow-up|1
2817103|NCT03192475|9629873|P2|Overall Study|Lost to Follow-up|8
2817104|NCT03192475|9629874|P1|Overall Study|Lost to Follow-up|13
2817105|NCT03192475|9629873|P2|Overall Study|Death|1
2817106|NCT03192475|9629874|P1|Overall Study|Death|0
2817107|NCT03192306|9629910|P2|Overall Study|Protocol Violation|1
2817108|NCT03192306|9629911|P1|Overall Study|Protocol Violation|1
2817109|NCT03192306|9629910|P2|Overall Study|Lost to Follow-up|0
2817110|NCT03192306|9629911|P1|Overall Study|Lost to Follow-up|1
2817111|NCT03192306|9629910|P2|Overall Study|Withdrawal by Subject|1
2817112|NCT03192306|9629911|P1|Overall Study|Withdrawal by Subject|1
2817113|NCT03192306|9629910|P2|Overall Study|Did not treat cold sore during study|143
2817114|NCT03192306|9629911|P1|Overall Study|Did not treat cold sore during study|149
2817115|NCT03191552|9629932|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
2817116|NCT03191552|9629933|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
2817117|NCT03191552|9629934|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
2817118|NCT03191552|9629932|P3|Overall Study|Lost to Follow-up|0
2817119|NCT03191552|9629933|P2|Overall Study|Lost to Follow-up|0
2817120|NCT03191552|9629934|P1|Overall Study|Lost to Follow-up|1
2817121|NCT03191396|9629987|P2|Overall Study|Withdrawal by Subject|2
2817122|NCT03191396|9629988|P1|Overall Study|Withdrawal by Subject|3
2817123|NCT03191396|9629987|P2|Overall Study|Lost to Follow-up|3
2817124|NCT03191396|9629988|P1|Overall Study|Lost to Follow-up|0
2817125|NCT03190369|9630085|P2|Overall Study|Randomized but not treated|2
2817126|NCT03190369|9630086|P1|Overall Study|Randomized but not treated|0
2817127|NCT03190369|9630085|P2|Overall Study|Withdraw before treatment|5
2817128|NCT03190369|9630086|P1|Overall Study|Withdraw before treatment|1
2817129|NCT03190369|9630085|P2|Overall Study|Poor compliance to protocol|1
2817130|NCT03190369|9630086|P1|Overall Study|Poor compliance to protocol|0
2817131|NCT03188120|9630227|P1|Overall Study|No visit after the first visit|13
2817132|NCT03188120|9630227|P1|Overall Study|Other than specified|3
2817133|NCT03188120|9630227|P1|Overall Study|Lost to Follow-up|7
2817134|NCT03188120|9630227|P1|Overall Study|Improved|12
2817135|NCT03188120|9630227|P1|Overall Study|Insufficient Effectiveness|8
2817136|NCT03188120|9630227|P1|Overall Study|Adverse Event|4
2817137|NCT03187756|9630232|P1|Overall Study|Termination of study|4
2817138|NCT03187197|9630253|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
2817139|NCT03187197|9630254|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
2817140|NCT03187197|9630255|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
2817141|NCT03187197|9630253|P3|Overall Study|Status missing|3
2817142|NCT03187197|9630254|P2|Overall Study|Status missing|33
2817143|NCT03187197|9630255|P1|Overall Study|Status missing|2
2817144|NCT03187197|9630253|P3|Overall Study|Missing|3
2817145|NCT03187197|9630254|P2|Overall Study|Missing|32
2817146|NCT03187197|9630255|P1|Overall Study|Missing|1
2817147|NCT03187197|9630253|P3|Overall Study|Reason not listed|1
2817148|NCT03187197|9630254|P2|Overall Study|Reason not listed|54
2817149|NCT03187197|9630255|P1|Overall Study|Reason not listed|2
2817150|NCT03187197|9630253|P3|Overall Study|Administrative problem|0
2817151|NCT03187197|9630254|P2|Overall Study|Administrative problem|1
2817152|NCT03187197|9630255|P1|Overall Study|Administrative problem|1
2817153|NCT03187197|9630253|P3|Overall Study|Death|0
2817154|NCT03187197|9630254|P2|Overall Study|Death|11
2817155|NCT03187197|9630255|P1|Overall Study|Death|0
2817156|NCT03187197|9630253|P3|Overall Study|Adverse Event|0
2817157|NCT03187197|9630254|P2|Overall Study|Adverse Event|29
2817158|NCT03187197|9630255|P1|Overall Study|Adverse Event|6
2817159|NCT03187197|9630253|P3|Overall Study|Lost to Follow-up|7
2817160|NCT03187197|9630254|P2|Overall Study|Lost to Follow-up|60
2817161|NCT03187197|9630255|P1|Overall Study|Lost to Follow-up|1
2817162|NCT03187197|9630253|P3|Overall Study|Withdrawal by Subject|4
2817163|NCT03187197|9630254|P2|Overall Study|Withdrawal by Subject|63
2817164|NCT03187197|9630255|P1|Overall Study|Withdrawal by Subject|8
2817165|NCT03187197|9630253|P3|Overall Study|Stopped Pradaxa®/VKA|4
2817166|NCT03187197|9630254|P2|Overall Study|Stopped Pradaxa®/VKA|65
2817167|NCT03187197|9630255|P1|Overall Study|Stopped Pradaxa®/VKA|11
2817168|NCT03185481|9630266|P1|Overall Study|Study Terminated by Sponsor|4
2817169|NCT03185481|9630266|P1|Overall Study|Adverse Event|1
2817170|NCT03184987|9630308|P3|Overall Study|Adverse Event|1
2817171|NCT03184987|9630309|P2|Overall Study|Adverse Event|0
2817172|NCT03184987|9630310|P1|Overall Study|Adverse Event|1
2817173|NCT03184987|9630308|P3|Overall Study|Physician Decision|1
2817174|NCT03184987|9630309|P2|Overall Study|Physician Decision|0
2817175|NCT03184987|9630310|P1|Overall Study|Physician Decision|0
2817176|NCT03184987|9630308|P3|Overall Study|Withdrawal by Subject|2
2817177|NCT03184987|9630309|P2|Overall Study|Withdrawal by Subject|1
2817178|NCT03184987|9630310|P1|Overall Study|Withdrawal by Subject|0
2817179|NCT03184701|9630375|P1|Overall Study|Lost to Follow-up|5
2817180|NCT03184701|9630375|P1|Overall Study|Withdrawal by Subject|6
2817181|NCT03184701|9630375|P1|Overall Study|Physician Decision|3
2817182|NCT03184701|9630375|P1|Overall Study|Death|3
2817183|NCT03184519|9630379|P1|Overall Study|Physician Decision|21
2817184|NCT03184519|9630379|P1|Overall Study|Lost to Follow-up|6
2817185|NCT03184441|9630383|P1|Overall Study|Withdrawal by Subject|1
2817186|NCT03184077|9630409|P2|Overall Study|Lost to Follow-up|21
2817187|NCT03184077|9630410|P1|Overall Study|Lost to Follow-up|21
2817188|NCT03183518|9630429|P1|Overall Study|Other (Withdrawal of consent)|1
2817189|NCT03183518|9630429|P1|Overall Study|Other (Not specified)|2
2817190|NCT03182738|9630492|P2|Overall Study|Withdrawal by Subject|1
2817191|NCT03182738|9630493|P1|Overall Study|Withdrawal by Subject|0
2817192|NCT03182738|9630492|P2|Overall Study|Pregnancy|1
2817193|NCT03182738|9630493|P1|Overall Study|Pregnancy|0
2817194|NCT03182738|9630492|P2|Overall Study|Lost to Follow-up|3
2817195|NCT03182738|9630493|P1|Overall Study|Lost to Follow-up|9
2817196|NCT03181594|9630542|P1|Overall Study|Physician Decision|1
2817197|NCT03181594|9630542|P1|Overall Study|Lost to Follow-up|1
2817198|NCT03181503|9630550|P2|Overall Study|Lost to Follow-up|1
2817199|NCT03181503|9630551|P1|Overall Study|Lost to Follow-up|1
2817200|NCT03181503|9630550|P2|Overall Study|Withdrawal by Subject|0
2817201|NCT03181503|9630551|P1|Overall Study|Withdrawal by Subject|3
2817202|NCT03181503|9630550|P2|Overall Study|Protocol Violation|0
2817203|NCT03181503|9630551|P1|Overall Study|Protocol Violation|1
2817204|NCT03181503|9630550|P2|Overall Study|Adverse Event|2
2817205|NCT03181503|9630551|P1|Overall Study|Adverse Event|2
2817206|NCT03180801|9630599|P3|Overall Study|Lost to Follow-up|3
2817207|NCT03180801|9630600|P2|Overall Study|Lost to Follow-up|2
2817208|NCT03180801|9630601|P1|Overall Study|Lost to Follow-up|0
2817209|NCT03180801|9630599|P3|Overall Study|Withdrawal by Subject|1
2817210|NCT03180801|9630600|P2|Overall Study|Withdrawal by Subject|2
2817211|NCT03180801|9630601|P1|Overall Study|Withdrawal by Subject|2
2817212|NCT03180801|9630599|P3|Overall Study|Adverse Event|2
2817213|NCT03180801|9630600|P2|Overall Study|Adverse Event|0
2817214|NCT03180801|9630601|P1|Overall Study|Adverse Event|1
2817215|NCT03180801|9630599|P3|Overall Study|Inoculation Target Reached|3
2817216|NCT03180801|9630600|P2|Overall Study|Inoculation Target Reached|1
2817217|NCT03180801|9630601|P1|Overall Study|Inoculation Target Reached|1
2817218|NCT03180801|9630599|P3|Overall Study|Non-compliance|0
2817219|NCT03180801|9630600|P2|Overall Study|Non-compliance|4
2817220|NCT03180801|9630601|P1|Overall Study|Non-compliance|1
2817221|NCT03180801|9630599|P3|Overall Study|Physician Decision|1
2817222|NCT03180801|9630600|P2|Overall Study|Physician Decision|3
2817223|NCT03180801|9630601|P1|Overall Study|Physician Decision|3
2817224|NCT03180645|9630642|P3|Overall Study|Adverse Event|2
2817225|NCT03180645|9630643|P2|Overall Study|Adverse Event|1
2817226|NCT03180645|9630644|P1|Overall Study|Adverse Event|0
2817227|NCT03180619|9630686|P3|Overall Study|Still on Study|30
2817228|NCT03180619|9630687|P2|Overall Study|Still on Study|15
2817229|NCT03180619|9630688|P1|Overall Study|Still on Study|75
2817230|NCT03180619|9630686|P3|Overall Study|Death|0
2817231|NCT03180619|9630687|P2|Overall Study|Death|0
2817232|NCT03180619|9630688|P1|Overall Study|Death|1
2817233|NCT03180619|9630686|P3|Overall Study|Withdrew Consent|1
2817234|NCT03180619|9630687|P2|Overall Study|Withdrew Consent|0
2817235|NCT03180619|9630688|P1|Overall Study|Withdrew Consent|2
2817236|NCT03180138|9630845|P3|Overall Study|Found to be >24 mon after randomization|3
2817237|NCT03180138|9630846|P2|Overall Study|Found to be >24 mon after randomization|0
2817238|NCT03180138|9630847|P1|Overall Study|Found to be >24 mon after randomization|3
2817239|NCT03180138|9630845|P3|Overall Study|No prior immunization records|6
2817240|NCT03180138|9630846|P2|Overall Study|No prior immunization records|0
2817241|NCT03180138|9630847|P1|Overall Study|No prior immunization records|17
2817242|NCT03180138|9630845|P3|Overall Study|Mobile-phone could not be verified|15
2817243|NCT03180138|9630846|P2|Overall Study|Mobile-phone could not be verified|13
2817244|NCT03180138|9630847|P1|Overall Study|Mobile-phone could not be verified|2
2817245|NCT03178942|9630917|P2|Overall Study|Lost to Follow-up|2
2817246|NCT03178942|9630918|P1|Overall Study|Lost to Follow-up|1
2817247|NCT03178942|9630917|P2|Overall Study|Withdrawal by Subject|0
2817248|NCT03178942|9630918|P1|Overall Study|Withdrawal by Subject|2
2817249|NCT03178266|9630947|P2|Overall Study|Withdrawal by Subject|2
2817250|NCT03178266|9630948|P1|Overall Study|Withdrawal by Subject|0
2817251|NCT03178266|9630947|P2|Overall Study|Disont. Early|1
2817252|NCT03178266|9630948|P1|Overall Study|Disont. Early|0
2817253|NCT03178266|9630947|P2|Overall Study|Death|1
2817254|NCT03178266|9630948|P1|Overall Study|Death|0
2817255|NCT03176407|9631272|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
2817256|NCT03176407|9631272|P1|Overall Study|human failure|1
2817257|NCT03176407|9631272|P1|Overall Study|Protocol Violation|1
2817258|NCT03176238|9631282|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
2817259|NCT03176238|9631283|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
2817260|NCT03176238|9631282|P2|Overall Study|Changes in the patient's condition|1
2817261|NCT03176238|9631283|P1|Overall Study|Changes in the patient's condition|2
2817262|NCT03176238|9631282|P2|Overall Study|Protocol Violation|0
2817263|NCT03176238|9631283|P1|Overall Study|Protocol Violation|1
2817264|NCT03176238|9631282|P2|Overall Study|Patient is switched to commercial drug|1
2817265|NCT03176238|9631283|P1|Overall Study|Patient is switched to commercial drug|16
2817266|NCT03176238|9631282|P2|Overall Study|Tx duration completed per EAP|1
2817267|NCT03176238|9631283|P1|Overall Study|Tx duration completed per EAP|0
2817268|NCT03176238|9631282|P2|Overall Study|Disease Progression|22
2817269|NCT03176238|9631283|P1|Overall Study|Disease Progression|133
2817270|NCT03176238|9631282|P2|Overall Study|Death|0
2817271|NCT03176238|9631283|P1|Overall Study|Death|3
2817272|NCT03176238|9631282|P2|Overall Study|Administrative problems|0
2817273|NCT03176238|9631283|P1|Overall Study|Administrative problems|1
2817274|NCT03176238|9631282|P2|Overall Study|Lost to Follow-up|0
2817275|NCT03176238|9631283|P1|Overall Study|Lost to Follow-up|3
2817276|NCT03176238|9631282|P2|Overall Study|Consent withdrawal|2
2817277|NCT03176238|9631283|P1|Overall Study|Consent withdrawal|14
2817278|NCT03176238|9631282|P2|Overall Study|Inter-current illness|1
2817279|NCT03176238|9631283|P1|Overall Study|Inter-current illness|0
2817280|NCT03176238|9631282|P2|Overall Study|Abnormal lab value(s)|0
2817281|NCT03176238|9631283|P1|Overall Study|Abnormal lab value(s)|2
2817282|NCT03176238|9631282|P2|Overall Study|Unacceptable AEs|8
2817283|NCT03176238|9631283|P1|Overall Study|Unacceptable AEs|15
2817284|NCT03175562|9631302|P1|Overall Study|Other (Not Specified)|5
2817285|NCT03175562|9631302|P1|Overall Study|Withdrawal by Subject|7
2817286|NCT03175562|9631302|P1|Overall Study|Lost to Follow-up|3
2817287|NCT03175562|9631302|P1|Overall Study|Adverse Event|1
2817288|NCT03175172|9631327|P1|Overall Study|Study Terminated by Sponsor|3
2817289|NCT03175172|9631327|P1|Overall Study|Lost to Follow-up|1
2817290|NCT03175172|9631327|P1|Overall Study|Withdrawal by Subject|3
2817291|NCT03175172|9631327|P1|Overall Study|Death|3
2817292|NCT03175120|9631337|P2|Overall Study|Other|3
2817293|NCT03175120|9631338|P1|Overall Study|Other|2
2817294|NCT03175120|9631337|P2|Overall Study|Withdrawal by Subject|5
2817295|NCT03175120|9631338|P1|Overall Study|Withdrawal by Subject|2
2817296|NCT03175120|9631337|P2|Overall Study|Lost to Follow-up|0
2817297|NCT03175120|9631338|P1|Overall Study|Lost to Follow-up|1
2817298|NCT03175120|9631337|P2|Overall Study|Protocol Violation|2
2817299|NCT03175120|9631338|P1|Overall Study|Protocol Violation|5
2817300|NCT03175120|9631337|P2|Overall Study|Adverse Event|2
2817301|NCT03175120|9631338|P1|Overall Study|Adverse Event|2
2817302|NCT03172702|9631522|P1|Overall Study|Other|2
2817303|NCT03172702|9631522|P1|Overall Study|Withdrawal by Subject|5
2817304|NCT03172702|9631522|P1|Overall Study|Study-specific Withdrawal Criteria|10
2817305|NCT03172702|9631522|P1|Overall Study|Death|2
2817306|NCT03172702|9631522|P1|Overall Study|Adverse Event|9
2817307|NCT03172481|9631549|P2|Double-blind|Withdrawal by Subject|0
2817308|NCT03172481|9631550|P1|Double-blind|Withdrawal by Subject|1
2817309|NCT03172364|9631558|P2|Overall Study|Protocol Violation|0
2817310|NCT03172364|9631559|P1|Overall Study|Protocol Violation|1
2817311|NCT03172364|9631558|P2|Overall Study|Adverse Event|1
2817312|NCT03172364|9631559|P1|Overall Study|Adverse Event|1
2817313|NCT03171415|9631580|P5|Overall Study|Lost to Follow-up|2
2817314|NCT03171415|9631581|P4|Overall Study|Lost to Follow-up|0
2817315|NCT03171415|9631582|P3|Overall Study|Lost to Follow-up|0
2817316|NCT03171415|9631583|P2|Overall Study|Lost to Follow-up|0
2817317|NCT03171415|9631584|P1|Overall Study|Lost to Follow-up|0
2817318|NCT03170609|9631652|P7|Overall Study|Other|0
2817319|NCT03170609|9631653|P6|Overall Study|Other|1
2817320|NCT03170609|9631654|P5|Overall Study|Other|0
2817321|NCT03170609|9631655|P4|Overall Study|Other|0
2817322|NCT03170609|9631656|P3|Overall Study|Other|0
2817323|NCT03170609|9631657|P2|Overall Study|Other|0
2817324|NCT03170609|9631658|P1|Overall Study|Other|1
2817325|NCT03170609|9631652|P7|Overall Study|Lost to Follow-up|0
2817326|NCT03170609|9631653|P6|Overall Study|Lost to Follow-up|1
2817327|NCT03170609|9631654|P5|Overall Study|Lost to Follow-up|1
2817328|NCT03170609|9631655|P4|Overall Study|Lost to Follow-up|2
2817329|NCT03170609|9631656|P3|Overall Study|Lost to Follow-up|5
2817330|NCT03170609|9631657|P2|Overall Study|Lost to Follow-up|0
2817331|NCT03170609|9631658|P1|Overall Study|Lost to Follow-up|1
2817332|NCT03170609|9631652|P7|Overall Study|Withdrawal by Subject|1
2817333|NCT03170609|9631653|P6|Overall Study|Withdrawal by Subject|0
2817334|NCT03170609|9631654|P5|Overall Study|Withdrawal by Subject|0
2817335|NCT03170609|9631655|P4|Overall Study|Withdrawal by Subject|0
2817336|NCT03170609|9631656|P3|Overall Study|Withdrawal by Subject|0
2817337|NCT03170609|9631657|P2|Overall Study|Withdrawal by Subject|2
2817338|NCT03170609|9631658|P1|Overall Study|Withdrawal by Subject|1
2817339|NCT03170609|9631652|P7|Overall Study|Death|0
2817340|NCT03170609|9631653|P6|Overall Study|Death|0
2817341|NCT03170609|9631654|P5|Overall Study|Death|0
2817342|NCT03170609|9631655|P4|Overall Study|Death|0
2817343|NCT03170609|9631656|P3|Overall Study|Death|1
2817344|NCT03170609|9631657|P2|Overall Study|Death|0
2817345|NCT03170609|9631658|P1|Overall Study|Death|0
2817346|NCT03170544|9631728|P12|Part 1|Not treated|0
2817347|NCT03170544|9631729|P11|Part 1|Not treated|0
2817348|NCT03170544|9631730|P10|Part 1|Not treated|0
2817349|NCT03170544|9631731|P9|Part 1|Not treated|0
2817350|NCT03170544|9631732|P8|Part 1|Not treated|0
2817351|NCT03170544|9631733|P7|Part 1|Not treated|0
2817352|NCT03170544|9631734|P6|Part 1|Not treated|0
2817353|NCT03170544|9631735|P5|Part 1|Not treated|0
2817354|NCT03170544|9631736|P4|Part 1|Not treated|1
2817355|NCT03170544|9631737|P3|Part 1|Not treated|0
2817356|NCT03170544|9631738|P2|Part 1|Not treated|0
2817357|NCT03170544|9631739|P1|Part 1|Not treated|0
2817358|NCT03170544|9631728|P12|Part 1|Lost to Follow-up|0
2817359|NCT03170544|9631729|P11|Part 1|Lost to Follow-up|0
2817360|NCT03170544|9631730|P10|Part 1|Lost to Follow-up|0
2817361|NCT03170544|9631731|P9|Part 1|Lost to Follow-up|0
2817362|NCT03170544|9631732|P8|Part 1|Lost to Follow-up|0
2817363|NCT03170544|9631733|P7|Part 1|Lost to Follow-up|0
2817364|NCT03170544|9631734|P6|Part 1|Lost to Follow-up|0
2817365|NCT03170544|9631735|P5|Part 1|Lost to Follow-up|0
2817366|NCT03170544|9631736|P4|Part 1|Lost to Follow-up|0
2817367|NCT03170544|9631737|P3|Part 1|Lost to Follow-up|0
2817368|NCT03170544|9631738|P2|Part 1|Lost to Follow-up|0
2817369|NCT03170544|9631739|P1|Part 1|Lost to Follow-up|1
2817370|NCT03170232|9631903|P2|Overall Study|Withdrawal by Subject|1
2817371|NCT03170232|9631904|P1|Overall Study|Withdrawal by Subject|0
2817372|NCT03170232|9631903|P2|Overall Study|Lost to Follow-up|0
2817373|NCT03170232|9631904|P1|Overall Study|Lost to Follow-up|1
2817374|NCT03170232|9631903|P2|Overall Study|Study closed/terminated|23
2817375|NCT03170232|9631904|P1|Overall Study|Study closed/terminated|26
2817376|NCT03170232|9631903|P2|Overall Study|Lack of Efficacy|1
2817377|NCT03170232|9631904|P1|Overall Study|Lack of Efficacy|0
2817378|NCT03170232|9631903|P2|Overall Study|Protocol Violation|1
2817379|NCT03170232|9631904|P1|Overall Study|Protocol Violation|0
2817380|NCT03170232|9631903|P2|Overall Study|Adverse Event|1
2817381|NCT03170232|9631904|P1|Overall Study|Adverse Event|0
2817382|NCT03170193|9631982|P7|Overall Study|Lost to Follow-up|0
2817383|NCT03170193|9631983|P6|Overall Study|Lost to Follow-up|0
2817384|NCT03170193|9631984|P5|Overall Study|Lost to Follow-up|0
2817385|NCT03170193|9631985|P4|Overall Study|Lost to Follow-up|0
2817386|NCT03170193|9631986|P3|Overall Study|Lost to Follow-up|0
2817387|NCT03170193|9631987|P2|Overall Study|Lost to Follow-up|1
2817388|NCT03170193|9631988|P1|Overall Study|Lost to Follow-up|1
2817389|NCT03170193|9631982|P7|Overall Study|Withdrawal by Subject|0
2817390|NCT03170193|9631983|P6|Overall Study|Withdrawal by Subject|0
2817391|NCT03170193|9631984|P5|Overall Study|Withdrawal by Subject|0
2817392|NCT03170193|9631985|P4|Overall Study|Withdrawal by Subject|1
2817393|NCT03170193|9631986|P3|Overall Study|Withdrawal by Subject|0
2817394|NCT03170193|9631987|P2|Overall Study|Withdrawal by Subject|0
2817395|NCT03170193|9631988|P1|Overall Study|Withdrawal by Subject|0
2817396|NCT03170154|9632057|P1|Overall Study|Withdrawal by Subject|2
2817397|NCT03170154|9632057|P1|Overall Study|Death|2
2817398|NCT03170154|9632057|P1|Overall Study|Lost to Follow-up|4
2817399|NCT03169530|9632072|P2|Overall Study|Study ended by NIH|17
2817400|NCT03169530|9632073|P1|Overall Study|Study ended by NIH|15
2817401|NCT03169153|9632091|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
2817402|NCT03169153|9632092|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
2817403|NCT03169153|9632091|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
2817404|NCT03169153|9632092|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
2817405|NCT03169153|9632091|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
2817406|NCT03169153|9632092|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
2817407|NCT03169153|9632091|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2817408|NCT03169153|9632092|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2817409|NCT03168919|9632103|P1|Overall Study|Withdrawal by Subject|2
2817410|NCT03168906|9632113|P2|Overall Study|Lack of Efficacy|6
2817411|NCT03168906|9632114|P1|Overall Study|Lack of Efficacy|6
2817412|NCT03168425|9632146|P2|Overall Study|unable to confirm post op opioids|3
2817413|NCT03168425|9632147|P1|Overall Study|unable to confirm post op opioids|2
2817414|NCT03168425|9632146|P2|Overall Study|Lost to Follow-up|8
2817415|NCT03168425|9632147|P1|Overall Study|Lost to Follow-up|5
2817416|NCT03166618|9632223|P2|Overall Study|Study was Terminated|1
2817417|NCT03166618|9632224|P1|Overall Study|Study was Terminated|0
2817418|NCT03166215|9632236|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
2817419|NCT03166215|9632237|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2817420|NCT03166215|9632238|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2817421|NCT03166215|9632236|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2817422|NCT03166215|9632237|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
2817423|NCT03166215|9632238|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2817424|NCT03166124|9632278|P4|Wash-out Period|Adverse Event|0
2817425|NCT03166124|9632279|P3|Wash-out Period|Adverse Event|1
2817426|NCT03166124|9632280|P2|Wash-out Period|Adverse Event|1
2817427|NCT03166124|9632281|P1|Wash-out Period|Adverse Event|0
2817428|NCT03166124|9632278|P4|Wash-out Period|Withdrawal by Subject|1
2817429|NCT03166124|9632279|P3|Wash-out Period|Withdrawal by Subject|0
2817430|NCT03166124|9632280|P2|Wash-out Period|Withdrawal by Subject|1
2817431|NCT03166124|9632281|P1|Wash-out Period|Withdrawal by Subject|0
2817432|NCT03166124|9632278|P4|Treatment Period 1|Adverse Event|0
2817433|NCT03166124|9632279|P3|Treatment Period 1|Adverse Event|1
2817434|NCT03166124|9632280|P2|Treatment Period 1|Adverse Event|0
2817435|NCT03166124|9632281|P1|Treatment Period 1|Adverse Event|0
2817436|NCT03165110|9632372|P1|Overall Study|Anroid phone software incompatibility|1
2817437|NCT03165045|9632384|P1|Visit 2|Available total CCQ score at vist 2 only|44
2817438|NCT03165045|9632384|P1|Visit 2|No available total CCQ score at all|29
2817439|NCT03165045|9632384|P1|Visit 2|Available CCQ score at visit 1 only|109
2817440|NCT03165045|9632384|P1|Visit 1|No visit 1|10
2817441|NCT03165045|9632384|P1|Visit 1|No treatment documented|10
2817442|NCT03165045|9632384|P1|Visit 1|No registration after visit 1|9
2817443|NCT03162614|9632442|P6|Overall Study|Missed vaccination, exclusion criteria|0
2817444|NCT03162614|9632443|P5|Overall Study|Missed vaccination, exclusion criteria|3
2817445|NCT03162614|9632444|P4|Overall Study|Missed vaccination, exclusion criteria|4
2817446|NCT03162614|9632445|P3|Overall Study|Missed vaccination, exclusion criteria|2
2817447|NCT03162614|9632446|P2|Overall Study|Missed vaccination, exclusion criteria|2
2817448|NCT03162614|9632447|P1|Overall Study|Missed vaccination, exclusion criteria|2
2817449|NCT03162614|9632442|P6|Overall Study|Withdrawal by Subject|0
2817450|NCT03162614|9632443|P5|Overall Study|Withdrawal by Subject|0
2817451|NCT03162614|9632444|P4|Overall Study|Withdrawal by Subject|1
2817452|NCT03162614|9632445|P3|Overall Study|Withdrawal by Subject|1
2817453|NCT03162614|9632446|P2|Overall Study|Withdrawal by Subject|1
2817454|NCT03162614|9632447|P1|Overall Study|Withdrawal by Subject|2
2817455|NCT03162614|9632442|P6|Overall Study|Protocol Violation|0
2817456|NCT03162614|9632443|P5|Overall Study|Protocol Violation|0
2817457|NCT03162614|9632444|P4|Overall Study|Protocol Violation|1
2817458|NCT03162614|9632445|P3|Overall Study|Protocol Violation|0
2817459|NCT03162614|9632446|P2|Overall Study|Protocol Violation|1
2817460|NCT03162614|9632447|P1|Overall Study|Protocol Violation|0
2817461|NCT03162614|9632442|P6|Overall Study|Lost to Follow-up|0
2817462|NCT03162614|9632443|P5|Overall Study|Lost to Follow-up|2
2817463|NCT03162614|9632444|P4|Overall Study|Lost to Follow-up|1
2817464|NCT03162614|9632445|P3|Overall Study|Lost to Follow-up|1
2817465|NCT03162614|9632446|P2|Overall Study|Lost to Follow-up|1
2817466|NCT03162614|9632447|P1|Overall Study|Lost to Follow-up|2
2817467|NCT03162328|9632566|P3|Study Period|Withdrawal by Subject|1
2817468|NCT03162328|9632567|P2|Study Period|Withdrawal by Subject|0
2817469|NCT03162328|9632568|P1|Study Period|Withdrawal by Subject|0
2817470|NCT03162328|9632566|P3|Screening Period|Withdrawal by Subject|0
2817471|NCT03162328|9632567|P2|Screening Period|Withdrawal by Subject|0
2817472|NCT03162328|9632568|P1|Screening Period|Withdrawal by Subject|1
2817473|NCT03162328|9632566|P3|Screening Period|Did not meet inclusion/exclusion|0
2817474|NCT03162328|9632567|P2|Screening Period|Did not meet inclusion/exclusion|0
2817475|NCT03162328|9632568|P1|Screening Period|Did not meet inclusion/exclusion|21
2817476|NCT03162055|9632597|P2|Overall Study|Other|15
2817477|NCT03162055|9632598|P1|Overall Study|Other|8
2817478|NCT03162055|9632597|P2|Overall Study|Incorrect randomization|3
2817479|NCT03162055|9632598|P1|Overall Study|Incorrect randomization|4
2817480|NCT03162055|9632597|P2|Overall Study|Did not receive treatment|0
2817481|NCT03162055|9632598|P1|Overall Study|Did not receive treatment|2
2817482|NCT03162055|9632597|P2|Overall Study|Withdrawal by Subject|2
2817483|NCT03162055|9632598|P1|Overall Study|Withdrawal by Subject|17
2817484|NCT03162055|9632597|P2|Overall Study|Study-specific withdrawal criteria|14
2817485|NCT03162055|9632598|P1|Overall Study|Study-specific withdrawal criteria|22
2817486|NCT03162055|9632597|P2|Overall Study|Lost to Follow-up|1
2817487|NCT03162055|9632598|P1|Overall Study|Lost to Follow-up|0
2817488|NCT03162055|9632597|P2|Overall Study|Death|3
2817489|NCT03162055|9632598|P1|Overall Study|Death|3
2817490|NCT03162055|9632597|P2|Overall Study|Adverse Event|5
2817491|NCT03162055|9632598|P1|Overall Study|Adverse Event|6
2817492|NCT03161405|9632651|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
2817493|NCT03160716|9632667|P1|Overall Study|Lost to Follow-up|1
2817494|NCT03160703|9632678|P4|Overall Study|Withdrawal by Subject|1
2817495|NCT03160703|9632679|P3|Overall Study|Withdrawal by Subject|0
2817496|NCT03160703|9632680|P2|Overall Study|Withdrawal by Subject|0
2817497|NCT03160703|9632681|P1|Overall Study|Withdrawal by Subject|0
2817498|NCT03159611|9632759|P2|Overall Study|Inability to perform procedures|0
2817499|NCT03159611|9632760|P1|Overall Study|Inability to perform procedures|1
2817500|NCT03159611|9632759|P2|Overall Study|Non-compliance with protocol requirement|2
2817501|NCT03159611|9632760|P1|Overall Study|Non-compliance with protocol requirement|3
2817502|NCT03159611|9632759|P2|Overall Study|Withdrawal by Subject|1
2817503|NCT03159611|9632760|P1|Overall Study|Withdrawal by Subject|1
2817504|NCT03159611|9632759|P2|Overall Study|Adverse Event|0
2817505|NCT03159611|9632760|P1|Overall Study|Adverse Event|1
2817506|NCT03159611|9632759|P2|Overall Study|Protocol Violation|4
2817507|NCT03159611|9632760|P1|Overall Study|Protocol Violation|7
2817508|NCT03159611|9632759|P2|Overall Study|Did Not Meet Exclusion Criteria|3
2817509|NCT03159611|9632760|P1|Overall Study|Did Not Meet Exclusion Criteria|1
2817510|NCT03159611|9632759|P2|Overall Study|Did Not Meet Inclusion Criteria|5
2817511|NCT03159611|9632760|P1|Overall Study|Did Not Meet Inclusion Criteria|9
2817512|NCT03159468|9632780|P6|Overall Study|Withdrawal by Subject|0
2817513|NCT03159468|9632781|P5|Overall Study|Withdrawal by Subject|0
2817514|NCT03159468|9632782|P4|Overall Study|Withdrawal by Subject|0
2817515|NCT03159468|9632783|P3|Overall Study|Withdrawal by Subject|3
2817516|NCT03159468|9632784|P2|Overall Study|Withdrawal by Subject|0
2817517|NCT03159468|9632785|P1|Overall Study|Withdrawal by Subject|0
2817518|NCT03158220|9632834|P2|Overall Study|Physician Decision|0
2817519|NCT03158220|9632835|P1|Overall Study|Physician Decision|1
2817520|NCT03158220|9632834|P2|Overall Study|Lost to Follow-up|5
2817521|NCT03158220|9632835|P1|Overall Study|Lost to Follow-up|8
2817522|NCT03158220|9632834|P2|Overall Study|Status unknown|1
2817523|NCT03158220|9632835|P1|Overall Study|Status unknown|0
2817524|NCT03158220|9632834|P2|Overall Study|Withdrawal by Subject|9
2817525|NCT03158220|9632835|P1|Overall Study|Withdrawal by Subject|8
2817526|NCT03158220|9632834|P2|Overall Study|Screen Failure|1
2817527|NCT03158220|9632835|P1|Overall Study|Screen Failure|0
2817528|NCT03158012|9632872|P2|Overall Study|Withdrawal by Subject|1
2817529|NCT03158012|9632873|P1|Overall Study|Withdrawal by Subject|0
2817530|NCT03157583|9632879|P1|Overall Study|Other (did not meet study criteria)|1
2817531|NCT03157531|9632897|P1|Overall Study|Lost to Follow-up|4
2817532|NCT03157531|9632897|P1|Overall Study|Death|2
2817533|NCT03155269|9632918|P2|Overall Study|Lost to Follow-up|2
2817534|NCT03155269|9632919|P1|Overall Study|Lost to Follow-up|1
2817535|NCT03155269|9632918|P2|Overall Study|Withdrawal by Subject|5
2817536|NCT03155269|9632919|P1|Overall Study|Withdrawal by Subject|4
2817537|NCT03155178|9632965|P4|Overall Study|Did not meet treatment day baseline|7
2817538|NCT03155178|9632966|P3|Overall Study|Did not meet treatment day baseline|7
2817539|NCT03155178|9632967|P2|Overall Study|Did not meet treatment day baseline|7
2817540|NCT03155178|9632968|P1|Overall Study|Did not meet treatment day baseline|7
2817541|NCT03154086|9633012|P15|Part B (Up to 25 Days)|Adverse Event|0
2817542|NCT03154086|9633013|P14|Part B (Up to 25 Days)|Adverse Event|0
2817543|NCT03154086|9633014|P13|Part B (Up to 25 Days)|Adverse Event|0
2817544|NCT03154086|9633015|P12|Part B (Up to 25 Days)|Adverse Event|0
2817545|NCT03154086|9633016|P11|Part B (Up to 25 Days)|Adverse Event|1
2817546|NCT03154086|9633017|P10|Part B (Up to 25 Days)|Adverse Event|0
2817547|NCT03154086|9633018|P9|Part B (Up to 25 Days)|Adverse Event|0
2817548|NCT03154086|9633019|P8|Part B (Up to 25 Days)|Adverse Event|0
2817549|NCT03154086|9633020|P7|Part B (Up to 25 Days)|Adverse Event|0
2817550|NCT03154086|9633021|P6|Part B (Up to 25 Days)|Adverse Event|0
2817551|NCT03154086|9633022|P5|Part B (Up to 25 Days)|Adverse Event|0
2817552|NCT03154086|9633023|P4|Part B (Up to 25 Days)|Adverse Event|0
2817553|NCT03154086|9633024|P3|Part B (Up to 25 Days)|Adverse Event|0
2817554|NCT03154086|9633025|P2|Part B (Up to 25 Days)|Adverse Event|0
2817555|NCT03154086|9633026|P1|Part B (Up to 25 Days)|Adverse Event|0
2817556|NCT03154086|9633012|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817557|NCT03154086|9633013|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817558|NCT03154086|9633014|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817559|NCT03154086|9633015|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817560|NCT03154086|9633016|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817561|NCT03154086|9633017|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817562|NCT03154086|9633018|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817563|NCT03154086|9633019|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
2817564|NCT03154086|9633020|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817565|NCT03154086|9633021|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817566|NCT03154086|9633022|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817567|NCT03154086|9633023|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817568|NCT03154086|9633024|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817569|NCT03154086|9633025|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817570|NCT03154086|9633026|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2817571|NCT03154086|9633012|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817572|NCT03154086|9633013|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817573|NCT03154086|9633014|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817574|NCT03154086|9633015|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817575|NCT03154086|9633016|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817576|NCT03154086|9633017|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817577|NCT03154086|9633018|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
2817578|NCT03154086|9633019|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817579|NCT03154086|9633020|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817580|NCT03154086|9633021|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817581|NCT03154086|9633022|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817582|NCT03154086|9633023|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817583|NCT03154086|9633024|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817584|NCT03154086|9633025|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817585|NCT03154086|9633026|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2817586|NCT03154086|9633012|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817587|NCT03154086|9633013|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817588|NCT03154086|9633014|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817589|NCT03154086|9633015|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817590|NCT03154086|9633016|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817591|NCT03154086|9633017|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817592|NCT03154086|9633018|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817593|NCT03154086|9633019|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817594|NCT03154086|9633020|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817595|NCT03154086|9633021|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817596|NCT03154086|9633022|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817597|NCT03154086|9633023|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817598|NCT03154086|9633024|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817599|NCT03154086|9633025|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2817600|NCT03154086|9633026|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
2817601|NCT03154086|9633012|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817602|NCT03154086|9633013|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817603|NCT03154086|9633014|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817604|NCT03154086|9633015|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817605|NCT03154086|9633016|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817606|NCT03154086|9633017|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817607|NCT03154086|9633018|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817608|NCT03154086|9633019|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817609|NCT03154086|9633020|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817610|NCT03154086|9633021|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817611|NCT03154086|9633022|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817612|NCT03154086|9633023|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817613|NCT03154086|9633024|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
2817614|NCT03154086|9633025|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817615|NCT03154086|9633026|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2817616|NCT03154086|9633012|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817617|NCT03154086|9633013|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817618|NCT03154086|9633014|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817619|NCT03154086|9633015|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817620|NCT03154086|9633016|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817621|NCT03154086|9633017|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817622|NCT03154086|9633018|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817623|NCT03154086|9633019|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817624|NCT03154086|9633020|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817625|NCT03154086|9633021|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817626|NCT03154086|9633022|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817627|NCT03154086|9633023|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817628|NCT03154086|9633024|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817629|NCT03154086|9633025|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
2817630|NCT03154086|9633026|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2817631|NCT03154086|9633012|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817632|NCT03154086|9633013|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817633|NCT03154086|9633014|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817634|NCT03154086|9633015|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817635|NCT03154086|9633016|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817636|NCT03154086|9633017|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817637|NCT03154086|9633018|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817638|NCT03154086|9633019|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817639|NCT03154086|9633020|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817640|NCT03154086|9633021|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817641|NCT03154086|9633022|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817642|NCT03154086|9633023|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
2817643|NCT03154086|9633024|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817644|NCT03154086|9633025|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817645|NCT03154086|9633026|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2817646|NCT03154047|9633426|P1|Overall Study|Withdrawal by Subject|3
2817647|NCT03154047|9633426|P1|Overall Study|Study terminated by sponsor|76
2817648|NCT03154047|9633426|P1|Overall Study|Death|1
2817649|NCT03152552|9633473|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
2817650|NCT03152552|9633474|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2817651|NCT03152552|9633475|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2817652|NCT03152552|9633476|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
2817653|NCT03152552|9633477|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
2817654|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2817655|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
2817656|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2817657|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2817658|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2817659|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
2817660|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
2817661|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
2817662|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
2817663|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
2817664|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2817665|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2817666|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2817667|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2817668|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2817669|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
2817670|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2817671|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2817672|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
2817673|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
2817674|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2817675|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2817676|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2817677|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
2817678|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2817679|NCT03152552|9633473|P5|Treatment Period 1 (12 Weeks)|Death|1
2817680|NCT03152552|9633474|P4|Treatment Period 1 (12 Weeks)|Death|0
2817681|NCT03152552|9633475|P3|Treatment Period 1 (12 Weeks)|Death|0
2817682|NCT03152552|9633476|P2|Treatment Period 1 (12 Weeks)|Death|1
2817683|NCT03152552|9633477|P1|Treatment Period 1 (12 Weeks)|Death|0
2817684|NCT03152526|9633610|P2|Overall Study|Withdrawal by Subject|1
2817685|NCT03152526|9633611|P1|Overall Study|Withdrawal by Subject|0
2817686|NCT03151551|9633633|P2|Overall Study|Ongoing|266
2817687|NCT03151551|9633634|P1|Overall Study|Ongoing|262
2817688|NCT03151551|9633633|P2|Overall Study|Physician Decision|0
2817689|NCT03151551|9633634|P1|Overall Study|Physician Decision|2
2817690|NCT03151551|9633633|P2|Overall Study|Lack of Efficacy|1
2817691|NCT03151551|9633634|P1|Overall Study|Lack of Efficacy|2
2817692|NCT03151551|9633633|P2|Overall Study|Protocol Violation|2
2817693|NCT03151551|9633634|P1|Overall Study|Protocol Violation|1
2817694|NCT03151551|9633633|P2|Overall Study|Withdrawal by Subject|6
2817695|NCT03151551|9633634|P1|Overall Study|Withdrawal by Subject|7
2817696|NCT03151551|9633633|P2|Overall Study|Adverse Event|1
2817697|NCT03151551|9633634|P1|Overall Study|Adverse Event|1
2817698|NCT03151226|9633669|P1|Overall Study|not wear device correctly|1
2817699|NCT03151226|9633669|P1|Overall Study|Withdrawal by Subject|2
2817700|NCT03151148|9633675|P2|Overall Study|Withdrawal by Subject|0
2817701|NCT03151148|9633676|P1|Overall Study|Withdrawal by Subject|1
2817702|NCT03151148|9633675|P2|Overall Study|Lost to Follow-up|0
2817703|NCT03151148|9633676|P1|Overall Study|Lost to Follow-up|1
2817704|NCT03150719|9633688|P2|Overall Study|Other|0
2817705|NCT03150719|9633689|P1|Overall Study|Other|1
2817706|NCT03150719|9633688|P2|Overall Study|Death|1
2817707|NCT03150719|9633689|P1|Overall Study|Death|0
2817708|NCT03150719|9633688|P2|Overall Study|Adverse Event|1
2817709|NCT03150719|9633689|P1|Overall Study|Adverse Event|0
2817710|NCT03150485|9633705|P6|Overall Study|Unsatisfactory Lens Fitting|0
2817711|NCT03150485|9633706|P5|Overall Study|Unsatisfactory Lens Fitting|0
2817712|NCT03150485|9633707|P4|Overall Study|Unsatisfactory Lens Fitting|0
2817713|NCT03150485|9633708|P3|Overall Study|Unsatisfactory Lens Fitting|0
2817714|NCT03150485|9633709|P2|Overall Study|Unsatisfactory Lens Fitting|1
2817715|NCT03150485|9633710|P1|Overall Study|Unsatisfactory Lens Fitting|0
2817716|NCT03150082|9633887|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2817717|NCT03150082|9633888|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
2817718|NCT03149848|9633965|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
2817719|NCT03149848|9633965|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
2817720|NCT03148756|9634004|P2|Overall Study|Study Terminated|1
2817721|NCT03148756|9634005|P1|Overall Study|Study Terminated|0
2817722|NCT03148691|9634038|P3|Overall Study|Withdrawal by Subject|0
2817723|NCT03148691|9634039|P2|Overall Study|Withdrawal by Subject|0
2817724|NCT03148691|9634040|P1|Overall Study|Withdrawal by Subject|1
2817725|NCT03148691|9634038|P3|Overall Study|Other|0
2817726|NCT03148691|9634039|P2|Overall Study|Other|0
2817727|NCT03148691|9634040|P1|Overall Study|Other|1
2817728|NCT03148691|9634038|P3|Overall Study|Lost to Follow-up|1
2817729|NCT03148691|9634039|P2|Overall Study|Lost to Follow-up|0
2817730|NCT03148691|9634040|P1|Overall Study|Lost to Follow-up|0
2817731|NCT03148691|9634038|P3|Overall Study|Protocol Violation|7
2817732|NCT03148691|9634039|P2|Overall Study|Protocol Violation|2
2817733|NCT03148691|9634040|P1|Overall Study|Protocol Violation|1
2817734|NCT03148067|9634103|P1|Overall Study|Death|1
2817735|NCT03148067|9634103|P1|Overall Study|Lost to Follow-up|3
2817736|NCT03147248|9634114|P6|Overall Study|Prolonged Dosing Interval|1
2817737|NCT03147248|9634115|P5|Overall Study|Prolonged Dosing Interval|1
2817738|NCT03147248|9634116|P4|Overall Study|Prolonged Dosing Interval|0
2817739|NCT03147248|9634117|P3|Overall Study|Prolonged Dosing Interval|0
2817740|NCT03147248|9634118|P2|Overall Study|Prolonged Dosing Interval|0
2817741|NCT03147248|9634119|P1|Overall Study|Prolonged Dosing Interval|0
2817742|NCT03147248|9634114|P6|Overall Study|Physician Decision|4
2817743|NCT03147248|9634115|P5|Overall Study|Physician Decision|2
2817744|NCT03147248|9634116|P4|Overall Study|Physician Decision|0
2817745|NCT03147248|9634117|P3|Overall Study|Physician Decision|0
2817746|NCT03147248|9634118|P2|Overall Study|Physician Decision|0
2817747|NCT03147248|9634119|P1|Overall Study|Physician Decision|0
2817748|NCT03147248|9634114|P6|Overall Study|Death|4
2817749|NCT03147248|9634115|P5|Overall Study|Death|0
2817750|NCT03147248|9634116|P4|Overall Study|Death|0
2817751|NCT03147248|9634117|P3|Overall Study|Death|0
2817752|NCT03147248|9634118|P2|Overall Study|Death|0
2817753|NCT03147248|9634119|P1|Overall Study|Death|0
2817754|NCT03147248|9634114|P6|Overall Study|Pregnancy|0
2817755|NCT03147248|9634115|P5|Overall Study|Pregnancy|1
2817756|NCT03147248|9634116|P4|Overall Study|Pregnancy|0
2817757|NCT03147248|9634117|P3|Overall Study|Pregnancy|0
2817758|NCT03147248|9634118|P2|Overall Study|Pregnancy|0
2817759|NCT03147248|9634119|P1|Overall Study|Pregnancy|0
2817760|NCT03147248|9634114|P6|Overall Study|Lost to Follow-up|0
2817761|NCT03147248|9634115|P5|Overall Study|Lost to Follow-up|2
2817762|NCT03147248|9634116|P4|Overall Study|Lost to Follow-up|0
2817763|NCT03147248|9634117|P3|Overall Study|Lost to Follow-up|0
2817764|NCT03147248|9634118|P2|Overall Study|Lost to Follow-up|0
2817765|NCT03147248|9634119|P1|Overall Study|Lost to Follow-up|0
2817766|NCT03147248|9634114|P6|Overall Study|Protocol Violation|0
2817767|NCT03147248|9634115|P5|Overall Study|Protocol Violation|2
2817768|NCT03147248|9634116|P4|Overall Study|Protocol Violation|0
2817769|NCT03147248|9634117|P3|Overall Study|Protocol Violation|0
2817770|NCT03147248|9634118|P2|Overall Study|Protocol Violation|0
2817771|NCT03147248|9634119|P1|Overall Study|Protocol Violation|0
2817772|NCT03147248|9634114|P6|Overall Study|Withdrawal by Subject|9
2817773|NCT03147248|9634115|P5|Overall Study|Withdrawal by Subject|12
2817774|NCT03147248|9634116|P4|Overall Study|Withdrawal by Subject|0
2817775|NCT03147248|9634117|P3|Overall Study|Withdrawal by Subject|0
2817776|NCT03147248|9634118|P2|Overall Study|Withdrawal by Subject|0
2817777|NCT03147248|9634119|P1|Overall Study|Withdrawal by Subject|0
2817778|NCT03147248|9634114|P6|Overall Study|Disease progression|2
2817779|NCT03147248|9634115|P5|Overall Study|Disease progression|0
2817780|NCT03147248|9634116|P4|Overall Study|Disease progression|0
2817781|NCT03147248|9634117|P3|Overall Study|Disease progression|0
2817782|NCT03147248|9634118|P2|Overall Study|Disease progression|0
2817783|NCT03147248|9634119|P1|Overall Study|Disease progression|1
2817784|NCT03147248|9634114|P6|Overall Study|Adverse Event|11
2817785|NCT03147248|9634115|P5|Overall Study|Adverse Event|6
2817786|NCT03147248|9634116|P4|Overall Study|Adverse Event|2
2817787|NCT03147248|9634117|P3|Overall Study|Adverse Event|2
2817788|NCT03147248|9634118|P2|Overall Study|Adverse Event|2
2817789|NCT03147248|9634119|P1|Overall Study|Adverse Event|0
2817790|NCT03146741|9634141|P1|Overall Study|Awaiting txp|2
2817791|NCT03146741|9634141|P1|Overall Study|Physician Decision|2
2817792|NCT03146741|9634141|P1|Overall Study|Listeted for MOT|2
2817793|NCT03146741|9634141|P1|Overall Study|Txp with non-HCV+ heart|4
2817794|NCT03146403|9634161|P2|Overall Study|Lost to Follow-up|0
2817795|NCT03146403|9634162|P1|Overall Study|Lost to Follow-up|2
2817796|NCT03146403|9634161|P2|Overall Study|Withdrawal by Subject|3
2817797|NCT03146403|9634162|P1|Overall Study|Withdrawal by Subject|0
2817798|NCT03144180|9634206|P2|Overall Study|Scrub tech removed tube cap|1
2817799|NCT03144180|9634207|P1|Overall Study|Scrub tech removed tube cap|0
2817800|NCT03144180|9634206|P2|Overall Study|Provider forgot to use the Q-cup|1
2817801|NCT03144180|9634207|P1|Overall Study|Provider forgot to use the Q-cup|0
2817802|NCT03144180|9634206|P2|Overall Study|Provider forgot to fill out forms|3
2817803|NCT03144180|9634207|P1|Overall Study|Provider forgot to fill out forms|1
2817804|NCT03144180|9634206|P2|Overall Study|STAT Delivery|1
2817805|NCT03144180|9634207|P1|Overall Study|STAT Delivery|1
2817806|NCT03143166|9634242|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
2817807|NCT03143101|9634261|P3|Overall Study|Lost to Follow-up|0
2817808|NCT03143101|9634262|P2|Overall Study|Lost to Follow-up|2
2817809|NCT03143101|9634263|P1|Overall Study|Lost to Follow-up|2
2817810|NCT03143101|9634261|P3|Overall Study|Withdrawal by Subject|0
2817811|NCT03143101|9634262|P2|Overall Study|Withdrawal by Subject|1
2817812|NCT03143101|9634263|P1|Overall Study|Withdrawal by Subject|0
2817813|NCT03142932|9634318|P2|Overall Study|Lost to Follow-up|11
2817814|NCT03142932|9634319|P1|Overall Study|Lost to Follow-up|2
2817815|NCT03142750|9634335|P2|Overall Study|Lost to Follow-up|1
2817816|NCT03142750|9634336|P1|Overall Study|Lost to Follow-up|4
2817817|NCT03141307|9634413|P2|Follow-Up|Lost to Follow-up|54
2817818|NCT03141307|9634414|P1|Follow-Up|Lost to Follow-up|97
2817819|NCT03141307|9634413|P2|In-Hospital|Protocol Violation|0
2817820|NCT03141307|9634414|P1|In-Hospital|Protocol Violation|4
2817821|NCT03141307|9634413|P2|In-Hospital|Withdrawal by Subject|2
2817822|NCT03141307|9634414|P1|In-Hospital|Withdrawal by Subject|0
2817823|NCT03141151|9634432|P2|Overall Study|Withdrawal by Subject|2
2817824|NCT03141151|9634433|P1|Overall Study|Withdrawal by Subject|3
2817825|NCT03141151|9634432|P2|Overall Study|Lost to Follow-up|2
2817826|NCT03141151|9634433|P1|Overall Study|Lost to Follow-up|3
2817827|NCT03141086|9634451|P2|Overall Study|Adverse Event|2
2817828|NCT03141086|9634452|P1|Overall Study|Adverse Event|0
2817829|NCT03141086|9634451|P2|Overall Study|Protocol Violation|1
2817830|NCT03141086|9634452|P1|Overall Study|Protocol Violation|0
2817831|NCT03141086|9634451|P2|Overall Study|Withdrawal by Subject|1
2817832|NCT03141086|9634452|P1|Overall Study|Withdrawal by Subject|0
2817833|NCT03141086|9634451|P2|Overall Study|Study Terminated By Sponsor|1
2817834|NCT03141086|9634452|P1|Overall Study|Study Terminated By Sponsor|1
2817835|NCT03139604|9634492|P2|Overall Study|Continuing on Study|136
2817836|NCT03139604|9634493|P1|Overall Study|Continuing on Study|134
2817837|NCT03139604|9634492|P2|Overall Study|Death|64
2817838|NCT03139604|9634493|P1|Overall Study|Death|60
2817839|NCT03139604|9634492|P2|Overall Study|Lost to Follow-up|1
2817840|NCT03139604|9634493|P1|Overall Study|Lost to Follow-up|1
2817841|NCT03139604|9634492|P2|Overall Study|Physician Decision|2
2817842|NCT03139604|9634493|P1|Overall Study|Physician Decision|1
2817843|NCT03139604|9634492|P2|Overall Study|Withdrawal by Subject|15
2817844|NCT03139604|9634493|P1|Overall Study|Withdrawal by Subject|16
2817845|NCT03139604|9634492|P2|Overall Study|Other|2
2817846|NCT03139604|9634493|P1|Overall Study|Other|7
2817847|NCT03139552|9634542|P1|Overall Study|unable to attend tasting due to schedule|3
2817848|NCT03139448|9634585|P2|Overall Study|Physician Decision|2
2817849|NCT03139448|9634586|P1|Overall Study|Physician Decision|0
2817850|NCT03139448|9634585|P2|Overall Study|Screen fail|3
2817851|NCT03139448|9634586|P1|Overall Study|Screen fail|1
2817852|NCT03139448|9634585|P2|Overall Study|Withdrawal by Subject|6
2817853|NCT03139448|9634586|P1|Overall Study|Withdrawal by Subject|3
2817854|NCT03139448|9634585|P2|Overall Study|Location of procedure changed|8
2817855|NCT03139448|9634586|P1|Overall Study|Location of procedure changed|2
2817856|NCT03139448|9634585|P2|Overall Study|Lack of Efficacy|7
2817857|NCT03139448|9634586|P1|Overall Study|Lack of Efficacy|6
2817858|NCT03139279|9634610|P2|Overall Study|Withdrawal by Subject|2
2817859|NCT03139279|9634611|P1|Overall Study|Withdrawal by Subject|0
2817860|NCT03139279|9634610|P2|Overall Study|Protocol Violation|4
2817861|NCT03139279|9634611|P1|Overall Study|Protocol Violation|5
2817862|NCT03139279|9634610|P2|Overall Study|Physician Decision|0
2817863|NCT03139279|9634611|P1|Overall Study|Physician Decision|2
2817864|NCT03139240|9634629|P4|Overall Study|Lost to Follow-up|0
2817865|NCT03139240|9634630|P3|Overall Study|Lost to Follow-up|1
2817866|NCT03139240|9634631|P2|Overall Study|Lost to Follow-up|1
2817867|NCT03139240|9634632|P1|Overall Study|Lost to Follow-up|0
2817868|NCT03138967|9634644|P2|Overall Study|Physician Decision|3
2817869|NCT03138967|9634645|P1|Overall Study|Physician Decision|1
2817870|NCT03138967|9634644|P2|Overall Study|Death|1
2817871|NCT03138967|9634645|P1|Overall Study|Death|0
2817872|NCT03137784|9634760|P6|Overall Study|Non-compliance with study treatment|0
2817873|NCT03137784|9634761|P5|Overall Study|Non-compliance with study treatment|1
2817874|NCT03137784|9634762|P4|Overall Study|Non-compliance with study treatment|0
2817875|NCT03137784|9634763|P3|Overall Study|Non-compliance with study treatment|0
2817876|NCT03137784|9634764|P2|Overall Study|Non-compliance with study treatment|0
2817877|NCT03137784|9634765|P1|Overall Study|Non-compliance with study treatment|0
2817878|NCT03137784|9634760|P6|Overall Study|Subject/guardian decision|0
2817879|NCT03137784|9634761|P5|Overall Study|Subject/guardian decision|0
2817880|NCT03137784|9634762|P4|Overall Study|Subject/guardian decision|0
2817881|NCT03137784|9634763|P3|Overall Study|Subject/guardian decision|0
2817882|NCT03137784|9634764|P2|Overall Study|Subject/guardian decision|0
2817883|NCT03137784|9634765|P1|Overall Study|Subject/guardian decision|1
2817884|NCT03137784|9634760|P6|Overall Study|Adverse Event|0
2817885|NCT03137784|9634761|P5|Overall Study|Adverse Event|0
2817886|NCT03137784|9634762|P4|Overall Study|Adverse Event|0
2817887|NCT03137784|9634763|P3|Overall Study|Adverse Event|0
2817888|NCT03137784|9634764|P2|Overall Study|Adverse Event|1
2817889|NCT03137784|9634765|P1|Overall Study|Adverse Event|1
2817890|NCT03137173|9634817|P2|Overall Study|Other reasons|2
2817891|NCT03137173|9634818|P1|Overall Study|Other reasons|3
2817892|NCT03137173|9634817|P2|Overall Study|Lost to Follow-up|18
2817893|NCT03137173|9634818|P1|Overall Study|Lost to Follow-up|13
2817894|NCT03137173|9634817|P2|Overall Study|Physician Decision|0
2817895|NCT03137173|9634818|P1|Overall Study|Physician Decision|1
2817896|NCT03137173|9634817|P2|Overall Study|Death|3
2817897|NCT03137173|9634818|P1|Overall Study|Death|1
2817898|NCT03137173|9634817|P2|Overall Study|Withdrawal by Subject|13
2817899|NCT03137173|9634818|P1|Overall Study|Withdrawal by Subject|8
2817900|NCT03136861|9634835|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817901|NCT03136861|9634836|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817902|NCT03136861|9634837|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817903|NCT03136861|9634838|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817904|NCT03136861|9634839|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
2817905|NCT03136861|9634840|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817906|NCT03136861|9634841|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2817907|NCT03136861|9634835|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817908|NCT03136861|9634836|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817909|NCT03136861|9634837|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817910|NCT03136861|9634838|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817911|NCT03136861|9634839|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
2817912|NCT03136861|9634840|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817913|NCT03136861|9634841|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2817914|NCT03136861|9634835|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2817915|NCT03136861|9634836|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2817916|NCT03136861|9634837|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
2817917|NCT03136861|9634838|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2817918|NCT03136861|9634839|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2817919|NCT03136861|9634840|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2817920|NCT03136861|9634841|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2817921|NCT03136861|9634835|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2817922|NCT03136861|9634836|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2817923|NCT03136861|9634837|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2817924|NCT03136861|9634838|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2817925|NCT03136861|9634839|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2817926|NCT03136861|9634840|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2817927|NCT03136861|9634841|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2817928|NCT03136861|9634835|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817929|NCT03136861|9634836|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817930|NCT03136861|9634837|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817931|NCT03136861|9634838|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817932|NCT03136861|9634839|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817933|NCT03136861|9634840|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
2817934|NCT03136861|9634841|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2817935|NCT03136861|9634835|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2817936|NCT03136861|9634836|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2817937|NCT03136861|9634837|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2817938|NCT03136861|9634838|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2817939|NCT03136861|9634839|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2817940|NCT03136861|9634840|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
2817941|NCT03136861|9634841|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
2817942|NCT03136861|9634835|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2817943|NCT03136861|9634836|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2817944|NCT03136861|9634837|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2817945|NCT03136861|9634838|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2817946|NCT03136861|9634839|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2817947|NCT03136861|9634840|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2817948|NCT03136861|9634841|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2817949|NCT03136861|9634835|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2817950|NCT03136861|9634836|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2817951|NCT03136861|9634837|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2817952|NCT03136861|9634838|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2817953|NCT03136861|9634839|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2817954|NCT03136861|9634840|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
2817955|NCT03136861|9634841|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
2817956|NCT03136484|9634856|P2|Overall Study|Death|0
2817957|NCT03136484|9634857|P1|Overall Study|Death|1
2817958|NCT03136484|9634856|P2|Overall Study|Lost to Follow-up|8
2817959|NCT03136484|9634857|P1|Overall Study|Lost to Follow-up|7
2817960|NCT03136484|9634856|P2|Overall Study|Withdrawal by Subject|14
2817961|NCT03136484|9634857|P1|Overall Study|Withdrawal by Subject|19
2817962|NCT03136380|9634985|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2817963|NCT03136380|9634986|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2817964|NCT03136380|9634987|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2817965|NCT03136380|9634988|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
2817966|NCT03136380|9634989|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2817967|NCT03136198|9635170|P2|Overall Study|Withdrawal by Subject|1
2817968|NCT03136198|9635171|P1|Overall Study|Withdrawal by Subject|0
2817969|NCT03136107|9635177|P1|Overall Study|Other (Not specified)|1
2817970|NCT03136068|9635187|P2|Overall Study|Protocol Violation|0
2817971|NCT03136068|9635188|P1|Overall Study|Protocol Violation|1
2817972|NCT03136068|9635187|P2|Overall Study|Lost to Follow-up|1
2817973|NCT03136068|9635188|P1|Overall Study|Lost to Follow-up|1
2817974|NCT03135899|9635210|P8|Overall Study|Withdrawal by Subject|0
2817975|NCT03135899|9635211|P7|Overall Study|Withdrawal by Subject|0
2817976|NCT03135899|9635212|P6|Overall Study|Withdrawal by Subject|2
2817977|NCT03135899|9635213|P5|Overall Study|Withdrawal by Subject|0
2817978|NCT03135899|9635214|P4|Overall Study|Withdrawal by Subject|0
2817979|NCT03135899|9635215|P3|Overall Study|Withdrawal by Subject|0
2817980|NCT03135899|9635216|P2|Overall Study|Withdrawal by Subject|0
2817981|NCT03135899|9635217|P1|Overall Study|Withdrawal by Subject|0
2817982|NCT03135899|9635210|P8|Overall Study|Failed spirometry,unable to repeat visit|0
2817983|NCT03135899|9635211|P7|Overall Study|Failed spirometry,unable to repeat visit|1
2817984|NCT03135899|9635212|P6|Overall Study|Failed spirometry,unable to repeat visit|0
2817985|NCT03135899|9635213|P5|Overall Study|Failed spirometry,unable to repeat visit|0
2817986|NCT03135899|9635214|P4|Overall Study|Failed spirometry,unable to repeat visit|0
2817987|NCT03135899|9635215|P3|Overall Study|Failed spirometry,unable to repeat visit|0
2817988|NCT03135899|9635216|P2|Overall Study|Failed spirometry,unable to repeat visit|0
2817989|NCT03135899|9635217|P1|Overall Study|Failed spirometry,unable to repeat visit|0
2817990|NCT03135548|9635250|P3|Overall Study|Other than listed|2
2817991|NCT03135548|9635251|P2|Overall Study|Other than listed|2
2817992|NCT03135548|9635252|P1|Overall Study|Other than listed|0
2817993|NCT03135548|9635250|P3|Overall Study|Withdrawal by Subject|1
2817994|NCT03135548|9635251|P2|Overall Study|Withdrawal by Subject|2
2817995|NCT03135548|9635252|P1|Overall Study|Withdrawal by Subject|2
2817996|NCT03135548|9635250|P3|Overall Study|Lost to Follow-up|0
2817997|NCT03135548|9635251|P2|Overall Study|Lost to Follow-up|0
2817998|NCT03135548|9635252|P1|Overall Study|Lost to Follow-up|3
2817999|NCT03135431|9635282|P2|Overall Study|Study Surgeon not available|0
2818000|NCT03135431|9635283|P1|Overall Study|Study Surgeon not available|2
2818001|NCT03135028|9635304|P1|Overall Study|Withdrew Consent|1
2818002|NCT03135028|9635304|P1|Overall Study|Study Terminated by Sponsor|2
2818003|NCT03135028|9635304|P1|Overall Study|Death|6
2818004|NCT03134911|9635421|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
2818005|NCT03134911|9635421|P1|Overall Study|Screen failure|31
2818006|NCT03134599|9635483|P6|Week 3|Lost to Follow-up|1
2818007|NCT03134599|9635484|P5|Week 3|Lost to Follow-up|0
2818008|NCT03134599|9635485|P4|Week 3|Lost to Follow-up|1
2818009|NCT03134599|9635486|P3|Week 3|Lost to Follow-up|0
2818010|NCT03134599|9635487|P2|Week 3|Lost to Follow-up|0
2818011|NCT03134599|9635488|P1|Week 3|Lost to Follow-up|0
2818012|NCT03134599|9635483|P6|Week 2|Lost to Follow-up|0
2818013|NCT03134599|9635484|P5|Week 2|Lost to Follow-up|1
2818014|NCT03134599|9635485|P4|Week 2|Lost to Follow-up|1
2818015|NCT03134599|9635486|P3|Week 2|Lost to Follow-up|0
2818016|NCT03134599|9635487|P2|Week 2|Lost to Follow-up|0
2818017|NCT03134599|9635488|P1|Week 2|Lost to Follow-up|1
2818018|NCT03134599|9635483|P6|Week 1|Lost to Follow-up|0
2818019|NCT03134599|9635484|P5|Week 1|Lost to Follow-up|1
2818020|NCT03134599|9635485|P4|Week 1|Lost to Follow-up|0
2818021|NCT03134599|9635486|P3|Week 1|Lost to Follow-up|0
2818022|NCT03134599|9635487|P2|Week 1|Lost to Follow-up|0
2818023|NCT03134599|9635488|P1|Week 1|Lost to Follow-up|0
2818024|NCT03134222|9635528|P3|Overall Study|Randomized but not treated|1
2818025|NCT03134222|9635529|P2|Overall Study|Randomized but not treated|1
2818026|NCT03134222|9635530|P1|Overall Study|Randomized but not treated|0
2818027|NCT03134222|9635528|P3|Overall Study|Still on the study|3
2818028|NCT03134222|9635529|P2|Overall Study|Still on the study|4
2818029|NCT03134222|9635530|P1|Overall Study|Still on the study|3
2818030|NCT03134222|9635528|P3|Overall Study|Lack of Efficacy|0
2818031|NCT03134222|9635529|P2|Overall Study|Lack of Efficacy|0
2818032|NCT03134222|9635530|P1|Overall Study|Lack of Efficacy|1
2818033|NCT03134222|9635528|P3|Overall Study|Investigator's Discretion|1
2818034|NCT03134222|9635529|P2|Overall Study|Investigator's Discretion|0
2818035|NCT03134222|9635530|P1|Overall Study|Investigator's Discretion|0
2818036|NCT03134222|9635528|P3|Overall Study|Withdrew Consent|1
2818037|NCT03134222|9635529|P2|Overall Study|Withdrew Consent|3
2818038|NCT03134222|9635530|P1|Overall Study|Withdrew Consent|0
2818039|NCT03134222|9635528|P3|Overall Study|Lost to Follow-up|1
2818040|NCT03134222|9635529|P2|Overall Study|Lost to Follow-up|2
2818041|NCT03134222|9635530|P1|Overall Study|Lost to Follow-up|1
2818042|NCT03134222|9635528|P3|Overall Study|Adverse Event|0
2818043|NCT03134222|9635529|P2|Overall Study|Adverse Event|1
2818044|NCT03134222|9635530|P1|Overall Study|Adverse Event|4
2818045|NCT03134183|9635546|P2|Overall Study|Withdrawal by Subject|1
2818046|NCT03134183|9635547|P1|Overall Study|Withdrawal by Subject|1
2818047|NCT03133767|9635557|P2|Overall Study|Protocol Violation|1
2818048|NCT03133767|9635558|P1|Overall Study|Protocol Violation|0
2818049|NCT03133767|9635557|P2|Overall Study|Lost to Follow-up|24
2818050|NCT03133767|9635558|P1|Overall Study|Lost to Follow-up|38
2818051|NCT03133481|9635574|P2|Overall Study|FC Catheter fell out post operative day1|4
2818052|NCT03133481|9635575|P1|Overall Study|FC Catheter fell out post operative day1|0
2818053|NCT03132220|9635662|P2|Overall Study|Withdrawal by Subject|4
2818054|NCT03132220|9635663|P1|Overall Study|Withdrawal by Subject|1
2818055|NCT03132220|9635662|P2|Overall Study|Lost to Follow-up|8
2818056|NCT03132220|9635663|P1|Overall Study|Lost to Follow-up|17
2818057|NCT03131999|9635691|P2|Overall Study|Withdrawal by Subject|1
2818058|NCT03131999|9635692|P1|Overall Study|Withdrawal by Subject|0
2818059|NCT03131895|9635702|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2818060|NCT03131895|9635703|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2818061|NCT03131895|9635704|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2818062|NCT03131895|9635705|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
2818063|NCT03131895|9635702|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2818064|NCT03131895|9635703|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2818065|NCT03131895|9635704|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
2818066|NCT03131895|9635705|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2818067|NCT03131895|9635702|P4|Washout Period (at Least 5 Days)|Other|0
2818068|NCT03131895|9635703|P3|Washout Period (at Least 5 Days)|Other|2
2818069|NCT03131895|9635704|P2|Washout Period (at Least 5 Days)|Other|0
2818070|NCT03131895|9635705|P1|Washout Period (at Least 5 Days)|Other|0
2818071|NCT03131895|9635702|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2818072|NCT03131895|9635703|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2818073|NCT03131895|9635704|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
2818074|NCT03131895|9635705|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2818075|NCT03131895|9635702|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2818076|NCT03131895|9635703|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
2818077|NCT03131895|9635704|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2818078|NCT03131895|9635705|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2818079|NCT03131895|9635702|P4|Washout Period (at Least 5 Days)|Adverse Event|1
2818080|NCT03131895|9635703|P3|Washout Period (at Least 5 Days)|Adverse Event|0
2818081|NCT03131895|9635704|P2|Washout Period (at Least 5 Days)|Adverse Event|0
2818082|NCT03131895|9635705|P1|Washout Period (at Least 5 Days)|Adverse Event|1
2818083|NCT03131713|9635725|P2|Overall Study|Lost to Follow-up|0
2818084|NCT03131713|9635726|P1|Overall Study|Lost to Follow-up|5
2818085|NCT03131687|9635750|P6|Overall Study|Inadvertent Enrollment|0
2818086|NCT03131687|9635751|P5|Overall Study|Inadvertent Enrollment|0
2818087|NCT03131687|9635752|P4|Overall Study|Inadvertent Enrollment|1
2818088|NCT03131687|9635753|P3|Overall Study|Inadvertent Enrollment|0
2818089|NCT03131687|9635754|P2|Overall Study|Inadvertent Enrollment|0
2818090|NCT03131687|9635755|P1|Overall Study|Inadvertent Enrollment|0
2818091|NCT03131687|9635750|P6|Overall Study|Principle Investigator Decision|0
2818092|NCT03131687|9635751|P5|Overall Study|Principle Investigator Decision|0
2818093|NCT03131687|9635752|P4|Overall Study|Principle Investigator Decision|0
2818094|NCT03131687|9635753|P3|Overall Study|Principle Investigator Decision|0
2818095|NCT03131687|9635754|P2|Overall Study|Principle Investigator Decision|1
2818096|NCT03131687|9635755|P1|Overall Study|Principle Investigator Decision|0
2818097|NCT03131687|9635750|P6|Overall Study|Participant Started New Diabetic Drug|0
2818098|NCT03131687|9635751|P5|Overall Study|Participant Started New Diabetic Drug|0
2818099|NCT03131687|9635752|P4|Overall Study|Participant Started New Diabetic Drug|0
2818100|NCT03131687|9635753|P3|Overall Study|Participant Started New Diabetic Drug|0
2818101|NCT03131687|9635754|P2|Overall Study|Participant Started New Diabetic Drug|0
2818102|NCT03131687|9635755|P1|Overall Study|Participant Started New Diabetic Drug|1
2818103|NCT03131687|9635750|P6|Overall Study|Lost to Follow-up|2
2818104|NCT03131687|9635751|P5|Overall Study|Lost to Follow-up|4
2818105|NCT03131687|9635752|P4|Overall Study|Lost to Follow-up|1
2818106|NCT03131687|9635753|P3|Overall Study|Lost to Follow-up|0
2818107|NCT03131687|9635754|P2|Overall Study|Lost to Follow-up|4
2818108|NCT03131687|9635755|P1|Overall Study|Lost to Follow-up|1
2818109|NCT03131687|9635750|P6|Overall Study|Withdrawal by Subject|1
2818110|NCT03131687|9635751|P5|Overall Study|Withdrawal by Subject|2
2818111|NCT03131687|9635752|P4|Overall Study|Withdrawal by Subject|1
2818112|NCT03131687|9635753|P3|Overall Study|Withdrawal by Subject|3
2818113|NCT03131687|9635754|P2|Overall Study|Withdrawal by Subject|3
2818114|NCT03131687|9635755|P1|Overall Study|Withdrawal by Subject|3
2818115|NCT03131687|9635750|P6|Overall Study|Death|0
2818116|NCT03131687|9635751|P5|Overall Study|Death|0
2818117|NCT03131687|9635752|P4|Overall Study|Death|0
2818118|NCT03131687|9635753|P3|Overall Study|Death|0
2818119|NCT03131687|9635754|P2|Overall Study|Death|0
2818120|NCT03131687|9635755|P1|Overall Study|Death|1
2818121|NCT03131687|9635750|P6|Overall Study|Adverse Event|2
2818122|NCT03131687|9635751|P5|Overall Study|Adverse Event|2
2818123|NCT03131687|9635752|P4|Overall Study|Adverse Event|1
2818124|NCT03131687|9635753|P3|Overall Study|Adverse Event|0
2818125|NCT03131687|9635754|P2|Overall Study|Adverse Event|1
2818126|NCT03131687|9635755|P1|Overall Study|Adverse Event|0
2818127|NCT03131596|9635865|P2|Overall Study|Lost to Follow-up|0
2818128|NCT03131596|9635866|P1|Overall Study|Lost to Follow-up|3
2818129|NCT03131596|9635865|P2|Overall Study|Protocol Violation|3
2818130|NCT03131596|9635866|P1|Overall Study|Protocol Violation|3
2818131|NCT03131479|9635883|P5|Overall Study|Subject/Guardian Decision|0
2818132|NCT03131479|9635884|P4|Overall Study|Subject/Guardian Decision|1
2818133|NCT03131479|9635885|P3|Overall Study|Subject/Guardian Decision|0
2818134|NCT03131479|9635886|P2|Overall Study|Subject/Guardian Decision|0
2818135|NCT03131479|9635887|P1|Overall Study|Subject/Guardian Decision|0
2818136|NCT03131479|9635883|P5|Overall Study|Adverse Event|0
2818137|NCT03131479|9635884|P4|Overall Study|Adverse Event|1
2818138|NCT03131479|9635885|P3|Overall Study|Adverse Event|1
2818139|NCT03131479|9635886|P2|Overall Study|Adverse Event|0
2818140|NCT03131479|9635887|P1|Overall Study|Adverse Event|0
2818141|NCT03131167|9635982|P13|Overall Study|Other (Unspecified)|0
2818142|NCT03131167|9635983|P12|Overall Study|Other (Unspecified)|0
2818143|NCT03131167|9635984|P11|Overall Study|Other (Unspecified)|0
2818144|NCT03131167|9635985|P10|Overall Study|Other (Unspecified)|0
2818145|NCT03131167|9635986|P9|Overall Study|Other (Unspecified)|0
2818146|NCT03131167|9635987|P8|Overall Study|Other (Unspecified)|0
2818147|NCT03131167|9635988|P7|Overall Study|Other (Unspecified)|0
2818148|NCT03131167|9635989|P6|Overall Study|Other (Unspecified)|1
2818149|NCT03131167|9635990|P5|Overall Study|Other (Unspecified)|0
2818150|NCT03131167|9635991|P4|Overall Study|Other (Unspecified)|0
2818151|NCT03131167|9635992|P3|Overall Study|Other (Unspecified)|0
2818152|NCT03131167|9635993|P2|Overall Study|Other (Unspecified)|0
2818153|NCT03131167|9635994|P1|Overall Study|Other (Unspecified)|0
2818154|NCT03128723|9636097|P1|Overall Study|Withdrawal by Subject|2
2818155|NCT03128307|9636116|P1|Overall Study|Withdrawal by Subject|5
2818156|NCT03128307|9636116|P1|Overall Study|Lost to Follow-up|29
2818157|NCT03128099|9636124|P3|Overall Study|Did not complete all the assessments|1
2818158|NCT03128099|9636125|P2|Overall Study|Did not complete all the assessments|0
2818159|NCT03128099|9636126|P1|Overall Study|Did not complete all the assessments|0
2818160|NCT03128099|9636124|P3|Overall Study|Became homeless and lost contact|0
2818161|NCT03128099|9636125|P2|Overall Study|Became homeless and lost contact|0
2818162|NCT03128099|9636126|P1|Overall Study|Became homeless and lost contact|1
2818163|NCT03128099|9636124|P3|Overall Study|Participant got a full time job.|0
2818164|NCT03128099|9636125|P2|Overall Study|Participant got a full time job.|0
2818165|NCT03128099|9636126|P1|Overall Study|Participant got a full time job.|1
2818166|NCT03128099|9636124|P3|Overall Study|High dose task was too long|0
2818167|NCT03128099|9636125|P2|Overall Study|High dose task was too long|4
2818168|NCT03128099|9636126|P1|Overall Study|High dose task was too long|0
2818169|NCT03127644|9636176|P3|Overall Study|Study-specific withdrawal criteria|2
2818170|NCT03127644|9636177|P2|Overall Study|Study-specific withdrawal criteria|0
2818171|NCT03127644|9636178|P1|Overall Study|Study-specific withdrawal criteria|0
2818172|NCT03127384|9636210|P1|Overall Study|Subject request|2
2818173|NCT03127384|9636210|P1|Overall Study|Lost to Follow-up|4
2818174|NCT03126539|9636246|P5|Overall Study|Lost to Follow-up|0
2818175|NCT03126539|9636247|P4|Overall Study|Lost to Follow-up|0
2818176|NCT03126539|9636248|P3|Overall Study|Lost to Follow-up|1
2818177|NCT03126539|9636249|P2|Overall Study|Lost to Follow-up|1
2818178|NCT03126539|9636250|P1|Overall Study|Lost to Follow-up|1
2818179|NCT03125941|9636278|P2|Overall Study|did not receive intervention|2
2818180|NCT03125941|9636279|P1|Overall Study|did not receive intervention|1
2818181|NCT03125915|9636315|P4|6 Month Follow-up|Lost to Follow-up|3
2818182|NCT03125915|9636316|P3|6 Month Follow-up|Lost to Follow-up|6
2818183|NCT03125915|9636317|P2|6 Month Follow-up|Lost to Follow-up|3
2818184|NCT03125915|9636318|P1|6 Month Follow-up|Lost to Follow-up|7
2818185|NCT03125915|9636315|P4|3 Month Follow-up|Lost to Follow-up|2
2818186|NCT03125915|9636316|P3|3 Month Follow-up|Lost to Follow-up|4
2818187|NCT03125915|9636317|P2|3 Month Follow-up|Lost to Follow-up|4
2818188|NCT03125915|9636318|P1|3 Month Follow-up|Lost to Follow-up|6
2818189|NCT03125915|9636315|P4|1 Month Follow up|Lost to Follow-up|3
2818190|NCT03125915|9636316|P3|1 Month Follow up|Lost to Follow-up|2
2818191|NCT03125915|9636317|P2|1 Month Follow up|Lost to Follow-up|3
2818192|NCT03125915|9636318|P1|1 Month Follow up|Lost to Follow-up|3
2818193|NCT03125200|9636343|P7|Overall Study|Consent Withdrawn by Subject|1
2818194|NCT03125200|9636344|P6|Overall Study|Consent Withdrawn by Subject|0
2818195|NCT03125200|9636345|P5|Overall Study|Consent Withdrawn by Subject|1
2818196|NCT03125200|9636346|P4|Overall Study|Consent Withdrawn by Subject|0
2818197|NCT03125200|9636347|P3|Overall Study|Consent Withdrawn by Subject|0
2818198|NCT03125200|9636348|P2|Overall Study|Consent Withdrawn by Subject|1
2818199|NCT03125200|9636349|P1|Overall Study|Consent Withdrawn by Subject|0
2818200|NCT03125200|9636343|P7|Overall Study|Toxicity|0
2818201|NCT03125200|9636344|P6|Overall Study|Toxicity|0
2818202|NCT03125200|9636345|P5|Overall Study|Toxicity|0
2818203|NCT03125200|9636346|P4|Overall Study|Toxicity|1
2818204|NCT03125200|9636347|P3|Overall Study|Toxicity|0
2818205|NCT03125200|9636348|P2|Overall Study|Toxicity|0
2818206|NCT03125200|9636349|P1|Overall Study|Toxicity|0
2818207|NCT03125200|9636343|P7|Overall Study|Lack of Efficacy|0
2818208|NCT03125200|9636344|P6|Overall Study|Lack of Efficacy|0
2818209|NCT03125200|9636345|P5|Overall Study|Lack of Efficacy|0
2818210|NCT03125200|9636346|P4|Overall Study|Lack of Efficacy|1
2818211|NCT03125200|9636347|P3|Overall Study|Lack of Efficacy|0
2818212|NCT03125200|9636348|P2|Overall Study|Lack of Efficacy|0
2818213|NCT03125200|9636349|P1|Overall Study|Lack of Efficacy|0
2818214|NCT03125200|9636343|P7|Overall Study|Progressive Disease|1
2818215|NCT03125200|9636344|P6|Overall Study|Progressive Disease|0
2818216|NCT03125200|9636345|P5|Overall Study|Progressive Disease|2
2818217|NCT03125200|9636346|P4|Overall Study|Progressive Disease|1
2818218|NCT03125200|9636347|P3|Overall Study|Progressive Disease|2
2818219|NCT03125200|9636348|P2|Overall Study|Progressive Disease|1
2818220|NCT03125200|9636349|P1|Overall Study|Progressive Disease|2
2818221|NCT03125200|9636343|P7|Overall Study|Clinical Progression|0
2818222|NCT03125200|9636344|P6|Overall Study|Clinical Progression|1
2818223|NCT03125200|9636345|P5|Overall Study|Clinical Progression|0
2818224|NCT03125200|9636346|P4|Overall Study|Clinical Progression|1
2818225|NCT03125200|9636347|P3|Overall Study|Clinical Progression|0
2818226|NCT03125200|9636348|P2|Overall Study|Clinical Progression|0
2818227|NCT03125200|9636349|P1|Overall Study|Clinical Progression|0
2818228|NCT03125200|9636343|P7|Overall Study|Study Termination|1
2818229|NCT03125200|9636344|P6|Overall Study|Study Termination|2
2818230|NCT03125200|9636345|P5|Overall Study|Study Termination|1
2818231|NCT03125200|9636346|P4|Overall Study|Study Termination|1
2818232|NCT03125200|9636347|P3|Overall Study|Study Termination|0
2818233|NCT03125200|9636348|P2|Overall Study|Study Termination|0
2818234|NCT03125200|9636349|P1|Overall Study|Study Termination|0
2818235|NCT03124784|9636589|P1|Overall Study|Computer/Equip Malfunction|1
2818236|NCT03124784|9636589|P1|Overall Study|Adverse Event|1
2818237|NCT03124563|9636611|P2|Overall Study|Withdrawal by Subject|1
2818238|NCT03124563|9636612|P1|Overall Study|Withdrawal by Subject|1
2818239|NCT03124563|9636611|P2|Overall Study|Lost to Follow-up|1
2818240|NCT03124563|9636612|P1|Overall Study|Lost to Follow-up|1
2818241|NCT03124407|9636632|P4|Overall Study|Adverse Event|0
2818242|NCT03124407|9636633|P3|Overall Study|Adverse Event|1
2818243|NCT03124407|9636634|P2|Overall Study|Adverse Event|0
2818244|NCT03124407|9636635|P1|Overall Study|Adverse Event|0
2818245|NCT03124407|9636632|P4|Overall Study|Lost to Follow-up|0
2818246|NCT03124407|9636633|P3|Overall Study|Lost to Follow-up|0
2818247|NCT03124407|9636634|P2|Overall Study|Lost to Follow-up|0
2818248|NCT03124407|9636635|P1|Overall Study|Lost to Follow-up|1
2818249|NCT03124381|9636655|P2|Overall Study|Non-Compliance with Study Treatment|0
2818250|NCT03124381|9636656|P1|Overall Study|Non-Compliance with Study Treatment|1
2818251|NCT03124381|9636655|P2|Overall Study|Adverse Event|1
2818252|NCT03124381|9636656|P1|Overall Study|Adverse Event|1
2818253|NCT03124381|9636655|P2|Overall Study|Protocol Violation|1
2818254|NCT03124381|9636656|P1|Overall Study|Protocol Violation|0
2818255|NCT03124381|9636655|P2|Overall Study|Withdrawal by Subject|3
2818256|NCT03124381|9636656|P1|Overall Study|Withdrawal by Subject|6
2818257|NCT03124381|9636655|P2|Overall Study|Lost to Follow-up|1
2818258|NCT03124381|9636656|P1|Overall Study|Lost to Follow-up|1
2818259|NCT03124199|9636763|P1|Overall Study|Lost to Follow-up|4
2818260|NCT03124108|9636772|P3|Overall Study|Adverse Event|0
2818261|NCT03124108|9636773|P2|Overall Study|Adverse Event|1
2818262|NCT03124108|9636774|P1|Overall Study|Adverse Event|0
2818263|NCT03123471|9636942|P2|Apremilast Extension Phase|Withdrawal by Subject|7
2818264|NCT03123471|9636943|P1|Apremilast Extension Phase|Withdrawal by Subject|3
2818265|NCT03123471|9636942|P2|Apremilast Extension Phase|Lack of Efficacy|8
2818266|NCT03123471|9636943|P1|Apremilast Extension Phase|Lack of Efficacy|2
2818267|NCT03123471|9636942|P2|Apremilast Extension Phase|Adverse Event|5
2818268|NCT03123471|9636943|P1|Apremilast Extension Phase|Adverse Event|1
2818269|NCT03123471|9636942|P2|Apremilast Extension Phase|Lost to Follow-up|5
2818270|NCT03123471|9636943|P1|Apremilast Extension Phase|Lost to Follow-up|2
2818271|NCT03123471|9636942|P2|Placebo-controlled Phase|Miscellaneous|1
2818272|NCT03123471|9636943|P1|Placebo-controlled Phase|Miscellaneous|0
2818273|NCT03123471|9636942|P2|Placebo-controlled Phase|Protocol Deviation|1
2818274|NCT03123471|9636943|P1|Placebo-controlled Phase|Protocol Deviation|2
2818275|NCT03123471|9636942|P2|Placebo-controlled Phase|Lost to Follow-up|3
2818276|NCT03123471|9636943|P1|Placebo-controlled Phase|Lost to Follow-up|1
2818277|NCT03123471|9636942|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
2818278|NCT03123471|9636943|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
2818279|NCT03123471|9636942|P2|Placebo-controlled Phase|Withdrawal by Subject|16
2818280|NCT03123471|9636943|P1|Placebo-controlled Phase|Withdrawal by Subject|6
2818281|NCT03123471|9636942|P2|Placebo-controlled Phase|Lack of Efficacy|4
2818282|NCT03123471|9636943|P1|Placebo-controlled Phase|Lack of Efficacy|3
2818283|NCT03123471|9636942|P2|Placebo-controlled Phase|Adverse Event|8
2818284|NCT03123471|9636943|P1|Placebo-controlled Phase|Adverse Event|3
2818285|NCT03123354|9636968|P1|Overall Study|Physician Decision|6
2818286|NCT03122886|9636993|P2|Overall Study|Withdrawal by Subject|2
2818287|NCT03122886|9636994|P1|Overall Study|Withdrawal by Subject|1
2818288|NCT03122548|9637016|P1|Overall Study|Study Terminated by Sponsor|2
2818289|NCT03122548|9637016|P1|Overall Study|Progression - subject went into hospice|1
2818290|NCT03122548|9637016|P1|Overall Study|Death|2
2818291|NCT03122184|9637026|P2|Overall Study|Terminated due to cognitive problem|0
2818292|NCT03122184|9637027|P1|Overall Study|Terminated due to cognitive problem|1
2818293|NCT03122184|9637026|P2|Overall Study|Withdrawal by Subject|0
2818294|NCT03122184|9637027|P1|Overall Study|Withdrawal by Subject|3
2818295|NCT03122184|9637026|P2|Overall Study|Lost to Follow-up|6
2818296|NCT03122184|9637027|P1|Overall Study|Lost to Follow-up|4
2818297|NCT03122145|9637066|P2|Overall Study|Concurrent respiratory disease|0
2818298|NCT03122145|9637067|P1|Overall Study|Concurrent respiratory disease|3
2818299|NCT03121950|9637077|P2|Overall Study|Withdrawal by Subject|2
2818300|NCT03121950|9637078|P1|Overall Study|Withdrawal by Subject|10
2818301|NCT03120676|9637155|P1|Overall Study|Not treated|1
2818302|NCT03120520|9637163|P4|Overall Study|Other|0
2818303|NCT03120520|9637164|P3|Overall Study|Other|0
2818304|NCT03120520|9637165|P2|Overall Study|Other|1
2818305|NCT03120520|9637166|P1|Overall Study|Other|0
2818306|NCT03120520|9637163|P4|Overall Study|Withdrawal by Subject|2
2818307|NCT03120520|9637164|P3|Overall Study|Withdrawal by Subject|3
2818308|NCT03120520|9637165|P2|Overall Study|Withdrawal by Subject|2
2818309|NCT03120520|9637166|P1|Overall Study|Withdrawal by Subject|3
2818310|NCT03120520|9637163|P4|Overall Study|Lost to Follow-up|1
2818311|NCT03120520|9637164|P3|Overall Study|Lost to Follow-up|1
2818312|NCT03120520|9637165|P2|Overall Study|Lost to Follow-up|1
2818313|NCT03120520|9637166|P1|Overall Study|Lost to Follow-up|1
2818314|NCT03120351|9637190|P2|Overall Study|Physician Decision|1
2818315|NCT03120351|9637191|P1|Overall Study|Physician Decision|1
2818316|NCT03120013|9637197|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
2818317|NCT03120013|9637198|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
2818318|NCT03119688|9637240|P1|Overall Study|Adverse Event|4
2818319|NCT03119662|9637273|P2|Overall Study|Withdrawal by Subject|1
2818320|NCT03119662|9637274|P1|Overall Study|Withdrawal by Subject|0
2818321|NCT03118947|9637390|P1|Overall Study|Lost to Follow-up|2
2818322|NCT03118947|9637390|P1|Overall Study|Change in patient's living situation|4
2818323|NCT03118947|9637390|P1|Overall Study|Withdrawal by caregiver|3
2818324|NCT03118947|9637390|P1|Overall Study|Withdrawal by Subject|3
2818325|NCT03118947|9637390|P1|Overall Study|Protocol Violation|2
2818326|NCT03118947|9637390|P1|Overall Study|Non-compliance with study drug|1
2818327|NCT03118947|9637390|P1|Overall Study|Lack of Efficacy|4
2818328|NCT03118947|9637390|P1|Overall Study|Death|3
2818329|NCT03118947|9637390|P1|Overall Study|Adverse Event|7
2818330|NCT03118934|9637397|P6|Overall Study|Discontinued prior to exposure|0
2818331|NCT03118934|9637398|P5|Overall Study|Discontinued prior to exposure|2
2818332|NCT03118934|9637399|P4|Overall Study|Discontinued prior to exposure|1
2818333|NCT03118934|9637400|P3|Overall Study|Discontinued prior to exposure|1
2818334|NCT03118934|9637401|P2|Overall Study|Discontinued prior to exposure|1
2818335|NCT03118934|9637402|P1|Overall Study|Discontinued prior to exposure|0
2818336|NCT03118934|9637397|P6|Overall Study|Physician Decision|1
2818337|NCT03118934|9637398|P5|Overall Study|Physician Decision|0
2818338|NCT03118934|9637399|P4|Overall Study|Physician Decision|0
2818339|NCT03118934|9637400|P3|Overall Study|Physician Decision|0
2818340|NCT03118934|9637401|P2|Overall Study|Physician Decision|0
2818341|NCT03118934|9637402|P1|Overall Study|Physician Decision|0
2818342|NCT03118934|9637397|P6|Overall Study|Adverse Event|1
2818343|NCT03118934|9637398|P5|Overall Study|Adverse Event|0
2818344|NCT03118934|9637399|P4|Overall Study|Adverse Event|0
2818345|NCT03118934|9637400|P3|Overall Study|Adverse Event|0
2818346|NCT03118934|9637401|P2|Overall Study|Adverse Event|0
2818347|NCT03118934|9637402|P1|Overall Study|Adverse Event|0
2818348|NCT03118765|9637426|P5|Overall Study|Sponsor Decision|1
2818349|NCT03118765|9637427|P4|Overall Study|Sponsor Decision|0
2818350|NCT03118765|9637428|P3|Overall Study|Sponsor Decision|1
2818351|NCT03118765|9637429|P2|Overall Study|Sponsor Decision|0
2818352|NCT03118765|9637430|P1|Overall Study|Sponsor Decision|1
2818353|NCT03118765|9637426|P5|Overall Study|Lost to Follow-up|0
2818354|NCT03118765|9637427|P4|Overall Study|Lost to Follow-up|0
2818355|NCT03118765|9637428|P3|Overall Study|Lost to Follow-up|1
2818356|NCT03118765|9637429|P2|Overall Study|Lost to Follow-up|0
2818357|NCT03118765|9637430|P1|Overall Study|Lost to Follow-up|1
2818358|NCT03118765|9637426|P5|Overall Study|COPD Exacerbation|0
2818359|NCT03118765|9637427|P4|Overall Study|COPD Exacerbation|1
2818360|NCT03118765|9637428|P3|Overall Study|COPD Exacerbation|0
2818361|NCT03118765|9637429|P2|Overall Study|COPD Exacerbation|0
2818362|NCT03118765|9637430|P1|Overall Study|COPD Exacerbation|1
2818363|NCT03118765|9637426|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2818364|NCT03118765|9637427|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2818365|NCT03118765|9637428|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2818366|NCT03118765|9637429|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2818367|NCT03118765|9637430|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2818368|NCT03118765|9637426|P5|Overall Study|Non compliance with Study Procedures|0
2818369|NCT03118765|9637427|P4|Overall Study|Non compliance with Study Procedures|1
2818370|NCT03118765|9637428|P3|Overall Study|Non compliance with Study Procedures|0
2818371|NCT03118765|9637429|P2|Overall Study|Non compliance with Study Procedures|0
2818372|NCT03118765|9637430|P1|Overall Study|Non compliance with Study Procedures|0
2818373|NCT03118765|9637426|P5|Overall Study|Adverse Event|1
2818374|NCT03118765|9637427|P4|Overall Study|Adverse Event|1
2818375|NCT03118765|9637428|P3|Overall Study|Adverse Event|1
2818376|NCT03118765|9637429|P2|Overall Study|Adverse Event|1
2818377|NCT03118765|9637430|P1|Overall Study|Adverse Event|1
2818378|NCT03118765|9637426|P5|Overall Study|Withdrawal by Subject|0
2818379|NCT03118765|9637427|P4|Overall Study|Withdrawal by Subject|0
2818380|NCT03118765|9637428|P3|Overall Study|Withdrawal by Subject|1
2818381|NCT03118765|9637429|P2|Overall Study|Withdrawal by Subject|0
2818382|NCT03118765|9637430|P1|Overall Study|Withdrawal by Subject|0
2818383|NCT03118739|9637526|P2|Overall Study|Lost to Follow-up|0
2818384|NCT03118739|9637527|P1|Overall Study|Lost to Follow-up|2
2818385|NCT03118739|9637526|P2|Overall Study|Withdrawal by Subject|3
2818386|NCT03118739|9637527|P1|Overall Study|Withdrawal by Subject|5
2818387|NCT03118739|9637526|P2|Overall Study|Physician Decision|1
2818388|NCT03118739|9637527|P1|Overall Study|Physician Decision|0
2818389|NCT03118297|9637640|P2|Overall Study|Lost to Follow-up|2
2818390|NCT03118297|9637641|P1|Overall Study|Lost to Follow-up|0
2818391|NCT03116698|9637787|P4|Overall Study|Death|0
2818392|NCT03116698|9637788|P3|Overall Study|Death|2
2818393|NCT03116698|9637789|P2|Overall Study|Death|0
2818394|NCT03116698|9637790|P1|Overall Study|Death|0
2818395|NCT03116698|9637787|P4|Overall Study|Protocol Violation|0
2818396|NCT03116698|9637788|P3|Overall Study|Protocol Violation|0
2818397|NCT03116698|9637789|P2|Overall Study|Protocol Violation|0
2818398|NCT03116698|9637790|P1|Overall Study|Protocol Violation|1
2818399|NCT03116698|9637787|P4|Overall Study|Physician Decision|0
2818400|NCT03116698|9637788|P3|Overall Study|Physician Decision|0
2818401|NCT03116698|9637789|P2|Overall Study|Physician Decision|1
2818402|NCT03116698|9637790|P1|Overall Study|Physician Decision|1
2818403|NCT03116698|9637787|P4|Overall Study|Lost to Follow-up|0
2818404|NCT03116698|9637788|P3|Overall Study|Lost to Follow-up|0
2818405|NCT03116698|9637789|P2|Overall Study|Lost to Follow-up|0
2818406|NCT03116698|9637790|P1|Overall Study|Lost to Follow-up|2
2818407|NCT03116698|9637787|P4|Overall Study|Withdrawal by Subject|2
2818408|NCT03116698|9637788|P3|Overall Study|Withdrawal by Subject|5
2818409|NCT03116698|9637789|P2|Overall Study|Withdrawal by Subject|4
2818410|NCT03116698|9637790|P1|Overall Study|Withdrawal by Subject|1
2818411|NCT03116698|9637787|P4|Overall Study|Adverse Event|0
2818412|NCT03116698|9637788|P3|Overall Study|Adverse Event|1
2818413|NCT03116698|9637789|P2|Overall Study|Adverse Event|1
2818414|NCT03116698|9637790|P1|Overall Study|Adverse Event|1
2818415|NCT03115476|9637852|P3|LP0084-1369|Trial terminated by Sponsor|160
2818416|NCT03115476|9637853|P2|LP0084-1369|Trial terminated by Sponsor|210
2818417|NCT03115476|9637854|P1|LP0084-1369|Trial terminated by Sponsor|190
2818418|NCT03115476|9637852|P3|LP0084-1369|Death|2
2818419|NCT03115476|9637853|P2|LP0084-1369|Death|0
2818420|NCT03115476|9637854|P1|LP0084-1369|Death|1
2818421|NCT03114969|9637903|P9|Overall Study|Adverse Event|2
2818422|NCT03114969|9637904|P8|Overall Study|Adverse Event|0
2818423|NCT03114969|9637905|P7|Overall Study|Adverse Event|1
2818424|NCT03114969|9637906|P6|Overall Study|Adverse Event|1
2818425|NCT03114969|9637907|P5|Overall Study|Adverse Event|0
2818426|NCT03114969|9637908|P4|Overall Study|Adverse Event|0
2818427|NCT03114969|9637909|P3|Overall Study|Adverse Event|1
2818428|NCT03114969|9637910|P2|Overall Study|Adverse Event|0
2818429|NCT03114969|9637911|P1|Overall Study|Adverse Event|0
2818430|NCT03114969|9637903|P9|Overall Study|Lost to Follow-up|0
2818431|NCT03114969|9637904|P8|Overall Study|Lost to Follow-up|0
2818432|NCT03114969|9637905|P7|Overall Study|Lost to Follow-up|0
2818433|NCT03114969|9637906|P6|Overall Study|Lost to Follow-up|0
2818434|NCT03114969|9637907|P5|Overall Study|Lost to Follow-up|0
2818435|NCT03114969|9637908|P4|Overall Study|Lost to Follow-up|2
2818436|NCT03114969|9637909|P3|Overall Study|Lost to Follow-up|3
2818437|NCT03114969|9637910|P2|Overall Study|Lost to Follow-up|0
2818438|NCT03114969|9637911|P1|Overall Study|Lost to Follow-up|0
2818439|NCT03114488|9638006|P2|Time Period 2|Withdrawal by Subject|3
2818440|NCT03114488|9638007|P1|Time Period 2|Withdrawal by Subject|1
2818441|NCT03111108|9638066|P2|Overall Study|Withdrawal by Subject|0
2818442|NCT03111108|9638067|P1|Overall Study|Withdrawal by Subject|1
2818443|NCT03111108|9638066|P2|Overall Study|Death|1
2818444|NCT03111108|9638067|P1|Overall Study|Death|0
2818445|NCT03110900|9638085|P2|Overall Study|Sponsor withdrew|1
2818446|NCT03110900|9638086|P1|Overall Study|Sponsor withdrew|1
2818447|NCT03110380|9638110|P2|Overall Study|Lost to Follow-up|1
2818448|NCT03110380|9638111|P1|Overall Study|Lost to Follow-up|4
2818449|NCT03110380|9638110|P2|Overall Study|Withdrew Consent|16
2818450|NCT03110380|9638111|P1|Overall Study|Withdrew Consent|9
2818451|NCT03110380|9638110|P2|Overall Study|Protocol Violation|1
2818452|NCT03110380|9638111|P1|Overall Study|Protocol Violation|0
2818453|NCT03110380|9638110|P2|Overall Study|Non-Compliance with Study Drug|1
2818454|NCT03110380|9638111|P1|Overall Study|Non-Compliance with Study Drug|1
2818455|NCT03110380|9638110|P2|Overall Study|Investigator's Discretion|2
2818456|NCT03110380|9638111|P1|Overall Study|Investigator's Discretion|1
2818457|NCT03110380|9638110|P2|Overall Study|Death|1
2818458|NCT03110380|9638111|P1|Overall Study|Death|2
2818459|NCT03110380|9638110|P2|Overall Study|Adverse Event|3
2818460|NCT03110380|9638111|P1|Overall Study|Adverse Event|3
2818461|NCT03110380|9638110|P2|Overall Study|Still in Study|256
2818462|NCT03110380|9638111|P1|Overall Study|Still in Study|264
2818463|NCT03110380|9638110|P2|Overall Study|Randomized and Never Treated|2
2818464|NCT03110380|9638111|P1|Overall Study|Randomized and Never Treated|0
2818465|NCT03110159|9638121|P1|Overall Study|Study termination|1
2818466|NCT03110029|9638132|P2|Overall Study|Withdrawal by Subject|1
2818467|NCT03110029|9638133|P1|Overall Study|Withdrawal by Subject|1
2818468|NCT03109184|9638207|P2|Overall Study|Withdrawal by Subject|1
2818469|NCT03109184|9638208|P1|Overall Study|Withdrawal by Subject|1
2818470|NCT03109184|9638207|P2|Overall Study|Lost to Follow-up|6
2818471|NCT03109184|9638208|P1|Overall Study|Lost to Follow-up|6
2818472|NCT03108157|9638369|P2|Overall Study|Protocol Violation|4
2818473|NCT03108157|9638370|P1|Overall Study|Protocol Violation|15
2818474|NCT03108027|9638376|P6|Period 3|Adverse Event|0
2818475|NCT03108027|9638377|P5|Period 3|Adverse Event|0
2818476|NCT03108027|9638378|P4|Period 3|Adverse Event|0
2818477|NCT03108027|9638379|P3|Period 3|Adverse Event|0
2818478|NCT03108027|9638380|P2|Period 3|Adverse Event|1
2818479|NCT03108027|9638381|P1|Period 3|Adverse Event|0
2818480|NCT03108027|9638376|P6|Period 1|Subject/Guardian Decision|0
2818481|NCT03108027|9638377|P5|Period 1|Subject/Guardian Decision|0
2818482|NCT03108027|9638378|P4|Period 1|Subject/Guardian Decision|2
2818483|NCT03108027|9638379|P3|Period 1|Subject/Guardian Decision|0
2818484|NCT03108027|9638380|P2|Period 1|Subject/Guardian Decision|0
2818485|NCT03108027|9638381|P1|Period 1|Subject/Guardian Decision|0
2818486|NCT03107611|9638409|P3|Overall Study|Worsening signs/symptoms|2
2818487|NCT03107611|9638410|P2|Overall Study|Worsening signs/symptoms|1
2818488|NCT03107611|9638411|P1|Overall Study|Worsening signs/symptoms|2
2818489|NCT03107611|9638409|P3|Overall Study|Withdrawal by Subject|1
2818490|NCT03107611|9638410|P2|Overall Study|Withdrawal by Subject|0
2818491|NCT03107611|9638411|P1|Overall Study|Withdrawal by Subject|1
2818492|NCT03107611|9638409|P3|Overall Study|Protocol Violation|1
2818493|NCT03107611|9638410|P2|Overall Study|Protocol Violation|0
2818494|NCT03107611|9638411|P1|Overall Study|Protocol Violation|0
2818495|NCT03107611|9638409|P3|Overall Study|Lost to Follow-up|3
2818496|NCT03107611|9638410|P2|Overall Study|Lost to Follow-up|3
2818497|NCT03107611|9638411|P1|Overall Study|Lost to Follow-up|3
2818498|NCT03107611|9638409|P3|Overall Study|Adverse Event|2
2818499|NCT03107611|9638410|P2|Overall Study|Adverse Event|0
2818500|NCT03107611|9638411|P1|Overall Study|Adverse Event|1
2818501|NCT03107052|9638431|P3|Overall Study|Study terminated due to futility|23
2818502|NCT03107052|9638432|P2|Overall Study|Study terminated due to futility|31
2818503|NCT03107052|9638433|P1|Overall Study|Study terminated due to futility|67
2818504|NCT03107052|9638431|P3|Overall Study|Other than specified|0
2818505|NCT03107052|9638432|P2|Overall Study|Other than specified|2
2818506|NCT03107052|9638433|P1|Overall Study|Other than specified|4
2818507|NCT03107052|9638431|P3|Overall Study|Lack of Efficacy|4
2818508|NCT03107052|9638432|P2|Overall Study|Lack of Efficacy|7
2818509|NCT03107052|9638433|P1|Overall Study|Lack of Efficacy|23
2818510|NCT03107052|9638431|P3|Overall Study|Lost to Follow-up|1
2818511|NCT03107052|9638432|P2|Overall Study|Lost to Follow-up|0
2818512|NCT03107052|9638433|P1|Overall Study|Lost to Follow-up|4
2818513|NCT03107052|9638431|P3|Overall Study|Protocol Violation|3
2818514|NCT03107052|9638432|P2|Overall Study|Protocol Violation|0
2818515|NCT03107052|9638433|P1|Overall Study|Protocol Violation|6
2818516|NCT03107052|9638431|P3|Overall Study|Withdrawal by Subject|8
2818517|NCT03107052|9638432|P2|Overall Study|Withdrawal by Subject|5
2818518|NCT03107052|9638433|P1|Overall Study|Withdrawal by Subject|9
2818519|NCT03107052|9638431|P3|Overall Study|Adverse Event|2
2818520|NCT03107052|9638432|P2|Overall Study|Adverse Event|1
2818521|NCT03107052|9638433|P1|Overall Study|Adverse Event|6
2818522|NCT03105362|9638526|P1|Overall Study|Lost to Follow-up|1
2818523|NCT03105362|9638526|P1|Overall Study|Withdrawal by Subject|1
2818524|NCT03105297|9638533|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
2818525|NCT03105297|9638533|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
2818526|NCT03105297|9638533|P1|Baseline Phase (Day 1)|Other|21
2818527|NCT03104816|9638577|P3|Overall Study|Protocol Violation|2
2818528|NCT03104816|9638578|P2|Overall Study|Protocol Violation|0
2818529|NCT03104816|9638579|P1|Overall Study|Protocol Violation|2
2818530|NCT03104816|9638577|P3|Overall Study|Lack of Efficacy|0
2818531|NCT03104816|9638578|P2|Overall Study|Lack of Efficacy|2
2818532|NCT03104816|9638579|P1|Overall Study|Lack of Efficacy|0
2818533|NCT03103919|9638631|P2|Overall Study|Adverse Event|2
2818534|NCT03103919|9638632|P1|Overall Study|Adverse Event|2
2818535|NCT03103906|9638668|P2|Overall Study|Other|0
2818536|NCT03103906|9638669|P1|Overall Study|Other|2
2818537|NCT03103906|9638668|P2|Overall Study|Adverse Event|3
2818538|NCT03103906|9638669|P1|Overall Study|Adverse Event|2
2818539|NCT03102918|9638696|P2|Overall Study|Protocol Violation|0
2818540|NCT03102918|9638697|P1|Overall Study|Protocol Violation|1
2818541|NCT03102762|9638723|P2|Overall Study|Lost to Follow-up|0
2818542|NCT03102762|9638724|P1|Overall Study|Lost to Follow-up|1
2818543|NCT03102034|9638761|P2|Overall Study|Withdrawal by Subject|0
2818544|NCT03102034|9638762|P1|Overall Study|Withdrawal by Subject|1
2818545|NCT03101462|9638790|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
2818546|NCT03101462|9638791|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
2818547|NCT03101371|9638807|P2|Overall Study|Did not meet eligibility criteria|1
2818548|NCT03101371|9638808|P1|Overall Study|Did not meet eligibility criteria|2
2818549|NCT03101371|9638807|P2|Overall Study|Lost to Follow-up|4
2818550|NCT03101371|9638808|P1|Overall Study|Lost to Follow-up|1
2818551|NCT03101371|9638807|P2|Overall Study|Physician Decision|1
2818552|NCT03101371|9638808|P1|Overall Study|Physician Decision|0
2818553|NCT03101293|9638828|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
2818554|NCT03101293|9638829|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
2818555|NCT03101150|9638843|P2|Overall Study|Miscarriage|6
2818556|NCT03101150|9638844|P1|Overall Study|Miscarriage|3
2818557|NCT03101150|9638843|P2|Overall Study|Lost to Follow-up|4
2818558|NCT03101150|9638844|P1|Overall Study|Lost to Follow-up|2
2818559|NCT03101020|9638879|P2|Overall Study|Withdrawal by Subject|2
2818560|NCT03101020|9638880|P1|Overall Study|Withdrawal by Subject|0
2818561|NCT03101020|9638879|P2|Overall Study|Ran over by a car|1
2818562|NCT03101020|9638880|P1|Overall Study|Ran over by a car|0
2818563|NCT03101020|9638879|P2|Overall Study|Lack of time to participate|0
2818564|NCT03101020|9638880|P1|Overall Study|Lack of time to participate|1
2818565|NCT03100942|9638915|P4|Overall Study|Randomized but didn't receive study drug|1
2818566|NCT03100942|9638916|P3|Overall Study|Randomized but didn't receive study drug|0
2818567|NCT03100942|9638917|P2|Overall Study|Randomized but didn't receive study drug|1
2818568|NCT03100942|9638918|P1|Overall Study|Randomized but didn't receive study drug|0
2818569|NCT03100942|9638915|P4|Overall Study|Still on the Study|17
2818570|NCT03100942|9638916|P3|Overall Study|Still on the Study|23
2818571|NCT03100942|9638917|P2|Overall Study|Still on the Study|15
2818572|NCT03100942|9638918|P1|Overall Study|Still on the Study|22
2818573|NCT03100942|9638915|P4|Overall Study|Protocol Violation|1
2818574|NCT03100942|9638916|P3|Overall Study|Protocol Violation|0
2818575|NCT03100942|9638917|P2|Overall Study|Protocol Violation|0
2818576|NCT03100942|9638918|P1|Overall Study|Protocol Violation|1
2818577|NCT03100942|9638915|P4|Overall Study|Investigator's Discretion|0
2818578|NCT03100942|9638916|P3|Overall Study|Investigator's Discretion|0
2818579|NCT03100942|9638917|P2|Overall Study|Investigator's Discretion|1
2818580|NCT03100942|9638918|P1|Overall Study|Investigator's Discretion|1
2818581|NCT03100942|9638915|P4|Overall Study|Adverse Event|0
2818582|NCT03100942|9638916|P3|Overall Study|Adverse Event|1
2818583|NCT03100942|9638917|P2|Overall Study|Adverse Event|6
2818584|NCT03100942|9638918|P1|Overall Study|Adverse Event|1
2818585|NCT03100942|9638915|P4|Overall Study|Withdrew Consent|4
2818586|NCT03100942|9638916|P3|Overall Study|Withdrew Consent|2
2818587|NCT03100942|9638917|P2|Overall Study|Withdrew Consent|4
2818588|NCT03100942|9638918|P1|Overall Study|Withdrew Consent|4
2818589|NCT03100838|9638944|P4|Overall Study|Lost to Follow-up|0
2818590|NCT03100838|9638945|P3|Overall Study|Lost to Follow-up|1
2818591|NCT03100838|9638946|P2|Overall Study|Lost to Follow-up|0
2818592|NCT03100838|9638947|P1|Overall Study|Lost to Follow-up|0
2818593|NCT03100838|9638944|P4|Overall Study|Pregnancy|0
2818594|NCT03100838|9638945|P3|Overall Study|Pregnancy|0
2818595|NCT03100838|9638946|P2|Overall Study|Pregnancy|1
2818596|NCT03100838|9638947|P1|Overall Study|Pregnancy|0
2818597|NCT03100838|9638944|P4|Overall Study|Physician Decision|1
2818598|NCT03100838|9638945|P3|Overall Study|Physician Decision|1
2818599|NCT03100838|9638946|P2|Overall Study|Physician Decision|1
2818600|NCT03100838|9638947|P1|Overall Study|Physician Decision|1
2818601|NCT03100838|9638944|P4|Overall Study|Adverse Event|0
2818602|NCT03100838|9638945|P3|Overall Study|Adverse Event|0
2818603|NCT03100838|9638946|P2|Overall Study|Adverse Event|0
2818604|NCT03100838|9638947|P1|Overall Study|Adverse Event|1
2818605|NCT03100825|9638973|P1|Overall Study|Physician Decision|1
2818606|NCT03100825|9638973|P1|Overall Study|Participant/Guardian Decision|7
2818607|NCT03100344|9639000|P4|Overall Study|Lost to Follow-up|1
2818608|NCT03100344|9639001|P3|Overall Study|Lost to Follow-up|1
2818609|NCT03100344|9639002|P2|Overall Study|Lost to Follow-up|1
2818610|NCT03100344|9639003|P1|Overall Study|Lost to Follow-up|1
2818611|NCT03100344|9639000|P4|Overall Study|Withdrawal by Subject|8
2818612|NCT03100344|9639001|P3|Overall Study|Withdrawal by Subject|4
2818613|NCT03100344|9639002|P2|Overall Study|Withdrawal by Subject|7
2818614|NCT03100344|9639003|P1|Overall Study|Withdrawal by Subject|10
2818615|NCT03100344|9639000|P4|Overall Study|Protocol Violation|0
2818616|NCT03100344|9639001|P3|Overall Study|Protocol Violation|0
2818617|NCT03100344|9639002|P2|Overall Study|Protocol Violation|0
2818618|NCT03100344|9639003|P1|Overall Study|Protocol Violation|1
2818619|NCT03100344|9639000|P4|Overall Study|Lack of Efficacy|0
2818620|NCT03100344|9639001|P3|Overall Study|Lack of Efficacy|0
2818621|NCT03100344|9639002|P2|Overall Study|Lack of Efficacy|0
2818622|NCT03100344|9639003|P1|Overall Study|Lack of Efficacy|2
2818623|NCT03100344|9639000|P4|Overall Study|Adverse Event|3
2818624|NCT03100344|9639001|P3|Overall Study|Adverse Event|2
2818625|NCT03100344|9639002|P2|Overall Study|Adverse Event|3
2818626|NCT03100344|9639003|P1|Overall Study|Adverse Event|0
2818627|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818628|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818629|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818630|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
2818631|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818632|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818633|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818634|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818635|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818636|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818637|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818638|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818639|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2818640|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
2818641|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818642|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818643|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818644|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818645|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818646|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818647|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818648|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818649|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818650|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818651|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818652|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2818653|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818654|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818655|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
2818656|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818657|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818658|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818659|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818660|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818661|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818662|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818663|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818664|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818665|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2818666|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
2818667|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818668|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
2818669|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
2818670|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818671|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818672|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818673|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818674|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818675|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818676|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818677|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818678|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2818679|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818680|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
2818681|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
2818682|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818683|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818684|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818685|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818686|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818687|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818688|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818689|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818690|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818691|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2818692|NCT03100058|9639106|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
2818693|NCT03100058|9639107|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
2818694|NCT03100058|9639108|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
2818695|NCT03100058|9639109|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818696|NCT03100058|9639110|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818697|NCT03100058|9639111|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818698|NCT03100058|9639112|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818699|NCT03100058|9639113|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818700|NCT03100058|9639114|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818701|NCT03100058|9639115|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818702|NCT03100058|9639116|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818703|NCT03100058|9639117|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818704|NCT03100058|9639118|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2818705|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818706|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818707|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818708|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818709|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818710|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818711|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
2818712|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818713|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818714|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818715|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818716|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818717|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2818718|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818719|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818720|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818721|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818722|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818723|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818724|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818725|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818726|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818727|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818728|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818729|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2818730|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
2818731|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
2818732|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
2818733|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
2818734|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
2818735|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
2818736|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
2818737|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
2818738|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
2818739|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
2818740|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
2818741|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
2818742|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
2818743|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
2818744|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818745|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818746|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818747|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818748|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818749|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818750|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2818751|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818752|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818753|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2818754|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818755|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818756|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2818757|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818758|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818759|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818760|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818761|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818762|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2818763|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818764|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818765|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818766|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2818767|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818768|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818769|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2818770|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818771|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818772|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818773|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818774|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2818775|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818776|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2818777|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818778|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818779|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818780|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2818781|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2818782|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2818783|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818784|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818785|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818786|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818787|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818788|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818789|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2818790|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2818791|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818792|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818793|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2818794|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2818795|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2818796|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2818797|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2818798|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2818799|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2818800|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2818801|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2818802|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2818803|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2818804|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2818805|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2818806|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
2818807|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2818808|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2818809|NCT03100058|9639106|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818810|NCT03100058|9639107|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818811|NCT03100058|9639108|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818812|NCT03100058|9639109|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818813|NCT03100058|9639110|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
2818814|NCT03100058|9639111|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
2818815|NCT03100058|9639112|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
2818816|NCT03100058|9639113|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818817|NCT03100058|9639114|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
2818818|NCT03100058|9639115|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
2818819|NCT03100058|9639116|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
2818820|NCT03100058|9639117|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818821|NCT03100058|9639118|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2818822|NCT03099694|9639325|P2|Overall Study|Lost to Follow-up|5
2818823|NCT03099694|9639326|P1|Overall Study|Lost to Follow-up|9
2818824|NCT03099694|9639325|P2|Overall Study|Withdrawal by Subject|13
2818825|NCT03099694|9639326|P1|Overall Study|Withdrawal by Subject|11
2818826|NCT03099538|9639365|P1|Overall Study|Lack of Efficacy|3
2818827|NCT03099187|9639390|P2|Overall Study|Non-compliance with Protocol procedure|2
2818828|NCT03099187|9639391|P1|Overall Study|Non-compliance with Protocol procedure|1
2818829|NCT03099187|9639390|P2|Overall Study|Randomization error|2
2818830|NCT03099187|9639391|P1|Overall Study|Randomization error|0
2818831|NCT03099187|9639390|P2|Overall Study|Symptomatic deterioration|1
2818832|NCT03099187|9639391|P1|Overall Study|Symptomatic deterioration|0
2818833|NCT03099187|9639390|P2|Overall Study|Disease progression|1
2818834|NCT03099187|9639391|P1|Overall Study|Disease progression|0
2818835|NCT03099187|9639390|P2|Overall Study|Non-compliance with study drug|1
2818836|NCT03099187|9639391|P1|Overall Study|Non-compliance with study drug|0
2818837|NCT03099187|9639390|P2|Overall Study|Lung transplantation|3
2818838|NCT03099187|9639391|P1|Overall Study|Lung transplantation|1
2818839|NCT03099187|9639390|P2|Overall Study|Withdrawal by Subject|6
2818840|NCT03099187|9639391|P1|Overall Study|Withdrawal by Subject|11
2818841|NCT03099187|9639390|P2|Overall Study|Physician Decision|2
2818842|NCT03099187|9639391|P1|Overall Study|Physician Decision|2
2818843|NCT03099187|9639390|P2|Overall Study|Lack of Efficacy|0
2818844|NCT03099187|9639391|P1|Overall Study|Lack of Efficacy|1
2818845|NCT03099187|9639390|P2|Overall Study|Death|7
2818846|NCT03099187|9639391|P1|Overall Study|Death|4
2818847|NCT03099187|9639390|P2|Overall Study|Adverse Event|9
2818848|NCT03099187|9639391|P1|Overall Study|Adverse Event|23
2818849|NCT03099161|9639440|P3|Overall Study|Progressive Disease|1
2818850|NCT03099161|9639441|P2|Overall Study|Progressive Disease|4
2818851|NCT03099161|9639442|P1|Overall Study|Progressive Disease|1
2818852|NCT03099161|9639440|P3|Overall Study|Physician Decision|0
2818853|NCT03099161|9639441|P2|Overall Study|Physician Decision|0
2818854|NCT03099161|9639442|P1|Overall Study|Physician Decision|2
2818855|NCT03099161|9639440|P3|Overall Study|Adverse Event|2
2818856|NCT03099161|9639441|P2|Overall Study|Adverse Event|0
2818857|NCT03099161|9639442|P1|Overall Study|Adverse Event|0
2818858|NCT03099096|9639459|P1|Overall Study|Physician Decision|1
2818859|NCT03099096|9639459|P1|Overall Study|Adverse Event|1
2818860|NCT03098979|9639472|P6|Overall Study|Protocol Violation|1
2818861|NCT03098979|9639473|P5|Overall Study|Protocol Violation|0
2818862|NCT03098979|9639474|P4|Overall Study|Protocol Violation|0
2818863|NCT03098979|9639475|P3|Overall Study|Protocol Violation|0
2818864|NCT03098979|9639476|P2|Overall Study|Protocol Violation|0
2818865|NCT03098979|9639477|P1|Overall Study|Protocol Violation|0
2818866|NCT03098979|9639472|P6|Overall Study|Non-compliance|1
2818867|NCT03098979|9639473|P5|Overall Study|Non-compliance|0
2818868|NCT03098979|9639474|P4|Overall Study|Non-compliance|0
2818869|NCT03098979|9639475|P3|Overall Study|Non-compliance|0
2818870|NCT03098979|9639476|P2|Overall Study|Non-compliance|0
2818871|NCT03098979|9639477|P1|Overall Study|Non-compliance|0
2818872|NCT03098979|9639472|P6|Overall Study|Physician Decision|0
2818873|NCT03098979|9639473|P5|Overall Study|Physician Decision|0
2818874|NCT03098979|9639474|P4|Overall Study|Physician Decision|0
2818875|NCT03098979|9639475|P3|Overall Study|Physician Decision|0
2818876|NCT03098979|9639476|P2|Overall Study|Physician Decision|1
2818877|NCT03098979|9639477|P1|Overall Study|Physician Decision|2
2818878|NCT03098979|9639472|P6|Overall Study|Death|0
2818879|NCT03098979|9639473|P5|Overall Study|Death|1
2818880|NCT03098979|9639474|P4|Overall Study|Death|0
2818881|NCT03098979|9639475|P3|Overall Study|Death|2
2818882|NCT03098979|9639476|P2|Overall Study|Death|0
2818883|NCT03098979|9639477|P1|Overall Study|Death|1
2818884|NCT03098979|9639472|P6|Overall Study|Withdrawal by Subject|1
2818885|NCT03098979|9639473|P5|Overall Study|Withdrawal by Subject|2
2818886|NCT03098979|9639474|P4|Overall Study|Withdrawal by Subject|1
2818887|NCT03098979|9639475|P3|Overall Study|Withdrawal by Subject|1
2818888|NCT03098979|9639476|P2|Overall Study|Withdrawal by Subject|1
2818889|NCT03098979|9639477|P1|Overall Study|Withdrawal by Subject|2
2818890|NCT03098979|9639472|P6|Overall Study|Adverse Event|1
2818891|NCT03098979|9639473|P5|Overall Study|Adverse Event|6
2818892|NCT03098979|9639474|P4|Overall Study|Adverse Event|4
2818893|NCT03098979|9639475|P3|Overall Study|Adverse Event|1
2818894|NCT03098979|9639476|P2|Overall Study|Adverse Event|0
2818895|NCT03098979|9639477|P1|Overall Study|Adverse Event|1
2818896|NCT03097861|9639619|P3|Overall Study|Reason not provided|1
2818897|NCT03097861|9639620|P2|Overall Study|Reason not provided|1
2818898|NCT03097861|9639621|P1|Overall Study|Reason not provided|3
2818899|NCT03097861|9639619|P3|Overall Study|Withdrawal by Subject|3
2818900|NCT03097861|9639620|P2|Overall Study|Withdrawal by Subject|5
2818901|NCT03097861|9639621|P1|Overall Study|Withdrawal by Subject|1
2818902|NCT03097861|9639619|P3|Overall Study|Lost to Follow-up|1
2818903|NCT03097861|9639620|P2|Overall Study|Lost to Follow-up|7
2818904|NCT03097861|9639621|P1|Overall Study|Lost to Follow-up|0
2818905|NCT03097861|9639619|P3|Overall Study|Investigator Decision|0
2818906|NCT03097861|9639620|P2|Overall Study|Investigator Decision|1
2818907|NCT03097861|9639621|P1|Overall Study|Investigator Decision|0
2818908|NCT03097861|9639619|P3|Overall Study|Adverse Event|4
2818909|NCT03097861|9639620|P2|Overall Study|Adverse Event|8
2818910|NCT03097861|9639621|P1|Overall Study|Adverse Event|3
2818911|NCT03097614|9639638|P1|Overall Study|Adverse Event|3
2818912|NCT03097289|9639740|P1|Overall Study|Collected platelet product unusable|3
2818913|NCT03097289|9639740|P1|Overall Study|Equipment failure|2
2818914|NCT03097289|9639740|P1|Overall Study|Adverse Event|1
2818915|NCT03097029|9639747|P1|Overall Study|Withdrawal by Subject|1
2818916|NCT03096483|9639791|P1|Overall Study|Withdrawal by site|1
2818917|NCT03096314|9639820|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
2818918|NCT03096314|9639821|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
2818919|NCT03095651|9639883|P8|Overall Study|Withdrawal by Subject|0
2818920|NCT03095651|9639884|P7|Overall Study|Withdrawal by Subject|0
2818921|NCT03095651|9639885|P6|Overall Study|Withdrawal by Subject|1
2818922|NCT03095651|9639886|P5|Overall Study|Withdrawal by Subject|0
2818923|NCT03095651|9639887|P4|Overall Study|Withdrawal by Subject|0
2818924|NCT03095651|9639888|P3|Overall Study|Withdrawal by Subject|0
2818925|NCT03095651|9639889|P2|Overall Study|Withdrawal by Subject|0
2818926|NCT03095651|9639890|P1|Overall Study|Withdrawal by Subject|0
2818927|NCT03095651|9639883|P8|Overall Study|Lost to Follow-up|0
2818928|NCT03095651|9639884|P7|Overall Study|Lost to Follow-up|0
2818929|NCT03095651|9639885|P6|Overall Study|Lost to Follow-up|0
2818930|NCT03095651|9639886|P5|Overall Study|Lost to Follow-up|0
2818931|NCT03095651|9639887|P4|Overall Study|Lost to Follow-up|1
2818932|NCT03095651|9639888|P3|Overall Study|Lost to Follow-up|0
2818933|NCT03095651|9639889|P2|Overall Study|Lost to Follow-up|1
2818934|NCT03095651|9639890|P1|Overall Study|Lost to Follow-up|1
2818935|NCT03095599|9640169|P2|Overall Study|Withdrawal prior to vaccination|0
2818936|NCT03095599|9640170|P1|Overall Study|Withdrawal prior to vaccination|1
2818937|NCT03095599|9640169|P2|Overall Study|Lost to Follow-up|0
2818938|NCT03095599|9640170|P1|Overall Study|Lost to Follow-up|1
2818939|NCT03095599|9640169|P2|Overall Study|Withdrawal by Subject|0
2818940|NCT03095599|9640170|P1|Overall Study|Withdrawal by Subject|1
2818941|NCT03095521|9640206|P2|Overall Study|Lost to Follow-up|1
2818942|NCT03095521|9640207|P1|Overall Study|Lost to Follow-up|0
2818943|NCT03095521|9640206|P2|Overall Study|Withdrawal by Subject|1
2818944|NCT03095521|9640207|P1|Overall Study|Withdrawal by Subject|0
2818945|NCT03095508|9640225|P2|Overall Study|Adverse Event|1
2818946|NCT03095508|9640226|P1|Overall Study|Adverse Event|0
2818947|NCT03095027|9640274|P2|Period 2, Second Week of Wear|Adverse Event|0
2818948|NCT03095027|9640275|P1|Period 2, Second Week of Wear|Adverse Event|1
2818949|NCT03094195|9640311|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818950|NCT03094195|9640312|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818951|NCT03094195|9640313|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818952|NCT03094195|9640314|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818953|NCT03094195|9640315|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818954|NCT03094195|9640316|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
2818955|NCT03094195|9640317|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
2818956|NCT03094195|9640318|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
2818957|NCT03094195|9640311|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
2818958|NCT03094195|9640312|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
2818959|NCT03094195|9640313|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
2818960|NCT03094195|9640314|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
2818961|NCT03094195|9640315|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
2818962|NCT03094195|9640316|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
2818963|NCT03094195|9640317|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
2818964|NCT03094195|9640318|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
2818965|NCT03094195|9640311|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
2818966|NCT03094195|9640312|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
2818967|NCT03094195|9640313|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
2818968|NCT03094195|9640314|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
2818969|NCT03094195|9640315|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
2818970|NCT03094195|9640316|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
2818971|NCT03094195|9640317|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
2818972|NCT03094195|9640318|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
2818973|NCT03094195|9640311|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2818974|NCT03094195|9640312|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2818975|NCT03094195|9640313|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2818976|NCT03094195|9640314|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2818977|NCT03094195|9640315|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
2818978|NCT03094195|9640316|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
2818979|NCT03094195|9640317|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
2818980|NCT03094195|9640318|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
2818981|NCT03093350|9640364|P1|Overall Study|Signed consent, never began treartment|1
2818982|NCT03093350|9640364|P1|Overall Study|Death|1
2818983|NCT03093181|9640382|P3|Overall Study|Other (Protocol violation)|1
2818984|NCT03093181|9640383|P2|Overall Study|Other (Protocol violation)|0
2818985|NCT03093181|9640384|P1|Overall Study|Other (Protocol violation)|0
2818986|NCT03093181|9640382|P3|Overall Study|Adverse Event|0
2818987|NCT03093181|9640383|P2|Overall Study|Adverse Event|1
2818988|NCT03093181|9640384|P1|Overall Study|Adverse Event|0
2818989|NCT03093181|9640382|P3|Overall Study|Other (Not specified)|0
2818990|NCT03093181|9640383|P2|Overall Study|Other (Not specified)|0
2818991|NCT03093181|9640384|P1|Overall Study|Other (Not specified)|1
2818992|NCT03093181|9640382|P3|Overall Study|Withdrawal by Subject|2
2818993|NCT03093181|9640383|P2|Overall Study|Withdrawal by Subject|1
2818994|NCT03093181|9640384|P1|Overall Study|Withdrawal by Subject|2
2818995|NCT03092791|9640446|P8|Overall Study|Reason Not Specified|0
2818996|NCT03092791|9640447|P7|Overall Study|Reason Not Specified|0
2818997|NCT03092791|9640448|P6|Overall Study|Reason Not Specified|1
2818998|NCT03092791|9640449|P5|Overall Study|Reason Not Specified|1
2818999|NCT03092791|9640450|P4|Overall Study|Reason Not Specified|0
2819000|NCT03092791|9640451|P3|Overall Study|Reason Not Specified|0
2819001|NCT03092791|9640452|P2|Overall Study|Reason Not Specified|0
2819002|NCT03092791|9640453|P1|Overall Study|Reason Not Specified|0
2819003|NCT03092791|9640446|P8|Overall Study|Death|1
2819004|NCT03092791|9640447|P7|Overall Study|Death|0
2819005|NCT03092791|9640448|P6|Overall Study|Death|1
2819006|NCT03092791|9640449|P5|Overall Study|Death|0
2819007|NCT03092791|9640450|P4|Overall Study|Death|0
2819008|NCT03092791|9640451|P3|Overall Study|Death|0
2819009|NCT03092791|9640452|P2|Overall Study|Death|0
2819010|NCT03092791|9640453|P1|Overall Study|Death|0
2819011|NCT03092791|9640446|P8|Overall Study|Study Termination|55
2819012|NCT03092791|9640447|P7|Overall Study|Study Termination|53
2819013|NCT03092791|9640448|P6|Overall Study|Study Termination|46
2819014|NCT03092791|9640449|P5|Overall Study|Study Termination|55
2819015|NCT03092791|9640450|P4|Overall Study|Study Termination|0
2819016|NCT03092791|9640451|P3|Overall Study|Study Termination|0
2819017|NCT03092791|9640452|P2|Overall Study|Study Termination|0
2819018|NCT03092791|9640453|P1|Overall Study|Study Termination|0
2819019|NCT03092791|9640446|P8|Overall Study|Withdrawal of Consent|4
2819020|NCT03092791|9640447|P7|Overall Study|Withdrawal of Consent|6
2819021|NCT03092791|9640448|P6|Overall Study|Withdrawal of Consent|12
2819022|NCT03092791|9640449|P5|Overall Study|Withdrawal of Consent|4
2819023|NCT03092791|9640450|P4|Overall Study|Withdrawal of Consent|0
2819024|NCT03092791|9640451|P3|Overall Study|Withdrawal of Consent|0
2819025|NCT03092791|9640452|P2|Overall Study|Withdrawal of Consent|0
2819026|NCT03092791|9640453|P1|Overall Study|Withdrawal of Consent|0
2819027|NCT03092791|9640446|P8|Overall Study|Lost to Follow-up|0
2819028|NCT03092791|9640447|P7|Overall Study|Lost to Follow-up|1
2819029|NCT03092791|9640448|P6|Overall Study|Lost to Follow-up|0
2819030|NCT03092791|9640449|P5|Overall Study|Lost to Follow-up|0
2819031|NCT03092791|9640450|P4|Overall Study|Lost to Follow-up|0
2819032|NCT03092791|9640451|P3|Overall Study|Lost to Follow-up|0
2819033|NCT03092791|9640452|P2|Overall Study|Lost to Follow-up|0
2819034|NCT03092791|9640453|P1|Overall Study|Lost to Follow-up|0
2819035|NCT03092752|9640568|P1|Overall Study|<6 month history|245900
2819036|NCT03092752|9640568|P1|Overall Study|Average hospital visit interval >92 days|10779
2819037|NCT03092752|9640568|P1|Overall Study|Having no claim of study drugs|29282
2819038|NCT03092752|9640568|P1|Overall Study|At least one claim with T2DM|61299
2819039|NCT03092752|9640568|P1|Overall Study|Aged <40 years|14209
2819040|NCT03092726|9640633|P2|Overall Study|Withdrawal by Subject|3
2819041|NCT03092726|9640634|P1|Overall Study|Withdrawal by Subject|5
2819042|NCT03092726|9640633|P2|Overall Study|Lost to Follow-up|0
2819043|NCT03092726|9640634|P1|Overall Study|Lost to Follow-up|1
2819044|NCT03092726|9640633|P2|Overall Study|Lack of Efficacy|1
2819045|NCT03092726|9640634|P1|Overall Study|Lack of Efficacy|0
2819046|NCT03092726|9640633|P2|Overall Study|Adverse Event|10
2819047|NCT03092726|9640634|P1|Overall Study|Adverse Event|3
2819048|NCT03092479|9640660|P2|Overall Study|Withdrawal by Subject|0
2819049|NCT03092479|9640661|P1|Overall Study|Withdrawal by Subject|4
2819050|NCT03092479|9640660|P2|Overall Study|Lost to Follow-up|2
2819051|NCT03092479|9640661|P1|Overall Study|Lost to Follow-up|3
2819052|NCT03092375|9640683|P4|Overall Study|Lack of Efficacy|0
2819053|NCT03092375|9640684|P3|Overall Study|Lack of Efficacy|1
2819054|NCT03092375|9640685|P2|Overall Study|Lack of Efficacy|1
2819055|NCT03092375|9640686|P1|Overall Study|Lack of Efficacy|0
2819056|NCT03091777|9640715|P3|Overall Study|Abnormal Laboratory Value|12
2819057|NCT03091777|9640716|P2|Overall Study|Abnormal Laboratory Value|11
2819058|NCT03091777|9640717|P1|Overall Study|Abnormal Laboratory Value|7
2819059|NCT03091777|9640715|P3|Overall Study|Physician Decision|1
2819060|NCT03091777|9640716|P2|Overall Study|Physician Decision|0
2819061|NCT03091777|9640717|P1|Overall Study|Physician Decision|1
2819062|NCT03091777|9640715|P3|Overall Study|Noncompliance with study drug|1
2819063|NCT03091777|9640716|P2|Overall Study|Noncompliance with study drug|3
2819064|NCT03091777|9640717|P1|Overall Study|Noncompliance with study drug|2
2819065|NCT03091777|9640715|P3|Overall Study|Lack of Efficacy|5
2819066|NCT03091777|9640716|P2|Overall Study|Lack of Efficacy|0
2819067|NCT03091777|9640717|P1|Overall Study|Lack of Efficacy|0
2819068|NCT03091777|9640715|P3|Overall Study|Lost to Follow-up|7
2819069|NCT03091777|9640716|P2|Overall Study|Lost to Follow-up|14
2819070|NCT03091777|9640717|P1|Overall Study|Lost to Follow-up|12
2819071|NCT03091777|9640715|P3|Overall Study|Protocol Violation|1
2819072|NCT03091777|9640716|P2|Overall Study|Protocol Violation|1
2819073|NCT03091777|9640717|P1|Overall Study|Protocol Violation|2
2819074|NCT03091777|9640715|P3|Overall Study|Withdrawal by Subject|6
2819075|NCT03091777|9640716|P2|Overall Study|Withdrawal by Subject|2
2819076|NCT03091777|9640717|P1|Overall Study|Withdrawal by Subject|4
2819077|NCT03091777|9640715|P3|Overall Study|Adverse Event|4
2819078|NCT03091777|9640716|P2|Overall Study|Adverse Event|1
2819079|NCT03091777|9640717|P1|Overall Study|Adverse Event|2
2819080|NCT03091777|9640715|P3|Overall Study|Pregnancy|0
2819081|NCT03091777|9640716|P2|Overall Study|Pregnancy|1
2819082|NCT03091777|9640717|P1|Overall Study|Pregnancy|2
2819083|NCT03091439|9640759|P2|Overall Study|Study Terminated by the Sponsor|0
2819084|NCT03091439|9640760|P1|Overall Study|Study Terminated by the Sponsor|1
2819085|NCT03091400|9640784|P2|Washout - 2 Weeks|Withdrawal by Subject|0
2819086|NCT03091400|9640785|P1|Washout - 2 Weeks|Withdrawal by Subject|1
2819087|NCT03091348|9640807|P2|Overall Study|Lost to Follow-up|1
2819088|NCT03091348|9640808|P1|Overall Study|Lost to Follow-up|2
2819089|NCT03090100|9640884|P2|Overall Study|Other|2
2819090|NCT03090100|9640885|P1|Overall Study|Other|2
2819091|NCT03090100|9640884|P2|Overall Study|Non-compliance|0
2819092|NCT03090100|9640885|P1|Overall Study|Non-compliance|2
2819093|NCT03090100|9640884|P2|Overall Study|Protocol Violation|6
2819094|NCT03090100|9640885|P1|Overall Study|Protocol Violation|2
2819095|NCT03090100|9640884|P2|Overall Study|Withdrawal by Subject|19
2819096|NCT03090100|9640885|P1|Overall Study|Withdrawal by Subject|7
2819097|NCT03090100|9640884|P2|Overall Study|Lost to Follow-up|2
2819098|NCT03090100|9640885|P1|Overall Study|Lost to Follow-up|2
2819099|NCT03090100|9640884|P2|Overall Study|Lack of Efficacy|7
2819100|NCT03090100|9640885|P1|Overall Study|Lack of Efficacy|2
2819101|NCT03090100|9640884|P2|Overall Study|Pregnancy|1
2819102|NCT03090100|9640885|P1|Overall Study|Pregnancy|1
2819103|NCT03090100|9640884|P2|Overall Study|Adverse Event|11
2819104|NCT03090100|9640885|P1|Overall Study|Adverse Event|9
2819105|NCT03089580|9640959|P1|Overall Study|Lost to Follow-up|2
2819106|NCT03089216|9640970|P4|Overall Study|Adverse Event|1
2819107|NCT03089216|9640971|P3|Overall Study|Adverse Event|0
2819108|NCT03089216|9640972|P2|Overall Study|Adverse Event|0
2819109|NCT03089216|9640973|P1|Overall Study|Adverse Event|0
2819110|NCT03088917|9640987|P1|Overall Study|Moved outside study region|50
2819111|NCT03088917|9640987|P1|Overall Study|Severe comorbidity/short life expectancy|5
2819112|NCT03088917|9640987|P1|Overall Study|Contact not established|13
2819113|NCT03088917|9640987|P1|Overall Study|Refuse re-evaluation|13
2819114|NCT03088917|9640987|P1|Overall Study|In care/cured elsewhere|15
2819115|NCT03087643|9641038|P2|Overall Study|Death|2
2819116|NCT03087643|9641039|P1|Overall Study|Death|2
2819117|NCT03087643|9641038|P2|Overall Study|Withdrawal by Subject|4
2819118|NCT03087643|9641039|P1|Overall Study|Withdrawal by Subject|2
2819119|NCT03086551|9641068|P2|Washout|Withdrawal by Subject|1
2819120|NCT03086551|9641069|P1|Washout|Withdrawal by Subject|2
2819121|NCT03086551|9641068|P2|Washout|Lost to Follow-up|2
2819122|NCT03086551|9641069|P1|Washout|Lost to Follow-up|1
2819123|NCT03086551|9641068|P2|First Intervention|Lost to Follow-up|1
2819124|NCT03086551|9641069|P1|First Intervention|Lost to Follow-up|0
2819125|NCT03086551|9641068|P2|First Intervention|Failure to meet inclusion criterion|0
2819126|NCT03086551|9641069|P1|First Intervention|Failure to meet inclusion criterion|1
2819127|NCT03086447|9641085|P2|Overall Study|Lens Discomfort|1
2819128|NCT03086447|9641086|P1|Overall Study|Lens Discomfort|2
2819129|NCT03086447|9641085|P2|Overall Study|Adverse Event|0
2819130|NCT03086447|9641086|P1|Overall Study|Adverse Event|3
2819131|NCT03086447|9641085|P2|Overall Study|Lost to Follow-up|1
2819132|NCT03086447|9641086|P1|Overall Study|Lost to Follow-up|0
2819133|NCT03086447|9641085|P2|Overall Study|Protocol Violation|4
2819134|NCT03086447|9641086|P1|Overall Study|Protocol Violation|2
2819135|NCT03086447|9641085|P2|Overall Study|Test Article No Longer Available|0
2819136|NCT03086447|9641086|P1|Overall Study|Test Article No Longer Available|1
2819137|NCT03086447|9641085|P2|Overall Study|Unsatisfactory Lens Fitting|1
2819138|NCT03086447|9641086|P1|Overall Study|Unsatisfactory Lens Fitting|0
2819139|NCT03086447|9641085|P2|Overall Study|Lens Damage|6
2819140|NCT03086447|9641086|P1|Overall Study|Lens Damage|1
2819141|NCT03086447|9641085|P2|Overall Study|Product quality complaint|1
2819142|NCT03086447|9641086|P1|Overall Study|Product quality complaint|0
2819143|NCT03086447|9641085|P2|Overall Study|Lost Lens|5
2819144|NCT03086447|9641086|P1|Overall Study|Lost Lens|2
2819145|NCT03086447|9641085|P2|Overall Study|No Longer Meets Eligibility Criteria|1
2819146|NCT03086447|9641086|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2819147|NCT03086330|9641117|P2|Overall Study|Lost to Follow-up|2
2819148|NCT03086330|9641118|P1|Overall Study|Lost to Follow-up|1
2819149|NCT03086330|9641117|P2|Overall Study|Withdrawal by Subject|2
2819150|NCT03086330|9641118|P1|Overall Study|Withdrawal by Subject|3
2819151|NCT03086135|9641315|P1|Overall Study|Lost to Follow-up|2
2819152|NCT03086135|9641315|P1|Overall Study|Adverse Event|1
2819153|NCT03086018|9641342|P1|Final Testing for End of Trial|Withdrawal by Subject|1
2819154|NCT03086018|9641342|P1|Final Testing for End of Trial|Adverse Event|1
2819155|NCT03085914|9641357|P7|Overall Study|Ongoing in Trial|3
2819156|NCT03085914|9641358|P6|Overall Study|Ongoing in Trial|3
2819157|NCT03085914|9641359|P5|Overall Study|Ongoing in Trial|4
2819158|NCT03085914|9641360|P4|Overall Study|Ongoing in Trial|3
2819159|NCT03085914|9641361|P3|Overall Study|Ongoing in Trial|5
2819160|NCT03085914|9641362|P2|Overall Study|Ongoing in Trial|0
2819161|NCT03085914|9641363|P1|Overall Study|Ongoing in Trial|1
2819162|NCT03085914|9641357|P7|Overall Study|Other Unspecified|4
2819163|NCT03085914|9641358|P6|Overall Study|Other Unspecified|2
2819164|NCT03085914|9641359|P5|Overall Study|Other Unspecified|2
2819165|NCT03085914|9641360|P4|Overall Study|Other Unspecified|3
2819166|NCT03085914|9641361|P3|Overall Study|Other Unspecified|1
2819167|NCT03085914|9641362|P2|Overall Study|Other Unspecified|2
2819168|NCT03085914|9641363|P1|Overall Study|Other Unspecified|2
2819169|NCT03085914|9641357|P7|Overall Study|Withdrawal by Subject|1
2819170|NCT03085914|9641358|P6|Overall Study|Withdrawal by Subject|0
2819171|NCT03085914|9641359|P5|Overall Study|Withdrawal by Subject|2
2819172|NCT03085914|9641360|P4|Overall Study|Withdrawal by Subject|2
2819173|NCT03085914|9641361|P3|Overall Study|Withdrawal by Subject|0
2819174|NCT03085914|9641362|P2|Overall Study|Withdrawal by Subject|1
2819175|NCT03085914|9641363|P1|Overall Study|Withdrawal by Subject|1
2819176|NCT03085914|9641357|P7|Overall Study|Lost to Follow-up|1
2819177|NCT03085914|9641358|P6|Overall Study|Lost to Follow-up|1
2819178|NCT03085914|9641359|P5|Overall Study|Lost to Follow-up|0
2819179|NCT03085914|9641360|P4|Overall Study|Lost to Follow-up|0
2819180|NCT03085914|9641361|P3|Overall Study|Lost to Follow-up|1
2819181|NCT03085914|9641362|P2|Overall Study|Lost to Follow-up|0
2819182|NCT03085914|9641363|P1|Overall Study|Lost to Follow-up|1
2819183|NCT03085914|9641357|P7|Overall Study|Death|2
2819184|NCT03085914|9641358|P6|Overall Study|Death|2
2819185|NCT03085914|9641359|P5|Overall Study|Death|5
2819186|NCT03085914|9641360|P4|Overall Study|Death|1
2819187|NCT03085914|9641361|P3|Overall Study|Death|4
2819188|NCT03085914|9641362|P2|Overall Study|Death|6
2819189|NCT03085914|9641363|P1|Overall Study|Death|4
2819190|NCT03085238|9641445|P1|Overall Study|Death|2
2819191|NCT03085238|9641445|P1|Overall Study|Adverse Event|2
2819192|NCT03084315|9641472|P2|Overall Study|Withdrawal by Subject|2
2819193|NCT03084315|9641473|P1|Overall Study|Withdrawal by Subject|2
2819194|NCT03084315|9641472|P2|Overall Study|Lost to Follow-up|7
2819195|NCT03084315|9641473|P1|Overall Study|Lost to Follow-up|8
2819196|NCT03083639|9641496|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
2819197|NCT03083639|9641497|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
2819198|NCT03083639|9641496|P2|Washout Period (at Least 6 Days)|Pregnancy|1
2819199|NCT03083639|9641497|P1|Washout Period (at Least 6 Days)|Pregnancy|0
2819200|NCT03083483|9641510|P3|Overall Study|technological issues|1
2819201|NCT03083483|9641511|P2|Overall Study|technological issues|0
2819202|NCT03083483|9641512|P1|Overall Study|technological issues|1
2819203|NCT03083483|9641510|P3|Overall Study|Lost to Follow-up|1
2819204|NCT03083483|9641511|P2|Overall Study|Lost to Follow-up|1
2819205|NCT03083483|9641512|P1|Overall Study|Lost to Follow-up|2
2819206|NCT03083483|9641510|P3|Overall Study|Adverse Event|1
2819207|NCT03083483|9641511|P2|Overall Study|Adverse Event|1
2819208|NCT03083483|9641512|P1|Overall Study|Adverse Event|1
2819209|NCT03083470|9641531|P5|Overall Study|Withdrawal by Subject|1
2819210|NCT03083470|9641532|P4|Overall Study|Withdrawal by Subject|0
2819211|NCT03083470|9641533|P3|Overall Study|Withdrawal by Subject|0
2819212|NCT03083470|9641534|P2|Overall Study|Withdrawal by Subject|0
2819213|NCT03083470|9641535|P1|Overall Study|Withdrawal by Subject|0
2819214|NCT03083470|9641531|P5|Overall Study|Lost to Follow-up|1
2819215|NCT03083470|9641532|P4|Overall Study|Lost to Follow-up|0
2819216|NCT03083470|9641533|P3|Overall Study|Lost to Follow-up|0
2819217|NCT03083470|9641534|P2|Overall Study|Lost to Follow-up|0
2819218|NCT03083470|9641535|P1|Overall Study|Lost to Follow-up|0
2819219|NCT03082599|9641583|P2|Overall Study|Lost to Follow-up|0
2819220|NCT03082599|9641584|P1|Overall Study|Lost to Follow-up|1
2819221|NCT03080961|9641610|P1|Overall Study|Withdrawal by Subject|3
2819222|NCT03080493|9641621|P2|Overall Study|Randomization error (parity group)|1
2819223|NCT03080493|9641622|P1|Overall Study|Randomization error (parity group)|0
2819224|NCT03080493|9641621|P2|Overall Study|Adverse Event|1
2819225|NCT03080493|9641622|P1|Overall Study|Adverse Event|0
2819226|NCT03080493|9641621|P2|Overall Study|Did not provide NRS pain results|0
2819227|NCT03080493|9641622|P1|Overall Study|Did not provide NRS pain results|1
2819228|NCT03080454|9641638|P1|Anodal FU (7 Days)|Lost to Follow-up|4
2819229|NCT03080454|9641638|P1|Anodal Doublestim (5 Days)|Adverse Event|1
2819230|NCT03080454|9641638|P1|Baseline|Adverse Event|2
2819231|NCT03078582|9641729|P2|Overall Study|Adverse Event|8
2819232|NCT03078582|9641730|P1|Overall Study|Adverse Event|0
2819233|NCT03078556|9641750|P4|Washout Period 1 (7 Days)|Physician Decision|0
2819234|NCT03078556|9641751|P3|Washout Period 1 (7 Days)|Physician Decision|0
2819235|NCT03078556|9641752|P2|Washout Period 1 (7 Days)|Physician Decision|1
2819236|NCT03078556|9641753|P1|Washout Period 1 (7 Days)|Physician Decision|0
2819237|NCT03078556|9641750|P4|Washout Period 1 (7 Days)|Adverse Event|1
2819238|NCT03078556|9641751|P3|Washout Period 1 (7 Days)|Adverse Event|0
2819239|NCT03078556|9641752|P2|Washout Period 1 (7 Days)|Adverse Event|1
2819240|NCT03078556|9641753|P1|Washout Period 1 (7 Days)|Adverse Event|0
2819241|NCT03078556|9641750|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
2819242|NCT03078556|9641751|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
2819243|NCT03078556|9641752|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
2819244|NCT03078556|9641753|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
2819245|NCT03078556|9641750|P4|Treatment Period 1 (4 Days)|Adverse Event|0
2819246|NCT03078556|9641751|P3|Treatment Period 1 (4 Days)|Adverse Event|0
2819247|NCT03078556|9641752|P2|Treatment Period 1 (4 Days)|Adverse Event|1
2819248|NCT03078556|9641753|P1|Treatment Period 1 (4 Days)|Adverse Event|0
2819249|NCT03078478|9641897|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
2819250|NCT03078478|9641898|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
2819251|NCT03078478|9641897|P2|Maintencance Period 2 (36 Weeks)|Death|6
2819252|NCT03078478|9641898|P1|Maintencance Period 2 (36 Weeks)|Death|4
2819253|NCT03078478|9641897|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
2819254|NCT03078478|9641898|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
2819255|NCT03078478|9641897|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
2819256|NCT03078478|9641898|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
2819257|NCT03078478|9641897|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
2819258|NCT03078478|9641898|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
2819259|NCT03078478|9641897|P2|Maintenance Period 1 (36 Weeks)|Death|3
2819260|NCT03078478|9641898|P1|Maintenance Period 1 (36 Weeks)|Death|3
2819261|NCT03078478|9641897|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
2819262|NCT03078478|9641898|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
2819263|NCT03078478|9641897|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
2819264|NCT03078478|9641898|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
2819265|NCT03077919|9641984|P2|Overall Study|Lost to Follow-up|1
2819266|NCT03077919|9641985|P1|Overall Study|Lost to Follow-up|4
2819267|NCT03077724|9642045|P2|Overall Study|Withdrawal by Subject|1
2819268|NCT03077724|9642046|P1|Overall Study|Withdrawal by Subject|3
2819269|NCT03077724|9642045|P2|Overall Study|Lost to Follow-up|1
2819270|NCT03077724|9642046|P1|Overall Study|Lost to Follow-up|5
2819271|NCT03077711|9642058|P2|Overall Study|noncompliant taking medication|0
2819272|NCT03077711|9642059|P1|Overall Study|noncompliant taking medication|2
2819273|NCT03077711|9642058|P2|Overall Study|Lost to Follow-up|2
2819274|NCT03077711|9642059|P1|Overall Study|Lost to Follow-up|2
2819275|NCT03077659|9642078|P3|Overall Study|Withdrawal by Subject|1
2819276|NCT03077659|9642079|P2|Overall Study|Withdrawal by Subject|0
2819277|NCT03077659|9642080|P1|Overall Study|Withdrawal by Subject|0
2819278|NCT03077607|9642111|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2819279|NCT03077607|9642112|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2819280|NCT03077607|9642111|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
2819281|NCT03077607|9642112|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
2819282|NCT03077607|9642111|P2|Period 1 (15 Days)|Death|0
2819283|NCT03077607|9642112|P1|Period 1 (15 Days)|Death|1
2819284|NCT03077607|9642111|P2|Period 1 (15 Days)|Adverse Event|0
2819285|NCT03077607|9642112|P1|Period 1 (15 Days)|Adverse Event|1
2819286|NCT03076996|9642178|P1|Overall Study|Literacy precluded participation|1
2819287|NCT03076996|9642178|P1|Overall Study|Lost to Follow-up|3
2819288|NCT03076996|9642178|P1|Overall Study|Withdrawal by Subject|2
2819289|NCT03076970|9642204|P6|Period 3|Failure to meet I/E criteria|0
2819290|NCT03076970|9642205|P5|Period 3|Failure to meet I/E criteria|1
2819291|NCT03076970|9642206|P4|Period 3|Failure to meet I/E criteria|0
2819292|NCT03076970|9642207|P3|Period 3|Failure to meet I/E criteria|0
2819293|NCT03076970|9642208|P2|Period 3|Failure to meet I/E criteria|0
2819294|NCT03076970|9642209|P1|Period 3|Failure to meet I/E criteria|0
2819295|NCT03076970|9642204|P6|Period 3|Withdrawal by Subject|1
2819296|NCT03076970|9642205|P5|Period 3|Withdrawal by Subject|0
2819297|NCT03076970|9642206|P4|Period 3|Withdrawal by Subject|0
2819298|NCT03076970|9642207|P3|Period 3|Withdrawal by Subject|0
2819299|NCT03076970|9642208|P2|Period 3|Withdrawal by Subject|0
2819300|NCT03076970|9642209|P1|Period 3|Withdrawal by Subject|0
2819301|NCT03076970|9642204|P6|Washout Period 2|Adverse Event|0
2819302|NCT03076970|9642205|P5|Washout Period 2|Adverse Event|1
2819303|NCT03076970|9642206|P4|Washout Period 2|Adverse Event|0
2819304|NCT03076970|9642207|P3|Washout Period 2|Adverse Event|0
2819305|NCT03076970|9642208|P2|Washout Period 2|Adverse Event|0
2819306|NCT03076970|9642209|P1|Washout Period 2|Adverse Event|0
2819307|NCT03076190|9642261|P2|Overall Study|Excluded from Analysis (zero duration ev|7
2819308|NCT03076190|9642262|P1|Overall Study|Excluded from Analysis (zero duration ev|9
2819309|NCT03076190|9642261|P2|Overall Study|Lost to Follow-up|34
2819310|NCT03076190|9642262|P1|Overall Study|Lost to Follow-up|9
2819311|NCT03075904|9642275|P1|Overall Study|Need for Medication not Permitted|1
2819312|NCT03075904|9642275|P1|Overall Study|Physician Decision|3
2819313|NCT03075891|9642285|P2|Overall Study|Drug abuse relapse issue|1
2819314|NCT03075891|9642286|P1|Overall Study|Drug abuse relapse issue|0
2819315|NCT03075891|9642285|P2|Overall Study|Patient requiring study withdrawal|1
2819316|NCT03075891|9642286|P1|Overall Study|Patient requiring study withdrawal|0
2819317|NCT03075891|9642285|P2|Overall Study|Other visits not performed (no time)|0
2819318|NCT03075891|9642286|P1|Overall Study|Other visits not performed (no time)|1
2819319|NCT03075891|9642285|P2|Overall Study|Pregnancy|1
2819320|NCT03075891|9642286|P1|Overall Study|Pregnancy|3
2819321|NCT03075891|9642285|P2|Overall Study|Lost to Follow-up|0
2819322|NCT03075891|9642286|P1|Overall Study|Lost to Follow-up|1
2819323|NCT03075891|9642285|P2|Overall Study|Withdrawal by Subject|6
2819324|NCT03075891|9642286|P1|Overall Study|Withdrawal by Subject|3
2819325|NCT03075891|9642285|P2|Overall Study|Adverse Event|4
2819326|NCT03075891|9642286|P1|Overall Study|Adverse Event|1
2819327|NCT03075878|9642292|P1|Overall Study|Physician Decision|1
2819328|NCT03075839|9642300|P1|Overall Study|Lost to Follow-up|4
2819329|NCT03075527|9642315|P1|Overall Study|Ongoing treatment|2
2819330|NCT03075410|9642339|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819331|NCT03075410|9642340|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819332|NCT03075410|9642341|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819333|NCT03075410|9642342|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819334|NCT03075410|9642343|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819335|NCT03075410|9642344|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819336|NCT03075410|9642345|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819337|NCT03075410|9642346|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2819338|NCT03075410|9642347|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
2819339|NCT03075410|9642339|P9|Part A-Period 2 (14 Days)|Personal reasons|0
2819340|NCT03075410|9642340|P8|Part A-Period 2 (14 Days)|Personal reasons|0
2819341|NCT03075410|9642341|P7|Part A-Period 2 (14 Days)|Personal reasons|0
2819342|NCT03075410|9642342|P6|Part A-Period 2 (14 Days)|Personal reasons|0
2819343|NCT03075410|9642343|P5|Part A-Period 2 (14 Days)|Personal reasons|0
2819344|NCT03075410|9642344|P4|Part A-Period 2 (14 Days)|Personal reasons|0
2819345|NCT03075410|9642345|P3|Part A-Period 2 (14 Days)|Personal reasons|1
2819346|NCT03075410|9642346|P2|Part A-Period 2 (14 Days)|Personal reasons|0
2819347|NCT03075410|9642347|P1|Part A-Period 2 (14 Days)|Personal reasons|1
2819348|NCT03075163|9642513|P2|Overall Study|not eligible for treatment limb|138
2819349|NCT03075163|9642514|P1|Overall Study|not eligible for treatment limb|138
2819350|NCT03074500|9642545|P3|Overall Study|Adverse Event|1
2819351|NCT03074500|9642546|P2|Overall Study|Adverse Event|0
2819352|NCT03074500|9642547|P1|Overall Study|Adverse Event|0
2819353|NCT03074500|9642545|P3|Overall Study|Lack of Efficacy|0
2819354|NCT03074500|9642546|P2|Overall Study|Lack of Efficacy|1
2819355|NCT03074500|9642547|P1|Overall Study|Lack of Efficacy|0
2819356|NCT03074500|9642545|P3|Overall Study|Lost to Follow-up|0
2819357|NCT03074500|9642546|P2|Overall Study|Lost to Follow-up|0
2819358|NCT03074500|9642547|P1|Overall Study|Lost to Follow-up|1
2819359|NCT03074331|9642584|P1|Overall Study|Withdrew Consent|1
2819360|NCT03074331|9642584|P1|Overall Study|Lost to Follow-up|5
2819361|NCT03074331|9642584|P1|Overall Study|Enrolled but Not Treated|1
2819362|NCT03074162|9642596|P6|Period 3|Withdrawal by Subject|0
2819363|NCT03074162|9642597|P5|Period 3|Withdrawal by Subject|1
2819364|NCT03074162|9642598|P4|Period 3|Withdrawal by Subject|0
2819365|NCT03074162|9642599|P3|Period 3|Withdrawal by Subject|0
2819366|NCT03074162|9642600|P2|Period 3|Withdrawal by Subject|0
2819367|NCT03074162|9642601|P1|Period 3|Withdrawal by Subject|1
2819368|NCT03074162|9642596|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
2819369|NCT03074162|9642597|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
2819370|NCT03074162|9642598|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
2819371|NCT03074162|9642599|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
2819372|NCT03074162|9642600|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
2819373|NCT03074162|9642601|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
2819374|NCT03074162|9642596|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
2819375|NCT03074162|9642597|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
2819376|NCT03074162|9642598|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
2819377|NCT03074162|9642599|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
2819378|NCT03074162|9642600|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
2819379|NCT03074162|9642601|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
2819380|NCT03073798|9642663|P1|Overall Study|Withdrawal by Subject|1
2819381|NCT03073798|9642663|P1|Overall Study|Adverse Event|1
2819382|NCT03073200|9642690|P3|Overall Study|Lack of Efficacy|0
2819383|NCT03073200|9642691|P2|Overall Study|Lack of Efficacy|0
2819384|NCT03073200|9642692|P1|Overall Study|Lack of Efficacy|1
2819385|NCT03073200|9642690|P3|Overall Study|Protocol Violation|0
2819386|NCT03073200|9642691|P2|Overall Study|Protocol Violation|0
2819387|NCT03073200|9642692|P1|Overall Study|Protocol Violation|2
2819388|NCT03073200|9642690|P3|Overall Study|Site closed by sponsor|1
2819389|NCT03073200|9642691|P2|Overall Study|Site closed by sponsor|0
2819390|NCT03073200|9642692|P1|Overall Study|Site closed by sponsor|0
2819391|NCT03073200|9642690|P3|Overall Study|Withdrawal by parent/guardian|1
2819392|NCT03073200|9642691|P2|Overall Study|Withdrawal by parent/guardian|1
2819393|NCT03073200|9642692|P1|Overall Study|Withdrawal by parent/guardian|0
2819394|NCT03073200|9642690|P3|Overall Study|Continuing treatment (Ongoing)|28
2819395|NCT03073200|9642691|P2|Overall Study|Continuing treatment (Ongoing)|106
2819396|NCT03073200|9642692|P1|Overall Study|Continuing treatment (Ongoing)|48
2819397|NCT03073200|9642690|P3|Overall Study|Withdrawal by Subject|0
2819398|NCT03073200|9642691|P2|Overall Study|Withdrawal by Subject|3
2819399|NCT03073200|9642692|P1|Overall Study|Withdrawal by Subject|3
2819400|NCT03073200|9642690|P3|Overall Study|Participant had Crohns disease|0
2819401|NCT03073200|9642691|P2|Overall Study|Participant had Crohns disease|1
2819402|NCT03073200|9642692|P1|Overall Study|Participant had Crohns disease|0
2819403|NCT03073200|9642690|P3|Overall Study|Lost to Follow-up|0
2819404|NCT03073200|9642691|P2|Overall Study|Lost to Follow-up|2
2819405|NCT03073200|9642692|P1|Overall Study|Lost to Follow-up|1
2819406|NCT03073200|9642690|P3|Overall Study|Adverse Event|0
2819407|NCT03073200|9642691|P2|Overall Study|Adverse Event|2
2819408|NCT03073200|9642692|P1|Overall Study|Adverse Event|0
2819409|NCT03072875|9642728|P1|Overall Study|Lost to Follow-up|1
2819410|NCT03072719|9642735|P2|Overall Study|Adverse Event|1
2819411|NCT03072719|9642736|P1|Overall Study|Adverse Event|1
2819412|NCT03071276|9642761|P1|Overall Study|Lack of Efficacy|14
2819413|NCT03071276|9642761|P1|Overall Study|Adverse Event|1
2819414|NCT03071263|9642769|P2|Overall Study|Participant moved to another city|1
2819415|NCT03071263|9642770|P1|Overall Study|Participant moved to another city|0
2819416|NCT03071263|9642769|P2|Overall Study|Physician Decision|0
2819417|NCT03071263|9642770|P1|Overall Study|Physician Decision|1
2819418|NCT03071263|9642769|P2|Overall Study|Withdrawal by Subject|3
2819419|NCT03071263|9642770|P1|Overall Study|Withdrawal by Subject|1
2819420|NCT03071263|9642769|P2|Overall Study|Adverse Event|3
2819421|NCT03071263|9642770|P1|Overall Study|Adverse Event|1
2819422|NCT03070431|9643004|P1|Overall Study|Lost to Follow-up|2
2819423|NCT03070431|9643004|P1|Overall Study|Withdrawal by Subject|2
2819424|NCT03070171|9643026|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
2819425|NCT03070171|9643027|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
2819426|NCT03070171|9643026|P2|Treatment Period 2 + Washout|Other Adverse Event|1
2819427|NCT03070171|9643027|P1|Treatment Period 2 + Washout|Other Adverse Event|0
2819428|NCT03070002|9643043|P1|Follow up for 2 Years|Death|1
2819429|NCT03069989|9643051|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
2819430|NCT03069989|9643052|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
2819431|NCT03069482|9643159|P2|Overall Study|Physician Decision|0
2819432|NCT03069482|9643160|P1|Overall Study|Physician Decision|1
2819433|NCT03069482|9643159|P2|Overall Study|Lost to Follow-up|1
2819434|NCT03069482|9643160|P1|Overall Study|Lost to Follow-up|0
2819435|NCT03069365|9643270|P1|Overall Study|Adverse Event|1
2819436|NCT03069352|9643278|P2|Overall Study|Ongoing|40
2819437|NCT03069352|9643279|P1|Overall Study|Ongoing|12
2819438|NCT03069313|9643321|P1|Overall Study|Adverse Event|5
2819439|NCT03068767|9643330|P2|Overall Study|Protocol Violation|0
2819440|NCT03068767|9643331|P1|Overall Study|Protocol Violation|3
2819441|NCT03068767|9643330|P2|Overall Study|Lost to Follow-up|3
2819442|NCT03068767|9643331|P1|Overall Study|Lost to Follow-up|7
2819443|NCT03066999|9643382|P2|Overall Study|abnormal urethraBladder neck contracture|2
2819444|NCT03066999|9643383|P1|Overall Study|abnormal urethraBladder neck contracture|0
2819445|NCT03066622|9643403|P2|Overall Study|Withdrawal by Subject|1
2819446|NCT03066622|9643404|P1|Overall Study|Withdrawal by Subject|2
2819447|NCT03066622|9643403|P2|Overall Study|Lost to Follow-up|25
2819448|NCT03066622|9643404|P1|Overall Study|Lost to Follow-up|24
2819449|NCT03066609|9643417|P4|OVERALL STUDY|discontinued follow up|0
2819450|NCT03066609|9643418|P3|OVERALL STUDY|discontinued follow up|0
2819451|NCT03066609|9643419|P2|OVERALL STUDY|discontinued follow up|2
2819452|NCT03066609|9643420|P1|OVERALL STUDY|discontinued follow up|0
2819453|NCT03066609|9643417|P4|OVERALL STUDY|Lack of Efficacy|1
2819454|NCT03066609|9643418|P3|OVERALL STUDY|Lack of Efficacy|1
2819455|NCT03066609|9643419|P2|OVERALL STUDY|Lack of Efficacy|1
2819456|NCT03066609|9643420|P1|OVERALL STUDY|Lack of Efficacy|2
2819457|NCT03066609|9643417|P4|OVERALL STUDY|Pregnancy|0
2819458|NCT03066609|9643418|P3|OVERALL STUDY|Pregnancy|1
2819459|NCT03066609|9643419|P2|OVERALL STUDY|Pregnancy|0
2819460|NCT03066609|9643420|P1|OVERALL STUDY|Pregnancy|1
2819461|NCT03066609|9643417|P4|OVERALL STUDY|Lost to Follow-up|1
2819462|NCT03066609|9643418|P3|OVERALL STUDY|Lost to Follow-up|1
2819463|NCT03066609|9643419|P2|OVERALL STUDY|Lost to Follow-up|1
2819464|NCT03066609|9643420|P1|OVERALL STUDY|Lost to Follow-up|1
2819465|NCT03066609|9643417|P4|OVERALL STUDY|Withdrawal by Subject|2
2819466|NCT03066609|9643418|P3|OVERALL STUDY|Withdrawal by Subject|1
2819467|NCT03066609|9643419|P2|OVERALL STUDY|Withdrawal by Subject|2
2819468|NCT03066609|9643420|P1|OVERALL STUDY|Withdrawal by Subject|4
2819469|NCT03066609|9643417|P4|OVERALL STUDY|Adverse Event|1
2819470|NCT03066609|9643418|P3|OVERALL STUDY|Adverse Event|0
2819471|NCT03066609|9643419|P2|OVERALL STUDY|Adverse Event|2
2819472|NCT03066609|9643420|P1|OVERALL STUDY|Adverse Event|2
2819473|NCT03066609|9643417|P4|MAINTENANCE|Lack of Efficacy|1
2819474|NCT03066609|9643418|P3|MAINTENANCE|Lack of Efficacy|0
2819475|NCT03066609|9643419|P2|MAINTENANCE|Lack of Efficacy|1
2819476|NCT03066609|9643420|P1|MAINTENANCE|Lack of Efficacy|2
2819477|NCT03066609|9643417|P4|MAINTENANCE|Pregnancy|0
2819478|NCT03066609|9643418|P3|MAINTENANCE|Pregnancy|0
2819479|NCT03066609|9643419|P2|MAINTENANCE|Pregnancy|0
2819480|NCT03066609|9643420|P1|MAINTENANCE|Pregnancy|1
2819481|NCT03066609|9643417|P4|MAINTENANCE|Lost to Follow-up|0
2819482|NCT03066609|9643418|P3|MAINTENANCE|Lost to Follow-up|1
2819483|NCT03066609|9643419|P2|MAINTENANCE|Lost to Follow-up|1
2819484|NCT03066609|9643420|P1|MAINTENANCE|Lost to Follow-up|0
2819485|NCT03066609|9643417|P4|MAINTENANCE|Withdrawal by Subject|1
2819486|NCT03066609|9643418|P3|MAINTENANCE|Withdrawal by Subject|1
2819487|NCT03066609|9643419|P2|MAINTENANCE|Withdrawal by Subject|2
2819488|NCT03066609|9643420|P1|MAINTENANCE|Withdrawal by Subject|4
2819489|NCT03066609|9643417|P4|MAINTENANCE|Adverse Event|1
2819490|NCT03066609|9643418|P3|MAINTENANCE|Adverse Event|0
2819491|NCT03066609|9643419|P2|MAINTENANCE|Adverse Event|0
2819492|NCT03066609|9643420|P1|MAINTENANCE|Adverse Event|0
2819493|NCT03066609|9643417|P4|INDUCTION|Adverse Event|0
2819494|NCT03066609|9643418|P3|INDUCTION|Adverse Event|0
2819495|NCT03066609|9643419|P2|INDUCTION|Adverse Event|2
2819496|NCT03066609|9643420|P1|INDUCTION|Adverse Event|2
2819497|NCT03066609|9643417|P4|INDUCTION|Lack of Efficacy|0
2819498|NCT03066609|9643418|P3|INDUCTION|Lack of Efficacy|1
2819499|NCT03066609|9643419|P2|INDUCTION|Lack of Efficacy|0
2819500|NCT03066609|9643420|P1|INDUCTION|Lack of Efficacy|0
2819501|NCT03066609|9643417|P4|INDUCTION|Pregnancy|0
2819502|NCT03066609|9643418|P3|INDUCTION|Pregnancy|1
2819503|NCT03066609|9643419|P2|INDUCTION|Pregnancy|0
2819504|NCT03066609|9643420|P1|INDUCTION|Pregnancy|0
2819505|NCT03066193|9643450|P1|Overall Study|Withdrawal by Subject|1
2819506|NCT03065933|9643463|P1|Overall Study|study terminated|5
2819507|NCT03065530|9643471|P4|Overall Study|Protocol Violation|1
2819508|NCT03065530|9643472|P3|Overall Study|Protocol Violation|1
2819509|NCT03065530|9643473|P2|Overall Study|Protocol Violation|0
2819510|NCT03065530|9643474|P1|Overall Study|Protocol Violation|1
2819511|NCT03065530|9643471|P4|Overall Study|Lack of Efficacy|1
2819512|NCT03065530|9643472|P3|Overall Study|Lack of Efficacy|0
2819513|NCT03065530|9643473|P2|Overall Study|Lack of Efficacy|1
2819514|NCT03065530|9643474|P1|Overall Study|Lack of Efficacy|1
2819515|NCT03065023|9643582|P5|Overall Study|Withdrawal by Subject|0
2819516|NCT03065023|9643583|P4|Overall Study|Withdrawal by Subject|1
2819517|NCT03065023|9643584|P3|Overall Study|Withdrawal by Subject|0
2819518|NCT03065023|9643585|P2|Overall Study|Withdrawal by Subject|0
2819519|NCT03065023|9643586|P1|Overall Study|Withdrawal by Subject|0
2819520|NCT03065023|9643582|P5|Overall Study|Participant Decision|0
2819521|NCT03065023|9643583|P4|Overall Study|Participant Decision|1
2819522|NCT03065023|9643584|P3|Overall Study|Participant Decision|0
2819523|NCT03065023|9643585|P2|Overall Study|Participant Decision|0
2819524|NCT03065023|9643586|P1|Overall Study|Participant Decision|0
2819525|NCT03065023|9643582|P5|Overall Study|Lost to Follow-up|0
2819526|NCT03065023|9643583|P4|Overall Study|Lost to Follow-up|0
2819527|NCT03065023|9643584|P3|Overall Study|Lost to Follow-up|0
2819528|NCT03065023|9643585|P2|Overall Study|Lost to Follow-up|1
2819529|NCT03065023|9643586|P1|Overall Study|Lost to Follow-up|0
2819530|NCT03065023|9643582|P5|Overall Study|Death|0
2819531|NCT03065023|9643583|P4|Overall Study|Death|1
2819532|NCT03065023|9643584|P3|Overall Study|Death|1
2819533|NCT03065023|9643585|P2|Overall Study|Death|0
2819534|NCT03065023|9643586|P1|Overall Study|Death|2
2819535|NCT03065023|9643582|P5|Overall Study|Progressive Disease|0
2819536|NCT03065023|9643583|P4|Overall Study|Progressive Disease|0
2819537|NCT03065023|9643584|P3|Overall Study|Progressive Disease|0
2819538|NCT03065023|9643585|P2|Overall Study|Progressive Disease|1
2819539|NCT03065023|9643586|P1|Overall Study|Progressive Disease|0
2819540|NCT03064841|9643652|P1|Overall Study|Screen failure|2
2819541|NCT03064841|9643652|P1|Overall Study|No glycated haemoglobinA1c measurement|11
2819542|NCT03064841|9643652|P1|Overall Study|Inclusion/exclusion criteria violation|4
2819543|NCT03064451|9643667|P1|Overall Study|Withdrew consent: 3-month FU visit|1
2819544|NCT03064451|9643667|P1|Overall Study|Exited prior to procedure|8
2819545|NCT03064451|9643667|P1|Overall Study|Mapping Failure|4
2819546|NCT03064451|9643667|P1|Overall Study|Lost to Follow-up|1
2819547|NCT03063086|9643769|P6|Overall Study|Physician Decision|0
2819548|NCT03063086|9643770|P5|Overall Study|Physician Decision|0
2819549|NCT03063086|9643771|P4|Overall Study|Physician Decision|1
2819550|NCT03063086|9643772|P3|Overall Study|Physician Decision|0
2819551|NCT03063086|9643773|P2|Overall Study|Physician Decision|0
2819552|NCT03063086|9643774|P1|Overall Study|Physician Decision|0
2819553|NCT03063086|9643769|P6|Overall Study|Non-compliance with study treatment|1
2819554|NCT03063086|9643770|P5|Overall Study|Non-compliance with study treatment|0
2819555|NCT03063086|9643771|P4|Overall Study|Non-compliance with study treatment|1
2819556|NCT03063086|9643772|P3|Overall Study|Non-compliance with study treatment|0
2819557|NCT03063086|9643773|P2|Overall Study|Non-compliance with study treatment|0
2819558|NCT03063086|9643774|P1|Overall Study|Non-compliance with study treatment|0
2819559|NCT03063086|9643769|P6|Overall Study|subject/guardian decision|0
2819560|NCT03063086|9643770|P5|Overall Study|subject/guardian decision|0
2819561|NCT03063086|9643771|P4|Overall Study|subject/guardian decision|0
2819562|NCT03063086|9643772|P3|Overall Study|subject/guardian decision|0
2819563|NCT03063086|9643773|P2|Overall Study|subject/guardian decision|0
2819564|NCT03063086|9643774|P1|Overall Study|subject/guardian decision|1
2819565|NCT03063086|9643769|P6|Overall Study|Adverse Event|0
2819566|NCT03063086|9643770|P5|Overall Study|Adverse Event|0
2819567|NCT03063086|9643771|P4|Overall Study|Adverse Event|1
2819568|NCT03063086|9643772|P3|Overall Study|Adverse Event|1
2819569|NCT03063086|9643773|P2|Overall Study|Adverse Event|1
2819570|NCT03063086|9643774|P1|Overall Study|Adverse Event|1
2819571|NCT03063086|9643769|P6|Overall Study|technical problems|0
2819572|NCT03063086|9643770|P5|Overall Study|technical problems|0
2819573|NCT03063086|9643771|P4|Overall Study|technical problems|0
2819574|NCT03063086|9643772|P3|Overall Study|technical problems|0
2819575|NCT03063086|9643773|P2|Overall Study|technical problems|0
2819576|NCT03063086|9643774|P1|Overall Study|technical problems|1
2819577|NCT03061331|9643870|P2|Washout Period (8 Weeks)|Adverse Event|1
2819578|NCT03061331|9643871|P1|Washout Period (8 Weeks)|Adverse Event|2
2819579|NCT03061214|9643901|P3|Overall Study|Death|0
2819580|NCT03061214|9643902|P2|Overall Study|Death|1
2819581|NCT03061214|9643903|P1|Overall Study|Death|1
2819582|NCT03061214|9643901|P3|Overall Study|Lost to Follow-up|1
2819583|NCT03061214|9643902|P2|Overall Study|Lost to Follow-up|1
2819584|NCT03061214|9643903|P1|Overall Study|Lost to Follow-up|3
2819585|NCT03061214|9643901|P3|Overall Study|Withdrawal by Subject|9
2819586|NCT03061214|9643902|P2|Overall Study|Withdrawal by Subject|26
2819587|NCT03061214|9643903|P1|Overall Study|Withdrawal by Subject|21
2819588|NCT03060512|9644136|P2|Overall Study|Non-compliance with study medication|2
2819589|NCT03060512|9644137|P1|Overall Study|Non-compliance with study medication|1
2819590|NCT03060512|9644136|P2|Overall Study|Withdrawal by Subject|0
2819591|NCT03060512|9644137|P1|Overall Study|Withdrawal by Subject|1
2819592|NCT03060512|9644136|P2|Overall Study|Lost to Follow-up|1
2819593|NCT03060512|9644137|P1|Overall Study|Lost to Follow-up|1
2819594|NCT03060512|9644136|P2|Overall Study|Adverse Event|6
2819595|NCT03060512|9644137|P1|Overall Study|Adverse Event|4
2819596|NCT03058991|9644174|P3|Overall Study|Withdrawal by Subject|0
2819597|NCT03058991|9644175|P2|Overall Study|Withdrawal by Subject|0
2819598|NCT03058991|9644176|P1|Overall Study|Withdrawal by Subject|1
2819599|NCT03058991|9644174|P3|Overall Study|Lost to Follow-up|12
2819600|NCT03058991|9644175|P2|Overall Study|Lost to Follow-up|12
2819601|NCT03058991|9644176|P1|Overall Study|Lost to Follow-up|17
2819602|NCT03058705|9644202|P1|Overall Study|Physician Decision|2
2819603|NCT03058705|9644202|P1|Overall Study|Withdrawal by Subject|2
2819604|NCT03058692|9644208|P2|Overall Study|Withdrawal by Subject|1
2819605|NCT03058692|9644209|P1|Overall Study|Withdrawal by Subject|1
2819606|NCT03058692|9644208|P2|Overall Study|Lost to Follow-up|1
2819607|NCT03058692|9644209|P1|Overall Study|Lost to Follow-up|2
2819608|NCT03056573|9644370|P2|Overall Study|Lost to Follow-up|1
2819609|NCT03056573|9644371|P1|Overall Study|Lost to Follow-up|1
2819610|NCT03056573|9644370|P2|Overall Study|Withdrawal by Subject|0
2819611|NCT03056573|9644371|P1|Overall Study|Withdrawal by Subject|2
2819612|NCT03056573|9644370|P2|Overall Study|Death|4
2819613|NCT03056573|9644371|P1|Overall Study|Death|2
2819614|NCT03056352|9644431|P1|Overall Study|Lost to Follow-up|1
2819615|NCT03056300|9644437|P1|Overall Study|Surgical reason per study protocol|3
2819616|NCT03056040|9644454|P2|Primary Evaluation Period|Pregnancy|1
2819617|NCT03056040|9644455|P1|Primary Evaluation Period|Pregnancy|0
2819618|NCT03056040|9644454|P2|Primary Evaluation Period|Lack of Efficacy|1
2819619|NCT03056040|9644455|P1|Primary Evaluation Period|Lack of Efficacy|0
2819620|NCT03056040|9644454|P2|Primary Evaluation Period|Withdrawal by Subject|1
2819621|NCT03056040|9644455|P1|Primary Evaluation Period|Withdrawal by Subject|1
2819622|NCT03055988|9644469|P2|Period 2|Other than listed|1
2819623|NCT03055988|9644470|P1|Period 2|Other than listed|1
2819624|NCT03055988|9644469|P2|Period 2|Adverse Event|1
2819625|NCT03055988|9644470|P1|Period 2|Adverse Event|0
2819626|NCT03055988|9644469|P2|Period 1|Withdrawal by Subject|4
2819627|NCT03055988|9644470|P1|Period 1|Withdrawal by Subject|0
2819628|NCT03055988|9644469|P2|Period 1|Lost to Follow-up|0
2819629|NCT03055988|9644470|P1|Period 1|Lost to Follow-up|1
2819630|NCT03055988|9644469|P2|Period 1|Adverse Event|1
2819631|NCT03055988|9644470|P1|Period 1|Adverse Event|0
2819632|NCT03055832|9644494|P2|Week 2|Withdrawal by Subject|0
2819633|NCT03055832|9644495|P1|Week 2|Withdrawal by Subject|1
2819634|NCT03055806|9644555|P4|Overall Study|Partner not willing to try intercourse|0
2819635|NCT03055806|9644556|P3|Overall Study|Partner not willing to try intercourse|0
2819636|NCT03055806|9644557|P2|Overall Study|Partner not willing to try intercourse|0
2819637|NCT03055806|9644558|P1|Overall Study|Partner not willing to try intercourse|1
2819638|NCT03055806|9644555|P4|Overall Study|Withdrawal of consent to continue study|6
2819639|NCT03055806|9644556|P3|Overall Study|Withdrawal of consent to continue study|4
2819640|NCT03055806|9644557|P2|Overall Study|Withdrawal of consent to continue study|3
2819641|NCT03055806|9644558|P1|Overall Study|Withdrawal of consent to continue study|2
2819642|NCT03055806|9644555|P4|Overall Study|Withdrawal of consent to continue drug|0
2819643|NCT03055806|9644556|P3|Overall Study|Withdrawal of consent to continue drug|2
2819644|NCT03055806|9644557|P2|Overall Study|Withdrawal of consent to continue drug|1
2819645|NCT03055806|9644558|P1|Overall Study|Withdrawal of consent to continue drug|1
2819646|NCT03055806|9644555|P4|Overall Study|Protocol Violation|0
2819647|NCT03055806|9644556|P3|Overall Study|Protocol Violation|0
2819648|NCT03055806|9644557|P2|Overall Study|Protocol Violation|0
2819649|NCT03055806|9644558|P1|Overall Study|Protocol Violation|1
2819650|NCT03055806|9644555|P4|Overall Study|Physician Decision|1
2819651|NCT03055806|9644556|P3|Overall Study|Physician Decision|0
2819652|NCT03055806|9644557|P2|Overall Study|Physician Decision|0
2819653|NCT03055806|9644558|P1|Overall Study|Physician Decision|1
2819654|NCT03055806|9644555|P4|Overall Study|Lost to Follow-up|7
2819655|NCT03055806|9644556|P3|Overall Study|Lost to Follow-up|6
2819656|NCT03055806|9644557|P2|Overall Study|Lost to Follow-up|3
2819657|NCT03055806|9644558|P1|Overall Study|Lost to Follow-up|0
2819658|NCT03055806|9644555|P4|Overall Study|Adverse Event|1
2819659|NCT03055806|9644556|P3|Overall Study|Adverse Event|1
2819660|NCT03055806|9644557|P2|Overall Study|Adverse Event|0
2819661|NCT03055806|9644558|P1|Overall Study|Adverse Event|0
2819662|NCT03055624|9644600|P1|Overall Study|Study closed|9
2819663|NCT03055494|9644611|P2|Overall Study|Non-compliance with study treatment|0
2819664|NCT03055494|9644612|P1|Overall Study|Non-compliance with study treatment|1
2819665|NCT03055494|9644611|P2|Overall Study|Adverse Event|1
2819666|NCT03055494|9644612|P1|Overall Study|Adverse Event|0
2819667|NCT03055494|9644611|P2|Overall Study|Withdrawal by Subject|0
2819668|NCT03055494|9644612|P1|Overall Study|Withdrawal by Subject|1
2819669|NCT03055494|9644611|P2|Overall Study|Physician Decision|0
2819670|NCT03055494|9644612|P1|Overall Study|Physician Decision|2
2819671|NCT03055494|9644611|P2|Overall Study|Lost to Follow-up|0
2819672|NCT03055494|9644612|P1|Overall Study|Lost to Follow-up|6
2819673|NCT03055338|9644643|P3|Overall Study|Withdrawal by Subject|7
2819674|NCT03055338|9644644|P2|Overall Study|Withdrawal by Subject|8
2819675|NCT03055338|9644645|P1|Overall Study|Withdrawal by Subject|9
2819676|NCT03055338|9644643|P3|Overall Study|Physician Decision|2
2819677|NCT03055338|9644644|P2|Overall Study|Physician Decision|0
2819678|NCT03055338|9644645|P1|Overall Study|Physician Decision|0
2819679|NCT03055338|9644643|P3|Overall Study|No Post-treatment Protocol Contact|0
2819680|NCT03055338|9644644|P2|Overall Study|No Post-treatment Protocol Contact|1
2819681|NCT03055338|9644645|P1|Overall Study|No Post-treatment Protocol Contact|0
2819682|NCT03055338|9644643|P3|Overall Study|Lost to Follow-up|3
2819683|NCT03055338|9644644|P2|Overall Study|Lost to Follow-up|2
2819684|NCT03055338|9644645|P1|Overall Study|Lost to Follow-up|9
2819685|NCT03055260|9644664|P2|Overall Study|Withdrawal by Subject|0
2819686|NCT03055260|9644665|P1|Overall Study|Withdrawal by Subject|1
2819687|NCT03055221|9644673|P1|Overall Study|Study terminated by Sponsor|3
2819688|NCT03055221|9644673|P1|Overall Study|Physician Decision|1
2819689|NCT03055221|9644673|P1|Overall Study|Death|6
2819690|NCT03055221|9644673|P1|Overall Study|Withdrawal by Subject|4
2819691|NCT03055221|9644673|P1|Overall Study|Adverse Event|2
2819692|NCT03055195|9644680|P2|Overall Study|Physician Decision|0
2819693|NCT03055195|9644681|P1|Overall Study|Physician Decision|1
2819694|NCT03055195|9644680|P2|Overall Study|Protocol Violation|1
2819695|NCT03055195|9644681|P1|Overall Study|Protocol Violation|2
2819696|NCT03055195|9644680|P2|Overall Study|Study Terminated by Sponsor|6
2819697|NCT03055195|9644681|P1|Overall Study|Study Terminated by Sponsor|2
2819698|NCT03055195|9644680|P2|Overall Study|Withdrawal by Subject|7
2819699|NCT03055195|9644681|P1|Overall Study|Withdrawal by Subject|6
2819700|NCT03055195|9644680|P2|Overall Study|Lack of Efficacy|0
2819701|NCT03055195|9644681|P1|Overall Study|Lack of Efficacy|1
2819702|NCT03054428|9644873|P3|Overall Study|Lost to Follow-up|1
2819703|NCT03054428|9644874|P2|Overall Study|Lost to Follow-up|0
2819704|NCT03054428|9644875|P1|Overall Study|Lost to Follow-up|0
2819705|NCT03054428|9644873|P3|Overall Study|Withdrawal by Subject|3
2819706|NCT03054428|9644874|P2|Overall Study|Withdrawal by Subject|2
2819707|NCT03054428|9644875|P1|Overall Study|Withdrawal by Subject|3
2819708|NCT03054428|9644873|P3|Overall Study|Transitioned to OLE study|73
2819709|NCT03054428|9644874|P2|Overall Study|Transitioned to OLE study|76
2819710|NCT03054428|9644875|P1|Overall Study|Transitioned to OLE study|76
2819711|NCT03054428|9644873|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2819712|NCT03054428|9644874|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2819713|NCT03054428|9644875|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
2819714|NCT03054428|9644873|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
2819715|NCT03054428|9644874|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
2819716|NCT03054428|9644875|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
2819717|NCT03054428|9644873|P3|Overall Study|Lack of Efficacy|0
2819718|NCT03054428|9644874|P2|Overall Study|Lack of Efficacy|1
2819719|NCT03054428|9644875|P1|Overall Study|Lack of Efficacy|3
2819720|NCT03054428|9644873|P3|Overall Study|Physician Decision|1
2819721|NCT03054428|9644874|P2|Overall Study|Physician Decision|1
2819722|NCT03054428|9644875|P1|Overall Study|Physician Decision|0
2819723|NCT03054064|9644971|P1|Overall Study|Change in Status|1
2819724|NCT03054064|9644971|P1|Overall Study|High Blood Pressure|1
2819725|NCT03054064|9644971|P1|Overall Study|Bladder Issue|1
2819726|NCT03054064|9644971|P1|Overall Study|Investigator Decision|2
2819727|NCT03054064|9644971|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
2819728|NCT03053427|9645018|P2|Overall Study|Miscellaneous|1
2819729|NCT03053427|9645019|P1|Overall Study|Miscellaneous|0
2819730|NCT03053427|9645018|P2|Overall Study|Withdrawal by Subject|2
2819731|NCT03053427|9645019|P1|Overall Study|Withdrawal by Subject|3
2819732|NCT03053427|9645018|P2|Overall Study|Protocol Deviation|3
2819733|NCT03053427|9645019|P1|Overall Study|Protocol Deviation|3
2819734|NCT03053427|9645018|P2|Overall Study|Worsening of the target disease|1
2819735|NCT03053427|9645019|P1|Overall Study|Worsening of the target disease|0
2819736|NCT03053427|9645018|P2|Overall Study|Lost to Follow-up|2
2819737|NCT03053427|9645019|P1|Overall Study|Lost to Follow-up|2
2819738|NCT03053427|9645018|P2|Overall Study|Lack of Efficacy|3
2819739|NCT03053427|9645019|P1|Overall Study|Lack of Efficacy|1
2819740|NCT03053427|9645018|P2|Overall Study|Adverse Event|4
2819741|NCT03053427|9645019|P1|Overall Study|Adverse Event|4
2819742|NCT03053180|9645041|P1|Overall Study|Failure to Return|1
2819743|NCT03053063|9645053|P4|Open-Label Phase|Investigator's discretion|2
2819744|NCT03053063|9645054|P3|Open-Label Phase|Investigator's discretion|0
2819745|NCT03053063|9645055|P2|Open-Label Phase|Investigator's discretion|0
2819746|NCT03053063|9645056|P1|Open-Label Phase|Investigator's discretion|0
2819747|NCT03053063|9645053|P4|Open-Label Phase|Death|2
2819748|NCT03053063|9645054|P3|Open-Label Phase|Death|0
2819749|NCT03053063|9645055|P2|Open-Label Phase|Death|0
2819750|NCT03053063|9645056|P1|Open-Label Phase|Death|0
2819751|NCT03053063|9645053|P4|Open-Label Phase|Study Terminated by Sponsor|19
2819752|NCT03053063|9645054|P3|Open-Label Phase|Study Terminated by Sponsor|0
2819753|NCT03053063|9645055|P2|Open-Label Phase|Study Terminated by Sponsor|0
2819754|NCT03053063|9645056|P1|Open-Label Phase|Study Terminated by Sponsor|0
2819755|NCT03053063|9645053|P4|Randomized Phase|Entered the Open-Label Phase|0
2819756|NCT03053063|9645054|P3|Randomized Phase|Entered the Open-Label Phase|3
2819757|NCT03053063|9645055|P2|Randomized Phase|Entered the Open-Label Phase|11
2819758|NCT03053063|9645056|P1|Randomized Phase|Entered the Open-Label Phase|9
2819759|NCT03053063|9645053|P4|Randomized Phase|Randomized but Never Treated|0
2819760|NCT03053063|9645054|P3|Randomized Phase|Randomized but Never Treated|2
2819761|NCT03053063|9645055|P2|Randomized Phase|Randomized but Never Treated|3
2819762|NCT03053063|9645056|P1|Randomized Phase|Randomized but Never Treated|1
2819763|NCT03053063|9645053|P4|Randomized Phase|Adverse Event|0
2819764|NCT03053063|9645054|P3|Randomized Phase|Adverse Event|0
2819765|NCT03053063|9645055|P2|Randomized Phase|Adverse Event|1
2819766|NCT03053063|9645056|P1|Randomized Phase|Adverse Event|0
2819767|NCT03053063|9645053|P4|Randomized Phase|Lost to Follow-up|0
2819768|NCT03053063|9645054|P3|Randomized Phase|Lost to Follow-up|1
2819769|NCT03053063|9645055|P2|Randomized Phase|Lost to Follow-up|5
2819770|NCT03053063|9645056|P1|Randomized Phase|Lost to Follow-up|3
2819771|NCT03053063|9645053|P4|Randomized Phase|Investigator's Discretion|0
2819772|NCT03053063|9645054|P3|Randomized Phase|Investigator's Discretion|2
2819773|NCT03053063|9645055|P2|Randomized Phase|Investigator's Discretion|6
2819774|NCT03053063|9645056|P1|Randomized Phase|Investigator's Discretion|8
2819775|NCT03053063|9645053|P4|Randomized Phase|Withdrew consent|0
2819776|NCT03053063|9645054|P3|Randomized Phase|Withdrew consent|5
2819777|NCT03053063|9645055|P2|Randomized Phase|Withdrew consent|11
2819778|NCT03053063|9645056|P1|Randomized Phase|Withdrew consent|8
2819779|NCT03053063|9645053|P4|Randomized Phase|Study Terminated by Sponsor|0
2819780|NCT03053063|9645054|P3|Randomized Phase|Study Terminated by Sponsor|161
2819781|NCT03053063|9645055|P2|Randomized Phase|Study Terminated by Sponsor|317
2819782|NCT03053063|9645056|P1|Randomized Phase|Study Terminated by Sponsor|326
2819783|NCT03052764|9645085|P2|Double-Blind Treatment Period|Reason not Specified|1
2819784|NCT03052764|9645086|P1|Double-Blind Treatment Period|Reason not Specified|2
2819785|NCT03052764|9645085|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2819786|NCT03052764|9645086|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
2819787|NCT03052764|9645085|P2|Double-Blind Treatment Period|Protocol Violation|1
2819788|NCT03052764|9645086|P1|Double-Blind Treatment Period|Protocol Violation|2
2819789|NCT03052764|9645085|P2|Double-Blind Treatment Period|Lack of Efficacy|0
2819790|NCT03052764|9645086|P1|Double-Blind Treatment Period|Lack of Efficacy|1
2819791|NCT03052764|9645085|P2|Double-Blind Treatment Period|Adverse Event|0
2819792|NCT03052764|9645086|P1|Double-Blind Treatment Period|Adverse Event|2
2819793|NCT03052725|9645106|P2|Overall Study|Study terminated by sponsor|144
2819794|NCT03052725|9645107|P1|Overall Study|Study terminated by sponsor|143
2819795|NCT03052725|9645106|P2|Overall Study|Site closure|1
2819796|NCT03052725|9645107|P1|Overall Study|Site closure|0
2819797|NCT03052725|9645106|P2|Overall Study|Pregnancy|1
2819798|NCT03052725|9645107|P1|Overall Study|Pregnancy|0
2819799|NCT03052725|9645106|P2|Overall Study|Withdrawal by Subject|4
2819800|NCT03052725|9645107|P1|Overall Study|Withdrawal by Subject|3
2819801|NCT03052725|9645106|P2|Overall Study|Adverse Event|0
2819802|NCT03052725|9645107|P1|Overall Study|Adverse Event|2
2819803|NCT03052426|9645154|P3|Overall Study|Lost to Follow-up|1
2819804|NCT03052426|9645155|P2|Overall Study|Lost to Follow-up|0
2819805|NCT03052426|9645156|P1|Overall Study|Lost to Follow-up|2
2819806|NCT03052426|9645154|P3|Overall Study|Withdrawal by Subject|0
2819807|NCT03052426|9645155|P2|Overall Study|Withdrawal by Subject|1
2819808|NCT03052426|9645156|P1|Overall Study|Withdrawal by Subject|0
2819809|NCT03052322|9645171|P2|Overall Study|Adverse Event|13
2819810|NCT03052322|9645172|P1|Overall Study|Adverse Event|6
2819811|NCT03052322|9645171|P2|Overall Study|Lost to Follow-up|4
2819812|NCT03052322|9645172|P1|Overall Study|Lost to Follow-up|2
2819813|NCT03052322|9645171|P2|Overall Study|Protocol Violation|0
2819814|NCT03052322|9645172|P1|Overall Study|Protocol Violation|1
2819815|NCT03052322|9645171|P2|Overall Study|Lack of Efficacy|2
2819816|NCT03052322|9645172|P1|Overall Study|Lack of Efficacy|1
2819817|NCT03052322|9645171|P2|Overall Study|Death|2
2819818|NCT03052322|9645172|P1|Overall Study|Death|0
2819819|NCT03052322|9645171|P2|Overall Study|Withdrawal by Subject|9
2819820|NCT03052322|9645172|P1|Overall Study|Withdrawal by Subject|10
2819821|NCT03052322|9645171|P2|Overall Study|Other un-specified|2
2819822|NCT03052322|9645172|P1|Overall Study|Other un-specified|1
2819823|NCT03051607|9645233|P1|Overall Study|Adverse Event|66
2819824|NCT03051217|9645243|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819825|NCT03051217|9645244|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
2819826|NCT03051217|9645245|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819827|NCT03051217|9645246|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819828|NCT03051217|9645247|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819829|NCT03051217|9645248|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819830|NCT03051217|9645249|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2819831|NCT03051217|9645243|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819832|NCT03051217|9645244|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819833|NCT03051217|9645245|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
2819834|NCT03051217|9645246|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819835|NCT03051217|9645247|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819836|NCT03051217|9645248|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819837|NCT03051217|9645249|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2819838|NCT03051217|9645243|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819839|NCT03051217|9645244|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819840|NCT03051217|9645245|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819841|NCT03051217|9645246|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
2819842|NCT03051217|9645247|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819843|NCT03051217|9645248|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819844|NCT03051217|9645249|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2819845|NCT03051217|9645243|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819846|NCT03051217|9645244|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819847|NCT03051217|9645245|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819848|NCT03051217|9645246|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
2819849|NCT03051217|9645247|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819850|NCT03051217|9645248|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819851|NCT03051217|9645249|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2819852|NCT03051217|9645243|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2819853|NCT03051217|9645244|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2819854|NCT03051217|9645245|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
2819855|NCT03051217|9645246|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2819856|NCT03051217|9645247|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2819857|NCT03051217|9645248|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2819858|NCT03051217|9645249|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2819859|NCT03051217|9645243|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2819860|NCT03051217|9645244|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2819861|NCT03051217|9645245|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2819862|NCT03051217|9645246|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2819863|NCT03051217|9645247|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2819864|NCT03051217|9645248|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2819865|NCT03051217|9645249|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2819866|NCT03051217|9645243|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819867|NCT03051217|9645244|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819868|NCT03051217|9645245|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819869|NCT03051217|9645246|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819870|NCT03051217|9645247|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819871|NCT03051217|9645248|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
2819872|NCT03051217|9645249|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2819873|NCT03051217|9645243|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2819874|NCT03051217|9645244|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2819875|NCT03051217|9645245|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2819876|NCT03051217|9645246|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2819877|NCT03051217|9645247|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2819878|NCT03051217|9645248|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
2819879|NCT03051217|9645249|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
2819880|NCT03051165|9645278|P1|Overall Study|Early termination of study|12
2819881|NCT03051165|9645278|P1|Overall Study|Withdrawal by Subject|1
2819882|NCT03051100|9645292|P2|Overall Study|Withdrawal by Subject|0
2819883|NCT03051100|9645293|P1|Overall Study|Withdrawal by Subject|1
2819884|NCT03050398|9645512|P1|Overall Study|Study terminated by sponsor|8
2819885|NCT03050372|9645517|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
2819886|NCT03050372|9645518|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
2819887|NCT03050372|9645517|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
2819888|NCT03050372|9645518|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
2819889|NCT03049852|9645613|P3|Overall Study|Lost to Follow-up|0
2819890|NCT03049852|9645614|P2|Overall Study|Lost to Follow-up|1
2819891|NCT03049852|9645615|P1|Overall Study|Lost to Follow-up|0
2819892|NCT03049748|9645627|P2|Overall Study|Moved out of state (relocation)|1
2819893|NCT03049748|9645628|P1|Overall Study|Moved out of state (relocation)|0
2819894|NCT03049748|9645627|P2|Overall Study|Protocol Violation|2
2819895|NCT03049748|9645628|P1|Overall Study|Protocol Violation|0
2819896|NCT03049748|9645627|P2|Overall Study|Withdrawal by Subject|3
2819897|NCT03049748|9645628|P1|Overall Study|Withdrawal by Subject|0
2819898|NCT03049748|9645627|P2|Overall Study|Death|0
2819899|NCT03049748|9645628|P1|Overall Study|Death|3
2819900|NCT03049748|9645627|P2|Overall Study|Lost to Follow-up|0
2819901|NCT03049748|9645628|P1|Overall Study|Lost to Follow-up|1
2819902|NCT03048058|9645681|P2|Overall Study|Withdrawal by Subject|4
2819903|NCT03048058|9645682|P1|Overall Study|Withdrawal by Subject|0
2819904|NCT03048058|9645681|P2|Overall Study|Lost to Follow-up|0
2819905|NCT03048058|9645682|P1|Overall Study|Lost to Follow-up|4
2819906|NCT03047551|9645708|P2|Overall Study|Ineligible|1
2819907|NCT03047551|9645709|P1|Overall Study|Ineligible|0
2819908|NCT03047551|9645708|P2|Overall Study|Probe malfunction|1
2819909|NCT03047551|9645709|P1|Overall Study|Probe malfunction|0
2819910|NCT03047551|9645708|P2|Overall Study|Withdrawal by Subject|1
2819911|NCT03047551|9645709|P1|Overall Study|Withdrawal by Subject|0
2819912|NCT03047551|9645708|P2|Overall Study|Physician Decision|0
2819913|NCT03047551|9645709|P1|Overall Study|Physician Decision|1
2819914|NCT03047551|9645708|P2|Overall Study|Did not receive TAS|0
2819915|NCT03047551|9645709|P1|Overall Study|Did not receive TAS|1
2819916|NCT03046446|9645786|P1|Overall Study|Non OA related knee surgery|1
2819917|NCT03046446|9645786|P1|Overall Study|Disease Progression (see caveats)|25
2819918|NCT03046446|9645786|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
2819919|NCT03046446|9645786|P1|Overall Study|Withdrawal by Subject|14
2819920|NCT03046446|9645786|P1|Overall Study|Lost to Follow-up|3
2819921|NCT03046446|9645786|P1|Overall Study|Adverse Event|6
2819922|NCT03046446|9645786|P1|Overall Study|Lack of Efficacy|7
2819923|NCT03045887|9645849|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819924|NCT03045887|9645850|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819925|NCT03045887|9645851|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819926|NCT03045887|9645852|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819927|NCT03045887|9645853|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819928|NCT03045887|9645854|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819929|NCT03045887|9645855|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
2819930|NCT03045887|9645856|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819931|NCT03045887|9645857|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819932|NCT03045887|9645858|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2819933|NCT03045887|9645849|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819934|NCT03045887|9645850|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819935|NCT03045887|9645851|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819936|NCT03045887|9645852|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819937|NCT03045887|9645853|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819938|NCT03045887|9645854|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819939|NCT03045887|9645855|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2819940|NCT03045887|9645856|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2819941|NCT03045887|9645857|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819942|NCT03045887|9645858|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2819943|NCT03045887|9645849|P10|Part A, Period 2 (1 Day)|Adverse Event|0
2819944|NCT03045887|9645850|P9|Part A, Period 2 (1 Day)|Adverse Event|0
2819945|NCT03045887|9645851|P8|Part A, Period 2 (1 Day)|Adverse Event|0
2819946|NCT03045887|9645852|P7|Part A, Period 2 (1 Day)|Adverse Event|0
2819947|NCT03045887|9645853|P6|Part A, Period 2 (1 Day)|Adverse Event|0
2819948|NCT03045887|9645854|P5|Part A, Period 2 (1 Day)|Adverse Event|0
2819949|NCT03045887|9645855|P4|Part A, Period 2 (1 Day)|Adverse Event|0
2819950|NCT03045887|9645856|P3|Part A, Period 2 (1 Day)|Adverse Event|0
2819951|NCT03045887|9645857|P2|Part A, Period 2 (1 Day)|Adverse Event|0
2819952|NCT03045887|9645858|P1|Part A, Period 2 (1 Day)|Adverse Event|1
2819953|NCT03045887|9645849|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819954|NCT03045887|9645850|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819955|NCT03045887|9645851|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819956|NCT03045887|9645852|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819957|NCT03045887|9645853|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819958|NCT03045887|9645854|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819959|NCT03045887|9645855|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
2819960|NCT03045887|9645856|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819961|NCT03045887|9645857|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819962|NCT03045887|9645858|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2819963|NCT03045887|9645849|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819964|NCT03045887|9645850|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819965|NCT03045887|9645851|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819966|NCT03045887|9645852|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819967|NCT03045887|9645853|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819968|NCT03045887|9645854|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819969|NCT03045887|9645855|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819970|NCT03045887|9645856|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819971|NCT03045887|9645857|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2819972|NCT03045887|9645858|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
2819973|NCT03045302|9646140|P1|Overall Study|Pre-treatment adverse event|1
2819974|NCT03045081|9646146|P2|Overall Study|Withdrawal by Subject|11
2819975|NCT03045081|9646147|P1|Overall Study|Withdrawal by Subject|6
2819976|NCT03044886|9646166|P3|Overall Study|Lost to Follow-up|12
2819977|NCT03044886|9646167|P2|Overall Study|Lost to Follow-up|10
2819978|NCT03044886|9646168|P1|Overall Study|Lost to Follow-up|15
2819979|NCT03044574|9646220|P2|Overall Study|Lost to Follow-up|45
2819980|NCT03044574|9646221|P1|Overall Study|Lost to Follow-up|37
2819981|NCT03044431|9646247|P1|Overall Study|Lost to Follow-up|59
2819982|NCT03044353|9646260|P3|Overall Study|Adverse Event|0
2819983|NCT03044353|9646261|P2|Overall Study|Adverse Event|1
2819984|NCT03044353|9646262|P1|Overall Study|Adverse Event|0
2819985|NCT03044197|9646345|P2|Overall Study|Withdrawal by Subject|1
2819986|NCT03044197|9646346|P1|Overall Study|Withdrawal by Subject|3
2819987|NCT03044106|9646356|P2|Washout (1 Week)|Withdrawal by Subject|2
2819988|NCT03044106|9646357|P1|Washout (1 Week)|Withdrawal by Subject|0
2819989|NCT03042910|9646476|P1|Overall Study|Enrolled but not treated|1
2819990|NCT03042910|9646476|P1|Overall Study|Withdrawal by Subject|3
2819991|NCT03042910|9646476|P1|Overall Study|Disease Progression|2
2819992|NCT03042910|9646476|P1|Overall Study|Adverse Event|1
2819993|NCT03042559|9646520|P2|Overall Study|drop out|1
2819994|NCT03042559|9646521|P1|Overall Study|drop out|1
2819995|NCT03041792|9646656|P2|Overall Study|Randomized but not treated|1
2819996|NCT03041792|9646657|P1|Overall Study|Randomized but not treated|0
2819997|NCT03041792|9646656|P2|Overall Study|Death in the family|2
2819998|NCT03041792|9646657|P1|Overall Study|Death in the family|0
2819999|NCT03041792|9646656|P2|Overall Study|Adverse Event|0
2820000|NCT03041792|9646657|P1|Overall Study|Adverse Event|4
2820001|NCT03041181|9646722|P2|Overall Study|Disease Progression|2
2820002|NCT03041181|9646723|P1|Overall Study|Disease Progression|1
2820003|NCT03041090|9646739|P2|Overall Study|technical error|3
2820004|NCT03041090|9646740|P1|Overall Study|technical error|0
2820005|NCT03040687|9646753|P3|Overall Study|Withdrawal by Subject|0
2820006|NCT03040687|9646754|P2|Overall Study|Withdrawal by Subject|0
2820007|NCT03040687|9646755|P1|Overall Study|Withdrawal by Subject|1
2820008|NCT03040336|9646811|P2|Overall Study|Withdrawal by Subject|3
2820009|NCT03040336|9646812|P1|Overall Study|Withdrawal by Subject|2
2820010|NCT03040336|9646811|P2|Overall Study|Death|0
2820011|NCT03040336|9646812|P1|Overall Study|Death|1
2820012|NCT03039738|9646925|P2|Overall Study|Incomplete data sets|0
2820013|NCT03039738|9646926|P1|Overall Study|Incomplete data sets|54
2820014|NCT03039621|9646948|P2|Overall Study|Violation of non-inclusion criteria|2
2820015|NCT03039621|9646949|P1|Overall Study|Violation of non-inclusion criteria|1
2820016|NCT03039621|9646948|P2|Overall Study|Necessity to use drugs forbidden by pro|7
2820017|NCT03039621|9646949|P1|Overall Study|Necessity to use drugs forbidden by pro|4
2820018|NCT03039621|9646948|P2|Overall Study|Non-compliance with protocol requirement|5
2820019|NCT03039621|9646949|P1|Overall Study|Non-compliance with protocol requirement|4
2820020|NCT03039621|9646948|P2|Overall Study|Violation of inclusion criteria|2
2820021|NCT03039621|9646949|P1|Overall Study|Violation of inclusion criteria|3
2820022|NCT03039569|9646973|P2|Overall Study|Lost to Follow-up|4
2820023|NCT03039569|9646974|P1|Overall Study|Lost to Follow-up|5
2820024|NCT03039283|9647019|P1|Overall Study|Protocol Violation|2
2820025|NCT03038126|9647180|P2|Overall Study|Too Ill to Participate|2
2820026|NCT03038126|9647181|P1|Overall Study|Too Ill to Participate|1
2820027|NCT03038126|9647180|P2|Overall Study|Long Term Hospitalization|0
2820028|NCT03038126|9647181|P1|Overall Study|Long Term Hospitalization|2
2820029|NCT03038126|9647180|P2|Overall Study|Lost to Follow-up|1
2820030|NCT03038126|9647181|P1|Overall Study|Lost to Follow-up|0
2820031|NCT03038126|9647180|P2|Overall Study|Withdrawal by Subject|0
2820032|NCT03038126|9647181|P1|Overall Study|Withdrawal by Subject|5
2820033|NCT03038126|9647180|P2|Overall Study|Death|1
2820034|NCT03038126|9647181|P1|Overall Study|Death|1
2820035|NCT03037619|9647208|P2|Overall Study|Lost to Follow-up|1
2820036|NCT03037619|9647209|P1|Overall Study|Lost to Follow-up|0
2820037|NCT03037489|9647234|P2|Overall Study|Withdrawal by Subject|0
2820038|NCT03037489|9647235|P1|Overall Study|Withdrawal by Subject|3
2820039|NCT03037489|9647234|P2|Overall Study|Adverse Event|0
2820040|NCT03037489|9647235|P1|Overall Study|Adverse Event|4
2820041|NCT03037307|9647241|P6|Period 1|Did Not Meet Study Criteria|0
2820042|NCT03037307|9647242|P5|Period 1|Did Not Meet Study Criteria|0
2820043|NCT03037307|9647243|P4|Period 1|Did Not Meet Study Criteria|1
2820044|NCT03037307|9647244|P3|Period 1|Did Not Meet Study Criteria|0
2820045|NCT03037307|9647245|P2|Period 1|Did Not Meet Study Criteria|0
2820046|NCT03037307|9647246|P1|Period 1|Did Not Meet Study Criteria|0
2820047|NCT03036852|9647285|P1|Overall Study|Lost to Follow-up|1
2820048|NCT03036852|9647285|P1|Overall Study|Adverse Event|1
2820049|NCT03036852|9647285|P1|Overall Study|Lack of Efficacy|2
2820050|NCT03036852|9647285|P1|Overall Study|Death|2
2820051|NCT03036839|9647342|P3|Overall Study|Withdrew Consent|1
2820052|NCT03036839|9647343|P2|Overall Study|Withdrew Consent|0
2820053|NCT03036839|9647344|P1|Overall Study|Withdrew Consent|0
2820054|NCT03036839|9647342|P3|Overall Study|Death|3
2820055|NCT03036839|9647343|P2|Overall Study|Death|0
2820056|NCT03036839|9647344|P1|Overall Study|Death|3
2820057|NCT03036839|9647342|P3|Overall Study|Adverse Event|1
2820058|NCT03036839|9647343|P2|Overall Study|Adverse Event|0
2820059|NCT03036839|9647344|P1|Overall Study|Adverse Event|0
2820060|NCT03036072|9647570|P2|Overall Study|Physician Decision|1
2820061|NCT03036072|9647571|P1|Overall Study|Physician Decision|0
2820062|NCT03036072|9647570|P2|Overall Study|Withdrawal by Subject|1
2820063|NCT03036072|9647571|P1|Overall Study|Withdrawal by Subject|0
2820064|NCT03036072|9647570|P2|Overall Study|Death|1
2820065|NCT03036072|9647571|P1|Overall Study|Death|0
2820066|NCT03035942|9647591|P3|Overall Study|Adverse Event|5
2820067|NCT03035942|9647592|P2|Overall Study|Adverse Event|4
2820068|NCT03035942|9647593|P1|Overall Study|Adverse Event|8
2820069|NCT03035916|9647622|P3|Overall Study|Puncture failed|0
2820070|NCT03035916|9647623|P2|Overall Study|Puncture failed|2
2820071|NCT03035916|9647624|P1|Overall Study|Puncture failed|0
2820072|NCT03035864|9647673|P2|Follow-up Period|Other|2
2820073|NCT03035864|9647674|P1|Follow-up Period|Other|3
2820074|NCT03035864|9647673|P2|Follow-up Period|Physician Decision|0
2820075|NCT03035864|9647674|P1|Follow-up Period|Physician Decision|1
2820076|NCT03035864|9647673|P2|Follow-up Period|Lost to Follow-up|2
2820077|NCT03035864|9647674|P1|Follow-up Period|Lost to Follow-up|6
2820078|NCT03035864|9647673|P2|Follow-up Period|Adverse Event|0
2820079|NCT03035864|9647674|P1|Follow-up Period|Adverse Event|1
2820080|NCT03035864|9647673|P2|Treatment Period|Other|1
2820081|NCT03035864|9647674|P1|Treatment Period|Other|3
2820082|NCT03035864|9647673|P2|Treatment Period|Adverse Event|0
2820083|NCT03035864|9647674|P1|Treatment Period|Adverse Event|1
2820084|NCT03034967|9647754|P6|Overall Study|Adverse Event, Serious Fatal|1
2820085|NCT03034967|9647755|P5|Overall Study|Adverse Event, Serious Fatal|1
2820086|NCT03034967|9647756|P4|Overall Study|Adverse Event, Serious Fatal|2
2820087|NCT03034967|9647757|P3|Overall Study|Adverse Event, Serious Fatal|1
2820088|NCT03034967|9647758|P2|Overall Study|Adverse Event, Serious Fatal|1
2820089|NCT03034967|9647759|P1|Overall Study|Adverse Event, Serious Fatal|0
2820090|NCT03034967|9647754|P6|Overall Study|Adverse Event, non-fatal|8
2820091|NCT03034967|9647755|P5|Overall Study|Adverse Event, non-fatal|2
2820092|NCT03034967|9647756|P4|Overall Study|Adverse Event, non-fatal|0
2820093|NCT03034967|9647757|P3|Overall Study|Adverse Event, non-fatal|2
2820094|NCT03034967|9647758|P2|Overall Study|Adverse Event, non-fatal|1
2820095|NCT03034967|9647759|P1|Overall Study|Adverse Event, non-fatal|3
2820096|NCT03034967|9647754|P6|Overall Study|Lack of Efficacy|0
2820097|NCT03034967|9647755|P5|Overall Study|Lack of Efficacy|1
2820098|NCT03034967|9647756|P4|Overall Study|Lack of Efficacy|1
2820099|NCT03034967|9647757|P3|Overall Study|Lack of Efficacy|2
2820100|NCT03034967|9647758|P2|Overall Study|Lack of Efficacy|1
2820101|NCT03034967|9647759|P1|Overall Study|Lack of Efficacy|0
2820102|NCT03034967|9647754|P6|Overall Study|Protocol Violation|2
2820103|NCT03034967|9647755|P5|Overall Study|Protocol Violation|0
2820104|NCT03034967|9647756|P4|Overall Study|Protocol Violation|0
2820105|NCT03034967|9647757|P3|Overall Study|Protocol Violation|0
2820106|NCT03034967|9647758|P2|Overall Study|Protocol Violation|0
2820107|NCT03034967|9647759|P1|Overall Study|Protocol Violation|1
2820108|NCT03034967|9647754|P6|Overall Study|Liver function test abnormality|0
2820109|NCT03034967|9647755|P5|Overall Study|Liver function test abnormality|0
2820110|NCT03034967|9647756|P4|Overall Study|Liver function test abnormality|0
2820111|NCT03034967|9647757|P3|Overall Study|Liver function test abnormality|1
2820112|NCT03034967|9647758|P2|Overall Study|Liver function test abnormality|0
2820113|NCT03034967|9647759|P1|Overall Study|Liver function test abnormality|0
2820114|NCT03034967|9647754|P6|Overall Study|Lost to Follow-up|2
2820115|NCT03034967|9647755|P5|Overall Study|Lost to Follow-up|0
2820116|NCT03034967|9647756|P4|Overall Study|Lost to Follow-up|1
2820117|NCT03034967|9647757|P3|Overall Study|Lost to Follow-up|0
2820118|NCT03034967|9647758|P2|Overall Study|Lost to Follow-up|0
2820119|NCT03034967|9647759|P1|Overall Study|Lost to Follow-up|0
2820120|NCT03034967|9647754|P6|Overall Study|Physician Decision|0
2820121|NCT03034967|9647755|P5|Overall Study|Physician Decision|1
2820122|NCT03034967|9647756|P4|Overall Study|Physician Decision|1
2820123|NCT03034967|9647757|P3|Overall Study|Physician Decision|1
2820124|NCT03034967|9647758|P2|Overall Study|Physician Decision|0
2820125|NCT03034967|9647759|P1|Overall Study|Physician Decision|1
2820126|NCT03034967|9647754|P6|Overall Study|Withdrawal by Subject|2
2820127|NCT03034967|9647755|P5|Overall Study|Withdrawal by Subject|9
2820128|NCT03034967|9647756|P4|Overall Study|Withdrawal by Subject|6
2820129|NCT03034967|9647757|P3|Overall Study|Withdrawal by Subject|6
2820130|NCT03034967|9647758|P2|Overall Study|Withdrawal by Subject|2
2820131|NCT03034967|9647759|P1|Overall Study|Withdrawal by Subject|9
2820132|NCT03034954|9647957|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
2820133|NCT03034954|9647958|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
2820134|NCT03034915|9648025|P3|Overall Study|Physician Decision|2
2820135|NCT03034915|9648026|P2|Overall Study|Physician Decision|5
2820136|NCT03034915|9648027|P1|Overall Study|Physician Decision|1
2820137|NCT03034915|9648025|P3|Overall Study|Protocol-defined withdrawal criteria met|29
2820138|NCT03034915|9648026|P2|Overall Study|Protocol-defined withdrawal criteria met|26
2820139|NCT03034915|9648027|P1|Overall Study|Protocol-defined withdrawal criteria met|19
2820140|NCT03034915|9648025|P3|Overall Study|Site closed|4
2820141|NCT03034915|9648026|P2|Overall Study|Site closed|2
2820142|NCT03034915|9648027|P1|Overall Study|Site closed|2
2820143|NCT03034915|9648025|P3|Overall Study|Lack of Efficacy|18
2820144|NCT03034915|9648026|P2|Overall Study|Lack of Efficacy|16
2820145|NCT03034915|9648027|P1|Overall Study|Lack of Efficacy|8
2820146|NCT03034915|9648025|P3|Overall Study|Protocol Deviation|7
2820147|NCT03034915|9648026|P2|Overall Study|Protocol Deviation|14
2820148|NCT03034915|9648027|P1|Overall Study|Protocol Deviation|2
2820149|NCT03034915|9648025|P3|Overall Study|Withdrawal by Subject|41
2820150|NCT03034915|9648026|P2|Overall Study|Withdrawal by Subject|46
2820151|NCT03034915|9648027|P1|Overall Study|Withdrawal by Subject|29
2820152|NCT03034915|9648025|P3|Overall Study|Lost to Follow-up|3
2820153|NCT03034915|9648026|P2|Overall Study|Lost to Follow-up|13
2820154|NCT03034915|9648027|P1|Overall Study|Lost to Follow-up|5
2820155|NCT03034915|9648025|P3|Overall Study|Adverse Event|22
2820156|NCT03034915|9648026|P2|Overall Study|Adverse Event|32
2820157|NCT03034915|9648027|P1|Overall Study|Adverse Event|29
2820158|NCT03034577|9648067|P2|Overall Study|Lost to Follow-up|26
2820159|NCT03034577|9648068|P1|Overall Study|Lost to Follow-up|25
2820160|NCT03034577|9648067|P2|Overall Study|Withdrawal by Subject|9
2820161|NCT03034577|9648068|P1|Overall Study|Withdrawal by Subject|6
2820162|NCT03034057|9648084|P1|Overall Study|Medication error without associated AE|1
2820163|NCT03034057|9648084|P1|Overall Study|Adverse Event|22
2820164|NCT03034057|9648084|P1|Overall Study|Lost to Follow-up|19
2820165|NCT03034057|9648084|P1|Overall Study|Not defined|2
2820166|NCT03034057|9648084|P1|Overall Study|Protocol Violation|1
2820167|NCT03034057|9648084|P1|Overall Study|Withdrawal by Subject|10
2820168|NCT03034044|9648090|P1|Overall Study|Enrolled, but not received Xyntha|1
2820169|NCT03033745|9648113|P3|Overall Study|Withdrawal by Subject|0
2820170|NCT03033745|9648114|P2|Overall Study|Withdrawal by Subject|1
2820171|NCT03033745|9648115|P1|Overall Study|Withdrawal by Subject|0
2820172|NCT03033745|9648113|P3|Overall Study|Adverse Event|1
2820173|NCT03033745|9648114|P2|Overall Study|Adverse Event|0
2820174|NCT03033745|9648115|P1|Overall Study|Adverse Event|1
2820175|NCT03033745|9648113|P3|Overall Study|Protocol Violation|1
2820176|NCT03033745|9648114|P2|Overall Study|Protocol Violation|0
2820177|NCT03033745|9648115|P1|Overall Study|Protocol Violation|0
2820178|NCT03032523|9648198|P2|Overall Study|Physician Decision|0
2820179|NCT03032523|9648199|P1|Overall Study|Physician Decision|1
2820180|NCT03032523|9648198|P2|Overall Study|Withdrawal by Subject|2
2820181|NCT03032523|9648199|P1|Overall Study|Withdrawal by Subject|2
2820182|NCT03032510|9648211|P2|Overall Study|Physician Decision|0
2820183|NCT03032510|9648212|P1|Overall Study|Physician Decision|2
2820184|NCT03032510|9648211|P2|Overall Study|Subject noncompliance|2
2820185|NCT03032510|9648212|P1|Overall Study|Subject noncompliance|4
2820186|NCT03032510|9648211|P2|Overall Study|Withdrawal by Subject|7
2820187|NCT03032510|9648212|P1|Overall Study|Withdrawal by Subject|8
2820188|NCT03032510|9648211|P2|Overall Study|Lost to Follow-up|7
2820189|NCT03032510|9648212|P1|Overall Study|Lost to Follow-up|8
2820190|NCT03032510|9648211|P2|Overall Study|Adverse Event|2
2820191|NCT03032510|9648212|P1|Overall Study|Adverse Event|5
2820192|NCT03031899|9648239|P1|Overall Study|lesion disappeared after stopping habit|1
2820193|NCT03031899|9648239|P1|Overall Study|Protocol Violation|1
2820194|NCT03031496|9648256|P2|Period 1|Withdrawal by Subject|2
2820195|NCT03031496|9648257|P1|Period 1|Withdrawal by Subject|0
2820196|NCT03031496|9648256|P2|Period 1|Adverse Event|0
2820197|NCT03031496|9648257|P1|Period 1|Adverse Event|2
2820198|NCT03031431|9648293|P1|Overall Study|Infant removed by maternal request|1
2820199|NCT03029832|9648381|P2|Overall Study|Study Terminated By Sponsor|1
2820200|NCT03029832|9648382|P1|Overall Study|Study Terminated By Sponsor|1
2820201|NCT03029832|9648381|P2|Overall Study|Death due to Disease Progression|0
2820202|NCT03029832|9648382|P1|Overall Study|Death due to Disease Progression|1
2820203|NCT03029832|9648381|P2|Overall Study|Safety Follow-Up Completed|0
2820204|NCT03029832|9648382|P1|Overall Study|Safety Follow-Up Completed|2
2820205|NCT03029819|9648412|P2|Overall Study|Removed due to disruptive behavior|1
2820206|NCT03029819|9648413|P1|Overall Study|Removed due to disruptive behavior|0
2820207|NCT03029819|9648412|P2|Overall Study|Lost to Follow-up|5
2820208|NCT03029819|9648413|P1|Overall Study|Lost to Follow-up|3
2820209|NCT03029780|9648427|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
2820210|NCT03029780|9648428|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
2820211|NCT03029780|9648427|P2|Overall Study|Study Drug Toxicity|5
2820212|NCT03029780|9648428|P1|Overall Study|Study Drug Toxicity|5
2820213|NCT03029780|9648427|P2|Overall Study|Disease Progression|3
2820214|NCT03029780|9648428|P1|Overall Study|Disease Progression|1
2820215|NCT03029650|9648440|P2|Washout (1 Week)|Physician Decision|1
2820216|NCT03029650|9648441|P1|Washout (1 Week)|Physician Decision|0
2820217|NCT03029650|9648440|P2|Washout (1 Week)|Withdrawal by Subject|1
2820218|NCT03029650|9648441|P1|Washout (1 Week)|Withdrawal by Subject|1
2820219|NCT03029234|9648456|P1|Overall Study|Death|61
2820220|NCT03029234|9648456|P1|Overall Study|Withdrawal by Subject|5
2820221|NCT03029234|9648456|P1|Overall Study|Sponsor Decision|1
2820222|NCT03028870|9648550|P4|Overall Study|Administrative|4
2820223|NCT03028870|9648551|P3|Overall Study|Administrative|12
2820224|NCT03028870|9648552|P2|Overall Study|Administrative|5
2820225|NCT03028870|9648553|P1|Overall Study|Administrative|5
2820226|NCT03028870|9648550|P4|Overall Study|Lack of Efficacy|0
2820227|NCT03028870|9648551|P3|Overall Study|Lack of Efficacy|0
2820228|NCT03028870|9648552|P2|Overall Study|Lack of Efficacy|0
2820229|NCT03028870|9648553|P1|Overall Study|Lack of Efficacy|3
2820230|NCT03028870|9648550|P4|Overall Study|Lost to Follow-up|0
2820231|NCT03028870|9648551|P3|Overall Study|Lost to Follow-up|0
2820232|NCT03028870|9648552|P2|Overall Study|Lost to Follow-up|0
2820233|NCT03028870|9648553|P1|Overall Study|Lost to Follow-up|1
2820234|NCT03028870|9648550|P4|Overall Study|Withdrawal by Subject|2
2820235|NCT03028870|9648551|P3|Overall Study|Withdrawal by Subject|1
2820236|NCT03028870|9648552|P2|Overall Study|Withdrawal by Subject|1
2820237|NCT03028870|9648553|P1|Overall Study|Withdrawal by Subject|1
2820238|NCT03028870|9648550|P4|Overall Study|Adverse Event|3
2820239|NCT03028870|9648551|P3|Overall Study|Adverse Event|3
2820240|NCT03028870|9648552|P2|Overall Study|Adverse Event|4
2820241|NCT03028870|9648553|P1|Overall Study|Adverse Event|7
2820242|NCT03028142|9648758|P6|Overall Study|Withdrawal by Subject|0
2820243|NCT03028142|9648759|P5|Overall Study|Withdrawal by Subject|1
2820244|NCT03028142|9648760|P4|Overall Study|Withdrawal by Subject|0
2820245|NCT03028142|9648761|P3|Overall Study|Withdrawal by Subject|0
2820246|NCT03028142|9648762|P2|Overall Study|Withdrawal by Subject|0
2820247|NCT03028142|9648763|P1|Overall Study|Withdrawal by Subject|0
2820248|NCT03028142|9648758|P6|Overall Study|Adverse Event|1
2820249|NCT03028142|9648759|P5|Overall Study|Adverse Event|0
2820250|NCT03028142|9648760|P4|Overall Study|Adverse Event|0
2820251|NCT03028142|9648761|P3|Overall Study|Adverse Event|0
2820252|NCT03028142|9648762|P2|Overall Study|Adverse Event|1
2820253|NCT03028142|9648763|P1|Overall Study|Adverse Event|1
2820254|NCT03028129|9648782|P2|Overall Study|Withdrawal by Subject|45
2820255|NCT03028129|9648783|P1|Overall Study|Withdrawal by Subject|62
2820256|NCT03028129|9648782|P2|Overall Study|Protocol Violation|1
2820257|NCT03028129|9648783|P1|Overall Study|Protocol Violation|1
2820258|NCT03028129|9648782|P2|Overall Study|Physician Decision|1
2820259|NCT03028129|9648783|P1|Overall Study|Physician Decision|0
2820260|NCT03028129|9648782|P2|Overall Study|Lost to Follow-up|38
2820261|NCT03028129|9648783|P1|Overall Study|Lost to Follow-up|50
2820262|NCT03028129|9648782|P2|Overall Study|Adverse Event|2
2820263|NCT03028129|9648783|P1|Overall Study|Adverse Event|13
2820264|NCT03026530|9648879|P2|Overall Study|Protocol Violation|5
2820265|NCT03026530|9648880|P1|Overall Study|Protocol Violation|2
2820266|NCT03026530|9648879|P2|Overall Study|Lost to Follow-up|24
2820267|NCT03026530|9648880|P1|Overall Study|Lost to Follow-up|19
2820268|NCT03026257|9648894|P6|Overall Study|Withdrawal by Subject|0
2820269|NCT03026257|9648895|P5|Overall Study|Withdrawal by Subject|0
2820270|NCT03026257|9648896|P4|Overall Study|Withdrawal by Subject|0
2820271|NCT03026257|9648897|P3|Overall Study|Withdrawal by Subject|0
2820272|NCT03026257|9648898|P2|Overall Study|Withdrawal by Subject|1
2820273|NCT03026257|9648899|P1|Overall Study|Withdrawal by Subject|1
2820274|NCT03026257|9648894|P6|Overall Study|Protocol Violation|0
2820275|NCT03026257|9648895|P5|Overall Study|Protocol Violation|1
2820276|NCT03026257|9648896|P4|Overall Study|Protocol Violation|1
2820277|NCT03026257|9648897|P3|Overall Study|Protocol Violation|0
2820278|NCT03026257|9648898|P2|Overall Study|Protocol Violation|0
2820279|NCT03026257|9648899|P1|Overall Study|Protocol Violation|1
2820280|NCT03026257|9648894|P6|Overall Study|Lost to Follow-up|0
2820281|NCT03026257|9648895|P5|Overall Study|Lost to Follow-up|0
2820282|NCT03026257|9648896|P4|Overall Study|Lost to Follow-up|0
2820283|NCT03026257|9648897|P3|Overall Study|Lost to Follow-up|0
2820284|NCT03026257|9648898|P2|Overall Study|Lost to Follow-up|0
2820285|NCT03026257|9648899|P1|Overall Study|Lost to Follow-up|1
2820286|NCT03026257|9648894|P6|Overall Study|Adverse Event|0
2820287|NCT03026257|9648895|P5|Overall Study|Adverse Event|0
2820288|NCT03026257|9648896|P4|Overall Study|Adverse Event|0
2820289|NCT03026257|9648897|P3|Overall Study|Adverse Event|0
2820290|NCT03026257|9648898|P2|Overall Study|Adverse Event|0
2820291|NCT03026257|9648899|P1|Overall Study|Adverse Event|3
2820292|NCT03026088|9648913|P1|Overall Study|Study termination|20
2820293|NCT03026075|9648937|P1|Overall Study|Physician Decision|1
2820294|NCT03025217|9648950|P1|Overall Study|Not eligible, poor English|2
2820295|NCT03025217|9648950|P1|Overall Study|Lost to Follow-up|1
2820296|NCT03025217|9648950|P1|Overall Study|Pregnancy|1
2820297|NCT03024606|9648957|P2|Overall Study|Withdrawal by Subject|10
2820298|NCT03024606|9648958|P1|Overall Study|Withdrawal by Subject|9
2820299|NCT03023878|9648986|P1|Long Term Follow-Up (as of 22-10-2019)|Death|2
2820300|NCT03023878|9648986|P1|Long Term Follow-Up (as of 22-10-2019)|Continuing in study|20
2820301|NCT03023878|9648986|P1|Treatment Period|Adverse Event|1
2820302|NCT03023878|9648986|P1|Treatment Period|Withdrawal by Subject|1
2820303|NCT03023878|9648986|P1|Treatment Period|Disease Progression|1
2820304|NCT03023878|9648986|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
2820305|NCT03023878|9648986|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
2820306|NCT03023878|9648986|P1|Pre-Study Run-In Period|Death|1
2820307|NCT03023878|9648986|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
2820308|NCT03023423|9649048|P3|Overall Study|Ongoing|24
2820309|NCT03023423|9649049|P2|Overall Study|Ongoing|32
2820310|NCT03023423|9649050|P1|Overall Study|Ongoing|2
2820311|NCT03023423|9649048|P3|Overall Study|Other|2
2820312|NCT03023423|9649049|P2|Overall Study|Other|2
2820313|NCT03023423|9649050|P1|Overall Study|Other|0
2820314|NCT03023423|9649048|P3|Overall Study|Death|20
2820315|NCT03023423|9649049|P2|Overall Study|Death|12
2820316|NCT03023423|9649050|P1|Overall Study|Death|5
2820317|NCT03023137|9649087|P2|Overall Study|Lost the baby in a car accident|0
2820318|NCT03023137|9649088|P1|Overall Study|Lost the baby in a car accident|1
2820319|NCT03023137|9649087|P2|Overall Study|Protocol Violation|4
2820320|NCT03023137|9649088|P1|Overall Study|Protocol Violation|0
2820321|NCT03023137|9649087|P2|Overall Study|Lost to Follow-up|1
2820322|NCT03023137|9649088|P1|Overall Study|Lost to Follow-up|1
2820323|NCT03023137|9649087|P2|Overall Study|Multiple pregnancy|4
2820324|NCT03023137|9649088|P1|Overall Study|Multiple pregnancy|2
2820325|NCT03022799|9649137|P13|Overall Study|Adverse Event|0
2820326|NCT03022799|9649138|P12|Overall Study|Adverse Event|0
2820327|NCT03022799|9649139|P11|Overall Study|Adverse Event|1
2820328|NCT03022799|9649140|P10|Overall Study|Adverse Event|1
2820329|NCT03022799|9649141|P9|Overall Study|Adverse Event|0
2820330|NCT03022799|9649142|P8|Overall Study|Adverse Event|0
2820331|NCT03022799|9649143|P7|Overall Study|Adverse Event|0
2820332|NCT03022799|9649144|P6|Overall Study|Adverse Event|0
2820333|NCT03022799|9649145|P5|Overall Study|Adverse Event|0
2820334|NCT03022799|9649146|P4|Overall Study|Adverse Event|0
2820335|NCT03022799|9649147|P3|Overall Study|Adverse Event|0
2820336|NCT03022799|9649148|P2|Overall Study|Adverse Event|0
2820337|NCT03022799|9649149|P1|Overall Study|Adverse Event|0
2820338|NCT03022630|9649346|P2|Overall Study|Withdrawal by Subject|5
2820339|NCT03022630|9649347|P1|Overall Study|Withdrawal by Subject|0
2820340|NCT03022630|9649346|P2|Overall Study|Death|7
2820341|NCT03022630|9649347|P1|Overall Study|Death|9
2820342|NCT03022422|9649427|P6|Overall Study|3 subjects consented but not vaccinated|0
2820343|NCT03022422|9649428|P5|Overall Study|3 subjects consented but not vaccinated|0
2820344|NCT03022422|9649429|P4|Overall Study|3 subjects consented but not vaccinated|0
2820345|NCT03022422|9649430|P3|Overall Study|3 subjects consented but not vaccinated|3
2820346|NCT03022422|9649431|P2|Overall Study|3 subjects consented but not vaccinated|0
2820347|NCT03022422|9649432|P1|Overall Study|3 subjects consented but not vaccinated|0
2820348|NCT03022045|9649485|P2|Overall Study|Withdrawal by Subject|1
2820349|NCT03022045|9649486|P1|Overall Study|Withdrawal by Subject|1
2820350|NCT03022045|9649485|P2|Overall Study|Adverse Event|1
2820351|NCT03022045|9649486|P1|Overall Study|Adverse Event|0
2820352|NCT03021668|9649515|P2|Overall Study|Physician Decision|1
2820353|NCT03021668|9649516|P1|Overall Study|Physician Decision|0
2820354|NCT03021642|9649528|P2|Washout Period (21 Days)|Adverse Event|1
2820355|NCT03021642|9649529|P1|Washout Period (21 Days)|Adverse Event|1
2820356|NCT03021304|9649587|P1|Overall Study|Lack of Efficacy|1
2820357|NCT03021265|9649592|P1|Overall Study|No visit since the first visit|4
2820358|NCT03021265|9649592|P1|Overall Study|No reason given|2
2820359|NCT03021265|9649592|P1|Overall Study|Lost to Follow-up|67
2820360|NCT03021265|9649592|P1|Overall Study|Improved|17
2820361|NCT03021265|9649592|P1|Overall Study|Lack of Efficacy|3
2820362|NCT03021265|9649592|P1|Overall Study|Adverse Event|29
2820363|NCT03021187|9649602|P4|Overall Study|Lost to Follow-up|4
2820364|NCT03021187|9649603|P3|Overall Study|Lost to Follow-up|1
2820365|NCT03021187|9649604|P2|Overall Study|Lost to Follow-up|3
2820366|NCT03021187|9649605|P1|Overall Study|Lost to Follow-up|10
2820367|NCT03021187|9649602|P4|Overall Study|Withdrawal by Subject|5
2820368|NCT03021187|9649603|P3|Overall Study|Withdrawal by Subject|2
2820369|NCT03021187|9649604|P2|Overall Study|Withdrawal by Subject|6
2820370|NCT03021187|9649605|P1|Overall Study|Withdrawal by Subject|0
2820371|NCT03021187|9649602|P4|Overall Study|Death|0
2820372|NCT03021187|9649603|P3|Overall Study|Death|3
2820373|NCT03021187|9649604|P2|Overall Study|Death|0
2820374|NCT03021187|9649605|P1|Overall Study|Death|0
2820375|NCT03021018|9649761|P3|Overall Study|Fall with subsequent nasal fracture|0
2820376|NCT03021018|9649762|P2|Overall Study|Fall with subsequent nasal fracture|0
2820377|NCT03021018|9649763|P1|Overall Study|Fall with subsequent nasal fracture|1
2820378|NCT03021018|9649761|P3|Overall Study|Adverse Event|0
2820379|NCT03021018|9649762|P2|Overall Study|Adverse Event|0
2820380|NCT03021018|9649763|P1|Overall Study|Adverse Event|1
2820381|NCT03021005|9649794|P2|Overall Study|Lost to Follow-up|26
2820382|NCT03021005|9649795|P1|Overall Study|Lost to Follow-up|39
2820383|NCT03020745|9649809|P10|Part 2 (Up to 169 Days)|Ongoing in study|0
2820384|NCT03020745|9649810|P9|Part 2 (Up to 169 Days)|Ongoing in study|0
2820385|NCT03020745|9649811|P8|Part 2 (Up to 169 Days)|Ongoing in study|1
2820386|NCT03020745|9649812|P7|Part 2 (Up to 169 Days)|Ongoing in study|0
2820387|NCT03020745|9649813|P6|Part 2 (Up to 169 Days)|Ongoing in study|0
2820388|NCT03020745|9649814|P5|Part 2 (Up to 169 Days)|Ongoing in study|0
2820389|NCT03020745|9649815|P4|Part 2 (Up to 169 Days)|Ongoing in study|0
2820390|NCT03020745|9649816|P3|Part 2 (Up to 169 Days)|Ongoing in study|0
2820391|NCT03020745|9649817|P2|Part 2 (Up to 169 Days)|Ongoing in study|0
2820392|NCT03020745|9649818|P1|Part 2 (Up to 169 Days)|Ongoing in study|0
2820393|NCT03020745|9649809|P10|Part 2 (Up to 169 Days)|Adverse Event|0
2820394|NCT03020745|9649810|P9|Part 2 (Up to 169 Days)|Adverse Event|1
2820395|NCT03020745|9649811|P8|Part 2 (Up to 169 Days)|Adverse Event|0
2820396|NCT03020745|9649812|P7|Part 2 (Up to 169 Days)|Adverse Event|0
2820397|NCT03020745|9649813|P6|Part 2 (Up to 169 Days)|Adverse Event|0
2820398|NCT03020745|9649814|P5|Part 2 (Up to 169 Days)|Adverse Event|0
2820399|NCT03020745|9649815|P4|Part 2 (Up to 169 Days)|Adverse Event|0
2820400|NCT03020745|9649816|P3|Part 2 (Up to 169 Days)|Adverse Event|0
2820401|NCT03020745|9649817|P2|Part 2 (Up to 169 Days)|Adverse Event|0
2820402|NCT03020745|9649818|P1|Part 2 (Up to 169 Days)|Adverse Event|0
2820403|NCT03020576|9650079|P2|Overall Study|Withdrawal by Subject|2
2820404|NCT03020576|9650080|P1|Overall Study|Withdrawal by Subject|1
2820405|NCT03020160|9650135|P2|Overall Study|Continuing to receive emicizumab|41
2820406|NCT03020160|9650136|P1|Overall Study|Continuing to receive emicizumab|7
2820407|NCT03020069|9650191|P2|Overall Study|Lost to Follow-up|1
2820408|NCT03020069|9650192|P1|Overall Study|Lost to Follow-up|0
2820409|NCT03019627|9650238|P2|Overall Study|Other|2
2820410|NCT03019627|9650239|P1|Overall Study|Other|2
2820411|NCT03019627|9650238|P2|Overall Study|not compliance|2
2820412|NCT03019627|9650239|P1|Overall Study|not compliance|2
2820413|NCT03019627|9650238|P2|Overall Study|Lost to Follow-up|1
2820414|NCT03019627|9650239|P1|Overall Study|Lost to Follow-up|2
2820415|NCT03019627|9650238|P2|Overall Study|Unrelated to adverse event|3
2820416|NCT03019627|9650239|P1|Overall Study|Unrelated to adverse event|1
2820417|NCT03019627|9650238|P2|Overall Study|Adverse Event|0
2820418|NCT03019627|9650239|P1|Overall Study|Adverse Event|8
2820419|NCT03019549|9650255|P1|Period 2|Withdrawal by Subject|1
2820420|NCT03019549|9650255|P1|Period 2|Physician Decision|2
2820421|NCT03019549|9650255|P1|Period 2|Adverse Event|2
2820422|NCT03019549|9650255|P1|Washout|DId not meet genotype criteria|11
2820423|NCT03019458|9650268|P2|Overall Study|Death|1
2820424|NCT03019458|9650269|P1|Overall Study|Death|0
2820425|NCT03018938|9650283|P2|Overall Study|Not recorded|2
2820426|NCT03018938|9650284|P1|Overall Study|Not recorded|0
2820427|NCT03018938|9650283|P2|Overall Study|Screen failure-After randomization|2
2820428|NCT03018938|9650284|P1|Overall Study|Screen failure-After randomization|4
2820429|NCT03018938|9650283|P2|Overall Study|Sponsor Decision|1
2820430|NCT03018938|9650284|P1|Overall Study|Sponsor Decision|0
2820431|NCT03018938|9650283|P2|Overall Study|Physician Decision|2
2820432|NCT03018938|9650284|P1|Overall Study|Physician Decision|3
2820433|NCT03018938|9650283|P2|Overall Study|Withdrawal by Subject|45
2820434|NCT03018938|9650284|P1|Overall Study|Withdrawal by Subject|38
2820435|NCT03018938|9650283|P2|Overall Study|Lost to Follow-up|32
2820436|NCT03018938|9650284|P1|Overall Study|Lost to Follow-up|21
2820437|NCT03018938|9650283|P2|Overall Study|Death|1
2820438|NCT03018938|9650284|P1|Overall Study|Death|0
2820439|NCT03018340|9650322|P2|Overall Study|Not further specified|1
2820440|NCT03018340|9650323|P1|Overall Study|Not further specified|0
2820441|NCT03018340|9650322|P2|Overall Study|Protocol Violation|7
2820442|NCT03018340|9650323|P1|Overall Study|Protocol Violation|3
2820443|NCT03018340|9650322|P2|Overall Study|Lost to Follow-up|7
2820444|NCT03018340|9650323|P1|Overall Study|Lost to Follow-up|1
2820445|NCT03018340|9650322|P2|Overall Study|Non-compliance with study drug/procedure|4
2820446|NCT03018340|9650323|P1|Overall Study|Non-compliance with study drug/procedure|3
2820447|NCT03018340|9650322|P2|Overall Study|Lack of Efficacy|1
2820448|NCT03018340|9650323|P1|Overall Study|Lack of Efficacy|0
2820449|NCT03018340|9650322|P2|Overall Study|Withdrawal by Subject|8
2820450|NCT03018340|9650323|P1|Overall Study|Withdrawal by Subject|0
2820451|NCT03018340|9650322|P2|Overall Study|Adverse Event|2
2820452|NCT03018340|9650323|P1|Overall Study|Adverse Event|1
2820453|NCT03018106|9650382|P2|Overall Study|Lost to Follow-up|1
2820454|NCT03018106|9650383|P1|Overall Study|Lost to Follow-up|0
2820455|NCT03018028|9650396|P5|Overall Study|Withdrawal by Subject|0
2820456|NCT03018028|9650397|P4|Overall Study|Withdrawal by Subject|2
2820457|NCT03018028|9650398|P3|Overall Study|Withdrawal by Subject|1
2820458|NCT03018028|9650399|P2|Overall Study|Withdrawal by Subject|0
2820459|NCT03018028|9650400|P1|Overall Study|Withdrawal by Subject|3
2820460|NCT03017846|9650645|P1|Overall Study|Adverse Event|2
2820461|NCT03017846|9650645|P1|Overall Study|Lost to Follow-up|3
2820462|NCT03017612|9650653|P1|Overall Study|Adverse Event|2
2820463|NCT03017235|9650698|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
2820464|NCT03017235|9650699|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
2820465|NCT03017235|9650698|P2|Overall Study|Protocol Violation|1
2820466|NCT03017235|9650699|P1|Overall Study|Protocol Violation|2
2820467|NCT03017235|9650698|P2|Overall Study|Adverse Event|1
2820468|NCT03017235|9650699|P1|Overall Study|Adverse Event|0
2820469|NCT03017235|9650698|P2|Overall Study|Lost to Follow-up|7
2820470|NCT03017235|9650699|P1|Overall Study|Lost to Follow-up|2
2820471|NCT03017235|9650698|P2|Overall Study|Withdrawal by Subject|3
2820472|NCT03017235|9650699|P1|Overall Study|Withdrawal by Subject|4
2820473|NCT03016078|9650760|P1|Overall Study|Protocol Violation|1
2820474|NCT03016078|9650760|P1|Overall Study|Protocol Violation|1
2820475|NCT03015220|9650779|P4|Overall Study|Lost to Follow-up|0
2820476|NCT03015220|9650780|P3|Overall Study|Lost to Follow-up|1
2820477|NCT03015220|9650781|P2|Overall Study|Lost to Follow-up|0
2820478|NCT03015220|9650782|P1|Overall Study|Lost to Follow-up|0
2820479|NCT03015220|9650779|P4|Overall Study|Withdrawal by Subject|2
2820480|NCT03015220|9650780|P3|Overall Study|Withdrawal by Subject|2
2820481|NCT03015220|9650781|P2|Overall Study|Withdrawal by Subject|2
2820482|NCT03015220|9650782|P1|Overall Study|Withdrawal by Subject|3
2820483|NCT03015181|9650927|P7|Overall Study|Physician Decision|1
2820484|NCT03015181|9650928|P6|Overall Study|Physician Decision|0
2820485|NCT03015181|9650929|P5|Overall Study|Physician Decision|0
2820486|NCT03015181|9650930|P4|Overall Study|Physician Decision|0
2820487|NCT03015181|9650931|P3|Overall Study|Physician Decision|0
2820488|NCT03015181|9650932|P2|Overall Study|Physician Decision|0
2820489|NCT03015181|9650933|P1|Overall Study|Physician Decision|0
2820490|NCT03015181|9650927|P7|Overall Study|Withdrawal by Subject|0
2820491|NCT03015181|9650928|P6|Overall Study|Withdrawal by Subject|1
2820492|NCT03015181|9650929|P5|Overall Study|Withdrawal by Subject|0
2820493|NCT03015181|9650930|P4|Overall Study|Withdrawal by Subject|0
2820494|NCT03015181|9650931|P3|Overall Study|Withdrawal by Subject|0
2820495|NCT03015181|9650932|P2|Overall Study|Withdrawal by Subject|0
2820496|NCT03015181|9650933|P1|Overall Study|Withdrawal by Subject|0
2820497|NCT03015181|9650927|P7|Overall Study|Enrolled, but product never administered|0
2820498|NCT03015181|9650928|P6|Overall Study|Enrolled, but product never administered|0
2820499|NCT03015181|9650929|P5|Overall Study|Enrolled, but product never administered|0
2820500|NCT03015181|9650930|P4|Overall Study|Enrolled, but product never administered|0
2820501|NCT03015181|9650931|P3|Overall Study|Enrolled, but product never administered|0
2820502|NCT03015181|9650932|P2|Overall Study|Enrolled, but product never administered|0
2820503|NCT03015181|9650933|P1|Overall Study|Enrolled, but product never administered|1
2820504|NCT03014674|9651079|P3|Overall Study|Withdrawal by Subject|0
2820505|NCT03014674|9651080|P2|Overall Study|Withdrawal by Subject|0
2820506|NCT03014674|9651081|P1|Overall Study|Withdrawal by Subject|1
2820507|NCT03014479|9651145|P2|Overall Study|Unacceptable Inability of Site Visit|1
2820508|NCT03014479|9651146|P1|Overall Study|Unacceptable Inability of Site Visit|0
2820509|NCT03014479|9651145|P2|Overall Study|Voluntary Withdrawal|2
2820510|NCT03014479|9651146|P1|Overall Study|Voluntary Withdrawal|0
2820511|NCT03014479|9651145|P2|Overall Study|Adverse Event|1
2820512|NCT03014479|9651146|P1|Overall Study|Adverse Event|0
2820513|NCT03014453|9651192|P1|Overall Study|Refused to take part in|37
2820514|NCT03014453|9651192|P1|Overall Study|Excluded|19
2820515|NCT03014453|9651192|P1|Overall Study|Discontinued GER|3
2820516|NCT03014453|9651192|P1|Overall Study|Lost to Follow-up|12
2820517|NCT03014206|9651196|P1|Overall Study|Registration Violation|12
2820518|NCT03014180|9651200|P1|Overall Study|Protocol Violation|2
2820519|NCT03014011|9651209|P2|Washout|Withdrawal by Subject|0
2820520|NCT03014011|9651210|P1|Washout|Withdrawal by Subject|1
2820521|NCT03014011|9651209|P2|First Intervention|Withdrawal by Subject|0
2820522|NCT03014011|9651210|P1|First Intervention|Withdrawal by Subject|1
2820523|NCT03013985|9651218|P2|Overall Study|Withdrawal by Subject|17
2820524|NCT03013985|9651219|P1|Overall Study|Withdrawal by Subject|14
2820525|NCT03013985|9651218|P2|Overall Study|Protocol Violation|2
2820526|NCT03013985|9651219|P1|Overall Study|Protocol Violation|2
2820527|NCT03012828|9651257|P6|Overall Study|Delay to last visit would delay DBL|1
2820528|NCT03012828|9651258|P5|Overall Study|Delay to last visit would delay DBL|0
2820529|NCT03012828|9651259|P4|Overall Study|Delay to last visit would delay DBL|0
2820530|NCT03012828|9651260|P3|Overall Study|Delay to last visit would delay DBL|0
2820531|NCT03012828|9651261|P2|Overall Study|Delay to last visit would delay DBL|0
2820532|NCT03012828|9651262|P1|Overall Study|Delay to last visit would delay DBL|0
2820533|NCT03012828|9651257|P6|Overall Study|Non-compliance with protocol|0
2820534|NCT03012828|9651258|P5|Overall Study|Non-compliance with protocol|1
2820535|NCT03012828|9651259|P4|Overall Study|Non-compliance with protocol|0
2820536|NCT03012828|9651260|P3|Overall Study|Non-compliance with protocol|0
2820537|NCT03012828|9651261|P2|Overall Study|Non-compliance with protocol|0
2820538|NCT03012828|9651262|P1|Overall Study|Non-compliance with protocol|0
2820539|NCT03012828|9651257|P6|Overall Study|Withdrawal by Subject|1
2820540|NCT03012828|9651258|P5|Overall Study|Withdrawal by Subject|0
2820541|NCT03012828|9651259|P4|Overall Study|Withdrawal by Subject|0
2820542|NCT03012828|9651260|P3|Overall Study|Withdrawal by Subject|1
2820543|NCT03012828|9651261|P2|Overall Study|Withdrawal by Subject|0
2820544|NCT03012828|9651262|P1|Overall Study|Withdrawal by Subject|0
2820545|NCT03012828|9651257|P6|Overall Study|Lost to Follow-up|0
2820546|NCT03012828|9651258|P5|Overall Study|Lost to Follow-up|1
2820547|NCT03012828|9651259|P4|Overall Study|Lost to Follow-up|0
2820548|NCT03012828|9651260|P3|Overall Study|Lost to Follow-up|1
2820549|NCT03012828|9651261|P2|Overall Study|Lost to Follow-up|0
2820550|NCT03012828|9651262|P1|Overall Study|Lost to Follow-up|1
2820551|NCT03012334|9651305|P10|Period 4|Adverse Event|0
2820552|NCT03012334|9651306|P9|Period 4|Adverse Event|1
2820553|NCT03012334|9651307|P8|Period 4|Adverse Event|0
2820554|NCT03012334|9651308|P7|Period 4|Adverse Event|0
2820555|NCT03012334|9651309|P6|Period 4|Adverse Event|0
2820556|NCT03012334|9651310|P5|Period 4|Adverse Event|0
2820557|NCT03012334|9651311|P4|Period 4|Adverse Event|0
2820558|NCT03012334|9651312|P3|Period 4|Adverse Event|0
2820559|NCT03012334|9651313|P2|Period 4|Adverse Event|0
2820560|NCT03012334|9651314|P1|Period 4|Adverse Event|0
2820561|NCT03012334|9651305|P10|Period 4|Non-Compliance|0
2820562|NCT03012334|9651306|P9|Period 4|Non-Compliance|0
2820563|NCT03012334|9651307|P8|Period 4|Non-Compliance|0
2820564|NCT03012334|9651308|P7|Period 4|Non-Compliance|1
2820565|NCT03012334|9651309|P6|Period 4|Non-Compliance|0
2820566|NCT03012334|9651310|P5|Period 4|Non-Compliance|0
2820567|NCT03012334|9651311|P4|Period 4|Non-Compliance|0
2820568|NCT03012334|9651312|P3|Period 4|Non-Compliance|0
2820569|NCT03012334|9651313|P2|Period 4|Non-Compliance|0
2820570|NCT03012334|9651314|P1|Period 4|Non-Compliance|0
2820571|NCT03012334|9651305|P10|Period 2|Protocol Violation|0
2820572|NCT03012334|9651306|P9|Period 2|Protocol Violation|0
2820573|NCT03012334|9651307|P8|Period 2|Protocol Violation|1
2820574|NCT03012334|9651308|P7|Period 2|Protocol Violation|0
2820575|NCT03012334|9651309|P6|Period 2|Protocol Violation|0
2820576|NCT03012334|9651310|P5|Period 2|Protocol Violation|0
2820577|NCT03012334|9651311|P4|Period 2|Protocol Violation|0
2820578|NCT03012334|9651312|P3|Period 2|Protocol Violation|1
2820579|NCT03012334|9651313|P2|Period 2|Protocol Violation|0
2820580|NCT03012334|9651314|P1|Period 2|Protocol Violation|0
2820581|NCT03012334|9651305|P10|Period 2|Withdrawal by Subject|0
2820582|NCT03012334|9651306|P9|Period 2|Withdrawal by Subject|0
2820583|NCT03012334|9651307|P8|Period 2|Withdrawal by Subject|0
2820584|NCT03012334|9651308|P7|Period 2|Withdrawal by Subject|0
2820585|NCT03012334|9651309|P6|Period 2|Withdrawal by Subject|0
2820586|NCT03012334|9651310|P5|Period 2|Withdrawal by Subject|0
2820587|NCT03012334|9651311|P4|Period 2|Withdrawal by Subject|0
2820588|NCT03012334|9651312|P3|Period 2|Withdrawal by Subject|0
2820589|NCT03012334|9651313|P2|Period 2|Withdrawal by Subject|1
2820590|NCT03012334|9651314|P1|Period 2|Withdrawal by Subject|0
2820591|NCT03012334|9651305|P10|Period 1|Withdrawal by Subject|1
2820592|NCT03012334|9651306|P9|Period 1|Withdrawal by Subject|0
2820593|NCT03012334|9651307|P8|Period 1|Withdrawal by Subject|0
2820594|NCT03012334|9651308|P7|Period 1|Withdrawal by Subject|0
2820595|NCT03012334|9651309|P6|Period 1|Withdrawal by Subject|0
2820596|NCT03012334|9651310|P5|Period 1|Withdrawal by Subject|0
2820597|NCT03012334|9651311|P4|Period 1|Withdrawal by Subject|0
2820598|NCT03012334|9651312|P3|Period 1|Withdrawal by Subject|0
2820599|NCT03012334|9651313|P2|Period 1|Withdrawal by Subject|0
2820600|NCT03012334|9651314|P1|Period 1|Withdrawal by Subject|0
2820601|NCT03012061|9651384|P3|Overall Study|Adverse Event|0
2820602|NCT03012061|9651385|P2|Overall Study|Adverse Event|0
2820603|NCT03012061|9651386|P1|Overall Study|Adverse Event|2
2820604|NCT03012061|9651384|P3|Overall Study|Lack of Efficacy|0
2820605|NCT03012061|9651385|P2|Overall Study|Lack of Efficacy|1
2820606|NCT03012061|9651386|P1|Overall Study|Lack of Efficacy|0
2820607|NCT03012061|9651384|P3|Overall Study|Protocol Violation|2
2820608|NCT03012061|9651385|P2|Overall Study|Protocol Violation|0
2820609|NCT03012061|9651386|P1|Overall Study|Protocol Violation|0
2820610|NCT03012061|9651384|P3|Overall Study|Met Protocol Withdrawal Criterion|1
2820611|NCT03012061|9651385|P2|Overall Study|Met Protocol Withdrawal Criterion|0
2820612|NCT03012061|9651386|P1|Overall Study|Met Protocol Withdrawal Criterion|0
2820613|NCT03012061|9651384|P3|Overall Study|Study closed/ Terminated|1
2820614|NCT03012061|9651385|P2|Overall Study|Study closed/ Terminated|0
2820615|NCT03012061|9651386|P1|Overall Study|Study closed/ Terminated|0
2820616|NCT03012061|9651384|P3|Overall Study|Lost to Follow-up|0
2820617|NCT03012061|9651385|P2|Overall Study|Lost to Follow-up|1
2820618|NCT03012061|9651386|P1|Overall Study|Lost to Follow-up|2
2820619|NCT03012061|9651384|P3|Overall Study|Investigator Site Closed|0
2820620|NCT03012061|9651385|P2|Overall Study|Investigator Site Closed|2
2820621|NCT03012061|9651386|P1|Overall Study|Investigator Site Closed|1
2820622|NCT03012061|9651384|P3|Overall Study|Withdrawal by Subject|4
2820623|NCT03012061|9651385|P2|Overall Study|Withdrawal by Subject|5
2820624|NCT03012061|9651386|P1|Overall Study|Withdrawal by Subject|1
2820625|NCT03011840|9651411|P2|Overall Study|Not received PIL in post PIL phase|21
2820626|NCT03011840|9651412|P1|Overall Study|Not received PIL in post PIL phase|0
2820627|NCT03011099|9651422|P2|Overall Study|Withdrawal by Subject|2
2820628|NCT03011099|9651423|P1|Overall Study|Withdrawal by Subject|0
2820629|NCT03011034|9651449|P2|Overall Study|Adverse Event|0
2820630|NCT03011034|9651450|P1|Overall Study|Adverse Event|1
2820631|NCT03010501|9651512|P6|Study Week 3|Withdrawal by Subject|0
2820632|NCT03010501|9651513|P5|Study Week 3|Withdrawal by Subject|0
2820633|NCT03010501|9651514|P4|Study Week 3|Withdrawal by Subject|1
2820634|NCT03010501|9651515|P3|Study Week 3|Withdrawal by Subject|0
2820635|NCT03010501|9651516|P2|Study Week 3|Withdrawal by Subject|0
2820636|NCT03010501|9651517|P1|Study Week 3|Withdrawal by Subject|0
2820637|NCT03010501|9651512|P6|Study Week 1|Withdrawal by Subject|0
2820638|NCT03010501|9651513|P5|Study Week 1|Withdrawal by Subject|0
2820639|NCT03010501|9651514|P4|Study Week 1|Withdrawal by Subject|2
2820640|NCT03010501|9651515|P3|Study Week 1|Withdrawal by Subject|0
2820641|NCT03010501|9651516|P2|Study Week 1|Withdrawal by Subject|1
2820642|NCT03010501|9651517|P1|Study Week 1|Withdrawal by Subject|2
2820643|NCT03010254|9651533|P2|Overall Study|Other|3
2820644|NCT03010254|9651534|P1|Overall Study|Other|2
2820645|NCT03010254|9651533|P2|Overall Study|Withdrawal by Subject|1
2820646|NCT03010254|9651534|P1|Overall Study|Withdrawal by Subject|1
2820647|NCT03010254|9651533|P2|Overall Study|Lost to Follow-up|0
2820648|NCT03010254|9651534|P1|Overall Study|Lost to Follow-up|4
2820649|NCT03010254|9651533|P2|Overall Study|Adverse Event|1
2820650|NCT03010254|9651534|P1|Overall Study|Adverse Event|0
2820651|NCT03007966|9651640|P2|Overall Study|Did not meeting inclusion/exclusion|0
2820652|NCT03007966|9651641|P1|Overall Study|Did not meeting inclusion/exclusion|1
2820653|NCT03006562|9651684|P2|Overall Study|Lost to Follow-up|1
2820654|NCT03006562|9651685|P1|Overall Study|Lost to Follow-up|0
2820655|NCT03006341|9651707|P4|Overall Study|Not linked in the EMR|10685
2820656|NCT03006341|9651708|P3|Overall Study|Not linked in the EMR|30993
2820657|NCT03006341|9651709|P2|Overall Study|Not linked in the EMR|67505
2820658|NCT03006341|9651710|P1|Overall Study|Not linked in the EMR|25069
2820659|NCT03005067|9651754|P2|Overall Study|Protocol Violation|1
2820660|NCT03005067|9651755|P1|Overall Study|Protocol Violation|0
2820661|NCT03005067|9651754|P2|Overall Study|Other (reason not specified)|1
2820662|NCT03005067|9651755|P1|Overall Study|Other (reason not specified)|3
2820663|NCT03005067|9651754|P2|Overall Study|Adverse Event|3
2820664|NCT03005067|9651755|P1|Overall Study|Adverse Event|4
2820665|NCT03005067|9651754|P2|Overall Study|Withdrawal by Subject|2
2820666|NCT03005067|9651755|P1|Overall Study|Withdrawal by Subject|3
2820667|NCT03004924|9651783|P3|Overall Study|HSV1 Positive|0
2820668|NCT03004924|9651784|P2|Overall Study|HSV1 Positive|0
2820669|NCT03004924|9651785|P1|Overall Study|HSV1 Positive|1
2820670|NCT03004924|9651783|P3|Overall Study|Missed Study Visit|2
2820671|NCT03004924|9651784|P2|Overall Study|Missed Study Visit|0
2820672|NCT03004924|9651785|P1|Overall Study|Missed Study Visit|0
2820673|NCT03004924|9651783|P3|Overall Study|Terminated by Sponsor|1
2820674|NCT03004924|9651784|P2|Overall Study|Terminated by Sponsor|0
2820675|NCT03004924|9651785|P1|Overall Study|Terminated by Sponsor|0
2820676|NCT03004924|9651783|P3|Overall Study|Pregnancy|0
2820677|NCT03004924|9651784|P2|Overall Study|Pregnancy|1
2820678|NCT03004924|9651785|P1|Overall Study|Pregnancy|0
2820679|NCT03004924|9651783|P3|Overall Study|Screen Failure|0
2820680|NCT03004924|9651784|P2|Overall Study|Screen Failure|0
2820681|NCT03004924|9651785|P1|Overall Study|Screen Failure|1
2820682|NCT03004924|9651783|P3|Overall Study|Withdrawal by parent/guardian|2
2820683|NCT03004924|9651784|P2|Overall Study|Withdrawal by parent/guardian|0
2820684|NCT03004924|9651785|P1|Overall Study|Withdrawal by parent/guardian|1
2820685|NCT03004924|9651783|P3|Overall Study|Physician Decision|1
2820686|NCT03004924|9651784|P2|Overall Study|Physician Decision|0
2820687|NCT03004924|9651785|P1|Overall Study|Physician Decision|1
2820688|NCT03004924|9651783|P3|Overall Study|Lack of Efficacy|2
2820689|NCT03004924|9651784|P2|Overall Study|Lack of Efficacy|4
2820690|NCT03004924|9651785|P1|Overall Study|Lack of Efficacy|2
2820691|NCT03004924|9651783|P3|Overall Study|Lost to Follow-up|4
2820692|NCT03004924|9651784|P2|Overall Study|Lost to Follow-up|1
2820693|NCT03004924|9651785|P1|Overall Study|Lost to Follow-up|6
2820694|NCT03004924|9651783|P3|Overall Study|Withdrawal by Subject|5
2820695|NCT03004924|9651784|P2|Overall Study|Withdrawal by Subject|3
2820696|NCT03004924|9651785|P1|Overall Study|Withdrawal by Subject|5
2820697|NCT03004924|9651783|P3|Overall Study|Protocol Violation|1
2820698|NCT03004924|9651784|P2|Overall Study|Protocol Violation|0
2820699|NCT03004924|9651785|P1|Overall Study|Protocol Violation|4
2820700|NCT03004924|9651783|P3|Overall Study|Adverse Event|10
2820701|NCT03004924|9651784|P2|Overall Study|Adverse Event|5
2820702|NCT03004924|9651785|P1|Overall Study|Adverse Event|6
2820703|NCT03004469|9652029|P3|Overall Study|Other unspecified reason|1
2820704|NCT03004469|9652030|P2|Overall Study|Other unspecified reason|4
2820705|NCT03004469|9652031|P1|Overall Study|Other unspecified reason|0
2820706|NCT03004469|9652029|P3|Overall Study|Withdrawal by Subject|10
2820707|NCT03004469|9652030|P2|Overall Study|Withdrawal by Subject|27
2820708|NCT03004469|9652031|P1|Overall Study|Withdrawal by Subject|29
2820709|NCT03004469|9652029|P3|Overall Study|Protocol Violation|1
2820710|NCT03004469|9652030|P2|Overall Study|Protocol Violation|0
2820711|NCT03004469|9652031|P1|Overall Study|Protocol Violation|0
2820712|NCT03004469|9652029|P3|Overall Study|Non-Compliance with Study Drug|0
2820713|NCT03004469|9652030|P2|Overall Study|Non-Compliance with Study Drug|0
2820714|NCT03004469|9652031|P1|Overall Study|Non-Compliance with Study Drug|2
2820715|NCT03004469|9652029|P3|Overall Study|Lost to Follow-up|6
2820716|NCT03004469|9652030|P2|Overall Study|Lost to Follow-up|14
2820717|NCT03004469|9652031|P1|Overall Study|Lost to Follow-up|23
2820718|NCT03004469|9652029|P3|Overall Study|Lack of Efficacy|1
2820719|NCT03004469|9652030|P2|Overall Study|Lack of Efficacy|0
2820720|NCT03004469|9652031|P1|Overall Study|Lack of Efficacy|1
2820721|NCT03004469|9652029|P3|Overall Study|Adverse Event|6
2820722|NCT03004469|9652030|P2|Overall Study|Adverse Event|4
2820723|NCT03004469|9652031|P1|Overall Study|Adverse Event|6
2820724|NCT03003520|9652074|P2|Follow-up|Withdrawal by Subject|0
2820725|NCT03003520|9652075|P1|Follow-up|Withdrawal by Subject|1
2820726|NCT03003520|9652074|P2|Follow-up|Ongoing|2
2820727|NCT03003520|9652075|P1|Follow-up|Ongoing|12
2820728|NCT03003520|9652074|P2|Follow-up|Death|1
2820729|NCT03003520|9652075|P1|Follow-up|Death|1
2820730|NCT03003520|9652074|P2|Consolidation|Withdrawal by Subject|0
2820731|NCT03003520|9652075|P1|Consolidation|Withdrawal by Subject|1
2820732|NCT03003520|9652074|P2|Consolidation|Progressive disease|1
2820733|NCT03003520|9652075|P1|Consolidation|Progressive disease|3
2820734|NCT03003520|9652074|P2|Consolidation|Adverse Event|0
2820735|NCT03003520|9652075|P1|Consolidation|Adverse Event|2
2820736|NCT03003520|9652074|P2|Consolidation|Ongoing|0
2820737|NCT03003520|9652075|P1|Consolidation|Ongoing|18
2820738|NCT03003520|9652074|P2|Induction|Progressive disease|0
2820739|NCT03003520|9652075|P1|Induction|Progressive disease|1
2820740|NCT03003520|9652074|P2|Induction|Withdrawal by Subject|0
2820741|NCT03003520|9652075|P1|Induction|Withdrawal by Subject|3
2820742|NCT03003520|9652074|P2|Induction|Physician Decision|0
2820743|NCT03003520|9652075|P1|Induction|Physician Decision|2
2820744|NCT03003520|9652074|P2|Induction|Palliative care|0
2820745|NCT03003520|9652075|P1|Induction|Palliative care|1
2820746|NCT03003520|9652074|P2|Induction|Death|0
2820747|NCT03003520|9652075|P1|Induction|Death|1
2820748|NCT03003520|9652074|P2|Induction|Adverse Event|0
2820749|NCT03003520|9652075|P1|Induction|Adverse Event|4
2820750|NCT03003520|9652074|P2|Induction|Ongoing|0
2820751|NCT03003520|9652075|P1|Induction|Ongoing|1
2820752|NCT03003494|9652093|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
2820753|NCT03003000|9652105|P3|Overall Study|Other than listed|1
2820754|NCT03003000|9652106|P2|Overall Study|Other than listed|1
2820755|NCT03003000|9652107|P1|Overall Study|Other than listed|1
2820756|NCT03003000|9652105|P3|Overall Study|Refused to continue medication|0
2820757|NCT03003000|9652106|P2|Overall Study|Refused to continue medication|0
2820758|NCT03003000|9652107|P1|Overall Study|Refused to continue medication|2
2820759|NCT03003000|9652105|P3|Overall Study|Non-compliant with protocol|1
2820760|NCT03003000|9652106|P2|Overall Study|Non-compliant with protocol|1
2820761|NCT03003000|9652107|P1|Overall Study|Non-compliant with protocol|0
2820762|NCT03003000|9652105|P3|Overall Study|Lack of Efficacy|0
2820763|NCT03003000|9652106|P2|Overall Study|Lack of Efficacy|0
2820764|NCT03003000|9652107|P1|Overall Study|Lack of Efficacy|1
2820765|NCT03003000|9652105|P3|Overall Study|Adverse Event|3
2820766|NCT03003000|9652106|P2|Overall Study|Adverse Event|2
2820767|NCT03003000|9652107|P1|Overall Study|Adverse Event|1
2820768|NCT03002818|9652133|P1|Overall Study|Decision of the investigator|1
2820769|NCT03002623|9652159|P2|Overall Study|Physician Decision|1
2820770|NCT03002623|9652160|P1|Overall Study|Physician Decision|1
2820771|NCT03002623|9652159|P2|Overall Study|Lost to Follow-up|0
2820772|NCT03002623|9652160|P1|Overall Study|Lost to Follow-up|1
2820773|NCT03002610|9652177|P3|Overall Study|Withdrawal by Subject|13
2820774|NCT03002610|9652178|P2|Overall Study|Withdrawal by Subject|25
2820775|NCT03002610|9652179|P1|Overall Study|Withdrawal by Subject|6
2820776|NCT03002194|9652201|P1|Overall Study|Withdrawal by Subject|2
2820777|NCT03002194|9652201|P1|Overall Study|Lack of Efficacy|1
2820778|NCT03002194|9652201|P1|Overall Study|Adverse Event|1
2820779|NCT03002194|9652201|P1|Overall Study|Lost to Follow-up|6
2820780|NCT03001557|9652253|P5|Overall Study|Randomized but not treated|0
2820781|NCT03001557|9652254|P4|Overall Study|Randomized but not treated|0
2820782|NCT03001557|9652255|P3|Overall Study|Randomized but not treated|1
2820783|NCT03001557|9652256|P2|Overall Study|Randomized but not treated|0
2820784|NCT03001557|9652257|P1|Overall Study|Randomized but not treated|0
2820785|NCT03001219|9652556|P2|Extension Period Analysis|Withdrawal by Subject|5
2820786|NCT03001219|9652557|P1|Extension Period Analysis|Withdrawal by Subject|4
2820787|NCT03001219|9652556|P2|Extension Period Analysis|Protocol Deviation|1
2820788|NCT03001219|9652557|P1|Extension Period Analysis|Protocol Deviation|0
2820789|NCT03001219|9652556|P2|Extension Period Analysis|Adverse Event|1
2820790|NCT03001219|9652557|P1|Extension Period Analysis|Adverse Event|1
2820791|NCT03001219|9652556|P2|Extension Period Analysis|Physician Decision|1
2820792|NCT03001219|9652557|P1|Extension Period Analysis|Physician Decision|0
2820793|NCT03001219|9652556|P2|Extension Period Analysis|Participant Non-Compliance|1
2820794|NCT03001219|9652557|P1|Extension Period Analysis|Participant Non-Compliance|0
2820795|NCT03001219|9652556|P2|Extension Period Analysis|Study Termination by Sponsor|36
2820796|NCT03001219|9652557|P1|Extension Period Analysis|Study Termination by Sponsor|0
2820797|NCT03001219|9652556|P2|Proof of Concept|Physician Decision|0
2820798|NCT03001219|9652557|P1|Proof of Concept|Physician Decision|1
2820799|NCT03001219|9652556|P2|Proof of Concept|Adverse Event|1
2820800|NCT03001219|9652557|P1|Proof of Concept|Adverse Event|1
2820801|NCT03001219|9652556|P2|Proof of Concept|Protocol Deviation|1
2820802|NCT03001219|9652557|P1|Proof of Concept|Protocol Deviation|0
2820803|NCT03001219|9652556|P2|Proof of Concept|Withdrawal by Subject|4
2820804|NCT03001219|9652557|P1|Proof of Concept|Withdrawal by Subject|0
2820805|NCT03001219|9652556|P2|Proof of Concept|Study Termination by Sponsor|1
2820806|NCT03001219|9652557|P1|Proof of Concept|Study Termination by Sponsor|0
2820807|NCT03001076|9652618|P2|Overall Study|Lost to Follow-up|2
2820808|NCT03001076|9652619|P1|Overall Study|Lost to Follow-up|0
2820809|NCT03001076|9652618|P2|Overall Study|Sponsor decision|0
2820810|NCT03001076|9652619|P1|Overall Study|Sponsor decision|1
2820811|NCT03001076|9652618|P2|Overall Study|Adverse Event|3
2820812|NCT03001076|9652619|P1|Overall Study|Adverse Event|3
2820813|NCT03001076|9652618|P2|Overall Study|Other|0
2820814|NCT03001076|9652619|P1|Overall Study|Other|1
2820815|NCT03001076|9652618|P2|Overall Study|Withdrawal by patient|0
2820816|NCT03001076|9652619|P1|Overall Study|Withdrawal by patient|2
2820817|NCT03000686|9652653|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
2820818|NCT03000686|9652654|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
2820819|NCT03000686|9652655|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
2820820|NCT03000686|9652656|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
2820821|NCT03000452|9652733|P1|Follow-Up Period|Withdrawal by Subject|3
2820822|NCT03000452|9652733|P1|Follow-Up Period|Death|3
2820823|NCT03000452|9652733|P1|Follow-Up Period|Study Terminated by Sponsor|1
2820824|NCT03000452|9652733|P1|Treatment Period|Miscellaneous|2
2820825|NCT03000452|9652733|P1|Treatment Period|Physician Decision|1
2820826|NCT03000452|9652733|P1|Treatment Period|Progressive Disease (PD)|14
2820827|NCT03000452|9652733|P1|Treatment Period|Death|1
2820828|NCT03000075|9652790|P7|Part B|Adverse Event|0
2820829|NCT03000075|9652791|P6|Part B|Adverse Event|0
2820830|NCT03000075|9652792|P5|Part B|Adverse Event|1
2820831|NCT03000075|9652793|P4|Part B|Adverse Event|0
2820832|NCT03000075|9652794|P3|Part B|Adverse Event|0
2820833|NCT03000075|9652795|P2|Part B|Adverse Event|0
2820834|NCT03000075|9652796|P1|Part B|Adverse Event|0
2820835|NCT03000075|9652790|P7|Part B|Not dosed due to AE|1
2820836|NCT03000075|9652791|P6|Part B|Not dosed due to AE|2
2820837|NCT03000075|9652792|P5|Part B|Not dosed due to AE|0
2820838|NCT03000075|9652793|P4|Part B|Not dosed due to AE|0
2820839|NCT03000075|9652794|P3|Part B|Not dosed due to AE|0
2820840|NCT03000075|9652795|P2|Part B|Not dosed due to AE|0
2820841|NCT03000075|9652796|P1|Part B|Not dosed due to AE|0
2820842|NCT03000075|9652790|P7|Part A|Adverse Event|0
2820843|NCT03000075|9652791|P6|Part A|Adverse Event|0
2820844|NCT03000075|9652792|P5|Part A|Adverse Event|0
2820845|NCT03000075|9652793|P4|Part A|Adverse Event|0
2820846|NCT03000075|9652794|P3|Part A|Adverse Event|0
2820847|NCT03000075|9652795|P2|Part A|Adverse Event|0
2820848|NCT03000075|9652796|P1|Part A|Adverse Event|4
2820849|NCT02999672|9652849|P2|Overall Study|Adverse Event|0
2820850|NCT02999672|9652850|P1|Overall Study|Adverse Event|4
2820851|NCT02999672|9652849|P2|Overall Study|Progressive Disease|5
2820852|NCT02999672|9652850|P1|Overall Study|Progressive Disease|9
2820853|NCT02999672|9652849|P2|Overall Study|Study Terminated by Sponsor|1
2820854|NCT02999672|9652850|P1|Overall Study|Study Terminated by Sponsor|0
2820855|NCT02999672|9652849|P2|Overall Study|Death|1
2820856|NCT02999672|9652850|P1|Overall Study|Death|0
2820857|NCT02999633|9652866|P1|Overall Study|Progressive disease|12
2820858|NCT02999633|9652866|P1|Overall Study|Adverse Event|2
2820859|NCT02999178|9652876|P2|Overall Study|Other reason not defined above|13
2820860|NCT02999178|9652877|P1|Overall Study|Other reason not defined above|7
2820861|NCT02999178|9652876|P2|Overall Study|Withdrawal by Subject|21
2820862|NCT02999178|9652877|P1|Overall Study|Withdrawal by Subject|21
2820863|NCT02999178|9652876|P2|Overall Study|Lost to Follow-up|2
2820864|NCT02999178|9652877|P1|Overall Study|Lost to Follow-up|0
2820865|NCT02999178|9652876|P2|Overall Study|Protocol Violation|2
2820866|NCT02999178|9652877|P1|Overall Study|Protocol Violation|1
2820867|NCT02999178|9652876|P2|Overall Study|Adverse Event|62
2820868|NCT02999178|9652877|P1|Overall Study|Adverse Event|85
2820869|NCT02999100|9652927|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2820870|NCT02999100|9652928|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2820871|NCT02999100|9652929|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2820872|NCT02999100|9652930|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
2820873|NCT02999100|9652931|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2820874|NCT02999100|9652932|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2820875|NCT02999100|9652927|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
2820876|NCT02999100|9652928|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2820877|NCT02999100|9652929|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2820878|NCT02999100|9652930|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2820879|NCT02999100|9652931|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2820880|NCT02999100|9652932|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2820881|NCT02999100|9652927|P6|Part 1 (up to 15 Days)|Adverse Event|0
2820882|NCT02999100|9652928|P5|Part 1 (up to 15 Days)|Adverse Event|0
2820883|NCT02999100|9652929|P4|Part 1 (up to 15 Days)|Adverse Event|0
2820884|NCT02999100|9652930|P3|Part 1 (up to 15 Days)|Adverse Event|0
2820885|NCT02999100|9652931|P2|Part 1 (up to 15 Days)|Adverse Event|1
2820886|NCT02999100|9652932|P1|Part 1 (up to 15 Days)|Adverse Event|0
2820887|NCT02998996|9653100|P6|Overall Study|Family reasons|0
2820888|NCT02998996|9653101|P5|Overall Study|Family reasons|1
2820889|NCT02998996|9653102|P4|Overall Study|Family reasons|0
2820890|NCT02998996|9653103|P3|Overall Study|Family reasons|0
2820891|NCT02998996|9653104|P2|Overall Study|Family reasons|0
2820892|NCT02998996|9653105|P1|Overall Study|Family reasons|0
2820893|NCT02998996|9653100|P6|Overall Study|Pregnancy|0
2820894|NCT02998996|9653101|P5|Overall Study|Pregnancy|0
2820895|NCT02998996|9653102|P4|Overall Study|Pregnancy|0
2820896|NCT02998996|9653103|P3|Overall Study|Pregnancy|0
2820897|NCT02998996|9653104|P2|Overall Study|Pregnancy|1
2820898|NCT02998996|9653105|P1|Overall Study|Pregnancy|0
2820899|NCT02998996|9653100|P6|Overall Study|Lost to Follow-up|0
2820900|NCT02998996|9653101|P5|Overall Study|Lost to Follow-up|0
2820901|NCT02998996|9653102|P4|Overall Study|Lost to Follow-up|0
2820902|NCT02998996|9653103|P3|Overall Study|Lost to Follow-up|1
2820903|NCT02998996|9653104|P2|Overall Study|Lost to Follow-up|0
2820904|NCT02998996|9653105|P1|Overall Study|Lost to Follow-up|0
2820905|NCT02998671|9653139|P5|Period 2|Lost to Follow-up|0
2820906|NCT02998671|9653140|P4|Period 2|Lost to Follow-up|1
2820907|NCT02998671|9653141|P3|Period 2|Lost to Follow-up|0
2820908|NCT02998671|9653142|P2|Period 2|Lost to Follow-up|0
2820909|NCT02998671|9653143|P1|Period 2|Lost to Follow-up|0
2820910|NCT02998671|9653139|P5|Period 2|Withdrawal by Subject|0
2820911|NCT02998671|9653140|P4|Period 2|Withdrawal by Subject|0
2820912|NCT02998671|9653141|P3|Period 2|Withdrawal by Subject|0
2820913|NCT02998671|9653142|P2|Period 2|Withdrawal by Subject|1
2820914|NCT02998671|9653143|P1|Period 2|Withdrawal by Subject|0
2820915|NCT02998671|9653139|P5|Period 2|Study Terminated By Sponsor|0
2820916|NCT02998671|9653140|P4|Period 2|Study Terminated By Sponsor|3
2820917|NCT02998671|9653141|P3|Period 2|Study Terminated By Sponsor|1
2820918|NCT02998671|9653142|P2|Period 2|Study Terminated By Sponsor|5
2820919|NCT02998671|9653143|P1|Period 2|Study Terminated By Sponsor|3
2820920|NCT02998671|9653139|P5|Period 2|Adverse Event|0
2820921|NCT02998671|9653140|P4|Period 2|Adverse Event|0
2820922|NCT02998671|9653141|P3|Period 2|Adverse Event|0
2820923|NCT02998671|9653142|P2|Period 2|Adverse Event|1
2820924|NCT02998671|9653143|P1|Period 2|Adverse Event|0
2820925|NCT02998671|9653139|P5|Period 1|Adverse Event|1
2820926|NCT02998671|9653140|P4|Period 1|Adverse Event|0
2820927|NCT02998671|9653141|P3|Period 1|Adverse Event|0
2820928|NCT02998671|9653142|P2|Period 1|Adverse Event|0
2820929|NCT02998671|9653143|P1|Period 1|Adverse Event|0
2820930|NCT02998671|9653139|P5|Period 1|Pregnancy|0
2820931|NCT02998671|9653140|P4|Period 1|Pregnancy|0
2820932|NCT02998671|9653141|P3|Period 1|Pregnancy|0
2820933|NCT02998671|9653142|P2|Period 1|Pregnancy|0
2820934|NCT02998671|9653143|P1|Period 1|Pregnancy|1
2820935|NCT02998671|9653139|P5|Period 1|Withdrawal by Subject|2
2820936|NCT02998671|9653140|P4|Period 1|Withdrawal by Subject|0
2820937|NCT02998671|9653141|P3|Period 1|Withdrawal by Subject|0
2820938|NCT02998671|9653142|P2|Period 1|Withdrawal by Subject|2
2820939|NCT02998671|9653143|P1|Period 1|Withdrawal by Subject|1
2820940|NCT02998671|9653139|P5|Period 1|Study Terminated By Sponsor|1
2820941|NCT02998671|9653140|P4|Period 1|Study Terminated By Sponsor|0
2820942|NCT02998671|9653141|P3|Period 1|Study Terminated By Sponsor|0
2820943|NCT02998671|9653142|P2|Period 1|Study Terminated By Sponsor|1
2820944|NCT02998671|9653143|P1|Period 1|Study Terminated By Sponsor|2
2820945|NCT02998554|9653188|P2|Overall Study|Lack of Efficacy|1
2820946|NCT02998554|9653189|P1|Overall Study|Lack of Efficacy|0
2820947|NCT02998554|9653188|P2|Overall Study|Lost to Follow-up|1
2820948|NCT02998554|9653189|P1|Overall Study|Lost to Follow-up|0
2820949|NCT02998554|9653188|P2|Overall Study|Withdrawal by Subject|6
2820950|NCT02998554|9653189|P1|Overall Study|Withdrawal by Subject|2
2820951|NCT02998554|9653188|P2|Overall Study|Protocol deviation|0
2820952|NCT02998554|9653189|P1|Overall Study|Protocol deviation|1
2820953|NCT02998554|9653188|P2|Overall Study|Adverse Event|3
2820954|NCT02998554|9653189|P1|Overall Study|Adverse Event|8
2820955|NCT02998541|9653220|P3|Overall Study|Withdrawal by Parent/Guardian|1
2820956|NCT02998541|9653221|P2|Overall Study|Withdrawal by Parent/Guardian|0
2820957|NCT02998541|9653222|P1|Overall Study|Withdrawal by Parent/Guardian|0
2820958|NCT02998541|9653220|P3|Overall Study|Physician Decision|3
2820959|NCT02998541|9653221|P2|Overall Study|Physician Decision|0
2820960|NCT02998541|9653222|P1|Overall Study|Physician Decision|0
2820961|NCT02998541|9653220|P3|Overall Study|Lost to Follow-up|1
2820962|NCT02998541|9653221|P2|Overall Study|Lost to Follow-up|3
2820963|NCT02998541|9653222|P1|Overall Study|Lost to Follow-up|0
2820964|NCT02998541|9653220|P3|Overall Study|Withdrawal by Subject|0
2820965|NCT02998541|9653221|P2|Overall Study|Withdrawal by Subject|1
2820966|NCT02998541|9653222|P1|Overall Study|Withdrawal by Subject|3
2820967|NCT02998541|9653220|P3|Overall Study|Protocol Violation|0
2820968|NCT02998541|9653221|P2|Overall Study|Protocol Violation|0
2820969|NCT02998541|9653222|P1|Overall Study|Protocol Violation|1
2820970|NCT02998541|9653220|P3|Overall Study|Adverse Event|1
2820971|NCT02998541|9653221|P2|Overall Study|Adverse Event|5
2820972|NCT02998541|9653222|P1|Overall Study|Adverse Event|4
2820973|NCT02998476|9653277|P2|Overall Study|Death|2
2820974|NCT02998476|9653278|P1|Overall Study|Death|32
2820975|NCT02998476|9653277|P2|Overall Study|Withdrawal by Subject|2
2820976|NCT02998476|9653278|P1|Overall Study|Withdrawal by Subject|1
2820977|NCT02998476|9653277|P2|Overall Study|Disease Progression|0
2820978|NCT02998476|9653278|P1|Overall Study|Disease Progression|1
2820979|NCT02998476|9653277|P2|Overall Study|Ongoing in study|1
2820980|NCT02998476|9653278|P1|Overall Study|Ongoing in study|21
2820981|NCT02998021|9653288|P2|Overall Study|unsafe home|1
2820982|NCT02998021|9653289|P1|Overall Study|unsafe home|0
2820983|NCT02998021|9653288|P2|Overall Study|Withdrawal by Subject|1
2820984|NCT02998021|9653289|P1|Overall Study|Withdrawal by Subject|3
2820985|NCT02997163|9653364|P4|Overall Study|Adverse Event|1
2820986|NCT02997163|9653365|P3|Overall Study|Adverse Event|0
2820987|NCT02997163|9653366|P2|Overall Study|Adverse Event|0
2820988|NCT02997163|9653367|P1|Overall Study|Adverse Event|1
2820989|NCT02996968|9653499|P2|Overall Study|Withdrawal by Subject|0
2820990|NCT02996968|9653500|P1|Overall Study|Withdrawal by Subject|1
2820991|NCT02996682|9653508|P2|Overall Study|Death|3
2820992|NCT02996682|9653509|P1|Overall Study|Death|0
2820993|NCT02996500|9653588|P6|Overall Study|Withdrawal by Subject|0
2820994|NCT02996500|9653589|P5|Overall Study|Withdrawal by Subject|2
2820995|NCT02996500|9653590|P4|Overall Study|Withdrawal by Subject|0
2820996|NCT02996500|9653591|P3|Overall Study|Withdrawal by Subject|3
2820997|NCT02996500|9653592|P2|Overall Study|Withdrawal by Subject|0
2820998|NCT02996500|9653593|P1|Overall Study|Withdrawal by Subject|3
2820999|NCT02996500|9653588|P6|Overall Study|Protocol Violation|0
2821000|NCT02996500|9653589|P5|Overall Study|Protocol Violation|0
2821001|NCT02996500|9653590|P4|Overall Study|Protocol Violation|1
2821002|NCT02996500|9653591|P3|Overall Study|Protocol Violation|0
2821003|NCT02996500|9653592|P2|Overall Study|Protocol Violation|0
2821004|NCT02996500|9653593|P1|Overall Study|Protocol Violation|0
2821005|NCT02996500|9653588|P6|Overall Study|Other|0
2821006|NCT02996500|9653589|P5|Overall Study|Other|0
2821007|NCT02996500|9653590|P4|Overall Study|Other|0
2821008|NCT02996500|9653591|P3|Overall Study|Other|2
2821009|NCT02996500|9653592|P2|Overall Study|Other|0
2821010|NCT02996500|9653593|P1|Overall Study|Other|2
2821011|NCT02996500|9653588|P6|Overall Study|Progressive Disease|0
2821012|NCT02996500|9653589|P5|Overall Study|Progressive Disease|0
2821013|NCT02996500|9653590|P4|Overall Study|Progressive Disease|0
2821014|NCT02996500|9653591|P3|Overall Study|Progressive Disease|0
2821015|NCT02996500|9653592|P2|Overall Study|Progressive Disease|0
2821016|NCT02996500|9653593|P1|Overall Study|Progressive Disease|1
2821017|NCT02996500|9653588|P6|Overall Study|Non-Compliance With Study Drug|1
2821018|NCT02996500|9653589|P5|Overall Study|Non-Compliance With Study Drug|0
2821019|NCT02996500|9653590|P4|Overall Study|Non-Compliance With Study Drug|0
2821020|NCT02996500|9653591|P3|Overall Study|Non-Compliance With Study Drug|0
2821021|NCT02996500|9653592|P2|Overall Study|Non-Compliance With Study Drug|0
2821022|NCT02996500|9653593|P1|Overall Study|Non-Compliance With Study Drug|0
2821023|NCT02996500|9653588|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2821024|NCT02996500|9653589|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2821025|NCT02996500|9653590|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2821026|NCT02996500|9653591|P3|Overall Study|No Longer Meets Eligibility Criteria|1
2821027|NCT02996500|9653592|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2821028|NCT02996500|9653593|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2821029|NCT02996500|9653588|P6|Overall Study|Lost to Follow-up|1
2821030|NCT02996500|9653589|P5|Overall Study|Lost to Follow-up|0
2821031|NCT02996500|9653590|P4|Overall Study|Lost to Follow-up|0
2821032|NCT02996500|9653591|P3|Overall Study|Lost to Follow-up|0
2821033|NCT02996500|9653592|P2|Overall Study|Lost to Follow-up|0
2821034|NCT02996500|9653593|P1|Overall Study|Lost to Follow-up|1
2821035|NCT02996500|9653588|P6|Overall Study|Lack of Efficacy|0
2821036|NCT02996500|9653589|P5|Overall Study|Lack of Efficacy|2
2821037|NCT02996500|9653590|P4|Overall Study|Lack of Efficacy|0
2821038|NCT02996500|9653591|P3|Overall Study|Lack of Efficacy|0
2821039|NCT02996500|9653592|P2|Overall Study|Lack of Efficacy|0
2821040|NCT02996500|9653593|P1|Overall Study|Lack of Efficacy|0
2821041|NCT02996500|9653588|P6|Overall Study|Adverse Event|2
2821042|NCT02996500|9653589|P5|Overall Study|Adverse Event|1
2821043|NCT02996500|9653590|P4|Overall Study|Adverse Event|3
2821044|NCT02996500|9653591|P3|Overall Study|Adverse Event|4
2821045|NCT02996500|9653592|P2|Overall Study|Adverse Event|1
2821046|NCT02996500|9653593|P1|Overall Study|Adverse Event|1
2821047|NCT02996097|9653780|P2|Overall Study|Lost to Follow-up|11
2821048|NCT02996097|9653781|P1|Overall Study|Lost to Follow-up|11
2821049|NCT02995980|9653788|P1|Overall Study|Lost to Follow-up|14
2821050|NCT02994056|9653863|P1|Overall Study|Withdrew Consent|1
2821051|NCT02994056|9653863|P1|Overall Study|Death|8
2821052|NCT02993926|9653897|P3|Enantone Treatment Phase|Reason Not Specified|0
2821053|NCT02993926|9653898|P2|Enantone Treatment Phase|Reason Not Specified|0
2821054|NCT02993926|9653899|P1|Enantone Treatment Phase|Reason Not Specified|4
2821055|NCT02993926|9653897|P3|Enantone Treatment Phase|Investigator Judgment|0
2821056|NCT02993926|9653898|P2|Enantone Treatment Phase|Investigator Judgment|0
2821057|NCT02993926|9653899|P1|Enantone Treatment Phase|Investigator Judgment|1
2821058|NCT02993926|9653897|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2821059|NCT02993926|9653898|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2821060|NCT02993926|9653899|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
2821061|NCT02993926|9653897|P3|Enantone Treatment Phase|Adverse Event|0
2821062|NCT02993926|9653898|P2|Enantone Treatment Phase|Adverse Event|0
2821063|NCT02993926|9653899|P1|Enantone Treatment Phase|Adverse Event|1
2821064|NCT02993783|9653931|P2|Overall Study|Reason not Specified|9
2821065|NCT02993783|9653932|P1|Overall Study|Reason not Specified|6
2821066|NCT02993471|9653962|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
2821067|NCT02993471|9653962|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
2821068|NCT02993250|9654013|P2|Overall Study|Lost to Follow-up|1
2821069|NCT02993250|9654014|P1|Overall Study|Lost to Follow-up|0
2821070|NCT02992691|9654034|P1|Overall Study|Withdrawal by Subject|1
2821071|NCT02992691|9654034|P1|Overall Study|Adverse Event|2
2821072|NCT02992288|9654057|P6|Overall Study|Withdrawal by Subject|4
2821073|NCT02992288|9654058|P5|Overall Study|Withdrawal by Subject|3
2821074|NCT02992288|9654059|P4|Overall Study|Withdrawal by Subject|5
2821075|NCT02992288|9654060|P3|Overall Study|Withdrawal by Subject|1
2821076|NCT02992288|9654061|P2|Overall Study|Withdrawal by Subject|2
2821077|NCT02992288|9654062|P1|Overall Study|Withdrawal by Subject|4
2821078|NCT02992288|9654057|P6|Overall Study|Protocol Violation|1
2821079|NCT02992288|9654058|P5|Overall Study|Protocol Violation|0
2821080|NCT02992288|9654059|P4|Overall Study|Protocol Violation|0
2821081|NCT02992288|9654060|P3|Overall Study|Protocol Violation|0
2821082|NCT02992288|9654061|P2|Overall Study|Protocol Violation|0
2821083|NCT02992288|9654062|P1|Overall Study|Protocol Violation|0
2821084|NCT02992288|9654057|P6|Overall Study|Lost to Follow-up|0
2821085|NCT02992288|9654058|P5|Overall Study|Lost to Follow-up|0
2821086|NCT02992288|9654059|P4|Overall Study|Lost to Follow-up|1
2821087|NCT02992288|9654060|P3|Overall Study|Lost to Follow-up|0
2821088|NCT02992288|9654061|P2|Overall Study|Lost to Follow-up|0
2821089|NCT02992288|9654062|P1|Overall Study|Lost to Follow-up|0
2821090|NCT02992288|9654057|P6|Overall Study|Death|0
2821091|NCT02992288|9654058|P5|Overall Study|Death|2
2821092|NCT02992288|9654059|P4|Overall Study|Death|1
2821093|NCT02992288|9654060|P3|Overall Study|Death|2
2821094|NCT02992288|9654061|P2|Overall Study|Death|0
2821095|NCT02992288|9654062|P1|Overall Study|Death|2
2821096|NCT02992288|9654057|P6|Overall Study|Physician Decision|1
2821097|NCT02992288|9654058|P5|Overall Study|Physician Decision|0
2821098|NCT02992288|9654059|P4|Overall Study|Physician Decision|0
2821099|NCT02992288|9654060|P3|Overall Study|Physician Decision|1
2821100|NCT02992288|9654061|P2|Overall Study|Physician Decision|0
2821101|NCT02992288|9654062|P1|Overall Study|Physician Decision|3
2821102|NCT02992288|9654057|P6|Overall Study|Non-compliance with study drug|0
2821103|NCT02992288|9654058|P5|Overall Study|Non-compliance with study drug|1
2821104|NCT02992288|9654059|P4|Overall Study|Non-compliance with study drug|0
2821105|NCT02992288|9654060|P3|Overall Study|Non-compliance with study drug|1
2821106|NCT02992288|9654061|P2|Overall Study|Non-compliance with study drug|1
2821107|NCT02992288|9654062|P1|Overall Study|Non-compliance with study drug|0
2821108|NCT02992288|9654057|P6|Overall Study|Adverse Event|7
2821109|NCT02992288|9654058|P5|Overall Study|Adverse Event|2
2821110|NCT02992288|9654059|P4|Overall Study|Adverse Event|2
2821111|NCT02992288|9654060|P3|Overall Study|Adverse Event|2
2821112|NCT02992288|9654061|P2|Overall Study|Adverse Event|2
2821113|NCT02992288|9654062|P1|Overall Study|Adverse Event|8
2821114|NCT02992132|9654134|P3|Overall Study|Physician Decision|1
2821115|NCT02992132|9654135|P2|Overall Study|Physician Decision|0
2821116|NCT02992132|9654136|P1|Overall Study|Physician Decision|0
2821117|NCT02992132|9654134|P3|Overall Study|Withdrawal by Subject|1
2821118|NCT02992132|9654135|P2|Overall Study|Withdrawal by Subject|2
2821119|NCT02992132|9654136|P1|Overall Study|Withdrawal by Subject|0
2821120|NCT02992132|9654134|P3|Overall Study|Caregiver withdrew consent|2
2821121|NCT02992132|9654135|P2|Overall Study|Caregiver withdrew consent|3
2821122|NCT02992132|9654136|P1|Overall Study|Caregiver withdrew consent|2
2821123|NCT02992132|9654134|P3|Overall Study|Protocol Violation|0
2821124|NCT02992132|9654135|P2|Overall Study|Protocol Violation|2
2821125|NCT02992132|9654136|P1|Overall Study|Protocol Violation|2
2821126|NCT02992132|9654134|P3|Overall Study|Progressive disease|0
2821127|NCT02992132|9654135|P2|Overall Study|Progressive disease|0
2821128|NCT02992132|9654136|P1|Overall Study|Progressive disease|1
2821129|NCT02992132|9654134|P3|Overall Study|Non-compliance with study drug|0
2821130|NCT02992132|9654135|P2|Overall Study|Non-compliance with study drug|0
2821131|NCT02992132|9654136|P1|Overall Study|Non-compliance with study drug|2
2821132|NCT02992132|9654134|P3|Overall Study|Lack of Efficacy|0
2821133|NCT02992132|9654135|P2|Overall Study|Lack of Efficacy|0
2821134|NCT02992132|9654136|P1|Overall Study|Lack of Efficacy|2
2821135|NCT02992132|9654134|P3|Overall Study|Adverse Event|3
2821136|NCT02992132|9654135|P2|Overall Study|Adverse Event|1
2821137|NCT02992132|9654136|P1|Overall Study|Adverse Event|4
2821138|NCT02991859|9654232|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821139|NCT02991859|9654233|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821140|NCT02991859|9654234|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821141|NCT02991859|9654235|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821142|NCT02991859|9654236|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821143|NCT02991859|9654237|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821144|NCT02991859|9654238|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821145|NCT02991859|9654239|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821146|NCT02991859|9654240|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
2821147|NCT02991859|9654241|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821148|NCT02991859|9654242|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821149|NCT02991859|9654243|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821150|NCT02991859|9654244|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821151|NCT02991859|9654245|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821152|NCT02991859|9654246|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821153|NCT02991859|9654247|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821154|NCT02991859|9654248|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2821155|NCT02991859|9654232|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
2821156|NCT02991859|9654233|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
2821157|NCT02991859|9654234|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
2821158|NCT02991859|9654235|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
2821159|NCT02991859|9654236|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
2821160|NCT02991859|9654237|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
2821161|NCT02991859|9654238|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
2821162|NCT02991859|9654239|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
2821163|NCT02991859|9654240|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
2821164|NCT02991859|9654241|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
2821165|NCT02991859|9654242|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
2821166|NCT02991859|9654243|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
2821167|NCT02991859|9654244|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
2821168|NCT02991859|9654245|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
2821169|NCT02991859|9654246|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
2821170|NCT02991859|9654247|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
2821171|NCT02991859|9654248|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
2821172|NCT02991859|9654232|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821173|NCT02991859|9654233|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821174|NCT02991859|9654234|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821175|NCT02991859|9654235|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821176|NCT02991859|9654236|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821177|NCT02991859|9654237|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821178|NCT02991859|9654238|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821179|NCT02991859|9654239|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821180|NCT02991859|9654240|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821181|NCT02991859|9654241|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821182|NCT02991859|9654242|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821183|NCT02991859|9654243|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
2821184|NCT02991859|9654244|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821185|NCT02991859|9654245|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821186|NCT02991859|9654246|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821187|NCT02991859|9654247|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821188|NCT02991859|9654248|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
2821189|NCT02991859|9654232|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821190|NCT02991859|9654233|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821191|NCT02991859|9654234|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821192|NCT02991859|9654235|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2821193|NCT02991859|9654236|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2821194|NCT02991859|9654237|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821195|NCT02991859|9654238|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821196|NCT02991859|9654239|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821197|NCT02991859|9654240|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821198|NCT02991859|9654241|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821199|NCT02991859|9654242|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821200|NCT02991859|9654243|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821201|NCT02991859|9654244|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821202|NCT02991859|9654245|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821203|NCT02991859|9654246|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821204|NCT02991859|9654247|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821205|NCT02991859|9654248|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2821206|NCT02991859|9654232|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821207|NCT02991859|9654233|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821208|NCT02991859|9654234|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821209|NCT02991859|9654235|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821210|NCT02991859|9654236|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821211|NCT02991859|9654237|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821212|NCT02991859|9654238|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821213|NCT02991859|9654239|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821214|NCT02991859|9654240|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821215|NCT02991859|9654241|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821216|NCT02991859|9654242|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821217|NCT02991859|9654243|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821218|NCT02991859|9654244|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2821219|NCT02991859|9654245|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821220|NCT02991859|9654246|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821221|NCT02991859|9654247|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2821222|NCT02991859|9654248|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2821223|NCT02991430|9654543|P3|Post-treatment Observation Period|Study Termination|5
2821224|NCT02991430|9654544|P2|Post-treatment Observation Period|Study Termination|6
2821225|NCT02991430|9654545|P1|Post-treatment Observation Period|Study Termination|3
2821226|NCT02991430|9654543|P3|Treatment Period 2|Lost to Follow-up|1
2821227|NCT02991430|9654544|P2|Treatment Period 2|Lost to Follow-up|0
2821228|NCT02991430|9654545|P1|Treatment Period 2|Lost to Follow-up|0
2821229|NCT02991430|9654543|P3|Treatment Period 2|Study Termination|3
2821230|NCT02991430|9654544|P2|Treatment Period 2|Study Termination|3
2821231|NCT02991430|9654545|P1|Treatment Period 2|Study Termination|6
2821232|NCT02991430|9654543|P3|Treatment Period 1|Withdrawal by Subject|0
2821233|NCT02991430|9654544|P2|Treatment Period 1|Withdrawal by Subject|4
2821234|NCT02991430|9654545|P1|Treatment Period 1|Withdrawal by Subject|0
2821235|NCT02991430|9654543|P3|Treatment Period 1|Adverse Event|2
2821236|NCT02991430|9654544|P2|Treatment Period 1|Adverse Event|0
2821237|NCT02991430|9654545|P1|Treatment Period 1|Adverse Event|1
2821238|NCT02991118|9654582|P2|Overall Study|Lost to Follow-up|9
2821239|NCT02991118|9654583|P1|Overall Study|Lost to Follow-up|1
2821240|NCT02991118|9654582|P2|Overall Study|Could not attend study visits|1
2821241|NCT02991118|9654583|P1|Overall Study|Could not attend study visits|0
2821242|NCT02991118|9654582|P2|Overall Study|Withdrawal by Subject|7
2821243|NCT02991118|9654583|P1|Overall Study|Withdrawal by Subject|1
2821244|NCT02991118|9654582|P2|Overall Study|Adverse Event|2
2821245|NCT02991118|9654583|P1|Overall Study|Adverse Event|2
2821246|NCT02991118|9654582|P2|Overall Study|Moved out of the country|1
2821247|NCT02991118|9654583|P1|Overall Study|Moved out of the country|0
2821248|NCT02991118|9654582|P2|Overall Study|Physician Decision|1
2821249|NCT02991118|9654583|P1|Overall Study|Physician Decision|0
2821250|NCT02991118|9654582|P2|Overall Study|Protocol Violation|3
2821251|NCT02991118|9654583|P1|Overall Study|Protocol Violation|0
2821252|NCT02991118|9654582|P2|Overall Study|Death|8
2821253|NCT02991118|9654583|P1|Overall Study|Death|3
2821254|NCT02991040|9654627|P1|Overall Study|Lost to Follow-up|2
2821255|NCT02991040|9654627|P1|Overall Study|Withdrawal by Subject|2
2821256|NCT02990910|9654642|P2|Overall Study|Lack of Efficacy|10
2821257|NCT02990910|9654643|P1|Overall Study|Lack of Efficacy|6
2821258|NCT02990338|9654653|P2|Overall Study|Randomized but not treated|2
2821259|NCT02990338|9654654|P1|Overall Study|Randomized but not treated|4
2821260|NCT02990338|9654653|P2|Overall Study|Other|4
2821261|NCT02990338|9654654|P1|Overall Study|Other|1
2821262|NCT02990338|9654653|P2|Overall Study|Withdrawal by Subject|5
2821263|NCT02990338|9654654|P1|Overall Study|Withdrawal by Subject|6
2821264|NCT02990338|9654653|P2|Overall Study|Poor compliance to protocol|1
2821265|NCT02990338|9654654|P1|Overall Study|Poor compliance to protocol|0
2821266|NCT02990338|9654653|P2|Overall Study|Progressive disease|66
2821267|NCT02990338|9654654|P1|Overall Study|Progressive disease|88
2821268|NCT02990338|9654653|P2|Overall Study|Adverse Event|11
2821269|NCT02990338|9654654|P1|Overall Study|Adverse Event|19
2821270|NCT02989805|9654702|P2|Overall Study|invalid consent|4
2821271|NCT02989805|9654703|P1|Overall Study|invalid consent|6
2821272|NCT02989649|9654803|P1|Overall Study|Reason Not Specified|13
2821273|NCT02989649|9654803|P1|Overall Study|Lost For Observation During Study|3
2821274|NCT02989649|9654803|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
2821275|NCT02989649|9654803|P1|Overall Study|Patient/Investigator’s Decision to Stop|403
2821276|NCT02989389|9654839|P10|Period 1|Physician Decision|0
2821277|NCT02989389|9654840|P9|Period 1|Physician Decision|1
2821278|NCT02989389|9654841|P8|Period 1|Physician Decision|0
2821279|NCT02989389|9654842|P7|Period 1|Physician Decision|0
2821280|NCT02989389|9654843|P6|Period 1|Physician Decision|0
2821281|NCT02989389|9654844|P5|Period 1|Physician Decision|0
2821282|NCT02989389|9654845|P4|Period 1|Physician Decision|0
2821283|NCT02989389|9654846|P3|Period 1|Physician Decision|0
2821284|NCT02989389|9654847|P2|Period 1|Physician Decision|0
2821285|NCT02989389|9654848|P1|Period 1|Physician Decision|0
2821286|NCT02989389|9654839|P10|Period 1|Lost to Follow-up|0
2821287|NCT02989389|9654840|P9|Period 1|Lost to Follow-up|0
2821288|NCT02989389|9654841|P8|Period 1|Lost to Follow-up|0
2821289|NCT02989389|9654842|P7|Period 1|Lost to Follow-up|0
2821290|NCT02989389|9654843|P6|Period 1|Lost to Follow-up|0
2821291|NCT02989389|9654844|P5|Period 1|Lost to Follow-up|0
2821292|NCT02989389|9654845|P4|Period 1|Lost to Follow-up|0
2821293|NCT02989389|9654846|P3|Period 1|Lost to Follow-up|0
2821294|NCT02989389|9654847|P2|Period 1|Lost to Follow-up|1
2821295|NCT02989389|9654848|P1|Period 1|Lost to Follow-up|0
2821296|NCT02988622|9654925|P1|Overall Study|Lost to Follow-up|17
2821297|NCT02988219|9654960|P2|Overall Study|Withdrawal by Subject|2
2821298|NCT02988219|9654961|P1|Overall Study|Withdrawal by Subject|0
2821299|NCT02988219|9654960|P2|Overall Study|Lack of Efficacy|1
2821300|NCT02988219|9654961|P1|Overall Study|Lack of Efficacy|1
2821301|NCT02988115|9654980|P2|Overall Study|Lost to Follow-up|0
2821302|NCT02988115|9654981|P1|Overall Study|Lost to Follow-up|1
2821303|NCT02988115|9654980|P2|Overall Study|Withdrawn by Mistake|0
2821304|NCT02988115|9654981|P1|Overall Study|Withdrawn by Mistake|1
2821305|NCT02988115|9654980|P2|Overall Study|Withdrawal by Subject|1
2821306|NCT02988115|9654981|P1|Overall Study|Withdrawal by Subject|1
2821307|NCT02988115|9654980|P2|Overall Study|Sponsor Decision|2
2821308|NCT02988115|9654981|P1|Overall Study|Sponsor Decision|5
2821309|NCT02988115|9654980|P2|Overall Study|Adverse Event|1
2821310|NCT02988115|9654981|P1|Overall Study|Adverse Event|6
2821311|NCT02987972|9654998|P3|Overall Study|Withdrawal by Subject|21
2821312|NCT02987972|9654999|P2|Overall Study|Withdrawal by Subject|17
2821313|NCT02987972|9655000|P1|Overall Study|Withdrawal by Subject|22
2821314|NCT02987972|9654998|P3|Overall Study|Protocol Violation|5
2821315|NCT02987972|9654999|P2|Overall Study|Protocol Violation|1
2821316|NCT02987972|9655000|P1|Overall Study|Protocol Violation|2
2821317|NCT02987972|9654998|P3|Overall Study|Physician Decision|0
2821318|NCT02987972|9654999|P2|Overall Study|Physician Decision|6
2821319|NCT02987972|9655000|P1|Overall Study|Physician Decision|1
2821320|NCT02987972|9654998|P3|Overall Study|Lost to Follow-up|4
2821321|NCT02987972|9654999|P2|Overall Study|Lost to Follow-up|8
2821322|NCT02987972|9655000|P1|Overall Study|Lost to Follow-up|7
2821323|NCT02987972|9654998|P3|Overall Study|Lack of Efficacy|12
2821324|NCT02987972|9654999|P2|Overall Study|Lack of Efficacy|12
2821325|NCT02987972|9655000|P1|Overall Study|Lack of Efficacy|9
2821326|NCT02987972|9654998|P3|Overall Study|Death|0
2821327|NCT02987972|9654999|P2|Overall Study|Death|0
2821328|NCT02987972|9655000|P1|Overall Study|Death|1
2821329|NCT02987972|9654998|P3|Overall Study|Adverse Event|0
2821330|NCT02987972|9654999|P2|Overall Study|Adverse Event|1
2821331|NCT02987972|9655000|P1|Overall Study|Adverse Event|1
2821332|NCT02987660|9655038|P2|Overall Study|Study terminated by sponsor|10
2821333|NCT02987660|9655039|P1|Overall Study|Study terminated by sponsor|10
2821334|NCT02987205|9655073|P1|Overall Study|Withdrawal by Subject|3
2821335|NCT02987205|9655073|P1|Overall Study|Adverse Event|1
2821336|NCT02986854|9655107|P3|Overall Study|Lost to Follow-up|2
2821337|NCT02986854|9655108|P2|Overall Study|Lost to Follow-up|11
2821338|NCT02986854|9655109|P1|Overall Study|Lost to Follow-up|3
2821339|NCT02986854|9655107|P3|Overall Study|Withdrawal by Subject|1
2821340|NCT02986854|9655108|P2|Overall Study|Withdrawal by Subject|1
2821341|NCT02986854|9655109|P1|Overall Study|Withdrawal by Subject|0
2821342|NCT02986373|9655193|P1|Overall Study|Other|24
2821343|NCT02986373|9655193|P1|Overall Study|Withdrawal by Subject|10
2821344|NCT02986373|9655193|P1|Overall Study|Lost to Follow-up|1
2821345|NCT02986373|9655193|P1|Overall Study|Adverse Event|4
2821346|NCT02986139|9655235|P2|Overall Study|Lost to Follow-up|1
2821347|NCT02986139|9655236|P1|Overall Study|Lost to Follow-up|0
2821348|NCT02986139|9655235|P2|Overall Study|Withdrawal by Subject|1
2821349|NCT02986139|9655236|P1|Overall Study|Withdrawal by Subject|0
2821350|NCT02986139|9655235|P2|Overall Study|Sponsor Decision|2
2821351|NCT02986139|9655236|P1|Overall Study|Sponsor Decision|1
2821352|NCT02985996|9655253|P5|Overall Study|Protocol Violation|0
2821353|NCT02985996|9655254|P4|Overall Study|Protocol Violation|0
2821354|NCT02985996|9655255|P3|Overall Study|Protocol Violation|0
2821355|NCT02985996|9655256|P2|Overall Study|Protocol Violation|1
2821356|NCT02985996|9655257|P1|Overall Study|Protocol Violation|0
2821357|NCT02985996|9655253|P5|Overall Study|Withdrawal by Subject|0
2821358|NCT02985996|9655254|P4|Overall Study|Withdrawal by Subject|0
2821359|NCT02985996|9655255|P3|Overall Study|Withdrawal by Subject|1
2821360|NCT02985996|9655256|P2|Overall Study|Withdrawal by Subject|0
2821361|NCT02985996|9655257|P1|Overall Study|Withdrawal by Subject|0
2821362|NCT02985684|9655391|P1|6-Month Closure Success Evaluation|Device Removal|3
2821363|NCT02985684|9655391|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
2821364|NCT02985684|9655391|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
2821365|NCT02985398|9655402|P1|Overall Study|Study Burden|9
2821366|NCT02985398|9655402|P1|Overall Study|Withdrawal by Subject|8
2821367|NCT02985398|9655402|P1|Overall Study|Lost to Follow-up|4
2821368|NCT02985398|9655402|P1|Overall Study|Adverse Event|1
2821369|NCT02984995|9655420|P2|Overall Study|Adverse Event|0
2821370|NCT02984995|9655421|P1|Overall Study|Adverse Event|1
2821371|NCT02984995|9655420|P2|Overall Study|Progressive disease|1
2821372|NCT02984995|9655421|P1|Overall Study|Progressive disease|11
2821373|NCT02984995|9655420|P2|Overall Study|Required stem cell transplant|2
2821374|NCT02984995|9655421|P1|Overall Study|Required stem cell transplant|13
2821375|NCT02984982|9655468|P2|Overall Study|Randomized but not treated|1
2821376|NCT02984982|9655469|P1|Overall Study|Randomized but not treated|0
2821377|NCT02984982|9655468|P2|Overall Study|Withdrawal by Subject|0
2821378|NCT02984982|9655469|P1|Overall Study|Withdrawal by Subject|2
2821379|NCT02984982|9655468|P2|Overall Study|Poor Compliance to Protocol|4
2821380|NCT02984982|9655469|P1|Overall Study|Poor Compliance to Protocol|4
2821381|NCT02984982|9655468|P2|Overall Study|Adverse Event|5
2821382|NCT02984982|9655469|P1|Overall Study|Adverse Event|2
2821383|NCT02984943|9655521|P1|Overall Study|Physician Decision|1
2821384|NCT02984943|9655521|P1|Overall Study|Withdrawal by Subject|3
2821385|NCT02984267|9655635|P2|Overall Study|Withdrawal by Subject|1
2821386|NCT02984267|9655636|P1|Overall Study|Withdrawal by Subject|0
2821387|NCT02984267|9655635|P2|Overall Study|Protocol Violation|0
2821388|NCT02984267|9655636|P1|Overall Study|Protocol Violation|1
2821389|NCT02983617|9655676|P2|Overall Study|Still on Study|28
2821390|NCT02983617|9655677|P1|Overall Study|Still on Study|6
2821391|NCT02983617|9655676|P2|Overall Study|Death|1
2821392|NCT02983617|9655677|P1|Overall Study|Death|0
2821393|NCT02983617|9655676|P2|Overall Study|Adverse Event|1
2821394|NCT02983617|9655677|P1|Overall Study|Adverse Event|0
2821395|NCT02983604|9655695|P4|Overall Study|Enrolled but not Treated|0
2821396|NCT02983604|9655696|P3|Overall Study|Enrolled but not Treated|1
2821397|NCT02983604|9655697|P2|Overall Study|Enrolled but not Treated|0
2821398|NCT02983604|9655698|P1|Overall Study|Enrolled but not Treated|0
2821399|NCT02983305|9655747|P2|Overall Study|incomplete data|0
2821400|NCT02983305|9655748|P1|Overall Study|incomplete data|2
2821401|NCT02982863|9655765|P5|Overall Study|Not eligible patients|492
2821402|NCT02982863|9655766|P4|Overall Study|Not eligible patients|1400
2821403|NCT02982863|9655767|P3|Overall Study|Not eligible patients|1852
2821404|NCT02982863|9655768|P2|Overall Study|Not eligible patients|4261
2821405|NCT02982863|9655769|P1|Overall Study|Not eligible patients|809
2821406|NCT02982720|9655826|P1|Overall Study|Death|1
2821407|NCT02982720|9655826|P1|Overall Study|Adverse Event|3
2821408|NCT02982239|9655836|P2|Overall Study|Lost to Follow-up|2
2821409|NCT02982239|9655837|P1|Overall Study|Lost to Follow-up|3
2821410|NCT02982187|9655853|P8|Overall Study|Withdrawal by Subject|0
2821411|NCT02982187|9655854|P7|Overall Study|Withdrawal by Subject|1
2821412|NCT02982187|9655855|P6|Overall Study|Withdrawal by Subject|0
2821413|NCT02982187|9655856|P5|Overall Study|Withdrawal by Subject|0
2821414|NCT02982187|9655857|P4|Overall Study|Withdrawal by Subject|0
2821415|NCT02982187|9655858|P3|Overall Study|Withdrawal by Subject|0
2821416|NCT02982187|9655859|P2|Overall Study|Withdrawal by Subject|0
2821417|NCT02982187|9655860|P1|Overall Study|Withdrawal by Subject|0
2821418|NCT02982018|9655910|P2|Overall Study|Withdrawal by Subject|1
2821419|NCT02982018|9655911|P1|Overall Study|Withdrawal by Subject|0
2821420|NCT02982018|9655910|P2|Overall Study|Lens Discomfort|0
2821421|NCT02982018|9655911|P1|Overall Study|Lens Discomfort|2
2821422|NCT02982018|9655910|P2|Overall Study|Adverse Event|1
2821423|NCT02982018|9655911|P1|Overall Study|Adverse Event|1
2821424|NCT02982018|9655910|P2|Overall Study|Protocol Violation|1
2821425|NCT02982018|9655911|P1|Overall Study|Protocol Violation|1
2821426|NCT02982018|9655910|P2|Overall Study|Incorrect Lens Dispensed|0
2821427|NCT02982018|9655911|P1|Overall Study|Incorrect Lens Dispensed|1
2821428|NCT02981524|9655925|P1|Overall Study|Withdrawal by Subject|1
2821429|NCT02981524|9655925|P1|Overall Study|Treatment Related Toxicity|1
2821430|NCT02981524|9655925|P1|Overall Study|Death (unrelated)|1
2821431|NCT02981524|9655925|P1|Overall Study|Progressive Disease|14
2821432|NCT02981342|9655937|P4|Overall Study|Lost to Follow-up|0
2821433|NCT02981342|9655938|P3|Overall Study|Lost to Follow-up|0
2821434|NCT02981342|9655939|P2|Overall Study|Lost to Follow-up|1
2821435|NCT02981342|9655940|P1|Overall Study|Lost to Follow-up|0
2821436|NCT02981342|9655937|P4|Overall Study|Randomized, Never Treated|7
2821437|NCT02981342|9655938|P3|Overall Study|Randomized, Never Treated|0
2821438|NCT02981342|9655939|P2|Overall Study|Randomized, Never Treated|1
2821439|NCT02981342|9655940|P1|Overall Study|Randomized, Never Treated|0
2821440|NCT02981342|9655937|P4|Overall Study|Study closed by sponsor|1
2821441|NCT02981342|9655938|P3|Overall Study|Study closed by sponsor|1
2821442|NCT02981342|9655939|P2|Overall Study|Study closed by sponsor|0
2821443|NCT02981342|9655940|P1|Overall Study|Study closed by sponsor|0
2821444|NCT02981342|9655937|P4|Overall Study|Withdrawal by Subject|1
2821445|NCT02981342|9655938|P3|Overall Study|Withdrawal by Subject|3
2821446|NCT02981342|9655939|P2|Overall Study|Withdrawal by Subject|0
2821447|NCT02981342|9655940|P1|Overall Study|Withdrawal by Subject|0
2821448|NCT02981342|9655937|P4|Overall Study|Death|4
2821449|NCT02981342|9655938|P3|Overall Study|Death|9
2821450|NCT02981342|9655939|P2|Overall Study|Death|9
2821451|NCT02981342|9655940|P1|Overall Study|Death|0
2821452|NCT02981342|9655937|P4|Overall Study|Adverse Event|1
2821453|NCT02981342|9655938|P3|Overall Study|Adverse Event|0
2821454|NCT02981342|9655939|P2|Overall Study|Adverse Event|0
2821455|NCT02981342|9655940|P1|Overall Study|Adverse Event|0
2821456|NCT02980783|9655998|P1|Overall Study|Lost to Follow-up|1
2821457|NCT02980601|9656011|P2|Overall Study|Failed to sign consent|0
2821458|NCT02980601|9656012|P1|Overall Study|Failed to sign consent|2
2821459|NCT02980601|9656011|P2|Overall Study|Graft loss|0
2821460|NCT02980601|9656012|P1|Overall Study|Graft loss|1
2821461|NCT02980601|9656011|P2|Overall Study|Death|1
2821462|NCT02980601|9656012|P1|Overall Study|Death|0
2821463|NCT02980601|9656011|P2|Overall Study|Lost to Follow-up|2
2821464|NCT02980601|9656012|P1|Overall Study|Lost to Follow-up|2
2821465|NCT02980523|9656105|P5|Overall Study|Did not receive intervention|0
2821466|NCT02980523|9656106|P4|Overall Study|Did not receive intervention|1
2821467|NCT02980523|9656107|P3|Overall Study|Did not receive intervention|0
2821468|NCT02980523|9656108|P2|Overall Study|Did not receive intervention|0
2821469|NCT02980523|9656109|P1|Overall Study|Did not receive intervention|0
2821470|NCT02980523|9656105|P5|Overall Study|Lack of Efficacy|8
2821471|NCT02980523|9656106|P4|Overall Study|Lack of Efficacy|5
2821472|NCT02980523|9656107|P3|Overall Study|Lack of Efficacy|4
2821473|NCT02980523|9656108|P2|Overall Study|Lack of Efficacy|4
2821474|NCT02980523|9656109|P1|Overall Study|Lack of Efficacy|1
2821475|NCT02980523|9656105|P5|Overall Study|Excluded from analysis|1
2821476|NCT02980523|9656106|P4|Overall Study|Excluded from analysis|1
2821477|NCT02980523|9656107|P3|Overall Study|Excluded from analysis|1
2821478|NCT02980523|9656108|P2|Overall Study|Excluded from analysis|3
2821479|NCT02980523|9656109|P1|Overall Study|Excluded from analysis|1
2821480|NCT02980523|9656105|P5|Overall Study|Lost to Follow-up|1
2821481|NCT02980523|9656106|P4|Overall Study|Lost to Follow-up|2
2821482|NCT02980523|9656107|P3|Overall Study|Lost to Follow-up|1
2821483|NCT02980523|9656108|P2|Overall Study|Lost to Follow-up|4
2821484|NCT02980523|9656109|P1|Overall Study|Lost to Follow-up|1
2821485|NCT02980224|9656153|P2|Overall Study|Withdrawal by Subject|2
2821486|NCT02980224|9656154|P1|Overall Study|Withdrawal by Subject|0
2821487|NCT02980224|9656153|P2|Overall Study|Adverse Event|1
2821488|NCT02980224|9656154|P1|Overall Study|Adverse Event|4
2821489|NCT02980133|9656172|P4|Overall Study|Withdrawal by Subject|0
2821490|NCT02980133|9656173|P3|Overall Study|Withdrawal by Subject|1
2821491|NCT02980133|9656174|P2|Overall Study|Withdrawal by Subject|0
2821492|NCT02980133|9656175|P1|Overall Study|Withdrawal by Subject|0
2821493|NCT02980133|9656172|P4|Overall Study|Withdrawal by parent/guardian|1
2821494|NCT02980133|9656173|P3|Overall Study|Withdrawal by parent/guardian|3
2821495|NCT02980133|9656174|P2|Overall Study|Withdrawal by parent/guardian|3
2821496|NCT02980133|9656175|P1|Overall Study|Withdrawal by parent/guardian|6
2821497|NCT02980133|9656172|P4|Overall Study|Protocol Violation|0
2821498|NCT02980133|9656173|P3|Overall Study|Protocol Violation|0
2821499|NCT02980133|9656174|P2|Overall Study|Protocol Violation|1
2821500|NCT02980133|9656175|P1|Overall Study|Protocol Violation|0
2821501|NCT02980133|9656172|P4|Overall Study|Lost to Follow-up|3
2821502|NCT02980133|9656173|P3|Overall Study|Lost to Follow-up|1
2821503|NCT02980133|9656174|P2|Overall Study|Lost to Follow-up|0
2821504|NCT02980133|9656175|P1|Overall Study|Lost to Follow-up|0
2821505|NCT02980133|9656172|P4|Overall Study|Other than specified|2
2821506|NCT02980133|9656173|P3|Overall Study|Other than specified|2
2821507|NCT02980133|9656174|P2|Overall Study|Other than specified|1
2821508|NCT02980133|9656175|P1|Overall Study|Other than specified|1
2821509|NCT02980107|9656213|P2|Overall Study|Withdrawal by Subject|62
2821510|NCT02980107|9656214|P1|Overall Study|Withdrawal by Subject|51
2821511|NCT02980042|9656228|P2|Overall Study|Insurance issues/treatment plan changes|0
2821512|NCT02980042|9656229|P1|Overall Study|Insurance issues/treatment plan changes|2
2821513|NCT02980042|9656228|P2|Overall Study|Lost to Follow-up|0
2821514|NCT02980042|9656229|P1|Overall Study|Lost to Follow-up|5
2821515|NCT02979639|9656261|P1|Overall Study|Adverse Event|2
2821516|NCT02979639|9656261|P1|Overall Study|Withdrawal by Subject|3
2821517|NCT02979639|9656261|P1|Overall Study|Lost to Follow-up|8
2821518|NCT02979639|9656261|P1|Overall Study|Withdrawal based on medical judgement|1
2821519|NCT02979613|9656293|P2|Open-Label Extension (OLE) Phase|Death|1
2821520|NCT02979613|9656294|P1|Open-Label Extension (OLE) Phase|Death|0
2821521|NCT02979613|9656293|P2|Open-Label Extension (OLE) Phase|Still in the OLE Phase|226
2821522|NCT02979613|9656294|P1|Open-Label Extension (OLE) Phase|Still in the OLE Phase|223
2821523|NCT02979613|9656293|P2|Double-Blind Phase|Randomized but Never Treated|0
2821524|NCT02979613|9656294|P1|Double-Blind Phase|Randomized but Never Treated|2
2821525|NCT02979613|9656293|P2|Double-Blind Phase|Protocol Violation|1
2821526|NCT02979613|9656294|P1|Double-Blind Phase|Protocol Violation|1
2821527|NCT02979613|9656293|P2|Double-Blind Phase|Lost to Follow-up|1
2821528|NCT02979613|9656294|P1|Double-Blind Phase|Lost to Follow-up|1
2821529|NCT02979613|9656293|P2|Double-Blind Phase|Adverse Event|0
2821530|NCT02979613|9656294|P1|Double-Blind Phase|Adverse Event|2
2821531|NCT02979613|9656293|P2|Double-Blind Phase|Pregnancy|2
2821532|NCT02979613|9656294|P1|Double-Blind Phase|Pregnancy|2
2821533|NCT02979613|9656293|P2|Double-Blind Phase|Withdrew Consent|4
2821534|NCT02979613|9656294|P1|Double-Blind Phase|Withdrew Consent|2
2821535|NCT02979535|9656328|P2|Overall Study|Lost to Follow-up|1
2821536|NCT02979535|9656329|P1|Overall Study|Lost to Follow-up|6
2821537|NCT02979535|9656328|P2|Overall Study|Consent withdrawn by participant|18
2821538|NCT02979535|9656329|P1|Overall Study|Consent withdrawn by participant|11
2821539|NCT02979535|9656328|P2|Overall Study|Non compliance with the protocol|82
2821540|NCT02979535|9656329|P1|Overall Study|Non compliance with the protocol|78
2821541|NCT02979431|9656392|P4|Overall Study|Subject left country after Day14|0
2821542|NCT02979431|9656393|P3|Overall Study|Subject left country after Day14|0
2821543|NCT02979431|9656394|P2|Overall Study|Subject left country after Day14|0
2821544|NCT02979431|9656395|P1|Overall Study|Subject left country after Day14|1
2821545|NCT02979431|9656392|P4|Overall Study|Adverse Event|0
2821546|NCT02979431|9656393|P3|Overall Study|Adverse Event|1
2821547|NCT02979431|9656394|P2|Overall Study|Adverse Event|0
2821548|NCT02979431|9656395|P1|Overall Study|Adverse Event|0
2821549|NCT02979431|9656392|P4|Overall Study|Randomized but received no study drug|0
2821550|NCT02979431|9656393|P3|Overall Study|Randomized but received no study drug|0
2821551|NCT02979431|9656394|P2|Overall Study|Randomized but received no study drug|1
2821552|NCT02979431|9656395|P1|Overall Study|Randomized but received no study drug|1
2821553|NCT02979431|9656392|P4|Overall Study|Parent/guardian withdrew consent|1
2821554|NCT02979431|9656393|P3|Overall Study|Parent/guardian withdrew consent|1
2821555|NCT02979431|9656394|P2|Overall Study|Parent/guardian withdrew consent|1
2821556|NCT02979431|9656395|P1|Overall Study|Parent/guardian withdrew consent|2
2821557|NCT02979197|9656476|P3|Overall Study|Subject unable to commit to study dates|0
2821558|NCT02979197|9656477|P2|Overall Study|Subject unable to commit to study dates|1
2821559|NCT02979197|9656478|P1|Overall Study|Subject unable to commit to study dates|0
2821560|NCT02979197|9656476|P3|Overall Study|Protocol Violation|0
2821561|NCT02979197|9656477|P2|Overall Study|Protocol Violation|1
2821562|NCT02979197|9656478|P1|Overall Study|Protocol Violation|0
2821563|NCT02979197|9656476|P3|Overall Study|Adverse Event|0
2821564|NCT02979197|9656477|P2|Overall Study|Adverse Event|2
2821565|NCT02979197|9656478|P1|Overall Study|Adverse Event|4
2821566|NCT02978833|9656521|P2|Overall Study|Study terminated|1
2821567|NCT02978833|9656522|P1|Overall Study|Study terminated|1
2821568|NCT02977572|9656559|P2|Overall Study|Exclusion criterion|2
2821569|NCT02977572|9656560|P1|Overall Study|Exclusion criterion|2
2821570|NCT02977507|9656582|P2|Overall Study|Lost to Follow-up|0
2821571|NCT02977507|9656583|P1|Overall Study|Lost to Follow-up|1
2821572|NCT02977507|9656582|P2|Overall Study|Protocol Deviation|0
2821573|NCT02977507|9656583|P1|Overall Study|Protocol Deviation|1
2821574|NCT02976519|9656613|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
2821575|NCT02976519|9656614|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821576|NCT02976519|9656615|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821577|NCT02976519|9656616|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821578|NCT02976519|9656617|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821579|NCT02976519|9656618|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821580|NCT02976519|9656619|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2821581|NCT02976519|9656613|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
2821582|NCT02976519|9656614|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821583|NCT02976519|9656615|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821584|NCT02976519|9656616|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821585|NCT02976519|9656617|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821586|NCT02976519|9656618|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821587|NCT02976519|9656619|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2821588|NCT02976519|9656613|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
2821589|NCT02976519|9656614|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
2821590|NCT02976519|9656615|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
2821591|NCT02976519|9656616|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
2821592|NCT02976519|9656617|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
2821593|NCT02976519|9656618|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
2821594|NCT02976519|9656619|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
2821595|NCT02976519|9656613|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821596|NCT02976519|9656614|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821597|NCT02976519|9656615|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821598|NCT02976519|9656616|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
2821599|NCT02976519|9656617|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821600|NCT02976519|9656618|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821601|NCT02976519|9656619|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2821602|NCT02976519|9656613|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821603|NCT02976519|9656614|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821604|NCT02976519|9656615|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821605|NCT02976519|9656616|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821606|NCT02976519|9656617|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821607|NCT02976519|9656618|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
2821608|NCT02976519|9656619|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2821609|NCT02976103|9656650|P2|Overall Study|Lost to Follow-up|8
2821610|NCT02976103|9656651|P1|Overall Study|Lost to Follow-up|12
2821611|NCT02976103|9656650|P2|Overall Study|Withdrawal by Subject|0
2821612|NCT02976103|9656651|P1|Overall Study|Withdrawal by Subject|1
2821613|NCT02975700|9656743|P1|Overall Study|Failed screening criteria|2
2821614|NCT02975700|9656743|P1|Overall Study|Progressive disease|3
2821615|NCT02975700|9656743|P1|Overall Study|Adverse Event|1
2821616|NCT02975206|9656777|P3|Overall Study|Other (e.g., lost to follow up)|6
2821617|NCT02975206|9656778|P2|Overall Study|Other (e.g., lost to follow up)|6
2821618|NCT02975206|9656779|P1|Overall Study|Other (e.g., lost to follow up)|13
2821619|NCT02975206|9656777|P3|Overall Study|Withdrawal by Subject|11
2821620|NCT02975206|9656778|P2|Overall Study|Withdrawal by Subject|11
2821621|NCT02975206|9656779|P1|Overall Study|Withdrawal by Subject|14
2821622|NCT02974868|9656796|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
2821623|NCT02974868|9656797|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
2821624|NCT02974868|9656798|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
2821625|NCT02974868|9656799|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
2821626|NCT02974868|9656796|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
2821627|NCT02974868|9656797|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
2821628|NCT02974868|9656798|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
2821629|NCT02974868|9656799|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
2821630|NCT02974868|9656796|P4|Initial 24-Week Treatment Period (TP)|others|8
2821631|NCT02974868|9656797|P3|Initial 24-Week Treatment Period (TP)|others|1
2821632|NCT02974868|9656798|P2|Initial 24-Week Treatment Period (TP)|others|8
2821633|NCT02974868|9656799|P1|Initial 24-Week Treatment Period (TP)|others|3
2821634|NCT02974868|9656796|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
2821635|NCT02974868|9656797|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
2821636|NCT02974868|9656798|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
2821637|NCT02974868|9656799|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
2821638|NCT02974855|9656921|P4|Overall Study|Adverse Event|1
2821639|NCT02974855|9656922|P3|Overall Study|Adverse Event|0
2821640|NCT02974855|9656923|P2|Overall Study|Adverse Event|1
2821641|NCT02974855|9656924|P1|Overall Study|Adverse Event|0
2821642|NCT02974842|9657110|P1|Overall Study|Screen failures|4
2821643|NCT02974842|9657110|P1|Overall Study|Withdrawal by Subject|4
2821644|NCT02974543|9657116|P2|Overall Study|Withdrawal by Subject|0
2821645|NCT02974543|9657117|P1|Overall Study|Withdrawal by Subject|1
2821646|NCT02974140|9657137|P1|Overall Study|Study Terminated by Sponsor|36
2821647|NCT02974140|9657137|P1|Overall Study|Lost to Follow-up|1
2821648|NCT02974140|9657137|P1|Overall Study|Adverse Event|2
2821649|NCT02974114|9657153|P3|Overall Study|Other (Not specified)|2
2821650|NCT02974114|9657154|P2|Overall Study|Other (Not specified)|1
2821651|NCT02974114|9657155|P1|Overall Study|Other (Not specified)|0
2821652|NCT02974088|9657198|P2|Overall Study|Adverse Event|1
2821653|NCT02974088|9657199|P1|Overall Study|Adverse Event|0
2821654|NCT02974088|9657198|P2|Overall Study|Lost to Follow-up|2
2821655|NCT02974088|9657199|P1|Overall Study|Lost to Follow-up|0
2821656|NCT02973802|9657205|P1|Overall Study|Withdrawal by Subject|1
2821657|NCT02973802|9657205|P1|Overall Study|Lost to Follow-up|1
2821658|NCT02973100|9657223|P4|Overall Study|Failed to attend Safety followup period|0
2821659|NCT02973100|9657224|P3|Overall Study|Failed to attend Safety followup period|1
2821660|NCT02973100|9657225|P2|Overall Study|Failed to attend Safety followup period|0
2821661|NCT02973100|9657226|P1|Overall Study|Failed to attend Safety followup period|0
2821662|NCT02973100|9657223|P4|Overall Study|Notification of change in address|1
2821663|NCT02973100|9657224|P3|Overall Study|Notification of change in address|0
2821664|NCT02973100|9657225|P2|Overall Study|Notification of change in address|0
2821665|NCT02973100|9657226|P1|Overall Study|Notification of change in address|0
2821666|NCT02973100|9657223|P4|Overall Study|Withdrawal by Subject|4
2821667|NCT02973100|9657224|P3|Overall Study|Withdrawal by Subject|1
2821668|NCT02973100|9657225|P2|Overall Study|Withdrawal by Subject|5
2821669|NCT02973100|9657226|P1|Overall Study|Withdrawal by Subject|3
2821670|NCT02973100|9657223|P4|Overall Study|Lost to Follow-up|0
2821671|NCT02973100|9657224|P3|Overall Study|Lost to Follow-up|1
2821672|NCT02973100|9657225|P2|Overall Study|Lost to Follow-up|1
2821673|NCT02973100|9657226|P1|Overall Study|Lost to Follow-up|3
2821674|NCT02973100|9657223|P4|Overall Study|Adverse Event|2
2821675|NCT02973100|9657224|P3|Overall Study|Adverse Event|1
2821676|NCT02973100|9657225|P2|Overall Study|Adverse Event|2
2821677|NCT02973100|9657226|P1|Overall Study|Adverse Event|1
2821678|NCT02972658|9657266|P4|Overall Study|Sponsor Decision|119
2821679|NCT02972658|9657267|P3|Overall Study|Sponsor Decision|72
2821680|NCT02972658|9657268|P2|Overall Study|Sponsor Decision|127
2821681|NCT02972658|9657269|P1|Overall Study|Sponsor Decision|70
2821682|NCT02972658|9657266|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
2821683|NCT02972658|9657267|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
2821684|NCT02972658|9657268|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
2821685|NCT02972658|9657269|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
2821686|NCT02972658|9657266|P4|Overall Study|Withdrawal by Subject|6
2821687|NCT02972658|9657267|P3|Overall Study|Withdrawal by Subject|1
2821688|NCT02972658|9657268|P2|Overall Study|Withdrawal by Subject|4
2821689|NCT02972658|9657269|P1|Overall Study|Withdrawal by Subject|4
2821690|NCT02972658|9657266|P4|Overall Study|Progressive Disease|1
2821691|NCT02972658|9657267|P3|Overall Study|Progressive Disease|0
2821692|NCT02972658|9657268|P2|Overall Study|Progressive Disease|1
2821693|NCT02972658|9657269|P1|Overall Study|Progressive Disease|0
2821694|NCT02972658|9657266|P4|Overall Study|Lost to Follow-up|2
2821695|NCT02972658|9657267|P3|Overall Study|Lost to Follow-up|1
2821696|NCT02972658|9657268|P2|Overall Study|Lost to Follow-up|1
2821697|NCT02972658|9657269|P1|Overall Study|Lost to Follow-up|0
2821698|NCT02972658|9657266|P4|Overall Study|Death|1
2821699|NCT02972658|9657267|P3|Overall Study|Death|0
2821700|NCT02972658|9657268|P2|Overall Study|Death|0
2821701|NCT02972658|9657269|P1|Overall Study|Death|0
2821702|NCT02972658|9657266|P4|Overall Study|Other-determined by Investigator|0
2821703|NCT02972658|9657267|P3|Overall Study|Other-determined by Investigator|0
2821704|NCT02972658|9657268|P2|Overall Study|Other-determined by Investigator|1
2821705|NCT02972658|9657269|P1|Overall Study|Other-determined by Investigator|1
2821706|NCT02972658|9657266|P4|Overall Study|Adverse Event|2
2821707|NCT02972658|9657267|P3|Overall Study|Adverse Event|0
2821708|NCT02972658|9657268|P2|Overall Study|Adverse Event|3
2821709|NCT02972658|9657269|P1|Overall Study|Adverse Event|0
2821710|NCT02972632|9657299|P1|Overall Study|Voluntary Withdrawal|10
2821711|NCT02972632|9657299|P1|Overall Study|Lost to Follow-up|4
2821712|NCT02972632|9657299|P1|Overall Study|Pretreatment Event/Adverse Event|3
2821713|NCT02972515|9657329|P1|Overall Study|Lost to Follow-up|78
2821714|NCT02972502|9657338|P2|Overall Study|Withdrawal by Subject|1
2821715|NCT02972502|9657339|P1|Overall Study|Withdrawal by Subject|1
2821716|NCT02972502|9657338|P2|Overall Study|Lost to Follow-up|1
2821717|NCT02972502|9657339|P1|Overall Study|Lost to Follow-up|3
2821718|NCT02972359|9657349|P1|Overall Study|Missing|1
2821719|NCT02972359|9657349|P1|Overall Study|Other reasons|5
2821720|NCT02972359|9657349|P1|Overall Study|Lost to Follow-up|26
2821721|NCT02972359|9657349|P1|Overall Study|Protocol Violation|1
2821722|NCT02972359|9657349|P1|Overall Study|Withdrawal by Subject|30
2821723|NCT02972359|9657349|P1|Overall Study|Death|1
2821724|NCT02972359|9657349|P1|Overall Study|Adverse Event|4
2821725|NCT02972359|9657349|P1|Overall Study|Lack of Efficacy|1
2821726|NCT02972359|9657349|P1|Overall Study|Incl. criteria not met/Exclusion met|2
2821727|NCT02971670|9657364|P4|Overall Study|Withdrawal by Subject|2
2821728|NCT02971670|9657365|P3|Overall Study|Withdrawal by Subject|1
2821729|NCT02971670|9657366|P2|Overall Study|Withdrawal by Subject|1
2821730|NCT02971670|9657367|P1|Overall Study|Withdrawal by Subject|4
2821731|NCT02971605|9657406|P1|Overall Study|Withdrawal by Subject|1
2821732|NCT02971202|9657520|P3|Overall Study|screen fail after consent|1
2821733|NCT02971202|9657521|P2|Overall Study|screen fail after consent|0
2821734|NCT02971202|9657522|P1|Overall Study|screen fail after consent|1
2821735|NCT02971202|9657520|P3|Overall Study|Pregnancy|0
2821736|NCT02971202|9657521|P2|Overall Study|Pregnancy|0
2821737|NCT02971202|9657522|P1|Overall Study|Pregnancy|1
2821738|NCT02971163|9657538|P2|Overall Study|Lost to Follow-up|2
2821739|NCT02971163|9657539|P1|Overall Study|Lost to Follow-up|4
2821740|NCT02971007|9657562|P3|Overall Study|Patient discontinued study drug|0
2821741|NCT02971007|9657563|P2|Overall Study|Patient discontinued study drug|1
2821742|NCT02971007|9657564|P1|Overall Study|Patient discontinued study drug|0
2821743|NCT02971007|9657562|P3|Overall Study|Patient had yeast at Day 5 visit|0
2821744|NCT02971007|9657563|P2|Overall Study|Patient had yeast at Day 5 visit|0
2821745|NCT02971007|9657564|P1|Overall Study|Patient had yeast at Day 5 visit|1
2821746|NCT02971007|9657562|P3|Overall Study|Withdrawal by Subject|0
2821747|NCT02971007|9657563|P2|Overall Study|Withdrawal by Subject|1
2821748|NCT02971007|9657564|P1|Overall Study|Withdrawal by Subject|0
2821749|NCT02971007|9657562|P3|Overall Study|Lost to Follow-up|1
2821750|NCT02971007|9657563|P2|Overall Study|Lost to Follow-up|1
2821751|NCT02971007|9657564|P1|Overall Study|Lost to Follow-up|0
2821752|NCT02971007|9657562|P3|Overall Study|Adverse Event|0
2821753|NCT02971007|9657563|P2|Overall Study|Adverse Event|0
2821754|NCT02971007|9657564|P1|Overall Study|Adverse Event|1
2821755|NCT02970669|9657596|P2|Open-label Period|Physician Decision|0
2821756|NCT02970669|9657597|P1|Open-label Period|Physician Decision|1
2821757|NCT02970669|9657596|P2|Open-label Period|Adverse Event|0
2821758|NCT02970669|9657597|P1|Open-label Period|Adverse Event|1
2821759|NCT02970669|9657596|P2|Open-label Period|Withdrawal by Subject|2
2821760|NCT02970669|9657597|P1|Open-label Period|Withdrawal by Subject|2
2821761|NCT02970669|9657596|P2|Double-blind Period|Withdrawal by Subject|2
2821762|NCT02970669|9657597|P1|Double-blind Period|Withdrawal by Subject|2
2821763|NCT02970669|9657596|P2|Double-blind Period|Physician Decision|2
2821764|NCT02970669|9657597|P1|Double-blind Period|Physician Decision|0
2821765|NCT02970669|9657596|P2|Double-blind Period|Study terminated by sponsor|2
2821766|NCT02970669|9657597|P1|Double-blind Period|Study terminated by sponsor|1
2821767|NCT02970669|9657596|P2|Double-blind Period|Death|0
2821768|NCT02970669|9657597|P1|Double-blind Period|Death|1
2821769|NCT02970669|9657596|P2|Double-blind Period|Adverse Event|0
2821770|NCT02970669|9657597|P1|Double-blind Period|Adverse Event|4
2821771|NCT02969863|9657673|P6|Overall Study|Physician Decision|0
2821772|NCT02969863|9657674|P5|Overall Study|Physician Decision|0
2821773|NCT02969863|9657675|P4|Overall Study|Physician Decision|0
2821774|NCT02969863|9657676|P3|Overall Study|Physician Decision|0
2821775|NCT02969863|9657677|P2|Overall Study|Physician Decision|0
2821776|NCT02969863|9657678|P1|Overall Study|Physician Decision|1
2821777|NCT02969655|9657694|P2|Overall Study|Adverse Event|8
2821778|NCT02969655|9657695|P1|Overall Study|Adverse Event|10
2821779|NCT02969655|9657694|P2|Overall Study|Protocol-specified withdrawal criteria|2
2821780|NCT02969655|9657695|P1|Overall Study|Protocol-specified withdrawal criteria|4
2821781|NCT02969655|9657694|P2|Overall Study|Physician Decision|3
2821782|NCT02969655|9657695|P1|Overall Study|Physician Decision|4
2821783|NCT02969655|9657694|P2|Overall Study|Withdrawal by Subject|2
2821784|NCT02969655|9657695|P1|Overall Study|Withdrawal by Subject|3
2821785|NCT02969590|9657730|P3|Screening Period|Hormones not suppressed post Lupron|0
2821786|NCT02969590|9657731|P2|Screening Period|Hormones not suppressed post Lupron|0
2821787|NCT02969590|9657732|P1|Screening Period|Hormones not suppressed post Lupron|1
2821788|NCT02969408|9657763|P1|Overall Study|Other than specified|1
2821789|NCT02969408|9657763|P1|Overall Study|Protocol Violation|1
2821790|NCT02969408|9657763|P1|Overall Study|Lost to Follow-up|4
2821791|NCT02969408|9657763|P1|Overall Study|Withdrawal by Subject|8
2821792|NCT02969408|9657763|P1|Overall Study|Adverse Event|2
2821793|NCT02969356|9657771|P1|Overall Study|Personal reasons|5
2821794|NCT02969356|9657771|P1|Overall Study|Did not need to be reinjected|6
2821795|NCT02969356|9657771|P1|Overall Study|Lost to Follow-up|3
2821796|NCT02969356|9657771|P1|Overall Study|Consent withdrawn|2
2821797|NCT02969356|9657771|P1|Overall Study|Adverse Event|7
2821798|NCT02969187|9657814|P2|Overall Study|Physician Decision|13
2821799|NCT02969187|9657815|P1|Overall Study|Physician Decision|12
2821800|NCT02969044|9657827|P2|Overall Study|Adverse Event|0
2821801|NCT02969044|9657828|P1|Overall Study|Adverse Event|3
2821802|NCT02969044|9657827|P2|Overall Study|Withdrawal by Subject|6
2821803|NCT02969044|9657828|P1|Overall Study|Withdrawal by Subject|2
2821804|NCT02969018|9657887|P8|Overall Study|Withdrawal by Subject|3
2821805|NCT02969018|9657888|P7|Overall Study|Withdrawal by Subject|4
2821806|NCT02969018|9657889|P6|Overall Study|Withdrawal by Subject|4
2821807|NCT02969018|9657890|P5|Overall Study|Withdrawal by Subject|0
2821808|NCT02969018|9657891|P4|Overall Study|Withdrawal by Subject|1
2821809|NCT02969018|9657892|P3|Overall Study|Withdrawal by Subject|2
2821810|NCT02969018|9657893|P2|Overall Study|Withdrawal by Subject|1
2821811|NCT02969018|9657894|P1|Overall Study|Withdrawal by Subject|0
2821812|NCT02969018|9657887|P8|Overall Study|Protocol Violation|0
2821813|NCT02969018|9657888|P7|Overall Study|Protocol Violation|0
2821814|NCT02969018|9657889|P6|Overall Study|Protocol Violation|0
2821815|NCT02969018|9657890|P5|Overall Study|Protocol Violation|0
2821816|NCT02969018|9657891|P4|Overall Study|Protocol Violation|1
2821817|NCT02969018|9657892|P3|Overall Study|Protocol Violation|1
2821818|NCT02969018|9657893|P2|Overall Study|Protocol Violation|0
2821819|NCT02969018|9657894|P1|Overall Study|Protocol Violation|0
2821820|NCT02969018|9657887|P8|Overall Study|Pregnancy|0
2821821|NCT02969018|9657888|P7|Overall Study|Pregnancy|0
2821822|NCT02969018|9657889|P6|Overall Study|Pregnancy|1
2821823|NCT02969018|9657890|P5|Overall Study|Pregnancy|0
2821824|NCT02969018|9657891|P4|Overall Study|Pregnancy|0
2821825|NCT02969018|9657892|P3|Overall Study|Pregnancy|0
2821826|NCT02969018|9657893|P2|Overall Study|Pregnancy|0
2821827|NCT02969018|9657894|P1|Overall Study|Pregnancy|0
2821828|NCT02969018|9657887|P8|Overall Study|Other|2
2821829|NCT02969018|9657888|P7|Overall Study|Other|0
2821830|NCT02969018|9657889|P6|Overall Study|Other|0
2821831|NCT02969018|9657890|P5|Overall Study|Other|0
2821832|NCT02969018|9657891|P4|Overall Study|Other|1
2821833|NCT02969018|9657892|P3|Overall Study|Other|0
2821834|NCT02969018|9657893|P2|Overall Study|Other|0
2821835|NCT02969018|9657894|P1|Overall Study|Other|0
2821836|NCT02969018|9657887|P8|Overall Study|Non-Compliance With Study Drug|0
2821837|NCT02969018|9657888|P7|Overall Study|Non-Compliance With Study Drug|0
2821838|NCT02969018|9657889|P6|Overall Study|Non-Compliance With Study Drug|0
2821839|NCT02969018|9657890|P5|Overall Study|Non-Compliance With Study Drug|0
2821840|NCT02969018|9657891|P4|Overall Study|Non-Compliance With Study Drug|0
2821841|NCT02969018|9657892|P3|Overall Study|Non-Compliance With Study Drug|0
2821842|NCT02969018|9657893|P2|Overall Study|Non-Compliance With Study Drug|0
2821843|NCT02969018|9657894|P1|Overall Study|Non-Compliance With Study Drug|1
2821844|NCT02969018|9657887|P8|Overall Study|No Longer Meets Eligibility Criteria|0
2821845|NCT02969018|9657888|P7|Overall Study|No Longer Meets Eligibility Criteria|1
2821846|NCT02969018|9657889|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2821847|NCT02969018|9657890|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2821848|NCT02969018|9657891|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2821849|NCT02969018|9657892|P3|Overall Study|No Longer Meets Eligibility Criteria|0
2821850|NCT02969018|9657893|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2821851|NCT02969018|9657894|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2821852|NCT02969018|9657887|P8|Overall Study|Lost to Follow-up|1
2821853|NCT02969018|9657888|P7|Overall Study|Lost to Follow-up|0
2821854|NCT02969018|9657889|P6|Overall Study|Lost to Follow-up|1
2821855|NCT02969018|9657890|P5|Overall Study|Lost to Follow-up|1
2821856|NCT02969018|9657891|P4|Overall Study|Lost to Follow-up|0
2821857|NCT02969018|9657892|P3|Overall Study|Lost to Follow-up|2
2821858|NCT02969018|9657893|P2|Overall Study|Lost to Follow-up|2
2821859|NCT02969018|9657894|P1|Overall Study|Lost to Follow-up|1
2821860|NCT02969018|9657887|P8|Overall Study|Lack of Efficacy|1
2821861|NCT02969018|9657888|P7|Overall Study|Lack of Efficacy|1
2821862|NCT02969018|9657889|P6|Overall Study|Lack of Efficacy|1
2821863|NCT02969018|9657890|P5|Overall Study|Lack of Efficacy|1
2821864|NCT02969018|9657891|P4|Overall Study|Lack of Efficacy|0
2821865|NCT02969018|9657892|P3|Overall Study|Lack of Efficacy|0
2821866|NCT02969018|9657893|P2|Overall Study|Lack of Efficacy|1
2821867|NCT02969018|9657894|P1|Overall Study|Lack of Efficacy|0
2821868|NCT02969018|9657887|P8|Overall Study|Adverse Event|0
2821869|NCT02969018|9657888|P7|Overall Study|Adverse Event|2
2821870|NCT02969018|9657889|P6|Overall Study|Adverse Event|1
2821871|NCT02969018|9657890|P5|Overall Study|Adverse Event|0
2821872|NCT02969018|9657891|P4|Overall Study|Adverse Event|2
2821873|NCT02969018|9657892|P3|Overall Study|Adverse Event|1
2821874|NCT02969018|9657893|P2|Overall Study|Adverse Event|4
2821875|NCT02969018|9657894|P1|Overall Study|Adverse Event|2
2821876|NCT02968979|9658034|P1|Overall Study|Withdrawal by Subject|1
2821877|NCT02968979|9658034|P1|Overall Study|Protocol Violation|7
2821878|NCT02968576|9658159|P2|Overall Study|Pregnancy|1
2821879|NCT02968576|9658160|P1|Overall Study|Pregnancy|0
2821880|NCT02968173|9658229|P1|Overall Study|Withdrawal by Subject|1
2821881|NCT02966795|9658484|P2|Overall Study|Patient Left the Country|1
2821882|NCT02966795|9658485|P1|Overall Study|Patient Left the Country|0
2821883|NCT02966509|9658496|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
2821884|NCT02966509|9658497|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
2821885|NCT02966509|9658496|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
2821886|NCT02966509|9658497|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
2821887|NCT02966509|9658496|P2|6 Month Satisfaction Survey|Refused to Answer|11
2821888|NCT02966509|9658497|P1|6 Month Satisfaction Survey|Refused to Answer|8
2821889|NCT02966509|9658496|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
2821890|NCT02966509|9658497|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
2821891|NCT02966509|9658496|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
2821892|NCT02966509|9658497|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
2821893|NCT02966509|9658496|P2|6 Month Satisfaction Survey|Death|33
2821894|NCT02966509|9658497|P1|6 Month Satisfaction Survey|Death|36
2821895|NCT02966509|9658496|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
2821896|NCT02966509|9658497|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
2821897|NCT02966509|9658496|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2821898|NCT02966509|9658497|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2821899|NCT02966509|9658496|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
2821900|NCT02966509|9658497|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
2821901|NCT02966509|9658496|P2|6 Month Satisfaction Decision Survey|Death|25
2821902|NCT02966509|9658497|P1|6 Month Satisfaction Decision Survey|Death|22
2821903|NCT02966509|9658496|P2|Baseline Satisfaction Survey|Refused to Answer|2
2821904|NCT02966509|9658497|P1|Baseline Satisfaction Survey|Refused to Answer|1
2821905|NCT02966509|9658496|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
2821906|NCT02966509|9658497|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
2821907|NCT02966509|9658496|P2|Baseline Satisfaction Survey|Death|1
2821908|NCT02966509|9658497|P1|Baseline Satisfaction Survey|Death|0
2821909|NCT02966509|9658496|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
2821910|NCT02966509|9658497|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
2821911|NCT02966353|9658521|P1|Overall Study|Protocol deviation|2
2821912|NCT02966353|9658521|P1|Overall Study|Progressive disease|2
2821913|NCT02966353|9658521|P1|Overall Study|Physician Decision|3
2821914|NCT02966353|9658521|P1|Overall Study|Death|4
2821915|NCT02966353|9658521|P1|Overall Study|Adverse Event|4
2821916|NCT02966353|9658521|P1|Overall Study|Withdrawal by Subject|7
2821917|NCT02966340|9658530|P2|Overall Study|startle non-responder|1
2821918|NCT02966340|9658531|P1|Overall Study|startle non-responder|1
2821919|NCT02966340|9658530|P2|Overall Study|data acquisition error|0
2821920|NCT02966340|9658531|P1|Overall Study|data acquisition error|1
2821921|NCT02966340|9658530|P2|Overall Study|Withdrawal by Subject|0
2821922|NCT02966340|9658531|P1|Overall Study|Withdrawal by Subject|1
2821923|NCT02966340|9658530|P2|Overall Study|Lost to Follow-up|1
2821924|NCT02966340|9658531|P1|Overall Study|Lost to Follow-up|0
2821925|NCT02966340|9658530|P2|Overall Study|Adverse Event|1
2821926|NCT02966340|9658531|P1|Overall Study|Adverse Event|0
2821927|NCT02966015|9658576|P2|Inclusion Visit|did not answer questionnaire|3
2821928|NCT02966015|9658577|P1|Inclusion Visit|did not answer questionnaire|8
2821929|NCT02966002|9658583|P1|Overall Study|Lost to Follow-up|1
2821930|NCT02966002|9658583|P1|Overall Study|Adverse Event|1
2821931|NCT02966002|9658583|P1|Overall Study|Withdrawal by Subject|2
2821932|NCT02965846|9658598|P3|Overall Study|Participants not randomized|33
2821933|NCT02965846|9658599|P2|Overall Study|Participants not randomized|0
2821934|NCT02965846|9658600|P1|Overall Study|Participants not randomized|0
2821935|NCT02965846|9658598|P3|Overall Study|Study Terminated By Sponsor|0
2821936|NCT02965846|9658599|P2|Overall Study|Study Terminated By Sponsor|4
2821937|NCT02965846|9658600|P1|Overall Study|Study Terminated By Sponsor|4
2821938|NCT02965846|9658598|P3|Overall Study|Withdrawal by Subject|0
2821939|NCT02965846|9658599|P2|Overall Study|Withdrawal by Subject|1
2821940|NCT02965846|9658600|P1|Overall Study|Withdrawal by Subject|0
2821941|NCT02965846|9658598|P3|Overall Study|Lost to Follow-up|0
2821942|NCT02965846|9658599|P2|Overall Study|Lost to Follow-up|0
2821943|NCT02965846|9658600|P1|Overall Study|Lost to Follow-up|1
2821944|NCT02965833|9658608|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
2821945|NCT02965833|9658609|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
2821946|NCT02965833|9658608|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2821947|NCT02965833|9658609|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2821948|NCT02965833|9658608|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
2821949|NCT02965833|9658609|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
2821950|NCT02965833|9658608|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2821951|NCT02965833|9658609|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2821952|NCT02965833|9658608|P2|Period 1, First 30 Days of Wear|Adverse Event|1
2821953|NCT02965833|9658609|P1|Period 1, First 30 Days of Wear|Adverse Event|0
2821954|NCT02965820|9658615|P2|Period 2, Second 30 Days|Adverse Event|1
2821955|NCT02965820|9658616|P1|Period 2, Second 30 Days|Adverse Event|1
2821956|NCT02965599|9658655|P2|Overall Study|Protocol-defined stop criteria reached|0
2821957|NCT02965599|9658656|P1|Overall Study|Protocol-defined stop criteria reached|1
2821958|NCT02965456|9658735|P2|Overall Study|Participant ran out of study drug|1
2821959|NCT02965456|9658736|P1|Overall Study|Participant ran out of study drug|0
2821960|NCT02965456|9658735|P2|Overall Study|Protocol Violation|1
2821961|NCT02965456|9658736|P1|Overall Study|Protocol Violation|0
2821962|NCT02965456|9658735|P2|Overall Study|Pregnancy|0
2821963|NCT02965456|9658736|P1|Overall Study|Pregnancy|1
2821964|NCT02965456|9658735|P2|Overall Study|Physician Decision|1
2821965|NCT02965456|9658736|P1|Overall Study|Physician Decision|0
2821966|NCT02965456|9658735|P2|Overall Study|Lack of Efficacy|0
2821967|NCT02965456|9658736|P1|Overall Study|Lack of Efficacy|1
2821968|NCT02965456|9658735|P2|Overall Study|Worsening Condition|2
2821969|NCT02965456|9658736|P1|Overall Study|Worsening Condition|0
2821970|NCT02965456|9658735|P2|Overall Study|Noncompliance with Study Drug|1
2821971|NCT02965456|9658736|P1|Overall Study|Noncompliance with Study Drug|1
2821972|NCT02965456|9658735|P2|Overall Study|Adverse Event|0
2821973|NCT02965456|9658736|P1|Overall Study|Adverse Event|3
2821974|NCT02965456|9658735|P2|Overall Study|Withdrawal by Parent or Guardian|6
2821975|NCT02965456|9658736|P1|Overall Study|Withdrawal by Parent or Guardian|3
2821976|NCT02965456|9658735|P2|Overall Study|Subject Request|13
2821977|NCT02965456|9658736|P1|Overall Study|Subject Request|22
2821978|NCT02965456|9658735|P2|Overall Study|Lost to Follow-up|18
2821979|NCT02965456|9658736|P1|Overall Study|Lost to Follow-up|40
2821980|NCT02964338|9658790|P3|Overall Study|Did not meet criteria|0
2821981|NCT02964338|9658791|P2|Overall Study|Did not meet criteria|0
2821982|NCT02964338|9658792|P1|Overall Study|Did not meet criteria|1
2821983|NCT02964338|9658790|P3|Overall Study|Non-compliant with e-diary|0
2821984|NCT02964338|9658791|P2|Overall Study|Non-compliant with e-diary|1
2821985|NCT02964338|9658792|P1|Overall Study|Non-compliant with e-diary|0
2821986|NCT02964338|9658790|P3|Overall Study|Adverse Event|1
2821987|NCT02964338|9658791|P2|Overall Study|Adverse Event|1
2821988|NCT02964338|9658792|P1|Overall Study|Adverse Event|2
2821989|NCT02964338|9658790|P3|Overall Study|Withdrawal by Subject|1
2821990|NCT02964338|9658791|P2|Overall Study|Withdrawal by Subject|3
2821991|NCT02964338|9658792|P1|Overall Study|Withdrawal by Subject|1
2821992|NCT02964338|9658790|P3|Overall Study|Protocol Violation|0
2821993|NCT02964338|9658791|P2|Overall Study|Protocol Violation|1
2821994|NCT02964338|9658792|P1|Overall Study|Protocol Violation|0
2821995|NCT02964338|9658790|P3|Overall Study|Lost to Follow-up|3
2821996|NCT02964338|9658791|P2|Overall Study|Lost to Follow-up|0
2821997|NCT02964338|9658792|P1|Overall Study|Lost to Follow-up|1
2821998|NCT02964338|9658790|P3|Overall Study|Lack of Efficacy|0
2821999|NCT02964338|9658791|P2|Overall Study|Lack of Efficacy|3
2822000|NCT02964338|9658792|P1|Overall Study|Lack of Efficacy|0
2822001|NCT02964338|9658790|P3|Overall Study|Sponsor terminated study for futility|14
2822002|NCT02964338|9658791|P2|Overall Study|Sponsor terminated study for futility|15
2822003|NCT02964338|9658792|P1|Overall Study|Sponsor terminated study for futility|12
2822004|NCT02964312|9658836|P1|Overall Study|Lack of Efficacy|7
2822005|NCT02964312|9658836|P1|Overall Study|Withdrawal by Subject|8
2822006|NCT02964312|9658836|P1|Overall Study|Lost to Follow-up|12
2822007|NCT02964247|9658844|P2|Overall Study|Withdrawal by Subject|2
2822008|NCT02964247|9658845|P1|Overall Study|Withdrawal by Subject|1
2822009|NCT02964247|9658844|P2|Overall Study|Lost to Follow-up|0
2822010|NCT02964247|9658845|P1|Overall Study|Lost to Follow-up|2
2822011|NCT02964234|9658903|P2|Overall Study|Lost to Follow-up|13
2822012|NCT02964234|9658904|P1|Overall Study|Lost to Follow-up|22
2822013|NCT02963935|9658933|P2|Overall Study|Unclassified|22
2822014|NCT02963935|9658934|P1|Overall Study|Unclassified|13
2822015|NCT02963935|9658933|P2|Overall Study|Lost to Follow-up|6
2822016|NCT02963935|9658934|P1|Overall Study|Lost to Follow-up|1
2822017|NCT02963935|9658933|P2|Overall Study|Lack of Efficacy|2
2822018|NCT02963935|9658934|P1|Overall Study|Lack of Efficacy|0
2822019|NCT02963935|9658933|P2|Overall Study|Protocol Violation|1
2822020|NCT02963935|9658934|P1|Overall Study|Protocol Violation|2
2822021|NCT02963935|9658933|P2|Overall Study|Adverse Event|6
2822022|NCT02963935|9658934|P1|Overall Study|Adverse Event|12
2822023|NCT02963922|9659042|P2|Overall Study|Other|14
2822024|NCT02963922|9659043|P1|Overall Study|Other|8
2822025|NCT02963922|9659042|P2|Overall Study|Lost to Follow-up|3
2822026|NCT02963922|9659043|P1|Overall Study|Lost to Follow-up|2
2822027|NCT02963922|9659042|P2|Overall Study|Lack of Efficacy|1
2822028|NCT02963922|9659043|P1|Overall Study|Lack of Efficacy|1
2822029|NCT02963922|9659042|P2|Overall Study|Protocol deviation|6
2822030|NCT02963922|9659043|P1|Overall Study|Protocol deviation|6
2822031|NCT02963922|9659042|P2|Overall Study|Adverse Event|6
2822032|NCT02963922|9659043|P1|Overall Study|Adverse Event|15
2822033|NCT02963701|9659141|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
2822034|NCT02963701|9659142|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
2822035|NCT02963311|9659197|P1|Overall Study|Screen Failure|4
2822036|NCT02963311|9659197|P1|Overall Study|Withdrawal by Subject|1
2822037|NCT02962960|9659224|P3|Overall Study|Protocol Violation|0
2822038|NCT02962960|9659225|P2|Overall Study|Protocol Violation|0
2822039|NCT02962960|9659226|P1|Overall Study|Protocol Violation|1
2822040|NCT02962960|9659224|P3|Overall Study|Adverse Event|0
2822041|NCT02962960|9659225|P2|Overall Study|Adverse Event|1
2822042|NCT02962960|9659226|P1|Overall Study|Adverse Event|1
2822043|NCT02962960|9659224|P3|Overall Study|Withdrawal by Subject|0
2822044|NCT02962960|9659225|P2|Overall Study|Withdrawal by Subject|1
2822045|NCT02962960|9659226|P1|Overall Study|Withdrawal by Subject|1
2822046|NCT02962908|9659310|P4|Overall Study|Physician Decision|0
2822047|NCT02962908|9659311|P3|Overall Study|Physician Decision|0
2822048|NCT02962908|9659312|P2|Overall Study|Physician Decision|1
2822049|NCT02962908|9659313|P1|Overall Study|Physician Decision|0
2822050|NCT02962908|9659310|P4|Overall Study|Protocol Violation|0
2822051|NCT02962908|9659311|P3|Overall Study|Protocol Violation|0
2822052|NCT02962908|9659312|P2|Overall Study|Protocol Violation|1
2822053|NCT02962908|9659313|P1|Overall Study|Protocol Violation|0
2822054|NCT02962908|9659310|P4|Overall Study|Withdrawal by Subject|2
2822055|NCT02962908|9659311|P3|Overall Study|Withdrawal by Subject|0
2822056|NCT02962908|9659312|P2|Overall Study|Withdrawal by Subject|3
2822057|NCT02962908|9659313|P1|Overall Study|Withdrawal by Subject|0
2822058|NCT02962908|9659310|P4|Overall Study|Lost to Follow-up|1
2822059|NCT02962908|9659311|P3|Overall Study|Lost to Follow-up|0
2822060|NCT02962908|9659312|P2|Overall Study|Lost to Follow-up|3
2822061|NCT02962908|9659313|P1|Overall Study|Lost to Follow-up|0
2822062|NCT02962882|9659355|P1|Overall Study|Transfer from ICU|32
2822063|NCT02962882|9659355|P1|Overall Study|Withdrawal by Subject|2
2822064|NCT02962882|9659355|P1|Overall Study|Adverse Event|2
2822065|NCT02962648|9659391|P1|Overall Study|Subject had problems with transportation|2
2822066|NCT02962648|9659391|P1|Overall Study|Physician Decision|1
2822067|NCT02962648|9659391|P1|Overall Study|Lost to Follow-up|3
2822068|NCT02962648|9659391|P1|Overall Study|Withdrawal by Subject|3
2822069|NCT02962284|9659429|P2|Overall Study|Withdrawal by Subject|0
2822070|NCT02962284|9659430|P1|Overall Study|Withdrawal by Subject|1
2822071|NCT02962284|9659429|P2|Overall Study|Progressive disease|3
2822072|NCT02962284|9659430|P1|Overall Study|Progressive disease|2
2822073|NCT02962284|9659429|P2|Overall Study|Death|0
2822074|NCT02962284|9659430|P1|Overall Study|Death|2
2822075|NCT02961920|9659461|P2|Overall Study|did not achive stydy protocol schedule|1
2822076|NCT02961920|9659462|P1|Overall Study|did not achive stydy protocol schedule|1
2822077|NCT02961790|9659472|P4|Overall Study|without post baseline data|1
2822078|NCT02961790|9659473|P3|Overall Study|without post baseline data|4
2822079|NCT02961790|9659474|P2|Overall Study|without post baseline data|6
2822080|NCT02961790|9659475|P1|Overall Study|without post baseline data|7
2822081|NCT02961790|9659472|P4|Overall Study|without baseline data|0
2822082|NCT02961790|9659473|P3|Overall Study|without baseline data|1
2822083|NCT02961790|9659474|P2|Overall Study|without baseline data|0
2822084|NCT02961790|9659475|P1|Overall Study|without baseline data|4
2822085|NCT02961790|9659472|P4|Overall Study|Canceled|4
2822086|NCT02961790|9659473|P3|Overall Study|Canceled|1
2822087|NCT02961790|9659474|P2|Overall Study|Canceled|5
2822088|NCT02961790|9659475|P1|Overall Study|Canceled|4
2822089|NCT02961764|9659498|P2|Overall Study|Withdrawal by Subject|0
2822090|NCT02961764|9659499|P1|Overall Study|Withdrawal by Subject|2
2822091|NCT02961764|9659498|P2|Overall Study|Lost to Follow-up|24
2822092|NCT02961764|9659499|P1|Overall Study|Lost to Follow-up|35
2822093|NCT02961764|9659498|P2|Overall Study|Death|0
2822094|NCT02961764|9659499|P1|Overall Study|Death|2
2822095|NCT02961764|9659498|P2|Overall Study|Protocol Violation|1
2822096|NCT02961764|9659499|P1|Overall Study|Protocol Violation|0
2822097|NCT02961751|9659573|P1|Overall Study|Protocol Violation|1
2822098|NCT02961751|9659573|P1|Overall Study|Not Eligible at Enrollment|1
2822099|NCT02961751|9659573|P1|Overall Study|Physician Decision|2
2822100|NCT02961751|9659573|P1|Overall Study|Lost to Follow-up|11
2822101|NCT02961244|9659586|P2|Overall Study|İnadequate data|2
2822102|NCT02961244|9659587|P1|Overall Study|İnadequate data|0
2822103|NCT02961244|9659586|P2|Overall Study|Lost to Follow-up|2
2822104|NCT02961244|9659587|P1|Overall Study|Lost to Follow-up|0
2822105|NCT02961244|9659586|P2|Overall Study|Surgery plan change after study approval|2
2822106|NCT02961244|9659587|P1|Overall Study|Surgery plan change after study approval|0
2822107|NCT02961244|9659586|P2|Overall Study|Withdrawal by Subject|2
2822108|NCT02961244|9659587|P1|Overall Study|Withdrawal by Subject|1
2822109|NCT02961244|9659586|P2|Overall Study|Protocol Violation|1
2822110|NCT02961244|9659587|P1|Overall Study|Protocol Violation|0
2822111|NCT02960854|9659640|P2|Overall Study|Death|6
2822112|NCT02960854|9659641|P1|Overall Study|Death|4
2822113|NCT02960854|9659640|P2|Overall Study|Subject Withdrew Consent|1
2822114|NCT02960854|9659641|P1|Overall Study|Subject Withdrew Consent|0
2822115|NCT02960854|9659640|P2|Overall Study|Subject No Longer Meets Study Criteria|0
2822116|NCT02960854|9659641|P1|Overall Study|Subject No Longer Meets Study Criteria|1
2822117|NCT02960854|9659640|P2|Overall Study|Not Disclosed|2
2822118|NCT02960854|9659641|P1|Overall Study|Not Disclosed|2
2822119|NCT02960217|9659680|P2|Open-Label Extension Phase|Other, Not Specified|1
2822120|NCT02960217|9659681|P1|Open-Label Extension Phase|Other, Not Specified|0
2822121|NCT02960217|9659680|P2|Open-Label Extension Phase|Lack of Efficacy|1
2822122|NCT02960217|9659681|P1|Open-Label Extension Phase|Lack of Efficacy|1
2822123|NCT02960217|9659680|P2|Open-Label Extension Phase|Sponsor Decision|11
2822124|NCT02960217|9659681|P1|Open-Label Extension Phase|Sponsor Decision|18
2822125|NCT02960217|9659680|P2|Open-Label Extension Phase|Adverse Event|0
2822126|NCT02960217|9659681|P1|Open-Label Extension Phase|Adverse Event|1
2822127|NCT02960217|9659680|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
2822128|NCT02960217|9659681|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
2822129|NCT02960217|9659680|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
2822130|NCT02960217|9659681|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
2822131|NCT02960217|9659680|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
2822132|NCT02960217|9659681|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
2822133|NCT02960217|9659680|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
2822134|NCT02960217|9659681|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
2822135|NCT02960217|9659680|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
2822136|NCT02960217|9659681|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
2822137|NCT02959983|9659760|P2|Overall Study|Withdrawal by Subject|12
2822138|NCT02959983|9659761|P1|Overall Study|Withdrawal by Subject|7
2822139|NCT02959983|9659760|P2|Overall Study|Adverse Event|1
2822140|NCT02959983|9659761|P1|Overall Study|Adverse Event|5
2822141|NCT02959983|9659760|P2|Overall Study|Physician Decision|0
2822142|NCT02959983|9659761|P1|Overall Study|Physician Decision|1
2822143|NCT02959983|9659760|P2|Overall Study|Other|1
2822144|NCT02959983|9659761|P1|Overall Study|Other|1
2822145|NCT02959983|9659760|P2|Overall Study|Lost to Follow-up|9
2822146|NCT02959983|9659761|P1|Overall Study|Lost to Follow-up|12
2822147|NCT02959983|9659760|P2|Overall Study|Lack of Efficacy|1
2822148|NCT02959983|9659761|P1|Overall Study|Lack of Efficacy|0
2822149|NCT02959983|9659760|P2|Overall Study|Protocol Violation|1
2822150|NCT02959983|9659761|P1|Overall Study|Protocol Violation|0
2822151|NCT02959970|9659775|P2|Overall Study|Lost to Follow-up|5
2822152|NCT02959970|9659776|P1|Overall Study|Lost to Follow-up|1
2822153|NCT02959970|9659775|P2|Overall Study|Withdrawal by Subject|2
2822154|NCT02959970|9659776|P1|Overall Study|Withdrawal by Subject|0
2822155|NCT02959970|9659775|P2|Overall Study|Adverse Event|0
2822156|NCT02959970|9659776|P1|Overall Study|Adverse Event|1
2822157|NCT02959892|9659810|P2|Overall Study|Study termination|1
2822158|NCT02959892|9659811|P1|Overall Study|Study termination|0
2822159|NCT02959892|9659810|P2|Overall Study|PET tracer synthesis failure|0
2822160|NCT02959892|9659811|P1|Overall Study|PET tracer synthesis failure|1
2822161|NCT02959866|9659819|P1|Overall Study|Withdrawal by Subject|1
2822162|NCT02959814|9659908|P1|Overall Study|Excluded by FFR core-lab|24
2822163|NCT02959814|9659908|P1|Overall Study|In-procedure QFR not computed|6
2822164|NCT02959814|9659908|P1|Overall Study|FFR not measured|2
2822165|NCT02959814|9659908|P1|Overall Study|Protocol Violation|7
2822166|NCT02959814|9659908|P1|Overall Study|Excluded based on anatomical criteria|2
2822167|NCT02959814|9659908|P1|Overall Study|Excluded based on diagnostic angiography|16
2822168|NCT02959437|9659931|P4|Overall Study|Participants Ongoing in Study|0
2822169|NCT02959437|9659932|P3|Overall Study|Participants Ongoing in Study|0
2822170|NCT02959437|9659933|P2|Overall Study|Participants Ongoing in Study|0
2822171|NCT02959437|9659934|P1|Overall Study|Participants Ongoing in Study|7
2822172|NCT02959437|9659931|P4|Overall Study|Other Unspecified|0
2822173|NCT02959437|9659932|P3|Overall Study|Other Unspecified|0
2822174|NCT02959437|9659933|P2|Overall Study|Other Unspecified|0
2822175|NCT02959437|9659934|P1|Overall Study|Other Unspecified|2
2822176|NCT02959437|9659931|P4|Overall Study|Study Terminated by Sponsor|0
2822177|NCT02959437|9659932|P3|Overall Study|Study Terminated by Sponsor|0
2822178|NCT02959437|9659933|P2|Overall Study|Study Terminated by Sponsor|0
2822179|NCT02959437|9659934|P1|Overall Study|Study Terminated by Sponsor|2
2822180|NCT02959437|9659931|P4|Overall Study|Progressive Disease|0
2822181|NCT02959437|9659932|P3|Overall Study|Progressive Disease|0
2822182|NCT02959437|9659933|P2|Overall Study|Progressive Disease|1
2822183|NCT02959437|9659934|P1|Overall Study|Progressive Disease|8
2822184|NCT02959437|9659931|P4|Overall Study|Withdrawal by Subject|0
2822185|NCT02959437|9659932|P3|Overall Study|Withdrawal by Subject|0
2822186|NCT02959437|9659933|P2|Overall Study|Withdrawal by Subject|3
2822187|NCT02959437|9659934|P1|Overall Study|Withdrawal by Subject|10
2822188|NCT02959437|9659931|P4|Overall Study|Lost to Follow-up|0
2822189|NCT02959437|9659932|P3|Overall Study|Lost to Follow-up|0
2822190|NCT02959437|9659933|P2|Overall Study|Lost to Follow-up|1
2822191|NCT02959437|9659934|P1|Overall Study|Lost to Follow-up|2
2822192|NCT02959437|9659931|P4|Overall Study|Death|0
2822193|NCT02959437|9659932|P3|Overall Study|Death|0
2822194|NCT02959437|9659933|P2|Overall Study|Death|3
2822195|NCT02959437|9659934|P1|Overall Study|Death|31
2822196|NCT02959177|9659949|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
2822197|NCT02959177|9659950|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2822198|NCT02959177|9659951|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2822199|NCT02959177|9659949|P3|Follow-up Post Treatment Phase|Adverse Event|0
2822200|NCT02959177|9659950|P2|Follow-up Post Treatment Phase|Adverse Event|1
2822201|NCT02959177|9659951|P1|Follow-up Post Treatment Phase|Adverse Event|0
2822202|NCT02959177|9659949|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
2822203|NCT02959177|9659950|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
2822204|NCT02959177|9659951|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
2822205|NCT02959177|9659949|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
2822206|NCT02959177|9659950|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
2822207|NCT02959177|9659951|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
2822208|NCT02959177|9659949|P3|Double-Blind Treatment Phase|Protocol Violation|0
2822209|NCT02959177|9659950|P2|Double-Blind Treatment Phase|Protocol Violation|1
2822210|NCT02959177|9659951|P1|Double-Blind Treatment Phase|Protocol Violation|0
2822211|NCT02959177|9659949|P3|Double-Blind Treatment Phase|Physician Decision|0
2822212|NCT02959177|9659950|P2|Double-Blind Treatment Phase|Physician Decision|0
2822213|NCT02959177|9659951|P1|Double-Blind Treatment Phase|Physician Decision|1
2822214|NCT02959177|9659949|P3|Double-Blind Treatment Phase|Adverse Event|0
2822215|NCT02959177|9659950|P2|Double-Blind Treatment Phase|Adverse Event|2
2822216|NCT02959177|9659951|P1|Double-Blind Treatment Phase|Adverse Event|5
2822217|NCT02959138|9660006|P3|Overall Study|Enrolled but Never Treated|0
2822218|NCT02959138|9660007|P2|Overall Study|Enrolled but Never Treated|1
2822219|NCT02959138|9660008|P1|Overall Study|Enrolled but Never Treated|0
2822220|NCT02958553|9660149|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
2822221|NCT02958553|9660149|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
2822222|NCT02958267|9660183|P2|Follow-up Visits|Additional treatment pursued|1
2822223|NCT02958267|9660184|P1|Follow-up Visits|Additional treatment pursued|2
2822224|NCT02958267|9660183|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
2822225|NCT02958267|9660184|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
2822226|NCT02958267|9660183|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
2822227|NCT02958267|9660184|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
2822228|NCT02957747|9660196|P2|Overall Study|Lost to Follow-up|5
2822229|NCT02957747|9660197|P1|Overall Study|Lost to Follow-up|10
2822230|NCT02957747|9660196|P2|Overall Study|Withdrawal by Subject|3
2822231|NCT02957747|9660197|P1|Overall Study|Withdrawal by Subject|0
2822232|NCT02956967|9660223|P1|Overall Study|Termination of Nivestim administration|29
2822233|NCT02956967|9660223|P1|Overall Study|Missing|1
2822234|NCT02956967|9660223|P1|Overall Study|Lost to Follow-up|5
2822235|NCT02956967|9660223|P1|Overall Study|Reason non-related to neutropenia|10
2822236|NCT02956967|9660223|P1|Overall Study|Adverse Event|3
2822237|NCT02956837|9660250|P4|Overall Study|Lost to Follow-up|0
2822238|NCT02956837|9660251|P3|Overall Study|Lost to Follow-up|2
2822239|NCT02956837|9660252|P2|Overall Study|Lost to Follow-up|1
2822240|NCT02956837|9660253|P1|Overall Study|Lost to Follow-up|0
2822241|NCT02956837|9660250|P4|Overall Study|Withdrawal by Subject|3
2822242|NCT02956837|9660251|P3|Overall Study|Withdrawal by Subject|0
2822243|NCT02956837|9660252|P2|Overall Study|Withdrawal by Subject|1
2822244|NCT02956837|9660253|P1|Overall Study|Withdrawal by Subject|0
2822245|NCT02956837|9660250|P4|Overall Study|Serious Adverse Events|0
2822246|NCT02956837|9660251|P3|Overall Study|Serious Adverse Events|0
2822247|NCT02956837|9660252|P2|Overall Study|Serious Adverse Events|1
2822248|NCT02956837|9660253|P1|Overall Study|Serious Adverse Events|0
2822249|NCT02956629|9660388|P6|Overall Study|Withdrawal by Subject|0
2822250|NCT02956629|9660389|P5|Overall Study|Withdrawal by Subject|0
2822251|NCT02956629|9660390|P4|Overall Study|Withdrawal by Subject|0
2822252|NCT02956629|9660391|P3|Overall Study|Withdrawal by Subject|0
2822253|NCT02956629|9660392|P2|Overall Study|Withdrawal by Subject|1
2822254|NCT02956629|9660393|P1|Overall Study|Withdrawal by Subject|3
2822255|NCT02956629|9660388|P6|Overall Study|Lost to Follow-up|1
2822256|NCT02956629|9660389|P5|Overall Study|Lost to Follow-up|0
2822257|NCT02956629|9660390|P4|Overall Study|Lost to Follow-up|1
2822258|NCT02956629|9660391|P3|Overall Study|Lost to Follow-up|3
2822259|NCT02956629|9660392|P2|Overall Study|Lost to Follow-up|5
2822260|NCT02956629|9660393|P1|Overall Study|Lost to Follow-up|2
2822261|NCT02956629|9660388|P6|Overall Study|Adverse Event|0
2822262|NCT02956629|9660389|P5|Overall Study|Adverse Event|0
2822263|NCT02956629|9660390|P4|Overall Study|Adverse Event|0
2822264|NCT02956629|9660391|P3|Overall Study|Adverse Event|1
2822265|NCT02956629|9660392|P2|Overall Study|Adverse Event|0
2822266|NCT02956629|9660393|P1|Overall Study|Adverse Event|0
2822267|NCT02956460|9660472|P2|Lens 1|Lost to Follow-up|0
2822268|NCT02956460|9660473|P1|Lens 1|Lost to Follow-up|1
2822269|NCT02956005|9660550|P1|Overall Study|Physician Decision|12
2822270|NCT02956005|9660550|P1|Overall Study|Withdrawal by Subject|3
2822271|NCT02956005|9660550|P1|Overall Study|Not eligible|1
2822272|NCT02954952|9660558|P3|Overall Study|No data collected|0
2822273|NCT02954952|9660559|P2|Overall Study|No data collected|1
2822274|NCT02954952|9660560|P1|Overall Study|No data collected|0
2822275|NCT02954952|9660558|P3|Overall Study|Withdrawal by Subject|0
2822276|NCT02954952|9660559|P2|Overall Study|Withdrawal by Subject|0
2822277|NCT02954952|9660560|P1|Overall Study|Withdrawal by Subject|1
2822278|NCT02954848|9660570|P2|Overall Study|Withdrawal by Participant|1
2822279|NCT02954848|9660571|P1|Overall Study|Withdrawal by Participant|0
2822280|NCT02954848|9660570|P2|Overall Study|Adverse Event|3
2822281|NCT02954848|9660571|P1|Overall Study|Adverse Event|2
2822282|NCT02954848|9660570|P2|Overall Study|Randomized but Not Treated|1
2822283|NCT02954848|9660571|P1|Overall Study|Randomized but Not Treated|0
2822284|NCT02954653|9660631|P9|Overall Study|Treatment failure and consent withdrawal|0
2822285|NCT02954653|9660632|P8|Overall Study|Treatment failure and consent withdrawal|0
2822286|NCT02954653|9660633|P7|Overall Study|Treatment failure and consent withdrawal|0
2822287|NCT02954653|9660634|P6|Overall Study|Treatment failure and consent withdrawal|0
2822288|NCT02954653|9660635|P5|Overall Study|Treatment failure and consent withdrawal|0
2822289|NCT02954653|9660636|P4|Overall Study|Treatment failure and consent withdrawal|0
2822290|NCT02954653|9660637|P3|Overall Study|Treatment failure and consent withdrawal|0
2822291|NCT02954653|9660638|P2|Overall Study|Treatment failure and consent withdrawal|1
2822292|NCT02954653|9660639|P1|Overall Study|Treatment failure and consent withdrawal|0
2822293|NCT02954653|9660631|P9|Overall Study|Started another anti-cancer therapy|0
2822294|NCT02954653|9660632|P8|Overall Study|Started another anti-cancer therapy|0
2822295|NCT02954653|9660633|P7|Overall Study|Started another anti-cancer therapy|0
2822296|NCT02954653|9660634|P6|Overall Study|Started another anti-cancer therapy|0
2822297|NCT02954653|9660635|P5|Overall Study|Started another anti-cancer therapy|0
2822298|NCT02954653|9660636|P4|Overall Study|Started another anti-cancer therapy|0
2822299|NCT02954653|9660637|P3|Overall Study|Started another anti-cancer therapy|0
2822300|NCT02954653|9660638|P2|Overall Study|Started another anti-cancer therapy|1
2822301|NCT02954653|9660639|P1|Overall Study|Started another anti-cancer therapy|0
2822302|NCT02954653|9660631|P9|Overall Study|Randomized but did not receive treatment|0
2822303|NCT02954653|9660632|P8|Overall Study|Randomized but did not receive treatment|0
2822304|NCT02954653|9660633|P7|Overall Study|Randomized but did not receive treatment|0
2822305|NCT02954653|9660634|P6|Overall Study|Randomized but did not receive treatment|0
2822306|NCT02954653|9660635|P5|Overall Study|Randomized but did not receive treatment|0
2822307|NCT02954653|9660636|P4|Overall Study|Randomized but did not receive treatment|0
2822308|NCT02954653|9660637|P3|Overall Study|Randomized but did not receive treatment|0
2822309|NCT02954653|9660638|P2|Overall Study|Randomized but did not receive treatment|0
2822310|NCT02954653|9660639|P1|Overall Study|Randomized but did not receive treatment|1
2822311|NCT02954653|9660631|P9|Overall Study|Death|0
2822312|NCT02954653|9660632|P8|Overall Study|Death|0
2822313|NCT02954653|9660633|P7|Overall Study|Death|0
2822314|NCT02954653|9660634|P6|Overall Study|Death|0
2822315|NCT02954653|9660635|P5|Overall Study|Death|0
2822316|NCT02954653|9660636|P4|Overall Study|Death|0
2822317|NCT02954653|9660637|P3|Overall Study|Death|0
2822318|NCT02954653|9660638|P2|Overall Study|Death|1
2822319|NCT02954653|9660639|P1|Overall Study|Death|3
2822320|NCT02954601|9660758|P4|First Intervention (Five Days)|Withdrawal by Subject|0
2822321|NCT02954601|9660759|P3|First Intervention (Five Days)|Withdrawal by Subject|1
2822322|NCT02954601|9660760|P2|First Intervention (Five Days)|Withdrawal by Subject|0
2822323|NCT02954601|9660761|P1|First Intervention (Five Days)|Withdrawal by Subject|0
2822324|NCT02954575|9660783|P1|Overall Study|Adverse Event|1
2822325|NCT02954575|9660783|P1|Overall Study|Withdrawal by Subject|2
2822326|NCT02954354|9660803|P3|Overall Study|Miscellaneous|1
2822327|NCT02954354|9660804|P2|Overall Study|Miscellaneous|2
2822328|NCT02954354|9660805|P1|Overall Study|Miscellaneous|2
2822329|NCT02954354|9660803|P3|Overall Study|Lost to Follow-up|0
2822330|NCT02954354|9660804|P2|Overall Study|Lost to Follow-up|5
2822331|NCT02954354|9660805|P1|Overall Study|Lost to Follow-up|12
2822332|NCT02954354|9660803|P3|Overall Study|Withdrawal by Subject|11
2822333|NCT02954354|9660804|P2|Overall Study|Withdrawal by Subject|9
2822334|NCT02954354|9660805|P1|Overall Study|Withdrawal by Subject|17
2822335|NCT02954354|9660803|P3|Overall Study|Lack of Efficacy|0
2822336|NCT02954354|9660804|P2|Overall Study|Lack of Efficacy|2
2822337|NCT02954354|9660805|P1|Overall Study|Lack of Efficacy|0
2822338|NCT02954354|9660803|P3|Overall Study|Failure to Meet Eligibility Criteria|0
2822339|NCT02954354|9660804|P2|Overall Study|Failure to Meet Eligibility Criteria|0
2822340|NCT02954354|9660805|P1|Overall Study|Failure to Meet Eligibility Criteria|1
2822341|NCT02954354|9660803|P3|Overall Study|Adverse Event|4
2822342|NCT02954354|9660804|P2|Overall Study|Adverse Event|2
2822343|NCT02954354|9660805|P1|Overall Study|Adverse Event|2
2822344|NCT02953938|9660906|P2|Overall Study|Withdrawal by Subject|1
2822345|NCT02953938|9660907|P1|Overall Study|Withdrawal by Subject|1
2822346|NCT02953938|9660906|P2|Overall Study|Adverse Event|1
2822347|NCT02953938|9660907|P1|Overall Study|Adverse Event|0
2822348|NCT02953678|9660936|P1|Overall Study|Reason unspecified|2
2822349|NCT02953678|9660936|P1|Overall Study|Withdrawal by Subject|3
2822350|NCT02953678|9660936|P1|Overall Study|Relapse of Underlying Malignancy|2
2822351|NCT02953678|9660936|P1|Overall Study|Progressive Disease of GVHD|6
2822352|NCT02953678|9660936|P1|Overall Study|Physician Decision|20
2822353|NCT02953678|9660936|P1|Overall Study|Death|7
2822354|NCT02953678|9660936|P1|Overall Study|Adverse Event|20
2822355|NCT02953314|9660947|P2|Overall Study|Withdrawal of consent (not due to AE)|2
2822356|NCT02953314|9660948|P1|Overall Study|Withdrawal of consent (not due to AE)|0
2822357|NCT02953314|9660947|P2|Overall Study|Adverse Event|1
2822358|NCT02953314|9660948|P1|Overall Study|Adverse Event|0
2822359|NCT02952898|9660974|P3|Overall Study|Non-compliance with study drug|2
2822360|NCT02952898|9660975|P2|Overall Study|Non-compliance with study drug|1
2822361|NCT02952898|9660976|P1|Overall Study|Non-compliance with study drug|1
2822362|NCT02952898|9660974|P3|Overall Study|Lost to Follow-up|2
2822363|NCT02952898|9660975|P2|Overall Study|Lost to Follow-up|2
2822364|NCT02952898|9660976|P1|Overall Study|Lost to Follow-up|3
2822365|NCT02952898|9660974|P3|Overall Study|Adverse Event|3
2822366|NCT02952898|9660975|P2|Overall Study|Adverse Event|8
2822367|NCT02952898|9660976|P1|Overall Study|Adverse Event|8
2822368|NCT02952898|9660974|P3|Overall Study|Withdrawal by Subject|8
2822369|NCT02952898|9660975|P2|Overall Study|Withdrawal by Subject|8
2822370|NCT02952898|9660976|P1|Overall Study|Withdrawal by Subject|10
2822371|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Not treated|1
2822372|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Not treated|0
2822373|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Not treated|0
2822374|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Other than specified|2
2822375|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Other than specified|6
2822376|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Other than specified|0
2822377|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
2822378|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
2822379|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
2822380|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
2822381|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
2822382|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
2822383|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Subject choice|7
2822384|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Subject choice|10
2822385|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Subject choice|0
2822386|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
2822387|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
2822388|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
2822389|NCT02952820|9661100|P3|Active Treatment Period (6 Months)|Adverse Event|5
2822390|NCT02952820|9661101|P2|Active Treatment Period (6 Months)|Adverse Event|6
2822391|NCT02952820|9661102|P1|Active Treatment Period (6 Months)|Adverse Event|0
2822392|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
2822393|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
2822394|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
2822395|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
2822396|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
2822397|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
2822398|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
2822399|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
2822400|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
2822401|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
2822402|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
2822403|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
2822404|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
2822405|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
2822406|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
2822407|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
2822408|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2822409|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2822410|NCT02952820|9661100|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
2822411|NCT02952820|9661101|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
2822412|NCT02952820|9661102|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
2822413|NCT02952313|9661162|P1|Overall Study|Missed visit|1
2822414|NCT02952313|9661162|P1|Overall Study|Lack of Efficacy|1
2822415|NCT02952313|9661162|P1|Overall Study|Withdrawal by Subject|1
2822416|NCT02952313|9661162|P1|Overall Study|Lost to Follow-up|4
2822417|NCT02952261|9661170|P2|Overall Study|Protocol Violation|0
2822418|NCT02952261|9661171|P1|Overall Study|Protocol Violation|1
2822419|NCT02952261|9661170|P2|Overall Study|Withdrawal by Subject|5
2822420|NCT02952261|9661171|P1|Overall Study|Withdrawal by Subject|4
2822421|NCT02951988|9661186|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
2822422|NCT02951988|9661187|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
2822423|NCT02951988|9661188|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
2822424|NCT02951988|9661189|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
2822425|NCT02951988|9661186|P4|Double-Blind Treatment Period|Adverse Event|6
2822426|NCT02951988|9661187|P3|Double-Blind Treatment Period|Adverse Event|3
2822427|NCT02951988|9661188|P2|Double-Blind Treatment Period|Adverse Event|8
2822428|NCT02951988|9661189|P1|Double-Blind Treatment Period|Adverse Event|0
2822429|NCT02951988|9661186|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
2822430|NCT02951988|9661187|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
2822431|NCT02951988|9661188|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
2822432|NCT02951988|9661189|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2822433|NCT02951988|9661186|P4|Double-Blind Treatment Period|Lost to Follow-up|3
2822434|NCT02951988|9661187|P3|Double-Blind Treatment Period|Lost to Follow-up|12
2822435|NCT02951988|9661188|P2|Double-Blind Treatment Period|Lost to Follow-up|4
2822436|NCT02951988|9661189|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2822437|NCT02951988|9661186|P4|Double-Blind Treatment Period|Pregnancy|0
2822438|NCT02951988|9661187|P3|Double-Blind Treatment Period|Pregnancy|1
2822439|NCT02951988|9661188|P2|Double-Blind Treatment Period|Pregnancy|1
2822440|NCT02951988|9661189|P1|Double-Blind Treatment Period|Pregnancy|0
2822441|NCT02951988|9661186|P4|Double-Blind Treatment Period|Protocol Violation|8
2822442|NCT02951988|9661187|P3|Double-Blind Treatment Period|Protocol Violation|4
2822443|NCT02951988|9661188|P2|Double-Blind Treatment Period|Protocol Violation|4
2822444|NCT02951988|9661189|P1|Double-Blind Treatment Period|Protocol Violation|0
2822445|NCT02951988|9661186|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
2822446|NCT02951988|9661187|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
2822447|NCT02951988|9661188|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
2822448|NCT02951988|9661189|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
2822449|NCT02951988|9661186|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
2822450|NCT02951988|9661187|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
2822451|NCT02951988|9661188|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
2822452|NCT02951988|9661189|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
2822453|NCT02951988|9661186|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
2822454|NCT02951988|9661187|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
2822455|NCT02951988|9661188|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
2822456|NCT02951988|9661189|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
2822457|NCT02951988|9661186|P4|Open-Label Treatment Period|Adverse Event|0
2822458|NCT02951988|9661187|P3|Open-Label Treatment Period|Adverse Event|0
2822459|NCT02951988|9661188|P2|Open-Label Treatment Period|Adverse Event|0
2822460|NCT02951988|9661189|P1|Open-Label Treatment Period|Adverse Event|45
2822461|NCT02951988|9661186|P4|Open-Label Treatment Period|Lack of Efficacy|0
2822462|NCT02951988|9661187|P3|Open-Label Treatment Period|Lack of Efficacy|0
2822463|NCT02951988|9661188|P2|Open-Label Treatment Period|Lack of Efficacy|0
2822464|NCT02951988|9661189|P1|Open-Label Treatment Period|Lack of Efficacy|49
2822465|NCT02951988|9661186|P4|Open-Label Treatment Period|Withdrawal by Subject|0
2822466|NCT02951988|9661187|P3|Open-Label Treatment Period|Withdrawal by Subject|0
2822467|NCT02951988|9661188|P2|Open-Label Treatment Period|Withdrawal by Subject|0
2822468|NCT02951988|9661189|P1|Open-Label Treatment Period|Withdrawal by Subject|78
2822469|NCT02951988|9661186|P4|Open-Label Treatment Period|Lost to Follow-up|0
2822470|NCT02951988|9661187|P3|Open-Label Treatment Period|Lost to Follow-up|0
2822471|NCT02951988|9661188|P2|Open-Label Treatment Period|Lost to Follow-up|0
2822472|NCT02951988|9661189|P1|Open-Label Treatment Period|Lost to Follow-up|28
2822473|NCT02951988|9661186|P4|Open-Label Treatment Period|Pregnancy|0
2822474|NCT02951988|9661187|P3|Open-Label Treatment Period|Pregnancy|0
2822475|NCT02951988|9661188|P2|Open-Label Treatment Period|Pregnancy|0
2822476|NCT02951988|9661189|P1|Open-Label Treatment Period|Pregnancy|2
2822477|NCT02951988|9661186|P4|Open-Label Treatment Period|Protocol Violation|0
2822478|NCT02951988|9661187|P3|Open-Label Treatment Period|Protocol Violation|0
2822479|NCT02951988|9661188|P2|Open-Label Treatment Period|Protocol Violation|0
2822480|NCT02951988|9661189|P1|Open-Label Treatment Period|Protocol Violation|22
2822481|NCT02951988|9661186|P4|Open-Label Treatment Period|Non-compliance with study drug|0
2822482|NCT02951988|9661187|P3|Open-Label Treatment Period|Non-compliance with study drug|0
2822483|NCT02951988|9661188|P2|Open-Label Treatment Period|Non-compliance with study drug|0
2822484|NCT02951988|9661189|P1|Open-Label Treatment Period|Non-compliance with study drug|5
2822485|NCT02951988|9661186|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
2822486|NCT02951988|9661187|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
2822487|NCT02951988|9661188|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
2822488|NCT02951988|9661189|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
2822489|NCT02951988|9661186|P4|Open-Label Treatment Period|Study terminated by sponsor|0
2822490|NCT02951988|9661187|P3|Open-Label Treatment Period|Study terminated by sponsor|0
2822491|NCT02951988|9661188|P2|Open-Label Treatment Period|Study terminated by sponsor|0
2822492|NCT02951988|9661189|P1|Open-Label Treatment Period|Study terminated by sponsor|9
2822493|NCT02951988|9661186|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
2822494|NCT02951988|9661187|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
2822495|NCT02951988|9661188|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
2822496|NCT02951988|9661189|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
2822497|NCT02951819|9661222|P2|Overall Study|Ongoing|11
2822498|NCT02951819|9661223|P1|Overall Study|Ongoing|83
2822499|NCT02951819|9661222|P2|Overall Study|Other|0
2822500|NCT02951819|9661223|P1|Overall Study|Other|1
2822501|NCT02951819|9661222|P2|Overall Study|Progressive Disease|0
2822502|NCT02951819|9661223|P1|Overall Study|Progressive Disease|1
2822503|NCT02951819|9661222|P2|Overall Study|Withdrawal by Subject|0
2822504|NCT02951819|9661223|P1|Overall Study|Withdrawal by Subject|1
2822505|NCT02951819|9661222|P2|Overall Study|Death|3
2822506|NCT02951819|9661223|P1|Overall Study|Death|1
2822507|NCT02951780|9661254|P9|Period 2|Scheduling Conflicts|0
2822508|NCT02951780|9661255|P8|Period 2|Scheduling Conflicts|1
2822509|NCT02951780|9661256|P7|Period 2|Scheduling Conflicts|0
2822510|NCT02951780|9661257|P6|Period 2|Scheduling Conflicts|0
2822511|NCT02951780|9661258|P5|Period 2|Scheduling Conflicts|0
2822512|NCT02951780|9661259|P4|Period 2|Scheduling Conflicts|0
2822513|NCT02951780|9661260|P3|Period 2|Scheduling Conflicts|0
2822514|NCT02951780|9661261|P2|Period 2|Scheduling Conflicts|0
2822515|NCT02951780|9661262|P1|Period 2|Scheduling Conflicts|0
2822516|NCT02951780|9661254|P9|Period 1|Scheduling Conflicts|0
2822517|NCT02951780|9661255|P8|Period 1|Scheduling Conflicts|1
2822518|NCT02951780|9661256|P7|Period 1|Scheduling Conflicts|0
2822519|NCT02951780|9661257|P6|Period 1|Scheduling Conflicts|0
2822520|NCT02951780|9661258|P5|Period 1|Scheduling Conflicts|0
2822521|NCT02951780|9661259|P4|Period 1|Scheduling Conflicts|0
2822522|NCT02951780|9661260|P3|Period 1|Scheduling Conflicts|0
2822523|NCT02951780|9661261|P2|Period 1|Scheduling Conflicts|0
2822524|NCT02951780|9661262|P1|Period 1|Scheduling Conflicts|0
2822525|NCT02951780|9661254|P9|Period 1|Adverse Event|0
2822526|NCT02951780|9661255|P8|Period 1|Adverse Event|0
2822527|NCT02951780|9661256|P7|Period 1|Adverse Event|0
2822528|NCT02951780|9661257|P6|Period 1|Adverse Event|0
2822529|NCT02951780|9661258|P5|Period 1|Adverse Event|0
2822530|NCT02951780|9661259|P4|Period 1|Adverse Event|1
2822531|NCT02951780|9661260|P3|Period 1|Adverse Event|0
2822532|NCT02951780|9661261|P2|Period 1|Adverse Event|0
2822533|NCT02951780|9661262|P1|Period 1|Adverse Event|0
2822534|NCT02951767|9661327|P1|Overall Study|Lost to Follow-up|1
2822535|NCT02951767|9661327|P1|Overall Study|Death|59
2822536|NCT02951767|9661327|P1|Overall Study|Withdrawal by Subject|5
2822537|NCT02951767|9661327|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
2822538|NCT02951533|9661359|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2822539|NCT02951533|9661360|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
2822540|NCT02951533|9661361|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2822541|NCT02951533|9661359|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2822542|NCT02951533|9661360|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2822543|NCT02951533|9661361|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
2822544|NCT02951533|9661359|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2822545|NCT02951533|9661360|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2822546|NCT02951533|9661361|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
2822547|NCT02951533|9661359|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
2822548|NCT02951533|9661360|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
2822549|NCT02951533|9661361|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
2822550|NCT02951533|9661359|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2822551|NCT02951533|9661360|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
2822552|NCT02951533|9661361|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2822553|NCT02951533|9661359|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2822554|NCT02951533|9661360|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2822555|NCT02951533|9661361|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
2822556|NCT02951533|9661359|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2822557|NCT02951533|9661360|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
2822558|NCT02951533|9661361|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2822559|NCT02951533|9661359|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2822560|NCT02951533|9661360|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
2822561|NCT02951533|9661361|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2822562|NCT02951533|9661359|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
2822563|NCT02951533|9661360|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
2822564|NCT02951533|9661361|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
2822565|NCT02951533|9661359|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
2822566|NCT02951533|9661360|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2822567|NCT02951533|9661361|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2822568|NCT02951533|9661359|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
2822569|NCT02951533|9661360|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
2822570|NCT02951533|9661361|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
2822571|NCT02951052|9661625|P2|Overall Study|Ongoing|0
2822572|NCT02951052|9661626|P1|Overall Study|Ongoing|1
2822573|NCT02951052|9661625|P2|Overall Study|Lack of Efficacy|4
2822574|NCT02951052|9661626|P1|Overall Study|Lack of Efficacy|3
2822575|NCT02951052|9661625|P2|Overall Study|Protocol Violation|3
2822576|NCT02951052|9661626|P1|Overall Study|Protocol Violation|5
2822577|NCT02951052|9661625|P2|Overall Study|Protocol-specified withdrawal criterion|0
2822578|NCT02951052|9661626|P1|Overall Study|Protocol-specified withdrawal criterion|1
2822579|NCT02951052|9661625|P2|Overall Study|Lost to Follow-up|1
2822580|NCT02951052|9661626|P1|Overall Study|Lost to Follow-up|1
2822581|NCT02951052|9661625|P2|Overall Study|Physician Decision|0
2822582|NCT02951052|9661626|P1|Overall Study|Physician Decision|2
2822583|NCT02951052|9661625|P2|Overall Study|Withdrawal by Subject|5
2822584|NCT02951052|9661626|P1|Overall Study|Withdrawal by Subject|1
2822585|NCT02951052|9661625|P2|Overall Study|Adverse Event|5
2822586|NCT02951052|9661626|P1|Overall Study|Adverse Event|13
2822587|NCT02950831|9661794|P1|Overall Study|stimulation trail failure|5
2822588|NCT02950831|9661794|P1|Overall Study|Withdrawal by Subject|3
2822589|NCT02950831|9661794|P1|Overall Study|Lost to Follow-up|1
2822590|NCT02950545|9661836|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
2822591|NCT02950545|9661837|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
2822592|NCT02950545|9661838|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
2822593|NCT02950545|9661839|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
2822594|NCT02950545|9661840|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
2822595|NCT02950545|9661841|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
2822596|NCT02950545|9661836|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2822597|NCT02950545|9661837|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2822598|NCT02950545|9661838|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2822599|NCT02950545|9661839|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2822600|NCT02950545|9661840|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2822601|NCT02950545|9661841|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
2822602|NCT02950545|9661836|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
2822603|NCT02950545|9661837|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
2822604|NCT02950545|9661838|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
2822605|NCT02950545|9661839|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
2822606|NCT02950545|9661840|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
2822607|NCT02950545|9661841|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
2822608|NCT02950545|9661836|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2822609|NCT02950545|9661837|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2822610|NCT02950545|9661838|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2822611|NCT02950545|9661839|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2822612|NCT02950545|9661840|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2822613|NCT02950545|9661841|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2822614|NCT02950545|9661836|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
2822615|NCT02950545|9661837|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
2822616|NCT02950545|9661838|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
2822617|NCT02950545|9661839|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
2822618|NCT02950545|9661840|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
2822619|NCT02950545|9661841|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
2822620|NCT02950480|9661850|P2|Overall Study|Withdrawal by Subject|0
2822621|NCT02950480|9661851|P1|Overall Study|Withdrawal by Subject|1
2822622|NCT02949947|9661884|P2|Overall Study|Insurance change|0
2822623|NCT02949947|9661885|P1|Overall Study|Insurance change|1
2822624|NCT02949947|9661884|P2|Overall Study|Non Compliance|1
2822625|NCT02949947|9661885|P1|Overall Study|Non Compliance|0
2822626|NCT02949908|9661918|P1|Overall Study|Study termination|2
2822627|NCT02949271|9661953|P2|Overall Study|Outside the window for cervical dilation|3
2822628|NCT02949271|9661954|P1|Overall Study|Outside the window for cervical dilation|2
2822629|NCT02949271|9661953|P2|Overall Study|Delivered prior to intervention|9
2822630|NCT02949271|9661954|P1|Overall Study|Delivered prior to intervention|7
2822631|NCT02949271|9661953|P2|Overall Study|Withdrawal by Subject|0
2822632|NCT02949271|9661954|P1|Overall Study|Withdrawal by Subject|1
2822633|NCT02949271|9661953|P2|Overall Study|Protocol Violation|3
2822634|NCT02949271|9661954|P1|Overall Study|Protocol Violation|6
2822635|NCT02949271|9661953|P2|Overall Study|Physician Decision|5
2822636|NCT02949271|9661954|P1|Overall Study|Physician Decision|5
2822637|NCT02949271|9661953|P2|Overall Study|Lost to Follow-up|6
2822638|NCT02949271|9661954|P1|Overall Study|Lost to Follow-up|3
2822639|NCT02949271|9661953|P2|Overall Study|Lack of Efficacy|4
2822640|NCT02949271|9661954|P1|Overall Study|Lack of Efficacy|5
2822641|NCT02949219|9661980|P1|Overall Study|Withdrawal by Subject|1
2822642|NCT02949128|9661994|P1|Extension Period|Withdrawal by Subject|1
2822643|NCT02949128|9661994|P1|Extension Period|Physician Decision|1
2822644|NCT02949128|9661994|P1|Initial Evaluation Period|Protocol Violation|1
2822645|NCT02949128|9661994|P1|Initial Evaluation Period|Physician Decision|1
2822646|NCT02949128|9661994|P1|Initial Evaluation Period|Death|2
2822647|NCT02949128|9661994|P1|Initial Evaluation Period|Adverse Event|3
2822648|NCT02949128|9661994|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
2822649|NCT02949011|9662011|P3|Overall Study|Miscellaneous|6
2822650|NCT02949011|9662012|P2|Overall Study|Miscellaneous|4
2822651|NCT02949011|9662013|P1|Overall Study|Miscellaneous|2
2822652|NCT02949011|9662011|P3|Overall Study|Death|1
2822653|NCT02949011|9662012|P2|Overall Study|Death|0
2822654|NCT02949011|9662013|P1|Overall Study|Death|0
2822655|NCT02949011|9662011|P3|Overall Study|Lost to Follow-up|5
2822656|NCT02949011|9662012|P2|Overall Study|Lost to Follow-up|5
2822657|NCT02949011|9662013|P1|Overall Study|Lost to Follow-up|7
2822658|NCT02949011|9662011|P3|Overall Study|Withdrawal by Subject|21
2822659|NCT02949011|9662012|P2|Overall Study|Withdrawal by Subject|13
2822660|NCT02949011|9662013|P1|Overall Study|Withdrawal by Subject|13
2822661|NCT02949011|9662011|P3|Overall Study|Lack of Efficacy|0
2822662|NCT02949011|9662012|P2|Overall Study|Lack of Efficacy|2
2822663|NCT02949011|9662013|P1|Overall Study|Lack of Efficacy|0
2822664|NCT02949011|9662011|P3|Overall Study|Protocol Deviation|3
2822665|NCT02949011|9662012|P2|Overall Study|Protocol Deviation|3
2822666|NCT02949011|9662013|P1|Overall Study|Protocol Deviation|5
2822667|NCT02949011|9662011|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
2822668|NCT02949011|9662012|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
2822669|NCT02949011|9662013|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
2822670|NCT02949011|9662011|P3|Overall Study|Adverse Event|3
2822671|NCT02949011|9662012|P2|Overall Study|Adverse Event|7
2822672|NCT02949011|9662013|P1|Overall Study|Adverse Event|6
2822673|NCT02948634|9662083|P2|Overall Study|Lack of efficacy and study suspended|2
2822674|NCT02948634|9662084|P1|Overall Study|Lack of efficacy and study suspended|10
2822675|NCT02948582|9662094|P6|Washout Period 4|Adverse Event|0
2822676|NCT02948582|9662095|P5|Washout Period 4|Adverse Event|0
2822677|NCT02948582|9662096|P4|Washout Period 4|Adverse Event|0
2822678|NCT02948582|9662097|P3|Washout Period 4|Adverse Event|1
2822679|NCT02948582|9662098|P2|Washout Period 4|Adverse Event|0
2822680|NCT02948582|9662099|P1|Washout Period 4|Adverse Event|1
2822681|NCT02948582|9662094|P6|Washout Period 2|personal reasons|0
2822682|NCT02948582|9662095|P5|Washout Period 2|personal reasons|0
2822683|NCT02948582|9662096|P4|Washout Period 2|personal reasons|1
2822684|NCT02948582|9662097|P3|Washout Period 2|personal reasons|0
2822685|NCT02948582|9662098|P2|Washout Period 2|personal reasons|0
2822686|NCT02948582|9662099|P1|Washout Period 2|personal reasons|0
2822687|NCT02948582|9662094|P6|Washout Period 2|Adverse Event|0
2822688|NCT02948582|9662095|P5|Washout Period 2|Adverse Event|0
2822689|NCT02948582|9662096|P4|Washout Period 2|Adverse Event|0
2822690|NCT02948582|9662097|P3|Washout Period 2|Adverse Event|0
2822691|NCT02948582|9662098|P2|Washout Period 2|Adverse Event|1
2822692|NCT02948582|9662099|P1|Washout Period 2|Adverse Event|0
2822693|NCT02948582|9662094|P6|Washout Period 1|Protocol Violation|1
2822694|NCT02948582|9662095|P5|Washout Period 1|Protocol Violation|0
2822695|NCT02948582|9662096|P4|Washout Period 1|Protocol Violation|0
2822696|NCT02948582|9662097|P3|Washout Period 1|Protocol Violation|0
2822697|NCT02948582|9662098|P2|Washout Period 1|Protocol Violation|0
2822698|NCT02948582|9662099|P1|Washout Period 1|Protocol Violation|0
2822699|NCT02948582|9662094|P6|Washout Period 1|Adverse Event|0
2822700|NCT02948582|9662095|P5|Washout Period 1|Adverse Event|0
2822701|NCT02948582|9662096|P4|Washout Period 1|Adverse Event|0
2822702|NCT02948582|9662097|P3|Washout Period 1|Adverse Event|0
2822703|NCT02948582|9662098|P2|Washout Period 1|Adverse Event|2
2822704|NCT02948582|9662099|P1|Washout Period 1|Adverse Event|0
2822705|NCT02947022|9662221|P1|Overall Study|Study Stopped|1
2822706|NCT02946580|9662242|P2|Overall Study|Did not undergo posterior spinal fusion|1
2822707|NCT02946580|9662243|P1|Overall Study|Did not undergo posterior spinal fusion|0
2822708|NCT02946580|9662242|P2|Overall Study|Adverse Event|2
2822709|NCT02946580|9662243|P1|Overall Study|Adverse Event|0
2822710|NCT02946580|9662242|P2|Overall Study|Withdrawal by Subject|2
2822711|NCT02946580|9662243|P1|Overall Study|Withdrawal by Subject|1
2822712|NCT02946515|9662261|P2|Overall Study|Lost to Follow-up|1
2822713|NCT02946515|9662262|P1|Overall Study|Lost to Follow-up|2
2822714|NCT02946463|9662275|P2|Primary Evaluation Period|Withdrawal by Subject|1
2822715|NCT02946463|9662276|P1|Primary Evaluation Period|Withdrawal by Subject|0
2822716|NCT02946463|9662275|P2|Primary Evaluation Period|Physician Decision|1
2822717|NCT02946463|9662276|P1|Primary Evaluation Period|Physician Decision|0
2822718|NCT02946385|9662298|P6|Overall Study|Lost to Follow-up|1
2822719|NCT02946385|9662299|P5|Overall Study|Lost to Follow-up|2
2822720|NCT02946385|9662300|P4|Overall Study|Lost to Follow-up|0
2822721|NCT02946385|9662301|P3|Overall Study|Lost to Follow-up|3
2822722|NCT02946385|9662302|P2|Overall Study|Lost to Follow-up|0
2822723|NCT02946385|9662303|P1|Overall Study|Lost to Follow-up|0
2822724|NCT02945657|9662406|P1|Overall Study|Withdrawal by Parent/Guardian|3
2822725|NCT02945657|9662406|P1|Overall Study|Adverse Event|1
2822726|NCT02945410|9662429|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
2822727|NCT02945410|9662430|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
2822728|NCT02945410|9662431|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
2822729|NCT02945410|9662432|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
2822730|NCT02945410|9662433|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
2822731|NCT02945410|9662434|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
2822732|NCT02945410|9662429|P6|Intervention 1 (5 Days)|Adverse Event|1
2822733|NCT02945410|9662430|P5|Intervention 1 (5 Days)|Adverse Event|0
2822734|NCT02945410|9662431|P4|Intervention 1 (5 Days)|Adverse Event|0
2822735|NCT02945410|9662432|P3|Intervention 1 (5 Days)|Adverse Event|0
2822736|NCT02945410|9662433|P2|Intervention 1 (5 Days)|Adverse Event|0
2822737|NCT02945410|9662434|P1|Intervention 1 (5 Days)|Adverse Event|1
2822738|NCT02945410|9662429|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
2822739|NCT02945410|9662430|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
2822740|NCT02945410|9662431|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
2822741|NCT02945410|9662432|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
2822742|NCT02945410|9662433|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
2822743|NCT02945410|9662434|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
2822744|NCT02945254|9662465|P2|Overall Study|Withdrawal by Subject|0
2822745|NCT02945254|9662466|P1|Overall Study|Withdrawal by Subject|1
2822746|NCT02945254|9662465|P2|Overall Study|Lost to Follow-up|0
2822747|NCT02945254|9662466|P1|Overall Study|Lost to Follow-up|1
2822748|NCT02945046|9662482|P3|Overall Study|Other than specified|7
2822749|NCT02945046|9662483|P2|Overall Study|Other than specified|4
2822750|NCT02945046|9662484|P1|Overall Study|Other than specified|5
2822751|NCT02945046|9662482|P3|Overall Study|Lack of Efficacy|1
2822752|NCT02945046|9662483|P2|Overall Study|Lack of Efficacy|2
2822753|NCT02945046|9662484|P1|Overall Study|Lack of Efficacy|1
2822754|NCT02945046|9662482|P3|Overall Study|Lost to Follow-up|0
2822755|NCT02945046|9662483|P2|Overall Study|Lost to Follow-up|1
2822756|NCT02945046|9662484|P1|Overall Study|Lost to Follow-up|1
2822757|NCT02945046|9662482|P3|Overall Study|Protocol Violation|2
2822758|NCT02945046|9662483|P2|Overall Study|Protocol Violation|3
2822759|NCT02945046|9662484|P1|Overall Study|Protocol Violation|2
2822760|NCT02945046|9662482|P3|Overall Study|Withdrawal by Subject|3
2822761|NCT02945046|9662483|P2|Overall Study|Withdrawal by Subject|3
2822762|NCT02945046|9662484|P1|Overall Study|Withdrawal by Subject|3
2822763|NCT02945046|9662482|P3|Overall Study|Adverse Event|2
2822764|NCT02945046|9662483|P2|Overall Study|Adverse Event|0
2822765|NCT02945046|9662484|P1|Overall Study|Adverse Event|1
2822766|NCT02944968|9662537|P1|Overall Study|Subject didn't meet eligibility criteria|2
2822767|NCT02944968|9662537|P1|Overall Study|Subject excluded before study procedure|1
2822768|NCT02944656|9662544|P2|Overall Study|Lost to Follow-up|10
2822769|NCT02944656|9662545|P1|Overall Study|Lost to Follow-up|7
2822770|NCT02944656|9662544|P2|Overall Study|No longer eligible|0
2822771|NCT02944656|9662545|P1|Overall Study|No longer eligible|3
2822772|NCT02944513|9662581|P2|Overall Study|Withdrawal by Subject|1
2822773|NCT02944513|9662582|P1|Overall Study|Withdrawal by Subject|4
2822774|NCT02943577|9662613|P2|Overall Study|Pregnancy|0
2822775|NCT02943577|9662614|P1|Overall Study|Pregnancy|1
2822776|NCT02943577|9662613|P2|Overall Study|Withdrawal by Subject|1
2822777|NCT02943577|9662614|P1|Overall Study|Withdrawal by Subject|1
2822778|NCT02943577|9662613|P2|Overall Study|Lost to Follow-up|1
2822779|NCT02943577|9662614|P1|Overall Study|Lost to Follow-up|0
2822780|NCT02943577|9662613|P2|Overall Study|Adverse Event|2
2822781|NCT02943577|9662614|P1|Overall Study|Adverse Event|3
2822782|NCT02943577|9662613|P2|Overall Study|Protocol Violation|1
2822783|NCT02943577|9662614|P1|Overall Study|Protocol Violation|0
2822784|NCT02943564|9662629|P3|Overall Study|Lack of Efficacy|0
2822785|NCT02943564|9662630|P2|Overall Study|Lack of Efficacy|1
2822786|NCT02943564|9662631|P1|Overall Study|Lack of Efficacy|0
2822787|NCT02943564|9662629|P3|Overall Study|Adverse Event|1
2822788|NCT02943564|9662630|P2|Overall Study|Adverse Event|2
2822789|NCT02943564|9662631|P1|Overall Study|Adverse Event|1
2822790|NCT02943564|9662629|P3|Overall Study|Withdrawal by Subject|2
2822791|NCT02943564|9662630|P2|Overall Study|Withdrawal by Subject|5
2822792|NCT02943564|9662631|P1|Overall Study|Withdrawal by Subject|6
2822793|NCT02943564|9662629|P3|Overall Study|Lost to Follow-up|0
2822794|NCT02943564|9662630|P2|Overall Study|Lost to Follow-up|0
2822795|NCT02943564|9662631|P1|Overall Study|Lost to Follow-up|1
2822796|NCT02943564|9662629|P3|Overall Study|Protocol Violation|2
2822797|NCT02943564|9662630|P2|Overall Study|Protocol Violation|2
2822798|NCT02943564|9662631|P1|Overall Study|Protocol Violation|2
2822799|NCT02943564|9662629|P3|Overall Study|Pregnancy|1
2822800|NCT02943564|9662630|P2|Overall Study|Pregnancy|1
2822801|NCT02943564|9662631|P1|Overall Study|Pregnancy|0
2822802|NCT02943564|9662629|P3|Overall Study|Non-compliance with study drug|0
2822803|NCT02943564|9662630|P2|Overall Study|Non-compliance with study drug|1
2822804|NCT02943564|9662631|P1|Overall Study|Non-compliance with study drug|0
2822805|NCT02943564|9662629|P3|Overall Study|Site terminated by sponsor|0
2822806|NCT02943564|9662630|P2|Overall Study|Site terminated by sponsor|1
2822807|NCT02943564|9662631|P1|Overall Study|Site terminated by sponsor|0
2822808|NCT02943564|9662629|P3|Overall Study|Miscellaneous Reasons|3
2822809|NCT02943564|9662630|P2|Overall Study|Miscellaneous Reasons|0
2822810|NCT02943564|9662631|P1|Overall Study|Miscellaneous Reasons|0
2822811|NCT02943460|9662654|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
2822812|NCT02943460|9662655|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
2822813|NCT02943460|9662656|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
2822814|NCT02943460|9662654|P3|Open Label Extension (OLE)|Investigator's Discretion|0
2822815|NCT02943460|9662655|P2|Open Label Extension (OLE)|Investigator's Discretion|1
2822816|NCT02943460|9662656|P1|Open Label Extension (OLE)|Investigator's Discretion|0
2822817|NCT02943460|9662654|P3|Open Label Extension (OLE)|Withdrew Consent|0
2822818|NCT02943460|9662655|P2|Open Label Extension (OLE)|Withdrew Consent|1
2822819|NCT02943460|9662656|P1|Open Label Extension (OLE)|Withdrew Consent|1
2822820|NCT02943460|9662654|P3|Open Label Extension (OLE)|Adverse Event|1
2822821|NCT02943460|9662655|P2|Open Label Extension (OLE)|Adverse Event|2
2822822|NCT02943460|9662656|P1|Open Label Extension (OLE)|Adverse Event|0
2822823|NCT02943460|9662654|P3|Blinded Study|Withdrew Consent|0
2822824|NCT02943460|9662655|P2|Blinded Study|Withdrew Consent|1
2822825|NCT02943460|9662656|P1|Blinded Study|Withdrew Consent|0
2822826|NCT02943460|9662654|P3|Blinded Study|Adverse Event|0
2822827|NCT02943460|9662655|P2|Blinded Study|Adverse Event|0
2822828|NCT02943460|9662656|P1|Blinded Study|Adverse Event|3
2822829|NCT02943447|9662674|P3|Overall Study|Still on Study|11
2822830|NCT02943447|9662675|P2|Overall Study|Still on Study|22
2822831|NCT02943447|9662676|P1|Overall Study|Still on Study|21
2822832|NCT02943447|9662674|P3|Overall Study|Withdrew Consent|1
2822833|NCT02943447|9662675|P2|Overall Study|Withdrew Consent|2
2822834|NCT02943447|9662676|P1|Overall Study|Withdrew Consent|1
2822835|NCT02943447|9662674|P3|Overall Study|Lack of Efficacy|0
2822836|NCT02943447|9662675|P2|Overall Study|Lack of Efficacy|2
2822837|NCT02943447|9662676|P1|Overall Study|Lack of Efficacy|2
2822838|NCT02943447|9662674|P3|Overall Study|Adverse Event|1
2822839|NCT02943447|9662675|P2|Overall Study|Adverse Event|4
2822840|NCT02943447|9662676|P1|Overall Study|Adverse Event|4
2822841|NCT02943096|9662745|P2|Overall Study|Lack of Efficacy|1
2822842|NCT02943096|9662746|P1|Overall Study|Lack of Efficacy|0
2822843|NCT02942576|9662771|P2|Overall Study|Other|8
2822844|NCT02942576|9662772|P1|Overall Study|Other|10
2822845|NCT02942576|9662771|P2|Overall Study|Physician Decision|4
2822846|NCT02942576|9662772|P1|Overall Study|Physician Decision|1
2822847|NCT02942576|9662771|P2|Overall Study|Withdrawal by Subject|5
2822848|NCT02942576|9662772|P1|Overall Study|Withdrawal by Subject|7
2822849|NCT02942576|9662771|P2|Overall Study|Adverse Event|6
2822850|NCT02942576|9662772|P1|Overall Study|Adverse Event|28
2822851|NCT02942017|9662786|P2|Overall Study|Randomized but not dosed|3
2822852|NCT02942017|9662787|P1|Overall Study|Randomized but not dosed|1
2822853|NCT02942017|9662786|P2|Overall Study|Lost to Follow-up|1
2822854|NCT02942017|9662787|P1|Overall Study|Lost to Follow-up|1
2822855|NCT02942017|9662786|P2|Overall Study|Withdrawal by Subject|1
2822856|NCT02942017|9662787|P1|Overall Study|Withdrawal by Subject|0
2822857|NCT02942017|9662786|P2|Overall Study|Adverse Event|1
2822858|NCT02942017|9662787|P1|Overall Study|Adverse Event|0
2822859|NCT02942004|9662818|P3|Overall Study|Randomized but not dosed|4
2822860|NCT02942004|9662819|P2|Overall Study|Randomized but not dosed|9
2822861|NCT02942004|9662820|P1|Overall Study|Randomized but not dosed|3
2822862|NCT02942004|9662818|P3|Overall Study|Lost to Follow-up|2
2822863|NCT02942004|9662819|P2|Overall Study|Lost to Follow-up|1
2822864|NCT02942004|9662820|P1|Overall Study|Lost to Follow-up|1
2822865|NCT02942004|9662818|P3|Overall Study|Withdrawal by Subject|3
2822866|NCT02942004|9662819|P2|Overall Study|Withdrawal by Subject|2
2822867|NCT02942004|9662820|P1|Overall Study|Withdrawal by Subject|0
2822868|NCT02940886|9662911|P2|Overall Study|Enrolment error|1
2822869|NCT02940886|9662912|P1|Overall Study|Enrolment error|0
2822870|NCT02940886|9662911|P2|Overall Study|No treatment|2
2822871|NCT02940886|9662912|P1|Overall Study|No treatment|7
2822872|NCT02940886|9662911|P2|Overall Study|Sponsor decision|1
2822873|NCT02940886|9662912|P1|Overall Study|Sponsor decision|0
2822874|NCT02940886|9662911|P2|Overall Study|Physician Decision|4
2822875|NCT02940886|9662912|P1|Overall Study|Physician Decision|9
2822876|NCT02940886|9662911|P2|Overall Study|Lost to Follow-up|21
2822877|NCT02940886|9662912|P1|Overall Study|Lost to Follow-up|49
2822878|NCT02940886|9662911|P2|Overall Study|Lack of Efficacy|0
2822879|NCT02940886|9662912|P1|Overall Study|Lack of Efficacy|1
2822880|NCT02940886|9662911|P2|Overall Study|Death|0
2822881|NCT02940886|9662912|P1|Overall Study|Death|1
2822882|NCT02940886|9662911|P2|Overall Study|Withdrawal by Subject|20
2822883|NCT02940886|9662912|P1|Overall Study|Withdrawal by Subject|28
2822884|NCT02940886|9662911|P2|Overall Study|Protocol Violation|2
2822885|NCT02940886|9662912|P1|Overall Study|Protocol Violation|0
2822886|NCT02940886|9662911|P2|Overall Study|Adverse Event|3
2822887|NCT02940886|9662912|P1|Overall Study|Adverse Event|7
2822888|NCT02940860|9662958|P2|Overall Study|Not treated|2
2822889|NCT02940860|9662959|P1|Overall Study|Not treated|2
2822890|NCT02940860|9662958|P2|Overall Study|Moved, poor venous access, transport|4
2822891|NCT02940860|9662959|P1|Overall Study|Moved, poor venous access, transport|6
2822892|NCT02940860|9662958|P2|Overall Study|Death|2
2822893|NCT02940860|9662959|P1|Overall Study|Death|3
2822894|NCT02940860|9662958|P2|Overall Study|Protocol Violation|2
2822895|NCT02940860|9662959|P1|Overall Study|Protocol Violation|0
2822896|NCT02940860|9662958|P2|Overall Study|Sponsor Decision|1
2822897|NCT02940860|9662959|P1|Overall Study|Sponsor Decision|0
2822898|NCT02940860|9662958|P2|Overall Study|Physician Decision|3
2822899|NCT02940860|9662959|P1|Overall Study|Physician Decision|5
2822900|NCT02940860|9662958|P2|Overall Study|Lost to Follow-up|7
2822901|NCT02940860|9662959|P1|Overall Study|Lost to Follow-up|13
2822902|NCT02940860|9662958|P2|Overall Study|Withdrawal by Subject|9
2822903|NCT02940860|9662959|P1|Overall Study|Withdrawal by Subject|19
2822904|NCT02940860|9662958|P2|Overall Study|Serious AE|3
2822905|NCT02940860|9662959|P1|Overall Study|Serious AE|7
2822906|NCT02940860|9662958|P2|Overall Study|Non-serious AE|2
2822907|NCT02940860|9662959|P1|Overall Study|Non-serious AE|1
2822908|NCT02940691|9663003|P1|Overall Study|Incarceration|1
2822909|NCT02940691|9663003|P1|Overall Study|Lost to Follow-up|5
2822910|NCT02940626|9663012|P2|Overall Study|Prohibited Concomitant Medication|1
2822911|NCT02940626|9663013|P1|Overall Study|Prohibited Concomitant Medication|0
2822912|NCT02940626|9663012|P2|Overall Study|Transfer to Hospice Care|0
2822913|NCT02940626|9663013|P1|Overall Study|Transfer to Hospice Care|1
2822914|NCT02940626|9663012|P2|Overall Study|Withdrawal by Subject|0
2822915|NCT02940626|9663013|P1|Overall Study|Withdrawal by Subject|1
2822916|NCT02940626|9663012|P2|Overall Study|Lost to Follow-up|2
2822917|NCT02940626|9663013|P1|Overall Study|Lost to Follow-up|5
2822918|NCT02940626|9663012|P2|Overall Study|Death|32
2822919|NCT02940626|9663013|P1|Overall Study|Death|40
2822920|NCT02940574|9663035|P2|1-year Follow-up|Lost to Follow-up|4
2822921|NCT02940574|9663036|P1|1-year Follow-up|Lost to Follow-up|3
2822922|NCT02940574|9663035|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
2822923|NCT02940574|9663036|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
2822924|NCT02940522|9663074|P2|Overall Study|Withdrawal by Subject|0
2822925|NCT02940522|9663075|P1|Overall Study|Withdrawal by Subject|1
2822926|NCT02940522|9663074|P2|Overall Study|Lost to Follow-up|2
2822927|NCT02940522|9663075|P1|Overall Study|Lost to Follow-up|1
2822928|NCT02939950|9663156|P2|Overall Study|Ineligible at Baseline|8
2822929|NCT02939950|9663157|P1|Overall Study|Ineligible at Baseline|2
2822930|NCT02939950|9663156|P2|Overall Study|Randomized, not dispensed|0
2822931|NCT02939950|9663157|P1|Overall Study|Randomized, not dispensed|1
2822932|NCT02939950|9663156|P2|Overall Study|Adverse Event|3
2822933|NCT02939950|9663157|P1|Overall Study|Adverse Event|7
2822934|NCT02939950|9663156|P2|Overall Study|Withdrawal by Subject|28
2822935|NCT02939950|9663157|P1|Overall Study|Withdrawal by Subject|12
2822936|NCT02939950|9663156|P2|Overall Study|Pregnancy|7
2822937|NCT02939950|9663157|P1|Overall Study|Pregnancy|6
2822938|NCT02939950|9663156|P2|Overall Study|Physician Decision|0
2822939|NCT02939950|9663157|P1|Overall Study|Physician Decision|2
2822940|NCT02939950|9663156|P2|Overall Study|Protocol Violation|3
2822941|NCT02939950|9663157|P1|Overall Study|Protocol Violation|6
2822942|NCT02939950|9663156|P2|Overall Study|Unacceptable lens movement|0
2822943|NCT02939950|9663157|P1|Overall Study|Unacceptable lens movement|2
2822944|NCT02939950|9663156|P2|Overall Study|Study related symptoms|8
2822945|NCT02939950|9663157|P1|Overall Study|Study related symptoms|8
2822946|NCT02939950|9663156|P2|Overall Study|Participant Relocated|3
2822947|NCT02939950|9663157|P1|Overall Study|Participant Relocated|5
2822948|NCT02939950|9663156|P2|Overall Study|Military orders|0
2822949|NCT02939950|9663157|P1|Overall Study|Military orders|1
2822950|NCT02939950|9663156|P2|Overall Study|Unacceptable distance lens visual acuity|1
2822951|NCT02939950|9663157|P1|Overall Study|Unacceptable distance lens visual acuity|1
2822952|NCT02939950|9663156|P2|Overall Study|Lack of motivation|2
2822953|NCT02939950|9663157|P1|Overall Study|Lack of motivation|0
2822954|NCT02939950|9663156|P2|Overall Study|Chalazion upper lid|1
2822955|NCT02939950|9663157|P1|Overall Study|Chalazion upper lid|0
2822956|NCT02939950|9663156|P2|Overall Study|Positive slit lamp findings|1
2822957|NCT02939950|9663157|P1|Overall Study|Positive slit lamp findings|0
2822958|NCT02939950|9663156|P2|Overall Study|Lost to Follow-up|16
2822959|NCT02939950|9663157|P1|Overall Study|Lost to Follow-up|13
2822960|NCT02939937|9663167|P2|Overall Study|Lost to Follow-up|3
2822961|NCT02939937|9663168|P1|Overall Study|Lost to Follow-up|1
2822962|NCT02939937|9663167|P2|Overall Study|Adverse Event|0
2822963|NCT02939937|9663168|P1|Overall Study|Adverse Event|5
2822964|NCT02939599|9663184|P2|Overall Study|Study Terminated By Sponsor|2
2822965|NCT02939599|9663185|P1|Overall Study|Study Terminated By Sponsor|2
2822966|NCT02939599|9663184|P2|Overall Study|Adverse Event|0
2822967|NCT02939599|9663185|P1|Overall Study|Adverse Event|1
2822968|NCT02939560|9663199|P1|Overall Study|Protocol Violation|1
2822969|NCT02939560|9663199|P1|Overall Study|Withdrawal by Subject|2
2822970|NCT02939079|9663257|P2|Overall Study|relapse during the study|1
2822971|NCT02939079|9663258|P1|Overall Study|relapse during the study|1
2822972|NCT02939079|9663257|P2|Overall Study|Withdrawal by Subject|1
2822973|NCT02939079|9663258|P1|Overall Study|Withdrawal by Subject|0
2822974|NCT02939079|9663257|P2|Overall Study|Protocol Violation|0
2822975|NCT02939079|9663258|P1|Overall Study|Protocol Violation|1
2822976|NCT02939079|9663257|P2|Overall Study|Lost to Follow-up|2
2822977|NCT02939079|9663258|P1|Overall Study|Lost to Follow-up|0
2822978|NCT02939079|9663257|P2|Overall Study|Adverse Event|1
2822979|NCT02939079|9663258|P1|Overall Study|Adverse Event|2
2822980|NCT02939014|9663288|P2|Overall Study|In Overall Survival Follow-up|4
2822981|NCT02939014|9663289|P1|Overall Study|In Overall Survival Follow-up|22
2822982|NCT02939014|9663288|P2|Overall Study|In Progression-Free Survival Follow-up|2
2822983|NCT02939014|9663289|P1|Overall Study|In Progression-Free Survival Follow-up|5
2822984|NCT02939014|9663288|P2|Overall Study|Death|3
2822985|NCT02939014|9663289|P1|Overall Study|Death|3
2822986|NCT02938585|9663333|P4|Overall Study|Withdrawal by Subject|5
2822987|NCT02938585|9663334|P3|Overall Study|Withdrawal by Subject|0
2822988|NCT02938585|9663335|P2|Overall Study|Withdrawal by Subject|0
2822989|NCT02938585|9663336|P1|Overall Study|Withdrawal by Subject|0
2822990|NCT02938585|9663333|P4|Overall Study|Withdrawal by parent or guardian|0
2822991|NCT02938585|9663334|P3|Overall Study|Withdrawal by parent or guardian|0
2822992|NCT02938585|9663335|P2|Overall Study|Withdrawal by parent or guardian|1
2822993|NCT02938585|9663336|P1|Overall Study|Withdrawal by parent or guardian|0
2822994|NCT02938520|9663500|P2|Overall Study|Adverse Event|4
2822995|NCT02938520|9663501|P1|Overall Study|Adverse Event|9
2822996|NCT02938520|9663500|P2|Overall Study|Lack of Efficacy|3
2822997|NCT02938520|9663501|P1|Overall Study|Lack of Efficacy|5
2822998|NCT02938520|9663500|P2|Overall Study|Protocol Violation|1
2822999|NCT02938520|9663501|P1|Overall Study|Protocol Violation|0
2823000|NCT02938520|9663500|P2|Overall Study|Withdrawal by Subject|7
2823001|NCT02938520|9663501|P1|Overall Study|Withdrawal by Subject|7
2823002|NCT02938520|9663500|P2|Overall Study|Lost to Follow-up|2
2823003|NCT02938520|9663501|P1|Overall Study|Lost to Follow-up|2
2823004|NCT02938520|9663500|P2|Overall Study|Physician Decision|5
2823005|NCT02938520|9663501|P1|Overall Study|Physician Decision|2
2823006|NCT02938520|9663500|P2|Overall Study|On-going at the time of analysis|261
2823007|NCT02938520|9663501|P1|Overall Study|On-going at the time of analysis|258
2823008|NCT02937870|9663646|P1|Overall Study|Protocol Deviation|2
2823009|NCT02937870|9663646|P1|Overall Study|Adverse Event|1
2823010|NCT02937740|9663677|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
2823011|NCT02937740|9663678|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
2823012|NCT02937740|9663677|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
2823013|NCT02937740|9663678|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
2823014|NCT02937740|9663677|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
2823015|NCT02937740|9663678|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
2823016|NCT02937740|9663677|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
2823017|NCT02937740|9663678|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
2823018|NCT02937740|9663677|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
2823019|NCT02937740|9663678|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
2823020|NCT02937740|9663677|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
2823021|NCT02937740|9663678|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
2823022|NCT02937701|9663694|P5|Week 22 to Week 50|Other|1
2823023|NCT02937701|9663695|P4|Week 22 to Week 50|Other|0
2823024|NCT02937701|9663696|P3|Week 22 to Week 50|Other|0
2823025|NCT02937701|9663697|P2|Week 22 to Week 50|Other|0
2823026|NCT02937701|9663698|P1|Week 22 to Week 50|Other|0
2823027|NCT02937701|9663694|P5|Week 22 to Week 50|Physician Decision|1
2823028|NCT02937701|9663695|P4|Week 22 to Week 50|Physician Decision|0
2823029|NCT02937701|9663696|P3|Week 22 to Week 50|Physician Decision|2
2823030|NCT02937701|9663697|P2|Week 22 to Week 50|Physician Decision|0
2823031|NCT02937701|9663698|P1|Week 22 to Week 50|Physician Decision|0
2823032|NCT02937701|9663694|P5|Week 22 to Week 50|Lost to Follow-up|1
2823033|NCT02937701|9663695|P4|Week 22 to Week 50|Lost to Follow-up|0
2823034|NCT02937701|9663696|P3|Week 22 to Week 50|Lost to Follow-up|2
2823035|NCT02937701|9663697|P2|Week 22 to Week 50|Lost to Follow-up|0
2823036|NCT02937701|9663698|P1|Week 22 to Week 50|Lost to Follow-up|0
2823037|NCT02937701|9663694|P5|Week 22 to Week 50|Withdrawal by Subject|1
2823038|NCT02937701|9663695|P4|Week 22 to Week 50|Withdrawal by Subject|2
2823039|NCT02937701|9663696|P3|Week 22 to Week 50|Withdrawal by Subject|8
2823040|NCT02937701|9663697|P2|Week 22 to Week 50|Withdrawal by Subject|0
2823041|NCT02937701|9663698|P1|Week 22 to Week 50|Withdrawal by Subject|0
2823042|NCT02937701|9663694|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
2823043|NCT02937701|9663695|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
2823044|NCT02937701|9663696|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
2823045|NCT02937701|9663697|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2823046|NCT02937701|9663698|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2823047|NCT02937701|9663694|P5|Week 22 to Week 50|Adverse Event|3
2823048|NCT02937701|9663695|P4|Week 22 to Week 50|Adverse Event|3
2823049|NCT02937701|9663696|P3|Week 22 to Week 50|Adverse Event|10
2823050|NCT02937701|9663697|P2|Week 22 to Week 50|Adverse Event|0
2823051|NCT02937701|9663698|P1|Week 22 to Week 50|Adverse Event|0
2823052|NCT02937701|9663694|P5|Day 1 to Week 22|Other|0
2823053|NCT02937701|9663695|P4|Day 1 to Week 22|Other|0
2823054|NCT02937701|9663696|P3|Day 1 to Week 22|Other|0
2823055|NCT02937701|9663697|P2|Day 1 to Week 22|Other|0
2823056|NCT02937701|9663698|P1|Day 1 to Week 22|Other|1
2823057|NCT02937701|9663694|P5|Day 1 to Week 22|Physician Decision|0
2823058|NCT02937701|9663695|P4|Day 1 to Week 22|Physician Decision|0
2823059|NCT02937701|9663696|P3|Day 1 to Week 22|Physician Decision|0
2823060|NCT02937701|9663697|P2|Day 1 to Week 22|Physician Decision|0
2823061|NCT02937701|9663698|P1|Day 1 to Week 22|Physician Decision|2
2823062|NCT02937701|9663694|P5|Day 1 to Week 22|Lost to Follow-up|0
2823063|NCT02937701|9663695|P4|Day 1 to Week 22|Lost to Follow-up|0
2823064|NCT02937701|9663696|P3|Day 1 to Week 22|Lost to Follow-up|0
2823065|NCT02937701|9663697|P2|Day 1 to Week 22|Lost to Follow-up|1
2823066|NCT02937701|9663698|P1|Day 1 to Week 22|Lost to Follow-up|1
2823067|NCT02937701|9663694|P5|Day 1 to Week 22|Protocol Violation|0
2823068|NCT02937701|9663695|P4|Day 1 to Week 22|Protocol Violation|0
2823069|NCT02937701|9663696|P3|Day 1 to Week 22|Protocol Violation|0
2823070|NCT02937701|9663697|P2|Day 1 to Week 22|Protocol Violation|1
2823071|NCT02937701|9663698|P1|Day 1 to Week 22|Protocol Violation|1
2823072|NCT02937701|9663694|P5|Day 1 to Week 22|Death|0
2823073|NCT02937701|9663695|P4|Day 1 to Week 22|Death|0
2823074|NCT02937701|9663696|P3|Day 1 to Week 22|Death|0
2823075|NCT02937701|9663697|P2|Day 1 to Week 22|Death|1
2823076|NCT02937701|9663698|P1|Day 1 to Week 22|Death|1
2823077|NCT02937701|9663694|P5|Day 1 to Week 22|Withdrawal by Subject|0
2823078|NCT02937701|9663695|P4|Day 1 to Week 22|Withdrawal by Subject|0
2823079|NCT02937701|9663696|P3|Day 1 to Week 22|Withdrawal by Subject|0
2823080|NCT02937701|9663697|P2|Day 1 to Week 22|Withdrawal by Subject|6
2823081|NCT02937701|9663698|P1|Day 1 to Week 22|Withdrawal by Subject|6
2823082|NCT02937701|9663694|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2823083|NCT02937701|9663695|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2823084|NCT02937701|9663696|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2823085|NCT02937701|9663697|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
2823086|NCT02937701|9663698|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
2823087|NCT02937701|9663694|P5|Day 1 to Week 22|Protocol Specified Criteria|0
2823088|NCT02937701|9663695|P4|Day 1 to Week 22|Protocol Specified Criteria|0
2823089|NCT02937701|9663696|P3|Day 1 to Week 22|Protocol Specified Criteria|0
2823090|NCT02937701|9663697|P2|Day 1 to Week 22|Protocol Specified Criteria|7
2823091|NCT02937701|9663698|P1|Day 1 to Week 22|Protocol Specified Criteria|7
2823092|NCT02937701|9663694|P5|Day 1 to Week 22|Adverse Event|0
2823093|NCT02937701|9663695|P4|Day 1 to Week 22|Adverse Event|0
2823094|NCT02937701|9663696|P3|Day 1 to Week 22|Adverse Event|0
2823095|NCT02937701|9663697|P2|Day 1 to Week 22|Adverse Event|14
2823096|NCT02937701|9663698|P1|Day 1 to Week 22|Adverse Event|11
2823097|NCT02937636|9663729|P2|Overall Study|Other (Not specified)|2
2823098|NCT02937636|9663730|P1|Overall Study|Other (Not specified)|3
2823099|NCT02937584|9663757|P2|Washout|Adverse Event|1
2823100|NCT02937584|9663758|P1|Washout|Adverse Event|0
2823101|NCT02937584|9663757|P2|Period 1|Adverse Event|2
2823102|NCT02937584|9663758|P1|Period 1|Adverse Event|1
2823103|NCT02936869|9663821|P2|Overall Study|Protocol Violation|0
2823104|NCT02936869|9663822|P1|Overall Study|Protocol Violation|1
2823105|NCT02936869|9663821|P2|Overall Study|Legal Case|1
2823106|NCT02936869|9663822|P1|Overall Study|Legal Case|0
2823107|NCT02936869|9663821|P2|Overall Study|Death|1
2823108|NCT02936869|9663822|P1|Overall Study|Death|0
2823109|NCT02936869|9663821|P2|Overall Study|Lost to Follow-up|3
2823110|NCT02936869|9663822|P1|Overall Study|Lost to Follow-up|1
2823111|NCT02935894|9663853|P1|Overall Study|Subject dismissed|1
2823112|NCT02935673|9663882|P3|Overall Study|Withdrawal by Subject|0
2823113|NCT02935673|9663883|P2|Overall Study|Withdrawal by Subject|2
2823114|NCT02935673|9663884|P1|Overall Study|Withdrawal by Subject|1
2823115|NCT02935673|9663882|P3|Overall Study|Adverse Event|0
2823116|NCT02935673|9663883|P2|Overall Study|Adverse Event|1
2823117|NCT02935673|9663884|P1|Overall Study|Adverse Event|0
2823118|NCT02935192|9664018|P2|Overall Study|Withdrawal by Subject|4
2823119|NCT02935192|9664019|P1|Overall Study|Withdrawal by Subject|8
2823120|NCT02934178|9664136|P2|Received Vaccination 3|Withdrawal by Subject|0
2823121|NCT02934178|9664137|P1|Received Vaccination 3|Withdrawal by Subject|1
2823122|NCT02934178|9664136|P2|Received Vaccination 2|Death|1
2823123|NCT02934178|9664137|P1|Received Vaccination 2|Death|0
2823124|NCT02933528|9664277|P1|Overall Study|Lost to Follow-up|2
2823125|NCT02933060|9664305|P2|Overall Study|Withdrawal by Subject|1
2823126|NCT02933060|9664306|P1|Overall Study|Withdrawal by Subject|0
2823127|NCT02932943|9664347|P2|Overall Study|Withdrawal by Subject|3
2823128|NCT02932943|9664348|P1|Overall Study|Withdrawal by Subject|3
2823129|NCT02932943|9664347|P2|Overall Study|Adverse Event|2
2823130|NCT02932943|9664348|P1|Overall Study|Adverse Event|2
2823131|NCT02932943|9664347|P2|Overall Study|Lost to Follow-up|2
2823132|NCT02932943|9664348|P1|Overall Study|Lost to Follow-up|0
2823133|NCT02932904|9664364|P4|Overall Study|Randomized But Not Treated|2
2823134|NCT02932904|9664365|P3|Overall Study|Randomized But Not Treated|0
2823135|NCT02932904|9664366|P2|Overall Study|Randomized But Not Treated|1
2823136|NCT02932904|9664367|P1|Overall Study|Randomized But Not Treated|1
2823137|NCT02932904|9664364|P4|Overall Study|Pretreatment Event/Adverse Event|3
2823138|NCT02932904|9664365|P3|Overall Study|Pretreatment Event/Adverse Event|1
2823139|NCT02932904|9664366|P2|Overall Study|Pretreatment Event/Adverse Event|5
2823140|NCT02932904|9664367|P1|Overall Study|Pretreatment Event/Adverse Event|3
2823141|NCT02932904|9664364|P4|Overall Study|Significant Protocol Deviation|1
2823142|NCT02932904|9664365|P3|Overall Study|Significant Protocol Deviation|6
2823143|NCT02932904|9664366|P2|Overall Study|Significant Protocol Deviation|3
2823144|NCT02932904|9664367|P1|Overall Study|Significant Protocol Deviation|2
2823145|NCT02932904|9664364|P4|Overall Study|Lost to Follow-up|0
2823146|NCT02932904|9664365|P3|Overall Study|Lost to Follow-up|6
2823147|NCT02932904|9664366|P2|Overall Study|Lost to Follow-up|3
2823148|NCT02932904|9664367|P1|Overall Study|Lost to Follow-up|5
2823149|NCT02932904|9664364|P4|Overall Study|Voluntary Withdrawal|2
2823150|NCT02932904|9664365|P3|Overall Study|Voluntary Withdrawal|4
2823151|NCT02932904|9664366|P2|Overall Study|Voluntary Withdrawal|1
2823152|NCT02932904|9664367|P1|Overall Study|Voluntary Withdrawal|2
2823153|NCT02932904|9664364|P4|Overall Study|Study Termination|0
2823154|NCT02932904|9664365|P3|Overall Study|Study Termination|0
2823155|NCT02932904|9664366|P2|Overall Study|Study Termination|1
2823156|NCT02932904|9664367|P1|Overall Study|Study Termination|0
2823157|NCT02932904|9664364|P4|Overall Study|Pregnancy|0
2823158|NCT02932904|9664365|P3|Overall Study|Pregnancy|1
2823159|NCT02932904|9664366|P2|Overall Study|Pregnancy|1
2823160|NCT02932904|9664367|P1|Overall Study|Pregnancy|0
2823161|NCT02932904|9664364|P4|Overall Study|Noncompliance with Study Drug|4
2823162|NCT02932904|9664365|P3|Overall Study|Noncompliance with Study Drug|3
2823163|NCT02932904|9664366|P2|Overall Study|Noncompliance with Study Drug|3
2823164|NCT02932904|9664367|P1|Overall Study|Noncompliance with Study Drug|2
2823165|NCT02932904|9664364|P4|Overall Study|Reason not Specified|2
2823166|NCT02932904|9664365|P3|Overall Study|Reason not Specified|2
2823167|NCT02932904|9664366|P2|Overall Study|Reason not Specified|0
2823168|NCT02932904|9664367|P1|Overall Study|Reason not Specified|1
2823169|NCT02932891|9664402|P1|Overall Study|HPA Suppress|2
2823170|NCT02932891|9664402|P1|Overall Study|Lost to Follow-up|2
2823171|NCT02932878|9664408|P2|Overall Study|Due to Lab Results|1
2823172|NCT02932878|9664409|P1|Overall Study|Due to Lab Results|2
2823173|NCT02932462|9664430|P2|Overall Study|Progressive Disease|0
2823174|NCT02932462|9664431|P1|Overall Study|Progressive Disease|1
2823175|NCT02932462|9664430|P2|Overall Study|Non-Compliance With Study Drug|1
2823176|NCT02932462|9664431|P1|Overall Study|Non-Compliance With Study Drug|0
2823177|NCT02932462|9664430|P2|Overall Study|Withdrawal by Subject|4
2823178|NCT02932462|9664431|P1|Overall Study|Withdrawal by Subject|1
2823179|NCT02932462|9664430|P2|Overall Study|Protocol Violation|5
2823180|NCT02932462|9664431|P1|Overall Study|Protocol Violation|0
2823181|NCT02932462|9664430|P2|Overall Study|Lost to Follow-up|1
2823182|NCT02932462|9664431|P1|Overall Study|Lost to Follow-up|4
2823183|NCT02932462|9664430|P2|Overall Study|Adverse Event|2
2823184|NCT02932462|9664431|P1|Overall Study|Adverse Event|1
2823185|NCT02932306|9664443|P2|Overall Study|Withdrew due to burning,itching,stinging|0
2823186|NCT02932306|9664444|P1|Overall Study|Withdrew due to burning,itching,stinging|1
2823187|NCT02932306|9664443|P2|Overall Study|Worsening condition|0
2823188|NCT02932306|9664444|P1|Overall Study|Worsening condition|2
2823189|NCT02932306|9664443|P2|Overall Study|Lack of Efficacy|2
2823190|NCT02932306|9664444|P1|Overall Study|Lack of Efficacy|0
2823191|NCT02932306|9664443|P2|Overall Study|Withdrawal by Parent or Guardian|8
2823192|NCT02932306|9664444|P1|Overall Study|Withdrawal by Parent or Guardian|6
2823193|NCT02932306|9664443|P2|Overall Study|Lost to Follow-up|40
2823194|NCT02932306|9664444|P1|Overall Study|Lost to Follow-up|36
2823195|NCT02932306|9664443|P2|Overall Study|Noncompliance with Study Drug|1
2823196|NCT02932306|9664444|P1|Overall Study|Noncompliance with Study Drug|1
2823197|NCT02932306|9664443|P2|Overall Study|Protocol Violation|1
2823198|NCT02932306|9664444|P1|Overall Study|Protocol Violation|1
2823199|NCT02932306|9664443|P2|Overall Study|Pregnancy|0
2823200|NCT02932306|9664444|P1|Overall Study|Pregnancy|2
2823201|NCT02932306|9664443|P2|Overall Study|Adverse Event|0
2823202|NCT02932306|9664444|P1|Overall Study|Adverse Event|3
2823203|NCT02932306|9664443|P2|Overall Study|Withdrawal by Subject|25
2823204|NCT02932306|9664444|P1|Overall Study|Withdrawal by Subject|16
2823205|NCT02932267|9664458|P1|Overall Study|Pregnancy|1
2823206|NCT02932267|9664458|P1|Overall Study|Lost to Follow-up|4
2823207|NCT02932267|9664458|P1|Overall Study|Withdrawal by Subject|3
2823208|NCT02932228|9664464|P2|Overall Study|not eligible upon chart review|5
2823209|NCT02932228|9664465|P1|Overall Study|not eligible upon chart review|2
2823210|NCT02932228|9664464|P2|Overall Study|Death|23
2823211|NCT02932228|9664465|P1|Overall Study|Death|8
2823212|NCT02931396|9664486|P2|Overall Study|Withdrawal by Subject|0
2823213|NCT02931396|9664487|P1|Overall Study|Withdrawal by Subject|2
2823214|NCT02931396|9664486|P2|Overall Study|Lost to Follow-up|0
2823215|NCT02931396|9664487|P1|Overall Study|Lost to Follow-up|3
2823216|NCT02930837|9664501|P1|Overall Study|Withdrawal by Subject|1
2823217|NCT02930837|9664501|P1|Overall Study|Lost to Follow-up|5
2823218|NCT02930837|9664501|P1|Overall Study|Adverse Event|6
2823219|NCT02930226|9664797|P6|Overall Study|Technical Problems: Leak in plasma bag|0
2823220|NCT02930226|9664798|P5|Overall Study|Technical Problems: Leak in plasma bag|1
2823221|NCT02930226|9664799|P4|Overall Study|Technical Problems: Leak in plasma bag|0
2823222|NCT02930226|9664800|P3|Overall Study|Technical Problems: Leak in plasma bag|0
2823223|NCT02930226|9664801|P2|Overall Study|Technical Problems: Leak in plasma bag|0
2823224|NCT02930226|9664802|P1|Overall Study|Technical Problems: Leak in plasma bag|0
2823225|NCT02930005|9664856|P2|Overall Study|Lost to Follow-up|5
2823226|NCT02930005|9664857|P1|Overall Study|Lost to Follow-up|1
2823227|NCT02929498|9664897|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2823228|NCT02929498|9664898|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2823229|NCT02929498|9664899|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
2823230|NCT02929498|9664897|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2823231|NCT02929498|9664898|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2823232|NCT02929498|9664899|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
2823233|NCT02929407|9664993|P1|Overall Study|Adverse Event|1
2823234|NCT02928770|9665008|P1|Overall Study|Withdrawal by Subject|2
2823235|NCT02928029|9665046|P2|Overall Study|AE not related to clinical progression|1
2823236|NCT02928029|9665047|P1|Overall Study|AE not related to clinical progression|1
2823237|NCT02928029|9665046|P2|Overall Study|Clinical progression|2
2823238|NCT02928029|9665047|P1|Overall Study|Clinical progression|1
2823239|NCT02928029|9665046|P2|Overall Study|Radiological progression|0
2823240|NCT02928029|9665047|P1|Overall Study|Radiological progression|1
2823241|NCT02928029|9665046|P2|Overall Study|Withdrawal by Subject|1
2823242|NCT02928029|9665047|P1|Overall Study|Withdrawal by Subject|0
2823243|NCT02927938|9665061|P4|Overall Study|Early Study Termination|3
2823244|NCT02927938|9665062|P3|Overall Study|Early Study Termination|4
2823245|NCT02927938|9665063|P2|Overall Study|Early Study Termination|5
2823246|NCT02927938|9665064|P1|Overall Study|Early Study Termination|1
2823247|NCT02927938|9665061|P4|Overall Study|Death|4
2823248|NCT02927938|9665062|P3|Overall Study|Death|0
2823249|NCT02927938|9665063|P2|Overall Study|Death|1
2823250|NCT02927938|9665064|P1|Overall Study|Death|0
2823251|NCT02927795|9665072|P1|Overall Study|Not Treated|4
2823252|NCT02927795|9665072|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
2823253|NCT02927431|9665119|P3|Overall Study|Withdrawal by Subject|1
2823254|NCT02927431|9665120|P2|Overall Study|Withdrawal by Subject|0
2823255|NCT02927431|9665121|P1|Overall Study|Withdrawal by Subject|0
2823256|NCT02927366|9665199|P2|Overall Study|Patient schedule|0
2823257|NCT02927366|9665200|P1|Overall Study|Patient schedule|1
2823258|NCT02927366|9665199|P2|Overall Study|Adverse Event|0
2823259|NCT02927366|9665200|P1|Overall Study|Adverse Event|1
2823260|NCT02927171|9665255|P2|Overall Study|Lost to Follow-up|1
2823261|NCT02927171|9665256|P1|Overall Study|Lost to Follow-up|0
2823262|NCT02926638|9665268|P2|Overall Study|Not protocol specified|0
2823263|NCT02926638|9665269|P1|Overall Study|Not protocol specified|1
2823264|NCT02926638|9665268|P2|Overall Study|Ineligible|0
2823265|NCT02926638|9665269|P1|Overall Study|Ineligible|1
2823266|NCT02926638|9665268|P2|Overall Study|Progression|5
2823267|NCT02926638|9665269|P1|Overall Study|Progression|2
2823268|NCT02926573|9665283|P2|Overall Study|Delirium|1
2823269|NCT02926573|9665284|P1|Overall Study|Delirium|0
2823270|NCT02926573|9665283|P2|Overall Study|Return to operating room|2
2823271|NCT02926573|9665284|P1|Overall Study|Return to operating room|0
2823272|NCT02926573|9665283|P2|Overall Study|Withdrawal by Subject|2
2823273|NCT02926573|9665284|P1|Overall Study|Withdrawal by Subject|0
2823274|NCT02926573|9665283|P2|Overall Study|Change to outpatient status|1
2823275|NCT02926573|9665284|P1|Overall Study|Change to outpatient status|5
2823276|NCT02926573|9665283|P2|Overall Study|Change in surgery plan|1
2823277|NCT02926573|9665284|P1|Overall Study|Change in surgery plan|3
2823278|NCT02926573|9665283|P2|Overall Study|Remain intubated|2
2823279|NCT02926573|9665284|P1|Overall Study|Remain intubated|2
2823280|NCT02926573|9665283|P2|Overall Study|Nausea|0
2823281|NCT02926573|9665284|P1|Overall Study|Nausea|1
2823282|NCT02926209|9665302|P2|Study Cohort|Poor Bowel Preparation|0
2823283|NCT02926209|9665303|P1|Study Cohort|Poor Bowel Preparation|1
2823284|NCT02925923|9665316|P2|Overall Study|blood samples hemolyzed|2
2823285|NCT02925923|9665317|P1|Overall Study|blood samples hemolyzed|0
2823286|NCT02925403|9665406|P2|Overall Study|Lost to Follow-up|1
2823287|NCT02925403|9665407|P1|Overall Study|Lost to Follow-up|0
2823288|NCT02924883|9665421|P2|Overall Study|Ongoing in Study|115
2823289|NCT02924883|9665422|P1|Overall Study|Ongoing in Study|56
2823290|NCT02924883|9665421|P2|Overall Study|Death|13
2823291|NCT02924883|9665422|P1|Overall Study|Death|8
2823292|NCT02924883|9665421|P2|Overall Study|Protocol Violation|1
2823293|NCT02924883|9665422|P1|Overall Study|Protocol Violation|0
2823294|NCT02924883|9665421|P2|Overall Study|Withdrawal by Subject|4
2823295|NCT02924883|9665422|P1|Overall Study|Withdrawal by Subject|5
2823296|NCT02924688|9665447|P6|Overall Study|Withdrawal by Subject|14
2823297|NCT02924688|9665448|P5|Overall Study|Withdrawal by Subject|13
2823298|NCT02924688|9665449|P4|Overall Study|Withdrawal by Subject|12
2823299|NCT02924688|9665450|P3|Overall Study|Withdrawal by Subject|9
2823300|NCT02924688|9665451|P2|Overall Study|Withdrawal by Subject|13
2823301|NCT02924688|9665452|P1|Overall Study|Withdrawal by Subject|14
2823302|NCT02924688|9665447|P6|Overall Study|Physician Decision|1
2823303|NCT02924688|9665448|P5|Overall Study|Physician Decision|1
2823304|NCT02924688|9665449|P4|Overall Study|Physician Decision|1
2823305|NCT02924688|9665450|P3|Overall Study|Physician Decision|0
2823306|NCT02924688|9665451|P2|Overall Study|Physician Decision|1
2823307|NCT02924688|9665452|P1|Overall Study|Physician Decision|2
2823308|NCT02924688|9665447|P6|Overall Study|Lost to Follow-up|4
2823309|NCT02924688|9665448|P5|Overall Study|Lost to Follow-up|2
2823310|NCT02924688|9665449|P4|Overall Study|Lost to Follow-up|4
2823311|NCT02924688|9665450|P3|Overall Study|Lost to Follow-up|2
2823312|NCT02924688|9665451|P2|Overall Study|Lost to Follow-up|4
2823313|NCT02924688|9665452|P1|Overall Study|Lost to Follow-up|2
2823314|NCT02924688|9665447|P6|Overall Study|Protocol defined withdrawal criteria met|0
2823315|NCT02924688|9665448|P5|Overall Study|Protocol defined withdrawal criteria met|1
2823316|NCT02924688|9665449|P4|Overall Study|Protocol defined withdrawal criteria met|1
2823317|NCT02924688|9665450|P3|Overall Study|Protocol defined withdrawal criteria met|1
2823318|NCT02924688|9665451|P2|Overall Study|Protocol defined withdrawal criteria met|0
2823319|NCT02924688|9665452|P1|Overall Study|Protocol defined withdrawal criteria met|1
2823320|NCT02924688|9665447|P6|Overall Study|Protocol Violation|2
2823321|NCT02924688|9665448|P5|Overall Study|Protocol Violation|2
2823322|NCT02924688|9665449|P4|Overall Study|Protocol Violation|6
2823323|NCT02924688|9665450|P3|Overall Study|Protocol Violation|5
2823324|NCT02924688|9665451|P2|Overall Study|Protocol Violation|7
2823325|NCT02924688|9665452|P1|Overall Study|Protocol Violation|3
2823326|NCT02924688|9665447|P6|Overall Study|Lack of Efficacy|1
2823327|NCT02924688|9665448|P5|Overall Study|Lack of Efficacy|1
2823328|NCT02924688|9665449|P4|Overall Study|Lack of Efficacy|2
2823329|NCT02924688|9665450|P3|Overall Study|Lack of Efficacy|4
2823330|NCT02924688|9665451|P2|Overall Study|Lack of Efficacy|3
2823331|NCT02924688|9665452|P1|Overall Study|Lack of Efficacy|2
2823332|NCT02924688|9665447|P6|Overall Study|Adverse Event|2
2823333|NCT02924688|9665448|P5|Overall Study|Adverse Event|3
2823334|NCT02924688|9665449|P4|Overall Study|Adverse Event|2
2823335|NCT02924688|9665450|P3|Overall Study|Adverse Event|2
2823336|NCT02924688|9665451|P2|Overall Study|Adverse Event|3
2823337|NCT02924688|9665452|P1|Overall Study|Adverse Event|9
2823338|NCT02924051|9665535|P2|Overall Study|Withdrawal by Subject|9
2823339|NCT02924051|9665536|P1|Overall Study|Withdrawal by Subject|1
2823340|NCT02923830|9665563|P2|Overall Study|Physician Decision|15
2823341|NCT02923830|9665564|P1|Overall Study|Physician Decision|13
2823342|NCT02923349|9665589|P7|Overall Study|Death|0
2823343|NCT02923349|9665590|P6|Overall Study|Death|3
2823344|NCT02923349|9665591|P5|Overall Study|Death|2
2823345|NCT02923349|9665592|P4|Overall Study|Death|4
2823346|NCT02923349|9665593|P3|Overall Study|Death|2
2823347|NCT02923349|9665594|P2|Overall Study|Death|0
2823348|NCT02923349|9665595|P1|Overall Study|Death|1
2823349|NCT02923349|9665589|P7|Overall Study|Lost to Follow-up|0
2823350|NCT02923349|9665590|P6|Overall Study|Lost to Follow-up|1
2823351|NCT02923349|9665591|P5|Overall Study|Lost to Follow-up|1
2823352|NCT02923349|9665592|P4|Overall Study|Lost to Follow-up|0
2823353|NCT02923349|9665593|P3|Overall Study|Lost to Follow-up|3
2823354|NCT02923349|9665594|P2|Overall Study|Lost to Follow-up|0
2823355|NCT02923349|9665595|P1|Overall Study|Lost to Follow-up|0
2823356|NCT02923349|9665589|P7|Overall Study|Physician Decision|2
2823357|NCT02923349|9665590|P6|Overall Study|Physician Decision|0
2823358|NCT02923349|9665591|P5|Overall Study|Physician Decision|1
2823359|NCT02923349|9665592|P4|Overall Study|Physician Decision|1
2823360|NCT02923349|9665593|P3|Overall Study|Physician Decision|0
2823361|NCT02923349|9665594|P2|Overall Study|Physician Decision|0
2823362|NCT02923349|9665595|P1|Overall Study|Physician Decision|0
2823363|NCT02923349|9665589|P7|Overall Study|Withdrawal by Subject|0
2823364|NCT02923349|9665590|P6|Overall Study|Withdrawal by Subject|3
2823365|NCT02923349|9665591|P5|Overall Study|Withdrawal by Subject|12
2823366|NCT02923349|9665592|P4|Overall Study|Withdrawal by Subject|10
2823367|NCT02923349|9665593|P3|Overall Study|Withdrawal by Subject|8
2823368|NCT02923349|9665594|P2|Overall Study|Withdrawal by Subject|2
2823369|NCT02923349|9665595|P1|Overall Study|Withdrawal by Subject|2
2823370|NCT02923349|9665589|P7|Overall Study|Other|1
2823371|NCT02923349|9665590|P6|Overall Study|Other|0
2823372|NCT02923349|9665591|P5|Overall Study|Other|3
2823373|NCT02923349|9665592|P4|Overall Study|Other|1
2823374|NCT02923349|9665593|P3|Overall Study|Other|4
2823375|NCT02923349|9665594|P2|Overall Study|Other|2
2823376|NCT02923349|9665595|P1|Overall Study|Other|1
2823377|NCT02923245|9665680|P2|Overall Study|ultrasound order was cancelled|1
2823378|NCT02923245|9665681|P1|Overall Study|ultrasound order was cancelled|2
2823379|NCT02921425|9665803|P1|Overall Study|Protocol Violation|9
2823380|NCT02921087|9665875|P2|Overall Study|Withdrawal by Subject|1
2823381|NCT02921087|9665876|P1|Overall Study|Withdrawal by Subject|0
2823382|NCT02920983|9665905|P6|Dispense 3|Unacceptable Lens Fit|0
2823383|NCT02920983|9665906|P5|Dispense 3|Unacceptable Lens Fit|1
2823384|NCT02920983|9665907|P4|Dispense 3|Unacceptable Lens Fit|0
2823385|NCT02920983|9665908|P3|Dispense 3|Unacceptable Lens Fit|0
2823386|NCT02920983|9665909|P2|Dispense 3|Unacceptable Lens Fit|1
2823387|NCT02920983|9665910|P1|Dispense 3|Unacceptable Lens Fit|1
2823388|NCT02920983|9665905|P6|Dispense 2|Unscceptable lens fit|0
2823389|NCT02920983|9665906|P5|Dispense 2|Unscceptable lens fit|1
2823390|NCT02920983|9665907|P4|Dispense 2|Unscceptable lens fit|0
2823391|NCT02920983|9665908|P3|Dispense 2|Unscceptable lens fit|0
2823392|NCT02920983|9665909|P2|Dispense 2|Unscceptable lens fit|0
2823393|NCT02920983|9665910|P1|Dispense 2|Unscceptable lens fit|1
2823394|NCT02920983|9665905|P6|Dispense 1|Unacceptable Lens Fit|0
2823395|NCT02920983|9665906|P5|Dispense 1|Unacceptable Lens Fit|1
2823396|NCT02920983|9665907|P4|Dispense 1|Unacceptable Lens Fit|0
2823397|NCT02920983|9665908|P3|Dispense 1|Unacceptable Lens Fit|0
2823398|NCT02920983|9665909|P2|Dispense 1|Unacceptable Lens Fit|0
2823399|NCT02920983|9665910|P1|Dispense 1|Unacceptable Lens Fit|0
2823400|NCT02920970|9665939|P2|Second Intervention|Poor Lens Fit|0
2823401|NCT02920970|9665940|P1|Second Intervention|Poor Lens Fit|1
2823402|NCT02920970|9665939|P2|First Intervention|Adverse Event|1
2823403|NCT02920970|9665940|P1|First Intervention|Adverse Event|0
2823404|NCT02920970|9665939|P2|First Intervention|Protocol Violation|1
2823405|NCT02920970|9665940|P1|First Intervention|Protocol Violation|0
2823406|NCT02920957|9665966|P2|Second Intervention: 1 Month|Lost to Follow-up|1
2823407|NCT02920957|9665967|P1|Second Intervention: 1 Month|Lost to Follow-up|0
2823408|NCT02920957|9665966|P2|First Intervention : 1 Month|Adverse Event|0
2823409|NCT02920957|9665967|P1|First Intervention : 1 Month|Adverse Event|1
2823410|NCT02920957|9665966|P2|First Intervention : 1 Month|Lost to Follow-up|0
2823411|NCT02920957|9665967|P1|First Intervention : 1 Month|Lost to Follow-up|1
2823412|NCT02920957|9665966|P2|First Intervention : 1 Month|Withdrawal by Subject|0
2823413|NCT02920957|9665967|P1|First Intervention : 1 Month|Withdrawal by Subject|2
2823414|NCT02920450|9666056|P4|Overall Study|Withdrawal by Subject|0
2823415|NCT02920450|9666057|P3|Overall Study|Withdrawal by Subject|0
2823416|NCT02920450|9666058|P2|Overall Study|Withdrawal by Subject|0
2823417|NCT02920450|9666059|P1|Overall Study|Withdrawal by Subject|1
2823418|NCT02920450|9666056|P4|Overall Study|Death|0
2823419|NCT02920450|9666057|P3|Overall Study|Death|0
2823420|NCT02920450|9666058|P2|Overall Study|Death|0
2823421|NCT02920450|9666059|P1|Overall Study|Death|1
2823422|NCT02920242|9666070|P3|Overall Study|Did not meet inc./exc. criteria|0
2823423|NCT02920242|9666071|P2|Overall Study|Did not meet inc./exc. criteria|0
2823424|NCT02920242|9666072|P1|Overall Study|Did not meet inc./exc. criteria|1
2823425|NCT02920242|9666070|P3|Overall Study|Withdrawal by Subject|1
2823426|NCT02920242|9666071|P2|Overall Study|Withdrawal by Subject|0
2823427|NCT02920242|9666072|P1|Overall Study|Withdrawal by Subject|1
2823428|NCT02920177|9666100|P2|Overall Study|Lost to Follow-up|1
2823429|NCT02920177|9666101|P1|Overall Study|Lost to Follow-up|0
2823430|NCT02920177|9666100|P2|Overall Study|Physician Decision|0
2823431|NCT02920177|9666101|P1|Overall Study|Physician Decision|1
2823432|NCT02920177|9666100|P2|Overall Study|Withdrawal by Subject|1
2823433|NCT02920177|9666101|P1|Overall Study|Withdrawal by Subject|1
2823434|NCT02919995|9666121|P6|Overall Study|Adverse Event|1
2823435|NCT02919995|9666122|P5|Overall Study|Adverse Event|0
2823436|NCT02919995|9666123|P4|Overall Study|Adverse Event|0
2823437|NCT02919995|9666124|P3|Overall Study|Adverse Event|0
2823438|NCT02919995|9666125|P2|Overall Study|Adverse Event|0
2823439|NCT02919995|9666126|P1|Overall Study|Adverse Event|0
2823440|NCT02919761|9666189|P3|Part 2: Double-blind|Discontinued exclusion 16|2
2823441|NCT02919761|9666190|P2|Part 2: Double-blind|Discontinued exclusion 16|0
2823442|NCT02919761|9666191|P1|Part 2: Double-blind|Discontinued exclusion 16|0
2823443|NCT02919761|9666189|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
2823444|NCT02919761|9666190|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
2823445|NCT02919761|9666191|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
2823446|NCT02919761|9666189|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
2823447|NCT02919761|9666190|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
2823448|NCT02919761|9666191|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
2823449|NCT02919761|9666189|P3|Part 2: Double-blind|Worsening of disease activity|10
2823450|NCT02919761|9666190|P2|Part 2: Double-blind|Worsening of disease activity|4
2823451|NCT02919761|9666191|P1|Part 2: Double-blind|Worsening of disease activity|0
2823452|NCT02919761|9666189|P3|Part 2: Double-blind|Met withdrawal criteria|2
2823453|NCT02919761|9666190|P2|Part 2: Double-blind|Met withdrawal criteria|1
2823454|NCT02919761|9666191|P1|Part 2: Double-blind|Met withdrawal criteria|0
2823455|NCT02919761|9666189|P3|Part 2: Double-blind|Lost to Follow-up|3
2823456|NCT02919761|9666190|P2|Part 2: Double-blind|Lost to Follow-up|0
2823457|NCT02919761|9666191|P1|Part 2: Double-blind|Lost to Follow-up|0
2823458|NCT02919761|9666189|P3|Part 2: Double-blind|Adverse Event|0
2823459|NCT02919761|9666190|P2|Part 2: Double-blind|Adverse Event|1
2823460|NCT02919761|9666191|P1|Part 2: Double-blind|Adverse Event|0
2823461|NCT02919761|9666189|P3|Part 2: Double-blind|Withdrawal by Subject|2
2823462|NCT02919761|9666190|P2|Part 2: Double-blind|Withdrawal by Subject|0
2823463|NCT02919761|9666191|P1|Part 2: Double-blind|Withdrawal by Subject|0
2823464|NCT02919761|9666189|P3|Part 1: Open Label|Termination by Sponsor|0
2823465|NCT02919761|9666190|P2|Part 1: Open Label|Termination by Sponsor|0
2823466|NCT02919761|9666191|P1|Part 1: Open Label|Termination by Sponsor|1
2823467|NCT02919761|9666189|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
2823468|NCT02919761|9666190|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
2823469|NCT02919761|9666191|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
2823470|NCT02919761|9666189|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2823471|NCT02919761|9666190|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2823472|NCT02919761|9666191|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
2823473|NCT02919761|9666189|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2823474|NCT02919761|9666190|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2823475|NCT02919761|9666191|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
2823476|NCT02919761|9666189|P3|Part 1: Open Label|Met withdrawal criteria|0
2823477|NCT02919761|9666190|P2|Part 1: Open Label|Met withdrawal criteria|0
2823478|NCT02919761|9666191|P1|Part 1: Open Label|Met withdrawal criteria|5
2823479|NCT02919761|9666189|P3|Part 1: Open Label|Lost to Follow-up|0
2823480|NCT02919761|9666190|P2|Part 1: Open Label|Lost to Follow-up|0
2823481|NCT02919761|9666191|P1|Part 1: Open Label|Lost to Follow-up|1
2823482|NCT02919761|9666189|P3|Part 1: Open Label|Adverse Event|0
2823483|NCT02919761|9666190|P2|Part 1: Open Label|Adverse Event|0
2823484|NCT02919761|9666191|P1|Part 1: Open Label|Adverse Event|1
2823485|NCT02919761|9666189|P3|Part 1: Open Label|Withdrawal by Subject|0
2823486|NCT02919761|9666190|P2|Part 1: Open Label|Withdrawal by Subject|0
2823487|NCT02919761|9666191|P1|Part 1: Open Label|Withdrawal by Subject|12
2823488|NCT02919618|9666224|P1|Overall Study|Death|1
2823489|NCT02919267|9666254|P4|Overall Study|Protocol Violation|4
2823490|NCT02919267|9666255|P3|Overall Study|Protocol Violation|3
2823491|NCT02919267|9666256|P2|Overall Study|Protocol Violation|3
2823492|NCT02919267|9666257|P1|Overall Study|Protocol Violation|0
2823493|NCT02918552|9666397|P2|Overall Study|Lost to Follow-up|1
2823494|NCT02918552|9666398|P1|Overall Study|Lost to Follow-up|0
2823495|NCT02918552|9666397|P2|Overall Study|Withdrawal by Subject|1
2823496|NCT02918552|9666398|P1|Overall Study|Withdrawal by Subject|0
2823497|NCT02918552|9666397|P2|Overall Study|Failed Pharmacokinetics|0
2823498|NCT02918552|9666398|P1|Overall Study|Failed Pharmacokinetics|1
2823499|NCT02918279|9666472|P2|Overall Study|Other|1
2823500|NCT02918279|9666473|P1|Overall Study|Other|3
2823501|NCT02918279|9666472|P2|Overall Study|Withdrawal by parent/guardian|1
2823502|NCT02918279|9666473|P1|Overall Study|Withdrawal by parent/guardian|2
2823503|NCT02918279|9666472|P2|Overall Study|Withdrawal by Subject|15
2823504|NCT02918279|9666473|P1|Overall Study|Withdrawal by Subject|5
2823505|NCT02918279|9666472|P2|Overall Study|Lost to Follow-up|6
2823506|NCT02918279|9666473|P1|Overall Study|Lost to Follow-up|3
2823507|NCT02918266|9666609|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823508|NCT02918266|9666610|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823509|NCT02918266|9666611|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2823510|NCT02918266|9666612|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823511|NCT02918266|9666613|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2823512|NCT02918266|9666614|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823513|NCT02918266|9666615|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823514|NCT02918266|9666616|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823515|NCT02918266|9666617|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823516|NCT02918266|9666618|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2823517|NCT02918266|9666619|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
2823518|NCT02918071|9666718|P1|Overall Study|Lost to Follow-up|1
2823519|NCT02918071|9666718|P1|Overall Study|Withdrawal by Subject|2
2823520|NCT02917265|9666769|P2|Overall Study|Withdrawal by Subject|0
2823521|NCT02917265|9666770|P1|Overall Study|Withdrawal by Subject|1
2823522|NCT02917265|9666769|P2|Overall Study|Physician Decision|0
2823523|NCT02917265|9666770|P1|Overall Study|Physician Decision|1
2823524|NCT02916927|9666786|P2|Overall Study|Withdrawal before first time point|0
2823525|NCT02916927|9666787|P1|Overall Study|Withdrawal before first time point|1
2823526|NCT02916927|9666786|P2|Overall Study|At radiology for 45 & 60 min time points|1
2823527|NCT02916927|9666787|P1|Overall Study|At radiology for 45 & 60 min time points|0
2823528|NCT02916927|9666786|P2|Overall Study|Discharged prior to study drug receipt|2
2823529|NCT02916927|9666787|P1|Overall Study|Discharged prior to study drug receipt|0
2823530|NCT02915978|9666854|P3|Overall Study|Adverse Event|0
2823531|NCT02915978|9666855|P2|Overall Study|Adverse Event|1
2823532|NCT02915978|9666856|P1|Overall Study|Adverse Event|2
2823533|NCT02915874|9666908|P2|Overall Study|Started New Anxiety Medication|1
2823534|NCT02915874|9666909|P1|Overall Study|Started New Anxiety Medication|0
2823535|NCT02915874|9666908|P2|Overall Study|Withdrawal by Subject|1
2823536|NCT02915874|9666909|P1|Overall Study|Withdrawal by Subject|1
2823537|NCT02915874|9666908|P2|Overall Study|Lost to Follow-up|4
2823538|NCT02915874|9666909|P1|Overall Study|Lost to Follow-up|5
2823539|NCT02915835|9666929|P2|Overall Study|Withdrawal by Subject|1
2823540|NCT02915835|9666930|P1|Overall Study|Withdrawal by Subject|0
2823541|NCT02915835|9666929|P2|Overall Study|Physician Decision|0
2823542|NCT02915835|9666930|P1|Overall Study|Physician Decision|1
2823543|NCT02915302|9667130|P2|Overall Study|Other|0
2823544|NCT02915302|9667131|P1|Overall Study|Other|1
2823545|NCT02915302|9667130|P2|Overall Study|Withdrawal by Subject|29
2823546|NCT02915302|9667131|P1|Overall Study|Withdrawal by Subject|22
2823547|NCT02915302|9667130|P2|Overall Study|Lost to Follow-up|22
2823548|NCT02915302|9667131|P1|Overall Study|Lost to Follow-up|19
2823549|NCT02915302|9667130|P2|Overall Study|Protocol Violation|27
2823550|NCT02915302|9667131|P1|Overall Study|Protocol Violation|20
2823551|NCT02915302|9667130|P2|Overall Study|Adverse Event|0
2823552|NCT02915302|9667131|P1|Overall Study|Adverse Event|3
2823553|NCT02915159|9667143|P2|Overall Study|Lack of Efficacy|3
2823554|NCT02915159|9667144|P1|Overall Study|Lack of Efficacy|0
2823555|NCT02915159|9667143|P2|Overall Study|Adverse Event|2
2823556|NCT02915159|9667144|P1|Overall Study|Adverse Event|2
2823557|NCT02915159|9667143|P2|Overall Study|Request to discontinue treatment|2
2823558|NCT02915159|9667144|P1|Overall Study|Request to discontinue treatment|1
2823559|NCT02915159|9667143|P2|Overall Study|Participant withdrew consent|1
2823560|NCT02915159|9667144|P1|Overall Study|Participant withdrew consent|5
2823561|NCT02915159|9667143|P2|Overall Study|poor/non-compliance|0
2823562|NCT02915159|9667144|P1|Overall Study|poor/non-compliance|1
2823563|NCT02915159|9667143|P2|Overall Study|Participant no longer meets criteria|0
2823564|NCT02915159|9667144|P1|Overall Study|Participant no longer meets criteria|2
2823565|NCT02914275|9667273|P2|Overall Study|Excluded due to invalid informed consent|0
2823566|NCT02914275|9667274|P1|Overall Study|Excluded due to invalid informed consent|3
2823567|NCT02914275|9667273|P2|Overall Study|Other|1
2823568|NCT02914275|9667274|P1|Overall Study|Other|4
2823569|NCT02914275|9667273|P2|Overall Study|Physician Decision|1
2823570|NCT02914275|9667274|P1|Overall Study|Physician Decision|3
2823571|NCT02914275|9667273|P2|Overall Study|Protocol Violation|1
2823572|NCT02914275|9667274|P1|Overall Study|Protocol Violation|1
2823573|NCT02914275|9667273|P2|Overall Study|Withdrawal by Subject|10
2823574|NCT02914275|9667274|P1|Overall Study|Withdrawal by Subject|26
2823575|NCT02914275|9667273|P2|Overall Study|Lost to Follow-up|29
2823576|NCT02914275|9667274|P1|Overall Study|Lost to Follow-up|84
2823577|NCT02914236|9667306|P1|Overall Study|Lost to Follow-up|1
2823578|NCT02914184|9667352|P4|Overall Study|Migrated/moved from the study area|1
2823579|NCT02914184|9667353|P3|Overall Study|Migrated/moved from the study area|2
2823580|NCT02914184|9667354|P2|Overall Study|Migrated/moved from the study area|1
2823581|NCT02914184|9667355|P1|Overall Study|Migrated/moved from the study area|2
2823582|NCT02914184|9667352|P4|Overall Study|Other|0
2823583|NCT02914184|9667353|P3|Overall Study|Other|0
2823584|NCT02914184|9667354|P2|Overall Study|Other|0
2823585|NCT02914184|9667355|P1|Overall Study|Other|1
2823586|NCT02914184|9667352|P4|Overall Study|Withdrawal by Subject|3
2823587|NCT02914184|9667353|P3|Overall Study|Withdrawal by Subject|7
2823588|NCT02914184|9667354|P2|Overall Study|Withdrawal by Subject|2
2823589|NCT02914184|9667355|P1|Overall Study|Withdrawal by Subject|4
2823590|NCT02914184|9667352|P4|Overall Study|Lost to Follow-up|7
2823591|NCT02914184|9667353|P3|Overall Study|Lost to Follow-up|8
2823592|NCT02914184|9667354|P2|Overall Study|Lost to Follow-up|10
2823593|NCT02914184|9667355|P1|Overall Study|Lost to Follow-up|7
2823594|NCT02913326|9667412|P2|Overall Study|Adverse Event|0
2823595|NCT02913326|9667413|P1|Overall Study|Adverse Event|1
2823596|NCT02913326|9667412|P2|Overall Study|Lost to Follow-up|1
2823597|NCT02913326|9667413|P1|Overall Study|Lost to Follow-up|0
2823598|NCT02913326|9667412|P2|Overall Study|Reason not listed|1
2823599|NCT02913326|9667413|P1|Overall Study|Reason not listed|0
2823600|NCT02913105|9667449|P3|Overall Study|Withdrawal by Subject|1
2823601|NCT02913105|9667450|P2|Overall Study|Withdrawal by Subject|3
2823602|NCT02913105|9667451|P1|Overall Study|Withdrawal by Subject|0
2823603|NCT02913105|9667449|P3|Overall Study|Physician Decision|0
2823604|NCT02913105|9667450|P2|Overall Study|Physician Decision|1
2823605|NCT02913105|9667451|P1|Overall Study|Physician Decision|1
2823606|NCT02913105|9667449|P3|Overall Study|Reason Not Specified|1
2823607|NCT02913105|9667450|P2|Overall Study|Reason Not Specified|1
2823608|NCT02913105|9667451|P1|Overall Study|Reason Not Specified|3
2823609|NCT02913105|9667449|P3|Overall Study|Non-Compliance With Study Drug|1
2823610|NCT02913105|9667450|P2|Overall Study|Non-Compliance With Study Drug|0
2823611|NCT02913105|9667451|P1|Overall Study|Non-Compliance With Study Drug|0
2823612|NCT02913105|9667449|P3|Overall Study|Adverse Event|4
2823613|NCT02913105|9667450|P2|Overall Study|Adverse Event|0
2823614|NCT02913105|9667451|P1|Overall Study|Adverse Event|11
2823615|NCT02912650|9667504|P4|Overall Study|Adverse Event|0
2823616|NCT02912650|9667505|P3|Overall Study|Adverse Event|1
2823617|NCT02912650|9667506|P2|Overall Study|Adverse Event|0
2823618|NCT02912650|9667507|P1|Overall Study|Adverse Event|0
2823619|NCT02912650|9667504|P4|Overall Study|Withdrawal by Subject|5
2823620|NCT02912650|9667505|P3|Overall Study|Withdrawal by Subject|1
2823621|NCT02912650|9667506|P2|Overall Study|Withdrawal by Subject|0
2823622|NCT02912650|9667507|P1|Overall Study|Withdrawal by Subject|1
2823623|NCT02912468|9667591|P2|Overall Study|Randomized and not treated|1
2823624|NCT02912468|9667592|P1|Overall Study|Randomized and not treated|0
2823625|NCT02912468|9667591|P2|Overall Study|Withdrawal by Subject|2
2823626|NCT02912468|9667592|P1|Overall Study|Withdrawal by Subject|6
2823627|NCT02912468|9667591|P2|Overall Study|Adverse Event|2
2823628|NCT02912468|9667592|P1|Overall Study|Adverse Event|3
2823629|NCT02911948|9667726|P2|Overall Study|Unclassified|3
2823630|NCT02911948|9667727|P1|Overall Study|Unclassified|0
2823631|NCT02911948|9667726|P2|Overall Study|Lack of Efficacy|1
2823632|NCT02911948|9667727|P1|Overall Study|Lack of Efficacy|0
2823633|NCT02911948|9667726|P2|Overall Study|Withdrawal by Subject|2
2823634|NCT02911948|9667727|P1|Overall Study|Withdrawal by Subject|0
2823635|NCT02911948|9667726|P2|Overall Study|Protocol Violation|1
2823636|NCT02911948|9667727|P1|Overall Study|Protocol Violation|0
2823637|NCT02911688|9667989|P2|Washout|Withdrawal by Subject|1
2823638|NCT02911688|9667990|P1|Washout|Withdrawal by Subject|0
2823639|NCT02911688|9667989|P2|Washout|Lost to Follow-up|1
2823640|NCT02911688|9667990|P1|Washout|Lost to Follow-up|1
2823641|NCT02911519|9668014|P2|Overall Study|Death|2
2823642|NCT02911519|9668015|P1|Overall Study|Death|0
2823643|NCT02911519|9668014|P2|Overall Study|Lost to Follow-up|2
2823644|NCT02911519|9668015|P1|Overall Study|Lost to Follow-up|2
2823645|NCT02910739|9668047|P4|Overall Study|Adverse Event|0
2823646|NCT02910739|9668048|P3|Overall Study|Adverse Event|0
2823647|NCT02910739|9668049|P2|Overall Study|Adverse Event|0
2823648|NCT02910739|9668050|P1|Overall Study|Adverse Event|1
2823649|NCT02910713|9668076|P1|Overall Study|Investigator Discretion|1
2823650|NCT02910713|9668076|P1|Overall Study|Enrollment cap|7
2823651|NCT02910713|9668076|P1|Overall Study|Received Neither Application|18
2823652|NCT02910713|9668076|P1|Overall Study|Received One Application|10
2823653|NCT02910713|9668076|P1|Overall Study|Subject Choice|4
2823654|NCT02910713|9668076|P1|Overall Study|Protocol Violation|2
2823655|NCT02910167|9668092|P1|Overall Study|Lost to Follow-up|18
2823656|NCT02910167|9668092|P1|Overall Study|Adverse Event|1
2823657|NCT02910089|9668117|P2|Overall Study|Lost insurance eligibility|16
2823658|NCT02910089|9668118|P1|Overall Study|Lost insurance eligibility|22
2823659|NCT02910011|9668130|P1|Overall Study|Physician Decision|2
2823660|NCT02909907|9668239|P2|Overall Study|Withdrawal by Subject|1
2823661|NCT02909907|9668240|P1|Overall Study|Withdrawal by Subject|0
2823662|NCT02909153|9668313|P5|Overall Study|Withdrawal by Subject|0
2823663|NCT02909153|9668314|P4|Overall Study|Withdrawal by Subject|0
2823664|NCT02909153|9668315|P3|Overall Study|Withdrawal by Subject|0
2823665|NCT02909153|9668316|P2|Overall Study|Withdrawal by Subject|1
2823666|NCT02909153|9668317|P1|Overall Study|Withdrawal by Subject|0
2823667|NCT02909101|9668407|P2|Overall Study|Lost to Follow-up|1
2823668|NCT02909101|9668408|P1|Overall Study|Lost to Follow-up|1
2823669|NCT02908880|9668426|P1|Overall Study|Death|5
2823670|NCT02908880|9668426|P1|Overall Study|Withdrawal by Subject|17
2823671|NCT02908880|9668426|P1|Overall Study|Explantation of the device|1
2823672|NCT02908880|9668426|P1|Overall Study|Lost to Follow-up|4
2823673|NCT02908529|9668475|P2|Overall Study|Lost to Follow-up|2
2823674|NCT02908529|9668476|P1|Overall Study|Lost to Follow-up|0
2823675|NCT02908516|9668486|P2|Overall Study|Study Terminated|3
2823676|NCT02908516|9668487|P1|Overall Study|Study Terminated|3
2823677|NCT02908347|9668503|P2|Overall Study|Lost to Follow-up|0
2823678|NCT02908347|9668504|P1|Overall Study|Lost to Follow-up|1
2823679|NCT02908347|9668503|P2|Overall Study|Adverse Event|1
2823680|NCT02908347|9668504|P1|Overall Study|Adverse Event|0
2823681|NCT02907892|9668599|P2|Overall Study|Lost to Follow-up|40
2823682|NCT02907892|9668600|P1|Overall Study|Lost to Follow-up|27
2823683|NCT02907619|9668620|P3|Overall Study|Other|0
2823684|NCT02907619|9668621|P2|Overall Study|Other|1
2823685|NCT02907619|9668622|P1|Overall Study|Other|0
2823686|NCT02907619|9668620|P3|Overall Study|Withdrawal by Subject|0
2823687|NCT02907619|9668621|P2|Overall Study|Withdrawal by Subject|1
2823688|NCT02907619|9668622|P1|Overall Study|Withdrawal by Subject|1
2823689|NCT02907619|9668620|P3|Overall Study|Death|1
2823690|NCT02907619|9668621|P2|Overall Study|Death|0
2823691|NCT02907619|9668622|P1|Overall Study|Death|0
2823692|NCT02907619|9668620|P3|Overall Study|Study terminated by sponsor|19
2823693|NCT02907619|9668621|P2|Overall Study|Study terminated by sponsor|18
2823694|NCT02907619|9668622|P1|Overall Study|Study terminated by sponsor|18
2823695|NCT02907463|9668838|P1|Overall Study|Missing Exit Form|1
2823696|NCT02907463|9668838|P1|Overall Study|Device Explanted|1
2823697|NCT02907463|9668838|P1|Overall Study|Not Implanted with Study Device|2
2823698|NCT02907463|9668838|P1|Overall Study|MIS Approach was not used|2
2823699|NCT02907463|9668838|P1|Overall Study|Withdrawal by Subject|4
2823700|NCT02907463|9668838|P1|Overall Study|Death|10
2823701|NCT02907463|9668838|P1|Overall Study|Lost to Follow-up|17
2823702|NCT02907216|9668920|P2|Overall Study|Withdrawal by Subject|0
2823703|NCT02907216|9668921|P1|Overall Study|Withdrawal by Subject|1
2823704|NCT02907216|9668920|P2|Overall Study|No benefit to be obtained by continuing|1
2823705|NCT02907216|9668921|P1|Overall Study|No benefit to be obtained by continuing|0
2823706|NCT02906930|9668973|P4|Overall Study|Other|2
2823707|NCT02906930|9668974|P3|Overall Study|Other|1
2823708|NCT02906930|9668975|P2|Overall Study|Other|2
2823709|NCT02906930|9668976|P1|Overall Study|Other|1
2823710|NCT02906930|9668973|P4|Overall Study|Death|0
2823711|NCT02906930|9668974|P3|Overall Study|Death|1
2823712|NCT02906930|9668975|P2|Overall Study|Death|0
2823713|NCT02906930|9668976|P1|Overall Study|Death|0
2823714|NCT02906930|9668973|P4|Overall Study|Lost to Follow-up|2
2823715|NCT02906930|9668974|P3|Overall Study|Lost to Follow-up|5
2823716|NCT02906930|9668975|P2|Overall Study|Lost to Follow-up|7
2823717|NCT02906930|9668976|P1|Overall Study|Lost to Follow-up|5
2823718|NCT02906930|9668973|P4|Overall Study|Withdrawal by Subject|4
2823719|NCT02906930|9668974|P3|Overall Study|Withdrawal by Subject|5
2823720|NCT02906930|9668975|P2|Overall Study|Withdrawal by Subject|5
2823721|NCT02906930|9668976|P1|Overall Study|Withdrawal by Subject|0
2823722|NCT02906917|9669169|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
2823723|NCT02906917|9669170|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
2823724|NCT02906917|9669169|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
2823725|NCT02906917|9669170|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
2823726|NCT02906917|9669169|P2|Intensification Period (Week 26-38)|Adverse Event|2
2823727|NCT02906917|9669170|P1|Intensification Period (Week 26-38)|Adverse Event|0
2823728|NCT02906917|9669169|P2|Intensification Period (Week 26-38)|Unclassified|2
2823729|NCT02906917|9669170|P1|Intensification Period (Week 26-38)|Unclassified|3
2823730|NCT02906917|9669169|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
2823731|NCT02906917|9669170|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
2823732|NCT02906917|9669169|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
2823733|NCT02906917|9669170|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
2823734|NCT02906917|9669169|P2|Initiation Period (Week 0-26)|Adverse Event|0
2823735|NCT02906917|9669170|P1|Initiation Period (Week 0-26)|Adverse Event|1
2823736|NCT02906917|9669169|P2|Initiation Period (Week 0-26)|Unclassified|3
2823737|NCT02906917|9669170|P1|Initiation Period (Week 0-26)|Unclassified|1
2823738|NCT02906709|9669231|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
2823739|NCT02906709|9669232|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
2823740|NCT02906709|9669231|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
2823741|NCT02906709|9669232|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
2823742|NCT02906709|9669231|P2|Phase A (Week 0 to Week 16)|Death|1
2823743|NCT02906709|9669232|P1|Phase A (Week 0 to Week 16)|Death|0
2823744|NCT02906709|9669231|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
2823745|NCT02906709|9669232|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
2823746|NCT02906644|9669278|P2|Weeks 3 to 14|Lost to Follow-up|4
2823747|NCT02906644|9669279|P1|Weeks 3 to 14|Lost to Follow-up|3
2823748|NCT02906644|9669278|P2|Weeks 3 to 14|Withdrawal by Subject|7
2823749|NCT02906644|9669279|P1|Weeks 3 to 14|Withdrawal by Subject|13
2823750|NCT02906644|9669278|P2|First 2 Weeks|Physician Decision|1
2823751|NCT02906644|9669279|P1|First 2 Weeks|Physician Decision|1
2823752|NCT02906644|9669278|P2|First 2 Weeks|Withdrawal by Subject|2
2823753|NCT02906644|9669279|P1|First 2 Weeks|Withdrawal by Subject|0
2823754|NCT02906579|9669295|P1|Overall Study|Physician Decision|1
2823755|NCT02906579|9669295|P1|Overall Study|Adverse Event|1
2823756|NCT02906358|9669499|P2|Overall Study|Lost to Follow-up|15
2823757|NCT02906358|9669500|P1|Overall Study|Lost to Follow-up|12
2823758|NCT02906358|9669499|P2|Overall Study|Withdrawal by Subject|7
2823759|NCT02906358|9669500|P1|Overall Study|Withdrawal by Subject|10
2823760|NCT02905825|9669528|P1|Overall Study|Device Malfunction|1
2823761|NCT02905825|9669528|P1|Overall Study|Protocol Violation|11
2823762|NCT02905331|9669536|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2823763|NCT02905331|9669537|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
2823764|NCT02905331|9669538|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2823765|NCT02905331|9669536|P3|Active Treatment and Follow up (wk16-40)|Other|0
2823766|NCT02905331|9669537|P2|Active Treatment and Follow up (wk16-40)|Other|6
2823767|NCT02905331|9669538|P1|Active Treatment and Follow up (wk16-40)|Other|0
2823768|NCT02905331|9669536|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2823769|NCT02905331|9669537|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
2823770|NCT02905331|9669538|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2823771|NCT02905331|9669536|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2823772|NCT02905331|9669537|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2823773|NCT02905331|9669538|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
2823774|NCT02905331|9669536|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2823775|NCT02905331|9669537|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2823776|NCT02905331|9669538|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
2823777|NCT02905266|9669566|P2|Maintenance Phase Part 2|Not Reported|17
2823778|NCT02905266|9669567|P1|Maintenance Phase Part 2|Not Reported|10
2823779|NCT02905266|9669566|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
2823780|NCT02905266|9669567|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
2823781|NCT02905266|9669566|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
2823782|NCT02905266|9669567|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
2823783|NCT02905266|9669566|P2|Maintenance Phase Part 2|Disease Progression|2
2823784|NCT02905266|9669567|P1|Maintenance Phase Part 2|Disease Progression|8
2823785|NCT02905266|9669566|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
2823786|NCT02905266|9669567|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
2823787|NCT02905266|9669566|P2|Treatment Period Part 1|Study Drug Toxicity|15
2823788|NCT02905266|9669567|P1|Treatment Period Part 1|Study Drug Toxicity|22
2823789|NCT02905266|9669566|P2|Treatment Period Part 1|Disease Progression|7
2823790|NCT02905266|9669567|P1|Treatment Period Part 1|Disease Progression|6
2823791|NCT02905266|9669566|P2|Treatment Period Part 1|Subject Withdrew Consent|0
2823792|NCT02905266|9669567|P1|Treatment Period Part 1|Subject Withdrew Consent|1
2823793|NCT02905149|9669589|P2|Overall Study|Lost to Follow-up|0
2823794|NCT02905149|9669590|P1|Overall Study|Lost to Follow-up|2
2823795|NCT02904902|9669615|P1|Overall Study|Withdrawal by Subject|1
2823796|NCT02904096|9669628|P2|Overall Study|Sponsor instructed|0
2823797|NCT02904096|9669629|P1|Overall Study|Sponsor instructed|1
2823798|NCT02904096|9669628|P2|Overall Study|Non-compliant|1
2823799|NCT02904096|9669629|P1|Overall Study|Non-compliant|3
2823800|NCT02904096|9669628|P2|Overall Study|Lost to Follow-up|17
2823801|NCT02904096|9669629|P1|Overall Study|Lost to Follow-up|10
2823802|NCT02904096|9669628|P2|Overall Study|Withdrawal by Subject|3
2823803|NCT02904096|9669629|P1|Overall Study|Withdrawal by Subject|4
2823804|NCT02904096|9669628|P2|Overall Study|Adverse Event|0
2823805|NCT02904096|9669629|P1|Overall Study|Adverse Event|1
2823806|NCT02903238|9669682|P1|Overall Study|Lost to Follow-up|4
2823807|NCT02903030|9669693|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
2823808|NCT02903030|9669694|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2823809|NCT02902965|9669712|P1|Overall Study|Withdrawal by Subject|10
2823810|NCT02902809|9669730|P1|Overall Study|Discontinuation of asthma program|28
2823811|NCT02901054|9669798|P1|Overall Study|Withdrawal by Subject|3
2823812|NCT02901054|9669798|P1|Overall Study|Physician Decision|1
2823813|NCT02900378|9669813|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
2823814|NCT02900378|9669814|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
2823815|NCT02900378|9669813|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
2823816|NCT02900378|9669814|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
2823817|NCT02900378|9669813|P2|Randomization (Visit 2)|Protocol Deviation|7
2823818|NCT02900378|9669814|P1|Randomization (Visit 2)|Protocol Deviation|1
2823819|NCT02900378|9669813|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
2823820|NCT02900378|9669814|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
2823821|NCT02900378|9669813|P2|Randomization (Visit 2)|Lost to Follow-up|0
2823822|NCT02900378|9669814|P1|Randomization (Visit 2)|Lost to Follow-up|1
2823823|NCT02900378|9669813|P2|Randomization (Visit 2)|Death|4
2823824|NCT02900378|9669814|P1|Randomization (Visit 2)|Death|1
2823825|NCT02900378|9669813|P2|Randomization (Visit 2)|Adverse Event|11
2823826|NCT02900378|9669814|P1|Randomization (Visit 2)|Adverse Event|14
2823827|NCT02900092|9669858|P1|Overall Study|Adverse Event|1
2823828|NCT02899377|9669876|P2|Overall Study|Adverse Event|0
2823829|NCT02899377|9669877|P1|Overall Study|Adverse Event|1
2823830|NCT02899338|9669910|P2|Overall Study|Withdrawal by Subject|0
2823831|NCT02899338|9669911|P1|Overall Study|Withdrawal by Subject|2
2823832|NCT02899338|9669910|P2|Overall Study|Adverse Event|2
2823833|NCT02899338|9669911|P1|Overall Study|Adverse Event|1
2823834|NCT02898662|9669947|P2|Overall Study|Other|1
2823835|NCT02898662|9669948|P1|Overall Study|Other|0
2823836|NCT02898662|9669947|P2|Overall Study|Subject decision|0
2823837|NCT02898662|9669948|P1|Overall Study|Subject decision|1
2823838|NCT02898662|9669947|P2|Overall Study|Randomized in error|1
2823839|NCT02898662|9669948|P1|Overall Study|Randomized in error|0
2823840|NCT02898662|9669947|P2|Overall Study|Technical issue|1
2823841|NCT02898662|9669948|P1|Overall Study|Technical issue|0
2823842|NCT02898662|9669947|P2|Overall Study|Withdrawal by Subject|1
2823843|NCT02898662|9669948|P1|Overall Study|Withdrawal by Subject|4
2823844|NCT02898662|9669947|P2|Overall Study|Loss of asthma control|24
2823845|NCT02898662|9669948|P1|Overall Study|Loss of asthma control|23
2823846|NCT02898662|9669947|P2|Overall Study|Adverse Event|0
2823847|NCT02898662|9669948|P1|Overall Study|Adverse Event|1
2823848|NCT02898597|9669972|P2|Overall Study|Death|1
2823849|NCT02898597|9669973|P1|Overall Study|Death|0
2823850|NCT02898597|9669972|P2|Overall Study|Lost to Follow-up|9
2823851|NCT02898597|9669973|P1|Overall Study|Lost to Follow-up|0
2823852|NCT02898597|9669972|P2|Overall Study|Protocol Violation|2
2823853|NCT02898597|9669973|P1|Overall Study|Protocol Violation|4
2823854|NCT02898454|9669982|P3|Overall Study|Did Not Met Eligibility Criteria|0
2823855|NCT02898454|9669983|P2|Overall Study|Did Not Met Eligibility Criteria|0
2823856|NCT02898454|9669984|P1|Overall Study|Did Not Met Eligibility Criteria|1
2823857|NCT02898454|9669982|P3|Overall Study|Lost to Follow-up|0
2823858|NCT02898454|9669983|P2|Overall Study|Lost to Follow-up|0
2823859|NCT02898454|9669984|P1|Overall Study|Lost to Follow-up|1
2823860|NCT02898454|9669982|P3|Overall Study|Withdrawal by Subject|3
2823861|NCT02898454|9669983|P2|Overall Study|Withdrawal by Subject|3
2823862|NCT02898454|9669984|P1|Overall Study|Withdrawal by Subject|6
2823863|NCT02898454|9669982|P3|Overall Study|Lack of Efficacy|0
2823864|NCT02898454|9669983|P2|Overall Study|Lack of Efficacy|1
2823865|NCT02898454|9669984|P1|Overall Study|Lack of Efficacy|4
2823866|NCT02898454|9669982|P3|Overall Study|Protocol Violation|1
2823867|NCT02898454|9669983|P2|Overall Study|Protocol Violation|0
2823868|NCT02898454|9669984|P1|Overall Study|Protocol Violation|1
2823869|NCT02898454|9669982|P3|Overall Study|Adverse Event|2
2823870|NCT02898454|9669983|P2|Overall Study|Adverse Event|1
2823871|NCT02898454|9669984|P1|Overall Study|Adverse Event|4
2823872|NCT02898116|9670097|P1|Overall Study|Progressive disease|1
2823873|NCT02898116|9670097|P1|Overall Study|Adverse Event|1
2823874|NCT02897349|9670105|P2|Overall Study|Other than listed above|1
2823875|NCT02897349|9670106|P1|Overall Study|Other than listed above|0
2823876|NCT02897349|9670105|P2|Overall Study|Adverse Event|3
2823877|NCT02897349|9670106|P1|Overall Study|Adverse Event|3
2823878|NCT02897349|9670105|P2|Overall Study|Lost to Follow-up|2
2823879|NCT02897349|9670106|P1|Overall Study|Lost to Follow-up|2
2823880|NCT02897115|9670148|P2|Overall Study|Early termination of study by sponsor|8
2823881|NCT02897115|9670149|P1|Overall Study|Early termination of study by sponsor|11
2823882|NCT02896855|9670226|P2|Overall Study|Withdrawal by Subject|1
2823883|NCT02896855|9670227|P1|Overall Study|Withdrawal by Subject|1
2823884|NCT02896855|9670226|P2|Overall Study|Lost to Follow-up|0
2823885|NCT02896855|9670227|P1|Overall Study|Lost to Follow-up|5
2823886|NCT02896855|9670226|P2|Overall Study|Death|12
2823887|NCT02896855|9670227|P1|Overall Study|Death|13
2823888|NCT02896855|9670226|P2|Overall Study|In Follow-Up|49
2823889|NCT02896855|9670227|P1|Overall Study|In Follow-Up|61
2823890|NCT02896855|9670226|P2|Overall Study|On Study Treatment|60
2823891|NCT02896855|9670227|P1|Overall Study|On Study Treatment|41
2823892|NCT02896361|9670308|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2823893|NCT02896361|9670309|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
2823894|NCT02896361|9670310|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2823895|NCT02896361|9670308|P3|Third Intervention (2 Weeks)|Protocol Violation|0
2823896|NCT02896361|9670309|P2|Third Intervention (2 Weeks)|Protocol Violation|0
2823897|NCT02896361|9670310|P1|Third Intervention (2 Weeks)|Protocol Violation|1
2823898|NCT02896296|9670328|P1|Overall Study|Relocation|1
2823899|NCT02896296|9670328|P1|Overall Study|Incarceration|1
2823900|NCT02896296|9670328|P1|Overall Study|Site closing|7
2823901|NCT02896296|9670328|P1|Overall Study|Withdrawal by Subject|10
2823902|NCT02896296|9670328|P1|Overall Study|Physician Decision|2
2823903|NCT02896296|9670328|P1|Overall Study|Pregnancy|1
2823904|NCT02896296|9670328|P1|Overall Study|Lost to Follow-up|19
2823905|NCT02896296|9670328|P1|Overall Study|Adverse Event|1
2823906|NCT02895347|9670336|P2|Overall Study|Withdrawal by Subject|1
2823907|NCT02895347|9670337|P1|Overall Study|Withdrawal by Subject|3
2823908|NCT02895295|9670349|P3|Overall Study|Survey Non-response|92
2823909|NCT02895295|9670350|P2|Overall Study|Survey Non-response|94
2823910|NCT02895295|9670351|P1|Overall Study|Survey Non-response|71
2823911|NCT02894840|9670385|P4|Overall Study|Lost to Follow-up|0
2823912|NCT02894840|9670386|P3|Overall Study|Lost to Follow-up|3
2823913|NCT02894840|9670387|P2|Overall Study|Lost to Follow-up|0
2823914|NCT02894840|9670388|P1|Overall Study|Lost to Follow-up|1
2823915|NCT02892734|9670660|P1|Follow up for 2 Years|Study closed early|1
2823916|NCT02892734|9670660|P1|Follow up for 2 Years|Death|2
2823917|NCT02892734|9670660|P1|Treatment on Study|Progressive Disease|2
2823918|NCT02892513|9670666|P2|Overall Study|Withdrawal by Subject|1
2823919|NCT02892513|9670667|P1|Overall Study|Withdrawal by Subject|0
2823920|NCT02892409|9670675|P2|Overall Study|Withdrawal by Subject|1
2823921|NCT02892409|9670676|P1|Overall Study|Withdrawal by Subject|2
2823922|NCT02892409|9670675|P2|Overall Study|Adverse Event|0
2823923|NCT02892409|9670676|P1|Overall Study|Adverse Event|1
2823924|NCT02892344|9670698|P2|Overall Study|Technical problems|1
2823925|NCT02892344|9670699|P1|Overall Study|Technical problems|0
2823926|NCT02892344|9670698|P2|Overall Study|Subject/guardian decision|4
2823927|NCT02892344|9670699|P1|Overall Study|Subject/guardian decision|0
2823928|NCT02892344|9670698|P2|Overall Study|Physician Decision|2
2823929|NCT02892344|9670699|P1|Overall Study|Physician Decision|0
2823930|NCT02892344|9670698|P2|Overall Study|Non-compliance with study treatment|1
2823931|NCT02892344|9670699|P1|Overall Study|Non-compliance with study treatment|0
2823932|NCT02892344|9670698|P2|Overall Study|Lost to Follow-up|1
2823933|NCT02892344|9670699|P1|Overall Study|Lost to Follow-up|0
2823934|NCT02892344|9670698|P2|Overall Study|Adverse Event|8
2823935|NCT02892344|9670699|P1|Overall Study|Adverse Event|1
2823936|NCT02892344|9670698|P2|Overall Study|Protocol deviation|4
2823937|NCT02892344|9670699|P1|Overall Study|Protocol deviation|3
2823938|NCT02892019|9670748|P2|Overall Study|Adverse Event|1
2823939|NCT02892019|9670749|P1|Overall Study|Adverse Event|1
2823940|NCT02892019|9670748|P2|Overall Study|Withdrawal by Subject|1
2823941|NCT02892019|9670749|P1|Overall Study|Withdrawal by Subject|0
2823942|NCT02892019|9670748|P2|Overall Study|randomized but not treated|1
2823943|NCT02892019|9670749|P1|Overall Study|randomized but not treated|0
2823944|NCT02891200|9670789|P2|Overall Study|Withdrawal by Subject|4
2823945|NCT02891200|9670790|P1|Overall Study|Withdrawal by Subject|1
2823946|NCT02891200|9670789|P2|Overall Study|Death|9
2823947|NCT02891200|9670790|P1|Overall Study|Death|10
2823948|NCT02891200|9670789|P2|Overall Study|Lost to Follow-up|36
2823949|NCT02891200|9670790|P1|Overall Study|Lost to Follow-up|31
2823950|NCT02891174|9670818|P2|Second Intervention (24 Hours)|Protocol Violation|1
2823951|NCT02891174|9670819|P1|Second Intervention (24 Hours)|Protocol Violation|0
2823952|NCT02891174|9670818|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
2823953|NCT02891174|9670819|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
2823954|NCT02891174|9670818|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
2823955|NCT02891174|9670819|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
2823956|NCT02891174|9670818|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
2823957|NCT02891174|9670819|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
2823958|NCT02891174|9670818|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
2823959|NCT02891174|9670819|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
2823960|NCT02891174|9670818|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
2823961|NCT02891174|9670819|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
2823962|NCT02891174|9670818|P2|First Intervention (24 Hours)|Declined any study medication|5
2823963|NCT02891174|9670819|P1|First Intervention (24 Hours)|Declined any study medication|1
2823964|NCT02891070|9670833|P2|Overall Study|Death|0
2823965|NCT02891070|9670834|P1|Overall Study|Death|3
2823966|NCT02891070|9670833|P2|Overall Study|Withdrawal by Subject|2
2823967|NCT02891070|9670834|P1|Overall Study|Withdrawal by Subject|1
2823968|NCT02891070|9670833|P2|Overall Study|Protocol Violation|1
2823969|NCT02891070|9670834|P1|Overall Study|Protocol Violation|0
2823970|NCT02891070|9670833|P2|Overall Study|Other|0
2823971|NCT02891070|9670834|P1|Overall Study|Other|1
2823972|NCT02891070|9670833|P2|Overall Study|Lost to Follow-up|4
2823973|NCT02891070|9670834|P1|Overall Study|Lost to Follow-up|4
2823974|NCT02891070|9670833|P2|Overall Study|Physician Decision|1
2823975|NCT02891070|9670834|P1|Overall Study|Physician Decision|0
2823976|NCT02891070|9670833|P2|Overall Study|Adverse Event|0
2823977|NCT02891070|9670834|P1|Overall Study|Adverse Event|1
2823978|NCT02890992|9670860|P8|130 Weeks Open-Label Extension Period|Other than specified|0
2823979|NCT02890992|9670861|P7|130 Weeks Open-Label Extension Period|Other than specified|0
2823980|NCT02890992|9670862|P6|130 Weeks Open-Label Extension Period|Other than specified|0
2823981|NCT02890992|9670863|P5|130 Weeks Open-Label Extension Period|Other than specified|0
2823982|NCT02890992|9670864|P4|130 Weeks Open-Label Extension Period|Other than specified|0
2823983|NCT02890992|9670865|P3|130 Weeks Open-Label Extension Period|Other than specified|0
2823984|NCT02890992|9670866|P2|130 Weeks Open-Label Extension Period|Other than specified|2
2823985|NCT02890992|9670867|P1|130 Weeks Open-Label Extension Period|Other than specified|0
2823986|NCT02890992|9670860|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
2823987|NCT02890992|9670861|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
2823988|NCT02890992|9670862|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
2823989|NCT02890992|9670863|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
2823990|NCT02890992|9670864|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
2823991|NCT02890992|9670865|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
2823992|NCT02890992|9670866|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
2823993|NCT02890992|9670867|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
2823994|NCT02890992|9670860|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
2823995|NCT02890992|9670861|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
2823996|NCT02890992|9670862|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
2823997|NCT02890992|9670863|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
2823998|NCT02890992|9670864|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
2823999|NCT02890992|9670865|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
2824000|NCT02890992|9670866|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
2824001|NCT02890992|9670867|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
2824002|NCT02888756|9671078|P3|Analytical Treatment Interruption|Physician Decision|5
2824003|NCT02888756|9671079|P2|Analytical Treatment Interruption|Physician Decision|6
2824004|NCT02888756|9671080|P1|Analytical Treatment Interruption|Physician Decision|10
2824005|NCT02888171|9671123|P2|Overall Study|Adverse Event|1
2824006|NCT02888171|9671124|P1|Overall Study|Adverse Event|0
2824007|NCT02888171|9671123|P2|Overall Study|Withdrawal by Subject|2
2824008|NCT02888171|9671124|P1|Overall Study|Withdrawal by Subject|3
2824009|NCT02888171|9671123|P2|Overall Study|Lost to Follow-up|1
2824010|NCT02888171|9671124|P1|Overall Study|Lost to Follow-up|2
2824011|NCT02888080|9671153|P2|Overall Study|Adverse Event|1
2824012|NCT02888080|9671154|P1|Overall Study|Adverse Event|0
2824013|NCT02888080|9671153|P2|Overall Study|Lack of Efficacy|1
2824014|NCT02888080|9671154|P1|Overall Study|Lack of Efficacy|0
2824015|NCT02888080|9671153|P2|Overall Study|New Therapy for study indication|0
2824016|NCT02888080|9671154|P1|Overall Study|New Therapy for study indication|1
2824017|NCT02888080|9671153|P2|Overall Study|Subject / Guardian decision|3
2824018|NCT02888080|9671154|P1|Overall Study|Subject / Guardian decision|1
2824019|NCT02887989|9671180|P2|Overall Study|Death|0
2824020|NCT02887989|9671181|P1|Overall Study|Death|1
2824021|NCT02887989|9671180|P2|Overall Study|Withdrawal by Subject|11
2824022|NCT02887989|9671181|P1|Overall Study|Withdrawal by Subject|8
2824023|NCT02887183|9671191|P1|Overall Study|Withdrawal by Subject|35
2824024|NCT02887183|9671191|P1|Overall Study|Physician Decision|10
2824025|NCT02887183|9671191|P1|Overall Study|Lost to Follow-up|13
2824026|NCT02887183|9671191|P1|Overall Study|Technical Problems|2
2824027|NCT02887183|9671191|P1|Overall Study|Protocol Violation|6
2824028|NCT02887183|9671191|P1|Overall Study|Pregnancy|1
2824029|NCT02887183|9671191|P1|Overall Study|Death|30
2824030|NCT02887183|9671191|P1|Overall Study|Adverse Event|44
2824031|NCT02886715|9671218|P3|Overall Study|missing|2
2824032|NCT02886715|9671219|P2|Overall Study|missing|2
2824033|NCT02886715|9671220|P1|Overall Study|missing|7
2824034|NCT02886715|9671218|P3|Overall Study|Withdrawal by Subject|5
2824035|NCT02886715|9671219|P2|Overall Study|Withdrawal by Subject|18
2824036|NCT02886715|9671220|P1|Overall Study|Withdrawal by Subject|20
2824037|NCT02886715|9671218|P3|Overall Study|Protocol Violation|1
2824038|NCT02886715|9671219|P2|Overall Study|Protocol Violation|2
2824039|NCT02886715|9671220|P1|Overall Study|Protocol Violation|3
2824040|NCT02886715|9671218|P3|Overall Study|Pregnancy|1
2824041|NCT02886715|9671219|P2|Overall Study|Pregnancy|1
2824042|NCT02886715|9671220|P1|Overall Study|Pregnancy|1
2824043|NCT02886715|9671218|P3|Overall Study|Lost to Follow-up|10
2824044|NCT02886715|9671219|P2|Overall Study|Lost to Follow-up|26
2824045|NCT02886715|9671220|P1|Overall Study|Lost to Follow-up|29
2824046|NCT02886715|9671218|P3|Overall Study|Lack of Efficacy|1
2824047|NCT02886715|9671219|P2|Overall Study|Lack of Efficacy|2
2824048|NCT02886715|9671220|P1|Overall Study|Lack of Efficacy|0
2824049|NCT02886715|9671218|P3|Overall Study|Adverse Event|0
2824050|NCT02886715|9671219|P2|Overall Study|Adverse Event|2
2824051|NCT02886715|9671220|P1|Overall Study|Adverse Event|4
2824052|NCT02886715|9671218|P3|Overall Study|Non-Compliance With Study Drug|0
2824053|NCT02886715|9671219|P2|Overall Study|Non-Compliance With Study Drug|2
2824054|NCT02886715|9671220|P1|Overall Study|Non-Compliance With Study Drug|0
2824055|NCT02886702|9671237|P3|Overall Study|Administrative Reasons|1
2824056|NCT02886702|9671238|P2|Overall Study|Administrative Reasons|0
2824057|NCT02886702|9671239|P1|Overall Study|Administrative Reasons|0
2824058|NCT02886702|9671237|P3|Overall Study|Adverse Event|3
2824059|NCT02886702|9671238|P2|Overall Study|Adverse Event|9
2824060|NCT02886702|9671239|P1|Overall Study|Adverse Event|4
2824061|NCT02886702|9671237|P3|Overall Study|Lack of Efficacy|5
2824062|NCT02886702|9671238|P2|Overall Study|Lack of Efficacy|4
2824063|NCT02886702|9671239|P1|Overall Study|Lack of Efficacy|3
2824064|NCT02886702|9671237|P3|Overall Study|Lost to Follow-up|8
2824065|NCT02886702|9671238|P2|Overall Study|Lost to Follow-up|13
2824066|NCT02886702|9671239|P1|Overall Study|Lost to Follow-up|11
2824067|NCT02886702|9671237|P3|Overall Study|Non-Compliance With Study Drug|4
2824068|NCT02886702|9671238|P2|Overall Study|Non-Compliance With Study Drug|1
2824069|NCT02886702|9671239|P1|Overall Study|Non-Compliance With Study Drug|0
2824070|NCT02886702|9671237|P3|Overall Study|Protocol Violation|1
2824071|NCT02886702|9671238|P2|Overall Study|Protocol Violation|2
2824072|NCT02886702|9671239|P1|Overall Study|Protocol Violation|2
2824073|NCT02886702|9671237|P3|Overall Study|Significant Worsening of Condition|0
2824074|NCT02886702|9671238|P2|Overall Study|Significant Worsening of Condition|1
2824075|NCT02886702|9671239|P1|Overall Study|Significant Worsening of Condition|0
2824076|NCT02886702|9671237|P3|Overall Study|Withdrawal by Subject|22
2824077|NCT02886702|9671238|P2|Overall Study|Withdrawal by Subject|18
2824078|NCT02886702|9671239|P1|Overall Study|Withdrawal by Subject|24
2824079|NCT02886702|9671237|P3|Overall Study|Other|9
2824080|NCT02886702|9671238|P2|Overall Study|Other|3
2824081|NCT02886702|9671239|P1|Overall Study|Other|4
2824082|NCT02886624|9671253|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
2824083|NCT02886624|9671253|P1|12-week Post Treatment Follow-up|Death|1
2824084|NCT02886338|9671262|P1|Overall Study|Withdrawal by Subject|1
2824085|NCT02885181|9671451|P4|Overall Study|Withdrawal by Subject|1
2824086|NCT02885181|9671452|P3|Overall Study|Withdrawal by Subject|0
2824087|NCT02885181|9671453|P2|Overall Study|Withdrawal by Subject|0
2824088|NCT02885181|9671454|P1|Overall Study|Withdrawal by Subject|0
2824089|NCT02885181|9671451|P4|Overall Study|Adverse Event|1
2824090|NCT02885181|9671452|P3|Overall Study|Adverse Event|0
2824091|NCT02885181|9671453|P2|Overall Study|Adverse Event|0
2824092|NCT02885181|9671454|P1|Overall Study|Adverse Event|0
2824093|NCT02885181|9671451|P4|Overall Study|Investigator's Discretion|1
2824094|NCT02885181|9671452|P3|Overall Study|Investigator's Discretion|0
2824095|NCT02885181|9671453|P2|Overall Study|Investigator's Discretion|1
2824096|NCT02885181|9671454|P1|Overall Study|Investigator's Discretion|0
2824097|NCT02884089|9671521|P4|Follow-up Visit|Withdrawal by Subject|1
2824098|NCT02884089|9671522|P3|Follow-up Visit|Withdrawal by Subject|0
2824099|NCT02884089|9671523|P2|Follow-up Visit|Withdrawal by Subject|0
2824100|NCT02884089|9671524|P1|Follow-up Visit|Withdrawal by Subject|1
2824101|NCT02884089|9671521|P4|Period 4|Lost to Follow-up|0
2824102|NCT02884089|9671522|P3|Period 4|Lost to Follow-up|0
2824103|NCT02884089|9671523|P2|Period 4|Lost to Follow-up|0
2824104|NCT02884089|9671524|P1|Period 4|Lost to Follow-up|1
2824105|NCT02884089|9671521|P4|Period 4|Withdrawal by Subject|0
2824106|NCT02884089|9671522|P3|Period 4|Withdrawal by Subject|0
2824107|NCT02884089|9671523|P2|Period 4|Withdrawal by Subject|1
2824108|NCT02884089|9671524|P1|Period 4|Withdrawal by Subject|0
2824109|NCT02884089|9671521|P4|Washout Period 3|Lost to Follow-up|1
2824110|NCT02884089|9671522|P3|Washout Period 3|Lost to Follow-up|0
2824111|NCT02884089|9671523|P2|Washout Period 3|Lost to Follow-up|0
2824112|NCT02884089|9671524|P1|Washout Period 3|Lost to Follow-up|0
2824113|NCT02884089|9671521|P4|Washout Period 3|Withdrawal by Subject|0
2824114|NCT02884089|9671522|P3|Washout Period 3|Withdrawal by Subject|1
2824115|NCT02884089|9671523|P2|Washout Period 3|Withdrawal by Subject|0
2824116|NCT02884089|9671524|P1|Washout Period 3|Withdrawal by Subject|0
2824117|NCT02884089|9671521|P4|Period 3|Withdrawal by Subject|0
2824118|NCT02884089|9671522|P3|Period 3|Withdrawal by Subject|1
2824119|NCT02884089|9671523|P2|Period 3|Withdrawal by Subject|0
2824120|NCT02884089|9671524|P1|Period 3|Withdrawal by Subject|0
2824121|NCT02884089|9671521|P4|Period 2|Adverse Event|0
2824122|NCT02884089|9671522|P3|Period 2|Adverse Event|0
2824123|NCT02884089|9671523|P2|Period 2|Adverse Event|0
2824124|NCT02884089|9671524|P1|Period 2|Adverse Event|1
2824125|NCT02884089|9671521|P4|Washout Period 1|Withdrawal by Subject|0
2824126|NCT02884089|9671522|P3|Washout Period 1|Withdrawal by Subject|0
2824127|NCT02884089|9671523|P2|Washout Period 1|Withdrawal by Subject|1
2824128|NCT02884089|9671524|P1|Washout Period 1|Withdrawal by Subject|0
2824129|NCT02884089|9671521|P4|Washout Period 1|Lost to Follow-up|1
2824130|NCT02884089|9671522|P3|Washout Period 1|Lost to Follow-up|0
2824131|NCT02884089|9671523|P2|Washout Period 1|Lost to Follow-up|1
2824132|NCT02884089|9671524|P1|Washout Period 1|Lost to Follow-up|0
2824133|NCT02884089|9671521|P4|Period 1|Dosing error|0
2824134|NCT02884089|9671522|P3|Period 1|Dosing error|0
2824135|NCT02884089|9671523|P2|Period 1|Dosing error|2
2824136|NCT02884089|9671524|P1|Period 1|Dosing error|2
2824137|NCT02883244|9671540|P2|Overall Study|Lost to Follow-up|1
2824138|NCT02883244|9671541|P1|Overall Study|Lost to Follow-up|0
2824139|NCT02882854|9671559|P2|Overall Study|Physician Decision|1
2824140|NCT02882854|9671560|P1|Overall Study|Physician Decision|0
2824141|NCT02882854|9671559|P2|Overall Study|Lost to Follow-up|2
2824142|NCT02882854|9671560|P1|Overall Study|Lost to Follow-up|1
2824143|NCT02882152|9671597|P2|Overall Study|Lost to Follow-up|0
2824144|NCT02882152|9671598|P1|Overall Study|Lost to Follow-up|1
2824145|NCT02881567|9671668|P1|Overall Study|Reason not Specified|3
2824146|NCT02881567|9671668|P1|Overall Study|Study terminated by sponsor|9
2824147|NCT02881567|9671668|P1|Overall Study|Investigator decision|1
2824148|NCT02881567|9671668|P1|Overall Study|Consent withdrawn|1
2824149|NCT02881567|9671668|P1|Overall Study|Lost to Follow-up|3
2824150|NCT02881567|9671668|P1|Overall Study|Adverse Event|1
2824151|NCT02881047|9671684|P1|Overall Study|Withdrawal by Subject|1
2824152|NCT02881047|9671684|P1|Overall Study|Adverse Event|1
2824153|NCT02880761|9671762|P2|Overall Study|Lost to Follow-up|4
2824154|NCT02880761|9671763|P1|Overall Study|Lost to Follow-up|3
2824155|NCT02880761|9671762|P2|Overall Study|Protocol Violation|3
2824156|NCT02880761|9671763|P1|Overall Study|Protocol Violation|4
2824157|NCT02880761|9671762|P2|Overall Study|Withdrawal by Subject|6
2824158|NCT02880761|9671763|P1|Overall Study|Withdrawal by Subject|3
2824159|NCT02880761|9671762|P2|Overall Study|Death|8
2824160|NCT02880761|9671763|P1|Overall Study|Death|6
2824161|NCT02878590|9671972|P1|Overall Study|Withdrawal by Subject|2
2824162|NCT02878330|9671997|P2|Overall Study|Other|7
2824163|NCT02878330|9671998|P1|Overall Study|Other|4
2824164|NCT02878330|9671997|P2|Overall Study|Withdrawal by Subject|21
2824165|NCT02878330|9671998|P1|Overall Study|Withdrawal by Subject|11
2824166|NCT02878330|9671997|P2|Overall Study|Lost to Follow-up|26
2824167|NCT02878330|9671998|P1|Overall Study|Lost to Follow-up|11
2824168|NCT02878330|9671997|P2|Overall Study|Death|2
2824169|NCT02878330|9671998|P1|Overall Study|Death|3
2824170|NCT02878213|9672014|P1|Overall Study|Adverse Event|1
2824171|NCT02878213|9672014|P1|Overall Study|Withdrawal by Subject|2
2824172|NCT02877927|9672021|P2|Overall Study|Missed EOT/PTE Visit|6
2824173|NCT02877927|9672022|P1|Overall Study|Missed EOT/PTE Visit|5
2824174|NCT02877927|9672021|P2|Overall Study|Physician Decision|1
2824175|NCT02877927|9672022|P1|Overall Study|Physician Decision|0
2824176|NCT02877927|9672021|P2|Overall Study|Withdrawal by Subject|12
2824177|NCT02877927|9672022|P1|Overall Study|Withdrawal by Subject|11
2824178|NCT02877927|9672021|P2|Overall Study|Lost to Follow-up|38
2824179|NCT02877927|9672022|P1|Overall Study|Lost to Follow-up|37
2824180|NCT02877927|9672021|P2|Overall Study|Adverse Event|0
2824181|NCT02877927|9672022|P1|Overall Study|Adverse Event|1
2824182|NCT02877082|9672060|P1|Overall Study|Trial was closed early|5
2824183|NCT02877004|9672071|P3|Overall Study|Pregnancy|1
2824184|NCT02877004|9672072|P2|Overall Study|Pregnancy|0
2824185|NCT02877004|9672073|P1|Overall Study|Pregnancy|0
2824186|NCT02876601|9672136|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2824187|NCT02876601|9672137|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
2824188|NCT02876601|9672138|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2824189|NCT02876601|9672139|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2824190|NCT02875977|9672237|P2|Overall Study|Lost to Follow-up|29
2824191|NCT02875977|9672238|P1|Overall Study|Lost to Follow-up|42
2824192|NCT02875613|9672252|P1|Overall Study|Withdrawal by Subject|1
2824193|NCT02875366|9672258|P2|Overall Study|Noncompliance|1
2824194|NCT02875366|9672259|P1|Overall Study|Noncompliance|0
2824195|NCT02875366|9672258|P2|Overall Study|Adverse Event|2
2824196|NCT02875366|9672259|P1|Overall Study|Adverse Event|0
2824197|NCT02875340|9672311|P1|Overall Study|Adverse Event|1
2824198|NCT02875340|9672311|P1|Overall Study|Physician Decision|3
2824199|NCT02875340|9672311|P1|Overall Study|Withdrawal by Subject|2
2824200|NCT02875340|9672311|P1|Overall Study|Death|2
2824201|NCT02875028|9672335|P2|Washout Period|Withdrawal by Subject|1
2824202|NCT02875028|9672336|P1|Washout Period|Withdrawal by Subject|0
2824203|NCT02874924|9672367|P3|Overall Study|Withdrawal by Subject|0
2824204|NCT02874924|9672368|P2|Overall Study|Withdrawal by Subject|0
2824205|NCT02874924|9672369|P1|Overall Study|Withdrawal by Subject|1
2824206|NCT02874924|9672367|P3|Overall Study|Adverse Event|0
2824207|NCT02874924|9672368|P2|Overall Study|Adverse Event|0
2824208|NCT02874924|9672369|P1|Overall Study|Adverse Event|2
2824209|NCT02874794|9672402|P2|Overall Study|Death|1
2824210|NCT02874794|9672403|P1|Overall Study|Death|2
2824211|NCT02874794|9672402|P2|Overall Study|Withdrawal by Subject|8
2824212|NCT02874794|9672403|P1|Overall Study|Withdrawal by Subject|2
2824213|NCT02874794|9672402|P2|Overall Study|Physician Decision|2
2824214|NCT02874794|9672403|P1|Overall Study|Physician Decision|3
2824215|NCT02874742|9672435|P3|Overall Study|Ongoing|15
2824216|NCT02874742|9672436|P2|Overall Study|Ongoing|98
2824217|NCT02874742|9672437|P1|Overall Study|Ongoing|87
2824218|NCT02874742|9672435|P3|Overall Study|Other|0
2824219|NCT02874742|9672436|P2|Overall Study|Other|1
2824220|NCT02874742|9672437|P1|Overall Study|Other|3
2824221|NCT02874742|9672435|P3|Overall Study|Withdrawal by Subject|0
2824222|NCT02874742|9672436|P2|Overall Study|Withdrawal by Subject|4
2824223|NCT02874742|9672437|P1|Overall Study|Withdrawal by Subject|8
2824224|NCT02874742|9672435|P3|Overall Study|Lost to Follow-up|0
2824225|NCT02874742|9672436|P2|Overall Study|Lost to Follow-up|0
2824226|NCT02874742|9672437|P1|Overall Study|Lost to Follow-up|2
2824227|NCT02874742|9672435|P3|Overall Study|Death|1
2824228|NCT02874742|9672436|P2|Overall Study|Death|1
2824229|NCT02874742|9672437|P1|Overall Study|Death|3
2824230|NCT02874534|9672491|P2|Overall Study|Ongoing in study|1
2824231|NCT02874534|9672492|P1|Overall Study|Ongoing in study|1
2824232|NCT02874534|9672491|P2|Overall Study|Lost to Follow-up|2
2824233|NCT02874534|9672492|P1|Overall Study|Lost to Follow-up|2
2824234|NCT02874534|9672491|P2|Overall Study|Withdrawal by Subject|8
2824235|NCT02874534|9672492|P1|Overall Study|Withdrawal by Subject|5
2824236|NCT02873754|9672514|P1|Overall Study|Couldn't complete study procedures|1
2824237|NCT02873754|9672514|P1|Overall Study|Lost to Follow-up|5
2824238|NCT02873702|9672531|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
2824239|NCT02873702|9672532|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
2824240|NCT02873702|9672533|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2824241|NCT02873702|9672534|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2824242|NCT02873702|9672531|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
2824243|NCT02873702|9672532|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
2824244|NCT02873702|9672533|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
2824245|NCT02873702|9672534|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
2824246|NCT02873702|9672531|P4|Maintenance Period (up to Month 6)|Adverse Event|0
2824247|NCT02873702|9672532|P3|Maintenance Period (up to Month 6)|Adverse Event|1
2824248|NCT02873702|9672533|P2|Maintenance Period (up to Month 6)|Adverse Event|0
2824249|NCT02873702|9672534|P1|Maintenance Period (up to Month 6)|Adverse Event|0
2824250|NCT02873702|9672531|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
2824251|NCT02873702|9672532|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
2824252|NCT02873702|9672533|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
2824253|NCT02873702|9672534|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
2824254|NCT02873702|9672531|P4|Healing Period (up to Week 8)|Adverse Event|0
2824255|NCT02873702|9672532|P3|Healing Period (up to Week 8)|Adverse Event|0
2824256|NCT02873702|9672533|P2|Healing Period (up to Week 8)|Adverse Event|0
2824257|NCT02873702|9672534|P1|Healing Period (up to Week 8)|Adverse Event|1
2824258|NCT02873689|9672546|P2|Overall Study|Randomized but not Treated|1
2824259|NCT02873689|9672547|P1|Overall Study|Randomized but not Treated|1
2824260|NCT02873689|9672546|P2|Overall Study|Adverse Event|2
2824261|NCT02873689|9672547|P1|Overall Study|Adverse Event|2
2824262|NCT02873689|9672546|P2|Overall Study|Protocol Violation|0
2824263|NCT02873689|9672547|P1|Overall Study|Protocol Violation|1
2824264|NCT02873689|9672546|P2|Overall Study|Withdrawal by Subject|2
2824265|NCT02873689|9672547|P1|Overall Study|Withdrawal by Subject|2
2824266|NCT02873689|9672546|P2|Overall Study|Lack of Efficacy|0
2824267|NCT02873689|9672547|P1|Overall Study|Lack of Efficacy|1
2824268|NCT02873429|9672575|P2|16 Weeks|Lost to Follow-up|0
2824269|NCT02873429|9672576|P1|16 Weeks|Lost to Follow-up|3
2824270|NCT02873429|9672575|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
2824271|NCT02873429|9672576|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
2824272|NCT02873429|9672575|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
2824273|NCT02873429|9672576|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
2824274|NCT02873377|9672588|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
2824275|NCT02873377|9672589|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
2824276|NCT02873377|9672588|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2824277|NCT02873377|9672589|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2824278|NCT02873221|9672611|P3|Safety Follow-up Period|Withdrawal of Consent|8
2824279|NCT02873221|9672612|P2|Safety Follow-up Period|Withdrawal of Consent|10
2824280|NCT02873221|9672613|P1|Safety Follow-up Period|Withdrawal of Consent|4
2824281|NCT02873221|9672611|P3|Safety Follow-up Period|Lost to Follow-up|5
2824282|NCT02873221|9672612|P2|Safety Follow-up Period|Lost to Follow-up|5
2824283|NCT02873221|9672613|P1|Safety Follow-up Period|Lost to Follow-up|3
2824284|NCT02873221|9672611|P3|Safety Follow-up Period|Protocol Violation|1
2824285|NCT02873221|9672612|P2|Safety Follow-up Period|Protocol Violation|0
2824286|NCT02873221|9672613|P1|Safety Follow-up Period|Protocol Violation|0
2824287|NCT02873221|9672611|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
2824288|NCT02873221|9672612|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
2824289|NCT02873221|9672613|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
2824290|NCT02873221|9672611|P3|Treatment Period|Lost to Follow-up|26
2824291|NCT02873221|9672612|P2|Treatment Period|Lost to Follow-up|30
2824292|NCT02873221|9672613|P1|Treatment Period|Lost to Follow-up|26
2824293|NCT02873221|9672611|P3|Treatment Period|Adverse Event|11
2824294|NCT02873221|9672612|P2|Treatment Period|Adverse Event|9
2824295|NCT02873221|9672613|P1|Treatment Period|Adverse Event|4
2824296|NCT02873221|9672611|P3|Treatment Period|Lack of Efficacy|12
2824297|NCT02873221|9672612|P2|Treatment Period|Lack of Efficacy|17
2824298|NCT02873221|9672613|P1|Treatment Period|Lack of Efficacy|0
2824299|NCT02873221|9672611|P3|Treatment Period|Withdrawal of Consent|41
2824300|NCT02873221|9672612|P2|Treatment Period|Withdrawal of Consent|51
2824301|NCT02873221|9672613|P1|Treatment Period|Withdrawal of Consent|52
2824302|NCT02873221|9672611|P3|Treatment Period|Lack of Qualifying Event|1
2824303|NCT02873221|9672612|P2|Treatment Period|Lack of Qualifying Event|3
2824304|NCT02873221|9672613|P1|Treatment Period|Lack of Qualifying Event|0
2824305|NCT02873221|9672611|P3|Treatment Period|Pregnancy|3
2824306|NCT02873221|9672612|P2|Treatment Period|Pregnancy|6
2824307|NCT02873221|9672613|P1|Treatment Period|Pregnancy|4
2824308|NCT02873221|9672611|P3|Treatment Period|Protocol Violation|8
2824309|NCT02873221|9672612|P2|Treatment Period|Protocol Violation|5
2824310|NCT02873221|9672613|P1|Treatment Period|Protocol Violation|2
2824311|NCT02873221|9672611|P3|Treatment Period|Non-Compliance with Study Drug|2
2824312|NCT02873221|9672612|P2|Treatment Period|Non-Compliance with Study Drug|3
2824313|NCT02873221|9672613|P1|Treatment Period|Non-Compliance with Study Drug|0
2824314|NCT02873221|9672611|P3|Treatment Period|Other Miscellaneous Reasons|1
2824315|NCT02873221|9672612|P2|Treatment Period|Other Miscellaneous Reasons|2
2824316|NCT02873221|9672613|P1|Treatment Period|Other Miscellaneous Reasons|0
2824317|NCT02873195|9672635|P2|Overall Study|Ineligible|0
2824318|NCT02873195|9672636|P1|Overall Study|Ineligible|5
2824319|NCT02872311|9672683|P5|Overall Study|Protocol Violation|0
2824320|NCT02872311|9672684|P4|Overall Study|Protocol Violation|0
2824321|NCT02872311|9672685|P3|Overall Study|Protocol Violation|1
2824322|NCT02872311|9672686|P2|Overall Study|Protocol Violation|2
2824323|NCT02872311|9672687|P1|Overall Study|Protocol Violation|0
2824324|NCT02872311|9672683|P5|Overall Study|Lost to Follow-up|0
2824325|NCT02872311|9672684|P4|Overall Study|Lost to Follow-up|0
2824326|NCT02872311|9672685|P3|Overall Study|Lost to Follow-up|0
2824327|NCT02872311|9672686|P2|Overall Study|Lost to Follow-up|0
2824328|NCT02872311|9672687|P1|Overall Study|Lost to Follow-up|2
2824329|NCT02872311|9672683|P5|Overall Study|Death|0
2824330|NCT02872311|9672684|P4|Overall Study|Death|0
2824331|NCT02872311|9672685|P3|Overall Study|Death|0
2824332|NCT02872311|9672686|P2|Overall Study|Death|0
2824333|NCT02872311|9672687|P1|Overall Study|Death|2
2824334|NCT02872285|9672748|P2|Overall Study|Discontinued due to back surgery|0
2824335|NCT02872285|9672749|P1|Overall Study|Discontinued due to back surgery|1
2824336|NCT02872285|9672748|P2|Overall Study|Lost to Follow-up|2
2824337|NCT02872285|9672749|P1|Overall Study|Lost to Follow-up|2
2824338|NCT02872285|9672748|P2|Overall Study|Withdrawal by Subject|0
2824339|NCT02872285|9672749|P1|Overall Study|Withdrawal by Subject|2
2824340|NCT02872012|9672795|P5|Overall Study|Withdrawal by Subject|0
2824341|NCT02872012|9672796|P4|Overall Study|Withdrawal by Subject|0
2824342|NCT02872012|9672797|P3|Overall Study|Withdrawal by Subject|0
2824343|NCT02872012|9672798|P2|Overall Study|Withdrawal by Subject|0
2824344|NCT02872012|9672799|P1|Overall Study|Withdrawal by Subject|1
2824345|NCT02871739|9672817|P4|Overall Study|Lost to Follow-up|2
2824346|NCT02871739|9672818|P3|Overall Study|Lost to Follow-up|0
2824347|NCT02871739|9672819|P2|Overall Study|Lost to Follow-up|2
2824348|NCT02871739|9672820|P1|Overall Study|Lost to Follow-up|3
2824349|NCT02871375|9672896|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
2824350|NCT02871375|9672897|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
2824351|NCT02870933|9672927|P2|Overall Study|Withdrawal by Subject|1
2824352|NCT02870933|9672928|P1|Overall Study|Withdrawal by Subject|0
2824353|NCT02870933|9672927|P2|Overall Study|Death|1
2824354|NCT02870933|9672928|P1|Overall Study|Death|2
2824355|NCT02869438|9673006|P2|Overall Study|Withdrawal by Subject|2
2824356|NCT02869438|9673007|P1|Overall Study|Withdrawal by Subject|1
2824357|NCT02869438|9673006|P2|Overall Study|Adverse Event|0
2824358|NCT02869438|9673007|P1|Overall Study|Adverse Event|1
2824359|NCT02869438|9673006|P2|Overall Study|Lost to Follow-up|0
2824360|NCT02869438|9673007|P1|Overall Study|Lost to Follow-up|1
2824361|NCT02868892|9673055|P1|Overall Study|Investigator left site and no follow-up|6
2824362|NCT02868554|9673064|P3|Overall Study|Lost to Follow-up|1
2824363|NCT02868554|9673065|P2|Overall Study|Lost to Follow-up|0
2824364|NCT02868554|9673066|P1|Overall Study|Lost to Follow-up|3
2824365|NCT02868216|9673101|P2|Overall Study|Withdrawal by Subject|5
2824366|NCT02868216|9673102|P1|Overall Study|Withdrawal by Subject|7
2824367|NCT02868216|9673101|P2|Overall Study|coronary artery bypass|0
2824368|NCT02868216|9673102|P1|Overall Study|coronary artery bypass|1
2824369|NCT02868216|9673101|P2|Overall Study|Death|1
2824370|NCT02868216|9673102|P1|Overall Study|Death|0
2824371|NCT02867995|9673110|P2|Overall Study|Lost to Follow-up|2
2824372|NCT02867995|9673111|P1|Overall Study|Lost to Follow-up|0
2824373|NCT02867995|9673110|P2|Overall Study|Withdrawal by Subject|1
2824374|NCT02867995|9673111|P1|Overall Study|Withdrawal by Subject|0
2824375|NCT02867709|9673130|P3|Safety Follow-up Period|Protocol Violation|1
2824376|NCT02867709|9673131|P2|Safety Follow-up Period|Protocol Violation|1
2824377|NCT02867709|9673132|P1|Safety Follow-up Period|Protocol Violation|0
2824378|NCT02867709|9673130|P3|Safety Follow-up Period|Pregnancy|0
2824379|NCT02867709|9673131|P2|Safety Follow-up Period|Pregnancy|1
2824380|NCT02867709|9673132|P1|Safety Follow-up Period|Pregnancy|0
2824381|NCT02867709|9673130|P3|Safety Follow-up Period|Lost to Follow-up|7
2824382|NCT02867709|9673131|P2|Safety Follow-up Period|Lost to Follow-up|5
2824383|NCT02867709|9673132|P1|Safety Follow-up Period|Lost to Follow-up|10
2824384|NCT02867709|9673130|P3|Safety Follow-up Period|Withdrawal of Consent|6
2824385|NCT02867709|9673131|P2|Safety Follow-up Period|Withdrawal of Consent|8
2824386|NCT02867709|9673132|P1|Safety Follow-up Period|Withdrawal of Consent|1
2824387|NCT02867709|9673130|P3|Treatment Period|Protocol Violation|3
2824388|NCT02867709|9673131|P2|Treatment Period|Protocol Violation|2
2824389|NCT02867709|9673132|P1|Treatment Period|Protocol Violation|3
2824390|NCT02867709|9673130|P3|Treatment Period|Lack of Qualifying Event|42
2824391|NCT02867709|9673131|P2|Treatment Period|Lack of Qualifying Event|55
2824392|NCT02867709|9673132|P1|Treatment Period|Lack of Qualifying Event|42
2824393|NCT02867709|9673130|P3|Treatment Period|Lost to Follow-up|20
2824394|NCT02867709|9673131|P2|Treatment Period|Lost to Follow-up|20
2824395|NCT02867709|9673132|P1|Treatment Period|Lost to Follow-up|17
2824396|NCT02867709|9673130|P3|Treatment Period|Withdrawal of Consent|8
2824397|NCT02867709|9673131|P2|Treatment Period|Withdrawal of Consent|9
2824398|NCT02867709|9673132|P1|Treatment Period|Withdrawal of Consent|7
2824399|NCT02867709|9673130|P3|Treatment Period|Adverse Event|2
2824400|NCT02867709|9673131|P2|Treatment Period|Adverse Event|1
2824401|NCT02867709|9673132|P1|Treatment Period|Adverse Event|1
2824402|NCT02866942|9673189|P1|Overall Study|Invalid consent|1
2824403|NCT02866695|9673194|P1|Overall Study|Lost to Follow-up|1
2824404|NCT02866695|9673194|P1|Overall Study|Adverse Event|1
2824405|NCT02866175|9673202|P2|Overall Study|Did not receive treatment|15
2824406|NCT02866175|9673203|P1|Overall Study|Did not receive treatment|5
2824407|NCT02866175|9673202|P2|Overall Study|Physician Decision|15
2824408|NCT02866175|9673203|P1|Overall Study|Physician Decision|3
2824409|NCT02866175|9673202|P2|Overall Study|Lack of Efficacy|1
2824410|NCT02866175|9673203|P1|Overall Study|Lack of Efficacy|0
2824411|NCT02866175|9673202|P2|Overall Study|Lost to Follow-up|0
2824412|NCT02866175|9673203|P1|Overall Study|Lost to Follow-up|2
2824413|NCT02866175|9673202|P2|Overall Study|Progressive disease|1
2824414|NCT02866175|9673203|P1|Overall Study|Progressive disease|1
2824415|NCT02866175|9673202|P2|Overall Study|Other|14
2824416|NCT02866175|9673203|P1|Overall Study|Other|7
2824417|NCT02866175|9673202|P2|Overall Study|Death|23
2824418|NCT02866175|9673203|P1|Overall Study|Death|30
2824419|NCT02866175|9673202|P2|Overall Study|Withdrawal by Subject|52
2824420|NCT02866175|9673203|P1|Overall Study|Withdrawal by Subject|31
2824421|NCT02866175|9673202|P2|Overall Study|Adverse Event|54
2824422|NCT02866175|9673203|P1|Overall Study|Adverse Event|56
2824423|NCT02865499|9673256|P1|Baseline|Withdrawal by Subject|1
2824424|NCT02865499|9673256|P1|Baseline|Adverse Event|1
2824425|NCT02865395|9673263|P3|Overall Study|Physician Decision|7
2824426|NCT02865395|9673264|P2|Overall Study|Physician Decision|10
2824427|NCT02865395|9673265|P1|Overall Study|Physician Decision|6
2824428|NCT02865083|9673278|P2|Overall Study|Early Termination|1
2824429|NCT02865083|9673279|P1|Overall Study|Early Termination|3
2824430|NCT02864342|9673340|P2|Overall Study|Adverse Event|0
2824431|NCT02864342|9673341|P1|Overall Study|Adverse Event|1
2824432|NCT02864342|9673340|P2|Overall Study|Lost Device|0
2824433|NCT02864342|9673341|P1|Overall Study|Lost Device|1
2824434|NCT02864342|9673340|P2|Overall Study|Lost to Follow-up|5
2824435|NCT02864342|9673341|P1|Overall Study|Lost to Follow-up|1
2824436|NCT02864342|9673340|P2|Overall Study|Did Not Start Treatment with Symbicort|1
2824437|NCT02864342|9673341|P1|Overall Study|Did Not Start Treatment with Symbicort|0
2824438|NCT02864342|9673340|P2|Overall Study|Death|1
2824439|NCT02864342|9673341|P1|Overall Study|Death|0
2824440|NCT02864342|9673340|P2|Overall Study|Device Technology Issue|7
2824441|NCT02864342|9673341|P1|Overall Study|Device Technology Issue|6
2824442|NCT02864342|9673340|P2|Overall Study|Withdrawal by Subject|2
2824443|NCT02864342|9673341|P1|Overall Study|Withdrawal by Subject|4
2824444|NCT02864342|9673340|P2|Overall Study|Eligibility Criteria Deviation|3
2824445|NCT02864342|9673341|P1|Overall Study|Eligibility Criteria Deviation|2
2824446|NCT02864316|9673358|P2|Overall Study|Adverse Event|1
2824447|NCT02864316|9673359|P1|Overall Study|Adverse Event|0
2824448|NCT02864316|9673358|P2|Overall Study|Progressive Disease|1
2824449|NCT02864316|9673359|P1|Overall Study|Progressive Disease|2
2824450|NCT02863575|9673397|P3|Overall Study|Adverse Event|0
2824451|NCT02863575|9673398|P2|Overall Study|Adverse Event|1
2824452|NCT02863575|9673399|P1|Overall Study|Adverse Event|0
2824453|NCT02863575|9673397|P3|Overall Study|Withdrawal by Subject|1
2824454|NCT02863575|9673398|P2|Overall Study|Withdrawal by Subject|1
2824455|NCT02863575|9673399|P1|Overall Study|Withdrawal by Subject|0
2824456|NCT02863575|9673397|P3|Overall Study|Participants Unable To Swallow Capsule|0
2824457|NCT02863575|9673398|P2|Overall Study|Participants Unable To Swallow Capsule|0
2824458|NCT02863575|9673399|P1|Overall Study|Participants Unable To Swallow Capsule|1
2824459|NCT02863419|9673451|P3|Overall Study|Died|1
2824460|NCT02863419|9673452|P2|Overall Study|Died|4
2824461|NCT02863419|9673453|P1|Overall Study|Died|3
2824462|NCT02863419|9673451|P3|Overall Study|Withdrawal by Subject|3
2824463|NCT02863419|9673452|P2|Overall Study|Withdrawal by Subject|5
2824464|NCT02863419|9673453|P1|Overall Study|Withdrawal by Subject|5
2824465|NCT02863419|9673451|P3|Overall Study|Lost to Follow-up|4
2824466|NCT02863419|9673452|P2|Overall Study|Lost to Follow-up|1
2824467|NCT02863419|9673453|P1|Overall Study|Lost to Follow-up|0
2824468|NCT02863328|9673570|P2|Overall Study|Died|1
2824469|NCT02863328|9673571|P1|Overall Study|Died|0
2824470|NCT02863328|9673570|P2|Overall Study|Withdrawal by Subject|12
2824471|NCT02863328|9673571|P1|Overall Study|Withdrawal by Subject|7
2824472|NCT02863328|9673570|P2|Overall Study|Lost to Follow-up|10
2824473|NCT02863328|9673571|P1|Overall Study|Lost to Follow-up|4
2824474|NCT02862730|9673726|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824475|NCT02862730|9673727|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824476|NCT02862730|9673728|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824477|NCT02862730|9673729|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
2824478|NCT02862730|9673730|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824479|NCT02862730|9673731|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824480|NCT02862730|9673732|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2824481|NCT02862730|9673726|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2824482|NCT02862730|9673727|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2824483|NCT02862730|9673728|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2824484|NCT02862730|9673729|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2824485|NCT02862730|9673730|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2824486|NCT02862730|9673731|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2824487|NCT02862730|9673732|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2824488|NCT02862730|9673726|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824489|NCT02862730|9673727|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824490|NCT02862730|9673728|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824491|NCT02862730|9673729|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824492|NCT02862730|9673730|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824493|NCT02862730|9673731|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
2824494|NCT02862730|9673732|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
2824495|NCT02862730|9673726|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824496|NCT02862730|9673727|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824497|NCT02862730|9673728|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824498|NCT02862730|9673729|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824499|NCT02862730|9673730|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
2824500|NCT02862730|9673731|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824501|NCT02862730|9673732|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2824502|NCT02862600|9673787|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
2824503|NCT02862600|9673787|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
2824504|NCT02862600|9673787|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
2824505|NCT02862600|9673787|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
2824506|NCT02862574|9673797|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
2824507|NCT02862574|9673798|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
2824508|NCT02862574|9673799|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
2824509|NCT02862574|9673797|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
2824510|NCT02862574|9673798|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
2824511|NCT02862574|9673799|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
2824512|NCT02862574|9673797|P3|Double-Blind Treatment Period|Adverse Event|0
2824513|NCT02862574|9673798|P2|Double-Blind Treatment Period|Adverse Event|1
2824514|NCT02862574|9673799|P1|Double-Blind Treatment Period|Adverse Event|0
2824515|NCT02862548|9673819|P2|Open-Label Extension Phase|Still on Study|24
2824516|NCT02862548|9673820|P1|Open-Label Extension Phase|Still on Study|26
2824517|NCT02862548|9673819|P2|Open-Label Phase|Death|1
2824518|NCT02862548|9673820|P1|Open-Label Phase|Death|0
2824519|NCT02862106|9673850|P2|Overall Study|Subjects moved to other city|0
2824520|NCT02862106|9673851|P1|Overall Study|Subjects moved to other city|1
2824521|NCT02862106|9673850|P2|Overall Study|Withdrawal by Subject|0
2824522|NCT02862106|9673851|P1|Overall Study|Withdrawal by Subject|2
2824523|NCT02862106|9673850|P2|Overall Study|Lost to Follow-up|5
2824524|NCT02862106|9673851|P1|Overall Study|Lost to Follow-up|15
2824525|NCT02862106|9673850|P2|Overall Study|Protocol Violation|1
2824526|NCT02862106|9673851|P1|Overall Study|Protocol Violation|16
2824527|NCT02862106|9673850|P2|Overall Study|Adverse Event|0
2824528|NCT02862106|9673851|P1|Overall Study|Adverse Event|4
2824529|NCT02861807|9673911|P2|Overall Study|Withdrawal by Subject|8
2824530|NCT02861807|9673912|P1|Overall Study|Withdrawal by Subject|5
2824531|NCT02861807|9673911|P2|Overall Study|Lost to Follow-up|6
2824532|NCT02861807|9673912|P1|Overall Study|Lost to Follow-up|7
2824533|NCT02861664|9673928|P2|Overall Study|Withdrawal of Consent|1
2824534|NCT02861664|9673929|P1|Overall Study|Withdrawal of Consent|0
2824535|NCT02860169|9674003|P1|Part C|Other (Screening failure)|1
2824536|NCT02860169|9674003|P1|Part B|Withdrawal by Subject|1
2824537|NCT02860169|9674003|P1|Part B|Other (Screening failure)|10
2824538|NCT02860169|9674003|P1|Part A|Other (did not completed consent)|1
2824539|NCT02860169|9674003|P1|Part A|Other (Survey not completed)|3
2824540|NCT02860169|9674003|P1|Part A|Other (Screening failure)|6
2824541|NCT02860169|9674003|P1|Part A|Withdrawal by Subject|1
2824542|NCT02859454|9674032|P1|Overall Study|PI discretion/off study prior to trtmt|1
2824543|NCT02859246|9674043|P1|Overall Study|Withdrawal by Subject|1
2824544|NCT02859246|9674043|P1|Overall Study|Adverse Event|1
2824545|NCT02859246|9674043|P1|Overall Study|Screen fails|3
2824546|NCT02858492|9674065|P4|Overall Study|Protocol defined stopping criteria|1
2824547|NCT02858492|9674066|P3|Overall Study|Protocol defined stopping criteria|0
2824548|NCT02858492|9674067|P2|Overall Study|Protocol defined stopping criteria|0
2824549|NCT02858492|9674068|P1|Overall Study|Protocol defined stopping criteria|0
2824550|NCT02858492|9674065|P4|Overall Study|Lack of Efficacy|1
2824551|NCT02858492|9674066|P3|Overall Study|Lack of Efficacy|0
2824552|NCT02858492|9674067|P2|Overall Study|Lack of Efficacy|0
2824553|NCT02858492|9674068|P1|Overall Study|Lack of Efficacy|0
2824554|NCT02858492|9674065|P4|Overall Study|Adverse Event|3
2824555|NCT02858492|9674066|P3|Overall Study|Adverse Event|0
2824556|NCT02858492|9674067|P2|Overall Study|Adverse Event|0
2824557|NCT02858492|9674068|P1|Overall Study|Adverse Event|0
2824558|NCT02858492|9674065|P4|Overall Study|Withdrawal by Subject|1
2824559|NCT02858492|9674066|P3|Overall Study|Withdrawal by Subject|0
2824560|NCT02858492|9674067|P2|Overall Study|Withdrawal by Subject|1
2824561|NCT02858492|9674068|P1|Overall Study|Withdrawal by Subject|0
2824562|NCT02858440|9674244|P1|Overall Study|Migrated/moved from study area|4
2824563|NCT02858440|9674244|P1|Overall Study|Consent withdrawal|3
2824564|NCT02858440|9674244|P1|Overall Study|Protocol Violation|2
2824565|NCT02858440|9674244|P1|Overall Study|Lost to Follow-up|3
2824566|NCT02858401|9674277|P7|Overall Study|Lost to Follow-up|0
2824567|NCT02858401|9674278|P6|Overall Study|Lost to Follow-up|0
2824568|NCT02858401|9674279|P5|Overall Study|Lost to Follow-up|0
2824569|NCT02858401|9674280|P4|Overall Study|Lost to Follow-up|0
2824570|NCT02858401|9674281|P3|Overall Study|Lost to Follow-up|0
2824571|NCT02858401|9674282|P2|Overall Study|Lost to Follow-up|1
2824572|NCT02858401|9674283|P1|Overall Study|Lost to Follow-up|0
2824573|NCT02858401|9674277|P7|Overall Study|Withdrew Consent|0
2824574|NCT02858401|9674278|P6|Overall Study|Withdrew Consent|1
2824575|NCT02858401|9674279|P5|Overall Study|Withdrew Consent|0
2824576|NCT02858401|9674280|P4|Overall Study|Withdrew Consent|0
2824577|NCT02858401|9674281|P3|Overall Study|Withdrew Consent|0
2824578|NCT02858401|9674282|P2|Overall Study|Withdrew Consent|0
2824579|NCT02858401|9674283|P1|Overall Study|Withdrew Consent|0
2824580|NCT02858362|9674694|P3|Overall Study|Lost to Follow-up|0
2824581|NCT02858362|9674695|P2|Overall Study|Lost to Follow-up|0
2824582|NCT02858362|9674696|P1|Overall Study|Lost to Follow-up|1
2824583|NCT02858362|9674694|P3|Overall Study|Early Study Termination|3
2824584|NCT02858362|9674695|P2|Overall Study|Early Study Termination|0
2824585|NCT02858362|9674696|P1|Overall Study|Early Study Termination|0
2824586|NCT02858362|9674694|P3|Overall Study|Withdrawal by Subject|0
2824587|NCT02858362|9674695|P2|Overall Study|Withdrawal by Subject|0
2824588|NCT02858362|9674696|P1|Overall Study|Withdrawal by Subject|1
2824589|NCT02858362|9674694|P3|Overall Study|Protocol Violation|0
2824590|NCT02858362|9674695|P2|Overall Study|Protocol Violation|1
2824591|NCT02858362|9674696|P1|Overall Study|Protocol Violation|0
2824592|NCT02858180|9674737|P2|Overall Study|Lost to Follow-up|2
2824593|NCT02858180|9674738|P1|Overall Study|Lost to Follow-up|0
2824594|NCT02857816|9674759|P1|Overall Study|Lost to Follow-up|1
2824595|NCT02857816|9674759|P1|Overall Study|Withdrawal by Subject|4
2824596|NCT02857816|9674759|P1|Overall Study|Screen Failure|33
2824597|NCT02857283|9674767|P2|First Exposure|Withdrawal by Subject|0
2824598|NCT02857283|9674768|P1|First Exposure|Withdrawal by Subject|1
2824599|NCT02856880|9674794|P1|Overall Study|Withdrawal of consent|1
2824600|NCT02856282|9674835|P1|Overall Study|Withdrawal by Subject|1
2824601|NCT02855541|9674867|P1|Overall Study|Withdrawal by Subject|2
2824602|NCT02855541|9674867|P1|Overall Study|Change in health status|2
2824603|NCT02855411|9674887|P1|Overall Study|Does not meet entrance criteria|14
2824604|NCT02855411|9674887|P1|Overall Study|Study terminated by sponsor|21
2824605|NCT02855359|9674909|P4|Overall Study|Study Termination by Sponsor|0
2824606|NCT02855359|9674910|P3|Overall Study|Study Termination by Sponsor|0
2824607|NCT02855359|9674911|P2|Overall Study|Study Termination by Sponsor|11
2824608|NCT02855359|9674912|P1|Overall Study|Study Termination by Sponsor|9
2824609|NCT02855359|9674909|P4|Overall Study|Death|0
2824610|NCT02855359|9674910|P3|Overall Study|Death|0
2824611|NCT02855359|9674911|P2|Overall Study|Death|2
2824612|NCT02855359|9674912|P1|Overall Study|Death|2
2824613|NCT02854631|9674957|P2|Overall Study|Lost to Follow-up|2
2824614|NCT02854631|9674958|P1|Overall Study|Lost to Follow-up|4
2824615|NCT02854631|9674957|P2|Overall Study|Subjects Randomized but Never Treated|0
2824616|NCT02854631|9674958|P1|Overall Study|Subjects Randomized but Never Treated|2
2824617|NCT02854631|9674957|P2|Overall Study|Protocol Violation|1
2824618|NCT02854631|9674958|P1|Overall Study|Protocol Violation|0
2824619|NCT02854631|9674957|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
2824620|NCT02854631|9674958|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
2824621|NCT02854631|9674957|P2|Overall Study|Death|8
2824622|NCT02854631|9674958|P1|Overall Study|Death|12
2824623|NCT02854631|9674957|P2|Overall Study|Investigator's Discretion|0
2824624|NCT02854631|9674958|P1|Overall Study|Investigator's Discretion|2
2824625|NCT02854631|9674957|P2|Overall Study|Withdrew Consent|2
2824626|NCT02854631|9674958|P1|Overall Study|Withdrew Consent|3
2824627|NCT02854631|9674957|P2|Overall Study|Adverse Event|2
2824628|NCT02854631|9674958|P1|Overall Study|Adverse Event|1
2824629|NCT02854605|9675019|P3|Overall Study|Protocol Violation|1
2824630|NCT02854605|9675020|P2|Overall Study|Protocol Violation|0
2824631|NCT02854605|9675021|P1|Overall Study|Protocol Violation|0
2824632|NCT02854605|9675019|P3|Overall Study|Investigator's Discretion|0
2824633|NCT02854605|9675020|P2|Overall Study|Investigator's Discretion|0
2824634|NCT02854605|9675021|P1|Overall Study|Investigator's Discretion|1
2824635|NCT02854605|9675019|P3|Overall Study|Withdrew Consent|1
2824636|NCT02854605|9675020|P2|Overall Study|Withdrew Consent|0
2824637|NCT02854605|9675021|P1|Overall Study|Withdrew Consent|1
2824638|NCT02854605|9675019|P3|Overall Study|Lost to Follow-up|0
2824639|NCT02854605|9675020|P2|Overall Study|Lost to Follow-up|2
2824640|NCT02854605|9675021|P1|Overall Study|Lost to Follow-up|0
2824641|NCT02854605|9675019|P3|Overall Study|Adverse Event|2
2824642|NCT02854605|9675020|P2|Overall Study|Adverse Event|5
2824643|NCT02854605|9675021|P1|Overall Study|Adverse Event|1
2824644|NCT02854527|9675051|P10|Overall Study|Lost to Follow-up|0
2824645|NCT02854527|9675052|P9|Overall Study|Lost to Follow-up|0
2824646|NCT02854527|9675053|P8|Overall Study|Lost to Follow-up|0
2824647|NCT02854527|9675054|P7|Overall Study|Lost to Follow-up|0
2824648|NCT02854527|9675055|P6|Overall Study|Lost to Follow-up|0
2824649|NCT02854527|9675056|P5|Overall Study|Lost to Follow-up|0
2824650|NCT02854527|9675057|P4|Overall Study|Lost to Follow-up|1
2824651|NCT02854527|9675058|P3|Overall Study|Lost to Follow-up|0
2824652|NCT02854527|9675059|P2|Overall Study|Lost to Follow-up|0
2824653|NCT02854527|9675060|P1|Overall Study|Lost to Follow-up|0
2824654|NCT02854527|9675051|P10|Overall Study|Adverse Event|0
2824655|NCT02854527|9675052|P9|Overall Study|Adverse Event|0
2824656|NCT02854527|9675053|P8|Overall Study|Adverse Event|0
2824657|NCT02854527|9675054|P7|Overall Study|Adverse Event|0
2824658|NCT02854527|9675055|P6|Overall Study|Adverse Event|0
2824659|NCT02854527|9675056|P5|Overall Study|Adverse Event|1
2824660|NCT02854527|9675057|P4|Overall Study|Adverse Event|0
2824661|NCT02854527|9675058|P3|Overall Study|Adverse Event|0
2824662|NCT02854527|9675059|P2|Overall Study|Adverse Event|0
2824663|NCT02854527|9675060|P1|Overall Study|Adverse Event|0
2824664|NCT02853929|9675118|P2|Overall Study|Subjects enrolled but not vaccinated|4
2824665|NCT02853929|9675119|P1|Overall Study|Subjects enrolled but not vaccinated|7
2824666|NCT02853929|9675118|P2|Overall Study|Withdrawal by Subject|0
2824667|NCT02853929|9675119|P1|Overall Study|Withdrawal by Subject|1
2824668|NCT02853929|9675118|P2|Overall Study|Lost to Follow-up|0
2824669|NCT02853929|9675119|P1|Overall Study|Lost to Follow-up|3
2824670|NCT02853435|9675160|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2824671|NCT02853435|9675161|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
2824672|NCT02853435|9675162|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2824673|NCT02853435|9675163|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2824674|NCT02853435|9675164|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2824675|NCT02853435|9675165|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2824676|NCT02853331|9675475|P2|Overall Study|Ongoing in study|325
2824677|NCT02853331|9675476|P1|Overall Study|Ongoing in study|368
2824678|NCT02853331|9675475|P2|Overall Study|Withdrawal by Subject|9
2824679|NCT02853331|9675476|P1|Overall Study|Withdrawal by Subject|5
2824680|NCT02853331|9675475|P2|Overall Study|Death|95
2824681|NCT02853331|9675476|P1|Overall Study|Death|59
2824682|NCT02853123|9675508|P2|Washout Period|Adverse Event|0
2824683|NCT02853123|9675509|P1|Washout Period|Adverse Event|1
2824684|NCT02853123|9675508|P2|Washout Period|Worsening of COPD|3
2824685|NCT02853123|9675509|P1|Washout Period|Worsening of COPD|0
2824686|NCT02853123|9675508|P2|Treatment Period 1|Adverse Event|3
2824687|NCT02853123|9675509|P1|Treatment Period 1|Adverse Event|0
2824688|NCT02852434|9675532|P2|Overall Study|Unsuccessful Dilator Procedure|0
2824689|NCT02852434|9675533|P1|Overall Study|Unsuccessful Dilator Procedure|2
2824690|NCT02852434|9675532|P2|Overall Study|Withdrawal by Subject|1
2824691|NCT02852434|9675533|P1|Overall Study|Withdrawal by Subject|0
2824692|NCT02852265|9675549|P2|3-month Follow-up|Lost to Follow-up|1
2824693|NCT02852265|9675550|P1|3-month Follow-up|Lost to Follow-up|1
2824694|NCT02851069|9675583|P1|Overall Study|Other|3
2824695|NCT02851069|9675583|P1|Overall Study|Failure to Return|3
2824696|NCT02850978|9675605|P1|Overall Study|Reason not listed|88
2824697|NCT02850978|9675605|P1|Overall Study|Lost to Follow-up|121
2824698|NCT02850978|9675605|P1|Overall Study|Improvement in condition|34
2824699|NCT02850978|9675605|P1|Overall Study|Lack of Efficacy|40
2824700|NCT02850978|9675605|P1|Overall Study|Adverse Event|81
2824701|NCT02850978|9675605|P1|Overall Study|No visit since the first visit|35
2824702|NCT02850978|9675605|P1|Overall Study|Uncollectable CRF|27
2824703|NCT02850965|9675612|P2|Overall Study|Randomized but not treated|1
2824704|NCT02850965|9675613|P1|Overall Study|Randomized but not treated|0
2824705|NCT02850965|9675612|P2|Overall Study|Physician Decision|1
2824706|NCT02850965|9675613|P1|Overall Study|Physician Decision|0
2824707|NCT02850965|9675612|P2|Overall Study|Withdrawal by Subject|4
2824708|NCT02850965|9675613|P1|Overall Study|Withdrawal by Subject|3
2824709|NCT02850965|9675612|P2|Overall Study|Adverse Event|2
2824710|NCT02850965|9675613|P1|Overall Study|Adverse Event|3
2824711|NCT02850965|9675612|P2|Overall Study|Lack of Efficacy|8
2824712|NCT02850965|9675613|P1|Overall Study|Lack of Efficacy|4
2824713|NCT02850965|9675612|P2|Overall Study|Lost to Follow-up|3
2824714|NCT02850965|9675613|P1|Overall Study|Lost to Follow-up|5
2824715|NCT02850965|9675612|P2|Overall Study|Protocol Violation|2
2824716|NCT02850965|9675613|P1|Overall Study|Protocol Violation|0
2824717|NCT02850965|9675612|P2|Overall Study|Other than listed|4
2824718|NCT02850965|9675613|P1|Overall Study|Other than listed|3
2824719|NCT02850276|9675629|P1|Overall Study|Lost to Follow-up|2
2824720|NCT02850276|9675629|P1|Overall Study|Physician Decision|2
2824721|NCT02850276|9675629|P1|Overall Study|Withdrawal by Subject|14
2824722|NCT02850276|9675629|P1|Overall Study|screen failure|43
2824723|NCT02849990|9675656|P1|Overall Study|Withdrawal by Subject|1
2824724|NCT02849990|9675656|P1|Overall Study|Adverse Event|1
2824725|NCT02849704|9675681|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
2824726|NCT02849704|9675682|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
2824727|NCT02849704|9675681|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
2824728|NCT02849704|9675682|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
2824729|NCT02849704|9675681|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
2824730|NCT02849704|9675682|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
2824731|NCT02849678|9675697|P2|Overall Study|Protocol Violation|6
2824732|NCT02849678|9675698|P1|Overall Study|Protocol Violation|3
2824733|NCT02849626|9675718|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
2824734|NCT02849626|9675719|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
2824735|NCT02849626|9675718|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
2824736|NCT02849626|9675719|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
2824737|NCT02849626|9675718|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
2824738|NCT02849626|9675719|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
2824739|NCT02849626|9675718|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
2824740|NCT02849626|9675719|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
2824741|NCT02849626|9675718|P2|Core Phase (up to 23 Weeks)|Non-specified|0
2824742|NCT02849626|9675719|P1|Core Phase (up to 23 Weeks)|Non-specified|3
2824743|NCT02849626|9675718|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
2824744|NCT02849626|9675719|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
2824745|NCT02849626|9675718|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
2824746|NCT02849626|9675719|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
2824747|NCT02849626|9675718|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
2824748|NCT02849626|9675719|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
2824749|NCT02849509|9675782|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
2824750|NCT02849509|9675783|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
2824751|NCT02849509|9675784|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
2824752|NCT02849509|9675782|P3|Overall Study|Other, reason not specified|25
2824753|NCT02849509|9675783|P2|Overall Study|Other, reason not specified|29
2824754|NCT02849509|9675784|P1|Overall Study|Other, reason not specified|14
2824755|NCT02849509|9675782|P3|Overall Study|Lost to Follow-up|36
2824756|NCT02849509|9675783|P2|Overall Study|Lost to Follow-up|67
2824757|NCT02849509|9675784|P1|Overall Study|Lost to Follow-up|27
2824758|NCT02849509|9675782|P3|Overall Study|Withdrawal by Subject|12
2824759|NCT02849509|9675783|P2|Overall Study|Withdrawal by Subject|17
2824760|NCT02849509|9675784|P1|Overall Study|Withdrawal by Subject|6
2824761|NCT02849509|9675782|P3|Overall Study|Other adverse event|8
2824762|NCT02849509|9675783|P2|Overall Study|Other adverse event|41
2824763|NCT02849509|9675784|P1|Overall Study|Other adverse event|36
2824764|NCT02849509|9675782|P3|Overall Study|Worsening of other pre-existing disease|2
2824765|NCT02849509|9675783|P2|Overall Study|Worsening of other pre-existing disease|1
2824766|NCT02849509|9675784|P1|Overall Study|Worsening of other pre-existing disease|0
2824767|NCT02849509|9675782|P3|Overall Study|Worsening of disease under study|1
2824768|NCT02849509|9675783|P2|Overall Study|Worsening of disease under study|1
2824769|NCT02849509|9675784|P1|Overall Study|Worsening of disease under study|1
2824770|NCT02849080|9675991|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2824771|NCT02849080|9675992|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2824772|NCT02849080|9675993|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2824773|NCT02849080|9675994|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
2824774|NCT02849080|9675991|P4|Extension Phase: 53 - 104 Weeks|Other|0
2824775|NCT02849080|9675992|P3|Extension Phase: 53 - 104 Weeks|Other|1
2824776|NCT02849080|9675993|P2|Extension Phase: 53 - 104 Weeks|Other|0
2824777|NCT02849080|9675994|P1|Extension Phase: 53 - 104 Weeks|Other|0
2824778|NCT02849080|9675991|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2824779|NCT02849080|9675992|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2824780|NCT02849080|9675993|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2824781|NCT02849080|9675994|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
2824782|NCT02849080|9675991|P4|Main Phase: 0 - 52 Weeks|Death|0
2824783|NCT02849080|9675992|P3|Main Phase: 0 - 52 Weeks|Death|0
2824784|NCT02849080|9675993|P2|Main Phase: 0 - 52 Weeks|Death|2
2824785|NCT02849080|9675994|P1|Main Phase: 0 - 52 Weeks|Death|0
2824786|NCT02849080|9675991|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2824787|NCT02849080|9675992|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2824788|NCT02849080|9675993|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
2824789|NCT02849080|9675994|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
2824790|NCT02849080|9675991|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2824791|NCT02849080|9675992|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2824792|NCT02849080|9675993|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
2824793|NCT02849080|9675994|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
2824794|NCT02848729|9676121|P2|Overall Study|Emesis|11
2824795|NCT02848729|9676122|P1|Overall Study|Emesis|15
2824796|NCT02848729|9676121|P2|Overall Study|Withdrawal by Subject|0
2824797|NCT02848729|9676122|P1|Overall Study|Withdrawal by Subject|1
2824798|NCT02848664|9676139|P1|Overall Study|no assistance for device training|1
2824799|NCT02848664|9676139|P1|Overall Study|Adverse Event|1
2824800|NCT02848664|9676139|P1|Overall Study|Withdrawal by Subject|2
2824801|NCT02848651|9676147|P1|Overall Study|Withdrawal by Subject|14
2824802|NCT02848651|9676147|P1|Overall Study|Physician Decision|4
2824803|NCT02848651|9676147|P1|Overall Study|Symptomatic Deterioration|1
2824804|NCT02848651|9676147|P1|Overall Study|Non-Compliance|1
2824805|NCT02848651|9676147|P1|Overall Study|Lost to Follow-up|1
2824806|NCT02848651|9676147|P1|Overall Study|Death|85
2824807|NCT02848326|9676180|P6|Safety Follow-up Period|Lost to Follow-up|3
2824808|NCT02848326|9676181|P5|Safety Follow-up Period|Lost to Follow-up|1
2824809|NCT02848326|9676182|P4|Safety Follow-up Period|Lost to Follow-up|0
2824810|NCT02848326|9676183|P3|Safety Follow-up Period|Lost to Follow-up|2
2824811|NCT02848326|9676184|P2|Safety Follow-up Period|Lost to Follow-up|0
2824812|NCT02848326|9676185|P1|Safety Follow-up Period|Lost to Follow-up|4
2824813|NCT02848326|9676180|P6|Safety Follow-up Period|Withdrawal of Consent|2
2824814|NCT02848326|9676181|P5|Safety Follow-up Period|Withdrawal of Consent|0
2824815|NCT02848326|9676182|P4|Safety Follow-up Period|Withdrawal of Consent|0
2824816|NCT02848326|9676183|P3|Safety Follow-up Period|Withdrawal of Consent|1
2824817|NCT02848326|9676184|P2|Safety Follow-up Period|Withdrawal of Consent|1
2824818|NCT02848326|9676185|P1|Safety Follow-up Period|Withdrawal of Consent|0
2824819|NCT02848326|9676180|P6|Treatment Period|Non-compliance with Study Drug|0
2824820|NCT02848326|9676181|P5|Treatment Period|Non-compliance with Study Drug|0
2824821|NCT02848326|9676182|P4|Treatment Period|Non-compliance with Study Drug|1
2824822|NCT02848326|9676183|P3|Treatment Period|Non-compliance with Study Drug|0
2824823|NCT02848326|9676184|P2|Treatment Period|Non-compliance with Study Drug|0
2824824|NCT02848326|9676185|P1|Treatment Period|Non-compliance with Study Drug|4
2824825|NCT02848326|9676180|P6|Treatment Period|Protocol Violation|3
2824826|NCT02848326|9676181|P5|Treatment Period|Protocol Violation|3
2824827|NCT02848326|9676182|P4|Treatment Period|Protocol Violation|2
2824828|NCT02848326|9676183|P3|Treatment Period|Protocol Violation|4
2824829|NCT02848326|9676184|P2|Treatment Period|Protocol Violation|3
2824830|NCT02848326|9676185|P1|Treatment Period|Protocol Violation|4
2824831|NCT02848326|9676180|P6|Treatment Period|Pregnancy|1
2824832|NCT02848326|9676181|P5|Treatment Period|Pregnancy|0
2824833|NCT02848326|9676182|P4|Treatment Period|Pregnancy|1
2824834|NCT02848326|9676183|P3|Treatment Period|Pregnancy|1
2824835|NCT02848326|9676184|P2|Treatment Period|Pregnancy|0
2824836|NCT02848326|9676185|P1|Treatment Period|Pregnancy|0
2824837|NCT02848326|9676180|P6|Treatment Period|Lost to Follow-up|3
2824838|NCT02848326|9676181|P5|Treatment Period|Lost to Follow-up|2
2824839|NCT02848326|9676182|P4|Treatment Period|Lost to Follow-up|7
2824840|NCT02848326|9676183|P3|Treatment Period|Lost to Follow-up|11
2824841|NCT02848326|9676184|P2|Treatment Period|Lost to Follow-up|1
2824842|NCT02848326|9676185|P1|Treatment Period|Lost to Follow-up|5
2824843|NCT02848326|9676180|P6|Treatment Period|Withdrawal of Consent|6
2824844|NCT02848326|9676181|P5|Treatment Period|Withdrawal of Consent|9
2824845|NCT02848326|9676182|P4|Treatment Period|Withdrawal of Consent|6
2824846|NCT02848326|9676183|P3|Treatment Period|Withdrawal of Consent|9
2824847|NCT02848326|9676184|P2|Treatment Period|Withdrawal of Consent|6
2824848|NCT02848326|9676185|P1|Treatment Period|Withdrawal of Consent|20
2824849|NCT02848326|9676180|P6|Treatment Period|Adverse Event|7
2824850|NCT02848326|9676181|P5|Treatment Period|Adverse Event|5
2824851|NCT02848326|9676182|P4|Treatment Period|Adverse Event|6
2824852|NCT02848326|9676183|P3|Treatment Period|Adverse Event|11
2824853|NCT02848326|9676184|P2|Treatment Period|Adverse Event|4
2824854|NCT02848326|9676185|P1|Treatment Period|Adverse Event|5
2824855|NCT02847858|9676232|P2|Overall Study|Lost to Follow-up|269
2824856|NCT02847858|9676233|P1|Overall Study|Lost to Follow-up|401
2824857|NCT02847650|9676259|P2|Overall Study|Withdrawal by Subject|1
2824858|NCT02847650|9676260|P1|Overall Study|Withdrawal by Subject|1
2824859|NCT02847650|9676259|P2|Overall Study|Protocol Violation|1
2824860|NCT02847650|9676260|P1|Overall Study|Protocol Violation|0
2824861|NCT02847650|9676259|P2|Overall Study|Lost to Follow-up|0
2824862|NCT02847650|9676260|P1|Overall Study|Lost to Follow-up|1
2824863|NCT02847650|9676259|P2|Overall Study|Adverse Event|4
2824864|NCT02847650|9676260|P1|Overall Study|Adverse Event|2
2824865|NCT02847637|9676284|P4|Overall Study|First emicizumab dose delayed|0
2824866|NCT02847637|9676285|P3|Overall Study|First emicizumab dose delayed|0
2824867|NCT02847637|9676286|P2|Overall Study|First emicizumab dose delayed|0
2824868|NCT02847637|9676287|P1|Overall Study|First emicizumab dose delayed|1
2824869|NCT02847637|9676284|P4|Overall Study|Ongoing treatment with emicizumab|63
2824870|NCT02847637|9676285|P3|Overall Study|Ongoing treatment with emicizumab|34
2824871|NCT02847637|9676286|P2|Overall Study|Ongoing treatment with emicizumab|35
2824872|NCT02847637|9676287|P1|Overall Study|Ongoing treatment with emicizumab|16
2824873|NCT02847637|9676284|P4|Overall Study|Withdrew from treatment due to AE|0
2824874|NCT02847637|9676285|P3|Overall Study|Withdrew from treatment due to AE|1
2824875|NCT02847637|9676286|P2|Overall Study|Withdrew from treatment due to AE|0
2824876|NCT02847637|9676287|P1|Overall Study|Withdrew from treatment due to AE|0
2824877|NCT02847494|9676401|P2|Overall Study|Lost to Follow-up|5
2824878|NCT02847494|9676402|P1|Overall Study|Lost to Follow-up|8
2824879|NCT02847260|9676412|P1|Overall Study|Physician Decision|1
2824880|NCT02847260|9676412|P1|Overall Study|Clinical Deterioration|1
2824881|NCT02847260|9676412|P1|Overall Study|Withdrawal by Subject|2
2824882|NCT02847260|9676412|P1|Overall Study|Adverse Event|3
2824883|NCT02847182|9676426|P2|Overall Study|Withdrawal by Subject|1
2824884|NCT02847182|9676427|P1|Overall Study|Withdrawal by Subject|0
2824885|NCT02846779|9676527|P3|Overall Study|Less than 31 days of follow-up|52
2824886|NCT02846779|9676528|P2|Overall Study|Less than 31 days of follow-up|45
2824887|NCT02846779|9676529|P1|Overall Study|Less than 31 days of follow-up|56
2824888|NCT02846779|9676527|P3|Overall Study|Lost Enrollment|86
2824889|NCT02846779|9676528|P2|Overall Study|Lost Enrollment|82
2824890|NCT02846779|9676529|P1|Overall Study|Lost Enrollment|83
2824891|NCT02846558|9676585|P4|Overall Study|Lost to Follow-up|0
2824892|NCT02846558|9676586|P3|Overall Study|Lost to Follow-up|0
2824893|NCT02846558|9676587|P2|Overall Study|Lost to Follow-up|0
2824894|NCT02846558|9676588|P1|Overall Study|Lost to Follow-up|2
2824895|NCT02846558|9676585|P4|Overall Study|Withdrawal by Subject|2
2824896|NCT02846558|9676586|P3|Overall Study|Withdrawal by Subject|2
2824897|NCT02846558|9676587|P2|Overall Study|Withdrawal by Subject|4
2824898|NCT02846558|9676588|P1|Overall Study|Withdrawal by Subject|5
2824899|NCT02846558|9676585|P4|Overall Study|Adverse Event|0
2824900|NCT02846558|9676586|P3|Overall Study|Adverse Event|0
2824901|NCT02846558|9676587|P2|Overall Study|Adverse Event|0
2824902|NCT02846558|9676588|P1|Overall Study|Adverse Event|1
2824903|NCT02845375|9676653|P3|Overall Study|upper airway obstruction|1
2824904|NCT02845375|9676654|P2|Overall Study|upper airway obstruction|2
2824905|NCT02845375|9676655|P1|Overall Study|upper airway obstruction|1
2824906|NCT02844946|9676684|P2|Overall Study|Lost to Follow-up|0
2824907|NCT02844946|9676685|P1|Overall Study|Lost to Follow-up|7
2824908|NCT02844920|9676703|P1|Overall Study|Lost to Follow-up|2
2824909|NCT02844543|9676721|P1|Overall Study|Did not meet eligibility criteria|1
2824910|NCT02844543|9676721|P1|Overall Study|Withdrawal by Subject|4
2824911|NCT02843659|9676731|P3|Overall Study|Adverse Event|0
2824912|NCT02843659|9676732|P2|Overall Study|Adverse Event|1
2824913|NCT02843659|9676733|P1|Overall Study|Adverse Event|0
2824914|NCT02843659|9676731|P3|Overall Study|Administrative Reason by Sponsor|4
2824915|NCT02843659|9676732|P2|Overall Study|Administrative Reason by Sponsor|5
2824916|NCT02843659|9676733|P1|Overall Study|Administrative Reason by Sponsor|4
2824917|NCT02843659|9676731|P3|Overall Study|Subject Withdrew Consent|1
2824918|NCT02843659|9676732|P2|Overall Study|Subject Withdrew Consent|0
2824919|NCT02843659|9676733|P1|Overall Study|Subject Withdrew Consent|0
2824920|NCT02843178|9676802|P4|Overall Study|Withdrawal by Subject|1
2824921|NCT02843178|9676803|P3|Overall Study|Withdrawal by Subject|1
2824922|NCT02843178|9676804|P2|Overall Study|Withdrawal by Subject|0
2824923|NCT02843178|9676805|P1|Overall Study|Withdrawal by Subject|0
2824924|NCT02843178|9676802|P4|Overall Study|Lost to Follow-up|3
2824925|NCT02843178|9676803|P3|Overall Study|Lost to Follow-up|6
2824926|NCT02843178|9676804|P2|Overall Study|Lost to Follow-up|8
2824927|NCT02843178|9676805|P1|Overall Study|Lost to Follow-up|8
2824928|NCT02842866|9676845|P2|Overall Study|Withdrawal by Subject|0
2824929|NCT02842866|9676846|P1|Overall Study|Withdrawal by Subject|1
2824930|NCT02842866|9676845|P2|Overall Study|Lost to Follow-up|0
2824931|NCT02842866|9676846|P1|Overall Study|Lost to Follow-up|2
2824932|NCT02842866|9676845|P2|Overall Study|Protocol Violation|2
2824933|NCT02842866|9676846|P1|Overall Study|Protocol Violation|4
2824934|NCT02842866|9676845|P2|Overall Study|Serious Adverse Event|1
2824935|NCT02842866|9676846|P1|Overall Study|Serious Adverse Event|0
2824936|NCT02842853|9676858|P4|Overall Study|Lost to Follow-up|11
2824937|NCT02842853|9676859|P3|Overall Study|Lost to Follow-up|10
2824938|NCT02842853|9676860|P2|Overall Study|Lost to Follow-up|13
2824939|NCT02842853|9676861|P1|Overall Study|Lost to Follow-up|9
2824940|NCT02842853|9676858|P4|Overall Study|Withdrawal by Subject|8
2824941|NCT02842853|9676859|P3|Overall Study|Withdrawal by Subject|9
2824942|NCT02842853|9676860|P2|Overall Study|Withdrawal by Subject|13
2824943|NCT02842853|9676861|P1|Overall Study|Withdrawal by Subject|11
2824944|NCT02842853|9676858|P4|Overall Study|Subject met exclusion criteria|0
2824945|NCT02842853|9676859|P3|Overall Study|Subject met exclusion criteria|0
2824946|NCT02842853|9676860|P2|Overall Study|Subject met exclusion criteria|1
2824947|NCT02842853|9676861|P1|Overall Study|Subject met exclusion criteria|0
2824948|NCT02842853|9676858|P4|Overall Study|Non-compliance with the protocol|5
2824949|NCT02842853|9676859|P3|Overall Study|Non-compliance with the protocol|2
2824950|NCT02842853|9676860|P2|Overall Study|Non-compliance with the protocol|7
2824951|NCT02842853|9676861|P1|Overall Study|Non-compliance with the protocol|3
2824952|NCT02842736|9676881|P1|Overall Study|Diary or safety evaluation not available|1
2824953|NCT02842736|9676881|P1|Overall Study|Intervention for menstrual bleeding|4
2824954|NCT02842736|9676881|P1|Overall Study|Lost to Follow-up|7
2824955|NCT02842151|9676911|P1|Overall Study|Subject moved too far away|1
2824956|NCT02842151|9676911|P1|Overall Study|Adverse Event|1
2824957|NCT02842086|9676919|P2|Overall Study|HIV-1 Infection|6
2824958|NCT02842086|9676920|P1|Overall Study|HIV-1 Infection|4
2824959|NCT02842086|9676919|P2|Overall Study|Lost to Follow-up|172
2824960|NCT02842086|9676920|P1|Overall Study|Lost to Follow-up|206
2824961|NCT02842086|9676919|P2|Overall Study|Withdrew Consent|146
2824962|NCT02842086|9676920|P1|Overall Study|Withdrew Consent|157
2824963|NCT02842086|9676919|P2|Overall Study|Protocol Violation|2
2824964|NCT02842086|9676920|P1|Overall Study|Protocol Violation|4
2824965|NCT02842086|9676919|P2|Overall Study|Non-Compliance with Study Drug|7
2824966|NCT02842086|9676920|P1|Overall Study|Non-Compliance with Study Drug|6
2824967|NCT02842086|9676919|P2|Overall Study|Investigator's Discretion|10
2824968|NCT02842086|9676920|P1|Overall Study|Investigator's Discretion|6
2824969|NCT02842086|9676919|P2|Overall Study|Death|2
2824970|NCT02842086|9676920|P1|Overall Study|Death|1
2824971|NCT02842086|9676919|P2|Overall Study|Adverse Event|20
2824972|NCT02842086|9676920|P1|Overall Study|Adverse Event|15
2824973|NCT02842086|9676919|P2|Overall Study|Still on Study|2328
2824974|NCT02842086|9676920|P1|Overall Study|Still on Study|2295
2824975|NCT02842086|9676919|P2|Overall Study|Randomized but Never Treated|6
2824976|NCT02842086|9676920|P1|Overall Study|Randomized but Never Treated|6
2824977|NCT02842073|9676954|P1|Overall Study|Withdrawal by Subject|1
2824978|NCT02841787|9676980|P3|Overall Study|Withdrawal by Subject|0
2824979|NCT02841787|9676981|P2|Overall Study|Withdrawal by Subject|4
2824980|NCT02841787|9676982|P1|Overall Study|Withdrawal by Subject|1
2824981|NCT02841787|9676980|P3|Overall Study|Symptoms dropped below threshold|0
2824982|NCT02841787|9676981|P2|Overall Study|Symptoms dropped below threshold|0
2824983|NCT02841787|9676982|P1|Overall Study|Symptoms dropped below threshold|1
2824984|NCT02841787|9676980|P3|Overall Study|Lost to Follow-up|0
2824985|NCT02841787|9676981|P2|Overall Study|Lost to Follow-up|0
2824986|NCT02841787|9676982|P1|Overall Study|Lost to Follow-up|1
2824987|NCT02841709|9676996|P5|5th Intervention|Adverse Event|2
2824988|NCT02841709|9676997|P4|5th Intervention|Adverse Event|0
2824989|NCT02841709|9676998|P3|5th Intervention|Adverse Event|0
2824990|NCT02841709|9676999|P2|5th Intervention|Adverse Event|0
2824991|NCT02841709|9677000|P1|5th Intervention|Adverse Event|2
2824992|NCT02840721|9677051|P1|Follow-Up|Withdrawal of Consent|2
2824993|NCT02840721|9677051|P1|Follow-Up|Withdrawal by Subject|4
2824994|NCT02840721|9677051|P1|Follow-Up|Lack of Efficacy|1
2824995|NCT02840721|9677051|P1|Treatment Period|Adverse Event|1
2824996|NCT02840253|9677070|P1|Overall Study|Unsuccessful block|4
2824997|NCT02839876|9677155|P2|Overall Study|Protocol Violation|11
2824998|NCT02839876|9677156|P1|Overall Study|Protocol Violation|10
2824999|NCT02839798|9677218|P1|Overall Study|Withdrawal by Subject|2
2825000|NCT02839746|9677264|P1|Overall Study|Not met selection criteria|12
2825001|NCT02839681|9677278|P1|Overall Study|Death|2
2825002|NCT02839330|9677291|P4|Overall Study|Other reason, not specified|6
2825003|NCT02839330|9677292|P3|Overall Study|Other reason, not specified|3
2825004|NCT02839330|9677293|P2|Overall Study|Other reason, not specified|3
2825005|NCT02839330|9677294|P1|Overall Study|Other reason, not specified|4
2825006|NCT02839330|9677291|P4|Overall Study|Protocol Violation|3
2825007|NCT02839330|9677292|P3|Overall Study|Protocol Violation|2
2825008|NCT02839330|9677293|P2|Overall Study|Protocol Violation|2
2825009|NCT02839330|9677294|P1|Overall Study|Protocol Violation|1
2825010|NCT02839330|9677291|P4|Overall Study|Administrative Reason|1
2825011|NCT02839330|9677292|P3|Overall Study|Administrative Reason|0
2825012|NCT02839330|9677293|P2|Overall Study|Administrative Reason|0
2825013|NCT02839330|9677294|P1|Overall Study|Administrative Reason|0
2825014|NCT02839330|9677291|P4|Overall Study|Lost to Follow-up|25
2825015|NCT02839330|9677292|P3|Overall Study|Lost to Follow-up|29
2825016|NCT02839330|9677293|P2|Overall Study|Lost to Follow-up|27
2825017|NCT02839330|9677294|P1|Overall Study|Lost to Follow-up|22
2825018|NCT02839330|9677291|P4|Overall Study|Withdrawal by Subject|13
2825019|NCT02839330|9677292|P3|Overall Study|Withdrawal by Subject|11
2825020|NCT02839330|9677293|P2|Overall Study|Withdrawal by Subject|19
2825021|NCT02839330|9677294|P1|Overall Study|Withdrawal by Subject|27
2825022|NCT02839330|9677291|P4|Overall Study|Death|1
2825023|NCT02839330|9677292|P3|Overall Study|Death|1
2825024|NCT02839330|9677293|P2|Overall Study|Death|6
2825025|NCT02839330|9677294|P1|Overall Study|Death|4
2825026|NCT02839330|9677291|P4|Overall Study|Adverse Event|2
2825027|NCT02839330|9677292|P3|Overall Study|Adverse Event|2
2825028|NCT02839330|9677293|P2|Overall Study|Adverse Event|1
2825029|NCT02839330|9677294|P1|Overall Study|Adverse Event|0
2825030|NCT02839200|9677329|P6|Overall Study|Randomized in error|0
2825031|NCT02839200|9677330|P5|Overall Study|Randomized in error|0
2825032|NCT02839200|9677331|P4|Overall Study|Randomized in error|0
2825033|NCT02839200|9677332|P3|Overall Study|Randomized in error|0
2825034|NCT02839200|9677333|P2|Overall Study|Randomized in error|1
2825035|NCT02839200|9677334|P1|Overall Study|Randomized in error|0
2825036|NCT02839200|9677329|P6|Overall Study|Adverse Event|0
2825037|NCT02839200|9677330|P5|Overall Study|Adverse Event|1
2825038|NCT02839200|9677331|P4|Overall Study|Adverse Event|0
2825039|NCT02839200|9677332|P3|Overall Study|Adverse Event|0
2825040|NCT02839200|9677333|P2|Overall Study|Adverse Event|0
2825041|NCT02839200|9677334|P1|Overall Study|Adverse Event|0
2825042|NCT02839200|9677329|P6|Overall Study|Lost to Follow-up|0
2825043|NCT02839200|9677330|P5|Overall Study|Lost to Follow-up|1
2825044|NCT02839200|9677331|P4|Overall Study|Lost to Follow-up|0
2825045|NCT02839200|9677332|P3|Overall Study|Lost to Follow-up|0
2825046|NCT02839200|9677333|P2|Overall Study|Lost to Follow-up|0
2825047|NCT02839200|9677334|P1|Overall Study|Lost to Follow-up|2
2825048|NCT02839200|9677329|P6|Overall Study|Withdrawal by Subject|1
2825049|NCT02839200|9677330|P5|Overall Study|Withdrawal by Subject|0
2825050|NCT02839200|9677331|P4|Overall Study|Withdrawal by Subject|0
2825051|NCT02839200|9677332|P3|Overall Study|Withdrawal by Subject|1
2825052|NCT02839200|9677333|P2|Overall Study|Withdrawal by Subject|0
2825053|NCT02839200|9677334|P1|Overall Study|Withdrawal by Subject|2
2825054|NCT02838901|9677368|P2|Overall Study|Lost to Follow-up|1
2825055|NCT02838901|9677369|P1|Overall Study|Lost to Follow-up|1
2825056|NCT02838901|9677368|P2|Overall Study|Withdrawal by Subject|1
2825057|NCT02838901|9677369|P1|Overall Study|Withdrawal by Subject|1
2825058|NCT02838420|9677399|P2|Overall Study|Death|13
2825059|NCT02838420|9677400|P1|Overall Study|Death|8
2825060|NCT02838420|9677399|P2|Overall Study|Withdrawal by Subject|4
2825061|NCT02838420|9677400|P1|Overall Study|Withdrawal by Subject|3
2825062|NCT02838420|9677399|P2|Overall Study|Lost to Follow-up|0
2825063|NCT02838420|9677400|P1|Overall Study|Lost to Follow-up|1
2825064|NCT02838420|9677399|P2|Overall Study|Ongoing in Study|45
2825065|NCT02838420|9677400|P1|Overall Study|Ongoing in Study|113
2825066|NCT02838134|9677463|P2|Overall Study|logistic problems|1
2825067|NCT02838134|9677464|P1|Overall Study|logistic problems|1
2825068|NCT02838134|9677463|P2|Overall Study|Lost to Follow-up|2
2825069|NCT02838134|9677464|P1|Overall Study|Lost to Follow-up|1
2825070|NCT02838017|9677496|P2|Overall Study|Lost to Follow-up|11
2825071|NCT02838017|9677497|P1|Overall Study|Lost to Follow-up|14
2825072|NCT02837952|9677515|P2|Overall Study|Medication Error|0
2825073|NCT02837952|9677516|P1|Overall Study|Medication Error|1
2825074|NCT02837952|9677515|P2|Overall Study|Withdrawal by Subject|5
2825075|NCT02837952|9677516|P1|Overall Study|Withdrawal by Subject|4
2825076|NCT02837952|9677515|P2|Overall Study|Adverse Event|1
2825077|NCT02837952|9677516|P1|Overall Study|Adverse Event|0
2825078|NCT02836613|9677568|P2|Overall Study|Withdrawal by Subject|2
2825079|NCT02836613|9677569|P1|Overall Study|Withdrawal by Subject|0
2825080|NCT02836613|9677568|P2|Overall Study|Lost to Follow-up|1
2825081|NCT02836613|9677569|P1|Overall Study|Lost to Follow-up|0
2825082|NCT02836613|9677568|P2|Overall Study|Accidental drowning|0
2825083|NCT02836613|9677569|P1|Overall Study|Accidental drowning|1
2825084|NCT02836496|9677583|P2|Overall Study|Withdrawal by Subject|1
2825085|NCT02836496|9677584|P1|Overall Study|Withdrawal by Subject|0
2825086|NCT02836496|9677583|P2|Overall Study|Adverse Event|1
2825087|NCT02836496|9677584|P1|Overall Study|Adverse Event|2
2825088|NCT02836249|9677600|P2|Overall Study|Still on Study|55
2825089|NCT02836249|9677601|P1|Overall Study|Still on Study|121
2825090|NCT02836249|9677600|P2|Overall Study|Lost to Follow-up|1
2825091|NCT02836249|9677601|P1|Overall Study|Lost to Follow-up|0
2825092|NCT02836249|9677600|P2|Overall Study|Withdrew Consent|1
2825093|NCT02836249|9677601|P1|Overall Study|Withdrew Consent|0
2825094|NCT02836249|9677600|P2|Overall Study|Pregnancy|0
2825095|NCT02836249|9677601|P1|Overall Study|Pregnancy|2
2825096|NCT02836249|9677600|P2|Overall Study|Randomized but Never Treated|1
2825097|NCT02836249|9677601|P1|Overall Study|Randomized but Never Treated|0
2825098|NCT02836236|9677619|P2|Overall Study|Still on Study|49
2825099|NCT02836236|9677620|P1|Overall Study|Still on Study|101
2825100|NCT02836236|9677619|P2|Overall Study|Investigator's Discretion|0
2825101|NCT02836236|9677620|P1|Overall Study|Investigator's Discretion|1
2825102|NCT02836236|9677619|P2|Overall Study|Adverse Event|1
2825103|NCT02836236|9677620|P1|Overall Study|Adverse Event|0
2825104|NCT02836236|9677619|P2|Overall Study|Withdrew Consent|0
2825105|NCT02836236|9677620|P1|Overall Study|Withdrew Consent|2
2825106|NCT02836236|9677619|P2|Overall Study|Randomized but Never Treated|0
2825107|NCT02836236|9677620|P1|Overall Study|Randomized but Never Treated|1
2825108|NCT02835820|9677636|P2|Overall Study|Baseline Screen Failure|3
2825109|NCT02835820|9677637|P1|Overall Study|Baseline Screen Failure|0
2825110|NCT02835690|9677684|P3|Overall Study|Not Treated|0
2825111|NCT02835690|9677685|P2|Overall Study|Not Treated|2
2825112|NCT02835690|9677686|P1|Overall Study|Not Treated|0
2825113|NCT02835690|9677684|P3|Overall Study|Ongoing in Study (Follow-up)|9
2825114|NCT02835690|9677685|P2|Overall Study|Ongoing in Study (Follow-up)|7
2825115|NCT02835690|9677686|P1|Overall Study|Ongoing in Study (Follow-up)|10
2825116|NCT02835690|9677684|P3|Overall Study|Death|6
2825117|NCT02835690|9677685|P2|Overall Study|Death|6
2825118|NCT02835690|9677686|P1|Overall Study|Death|4
2825119|NCT02835339|9677749|P2|Overall Study|Did not receive allocated intervention|16
2825120|NCT02835339|9677750|P1|Overall Study|Did not receive allocated intervention|13
2825121|NCT02835092|9677772|P3|Overall Study|Lost to Follow-up|0
2825122|NCT02835092|9677773|P2|Overall Study|Lost to Follow-up|2
2825123|NCT02835092|9677774|P1|Overall Study|Lost to Follow-up|0
2825124|NCT02835092|9677772|P3|Overall Study|Withdrawal by Subject|3
2825125|NCT02835092|9677773|P2|Overall Study|Withdrawal by Subject|6
2825126|NCT02835092|9677774|P1|Overall Study|Withdrawal by Subject|3
2825127|NCT02834819|9677784|P2|Overall Study|Did not complete 7 day follow up call.|0
2825128|NCT02834819|9677785|P1|Overall Study|Did not complete 7 day follow up call.|5
2825129|NCT02834247|9677840|P4|Dose Expansion Phase|Withdrawal by Subject|1
2825130|NCT02834247|9677841|P3|Dose Expansion Phase|Withdrawal by Subject|0
2825131|NCT02834247|9677842|P2|Dose Expansion Phase|Withdrawal by Subject|0
2825132|NCT02834247|9677843|P1|Dose Expansion Phase|Withdrawal by Subject|0
2825133|NCT02834247|9677840|P4|Dose Expansion Phase|Lost to Follow-up|1
2825134|NCT02834247|9677841|P3|Dose Expansion Phase|Lost to Follow-up|0
2825135|NCT02834247|9677842|P2|Dose Expansion Phase|Lost to Follow-up|0
2825136|NCT02834247|9677843|P1|Dose Expansion Phase|Lost to Follow-up|0
2825137|NCT02834247|9677840|P4|Dose Expansion Phase|Death|8
2825138|NCT02834247|9677841|P3|Dose Expansion Phase|Death|0
2825139|NCT02834247|9677842|P2|Dose Expansion Phase|Death|0
2825140|NCT02834247|9677843|P1|Dose Expansion Phase|Death|0
2825141|NCT02834247|9677840|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
2825142|NCT02834247|9677841|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
2825143|NCT02834247|9677842|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
2825144|NCT02834247|9677843|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
2825145|NCT02834247|9677840|P4|Dose Escalation Phase|Withdrawal by Subject|0
2825146|NCT02834247|9677841|P3|Dose Escalation Phase|Withdrawal by Subject|0
2825147|NCT02834247|9677842|P2|Dose Escalation Phase|Withdrawal by Subject|2
2825148|NCT02834247|9677843|P1|Dose Escalation Phase|Withdrawal by Subject|2
2825149|NCT02834247|9677840|P4|Dose Escalation Phase|Lost to Follow-up|0
2825150|NCT02834247|9677841|P3|Dose Escalation Phase|Lost to Follow-up|0
2825151|NCT02834247|9677842|P2|Dose Escalation Phase|Lost to Follow-up|1
2825152|NCT02834247|9677843|P1|Dose Escalation Phase|Lost to Follow-up|0
2825153|NCT02834247|9677840|P4|Dose Escalation Phase|Death|0
2825154|NCT02834247|9677841|P3|Dose Escalation Phase|Death|5
2825155|NCT02834247|9677842|P2|Dose Escalation Phase|Death|6
2825156|NCT02834247|9677843|P1|Dose Escalation Phase|Death|5
2825157|NCT02834247|9677840|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
2825158|NCT02834247|9677841|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
2825159|NCT02834247|9677842|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
2825160|NCT02834247|9677843|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
2825161|NCT02833974|9677872|P2|Overall Study|Adverse Event|3
2825162|NCT02833974|9677873|P1|Overall Study|Adverse Event|0
2825163|NCT02833974|9677872|P2|Overall Study|Lost to Follow-up|0
2825164|NCT02833974|9677873|P1|Overall Study|Lost to Follow-up|1
2825165|NCT02833948|9677899|P2|Overall Study|scans could not be evaluated|2
2825166|NCT02833948|9677900|P1|Overall Study|scans could not be evaluated|5
2825167|NCT02833948|9677899|P2|Overall Study|were not scanned|13
2825168|NCT02833948|9677900|P1|Overall Study|were not scanned|8
2825169|NCT02833948|9677899|P2|Overall Study|Death|3
2825170|NCT02833948|9677900|P1|Overall Study|Death|2
2825171|NCT02833350|9677973|P7|Overall Study|Withdrawal by Subject|2
2825172|NCT02833350|9677974|P6|Overall Study|Withdrawal by Subject|0
2825173|NCT02833350|9677975|P5|Overall Study|Withdrawal by Subject|2
2825174|NCT02833350|9677976|P4|Overall Study|Withdrawal by Subject|0
2825175|NCT02833350|9677977|P3|Overall Study|Withdrawal by Subject|2
2825176|NCT02833350|9677978|P2|Overall Study|Withdrawal by Subject|3
2825177|NCT02833350|9677979|P1|Overall Study|Withdrawal by Subject|3
2825178|NCT02833350|9677973|P7|Overall Study|Lost to Follow-up|1
2825179|NCT02833350|9677974|P6|Overall Study|Lost to Follow-up|0
2825180|NCT02833350|9677975|P5|Overall Study|Lost to Follow-up|0
2825181|NCT02833350|9677976|P4|Overall Study|Lost to Follow-up|0
2825182|NCT02833350|9677977|P3|Overall Study|Lost to Follow-up|0
2825183|NCT02833350|9677978|P2|Overall Study|Lost to Follow-up|1
2825184|NCT02833350|9677979|P1|Overall Study|Lost to Follow-up|0
2825185|NCT02833350|9677973|P7|Overall Study|Lack of Efficacy|1
2825186|NCT02833350|9677974|P6|Overall Study|Lack of Efficacy|1
2825187|NCT02833350|9677975|P5|Overall Study|Lack of Efficacy|0
2825188|NCT02833350|9677976|P4|Overall Study|Lack of Efficacy|4
2825189|NCT02833350|9677977|P3|Overall Study|Lack of Efficacy|1
2825190|NCT02833350|9677978|P2|Overall Study|Lack of Efficacy|2
2825191|NCT02833350|9677979|P1|Overall Study|Lack of Efficacy|0
2825192|NCT02833350|9677973|P7|Overall Study|Death|0
2825193|NCT02833350|9677974|P6|Overall Study|Death|0
2825194|NCT02833350|9677975|P5|Overall Study|Death|0
2825195|NCT02833350|9677976|P4|Overall Study|Death|0
2825196|NCT02833350|9677977|P3|Overall Study|Death|1
2825197|NCT02833350|9677978|P2|Overall Study|Death|0
2825198|NCT02833350|9677979|P1|Overall Study|Death|0
2825199|NCT02833350|9677973|P7|Overall Study|Adverse Event|1
2825200|NCT02833350|9677974|P6|Overall Study|Adverse Event|0
2825201|NCT02833350|9677975|P5|Overall Study|Adverse Event|1
2825202|NCT02833350|9677976|P4|Overall Study|Adverse Event|4
2825203|NCT02833350|9677977|P3|Overall Study|Adverse Event|4
2825204|NCT02833350|9677978|P2|Overall Study|Adverse Event|3
2825205|NCT02833350|9677979|P1|Overall Study|Adverse Event|0
2825206|NCT02832375|9678191|P2|Overall Study|Withdrawal of Consent|0
2825207|NCT02832375|9678192|P1|Overall Study|Withdrawal of Consent|1
2825208|NCT02832375|9678191|P2|Overall Study|Lost to Follow-up|0
2825209|NCT02832375|9678192|P1|Overall Study|Lost to Follow-up|1
2825210|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2825211|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
2825212|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2825213|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
2825214|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
2825215|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
2825216|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
2825217|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
2825218|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
2825219|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Other|5
2825220|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Other|2
2825221|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Other|0
2825222|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
2825223|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
2825224|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
2825225|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
2825226|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
2825227|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
2825228|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2825229|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2825230|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
2825231|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Death|2
2825232|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Death|0
2825233|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Death|0
2825234|NCT02831855|9678210|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
2825235|NCT02831855|9678211|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
2825236|NCT02831855|9678212|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
2825237|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Other|0
2825238|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Other|0
2825239|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Other|4
2825240|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2825241|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2825242|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
2825243|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
2825244|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
2825245|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
2825246|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2825247|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2825248|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
2825249|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2825250|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2825251|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
2825252|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2825253|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2825254|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
2825255|NCT02831855|9678210|P3|Open Label Phase (24 Weeks)|Adverse Event|0
2825256|NCT02831855|9678211|P2|Open Label Phase (24 Weeks)|Adverse Event|0
2825257|NCT02831855|9678212|P1|Open Label Phase (24 Weeks)|Adverse Event|39
2825258|NCT02831764|9678273|P2|Overall Study|Ongoing at the time of the analysis|335
2825259|NCT02831764|9678274|P1|Overall Study|Ongoing at the time of the analysis|330
2825260|NCT02831764|9678273|P2|Overall Study|Protocol Violation|2
2825261|NCT02831764|9678274|P1|Overall Study|Protocol Violation|5
2825262|NCT02831764|9678273|P2|Overall Study|Lack of Efficacy|2
2825263|NCT02831764|9678274|P1|Overall Study|Lack of Efficacy|2
2825264|NCT02831764|9678273|P2|Overall Study|Adverse Event|5
2825265|NCT02831764|9678274|P1|Overall Study|Adverse Event|8
2825266|NCT02831764|9678273|P2|Overall Study|Lost to Follow-up|5
2825267|NCT02831764|9678274|P1|Overall Study|Lost to Follow-up|6
2825268|NCT02831764|9678273|P2|Overall Study|Physician Decision|2
2825269|NCT02831764|9678274|P1|Overall Study|Physician Decision|2
2825270|NCT02831764|9678273|P2|Overall Study|Withdrawal by Subject|6
2825271|NCT02831764|9678274|P1|Overall Study|Withdrawal by Subject|7
2825272|NCT02831764|9678273|P2|Overall Study|Protocol specific withdrawal criteria|2
2825273|NCT02831764|9678274|P1|Overall Study|Protocol specific withdrawal criteria|0
2825274|NCT02831673|9678338|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
2825275|NCT02831673|9678339|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
2825276|NCT02831673|9678338|P2|Overall Study|Withdrawal by Subject|4
2825277|NCT02831673|9678339|P1|Overall Study|Withdrawal by Subject|6
2825278|NCT02831673|9678338|P2|Overall Study|Physician Decision|3
2825279|NCT02831673|9678339|P1|Overall Study|Physician Decision|6
2825280|NCT02831673|9678338|P2|Overall Study|Lost to Follow-up|6
2825281|NCT02831673|9678339|P1|Overall Study|Lost to Follow-up|9
2825282|NCT02831673|9678338|P2|Overall Study|Protocol Withdrawal Criterion Met|6
2825283|NCT02831673|9678339|P1|Overall Study|Protocol Withdrawal Criterion Met|1
2825284|NCT02831673|9678338|P2|Overall Study|Protocol Violation|4
2825285|NCT02831673|9678339|P1|Overall Study|Protocol Violation|5
2825286|NCT02831673|9678338|P2|Overall Study|Lack of Efficacy|1
2825287|NCT02831673|9678339|P1|Overall Study|Lack of Efficacy|3
2825288|NCT02831673|9678338|P2|Overall Study|Adverse Event|4
2825289|NCT02831673|9678339|P1|Overall Study|Adverse Event|6
2825290|NCT02831387|9678412|P2|Overall Study|Discontinued due to stock recovery|1
2825291|NCT02831387|9678413|P1|Overall Study|Discontinued due to stock recovery|0
2825292|NCT02831387|9678412|P2|Overall Study|Withdrawal by Subject|1
2825293|NCT02831387|9678413|P1|Overall Study|Withdrawal by Subject|1
2825294|NCT02830880|9678431|P1|Overall Study|Physician Decision|1
2825295|NCT02830880|9678431|P1|Overall Study|Death|1
2825296|NCT02830880|9678431|P1|Overall Study|Adverse reaction to chemotherapy|1
2825297|NCT02830087|9678446|P6|Overall Study|No study staff to follow-up patients|3
2825298|NCT02830087|9678447|P5|Overall Study|No study staff to follow-up patients|3
2825299|NCT02830087|9678448|P4|Overall Study|No study staff to follow-up patients|3
2825300|NCT02830087|9678449|P3|Overall Study|No study staff to follow-up patients|4
2825301|NCT02830087|9678450|P2|Overall Study|No study staff to follow-up patients|4
2825302|NCT02830087|9678451|P1|Overall Study|No study staff to follow-up patients|4
2825303|NCT02829996|9678518|P5|Overall Study|Withdrawal by Subject|0
2825304|NCT02829996|9678519|P4|Overall Study|Withdrawal by Subject|0
2825305|NCT02829996|9678520|P3|Overall Study|Withdrawal by Subject|0
2825306|NCT02829996|9678521|P2|Overall Study|Withdrawal by Subject|0
2825307|NCT02829996|9678522|P1|Overall Study|Withdrawal by Subject|1
2825308|NCT02829944|9678547|P2|Overall Study|Staff unavailable|1
2825309|NCT02829944|9678548|P1|Overall Study|Staff unavailable|0
2825310|NCT02829944|9678547|P2|Overall Study|Catheter broke|1
2825311|NCT02829944|9678548|P1|Overall Study|Catheter broke|0
2825312|NCT02829944|9678547|P2|Overall Study|Catheter Displacement|0
2825313|NCT02829944|9678548|P1|Overall Study|Catheter Displacement|1
2825314|NCT02829944|9678547|P2|Overall Study|Withdrawal by Subject|1
2825315|NCT02829944|9678548|P1|Overall Study|Withdrawal by Subject|2
2825316|NCT02829944|9678547|P2|Overall Study|Inadequate Neuraxial Block|1
2825317|NCT02829944|9678548|P1|Overall Study|Inadequate Neuraxial Block|1
2825318|NCT02829944|9678547|P2|Overall Study|Screen Failure|2
2825319|NCT02829944|9678548|P1|Overall Study|Screen Failure|2
2825320|NCT02829944|9678547|P2|Overall Study|Physician Decision|1
2825321|NCT02829944|9678548|P1|Overall Study|Physician Decision|0
2825322|NCT02829918|9678598|P1|Overall Study|Progression|1
2825323|NCT02829918|9678598|P1|Overall Study|Adverse Event|1
2825324|NCT02829918|9678598|P1|Overall Study|Withdrawal by Subject|4
2825325|NCT02829918|9678598|P1|Overall Study|Death|2
2825326|NCT02829775|9678603|P1|Overall Study|Disease remission|1
2825327|NCT02829775|9678603|P1|Overall Study|Withdrawal by Subject|3
2825328|NCT02829775|9678603|P1|Overall Study|Death|1
2825329|NCT02829138|9678685|P2|Overall Study|Withdrawal by Subject|0
2825330|NCT02829138|9678686|P1|Overall Study|Withdrawal by Subject|1
2825331|NCT02828644|9678711|P2|Overall Study|Lost to Follow-up|22
2825332|NCT02828644|9678712|P1|Overall Study|Lost to Follow-up|23
2825333|NCT02828241|9678721|P2|Overall Study|Protocol Violation|0
2825334|NCT02828241|9678722|P1|Overall Study|Protocol Violation|1
2825335|NCT02828241|9678721|P2|Overall Study|Adverse Event|2
2825336|NCT02828241|9678722|P1|Overall Study|Adverse Event|7
2825337|NCT02828124|9678749|P4|Overall Study|Subject Withdrew Consent|1
2825338|NCT02828124|9678750|P3|Overall Study|Subject Withdrew Consent|0
2825339|NCT02828124|9678751|P2|Overall Study|Subject Withdrew Consent|0
2825340|NCT02828124|9678752|P1|Overall Study|Subject Withdrew Consent|0
2825341|NCT02828124|9678749|P4|Overall Study|AE Unrelated to Study Drug|1
2825342|NCT02828124|9678750|P3|Overall Study|AE Unrelated to Study Drug|0
2825343|NCT02828124|9678751|P2|Overall Study|AE Unrelated to Study Drug|0
2825344|NCT02828124|9678752|P1|Overall Study|AE Unrelated to Study Drug|0
2825345|NCT02828124|9678749|P4|Overall Study|Disease Progression|4
2825346|NCT02828124|9678750|P3|Overall Study|Disease Progression|1
2825347|NCT02828124|9678751|P2|Overall Study|Disease Progression|2
2825348|NCT02828124|9678752|P1|Overall Study|Disease Progression|1
2825349|NCT02828111|9678867|P5|Overall Study|Lost to Follow-up|1
2825350|NCT02828111|9678868|P4|Overall Study|Lost to Follow-up|1
2825351|NCT02828111|9678869|P3|Overall Study|Lost to Follow-up|0
2825352|NCT02828111|9678870|P2|Overall Study|Lost to Follow-up|0
2825353|NCT02828111|9678871|P1|Overall Study|Lost to Follow-up|0
2825354|NCT02828111|9678867|P5|Overall Study|Withdrawal by Subject|0
2825355|NCT02828111|9678868|P4|Overall Study|Withdrawal by Subject|0
2825356|NCT02828111|9678869|P3|Overall Study|Withdrawal by Subject|2
2825357|NCT02828111|9678870|P2|Overall Study|Withdrawal by Subject|0
2825358|NCT02828111|9678871|P1|Overall Study|Withdrawal by Subject|0
2825359|NCT02828020|9678932|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
2825360|NCT02828020|9678933|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
2825361|NCT02828020|9678934|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
2825362|NCT02828020|9678932|P3|Safety Follow-up Period|Protocol Violation|1
2825363|NCT02828020|9678933|P2|Safety Follow-up Period|Protocol Violation|2
2825364|NCT02828020|9678934|P1|Safety Follow-up Period|Protocol Violation|0
2825365|NCT02828020|9678932|P3|Safety Follow-up Period|Lost to Follow-up|11
2825366|NCT02828020|9678933|P2|Safety Follow-up Period|Lost to Follow-up|8
2825367|NCT02828020|9678934|P1|Safety Follow-up Period|Lost to Follow-up|9
2825368|NCT02828020|9678932|P3|Safety Follow-up Period|Withdrawal of Consent|7
2825369|NCT02828020|9678933|P2|Safety Follow-up Period|Withdrawal of Consent|8
2825370|NCT02828020|9678934|P1|Safety Follow-up Period|Withdrawal of Consent|10
2825371|NCT02828020|9678932|P3|Treatment Period|Other Miscellaneous Reasons|0
2825372|NCT02828020|9678933|P2|Treatment Period|Other Miscellaneous Reasons|1
2825373|NCT02828020|9678934|P1|Treatment Period|Other Miscellaneous Reasons|0
2825374|NCT02828020|9678932|P3|Treatment Period|Protocol Violation|7
2825375|NCT02828020|9678933|P2|Treatment Period|Protocol Violation|4
2825376|NCT02828020|9678934|P1|Treatment Period|Protocol Violation|2
2825377|NCT02828020|9678932|P3|Treatment Period|Pregnancy|0
2825378|NCT02828020|9678933|P2|Treatment Period|Pregnancy|2
2825379|NCT02828020|9678934|P1|Treatment Period|Pregnancy|0
2825380|NCT02828020|9678932|P3|Treatment Period|Lack of Qualifying Event|43
2825381|NCT02828020|9678933|P2|Treatment Period|Lack of Qualifying Event|53
2825382|NCT02828020|9678934|P1|Treatment Period|Lack of Qualifying Event|44
2825383|NCT02828020|9678932|P3|Treatment Period|Lost to Follow-up|18
2825384|NCT02828020|9678933|P2|Treatment Period|Lost to Follow-up|24
2825385|NCT02828020|9678934|P1|Treatment Period|Lost to Follow-up|21
2825386|NCT02828020|9678932|P3|Treatment Period|Withdrawal of Consent|9
2825387|NCT02828020|9678933|P2|Treatment Period|Withdrawal of Consent|14
2825388|NCT02828020|9678934|P1|Treatment Period|Withdrawal of Consent|10
2825389|NCT02828020|9678932|P3|Treatment Period|Adverse Event|1
2825390|NCT02828020|9678933|P2|Treatment Period|Adverse Event|1
2825391|NCT02828020|9678934|P1|Treatment Period|Adverse Event|3
2825392|NCT02827708|9678965|P2|Overall Study|Death|2
2825393|NCT02827708|9678966|P1|Overall Study|Death|1
2825394|NCT02827708|9678965|P2|Overall Study|Withdrawal by Subject|2
2825395|NCT02827708|9678966|P1|Overall Study|Withdrawal by Subject|1
2825396|NCT02827708|9678965|P2|Overall Study|Lost to Follow-up|1
2825397|NCT02827708|9678966|P1|Overall Study|Lost to Follow-up|3
2825398|NCT02827500|9679045|P2|Overall Study|Other|1
2825399|NCT02827500|9679046|P1|Overall Study|Other|5
2825400|NCT02827500|9679045|P2|Overall Study|Missing primary endpoint data|1
2825401|NCT02827500|9679046|P1|Overall Study|Missing primary endpoint data|3
2825402|NCT02827500|9679045|P2|Overall Study|Withdrawal by Subject|1
2825403|NCT02827500|9679046|P1|Overall Study|Withdrawal by Subject|3
2825404|NCT02827500|9679045|P2|Overall Study|Lost to Follow-up|1
2825405|NCT02827500|9679046|P1|Overall Study|Lost to Follow-up|1
2825406|NCT02827500|9679045|P2|Overall Study|Death|3
2825407|NCT02827500|9679046|P1|Overall Study|Death|7
2825408|NCT02826798|9679067|P5|Overall Study|Withdrawal by Subject|0
2825409|NCT02826798|9679068|P4|Overall Study|Withdrawal by Subject|1
2825410|NCT02826798|9679069|P3|Overall Study|Withdrawal by Subject|0
2825411|NCT02826798|9679070|P2|Overall Study|Withdrawal by Subject|1
2825412|NCT02826798|9679071|P1|Overall Study|Withdrawal by Subject|0
2825413|NCT02826603|9679120|P2|Overall Study|New therapy for study indication|1
2825414|NCT02826603|9679121|P1|Overall Study|New therapy for study indication|0
2825415|NCT02826603|9679120|P2|Overall Study|Death|0
2825416|NCT02826603|9679121|P1|Overall Study|Death|2
2825417|NCT02826603|9679120|P2|Overall Study|Withdrawal by Subject|19
2825418|NCT02826603|9679121|P1|Overall Study|Withdrawal by Subject|20
2825419|NCT02826603|9679120|P2|Overall Study|Protocol Violation|3
2825420|NCT02826603|9679121|P1|Overall Study|Protocol Violation|3
2825421|NCT02826603|9679120|P2|Overall Study|Pregnancy|2
2825422|NCT02826603|9679121|P1|Overall Study|Pregnancy|1
2825423|NCT02826603|9679120|P2|Overall Study|Physician Decision|7
2825424|NCT02826603|9679121|P1|Overall Study|Physician Decision|1
2825425|NCT02826603|9679120|P2|Overall Study|Noncompliance with treatment|2
2825426|NCT02826603|9679121|P1|Overall Study|Noncompliance with treatment|0
2825427|NCT02826603|9679120|P2|Overall Study|Lost to Follow-up|12
2825428|NCT02826603|9679121|P1|Overall Study|Lost to Follow-up|13
2825429|NCT02826603|9679120|P2|Overall Study|Lack of Efficacy|9
2825430|NCT02826603|9679121|P1|Overall Study|Lack of Efficacy|4
2825431|NCT02826603|9679120|P2|Overall Study|Adverse Event|9
2825432|NCT02826603|9679121|P1|Overall Study|Adverse Event|17
2825433|NCT02826421|9679161|P4|Overall Study|Reason not given|0
2825434|NCT02826421|9679162|P3|Overall Study|Reason not given|1
2825435|NCT02826421|9679163|P2|Overall Study|Reason not given|0
2825436|NCT02826421|9679164|P1|Overall Study|Reason not given|1
2825437|NCT02826421|9679161|P4|Overall Study|Withdrawal by Subject|1
2825438|NCT02826421|9679162|P3|Overall Study|Withdrawal by Subject|1
2825439|NCT02826421|9679163|P2|Overall Study|Withdrawal by Subject|3
2825440|NCT02826421|9679164|P1|Overall Study|Withdrawal by Subject|1
2825441|NCT02826421|9679161|P4|Overall Study|Adverse Event|1
2825442|NCT02826421|9679162|P3|Overall Study|Adverse Event|0
2825443|NCT02826421|9679163|P2|Overall Study|Adverse Event|0
2825444|NCT02826421|9679164|P1|Overall Study|Adverse Event|1
2825445|NCT02825550|9679176|P1|Overall Study|Physician Decision|1
2825446|NCT02825251|9679184|P2|Overall Study|Unclassified|0
2825447|NCT02825251|9679185|P1|Overall Study|Unclassified|2
2825448|NCT02825251|9679184|P2|Overall Study|Withdrawal by Subject|4
2825449|NCT02825251|9679185|P1|Overall Study|Withdrawal by Subject|1
2825450|NCT02825251|9679184|P2|Overall Study|Lost to Follow-up|1
2825451|NCT02825251|9679185|P1|Overall Study|Lost to Follow-up|0
2825452|NCT02825251|9679184|P2|Overall Study|Adverse Event|1
2825453|NCT02825251|9679185|P1|Overall Study|Adverse Event|0
2825454|NCT02824562|9679388|P2|Overall Study|Death|1
2825455|NCT02824562|9679389|P1|Overall Study|Death|0
2825456|NCT02824562|9679388|P2|Overall Study|Lost to Follow-up|4
2825457|NCT02824562|9679389|P1|Overall Study|Lost to Follow-up|3
2825458|NCT02824432|9679398|P2|Overall Study|Major Protocol Deviation|0
2825459|NCT02824432|9679399|P1|Overall Study|Major Protocol Deviation|1
2825460|NCT02824224|9679475|P2|Overall Study|Did not show up for allocation visit|0
2825461|NCT02824224|9679476|P1|Overall Study|Did not show up for allocation visit|2
2825462|NCT02824224|9679475|P2|Overall Study|Discontinued, IUS expulsion|1
2825463|NCT02824224|9679476|P1|Overall Study|Discontinued, IUS expulsion|0
2825464|NCT02824198|9679496|P2|Overall Study|Withdrawal by Subject|0
2825465|NCT02824198|9679497|P1|Overall Study|Withdrawal by Subject|5
2825466|NCT02824198|9679496|P2|Overall Study|Lost to Follow-up|2
2825467|NCT02824198|9679497|P1|Overall Study|Lost to Follow-up|5
2825468|NCT02824198|9679496|P2|Overall Study|Non-compliance with the protocol|1
2825469|NCT02824198|9679497|P1|Overall Study|Non-compliance with the protocol|5
2825470|NCT02823964|9679527|P1|Overall Study|Withdrawal by Subject|1
2825471|NCT02823964|9679527|P1|Overall Study|Lack of Efficacy|1
2825472|NCT02823964|9679527|P1|Overall Study|Physician Decision|1
2825473|NCT02823964|9679527|P1|Overall Study|Adverse Event|2
2825474|NCT02823470|9679541|P2|Overall Study|Study terminated by sponsor|15
2825475|NCT02823470|9679542|P1|Overall Study|Study terminated by sponsor|8
2825476|NCT02823470|9679541|P2|Overall Study|Adverse Event|0
2825477|NCT02823470|9679542|P1|Overall Study|Adverse Event|1
2825478|NCT02822794|9679610|P2|Overall Study|Withdrew Consent|0
2825479|NCT02822794|9679611|P1|Overall Study|Withdrew Consent|1
2825480|NCT02822235|9679712|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
2825481|NCT02822235|9679713|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
2825482|NCT02822235|9679712|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
2825483|NCT02822235|9679713|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
2825484|NCT02822235|9679712|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
2825485|NCT02822235|9679713|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
2825486|NCT02822235|9679712|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
2825487|NCT02822235|9679713|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
2825488|NCT02822235|9679712|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
2825489|NCT02822235|9679713|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
2825490|NCT02822235|9679712|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
2825491|NCT02822235|9679713|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
2825492|NCT02821962|9679768|P2|Overall Study|Lost to Follow-up|0
2825493|NCT02821962|9679769|P1|Overall Study|Lost to Follow-up|2
2825494|NCT02821910|9679813|P6|Overall Study|Other than specified|0
2825495|NCT02821910|9679814|P5|Overall Study|Other than specified|0
2825496|NCT02821910|9679815|P4|Overall Study|Other than specified|0
2825497|NCT02821910|9679816|P3|Overall Study|Other than specified|1
2825498|NCT02821910|9679817|P2|Overall Study|Other than specified|0
2825499|NCT02821910|9679818|P1|Overall Study|Other than specified|1
2825500|NCT02821910|9679813|P6|Overall Study|Withdrawal by Subject|1
2825501|NCT02821910|9679814|P5|Overall Study|Withdrawal by Subject|0
2825502|NCT02821910|9679815|P4|Overall Study|Withdrawal by Subject|0
2825503|NCT02821910|9679816|P3|Overall Study|Withdrawal by Subject|1
2825504|NCT02821910|9679817|P2|Overall Study|Withdrawal by Subject|0
2825505|NCT02821910|9679818|P1|Overall Study|Withdrawal by Subject|0
2825506|NCT02821819|9679880|P1|Overall Study|Protocol Violation|1
2825507|NCT02821000|9679928|P1|Overall Study|Ongoing in Study|58
2825508|NCT02821000|9679928|P1|Overall Study|Withdrawal by Subject|1
2825509|NCT02821000|9679928|P1|Overall Study|Death|44
2825510|NCT02820844|9679966|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
2825511|NCT02820844|9679967|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825512|NCT02820844|9679968|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825513|NCT02820844|9679969|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825514|NCT02820844|9679970|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825515|NCT02820844|9679971|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825516|NCT02820844|9679966|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2825517|NCT02820844|9679967|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
2825518|NCT02820844|9679968|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2825519|NCT02820844|9679969|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2825520|NCT02820844|9679970|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2825521|NCT02820844|9679971|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2825522|NCT02820844|9679966|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825523|NCT02820844|9679967|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825524|NCT02820844|9679968|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
2825525|NCT02820844|9679969|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
2825526|NCT02820844|9679970|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825527|NCT02820844|9679971|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2825528|NCT02820844|9679966|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2825529|NCT02820844|9679967|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2825530|NCT02820844|9679968|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2825531|NCT02820844|9679969|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
2825532|NCT02820844|9679970|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2825533|NCT02820844|9679971|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2825534|NCT02820844|9679966|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2825535|NCT02820844|9679967|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2825536|NCT02820844|9679968|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
2825537|NCT02820844|9679969|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
2825538|NCT02820844|9679970|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2825539|NCT02820844|9679971|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2825540|NCT02820844|9679966|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2825541|NCT02820844|9679967|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2825542|NCT02820844|9679968|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2825543|NCT02820844|9679969|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2825544|NCT02820844|9679970|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2825545|NCT02820844|9679971|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
2825546|NCT02820844|9679966|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2825547|NCT02820844|9679967|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2825548|NCT02820844|9679968|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2825549|NCT02820844|9679969|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2825550|NCT02820844|9679970|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
2825551|NCT02820844|9679971|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
2825552|NCT02820844|9679966|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2825553|NCT02820844|9679967|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2825554|NCT02820844|9679968|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2825555|NCT02820844|9679969|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2825556|NCT02820844|9679970|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
2825557|NCT02820844|9679971|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2825558|NCT02820844|9679966|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2825559|NCT02820844|9679967|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2825560|NCT02820844|9679968|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2825561|NCT02820844|9679969|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2825562|NCT02820844|9679970|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
2825563|NCT02820844|9679971|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
2825564|NCT02820844|9679966|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2825565|NCT02820844|9679967|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2825566|NCT02820844|9679968|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2825567|NCT02820844|9679969|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2825568|NCT02820844|9679970|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
2825569|NCT02820844|9679971|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
2825570|NCT02820597|9680185|P1|Overall Study|Lost to Follow-up|12
2825571|NCT02820038|9680197|P4|Overall Study|Withdrawal by Subject|13
2825572|NCT02820038|9680198|P3|Overall Study|Withdrawal by Subject|3
2825573|NCT02820038|9680199|P2|Overall Study|Withdrawal by Subject|14
2825574|NCT02820038|9680200|P1|Overall Study|Withdrawal by Subject|3
2825575|NCT02820038|9680197|P4|Overall Study|Lost to Follow-up|9
2825576|NCT02820038|9680198|P3|Overall Study|Lost to Follow-up|2
2825577|NCT02820038|9680199|P2|Overall Study|Lost to Follow-up|11
2825578|NCT02820038|9680200|P1|Overall Study|Lost to Follow-up|7
2825579|NCT02819804|9680327|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
2825580|NCT02819726|9680334|P4|Part B (All Participants)|Protocol non-compliance|0
2825581|NCT02819726|9680335|P3|Part B (All Participants)|Protocol non-compliance|1
2825582|NCT02819726|9680336|P2|Part B (All Participants)|Protocol non-compliance|0
2825583|NCT02819726|9680337|P1|Part B (All Participants)|Protocol non-compliance|0
2825584|NCT02819726|9680334|P4|Part B (All Participants)|Withdrawal by Subject|0
2825585|NCT02819726|9680335|P3|Part B (All Participants)|Withdrawal by Subject|1
2825586|NCT02819726|9680336|P2|Part B (All Participants)|Withdrawal by Subject|1
2825587|NCT02819726|9680337|P1|Part B (All Participants)|Withdrawal by Subject|2
2825588|NCT02819726|9680334|P4|Part B (All Participants)|Lost to Follow-up|2
2825589|NCT02819726|9680335|P3|Part B (All Participants)|Lost to Follow-up|2
2825590|NCT02819726|9680336|P2|Part B (All Participants)|Lost to Follow-up|1
2825591|NCT02819726|9680337|P1|Part B (All Participants)|Lost to Follow-up|1
2825592|NCT02819726|9680334|P4|Part A (All Participants)|Protocol non-compliance|0
2825593|NCT02819726|9680335|P3|Part A (All Participants)|Protocol non-compliance|5
2825594|NCT02819726|9680336|P2|Part A (All Participants)|Protocol non-compliance|4
2825595|NCT02819726|9680337|P1|Part A (All Participants)|Protocol non-compliance|3
2825596|NCT02819726|9680334|P4|Part A (All Participants)|Withdrawal by Subject|0
2825597|NCT02819726|9680335|P3|Part A (All Participants)|Withdrawal by Subject|6
2825598|NCT02819726|9680336|P2|Part A (All Participants)|Withdrawal by Subject|5
2825599|NCT02819726|9680337|P1|Part A (All Participants)|Withdrawal by Subject|3
2825600|NCT02819726|9680334|P4|Part A (All Participants)|Lost to Follow-up|0
2825601|NCT02819726|9680335|P3|Part A (All Participants)|Lost to Follow-up|0
2825602|NCT02819726|9680336|P2|Part A (All Participants)|Lost to Follow-up|1
2825603|NCT02819726|9680337|P1|Part A (All Participants)|Lost to Follow-up|0
2825604|NCT02818998|9680480|P3|Overall Study|Withdrawal by Subject|5
2825605|NCT02818998|9680481|P2|Overall Study|Withdrawal by Subject|4
2825606|NCT02818998|9680482|P1|Overall Study|Withdrawal by Subject|4
2825607|NCT02818998|9680480|P3|Overall Study|Death|4
2825608|NCT02818998|9680481|P2|Overall Study|Death|3
2825609|NCT02818998|9680482|P1|Overall Study|Death|2
2825610|NCT02818998|9680480|P3|Overall Study|Other|1
2825611|NCT02818998|9680481|P2|Overall Study|Other|1
2825612|NCT02818998|9680482|P1|Overall Study|Other|0
2825613|NCT02818998|9680480|P3|Overall Study|Missing information|2
2825614|NCT02818998|9680481|P2|Overall Study|Missing information|0
2825615|NCT02818998|9680482|P1|Overall Study|Missing information|0
2825616|NCT02818998|9680480|P3|Overall Study|Lost to Follow-up|2
2825617|NCT02818998|9680481|P2|Overall Study|Lost to Follow-up|0
2825618|NCT02818998|9680482|P1|Overall Study|Lost to Follow-up|2
2825619|NCT02818998|9680480|P3|Overall Study|Adverse Event|0
2825620|NCT02818998|9680481|P2|Overall Study|Adverse Event|0
2825621|NCT02818998|9680482|P1|Overall Study|Adverse Event|3
2825622|NCT02818920|9680503|P1|Overall Study|Refused Further Treatment|1
2825623|NCT02818920|9680503|P1|Overall Study|Developed Other Disease|1
2825624|NCT02818920|9680503|P1|Overall Study|Adverse Event|3
2825625|NCT02818920|9680503|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
2825626|NCT02818920|9680503|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
2825627|NCT02818920|9680503|P1|Overall Study|Unresectable|4
2825628|NCT02818777|9680507|P1|Overall Study|Adverse Event|3
2825629|NCT02818036|9680574|P2|Overall Study|Withdrawal by Subject|0
2825630|NCT02818036|9680575|P1|Overall Study|Withdrawal by Subject|1
2825631|NCT02818036|9680574|P2|Overall Study|head did not fit in fMRI scanner headres|0
2825632|NCT02818036|9680575|P1|Overall Study|head did not fit in fMRI scanner headres|1
2825633|NCT02817841|9680583|P1|Overall Study|Protocol Violation|94
2825634|NCT02817841|9680583|P1|Overall Study|Other reasons|53
2825635|NCT02817841|9680583|P1|Overall Study|Pregnancy wish|17
2825636|NCT02817841|9680583|P1|Overall Study|Pregnancy|32
2825637|NCT02817841|9680583|P1|Overall Study|Adverse event related to bleeding|51
2825638|NCT02817841|9680583|P1|Overall Study|Adverse event not related to bleeding|131
2825639|NCT02817841|9680583|P1|Overall Study|Withdrawal by Subject|183
2825640|NCT02817841|9680583|P1|Overall Study|Lost to Follow-up|287
2825641|NCT02817828|9680610|P1|Overall Study|Other|26
2825642|NCT02817828|9680610|P1|Overall Study|Withdrawal by Subject|78
2825643|NCT02817828|9680610|P1|Overall Study|Pregnancy wish|15
2825644|NCT02817828|9680610|P1|Overall Study|Pregnancy|7
2825645|NCT02817828|9680610|P1|Overall Study|Protocol Violation|11
2825646|NCT02817828|9680610|P1|Overall Study|Adverse event related to bleeding|53
2825647|NCT02817828|9680610|P1|Overall Study|Adverse event not related to bleeding|104
2825648|NCT02817828|9680610|P1|Overall Study|Lost to Follow-up|41
2825649|NCT02817594|9680645|P1|Overall Study|Did Not Receive Treatment|1
2825650|NCT02817594|9680645|P1|Overall Study|Other|1
2825651|NCT02817594|9680645|P1|Overall Study|Withdrawal by Subject|1
2825652|NCT02817555|9680666|P2|Overall Study|changed to Peritoneal Dialysis|1
2825653|NCT02817555|9680667|P1|Overall Study|changed to Peritoneal Dialysis|0
2825654|NCT02817555|9680666|P2|Overall Study|transplant|1
2825655|NCT02817555|9680667|P1|Overall Study|transplant|1
2825656|NCT02817555|9680666|P2|Overall Study|moved away|0
2825657|NCT02817555|9680667|P1|Overall Study|moved away|1
2825658|NCT02817555|9680666|P2|Overall Study|Death|3
2825659|NCT02817555|9680667|P1|Overall Study|Death|1
2825660|NCT02817516|9680687|P4|Overall Study|Other|0
2825661|NCT02817516|9680688|P3|Overall Study|Other|1
2825662|NCT02817516|9680689|P2|Overall Study|Other|0
2825663|NCT02817516|9680690|P1|Overall Study|Other|0
2825664|NCT02816138|9680829|P1|Overall Study|Adverse Event|1
2825665|NCT02815735|9680875|P2|Second Intervention (4 Weeks)|Protocol Violation|0
2825666|NCT02815735|9680876|P1|Second Intervention (4 Weeks)|Protocol Violation|1
2825667|NCT02815735|9680875|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
2825668|NCT02815735|9680876|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
2825669|NCT02815735|9680875|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
2825670|NCT02815735|9680876|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
2825671|NCT02815735|9680875|P2|First Intervention (4 Weeks)|Discomfort|0
2825672|NCT02815735|9680876|P1|First Intervention (4 Weeks)|Discomfort|1
2825673|NCT02815670|9680891|P1|Overall Study|Prematurely discontinued of the trial|1
2825674|NCT02815397|9680923|P1|Overall Study|Physician Decision|2
2825675|NCT02815293|9680933|P3|Overall Study|Adverse Event|0
2825676|NCT02815293|9680934|P2|Overall Study|Adverse Event|1
2825677|NCT02815293|9680935|P1|Overall Study|Adverse Event|0
2825678|NCT02815293|9680933|P3|Overall Study|Participants not randomized|18
2825679|NCT02815293|9680934|P2|Overall Study|Participants not randomized|0
2825680|NCT02815293|9680935|P1|Overall Study|Participants not randomized|0
2825681|NCT02815293|9680933|P3|Overall Study|Study termination by sponsor|0
2825682|NCT02815293|9680934|P2|Overall Study|Study termination by sponsor|7
2825683|NCT02815293|9680935|P1|Overall Study|Study termination by sponsor|10
2825684|NCT02814643|9681050|P2|Overall Study|Withdrawal by Subject|2
2825685|NCT02814643|9681051|P1|Overall Study|Withdrawal by Subject|1
2825686|NCT02814643|9681050|P2|Overall Study|Lost to Follow-up|1
2825687|NCT02814643|9681051|P1|Overall Study|Lost to Follow-up|0
2825688|NCT02814565|9681075|P2|Overall Study|Subject decision, caused by AE Influenza|1
2825689|NCT02814565|9681076|P1|Overall Study|Subject decision, caused by AE Influenza|1
2825690|NCT02814565|9681075|P2|Overall Study|Lack of Efficacy|1
2825691|NCT02814565|9681076|P1|Overall Study|Lack of Efficacy|0
2825692|NCT02813694|9681146|P2|Overall Study|Patient hospitalized|0
2825693|NCT02813694|9681147|P1|Overall Study|Patient hospitalized|1
2825694|NCT02813694|9681146|P2|Overall Study|Randomized- did not receive study drug|0
2825695|NCT02813694|9681147|P1|Overall Study|Randomized- did not receive study drug|2
2825696|NCT02813694|9681146|P2|Overall Study|Death|3
2825697|NCT02813694|9681147|P1|Overall Study|Death|3
2825698|NCT02813694|9681146|P2|Overall Study|Lost to Follow-up|1
2825699|NCT02813694|9681147|P1|Overall Study|Lost to Follow-up|1
2825700|NCT02813694|9681146|P2|Overall Study|Withdrawal by Subject|9
2825701|NCT02813694|9681147|P1|Overall Study|Withdrawal by Subject|10
2825702|NCT02813694|9681146|P2|Overall Study|Physician Decision|1
2825703|NCT02813694|9681147|P1|Overall Study|Physician Decision|0
2825704|NCT02813681|9681160|P3|Overall Study|Lost to Follow-up|0
2825705|NCT02813681|9681161|P2|Overall Study|Lost to Follow-up|1
2825706|NCT02813681|9681162|P1|Overall Study|Lost to Follow-up|0
2825707|NCT02813681|9681160|P3|Overall Study|Physician Decision|0
2825708|NCT02813681|9681161|P2|Overall Study|Physician Decision|5
2825709|NCT02813681|9681162|P1|Overall Study|Physician Decision|5
2825710|NCT02813577|9681183|P1|Overall Study|Study terminated|4
2825711|NCT02812186|9681260|P2|Period 1|nonevaluable data sets|6
2825712|NCT02812186|9681261|P1|Period 1|nonevaluable data sets|6
2825713|NCT02812186|9681260|P2|Period 1|Post randomization screen failure|9
2825714|NCT02812186|9681261|P1|Period 1|Post randomization screen failure|5
2825715|NCT02811159|9681310|P1|Treatment Course 1|Lost to Follow-up|1
2825716|NCT02810457|9681349|P2|Overall Study|Physician Decision|1
2825717|NCT02810457|9681350|P1|Overall Study|Physician Decision|0
2825718|NCT02810457|9681349|P2|Overall Study|Miscalculated PD|0
2825719|NCT02810457|9681350|P1|Overall Study|Miscalculated PD|1
2825720|NCT02810457|9681349|P2|Overall Study|Patient ineligibility|0
2825721|NCT02810457|9681350|P1|Overall Study|Patient ineligibility|3
2825722|NCT02810457|9681349|P2|Overall Study|Investigator decision|2
2825723|NCT02810457|9681350|P1|Overall Study|Investigator decision|3
2825724|NCT02810457|9681349|P2|Overall Study|Clinical progression|16
2825725|NCT02810457|9681350|P1|Overall Study|Clinical progression|15
2825726|NCT02810457|9681349|P2|Overall Study|Ongoing at data cutoff and discontinued|2
2825727|NCT02810457|9681350|P1|Overall Study|Ongoing at data cutoff and discontinued|3
2825728|NCT02810457|9681349|P2|Overall Study|Death|28
2825729|NCT02810457|9681350|P1|Overall Study|Death|39
2825730|NCT02810457|9681349|P2|Overall Study|Patient lost to follow-up|2
2825731|NCT02810457|9681350|P1|Overall Study|Patient lost to follow-up|2
2825732|NCT02810457|9681349|P2|Overall Study|Patient decision|35
2825733|NCT02810457|9681350|P1|Overall Study|Patient decision|31
2825734|NCT02810457|9681349|P2|Overall Study|Adverse Event|43
2825735|NCT02810457|9681350|P1|Overall Study|Adverse Event|37
2825736|NCT02810457|9681349|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
2825737|NCT02810457|9681350|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
2825738|NCT02810457|9681349|P2|Overall Study|Randomised but no treatment received|1
2825739|NCT02810457|9681350|P1|Overall Study|Randomised but no treatment received|2
2825740|NCT02809833|9681407|P1|Overall Study|Missing Information|52
2825741|NCT02809833|9681407|P1|Overall Study|Other|5
2825742|NCT02809833|9681407|P1|Overall Study|Adverse Event (AE)|24
2825743|NCT02809833|9681407|P1|Overall Study|Lost to Follow-up|35
2825744|NCT02809833|9681407|P1|Overall Study|Withdrawal by Subject|34
2825745|NCT02809833|9681407|P1|Overall Study|Noncompliance|1
2825746|NCT02809833|9681407|P1|Overall Study|Remission/Treatment No Longer Needed|3
2825747|NCT02809833|9681407|P1|Overall Study|Lack of Efficacy|89
2825748|NCT02809833|9681407|P1|Overall Study|Intolerance|54
2825749|NCT02809833|9681407|P1|Overall Study|Death|3
2825750|NCT02808975|9681527|P2|Overall Study|Other, not specified|1
2825751|NCT02808975|9681528|P1|Overall Study|Other, not specified|5
2825752|NCT02808975|9681527|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
2825753|NCT02808975|9681528|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
2825754|NCT02808975|9681527|P2|Overall Study|Lost to Follow-up|6
2825755|NCT02808975|9681528|P1|Overall Study|Lost to Follow-up|4
2825756|NCT02808975|9681527|P2|Overall Study|Withdrew consent|8
2825757|NCT02808975|9681528|P1|Overall Study|Withdrew consent|9
2825758|NCT02808975|9681527|P2|Overall Study|Adverse Event|4
2825759|NCT02808975|9681528|P1|Overall Study|Adverse Event|3
2825760|NCT02808338|9681555|P1|Overnight In-lab Polysomonography|Reason not given|1
2825761|NCT02808338|9681555|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
2825762|NCT02808338|9681555|P1|Screening|Screen Failure|10
2825763|NCT02807948|9681616|P2|Overall Study|Physician Decision|0
2825764|NCT02807948|9681617|P1|Overall Study|Physician Decision|1
2825765|NCT02807402|9681622|P1|Overall Study|Other|2
2825766|NCT02807402|9681622|P1|Overall Study|Death|3
2825767|NCT02807402|9681622|P1|Overall Study|Failure to Return|1
2825768|NCT02807376|9681660|P2|Overall Study|Lost to Follow-up|1
2825769|NCT02807376|9681661|P1|Overall Study|Lost to Follow-up|0
2825770|NCT02807376|9681660|P2|Overall Study|Intra-operative exclusion criteria|0
2825771|NCT02807376|9681661|P1|Overall Study|Intra-operative exclusion criteria|3
2825772|NCT02807259|9681671|P2|Endline (3 Months)|migration, refusal, not available|87
2825773|NCT02807259|9681672|P1|Endline (3 Months)|migration, refusal, not available|35
2825774|NCT02807259|9681671|P2|Midline (3 Months)|migration, refusal, not available|34
2825775|NCT02807259|9681672|P1|Midline (3 Months)|migration, refusal, not available|30
2825776|NCT02807259|9681671|P2|Baseline (3 Months)|migration, refusal, not available|112
2825777|NCT02807259|9681672|P1|Baseline (3 Months)|migration, refusal, not available|77
2825778|NCT02806973|9681690|P4|Period 3|Adverse Event|0
2825779|NCT02806973|9681691|P3|Period 3|Adverse Event|1
2825780|NCT02806973|9681692|P2|Period 3|Adverse Event|0
2825781|NCT02806973|9681693|P1|Period 3|Adverse Event|0
2825782|NCT02806973|9681690|P4|Period 3|Withdrawal by Subject|3
2825783|NCT02806973|9681691|P3|Period 3|Withdrawal by Subject|0
2825784|NCT02806973|9681692|P2|Period 3|Withdrawal by Subject|0
2825785|NCT02806973|9681693|P1|Period 3|Withdrawal by Subject|0
2825786|NCT02806973|9681690|P4|Period 1|Adverse Event|1
2825787|NCT02806973|9681691|P3|Period 1|Adverse Event|0
2825788|NCT02806973|9681692|P2|Period 1|Adverse Event|0
2825789|NCT02806973|9681693|P1|Period 1|Adverse Event|0
2825790|NCT02806973|9681690|P4|Period 1|Withdrawal by Subject|1
2825791|NCT02806973|9681691|P3|Period 1|Withdrawal by Subject|1
2825792|NCT02806973|9681692|P2|Period 1|Withdrawal by Subject|2
2825793|NCT02806973|9681693|P1|Period 1|Withdrawal by Subject|0
2825794|NCT02806960|9681727|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
2825795|NCT02806960|9681728|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
2825796|NCT02806960|9681729|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
2825797|NCT02806960|9681730|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
2825798|NCT02806947|9681766|P2|Overall Study|Withdrawal by Subject|1
2825799|NCT02806947|9681767|P1|Overall Study|Withdrawal by Subject|5
2825800|NCT02806726|9681808|P1|Overall Study|Lost to Follow-up|1
2825801|NCT02806713|9681817|P2|Overall Study|cancelled surgery|2
2825802|NCT02806713|9681818|P1|Overall Study|cancelled surgery|1
2825803|NCT02806713|9681817|P2|Overall Study|Urethral injury during procedure|0
2825804|NCT02806713|9681818|P1|Overall Study|Urethral injury during procedure|1
2825805|NCT02806505|9681837|P2|Overall Study|Insufficient therapeutic response|4
2825806|NCT02806505|9681838|P1|Overall Study|Insufficient therapeutic response|2
2825807|NCT02806505|9681837|P2|Overall Study|Failure to return|1
2825808|NCT02806505|9681838|P1|Overall Study|Failure to return|0
2825809|NCT02806505|9681837|P2|Overall Study|Did not cooperate/refused treatment|3
2825810|NCT02806505|9681838|P1|Overall Study|Did not cooperate/refused treatment|3
2825811|NCT02806505|9681837|P2|Overall Study|Death|0
2825812|NCT02806505|9681838|P1|Overall Study|Death|4
2825813|NCT02806505|9681837|P2|Overall Study|Adverse event/intercurrent illness|3
2825814|NCT02806505|9681838|P1|Overall Study|Adverse event/intercurrent illness|1
2825815|NCT02806232|9681857|P9|Overall Study|Withdrawal by Subject|0
2825816|NCT02806232|9681858|P8|Overall Study|Withdrawal by Subject|0
2825817|NCT02806232|9681859|P7|Overall Study|Withdrawal by Subject|0
2825818|NCT02806232|9681860|P6|Overall Study|Withdrawal by Subject|1
2825819|NCT02806232|9681861|P5|Overall Study|Withdrawal by Subject|2
2825820|NCT02806232|9681862|P4|Overall Study|Withdrawal by Subject|0
2825821|NCT02806232|9681863|P3|Overall Study|Withdrawal by Subject|0
2825822|NCT02806232|9681864|P2|Overall Study|Withdrawal by Subject|2
2825823|NCT02806232|9681865|P1|Overall Study|Withdrawal by Subject|0
2825824|NCT02806232|9681857|P9|Overall Study|Lost to Follow-up|0
2825825|NCT02806232|9681858|P8|Overall Study|Lost to Follow-up|0
2825826|NCT02806232|9681859|P7|Overall Study|Lost to Follow-up|0
2825827|NCT02806232|9681860|P6|Overall Study|Lost to Follow-up|1
2825828|NCT02806232|9681861|P5|Overall Study|Lost to Follow-up|0
2825829|NCT02806232|9681862|P4|Overall Study|Lost to Follow-up|0
2825830|NCT02806232|9681863|P3|Overall Study|Lost to Follow-up|1
2825831|NCT02806232|9681864|P2|Overall Study|Lost to Follow-up|2
2825832|NCT02806232|9681865|P1|Overall Study|Lost to Follow-up|1
2825833|NCT02806024|9681905|P2|Overall Study|DVT during antepartum admission|1
2825834|NCT02806024|9681906|P1|Overall Study|DVT during antepartum admission|0
2825835|NCT02806024|9681905|P2|Overall Study|Night Delivery|1
2825836|NCT02806024|9681906|P1|Overall Study|Night Delivery|1
2825837|NCT02805907|9681916|P2|Overall Study|Lost to Follow-up|3
2825838|NCT02805907|9681917|P1|Overall Study|Lost to Follow-up|3
2825839|NCT02804750|9681940|P2|Period 4|Adverse Event|5
2825840|NCT02804750|9681941|P1|Period 4|Adverse Event|0
2825841|NCT02804750|9681940|P2|Period 3|Adverse Event|2
2825842|NCT02804750|9681941|P1|Period 3|Adverse Event|0
2825843|NCT02804750|9681940|P2|Period 2|Adverse Event|0
2825844|NCT02804750|9681941|P1|Period 2|Adverse Event|1
2825845|NCT02804750|9681940|P2|Period 1|Withdrawal by Subject|1
2825846|NCT02804750|9681941|P1|Period 1|Withdrawal by Subject|0
2825847|NCT02804750|9681940|P2|Period 1|Adverse Event|2
2825848|NCT02804750|9681941|P1|Period 1|Adverse Event|0
2825849|NCT02804399|9681968|P2|Period 2|Adverse Event|1
2825850|NCT02804399|9681969|P1|Period 2|Adverse Event|0
2825851|NCT02803580|9682041|P1|Overall Study|Inclusion in clinical trial|1
2825852|NCT02803580|9682041|P1|Overall Study|Withdrawal by Subject|3
2825853|NCT02803580|9682041|P1|Overall Study|Lost to Follow-up|19
2825854|NCT02803580|9682041|P1|Overall Study|Death|13
2825855|NCT02803138|9682080|P1|Overall Study|Other, not specified|28
2825856|NCT02803138|9682080|P1|Overall Study|Death|1
2825857|NCT02803138|9682080|P1|Overall Study|Withdrawn consent|1
2825858|NCT02803138|9682080|P1|Overall Study|Insufficient virological response|2
2825859|NCT02803138|9682080|P1|Overall Study|Failure to return|38
2825860|NCT02802878|9682096|P2|Overall Study|Protocol Violation|0
2825861|NCT02802878|9682097|P1|Overall Study|Protocol Violation|1
2825862|NCT02802878|9682096|P2|Overall Study|Withdrawal by Subject|3
2825863|NCT02802878|9682097|P1|Overall Study|Withdrawal by Subject|3
2825864|NCT02802865|9682113|P2|Overall Study|Ineliegible due to tuberculosis|1
2825865|NCT02802865|9682114|P1|Overall Study|Ineliegible due to tuberculosis|0
2825866|NCT02802865|9682113|P2|Overall Study|Pregnancy|1
2825867|NCT02802865|9682114|P1|Overall Study|Pregnancy|1
2825868|NCT02802592|9682136|P1|Overall Study|Study terminated due to loss of funding|4
2825869|NCT02802345|9682168|P2|Overall Study|Other than listed|5
2825870|NCT02802345|9682169|P1|Overall Study|Other than listed|1
2825871|NCT02802345|9682168|P2|Overall Study|Protocol Violation|1
2825872|NCT02802345|9682169|P1|Overall Study|Protocol Violation|0
2825873|NCT02802345|9682168|P2|Overall Study|Withdrawal by Subject|3
2825874|NCT02802345|9682169|P1|Overall Study|Withdrawal by Subject|3
2825875|NCT02802345|9682168|P2|Overall Study|Adverse Event|20
2825876|NCT02802345|9682169|P1|Overall Study|Adverse Event|28
2825877|NCT02802345|9682168|P2|Overall Study|Not Treated|1
2825878|NCT02802345|9682169|P1|Overall Study|Not Treated|0
2825879|NCT02802319|9682185|P2|Overall Study|Lost to Follow-up|4
2825880|NCT02802319|9682186|P1|Overall Study|Lost to Follow-up|0
2825881|NCT02802319|9682185|P2|Overall Study|Physician Decision|1
2825882|NCT02802319|9682186|P1|Overall Study|Physician Decision|2
2825883|NCT02801877|9682321|P4|Overall Study|Never Started Treatment|0
2825884|NCT02801877|9682322|P3|Overall Study|Never Started Treatment|4
2825885|NCT02801877|9682323|P2|Overall Study|Never Started Treatment|0
2825886|NCT02801877|9682324|P1|Overall Study|Never Started Treatment|2
2825887|NCT02801877|9682321|P4|Overall Study|Lost to Follow-up|0
2825888|NCT02801877|9682322|P3|Overall Study|Lost to Follow-up|2
2825889|NCT02801877|9682323|P2|Overall Study|Lost to Follow-up|1
2825890|NCT02801877|9682324|P1|Overall Study|Lost to Follow-up|1
2825891|NCT02801617|9682344|P2|Overall Study|Protocol Violation|6
2825892|NCT02801617|9682345|P1|Overall Study|Protocol Violation|2
2825893|NCT02801578|9682363|P1|Overall Study|Adverse Event|2
2825894|NCT02801396|9682367|P6|Period 1|Withdrawal by Subject|0
2825895|NCT02801396|9682368|P5|Period 1|Withdrawal by Subject|1
2825896|NCT02801396|9682369|P4|Period 1|Withdrawal by Subject|0
2825897|NCT02801396|9682370|P3|Period 1|Withdrawal by Subject|0
2825898|NCT02801396|9682371|P2|Period 1|Withdrawal by Subject|0
2825899|NCT02801396|9682372|P1|Period 1|Withdrawal by Subject|0
2825900|NCT02800928|9682406|P2|Overall Study|Protocol Violation|1
2825901|NCT02800928|9682407|P1|Overall Study|Protocol Violation|1
2825902|NCT02800928|9682406|P2|Overall Study|Withdrawal by Subject|1
2825903|NCT02800928|9682407|P1|Overall Study|Withdrawal by Subject|1
2825904|NCT02799784|9682433|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
2825905|NCT02799784|9682434|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
2825906|NCT02799784|9682433|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
2825907|NCT02799784|9682434|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
2825908|NCT02799784|9682433|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
2825909|NCT02799784|9682434|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
2825910|NCT02799784|9682433|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
2825911|NCT02799784|9682434|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
2825912|NCT02799784|9682433|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
2825913|NCT02799784|9682434|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
2825914|NCT02799784|9682433|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2825915|NCT02799784|9682434|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2825916|NCT02799472|9682442|P2|Overall Study|Lost to Follow-up|1
2825917|NCT02799472|9682443|P1|Overall Study|Lost to Follow-up|0
2825918|NCT02799472|9682442|P2|Overall Study|Lack of Efficacy|0
2825919|NCT02799472|9682443|P1|Overall Study|Lack of Efficacy|2
2825920|NCT02799472|9682442|P2|Overall Study|Withdrawal by Subject|4
2825921|NCT02799472|9682443|P1|Overall Study|Withdrawal by Subject|2
2825922|NCT02799082|9682503|P2|Overall Study|Protocol Violation|1
2825923|NCT02799082|9682504|P1|Overall Study|Protocol Violation|0
2825924|NCT02799082|9682503|P2|Overall Study|Refused second PDT or withdraw consent|3
2825925|NCT02799082|9682504|P1|Overall Study|Refused second PDT or withdraw consent|4
2825926|NCT02799069|9682541|P3|Overall Study|Protocol Violation|2
2825927|NCT02799069|9682542|P2|Overall Study|Protocol Violation|0
2825928|NCT02799069|9682543|P1|Overall Study|Protocol Violation|1
2825929|NCT02799069|9682541|P3|Overall Study|Withdrawal by Subject|3
2825930|NCT02799069|9682542|P2|Overall Study|Withdrawal by Subject|4
2825931|NCT02799069|9682543|P1|Overall Study|Withdrawal by Subject|4
2825932|NCT02799069|9682541|P3|Overall Study|Lost to Follow-up|0
2825933|NCT02799069|9682542|P2|Overall Study|Lost to Follow-up|1
2825934|NCT02799069|9682543|P1|Overall Study|Lost to Follow-up|1
2825935|NCT02799069|9682541|P3|Overall Study|Lack of Efficacy|0
2825936|NCT02799069|9682542|P2|Overall Study|Lack of Efficacy|0
2825937|NCT02799069|9682543|P1|Overall Study|Lack of Efficacy|2
2825938|NCT02799069|9682541|P3|Overall Study|Adverse Event|2
2825939|NCT02799069|9682542|P2|Overall Study|Adverse Event|2
2825940|NCT02799069|9682543|P1|Overall Study|Adverse Event|0
2825941|NCT02798315|9682912|P1|Overall Study|Failure to return|1
2825942|NCT02797678|9682946|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
2825943|NCT02797678|9682947|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
2825944|NCT02797678|9682948|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
2825945|NCT02797678|9682949|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
2825946|NCT02797678|9682946|P4|First Intervention (5 Nights)|study/device use non-compliance|0
2825947|NCT02797678|9682947|P3|First Intervention (5 Nights)|study/device use non-compliance|0
2825948|NCT02797678|9682948|P2|First Intervention (5 Nights)|study/device use non-compliance|1
2825949|NCT02797678|9682949|P1|First Intervention (5 Nights)|study/device use non-compliance|0
2825950|NCT02797678|9682946|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2825951|NCT02797678|9682947|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2825952|NCT02797678|9682948|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2825953|NCT02797678|9682949|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
2825954|NCT02797522|9682984|P11|Overall Study|Study Terminated by Sponsor|1
2825955|NCT02797522|9682985|P10|Overall Study|Study Terminated by Sponsor|4
2825956|NCT02797522|9682986|P9|Overall Study|Study Terminated by Sponsor|2
2825957|NCT02797522|9682987|P8|Overall Study|Study Terminated by Sponsor|4
2825958|NCT02797522|9682988|P7|Overall Study|Study Terminated by Sponsor|0
2825959|NCT02797522|9682989|P6|Overall Study|Study Terminated by Sponsor|0
2825960|NCT02797522|9682990|P5|Overall Study|Study Terminated by Sponsor|0
2825961|NCT02797522|9682991|P4|Overall Study|Study Terminated by Sponsor|0
2825962|NCT02797522|9682992|P3|Overall Study|Study Terminated by Sponsor|0
2825963|NCT02797522|9682993|P2|Overall Study|Study Terminated by Sponsor|0
2825964|NCT02797522|9682994|P1|Overall Study|Study Terminated by Sponsor|0
2825965|NCT02797132|9683100|P1|Part B (24 Weeks)|Adverse Event|3
2825966|NCT02797132|9683100|P1|Part A (15 Days)|Adverse Event|1
2825967|NCT02797080|9683152|P1|Overall Study|Withdrawal by Subject|1
2825968|NCT02797080|9683152|P1|Overall Study|Lost to Follow-up|1
2825969|NCT02796963|9683194|P4|Overall Study|Lost to Follow-up|72
2825970|NCT02796963|9683195|P3|Overall Study|Lost to Follow-up|69
2825971|NCT02796963|9683196|P2|Overall Study|Lost to Follow-up|76
2825972|NCT02796963|9683197|P1|Overall Study|Lost to Follow-up|89
2825973|NCT02796677|9683263|P4|Overall Study|Reason not mentioned|5
2825974|NCT02796677|9683264|P3|Overall Study|Reason not mentioned|0
2825975|NCT02796677|9683265|P2|Overall Study|Reason not mentioned|3
2825976|NCT02796677|9683266|P1|Overall Study|Reason not mentioned|2
2825977|NCT02796677|9683263|P4|Overall Study|Progressive disease|18
2825978|NCT02796677|9683264|P3|Overall Study|Progressive disease|13
2825979|NCT02796677|9683265|P2|Overall Study|Progressive disease|15
2825980|NCT02796677|9683266|P1|Overall Study|Progressive disease|6
2825981|NCT02796677|9683263|P4|Overall Study|Withdrawal by Subject|7
2825982|NCT02796677|9683264|P3|Overall Study|Withdrawal by Subject|6
2825983|NCT02796677|9683265|P2|Overall Study|Withdrawal by Subject|14
2825984|NCT02796677|9683266|P1|Overall Study|Withdrawal by Subject|4
2825985|NCT02796677|9683263|P4|Overall Study|Lack of Efficacy|20
2825986|NCT02796677|9683264|P3|Overall Study|Lack of Efficacy|14
2825987|NCT02796677|9683265|P2|Overall Study|Lack of Efficacy|9
2825988|NCT02796677|9683266|P1|Overall Study|Lack of Efficacy|7
2825989|NCT02796677|9683263|P4|Overall Study|Lost to Follow-up|2
2825990|NCT02796677|9683264|P3|Overall Study|Lost to Follow-up|2
2825991|NCT02796677|9683265|P2|Overall Study|Lost to Follow-up|5
2825992|NCT02796677|9683266|P1|Overall Study|Lost to Follow-up|1
2825993|NCT02796677|9683263|P4|Overall Study|Protocol Violation|8
2825994|NCT02796677|9683264|P3|Overall Study|Protocol Violation|4
2825995|NCT02796677|9683265|P2|Overall Study|Protocol Violation|5
2825996|NCT02796677|9683266|P1|Overall Study|Protocol Violation|7
2825997|NCT02796677|9683263|P4|Overall Study|Adverse Event|14
2825998|NCT02796677|9683264|P3|Overall Study|Adverse Event|14
2825999|NCT02796677|9683265|P2|Overall Study|Adverse Event|22
2826000|NCT02796677|9683266|P1|Overall Study|Adverse Event|11
2826001|NCT02796651|9683290|P1|Overall Study|Other|10
2826002|NCT02796651|9683290|P1|Overall Study|Lack of Efficacy|1
2826003|NCT02796651|9683290|P1|Overall Study|Protocol Violation|4
2826004|NCT02796651|9683290|P1|Overall Study|Withdrawal by Subject|4
2826005|NCT02796651|9683290|P1|Overall Study|Lost to Follow-up|1
2826006|NCT02796651|9683290|P1|Overall Study|Adverse Event|6
2826007|NCT02795832|9683384|P6|Overall Study|Adverse Event|3
2826008|NCT02795832|9683385|P5|Overall Study|Adverse Event|0
2826009|NCT02795832|9683386|P4|Overall Study|Adverse Event|0
2826010|NCT02795832|9683387|P3|Overall Study|Adverse Event|0
2826011|NCT02795832|9683388|P2|Overall Study|Adverse Event|0
2826012|NCT02795832|9683389|P1|Overall Study|Adverse Event|0
2826013|NCT02795767|9683456|P3|Overall Study|Lack of Efficacy|1
2826014|NCT02795767|9683457|P2|Overall Study|Lack of Efficacy|0
2826015|NCT02795767|9683458|P1|Overall Study|Lack of Efficacy|0
2826016|NCT02795767|9683456|P3|Overall Study|Ongoing Study Treatment|9
2826017|NCT02795767|9683457|P2|Overall Study|Ongoing Study Treatment|10
2826018|NCT02795767|9683458|P1|Overall Study|Ongoing Study Treatment|66
2826019|NCT02795767|9683456|P3|Overall Study|Received Commercial Emicizumab|0
2826020|NCT02795767|9683457|P2|Overall Study|Received Commercial Emicizumab|0
2826021|NCT02795767|9683458|P1|Overall Study|Received Commercial Emicizumab|2
2826022|NCT02794974|9683579|P2|Overall Study|Physician Decision|1
2826023|NCT02794974|9683580|P1|Overall Study|Physician Decision|0
2826024|NCT02794870|9683596|P2|Overall Study|Withdrawal by Subject|0
2826025|NCT02794870|9683597|P1|Overall Study|Withdrawal by Subject|2
2826026|NCT02794480|9683645|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2826027|NCT02794480|9683646|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2826028|NCT02794480|9683647|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2826029|NCT02794480|9683648|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2826030|NCT02794480|9683645|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2826031|NCT02794480|9683646|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2826032|NCT02794480|9683647|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
2826033|NCT02794480|9683648|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2826034|NCT02794480|9683645|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
2826035|NCT02794480|9683646|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2826036|NCT02794480|9683647|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2826037|NCT02794480|9683648|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2826038|NCT02794480|9683645|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2826039|NCT02794480|9683646|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
2826040|NCT02794480|9683647|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2826041|NCT02794480|9683648|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2826042|NCT02794480|9683645|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2826043|NCT02794480|9683646|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
2826044|NCT02794480|9683647|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2826045|NCT02794480|9683648|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2826046|NCT02794246|9683691|P1|Overall Study|Physician Decision|4
2826047|NCT02794246|9683691|P1|Overall Study|Withdrawal by Subject|2
2826048|NCT02794103|9683703|P1|Overall Study|Loss to follow up due to high sedation|3
2826049|NCT02793947|9683714|P2|Overall Study|Physician Decision|5
2826050|NCT02793947|9683715|P1|Overall Study|Physician Decision|1
2826051|NCT02793947|9683714|P2|Overall Study|Death|0
2826052|NCT02793947|9683715|P1|Overall Study|Death|1
2826053|NCT02793232|9683770|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826054|NCT02793232|9683771|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826055|NCT02793232|9683772|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2826056|NCT02793232|9683773|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826057|NCT02793232|9683774|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2826058|NCT02793232|9683775|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826059|NCT02793232|9683776|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826060|NCT02793232|9683777|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826061|NCT02793232|9683778|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2826062|NCT02792829|9684039|P8|Treatment Period 2|Use of proscribed medications|1
2826063|NCT02792829|9684040|P7|Treatment Period 2|Use of proscribed medications|0
2826064|NCT02792829|9684041|P6|Treatment Period 2|Use of proscribed medications|0
2826065|NCT02792829|9684042|P5|Treatment Period 2|Use of proscribed medications|0
2826066|NCT02792829|9684043|P4|Treatment Period 2|Use of proscribed medications|0
2826067|NCT02792829|9684044|P3|Treatment Period 2|Use of proscribed medications|0
2826068|NCT02792829|9684045|P2|Treatment Period 2|Use of proscribed medications|0
2826069|NCT02792829|9684046|P1|Treatment Period 2|Use of proscribed medications|0
2826070|NCT02792829|9684039|P8|Treatment Period 2|Adverse Event|1
2826071|NCT02792829|9684040|P7|Treatment Period 2|Adverse Event|1
2826072|NCT02792829|9684041|P6|Treatment Period 2|Adverse Event|0
2826073|NCT02792829|9684042|P5|Treatment Period 2|Adverse Event|1
2826074|NCT02792829|9684043|P4|Treatment Period 2|Adverse Event|0
2826075|NCT02792829|9684044|P3|Treatment Period 2|Adverse Event|0
2826076|NCT02792829|9684045|P2|Treatment Period 2|Adverse Event|0
2826077|NCT02792829|9684046|P1|Treatment Period 2|Adverse Event|0
2826078|NCT02792829|9684039|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
2826079|NCT02792829|9684040|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
2826080|NCT02792829|9684041|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
2826081|NCT02792829|9684042|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
2826082|NCT02792829|9684043|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
2826083|NCT02792829|9684044|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
2826084|NCT02792829|9684045|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
2826085|NCT02792829|9684046|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
2826086|NCT02792777|9684154|P2|Overall Study|Participant interviewed twice|0
2826087|NCT02792777|9684155|P1|Overall Study|Participant interviewed twice|1
2826088|NCT02792777|9684154|P2|Overall Study|Later determined to be ineligible|0
2826089|NCT02792777|9684155|P1|Overall Study|Later determined to be ineligible|2
2826090|NCT02792777|9684154|P2|Overall Study|Recording malfunction|0
2826091|NCT02792777|9684155|P1|Overall Study|Recording malfunction|2
2826092|NCT02792777|9684154|P2|Overall Study|Withdrawal by Subject|0
2826093|NCT02792777|9684155|P1|Overall Study|Withdrawal by Subject|2
2826094|NCT02792699|9684171|P3|Overall Study|Other|0
2826095|NCT02792699|9684172|P2|Overall Study|Other|0
2826096|NCT02792699|9684173|P1|Overall Study|Other|1
2826097|NCT02792699|9684171|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
2826098|NCT02792699|9684172|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
2826099|NCT02792699|9684173|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
2826100|NCT02792699|9684171|P3|Overall Study|Physician Decision|0
2826101|NCT02792699|9684172|P2|Overall Study|Physician Decision|0
2826102|NCT02792699|9684173|P1|Overall Study|Physician Decision|2
2826103|NCT02792699|9684171|P3|Overall Study|Lost to Follow-up|2
2826104|NCT02792699|9684172|P2|Overall Study|Lost to Follow-up|1
2826105|NCT02792699|9684173|P1|Overall Study|Lost to Follow-up|0
2826106|NCT02792699|9684171|P3|Overall Study|Withdrawal by Subject|3
2826107|NCT02792699|9684172|P2|Overall Study|Withdrawal by Subject|4
2826108|NCT02792699|9684173|P1|Overall Study|Withdrawal by Subject|4
2826109|NCT02792699|9684171|P3|Overall Study|Adverse Event|4
2826110|NCT02792699|9684172|P2|Overall Study|Adverse Event|2
2826111|NCT02792699|9684173|P1|Overall Study|Adverse Event|1
2826112|NCT02792517|9684254|P1|Overall Study|Lost to Follow-up|3
2826113|NCT02792517|9684254|P1|Overall Study|Decision by Sponsor|7
2826114|NCT02792517|9684254|P1|Overall Study|Withdrawal by Subject|10
2826115|NCT02792062|9684274|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2826116|NCT02792062|9684275|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2826117|NCT02792062|9684276|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2826118|NCT02792062|9684277|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2826119|NCT02792062|9684278|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2826120|NCT02792062|9684279|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
2826121|NCT02791763|9684331|P3|Overall Study|Adverse Event|7
2826122|NCT02791763|9684332|P2|Overall Study|Adverse Event|13
2826123|NCT02791763|9684333|P1|Overall Study|Adverse Event|12
2826124|NCT02791763|9684331|P3|Overall Study|Met hemoglobin stopping criteria|0
2826125|NCT02791763|9684332|P2|Overall Study|Met hemoglobin stopping criteria|0
2826126|NCT02791763|9684333|P1|Overall Study|Met hemoglobin stopping criteria|1
2826127|NCT02791763|9684331|P3|Overall Study|Participant had renal transplant|0
2826128|NCT02791763|9684332|P2|Overall Study|Participant had renal transplant|0
2826129|NCT02791763|9684333|P1|Overall Study|Participant had renal transplant|3
2826130|NCT02791763|9684331|P3|Overall Study|Cancer event|0
2826131|NCT02791763|9684332|P2|Overall Study|Cancer event|3
2826132|NCT02791763|9684333|P1|Overall Study|Cancer event|1
2826133|NCT02791763|9684331|P3|Overall Study|Needs maintenance/changes in dialysis|5
2826134|NCT02791763|9684332|P2|Overall Study|Needs maintenance/changes in dialysis|19
2826135|NCT02791763|9684333|P1|Overall Study|Needs maintenance/changes in dialysis|16
2826136|NCT02791763|9684331|P3|Overall Study|Physician Decision|0
2826137|NCT02791763|9684332|P2|Overall Study|Physician Decision|1
2826138|NCT02791763|9684333|P1|Overall Study|Physician Decision|0
2826139|NCT02791763|9684331|P3|Overall Study|Withdrawal by Subject|0
2826140|NCT02791763|9684332|P2|Overall Study|Withdrawal by Subject|1
2826141|NCT02791763|9684333|P1|Overall Study|Withdrawal by Subject|5
2826142|NCT02791763|9684331|P3|Overall Study|Protocol Violation|1
2826143|NCT02791763|9684332|P2|Overall Study|Protocol Violation|0
2826144|NCT02791763|9684333|P1|Overall Study|Protocol Violation|0
2826145|NCT02791659|9684452|P2|Overall Study|Protocol Violation|1
2826146|NCT02791659|9684453|P1|Overall Study|Protocol Violation|0
2826147|NCT02791516|9684461|P2|Overall Study|Withdrawal by Subject|1
2826148|NCT02791516|9684462|P1|Overall Study|Withdrawal by Subject|1
2826149|NCT02791490|9684474|P2|Overall Study|Withdrawal by Subject|6
2826150|NCT02791490|9684475|P1|Overall Study|Withdrawal by Subject|2
2826151|NCT02791490|9684474|P2|Overall Study|Lost to Follow-up|2
2826152|NCT02791490|9684475|P1|Overall Study|Lost to Follow-up|1
2826153|NCT02791438|9684495|P2|Treatment Period|Withdrawal by Parent/Guardian|0
2826154|NCT02791438|9684496|P1|Treatment Period|Withdrawal by Parent/Guardian|2
2826155|NCT02791438|9684495|P2|Treatment Period|Withdrawal by Subject|1
2826156|NCT02791438|9684496|P1|Treatment Period|Withdrawal by Subject|0
2826157|NCT02791438|9684495|P2|Treatment Period|Adverse Event|0
2826158|NCT02791438|9684496|P1|Treatment Period|Adverse Event|1
2826159|NCT02791269|9684537|P2|Overall Study|Lost to Follow-up|1
2826160|NCT02791269|9684538|P1|Overall Study|Lost to Follow-up|0
2826161|NCT02790606|9684616|P1|Overall Study|Withdrawal by Subject|1
2826162|NCT02790606|9684616|P1|Overall Study|Physician Decision|3
2826163|NCT02790606|9684616|P1|Overall Study|Lost to Follow-up|4
2826164|NCT02790606|9684616|P1|Overall Study|Death|27
2826165|NCT02790073|9684648|P1|Overall Study|Withdrawal by Subject|1
2826166|NCT02790073|9684648|P1|Overall Study|Withdrawal from HD|1
2826167|NCT02790073|9684648|P1|Overall Study|Death|1
2826168|NCT02788747|9684670|P3|Overall Study|Adverse Event|0
2826169|NCT02788747|9684671|P2|Overall Study|Adverse Event|0
2826170|NCT02788747|9684672|P1|Overall Study|Adverse Event|1
2826171|NCT02788656|9684742|P2|Overall Study|Withdrawal by Subject|0
2826172|NCT02788656|9684743|P1|Overall Study|Withdrawal by Subject|1
2826173|NCT02788474|9684765|P2|Open Label Treatment Period|Non-compliance|0
2826174|NCT02788474|9684766|P1|Open Label Treatment Period|Non-compliance|1
2826175|NCT02788474|9684765|P2|Open Label Treatment Period|Patient's refusal|3
2826176|NCT02788474|9684766|P1|Open Label Treatment Period|Patient's refusal|1
2826177|NCT02788474|9684765|P2|Open Label Treatment Period|Other than reason specified|0
2826178|NCT02788474|9684766|P1|Open Label Treatment Period|Other than reason specified|1
2826179|NCT02788474|9684765|P2|Open Label Treatment Period|Adverse Event|9
2826180|NCT02788474|9684766|P1|Open Label Treatment Period|Adverse Event|29
2826181|NCT02788474|9684765|P2|Double Blind Treatment Period|Adverse Event|4
2826182|NCT02788474|9684766|P1|Double Blind Treatment Period|Adverse Event|6
2826183|NCT02788474|9684765|P2|Double Blind Treatment Period|Patient's refusal|0
2826184|NCT02788474|9684766|P1|Double Blind Treatment Period|Patient's refusal|3
2826185|NCT02788474|9684765|P2|Double Blind Treatment Period|Not treated|0
2826186|NCT02788474|9684766|P1|Double Blind Treatment Period|Not treated|1
2826187|NCT02788357|9684781|P2|Overall Study|Lost to Follow-up|0
2826188|NCT02788357|9684782|P1|Overall Study|Lost to Follow-up|3
2826189|NCT02788279|9684797|P3|Overall Study|Sponsor decision|11
2826190|NCT02788279|9684798|P2|Overall Study|Sponsor decision|29
2826191|NCT02788279|9684799|P1|Overall Study|Sponsor decision|18
2826192|NCT02788279|9684797|P3|Overall Study|Lost to Follow-up|2
2826193|NCT02788279|9684798|P2|Overall Study|Lost to Follow-up|3
2826194|NCT02788279|9684799|P1|Overall Study|Lost to Follow-up|0
2826195|NCT02788279|9684797|P3|Overall Study|Withdrawal by Subject|5
2826196|NCT02788279|9684798|P2|Overall Study|Withdrawal by Subject|15
2826197|NCT02788279|9684799|P1|Overall Study|Withdrawal by Subject|10
2826198|NCT02788279|9684797|P3|Overall Study|Death|72
2826199|NCT02788279|9684798|P2|Overall Study|Death|136
2826200|NCT02788279|9684799|P1|Overall Study|Death|62
2826201|NCT02788175|9684859|P1|Overall Study|Ineligible prior to study agent|6
2826202|NCT02788175|9684859|P1|Overall Study|Withdrawal by Subject|4
2826203|NCT02788175|9684859|P1|Overall Study|Protocol Violation|3
2826204|NCT02787863|9684881|P8|Overall Study|Withdrawal by Subject|0
2826205|NCT02787863|9684882|P7|Overall Study|Withdrawal by Subject|0
2826206|NCT02787863|9684883|P6|Overall Study|Withdrawal by Subject|0
2826207|NCT02787863|9684884|P5|Overall Study|Withdrawal by Subject|0
2826208|NCT02787863|9684885|P4|Overall Study|Withdrawal by Subject|0
2826209|NCT02787863|9684886|P3|Overall Study|Withdrawal by Subject|1
2826210|NCT02787863|9684887|P2|Overall Study|Withdrawal by Subject|1
2826211|NCT02787863|9684888|P1|Overall Study|Withdrawal by Subject|0
2826212|NCT02787863|9684881|P8|Overall Study|Death|0
2826213|NCT02787863|9684882|P7|Overall Study|Death|0
2826214|NCT02787863|9684883|P6|Overall Study|Death|0
2826215|NCT02787863|9684884|P5|Overall Study|Death|0
2826216|NCT02787863|9684885|P4|Overall Study|Death|0
2826217|NCT02787863|9684886|P3|Overall Study|Death|1
2826218|NCT02787863|9684887|P2|Overall Study|Death|0
2826219|NCT02787863|9684888|P1|Overall Study|Death|1
2826220|NCT02787551|9684973|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
2826221|NCT02787551|9684974|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
2826222|NCT02787551|9684973|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
2826223|NCT02787551|9684974|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
2826224|NCT02787551|9684973|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
2826225|NCT02787551|9684974|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
2826226|NCT02787551|9684973|P2|Core Period: 26 Weeks|Other than specified|1
2826227|NCT02787551|9684974|P1|Core Period: 26 Weeks|Other than specified|3
2826228|NCT02787551|9684973|P2|Core Period: 26 Weeks|Randomized but not treated|1
2826229|NCT02787551|9684974|P1|Core Period: 26 Weeks|Randomized but not treated|2
2826230|NCT02787551|9684973|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
2826231|NCT02787551|9684974|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
2826232|NCT02787551|9684973|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
2826233|NCT02787551|9684974|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
2826234|NCT02787551|9684973|P2|Core Period: 26 Weeks|Lack of Efficacy|0
2826235|NCT02787551|9684974|P1|Core Period: 26 Weeks|Lack of Efficacy|1
2826236|NCT02787551|9684973|P2|Core Period: 26 Weeks|Adverse Event|0
2826237|NCT02787551|9684974|P1|Core Period: 26 Weeks|Adverse Event|10
2826238|NCT02787304|9685010|P4|Overall Study|Study terminated by sponsor|32
2826239|NCT02787304|9685011|P3|Overall Study|Study terminated by sponsor|31
2826240|NCT02787304|9685012|P2|Overall Study|Study terminated by sponsor|31
2826241|NCT02787304|9685013|P1|Overall Study|Study terminated by sponsor|25
2826242|NCT02787304|9685010|P4|Overall Study|Physician Decision|0
2826243|NCT02787304|9685011|P3|Overall Study|Physician Decision|1
2826244|NCT02787304|9685012|P2|Overall Study|Physician Decision|0
2826245|NCT02787304|9685013|P1|Overall Study|Physician Decision|0
2826246|NCT02787304|9685010|P4|Overall Study|Noncompliance with study drug|0
2826247|NCT02787304|9685011|P3|Overall Study|Noncompliance with study drug|1
2826248|NCT02787304|9685012|P2|Overall Study|Noncompliance with study drug|0
2826249|NCT02787304|9685013|P1|Overall Study|Noncompliance with study drug|0
2826250|NCT02787304|9685010|P4|Overall Study|Lost to Follow-up|1
2826251|NCT02787304|9685011|P3|Overall Study|Lost to Follow-up|0
2826252|NCT02787304|9685012|P2|Overall Study|Lost to Follow-up|0
2826253|NCT02787304|9685013|P1|Overall Study|Lost to Follow-up|1
2826254|NCT02787304|9685010|P4|Overall Study|Withdrawal by Subject|0
2826255|NCT02787304|9685011|P3|Overall Study|Withdrawal by Subject|0
2826256|NCT02787304|9685012|P2|Overall Study|Withdrawal by Subject|4
2826257|NCT02787304|9685013|P1|Overall Study|Withdrawal by Subject|1
2826258|NCT02787304|9685010|P4|Overall Study|Adverse Event|1
2826259|NCT02787304|9685011|P3|Overall Study|Adverse Event|8
2826260|NCT02787304|9685012|P2|Overall Study|Adverse Event|3
2826261|NCT02787304|9685013|P1|Overall Study|Adverse Event|9
2826262|NCT02787083|9685061|P2|Overall Study|Withdrawal by Subject|2
2826263|NCT02787083|9685062|P1|Overall Study|Withdrawal by Subject|2
2826264|NCT02787083|9685061|P2|Overall Study|Adverse Event|0
2826265|NCT02787083|9685062|P1|Overall Study|Adverse Event|1
2826266|NCT02786953|9685087|P2|Overall Study|Physician Decision|1
2826267|NCT02786953|9685088|P1|Overall Study|Physician Decision|0
2826268|NCT02786953|9685087|P2|Overall Study|Withdrawal by Subject|0
2826269|NCT02786953|9685088|P1|Overall Study|Withdrawal by Subject|3
2826270|NCT02786927|9685110|P1|Overall Study|Protocol Violation|4
2826271|NCT02786927|9685110|P1|Overall Study|Adverse Event|1
2826272|NCT02786901|9685120|P3|Overall Study|Randomized in error|1
2826273|NCT02786901|9685121|P2|Overall Study|Randomized in error|0
2826274|NCT02786901|9685122|P1|Overall Study|Randomized in error|2
2826275|NCT02786901|9685120|P3|Overall Study|Disallowed medication|0
2826276|NCT02786901|9685121|P2|Overall Study|Disallowed medication|1
2826277|NCT02786901|9685122|P1|Overall Study|Disallowed medication|1
2826278|NCT02786901|9685120|P3|Overall Study|Subject Request/Lost to Follow up|5
2826279|NCT02786901|9685121|P2|Overall Study|Subject Request/Lost to Follow up|5
2826280|NCT02786901|9685122|P1|Overall Study|Subject Request/Lost to Follow up|1
2826281|NCT02786901|9685120|P3|Overall Study|Rescue Therapy Use|33
2826282|NCT02786901|9685121|P2|Overall Study|Rescue Therapy Use|49
2826283|NCT02786901|9685122|P1|Overall Study|Rescue Therapy Use|71
2826284|NCT02786901|9685120|P3|Overall Study|Physician Decision|0
2826285|NCT02786901|9685121|P2|Overall Study|Physician Decision|0
2826286|NCT02786901|9685122|P1|Overall Study|Physician Decision|1
2826287|NCT02786901|9685120|P3|Overall Study|Adverse Event|2
2826288|NCT02786901|9685121|P2|Overall Study|Adverse Event|1
2826289|NCT02786901|9685122|P1|Overall Study|Adverse Event|1
2826290|NCT02786004|9685180|P2|Overall Study|Withdrawal by Subject|1
2826291|NCT02786004|9685181|P1|Overall Study|Withdrawal by Subject|0
2826292|NCT02785913|9685189|P1|Overall Study|Ineligible|4
2826293|NCT02785913|9685189|P1|Overall Study|Never Received Treatment|1
2826294|NCT02785913|9685189|P1|Overall Study|Not protocol specified|1
2826295|NCT02785913|9685189|P1|Overall Study|Progression|18
2826296|NCT02785913|9685189|P1|Overall Study|Death|2
2826297|NCT02785913|9685189|P1|Overall Study|Adverse Event|5
2826298|NCT02785900|9685198|P2|Overall Study|Physician Decision|2
2826299|NCT02785900|9685199|P1|Overall Study|Physician Decision|3
2826300|NCT02785900|9685198|P2|Overall Study|Withdrawal by Subject|8
2826301|NCT02785900|9685199|P1|Overall Study|Withdrawal by Subject|4
2826302|NCT02785900|9685198|P2|Overall Study|Death|32
2826303|NCT02785900|9685199|P1|Overall Study|Death|46
2826304|NCT02785900|9685198|P2|Overall Study|Study Termination by Sponsor|81
2826305|NCT02785900|9685199|P1|Overall Study|Study Termination by Sponsor|64
2826306|NCT02785770|9685223|P4|Intervention Period 3 (1 Day)|Adverse Event|1
2826307|NCT02785770|9685224|P3|Intervention Period 3 (1 Day)|Adverse Event|0
2826308|NCT02785770|9685225|P2|Intervention Period 3 (1 Day)|Adverse Event|0
2826309|NCT02785770|9685226|P1|Intervention Period 3 (1 Day)|Adverse Event|0
2826310|NCT02785770|9685223|P4|Intervention Period 2 (1 Day)|Family related obligations|0
2826311|NCT02785770|9685224|P3|Intervention Period 2 (1 Day)|Family related obligations|1
2826312|NCT02785770|9685225|P2|Intervention Period 2 (1 Day)|Family related obligations|0
2826313|NCT02785770|9685226|P1|Intervention Period 2 (1 Day)|Family related obligations|0
2826314|NCT02785770|9685223|P4|Intervention Period 2 (1 Day)|Adverse Event|0
2826315|NCT02785770|9685224|P3|Intervention Period 2 (1 Day)|Adverse Event|0
2826316|NCT02785770|9685225|P2|Intervention Period 2 (1 Day)|Adverse Event|1
2826317|NCT02785770|9685226|P1|Intervention Period 2 (1 Day)|Adverse Event|0
2826318|NCT02785588|9685293|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
2826319|NCT02785588|9685293|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
2826320|NCT02784834|9685420|P1|Overall Study|Lack of Efficacy|1
2826321|NCT02784704|9685426|P2|Overall Study|Subject Non Compliance|0
2826322|NCT02784704|9685427|P1|Overall Study|Subject Non Compliance|2
2826323|NCT02784704|9685426|P2|Overall Study|Withdrawal by Subject|3
2826324|NCT02784704|9685427|P1|Overall Study|Withdrawal by Subject|1
2826325|NCT02784704|9685426|P2|Overall Study|Lost to Follow-up|4
2826326|NCT02784704|9685427|P1|Overall Study|Lost to Follow-up|6
2826327|NCT02784704|9685426|P2|Overall Study|Adverse Event|2
2826328|NCT02784704|9685427|P1|Overall Study|Adverse Event|4
2826329|NCT02784106|9685503|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2826330|NCT02784106|9685504|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2826331|NCT02784106|9685505|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2826332|NCT02784106|9685506|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2826333|NCT02784106|9685503|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
2826334|NCT02784106|9685504|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
2826335|NCT02784106|9685505|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2826336|NCT02784106|9685506|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2826337|NCT02784106|9685503|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2826338|NCT02784106|9685504|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2826339|NCT02784106|9685505|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2826340|NCT02784106|9685506|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
2826341|NCT02784106|9685503|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
2826342|NCT02784106|9685504|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
2826343|NCT02784106|9685505|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
2826344|NCT02784106|9685506|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
2826345|NCT02784106|9685503|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2826346|NCT02784106|9685504|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2826347|NCT02784106|9685505|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
2826348|NCT02784106|9685506|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
2826349|NCT02784106|9685503|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2826350|NCT02784106|9685504|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2826351|NCT02784106|9685505|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
2826352|NCT02784106|9685506|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
2826353|NCT02783729|9685594|P4|Overall Study|Lost to Follow-up|0
2826354|NCT02783729|9685595|P3|Overall Study|Lost to Follow-up|1
2826355|NCT02783729|9685596|P2|Overall Study|Lost to Follow-up|1
2826356|NCT02783729|9685597|P1|Overall Study|Lost to Follow-up|2
2826357|NCT02783729|9685594|P4|Overall Study|Participant's choice|1
2826358|NCT02783729|9685595|P3|Overall Study|Participant's choice|2
2826359|NCT02783729|9685596|P2|Overall Study|Participant's choice|1
2826360|NCT02783729|9685597|P1|Overall Study|Participant's choice|2
2826361|NCT02783729|9685594|P4|Overall Study|Withdrawal by Subject|2
2826362|NCT02783729|9685595|P3|Overall Study|Withdrawal by Subject|1
2826363|NCT02783729|9685596|P2|Overall Study|Withdrawal by Subject|3
2826364|NCT02783729|9685597|P1|Overall Study|Withdrawal by Subject|2
2826365|NCT02783729|9685594|P4|Overall Study|Other|3
2826366|NCT02783729|9685595|P3|Overall Study|Other|2
2826367|NCT02783729|9685596|P2|Overall Study|Other|6
2826368|NCT02783729|9685597|P1|Overall Study|Other|1
2826369|NCT02783729|9685594|P4|Overall Study|Adverse Event|3
2826370|NCT02783729|9685595|P3|Overall Study|Adverse Event|2
2826371|NCT02783729|9685596|P2|Overall Study|Adverse Event|6
2826372|NCT02783729|9685597|P1|Overall Study|Adverse Event|2
2826373|NCT02783729|9685594|P4|Overall Study|Lack of Efficacy|0
2826374|NCT02783729|9685595|P3|Overall Study|Lack of Efficacy|0
2826375|NCT02783729|9685596|P2|Overall Study|Lack of Efficacy|0
2826376|NCT02783729|9685597|P1|Overall Study|Lack of Efficacy|1
2826377|NCT02783599|9685663|P1|Overall Study|Death|1
2826378|NCT02783599|9685663|P1|Overall Study|Physician Decision|2
2826379|NCT02783599|9685663|P1|Overall Study|Adverse Event|4
2826380|NCT02783599|9685663|P1|Overall Study|Surgical Resection|10
2826381|NCT02783599|9685663|P1|Overall Study|Progressive disease|23
2826382|NCT02783573|9685679|P3|Delayed-Start Period|Sponsor Decision|12
2826383|NCT02783573|9685680|P2|Delayed-Start Period|Sponsor Decision|17
2826384|NCT02783573|9685681|P1|Delayed-Start Period|Sponsor Decision|0
2826385|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
2826386|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
2826387|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
2826388|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
2826389|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2826390|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2826391|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
2826392|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
2826393|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
2826394|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
2826395|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
2826396|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
2826397|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Physician Decision|3
2826398|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Physician Decision|1
2826399|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Physician Decision|3
2826400|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
2826401|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
2826402|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
2826403|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
2826404|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
2826405|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
2826406|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
2826407|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2826408|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2826409|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
2826410|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2826411|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2826412|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Death|3
2826413|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Death|2
2826414|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Death|4
2826415|NCT02783573|9685679|P3|Placebo-Controlled Treatment Period|Adverse Event|13
2826416|NCT02783573|9685680|P2|Placebo-Controlled Treatment Period|Adverse Event|17
2826417|NCT02783573|9685681|P1|Placebo-Controlled Treatment Period|Adverse Event|13
2826418|NCT02783170|9685746|P2|Overall Study|Randomized but not Vaccinated|0
2826419|NCT02783170|9685747|P1|Overall Study|Randomized but not Vaccinated|1
2826420|NCT02782923|9685805|P1|Overall Study|Lost to Follow-up|15
2826421|NCT02782676|9685811|P2|Overall Study|Lost to Follow-up|1
2826422|NCT02782676|9685812|P1|Overall Study|Lost to Follow-up|0
2826423|NCT02782377|9685840|P1|Overall Study|Physician Decision|5
2826424|NCT02782325|9685855|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
2826425|NCT02782325|9685856|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2826426|NCT02782325|9685857|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2826427|NCT02782325|9685855|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
2826428|NCT02782325|9685856|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
2826429|NCT02782325|9685857|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
2826430|NCT02782169|9685885|P2|Overall Study|Lost to Follow-up|2
2826431|NCT02782169|9685886|P1|Overall Study|Lost to Follow-up|1
2826432|NCT02781844|9685904|P8|Treatment Period 1|Adverse Event|0
2826433|NCT02781844|9685905|P7|Treatment Period 1|Adverse Event|0
2826434|NCT02781844|9685906|P6|Treatment Period 1|Adverse Event|1
2826435|NCT02781844|9685907|P5|Treatment Period 1|Adverse Event|0
2826436|NCT02781844|9685908|P4|Treatment Period 1|Adverse Event|0
2826437|NCT02781844|9685909|P3|Treatment Period 1|Adverse Event|0
2826438|NCT02781844|9685910|P2|Treatment Period 1|Adverse Event|0
2826439|NCT02781844|9685911|P1|Treatment Period 1|Adverse Event|0
2826440|NCT02781818|9686044|P3|Overall Study|Lost to Follow-up|1
2826441|NCT02781818|9686045|P2|Overall Study|Lost to Follow-up|2
2826442|NCT02781818|9686046|P1|Overall Study|Lost to Follow-up|4
2826443|NCT02781558|9686112|P2|Overall Study|Adverse Event|0
2826444|NCT02781558|9686113|P1|Overall Study|Adverse Event|1
2826445|NCT02781558|9686112|P2|Overall Study|Lost to Follow-up|2
2826446|NCT02781558|9686113|P1|Overall Study|Lost to Follow-up|2
2826447|NCT02781324|9686200|P2|Overall Study|Physician Decision|2
2826448|NCT02781324|9686201|P1|Overall Study|Physician Decision|1
2826449|NCT02781324|9686200|P2|Overall Study|Withdrawal by Subject|0
2826450|NCT02781324|9686201|P1|Overall Study|Withdrawal by Subject|1
2826451|NCT02781311|9686230|P3|Overall Study|Non-Compliance with Study Drug|0
2826452|NCT02781311|9686231|P2|Overall Study|Non-Compliance with Study Drug|0
2826453|NCT02781311|9686232|P1|Overall Study|Non-Compliance with Study Drug|2
2826454|NCT02781311|9686230|P3|Overall Study|Lost to Follow-up|1
2826455|NCT02781311|9686231|P2|Overall Study|Lost to Follow-up|8
2826456|NCT02781311|9686232|P1|Overall Study|Lost to Follow-up|11
2826457|NCT02781311|9686230|P3|Overall Study|Withdrawal of Consent|2
2826458|NCT02781311|9686231|P2|Overall Study|Withdrawal of Consent|12
2826459|NCT02781311|9686232|P1|Overall Study|Withdrawal of Consent|11
2826460|NCT02781311|9686230|P3|Overall Study|Adverse Event|1
2826461|NCT02781311|9686231|P2|Overall Study|Adverse Event|6
2826462|NCT02781311|9686232|P1|Overall Study|Adverse Event|2
2826463|NCT02780856|9686259|P1|Overall Study|Lost to Follow-up|1
2826464|NCT02780700|9686278|P1|Overall Study|Progressive disease|1
2826465|NCT02780388|9686347|P5|Overall Study|Withdrawal by Subject|0
2826466|NCT02780388|9686348|P4|Overall Study|Withdrawal by Subject|0
2826467|NCT02780388|9686349|P3|Overall Study|Withdrawal by Subject|0
2826468|NCT02780388|9686350|P2|Overall Study|Withdrawal by Subject|1
2826469|NCT02780388|9686351|P1|Overall Study|Withdrawal by Subject|1
2826470|NCT02780388|9686347|P5|Overall Study|Lost to Follow-up|0
2826471|NCT02780388|9686348|P4|Overall Study|Lost to Follow-up|0
2826472|NCT02780388|9686349|P3|Overall Study|Lost to Follow-up|0
2826473|NCT02780388|9686350|P2|Overall Study|Lost to Follow-up|1
2826474|NCT02780388|9686351|P1|Overall Study|Lost to Follow-up|0
2826475|NCT02780167|9686417|P5|Overall Study|Other|2
2826476|NCT02780167|9686418|P4|Overall Study|Other|1
2826477|NCT02780167|9686419|P3|Overall Study|Other|3
2826478|NCT02780167|9686420|P2|Overall Study|Other|0
2826479|NCT02780167|9686421|P1|Overall Study|Other|0
2826480|NCT02780167|9686417|P5|Overall Study|Withdrawal by Subject|4
2826481|NCT02780167|9686418|P4|Overall Study|Withdrawal by Subject|3
2826482|NCT02780167|9686419|P3|Overall Study|Withdrawal by Subject|4
2826483|NCT02780167|9686420|P2|Overall Study|Withdrawal by Subject|4
2826484|NCT02780167|9686421|P1|Overall Study|Withdrawal by Subject|6
2826485|NCT02780167|9686417|P5|Overall Study|Protocol Violation|2
2826486|NCT02780167|9686418|P4|Overall Study|Protocol Violation|1
2826487|NCT02780167|9686419|P3|Overall Study|Protocol Violation|1
2826488|NCT02780167|9686420|P2|Overall Study|Protocol Violation|5
2826489|NCT02780167|9686421|P1|Overall Study|Protocol Violation|5
2826490|NCT02780167|9686417|P5|Overall Study|No longer meets eligibility criteria|1
2826491|NCT02780167|9686418|P4|Overall Study|No longer meets eligibility criteria|1
2826492|NCT02780167|9686419|P3|Overall Study|No longer meets eligibility criteria|0
2826493|NCT02780167|9686420|P2|Overall Study|No longer meets eligibility criteria|0
2826494|NCT02780167|9686421|P1|Overall Study|No longer meets eligibility criteria|0
2826495|NCT02780167|9686417|P5|Overall Study|Does not meet entrance criteria|0
2826496|NCT02780167|9686418|P4|Overall Study|Does not meet entrance criteria|0
2826497|NCT02780167|9686419|P3|Overall Study|Does not meet entrance criteria|1
2826498|NCT02780167|9686420|P2|Overall Study|Does not meet entrance criteria|0
2826499|NCT02780167|9686421|P1|Overall Study|Does not meet entrance criteria|0
2826500|NCT02780167|9686417|P5|Overall Study|Lost to Follow-up|0
2826501|NCT02780167|9686418|P4|Overall Study|Lost to Follow-up|0
2826502|NCT02780167|9686419|P3|Overall Study|Lost to Follow-up|1
2826503|NCT02780167|9686420|P2|Overall Study|Lost to Follow-up|0
2826504|NCT02780167|9686421|P1|Overall Study|Lost to Follow-up|2
2826505|NCT02780167|9686417|P5|Overall Study|Lack of Efficacy|0
2826506|NCT02780167|9686418|P4|Overall Study|Lack of Efficacy|1
2826507|NCT02780167|9686419|P3|Overall Study|Lack of Efficacy|6
2826508|NCT02780167|9686420|P2|Overall Study|Lack of Efficacy|5
2826509|NCT02780167|9686421|P1|Overall Study|Lack of Efficacy|6
2826510|NCT02780167|9686417|P5|Overall Study|Adverse Event|8
2826511|NCT02780167|9686418|P4|Overall Study|Adverse Event|12
2826512|NCT02780167|9686419|P3|Overall Study|Adverse Event|8
2826513|NCT02780167|9686420|P2|Overall Study|Adverse Event|8
2826514|NCT02780167|9686421|P1|Overall Study|Adverse Event|9
2826515|NCT02779075|9686606|P2|Overall Study|IV lost during 2nd study|0
2826516|NCT02779075|9686607|P1|Overall Study|IV lost during 2nd study|1
2826517|NCT02779075|9686606|P2|Overall Study|Withdrawal by Subject|3
2826518|NCT02779075|9686607|P1|Overall Study|Withdrawal by Subject|1
2826519|NCT02778867|9686617|P4|Phase 2|Adverse Event|1
2826520|NCT02778867|9686618|P3|Phase 2|Adverse Event|0
2826521|NCT02778867|9686619|P2|Phase 2|Adverse Event|0
2826522|NCT02778867|9686620|P1|Phase 2|Adverse Event|0
2826523|NCT02778867|9686617|P4|Phase 2|Physician Decision|1
2826524|NCT02778867|9686618|P3|Phase 2|Physician Decision|0
2826525|NCT02778867|9686619|P2|Phase 2|Physician Decision|0
2826526|NCT02778867|9686620|P1|Phase 2|Physician Decision|0
2826527|NCT02778867|9686617|P4|Phase 2|Withdrawal by Subject|0
2826528|NCT02778867|9686618|P3|Phase 2|Withdrawal by Subject|1
2826529|NCT02778867|9686619|P2|Phase 2|Withdrawal by Subject|0
2826530|NCT02778867|9686620|P1|Phase 2|Withdrawal by Subject|0
2826531|NCT02778867|9686617|P4|Phase 1|Withdrawal by Subject|0
2826532|NCT02778867|9686618|P3|Phase 1|Withdrawal by Subject|0
2826533|NCT02778867|9686619|P2|Phase 1|Withdrawal by Subject|3
2826534|NCT02778867|9686620|P1|Phase 1|Withdrawal by Subject|2
2826535|NCT02778555|9686641|P3|Overall Study|Withdrawal by Subject|107
2826536|NCT02778555|9686642|P2|Overall Study|Withdrawal by Subject|32
2826537|NCT02778555|9686643|P1|Overall Study|Withdrawal by Subject|55
2826538|NCT02778100|9686699|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
2826539|NCT02778100|9686700|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
2826540|NCT02778074|9686731|P2|Overall Study|Lost to Follow-up|10
2826541|NCT02778074|9686732|P1|Overall Study|Lost to Follow-up|7
2826542|NCT02777918|9686764|P2|Overall Study|Withdrawal by Subject|1
2826543|NCT02777918|9686765|P1|Overall Study|Withdrawal by Subject|1
2826544|NCT02777918|9686764|P2|Overall Study|Too busy / stressed|1
2826545|NCT02777918|9686765|P1|Overall Study|Too busy / stressed|1
2826546|NCT02777918|9686764|P2|Overall Study|Medical reasons|2
2826547|NCT02777918|9686765|P1|Overall Study|Medical reasons|1
2826548|NCT02777827|9686783|P6|Washout Between Periods 3 and 4|Protocol Violation|0
2826549|NCT02777827|9686784|P5|Washout Between Periods 3 and 4|Protocol Violation|0
2826550|NCT02777827|9686785|P4|Washout Between Periods 3 and 4|Protocol Violation|0
2826551|NCT02777827|9686786|P3|Washout Between Periods 3 and 4|Protocol Violation|1
2826552|NCT02777827|9686787|P2|Washout Between Periods 3 and 4|Protocol Violation|0
2826553|NCT02777827|9686788|P1|Washout Between Periods 3 and 4|Protocol Violation|0
2826554|NCT02777242|9686991|P1|Overall Study|Withdrawal by Subject|1
2826555|NCT02777242|9686991|P1|Overall Study|Sponsor's request|1
2826556|NCT02777242|9686991|P1|Overall Study|Multiple|1
2826557|NCT02777242|9686991|P1|Overall Study|Lost to Follow-up|1
2826558|NCT02777242|9686991|P1|Overall Study|Other|2
2826559|NCT02777125|9686997|P2|Overall Study|Protocol Violation|12
2826560|NCT02777125|9686998|P1|Overall Study|Protocol Violation|8
2826561|NCT02777125|9686997|P2|Overall Study|Assent form violation|23
2826562|NCT02777125|9686998|P1|Overall Study|Assent form violation|21
2826563|NCT02777125|9686997|P2|Overall Study|Consent form violation|12
2826564|NCT02777125|9686998|P1|Overall Study|Consent form violation|14
2826565|NCT02776683|9687043|P2|Post-switch Period|Other than listed|15
2826566|NCT02776683|9687044|P1|Post-switch Period|Other than listed|0
2826567|NCT02776683|9687043|P2|Post-switch Period|Progressive disease|20
2826568|NCT02776683|9687044|P1|Post-switch Period|Progressive disease|0
2826569|NCT02776683|9687043|P2|Post-switch Period|Physician Decision|3
2826570|NCT02776683|9687044|P1|Post-switch Period|Physician Decision|0
2826571|NCT02776683|9687043|P2|Post-switch Period|Withdrawal by Subject|2
2826572|NCT02776683|9687044|P1|Post-switch Period|Withdrawal by Subject|0
2826573|NCT02776683|9687043|P2|Post-switch Period|Adverse Event|3
2826574|NCT02776683|9687044|P1|Post-switch Period|Adverse Event|0
2826575|NCT02776683|9687043|P2|Pre-switch Period|Other than listed|0
2826576|NCT02776683|9687044|P1|Pre-switch Period|Other than listed|3
2826577|NCT02776683|9687043|P2|Pre-switch Period|Progressive disease|0
2826578|NCT02776683|9687044|P1|Pre-switch Period|Progressive disease|39
2826579|NCT02776683|9687043|P2|Pre-switch Period|Physician Decision|0
2826580|NCT02776683|9687044|P1|Pre-switch Period|Physician Decision|7
2826581|NCT02776683|9687043|P2|Pre-switch Period|Withdrawal by Subject|0
2826582|NCT02776683|9687044|P1|Pre-switch Period|Withdrawal by Subject|9
2826583|NCT02776683|9687043|P2|Pre-switch Period|Adverse Event|0
2826584|NCT02776683|9687044|P1|Pre-switch Period|Adverse Event|21
2826585|NCT02776683|9687043|P2|Pre-switch Period|Protocol Violation|0
2826586|NCT02776683|9687044|P1|Pre-switch Period|Protocol Violation|1
2826587|NCT02776670|9687055|P2|Overall Study|Other - Reason not given|1
2826588|NCT02776670|9687056|P1|Overall Study|Other - Reason not given|0
2826589|NCT02776670|9687055|P2|Overall Study|Withdrawal by Subject|1
2826590|NCT02776670|9687056|P1|Overall Study|Withdrawal by Subject|0
2826591|NCT02776670|9687055|P2|Overall Study|Protocol Violation|2
2826592|NCT02776670|9687056|P1|Overall Study|Protocol Violation|0
2826593|NCT02776670|9687055|P2|Overall Study|Adverse Event|2
2826594|NCT02776670|9687056|P1|Overall Study|Adverse Event|0
2826595|NCT02776033|9687114|P3|Overall Study|Adverse Event|0
2826596|NCT02776033|9687115|P2|Overall Study|Adverse Event|2
2826597|NCT02776033|9687116|P1|Overall Study|Adverse Event|1
2826598|NCT02776033|9687114|P3|Overall Study|Lost to Follow-up|0
2826599|NCT02776033|9687115|P2|Overall Study|Lost to Follow-up|0
2826600|NCT02776033|9687116|P1|Overall Study|Lost to Follow-up|1
2826601|NCT02776033|9687114|P3|Overall Study|Physician Decision|0
2826602|NCT02776033|9687115|P2|Overall Study|Physician Decision|0
2826603|NCT02776033|9687116|P1|Overall Study|Physician Decision|2
2826604|NCT02776033|9687114|P3|Overall Study|Withdrawal by Subject|2
2826605|NCT02776033|9687115|P2|Overall Study|Withdrawal by Subject|0
2826606|NCT02776033|9687116|P1|Overall Study|Withdrawal by Subject|0
2826607|NCT02775916|9687181|P2|Overall Study|Subject/Guardian Decision|0
2826608|NCT02775916|9687182|P1|Overall Study|Subject/Guardian Decision|2
2826609|NCT02775916|9687181|P2|Overall Study|Adverse Event|0
2826610|NCT02775916|9687182|P1|Overall Study|Adverse Event|1
2826611|NCT02775903|9687204|P4|Overall Study|Other-Miscellaneous|5
2826612|NCT02775903|9687205|P3|Overall Study|Other-Miscellaneous|4
2826613|NCT02775903|9687206|P2|Overall Study|Other-Miscellaneous|3
2826614|NCT02775903|9687207|P1|Overall Study|Other-Miscellaneous|4
2826615|NCT02775903|9687204|P4|Overall Study|Lost to Follow-up|1
2826616|NCT02775903|9687205|P3|Overall Study|Lost to Follow-up|1
2826617|NCT02775903|9687206|P2|Overall Study|Lost to Follow-up|0
2826618|NCT02775903|9687207|P1|Overall Study|Lost to Follow-up|0
2826619|NCT02775903|9687204|P4|Overall Study|Adverse Event|1
2826620|NCT02775903|9687205|P3|Overall Study|Adverse Event|1
2826621|NCT02775903|9687206|P2|Overall Study|Adverse Event|0
2826622|NCT02775903|9687207|P1|Overall Study|Adverse Event|0
2826623|NCT02775903|9687204|P4|Overall Study|Withdrawal by Subject|4
2826624|NCT02775903|9687205|P3|Overall Study|Withdrawal by Subject|5
2826625|NCT02775903|9687206|P2|Overall Study|Withdrawal by Subject|5
2826626|NCT02775903|9687207|P1|Overall Study|Withdrawal by Subject|5
2826627|NCT02775903|9687204|P4|Overall Study|Death|35
2826628|NCT02775903|9687205|P3|Overall Study|Death|38
2826629|NCT02775903|9687206|P2|Overall Study|Death|18
2826630|NCT02775903|9687207|P1|Overall Study|Death|19
2826631|NCT02775903|9687204|P4|Overall Study|Ongoing|19
2826632|NCT02775903|9687205|P3|Overall Study|Ongoing|15
2826633|NCT02775903|9687206|P2|Overall Study|Ongoing|15
2826634|NCT02775903|9687207|P1|Overall Study|Ongoing|14
2826635|NCT02775864|9687259|P4|Overall Study|Medicaid eligibility discontinued|890
2826636|NCT02775864|9687260|P3|Overall Study|Medicaid eligibility discontinued|720
2826637|NCT02775864|9687261|P2|Overall Study|Medicaid eligibility discontinued|2019
2826638|NCT02775864|9687262|P1|Overall Study|Medicaid eligibility discontinued|1478
2826639|NCT02775864|9687259|P4|Overall Study|Data ended end of 2010|1194
2826640|NCT02775864|9687260|P3|Overall Study|Data ended end of 2010|1140
2826641|NCT02775864|9687261|P2|Overall Study|Data ended end of 2010|2880
2826642|NCT02775864|9687262|P1|Overall Study|Data ended end of 2010|1764
2826643|NCT02775435|9687295|P2|Overall Study|Not Treated|1
2826644|NCT02775435|9687296|P1|Overall Study|Not Treated|0
2826645|NCT02775435|9687295|P2|Overall Study|Ongoing in Study|72
2826646|NCT02775435|9687296|P1|Overall Study|Ongoing in Study|121
2826647|NCT02775435|9687295|P2|Overall Study|Clinical Progression|26
2826648|NCT02775435|9687296|P1|Overall Study|Clinical Progression|13
2826649|NCT02775435|9687295|P2|Overall Study|Progressive Disease|140
2826650|NCT02775435|9687296|P1|Overall Study|Progressive Disease|86
2826651|NCT02775435|9687295|P2|Overall Study|Withdrawal by Subject|9
2826652|NCT02775435|9687296|P1|Overall Study|Withdrawal by Subject|5
2826653|NCT02775435|9687295|P2|Overall Study|Physician Decision|6
2826654|NCT02775435|9687296|P1|Overall Study|Physician Decision|5
2826655|NCT02775435|9687295|P2|Overall Study|Lost to Follow-up|2
2826656|NCT02775435|9687296|P1|Overall Study|Lost to Follow-up|0
2826657|NCT02775435|9687295|P2|Overall Study|Adverse Event|25
2826658|NCT02775435|9687296|P1|Overall Study|Adverse Event|48
2826659|NCT02775344|9687314|P2|Overall Study|No ovarian cyst identified|2
2826660|NCT02775344|9687315|P1|Overall Study|No ovarian cyst identified|3
2826661|NCT02774681|9687448|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
2826662|NCT02774681|9687448|P1|Follow-Up for 3 Years|Death|11
2826663|NCT02774681|9687448|P1|Treatment on Study|Progressive Disease|7
2826664|NCT02774278|9687512|P1|Overall Study|Protocol Violation|2
2826665|NCT02774278|9687512|P1|Overall Study|Withdrawal by Subject|3
2826666|NCT02774278|9687512|P1|Overall Study|Administrative reasons|6
2826667|NCT02774278|9687512|P1|Overall Study|Refused treatment/did not cooperate|9
2826668|NCT02774278|9687512|P1|Overall Study|Adverse event/intercurrent illness|16
2826669|NCT02774278|9687512|P1|Overall Study|Death|29
2826670|NCT02774278|9687512|P1|Overall Study|Lack of Efficacy|199
2826671|NCT02773537|9687687|P3|Overall Study|Lost to Follow-up|4
2826672|NCT02773537|9687688|P2|Overall Study|Lost to Follow-up|1
2826673|NCT02773537|9687689|P1|Overall Study|Lost to Follow-up|0
2826674|NCT02773446|9687724|P6|First Admission|Lost to Follow-up|0
2826675|NCT02773446|9687725|P5|First Admission|Lost to Follow-up|0
2826676|NCT02773446|9687726|P4|First Admission|Lost to Follow-up|0
2826677|NCT02773446|9687727|P3|First Admission|Lost to Follow-up|0
2826678|NCT02773446|9687728|P2|First Admission|Lost to Follow-up|0
2826679|NCT02773446|9687729|P1|First Admission|Lost to Follow-up|1
2826680|NCT02773446|9687724|P6|First Admission|Withdrawal by Subject|0
2826681|NCT02773446|9687725|P5|First Admission|Withdrawal by Subject|0
2826682|NCT02773446|9687726|P4|First Admission|Withdrawal by Subject|1
2826683|NCT02773446|9687727|P3|First Admission|Withdrawal by Subject|0
2826684|NCT02773446|9687728|P2|First Admission|Withdrawal by Subject|0
2826685|NCT02773446|9687729|P1|First Admission|Withdrawal by Subject|0
2826686|NCT02773368|9687770|P2|Overall Study|Missing|1
2826687|NCT02773368|9687771|P1|Overall Study|Missing|0
2826688|NCT02773368|9687770|P2|Overall Study|Unclassified|1
2826689|NCT02773368|9687771|P1|Overall Study|Unclassified|1
2826690|NCT02773368|9687770|P2|Overall Study|Withdrawal by Subject|1
2826691|NCT02773368|9687771|P1|Overall Study|Withdrawal by Subject|5
2826692|NCT02773368|9687770|P2|Overall Study|Lost to Follow-up|1
2826693|NCT02773368|9687771|P1|Overall Study|Lost to Follow-up|4
2826694|NCT02772757|9687844|P3|Overall Study|Physician Decision|3
2826695|NCT02772757|9687845|P2|Overall Study|Physician Decision|3
2826696|NCT02772757|9687846|P1|Overall Study|Physician Decision|0
2826697|NCT02772757|9687844|P3|Overall Study|Protocol Violation|1
2826698|NCT02772757|9687845|P2|Overall Study|Protocol Violation|0
2826699|NCT02772757|9687846|P1|Overall Study|Protocol Violation|0
2826700|NCT02772757|9687844|P3|Overall Study|Withdrawal by Subject|1
2826701|NCT02772757|9687845|P2|Overall Study|Withdrawal by Subject|0
2826702|NCT02772757|9687846|P1|Overall Study|Withdrawal by Subject|1
2826703|NCT02771522|9687881|P1|Overall Study|No white spot lesions|3
2826704|NCT02771522|9687881|P1|Overall Study|Withdrawal by Subject|2
2826705|NCT02771522|9687881|P1|Overall Study|Lost to Follow-up|3
2826706|NCT02771366|9687892|P2|Period 2 (Crossover)|Withdrawal by Subject|0
2826707|NCT02771366|9687893|P1|Period 2 (Crossover)|Withdrawal by Subject|2
2826708|NCT02771366|9687892|P2|Period 1|Withdrawal by Subject|2
2826709|NCT02771366|9687893|P1|Period 1|Withdrawal by Subject|0
2826710|NCT02771275|9687900|P1|Overall Study|On Study|11
2826711|NCT02771275|9687900|P1|Overall Study|Reoperation|2
2826712|NCT02771145|9687908|P1|Overall Study|Lost to Follow-up|1
2826713|NCT02771145|9687908|P1|Overall Study|Adverse Event|3
2826714|NCT02770612|9688042|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
2826715|NCT02770547|9688048|P2|Overall Study|Adverse Event|1
2826716|NCT02770547|9688049|P1|Overall Study|Adverse Event|0
2826717|NCT02770547|9688048|P2|Overall Study|Patient non-compliant|0
2826718|NCT02770547|9688049|P1|Overall Study|Patient non-compliant|1
2826719|NCT02770248|9688078|P2|Overall Study|Randomized in error, prior to treatment|1
2826720|NCT02770248|9688079|P1|Overall Study|Randomized in error, prior to treatment|0
2826721|NCT02770248|9688078|P2|Overall Study|Adverse Event|1
2826722|NCT02770248|9688079|P1|Overall Study|Adverse Event|0
2826723|NCT02769858|9688097|P1|Overall Study|Withdrawal by Subject|2
2826724|NCT02769312|9688121|P2|Follow-up|Lost to Follow-up|1
2826725|NCT02769312|9688122|P1|Follow-up|Lost to Follow-up|1
2826726|NCT02769312|9688121|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
2826727|NCT02769312|9688122|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
2826728|NCT02769312|9688121|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
2826729|NCT02769312|9688122|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
2826730|NCT02769312|9688121|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
2826731|NCT02769312|9688122|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
2826732|NCT02769312|9688121|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2826733|NCT02769312|9688122|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2826734|NCT02769247|9688139|P4|Overall Study|Physician Decision|0
2826735|NCT02769247|9688140|P3|Overall Study|Physician Decision|0
2826736|NCT02769247|9688141|P2|Overall Study|Physician Decision|0
2826737|NCT02769247|9688142|P1|Overall Study|Physician Decision|1
2826738|NCT02769247|9688139|P4|Overall Study|Protocol Violation|0
2826739|NCT02769247|9688140|P3|Overall Study|Protocol Violation|1
2826740|NCT02769247|9688141|P2|Overall Study|Protocol Violation|0
2826741|NCT02769247|9688142|P1|Overall Study|Protocol Violation|0
2826742|NCT02769247|9688139|P4|Overall Study|Withdrawal by Subject|1
2826743|NCT02769247|9688140|P3|Overall Study|Withdrawal by Subject|0
2826744|NCT02769247|9688141|P2|Overall Study|Withdrawal by Subject|0
2826745|NCT02769247|9688142|P1|Overall Study|Withdrawal by Subject|1
2826746|NCT02769065|9688210|P30|Overall Study|Pre-treatment Event/Adverse Event|0
2826747|NCT02769065|9688211|P29|Overall Study|Pre-treatment Event/Adverse Event|0
2826748|NCT02769065|9688212|P28|Overall Study|Pre-treatment Event/Adverse Event|0
2826749|NCT02769065|9688213|P27|Overall Study|Pre-treatment Event/Adverse Event|0
2826750|NCT02769065|9688214|P26|Overall Study|Pre-treatment Event/Adverse Event|0
2826751|NCT02769065|9688215|P25|Overall Study|Pre-treatment Event/Adverse Event|0
2826752|NCT02769065|9688216|P24|Overall Study|Pre-treatment Event/Adverse Event|0
2826753|NCT02769065|9688217|P23|Overall Study|Pre-treatment Event/Adverse Event|0
2826754|NCT02769065|9688218|P22|Overall Study|Pre-treatment Event/Adverse Event|0
2826755|NCT02769065|9688219|P21|Overall Study|Pre-treatment Event/Adverse Event|0
2826756|NCT02769065|9688220|P20|Overall Study|Pre-treatment Event/Adverse Event|0
2826757|NCT02769065|9688221|P19|Overall Study|Pre-treatment Event/Adverse Event|0
2826758|NCT02769065|9688222|P18|Overall Study|Pre-treatment Event/Adverse Event|0
2826759|NCT02769065|9688223|P17|Overall Study|Pre-treatment Event/Adverse Event|0
2826760|NCT02769065|9688224|P16|Overall Study|Pre-treatment Event/Adverse Event|0
2826761|NCT02769065|9688225|P15|Overall Study|Pre-treatment Event/Adverse Event|0
2826762|NCT02769065|9688226|P14|Overall Study|Pre-treatment Event/Adverse Event|0
2826763|NCT02769065|9688227|P13|Overall Study|Pre-treatment Event/Adverse Event|0
2826764|NCT02769065|9688228|P12|Overall Study|Pre-treatment Event/Adverse Event|0
2826765|NCT02769065|9688229|P11|Overall Study|Pre-treatment Event/Adverse Event|1
2826766|NCT02769065|9688230|P10|Overall Study|Pre-treatment Event/Adverse Event|0
2826767|NCT02769065|9688231|P9|Overall Study|Pre-treatment Event/Adverse Event|0
2826768|NCT02769065|9688232|P8|Overall Study|Pre-treatment Event/Adverse Event|0
2826769|NCT02769065|9688233|P7|Overall Study|Pre-treatment Event/Adverse Event|0
2826770|NCT02769065|9688234|P6|Overall Study|Pre-treatment Event/Adverse Event|0
2826771|NCT02769065|9688235|P5|Overall Study|Pre-treatment Event/Adverse Event|0
2826772|NCT02769065|9688236|P4|Overall Study|Pre-treatment Event/Adverse Event|0
2826773|NCT02769065|9688237|P3|Overall Study|Pre-treatment Event/Adverse Event|0
2826774|NCT02769065|9688238|P2|Overall Study|Pre-treatment Event/Adverse Event|0
2826775|NCT02769065|9688239|P1|Overall Study|Pre-treatment Event/Adverse Event|0
2826776|NCT02769065|9688210|P30|Overall Study|Reason Not Specified|0
2826777|NCT02769065|9688211|P29|Overall Study|Reason Not Specified|0
2826778|NCT02769065|9688212|P28|Overall Study|Reason Not Specified|0
2826779|NCT02769065|9688213|P27|Overall Study|Reason Not Specified|0
2826780|NCT02769065|9688214|P26|Overall Study|Reason Not Specified|0
2826781|NCT02769065|9688215|P25|Overall Study|Reason Not Specified|0
2826782|NCT02769065|9688216|P24|Overall Study|Reason Not Specified|0
2826783|NCT02769065|9688217|P23|Overall Study|Reason Not Specified|0
2826784|NCT02769065|9688218|P22|Overall Study|Reason Not Specified|0
2826785|NCT02769065|9688219|P21|Overall Study|Reason Not Specified|0
2826786|NCT02769065|9688220|P20|Overall Study|Reason Not Specified|0
2826787|NCT02769065|9688221|P19|Overall Study|Reason Not Specified|0
2826788|NCT02769065|9688222|P18|Overall Study|Reason Not Specified|0
2826789|NCT02769065|9688223|P17|Overall Study|Reason Not Specified|0
2826790|NCT02769065|9688224|P16|Overall Study|Reason Not Specified|0
2826791|NCT02769065|9688225|P15|Overall Study|Reason Not Specified|0
2826792|NCT02769065|9688226|P14|Overall Study|Reason Not Specified|0
2826793|NCT02769065|9688227|P13|Overall Study|Reason Not Specified|0
2826794|NCT02769065|9688228|P12|Overall Study|Reason Not Specified|0
2826795|NCT02769065|9688229|P11|Overall Study|Reason Not Specified|0
2826796|NCT02769065|9688230|P10|Overall Study|Reason Not Specified|0
2826797|NCT02769065|9688231|P9|Overall Study|Reason Not Specified|0
2826798|NCT02769065|9688232|P8|Overall Study|Reason Not Specified|0
2826799|NCT02769065|9688233|P7|Overall Study|Reason Not Specified|1
2826800|NCT02769065|9688234|P6|Overall Study|Reason Not Specified|0
2826801|NCT02769065|9688235|P5|Overall Study|Reason Not Specified|0
2826802|NCT02769065|9688236|P4|Overall Study|Reason Not Specified|0
2826803|NCT02769065|9688237|P3|Overall Study|Reason Not Specified|0
2826804|NCT02769065|9688238|P2|Overall Study|Reason Not Specified|0
2826805|NCT02769065|9688239|P1|Overall Study|Reason Not Specified|0
2826806|NCT02769065|9688210|P30|Overall Study|Voluntary Withdrawal|0
2826807|NCT02769065|9688211|P29|Overall Study|Voluntary Withdrawal|0
2826808|NCT02769065|9688212|P28|Overall Study|Voluntary Withdrawal|0
2826809|NCT02769065|9688213|P27|Overall Study|Voluntary Withdrawal|0
2826810|NCT02769065|9688214|P26|Overall Study|Voluntary Withdrawal|0
2826811|NCT02769065|9688215|P25|Overall Study|Voluntary Withdrawal|0
2826812|NCT02769065|9688216|P24|Overall Study|Voluntary Withdrawal|0
2826813|NCT02769065|9688217|P23|Overall Study|Voluntary Withdrawal|0
2826814|NCT02769065|9688218|P22|Overall Study|Voluntary Withdrawal|0
2826815|NCT02769065|9688219|P21|Overall Study|Voluntary Withdrawal|0
2826816|NCT02769065|9688220|P20|Overall Study|Voluntary Withdrawal|0
2826817|NCT02769065|9688221|P19|Overall Study|Voluntary Withdrawal|0
2826818|NCT02769065|9688222|P18|Overall Study|Voluntary Withdrawal|0
2826819|NCT02769065|9688223|P17|Overall Study|Voluntary Withdrawal|0
2826820|NCT02769065|9688224|P16|Overall Study|Voluntary Withdrawal|0
2826821|NCT02769065|9688225|P15|Overall Study|Voluntary Withdrawal|0
2826822|NCT02769065|9688226|P14|Overall Study|Voluntary Withdrawal|0
2826823|NCT02769065|9688227|P13|Overall Study|Voluntary Withdrawal|0
2826824|NCT02769065|9688228|P12|Overall Study|Voluntary Withdrawal|0
2826825|NCT02769065|9688229|P11|Overall Study|Voluntary Withdrawal|0
2826826|NCT02769065|9688230|P10|Overall Study|Voluntary Withdrawal|0
2826827|NCT02769065|9688231|P9|Overall Study|Voluntary Withdrawal|0
2826828|NCT02769065|9688232|P8|Overall Study|Voluntary Withdrawal|0
2826829|NCT02769065|9688233|P7|Overall Study|Voluntary Withdrawal|0
2826830|NCT02769065|9688234|P6|Overall Study|Voluntary Withdrawal|0
2826831|NCT02769065|9688235|P5|Overall Study|Voluntary Withdrawal|0
2826832|NCT02769065|9688236|P4|Overall Study|Voluntary Withdrawal|0
2826833|NCT02769065|9688237|P3|Overall Study|Voluntary Withdrawal|0
2826834|NCT02769065|9688238|P2|Overall Study|Voluntary Withdrawal|0
2826835|NCT02769065|9688239|P1|Overall Study|Voluntary Withdrawal|1
2826836|NCT02768870|9688649|P1|Overall Study|On Study|19
2826837|NCT02768870|9688649|P1|Overall Study|Reoperation|4
2826838|NCT02768870|9688649|P1|Overall Study|Death|1
2826839|NCT02768870|9688649|P1|Overall Study|Not Implanted with Device|2
2826840|NCT02768194|9688691|P6|Period 3|Other (Reason not specified)|0
2826841|NCT02768194|9688692|P5|Period 3|Other (Reason not specified)|0
2826842|NCT02768194|9688693|P4|Period 3|Other (Reason not specified)|0
2826843|NCT02768194|9688694|P3|Period 3|Other (Reason not specified)|0
2826844|NCT02768194|9688695|P2|Period 3|Other (Reason not specified)|1
2826845|NCT02768194|9688696|P1|Period 3|Other (Reason not specified)|0
2826846|NCT02768194|9688691|P6|Period 2|Other (Reason not specified)|0
2826847|NCT02768194|9688692|P5|Period 2|Other (Reason not specified)|0
2826848|NCT02768194|9688693|P4|Period 2|Other (Reason not specified)|0
2826849|NCT02768194|9688694|P3|Period 2|Other (Reason not specified)|0
2826850|NCT02768194|9688695|P2|Period 2|Other (Reason not specified)|0
2826851|NCT02768194|9688696|P1|Period 2|Other (Reason not specified)|1
2826852|NCT02768194|9688691|P6|Period 1|Adverse Event|0
2826853|NCT02768194|9688692|P5|Period 1|Adverse Event|0
2826854|NCT02768194|9688693|P4|Period 1|Adverse Event|1
2826855|NCT02768194|9688694|P3|Period 1|Adverse Event|0
2826856|NCT02768194|9688695|P2|Period 1|Adverse Event|0
2826857|NCT02768194|9688696|P1|Period 1|Adverse Event|0
2826858|NCT02768103|9688718|P1|Overall Study|1 participant did not fit in the fMRI|1
2826859|NCT02767765|9688740|P1|Overall Study|Withdrawal by Subject|1
2826860|NCT02767765|9688740|P1|Overall Study|Non-Compliance|1
2826861|NCT02767765|9688740|P1|Overall Study|Investigator decision|1
2826862|NCT02767765|9688740|P1|Overall Study|Lost to Follow-up|2
2826863|NCT02767765|9688740|P1|Overall Study|Insufficient response|1
2826864|NCT02767765|9688740|P1|Overall Study|Death|1
2826865|NCT02767765|9688740|P1|Overall Study|Adverse Event|4
2826866|NCT02766777|9688866|P1|Overall Study|Withdrawal by Subject|4
2826867|NCT02766777|9688866|P1|Overall Study|Protocol Violation|1
2826868|NCT02766777|9688866|P1|Overall Study|Non-Compliance With Study Drug|1
2826869|NCT02766777|9688866|P1|Overall Study|Lost to Follow-up|16
2826870|NCT02766777|9688866|P1|Overall Study|Adverse Event|12
2826871|NCT02766608|9688891|P5|Overall Study|Administrative Reasons|0
2826872|NCT02766608|9688892|P4|Overall Study|Administrative Reasons|0
2826873|NCT02766608|9688893|P3|Overall Study|Administrative Reasons|1
2826874|NCT02766608|9688894|P2|Overall Study|Administrative Reasons|1
2826875|NCT02766608|9688895|P1|Overall Study|Administrative Reasons|3
2826876|NCT02766608|9688891|P5|Overall Study|Protocol Violation|1
2826877|NCT02766608|9688892|P4|Overall Study|Protocol Violation|0
2826878|NCT02766608|9688893|P3|Overall Study|Protocol Violation|4
2826879|NCT02766608|9688894|P2|Overall Study|Protocol Violation|4
2826880|NCT02766608|9688895|P1|Overall Study|Protocol Violation|0
2826881|NCT02766608|9688891|P5|Overall Study|Protocol disc criteria|0
2826882|NCT02766608|9688892|P4|Overall Study|Protocol disc criteria|0
2826883|NCT02766608|9688893|P3|Overall Study|Protocol disc criteria|4
2826884|NCT02766608|9688894|P2|Overall Study|Protocol disc criteria|3
2826885|NCT02766608|9688895|P1|Overall Study|Protocol disc criteria|3
2826886|NCT02766608|9688891|P5|Overall Study|Physician Decision|2
2826887|NCT02766608|9688892|P4|Overall Study|Physician Decision|1
2826888|NCT02766608|9688893|P3|Overall Study|Physician Decision|3
2826889|NCT02766608|9688894|P2|Overall Study|Physician Decision|2
2826890|NCT02766608|9688895|P1|Overall Study|Physician Decision|3
2826891|NCT02766608|9688891|P5|Overall Study|Lost to Follow-up|2
2826892|NCT02766608|9688892|P4|Overall Study|Lost to Follow-up|2
2826893|NCT02766608|9688893|P3|Overall Study|Lost to Follow-up|5
2826894|NCT02766608|9688894|P2|Overall Study|Lost to Follow-up|3
2826895|NCT02766608|9688895|P1|Overall Study|Lost to Follow-up|6
2826896|NCT02766608|9688891|P5|Overall Study|Lack of Efficacy|2
2826897|NCT02766608|9688892|P4|Overall Study|Lack of Efficacy|8
2826898|NCT02766608|9688893|P3|Overall Study|Lack of Efficacy|32
2826899|NCT02766608|9688894|P2|Overall Study|Lack of Efficacy|15
2826900|NCT02766608|9688895|P1|Overall Study|Lack of Efficacy|16
2826901|NCT02766608|9688891|P5|Overall Study|Withdrawal by Subject|10
2826902|NCT02766608|9688892|P4|Overall Study|Withdrawal by Subject|13
2826903|NCT02766608|9688893|P3|Overall Study|Withdrawal by Subject|24
2826904|NCT02766608|9688894|P2|Overall Study|Withdrawal by Subject|20
2826905|NCT02766608|9688895|P1|Overall Study|Withdrawal by Subject|21
2826906|NCT02766608|9688891|P5|Overall Study|Adverse Event|12
2826907|NCT02766608|9688892|P4|Overall Study|Adverse Event|13
2826908|NCT02766608|9688893|P3|Overall Study|Adverse Event|17
2826909|NCT02766608|9688894|P2|Overall Study|Adverse Event|22
2826910|NCT02766608|9688895|P1|Overall Study|Adverse Event|27
2826911|NCT02766400|9688987|P2|Overall Study|Withdrawal by Subject|0
2826912|NCT02766400|9688988|P1|Overall Study|Withdrawal by Subject|1
2826913|NCT02766400|9688987|P2|Overall Study|Death|2
2826914|NCT02766400|9688988|P1|Overall Study|Death|1
2826915|NCT02766283|9689003|P1|Overall Study|Lost to Follow-up|27
2826916|NCT02766088|9689036|P1|Overall Study|Death|1
2826917|NCT02766088|9689036|P1|Overall Study|Other|1
2826918|NCT02766088|9689036|P1|Overall Study|Lost to Follow-up|5
2826919|NCT02766088|9689036|P1|Overall Study|Migrated/moved from the study area|1
2826920|NCT02766088|9689036|P1|Overall Study|Sponsor study termination|498
2826921|NCT02766023|9689051|P2|Overall Study|Not Eligible at Enrollment|1
2826922|NCT02766023|9689052|P1|Overall Study|Not Eligible at Enrollment|0
2826923|NCT02766023|9689051|P2|Overall Study|Physician Decision|0
2826924|NCT02766023|9689052|P1|Overall Study|Physician Decision|1
2826925|NCT02766023|9689051|P2|Overall Study|Withdrawal by Subject|5
2826926|NCT02766023|9689052|P1|Overall Study|Withdrawal by Subject|4
2826927|NCT02766023|9689051|P2|Overall Study|Adverse Event|0
2826928|NCT02766023|9689052|P1|Overall Study|Adverse Event|1
2826929|NCT02766023|9689051|P2|Overall Study|Pregnancy|0
2826930|NCT02766023|9689052|P1|Overall Study|Pregnancy|1
2826931|NCT02766023|9689051|P2|Overall Study|Lost to Follow-up|11
2826932|NCT02766023|9689052|P1|Overall Study|Lost to Follow-up|23
2826933|NCT02765490|9689102|P2|Overall Study|Death|1
2826934|NCT02765490|9689103|P1|Overall Study|Death|0
2826935|NCT02765490|9689102|P2|Overall Study|Other|1
2826936|NCT02765490|9689103|P1|Overall Study|Other|0
2826937|NCT02765490|9689102|P2|Overall Study|Lost to Follow-up|1
2826938|NCT02765490|9689103|P1|Overall Study|Lost to Follow-up|1
2826939|NCT02764775|9689149|P1|Overall Study|Withdrawal by Subject|3
2826940|NCT02764775|9689149|P1|Overall Study|Lost to Follow-up|2
2826941|NCT02764775|9689149|P1|Overall Study|Death|1
2826942|NCT02764697|9689153|P1|Overall Study|Lack of Efficacy|3
2826943|NCT02764229|9689158|P1|Overall Study|Study Stopped by Sponsor|69
2826944|NCT02764229|9689158|P1|Overall Study|Lack of Efficacy|1
2826945|NCT02764229|9689158|P1|Overall Study|Lost to Follow-up|3
2826946|NCT02764229|9689158|P1|Overall Study|Physician Decision|5
2826947|NCT02764229|9689158|P1|Overall Study|Adverse Event|9
2826948|NCT02764229|9689158|P1|Overall Study|Withdrawal by Subject|15
2826949|NCT02764190|9689164|P2|Overall Study|Lost to Follow-up|13
2826950|NCT02764190|9689165|P1|Overall Study|Lost to Follow-up|17
2826951|NCT02764151|9689213|P4|Overall Study|Other|2
2826952|NCT02764151|9689214|P3|Overall Study|Other|0
2826953|NCT02764151|9689215|P2|Overall Study|Other|0
2826954|NCT02764151|9689216|P1|Overall Study|Other|0
2826955|NCT02764151|9689213|P4|Overall Study|Subject refused further follow-up|1
2826956|NCT02764151|9689214|P3|Overall Study|Subject refused further follow-up|0
2826957|NCT02764151|9689215|P2|Overall Study|Subject refused further follow-up|0
2826958|NCT02764151|9689216|P1|Overall Study|Subject refused further follow-up|0
2826959|NCT02763644|9689355|P2|Overall Study|Adverse Event|1
2826960|NCT02763644|9689356|P1|Overall Study|Adverse Event|1
2826961|NCT02763644|9689355|P2|Overall Study|Death|1
2826962|NCT02763644|9689356|P1|Overall Study|Death|1
2826963|NCT02763644|9689355|P2|Overall Study|Patient/guardian decision|0
2826964|NCT02763644|9689356|P1|Overall Study|Patient/guardian decision|1
2826965|NCT02763579|9689376|P2|Overall Study|On-going in study|60
2826966|NCT02763579|9689377|P1|Overall Study|On-going in study|77
2826967|NCT02763579|9689376|P2|Overall Study|Physician Decision|0
2826968|NCT02763579|9689377|P1|Overall Study|Physician Decision|2
2826969|NCT02763579|9689376|P2|Overall Study|Withdrawal by Subject|9
2826970|NCT02763579|9689377|P1|Overall Study|Withdrawal by Subject|18
2826971|NCT02763579|9689376|P2|Overall Study|Lost to Follow-up|1
2826972|NCT02763579|9689377|P1|Overall Study|Lost to Follow-up|3
2826973|NCT02763579|9689376|P2|Overall Study|Death|132
2826974|NCT02763579|9689377|P1|Overall Study|Death|101
2826975|NCT02763566|9689389|P4|Overall Study|Withdrawal by Subject|0
2826976|NCT02763566|9689390|P3|Overall Study|Withdrawal by Subject|0
2826977|NCT02763566|9689391|P2|Overall Study|Withdrawal by Subject|1
2826978|NCT02763566|9689392|P1|Overall Study|Withdrawal by Subject|3
2826979|NCT02763566|9689389|P4|Overall Study|On study treatment at study conclusion|13
2826980|NCT02763566|9689390|P3|Overall Study|On study treatment at study conclusion|54
2826981|NCT02763566|9689391|P2|Overall Study|On study treatment at study conclusion|34
2826982|NCT02763566|9689392|P1|Overall Study|On study treatment at study conclusion|114
2826983|NCT02763566|9689389|P4|Overall Study|Lost to Follow-up|1
2826984|NCT02763566|9689390|P3|Overall Study|Lost to Follow-up|0
2826985|NCT02763566|9689391|P2|Overall Study|Lost to Follow-up|4
2826986|NCT02763566|9689392|P1|Overall Study|Lost to Follow-up|1
2826987|NCT02763254|9689420|P1|Overall Study|Adverse Event|1
2826988|NCT02763189|9689427|P2|Overall Study|Device failure|2
2826989|NCT02763189|9689428|P1|Overall Study|Device failure|0
2826990|NCT02762578|9689532|P2|Overall Study|Unclassified|0
2826991|NCT02762578|9689533|P1|Overall Study|Unclassified|6
2826992|NCT02762578|9689532|P2|Overall Study|Withdrawal by Subject|2
2826993|NCT02762578|9689533|P1|Overall Study|Withdrawal by Subject|4
2826994|NCT02762578|9689532|P2|Overall Study|Protocol Violation|2
2826995|NCT02762578|9689533|P1|Overall Study|Protocol Violation|4
2826996|NCT02762578|9689532|P2|Overall Study|Adverse Event|6
2826997|NCT02762578|9689533|P1|Overall Study|Adverse Event|1
2826998|NCT02762500|9689635|P2|Overall Study|Adverse Event|2
2826999|NCT02762500|9689636|P1|Overall Study|Adverse Event|0
2827000|NCT02762500|9689635|P2|Overall Study|Withdrawal by Subject|1
2827001|NCT02762500|9689636|P1|Overall Study|Withdrawal by Subject|1
2827002|NCT02762500|9689635|P2|Overall Study|Lack of Efficacy|0
2827003|NCT02762500|9689636|P1|Overall Study|Lack of Efficacy|1
2827004|NCT02762370|9689656|P2|Overall Study|Protocol Violation|0
2827005|NCT02762370|9689657|P1|Overall Study|Protocol Violation|1
2827006|NCT02762084|9689697|P3|Overall Study|Adverse Event|1
2827007|NCT02762084|9689698|P2|Overall Study|Adverse Event|0
2827008|NCT02762084|9689699|P1|Overall Study|Adverse Event|0
2827009|NCT02762084|9689697|P3|Overall Study|Withdrawal by Subject|0
2827010|NCT02762084|9689698|P2|Overall Study|Withdrawal by Subject|0
2827011|NCT02762084|9689699|P1|Overall Study|Withdrawal by Subject|1
2827012|NCT02761980|9689760|P4|Overall Study|Other|0
2827013|NCT02761980|9689761|P3|Overall Study|Other|1
2827014|NCT02761980|9689762|P2|Overall Study|Other|0
2827015|NCT02761980|9689763|P1|Overall Study|Other|0
2827016|NCT02761980|9689760|P4|Overall Study|Withdrawal by Subject|0
2827017|NCT02761980|9689761|P3|Overall Study|Withdrawal by Subject|0
2827018|NCT02761980|9689762|P2|Overall Study|Withdrawal by Subject|1
2827019|NCT02761980|9689763|P1|Overall Study|Withdrawal by Subject|0
2827020|NCT02761980|9689760|P4|Overall Study|Adverse Event|6
2827021|NCT02761980|9689761|P3|Overall Study|Adverse Event|5
2827022|NCT02761980|9689762|P2|Overall Study|Adverse Event|6
2827023|NCT02761980|9689763|P1|Overall Study|Adverse Event|4
2827024|NCT02761733|9689810|P4|Overall Study|Cognitive Impairment|0
2827025|NCT02761733|9689811|P3|Overall Study|Cognitive Impairment|1
2827026|NCT02761733|9689812|P2|Overall Study|Cognitive Impairment|0
2827027|NCT02761733|9689813|P1|Overall Study|Cognitive Impairment|5
2827028|NCT02761733|9689810|P4|Overall Study|Discharged from Study Site|11
2827029|NCT02761733|9689811|P3|Overall Study|Discharged from Study Site|25
2827030|NCT02761733|9689812|P2|Overall Study|Discharged from Study Site|9
2827031|NCT02761733|9689813|P1|Overall Study|Discharged from Study Site|10
2827032|NCT02761733|9689810|P4|Overall Study|Withdrawal by Subject|0
2827033|NCT02761733|9689811|P3|Overall Study|Withdrawal by Subject|0
2827034|NCT02761733|9689812|P2|Overall Study|Withdrawal by Subject|0
2827035|NCT02761733|9689813|P1|Overall Study|Withdrawal by Subject|2
2827036|NCT02761733|9689810|P4|Overall Study|Physician Decision|0
2827037|NCT02761733|9689811|P3|Overall Study|Physician Decision|0
2827038|NCT02761733|9689812|P2|Overall Study|Physician Decision|0
2827039|NCT02761733|9689813|P1|Overall Study|Physician Decision|4
2827040|NCT02761733|9689810|P4|Overall Study|Lost to Follow-up|3
2827041|NCT02761733|9689811|P3|Overall Study|Lost to Follow-up|0
2827042|NCT02761733|9689812|P2|Overall Study|Lost to Follow-up|7
2827043|NCT02761733|9689813|P1|Overall Study|Lost to Follow-up|6
2827044|NCT02761733|9689810|P4|Overall Study|Death|1
2827045|NCT02761733|9689811|P3|Overall Study|Death|1
2827046|NCT02761733|9689812|P2|Overall Study|Death|5
2827047|NCT02761733|9689813|P1|Overall Study|Death|3
2827048|NCT02761642|9689843|P1|Overall Study|Reason Unspecified|21
2827049|NCT02761642|9689843|P1|Overall Study|Physician Decision|1
2827050|NCT02761642|9689843|P1|Overall Study|Lack of Efficacy|20
2827051|NCT02761642|9689843|P1|Overall Study|Death|3
2827052|NCT02761642|9689843|P1|Overall Study|Non-compliant|7
2827053|NCT02761642|9689843|P1|Overall Study|Withdrawal by Subject|2
2827054|NCT02761642|9689843|P1|Overall Study|Adverse Event|13
2827055|NCT02761642|9689843|P1|Overall Study|Did not Receive Study Treatment|3
2827056|NCT02761629|9689856|P2|Overall Study|Randomized But Not Treated|4
2827057|NCT02761629|9689857|P1|Overall Study|Randomized But Not Treated|8
2827058|NCT02761629|9689856|P2|Overall Study|Lost to Follow-up|1
2827059|NCT02761629|9689857|P1|Overall Study|Lost to Follow-up|4
2827060|NCT02761629|9689856|P2|Overall Study|Other|2
2827061|NCT02761629|9689857|P1|Overall Study|Other|0
2827062|NCT02761629|9689856|P2|Overall Study|Withdrawal by Subject|3
2827063|NCT02761629|9689857|P1|Overall Study|Withdrawal by Subject|0
2827064|NCT02761629|9689856|P2|Overall Study|Protocol Violation|2
2827065|NCT02761629|9689857|P1|Overall Study|Protocol Violation|2
2827066|NCT02761629|9689856|P2|Overall Study|Did not Cooperate/Refused Treatment|4
2827067|NCT02761629|9689857|P1|Overall Study|Did not Cooperate/Refused Treatment|2
2827068|NCT02761629|9689856|P2|Overall Study|Failure to Return|4
2827069|NCT02761629|9689857|P1|Overall Study|Failure to Return|2
2827070|NCT02761629|9689856|P2|Overall Study|Insufficient Therapeutic Response|7
2827071|NCT02761629|9689857|P1|Overall Study|Insufficient Therapeutic Response|2
2827072|NCT02761629|9689856|P2|Overall Study|Adverse Event/Intercurrent Illness|5
2827073|NCT02761629|9689857|P1|Overall Study|Adverse Event/Intercurrent Illness|7
2827074|NCT02760927|9689904|P1|Overall Study|Tube Slippage from Device|1
2827075|NCT02760810|9689912|P1|Overall Study|Protocol Violation|1
2827076|NCT02760654|9689920|P2|Overall Study|Withdrawal by Subject|3
2827077|NCT02760654|9689921|P1|Overall Study|Withdrawal by Subject|4
2827078|NCT02760654|9689920|P2|Overall Study|Lost to Follow-up|3
2827079|NCT02760654|9689921|P1|Overall Study|Lost to Follow-up|3
2827080|NCT02760602|9689947|P2|Overall Study|Terminated by sponsor|13
2827081|NCT02760602|9689948|P1|Overall Study|Terminated by sponsor|12
2827082|NCT02760602|9689947|P2|Overall Study|Withdrawal by Subject|0
2827083|NCT02760602|9689948|P1|Overall Study|Withdrawal by Subject|1
2827084|NCT02759939|9690160|P4|Overall Study|Lost to Follow-up|650
2827085|NCT02759939|9690161|P3|Overall Study|Lost to Follow-up|783
2827086|NCT02759939|9690162|P2|Overall Study|Lost to Follow-up|791
2827087|NCT02759939|9690163|P1|Overall Study|Lost to Follow-up|735
2827088|NCT02759939|9690160|P4|Overall Study|Ineligible for T2 and T3|391
2827089|NCT02759939|9690161|P3|Overall Study|Ineligible for T2 and T3|366
2827090|NCT02759939|9690162|P2|Overall Study|Ineligible for T2 and T3|179
2827091|NCT02759939|9690163|P1|Overall Study|Ineligible for T2 and T3|310
2827092|NCT02759939|9690160|P4|Overall Study|Missing data on first outcome assessed|2
2827093|NCT02759939|9690161|P3|Overall Study|Missing data on first outcome assessed|5
2827094|NCT02759939|9690162|P2|Overall Study|Missing data on first outcome assessed|2
2827095|NCT02759939|9690163|P1|Overall Study|Missing data on first outcome assessed|11
2827096|NCT02759692|9690173|P2|Period 2|Test article no longer available|1
2827097|NCT02759692|9690174|P1|Period 2|Test article no longer available|0
2827098|NCT02759692|9690173|P2|Period 2|Lost to Follow-up|0
2827099|NCT02759692|9690174|P1|Period 2|Lost to Follow-up|1
2827100|NCT02759692|9690173|P2|Period 1|Miss-Randomized|1
2827101|NCT02759692|9690174|P1|Period 1|Miss-Randomized|1
2827102|NCT02759692|9690173|P2|Period 1|No longer meets eligibility criteria.|0
2827103|NCT02759692|9690174|P1|Period 1|No longer meets eligibility criteria.|1
2827104|NCT02759692|9690173|P2|Period 1|Test article no longer available|1
2827105|NCT02759692|9690174|P1|Period 1|Test article no longer available|1
2827106|NCT02759562|9690192|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
2827107|NCT02759562|9690193|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
2827108|NCT02759562|9690192|P2|Open-Label Treatment Period|Withdrew Consent|0
2827109|NCT02759562|9690193|P1|Open-Label Treatment Period|Withdrew Consent|1
2827110|NCT02759471|9690206|P1|Overall Study|discomfort|2
2827111|NCT02759315|9690262|P5|Overall Study|Study terminated prior to completion|1
2827112|NCT02759315|9690263|P4|Overall Study|Study terminated prior to completion|0
2827113|NCT02759315|9690264|P3|Overall Study|Study terminated prior to completion|5
2827114|NCT02759315|9690265|P2|Overall Study|Study terminated prior to completion|0
2827115|NCT02759315|9690266|P1|Overall Study|Study terminated prior to completion|2
2827116|NCT02759315|9690262|P5|Overall Study|Protocol Violation|0
2827117|NCT02759315|9690263|P4|Overall Study|Protocol Violation|0
2827118|NCT02759315|9690264|P3|Overall Study|Protocol Violation|0
2827119|NCT02759315|9690265|P2|Overall Study|Protocol Violation|1
2827120|NCT02759315|9690266|P1|Overall Study|Protocol Violation|0
2827121|NCT02759315|9690262|P5|Overall Study|Lost to Follow-up|0
2827122|NCT02759315|9690263|P4|Overall Study|Lost to Follow-up|0
2827123|NCT02759315|9690264|P3|Overall Study|Lost to Follow-up|4
2827124|NCT02759315|9690265|P2|Overall Study|Lost to Follow-up|0
2827125|NCT02759315|9690266|P1|Overall Study|Lost to Follow-up|2
2827126|NCT02759315|9690262|P5|Overall Study|Death|0
2827127|NCT02759315|9690263|P4|Overall Study|Death|0
2827128|NCT02759315|9690264|P3|Overall Study|Death|1
2827129|NCT02759315|9690265|P2|Overall Study|Death|0
2827130|NCT02759315|9690266|P1|Overall Study|Death|0
2827131|NCT02759315|9690262|P5|Overall Study|Adverse Event|0
2827132|NCT02759315|9690263|P4|Overall Study|Adverse Event|1
2827133|NCT02759315|9690264|P3|Overall Study|Adverse Event|0
2827134|NCT02759315|9690265|P2|Overall Study|Adverse Event|0
2827135|NCT02759315|9690266|P1|Overall Study|Adverse Event|0
2827136|NCT02758613|9690314|P4|Treatment|Withdrawal by Subject|0
2827137|NCT02758613|9690315|P3|Treatment|Withdrawal by Subject|1
2827138|NCT02758613|9690316|P2|Treatment|Withdrawal by Subject|0
2827139|NCT02758613|9690317|P1|Treatment|Withdrawal by Subject|1
2827140|NCT02758613|9690314|P4|Treatment|Physician and Sponsor Decision|0
2827141|NCT02758613|9690315|P3|Treatment|Physician and Sponsor Decision|0
2827142|NCT02758613|9690316|P2|Treatment|Physician and Sponsor Decision|0
2827143|NCT02758613|9690317|P1|Treatment|Physician and Sponsor Decision|1
2827144|NCT02758301|9690335|P2|Overall Study|Protocol Violation|1
2827145|NCT02758301|9690336|P1|Overall Study|Protocol Violation|0
2827146|NCT02758301|9690335|P2|Overall Study|Lost to Follow-up|0
2827147|NCT02758301|9690336|P1|Overall Study|Lost to Follow-up|7
2827148|NCT02758301|9690335|P2|Overall Study|Withdrawal by Subject|6
2827149|NCT02758301|9690336|P1|Overall Study|Withdrawal by Subject|5
2827150|NCT02758301|9690335|P2|Overall Study|Physician Decision|1
2827151|NCT02758301|9690336|P1|Overall Study|Physician Decision|10
2827152|NCT02758301|9690335|P2|Overall Study|Death|0
2827153|NCT02758301|9690336|P1|Overall Study|Death|12
2827154|NCT02758171|9690355|P2|Wash-out|Other reason|0
2827155|NCT02758171|9690356|P1|Wash-out|Other reason|1
2827156|NCT02758171|9690355|P2|Wash-out|Withdrawal by Subject|0
2827157|NCT02758171|9690356|P1|Wash-out|Withdrawal by Subject|1
2827158|NCT02757963|9690410|P1|Overall Study|Withdrawal by Subject|34
2827159|NCT02757963|9690410|P1|Overall Study|Physician Decision|1
2827160|NCT02757963|9690410|P1|Overall Study|Lost to Follow-up|5
2827161|NCT02757963|9690410|P1|Overall Study|Reached Stopping Criteria|1054
2827162|NCT02757963|9690410|P1|Overall Study|Adverse Event|3
2827163|NCT02757768|9690450|P2|Overall Study|Miscellaneous|2
2827164|NCT02757768|9690451|P1|Overall Study|Miscellaneous|4
2827165|NCT02757768|9690450|P2|Overall Study|Withdrawal by Subject|9
2827166|NCT02757768|9690451|P1|Overall Study|Withdrawal by Subject|16
2827167|NCT02757768|9690450|P2|Overall Study|Protocol Deviation|9
2827168|NCT02757768|9690451|P1|Overall Study|Protocol Deviation|2
2827169|NCT02757768|9690450|P2|Overall Study|Lost to Follow-up|0
2827170|NCT02757768|9690451|P1|Overall Study|Lost to Follow-up|1
2827171|NCT02757768|9690450|P2|Overall Study|Lack of Efficacy|1
2827172|NCT02757768|9690451|P1|Overall Study|Lack of Efficacy|2
2827173|NCT02757768|9690450|P2|Overall Study|Adverse Event|3
2827174|NCT02757768|9690451|P1|Overall Study|Adverse Event|5
2827175|NCT02757768|9690450|P2|Overall Study|Randomized Never Received Study Drug|4
2827176|NCT02757768|9690451|P1|Overall Study|Randomized Never Received Study Drug|3
2827177|NCT02757625|9690501|P4|Overall Study|Adverse Event|0
2827178|NCT02757625|9690502|P3|Overall Study|Adverse Event|1
2827179|NCT02757625|9690503|P2|Overall Study|Adverse Event|0
2827180|NCT02757625|9690504|P1|Overall Study|Adverse Event|0
2827181|NCT02757625|9690501|P4|Overall Study|Investigator’s discretion|0
2827182|NCT02757625|9690502|P3|Overall Study|Investigator’s discretion|1
2827183|NCT02757625|9690503|P2|Overall Study|Investigator’s discretion|0
2827184|NCT02757625|9690504|P1|Overall Study|Investigator’s discretion|0
2827185|NCT02757521|9690663|P2|Overall Study|Adverse Event|0
2827186|NCT02757521|9690664|P1|Overall Study|Adverse Event|1
2827187|NCT02757430|9690670|P1|Overall Study|No procedure performed|2
2827188|NCT02757430|9690670|P1|Overall Study|No informed consent|1
2827189|NCT02757430|9690670|P1|Overall Study|Inclusion/Exclusion criteria not met|3
2827190|NCT02757430|9690670|P1|Overall Study|Physician Decision|6
2827191|NCT02757352|9690689|P10|Follow-Up Period|Withdrawal by Subject|2
2827192|NCT02757352|9690690|P9|Follow-Up Period|Withdrawal by Subject|6
2827193|NCT02757352|9690691|P8|Follow-Up Period|Withdrawal by Subject|1
2827194|NCT02757352|9690692|P7|Follow-Up Period|Withdrawal by Subject|0
2827195|NCT02757352|9690693|P6|Follow-Up Period|Withdrawal by Subject|0
2827196|NCT02757352|9690694|P5|Follow-Up Period|Withdrawal by Subject|0
2827197|NCT02757352|9690695|P4|Follow-Up Period|Withdrawal by Subject|0
2827198|NCT02757352|9690696|P3|Follow-Up Period|Withdrawal by Subject|0
2827199|NCT02757352|9690697|P2|Follow-Up Period|Withdrawal by Subject|0
2827200|NCT02757352|9690698|P1|Follow-Up Period|Withdrawal by Subject|0
2827201|NCT02757352|9690689|P10|Follow-Up Period|Lack of Efficacy|1
2827202|NCT02757352|9690690|P9|Follow-Up Period|Lack of Efficacy|1
2827203|NCT02757352|9690691|P8|Follow-Up Period|Lack of Efficacy|0
2827204|NCT02757352|9690692|P7|Follow-Up Period|Lack of Efficacy|0
2827205|NCT02757352|9690693|P6|Follow-Up Period|Lack of Efficacy|0
2827206|NCT02757352|9690694|P5|Follow-Up Period|Lack of Efficacy|0
2827207|NCT02757352|9690695|P4|Follow-Up Period|Lack of Efficacy|0
2827208|NCT02757352|9690696|P3|Follow-Up Period|Lack of Efficacy|0
2827209|NCT02757352|9690697|P2|Follow-Up Period|Lack of Efficacy|0
2827210|NCT02757352|9690698|P1|Follow-Up Period|Lack of Efficacy|0
2827211|NCT02757352|9690689|P10|Follow-Up Period|Lost to Follow-up|0
2827212|NCT02757352|9690690|P9|Follow-Up Period|Lost to Follow-up|1
2827213|NCT02757352|9690691|P8|Follow-Up Period|Lost to Follow-up|0
2827214|NCT02757352|9690692|P7|Follow-Up Period|Lost to Follow-up|0
2827215|NCT02757352|9690693|P6|Follow-Up Period|Lost to Follow-up|0
2827216|NCT02757352|9690694|P5|Follow-Up Period|Lost to Follow-up|0
2827217|NCT02757352|9690695|P4|Follow-Up Period|Lost to Follow-up|0
2827218|NCT02757352|9690696|P3|Follow-Up Period|Lost to Follow-up|0
2827219|NCT02757352|9690697|P2|Follow-Up Period|Lost to Follow-up|0
2827220|NCT02757352|9690698|P1|Follow-Up Period|Lost to Follow-up|0
2827221|NCT02757352|9690689|P10|Follow-Up Period|Adverse Event|0
2827222|NCT02757352|9690690|P9|Follow-Up Period|Adverse Event|2
2827223|NCT02757352|9690691|P8|Follow-Up Period|Adverse Event|0
2827224|NCT02757352|9690692|P7|Follow-Up Period|Adverse Event|1
2827225|NCT02757352|9690693|P6|Follow-Up Period|Adverse Event|0
2827226|NCT02757352|9690694|P5|Follow-Up Period|Adverse Event|0
2827227|NCT02757352|9690695|P4|Follow-Up Period|Adverse Event|0
2827228|NCT02757352|9690696|P3|Follow-Up Period|Adverse Event|0
2827229|NCT02757352|9690697|P2|Follow-Up Period|Adverse Event|0
2827230|NCT02757352|9690698|P1|Follow-Up Period|Adverse Event|0
2827231|NCT02757352|9690689|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827373|NCT02756611|9690991|P1|Overall Study|Withdrawal by Subject|1
2827232|NCT02757352|9690690|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827233|NCT02757352|9690691|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827234|NCT02757352|9690692|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827235|NCT02757352|9690693|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2827236|NCT02757352|9690694|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2827237|NCT02757352|9690695|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
2827238|NCT02757352|9690696|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827239|NCT02757352|9690697|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827240|NCT02757352|9690698|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827241|NCT02757352|9690689|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827242|NCT02757352|9690690|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827243|NCT02757352|9690691|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827244|NCT02757352|9690692|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827245|NCT02757352|9690693|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
2827246|NCT02757352|9690694|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827247|NCT02757352|9690695|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827248|NCT02757352|9690696|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827249|NCT02757352|9690697|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827250|NCT02757352|9690698|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2827251|NCT02757352|9690689|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827252|NCT02757352|9690690|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827253|NCT02757352|9690691|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827254|NCT02757352|9690692|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827255|NCT02757352|9690693|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827256|NCT02757352|9690694|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
2827257|NCT02757352|9690695|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827258|NCT02757352|9690696|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827259|NCT02757352|9690697|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827260|NCT02757352|9690698|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2827261|NCT02757352|9690689|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827262|NCT02757352|9690690|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827263|NCT02757352|9690691|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827264|NCT02757352|9690692|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827265|NCT02757352|9690693|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
2827266|NCT02757352|9690694|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
2827267|NCT02757352|9690695|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
2827268|NCT02757352|9690696|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827269|NCT02757352|9690697|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827270|NCT02757352|9690698|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2827271|NCT02757352|9690689|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827272|NCT02757352|9690690|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827273|NCT02757352|9690691|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827274|NCT02757352|9690692|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827275|NCT02757352|9690693|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
2827276|NCT02757352|9690694|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827277|NCT02757352|9690695|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
2827278|NCT02757352|9690696|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827279|NCT02757352|9690697|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827280|NCT02757352|9690698|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2827281|NCT02757352|9690689|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827282|NCT02757352|9690690|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827283|NCT02757352|9690691|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827284|NCT02757352|9690692|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827285|NCT02757352|9690693|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827286|NCT02757352|9690694|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827287|NCT02757352|9690695|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2827288|NCT02757352|9690696|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
2827289|NCT02757352|9690697|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
2827290|NCT02757352|9690698|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
2827291|NCT02757352|9690689|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827292|NCT02757352|9690690|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827293|NCT02757352|9690691|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827294|NCT02757352|9690692|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827295|NCT02757352|9690693|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827296|NCT02757352|9690694|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827297|NCT02757352|9690695|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2827298|NCT02757352|9690696|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
2827374|NCT02756611|9690991|P1|Overall Study|Death|39
2827299|NCT02757352|9690697|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2827300|NCT02757352|9690698|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2827301|NCT02757352|9690689|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827302|NCT02757352|9690690|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827303|NCT02757352|9690691|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827304|NCT02757352|9690692|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827305|NCT02757352|9690693|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827306|NCT02757352|9690694|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827307|NCT02757352|9690695|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827308|NCT02757352|9690696|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827309|NCT02757352|9690697|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
2827310|NCT02757352|9690698|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2827311|NCT02757352|9690689|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827312|NCT02757352|9690690|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827313|NCT02757352|9690691|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827314|NCT02757352|9690692|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827315|NCT02757352|9690693|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827316|NCT02757352|9690694|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827317|NCT02757352|9690695|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827318|NCT02757352|9690696|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827319|NCT02757352|9690697|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
2827320|NCT02757352|9690698|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2827321|NCT02757352|9690689|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827322|NCT02757352|9690690|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827323|NCT02757352|9690691|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827324|NCT02757352|9690692|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827325|NCT02757352|9690693|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827326|NCT02757352|9690694|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827327|NCT02757352|9690695|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2827328|NCT02757352|9690696|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
2827329|NCT02757352|9690697|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
2827330|NCT02757352|9690698|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
2827331|NCT02757352|9690689|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827332|NCT02757352|9690690|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827333|NCT02757352|9690691|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827334|NCT02757352|9690692|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827335|NCT02757352|9690693|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827336|NCT02757352|9690694|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827337|NCT02757352|9690695|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827338|NCT02757352|9690696|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
2827339|NCT02757352|9690697|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827340|NCT02757352|9690698|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2827341|NCT02757352|9690689|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827342|NCT02757352|9690690|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827343|NCT02757352|9690691|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827344|NCT02757352|9690692|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827345|NCT02757352|9690693|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827346|NCT02757352|9690694|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827347|NCT02757352|9690695|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827348|NCT02757352|9690696|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
2827349|NCT02757352|9690697|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2827350|NCT02757352|9690698|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
2827351|NCT02756832|9690854|P1|Overall Study|Protocol Deviation|10
2827352|NCT02756832|9690854|P1|Overall Study|Reason not Specified|9
2827353|NCT02756832|9690854|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
2827354|NCT02756832|9690854|P1|Overall Study|Insufficient Efficacy|2
2827355|NCT02756832|9690854|P1|Overall Study|Patient’s Unwillingness|12
2827356|NCT02756832|9690854|P1|Overall Study|Lost for Observation|13
2827357|NCT02756832|9690854|P1|Overall Study|Lost for Observation after Baseline|6
2827358|NCT02756819|9690868|P1|Overall Study|Reason not Specified|9
2827359|NCT02756819|9690868|P1|Overall Study|Adverse Event|2
2827360|NCT02756819|9690868|P1|Overall Study|Insufficient efficacy|2
2827361|NCT02756819|9690868|P1|Overall Study|Patient’s unwillingness|16
2827362|NCT02756819|9690868|P1|Overall Study|Lost for observation|23
2827363|NCT02756637|9690969|P2|Overall Study|Did not complete curative therapy|0
2827364|NCT02756637|9690970|P1|Overall Study|Did not complete curative therapy|33
2827365|NCT02756637|9690969|P2|Overall Study|No available NLR value|44
2827366|NCT02756637|9690970|P1|Overall Study|No available NLR value|44
2827367|NCT02756637|9690969|P2|Overall Study|Not eligible for initial SWOG study|10
2827368|NCT02756637|9690970|P1|Overall Study|Not eligible for initial SWOG study|10
2827369|NCT02756611|9690991|P1|Overall Study|Active on Study|205
2827370|NCT02756611|9690991|P1|Overall Study|Missing|2
2827371|NCT02756611|9690991|P1|Overall Study|Other|7
2827372|NCT02756611|9690991|P1|Overall Study|Lost to Follow-up|2
2827375|NCT02756338|9691013|P1|Overall Study|Device Replaced with Pacemaker|4
2827376|NCT02756338|9691013|P1|Overall Study|Withdrawn by Investigator|1
2827377|NCT02756182|9691022|P1|Overall Study|StudyTechnical Difficulties|4
2827378|NCT02756078|9691037|P2|Period 2|Withdrawal by Subject|1
2827379|NCT02756078|9691038|P1|Period 2|Withdrawal by Subject|3
2827380|NCT02756078|9691037|P2|Period 2|Unsatisfactory Lens Fitting|1
2827381|NCT02756078|9691038|P1|Period 2|Unsatisfactory Lens Fitting|0
2827382|NCT02756078|9691037|P2|Period 2|Adverse Event|5
2827383|NCT02756078|9691038|P1|Period 2|Adverse Event|3
2827384|NCT02756078|9691037|P2|Period 1|Lens Discomfort|2
2827385|NCT02756078|9691038|P1|Period 1|Lens Discomfort|2
2827386|NCT02756078|9691037|P2|Period 1|Withdrawal by Subject|6
2827387|NCT02756078|9691038|P1|Period 1|Withdrawal by Subject|6
2827388|NCT02756078|9691037|P2|Period 1|Adverse Event|10
2827389|NCT02756078|9691038|P1|Period 1|Adverse Event|1
2827390|NCT02756078|9691037|P2|Period 1|Protocol Violation|1
2827391|NCT02756078|9691038|P1|Period 1|Protocol Violation|0
2827392|NCT02756078|9691037|P2|Period 1|Lost to Follow-up|2
2827393|NCT02756078|9691038|P1|Period 1|Lost to Follow-up|0
2827394|NCT02756078|9691037|P2|Period 1|Unsatisfactory Lens Fitting|1
2827395|NCT02756078|9691038|P1|Period 1|Unsatisfactory Lens Fitting|0
2827396|NCT02755831|9691063|P2|Overall Study|Lost to Follow-up|3
2827397|NCT02755831|9691064|P1|Overall Study|Lost to Follow-up|3
2827398|NCT02755818|9691080|P4|Overall Study|withdrawal by PI|1
2827399|NCT02755818|9691081|P3|Overall Study|withdrawal by PI|1
2827400|NCT02755818|9691082|P2|Overall Study|withdrawal by PI|0
2827401|NCT02755818|9691083|P1|Overall Study|withdrawal by PI|0
2827402|NCT02755818|9691080|P4|Overall Study|Withdrawal by Subject|2
2827403|NCT02755818|9691081|P3|Overall Study|Withdrawal by Subject|0
2827404|NCT02755818|9691082|P2|Overall Study|Withdrawal by Subject|0
2827405|NCT02755818|9691083|P1|Overall Study|Withdrawal by Subject|0
2827406|NCT02755805|9691119|P2|Overall Study|Withdrawal by Subject|2
2827407|NCT02755805|9691120|P1|Overall Study|Withdrawal by Subject|0
2827408|NCT02755805|9691119|P2|Overall Study|Refused assessments|0
2827409|NCT02755805|9691120|P1|Overall Study|Refused assessments|1
2827410|NCT02755805|9691119|P2|Overall Study|Lost to Follow-up|2
2827411|NCT02755805|9691120|P1|Overall Study|Lost to Follow-up|1
2827412|NCT02755090|9691145|P2|Overall Study|equipment malfunction|0
2827413|NCT02755090|9691146|P1|Overall Study|equipment malfunction|1
2827414|NCT02754492|9691198|P4|Overall Study|Venous access issues not resulting in AE|4
2827415|NCT02754492|9691199|P3|Overall Study|Venous access issues not resulting in AE|0
2827416|NCT02754492|9691200|P2|Overall Study|Venous access issues not resulting in AE|0
2827417|NCT02754492|9691201|P1|Overall Study|Venous access issues not resulting in AE|0
2827418|NCT02754492|9691198|P4|Overall Study|Adverse Event|13
2827419|NCT02754492|9691199|P3|Overall Study|Adverse Event|0
2827420|NCT02754492|9691200|P2|Overall Study|Adverse Event|0
2827421|NCT02754492|9691201|P1|Overall Study|Adverse Event|0
2827422|NCT02754492|9691198|P4|Overall Study|Equipment malfuntion|5
2827423|NCT02754492|9691199|P3|Overall Study|Equipment malfuntion|2
2827424|NCT02754492|9691200|P2|Overall Study|Equipment malfuntion|0
2827425|NCT02754492|9691201|P1|Overall Study|Equipment malfuntion|0
2827426|NCT02754492|9691198|P4|Overall Study|Withdrawal by Subject|0
2827427|NCT02754492|9691199|P3|Overall Study|Withdrawal by Subject|0
2827428|NCT02754492|9691200|P2|Overall Study|Withdrawal by Subject|0
2827429|NCT02754492|9691201|P1|Overall Study|Withdrawal by Subject|2
2827430|NCT02754492|9691198|P4|Overall Study|Protocol Violation|1
2827431|NCT02754492|9691199|P3|Overall Study|Protocol Violation|0
2827432|NCT02754492|9691200|P2|Overall Study|Protocol Violation|2
2827433|NCT02754492|9691201|P1|Overall Study|Protocol Violation|2
2827434|NCT02754440|9691217|P4|Overall Study|Subject issues not resulting in AE|12
2827435|NCT02754440|9691218|P3|Overall Study|Subject issues not resulting in AE|0
2827436|NCT02754440|9691219|P2|Overall Study|Subject issues not resulting in AE|0
2827437|NCT02754440|9691220|P1|Overall Study|Subject issues not resulting in AE|0
2827438|NCT02754440|9691217|P4|Overall Study|Equipment failure|7
2827439|NCT02754440|9691218|P3|Overall Study|Equipment failure|5
2827440|NCT02754440|9691219|P2|Overall Study|Equipment failure|5
2827441|NCT02754440|9691220|P1|Overall Study|Equipment failure|0
2827442|NCT02754440|9691217|P4|Overall Study|Withdrawal by Subject|1
2827443|NCT02754440|9691218|P3|Overall Study|Withdrawal by Subject|0
2827444|NCT02754440|9691219|P2|Overall Study|Withdrawal by Subject|0
2827445|NCT02754440|9691220|P1|Overall Study|Withdrawal by Subject|0
2827446|NCT02754440|9691217|P4|Overall Study|Adverse Event|9
2827447|NCT02754440|9691218|P3|Overall Study|Adverse Event|0
2827448|NCT02754440|9691219|P2|Overall Study|Adverse Event|1
2827449|NCT02754440|9691220|P1|Overall Study|Adverse Event|3
2827450|NCT02754440|9691217|P4|Overall Study|Protocol Violation|6
2827451|NCT02754440|9691218|P3|Overall Study|Protocol Violation|2
2827452|NCT02754440|9691219|P2|Overall Study|Protocol Violation|2
2827453|NCT02754440|9691220|P1|Overall Study|Protocol Violation|3
2827454|NCT02753946|9691272|P2|Overall Study|Physician Decision|2
2827455|NCT02753946|9691273|P1|Overall Study|Physician Decision|0
2827456|NCT02753946|9691272|P2|Overall Study|Lack of Efficacy|0
2827457|NCT02753946|9691273|P1|Overall Study|Lack of Efficacy|1
2827458|NCT02753946|9691272|P2|Overall Study|Withdrawal by Subject|1
2827459|NCT02753946|9691273|P1|Overall Study|Withdrawal by Subject|6
2827460|NCT02753946|9691272|P2|Overall Study|Adverse Event|6
2827461|NCT02753946|9691273|P1|Overall Study|Adverse Event|7
2827462|NCT02753075|9691353|P3|Overall Study|Physician Decision|0
2827463|NCT02753075|9691354|P2|Overall Study|Physician Decision|1
2827464|NCT02753075|9691355|P1|Overall Study|Physician Decision|3
2827465|NCT02753075|9691353|P3|Overall Study|Withdrawal of Consent|3
2827466|NCT02753075|9691354|P2|Overall Study|Withdrawal of Consent|1
2827467|NCT02753075|9691355|P1|Overall Study|Withdrawal of Consent|1
2827468|NCT02753075|9691353|P3|Overall Study|Lost to Follow-up|0
2827469|NCT02753075|9691354|P2|Overall Study|Lost to Follow-up|0
2827470|NCT02753075|9691355|P1|Overall Study|Lost to Follow-up|2
2827471|NCT02753075|9691353|P3|Overall Study|Adverse Event|0
2827472|NCT02753075|9691354|P2|Overall Study|Adverse Event|1
2827473|NCT02753075|9691355|P1|Overall Study|Adverse Event|2
2827474|NCT02752958|9691380|P1|Overall Study|Other (Reason not specified)|2
2827475|NCT02752958|9691380|P1|Overall Study|Withdrawal by Subject|2
2827476|NCT02752958|9691380|P1|Overall Study|Protocol Violation|1
2827477|NCT02752958|9691380|P1|Overall Study|Lost to Follow-up|1
2827478|NCT02752958|9691380|P1|Overall Study|Adverse Event|3
2827479|NCT02752802|9691462|P2|Overall Study|Contrast Volume Not Collected|0
2827480|NCT02752802|9691463|P1|Overall Study|Contrast Volume Not Collected|1
2827481|NCT02752776|9691475|P3|Overall Study|Withdrawal by Subject|2
2827482|NCT02752776|9691476|P2|Overall Study|Withdrawal by Subject|4
2827483|NCT02752776|9691477|P1|Overall Study|Withdrawal by Subject|3
2827484|NCT02752776|9691475|P3|Overall Study|Death|1
2827485|NCT02752776|9691476|P2|Overall Study|Death|0
2827486|NCT02752776|9691477|P1|Overall Study|Death|0
2827487|NCT02752776|9691475|P3|Overall Study|Subject/guardian decision|4
2827488|NCT02752776|9691476|P2|Overall Study|Subject/guardian decision|6
2827489|NCT02752776|9691477|P1|Overall Study|Subject/guardian decision|8
2827490|NCT02752776|9691475|P3|Overall Study|Protocol Violation|6
2827491|NCT02752776|9691476|P2|Overall Study|Protocol Violation|13
2827492|NCT02752776|9691477|P1|Overall Study|Protocol Violation|10
2827493|NCT02752776|9691475|P3|Overall Study|Pregnancy|3
2827494|NCT02752776|9691476|P2|Overall Study|Pregnancy|6
2827495|NCT02752776|9691477|P1|Overall Study|Pregnancy|1
2827496|NCT02752776|9691475|P3|Overall Study|Physician Decision|2
2827497|NCT02752776|9691476|P2|Overall Study|Physician Decision|6
2827498|NCT02752776|9691477|P1|Overall Study|Physician Decision|2
2827499|NCT02752776|9691475|P3|Overall Study|Non-compliance with study treatment|1
2827500|NCT02752776|9691476|P2|Overall Study|Non-compliance with study treatment|0
2827501|NCT02752776|9691477|P1|Overall Study|Non-compliance with study treatment|0
2827502|NCT02752776|9691475|P3|Overall Study|Lost to Follow-up|4
2827503|NCT02752776|9691476|P2|Overall Study|Lost to Follow-up|12
2827504|NCT02752776|9691477|P1|Overall Study|Lost to Follow-up|11
2827505|NCT02752776|9691475|P3|Overall Study|Lack of Efficacy|14
2827506|NCT02752776|9691476|P2|Overall Study|Lack of Efficacy|6
2827507|NCT02752776|9691477|P1|Overall Study|Lack of Efficacy|2
2827508|NCT02752776|9691475|P3|Overall Study|Adverse Event|11
2827509|NCT02752776|9691476|P2|Overall Study|Adverse Event|23
2827510|NCT02752776|9691477|P1|Overall Study|Adverse Event|15
2827511|NCT02752633|9691523|P1|Overall Study|Withdrawal by Subject|1
2827512|NCT02752087|9691561|P2|Washout|Physician Decision|0
2827513|NCT02752087|9691562|P1|Washout|Physician Decision|1
2827514|NCT02752074|9691572|P2|Overall Study|Status not Recorded|251
2827515|NCT02752074|9691573|P1|Overall Study|Status not Recorded|244
2827516|NCT02752074|9691572|P2|Overall Study|Withdrawal by Subject|8
2827517|NCT02752074|9691573|P1|Overall Study|Withdrawal by Subject|6
2827518|NCT02752074|9691572|P2|Overall Study|Death|91
2827519|NCT02752074|9691573|P1|Overall Study|Death|104
2827520|NCT02752074|9691572|P2|Overall Study|Lost to Follow-up|2
2827521|NCT02752074|9691573|P1|Overall Study|Lost to Follow-up|0
2827522|NCT02752048|9691598|P3|Overall Study|Withdrawal by Subject|3
2827523|NCT02752048|9691599|P2|Overall Study|Withdrawal by Subject|0
2827524|NCT02752048|9691600|P1|Overall Study|Withdrawal by Subject|0
2827525|NCT02751983|9691619|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
2827526|NCT02751983|9691620|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
2827527|NCT02751983|9691619|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
2827528|NCT02751983|9691620|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
2827529|NCT02751983|9691619|P2|Post-Treatment Assessment|Lost to Follow-up|0
2827530|NCT02751983|9691620|P1|Post-Treatment Assessment|Lost to Follow-up|5
2827531|NCT02751983|9691619|P2|Treatment|Discharged prior to beginning ACT|0
2827532|NCT02751983|9691620|P1|Treatment|Discharged prior to beginning ACT|2
2827533|NCT02751983|9691619|P2|Treatment|Stopped ACT, but Remained in study|0
2827534|NCT02751983|9691620|P1|Treatment|Stopped ACT, but Remained in study|2
2827535|NCT02751931|9691641|P2|Overall Study|Other: Miscelleneous|8
2827536|NCT02751931|9691642|P1|Overall Study|Other: Miscelleneous|10
2827537|NCT02751931|9691641|P2|Overall Study|Adverse Event|0
2827538|NCT02751931|9691642|P1|Overall Study|Adverse Event|3
2827539|NCT02751450|9691732|P2|Overall Study|Adverse Event|0
2827540|NCT02751450|9691733|P1|Overall Study|Adverse Event|1
2827541|NCT02751424|9691754|P9|Part 2|Adverse Event|0
2827542|NCT02751424|9691755|P8|Part 2|Adverse Event|5
2827543|NCT02751424|9691756|P7|Part 2|Adverse Event|0
2827544|NCT02751424|9691757|P6|Part 2|Adverse Event|0
2827545|NCT02751424|9691758|P5|Part 2|Adverse Event|0
2827546|NCT02751424|9691759|P4|Part 2|Adverse Event|0
2827547|NCT02751424|9691760|P3|Part 2|Adverse Event|0
2827548|NCT02751424|9691761|P2|Part 2|Adverse Event|0
2827549|NCT02751424|9691762|P1|Part 2|Adverse Event|0
2827550|NCT02751320|9691918|P1|Overall Study|Withdrawal by Subject|1
2827551|NCT02751320|9691918|P1|Overall Study|Adverse Event|2
2827552|NCT02750943|9691956|P2|Overall Study|Withdrawal by Subject|7
2827553|NCT02750943|9691957|P1|Overall Study|Withdrawal by Subject|5
2827554|NCT02750943|9691956|P2|Overall Study|Lost to Follow-up|2
2827555|NCT02750943|9691957|P1|Overall Study|Lost to Follow-up|1
2827556|NCT02750930|9691971|P1|Overall Study|Study closed/terminated|8
2827557|NCT02750813|9691983|P2|Period 1, First 14 Days of Wear|Reason not given|1
2827558|NCT02750813|9691984|P1|Period 1, First 14 Days of Wear|Reason not given|0
2827559|NCT02750813|9691983|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
2827560|NCT02750813|9691984|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
2827561|NCT02750800|9691999|P1|Overall Study|Other, not specified|3
2827562|NCT02750800|9691999|P1|Overall Study|Patient request|12
2827563|NCT02750800|9691999|P1|Overall Study|Investigator decision|53
2827564|NCT02750800|9691999|P1|Overall Study|Lost to Follow-up|12
2827565|NCT02750800|9691999|P1|Overall Study|Adverse Event|18
2827566|NCT02750761|9692104|P6|Overall Study|Lost to Follow-up|0
2827567|NCT02750761|9692105|P5|Overall Study|Lost to Follow-up|0
2827568|NCT02750761|9692106|P4|Overall Study|Lost to Follow-up|0
2827569|NCT02750761|9692107|P3|Overall Study|Lost to Follow-up|1
2827570|NCT02750761|9692108|P2|Overall Study|Lost to Follow-up|0
2827571|NCT02750761|9692109|P1|Overall Study|Lost to Follow-up|0
2827572|NCT02750709|9692205|P6|Treatment Period 1|Adverse Event|1
2827573|NCT02750709|9692206|P5|Treatment Period 1|Adverse Event|0
2827574|NCT02750709|9692207|P4|Treatment Period 1|Adverse Event|0
2827575|NCT02750709|9692208|P3|Treatment Period 1|Adverse Event|0
2827576|NCT02750709|9692209|P2|Treatment Period 1|Adverse Event|0
2827577|NCT02750709|9692210|P1|Treatment Period 1|Adverse Event|0
2827578|NCT02750618|9692236|P1|Overall Study|Withdrawal by Subject|1
2827579|NCT02750592|9692252|P1|Overall Study|Lack of Efficacy|2
2827580|NCT02750592|9692252|P1|Overall Study|Adverse Event|3
2827581|NCT02750501|9692271|P1|Overall Study|Non-compliant use of PERT|1
2827582|NCT02750501|9692271|P1|Overall Study|G-tube came out|1
2827583|NCT02750501|9692271|P1|Overall Study|Protocol Violation|1
2827584|NCT02750501|9692271|P1|Overall Study|Physician Decision|1
2827585|NCT02750501|9692271|P1|Overall Study|Adverse Event|4
2827586|NCT02750410|9692285|P2|Open-Label Extension Period|Withdrawal by Subject|2
2827587|NCT02750410|9692286|P1|Open-Label Extension Period|Withdrawal by Subject|1
2827588|NCT02750410|9692285|P2|Open-Label Extension Period|Protocol Violation|1
2827589|NCT02750410|9692286|P1|Open-Label Extension Period|Protocol Violation|0
2827590|NCT02750410|9692285|P2|Open-Label Extension Period|Adverse Event|3
2827591|NCT02750410|9692286|P1|Open-Label Extension Period|Adverse Event|5
2827592|NCT02750410|9692285|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2827593|NCT02750410|9692286|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2827594|NCT02750410|9692285|P2|Double-Blind Treatment Period|Adverse Event|2
2827595|NCT02750410|9692286|P1|Double-Blind Treatment Period|Adverse Event|2
2827596|NCT02750345|9692304|P6|Intervention 1|Adverse Event|0
2827597|NCT02750345|9692305|P5|Intervention 1|Adverse Event|1
2827598|NCT02750345|9692306|P4|Intervention 1|Adverse Event|0
2827599|NCT02750345|9692307|P3|Intervention 1|Adverse Event|0
2827600|NCT02750345|9692308|P2|Intervention 1|Adverse Event|0
2827601|NCT02750345|9692309|P1|Intervention 1|Adverse Event|0
2827602|NCT02750332|9692335|P2|Treatment Period 1|Withdrawal by Subject|1
2827603|NCT02750332|9692336|P1|Treatment Period 1|Withdrawal by Subject|0
2827604|NCT02750306|9692356|P2|Overall Study|Protocol Violation|0
2827605|NCT02750306|9692357|P1|Overall Study|Protocol Violation|1
2827606|NCT02750306|9692356|P2|Overall Study|Withdrawal by Subject|2
2827607|NCT02750306|9692357|P1|Overall Study|Withdrawal by Subject|5
2827608|NCT02749370|9692416|P1|Overall Study|Lost to Follow-up|3
2827609|NCT02749370|9692416|P1|Overall Study|Withdrawal by Subject|11
2827610|NCT02748863|9692466|P5|Treatment Period 2|Pregnancy|1
2827611|NCT02748863|9692467|P4|Treatment Period 2|Pregnancy|0
2827612|NCT02748863|9692468|P3|Treatment Period 2|Pregnancy|0
2827613|NCT02748863|9692469|P2|Treatment Period 2|Pregnancy|0
2827614|NCT02748863|9692470|P1|Treatment Period 2|Pregnancy|0
2827615|NCT02748863|9692466|P5|Treatment Period 2|Lack of Efficacy|0
2827616|NCT02748863|9692467|P4|Treatment Period 2|Lack of Efficacy|0
2827617|NCT02748863|9692468|P3|Treatment Period 2|Lack of Efficacy|0
2827618|NCT02748863|9692469|P2|Treatment Period 2|Lack of Efficacy|1
2827619|NCT02748863|9692470|P1|Treatment Period 2|Lack of Efficacy|0
2827620|NCT02748863|9692466|P5|Treatment Period 2|Adverse Event|0
2827621|NCT02748863|9692467|P4|Treatment Period 2|Adverse Event|2
2827622|NCT02748863|9692468|P3|Treatment Period 2|Adverse Event|0
2827623|NCT02748863|9692469|P2|Treatment Period 2|Adverse Event|2
2827624|NCT02748863|9692470|P1|Treatment Period 2|Adverse Event|3
2827625|NCT02748863|9692466|P5|Treatment Period 2|Lost to Follow-up|0
2827626|NCT02748863|9692467|P4|Treatment Period 2|Lost to Follow-up|0
2827627|NCT02748863|9692468|P3|Treatment Period 2|Lost to Follow-up|0
2827628|NCT02748863|9692469|P2|Treatment Period 2|Lost to Follow-up|0
2827629|NCT02748863|9692470|P1|Treatment Period 2|Lost to Follow-up|2
2827630|NCT02748863|9692466|P5|Treatment Period 1|Withdrawal by Subject|0
2827631|NCT02748863|9692467|P4|Treatment Period 1|Withdrawal by Subject|0
2827632|NCT02748863|9692468|P3|Treatment Period 1|Withdrawal by Subject|1
2827633|NCT02748863|9692469|P2|Treatment Period 1|Withdrawal by Subject|1
2827634|NCT02748863|9692470|P1|Treatment Period 1|Withdrawal by Subject|0
2827635|NCT02748863|9692466|P5|Treatment Period 1|Lack of Efficacy|0
2827636|NCT02748863|9692467|P4|Treatment Period 1|Lack of Efficacy|0
2827637|NCT02748863|9692468|P3|Treatment Period 1|Lack of Efficacy|1
2827638|NCT02748863|9692469|P2|Treatment Period 1|Lack of Efficacy|0
2827639|NCT02748863|9692470|P1|Treatment Period 1|Lack of Efficacy|0
2827640|NCT02748863|9692466|P5|Treatment Period 1|Adverse Event|0
2827641|NCT02748863|9692467|P4|Treatment Period 1|Adverse Event|0
2827642|NCT02748863|9692468|P3|Treatment Period 1|Adverse Event|0
2827643|NCT02748863|9692469|P2|Treatment Period 1|Adverse Event|1
2827644|NCT02748863|9692470|P1|Treatment Period 1|Adverse Event|0
2827645|NCT02748512|9692554|P2|Overall Study|Lost to Follow-up|1
2827646|NCT02748512|9692555|P1|Overall Study|Lost to Follow-up|1
2827647|NCT02748356|9692563|P1|Overall Study|Withdrawal by Subject|1
2827648|NCT02748317|9692568|P1|Overall Study|Death|1
2827649|NCT02748317|9692568|P1|Overall Study|Lost to Follow-up|8
2827650|NCT02748317|9692568|P1|Overall Study|Withdrawal by Subject|14
2827651|NCT02748213|9692575|P2|Overall Study|Other|29
2827652|NCT02748213|9692576|P1|Overall Study|Other|30
2827653|NCT02748213|9692575|P2|Overall Study|Failure to Return|0
2827654|NCT02748213|9692576|P1|Overall Study|Failure to Return|1
2827655|NCT02748213|9692575|P2|Overall Study|Refused Treatment*|6
2827656|NCT02748213|9692576|P1|Overall Study|Refused Treatment*|6
2827657|NCT02748213|9692575|P2|Overall Study|Protocol Violation|4
2827658|NCT02748213|9692576|P1|Overall Study|Protocol Violation|6
2827659|NCT02748213|9692575|P2|Overall Study|Violation of Selection Criteria|0
2827660|NCT02748213|9692576|P1|Overall Study|Violation of Selection Criteria|2
2827661|NCT02748213|9692575|P2|Overall Study|Insufficient Therapeutic Response|57
2827662|NCT02748213|9692576|P1|Overall Study|Insufficient Therapeutic Response|56
2827663|NCT02748213|9692575|P2|Overall Study|Death|3
2827664|NCT02748213|9692576|P1|Overall Study|Death|5
2827665|NCT02748213|9692575|P2|Overall Study|Adverse Event or Intercurrent Illness|11
2827666|NCT02748213|9692576|P1|Overall Study|Adverse Event or Intercurrent Illness|5
2827667|NCT02748213|9692575|P2|Overall Study|Abnormal Laboratory Test|0
2827668|NCT02748213|9692576|P1|Overall Study|Abnormal Laboratory Test|1
2827669|NCT02748213|9692575|P2|Overall Study|Withdrawal Prior to Treatment|2
2827670|NCT02748213|9692576|P1|Overall Study|Withdrawal Prior to Treatment|1
2827671|NCT02748057|9692594|P2|Overall Study|Withdrawal by Subject|0
2827672|NCT02748057|9692595|P1|Overall Study|Withdrawal by Subject|1
2827673|NCT02748057|9692594|P2|Overall Study|Participant Moved|0
2827674|NCT02748057|9692595|P1|Overall Study|Participant Moved|1
2827675|NCT02748057|9692594|P2|Overall Study|Protocol Violation|1
2827676|NCT02748057|9692595|P1|Overall Study|Protocol Violation|2
2827677|NCT02748057|9692594|P2|Overall Study|Physician Decision|1
2827678|NCT02748057|9692595|P1|Overall Study|Physician Decision|0
2827679|NCT02748057|9692594|P2|Overall Study|Adverse Event|0
2827680|NCT02748057|9692595|P1|Overall Study|Adverse Event|1
2827681|NCT02747004|9692650|P3|Overall Study|on study treatment/follow-up|41
2827682|NCT02747004|9692651|P2|Overall Study|on study treatment/follow-up|42
2827683|NCT02747004|9692652|P1|Overall Study|on study treatment/follow-up|48
2827684|NCT02747004|9692650|P3|Overall Study|Lost to Follow-up|2
2827685|NCT02747004|9692651|P2|Overall Study|Lost to Follow-up|2
2827686|NCT02747004|9692652|P1|Overall Study|Lost to Follow-up|1
2827687|NCT02747004|9692650|P3|Overall Study|Withdrawal by Subject|4
2827688|NCT02747004|9692651|P2|Overall Study|Withdrawal by Subject|5
2827689|NCT02747004|9692652|P1|Overall Study|Withdrawal by Subject|8
2827690|NCT02746705|9692700|P2|Overall Study|outlier scores deemed not valid|1
2827691|NCT02746705|9692701|P1|Overall Study|outlier scores deemed not valid|0
2827692|NCT02746705|9692700|P2|Overall Study|Lost to Follow-up|0
2827693|NCT02746705|9692701|P1|Overall Study|Lost to Follow-up|1
2827694|NCT02746705|9692700|P2|Overall Study|Physician Decision|1
2827695|NCT02746705|9692701|P1|Overall Study|Physician Decision|1
2827696|NCT02746679|9692715|P2|Overall Study|Lost to Follow-up|6
2827697|NCT02746679|9692716|P1|Overall Study|Lost to Follow-up|4
2827698|NCT02746627|9692749|P3|Overall Study|Withdrawal by Subject|1
2827699|NCT02746627|9692750|P2|Overall Study|Withdrawal by Subject|1
2827700|NCT02746627|9692751|P1|Overall Study|Withdrawal by Subject|1
2827701|NCT02746575|9692774|P1|Overall Study|Unknown history of CVA|1
2827702|NCT02746575|9692774|P1|Overall Study|PI unavailable|1
2827703|NCT02746575|9692774|P1|Overall Study|typ of surgery|1
2827704|NCT02746575|9692774|P1|Overall Study|type of surgery|1
2827705|NCT02746575|9692774|P1|Overall Study|put on beta-blocker|3
2827706|NCT02746575|9692774|P1|Overall Study|Study paused|8
2827707|NCT02746575|9692774|P1|Overall Study|Bradycardia/hypotension|9
2827708|NCT02746575|9692774|P1|Overall Study|Withdrawal by Subject|3
2827709|NCT02746575|9692774|P1|Overall Study|Received epidural|10
2827710|NCT02746575|9692774|P1|Overall Study|Surgery cancelled or time chaned|13
2827711|NCT02745535|9692837|P1|Overall Study|Lost to Follow-up|2
2827712|NCT02745535|9692837|P1|Overall Study|Adverse Event|3
2827713|NCT02745535|9692837|P1|Overall Study|Death|1
2827714|NCT02745392|9692849|P4|Overall Study|Lost to Follow-up|0
2827715|NCT02745392|9692850|P3|Overall Study|Lost to Follow-up|0
2827716|NCT02745392|9692851|P2|Overall Study|Lost to Follow-up|1
2827717|NCT02745392|9692852|P1|Overall Study|Lost to Follow-up|0
2827718|NCT02745145|9692878|P3|Overall Study|Study Termination|7
2827719|NCT02745145|9692879|P2|Overall Study|Study Termination|3
2827720|NCT02745145|9692880|P1|Overall Study|Study Termination|8
2827721|NCT02745145|9692878|P3|Overall Study|Withdrew consent|1
2827722|NCT02745145|9692879|P2|Overall Study|Withdrew consent|1
2827723|NCT02745145|9692880|P1|Overall Study|Withdrew consent|1
2827724|NCT02745145|9692878|P3|Overall Study|Progressive disease|1
2827725|NCT02745145|9692879|P2|Overall Study|Progressive disease|0
2827726|NCT02745145|9692880|P1|Overall Study|Progressive disease|0
2827727|NCT02745145|9692878|P3|Overall Study|Death|0
2827728|NCT02745145|9692879|P2|Overall Study|Death|1
2827729|NCT02745145|9692880|P1|Overall Study|Death|0
2827730|NCT02745145|9692878|P3|Overall Study|Adverse Event|0
2827731|NCT02745145|9692879|P2|Overall Study|Adverse Event|0
2827732|NCT02745145|9692880|P1|Overall Study|Adverse Event|1
2827733|NCT02745119|9692919|P4|Overall Study|Reason Not Specified|1
2827734|NCT02745119|9692920|P3|Overall Study|Reason Not Specified|0
2827735|NCT02745119|9692921|P2|Overall Study|Reason Not Specified|2
2827736|NCT02745119|9692922|P1|Overall Study|Reason Not Specified|0
2827737|NCT02745119|9692919|P4|Overall Study|Physician Decision|2
2827738|NCT02745119|9692920|P3|Overall Study|Physician Decision|2
2827739|NCT02745119|9692921|P2|Overall Study|Physician Decision|2
2827740|NCT02745119|9692922|P1|Overall Study|Physician Decision|0
2827741|NCT02745119|9692919|P4|Overall Study|Study Terminated by Sponsor|251
2827742|NCT02745119|9692920|P3|Overall Study|Study Terminated by Sponsor|135
2827743|NCT02745119|9692921|P2|Overall Study|Study Terminated by Sponsor|252
2827744|NCT02745119|9692922|P1|Overall Study|Study Terminated by Sponsor|134
2827745|NCT02745119|9692919|P4|Overall Study|Withdrawal by Subject|14
2827746|NCT02745119|9692920|P3|Overall Study|Withdrawal by Subject|8
2827747|NCT02745119|9692921|P2|Overall Study|Withdrawal by Subject|15
2827748|NCT02745119|9692922|P1|Overall Study|Withdrawal by Subject|7
2827749|NCT02745119|9692919|P4|Overall Study|Protocol Deviation|1
2827750|NCT02745119|9692920|P3|Overall Study|Protocol Deviation|0
2827751|NCT02745119|9692921|P2|Overall Study|Protocol Deviation|0
2827752|NCT02745119|9692922|P1|Overall Study|Protocol Deviation|0
2827753|NCT02745119|9692919|P4|Overall Study|Lost to Follow-up|1
2827754|NCT02745119|9692920|P3|Overall Study|Lost to Follow-up|0
2827755|NCT02745119|9692921|P2|Overall Study|Lost to Follow-up|0
2827756|NCT02745119|9692922|P1|Overall Study|Lost to Follow-up|0
2827757|NCT02745119|9692919|P4|Overall Study|Death|4
2827758|NCT02745119|9692920|P3|Overall Study|Death|0
2827759|NCT02745119|9692921|P2|Overall Study|Death|3
2827760|NCT02745119|9692922|P1|Overall Study|Death|3
2827761|NCT02745119|9692919|P4|Overall Study|Adverse Event|3
2827762|NCT02745119|9692920|P3|Overall Study|Adverse Event|1
2827763|NCT02745119|9692921|P2|Overall Study|Adverse Event|0
2827764|NCT02745119|9692922|P1|Overall Study|Adverse Event|1
2827765|NCT02744898|9692944|P1|Overall Study|Toxicity|1
2827766|NCT02744898|9692944|P1|Overall Study|Physician Decision|1
2827767|NCT02744898|9692944|P1|Overall Study|Progressive Disease|2
2827768|NCT02744755|9692958|P2|Study Period 2|Lack of Efficacy|2
2827769|NCT02744755|9692959|P1|Study Period 2|Lack of Efficacy|3
2827770|NCT02744755|9692958|P2|Study Period 2|Withdrawal by Subject|2
2827771|NCT02744755|9692959|P1|Study Period 2|Withdrawal by Subject|2
2827772|NCT02744755|9692958|P2|Study Period 2|Lost to Follow-up|2
2827773|NCT02744755|9692959|P1|Study Period 2|Lost to Follow-up|0
2827774|NCT02744755|9692958|P2|Study Period 2|not defined|2
2827775|NCT02744755|9692959|P1|Study Period 2|not defined|3
2827776|NCT02744755|9692958|P2|Study Period 2|Protocol Violation|0
2827777|NCT02744755|9692959|P1|Study Period 2|Protocol Violation|1
2827778|NCT02744755|9692958|P2|Study Period 2|Adverse Event|0
2827779|NCT02744755|9692959|P1|Study Period 2|Adverse Event|5
2827780|NCT02744755|9692958|P2|Study Period 1|Withdrawal by Subject|4
2827781|NCT02744755|9692959|P1|Study Period 1|Withdrawal by Subject|8
2827782|NCT02744755|9692958|P2|Study Period 1|Lack of Efficacy|0
2827783|NCT02744755|9692959|P1|Study Period 1|Lack of Efficacy|1
2827784|NCT02744755|9692958|P2|Study Period 1|Lost to Follow-up|1
2827785|NCT02744755|9692959|P1|Study Period 1|Lost to Follow-up|1
2827786|NCT02744755|9692958|P2|Study Period 1|Adverse Event|1
2827787|NCT02744755|9692959|P1|Study Period 1|Adverse Event|1
2827788|NCT02744755|9692958|P2|Study Period 1|Pregnancy|0
2827789|NCT02744755|9692959|P1|Study Period 1|Pregnancy|1
2827790|NCT02744755|9692958|P2|Study Period 1|not defined|1
2827791|NCT02744755|9692959|P1|Study Period 1|not defined|0
2827792|NCT02744755|9692958|P2|Study Period 1|Protocol Violation|1
2827793|NCT02744755|9692959|P1|Study Period 1|Protocol Violation|2
2827794|NCT02744391|9693019|P1|Overall Study|Withdrawal by Subject|3
2827795|NCT02744391|9693019|P1|Overall Study|Physician Decision|2
2827796|NCT02744391|9693019|P1|Overall Study|Lost to Follow-up|9
2827797|NCT02744066|9693060|P2|Overall Study|Discharged from NICU prior to completion|4
2827798|NCT02744066|9693061|P1|Overall Study|Discharged from NICU prior to completion|0
2827799|NCT02744066|9693060|P2|Overall Study|Withdrawal by parent|1
2827800|NCT02744066|9693061|P1|Overall Study|Withdrawal by parent|0
2827801|NCT02743962|9693071|P2|Overall Study|Atrophic vaginitis diagnosed|0
2827802|NCT02743962|9693072|P1|Overall Study|Atrophic vaginitis diagnosed|1
2827803|NCT02743949|9693094|P3|Overall Study|Voluntary Withdrawal|0
2827804|NCT02743949|9693095|P2|Overall Study|Voluntary Withdrawal|1
2827805|NCT02743949|9693096|P1|Overall Study|Voluntary Withdrawal|2
2827806|NCT02743949|9693094|P3|Overall Study|Significant Protocol Deviation|1
2827807|NCT02743949|9693095|P2|Overall Study|Significant Protocol Deviation|0
2827808|NCT02743949|9693096|P1|Overall Study|Significant Protocol Deviation|2
2827809|NCT02743949|9693094|P3|Overall Study|Adverse Event|2
2827810|NCT02743949|9693095|P2|Overall Study|Adverse Event|0
2827811|NCT02743949|9693096|P1|Overall Study|Adverse Event|0
2827812|NCT02743780|9693123|P5|Part 3 (7 Days)|Adverse Event|0
2827813|NCT02743780|9693124|P4|Part 3 (7 Days)|Adverse Event|0
2827814|NCT02743780|9693125|P3|Part 3 (7 Days)|Adverse Event|1
2827815|NCT02743780|9693126|P2|Part 3 (7 Days)|Adverse Event|0
2827816|NCT02743780|9693127|P1|Part 3 (7 Days)|Adverse Event|0
2827817|NCT02743221|9693217|P2|Overall Study|Patient not eligible, not treated|1
2827818|NCT02743221|9693218|P1|Overall Study|Patient not eligible, not treated|0
2827819|NCT02743221|9693217|P2|Overall Study|Physician Decision|5
2827820|NCT02743221|9693218|P1|Overall Study|Physician Decision|2
2827821|NCT02743221|9693217|P2|Overall Study|non medical reason|2
2827822|NCT02743221|9693218|P1|Overall Study|non medical reason|8
2827823|NCT02743221|9693217|P2|Overall Study|Adverse Event|14
2827824|NCT02743221|9693218|P1|Overall Study|Adverse Event|17
2827825|NCT02743221|9693217|P2|Overall Study|Progressive disease|38
2827826|NCT02743221|9693218|P1|Overall Study|Progressive disease|29
2827827|NCT02743117|9693234|P2|Overall Study|Other|0
2827828|NCT02743117|9693235|P1|Overall Study|Other|1
2827829|NCT02743117|9693234|P2|Overall Study|Lost to Follow-up|1
2827830|NCT02743117|9693235|P1|Overall Study|Lost to Follow-up|0
2827831|NCT02742818|9693260|P2|Overall Study|Protocol Violation|1
2827832|NCT02742818|9693261|P1|Overall Study|Protocol Violation|0
2827833|NCT02742818|9693260|P2|Overall Study|Adverse Event|1
2827834|NCT02742818|9693261|P1|Overall Study|Adverse Event|0
2827835|NCT02742766|9693294|P19|Part 2 (Up to 22 Days)|Physician Decision|0
2827836|NCT02742766|9693295|P18|Part 2 (Up to 22 Days)|Physician Decision|0
2827837|NCT02742766|9693296|P17|Part 2 (Up to 22 Days)|Physician Decision|0
2827838|NCT02742766|9693297|P16|Part 2 (Up to 22 Days)|Physician Decision|1
2827839|NCT02742766|9693298|P15|Part 2 (Up to 22 Days)|Physician Decision|0
2827840|NCT02742766|9693299|P14|Part 2 (Up to 22 Days)|Physician Decision|5
2827841|NCT02742766|9693300|P13|Part 2 (Up to 22 Days)|Physician Decision|2
2827842|NCT02742766|9693301|P12|Part 2 (Up to 22 Days)|Physician Decision|0
2827843|NCT02742766|9693302|P11|Part 2 (Up to 22 Days)|Physician Decision|0
2827844|NCT02742766|9693303|P10|Part 2 (Up to 22 Days)|Physician Decision|0
2827845|NCT02742766|9693304|P9|Part 2 (Up to 22 Days)|Physician Decision|0
2827846|NCT02742766|9693305|P8|Part 2 (Up to 22 Days)|Physician Decision|0
2827847|NCT02742766|9693306|P7|Part 2 (Up to 22 Days)|Physician Decision|0
2827848|NCT02742766|9693307|P6|Part 2 (Up to 22 Days)|Physician Decision|0
2827849|NCT02742766|9693308|P5|Part 2 (Up to 22 Days)|Physician Decision|0
2827850|NCT02742766|9693309|P4|Part 2 (Up to 22 Days)|Physician Decision|0
2827851|NCT02742766|9693310|P3|Part 2 (Up to 22 Days)|Physician Decision|0
2827852|NCT02742766|9693311|P2|Part 2 (Up to 22 Days)|Physician Decision|0
2827853|NCT02742766|9693312|P1|Part 2 (Up to 22 Days)|Physician Decision|0
2827854|NCT02742766|9693294|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827855|NCT02742766|9693295|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827856|NCT02742766|9693296|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827857|NCT02742766|9693297|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827858|NCT02742766|9693298|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827859|NCT02742766|9693299|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
2827860|NCT02742766|9693300|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827861|NCT02742766|9693301|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827862|NCT02742766|9693302|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827863|NCT02742766|9693303|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827864|NCT02742766|9693304|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827865|NCT02742766|9693305|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827866|NCT02742766|9693306|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827867|NCT02742766|9693307|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827868|NCT02742766|9693308|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827869|NCT02742766|9693309|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827870|NCT02742766|9693310|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827871|NCT02742766|9693311|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827872|NCT02742766|9693312|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2827873|NCT02742649|9693572|P5|Open-Label Period|Lost to Follow-up|1
2827874|NCT02742649|9693573|P4|Open-Label Period|Lost to Follow-up|0
2827875|NCT02742649|9693574|P3|Open-Label Period|Lost to Follow-up|0
2827876|NCT02742649|9693575|P2|Open-Label Period|Lost to Follow-up|0
2827877|NCT02742649|9693576|P1|Open-Label Period|Lost to Follow-up|0
2827878|NCT02742649|9693572|P5|Double-Blind Treatment Period|Adverse Event|0
2827879|NCT02742649|9693573|P4|Double-Blind Treatment Period|Adverse Event|0
2827880|NCT02742649|9693574|P3|Double-Blind Treatment Period|Adverse Event|0
2827881|NCT02742649|9693575|P2|Double-Blind Treatment Period|Adverse Event|1
2827882|NCT02742649|9693576|P1|Double-Blind Treatment Period|Adverse Event|0
2827883|NCT02742649|9693572|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2827884|NCT02742649|9693573|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2827885|NCT02742649|9693574|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2827886|NCT02742649|9693575|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2827887|NCT02742649|9693576|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
2827888|NCT02742519|9693604|P3|Part 2 Open Label Period (32 Weeks)|Other|1
2827889|NCT02742519|9693605|P2|Part 2 Open Label Period (32 Weeks)|Other|0
2827890|NCT02742519|9693606|P1|Part 2 Open Label Period (32 Weeks)|Other|0
2827891|NCT02742519|9693604|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
2827892|NCT02742519|9693605|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2827893|NCT02742519|9693606|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2827894|NCT02742519|9693604|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
2827895|NCT02742519|9693605|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2827896|NCT02742519|9693606|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2827897|NCT02742441|9693626|P2|Overall Study|Adverse Event|2
2827898|NCT02742441|9693627|P1|Overall Study|Adverse Event|0
2827899|NCT02742441|9693626|P2|Overall Study|Withdrawal by Subject|2
2827900|NCT02742441|9693627|P1|Overall Study|Withdrawal by Subject|2
2827901|NCT02742441|9693626|P2|Overall Study|Lost to Follow-up|4
2827902|NCT02742441|9693627|P1|Overall Study|Lost to Follow-up|4
2827903|NCT02741713|9693674|P2|Overall Study|Surgery type changed intra-operatively|1
2827904|NCT02741713|9693675|P1|Overall Study|Surgery type changed intra-operatively|2
2827905|NCT02741635|9693715|P1|Overall Study|Withdrawal by Subject|1
2827906|NCT02741596|9693723|P2|Overall Study|Subject withdrawn-to commercial product|63
2827907|NCT02741596|9693724|P1|Overall Study|Subject withdrawn-to commercial product|54
2827908|NCT02741596|9693723|P2|Overall Study|Subject withdrawn–Other|4
2827909|NCT02741596|9693724|P1|Overall Study|Subject withdrawn–Other|17
2827910|NCT02741596|9693723|P2|Overall Study|Other (Unspecified)|3
2827911|NCT02741596|9693724|P1|Overall Study|Other (Unspecified)|0
2827912|NCT02741596|9693723|P2|Overall Study|Pregnancy|1
2827913|NCT02741596|9693724|P1|Overall Study|Pregnancy|3
2827914|NCT02741596|9693723|P2|Overall Study|Physician Decision|1
2827915|NCT02741596|9693724|P1|Overall Study|Physician Decision|2
2827916|NCT02741596|9693723|P2|Overall Study|Lost to Follow-up|1
2827917|NCT02741596|9693724|P1|Overall Study|Lost to Follow-up|1
2827918|NCT02741596|9693723|P2|Overall Study|Adverse Event|5
2827919|NCT02741596|9693724|P1|Overall Study|Adverse Event|1
2827920|NCT02741518|9693742|P2|Overall Study|Withdrawal by Subject|1
2827921|NCT02741518|9693743|P1|Overall Study|Withdrawal by Subject|1
2827922|NCT02741310|9693753|P2|Overall Study|Sponsor Decision|2
2827923|NCT02741310|9693754|P1|Overall Study|Sponsor Decision|2
2827924|NCT02741271|9693799|P2|Overall Study|Withdrawal by Parent/Guardian|2
2827925|NCT02741271|9693800|P1|Overall Study|Withdrawal by Parent/Guardian|0
2827926|NCT02741271|9693799|P2|Overall Study|Lost to Follow-up|0
2827927|NCT02741271|9693800|P1|Overall Study|Lost to Follow-up|2
2827928|NCT02741245|9693833|P5|Overall Study|Withdrawal by Subject|0
2827929|NCT02741245|9693834|P4|Overall Study|Withdrawal by Subject|1
2827930|NCT02741245|9693835|P3|Overall Study|Withdrawal by Subject|0
2827931|NCT02741245|9693836|P2|Overall Study|Withdrawal by Subject|0
2827932|NCT02741245|9693837|P1|Overall Study|Withdrawal by Subject|0
2827933|NCT02741245|9693833|P5|Overall Study|Protocol Violation|0
2827934|NCT02741245|9693834|P4|Overall Study|Protocol Violation|1
2827935|NCT02741245|9693835|P3|Overall Study|Protocol Violation|0
2827936|NCT02741245|9693836|P2|Overall Study|Protocol Violation|1
2827937|NCT02741245|9693837|P1|Overall Study|Protocol Violation|0
2827938|NCT02741245|9693833|P5|Overall Study|Adverse Event|2
2827939|NCT02741245|9693834|P4|Overall Study|Adverse Event|2
2827940|NCT02741245|9693835|P3|Overall Study|Adverse Event|0
2827941|NCT02741245|9693836|P2|Overall Study|Adverse Event|0
2827942|NCT02741245|9693837|P1|Overall Study|Adverse Event|0
2827943|NCT02741076|9693943|P4|Overall Study|No additional information available|1
2827944|NCT02741076|9693944|P3|Overall Study|No additional information available|1
2827945|NCT02741076|9693945|P2|Overall Study|No additional information available|0
2827946|NCT02741076|9693946|P1|Overall Study|No additional information available|0
2827947|NCT02741076|9693943|P4|Overall Study|Sponsor Request|1
2827948|NCT02741076|9693944|P3|Overall Study|Sponsor Request|0
2827949|NCT02741076|9693945|P2|Overall Study|Sponsor Request|3
2827950|NCT02741076|9693946|P1|Overall Study|Sponsor Request|2
2827951|NCT02741076|9693943|P4|Overall Study|Withdrawal by Subject|0
2827952|NCT02741076|9693944|P3|Overall Study|Withdrawal by Subject|0
2827953|NCT02741076|9693945|P2|Overall Study|Withdrawal by Subject|1
2827954|NCT02741076|9693946|P1|Overall Study|Withdrawal by Subject|0
2827955|NCT02741076|9693943|P4|Overall Study|Lack of Efficacy|0
2827956|NCT02741076|9693944|P3|Overall Study|Lack of Efficacy|0
2827957|NCT02741076|9693945|P2|Overall Study|Lack of Efficacy|0
2827958|NCT02741076|9693946|P1|Overall Study|Lack of Efficacy|1
2827959|NCT02741076|9693943|P4|Overall Study|Adverse Event|0
2827960|NCT02741076|9693944|P3|Overall Study|Adverse Event|1
2827961|NCT02741076|9693945|P2|Overall Study|Adverse Event|1
2827962|NCT02741076|9693946|P1|Overall Study|Adverse Event|0
2827963|NCT02740049|9694062|P1|Overall Study|Isolated cells did not grow sufficiently|1
2827964|NCT02739997|9694068|P1|Overall Study|Withdrawal by Subject|1
2827965|NCT02739997|9694068|P1|Overall Study|Death|1
2827966|NCT02739984|9694082|P2|Overall Study|Lost to Follow-up|0
2827967|NCT02739984|9694083|P1|Overall Study|Lost to Follow-up|3
2827968|NCT02739984|9694082|P2|Overall Study|Death|1
2827969|NCT02739984|9694083|P1|Overall Study|Death|0
2827970|NCT02739984|9694082|P2|Overall Study|Withdrawal by Subject|1
2827971|NCT02739984|9694083|P1|Overall Study|Withdrawal by Subject|1
2827972|NCT02739984|9694082|P2|Overall Study|Sponsor Decision|0
2827973|NCT02739984|9694083|P1|Overall Study|Sponsor Decision|1
2827974|NCT02739828|9694131|P1|Overall Study|Lost to Follow-up|4
2827975|NCT02739828|9694131|P1|Overall Study|Adverse Event|1
2827976|NCT02739594|9694176|P2|Overall Study|Other|2
2827977|NCT02739594|9694177|P1|Overall Study|Other|6
2827978|NCT02739594|9694176|P2|Overall Study|Elevated Serum Creatinine|1
2827979|NCT02739594|9694177|P1|Overall Study|Elevated Serum Creatinine|0
2827980|NCT02739594|9694176|P2|Overall Study|Lost to Follow-up|1
2827981|NCT02739594|9694177|P1|Overall Study|Lost to Follow-up|0
2827982|NCT02739594|9694176|P2|Overall Study|Withdrawal by Subject|1
2827983|NCT02739594|9694177|P1|Overall Study|Withdrawal by Subject|1
2827984|NCT02739594|9694176|P2|Overall Study|Administrative Reasons|3
2827985|NCT02739594|9694177|P1|Overall Study|Administrative Reasons|1
2827986|NCT02739594|9694176|P2|Overall Study|Renal Insufficiency|6
2827987|NCT02739594|9694177|P1|Overall Study|Renal Insufficiency|4
2827988|NCT02739594|9694176|P2|Overall Study|Death|2
2827989|NCT02739594|9694177|P1|Overall Study|Death|4
2827990|NCT02739594|9694176|P2|Overall Study|Protocol Violation|6
2827991|NCT02739594|9694177|P1|Overall Study|Protocol Violation|5
2827992|NCT02739594|9694176|P2|Overall Study|Violation of Eligibility Criteria|2
2827993|NCT02739594|9694177|P1|Overall Study|Violation of Eligibility Criteria|1
2827994|NCT02739594|9694176|P2|Overall Study|Undesired Event|4
2827995|NCT02739594|9694177|P1|Overall Study|Undesired Event|3
2827996|NCT02739360|9694207|P1|Overall Study|Study terminated by Sponsor|2
2827997|NCT02739360|9694207|P1|Overall Study|Adverse Event|1
2827998|NCT02739321|9694213|P2|Overall Study|Withdrawal by Subject|2
2827999|NCT02739321|9694214|P1|Overall Study|Withdrawal by Subject|1
2828000|NCT02739321|9694213|P2|Overall Study|Lost to Follow-up|1
2828001|NCT02739321|9694214|P1|Overall Study|Lost to Follow-up|1
2828002|NCT02739321|9694213|P2|Overall Study|Lack of Efficacy|1
2828003|NCT02739321|9694214|P1|Overall Study|Lack of Efficacy|1
2828004|NCT02739269|9694260|P2|Overall Study|Withdrawal by Subject|2
2828005|NCT02739269|9694261|P1|Overall Study|Withdrawal by Subject|0
2828006|NCT02739269|9694260|P2|Overall Study|Cycle cancellation|2
2828007|NCT02739269|9694261|P1|Overall Study|Cycle cancellation|2
2828008|NCT02739269|9694260|P2|Overall Study|Protocol Violation|0
2828009|NCT02739269|9694261|P1|Overall Study|Protocol Violation|5
2828010|NCT02738879|9694288|P2|Overall Study|Withdrawal by Subject|7
2828011|NCT02738879|9694289|P1|Overall Study|Withdrawal by Subject|5
2828012|NCT02738879|9694288|P2|Overall Study|Site Discontinued Study Participation|0
2828013|NCT02738879|9694289|P1|Overall Study|Site Discontinued Study Participation|1
2828014|NCT02738879|9694288|P2|Overall Study|Screen Failure|2
2828015|NCT02738879|9694289|P1|Overall Study|Screen Failure|1
2828016|NCT02738879|9694288|P2|Overall Study|Pregnancy|1
2828017|NCT02738879|9694289|P1|Overall Study|Pregnancy|0
2828018|NCT02738879|9694288|P2|Overall Study|Physician Decision|4
2828019|NCT02738879|9694289|P1|Overall Study|Physician Decision|3
2828020|NCT02738879|9694288|P2|Overall Study|Protocol Violation|3
2828021|NCT02738879|9694289|P1|Overall Study|Protocol Violation|1
2828022|NCT02738879|9694288|P2|Overall Study|Lost to Follow-up|5
2828023|NCT02738879|9694289|P1|Overall Study|Lost to Follow-up|1
2828024|NCT02738879|9694288|P2|Overall Study|Death|2
2828025|NCT02738879|9694289|P1|Overall Study|Death|0
2828026|NCT02738879|9694288|P2|Overall Study|Adverse Event|1
2828027|NCT02738879|9694289|P1|Overall Study|Adverse Event|1
2828028|NCT02738580|9694341|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
2828029|NCT02738580|9694342|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
2828030|NCT02738580|9694341|P2|Overall Study|Withdrawal by Subject|1
2828031|NCT02738580|9694342|P1|Overall Study|Withdrawal by Subject|0
2828032|NCT02738580|9694341|P2|Overall Study|Lack of Efficacy|2
2828033|NCT02738580|9694342|P1|Overall Study|Lack of Efficacy|3
2828034|NCT02738580|9694341|P2|Overall Study|Adverse Event|0
2828035|NCT02738580|9694342|P1|Overall Study|Adverse Event|1
2828036|NCT02738333|9694353|P3|Overall Study|Lost to Follow-up|0
2828037|NCT02738333|9694354|P2|Overall Study|Lost to Follow-up|0
2828038|NCT02738333|9694355|P1|Overall Study|Lost to Follow-up|1
2828039|NCT02738333|9694353|P3|Overall Study|Death|0
2828040|NCT02738333|9694354|P2|Overall Study|Death|0
2828041|NCT02738333|9694355|P1|Overall Study|Death|1
2828042|NCT02738203|9694444|P2|Overall Study|Protocol Violation|1
2828043|NCT02738203|9694445|P1|Overall Study|Protocol Violation|0
2828044|NCT02738203|9694444|P2|Overall Study|Failed IUD Insertion|2
2828045|NCT02738203|9694445|P1|Overall Study|Failed IUD Insertion|2
2828046|NCT02738151|9694461|P2|Overall Study|Other than specified above|21
2828047|NCT02738151|9694462|P1|Overall Study|Other than specified above|11
2828048|NCT02738151|9694461|P2|Overall Study|Poor Compliance to Protocol|3
2828049|NCT02738151|9694462|P1|Overall Study|Poor Compliance to Protocol|4
2828050|NCT02738151|9694461|P2|Overall Study|Hypoglycemia|1
2828051|NCT02738151|9694462|P1|Overall Study|Hypoglycemia|0
2828052|NCT02738151|9694461|P2|Overall Study|Adverse Event|5
2828053|NCT02738151|9694462|P1|Overall Study|Adverse Event|4
2828054|NCT02738151|9694461|P2|Overall Study|Randomized but not treated|1
2828055|NCT02738151|9694462|P1|Overall Study|Randomized but not treated|4
2828056|NCT02738138|9694506|P2|Overall Study|Other - not further specified|0
2828057|NCT02738138|9694507|P1|Overall Study|Other - not further specified|1
2828058|NCT02738138|9694506|P2|Overall Study|Lost to Follow-up|0
2828059|NCT02738138|9694507|P1|Overall Study|Lost to Follow-up|2
2828060|NCT02738138|9694506|P2|Overall Study|Adverse Event|1
2828061|NCT02738138|9694507|P1|Overall Study|Adverse Event|0
2828062|NCT02738008|9694544|P3|Overall Study|Adverse Event|2
2828063|NCT02738008|9694545|P2|Overall Study|Adverse Event|1
2828064|NCT02738008|9694546|P1|Overall Study|Adverse Event|0
2828065|NCT02738008|9694544|P3|Overall Study|Study Terminated by Sponsor|3
2828066|NCT02738008|9694545|P2|Overall Study|Study Terminated by Sponsor|5
2828067|NCT02738008|9694546|P1|Overall Study|Study Terminated by Sponsor|1
2828068|NCT02737852|9694584|P1|Overall Study|Withdrawal by Subject|2
2828069|NCT02737722|9694593|P4|Overall Study|Physician Decision|0
2828070|NCT02737722|9694594|P3|Overall Study|Physician Decision|1
2828071|NCT02737722|9694595|P2|Overall Study|Physician Decision|0
2828072|NCT02737722|9694596|P1|Overall Study|Physician Decision|0
2828073|NCT02737618|9694647|P1|Overall Study|Withdrawal by Subject|9
2828074|NCT02737592|9694652|P1|Overall Study|Withdrawal by Subject|1
2828075|NCT02736890|9694725|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
2828076|NCT02736890|9694726|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
2828077|NCT02736890|9694725|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
2828078|NCT02736890|9694726|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
2828079|NCT02736825|9694748|P2|Overall Study|Early Termination|1
2828080|NCT02736825|9694749|P1|Overall Study|Early Termination|0
2828081|NCT02736825|9694748|P2|Overall Study|Lost to Follow-up|11
2828082|NCT02736825|9694749|P1|Overall Study|Lost to Follow-up|10
2828083|NCT02736721|9694789|P1|Overall Study|Other|5
2828084|NCT02736721|9694789|P1|Overall Study|Lost to Follow-up|3
2828085|NCT02736721|9694789|P1|Overall Study|Adverse Event|8
2828086|NCT02736578|9694800|P2|Overall Study|Adverse Event|0
2828087|NCT02736578|9694801|P1|Overall Study|Adverse Event|1
2828088|NCT02736188|9694819|P1|Overall Study|Other|6
2828089|NCT02736188|9694819|P1|Overall Study|Withdrawal by Subject|1
2828090|NCT02736188|9694819|P1|Overall Study|Adverse Event|1
2828091|NCT02736188|9694819|P1|Overall Study|Discontinuation of Study by Sponsor|134
2828092|NCT02735980|9694857|P3|Overall Study|Withdrawal by Subject|0
2828093|NCT02735980|9694858|P2|Overall Study|Withdrawal by Subject|2
2828094|NCT02735980|9694859|P1|Overall Study|Withdrawal by Subject|1
2828095|NCT02735980|9694857|P3|Overall Study|Screen failure|0
2828096|NCT02735980|9694858|P2|Overall Study|Screen failure|0
2828097|NCT02735980|9694859|P1|Overall Study|Screen failure|1
2828098|NCT02735980|9694857|P3|Overall Study|Physician Decision|0
2828099|NCT02735980|9694858|P2|Overall Study|Physician Decision|1
2828100|NCT02735980|9694859|P1|Overall Study|Physician Decision|3
2828101|NCT02735980|9694857|P3|Overall Study|Death|0
2828102|NCT02735980|9694858|P2|Overall Study|Death|4
2828103|NCT02735980|9694859|P1|Overall Study|Death|5
2828104|NCT02735980|9694857|P3|Overall Study|Adverse Event|1
2828105|NCT02735980|9694858|P2|Overall Study|Adverse Event|4
2828106|NCT02735980|9694859|P1|Overall Study|Adverse Event|0
2828107|NCT02735915|9694888|P1|Overall Study|Withdrawal by Subject|1
2828108|NCT02735915|9694888|P1|Overall Study|Withdrawal following SAE|2
2828109|NCT02735915|9694888|P1|Overall Study|Not vaccinated but subject ID assigned|8
2828110|NCT02735421|9694920|P1|Overall Study|Pregnancy|1
2828111|NCT02735421|9694920|P1|Overall Study|Inadequate compliance to treatment|1
2828112|NCT02735421|9694920|P1|Overall Study|Lost to Follow-up|3
2828113|NCT02735421|9694920|P1|Overall Study|Withdrawal by Subject|6
2828114|NCT02735421|9694920|P1|Overall Study|Adverse Event|2
2828115|NCT02735200|9694950|P2|Overall Study|Withdrawal by Subject|0
2828116|NCT02735200|9694951|P1|Overall Study|Withdrawal by Subject|8
2828117|NCT02735200|9694950|P2|Overall Study|Lost to Follow-up|5
2828118|NCT02735200|9694951|P1|Overall Study|Lost to Follow-up|0
2828119|NCT02735096|9694990|P1|Overall Study|No symptoms in clinic/personal leave|1
2828120|NCT02735044|9694999|P2|Overall Study|Other, not specified above|11
2828121|NCT02735044|9695000|P1|Overall Study|Other, not specified above|5
2828122|NCT02735044|9694999|P2|Overall Study|Randomized and not treated|2
2828123|NCT02735044|9695000|P1|Overall Study|Randomized and not treated|0
2828124|NCT02735044|9694999|P2|Overall Study|Poor compliance to protocol|7
2828125|NCT02735044|9695000|P1|Overall Study|Poor compliance to protocol|7
2828126|NCT02735044|9694999|P2|Overall Study|Lack of Efficacy|0
2828127|NCT02735044|9695000|P1|Overall Study|Lack of Efficacy|1
2828128|NCT02735044|9694999|P2|Overall Study|Adverse Event|3
2828129|NCT02735044|9695000|P1|Overall Study|Adverse Event|3
2828130|NCT02734810|9695068|P2|Overall Study|Lack of Efficacy|0
2828131|NCT02734810|9695069|P1|Overall Study|Lack of Efficacy|1
2828132|NCT02734810|9695068|P2|Overall Study|Adverse Event|0
2828133|NCT02734810|9695069|P1|Overall Study|Adverse Event|1
2828134|NCT02734693|9695078|P3|Overall Study|Withdrawal by Subject|0
2828135|NCT02734693|9695079|P2|Overall Study|Withdrawal by Subject|0
2828136|NCT02734693|9695080|P1|Overall Study|Withdrawal by Subject|1
2828137|NCT02734693|9695078|P3|Overall Study|Protocol Violation|0
2828138|NCT02734693|9695079|P2|Overall Study|Protocol Violation|0
2828139|NCT02734693|9695080|P1|Overall Study|Protocol Violation|1
2828140|NCT02734693|9695078|P3|Overall Study|Lost to Follow-up|0
2828141|NCT02734693|9695079|P2|Overall Study|Lost to Follow-up|0
2828142|NCT02734693|9695080|P1|Overall Study|Lost to Follow-up|2
2828143|NCT02734693|9695078|P3|Overall Study|Lack of Efficacy|0
2828144|NCT02734693|9695079|P2|Overall Study|Lack of Efficacy|0
2828145|NCT02734693|9695080|P1|Overall Study|Lack of Efficacy|1
2828146|NCT02734693|9695078|P3|Overall Study|Adverse Event|3
2828147|NCT02734693|9695079|P2|Overall Study|Adverse Event|3
2828148|NCT02734693|9695080|P1|Overall Study|Adverse Event|1
2828149|NCT02734433|9695121|P2|Overall Study|Withdrawal by Subject|2
2828150|NCT02734433|9695122|P1|Overall Study|Withdrawal by Subject|1
2828151|NCT02734433|9695121|P2|Overall Study|Clinical progression|1
2828152|NCT02734433|9695122|P1|Overall Study|Clinical progression|0
2828153|NCT02734433|9695121|P2|Overall Study|Disease progression|5
2828154|NCT02734433|9695122|P1|Overall Study|Disease progression|1
2828155|NCT02734212|9695198|P2|Overall Study|Lost to Follow-up|10
2828156|NCT02734212|9695199|P1|Overall Study|Lost to Follow-up|5
2828157|NCT02733991|9695220|P2|Overall Study|Withdrawal by Subject|5
2828158|NCT02733991|9695221|P1|Overall Study|Withdrawal by Subject|0
2828159|NCT02733991|9695220|P2|Overall Study|Adverse Event|0
2828160|NCT02733991|9695221|P1|Overall Study|Adverse Event|1
2828161|NCT02733367|9695244|P1|Overall Study|Withdrawal by Subject|6
2828162|NCT02733042|9695270|P19|Follow-up Period|Withdrawal by Subject|0
2828163|NCT02733042|9695271|P18|Follow-up Period|Withdrawal by Subject|0
2828164|NCT02733042|9695272|P17|Follow-up Period|Withdrawal by Subject|0
2828165|NCT02733042|9695273|P16|Follow-up Period|Withdrawal by Subject|1
2828166|NCT02733042|9695274|P15|Follow-up Period|Withdrawal by Subject|0
2828167|NCT02733042|9695275|P14|Follow-up Period|Withdrawal by Subject|0
2828168|NCT02733042|9695276|P13|Follow-up Period|Withdrawal by Subject|0
2828169|NCT02733042|9695277|P12|Follow-up Period|Withdrawal by Subject|0
2828170|NCT02733042|9695278|P11|Follow-up Period|Withdrawal by Subject|1
2828171|NCT02733042|9695279|P10|Follow-up Period|Withdrawal by Subject|0
2828172|NCT02733042|9695280|P9|Follow-up Period|Withdrawal by Subject|1
2828173|NCT02733042|9695281|P8|Follow-up Period|Withdrawal by Subject|0
2828174|NCT02733042|9695282|P7|Follow-up Period|Withdrawal by Subject|0
2828175|NCT02733042|9695283|P6|Follow-up Period|Withdrawal by Subject|0
2828176|NCT02733042|9695284|P5|Follow-up Period|Withdrawal by Subject|0
2828177|NCT02733042|9695285|P4|Follow-up Period|Withdrawal by Subject|0
2828178|NCT02733042|9695286|P3|Follow-up Period|Withdrawal by Subject|0
2828179|NCT02733042|9695287|P2|Follow-up Period|Withdrawal by Subject|0
2828180|NCT02733042|9695288|P1|Follow-up Period|Withdrawal by Subject|0
2828181|NCT02733042|9695270|P19|Follow-up Period|Other|0
2828182|NCT02733042|9695271|P18|Follow-up Period|Other|0
2828183|NCT02733042|9695272|P17|Follow-up Period|Other|0
2828184|NCT02733042|9695273|P16|Follow-up Period|Other|0
2828185|NCT02733042|9695274|P15|Follow-up Period|Other|0
2828186|NCT02733042|9695275|P14|Follow-up Period|Other|0
2828187|NCT02733042|9695276|P13|Follow-up Period|Other|0
2828188|NCT02733042|9695277|P12|Follow-up Period|Other|0
2828189|NCT02733042|9695278|P11|Follow-up Period|Other|0
2828190|NCT02733042|9695279|P10|Follow-up Period|Other|0
2828191|NCT02733042|9695280|P9|Follow-up Period|Other|0
2828192|NCT02733042|9695281|P8|Follow-up Period|Other|0
2828193|NCT02733042|9695282|P7|Follow-up Period|Other|0
2828194|NCT02733042|9695283|P6|Follow-up Period|Other|0
2828195|NCT02733042|9695284|P5|Follow-up Period|Other|0
2828196|NCT02733042|9695285|P4|Follow-up Period|Other|1
2828197|NCT02733042|9695286|P3|Follow-up Period|Other|0
2828198|NCT02733042|9695287|P2|Follow-up Period|Other|0
2828199|NCT02733042|9695288|P1|Follow-up Period|Other|0
2828200|NCT02733042|9695270|P19|Follow-up Period|Death|2
2828201|NCT02733042|9695271|P18|Follow-up Period|Death|1
2828202|NCT02733042|9695272|P17|Follow-up Period|Death|0
2828203|NCT02733042|9695273|P16|Follow-up Period|Death|4
2828204|NCT02733042|9695274|P15|Follow-up Period|Death|1
2828205|NCT02733042|9695275|P14|Follow-up Period|Death|1
2828206|NCT02733042|9695276|P13|Follow-up Period|Death|8
2828207|NCT02733042|9695277|P12|Follow-up Period|Death|0
2828208|NCT02733042|9695278|P11|Follow-up Period|Death|0
2828209|NCT02733042|9695279|P10|Follow-up Period|Death|0
2828210|NCT02733042|9695280|P9|Follow-up Period|Death|3
2828211|NCT02733042|9695281|P8|Follow-up Period|Death|3
2828212|NCT02733042|9695282|P7|Follow-up Period|Death|0
2828213|NCT02733042|9695283|P6|Follow-up Period|Death|2
2828214|NCT02733042|9695284|P5|Follow-up Period|Death|1
2828215|NCT02733042|9695285|P4|Follow-up Period|Death|0
2828216|NCT02733042|9695286|P3|Follow-up Period|Death|2
2828217|NCT02733042|9695287|P2|Follow-up Period|Death|1
2828218|NCT02733042|9695288|P1|Follow-up Period|Death|1
2828219|NCT02733042|9695270|P19|Follow-up Period|Ongoing on Follow-up|0
2828220|NCT02733042|9695271|P18|Follow-up Period|Ongoing on Follow-up|1
2828221|NCT02733042|9695272|P17|Follow-up Period|Ongoing on Follow-up|0
2828222|NCT02733042|9695273|P16|Follow-up Period|Ongoing on Follow-up|0
2828223|NCT02733042|9695274|P15|Follow-up Period|Ongoing on Follow-up|0
2828224|NCT02733042|9695275|P14|Follow-up Period|Ongoing on Follow-up|3
2828225|NCT02733042|9695276|P13|Follow-up Period|Ongoing on Follow-up|1
2828226|NCT02733042|9695277|P12|Follow-up Period|Ongoing on Follow-up|9
2828227|NCT02733042|9695278|P11|Follow-up Period|Ongoing on Follow-up|4
2828228|NCT02733042|9695279|P10|Follow-up Period|Ongoing on Follow-up|2
2828229|NCT02733042|9695280|P9|Follow-up Period|Ongoing on Follow-up|0
2828230|NCT02733042|9695281|P8|Follow-up Period|Ongoing on Follow-up|1
2828231|NCT02733042|9695282|P7|Follow-up Period|Ongoing on Follow-up|0
2828232|NCT02733042|9695283|P6|Follow-up Period|Ongoing on Follow-up|0
2828233|NCT02733042|9695284|P5|Follow-up Period|Ongoing on Follow-up|0
2828234|NCT02733042|9695285|P4|Follow-up Period|Ongoing on Follow-up|2
2828235|NCT02733042|9695286|P3|Follow-up Period|Ongoing on Follow-up|4
2828236|NCT02733042|9695287|P2|Follow-up Period|Ongoing on Follow-up|2
2828237|NCT02733042|9695288|P1|Follow-up Period|Ongoing on Follow-up|2
2828238|NCT02733042|9695270|P19|Treatment Period|Death|0
2828239|NCT02733042|9695271|P18|Treatment Period|Death|0
2828240|NCT02733042|9695272|P17|Treatment Period|Death|0
2828241|NCT02733042|9695273|P16|Treatment Period|Death|2
2828242|NCT02733042|9695274|P15|Treatment Period|Death|1
2828243|NCT02733042|9695275|P14|Treatment Period|Death|0
2828244|NCT02733042|9695276|P13|Treatment Period|Death|0
2828245|NCT02733042|9695277|P12|Treatment Period|Death|0
2828246|NCT02733042|9695278|P11|Treatment Period|Death|1
2828247|NCT02733042|9695279|P10|Treatment Period|Death|0
2828248|NCT02733042|9695280|P9|Treatment Period|Death|1
2828249|NCT02733042|9695281|P8|Treatment Period|Death|0
2828250|NCT02733042|9695282|P7|Treatment Period|Death|1
2828251|NCT02733042|9695283|P6|Treatment Period|Death|0
2828252|NCT02733042|9695284|P5|Treatment Period|Death|0
2828253|NCT02733042|9695285|P4|Treatment Period|Death|0
2828254|NCT02733042|9695286|P3|Treatment Period|Death|0
2828255|NCT02733042|9695287|P2|Treatment Period|Death|0
2828256|NCT02733042|9695288|P1|Treatment Period|Death|0
2828257|NCT02733042|9695270|P19|Treatment Period|Ongoing on Assigned Treatment|1
2828258|NCT02733042|9695271|P18|Treatment Period|Ongoing on Assigned Treatment|0
2828259|NCT02733042|9695272|P17|Treatment Period|Ongoing on Assigned Treatment|0
2828260|NCT02733042|9695273|P16|Treatment Period|Ongoing on Assigned Treatment|0
2828261|NCT02733042|9695274|P15|Treatment Period|Ongoing on Assigned Treatment|0
2828262|NCT02733042|9695275|P14|Treatment Period|Ongoing on Assigned Treatment|0
2828263|NCT02733042|9695276|P13|Treatment Period|Ongoing on Assigned Treatment|0
2828264|NCT02733042|9695277|P12|Treatment Period|Ongoing on Assigned Treatment|0
2828265|NCT02733042|9695278|P11|Treatment Period|Ongoing on Assigned Treatment|4
2828266|NCT02733042|9695279|P10|Treatment Period|Ongoing on Assigned Treatment|8
2828267|NCT02733042|9695280|P9|Treatment Period|Ongoing on Assigned Treatment|0
2828268|NCT02733042|9695281|P8|Treatment Period|Ongoing on Assigned Treatment|0
2828269|NCT02733042|9695282|P7|Treatment Period|Ongoing on Assigned Treatment|0
2828270|NCT02733042|9695283|P6|Treatment Period|Ongoing on Assigned Treatment|0
2828271|NCT02733042|9695284|P5|Treatment Period|Ongoing on Assigned Treatment|3
2828272|NCT02733042|9695285|P4|Treatment Period|Ongoing on Assigned Treatment|0
2828273|NCT02733042|9695286|P3|Treatment Period|Ongoing on Assigned Treatment|0
2828274|NCT02733042|9695287|P2|Treatment Period|Ongoing on Assigned Treatment|0
2828275|NCT02733042|9695288|P1|Treatment Period|Ongoing on Assigned Treatment|0
2828276|NCT02733042|9695270|P19|Treatment Period|Other|0
2828277|NCT02733042|9695271|P18|Treatment Period|Other|1
2828278|NCT02733042|9695272|P17|Treatment Period|Other|0
2828279|NCT02733042|9695273|P16|Treatment Period|Other|1
2828280|NCT02733042|9695274|P15|Treatment Period|Other|0
2828281|NCT02733042|9695275|P14|Treatment Period|Other|0
2828282|NCT02733042|9695276|P13|Treatment Period|Other|0
2828283|NCT02733042|9695277|P12|Treatment Period|Other|0
2828284|NCT02733042|9695278|P11|Treatment Period|Other|1
2828285|NCT02733042|9695279|P10|Treatment Period|Other|1
2828286|NCT02733042|9695280|P9|Treatment Period|Other|0
2828287|NCT02733042|9695281|P8|Treatment Period|Other|0
2828288|NCT02733042|9695282|P7|Treatment Period|Other|0
2828289|NCT02733042|9695283|P6|Treatment Period|Other|0
2828290|NCT02733042|9695284|P5|Treatment Period|Other|0
2828291|NCT02733042|9695285|P4|Treatment Period|Other|0
2828292|NCT02733042|9695286|P3|Treatment Period|Other|1
2828293|NCT02733042|9695287|P2|Treatment Period|Other|0
2828294|NCT02733042|9695288|P1|Treatment Period|Other|0
2828295|NCT02733042|9695270|P19|Treatment Period|Withdrawal by Subject|0
2828296|NCT02733042|9695271|P18|Treatment Period|Withdrawal by Subject|0
2828297|NCT02733042|9695272|P17|Treatment Period|Withdrawal by Subject|0
2828298|NCT02733042|9695273|P16|Treatment Period|Withdrawal by Subject|0
2828299|NCT02733042|9695274|P15|Treatment Period|Withdrawal by Subject|0
2828300|NCT02733042|9695275|P14|Treatment Period|Withdrawal by Subject|1
2828301|NCT02733042|9695276|P13|Treatment Period|Withdrawal by Subject|1
2828302|NCT02733042|9695277|P12|Treatment Period|Withdrawal by Subject|2
2828303|NCT02733042|9695278|P11|Treatment Period|Withdrawal by Subject|0
2828304|NCT02733042|9695279|P10|Treatment Period|Withdrawal by Subject|1
2828305|NCT02733042|9695280|P9|Treatment Period|Withdrawal by Subject|1
2828306|NCT02733042|9695281|P8|Treatment Period|Withdrawal by Subject|0
2828307|NCT02733042|9695282|P7|Treatment Period|Withdrawal by Subject|0
2828308|NCT02733042|9695283|P6|Treatment Period|Withdrawal by Subject|0
2828309|NCT02733042|9695284|P5|Treatment Period|Withdrawal by Subject|0
2828310|NCT02733042|9695285|P4|Treatment Period|Withdrawal by Subject|1
2828311|NCT02733042|9695286|P3|Treatment Period|Withdrawal by Subject|2
2828312|NCT02733042|9695287|P2|Treatment Period|Withdrawal by Subject|1
2828313|NCT02733042|9695288|P1|Treatment Period|Withdrawal by Subject|0
2828314|NCT02733042|9695270|P19|Treatment Period|Progressive Disease|4
2828315|NCT02733042|9695271|P18|Treatment Period|Progressive Disease|3
2828316|NCT02733042|9695272|P17|Treatment Period|Progressive Disease|2
2828317|NCT02733042|9695273|P16|Treatment Period|Progressive Disease|7
2828318|NCT02733042|9695274|P15|Treatment Period|Progressive Disease|4
2828319|NCT02733042|9695275|P14|Treatment Period|Progressive Disease|1
2828320|NCT02733042|9695276|P13|Treatment Period|Progressive Disease|8
2828321|NCT02733042|9695277|P12|Treatment Period|Progressive Disease|2
2828322|NCT02733042|9695278|P11|Treatment Period|Progressive Disease|2
2828323|NCT02733042|9695279|P10|Treatment Period|Progressive Disease|0
2828324|NCT02733042|9695280|P9|Treatment Period|Progressive Disease|3
2828325|NCT02733042|9695281|P8|Treatment Period|Progressive Disease|3
2828326|NCT02733042|9695282|P7|Treatment Period|Progressive Disease|0
2828327|NCT02733042|9695283|P6|Treatment Period|Progressive Disease|3
2828328|NCT02733042|9695284|P5|Treatment Period|Progressive Disease|1
2828329|NCT02733042|9695285|P4|Treatment Period|Progressive Disease|1
2828330|NCT02733042|9695286|P3|Treatment Period|Progressive Disease|3
2828331|NCT02733042|9695287|P2|Treatment Period|Progressive Disease|1
2828332|NCT02733042|9695288|P1|Treatment Period|Progressive Disease|2
2828333|NCT02733042|9695270|P19|Treatment Period|Adverse Event|0
2828334|NCT02733042|9695271|P18|Treatment Period|Adverse Event|1
2828335|NCT02733042|9695272|P17|Treatment Period|Adverse Event|0
2828336|NCT02733042|9695273|P16|Treatment Period|Adverse Event|0
2828337|NCT02733042|9695274|P15|Treatment Period|Adverse Event|0
2828338|NCT02733042|9695275|P14|Treatment Period|Adverse Event|2
2828339|NCT02733042|9695276|P13|Treatment Period|Adverse Event|0
2828340|NCT02733042|9695277|P12|Treatment Period|Adverse Event|2
2828341|NCT02733042|9695278|P11|Treatment Period|Adverse Event|2
2828342|NCT02733042|9695279|P10|Treatment Period|Adverse Event|0
2828343|NCT02733042|9695280|P9|Treatment Period|Adverse Event|0
2828344|NCT02733042|9695281|P8|Treatment Period|Adverse Event|0
2828345|NCT02733042|9695282|P7|Treatment Period|Adverse Event|0
2828346|NCT02733042|9695283|P6|Treatment Period|Adverse Event|0
2828347|NCT02733042|9695284|P5|Treatment Period|Adverse Event|0
2828348|NCT02733042|9695285|P4|Treatment Period|Adverse Event|1
2828349|NCT02733042|9695286|P3|Treatment Period|Adverse Event|1
2828350|NCT02733042|9695287|P2|Treatment Period|Adverse Event|0
2828351|NCT02733042|9695288|P1|Treatment Period|Adverse Event|1
2828352|NCT02732951|9695493|P2|Overall Study|Protocol Violation|1
2828353|NCT02732951|9695494|P1|Overall Study|Protocol Violation|0
2828354|NCT02732951|9695493|P2|Overall Study|Adverse Event|4
2828355|NCT02732951|9695494|P1|Overall Study|Adverse Event|4
2828356|NCT02732951|9695493|P2|Overall Study|Lost to Follow-up|1
2828357|NCT02732951|9695494|P1|Overall Study|Lost to Follow-up|0
2828358|NCT02732951|9695493|P2|Overall Study|Other than listed|0
2828359|NCT02732951|9695494|P1|Overall Study|Other than listed|1
2828360|NCT02732938|9695504|P3|Overall Study|Study terminated by sponsor|0
2828361|NCT02732938|9695505|P2|Overall Study|Study terminated by sponsor|6
2828362|NCT02732938|9695506|P1|Overall Study|Study terminated by sponsor|3
2828363|NCT02732938|9695504|P3|Overall Study|Refused further follow-up|0
2828364|NCT02732938|9695505|P2|Overall Study|Refused further follow-up|0
2828365|NCT02732938|9695506|P1|Overall Study|Refused further follow-up|1
2828366|NCT02732938|9695504|P3|Overall Study|Randomized but did not receive treatment|0
2828367|NCT02732938|9695505|P2|Overall Study|Randomized but did not receive treatment|1
2828368|NCT02732938|9695506|P1|Overall Study|Randomized but did not receive treatment|0
2828369|NCT02732938|9695504|P3|Overall Study|Death|0
2828370|NCT02732938|9695505|P2|Overall Study|Death|11
2828371|NCT02732938|9695506|P1|Overall Study|Death|0
2828372|NCT02732912|9695552|P2|Overall Study|No outcome; discharged or refused|9
2828373|NCT02732912|9695553|P1|Overall Study|No outcome; discharged or refused|6
2828374|NCT02732912|9695552|P2|Overall Study|Incomplete completion of questionnaire|3
2828375|NCT02732912|9695553|P1|Overall Study|Incomplete completion of questionnaire|2
2828376|NCT02732912|9695552|P2|Overall Study|Discharged before night|6
2828377|NCT02732912|9695553|P1|Overall Study|Discharged before night|2
2828378|NCT02732639|9695578|P1|Overall Study|Lost to Follow-up|1
2828379|NCT02732561|9695595|P2|Overall Study|Withdrawal by Subject|0
2828380|NCT02732561|9695596|P1|Overall Study|Withdrawal by Subject|1
2828381|NCT02732561|9695595|P2|Overall Study|Lost to Follow-up|1
2828382|NCT02732561|9695596|P1|Overall Study|Lost to Follow-up|1
2828383|NCT02732327|9695622|P2|Overall Study|Protocol Violation|1
2828384|NCT02732327|9695623|P1|Overall Study|Protocol Violation|0
2828385|NCT02732210|9695631|P2|Overall Study|Missing|8
2828386|NCT02732210|9695632|P1|Overall Study|Missing|0
2828387|NCT02732210|9695631|P2|Overall Study|Other|103
2828388|NCT02732210|9695632|P1|Overall Study|Other|35
2828389|NCT02732210|9695631|P2|Overall Study|Death|15
2828390|NCT02732210|9695632|P1|Overall Study|Death|4
2828391|NCT02732210|9695631|P2|Overall Study|Lost to Follow-up|57
2828392|NCT02732210|9695632|P1|Overall Study|Lost to Follow-up|5
2828393|NCT02732210|9695631|P2|Overall Study|Withdrawal by Subject|87
2828394|NCT02732210|9695632|P1|Overall Study|Withdrawal by Subject|28
2828395|NCT02732210|9695631|P2|Overall Study|Study Ended|13
2828396|NCT02732210|9695632|P1|Overall Study|Study Ended|13
2828397|NCT02732210|9695631|P2|Overall Study|Site Closed|11
2828398|NCT02732210|9695632|P1|Overall Study|Site Closed|0
2828399|NCT02731755|9695811|P2|First Intervention|Withdrawal by Subject|2
2828400|NCT02731755|9695812|P1|First Intervention|Withdrawal by Subject|0
2828401|NCT02731742|9695836|P4|Overall Study|Study Terminated by Sponsor|1
2828402|NCT02731742|9695837|P3|Overall Study|Study Terminated by Sponsor|1
2828403|NCT02731742|9695838|P2|Overall Study|Study Terminated by Sponsor|1
2828404|NCT02731742|9695839|P1|Overall Study|Study Terminated by Sponsor|2
2828405|NCT02731742|9695836|P4|Overall Study|Physician Decision|1
2828406|NCT02731742|9695837|P3|Overall Study|Physician Decision|0
2828407|NCT02731742|9695838|P2|Overall Study|Physician Decision|0
2828408|NCT02731742|9695839|P1|Overall Study|Physician Decision|0
2828409|NCT02731742|9695836|P4|Overall Study|Death|0
2828410|NCT02731742|9695837|P3|Overall Study|Death|5
2828411|NCT02731742|9695838|P2|Overall Study|Death|2
2828412|NCT02731742|9695839|P1|Overall Study|Death|1
2828413|NCT02731690|9695857|P1|Overall Study|Discontinuation of Study by Sponsor|26
2828414|NCT02731690|9695857|P1|Overall Study|Withdrawal by Subject|3
2828415|NCT02731690|9695857|P1|Overall Study|Adverse Event|1
2828416|NCT02731638|9695877|P2|Overall Study|Lost to Follow-up|9
2828417|NCT02731638|9695878|P1|Overall Study|Lost to Follow-up|6
2828418|NCT02731157|9696121|P1|First Rejuvenated RCE|Withdrawal by Subject|1
2828419|NCT02731131|9696139|P2|Overall Study|Refused Therapy|1
2828420|NCT02731131|9696140|P1|Overall Study|Refused Therapy|0
2828421|NCT02731131|9696139|P2|Overall Study|Psychiatric Disorder|1
2828422|NCT02731131|9696140|P1|Overall Study|Psychiatric Disorder|0
2828423|NCT02730871|9696169|P2|Overall Study|Adverse Event|0
2828424|NCT02730871|9696170|P1|Overall Study|Adverse Event|6
2828425|NCT02730819|9696184|P1|Overall Study|Lost to Follow-up|9
2828426|NCT02730728|9696193|P3|Overall Study|Lack of Efficacy|1
2828427|NCT02730728|9696194|P2|Overall Study|Lack of Efficacy|1
2828428|NCT02730728|9696195|P1|Overall Study|Lack of Efficacy|0
2828429|NCT02730728|9696193|P3|Overall Study|Withdrawal by Subject|0
2828430|NCT02730728|9696194|P2|Overall Study|Withdrawal by Subject|1
2828431|NCT02730728|9696195|P1|Overall Study|Withdrawal by Subject|0
2828432|NCT02730598|9696224|P2|Overall Study|Unrelated Injury affecting outcomes.|0
2828433|NCT02730598|9696225|P1|Overall Study|Unrelated Injury affecting outcomes.|1
2828434|NCT02730598|9696224|P2|Overall Study|Protocol Violation|1
2828435|NCT02730598|9696225|P1|Overall Study|Protocol Violation|0
2828436|NCT02730598|9696224|P2|Overall Study|Withdrawal by Subject|3
2828437|NCT02730598|9696225|P1|Overall Study|Withdrawal by Subject|3
2828438|NCT02730455|9696248|P3|Overall Study|Other|0
2828439|NCT02730455|9696249|P2|Overall Study|Other|2
2828440|NCT02730455|9696250|P1|Overall Study|Other|2
2828441|NCT02730455|9696248|P3|Overall Study|Other|2
2828442|NCT02730455|9696249|P2|Overall Study|Other|1
2828443|NCT02730455|9696250|P1|Overall Study|Other|1
2828444|NCT02730455|9696248|P3|Overall Study|Lost to Follow-up|4
2828445|NCT02730455|9696249|P2|Overall Study|Lost to Follow-up|1
2828446|NCT02730455|9696250|P1|Overall Study|Lost to Follow-up|3
2828447|NCT02730455|9696248|P3|Overall Study|Consent withdrawn|1
2828448|NCT02730455|9696249|P2|Overall Study|Consent withdrawn|4
2828449|NCT02730455|9696250|P1|Overall Study|Consent withdrawn|2
2828450|NCT02730455|9696248|P3|Overall Study|Death|4
2828451|NCT02730455|9696249|P2|Overall Study|Death|6
2828452|NCT02730455|9696250|P1|Overall Study|Death|5
2828453|NCT02730351|9696298|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
2828454|NCT02730351|9696299|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
2828455|NCT02730351|9696298|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
2828456|NCT02730351|9696299|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
2828457|NCT02730351|9696298|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
2828458|NCT02730351|9696299|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
2828459|NCT02730351|9696298|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
2828460|NCT02730351|9696299|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
2828461|NCT02730351|9696298|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
2828462|NCT02730351|9696299|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
2828463|NCT02730208|9696322|P2|Overall Study|Withdrawal of consent (not due to AE)|1
2828464|NCT02730208|9696323|P1|Overall Study|Withdrawal of consent (not due to AE)|0
2828465|NCT02730195|9696331|P1|Overall Study|Withdrawal by Subject|1
2828466|NCT02729909|9696345|P2|Overall Study|Voluntary Withdrawal|0
2828467|NCT02729909|9696346|P1|Overall Study|Voluntary Withdrawal|1
2828468|NCT02729909|9696345|P2|Overall Study|Significant Protocol Deviation|2
2828469|NCT02729909|9696346|P1|Overall Study|Significant Protocol Deviation|0
2828470|NCT02729909|9696345|P2|Overall Study|Lack of Efficacy|2
2828471|NCT02729909|9696346|P1|Overall Study|Lack of Efficacy|0
2828472|NCT02729909|9696345|P2|Overall Study|Lost to Follow-up|1
2828473|NCT02729909|9696346|P1|Overall Study|Lost to Follow-up|0
2828474|NCT02729896|9696365|P3|Overall Study|Progressive Disease|1
2828475|NCT02729896|9696366|P2|Overall Study|Progressive Disease|0
2828476|NCT02729896|9696367|P1|Overall Study|Progressive Disease|0
2828477|NCT02729896|9696365|P3|Overall Study|Physician Decision|5
2828478|NCT02729896|9696366|P2|Overall Study|Physician Decision|0
2828479|NCT02729896|9696367|P1|Overall Study|Physician Decision|0
2828480|NCT02729896|9696365|P3|Overall Study|Death|10
2828481|NCT02729896|9696366|P2|Overall Study|Death|2
2828482|NCT02729896|9696367|P1|Overall Study|Death|0
2828483|NCT02729831|9696388|P4|6 Month Follow-up|Death|1
2828484|NCT02729831|9696389|P3|6 Month Follow-up|Death|0
2828485|NCT02729831|9696390|P2|6 Month Follow-up|Death|3
2828486|NCT02729831|9696391|P1|6 Month Follow-up|Death|1
2828487|NCT02729831|9696388|P4|6 Month Follow-up|Lost to Follow-up|42
2828488|NCT02729831|9696389|P3|6 Month Follow-up|Lost to Follow-up|48
2828489|NCT02729831|9696390|P2|6 Month Follow-up|Lost to Follow-up|51
2828490|NCT02729831|9696391|P1|6 Month Follow-up|Lost to Follow-up|54
2828491|NCT02729831|9696388|P4|1 Week Post-visit|Lost to Follow-up|36
2828492|NCT02729831|9696389|P3|1 Week Post-visit|Lost to Follow-up|38
2828493|NCT02729831|9696390|P2|1 Week Post-visit|Lost to Follow-up|40
2828494|NCT02729831|9696391|P1|1 Week Post-visit|Lost to Follow-up|43
2828495|NCT02729831|9696388|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
2828496|NCT02729831|9696389|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
2828497|NCT02729831|9696390|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
2828498|NCT02729831|9696391|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
2828499|NCT02729753|9696419|P2|Overall Study|Device Malfunction. No units in stock.|1
2828500|NCT02729753|9696420|P1|Overall Study|Device Malfunction. No units in stock.|0
2828501|NCT02729545|9696434|P2|Overall Study|Withdrawal by Subject|3
2828502|NCT02729545|9696435|P1|Overall Study|Withdrawal by Subject|2
2828503|NCT02729545|9696434|P2|Overall Study|Lost to Follow-up|1
2828504|NCT02729545|9696435|P1|Overall Study|Lost to Follow-up|0
2828505|NCT02729545|9696434|P2|Overall Study|Pregnancy|1
2828506|NCT02729545|9696435|P1|Overall Study|Pregnancy|1
2828507|NCT02729194|9696457|P1|Overall Study|Withdrawal by Subject|3
2828508|NCT02729051|9696469|P2|Overall Study|Withdrawal by Subject|17
2828509|NCT02729051|9696470|P1|Overall Study|Withdrawal by Subject|6
2828510|NCT02729051|9696469|P2|Overall Study|Physician Decision|1
2828511|NCT02729051|9696470|P1|Overall Study|Physician Decision|1
2828512|NCT02729051|9696469|P2|Overall Study|Lost to Follow-up|2
2828513|NCT02729051|9696470|P1|Overall Study|Lost to Follow-up|1
2828514|NCT02729051|9696469|P2|Overall Study|Lack of Efficacy|1
2828515|NCT02729051|9696470|P1|Overall Study|Lack of Efficacy|1
2828516|NCT02729051|9696469|P2|Overall Study|Adverse Event|11
2828517|NCT02729051|9696470|P1|Overall Study|Adverse Event|21
2828518|NCT02729025|9696614|P2|Overall Study|Sponsor Decision|1
2828519|NCT02729025|9696615|P1|Overall Study|Sponsor Decision|0
2828520|NCT02728895|9696629|P2|Overall Study|Withdrawal by Subject|3
2828521|NCT02728895|9696630|P1|Overall Study|Withdrawal by Subject|0
2828522|NCT02728895|9696629|P2|Overall Study|Other|2
2828523|NCT02728895|9696630|P1|Overall Study|Other|1
2828524|NCT02728206|9696658|P1|Overall Study|Death|1
2828525|NCT02728089|9696666|P1|Overall Study|Withdrawal by Subject|1
2828526|NCT02728089|9696666|P1|Overall Study|Physician Decision|2
2828527|NCT02727777|9696754|P3|Overall Study|Progressive disease|0
2828528|NCT02727777|9696755|P2|Overall Study|Progressive disease|0
2828529|NCT02727777|9696756|P1|Overall Study|Progressive disease|2
2828530|NCT02727777|9696754|P3|Overall Study|Screen Failure|0
2828531|NCT02727777|9696755|P2|Overall Study|Screen Failure|0
2828532|NCT02727777|9696756|P1|Overall Study|Screen Failure|2
2828533|NCT02727660|9696777|P3|Overall Study|Administrative Reasons|4
2828534|NCT02727660|9696778|P2|Overall Study|Administrative Reasons|3
2828535|NCT02727660|9696779|P1|Overall Study|Administrative Reasons|2
2828536|NCT02727660|9696777|P3|Overall Study|Protocol Specified Disc. Criteria|2
2828537|NCT02727660|9696778|P2|Overall Study|Protocol Specified Disc. Criteria|5
2828538|NCT02727660|9696779|P1|Overall Study|Protocol Specified Disc. Criteria|5
2828539|NCT02727660|9696777|P3|Overall Study|Protocol Violation|5
2828540|NCT02727660|9696778|P2|Overall Study|Protocol Violation|5
2828541|NCT02727660|9696779|P1|Overall Study|Protocol Violation|7
2828542|NCT02727660|9696777|P3|Overall Study|Lost to Follow-up|8
2828543|NCT02727660|9696778|P2|Overall Study|Lost to Follow-up|9
2828544|NCT02727660|9696779|P1|Overall Study|Lost to Follow-up|5
2828545|NCT02727660|9696777|P3|Overall Study|Physician Decision|14
2828546|NCT02727660|9696778|P2|Overall Study|Physician Decision|8
2828547|NCT02727660|9696779|P1|Overall Study|Physician Decision|3
2828548|NCT02727660|9696777|P3|Overall Study|Withdrawal by Subject|30
2828549|NCT02727660|9696778|P2|Overall Study|Withdrawal by Subject|25
2828550|NCT02727660|9696779|P1|Overall Study|Withdrawal by Subject|26
2828551|NCT02727660|9696777|P3|Overall Study|Adverse Event|32
2828552|NCT02727660|9696778|P2|Overall Study|Adverse Event|21
2828553|NCT02727660|9696779|P1|Overall Study|Adverse Event|28
2828554|NCT02727660|9696777|P3|Overall Study|Lack of Efficacy|70
2828555|NCT02727660|9696778|P2|Overall Study|Lack of Efficacy|40
2828556|NCT02727660|9696779|P1|Overall Study|Lack of Efficacy|40
2828557|NCT02727322|9696798|P2|Overall Study|Protocol Violation|0
2828558|NCT02727322|9696799|P1|Overall Study|Protocol Violation|1
2828559|NCT02727322|9696798|P2|Overall Study|Withdrawal by Subject|1
2828560|NCT02727322|9696799|P1|Overall Study|Withdrawal by Subject|1
2828561|NCT02726945|9696825|P3|Overall Study|Elected to have total knee replacement|0
2828562|NCT02726945|9696826|P2|Overall Study|Elected to have total knee replacement|1
2828563|NCT02726945|9696827|P1|Overall Study|Elected to have total knee replacement|0
2828564|NCT02726945|9696825|P3|Overall Study|Withdrawal by Subject|1
2828565|NCT02726945|9696826|P2|Overall Study|Withdrawal by Subject|0
2828566|NCT02726945|9696827|P1|Overall Study|Withdrawal by Subject|0
2828567|NCT02726399|9696944|P1|Overall Study|Progression of disease|4
2828568|NCT02726399|9696944|P1|Overall Study|Adverse Event|2
2828569|NCT02726399|9696944|P1|Overall Study|Participant Non-Compliance|1
2828570|NCT02726113|9696961|P2|Genomic Analysis|Insurance non-coverage for surgery|1
2828571|NCT02726113|9696962|P1|Genomic Analysis|Insurance non-coverage for surgery|1
2828572|NCT02726113|9696961|P2|Genomic Analysis|Withdrawal by Subject|1
2828573|NCT02726113|9696962|P1|Genomic Analysis|Withdrawal by Subject|2
2828574|NCT02726113|9696961|P2|Genomic Analysis|Protocol Violation|0
2828575|NCT02726113|9696962|P1|Genomic Analysis|Protocol Violation|1
2828576|NCT02726113|9696961|P2|Total Enrollment|Insurance non-coverage for surgery|1
2828577|NCT02726113|9696962|P1|Total Enrollment|Insurance non-coverage for surgery|1
2828578|NCT02726113|9696961|P2|Total Enrollment|Withdrawal by Subject|1
2828579|NCT02726113|9696962|P1|Total Enrollment|Withdrawal by Subject|2
2828580|NCT02726113|9696961|P2|Total Enrollment|Protocol Violation|0
2828581|NCT02726113|9696962|P1|Total Enrollment|Protocol Violation|1
2828582|NCT02726113|9696961|P2|Total Enrollment|Physician Decision|1
2828583|NCT02726113|9696962|P1|Total Enrollment|Physician Decision|0
2828584|NCT02726074|9696969|P1|Overall Study|Others|3
2828585|NCT02726074|9696969|P1|Overall Study|Lost to Follow-up|2
2828586|NCT02726074|9696969|P1|Overall Study|Protocol Violation|3
2828587|NCT02726074|9696969|P1|Overall Study|Adverse Event|14
2828588|NCT02726074|9696969|P1|Overall Study|Withdrawal by Subject|4
2828589|NCT02726022|9696981|P1|Overall Study|Treatment Failure and Poor Compliance|1
2828590|NCT02726022|9696981|P1|Overall Study|Poor Compliance|13
2828591|NCT02726022|9696981|P1|Overall Study|Treatment Failure|8
2828592|NCT02726022|9696981|P1|Overall Study|Adverse Event|14
2828593|NCT02725866|9696990|P1|Overall Study|Other, not specified|4
2828594|NCT02725866|9696990|P1|Overall Study|Insufficient virological response|1
2828595|NCT02725866|9696990|P1|Overall Study|Withdrew consent|3
2828596|NCT02725866|9696990|P1|Overall Study|Failure to return|6
2828597|NCT02725788|9697003|P2|Overall Study|Protocol Violation|1
2828598|NCT02725788|9697004|P1|Overall Study|Protocol Violation|0
2828599|NCT02725788|9697003|P2|Overall Study|Lost to Follow-up|1
2828600|NCT02725788|9697004|P1|Overall Study|Lost to Follow-up|1
2828601|NCT02725710|9697012|P2|Overall Study|Lost to Follow-up|0
2828602|NCT02725710|9697013|P1|Overall Study|Lost to Follow-up|1
2828603|NCT02725671|9697041|P1|Overall Study|Lost to Follow-up|1
2828604|NCT02725515|9697056|P2|Overall Study|Lack of Response|1
2828605|NCT02725515|9697057|P1|Overall Study|Lack of Response|0
2828606|NCT02725515|9697056|P2|Overall Study|Completed Study Under Original Protocol|1
2828607|NCT02725515|9697057|P1|Overall Study|Completed Study Under Original Protocol|0
2828608|NCT02725515|9697056|P2|Overall Study|No Documented Disease Improvement|1
2828609|NCT02725515|9697057|P1|Overall Study|No Documented Disease Improvement|0
2828610|NCT02725515|9697056|P2|Overall Study|Adverse Event|2
2828611|NCT02725515|9697057|P1|Overall Study|Adverse Event|7
2828612|NCT02725515|9697056|P2|Overall Study|Lost to Follow-up|1
2828613|NCT02725515|9697057|P1|Overall Study|Lost to Follow-up|1
2828614|NCT02725515|9697056|P2|Overall Study|Non-Compliance With Study Drug|3
2828615|NCT02725515|9697057|P1|Overall Study|Non-Compliance With Study Drug|0
2828616|NCT02725515|9697056|P2|Overall Study|Withdrawal by Subject|1
2828617|NCT02725515|9697057|P1|Overall Study|Withdrawal by Subject|2
2828618|NCT02725515|9697056|P2|Overall Study|Loss of Improvement per Protocol|25
2828619|NCT02725515|9697057|P1|Overall Study|Loss of Improvement per Protocol|14
2828620|NCT02725515|9697056|P2|Overall Study|Refused infusion (no study treatment)|0
2828621|NCT02725515|9697057|P1|Overall Study|Refused infusion (no study treatment)|1
2828622|NCT02725476|9697069|P2|Overall Study|Adverse Event|1
2828623|NCT02725476|9697070|P1|Overall Study|Adverse Event|1
2828624|NCT02725476|9697069|P2|Overall Study|Physician Decision|0
2828625|NCT02725476|9697070|P1|Overall Study|Physician Decision|2
2828626|NCT02725008|9697080|P2|Overall Study|Admitted to hospital|1
2828627|NCT02725008|9697081|P1|Overall Study|Admitted to hospital|0
2828628|NCT02725008|9697080|P2|Overall Study|Withdrawal by Subject|2
2828629|NCT02725008|9697081|P1|Overall Study|Withdrawal by Subject|2
2828630|NCT02725008|9697080|P2|Overall Study|Lost to Follow-up|9
2828631|NCT02725008|9697081|P1|Overall Study|Lost to Follow-up|7
2828632|NCT02724644|9697099|P2|Overall Study|Administrative|0
2828633|NCT02724644|9697100|P1|Overall Study|Administrative|1
2828634|NCT02724644|9697099|P2|Overall Study|Withdrawal by Subject|1
2828635|NCT02724644|9697100|P1|Overall Study|Withdrawal by Subject|7
2828636|NCT02724644|9697099|P2|Overall Study|Lost to Follow-up|2
2828637|NCT02724644|9697100|P1|Overall Study|Lost to Follow-up|6
2828638|NCT02724644|9697099|P2|Overall Study|Adverse Event|1
2828639|NCT02724644|9697100|P1|Overall Study|Adverse Event|7
2828640|NCT02724111|9697134|P2|Overall Study|Protocol Violation|5
2828641|NCT02724111|9697135|P1|Overall Study|Protocol Violation|2
2828642|NCT02723786|9697155|P1|Overall Study|Lost to Follow-up|1
2828643|NCT02723630|9697183|P6|Intervention Period 3|consumption of restricted item|0
2828644|NCT02723630|9697184|P5|Intervention Period 3|consumption of restricted item|0
2828645|NCT02723630|9697185|P4|Intervention Period 3|consumption of restricted item|0
2828646|NCT02723630|9697186|P3|Intervention Period 3|consumption of restricted item|0
2828647|NCT02723630|9697187|P2|Intervention Period 3|consumption of restricted item|1
2828648|NCT02723630|9697188|P1|Intervention Period 3|consumption of restricted item|0
2828649|NCT02723630|9697183|P6|Intervention Period 1|Adverse Event|0
2828650|NCT02723630|9697184|P5|Intervention Period 1|Adverse Event|0
2828651|NCT02723630|9697185|P4|Intervention Period 1|Adverse Event|0
2828652|NCT02723630|9697186|P3|Intervention Period 1|Adverse Event|0
2828653|NCT02723630|9697187|P2|Intervention Period 1|Adverse Event|0
2828654|NCT02723630|9697188|P1|Intervention Period 1|Adverse Event|1
2828655|NCT02723201|9697220|P3|Second Intervention Period|Adverse Event|0
2828656|NCT02723201|9697221|P2|Second Intervention Period|Adverse Event|0
2828657|NCT02723201|9697222|P1|Second Intervention Period|Adverse Event|1
2828658|NCT02723201|9697220|P3|Second Intervention Period|Protocol Violation|0
2828659|NCT02723201|9697221|P2|Second Intervention Period|Protocol Violation|0
2828660|NCT02723201|9697222|P1|Second Intervention Period|Protocol Violation|1
2828661|NCT02723188|9697281|P3|Overall Study|Withdrawal by Subject|0
2828662|NCT02723188|9697282|P2|Overall Study|Withdrawal by Subject|0
2828663|NCT02723188|9697283|P1|Overall Study|Withdrawal by Subject|1
2828664|NCT02723175|9697296|P2|Overall Study|Lost to 3 Month Follow Up|1
2828665|NCT02723175|9697297|P1|Overall Study|Lost to 3 Month Follow Up|1
2828666|NCT02723175|9697296|P2|Overall Study|Lost to 1 Month Follow Up|2
2828667|NCT02723175|9697297|P1|Overall Study|Lost to 1 Month Follow Up|3
2828668|NCT02723084|9697339|P2|Overall Study|Lost to Follow-up|0
2828669|NCT02723084|9697340|P1|Overall Study|Lost to Follow-up|3
2828670|NCT02723084|9697339|P2|Overall Study|Withdrawal by Subject|1
2828671|NCT02723084|9697340|P1|Overall Study|Withdrawal by Subject|1
2828672|NCT02722967|9697354|P3|Overall Study|Non-adherence of the patch to the skin|2
2828673|NCT02722967|9697355|P2|Overall Study|Non-adherence of the patch to the skin|0
2828674|NCT02722967|9697356|P1|Overall Study|Non-adherence of the patch to the skin|0
2828675|NCT02722967|9697354|P3|Overall Study|Physician Decision|0
2828676|NCT02722967|9697355|P2|Overall Study|Physician Decision|0
2828677|NCT02722967|9697356|P1|Overall Study|Physician Decision|1
2828678|NCT02722967|9697354|P3|Overall Study|Withdrawal by Subject|1
2828679|NCT02722967|9697355|P2|Overall Study|Withdrawal by Subject|0
2828680|NCT02722967|9697356|P1|Overall Study|Withdrawal by Subject|1
2828681|NCT02722967|9697354|P3|Overall Study|Non-compliance with patch wearing|1
2828682|NCT02722967|9697355|P2|Overall Study|Non-compliance with patch wearing|1
2828683|NCT02722967|9697356|P1|Overall Study|Non-compliance with patch wearing|2
2828684|NCT02722967|9697354|P3|Overall Study|Lost to Follow-up|0
2828685|NCT02722967|9697355|P2|Overall Study|Lost to Follow-up|1
2828686|NCT02722967|9697356|P1|Overall Study|Lost to Follow-up|0
2828687|NCT02722967|9697354|P3|Overall Study|Adverse Event|0
2828688|NCT02722967|9697355|P2|Overall Study|Adverse Event|0
2828689|NCT02722967|9697356|P1|Overall Study|Adverse Event|1
2828690|NCT02722928|9697366|P2|Overall Study|Required Intraoperative MRI|7
2828691|NCT02722928|9697367|P1|Overall Study|Required Intraoperative MRI|5
2828692|NCT02722928|9697366|P2|Overall Study|Standard CT was not as required per prot|13
2828693|NCT02722928|9697367|P1|Overall Study|Standard CT was not as required per prot|5
2828694|NCT02722304|9697443|P5|Overall Study|Other|1
2828695|NCT02722304|9697444|P4|Overall Study|Other|1
2828696|NCT02722304|9697445|P3|Overall Study|Other|0
2828697|NCT02722304|9697446|P2|Overall Study|Other|0
2828698|NCT02722304|9697447|P1|Overall Study|Other|0
2828699|NCT02722304|9697443|P5|Overall Study|Study Terminated by Sponsor|1
2828700|NCT02722304|9697444|P4|Overall Study|Study Terminated by Sponsor|1
2828701|NCT02722304|9697445|P3|Overall Study|Study Terminated by Sponsor|2
2828702|NCT02722304|9697446|P2|Overall Study|Study Terminated by Sponsor|0
2828703|NCT02722304|9697447|P1|Overall Study|Study Terminated by Sponsor|1
2828704|NCT02722278|9697499|P2|Overall Study|Site closure not study related|1
2828705|NCT02722278|9697500|P1|Overall Study|Site closure not study related|0
2828706|NCT02722278|9697499|P2|Overall Study|Subject declined after tx assignment|1
2828707|NCT02722278|9697500|P1|Overall Study|Subject declined after tx assignment|0
2828708|NCT02722278|9697499|P2|Overall Study|High PSA pre-study/ not eligible|1
2828709|NCT02722278|9697500|P1|Overall Study|High PSA pre-study/ not eligible|0
2828710|NCT02722278|9697499|P2|Overall Study|Protocol Violation|0
2828711|NCT02722278|9697500|P1|Overall Study|Protocol Violation|1
2828712|NCT02722278|9697499|P2|Overall Study|Lost to Follow-up|0
2828713|NCT02722278|9697500|P1|Overall Study|Lost to Follow-up|2
2828714|NCT02722278|9697499|P2|Overall Study|Adverse Event|1
2828715|NCT02722278|9697500|P1|Overall Study|Adverse Event|4
2828716|NCT02722278|9697499|P2|Overall Study|Withdrawal by Subject|3
2828717|NCT02722278|9697500|P1|Overall Study|Withdrawal by Subject|5
2828718|NCT02722148|9697524|P1|Overall Study|Non compliant with treatment regimen|3
2828719|NCT02722148|9697524|P1|Overall Study|Lost to Follow-up|2
2828720|NCT02722044|9697531|P1|Overall Study|Did Not Meet Criteria at Week 14|1
2828721|NCT02722044|9697531|P1|Overall Study|Withdrawal by Subject|1
2828722|NCT02722044|9697531|P1|Overall Study|Physician Decision|1
2828723|NCT02722044|9697531|P1|Overall Study|Adverse Event|2
2828724|NCT02721875|9697560|P2|Overall Study|Progressive disease/relapse|0
2828725|NCT02721875|9697561|P1|Overall Study|Progressive disease/relapse|1
2828726|NCT02721147|9697612|P3|Overall Study|Lost to Follow-up|0
2828727|NCT02721147|9697613|P2|Overall Study|Lost to Follow-up|0
2828728|NCT02721147|9697614|P1|Overall Study|Lost to Follow-up|2
2828729|NCT02720757|9697658|P1|Overall Study|General exclusion|3
2828730|NCT02720757|9697658|P1|Overall Study|Missing|3
2828731|NCT02720757|9697658|P1|Overall Study|Patients wish to withdraw|2
2828732|NCT02720757|9697658|P1|Overall Study|Informed consent withdrawal|1
2828733|NCT02720757|9697658|P1|Overall Study|Loss of contact|4
2828734|NCT02720757|9697658|P1|Overall Study|Other reason|5
2828735|NCT02720536|9697667|P1|Overall Study|PR- unwilling to comply with procedures|1
2828736|NCT02720536|9697667|P1|Overall Study|PR - abnormal lab value(s)|1
2828737|NCT02720536|9697667|P1|Overall Study|PR - adverse event|1
2828738|NCT02720536|9697667|P1|Overall Study|PR - death|1
2828739|NCT02720536|9697667|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
2828740|NCT02720536|9697667|P1|Overall Study|PR - pregnancy|2
2828741|NCT02720536|9697667|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
2828742|NCT02720523|9697702|P7|Period 2: Long-term Extension Period|Other|3
2828743|NCT02720523|9697703|P6|Period 2: Long-term Extension Period|Other|0
2828744|NCT02720523|9697704|P5|Period 2: Long-term Extension Period|Other|2
2828745|NCT02720523|9697705|P4|Period 2: Long-term Extension Period|Other|0
2828746|NCT02720523|9697706|P3|Period 2: Long-term Extension Period|Other|0
2828747|NCT02720523|9697707|P2|Period 2: Long-term Extension Period|Other|0
2828748|NCT02720523|9697708|P1|Period 2: Long-term Extension Period|Other|0
2828749|NCT02720523|9697702|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2828750|NCT02720523|9697703|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2828751|NCT02720523|9697704|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
2828752|NCT02720523|9697705|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2828753|NCT02720523|9697706|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2828754|NCT02720523|9697707|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2828755|NCT02720523|9697708|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2828756|NCT02720523|9697702|P7|Period 2: Long-term Extension Period|Adverse Event|11
2828757|NCT02720523|9697703|P6|Period 2: Long-term Extension Period|Adverse Event|7
2828758|NCT02720523|9697704|P5|Period 2: Long-term Extension Period|Adverse Event|4
2828759|NCT02720523|9697705|P4|Period 2: Long-term Extension Period|Adverse Event|0
2828760|NCT02720523|9697706|P3|Period 2: Long-term Extension Period|Adverse Event|0
2828761|NCT02720523|9697707|P2|Period 2: Long-term Extension Period|Adverse Event|0
2828762|NCT02720523|9697708|P1|Period 2: Long-term Extension Period|Adverse Event|0
2828763|NCT02720523|9697702|P7|Period 2: Long-term Extension Period|Ongoing|45
2828764|NCT02720523|9697703|P6|Period 2: Long-term Extension Period|Ongoing|54
2828765|NCT02720523|9697704|P5|Period 2: Long-term Extension Period|Ongoing|57
2828766|NCT02720523|9697705|P4|Period 2: Long-term Extension Period|Ongoing|0
2828767|NCT02720523|9697706|P3|Period 2: Long-term Extension Period|Ongoing|0
2828768|NCT02720523|9697707|P2|Period 2: Long-term Extension Period|Ongoing|0
2828769|NCT02720523|9697708|P1|Period 2: Long-term Extension Period|Ongoing|0
2828770|NCT02720523|9697702|P7|Period 1: Placebo-controlled Period|Other|0
2828771|NCT02720523|9697703|P6|Period 1: Placebo-controlled Period|Other|0
2828772|NCT02720523|9697704|P5|Period 1: Placebo-controlled Period|Other|0
2828773|NCT02720523|9697705|P4|Period 1: Placebo-controlled Period|Other|1
2828774|NCT02720523|9697706|P3|Period 1: Placebo-controlled Period|Other|1
2828775|NCT02720523|9697707|P2|Period 1: Placebo-controlled Period|Other|0
2828776|NCT02720523|9697708|P1|Period 1: Placebo-controlled Period|Other|0
2828777|NCT02720523|9697702|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828778|NCT02720523|9697703|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828779|NCT02720523|9697704|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828780|NCT02720523|9697705|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828781|NCT02720523|9697706|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828782|NCT02720523|9697707|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2828783|NCT02720523|9697708|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
2828784|NCT02720523|9697702|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828785|NCT02720523|9697703|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828786|NCT02720523|9697704|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828787|NCT02720523|9697705|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828788|NCT02720523|9697706|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828789|NCT02720523|9697707|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2828790|NCT02720523|9697708|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
2828791|NCT02720523|9697702|P7|Period 1: Placebo-controlled Period|Adverse Event|0
2828792|NCT02720523|9697703|P6|Period 1: Placebo-controlled Period|Adverse Event|0
2828793|NCT02720523|9697704|P5|Period 1: Placebo-controlled Period|Adverse Event|0
2828794|NCT02720523|9697705|P4|Period 1: Placebo-controlled Period|Adverse Event|5
2828795|NCT02720523|9697706|P3|Period 1: Placebo-controlled Period|Adverse Event|1
2828796|NCT02720523|9697707|P2|Period 1: Placebo-controlled Period|Adverse Event|0
2828797|NCT02720523|9697708|P1|Period 1: Placebo-controlled Period|Adverse Event|0
2828798|NCT02720510|9697767|P2|Overall Study|Physician Decision|2
2828799|NCT02720510|9697768|P1|Overall Study|Physician Decision|1
2828800|NCT02720510|9697767|P2|Overall Study|Adverse Event|1
2828801|NCT02720510|9697768|P1|Overall Study|Adverse Event|0
2828802|NCT02720510|9697767|P2|Overall Study|Study Terminated by the sponsor|0
2828803|NCT02720510|9697768|P1|Overall Study|Study Terminated by the sponsor|2
2828804|NCT02720484|9697786|P1|Follow Up for 2 Years|Lost to Follow-up|2
2828805|NCT02720484|9697786|P1|Follow Up for 2 Years|Death|3
2828806|NCT02720484|9697786|P1|Follow Up for 2 Years|Withdrawal by Subject|1
2828807|NCT02720484|9697786|P1|Treatment on Study|Progressive Disease|4
2828808|NCT02720484|9697786|P1|Treatment on Study|Withdrawal by Subject|1
2828809|NCT02720484|9697786|P1|Treatment on Study|Adverse Event|1
2828810|NCT02720198|9697818|P2|Overall Study|Withdrawal by Subject|1
2828811|NCT02720198|9697819|P1|Overall Study|Withdrawal by Subject|0
2828812|NCT02720081|9697854|P2|Overall Study|Protocol Violation|1
2828813|NCT02720081|9697855|P1|Overall Study|Protocol Violation|4
2828814|NCT02720081|9697854|P2|Overall Study|Adverse Event|3
2828815|NCT02720081|9697855|P1|Overall Study|Adverse Event|0
2828816|NCT02719743|9697937|P5|Overall Study|Lost to Follow-up|0
2828817|NCT02719743|9697938|P4|Overall Study|Lost to Follow-up|0
2828818|NCT02719743|9697939|P3|Overall Study|Lost to Follow-up|0
2828819|NCT02719743|9697940|P2|Overall Study|Lost to Follow-up|1
2828820|NCT02719743|9697941|P1|Overall Study|Lost to Follow-up|1
2828821|NCT02719743|9697937|P5|Overall Study|Migrated/moved from study area|2
2828822|NCT02719743|9697938|P4|Overall Study|Migrated/moved from study area|0
2828823|NCT02719743|9697939|P3|Overall Study|Migrated/moved from study area|0
2828824|NCT02719743|9697940|P2|Overall Study|Migrated/moved from study area|0
2828825|NCT02719743|9697941|P1|Overall Study|Migrated/moved from study area|0
2828826|NCT02719743|9697937|P5|Overall Study|Consent withdrawal|0
2828827|NCT02719743|9697938|P4|Overall Study|Consent withdrawal|1
2828828|NCT02719743|9697939|P3|Overall Study|Consent withdrawal|0
2828829|NCT02719743|9697940|P2|Overall Study|Consent withdrawal|2
2828830|NCT02719743|9697941|P1|Overall Study|Consent withdrawal|0
2828831|NCT02719171|9698087|P5|Overall Study|Other|0
2828832|NCT02719171|9698088|P4|Overall Study|Other|1
2828833|NCT02719171|9698089|P3|Overall Study|Other|0
2828834|NCT02719171|9698090|P2|Overall Study|Other|0
2828835|NCT02719171|9698091|P1|Overall Study|Other|0
2828836|NCT02719171|9698087|P5|Overall Study|Subject Withdrawal|0
2828837|NCT02719171|9698088|P4|Overall Study|Subject Withdrawal|1
2828838|NCT02719171|9698089|P3|Overall Study|Subject Withdrawal|2
2828839|NCT02719171|9698090|P2|Overall Study|Subject Withdrawal|2
2828840|NCT02719171|9698091|P1|Overall Study|Subject Withdrawal|0
2828841|NCT02719171|9698087|P5|Overall Study|Lost to Follow-up|0
2828842|NCT02719171|9698088|P4|Overall Study|Lost to Follow-up|0
2828843|NCT02719171|9698089|P3|Overall Study|Lost to Follow-up|1
2828844|NCT02719171|9698090|P2|Overall Study|Lost to Follow-up|0
2828845|NCT02719171|9698091|P1|Overall Study|Lost to Follow-up|0
2828846|NCT02719171|9698087|P5|Overall Study|Adverse Event|2
2828847|NCT02719171|9698088|P4|Overall Study|Adverse Event|0
2828848|NCT02719171|9698089|P3|Overall Study|Adverse Event|0
2828849|NCT02719171|9698090|P2|Overall Study|Adverse Event|2
2828850|NCT02719171|9698091|P1|Overall Study|Adverse Event|1
2828851|NCT02719028|9698186|P4|Overall Study|Protocol Violation|1
2828852|NCT02719028|9698187|P3|Overall Study|Protocol Violation|0
2828853|NCT02719028|9698188|P2|Overall Study|Protocol Violation|0
2828854|NCT02719028|9698189|P1|Overall Study|Protocol Violation|0
2828855|NCT02719028|9698186|P4|Overall Study|Use of prohibited medication|0
2828856|NCT02719028|9698187|P3|Overall Study|Use of prohibited medication|1
2828857|NCT02719028|9698188|P2|Overall Study|Use of prohibited medication|0
2828858|NCT02719028|9698189|P1|Overall Study|Use of prohibited medication|0
2828859|NCT02719028|9698186|P4|Overall Study|Physician Decision|1
2828860|NCT02719028|9698187|P3|Overall Study|Physician Decision|1
2828861|NCT02719028|9698188|P2|Overall Study|Physician Decision|1
2828862|NCT02719028|9698189|P1|Overall Study|Physician Decision|0
2828863|NCT02719028|9698186|P4|Overall Study|Adverse Event|8
2828864|NCT02719028|9698187|P3|Overall Study|Adverse Event|4
2828865|NCT02719028|9698188|P2|Overall Study|Adverse Event|1
2828866|NCT02719028|9698189|P1|Overall Study|Adverse Event|2
2828867|NCT02718898|9698213|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
2828868|NCT02718898|9698214|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
2828869|NCT02718898|9698215|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
2828870|NCT02718898|9698216|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
2828871|NCT02718898|9698217|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
2828872|NCT02718898|9698218|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
2828873|NCT02718898|9698219|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
2828874|NCT02718898|9698213|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
2828875|NCT02718898|9698214|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
2828876|NCT02718898|9698215|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
2828877|NCT02718898|9698216|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
2828878|NCT02718898|9698217|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
2828879|NCT02718898|9698218|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
2828880|NCT02718898|9698219|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
2828881|NCT02718898|9698213|P7|Post Treatment Follow-up Period|Adverse Event|1
2828882|NCT02718898|9698214|P6|Post Treatment Follow-up Period|Adverse Event|1
2828883|NCT02718898|9698215|P5|Post Treatment Follow-up Period|Adverse Event|0
2828884|NCT02718898|9698216|P4|Post Treatment Follow-up Period|Adverse Event|0
2828885|NCT02718898|9698217|P3|Post Treatment Follow-up Period|Adverse Event|0
2828886|NCT02718898|9698218|P2|Post Treatment Follow-up Period|Adverse Event|0
2828887|NCT02718898|9698219|P1|Post Treatment Follow-up Period|Adverse Event|0
2828888|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828889|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828890|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828891|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
2828892|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828893|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828894|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2828895|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828896|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828897|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828898|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
2828899|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828900|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828901|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2828902|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2828903|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2828904|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2828905|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
2828906|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
2828907|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2828908|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2828909|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2828910|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2828911|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2828912|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
2828913|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
2828914|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2828915|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2828916|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828917|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828918|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828919|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
2828920|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828921|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828922|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2828923|NCT02718898|9698213|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
2828924|NCT02718898|9698214|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
2828925|NCT02718898|9698215|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
2828926|NCT02718898|9698216|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
2828927|NCT02718898|9698217|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
2828928|NCT02718898|9698218|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
2828929|NCT02718898|9698219|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
2828930|NCT02718898|9698213|P7|Blinded Treatment Period|Lost to Follow-up|0
2828931|NCT02718898|9698214|P6|Blinded Treatment Period|Lost to Follow-up|0
2828932|NCT02718898|9698215|P5|Blinded Treatment Period|Lost to Follow-up|0
2828933|NCT02718898|9698216|P4|Blinded Treatment Period|Lost to Follow-up|0
2828934|NCT02718898|9698217|P3|Blinded Treatment Period|Lost to Follow-up|0
2828935|NCT02718898|9698218|P2|Blinded Treatment Period|Lost to Follow-up|0
2828936|NCT02718898|9698219|P1|Blinded Treatment Period|Lost to Follow-up|2
2828937|NCT02718898|9698213|P7|Blinded Treatment Period|Lack of Efficacy|0
2828938|NCT02718898|9698214|P6|Blinded Treatment Period|Lack of Efficacy|0
2828939|NCT02718898|9698215|P5|Blinded Treatment Period|Lack of Efficacy|0
2828940|NCT02718898|9698216|P4|Blinded Treatment Period|Lack of Efficacy|0
2828941|NCT02718898|9698217|P3|Blinded Treatment Period|Lack of Efficacy|0
2828942|NCT02718898|9698218|P2|Blinded Treatment Period|Lack of Efficacy|0
2828943|NCT02718898|9698219|P1|Blinded Treatment Period|Lack of Efficacy|1
2828944|NCT02718898|9698213|P7|Blinded Treatment Period|Physician Decision|0
2828945|NCT02718898|9698214|P6|Blinded Treatment Period|Physician Decision|0
2828946|NCT02718898|9698215|P5|Blinded Treatment Period|Physician Decision|0
2828947|NCT02718898|9698216|P4|Blinded Treatment Period|Physician Decision|0
2828948|NCT02718898|9698217|P3|Blinded Treatment Period|Physician Decision|0
2828949|NCT02718898|9698218|P2|Blinded Treatment Period|Physician Decision|0
2828950|NCT02718898|9698219|P1|Blinded Treatment Period|Physician Decision|1
2828951|NCT02718898|9698213|P7|Blinded Treatment Period|Adverse Event|0
2828952|NCT02718898|9698214|P6|Blinded Treatment Period|Adverse Event|0
2828953|NCT02718898|9698215|P5|Blinded Treatment Period|Adverse Event|0
2828954|NCT02718898|9698216|P4|Blinded Treatment Period|Adverse Event|0
2828955|NCT02718898|9698217|P3|Blinded Treatment Period|Adverse Event|0
2828956|NCT02718898|9698218|P2|Blinded Treatment Period|Adverse Event|1
2828957|NCT02718898|9698219|P1|Blinded Treatment Period|Adverse Event|5
2828958|NCT02718625|9698254|P2|Overall Study|Termination of Study by Sponsor|1
2828959|NCT02718625|9698255|P1|Overall Study|Termination of Study by Sponsor|0
2828960|NCT02718625|9698254|P2|Overall Study|Adverse Event|1
2828961|NCT02718625|9698255|P1|Overall Study|Adverse Event|0
2828962|NCT02718417|9698274|P3|Maintenance Phase|Ongoing|172
2828963|NCT02718417|9698275|P2|Maintenance Phase|Ongoing|180
2828964|NCT02718417|9698276|P1|Maintenance Phase|Ongoing|155
2828965|NCT02718417|9698274|P3|Maintenance Phase|Lost to Follow-up|2
2828966|NCT02718417|9698275|P2|Maintenance Phase|Lost to Follow-up|0
2828967|NCT02718417|9698276|P1|Maintenance Phase|Lost to Follow-up|0
2828968|NCT02718417|9698274|P3|Maintenance Phase|Study terminated by sponsor|1
2828969|NCT02718417|9698275|P2|Maintenance Phase|Study terminated by sponsor|0
2828970|NCT02718417|9698276|P1|Maintenance Phase|Study terminated by sponsor|0
2828971|NCT02718417|9698274|P3|Maintenance Phase|Withdrawal by Subject|27
2828972|NCT02718417|9698275|P2|Maintenance Phase|Withdrawal by Subject|10
2828973|NCT02718417|9698276|P1|Maintenance Phase|Withdrawal by Subject|13
2828974|NCT02718417|9698274|P3|Maintenance Phase|Other|5
2828975|NCT02718417|9698275|P2|Maintenance Phase|Other|1
2828976|NCT02718417|9698276|P1|Maintenance Phase|Other|2
2828977|NCT02718417|9698274|P3|Maintenance Phase|Progressive disease|66
2828978|NCT02718417|9698275|P2|Maintenance Phase|Progressive disease|64
2828979|NCT02718417|9698276|P1|Maintenance Phase|Progressive disease|72
2828980|NCT02718417|9698274|P3|Maintenance Phase|Physician's decision|9
2828981|NCT02718417|9698275|P2|Maintenance Phase|Physician's decision|5
2828982|NCT02718417|9698276|P1|Maintenance Phase|Physician's decision|4
2828983|NCT02718417|9698274|P3|Maintenance Phase|No longer met eligibility criteria|0
2828984|NCT02718417|9698275|P2|Maintenance Phase|No longer met eligibility criteria|1
2828985|NCT02718417|9698276|P1|Maintenance Phase|No longer met eligibility criteria|0
2828986|NCT02718417|9698274|P3|Maintenance Phase|Global deterioration of health status|1
2828987|NCT02718417|9698275|P2|Maintenance Phase|Global deterioration of health status|2
2828988|NCT02718417|9698276|P1|Maintenance Phase|Global deterioration of health status|5
2828989|NCT02718417|9698274|P3|Maintenance Phase|Death leading to discontinuation|2
2828990|NCT02718417|9698275|P2|Maintenance Phase|Death leading to discontinuation|1
2828991|NCT02718417|9698276|P1|Maintenance Phase|Death leading to discontinuation|0
2828992|NCT02718417|9698274|P3|Maintenance Phase|Adverse Event|1
2828993|NCT02718417|9698275|P2|Maintenance Phase|Adverse Event|23
2828994|NCT02718417|9698276|P1|Maintenance Phase|Adverse Event|16
2828995|NCT02718417|9698274|P3|Chemotherapy Phase|Other|0
2828996|NCT02718417|9698275|P2|Chemotherapy Phase|Other|0
2828997|NCT02718417|9698276|P1|Chemotherapy Phase|Other|2
2828998|NCT02718417|9698274|P3|Chemotherapy Phase|Withdrawal by Subject|15
2828999|NCT02718417|9698275|P2|Chemotherapy Phase|Withdrawal by Subject|8
2829000|NCT02718417|9698276|P1|Chemotherapy Phase|Withdrawal by Subject|13
2829001|NCT02718417|9698274|P3|Chemotherapy Phase|Progressive disease|10
2829002|NCT02718417|9698275|P2|Chemotherapy Phase|Progressive disease|7
2829003|NCT02718417|9698276|P1|Chemotherapy Phase|Progressive disease|11
2829004|NCT02718417|9698274|P3|Chemotherapy Phase|Physician's decision|4
2829005|NCT02718417|9698275|P2|Chemotherapy Phase|Physician's decision|0
2829006|NCT02718417|9698276|P1|Chemotherapy Phase|Physician's decision|5
2829007|NCT02718417|9698274|P3|Chemotherapy Phase|No longer met eligibility criteria|1
2829008|NCT02718417|9698275|P2|Chemotherapy Phase|No longer met eligibility criteria|2
2829009|NCT02718417|9698276|P1|Chemotherapy Phase|No longer met eligibility criteria|4
2829010|NCT02718417|9698274|P3|Chemotherapy Phase|Global deterioration of health status|1
2829011|NCT02718417|9698275|P2|Chemotherapy Phase|Global deterioration of health status|2
2829012|NCT02718417|9698276|P1|Chemotherapy Phase|Global deterioration of health status|3
2829013|NCT02718417|9698274|P3|Chemotherapy Phase|Death leading to discontinuation|1
2829014|NCT02718417|9698275|P2|Chemotherapy Phase|Death leading to discontinuation|4
2829015|NCT02718417|9698276|P1|Chemotherapy Phase|Death leading to discontinuation|5
2829016|NCT02718417|9698274|P3|Chemotherapy Phase|Adverse Event|13
2829017|NCT02718417|9698275|P2|Chemotherapy Phase|Adverse Event|14
2829018|NCT02718417|9698276|P1|Chemotherapy Phase|Adverse Event|9
2829019|NCT02718326|9698338|P3|Overall Study|Un-specified|0
2829020|NCT02718326|9698339|P2|Overall Study|Un-specified|0
2829021|NCT02718326|9698340|P1|Overall Study|Un-specified|1
2829022|NCT02718326|9698338|P3|Overall Study|Protocol Deviation|0
2829023|NCT02718326|9698339|P2|Overall Study|Protocol Deviation|0
2829024|NCT02718326|9698340|P1|Overall Study|Protocol Deviation|1
2829025|NCT02718326|9698338|P3|Overall Study|Lost to Follow-up|5
2829026|NCT02718326|9698339|P2|Overall Study|Lost to Follow-up|4
2829027|NCT02718326|9698340|P1|Overall Study|Lost to Follow-up|12
2829028|NCT02718326|9698338|P3|Overall Study|Withdrawal by Subject|4
2829029|NCT02718326|9698339|P2|Overall Study|Withdrawal by Subject|5
2829030|NCT02718326|9698340|P1|Overall Study|Withdrawal by Subject|2
2829031|NCT02718326|9698338|P3|Overall Study|Death|1
2829032|NCT02718326|9698339|P2|Overall Study|Death|0
2829033|NCT02718326|9698340|P1|Overall Study|Death|6
2829034|NCT02718326|9698338|P3|Overall Study|Adverse Event|0
2829035|NCT02718326|9698339|P2|Overall Study|Adverse Event|4
2829036|NCT02718326|9698340|P1|Overall Study|Adverse Event|2
2829037|NCT02717754|9698461|P6|Overall Study|Incorrect Infusion Duration|20
2829038|NCT02717754|9698462|P5|Overall Study|Incorrect Infusion Duration|20
2829039|NCT02717754|9698463|P4|Overall Study|Incorrect Infusion Duration|10
2829040|NCT02717754|9698464|P3|Overall Study|Incorrect Infusion Duration|0
2829041|NCT02717754|9698465|P2|Overall Study|Incorrect Infusion Duration|0
2829042|NCT02717754|9698466|P1|Overall Study|Incorrect Infusion Duration|0
2829043|NCT02717494|9698497|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
2829044|NCT02717494|9698498|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2829045|NCT02717494|9698499|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2829046|NCT02717494|9698497|P3|First Intervention (Step 1)|Death|1
2829047|NCT02717494|9698498|P2|First Intervention (Step 1)|Death|0
2829048|NCT02717494|9698499|P1|First Intervention (Step 1)|Death|0
2829049|NCT02717494|9698497|P3|First Intervention (Step 1)|Withdrawal by Subject|1
2829050|NCT02717494|9698498|P2|First Intervention (Step 1)|Withdrawal by Subject|0
2829051|NCT02717494|9698499|P1|First Intervention (Step 1)|Withdrawal by Subject|2
2829052|NCT02717494|9698497|P3|First Intervention (Step 1)|Lost to Follow-up|3
2829053|NCT02717494|9698498|P2|First Intervention (Step 1)|Lost to Follow-up|7
2829054|NCT02717494|9698499|P1|First Intervention (Step 1)|Lost to Follow-up|4
2829055|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2829056|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2829057|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2829058|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2829059|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2829060|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2829061|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2829062|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
2829063|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2829064|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2829065|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
2829066|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2829067|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2829068|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2829069|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2829070|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Change of residence|1
2829071|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Change of residence|1
2829072|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Change of residence|0
2829073|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Change of residence|0
2829074|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Change of residence|0
2829075|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
2829076|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
2829077|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
2829078|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
2829079|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
2829080|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
2829081|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
2829082|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
2829083|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
2829084|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
2829085|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Patient decision|2
2829086|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Patient decision|2
2829087|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Patient decision|0
2829088|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Patient decision|0
2829089|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Patient decision|0
2829090|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2829091|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2829092|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
2829093|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2829094|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2829095|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
2829096|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
2829097|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2829098|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2829099|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2829100|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
2829101|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
2829102|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
2829103|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2829104|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2829105|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
2829106|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
2829107|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
2829108|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
2829109|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
2829110|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
2829111|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
2829112|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
2829113|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2829114|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2829115|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
2829116|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
2829117|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
2829118|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2829119|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2829120|NCT02717195|9698561|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
2829121|NCT02717195|9698562|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
2829122|NCT02717195|9698563|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
2829123|NCT02717195|9698564|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
2829124|NCT02717195|9698565|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
2829125|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2829126|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2829127|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2829128|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2829129|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
2829130|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2829131|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2829132|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2829133|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2829134|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
2829135|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
2829136|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
2829137|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
2829138|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
2829139|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
2829140|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
2829141|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
2829142|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
2829143|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
2829144|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
2829145|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2829146|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2829147|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2829148|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
2829149|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2829150|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2829151|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2829152|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2829153|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2829154|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
2829155|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2829156|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2829157|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2829158|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
2829159|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2829160|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Investigator decision|0
2829161|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Investigator decision|0
2829162|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Investigator decision|0
2829163|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Investigator decision|1
2829164|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Investigator decision|2
2829165|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2829166|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2829167|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2829168|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
2829169|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2829170|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
2829171|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
2829172|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
2829173|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
2829174|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
2829175|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2829176|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2829177|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2829178|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2829179|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
2829180|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Patient decision|0
2829181|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Patient decision|0
2829182|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Patient decision|0
2829183|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Patient decision|2
2829184|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Patient decision|5
2829185|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Technical error|0
2829186|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Technical error|0
2829187|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Technical error|0
2829188|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Technical error|0
2829189|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Technical error|1
2829190|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2829191|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2829192|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2829193|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2829194|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
2829195|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2829196|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2829197|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2829198|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2829199|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2829200|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2829201|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2829202|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2829203|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
2829204|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
2829205|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2829206|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2829207|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2829208|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
2829209|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
2829210|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2829211|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2829212|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2829213|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
2829214|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
2829215|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
2829216|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
2829217|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
2829301|NCT02714218|9699073|P1|Overall Study|Participant Withdrew Consent|2
2829218|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
2829219|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
2829220|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2829221|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2829222|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2829223|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
2829224|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
2829225|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2829226|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2829227|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2829228|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
2829229|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2829230|NCT02717195|9698561|P5|Prospective Confirmation (PC) Period|Adverse Event|0
2829231|NCT02717195|9698562|P4|Prospective Confirmation (PC) Period|Adverse Event|0
2829232|NCT02717195|9698563|P3|Prospective Confirmation (PC) Period|Adverse Event|0
2829233|NCT02717195|9698564|P2|Prospective Confirmation (PC) Period|Adverse Event|7
2829234|NCT02717195|9698565|P1|Prospective Confirmation (PC) Period|Adverse Event|19
2829235|NCT02717130|9698596|P1|Overall Study|Study Closure|4
2829236|NCT02717130|9698596|P1|Overall Study|Physician Decision|1
2829237|NCT02717130|9698596|P1|Overall Study|Adverse Event|1
2829238|NCT02717130|9698596|P1|Overall Study|Withdrawal by Subject|1
2829239|NCT02716896|9698602|P2|Overall Study|Physician Decision|1
2829240|NCT02716896|9698603|P1|Overall Study|Physician Decision|0
2829241|NCT02716805|9698654|P4|Overall Study|Progressive disease|0
2829242|NCT02716805|9698655|P3|Overall Study|Progressive disease|0
2829243|NCT02716805|9698656|P2|Overall Study|Progressive disease|0
2829244|NCT02716805|9698657|P1|Overall Study|Progressive disease|2
2829245|NCT02716779|9698665|P3|Combination Therapy|Adverse Event|1
2829246|NCT02716779|9698666|P2|Combination Therapy|Adverse Event|2
2829247|NCT02716779|9698667|P1|Combination Therapy|Adverse Event|0
2829248|NCT02716779|9698665|P3|Monotherapy|Adverse Event|1
2829249|NCT02716779|9698666|P2|Monotherapy|Adverse Event|1
2829250|NCT02716779|9698667|P1|Monotherapy|Adverse Event|0
2829251|NCT02716584|9698742|P2|Overall Study|Lost to Follow-up|5
2829252|NCT02716584|9698743|P1|Overall Study|Lost to Follow-up|8
2829253|NCT02716298|9698799|P2|First Intervention (1 Month)|Lens discomfort|1
2829254|NCT02716298|9698800|P1|First Intervention (1 Month)|Lens discomfort|1
2829255|NCT02716194|9698818|P3|Period 1 - ADVATE|Withdrawal by Subject|0
2829256|NCT02716194|9698819|P2|Period 1 - ADVATE|Withdrawal by Subject|1
2829257|NCT02716194|9698820|P1|Period 1 - ADVATE|Withdrawal by Subject|1
2829258|NCT02715726|9698900|P2|Overall Study|Randomized but not treated|2
2829259|NCT02715726|9698901|P1|Overall Study|Randomized but not treated|1
2829260|NCT02715726|9698900|P2|Overall Study|Other than specified above|15
2829261|NCT02715726|9698901|P1|Overall Study|Other than specified above|11
2829262|NCT02715726|9698900|P2|Overall Study|Participant moved|3
2829263|NCT02715726|9698901|P1|Overall Study|Participant moved|1
2829264|NCT02715726|9698900|P2|Overall Study|Death|1
2829265|NCT02715726|9698901|P1|Overall Study|Death|2
2829266|NCT02715726|9698900|P2|Overall Study|Protocol Violation|0
2829267|NCT02715726|9698901|P1|Overall Study|Protocol Violation|1
2829268|NCT02715726|9698900|P2|Overall Study|Adverse Event|6
2829269|NCT02715726|9698901|P1|Overall Study|Adverse Event|2
2829270|NCT02714868|9698981|P2|Overall Study|PI withdraw did not meet inclusion|0
2829271|NCT02714868|9698982|P1|Overall Study|PI withdraw did not meet inclusion|1
2829272|NCT02714868|9698981|P2|Overall Study|PI withdrawal safety risk self/others|0
2829273|NCT02714868|9698982|P1|Overall Study|PI withdrawal safety risk self/others|1
2829274|NCT02714868|9698981|P2|Overall Study|Withdrawal by Subject|0
2829275|NCT02714868|9698982|P1|Overall Study|Withdrawal by Subject|3
2829276|NCT02714426|9699009|P2|Overall Study|Withdrawal by Subject|2
2829277|NCT02714426|9699010|P1|Overall Study|Withdrawal by Subject|2
2829278|NCT02714218|9699071|P3|Overall Study|Stop treatment, but will do follow up|0
2829279|NCT02714218|9699072|P2|Overall Study|Stop treatment, but will do follow up|1
2829280|NCT02714218|9699073|P1|Overall Study|Stop treatment, but will do follow up|0
2829281|NCT02714218|9699071|P3|Overall Study|Complete Response|0
2829282|NCT02714218|9699072|P2|Overall Study|Complete Response|0
2829283|NCT02714218|9699073|P1|Overall Study|Complete Response|1
2829284|NCT02714218|9699071|P3|Overall Study|Dose Delayed > 6 weeks|0
2829285|NCT02714218|9699072|P2|Overall Study|Dose Delayed > 6 weeks|0
2829286|NCT02714218|9699073|P1|Overall Study|Dose Delayed > 6 weeks|1
2829287|NCT02714218|9699071|P3|Overall Study|Completed|0
2829288|NCT02714218|9699072|P2|Overall Study|Completed|0
2829289|NCT02714218|9699073|P1|Overall Study|Completed|2
2829290|NCT02714218|9699071|P3|Overall Study|Not Reported|0
2829291|NCT02714218|9699072|P2|Overall Study|Not Reported|5
2829292|NCT02714218|9699073|P1|Overall Study|Not Reported|9
2829293|NCT02714218|9699071|P3|Overall Study|Medical Decision|0
2829294|NCT02714218|9699072|P2|Overall Study|Medical Decision|1
2829295|NCT02714218|9699073|P1|Overall Study|Medical Decision|0
2829296|NCT02714218|9699071|P3|Overall Study|Maximum Clinical Benefit|0
2829297|NCT02714218|9699072|P2|Overall Study|Maximum Clinical Benefit|2
2829298|NCT02714218|9699073|P1|Overall Study|Maximum Clinical Benefit|2
2829299|NCT02714218|9699071|P3|Overall Study|Participant Withdrew Consent|0
2829300|NCT02714218|9699072|P2|Overall Study|Participant Withdrew Consent|3
2829302|NCT02714218|9699071|P3|Overall Study|Request to Discontinue Treatment|1
2829303|NCT02714218|9699072|P2|Overall Study|Request to Discontinue Treatment|5
2829304|NCT02714218|9699073|P1|Overall Study|Request to Discontinue Treatment|1
2829305|NCT02714218|9699071|P3|Overall Study|Study Drug Toxicity|4
2829306|NCT02714218|9699072|P2|Overall Study|Study Drug Toxicity|69
2829307|NCT02714218|9699073|P1|Overall Study|Study Drug Toxicity|46
2829308|NCT02714218|9699071|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
2829309|NCT02714218|9699072|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
2829310|NCT02714218|9699073|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
2829311|NCT02714218|9699071|P3|Overall Study|Disease Progression|14
2829312|NCT02714218|9699072|P2|Overall Study|Disease Progression|51
2829313|NCT02714218|9699073|P1|Overall Study|Disease Progression|56
2829314|NCT02714062|9699123|P3|Overall Study|Protocol Violation|0
2829315|NCT02714062|9699124|P2|Overall Study|Protocol Violation|1
2829316|NCT02714062|9699125|P1|Overall Study|Protocol Violation|0
2829317|NCT02714062|9699123|P3|Overall Study|Withdrawal by Subject|1
2829318|NCT02714062|9699124|P2|Overall Study|Withdrawal by Subject|0
2829319|NCT02714062|9699125|P1|Overall Study|Withdrawal by Subject|1
2829320|NCT02714062|9699123|P3|Overall Study|Adverse Event|2
2829321|NCT02714062|9699124|P2|Overall Study|Adverse Event|0
2829322|NCT02714062|9699125|P1|Overall Study|Adverse Event|0
2829323|NCT02713828|9699171|P2|Overall Study|study terminated but patient allowed to|0
2829324|NCT02713828|9699172|P1|Overall Study|study terminated but patient allowed to|2
2829325|NCT02713828|9699171|P2|Overall Study|Withdrawal by Subject|0
2829326|NCT02713828|9699172|P1|Overall Study|Withdrawal by Subject|1
2829327|NCT02713828|9699171|P2|Overall Study|Death|0
2829328|NCT02713828|9699172|P1|Overall Study|Death|2
2829329|NCT02713789|9699184|P3|Overall Study|Lost to Follow-up|1
2829330|NCT02713789|9699185|P2|Overall Study|Lost to Follow-up|1
2829331|NCT02713789|9699186|P1|Overall Study|Lost to Follow-up|0
2829332|NCT02713594|9699249|P2|Overall Study|Lost to Follow-up|374
2829333|NCT02713594|9699250|P1|Overall Study|Lost to Follow-up|358
2829334|NCT02713594|9699249|P2|Overall Study|Withdrawal by Subject|22
2829335|NCT02713594|9699250|P1|Overall Study|Withdrawal by Subject|32
2829336|NCT02713542|9699262|P2|Overall Study|Withdrawal by Subject|1
2829337|NCT02713542|9699263|P1|Overall Study|Withdrawal by Subject|4
2829338|NCT02713542|9699262|P2|Overall Study|Use of prohibited medication|5
2829339|NCT02713542|9699263|P1|Overall Study|Use of prohibited medication|14
2829340|NCT02713243|9699282|P2|Overall Study|Protocol deviation|1
2829341|NCT02713243|9699283|P1|Overall Study|Protocol deviation|0
2829342|NCT02713243|9699282|P2|Overall Study|Administrative problems|1
2829343|NCT02713243|9699283|P1|Overall Study|Administrative problems|0
2829344|NCT02713243|9699282|P2|Overall Study|Abnormal laboratory value(s)#|0
2829345|NCT02713243|9699283|P1|Overall Study|Abnormal laboratory value(s)#|1
2829346|NCT02713204|9699301|P8|From Week 12 up to Week 36|Participant Re-located|0
2829347|NCT02713204|9699302|P7|From Week 12 up to Week 36|Participant Re-located|0
2829348|NCT02713204|9699303|P6|From Week 12 up to Week 36|Participant Re-located|0
2829349|NCT02713204|9699304|P5|From Week 12 up to Week 36|Participant Re-located|1
2829350|NCT02713204|9699305|P4|From Week 12 up to Week 36|Participant Re-located|0
2829351|NCT02713204|9699306|P3|From Week 12 up to Week 36|Participant Re-located|0
2829352|NCT02713204|9699307|P2|From Week 12 up to Week 36|Participant Re-located|0
2829353|NCT02713204|9699308|P1|From Week 12 up to Week 36|Participant Re-located|0
2829354|NCT02713204|9699301|P8|From Week 12 up to Week 36|Lost to Follow-up|0
2829355|NCT02713204|9699302|P7|From Week 12 up to Week 36|Lost to Follow-up|0
2829356|NCT02713204|9699303|P6|From Week 12 up to Week 36|Lost to Follow-up|0
2829357|NCT02713204|9699304|P5|From Week 12 up to Week 36|Lost to Follow-up|0
2829358|NCT02713204|9699305|P4|From Week 12 up to Week 36|Lost to Follow-up|2
2829359|NCT02713204|9699306|P3|From Week 12 up to Week 36|Lost to Follow-up|0
2829360|NCT02713204|9699307|P2|From Week 12 up to Week 36|Lost to Follow-up|0
2829361|NCT02713204|9699308|P1|From Week 12 up to Week 36|Lost to Follow-up|0
2829362|NCT02713204|9699301|P8|From Week 12 up to Week 36|Death|3
2829363|NCT02713204|9699302|P7|From Week 12 up to Week 36|Death|0
2829364|NCT02713204|9699303|P6|From Week 12 up to Week 36|Death|1
2829365|NCT02713204|9699304|P5|From Week 12 up to Week 36|Death|0
2829366|NCT02713204|9699305|P4|From Week 12 up to Week 36|Death|1
2829367|NCT02713204|9699306|P3|From Week 12 up to Week 36|Death|0
2829368|NCT02713204|9699307|P2|From Week 12 up to Week 36|Death|0
2829369|NCT02713204|9699308|P1|From Week 12 up to Week 36|Death|0
2829370|NCT02713204|9699301|P8|From Week 12 up to Week 36|Adverse Event|1
2829371|NCT02713204|9699302|P7|From Week 12 up to Week 36|Adverse Event|2
2829372|NCT02713204|9699303|P6|From Week 12 up to Week 36|Adverse Event|0
2829373|NCT02713204|9699304|P5|From Week 12 up to Week 36|Adverse Event|1
2829374|NCT02713204|9699305|P4|From Week 12 up to Week 36|Adverse Event|1
2829375|NCT02713204|9699306|P3|From Week 12 up to Week 36|Adverse Event|0
2829376|NCT02713204|9699307|P2|From Week 12 up to Week 36|Adverse Event|0
2829377|NCT02713204|9699308|P1|From Week 12 up to Week 36|Adverse Event|1
2829378|NCT02713204|9699301|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829379|NCT02713204|9699302|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829380|NCT02713204|9699303|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829381|NCT02713204|9699304|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829382|NCT02713204|9699305|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829383|NCT02713204|9699306|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829384|NCT02713204|9699307|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2829385|NCT02713204|9699308|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829386|NCT02713204|9699301|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829387|NCT02713204|9699302|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829388|NCT02713204|9699303|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829389|NCT02713204|9699304|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829390|NCT02713204|9699305|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829391|NCT02713204|9699306|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2829392|NCT02713204|9699307|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829393|NCT02713204|9699308|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829394|NCT02713204|9699301|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
2829395|NCT02713204|9699302|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
2829396|NCT02713204|9699303|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
2829397|NCT02713204|9699304|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
2829398|NCT02713204|9699305|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
2829399|NCT02713204|9699306|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
2829400|NCT02713204|9699307|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
2829401|NCT02713204|9699308|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
2829402|NCT02712788|9699367|P2|Overall Study|Protocol Violation|0
2829403|NCT02712788|9699368|P1|Overall Study|Protocol Violation|1
2829404|NCT02712788|9699367|P2|Overall Study|Physician Decision|0
2829405|NCT02712788|9699368|P1|Overall Study|Physician Decision|1
2829406|NCT02712554|9699378|P2|Part B: Treatment Phase|Other|1
2829407|NCT02712554|9699379|P1|Part B: Treatment Phase|Other|0
2829408|NCT02712554|9699378|P2|Part B: Treatment Phase|Withdrawal by Subject|1
2829409|NCT02712554|9699379|P1|Part B: Treatment Phase|Withdrawal by Subject|0
2829410|NCT02712554|9699378|P2|Part B: Treatment Phase|Adverse Event|1
2829411|NCT02712554|9699379|P1|Part B: Treatment Phase|Adverse Event|0
2829412|NCT02712554|9699378|P2|Part B: Qualification Phase|Adverse Event|1
2829413|NCT02712554|9699379|P1|Part B: Qualification Phase|Adverse Event|0
2829414|NCT02712554|9699378|P2|Part B: Qualification Phase|Withdrawal by Subject|3
2829415|NCT02712554|9699379|P1|Part B: Qualification Phase|Withdrawal by Subject|0
2829416|NCT02712554|9699378|P2|Part B: Qualification Phase|Sponsor Decision|4
2829417|NCT02712554|9699379|P1|Part B: Qualification Phase|Sponsor Decision|0
2829418|NCT02712554|9699378|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
2829419|NCT02712554|9699379|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
2829420|NCT02712333|9699524|P2|First Period|Withdrawal by Subject|2
2829421|NCT02712333|9699525|P1|First Period|Withdrawal by Subject|3
2829422|NCT02712320|9699543|P1|Overall Study|Treating with the prohibited medications|2
2829423|NCT02712320|9699543|P1|Overall Study|Transferred to another facility|1
2829424|NCT02712320|9699543|P1|Overall Study|Withdrawal by Subject|1
2829425|NCT02712320|9699543|P1|Overall Study|Lost to Follow-up|1
2829426|NCT02712008|9699586|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
2829427|NCT02712008|9699587|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
2829428|NCT02712008|9699588|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
2829429|NCT02712008|9699589|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
2829430|NCT02712008|9699590|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
2829431|NCT02712008|9699591|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
2829432|NCT02712008|9699592|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
2829433|NCT02712008|9699593|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
2829434|NCT02712008|9699586|P8|From Week 12 up to Week 36|Physician Decision|0
2829435|NCT02712008|9699587|P7|From Week 12 up to Week 36|Physician Decision|0
2829436|NCT02712008|9699588|P6|From Week 12 up to Week 36|Physician Decision|0
2829437|NCT02712008|9699589|P5|From Week 12 up to Week 36|Physician Decision|1
2829438|NCT02712008|9699590|P4|From Week 12 up to Week 36|Physician Decision|1
2829439|NCT02712008|9699591|P3|From Week 12 up to Week 36|Physician Decision|0
2829440|NCT02712008|9699592|P2|From Week 12 up to Week 36|Physician Decision|0
2829441|NCT02712008|9699593|P1|From Week 12 up to Week 36|Physician Decision|0
2829442|NCT02712008|9699586|P8|From Week 12 up to Week 36|Lost to Follow-up|0
2829443|NCT02712008|9699587|P7|From Week 12 up to Week 36|Lost to Follow-up|1
2829444|NCT02712008|9699588|P6|From Week 12 up to Week 36|Lost to Follow-up|0
2829445|NCT02712008|9699589|P5|From Week 12 up to Week 36|Lost to Follow-up|0
2829446|NCT02712008|9699590|P4|From Week 12 up to Week 36|Lost to Follow-up|1
2829447|NCT02712008|9699591|P3|From Week 12 up to Week 36|Lost to Follow-up|0
2829448|NCT02712008|9699592|P2|From Week 12 up to Week 36|Lost to Follow-up|0
2829449|NCT02712008|9699593|P1|From Week 12 up to Week 36|Lost to Follow-up|0
2829450|NCT02712008|9699586|P8|From Week 12 up to Week 36|Death|0
2829451|NCT02712008|9699587|P7|From Week 12 up to Week 36|Death|1
2829452|NCT02712008|9699588|P6|From Week 12 up to Week 36|Death|0
2829453|NCT02712008|9699589|P5|From Week 12 up to Week 36|Death|0
2829454|NCT02712008|9699590|P4|From Week 12 up to Week 36|Death|0
2829455|NCT02712008|9699591|P3|From Week 12 up to Week 36|Death|0
2829456|NCT02712008|9699592|P2|From Week 12 up to Week 36|Death|0
2829457|NCT02712008|9699593|P1|From Week 12 up to Week 36|Death|1
2829458|NCT02712008|9699586|P8|From Week 12 up to Week 36|Adverse Event|2
2829459|NCT02712008|9699587|P7|From Week 12 up to Week 36|Adverse Event|0
2829460|NCT02712008|9699588|P6|From Week 12 up to Week 36|Adverse Event|0
2829461|NCT02712008|9699589|P5|From Week 12 up to Week 36|Adverse Event|1
2829462|NCT02712008|9699590|P4|From Week 12 up to Week 36|Adverse Event|0
2829463|NCT02712008|9699591|P3|From Week 12 up to Week 36|Adverse Event|0
2829464|NCT02712008|9699592|P2|From Week 12 up to Week 36|Adverse Event|0
2829465|NCT02712008|9699593|P1|From Week 12 up to Week 36|Adverse Event|0
2829466|NCT02712008|9699586|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829467|NCT02712008|9699587|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829468|NCT02712008|9699588|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829469|NCT02712008|9699589|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829470|NCT02712008|9699590|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829471|NCT02712008|9699591|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829472|NCT02712008|9699592|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
2829473|NCT02712008|9699593|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
2829474|NCT02712008|9699586|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829475|NCT02712008|9699587|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829476|NCT02712008|9699588|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829477|NCT02712008|9699589|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829478|NCT02712008|9699590|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829479|NCT02712008|9699591|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
2829480|NCT02712008|9699592|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829481|NCT02712008|9699593|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
2829482|NCT02712008|9699586|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829483|NCT02712008|9699587|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829484|NCT02712008|9699588|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829485|NCT02712008|9699589|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829486|NCT02712008|9699590|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829487|NCT02712008|9699591|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
2829488|NCT02712008|9699592|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2829489|NCT02712008|9699593|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2829490|NCT02712008|9699586|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829491|NCT02712008|9699587|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829492|NCT02712008|9699588|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829493|NCT02712008|9699589|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829494|NCT02712008|9699590|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829495|NCT02712008|9699591|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2829496|NCT02712008|9699592|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
2829497|NCT02712008|9699593|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2829498|NCT02712008|9699586|P8|Baseline (Day 1) up to Week 12|Death|0
2829499|NCT02712008|9699587|P7|Baseline (Day 1) up to Week 12|Death|0
2829500|NCT02712008|9699588|P6|Baseline (Day 1) up to Week 12|Death|0
2829501|NCT02712008|9699589|P5|Baseline (Day 1) up to Week 12|Death|0
2829502|NCT02712008|9699590|P4|Baseline (Day 1) up to Week 12|Death|0
2829503|NCT02712008|9699591|P3|Baseline (Day 1) up to Week 12|Death|0
2829504|NCT02712008|9699592|P2|Baseline (Day 1) up to Week 12|Death|0
2829505|NCT02712008|9699593|P1|Baseline (Day 1) up to Week 12|Death|3
2829506|NCT02711995|9699625|P1|Washout (90 Days)|Conflicting medication|1
2829507|NCT02711800|9699664|P1|Overall Study|Withdrawal by Subject|1
2829508|NCT02711800|9699664|P1|Overall Study|Lost to Follow-up|1
2829509|NCT02711345|9699683|P10|Overall Study|Death|0
2829510|NCT02711345|9699684|P9|Overall Study|Death|0
2829511|NCT02711345|9699685|P8|Overall Study|Death|1
2829512|NCT02711345|9699686|P7|Overall Study|Death|0
2829513|NCT02711345|9699687|P6|Overall Study|Death|0
2829514|NCT02711345|9699688|P5|Overall Study|Death|0
2829515|NCT02711345|9699689|P4|Overall Study|Death|0
2829516|NCT02711345|9699690|P3|Overall Study|Death|0
2829517|NCT02711345|9699691|P2|Overall Study|Death|0
2829518|NCT02711345|9699692|P1|Overall Study|Death|1
2829519|NCT02711345|9699683|P10|Overall Study|Subject/guardian decision|4
2829520|NCT02711345|9699684|P9|Overall Study|Subject/guardian decision|0
2829521|NCT02711345|9699685|P8|Overall Study|Subject/guardian decision|1
2829522|NCT02711345|9699686|P7|Overall Study|Subject/guardian decision|3
2829523|NCT02711345|9699687|P6|Overall Study|Subject/guardian decision|2
2829524|NCT02711345|9699688|P5|Overall Study|Subject/guardian decision|0
2829525|NCT02711345|9699689|P4|Overall Study|Subject/guardian decision|0
2829526|NCT02711345|9699690|P3|Overall Study|Subject/guardian decision|0
2829527|NCT02711345|9699691|P2|Overall Study|Subject/guardian decision|0
2829528|NCT02711345|9699692|P1|Overall Study|Subject/guardian decision|0
2829529|NCT02711345|9699683|P10|Overall Study|Progressive disease|6
2829530|NCT02711345|9699684|P9|Overall Study|Progressive disease|5
2829531|NCT02711345|9699685|P8|Overall Study|Progressive disease|4
2829532|NCT02711345|9699686|P7|Overall Study|Progressive disease|8
2829533|NCT02711345|9699687|P6|Overall Study|Progressive disease|2
2829534|NCT02711345|9699688|P5|Overall Study|Progressive disease|7
2829535|NCT02711345|9699689|P4|Overall Study|Progressive disease|3
2829536|NCT02711345|9699690|P3|Overall Study|Progressive disease|5
2829537|NCT02711345|9699691|P2|Overall Study|Progressive disease|3
2829538|NCT02711345|9699692|P1|Overall Study|Progressive disease|1
2829539|NCT02711345|9699683|P10|Overall Study|Physician Decision|0
2829540|NCT02711345|9699684|P9|Overall Study|Physician Decision|1
2829541|NCT02711345|9699685|P8|Overall Study|Physician Decision|0
2829542|NCT02711345|9699686|P7|Overall Study|Physician Decision|0
2829543|NCT02711345|9699687|P6|Overall Study|Physician Decision|0
2829544|NCT02711345|9699688|P5|Overall Study|Physician Decision|0
2829545|NCT02711345|9699689|P4|Overall Study|Physician Decision|0
2829546|NCT02711345|9699690|P3|Overall Study|Physician Decision|1
2829547|NCT02711345|9699691|P2|Overall Study|Physician Decision|0
2829548|NCT02711345|9699692|P1|Overall Study|Physician Decision|0
2829549|NCT02711345|9699683|P10|Overall Study|Adverse Event|2
2829550|NCT02711345|9699684|P9|Overall Study|Adverse Event|0
2829551|NCT02711345|9699685|P8|Overall Study|Adverse Event|0
2829552|NCT02711345|9699686|P7|Overall Study|Adverse Event|1
2829553|NCT02711345|9699687|P6|Overall Study|Adverse Event|2
2829554|NCT02711345|9699688|P5|Overall Study|Adverse Event|1
2829555|NCT02711345|9699689|P4|Overall Study|Adverse Event|1
2829556|NCT02711345|9699690|P3|Overall Study|Adverse Event|0
2829557|NCT02711345|9699691|P2|Overall Study|Adverse Event|0
2829558|NCT02711345|9699692|P1|Overall Study|Adverse Event|0
2829559|NCT02711306|9699878|P2|Overall Study|Withdrawal by Subject|2
2829560|NCT02711306|9699879|P1|Overall Study|Withdrawal by Subject|2
2829561|NCT02710422|9700061|P2|Overall Study|Termination of study|9
2829562|NCT02710422|9700062|P1|Overall Study|Termination of study|9
2829563|NCT02710292|9700078|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
2829564|NCT02710292|9700079|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
2829565|NCT02710292|9700078|P2|Period 1, First 10 Days of Wear|Adverse Event|1
2829566|NCT02710292|9700079|P1|Period 1, First 10 Days of Wear|Adverse Event|0
2829567|NCT02710136|9700088|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
2829568|NCT02710136|9700089|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
2829569|NCT02710045|9700115|P3|Overall Study|Poor Attendance|0
2829570|NCT02710045|9700116|P2|Overall Study|Poor Attendance|1
2829571|NCT02710045|9700117|P1|Overall Study|Poor Attendance|0
2829572|NCT02710045|9700115|P3|Overall Study|Physician Decision|1
2829573|NCT02710045|9700116|P2|Overall Study|Physician Decision|0
2829574|NCT02710045|9700117|P1|Overall Study|Physician Decision|0
2829575|NCT02710045|9700115|P3|Overall Study|Lost to Follow-up|7
2829576|NCT02710045|9700116|P2|Overall Study|Lost to Follow-up|6
2829577|NCT02710045|9700117|P1|Overall Study|Lost to Follow-up|3
2829578|NCT02710045|9700115|P3|Overall Study|Protocol Violation|3
2829579|NCT02710045|9700116|P2|Overall Study|Protocol Violation|2
2829580|NCT02710045|9700117|P1|Overall Study|Protocol Violation|1
2829581|NCT02710045|9700115|P3|Overall Study|Withdrawal by Subject|2
2829582|NCT02710045|9700116|P2|Overall Study|Withdrawal by Subject|6
2829583|NCT02710045|9700117|P1|Overall Study|Withdrawal by Subject|6
2829584|NCT02710045|9700115|P3|Overall Study|Death|0
2829585|NCT02710045|9700116|P2|Overall Study|Death|2
2829586|NCT02710045|9700117|P1|Overall Study|Death|1
2829587|NCT02709785|9700146|P3|Overall Study|Withdrawal by Subject|1
2829588|NCT02709785|9700147|P2|Overall Study|Withdrawal by Subject|2
2829589|NCT02709785|9700148|P1|Overall Study|Withdrawal by Subject|1
2829590|NCT02709577|9700170|P4|Overall Study|Withdrawal by Subject|0
2829591|NCT02709577|9700171|P3|Overall Study|Withdrawal by Subject|2
2829592|NCT02709577|9700172|P2|Overall Study|Withdrawal by Subject|3
2829593|NCT02709577|9700173|P1|Overall Study|Withdrawal by Subject|2
2829594|NCT02709577|9700170|P4|Overall Study|procedural complication|0
2829595|NCT02709577|9700171|P3|Overall Study|procedural complication|0
2829596|NCT02709577|9700172|P2|Overall Study|procedural complication|1
2829597|NCT02709577|9700173|P1|Overall Study|procedural complication|0
2829598|NCT02709577|9700170|P4|Overall Study|non-accommodating anatomy|0
2829599|NCT02709577|9700171|P3|Overall Study|non-accommodating anatomy|0
2829600|NCT02709577|9700172|P2|Overall Study|non-accommodating anatomy|1
2829601|NCT02709577|9700173|P1|Overall Study|non-accommodating anatomy|0
2829602|NCT02709538|9700188|P3|Overall Study|Other|5
2829603|NCT02709538|9700189|P2|Overall Study|Other|7
2829604|NCT02709538|9700190|P1|Overall Study|Other|16
2829605|NCT02709538|9700188|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
2829606|NCT02709538|9700189|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
2829607|NCT02709538|9700190|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
2829608|NCT02709538|9700188|P3|Overall Study|Protocol deviation|4
2829609|NCT02709538|9700189|P2|Overall Study|Protocol deviation|4
2829610|NCT02709538|9700190|P1|Overall Study|Protocol deviation|10
2829611|NCT02709538|9700188|P3|Overall Study|Non-compliance with study drug|0
2829612|NCT02709538|9700189|P2|Overall Study|Non-compliance with study drug|0
2829613|NCT02709538|9700190|P1|Overall Study|Non-compliance with study drug|2
2829614|NCT02709538|9700188|P3|Overall Study|Non-compliance with study procedures|0
2829615|NCT02709538|9700189|P2|Overall Study|Non-compliance with study procedures|0
2829616|NCT02709538|9700190|P1|Overall Study|Non-compliance with study procedures|5
2829617|NCT02709538|9700188|P3|Overall Study|Withdrawal by Subject|4
2829618|NCT02709538|9700189|P2|Overall Study|Withdrawal by Subject|7
2829619|NCT02709538|9700190|P1|Overall Study|Withdrawal by Subject|40
2829620|NCT02709538|9700188|P3|Overall Study|Physician Decision|0
2829621|NCT02709538|9700189|P2|Overall Study|Physician Decision|0
2829622|NCT02709538|9700190|P1|Overall Study|Physician Decision|1
2829623|NCT02709538|9700188|P3|Overall Study|Lost to Follow-up|4
2829624|NCT02709538|9700189|P2|Overall Study|Lost to Follow-up|8
2829625|NCT02709538|9700190|P1|Overall Study|Lost to Follow-up|24
2829626|NCT02709538|9700188|P3|Overall Study|Lack of Efficacy|0
2829627|NCT02709538|9700189|P2|Overall Study|Lack of Efficacy|0
2829628|NCT02709538|9700190|P1|Overall Study|Lack of Efficacy|1
2829629|NCT02709538|9700188|P3|Overall Study|Adverse Event|3
2829630|NCT02709538|9700189|P2|Overall Study|Adverse Event|2
2829631|NCT02709538|9700190|P1|Overall Study|Adverse Event|13
2829632|NCT02709486|9700201|P3|Overall Study|Withdrawal by Subject|32
2829633|NCT02709486|9700202|P2|Overall Study|Withdrawal by Subject|22
2829634|NCT02709486|9700203|P1|Overall Study|Withdrawal by Subject|32
2829635|NCT02709486|9700201|P3|Overall Study|Other|3
2829636|NCT02709486|9700202|P2|Overall Study|Other|2
2829637|NCT02709486|9700203|P1|Overall Study|Other|0
2829638|NCT02709486|9700201|P3|Overall Study|Lost to Follow-up|2
2829639|NCT02709486|9700202|P2|Overall Study|Lost to Follow-up|2
2829640|NCT02709486|9700203|P1|Overall Study|Lost to Follow-up|3
2829641|NCT02709486|9700201|P3|Overall Study|Insufficient clinical response|3
2829642|NCT02709486|9700202|P2|Overall Study|Insufficient clinical response|3
2829643|NCT02709486|9700203|P1|Overall Study|Insufficient clinical response|7
2829644|NCT02709486|9700201|P3|Overall Study|Death|2
2829645|NCT02709486|9700202|P2|Overall Study|Death|0
2829646|NCT02709486|9700203|P1|Overall Study|Death|0
2829647|NCT02709486|9700201|P3|Overall Study|Adverse Event|3
2829648|NCT02709486|9700202|P2|Overall Study|Adverse Event|5
2829649|NCT02709486|9700203|P1|Overall Study|Adverse Event|2
2829650|NCT02709369|9700394|P1|Overall Study|Did not received intervention|2
2829651|NCT02709369|9700394|P1|Overall Study|Withdrawal by Subject|10
2829652|NCT02709369|9700394|P1|Overall Study|Lost to Follow-up|15
2829653|NCT02709330|9700428|P2|Overall Study|Withdrawal by Subject|0
2829654|NCT02709330|9700429|P1|Overall Study|Withdrawal by Subject|4
2829655|NCT02709330|9700428|P2|Overall Study|Physician Decision|0
2829656|NCT02709330|9700429|P1|Overall Study|Physician Decision|2
2829657|NCT02709330|9700428|P2|Overall Study|Lost to Follow-up|0
2829658|NCT02709330|9700429|P1|Overall Study|Lost to Follow-up|2
2829659|NCT02709330|9700428|P2|Overall Study|Death|0
2829660|NCT02709330|9700429|P1|Overall Study|Death|5
2829661|NCT02709096|9700443|P2|Overall Study|non-compliance|1
2829662|NCT02709096|9700444|P1|Overall Study|non-compliance|1
2829663|NCT02709083|9700450|P1|Overall Study|Original PI left institution|7
2829664|NCT02709005|9700463|P2|Overall Study|Withdrawal by Subject|0
2829665|NCT02709005|9700464|P1|Overall Study|Withdrawal by Subject|3
2829666|NCT02709005|9700463|P2|Overall Study|Lost to Follow-up|1
2829667|NCT02709005|9700464|P1|Overall Study|Lost to Follow-up|1
2829668|NCT02708524|9700522|P4|Overall Study|Subject lost study lens|0
2829669|NCT02708524|9700523|P3|Overall Study|Subject lost study lens|0
2829670|NCT02708524|9700524|P2|Overall Study|Subject lost study lens|0
2829671|NCT02708524|9700525|P1|Overall Study|Subject lost study lens|1
2829672|NCT02708524|9700522|P4|Overall Study|Did not wear lens at final visit|0
2829673|NCT02708524|9700523|P3|Overall Study|Did not wear lens at final visit|0
2829674|NCT02708524|9700524|P2|Overall Study|Did not wear lens at final visit|1
2829675|NCT02708524|9700525|P1|Overall Study|Did not wear lens at final visit|0
2829676|NCT02708524|9700522|P4|Overall Study|Dispensed incorrect study lens|0
2829677|NCT02708524|9700523|P3|Overall Study|Dispensed incorrect study lens|1
2829678|NCT02708524|9700524|P2|Overall Study|Dispensed incorrect study lens|1
2829679|NCT02708524|9700525|P1|Overall Study|Dispensed incorrect study lens|0
2829680|NCT02708524|9700522|P4|Overall Study|Withdrawal by Subject|0
2829681|NCT02708524|9700523|P3|Overall Study|Withdrawal by Subject|0
2829682|NCT02708524|9700524|P2|Overall Study|Withdrawal by Subject|1
2829683|NCT02708524|9700525|P1|Overall Study|Withdrawal by Subject|1
2829684|NCT02708524|9700522|P4|Overall Study|Protocol Violation|0
2829685|NCT02708524|9700523|P3|Overall Study|Protocol Violation|0
2829686|NCT02708524|9700524|P2|Overall Study|Protocol Violation|1
2829687|NCT02708524|9700525|P1|Overall Study|Protocol Violation|0
2829688|NCT02708524|9700522|P4|Overall Study|Lost to Follow-up|0
2829689|NCT02708524|9700523|P3|Overall Study|Lost to Follow-up|1
2829690|NCT02708524|9700524|P2|Overall Study|Lost to Follow-up|1
2829691|NCT02708524|9700525|P1|Overall Study|Lost to Follow-up|1
2829692|NCT02708524|9700522|P4|Overall Study|Lens Discomfort|0
2829693|NCT02708524|9700523|P3|Overall Study|Lens Discomfort|1
2829694|NCT02708524|9700524|P2|Overall Study|Lens Discomfort|0
2829695|NCT02708524|9700525|P1|Overall Study|Lens Discomfort|1
2829696|NCT02708524|9700522|P4|Overall Study|Adverse Event|0
2829697|NCT02708524|9700523|P3|Overall Study|Adverse Event|0
2829698|NCT02708524|9700524|P2|Overall Study|Adverse Event|1
2829699|NCT02708524|9700525|P1|Overall Study|Adverse Event|0
2829700|NCT02708485|9700573|P2|Overall Study|Withdrawal by Subject|2
2829701|NCT02708485|9700574|P1|Overall Study|Withdrawal by Subject|3
2829702|NCT02708355|9700594|P3|Overall Study|Adverse Event|0
2829703|NCT02708355|9700595|P2|Overall Study|Adverse Event|0
2829704|NCT02708355|9700596|P1|Overall Study|Adverse Event|1
2829705|NCT02708277|9700620|P2|Overall Study|Lost to Follow-up|4
2829706|NCT02708277|9700621|P1|Overall Study|Lost to Follow-up|7
2829707|NCT02708121|9700673|P2|Overall Study|Withdrawal by Subject|4
2829708|NCT02708121|9700674|P1|Overall Study|Withdrawal by Subject|0
2829709|NCT02708121|9700673|P2|Overall Study|Withdrawn by Study Team|1
2829710|NCT02708121|9700674|P1|Overall Study|Withdrawn by Study Team|1
2829711|NCT02708095|9700686|P3|Overall Study|Withdrawal by Subject|4
2829712|NCT02708095|9700687|P2|Overall Study|Withdrawal by Subject|3
2829713|NCT02708095|9700688|P1|Overall Study|Withdrawal by Subject|5
2829714|NCT02708095|9700686|P3|Overall Study|Protocol Violation|1
2829715|NCT02708095|9700687|P2|Overall Study|Protocol Violation|0
2829716|NCT02708095|9700688|P1|Overall Study|Protocol Violation|0
2829717|NCT02708095|9700686|P3|Overall Study|Physician Decision|2
2829718|NCT02708095|9700687|P2|Overall Study|Physician Decision|3
2829719|NCT02708095|9700688|P1|Overall Study|Physician Decision|2
2829720|NCT02708095|9700686|P3|Overall Study|Lost to Follow-up|0
2829721|NCT02708095|9700687|P2|Overall Study|Lost to Follow-up|0
2829722|NCT02708095|9700688|P1|Overall Study|Lost to Follow-up|2
2829723|NCT02708095|9700686|P3|Overall Study|Lack of Efficacy|0
2829724|NCT02708095|9700687|P2|Overall Study|Lack of Efficacy|3
2829725|NCT02708095|9700688|P1|Overall Study|Lack of Efficacy|9
2829726|NCT02708095|9700686|P3|Overall Study|Adverse Event|11
2829727|NCT02708095|9700687|P2|Overall Study|Adverse Event|10
2829728|NCT02708095|9700688|P1|Overall Study|Adverse Event|4
2829729|NCT02707991|9700711|P2|Overall Study|Became ineligible|1
2829730|NCT02707991|9700712|P1|Overall Study|Became ineligible|0
2829731|NCT02707991|9700711|P2|Overall Study|Protocol Violation|0
2829732|NCT02707991|9700712|P1|Overall Study|Protocol Violation|1
2829733|NCT02707965|9700729|P16|Overall Study|Protocol deviation|0
2829734|NCT02707965|9700730|P15|Overall Study|Protocol deviation|0
2829735|NCT02707965|9700731|P14|Overall Study|Protocol deviation|0
2829736|NCT02707965|9700732|P13|Overall Study|Protocol deviation|0
2829737|NCT02707965|9700733|P12|Overall Study|Protocol deviation|0
2829738|NCT02707965|9700734|P11|Overall Study|Protocol deviation|0
2829739|NCT02707965|9700735|P10|Overall Study|Protocol deviation|0
2829740|NCT02707965|9700736|P9|Overall Study|Protocol deviation|0
2829741|NCT02707965|9700737|P8|Overall Study|Protocol deviation|1
2829742|NCT02707965|9700738|P7|Overall Study|Protocol deviation|0
2829743|NCT02707965|9700739|P6|Overall Study|Protocol deviation|0
2829744|NCT02707965|9700740|P5|Overall Study|Protocol deviation|0
2829745|NCT02707965|9700741|P4|Overall Study|Protocol deviation|0
2829746|NCT02707965|9700742|P3|Overall Study|Protocol deviation|0
2829747|NCT02707965|9700743|P2|Overall Study|Protocol deviation|1
2829748|NCT02707965|9700744|P1|Overall Study|Protocol deviation|1
2829749|NCT02707965|9700729|P16|Overall Study|PI decisions|0
2829750|NCT02707965|9700730|P15|Overall Study|PI decisions|2
2829751|NCT02707965|9700731|P14|Overall Study|PI decisions|0
2829752|NCT02707965|9700732|P13|Overall Study|PI decisions|0
2829753|NCT02707965|9700733|P12|Overall Study|PI decisions|0
2829754|NCT02707965|9700734|P11|Overall Study|PI decisions|0
2829755|NCT02707965|9700735|P10|Overall Study|PI decisions|0
2829756|NCT02707965|9700736|P9|Overall Study|PI decisions|0
2829757|NCT02707965|9700737|P8|Overall Study|PI decisions|0
2829758|NCT02707965|9700738|P7|Overall Study|PI decisions|0
2829759|NCT02707965|9700739|P6|Overall Study|PI decisions|0
2829760|NCT02707965|9700740|P5|Overall Study|PI decisions|0
2829761|NCT02707965|9700741|P4|Overall Study|PI decisions|0
2829762|NCT02707965|9700742|P3|Overall Study|PI decisions|0
2829763|NCT02707965|9700743|P2|Overall Study|PI decisions|0
2829764|NCT02707965|9700744|P1|Overall Study|PI decisions|0
2829765|NCT02707965|9700729|P16|Overall Study|Withdrawal by Subject|0
2829766|NCT02707965|9700730|P15|Overall Study|Withdrawal by Subject|0
2829767|NCT02707965|9700731|P14|Overall Study|Withdrawal by Subject|0
2829768|NCT02707965|9700732|P13|Overall Study|Withdrawal by Subject|0
2829769|NCT02707965|9700733|P12|Overall Study|Withdrawal by Subject|0
2829770|NCT02707965|9700734|P11|Overall Study|Withdrawal by Subject|0
2829771|NCT02707965|9700735|P10|Overall Study|Withdrawal by Subject|0
2829772|NCT02707965|9700736|P9|Overall Study|Withdrawal by Subject|0
2829773|NCT02707965|9700737|P8|Overall Study|Withdrawal by Subject|2
2829774|NCT02707965|9700738|P7|Overall Study|Withdrawal by Subject|0
2829775|NCT02707965|9700739|P6|Overall Study|Withdrawal by Subject|0
2829776|NCT02707965|9700740|P5|Overall Study|Withdrawal by Subject|0
2829777|NCT02707965|9700741|P4|Overall Study|Withdrawal by Subject|0
2829778|NCT02707965|9700742|P3|Overall Study|Withdrawal by Subject|1
2829779|NCT02707965|9700743|P2|Overall Study|Withdrawal by Subject|0
2829780|NCT02707965|9700744|P1|Overall Study|Withdrawal by Subject|0
2829781|NCT02707952|9700796|P4|Overall Study|Withdrawal by Subject|0
2829782|NCT02707952|9700797|P3|Overall Study|Withdrawal by Subject|2
2829783|NCT02707952|9700798|P2|Overall Study|Withdrawal by Subject|1
2829784|NCT02707952|9700799|P1|Overall Study|Withdrawal by Subject|0
2829785|NCT02707952|9700796|P4|Overall Study|Lost to Follow-up|0
2829786|NCT02707952|9700797|P3|Overall Study|Lost to Follow-up|0
2829787|NCT02707952|9700798|P2|Overall Study|Lost to Follow-up|0
2829788|NCT02707952|9700799|P1|Overall Study|Lost to Follow-up|1
2829789|NCT02707952|9700796|P4|Overall Study|Adverse Event|0
2829790|NCT02707952|9700797|P3|Overall Study|Adverse Event|0
2829791|NCT02707952|9700798|P2|Overall Study|Adverse Event|0
2829792|NCT02707952|9700799|P1|Overall Study|Adverse Event|1
2829793|NCT02707640|9700820|P2|Overall Study|Sponsor Discretion|0
2829794|NCT02707640|9700821|P1|Overall Study|Sponsor Discretion|1
2829795|NCT02707640|9700820|P2|Overall Study|Participant's Personal Decision|2
2829796|NCT02707640|9700821|P1|Overall Study|Participant's Personal Decision|1
2829797|NCT02707640|9700820|P2|Overall Study|Withdrawal by Subject|1
2829798|NCT02707640|9700821|P1|Overall Study|Withdrawal by Subject|0
2829799|NCT02707640|9700820|P2|Overall Study|Physician Decision|0
2829800|NCT02707640|9700821|P1|Overall Study|Physician Decision|2
2829801|NCT02707640|9700820|P2|Overall Study|Death|2
2829802|NCT02707640|9700821|P1|Overall Study|Death|1
2829803|NCT02707640|9700820|P2|Overall Study|Adverse Event|2
2829804|NCT02707640|9700821|P1|Overall Study|Adverse Event|4
2829805|NCT02707601|9700841|P2|Overall Study|Participants Randomized but Not Treated|0
2829806|NCT02707601|9700842|P1|Overall Study|Participants Randomized but Not Treated|2
2829807|NCT02707601|9700841|P2|Overall Study|Lost to Follow-up|1
2829808|NCT02707601|9700842|P1|Overall Study|Lost to Follow-up|1
2829809|NCT02707601|9700841|P2|Overall Study|Withdrew Consent|1
2829810|NCT02707601|9700842|P1|Overall Study|Withdrew Consent|0
2829811|NCT02707601|9700841|P2|Overall Study|Investigator's Discretion|0
2829812|NCT02707601|9700842|P1|Overall Study|Investigator's Discretion|1
2829813|NCT02707601|9700841|P2|Overall Study|Lack of Efficacy|1
2829814|NCT02707601|9700842|P1|Overall Study|Lack of Efficacy|0
2829815|NCT02707601|9700841|P2|Overall Study|Death|1
2829816|NCT02707601|9700842|P1|Overall Study|Death|0
2829817|NCT02706951|9700931|P3|Overall Study|Other|0
2829818|NCT02706951|9700932|P2|Overall Study|Other|1
2829819|NCT02706951|9700933|P1|Overall Study|Other|2
2829820|NCT02706951|9700931|P3|Overall Study|Lost to Follow-up|1
2829821|NCT02706951|9700932|P2|Overall Study|Lost to Follow-up|4
2829822|NCT02706951|9700933|P1|Overall Study|Lost to Follow-up|0
2829823|NCT02706951|9700931|P3|Overall Study|Withdrawal by Subject|6
2829824|NCT02706951|9700932|P2|Overall Study|Withdrawal by Subject|6
2829825|NCT02706951|9700933|P1|Overall Study|Withdrawal by Subject|11
2829826|NCT02706951|9700931|P3|Overall Study|Adverse Event|3
2829827|NCT02706951|9700932|P2|Overall Study|Adverse Event|5
2829828|NCT02706951|9700933|P1|Overall Study|Adverse Event|1
2829829|NCT02706938|9700967|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
2829830|NCT02706938|9700968|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
2829831|NCT02706938|9700967|P2|Second Period, 6 Weeks|Adverse Event|7
2829832|NCT02706938|9700968|P1|Second Period, 6 Weeks|Adverse Event|0
2829833|NCT02706938|9700967|P2|First Period, 6 Weeks|Withdrawal by Subject|0
2829834|NCT02706938|9700968|P1|First Period, 6 Weeks|Withdrawal by Subject|1
2829835|NCT02706938|9700967|P2|First Period, 6 Weeks|Lost to Follow-up|2
2829836|NCT02706938|9700968|P1|First Period, 6 Weeks|Lost to Follow-up|2
2829837|NCT02706938|9700967|P2|First Period, 6 Weeks|Adverse Event|0
2829838|NCT02706938|9700968|P1|First Period, 6 Weeks|Adverse Event|8
2829839|NCT02706899|9701032|P2|Overall Study|Study Termination by Sponsor|6
2829840|NCT02706899|9701033|P1|Overall Study|Study Termination by Sponsor|4
2829841|NCT02706899|9701032|P2|Overall Study|Death|0
2829842|NCT02706899|9701033|P1|Overall Study|Death|8
2829843|NCT02706899|9701032|P2|Overall Study|Withdrawal by Subject|0
2829844|NCT02706899|9701033|P1|Overall Study|Withdrawal by Subject|1
2829845|NCT02706886|9701064|P9|Part A: SAD Period|Withdrawal by Subject|0
2829846|NCT02706886|9701065|P8|Part A: SAD Period|Withdrawal by Subject|0
2829847|NCT02706886|9701066|P7|Part A: SAD Period|Withdrawal by Subject|0
2829848|NCT02706886|9701067|P6|Part A: SAD Period|Withdrawal by Subject|0
2829849|NCT02706886|9701068|P5|Part A: SAD Period|Withdrawal by Subject|0
2829850|NCT02706886|9701069|P4|Part A: SAD Period|Withdrawal by Subject|2
2829851|NCT02706886|9701070|P3|Part A: SAD Period|Withdrawal by Subject|0
2829852|NCT02706886|9701071|P2|Part A: SAD Period|Withdrawal by Subject|0
2829853|NCT02706886|9701072|P1|Part A: SAD Period|Withdrawal by Subject|0
2829854|NCT02706873|9701189|P4|Overall Study|Ongoing|1
2829855|NCT02706873|9701190|P3|Overall Study|Ongoing|0
2829856|NCT02706873|9701191|P2|Overall Study|Ongoing|0
2829857|NCT02706873|9701192|P1|Overall Study|Ongoing|0
2829858|NCT02706873|9701189|P4|Overall Study|Not Dosed|1
2829859|NCT02706873|9701190|P3|Overall Study|Not Dosed|0
2829860|NCT02706873|9701191|P2|Overall Study|Not Dosed|0
2829861|NCT02706873|9701192|P1|Overall Study|Not Dosed|1
2829862|NCT02706873|9701189|P4|Overall Study|Other|3
2829863|NCT02706873|9701190|P3|Overall Study|Other|2
2829864|NCT02706873|9701191|P2|Overall Study|Other|1
2829865|NCT02706873|9701192|P1|Overall Study|Other|5
2829866|NCT02706873|9701189|P4|Overall Study|Lack of Efficacy|3
2829867|NCT02706873|9701190|P3|Overall Study|Lack of Efficacy|0
2829868|NCT02706873|9701191|P2|Overall Study|Lack of Efficacy|0
2829869|NCT02706873|9701192|P1|Overall Study|Lack of Efficacy|10
2829870|NCT02706873|9701189|P4|Overall Study|Lost to Follow-up|2
2829871|NCT02706873|9701190|P3|Overall Study|Lost to Follow-up|4
2829872|NCT02706873|9701191|P2|Overall Study|Lost to Follow-up|0
2829873|NCT02706873|9701192|P1|Overall Study|Lost to Follow-up|3
2829874|NCT02706873|9701189|P4|Overall Study|Withdrawal by Subject|11
2829875|NCT02706873|9701190|P3|Overall Study|Withdrawal by Subject|8
2829876|NCT02706873|9701191|P2|Overall Study|Withdrawal by Subject|0
2829877|NCT02706873|9701192|P1|Overall Study|Withdrawal by Subject|15
2829878|NCT02706873|9701189|P4|Overall Study|Adverse Event|12
2829879|NCT02706873|9701190|P3|Overall Study|Adverse Event|13
2829880|NCT02706873|9701191|P2|Overall Study|Adverse Event|3
2829881|NCT02706873|9701192|P1|Overall Study|Adverse Event|13
2829882|NCT02706847|9701292|P4|Week 12 to Week 24|Other|4
2829883|NCT02706847|9701293|P3|Week 12 to Week 24|Other|1
2829884|NCT02706847|9701294|P2|Week 12 to Week 24|Other|0
2829885|NCT02706847|9701295|P1|Week 12 to Week 24|Other|1
2829886|NCT02706847|9701292|P4|Week 12 to Week 24|Lost to Follow-up|1
2829887|NCT02706847|9701293|P3|Week 12 to Week 24|Lost to Follow-up|0
2829888|NCT02706847|9701294|P2|Week 12 to Week 24|Lost to Follow-up|0
2829889|NCT02706847|9701295|P1|Week 12 to Week 24|Lost to Follow-up|0
2829890|NCT02706847|9701292|P4|Week 12 to Week 24|Withdrawal by Subject|4
2829891|NCT02706847|9701293|P3|Week 12 to Week 24|Withdrawal by Subject|1
2829892|NCT02706847|9701294|P2|Week 12 to Week 24|Withdrawal by Subject|0
2829893|NCT02706847|9701295|P1|Week 12 to Week 24|Withdrawal by Subject|1
2829894|NCT02706847|9701292|P4|Week 12 to Week 24|Adverse Event|5
2829895|NCT02706847|9701293|P3|Week 12 to Week 24|Adverse Event|2
2829896|NCT02706847|9701294|P2|Week 12 to Week 24|Adverse Event|2
2829897|NCT02706847|9701295|P1|Week 12 to Week 24|Adverse Event|1
2829898|NCT02706847|9701292|P4|Day 1 to Week 12|Randomized in Error|0
2829899|NCT02706847|9701293|P3|Day 1 to Week 12|Randomized in Error|1
2829900|NCT02706847|9701294|P2|Day 1 to Week 12|Randomized in Error|0
2829901|NCT02706847|9701295|P1|Day 1 to Week 12|Randomized in Error|0
2829902|NCT02706847|9701292|P4|Day 1 to Week 12|Other|2
2829903|NCT02706847|9701293|P3|Day 1 to Week 12|Other|2
2829904|NCT02706847|9701294|P2|Day 1 to Week 12|Other|4
2829905|NCT02706847|9701295|P1|Day 1 to Week 12|Other|4
2829906|NCT02706847|9701292|P4|Day 1 to Week 12|Lost to Follow-up|0
2829907|NCT02706847|9701293|P3|Day 1 to Week 12|Lost to Follow-up|0
2829908|NCT02706847|9701294|P2|Day 1 to Week 12|Lost to Follow-up|1
2829909|NCT02706847|9701295|P1|Day 1 to Week 12|Lost to Follow-up|2
2829910|NCT02706847|9701292|P4|Day 1 to Week 12|Withdrawal by Subject|2
2829911|NCT02706847|9701293|P3|Day 1 to Week 12|Withdrawal by Subject|4
2829912|NCT02706847|9701294|P2|Day 1 to Week 12|Withdrawal by Subject|1
2829913|NCT02706847|9701295|P1|Day 1 to Week 12|Withdrawal by Subject|2
2829914|NCT02706847|9701292|P4|Day 1 to Week 12|Adverse Event|12
2829915|NCT02706847|9701293|P3|Day 1 to Week 12|Adverse Event|1
2829916|NCT02706847|9701294|P2|Day 1 to Week 12|Adverse Event|2
2829917|NCT02706847|9701295|P1|Day 1 to Week 12|Adverse Event|2
2829918|NCT02706834|9701337|P11|Overall Study|Other Reason Not Specified|0
2829919|NCT02706834|9701338|P10|Overall Study|Other Reason Not Specified|0
2829920|NCT02706834|9701339|P9|Overall Study|Other Reason Not Specified|0
2829921|NCT02706834|9701340|P8|Overall Study|Other Reason Not Specified|0
2829922|NCT02706834|9701341|P7|Overall Study|Other Reason Not Specified|0
2829923|NCT02706834|9701342|P6|Overall Study|Other Reason Not Specified|0
2829924|NCT02706834|9701343|P5|Overall Study|Other Reason Not Specified|1
2829925|NCT02706834|9701344|P4|Overall Study|Other Reason Not Specified|0
2829926|NCT02706834|9701345|P3|Overall Study|Other Reason Not Specified|0
2829927|NCT02706834|9701346|P2|Overall Study|Other Reason Not Specified|0
2829928|NCT02706834|9701347|P1|Overall Study|Other Reason Not Specified|1
2829929|NCT02706834|9701337|P11|Overall Study|Voluntary Withdrawal|0
2829930|NCT02706834|9701338|P10|Overall Study|Voluntary Withdrawal|1
2829931|NCT02706834|9701339|P9|Overall Study|Voluntary Withdrawal|0
2829932|NCT02706834|9701340|P8|Overall Study|Voluntary Withdrawal|0
2829933|NCT02706834|9701341|P7|Overall Study|Voluntary Withdrawal|0
2829934|NCT02706834|9701342|P6|Overall Study|Voluntary Withdrawal|0
2829935|NCT02706834|9701343|P5|Overall Study|Voluntary Withdrawal|0
2829936|NCT02706834|9701344|P4|Overall Study|Voluntary Withdrawal|0
2829937|NCT02706834|9701345|P3|Overall Study|Voluntary Withdrawal|0
2829938|NCT02706834|9701346|P2|Overall Study|Voluntary Withdrawal|0
2829939|NCT02706834|9701347|P1|Overall Study|Voluntary Withdrawal|1
2829940|NCT02706834|9701337|P11|Overall Study|Lost to Follow-up|0
2829941|NCT02706834|9701338|P10|Overall Study|Lost to Follow-up|0
2829942|NCT02706834|9701339|P9|Overall Study|Lost to Follow-up|0
2829943|NCT02706834|9701340|P8|Overall Study|Lost to Follow-up|0
2829944|NCT02706834|9701341|P7|Overall Study|Lost to Follow-up|0
2829945|NCT02706834|9701342|P6|Overall Study|Lost to Follow-up|0
2829946|NCT02706834|9701343|P5|Overall Study|Lost to Follow-up|0
2829947|NCT02706834|9701344|P4|Overall Study|Lost to Follow-up|0
2829948|NCT02706834|9701345|P3|Overall Study|Lost to Follow-up|1
2829949|NCT02706834|9701346|P2|Overall Study|Lost to Follow-up|0
2829950|NCT02706834|9701347|P1|Overall Study|Lost to Follow-up|0
2829951|NCT02706834|9701337|P11|Overall Study|Pretreatment Event/Adverse Event|1
2829952|NCT02706834|9701338|P10|Overall Study|Pretreatment Event/Adverse Event|0
2829953|NCT02706834|9701339|P9|Overall Study|Pretreatment Event/Adverse Event|0
2829954|NCT02706834|9701340|P8|Overall Study|Pretreatment Event/Adverse Event|0
2829955|NCT02706834|9701341|P7|Overall Study|Pretreatment Event/Adverse Event|0
2829956|NCT02706834|9701342|P6|Overall Study|Pretreatment Event/Adverse Event|0
2829957|NCT02706834|9701343|P5|Overall Study|Pretreatment Event/Adverse Event|0
2829958|NCT02706834|9701344|P4|Overall Study|Pretreatment Event/Adverse Event|0
2829959|NCT02706834|9701345|P3|Overall Study|Pretreatment Event/Adverse Event|0
2829960|NCT02706834|9701346|P2|Overall Study|Pretreatment Event/Adverse Event|1
2829961|NCT02706834|9701347|P1|Overall Study|Pretreatment Event/Adverse Event|0
2829962|NCT02706717|9701491|P2|Overall Study|Death|1
2829963|NCT02706717|9701492|P1|Overall Study|Death|0
2829964|NCT02706717|9701491|P2|Overall Study|Physician Decision|1
2829965|NCT02706717|9701492|P1|Overall Study|Physician Decision|0
2829966|NCT02706717|9701491|P2|Overall Study|Lost to Follow-up|1
2829967|NCT02706717|9701492|P1|Overall Study|Lost to Follow-up|0
2829968|NCT02706717|9701491|P2|Overall Study|Withdrawal by Subject|8
2829969|NCT02706717|9701492|P1|Overall Study|Withdrawal by Subject|1
2829970|NCT02706691|9701556|P1|Overall Study|Adverse Event|1
2829971|NCT02706327|9701566|P3|Overall Study|Lost to Follow-up|2
2829972|NCT02706327|9701567|P2|Overall Study|Lost to Follow-up|1
2829973|NCT02706327|9701568|P1|Overall Study|Lost to Follow-up|1
2829974|NCT02705716|9701620|P2|Overall Study|Withdrawal of Consent|1
2829975|NCT02705716|9701621|P1|Overall Study|Withdrawal of Consent|1
2829976|NCT02705716|9701620|P2|Overall Study|Protocol Violation|0
2829977|NCT02705716|9701621|P1|Overall Study|Protocol Violation|3
2829978|NCT02705716|9701620|P2|Overall Study|Adverse Event|1
2829979|NCT02705716|9701621|P1|Overall Study|Adverse Event|0
2829980|NCT02705625|9701634|P3|Overall Study|Overdosing|1
2829981|NCT02705625|9701635|P2|Overall Study|Overdosing|0
2829982|NCT02705625|9701636|P1|Overall Study|Overdosing|0
2829983|NCT02705625|9701634|P3|Overall Study|Non-compliance|1
2829984|NCT02705625|9701635|P2|Overall Study|Non-compliance|1
2829985|NCT02705625|9701636|P1|Overall Study|Non-compliance|0
2829986|NCT02705625|9701634|P3|Overall Study|Lost to Follow-up|1
2829987|NCT02705625|9701635|P2|Overall Study|Lost to Follow-up|0
2829988|NCT02705625|9701636|P1|Overall Study|Lost to Follow-up|0
2829989|NCT02705625|9701634|P3|Overall Study|Withdrawal by Subject|5
2829990|NCT02705625|9701635|P2|Overall Study|Withdrawal by Subject|4
2829991|NCT02705625|9701636|P1|Overall Study|Withdrawal by Subject|1
2829992|NCT02705625|9701634|P3|Overall Study|Death|1
2829993|NCT02705625|9701635|P2|Overall Study|Death|0
2829994|NCT02705625|9701636|P1|Overall Study|Death|0
2829995|NCT02705625|9701634|P3|Overall Study|Adverse Event|2
2829996|NCT02705625|9701635|P2|Overall Study|Adverse Event|5
2829997|NCT02705625|9701636|P1|Overall Study|Adverse Event|6
2829998|NCT02705625|9701634|P3|Overall Study|Protocol Violation|0
2829999|NCT02705625|9701635|P2|Overall Study|Protocol Violation|0
2830000|NCT02705625|9701636|P1|Overall Study|Protocol Violation|1
2830001|NCT02705586|9701665|P1|Overall Study|Vacation/Planned Absence|1
2830002|NCT02705586|9701665|P1|Overall Study|Transportation Difficulties|5
2830003|NCT02705586|9701665|P1|Overall Study|Health Issues|2
2830004|NCT02704689|9701738|P1|Overall Study|Study device not implanted|2
2830005|NCT02704689|9701738|P1|Overall Study|Physician Decision|1
2830006|NCT02704091|9701771|P2|Overall Study|Other|8
2830007|NCT02704091|9701772|P1|Overall Study|Other|2
2830008|NCT02704091|9701771|P2|Overall Study|Lost to Follow-up|5
2830009|NCT02704091|9701772|P1|Overall Study|Lost to Follow-up|13
2830010|NCT02704091|9701771|P2|Overall Study|Consent withdrawn|4
2830011|NCT02704091|9701772|P1|Overall Study|Consent withdrawn|4
2830012|NCT02704091|9701771|P2|Overall Study|Protocol Violation|3
2830013|NCT02704091|9701772|P1|Overall Study|Protocol Violation|5
2830014|NCT02704091|9701771|P2|Overall Study|Adverse Event|3
2830015|NCT02704091|9701772|P1|Overall Study|Adverse Event|4
2830016|NCT02703636|9701832|P1|Overall Study|Withdrawal by Subject|1
2830017|NCT02703636|9701832|P1|Overall Study|Study stopped by sponsor|1
2830018|NCT02703636|9701832|P1|Overall Study|Adverse Event|14
2830019|NCT02703532|9701847|P4|Overall Study|Lost to Follow-up|0
2830020|NCT02703532|9701848|P3|Overall Study|Lost to Follow-up|2
2830021|NCT02703532|9701849|P2|Overall Study|Lost to Follow-up|0
2830022|NCT02703532|9701850|P1|Overall Study|Lost to Follow-up|2
2830023|NCT02703532|9701847|P4|Overall Study|Withdrawal by Subject|1
2830024|NCT02703532|9701848|P3|Overall Study|Withdrawal by Subject|0
2830025|NCT02703532|9701849|P2|Overall Study|Withdrawal by Subject|1
2830026|NCT02703532|9701850|P1|Overall Study|Withdrawal by Subject|0
2830027|NCT02703454|9701912|P2|Overall Study|Study discontinuation|8
2830028|NCT02703454|9701913|P1|Overall Study|Study discontinuation|5
2830029|NCT02703454|9701912|P2|Overall Study|Lost to Follow-up|2
2830030|NCT02703454|9701913|P1|Overall Study|Lost to Follow-up|1
2830031|NCT02703454|9701912|P2|Overall Study|Withdrawal by Subject|3
2830032|NCT02703454|9701913|P1|Overall Study|Withdrawal by Subject|4
2830033|NCT02703454|9701912|P2|Overall Study|Not treated|3
2830034|NCT02703454|9701913|P1|Overall Study|Not treated|1
2830035|NCT02703337|9701948|P8|Period One (Part A)|Withdrawal by Subject|0
2830036|NCT02703337|9701949|P7|Period One (Part A)|Withdrawal by Subject|0
2830037|NCT02703337|9701950|P6|Period One (Part A)|Withdrawal by Subject|0
2830038|NCT02703337|9701951|P5|Period One (Part A)|Withdrawal by Subject|1
2830039|NCT02703337|9701952|P4|Period One (Part A)|Withdrawal by Subject|0
2830040|NCT02703337|9701953|P3|Period One (Part A)|Withdrawal by Subject|0
2830041|NCT02703337|9701954|P2|Period One (Part A)|Withdrawal by Subject|0
2830042|NCT02703337|9701955|P1|Period One (Part A)|Withdrawal by Subject|0
2830043|NCT02703324|9701975|P6|Period Two|Withdrawal by Subject|0
2830044|NCT02703324|9701976|P5|Period Two|Withdrawal by Subject|0
2830045|NCT02703324|9701977|P4|Period Two|Withdrawal by Subject|0
2830046|NCT02703324|9701978|P3|Period Two|Withdrawal by Subject|1
2830047|NCT02703324|9701979|P2|Period Two|Withdrawal by Subject|0
2830048|NCT02703324|9701980|P1|Period Two|Withdrawal by Subject|0
2830049|NCT02703259|9701991|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2830050|NCT02703259|9701992|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2830051|NCT02703259|9701991|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
2830052|NCT02703259|9701992|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
2830053|NCT02703259|9701991|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
2830054|NCT02703259|9701992|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
2830055|NCT02702401|9702040|P2|Overall Study|Ongoing in study|34
2830056|NCT02702401|9702041|P1|Overall Study|Ongoing in study|94
2830057|NCT02702401|9702040|P2|Overall Study|Withdrawal by Subject|0
2830058|NCT02702401|9702041|P1|Overall Study|Withdrawal by Subject|4
2830059|NCT02702401|9702040|P2|Overall Study|Death|101
2830060|NCT02702401|9702041|P1|Overall Study|Death|180
2830061|NCT02702193|9702063|P2|12 Month Follow up|Lost to Follow-up|18
2830062|NCT02702193|9702064|P1|12 Month Follow up|Lost to Follow-up|16
2830063|NCT02702193|9702063|P2|12 Month Follow up|Withdrawal by Subject|0
2830064|NCT02702193|9702064|P1|12 Month Follow up|Withdrawal by Subject|1
2830065|NCT02702193|9702063|P2|8 Month Follow up|Lost to Follow-up|18
2830066|NCT02702193|9702064|P1|8 Month Follow up|Lost to Follow-up|14
2830067|NCT02702193|9702063|P2|8 Month Follow up|Withdrawal by Subject|0
2830068|NCT02702193|9702064|P1|8 Month Follow up|Withdrawal by Subject|1
2830069|NCT02702193|9702063|P2|4 Month Follow up|Lost to Follow-up|18
2830070|NCT02702193|9702064|P1|4 Month Follow up|Lost to Follow-up|17
2830071|NCT02702193|9702063|P2|4 Month Follow up|Withdrawal by Subject|0
2830072|NCT02702193|9702064|P1|4 Month Follow up|Withdrawal by Subject|1
2830073|NCT02702193|9702063|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
2830074|NCT02702193|9702064|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
2830075|NCT02702011|9702092|P4|Overall Study|Withdrawal by Subject|0
2830076|NCT02702011|9702093|P3|Overall Study|Withdrawal by Subject|0
2830077|NCT02702011|9702094|P2|Overall Study|Withdrawal by Subject|1
2830078|NCT02702011|9702095|P1|Overall Study|Withdrawal by Subject|0
2830079|NCT02701985|9702107|P2|Overall Study|Adverse Event|5
2830080|NCT02701985|9702108|P1|Overall Study|Adverse Event|0
2830081|NCT02701985|9702107|P2|Overall Study|Death|0
2830082|NCT02701985|9702108|P1|Overall Study|Death|1
2830083|NCT02701985|9702107|P2|Overall Study|Lost to Follow-up|0
2830084|NCT02701985|9702108|P1|Overall Study|Lost to Follow-up|1
2830085|NCT02701985|9702107|P2|Overall Study|Withdrawal by Subject|1
2830086|NCT02701985|9702108|P1|Overall Study|Withdrawal by Subject|1
2830087|NCT02701764|9702151|P2|Overall Study|Lost to Follow-up|1
2830088|NCT02701764|9702152|P1|Overall Study|Lost to Follow-up|0
2830089|NCT02701634|9702211|P2|Overall Study|Randomized but not treated|0
2830090|NCT02701634|9702212|P1|Overall Study|Randomized but not treated|1
2830091|NCT02701634|9702211|P2|Overall Study|Withdrew Consent|7
2830092|NCT02701634|9702212|P1|Overall Study|Withdrew Consent|6
2830093|NCT02701634|9702211|P2|Overall Study|Study terminated by Sponsor|17
2830094|NCT02701634|9702212|P1|Overall Study|Study terminated by Sponsor|15
2830095|NCT02701634|9702211|P2|Overall Study|Investigator's Discretion|4
2830096|NCT02701634|9702212|P1|Overall Study|Investigator's Discretion|7
2830097|NCT02701634|9702211|P2|Overall Study|Death|0
2830098|NCT02701634|9702212|P1|Overall Study|Death|1
2830099|NCT02701634|9702211|P2|Overall Study|Adverse Event|3
2830100|NCT02701634|9702212|P1|Overall Study|Adverse Event|2
2830101|NCT02701361|9702282|P3|Overall Study|incarceration|1
2830102|NCT02701361|9702283|P2|Overall Study|incarceration|0
2830103|NCT02701361|9702284|P1|Overall Study|incarceration|0
2830104|NCT02701361|9702282|P3|Overall Study|timed out in rehab center|0
2830105|NCT02701361|9702283|P2|Overall Study|timed out in rehab center|1
2830106|NCT02701361|9702284|P1|Overall Study|timed out in rehab center|0
2830107|NCT02701361|9702282|P3|Overall Study|Withdrawal by Subject|0
2830108|NCT02701361|9702283|P2|Overall Study|Withdrawal by Subject|0
2830109|NCT02701361|9702284|P1|Overall Study|Withdrawal by Subject|4
2830110|NCT02701361|9702282|P3|Overall Study|Lost to Follow-up|1
2830111|NCT02701361|9702283|P2|Overall Study|Lost to Follow-up|2
2830112|NCT02701361|9702284|P1|Overall Study|Lost to Follow-up|5
2830113|NCT02701296|9702325|P2|Overall Study|Incomplete Data|2
2830114|NCT02701296|9702326|P1|Overall Study|Incomplete Data|0
2830115|NCT02700997|9702572|P1|Overall Study|No CT measurement - pelvic calcification|1
2830116|NCT02700997|9702572|P1|Overall Study|Did not undergo CT imaging|1
2830117|NCT02700984|9702578|P2|Overall Study|Reason not specified|2
2830118|NCT02700984|9702579|P1|Overall Study|Reason not specified|3
2830119|NCT02700984|9702578|P2|Overall Study|Withdrawal by Subject|9
2830120|NCT02700984|9702579|P1|Overall Study|Withdrawal by Subject|8
2830121|NCT02700984|9702578|P2|Overall Study|Physician Decision|1
2830122|NCT02700984|9702579|P1|Overall Study|Physician Decision|0
2830123|NCT02700984|9702578|P2|Overall Study|Lost to Follow-up|1
2830124|NCT02700984|9702579|P1|Overall Study|Lost to Follow-up|2
2830125|NCT02700984|9702578|P2|Overall Study|Death|1
2830126|NCT02700984|9702579|P1|Overall Study|Death|2
2830127|NCT02700815|9702632|P4|Overall Study|Withdrawal by Subject|0
2830128|NCT02700815|9702633|P3|Overall Study|Withdrawal by Subject|1
2830129|NCT02700815|9702634|P2|Overall Study|Withdrawal by Subject|0
2830130|NCT02700815|9702635|P1|Overall Study|Withdrawal by Subject|0
2830131|NCT02700815|9702632|P4|Overall Study|Refusal to continue medication|1
2830132|NCT02700815|9702633|P3|Overall Study|Refusal to continue medication|0
2830133|NCT02700815|9702634|P2|Overall Study|Refusal to continue medication|1
2830134|NCT02700815|9702635|P1|Overall Study|Refusal to continue medication|0
2830135|NCT02700815|9702632|P4|Overall Study|Lost to Follow-up|1
2830136|NCT02700815|9702633|P3|Overall Study|Lost to Follow-up|0
2830137|NCT02700815|9702634|P2|Overall Study|Lost to Follow-up|0
2830138|NCT02700815|9702635|P1|Overall Study|Lost to Follow-up|1
2830139|NCT02700815|9702632|P4|Overall Study|Lack of Efficacy|2
2830140|NCT02700815|9702633|P3|Overall Study|Lack of Efficacy|1
2830141|NCT02700815|9702634|P2|Overall Study|Lack of Efficacy|0
2830142|NCT02700815|9702635|P1|Overall Study|Lack of Efficacy|0
2830143|NCT02700815|9702632|P4|Overall Study|Adverse Event|3
2830144|NCT02700815|9702633|P3|Overall Study|Adverse Event|2
2830145|NCT02700815|9702634|P2|Overall Study|Adverse Event|6
2830146|NCT02700815|9702635|P1|Overall Study|Adverse Event|0
2830147|NCT02700412|9702673|P1|Overall Study|Withdrawal by Subject|2
2830148|NCT02700412|9702673|P1|Overall Study|Protocol Violation|5
2830149|NCT02700412|9702673|P1|Overall Study|Lack of Efficacy|19
2830150|NCT02700412|9702673|P1|Overall Study|Death|1
2830151|NCT02700412|9702673|P1|Overall Study|Adverse Event|6
2830152|NCT02699983|9702683|P2|Overall Study|Withdrawal by Subject|0
2830153|NCT02699983|9702684|P1|Overall Study|Withdrawal by Subject|1
2830154|NCT02699892|9702749|P1|Overall Study|Other|36
2830155|NCT02699684|9702754|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
2830156|NCT02699684|9702755|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
2830157|NCT02699593|9702772|P2|Period 2|Torn Contact Lens|0
2830158|NCT02699593|9702773|P1|Period 2|Torn Contact Lens|1
2830159|NCT02699593|9702772|P2|Period 2|Lost Contact Lens|1
2830160|NCT02699593|9702773|P1|Period 2|Lost Contact Lens|0
2830161|NCT02699593|9702772|P2|Period 2|Adverse Event|1
2830162|NCT02699593|9702773|P1|Period 2|Adverse Event|1
2830163|NCT02699593|9702772|P2|Period 1|Adverse Event|1
2830164|NCT02699593|9702773|P1|Period 1|Adverse Event|1
2830165|NCT02699593|9702772|P2|Period 1|Withdrawal by Subject|1
2830166|NCT02699593|9702773|P1|Period 1|Withdrawal by Subject|0
2830167|NCT02699593|9702772|P2|Period 1|Protocol Violation|1
2830168|NCT02699593|9702773|P1|Period 1|Protocol Violation|0
2830169|NCT02699593|9702772|P2|Period 1|Torn Contact Len|3
2830170|NCT02699593|9702773|P1|Period 1|Torn Contact Len|4
2830171|NCT02699593|9702772|P2|Period 1|Unsatisfactory Visual Response|1
2830172|NCT02699593|9702773|P1|Period 1|Unsatisfactory Visual Response|0
2830173|NCT02699099|9702784|P3|Overall Study|Withdrawal by Subject|2
2830174|NCT02699099|9702785|P2|Overall Study|Withdrawal by Subject|1
2830175|NCT02699099|9702786|P1|Overall Study|Withdrawal by Subject|6
2830176|NCT02699099|9702784|P3|Overall Study|Lost to Follow-up|0
2830177|NCT02699099|9702785|P2|Overall Study|Lost to Follow-up|1
2830178|NCT02699099|9702786|P1|Overall Study|Lost to Follow-up|0
2830179|NCT02699099|9702784|P3|Overall Study|Adverse Event|1
2830180|NCT02699099|9702785|P2|Overall Study|Adverse Event|0
2830181|NCT02699099|9702786|P1|Overall Study|Adverse Event|1
2830182|NCT02698865|9702862|P2|Overall Study|Lost to Follow-up|2
2830183|NCT02698865|9702863|P1|Overall Study|Lost to Follow-up|4
2830184|NCT02698865|9702862|P2|Overall Study|Physician Decision|4
2830185|NCT02698865|9702863|P1|Overall Study|Physician Decision|0
2830186|NCT02698865|9702862|P2|Overall Study|Withdrawal by Subject|16
2830187|NCT02698865|9702863|P1|Overall Study|Withdrawal by Subject|20
2830188|NCT02698865|9702862|P2|Overall Study|Other|11
2830189|NCT02698865|9702863|P1|Overall Study|Other|11
2830190|NCT02698436|9702903|P2|Overall Study|Non-compliance with study regimen|0
2830191|NCT02698436|9702904|P1|Overall Study|Non-compliance with study regimen|1
2830192|NCT02698436|9702903|P2|Overall Study|Lost to Follow-up|4
2830193|NCT02698436|9702904|P1|Overall Study|Lost to Follow-up|2
2830194|NCT02698436|9702903|P2|Overall Study|Withdrawal by Subject|3
2830195|NCT02698436|9702904|P1|Overall Study|Withdrawal by Subject|3
2830196|NCT02698436|9702903|P2|Overall Study|Adverse Event|0
2830197|NCT02698436|9702904|P1|Overall Study|Adverse Event|1
2830198|NCT02698423|9702944|P2|Overall Study|Lost to Follow-up|24
2830199|NCT02698423|9702945|P1|Overall Study|Lost to Follow-up|19
2830200|NCT02698371|9702953|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
2830201|NCT02698371|9702953|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
2830202|NCT02698371|9702953|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
2830203|NCT02698371|9702953|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
2830204|NCT02698371|9702953|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
2830205|NCT02698371|9702953|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
2830206|NCT02698371|9702953|P1|All Participants Flow|Lost to Follow-up|3
2830207|NCT02698241|9703075|P1|Overall Study|Death|2
2830208|NCT02698241|9703075|P1|Overall Study|geographic and licensing issue|1
2830209|NCT02698241|9703075|P1|Overall Study|Subject on inodrip not safe to continue|6
2830210|NCT02698241|9703075|P1|Overall Study|Lost to Follow-up|3
2830211|NCT02698241|9703075|P1|Overall Study|Subject underwent system modification|2
2830212|NCT02698241|9703075|P1|Overall Study|Physician Decision|2
2830213|NCT02698241|9703075|P1|Overall Study|Withdrawal by Subject|7
2830214|NCT02698241|9703075|P1|Overall Study|Screening not met|7
2830215|NCT02698241|9703075|P1|Overall Study|Inclusion/exclusion criteria not met|4
2830216|NCT02698189|9703082|P2|Overall Study|Still ongoing in the study|1
2830217|NCT02698189|9703083|P1|Overall Study|Still ongoing in the study|0
2830218|NCT02698189|9703082|P2|Overall Study|Progressive disease|5
2830219|NCT02698189|9703083|P1|Overall Study|Progressive disease|3
2830220|NCT02698176|9703113|P4|Overall Study|Clinical progression|0
2830221|NCT02698176|9703114|P3|Overall Study|Clinical progression|0
2830222|NCT02698176|9703115|P2|Overall Study|Clinical progression|0
2830223|NCT02698176|9703116|P1|Overall Study|Clinical progression|3
2830224|NCT02698176|9703113|P4|Overall Study|Adverse Event|0
2830225|NCT02698176|9703114|P3|Overall Study|Adverse Event|0
2830226|NCT02698176|9703115|P2|Overall Study|Adverse Event|0
2830227|NCT02698176|9703116|P1|Overall Study|Adverse Event|2
2830228|NCT02698176|9703113|P4|Overall Study|Progressive disease|0
2830229|NCT02698176|9703114|P3|Overall Study|Progressive disease|1
2830230|NCT02698176|9703115|P2|Overall Study|Progressive disease|3
2830231|NCT02698176|9703116|P1|Overall Study|Progressive disease|4
2830232|NCT02697773|9703173|P3|Overall Study|Randomized but not treated|0
2830233|NCT02697773|9703174|P2|Overall Study|Randomized but not treated|1
2830234|NCT02697773|9703175|P1|Overall Study|Randomized but not treated|1
2830235|NCT02697773|9703173|P3|Overall Study|Withdrawal by Subject|13
2830236|NCT02697773|9703174|P2|Overall Study|Withdrawal by Subject|13
2830237|NCT02697773|9703175|P1|Overall Study|Withdrawal by Subject|10
2830238|NCT02697773|9703173|P3|Overall Study|Protocol Violation|0
2830239|NCT02697773|9703174|P2|Overall Study|Protocol Violation|1
2830240|NCT02697773|9703175|P1|Overall Study|Protocol Violation|1
2830241|NCT02697773|9703173|P3|Overall Study|Other|10
2830242|NCT02697773|9703174|P2|Overall Study|Other|11
2830243|NCT02697773|9703175|P1|Overall Study|Other|15
2830244|NCT02697773|9703173|P3|Overall Study|Lost to Follow-up|7
2830245|NCT02697773|9703174|P2|Overall Study|Lost to Follow-up|5
2830246|NCT02697773|9703175|P1|Overall Study|Lost to Follow-up|5
2830247|NCT02697773|9703173|P3|Overall Study|Lack of Efficacy|6
2830248|NCT02697773|9703174|P2|Overall Study|Lack of Efficacy|6
2830249|NCT02697773|9703175|P1|Overall Study|Lack of Efficacy|4
2830250|NCT02697773|9703173|P3|Overall Study|Death|2
2830251|NCT02697773|9703174|P2|Overall Study|Death|0
2830252|NCT02697773|9703175|P1|Overall Study|Death|0
2830253|NCT02697773|9703173|P3|Overall Study|Adverse Event|2
2830254|NCT02697773|9703174|P2|Overall Study|Adverse Event|1
2830255|NCT02697773|9703175|P1|Overall Study|Adverse Event|2
2830256|NCT02697435|9703356|P2|Overall Study|Physician Decision|4
2830257|NCT02697435|9703357|P1|Overall Study|Physician Decision|0
2830258|NCT02697435|9703356|P2|Overall Study|Withdrawal by Subject|0
2830259|NCT02697435|9703357|P1|Overall Study|Withdrawal by Subject|1
2830260|NCT02696850|9703465|P2|Overall Study|Lost to Follow-up|5
2830261|NCT02696850|9703466|P1|Overall Study|Lost to Follow-up|8
2830262|NCT02696850|9703465|P2|Overall Study|Withdrawal by Subject|3
2830263|NCT02696850|9703466|P1|Overall Study|Withdrawal by Subject|3
2830264|NCT02696798|9703479|P3|Post-treatment Follow-up Period|No progressive improvement|0
2830265|NCT02696798|9703480|P2|Post-treatment Follow-up Period|No progressive improvement|1
2830266|NCT02696798|9703481|P1|Post-treatment Follow-up Period|No progressive improvement|0
2830267|NCT02696798|9703479|P3|Post-treatment Follow-up Period|Physician Decision|0
2830268|NCT02696798|9703480|P2|Post-treatment Follow-up Period|Physician Decision|2
2830269|NCT02696798|9703481|P1|Post-treatment Follow-up Period|Physician Decision|0
2830270|NCT02696798|9703479|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
2830271|NCT02696798|9703480|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
2830272|NCT02696798|9703481|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
2830273|NCT02696798|9703479|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
2830274|NCT02696798|9703480|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
2830275|NCT02696798|9703481|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
2830276|NCT02696798|9703479|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
2830277|NCT02696798|9703480|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
2830278|NCT02696798|9703481|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
2830279|NCT02696798|9703479|P3|Post-treatment Follow-up Period|Adverse Event|6
2830280|NCT02696798|9703480|P2|Post-treatment Follow-up Period|Adverse Event|12
2830281|NCT02696798|9703481|P1|Post-treatment Follow-up Period|Adverse Event|2
2830282|NCT02696798|9703479|P3|Extended Treatment Period|Withdrawal by Subject|3
2830283|NCT02696798|9703480|P2|Extended Treatment Period|Withdrawal by Subject|2
2830284|NCT02696798|9703481|P1|Extended Treatment Period|Withdrawal by Subject|3
2830285|NCT02696798|9703479|P3|Extended Treatment Period|Physician Decision|0
2830286|NCT02696798|9703480|P2|Extended Treatment Period|Physician Decision|1
2830287|NCT02696798|9703481|P1|Extended Treatment Period|Physician Decision|0
2830288|NCT02696798|9703479|P3|Extended Treatment Period|Lost to Follow-up|0
2830289|NCT02696798|9703480|P2|Extended Treatment Period|Lost to Follow-up|0
2830290|NCT02696798|9703481|P1|Extended Treatment Period|Lost to Follow-up|1
2830291|NCT02696798|9703479|P3|Extended Treatment Period|Lack of Efficacy|2
2830292|NCT02696798|9703480|P2|Extended Treatment Period|Lack of Efficacy|2
2830293|NCT02696798|9703481|P1|Extended Treatment Period|Lack of Efficacy|7
2830294|NCT02696798|9703479|P3|Extended Treatment Period|Adverse Event|5
2830295|NCT02696798|9703480|P2|Extended Treatment Period|Adverse Event|4
2830296|NCT02696798|9703481|P1|Extended Treatment Period|Adverse Event|1
2830297|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
2830298|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
2830299|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
2830300|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Physician Decision|0
2830301|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Physician Decision|1
2830302|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Physician Decision|0
2830303|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
2830304|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
2830305|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
2830306|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
2830307|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
2830308|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
2830309|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Death|1
2830310|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Death|0
2830311|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Death|0
2830312|NCT02696798|9703479|P3|Blinded Treatment Dosing Period|Adverse Event|2
2830313|NCT02696798|9703480|P2|Blinded Treatment Dosing Period|Adverse Event|9
2830314|NCT02696798|9703481|P1|Blinded Treatment Dosing Period|Adverse Event|2
2830315|NCT02696785|9703578|P4|Follow-up Period|Withdrawal by Subject|4
2830316|NCT02696785|9703579|P3|Follow-up Period|Withdrawal by Subject|5
2830317|NCT02696785|9703580|P2|Follow-up Period|Withdrawal by Subject|0
2830318|NCT02696785|9703581|P1|Follow-up Period|Withdrawal by Subject|1
2830319|NCT02696785|9703578|P4|Follow-up Period|Lack of Efficacy|1
2830320|NCT02696785|9703579|P3|Follow-up Period|Lack of Efficacy|0
2830321|NCT02696785|9703580|P2|Follow-up Period|Lack of Efficacy|0
2830322|NCT02696785|9703581|P1|Follow-up Period|Lack of Efficacy|0
2830323|NCT02696785|9703578|P4|Follow-up Period|Lost to Follow-up|1
2830324|NCT02696785|9703579|P3|Follow-up Period|Lost to Follow-up|0
2830325|NCT02696785|9703580|P2|Follow-up Period|Lost to Follow-up|0
2830326|NCT02696785|9703581|P1|Follow-up Period|Lost to Follow-up|0
2830327|NCT02696785|9703578|P4|Follow-up Period|Adverse Event|2
2830328|NCT02696785|9703579|P3|Follow-up Period|Adverse Event|8
2830329|NCT02696785|9703580|P2|Follow-up Period|Adverse Event|0
2830330|NCT02696785|9703581|P1|Follow-up Period|Adverse Event|0
2830331|NCT02696785|9703578|P4|Extended Treatment Period|Withdrawal by Subject|5
2830332|NCT02696785|9703579|P3|Extended Treatment Period|Withdrawal by Subject|3
2830333|NCT02696785|9703580|P2|Extended Treatment Period|Withdrawal by Subject|2
2830334|NCT02696785|9703581|P1|Extended Treatment Period|Withdrawal by Subject|1
2830335|NCT02696785|9703578|P4|Extended Treatment Period|Lack of Efficacy|0
2830336|NCT02696785|9703579|P3|Extended Treatment Period|Lack of Efficacy|0
2830337|NCT02696785|9703580|P2|Extended Treatment Period|Lack of Efficacy|1
2830338|NCT02696785|9703581|P1|Extended Treatment Period|Lack of Efficacy|0
2830339|NCT02696785|9703578|P4|Extended Treatment Period|Adverse Event|1
2830340|NCT02696785|9703579|P3|Extended Treatment Period|Adverse Event|2
2830341|NCT02696785|9703580|P2|Extended Treatment Period|Adverse Event|3
2830342|NCT02696785|9703581|P1|Extended Treatment Period|Adverse Event|2
2830343|NCT02696785|9703578|P4|Washout Period|Lack of Efficacy|0
2830344|NCT02696785|9703579|P3|Washout Period|Lack of Efficacy|0
2830345|NCT02696785|9703580|P2|Washout Period|Lack of Efficacy|1
2830346|NCT02696785|9703581|P1|Washout Period|Lack of Efficacy|0
2830347|NCT02696785|9703578|P4|Washout Period|Withdrawal by Subject|0
2830348|NCT02696785|9703579|P3|Washout Period|Withdrawal by Subject|0
2830349|NCT02696785|9703580|P2|Washout Period|Withdrawal by Subject|1
2830350|NCT02696785|9703581|P1|Washout Period|Withdrawal by Subject|0
2830351|NCT02696785|9703578|P4|Blinded Treatment Period|Screen Failure|0
2830352|NCT02696785|9703579|P3|Blinded Treatment Period|Screen Failure|0
2830353|NCT02696785|9703580|P2|Blinded Treatment Period|Screen Failure|0
2830354|NCT02696785|9703581|P1|Blinded Treatment Period|Screen Failure|1
2830355|NCT02696785|9703578|P4|Blinded Treatment Period|Lack of Efficacy|1
2830356|NCT02696785|9703579|P3|Blinded Treatment Period|Lack of Efficacy|0
2830357|NCT02696785|9703580|P2|Blinded Treatment Period|Lack of Efficacy|0
2830358|NCT02696785|9703581|P1|Blinded Treatment Period|Lack of Efficacy|0
2830359|NCT02696785|9703578|P4|Blinded Treatment Period|Withdrawal by Subject|2
2830360|NCT02696785|9703579|P3|Blinded Treatment Period|Withdrawal by Subject|1
2830361|NCT02696785|9703580|P2|Blinded Treatment Period|Withdrawal by Subject|1
2830362|NCT02696785|9703581|P1|Blinded Treatment Period|Withdrawal by Subject|0
2830363|NCT02696785|9703578|P4|Blinded Treatment Period|Adverse Event|0
2830364|NCT02696785|9703579|P3|Blinded Treatment Period|Adverse Event|3
2830365|NCT02696785|9703580|P2|Blinded Treatment Period|Adverse Event|1
2830366|NCT02696785|9703581|P1|Blinded Treatment Period|Adverse Event|0
2830367|NCT02696434|9703701|P2|Overall Study|Physician Decision|1
2830368|NCT02696434|9703702|P1|Overall Study|Physician Decision|0
2830369|NCT02696434|9703701|P2|Overall Study|Withdrawal by Subject|12
2830370|NCT02696434|9703702|P1|Overall Study|Withdrawal by Subject|14
2830371|NCT02696434|9703701|P2|Overall Study|Lost to Follow-up|4
2830372|NCT02696434|9703702|P1|Overall Study|Lost to Follow-up|5
2830373|NCT02696434|9703701|P2|Overall Study|Adverse Event|1
2830374|NCT02696434|9703702|P1|Overall Study|Adverse Event|3
2830375|NCT02696317|9703720|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
2830376|NCT02696317|9703721|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
2830377|NCT02696317|9703720|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
2830378|NCT02696317|9703721|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
2830379|NCT02696226|9703765|P4|Overall Study|Study terminated - lack of enrollment|0
2830380|NCT02696226|9703766|P3|Overall Study|Study terminated - lack of enrollment|2
2830381|NCT02696226|9703767|P2|Overall Study|Study terminated - lack of enrollment|0
2830382|NCT02696226|9703768|P1|Overall Study|Study terminated - lack of enrollment|1
2830383|NCT02695719|9703798|P2|Overall Study|Voluntary Withdrawal|0
2830384|NCT02695719|9703799|P1|Overall Study|Voluntary Withdrawal|1
2830385|NCT02695719|9703798|P2|Overall Study|Significant Protocol Deviation|1
2830386|NCT02695719|9703799|P1|Overall Study|Significant Protocol Deviation|0
2830387|NCT02695719|9703798|P2|Overall Study|Pretreatment Event/Adverse Event|9
2830388|NCT02695719|9703799|P1|Overall Study|Pretreatment Event/Adverse Event|2
2830389|NCT02695628|9703817|P1|Overall Study|Withdrawal by Subject|1
2830390|NCT02695537|9703823|P1|Overall Study|Protocol Violation|3
2830391|NCT02695537|9703823|P1|Overall Study|Withdrawal by Subject|4
2830392|NCT02695537|9703823|P1|Overall Study|Lack of Efficacy|28
2830393|NCT02695537|9703823|P1|Overall Study|Adverse Event|3
2830394|NCT02695524|9703833|P2|Overall Study|Death|1
2830395|NCT02695524|9703834|P1|Overall Study|Death|0
2830396|NCT02695524|9703833|P2|Overall Study|Lost to Follow-up|2
2830397|NCT02695524|9703834|P1|Overall Study|Lost to Follow-up|3
2830398|NCT02695420|9703863|P4|Overall Study|Death|0
2830399|NCT02695420|9703864|P3|Overall Study|Death|0
2830400|NCT02695420|9703865|P2|Overall Study|Death|1
2830401|NCT02695420|9703866|P1|Overall Study|Death|0
2830402|NCT02695329|9703888|P2|Overall Study|Poor X-ray quality for measurement|5
2830403|NCT02695329|9703889|P1|Overall Study|Poor X-ray quality for measurement|4
2830404|NCT02695329|9703888|P2|Overall Study|Adverse Event|0
2830405|NCT02695329|9703889|P1|Overall Study|Adverse Event|1
2830406|NCT02694978|9703909|P2|Overall Study|Other-Withdrew prior to dosing|8
2830407|NCT02694978|9703910|P1|Overall Study|Other-Withdrew prior to dosing|9
2830408|NCT02694978|9703909|P2|Overall Study|Other-Personal reasons|3
2830409|NCT02694978|9703910|P1|Overall Study|Other-Personal reasons|3
2830410|NCT02694978|9703909|P2|Overall Study|Other-Protocol noncompliant|1
2830411|NCT02694978|9703910|P1|Overall Study|Other-Protocol noncompliant|2
2830412|NCT02694978|9703909|P2|Overall Study|Other-Unable to be reached|1
2830413|NCT02694978|9703910|P1|Overall Study|Other-Unable to be reached|0
2830414|NCT02694978|9703909|P2|Overall Study|Other-Investigator’s decision|0
2830415|NCT02694978|9703910|P1|Overall Study|Other-Investigator’s decision|1
2830416|NCT02694978|9703909|P2|Overall Study|Other-Decision of Participant|1
2830417|NCT02694978|9703910|P1|Overall Study|Other-Decision of Participant|6
2830418|NCT02694978|9703909|P2|Overall Study|Death|1
2830419|NCT02694978|9703910|P1|Overall Study|Death|4
2830420|NCT02694978|9703909|P2|Overall Study|Lost to Follow-up|17
2830421|NCT02694978|9703910|P1|Overall Study|Lost to Follow-up|14
2830422|NCT02694978|9703909|P2|Overall Study|Withdrawal by Subject|19
2830423|NCT02694978|9703910|P1|Overall Study|Withdrawal by Subject|22
2830424|NCT02694978|9703909|P2|Overall Study|Adverse Event|9
2830425|NCT02694978|9703910|P1|Overall Study|Adverse Event|10
2830426|NCT02694757|9703931|P1|Overall Study|Lack of Efficacy|3
2830427|NCT02694744|9703937|P2|Overall Study|Taking potassium supplement: exclusion 6|1
2830428|NCT02694744|9703938|P1|Overall Study|Taking potassium supplement: exclusion 6|0
2830429|NCT02694744|9703937|P2|Overall Study|Lost to Follow-up|0
2830430|NCT02694744|9703938|P1|Overall Study|Lost to Follow-up|1
2830431|NCT02694744|9703937|P2|Overall Study|Physician Decision|2
2830432|NCT02694744|9703938|P1|Overall Study|Physician Decision|1
2830433|NCT02694744|9703937|P2|Overall Study|Withdrawal by Subject|1
2830434|NCT02694744|9703938|P1|Overall Study|Withdrawal by Subject|2
2830435|NCT02694744|9703937|P2|Overall Study|Adverse Event|1
2830436|NCT02694744|9703938|P1|Overall Study|Adverse Event|2
2830437|NCT02694718|9703946|P1|Overall Study|Withdrawal by Subject|1
2830438|NCT02694718|9703946|P1|Overall Study|Death|1
2830439|NCT02694562|9703964|P1|Overall Study|Physician Decision|1
2830440|NCT02694562|9703964|P1|Overall Study|Screen Failure|2
2830441|NCT02694562|9703964|P1|Overall Study|Lost to Follow-up|3
2830442|NCT02694562|9703964|P1|Overall Study|Protocol Violation|4
2830443|NCT02694562|9703964|P1|Overall Study|Death|8
2830444|NCT02694549|9703973|P1|Overall Study|screen failures|2
2830445|NCT02694536|9703979|P1|Overall Study|Other|22
2830446|NCT02694536|9703979|P1|Overall Study|Death|8
2830447|NCT02694536|9703979|P1|Overall Study|Withdrawal by Subject|8
2830448|NCT02694536|9703979|P1|Overall Study|Study Drug-Related Adverse Event|1
2830449|NCT02694536|9703979|P1|Overall Study|Lost to Follow-up|1
2830450|NCT02694536|9703979|P1|Overall Study|Progressive Disease|40
2830451|NCT02694523|9703990|P7|Part B|Other|1
2830452|NCT02694523|9703991|P6|Part B|Other|0
2830453|NCT02694523|9703992|P5|Part B|Other|0
2830454|NCT02694523|9703993|P4|Part B|Other|0
2830455|NCT02694523|9703994|P3|Part B|Other|1
2830456|NCT02694523|9703995|P2|Part B|Other|0
2830457|NCT02694523|9703996|P1|Part B|Other|0
2830458|NCT02694523|9703990|P7|Part B|Withdrawal by Subject|0
2830459|NCT02694523|9703991|P6|Part B|Withdrawal by Subject|3
2830460|NCT02694523|9703992|P5|Part B|Withdrawal by Subject|1
2830461|NCT02694523|9703993|P4|Part B|Withdrawal by Subject|0
2830462|NCT02694523|9703994|P3|Part B|Withdrawal by Subject|9
2830463|NCT02694523|9703995|P2|Part B|Withdrawal by Subject|0
2830464|NCT02694523|9703996|P1|Part B|Withdrawal by Subject|0
2830465|NCT02694523|9703990|P7|Part B|Lost to Follow-up|1
2830466|NCT02694523|9703991|P6|Part B|Lost to Follow-up|0
2830467|NCT02694523|9703992|P5|Part B|Lost to Follow-up|2
2830468|NCT02694523|9703993|P4|Part B|Lost to Follow-up|3
2830469|NCT02694523|9703994|P3|Part B|Lost to Follow-up|2
2830470|NCT02694523|9703995|P2|Part B|Lost to Follow-up|0
2830471|NCT02694523|9703996|P1|Part B|Lost to Follow-up|0
2830472|NCT02694523|9703990|P7|Part B|Protocol Violation|0
2830473|NCT02694523|9703991|P6|Part B|Protocol Violation|0
2830474|NCT02694523|9703992|P5|Part B|Protocol Violation|0
2830475|NCT02694523|9703993|P4|Part B|Protocol Violation|0
2830476|NCT02694523|9703994|P3|Part B|Protocol Violation|1
2830477|NCT02694523|9703995|P2|Part B|Protocol Violation|0
2830478|NCT02694523|9703996|P1|Part B|Protocol Violation|0
2830479|NCT02694523|9703990|P7|Part B|Adverse Event|0
2830480|NCT02694523|9703991|P6|Part B|Adverse Event|2
2830481|NCT02694523|9703992|P5|Part B|Adverse Event|1
2830482|NCT02694523|9703993|P4|Part B|Adverse Event|1
2830483|NCT02694523|9703994|P3|Part B|Adverse Event|7
2830484|NCT02694523|9703995|P2|Part B|Adverse Event|0
2830485|NCT02694523|9703996|P1|Part B|Adverse Event|0
2830486|NCT02694523|9703990|P7|Part A|Other|0
2830487|NCT02694523|9703991|P6|Part A|Other|0
2830488|NCT02694523|9703992|P5|Part A|Other|0
2830489|NCT02694523|9703993|P4|Part A|Other|0
2830490|NCT02694523|9703994|P3|Part A|Other|0
2830491|NCT02694523|9703995|P2|Part A|Other|1
2830492|NCT02694523|9703996|P1|Part A|Other|1
2830493|NCT02694523|9703990|P7|Part A|Withdrawal by Subject|0
2830494|NCT02694523|9703991|P6|Part A|Withdrawal by Subject|0
2830495|NCT02694523|9703992|P5|Part A|Withdrawal by Subject|0
2830496|NCT02694523|9703993|P4|Part A|Withdrawal by Subject|0
2830497|NCT02694523|9703994|P3|Part A|Withdrawal by Subject|0
2830498|NCT02694523|9703995|P2|Part A|Withdrawal by Subject|1
2830499|NCT02694523|9703996|P1|Part A|Withdrawal by Subject|3
2830500|NCT02694523|9703990|P7|Part A|Lost to Follow-up|0
2830501|NCT02694523|9703991|P6|Part A|Lost to Follow-up|0
2830502|NCT02694523|9703992|P5|Part A|Lost to Follow-up|0
2830503|NCT02694523|9703993|P4|Part A|Lost to Follow-up|0
2830504|NCT02694523|9703994|P3|Part A|Lost to Follow-up|0
2830505|NCT02694523|9703995|P2|Part A|Lost to Follow-up|2
2830506|NCT02694523|9703996|P1|Part A|Lost to Follow-up|1
2830507|NCT02694523|9703990|P7|Part A|Protocol Violation|0
2830508|NCT02694523|9703991|P6|Part A|Protocol Violation|0
2830509|NCT02694523|9703992|P5|Part A|Protocol Violation|0
2830510|NCT02694523|9703993|P4|Part A|Protocol Violation|0
2830511|NCT02694523|9703994|P3|Part A|Protocol Violation|0
2830512|NCT02694523|9703995|P2|Part A|Protocol Violation|0
2830513|NCT02694523|9703996|P1|Part A|Protocol Violation|1
2830514|NCT02694523|9703990|P7|Part A|Adverse Event|0
2830515|NCT02694523|9703991|P6|Part A|Adverse Event|0
2830516|NCT02694523|9703992|P5|Part A|Adverse Event|0
2830517|NCT02694523|9703993|P4|Part A|Adverse Event|0
2830518|NCT02694523|9703994|P3|Part A|Adverse Event|0
2830519|NCT02694523|9703995|P2|Part A|Adverse Event|3
2830520|NCT02694523|9703996|P1|Part A|Adverse Event|7
2830521|NCT02694328|9704026|P2|Overall Study|Abnormal Laboratory Value|3
2830522|NCT02694328|9704027|P1|Overall Study|Abnormal Laboratory Value|0
2830523|NCT02694328|9704026|P2|Overall Study|Protocol Violation|5
2830524|NCT02694328|9704027|P1|Overall Study|Protocol Violation|6
2830525|NCT02694328|9704026|P2|Overall Study|Pregnancy|1
2830526|NCT02694328|9704027|P1|Overall Study|Pregnancy|1
2830527|NCT02694328|9704026|P2|Overall Study|Lack of Efficacy|2
2830528|NCT02694328|9704027|P1|Overall Study|Lack of Efficacy|1
2830529|NCT02694328|9704026|P2|Overall Study|Incarceration|1
2830530|NCT02694328|9704027|P1|Overall Study|Incarceration|1
2830531|NCT02694328|9704026|P2|Overall Study|Noncompliant with study drug|8
2830532|NCT02694328|9704027|P1|Overall Study|Noncompliant with study drug|11
2830533|NCT02694328|9704026|P2|Overall Study|Lost to Follow-up|22
2830534|NCT02694328|9704027|P1|Overall Study|Lost to Follow-up|26
2830535|NCT02694328|9704026|P2|Overall Study|Withdrawal by Subject|23
2830536|NCT02694328|9704027|P1|Overall Study|Withdrawal by Subject|27
2830537|NCT02694328|9704026|P2|Overall Study|Adverse Event|33
2830538|NCT02694328|9704027|P1|Overall Study|Adverse Event|27
2830539|NCT02693834|9704049|P2|Week 2 Practice|Adverse Event|1
2830540|NCT02693834|9704050|P1|Week 2 Practice|Adverse Event|0
2830541|NCT02693834|9704049|P2|Baseline Measurement|Adverse Event|0
2830542|NCT02693834|9704050|P1|Baseline Measurement|Adverse Event|1
2830543|NCT02693834|9704049|P2|Baseline Measurement|Withdrawal by Subject|0
2830544|NCT02693834|9704050|P1|Baseline Measurement|Withdrawal by Subject|1
2830545|NCT02693743|9704060|P2|Overall Study|Physician Decision|0
2830546|NCT02693743|9704061|P1|Overall Study|Physician Decision|1
2830547|NCT02693171|9704092|P1|Overall Study|Discontinuation of Study by Sponsor|8
2830548|NCT02693171|9704092|P1|Overall Study|Adverse Event|1
2830549|NCT02693106|9704124|P1|Overall Study|No time|3
2830550|NCT02693002|9704136|P2|Overall Study|Withdrawal by Subject|0
2830551|NCT02693002|9704137|P1|Overall Study|Withdrawal by Subject|1
2830552|NCT02692716|9704160|P2|Overall Study|Withdrawal by Subject|1
2830553|NCT02692716|9704161|P1|Overall Study|Withdrawal by Subject|3
2830554|NCT02692716|9704160|P2|Overall Study|Lost to Follow-up|5
2830555|NCT02692716|9704161|P1|Overall Study|Lost to Follow-up|2
2830556|NCT02692703|9704201|P1|Overall Study|Other|1
2830557|NCT02692703|9704201|P1|Overall Study|Lost to Follow-up|1
2830558|NCT02692560|9704209|P2|Overall Study|Withdrawal by Subject|6
2830559|NCT02692560|9704210|P1|Overall Study|Withdrawal by Subject|0
2830560|NCT02692482|9704250|P2|Overall Study|Withdrawal by Subject|2
2830561|NCT02692482|9704251|P1|Overall Study|Withdrawal by Subject|1
2830562|NCT02692482|9704250|P2|Overall Study|Death|2
2830563|NCT02692482|9704251|P1|Overall Study|Death|2
2830564|NCT02692417|9704265|P2|Overall Study|Adverse Event|0
2830565|NCT02692417|9704266|P1|Overall Study|Adverse Event|1
2830566|NCT02692417|9704265|P2|Overall Study|Withdrawal by Subject|1
2830567|NCT02692417|9704266|P1|Overall Study|Withdrawal by Subject|5
2830568|NCT02692235|9704278|P2|Overall Study|Adverse Event|2
2830569|NCT02692235|9704279|P1|Overall Study|Adverse Event|1
2830570|NCT02692235|9704278|P2|Overall Study|Withdrawal by Subject|1
2830571|NCT02692235|9704279|P1|Overall Study|Withdrawal by Subject|2
2830572|NCT02691936|9704289|P2|Overall Study|Withdrawal by Subject|5
2830573|NCT02691936|9704290|P1|Overall Study|Withdrawal by Subject|2
2830574|NCT02691741|9704312|P2|Overall Study|Withdrawal by Subject|4
2830575|NCT02691741|9704313|P1|Overall Study|Withdrawal by Subject|0
2830576|NCT02691741|9704312|P2|Overall Study|Physician Decision|1
2830577|NCT02691741|9704313|P1|Overall Study|Physician Decision|0
2830578|NCT02691741|9704312|P2|Overall Study|Lost to Follow-up|0
2830579|NCT02691741|9704313|P1|Overall Study|Lost to Follow-up|1
2830580|NCT02691741|9704312|P2|Overall Study|Adverse Event|2
2830581|NCT02691741|9704313|P1|Overall Study|Adverse Event|0
2830582|NCT02691702|9704353|P11|Overall Study|Protocol Violation|0
2830583|NCT02691702|9704354|P10|Overall Study|Protocol Violation|2
2830584|NCT02691702|9704355|P9|Overall Study|Protocol Violation|0
2830585|NCT02691702|9704356|P8|Overall Study|Protocol Violation|0
2830586|NCT02691702|9704357|P7|Overall Study|Protocol Violation|0
2830587|NCT02691702|9704358|P6|Overall Study|Protocol Violation|0
2830588|NCT02691702|9704359|P5|Overall Study|Protocol Violation|0
2830589|NCT02691702|9704360|P4|Overall Study|Protocol Violation|0
2830590|NCT02691702|9704361|P3|Overall Study|Protocol Violation|0
2830591|NCT02691702|9704362|P2|Overall Study|Protocol Violation|0
2830592|NCT02691702|9704363|P1|Overall Study|Protocol Violation|0
2830593|NCT02691702|9704353|P11|Overall Study|Other|0
2830594|NCT02691702|9704354|P10|Overall Study|Other|0
2830595|NCT02691702|9704355|P9|Overall Study|Other|1
2830596|NCT02691702|9704356|P8|Overall Study|Other|0
2830597|NCT02691702|9704357|P7|Overall Study|Other|1
2830598|NCT02691702|9704358|P6|Overall Study|Other|0
2830599|NCT02691702|9704359|P5|Overall Study|Other|0
2830600|NCT02691702|9704360|P4|Overall Study|Other|0
2830601|NCT02691702|9704361|P3|Overall Study|Other|0
2830602|NCT02691702|9704362|P2|Overall Study|Other|0
2830603|NCT02691702|9704363|P1|Overall Study|Other|0
2830604|NCT02691702|9704353|P11|Overall Study|Withdrawal by Subject|0
2830605|NCT02691702|9704354|P10|Overall Study|Withdrawal by Subject|0
2830606|NCT02691702|9704355|P9|Overall Study|Withdrawal by Subject|0
2830607|NCT02691702|9704356|P8|Overall Study|Withdrawal by Subject|0
2830608|NCT02691702|9704357|P7|Overall Study|Withdrawal by Subject|2
2830609|NCT02691702|9704358|P6|Overall Study|Withdrawal by Subject|1
2830610|NCT02691702|9704359|P5|Overall Study|Withdrawal by Subject|0
2830611|NCT02691702|9704360|P4|Overall Study|Withdrawal by Subject|0
2830612|NCT02691702|9704361|P3|Overall Study|Withdrawal by Subject|0
2830613|NCT02691702|9704362|P2|Overall Study|Withdrawal by Subject|1
2830614|NCT02691702|9704363|P1|Overall Study|Withdrawal by Subject|1
2830615|NCT02691702|9704353|P11|Overall Study|Lost to Follow-up|1
2830616|NCT02691702|9704354|P10|Overall Study|Lost to Follow-up|0
2830617|NCT02691702|9704355|P9|Overall Study|Lost to Follow-up|0
2830618|NCT02691702|9704356|P8|Overall Study|Lost to Follow-up|0
2830619|NCT02691702|9704357|P7|Overall Study|Lost to Follow-up|0
2830620|NCT02691702|9704358|P6|Overall Study|Lost to Follow-up|2
2830621|NCT02691702|9704359|P5|Overall Study|Lost to Follow-up|0
2830622|NCT02691702|9704360|P4|Overall Study|Lost to Follow-up|0
2830623|NCT02691702|9704361|P3|Overall Study|Lost to Follow-up|1
2830624|NCT02691702|9704362|P2|Overall Study|Lost to Follow-up|0
2830625|NCT02691702|9704363|P1|Overall Study|Lost to Follow-up|0
2830626|NCT02691702|9704353|P11|Overall Study|Adverse Event|1
2830627|NCT02691702|9704354|P10|Overall Study|Adverse Event|0
2830628|NCT02691702|9704355|P9|Overall Study|Adverse Event|1
2830629|NCT02691702|9704356|P8|Overall Study|Adverse Event|0
2830630|NCT02691702|9704357|P7|Overall Study|Adverse Event|0
2830631|NCT02691702|9704358|P6|Overall Study|Adverse Event|0
2830632|NCT02691702|9704359|P5|Overall Study|Adverse Event|0
2830633|NCT02691702|9704360|P4|Overall Study|Adverse Event|0
2830634|NCT02691702|9704361|P3|Overall Study|Adverse Event|0
2830635|NCT02691702|9704362|P2|Overall Study|Adverse Event|0
2830636|NCT02691702|9704363|P1|Overall Study|Adverse Event|1
2830637|NCT02691572|9704649|P2|Overall Study|Protocol Violation|1
2830638|NCT02691572|9704650|P1|Overall Study|Protocol Violation|0
2830639|NCT02691572|9704649|P2|Overall Study|Withdrawal by Subject|0
2830640|NCT02691572|9704650|P1|Overall Study|Withdrawal by Subject|1
2830641|NCT02691507|9704658|P2|Overall Study|Missed Visit 3|1
2830642|NCT02691507|9704659|P1|Overall Study|Missed Visit 3|0
2830643|NCT02691468|9704791|P2|Overall Study|Failure to advance FOB|0
2830644|NCT02691468|9704792|P1|Overall Study|Failure to advance FOB|2
2830645|NCT02691468|9704791|P2|Overall Study|Lost to Follow-up|1
2830646|NCT02691468|9704792|P1|Overall Study|Lost to Follow-up|2
2830647|NCT02691468|9704791|P2|Overall Study|Bronchial blocker use|1
2830648|NCT02691468|9704792|P1|Overall Study|Bronchial blocker use|2
2830649|NCT02691013|9704853|P2|Overall Study|Withdrawal by Subject|0
2830650|NCT02691013|9704854|P1|Overall Study|Withdrawal by Subject|3
2830651|NCT02690974|9704868|P1|Overall Study|Protocol Deviation|1
2830652|NCT02690974|9704868|P1|Overall Study|Protocol-defined stopping criteria|1
2830653|NCT02690974|9704868|P1|Overall Study|Non-compliance with study treatment|1
2830654|NCT02690974|9704868|P1|Overall Study|Physician Decision|2
2830655|NCT02690974|9704868|P1|Overall Study|Withdrawal of Informed Consent|3
2830656|NCT02690974|9704868|P1|Overall Study|Lost to Follow-up|3
2830657|NCT02690974|9704868|P1|Overall Study|Subject/guardian decision|4
2830658|NCT02690974|9704868|P1|Overall Study|Death|9
2830659|NCT02690974|9704868|P1|Overall Study|Adverse Event|16
2830660|NCT02690727|9704909|P2|Overall Study|Adverse Event|2
2830661|NCT02690727|9704910|P1|Overall Study|Adverse Event|2
2830662|NCT02690701|9704922|P2|Treatment Period 2|Protocol Violation|1
2830663|NCT02690701|9704923|P1|Treatment Period 2|Protocol Violation|0
2830664|NCT02690701|9704922|P2|Treatment Period 2|Withdrawal by Subject|2
2830665|NCT02690701|9704923|P1|Treatment Period 2|Withdrawal by Subject|0
2830666|NCT02690701|9704922|P2|Treatment Period 2|Lost to Follow-up|2
2830667|NCT02690701|9704923|P1|Treatment Period 2|Lost to Follow-up|0
2830668|NCT02690701|9704922|P2|Treatment Period 2|Lack of Efficacy|0
2830669|NCT02690701|9704923|P1|Treatment Period 2|Lack of Efficacy|1
2830670|NCT02690701|9704922|P2|Treatment Period 2|Adverse Event|0
2830671|NCT02690701|9704923|P1|Treatment Period 2|Adverse Event|2
2830672|NCT02690701|9704922|P2|Treatment Period 1|Withdrawal by Subject|1
2830673|NCT02690701|9704923|P1|Treatment Period 1|Withdrawal by Subject|0
2830674|NCT02690701|9704922|P2|Treatment Period 1|Adverse Event|2
2830675|NCT02690701|9704923|P1|Treatment Period 1|Adverse Event|2
2830676|NCT02690207|9704988|P1|Overall Study|Other reasons for withdrawal|23
2830677|NCT02690207|9704988|P1|Overall Study|Suspected HZ Episode|1
2830678|NCT02690207|9704988|P1|Overall Study|Migrated/moved from study area|5
2830679|NCT02690207|9704988|P1|Overall Study|Non-serious Adverse Event|18
2830680|NCT02690207|9704988|P1|Overall Study|Serious adverse event|110
2830681|NCT02690207|9704988|P1|Overall Study|Protocol Violation|2
2830682|NCT02690207|9704988|P1|Overall Study|Withdrawal by Subject|46
2830683|NCT02690207|9704988|P1|Overall Study|Lost to Follow-up|48
2830684|NCT02690194|9704998|P3|Overall Study|Withdrawal by Subject|0
2830685|NCT02690194|9704999|P2|Overall Study|Withdrawal by Subject|4
2830686|NCT02690194|9705000|P1|Overall Study|Withdrawal by Subject|1
2830687|NCT02689804|9705207|P2|Overall Study|Withdrawal by Subject|0
2830688|NCT02689804|9705208|P1|Overall Study|Withdrawal by Subject|2
2830689|NCT02689492|9705234|P1|Overall Study|Other than listed|1
2830690|NCT02689492|9705234|P1|Overall Study|Withdrawal/ Physician’s Decision|1
2830691|NCT02689492|9705234|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
2830692|NCT02689492|9705234|P1|Overall Study|Physician Decision|2
2830693|NCT02689492|9705234|P1|Overall Study|Death|9
2830694|NCT02689492|9705234|P1|Overall Study|Withdrawal by Subject|11
2830695|NCT02689492|9705234|P1|Overall Study|Lost to Follow-up|61
2830696|NCT02689219|9705250|P2|Overall Study|Disease Progression|6
2830697|NCT02689219|9705251|P1|Overall Study|Disease Progression|10
2830698|NCT02689219|9705250|P2|Overall Study|Death|1
2830699|NCT02689219|9705251|P1|Overall Study|Death|1
2830700|NCT02689206|9705268|P5|Overall Study|Withdrawal by Subject|0
2830701|NCT02689206|9705269|P4|Overall Study|Withdrawal by Subject|0
2830702|NCT02689206|9705270|P3|Overall Study|Withdrawal by Subject|1
2830703|NCT02689206|9705271|P2|Overall Study|Withdrawal by Subject|0
2830704|NCT02689206|9705272|P1|Overall Study|Withdrawal by Subject|1
2830705|NCT02689206|9705268|P5|Overall Study|Physician Decision|0
2830706|NCT02689206|9705269|P4|Overall Study|Physician Decision|0
2830707|NCT02689206|9705270|P3|Overall Study|Physician Decision|0
2830708|NCT02689206|9705271|P2|Overall Study|Physician Decision|0
2830709|NCT02689206|9705272|P1|Overall Study|Physician Decision|1
2830710|NCT02689206|9705268|P5|Overall Study|Other: Reached stopping criteria|4
2830711|NCT02689206|9705269|P4|Overall Study|Other: Reached stopping criteria|3
2830712|NCT02689206|9705270|P3|Overall Study|Other: Reached stopping criteria|2
2830713|NCT02689206|9705271|P2|Overall Study|Other: Reached stopping criteria|1
2830714|NCT02689206|9705272|P1|Overall Study|Other: Reached stopping criteria|0
2830715|NCT02689206|9705268|P5|Overall Study|Protocol Violation|2
2830716|NCT02689206|9705269|P4|Overall Study|Protocol Violation|1
2830717|NCT02689206|9705270|P3|Overall Study|Protocol Violation|0
2830718|NCT02689206|9705271|P2|Overall Study|Protocol Violation|0
2830719|NCT02689206|9705272|P1|Overall Study|Protocol Violation|1
2830720|NCT02689206|9705268|P5|Overall Study|Adverse Event|2
2830721|NCT02689206|9705269|P4|Overall Study|Adverse Event|0
2830722|NCT02689206|9705270|P3|Overall Study|Adverse Event|1
2830723|NCT02689206|9705271|P2|Overall Study|Adverse Event|0
2830724|NCT02689206|9705272|P1|Overall Study|Adverse Event|0
2830725|NCT02688933|9705485|P2|Overall Study|Lost to Follow-up|5
2830726|NCT02688933|9705486|P1|Overall Study|Lost to Follow-up|1
2830727|NCT02688933|9705485|P2|Overall Study|Other than Specified|25
2830728|NCT02688933|9705486|P1|Overall Study|Other than Specified|14
2830729|NCT02688933|9705485|P2|Overall Study|Hypoglycemia|0
2830730|NCT02688933|9705486|P1|Overall Study|Hypoglycemia|2
2830731|NCT02688933|9705485|P2|Overall Study|Poor compliance to protocol|4
2830732|NCT02688933|9705486|P1|Overall Study|Poor compliance to protocol|7
2830733|NCT02688933|9705485|P2|Overall Study|Lack of Efficacy|2
2830734|NCT02688933|9705486|P1|Overall Study|Lack of Efficacy|2
2830735|NCT02688933|9705485|P2|Overall Study|Adverse Event|1
2830736|NCT02688933|9705486|P1|Overall Study|Adverse Event|3
2830737|NCT02688764|9705546|P2|Overall Study|Withdrawal by parent|0
2830738|NCT02688764|9705547|P1|Overall Study|Withdrawal by parent|3
2830739|NCT02688764|9705546|P2|Overall Study|Subject taken off dialysis|0
2830740|NCT02688764|9705547|P1|Overall Study|Subject taken off dialysis|1
2830741|NCT02688764|9705546|P2|Overall Study|Subject moving out|0
2830742|NCT02688764|9705547|P1|Overall Study|Subject moving out|2
2830743|NCT02688764|9705546|P2|Overall Study|Study drug taste/Withd. parent|0
2830744|NCT02688764|9705547|P1|Overall Study|Study drug taste/Withd. parent|1
2830745|NCT02688764|9705546|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
2830746|NCT02688764|9705547|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
2830747|NCT02688764|9705546|P2|Overall Study|Phosphorus level outside safe range|1
2830748|NCT02688764|9705547|P1|Overall Study|Phosphorus level outside safe range|0
2830749|NCT02688764|9705546|P2|Overall Study|Non-compl./Withd. subject|2
2830750|NCT02688764|9705547|P1|Overall Study|Non-compl./Withd. subject|0
2830751|NCT02688764|9705546|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2830752|NCT02688764|9705547|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2830753|NCT02688764|9705546|P2|Overall Study|Non-compl./Physician decision|0
2830754|NCT02688764|9705547|P1|Overall Study|Non-compl./Physician decision|2
2830755|NCT02688764|9705546|P2|Overall Study|Non-compliance with study drug|0
2830756|NCT02688764|9705547|P1|Overall Study|Non-compliance with study drug|4
2830757|NCT02688764|9705546|P2|Overall Study|Lack of efficacy/Physician decision|1
2830758|NCT02688764|9705547|P1|Overall Study|Lack of efficacy/Physician decision|0
2830759|NCT02688764|9705546|P2|Overall Study|Lack of Efficacy|2
2830760|NCT02688764|9705547|P1|Overall Study|Lack of Efficacy|3
2830761|NCT02688764|9705546|P2|Overall Study|Kidney transplant|4
2830762|NCT02688764|9705547|P1|Overall Study|Kidney transplant|10
2830763|NCT02688764|9705546|P2|Overall Study|AE/Withd. subject|0
2830764|NCT02688764|9705547|P1|Overall Study|AE/Withd. subject|1
2830765|NCT02688764|9705546|P2|Overall Study|AE/Withd. parent/Withd. subject|1
2830766|NCT02688764|9705547|P1|Overall Study|AE/Withd. parent/Withd. subject|1
2830767|NCT02688764|9705546|P2|Overall Study|AE/Withd. parent|0
2830768|NCT02688764|9705547|P1|Overall Study|AE/Withd. parent|3
2830769|NCT02688764|9705546|P2|Overall Study|AE/Physician decision|0
2830770|NCT02688764|9705547|P1|Overall Study|AE/Physician decision|1
2830771|NCT02688764|9705546|P2|Overall Study|AE/Other|1
2830772|NCT02688764|9705547|P1|Overall Study|AE/Other|0
2830773|NCT02688764|9705546|P2|Overall Study|AE/Non-compl./Withd. parent|1
2830774|NCT02688764|9705547|P1|Overall Study|AE/Non-compl./Withd. parent|0
2830775|NCT02688764|9705546|P2|Overall Study|AE/Non-compl.|0
2830776|NCT02688764|9705547|P1|Overall Study|AE/Non-compl.|1
2830777|NCT02688764|9705546|P2|Overall Study|AE/Lack of efficacy|0
2830778|NCT02688764|9705547|P1|Overall Study|AE/Lack of efficacy|1
2830779|NCT02688764|9705546|P2|Overall Study|AE/Kidney transplant|0
2830780|NCT02688764|9705547|P1|Overall Study|AE/Kidney transplant|1
2830781|NCT02688764|9705546|P2|Overall Study|Adverse Event|3
2830782|NCT02688764|9705547|P1|Overall Study|Adverse Event|3
2830783|NCT02688387|9705614|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830784|NCT02688387|9705615|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830785|NCT02688387|9705616|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
2830786|NCT02688387|9705617|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830787|NCT02688387|9705618|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830788|NCT02688387|9705619|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830789|NCT02688387|9705620|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830790|NCT02688387|9705621|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830791|NCT02688387|9705622|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830792|NCT02688387|9705623|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830793|NCT02688387|9705624|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830794|NCT02688387|9705625|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830795|NCT02688387|9705626|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830796|NCT02688387|9705627|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830797|NCT02688387|9705628|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830798|NCT02688387|9705629|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830799|NCT02688387|9705630|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830800|NCT02688387|9705631|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830801|NCT02688387|9705632|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830802|NCT02688387|9705633|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830803|NCT02688387|9705634|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830804|NCT02688387|9705635|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2830805|NCT02688387|9705614|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830806|NCT02688387|9705615|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2830807|NCT02688387|9705616|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830808|NCT02688387|9705617|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2830809|NCT02688387|9705618|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830810|NCT02688387|9705619|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830811|NCT02688387|9705620|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830812|NCT02688387|9705621|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830813|NCT02688387|9705622|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830814|NCT02688387|9705623|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830815|NCT02688387|9705624|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830816|NCT02688387|9705625|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830817|NCT02688387|9705626|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830818|NCT02688387|9705627|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830819|NCT02688387|9705628|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830820|NCT02688387|9705629|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830821|NCT02688387|9705630|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830822|NCT02688387|9705631|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830823|NCT02688387|9705632|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830824|NCT02688387|9705633|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830825|NCT02688387|9705634|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830826|NCT02688387|9705635|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2830827|NCT02688387|9705614|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830828|NCT02688387|9705615|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
2830829|NCT02688387|9705616|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830830|NCT02688387|9705617|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830831|NCT02688387|9705618|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830832|NCT02688387|9705619|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830833|NCT02688387|9705620|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830834|NCT02688387|9705621|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830835|NCT02688387|9705622|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830836|NCT02688387|9705623|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830837|NCT02688387|9705624|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830838|NCT02688387|9705625|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830839|NCT02688387|9705626|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830840|NCT02688387|9705627|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830841|NCT02688387|9705628|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830842|NCT02688387|9705629|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830843|NCT02688387|9705630|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830844|NCT02688387|9705631|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830845|NCT02688387|9705632|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830846|NCT02688387|9705633|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830847|NCT02688387|9705634|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830848|NCT02688387|9705635|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2830849|NCT02688387|9705614|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830850|NCT02688387|9705615|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830851|NCT02688387|9705616|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830852|NCT02688387|9705617|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830853|NCT02688387|9705618|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830854|NCT02688387|9705619|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830855|NCT02688387|9705620|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830856|NCT02688387|9705621|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2830857|NCT02688387|9705622|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830858|NCT02688387|9705623|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830859|NCT02688387|9705624|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830860|NCT02688387|9705625|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830861|NCT02688387|9705626|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830862|NCT02688387|9705627|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830863|NCT02688387|9705628|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830864|NCT02688387|9705629|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830865|NCT02688387|9705630|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830866|NCT02688387|9705631|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830867|NCT02688387|9705632|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830868|NCT02688387|9705633|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830869|NCT02688387|9705634|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830870|NCT02688387|9705635|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830871|NCT02688387|9705614|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830872|NCT02688387|9705615|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830873|NCT02688387|9705616|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830874|NCT02688387|9705617|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830875|NCT02688387|9705618|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830876|NCT02688387|9705619|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830877|NCT02688387|9705620|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830878|NCT02688387|9705621|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830879|NCT02688387|9705622|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830880|NCT02688387|9705623|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830881|NCT02688387|9705624|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830882|NCT02688387|9705625|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
2830883|NCT02688387|9705626|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830884|NCT02688387|9705627|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830885|NCT02688387|9705628|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830886|NCT02688387|9705629|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830887|NCT02688387|9705630|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830888|NCT02688387|9705631|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830889|NCT02688387|9705632|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830890|NCT02688387|9705633|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830891|NCT02688387|9705634|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830892|NCT02688387|9705635|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2830893|NCT02688387|9705614|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830894|NCT02688387|9705615|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830895|NCT02688387|9705616|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830896|NCT02688387|9705617|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830897|NCT02688387|9705618|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830898|NCT02688387|9705619|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830899|NCT02688387|9705620|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830900|NCT02688387|9705621|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830901|NCT02688387|9705622|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830902|NCT02688387|9705623|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830903|NCT02688387|9705624|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830904|NCT02688387|9705625|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830905|NCT02688387|9705626|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830906|NCT02688387|9705627|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830907|NCT02688387|9705628|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830908|NCT02688387|9705629|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830909|NCT02688387|9705630|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830910|NCT02688387|9705631|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830911|NCT02688387|9705632|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830912|NCT02688387|9705633|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830913|NCT02688387|9705634|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2830914|NCT02688387|9705635|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
2830915|NCT02688387|9705614|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830916|NCT02688387|9705615|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830917|NCT02688387|9705616|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830918|NCT02688387|9705617|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830919|NCT02688387|9705618|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830920|NCT02688387|9705619|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830921|NCT02688387|9705620|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830922|NCT02688387|9705621|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830923|NCT02688387|9705622|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830924|NCT02688387|9705623|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830925|NCT02688387|9705624|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830926|NCT02688387|9705625|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2831079|NCT02686034|9706351|P1|Run-In Period 1|Eligibility|12
2830927|NCT02688387|9705626|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830928|NCT02688387|9705627|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830929|NCT02688387|9705628|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830930|NCT02688387|9705629|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830931|NCT02688387|9705630|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830932|NCT02688387|9705631|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2830933|NCT02688387|9705632|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830934|NCT02688387|9705633|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2830935|NCT02688387|9705634|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830936|NCT02688387|9705635|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2830937|NCT02688387|9705614|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830938|NCT02688387|9705615|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830939|NCT02688387|9705616|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830940|NCT02688387|9705617|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830941|NCT02688387|9705618|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830942|NCT02688387|9705619|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830943|NCT02688387|9705620|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830944|NCT02688387|9705621|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830945|NCT02688387|9705622|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830946|NCT02688387|9705623|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830947|NCT02688387|9705624|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830948|NCT02688387|9705625|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830949|NCT02688387|9705626|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830950|NCT02688387|9705627|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830951|NCT02688387|9705628|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830952|NCT02688387|9705629|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830953|NCT02688387|9705630|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830954|NCT02688387|9705631|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830955|NCT02688387|9705632|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830956|NCT02688387|9705633|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830957|NCT02688387|9705634|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
2830958|NCT02688387|9705635|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2830959|NCT02688387|9705614|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830960|NCT02688387|9705615|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830961|NCT02688387|9705616|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830962|NCT02688387|9705617|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830963|NCT02688387|9705618|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830964|NCT02688387|9705619|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830965|NCT02688387|9705620|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830966|NCT02688387|9705621|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830967|NCT02688387|9705622|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830968|NCT02688387|9705623|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830969|NCT02688387|9705624|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830970|NCT02688387|9705625|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830971|NCT02688387|9705626|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830972|NCT02688387|9705627|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830973|NCT02688387|9705628|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830974|NCT02688387|9705629|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830975|NCT02688387|9705630|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830976|NCT02688387|9705631|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830977|NCT02688387|9705632|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2830978|NCT02688387|9705633|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830979|NCT02688387|9705634|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830980|NCT02688387|9705635|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2830981|NCT02688387|9705614|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830982|NCT02688387|9705615|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830983|NCT02688387|9705616|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830984|NCT02688387|9705617|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830985|NCT02688387|9705618|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830986|NCT02688387|9705619|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830987|NCT02688387|9705620|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830988|NCT02688387|9705621|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830989|NCT02688387|9705622|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830990|NCT02688387|9705623|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830991|NCT02688387|9705624|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830992|NCT02688387|9705625|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830993|NCT02688387|9705626|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830994|NCT02688387|9705627|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830995|NCT02688387|9705628|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830996|NCT02688387|9705629|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830997|NCT02688387|9705630|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830998|NCT02688387|9705631|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2830999|NCT02688387|9705632|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2831000|NCT02688387|9705633|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
2831001|NCT02688387|9705634|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2831002|NCT02688387|9705635|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2831003|NCT02688192|9705903|P2|Overall Study|Physician Decision|0
2831004|NCT02688192|9705904|P1|Overall Study|Physician Decision|1
2831005|NCT02688192|9705903|P2|Overall Study|Lost to Follow-up|5
2831006|NCT02688192|9705904|P1|Overall Study|Lost to Follow-up|10
2831007|NCT02688153|9705923|P2|Overall Study|Conversion to Commercial Valve|0
2831008|NCT02688153|9705924|P1|Overall Study|Conversion to Commercial Valve|3
2831009|NCT02688153|9705923|P2|Overall Study|Valve Explant|0
2831010|NCT02688153|9705924|P1|Overall Study|Valve Explant|1
2831011|NCT02688153|9705923|P2|Overall Study|Withdrawal by Subject|2
2831012|NCT02688153|9705924|P1|Overall Study|Withdrawal by Subject|4
2831013|NCT02688153|9705923|P2|Overall Study|Death|5
2831014|NCT02688153|9705924|P1|Overall Study|Death|7
2831015|NCT02687919|9705984|P2|Overall Study|Protocol Violation|0
2831016|NCT02687919|9705985|P1|Overall Study|Protocol Violation|2
2831017|NCT02687919|9705984|P2|Overall Study|Withdrawal by Subject|6
2831018|NCT02687919|9705985|P1|Overall Study|Withdrawal by Subject|6
2831019|NCT02687542|9706018|P5|Overall Study|Withdrawal by Subject|4
2831020|NCT02687542|9706019|P4|Overall Study|Withdrawal by Subject|2
2831021|NCT02687542|9706020|P3|Overall Study|Withdrawal by Subject|1
2831022|NCT02687542|9706021|P2|Overall Study|Withdrawal by Subject|1
2831023|NCT02687542|9706022|P1|Overall Study|Withdrawal by Subject|0
2831024|NCT02687542|9706018|P5|Overall Study|Adverse Event|9
2831025|NCT02687542|9706019|P4|Overall Study|Adverse Event|2
2831026|NCT02687542|9706020|P3|Overall Study|Adverse Event|3
2831027|NCT02687542|9706021|P2|Overall Study|Adverse Event|1
2831028|NCT02687542|9706022|P1|Overall Study|Adverse Event|3
2831029|NCT02687542|9706018|P5|Overall Study|Other|5
2831030|NCT02687542|9706019|P4|Overall Study|Other|6
2831031|NCT02687542|9706020|P3|Overall Study|Other|10
2831032|NCT02687542|9706021|P2|Overall Study|Other|9
2831033|NCT02687542|9706022|P1|Overall Study|Other|5
2831034|NCT02687542|9706018|P5|Overall Study|Protocol Violation|0
2831035|NCT02687542|9706019|P4|Overall Study|Protocol Violation|0
2831036|NCT02687542|9706020|P3|Overall Study|Protocol Violation|0
2831037|NCT02687542|9706021|P2|Overall Study|Protocol Violation|1
2831038|NCT02687542|9706022|P1|Overall Study|Protocol Violation|0
2831039|NCT02687542|9706018|P5|Overall Study|Lost to Follow-up|1
2831040|NCT02687542|9706019|P4|Overall Study|Lost to Follow-up|0
2831041|NCT02687542|9706020|P3|Overall Study|Lost to Follow-up|0
2831042|NCT02687542|9706021|P2|Overall Study|Lost to Follow-up|0
2831043|NCT02687542|9706022|P1|Overall Study|Lost to Follow-up|0
2831044|NCT02687542|9706018|P5|Overall Study|Medication error without associated AEs|1
2831045|NCT02687542|9706019|P4|Overall Study|Medication error without associated AEs|0
2831046|NCT02687542|9706020|P3|Overall Study|Medication error without associated AEs|0
2831047|NCT02687542|9706021|P2|Overall Study|Medication error without associated AEs|0
2831048|NCT02687542|9706022|P1|Overall Study|Medication error without associated AEs|0
2831049|NCT02687191|9706151|P6|Overall Study|Withdrawal by Subject|0
2831050|NCT02687191|9706152|P5|Overall Study|Withdrawal by Subject|0
2831051|NCT02687191|9706153|P4|Overall Study|Withdrawal by Subject|1
2831052|NCT02687191|9706154|P3|Overall Study|Withdrawal by Subject|0
2831053|NCT02687191|9706155|P2|Overall Study|Withdrawal by Subject|0
2831054|NCT02687191|9706156|P1|Overall Study|Withdrawal by Subject|0
2831055|NCT02687191|9706151|P6|Overall Study|Death|1
2831056|NCT02687191|9706152|P5|Overall Study|Death|1
2831057|NCT02687191|9706153|P4|Overall Study|Death|0
2831058|NCT02687191|9706154|P3|Overall Study|Death|1
2831059|NCT02687191|9706155|P2|Overall Study|Death|1
2831060|NCT02687191|9706156|P1|Overall Study|Death|0
2831061|NCT02686164|9706313|P1|Overall Study|Clinical progression|1
2831062|NCT02686164|9706313|P1|Overall Study|Withdrawal of consent|1
2831063|NCT02686164|9706313|P1|Overall Study|Adverse Event|1
2831064|NCT02686034|9706350|P2|Open Label Period 3|Lost to Follow-up|1
2831065|NCT02686034|9706351|P1|Open Label Period 3|Lost to Follow-up|0
2831066|NCT02686034|9706350|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
2831067|NCT02686034|9706351|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
2831068|NCT02686034|9706350|P2|Randomized Controlled Period 2|Adverse Event|2
2831069|NCT02686034|9706351|P1|Randomized Controlled Period 2|Adverse Event|0
2831070|NCT02686034|9706350|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
2831071|NCT02686034|9706351|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
2831072|NCT02686034|9706350|P2|Randomized Controlled Period 2|Lost to Follow-up|2
2831073|NCT02686034|9706351|P1|Randomized Controlled Period 2|Lost to Follow-up|1
2831074|NCT02686034|9706350|P2|Run-In Period 1|Lost to Follow-up|4
2831075|NCT02686034|9706351|P1|Run-In Period 1|Lost to Follow-up|4
2831076|NCT02686034|9706350|P2|Run-In Period 1|Withdrawal by Subject|3
2831077|NCT02686034|9706351|P1|Run-In Period 1|Withdrawal by Subject|4
2831078|NCT02686034|9706350|P2|Run-In Period 1|Eligibility|10
2831080|NCT02685826|9706390|P3|Overall Study|Full Clinical Hold by FDA|20
2831081|NCT02685826|9706391|P2|Overall Study|Full Clinical Hold by FDA|9
2831082|NCT02685826|9706392|P1|Overall Study|Full Clinical Hold by FDA|19
2831083|NCT02685826|9706390|P3|Overall Study|Withdrawal by Subject|0
2831084|NCT02685826|9706391|P2|Overall Study|Withdrawal by Subject|0
2831085|NCT02685826|9706392|P1|Overall Study|Withdrawal by Subject|2
2831086|NCT02685826|9706390|P3|Overall Study|Progressive Disease|0
2831087|NCT02685826|9706391|P2|Overall Study|Progressive Disease|1
2831088|NCT02685826|9706392|P1|Overall Study|Progressive Disease|2
2831089|NCT02685826|9706390|P3|Overall Study|Adverse Event|1
2831090|NCT02685826|9706391|P2|Overall Study|Adverse Event|0
2831091|NCT02685826|9706392|P1|Overall Study|Adverse Event|2
2831092|NCT02685488|9706477|P2|Overall Study|Withdrawal by Subject|1
2831093|NCT02685488|9706478|P1|Overall Study|Withdrawal by Subject|0
2831094|NCT02685202|9706531|P1|Overall Study|Lost to Follow-up|9
2831095|NCT02685072|9706539|P2|1-Month Follow-Up|Withdrawal by Subject|0
2831096|NCT02685072|9706540|P1|1-Month Follow-Up|Withdrawal by Subject|1
2831097|NCT02685072|9706539|P2|Treatment Period|Withdrawal by Subject|3
2831098|NCT02685072|9706540|P1|Treatment Period|Withdrawal by Subject|1
2831099|NCT02685072|9706539|P2|Treatment Period|Lost to Follow-up|6
2831100|NCT02685072|9706540|P1|Treatment Period|Lost to Follow-up|12
2831101|NCT02685033|9706584|P2|Overall Study|Adverse Event|0
2831102|NCT02685033|9706585|P1|Overall Study|Adverse Event|1
2831103|NCT02685033|9706584|P2|Overall Study|Lost to Follow-up|1
2831104|NCT02685033|9706585|P1|Overall Study|Lost to Follow-up|2
2831105|NCT02685033|9706584|P2|Overall Study|Withdrawal of Consent|1
2831106|NCT02685033|9706585|P1|Overall Study|Withdrawal of Consent|0
2831107|NCT02684981|9706621|P3|Overall Study|Other|17
2831108|NCT02684981|9706622|P2|Overall Study|Other|49
2831109|NCT02684981|9706623|P1|Overall Study|Other|83
2831110|NCT02684981|9706621|P3|Overall Study|Permanently discontinued the treatment|110
2831111|NCT02684981|9706622|P2|Overall Study|Permanently discontinued the treatment|161
2831112|NCT02684981|9706623|P1|Overall Study|Permanently discontinued the treatment|157
2831113|NCT02684370|9706783|P6|Part B|Subject Withdrawal|2
2831114|NCT02684370|9706784|P5|Part B|Subject Withdrawal|1
2831115|NCT02684370|9706785|P4|Part B|Subject Withdrawal|1
2831116|NCT02684370|9706786|P3|Part B|Subject Withdrawal|0
2831117|NCT02684370|9706787|P2|Part B|Subject Withdrawal|0
2831118|NCT02684370|9706788|P1|Part B|Subject Withdrawal|0
2831119|NCT02684370|9706783|P6|Part B|Lost to Follow-up|5
2831120|NCT02684370|9706784|P5|Part B|Lost to Follow-up|2
2831121|NCT02684370|9706785|P4|Part B|Lost to Follow-up|1
2831122|NCT02684370|9706786|P3|Part B|Lost to Follow-up|0
2831123|NCT02684370|9706787|P2|Part B|Lost to Follow-up|0
2831124|NCT02684370|9706788|P1|Part B|Lost to Follow-up|0
2831125|NCT02684370|9706783|P6|Part B|Adverse Event|1
2831126|NCT02684370|9706784|P5|Part B|Adverse Event|2
2831127|NCT02684370|9706785|P4|Part B|Adverse Event|0
2831128|NCT02684370|9706786|P3|Part B|Adverse Event|0
2831129|NCT02684370|9706787|P2|Part B|Adverse Event|0
2831130|NCT02684370|9706788|P1|Part B|Adverse Event|0
2831131|NCT02684370|9706783|P6|Part A|Other|0
2831132|NCT02684370|9706784|P5|Part A|Other|0
2831133|NCT02684370|9706785|P4|Part A|Other|0
2831134|NCT02684370|9706786|P3|Part A|Other|1
2831135|NCT02684370|9706787|P2|Part A|Other|0
2831136|NCT02684370|9706788|P1|Part A|Other|0
2831137|NCT02684370|9706783|P6|Part A|Subject Withdrawal|0
2831138|NCT02684370|9706784|P5|Part A|Subject Withdrawal|0
2831139|NCT02684370|9706785|P4|Part A|Subject Withdrawal|0
2831140|NCT02684370|9706786|P3|Part A|Subject Withdrawal|3
2831141|NCT02684370|9706787|P2|Part A|Subject Withdrawal|0
2831142|NCT02684370|9706788|P1|Part A|Subject Withdrawal|1
2831143|NCT02684370|9706783|P6|Part A|Lost to Follow-up|0
2831144|NCT02684370|9706784|P5|Part A|Lost to Follow-up|0
2831145|NCT02684370|9706785|P4|Part A|Lost to Follow-up|0
2831146|NCT02684370|9706786|P3|Part A|Lost to Follow-up|0
2831147|NCT02684370|9706787|P2|Part A|Lost to Follow-up|1
2831148|NCT02684370|9706788|P1|Part A|Lost to Follow-up|1
2831149|NCT02684370|9706783|P6|Part A|Adverse Event|0
2831150|NCT02684370|9706784|P5|Part A|Adverse Event|0
2831151|NCT02684370|9706785|P4|Part A|Adverse Event|0
2831152|NCT02684370|9706786|P3|Part A|Adverse Event|1
2831153|NCT02684370|9706787|P2|Part A|Adverse Event|0
2831154|NCT02684370|9706788|P1|Part A|Adverse Event|2
2831155|NCT02684357|9706833|P6|Part B|Other|1
2831156|NCT02684357|9706834|P5|Part B|Other|0
2831157|NCT02684357|9706835|P4|Part B|Other|1
2831158|NCT02684357|9706836|P3|Part B|Other|0
2831159|NCT02684357|9706837|P2|Part B|Other|0
2831160|NCT02684357|9706838|P1|Part B|Other|0
2831161|NCT02684357|9706833|P6|Part B|Withdrawal by Subject|4
2831162|NCT02684357|9706834|P5|Part B|Withdrawal by Subject|2
2831163|NCT02684357|9706835|P4|Part B|Withdrawal by Subject|0
2831164|NCT02684357|9706836|P3|Part B|Withdrawal by Subject|0
2831165|NCT02684357|9706837|P2|Part B|Withdrawal by Subject|0
2831166|NCT02684357|9706838|P1|Part B|Withdrawal by Subject|0
2831167|NCT02684357|9706833|P6|Part B|Lost to Follow-up|7
2831168|NCT02684357|9706834|P5|Part B|Lost to Follow-up|1
2831169|NCT02684357|9706835|P4|Part B|Lost to Follow-up|1
2831170|NCT02684357|9706836|P3|Part B|Lost to Follow-up|0
2831171|NCT02684357|9706837|P2|Part B|Lost to Follow-up|0
2831172|NCT02684357|9706838|P1|Part B|Lost to Follow-up|0
2831173|NCT02684357|9706833|P6|Part B|Adverse Event (Other)|1
2831174|NCT02684357|9706834|P5|Part B|Adverse Event (Other)|1
2831175|NCT02684357|9706835|P4|Part B|Adverse Event (Other)|1
2831176|NCT02684357|9706836|P3|Part B|Adverse Event (Other)|0
2831177|NCT02684357|9706837|P2|Part B|Adverse Event (Other)|0
2831178|NCT02684357|9706838|P1|Part B|Adverse Event (Other)|0
2831179|NCT02684357|9706833|P6|Part A|Other|0
2831180|NCT02684357|9706834|P5|Part A|Other|0
2831181|NCT02684357|9706835|P4|Part A|Other|0
2831182|NCT02684357|9706836|P3|Part A|Other|0
2831183|NCT02684357|9706837|P2|Part A|Other|1
2831184|NCT02684357|9706838|P1|Part A|Other|0
2831185|NCT02684357|9706833|P6|Part A|Withdrawal by Subject|0
2831186|NCT02684357|9706834|P5|Part A|Withdrawal by Subject|0
2831187|NCT02684357|9706835|P4|Part A|Withdrawal by Subject|0
2831188|NCT02684357|9706836|P3|Part A|Withdrawal by Subject|0
2831189|NCT02684357|9706837|P2|Part A|Withdrawal by Subject|0
2831190|NCT02684357|9706838|P1|Part A|Withdrawal by Subject|3
2831191|NCT02684357|9706833|P6|Part A|Lost to Follow-up|0
2831192|NCT02684357|9706834|P5|Part A|Lost to Follow-up|0
2831193|NCT02684357|9706835|P4|Part A|Lost to Follow-up|0
2831194|NCT02684357|9706836|P3|Part A|Lost to Follow-up|2
2831195|NCT02684357|9706837|P2|Part A|Lost to Follow-up|2
2831196|NCT02684357|9706838|P1|Part A|Lost to Follow-up|0
2831197|NCT02684357|9706833|P6|Part A|Adverse Event (Worsening of Disease)|0
2831198|NCT02684357|9706834|P5|Part A|Adverse Event (Worsening of Disease)|0
2831199|NCT02684357|9706835|P4|Part A|Adverse Event (Worsening of Disease)|0
2831200|NCT02684357|9706836|P3|Part A|Adverse Event (Worsening of Disease)|0
2831201|NCT02684357|9706837|P2|Part A|Adverse Event (Worsening of Disease)|0
2831202|NCT02684357|9706838|P1|Part A|Adverse Event (Worsening of Disease)|1
2831203|NCT02684344|9706888|P2|Overall Study|Withdrawal by Subject|1
2831204|NCT02684344|9706889|P1|Overall Study|Withdrawal by Subject|0
2831205|NCT02684097|9706924|P2|Overall Study|Lack of Efficacy|6
2831206|NCT02684097|9706925|P1|Overall Study|Lack of Efficacy|13
2831207|NCT02683889|9706971|P1|Overall Study|Withdrawal by Subject|1
2831208|NCT02683785|9706979|P2|Overall Study|Adverse Event|2
2831209|NCT02683785|9706980|P1|Overall Study|Adverse Event|0
2831210|NCT02683785|9706979|P2|Overall Study|Lost to Follow-up|1
2831211|NCT02683785|9706980|P1|Overall Study|Lost to Follow-up|0
2831212|NCT02683785|9706979|P2|Overall Study|Withdrawal by Subject|1
2831213|NCT02683785|9706980|P1|Overall Study|Withdrawal by Subject|1
2831214|NCT02683746|9707037|P2|Overall Study|Physician Decision|1
2831215|NCT02683746|9707038|P1|Overall Study|Physician Decision|2
2831216|NCT02683746|9707037|P2|Overall Study|Withdrawal by Subject|5
2831217|NCT02683746|9707038|P1|Overall Study|Withdrawal by Subject|6
2831218|NCT02683746|9707037|P2|Overall Study|Lost to Follow-up|6
2831219|NCT02683746|9707038|P1|Overall Study|Lost to Follow-up|5
2831220|NCT02683746|9707037|P2|Overall Study|Adverse Event|2
2831221|NCT02683746|9707038|P1|Overall Study|Adverse Event|3
2831222|NCT02683668|9707081|P3|Period 2|Withdrawal by Subject|0
2831223|NCT02683668|9707082|P2|Period 2|Withdrawal by Subject|1
2831224|NCT02683668|9707083|P1|Period 2|Withdrawal by Subject|0
2831225|NCT02683109|9707190|P2|Overall Study|Adverse Event|0
2831226|NCT02683109|9707191|P1|Overall Study|Adverse Event|1
2831227|NCT02682823|9707212|P5|Overall Study|Adverse Event|0
2831228|NCT02682823|9707213|P4|Overall Study|Adverse Event|1
2831229|NCT02682823|9707214|P3|Overall Study|Adverse Event|0
2831230|NCT02682823|9707215|P2|Overall Study|Adverse Event|0
2831231|NCT02682823|9707216|P1|Overall Study|Adverse Event|0
2831232|NCT02682823|9707212|P5|Overall Study|Protocol Deviation|0
2831233|NCT02682823|9707213|P4|Overall Study|Protocol Deviation|0
2831234|NCT02682823|9707214|P3|Overall Study|Protocol Deviation|0
2831235|NCT02682823|9707215|P2|Overall Study|Protocol Deviation|1
2831236|NCT02682823|9707216|P1|Overall Study|Protocol Deviation|0
2831237|NCT02682823|9707212|P5|Overall Study|Withdrawal by Subject|1
2831238|NCT02682823|9707213|P4|Overall Study|Withdrawal by Subject|0
2831239|NCT02682823|9707214|P3|Overall Study|Withdrawal by Subject|1
2831240|NCT02682823|9707215|P2|Overall Study|Withdrawal by Subject|0
2831241|NCT02682823|9707216|P1|Overall Study|Withdrawal by Subject|0
2831242|NCT02682602|9707252|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
2831243|NCT02682602|9707253|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
2831244|NCT02682602|9707252|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
2831245|NCT02682602|9707253|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
2831246|NCT02681510|9707388|P1|Overall Study|Lost to Follow-up|9
2831247|NCT02681510|9707388|P1|Overall Study|Withdrawal by Subject|1
2831248|NCT02681094|9707418|P3|2 - Enrolled Participants Set|No treatment given|1
2831249|NCT02681094|9707419|P2|2 - Enrolled Participants Set|No treatment given|1
2831250|NCT02681094|9707420|P1|2 - Enrolled Participants Set|No treatment given|0
2831251|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Other|7
2831252|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Other|6
2831253|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Other|6
2831254|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
2831255|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
2831256|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
2831257|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
2831258|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
2831259|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
2831260|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
2831261|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
2831262|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
2831263|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Adverse Event|1
2831264|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Adverse Event|4
2831265|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Adverse Event|10
2831266|NCT02681094|9707418|P3|2 - Enrolled Participants Set|Participant decision|9
2831267|NCT02681094|9707419|P2|2 - Enrolled Participants Set|Participant decision|10
2831268|NCT02681094|9707420|P1|2 - Enrolled Participants Set|Participant decision|7
2831269|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|No treatment given|1
2831270|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|No treatment given|1
2831271|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|No treatment given|0
2831272|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Other|7
2831273|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Other|6
2831274|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Other|6
2831275|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
2831276|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
2831277|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
2831278|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
2831279|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
2831280|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
2831281|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
2831282|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
2831283|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
2831284|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
2831285|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
2831286|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
2831287|NCT02681094|9707418|P3|1 -Modified Enrolled Participants Set|Participant decision|9
2831288|NCT02681094|9707419|P2|1 -Modified Enrolled Participants Set|Participant decision|10
2831289|NCT02681094|9707420|P1|1 -Modified Enrolled Participants Set|Participant decision|7
2831290|NCT02680847|9707439|P3|Overall Study|Adverse Event|1
2831291|NCT02680847|9707440|P2|Overall Study|Adverse Event|0
2831292|NCT02680847|9707441|P1|Overall Study|Adverse Event|0
2831293|NCT02680847|9707439|P3|Overall Study|Lack of Efficacy|2
2831294|NCT02680847|9707440|P2|Overall Study|Lack of Efficacy|0
2831295|NCT02680847|9707441|P1|Overall Study|Lack of Efficacy|0
2831296|NCT02680847|9707439|P3|Overall Study|Unwilling to participate in study|0
2831297|NCT02680847|9707440|P2|Overall Study|Unwilling to participate in study|1
2831298|NCT02680847|9707441|P1|Overall Study|Unwilling to participate in study|1
2831299|NCT02680847|9707439|P3|Overall Study|No longer met eligibility criteria|0
2831300|NCT02680847|9707440|P2|Overall Study|No longer met eligibility criteria|2
2831301|NCT02680847|9707441|P1|Overall Study|No longer met eligibility criteria|2
2831302|NCT02680847|9707439|P3|Overall Study|Other|0
2831303|NCT02680847|9707440|P2|Overall Study|Other|0
2831304|NCT02680847|9707441|P1|Overall Study|Other|2
2831305|NCT02680834|9707478|P2|Overall Study|Lost to Follow-up|1
2831306|NCT02680834|9707479|P1|Overall Study|Lost to Follow-up|0
2831307|NCT02680834|9707478|P2|Overall Study|Withdrawal by Subject|0
2831308|NCT02680834|9707479|P1|Overall Study|Withdrawal by Subject|6
2831309|NCT02680834|9707478|P2|Overall Study|Physician Decision|2
2831310|NCT02680834|9707479|P1|Overall Study|Physician Decision|5
2831311|NCT02680756|9707491|P2|Overall Study|None of above or not recorded|2
2831312|NCT02680756|9707492|P1|Overall Study|None of above or not recorded|3
2831313|NCT02680756|9707491|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
2831314|NCT02680756|9707492|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
2831315|NCT02680756|9707491|P2|Overall Study|Protocol Violation|0
2831316|NCT02680756|9707492|P1|Overall Study|Protocol Violation|1
2831317|NCT02680756|9707491|P2|Overall Study|Death|0
2831318|NCT02680756|9707492|P1|Overall Study|Death|1
2831319|NCT02680756|9707491|P2|Overall Study|Blood transfusion for any reason|1
2831320|NCT02680756|9707492|P1|Overall Study|Blood transfusion for any reason|0
2831321|NCT02680756|9707491|P2|Overall Study|Hb ≤7.5 g/dL|2
2831322|NCT02680756|9707492|P1|Overall Study|Hb ≤7.5 g/dL|0
2831323|NCT02680756|9707491|P2|Overall Study|Physician Decision|1
2831324|NCT02680756|9707492|P1|Overall Study|Physician Decision|4
2831325|NCT02680756|9707491|P2|Overall Study|Withdrawal by Subject|5
2831326|NCT02680756|9707492|P1|Overall Study|Withdrawal by Subject|5
2831327|NCT02680756|9707491|P2|Overall Study|Lost to Follow-up|6
2831328|NCT02680756|9707492|P1|Overall Study|Lost to Follow-up|7
2831329|NCT02680756|9707491|P2|Overall Study|Adverse Event|2
2831330|NCT02680756|9707492|P1|Overall Study|Adverse Event|10
2831331|NCT02680665|9707540|P1|Overall Study|No visit after the first prescription|5
2831332|NCT02680639|9707546|P3|Screening Period|Screen Failure|0
2831333|NCT02680639|9707547|P2|Screening Period|Screen Failure|0
2831334|NCT02680639|9707548|P1|Screening Period|Screen Failure|7
2831335|NCT02680041|9707614|P1|Overall Study|Lost to Follow-up|2
2831336|NCT02680041|9707614|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
2831337|NCT02679729|9707657|P9|Overall Study|Participant decision|0
2831338|NCT02679729|9707658|P8|Overall Study|Participant decision|0
2831339|NCT02679729|9707659|P7|Overall Study|Participant decision|1
2831340|NCT02679729|9707660|P6|Overall Study|Participant decision|0
2831341|NCT02679729|9707661|P5|Overall Study|Participant decision|0
2831342|NCT02679729|9707662|P4|Overall Study|Participant decision|0
2831343|NCT02679729|9707663|P3|Overall Study|Participant decision|0
2831344|NCT02679729|9707664|P2|Overall Study|Participant decision|1
2831345|NCT02679729|9707665|P1|Overall Study|Participant decision|0
2831346|NCT02679729|9707657|P9|Overall Study|Lost to Follow-up|0
2831347|NCT02679729|9707658|P8|Overall Study|Lost to Follow-up|0
2831348|NCT02679729|9707659|P7|Overall Study|Lost to Follow-up|0
2831349|NCT02679729|9707660|P6|Overall Study|Lost to Follow-up|0
2831350|NCT02679729|9707661|P5|Overall Study|Lost to Follow-up|1
2831351|NCT02679729|9707662|P4|Overall Study|Lost to Follow-up|0
2831352|NCT02679729|9707663|P3|Overall Study|Lost to Follow-up|0
2831353|NCT02679729|9707664|P2|Overall Study|Lost to Follow-up|1
2831354|NCT02679729|9707665|P1|Overall Study|Lost to Follow-up|0
2831355|NCT02679573|9707777|P2|Overall Study|Lost to Follow-up|3
2831356|NCT02679573|9707778|P1|Overall Study|Lost to Follow-up|0
2831357|NCT02679573|9707777|P2|Overall Study|Physician Decision|4
2831358|NCT02679573|9707778|P1|Overall Study|Physician Decision|2
2831359|NCT02679573|9707777|P2|Overall Study|Death|0
2831360|NCT02679573|9707778|P1|Overall Study|Death|2
2831361|NCT02679573|9707777|P2|Overall Study|Withdrawal by Subject|9
2831362|NCT02679573|9707778|P1|Overall Study|Withdrawal by Subject|2
2831363|NCT02679573|9707777|P2|Overall Study|Could not complete required study visits|2
2831364|NCT02679573|9707778|P1|Overall Study|Could not complete required study visits|6
2831365|NCT02679573|9707777|P2|Overall Study|Lack of Efficacy|15
2831366|NCT02679573|9707778|P1|Overall Study|Lack of Efficacy|12
2831367|NCT02679573|9707777|P2|Overall Study|Adverse Event|6
2831368|NCT02679573|9707778|P1|Overall Study|Adverse Event|13
2831369|NCT02679274|9707802|P2|Overall Study|Withdrawal by Subject|0
2831370|NCT02679274|9707803|P1|Overall Study|Withdrawal by Subject|1
2831371|NCT02679235|9707833|P1|Overall Study|Adverse Event|1
2831372|NCT02679235|9707833|P1|Overall Study|Withdrawal by Subject|3
2831373|NCT02679222|9707840|P1|Overall Study|No time for project|1
2831374|NCT02678923|9707870|P2|Overall Study|Did Not Return for Study Visits|0
2831375|NCT02678923|9707871|P1|Overall Study|Did Not Return for Study Visits|1
2831376|NCT02678923|9707870|P2|Overall Study|Lost to Follow-up|0
2831377|NCT02678923|9707871|P1|Overall Study|Lost to Follow-up|1
2831378|NCT02678923|9707870|P2|Overall Study|Withdrawal by Subject|2
2831379|NCT02678923|9707871|P1|Overall Study|Withdrawal by Subject|3
2831380|NCT02678923|9707870|P2|Overall Study|Protocol Deviation (Not Dosed)|3
2831381|NCT02678923|9707871|P1|Overall Study|Protocol Deviation (Not Dosed)|1
2831382|NCT02678676|9707887|P2|Overall Study|Unconfirmed for lost to follow-up|67
2831383|NCT02678676|9707888|P1|Overall Study|Unconfirmed for lost to follow-up|85
2831384|NCT02678676|9707887|P2|Overall Study|Lost to Follow-up|151
2831385|NCT02678676|9707888|P1|Overall Study|Lost to Follow-up|171
2831386|NCT02678676|9707887|P2|Overall Study|Withdrawal by Subject|5
2831387|NCT02678676|9707888|P1|Overall Study|Withdrawal by Subject|13
2831388|NCT02678676|9707887|P2|Overall Study|Death|649
2831389|NCT02678676|9707888|P1|Overall Study|Death|619
2831390|NCT02678416|9707919|P1|Part 2|Withdrawal by Subject|1
2831391|NCT02678416|9707919|P1|Part 2|Adverse Event|2
2831392|NCT02678416|9707919|P1|Part 1|Withdrawal by Subject|1
2831393|NCT02678390|9707939|P2|AE (1 Day)|Withdrawal by Subject|1
2831394|NCT02678390|9707940|P1|AE (1 Day)|Withdrawal by Subject|0
2831395|NCT02678286|9707956|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2831396|NCT02678286|9707957|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2831397|NCT02678286|9707956|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
2831398|NCT02678286|9707957|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
2831399|NCT02678286|9707956|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
2831400|NCT02678286|9707957|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
2831401|NCT02678286|9707956|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
2831402|NCT02678286|9707957|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
2831403|NCT02678286|9707956|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
2831404|NCT02678286|9707957|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
2831405|NCT02678000|9708009|P5|PART 2|Withdrawal by Subject|0
2831406|NCT02678000|9708010|P4|PART 2|Withdrawal by Subject|0
2831407|NCT02678000|9708011|P3|PART 2|Withdrawal by Subject|1
2831408|NCT02678000|9708012|P2|PART 2|Withdrawal by Subject|0
2831409|NCT02678000|9708013|P1|PART 2|Withdrawal by Subject|0
2831410|NCT02678000|9708009|P5|PART 2|Adverse Event|0
2831411|NCT02678000|9708010|P4|PART 2|Adverse Event|1
2831412|NCT02678000|9708011|P3|PART 2|Adverse Event|2
2831413|NCT02678000|9708012|P2|PART 2|Adverse Event|0
2831414|NCT02678000|9708013|P1|PART 2|Adverse Event|0
2831415|NCT02677896|9708051|P2|Overall Study|Did not receive study drug|2
2831416|NCT02677896|9708052|P1|Overall Study|Did not receive study drug|2
2831417|NCT02677896|9708051|P2|Overall Study|Miscellaneous|11
2831418|NCT02677896|9708052|P1|Overall Study|Miscellaneous|6
2831419|NCT02677896|9708051|P2|Overall Study|Withdrawal by patient:|30
2831420|NCT02677896|9708052|P1|Overall Study|Withdrawal by patient:|25
2831421|NCT02677896|9708051|P2|Overall Study|Protocol deviation|1
2831422|NCT02677896|9708052|P1|Overall Study|Protocol deviation|2
2831423|NCT02677896|9708051|P2|Overall Study|Progressive disease:|171
2831424|NCT02677896|9708052|P1|Overall Study|Progressive disease:|65
2831425|NCT02677896|9708051|P2|Overall Study|Lost to Follow-up|1
2831426|NCT02677896|9708052|P1|Overall Study|Lost to Follow-up|0
2831427|NCT02677896|9708051|P2|Overall Study|Death|7
2831428|NCT02677896|9708052|P1|Overall Study|Death|9
2831429|NCT02677896|9708051|P2|Overall Study|Adverse Event|21
2831430|NCT02677896|9708052|P1|Overall Study|Adverse Event|28
2831431|NCT02677844|9708080|P7|Period 3|Withdrawal by Subject|0
2831432|NCT02677844|9708081|P6|Period 3|Withdrawal by Subject|0
2831433|NCT02677844|9708082|P5|Period 3|Withdrawal by Subject|0
2831434|NCT02677844|9708083|P4|Period 3|Withdrawal by Subject|1
2831435|NCT02677844|9708084|P3|Period 3|Withdrawal by Subject|0
2831436|NCT02677844|9708085|P2|Period 3|Withdrawal by Subject|0
2831437|NCT02677844|9708086|P1|Period 3|Withdrawal by Subject|0
2831438|NCT02677220|9708188|P1|Overall Study|Adverse Event|1
2831439|NCT02677116|9708203|P9|Overall Study|Withdrawal by Subject|0
2831440|NCT02677116|9708204|P8|Overall Study|Withdrawal by Subject|0
2831441|NCT02677116|9708205|P7|Overall Study|Withdrawal by Subject|0
2831442|NCT02677116|9708206|P6|Overall Study|Withdrawal by Subject|0
2831443|NCT02677116|9708207|P5|Overall Study|Withdrawal by Subject|0
2831444|NCT02677116|9708208|P4|Overall Study|Withdrawal by Subject|0
2831445|NCT02677116|9708209|P3|Overall Study|Withdrawal by Subject|0
2831446|NCT02677116|9708210|P2|Overall Study|Withdrawal by Subject|0
2831447|NCT02677116|9708211|P1|Overall Study|Withdrawal by Subject|1
2831448|NCT02677116|9708203|P9|Overall Study|Withdrawal by parent or guardian|0
2831449|NCT02677116|9708204|P8|Overall Study|Withdrawal by parent or guardian|1
2831450|NCT02677116|9708205|P7|Overall Study|Withdrawal by parent or guardian|2
2831451|NCT02677116|9708206|P6|Overall Study|Withdrawal by parent or guardian|0
2831452|NCT02677116|9708207|P5|Overall Study|Withdrawal by parent or guardian|0
2831453|NCT02677116|9708208|P4|Overall Study|Withdrawal by parent or guardian|1
2831454|NCT02677116|9708209|P3|Overall Study|Withdrawal by parent or guardian|0
2831455|NCT02677116|9708210|P2|Overall Study|Withdrawal by parent or guardian|1
2831456|NCT02677116|9708211|P1|Overall Study|Withdrawal by parent or guardian|2
2831457|NCT02677116|9708203|P9|Overall Study|Physician Decision|2
2831458|NCT02677116|9708204|P8|Overall Study|Physician Decision|1
2831459|NCT02677116|9708205|P7|Overall Study|Physician Decision|1
2831460|NCT02677116|9708206|P6|Overall Study|Physician Decision|3
2831461|NCT02677116|9708207|P5|Overall Study|Physician Decision|1
2831462|NCT02677116|9708208|P4|Overall Study|Physician Decision|2
2831463|NCT02677116|9708209|P3|Overall Study|Physician Decision|3
2831464|NCT02677116|9708210|P2|Overall Study|Physician Decision|2
2831465|NCT02677116|9708211|P1|Overall Study|Physician Decision|0
2831466|NCT02677116|9708203|P9|Overall Study|Adverse Event|0
2831467|NCT02677116|9708204|P8|Overall Study|Adverse Event|0
2831468|NCT02677116|9708205|P7|Overall Study|Adverse Event|1
2831469|NCT02677116|9708206|P6|Overall Study|Adverse Event|1
2831470|NCT02677116|9708207|P5|Overall Study|Adverse Event|0
2831471|NCT02677116|9708208|P4|Overall Study|Adverse Event|0
2831472|NCT02677116|9708209|P3|Overall Study|Adverse Event|0
2831473|NCT02677116|9708210|P2|Overall Study|Adverse Event|1
2831474|NCT02677116|9708211|P1|Overall Study|Adverse Event|0
2831475|NCT02676895|9708284|P3|Overall Study|Withdrawal by Subject|1
2831476|NCT02676895|9708285|P2|Overall Study|Withdrawal by Subject|0
2831477|NCT02676895|9708286|P1|Overall Study|Withdrawal by Subject|0
2831478|NCT02676895|9708284|P3|Overall Study|Lost to Follow-up|1
2831479|NCT02676895|9708285|P2|Overall Study|Lost to Follow-up|0
2831480|NCT02676895|9708286|P1|Overall Study|Lost to Follow-up|0
2831481|NCT02676895|9708284|P3|Overall Study|Adverse Event|1
2831482|NCT02676895|9708285|P2|Overall Study|Adverse Event|3
2831483|NCT02676895|9708286|P1|Overall Study|Adverse Event|0
2831484|NCT02676895|9708284|P3|Overall Study|Protocol Violation|0
2831485|NCT02676895|9708285|P2|Overall Study|Protocol Violation|0
2831486|NCT02676895|9708286|P1|Overall Study|Protocol Violation|1
2831487|NCT02676895|9708284|P3|Overall Study|Administrative reason|0
2831488|NCT02676895|9708285|P2|Overall Study|Administrative reason|0
2831489|NCT02676895|9708286|P1|Overall Study|Administrative reason|1
2831490|NCT02676882|9708329|P2|Overall Study|Withdrawal by Subject|2
2831491|NCT02676882|9708330|P1|Overall Study|Withdrawal by Subject|1
2831492|NCT02676882|9708329|P2|Overall Study|Lost to Follow-up|0
2831493|NCT02676882|9708330|P1|Overall Study|Lost to Follow-up|1
2831494|NCT02676882|9708329|P2|Overall Study|Adverse Event|0
2831495|NCT02676882|9708330|P1|Overall Study|Adverse Event|1
2831496|NCT02676466|9708349|P8|Overall Study|Withdrawal by Subject|1
2831497|NCT02676466|9708350|P7|Overall Study|Withdrawal by Subject|1
2831498|NCT02676466|9708351|P6|Overall Study|Withdrawal by Subject|1
2831499|NCT02676466|9708352|P5|Overall Study|Withdrawal by Subject|3
2831500|NCT02676466|9708353|P4|Overall Study|Withdrawal by Subject|0
2831501|NCT02676466|9708354|P3|Overall Study|Withdrawal by Subject|1
2831502|NCT02676466|9708355|P2|Overall Study|Withdrawal by Subject|3
2831503|NCT02676466|9708356|P1|Overall Study|Withdrawal by Subject|4
2831504|NCT02676466|9708349|P8|Overall Study|Death|0
2831505|NCT02676466|9708350|P7|Overall Study|Death|0
2831506|NCT02676466|9708351|P6|Overall Study|Death|0
2831507|NCT02676466|9708352|P5|Overall Study|Death|0
2831508|NCT02676466|9708353|P4|Overall Study|Death|0
2831509|NCT02676466|9708354|P3|Overall Study|Death|1
2831510|NCT02676466|9708355|P2|Overall Study|Death|2
2831511|NCT02676466|9708356|P1|Overall Study|Death|0
2831512|NCT02675907|9708437|P2|Study Overall|Lost to Follow-up|2
2831513|NCT02675907|9708438|P1|Study Overall|Lost to Follow-up|0
2831514|NCT02675907|9708437|P2|Study Overall|Withdrawal by Subject|2
2831515|NCT02675907|9708438|P1|Study Overall|Withdrawal by Subject|2
2831516|NCT02675907|9708437|P2|Study Overall|Lack of Efficacy|0
2831517|NCT02675907|9708438|P1|Study Overall|Lack of Efficacy|1
2831518|NCT02675907|9708437|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2831519|NCT02675907|9708438|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2831520|NCT02675907|9708437|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2831521|NCT02675907|9708438|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2831522|NCT02675751|9708483|P1|Overall Study|Lost to Follow-up|16
2831523|NCT02675634|9708487|P6|Test Period 2|Adverse Event|1
2831524|NCT02675634|9708488|P5|Test Period 2|Adverse Event|0
2831525|NCT02675634|9708489|P4|Test Period 2|Adverse Event|0
2831526|NCT02675634|9708490|P3|Test Period 2|Adverse Event|0
2831527|NCT02675634|9708491|P2|Test Period 2|Adverse Event|0
2831528|NCT02675634|9708492|P1|Test Period 2|Adverse Event|0
2831529|NCT02675634|9708487|P6|Test Period 2|Lack of Efficacy|0
2831530|NCT02675634|9708488|P5|Test Period 2|Lack of Efficacy|0
2831531|NCT02675634|9708489|P4|Test Period 2|Lack of Efficacy|0
2831532|NCT02675634|9708490|P3|Test Period 2|Lack of Efficacy|0
2831533|NCT02675634|9708491|P2|Test Period 2|Lack of Efficacy|0
2831534|NCT02675634|9708492|P1|Test Period 2|Lack of Efficacy|1
2831535|NCT02675634|9708487|P6|Test Period 1|Device deficiency that did not lead to A|0
2831536|NCT02675634|9708488|P5|Test Period 1|Device deficiency that did not lead to A|0
2831537|NCT02675634|9708489|P4|Test Period 1|Device deficiency that did not lead to A|0
2831538|NCT02675634|9708490|P3|Test Period 1|Device deficiency that did not lead to A|1
2831539|NCT02675634|9708491|P2|Test Period 1|Device deficiency that did not lead to A|0
2831540|NCT02675634|9708492|P1|Test Period 1|Device deficiency that did not lead to A|0
2831541|NCT02675634|9708487|P6|Test Period 1|Adverse Event|0
2831542|NCT02675634|9708488|P5|Test Period 1|Adverse Event|0
2831543|NCT02675634|9708489|P4|Test Period 1|Adverse Event|1
2831544|NCT02675634|9708490|P3|Test Period 1|Adverse Event|0
2831545|NCT02675634|9708491|P2|Test Period 1|Adverse Event|1
2831546|NCT02675634|9708492|P1|Test Period 1|Adverse Event|0
2831547|NCT02675517|9708509|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
2831548|NCT02675517|9708509|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
2831549|NCT02675426|9708521|P3|Overall Study|Other|2
2831550|NCT02675426|9708522|P2|Overall Study|Other|1
2831551|NCT02675426|9708523|P1|Overall Study|Other|3
2831552|NCT02675426|9708521|P3|Overall Study|Lost to Follow-up|2
2831553|NCT02675426|9708522|P2|Overall Study|Lost to Follow-up|0
2831554|NCT02675426|9708523|P1|Overall Study|Lost to Follow-up|1
2831555|NCT02675426|9708521|P3|Overall Study|Withdrawal by Subject|5
2831556|NCT02675426|9708522|P2|Overall Study|Withdrawal by Subject|5
2831557|NCT02675426|9708523|P1|Overall Study|Withdrawal by Subject|3
2831558|NCT02675426|9708521|P3|Overall Study|Adverse Event|9
2831559|NCT02675426|9708522|P2|Overall Study|Adverse Event|2
2831560|NCT02675426|9708523|P1|Overall Study|Adverse Event|6
2831561|NCT02675231|9708567|P3|Overall Study|On study treatment/follow up|23
2831562|NCT02675231|9708568|P2|Overall Study|On study treatment/follow up|31
2831563|NCT02675231|9708569|P1|Overall Study|On study treatment/follow up|23
2831564|NCT02675231|9708567|P3|Overall Study|Lost to Follow-up|2
2831565|NCT02675231|9708568|P2|Overall Study|Lost to Follow-up|2
2831566|NCT02675231|9708569|P1|Overall Study|Lost to Follow-up|2
2831567|NCT02675231|9708567|P3|Overall Study|Withdrawal by Subject|1
2831568|NCT02675231|9708568|P2|Overall Study|Withdrawal by Subject|3
2831569|NCT02675231|9708569|P1|Overall Study|Withdrawal by Subject|1
2831570|NCT02674854|9708606|P3|Overall Study|Subject missed V6.2|0
2831571|NCT02674854|9708607|P2|Overall Study|Subject missed V6.2|0
2831572|NCT02674854|9708608|P1|Overall Study|Subject missed V6.2|1
2831573|NCT02674854|9708606|P3|Overall Study|Death|0
2831574|NCT02674854|9708607|P2|Overall Study|Death|1
2831575|NCT02674854|9708608|P1|Overall Study|Death|0
2831576|NCT02674854|9708606|P3|Overall Study|Protocol Violation|2
2831577|NCT02674854|9708607|P2|Overall Study|Protocol Violation|1
2831578|NCT02674854|9708608|P1|Overall Study|Protocol Violation|1
2831579|NCT02674854|9708606|P3|Overall Study|Disallowed Concurrent Medication|0
2831580|NCT02674854|9708607|P2|Overall Study|Disallowed Concurrent Medication|2
2831581|NCT02674854|9708608|P1|Overall Study|Disallowed Concurrent Medication|2
2831582|NCT02674854|9708606|P3|Overall Study|Lack of Efficacy|0
2831583|NCT02674854|9708607|P2|Overall Study|Lack of Efficacy|3
2831584|NCT02674854|9708608|P1|Overall Study|Lack of Efficacy|0
2831585|NCT02674854|9708606|P3|Overall Study|Lost to Follow-up|2
2831586|NCT02674854|9708607|P2|Overall Study|Lost to Follow-up|0
2831587|NCT02674854|9708608|P1|Overall Study|Lost to Follow-up|1
2831588|NCT02674854|9708606|P3|Overall Study|No-compliant subject|1
2831589|NCT02674854|9708607|P2|Overall Study|No-compliant subject|0
2831590|NCT02674854|9708608|P1|Overall Study|No-compliant subject|1
2831591|NCT02674854|9708606|P3|Overall Study|Withdrawal by Subject|4
2831592|NCT02674854|9708607|P2|Overall Study|Withdrawal by Subject|5
2831593|NCT02674854|9708608|P1|Overall Study|Withdrawal by Subject|1
2831594|NCT02674854|9708606|P3|Overall Study|Adverse Event|5
2831595|NCT02674854|9708607|P2|Overall Study|Adverse Event|15
2831596|NCT02674854|9708608|P1|Overall Study|Adverse Event|17
2831597|NCT02674568|9708641|P1|Overall Study|Other, Not Specified|20
2831598|NCT02674568|9708641|P1|Overall Study|Lost to Follow-up|9
2831599|NCT02674568|9708641|P1|Overall Study|Physician Decision|2
2831600|NCT02674568|9708641|P1|Overall Study|Death|303
2831601|NCT02674568|9708641|P1|Overall Study|Withdrawal by Subject|5
2831602|NCT02674477|9708666|P2|Overall Study|Protocol Violation|2
2831603|NCT02674477|9708667|P1|Overall Study|Protocol Violation|8
2831604|NCT02674334|9708690|P2|Overall Study|NIRS not recording|0
2831605|NCT02674334|9708691|P1|Overall Study|NIRS not recording|1
2831606|NCT02674334|9708690|P2|Overall Study|participant difficulty breathing|0
2831607|NCT02674334|9708691|P1|Overall Study|participant difficulty breathing|1
2831608|NCT02674334|9708690|P2|Overall Study|Lost to Follow-up|3
2831609|NCT02674334|9708691|P1|Overall Study|Lost to Follow-up|5
2831610|NCT02674204|9708701|P2|Overall Study|Adverse Event|0
2831611|NCT02674204|9708702|P1|Overall Study|Adverse Event|1
2831612|NCT02673684|9708772|P2|Overall Study|Study not completed d/t loss of funding|8
2831613|NCT02673684|9708773|P1|Overall Study|Study not completed d/t loss of funding|9
2831614|NCT02673619|9708789|P4|Overall Study|Lack of Efficacy|0
2831615|NCT02673619|9708790|P3|Overall Study|Lack of Efficacy|1
2831616|NCT02673619|9708791|P2|Overall Study|Lack of Efficacy|0
2831617|NCT02673619|9708792|P1|Overall Study|Lack of Efficacy|0
2831618|NCT02673619|9708789|P4|Overall Study|Adverse Event|0
2831619|NCT02673619|9708790|P3|Overall Study|Adverse Event|1
2831620|NCT02673619|9708791|P2|Overall Study|Adverse Event|0
2831621|NCT02673619|9708792|P1|Overall Study|Adverse Event|0
2831622|NCT02673619|9708789|P4|Overall Study|Withdrawal by Subject|0
2831623|NCT02673619|9708790|P3|Overall Study|Withdrawal by Subject|1
2831624|NCT02673619|9708791|P2|Overall Study|Withdrawal by Subject|1
2831625|NCT02673619|9708792|P1|Overall Study|Withdrawal by Subject|1
2831626|NCT02673619|9708789|P4|Overall Study|Lost to Follow-up|0
2831627|NCT02673619|9708790|P3|Overall Study|Lost to Follow-up|0
2831628|NCT02673619|9708791|P2|Overall Study|Lost to Follow-up|0
2831629|NCT02673619|9708792|P1|Overall Study|Lost to Follow-up|1
2831630|NCT02673515|9708903|P2|Overall Study|Lack of motivation|1
2831631|NCT02673515|9708904|P1|Overall Study|Lack of motivation|2
2831632|NCT02673489|9708920|P2|Follow Up Period|Unable to return for follow-up|1
2831633|NCT02673489|9708921|P1|Follow Up Period|Unable to return for follow-up|0
2831634|NCT02673489|9708920|P2|Follow Up Period|Unable to return for week 24 follow-up|1
2831635|NCT02673489|9708921|P1|Follow Up Period|Unable to return for week 24 follow-up|0
2831636|NCT02673489|9708920|P2|Treatment Period|Adverse Event|1
2831637|NCT02673489|9708921|P1|Treatment Period|Adverse Event|0
2831638|NCT02673489|9708920|P2|Treatment Period|Participant was incarcerated|1
2831639|NCT02673489|9708921|P1|Treatment Period|Participant was incarcerated|0
2831640|NCT02673489|9708920|P2|Treatment Period|Participant moved to another province|0
2831641|NCT02673489|9708921|P1|Treatment Period|Participant moved to another province|1
2831642|NCT02673489|9708920|P2|Treatment Period|Participant request to discontinue|1
2831643|NCT02673489|9708921|P1|Treatment Period|Participant request to discontinue|1
2831644|NCT02673489|9708920|P2|Treatment Period|Lost to Follow-up|0
2831645|NCT02673489|9708921|P1|Treatment Period|Lost to Follow-up|3
2831646|NCT02672852|9708986|P7|Part B|Other|2
2831647|NCT02672852|9708987|P6|Part B|Other|1
2831648|NCT02672852|9708988|P5|Part B|Other|4
2831649|NCT02672852|9708989|P4|Part B|Other|0
2831650|NCT02672852|9708990|P3|Part B|Other|0
2831651|NCT02672852|9708991|P2|Part B|Other|0
2831652|NCT02672852|9708992|P1|Part B|Other|0
2831653|NCT02672852|9708986|P7|Part B|Withdrawal by Subject|7
2831654|NCT02672852|9708987|P6|Part B|Withdrawal by Subject|0
2831655|NCT02672852|9708988|P5|Part B|Withdrawal by Subject|5
2831656|NCT02672852|9708989|P4|Part B|Withdrawal by Subject|0
2831657|NCT02672852|9708990|P3|Part B|Withdrawal by Subject|0
2831658|NCT02672852|9708991|P2|Part B|Withdrawal by Subject|0
2831659|NCT02672852|9708992|P1|Part B|Withdrawal by Subject|0
2831660|NCT02672852|9708986|P7|Part B|Lost to Follow-up|1
2831661|NCT02672852|9708987|P6|Part B|Lost to Follow-up|4
2831662|NCT02672852|9708988|P5|Part B|Lost to Follow-up|3
2831663|NCT02672852|9708989|P4|Part B|Lost to Follow-up|0
2831664|NCT02672852|9708990|P3|Part B|Lost to Follow-up|0
2831665|NCT02672852|9708991|P2|Part B|Lost to Follow-up|0
2831666|NCT02672852|9708992|P1|Part B|Lost to Follow-up|0
2831667|NCT02672852|9708986|P7|Part B|Other adverse event|1
2831668|NCT02672852|9708987|P6|Part B|Other adverse event|5
2831669|NCT02672852|9708988|P5|Part B|Other adverse event|3
2831670|NCT02672852|9708989|P4|Part B|Other adverse event|0
2831671|NCT02672852|9708990|P3|Part B|Other adverse event|0
2831672|NCT02672852|9708991|P2|Part B|Other adverse event|0
2831673|NCT02672852|9708992|P1|Part B|Other adverse event|0
2831674|NCT02672852|9708986|P7|Part B|Worsening pre-existing condition|0
2831675|NCT02672852|9708987|P6|Part B|Worsening pre-existing condition|1
2831676|NCT02672852|9708988|P5|Part B|Worsening pre-existing condition|0
2831677|NCT02672852|9708989|P4|Part B|Worsening pre-existing condition|0
2831678|NCT02672852|9708990|P3|Part B|Worsening pre-existing condition|0
2831679|NCT02672852|9708991|P2|Part B|Worsening pre-existing condition|0
2831680|NCT02672852|9708992|P1|Part B|Worsening pre-existing condition|0
2831681|NCT02672852|9708986|P7|Part B|Disease worsening|1
2831682|NCT02672852|9708987|P6|Part B|Disease worsening|0
2831683|NCT02672852|9708988|P5|Part B|Disease worsening|1
2831684|NCT02672852|9708989|P4|Part B|Disease worsening|0
2831685|NCT02672852|9708990|P3|Part B|Disease worsening|0
2831686|NCT02672852|9708991|P2|Part B|Disease worsening|0
2831687|NCT02672852|9708992|P1|Part B|Disease worsening|0
2831688|NCT02672852|9708986|P7|Part A2|Not entered in Part B|0
2831689|NCT02672852|9708987|P6|Part A2|Not entered in Part B|0
2831690|NCT02672852|9708988|P5|Part A2|Not entered in Part B|0
2831691|NCT02672852|9708989|P4|Part A2|Not entered in Part B|4
2831692|NCT02672852|9708990|P3|Part A2|Not entered in Part B|0
2831693|NCT02672852|9708991|P2|Part A2|Not entered in Part B|0
2831694|NCT02672852|9708992|P1|Part A2|Not entered in Part B|0
2831695|NCT02672852|9708986|P7|Part A2|Other|0
2831696|NCT02672852|9708987|P6|Part A2|Other|0
2831697|NCT02672852|9708988|P5|Part A2|Other|0
2831698|NCT02672852|9708989|P4|Part A2|Other|0
2831699|NCT02672852|9708990|P3|Part A2|Other|3
2831700|NCT02672852|9708991|P2|Part A2|Other|0
2831701|NCT02672852|9708992|P1|Part A2|Other|0
2831702|NCT02672852|9708986|P7|Part A2|Withdrawal by Subject|0
2831703|NCT02672852|9708987|P6|Part A2|Withdrawal by Subject|0
2831704|NCT02672852|9708988|P5|Part A2|Withdrawal by Subject|0
2831705|NCT02672852|9708989|P4|Part A2|Withdrawal by Subject|0
2831706|NCT02672852|9708990|P3|Part A2|Withdrawal by Subject|1
2831707|NCT02672852|9708991|P2|Part A2|Withdrawal by Subject|0
2831708|NCT02672852|9708992|P1|Part A2|Withdrawal by Subject|0
2831709|NCT02672852|9708986|P7|Part A2|Lost to Follow-up|0
2831710|NCT02672852|9708987|P6|Part A2|Lost to Follow-up|0
2831711|NCT02672852|9708988|P5|Part A2|Lost to Follow-up|0
2831712|NCT02672852|9708989|P4|Part A2|Lost to Follow-up|0
2831713|NCT02672852|9708990|P3|Part A2|Lost to Follow-up|2
2831714|NCT02672852|9708991|P2|Part A2|Lost to Follow-up|0
2831715|NCT02672852|9708992|P1|Part A2|Lost to Follow-up|0
2831716|NCT02672852|9708986|P7|Part A2|Adverse Event|0
2831717|NCT02672852|9708987|P6|Part A2|Adverse Event|0
2831718|NCT02672852|9708988|P5|Part A2|Adverse Event|0
2831719|NCT02672852|9708989|P4|Part A2|Adverse Event|0
2831720|NCT02672852|9708990|P3|Part A2|Adverse Event|3
2831721|NCT02672852|9708991|P2|Part A2|Adverse Event|0
2831722|NCT02672852|9708992|P1|Part A2|Adverse Event|0
2831723|NCT02672852|9708986|P7|Part A2|Disease worsening|0
2831724|NCT02672852|9708987|P6|Part A2|Disease worsening|0
2831725|NCT02672852|9708988|P5|Part A2|Disease worsening|0
2831726|NCT02672852|9708989|P4|Part A2|Disease worsening|0
2831727|NCT02672852|9708990|P3|Part A2|Disease worsening|1
2831728|NCT02672852|9708991|P2|Part A2|Disease worsening|0
2831729|NCT02672852|9708992|P1|Part A2|Disease worsening|0
2831730|NCT02672852|9708986|P7|Part A1|Withdrawal by Subject|0
2831731|NCT02672852|9708987|P6|Part A1|Withdrawal by Subject|0
2831732|NCT02672852|9708988|P5|Part A1|Withdrawal by Subject|0
2831733|NCT02672852|9708989|P4|Part A1|Withdrawal by Subject|0
2831734|NCT02672852|9708990|P3|Part A1|Withdrawal by Subject|0
2831735|NCT02672852|9708991|P2|Part A1|Withdrawal by Subject|1
2831736|NCT02672852|9708992|P1|Part A1|Withdrawal by Subject|1
2831737|NCT02672852|9708986|P7|Part A1|Lost to Follow-up|0
2831738|NCT02672852|9708987|P6|Part A1|Lost to Follow-up|0
2831739|NCT02672852|9708988|P5|Part A1|Lost to Follow-up|0
2831740|NCT02672852|9708989|P4|Part A1|Lost to Follow-up|0
2831741|NCT02672852|9708990|P3|Part A1|Lost to Follow-up|0
2831742|NCT02672852|9708991|P2|Part A1|Lost to Follow-up|2
2831743|NCT02672852|9708992|P1|Part A1|Lost to Follow-up|1
2831744|NCT02672852|9708986|P7|Part A1|Adverse Event|0
2831745|NCT02672852|9708987|P6|Part A1|Adverse Event|0
2831746|NCT02672852|9708988|P5|Part A1|Adverse Event|0
2831747|NCT02672852|9708989|P4|Part A1|Adverse Event|0
2831748|NCT02672852|9708990|P3|Part A1|Adverse Event|0
2831749|NCT02672852|9708991|P2|Part A1|Adverse Event|1
2831750|NCT02672852|9708992|P1|Part A1|Adverse Event|0
2831751|NCT02672852|9708986|P7|Part A1|Disease Worsening|0
2831752|NCT02672852|9708987|P6|Part A1|Disease Worsening|0
2831753|NCT02672852|9708988|P5|Part A1|Disease Worsening|0
2831754|NCT02672852|9708989|P4|Part A1|Disease Worsening|0
2831755|NCT02672852|9708990|P3|Part A1|Disease Worsening|0
2831756|NCT02672852|9708991|P2|Part A1|Disease Worsening|0
2831757|NCT02672852|9708992|P1|Part A1|Disease Worsening|1
2831758|NCT02672553|9709023|P2|Overall Study|Intraoperative screen failure|0
2831759|NCT02672553|9709024|P1|Overall Study|Intraoperative screen failure|2
2831760|NCT02672553|9709023|P2|Overall Study|Withdrawal by Subject|3
2831761|NCT02672553|9709024|P1|Overall Study|Withdrawal by Subject|3
2831762|NCT02672553|9709023|P2|Overall Study|Conversion to Commercial Valve|0
2831763|NCT02672553|9709024|P1|Overall Study|Conversion to Commercial Valve|3
2831764|NCT02672553|9709023|P2|Overall Study|Valve Explant|0
2831765|NCT02672553|9709024|P1|Overall Study|Valve Explant|1
2831766|NCT02672553|9709023|P2|Overall Study|Death|5
2831767|NCT02672553|9709024|P1|Overall Study|Death|3
2831768|NCT02672423|9709096|P10|Period 3|Physician Decision|0
2831769|NCT02672423|9709097|P9|Period 3|Physician Decision|0
2831770|NCT02672423|9709098|P8|Period 3|Physician Decision|0
2831771|NCT02672423|9709099|P7|Period 3|Physician Decision|0
2831772|NCT02672423|9709100|P6|Period 3|Physician Decision|1
2831773|NCT02672423|9709101|P5|Period 3|Physician Decision|0
2831774|NCT02672423|9709102|P4|Period 3|Physician Decision|0
2831775|NCT02672423|9709103|P3|Period 3|Physician Decision|0
2831776|NCT02672423|9709104|P2|Period 3|Physician Decision|0
2831777|NCT02672423|9709105|P1|Period 3|Physician Decision|0
2831778|NCT02672423|9709096|P10|Period 3|Withdrawal by Subject|0
2831779|NCT02672423|9709097|P9|Period 3|Withdrawal by Subject|0
2831780|NCT02672423|9709098|P8|Period 3|Withdrawal by Subject|1
2831781|NCT02672423|9709099|P7|Period 3|Withdrawal by Subject|0
2831782|NCT02672423|9709100|P6|Period 3|Withdrawal by Subject|0
2831783|NCT02672423|9709101|P5|Period 3|Withdrawal by Subject|0
2831784|NCT02672423|9709102|P4|Period 3|Withdrawal by Subject|0
2831785|NCT02672423|9709103|P3|Period 3|Withdrawal by Subject|0
2831786|NCT02672423|9709104|P2|Period 3|Withdrawal by Subject|0
2831787|NCT02672423|9709105|P1|Period 3|Withdrawal by Subject|0
2831788|NCT02672423|9709096|P10|Period 2|Withdrawal by Subject|0
2831789|NCT02672423|9709097|P9|Period 2|Withdrawal by Subject|0
2831790|NCT02672423|9709098|P8|Period 2|Withdrawal by Subject|0
2831791|NCT02672423|9709099|P7|Period 2|Withdrawal by Subject|0
2831792|NCT02672423|9709100|P6|Period 2|Withdrawal by Subject|0
2831793|NCT02672423|9709101|P5|Period 2|Withdrawal by Subject|0
2831794|NCT02672423|9709102|P4|Period 2|Withdrawal by Subject|0
2831795|NCT02672423|9709103|P3|Period 2|Withdrawal by Subject|1
2831796|NCT02672423|9709104|P2|Period 2|Withdrawal by Subject|0
2831797|NCT02672423|9709105|P1|Period 2|Withdrawal by Subject|0
2831798|NCT02672423|9709096|P10|Period 1|Adverse Event|0
2831799|NCT02672423|9709097|P9|Period 1|Adverse Event|0
2831800|NCT02672423|9709098|P8|Period 1|Adverse Event|0
2831801|NCT02672423|9709099|P7|Period 1|Adverse Event|0
2831802|NCT02672423|9709100|P6|Period 1|Adverse Event|0
2831803|NCT02672423|9709101|P5|Period 1|Adverse Event|1
2831804|NCT02672423|9709102|P4|Period 1|Adverse Event|0
2831805|NCT02672423|9709103|P3|Period 1|Adverse Event|0
2831806|NCT02672423|9709104|P2|Period 1|Adverse Event|0
2831807|NCT02672423|9709105|P1|Period 1|Adverse Event|0
2831808|NCT02671760|9709200|P3|Overall Study|Lost to Follow-up|0
2831809|NCT02671760|9709201|P2|Overall Study|Lost to Follow-up|1
2831810|NCT02671760|9709202|P1|Overall Study|Lost to Follow-up|0
2831811|NCT02671500|9709228|P1|Overall Study|Lost to Follow-up|2
2831812|NCT02671500|9709228|P1|Overall Study|Lack of Efficacy|12
2831813|NCT02671461|9709243|P3|Follow-up|Administrative Reason by Sponsor|0
2831814|NCT02671461|9709244|P2|Follow-up|Administrative Reason by Sponsor|1
2831815|NCT02671461|9709245|P1|Follow-up|Administrative Reason by Sponsor|0
2831816|NCT02671461|9709243|P3|Follow-up|Lost to Follow-up|1
2831817|NCT02671461|9709244|P2|Follow-up|Lost to Follow-up|0
2831818|NCT02671461|9709245|P1|Follow-up|Lost to Follow-up|0
2831819|NCT02671461|9709243|P3|Follow-up|Withdrawal by Subject|0
2831820|NCT02671461|9709244|P2|Follow-up|Withdrawal by Subject|0
2831821|NCT02671461|9709245|P1|Follow-up|Withdrawal by Subject|1
2831822|NCT02671461|9709243|P3|Treatment|Randomized, not treated|0
2831823|NCT02671461|9709244|P2|Treatment|Randomized, not treated|0
2831824|NCT02671461|9709245|P1|Treatment|Randomized, not treated|1
2831825|NCT02671461|9709243|P3|Treatment|Administrative Reason by Sponsor|4
2831826|NCT02671461|9709244|P2|Treatment|Administrative Reason by Sponsor|3
2831827|NCT02671461|9709245|P1|Treatment|Administrative Reason by Sponsor|1
2831828|NCT02671461|9709243|P3|Treatment|Adverse Event|1
2831829|NCT02671461|9709244|P2|Treatment|Adverse Event|0
2831830|NCT02671461|9709245|P1|Treatment|Adverse Event|0
2831831|NCT02671266|9709270|P2|Overall Study|Withdrawal by Subject|1
2831832|NCT02671266|9709271|P1|Overall Study|Withdrawal by Subject|1
2831833|NCT02670928|9709294|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
2831834|NCT02670928|9709295|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
2831835|NCT02670928|9709294|P2|Overall Study|Lost to Follow-up|0
2831836|NCT02670928|9709295|P1|Overall Study|Lost to Follow-up|1
2831837|NCT02670928|9709294|P2|Overall Study|Withdrawal by Subject|0
2831838|NCT02670928|9709295|P1|Overall Study|Withdrawal by Subject|4
2831839|NCT02670928|9709294|P2|Overall Study|Adverse Event|1
2831840|NCT02670928|9709295|P1|Overall Study|Adverse Event|3
2831841|NCT02670915|9709322|P3|Overall Study|Unclassified|0
2831842|NCT02670915|9709323|P2|Overall Study|Unclassified|3
2831843|NCT02670915|9709324|P1|Overall Study|Unclassified|0
2831844|NCT02670915|9709322|P3|Overall Study|Withdrawal by parent/guardian|1
2831845|NCT02670915|9709323|P2|Overall Study|Withdrawal by parent/guardian|4
2831846|NCT02670915|9709324|P1|Overall Study|Withdrawal by parent/guardian|4
2831847|NCT02670915|9709322|P3|Overall Study|Withdrawal by Subject|4
2831848|NCT02670915|9709323|P2|Overall Study|Withdrawal by Subject|1
2831849|NCT02670915|9709324|P1|Overall Study|Withdrawal by Subject|0
2831850|NCT02670551|9709608|P3|Overall Study|Did Not Receive Treatment|0
2831851|NCT02670551|9709609|P2|Overall Study|Did Not Receive Treatment|3
2831852|NCT02670551|9709610|P1|Overall Study|Did Not Receive Treatment|5
2831853|NCT02670551|9709608|P3|Overall Study|Other Miscellaneous Reasons|3
2831854|NCT02670551|9709609|P2|Overall Study|Other Miscellaneous Reasons|3
2831855|NCT02670551|9709610|P1|Overall Study|Other Miscellaneous Reasons|2
2831856|NCT02670551|9709608|P3|Overall Study|Noncompliance with study drug|2
2831857|NCT02670551|9709609|P2|Overall Study|Noncompliance with study drug|3
2831858|NCT02670551|9709610|P1|Overall Study|Noncompliance with study drug|3
2831859|NCT02670551|9709608|P3|Overall Study|Protocol Violation|0
2831860|NCT02670551|9709609|P2|Overall Study|Protocol Violation|0
2831861|NCT02670551|9709610|P1|Overall Study|Protocol Violation|1
2831862|NCT02670551|9709608|P3|Overall Study|Lost to Follow-up|6
2831863|NCT02670551|9709609|P2|Overall Study|Lost to Follow-up|7
2831864|NCT02670551|9709610|P1|Overall Study|Lost to Follow-up|5
2831865|NCT02670551|9709608|P3|Overall Study|Withdrawal of Consent|8
2831866|NCT02670551|9709609|P2|Overall Study|Withdrawal of Consent|3
2831867|NCT02670551|9709610|P1|Overall Study|Withdrawal of Consent|6
2831868|NCT02670551|9709608|P3|Overall Study|Lack of Efficacy|3
2831869|NCT02670551|9709609|P2|Overall Study|Lack of Efficacy|0
2831870|NCT02670551|9709610|P1|Overall Study|Lack of Efficacy|2
2831871|NCT02670551|9709608|P3|Overall Study|Adverse Event|9
2831872|NCT02670551|9709609|P2|Overall Study|Adverse Event|7
2831873|NCT02670551|9709610|P1|Overall Study|Adverse Event|4
2831874|NCT02670538|9709624|P3|Overall Study|Other Miscellaneous Reasons|2
2831875|NCT02670538|9709625|P2|Overall Study|Other Miscellaneous Reasons|1
2831876|NCT02670538|9709626|P1|Overall Study|Other Miscellaneous Reasons|0
2831877|NCT02670538|9709624|P3|Overall Study|Noncompliance with Study Drug|2
2831878|NCT02670538|9709625|P2|Overall Study|Noncompliance with Study Drug|3
2831879|NCT02670538|9709626|P1|Overall Study|Noncompliance with Study Drug|1
2831880|NCT02670538|9709624|P3|Overall Study|Protocol Violation|1
2831881|NCT02670538|9709625|P2|Overall Study|Protocol Violation|4
2831882|NCT02670538|9709626|P1|Overall Study|Protocol Violation|3
2831883|NCT02670538|9709624|P3|Overall Study|Lack of Efficacy|2
2831884|NCT02670538|9709625|P2|Overall Study|Lack of Efficacy|1
2831885|NCT02670538|9709626|P1|Overall Study|Lack of Efficacy|7
2831886|NCT02670538|9709624|P3|Overall Study|Adverse Event|11
2831887|NCT02670538|9709625|P2|Overall Study|Adverse Event|5
2831888|NCT02670538|9709626|P1|Overall Study|Adverse Event|5
2831889|NCT02670538|9709624|P3|Overall Study|Lost to Follow-up|7
2831890|NCT02670538|9709625|P2|Overall Study|Lost to Follow-up|12
2831891|NCT02670538|9709626|P1|Overall Study|Lost to Follow-up|8
2831892|NCT02670538|9709624|P3|Overall Study|Withdrawal of Consent|5
2831893|NCT02670538|9709625|P2|Overall Study|Withdrawal of Consent|6
2831894|NCT02670538|9709626|P1|Overall Study|Withdrawal of Consent|8
2831895|NCT02670473|9709637|P1|Overall Study|Withdrawal by Subject|1
2831896|NCT02670330|9709696|P2|Overall Study|Lost to Follow-up|2
2831897|NCT02670330|9709697|P1|Overall Study|Lost to Follow-up|3
2831898|NCT02670330|9709696|P2|Overall Study|Withdrawal by Subject|29
2831899|NCT02670330|9709697|P1|Overall Study|Withdrawal by Subject|34
2831900|NCT02670330|9709696|P2|Overall Study|Adverse Event|3
2831901|NCT02670330|9709697|P1|Overall Study|Adverse Event|1
2831902|NCT02670330|9709696|P2|Overall Study|Study Terminated By Sponsor|43
2831903|NCT02670330|9709697|P1|Overall Study|Study Terminated By Sponsor|36
2831904|NCT02670330|9709696|P2|Overall Study|Protocol Deviation|0
2831905|NCT02670330|9709697|P1|Overall Study|Protocol Deviation|1
2831906|NCT02669940|9709709|P2|Overall Study|Insufficient follow-up data|0
2831907|NCT02669940|9709710|P1|Overall Study|Insufficient follow-up data|1
2831908|NCT02669940|9709709|P2|Overall Study|Failure to return|3
2831909|NCT02669940|9709710|P1|Overall Study|Failure to return|0
2831910|NCT02669862|9709812|P3|Overall Study|Protocol Violation|1
2831911|NCT02669862|9709813|P2|Overall Study|Protocol Violation|0
2831912|NCT02669862|9709814|P1|Overall Study|Protocol Violation|0
2831913|NCT02669862|9709812|P3|Overall Study|moved|0
2831914|NCT02669862|9709813|P2|Overall Study|moved|1
2831915|NCT02669862|9709814|P1|Overall Study|moved|0
2831916|NCT02669862|9709812|P3|Overall Study|Withdrawal by Subject|3
2831917|NCT02669862|9709813|P2|Overall Study|Withdrawal by Subject|2
2831918|NCT02669862|9709814|P1|Overall Study|Withdrawal by Subject|2
2831919|NCT02669862|9709812|P3|Overall Study|Lost to Follow-up|1
2831920|NCT02669862|9709813|P2|Overall Study|Lost to Follow-up|2
2831921|NCT02669862|9709814|P1|Overall Study|Lost to Follow-up|0
2831922|NCT02669849|9709830|P3|Overall Study|Other|2
2831923|NCT02669849|9709831|P2|Overall Study|Other|0
2831924|NCT02669849|9709832|P1|Overall Study|Other|0
2831925|NCT02669849|9709830|P3|Overall Study|Study terminated by sponsor|14
2831926|NCT02669849|9709831|P2|Overall Study|Study terminated by sponsor|1
2831927|NCT02669849|9709832|P1|Overall Study|Study terminated by sponsor|16
2831928|NCT02669849|9709830|P3|Overall Study|Death|2
2831929|NCT02669849|9709831|P2|Overall Study|Death|1
2831930|NCT02669849|9709832|P1|Overall Study|Death|1
2831931|NCT02669849|9709830|P3|Overall Study|Lost to Follow-up|3
2831932|NCT02669849|9709831|P2|Overall Study|Lost to Follow-up|0
2831933|NCT02669849|9709832|P1|Overall Study|Lost to Follow-up|1
2831934|NCT02669849|9709830|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
2831935|NCT02669849|9709831|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
2831936|NCT02669849|9709832|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
2831937|NCT02669758|9709875|P1|Overall Study|Protocol Violation|1
2831938|NCT02669758|9709875|P1|Overall Study|Study noncompliance|1
2831939|NCT02669758|9709875|P1|Overall Study|Pregnancy|1
2831940|NCT02669758|9709875|P1|Overall Study|Lack of Efficacy|5
2831941|NCT02669758|9709875|P1|Overall Study|Non-Compliance with Study Drug|8
2831942|NCT02669758|9709875|P1|Overall Study|Adverse Event|16
2831943|NCT02669758|9709875|P1|Overall Study|Lost to Follow-up|19
2831944|NCT02669758|9709875|P1|Overall Study|Withdrawal by Subject|43
2831945|NCT02669667|9709886|P7|Overall Study|Lost to Follow-up|0
2831946|NCT02669667|9709887|P6|Overall Study|Lost to Follow-up|1
2831947|NCT02669667|9709888|P5|Overall Study|Lost to Follow-up|0
2831948|NCT02669667|9709889|P4|Overall Study|Lost to Follow-up|0
2831949|NCT02669667|9709890|P3|Overall Study|Lost to Follow-up|0
2831950|NCT02669667|9709891|P2|Overall Study|Lost to Follow-up|0
2831951|NCT02669667|9709892|P1|Overall Study|Lost to Follow-up|0
2831952|NCT02669433|9709995|P3|Overall Study|Death|1
2831953|NCT02669433|9709996|P2|Overall Study|Death|1
2831954|NCT02669433|9709997|P1|Overall Study|Death|0
2831955|NCT02669433|9709995|P3|Overall Study|Withdrawal by Caregiver|2
2831956|NCT02669433|9709996|P2|Overall Study|Withdrawal by Caregiver|0
2831957|NCT02669433|9709997|P1|Overall Study|Withdrawal by Caregiver|1
2831958|NCT02669433|9709995|P3|Overall Study|Withdrawal by Subject|0
2831959|NCT02669433|9709996|P2|Overall Study|Withdrawal by Subject|1
2831960|NCT02669433|9709997|P1|Overall Study|Withdrawal by Subject|5
2831961|NCT02669433|9709995|P3|Overall Study|Sponsor Termination|1
2831962|NCT02669433|9709996|P2|Overall Study|Sponsor Termination|0
2831963|NCT02669433|9709997|P1|Overall Study|Sponsor Termination|1
2831964|NCT02669433|9709995|P3|Overall Study|Adverse Event|10
2831965|NCT02669433|9709996|P2|Overall Study|Adverse Event|7
2831966|NCT02669433|9709997|P1|Overall Study|Adverse Event|6
2831967|NCT02669433|9709995|P3|Overall Study|Physician Decision|0
2831968|NCT02669433|9709996|P2|Overall Study|Physician Decision|1
2831969|NCT02669433|9709997|P1|Overall Study|Physician Decision|1
2831970|NCT02669433|9709995|P3|Overall Study|Disease Progression|0
2831971|NCT02669433|9709996|P2|Overall Study|Disease Progression|0
2831972|NCT02669433|9709997|P1|Overall Study|Disease Progression|1
2831973|NCT02669433|9709995|P3|Overall Study|Protocol Violation|1
2831974|NCT02669433|9709996|P2|Overall Study|Protocol Violation|4
2831975|NCT02669433|9709997|P1|Overall Study|Protocol Violation|0
2831976|NCT02669407|9710011|P1|Overall Study|Physician Decision|3
2831977|NCT02669264|9710035|P7|Overall Study|Miscellaneous|2
2831978|NCT02669264|9710036|P6|Overall Study|Miscellaneous|0
2831979|NCT02669264|9710037|P5|Overall Study|Miscellaneous|0
2831980|NCT02669264|9710038|P4|Overall Study|Miscellaneous|0
2831981|NCT02669264|9710039|P3|Overall Study|Miscellaneous|0
2831982|NCT02669264|9710040|P2|Overall Study|Miscellaneous|0
2831983|NCT02669264|9710041|P1|Overall Study|Miscellaneous|0
2831984|NCT02669264|9710035|P7|Overall Study|Lost to Follow-up|0
2831985|NCT02669264|9710036|P6|Overall Study|Lost to Follow-up|0
2831986|NCT02669264|9710037|P5|Overall Study|Lost to Follow-up|1
2831987|NCT02669264|9710038|P4|Overall Study|Lost to Follow-up|0
2831988|NCT02669264|9710039|P3|Overall Study|Lost to Follow-up|0
2831989|NCT02669264|9710040|P2|Overall Study|Lost to Follow-up|0
2831990|NCT02669264|9710041|P1|Overall Study|Lost to Follow-up|0
2831991|NCT02669264|9710035|P7|Overall Study|Withdrawal by Subject|0
2831992|NCT02669264|9710036|P6|Overall Study|Withdrawal by Subject|0
2831993|NCT02669264|9710037|P5|Overall Study|Withdrawal by Subject|1
2831994|NCT02669264|9710038|P4|Overall Study|Withdrawal by Subject|0
2831995|NCT02669264|9710039|P3|Overall Study|Withdrawal by Subject|0
2831996|NCT02669264|9710040|P2|Overall Study|Withdrawal by Subject|1
2831997|NCT02669264|9710041|P1|Overall Study|Withdrawal by Subject|0
2831998|NCT02669264|9710035|P7|Overall Study|Death|3
2831999|NCT02669264|9710036|P6|Overall Study|Death|6
2832000|NCT02669264|9710037|P5|Overall Study|Death|3
2832001|NCT02669264|9710038|P4|Overall Study|Death|3
2832002|NCT02669264|9710039|P3|Overall Study|Death|3
2832003|NCT02669264|9710040|P2|Overall Study|Death|5
2832004|NCT02669264|9710041|P1|Overall Study|Death|5
2832005|NCT02669095|9710187|P2|Overall Study|Visit 5 assessments not completed|1
2832006|NCT02669095|9710188|P1|Overall Study|Visit 5 assessments not completed|0
2832007|NCT02669095|9710187|P2|Overall Study|Torn Lens|1
2832008|NCT02669095|9710188|P1|Overall Study|Torn Lens|0
2832009|NCT02669095|9710187|P2|Overall Study|Unsatisfactory Lens Fitting|1
2832010|NCT02669095|9710188|P1|Overall Study|Unsatisfactory Lens Fitting|0
2832011|NCT02669095|9710187|P2|Overall Study|Adverse Event|0
2832012|NCT02669095|9710188|P1|Overall Study|Adverse Event|1
2832013|NCT02669082|9710196|P1|Overall Study|Adverse Event|1
2832014|NCT02669043|9710208|P1|Overall Study|Didn't meet I/E criteria|4
2832015|NCT02669017|9710221|P9|Overall Study|Miscellaneous|2
2832016|NCT02669017|9710222|P8|Overall Study|Miscellaneous|13
2832017|NCT02669017|9710223|P7|Overall Study|Miscellaneous|1
2832018|NCT02669017|9710224|P6|Overall Study|Miscellaneous|1
2832019|NCT02669017|9710225|P5|Overall Study|Miscellaneous|2
2832020|NCT02669017|9710226|P4|Overall Study|Miscellaneous|0
2832021|NCT02669017|9710227|P3|Overall Study|Miscellaneous|0
2832022|NCT02669017|9710228|P2|Overall Study|Miscellaneous|0
2832023|NCT02669017|9710229|P1|Overall Study|Miscellaneous|0
2832024|NCT02669017|9710221|P9|Overall Study|Lost to Follow-up|1
2832025|NCT02669017|9710222|P8|Overall Study|Lost to Follow-up|0
2832026|NCT02669017|9710223|P7|Overall Study|Lost to Follow-up|0
2832027|NCT02669017|9710224|P6|Overall Study|Lost to Follow-up|0
2832028|NCT02669017|9710225|P5|Overall Study|Lost to Follow-up|0
2832029|NCT02669017|9710226|P4|Overall Study|Lost to Follow-up|0
2832030|NCT02669017|9710227|P3|Overall Study|Lost to Follow-up|0
2832031|NCT02669017|9710228|P2|Overall Study|Lost to Follow-up|0
2832032|NCT02669017|9710229|P1|Overall Study|Lost to Follow-up|0
2832033|NCT02669017|9710221|P9|Overall Study|Withdrawal by Subject|2
2832034|NCT02669017|9710222|P8|Overall Study|Withdrawal by Subject|2
2832035|NCT02669017|9710223|P7|Overall Study|Withdrawal by Subject|0
2832036|NCT02669017|9710224|P6|Overall Study|Withdrawal by Subject|0
2832037|NCT02669017|9710225|P5|Overall Study|Withdrawal by Subject|2
2832038|NCT02669017|9710226|P4|Overall Study|Withdrawal by Subject|1
2832039|NCT02669017|9710227|P3|Overall Study|Withdrawal by Subject|0
2832040|NCT02669017|9710228|P2|Overall Study|Withdrawal by Subject|0
2832041|NCT02669017|9710229|P1|Overall Study|Withdrawal by Subject|0
2832042|NCT02669017|9710221|P9|Overall Study|Death|20
2832043|NCT02669017|9710222|P8|Overall Study|Death|47
2832044|NCT02669017|9710223|P7|Overall Study|Death|10
2832045|NCT02669017|9710224|P6|Overall Study|Death|18
2832046|NCT02669017|9710225|P5|Overall Study|Death|8
2832047|NCT02669017|9710226|P4|Overall Study|Death|3
2832048|NCT02669017|9710227|P3|Overall Study|Death|2
2832049|NCT02669017|9710228|P2|Overall Study|Death|2
2832050|NCT02669017|9710229|P1|Overall Study|Death|1
2832051|NCT02668822|9710374|P2|Overall Study|Study Terminated by Sponsor|9
2832052|NCT02668822|9710375|P1|Overall Study|Study Terminated by Sponsor|7
2832053|NCT02668822|9710374|P2|Overall Study|Protocol Violation|0
2832054|NCT02668822|9710375|P1|Overall Study|Protocol Violation|2
2832055|NCT02668783|9710397|P2|Overall Study|Withdrawal by Subject|0
2832056|NCT02668783|9710398|P1|Overall Study|Withdrawal by Subject|1
2832057|NCT02668783|9710397|P2|Overall Study|Subject moved|0
2832058|NCT02668783|9710398|P1|Overall Study|Subject moved|1
2832059|NCT02668783|9710397|P2|Overall Study|Study terminated by sponsor|10
2832060|NCT02668783|9710398|P1|Overall Study|Study terminated by sponsor|9
2832061|NCT02668783|9710397|P2|Overall Study|Protocol Violation|1
2832062|NCT02668783|9710398|P1|Overall Study|Protocol Violation|2
2832063|NCT02668783|9710397|P2|Overall Study|Pregnancy|1
2832064|NCT02668783|9710398|P1|Overall Study|Pregnancy|0
2832065|NCT02668640|9710418|P1|Overall Study|Other, not specified|1
2832066|NCT02668640|9710418|P1|Overall Study|Lost to Follow-up|13
2832067|NCT02668302|9710470|P2|Overall Study|Withdrawal by Subject|0
2832068|NCT02668302|9710471|P1|Overall Study|Withdrawal by Subject|1
2832069|NCT02667912|9710491|P2|Overall Study|Withdrawal by Subject|0
2832070|NCT02667912|9710492|P1|Overall Study|Withdrawal by Subject|1
2832071|NCT02667912|9710491|P2|Overall Study|Withdrawal by Subject|2
2832072|NCT02667912|9710492|P1|Overall Study|Withdrawal by Subject|1
2832073|NCT02667912|9710491|P2|Overall Study|Death|1
2832074|NCT02667912|9710492|P1|Overall Study|Death|3
2832075|NCT02667626|9710592|P2|Overall Study|Withdrawal by Subject|1
2832076|NCT02667626|9710593|P1|Overall Study|Withdrawal by Subject|0
2832077|NCT02667288|9710607|P1|Overall Study|Withdrawal by Subject|5
2832078|NCT02667288|9710607|P1|Overall Study|Lost to Follow-up|3
2832079|NCT02667288|9710607|P1|Overall Study|Protocol Violation|5
2832080|NCT02667275|9710614|P2|Overall Study|Discontinued early without completing|1
2832081|NCT02667275|9710615|P1|Overall Study|Discontinued early without completing|0
2832082|NCT02667275|9710614|P2|Overall Study|Withdrawal by Subject|5
2832083|NCT02667275|9710615|P1|Overall Study|Withdrawal by Subject|0
2832084|NCT02667275|9710614|P2|Overall Study|Lost to Follow-up|2
2832085|NCT02667275|9710615|P1|Overall Study|Lost to Follow-up|0
2832086|NCT02667275|9710614|P2|Overall Study|Protocol Violation|7
2832087|NCT02667275|9710615|P1|Overall Study|Protocol Violation|11
2832088|NCT02667236|9710625|P2|Overall Study|Withdrawal by Subject|0
2832089|NCT02667236|9710626|P1|Overall Study|Withdrawal by Subject|2
2832090|NCT02667236|9710625|P2|Overall Study|Adverse Event|1
2832091|NCT02667236|9710626|P1|Overall Study|Adverse Event|1
2832092|NCT02666664|9710646|P2|Overall Study|Lost to Follow-up|2
2832093|NCT02666664|9710647|P1|Overall Study|Lost to Follow-up|1
2832094|NCT02666664|9710646|P2|Overall Study|Sponsor decision|1
2832095|NCT02666664|9710647|P1|Overall Study|Sponsor decision|0
2832096|NCT02666664|9710646|P2|Overall Study|Withdrawal by participant|40
2832097|NCT02666664|9710647|P1|Overall Study|Withdrawal by participant|23
2832098|NCT02666664|9710646|P2|Overall Study|Adverse Event|37
2832099|NCT02666664|9710647|P1|Overall Study|Adverse Event|12
2832100|NCT02666664|9710646|P2|Overall Study|Other|1
2832101|NCT02666664|9710647|P1|Overall Study|Other|0
2832102|NCT02666664|9710646|P2|Overall Study|Protocol Violation|2
2832103|NCT02666664|9710647|P1|Overall Study|Protocol Violation|0
2832104|NCT02666664|9710646|P2|Overall Study|Physician Decision|1
2832105|NCT02666664|9710647|P1|Overall Study|Physician Decision|0
2832106|NCT02666222|9710837|P1|Overall Study|Death|2
2832107|NCT02665689|9710847|P2|Overall Study|Lost to Follow-up|1
2832108|NCT02665689|9710848|P1|Overall Study|Lost to Follow-up|0
2832109|NCT02665689|9710847|P2|Overall Study|Trial termination|1
2832110|NCT02665689|9710848|P1|Overall Study|Trial termination|1
2832111|NCT02665689|9710847|P2|Overall Study|Adverse Event|0
2832112|NCT02665689|9710848|P1|Overall Study|Adverse Event|1
2832113|NCT02665455|9710883|P1|Overall Study|Protocol Violation|1
2832114|NCT02665455|9710883|P1|Overall Study|Adverse Event|1
2832115|NCT02665455|9710883|P1|Overall Study|Lost to Follow-up|1
2832116|NCT02665455|9710883|P1|Overall Study|Withdrawal by Subject|6
2832117|NCT02665286|9710927|P3|Overall Study|Lost to Follow-up|1
2832118|NCT02665286|9710928|P2|Overall Study|Lost to Follow-up|2
2832119|NCT02665286|9710929|P1|Overall Study|Lost to Follow-up|3
2832120|NCT02664415|9711028|P2|Overall Study|Adverse Event|0
2832121|NCT02664415|9711029|P1|Overall Study|Adverse Event|1
2832122|NCT02664272|9711070|P1|Overall Study|Fluoroscopic images not made available|2
2832123|NCT02663817|9711091|P1|Overall Study|Screen failure|2
2832124|NCT02663687|9711111|P5|Overall Study|Other|0
2832125|NCT02663687|9711112|P4|Overall Study|Other|0
2832126|NCT02663687|9711113|P3|Overall Study|Other|1
2832127|NCT02663687|9711114|P2|Overall Study|Other|0
2832128|NCT02663687|9711115|P1|Overall Study|Other|1
2832129|NCT02663687|9711111|P5|Overall Study|Adverse Event|0
2832130|NCT02663687|9711112|P4|Overall Study|Adverse Event|0
2832131|NCT02663687|9711113|P3|Overall Study|Adverse Event|0
2832132|NCT02663687|9711114|P2|Overall Study|Adverse Event|0
2832133|NCT02663687|9711115|P1|Overall Study|Adverse Event|1
2832134|NCT02663674|9711169|P2|Overall Study|Other Event (Health Related)|1
2832135|NCT02663674|9711170|P1|Overall Study|Other Event (Health Related)|0
2832136|NCT02663674|9711169|P2|Overall Study|Physician Decision|1
2832137|NCT02663674|9711170|P1|Overall Study|Physician Decision|1
2832138|NCT02663674|9711169|P2|Overall Study|Withdrawal by Subject|4
2832139|NCT02663674|9711170|P1|Overall Study|Withdrawal by Subject|1
2832140|NCT02663674|9711169|P2|Overall Study|Lost to Follow-up|4
2832141|NCT02663674|9711170|P1|Overall Study|Lost to Follow-up|5
2832142|NCT02663453|9711434|P2|Overall Study|Withdrawal by Subject|0
2832143|NCT02663453|9711435|P1|Overall Study|Withdrawal by Subject|1
2832144|NCT02663453|9711434|P2|Overall Study|Death|4
2832145|NCT02663453|9711435|P1|Overall Study|Death|4
2832146|NCT02663128|9711480|P6|Period 2|Physician Decision|0
2832147|NCT02663128|9711481|P5|Period 2|Physician Decision|1
2832148|NCT02663128|9711482|P4|Period 2|Physician Decision|0
2832149|NCT02663128|9711483|P3|Period 2|Physician Decision|0
2832150|NCT02663128|9711484|P2|Period 2|Physician Decision|0
2832151|NCT02663128|9711485|P1|Period 2|Physician Decision|0
2832152|NCT02662764|9711499|P1|Overall Study|Patient discharged prior to 24 hrs|5
2832153|NCT02662764|9711499|P1|Overall Study|Patient changed treatment|1
2832154|NCT02662764|9711499|P1|Overall Study|Device failure|4
2832155|NCT02662764|9711499|P1|Overall Study|Withdrawal by Subject|5
2832156|NCT02662764|9711499|P1|Overall Study|Protocol Violation|1
2832157|NCT02662764|9711499|P1|Overall Study|Lack of Efficacy|8
2832158|NCT02662764|9711499|P1|Overall Study|Adverse Event|6
2832159|NCT02662569|9711567|P4|Overall Study|Lost to Follow-up|0
2832160|NCT02662569|9711568|P3|Overall Study|Lost to Follow-up|0
2832161|NCT02662569|9711569|P2|Overall Study|Lost to Follow-up|0
2832162|NCT02662569|9711570|P1|Overall Study|Lost to Follow-up|1
2832163|NCT02662569|9711567|P4|Overall Study|Withdrawal by Subject|4
2832164|NCT02662569|9711568|P3|Overall Study|Withdrawal by Subject|6
2832165|NCT02662569|9711569|P2|Overall Study|Withdrawal by Subject|1
2832166|NCT02662569|9711570|P1|Overall Study|Withdrawal by Subject|6
2832167|NCT02662556|9711668|P1|Overall Study|Lack of Efficacy|4
2832168|NCT02662556|9711668|P1|Overall Study|Adverse Event|4
2832169|NCT02661815|9711737|P4|Overall Study|Withdrawal by Subject|0
2832170|NCT02661815|9711738|P3|Overall Study|Withdrawal by Subject|0
2832171|NCT02661815|9711739|P2|Overall Study|Withdrawal by Subject|0
2832172|NCT02661815|9711740|P1|Overall Study|Withdrawal by Subject|1
2832173|NCT02661594|9711762|P4|Overall Study|Protocol Violation|0
2832174|NCT02661594|9711763|P3|Overall Study|Protocol Violation|1
2832175|NCT02661594|9711764|P2|Overall Study|Protocol Violation|0
2832176|NCT02661594|9711765|P1|Overall Study|Protocol Violation|1
2832177|NCT02661490|9711780|P5|Overall Study|Reason not Specified|1
2832178|NCT02661490|9711781|P4|Overall Study|Reason not Specified|0
2832179|NCT02661490|9711782|P3|Overall Study|Reason not Specified|0
2832180|NCT02661490|9711783|P2|Overall Study|Reason not Specified|0
2832181|NCT02661490|9711784|P1|Overall Study|Reason not Specified|0
2832182|NCT02661490|9711780|P5|Overall Study|Death|0
2832183|NCT02661490|9711781|P4|Overall Study|Death|1
2832184|NCT02661490|9711782|P3|Overall Study|Death|0
2832185|NCT02661490|9711783|P2|Overall Study|Death|1
2832186|NCT02661490|9711784|P1|Overall Study|Death|1
2832187|NCT02661490|9711780|P5|Overall Study|Withdrawal by Subject|0
2832188|NCT02661490|9711781|P4|Overall Study|Withdrawal by Subject|0
2832189|NCT02661490|9711782|P3|Overall Study|Withdrawal by Subject|2
2832190|NCT02661490|9711783|P2|Overall Study|Withdrawal by Subject|0
2832191|NCT02661490|9711784|P1|Overall Study|Withdrawal by Subject|2
2832192|NCT02661490|9711780|P5|Overall Study|Lost to Follow-up|2
2832193|NCT02661490|9711781|P4|Overall Study|Lost to Follow-up|0
2832194|NCT02661490|9711782|P3|Overall Study|Lost to Follow-up|0
2832195|NCT02661490|9711783|P2|Overall Study|Lost to Follow-up|1
2832196|NCT02661490|9711784|P1|Overall Study|Lost to Follow-up|0
2832197|NCT02661178|9711952|P15|Part 1|Protocol Violation|0
2832198|NCT02661178|9711953|P14|Part 1|Protocol Violation|0
2832199|NCT02661178|9711954|P13|Part 1|Protocol Violation|0
2832200|NCT02661178|9711955|P12|Part 1|Protocol Violation|0
2832201|NCT02661178|9711956|P11|Part 1|Protocol Violation|0
2832202|NCT02661178|9711957|P10|Part 1|Protocol Violation|0
2832203|NCT02661178|9711958|P9|Part 1|Protocol Violation|0
2832204|NCT02661178|9711959|P8|Part 1|Protocol Violation|0
2832205|NCT02661178|9711960|P7|Part 1|Protocol Violation|0
2832206|NCT02661178|9711961|P6|Part 1|Protocol Violation|0
2832207|NCT02661178|9711962|P5|Part 1|Protocol Violation|0
2832208|NCT02661178|9711963|P4|Part 1|Protocol Violation|0
2832209|NCT02661178|9711964|P3|Part 1|Protocol Violation|0
2832210|NCT02661178|9711965|P2|Part 1|Protocol Violation|0
2832211|NCT02661178|9711966|P1|Part 1|Protocol Violation|1
2832212|NCT02661061|9712324|P2|Overall Study|Withdrawal by Subject|1
2832213|NCT02661061|9712325|P1|Overall Study|Withdrawal by Subject|1
2832214|NCT02661061|9712324|P2|Overall Study|Lack of Efficacy|1
2832215|NCT02661061|9712325|P1|Overall Study|Lack of Efficacy|1
2832216|NCT02660983|9712335|P2|Open Label Extension Phase (24 Weeks)|Other|1
2832217|NCT02660983|9712336|P1|Open Label Extension Phase (24 Weeks)|Other|0
2832218|NCT02660983|9712335|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
2832219|NCT02660983|9712336|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
2832220|NCT02660983|9712335|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
2832221|NCT02660983|9712336|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
2832222|NCT02660983|9712335|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2832223|NCT02660983|9712336|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2832224|NCT02660983|9712335|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
2832225|NCT02660983|9712336|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
2832226|NCT02660983|9712335|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
2832227|NCT02660983|9712336|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
2832228|NCT02660983|9712335|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
2832229|NCT02660983|9712336|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
2832230|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2832231|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2832232|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2832233|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2832234|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2832235|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2832236|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2832237|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
2832238|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2832239|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2832240|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
2832241|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
2832242|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
2832243|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2832244|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2832245|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2832246|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2832247|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
2832248|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2832249|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2832250|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2832251|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2832252|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2832253|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2832254|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2832255|NCT02660580|9712412|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
2832256|NCT02660580|9712413|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2832257|NCT02660580|9712414|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
2832258|NCT02660580|9712415|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2832259|NCT02660580|9712416|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2832260|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2832261|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2832262|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2832263|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
2832264|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
2832265|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2832266|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2832267|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2832268|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
2832269|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
2832270|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2832271|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2832272|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2832273|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
2832274|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
2832275|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2832276|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2832277|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2832278|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
2832279|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2832280|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2832281|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2832282|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2832283|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2832284|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
2832285|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2832286|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2832287|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2832288|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
2832289|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
2832290|NCT02660580|9712412|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2832291|NCT02660580|9712413|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2832292|NCT02660580|9712414|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2832293|NCT02660580|9712415|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2832294|NCT02660580|9712416|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2832295|NCT02660242|9712525|P1|Glucagon Injection|Lost to Follow-up|1
2832296|NCT02660242|9712525|P1|Glucose Tabs|Lost to Follow-up|1
2832297|NCT02660229|9712581|P2|Overall Study|Withdrawal by Subject|1
2832298|NCT02660229|9712582|P1|Overall Study|Withdrawal by Subject|0
2832299|NCT02660229|9712581|P2|Overall Study|Adverse Event|0
2832300|NCT02660229|9712582|P1|Overall Study|Adverse Event|2
2832301|NCT02659631|9712623|P10|Overall Study|Death (treatment phase)|0
2832302|NCT02659631|9712624|P9|Overall Study|Death (treatment phase)|0
2832303|NCT02659631|9712625|P8|Overall Study|Death (treatment phase)|0
2832304|NCT02659631|9712626|P7|Overall Study|Death (treatment phase)|1
2832305|NCT02659631|9712627|P6|Overall Study|Death (treatment phase)|0
2832306|NCT02659631|9712628|P5|Overall Study|Death (treatment phase)|1
2832307|NCT02659631|9712629|P4|Overall Study|Death (treatment phase)|0
2832308|NCT02659631|9712630|P3|Overall Study|Death (treatment phase)|0
2832309|NCT02659631|9712631|P2|Overall Study|Death (treatment phase)|0
2832310|NCT02659631|9712632|P1|Overall Study|Death (treatment phase)|0
2832311|NCT02659631|9712623|P10|Overall Study|Death (follow-up phase)|0
2832312|NCT02659631|9712624|P9|Overall Study|Death (follow-up phase)|1
2832313|NCT02659631|9712625|P8|Overall Study|Death (follow-up phase)|3
2832314|NCT02659631|9712626|P7|Overall Study|Death (follow-up phase)|0
2832315|NCT02659631|9712627|P6|Overall Study|Death (follow-up phase)|2
2832316|NCT02659631|9712628|P5|Overall Study|Death (follow-up phase)|3
2832317|NCT02659631|9712629|P4|Overall Study|Death (follow-up phase)|1
2832318|NCT02659631|9712630|P3|Overall Study|Death (follow-up phase)|1
2832319|NCT02659631|9712631|P2|Overall Study|Death (follow-up phase)|2
2832320|NCT02659631|9712632|P1|Overall Study|Death (follow-up phase)|1
2832321|NCT02659631|9712623|P10|Overall Study|Participant refused further follow-up|0
2832322|NCT02659631|9712624|P9|Overall Study|Participant refused further follow-up|1
2832323|NCT02659631|9712625|P8|Overall Study|Participant refused further follow-up|0
2832324|NCT02659631|9712626|P7|Overall Study|Participant refused further follow-up|0
2832325|NCT02659631|9712627|P6|Overall Study|Participant refused further follow-up|0
2832326|NCT02659631|9712628|P5|Overall Study|Participant refused further follow-up|0
2832327|NCT02659631|9712629|P4|Overall Study|Participant refused further follow-up|1
2832328|NCT02659631|9712630|P3|Overall Study|Participant refused further follow-up|0
2832329|NCT02659631|9712631|P2|Overall Study|Participant refused further follow-up|0
2832330|NCT02659631|9712632|P1|Overall Study|Participant refused further follow-up|0
2832331|NCT02659631|9712623|P10|Overall Study|Withdrawal prior to treatment|0
2832332|NCT02659631|9712624|P9|Overall Study|Withdrawal prior to treatment|0
2832333|NCT02659631|9712625|P8|Overall Study|Withdrawal prior to treatment|0
2832334|NCT02659631|9712626|P7|Overall Study|Withdrawal prior to treatment|0
2832335|NCT02659631|9712627|P6|Overall Study|Withdrawal prior to treatment|0
2832336|NCT02659631|9712628|P5|Overall Study|Withdrawal prior to treatment|1
2832337|NCT02659631|9712629|P4|Overall Study|Withdrawal prior to treatment|0
2832338|NCT02659631|9712630|P3|Overall Study|Withdrawal prior to treatment|0
2832339|NCT02659631|9712631|P2|Overall Study|Withdrawal prior to treatment|0
2832340|NCT02659631|9712632|P1|Overall Study|Withdrawal prior to treatment|0
2832341|NCT02659631|9712623|P10|Overall Study|Lost to Follow-up|0
2832342|NCT02659631|9712624|P9|Overall Study|Lost to Follow-up|0
2832343|NCT02659631|9712625|P8|Overall Study|Lost to Follow-up|0
2832344|NCT02659631|9712626|P7|Overall Study|Lost to Follow-up|0
2832345|NCT02659631|9712627|P6|Overall Study|Lost to Follow-up|1
2832346|NCT02659631|9712628|P5|Overall Study|Lost to Follow-up|0
2832347|NCT02659631|9712629|P4|Overall Study|Lost to Follow-up|0
2832348|NCT02659631|9712630|P3|Overall Study|Lost to Follow-up|2
2832349|NCT02659631|9712631|P2|Overall Study|Lost to Follow-up|0
2832350|NCT02659631|9712632|P1|Overall Study|Lost to Follow-up|0
2832351|NCT02659540|9712766|P2|Overall Study|Progressive disease|6
2832352|NCT02659540|9712767|P1|Overall Study|Progressive disease|2
2832353|NCT02659540|9712766|P2|Overall Study|Death|0
2832354|NCT02659540|9712767|P1|Overall Study|Death|1
2832355|NCT02659540|9712766|P2|Overall Study|Adverse Event|2
2832356|NCT02659540|9712767|P1|Overall Study|Adverse Event|3
2832357|NCT02658149|9712888|P2|Overall Study|Physician Decision|0
2832358|NCT02658149|9712889|P1|Overall Study|Physician Decision|1
2832359|NCT02658084|9712905|P2|Overall Study|Study Termination|0
2832360|NCT02658084|9712906|P1|Overall Study|Study Termination|1
2832361|NCT02658084|9712905|P2|Overall Study|Withdrawal by Subject|0
2832362|NCT02658084|9712906|P1|Overall Study|Withdrawal by Subject|1
2832363|NCT02657889|9712959|P4|Overall Study|Ongoing in Study|19
2832364|NCT02657889|9712960|P3|Overall Study|Ongoing in Study|24
2832365|NCT02657889|9712961|P2|Overall Study|Ongoing in Study|5
2832366|NCT02657889|9712962|P1|Overall Study|Ongoing in Study|0
2832367|NCT02657889|9712959|P4|Overall Study|Withdrawal by Subject|0
2832368|NCT02657889|9712960|P3|Overall Study|Withdrawal by Subject|8
2832369|NCT02657889|9712961|P2|Overall Study|Withdrawal by Subject|0
2832370|NCT02657889|9712962|P1|Overall Study|Withdrawal by Subject|0
2832371|NCT02657889|9712959|P4|Overall Study|Lost to Follow-up|2
2832372|NCT02657889|9712960|P3|Overall Study|Lost to Follow-up|1
2832373|NCT02657889|9712961|P2|Overall Study|Lost to Follow-up|0
2832374|NCT02657889|9712962|P1|Overall Study|Lost to Follow-up|2
2832375|NCT02657889|9712959|P4|Overall Study|Death|34
2832376|NCT02657889|9712960|P3|Overall Study|Death|20
2832377|NCT02657889|9712961|P2|Overall Study|Death|2
2832378|NCT02657889|9712962|P1|Overall Study|Death|5
2832379|NCT02657408|9713003|P2|Overall Study|Adverse Event|7
2832380|NCT02657408|9713004|P1|Overall Study|Adverse Event|3
2832381|NCT02657369|9713028|P1|Overall Study|Study terminated by sponsor|7
2832382|NCT02657369|9713028|P1|Overall Study|Death|27
2832383|NCT02657031|9713059|P2|Overall Study|Adverse Event|2
2832384|NCT02657031|9713060|P1|Overall Study|Adverse Event|1
2832385|NCT02656693|9713088|P3|Overall Study|Bariatric surgery|2
2832386|NCT02656693|9713089|P2|Overall Study|Bariatric surgery|1
2832387|NCT02656693|9713090|P1|Overall Study|Bariatric surgery|0
2832388|NCT02656693|9713088|P3|Overall Study|Pregnancy|1
2832389|NCT02656693|9713089|P2|Overall Study|Pregnancy|1
2832390|NCT02656693|9713090|P1|Overall Study|Pregnancy|1
2832391|NCT02656329|9713173|P2|Overall Study|Other than specified above|6
2832392|NCT02656329|9713174|P1|Overall Study|Other than specified above|5
2832393|NCT02656329|9713173|P2|Overall Study|Study termination by Sponsor|142
2832394|NCT02656329|9713174|P1|Overall Study|Study termination by Sponsor|150
2832395|NCT02656329|9713173|P2|Overall Study|Withdrawal by Subject|6
2832396|NCT02656329|9713174|P1|Overall Study|Withdrawal by Subject|7
2832397|NCT02656329|9713173|P2|Overall Study|Lost to Follow-up|3
2832398|NCT02656329|9713174|P1|Overall Study|Lost to Follow-up|2
2832399|NCT02656290|9713197|P1|Overall Study|Subjects Remain On Study|26
2832400|NCT02656173|9713207|P2|Overall Study|Miscellaneous|0
2832401|NCT02656173|9713208|P1|Overall Study|Miscellaneous|2
2832402|NCT02656173|9713207|P2|Overall Study|Protocol Violation|1
2832403|NCT02656173|9713208|P1|Overall Study|Protocol Violation|0
2832404|NCT02656173|9713207|P2|Overall Study|Withdrawal by Subject|3
2832405|NCT02656173|9713208|P1|Overall Study|Withdrawal by Subject|1
2832406|NCT02656173|9713207|P2|Overall Study|Adverse Event|5
2832407|NCT02656173|9713208|P1|Overall Study|Adverse Event|7
2832408|NCT02656173|9713207|P2|Overall Study|Deviation from the Eligible Criteria|2
2832409|NCT02656173|9713208|P1|Overall Study|Deviation from the Eligible Criteria|3
2832410|NCT02655887|9713280|P1|Overall Study|Missed 12-month follow-up visit|4
2832411|NCT02655887|9713280|P1|Overall Study|Withdrawal by Subject|3
2832412|NCT02655887|9713280|P1|Overall Study|Death|4
2832413|NCT02655887|9713280|P1|Overall Study|Lost to Follow-up|3
2832414|NCT02655679|9713299|P5|Overall Study|Other Miscellaneous Reasons|0
2832415|NCT02655679|9713300|P4|Overall Study|Other Miscellaneous Reasons|0
2832416|NCT02655679|9713301|P3|Overall Study|Other Miscellaneous Reasons|0
2832417|NCT02655679|9713302|P2|Overall Study|Other Miscellaneous Reasons|0
2832418|NCT02655679|9713303|P1|Overall Study|Other Miscellaneous Reasons|1
2832419|NCT02655679|9713299|P5|Overall Study|Lost to Follow-up|0
2832420|NCT02655679|9713300|P4|Overall Study|Lost to Follow-up|1
2832421|NCT02655679|9713301|P3|Overall Study|Lost to Follow-up|1
2832422|NCT02655679|9713302|P2|Overall Study|Lost to Follow-up|1
2832423|NCT02655679|9713303|P1|Overall Study|Lost to Follow-up|0
2832424|NCT02655679|9713299|P5|Overall Study|Inability to Comply with the Protocol|0
2832425|NCT02655679|9713300|P4|Overall Study|Inability to Comply with the Protocol|0
2832426|NCT02655679|9713301|P3|Overall Study|Inability to Comply with the Protocol|0
2832427|NCT02655679|9713302|P2|Overall Study|Inability to Comply with the Protocol|0
2832428|NCT02655679|9713303|P1|Overall Study|Inability to Comply with the Protocol|1
2832429|NCT02655679|9713299|P5|Overall Study|Withdrawal by Subject|1
2832430|NCT02655679|9713300|P4|Overall Study|Withdrawal by Subject|3
2832431|NCT02655679|9713301|P3|Overall Study|Withdrawal by Subject|0
2832432|NCT02655679|9713302|P2|Overall Study|Withdrawal by Subject|1
2832433|NCT02655679|9713303|P1|Overall Study|Withdrawal by Subject|1
2832434|NCT02655679|9713299|P5|Overall Study|Adverse Event|0
2832435|NCT02655679|9713300|P4|Overall Study|Adverse Event|0
2832436|NCT02655679|9713301|P3|Overall Study|Adverse Event|0
2832437|NCT02655679|9713302|P2|Overall Study|Adverse Event|1
2832438|NCT02655679|9713303|P1|Overall Study|Adverse Event|0
2832439|NCT02655666|9713375|P1|Overall Study|Sponsor stopped this clinical research.|12
2832440|NCT02655419|9713404|P2|Overall Study|Other|1
2832441|NCT02655419|9713405|P1|Overall Study|Other|0
2832442|NCT02655419|9713404|P2|Overall Study|Withdrawal by Subject|1
2832443|NCT02655419|9713405|P1|Overall Study|Withdrawal by Subject|4
2832444|NCT02655419|9713404|P2|Overall Study|Enrolled but not treated|5
2832445|NCT02655419|9713405|P1|Overall Study|Enrolled but not treated|1
2832446|NCT02655237|9713525|P2|Overall Study|Randomized but Not Treated|0
2832447|NCT02655237|9713526|P1|Overall Study|Randomized but Not Treated|1
2832448|NCT02655237|9713525|P2|Overall Study|Reduction of Hemoglobin Concentration|0
2832449|NCT02655237|9713526|P1|Overall Study|Reduction of Hemoglobin Concentration|1
2832450|NCT02655237|9713525|P2|Overall Study|Recovery Leading to Surgery|1
2832451|NCT02655237|9713526|P1|Overall Study|Recovery Leading to Surgery|2
2832452|NCT02655237|9713525|P2|Overall Study|Lack of Efficacy|1
2832453|NCT02655237|9713526|P1|Overall Study|Lack of Efficacy|0
2832454|NCT02655237|9713525|P2|Overall Study|Withdrawal by Participant|2
2832455|NCT02655237|9713526|P1|Overall Study|Withdrawal by Participant|1
2832456|NCT02655237|9713525|P2|Overall Study|Protocol Deviation|0
2832457|NCT02655237|9713526|P1|Overall Study|Protocol Deviation|2
2832458|NCT02655237|9713525|P2|Overall Study|Adverse Event|7
2832459|NCT02655237|9713526|P1|Overall Study|Adverse Event|10
2832460|NCT02655224|9713566|P2|Overall Study|Adverse Event|1
2832461|NCT02655224|9713567|P1|Overall Study|Adverse Event|1
2832462|NCT02654717|9713626|P2|Overall Study|Non-permitted medication|0
2832463|NCT02654717|9713627|P1|Overall Study|Non-permitted medication|3
2832464|NCT02654717|9713626|P2|Overall Study|Withdrawal by Subject|1
2832465|NCT02654717|9713627|P1|Overall Study|Withdrawal by Subject|0
2832466|NCT02654717|9713626|P2|Overall Study|Protocol Violation|2
2832467|NCT02654717|9713627|P1|Overall Study|Protocol Violation|1
2832468|NCT02654717|9713626|P2|Overall Study|Adverse Event|2
2832469|NCT02654717|9713627|P1|Overall Study|Adverse Event|2
2832470|NCT02654145|9713678|P1|Overall Study|Withdrawal by Subject|5
2832471|NCT02654145|9713678|P1|Overall Study|Protocol Violation|1
2832472|NCT02654145|9713678|P1|Overall Study|Lack of Efficacy|1
2832473|NCT02654132|9713687|P2|Overall Study|Never treated|2
2832474|NCT02654132|9713688|P1|Overall Study|Never treated|0
2832475|NCT02654132|9713687|P2|Overall Study|Clinical Progression (not protocol)|1
2832476|NCT02654132|9713688|P1|Overall Study|Clinical Progression (not protocol)|0
2832477|NCT02654132|9713687|P2|Overall Study|Inadequate response to therapy|0
2832478|NCT02654132|9713688|P1|Overall Study|Inadequate response to therapy|1
2832479|NCT02654132|9713687|P2|Overall Study|Subject Withdrew Consent|1
2832480|NCT02654132|9713688|P1|Overall Study|Subject Withdrew Consent|2
2832481|NCT02654132|9713687|P2|Overall Study|Not Reported|1
2832482|NCT02654132|9713688|P1|Overall Study|Not Reported|0
2832483|NCT02654132|9713687|P2|Overall Study|Subj Request to Discontinue Treatment|0
2832484|NCT02654132|9713688|P1|Overall Study|Subj Request to Discontinue Treatment|1
2832485|NCT02654132|9713687|P2|Overall Study|Maximum Clinical Benefit|2
2832486|NCT02654132|9713688|P1|Overall Study|Maximum Clinical Benefit|0
2832487|NCT02654132|9713687|P2|Overall Study|Study Drug Toxicity|2
2832488|NCT02654132|9713688|P1|Overall Study|Study Drug Toxicity|1
2832489|NCT02654132|9713687|P2|Overall Study|Switched to another tx|1
2832490|NCT02654132|9713688|P1|Overall Study|Switched to another tx|0
2832491|NCT02654132|9713687|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
2832492|NCT02654132|9713688|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
2832493|NCT02654132|9713687|P2|Overall Study|Disease Progression|31
2832494|NCT02654132|9713688|P1|Overall Study|Disease Progression|26
2832495|NCT02653625|9713744|P1|Overall Study|Suspected Drug Induced Liver Injury|1
2832496|NCT02653625|9713744|P1|Overall Study|Protocol Violation|1
2832497|NCT02653625|9713744|P1|Overall Study|Non-compliance with Study Drug|1
2832498|NCT02653625|9713744|P1|Overall Study|Adverse Event|1
2832499|NCT02653495|9713768|P2|Overall Study|Screening Failure|0
2832500|NCT02653495|9713769|P1|Overall Study|Screening Failure|10
2832501|NCT02653495|9713768|P2|Overall Study|Lost to Follow-up|0
2832502|NCT02653495|9713769|P1|Overall Study|Lost to Follow-up|2
2832503|NCT02653326|9713821|P2|Overall Study|Lost to Follow-up|7
2832504|NCT02653326|9713822|P1|Overall Study|Lost to Follow-up|10
2832505|NCT02653170|9713860|P3|Overall Study|Lost to Follow-up|10
2832506|NCT02653170|9713861|P2|Overall Study|Lost to Follow-up|4
2832507|NCT02653170|9713862|P1|Overall Study|Lost to Follow-up|12
2832508|NCT02653170|9713860|P3|Overall Study|withdrawn by study team|5
2832509|NCT02653170|9713861|P2|Overall Study|withdrawn by study team|4
2832510|NCT02653170|9713862|P1|Overall Study|withdrawn by study team|2
2832511|NCT02653170|9713860|P3|Overall Study|Withdrawal by Subject|3
2832512|NCT02653170|9713861|P2|Overall Study|Withdrawal by Subject|8
2832513|NCT02653170|9713862|P1|Overall Study|Withdrawal by Subject|3
2832514|NCT02652949|9713882|P1|12-Month Follow-up Secondary Endpoint|Death|4
2832515|NCT02652949|9713882|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
2832516|NCT02652949|9713882|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
2832517|NCT02652949|9713882|P1|6-Month Follow-up Secondary Endpoint|Death|5
2832518|NCT02652949|9713882|P1|30-Day Follow-up for Secondary Endpoint|Death|1
2832519|NCT02652949|9713882|P1|30-Day Follow-up for Primary Endpoint|Death|1
2832520|NCT02652767|9713917|P1|Overall Study|Withdrawal by Subject|1
2832521|NCT02652767|9713917|P1|Overall Study|Lost to Follow-up|1
2832522|NCT02652767|9713917|P1|Overall Study|Death|2
2832523|NCT02652624|9713945|P2|Extension Phase|Withdrew Consent|1
2832524|NCT02652624|9713946|P1|Extension Phase|Withdrew Consent|0
2832525|NCT02652624|9713945|P2|Extension Phase|Adverse Event|1
2832526|NCT02652624|9713946|P1|Extension Phase|Adverse Event|0
2832527|NCT02652624|9713945|P2|Extension Phase|Pregnancy|1
2832528|NCT02652624|9713946|P1|Extension Phase|Pregnancy|1
2832529|NCT02652624|9713945|P2|Extension Phase|Lost to Follow-up|1
2832530|NCT02652624|9713946|P1|Extension Phase|Lost to Follow-up|3
2832531|NCT02652624|9713945|P2|Randomized Phase|Lost to Follow-up|1
2832532|NCT02652624|9713946|P1|Randomized Phase|Lost to Follow-up|0
2832533|NCT02652624|9713945|P2|Randomized Phase|Death|1
2832534|NCT02652624|9713946|P1|Randomized Phase|Death|0
2832535|NCT02652624|9713945|P2|Randomized Phase|Investigator's Discretion|2
2832536|NCT02652624|9713946|P1|Randomized Phase|Investigator's Discretion|0
2832537|NCT02652624|9713945|P2|Randomized Phase|Pregnancy|1
2832538|NCT02652624|9713946|P1|Randomized Phase|Pregnancy|3
2832539|NCT02652260|9714034|P2|Overall Study|Withdrawal by Subject|1
2832540|NCT02652260|9714035|P1|Overall Study|Withdrawal by Subject|0
2832541|NCT02652260|9714034|P2|Overall Study|Pregnancy|1
2832542|NCT02652260|9714035|P1|Overall Study|Pregnancy|0
2832543|NCT02652156|9714094|P3|Overall Study|Physician Decision|0
2832544|NCT02652156|9714095|P2|Overall Study|Physician Decision|0
2832545|NCT02652156|9714096|P1|Overall Study|Physician Decision|1
2832546|NCT02651922|9714122|P1|Overall Study|due to exclusion criteria|2
2832547|NCT02651688|9714142|P3|Overall Study|Withdrawal by Subject|2
2832548|NCT02651688|9714143|P2|Overall Study|Withdrawal by Subject|0
2832549|NCT02651688|9714144|P1|Overall Study|Withdrawal by Subject|1
2832550|NCT02651688|9714142|P3|Overall Study|Lost to Follow-up|0
2832551|NCT02651688|9714143|P2|Overall Study|Lost to Follow-up|3
2832552|NCT02651688|9714144|P1|Overall Study|Lost to Follow-up|1
2832553|NCT02651688|9714142|P3|Overall Study|Principal Investigator (PI) decision|0
2832554|NCT02651688|9714143|P2|Overall Study|Principal Investigator (PI) decision|2
2832555|NCT02651688|9714144|P1|Overall Study|Principal Investigator (PI) decision|0
2832556|NCT02651688|9714142|P3|Overall Study|Non-compliance|1
2832557|NCT02651688|9714143|P2|Overall Study|Non-compliance|0
2832558|NCT02651688|9714144|P1|Overall Study|Non-compliance|0
2832559|NCT02651467|9714227|P3|Overall Study|Other (Not specified)|2
2832560|NCT02651467|9714228|P2|Overall Study|Other (Not specified)|0
2832561|NCT02651467|9714229|P1|Overall Study|Other (Not specified)|1
2832562|NCT02651467|9714227|P3|Overall Study|Withdrawal by Subject|2
2832563|NCT02651467|9714228|P2|Overall Study|Withdrawal by Subject|0
2832564|NCT02651467|9714229|P1|Overall Study|Withdrawal by Subject|0
2832565|NCT02651194|9714301|P1|Overall Study|Other|2
2832566|NCT02651194|9714301|P1|Overall Study|Lost to Follow-up|3
2832567|NCT02651155|9714309|P2|Overall Study|Voluntary Withdrawal|0
2832568|NCT02651155|9714310|P1|Overall Study|Voluntary Withdrawal|5
2832569|NCT02651155|9714309|P2|Overall Study|Pretreatment Event/Adverse Event|2
2832570|NCT02651155|9714310|P1|Overall Study|Pretreatment Event/Adverse Event|1
2832571|NCT02650921|9714335|P1|Overall Study|Due to Medical Condition|1
2832572|NCT02650921|9714335|P1|Overall Study|Adverse Event|1
2832573|NCT02650921|9714335|P1|Overall Study|Lost to Follow-up|2
2832574|NCT02650921|9714335|P1|Overall Study|Withdrawal by Subject|4
2832575|NCT02650895|9714389|P6|Overall Study|Withdrawal by Subject|0
2832576|NCT02650895|9714390|P5|Overall Study|Withdrawal by Subject|0
2832577|NCT02650895|9714391|P4|Overall Study|Withdrawal by Subject|0
2832578|NCT02650895|9714392|P3|Overall Study|Withdrawal by Subject|0
2832579|NCT02650895|9714393|P2|Overall Study|Withdrawal by Subject|1
2832580|NCT02650895|9714394|P1|Overall Study|Withdrawal by Subject|0
2832581|NCT02650466|9714441|P1|Overall Study|Lost to Follow-up|1
2832582|NCT02650466|9714441|P1|Overall Study|Withdrawal by Subject|5
2832583|NCT02650466|9714441|P1|Overall Study|Physician Decision|1
2832584|NCT02650128|9714571|P1|Overall Study|Death|2
2832585|NCT02649946|9714580|P2|Overall Study|Missed 6-month follow-up visit|4
2832586|NCT02649946|9714581|P1|Overall Study|Missed 6-month follow-up visit|0
2832587|NCT02649946|9714580|P2|Overall Study|Erroneously enrolled|0
2832588|NCT02649946|9714581|P1|Overall Study|Erroneously enrolled|1
2832589|NCT02649946|9714580|P2|Overall Study|Lost to Follow-up|1
2832590|NCT02649946|9714581|P1|Overall Study|Lost to Follow-up|2
2832591|NCT02649946|9714580|P2|Overall Study|Physician Decision|0
2832592|NCT02649946|9714581|P1|Overall Study|Physician Decision|1
2832593|NCT02649946|9714580|P2|Overall Study|Death|9
2832594|NCT02649946|9714581|P1|Overall Study|Death|7
2832595|NCT02649946|9714580|P2|Overall Study|Withdrawal by Subject|1
2832596|NCT02649946|9714581|P1|Overall Study|Withdrawal by Subject|1
2832597|NCT02649634|9714616|P2|Overall Study|Lost to Follow-up|1
2832598|NCT02649634|9714617|P1|Overall Study|Lost to Follow-up|0
2832599|NCT02649634|9714616|P2|Overall Study|Withdrawal by Subject|5
2832600|NCT02649634|9714617|P1|Overall Study|Withdrawal by Subject|3
2832601|NCT02648438|9714852|P3|Overall Study|Withdrawal by Subject|0
2832602|NCT02648438|9714853|P2|Overall Study|Withdrawal by Subject|1
2832603|NCT02648438|9714854|P1|Overall Study|Withdrawal by Subject|1
2832604|NCT02648438|9714852|P3|Overall Study|Protocol Violation|0
2832605|NCT02648438|9714853|P2|Overall Study|Protocol Violation|0
2832606|NCT02648438|9714854|P1|Overall Study|Protocol Violation|2
2832607|NCT02648438|9714852|P3|Overall Study|Eligibility criteria not fulfilled|0
2832608|NCT02648438|9714853|P2|Overall Study|Eligibility criteria not fulfilled|2
2832609|NCT02648438|9714854|P1|Overall Study|Eligibility criteria not fulfilled|0
2832610|NCT02648217|9714900|P2|Overall Study|Unclassified|0
2832611|NCT02648217|9714901|P1|Overall Study|Unclassified|5
2832612|NCT02648217|9714900|P2|Overall Study|Withdrawal by Subject|3
2832613|NCT02648217|9714901|P1|Overall Study|Withdrawal by Subject|4
2832614|NCT02648217|9714900|P2|Overall Study|Lost to Follow-up|1
2832615|NCT02648217|9714901|P1|Overall Study|Lost to Follow-up|1
2832616|NCT02648217|9714900|P2|Overall Study|Adverse Event|1
2832617|NCT02648217|9714901|P1|Overall Study|Adverse Event|0
2832618|NCT02648204|9714923|P4|Overall Study|Adverse Event|0
2832619|NCT02648204|9714924|P3|Overall Study|Adverse Event|1
2832620|NCT02648204|9714925|P2|Overall Study|Adverse Event|0
2832621|NCT02648204|9714926|P1|Overall Study|Adverse Event|0
2832622|NCT02648204|9714923|P4|Overall Study|Death|2
2832623|NCT02648204|9714924|P3|Overall Study|Death|2
2832624|NCT02648204|9714925|P2|Overall Study|Death|1
2832625|NCT02648204|9714926|P1|Overall Study|Death|1
2832626|NCT02648204|9714923|P4|Overall Study|Missing follow-up information|2
2832627|NCT02648204|9714924|P3|Overall Study|Missing follow-up information|4
2832628|NCT02648204|9714925|P2|Overall Study|Missing follow-up information|4
2832629|NCT02648204|9714926|P1|Overall Study|Missing follow-up information|4
2832630|NCT02648204|9714923|P4|Overall Study|Lost to Follow-up|6
2832631|NCT02648204|9714924|P3|Overall Study|Lost to Follow-up|4
2832632|NCT02648204|9714925|P2|Overall Study|Lost to Follow-up|8
2832633|NCT02648204|9714926|P1|Overall Study|Lost to Follow-up|5
2832634|NCT02648204|9714923|P4|Overall Study|Withdrawal by Subject|6
2832635|NCT02648204|9714924|P3|Overall Study|Withdrawal by Subject|2
2832636|NCT02648204|9714925|P2|Overall Study|Withdrawal by Subject|8
2832637|NCT02648204|9714926|P1|Overall Study|Withdrawal by Subject|12
2832638|NCT02647944|9715064|P2|Overall Study|Adverse Event|0
2832639|NCT02647944|9715065|P1|Overall Study|Adverse Event|2
2832640|NCT02647944|9715064|P2|Overall Study|Withdrawal by Subject|3
2832641|NCT02647944|9715065|P1|Overall Study|Withdrawal by Subject|0
2832642|NCT02647905|9715089|P1|Overall Study|Withdrawal by Subject|2
2832643|NCT02647905|9715089|P1|Overall Study|Lost to Follow-up|1
2832644|NCT02647866|9715099|P5|Overall Study|Subject moved to different country|0
2832645|NCT02647866|9715100|P4|Overall Study|Subject moved to different country|0
2832646|NCT02647866|9715101|P3|Overall Study|Subject moved to different country|0
2832647|NCT02647866|9715102|P2|Overall Study|Subject moved to different country|0
2832648|NCT02647866|9715103|P1|Overall Study|Subject moved to different country|1
2832649|NCT02647866|9715099|P5|Overall Study|Death|0
2832650|NCT02647866|9715100|P4|Overall Study|Death|0
2832651|NCT02647866|9715101|P3|Overall Study|Death|0
2832652|NCT02647866|9715102|P2|Overall Study|Death|1
2832653|NCT02647866|9715103|P1|Overall Study|Death|0
2832654|NCT02647866|9715099|P5|Overall Study|Physician Decision|2
2832655|NCT02647866|9715100|P4|Overall Study|Physician Decision|0
2832656|NCT02647866|9715101|P3|Overall Study|Physician Decision|1
2832657|NCT02647866|9715102|P2|Overall Study|Physician Decision|1
2832658|NCT02647866|9715103|P1|Overall Study|Physician Decision|0
2832659|NCT02647866|9715099|P5|Overall Study|Withdrawal by Subject|4
2832660|NCT02647866|9715100|P4|Overall Study|Withdrawal by Subject|4
2832661|NCT02647866|9715101|P3|Overall Study|Withdrawal by Subject|2
2832662|NCT02647866|9715102|P2|Overall Study|Withdrawal by Subject|1
2832663|NCT02647866|9715103|P1|Overall Study|Withdrawal by Subject|1
2832664|NCT02647866|9715099|P5|Overall Study|Disease Worsening|1
2832665|NCT02647866|9715100|P4|Overall Study|Disease Worsening|0
2832666|NCT02647866|9715101|P3|Overall Study|Disease Worsening|0
2832667|NCT02647866|9715102|P2|Overall Study|Disease Worsening|1
2832668|NCT02647866|9715103|P1|Overall Study|Disease Worsening|3
2832669|NCT02647866|9715099|P5|Overall Study|Adverse Event|1
2832670|NCT02647866|9715100|P4|Overall Study|Adverse Event|2
2832671|NCT02647866|9715101|P3|Overall Study|Adverse Event|2
2832672|NCT02647866|9715102|P2|Overall Study|Adverse Event|0
2832673|NCT02647866|9715103|P1|Overall Study|Adverse Event|0
2832674|NCT02647788|9715180|P2|Overall Study|Felt nauseous with assigned medication|1
2832675|NCT02647788|9715181|P1|Overall Study|Felt nauseous with assigned medication|1
2832676|NCT02647788|9715180|P2|Overall Study|Felt itchy with assigned medication|0
2832677|NCT02647788|9715181|P1|Overall Study|Felt itchy with assigned medication|1
2832678|NCT02647788|9715180|P2|Overall Study|Withdrawal by Subject|0
2832679|NCT02647788|9715181|P1|Overall Study|Withdrawal by Subject|1
2832680|NCT02647788|9715180|P2|Overall Study|Did not want opiate|1
2832681|NCT02647788|9715181|P1|Overall Study|Did not want opiate|0
2832682|NCT02647788|9715180|P2|Overall Study|Lost to Follow-up|11
2832683|NCT02647788|9715181|P1|Overall Study|Lost to Follow-up|13
2832684|NCT02647658|9715193|P2|Overall Study|Consent refusal|24
2832685|NCT02647658|9715194|P1|Overall Study|Consent refusal|15
2832686|NCT02647645|9715222|P2|Overall Study|Lost to Follow-up|1
2832687|NCT02647645|9715223|P1|Overall Study|Lost to Follow-up|2
2832688|NCT02647320|9715245|P5|Overall Study|Disposition Missing Due to Fire at Site|4
2832689|NCT02647320|9715246|P4|Overall Study|Disposition Missing Due to Fire at Site|3
2832690|NCT02647320|9715247|P3|Overall Study|Disposition Missing Due to Fire at Site|4
2832691|NCT02647320|9715248|P2|Overall Study|Disposition Missing Due to Fire at Site|3
2832692|NCT02647320|9715249|P1|Overall Study|Disposition Missing Due to Fire at Site|2
2832693|NCT02647320|9715245|P5|Overall Study|Lack of Efficacy|0
2832694|NCT02647320|9715246|P4|Overall Study|Lack of Efficacy|1
2832695|NCT02647320|9715247|P3|Overall Study|Lack of Efficacy|0
2832696|NCT02647320|9715248|P2|Overall Study|Lack of Efficacy|0
2832697|NCT02647320|9715249|P1|Overall Study|Lack of Efficacy|0
2832698|NCT02647320|9715245|P5|Overall Study|Develop anemia|0
2832699|NCT02647320|9715246|P4|Overall Study|Develop anemia|0
2832700|NCT02647320|9715247|P3|Overall Study|Develop anemia|0
2832701|NCT02647320|9715248|P2|Overall Study|Develop anemia|0
2832702|NCT02647320|9715249|P1|Overall Study|Develop anemia|1
2832703|NCT02647320|9715245|P5|Overall Study|Lost to Follow-up|0
2832704|NCT02647320|9715246|P4|Overall Study|Lost to Follow-up|0
2832705|NCT02647320|9715247|P3|Overall Study|Lost to Follow-up|0
2832706|NCT02647320|9715248|P2|Overall Study|Lost to Follow-up|1
2832707|NCT02647320|9715249|P1|Overall Study|Lost to Follow-up|1
2832708|NCT02647320|9715245|P5|Overall Study|Reason not provided|2
2832709|NCT02647320|9715246|P4|Overall Study|Reason not provided|0
2832710|NCT02647320|9715247|P3|Overall Study|Reason not provided|1
2832711|NCT02647320|9715248|P2|Overall Study|Reason not provided|0
2832712|NCT02647320|9715249|P1|Overall Study|Reason not provided|0
2832713|NCT02647320|9715245|P5|Overall Study|Study terminated by sponsor|2
2832714|NCT02647320|9715246|P4|Overall Study|Study terminated by sponsor|1
2832715|NCT02647320|9715247|P3|Overall Study|Study terminated by sponsor|1
2832716|NCT02647320|9715248|P2|Overall Study|Study terminated by sponsor|1
2832717|NCT02647320|9715249|P1|Overall Study|Study terminated by sponsor|1
2832718|NCT02647320|9715245|P5|Overall Study|Persistent hyperglycemia|1
2832719|NCT02647320|9715246|P4|Overall Study|Persistent hyperglycemia|1
2832720|NCT02647320|9715247|P3|Overall Study|Persistent hyperglycemia|1
2832721|NCT02647320|9715248|P2|Overall Study|Persistent hyperglycemia|1
2832722|NCT02647320|9715249|P1|Overall Study|Persistent hyperglycemia|0
2832723|NCT02647320|9715245|P5|Overall Study|Withdrawal by Subject|7
2832724|NCT02647320|9715246|P4|Overall Study|Withdrawal by Subject|2
2832725|NCT02647320|9715247|P3|Overall Study|Withdrawal by Subject|2
2832726|NCT02647320|9715248|P2|Overall Study|Withdrawal by Subject|4
2832727|NCT02647320|9715249|P1|Overall Study|Withdrawal by Subject|7
2832728|NCT02647320|9715245|P5|Overall Study|Protocol Violation|0
2832729|NCT02647320|9715246|P4|Overall Study|Protocol Violation|0
2832730|NCT02647320|9715247|P3|Overall Study|Protocol Violation|3
2832731|NCT02647320|9715248|P2|Overall Study|Protocol Violation|0
2832732|NCT02647320|9715249|P1|Overall Study|Protocol Violation|0
2832733|NCT02647320|9715245|P5|Overall Study|Adverse Event|1
2832734|NCT02647320|9715246|P4|Overall Study|Adverse Event|2
2832735|NCT02647320|9715247|P3|Overall Study|Adverse Event|3
2832736|NCT02647320|9715248|P2|Overall Study|Adverse Event|1
2832737|NCT02647320|9715249|P1|Overall Study|Adverse Event|0
2832738|NCT02647281|9715340|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
2832739|NCT02647281|9715341|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832740|NCT02647281|9715342|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832741|NCT02647281|9715343|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832742|NCT02647281|9715344|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832743|NCT02647281|9715345|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832744|NCT02647281|9715346|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832745|NCT02647281|9715347|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832746|NCT02647281|9715348|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2832747|NCT02646891|9715536|P10|Overall Study|Death|0
2832748|NCT02646891|9715537|P9|Overall Study|Death|1
2832749|NCT02646891|9715538|P8|Overall Study|Death|1
2832750|NCT02646891|9715539|P7|Overall Study|Death|1
2832751|NCT02646891|9715540|P6|Overall Study|Death|0
2832752|NCT02646891|9715541|P5|Overall Study|Death|0
2832753|NCT02646891|9715542|P4|Overall Study|Death|0
2832754|NCT02646891|9715543|P3|Overall Study|Death|0
2832755|NCT02646891|9715544|P2|Overall Study|Death|0
2832756|NCT02646891|9715545|P1|Overall Study|Death|0
2832757|NCT02646891|9715536|P10|Overall Study|Withdrawal by Subject|3
2832758|NCT02646891|9715537|P9|Overall Study|Withdrawal by Subject|7
2832759|NCT02646891|9715538|P8|Overall Study|Withdrawal by Subject|9
2832760|NCT02646891|9715539|P7|Overall Study|Withdrawal by Subject|5
2832761|NCT02646891|9715540|P6|Overall Study|Withdrawal by Subject|0
2832762|NCT02646891|9715541|P5|Overall Study|Withdrawal by Subject|0
2832763|NCT02646891|9715542|P4|Overall Study|Withdrawal by Subject|0
2832764|NCT02646891|9715543|P3|Overall Study|Withdrawal by Subject|1
2832765|NCT02646891|9715544|P2|Overall Study|Withdrawal by Subject|0
2832766|NCT02646891|9715545|P1|Overall Study|Withdrawal by Subject|2
2832767|NCT02646891|9715536|P10|Overall Study|Protocol Violation|0
2832768|NCT02646891|9715537|P9|Overall Study|Protocol Violation|0
2832769|NCT02646891|9715538|P8|Overall Study|Protocol Violation|1
2832770|NCT02646891|9715539|P7|Overall Study|Protocol Violation|1
2832771|NCT02646891|9715540|P6|Overall Study|Protocol Violation|0
2832772|NCT02646891|9715541|P5|Overall Study|Protocol Violation|0
2832773|NCT02646891|9715542|P4|Overall Study|Protocol Violation|0
2832774|NCT02646891|9715543|P3|Overall Study|Protocol Violation|0
2832775|NCT02646891|9715544|P2|Overall Study|Protocol Violation|0
2832776|NCT02646891|9715545|P1|Overall Study|Protocol Violation|0
2832777|NCT02646891|9715536|P10|Overall Study|Lost to Follow-up|2
2832778|NCT02646891|9715537|P9|Overall Study|Lost to Follow-up|2
2832779|NCT02646891|9715538|P8|Overall Study|Lost to Follow-up|2
2832780|NCT02646891|9715539|P7|Overall Study|Lost to Follow-up|2
2832781|NCT02646891|9715540|P6|Overall Study|Lost to Follow-up|0
2832782|NCT02646891|9715541|P5|Overall Study|Lost to Follow-up|0
2832783|NCT02646891|9715542|P4|Overall Study|Lost to Follow-up|0
2832784|NCT02646891|9715543|P3|Overall Study|Lost to Follow-up|0
2832785|NCT02646891|9715544|P2|Overall Study|Lost to Follow-up|0
2832786|NCT02646891|9715545|P1|Overall Study|Lost to Follow-up|0
2832787|NCT02646891|9715536|P10|Overall Study|Adverse Event|0
2832788|NCT02646891|9715537|P9|Overall Study|Adverse Event|0
2832789|NCT02646891|9715538|P8|Overall Study|Adverse Event|0
2832790|NCT02646891|9715539|P7|Overall Study|Adverse Event|0
2832791|NCT02646891|9715540|P6|Overall Study|Adverse Event|0
2832792|NCT02646891|9715541|P5|Overall Study|Adverse Event|0
2832793|NCT02646891|9715542|P4|Overall Study|Adverse Event|0
2832794|NCT02646891|9715543|P3|Overall Study|Adverse Event|0
2832795|NCT02646891|9715544|P2|Overall Study|Adverse Event|1
2832796|NCT02646891|9715545|P1|Overall Study|Adverse Event|0
2832797|NCT02646566|9715719|P3|Overall Study|Treatment failure|0
2832798|NCT02646566|9715720|P2|Overall Study|Treatment failure|0
2832799|NCT02646566|9715721|P1|Overall Study|Treatment failure|1
2832800|NCT02646566|9715719|P3|Overall Study|Lost to Follow-up|5
2832801|NCT02646566|9715720|P2|Overall Study|Lost to Follow-up|4
2832802|NCT02646566|9715721|P1|Overall Study|Lost to Follow-up|5
2832803|NCT02646124|9715772|P2|Overall Study|Lost to Follow-up|2
2832804|NCT02646124|9715773|P1|Overall Study|Lost to Follow-up|0
2832805|NCT02645409|9715809|P2|Overall Study|Physician Decision|0
2832806|NCT02645409|9715810|P1|Overall Study|Physician Decision|1
2832807|NCT02645409|9715809|P2|Overall Study|Withdrawal by Subject|0
2832808|NCT02645409|9715810|P1|Overall Study|Withdrawal by Subject|3
2832809|NCT02644356|9715994|P1|Overall Study|Withdrawal by Subject|2
2832810|NCT02644122|9716077|P1|Overall Study|Withdrawal by Subject|1
2832811|NCT02644109|9716087|P2|Overall Study|Adverse Event|4
2832812|NCT02644109|9716088|P1|Overall Study|Adverse Event|0
2832813|NCT02644096|9716096|P2|Overall Study|Withdrawal by Subject|25
2832814|NCT02644096|9716097|P1|Overall Study|Withdrawal by Subject|28
2832815|NCT02643693|9716135|P6|Overall Study|Protocol Adherence Issues|1
2832816|NCT02643693|9716136|P5|Overall Study|Protocol Adherence Issues|0
2832817|NCT02643693|9716137|P4|Overall Study|Protocol Adherence Issues|0
2832818|NCT02643693|9716138|P3|Overall Study|Protocol Adherence Issues|1
2832819|NCT02643693|9716139|P2|Overall Study|Protocol Adherence Issues|0
2832820|NCT02643693|9716140|P1|Overall Study|Protocol Adherence Issues|2
2832821|NCT02643693|9716135|P6|Overall Study|Withdrawal by Subject|0
2832822|NCT02643693|9716136|P5|Overall Study|Withdrawal by Subject|0
2832823|NCT02643693|9716137|P4|Overall Study|Withdrawal by Subject|0
2832824|NCT02643693|9716138|P3|Overall Study|Withdrawal by Subject|0
2832825|NCT02643693|9716139|P2|Overall Study|Withdrawal by Subject|1
2832826|NCT02643693|9716140|P1|Overall Study|Withdrawal by Subject|0
2832827|NCT02643693|9716135|P6|Overall Study|Physician Decision|0
2832828|NCT02643693|9716136|P5|Overall Study|Physician Decision|0
2832829|NCT02643693|9716137|P4|Overall Study|Physician Decision|0
2832830|NCT02643693|9716138|P3|Overall Study|Physician Decision|0
2832831|NCT02643693|9716139|P2|Overall Study|Physician Decision|1
2832832|NCT02643693|9716140|P1|Overall Study|Physician Decision|0
2832833|NCT02643628|9716153|P2|Overall Study|Relocated out of state|1
2832834|NCT02643628|9716154|P1|Overall Study|Relocated out of state|0
2832835|NCT02643628|9716153|P2|Overall Study|Withdrawal by Subject|1
2832836|NCT02643628|9716154|P1|Overall Study|Withdrawal by Subject|0
2832837|NCT02643628|9716153|P2|Overall Study|Lost to Follow-up|4
2832838|NCT02643628|9716154|P1|Overall Study|Lost to Follow-up|1
2832839|NCT02643472|9716185|P2|Overall Study|Lost to Follow-up|26
2832840|NCT02643472|9716186|P1|Overall Study|Lost to Follow-up|22
2832841|NCT02643472|9716185|P2|Overall Study|Protocol Violation|1
2832842|NCT02643472|9716186|P1|Overall Study|Protocol Violation|0
2832843|NCT02643472|9716185|P2|Overall Study|Withdrawal by Subject|2
2832844|NCT02643472|9716186|P1|Overall Study|Withdrawal by Subject|3
2832845|NCT02643472|9716185|P2|Overall Study|Death|5
2832846|NCT02643472|9716186|P1|Overall Study|Death|2
2832847|NCT02643394|9716212|P2|Overall Study|Protocol Violation|5
2832848|NCT02643394|9716213|P1|Overall Study|Protocol Violation|4
2832849|NCT02643355|9716223|P2|Overall Study|Protocol Violation|2
2832850|NCT02643355|9716224|P1|Overall Study|Protocol Violation|0
2832851|NCT02643355|9716223|P2|Overall Study|Withdrawal by Subject|3
2832852|NCT02643355|9716224|P1|Overall Study|Withdrawal by Subject|1
2832853|NCT02643251|9716238|P2|Overall Study|PI Decision to terminate patient|0
2832854|NCT02643251|9716239|P1|Overall Study|PI Decision to terminate patient|1
2832855|NCT02643251|9716238|P2|Overall Study|Protocol Violation|0
2832856|NCT02643251|9716239|P1|Overall Study|Protocol Violation|1
2832857|NCT02643251|9716238|P2|Overall Study|Lost to Follow-up|1
2832858|NCT02643251|9716239|P1|Overall Study|Lost to Follow-up|4
2832859|NCT02643251|9716238|P2|Overall Study|Withdrawal by Subject|0
2832860|NCT02643251|9716239|P1|Overall Study|Withdrawal by Subject|2
2832861|NCT02643251|9716238|P2|Overall Study|Adverse Event|1
2832862|NCT02643251|9716239|P1|Overall Study|Adverse Event|3
2832863|NCT02643082|9716271|P2|Period 1|Adverse Event|0
2832864|NCT02643082|9716272|P1|Period 1|Adverse Event|1
2832865|NCT02642965|9716330|P1|Overall Study|Physician Decision|9
2832866|NCT02642965|9716330|P1|Overall Study|Lack of Efficacy|4
2832867|NCT02642679|9716374|P1|Overall Study|Physician Decision|1
2832868|NCT02642679|9716374|P1|Overall Study|Physician Decision|1
2832869|NCT02642679|9716374|P1|Overall Study|Withdrawal by Subject|1
2832870|NCT02642653|9716382|P2|Overall Study|Adverse Event|0
2832871|NCT02642653|9716383|P1|Overall Study|Adverse Event|2
2832872|NCT02642614|9716424|P4|Overall Study|Withdrawal by Subject|0
2832873|NCT02642614|9716425|P3|Overall Study|Withdrawal by Subject|0
2832874|NCT02642614|9716426|P2|Overall Study|Withdrawal by Subject|1
2832875|NCT02642614|9716427|P1|Overall Study|Withdrawal by Subject|1
2832876|NCT02642614|9716424|P4|Overall Study|Lost to Follow-up|0
2832877|NCT02642614|9716425|P3|Overall Study|Lost to Follow-up|0
2832878|NCT02642614|9716426|P2|Overall Study|Lost to Follow-up|0
2832879|NCT02642614|9716427|P1|Overall Study|Lost to Follow-up|1
2832880|NCT02642614|9716424|P4|Overall Study|Adverse Event|2
2832881|NCT02642614|9716425|P3|Overall Study|Adverse Event|2
2832882|NCT02642614|9716426|P2|Overall Study|Adverse Event|1
2832883|NCT02642614|9716427|P1|Overall Study|Adverse Event|1
2832884|NCT02642432|9716494|P1|Overall Study|Other|3
2832885|NCT02642432|9716494|P1|Overall Study|Lost to Follow-up|2
2832886|NCT02642432|9716494|P1|Overall Study|Withdrew Consent|1
2832887|NCT02642432|9716494|P1|Overall Study|Adverse Event|2
2832888|NCT02642159|9716511|P2|Overall Study|Other than specified above|3
2832889|NCT02642159|9716512|P1|Overall Study|Other than specified above|10
2832890|NCT02642159|9716511|P2|Overall Study|Poor compliance to study protocol|0
2832891|NCT02642159|9716512|P1|Overall Study|Poor compliance to study protocol|1
2832892|NCT02642159|9716511|P2|Overall Study|Withdrawal by Subject|1
2832893|NCT02642159|9716512|P1|Overall Study|Withdrawal by Subject|9
2832894|NCT02642159|9716511|P2|Overall Study|Adverse Event|4
2832895|NCT02642159|9716512|P1|Overall Study|Adverse Event|10
2832896|NCT02642159|9716511|P2|Overall Study|Randomized but not treated|0
2832897|NCT02642159|9716512|P1|Overall Study|Randomized but not treated|1
2832898|NCT02641730|9716636|P5|Observational Period (Week 60 - Week 84)|Other|1
2832899|NCT02641730|9716637|P4|Observational Period (Week 60 - Week 84)|Other|0
2832900|NCT02641730|9716638|P3|Observational Period (Week 60 - Week 84)|Other|0
2832901|NCT02641730|9716639|P2|Observational Period (Week 60 - Week 84)|Other|0
2832902|NCT02641730|9716640|P1|Observational Period (Week 60 - Week 84)|Other|0
2832903|NCT02641730|9716636|P5|After Controlled Period (Week 16 – 52)|Other|1
2832904|NCT02641730|9716637|P4|After Controlled Period (Week 16 – 52)|Other|0
2832905|NCT02641730|9716638|P3|After Controlled Period (Week 16 – 52)|Other|1
2832906|NCT02641730|9716639|P2|After Controlled Period (Week 16 – 52)|Other|1
2832907|NCT02641730|9716640|P1|After Controlled Period (Week 16 – 52)|Other|0
2832908|NCT02641730|9716636|P5|After Controlled Period (Week 16 – 52)|Pregnancy|1
2832909|NCT02641730|9716637|P4|After Controlled Period (Week 16 – 52)|Pregnancy|1
2832910|NCT02641730|9716638|P3|After Controlled Period (Week 16 – 52)|Pregnancy|0
2832911|NCT02641730|9716639|P2|After Controlled Period (Week 16 – 52)|Pregnancy|0
2832912|NCT02641730|9716640|P1|After Controlled Period (Week 16 – 52)|Pregnancy|0
2832913|NCT02641730|9716636|P5|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2832914|NCT02641730|9716637|P4|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
2832915|NCT02641730|9716638|P3|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2832916|NCT02641730|9716639|P2|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
2832917|NCT02641730|9716640|P1|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2832918|NCT02641730|9716636|P5|After Controlled Period (Week 16 – 52)|Adverse Event|4
2832919|NCT02641730|9716637|P4|After Controlled Period (Week 16 – 52)|Adverse Event|5
2832920|NCT02641730|9716638|P3|After Controlled Period (Week 16 – 52)|Adverse Event|1
2832921|NCT02641730|9716639|P2|After Controlled Period (Week 16 – 52)|Adverse Event|1
2832922|NCT02641730|9716640|P1|After Controlled Period (Week 16 – 52)|Adverse Event|0
2832923|NCT02641730|9716636|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2832924|NCT02641730|9716637|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
2832925|NCT02641730|9716638|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2832926|NCT02641730|9716639|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2832927|NCT02641730|9716640|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2832928|NCT02641587|9716744|P2|Ambulatory Period|Withdrawal by Subject|0
2832929|NCT02641587|9716745|P1|Ambulatory Period|Withdrawal by Subject|1
2832930|NCT02641587|9716744|P2|Confinement Period|Withdrawal by Subject|1
2832931|NCT02641587|9716745|P1|Confinement Period|Withdrawal by Subject|2
2832932|NCT02641587|9716744|P2|Confinement Period|Adverse Event|0
2832933|NCT02641587|9716745|P1|Confinement Period|Adverse Event|1
2832934|NCT02641392|9716866|P3|Overall Study|Death|1
2832935|NCT02641392|9716867|P2|Overall Study|Death|0
2832936|NCT02641392|9716868|P1|Overall Study|Death|0
2832937|NCT02641392|9716866|P3|Overall Study|Miscellaneous|3
2832938|NCT02641392|9716867|P2|Overall Study|Miscellaneous|0
2832939|NCT02641392|9716868|P1|Overall Study|Miscellaneous|0
2832940|NCT02641392|9716866|P3|Overall Study|Lack of Efficacy|101
2832941|NCT02641392|9716867|P2|Overall Study|Lack of Efficacy|0
2832942|NCT02641392|9716868|P1|Overall Study|Lack of Efficacy|0
2832943|NCT02641392|9716866|P3|Overall Study|Study Terminated by Sponsor|144
2832944|NCT02641392|9716867|P2|Overall Study|Study Terminated by Sponsor|12
2832945|NCT02641392|9716868|P1|Overall Study|Study Terminated by Sponsor|4
2832946|NCT02641392|9716866|P3|Overall Study|Adverse Event|25
2832947|NCT02641392|9716867|P2|Overall Study|Adverse Event|1
2832948|NCT02641392|9716868|P1|Overall Study|Adverse Event|0
2832949|NCT02641392|9716866|P3|Overall Study|Withdrawal by Subject|17
2832950|NCT02641392|9716867|P2|Overall Study|Withdrawal by Subject|0
2832951|NCT02641392|9716868|P1|Overall Study|Withdrawal by Subject|0
2832952|NCT02641392|9716866|P3|Overall Study|Lost to Follow-up|2
2832953|NCT02641392|9716867|P2|Overall Study|Lost to Follow-up|0
2832954|NCT02641392|9716868|P1|Overall Study|Lost to Follow-up|0
2832955|NCT02641379|9716887|P11|Overall Study|PCR positive|0
2832956|NCT02641379|9716888|P10|Overall Study|PCR positive|0
2832957|NCT02641379|9716889|P9|Overall Study|PCR positive|0
2832958|NCT02641379|9716890|P8|Overall Study|PCR positive|0
2832959|NCT02641379|9716891|P7|Overall Study|PCR positive|1
2832960|NCT02641379|9716892|P6|Overall Study|PCR positive|0
2832961|NCT02641379|9716893|P5|Overall Study|PCR positive|0
2832962|NCT02641379|9716894|P4|Overall Study|PCR positive|0
2832963|NCT02641379|9716895|P3|Overall Study|PCR positive|0
2832964|NCT02641379|9716896|P2|Overall Study|PCR positive|0
2832965|NCT02641379|9716897|P1|Overall Study|PCR positive|0
2832966|NCT02641379|9716887|P11|Overall Study|Missing PCR result at Week 8|0
2832967|NCT02641379|9716888|P10|Overall Study|Missing PCR result at Week 8|1
2832968|NCT02641379|9716889|P9|Overall Study|Missing PCR result at Week 8|0
2832969|NCT02641379|9716890|P8|Overall Study|Missing PCR result at Week 8|0
2832970|NCT02641379|9716891|P7|Overall Study|Missing PCR result at Week 8|0
2832971|NCT02641379|9716892|P6|Overall Study|Missing PCR result at Week 8|0
2832972|NCT02641379|9716893|P5|Overall Study|Missing PCR result at Week 8|0
2832973|NCT02641379|9716894|P4|Overall Study|Missing PCR result at Week 8|0
2832974|NCT02641379|9716895|P3|Overall Study|Missing PCR result at Week 8|0
2832975|NCT02641379|9716896|P2|Overall Study|Missing PCR result at Week 8|0
2832976|NCT02641379|9716897|P1|Overall Study|Missing PCR result at Week 8|0
2832977|NCT02641379|9716887|P11|Overall Study|Participant treated after Week 24|0
2832978|NCT02641379|9716888|P10|Overall Study|Participant treated after Week 24|0
2832979|NCT02641379|9716889|P9|Overall Study|Participant treated after Week 24|1
2832980|NCT02641379|9716890|P8|Overall Study|Participant treated after Week 24|0
2832981|NCT02641379|9716891|P7|Overall Study|Participant treated after Week 24|0
2832982|NCT02641379|9716892|P6|Overall Study|Participant treated after Week 24|0
2832983|NCT02641379|9716893|P5|Overall Study|Participant treated after Week 24|0
2832984|NCT02641379|9716894|P4|Overall Study|Participant treated after Week 24|0
2832985|NCT02641379|9716895|P3|Overall Study|Participant treated after Week 24|0
2832986|NCT02641379|9716896|P2|Overall Study|Participant treated after Week 24|0
2832987|NCT02641379|9716897|P1|Overall Study|Participant treated after Week 24|0
2832988|NCT02641379|9716887|P11|Overall Study|Participant’s PCR high|0
2832989|NCT02641379|9716888|P10|Overall Study|Participant’s PCR high|0
2832990|NCT02641379|9716889|P9|Overall Study|Participant’s PCR high|0
2832991|NCT02641379|9716890|P8|Overall Study|Participant’s PCR high|1
2832992|NCT02641379|9716891|P7|Overall Study|Participant’s PCR high|0
2832993|NCT02641379|9716892|P6|Overall Study|Participant’s PCR high|0
2832994|NCT02641379|9716893|P5|Overall Study|Participant’s PCR high|0
2832995|NCT02641379|9716894|P4|Overall Study|Participant’s PCR high|0
2832996|NCT02641379|9716895|P3|Overall Study|Participant’s PCR high|0
2832997|NCT02641379|9716896|P2|Overall Study|Participant’s PCR high|0
2832998|NCT02641379|9716897|P1|Overall Study|Participant’s PCR high|0
2832999|NCT02641379|9716887|P11|Overall Study|Negative PCR result|0
2833000|NCT02641379|9716888|P10|Overall Study|Negative PCR result|1
2833001|NCT02641379|9716889|P9|Overall Study|Negative PCR result|0
2833002|NCT02641379|9716890|P8|Overall Study|Negative PCR result|0
2833003|NCT02641379|9716891|P7|Overall Study|Negative PCR result|0
2833004|NCT02641379|9716892|P6|Overall Study|Negative PCR result|0
2833005|NCT02641379|9716893|P5|Overall Study|Negative PCR result|0
2833006|NCT02641379|9716894|P4|Overall Study|Negative PCR result|0
2833007|NCT02641379|9716895|P3|Overall Study|Negative PCR result|0
2833008|NCT02641379|9716896|P2|Overall Study|Negative PCR result|0
2833009|NCT02641379|9716897|P1|Overall Study|Negative PCR result|0
2833010|NCT02641379|9716887|P11|Overall Study|No 2 Log drop at Week 12|1
2833011|NCT02641379|9716888|P10|Overall Study|No 2 Log drop at Week 12|0
2833012|NCT02641379|9716889|P9|Overall Study|No 2 Log drop at Week 12|0
2833013|NCT02641379|9716890|P8|Overall Study|No 2 Log drop at Week 12|0
2833014|NCT02641379|9716891|P7|Overall Study|No 2 Log drop at Week 12|0
2833015|NCT02641379|9716892|P6|Overall Study|No 2 Log drop at Week 12|0
2833016|NCT02641379|9716893|P5|Overall Study|No 2 Log drop at Week 12|0
2833017|NCT02641379|9716894|P4|Overall Study|No 2 Log drop at Week 12|0
2833018|NCT02641379|9716895|P3|Overall Study|No 2 Log drop at Week 12|0
2833019|NCT02641379|9716896|P2|Overall Study|No 2 Log drop at Week 12|0
2833020|NCT02641379|9716897|P1|Overall Study|No 2 Log drop at Week 12|0
2833021|NCT02641379|9716887|P11|Overall Study|Non-response Week 12|0
2833022|NCT02641379|9716888|P10|Overall Study|Non-response Week 12|0
2833023|NCT02641379|9716889|P9|Overall Study|Non-response Week 12|0
2833024|NCT02641379|9716890|P8|Overall Study|Non-response Week 12|1
2833025|NCT02641379|9716891|P7|Overall Study|Non-response Week 12|0
2833026|NCT02641379|9716892|P6|Overall Study|Non-response Week 12|0
2833027|NCT02641379|9716893|P5|Overall Study|Non-response Week 12|0
2833028|NCT02641379|9716894|P4|Overall Study|Non-response Week 12|0
2833029|NCT02641379|9716895|P3|Overall Study|Non-response Week 12|0
2833030|NCT02641379|9716896|P2|Overall Study|Non-response Week 12|0
2833031|NCT02641379|9716897|P1|Overall Study|Non-response Week 12|0
2833032|NCT02641379|9716887|P11|Overall Study|Participant showed weight reduction|0
2833033|NCT02641379|9716888|P10|Overall Study|Participant showed weight reduction|0
2833034|NCT02641379|9716889|P9|Overall Study|Participant showed weight reduction|0
2833035|NCT02641379|9716890|P8|Overall Study|Participant showed weight reduction|1
2833036|NCT02641379|9716891|P7|Overall Study|Participant showed weight reduction|0
2833037|NCT02641379|9716892|P6|Overall Study|Participant showed weight reduction|0
2833038|NCT02641379|9716893|P5|Overall Study|Participant showed weight reduction|0
2833039|NCT02641379|9716894|P4|Overall Study|Participant showed weight reduction|0
2833040|NCT02641379|9716895|P3|Overall Study|Participant showed weight reduction|0
2833041|NCT02641379|9716896|P2|Overall Study|Participant showed weight reduction|0
2833042|NCT02641379|9716897|P1|Overall Study|Participant showed weight reduction|0
2833043|NCT02641379|9716887|P11|Overall Study|Source data not found|0
2833044|NCT02641379|9716888|P10|Overall Study|Source data not found|0
2833045|NCT02641379|9716889|P9|Overall Study|Source data not found|0
2833046|NCT02641379|9716890|P8|Overall Study|Source data not found|0
2833047|NCT02641379|9716891|P7|Overall Study|Source data not found|0
2833048|NCT02641379|9716892|P6|Overall Study|Source data not found|1
2833049|NCT02641379|9716893|P5|Overall Study|Source data not found|0
2833050|NCT02641379|9716894|P4|Overall Study|Source data not found|0
2833051|NCT02641379|9716895|P3|Overall Study|Source data not found|0
2833052|NCT02641379|9716896|P2|Overall Study|Source data not found|0
2833053|NCT02641379|9716897|P1|Overall Study|Source data not found|0
2833054|NCT02641379|9716887|P11|Overall Study|Lost to Follow-up|0
2833055|NCT02641379|9716888|P10|Overall Study|Lost to Follow-up|0
2833056|NCT02641379|9716889|P9|Overall Study|Lost to Follow-up|1
2833057|NCT02641379|9716890|P8|Overall Study|Lost to Follow-up|0
2833058|NCT02641379|9716891|P7|Overall Study|Lost to Follow-up|0
2833059|NCT02641379|9716892|P6|Overall Study|Lost to Follow-up|0
2833060|NCT02641379|9716893|P5|Overall Study|Lost to Follow-up|0
2833061|NCT02641379|9716894|P4|Overall Study|Lost to Follow-up|0
2833062|NCT02641379|9716895|P3|Overall Study|Lost to Follow-up|0
2833063|NCT02641379|9716896|P2|Overall Study|Lost to Follow-up|0
2833064|NCT02641379|9716897|P1|Overall Study|Lost to Follow-up|0
2833065|NCT02641379|9716887|P11|Overall Study|Participation in sili rescue study|0
2833066|NCT02641379|9716888|P10|Overall Study|Participation in sili rescue study|0
2833067|NCT02641379|9716889|P9|Overall Study|Participation in sili rescue study|0
2833068|NCT02641379|9716890|P8|Overall Study|Participation in sili rescue study|0
2833069|NCT02641379|9716891|P7|Overall Study|Participation in sili rescue study|0
2833070|NCT02641379|9716892|P6|Overall Study|Participation in sili rescue study|1
2833071|NCT02641379|9716893|P5|Overall Study|Participation in sili rescue study|0
2833072|NCT02641379|9716894|P4|Overall Study|Participation in sili rescue study|0
2833073|NCT02641379|9716895|P3|Overall Study|Participation in sili rescue study|0
2833074|NCT02641379|9716896|P2|Overall Study|Participation in sili rescue study|0
2833075|NCT02641379|9716897|P1|Overall Study|Participation in sili rescue study|0
2833076|NCT02641379|9716887|P11|Overall Study|Protocol Violation|0
2833077|NCT02641379|9716888|P10|Overall Study|Protocol Violation|0
2833078|NCT02641379|9716889|P9|Overall Study|Protocol Violation|1
2833079|NCT02641379|9716890|P8|Overall Study|Protocol Violation|0
2833080|NCT02641379|9716891|P7|Overall Study|Protocol Violation|0
2833081|NCT02641379|9716892|P6|Overall Study|Protocol Violation|0
2833082|NCT02641379|9716893|P5|Overall Study|Protocol Violation|2
2833083|NCT02641379|9716894|P4|Overall Study|Protocol Violation|0
2833084|NCT02641379|9716895|P3|Overall Study|Protocol Violation|0
2833085|NCT02641379|9716896|P2|Overall Study|Protocol Violation|0
2833086|NCT02641379|9716897|P1|Overall Study|Protocol Violation|0
2833087|NCT02641379|9716887|P11|Overall Study|Blood could not be drawn|0
2833088|NCT02641379|9716888|P10|Overall Study|Blood could not be drawn|0
2833089|NCT02641379|9716889|P9|Overall Study|Blood could not be drawn|0
2833090|NCT02641379|9716890|P8|Overall Study|Blood could not be drawn|0
2833091|NCT02641379|9716891|P7|Overall Study|Blood could not be drawn|0
2833092|NCT02641379|9716892|P6|Overall Study|Blood could not be drawn|0
2833093|NCT02641379|9716893|P5|Overall Study|Blood could not be drawn|1
2833094|NCT02641379|9716894|P4|Overall Study|Blood could not be drawn|0
2833095|NCT02641379|9716895|P3|Overall Study|Blood could not be drawn|0
2833096|NCT02641379|9716896|P2|Overall Study|Blood could not be drawn|0
2833097|NCT02641379|9716897|P1|Overall Study|Blood could not be drawn|0
2833098|NCT02641379|9716887|P11|Overall Study|Baseline viral load unavailable|0
2833099|NCT02641379|9716888|P10|Overall Study|Baseline viral load unavailable|0
2833100|NCT02641379|9716889|P9|Overall Study|Baseline viral load unavailable|0
2833101|NCT02641379|9716890|P8|Overall Study|Baseline viral load unavailable|0
2833102|NCT02641379|9716891|P7|Overall Study|Baseline viral load unavailable|0
2833103|NCT02641379|9716892|P6|Overall Study|Baseline viral load unavailable|0
2833104|NCT02641379|9716893|P5|Overall Study|Baseline viral load unavailable|0
2833105|NCT02641379|9716894|P4|Overall Study|Baseline viral load unavailable|1
2833106|NCT02641379|9716895|P3|Overall Study|Baseline viral load unavailable|0
2833107|NCT02641379|9716896|P2|Overall Study|Baseline viral load unavailable|0
2833108|NCT02641379|9716897|P1|Overall Study|Baseline viral load unavailable|0
2833109|NCT02641379|9716887|P11|Overall Study|Inclusion criteria not fulfilled|0
2833110|NCT02641379|9716888|P10|Overall Study|Inclusion criteria not fulfilled|0
2833111|NCT02641379|9716889|P9|Overall Study|Inclusion criteria not fulfilled|0
2833112|NCT02641379|9716890|P8|Overall Study|Inclusion criteria not fulfilled|0
2833113|NCT02641379|9716891|P7|Overall Study|Inclusion criteria not fulfilled|0
2833114|NCT02641379|9716892|P6|Overall Study|Inclusion criteria not fulfilled|0
2833115|NCT02641379|9716893|P5|Overall Study|Inclusion criteria not fulfilled|0
2833116|NCT02641379|9716894|P4|Overall Study|Inclusion criteria not fulfilled|1
2833117|NCT02641379|9716895|P3|Overall Study|Inclusion criteria not fulfilled|0
2833118|NCT02641379|9716896|P2|Overall Study|Inclusion criteria not fulfilled|0
2833119|NCT02641379|9716897|P1|Overall Study|Inclusion criteria not fulfilled|0
2833120|NCT02641379|9716887|P11|Overall Study|PCR sample for Week 4 not drawn|0
2833121|NCT02641379|9716888|P10|Overall Study|PCR sample for Week 4 not drawn|0
2833122|NCT02641379|9716889|P9|Overall Study|PCR sample for Week 4 not drawn|0
2833123|NCT02641379|9716890|P8|Overall Study|PCR sample for Week 4 not drawn|0
2833124|NCT02641379|9716891|P7|Overall Study|PCR sample for Week 4 not drawn|0
2833125|NCT02641379|9716892|P6|Overall Study|PCR sample for Week 4 not drawn|0
2833126|NCT02641379|9716893|P5|Overall Study|PCR sample for Week 4 not drawn|0
2833127|NCT02641379|9716894|P4|Overall Study|PCR sample for Week 4 not drawn|1
2833128|NCT02641379|9716895|P3|Overall Study|PCR sample for Week 4 not drawn|0
2833129|NCT02641379|9716896|P2|Overall Study|PCR sample for Week 4 not drawn|0
2833130|NCT02641379|9716897|P1|Overall Study|PCR sample for Week 4 not drawn|0
2833131|NCT02641379|9716887|P11|Overall Study|PCR positive at Week 28|0
2833132|NCT02641379|9716888|P10|Overall Study|PCR positive at Week 28|0
2833133|NCT02641379|9716889|P9|Overall Study|PCR positive at Week 28|0
2833134|NCT02641379|9716890|P8|Overall Study|PCR positive at Week 28|0
2833135|NCT02641379|9716891|P7|Overall Study|PCR positive at Week 28|0
2833136|NCT02641379|9716892|P6|Overall Study|PCR positive at Week 28|0
2833137|NCT02641379|9716893|P5|Overall Study|PCR positive at Week 28|0
2833138|NCT02641379|9716894|P4|Overall Study|PCR positive at Week 28|0
2833139|NCT02641379|9716895|P3|Overall Study|PCR positive at Week 28|1
2833140|NCT02641379|9716896|P2|Overall Study|PCR positive at Week 28|0
2833141|NCT02641379|9716897|P1|Overall Study|PCR positive at Week 28|0
2833142|NCT02641379|9716887|P11|Overall Study|No PCR at baseline|0
2833143|NCT02641379|9716888|P10|Overall Study|No PCR at baseline|0
2833144|NCT02641379|9716889|P9|Overall Study|No PCR at baseline|0
2833145|NCT02641379|9716890|P8|Overall Study|No PCR at baseline|0
2833146|NCT02641379|9716891|P7|Overall Study|No PCR at baseline|0
2833147|NCT02641379|9716892|P6|Overall Study|No PCR at baseline|0
2833148|NCT02641379|9716893|P5|Overall Study|No PCR at baseline|0
2833149|NCT02641379|9716894|P4|Overall Study|No PCR at baseline|0
2833150|NCT02641379|9716895|P3|Overall Study|No PCR at baseline|1
2833151|NCT02641379|9716896|P2|Overall Study|No PCR at baseline|0
2833152|NCT02641379|9716897|P1|Overall Study|No PCR at baseline|0
2833153|NCT02641379|9716887|P11|Overall Study|PCR not performed at Week 12|0
2833154|NCT02641379|9716888|P10|Overall Study|PCR not performed at Week 12|0
2833155|NCT02641379|9716889|P9|Overall Study|PCR not performed at Week 12|0
2833156|NCT02641379|9716890|P8|Overall Study|PCR not performed at Week 12|0
2833157|NCT02641379|9716891|P7|Overall Study|PCR not performed at Week 12|0
2833158|NCT02641379|9716892|P6|Overall Study|PCR not performed at Week 12|0
2833159|NCT02641379|9716893|P5|Overall Study|PCR not performed at Week 12|0
2833160|NCT02641379|9716894|P4|Overall Study|PCR not performed at Week 12|0
2833161|NCT02641379|9716895|P3|Overall Study|PCR not performed at Week 12|1
2833162|NCT02641379|9716896|P2|Overall Study|PCR not performed at Week 12|0
2833163|NCT02641379|9716897|P1|Overall Study|PCR not performed at Week 12|0
2833164|NCT02641379|9716887|P11|Overall Study|PCR positive at Week 48|0
2833165|NCT02641379|9716888|P10|Overall Study|PCR positive at Week 48|0
2833166|NCT02641379|9716889|P9|Overall Study|PCR positive at Week 48|0
2833167|NCT02641379|9716890|P8|Overall Study|PCR positive at Week 48|0
2833168|NCT02641379|9716891|P7|Overall Study|PCR positive at Week 48|0
2833169|NCT02641379|9716892|P6|Overall Study|PCR positive at Week 48|0
2833170|NCT02641379|9716893|P5|Overall Study|PCR positive at Week 48|0
2833171|NCT02641379|9716894|P4|Overall Study|PCR positive at Week 48|0
2833172|NCT02641379|9716895|P3|Overall Study|PCR positive at Week 48|0
2833173|NCT02641379|9716896|P2|Overall Study|PCR positive at Week 48|1
2833174|NCT02641379|9716897|P1|Overall Study|PCR positive at Week 48|0
2833175|NCT02641379|9716887|P11|Overall Study|PCR positive at Week 68|0
2833176|NCT02641379|9716888|P10|Overall Study|PCR positive at Week 68|0
2833177|NCT02641379|9716889|P9|Overall Study|PCR positive at Week 68|0
2833178|NCT02641379|9716890|P8|Overall Study|PCR positive at Week 68|0
2833179|NCT02641379|9716891|P7|Overall Study|PCR positive at Week 68|0
2833180|NCT02641379|9716892|P6|Overall Study|PCR positive at Week 68|0
2833181|NCT02641379|9716893|P5|Overall Study|PCR positive at Week 68|0
2833182|NCT02641379|9716894|P4|Overall Study|PCR positive at Week 68|0
2833183|NCT02641379|9716895|P3|Overall Study|PCR positive at Week 68|0
2833184|NCT02641379|9716896|P2|Overall Study|PCR positive at Week 68|1
2833185|NCT02641379|9716897|P1|Overall Study|PCR positive at Week 68|0
2833186|NCT02641379|9716887|P11|Overall Study|Financial problems|0
2833187|NCT02641379|9716888|P10|Overall Study|Financial problems|0
2833188|NCT02641379|9716889|P9|Overall Study|Financial problems|0
2833189|NCT02641379|9716890|P8|Overall Study|Financial problems|0
2833190|NCT02641379|9716891|P7|Overall Study|Financial problems|0
2833191|NCT02641379|9716892|P6|Overall Study|Financial problems|0
2833192|NCT02641379|9716893|P5|Overall Study|Financial problems|0
2833193|NCT02641379|9716894|P4|Overall Study|Financial problems|0
2833194|NCT02641379|9716895|P3|Overall Study|Financial problems|0
2833195|NCT02641379|9716896|P2|Overall Study|Financial problems|1
2833196|NCT02641379|9716897|P1|Overall Study|Financial problems|0
2833197|NCT02641379|9716887|P11|Overall Study|Therapy stopped due to misunderstanding|0
2833198|NCT02641379|9716888|P10|Overall Study|Therapy stopped due to misunderstanding|0
2833199|NCT02641379|9716889|P9|Overall Study|Therapy stopped due to misunderstanding|0
2833200|NCT02641379|9716890|P8|Overall Study|Therapy stopped due to misunderstanding|0
2833201|NCT02641379|9716891|P7|Overall Study|Therapy stopped due to misunderstanding|0
2833202|NCT02641379|9716892|P6|Overall Study|Therapy stopped due to misunderstanding|0
2833203|NCT02641379|9716893|P5|Overall Study|Therapy stopped due to misunderstanding|0
2833204|NCT02641379|9716894|P4|Overall Study|Therapy stopped due to misunderstanding|0
2833205|NCT02641379|9716895|P3|Overall Study|Therapy stopped due to misunderstanding|0
2833206|NCT02641379|9716896|P2|Overall Study|Therapy stopped due to misunderstanding|0
2833207|NCT02641379|9716897|P1|Overall Study|Therapy stopped due to misunderstanding|1
2833208|NCT02641379|9716887|P11|Overall Study|Participant stopped study/treatment|0
2833209|NCT02641379|9716888|P10|Overall Study|Participant stopped study/treatment|0
2833210|NCT02641379|9716889|P9|Overall Study|Participant stopped study/treatment|1
2833211|NCT02641379|9716890|P8|Overall Study|Participant stopped study/treatment|0
2833212|NCT02641379|9716891|P7|Overall Study|Participant stopped study/treatment|2
2833213|NCT02641379|9716892|P6|Overall Study|Participant stopped study/treatment|1
2833214|NCT02641379|9716893|P5|Overall Study|Participant stopped study/treatment|0
2833215|NCT02641379|9716894|P4|Overall Study|Participant stopped study/treatment|0
2833216|NCT02641379|9716895|P3|Overall Study|Participant stopped study/treatment|1
2833217|NCT02641379|9716896|P2|Overall Study|Participant stopped study/treatment|3
2833218|NCT02641379|9716897|P1|Overall Study|Participant stopped study/treatment|1
2833219|NCT02641379|9716887|P11|Overall Study|Participant showed relapse|0
2833220|NCT02641379|9716888|P10|Overall Study|Participant showed relapse|0
2833221|NCT02641379|9716889|P9|Overall Study|Participant showed relapse|0
2833222|NCT02641379|9716890|P8|Overall Study|Participant showed relapse|0
2833223|NCT02641379|9716891|P7|Overall Study|Participant showed relapse|1
2833224|NCT02641379|9716892|P6|Overall Study|Participant showed relapse|0
2833225|NCT02641379|9716893|P5|Overall Study|Participant showed relapse|0
2833226|NCT02641379|9716894|P4|Overall Study|Participant showed relapse|0
2833227|NCT02641379|9716895|P3|Overall Study|Participant showed relapse|0
2833228|NCT02641379|9716896|P2|Overall Study|Participant showed relapse|0
2833229|NCT02641379|9716897|P1|Overall Study|Participant showed relapse|1
2833230|NCT02641379|9716887|P11|Overall Study|PCR positive at follow up 2|0
2833231|NCT02641379|9716888|P10|Overall Study|PCR positive at follow up 2|0
2833232|NCT02641379|9716889|P9|Overall Study|PCR positive at follow up 2|0
2833233|NCT02641379|9716890|P8|Overall Study|PCR positive at follow up 2|0
2833234|NCT02641379|9716891|P7|Overall Study|PCR positive at follow up 2|0
2833235|NCT02641379|9716892|P6|Overall Study|PCR positive at follow up 2|0
2833236|NCT02641379|9716893|P5|Overall Study|PCR positive at follow up 2|0
2833237|NCT02641379|9716894|P4|Overall Study|PCR positive at follow up 2|0
2833238|NCT02641379|9716895|P3|Overall Study|PCR positive at follow up 2|0
2833239|NCT02641379|9716896|P2|Overall Study|PCR positive at follow up 2|0
2833240|NCT02641379|9716897|P1|Overall Study|PCR positive at follow up 2|1
2833241|NCT02641379|9716887|P11|Overall Study|PCR positive at Week 24|0
2833242|NCT02641379|9716888|P10|Overall Study|PCR positive at Week 24|1
2833243|NCT02641379|9716889|P9|Overall Study|PCR positive at Week 24|0
2833244|NCT02641379|9716890|P8|Overall Study|PCR positive at Week 24|8
2833245|NCT02641379|9716891|P7|Overall Study|PCR positive at Week 24|3
2833246|NCT02641379|9716892|P6|Overall Study|PCR positive at Week 24|6
2833247|NCT02641379|9716893|P5|Overall Study|PCR positive at Week 24|0
2833248|NCT02641379|9716894|P4|Overall Study|PCR positive at Week 24|0
2833249|NCT02641379|9716895|P3|Overall Study|PCR positive at Week 24|62
2833250|NCT02641379|9716896|P2|Overall Study|PCR positive at Week 24|21
2833251|NCT02641379|9716897|P1|Overall Study|PCR positive at Week 24|15
2833252|NCT02641379|9716887|P11|Overall Study|Participant cannot be reached|1
2833253|NCT02641379|9716888|P10|Overall Study|Participant cannot be reached|2
2833254|NCT02641379|9716889|P9|Overall Study|Participant cannot be reached|0
2833255|NCT02641379|9716890|P8|Overall Study|Participant cannot be reached|1
2833256|NCT02641379|9716891|P7|Overall Study|Participant cannot be reached|0
2833257|NCT02641379|9716892|P6|Overall Study|Participant cannot be reached|1
2833258|NCT02641379|9716893|P5|Overall Study|Participant cannot be reached|2
2833259|NCT02641379|9716894|P4|Overall Study|Participant cannot be reached|8
2833260|NCT02641379|9716895|P3|Overall Study|Participant cannot be reached|0
2833261|NCT02641379|9716896|P2|Overall Study|Participant cannot be reached|4
2833262|NCT02641379|9716897|P1|Overall Study|Participant cannot be reached|4
2833263|NCT02641379|9716887|P11|Overall Study|Participant’s compliance|1
2833264|NCT02641379|9716888|P10|Overall Study|Participant’s compliance|1
2833265|NCT02641379|9716889|P9|Overall Study|Participant’s compliance|1
2833266|NCT02641379|9716890|P8|Overall Study|Participant’s compliance|0
2833267|NCT02641379|9716891|P7|Overall Study|Participant’s compliance|0
2833268|NCT02641379|9716892|P6|Overall Study|Participant’s compliance|2
2833269|NCT02641379|9716893|P5|Overall Study|Participant’s compliance|0
2833270|NCT02641379|9716894|P4|Overall Study|Participant’s compliance|1
2833271|NCT02641379|9716895|P3|Overall Study|Participant’s compliance|0
2833272|NCT02641379|9716896|P2|Overall Study|Participant’s compliance|1
2833273|NCT02641379|9716897|P1|Overall Study|Participant’s compliance|0
2833274|NCT02641379|9716887|P11|Overall Study|Participant unable to attend study visit|0
2833275|NCT02641379|9716888|P10|Overall Study|Participant unable to attend study visit|2
2833276|NCT02641379|9716889|P9|Overall Study|Participant unable to attend study visit|0
2833277|NCT02641379|9716890|P8|Overall Study|Participant unable to attend study visit|1
2833278|NCT02641379|9716891|P7|Overall Study|Participant unable to attend study visit|1
2833279|NCT02641379|9716892|P6|Overall Study|Participant unable to attend study visit|1
2833280|NCT02641379|9716893|P5|Overall Study|Participant unable to attend study visit|5
2833281|NCT02641379|9716894|P4|Overall Study|Participant unable to attend study visit|2
2833282|NCT02641379|9716895|P3|Overall Study|Participant unable to attend study visit|1
2833283|NCT02641379|9716896|P2|Overall Study|Participant unable to attend study visit|10
2833284|NCT02641379|9716897|P1|Overall Study|Participant unable to attend study visit|4
2833285|NCT02641379|9716887|P11|Overall Study|Lack of Efficacy|0
2833286|NCT02641379|9716888|P10|Overall Study|Lack of Efficacy|0
2833287|NCT02641379|9716889|P9|Overall Study|Lack of Efficacy|0
2833288|NCT02641379|9716890|P8|Overall Study|Lack of Efficacy|5
2833289|NCT02641379|9716891|P7|Overall Study|Lack of Efficacy|0
2833290|NCT02641379|9716892|P6|Overall Study|Lack of Efficacy|2
2833291|NCT02641379|9716893|P5|Overall Study|Lack of Efficacy|0
2833292|NCT02641379|9716894|P4|Overall Study|Lack of Efficacy|0
2833293|NCT02641379|9716895|P3|Overall Study|Lack of Efficacy|2
2833294|NCT02641379|9716896|P2|Overall Study|Lack of Efficacy|0
2833295|NCT02641379|9716897|P1|Overall Study|Lack of Efficacy|0
2833296|NCT02641379|9716887|P11|Overall Study|Adverse Event|5
2833297|NCT02641379|9716888|P10|Overall Study|Adverse Event|1
2833298|NCT02641379|9716889|P9|Overall Study|Adverse Event|1
2833299|NCT02641379|9716890|P8|Overall Study|Adverse Event|0
2833300|NCT02641379|9716891|P7|Overall Study|Adverse Event|5
2833301|NCT02641379|9716892|P6|Overall Study|Adverse Event|1
2833302|NCT02641379|9716893|P5|Overall Study|Adverse Event|5
2833303|NCT02641379|9716894|P4|Overall Study|Adverse Event|2
2833304|NCT02641379|9716895|P3|Overall Study|Adverse Event|2
2833305|NCT02641379|9716896|P2|Overall Study|Adverse Event|8
2833306|NCT02641379|9716897|P1|Overall Study|Adverse Event|7
2833307|NCT02641379|9716887|P11|Overall Study|Withdrawal of informed consent|0
2833308|NCT02641379|9716888|P10|Overall Study|Withdrawal of informed consent|0
2833309|NCT02641379|9716889|P9|Overall Study|Withdrawal of informed consent|0
2833310|NCT02641379|9716890|P8|Overall Study|Withdrawal of informed consent|1
2833311|NCT02641379|9716891|P7|Overall Study|Withdrawal of informed consent|0
2833312|NCT02641379|9716892|P6|Overall Study|Withdrawal of informed consent|0
2833313|NCT02641379|9716893|P5|Overall Study|Withdrawal of informed consent|0
2833314|NCT02641379|9716894|P4|Overall Study|Withdrawal of informed consent|0
2833315|NCT02641379|9716895|P3|Overall Study|Withdrawal of informed consent|0
2833316|NCT02641379|9716896|P2|Overall Study|Withdrawal of informed consent|1
2833317|NCT02641379|9716897|P1|Overall Study|Withdrawal of informed consent|0
2833318|NCT02641379|9716887|P11|Overall Study|Exclusion criterion during screening|0
2833319|NCT02641379|9716888|P10|Overall Study|Exclusion criterion during screening|0
2833320|NCT02641379|9716889|P9|Overall Study|Exclusion criterion during screening|0
2833321|NCT02641379|9716890|P8|Overall Study|Exclusion criterion during screening|0
2833322|NCT02641379|9716891|P7|Overall Study|Exclusion criterion during screening|0
2833323|NCT02641379|9716892|P6|Overall Study|Exclusion criterion during screening|0
2833324|NCT02641379|9716893|P5|Overall Study|Exclusion criterion during screening|2
2833325|NCT02641379|9716894|P4|Overall Study|Exclusion criterion during screening|1
2833326|NCT02641379|9716895|P3|Overall Study|Exclusion criterion during screening|0
2833327|NCT02641379|9716896|P2|Overall Study|Exclusion criterion during screening|0
2833328|NCT02641379|9716897|P1|Overall Study|Exclusion criterion during screening|1
2833329|NCT02640755|9716996|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
2833330|NCT02640755|9716997|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
2833331|NCT02640755|9716996|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
2833332|NCT02640755|9716997|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
2833333|NCT02640755|9716996|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
2833334|NCT02640755|9716997|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
2833335|NCT02640625|9717032|P1|Overall Study|Adverse Event|1
2833336|NCT02640612|9717041|P3|Overall Study|Lack of Efficacy|0
2833337|NCT02640612|9717042|P2|Overall Study|Lack of Efficacy|1
2833338|NCT02640612|9717043|P1|Overall Study|Lack of Efficacy|1
2833339|NCT02640612|9717041|P3|Overall Study|Protocol Violation|0
2833340|NCT02640612|9717042|P2|Overall Study|Protocol Violation|2
2833341|NCT02640612|9717043|P1|Overall Study|Protocol Violation|0
2833342|NCT02640612|9717041|P3|Overall Study|Lost to Follow-up|1
2833343|NCT02640612|9717042|P2|Overall Study|Lost to Follow-up|1
2833344|NCT02640612|9717043|P1|Overall Study|Lost to Follow-up|4
2833345|NCT02640612|9717041|P3|Overall Study|Withdrawal by Subject|3
2833346|NCT02640612|9717042|P2|Overall Study|Withdrawal by Subject|3
2833347|NCT02640612|9717043|P1|Overall Study|Withdrawal by Subject|10
2833348|NCT02640612|9717041|P3|Overall Study|Death|0
2833349|NCT02640612|9717042|P2|Overall Study|Death|0
2833350|NCT02640612|9717043|P1|Overall Study|Death|1
2833351|NCT02640612|9717041|P3|Overall Study|Adverse Event|2
2833352|NCT02640612|9717042|P2|Overall Study|Adverse Event|7
2833353|NCT02640612|9717043|P1|Overall Study|Adverse Event|6
2833354|NCT02640547|9717067|P1|Overall Study|Miscellaneous|3
2833355|NCT02640547|9717067|P1|Overall Study|Death|6
2833356|NCT02640547|9717067|P1|Overall Study|Withdrawal by Subject|1
2833357|NCT02640547|9717067|P1|Overall Study|Failure to Return|1
2833358|NCT02640482|9717144|P2|Overall Study|Lost to Follow-up|0
2833359|NCT02640482|9717145|P1|Overall Study|Lost to Follow-up|3
2833360|NCT02640404|9717157|P2|Overall Study|Withdrawal by Subject|0
2833361|NCT02640404|9717158|P1|Overall Study|Withdrawal by Subject|1
2833362|NCT02640404|9717157|P2|Overall Study|Protocol Violation|0
2833363|NCT02640404|9717158|P1|Overall Study|Protocol Violation|1
2833364|NCT02640157|9717169|P3|Overall Study|Randomized in error; did not receive Tx|0
2833365|NCT02640157|9717170|P2|Overall Study|Randomized in error; did not receive Tx|1
2833366|NCT02640157|9717171|P1|Overall Study|Randomized in error; did not receive Tx|0
2833367|NCT02640157|9717169|P3|Overall Study|Lost to Follow-up|7
2833368|NCT02640157|9717170|P2|Overall Study|Lost to Follow-up|2
2833369|NCT02640157|9717171|P1|Overall Study|Lost to Follow-up|9
2833370|NCT02640157|9717169|P3|Overall Study|Withdrew consent|2
2833371|NCT02640157|9717170|P2|Overall Study|Withdrew consent|0
2833372|NCT02640157|9717171|P1|Overall Study|Withdrew consent|2
2833373|NCT02640157|9717169|P3|Overall Study|Adverse Event|1
2833374|NCT02640157|9717170|P2|Overall Study|Adverse Event|2
2833375|NCT02640157|9717171|P1|Overall Study|Adverse Event|2
2833376|NCT02640053|9717190|P2|Overall Study|Chemo regimen changed after 1st Rx|1
2833377|NCT02640053|9717191|P1|Overall Study|Chemo regimen changed after 1st Rx|0
2833378|NCT02640053|9717190|P2|Overall Study|Alternative Therapy|1
2833379|NCT02640053|9717191|P1|Overall Study|Alternative Therapy|1
2833380|NCT02640053|9717190|P2|Overall Study|Adverse Event|1
2833381|NCT02640053|9717191|P1|Overall Study|Adverse Event|1
2833382|NCT02640053|9717190|P2|Overall Study|Withdrawal by Subject|1
2833383|NCT02640053|9717191|P1|Overall Study|Withdrawal by Subject|2
2833384|NCT02639559|9717298|P2|Overall Study|Issues with vascular acess|0
2833385|NCT02639559|9717299|P1|Overall Study|Issues with vascular acess|1
2833386|NCT02639559|9717298|P2|Overall Study|Mobilization failure|3
2833387|NCT02639559|9717299|P1|Overall Study|Mobilization failure|0
2833388|NCT02639338|9717735|P2|Overall Study|Randomized but Not Treated|1
2833389|NCT02639338|9717736|P1|Overall Study|Randomized but Not Treated|0
2833390|NCT02639338|9717735|P2|Overall Study|Death|0
2833391|NCT02639338|9717736|P1|Overall Study|Death|1
2833392|NCT02639338|9717735|P2|Overall Study|Withdrew Consent|2
2833393|NCT02639338|9717736|P1|Overall Study|Withdrew Consent|1
2833394|NCT02639338|9717735|P2|Overall Study|Lost to Follow-up|2
2833395|NCT02639338|9717736|P1|Overall Study|Lost to Follow-up|2
2833396|NCT02639247|9717754|P2|Overall Study|Protocol Violation|0
2833397|NCT02639247|9717755|P1|Overall Study|Protocol Violation|1
2833398|NCT02639247|9717754|P2|Overall Study|Withdrew Consent|1
2833399|NCT02639247|9717755|P1|Overall Study|Withdrew Consent|0
2833400|NCT02639247|9717754|P2|Overall Study|Death|0
2833401|NCT02639247|9717755|P1|Overall Study|Death|2
2833402|NCT02639247|9717754|P2|Overall Study|Lost to Follow-up|1
2833403|NCT02639247|9717755|P1|Overall Study|Lost to Follow-up|2
2833404|NCT02639052|9717771|P1|Overall Study|Lost to Follow-up|1
2833405|NCT02638948|9717808|P4|Overall Study|Other than specified above|1
2833406|NCT02638948|9717809|P3|Overall Study|Other than specified above|1
2833407|NCT02638948|9717810|P2|Overall Study|Other than specified above|1
2833408|NCT02638948|9717811|P1|Overall Study|Other than specified above|4
2833409|NCT02638948|9717808|P4|Overall Study|Participant no longer met study criteria|0
2833410|NCT02638948|9717809|P3|Overall Study|Participant no longer met study criteria|0
2833497|NCT02638103|9718139|P3|Overall Study|Adverse Event|19
2833411|NCT02638948|9717810|P2|Overall Study|Participant no longer met study criteria|1
2833412|NCT02638948|9717811|P1|Overall Study|Participant no longer met study criteria|0
2833413|NCT02638948|9717808|P4|Overall Study|Poor/Non-Compliance|0
2833414|NCT02638948|9717809|P3|Overall Study|Poor/Non-Compliance|1
2833415|NCT02638948|9717810|P2|Overall Study|Poor/Non-Compliance|2
2833416|NCT02638948|9717811|P1|Overall Study|Poor/Non-Compliance|0
2833417|NCT02638948|9717808|P4|Overall Study|Lost to Follow-up|1
2833418|NCT02638948|9717809|P3|Overall Study|Lost to Follow-up|1
2833419|NCT02638948|9717810|P2|Overall Study|Lost to Follow-up|0
2833420|NCT02638948|9717811|P1|Overall Study|Lost to Follow-up|0
2833421|NCT02638948|9717808|P4|Overall Study|Lack of Efficacy|0
2833422|NCT02638948|9717809|P3|Overall Study|Lack of Efficacy|0
2833423|NCT02638948|9717810|P2|Overall Study|Lack of Efficacy|1
2833424|NCT02638948|9717811|P1|Overall Study|Lack of Efficacy|1
2833425|NCT02638948|9717808|P4|Overall Study|Adverse Event|1
2833426|NCT02638948|9717809|P3|Overall Study|Adverse Event|1
2833427|NCT02638948|9717810|P2|Overall Study|Adverse Event|0
2833428|NCT02638948|9717811|P1|Overall Study|Adverse Event|0
2833429|NCT02638948|9717808|P4|Overall Study|Administrative Reason by Sponsor|4
2833430|NCT02638948|9717809|P3|Overall Study|Administrative Reason by Sponsor|0
2833431|NCT02638948|9717810|P2|Overall Study|Administrative Reason by Sponsor|1
2833432|NCT02638948|9717811|P1|Overall Study|Administrative Reason by Sponsor|0
2833433|NCT02638948|9717808|P4|Overall Study|Withdrawal by Subject|1
2833434|NCT02638948|9717809|P3|Overall Study|Withdrawal by Subject|3
2833435|NCT02638948|9717810|P2|Overall Study|Withdrawal by Subject|5
2833436|NCT02638948|9717811|P1|Overall Study|Withdrawal by Subject|4
2833437|NCT02638493|9717910|P3|Overall Study|Inability to provide semen samples|0
2833438|NCT02638493|9717911|P2|Overall Study|Inability to provide semen samples|0
2833439|NCT02638493|9717912|P1|Overall Study|Inability to provide semen samples|2
2833440|NCT02638337|9717943|P2|Overall Study|Other - Miscellaneous|3
2833441|NCT02638337|9717944|P1|Overall Study|Other - Miscellaneous|4
2833442|NCT02638337|9717943|P2|Overall Study|Lost to Follow-up|7
2833443|NCT02638337|9717944|P1|Overall Study|Lost to Follow-up|7
2833444|NCT02638337|9717943|P2|Overall Study|Withdrawal by Subject|16
2833445|NCT02638337|9717944|P1|Overall Study|Withdrawal by Subject|13
2833446|NCT02638337|9717943|P2|Overall Study|Protocol Violation|0
2833447|NCT02638337|9717944|P1|Overall Study|Protocol Violation|3
2833448|NCT02638337|9717943|P2|Overall Study|Adverse Event|10
2833449|NCT02638337|9717944|P1|Overall Study|Adverse Event|6
2833450|NCT02638259|9718028|P2|Treatment Period 2|Withdrawal by Subject|7
2833451|NCT02638259|9718029|P1|Treatment Period 2|Withdrawal by Subject|1
2833452|NCT02638259|9718028|P2|Treatment Period 2|Adverse Event|4
2833453|NCT02638259|9718029|P1|Treatment Period 2|Adverse Event|5
2833454|NCT02638259|9718028|P2|Treatment Period 1|Withdrawn per sponsor decision|2
2833455|NCT02638259|9718029|P1|Treatment Period 1|Withdrawn per sponsor decision|0
2833456|NCT02638259|9718028|P2|Treatment Period 1|Withdrawal by Subject|6
2833457|NCT02638259|9718029|P1|Treatment Period 1|Withdrawal by Subject|4
2833458|NCT02638259|9718028|P2|Treatment Period 1|Protocol Violation|3
2833459|NCT02638259|9718029|P1|Treatment Period 1|Protocol Violation|0
2833460|NCT02638259|9718028|P2|Treatment Period 1|Lack of Efficacy|1
2833461|NCT02638259|9718029|P1|Treatment Period 1|Lack of Efficacy|0
2833462|NCT02638259|9718028|P2|Treatment Period 1|Death|1
2833463|NCT02638259|9718029|P1|Treatment Period 1|Death|0
2833464|NCT02638259|9718028|P2|Treatment Period 1|Adverse Event|5
2833465|NCT02638259|9718029|P1|Treatment Period 1|Adverse Event|1
2833466|NCT02638129|9718121|P2|Overall Study|Study terminated|30
2833467|NCT02638129|9718122|P1|Overall Study|Study terminated|28
2833468|NCT02638103|9718138|P4|Overall Study|Other than specified|4
2833469|NCT02638103|9718139|P3|Overall Study|Other than specified|2
2833470|NCT02638103|9718140|P2|Overall Study|Other than specified|4
2833471|NCT02638103|9718141|P1|Overall Study|Other than specified|5
2833472|NCT02638103|9718138|P4|Overall Study|Lack of Efficacy|22
2833473|NCT02638103|9718139|P3|Overall Study|Lack of Efficacy|12
2833474|NCT02638103|9718140|P2|Overall Study|Lack of Efficacy|10
2833475|NCT02638103|9718141|P1|Overall Study|Lack of Efficacy|14
2833476|NCT02638103|9718138|P4|Overall Study|Lost to Follow-up|37
2833477|NCT02638103|9718139|P3|Overall Study|Lost to Follow-up|20
2833478|NCT02638103|9718140|P2|Overall Study|Lost to Follow-up|33
2833479|NCT02638103|9718141|P1|Overall Study|Lost to Follow-up|26
2833480|NCT02638103|9718138|P4|Overall Study|Non-compliance to Study Procedures|1
2833481|NCT02638103|9718139|P3|Overall Study|Non-compliance to Study Procedures|1
2833482|NCT02638103|9718140|P2|Overall Study|Non-compliance to Study Procedures|1
2833483|NCT02638103|9718141|P1|Overall Study|Non-compliance to Study Procedures|2
2833484|NCT02638103|9718138|P4|Overall Study|Pregnancy|1
2833485|NCT02638103|9718139|P3|Overall Study|Pregnancy|0
2833486|NCT02638103|9718140|P2|Overall Study|Pregnancy|3
2833487|NCT02638103|9718141|P1|Overall Study|Pregnancy|2
2833488|NCT02638103|9718138|P4|Overall Study|Protocol Violation|4
2833489|NCT02638103|9718139|P3|Overall Study|Protocol Violation|1
2833490|NCT02638103|9718140|P2|Overall Study|Protocol Violation|2
2833491|NCT02638103|9718141|P1|Overall Study|Protocol Violation|1
2833492|NCT02638103|9718138|P4|Overall Study|Withdrawal by Subject|61
2833493|NCT02638103|9718139|P3|Overall Study|Withdrawal by Subject|30
2833494|NCT02638103|9718140|P2|Overall Study|Withdrawal by Subject|53
2833495|NCT02638103|9718141|P1|Overall Study|Withdrawal by Subject|43
2833496|NCT02638103|9718138|P4|Overall Study|Adverse Event|12
2833498|NCT02638103|9718140|P2|Overall Study|Adverse Event|12
2833499|NCT02638103|9718141|P1|Overall Study|Adverse Event|13
2833500|NCT02638012|9718228|P1|Overall Study|Lost to Follow-up|1
2833501|NCT02637856|9718273|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
2833502|NCT02637856|9718274|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
2833503|NCT02637856|9718273|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
2833504|NCT02637856|9718274|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
2833505|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Site Closing|0
2833506|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Site Closing|6
2833507|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
2833508|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
2833509|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Incarceration|0
2833510|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Incarceration|1
2833511|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
2833512|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
2833513|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
2833514|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
2833515|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
2833516|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
2833517|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
2833518|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
2833519|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Pregnancy|0
2833520|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Pregnancy|7
2833521|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Physician Decision|0
2833522|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Physician Decision|2
2833523|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
2833524|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
2833525|NCT02637856|9718273|P2|Main Study (Baseline to Week 100)|Adverse Event|0
2833526|NCT02637856|9718274|P1|Main Study (Baseline to Week 100)|Adverse Event|9
2833527|NCT02637557|9718404|P4|Overall Study|Withdrawal by Subject|2
2833528|NCT02637557|9718405|P3|Overall Study|Withdrawal by Subject|4
2833529|NCT02637557|9718406|P2|Overall Study|Withdrawal by Subject|3
2833530|NCT02637557|9718407|P1|Overall Study|Withdrawal by Subject|1
2833531|NCT02637557|9718404|P4|Overall Study|Protocol Violation|1
2833532|NCT02637557|9718405|P3|Overall Study|Protocol Violation|2
2833533|NCT02637557|9718406|P2|Overall Study|Protocol Violation|0
2833534|NCT02637557|9718407|P1|Overall Study|Protocol Violation|2
2833535|NCT02637557|9718404|P4|Overall Study|Physician Decision|0
2833536|NCT02637557|9718405|P3|Overall Study|Physician Decision|0
2833537|NCT02637557|9718406|P2|Overall Study|Physician Decision|0
2833538|NCT02637557|9718407|P1|Overall Study|Physician Decision|1
2833539|NCT02637557|9718404|P4|Overall Study|Lost to Follow-up|1
2833540|NCT02637557|9718405|P3|Overall Study|Lost to Follow-up|0
2833541|NCT02637557|9718406|P2|Overall Study|Lost to Follow-up|1
2833542|NCT02637557|9718407|P1|Overall Study|Lost to Follow-up|1
2833543|NCT02637557|9718404|P4|Overall Study|Adverse Event|3
2833544|NCT02637557|9718405|P3|Overall Study|Adverse Event|3
2833545|NCT02637557|9718406|P2|Overall Study|Adverse Event|1
2833546|NCT02637557|9718407|P1|Overall Study|Adverse Event|3
2833547|NCT02637323|9718499|P2|Overall Study|Protocol Violation|1
2833548|NCT02637323|9718500|P1|Overall Study|Protocol Violation|0
2833549|NCT02637323|9718499|P2|Overall Study|Lost to Follow-up|0
2833550|NCT02637323|9718500|P1|Overall Study|Lost to Follow-up|2
2833551|NCT02637141|9718511|P3|Overall Study|Withdrawal by Subject|1
2833552|NCT02637141|9718512|P2|Overall Study|Withdrawal by Subject|1
2833553|NCT02637141|9718513|P1|Overall Study|Withdrawal by Subject|1
2833554|NCT02637141|9718511|P3|Overall Study|Adverse Event|0
2833555|NCT02637141|9718512|P2|Overall Study|Adverse Event|1
2833556|NCT02637141|9718513|P1|Overall Study|Adverse Event|1
2833557|NCT02637063|9718548|P3|Overall Study|Withdrawal by Subject|3
2833558|NCT02637063|9718549|P2|Overall Study|Withdrawal by Subject|2
2833559|NCT02637063|9718550|P1|Overall Study|Withdrawal by Subject|2
2833560|NCT02637063|9718548|P3|Overall Study|Lost to Follow-up|3
2833561|NCT02637063|9718549|P2|Overall Study|Lost to Follow-up|2
2833562|NCT02637063|9718550|P1|Overall Study|Lost to Follow-up|3
2833563|NCT02637037|9718578|P2|Overall Study|Adverse Event|0
2833564|NCT02637037|9718579|P1|Overall Study|Adverse Event|1
2833565|NCT02637037|9718578|P2|Overall Study|Withdrawal by Subject|1
2833566|NCT02637037|9718579|P1|Overall Study|Withdrawal by Subject|2
2833567|NCT02637037|9718578|P2|Overall Study|Positive drug screen at admission|0
2833568|NCT02637037|9718579|P1|Overall Study|Positive drug screen at admission|1
2833569|NCT02636907|9718645|P1|Extension Phase|Lack of Efficacy|1
2833570|NCT02636907|9718645|P1|Extension Phase|Lost to Follow-up|2
2833571|NCT02636907|9718645|P1|Extension Phase|Physician Decision|1
2833572|NCT02636907|9718645|P1|Extension Phase|Withdrawal by Subject|4
2833573|NCT02636907|9718645|P1|Extension Phase|Adverse Event|2
2833574|NCT02636907|9718645|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
2833575|NCT02636907|9718645|P1|Autoinjector Assessment Period|Adverse Event|2
2833576|NCT02636608|9718662|P1|Overall Study|Did Not Receive Treatment|1
2833577|NCT02636608|9718662|P1|Overall Study|Other|2
2833578|NCT02636608|9718662|P1|Overall Study|Death|3
2833579|NCT02636608|9718662|P1|Overall Study|Insufficient Virological Response|1
2833580|NCT02636608|9718662|P1|Overall Study|Failure to Return|4
2833581|NCT02636595|9718690|P1|Overall Study|Other|1
2833582|NCT02636595|9718690|P1|Overall Study|Lost to Follow-up|1
2833583|NCT02636361|9718696|P5|Period 4|Physician Decision|0
2833584|NCT02636361|9718697|P4|Period 4|Physician Decision|1
2833585|NCT02636361|9718698|P3|Period 4|Physician Decision|0
2833586|NCT02636361|9718699|P2|Period 4|Physician Decision|0
2833587|NCT02636361|9718700|P1|Period 4|Physician Decision|0
2833588|NCT02636283|9718719|P2|Overall Study|Trial Terminated Prematurely|3
2833589|NCT02636283|9718720|P1|Overall Study|Trial Terminated Prematurely|0
2833590|NCT02636283|9718719|P2|Overall Study|Adverse Event|0
2833591|NCT02636283|9718720|P1|Overall Study|Adverse Event|2
2833592|NCT02635984|9718748|P2|Overall Study|Study Arm Closed|0
2833593|NCT02635984|9718749|P1|Overall Study|Study Arm Closed|1
2833594|NCT02635984|9718748|P2|Overall Study|Lost to Follow-up|4
2833595|NCT02635984|9718749|P1|Overall Study|Lost to Follow-up|2
2833596|NCT02635646|9718781|P2|Overall Study|Pregnancy|1
2833597|NCT02635646|9718782|P1|Overall Study|Pregnancy|1
2833598|NCT02635646|9718781|P2|Overall Study|Lost to Follow-up|25
2833599|NCT02635646|9718782|P1|Overall Study|Lost to Follow-up|24
2833600|NCT02635347|9718818|P2|Overall Study|Failed screening|7
2833601|NCT02635347|9718819|P1|Overall Study|Failed screening|20
2833602|NCT02635204|9718850|P2|Overall Study|Lost to Follow-up|1
2833603|NCT02635204|9718851|P1|Overall Study|Lost to Follow-up|1
2833604|NCT02635204|9718850|P2|Overall Study|Adverse Event|0
2833605|NCT02635204|9718851|P1|Overall Study|Adverse Event|1
2833606|NCT02634983|9718861|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
2833607|NCT02634983|9718862|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
2833608|NCT02634801|9718921|P3|Follow-up Period|Adverse Event|0
2833609|NCT02634801|9718922|P2|Follow-up Period|Adverse Event|5
2833610|NCT02634801|9718923|P1|Follow-up Period|Adverse Event|1
2833611|NCT02634801|9718921|P3|Follow-up Period|Withdrawal by Subject|5
2833612|NCT02634801|9718922|P2|Follow-up Period|Withdrawal by Subject|2
2833613|NCT02634801|9718923|P1|Follow-up Period|Withdrawal by Subject|1
2833614|NCT02634801|9718921|P3|Follow-up Period|Physician Decision|1
2833615|NCT02634801|9718922|P2|Follow-up Period|Physician Decision|0
2833616|NCT02634801|9718923|P1|Follow-up Period|Physician Decision|0
2833617|NCT02634801|9718921|P3|Follow-up Period|Lost to Follow-up|2
2833618|NCT02634801|9718922|P2|Follow-up Period|Lost to Follow-up|1
2833619|NCT02634801|9718923|P1|Follow-up Period|Lost to Follow-up|3
2833620|NCT02634801|9718921|P3|Extension Period (Weeks 24 to 36)|Missing|0
2833621|NCT02634801|9718922|P2|Extension Period (Weeks 24 to 36)|Missing|0
2833622|NCT02634801|9718923|P1|Extension Period (Weeks 24 to 36)|Missing|1
2833623|NCT02634801|9718921|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2833624|NCT02634801|9718922|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2833625|NCT02634801|9718923|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2833626|NCT02634801|9718921|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2833627|NCT02634801|9718922|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2833628|NCT02634801|9718923|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
2833629|NCT02634801|9718921|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
2833630|NCT02634801|9718922|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
2833631|NCT02634801|9718923|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
2833632|NCT02634801|9718921|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
2833633|NCT02634801|9718922|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
2833634|NCT02634801|9718923|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
2833635|NCT02634801|9718921|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
2833636|NCT02634801|9718922|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2833637|NCT02634801|9718923|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2833638|NCT02634801|9718921|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2833639|NCT02634801|9718922|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2833640|NCT02634801|9718923|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
2833641|NCT02634801|9718921|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2833642|NCT02634801|9718922|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
2833643|NCT02634801|9718923|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2833644|NCT02634801|9718921|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
2833645|NCT02634801|9718922|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
2833646|NCT02634801|9718923|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
2833647|NCT02634788|9719023|P4|Overall Study|Withdrawal by Subject|0
2833648|NCT02634788|9719024|P3|Overall Study|Withdrawal by Subject|1
2833649|NCT02634788|9719025|P2|Overall Study|Withdrawal by Subject|1
2833650|NCT02634788|9719026|P1|Overall Study|Withdrawal by Subject|0
2833651|NCT02634788|9719023|P4|Overall Study|Lost to Follow-up|0
2833652|NCT02634788|9719024|P3|Overall Study|Lost to Follow-up|0
2833653|NCT02634788|9719025|P2|Overall Study|Lost to Follow-up|1
2833654|NCT02634788|9719026|P1|Overall Study|Lost to Follow-up|0
2833655|NCT02634788|9719023|P4|Overall Study|Lack of Efficacy|4
2833656|NCT02634788|9719024|P3|Overall Study|Lack of Efficacy|1
2833657|NCT02634788|9719025|P2|Overall Study|Lack of Efficacy|0
2833658|NCT02634788|9719026|P1|Overall Study|Lack of Efficacy|4
2833659|NCT02634788|9719023|P4|Overall Study|Adverse Event|1
2833660|NCT02634788|9719024|P3|Overall Study|Adverse Event|3
2833661|NCT02634788|9719025|P2|Overall Study|Adverse Event|8
2833662|NCT02634788|9719026|P1|Overall Study|Adverse Event|0
2833663|NCT02634606|9719092|P1|Overall Study|unable to obtain the drug at start|13
2833664|NCT02634580|9719104|P4|Overall Study|Subject Request|1
2833665|NCT02634580|9719105|P3|Overall Study|Subject Request|1
2833666|NCT02634580|9719106|P2|Overall Study|Subject Request|0
2833667|NCT02634580|9719107|P1|Overall Study|Subject Request|1
2833668|NCT02634346|9719164|P3|Overall Study|Protocol Violation|0
2833669|NCT02634346|9719165|P2|Overall Study|Protocol Violation|1
2833670|NCT02634346|9719166|P1|Overall Study|Protocol Violation|0
2833671|NCT02634346|9719164|P3|Overall Study|Lost to Follow-up|0
2833672|NCT02634346|9719165|P2|Overall Study|Lost to Follow-up|0
2833673|NCT02634346|9719166|P1|Overall Study|Lost to Follow-up|1
2833674|NCT02634346|9719164|P3|Overall Study|Lack of Efficacy|8
2833675|NCT02634346|9719165|P2|Overall Study|Lack of Efficacy|2
2833676|NCT02634346|9719166|P1|Overall Study|Lack of Efficacy|1
2833677|NCT02634346|9719164|P3|Overall Study|Adverse Event|7
2833678|NCT02634346|9719165|P2|Overall Study|Adverse Event|2
2833679|NCT02634346|9719166|P1|Overall Study|Adverse Event|2
2833680|NCT02634346|9719164|P3|Overall Study|Withdrawal by Subject|8
2833681|NCT02634346|9719165|P2|Overall Study|Withdrawal by Subject|9
2833682|NCT02634346|9719166|P1|Overall Study|Withdrawal by Subject|8
2833683|NCT02634320|9719180|P1|Overall Study|Lack of Efficacy|2
2833684|NCT02634320|9719180|P1|Overall Study|Withdrawal by Subject|5
2833685|NCT02634320|9719180|P1|Overall Study|Protocol Violation|1
2833686|NCT02634320|9719180|P1|Overall Study|Out of window for study visits|1
2833687|NCT02634320|9719180|P1|Overall Study|Moved out of area|2
2833688|NCT02634320|9719180|P1|Overall Study|Lost to Follow-up|3
2833689|NCT02634320|9719180|P1|Overall Study|Adverse Event|2
2833690|NCT02633800|9719305|P2|Overall Study|Patient Request|1
2833691|NCT02633800|9719306|P1|Overall Study|Patient Request|1
2833692|NCT02633800|9719305|P2|Overall Study|Withdrawal by Subject|3
2833693|NCT02633800|9719306|P1|Overall Study|Withdrawal by Subject|0
2833694|NCT02633800|9719305|P2|Overall Study|Adverse event, non-fatal|2
2833695|NCT02633800|9719306|P1|Overall Study|Adverse event, non-fatal|7
2833696|NCT02633800|9719305|P2|Overall Study|Study terminated by sponsor|5
2833697|NCT02633800|9719306|P1|Overall Study|Study terminated by sponsor|6
2833698|NCT02633800|9719305|P2|Overall Study|Clinical progression|6
2833699|NCT02633800|9719306|P1|Overall Study|Clinical progression|3
2833700|NCT02633800|9719305|P2|Overall Study|Radiologic(al) progression|23
2833701|NCT02633800|9719306|P1|Overall Study|Radiologic(al) progression|23
2833702|NCT02633800|9719305|P2|Overall Study|Reason not provided|0
2833703|NCT02633800|9719306|P1|Overall Study|Reason not provided|1
2833704|NCT02633800|9719305|P2|Overall Study|Death|3
2833705|NCT02633800|9719306|P1|Overall Study|Death|3
2833706|NCT02633787|9719316|P1|Overall Study|Withdrawal by Subject|1
2833707|NCT02633501|9719328|P6|Overall Study|Lost to Follow-up|0
2833708|NCT02633501|9719329|P5|Overall Study|Lost to Follow-up|2
2833709|NCT02633501|9719330|P4|Overall Study|Lost to Follow-up|1
2833710|NCT02633501|9719331|P3|Overall Study|Lost to Follow-up|0
2833711|NCT02633501|9719332|P2|Overall Study|Lost to Follow-up|0
2833712|NCT02633501|9719333|P1|Overall Study|Lost to Follow-up|0
2833713|NCT02633501|9719328|P6|Overall Study|Various other reasons|11
2833714|NCT02633501|9719329|P5|Overall Study|Various other reasons|7
2833715|NCT02633501|9719330|P4|Overall Study|Various other reasons|1
2833716|NCT02633501|9719331|P3|Overall Study|Various other reasons|4
2833717|NCT02633501|9719332|P2|Overall Study|Various other reasons|2
2833718|NCT02633501|9719333|P1|Overall Study|Various other reasons|0
2833719|NCT02633501|9719328|P6|Overall Study|Withdrawal by Subject|3
2833720|NCT02633501|9719329|P5|Overall Study|Withdrawal by Subject|1
2833721|NCT02633501|9719330|P4|Overall Study|Withdrawal by Subject|2
2833722|NCT02633501|9719331|P3|Overall Study|Withdrawal by Subject|2
2833723|NCT02633501|9719332|P2|Overall Study|Withdrawal by Subject|1
2833724|NCT02633501|9719333|P1|Overall Study|Withdrawal by Subject|2
2833725|NCT02633501|9719328|P6|Overall Study|Adverse Event|1
2833726|NCT02633501|9719329|P5|Overall Study|Adverse Event|1
2833727|NCT02633501|9719330|P4|Overall Study|Adverse Event|0
2833728|NCT02633501|9719331|P3|Overall Study|Adverse Event|1
2833729|NCT02633501|9719332|P2|Overall Study|Adverse Event|0
2833730|NCT02633501|9719333|P1|Overall Study|Adverse Event|0
2833731|NCT02633215|9719395|P2|Overall Study|Lost to Follow-up|3
2833732|NCT02633215|9719396|P1|Overall Study|Lost to Follow-up|2
2833733|NCT02633020|9719408|P2|Overall Study|Adverse Event|0
2833734|NCT02633020|9719409|P1|Overall Study|Adverse Event|1
2833735|NCT02632838|9719433|P2|Overall Study|Lost to Follow-up|2
2833736|NCT02632838|9719434|P1|Overall Study|Lost to Follow-up|0
2833737|NCT02632838|9719433|P2|Overall Study|Withdrawal by Subject|0
2833738|NCT02632838|9719434|P1|Overall Study|Withdrawal by Subject|3
2833739|NCT02632786|9719471|P2|Overall Study|Withdrawal by Subject|0
2833740|NCT02632786|9719472|P1|Overall Study|Withdrawal by Subject|1
2833741|NCT02632786|9719471|P2|Overall Study|Physician Decision|4
2833742|NCT02632786|9719472|P1|Overall Study|Physician Decision|5
2833743|NCT02632786|9719471|P2|Overall Study|Death|2
2833744|NCT02632786|9719472|P1|Overall Study|Death|3
2833745|NCT02632786|9719471|P2|Overall Study|Adverse Event|1
2833746|NCT02632786|9719472|P1|Overall Study|Adverse Event|2
2833747|NCT02632110|9719682|P10|Overall Study|Withdrawal by Subject|1
2833748|NCT02632110|9719683|P9|Overall Study|Withdrawal by Subject|1
2833749|NCT02632110|9719684|P8|Overall Study|Withdrawal by Subject|3
2833750|NCT02632110|9719685|P7|Overall Study|Withdrawal by Subject|3
2833751|NCT02632110|9719686|P6|Overall Study|Withdrawal by Subject|1
2833752|NCT02632110|9719687|P5|Overall Study|Withdrawal by Subject|1
2833753|NCT02632110|9719688|P4|Overall Study|Withdrawal by Subject|0
2833754|NCT02632110|9719689|P3|Overall Study|Withdrawal by Subject|0
2833755|NCT02632110|9719690|P2|Overall Study|Withdrawal by Subject|1
2833756|NCT02632110|9719691|P1|Overall Study|Withdrawal by Subject|1
2833757|NCT02631746|9720192|P1|Overall Study|Lack of Efficacy|3
2833758|NCT02631577|9720205|P2|Overall Study|Withdrawal by Subject|1
2833759|NCT02631577|9720206|P1|Overall Study|Withdrawal by Subject|0
2833760|NCT02631577|9720205|P2|Overall Study|Death|3
2833761|NCT02631577|9720206|P1|Overall Study|Death|1
2833762|NCT02631551|9720224|P4|Overall Study|Other, specific reasons not collected|2
2833763|NCT02631551|9720225|P3|Overall Study|Other, specific reasons not collected|2
2833764|NCT02631551|9720226|P2|Overall Study|Other, specific reasons not collected|7
2833765|NCT02631551|9720227|P1|Overall Study|Other, specific reasons not collected|5
2833766|NCT02631551|9720224|P4|Overall Study|Non-compliance with study drug|0
2833767|NCT02631551|9720225|P3|Overall Study|Non-compliance with study drug|0
2833768|NCT02631551|9720226|P2|Overall Study|Non-compliance with study drug|0
2833769|NCT02631551|9720227|P1|Overall Study|Non-compliance with study drug|1
2833770|NCT02631551|9720224|P4|Overall Study|Non-compliance with study procedures|1
2833771|NCT02631551|9720225|P3|Overall Study|Non-compliance with study procedures|1
2833772|NCT02631551|9720226|P2|Overall Study|Non-compliance with study procedures|0
2833773|NCT02631551|9720227|P1|Overall Study|Non-compliance with study procedures|0
2833774|NCT02631551|9720224|P4|Overall Study|Protocol deviation|0
2833775|NCT02631551|9720225|P3|Overall Study|Protocol deviation|3
2833776|NCT02631551|9720226|P2|Overall Study|Protocol deviation|6
2833777|NCT02631551|9720227|P1|Overall Study|Protocol deviation|3
2833778|NCT02631551|9720224|P4|Overall Study|Withdrawal by Subject|5
2833779|NCT02631551|9720225|P3|Overall Study|Withdrawal by Subject|0
2833780|NCT02631551|9720226|P2|Overall Study|Withdrawal by Subject|2
2833781|NCT02631551|9720227|P1|Overall Study|Withdrawal by Subject|2
2833782|NCT02631551|9720224|P4|Overall Study|Lost to Follow-up|3
2833783|NCT02631551|9720225|P3|Overall Study|Lost to Follow-up|0
2833784|NCT02631551|9720226|P2|Overall Study|Lost to Follow-up|2
2833785|NCT02631551|9720227|P1|Overall Study|Lost to Follow-up|1
2833786|NCT02631551|9720224|P4|Overall Study|Lack of Efficacy|0
2833787|NCT02631551|9720225|P3|Overall Study|Lack of Efficacy|1
2833788|NCT02631551|9720226|P2|Overall Study|Lack of Efficacy|0
2833789|NCT02631551|9720227|P1|Overall Study|Lack of Efficacy|0
2833790|NCT02631551|9720224|P4|Overall Study|Adverse Event|0
2833791|NCT02631551|9720225|P3|Overall Study|Adverse Event|4
2833792|NCT02631551|9720226|P2|Overall Study|Adverse Event|2
2833793|NCT02631551|9720227|P1|Overall Study|Adverse Event|1
2833794|NCT02631070|9720239|P2|Overall Study|Miscellaneous|10
2833795|NCT02631070|9720240|P1|Overall Study|Miscellaneous|4
2833796|NCT02631070|9720239|P2|Overall Study|Progressive Disease|2
2833797|NCT02631070|9720240|P1|Overall Study|Progressive Disease|6
2833798|NCT02631070|9720239|P2|Overall Study|Protocol Violation|0
2833799|NCT02631070|9720240|P1|Overall Study|Protocol Violation|2
2833800|NCT02631070|9720239|P2|Overall Study|Withdrawal by Subject|10
2833801|NCT02631070|9720240|P1|Overall Study|Withdrawal by Subject|17
2833802|NCT02631070|9720239|P2|Overall Study|Lack of Efficacy|50
2833803|NCT02631070|9720240|P1|Overall Study|Lack of Efficacy|68
2833804|NCT02631070|9720239|P2|Overall Study|Adverse Event|4
2833805|NCT02631070|9720240|P1|Overall Study|Adverse Event|15
2833806|NCT02630966|9720334|P2|Overall Study|Lack of Efficacy|2
2833807|NCT02630966|9720335|P1|Overall Study|Lack of Efficacy|0
2833808|NCT02630966|9720334|P2|Overall Study|Voluntary Withdrawal|1
2833809|NCT02630966|9720335|P1|Overall Study|Voluntary Withdrawal|1
2833810|NCT02630966|9720334|P2|Overall Study|Significant Protocol Deviation|2
2833811|NCT02630966|9720335|P1|Overall Study|Significant Protocol Deviation|0
2833812|NCT02630966|9720334|P2|Overall Study|Adverse Event|3
2833813|NCT02630966|9720335|P1|Overall Study|Adverse Event|1
2833814|NCT02630706|9720363|P3|Overall Study|Withdrawal by Subject|7
2833815|NCT02630706|9720364|P2|Overall Study|Withdrawal by Subject|5
2833816|NCT02630706|9720365|P1|Overall Study|Withdrawal by Subject|4
2833817|NCT02630706|9720363|P3|Overall Study|Pregnancy|0
2833818|NCT02630706|9720364|P2|Overall Study|Pregnancy|1
2833819|NCT02630706|9720365|P1|Overall Study|Pregnancy|0
2833820|NCT02630706|9720363|P3|Overall Study|Physician Decision|0
2833821|NCT02630706|9720364|P2|Overall Study|Physician Decision|1
2833822|NCT02630706|9720365|P1|Overall Study|Physician Decision|1
2833823|NCT02630706|9720363|P3|Overall Study|Lost to Follow-up|2
2833824|NCT02630706|9720364|P2|Overall Study|Lost to Follow-up|1
2833825|NCT02630706|9720365|P1|Overall Study|Lost to Follow-up|0
2833826|NCT02630706|9720363|P3|Overall Study|Adverse Event|1
2833827|NCT02630706|9720364|P2|Overall Study|Adverse Event|1
2833828|NCT02630706|9720365|P1|Overall Study|Adverse Event|2
2833829|NCT02630693|9720474|P2|Overall Study|No receive treatment|1
2833830|NCT02630693|9720475|P1|Overall Study|No receive treatment|0
2833831|NCT02630563|9720487|P1|Overall Study|Administrative|1
2833832|NCT02630472|9720498|P2|Overall Study|Physician Decision|0
2833833|NCT02630472|9720499|P1|Overall Study|Physician Decision|10
2833834|NCT02630459|9720517|P4|Overall Study|Subject missed week 24 assessment|0
2833835|NCT02630459|9720518|P3|Overall Study|Subject missed week 24 assessment|0
2833836|NCT02630459|9720519|P2|Overall Study|Subject missed week 24 assessment|0
2833837|NCT02630459|9720520|P1|Overall Study|Subject missed week 24 assessment|1
2833838|NCT02630459|9720517|P4|Overall Study|Withdrawal by Subject|1
2833839|NCT02630459|9720518|P3|Overall Study|Withdrawal by Subject|4
2833840|NCT02630459|9720519|P2|Overall Study|Withdrawal by Subject|1
2833841|NCT02630459|9720520|P1|Overall Study|Withdrawal by Subject|2
2833842|NCT02630459|9720517|P4|Overall Study|Sponsor decision|0
2833843|NCT02630459|9720518|P3|Overall Study|Sponsor decision|1
2833844|NCT02630459|9720519|P2|Overall Study|Sponsor decision|0
2833845|NCT02630459|9720520|P1|Overall Study|Sponsor decision|0
2833846|NCT02630459|9720517|P4|Overall Study|Protocol-specified criteria|2
2833847|NCT02630459|9720518|P3|Overall Study|Protocol-specified criteria|0
2833848|NCT02630459|9720519|P2|Overall Study|Protocol-specified criteria|1
2833849|NCT02630459|9720520|P1|Overall Study|Protocol-specified criteria|0
2833850|NCT02630251|9720542|P4|Overall Study|Physician Decision|0
2833851|NCT02630251|9720543|P3|Overall Study|Physician Decision|1
2833852|NCT02630251|9720544|P2|Overall Study|Physician Decision|0
2833853|NCT02630251|9720545|P1|Overall Study|Physician Decision|0
2833854|NCT02630186|9720659|P1|Overall Study|Withdrawal by Subject|1
2833855|NCT02629965|9720675|P2|Period 2|Adverse Event|0
2833856|NCT02629965|9720676|P1|Period 2|Adverse Event|1
2833857|NCT02629965|9720675|P2|Period 1|Other than listed above|2
2833858|NCT02629965|9720676|P1|Period 1|Other than listed above|1
2833859|NCT02629965|9720675|P2|Period 1|Unexpected worsening of disease|0
2833860|NCT02629965|9720676|P1|Period 1|Unexpected worsening of disease|2
2833861|NCT02629965|9720675|P2|Period 1|Adverse Event|0
2833862|NCT02629965|9720676|P1|Period 1|Adverse Event|1
2833863|NCT02629861|9720715|P3|Overall Study|Pregnancy|0
2833864|NCT02629861|9720716|P2|Overall Study|Pregnancy|1
2833865|NCT02629861|9720717|P1|Overall Study|Pregnancy|2
2833866|NCT02629861|9720715|P3|Overall Study|Other|0
2833867|NCT02629861|9720716|P2|Overall Study|Other|1
2833868|NCT02629861|9720717|P1|Overall Study|Other|1
2833869|NCT02629861|9720715|P3|Overall Study|Lost to Follow-up|4
2833870|NCT02629861|9720716|P2|Overall Study|Lost to Follow-up|9
2833871|NCT02629861|9720717|P1|Overall Study|Lost to Follow-up|12
2833872|NCT02629861|9720715|P3|Overall Study|Protocol Violation|7
2833873|NCT02629861|9720716|P2|Overall Study|Protocol Violation|3
2833874|NCT02629861|9720717|P1|Overall Study|Protocol Violation|2
2833875|NCT02629861|9720715|P3|Overall Study|Withdrawal by Subject|13
2833876|NCT02629861|9720716|P2|Overall Study|Withdrawal by Subject|8
2833877|NCT02629861|9720717|P1|Overall Study|Withdrawal by Subject|5
2833878|NCT02629861|9720715|P3|Overall Study|Adverse Event|4
2833879|NCT02629861|9720716|P2|Overall Study|Adverse Event|5
2833880|NCT02629861|9720717|P1|Overall Study|Adverse Event|7
2833881|NCT02629822|9720764|P1|Extension Study|Extension Period is Ongoing|6
2833882|NCT02629822|9720764|P1|Base Study|Non-Compliance With Study Drug|1
2833883|NCT02629822|9720764|P1|Base Study|Lost to Follow-up|2
2833884|NCT02629159|9720806|P3|Overall Study|Other|8
2833885|NCT02629159|9720807|P2|Overall Study|Other|4
2833886|NCT02629159|9720808|P1|Overall Study|Other|6
2833887|NCT02629159|9720806|P3|Overall Study|Lack of Efficacy|1
2833888|NCT02629159|9720807|P2|Overall Study|Lack of Efficacy|0
2833889|NCT02629159|9720808|P1|Overall Study|Lack of Efficacy|4
2833890|NCT02629159|9720806|P3|Overall Study|Lost to Follow-up|5
2833891|NCT02629159|9720807|P2|Overall Study|Lost to Follow-up|4
2833892|NCT02629159|9720808|P1|Overall Study|Lost to Follow-up|7
2833893|NCT02629159|9720806|P3|Overall Study|Withdrawal by Subject|15
2833894|NCT02629159|9720807|P2|Overall Study|Withdrawal by Subject|11
2833895|NCT02629159|9720808|P1|Overall Study|Withdrawal by Subject|22
2833896|NCT02629159|9720806|P3|Overall Study|Adverse Event|22
2833897|NCT02629159|9720807|P2|Overall Study|Adverse Event|20
2833898|NCT02629159|9720808|P1|Overall Study|Adverse Event|17
2833899|NCT02629133|9720860|P2|Overall Study|Withdrawal by Subject|1
2833900|NCT02629133|9720861|P1|Overall Study|Withdrawal by Subject|1
2833901|NCT02629133|9720860|P2|Overall Study|Lost to Follow-up|1
2833902|NCT02629133|9720861|P1|Overall Study|Lost to Follow-up|3
2833903|NCT02628938|9720904|P3|Overall Study|Failure to comply with the instructions|3
2833904|NCT02628938|9720905|P2|Overall Study|Failure to comply with the instructions|0
2833905|NCT02628938|9720906|P1|Overall Study|Failure to comply with the instructions|3
2833906|NCT02628938|9720904|P3|Overall Study|Did not attend the follow up recall|1
2833907|NCT02628938|9720905|P2|Overall Study|Did not attend the follow up recall|2
2833908|NCT02628938|9720906|P1|Overall Study|Did not attend the follow up recall|2
2833909|NCT02628769|9720920|P2|Second Intervention|Physician Decision|1
2833910|NCT02628769|9720921|P1|Second Intervention|Physician Decision|0
2833911|NCT02628769|9720920|P2|Second Intervention|Adverse Event|0
2833912|NCT02628769|9720921|P1|Second Intervention|Adverse Event|2
2833913|NCT02628769|9720920|P2|First Intervention|Withdrawal by Subject|1
2833914|NCT02628769|9720921|P1|First Intervention|Withdrawal by Subject|0
2833915|NCT02628769|9720920|P2|First Intervention|Adverse Event|0
2833916|NCT02628769|9720921|P1|First Intervention|Adverse Event|1
2833917|NCT02628743|9720959|P1|Overall Study|Physician Decision|2
2833918|NCT02628743|9720959|P1|Overall Study|Study Terminated by Sponsor|76
2833919|NCT02628743|9720959|P1|Overall Study|Withdrawal by Subject|50
2833920|NCT02628743|9720959|P1|Overall Study|Other|3
2833921|NCT02628600|9720985|P2|Overall Study|Other not specified|0
2833922|NCT02628600|9720986|P1|Overall Study|Other not specified|1
2833923|NCT02628600|9720985|P2|Overall Study|Physician Decision|2
2833924|NCT02628600|9720986|P1|Overall Study|Physician Decision|2
2833925|NCT02628600|9720985|P2|Overall Study|Lost to Follow-up|0
2833926|NCT02628600|9720986|P1|Overall Study|Lost to Follow-up|1
2833927|NCT02628600|9720985|P2|Overall Study|Withdrawal by Subject|8
2833928|NCT02628600|9720986|P1|Overall Study|Withdrawal by Subject|13
2833929|NCT02628600|9720985|P2|Overall Study|Lack of Efficacy|0
2833930|NCT02628600|9720986|P1|Overall Study|Lack of Efficacy|2
2833931|NCT02628600|9720985|P2|Overall Study|Protocol Violation|1
2833932|NCT02628600|9720986|P1|Overall Study|Protocol Violation|0
2833933|NCT02628600|9720985|P2|Overall Study|Adverse Event|20
2833934|NCT02628600|9720986|P1|Overall Study|Adverse Event|3
2833935|NCT02628600|9720985|P2|Overall Study|Death|1
2833936|NCT02628600|9720986|P1|Overall Study|Death|2
2833937|NCT02628418|9721000|P2|Overall Study|Lost to Follow-up|2
2833938|NCT02628418|9721001|P1|Overall Study|Lost to Follow-up|1
2833939|NCT02628028|9721092|P8|Long-term Extension (LTE) Period|Other|3
2833940|NCT02628028|9721093|P7|Long-term Extension (LTE) Period|Other|4
2833941|NCT02628028|9721094|P6|Long-term Extension (LTE) Period|Other|3
2833942|NCT02628028|9721095|P5|Long-term Extension (LTE) Period|Other|0
2833943|NCT02628028|9721096|P4|Long-term Extension (LTE) Period|Other|0
2833944|NCT02628028|9721097|P3|Long-term Extension (LTE) Period|Other|0
2833945|NCT02628028|9721098|P2|Long-term Extension (LTE) Period|Other|0
2833946|NCT02628028|9721099|P1|Long-term Extension (LTE) Period|Other|0
2833947|NCT02628028|9721092|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2833948|NCT02628028|9721093|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2833949|NCT02628028|9721094|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
2833950|NCT02628028|9721095|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2833951|NCT02628028|9721096|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2833952|NCT02628028|9721097|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2833953|NCT02628028|9721098|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2833954|NCT02628028|9721099|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2833955|NCT02628028|9721092|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2833956|NCT02628028|9721093|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2833957|NCT02628028|9721094|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
2833958|NCT02628028|9721095|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2833959|NCT02628028|9721096|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2833960|NCT02628028|9721097|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2833961|NCT02628028|9721098|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2833962|NCT02628028|9721099|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2833963|NCT02628028|9721092|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
2833964|NCT02628028|9721093|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833965|NCT02628028|9721094|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
2833966|NCT02628028|9721095|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833967|NCT02628028|9721096|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833968|NCT02628028|9721097|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833969|NCT02628028|9721098|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833970|NCT02628028|9721099|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
2833971|NCT02628028|9721092|P8|Long-term Extension (LTE) Period|Adverse Event|3
2833972|NCT02628028|9721093|P7|Long-term Extension (LTE) Period|Adverse Event|0
2833973|NCT02628028|9721094|P6|Long-term Extension (LTE) Period|Adverse Event|1
2833974|NCT02628028|9721095|P5|Long-term Extension (LTE) Period|Adverse Event|0
2833975|NCT02628028|9721096|P4|Long-term Extension (LTE) Period|Adverse Event|0
2833976|NCT02628028|9721097|P3|Long-term Extension (LTE) Period|Adverse Event|0
2833977|NCT02628028|9721098|P2|Long-term Extension (LTE) Period|Adverse Event|0
2833978|NCT02628028|9721099|P1|Long-term Extension (LTE) Period|Adverse Event|0
2833979|NCT02628028|9721092|P8|Dosing Period|Other|4
2833980|NCT02628028|9721093|P7|Dosing Period|Other|2
2833981|NCT02628028|9721094|P6|Dosing Period|Other|1
2833982|NCT02628028|9721095|P5|Dosing Period|Other|2
2833983|NCT02628028|9721096|P4|Dosing Period|Other|0
2833984|NCT02628028|9721097|P3|Dosing Period|Other|0
2833985|NCT02628028|9721098|P2|Dosing Period|Other|0
2833986|NCT02628028|9721099|P1|Dosing Period|Other|0
2833987|NCT02628028|9721092|P8|Dosing Period|Lost to Follow-up|0
2833988|NCT02628028|9721093|P7|Dosing Period|Lost to Follow-up|1
2833989|NCT02628028|9721094|P6|Dosing Period|Lost to Follow-up|0
2833990|NCT02628028|9721095|P5|Dosing Period|Lost to Follow-up|0
2833991|NCT02628028|9721096|P4|Dosing Period|Lost to Follow-up|0
2833992|NCT02628028|9721097|P3|Dosing Period|Lost to Follow-up|0
2833993|NCT02628028|9721098|P2|Dosing Period|Lost to Follow-up|0
2833994|NCT02628028|9721099|P1|Dosing Period|Lost to Follow-up|0
2833995|NCT02628028|9721092|P8|Dosing Period|Site Terminated by Sponsor|0
2833996|NCT02628028|9721093|P7|Dosing Period|Site Terminated by Sponsor|1
2833997|NCT02628028|9721094|P6|Dosing Period|Site Terminated by Sponsor|1
2833998|NCT02628028|9721095|P5|Dosing Period|Site Terminated by Sponsor|0
2833999|NCT02628028|9721096|P4|Dosing Period|Site Terminated by Sponsor|0
2834000|NCT02628028|9721097|P3|Dosing Period|Site Terminated by Sponsor|0
2834001|NCT02628028|9721098|P2|Dosing Period|Site Terminated by Sponsor|0
2834002|NCT02628028|9721099|P1|Dosing Period|Site Terminated by Sponsor|0
2834003|NCT02628028|9721092|P8|Dosing Period|Physician Decision|0
2834004|NCT02628028|9721093|P7|Dosing Period|Physician Decision|0
2834005|NCT02628028|9721094|P6|Dosing Period|Physician Decision|1
2834006|NCT02628028|9721095|P5|Dosing Period|Physician Decision|0
2834007|NCT02628028|9721096|P4|Dosing Period|Physician Decision|0
2834008|NCT02628028|9721097|P3|Dosing Period|Physician Decision|0
2834009|NCT02628028|9721098|P2|Dosing Period|Physician Decision|0
2834010|NCT02628028|9721099|P1|Dosing Period|Physician Decision|0
2834011|NCT02628028|9721092|P8|Dosing Period|Study Terminated by Sponsor|7
2834012|NCT02628028|9721093|P7|Dosing Period|Study Terminated by Sponsor|7
2834013|NCT02628028|9721094|P6|Dosing Period|Study Terminated by Sponsor|6
2834014|NCT02628028|9721095|P5|Dosing Period|Study Terminated by Sponsor|7
2834015|NCT02628028|9721096|P4|Dosing Period|Study Terminated by Sponsor|0
2834016|NCT02628028|9721097|P3|Dosing Period|Study Terminated by Sponsor|0
2834017|NCT02628028|9721098|P2|Dosing Period|Study Terminated by Sponsor|0
2834018|NCT02628028|9721099|P1|Dosing Period|Study Terminated by Sponsor|0
2834019|NCT02628028|9721092|P8|Dosing Period|Lack of Efficacy|0
2834020|NCT02628028|9721093|P7|Dosing Period|Lack of Efficacy|1
2834021|NCT02628028|9721094|P6|Dosing Period|Lack of Efficacy|0
2834022|NCT02628028|9721095|P5|Dosing Period|Lack of Efficacy|3
2834023|NCT02628028|9721096|P4|Dosing Period|Lack of Efficacy|0
2834024|NCT02628028|9721097|P3|Dosing Period|Lack of Efficacy|0
2834025|NCT02628028|9721098|P2|Dosing Period|Lack of Efficacy|0
2834026|NCT02628028|9721099|P1|Dosing Period|Lack of Efficacy|0
2834027|NCT02628028|9721092|P8|Dosing Period|Death|1
2834028|NCT02628028|9721093|P7|Dosing Period|Death|0
2834029|NCT02628028|9721094|P6|Dosing Period|Death|0
2834030|NCT02628028|9721095|P5|Dosing Period|Death|0
2834031|NCT02628028|9721096|P4|Dosing Period|Death|0
2834032|NCT02628028|9721097|P3|Dosing Period|Death|0
2834033|NCT02628028|9721098|P2|Dosing Period|Death|0
2834034|NCT02628028|9721099|P1|Dosing Period|Death|0
2834035|NCT02628028|9721092|P8|Dosing Period|Adverse Event|2
2834036|NCT02628028|9721093|P7|Dosing Period|Adverse Event|3
2834037|NCT02628028|9721094|P6|Dosing Period|Adverse Event|1
2834038|NCT02628028|9721095|P5|Dosing Period|Adverse Event|2
2834039|NCT02628028|9721096|P4|Dosing Period|Adverse Event|0
2834040|NCT02628028|9721097|P3|Dosing Period|Adverse Event|0
2834041|NCT02628028|9721098|P2|Dosing Period|Adverse Event|0
2834042|NCT02628028|9721099|P1|Dosing Period|Adverse Event|0
2834043|NCT02628028|9721092|P8|Dosing Period|Withdrawal by Subject|1
2834044|NCT02628028|9721093|P7|Dosing Period|Withdrawal by Subject|1
2834045|NCT02628028|9721094|P6|Dosing Period|Withdrawal by Subject|4
2834046|NCT02628028|9721095|P5|Dosing Period|Withdrawal by Subject|2
2834047|NCT02628028|9721096|P4|Dosing Period|Withdrawal by Subject|0
2834048|NCT02628028|9721097|P3|Dosing Period|Withdrawal by Subject|1
2834049|NCT02628028|9721098|P2|Dosing Period|Withdrawal by Subject|0
2834050|NCT02628028|9721099|P1|Dosing Period|Withdrawal by Subject|0
2834051|NCT02627144|9721184|P1|Overall Study|Other|17
2834052|NCT02627144|9721184|P1|Overall Study|Enrolled, not treated|6
2834053|NCT02627144|9721184|P1|Overall Study|Lost to Follow-up|8
2834054|NCT02627144|9721184|P1|Overall Study|Administrative reasons|65
2834055|NCT02627144|9721184|P1|Overall Study|Refusal of treatment / poor cooperation|38
2834056|NCT02627144|9721184|P1|Overall Study|Death from other cause|8
2834057|NCT02627144|9721184|P1|Overall Study|Death from cancer|20
2834058|NCT02627144|9721184|P1|Overall Study|Cancer progression|171
2834059|NCT02627144|9721184|P1|Overall Study|Serious adverse event|32
2834060|NCT02626819|9721225|P2|Overall Study|Diagnosed w/ catastrophic illness|1
2834061|NCT02626819|9721226|P1|Overall Study|Diagnosed w/ catastrophic illness|0
2834062|NCT02626819|9721225|P2|Overall Study|Withdrawal by Subject|0
2834063|NCT02626819|9721226|P1|Overall Study|Withdrawal by Subject|1
2834064|NCT02626819|9721225|P2|Overall Study|Lost to Follow-up|2
2834065|NCT02626819|9721226|P1|Overall Study|Lost to Follow-up|3
2834066|NCT02626780|9721246|P1|Overall Study|Withdrawal by Subject|3
2834067|NCT02626520|9721279|P2|Overall Study|Study terminated|1
2834068|NCT02626520|9721280|P1|Overall Study|Study terminated|0
2834069|NCT02626520|9721279|P2|Overall Study|Did not start protocol therapy|2
2834070|NCT02626520|9721280|P1|Overall Study|Did not start protocol therapy|0
2834071|NCT02626520|9721279|P2|Overall Study|Lack of Efficacy|2
2834072|NCT02626520|9721280|P1|Overall Study|Lack of Efficacy|0
2834073|NCT02626520|9721279|P2|Overall Study|Adverse Event|4
2834074|NCT02626520|9721280|P1|Overall Study|Adverse Event|0
2834075|NCT02626520|9721279|P2|Overall Study|Physician Decision|1
2834076|NCT02626520|9721280|P1|Overall Study|Physician Decision|1
2834077|NCT02626182|9721292|P2|Overall Study|Adverse Event|0
2834078|NCT02626182|9721293|P1|Overall Study|Adverse Event|2
2834079|NCT02626000|9721303|P1|Overall Study|Death|23
2834080|NCT02626000|9721303|P1|Overall Study|Continuing Study|13
2834081|NCT02625974|9721317|P2|Overall Study|Protocol Violation|1
2834082|NCT02625974|9721318|P1|Overall Study|Protocol Violation|0
2834083|NCT02625974|9721317|P2|Overall Study|non-compliance with study drug|2
2834084|NCT02625974|9721318|P1|Overall Study|non-compliance with study drug|0
2834085|NCT02625974|9721317|P2|Overall Study|positive parasitemia|0
2834086|NCT02625974|9721318|P1|Overall Study|positive parasitemia|1
2834087|NCT02625974|9721317|P2|Overall Study|Withdrawal by Subject|1
2834088|NCT02625974|9721318|P1|Overall Study|Withdrawal by Subject|3
2834089|NCT02625974|9721317|P2|Overall Study|Adverse Event|2
2834090|NCT02625974|9721318|P1|Overall Study|Adverse Event|12
2834091|NCT02625922|9721426|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
2834092|NCT02625922|9721427|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
2834093|NCT02625922|9721426|P2|Overall Study|Non-availability of IMP|1
2834094|NCT02625922|9721427|P1|Overall Study|Non-availability of IMP|1
2834095|NCT02625623|9721446|P2|Overall Study|Off-Treatment, but follow up ongoing|24
2834096|NCT02625623|9721447|P1|Overall Study|Off-Treatment, but follow up ongoing|30
2834097|NCT02625623|9721446|P2|Overall Study|Still on Treatment|10
2834098|NCT02625623|9721447|P1|Overall Study|Still on Treatment|10
2834099|NCT02625623|9721446|P2|Overall Study|Participants randomized but not treated|1
2834100|NCT02625623|9721447|P1|Overall Study|Participants randomized but not treated|9
2834101|NCT02625324|9721510|P1|12-Month Follow-up Secondary Endpoint|Death|4
2834102|NCT02625324|9721510|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
2834103|NCT02625324|9721510|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
2834104|NCT02625324|9721510|P1|6-Month Follow-up Subject Accountability|Death|5
2834105|NCT02625324|9721510|P1|30-Day Follow-up for Secondary Endpoint|Death|1
2834106|NCT02625324|9721510|P1|30-Day Follow-up for Primary Endpoint|Death|1
2834107|NCT02625259|9721535|P5|First Intervention (Day 1)|Withdrawal by Subject|0
2834108|NCT02625259|9721536|P4|First Intervention (Day 1)|Withdrawal by Subject|1
2834109|NCT02625259|9721537|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2834110|NCT02625259|9721538|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2834111|NCT02625259|9721539|P1|First Intervention (Day 1)|Withdrawal by Subject|0
2834112|NCT02625259|9721535|P5|First Intervention (Day 1)|Adverse Event|0
2834113|NCT02625259|9721536|P4|First Intervention (Day 1)|Adverse Event|0
2834114|NCT02625259|9721537|P3|First Intervention (Day 1)|Adverse Event|0
2834115|NCT02625259|9721538|P2|First Intervention (Day 1)|Adverse Event|1
2834116|NCT02625259|9721539|P1|First Intervention (Day 1)|Adverse Event|2
2834117|NCT02625259|9721535|P5|First Intervention (Day 1)|Other|0
2834118|NCT02625259|9721536|P4|First Intervention (Day 1)|Other|0
2834119|NCT02625259|9721537|P3|First Intervention (Day 1)|Other|1
2834120|NCT02625259|9721538|P2|First Intervention (Day 1)|Other|0
2834121|NCT02625259|9721539|P1|First Intervention (Day 1)|Other|0
2834122|NCT02625233|9721576|P2|Overall Study|Adverse Event|0
2834123|NCT02625233|9721577|P1|Overall Study|Adverse Event|2
2834124|NCT02625220|9721585|P1|Overall Study|Study discontinued at site|2
2834125|NCT02625220|9721585|P1|Overall Study|Protocol Violation|1
2834126|NCT02625220|9721585|P1|Overall Study|Lost to Follow-up|2
2834127|NCT02625220|9721585|P1|Overall Study|Adverse Event|2
2834128|NCT02624986|9721713|P8|Overall Study|Withdrawal by Subject|1
2834129|NCT02624986|9721714|P7|Overall Study|Withdrawal by Subject|0
2834130|NCT02624986|9721715|P6|Overall Study|Withdrawal by Subject|0
2834131|NCT02624986|9721716|P5|Overall Study|Withdrawal by Subject|0
2834132|NCT02624986|9721717|P4|Overall Study|Withdrawal by Subject|0
2834133|NCT02624986|9721718|P3|Overall Study|Withdrawal by Subject|0
2834134|NCT02624986|9721719|P2|Overall Study|Withdrawal by Subject|0
2834135|NCT02624986|9721720|P1|Overall Study|Withdrawal by Subject|0
2834136|NCT02624986|9721713|P8|Overall Study|Protocol Violation|0
2834137|NCT02624986|9721714|P7|Overall Study|Protocol Violation|0
2834138|NCT02624986|9721715|P6|Overall Study|Protocol Violation|0
2834139|NCT02624986|9721716|P5|Overall Study|Protocol Violation|0
2834140|NCT02624986|9721717|P4|Overall Study|Protocol Violation|0
2834141|NCT02624986|9721718|P3|Overall Study|Protocol Violation|0
2834142|NCT02624986|9721719|P2|Overall Study|Protocol Violation|0
2834143|NCT02624986|9721720|P1|Overall Study|Protocol Violation|1
2834144|NCT02624986|9721713|P8|Overall Study|Progressive Disease|0
2834145|NCT02624986|9721714|P7|Overall Study|Progressive Disease|0
2834146|NCT02624986|9721715|P6|Overall Study|Progressive Disease|0
2834147|NCT02624986|9721716|P5|Overall Study|Progressive Disease|0
2834148|NCT02624986|9721717|P4|Overall Study|Progressive Disease|0
2834149|NCT02624986|9721718|P3|Overall Study|Progressive Disease|0
2834150|NCT02624986|9721719|P2|Overall Study|Progressive Disease|1
2834151|NCT02624986|9721720|P1|Overall Study|Progressive Disease|0
2834152|NCT02624986|9721713|P8|Overall Study|Study Terminated by Sponsor|3
2834153|NCT02624986|9721714|P7|Overall Study|Study Terminated by Sponsor|4
2834154|NCT02624986|9721715|P6|Overall Study|Study Terminated by Sponsor|2
2834155|NCT02624986|9721716|P5|Overall Study|Study Terminated by Sponsor|2
2834156|NCT02624986|9721717|P4|Overall Study|Study Terminated by Sponsor|1
2834157|NCT02624986|9721718|P3|Overall Study|Study Terminated by Sponsor|0
2834158|NCT02624986|9721719|P2|Overall Study|Study Terminated by Sponsor|1
2834159|NCT02624986|9721720|P1|Overall Study|Study Terminated by Sponsor|1
2834160|NCT02624986|9721713|P8|Overall Study|Death|1
2834161|NCT02624986|9721714|P7|Overall Study|Death|0
2834162|NCT02624986|9721715|P6|Overall Study|Death|0
2834163|NCT02624986|9721716|P5|Overall Study|Death|2
2834164|NCT02624986|9721717|P4|Overall Study|Death|2
2834165|NCT02624986|9721718|P3|Overall Study|Death|2
2834166|NCT02624986|9721719|P2|Overall Study|Death|1
2834167|NCT02624986|9721720|P1|Overall Study|Death|0
2834168|NCT02624791|9721897|P6|Overall Study|Withdrawal by Subject|0
2834169|NCT02624791|9721898|P5|Overall Study|Withdrawal by Subject|0
2834170|NCT02624791|9721899|P4|Overall Study|Withdrawal by Subject|0
2834171|NCT02624791|9721900|P3|Overall Study|Withdrawal by Subject|0
2834172|NCT02624791|9721901|P2|Overall Study|Withdrawal by Subject|0
2834173|NCT02624791|9721902|P1|Overall Study|Withdrawal by Subject|2
2834174|NCT02624713|9721909|P2|Overall Study|Lost to Follow-up|0
2834175|NCT02624713|9721910|P1|Overall Study|Lost to Follow-up|14
2834176|NCT02624687|9721919|P2|Overall Study|medical leave from work|1
2834177|NCT02624687|9721920|P1|Overall Study|medical leave from work|0
2834178|NCT02624687|9721919|P2|Overall Study|Withdrawal by Subject|1
2834179|NCT02624687|9721920|P1|Overall Study|Withdrawal by Subject|1
2834180|NCT02624492|9721951|P3|Overall Study|Progressive disease|3
2834181|NCT02624492|9721952|P2|Overall Study|Progressive disease|2
2834182|NCT02624492|9721953|P1|Overall Study|Progressive disease|0
2834183|NCT02624492|9721951|P3|Overall Study|Adverse Event|2
2834184|NCT02624492|9721952|P2|Overall Study|Adverse Event|2
2834185|NCT02624492|9721953|P1|Overall Study|Adverse Event|2
2834186|NCT02624284|9721988|P3|Overall Study|Adverse Event|1
2834187|NCT02624284|9721989|P2|Overall Study|Adverse Event|0
2834188|NCT02624284|9721990|P1|Overall Study|Adverse Event|0
2834189|NCT02624284|9721988|P3|Overall Study|Revealed exclusionary condition|0
2834190|NCT02624284|9721989|P2|Overall Study|Revealed exclusionary condition|2
2834191|NCT02624284|9721990|P1|Overall Study|Revealed exclusionary condition|2
2834192|NCT02624284|9721988|P3|Overall Study|Protocol Violation|7
2834193|NCT02624284|9721989|P2|Overall Study|Protocol Violation|10
2834194|NCT02624284|9721990|P1|Overall Study|Protocol Violation|9
2834195|NCT02624284|9721988|P3|Overall Study|Withdrawal by Subject|3
2834196|NCT02624284|9721989|P2|Overall Study|Withdrawal by Subject|6
2834197|NCT02624284|9721990|P1|Overall Study|Withdrawal by Subject|3
2834198|NCT02624050|9722009|P2|Overall Study|Protocol Violation|0
2834199|NCT02624050|9722010|P1|Overall Study|Protocol Violation|2
2834200|NCT02624050|9722009|P2|Overall Study|Physician Decision|0
2834201|NCT02624050|9722010|P1|Overall Study|Physician Decision|4
2834202|NCT02623959|9722038|P2|Overall Study|Progression|1
2834203|NCT02623959|9722039|P1|Overall Study|Progression|0
2834204|NCT02623725|9722119|P2|Overall Study|Withdrawal by Subject|1
2834205|NCT02623725|9722120|P1|Overall Study|Withdrawal by Subject|7
2834206|NCT02623725|9722119|P2|Overall Study|Serious adverse event|2
2834207|NCT02623725|9722120|P1|Overall Study|Serious adverse event|0
2834208|NCT02623725|9722119|P2|Overall Study|Non compliance with protocol|3
2834209|NCT02623725|9722120|P1|Overall Study|Non compliance with protocol|9
2834210|NCT02623361|9722154|P2|Overall Study|Withdrawal by Subject|1
2834211|NCT02623361|9722155|P1|Overall Study|Withdrawal by Subject|0
2834212|NCT02623361|9722154|P2|Overall Study|Protocol Violation|1
2834213|NCT02623361|9722155|P1|Overall Study|Protocol Violation|0
2834214|NCT02623335|9722194|P2|Overall Study|Protocol Violation|1
2834215|NCT02623335|9722195|P1|Overall Study|Protocol Violation|2
2834216|NCT02623335|9722194|P2|Overall Study|Withdrawal by Subject|5
2834217|NCT02623335|9722195|P1|Overall Study|Withdrawal by Subject|2
2834218|NCT02623335|9722194|P2|Overall Study|Lost to Follow-up|23
2834219|NCT02623335|9722195|P1|Overall Study|Lost to Follow-up|15
2834220|NCT02623335|9722194|P2|Overall Study|Death|7
2834221|NCT02623335|9722195|P1|Overall Study|Death|8
2834222|NCT02623322|9722222|P3|Overall Study|Lost to Follow-up|0
2834223|NCT02623322|9722223|P2|Overall Study|Lost to Follow-up|1
2834224|NCT02623322|9722224|P1|Overall Study|Lost to Follow-up|2
2834225|NCT02623218|9722262|P5|Overall Study|Lost to Follow-up|0
2834226|NCT02623218|9722263|P4|Overall Study|Lost to Follow-up|0
2834227|NCT02623218|9722264|P3|Overall Study|Lost to Follow-up|0
2834228|NCT02623218|9722265|P2|Overall Study|Lost to Follow-up|1
2834229|NCT02623218|9722266|P1|Overall Study|Lost to Follow-up|0
2834230|NCT02622828|9722288|P1|Overall Study|participant withdrew|3
2834231|NCT02622724|9722295|P2|Overall Study|Early termination of study|43
2834232|NCT02622724|9722296|P1|Overall Study|Early termination of study|38
2834233|NCT02622724|9722295|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
2834234|NCT02622724|9722296|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
2834235|NCT02622724|9722295|P2|Overall Study|Death|53
2834236|NCT02622724|9722296|P1|Overall Study|Death|51
2834237|NCT02622568|9722374|P2|Overall Study|Lost to Follow-up|5
2834238|NCT02622568|9722375|P1|Overall Study|Lost to Follow-up|5
2834239|NCT02622321|9722385|P4|Overall Study|Withdrawal by Subject|0
2834240|NCT02622321|9722386|P3|Overall Study|Withdrawal by Subject|0
2834241|NCT02622321|9722387|P2|Overall Study|Withdrawal by Subject|0
2834242|NCT02622321|9722388|P1|Overall Study|Withdrawal by Subject|1
2834243|NCT02622321|9722385|P4|Overall Study|Ongoing treatment with emicizumab|7
2834244|NCT02622321|9722386|P3|Overall Study|Ongoing treatment with emicizumab|49
2834245|NCT02622321|9722387|P2|Overall Study|Ongoing treatment with emicizumab|13
2834246|NCT02622321|9722388|P1|Overall Study|Ongoing treatment with emicizumab|31
2834247|NCT02622321|9722385|P4|Overall Study|Ongoing in safety follow-up|0
2834248|NCT02622321|9722386|P3|Overall Study|Ongoing in safety follow-up|0
2834249|NCT02622321|9722387|P2|Overall Study|Ongoing in safety follow-up|0
2834250|NCT02622321|9722388|P1|Overall Study|Ongoing in safety follow-up|3
2834251|NCT02622321|9722385|P4|Overall Study|Ongoing treatment with no emicizumab|0
2834252|NCT02622321|9722386|P3|Overall Study|Ongoing treatment with no emicizumab|0
2834253|NCT02622321|9722387|P2|Overall Study|Ongoing treatment with no emicizumab|5
2834254|NCT02622321|9722388|P1|Overall Study|Ongoing treatment with no emicizumab|0
2834255|NCT02622113|9722459|P2|Overall Study|Stopping Criteria|3
2834256|NCT02622113|9722460|P1|Overall Study|Stopping Criteria|1
2834257|NCT02622113|9722459|P2|Overall Study|Withdrawal by Subject|2
2834258|NCT02622113|9722460|P1|Overall Study|Withdrawal by Subject|0
2834259|NCT02622113|9722459|P2|Overall Study|Physician Decision|1
2834260|NCT02622113|9722460|P1|Overall Study|Physician Decision|0
2834261|NCT02622113|9722459|P2|Overall Study|Adverse Event|4
2834262|NCT02622113|9722460|P1|Overall Study|Adverse Event|4
2834263|NCT02622074|9722478|P6|Overall Study|Ongoing in Study|10
2834264|NCT02622074|9722479|P5|Overall Study|Ongoing in Study|10
2834265|NCT02622074|9722480|P4|Overall Study|Ongoing in Study|9
2834266|NCT02622074|9722481|P3|Overall Study|Ongoing in Study|10
2834267|NCT02622074|9722482|P2|Overall Study|Ongoing in Study|9
2834268|NCT02622074|9722483|P1|Overall Study|Ongoing in Study|6
2834269|NCT02622074|9722478|P6|Overall Study|Withdrawal by Subject|0
2834270|NCT02622074|9722479|P5|Overall Study|Withdrawal by Subject|0
2834271|NCT02622074|9722480|P4|Overall Study|Withdrawal by Subject|0
2834272|NCT02622074|9722481|P3|Overall Study|Withdrawal by Subject|0
2834273|NCT02622074|9722482|P2|Overall Study|Withdrawal by Subject|1
2834274|NCT02622074|9722483|P1|Overall Study|Withdrawal by Subject|0
2834275|NCT02622074|9722478|P6|Overall Study|Death|0
2834276|NCT02622074|9722479|P5|Overall Study|Death|0
2834277|NCT02622074|9722480|P4|Overall Study|Death|1
2834278|NCT02622074|9722481|P3|Overall Study|Death|0
2834279|NCT02622074|9722482|P2|Overall Study|Death|0
2834280|NCT02622074|9722483|P1|Overall Study|Death|4
2834281|NCT02621931|9722575|P3|Overall Study|Other|3
2834282|NCT02621931|9722576|P2|Overall Study|Other|1
2834283|NCT02621931|9722577|P1|Overall Study|Other|1
2834284|NCT02621931|9722575|P3|Overall Study|Lack of Efficacy|1
2834285|NCT02621931|9722576|P2|Overall Study|Lack of Efficacy|0
2834286|NCT02621931|9722577|P1|Overall Study|Lack of Efficacy|0
2834287|NCT02621931|9722575|P3|Overall Study|Lost to Follow-up|10
2834288|NCT02621931|9722576|P2|Overall Study|Lost to Follow-up|7
2834289|NCT02621931|9722577|P1|Overall Study|Lost to Follow-up|8
2834290|NCT02621931|9722575|P3|Overall Study|Noncompliance to study procedures|2
2834291|NCT02621931|9722576|P2|Overall Study|Noncompliance to study procedures|1
2834292|NCT02621931|9722577|P1|Overall Study|Noncompliance to study procedures|0
2834293|NCT02621931|9722575|P3|Overall Study|Pregnancy|0
2834294|NCT02621931|9722576|P2|Overall Study|Pregnancy|0
2834295|NCT02621931|9722577|P1|Overall Study|Pregnancy|2
2834296|NCT02621931|9722575|P3|Overall Study|Protocol Violation|2
2834297|NCT02621931|9722576|P2|Overall Study|Protocol Violation|2
2834298|NCT02621931|9722577|P1|Overall Study|Protocol Violation|2
2834299|NCT02621931|9722575|P3|Overall Study|Withdrawal by Subject|11
2834300|NCT02621931|9722576|P2|Overall Study|Withdrawal by Subject|10
2834301|NCT02621931|9722577|P1|Overall Study|Withdrawal by Subject|12
2834302|NCT02621931|9722575|P3|Overall Study|Adverse Event|7
2834303|NCT02621931|9722576|P2|Overall Study|Adverse Event|5
2834304|NCT02621931|9722577|P1|Overall Study|Adverse Event|8
2834305|NCT02621931|9722575|P3|Overall Study|Death|0
2834306|NCT02621931|9722576|P2|Overall Study|Death|1
2834307|NCT02621931|9722577|P1|Overall Study|Death|0
2834308|NCT02621606|9722659|P3|Overall Study|Withdrawal by Subject|0
2834309|NCT02621606|9722660|P2|Overall Study|Withdrawal by Subject|1
2834310|NCT02621606|9722661|P1|Overall Study|Withdrawal by Subject|0
2834311|NCT02621424|9722689|P2|Overall Study|Withdrawal by Subject|2
2834312|NCT02621424|9722690|P1|Overall Study|Withdrawal by Subject|1
2834313|NCT02621073|9722698|P2|Overall Study|Physician Decision|2
2834314|NCT02621073|9722699|P1|Overall Study|Physician Decision|3
2834315|NCT02621073|9722698|P2|Overall Study|Lost to Follow-up|1
2834316|NCT02621073|9722699|P1|Overall Study|Lost to Follow-up|0
2834317|NCT02621047|9722761|P3|Overall Study|Adverse Event|1
2834318|NCT02621047|9722762|P2|Overall Study|Adverse Event|0
2834319|NCT02621047|9722763|P1|Overall Study|Adverse Event|0
2834320|NCT02621034|9722879|P3|Overall Study|Lost to Follow-up|5
2834321|NCT02621034|9722880|P2|Overall Study|Lost to Follow-up|2
2834322|NCT02621034|9722881|P1|Overall Study|Lost to Follow-up|3
2834323|NCT02620787|9722915|P2|Overall Study|Eligibility Criteria Not Met|0
2834324|NCT02620787|9722916|P1|Overall Study|Eligibility Criteria Not Met|1
2834325|NCT02620787|9722915|P2|Overall Study|Adverse Event|0
2834326|NCT02620787|9722916|P1|Overall Study|Adverse Event|1
2834327|NCT02620384|9722958|P2|Overall Study|Drug shortage prevented 2nd dose|1
2834328|NCT02620384|9722959|P1|Overall Study|Drug shortage prevented 2nd dose|0
2834329|NCT02620384|9722958|P2|Overall Study|Discharged prior to 2nd dose|5
2834330|NCT02620384|9722959|P1|Overall Study|Discharged prior to 2nd dose|2
2834331|NCT02620384|9722958|P2|Overall Study|Adverse Event|1
2834332|NCT02620384|9722959|P1|Overall Study|Adverse Event|2
2834333|NCT02620020|9722991|P4|Overall Study|Death|0
2834334|NCT02620020|9722992|P3|Overall Study|Death|0
2834335|NCT02620020|9722993|P2|Overall Study|Death|1
2834336|NCT02620020|9722994|P1|Overall Study|Death|0
2834337|NCT02620020|9722991|P4|Overall Study|Withdrawal by Subject|12
2834338|NCT02620020|9722992|P3|Overall Study|Withdrawal by Subject|17
2834339|NCT02620020|9722993|P2|Overall Study|Withdrawal by Subject|16
2834340|NCT02620020|9722994|P1|Overall Study|Withdrawal by Subject|20
2834341|NCT02620020|9722991|P4|Overall Study|Protocol Violation|1
2834342|NCT02620020|9722992|P3|Overall Study|Protocol Violation|1
2834343|NCT02620020|9722993|P2|Overall Study|Protocol Violation|2
2834344|NCT02620020|9722994|P1|Overall Study|Protocol Violation|5
2834345|NCT02620020|9722991|P4|Overall Study|Physician Decision|4
2834346|NCT02620020|9722992|P3|Overall Study|Physician Decision|3
2834347|NCT02620020|9722993|P2|Overall Study|Physician Decision|4
2834348|NCT02620020|9722994|P1|Overall Study|Physician Decision|7
2834349|NCT02620020|9722991|P4|Overall Study|Lost to Follow-up|4
2834350|NCT02620020|9722992|P3|Overall Study|Lost to Follow-up|1
2834351|NCT02620020|9722993|P2|Overall Study|Lost to Follow-up|8
2834352|NCT02620020|9722994|P1|Overall Study|Lost to Follow-up|4
2834353|NCT02620020|9722991|P4|Overall Study|Adverse Event|5
2834354|NCT02620020|9722992|P3|Overall Study|Adverse Event|3
2834355|NCT02620020|9722993|P2|Overall Study|Adverse Event|4
2834356|NCT02620020|9722994|P1|Overall Study|Adverse Event|8
2834357|NCT02619812|9723020|P4|Overall Study|Withdrawal by Subject|2
2834358|NCT02619812|9723021|P3|Overall Study|Withdrawal by Subject|1
2834359|NCT02619812|9723022|P2|Overall Study|Withdrawal by Subject|0
2834360|NCT02619812|9723023|P1|Overall Study|Withdrawal by Subject|0
2834361|NCT02619617|9723056|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
2834362|NCT02619617|9723057|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
2834363|NCT02619617|9723056|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
2834364|NCT02619617|9723057|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
2834365|NCT02619175|9723104|P2|Overall Study|foot pain|0
2834366|NCT02619175|9723105|P1|Overall Study|foot pain|1
2834367|NCT02619175|9723104|P2|Overall Study|Withdrawal by Subject|0
2834368|NCT02619175|9723105|P1|Overall Study|Withdrawal by Subject|1
2834369|NCT02618928|9723119|P1|Overall Study|Treatment Never Started|7
2834370|NCT02618928|9723119|P1|Overall Study|Missing|6
2834371|NCT02618928|9723119|P1|Overall Study|Other|11
2834372|NCT02618928|9723119|P1|Overall Study|Death|3
2834373|NCT02618928|9723119|P1|Overall Study|Withdrawal by Subject|2
2834374|NCT02618928|9723119|P1|Overall Study|Insufficient Virological Response|1
2834375|NCT02618928|9723119|P1|Overall Study|Failure to Return|28
2834376|NCT02618759|9723214|P2|Overall Study|Other Reasons|4
2834377|NCT02618759|9723215|P1|Overall Study|Other Reasons|1
2834378|NCT02618759|9723214|P2|Overall Study|Withdrawal by Subject|0
2834379|NCT02618759|9723215|P1|Overall Study|Withdrawal by Subject|1
2834380|NCT02618759|9723214|P2|Overall Study|Lost to Follow-up|1
2834381|NCT02618759|9723215|P1|Overall Study|Lost to Follow-up|0
2834382|NCT02617628|9723403|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
2834383|NCT02617628|9723404|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
2834384|NCT02616900|9723412|P1|Overall Study|Incomplete data|6
2834385|NCT02616900|9723412|P1|Overall Study|Withdrawal by Subject|3
2834386|NCT02616900|9723412|P1|Overall Study|Protocol Violation|5
2834387|NCT02616900|9723412|P1|Overall Study|Lost to Follow-up|2
2834388|NCT02616900|9723412|P1|Overall Study|Lack of Efficacy|7
2834389|NCT02616783|9723420|P2|Overall Study|Withdrew Consent|1
2834390|NCT02616783|9723421|P1|Overall Study|Withdrew Consent|1
2834391|NCT02616783|9723420|P2|Overall Study|Protocol Violation|1
2834392|NCT02616783|9723421|P1|Overall Study|Protocol Violation|1
2834393|NCT02616783|9723420|P2|Overall Study|Non-Compliance with Study Drug|0
2834394|NCT02616783|9723421|P1|Overall Study|Non-Compliance with Study Drug|1
2834395|NCT02616783|9723420|P2|Overall Study|Death|0
2834396|NCT02616783|9723421|P1|Overall Study|Death|1
2834397|NCT02616783|9723420|P2|Overall Study|Adverse Event|0
2834398|NCT02616783|9723421|P1|Overall Study|Adverse Event|1
2834399|NCT02616783|9723420|P2|Overall Study|Randomized but Not Treated|0
2834400|NCT02616783|9723421|P1|Overall Study|Randomized but Not Treated|1
2834401|NCT02616614|9723444|P3|Overall Study|Other|1
2834402|NCT02616614|9723445|P2|Overall Study|Other|2
2834403|NCT02616614|9723446|P1|Overall Study|Other|1
2834404|NCT02616614|9723444|P3|Overall Study|Pregnancy|1
2834405|NCT02616614|9723445|P2|Overall Study|Pregnancy|0
2834406|NCT02616614|9723446|P1|Overall Study|Pregnancy|2
2834407|NCT02616614|9723444|P3|Overall Study|Lost to Follow-up|13
2834408|NCT02616614|9723445|P2|Overall Study|Lost to Follow-up|28
2834409|NCT02616614|9723446|P1|Overall Study|Lost to Follow-up|31
2834410|NCT02616614|9723444|P3|Overall Study|More than 3 applications missed|1
2834411|NCT02616614|9723445|P2|Overall Study|More than 3 applications missed|8
2834412|NCT02616614|9723446|P1|Overall Study|More than 3 applications missed|6
2834413|NCT02616614|9723444|P3|Overall Study|Prohibited Medication|5
2834414|NCT02616614|9723445|P2|Overall Study|Prohibited Medication|9
2834415|NCT02616614|9723446|P1|Overall Study|Prohibited Medication|12
2834416|NCT02616614|9723444|P3|Overall Study|Protocol Violation|1
2834417|NCT02616614|9723445|P2|Overall Study|Protocol Violation|3
2834418|NCT02616614|9723446|P1|Overall Study|Protocol Violation|0
2834419|NCT02616614|9723444|P3|Overall Study|Adverse Event|1
2834420|NCT02616614|9723445|P2|Overall Study|Adverse Event|4
2834421|NCT02616614|9723446|P1|Overall Study|Adverse Event|1
2834422|NCT02616614|9723444|P3|Overall Study|Physician Decision|0
2834423|NCT02616614|9723445|P2|Overall Study|Physician Decision|1
2834424|NCT02616614|9723446|P1|Overall Study|Physician Decision|2
2834425|NCT02616614|9723444|P3|Overall Study|Withdrawal by Subject|6
2834426|NCT02616614|9723445|P2|Overall Study|Withdrawal by Subject|5
2834427|NCT02616614|9723446|P1|Overall Study|Withdrawal by Subject|10
2834428|NCT02616601|9723463|P3|Overall Study|Non-Compliance with Test Article|1
2834429|NCT02616601|9723464|P2|Overall Study|Non-Compliance with Test Article|0
2834430|NCT02616601|9723465|P1|Overall Study|Non-Compliance with Test Article|1
2834431|NCT02616601|9723463|P3|Overall Study|Lost to Follow-up|1
2834432|NCT02616601|9723464|P2|Overall Study|Lost to Follow-up|0
2834433|NCT02616601|9723465|P1|Overall Study|Lost to Follow-up|1
2834434|NCT02616601|9723463|P3|Overall Study|Death|0
2834435|NCT02616601|9723464|P2|Overall Study|Death|0
2834436|NCT02616601|9723465|P1|Overall Study|Death|1
2834437|NCT02616601|9723463|P3|Overall Study|Adverse Event|2
2834438|NCT02616601|9723464|P2|Overall Study|Adverse Event|0
2834439|NCT02616601|9723465|P1|Overall Study|Adverse Event|2
2834440|NCT02616601|9723463|P3|Overall Study|Withdrawal by Subject|3
2834441|NCT02616601|9723464|P2|Overall Study|Withdrawal by Subject|4
2834442|NCT02616601|9723465|P1|Overall Study|Withdrawal by Subject|4
2834443|NCT02616380|9723492|P1|Overall Study|Other|2
2834444|NCT02616380|9723492|P1|Overall Study|Lost to Follow-up|1
2834445|NCT02616146|9723516|P2|Overall Study|Physician Decision|1
2834446|NCT02616146|9723517|P1|Overall Study|Physician Decision|2
2834447|NCT02616146|9723516|P2|Overall Study|Withdrawal by Subject|24
2834448|NCT02616146|9723517|P1|Overall Study|Withdrawal by Subject|30
2834449|NCT02616146|9723516|P2|Overall Study|Participant moved|3
2834450|NCT02616146|9723517|P1|Overall Study|Participant moved|4
2834451|NCT02616146|9723516|P2|Overall Study|Study terminated by sponsor|432
2834452|NCT02616146|9723517|P1|Overall Study|Study terminated by sponsor|1372
2834453|NCT02616146|9723516|P2|Overall Study|Protocol Violation|3
2834454|NCT02616146|9723517|P1|Overall Study|Protocol Violation|6
2834455|NCT02616146|9723516|P2|Overall Study|Pregnancy wish|0
2834456|NCT02616146|9723517|P1|Overall Study|Pregnancy wish|3
2834457|NCT02616146|9723516|P2|Overall Study|Pregnancy|2
2834458|NCT02616146|9723517|P1|Overall Study|Pregnancy|2
2834459|NCT02616146|9723516|P2|Overall Study|Non-compliance with study drug|2
2834460|NCT02616146|9723517|P1|Overall Study|Non-compliance with study drug|4
2834461|NCT02616146|9723516|P2|Overall Study|Non-compliance with study protocol|0
2834462|NCT02616146|9723517|P1|Overall Study|Non-compliance with study protocol|2
2834463|NCT02616146|9723516|P2|Overall Study|Lost to Follow-up|13
2834464|NCT02616146|9723517|P1|Overall Study|Lost to Follow-up|23
2834465|NCT02616146|9723516|P2|Overall Study|Adverse Event|24
2834466|NCT02616146|9723517|P1|Overall Study|Adverse Event|64
2834467|NCT02616029|9723533|P2|Overall Study|Still on Study|8
2834468|NCT02616029|9723534|P1|Overall Study|Still on Study|0
2834469|NCT02616029|9723533|P2|Overall Study|Withdrew Consent|0
2834470|NCT02616029|9723534|P1|Overall Study|Withdrew Consent|1
2834471|NCT02616029|9723533|P2|Overall Study|Protocol Violation|0
2834472|NCT02616029|9723534|P1|Overall Study|Protocol Violation|1
2834473|NCT02616029|9723533|P2|Overall Study|Adverse Event|0
2834474|NCT02616029|9723534|P1|Overall Study|Adverse Event|1
2834475|NCT02616029|9723533|P2|Overall Study|Enrolled and Never Treated|1
2834476|NCT02616029|9723534|P1|Overall Study|Enrolled and Never Treated|1
2834477|NCT02615990|9723557|P2|Overall Study|study terminated|1
2834478|NCT02615990|9723558|P1|Overall Study|study terminated|1
2834479|NCT02615509|9723655|P1|Overall Study|Withdrawal by Subject|8
2834480|NCT02615509|9723655|P1|Overall Study|Death|4
2834481|NCT02615509|9723655|P1|Overall Study|Lost to Follow-up|134
2834482|NCT02615470|9723665|P2|Overall Study|Lost to Follow-up|32
2834483|NCT02615470|9723666|P1|Overall Study|Lost to Follow-up|21
2834484|NCT02615145|9723710|P4|Overall Study|Other, Not Specified|0
2834485|NCT02615145|9723711|P3|Overall Study|Other, Not Specified|0
2834486|NCT02615145|9723712|P2|Overall Study|Other, Not Specified|2
2834487|NCT02615145|9723713|P1|Overall Study|Other, Not Specified|5
2834488|NCT02615145|9723710|P4|Overall Study|Death|0
2834489|NCT02615145|9723711|P3|Overall Study|Death|0
2834490|NCT02615145|9723712|P2|Overall Study|Death|3
2834491|NCT02615145|9723713|P1|Overall Study|Death|2
2834492|NCT02615145|9723710|P4|Overall Study|Failure to Return|0
2834493|NCT02615145|9723711|P3|Overall Study|Failure to Return|7
2834494|NCT02615145|9723712|P2|Overall Study|Failure to Return|10
2834495|NCT02615145|9723713|P1|Overall Study|Failure to Return|20
2834496|NCT02615145|9723710|P4|Overall Study|Did Not Start Treatment|1
2834497|NCT02615145|9723711|P3|Overall Study|Did Not Start Treatment|1
2834498|NCT02615145|9723712|P2|Overall Study|Did Not Start Treatment|0
2834499|NCT02615145|9723713|P1|Overall Study|Did Not Start Treatment|0
2834500|NCT02614898|9723800|P2|Overall Study|Missing|1
2834501|NCT02614898|9723801|P1|Overall Study|Missing|0
2834502|NCT02614898|9723800|P2|Overall Study|Other-Additional Information Unavailable|11
2834503|NCT02614898|9723801|P1|Overall Study|Other-Additional Information Unavailable|0
2834504|NCT02614898|9723800|P2|Overall Study|Withdrawal by Parent/Guardian|1
2834505|NCT02614898|9723801|P1|Overall Study|Withdrawal by Parent/Guardian|1
2834506|NCT02614898|9723800|P2|Overall Study|Withdrawal by Subject|2
2834507|NCT02614898|9723801|P1|Overall Study|Withdrawal by Subject|0
2834508|NCT02614898|9723800|P2|Overall Study|Study Terminated by Sponsor|0
2834509|NCT02614898|9723801|P1|Overall Study|Study Terminated by Sponsor|3
2834510|NCT02614898|9723800|P2|Overall Study|Physician Decision|8
2834511|NCT02614898|9723801|P1|Overall Study|Physician Decision|1
2834512|NCT02614898|9723800|P2|Overall Study|Lost to Follow-up|2
2834513|NCT02614898|9723801|P1|Overall Study|Lost to Follow-up|0
2834514|NCT02614898|9723800|P2|Overall Study|Participated until study termination|26
2834515|NCT02614898|9723801|P1|Overall Study|Participated until study termination|10
2834516|NCT02614729|9723813|P2|Overall Study|Withdrawal by Subject|0
2834517|NCT02614729|9723814|P1|Overall Study|Withdrawal by Subject|1
2834518|NCT02614703|9723834|P2|Overall Study|Withdrawal by Subject|1
2834519|NCT02614703|9723835|P1|Overall Study|Withdrawal by Subject|7
2834520|NCT02614560|9723879|P2|Overall Study|Death|2
2834521|NCT02614560|9723880|P1|Overall Study|Death|6
2834522|NCT02614287|9723928|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
2834523|NCT02614287|9723929|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
2834524|NCT02614287|9723928|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
2834525|NCT02614287|9723929|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
2834526|NCT02614287|9723928|P2|Post Treatment Follow-up Phase|Adverse Event|0
2834527|NCT02614287|9723929|P1|Post Treatment Follow-up Phase|Adverse Event|1
2834528|NCT02614287|9723928|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
2834529|NCT02614287|9723929|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
2834530|NCT02614287|9723928|P2|Open Label (OL) Treatment Phase|Physician Decision|0
2834531|NCT02614287|9723929|P1|Open Label (OL) Treatment Phase|Physician Decision|1
2834532|NCT02614287|9723928|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
2834533|NCT02614287|9723929|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
2834534|NCT02614287|9723928|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
2834535|NCT02614287|9723929|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
2834536|NCT02614287|9723928|P2|Open Label (OL) Treatment Phase|Adverse Event|6
2834537|NCT02614287|9723929|P1|Open Label (OL) Treatment Phase|Adverse Event|7
2834538|NCT02614261|9723975|P3|Overall Study|Withdrawal by Subject|7
2834539|NCT02614261|9723976|P2|Overall Study|Withdrawal by Subject|4
2834540|NCT02614261|9723977|P1|Overall Study|Withdrawal by Subject|19
2834541|NCT02614261|9723975|P3|Overall Study|Protocol Violation|0
2834542|NCT02614261|9723976|P2|Overall Study|Protocol Violation|1
2834543|NCT02614261|9723977|P1|Overall Study|Protocol Violation|6
2834544|NCT02614261|9723975|P3|Overall Study|Pregnancy|0
2834545|NCT02614261|9723976|P2|Overall Study|Pregnancy|2
2834546|NCT02614261|9723977|P1|Overall Study|Pregnancy|2
2834547|NCT02614261|9723975|P3|Overall Study|Physician Decision|1
2834548|NCT02614261|9723976|P2|Overall Study|Physician Decision|1
2834549|NCT02614261|9723977|P1|Overall Study|Physician Decision|2
2834550|NCT02614261|9723975|P3|Overall Study|Lost to Follow-up|1
2834551|NCT02614261|9723976|P2|Overall Study|Lost to Follow-up|4
2834552|NCT02614261|9723977|P1|Overall Study|Lost to Follow-up|10
2834553|NCT02614261|9723975|P3|Overall Study|Lack of Efficacy|0
2834554|NCT02614261|9723976|P2|Overall Study|Lack of Efficacy|0
2834555|NCT02614261|9723977|P1|Overall Study|Lack of Efficacy|4
2834556|NCT02614261|9723975|P3|Overall Study|Adverse Event|2
2834557|NCT02614261|9723976|P2|Overall Study|Adverse Event|3
2834558|NCT02614261|9723977|P1|Overall Study|Adverse Event|6
2834559|NCT02614196|9724043|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2834560|NCT02614196|9724044|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2834561|NCT02614196|9724045|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2834562|NCT02614196|9724046|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2834563|NCT02614196|9724047|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2834564|NCT02614196|9724048|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
2834565|NCT02614196|9724043|P6|Post Treatment Follow-up Phase|Protocol Violation|0
2834566|NCT02614196|9724044|P5|Post Treatment Follow-up Phase|Protocol Violation|1
2834567|NCT02614196|9724045|P4|Post Treatment Follow-up Phase|Protocol Violation|0
2834568|NCT02614196|9724046|P3|Post Treatment Follow-up Phase|Protocol Violation|0
2834569|NCT02614196|9724047|P2|Post Treatment Follow-up Phase|Protocol Violation|1
2834570|NCT02614196|9724048|P1|Post Treatment Follow-up Phase|Protocol Violation|0
2834571|NCT02614196|9724043|P6|Post Treatment Follow-up Phase|Pregnancy|0
2834572|NCT02614196|9724044|P5|Post Treatment Follow-up Phase|Pregnancy|0
2834573|NCT02614196|9724045|P4|Post Treatment Follow-up Phase|Pregnancy|0
2834574|NCT02614196|9724046|P3|Post Treatment Follow-up Phase|Pregnancy|0
2834575|NCT02614196|9724047|P2|Post Treatment Follow-up Phase|Pregnancy|0
2834576|NCT02614196|9724048|P1|Post Treatment Follow-up Phase|Pregnancy|2
2834577|NCT02614196|9724043|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
2834578|NCT02614196|9724044|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
2834579|NCT02614196|9724045|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
2834580|NCT02614196|9724046|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
2834581|NCT02614196|9724047|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
2834582|NCT02614196|9724048|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
2834583|NCT02614196|9724043|P6|Double Blind Treatment Phase|Did not receive study drug|0
2834584|NCT02614196|9724044|P5|Double Blind Treatment Phase|Did not receive study drug|0
2834585|NCT02614196|9724045|P4|Double Blind Treatment Phase|Did not receive study drug|0
2834586|NCT02614196|9724046|P3|Double Blind Treatment Phase|Did not receive study drug|3
2834587|NCT02614196|9724047|P2|Double Blind Treatment Phase|Did not receive study drug|2
2834588|NCT02614196|9724048|P1|Double Blind Treatment Phase|Did not receive study drug|2
2834589|NCT02614196|9724043|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
2834590|NCT02614196|9724044|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
2834591|NCT02614196|9724045|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
2834592|NCT02614196|9724046|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
2834593|NCT02614196|9724047|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
2834594|NCT02614196|9724048|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
2834595|NCT02614196|9724043|P6|Double Blind Treatment Phase|Terminated by sponsor|0
2834596|NCT02614196|9724044|P5|Double Blind Treatment Phase|Terminated by sponsor|0
2834597|NCT02614196|9724045|P4|Double Blind Treatment Phase|Terminated by sponsor|0
2834598|NCT02614196|9724046|P3|Double Blind Treatment Phase|Terminated by sponsor|0
2834599|NCT02614196|9724047|P2|Double Blind Treatment Phase|Terminated by sponsor|0
2834600|NCT02614196|9724048|P1|Double Blind Treatment Phase|Terminated by sponsor|1
2834601|NCT02614196|9724043|P6|Double Blind Treatment Phase|Protocol Violation|0
2834602|NCT02614196|9724044|P5|Double Blind Treatment Phase|Protocol Violation|1
2834603|NCT02614196|9724045|P4|Double Blind Treatment Phase|Protocol Violation|0
2834604|NCT02614196|9724046|P3|Double Blind Treatment Phase|Protocol Violation|1
2834605|NCT02614196|9724047|P2|Double Blind Treatment Phase|Protocol Violation|2
2834606|NCT02614196|9724048|P1|Double Blind Treatment Phase|Protocol Violation|5
2834607|NCT02614196|9724043|P6|Double Blind Treatment Phase|Pregnancy|0
2834608|NCT02614196|9724044|P5|Double Blind Treatment Phase|Pregnancy|0
2834609|NCT02614196|9724045|P4|Double Blind Treatment Phase|Pregnancy|0
2834610|NCT02614196|9724046|P3|Double Blind Treatment Phase|Pregnancy|0
2834611|NCT02614196|9724047|P2|Double Blind Treatment Phase|Pregnancy|2
2834612|NCT02614196|9724048|P1|Double Blind Treatment Phase|Pregnancy|1
2834613|NCT02614196|9724043|P6|Double Blind Treatment Phase|Physician Decision|0
2834614|NCT02614196|9724044|P5|Double Blind Treatment Phase|Physician Decision|0
2834615|NCT02614196|9724045|P4|Double Blind Treatment Phase|Physician Decision|0
2834616|NCT02614196|9724046|P3|Double Blind Treatment Phase|Physician Decision|2
2834617|NCT02614196|9724047|P2|Double Blind Treatment Phase|Physician Decision|0
2834618|NCT02614196|9724048|P1|Double Blind Treatment Phase|Physician Decision|4
2834619|NCT02614196|9724043|P6|Double Blind Treatment Phase|Lost to Follow-up|0
2834620|NCT02614196|9724044|P5|Double Blind Treatment Phase|Lost to Follow-up|0
2834621|NCT02614196|9724045|P4|Double Blind Treatment Phase|Lost to Follow-up|0
2834622|NCT02614196|9724046|P3|Double Blind Treatment Phase|Lost to Follow-up|1
2834623|NCT02614196|9724047|P2|Double Blind Treatment Phase|Lost to Follow-up|7
2834624|NCT02614196|9724048|P1|Double Blind Treatment Phase|Lost to Follow-up|10
2834625|NCT02614196|9724043|P6|Double Blind Treatment Phase|Lack of Efficacy|0
2834626|NCT02614196|9724044|P5|Double Blind Treatment Phase|Lack of Efficacy|0
2834627|NCT02614196|9724045|P4|Double Blind Treatment Phase|Lack of Efficacy|0
2834628|NCT02614196|9724046|P3|Double Blind Treatment Phase|Lack of Efficacy|1
2834629|NCT02614196|9724047|P2|Double Blind Treatment Phase|Lack of Efficacy|1
2834630|NCT02614196|9724048|P1|Double Blind Treatment Phase|Lack of Efficacy|6
2834631|NCT02614196|9724043|P6|Double Blind Treatment Phase|Adverse Event|0
2834632|NCT02614196|9724044|P5|Double Blind Treatment Phase|Adverse Event|0
2834633|NCT02614196|9724045|P4|Double Blind Treatment Phase|Adverse Event|0
2834634|NCT02614196|9724046|P3|Double Blind Treatment Phase|Adverse Event|9
2834635|NCT02614196|9724047|P2|Double Blind Treatment Phase|Adverse Event|5
2834636|NCT02614196|9724048|P1|Double Blind Treatment Phase|Adverse Event|8
2834637|NCT02614183|9724094|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2834638|NCT02614183|9724095|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
2834639|NCT02614183|9724096|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
2834640|NCT02614183|9724094|P3|Post Treatment Follow-up Phase|Protocol Violation|0
2834641|NCT02614183|9724095|P2|Post Treatment Follow-up Phase|Protocol Violation|0
2834642|NCT02614183|9724096|P1|Post Treatment Follow-up Phase|Protocol Violation|1
2834643|NCT02614183|9724094|P3|Post Treatment Follow-up Phase|Physician Decision|2
2834644|NCT02614183|9724095|P2|Post Treatment Follow-up Phase|Physician Decision|1
2834645|NCT02614183|9724096|P1|Post Treatment Follow-up Phase|Physician Decision|5
2834646|NCT02614183|9724094|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
2834647|NCT02614183|9724095|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
2834648|NCT02614183|9724096|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
2834649|NCT02614183|9724094|P3|Double Blind Treatment Phase|Did not receive study drug|2
2834650|NCT02614183|9724095|P2|Double Blind Treatment Phase|Did not receive study drug|1
2834651|NCT02614183|9724096|P1|Double Blind Treatment Phase|Did not receive study drug|1
2834652|NCT02614183|9724094|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
2834653|NCT02614183|9724095|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
2834654|NCT02614183|9724096|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
2834655|NCT02614183|9724094|P3|Double Blind Treatment Phase|Protocol Violation|2
2834656|NCT02614183|9724095|P2|Double Blind Treatment Phase|Protocol Violation|2
2834657|NCT02614183|9724096|P1|Double Blind Treatment Phase|Protocol Violation|2
2834658|NCT02614183|9724094|P3|Double Blind Treatment Phase|Pregnancy|3
2834659|NCT02614183|9724095|P2|Double Blind Treatment Phase|Pregnancy|1
2834660|NCT02614183|9724096|P1|Double Blind Treatment Phase|Pregnancy|2
2834661|NCT02614183|9724094|P3|Double Blind Treatment Phase|Physician Decision|2
2834662|NCT02614183|9724095|P2|Double Blind Treatment Phase|Physician Decision|3
2834663|NCT02614183|9724096|P1|Double Blind Treatment Phase|Physician Decision|7
2834664|NCT02614183|9724094|P3|Double Blind Treatment Phase|Lost to Follow-up|5
2834665|NCT02614183|9724095|P2|Double Blind Treatment Phase|Lost to Follow-up|9
2834666|NCT02614183|9724096|P1|Double Blind Treatment Phase|Lost to Follow-up|18
2834667|NCT02614183|9724094|P3|Double Blind Treatment Phase|Lack of Efficacy|2
2834668|NCT02614183|9724095|P2|Double Blind Treatment Phase|Lack of Efficacy|1
2834669|NCT02614183|9724096|P1|Double Blind Treatment Phase|Lack of Efficacy|10
2834670|NCT02614183|9724094|P3|Double Blind Treatment Phase|Adverse Event|7
2834671|NCT02614183|9724095|P2|Double Blind Treatment Phase|Adverse Event|9
2834672|NCT02614183|9724096|P1|Double Blind Treatment Phase|Adverse Event|10
2834673|NCT02614131|9724140|P7|Overall Study|Adverse Event|1
2834674|NCT02614131|9724141|P6|Overall Study|Adverse Event|0
2834675|NCT02614131|9724142|P5|Overall Study|Adverse Event|0
2834676|NCT02614131|9724143|P4|Overall Study|Adverse Event|0
2834677|NCT02614131|9724144|P3|Overall Study|Adverse Event|0
2834678|NCT02614131|9724145|P2|Overall Study|Adverse Event|0
2834679|NCT02614131|9724146|P1|Overall Study|Adverse Event|0
2834680|NCT02614131|9724140|P7|Overall Study|Withdrawal by Subject|0
2834681|NCT02614131|9724141|P6|Overall Study|Withdrawal by Subject|0
2834682|NCT02614131|9724142|P5|Overall Study|Withdrawal by Subject|0
2834683|NCT02614131|9724143|P4|Overall Study|Withdrawal by Subject|0
2834684|NCT02614131|9724144|P3|Overall Study|Withdrawal by Subject|0
2834685|NCT02614131|9724145|P2|Overall Study|Withdrawal by Subject|0
2834686|NCT02614131|9724146|P1|Overall Study|Withdrawal by Subject|1
2834687|NCT02614079|9724177|P1|Overall Study|Withdrawal by Subject|1
2834688|NCT02613910|9724181|P1|Overall Study|Termination of study|1
2834689|NCT02613871|9724267|P1|Overall Study|Withdrew Consent|1
2834690|NCT02613871|9724267|P1|Overall Study|Death|2
2834691|NCT02613507|9724288|P2|Overall Study|Randomized but not Treated|10
2834692|NCT02613507|9724289|P1|Overall Study|Randomized but not Treated|1
2834693|NCT02613507|9724288|P2|Overall Study|Subject no Longer Meets Study Criteria|0
2834694|NCT02613507|9724289|P1|Overall Study|Subject no Longer Meets Study Criteria|1
2834695|NCT02613507|9724288|P2|Overall Study|Brain Radiotherapy Activity Limited|0
2834696|NCT02613507|9724289|P1|Overall Study|Brain Radiotherapy Activity Limited|1
2834697|NCT02613507|9724288|P2|Overall Study|Maximum Clinical Benefit|10
2834698|NCT02613507|9724289|P1|Overall Study|Maximum Clinical Benefit|4
2834699|NCT02613507|9724288|P2|Overall Study|Lost to Follow-up|0
2834700|NCT02613507|9724289|P1|Overall Study|Lost to Follow-up|1
2834701|NCT02613507|9724288|P2|Overall Study|Participant Withdrew Consent|2
2834702|NCT02613507|9724289|P1|Overall Study|Participant Withdrew Consent|0
2834703|NCT02613507|9724288|P2|Overall Study|Request to Discontinue Study Treatment|17
2834704|NCT02613507|9724289|P1|Overall Study|Request to Discontinue Study Treatment|8
2834705|NCT02613507|9724288|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
2834706|NCT02613507|9724289|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
2834707|NCT02613507|9724288|P2|Overall Study|Death|0
2834708|NCT02613507|9724289|P1|Overall Study|Death|3
2834709|NCT02613507|9724288|P2|Overall Study|Study Drug Toxicity|14
2834710|NCT02613507|9724289|P1|Overall Study|Study Drug Toxicity|15
2834711|NCT02613507|9724288|P2|Overall Study|Disease Progression|109
2834712|NCT02613507|9724289|P1|Overall Study|Disease Progression|237
2834713|NCT02613481|9724305|P1|Overall Study|Withdrawal by Subject|2
2834714|NCT02613481|9724305|P1|Overall Study|Lost to Follow-up|7
2834715|NCT02613403|9724316|P5|Overall Study|Withdrawal by Subject|0
2834716|NCT02613403|9724317|P4|Overall Study|Withdrawal by Subject|0
2834717|NCT02613403|9724318|P3|Overall Study|Withdrawal by Subject|0
2834718|NCT02613403|9724319|P2|Overall Study|Withdrawal by Subject|0
2834719|NCT02613403|9724320|P1|Overall Study|Withdrawal by Subject|2
2834720|NCT02613403|9724316|P5|Overall Study|Lost to Follow-up|0
2834721|NCT02613403|9724317|P4|Overall Study|Lost to Follow-up|0
2834722|NCT02613403|9724318|P3|Overall Study|Lost to Follow-up|0
2834723|NCT02613403|9724319|P2|Overall Study|Lost to Follow-up|1
2834724|NCT02613403|9724320|P1|Overall Study|Lost to Follow-up|0
2834725|NCT02613221|9724372|P1|Overall Study|Enrolled but Not Treated|1
2834726|NCT02613221|9724372|P1|Overall Study|Delayed Treatment|1
2834727|NCT02613221|9724372|P1|Overall Study|Voluntary Discontinuation|1
2834728|NCT02613221|9724372|P1|Overall Study|Adverse Event|2
2834729|NCT02613221|9724372|P1|Overall Study|Lack of efficacy (exacerbation)|50
2834730|NCT02613208|9724384|P1|Overall Study|Death|37
2834731|NCT02613208|9724384|P1|Overall Study|Lost to Follow-up|5
2834732|NCT02613208|9724384|P1|Overall Study|Physician Decision|2
2834733|NCT02613208|9724384|P1|Overall Study|Change of address|2
2834734|NCT02613208|9724384|P1|Overall Study|Withdrawal by Subject|1
2834735|NCT02613182|9724398|P1|Overall Study|Withdrawal by Subject|6
2834736|NCT02613182|9724398|P1|Overall Study|Study Terminated by Sponsor|21
2834737|NCT02613182|9724398|P1|Overall Study|Physician Decision|1
2834738|NCT02613182|9724398|P1|Overall Study|Death|6
2834739|NCT02612909|9724407|P5|Phase 3|Withdrawal by Subject|0
2834740|NCT02612909|9724408|P4|Phase 3|Withdrawal by Subject|1
2834741|NCT02612909|9724409|P3|Phase 3|Withdrawal by Subject|0
2834742|NCT02612909|9724410|P2|Phase 3|Withdrawal by Subject|0
2834743|NCT02612909|9724411|P1|Phase 3|Withdrawal by Subject|0
2834744|NCT02612909|9724407|P5|Phase 2|Pregnancy|0
2834745|NCT02612909|9724408|P4|Phase 2|Pregnancy|0
2834746|NCT02612909|9724409|P3|Phase 2|Pregnancy|1
2834747|NCT02612909|9724410|P2|Phase 2|Pregnancy|0
2834748|NCT02612909|9724411|P1|Phase 2|Pregnancy|0
2834749|NCT02612909|9724407|P5|Phase 2|Withdrawal by Subject|0
2834750|NCT02612909|9724408|P4|Phase 2|Withdrawal by Subject|0
2834751|NCT02612909|9724409|P3|Phase 2|Withdrawal by Subject|0
2834752|NCT02612909|9724410|P2|Phase 2|Withdrawal by Subject|5
2834753|NCT02612909|9724411|P1|Phase 2|Withdrawal by Subject|2
2834754|NCT02612727|9724494|P2|Overall Study|Direct hyperbilirubinemia|2
2834755|NCT02612727|9724495|P1|Overall Study|Direct hyperbilirubinemia|0
2834756|NCT02612727|9724494|P2|Overall Study|Needed treatment incompatible with PT|1
2834757|NCT02612727|9724495|P1|Overall Study|Needed treatment incompatible with PT|1
2834758|NCT02612727|9724494|P2|Overall Study|Parent request|1
2834759|NCT02612727|9724495|P1|Overall Study|Parent request|4
2834760|NCT02612623|9724507|P4|Overall Study|Adverse Event|0
2834761|NCT02612623|9724508|P3|Overall Study|Adverse Event|1
2834762|NCT02612623|9724509|P2|Overall Study|Adverse Event|0
2834763|NCT02612623|9724510|P1|Overall Study|Adverse Event|1
2834764|NCT02612623|9724507|P4|Overall Study|Withdrawal by Subject|0
2834765|NCT02612623|9724508|P3|Overall Study|Withdrawal by Subject|0
2834766|NCT02612623|9724509|P2|Overall Study|Withdrawal by Subject|1
2834767|NCT02612623|9724510|P1|Overall Study|Withdrawal by Subject|0
2834768|NCT02612610|9724524|P4|Overall Study|Cough Improvement|0
2834769|NCT02612610|9724525|P3|Overall Study|Cough Improvement|1
2834770|NCT02612610|9724526|P2|Overall Study|Cough Improvement|0
2834771|NCT02612610|9724527|P1|Overall Study|Cough Improvement|0
2834772|NCT02612610|9724524|P4|Overall Study|Noncompliance|0
2834773|NCT02612610|9724525|P3|Overall Study|Noncompliance|0
2834774|NCT02612610|9724526|P2|Overall Study|Noncompliance|0
2834775|NCT02612610|9724527|P1|Overall Study|Noncompliance|1
2834776|NCT02612610|9724524|P4|Overall Study|Physician Decision|0
2834777|NCT02612610|9724525|P3|Overall Study|Physician Decision|0
2834778|NCT02612610|9724526|P2|Overall Study|Physician Decision|1
2834779|NCT02612610|9724527|P1|Overall Study|Physician Decision|0
2834780|NCT02612610|9724524|P4|Overall Study|Lack of Efficacy|1
2834781|NCT02612610|9724525|P3|Overall Study|Lack of Efficacy|0
2834782|NCT02612610|9724526|P2|Overall Study|Lack of Efficacy|2
2834783|NCT02612610|9724527|P1|Overall Study|Lack of Efficacy|1
2834784|NCT02612610|9724524|P4|Overall Study|Protocol Violation|0
2834785|NCT02612610|9724525|P3|Overall Study|Protocol Violation|1
2834786|NCT02612610|9724526|P2|Overall Study|Protocol Violation|1
2834787|NCT02612610|9724527|P1|Overall Study|Protocol Violation|0
2834788|NCT02612610|9724524|P4|Overall Study|Lost to Follow-up|0
2834789|NCT02612610|9724525|P3|Overall Study|Lost to Follow-up|0
2834790|NCT02612610|9724526|P2|Overall Study|Lost to Follow-up|1
2834791|NCT02612610|9724527|P1|Overall Study|Lost to Follow-up|0
2834792|NCT02612610|9724524|P4|Overall Study|Adverse Event|10
2834793|NCT02612610|9724525|P3|Overall Study|Adverse Event|3
2834794|NCT02612610|9724526|P2|Overall Study|Adverse Event|2
2834795|NCT02612610|9724527|P1|Overall Study|Adverse Event|2
2834796|NCT02612610|9724524|P4|Overall Study|Withdrawal by Subject|2
2834797|NCT02612610|9724525|P3|Overall Study|Withdrawal by Subject|0
2834798|NCT02612610|9724526|P2|Overall Study|Withdrawal by Subject|1
2834799|NCT02612610|9724527|P1|Overall Study|Withdrawal by Subject|1
2834800|NCT02612428|9724771|P2|VTL-308E|Lost to Follow-up|0
2834801|NCT02612428|9724772|P1|VTL-308E|Lost to Follow-up|2
2834802|NCT02612428|9724771|P2|VTL-308E|Death|7
2834803|NCT02612428|9724772|P1|VTL-308E|Death|9
2834804|NCT02612428|9724771|P2|VTL-308|Withdrawal by Subject|1
2834805|NCT02612428|9724772|P1|VTL-308|Withdrawal by Subject|0
2834806|NCT02612428|9724771|P2|VTL-308|Death|16
2834807|NCT02612428|9724772|P1|VTL-308|Death|14
2834808|NCT02612285|9724782|P1|Overall Study|Withdrawal by Subject|1
2834809|NCT02612077|9724786|P1|Overall Study|Unknown reason|2
2834810|NCT02612077|9724786|P1|Overall Study|Disease Progression|3
2834811|NCT02612077|9724786|P1|Overall Study|Enrollment in a Clinical Trial|1
2834812|NCT02612077|9724786|P1|Overall Study|Moved or Changed Medical Team|23
2834813|NCT02612077|9724786|P1|Overall Study|Death|377
2834814|NCT02612077|9724786|P1|Overall Study|Lost to Follow-up|20
2834815|NCT02612077|9724786|P1|Overall Study|Protocol Violation|28
2834816|NCT02612077|9724786|P1|Overall Study|Withdrawal by Subject|9
2834817|NCT02612077|9724786|P1|Overall Study|Adverse Event|3
2834818|NCT02612064|9724798|P2|Overall Study|Other|2
2834819|NCT02612064|9724799|P1|Overall Study|Other|0
2834820|NCT02612064|9724798|P2|Overall Study|Withdrawal by Subject|1
2834821|NCT02612064|9724799|P1|Overall Study|Withdrawal by Subject|1
2834822|NCT02611830|9724813|P4|Maintenance Phase|Reason not specified|0
2834823|NCT02611830|9724814|P3|Maintenance Phase|Reason not specified|4
2834824|NCT02611830|9724815|P2|Maintenance Phase|Reason not specified|1
2834825|NCT02611830|9724816|P1|Maintenance Phase|Reason not specified|0
2834826|NCT02611830|9724813|P4|Maintenance Phase|Pregnancy|0
2834827|NCT02611830|9724814|P3|Maintenance Phase|Pregnancy|1
2834828|NCT02611830|9724815|P2|Maintenance Phase|Pregnancy|0
2834829|NCT02611830|9724816|P1|Maintenance Phase|Pregnancy|0
2834830|NCT02611830|9724813|P4|Maintenance Phase|Voluntary Withdrawal|5
2834831|NCT02611830|9724814|P3|Maintenance Phase|Voluntary Withdrawal|2
2834832|NCT02611830|9724815|P2|Maintenance Phase|Voluntary Withdrawal|1
2834833|NCT02611830|9724816|P1|Maintenance Phase|Voluntary Withdrawal|0
2834834|NCT02611830|9724813|P4|Maintenance Phase|Lost to Follow-up|1
2834835|NCT02611830|9724814|P3|Maintenance Phase|Lost to Follow-up|0
2834836|NCT02611830|9724815|P2|Maintenance Phase|Lost to Follow-up|0
2834837|NCT02611830|9724816|P1|Maintenance Phase|Lost to Follow-up|0
2834838|NCT02611830|9724813|P4|Maintenance Phase|Significant Protocol Deviation|1
2834839|NCT02611830|9724814|P3|Maintenance Phase|Significant Protocol Deviation|1
2834840|NCT02611830|9724815|P2|Maintenance Phase|Significant Protocol Deviation|0
2834841|NCT02611830|9724816|P1|Maintenance Phase|Significant Protocol Deviation|0
2834842|NCT02611830|9724813|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
2834843|NCT02611830|9724814|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
2834844|NCT02611830|9724815|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
2834845|NCT02611830|9724816|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
2834846|NCT02611830|9724813|P4|Maintenance Phase|Lack of Efficacy|6
2834847|NCT02611830|9724814|P3|Maintenance Phase|Lack of Efficacy|18
2834848|NCT02611830|9724815|P2|Maintenance Phase|Lack of Efficacy|29
2834849|NCT02611830|9724816|P1|Maintenance Phase|Lack of Efficacy|0
2834850|NCT02611830|9724813|P4|OL Induction Phase|Reason not specified|0
2834851|NCT02611830|9724814|P3|OL Induction Phase|Reason not specified|0
2834852|NCT02611830|9724815|P2|OL Induction Phase|Reason not specified|0
2834853|NCT02611830|9724816|P1|OL Induction Phase|Reason not specified|3
2834854|NCT02611830|9724813|P4|OL Induction Phase|Lack of Efficacy|0
2834855|NCT02611830|9724814|P3|OL Induction Phase|Lack of Efficacy|0
2834856|NCT02611830|9724815|P2|OL Induction Phase|Lack of Efficacy|0
2834857|NCT02611830|9724816|P1|OL Induction Phase|Lack of Efficacy|9
2834858|NCT02611830|9724813|P4|OL Induction Phase|Voluntary Withdrawal|0
2834859|NCT02611830|9724814|P3|OL Induction Phase|Voluntary Withdrawal|0
2834860|NCT02611830|9724815|P2|OL Induction Phase|Voluntary Withdrawal|0
2834861|NCT02611830|9724816|P1|OL Induction Phase|Voluntary Withdrawal|5
2834862|NCT02611830|9724813|P4|OL Induction Phase|Significant Protocol Deviation|0
2834863|NCT02611830|9724814|P3|OL Induction Phase|Significant Protocol Deviation|0
2834864|NCT02611830|9724815|P2|OL Induction Phase|Significant Protocol Deviation|0
2834865|NCT02611830|9724816|P1|OL Induction Phase|Significant Protocol Deviation|4
2834866|NCT02611830|9724813|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
2834867|NCT02611830|9724814|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
2834868|NCT02611830|9724815|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
2834869|NCT02611830|9724816|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
2834870|NCT02611752|9724848|P2|Overall Study|Adverse Event|1
2834871|NCT02611752|9724849|P1|Overall Study|Adverse Event|0
2834872|NCT02611479|9724881|P1|Data Cleaning|No baseline function or pain metrics|2
2834873|NCT02611479|9724881|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
2834874|NCT02611479|9724881|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
2834875|NCT02611479|9724881|P1|Baseline Enrollment|Exited study|13
2834876|NCT02610842|9725013|P1|Overall Study|Lost to Follow-up|5
2834877|NCT02610816|9725022|P4|Phase 2|Pregnancy|1
2834878|NCT02610816|9725023|P3|Phase 2|Pregnancy|0
2834879|NCT02610816|9725024|P2|Phase 2|Pregnancy|0
2834880|NCT02610816|9725025|P1|Phase 2|Pregnancy|0
2834881|NCT02610816|9725022|P4|Phase 2|Physician Decision|2
2834882|NCT02610816|9725023|P3|Phase 2|Physician Decision|0
2834883|NCT02610816|9725024|P2|Phase 2|Physician Decision|0
2834884|NCT02610816|9725025|P1|Phase 2|Physician Decision|0
2834885|NCT02610816|9725022|P4|Phase 2|Lost to Follow-up|0
2834886|NCT02610816|9725023|P3|Phase 2|Lost to Follow-up|2
2834887|NCT02610816|9725024|P2|Phase 2|Lost to Follow-up|0
2834888|NCT02610816|9725025|P1|Phase 2|Lost to Follow-up|0
2834889|NCT02610816|9725022|P4|Phase 2|Withdrawal by Subject|3
2834890|NCT02610816|9725023|P3|Phase 2|Withdrawal by Subject|9
2834891|NCT02610816|9725024|P2|Phase 2|Withdrawal by Subject|0
2834892|NCT02610816|9725025|P1|Phase 2|Withdrawal by Subject|0
2834893|NCT02610816|9725022|P4|Phase 1|Physician Decision|0
2834894|NCT02610816|9725023|P3|Phase 1|Physician Decision|0
2834895|NCT02610816|9725024|P2|Phase 1|Physician Decision|1
2834896|NCT02610816|9725025|P1|Phase 1|Physician Decision|0
2834897|NCT02610816|9725022|P4|Phase 1|Lost to Follow-up|0
2834898|NCT02610816|9725023|P3|Phase 1|Lost to Follow-up|0
2834899|NCT02610816|9725024|P2|Phase 1|Lost to Follow-up|1
2834900|NCT02610816|9725025|P1|Phase 1|Lost to Follow-up|2
2834901|NCT02610816|9725022|P4|Phase 1|Withdrawal by Subject|0
2834902|NCT02610816|9725023|P3|Phase 1|Withdrawal by Subject|0
2834903|NCT02610816|9725024|P2|Phase 1|Withdrawal by Subject|6
2834904|NCT02610816|9725025|P1|Phase 1|Withdrawal by Subject|2
2834905|NCT02610725|9725046|P1|Overall Study|self-reported contraindication|9
2834906|NCT02610725|9725046|P1|Overall Study|Lost to Follow-up|197
2834907|NCT02610231|9725061|P1|Overall Study|Other|3
2834908|NCT02610231|9725061|P1|Overall Study|Non Compliance|2
2834909|NCT02610231|9725061|P1|Overall Study|Physician Decision|1
2834910|NCT02610231|9725061|P1|Overall Study|Surgery|2
2834911|NCT02610231|9725061|P1|Overall Study|Death|5
2834912|NCT02610231|9725061|P1|Overall Study|Adverse Event|20
2834913|NCT02610231|9725061|P1|Overall Study|Withdrawal by Subject|27
2834914|NCT02610192|9725068|P1|Overall Study|Physician Decision|1
2834915|NCT02610192|9725068|P1|Overall Study|Received other treatment|8
2834916|NCT02609984|9725083|P2|Overall Study|Disease Progression|0
2834917|NCT02609984|9725084|P1|Overall Study|Disease Progression|2
2834918|NCT02609984|9725083|P2|Overall Study|Withdrawal by Subject|1
2834919|NCT02609984|9725084|P1|Overall Study|Withdrawal by Subject|0
2834920|NCT02609984|9725083|P2|Overall Study|Lost to Follow-up|2
2834921|NCT02609984|9725084|P1|Overall Study|Lost to Follow-up|1
2834922|NCT02609984|9725083|P2|Overall Study|Participation Discontinued by Sponsor|10
2834923|NCT02609984|9725084|P1|Overall Study|Participation Discontinued by Sponsor|12
2834924|NCT02609984|9725083|P2|Overall Study|Death|26
2834925|NCT02609984|9725084|P1|Overall Study|Death|29
2834926|NCT02609672|9725126|P2|Overall Study|Lost to Follow-up|1
2834927|NCT02609672|9725127|P1|Overall Study|Lost to Follow-up|3
2834928|NCT02609659|9725161|P1|Overall Study|Other|1
2834929|NCT02609659|9725161|P1|Overall Study|Lost to Follow-up|6
2834930|NCT02609659|9725161|P1|Overall Study|Adverse Event|1
2834931|NCT02609633|9725171|P2|Overall Study|Reason not Specified|1
2834932|NCT02609633|9725172|P1|Overall Study|Reason not Specified|2
2834933|NCT02609633|9725171|P2|Overall Study|Non-Compliant with Study Procedures|0
2834934|NCT02609633|9725172|P1|Overall Study|Non-Compliant with Study Procedures|2
2834935|NCT02609633|9725171|P2|Overall Study|Protocol Deviation|0
2834936|NCT02609633|9725172|P1|Overall Study|Protocol Deviation|1
2834937|NCT02609633|9725171|P2|Overall Study|Consent Withdrawn|1
2834938|NCT02609633|9725172|P1|Overall Study|Consent Withdrawn|0
2834939|NCT02609607|9725199|P2|Overall Study|Lost to Follow-up|1
2834940|NCT02609607|9725200|P1|Overall Study|Lost to Follow-up|0
2834941|NCT02609399|9725224|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
2834942|NCT02609399|9725225|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
2834943|NCT02609399|9725224|P2|Influenza Season 2016-2017|Lost to Follow-up|5
2834944|NCT02609399|9725225|P1|Influenza Season 2016-2017|Lost to Follow-up|8
2834945|NCT02609399|9725224|P2|Influenza Season 2015-2016|Lost to Follow-up|2
2834946|NCT02609399|9725225|P1|Influenza Season 2015-2016|Lost to Follow-up|3
2834947|NCT02609178|9725255|P6|First Crown|Withdrawal by Subject|0
2834948|NCT02609178|9725256|P5|First Crown|Withdrawal by Subject|0
2834949|NCT02609178|9725257|P4|First Crown|Withdrawal by Subject|1
2834950|NCT02609178|9725258|P3|First Crown|Withdrawal by Subject|1
2834951|NCT02609178|9725259|P2|First Crown|Withdrawal by Subject|0
2834952|NCT02609178|9725260|P1|First Crown|Withdrawal by Subject|0
2834953|NCT02608892|9725322|P2|Overall Study|Lost to Follow-up|0
2834954|NCT02608892|9725323|P1|Overall Study|Lost to Follow-up|1
2834955|NCT02608684|9725332|P1|Overall Study|Withdrawal by Subject|1
2834956|NCT02608684|9725332|P1|Overall Study|Physician Decision|2
2834957|NCT02608099|9725409|P2|Overall Study|Ablation procedure not initiated|2
2834958|NCT02608099|9725410|P1|Overall Study|Ablation procedure not initiated|3
2834959|NCT02607956|9725448|P2|Overall Study|Lost to Follow-up|15
2834960|NCT02607956|9725449|P1|Overall Study|Lost to Follow-up|18
2834961|NCT02607956|9725448|P2|Overall Study|Withdrew Consent|16
2834962|NCT02607956|9725449|P1|Overall Study|Withdrew Consent|16
2834963|NCT02607956|9725448|P2|Overall Study|Protocol Violation|1
2834964|NCT02607956|9725449|P1|Overall Study|Protocol Violation|3
2834965|NCT02607956|9725448|P2|Overall Study|Non-Compliance with Study Drug|3
2834966|NCT02607956|9725449|P1|Overall Study|Non-Compliance with Study Drug|0
2834967|NCT02607956|9725448|P2|Overall Study|Investigator's Discretion|2
2834968|NCT02607956|9725449|P1|Overall Study|Investigator's Discretion|7
2834969|NCT02607956|9725448|P2|Overall Study|Death|4
2834970|NCT02607956|9725449|P1|Overall Study|Death|4
2834971|NCT02607956|9725448|P2|Overall Study|Adverse Event|3
2834972|NCT02607956|9725449|P1|Overall Study|Adverse Event|4
2834973|NCT02607956|9725448|P2|Overall Study|Still on Study|281
2834974|NCT02607956|9725449|P1|Overall Study|Still on Study|268
2834975|NCT02607956|9725448|P2|Overall Study|Randomized and Never Treated|5
2834976|NCT02607956|9725449|P1|Overall Study|Randomized and Never Treated|7
2834977|NCT02607930|9725479|P2|Overall Study|Lost to Follow-up|16
2834978|NCT02607930|9725480|P1|Overall Study|Lost to Follow-up|24
2834979|NCT02607930|9725479|P2|Overall Study|Withdrew Consent|15
2834980|NCT02607930|9725480|P1|Overall Study|Withdrew Consent|14
2834981|NCT02607930|9725479|P2|Overall Study|Protocol Violation|3
2834982|NCT02607930|9725480|P1|Overall Study|Protocol Violation|2
2834983|NCT02607930|9725479|P2|Overall Study|Non-Compliance with Study Drug|5
2834984|NCT02607930|9725480|P1|Overall Study|Non-Compliance with Study Drug|3
2834985|NCT02607930|9725479|P2|Overall Study|Investigator's Discretion|2
2834986|NCT02607930|9725480|P1|Overall Study|Investigator's Discretion|6
2834987|NCT02607930|9725479|P2|Overall Study|Death|1
2834988|NCT02607930|9725480|P1|Overall Study|Death|2
2834989|NCT02607930|9725479|P2|Overall Study|Adverse Event|4
2834990|NCT02607930|9725480|P1|Overall Study|Adverse Event|0
2834991|NCT02607930|9725479|P2|Overall Study|Still in Study|269
2834992|NCT02607930|9725480|P1|Overall Study|Still in Study|263
2834993|NCT02607930|9725479|P2|Overall Study|Randomized and Never Treated|0
2834994|NCT02607930|9725480|P1|Overall Study|Randomized and Never Treated|2
2834995|NCT02607865|9725524|P4|Overall Study|Unclassified|0
2834996|NCT02607865|9725525|P3|Overall Study|Unclassified|2
2834997|NCT02607865|9725526|P2|Overall Study|Unclassified|1
2834998|NCT02607865|9725527|P1|Overall Study|Unclassified|1
2834999|NCT02607865|9725524|P4|Overall Study|Death|3
2835000|NCT02607865|9725525|P3|Overall Study|Death|1
2835001|NCT02607865|9725526|P2|Overall Study|Death|4
2835002|NCT02607865|9725527|P1|Overall Study|Death|5
2835003|NCT02607865|9725524|P4|Overall Study|Withdrawal by Subject|8
2835004|NCT02607865|9725525|P3|Overall Study|Withdrawal by Subject|17
2835005|NCT02607865|9725526|P2|Overall Study|Withdrawal by Subject|18
2835006|NCT02607865|9725527|P1|Overall Study|Withdrawal by Subject|18
2835007|NCT02607865|9725524|P4|Overall Study|Lost to Follow-up|5
2835008|NCT02607865|9725525|P3|Overall Study|Lost to Follow-up|7
2835009|NCT02607865|9725526|P2|Overall Study|Lost to Follow-up|7
2835010|NCT02607865|9725527|P1|Overall Study|Lost to Follow-up|9
2835011|NCT02607800|9725701|P2|Overall Study|Randomized/Enrolled but Not Treated|1
2835012|NCT02607800|9725702|P1|Overall Study|Randomized/Enrolled but Not Treated|1
2835013|NCT02607800|9725701|P2|Overall Study|Withdrew Consent|0
2835014|NCT02607800|9725702|P1|Overall Study|Withdrew Consent|2
2835015|NCT02607800|9725701|P2|Overall Study|Lost to Follow-up|10
2835016|NCT02607800|9725702|P1|Overall Study|Lost to Follow-up|7
2835017|NCT02607735|9725720|P3|Deferred Treatment Substudy|Withdrew Consent|1
2835018|NCT02607735|9725721|P2|Deferred Treatment Substudy|Withdrew Consent|0
2835019|NCT02607735|9725722|P1|Deferred Treatment Substudy|Withdrew Consent|0
2835020|NCT02607735|9725720|P3|Deferred Treatment Substudy|Lost to Follow-up|4
2835021|NCT02607735|9725721|P2|Deferred Treatment Substudy|Lost to Follow-up|0
2835022|NCT02607735|9725722|P1|Deferred Treatment Substudy|Lost to Follow-up|0
2835023|NCT02607735|9725720|P3|Primary Study|Withdrew Consent|0
2835024|NCT02607735|9725721|P2|Primary Study|Withdrew Consent|0
2835025|NCT02607735|9725722|P1|Primary Study|Withdrew Consent|2
2835026|NCT02607735|9725720|P3|Primary Study|Lost to Follow-up|0
2835027|NCT02607735|9725721|P2|Primary Study|Lost to Follow-up|0
2835028|NCT02607735|9725722|P1|Primary Study|Lost to Follow-up|4
2835029|NCT02607735|9725720|P3|Primary Study|Randomized but Never Treated|0
2835030|NCT02607735|9725721|P2|Primary Study|Randomized but Never Treated|0
2835031|NCT02607735|9725722|P1|Primary Study|Randomized but Never Treated|1
2835032|NCT02607306|9725756|P3|Overall Study|Protocol Violation|1
2835033|NCT02607306|9725757|P2|Overall Study|Protocol Violation|2
2835034|NCT02607306|9725758|P1|Overall Study|Protocol Violation|4
2835035|NCT02607306|9725756|P3|Overall Study|Lack of Efficacy|1
2835036|NCT02607306|9725757|P2|Overall Study|Lack of Efficacy|1
2835037|NCT02607306|9725758|P1|Overall Study|Lack of Efficacy|0
2835038|NCT02607306|9725756|P3|Overall Study|Withdrawal by Subject|2
2835039|NCT02607306|9725757|P2|Overall Study|Withdrawal by Subject|10
2835040|NCT02607306|9725758|P1|Overall Study|Withdrawal by Subject|8
2835041|NCT02607306|9725756|P3|Overall Study|Unclassified|0
2835042|NCT02607306|9725757|P2|Overall Study|Unclassified|4
2835043|NCT02607306|9725758|P1|Overall Study|Unclassified|1
2835044|NCT02607306|9725756|P3|Overall Study|Adverse Event|6
2835045|NCT02607306|9725757|P2|Overall Study|Adverse Event|6
2835046|NCT02607306|9725758|P1|Overall Study|Adverse Event|8
2835047|NCT02606877|9725917|P2|Overall Study|Other than listed above|0
2835048|NCT02606877|9725918|P1|Overall Study|Other than listed above|1
2835049|NCT02606877|9725917|P2|Overall Study|Non-compliance with protocol|1
2835050|NCT02606877|9725918|P1|Overall Study|Non-compliance with protocol|0
2835051|NCT02606877|9725917|P2|Overall Study|Adverse Event|0
2835052|NCT02606877|9725918|P1|Overall Study|Adverse Event|3
2835053|NCT02606643|9725946|P2|Overall Study|did not meet inclusion criteria|3
2835054|NCT02606643|9725947|P1|Overall Study|did not meet inclusion criteria|1
2835055|NCT02606279|9726005|P2|Overall Study|Lost to Follow-up|1
2835056|NCT02606279|9726006|P1|Overall Study|Lost to Follow-up|0
2835057|NCT02606253|9726021|P3|Overall Study|Physician Decision|0
2835058|NCT02606253|9726022|P2|Overall Study|Physician Decision|1
2835059|NCT02606253|9726023|P1|Overall Study|Physician Decision|1
2835060|NCT02606253|9726021|P3|Overall Study|Protocol Violation|0
2835061|NCT02606253|9726022|P2|Overall Study|Protocol Violation|1
2835062|NCT02606253|9726023|P1|Overall Study|Protocol Violation|2
2835063|NCT02606253|9726021|P3|Overall Study|Adverse Event|0
2835064|NCT02606253|9726022|P2|Overall Study|Adverse Event|0
2835065|NCT02606253|9726023|P1|Overall Study|Adverse Event|2
2835066|NCT02605954|9726125|P2|Overall Study|Randomized but not treated|1
2835067|NCT02605954|9726126|P1|Overall Study|Randomized but not treated|0
2835068|NCT02605954|9726125|P2|Overall Study|Lost to Follow-up|0
2835069|NCT02605954|9726126|P1|Overall Study|Lost to Follow-up|3
2835070|NCT02605954|9726125|P2|Overall Study|Withdrew Consent|2
2835071|NCT02605954|9726126|P1|Overall Study|Withdrew Consent|2
2835072|NCT02605954|9726125|P2|Overall Study|Non-Compliance with Study Drug|0
2835073|NCT02605954|9726126|P1|Overall Study|Non-Compliance with Study Drug|1
2835074|NCT02605954|9726125|P2|Overall Study|Investigator's Discretion|0
2835075|NCT02605954|9726126|P1|Overall Study|Investigator's Discretion|1
2835076|NCT02605954|9726125|P2|Overall Study|Adverse Event|1
2835077|NCT02605954|9726126|P1|Overall Study|Adverse Event|5
2835078|NCT02605928|9726143|P1|Overall Study|Lack of Efficacy|5
2835079|NCT02605928|9726143|P1|Overall Study|Model tuning phase|28
2835080|NCT02605837|9726186|P2|Overall Study|Physician Decision|1
2835081|NCT02605837|9726187|P1|Overall Study|Physician Decision|0
2835082|NCT02605837|9726186|P2|Overall Study|Withdrawal by Subject|8
2835083|NCT02605837|9726187|P1|Overall Study|Withdrawal by Subject|8
2835084|NCT02605837|9726186|P2|Overall Study|Non-Compliance with Study Drug|1
2835085|NCT02605837|9726187|P1|Overall Study|Non-Compliance with Study Drug|0
2835086|NCT02605837|9726186|P2|Overall Study|Adverse Event|1
2835087|NCT02605837|9726187|P1|Overall Study|Adverse Event|3
2835088|NCT02605824|9726226|P2|Overall Study|Physician Decision|0
2835089|NCT02605824|9726227|P1|Overall Study|Physician Decision|1
2835090|NCT02605642|9726237|P2|Overall Study|Lack of response|11
2835091|NCT02605642|9726238|P1|Overall Study|Lack of response|24
2835092|NCT02605642|9726237|P2|Overall Study|Withdrawal by Subject|2
2835093|NCT02605642|9726238|P1|Overall Study|Withdrawal by Subject|23
2835094|NCT02605642|9726237|P2|Overall Study|Adverse Event|2
2835095|NCT02605642|9726238|P1|Overall Study|Adverse Event|14
2835096|NCT02605642|9726237|P2|Overall Study|Lost to Follow-up|1
2835097|NCT02605642|9726238|P1|Overall Study|Lost to Follow-up|12
2835098|NCT02605642|9726237|P2|Overall Study|Physician Decision|0
2835099|NCT02605642|9726238|P1|Overall Study|Physician Decision|10
2835100|NCT02605642|9726237|P2|Overall Study|Participant non-compliance|4
2835101|NCT02605642|9726238|P1|Overall Study|Participant non-compliance|2
2835102|NCT02605642|9726237|P2|Overall Study|Other|1
2835103|NCT02605642|9726238|P1|Overall Study|Other|11
2835104|NCT02605174|9726385|P7|Overall Study|Randomization Failure|30
2835105|NCT02605174|9726386|P6|Overall Study|Randomization Failure|11
2835106|NCT02605174|9726387|P5|Overall Study|Randomization Failure|16
2835107|NCT02605174|9726388|P4|Overall Study|Randomization Failure|7
2835108|NCT02605174|9726389|P3|Overall Study|Randomization Failure|20
2835109|NCT02605174|9726390|P2|Overall Study|Randomization Failure|6
2835110|NCT02605174|9726391|P1|Overall Study|Randomization Failure|22
2835111|NCT02605174|9726385|P7|Overall Study|Physician Decision|3
2835112|NCT02605174|9726386|P6|Overall Study|Physician Decision|0
2835113|NCT02605174|9726387|P5|Overall Study|Physician Decision|0
2835114|NCT02605174|9726388|P4|Overall Study|Physician Decision|0
2835115|NCT02605174|9726389|P3|Overall Study|Physician Decision|0
2835116|NCT02605174|9726390|P2|Overall Study|Physician Decision|0
2835117|NCT02605174|9726391|P1|Overall Study|Physician Decision|2
2835118|NCT02605174|9726385|P7|Overall Study|Withdrawal by Subject|15
2835119|NCT02605174|9726386|P6|Overall Study|Withdrawal by Subject|4
2835120|NCT02605174|9726387|P5|Overall Study|Withdrawal by Subject|6
2835121|NCT02605174|9726388|P4|Overall Study|Withdrawal by Subject|11
2835122|NCT02605174|9726389|P3|Overall Study|Withdrawal by Subject|14
2835123|NCT02605174|9726390|P2|Overall Study|Withdrawal by Subject|6
2835124|NCT02605174|9726391|P1|Overall Study|Withdrawal by Subject|9
2835125|NCT02605174|9726385|P7|Overall Study|Pregnancy|0
2835126|NCT02605174|9726386|P6|Overall Study|Pregnancy|0
2835127|NCT02605174|9726387|P5|Overall Study|Pregnancy|0
2835128|NCT02605174|9726388|P4|Overall Study|Pregnancy|2
2835129|NCT02605174|9726389|P3|Overall Study|Pregnancy|0
2835130|NCT02605174|9726390|P2|Overall Study|Pregnancy|0
2835131|NCT02605174|9726391|P1|Overall Study|Pregnancy|1
2835132|NCT02605174|9726385|P7|Overall Study|Protocol Violation|12
2835133|NCT02605174|9726386|P6|Overall Study|Protocol Violation|7
2835134|NCT02605174|9726387|P5|Overall Study|Protocol Violation|7
2835135|NCT02605174|9726388|P4|Overall Study|Protocol Violation|6
2835136|NCT02605174|9726389|P3|Overall Study|Protocol Violation|14
2835137|NCT02605174|9726390|P2|Overall Study|Protocol Violation|4
2835138|NCT02605174|9726391|P1|Overall Study|Protocol Violation|10
2835139|NCT02605174|9726385|P7|Overall Study|Lost to Follow-up|29
2835140|NCT02605174|9726386|P6|Overall Study|Lost to Follow-up|10
2835141|NCT02605174|9726387|P5|Overall Study|Lost to Follow-up|20
2835142|NCT02605174|9726388|P4|Overall Study|Lost to Follow-up|10
2835143|NCT02605174|9726389|P3|Overall Study|Lost to Follow-up|27
2835144|NCT02605174|9726390|P2|Overall Study|Lost to Follow-up|7
2835145|NCT02605174|9726391|P1|Overall Study|Lost to Follow-up|20
2835146|NCT02605174|9726385|P7|Overall Study|Adverse Event|0
2835147|NCT02605174|9726386|P6|Overall Study|Adverse Event|0
2835148|NCT02605174|9726387|P5|Overall Study|Adverse Event|4
2835149|NCT02605174|9726388|P4|Overall Study|Adverse Event|0
2835150|NCT02605174|9726389|P3|Overall Study|Adverse Event|1
2835151|NCT02605174|9726390|P2|Overall Study|Adverse Event|0
2835152|NCT02605174|9726391|P1|Overall Study|Adverse Event|0
2835153|NCT02605122|9726453|P2|Overall Study|Lost to Follow-up|1
2835154|NCT02605122|9726454|P1|Overall Study|Lost to Follow-up|1
2835155|NCT02605122|9726453|P2|Overall Study|Withdrawal by Subject|1
2835156|NCT02605122|9726454|P1|Overall Study|Withdrawal by Subject|4
2835157|NCT02604589|9726477|P3|Overall Study|catheter dislodgement|1
2835158|NCT02604589|9726478|P2|Overall Study|catheter dislodgement|0
2835159|NCT02604589|9726479|P1|Overall Study|catheter dislodgement|0
2835160|NCT02604550|9726507|P2|Overall Study|Incomplete data using paper journal|19
2835161|NCT02604550|9726508|P1|Overall Study|Incomplete data using paper journal|18
2835162|NCT02604550|9726507|P2|Overall Study|Withdrawal by Subject|1
2835163|NCT02604550|9726508|P1|Overall Study|Withdrawal by Subject|0
2835164|NCT02604550|9726507|P2|Overall Study|Lost to Follow-up|6
2835165|NCT02604550|9726508|P1|Overall Study|Lost to Follow-up|7
2835166|NCT02604433|9726534|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
2835167|NCT02604433|9726535|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
2835168|NCT02604433|9726534|P2|Double-blind Treatment Period|Study is ongoing|74
2835169|NCT02604433|9726535|P1|Double-blind Treatment Period|Study is ongoing|156
2835170|NCT02604433|9726534|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
2835171|NCT02604433|9726535|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
2835172|NCT02604433|9726534|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
2835173|NCT02604433|9726535|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
2835174|NCT02604433|9726534|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
2835175|NCT02604433|9726535|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
2835176|NCT02604433|9726534|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
2835177|NCT02604433|9726535|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
2835178|NCT02604433|9726534|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
2835179|NCT02604433|9726535|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
2835180|NCT02604433|9726534|P2|Double-blind Treatment Period|Death|1
2835181|NCT02604433|9726535|P1|Double-blind Treatment Period|Death|1
2835182|NCT02604433|9726534|P2|Double-blind Treatment Period|Personal reasons or moved|1
2835183|NCT02604433|9726535|P1|Double-blind Treatment Period|Personal reasons or moved|2
2835184|NCT02604433|9726534|P2|Double-blind Treatment Period|Adverse Event|0
2835185|NCT02604433|9726535|P1|Double-blind Treatment Period|Adverse Event|4
2835186|NCT02604433|9726534|P2|Double-blind Treatment Period|Withdrawal by Subject|6
2835187|NCT02604433|9726535|P1|Double-blind Treatment Period|Withdrawal by Subject|13
2835188|NCT02604407|9726604|P3|Overall Study|Other|4
2835189|NCT02604407|9726605|P2|Overall Study|Other|1
2835190|NCT02604407|9726606|P1|Overall Study|Other|3
2835191|NCT02604407|9726604|P3|Overall Study|Lack of Efficacy|0
2835192|NCT02604407|9726605|P2|Overall Study|Lack of Efficacy|0
2835193|NCT02604407|9726606|P1|Overall Study|Lack of Efficacy|1
2835194|NCT02604407|9726604|P3|Overall Study|Lost to Follow-up|2
2835195|NCT02604407|9726605|P2|Overall Study|Lost to Follow-up|1
2835196|NCT02604407|9726606|P1|Overall Study|Lost to Follow-up|2
2835197|NCT02604407|9726604|P3|Overall Study|Withdrawal by Subject|5
2835198|NCT02604407|9726605|P2|Overall Study|Withdrawal by Subject|3
2835199|NCT02604407|9726606|P1|Overall Study|Withdrawal by Subject|3
2835200|NCT02604407|9726604|P3|Overall Study|Protocol Violation|0
2835201|NCT02604407|9726605|P2|Overall Study|Protocol Violation|0
2835202|NCT02604407|9726606|P1|Overall Study|Protocol Violation|2
2835203|NCT02604407|9726604|P3|Overall Study|Adverse Event|5
2835204|NCT02604407|9726605|P2|Overall Study|Adverse Event|7
2835205|NCT02604407|9726606|P1|Overall Study|Adverse Event|0
2835206|NCT02604342|9726619|P2|Overall Study|Physician Decision|0
2835207|NCT02604342|9726620|P1|Overall Study|Physician Decision|2
2835208|NCT02604342|9726619|P2|Overall Study|Lost to Follow-up|1
2835209|NCT02604342|9726620|P1|Overall Study|Lost to Follow-up|1
2835210|NCT02604342|9726619|P2|Overall Study|Study Termination by Sponsor|0
2835211|NCT02604342|9726620|P1|Overall Study|Study Termination by Sponsor|1
2835212|NCT02604342|9726619|P2|Overall Study|Other|0
2835213|NCT02604342|9726620|P1|Overall Study|Other|1
2835214|NCT02604342|9726619|P2|Overall Study|Withdrawal by Subject|6
2835215|NCT02604342|9726620|P1|Overall Study|Withdrawal by Subject|5
2835216|NCT02604342|9726619|P2|Overall Study|Progression of disease|0
2835217|NCT02604342|9726620|P1|Overall Study|Progression of disease|1
2835218|NCT02604342|9726619|P2|Overall Study|Death|16
2835219|NCT02604342|9726620|P1|Overall Study|Death|32
2835220|NCT02604264|9726672|P2|Intervention|Didn't use CVC for at least 21 days|242
2835221|NCT02604264|9726673|P1|Intervention|Didn't use CVC for at least 21 days|200
2835222|NCT02604212|9726683|P4|Overall Study|Withdrawal by Subject|0
2835223|NCT02604212|9726684|P3|Overall Study|Withdrawal by Subject|1
2835224|NCT02604212|9726685|P2|Overall Study|Withdrawal by Subject|0
2835225|NCT02604212|9726686|P1|Overall Study|Withdrawal by Subject|0
2835226|NCT02604212|9726683|P4|Overall Study|Study Terminated by Sponsor|3
2835227|NCT02604212|9726684|P3|Overall Study|Study Terminated by Sponsor|3
2835228|NCT02604212|9726685|P2|Overall Study|Study Terminated by Sponsor|1
2835229|NCT02604212|9726686|P1|Overall Study|Study Terminated by Sponsor|2
2835230|NCT02604199|9726754|P4|Overall Study|Withdrawal by Subject|0
2835231|NCT02604199|9726755|P3|Overall Study|Withdrawal by Subject|0
2835232|NCT02604199|9726756|P2|Overall Study|Withdrawal by Subject|1
2835233|NCT02604199|9726757|P1|Overall Study|Withdrawal by Subject|0
2835234|NCT02604199|9726754|P4|Overall Study|Study terminated by sponsor|2
2835235|NCT02604199|9726755|P3|Overall Study|Study terminated by sponsor|0
2835236|NCT02604199|9726756|P2|Overall Study|Study terminated by sponsor|2
2835237|NCT02604199|9726757|P1|Overall Study|Study terminated by sponsor|0
2835238|NCT02604199|9726754|P4|Overall Study|Pregnancy|1
2835239|NCT02604199|9726755|P3|Overall Study|Pregnancy|0
2835240|NCT02604199|9726756|P2|Overall Study|Pregnancy|0
2835241|NCT02604199|9726757|P1|Overall Study|Pregnancy|0
2835242|NCT02604160|9726826|P2|Overall Study|Physician Decision|1
2835243|NCT02604160|9726827|P1|Overall Study|Physician Decision|0
2835244|NCT02604160|9726826|P2|Overall Study|Protocol Violation|1
2835245|NCT02604160|9726827|P1|Overall Study|Protocol Violation|0
2835246|NCT02604017|9726841|P2|Overall Study|Other|0
2835247|NCT02604017|9726842|P1|Overall Study|Other|1
2835248|NCT02604017|9726841|P2|Overall Study|Lost to Follow-up|6
2835249|NCT02604017|9726842|P1|Overall Study|Lost to Follow-up|5
2835250|NCT02604017|9726841|P2|Overall Study|Withdrew Consent|2
2835251|NCT02604017|9726842|P1|Overall Study|Withdrew Consent|0
2835252|NCT02603952|9726871|P4|Overall Study|Received oseltamivir by error|1
2835253|NCT02603952|9726872|P3|Overall Study|Received oseltamivir by error|0
2835254|NCT02603952|9726873|P2|Overall Study|Received oseltamivir by error|0
2835255|NCT02603952|9726874|P1|Overall Study|Received oseltamivir by error|0
2835256|NCT02603952|9726871|P4|Overall Study|Withdrawal by Subject|0
2835257|NCT02603952|9726872|P3|Overall Study|Withdrawal by Subject|0
2835258|NCT02603952|9726873|P2|Overall Study|Withdrawal by Subject|0
2835259|NCT02603952|9726874|P1|Overall Study|Withdrawal by Subject|1
2835260|NCT02603887|9726922|P1|Overall Study|Disease progression|1
2835261|NCT02603887|9726922|P1|Overall Study|Adverse Event|4
2835262|NCT02603887|9726922|P1|Overall Study|FDA Guidance|1
2835263|NCT02603809|9726935|P6|Overall Study|Lack of Efficacy|1
2835264|NCT02603809|9726936|P5|Overall Study|Lack of Efficacy|0
2835265|NCT02603809|9726937|P4|Overall Study|Lack of Efficacy|0
2835266|NCT02603809|9726938|P3|Overall Study|Lack of Efficacy|0
2835267|NCT02603809|9726939|P2|Overall Study|Lack of Efficacy|1
2835268|NCT02603809|9726940|P1|Overall Study|Lack of Efficacy|0
2835269|NCT02603809|9726935|P6|Overall Study|Adverse Event|1
2835270|NCT02603809|9726936|P5|Overall Study|Adverse Event|1
2835271|NCT02603809|9726937|P4|Overall Study|Adverse Event|2
2835272|NCT02603809|9726938|P3|Overall Study|Adverse Event|2
2835273|NCT02603809|9726939|P2|Overall Study|Adverse Event|0
2835274|NCT02603809|9726940|P1|Overall Study|Adverse Event|3
2835275|NCT02603809|9726935|P6|Overall Study|Physician Decision|1
2835276|NCT02603809|9726936|P5|Overall Study|Physician Decision|2
2835277|NCT02603809|9726937|P4|Overall Study|Physician Decision|1
2835278|NCT02603809|9726938|P3|Overall Study|Physician Decision|0
2835279|NCT02603809|9726939|P2|Overall Study|Physician Decision|0
2835280|NCT02603809|9726940|P1|Overall Study|Physician Decision|0
2835281|NCT02603809|9726935|P6|Overall Study|Pre-specified discontinuation criteria|1
2835282|NCT02603809|9726936|P5|Overall Study|Pre-specified discontinuation criteria|3
2835283|NCT02603809|9726937|P4|Overall Study|Pre-specified discontinuation criteria|2
2835284|NCT02603809|9726938|P3|Overall Study|Pre-specified discontinuation criteria|2
2835285|NCT02603809|9726939|P2|Overall Study|Pre-specified discontinuation criteria|3
2835286|NCT02603809|9726940|P1|Overall Study|Pre-specified discontinuation criteria|3
2835287|NCT02603809|9726935|P6|Overall Study|Lost to Follow-up|2
2835288|NCT02603809|9726936|P5|Overall Study|Lost to Follow-up|2
2835289|NCT02603809|9726937|P4|Overall Study|Lost to Follow-up|4
2835290|NCT02603809|9726938|P3|Overall Study|Lost to Follow-up|1
2835291|NCT02603809|9726939|P2|Overall Study|Lost to Follow-up|3
2835292|NCT02603809|9726940|P1|Overall Study|Lost to Follow-up|2
2835293|NCT02603809|9726935|P6|Overall Study|Withdrawal by Subject|4
2835294|NCT02603809|9726936|P5|Overall Study|Withdrawal by Subject|3
2835295|NCT02603809|9726937|P4|Overall Study|Withdrawal by Subject|3
2835296|NCT02603809|9726938|P3|Overall Study|Withdrawal by Subject|2
2835297|NCT02603809|9726939|P2|Overall Study|Withdrawal by Subject|1
2835298|NCT02603809|9726940|P1|Overall Study|Withdrawal by Subject|4
2835299|NCT02603419|9727006|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
2835300|NCT02603419|9727007|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2835301|NCT02603419|9727008|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2835302|NCT02603419|9727009|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2835303|NCT02603419|9727010|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2835304|NCT02603419|9727011|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2835305|NCT02603419|9727006|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
2835306|NCT02603419|9727007|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2835307|NCT02603419|9727008|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2835308|NCT02603419|9727009|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2835309|NCT02603419|9727010|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2835310|NCT02603419|9727011|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2835311|NCT02603419|9727006|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
2835312|NCT02603419|9727007|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2835313|NCT02603419|9727008|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2835314|NCT02603419|9727009|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2835315|NCT02603419|9727010|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2835316|NCT02603419|9727011|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2835317|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2835318|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2835319|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
2835320|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2835321|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2835322|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2835323|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2835324|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2835325|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2835326|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2835327|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2835328|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
2835329|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2835330|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2835331|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2835332|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2835333|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
2835334|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2835335|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2835336|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
2835337|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2835338|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2835339|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2835340|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2835341|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2835342|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
2835343|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2835344|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
2835345|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2835346|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
2835347|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
2835348|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
2835349|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2835350|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2835351|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2835352|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2835353|NCT02603419|9727006|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2835354|NCT02603419|9727007|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2835355|NCT02603419|9727008|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2835356|NCT02603419|9727009|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2835357|NCT02603419|9727010|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
2835358|NCT02603419|9727011|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2835359|NCT02603393|9727198|P2|Overall Study|Sponsor decision|0
2835360|NCT02603393|9727199|P1|Overall Study|Sponsor decision|1
2835361|NCT02603393|9727198|P2|Overall Study|Non-compliance with study treatment|0
2835362|NCT02603393|9727199|P1|Overall Study|Non-compliance with study treatment|1
2835363|NCT02603393|9727198|P2|Overall Study|Lost to Follow-up|2
2835364|NCT02603393|9727199|P1|Overall Study|Lost to Follow-up|1
2835365|NCT02603393|9727198|P2|Overall Study|Protocol deviation|3
2835366|NCT02603393|9727199|P1|Overall Study|Protocol deviation|2
2835367|NCT02603393|9727198|P2|Overall Study|Physician Decision|3
2835368|NCT02603393|9727199|P1|Overall Study|Physician Decision|3
2835369|NCT02603393|9727198|P2|Overall Study|Death|4
2835370|NCT02603393|9727199|P1|Overall Study|Death|3
2835371|NCT02603393|9727198|P2|Overall Study|Lack of Efficacy|2
2835372|NCT02603393|9727199|P1|Overall Study|Lack of Efficacy|7
2835373|NCT02603393|9727198|P2|Overall Study|Technical problems|7
2835374|NCT02603393|9727199|P1|Overall Study|Technical problems|4
2835375|NCT02603393|9727198|P2|Overall Study|Adverse Event|15
2835376|NCT02603393|9727199|P1|Overall Study|Adverse Event|17
2835377|NCT02603393|9727198|P2|Overall Study|Patient/guardian decision|18
2835378|NCT02603393|9727199|P1|Overall Study|Patient/guardian decision|32
2835379|NCT02603172|9727238|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
2835380|NCT02603172|9727239|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
2835381|NCT02603172|9727240|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
2835382|NCT02603172|9727241|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
2835383|NCT02603172|9727242|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
2835384|NCT02603172|9727243|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
2835385|NCT02603172|9727244|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
2835386|NCT02603172|9727245|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
2835387|NCT02603120|9727373|P2|Overall Study|Lost to Follow-up|2
2835388|NCT02603120|9727374|P1|Overall Study|Lost to Follow-up|2
2835389|NCT02603120|9727373|P2|Overall Study|Withdrew Consent|7
2835390|NCT02603120|9727374|P1|Overall Study|Withdrew Consent|3
2835391|NCT02603120|9727373|P2|Overall Study|Pregnancy|1
2835392|NCT02603120|9727374|P1|Overall Study|Pregnancy|0
2835393|NCT02603120|9727373|P2|Overall Study|Death|0
2835394|NCT02603120|9727374|P1|Overall Study|Death|2
2835395|NCT02603120|9727373|P2|Overall Study|Adverse Event|2
2835396|NCT02603120|9727374|P1|Overall Study|Adverse Event|3
2835397|NCT02603120|9727373|P2|Overall Study|Still in Study|269
2835398|NCT02603120|9727374|P1|Overall Study|Still in Study|272
2835399|NCT02603120|9727373|P2|Overall Study|Randomized but Never Treated|2
2835400|NCT02603120|9727374|P1|Overall Study|Randomized but Never Treated|2
2835401|NCT02603107|9727394|P2|Optional Extension Phase|Still in Study|213
2835402|NCT02603107|9727395|P1|Optional Extension Phase|Still in Study|241
2835403|NCT02603107|9727394|P2|Randomized Phase|Lost to Follow-up|3
2835404|NCT02603107|9727395|P1|Randomized Phase|Lost to Follow-up|0
2835405|NCT02603107|9727394|P2|Randomized Phase|Withdrew Consent|14
2835406|NCT02603107|9727395|P1|Randomized Phase|Withdrew Consent|8
2835407|NCT02603107|9727394|P2|Randomized Phase|Protocol Violation|0
2835408|NCT02603107|9727395|P1|Randomized Phase|Protocol Violation|1
2835409|NCT02603107|9727394|P2|Randomized Phase|Non-Compliance with Study Drug|1
2835410|NCT02603107|9727395|P1|Randomized Phase|Non-Compliance with Study Drug|1
2835411|NCT02603107|9727394|P2|Randomized Phase|Investigator's Discretion|1
2835412|NCT02603107|9727395|P1|Randomized Phase|Investigator's Discretion|0
2835413|NCT02603107|9727394|P2|Randomized Phase|Death|1
2835414|NCT02603107|9727395|P1|Randomized Phase|Death|1
2835415|NCT02603107|9727394|P2|Randomized Phase|Adverse Event|0
2835416|NCT02603107|9727395|P1|Randomized Phase|Adverse Event|2
2835417|NCT02603107|9727394|P2|Randomized Phase|Still in Study|27
2835418|NCT02603107|9727395|P1|Randomized Phase|Still in Study|32
2835419|NCT02603107|9727394|P2|Randomized Phase|Randomized and Never Treated|1
2835420|NCT02603107|9727395|P1|Randomized Phase|Randomized and Never Treated|0
2835421|NCT02602080|9727458|P3|Overall Study|Protocol Violation|3
2835422|NCT02602080|9727459|P2|Overall Study|Protocol Violation|1
2835423|NCT02602080|9727460|P1|Overall Study|Protocol Violation|6
2835424|NCT02601820|9727503|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
2835425|NCT02601820|9727503|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
2835426|NCT02601820|9727503|P1|Late On-Treatment (T3)|missing T3 Record|49
2835427|NCT02601820|9727503|P1|Early On-Treatment (T2)|Missing T2 Record|51
2835428|NCT02601625|9727532|P4|Overall Study|Lost to Follow-up|1
2835429|NCT02601625|9727533|P3|Overall Study|Lost to Follow-up|1
2835430|NCT02601625|9727534|P2|Overall Study|Lost to Follow-up|0
2835431|NCT02601625|9727535|P1|Overall Study|Lost to Follow-up|0
2835432|NCT02601573|9727588|P5|Overall Study|Withdrawal by Subject|0
2835433|NCT02601573|9727589|P4|Overall Study|Withdrawal by Subject|1
2835434|NCT02601573|9727590|P3|Overall Study|Withdrawal by Subject|0
2835435|NCT02601573|9727591|P2|Overall Study|Withdrawal by Subject|1
2835436|NCT02601573|9727592|P1|Overall Study|Withdrawal by Subject|0
2835437|NCT02601573|9727588|P5|Overall Study|Lost to Follow-up|2
2835438|NCT02601573|9727589|P4|Overall Study|Lost to Follow-up|0
2835439|NCT02601573|9727590|P3|Overall Study|Lost to Follow-up|1
2835440|NCT02601573|9727591|P2|Overall Study|Lost to Follow-up|3
2835441|NCT02601573|9727592|P1|Overall Study|Lost to Follow-up|0
2835442|NCT02601560|9727627|P8|Overall Study|Other|0
2835443|NCT02601560|9727628|P7|Overall Study|Other|1
2835444|NCT02601560|9727629|P6|Overall Study|Other|0
2835445|NCT02601560|9727630|P5|Overall Study|Other|0
2835446|NCT02601560|9727631|P4|Overall Study|Other|0
2835447|NCT02601560|9727632|P3|Overall Study|Other|0
2835448|NCT02601560|9727633|P2|Overall Study|Other|0
2835449|NCT02601560|9727634|P1|Overall Study|Other|0
2835450|NCT02601469|9727818|P2|Overall Study|Enrolled in Error|0
2835451|NCT02601469|9727819|P1|Overall Study|Enrolled in Error|1
2835452|NCT02601300|9727825|P1|Extension Phase|Lack of Efficacy|10
2835453|NCT02601300|9727825|P1|Extension Phase|Adverse Event|4
2835454|NCT02601300|9727825|P1|Extension Phase|Withdrawal by Subject|3
2835455|NCT02601300|9727825|P1|Induction Phase|Protocol Violation|1
2835456|NCT02601300|9727825|P1|Induction Phase|Lack of Efficacy|2
2835457|NCT02601209|9727845|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835458|NCT02601209|9727846|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835459|NCT02601209|9727847|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
2835460|NCT02601209|9727848|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
2835461|NCT02601209|9727849|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
2835462|NCT02601209|9727850|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835463|NCT02601209|9727851|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835464|NCT02601209|9727852|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835465|NCT02601209|9727853|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2835466|NCT02601209|9727845|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835467|NCT02601209|9727846|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835468|NCT02601209|9727847|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835469|NCT02601209|9727848|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835470|NCT02601209|9727849|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835471|NCT02601209|9727850|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2835472|NCT02601209|9727851|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2835473|NCT02601209|9727852|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2835474|NCT02601209|9727853|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2835475|NCT02600923|9727879|P1|Overall Study|Not treated|1
2835476|NCT02600923|9727879|P1|Overall Study|Study terminated by Sponsor|53
2835477|NCT02600923|9727879|P1|Overall Study|Objective progression or relapse|50
2835478|NCT02600923|9727879|P1|Overall Study|Withdrawal by Subject|5
2835479|NCT02600923|9727879|P1|Overall Study|Lost to Follow-up|1
2835480|NCT02600923|9727879|P1|Overall Study|Insufficient clinical response|6
2835481|NCT02600923|9727879|P1|Overall Study|Global deterioration of health status|2
2835482|NCT02600923|9727879|P1|Overall Study|Adverse Event|3
2835483|NCT02600923|9727879|P1|Overall Study|Death|10
2835484|NCT02600871|9727889|P2|Overall Study|Lost to Follow-up|10
2835485|NCT02600871|9727890|P1|Overall Study|Lost to Follow-up|13
2835486|NCT02600845|9727900|P1|Overall Study|Consent Withdrawal|5
2835487|NCT02600845|9727900|P1|Overall Study|Non-compliance with Study Procedures|10
2835488|NCT02600845|9727900|P1|Overall Study|Reason Not Specified|3
2835489|NCT02600819|9727915|P2|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|7
2835490|NCT02600819|9727916|P1|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|0
2835491|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|0
2835492|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|3
2835493|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Lost to Follow-up|0
2835494|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Lost to Follow-up|2
2835495|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Withdrew Consent|0
2835496|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Withdrew Consent|5
2835497|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|0
2835498|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|1
2835499|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Investigator's Discretion|0
2835500|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Investigator's Discretion|4
2835501|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Death|0
2835502|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Death|2
2835503|NCT02600819|9727915|P2|Main Study (E/C/F/TAF)|Adverse Event|0
2835504|NCT02600819|9727916|P1|Main Study (E/C/F/TAF)|Adverse Event|2
2835505|NCT02600351|9728020|P4|Overall Study|Randomized but Not Treated|3
2835506|NCT02600351|9728021|P3|Overall Study|Randomized but Not Treated|1
2835507|NCT02600351|9728022|P2|Overall Study|Randomized but Not Treated|0
2835508|NCT02600351|9728023|P1|Overall Study|Randomized but Not Treated|1
2835509|NCT02600351|9728020|P4|Overall Study|Lost to Follow-up|0
2835510|NCT02600351|9728021|P3|Overall Study|Lost to Follow-up|0
2835511|NCT02600351|9728022|P2|Overall Study|Lost to Follow-up|0
2835512|NCT02600351|9728023|P1|Overall Study|Lost to Follow-up|1
2835513|NCT02600351|9728020|P4|Overall Study|Lack of Efficacy|2
2835514|NCT02600351|9728021|P3|Overall Study|Lack of Efficacy|5
2835515|NCT02600351|9728022|P2|Overall Study|Lack of Efficacy|0
2835516|NCT02600351|9728023|P1|Overall Study|Lack of Efficacy|3
2835517|NCT02599961|9728058|P1|Overall Study|Other, Not Specified|3
2835518|NCT02599961|9728058|P1|Overall Study|Discontinuation of Study by Sponsor|9
2835519|NCT02599961|9728058|P1|Overall Study|Subject Non-Compliance|2
2835520|NCT02599961|9728058|P1|Overall Study|Withdrawal by Subject|1
2835521|NCT02599129|9728132|P2|Overall Study|Withdrawal by Subject|1
2835522|NCT02599129|9728133|P1|Overall Study|Withdrawal by Subject|2
2835523|NCT02599129|9728132|P2|Overall Study|Lost to Follow-up|0
2835524|NCT02599129|9728133|P1|Overall Study|Lost to Follow-up|1
2835525|NCT02599129|9728132|P2|Overall Study|Lack of Efficacy|2
2835526|NCT02599129|9728133|P1|Overall Study|Lack of Efficacy|2
2835527|NCT02598934|9728149|P2|Overall Study|Protocol Violation|2
2835528|NCT02598934|9728150|P1|Overall Study|Protocol Violation|1
2835529|NCT02598934|9728149|P2|Overall Study|Administrative|1
2835530|NCT02598934|9728150|P1|Overall Study|Administrative|2
2835531|NCT02598934|9728149|P2|Overall Study|Withdrawal by Subject|3
2835532|NCT02598934|9728150|P1|Overall Study|Withdrawal by Subject|2
2835533|NCT02598934|9728149|P2|Overall Study|Failure to Return|3
2835534|NCT02598934|9728150|P1|Overall Study|Failure to Return|3
2835535|NCT02598934|9728149|P2|Overall Study|Adverse Event|13
2835536|NCT02598934|9728150|P1|Overall Study|Adverse Event|11
2835537|NCT02598622|9728162|P2|Overall Study|Physician Decision|0
2835538|NCT02598622|9728163|P1|Overall Study|Physician Decision|3
2835539|NCT02598622|9728162|P2|Overall Study|Withdrawal by Subject|0
2835540|NCT02598622|9728163|P1|Overall Study|Withdrawal by Subject|3
2835541|NCT02598297|9728192|P2|Overall Study|Followed for survival|0
2835542|NCT02598297|9728193|P1|Overall Study|Followed for survival|1
2835543|NCT02598297|9728192|P2|Overall Study|Subject/guardian decision|0
2835544|NCT02598297|9728193|P1|Overall Study|Subject/guardian decision|1
2835545|NCT02598297|9728192|P2|Overall Study|Physician Decision|0
2835546|NCT02598297|9728193|P1|Overall Study|Physician Decision|1
2835547|NCT02598297|9728192|P2|Overall Study|Adverse Event|1
2835548|NCT02598297|9728193|P1|Overall Study|Adverse Event|1
2835549|NCT02598297|9728192|P2|Overall Study|Study terminated by Sponsor|23
2835550|NCT02598297|9728193|P1|Overall Study|Study terminated by Sponsor|21
2835551|NCT02598193|9728219|P1|Overall Study|Does not want to take Nintedanib|1
2835552|NCT02598193|9728219|P1|Overall Study|Listed in active lung transplant list|1
2835553|NCT02598193|9728219|P1|Overall Study|Withdrawal by Subject|1
2835554|NCT02598193|9728219|P1|Overall Study|Adverse Event|13
2835555|NCT02598128|9728227|P4|Period A: Days -7 to -1|Adverse Event|0
2835556|NCT02598128|9728228|P3|Period A: Days -7 to -1|Adverse Event|0
2835557|NCT02598128|9728229|P2|Period A: Days -7 to -1|Adverse Event|0
2835558|NCT02598128|9728230|P1|Period A: Days -7 to -1|Adverse Event|1
2835559|NCT02598076|9728273|P2|Overall Study|Lost to Follow-up|3
2835560|NCT02598076|9728274|P1|Overall Study|Lost to Follow-up|2
2835561|NCT02597946|9728288|P1|Overall Study|Other than above|1
2835562|NCT02597946|9728288|P1|Overall Study|Progressive disease|16
2835563|NCT02597946|9728288|P1|Overall Study|Withdrawal by Subject|1
2835564|NCT02597933|9728299|P2|Overall Study|Other than stated above|14
2835565|NCT02597933|9728300|P1|Overall Study|Other than stated above|7
2835566|NCT02597933|9728299|P2|Overall Study|Not treated|2
2835567|NCT02597933|9728300|P1|Overall Study|Not treated|2
2835568|NCT02597933|9728299|P2|Overall Study|Adverse Event|28
2835569|NCT02597933|9728300|P1|Overall Study|Adverse Event|20
2835570|NCT02597933|9728299|P2|Overall Study|Protocol Violation|2
2835571|NCT02597933|9728300|P1|Overall Study|Protocol Violation|2
2835572|NCT02597933|9728299|P2|Overall Study|Withdrawal by Subject|5
2835573|NCT02597933|9728300|P1|Overall Study|Withdrawal by Subject|7
2835574|NCT02597920|9728331|P3|Overall Study|Other|0
2835575|NCT02597920|9728332|P2|Overall Study|Other|0
2835576|NCT02597920|9728333|P1|Overall Study|Other|1
2835577|NCT02597920|9728331|P3|Overall Study|Other than specified|5
2835578|NCT02597920|9728332|P2|Overall Study|Other than specified|31
2835579|NCT02597920|9728333|P1|Overall Study|Other than specified|10
2835580|NCT02597920|9728331|P3|Overall Study|Refuse to continue in the study|1
2835581|NCT02597920|9728332|P2|Overall Study|Refuse to continue in the study|13
2835582|NCT02597920|9728333|P1|Overall Study|Refuse to continue in the study|3
2835583|NCT02597920|9728331|P3|Overall Study|Lost to Follow-up|0
2835584|NCT02597920|9728332|P2|Overall Study|Lost to Follow-up|9
2835585|NCT02597920|9728333|P1|Overall Study|Lost to Follow-up|7
2835586|NCT02597920|9728331|P3|Overall Study|Other adverse event|0
2835587|NCT02597920|9728332|P2|Overall Study|Other adverse event|30
2835588|NCT02597920|9728333|P1|Overall Study|Other adverse event|20
2835589|NCT02597920|9728331|P3|Overall Study|Worsening of other pre-existing disease|0
2835590|NCT02597920|9728332|P2|Overall Study|Worsening of other pre-existing disease|1
2835591|NCT02597920|9728333|P1|Overall Study|Worsening of other pre-existing disease|0
2835592|NCT02597855|9728367|P2|Overall Study|Lost to Follow-up|1
2835593|NCT02597855|9728368|P1|Overall Study|Lost to Follow-up|2
2835594|NCT02597452|9728414|P1|Overall Study|testing incomplete|30
2835595|NCT02597062|9728526|P1|Overall Study|Ineligible|1
2835596|NCT02597049|9728535|P3|Overall Study|Noncompliant with Study Visits|0
2835597|NCT02597049|9728536|P2|Overall Study|Noncompliant with Study Visits|0
2835598|NCT02597049|9728537|P1|Overall Study|Noncompliant with Study Visits|1
2835599|NCT02597049|9728535|P3|Overall Study|Death|0
2835600|NCT02597049|9728536|P2|Overall Study|Death|0
2835601|NCT02597049|9728537|P1|Overall Study|Death|2
2835602|NCT02597049|9728535|P3|Overall Study|Adverse Event|0
2835603|NCT02597049|9728536|P2|Overall Study|Adverse Event|0
2835604|NCT02597049|9728537|P1|Overall Study|Adverse Event|2
2835605|NCT02597049|9728535|P3|Overall Study|Withdrawal by Subject|1
2835606|NCT02597049|9728536|P2|Overall Study|Withdrawal by Subject|2
2835607|NCT02597049|9728537|P1|Overall Study|Withdrawal by Subject|2
2835608|NCT02597049|9728535|P3|Overall Study|Lost to Follow-up|2
2835609|NCT02597049|9728536|P2|Overall Study|Lost to Follow-up|3
2835610|NCT02597049|9728537|P1|Overall Study|Lost to Follow-up|0
2835611|NCT02596971|9728578|P3|Overall Study|Death|0
2835612|NCT02596971|9728579|P2|Overall Study|Death|0
2835613|NCT02596971|9728580|P1|Overall Study|Death|2
2835614|NCT02596971|9728578|P3|Overall Study|In Follow-up|15
2835615|NCT02596971|9728579|P2|Overall Study|In Follow-up|0
2835616|NCT02596971|9728580|P1|Overall Study|In Follow-up|4
2835617|NCT02596971|9728578|P3|Overall Study|Ongoing|24
2835618|NCT02596971|9728579|P2|Overall Study|Ongoing|6
2835619|NCT02596971|9728580|P1|Overall Study|Ongoing|36
2835620|NCT02596971|9728578|P3|Overall Study|Withdrawal by Subject|2
2835621|NCT02596971|9728579|P2|Overall Study|Withdrawal by Subject|0
2835622|NCT02596971|9728580|P1|Overall Study|Withdrawal by Subject|0
2835623|NCT02596971|9728578|P3|Overall Study|Physician Decision|1
2835624|NCT02596971|9728579|P2|Overall Study|Physician Decision|0
2835625|NCT02596971|9728580|P1|Overall Study|Physician Decision|0
2835626|NCT02596971|9728578|P3|Overall Study|Disease Progression|0
2835627|NCT02596971|9728579|P2|Overall Study|Disease Progression|1
2835628|NCT02596971|9728580|P1|Overall Study|Disease Progression|0
2835629|NCT02596958|9728609|P1|Overall Study|Excluded Due to Second Line Treatment|9
2835630|NCT02596958|9728609|P1|Overall Study|Missing|32
2835631|NCT02596958|9728609|P1|Overall Study|Lost to Follow-up|33
2835632|NCT02596958|9728609|P1|Overall Study|Administrative Reasons/Other|231
2835633|NCT02596958|9728609|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
2835634|NCT02596958|9728609|P1|Overall Study|Death From Other Cause|33
2835635|NCT02596958|9728609|P1|Overall Study|Death From Cancer|112
2835636|NCT02596958|9728609|P1|Overall Study|Cancer Progression|441
2835637|NCT02596958|9728609|P1|Overall Study|Serious Adverse Drug Reactions|44
2835638|NCT02596945|9728621|P1|Overall Study|Missing|1
2835639|NCT02596945|9728621|P1|Overall Study|Withdrawal by Subject|1
2835640|NCT02596945|9728621|P1|Overall Study|Other Erythropoietin stimulating agent|4
2835641|NCT02596945|9728621|P1|Overall Study|Change to hemodialysis|15
2835642|NCT02596945|9728621|P1|Overall Study|Other|32
2835643|NCT02596945|9728621|P1|Overall Study|No documentation of study drug dosing|3
2835644|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
2835645|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
2835646|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
2835647|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
2835648|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
2835649|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2835650|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2835651|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2835652|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Death|0
2835653|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Death|1
2835654|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Death|0
2835655|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Death|0
2835656|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
2835657|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
2835658|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2835659|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2835660|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2835661|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2835662|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2835663|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
2835664|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2835665|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
2835666|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2835667|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
2835668|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
2835669|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
2835670|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
2835671|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
2835672|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
2835673|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2835674|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2835675|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
2835676|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
2835677|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2835678|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2835679|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2835680|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
2835681|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2835682|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2835683|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
2835684|NCT02596893|9728631|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
2835685|NCT02596893|9728632|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
2835686|NCT02596893|9728633|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
2835687|NCT02596893|9728634|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
2835688|NCT02596854|9728693|P1|Overall Study|Withdrawn|8
2835689|NCT02596711|9728715|P3|Overall Study|Lost to Follow-up|3
2835690|NCT02596711|9728716|P2|Overall Study|Lost to Follow-up|2
2835691|NCT02596711|9728717|P1|Overall Study|Lost to Follow-up|1
2835692|NCT02596620|9728733|P2|Overall Study|Lost to Follow-up|1
2835693|NCT02596620|9728734|P1|Overall Study|Lost to Follow-up|1
2835694|NCT02596230|9728772|P5|Objective 2, One Year|Other|0
2835695|NCT02596230|9728773|P4|Objective 2, One Year|Other|0
2835696|NCT02596230|9728774|P3|Objective 2, One Year|Other|2
2835697|NCT02596230|9728775|P2|Objective 2, One Year|Other|3
2835698|NCT02596230|9728776|P1|Objective 2, One Year|Other|0
2835699|NCT02596230|9728772|P5|Objective 2, One Year|Death|30
2835700|NCT02596230|9728773|P4|Objective 2, One Year|Death|21
2835701|NCT02596230|9728774|P3|Objective 2, One Year|Death|41
2835702|NCT02596230|9728775|P2|Objective 2, One Year|Death|12
2835703|NCT02596230|9728776|P1|Objective 2, One Year|Death|0
2835704|NCT02596230|9728772|P5|Objective 2, One Year|Adverse drug reaction|0
2835705|NCT02596230|9728773|P4|Objective 2, One Year|Adverse drug reaction|0
2835706|NCT02596230|9728774|P3|Objective 2, One Year|Adverse drug reaction|0
2835707|NCT02596230|9728775|P2|Objective 2, One Year|Adverse drug reaction|1
2835708|NCT02596230|9728776|P1|Objective 2, One Year|Adverse drug reaction|0
2835709|NCT02596230|9728772|P5|Objective 2, One Year|Withdrawal by Subject|2
2835710|NCT02596230|9728773|P4|Objective 2, One Year|Withdrawal by Subject|5
2835711|NCT02596230|9728774|P3|Objective 2, One Year|Withdrawal by Subject|14
2835712|NCT02596230|9728775|P2|Objective 2, One Year|Withdrawal by Subject|11
2835713|NCT02596230|9728776|P1|Objective 2, One Year|Withdrawal by Subject|0
2835714|NCT02596230|9728772|P5|Objective 2, One Year|Lost to Follow-up|46
2835715|NCT02596230|9728773|P4|Objective 2, One Year|Lost to Follow-up|32
2835716|NCT02596230|9728774|P3|Objective 2, One Year|Lost to Follow-up|41
2835717|NCT02596230|9728775|P2|Objective 2, One Year|Lost to Follow-up|41
2835718|NCT02596230|9728776|P1|Objective 2, One Year|Lost to Follow-up|0
2835719|NCT02596230|9728772|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
2835720|NCT02596230|9728773|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
2835721|NCT02596230|9728774|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
2835722|NCT02596230|9728775|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
2835723|NCT02596230|9728776|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
2835724|NCT02596035|9728800|P3|Overall Study|Other Reasons|0
2835725|NCT02596035|9728801|P2|Overall Study|Other Reasons|4
2835726|NCT02596035|9728802|P1|Overall Study|Other Reasons|3
2835727|NCT02596035|9728800|P3|Overall Study|Poor/Non-Compliance|0
2835728|NCT02596035|9728801|P2|Overall Study|Poor/Non-Compliance|1
2835729|NCT02596035|9728802|P1|Overall Study|Poor/Non-Compliance|0
2835730|NCT02596035|9728800|P3|Overall Study|Withdrawal by Subject|0
2835731|NCT02596035|9728801|P2|Overall Study|Withdrawal by Subject|2
2835732|NCT02596035|9728802|P1|Overall Study|Withdrawal by Subject|4
2835733|NCT02596035|9728800|P3|Overall Study|Adverse Event|0
2835734|NCT02596035|9728801|P2|Overall Study|Adverse Event|2
2835735|NCT02596035|9728802|P1|Overall Study|Adverse Event|6
2835736|NCT02596035|9728800|P3|Overall Study|Study Drug Toxicity|0
2835737|NCT02596035|9728801|P2|Overall Study|Study Drug Toxicity|3
2835738|NCT02596035|9728802|P1|Overall Study|Study Drug Toxicity|11
2835739|NCT02596035|9728800|P3|Overall Study|Disease Progression|1
2835740|NCT02596035|9728801|P2|Overall Study|Disease Progression|32
2835741|NCT02596035|9728802|P1|Overall Study|Disease Progression|62
2835742|NCT02596009|9728838|P6|Overall Study|Administrative problems|0
2835743|NCT02596009|9728839|P5|Overall Study|Administrative problems|0
2835744|NCT02596009|9728840|P4|Overall Study|Administrative problems|0
2835745|NCT02596009|9728841|P3|Overall Study|Administrative problems|0
2835746|NCT02596009|9728842|P2|Overall Study|Administrative problems|1
2835747|NCT02596009|9728843|P1|Overall Study|Administrative problems|0
2835748|NCT02595970|9728860|P1|Overall Study|Lack of Efficacy|7
2835749|NCT02595970|9728860|P1|Overall Study|Adverse Event|5
2835750|NCT02595970|9728860|P1|Overall Study|Protocol Violation|4
2835751|NCT02595970|9728860|P1|Overall Study|Physician Decision|2
2835752|NCT02595970|9728860|P1|Overall Study|Withdrawal by Subject|2
2835753|NCT02595723|9728877|P3|First Washout (21 Days)|Lost to Follow-up|0
2835754|NCT02595723|9728878|P2|First Washout (21 Days)|Lost to Follow-up|0
2835755|NCT02595723|9728879|P1|First Washout (21 Days)|Lost to Follow-up|1
2835756|NCT02595723|9728877|P3|First Washout (21 Days)|Withdrawal by Subject|0
2835757|NCT02595723|9728878|P2|First Washout (21 Days)|Withdrawal by Subject|0
2835758|NCT02595723|9728879|P1|First Washout (21 Days)|Withdrawal by Subject|1
2835759|NCT02595502|9728891|P2|Period 3|Received Incorrect Treatment at period 3|1
2835760|NCT02595502|9728892|P1|Period 3|Received Incorrect Treatment at period 3|0
2835761|NCT02595502|9728891|P2|Period 3|Lost to Follow-up|0
2835762|NCT02595502|9728892|P1|Period 3|Lost to Follow-up|1
2835763|NCT02595502|9728891|P2|Period 3|Protocol Violation|1
2835764|NCT02595502|9728892|P1|Period 3|Protocol Violation|0
2835765|NCT02595502|9728891|P2|Period 2|Received incorrect lens at Period 1|1
2835766|NCT02595502|9728892|P1|Period 2|Received incorrect lens at Period 1|0
2835767|NCT02595502|9728891|P2|Period 2|Adverse Event|1
2835768|NCT02595502|9728892|P1|Period 2|Adverse Event|1
2835769|NCT02595502|9728891|P2|Period 1|Lost to Follow-up|1
2835770|NCT02595502|9728892|P1|Period 1|Lost to Follow-up|0
2835771|NCT02595502|9728891|P2|Period 1|Withdrawal by Subject|0
2835772|NCT02595502|9728892|P1|Period 1|Withdrawal by Subject|1
2835773|NCT02595502|9728891|P2|Period 1|Adverse Event|1
2835774|NCT02595502|9728892|P1|Period 1|Adverse Event|0
2835775|NCT02595450|9728898|P1|Overall Study|Enrolled, but not treated|8
2835776|NCT02595450|9728898|P1|Overall Study|Unspecified (only completed 1 cycle)|73
2835777|NCT02595437|9728904|P1|Triferic Via IV|Withdrawal by Subject|1
2835778|NCT02595073|9728924|P2|Overall Study|Protocol Violation|0
2835779|NCT02595073|9728925|P1|Overall Study|Protocol Violation|2
2835780|NCT02595073|9728924|P2|Overall Study|Progressive Disease|1
2835781|NCT02595073|9728925|P1|Overall Study|Progressive Disease|0
2835782|NCT02595008|9728935|P2|Overall Study|Enrolled In Error|0
2835783|NCT02595008|9728936|P1|Overall Study|Enrolled In Error|1
2835784|NCT02594163|9728974|P2|Follow-up Period|Physician Decision|1
2835785|NCT02594163|9728975|P1|Follow-up Period|Physician Decision|0
2835786|NCT02594163|9728974|P2|Follow-up Period|Progressive Disease|0
2835787|NCT02594163|9728975|P1|Follow-up Period|Progressive Disease|2
2835788|NCT02594163|9728974|P2|Follow-up Period|Adverse Event|1
2835789|NCT02594163|9728975|P1|Follow-up Period|Adverse Event|0
2835790|NCT02594163|9728974|P2|Follow-up Period|Death|5
2835791|NCT02594163|9728975|P1|Follow-up Period|Death|2
2835792|NCT02594163|9728974|P2|Follow-up Period|Lost to Follow-up|0
2835793|NCT02594163|9728975|P1|Follow-up Period|Lost to Follow-up|1
2835794|NCT02594163|9728974|P2|Follow-up Period|Study Termination by Sponsor|4
2835795|NCT02594163|9728975|P1|Follow-up Period|Study Termination by Sponsor|6
2835796|NCT02594163|9728974|P2|Follow-up Period|Withdrawal by Subject|1
2835797|NCT02594163|9728975|P1|Follow-up Period|Withdrawal by Subject|0
2835798|NCT02594163|9728974|P2|Treatment Period|Other, Non-AE|0
2835799|NCT02594163|9728975|P1|Treatment Period|Other, Non-AE|1
2835800|NCT02594163|9728974|P2|Treatment Period|Study termination by sponsor|1
2835801|NCT02594163|9728975|P1|Treatment Period|Study termination by sponsor|2
2835802|NCT02594163|9728974|P2|Treatment Period|Physician Decision|3
2835803|NCT02594163|9728975|P1|Treatment Period|Physician Decision|1
2835804|NCT02594163|9728974|P2|Treatment Period|Adverse Event|5
2835805|NCT02594163|9728975|P1|Treatment Period|Adverse Event|1
2835806|NCT02594163|9728974|P2|Treatment Period|Progressive disease|3
2835807|NCT02594163|9728975|P1|Treatment Period|Progressive disease|2
2835808|NCT02594098|9728993|P2|Overall Study|Other|1
2835809|NCT02594098|9728994|P1|Overall Study|Other|0
2835810|NCT02594098|9728993|P2|Overall Study|Seek alternative treatment|1
2835811|NCT02594098|9728994|P1|Overall Study|Seek alternative treatment|2
2835812|NCT02594098|9728993|P2|Overall Study|Terminated participation|2
2835813|NCT02594098|9728994|P1|Overall Study|Terminated participation|6
2835814|NCT02594098|9728993|P2|Overall Study|Withdrawal by Subject|3
2835815|NCT02594098|9728994|P1|Overall Study|Withdrawal by Subject|1
2835816|NCT02594098|9728993|P2|Overall Study|Lack of Efficacy|6
2835817|NCT02594098|9728994|P1|Overall Study|Lack of Efficacy|17
2835818|NCT02593864|9729063|P1|Overall Study|Lost to Follow-up|3
2835819|NCT02593864|9729063|P1|Overall Study|Withdrawal by Subject|3
2835820|NCT02593773|9729068|P1|Overall Study|Death|1
2835821|NCT02593773|9729068|P1|Overall Study|Study Terminated by Sponsor|31
2835822|NCT02593773|9729068|P1|Overall Study|Voluntary Withdrawal|3
2835823|NCT02593305|9729100|P3|Post 1|Comparison only group. No intervention.|10
2835824|NCT02593305|9729101|P2|Post 1|Comparison only group. No intervention.|0
2835825|NCT02593305|9729102|P1|Post 1|Comparison only group. No intervention.|0
2835826|NCT02593149|9729117|P2|Intervention|Didn't use CVC for at least 21 day|115
2835827|NCT02593149|9729118|P1|Intervention|Didn't use CVC for at least 21 day|116
2835828|NCT02593149|9729117|P2|Run-In|Didn't use CVC for at least 21 days|38
2835829|NCT02593149|9729118|P1|Run-In|Didn't use CVC for at least 21 days|36
2835830|NCT02592876|9729126|P2|Overall Study|Death|9
2835831|NCT02592876|9729127|P1|Overall Study|Death|6
2835832|NCT02592876|9729126|P2|Overall Study|Lost to Follow-up|1
2835833|NCT02592876|9729127|P1|Overall Study|Lost to Follow-up|0
2835834|NCT02592876|9729126|P2|Overall Study|Study Termination by Sponsor|27
2835835|NCT02592876|9729127|P1|Overall Study|Study Termination by Sponsor|32
2835836|NCT02592876|9729126|P2|Overall Study|Withdrawal by Subject|3
2835837|NCT02592876|9729127|P1|Overall Study|Withdrawal by Subject|3
2835838|NCT02592447|9729198|P2|Overall Study|Withdrawal by Subject|1
2835839|NCT02592447|9729199|P1|Overall Study|Withdrawal by Subject|0
2835840|NCT02592447|9729198|P2|Overall Study|Ineligible after randomization|0
2835841|NCT02592447|9729199|P1|Overall Study|Ineligible after randomization|1
2835842|NCT02592447|9729198|P2|Overall Study|Lost to Follow-up|0
2835843|NCT02592447|9729199|P1|Overall Study|Lost to Follow-up|1
2835844|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2835845|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
2835846|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2835847|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2835848|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
2835849|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2835850|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
2835851|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2835852|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2835853|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Other|0
2835854|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Other|1
2835855|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Other|0
2835856|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
2835857|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
2835858|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
2835859|NCT02592434|9729207|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
2835860|NCT02592434|9729208|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
2835861|NCT02592434|9729209|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
2835862|NCT02592434|9729207|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2835863|NCT02592434|9729208|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2835864|NCT02592434|9729209|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
2835865|NCT02592434|9729207|P3|Open-Label Phase (18 Weeks)|Other|0
2835866|NCT02592434|9729208|P2|Open-Label Phase (18 Weeks)|Other|0
2835867|NCT02592434|9729209|P1|Open-Label Phase (18 Weeks)|Other|3
2835868|NCT02592434|9729207|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2835869|NCT02592434|9729208|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2835870|NCT02592434|9729209|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
2835871|NCT02592434|9729207|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
2835872|NCT02592434|9729208|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
2835873|NCT02592434|9729209|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
2835874|NCT02591290|9729372|P1|Overall Study|Withdrawal by Subject|2
2835875|NCT02591238|9729382|P4|Overall Study|personal circumstances|0
2835876|NCT02591238|9729383|P3|Overall Study|personal circumstances|0
2835877|NCT02591238|9729384|P2|Overall Study|personal circumstances|1
2835878|NCT02591238|9729385|P1|Overall Study|personal circumstances|0
2835879|NCT02591238|9729382|P4|Overall Study|personal circumstances|1
2835880|NCT02591238|9729383|P3|Overall Study|personal circumstances|0
2835881|NCT02591238|9729384|P2|Overall Study|personal circumstances|0
2835882|NCT02591238|9729385|P1|Overall Study|personal circumstances|0
2835883|NCT02591238|9729382|P4|Overall Study|influenza|1
2835884|NCT02591238|9729383|P3|Overall Study|influenza|0
2835885|NCT02591238|9729384|P2|Overall Study|influenza|0
2835886|NCT02591238|9729385|P1|Overall Study|influenza|0
2835887|NCT02591238|9729382|P4|Overall Study|Withdrawal by Subject|1
2835888|NCT02591238|9729383|P3|Overall Study|Withdrawal by Subject|0
2835889|NCT02591238|9729384|P2|Overall Study|Withdrawal by Subject|0
2835890|NCT02591238|9729385|P1|Overall Study|Withdrawal by Subject|0
2835891|NCT02591238|9729382|P4|Overall Study|Pregnancy|0
2835892|NCT02591238|9729383|P3|Overall Study|Pregnancy|0
2835893|NCT02591238|9729384|P2|Overall Study|Pregnancy|0
2835894|NCT02591238|9729385|P1|Overall Study|Pregnancy|1
2835895|NCT02590939|9729421|P2|Overall Study|Failed the nociceptive test|1
2835896|NCT02590939|9729422|P1|Overall Study|Failed the nociceptive test|2
2835897|NCT02590939|9729421|P2|Overall Study|Withdrawal by Subject|1
2835898|NCT02590939|9729422|P1|Overall Study|Withdrawal by Subject|3
2835899|NCT02590588|9729442|P1|Overall Study|Adverse Event|1
2835900|NCT02590562|9729450|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
2835901|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835902|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
2835903|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835904|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835905|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835906|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835907|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835908|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835909|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2835910|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835911|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
2835912|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835913|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835914|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835915|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835916|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835917|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835918|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2835919|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
2835920|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835921|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835922|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835923|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835924|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835925|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835926|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835927|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2835928|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
2835929|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835930|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835931|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835932|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835933|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835934|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835935|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835936|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2835937|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
2835938|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
2835939|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835940|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835941|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835942|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835943|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835944|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835945|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2835946|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835947|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
2835948|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835949|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835950|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835951|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835952|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835953|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835954|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2835955|NCT02590432|9729509|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
2835956|NCT02590432|9729510|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
2835957|NCT02590432|9729511|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835958|NCT02590432|9729512|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835959|NCT02590432|9729513|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835960|NCT02590432|9729514|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835961|NCT02590432|9729515|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835962|NCT02590432|9729516|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835963|NCT02590432|9729517|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
2835964|NCT02590432|9729509|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835965|NCT02590432|9729510|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835966|NCT02590432|9729511|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835967|NCT02590432|9729512|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
2835968|NCT02590432|9729513|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835969|NCT02590432|9729514|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835970|NCT02590432|9729515|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835971|NCT02590432|9729516|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835972|NCT02590432|9729517|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
2835973|NCT02590432|9729509|P9|Double-blind Treatment Period|Lost to Follow-up|0
2835974|NCT02590432|9729510|P8|Double-blind Treatment Period|Lost to Follow-up|0
2835975|NCT02590432|9729511|P7|Double-blind Treatment Period|Lost to Follow-up|0
2835976|NCT02590432|9729512|P6|Double-blind Treatment Period|Lost to Follow-up|2
2835977|NCT02590432|9729513|P5|Double-blind Treatment Period|Lost to Follow-up|0
2835978|NCT02590432|9729514|P4|Double-blind Treatment Period|Lost to Follow-up|0
2835979|NCT02590432|9729515|P3|Double-blind Treatment Period|Lost to Follow-up|1
2835980|NCT02590432|9729516|P2|Double-blind Treatment Period|Lost to Follow-up|0
2835981|NCT02590432|9729517|P1|Double-blind Treatment Period|Lost to Follow-up|0
2835982|NCT02590432|9729509|P9|Double-blind Treatment Period|Withdrawal of Consent|0
2835983|NCT02590432|9729510|P8|Double-blind Treatment Period|Withdrawal of Consent|0
2835984|NCT02590432|9729511|P7|Double-blind Treatment Period|Withdrawal of Consent|1
2835985|NCT02590432|9729512|P6|Double-blind Treatment Period|Withdrawal of Consent|1
2835986|NCT02590432|9729513|P5|Double-blind Treatment Period|Withdrawal of Consent|3
2835987|NCT02590432|9729514|P4|Double-blind Treatment Period|Withdrawal of Consent|3
2835988|NCT02590432|9729515|P3|Double-blind Treatment Period|Withdrawal of Consent|1
2835989|NCT02590432|9729516|P2|Double-blind Treatment Period|Withdrawal of Consent|0
2835990|NCT02590432|9729517|P1|Double-blind Treatment Period|Withdrawal of Consent|0
2835991|NCT02590432|9729509|P9|Double-blind Treatment Period|Lack of Efficacy|0
2835992|NCT02590432|9729510|P8|Double-blind Treatment Period|Lack of Efficacy|0
2835993|NCT02590432|9729511|P7|Double-blind Treatment Period|Lack of Efficacy|0
2835994|NCT02590432|9729512|P6|Double-blind Treatment Period|Lack of Efficacy|0
2835995|NCT02590432|9729513|P5|Double-blind Treatment Period|Lack of Efficacy|0
2835996|NCT02590432|9729514|P4|Double-blind Treatment Period|Lack of Efficacy|0
2835997|NCT02590432|9729515|P3|Double-blind Treatment Period|Lack of Efficacy|1
2835998|NCT02590432|9729516|P2|Double-blind Treatment Period|Lack of Efficacy|0
2835999|NCT02590432|9729517|P1|Double-blind Treatment Period|Lack of Efficacy|0
2836000|NCT02590432|9729509|P9|Double-blind Treatment Period|Adverse Event|0
2836001|NCT02590432|9729510|P8|Double-blind Treatment Period|Adverse Event|0
2836002|NCT02590432|9729511|P7|Double-blind Treatment Period|Adverse Event|20
2836003|NCT02590432|9729512|P6|Double-blind Treatment Period|Adverse Event|22
2836004|NCT02590432|9729513|P5|Double-blind Treatment Period|Adverse Event|6
2836005|NCT02590432|9729514|P4|Double-blind Treatment Period|Adverse Event|12
2836006|NCT02590432|9729515|P3|Double-blind Treatment Period|Adverse Event|14
2836007|NCT02590432|9729516|P2|Double-blind Treatment Period|Adverse Event|0
2836008|NCT02590432|9729517|P1|Double-blind Treatment Period|Adverse Event|0
2836009|NCT02590432|9729509|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836010|NCT02590432|9729510|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836011|NCT02590432|9729511|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836012|NCT02590432|9729512|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836013|NCT02590432|9729513|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836014|NCT02590432|9729514|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836015|NCT02590432|9729515|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
2836016|NCT02590432|9729516|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
2836017|NCT02590432|9729517|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
2836018|NCT02590432|9729509|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
2836019|NCT02590432|9729510|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
2836020|NCT02590432|9729511|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
2836021|NCT02590432|9729512|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
2836022|NCT02590432|9729513|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
2836023|NCT02590432|9729514|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
2836024|NCT02590432|9729515|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
2836025|NCT02590432|9729516|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
2836026|NCT02590432|9729517|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
2836027|NCT02590432|9729509|P9|Open-label Treatment Period|Protocol Violation|0
2836028|NCT02590432|9729510|P8|Open-label Treatment Period|Protocol Violation|0
2836029|NCT02590432|9729511|P7|Open-label Treatment Period|Protocol Violation|0
2836030|NCT02590432|9729512|P6|Open-label Treatment Period|Protocol Violation|0
2836031|NCT02590432|9729513|P5|Open-label Treatment Period|Protocol Violation|0
2836032|NCT02590432|9729514|P4|Open-label Treatment Period|Protocol Violation|0
2836033|NCT02590432|9729515|P3|Open-label Treatment Period|Protocol Violation|0
2836034|NCT02590432|9729516|P2|Open-label Treatment Period|Protocol Violation|4
2836035|NCT02590432|9729517|P1|Open-label Treatment Period|Protocol Violation|10
2836036|NCT02590432|9729509|P9|Open-label Treatment Period|Lost to Follow-up|0
2836037|NCT02590432|9729510|P8|Open-label Treatment Period|Lost to Follow-up|0
2836038|NCT02590432|9729511|P7|Open-label Treatment Period|Lost to Follow-up|0
2836039|NCT02590432|9729512|P6|Open-label Treatment Period|Lost to Follow-up|0
2836040|NCT02590432|9729513|P5|Open-label Treatment Period|Lost to Follow-up|0
2836041|NCT02590432|9729514|P4|Open-label Treatment Period|Lost to Follow-up|0
2836042|NCT02590432|9729515|P3|Open-label Treatment Period|Lost to Follow-up|0
2836043|NCT02590432|9729516|P2|Open-label Treatment Period|Lost to Follow-up|29
2836044|NCT02590432|9729517|P1|Open-label Treatment Period|Lost to Follow-up|51
2836045|NCT02590432|9729509|P9|Open-label Treatment Period|Withdrawal of Consent|0
2836046|NCT02590432|9729510|P8|Open-label Treatment Period|Withdrawal of Consent|0
2836047|NCT02590432|9729511|P7|Open-label Treatment Period|Withdrawal of Consent|0
2836048|NCT02590432|9729512|P6|Open-label Treatment Period|Withdrawal of Consent|0
2836049|NCT02590432|9729513|P5|Open-label Treatment Period|Withdrawal of Consent|0
2836050|NCT02590432|9729514|P4|Open-label Treatment Period|Withdrawal of Consent|0
2836051|NCT02590432|9729515|P3|Open-label Treatment Period|Withdrawal of Consent|0
2836052|NCT02590432|9729516|P2|Open-label Treatment Period|Withdrawal of Consent|28
2836053|NCT02590432|9729517|P1|Open-label Treatment Period|Withdrawal of Consent|43
2836054|NCT02590432|9729509|P9|Open-label Treatment Period|Lack of Efficacy|0
2836055|NCT02590432|9729510|P8|Open-label Treatment Period|Lack of Efficacy|0
2836056|NCT02590432|9729511|P7|Open-label Treatment Period|Lack of Efficacy|0
2836057|NCT02590432|9729512|P6|Open-label Treatment Period|Lack of Efficacy|0
2836058|NCT02590432|9729513|P5|Open-label Treatment Period|Lack of Efficacy|0
2836059|NCT02590432|9729514|P4|Open-label Treatment Period|Lack of Efficacy|0
2836060|NCT02590432|9729515|P3|Open-label Treatment Period|Lack of Efficacy|0
2836061|NCT02590432|9729516|P2|Open-label Treatment Period|Lack of Efficacy|5
2836062|NCT02590432|9729517|P1|Open-label Treatment Period|Lack of Efficacy|14
2836063|NCT02590432|9729509|P9|Open-label Treatment Period|Adverse Event|0
2836064|NCT02590432|9729510|P8|Open-label Treatment Period|Adverse Event|0
2836065|NCT02590432|9729511|P7|Open-label Treatment Period|Adverse Event|0
2836066|NCT02590432|9729512|P6|Open-label Treatment Period|Adverse Event|0
2836067|NCT02590432|9729513|P5|Open-label Treatment Period|Adverse Event|0
2836068|NCT02590432|9729514|P4|Open-label Treatment Period|Adverse Event|0
2836069|NCT02590432|9729515|P3|Open-label Treatment Period|Adverse Event|0
2836070|NCT02590432|9729516|P2|Open-label Treatment Period|Adverse Event|79
2836071|NCT02590432|9729517|P1|Open-label Treatment Period|Adverse Event|97
2836072|NCT02590406|9729553|P2|Overall Study|Saturometer malfunction|1
2836073|NCT02590406|9729554|P1|Overall Study|Saturometer malfunction|0
2836074|NCT02590406|9729553|P2|Overall Study|Adverse Event|0
2836075|NCT02590406|9729554|P1|Overall Study|Adverse Event|1
2836076|NCT02590354|9729568|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
2836077|NCT02590354|9729568|P1|Phase 1|Lost to Follow-up|1
2836078|NCT02590354|9729568|P1|Phase 1|Subject does not want to participate|20
2836079|NCT02590354|9729568|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
2836080|NCT02590354|9729568|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
2836081|NCT02590354|9729568|P1|Phase 1|Active hepatitis B or C infection|1
2836082|NCT02590003|9729595|P2|Overall Study|Death|2
2836083|NCT02590003|9729596|P1|Overall Study|Death|1
2836084|NCT02589665|9729633|P10|Maintenance Extension Period|Non-responder|1
2836085|NCT02589665|9729634|P9|Maintenance Extension Period|Non-responder|0
2836086|NCT02589665|9729635|P8|Maintenance Extension Period|Non-responder|0
2836087|NCT02589665|9729636|P7|Maintenance Extension Period|Non-responder|0
2836088|NCT02589665|9729637|P6|Maintenance Extension Period|Non-responder|0
2836089|NCT02589665|9729638|P5|Maintenance Extension Period|Non-responder|0
2836090|NCT02589665|9729639|P4|Maintenance Extension Period|Non-responder|0
2836091|NCT02589665|9729640|P3|Maintenance Extension Period|Non-responder|0
2836092|NCT02589665|9729641|P2|Maintenance Extension Period|Non-responder|0
2836093|NCT02589665|9729642|P1|Maintenance Extension Period|Non-responder|0
2836094|NCT02589665|9729633|P10|Maintenance Extension Period|Adverse Event|2
2836095|NCT02589665|9729634|P9|Maintenance Extension Period|Adverse Event|0
2836096|NCT02589665|9729635|P8|Maintenance Extension Period|Adverse Event|0
2836097|NCT02589665|9729636|P7|Maintenance Extension Period|Adverse Event|0
2836098|NCT02589665|9729637|P6|Maintenance Extension Period|Adverse Event|0
2836099|NCT02589665|9729638|P5|Maintenance Extension Period|Adverse Event|0
2836100|NCT02589665|9729639|P4|Maintenance Extension Period|Adverse Event|0
2836101|NCT02589665|9729640|P3|Maintenance Extension Period|Adverse Event|0
2836102|NCT02589665|9729641|P2|Maintenance Extension Period|Adverse Event|0
2836103|NCT02589665|9729642|P1|Maintenance Extension Period|Adverse Event|0
2836104|NCT02589665|9729633|P10|Maintenance Extension Period|Lack of Efficacy|4
2836105|NCT02589665|9729634|P9|Maintenance Extension Period|Lack of Efficacy|0
2836106|NCT02589665|9729635|P8|Maintenance Extension Period|Lack of Efficacy|0
2836107|NCT02589665|9729636|P7|Maintenance Extension Period|Lack of Efficacy|0
2836108|NCT02589665|9729637|P6|Maintenance Extension Period|Lack of Efficacy|0
2836109|NCT02589665|9729638|P5|Maintenance Extension Period|Lack of Efficacy|0
2836110|NCT02589665|9729639|P4|Maintenance Extension Period|Lack of Efficacy|0
2836111|NCT02589665|9729640|P3|Maintenance Extension Period|Lack of Efficacy|0
2836112|NCT02589665|9729641|P2|Maintenance Extension Period|Lack of Efficacy|0
2836113|NCT02589665|9729642|P1|Maintenance Extension Period|Lack of Efficacy|0
2836114|NCT02589665|9729633|P10|Maintenance Extension Period|Withdrawal by Subject|4
2836115|NCT02589665|9729634|P9|Maintenance Extension Period|Withdrawal by Subject|0
2836116|NCT02589665|9729635|P8|Maintenance Extension Period|Withdrawal by Subject|0
2836117|NCT02589665|9729636|P7|Maintenance Extension Period|Withdrawal by Subject|0
2836118|NCT02589665|9729637|P6|Maintenance Extension Period|Withdrawal by Subject|0
2836119|NCT02589665|9729638|P5|Maintenance Extension Period|Withdrawal by Subject|0
2836120|NCT02589665|9729639|P4|Maintenance Extension Period|Withdrawal by Subject|0
2836121|NCT02589665|9729640|P3|Maintenance Extension Period|Withdrawal by Subject|0
2836122|NCT02589665|9729641|P2|Maintenance Extension Period|Withdrawal by Subject|0
2836123|NCT02589665|9729642|P1|Maintenance Extension Period|Withdrawal by Subject|0
2836124|NCT02589665|9729633|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
2836125|NCT02589665|9729634|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836126|NCT02589665|9729635|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836127|NCT02589665|9729636|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836128|NCT02589665|9729637|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836129|NCT02589665|9729638|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836130|NCT02589665|9729639|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836131|NCT02589665|9729640|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836132|NCT02589665|9729641|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836133|NCT02589665|9729642|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
2836134|NCT02589665|9729633|P10|Induction Extension Period|Reason Not Collected|0
2836135|NCT02589665|9729634|P9|Induction Extension Period|Reason Not Collected|1
2836136|NCT02589665|9729635|P8|Induction Extension Period|Reason Not Collected|0
2836137|NCT02589665|9729636|P7|Induction Extension Period|Reason Not Collected|0
2836138|NCT02589665|9729637|P6|Induction Extension Period|Reason Not Collected|0
2836139|NCT02589665|9729638|P5|Induction Extension Period|Reason Not Collected|0
2836140|NCT02589665|9729639|P4|Induction Extension Period|Reason Not Collected|0
2836141|NCT02589665|9729640|P3|Induction Extension Period|Reason Not Collected|0
2836142|NCT02589665|9729641|P2|Induction Extension Period|Reason Not Collected|0
2836143|NCT02589665|9729642|P1|Induction Extension Period|Reason Not Collected|0
2836144|NCT02589665|9729633|P10|Induction Extension Period|Physician Decision|0
2836145|NCT02589665|9729634|P9|Induction Extension Period|Physician Decision|1
2836146|NCT02589665|9729635|P8|Induction Extension Period|Physician Decision|0
2836147|NCT02589665|9729636|P7|Induction Extension Period|Physician Decision|0
2836148|NCT02589665|9729637|P6|Induction Extension Period|Physician Decision|0
2836149|NCT02589665|9729638|P5|Induction Extension Period|Physician Decision|0
2836150|NCT02589665|9729639|P4|Induction Extension Period|Physician Decision|0
2836151|NCT02589665|9729640|P3|Induction Extension Period|Physician Decision|0
2836152|NCT02589665|9729641|P2|Induction Extension Period|Physician Decision|0
2836153|NCT02589665|9729642|P1|Induction Extension Period|Physician Decision|0
2836154|NCT02589665|9729633|P10|Induction Extension Period|Withdrawal by Subject|0
2836155|NCT02589665|9729634|P9|Induction Extension Period|Withdrawal by Subject|3
2836156|NCT02589665|9729635|P8|Induction Extension Period|Withdrawal by Subject|2
2836157|NCT02589665|9729636|P7|Induction Extension Period|Withdrawal by Subject|0
2836158|NCT02589665|9729637|P6|Induction Extension Period|Withdrawal by Subject|0
2836159|NCT02589665|9729638|P5|Induction Extension Period|Withdrawal by Subject|0
2836160|NCT02589665|9729639|P4|Induction Extension Period|Withdrawal by Subject|0
2836161|NCT02589665|9729640|P3|Induction Extension Period|Withdrawal by Subject|0
2836162|NCT02589665|9729641|P2|Induction Extension Period|Withdrawal by Subject|0
2836163|NCT02589665|9729642|P1|Induction Extension Period|Withdrawal by Subject|0
2836164|NCT02589665|9729633|P10|Induction Extension Period|Lack of Efficacy|0
2836165|NCT02589665|9729634|P9|Induction Extension Period|Lack of Efficacy|3
2836166|NCT02589665|9729635|P8|Induction Extension Period|Lack of Efficacy|0
2836167|NCT02589665|9729636|P7|Induction Extension Period|Lack of Efficacy|0
2836168|NCT02589665|9729637|P6|Induction Extension Period|Lack of Efficacy|0
2836169|NCT02589665|9729638|P5|Induction Extension Period|Lack of Efficacy|0
2836170|NCT02589665|9729639|P4|Induction Extension Period|Lack of Efficacy|0
2836171|NCT02589665|9729640|P3|Induction Extension Period|Lack of Efficacy|0
2836172|NCT02589665|9729641|P2|Induction Extension Period|Lack of Efficacy|0
2836173|NCT02589665|9729642|P1|Induction Extension Period|Lack of Efficacy|0
2836174|NCT02589665|9729633|P10|Induction Extension Period|Adverse Event|0
2836175|NCT02589665|9729634|P9|Induction Extension Period|Adverse Event|4
2836176|NCT02589665|9729635|P8|Induction Extension Period|Adverse Event|0
2836177|NCT02589665|9729636|P7|Induction Extension Period|Adverse Event|0
2836178|NCT02589665|9729637|P6|Induction Extension Period|Adverse Event|0
2836179|NCT02589665|9729638|P5|Induction Extension Period|Adverse Event|0
2836180|NCT02589665|9729639|P4|Induction Extension Period|Adverse Event|0
2836181|NCT02589665|9729640|P3|Induction Extension Period|Adverse Event|0
2836182|NCT02589665|9729641|P2|Induction Extension Period|Adverse Event|0
2836183|NCT02589665|9729642|P1|Induction Extension Period|Adverse Event|0
2836184|NCT02589665|9729633|P10|Maintenance Period|Reason Not Collected|0
2836185|NCT02589665|9729634|P9|Maintenance Period|Reason Not Collected|0
2836186|NCT02589665|9729635|P8|Maintenance Period|Reason Not Collected|0
2836187|NCT02589665|9729636|P7|Maintenance Period|Reason Not Collected|1
2836188|NCT02589665|9729637|P6|Maintenance Period|Reason Not Collected|1
2836189|NCT02589665|9729638|P5|Maintenance Period|Reason Not Collected|0
2836190|NCT02589665|9729639|P4|Maintenance Period|Reason Not Collected|0
2836191|NCT02589665|9729640|P3|Maintenance Period|Reason Not Collected|0
2836192|NCT02589665|9729641|P2|Maintenance Period|Reason Not Collected|0
2836193|NCT02589665|9729642|P1|Maintenance Period|Reason Not Collected|0
2836194|NCT02589665|9729633|P10|Maintenance Period|Physician Decision|0
2836195|NCT02589665|9729634|P9|Maintenance Period|Physician Decision|0
2836196|NCT02589665|9729635|P8|Maintenance Period|Physician Decision|0
2836197|NCT02589665|9729636|P7|Maintenance Period|Physician Decision|0
2836198|NCT02589665|9729637|P6|Maintenance Period|Physician Decision|1
2836199|NCT02589665|9729638|P5|Maintenance Period|Physician Decision|0
2836200|NCT02589665|9729639|P4|Maintenance Period|Physician Decision|0
2836201|NCT02589665|9729640|P3|Maintenance Period|Physician Decision|0
2836202|NCT02589665|9729641|P2|Maintenance Period|Physician Decision|0
2836203|NCT02589665|9729642|P1|Maintenance Period|Physician Decision|0
2836204|NCT02589665|9729633|P10|Maintenance Period|Lost to Follow-up|0
2836205|NCT02589665|9729634|P9|Maintenance Period|Lost to Follow-up|0
2836206|NCT02589665|9729635|P8|Maintenance Period|Lost to Follow-up|0
2836207|NCT02589665|9729636|P7|Maintenance Period|Lost to Follow-up|0
2836208|NCT02589665|9729637|P6|Maintenance Period|Lost to Follow-up|1
2836209|NCT02589665|9729638|P5|Maintenance Period|Lost to Follow-up|0
2836210|NCT02589665|9729639|P4|Maintenance Period|Lost to Follow-up|0
2836211|NCT02589665|9729640|P3|Maintenance Period|Lost to Follow-up|0
2836212|NCT02589665|9729641|P2|Maintenance Period|Lost to Follow-up|0
2836213|NCT02589665|9729642|P1|Maintenance Period|Lost to Follow-up|0
2836214|NCT02589665|9729633|P10|Maintenance Period|Adverse Event|0
2836215|NCT02589665|9729634|P9|Maintenance Period|Adverse Event|0
2836216|NCT02589665|9729635|P8|Maintenance Period|Adverse Event|0
2836217|NCT02589665|9729636|P7|Maintenance Period|Adverse Event|2
2836218|NCT02589665|9729637|P6|Maintenance Period|Adverse Event|0
2836219|NCT02589665|9729638|P5|Maintenance Period|Adverse Event|0
2836220|NCT02589665|9729639|P4|Maintenance Period|Adverse Event|0
2836221|NCT02589665|9729640|P3|Maintenance Period|Adverse Event|0
2836222|NCT02589665|9729641|P2|Maintenance Period|Adverse Event|0
2836223|NCT02589665|9729642|P1|Maintenance Period|Adverse Event|0
2836224|NCT02589665|9729633|P10|Maintenance Period|Lack of Efficacy|0
2836225|NCT02589665|9729634|P9|Maintenance Period|Lack of Efficacy|0
2836226|NCT02589665|9729635|P8|Maintenance Period|Lack of Efficacy|0
2836227|NCT02589665|9729636|P7|Maintenance Period|Lack of Efficacy|0
2836228|NCT02589665|9729637|P6|Maintenance Period|Lack of Efficacy|1
2836229|NCT02589665|9729638|P5|Maintenance Period|Lack of Efficacy|2
2836230|NCT02589665|9729639|P4|Maintenance Period|Lack of Efficacy|0
2836231|NCT02589665|9729640|P3|Maintenance Period|Lack of Efficacy|0
2836232|NCT02589665|9729641|P2|Maintenance Period|Lack of Efficacy|0
2836233|NCT02589665|9729642|P1|Maintenance Period|Lack of Efficacy|0
2836234|NCT02589665|9729633|P10|Maintenance Period|Withdrawal by Subject|0
2836235|NCT02589665|9729634|P9|Maintenance Period|Withdrawal by Subject|0
2836236|NCT02589665|9729635|P8|Maintenance Period|Withdrawal by Subject|0
2836237|NCT02589665|9729636|P7|Maintenance Period|Withdrawal by Subject|4
2836238|NCT02589665|9729637|P6|Maintenance Period|Withdrawal by Subject|2
2836239|NCT02589665|9729638|P5|Maintenance Period|Withdrawal by Subject|4
2836240|NCT02589665|9729639|P4|Maintenance Period|Withdrawal by Subject|0
2836241|NCT02589665|9729640|P3|Maintenance Period|Withdrawal by Subject|0
2836242|NCT02589665|9729641|P2|Maintenance Period|Withdrawal by Subject|0
2836243|NCT02589665|9729642|P1|Maintenance Period|Withdrawal by Subject|0
2836244|NCT02589665|9729633|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836245|NCT02589665|9729634|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836246|NCT02589665|9729635|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836247|NCT02589665|9729636|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
2836248|NCT02589665|9729637|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
2836249|NCT02589665|9729638|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
2836250|NCT02589665|9729639|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836251|NCT02589665|9729640|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836252|NCT02589665|9729641|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836253|NCT02589665|9729642|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
2836254|NCT02589665|9729633|P10|Induction Period|Protocol Violation|0
2836255|NCT02589665|9729634|P9|Induction Period|Protocol Violation|0
2836256|NCT02589665|9729635|P8|Induction Period|Protocol Violation|0
2836257|NCT02589665|9729636|P7|Induction Period|Protocol Violation|0
2836258|NCT02589665|9729637|P6|Induction Period|Protocol Violation|0
2836259|NCT02589665|9729638|P5|Induction Period|Protocol Violation|0
2836260|NCT02589665|9729639|P4|Induction Period|Protocol Violation|0
2836261|NCT02589665|9729640|P3|Induction Period|Protocol Violation|0
2836262|NCT02589665|9729641|P2|Induction Period|Protocol Violation|1
2836263|NCT02589665|9729642|P1|Induction Period|Protocol Violation|0
2836264|NCT02589665|9729633|P10|Induction Period|Withdrawal by Subject|0
2836265|NCT02589665|9729634|P9|Induction Period|Withdrawal by Subject|0
2836266|NCT02589665|9729635|P8|Induction Period|Withdrawal by Subject|0
2836267|NCT02589665|9729636|P7|Induction Period|Withdrawal by Subject|0
2836268|NCT02589665|9729637|P6|Induction Period|Withdrawal by Subject|0
2836269|NCT02589665|9729638|P5|Induction Period|Withdrawal by Subject|0
2836270|NCT02589665|9729639|P4|Induction Period|Withdrawal by Subject|1
2836271|NCT02589665|9729640|P3|Induction Period|Withdrawal by Subject|0
2836272|NCT02589665|9729641|P2|Induction Period|Withdrawal by Subject|1
2836273|NCT02589665|9729642|P1|Induction Period|Withdrawal by Subject|0
2836274|NCT02589665|9729633|P10|Induction Period|Adverse Event|0
2836275|NCT02589665|9729634|P9|Induction Period|Adverse Event|0
2836276|NCT02589665|9729635|P8|Induction Period|Adverse Event|0
2836277|NCT02589665|9729636|P7|Induction Period|Adverse Event|0
2836278|NCT02589665|9729637|P6|Induction Period|Adverse Event|0
2836279|NCT02589665|9729638|P5|Induction Period|Adverse Event|0
2836280|NCT02589665|9729639|P4|Induction Period|Adverse Event|2
2836281|NCT02589665|9729640|P3|Induction Period|Adverse Event|2
2836282|NCT02589665|9729641|P2|Induction Period|Adverse Event|0
2836283|NCT02589665|9729642|P1|Induction Period|Adverse Event|3
2836284|NCT02589665|9729633|P10|Induction Period|Did not receive drug|0
2836285|NCT02589665|9729634|P9|Induction Period|Did not receive drug|0
2836286|NCT02589665|9729635|P8|Induction Period|Did not receive drug|0
2836287|NCT02589665|9729636|P7|Induction Period|Did not receive drug|0
2836288|NCT02589665|9729637|P6|Induction Period|Did not receive drug|0
2836289|NCT02589665|9729638|P5|Induction Period|Did not receive drug|0
2836290|NCT02589665|9729639|P4|Induction Period|Did not receive drug|1
2836291|NCT02589665|9729640|P3|Induction Period|Did not receive drug|0
2836292|NCT02589665|9729641|P2|Induction Period|Did not receive drug|0
2836293|NCT02589665|9729642|P1|Induction Period|Did not receive drug|0
2836294|NCT02589639|9729707|P3|Overall Study|Not Treated|0
2836295|NCT02589639|9729708|P2|Overall Study|Not Treated|3
2836296|NCT02589639|9729709|P1|Overall Study|Not Treated|0
2836297|NCT02589639|9729707|P3|Overall Study|Other reason than specified above|1
2836298|NCT02589639|9729708|P2|Overall Study|Other reason than specified above|2
2836299|NCT02589639|9729709|P1|Overall Study|Other reason than specified above|1
2836300|NCT02589639|9729707|P3|Overall Study|Adverse Event|3
2836301|NCT02589639|9729708|P2|Overall Study|Adverse Event|5
2836302|NCT02589639|9729709|P1|Overall Study|Adverse Event|4
2836303|NCT02589639|9729707|P3|Overall Study|Patient withdrawal, not due to AE|0
2836304|NCT02589639|9729708|P2|Overall Study|Patient withdrawal, not due to AE|0
2836305|NCT02589639|9729709|P1|Overall Study|Patient withdrawal, not due to AE|3
2836306|NCT02589639|9729707|P3|Overall Study|Protocol Violation|0
2836307|NCT02589639|9729708|P2|Overall Study|Protocol Violation|0
2836308|NCT02589639|9729709|P1|Overall Study|Protocol Violation|1
2836309|NCT02589639|9729707|P3|Overall Study|Lost to Follow-up|0
2836310|NCT02589639|9729708|P2|Overall Study|Lost to Follow-up|0
2836311|NCT02589639|9729709|P1|Overall Study|Lost to Follow-up|1
2836312|NCT02589626|9729722|P2|Overall Study|Adverse Event|1
2836313|NCT02589626|9729723|P1|Overall Study|Adverse Event|1
2836314|NCT02589626|9729722|P2|Overall Study|Withdrawal by Subject|1
2836315|NCT02589626|9729723|P1|Overall Study|Withdrawal by Subject|1
2836316|NCT02589626|9729722|P2|Overall Study|Other than the reason specified|0
2836317|NCT02589626|9729723|P1|Overall Study|Other than the reason specified|1
2836318|NCT02589405|9729731|P1|Overall Study|Withdrawal by Subject|1
2836319|NCT02589405|9729731|P1|Overall Study|Adverse Event|3
2836320|NCT02588339|9729869|P1|Overall Study|GVHD Progression prior to treatment|2
2836321|NCT02588339|9729869|P1|Overall Study|Withdrawal by Subject|1
2836322|NCT02588261|9729881|P2|Overall Study|Lost to Follow-up|0
2836323|NCT02588261|9729882|P1|Overall Study|Lost to Follow-up|1
2836324|NCT02588261|9729881|P2|Overall Study|Adverse Event|24
2836325|NCT02588261|9729882|P1|Overall Study|Adverse Event|29
2836326|NCT02588261|9729881|P2|Overall Study|Progressive Disease|82
2836327|NCT02588261|9729882|P1|Overall Study|Progressive Disease|61
2836328|NCT02588261|9729881|P2|Overall Study|Miscellaneous|4
2836329|NCT02588261|9729882|P1|Overall Study|Miscellaneous|5
2836330|NCT02588261|9729881|P2|Overall Study|Noncompliance with Study Drug|1
2836331|NCT02588261|9729882|P1|Overall Study|Noncompliance with Study Drug|0
2836332|NCT02588261|9729881|P2|Overall Study|Withdrawal by Subject|8
2836333|NCT02588261|9729882|P1|Overall Study|Withdrawal by Subject|12
2836334|NCT02588261|9729881|P2|Overall Study|Death|2
2836335|NCT02588261|9729882|P1|Overall Study|Death|1
2836336|NCT02588261|9729881|P2|Overall Study|Protocol Deviation|0
2836337|NCT02588261|9729882|P1|Overall Study|Protocol Deviation|1
2836338|NCT02588261|9729881|P2|Overall Study|Study Terminated by Sponsor|142
2836339|NCT02588261|9729882|P1|Overall Study|Study Terminated by Sponsor|157
2836340|NCT02588092|9729918|P10|Overall Study|Sponsor Decision|1
2836341|NCT02588092|9729919|P9|Overall Study|Sponsor Decision|1
2836342|NCT02588092|9729920|P8|Overall Study|Sponsor Decision|0
2836343|NCT02588092|9729921|P7|Overall Study|Sponsor Decision|0
2836344|NCT02588092|9729922|P6|Overall Study|Sponsor Decision|0
2836345|NCT02588092|9729923|P5|Overall Study|Sponsor Decision|0
2836346|NCT02588092|9729924|P4|Overall Study|Sponsor Decision|0
2836347|NCT02588092|9729925|P3|Overall Study|Sponsor Decision|0
2836348|NCT02588092|9729926|P2|Overall Study|Sponsor Decision|0
2836349|NCT02588092|9729927|P1|Overall Study|Sponsor Decision|0
2836350|NCT02588092|9729918|P10|Overall Study|Started Another Treatment|0
2836351|NCT02588092|9729919|P9|Overall Study|Started Another Treatment|0
2836352|NCT02588092|9729920|P8|Overall Study|Started Another Treatment|1
2836353|NCT02588092|9729921|P7|Overall Study|Started Another Treatment|0
2836354|NCT02588092|9729922|P6|Overall Study|Started Another Treatment|0
2836355|NCT02588092|9729923|P5|Overall Study|Started Another Treatment|1
2836356|NCT02588092|9729924|P4|Overall Study|Started Another Treatment|0
2836357|NCT02588092|9729925|P3|Overall Study|Started Another Treatment|0
2836358|NCT02588092|9729926|P2|Overall Study|Started Another Treatment|0
2836359|NCT02588092|9729927|P1|Overall Study|Started Another Treatment|0
2836360|NCT02588092|9729918|P10|Overall Study|Withdrawal by Subject|0
2836361|NCT02588092|9729919|P9|Overall Study|Withdrawal by Subject|0
2836362|NCT02588092|9729920|P8|Overall Study|Withdrawal by Subject|2
2836363|NCT02588092|9729921|P7|Overall Study|Withdrawal by Subject|1
2836364|NCT02588092|9729922|P6|Overall Study|Withdrawal by Subject|1
2836365|NCT02588092|9729923|P5|Overall Study|Withdrawal by Subject|0
2836366|NCT02588092|9729924|P4|Overall Study|Withdrawal by Subject|0
2836367|NCT02588092|9729925|P3|Overall Study|Withdrawal by Subject|0
2836368|NCT02588092|9729926|P2|Overall Study|Withdrawal by Subject|0
2836369|NCT02588092|9729927|P1|Overall Study|Withdrawal by Subject|0
2836370|NCT02588092|9729918|P10|Overall Study|Death|2
2836371|NCT02588092|9729919|P9|Overall Study|Death|5
2836372|NCT02588092|9729920|P8|Overall Study|Death|1
2836373|NCT02588092|9729921|P7|Overall Study|Death|2
2836374|NCT02588092|9729922|P6|Overall Study|Death|2
2836375|NCT02588092|9729923|P5|Overall Study|Death|2
2836376|NCT02588092|9729924|P4|Overall Study|Death|3
2836377|NCT02588092|9729925|P3|Overall Study|Death|3
2836378|NCT02588092|9729926|P2|Overall Study|Death|3
2836379|NCT02588092|9729927|P1|Overall Study|Death|4
2836380|NCT02587819|9730121|P1|Overall Study|Lost to Follow-up|1
2836381|NCT02587819|9730121|P1|Overall Study|Adverse Event|1
2836382|NCT02587520|9730157|P18|Overall Study|Lost to Follow-up|0
2836383|NCT02587520|9730158|P17|Overall Study|Lost to Follow-up|0
2836384|NCT02587520|9730159|P16|Overall Study|Lost to Follow-up|0
2836385|NCT02587520|9730160|P15|Overall Study|Lost to Follow-up|0
2836386|NCT02587520|9730161|P14|Overall Study|Lost to Follow-up|0
2836387|NCT02587520|9730162|P13|Overall Study|Lost to Follow-up|0
2836388|NCT02587520|9730163|P12|Overall Study|Lost to Follow-up|1
2836389|NCT02587520|9730164|P11|Overall Study|Lost to Follow-up|2
2836390|NCT02587520|9730165|P10|Overall Study|Lost to Follow-up|2
2836391|NCT02587520|9730166|P9|Overall Study|Lost to Follow-up|0
2836392|NCT02587520|9730167|P8|Overall Study|Lost to Follow-up|1
2836393|NCT02587520|9730168|P7|Overall Study|Lost to Follow-up|1
2836394|NCT02587520|9730169|P6|Overall Study|Lost to Follow-up|1
2836395|NCT02587520|9730170|P5|Overall Study|Lost to Follow-up|0
2836396|NCT02587520|9730171|P4|Overall Study|Lost to Follow-up|2
2836397|NCT02587520|9730172|P3|Overall Study|Lost to Follow-up|0
2836398|NCT02587520|9730173|P2|Overall Study|Lost to Follow-up|2
2836399|NCT02587520|9730174|P1|Overall Study|Lost to Follow-up|0
2836400|NCT02587520|9730157|P18|Overall Study|Withdrawal by Subject|0
2836401|NCT02587520|9730158|P17|Overall Study|Withdrawal by Subject|0
2836402|NCT02587520|9730159|P16|Overall Study|Withdrawal by Subject|0
2836403|NCT02587520|9730160|P15|Overall Study|Withdrawal by Subject|0
2836404|NCT02587520|9730161|P14|Overall Study|Withdrawal by Subject|1
2836405|NCT02587520|9730162|P13|Overall Study|Withdrawal by Subject|0
2836406|NCT02587520|9730163|P12|Overall Study|Withdrawal by Subject|0
2836407|NCT02587520|9730164|P11|Overall Study|Withdrawal by Subject|0
2836408|NCT02587520|9730165|P10|Overall Study|Withdrawal by Subject|0
2836409|NCT02587520|9730166|P9|Overall Study|Withdrawal by Subject|0
2836410|NCT02587520|9730167|P8|Overall Study|Withdrawal by Subject|0
2836411|NCT02587520|9730168|P7|Overall Study|Withdrawal by Subject|1
2836412|NCT02587520|9730169|P6|Overall Study|Withdrawal by Subject|1
2836413|NCT02587520|9730170|P5|Overall Study|Withdrawal by Subject|0
2836414|NCT02587520|9730171|P4|Overall Study|Withdrawal by Subject|1
2836415|NCT02587520|9730172|P3|Overall Study|Withdrawal by Subject|1
2836416|NCT02587520|9730173|P2|Overall Study|Withdrawal by Subject|0
2836417|NCT02587520|9730174|P1|Overall Study|Withdrawal by Subject|0
2836418|NCT02587520|9730157|P18|Overall Study|Adverse Event|0
2836419|NCT02587520|9730158|P17|Overall Study|Adverse Event|0
2836420|NCT02587520|9730159|P16|Overall Study|Adverse Event|0
2836421|NCT02587520|9730160|P15|Overall Study|Adverse Event|0
2836422|NCT02587520|9730161|P14|Overall Study|Adverse Event|0
2836423|NCT02587520|9730162|P13|Overall Study|Adverse Event|0
2836424|NCT02587520|9730163|P12|Overall Study|Adverse Event|1
2836425|NCT02587520|9730164|P11|Overall Study|Adverse Event|0
2836426|NCT02587520|9730165|P10|Overall Study|Adverse Event|0
2836427|NCT02587520|9730166|P9|Overall Study|Adverse Event|0
2836428|NCT02587520|9730167|P8|Overall Study|Adverse Event|0
2836429|NCT02587520|9730168|P7|Overall Study|Adverse Event|0
2836430|NCT02587520|9730169|P6|Overall Study|Adverse Event|0
2836431|NCT02587520|9730170|P5|Overall Study|Adverse Event|0
2836432|NCT02587520|9730171|P4|Overall Study|Adverse Event|0
2836433|NCT02587520|9730172|P3|Overall Study|Adverse Event|0
2836434|NCT02587520|9730173|P2|Overall Study|Adverse Event|0
2836435|NCT02587520|9730174|P1|Overall Study|Adverse Event|0
2836436|NCT02587520|9730157|P18|Overall Study|Protocol Violation|0
2836437|NCT02587520|9730158|P17|Overall Study|Protocol Violation|0
2836438|NCT02587520|9730159|P16|Overall Study|Protocol Violation|0
2836439|NCT02587520|9730160|P15|Overall Study|Protocol Violation|0
2836440|NCT02587520|9730161|P14|Overall Study|Protocol Violation|0
2836441|NCT02587520|9730162|P13|Overall Study|Protocol Violation|0
2836442|NCT02587520|9730163|P12|Overall Study|Protocol Violation|2
2836443|NCT02587520|9730164|P11|Overall Study|Protocol Violation|1
2836444|NCT02587520|9730165|P10|Overall Study|Protocol Violation|3
2836445|NCT02587520|9730166|P9|Overall Study|Protocol Violation|3
2836446|NCT02587520|9730167|P8|Overall Study|Protocol Violation|1
2836447|NCT02587520|9730168|P7|Overall Study|Protocol Violation|1
2836448|NCT02587520|9730169|P6|Overall Study|Protocol Violation|1
2836449|NCT02587520|9730170|P5|Overall Study|Protocol Violation|0
2836450|NCT02587520|9730171|P4|Overall Study|Protocol Violation|2
2836451|NCT02587520|9730172|P3|Overall Study|Protocol Violation|0
2836452|NCT02587520|9730173|P2|Overall Study|Protocol Violation|0
2836453|NCT02587520|9730174|P1|Overall Study|Protocol Violation|2
2836454|NCT02587234|9730214|P2|Overall Study|Lost to Follow-up|2
2836455|NCT02587234|9730215|P1|Overall Study|Lost to Follow-up|0
2836456|NCT02587234|9730214|P2|Overall Study|Withdrawal by Subject|1
2836457|NCT02587234|9730215|P1|Overall Study|Withdrawal by Subject|1
2836458|NCT02587143|9730227|P2|Overall Study|Adverse Event|0
2836459|NCT02587143|9730228|P1|Overall Study|Adverse Event|1
2836460|NCT02587065|9730245|P1|Overall Study|Reason not Specified|3
2836461|NCT02587065|9730245|P1|Overall Study|Discontinuation of Study Medication|2
2836462|NCT02587065|9730245|P1|Overall Study|Non-adherence to the Protocol|3
2836463|NCT02587065|9730245|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
2836464|NCT02587065|9730245|P1|Overall Study|Adverse Event|14
2836465|NCT02586805|9730301|P4|Overall Study|Physician Decision|0
2836466|NCT02586805|9730302|P3|Overall Study|Physician Decision|0
2836467|NCT02586805|9730303|P2|Overall Study|Physician Decision|0
2836468|NCT02586805|9730304|P1|Overall Study|Physician Decision|1
2836469|NCT02586805|9730301|P4|Overall Study|Lost to Follow-up|0
2836470|NCT02586805|9730302|P3|Overall Study|Lost to Follow-up|1
2836471|NCT02586805|9730303|P2|Overall Study|Lost to Follow-up|0
2836472|NCT02586805|9730304|P1|Overall Study|Lost to Follow-up|0
2836473|NCT02586805|9730301|P4|Overall Study|Adverse Event|0
2836474|NCT02586805|9730302|P3|Overall Study|Adverse Event|1
2836475|NCT02586805|9730303|P2|Overall Study|Adverse Event|0
2836476|NCT02586805|9730304|P1|Overall Study|Adverse Event|2
2836477|NCT02586805|9730301|P4|Overall Study|Withdrawal by Subject|2
2836478|NCT02586805|9730302|P3|Overall Study|Withdrawal by Subject|1
2836479|NCT02586805|9730303|P2|Overall Study|Withdrawal by Subject|1
2836480|NCT02586805|9730304|P1|Overall Study|Withdrawal by Subject|3
2836481|NCT02586506|9730332|P1|Overall Study|Other Reason|2
2836482|NCT02586506|9730332|P1|Overall Study|Lost to Follow-up|1
2836483|NCT02586506|9730332|P1|Overall Study|Protocol Violation|6
2836484|NCT02586493|9730338|P1|Overall Study|Withdrawal by Subject|1
2836485|NCT02586493|9730338|P1|Overall Study|Lost to Follow-up|1
2836486|NCT02586493|9730338|P1|Overall Study|Protocol Violation|6
2836487|NCT02586493|9730338|P1|Overall Study|Adverse Event|4
2836488|NCT02586415|9730346|P2|Overall Study|Lost to Follow-up|2
2836489|NCT02586415|9730347|P1|Overall Study|Lost to Follow-up|1
2836490|NCT02586415|9730346|P2|Overall Study|Death|23
2836491|NCT02586415|9730347|P1|Overall Study|Death|13
2836492|NCT02586025|9730359|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
2836493|NCT02586025|9730360|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
2836494|NCT02586025|9730359|P2|Adjuvant Treatment|Recurrent Disease|4
2836495|NCT02586025|9730360|P1|Adjuvant Treatment|Recurrent Disease|1
2836496|NCT02586025|9730359|P2|Adjuvant Treatment|Physician Decision|1
2836497|NCT02586025|9730360|P1|Adjuvant Treatment|Physician Decision|0
2836498|NCT02586025|9730359|P2|Adjuvant Treatment|Withdrawal by Subject|3
2836499|NCT02586025|9730360|P1|Adjuvant Treatment|Withdrawal by Subject|5
2836500|NCT02586025|9730359|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
2836501|NCT02586025|9730360|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
2836502|NCT02586025|9730359|P2|Neoadjuvant Treatment|Progressive Disease|3
2836503|NCT02586025|9730360|P1|Neoadjuvant Treatment|Progressive Disease|2
2836504|NCT02586025|9730359|P2|Neoadjuvant Treatment|Physician Decision|1
2836505|NCT02586025|9730360|P1|Neoadjuvant Treatment|Physician Decision|2
2836506|NCT02586025|9730359|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
2836507|NCT02586025|9730360|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
2836508|NCT02586025|9730359|P2|Neoadjuvant Treatment|Adverse Event|0
2836509|NCT02586025|9730360|P1|Neoadjuvant Treatment|Adverse Event|1
2836510|NCT02586025|9730359|P2|Neoadjuvant Treatment|Death|0
2836511|NCT02586025|9730360|P1|Neoadjuvant Treatment|Death|1
2836512|NCT02586025|9730359|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
2836513|NCT02586025|9730360|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
2836514|NCT02585999|9730396|P1|Overall Study|Protocol Violation|1
2836515|NCT02585999|9730396|P1|Overall Study|Lost to Follow-up|1
2836516|NCT02585960|9730404|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2836517|NCT02585960|9730405|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
2836518|NCT02585960|9730406|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2836519|NCT02585960|9730404|P3|Prophylactic Treatment Period|Major protocol deviation|0
2836520|NCT02585960|9730405|P2|Prophylactic Treatment Period|Major protocol deviation|4
2836521|NCT02585960|9730406|P1|Prophylactic Treatment Period|Major protocol deviation|0
2836522|NCT02585960|9730404|P3|PK/Safety Assessment Period|Screen Failure|1
2836523|NCT02585960|9730405|P2|PK/Safety Assessment Period|Screen Failure|0
2836524|NCT02585960|9730406|P1|PK/Safety Assessment Period|Screen Failure|0
2836525|NCT02585960|9730404|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
2836526|NCT02585960|9730405|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
2836527|NCT02585960|9730406|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
2836528|NCT02585960|9730404|P3|PK/Safety Assessment Period|Other|0
2836529|NCT02585960|9730405|P2|PK/Safety Assessment Period|Other|4
2836530|NCT02585960|9730406|P1|PK/Safety Assessment Period|Other|4
2836531|NCT02585960|9730404|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
2836532|NCT02585960|9730405|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
2836533|NCT02585960|9730406|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
2836534|NCT02585960|9730404|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
2836535|NCT02585960|9730405|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
2836536|NCT02585960|9730406|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
2836537|NCT02585960|9730404|P3|PK/Safety Assessment Period|Physician Decision|0
2836538|NCT02585960|9730405|P2|PK/Safety Assessment Period|Physician Decision|1
2836539|NCT02585960|9730406|P1|PK/Safety Assessment Period|Physician Decision|0
2836540|NCT02585934|9730476|P2|Overall Study|Another Reason|5
2836541|NCT02585934|9730477|P1|Overall Study|Another Reason|10
2836542|NCT02585934|9730476|P2|Overall Study|Sponsor Termination|2
2836543|NCT02585934|9730477|P1|Overall Study|Sponsor Termination|1
2836544|NCT02585934|9730476|P2|Overall Study|Caregiver Withdrew Consent|7
2836545|NCT02585934|9730477|P1|Overall Study|Caregiver Withdrew Consent|7
2836546|NCT02585934|9730476|P2|Overall Study|Death|0
2836547|NCT02585934|9730477|P1|Overall Study|Death|2
2836548|NCT02585934|9730476|P2|Overall Study|Lack of Efficacy|1
2836549|NCT02585934|9730477|P1|Overall Study|Lack of Efficacy|2
2836550|NCT02585934|9730476|P2|Overall Study|Withdrawal by Subject|21
2836551|NCT02585934|9730477|P1|Overall Study|Withdrawal by Subject|7
2836552|NCT02585934|9730476|P2|Overall Study|Physician Decision|2
2836553|NCT02585934|9730477|P1|Overall Study|Physician Decision|3
2836554|NCT02585934|9730476|P2|Overall Study|Adverse Event|22
2836555|NCT02585934|9730477|P1|Overall Study|Adverse Event|21
2836556|NCT02585934|9730476|P2|Overall Study|Protocol Violation|11
2836557|NCT02585934|9730477|P1|Overall Study|Protocol Violation|14
2836558|NCT02585934|9730476|P2|Overall Study|Lost to Follow-up|2
2836559|NCT02585934|9730477|P1|Overall Study|Lost to Follow-up|2
2836560|NCT02585830|9730533|P1|Overall Study|Withdrawal by Subject|3
2836561|NCT02585778|9730542|P2|Overall Study|Other than specified above|2
2836562|NCT02585778|9730543|P1|Overall Study|Other than specified above|6
2836563|NCT02585778|9730542|P2|Overall Study|Randomized but not treated|2
2836564|NCT02585778|9730543|P1|Overall Study|Randomized but not treated|1
2836565|NCT02585778|9730542|P2|Overall Study|Death|1
2836566|NCT02585778|9730543|P1|Overall Study|Death|0
2836567|NCT02585778|9730542|P2|Overall Study|Poor compliance to study protocol|2
2836568|NCT02585778|9730543|P1|Overall Study|Poor compliance to study protocol|0
2836569|NCT02585778|9730542|P2|Overall Study|Participant did not wish to continue|4
2836570|NCT02585778|9730543|P1|Overall Study|Participant did not wish to continue|9
2836571|NCT02585778|9730542|P2|Overall Study|Adverse Event|4
2836572|NCT02585778|9730543|P1|Overall Study|Adverse Event|17
2836573|NCT02585713|9730659|P2|Overall Study|Other|1
2836574|NCT02585713|9730660|P1|Overall Study|Other|3
2836575|NCT02585713|9730659|P2|Overall Study|Withdrew prior to treatment|7
2836576|NCT02585713|9730660|P1|Overall Study|Withdrew prior to treatment|2
2836577|NCT02584959|9730723|P3|Period 2|Withdrawn from study|2
2836578|NCT02584959|9730724|P2|Period 2|Withdrawn from study|1
2836579|NCT02584959|9730725|P1|Period 2|Withdrawn from study|6
2836580|NCT02584959|9730723|P3|Period 1|Withdrawn from study|0
2836581|NCT02584959|9730724|P2|Period 1|Withdrawn from study|4
2836582|NCT02584959|9730725|P1|Period 1|Withdrawn from study|3
2836583|NCT02584855|9730780|P6|Post Treatment Follow-up Period|Protocol Violation|0
2836584|NCT02584855|9730781|P5|Post Treatment Follow-up Period|Protocol Violation|1
2836585|NCT02584855|9730782|P4|Post Treatment Follow-up Period|Protocol Violation|0
2836586|NCT02584855|9730783|P3|Post Treatment Follow-up Period|Protocol Violation|0
2836587|NCT02584855|9730784|P2|Post Treatment Follow-up Period|Protocol Violation|0
2836588|NCT02584855|9730785|P1|Post Treatment Follow-up Period|Protocol Violation|0
2836589|NCT02584855|9730780|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
2836590|NCT02584855|9730781|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
2836591|NCT02584855|9730782|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
2836592|NCT02584855|9730783|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
2836593|NCT02584855|9730784|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
2836594|NCT02584855|9730785|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
2836595|NCT02584855|9730780|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2836596|NCT02584855|9730781|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2836597|NCT02584855|9730782|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2836598|NCT02584855|9730783|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2836599|NCT02584855|9730784|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
2836600|NCT02584855|9730785|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2836601|NCT02584855|9730780|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
2836602|NCT02584855|9730781|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
2836603|NCT02584855|9730782|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
2836604|NCT02584855|9730783|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
2836605|NCT02584855|9730784|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
2836606|NCT02584855|9730785|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
2836607|NCT02584855|9730780|P6|Double-Blind Withdrawal Period|Adverse Event|0
2836608|NCT02584855|9730781|P5|Double-Blind Withdrawal Period|Adverse Event|0
2836609|NCT02584855|9730782|P4|Double-Blind Withdrawal Period|Adverse Event|1
2836610|NCT02584855|9730783|P3|Double-Blind Withdrawal Period|Adverse Event|0
2836611|NCT02584855|9730784|P2|Double-Blind Withdrawal Period|Adverse Event|4
2836612|NCT02584855|9730785|P1|Double-Blind Withdrawal Period|Adverse Event|0
2836613|NCT02584855|9730780|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2836614|NCT02584855|9730781|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2836615|NCT02584855|9730782|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2836616|NCT02584855|9730783|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
2836617|NCT02584855|9730784|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2836618|NCT02584855|9730785|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2836619|NCT02584855|9730780|P6|Open-Label Treatment Period|Sponsor Decision|0
2836620|NCT02584855|9730781|P5|Open-Label Treatment Period|Sponsor Decision|0
2836621|NCT02584855|9730782|P4|Open-Label Treatment Period|Sponsor Decision|0
2836622|NCT02584855|9730783|P3|Open-Label Treatment Period|Sponsor Decision|0
2836623|NCT02584855|9730784|P2|Open-Label Treatment Period|Sponsor Decision|0
2836624|NCT02584855|9730785|P1|Open-Label Treatment Period|Sponsor Decision|1
2836625|NCT02584855|9730780|P6|Open-Label Treatment Period|No PI Available|0
2836626|NCT02584855|9730781|P5|Open-Label Treatment Period|No PI Available|0
2836627|NCT02584855|9730782|P4|Open-Label Treatment Period|No PI Available|0
2836628|NCT02584855|9730783|P3|Open-Label Treatment Period|No PI Available|0
2836629|NCT02584855|9730784|P2|Open-Label Treatment Period|No PI Available|0
2836630|NCT02584855|9730785|P1|Open-Label Treatment Period|No PI Available|2
2836631|NCT02584855|9730780|P6|Open-Label Treatment Period|Protocol Violation|0
2836632|NCT02584855|9730781|P5|Open-Label Treatment Period|Protocol Violation|0
2836633|NCT02584855|9730782|P4|Open-Label Treatment Period|Protocol Violation|0
2836634|NCT02584855|9730783|P3|Open-Label Treatment Period|Protocol Violation|0
2836635|NCT02584855|9730784|P2|Open-Label Treatment Period|Protocol Violation|0
2836636|NCT02584855|9730785|P1|Open-Label Treatment Period|Protocol Violation|1
2836637|NCT02584855|9730780|P6|Open-Label Treatment Period|Lost to Follow-up|0
2836638|NCT02584855|9730781|P5|Open-Label Treatment Period|Lost to Follow-up|0
2836639|NCT02584855|9730782|P4|Open-Label Treatment Period|Lost to Follow-up|0
2836640|NCT02584855|9730783|P3|Open-Label Treatment Period|Lost to Follow-up|0
2836641|NCT02584855|9730784|P2|Open-Label Treatment Period|Lost to Follow-up|0
2836642|NCT02584855|9730785|P1|Open-Label Treatment Period|Lost to Follow-up|1
2836643|NCT02584855|9730780|P6|Open-Label Treatment Period|Death|0
2836644|NCT02584855|9730781|P5|Open-Label Treatment Period|Death|0
2836645|NCT02584855|9730782|P4|Open-Label Treatment Period|Death|0
2836646|NCT02584855|9730783|P3|Open-Label Treatment Period|Death|0
2836647|NCT02584855|9730784|P2|Open-Label Treatment Period|Death|0
2836648|NCT02584855|9730785|P1|Open-Label Treatment Period|Death|2
2836649|NCT02584855|9730780|P6|Open-Label Treatment Period|Adverse Event|0
2836650|NCT02584855|9730781|P5|Open-Label Treatment Period|Adverse Event|0
2836651|NCT02584855|9730782|P4|Open-Label Treatment Period|Adverse Event|0
2836652|NCT02584855|9730783|P3|Open-Label Treatment Period|Adverse Event|0
2836653|NCT02584855|9730784|P2|Open-Label Treatment Period|Adverse Event|0
2836654|NCT02584855|9730785|P1|Open-Label Treatment Period|Adverse Event|14
2836655|NCT02584855|9730780|P6|Open-Label Treatment Period|Withdrawal by Subject|0
2836656|NCT02584855|9730781|P5|Open-Label Treatment Period|Withdrawal by Subject|0
2836657|NCT02584855|9730782|P4|Open-Label Treatment Period|Withdrawal by Subject|0
2836658|NCT02584855|9730783|P3|Open-Label Treatment Period|Withdrawal by Subject|0
2836659|NCT02584855|9730784|P2|Open-Label Treatment Period|Withdrawal by Subject|0
2836660|NCT02584855|9730785|P1|Open-Label Treatment Period|Withdrawal by Subject|21
2836661|NCT02584855|9730780|P6|Open-Label Treatment Period|Lack of Efficacy|0
2836662|NCT02584855|9730781|P5|Open-Label Treatment Period|Lack of Efficacy|0
2836663|NCT02584855|9730782|P4|Open-Label Treatment Period|Lack of Efficacy|0
2836664|NCT02584855|9730783|P3|Open-Label Treatment Period|Lack of Efficacy|0
2836665|NCT02584855|9730784|P2|Open-Label Treatment Period|Lack of Efficacy|0
2836666|NCT02584855|9730785|P1|Open-Label Treatment Period|Lack of Efficacy|61
2836667|NCT02584660|9730871|P2|Overall Study|Other|1
2836668|NCT02584660|9730872|P1|Overall Study|Other|0
2836669|NCT02584660|9730871|P2|Overall Study|Withdrawal by Subject|2
2836670|NCT02584660|9730872|P1|Overall Study|Withdrawal by Subject|0
2836671|NCT02584660|9730871|P2|Overall Study|Protocol Violation|1
2836672|NCT02584660|9730872|P1|Overall Study|Protocol Violation|0
2836673|NCT02584660|9730871|P2|Overall Study|Lost to Follow-up|4
2836674|NCT02584660|9730872|P1|Overall Study|Lost to Follow-up|3
2836675|NCT02584660|9730871|P2|Overall Study|Adverse Event|0
2836676|NCT02584660|9730872|P1|Overall Study|Adverse Event|4
2836677|NCT02584504|9730891|P3|Open-label Treatment|Entered but not treated|1
2836678|NCT02584504|9730892|P2|Open-label Treatment|Entered but not treated|1
2836679|NCT02584504|9730893|P1|Open-label Treatment|Entered but not treated|0
2836680|NCT02584504|9730891|P3|Open-label Treatment|Physician Decision|0
2836681|NCT02584504|9730892|P2|Open-label Treatment|Physician Decision|1
2836682|NCT02584504|9730893|P1|Open-label Treatment|Physician Decision|0
2836683|NCT02584504|9730891|P3|Open-label Treatment|Adverse Event|3
2836684|NCT02584504|9730892|P2|Open-label Treatment|Adverse Event|2
2836685|NCT02584504|9730893|P1|Open-label Treatment|Adverse Event|2
2836686|NCT02584504|9730891|P3|Open-label Treatment|Participant withdrew consent|4
2836687|NCT02584504|9730892|P2|Open-label Treatment|Participant withdrew consent|0
2836688|NCT02584504|9730893|P1|Open-label Treatment|Participant withdrew consent|0
2836689|NCT02584504|9730891|P3|Double-blind Treatment|Family Matter|0
2836690|NCT02584504|9730892|P2|Double-blind Treatment|Family Matter|1
2836691|NCT02584504|9730893|P1|Double-blind Treatment|Family Matter|0
2836692|NCT02584504|9730891|P3|Double-blind Treatment|Adverse Event|0
2836693|NCT02584504|9730892|P2|Double-blind Treatment|Adverse Event|1
2836694|NCT02584504|9730893|P1|Double-blind Treatment|Adverse Event|0
2836695|NCT02584504|9730891|P3|Double-blind Treatment|Participant withdrew consent|1
2836696|NCT02584504|9730892|P2|Double-blind Treatment|Participant withdrew consent|0
2836697|NCT02584504|9730893|P1|Double-blind Treatment|Participant withdrew consent|0
2836698|NCT02584452|9730949|P2|Overall Study|Lost to Follow-up|1
2836699|NCT02584452|9730950|P1|Overall Study|Lost to Follow-up|1
2836700|NCT02584452|9730949|P2|Overall Study|Physician Decision|1
2836701|NCT02584452|9730950|P1|Overall Study|Physician Decision|1
2836702|NCT02583477|9730987|P2|Overall Study|Study terminated|2
2836703|NCT02583477|9730988|P1|Overall Study|Study terminated|2
2836704|NCT02583477|9730987|P2|Overall Study|Death|16
2836705|NCT02583477|9730988|P1|Overall Study|Death|1
2836706|NCT02583477|9730987|P2|Overall Study|Adverse Event|2
2836707|NCT02583477|9730988|P1|Overall Study|Adverse Event|0
2836708|NCT02583425|9731008|P1|Treatment Period|Adverse Event|1
2836709|NCT02583425|9731008|P1|Baseline|Did not meet continued criteria|5
2836710|NCT02583425|9731008|P1|Screening|Did not meet entry criteria|12
2836711|NCT02583269|9731018|P5|Overall Study|Patient hospitalized prior to start|0
2836712|NCT02583269|9731019|P4|Overall Study|Patient hospitalized prior to start|0
2836713|NCT02583269|9731020|P3|Overall Study|Patient hospitalized prior to start|0
2836714|NCT02583269|9731021|P2|Overall Study|Patient hospitalized prior to start|0
2836715|NCT02583269|9731022|P1|Overall Study|Patient hospitalized prior to start|1
2836716|NCT02583256|9731051|P4|Overall Study|Administrative/Other|2
2836717|NCT02583256|9731052|P3|Overall Study|Administrative/Other|1
2836718|NCT02583256|9731053|P2|Overall Study|Administrative/Other|0
2836719|NCT02583256|9731054|P1|Overall Study|Administrative/Other|2
2836720|NCT02583256|9731051|P4|Overall Study|Lost to Follow-up|1
2836721|NCT02583256|9731052|P3|Overall Study|Lost to Follow-up|0
2836722|NCT02583256|9731053|P2|Overall Study|Lost to Follow-up|1
2836723|NCT02583256|9731054|P1|Overall Study|Lost to Follow-up|1
2836724|NCT02583256|9731051|P4|Overall Study|Withdrawal by Subject|0
2836725|NCT02583256|9731052|P3|Overall Study|Withdrawal by Subject|1
2836726|NCT02583256|9731053|P2|Overall Study|Withdrawal by Subject|1
2836727|NCT02583256|9731054|P1|Overall Study|Withdrawal by Subject|0
2836728|NCT02583048|9731151|P3|Overall Study|Failed to meet eligibility criterion|1
2836729|NCT02583048|9731152|P2|Overall Study|Failed to meet eligibility criterion|0
2836730|NCT02583048|9731153|P1|Overall Study|Failed to meet eligibility criterion|0
2836731|NCT02583048|9731151|P3|Overall Study|Withdrawal by Subject|0
2836732|NCT02583048|9731152|P2|Overall Study|Withdrawal by Subject|1
2836733|NCT02583048|9731153|P1|Overall Study|Withdrawal by Subject|0
2836734|NCT02582983|9731188|P1|Overall Study|Adverse Event|1
2836735|NCT02582983|9731188|P1|Overall Study|Withdrawal by Subject|2
2836736|NCT02582983|9731188|P1|Overall Study|Death|3
2836737|NCT02582814|9731251|P2|Overall Study|Adverse Event|4
2836738|NCT02582814|9731252|P1|Overall Study|Adverse Event|4
2836739|NCT02582814|9731251|P2|Overall Study|Withdrawal by Subject|3
2836740|NCT02582814|9731252|P1|Overall Study|Withdrawal by Subject|4
2836741|NCT02582814|9731251|P2|Overall Study|Study-specific withdrawal criteria|0
2836742|NCT02582814|9731252|P1|Overall Study|Study-specific withdrawal criteria|1
2836743|NCT02582749|9731292|P2|Overall Study|Withdrawal by Subject|1
2836744|NCT02582749|9731293|P1|Overall Study|Withdrawal by Subject|0
2836745|NCT02582749|9731292|P2|Overall Study|Study terminated by funder|10
2836746|NCT02582749|9731293|P1|Overall Study|Study terminated by funder|5
2836747|NCT02582684|9731323|P1|Overall Study|Found to be ineligible after enrollment|2
2836748|NCT02582684|9731323|P1|Overall Study|Subject withdrew consent|1
2836749|NCT02582684|9731323|P1|Overall Study|Subject not able to get to clinic|10
2836750|NCT02582684|9731323|P1|Overall Study|Unable to contact subject/parent|4
2836751|NCT02582671|9731342|P1|Overall Study|Other, not specified|1
2836752|NCT02582671|9731342|P1|Overall Study|Failure to return|1
2836753|NCT02582658|9731354|P1|Overall Study|Not further specified|11
2836754|NCT02582658|9731354|P1|Overall Study|Death|1
2836755|NCT02582658|9731354|P1|Overall Study|Withdrawn Consent|1
2836756|NCT02582658|9731354|P1|Overall Study|Insufficient Virological Response|2
2836757|NCT02582658|9731354|P1|Overall Study|Failure to Return|10
2836758|NCT02582632|9731372|P1|Overall Study|Other|1
2836759|NCT02582515|9731387|P2|Overall Study|Withdrawal by Subject|1
2836760|NCT02582515|9731388|P1|Overall Study|Withdrawal by Subject|0
2836761|NCT02582255|9731396|P2|Overall Study|Protocol Violation|3
2836762|NCT02582255|9731397|P1|Overall Study|Protocol Violation|0
2836763|NCT02582242|9731410|P2|Overall Study|Unclassified|1
2836764|NCT02582242|9731411|P1|Overall Study|Unclassified|2
2836765|NCT02582242|9731410|P2|Overall Study|Withdrawal by Subject|11
2836766|NCT02582242|9731411|P1|Overall Study|Withdrawal by Subject|11
2836767|NCT02582242|9731410|P2|Overall Study|Lost to Follow-up|1
2836768|NCT02582242|9731411|P1|Overall Study|Lost to Follow-up|0
2836769|NCT02582242|9731410|P2|Overall Study|Protocol Violation|1
2836770|NCT02582242|9731411|P1|Overall Study|Protocol Violation|3
2836771|NCT02582242|9731410|P2|Overall Study|Adverse Event|3
2836772|NCT02582242|9731411|P1|Overall Study|Adverse Event|4
2836773|NCT02581995|9731470|P1|Overall Study|Death|4
2836774|NCT02581995|9731470|P1|Overall Study|Physician Decision|1
2836775|NCT02581995|9731470|P1|Overall Study|Withdrawal by participant|12
2836776|NCT02581995|9731470|P1|Overall Study|Lost to Follow-up|5
2836777|NCT02581995|9731470|P1|Overall Study|Adverse Event|6
2836778|NCT02581995|9731470|P1|Overall Study|Unspecified other|3
2836779|NCT02581930|9731484|P1|Overall Study|patient declined further treatment|1
2836780|NCT02581930|9731484|P1|Overall Study|Withdrawal by Subject|1
2836781|NCT02581891|9731492|P2|Overall Study|Discontinued during followup|0
2836782|NCT02581891|9731493|P1|Overall Study|Discontinued during followup|1
2836783|NCT02581891|9731492|P2|Overall Study|Other Reasons|1
2836784|NCT02581891|9731493|P1|Overall Study|Other Reasons|3
2836785|NCT02581891|9731492|P2|Overall Study|Withdrawal by Subject|5
2836786|NCT02581891|9731493|P1|Overall Study|Withdrawal by Subject|4
2836787|NCT02581891|9731492|P2|Overall Study|Physician Decision|1
2836788|NCT02581891|9731493|P1|Overall Study|Physician Decision|0
2836789|NCT02581891|9731492|P2|Overall Study|Lost to Follow-up|2
2836790|NCT02581891|9731493|P1|Overall Study|Lost to Follow-up|1
2836791|NCT02581891|9731492|P2|Overall Study|Death|4
2836792|NCT02581891|9731493|P1|Overall Study|Death|3
2836793|NCT02581891|9731492|P2|Overall Study|Adverse Event|6
2836794|NCT02581891|9731493|P1|Overall Study|Adverse Event|4
2836795|NCT02581488|9731556|P2|Overall Study|Protocol Violation|4
2836796|NCT02581488|9731557|P1|Overall Study|Protocol Violation|0
2836797|NCT02581488|9731556|P2|Overall Study|Non-Compliance|0
2836798|NCT02581488|9731557|P1|Overall Study|Non-Compliance|1
2836799|NCT02581488|9731556|P2|Overall Study|Withdrawal by Subject|0
2836800|NCT02581488|9731557|P1|Overall Study|Withdrawal by Subject|1
2836801|NCT02581488|9731556|P2|Overall Study|Lost to Follow-up|0
2836802|NCT02581488|9731557|P1|Overall Study|Lost to Follow-up|1
2836803|NCT02581488|9731556|P2|Overall Study|Adverse Event|7
2836804|NCT02581488|9731557|P1|Overall Study|Adverse Event|6
2836805|NCT02581410|9731588|P2|End of Study Phase|Other-transfer of subject not completed|1
2836806|NCT02581410|9731589|P1|End of Study Phase|Other-transfer of subject not completed|0
2836807|NCT02581410|9731588|P2|End of Study Phase|Lost to Follow-up|2
2836808|NCT02581410|9731589|P1|End of Study Phase|Lost to Follow-up|0
2836809|NCT02581410|9731588|P2|End of Study Phase|Migrated/moved from study area|3
2836810|NCT02581410|9731589|P1|End of Study Phase|Migrated/moved from study area|0
2836811|NCT02581410|9731588|P2|End of Study Phase|Withdrawal by Subject|2
2836812|NCT02581410|9731589|P1|End of Study Phase|Withdrawal by Subject|1
2836813|NCT02581410|9731588|P2|End of Study Phase|Adverse Event|3
2836814|NCT02581410|9731589|P1|End of Study Phase|Adverse Event|4
2836815|NCT02581410|9731588|P2|Vaccination Phase|Migrated/moved from study area|1
2836816|NCT02581410|9731589|P1|Vaccination Phase|Migrated/moved from study area|0
2836817|NCT02581410|9731588|P2|Vaccination Phase|Withdrawal by Subject|1
2836818|NCT02581410|9731589|P1|Vaccination Phase|Withdrawal by Subject|0
2836819|NCT02581410|9731588|P2|Vaccination Phase|Adverse Event|1
2836820|NCT02581410|9731589|P1|Vaccination Phase|Adverse Event|2
2836821|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
2836822|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
2836823|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
2836824|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
2836825|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
2836826|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2836827|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2836828|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
2836829|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
2836830|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
2836831|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
2836832|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
2836833|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
2836834|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
2836835|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
2836836|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
2836837|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Physician Decision|1
2836838|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Physician Decision|2
2836839|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Physician Decision|0
2836840|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Physician Decision|3
2836841|NCT02581345|9731619|P4|Part 2: Week 17 to Week 47|Adverse Event|2
2836842|NCT02581345|9731620|P3|Part 2: Week 17 to Week 47|Adverse Event|2
2836843|NCT02581345|9731621|P2|Part 2: Week 17 to Week 47|Adverse Event|0
2836844|NCT02581345|9731622|P1|Part 2: Week 17 to Week 47|Adverse Event|5
2836845|NCT02581345|9731619|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
2836846|NCT02581345|9731620|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
2836847|NCT02581345|9731621|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
2836848|NCT02581345|9731622|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
2836849|NCT02581345|9731619|P4|Part 1: up to Week 16|Unspecified Reason|0
2836850|NCT02581345|9731620|P3|Part 1: up to Week 16|Unspecified Reason|0
2836851|NCT02581345|9731621|P2|Part 1: up to Week 16|Unspecified Reason|3
2836852|NCT02581345|9731622|P1|Part 1: up to Week 16|Unspecified Reason|3
2836853|NCT02581345|9731619|P4|Part 1: up to Week 16|Lost to Follow-up|0
2836854|NCT02581345|9731620|P3|Part 1: up to Week 16|Lost to Follow-up|0
2836855|NCT02581345|9731621|P2|Part 1: up to Week 16|Lost to Follow-up|0
2836856|NCT02581345|9731622|P1|Part 1: up to Week 16|Lost to Follow-up|2
2836857|NCT02581345|9731619|P4|Part 1: up to Week 16|Withdrawal by Subject|0
2836858|NCT02581345|9731620|P3|Part 1: up to Week 16|Withdrawal by Subject|0
2836859|NCT02581345|9731621|P2|Part 1: up to Week 16|Withdrawal by Subject|7
2836860|NCT02581345|9731622|P1|Part 1: up to Week 16|Withdrawal by Subject|4
2836861|NCT02581345|9731619|P4|Part 1: up to Week 16|Physician Decision|0
2836862|NCT02581345|9731620|P3|Part 1: up to Week 16|Physician Decision|0
2836863|NCT02581345|9731621|P2|Part 1: up to Week 16|Physician Decision|4
2836864|NCT02581345|9731622|P1|Part 1: up to Week 16|Physician Decision|2
2836865|NCT02581345|9731619|P4|Part 1: up to Week 16|Adverse Event|0
2836866|NCT02581345|9731620|P3|Part 1: up to Week 16|Adverse Event|0
2836867|NCT02581345|9731621|P2|Part 1: up to Week 16|Adverse Event|8
2836868|NCT02581345|9731622|P1|Part 1: up to Week 16|Adverse Event|3
2836869|NCT02581202|9731724|P1|Overall Study|Pregnancy|3
2836870|NCT02581202|9731724|P1|Overall Study|Lost to Follow-up|5
2836871|NCT02581202|9731724|P1|Overall Study|Withdrawal by Subject|4
2836872|NCT02581202|9731724|P1|Overall Study|Lack of Efficacy|2
2836873|NCT02581189|9731763|P1|Overall Study|Other, not specified|7
2836874|NCT02581189|9731763|P1|Overall Study|Insufficient virological response|2
2836875|NCT02581189|9731763|P1|Overall Study|Death|3
2836876|NCT02581189|9731763|P1|Overall Study|Withdrew consent|5
2836877|NCT02581189|9731763|P1|Overall Study|Failure to return|36
2836878|NCT02581163|9731777|P1|Overall Study|Other, not specified|9
2836879|NCT02581163|9731777|P1|Overall Study|Death|1
2836880|NCT02581163|9731777|P1|Overall Study|Withdrew consent|1
2836881|NCT02581163|9731777|P1|Overall Study|Insufficient virological response|3
2836882|NCT02581163|9731777|P1|Overall Study|Failure to return|15
2836883|NCT02580591|9731835|P4|Overall Study|Other than specified|2
2836884|NCT02580591|9731836|P3|Overall Study|Other than specified|5
2836885|NCT02580591|9731837|P2|Overall Study|Other than specified|2
2836886|NCT02580591|9731838|P1|Overall Study|Other than specified|3
2836887|NCT02580591|9731835|P4|Overall Study|Not treated|0
2836888|NCT02580591|9731836|P3|Overall Study|Not treated|0
2836889|NCT02580591|9731837|P2|Overall Study|Not treated|1
2836890|NCT02580591|9731838|P1|Overall Study|Not treated|1
2836891|NCT02580591|9731835|P4|Overall Study|Withdrawal by Subject|3
2836892|NCT02580591|9731836|P3|Overall Study|Withdrawal by Subject|2
2836893|NCT02580591|9731837|P2|Overall Study|Withdrawal by Subject|1
2836894|NCT02580591|9731838|P1|Overall Study|Withdrawal by Subject|6
2836895|NCT02580591|9731835|P4|Overall Study|Lost to Follow-up|1
2836896|NCT02580591|9731836|P3|Overall Study|Lost to Follow-up|3
2836897|NCT02580591|9731837|P2|Overall Study|Lost to Follow-up|3
2836898|NCT02580591|9731838|P1|Overall Study|Lost to Follow-up|5
2836899|NCT02580591|9731835|P4|Overall Study|Protocol Violation|1
2836900|NCT02580591|9731836|P3|Overall Study|Protocol Violation|1
2836901|NCT02580591|9731837|P2|Overall Study|Protocol Violation|2
2836902|NCT02580591|9731838|P1|Overall Study|Protocol Violation|3
2836903|NCT02580591|9731835|P4|Overall Study|Adverse Event|5
2836904|NCT02580591|9731836|P3|Overall Study|Adverse Event|2
2836905|NCT02580591|9731837|P2|Overall Study|Adverse Event|1
2836906|NCT02580591|9731838|P1|Overall Study|Adverse Event|0
2836907|NCT02580357|9731871|P3|Overall Study|Protocol Violation|0
2836908|NCT02580357|9731872|P2|Overall Study|Protocol Violation|0
2836909|NCT02580357|9731873|P1|Overall Study|Protocol Violation|1
2836910|NCT02580357|9731871|P3|Overall Study|Lost to Follow-up|0
2836911|NCT02580357|9731872|P2|Overall Study|Lost to Follow-up|0
2836912|NCT02580357|9731873|P1|Overall Study|Lost to Follow-up|2
2836913|NCT02580240|9731890|P2|Overall Study|Physician Decision|0
2836914|NCT02580240|9731891|P1|Overall Study|Physician Decision|2
2836915|NCT02580058|9731915|P3|Overall Study|Withdrawal by Subject|36
2836916|NCT02580058|9731916|P2|Overall Study|Withdrawal by Subject|26
2836917|NCT02580058|9731917|P1|Overall Study|Withdrawal by Subject|24
2836918|NCT02580058|9731915|P3|Overall Study|Ongoing|46
2836919|NCT02580058|9731916|P2|Overall Study|Ongoing|55
2836920|NCT02580058|9731917|P1|Overall Study|Ongoing|51
2836921|NCT02580058|9731915|P3|Overall Study|Lost to Follow-up|4
2836922|NCT02580058|9731916|P2|Overall Study|Lost to Follow-up|5
2836923|NCT02580058|9731917|P1|Overall Study|Lost to Follow-up|4
2836924|NCT02579928|9731984|P2|Overall Study|Withdrawal by Subject|0
2836925|NCT02579928|9731985|P1|Overall Study|Withdrawal by Subject|1
2836926|NCT02579863|9732025|P2|Overall Study|Withdrawal by Subject|19
2836927|NCT02579863|9732026|P1|Overall Study|Withdrawal by Subject|17
2836928|NCT02579863|9732025|P2|Overall Study|Study Terminated at Selected Sites|3
2836929|NCT02579863|9732026|P1|Overall Study|Study Terminated at Selected Sites|3
2836930|NCT02579863|9732025|P2|Overall Study|Screen Failure|2
2836931|NCT02579863|9732026|P1|Overall Study|Screen Failure|1
2836932|NCT02579863|9732025|P2|Overall Study|Physician Decision|2
2836933|NCT02579863|9732026|P1|Overall Study|Physician Decision|0
2836934|NCT02579863|9732025|P2|Overall Study|Lost to Follow-up|1
2836935|NCT02579863|9732026|P1|Overall Study|Lost to Follow-up|2
2836936|NCT02579863|9732025|P2|Overall Study|Death|3
2836937|NCT02579863|9732026|P1|Overall Study|Death|11
2836938|NCT02579863|9732025|P2|Overall Study|Adverse Event|12
2836939|NCT02579863|9732026|P1|Overall Study|Adverse Event|17
2836940|NCT02579863|9732025|P2|Overall Study|Ongoing in Trial|112
2836941|NCT02579863|9732026|P1|Overall Study|Ongoing in Trial|105
2836942|NCT02579772|9732046|P2|Overall Study|flu-like illness, orthopedic trauma|1
2836943|NCT02579772|9732047|P1|Overall Study|flu-like illness, orthopedic trauma|1
2836944|NCT02579772|9732046|P2|Overall Study|Usage of additional antioxidants|0
2836945|NCT02579772|9732047|P1|Overall Study|Usage of additional antioxidants|1
2836946|NCT02579772|9732046|P2|Overall Study|Withdrawal by Subject|1
2836947|NCT02579772|9732047|P1|Overall Study|Withdrawal by Subject|0
2836948|NCT02579759|9732068|P3|Overall Study|Lost to Follow-up|2
2836949|NCT02579759|9732069|P2|Overall Study|Lost to Follow-up|2
2836950|NCT02579759|9732070|P1|Overall Study|Lost to Follow-up|2
2836951|NCT02579759|9732068|P3|Overall Study|Withdrawal by Subject|5
2836952|NCT02579759|9732069|P2|Overall Study|Withdrawal by Subject|3
2836953|NCT02579759|9732070|P1|Overall Study|Withdrawal by Subject|3
2836954|NCT02579759|9732068|P3|Overall Study|Adverse Event|1
2836955|NCT02579759|9732069|P2|Overall Study|Adverse Event|3
2836956|NCT02579759|9732070|P1|Overall Study|Adverse Event|4
2836957|NCT02579759|9732068|P3|Overall Study|Inclusion/exclusion criteria|1
2836958|NCT02579759|9732069|P2|Overall Study|Inclusion/exclusion criteria|0
2836959|NCT02579759|9732070|P1|Overall Study|Inclusion/exclusion criteria|0
2836960|NCT02579759|9732068|P3|Overall Study|Pregnancy|0
2836961|NCT02579759|9732069|P2|Overall Study|Pregnancy|1
2836962|NCT02579759|9732070|P1|Overall Study|Pregnancy|0
2836963|NCT02579759|9732068|P3|Overall Study|Non compliance|0
2836964|NCT02579759|9732069|P2|Overall Study|Non compliance|1
2836965|NCT02579759|9732070|P1|Overall Study|Non compliance|0
2836966|NCT02579759|9732068|P3|Overall Study|Sponsor stopped Dose 2|0
2836967|NCT02579759|9732069|P2|Overall Study|Sponsor stopped Dose 2|41
2836968|NCT02579759|9732070|P1|Overall Study|Sponsor stopped Dose 2|0
2836969|NCT02579759|9732068|P3|Overall Study|BfArM hold|12
2836970|NCT02579759|9732069|P2|Overall Study|BfArM hold|12
2836971|NCT02579759|9732070|P1|Overall Study|BfArM hold|13
2836972|NCT02579759|9732068|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
2836973|NCT02579759|9732069|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
2836974|NCT02579759|9732070|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
2836975|NCT02579759|9732068|P3|Overall Study|Protocol Violation|0
2836976|NCT02579759|9732069|P2|Overall Study|Protocol Violation|0
2836977|NCT02579759|9732070|P1|Overall Study|Protocol Violation|2
2836978|NCT02579603|9732116|P2|Overall Study|Other than stated|0
2836979|NCT02579603|9732117|P1|Overall Study|Other than stated|1
2836980|NCT02579603|9732116|P2|Overall Study|Adverse Event|2
2836981|NCT02579603|9732117|P1|Overall Study|Adverse Event|2
2836982|NCT02579603|9732116|P2|Overall Study|Not treated|0
2836983|NCT02579603|9732117|P1|Overall Study|Not treated|1
2836984|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2836985|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2836986|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
2836987|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
2836988|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2836989|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2836990|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
2836991|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
2836992|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2836993|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2836994|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
2836995|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
2836996|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2836997|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2836998|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
2836999|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
2837000|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Investigator’s discretion|0
2837001|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Investigator’s discretion|2
2837002|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Investigator’s discretion|0
2837003|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Investigator’s discretion|1
2837004|NCT02579382|9732147|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
2837005|NCT02579382|9732148|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
2837006|NCT02579382|9732149|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
2837007|NCT02579382|9732150|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
2837008|NCT02579382|9732147|P4|Main Study Phase|Lack of Efficacy|1
2837009|NCT02579382|9732148|P3|Main Study Phase|Lack of Efficacy|0
2837010|NCT02579382|9732149|P2|Main Study Phase|Lack of Efficacy|0
2837011|NCT02579382|9732150|P1|Main Study Phase|Lack of Efficacy|0
2837012|NCT02579382|9732147|P4|Main Study Phase|Withdrew Consent|2
2837013|NCT02579382|9732148|P3|Main Study Phase|Withdrew Consent|0
2837014|NCT02579382|9732149|P2|Main Study Phase|Withdrew Consent|0
2837015|NCT02579382|9732150|P1|Main Study Phase|Withdrew Consent|0
2837016|NCT02579382|9732147|P4|Main Study Phase|Lost to Follow-up|0
2837017|NCT02579382|9732148|P3|Main Study Phase|Lost to Follow-up|2
2837018|NCT02579382|9732149|P2|Main Study Phase|Lost to Follow-up|0
2837019|NCT02579382|9732150|P1|Main Study Phase|Lost to Follow-up|0
2837020|NCT02578992|9732272|P2|Overall Study|equipment not available or malfunction|3
2837021|NCT02578992|9732273|P1|Overall Study|equipment not available or malfunction|3
2837022|NCT02578940|9732285|P1|Overall Study|Lost to Follow-up|1
2837023|NCT02578940|9732285|P1|Overall Study|Screening failure|5
2837024|NCT02578862|9732294|P2|Overall Study|Unplanned unilateral procedure|1
2837025|NCT02578862|9732295|P1|Overall Study|Unplanned unilateral procedure|0
2837026|NCT02578862|9732294|P2|Overall Study|Withdrawal by Subject|1
2837027|NCT02578862|9732295|P1|Overall Study|Withdrawal by Subject|0
2837028|NCT02578706|9732333|P3|Overall Study|Physician Decision|0
2837029|NCT02578706|9732334|P2|Overall Study|Physician Decision|1
2837030|NCT02578706|9732335|P1|Overall Study|Physician Decision|0
2837031|NCT02578706|9732333|P3|Overall Study|Lost to Follow-up|0
2837032|NCT02578706|9732334|P2|Overall Study|Lost to Follow-up|4
2837033|NCT02578706|9732335|P1|Overall Study|Lost to Follow-up|0
2837034|NCT02578706|9732333|P3|Overall Study|Withdrawal by Subject|0
2837035|NCT02578706|9732334|P2|Overall Study|Withdrawal by Subject|0
2837036|NCT02578706|9732335|P1|Overall Study|Withdrawal by Subject|1
2837037|NCT02578680|9732414|P2|Overall Study|Ongoing in Study|96
2837038|NCT02578680|9732415|P1|Overall Study|Ongoing in Study|276
2837039|NCT02578680|9732414|P2|Overall Study|Withdrawal by Subject|5
2837040|NCT02578680|9732415|P1|Overall Study|Withdrawal by Subject|8
2837041|NCT02578680|9732414|P2|Overall Study|Withdrawal by Parent/Guardian|0
2837042|NCT02578680|9732415|P1|Overall Study|Withdrawal by Parent/Guardian|1
2837043|NCT02578680|9732414|P2|Overall Study|Protocol Violation|1
2837044|NCT02578680|9732415|P1|Overall Study|Protocol Violation|1
2837045|NCT02578680|9732414|P2|Overall Study|Death|104
2837046|NCT02578680|9732415|P1|Overall Study|Death|124
2837047|NCT02578316|9732431|P1|Extension Phase|Progression of disease|6
2837048|NCT02578186|9732464|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
2837049|NCT02578186|9732465|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
2837050|NCT02578186|9732464|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2837051|NCT02578186|9732465|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2837052|NCT02577887|9732554|P1|Overall Study|Withdrawal by Subject|80
2837053|NCT02577887|9732554|P1|Overall Study|Protocol Violation|125
2837054|NCT02577887|9732554|P1|Overall Study|Death|93
2837055|NCT02577718|9732580|P1|Overall Study|Withdrawal by Subject|2
2837056|NCT02577718|9732580|P1|Overall Study|Death|6
2837057|NCT02577315|9732622|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2837058|NCT02577315|9732623|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2837059|NCT02577146|9732639|P1|Overall Study|Screen Failure|17
2837060|NCT02577146|9732639|P1|Overall Study|Physician Decision|3
2837061|NCT02577146|9732639|P1|Overall Study|Lost to Follow-up|8
2837062|NCT02577107|9732646|P2|Overall Study|Protocol deviation|1
2837063|NCT02577107|9732647|P1|Overall Study|Protocol deviation|0
2837064|NCT02577029|9732667|P8|Overall Study|Sponsor Termination of the Study|12
2837065|NCT02577029|9732668|P7|Overall Study|Sponsor Termination of the Study|12
2837066|NCT02577029|9732669|P6|Overall Study|Sponsor Termination of the Study|12
2837067|NCT02577029|9732670|P5|Overall Study|Sponsor Termination of the Study|10
2837068|NCT02577029|9732671|P4|Overall Study|Sponsor Termination of the Study|12
2837069|NCT02577029|9732672|P3|Overall Study|Sponsor Termination of the Study|5
2837070|NCT02577029|9732673|P2|Overall Study|Sponsor Termination of the Study|2
2837071|NCT02577029|9732674|P1|Overall Study|Sponsor Termination of the Study|9
2837072|NCT02577029|9732667|P8|Overall Study|Withdrawal by Subject|0
2837073|NCT02577029|9732668|P7|Overall Study|Withdrawal by Subject|0
2837074|NCT02577029|9732669|P6|Overall Study|Withdrawal by Subject|1
2837075|NCT02577029|9732670|P5|Overall Study|Withdrawal by Subject|0
2837076|NCT02577029|9732671|P4|Overall Study|Withdrawal by Subject|0
2837077|NCT02577029|9732672|P3|Overall Study|Withdrawal by Subject|0
2837078|NCT02577029|9732673|P2|Overall Study|Withdrawal by Subject|0
2837079|NCT02577029|9732674|P1|Overall Study|Withdrawal by Subject|0
2837080|NCT02577029|9732667|P8|Overall Study|Adverse Event|0
2837081|NCT02577029|9732668|P7|Overall Study|Adverse Event|0
2837082|NCT02577029|9732669|P6|Overall Study|Adverse Event|0
2837083|NCT02577029|9732670|P5|Overall Study|Adverse Event|1
2837084|NCT02577029|9732671|P4|Overall Study|Adverse Event|0
2837085|NCT02577029|9732672|P3|Overall Study|Adverse Event|2
2837086|NCT02577029|9732673|P2|Overall Study|Adverse Event|0
2837087|NCT02577029|9732674|P1|Overall Study|Adverse Event|1
2837088|NCT02577016|9732782|P2|Overall Study|Physician Decision|1
2837089|NCT02577016|9732783|P1|Overall Study|Physician Decision|0
2837090|NCT02577016|9732782|P2|Overall Study|Adverse Event|1
2837091|NCT02577016|9732783|P1|Overall Study|Adverse Event|2
2837092|NCT02577003|9732801|P2|Overall Study|Withdrawal by Subject|1
2837093|NCT02577003|9732802|P1|Overall Study|Withdrawal by Subject|0
2837094|NCT02577003|9732801|P2|Overall Study|Adverse Event|4
2837095|NCT02577003|9732802|P1|Overall Study|Adverse Event|2
2837096|NCT02576977|9732822|P2|Overall Study|Ongoing in trial|77
2837097|NCT02576977|9732823|P1|Overall Study|Ongoing in trial|53
2837098|NCT02576977|9732822|P2|Overall Study|Withdrawal by Subject|9
2837099|NCT02576977|9732823|P1|Overall Study|Withdrawal by Subject|9
2837100|NCT02576977|9732822|P2|Overall Study|Study Terminated at Selected Sites|2
2837101|NCT02576977|9732823|P1|Overall Study|Study Terminated at Selected Sites|3
2837102|NCT02576977|9732822|P2|Overall Study|Screen failure|0
2837103|NCT02576977|9732823|P1|Overall Study|Screen failure|1
2837104|NCT02576977|9732822|P2|Overall Study|Death|35
2837105|NCT02576977|9732823|P1|Overall Study|Death|47
2837106|NCT02576977|9732822|P2|Overall Study|Adverse Event|2
2837107|NCT02576977|9732823|P1|Overall Study|Adverse Event|13
2837108|NCT02576951|9732845|P4|Overall Study|Protocol Violation|1
2837109|NCT02576951|9732846|P3|Overall Study|Protocol Violation|0
2837110|NCT02576951|9732847|P2|Overall Study|Protocol Violation|0
2837111|NCT02576951|9732848|P1|Overall Study|Protocol Violation|0
2837112|NCT02576951|9732845|P4|Overall Study|Withdrawal by Subject|2
2837113|NCT02576951|9732846|P3|Overall Study|Withdrawal by Subject|0
2837114|NCT02576951|9732847|P2|Overall Study|Withdrawal by Subject|0
2837115|NCT02576951|9732848|P1|Overall Study|Withdrawal by Subject|1
2837116|NCT02576951|9732845|P4|Overall Study|Lost to Follow-up|2
2837117|NCT02576951|9732846|P3|Overall Study|Lost to Follow-up|2
2837118|NCT02576951|9732847|P2|Overall Study|Lost to Follow-up|0
2837119|NCT02576951|9732848|P1|Overall Study|Lost to Follow-up|0
2837120|NCT02576938|9732872|P3|Overall Study|Met Exclusion Criteria|0
2837121|NCT02576938|9732873|P2|Overall Study|Met Exclusion Criteria|1
2837122|NCT02576938|9732874|P1|Overall Study|Met Exclusion Criteria|0
2837123|NCT02576938|9732872|P3|Overall Study|Physician Decision|0
2837124|NCT02576938|9732873|P2|Overall Study|Physician Decision|1
2837125|NCT02576938|9732874|P1|Overall Study|Physician Decision|0
2837126|NCT02576938|9732872|P3|Overall Study|Lost to Follow-up|1
2837127|NCT02576938|9732873|P2|Overall Study|Lost to Follow-up|0
2837128|NCT02576938|9732874|P1|Overall Study|Lost to Follow-up|2
2837129|NCT02576938|9732872|P3|Overall Study|Lack of Efficacy|0
2837130|NCT02576938|9732873|P2|Overall Study|Lack of Efficacy|4
2837131|NCT02576938|9732874|P1|Overall Study|Lack of Efficacy|9
2837132|NCT02576938|9732872|P3|Overall Study|Withdrawal by Subject|4
2837133|NCT02576938|9732873|P2|Overall Study|Withdrawal by Subject|2
2837134|NCT02576938|9732874|P1|Overall Study|Withdrawal by Subject|3
2837135|NCT02576938|9732872|P3|Overall Study|Protocol Violation|1
2837136|NCT02576938|9732873|P2|Overall Study|Protocol Violation|1
2837137|NCT02576938|9732874|P1|Overall Study|Protocol Violation|1
2837138|NCT02576938|9732872|P3|Overall Study|Adverse Event|6
2837139|NCT02576938|9732873|P2|Overall Study|Adverse Event|3
2837140|NCT02576938|9732874|P1|Overall Study|Adverse Event|5
2837141|NCT02576678|9732920|P3|Overall Study|Miscellaneous|0
2837142|NCT02576678|9732921|P2|Overall Study|Miscellaneous|0
2837143|NCT02576678|9732922|P1|Overall Study|Miscellaneous|2
2837144|NCT02576678|9732920|P3|Overall Study|Lost to Follow-up|1
2837145|NCT02576678|9732921|P2|Overall Study|Lost to Follow-up|0
2837146|NCT02576678|9732922|P1|Overall Study|Lost to Follow-up|0
2837147|NCT02576678|9732920|P3|Overall Study|Withdrawal by Subject|2
2837148|NCT02576678|9732921|P2|Overall Study|Withdrawal by Subject|1
2837149|NCT02576678|9732922|P1|Overall Study|Withdrawal by Subject|3
2837150|NCT02576678|9732920|P3|Overall Study|Adverse Event|2
2837151|NCT02576678|9732921|P2|Overall Study|Adverse Event|0
2837152|NCT02576678|9732922|P1|Overall Study|Adverse Event|0
2837153|NCT02576652|9732954|P1|Overall Study|Withdrawal by Subject|2
2837154|NCT02576639|9732966|P5|Overall Study|Physician Decision|1
2837155|NCT02576639|9732967|P4|Overall Study|Physician Decision|0
2837156|NCT02576639|9732968|P3|Overall Study|Physician Decision|0
2837157|NCT02576639|9732969|P2|Overall Study|Physician Decision|0
2837158|NCT02576639|9732970|P1|Overall Study|Physician Decision|0
2837159|NCT02576639|9732966|P5|Overall Study|Adverse Event|2
2837160|NCT02576639|9732967|P4|Overall Study|Adverse Event|1
2837161|NCT02576639|9732968|P3|Overall Study|Adverse Event|1
2837162|NCT02576639|9732969|P2|Overall Study|Adverse Event|0
2837163|NCT02576639|9732970|P1|Overall Study|Adverse Event|1
2837164|NCT02576639|9732966|P5|Overall Study|Withdrawal by Subject|1
2837165|NCT02576639|9732967|P4|Overall Study|Withdrawal by Subject|0
2837166|NCT02576639|9732968|P3|Overall Study|Withdrawal by Subject|1
2837167|NCT02576639|9732969|P2|Overall Study|Withdrawal by Subject|2
2837168|NCT02576639|9732970|P1|Overall Study|Withdrawal by Subject|1
2837169|NCT02576587|9733029|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
2837170|NCT02576587|9733030|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
2837171|NCT02576587|9733029|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
2837172|NCT02576587|9733030|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
2837173|NCT02576587|9733029|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
2837174|NCT02576587|9733030|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
2837175|NCT02576587|9733029|P2|Baseline|Equipment failure|1
2837176|NCT02576587|9733030|P1|Baseline|Equipment failure|0
2837177|NCT02576535|9733048|P1|Overall Study|Withdrawal by Subject|2
2837178|NCT02576145|9733072|P2|Overall Study|Tetanus Titers Decreased|1
2837179|NCT02576145|9733073|P1|Overall Study|Tetanus Titers Decreased|0
2837180|NCT02576145|9733072|P2|Overall Study|Acute rejection|0
2837181|NCT02576145|9733073|P1|Overall Study|Acute rejection|1
2837182|NCT02576145|9733072|P2|Overall Study|Withdrawal by Subject|0
2837183|NCT02576145|9733073|P1|Overall Study|Withdrawal by Subject|1
2837184|NCT02576145|9733072|P2|Overall Study|Adverse Event|0
2837185|NCT02576145|9733073|P1|Overall Study|Adverse Event|1
2837186|NCT02576067|9733111|P2|Overall Study|Physician Decision|0
2837187|NCT02576067|9733112|P1|Overall Study|Physician Decision|4
2837188|NCT02576067|9733111|P2|Overall Study|screen failure/ re-enrolled|25
2837189|NCT02576067|9733112|P1|Overall Study|screen failure/ re-enrolled|0
2837190|NCT02576067|9733111|P2|Overall Study|not randomized, failed run-in|0
2837191|NCT02576067|9733112|P1|Overall Study|not randomized, failed run-in|7
2837192|NCT02576067|9733111|P2|Overall Study|study closure of main CIRT trial)|8
2837193|NCT02576067|9733112|P1|Overall Study|study closure of main CIRT trial)|0
2837194|NCT02576067|9733111|P2|Overall Study|Withdrawal by Subject|2
2837195|NCT02576067|9733112|P1|Overall Study|Withdrawal by Subject|11
2837196|NCT02576067|9733111|P2|Overall Study|Lost to Follow-up|0
2837197|NCT02576067|9733112|P1|Overall Study|Lost to Follow-up|11
2837198|NCT02576067|9733111|P2|Overall Study|Lack of Efficacy|0
2837199|NCT02576067|9733112|P1|Overall Study|Lack of Efficacy|1
2837200|NCT02576067|9733111|P2|Overall Study|Death|1
2837201|NCT02576067|9733112|P1|Overall Study|Death|0
2837202|NCT02576054|9733122|P1|Overall Study|Withdrawal by Subject|1
2837203|NCT02575950|9733143|P4|Overall Study|Lost to Follow-up|3
2837204|NCT02575950|9733144|P3|Overall Study|Lost to Follow-up|0
2837205|NCT02575950|9733145|P2|Overall Study|Lost to Follow-up|1
2837206|NCT02575950|9733146|P1|Overall Study|Lost to Follow-up|0
2837207|NCT02575950|9733143|P4|Overall Study|Withdrawal by Subject|2
2837208|NCT02575950|9733144|P3|Overall Study|Withdrawal by Subject|0
2837209|NCT02575950|9733145|P2|Overall Study|Withdrawal by Subject|0
2837210|NCT02575950|9733146|P1|Overall Study|Withdrawal by Subject|0
2837211|NCT02575911|9733175|P1|Overall Study|Lost to Follow-up|1
2837212|NCT02575833|9733195|P2|Overall Study|Lost to Follow-up|0
2837213|NCT02575833|9733196|P1|Overall Study|Lost to Follow-up|1
2837214|NCT02575833|9733195|P2|Overall Study|Withdrawal by Subject|1
2837215|NCT02575833|9733196|P1|Overall Study|Withdrawal by Subject|0
2837216|NCT02575807|9733211|P5|Overall Study|Withdrawal by Subject|2
2837217|NCT02575807|9733212|P4|Overall Study|Withdrawal by Subject|1
2837218|NCT02575807|9733213|P3|Overall Study|Withdrawal by Subject|1
2837219|NCT02575807|9733214|P2|Overall Study|Withdrawal by Subject|0
2837220|NCT02575807|9733215|P1|Overall Study|Withdrawal by Subject|0
2837221|NCT02575807|9733211|P5|Overall Study|Subject ineligible - medical implant|0
2837222|NCT02575807|9733212|P4|Overall Study|Subject ineligible - medical implant|1
2837223|NCT02575807|9733213|P3|Overall Study|Subject ineligible - medical implant|0
2837224|NCT02575807|9733214|P2|Overall Study|Subject ineligible - medical implant|0
2837225|NCT02575807|9733215|P1|Overall Study|Subject ineligible - medical implant|0
2837226|NCT02575807|9733211|P5|Overall Study|Terminated due to physician decision|0
2837227|NCT02575807|9733212|P4|Overall Study|Terminated due to physician decision|0
2837228|NCT02575807|9733213|P3|Overall Study|Terminated due to physician decision|1
2837229|NCT02575807|9733214|P2|Overall Study|Terminated due to physician decision|0
2837230|NCT02575807|9733215|P1|Overall Study|Terminated due to physician decision|0
2837231|NCT02575807|9733211|P5|Overall Study|Terminated due to FDA clinical hold|0
2837232|NCT02575807|9733212|P4|Overall Study|Terminated due to FDA clinical hold|0
2837233|NCT02575807|9733213|P3|Overall Study|Terminated due to FDA clinical hold|0
2837234|NCT02575807|9733214|P2|Overall Study|Terminated due to FDA clinical hold|0
2837235|NCT02575807|9733215|P1|Overall Study|Terminated due to FDA clinical hold|1
2837236|NCT02575807|9733211|P5|Overall Study|Study terminated by Sponsor|1
2837237|NCT02575807|9733212|P4|Overall Study|Study terminated by Sponsor|0
2837238|NCT02575807|9733213|P3|Overall Study|Study terminated by Sponsor|7
2837239|NCT02575807|9733214|P2|Overall Study|Study terminated by Sponsor|1
2837240|NCT02575807|9733215|P1|Overall Study|Study terminated by Sponsor|0
2837241|NCT02575807|9733211|P5|Overall Study|Death|1
2837242|NCT02575807|9733212|P4|Overall Study|Death|0
2837243|NCT02575807|9733213|P3|Overall Study|Death|7
2837244|NCT02575807|9733214|P2|Overall Study|Death|3
2837245|NCT02575807|9733215|P1|Overall Study|Death|8
2837246|NCT02575365|9733255|P1|Overall Study|Lost to Follow-up|4
2837247|NCT02575079|9733275|P2|Overall Study|Withdrawal by Subject|0
2837248|NCT02575079|9733276|P1|Overall Study|Withdrawal by Subject|3
2837249|NCT02575079|9733275|P2|Overall Study|Death|0
2837250|NCT02575079|9733276|P1|Overall Study|Death|3
2837251|NCT02574845|9733301|P6|Overall Study|Adverse Event|1
2837252|NCT02574845|9733302|P5|Overall Study|Adverse Event|0
2837253|NCT02574845|9733303|P4|Overall Study|Adverse Event|0
2837254|NCT02574845|9733304|P3|Overall Study|Adverse Event|0
2837255|NCT02574845|9733305|P2|Overall Study|Adverse Event|1
2837256|NCT02574845|9733306|P1|Overall Study|Adverse Event|0
2837257|NCT02574845|9733301|P6|Overall Study|Consent withdrawn further participation|0
2837258|NCT02574845|9733302|P5|Overall Study|Consent withdrawn further participation|1
2837259|NCT02574845|9733303|P4|Overall Study|Consent withdrawn further participation|0
2837260|NCT02574845|9733304|P3|Overall Study|Consent withdrawn further participation|0
2837261|NCT02574845|9733305|P2|Overall Study|Consent withdrawn further participation|0
2837262|NCT02574845|9733306|P1|Overall Study|Consent withdrawn further participation|0
2837263|NCT02574637|9733341|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
2837264|NCT02574637|9733342|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
2837265|NCT02574637|9733343|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
2837266|NCT02574637|9733344|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
2837267|NCT02574637|9733345|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
2837268|NCT02574637|9733346|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
2837269|NCT02574637|9733347|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
2837270|NCT02574637|9733348|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
2837271|NCT02574637|9733349|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
2837272|NCT02574637|9733350|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
2837273|NCT02574637|9733341|P10|Open-label (OL) Period|Withdrawal by Subject|1
2837274|NCT02574637|9733342|P9|Open-label (OL) Period|Withdrawal by Subject|0
2837275|NCT02574637|9733343|P8|Open-label (OL) Period|Withdrawal by Subject|0
2837276|NCT02574637|9733344|P7|Open-label (OL) Period|Withdrawal by Subject|0
2837277|NCT02574637|9733345|P6|Open-label (OL) Period|Withdrawal by Subject|1
2837278|NCT02574637|9733346|P5|Open-label (OL) Period|Withdrawal by Subject|0
2837279|NCT02574637|9733347|P4|Open-label (OL) Period|Withdrawal by Subject|0
2837280|NCT02574637|9733348|P3|Open-label (OL) Period|Withdrawal by Subject|0
2837281|NCT02574637|9733349|P2|Open-label (OL) Period|Withdrawal by Subject|0
2837282|NCT02574637|9733350|P1|Open-label (OL) Period|Withdrawal by Subject|0
2837283|NCT02574637|9733341|P10|Open-label (OL) Period|Adverse Event|0
2837284|NCT02574637|9733342|P9|Open-label (OL) Period|Adverse Event|1
2837285|NCT02574637|9733343|P8|Open-label (OL) Period|Adverse Event|0
2837286|NCT02574637|9733344|P7|Open-label (OL) Period|Adverse Event|0
2837287|NCT02574637|9733345|P6|Open-label (OL) Period|Adverse Event|0
2837288|NCT02574637|9733346|P5|Open-label (OL) Period|Adverse Event|0
2837289|NCT02574637|9733347|P4|Open-label (OL) Period|Adverse Event|0
2837290|NCT02574637|9733348|P3|Open-label (OL) Period|Adverse Event|0
2837291|NCT02574637|9733349|P2|Open-label (OL) Period|Adverse Event|0
2837292|NCT02574637|9733350|P1|Open-label (OL) Period|Adverse Event|0
2837293|NCT02574637|9733341|P10|Double-blind Period|Reason Not Specified|0
2837294|NCT02574637|9733342|P9|Double-blind Period|Reason Not Specified|0
2837295|NCT02574637|9733343|P8|Double-blind Period|Reason Not Specified|0
2837296|NCT02574637|9733344|P7|Double-blind Period|Reason Not Specified|0
2837297|NCT02574637|9733345|P6|Double-blind Period|Reason Not Specified|0
2837298|NCT02574637|9733346|P5|Double-blind Period|Reason Not Specified|0
2837299|NCT02574637|9733347|P4|Double-blind Period|Reason Not Specified|1
2837300|NCT02574637|9733348|P3|Double-blind Period|Reason Not Specified|0
2837301|NCT02574637|9733349|P2|Double-blind Period|Reason Not Specified|0
2837302|NCT02574637|9733350|P1|Double-blind Period|Reason Not Specified|0
2837303|NCT02574637|9733341|P10|Double-blind Period|Study Terminated By Sponsor|0
2837304|NCT02574637|9733342|P9|Double-blind Period|Study Terminated By Sponsor|0
2837305|NCT02574637|9733343|P8|Double-blind Period|Study Terminated By Sponsor|0
2837306|NCT02574637|9733344|P7|Double-blind Period|Study Terminated By Sponsor|0
2837307|NCT02574637|9733345|P6|Double-blind Period|Study Terminated By Sponsor|0
2837308|NCT02574637|9733346|P5|Double-blind Period|Study Terminated By Sponsor|2
2837309|NCT02574637|9733347|P4|Double-blind Period|Study Terminated By Sponsor|2
2837310|NCT02574637|9733348|P3|Double-blind Period|Study Terminated By Sponsor|5
2837311|NCT02574637|9733349|P2|Double-blind Period|Study Terminated By Sponsor|1
2837312|NCT02574637|9733350|P1|Double-blind Period|Study Terminated By Sponsor|1
2837313|NCT02574637|9733341|P10|Double-blind Period|Non-Compliance With Study Drug|0
2837314|NCT02574637|9733342|P9|Double-blind Period|Non-Compliance With Study Drug|0
2837315|NCT02574637|9733343|P8|Double-blind Period|Non-Compliance With Study Drug|0
2837316|NCT02574637|9733344|P7|Double-blind Period|Non-Compliance With Study Drug|0
2837317|NCT02574637|9733345|P6|Double-blind Period|Non-Compliance With Study Drug|0
2837318|NCT02574637|9733346|P5|Double-blind Period|Non-Compliance With Study Drug|0
2837319|NCT02574637|9733347|P4|Double-blind Period|Non-Compliance With Study Drug|1
2837320|NCT02574637|9733348|P3|Double-blind Period|Non-Compliance With Study Drug|0
2837321|NCT02574637|9733349|P2|Double-blind Period|Non-Compliance With Study Drug|0
2837322|NCT02574637|9733350|P1|Double-blind Period|Non-Compliance With Study Drug|0
2837323|NCT02574637|9733341|P10|Double-blind Period|Protocol Deviation|0
2837324|NCT02574637|9733342|P9|Double-blind Period|Protocol Deviation|0
2837325|NCT02574637|9733343|P8|Double-blind Period|Protocol Deviation|0
2837326|NCT02574637|9733344|P7|Double-blind Period|Protocol Deviation|0
2837327|NCT02574637|9733345|P6|Double-blind Period|Protocol Deviation|0
2837328|NCT02574637|9733346|P5|Double-blind Period|Protocol Deviation|0
2837329|NCT02574637|9733347|P4|Double-blind Period|Protocol Deviation|0
2837330|NCT02574637|9733348|P3|Double-blind Period|Protocol Deviation|0
2837331|NCT02574637|9733349|P2|Double-blind Period|Protocol Deviation|0
2837332|NCT02574637|9733350|P1|Double-blind Period|Protocol Deviation|1
2837333|NCT02574637|9733341|P10|Double-blind Period|Lack of Efficacy|0
2837334|NCT02574637|9733342|P9|Double-blind Period|Lack of Efficacy|0
2837335|NCT02574637|9733343|P8|Double-blind Period|Lack of Efficacy|0
2837336|NCT02574637|9733344|P7|Double-blind Period|Lack of Efficacy|0
2837337|NCT02574637|9733345|P6|Double-blind Period|Lack of Efficacy|0
2837338|NCT02574637|9733346|P5|Double-blind Period|Lack of Efficacy|0
2837339|NCT02574637|9733347|P4|Double-blind Period|Lack of Efficacy|0
2837340|NCT02574637|9733348|P3|Double-blind Period|Lack of Efficacy|2
2837341|NCT02574637|9733349|P2|Double-blind Period|Lack of Efficacy|0
2837342|NCT02574637|9733350|P1|Double-blind Period|Lack of Efficacy|0
2837343|NCT02574637|9733341|P10|Double-blind Period|Adverse Event|0
2837344|NCT02574637|9733342|P9|Double-blind Period|Adverse Event|0
2837345|NCT02574637|9733343|P8|Double-blind Period|Adverse Event|0
2837346|NCT02574637|9733344|P7|Double-blind Period|Adverse Event|0
2837347|NCT02574637|9733345|P6|Double-blind Period|Adverse Event|0
2837348|NCT02574637|9733346|P5|Double-blind Period|Adverse Event|0
2837349|NCT02574637|9733347|P4|Double-blind Period|Adverse Event|0
2837350|NCT02574637|9733348|P3|Double-blind Period|Adverse Event|0
2837351|NCT02574637|9733349|P2|Double-blind Period|Adverse Event|0
2837352|NCT02574637|9733350|P1|Double-blind Period|Adverse Event|1
2837353|NCT02574481|9733450|P4|Overall Study|Death|0
2837354|NCT02574481|9733451|P3|Overall Study|Death|0
2837355|NCT02574481|9733452|P2|Overall Study|Death|6
2837356|NCT02574481|9733453|P1|Overall Study|Death|6
2837357|NCT02574481|9733450|P4|Overall Study|Other|0
2837358|NCT02574481|9733451|P3|Overall Study|Other|0
2837359|NCT02574481|9733452|P2|Overall Study|Other|0
2837360|NCT02574481|9733453|P1|Overall Study|Other|1
2837361|NCT02574481|9733450|P4|Overall Study|Visit Missed|0
2837362|NCT02574481|9733451|P3|Overall Study|Visit Missed|2
2837363|NCT02574481|9733452|P2|Overall Study|Visit Missed|4
2837364|NCT02574481|9733453|P1|Overall Study|Visit Missed|12
2837365|NCT02574481|9733450|P4|Overall Study|Adverse Event|0
2837366|NCT02574481|9733451|P3|Overall Study|Adverse Event|0
2837367|NCT02574481|9733452|P2|Overall Study|Adverse Event|0
2837368|NCT02574481|9733453|P1|Overall Study|Adverse Event|2
2837369|NCT02574481|9733450|P4|Overall Study|Withdrawal by Subject|0
2837370|NCT02574481|9733451|P3|Overall Study|Withdrawal by Subject|1
2837371|NCT02574481|9733452|P2|Overall Study|Withdrawal by Subject|4
2837372|NCT02574481|9733453|P1|Overall Study|Withdrawal by Subject|6
2837373|NCT02574312|9733493|P2|3 Months Follow-up|Withdrawal by Subject|0
2837374|NCT02574312|9733494|P1|3 Months Follow-up|Withdrawal by Subject|1
2837375|NCT02574260|9733510|P1|Overall Study|Disease Progression|1
2837376|NCT02574247|9733519|P3|Overall Study|Did not meet inclusion criteria|5
2837377|NCT02574247|9733520|P2|Overall Study|Did not meet inclusion criteria|3
2837378|NCT02574247|9733521|P1|Overall Study|Did not meet inclusion criteria|4
2837379|NCT02574247|9733519|P3|Overall Study|Withdrawal by Subject|0
2837380|NCT02574247|9733520|P2|Overall Study|Withdrawal by Subject|0
2837381|NCT02574247|9733521|P1|Overall Study|Withdrawal by Subject|1
2837382|NCT02573948|9733533|P1|Longitudinal Cohort|Incarcerated|25
2837383|NCT02573948|9733533|P1|Longitudinal Cohort|Lost to Follow-up|22
2837384|NCT02573948|9733533|P1|Longitudinal Cohort|Death|9
2837385|NCT02573870|9733543|P2|Overall Study|Other: Fail to Meet Visit|2
2837386|NCT02573870|9733544|P1|Overall Study|Other: Fail to Meet Visit|0
2837387|NCT02573870|9733543|P2|Overall Study|Lost to Follow-up|1
2837388|NCT02573870|9733544|P1|Overall Study|Lost to Follow-up|0
2837389|NCT02573870|9733543|P2|Overall Study|Other: Reached defined stopping criteria|1
2837390|NCT02573870|9733544|P1|Overall Study|Other: Reached defined stopping criteria|0
2837391|NCT02573870|9733543|P2|Overall Study|Lack of Efficacy|1
2837392|NCT02573870|9733544|P1|Overall Study|Lack of Efficacy|0
2837393|NCT02573870|9733543|P2|Overall Study|Adverse Event|2
2837394|NCT02573870|9733544|P1|Overall Study|Adverse Event|0
2837395|NCT02573467|9733579|P4|Post-treatment Follow up Epoch|Technical problems|0
2837396|NCT02573467|9733580|P3|Post-treatment Follow up Epoch|Technical problems|1
2837397|NCT02573467|9733581|P2|Post-treatment Follow up Epoch|Technical problems|0
2837398|NCT02573467|9733582|P1|Post-treatment Follow up Epoch|Technical problems|0
2837399|NCT02573467|9733579|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
2837400|NCT02573467|9733580|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
2837401|NCT02573467|9733581|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
2837402|NCT02573467|9733582|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
2837403|NCT02573467|9733579|P4|Post-treatment Follow up Epoch|Death|1
2837404|NCT02573467|9733580|P3|Post-treatment Follow up Epoch|Death|0
2837405|NCT02573467|9733581|P2|Post-treatment Follow up Epoch|Death|1
2837406|NCT02573467|9733582|P1|Post-treatment Follow up Epoch|Death|1
2837407|NCT02573467|9733579|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
2837408|NCT02573467|9733580|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
2837409|NCT02573467|9733581|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
2837410|NCT02573467|9733582|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
2837411|NCT02573467|9733579|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
2837412|NCT02573467|9733580|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
2837413|NCT02573467|9733581|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
2837414|NCT02573467|9733582|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
2837415|NCT02573467|9733579|P4|Double-blind Treatment Epoch|Adverse Event|0
2837416|NCT02573467|9733580|P3|Double-blind Treatment Epoch|Adverse Event|1
2837417|NCT02573467|9733581|P2|Double-blind Treatment Epoch|Adverse Event|0
2837418|NCT02573467|9733582|P1|Double-blind Treatment Epoch|Adverse Event|1
2837419|NCT02573467|9733579|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
2837420|NCT02573467|9733580|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
2837421|NCT02573467|9733581|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
2837422|NCT02573467|9733582|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
2837423|NCT02573311|9733646|P2|Disposition for Part 2|Other than specified above|3
2837424|NCT02573311|9733647|P1|Disposition for Part 2|Other than specified above|13
2837425|NCT02573311|9733646|P2|Disposition for Part 2|Investigator decision|1
2837426|NCT02573311|9733647|P1|Disposition for Part 2|Investigator decision|0
2837427|NCT02573311|9733646|P2|Disposition for Part 2|Withdrawal by Subject|3
2837428|NCT02573311|9733647|P1|Disposition for Part 2|Withdrawal by Subject|60
2837429|NCT02573311|9733646|P2|Disposition for Part 2|Lost to Follow-up|7
2837430|NCT02573311|9733647|P1|Disposition for Part 2|Lost to Follow-up|76
2837431|NCT02573311|9733646|P2|Disposition for Part 2|Adverse Event|5
2837432|NCT02573311|9733647|P1|Disposition for Part 2|Adverse Event|36
2837433|NCT02573311|9733646|P2|Disposition for Part 2|Physician Decision|7
2837434|NCT02573311|9733647|P1|Disposition for Part 2|Physician Decision|25
2837435|NCT02573311|9733646|P2|Disposition for Part 1|Withdrawal by Subject|3
2837436|NCT02573311|9733647|P1|Disposition for Part 1|Withdrawal by Subject|7
2837437|NCT02573155|9733716|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
2837438|NCT02573155|9733717|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
2837439|NCT02573155|9733716|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
2837440|NCT02573155|9733717|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
2837441|NCT02573155|9733716|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
2837442|NCT02573155|9733717|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
2837443|NCT02573155|9733716|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
2837444|NCT02573155|9733717|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
2837445|NCT02573155|9733716|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
2837446|NCT02573155|9733717|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
2837447|NCT02573155|9733716|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
2837448|NCT02573155|9733717|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
2837449|NCT02573155|9733716|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
2837450|NCT02573155|9733717|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
2837451|NCT02573155|9733716|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
2837452|NCT02573155|9733717|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
2837453|NCT02573012|9733865|P2|Overall Study|Physician Decision|2
2837454|NCT02573012|9733866|P1|Overall Study|Physician Decision|1
2837455|NCT02573012|9733865|P2|Overall Study|Study Ended per Protocol|0
2837456|NCT02573012|9733866|P1|Overall Study|Study Ended per Protocol|1
2837457|NCT02573012|9733865|P2|Overall Study|Withdrawal by Subject|2
2837458|NCT02573012|9733866|P1|Overall Study|Withdrawal by Subject|2
2837459|NCT02573012|9733865|P2|Overall Study|Non-compliance|2
2837460|NCT02573012|9733866|P1|Overall Study|Non-compliance|1
2837461|NCT02573012|9733865|P2|Overall Study|Lack of Efficacy|4
2837462|NCT02573012|9733866|P1|Overall Study|Lack of Efficacy|5
2837463|NCT02573012|9733865|P2|Overall Study|Adverse Event|5
2837464|NCT02573012|9733866|P1|Overall Study|Adverse Event|5
2837465|NCT02572817|9733918|P2|Overall Study|Lost to Follow-up|3
2837466|NCT02572817|9733919|P1|Overall Study|Lost to Follow-up|3
2837467|NCT02572817|9733918|P2|Overall Study|Death|3
2837468|NCT02572817|9733919|P1|Overall Study|Death|6
2837469|NCT02572401|9734027|P4|Overall Study|Death|1
2837470|NCT02572401|9734028|P3|Overall Study|Death|0
2837471|NCT02572401|9734029|P2|Overall Study|Death|0
2837472|NCT02572401|9734030|P1|Overall Study|Death|0
2837473|NCT02572401|9734027|P4|Overall Study|Lost to Follow-up|9
2837474|NCT02572401|9734028|P3|Overall Study|Lost to Follow-up|9
2837475|NCT02572401|9734029|P2|Overall Study|Lost to Follow-up|8
2837476|NCT02572401|9734030|P1|Overall Study|Lost to Follow-up|5
2837477|NCT02572388|9734060|P4|Overall Study|Withdrawal by Subject|2
2837478|NCT02572388|9734061|P3|Overall Study|Withdrawal by Subject|2
2837479|NCT02572388|9734062|P2|Overall Study|Withdrawal by Subject|1
2837480|NCT02572388|9734063|P1|Overall Study|Withdrawal by Subject|1
2837481|NCT02572167|9734088|P3|Overall Study|Did not meet inclusion criteria|1
2837482|NCT02572167|9734089|P2|Overall Study|Did not meet inclusion criteria|0
2837483|NCT02572167|9734090|P1|Overall Study|Did not meet inclusion criteria|0
2837484|NCT02572167|9734088|P3|Overall Study|Death|1
2837485|NCT02572167|9734089|P2|Overall Study|Death|3
2837486|NCT02572167|9734090|P1|Overall Study|Death|0
2837487|NCT02572167|9734088|P3|Overall Study|Lost to Follow-up|1
2837488|NCT02572167|9734089|P2|Overall Study|Lost to Follow-up|2
2837489|NCT02572167|9734090|P1|Overall Study|Lost to Follow-up|0
2837490|NCT02572167|9734088|P3|Overall Study|Withdrawal by Subject|1
2837491|NCT02572167|9734089|P2|Overall Study|Withdrawal by Subject|3
2837492|NCT02572167|9734090|P1|Overall Study|Withdrawal by Subject|0
2837493|NCT02572167|9734088|P3|Overall Study|In follow up|27
2837494|NCT02572167|9734089|P2|Overall Study|In follow up|48
2837495|NCT02572167|9734090|P1|Overall Study|In follow up|6
2837496|NCT02572076|9734104|P1|Overall Study|Protocol Violation|1
2837497|NCT02571972|9734108|P1|Overall Study|Withdrawal by Subject|2
2837498|NCT02571972|9734108|P1|Overall Study|Protocol Violation|2
2837499|NCT02571452|9734125|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
2837500|NCT02571452|9734126|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
2837501|NCT02571452|9734125|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
2837502|NCT02571452|9734126|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
2837503|NCT02571452|9734125|P2|Overall Study Treatment|Protocol Violation|1
2837504|NCT02571452|9734126|P1|Overall Study Treatment|Protocol Violation|0
2837505|NCT02571244|9734167|P2|Overall Study|Unable to reach out post discharge|0
2837506|NCT02571244|9734168|P1|Overall Study|Unable to reach out post discharge|3
2837507|NCT02571244|9734167|P2|Overall Study|Lost to Follow-up|1
2837508|NCT02571244|9734168|P1|Overall Study|Lost to Follow-up|0
2837509|NCT02571075|9734226|P2|Overall Study|Lost to Follow-up|24
2837510|NCT02571075|9734227|P1|Overall Study|Lost to Follow-up|20
2837511|NCT02571049|9734241|P2|Randomization|Adverse Event|1
2837512|NCT02571049|9734242|P1|Randomization|Adverse Event|0
2837513|NCT02571049|9734241|P2|Randomization|No migraine attack|1
2837514|NCT02571049|9734242|P1|Randomization|No migraine attack|0
2837515|NCT02571049|9734241|P2|Screening|Did not meet entry criteria|2
2837516|NCT02571049|9734242|P1|Screening|Did not meet entry criteria|2
2837517|NCT02570750|9734250|P2|Overall Study|Adverse Event|1
2837518|NCT02570750|9734251|P1|Overall Study|Adverse Event|2
2837519|NCT02570750|9734250|P2|Overall Study|Lost to Follow-up|2
2837520|NCT02570750|9734251|P1|Overall Study|Lost to Follow-up|2
2837521|NCT02570750|9734250|P2|Overall Study|Withdrawal by Subject|0
2837522|NCT02570750|9734251|P1|Overall Study|Withdrawal by Subject|5
2837523|NCT02570750|9734250|P2|Overall Study|Protocol deviation|2
2837524|NCT02570750|9734251|P1|Overall Study|Protocol deviation|4
2837525|NCT02570750|9734250|P2|Overall Study|Inclusion/exclusion criteria deviation|0
2837526|NCT02570750|9734251|P1|Overall Study|Inclusion/exclusion criteria deviation|1
2837527|NCT02570711|9734269|P2|Overall Study|Early Termination of Study by Sponsor|2
2837528|NCT02570711|9734270|P1|Overall Study|Early Termination of Study by Sponsor|0
2837529|NCT02570711|9734269|P2|Overall Study|Death|0
2837530|NCT02570711|9734270|P1|Overall Study|Death|1
2837531|NCT02570165|9734358|P7|Overall Study|Withdrawal Request by GSK|0
2837532|NCT02570165|9734359|P6|Overall Study|Withdrawal Request by GSK|0
2837533|NCT02570165|9734360|P5|Overall Study|Withdrawal Request by GSK|0
2837534|NCT02570165|9734361|P4|Overall Study|Withdrawal Request by GSK|0
2837535|NCT02570165|9734362|P3|Overall Study|Withdrawal Request by GSK|2
2837536|NCT02570165|9734363|P2|Overall Study|Withdrawal Request by GSK|0
2837537|NCT02570165|9734364|P1|Overall Study|Withdrawal Request by GSK|0
2837538|NCT02570165|9734358|P7|Overall Study|Par. did not Meet Continuation Criteria|0
2837539|NCT02570165|9734359|P6|Overall Study|Par. did not Meet Continuation Criteria|1
2837540|NCT02570165|9734360|P5|Overall Study|Par. did not Meet Continuation Criteria|0
2837541|NCT02570165|9734361|P4|Overall Study|Par. did not Meet Continuation Criteria|0
2837542|NCT02570165|9734362|P3|Overall Study|Par. did not Meet Continuation Criteria|0
2837543|NCT02570165|9734363|P2|Overall Study|Par. did not Meet Continuation Criteria|0
2837544|NCT02570165|9734364|P1|Overall Study|Par. did not Meet Continuation Criteria|0
2837545|NCT02570165|9734358|P7|Overall Study|Withdrawal by Subject|0
2837546|NCT02570165|9734359|P6|Overall Study|Withdrawal by Subject|0
2837547|NCT02570165|9734360|P5|Overall Study|Withdrawal by Subject|1
2837548|NCT02570165|9734361|P4|Overall Study|Withdrawal by Subject|2
2837549|NCT02570165|9734362|P3|Overall Study|Withdrawal by Subject|0
2837550|NCT02570165|9734363|P2|Overall Study|Withdrawal by Subject|0
2837551|NCT02570165|9734364|P1|Overall Study|Withdrawal by Subject|0
2837552|NCT02570165|9734358|P7|Overall Study|Physician Decision|0
2837553|NCT02570165|9734359|P6|Overall Study|Physician Decision|0
2837554|NCT02570165|9734360|P5|Overall Study|Physician Decision|0
2837555|NCT02570165|9734361|P4|Overall Study|Physician Decision|0
2837556|NCT02570165|9734362|P3|Overall Study|Physician Decision|0
2837557|NCT02570165|9734363|P2|Overall Study|Physician Decision|1
2837558|NCT02570165|9734364|P1|Overall Study|Physician Decision|0
2837559|NCT02570165|9734358|P7|Overall Study|Lost to Follow-up|0
2837560|NCT02570165|9734359|P6|Overall Study|Lost to Follow-up|0
2837561|NCT02570165|9734360|P5|Overall Study|Lost to Follow-up|0
2837562|NCT02570165|9734361|P4|Overall Study|Lost to Follow-up|1
2837563|NCT02570165|9734362|P3|Overall Study|Lost to Follow-up|1
2837564|NCT02570165|9734363|P2|Overall Study|Lost to Follow-up|0
2837565|NCT02570165|9734364|P1|Overall Study|Lost to Follow-up|0
2837566|NCT02570165|9734358|P7|Overall Study|Par. Reached Stopping Criteria|0
2837567|NCT02570165|9734359|P6|Overall Study|Par. Reached Stopping Criteria|1
2837568|NCT02570165|9734360|P5|Overall Study|Par. Reached Stopping Criteria|1
2837569|NCT02570165|9734361|P4|Overall Study|Par. Reached Stopping Criteria|2
2837570|NCT02570165|9734362|P3|Overall Study|Par. Reached Stopping Criteria|0
2837571|NCT02570165|9734363|P2|Overall Study|Par. Reached Stopping Criteria|1
2837572|NCT02570165|9734364|P1|Overall Study|Par. Reached Stopping Criteria|1
2837573|NCT02570165|9734358|P7|Overall Study|Lack of Efficacy|0
2837574|NCT02570165|9734359|P6|Overall Study|Lack of Efficacy|0
2837575|NCT02570165|9734360|P5|Overall Study|Lack of Efficacy|4
2837576|NCT02570165|9734361|P4|Overall Study|Lack of Efficacy|0
2837577|NCT02570165|9734362|P3|Overall Study|Lack of Efficacy|0
2837578|NCT02570165|9734363|P2|Overall Study|Lack of Efficacy|1
2837579|NCT02570165|9734364|P1|Overall Study|Lack of Efficacy|0
2837580|NCT02570165|9734358|P7|Overall Study|Adverse Event|0
2837581|NCT02570165|9734359|P6|Overall Study|Adverse Event|0
2837582|NCT02570165|9734360|P5|Overall Study|Adverse Event|0
2837583|NCT02570165|9734361|P4|Overall Study|Adverse Event|0
2837584|NCT02570165|9734362|P3|Overall Study|Adverse Event|2
2837585|NCT02570165|9734363|P2|Overall Study|Adverse Event|0
2837586|NCT02570165|9734364|P1|Overall Study|Adverse Event|1
2837587|NCT02570126|9734404|P2|Overall Study|Withdrawal by Subject|7
2837588|NCT02570126|9734405|P1|Overall Study|Withdrawal by Subject|3
2837589|NCT02570126|9734404|P2|Overall Study|Protocol Violation|1
2837590|NCT02570126|9734405|P1|Overall Study|Protocol Violation|0
2837591|NCT02570126|9734404|P2|Overall Study|Violation Of Procedures GSK|1
2837592|NCT02570126|9734405|P1|Overall Study|Violation Of Procedures GSK|0
2837593|NCT02570126|9734404|P2|Overall Study|Unable To Arrange Visit 3|0
2837594|NCT02570126|9734405|P1|Overall Study|Unable To Arrange Visit 3|1
2837595|NCT02570126|9734404|P2|Overall Study|Lost to Follow-up|0
2837596|NCT02570126|9734405|P1|Overall Study|Lost to Follow-up|2
2837597|NCT02570074|9734431|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
2837598|NCT02570074|9734432|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
2837599|NCT02569996|9734501|P1|Overall Study|Unknown reason|1
2837600|NCT02569996|9734501|P1|Overall Study|Complete remission|7
2837601|NCT02569996|9734501|P1|Overall Study|Lost to Follow-up|5
2837602|NCT02569996|9734501|P1|Overall Study|Withdrawal by Subject|5
2837603|NCT02569996|9734501|P1|Overall Study|Non-compliance|9
2837604|NCT02569996|9734501|P1|Overall Study|New anti-lymphoma treatment|1
2837605|NCT02569996|9734501|P1|Overall Study|Progression of the disease|18
2837606|NCT02569996|9734501|P1|Overall Study|Physician Decision|3
2837607|NCT02569996|9734501|P1|Overall Study|Adverse Event|6
2837608|NCT02569957|9734513|P2|Overall Study|Withdrawal by Subject|1
2837609|NCT02569957|9734514|P1|Overall Study|Withdrawal by Subject|0
2837610|NCT02569853|9734546|P2|Overall Study|Physician Decision|1
2837611|NCT02569853|9734547|P1|Overall Study|Physician Decision|1
2837612|NCT02569853|9734546|P2|Overall Study|Did not experience migraine attack|7
2837613|NCT02569853|9734547|P1|Overall Study|Did not experience migraine attack|10
2837614|NCT02569853|9734546|P2|Overall Study|Protocol Violation|1
2837615|NCT02569853|9734547|P1|Overall Study|Protocol Violation|1
2837616|NCT02569853|9734546|P2|Overall Study|Lost to Follow-up|3
2837617|NCT02569853|9734547|P1|Overall Study|Lost to Follow-up|3
2837618|NCT02569853|9734546|P2|Overall Study|Withdrawal by Subject|2
2837619|NCT02569853|9734547|P1|Overall Study|Withdrawal by Subject|3
2837620|NCT02569853|9734546|P2|Overall Study|Adverse Event|0
2837621|NCT02569853|9734547|P1|Overall Study|Adverse Event|2
2837622|NCT02569710|9734565|P10|Overall Study|Withdrawal by Subject|0
2837623|NCT02569710|9734566|P9|Overall Study|Withdrawal by Subject|0
2837624|NCT02569710|9734567|P8|Overall Study|Withdrawal by Subject|0
2837625|NCT02569710|9734568|P7|Overall Study|Withdrawal by Subject|0
2837626|NCT02569710|9734569|P6|Overall Study|Withdrawal by Subject|1
2837627|NCT02569710|9734570|P5|Overall Study|Withdrawal by Subject|0
2837628|NCT02569710|9734571|P4|Overall Study|Withdrawal by Subject|0
2837629|NCT02569710|9734572|P3|Overall Study|Withdrawal by Subject|0
2837630|NCT02569710|9734573|P2|Overall Study|Withdrawal by Subject|0
2837631|NCT02569710|9734574|P1|Overall Study|Withdrawal by Subject|0
2837632|NCT02569710|9734565|P10|Overall Study|Virologic failure|0
2837633|NCT02569710|9734566|P9|Overall Study|Virologic failure|0
2837634|NCT02569710|9734567|P8|Overall Study|Virologic failure|0
2837635|NCT02569710|9734568|P7|Overall Study|Virologic failure|1
2837636|NCT02569710|9734569|P6|Overall Study|Virologic failure|0
2837637|NCT02569710|9734570|P5|Overall Study|Virologic failure|1
2837638|NCT02569710|9734571|P4|Overall Study|Virologic failure|0
2837639|NCT02569710|9734572|P3|Overall Study|Virologic failure|0
2837640|NCT02569710|9734573|P2|Overall Study|Virologic failure|0
2837641|NCT02569710|9734574|P1|Overall Study|Virologic failure|0
2837642|NCT02569710|9734565|P10|Overall Study|Lost to Follow-up|0
2837643|NCT02569710|9734566|P9|Overall Study|Lost to Follow-up|1
2837644|NCT02569710|9734567|P8|Overall Study|Lost to Follow-up|0
2837645|NCT02569710|9734568|P7|Overall Study|Lost to Follow-up|1
2837646|NCT02569710|9734569|P6|Overall Study|Lost to Follow-up|0
2837647|NCT02569710|9734570|P5|Overall Study|Lost to Follow-up|0
2837648|NCT02569710|9734571|P4|Overall Study|Lost to Follow-up|0
2837649|NCT02569710|9734572|P3|Overall Study|Lost to Follow-up|0
2837650|NCT02569710|9734573|P2|Overall Study|Lost to Follow-up|0
2837651|NCT02569710|9734574|P1|Overall Study|Lost to Follow-up|0
2837652|NCT02569710|9734565|P10|Overall Study|Adverse Event|0
2837653|NCT02569710|9734566|P9|Overall Study|Adverse Event|0
2837654|NCT02569710|9734567|P8|Overall Study|Adverse Event|0
2837655|NCT02569710|9734568|P7|Overall Study|Adverse Event|0
2837656|NCT02569710|9734569|P6|Overall Study|Adverse Event|0
2837657|NCT02569710|9734570|P5|Overall Study|Adverse Event|0
2837658|NCT02569710|9734571|P4|Overall Study|Adverse Event|0
2837659|NCT02569710|9734572|P3|Overall Study|Adverse Event|0
2837660|NCT02569710|9734573|P2|Overall Study|Adverse Event|0
2837661|NCT02569710|9734574|P1|Overall Study|Adverse Event|1
2837662|NCT02569437|9734914|P2|Overall Study|Lost to Follow-up|14
2837663|NCT02569437|9734915|P1|Overall Study|Lost to Follow-up|12
2837664|NCT02569398|9734932|P3|Overall Study|Other|13
2837665|NCT02569398|9734933|P2|Overall Study|Other|14
2837666|NCT02569398|9734934|P1|Overall Study|Other|12
2837667|NCT02569398|9734932|P3|Overall Study|Study terminated by sponsor|134
2837668|NCT02569398|9734933|P2|Overall Study|Study terminated by sponsor|131
2837669|NCT02569398|9734934|P1|Overall Study|Study terminated by sponsor|130
2837670|NCT02569398|9734932|P3|Overall Study|Withdrawal by Subject|30
2837671|NCT02569398|9734933|P2|Overall Study|Withdrawal by Subject|43
2837672|NCT02569398|9734934|P1|Overall Study|Withdrawal by Subject|43
2837673|NCT02569398|9734932|P3|Overall Study|Adverse Event|6
2837674|NCT02569398|9734933|P2|Overall Study|Adverse Event|1
2837675|NCT02569398|9734934|P1|Overall Study|Adverse Event|0
2837676|NCT02568683|9735009|P2|Overall Study|Study Terminated By Sponsor|2
2837677|NCT02568683|9735010|P1|Overall Study|Study Terminated By Sponsor|5
2837678|NCT02568683|9735009|P2|Overall Study|Withdrew Consent|0
2837679|NCT02568683|9735010|P1|Overall Study|Withdrew Consent|1
2837680|NCT02568683|9735009|P2|Overall Study|Death|2
2837681|NCT02568683|9735010|P1|Overall Study|Death|0
2837682|NCT02568397|9735037|P2|Period 2|Physician Decision|1
2837683|NCT02568397|9735038|P1|Period 2|Physician Decision|0
2837684|NCT02568397|9735037|P2|Period 2|Withdrawal by Subject|1
2837685|NCT02568397|9735038|P1|Period 2|Withdrawal by Subject|0
2837686|NCT02568384|9735062|P1|Overall Study|Mobile devices incompatible with App|2
2837687|NCT02568254|9735076|P6|Period 3|Unstatisfactory Lens fitting|0
2837688|NCT02568254|9735077|P5|Period 3|Unstatisfactory Lens fitting|1
2837689|NCT02568254|9735078|P4|Period 3|Unstatisfactory Lens fitting|0
2837690|NCT02568254|9735079|P3|Period 3|Unstatisfactory Lens fitting|0
2837691|NCT02568254|9735080|P2|Period 3|Unstatisfactory Lens fitting|0
2837692|NCT02568254|9735081|P1|Period 3|Unstatisfactory Lens fitting|0
2837693|NCT02568254|9735076|P6|Period 2|Adverse Event|0
2837694|NCT02568254|9735077|P5|Period 2|Adverse Event|0
2837695|NCT02568254|9735078|P4|Period 2|Adverse Event|0
2837696|NCT02568254|9735079|P3|Period 2|Adverse Event|1
2837697|NCT02568254|9735080|P2|Period 2|Adverse Event|0
2837698|NCT02568254|9735081|P1|Period 2|Adverse Event|0
2837699|NCT02568046|9735091|P2|Overall Study|Other Events|1
2837700|NCT02568046|9735092|P1|Overall Study|Other Events|0
2837701|NCT02568046|9735091|P2|Overall Study|Withdrawal by Subject|1
2837702|NCT02568046|9735092|P1|Overall Study|Withdrawal by Subject|2
2837703|NCT02568046|9735091|P2|Overall Study|Progressive Disease|0
2837704|NCT02568046|9735092|P1|Overall Study|Progressive Disease|1
2837705|NCT02568046|9735091|P2|Overall Study|Death|0
2837706|NCT02568046|9735092|P1|Overall Study|Death|2
2837707|NCT02568046|9735091|P2|Overall Study|Adverse Event|1
2837708|NCT02568046|9735092|P1|Overall Study|Adverse Event|0
2837709|NCT02567708|9735155|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
2837710|NCT02567708|9735156|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2837711|NCT02567708|9735155|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2837712|NCT02567708|9735156|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
2837713|NCT02567708|9735155|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
2837714|NCT02567708|9735156|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
2837715|NCT02567708|9735155|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
2837716|NCT02567708|9735156|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2837717|NCT02567656|9735201|P6|Overall Study|Premature discontinuation due to PD|0
2837718|NCT02567656|9735202|P5|Overall Study|Premature discontinuation due to PD|0
2837719|NCT02567656|9735203|P4|Overall Study|Premature discontinuation due to PD|0
2837720|NCT02567656|9735204|P3|Overall Study|Premature discontinuation due to PD|2
2837721|NCT02567656|9735205|P2|Overall Study|Premature discontinuation due to PD|1
2837722|NCT02567656|9735206|P1|Overall Study|Premature discontinuation due to PD|1
2837723|NCT02567552|9735238|P2|Overall Study|Adverse Event|1
2837724|NCT02567552|9735239|P1|Overall Study|Adverse Event|0
2837725|NCT02567188|9735269|P1|Overall Study|Protocol Violation|5
2837726|NCT02567188|9735269|P1|Overall Study|Started Hemodialysis|2
2837727|NCT02567188|9735269|P1|Overall Study|Moved and Changed Clinic|1
2837728|NCT02567188|9735269|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
2837729|NCT02567188|9735269|P1|Overall Study|Withdrawal by Subject|1
2837730|NCT02567188|9735269|P1|Overall Study|Adverse Event|1
2837731|NCT02567188|9735269|P1|Overall Study|Lost to Follow-up|5
2837732|NCT02567188|9735269|P1|Overall Study|Terminated Mircera Treatment|9
2837733|NCT02567188|9735269|P1|Overall Study|Death|10
2837734|NCT02566785|9735300|P2|Overall Study|Worsening condition|1
2837735|NCT02566785|9735301|P1|Overall Study|Worsening condition|1
2837736|NCT02566785|9735300|P2|Overall Study|Lost to Follow-up|2
2837737|NCT02566785|9735301|P1|Overall Study|Lost to Follow-up|0
2837738|NCT02566759|9735328|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
2837739|NCT02566759|9735329|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837740|NCT02566759|9735330|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837741|NCT02566759|9735331|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837742|NCT02566759|9735332|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837743|NCT02566759|9735333|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837744|NCT02566759|9735334|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837745|NCT02566759|9735335|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837746|NCT02566759|9735336|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837747|NCT02566759|9735337|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837748|NCT02566759|9735338|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837749|NCT02566759|9735339|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837750|NCT02566759|9735340|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837751|NCT02566759|9735341|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837752|NCT02566759|9735342|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837753|NCT02566759|9735343|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837754|NCT02566759|9735344|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2837755|NCT02566759|9735328|P17|All Parts|Other|0
2837756|NCT02566759|9735329|P16|All Parts|Other|0
2837757|NCT02566759|9735330|P15|All Parts|Other|0
2837758|NCT02566759|9735331|P14|All Parts|Other|2
2837759|NCT02566759|9735332|P13|All Parts|Other|0
2837760|NCT02566759|9735333|P12|All Parts|Other|0
2837761|NCT02566759|9735334|P11|All Parts|Other|0
2837762|NCT02566759|9735335|P10|All Parts|Other|0
2837763|NCT02566759|9735336|P9|All Parts|Other|0
2837764|NCT02566759|9735337|P8|All Parts|Other|0
2837765|NCT02566759|9735338|P7|All Parts|Other|0
2837766|NCT02566759|9735339|P6|All Parts|Other|0
2837767|NCT02566759|9735340|P5|All Parts|Other|0
2837768|NCT02566759|9735341|P4|All Parts|Other|0
2837769|NCT02566759|9735342|P3|All Parts|Other|0
2837770|NCT02566759|9735343|P2|All Parts|Other|0
2837771|NCT02566759|9735344|P1|All Parts|Other|0
2837772|NCT02566759|9735328|P17|All Parts|Adverse Event|0
2837773|NCT02566759|9735329|P16|All Parts|Adverse Event|0
2837774|NCT02566759|9735330|P15|All Parts|Adverse Event|0
2837775|NCT02566759|9735331|P14|All Parts|Adverse Event|3
2837776|NCT02566759|9735332|P13|All Parts|Adverse Event|1
2837777|NCT02566759|9735333|P12|All Parts|Adverse Event|0
2837778|NCT02566759|9735334|P11|All Parts|Adverse Event|0
2837779|NCT02566759|9735335|P10|All Parts|Adverse Event|0
2837780|NCT02566759|9735336|P9|All Parts|Adverse Event|0
2837781|NCT02566759|9735337|P8|All Parts|Adverse Event|0
2837782|NCT02566759|9735338|P7|All Parts|Adverse Event|0
2837783|NCT02566759|9735339|P6|All Parts|Adverse Event|0
2837784|NCT02566759|9735340|P5|All Parts|Adverse Event|0
2837785|NCT02566759|9735341|P4|All Parts|Adverse Event|0
2837786|NCT02566759|9735342|P3|All Parts|Adverse Event|0
2837787|NCT02566759|9735343|P2|All Parts|Adverse Event|0
2837788|NCT02566759|9735344|P1|All Parts|Adverse Event|0
2837789|NCT02566759|9735328|P17|All Parts|Withdrawal by Subject|0
2837790|NCT02566759|9735329|P16|All Parts|Withdrawal by Subject|0
2837791|NCT02566759|9735330|P15|All Parts|Withdrawal by Subject|0
2837792|NCT02566759|9735331|P14|All Parts|Withdrawal by Subject|0
2837793|NCT02566759|9735332|P13|All Parts|Withdrawal by Subject|0
2837794|NCT02566759|9735333|P12|All Parts|Withdrawal by Subject|0
2837795|NCT02566759|9735334|P11|All Parts|Withdrawal by Subject|0
2837796|NCT02566759|9735335|P10|All Parts|Withdrawal by Subject|0
2837797|NCT02566759|9735336|P9|All Parts|Withdrawal by Subject|0
2837798|NCT02566759|9735337|P8|All Parts|Withdrawal by Subject|0
2837799|NCT02566759|9735338|P7|All Parts|Withdrawal by Subject|0
2837800|NCT02566759|9735339|P6|All Parts|Withdrawal by Subject|0
2837801|NCT02566759|9735340|P5|All Parts|Withdrawal by Subject|0
2837802|NCT02566759|9735341|P4|All Parts|Withdrawal by Subject|0
2837803|NCT02566759|9735342|P3|All Parts|Withdrawal by Subject|0
2837804|NCT02566759|9735343|P2|All Parts|Withdrawal by Subject|1
2837805|NCT02566759|9735344|P1|All Parts|Withdrawal by Subject|0
2837806|NCT02566577|9735506|P2|Overall Study|Physical limitation|0
2837807|NCT02566577|9735507|P1|Overall Study|Physical limitation|1
2837808|NCT02566577|9735506|P2|Overall Study|Equipment failure|1
2837809|NCT02566577|9735507|P1|Overall Study|Equipment failure|1
2837810|NCT02566577|9735506|P2|Overall Study|Withdrawal by Subject|1
2837811|NCT02566577|9735507|P1|Overall Study|Withdrawal by Subject|1
2837812|NCT02566109|9735587|P1|Overall Study|Withdrawal by Subject|1
2837813|NCT02566031|9735651|P2|Overall Study|Lost to Follow-up|1
2837814|NCT02566031|9735652|P1|Overall Study|Lost to Follow-up|1
2837815|NCT02566031|9735651|P2|Overall Study|Adverse Event|1
2837816|NCT02566031|9735652|P1|Overall Study|Adverse Event|3
2837817|NCT02566031|9735651|P2|Overall Study|Protocol deviation|3
2837818|NCT02566031|9735652|P1|Overall Study|Protocol deviation|2
2837819|NCT02566031|9735651|P2|Overall Study|Patient/guardian decision|7
2837820|NCT02566031|9735652|P1|Overall Study|Patient/guardian decision|14
2837821|NCT02566005|9735669|P2|Overall Study|labor after randomization|4
2837822|NCT02566005|9735670|P1|Overall Study|labor after randomization|0
2837823|NCT02566005|9735669|P2|Overall Study|did not receive foley|1
2837824|NCT02566005|9735670|P1|Overall Study|did not receive foley|0
2837825|NCT02566005|9735669|P2|Overall Study|received foley|0
2837826|NCT02566005|9735670|P1|Overall Study|received foley|8
2837827|NCT02566005|9735669|P2|Overall Study|vaginal bleeding|1
2837828|NCT02566005|9735670|P1|Overall Study|vaginal bleeding|0
2837829|NCT02565810|9735698|P1|Overall Study|Withdrawal by Subject|1
2837830|NCT02565784|9735707|P1|Second Treatment|Withdrawal by Subject|2
2837831|NCT02565784|9735707|P1|First Treatment|Withdrawal by Subject|1
2837832|NCT02565784|9735707|P1|First Treatment|Adverse Event|1
2837833|NCT02565706|9735719|P4|Overall Study|Lost to Follow-up|74
2837834|NCT02565706|9735720|P3|Overall Study|Lost to Follow-up|82
2837835|NCT02565706|9735721|P2|Overall Study|Lost to Follow-up|75
2837836|NCT02565706|9735722|P1|Overall Study|Lost to Follow-up|72
2837837|NCT02565706|9735719|P4|Overall Study|Withdrawal by Subject|11
2837838|NCT02565706|9735720|P3|Overall Study|Withdrawal by Subject|7
2837839|NCT02565706|9735721|P2|Overall Study|Withdrawal by Subject|7
2837840|NCT02565706|9735722|P1|Overall Study|Withdrawal by Subject|5
2837841|NCT02565615|9735828|P5|Overall Study|Untreated|567
2837842|NCT02565615|9735829|P4|Overall Study|Untreated|0
2837843|NCT02565615|9735830|P3|Overall Study|Untreated|0
2837844|NCT02565615|9735831|P2|Overall Study|Untreated|0
2837845|NCT02565615|9735832|P1|Overall Study|Untreated|0
2837846|NCT02565615|9735828|P5|Overall Study|Adverse Event|9
2837847|NCT02565615|9735829|P4|Overall Study|Adverse Event|0
2837848|NCT02565615|9735830|P3|Overall Study|Adverse Event|0
2837849|NCT02565615|9735831|P2|Overall Study|Adverse Event|1
2837850|NCT02565615|9735832|P1|Overall Study|Adverse Event|1
2837851|NCT02565615|9735828|P5|Overall Study|Reason not defined|62
2837852|NCT02565615|9735829|P4|Overall Study|Reason not defined|1
2837853|NCT02565615|9735830|P3|Overall Study|Reason not defined|0
2837854|NCT02565615|9735831|P2|Overall Study|Reason not defined|2
2837855|NCT02565615|9735832|P1|Overall Study|Reason not defined|0
2837856|NCT02565615|9735828|P5|Overall Study|Not meeting eligibility criteria|25
2837857|NCT02565615|9735829|P4|Overall Study|Not meeting eligibility criteria|0
2837858|NCT02565615|9735830|P3|Overall Study|Not meeting eligibility criteria|0
2837859|NCT02565615|9735831|P2|Overall Study|Not meeting eligibility criteria|7
2837860|NCT02565615|9735832|P1|Overall Study|Not meeting eligibility criteria|0
2837861|NCT02565615|9735828|P5|Overall Study|Lost to Follow-up|765
2837862|NCT02565615|9735829|P4|Overall Study|Lost to Follow-up|1
2837863|NCT02565615|9735830|P3|Overall Study|Lost to Follow-up|0
2837864|NCT02565615|9735831|P2|Overall Study|Lost to Follow-up|4
2837865|NCT02565615|9735832|P1|Overall Study|Lost to Follow-up|0
2837866|NCT02565615|9735828|P5|Overall Study|Not willing to participate in study|169
2837867|NCT02565615|9735829|P4|Overall Study|Not willing to participate in study|1
2837868|NCT02565615|9735830|P3|Overall Study|Not willing to participate in study|0
2837869|NCT02565615|9735831|P2|Overall Study|Not willing to participate in study|21
2837870|NCT02565615|9735832|P1|Overall Study|Not willing to participate in study|2
2837871|NCT02565615|9735828|P5|Overall Study|Death|4
2837872|NCT02565615|9735829|P4|Overall Study|Death|0
2837873|NCT02565615|9735830|P3|Overall Study|Death|0
2837874|NCT02565615|9735831|P2|Overall Study|Death|1
2837875|NCT02565615|9735832|P1|Overall Study|Death|0
2837876|NCT02565576|9735946|P2|Overall Study|Adverse Event|0
2837877|NCT02565576|9735947|P1|Overall Study|Adverse Event|1
2837878|NCT02565576|9735946|P2|Overall Study|Death|2
2837879|NCT02565576|9735947|P1|Overall Study|Death|0
2837880|NCT02565576|9735946|P2|Overall Study|Lost to Follow-up|0
2837881|NCT02565576|9735947|P1|Overall Study|Lost to Follow-up|1
2837882|NCT02565576|9735946|P2|Overall Study|subject / guardian decision|3
2837883|NCT02565576|9735947|P1|Overall Study|subject / guardian decision|1
2837884|NCT02565576|9735946|P2|Overall Study|abnormal lab value|0
2837885|NCT02565576|9735947|P1|Overall Study|abnormal lab value|2
2837886|NCT02565381|9735990|P3|Overall Study|Lost to Follow-up|1
2837887|NCT02565381|9735991|P2|Overall Study|Lost to Follow-up|0
2837888|NCT02565381|9735992|P1|Overall Study|Lost to Follow-up|1
2837889|NCT02565147|9736032|P2|Overall Study|Death|1
2837890|NCT02565147|9736033|P1|Overall Study|Death|1
2837891|NCT02565147|9736032|P2|Overall Study|Lost to Follow-up|1
2837892|NCT02565147|9736033|P1|Overall Study|Lost to Follow-up|0
2837893|NCT02565147|9736032|P2|Overall Study|Withdrawal by Subject|1
2837894|NCT02565147|9736033|P1|Overall Study|Withdrawal by Subject|5
2837895|NCT02565108|9736057|P2|Overall Study|Withdrew Consent|0
2837896|NCT02565108|9736058|P1|Overall Study|Withdrew Consent|1
2837897|NCT02565108|9736057|P2|Overall Study|Adverse Event|0
2837898|NCT02565108|9736058|P1|Overall Study|Adverse Event|1
2837899|NCT02564952|9736074|P1|Overall Study|Participant Met Withdrawal Criteria|1
2837900|NCT02564952|9736074|P1|Overall Study|Low Efficacy|1
2837901|NCT02564952|9736074|P1|Overall Study|Withdrawal by Subject|1
2837902|NCT02564952|9736074|P1|Overall Study|Participant Withdrawn by Investigator|1
2837903|NCT02564952|9736074|P1|Overall Study|Lost to Follow-up|1
2837904|NCT02564952|9736074|P1|Overall Study|Adverse Event|6
2837905|NCT02564887|9736119|P2|Overall Study|Lost to Follow-up|0
2837906|NCT02564887|9736120|P1|Overall Study|Lost to Follow-up|6
2837907|NCT02564718|9736138|P2|Overall Study|Withdrew from treatment|1
2837908|NCT02564718|9736139|P1|Overall Study|Withdrew from treatment|0
2837909|NCT02564263|9736196|P2|Overall Study|Ongoing in Study|25
2837910|NCT02564263|9736197|P1|Overall Study|Ongoing in Study|42
2837911|NCT02564263|9736196|P2|Overall Study|Withdrawal by Subject|18
2837912|NCT02564263|9736197|P1|Overall Study|Withdrawal by Subject|5
2837913|NCT02564263|9736196|P2|Overall Study|Death|242
2837914|NCT02564263|9736197|P1|Overall Study|Death|236
2837915|NCT02564263|9736196|P2|Overall Study|Adverse Event|29
2837916|NCT02564263|9736197|P1|Overall Study|Adverse Event|31
2837917|NCT02564211|9736219|P1|Overall Study|Adverse Event|4
2837918|NCT02564120|9736230|P1|Overall Study|Other medical condition|24
2837919|NCT02564120|9736230|P1|Overall Study|Withdrawal by Subject|204
2837920|NCT02564120|9736230|P1|Overall Study|Death|58
2837921|NCT02564120|9736230|P1|Overall Study|Did not return release forms|160
2837922|NCT02564055|9736278|P6|Overall Study|Withdrawal by Subject|10
2837923|NCT02564055|9736279|P5|Overall Study|Withdrawal by Subject|10
2837924|NCT02564055|9736280|P4|Overall Study|Withdrawal by Subject|3
2837925|NCT02564055|9736281|P3|Overall Study|Withdrawal by Subject|3
2837926|NCT02564055|9736282|P2|Overall Study|Withdrawal by Subject|4
2837927|NCT02564055|9736283|P1|Overall Study|Withdrawal by Subject|4
2837928|NCT02564055|9736278|P6|Overall Study|Physician Decision|0
2837929|NCT02564055|9736279|P5|Overall Study|Physician Decision|0
2837930|NCT02564055|9736280|P4|Overall Study|Physician Decision|0
2837931|NCT02564055|9736281|P3|Overall Study|Physician Decision|1
2837932|NCT02564055|9736282|P2|Overall Study|Physician Decision|0
2837933|NCT02564055|9736283|P1|Overall Study|Physician Decision|0
2837934|NCT02564055|9736278|P6|Overall Study|Lost to Follow-up|0
2837935|NCT02564055|9736279|P5|Overall Study|Lost to Follow-up|1
2837936|NCT02564055|9736280|P4|Overall Study|Lost to Follow-up|2
2837937|NCT02564055|9736281|P3|Overall Study|Lost to Follow-up|4
2837938|NCT02564055|9736282|P2|Overall Study|Lost to Follow-up|1
2837939|NCT02564055|9736283|P1|Overall Study|Lost to Follow-up|0
2837940|NCT02564055|9736278|P6|Overall Study|Reached stopping criteria|1
2837941|NCT02564055|9736279|P5|Overall Study|Reached stopping criteria|0
2837942|NCT02564055|9736280|P4|Overall Study|Reached stopping criteria|0
2837943|NCT02564055|9736281|P3|Overall Study|Reached stopping criteria|0
2837944|NCT02564055|9736282|P2|Overall Study|Reached stopping criteria|0
2837945|NCT02564055|9736283|P1|Overall Study|Reached stopping criteria|0
2837946|NCT02564055|9736278|P6|Overall Study|Protocol Violation|0
2837947|NCT02564055|9736279|P5|Overall Study|Protocol Violation|0
2837948|NCT02564055|9736280|P4|Overall Study|Protocol Violation|0
2837949|NCT02564055|9736281|P3|Overall Study|Protocol Violation|0
2837950|NCT02564055|9736282|P2|Overall Study|Protocol Violation|0
2837951|NCT02564055|9736283|P1|Overall Study|Protocol Violation|1
2837952|NCT02564055|9736278|P6|Overall Study|Adverse Event|1
2837953|NCT02564055|9736279|P5|Overall Study|Adverse Event|4
2837954|NCT02564055|9736280|P4|Overall Study|Adverse Event|1
2837955|NCT02564055|9736281|P3|Overall Study|Adverse Event|4
2837956|NCT02564055|9736282|P2|Overall Study|Adverse Event|0
2837957|NCT02564055|9736283|P1|Overall Study|Adverse Event|1
2837958|NCT02564042|9736537|P6|Overall Study|Withdrawal by Subject|12
2837959|NCT02564042|9736538|P5|Overall Study|Withdrawal by Subject|10
2837960|NCT02564042|9736539|P4|Overall Study|Withdrawal by Subject|2
2837961|NCT02564042|9736540|P3|Overall Study|Withdrawal by Subject|2
2837962|NCT02564042|9736541|P2|Overall Study|Withdrawal by Subject|3
2837963|NCT02564042|9736542|P1|Overall Study|Withdrawal by Subject|5
2837964|NCT02564042|9736537|P6|Overall Study|Physician Decision|0
2837965|NCT02564042|9736538|P5|Overall Study|Physician Decision|0
2837966|NCT02564042|9736539|P4|Overall Study|Physician Decision|1
2837967|NCT02564042|9736540|P3|Overall Study|Physician Decision|0
2837968|NCT02564042|9736541|P2|Overall Study|Physician Decision|0
2837969|NCT02564042|9736542|P1|Overall Study|Physician Decision|1
2837970|NCT02564042|9736537|P6|Overall Study|Lost to Follow-up|1
2837971|NCT02564042|9736538|P5|Overall Study|Lost to Follow-up|1
2837972|NCT02564042|9736539|P4|Overall Study|Lost to Follow-up|0
2837973|NCT02564042|9736540|P3|Overall Study|Lost to Follow-up|1
2837974|NCT02564042|9736541|P2|Overall Study|Lost to Follow-up|1
2837975|NCT02564042|9736542|P1|Overall Study|Lost to Follow-up|1
2837976|NCT02564042|9736537|P6|Overall Study|Adverse Event|1
2837977|NCT02564042|9736538|P5|Overall Study|Adverse Event|0
2837978|NCT02564042|9736539|P4|Overall Study|Adverse Event|0
2837979|NCT02564042|9736540|P3|Overall Study|Adverse Event|3
2837980|NCT02564042|9736541|P2|Overall Study|Adverse Event|4
2837981|NCT02564042|9736542|P1|Overall Study|Adverse Event|4
2837982|NCT02563899|9736837|P4|Overall Study|Withdrawal by Subject|0
2837983|NCT02563899|9736838|P3|Overall Study|Withdrawal by Subject|1
2837984|NCT02563899|9736839|P2|Overall Study|Withdrawal by Subject|0
2837985|NCT02563899|9736840|P1|Overall Study|Withdrawal by Subject|0
2837986|NCT02563899|9736837|P4|Overall Study|Protocol Violation|0
2837987|NCT02563899|9736838|P3|Overall Study|Protocol Violation|0
2837988|NCT02563899|9736839|P2|Overall Study|Protocol Violation|0
2837989|NCT02563899|9736840|P1|Overall Study|Protocol Violation|1
2837990|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2837991|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
2837992|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2837993|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2837994|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2837995|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2837996|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
2837997|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2837998|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2837999|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2838000|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2838001|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2838002|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
2838003|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2838004|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2838005|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2838006|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2838007|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2838008|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
2838009|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2838010|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2838011|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2838012|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2838013|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2838014|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
2838015|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
2838016|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2838017|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2838018|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2838019|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2838020|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2838021|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
2838022|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2838023|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2838024|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2838025|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2838026|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
2838027|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
2838028|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2838029|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2838030|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2838031|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2838032|NCT02563548|9736916|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
2838033|NCT02563548|9736917|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
2838034|NCT02563548|9736918|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2838035|NCT02563548|9736919|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2838036|NCT02563548|9736920|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2838037|NCT02563548|9736921|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2838038|NCT02563548|9736916|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2838039|NCT02563548|9736917|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2838040|NCT02563548|9736918|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
2838041|NCT02563548|9736919|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
2838042|NCT02563548|9736920|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2838043|NCT02563548|9736921|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2838044|NCT02563548|9736916|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2838045|NCT02563548|9736917|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2838046|NCT02563548|9736918|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2838047|NCT02563548|9736919|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
2838048|NCT02563548|9736920|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2838049|NCT02563548|9736921|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2838050|NCT02563548|9736916|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2838051|NCT02563548|9736917|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2838052|NCT02563548|9736918|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2838053|NCT02563548|9736919|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2838054|NCT02563548|9736920|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2838055|NCT02563548|9736921|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
2838056|NCT02563548|9736916|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2838057|NCT02563548|9736917|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2838058|NCT02563548|9736918|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
2838059|NCT02563548|9736919|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2838060|NCT02563548|9736920|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2838061|NCT02563548|9736921|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
2838062|NCT02563106|9736985|P2|Overall Study|Other reason - not specified|1
2838063|NCT02563106|9736986|P1|Overall Study|Other reason - not specified|2
2838064|NCT02563106|9736985|P2|Overall Study|Physician Decision|1
2838065|NCT02563106|9736986|P1|Overall Study|Physician Decision|3
2838066|NCT02563106|9736985|P2|Overall Study|Lost to Follow-up|2
2838067|NCT02563106|9736986|P1|Overall Study|Lost to Follow-up|3
2838068|NCT02563106|9736985|P2|Overall Study|Use of non-permitted concurrent therapy|2
2838069|NCT02563106|9736986|P1|Overall Study|Use of non-permitted concurrent therapy|1
2838070|NCT02563106|9736985|P2|Overall Study|Protocol Violation|0
2838071|NCT02563106|9736986|P1|Overall Study|Protocol Violation|1
2838072|NCT02563106|9736985|P2|Overall Study|Adverse Event|15
2838073|NCT02563106|9736986|P1|Overall Study|Adverse Event|17
2838074|NCT02563106|9736985|P2|Overall Study|Withdrawal by Subject|8
2838075|NCT02563106|9736986|P1|Overall Study|Withdrawal by Subject|7
2838076|NCT02563028|9737025|P1|Overall Study|Unable to elicit VEP post induction|1
2838077|NCT02563028|9737025|P1|Overall Study|Lack of equipment|1
2838078|NCT02562482|9737101|P2|Overall Study|Illness/Injury unrelated to product|1
2838079|NCT02562482|9737102|P1|Overall Study|Illness/Injury unrelated to product|0
2838080|NCT02562482|9737101|P2|Overall Study|Physician Decision|3
2838081|NCT02562482|9737102|P1|Overall Study|Physician Decision|1
2838082|NCT02562482|9737101|P2|Overall Study|Withdrawal by Subject|3
2838083|NCT02562482|9737102|P1|Overall Study|Withdrawal by Subject|5
2838084|NCT02562482|9737101|P2|Overall Study|Moved from area|3
2838085|NCT02562482|9737102|P1|Overall Study|Moved from area|2
2838086|NCT02562482|9737101|P2|Overall Study|Lost to Follow-up|6
2838087|NCT02562482|9737102|P1|Overall Study|Lost to Follow-up|9
2838088|NCT02562482|9737101|P2|Overall Study|Enrolled, but did not receive product|0
2838089|NCT02562482|9737102|P1|Overall Study|Enrolled, but did not receive product|4
2838090|NCT02561832|9737137|P2|Overall Study|Disease progression|3
2838091|NCT02561832|9737138|P1|Overall Study|Disease progression|3
2838092|NCT02561832|9737137|P2|Overall Study|Adverse Event|0
2838093|NCT02561832|9737138|P1|Overall Study|Adverse Event|3
2838094|NCT02561832|9737137|P2|Overall Study|Withdrawal by Subject|1
2838095|NCT02561832|9737138|P1|Overall Study|Withdrawal by Subject|1
2838096|NCT02561806|9737146|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
2838097|NCT02561806|9737147|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
2838098|NCT02561806|9737146|P2|Post-Treatment Follow-up|Lost to Follow-up|1
2838099|NCT02561806|9737147|P1|Post-Treatment Follow-up|Lost to Follow-up|1
2838100|NCT02561806|9737146|P2|Maintenance Period|Site staff became unblinded|1
2838101|NCT02561806|9737147|P1|Maintenance Period|Site staff became unblinded|0
2838102|NCT02561806|9737146|P2|Maintenance Period|Withdrawal by Subject|3
2838103|NCT02561806|9737147|P1|Maintenance Period|Withdrawal by Subject|5
2838104|NCT02561806|9737146|P2|Maintenance Period|Protocol Violation|0
2838105|NCT02561806|9737147|P1|Maintenance Period|Protocol Violation|1
2838106|NCT02561806|9737146|P2|Maintenance Period|Lost to Follow-up|2
2838107|NCT02561806|9737147|P1|Maintenance Period|Lost to Follow-up|2
2838108|NCT02561806|9737146|P2|Maintenance Period|Lack of Efficacy|1
2838109|NCT02561806|9737147|P1|Maintenance Period|Lack of Efficacy|3
2838110|NCT02561806|9737146|P2|Maintenance Period|Adverse Event|1
2838111|NCT02561806|9737147|P1|Maintenance Period|Adverse Event|2
2838112|NCT02561806|9737146|P2|Induction Period|Randomized but not treated|1
2838113|NCT02561806|9737147|P1|Induction Period|Randomized but not treated|0
2838114|NCT02561806|9737146|P2|Induction Period|Site staff became unblinded|0
2838115|NCT02561806|9737147|P1|Induction Period|Site staff became unblinded|1
2838116|NCT02561806|9737146|P2|Induction Period|Withdrawal by Subject|2
2838117|NCT02561806|9737147|P1|Induction Period|Withdrawal by Subject|0
2838118|NCT02561806|9737146|P2|Induction Period|Lack of Efficacy|0
2838119|NCT02561806|9737147|P1|Induction Period|Lack of Efficacy|1
2838120|NCT02561806|9737146|P2|Induction Period|Adverse Event|2
2838121|NCT02561806|9737147|P1|Induction Period|Adverse Event|0
2838122|NCT02561572|9737251|P2|Overall Study|Protocol Violation|1
2838123|NCT02561572|9737252|P1|Overall Study|Protocol Violation|0
2838124|NCT02561572|9737251|P2|Overall Study|Inadequate time before surgery|1
2838125|NCT02561572|9737252|P1|Overall Study|Inadequate time before surgery|2
2838126|NCT02561195|9737310|P6|Overall Study|Randomized but not treated|0
2838127|NCT02561195|9737311|P5|Overall Study|Randomized but not treated|0
2838128|NCT02561195|9737312|P4|Overall Study|Randomized but not treated|0
2838129|NCT02561195|9737313|P3|Overall Study|Randomized but not treated|0
2838130|NCT02561195|9737314|P2|Overall Study|Randomized but not treated|0
2838131|NCT02561195|9737315|P1|Overall Study|Randomized but not treated|1
2838132|NCT02561195|9737310|P6|Overall Study|Withdrawal by Subject|0
2838133|NCT02561195|9737311|P5|Overall Study|Withdrawal by Subject|6
2838134|NCT02561195|9737312|P4|Overall Study|Withdrawal by Subject|2
2838135|NCT02561195|9737313|P3|Overall Study|Withdrawal by Subject|4
2838136|NCT02561195|9737314|P2|Overall Study|Withdrawal by Subject|4
2838137|NCT02561195|9737315|P1|Overall Study|Withdrawal by Subject|3
2838138|NCT02561195|9737310|P6|Overall Study|Death|0
2838139|NCT02561195|9737311|P5|Overall Study|Death|0
2838140|NCT02561195|9737312|P4|Overall Study|Death|2
2838141|NCT02561195|9737313|P3|Overall Study|Death|0
2838142|NCT02561195|9737314|P2|Overall Study|Death|1
2838143|NCT02561195|9737315|P1|Overall Study|Death|2
2838144|NCT02561195|9737310|P6|Overall Study|Protocol Violation|2
2838145|NCT02561195|9737311|P5|Overall Study|Protocol Violation|5
2838146|NCT02561195|9737312|P4|Overall Study|Protocol Violation|2
2838147|NCT02561195|9737313|P3|Overall Study|Protocol Violation|1
2838148|NCT02561195|9737314|P2|Overall Study|Protocol Violation|0
2838149|NCT02561195|9737315|P1|Overall Study|Protocol Violation|1
2838150|NCT02561195|9737310|P6|Overall Study|Other|1
2838151|NCT02561195|9737311|P5|Overall Study|Other|5
2838152|NCT02561195|9737312|P4|Overall Study|Other|7
2838153|NCT02561195|9737313|P3|Overall Study|Other|1
2838154|NCT02561195|9737314|P2|Overall Study|Other|3
2838155|NCT02561195|9737315|P1|Overall Study|Other|7
2838156|NCT02561195|9737310|P6|Overall Study|No longer willing to participate|3
2838157|NCT02561195|9737311|P5|Overall Study|No longer willing to participate|1
2838158|NCT02561195|9737312|P4|Overall Study|No longer willing to participate|4
2838159|NCT02561195|9737313|P3|Overall Study|No longer willing to participate|0
2838160|NCT02561195|9737314|P2|Overall Study|No longer willing to participate|4
2838161|NCT02561195|9737315|P1|Overall Study|No longer willing to participate|2
2838162|NCT02561195|9737310|P6|Overall Study|No longer meets eligibility criteria|1
2838163|NCT02561195|9737311|P5|Overall Study|No longer meets eligibility criteria|4
2838164|NCT02561195|9737312|P4|Overall Study|No longer meets eligibility criteria|4
2838165|NCT02561195|9737313|P3|Overall Study|No longer meets eligibility criteria|0
2838166|NCT02561195|9737314|P2|Overall Study|No longer meets eligibility criteria|1
2838167|NCT02561195|9737315|P1|Overall Study|No longer meets eligibility criteria|0
2838168|NCT02561195|9737310|P6|Overall Study|Lost to Follow-up|3
2838169|NCT02561195|9737311|P5|Overall Study|Lost to Follow-up|3
2838170|NCT02561195|9737312|P4|Overall Study|Lost to Follow-up|2
2838171|NCT02561195|9737313|P3|Overall Study|Lost to Follow-up|0
2838172|NCT02561195|9737314|P2|Overall Study|Lost to Follow-up|4
2838173|NCT02561195|9737315|P1|Overall Study|Lost to Follow-up|3
2838174|NCT02561195|9737310|P6|Overall Study|Adverse Event|0
2838175|NCT02561195|9737311|P5|Overall Study|Adverse Event|4
2838176|NCT02561195|9737312|P4|Overall Study|Adverse Event|3
2838177|NCT02561195|9737313|P3|Overall Study|Adverse Event|0
2838178|NCT02561195|9737314|P2|Overall Study|Adverse Event|5
2838179|NCT02561195|9737315|P1|Overall Study|Adverse Event|4
2838180|NCT02561156|9737476|P13|Part 2|Adverse Event|0
2838181|NCT02561156|9737477|P12|Part 2|Adverse Event|1
2838182|NCT02561156|9737478|P11|Part 2|Adverse Event|0
2838183|NCT02561156|9737479|P10|Part 2|Adverse Event|0
2838184|NCT02561156|9737480|P9|Part 2|Adverse Event|0
2838185|NCT02561156|9737481|P8|Part 2|Adverse Event|0
2838186|NCT02561156|9737482|P7|Part 2|Adverse Event|0
2838187|NCT02561156|9737483|P6|Part 2|Adverse Event|0
2838188|NCT02561156|9737484|P5|Part 2|Adverse Event|0
2838189|NCT02561156|9737485|P4|Part 2|Adverse Event|0
2838190|NCT02561156|9737486|P3|Part 2|Adverse Event|0
2838191|NCT02561156|9737487|P2|Part 2|Adverse Event|0
2838192|NCT02561156|9737488|P1|Part 2|Adverse Event|0
2838193|NCT02561078|9737660|P2|Overall Study|Withdrawal by Subject|10
2838194|NCT02561078|9737661|P1|Overall Study|Withdrawal by Subject|13
2838195|NCT02561078|9737660|P2|Overall Study|Physician Decision|3
2838196|NCT02561078|9737661|P1|Overall Study|Physician Decision|2
2838197|NCT02561078|9737660|P2|Overall Study|Non-Compliance with Study Drug|3
2838198|NCT02561078|9737661|P1|Overall Study|Non-Compliance with Study Drug|6
2838199|NCT02561078|9737660|P2|Overall Study|Lost to Follow-up|6
2838200|NCT02561078|9737661|P1|Overall Study|Lost to Follow-up|2
2838201|NCT02561078|9737660|P2|Overall Study|Death|1
2838202|NCT02561078|9737661|P1|Overall Study|Death|2
2838203|NCT02561078|9737660|P2|Overall Study|Adverse Event|2
2838204|NCT02561078|9737661|P1|Overall Study|Adverse Event|5
2838205|NCT02560389|9737795|P3|Overall Study|Tested positive for illicit substance|0
2838206|NCT02560389|9737796|P2|Overall Study|Tested positive for illicit substance|1
2838207|NCT02560389|9737797|P1|Overall Study|Tested positive for illicit substance|0
2838208|NCT02560389|9737795|P3|Overall Study|Lost to Follow-up|2
2838209|NCT02560389|9737796|P2|Overall Study|Lost to Follow-up|2
2838210|NCT02560389|9737797|P1|Overall Study|Lost to Follow-up|1
2838211|NCT02560025|9737895|P1|Overall Study|Ineligible after consent/ registration|3
2838212|NCT02560012|9737904|P1|Overall Study|Study Terminated|2
2838213|NCT02559895|9737912|P4|Overall Study|Other|3
2838214|NCT02559895|9737913|P3|Overall Study|Other|3
2838215|NCT02559895|9737914|P2|Overall Study|Other|5
2838216|NCT02559895|9737915|P1|Overall Study|Other|1
2838217|NCT02559895|9737912|P4|Overall Study|Study Burden|22
2838218|NCT02559895|9737913|P3|Overall Study|Study Burden|12
2838219|NCT02559895|9737914|P2|Overall Study|Study Burden|16
2838220|NCT02559895|9737915|P1|Overall Study|Study Burden|10
2838221|NCT02559895|9737912|P4|Overall Study|Withdrawal by Subject|9
2838222|NCT02559895|9737913|P3|Overall Study|Withdrawal by Subject|20
2838223|NCT02559895|9737914|P2|Overall Study|Withdrawal by Subject|9
2838224|NCT02559895|9737915|P1|Overall Study|Withdrawal by Subject|16
2838225|NCT02559895|9737912|P4|Overall Study|Physician Decision|0
2838226|NCT02559895|9737913|P3|Overall Study|Physician Decision|3
2838227|NCT02559895|9737914|P2|Overall Study|Physician Decision|1
2838228|NCT02559895|9737915|P1|Overall Study|Physician Decision|1
2838229|NCT02559895|9737912|P4|Overall Study|Lost to Follow-up|17
2838230|NCT02559895|9737913|P3|Overall Study|Lost to Follow-up|12
2838231|NCT02559895|9737914|P2|Overall Study|Lost to Follow-up|16
2838232|NCT02559895|9737915|P1|Overall Study|Lost to Follow-up|22
2838233|NCT02559895|9737912|P4|Overall Study|Lack of Efficacy|8
2838234|NCT02559895|9737913|P3|Overall Study|Lack of Efficacy|2
2838235|NCT02559895|9737914|P2|Overall Study|Lack of Efficacy|3
2838236|NCT02559895|9737915|P1|Overall Study|Lack of Efficacy|2
2838237|NCT02559895|9737912|P4|Overall Study|Adverse Event|1
2838238|NCT02559895|9737913|P3|Overall Study|Adverse Event|2
2838239|NCT02559895|9737914|P2|Overall Study|Adverse Event|3
2838240|NCT02559895|9737915|P1|Overall Study|Adverse Event|3
2838241|NCT02559713|9738005|P1|Overall Study|Pretreatment Event/ Adverse Event|1
2838242|NCT02559687|9738015|P1|Overall Study|Ongoing Follow-Up|14
2838243|NCT02559687|9738015|P1|Overall Study|Withdrawal by Subject|4
2838244|NCT02559687|9738015|P1|Overall Study|Death|103
2838245|NCT02559622|9738028|P4|Overall Study|Patient/guardian decision|1
2838246|NCT02559622|9738029|P3|Overall Study|Patient/guardian decision|0
2838247|NCT02559622|9738030|P2|Overall Study|Patient/guardian decision|2
2838248|NCT02559622|9738031|P1|Overall Study|Patient/guardian decision|1
2838249|NCT02559622|9738028|P4|Overall Study|Adverse Event|2
2838250|NCT02559622|9738029|P3|Overall Study|Adverse Event|2
2838251|NCT02559622|9738030|P2|Overall Study|Adverse Event|2
2838252|NCT02559622|9738031|P1|Overall Study|Adverse Event|0
2838253|NCT02559622|9738028|P4|Overall Study|Progressive disease|0
2838254|NCT02559622|9738029|P3|Overall Study|Progressive disease|0
2838255|NCT02559622|9738030|P2|Overall Study|Progressive disease|1
2838256|NCT02559622|9738031|P1|Overall Study|Progressive disease|0
2838257|NCT02559570|9738115|P5|Overall Study|Other Miscellaneous Reasons|0
2838258|NCT02559570|9738116|P4|Overall Study|Other Miscellaneous Reasons|0
2838259|NCT02559570|9738117|P3|Overall Study|Other Miscellaneous Reasons|1
2838260|NCT02559570|9738118|P2|Overall Study|Other Miscellaneous Reasons|0
2838261|NCT02559570|9738119|P1|Overall Study|Other Miscellaneous Reasons|0
2838262|NCT02559570|9738115|P5|Overall Study|Protocol Violation|1
2838263|NCT02559570|9738116|P4|Overall Study|Protocol Violation|0
2838264|NCT02559570|9738117|P3|Overall Study|Protocol Violation|0
2838265|NCT02559570|9738118|P2|Overall Study|Protocol Violation|0
2838266|NCT02559570|9738119|P1|Overall Study|Protocol Violation|1
2838267|NCT02559570|9738115|P5|Overall Study|Lost to Follow-up|0
2838268|NCT02559570|9738116|P4|Overall Study|Lost to Follow-up|0
2838269|NCT02559570|9738117|P3|Overall Study|Lost to Follow-up|0
2838270|NCT02559570|9738118|P2|Overall Study|Lost to Follow-up|0
2838271|NCT02559570|9738119|P1|Overall Study|Lost to Follow-up|1
2838272|NCT02559570|9738115|P5|Overall Study|Withdrawal of Consent|1
2838273|NCT02559570|9738116|P4|Overall Study|Withdrawal of Consent|2
2838274|NCT02559570|9738117|P3|Overall Study|Withdrawal of Consent|1
2838275|NCT02559570|9738118|P2|Overall Study|Withdrawal of Consent|0
2838276|NCT02559570|9738119|P1|Overall Study|Withdrawal of Consent|0
2838277|NCT02559570|9738115|P5|Overall Study|Adverse Event|0
2838278|NCT02559570|9738116|P4|Overall Study|Adverse Event|1
2838279|NCT02559570|9738117|P3|Overall Study|Adverse Event|0
2838280|NCT02559570|9738118|P2|Overall Study|Adverse Event|2
2838281|NCT02559570|9738119|P1|Overall Study|Adverse Event|0
2838282|NCT02559414|9738157|P3|Overall Study|Other|1
2838283|NCT02559414|9738158|P2|Overall Study|Other|1
2838284|NCT02559414|9738159|P1|Overall Study|Other|0
2838285|NCT02559414|9738157|P3|Overall Study|Withdrawal by Subject|1
2838286|NCT02559414|9738158|P2|Overall Study|Withdrawal by Subject|0
2838287|NCT02559414|9738159|P1|Overall Study|Withdrawal by Subject|1
2838288|NCT02559414|9738157|P3|Overall Study|Lost to Follow-up|0
2838289|NCT02559414|9738158|P2|Overall Study|Lost to Follow-up|1
2838290|NCT02559414|9738159|P1|Overall Study|Lost to Follow-up|0
2838291|NCT02559310|9738199|P2|Overall Study|Randomized but not treated|2
2838292|NCT02559310|9738200|P1|Overall Study|Randomized but not treated|3
2838293|NCT02559310|9738199|P2|Overall Study|Sponsor Decision|1
2838294|NCT02559310|9738200|P1|Overall Study|Sponsor Decision|0
2838295|NCT02559310|9738199|P2|Overall Study|Withdrawal by Subject|9
2838296|NCT02559310|9738200|P1|Overall Study|Withdrawal by Subject|13
2838297|NCT02559310|9738199|P2|Overall Study|Physician Decision|1
2838298|NCT02559310|9738200|P1|Overall Study|Physician Decision|2
2838299|NCT02559310|9738199|P2|Overall Study|Lost to Follow-up|3
2838300|NCT02559310|9738200|P1|Overall Study|Lost to Follow-up|5
2838301|NCT02559310|9738199|P2|Overall Study|Death|3
2838302|NCT02559310|9738200|P1|Overall Study|Death|4
2838303|NCT02559206|9738218|P8|Overall Study|Other Not Specified|0
2838304|NCT02559206|9738219|P7|Overall Study|Other Not Specified|0
2838305|NCT02559206|9738220|P6|Overall Study|Other Not Specified|0
2838306|NCT02559206|9738221|P5|Overall Study|Other Not Specified|0
2838307|NCT02559206|9738222|P4|Overall Study|Other Not Specified|1
2838308|NCT02559206|9738223|P3|Overall Study|Other Not Specified|0
2838309|NCT02559206|9738224|P2|Overall Study|Other Not Specified|0
2838310|NCT02559206|9738225|P1|Overall Study|Other Not Specified|0
2838311|NCT02559206|9738218|P8|Overall Study|Lack of Efficacy|3
2838312|NCT02559206|9738219|P7|Overall Study|Lack of Efficacy|3
2838313|NCT02559206|9738220|P6|Overall Study|Lack of Efficacy|3
2838314|NCT02559206|9738221|P5|Overall Study|Lack of Efficacy|2
2838315|NCT02559206|9738222|P4|Overall Study|Lack of Efficacy|2
2838316|NCT02559206|9738223|P3|Overall Study|Lack of Efficacy|3
2838317|NCT02559206|9738224|P2|Overall Study|Lack of Efficacy|0
2838318|NCT02559206|9738225|P1|Overall Study|Lack of Efficacy|1
2838319|NCT02559206|9738218|P8|Overall Study|Lost to Follow-up|4
2838320|NCT02559206|9738219|P7|Overall Study|Lost to Follow-up|1
2838321|NCT02559206|9738220|P6|Overall Study|Lost to Follow-up|5
2838322|NCT02559206|9738221|P5|Overall Study|Lost to Follow-up|2
2838323|NCT02559206|9738222|P4|Overall Study|Lost to Follow-up|3
2838324|NCT02559206|9738223|P3|Overall Study|Lost to Follow-up|3
2838325|NCT02559206|9738224|P2|Overall Study|Lost to Follow-up|5
2838326|NCT02559206|9738225|P1|Overall Study|Lost to Follow-up|3
2838327|NCT02559206|9738218|P8|Overall Study|Withdrawal by Subject|2
2838328|NCT02559206|9738219|P7|Overall Study|Withdrawal by Subject|1
2838329|NCT02559206|9738220|P6|Overall Study|Withdrawal by Subject|4
2838330|NCT02559206|9738221|P5|Overall Study|Withdrawal by Subject|5
2838331|NCT02559206|9738222|P4|Overall Study|Withdrawal by Subject|3
2838332|NCT02559206|9738223|P3|Overall Study|Withdrawal by Subject|1
2838333|NCT02559206|9738224|P2|Overall Study|Withdrawal by Subject|3
2838334|NCT02559206|9738225|P1|Overall Study|Withdrawal by Subject|3
2838335|NCT02559206|9738218|P8|Overall Study|Protocol Violation|0
2838336|NCT02559206|9738219|P7|Overall Study|Protocol Violation|0
2838337|NCT02559206|9738220|P6|Overall Study|Protocol Violation|2
2838338|NCT02559206|9738221|P5|Overall Study|Protocol Violation|0
2838339|NCT02559206|9738222|P4|Overall Study|Protocol Violation|0
2838340|NCT02559206|9738223|P3|Overall Study|Protocol Violation|1
2838341|NCT02559206|9738224|P2|Overall Study|Protocol Violation|0
2838342|NCT02559206|9738225|P1|Overall Study|Protocol Violation|1
2838343|NCT02559206|9738218|P8|Overall Study|Adverse Event|0
2838344|NCT02559206|9738219|P7|Overall Study|Adverse Event|1
2838345|NCT02559206|9738220|P6|Overall Study|Adverse Event|0
2838346|NCT02559206|9738221|P5|Overall Study|Adverse Event|3
2838347|NCT02559206|9738222|P4|Overall Study|Adverse Event|5
2838348|NCT02559206|9738223|P3|Overall Study|Adverse Event|1
2838349|NCT02559206|9738224|P2|Overall Study|Adverse Event|4
2838350|NCT02559206|9738225|P1|Overall Study|Adverse Event|0
2838351|NCT02558894|9738267|P2|Overall Study|Closure of Part A|1
2838352|NCT02558894|9738268|P1|Overall Study|Closure of Part A|2
2838353|NCT02558894|9738267|P2|Overall Study|Withdrawal by Subject|1
2838354|NCT02558894|9738268|P1|Overall Study|Withdrawal by Subject|2
2838355|NCT02558894|9738267|P2|Overall Study|Death; any cause, entire study duration|31
2838356|NCT02558894|9738268|P1|Overall Study|Death; any cause, entire study duration|28
2838357|NCT02558790|9738329|P1|Overall Study|Screen Fail|3
2838358|NCT02558790|9738329|P1|Overall Study|Withdrawal by Subject|1
2838359|NCT02558790|9738329|P1|Overall Study|Physician Decision|1
2838360|NCT02558790|9738329|P1|Overall Study|Lost to Follow-up|2
2838361|NCT02558400|9738336|P3|Overall Study|Ineligible for the study|0
2838362|NCT02558400|9738337|P2|Overall Study|Ineligible for the study|2
2838363|NCT02558400|9738338|P1|Overall Study|Ineligible for the study|0
2838364|NCT02558400|9738336|P3|Overall Study|Death|0
2838365|NCT02558400|9738337|P2|Overall Study|Death|1
2838366|NCT02558400|9738338|P1|Overall Study|Death|0
2838367|NCT02558400|9738336|P3|Overall Study|Protocol Violation|8
2838368|NCT02558400|9738337|P2|Overall Study|Protocol Violation|3
2838369|NCT02558400|9738338|P1|Overall Study|Protocol Violation|6
2838370|NCT02558400|9738336|P3|Overall Study|Physician Decision|0
2838371|NCT02558400|9738337|P2|Overall Study|Physician Decision|2
2838372|NCT02558400|9738338|P1|Overall Study|Physician Decision|2
2838373|NCT02558400|9738336|P3|Overall Study|Disallowed Concurrent Medication|5
2838374|NCT02558400|9738337|P2|Overall Study|Disallowed Concurrent Medication|7
2838375|NCT02558400|9738338|P1|Overall Study|Disallowed Concurrent Medication|6
2838376|NCT02558400|9738336|P3|Overall Study|Lack of Efficacy|1
2838377|NCT02558400|9738337|P2|Overall Study|Lack of Efficacy|13
2838378|NCT02558400|9738338|P1|Overall Study|Lack of Efficacy|0
2838379|NCT02558400|9738336|P3|Overall Study|Lost to Follow-up|4
2838380|NCT02558400|9738337|P2|Overall Study|Lost to Follow-up|5
2838381|NCT02558400|9738338|P1|Overall Study|Lost to Follow-up|5
2838382|NCT02558400|9738336|P3|Overall Study|Non-Compliant|3
2838383|NCT02558400|9738337|P2|Overall Study|Non-Compliant|1
2838384|NCT02558400|9738338|P1|Overall Study|Non-Compliant|0
2838385|NCT02558400|9738336|P3|Overall Study|Withdrawal by Subject|8
2838386|NCT02558400|9738337|P2|Overall Study|Withdrawal by Subject|9
2838387|NCT02558400|9738338|P1|Overall Study|Withdrawal by Subject|13
2838388|NCT02558400|9738336|P3|Overall Study|Adverse Event|4
2838389|NCT02558400|9738337|P2|Overall Study|Adverse Event|53
2838390|NCT02558400|9738338|P1|Overall Study|Adverse Event|47
2838391|NCT02557646|9738427|P1|Overall Study|Other|14
2838392|NCT02557646|9738427|P1|Overall Study|Lost to Follow-up|17
2838393|NCT02557646|9738427|P1|Overall Study|Withdrawal by Subject|18
2838394|NCT02557646|9738427|P1|Overall Study|Lack of Efficacy|186
2838395|NCT02557646|9738427|P1|Overall Study|Death|1
2838396|NCT02557646|9738427|P1|Overall Study|Adverse Event|40
2838397|NCT02557516|9738454|P4|Overall Study|Sponsor decision|8
2838398|NCT02557516|9738455|P3|Overall Study|Sponsor decision|2
2838399|NCT02557516|9738456|P2|Overall Study|Sponsor decision|1
2838400|NCT02557516|9738457|P1|Overall Study|Sponsor decision|0
2838401|NCT02557516|9738454|P4|Overall Study|Physician Decision|0
2838402|NCT02557516|9738455|P3|Overall Study|Physician Decision|0
2838403|NCT02557516|9738456|P2|Overall Study|Physician Decision|2
2838404|NCT02557516|9738457|P1|Overall Study|Physician Decision|0
2838405|NCT02557516|9738454|P4|Overall Study|Disease progression|0
2838406|NCT02557516|9738455|P3|Overall Study|Disease progression|0
2838407|NCT02557516|9738456|P2|Overall Study|Disease progression|2
2838408|NCT02557516|9738457|P1|Overall Study|Disease progression|0
2838409|NCT02557516|9738454|P4|Overall Study|Adverse Event|1
2838410|NCT02557516|9738455|P3|Overall Study|Adverse Event|2
2838411|NCT02557516|9738456|P2|Overall Study|Adverse Event|0
2838412|NCT02557516|9738457|P1|Overall Study|Adverse Event|1
2838413|NCT02557399|9738478|P2|Overall Study|Withdrawal by Subject|1
2838414|NCT02557399|9738479|P1|Overall Study|Withdrawal by Subject|1
2838415|NCT02557399|9738478|P2|Overall Study|Protocol-defined stopping criteria|1
2838416|NCT02557399|9738479|P1|Overall Study|Protocol-defined stopping criteria|0
2838417|NCT02557399|9738478|P2|Overall Study|Protocol Violation|1
2838418|NCT02557399|9738479|P1|Overall Study|Protocol Violation|0
2838419|NCT02557399|9738478|P2|Overall Study|Adverse Event|5
2838420|NCT02557399|9738479|P1|Overall Study|Adverse Event|6
2838421|NCT02556918|9738538|P2|Overall Study|Withdrawal by Subject|4
2838422|NCT02556918|9738539|P1|Overall Study|Withdrawal by Subject|4
2838423|NCT02556918|9738538|P2|Overall Study|Protocol Violation|6
2838424|NCT02556918|9738539|P1|Overall Study|Protocol Violation|5
2838425|NCT02556801|9738599|P4|Overall Study|Personal reasons patient|1
2838426|NCT02556801|9738600|P3|Overall Study|Personal reasons patient|0
2838427|NCT02556801|9738601|P2|Overall Study|Personal reasons patient|0
2838428|NCT02556801|9738602|P1|Overall Study|Personal reasons patient|0
2838429|NCT02556801|9738599|P4|Overall Study|Pregnancy|0
2838430|NCT02556801|9738600|P3|Overall Study|Pregnancy|0
2838431|NCT02556801|9738601|P2|Overall Study|Pregnancy|1
2838432|NCT02556801|9738602|P1|Overall Study|Pregnancy|0
2838433|NCT02556801|9738599|P4|Overall Study|Adverse Event|3
2838434|NCT02556801|9738600|P3|Overall Study|Adverse Event|0
2838435|NCT02556801|9738601|P2|Overall Study|Adverse Event|2
2838436|NCT02556801|9738602|P1|Overall Study|Adverse Event|0
2838437|NCT02556801|9738599|P4|Overall Study|Protocol Violation|1
2838438|NCT02556801|9738600|P3|Overall Study|Protocol Violation|1
2838439|NCT02556801|9738601|P2|Overall Study|Protocol Violation|3
2838440|NCT02556801|9738602|P1|Overall Study|Protocol Violation|0
2838441|NCT02556801|9738599|P4|Overall Study|Withdrawal by Subject|0
2838442|NCT02556801|9738600|P3|Overall Study|Withdrawal by Subject|1
2838443|NCT02556801|9738601|P2|Overall Study|Withdrawal by Subject|1
2838444|NCT02556801|9738602|P1|Overall Study|Withdrawal by Subject|1
2838445|NCT02556801|9738599|P4|Overall Study|Lost to Follow-up|0
2838446|NCT02556801|9738600|P3|Overall Study|Lost to Follow-up|2
2838447|NCT02556801|9738601|P2|Overall Study|Lost to Follow-up|0
2838448|NCT02556801|9738602|P1|Overall Study|Lost to Follow-up|1
2838449|NCT02556632|9738664|P3|Overall Study|Treatment or Change Delay|1
2838450|NCT02556632|9738665|P2|Overall Study|Treatment or Change Delay|0
2838451|NCT02556632|9738666|P1|Overall Study|Treatment or Change Delay|0
2838452|NCT02556632|9738664|P3|Overall Study|Disliked Study Procedures|1
2838453|NCT02556632|9738665|P2|Overall Study|Disliked Study Procedures|0
2838454|NCT02556632|9738666|P1|Overall Study|Disliked Study Procedures|0
2838455|NCT02556632|9738664|P3|Overall Study|Ineligible|0
2838456|NCT02556632|9738665|P2|Overall Study|Ineligible|1
2838457|NCT02556632|9738666|P1|Overall Study|Ineligible|0
2838458|NCT02556632|9738664|P3|Overall Study|Did Not Start RT|0
2838459|NCT02556632|9738665|P2|Overall Study|Did Not Start RT|1
2838460|NCT02556632|9738666|P1|Overall Study|Did Not Start RT|0
2838461|NCT02556632|9738664|P3|Overall Study|Possibly Related Adverse Event|1
2838462|NCT02556632|9738665|P2|Overall Study|Possibly Related Adverse Event|0
2838463|NCT02556632|9738666|P1|Overall Study|Possibly Related Adverse Event|0
2838464|NCT02556632|9738664|P3|Overall Study|Related Adverse Event|0
2838465|NCT02556632|9738665|P2|Overall Study|Related Adverse Event|1
2838466|NCT02556632|9738666|P1|Overall Study|Related Adverse Event|0
2838467|NCT02556632|9738664|P3|Overall Study|Unrelated Adverse Event|3
2838468|NCT02556632|9738665|P2|Overall Study|Unrelated Adverse Event|0
2838469|NCT02556632|9738666|P1|Overall Study|Unrelated Adverse Event|1
2838470|NCT02556632|9738664|P3|Overall Study|Withdrew (Unrelated Medical)|0
2838471|NCT02556632|9738665|P2|Overall Study|Withdrew (Unrelated Medical)|0
2838472|NCT02556632|9738666|P1|Overall Study|Withdrew (Unrelated Medical)|1
2838473|NCT02556632|9738664|P3|Overall Study|Changed Mind|0
2838474|NCT02556632|9738665|P2|Overall Study|Changed Mind|1
2838475|NCT02556632|9738666|P1|Overall Study|Changed Mind|0
2838476|NCT02556632|9738664|P3|Overall Study|Personal Issues|1
2838477|NCT02556632|9738665|P2|Overall Study|Personal Issues|1
2838478|NCT02556632|9738666|P1|Overall Study|Personal Issues|0
2838479|NCT02556632|9738664|P3|Overall Study|No Reason|1
2838480|NCT02556632|9738665|P2|Overall Study|No Reason|0
2838481|NCT02556632|9738666|P1|Overall Study|No Reason|1
2838482|NCT02556632|9738664|P3|Overall Study|Disliked Intervention|1
2838483|NCT02556632|9738665|P2|Overall Study|Disliked Intervention|1
2838484|NCT02556632|9738666|P1|Overall Study|Disliked Intervention|1
2838485|NCT02556632|9738664|P3|Overall Study|Lost to Follow-up|0
2838486|NCT02556632|9738665|P2|Overall Study|Lost to Follow-up|0
2838487|NCT02556632|9738666|P1|Overall Study|Lost to Follow-up|1
2838488|NCT02556307|9738684|P1|Overall Study|Enrolled but not treated|2
2838489|NCT02556307|9738684|P1|Overall Study|Change to triple therapy|4
2838490|NCT02556307|9738684|P1|Overall Study|Lost to Follow-up|36
2838491|NCT02556307|9738684|P1|Overall Study|Premature treatment interruption|11
2838492|NCT02556255|9738694|P1|Overall Study|Lost to Follow-up|4
2838493|NCT02556203|9738709|P2|Overall Study|Adverse Event|0
2838494|NCT02556203|9738710|P1|Overall Study|Adverse Event|1
2838495|NCT02556203|9738709|P2|Overall Study|Lost to Follow-up|5
2838496|NCT02556203|9738710|P1|Overall Study|Lost to Follow-up|5
2838497|NCT02556203|9738709|P2|Overall Study|Withdrawal by Subject|21
2838498|NCT02556203|9738710|P1|Overall Study|Withdrawal by Subject|21
2838499|NCT02556177|9738732|P2|Overall Study|Subjects did not complete all 4 visits|61
2838500|NCT02556177|9738733|P1|Overall Study|Subjects did not complete all 4 visits|283
2838501|NCT02556138|9738741|P1|Overall Study|Withdrawal by Subject|1
2838502|NCT02555878|9738749|P2|Overall Study|Other|17
2838503|NCT02555878|9738750|P1|Overall Study|Other|17
2838504|NCT02555878|9738749|P2|Overall Study|Physician Decision|13
2838505|NCT02555878|9738750|P1|Overall Study|Physician Decision|12
2838506|NCT02555878|9738749|P2|Overall Study|Protocol Violation|2
2838507|NCT02555878|9738750|P1|Overall Study|Protocol Violation|1
2838508|NCT02555878|9738749|P2|Overall Study|Death|59
2838509|NCT02555878|9738750|P1|Overall Study|Death|74
2838510|NCT02555878|9738749|P2|Overall Study|Adverse Event|8
2838511|NCT02555878|9738750|P1|Overall Study|Adverse Event|12
2838512|NCT02555878|9738749|P2|Overall Study|Withdrawal by Subject|48
2838513|NCT02555878|9738750|P1|Overall Study|Withdrawal by Subject|48
2838514|NCT02555878|9738749|P2|Overall Study|Lost to Follow-up|3
2838515|NCT02555878|9738750|P1|Overall Study|Lost to Follow-up|2
2838516|NCT02555722|9738782|P2|Month 2|Lost to Follow-up|0
2838517|NCT02555722|9738783|P1|Month 2|Lost to Follow-up|1
2838518|NCT02555722|9738782|P2|Month 2|Withdrawal by Subject|0
2838519|NCT02555722|9738783|P1|Month 2|Withdrawal by Subject|3
2838520|NCT02555722|9738782|P2|Month 1|Lens Discomfort|0
2838521|NCT02555722|9738783|P1|Month 1|Lens Discomfort|1
2838522|NCT02555722|9738782|P2|Week 2|Withdrawal by Subject|0
2838523|NCT02555722|9738783|P1|Week 2|Withdrawal by Subject|1
2838524|NCT02555722|9738782|P2|Week 2|Adverse Event|1
2838525|NCT02555722|9738783|P1|Week 2|Adverse Event|0
2838526|NCT02555683|9738968|P3|Overall Study|Death post Treatment/safety period|0
2838527|NCT02555683|9738969|P2|Overall Study|Death post Treatment/safety period|1
2838528|NCT02555683|9738970|P1|Overall Study|Death post Treatment/safety period|0
2838529|NCT02555683|9738968|P3|Overall Study|Subject/guardian decision|22
2838530|NCT02555683|9738969|P2|Overall Study|Subject/guardian decision|12
2838531|NCT02555683|9738970|P1|Overall Study|Subject/guardian decision|12
2838532|NCT02555683|9738968|P3|Overall Study|Adverse Event|1
2838533|NCT02555683|9738969|P2|Overall Study|Adverse Event|0
2838534|NCT02555683|9738970|P1|Overall Study|Adverse Event|1
2838535|NCT02555683|9738968|P3|Overall Study|Death|2
2838536|NCT02555683|9738969|P2|Overall Study|Death|1
2838537|NCT02555683|9738970|P1|Overall Study|Death|0
2838538|NCT02555683|9738968|P3|Overall Study|Lack of Efficacy|0
2838539|NCT02555683|9738969|P2|Overall Study|Lack of Efficacy|0
2838540|NCT02555683|9738970|P1|Overall Study|Lack of Efficacy|2
2838541|NCT02555683|9738968|P3|Overall Study|Protocol deviation|0
2838542|NCT02555683|9738969|P2|Overall Study|Protocol deviation|1
2838543|NCT02555683|9738970|P1|Overall Study|Protocol deviation|0
2838544|NCT02555683|9738968|P3|Overall Study|Technical Problems|0
2838545|NCT02555683|9738969|P2|Overall Study|Technical Problems|1
2838546|NCT02555683|9738970|P1|Overall Study|Technical Problems|1
2838547|NCT02555683|9738968|P3|Overall Study|Lost to Follow-up|2
2838548|NCT02555683|9738969|P2|Overall Study|Lost to Follow-up|1
2838549|NCT02555683|9738970|P1|Overall Study|Lost to Follow-up|2
2838550|NCT02555683|9738968|P3|Overall Study|Physician Decision|2
2838551|NCT02555683|9738969|P2|Overall Study|Physician Decision|0
2838552|NCT02555683|9738970|P1|Overall Study|Physician Decision|1
2838553|NCT02555657|9739001|P2|Overall Study|Status Not Recorded|31
2838554|NCT02555657|9739002|P1|Overall Study|Status Not Recorded|44
2838555|NCT02555657|9739001|P2|Overall Study|Withdrawal by Subject|32
2838556|NCT02555657|9739002|P1|Overall Study|Withdrawal by Subject|11
2838557|NCT02555657|9739001|P2|Overall Study|Death|247
2838558|NCT02555657|9739002|P1|Overall Study|Death|257
2838559|NCT02555618|9739049|P2|Overall Study|Sponsor's Circumstances|0
2838560|NCT02555618|9739050|P1|Overall Study|Sponsor's Circumstances|1
2838561|NCT02555371|9739092|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2838562|NCT02555371|9739093|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
2838563|NCT02555371|9739094|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2838564|NCT02555371|9739095|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2838565|NCT02555371|9739096|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2838566|NCT02555371|9739092|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
2838567|NCT02555371|9739093|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2838568|NCT02555371|9739094|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2838569|NCT02555371|9739095|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2838570|NCT02555371|9739096|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2838571|NCT02555371|9739092|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
2838572|NCT02555371|9739093|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2838573|NCT02555371|9739094|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2838574|NCT02555371|9739095|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2838575|NCT02555371|9739096|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2838576|NCT02555371|9739092|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2838577|NCT02555371|9739093|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
2838578|NCT02555371|9739094|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2838579|NCT02555371|9739095|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2838580|NCT02555371|9739096|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2838581|NCT02555371|9739092|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2838582|NCT02555371|9739093|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
2838583|NCT02555371|9739094|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2838584|NCT02555371|9739095|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2838585|NCT02555371|9739096|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2838586|NCT02555371|9739092|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
2838587|NCT02555371|9739093|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
2838588|NCT02555371|9739094|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
2838589|NCT02555371|9739095|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
2838590|NCT02555371|9739096|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
2838591|NCT02555371|9739092|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2838592|NCT02555371|9739093|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2838593|NCT02555371|9739094|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2838594|NCT02555371|9739095|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
2838595|NCT02555371|9739096|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2838596|NCT02555371|9739092|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2838597|NCT02555371|9739093|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2838598|NCT02555371|9739094|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2838599|NCT02555371|9739095|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2838600|NCT02555371|9739096|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2838601|NCT02555371|9739092|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2838602|NCT02555371|9739093|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2838603|NCT02555371|9739094|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
2838604|NCT02555371|9739095|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
2838605|NCT02555371|9739096|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2838606|NCT02555371|9739092|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2838607|NCT02555371|9739093|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2838608|NCT02555371|9739094|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2838609|NCT02555371|9739095|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2838610|NCT02555371|9739096|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
2838611|NCT02555371|9739092|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2838612|NCT02555371|9739093|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2838613|NCT02555371|9739094|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2838614|NCT02555371|9739095|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2838615|NCT02555371|9739096|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
2838616|NCT02555371|9739092|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2838617|NCT02555371|9739093|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2838618|NCT02555371|9739094|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2838619|NCT02555371|9739095|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2838620|NCT02555371|9739096|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
2838621|NCT02555371|9739092|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2838622|NCT02555371|9739093|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2838623|NCT02555371|9739094|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2838624|NCT02555371|9739095|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2838625|NCT02555371|9739096|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
2838626|NCT02555371|9739092|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2838627|NCT02555371|9739093|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2838628|NCT02555371|9739094|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2838629|NCT02555371|9739095|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2838630|NCT02555371|9739096|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
2838631|NCT02555215|9739147|P1|Overall Study|Investigator Decision|2
2838632|NCT02555215|9739147|P1|Overall Study|Other|1
2838633|NCT02554981|9739158|P1|Overall Study|Other Miscellaneous Reasons|3
2838634|NCT02554981|9739158|P1|Overall Study|Administrative Reasons|1
2838635|NCT02554981|9739158|P1|Overall Study|Adverse Event|1
2838636|NCT02554929|9739184|P2|Overall Study|Withdrawal by Subject|8
2838637|NCT02554929|9739185|P1|Overall Study|Withdrawal by Subject|2
2838638|NCT02554929|9739184|P2|Overall Study|Lost to Follow-up|4
2838639|NCT02554929|9739185|P1|Overall Study|Lost to Follow-up|4
2838640|NCT02554890|9739203|P2|Open-label|Withdrawal by Subject|1
2838641|NCT02554890|9739204|P1|Open-label|Withdrawal by Subject|0
2838642|NCT02554890|9739203|P2|Open-label|Technical problems|1
2838643|NCT02554890|9739204|P1|Open-label|Technical problems|0
2838644|NCT02554890|9739203|P2|Open-label|Lost to Follow-up|7
2838645|NCT02554890|9739204|P1|Open-label|Lost to Follow-up|0
2838646|NCT02554890|9739203|P2|Open-label|Subject/Guardian decision|11
2838647|NCT02554890|9739204|P1|Open-label|Subject/Guardian decision|0
2838648|NCT02554890|9739203|P2|Open-label|Physician Decision|1
2838649|NCT02554890|9739204|P1|Open-label|Physician Decision|0
2838650|NCT02554890|9739203|P2|Open-label|Death|1
2838651|NCT02554890|9739204|P1|Open-label|Death|0
2838652|NCT02554890|9739203|P2|Open-label|Adverse Event|30
2838653|NCT02554890|9739204|P1|Open-label|Adverse Event|0
2838654|NCT02554890|9739203|P2|Double-blind|Noncompliance with study treatment|5
2838655|NCT02554890|9739204|P1|Double-blind|Noncompliance with study treatment|6
2838656|NCT02554890|9739203|P2|Double-blind|Withdrawal by Subject|6
2838657|NCT02554890|9739204|P1|Double-blind|Withdrawal by Subject|5
2838658|NCT02554890|9739203|P2|Double-blind|Technical problems|0
2838659|NCT02554890|9739204|P1|Double-blind|Technical problems|1
2838660|NCT02554890|9739203|P2|Double-blind|Lost to Follow-up|5
2838661|NCT02554890|9739204|P1|Double-blind|Lost to Follow-up|7
2838662|NCT02554890|9739203|P2|Double-blind|Subject/Guardian decision|16
2838663|NCT02554890|9739204|P1|Double-blind|Subject/Guardian decision|21
2838664|NCT02554890|9739203|P2|Double-blind|Physician Decision|3
2838665|NCT02554890|9739204|P1|Double-blind|Physician Decision|4
2838666|NCT02554890|9739203|P2|Double-blind|Protocol Violation|1
2838667|NCT02554890|9739204|P1|Double-blind|Protocol Violation|1
2838668|NCT02554890|9739203|P2|Double-blind|Death|4
2838669|NCT02554890|9739204|P1|Double-blind|Death|6
2838670|NCT02554890|9739203|P2|Double-blind|Adverse Event|51
2838671|NCT02554890|9739204|P1|Double-blind|Adverse Event|45
2838672|NCT02554877|9739232|P4|Overall Study|No longer willing to participate|0
2838673|NCT02554877|9739233|P3|Overall Study|No longer willing to participate|2
2838674|NCT02554877|9739234|P2|Overall Study|No longer willing to participate|2
2838675|NCT02554877|9739235|P1|Overall Study|No longer willing to participate|0
2838676|NCT02554877|9739232|P4|Overall Study|Insufficient clinical response|0
2838677|NCT02554877|9739233|P3|Overall Study|Insufficient clinical response|0
2838678|NCT02554877|9739234|P2|Overall Study|Insufficient clinical response|0
2838679|NCT02554877|9739235|P1|Overall Study|Insufficient clinical response|4
2838680|NCT02554877|9739232|P4|Overall Study|Other|3
2838681|NCT02554877|9739233|P3|Overall Study|Other|0
2838682|NCT02554877|9739234|P2|Overall Study|Other|3
2838683|NCT02554877|9739235|P1|Overall Study|Other|1
2838684|NCT02554877|9739232|P4|Overall Study|Protocol Violation|0
2838685|NCT02554877|9739233|P3|Overall Study|Protocol Violation|1
2838686|NCT02554877|9739234|P2|Overall Study|Protocol Violation|1
2838687|NCT02554877|9739235|P1|Overall Study|Protocol Violation|3
2838688|NCT02554877|9739232|P4|Overall Study|No longer met eligibility criteria|1
2838689|NCT02554877|9739233|P3|Overall Study|No longer met eligibility criteria|1
2838690|NCT02554877|9739234|P2|Overall Study|No longer met eligibility criteria|0
2838691|NCT02554877|9739235|P1|Overall Study|No longer met eligibility criteria|1
2838692|NCT02554877|9739232|P4|Overall Study|Did not meet entrance criteria|0
2838693|NCT02554877|9739233|P3|Overall Study|Did not meet entrance criteria|1
2838694|NCT02554877|9739234|P2|Overall Study|Did not meet entrance criteria|0
2838695|NCT02554877|9739235|P1|Overall Study|Did not meet entrance criteria|0
2838696|NCT02554877|9739232|P4|Overall Study|Lost to Follow-up|2
2838697|NCT02554877|9739233|P3|Overall Study|Lost to Follow-up|1
2838698|NCT02554877|9739234|P2|Overall Study|Lost to Follow-up|1
2838699|NCT02554877|9739235|P1|Overall Study|Lost to Follow-up|1
2838700|NCT02554877|9739232|P4|Overall Study|Adverse Event|1
2838701|NCT02554877|9739233|P3|Overall Study|Adverse Event|0
2838702|NCT02554877|9739234|P2|Overall Study|Adverse Event|0
2838703|NCT02554877|9739235|P1|Overall Study|Adverse Event|2
2838704|NCT02554786|9739323|P5|Overall Study|Pregnancy|1
2838705|NCT02554786|9739324|P4|Overall Study|Pregnancy|1
2838706|NCT02554786|9739325|P3|Overall Study|Pregnancy|0
2838707|NCT02554786|9739326|P2|Overall Study|Pregnancy|0
2838708|NCT02554786|9739327|P1|Overall Study|Pregnancy|0
2838709|NCT02554786|9739323|P5|Overall Study|Physician Decision|1
2838710|NCT02554786|9739324|P4|Overall Study|Physician Decision|1
2838711|NCT02554786|9739325|P3|Overall Study|Physician Decision|4
2838712|NCT02554786|9739326|P2|Overall Study|Physician Decision|1
2838713|NCT02554786|9739327|P1|Overall Study|Physician Decision|0
2838714|NCT02554786|9739323|P5|Overall Study|Non-compliance with study treatment|1
2838715|NCT02554786|9739324|P4|Overall Study|Non-compliance with study treatment|0
2838716|NCT02554786|9739325|P3|Overall Study|Non-compliance with study treatment|1
2838717|NCT02554786|9739326|P2|Overall Study|Non-compliance with study treatment|1
2838718|NCT02554786|9739327|P1|Overall Study|Non-compliance with study treatment|0
2838719|NCT02554786|9739323|P5|Overall Study|Death|0
2838720|NCT02554786|9739324|P4|Overall Study|Death|1
2838721|NCT02554786|9739325|P3|Overall Study|Death|0
2838722|NCT02554786|9739326|P2|Overall Study|Death|0
2838723|NCT02554786|9739327|P1|Overall Study|Death|0
2838724|NCT02554786|9739323|P5|Overall Study|Adverse Event|2
2838725|NCT02554786|9739324|P4|Overall Study|Adverse Event|0
2838726|NCT02554786|9739325|P3|Overall Study|Adverse Event|0
2838727|NCT02554786|9739326|P2|Overall Study|Adverse Event|0
2838728|NCT02554786|9739327|P1|Overall Study|Adverse Event|0
2838729|NCT02554786|9739323|P5|Overall Study|Technical problems|1
2838730|NCT02554786|9739324|P4|Overall Study|Technical problems|2
2838731|NCT02554786|9739325|P3|Overall Study|Technical problems|0
2838732|NCT02554786|9739326|P2|Overall Study|Technical problems|1
2838733|NCT02554786|9739327|P1|Overall Study|Technical problems|1
2838734|NCT02554786|9739323|P5|Overall Study|Protocol deviation|2
2838735|NCT02554786|9739324|P4|Overall Study|Protocol deviation|4
2838736|NCT02554786|9739325|P3|Overall Study|Protocol deviation|3
2838737|NCT02554786|9739326|P2|Overall Study|Protocol deviation|3
2838738|NCT02554786|9739327|P1|Overall Study|Protocol deviation|1
2838739|NCT02554786|9739323|P5|Overall Study|Lost to Follow-up|2
2838740|NCT02554786|9739324|P4|Overall Study|Lost to Follow-up|2
2838741|NCT02554786|9739325|P3|Overall Study|Lost to Follow-up|4
2838742|NCT02554786|9739326|P2|Overall Study|Lost to Follow-up|3
2838743|NCT02554786|9739327|P1|Overall Study|Lost to Follow-up|4
2838744|NCT02554786|9739323|P5|Overall Study|Subject/guardian decision|20
2838745|NCT02554786|9739324|P4|Overall Study|Subject/guardian decision|30
2838746|NCT02554786|9739325|P3|Overall Study|Subject/guardian decision|18
2838747|NCT02554786|9739326|P2|Overall Study|Subject/guardian decision|17
2838748|NCT02554786|9739327|P1|Overall Study|Subject/guardian decision|29
2838749|NCT02554682|9739479|P10|Overall Study|Physician Decision|0
2838750|NCT02554682|9739480|P9|Overall Study|Physician Decision|0
2838751|NCT02554682|9739481|P8|Overall Study|Physician Decision|0
2838752|NCT02554682|9739482|P7|Overall Study|Physician Decision|0
2838753|NCT02554682|9739483|P6|Overall Study|Physician Decision|0
2838754|NCT02554682|9739484|P5|Overall Study|Physician Decision|0
2838755|NCT02554682|9739485|P4|Overall Study|Physician Decision|0
2838756|NCT02554682|9739486|P3|Overall Study|Physician Decision|0
2838757|NCT02554682|9739487|P2|Overall Study|Physician Decision|2
2838758|NCT02554682|9739488|P1|Overall Study|Physician Decision|2
2838759|NCT02554682|9739479|P10|Overall Study|Withdrawal by Subject|0
2838760|NCT02554682|9739480|P9|Overall Study|Withdrawal by Subject|0
2838761|NCT02554682|9739481|P8|Overall Study|Withdrawal by Subject|0
2838762|NCT02554682|9739482|P7|Overall Study|Withdrawal by Subject|0
2838763|NCT02554682|9739483|P6|Overall Study|Withdrawal by Subject|0
2838764|NCT02554682|9739484|P5|Overall Study|Withdrawal by Subject|0
2838765|NCT02554682|9739485|P4|Overall Study|Withdrawal by Subject|0
2838766|NCT02554682|9739486|P3|Overall Study|Withdrawal by Subject|0
2838767|NCT02554682|9739487|P2|Overall Study|Withdrawal by Subject|1
2838768|NCT02554682|9739488|P1|Overall Study|Withdrawal by Subject|2
2838769|NCT02554682|9739479|P10|Overall Study|Lost to Follow-up|2
2838770|NCT02554682|9739480|P9|Overall Study|Lost to Follow-up|2
2838771|NCT02554682|9739481|P8|Overall Study|Lost to Follow-up|6
2838772|NCT02554682|9739482|P7|Overall Study|Lost to Follow-up|6
2838773|NCT02554682|9739483|P6|Overall Study|Lost to Follow-up|1
2838774|NCT02554682|9739484|P5|Overall Study|Lost to Follow-up|2
2838775|NCT02554682|9739485|P4|Overall Study|Lost to Follow-up|3
2838776|NCT02554682|9739486|P3|Overall Study|Lost to Follow-up|4
2838777|NCT02554682|9739487|P2|Overall Study|Lost to Follow-up|9
2838778|NCT02554682|9739488|P1|Overall Study|Lost to Follow-up|11
2838779|NCT02554656|9739537|P1|Overall Study|Protocol Violation|3
2838780|NCT02554279|9739582|P2|Overall Study|Other reason|6
2838781|NCT02554279|9739583|P1|Overall Study|Other reason|19
2838782|NCT02554279|9739582|P2|Overall Study|Protocol Violation|1
2838783|NCT02554279|9739583|P1|Overall Study|Protocol Violation|2
2838784|NCT02554279|9739582|P2|Overall Study|Withdrawal by Subject|4
2838785|NCT02554279|9739583|P1|Overall Study|Withdrawal by Subject|6
2838786|NCT02554279|9739582|P2|Overall Study|Lost to Follow-up|2
2838787|NCT02554279|9739583|P1|Overall Study|Lost to Follow-up|3
2838788|NCT02554279|9739582|P2|Overall Study|Adverse Event|5
2838789|NCT02554279|9739583|P1|Overall Study|Adverse Event|2
2838790|NCT02554019|9739618|P3|Overall Study|Adverse Event|0
2838791|NCT02554019|9739619|P2|Overall Study|Adverse Event|0
2838792|NCT02554019|9739620|P1|Overall Study|Adverse Event|1
2838793|NCT02554019|9739618|P3|Overall Study|Withdrawal by Subject|2
2838794|NCT02554019|9739619|P2|Overall Study|Withdrawal by Subject|0
2838795|NCT02554019|9739620|P1|Overall Study|Withdrawal by Subject|1
2838796|NCT02553928|9739642|P2|Overall Study|Administrative reason(s)|1
2838797|NCT02553928|9739643|P1|Overall Study|Administrative reason(s)|0
2838798|NCT02553928|9739642|P2|Overall Study|Lost to Follow-up|1
2838799|NCT02553928|9739643|P1|Overall Study|Lost to Follow-up|0
2838800|NCT02553928|9739642|P2|Overall Study|Adverse Event|1
2838801|NCT02553928|9739643|P1|Overall Study|Adverse Event|2
2838802|NCT02553772|9739697|P2|Overall Study|Other Miscellaneous Reasons|1
2838803|NCT02553772|9739698|P1|Overall Study|Other Miscellaneous Reasons|0
2838804|NCT02553772|9739697|P2|Overall Study|Lack of Efficacy|0
2838805|NCT02553772|9739698|P1|Overall Study|Lack of Efficacy|1
2838806|NCT02553772|9739697|P2|Overall Study|Withdrawal of Consent|1
2838807|NCT02553772|9739698|P1|Overall Study|Withdrawal of Consent|1
2838808|NCT02553772|9739697|P2|Overall Study|Lost to Follow-up|1
2838809|NCT02553772|9739698|P1|Overall Study|Lost to Follow-up|2
2838810|NCT02553772|9739697|P2|Overall Study|Adverse Event|3
2838811|NCT02553772|9739698|P1|Overall Study|Adverse Event|2
2838812|NCT02553629|9739743|P2|Overall Study|Logistic reasons|6
2838813|NCT02553629|9739744|P1|Overall Study|Logistic reasons|3
2838814|NCT02553538|9739760|P2|Overall Study|Died or Left Network|56
2838815|NCT02553538|9739761|P1|Overall Study|Died or Left Network|54
2838816|NCT02553538|9739760|P2|Overall Study|Could Not Reach by Telephone|0
2838817|NCT02553538|9739761|P1|Overall Study|Could Not Reach by Telephone|133
2838818|NCT02553499|9739795|P14|Overall Study|Withdrawal by Subject|0
2838819|NCT02553499|9739796|P13|Overall Study|Withdrawal by Subject|0
2838820|NCT02553499|9739797|P12|Overall Study|Withdrawal by Subject|0
2838821|NCT02553499|9739798|P11|Overall Study|Withdrawal by Subject|1
2838822|NCT02553499|9739799|P10|Overall Study|Withdrawal by Subject|0
2838823|NCT02553499|9739800|P9|Overall Study|Withdrawal by Subject|1
2838824|NCT02553499|9739801|P8|Overall Study|Withdrawal by Subject|1
2838825|NCT02553499|9739802|P7|Overall Study|Withdrawal by Subject|0
2838826|NCT02553499|9739803|P6|Overall Study|Withdrawal by Subject|0
2838827|NCT02553499|9739804|P5|Overall Study|Withdrawal by Subject|0
2838828|NCT02553499|9739805|P4|Overall Study|Withdrawal by Subject|0
2838829|NCT02553499|9739806|P3|Overall Study|Withdrawal by Subject|0
2838830|NCT02553499|9739807|P2|Overall Study|Withdrawal by Subject|0
2838831|NCT02553499|9739808|P1|Overall Study|Withdrawal by Subject|2
2838832|NCT02553499|9739795|P14|Overall Study|Study Terminated by Sponsor|0
2838833|NCT02553499|9739796|P13|Overall Study|Study Terminated by Sponsor|0
2838834|NCT02553499|9739797|P12|Overall Study|Study Terminated by Sponsor|0
2838835|NCT02553499|9739798|P11|Overall Study|Study Terminated by Sponsor|0
2838836|NCT02553499|9739799|P10|Overall Study|Study Terminated by Sponsor|0
2838837|NCT02553499|9739800|P9|Overall Study|Study Terminated by Sponsor|1
2838838|NCT02553499|9739801|P8|Overall Study|Study Terminated by Sponsor|0
2838839|NCT02553499|9739802|P7|Overall Study|Study Terminated by Sponsor|0
2838840|NCT02553499|9739803|P6|Overall Study|Study Terminated by Sponsor|0
2838841|NCT02553499|9739804|P5|Overall Study|Study Terminated by Sponsor|0
2838842|NCT02553499|9739805|P4|Overall Study|Study Terminated by Sponsor|0
2838843|NCT02553499|9739806|P3|Overall Study|Study Terminated by Sponsor|0
2838844|NCT02553499|9739807|P2|Overall Study|Study Terminated by Sponsor|0
2838845|NCT02553499|9739808|P1|Overall Study|Study Terminated by Sponsor|0
2838846|NCT02553499|9739795|P14|Overall Study|Progressive Disease|1
2838847|NCT02553499|9739796|P13|Overall Study|Progressive Disease|2
2838848|NCT02553499|9739797|P12|Overall Study|Progressive Disease|0
2838849|NCT02553499|9739798|P11|Overall Study|Progressive Disease|0
2838850|NCT02553499|9739799|P10|Overall Study|Progressive Disease|1
2838851|NCT02553499|9739800|P9|Overall Study|Progressive Disease|0
2838852|NCT02553499|9739801|P8|Overall Study|Progressive Disease|0
2838853|NCT02553499|9739802|P7|Overall Study|Progressive Disease|1
2838854|NCT02553499|9739803|P6|Overall Study|Progressive Disease|1
2838855|NCT02553499|9739804|P5|Overall Study|Progressive Disease|1
2838856|NCT02553499|9739805|P4|Overall Study|Progressive Disease|2
2838857|NCT02553499|9739806|P3|Overall Study|Progressive Disease|0
2838858|NCT02553499|9739807|P2|Overall Study|Progressive Disease|0
2838859|NCT02553499|9739808|P1|Overall Study|Progressive Disease|0
2838860|NCT02553499|9739795|P14|Overall Study|Physician Decision|0
2838861|NCT02553499|9739796|P13|Overall Study|Physician Decision|1
2838862|NCT02553499|9739797|P12|Overall Study|Physician Decision|3
2838863|NCT02553499|9739798|P11|Overall Study|Physician Decision|1
2838864|NCT02553499|9739799|P10|Overall Study|Physician Decision|2
2838865|NCT02553499|9739800|P9|Overall Study|Physician Decision|1
2838866|NCT02553499|9739801|P8|Overall Study|Physician Decision|1
2838867|NCT02553499|9739802|P7|Overall Study|Physician Decision|0
2838868|NCT02553499|9739803|P6|Overall Study|Physician Decision|0
2838869|NCT02553499|9739804|P5|Overall Study|Physician Decision|1
2838870|NCT02553499|9739805|P4|Overall Study|Physician Decision|0
2838871|NCT02553499|9739806|P3|Overall Study|Physician Decision|1
2838872|NCT02553499|9739807|P2|Overall Study|Physician Decision|1
2838873|NCT02553499|9739808|P1|Overall Study|Physician Decision|0
2838874|NCT02553499|9739795|P14|Overall Study|Lost to Follow-up|0
2838875|NCT02553499|9739796|P13|Overall Study|Lost to Follow-up|0
2838876|NCT02553499|9739797|P12|Overall Study|Lost to Follow-up|0
2838877|NCT02553499|9739798|P11|Overall Study|Lost to Follow-up|0
2838878|NCT02553499|9739799|P10|Overall Study|Lost to Follow-up|0
2838879|NCT02553499|9739800|P9|Overall Study|Lost to Follow-up|0
2838880|NCT02553499|9739801|P8|Overall Study|Lost to Follow-up|0
2838881|NCT02553499|9739802|P7|Overall Study|Lost to Follow-up|1
2838882|NCT02553499|9739803|P6|Overall Study|Lost to Follow-up|0
2838883|NCT02553499|9739804|P5|Overall Study|Lost to Follow-up|0
2838884|NCT02553499|9739805|P4|Overall Study|Lost to Follow-up|0
2838885|NCT02553499|9739806|P3|Overall Study|Lost to Follow-up|0
2838886|NCT02553499|9739807|P2|Overall Study|Lost to Follow-up|0
2838887|NCT02553499|9739808|P1|Overall Study|Lost to Follow-up|0
2838888|NCT02553499|9739795|P14|Overall Study|Death|0
2838889|NCT02553499|9739796|P13|Overall Study|Death|0
2838890|NCT02553499|9739797|P12|Overall Study|Death|0
2838891|NCT02553499|9739798|P11|Overall Study|Death|1
2838892|NCT02553499|9739799|P10|Overall Study|Death|0
2838893|NCT02553499|9739800|P9|Overall Study|Death|0
2838894|NCT02553499|9739801|P8|Overall Study|Death|0
2838895|NCT02553499|9739802|P7|Overall Study|Death|0
2838896|NCT02553499|9739803|P6|Overall Study|Death|2
2838897|NCT02553499|9739804|P5|Overall Study|Death|1
2838898|NCT02553499|9739805|P4|Overall Study|Death|0
2838899|NCT02553499|9739806|P3|Overall Study|Death|1
2838900|NCT02553499|9739807|P2|Overall Study|Death|1
2838901|NCT02553499|9739808|P1|Overall Study|Death|0
2838902|NCT02553499|9739795|P14|Overall Study|Adverse Event|1
2838903|NCT02553499|9739796|P13|Overall Study|Adverse Event|0
2838904|NCT02553499|9739797|P12|Overall Study|Adverse Event|0
2838905|NCT02553499|9739798|P11|Overall Study|Adverse Event|0
2838906|NCT02553499|9739799|P10|Overall Study|Adverse Event|0
2838907|NCT02553499|9739800|P9|Overall Study|Adverse Event|0
2838908|NCT02553499|9739801|P8|Overall Study|Adverse Event|1
2838909|NCT02553499|9739802|P7|Overall Study|Adverse Event|1
2838910|NCT02553499|9739803|P6|Overall Study|Adverse Event|0
2838911|NCT02553499|9739804|P5|Overall Study|Adverse Event|0
2838912|NCT02553499|9739805|P4|Overall Study|Adverse Event|0
2838913|NCT02553499|9739806|P3|Overall Study|Adverse Event|0
2838914|NCT02553499|9739807|P2|Overall Study|Adverse Event|0
2838915|NCT02553499|9739808|P1|Overall Study|Adverse Event|0
2838916|NCT02553421|9739910|P2|Overall Study|Improper Device Placement|0
2838917|NCT02553421|9739911|P1|Overall Study|Improper Device Placement|3
2838918|NCT02553421|9739910|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
2838919|NCT02553421|9739911|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
2838920|NCT02553421|9739910|P2|Overall Study|Lost to Follow-up|1
2838921|NCT02553421|9739911|P1|Overall Study|Lost to Follow-up|21
2838922|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
2838923|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
2838924|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
2838925|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
2838926|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2838927|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2838928|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
2838929|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
2838930|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
2838931|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
2838932|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Adverse Event|5
2838933|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Adverse Event|6
2838934|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Death|3
2838935|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Death|1
2838936|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
2838937|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
2838938|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Physician Decision|4
2838939|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Physician Decision|2
2838940|NCT02553317|9739921|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
2838941|NCT02553317|9739922|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
2838942|NCT02552966|9739952|P1|Overall Study|Withdrawal by Subject|3
2838943|NCT02552966|9739952|P1|Overall Study|Lost to Follow-up|2
2838944|NCT02552355|9739987|P4|Overall Study|Withdrawal by Subject|1
2838945|NCT02552355|9739988|P3|Overall Study|Withdrawal by Subject|0
2838946|NCT02552355|9739989|P2|Overall Study|Withdrawal by Subject|0
2838947|NCT02552355|9739990|P1|Overall Study|Withdrawal by Subject|0
2838948|NCT02552355|9739987|P4|Overall Study|Adverse Event|0
2838949|NCT02552355|9739988|P3|Overall Study|Adverse Event|2
2838950|NCT02552355|9739989|P2|Overall Study|Adverse Event|2
2838951|NCT02552355|9739990|P1|Overall Study|Adverse Event|0
2838952|NCT02552303|9740036|P4|Follow-Up|ineligible|0
2838953|NCT02552303|9740037|P3|Follow-Up|ineligible|0
2838954|NCT02552303|9740038|P2|Follow-Up|ineligible|2
2838955|NCT02552303|9740039|P1|Follow-Up|ineligible|0
2838956|NCT02552303|9740036|P4|Follow-Up|Lost to Follow-up|0
2838957|NCT02552303|9740037|P3|Follow-Up|Lost to Follow-up|1
2838958|NCT02552303|9740038|P2|Follow-Up|Lost to Follow-up|0
2838959|NCT02552303|9740039|P1|Follow-Up|Lost to Follow-up|0
2838960|NCT02552303|9740036|P4|Allocation|ineligible|0
2838961|NCT02552303|9740037|P3|Allocation|ineligible|0
2838962|NCT02552303|9740038|P2|Allocation|ineligible|1
2838963|NCT02552303|9740039|P1|Allocation|ineligible|1
2838964|NCT02552303|9740036|P4|Allocation|Withdrawal by Subject|1
2838965|NCT02552303|9740037|P3|Allocation|Withdrawal by Subject|1
2838966|NCT02552303|9740038|P2|Allocation|Withdrawal by Subject|1
2838967|NCT02552303|9740039|P1|Allocation|Withdrawal by Subject|2
2838968|NCT02552147|9740053|P2|Second Intervention (7 Days)|Protocol Violation|0
2838969|NCT02552147|9740054|P1|Second Intervention (7 Days)|Protocol Violation|2
2838970|NCT02552147|9740053|P2|First Intervention (7 Days)|Protocol Violation|0
2838971|NCT02552147|9740054|P1|First Intervention (7 Days)|Protocol Violation|1
2838972|NCT02552121|9740088|P8|Part 2: Cohort Expansion|Death|0
2838973|NCT02552121|9740089|P7|Part 2: Cohort Expansion|Death|0
2838974|NCT02552121|9740090|P6|Part 2: Cohort Expansion|Death|0
2838975|NCT02552121|9740091|P5|Part 2: Cohort Expansion|Death|0
2838976|NCT02552121|9740092|P4|Part 2: Cohort Expansion|Death|0
2838977|NCT02552121|9740093|P3|Part 2: Cohort Expansion|Death|1
2838978|NCT02552121|9740094|P2|Part 2: Cohort Expansion|Death|0
2838979|NCT02552121|9740095|P1|Part 2: Cohort Expansion|Death|0
2838980|NCT02552121|9740088|P8|Part 2: Cohort Expansion|Adverse Event|0
2838981|NCT02552121|9740089|P7|Part 2: Cohort Expansion|Adverse Event|0
2838982|NCT02552121|9740090|P6|Part 2: Cohort Expansion|Adverse Event|0
2838983|NCT02552121|9740091|P5|Part 2: Cohort Expansion|Adverse Event|0
2838984|NCT02552121|9740092|P4|Part 2: Cohort Expansion|Adverse Event|1
2838985|NCT02552121|9740093|P3|Part 2: Cohort Expansion|Adverse Event|6
2838986|NCT02552121|9740094|P2|Part 2: Cohort Expansion|Adverse Event|0
2838987|NCT02552121|9740095|P1|Part 2: Cohort Expansion|Adverse Event|0
2838988|NCT02552121|9740088|P8|Part 2: Cohort Expansion|Disease Progression|3
2838989|NCT02552121|9740089|P7|Part 2: Cohort Expansion|Disease Progression|0
2838990|NCT02552121|9740090|P6|Part 2: Cohort Expansion|Disease Progression|4
2838991|NCT02552121|9740091|P5|Part 2: Cohort Expansion|Disease Progression|1
2838992|NCT02552121|9740092|P4|Part 2: Cohort Expansion|Disease Progression|2
2838993|NCT02552121|9740093|P3|Part 2: Cohort Expansion|Disease Progression|3
2838994|NCT02552121|9740094|P2|Part 2: Cohort Expansion|Disease Progression|0
2838995|NCT02552121|9740095|P1|Part 2: Cohort Expansion|Disease Progression|0
2838996|NCT02552121|9740088|P8|Part 2: Cohort Expansion|Patient Choice|0
2838997|NCT02552121|9740089|P7|Part 2: Cohort Expansion|Patient Choice|1
2838998|NCT02552121|9740090|P6|Part 2: Cohort Expansion|Patient Choice|0
2838999|NCT02552121|9740091|P5|Part 2: Cohort Expansion|Patient Choice|0
2839000|NCT02552121|9740092|P4|Part 2: Cohort Expansion|Patient Choice|0
2839001|NCT02552121|9740093|P3|Part 2: Cohort Expansion|Patient Choice|1
2839002|NCT02552121|9740094|P2|Part 2: Cohort Expansion|Patient Choice|0
2839003|NCT02552121|9740095|P1|Part 2: Cohort Expansion|Patient Choice|0
2839004|NCT02552121|9740088|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839005|NCT02552121|9740089|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839006|NCT02552121|9740090|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839007|NCT02552121|9740091|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839008|NCT02552121|9740092|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839009|NCT02552121|9740093|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839010|NCT02552121|9740094|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
2839011|NCT02552121|9740095|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2839012|NCT02552121|9740088|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839013|NCT02552121|9740089|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839014|NCT02552121|9740090|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839015|NCT02552121|9740091|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839016|NCT02552121|9740092|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839017|NCT02552121|9740093|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839018|NCT02552121|9740094|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
2839019|NCT02552121|9740095|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2839020|NCT02552121|9740088|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839021|NCT02552121|9740089|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839022|NCT02552121|9740090|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839023|NCT02552121|9740091|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839024|NCT02552121|9740092|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839025|NCT02552121|9740093|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839026|NCT02552121|9740094|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
2839027|NCT02552121|9740095|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2839028|NCT02552121|9740088|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839029|NCT02552121|9740089|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839030|NCT02552121|9740090|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839031|NCT02552121|9740091|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839032|NCT02552121|9740092|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839033|NCT02552121|9740093|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839034|NCT02552121|9740094|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
2839035|NCT02552121|9740095|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2839036|NCT02552121|9740088|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839037|NCT02552121|9740089|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839038|NCT02552121|9740090|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839039|NCT02552121|9740091|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839040|NCT02552121|9740092|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839041|NCT02552121|9740093|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839042|NCT02552121|9740094|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2839043|NCT02552121|9740095|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
2839044|NCT02552121|9740088|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839045|NCT02552121|9740089|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839046|NCT02552121|9740090|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839047|NCT02552121|9740091|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839048|NCT02552121|9740092|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839049|NCT02552121|9740093|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839050|NCT02552121|9740094|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2839051|NCT02552121|9740095|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
2839052|NCT02551874|9740356|P2|Overall Study|Did not enter long-term study|25
2839053|NCT02551874|9740357|P1|Overall Study|Did not enter long-term study|18
2839054|NCT02551874|9740356|P2|Overall Study|Did not receive randomized treatment|7
2839055|NCT02551874|9740357|P1|Overall Study|Did not receive randomized treatment|0
2839056|NCT02551874|9740356|P2|Overall Study|Reason not reported|4
2839057|NCT02551874|9740357|P1|Overall Study|Reason not reported|10
2839058|NCT02551874|9740356|P2|Overall Study|Pregnancy|1
2839059|NCT02551874|9740357|P1|Overall Study|Pregnancy|0
2839060|NCT02551874|9740356|P2|Overall Study|Lost to Follow-up|2
2839061|NCT02551874|9740357|P1|Overall Study|Lost to Follow-up|0
2839062|NCT02551731|9740426|P1|Overall Study|Withdrawal by Subject|2
2839063|NCT02551692|9740446|P3|Overall Study|Withdrawal by Subject|1
2839064|NCT02551692|9740447|P2|Overall Study|Withdrawal by Subject|0
2839065|NCT02551692|9740448|P1|Overall Study|Withdrawal by Subject|1
2839066|NCT02551692|9740446|P3|Overall Study|Lost to Follow-up|4
2839067|NCT02551692|9740447|P2|Overall Study|Lost to Follow-up|1
2839068|NCT02551692|9740448|P1|Overall Study|Lost to Follow-up|0
2839069|NCT02551055|9740495|P8|Overall Study|Reason not specified|0
2839070|NCT02551055|9740496|P7|Overall Study|Reason not specified|1
2839071|NCT02551055|9740497|P6|Overall Study|Reason not specified|0
2839072|NCT02551055|9740498|P5|Overall Study|Reason not specified|1
2839073|NCT02551055|9740499|P4|Overall Study|Reason not specified|0
2839074|NCT02551055|9740500|P3|Overall Study|Reason not specified|0
2839075|NCT02551055|9740501|P2|Overall Study|Reason not specified|0
2839076|NCT02551055|9740502|P1|Overall Study|Reason not specified|0
2839077|NCT02551055|9740495|P8|Overall Study|Withdrawal by Subject|0
2839078|NCT02551055|9740496|P7|Overall Study|Withdrawal by Subject|0
2839079|NCT02551055|9740497|P6|Overall Study|Withdrawal by Subject|0
2839080|NCT02551055|9740498|P5|Overall Study|Withdrawal by Subject|2
2839081|NCT02551055|9740499|P4|Overall Study|Withdrawal by Subject|1
2839082|NCT02551055|9740500|P3|Overall Study|Withdrawal by Subject|0
2839083|NCT02551055|9740501|P2|Overall Study|Withdrawal by Subject|1
2839084|NCT02551055|9740502|P1|Overall Study|Withdrawal by Subject|1
2839085|NCT02551055|9740495|P8|Overall Study|Study Terminated by Sponsor|0
2839086|NCT02551055|9740496|P7|Overall Study|Study Terminated by Sponsor|0
2839087|NCT02551055|9740497|P6|Overall Study|Study Terminated by Sponsor|0
2839088|NCT02551055|9740498|P5|Overall Study|Study Terminated by Sponsor|2
2839089|NCT02551055|9740499|P4|Overall Study|Study Terminated by Sponsor|2
2839090|NCT02551055|9740500|P3|Overall Study|Study Terminated by Sponsor|0
2839091|NCT02551055|9740501|P2|Overall Study|Study Terminated by Sponsor|1
2839092|NCT02551055|9740502|P1|Overall Study|Study Terminated by Sponsor|1
2839093|NCT02551055|9740495|P8|Overall Study|Death|0
2839094|NCT02551055|9740496|P7|Overall Study|Death|2
2839095|NCT02551055|9740497|P6|Overall Study|Death|1
2839096|NCT02551055|9740498|P5|Overall Study|Death|2
2839097|NCT02551055|9740499|P4|Overall Study|Death|2
2839098|NCT02551055|9740500|P3|Overall Study|Death|2
2839099|NCT02551055|9740501|P2|Overall Study|Death|4
2839100|NCT02551055|9740502|P1|Overall Study|Death|2
2839101|NCT02550873|9740577|P3|Open Label Extension|Study ongoing|111
2839102|NCT02550873|9740578|P2|Open Label Extension|Study ongoing|0
2839103|NCT02550873|9740579|P1|Open Label Extension|Study ongoing|0
2839104|NCT02550873|9740577|P3|Randomized Double Blind|Disease progression|0
2839105|NCT02550873|9740578|P2|Randomized Double Blind|Disease progression|1
2839106|NCT02550873|9740579|P1|Randomized Double Blind|Disease progression|1
2839107|NCT02550873|9740577|P3|Randomized Double Blind|Adverse Event|0
2839108|NCT02550873|9740578|P2|Randomized Double Blind|Adverse Event|1
2839109|NCT02550873|9740579|P1|Randomized Double Blind|Adverse Event|3
2839110|NCT02550652|9740659|P2|Overall Study|Ongoing in study|56
2839111|NCT02550652|9740660|P1|Overall Study|Ongoing in study|59
2839112|NCT02550652|9740659|P2|Overall Study|Withdrawal by Subject|4
2839113|NCT02550652|9740660|P1|Overall Study|Withdrawal by Subject|3
2839114|NCT02550652|9740659|P2|Overall Study|Lack of Efficacy|0
2839115|NCT02550652|9740660|P1|Overall Study|Lack of Efficacy|1
2839116|NCT02550652|9740659|P2|Overall Study|Death|2
2839117|NCT02550652|9740660|P1|Overall Study|Death|0
2839118|NCT02550288|9740707|P5|Overall Study|Withdrawal by Subject|0
2839119|NCT02550288|9740708|P4|Overall Study|Withdrawal by Subject|1
2839120|NCT02550288|9740709|P3|Overall Study|Withdrawal by Subject|0
2839121|NCT02550288|9740710|P2|Overall Study|Withdrawal by Subject|0
2839122|NCT02550288|9740711|P1|Overall Study|Withdrawal by Subject|0
2839123|NCT02550288|9740707|P5|Overall Study|Participant moved|0
2839124|NCT02550288|9740708|P4|Overall Study|Participant moved|1
2839125|NCT02550288|9740709|P3|Overall Study|Participant moved|0
2839126|NCT02550288|9740710|P2|Overall Study|Participant moved|0
2839127|NCT02550288|9740711|P1|Overall Study|Participant moved|0
2839128|NCT02550288|9740707|P5|Overall Study|Protocol Violation|3
2839129|NCT02550288|9740708|P4|Overall Study|Protocol Violation|0
2839130|NCT02550288|9740709|P3|Overall Study|Protocol Violation|1
2839131|NCT02550288|9740710|P2|Overall Study|Protocol Violation|2
2839132|NCT02550288|9740711|P1|Overall Study|Protocol Violation|2
2839133|NCT02550288|9740707|P5|Overall Study|Physician Decision|0
2839134|NCT02550288|9740708|P4|Overall Study|Physician Decision|1
2839135|NCT02550288|9740709|P3|Overall Study|Physician Decision|0
2839136|NCT02550288|9740710|P2|Overall Study|Physician Decision|0
2839137|NCT02550288|9740711|P1|Overall Study|Physician Decision|0
2839138|NCT02550288|9740707|P5|Overall Study|Adverse Event|0
2839139|NCT02550288|9740708|P4|Overall Study|Adverse Event|0
2839140|NCT02550288|9740709|P3|Overall Study|Adverse Event|0
2839141|NCT02550288|9740710|P2|Overall Study|Adverse Event|1
2839142|NCT02550288|9740711|P1|Overall Study|Adverse Event|0
2839143|NCT02550106|9740867|P1|Overall Study|Withdrawal by Subject|2
2839144|NCT02550106|9740867|P1|Overall Study|Protocol Violation|6
2839145|NCT02550106|9740867|P1|Overall Study|Lack of Efficacy|3
2839146|NCT02550106|9740867|P1|Overall Study|Adverse Event|1
2839147|NCT02549573|9740912|P2|Overall Study|Protocol Violation|1
2839148|NCT02549573|9740913|P1|Overall Study|Protocol Violation|0
2839149|NCT02549573|9740912|P2|Overall Study|Withdrawal by Subject|2
2839150|NCT02549573|9740913|P1|Overall Study|Withdrawal by Subject|0
2839151|NCT02549352|9740967|P2|12-month Follow-up|Other|3
2839152|NCT02549352|9740968|P1|12-month Follow-up|Other|1
2839153|NCT02549352|9740967|P2|12-month Follow-up|Protocol Violation|1
2839154|NCT02549352|9740968|P1|12-month Follow-up|Protocol Violation|0
2839155|NCT02549352|9740967|P2|12-month Follow-up|Death|1
2839156|NCT02549352|9740968|P1|12-month Follow-up|Death|0
2839157|NCT02549352|9740967|P2|12-month Follow-up|Lost to Follow-up|2
2839158|NCT02549352|9740968|P1|12-month Follow-up|Lost to Follow-up|3
2839159|NCT02549352|9740967|P2|12-month Follow-up|Withdrawal by Subject|5
2839160|NCT02549352|9740968|P1|12-month Follow-up|Withdrawal by Subject|4
2839161|NCT02549352|9740967|P2|3-day Treatment and 8-week Follow-up|Other|2
2839162|NCT02549352|9740968|P1|3-day Treatment and 8-week Follow-up|Other|0
2839163|NCT02549352|9740967|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2839164|NCT02549352|9740968|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2839165|NCT02549352|9740967|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
2839166|NCT02549352|9740968|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
2839167|NCT02549339|9740984|P2|12-month Follow-up|Other|3
2839168|NCT02549339|9740985|P1|12-month Follow-up|Other|0
2839169|NCT02549339|9740984|P2|12-month Follow-up|Lost to Follow-up|3
2839170|NCT02549339|9740985|P1|12-month Follow-up|Lost to Follow-up|1
2839171|NCT02549339|9740984|P2|12-month Follow-up|Withdrawal by Subject|3
2839172|NCT02549339|9740985|P1|12-month Follow-up|Withdrawal by Subject|8
2839173|NCT02549339|9740984|P2|12-month Follow-up|Lack of Efficacy|2
2839174|NCT02549339|9740985|P1|12-month Follow-up|Lack of Efficacy|0
2839175|NCT02549339|9740984|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
2839176|NCT02549339|9740985|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2839177|NCT02549339|9740984|P2|3-day Treatment and 8-week Follow-up|Other|0
2839178|NCT02549339|9740985|P1|3-day Treatment and 8-week Follow-up|Other|1
2839179|NCT02549339|9740984|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2839180|NCT02549339|9740985|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
2839181|NCT02549339|9740984|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
2839182|NCT02549339|9740985|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
2839183|NCT02549287|9741001|P2|Overall Study|Withdrawal by Subject|6
2839184|NCT02549287|9741002|P1|Overall Study|Withdrawal by Subject|15
2839185|NCT02549287|9741001|P2|Overall Study|Lost to Follow-up|26
2839186|NCT02549287|9741002|P1|Overall Study|Lost to Follow-up|65
2839187|NCT02549196|9741036|P4|Overall Study|Withdrawal by Subject|0
2839188|NCT02549196|9741037|P3|Overall Study|Withdrawal by Subject|1
2839189|NCT02549196|9741038|P2|Overall Study|Withdrawal by Subject|0
2839190|NCT02549196|9741039|P1|Overall Study|Withdrawal by Subject|1
2839191|NCT02549196|9741036|P4|Overall Study|Protocol Violation|1
2839192|NCT02549196|9741037|P3|Overall Study|Protocol Violation|0
2839193|NCT02549196|9741038|P2|Overall Study|Protocol Violation|0
2839194|NCT02549196|9741039|P1|Overall Study|Protocol Violation|0
2839195|NCT02549027|9741095|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2839196|NCT02549027|9741096|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
2839197|NCT02549027|9741097|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2839198|NCT02549027|9741098|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2839199|NCT02549027|9741099|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2839200|NCT02549027|9741100|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2839201|NCT02549027|9741095|P6|Washout After Period 4|Withdrawal by Subject|0
2839202|NCT02549027|9741096|P5|Washout After Period 4|Withdrawal by Subject|0
2839203|NCT02549027|9741097|P4|Washout After Period 4|Withdrawal by Subject|1
2839204|NCT02549027|9741098|P3|Washout After Period 4|Withdrawal by Subject|1
2839205|NCT02549027|9741099|P2|Washout After Period 4|Withdrawal by Subject|1
2839206|NCT02549027|9741100|P1|Washout After Period 4|Withdrawal by Subject|0
2839207|NCT02548962|9741230|P2|Overall Study|Withdrawal by Subject|0
2839208|NCT02548962|9741231|P1|Overall Study|Withdrawal by Subject|1
2839209|NCT02548650|9741283|P2|Double Therapy|Withdrawal by Subject|1
2839210|NCT02548650|9741284|P1|Double Therapy|Withdrawal by Subject|0
2839211|NCT02548650|9741283|P2|Double Therapy|Adverse Event|1
2839212|NCT02548650|9741284|P1|Double Therapy|Adverse Event|1
2839213|NCT02548650|9741283|P2|Triple Therapy|Withdrawal by Subject|4
2839214|NCT02548650|9741284|P1|Triple Therapy|Withdrawal by Subject|0
2839215|NCT02548650|9741283|P2|Triple Therapy|Adverse Event|0
2839216|NCT02548650|9741284|P1|Triple Therapy|Adverse Event|1
2839217|NCT02548585|9741299|P7|Overall Study|Randomized but not treated|0
2839218|NCT02548585|9741300|P6|Overall Study|Randomized but not treated|1
2839219|NCT02548585|9741301|P5|Overall Study|Randomized but not treated|0
2839220|NCT02548585|9741302|P4|Overall Study|Randomized but not treated|0
2839221|NCT02548585|9741303|P3|Overall Study|Randomized but not treated|0
2839222|NCT02548585|9741304|P2|Overall Study|Randomized but not treated|0
2839223|NCT02548585|9741305|P1|Overall Study|Randomized but not treated|0
2839224|NCT02548585|9741299|P7|Overall Study|Other|1
2839225|NCT02548585|9741300|P6|Overall Study|Other|0
2839226|NCT02548585|9741301|P5|Overall Study|Other|3
2839227|NCT02548585|9741302|P4|Overall Study|Other|2
2839228|NCT02548585|9741303|P3|Overall Study|Other|0
2839229|NCT02548585|9741304|P2|Overall Study|Other|0
2839230|NCT02548585|9741305|P1|Overall Study|Other|1
2839231|NCT02548585|9741299|P7|Overall Study|Lost to Follow-up|0
2839232|NCT02548585|9741300|P6|Overall Study|Lost to Follow-up|0
2839233|NCT02548585|9741301|P5|Overall Study|Lost to Follow-up|0
2839234|NCT02548585|9741302|P4|Overall Study|Lost to Follow-up|0
2839235|NCT02548585|9741303|P3|Overall Study|Lost to Follow-up|0
2839236|NCT02548585|9741304|P2|Overall Study|Lost to Follow-up|0
2839237|NCT02548585|9741305|P1|Overall Study|Lost to Follow-up|1
2839238|NCT02548585|9741299|P7|Overall Study|Withdrawal by Subject|0
2839239|NCT02548585|9741300|P6|Overall Study|Withdrawal by Subject|1
2839240|NCT02548585|9741301|P5|Overall Study|Withdrawal by Subject|0
2839241|NCT02548585|9741302|P4|Overall Study|Withdrawal by Subject|0
2839242|NCT02548585|9741303|P3|Overall Study|Withdrawal by Subject|0
2839243|NCT02548585|9741304|P2|Overall Study|Withdrawal by Subject|0
2839244|NCT02548585|9741305|P1|Overall Study|Withdrawal by Subject|0
2839245|NCT02548455|9741523|P1|Overall Study|Visit not completed|173
2839246|NCT02548455|9741523|P1|Overall Study|Lost to Follow-up|14
2839247|NCT02548455|9741523|P1|Overall Study|Death|26
2839248|NCT02548455|9741523|P1|Overall Study|Withdrawal by Subject|27
2839249|NCT02548156|9741584|P6|Washout Period 1|Lost to Follow-up|0
2839250|NCT02548156|9741585|P5|Washout Period 1|Lost to Follow-up|1
2839251|NCT02548156|9741586|P4|Washout Period 1|Lost to Follow-up|0
2839252|NCT02548156|9741587|P3|Washout Period 1|Lost to Follow-up|0
2839253|NCT02548156|9741588|P2|Washout Period 1|Lost to Follow-up|0
2839254|NCT02548156|9741589|P1|Washout Period 1|Lost to Follow-up|0
2839255|NCT02548143|9741608|P2|Overall Study|Withdrawal by Subject|1
2839256|NCT02548143|9741609|P1|Overall Study|Withdrawal by Subject|0
2839257|NCT02548143|9741608|P2|Overall Study|Adverse Event|0
2839258|NCT02548143|9741609|P1|Overall Study|Adverse Event|1
2839259|NCT02548078|9741621|P2|Overall Study|Lost to Follow-up|3
2839260|NCT02548078|9741622|P1|Overall Study|Lost to Follow-up|1
2839261|NCT02548078|9741621|P2|Overall Study|Moved from study area|3
2839262|NCT02548078|9741622|P1|Overall Study|Moved from study area|3
2839263|NCT02548078|9741621|P2|Overall Study|Serious adverse event/Adverse event|0
2839264|NCT02548078|9741622|P1|Overall Study|Serious adverse event/Adverse event|1
2839265|NCT02547987|9741810|P1|Overall Study|Adverse Event|2
2839266|NCT02547987|9741810|P1|Overall Study|Withdrawal by Subject|1
2839267|NCT02547974|9741818|P4|Overall Study|Withdrawal by Subject|0
2839268|NCT02547974|9741819|P3|Overall Study|Withdrawal by Subject|0
2839269|NCT02547974|9741820|P2|Overall Study|Withdrawal by Subject|0
2839270|NCT02547974|9741821|P1|Overall Study|Withdrawal by Subject|1
2839271|NCT02547935|9741908|P3|Overall Study|Death|0
2839272|NCT02547935|9741909|P2|Overall Study|Death|1
2839273|NCT02547935|9741910|P1|Overall Study|Death|1
2839274|NCT02547935|9741908|P3|Overall Study|Lost to Follow-up|1
2839275|NCT02547935|9741909|P2|Overall Study|Lost to Follow-up|2
2839276|NCT02547935|9741910|P1|Overall Study|Lost to Follow-up|0
2839277|NCT02547935|9741908|P3|Overall Study|Physician Decision|0
2839278|NCT02547935|9741909|P2|Overall Study|Physician Decision|1
2839279|NCT02547935|9741910|P1|Overall Study|Physician Decision|0
2839280|NCT02547935|9741908|P3|Overall Study|Screen Failure|0
2839281|NCT02547935|9741909|P2|Overall Study|Screen Failure|0
2839282|NCT02547935|9741910|P1|Overall Study|Screen Failure|2
2839283|NCT02547935|9741908|P3|Overall Study|Withdrawal by Subject|4
2839284|NCT02547935|9741909|P2|Overall Study|Withdrawal by Subject|3
2839285|NCT02547935|9741910|P1|Overall Study|Withdrawal by Subject|2
2839286|NCT02547935|9741908|P3|Overall Study|Other|0
2839287|NCT02547935|9741909|P2|Overall Study|Other|1
2839288|NCT02547935|9741910|P1|Overall Study|Other|0
2839289|NCT02547766|9741948|P1|Overall Study|Withdrawal by Subject|1
2839290|NCT02547649|9741968|P3|Overall Study|Withdrawal by Subject|2
2839291|NCT02547649|9741969|P2|Overall Study|Withdrawal by Subject|4
2839292|NCT02547649|9741970|P1|Overall Study|Withdrawal by Subject|0
2839293|NCT02547649|9741968|P3|Overall Study|Not vaccinated|1
2839294|NCT02547649|9741969|P2|Overall Study|Not vaccinated|0
2839295|NCT02547649|9741970|P1|Overall Study|Not vaccinated|0
2839296|NCT02547649|9741968|P3|Overall Study|Lost to Follow-up|1
2839297|NCT02547649|9741969|P2|Overall Study|Lost to Follow-up|1
2839298|NCT02547649|9741970|P1|Overall Study|Lost to Follow-up|3
2839299|NCT02547454|9742035|P1|Overall Study|No data|11
2839300|NCT02547454|9742035|P1|Overall Study|Other|39
2839301|NCT02547454|9742035|P1|Overall Study|Lost to Follow-up|26
2839302|NCT02547454|9742035|P1|Overall Study|Death|38
2839303|NCT02547454|9742035|P1|Overall Study|Due to no further need to treat|4
2839304|NCT02547454|9742035|P1|Overall Study|Due to transplantation|1
2839305|NCT02547454|9742035|P1|Overall Study|Due to hemodialysis|53
2839306|NCT02547363|9742065|P2|12-month Follow-up|Other|0
2839307|NCT02547363|9742066|P1|12-month Follow-up|Other|1
2839308|NCT02547363|9742065|P2|12-month Follow-up|Lack of Efficacy|1
2839309|NCT02547363|9742066|P1|12-month Follow-up|Lack of Efficacy|1
2839310|NCT02547363|9742065|P2|12-month Follow-up|Lost to Follow-up|1
2839311|NCT02547363|9742066|P1|12-month Follow-up|Lost to Follow-up|4
2839312|NCT02547363|9742065|P2|12-month Follow-up|Withdrawal by Subject|3
2839313|NCT02547363|9742066|P1|12-month Follow-up|Withdrawal by Subject|4
2839314|NCT02547363|9742065|P2|3-day Treatment and 8-week Follow-up|Other|1
2839315|NCT02547363|9742066|P1|3-day Treatment and 8-week Follow-up|Other|1
2839316|NCT02547363|9742065|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2839317|NCT02547363|9742066|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2839318|NCT02547363|9742065|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
2839319|NCT02547363|9742066|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2839320|NCT02547363|9742065|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
2839321|NCT02547363|9742066|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
2839322|NCT02547233|9742082|P2|12-month Follow-up|Other|1
2839323|NCT02547233|9742083|P1|12-month Follow-up|Other|0
2839324|NCT02547233|9742082|P2|12-month Follow-up|Protocol Violation|1
2839325|NCT02547233|9742083|P1|12-month Follow-up|Protocol Violation|0
2839326|NCT02547233|9742082|P2|12-month Follow-up|Lack of Efficacy|2
2839327|NCT02547233|9742083|P1|12-month Follow-up|Lack of Efficacy|1
2839328|NCT02547233|9742082|P2|12-month Follow-up|Lost to Follow-up|3
2839329|NCT02547233|9742083|P1|12-month Follow-up|Lost to Follow-up|3
2839330|NCT02547233|9742082|P2|12-month Follow-up|Withdrawal by Subject|10
2839331|NCT02547233|9742083|P1|12-month Follow-up|Withdrawal by Subject|10
2839332|NCT02547233|9742082|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2839333|NCT02547233|9742083|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2839334|NCT02547233|9742082|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
2839335|NCT02547233|9742083|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
2839336|NCT02547233|9742082|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
2839337|NCT02547233|9742083|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
2839338|NCT02547233|9742082|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
2839339|NCT02547233|9742083|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
2839340|NCT02547129|9742099|P2|Overall Study|Difficulty with ongoing infection|0
2839341|NCT02547129|9742100|P1|Overall Study|Difficulty with ongoing infection|1
2839342|NCT02547038|9742143|P2|Overall Study|Lost to Follow-up|2
2839343|NCT02547038|9742144|P1|Overall Study|Lost to Follow-up|3
2839344|NCT02546986|9742161|P2|Survival Follow-Up Phase|Lost to Follow-up|2
2839345|NCT02546986|9742162|P1|Survival Follow-Up Phase|Lost to Follow-up|2
2839346|NCT02546986|9742161|P2|Survival Follow-Up Phase|Alive|16
2839347|NCT02546986|9742162|P1|Survival Follow-Up Phase|Alive|13
2839348|NCT02546986|9742161|P2|Survival Follow-Up Phase|Death|12
2839349|NCT02546986|9742162|P1|Survival Follow-Up Phase|Death|18
2839350|NCT02546986|9742161|P2|Survival Follow-Up Phase|Missing Status|5
2839351|NCT02546986|9742162|P1|Survival Follow-Up Phase|Missing Status|3
2839352|NCT02546986|9742161|P2|Treatment Period|Miscellaneous|9
2839353|NCT02546986|9742162|P1|Treatment Period|Miscellaneous|7
2839354|NCT02546986|9742161|P2|Treatment Period|Study Terminated by Sponsor|1
2839355|NCT02546986|9742162|P1|Treatment Period|Study Terminated by Sponsor|0
2839356|NCT02546986|9742161|P2|Treatment Period|Non-compliance with Study Drug|1
2839357|NCT02546986|9742162|P1|Treatment Period|Non-compliance with Study Drug|0
2839358|NCT02546986|9742161|P2|Treatment Period|Withdrawal by Subject|1
2839359|NCT02546986|9742162|P1|Treatment Period|Withdrawal by Subject|1
2839360|NCT02546986|9742161|P2|Treatment Period|Protocol Violation|0
2839361|NCT02546986|9742162|P1|Treatment Period|Protocol Violation|1
2839362|NCT02546986|9742161|P2|Treatment Period|Physician Decision|2
2839363|NCT02546986|9742162|P1|Treatment Period|Physician Decision|1
2839364|NCT02546986|9742161|P2|Treatment Period|Death|4
2839365|NCT02546986|9742162|P1|Treatment Period|Death|3
2839366|NCT02546986|9742161|P2|Treatment Period|Symptomatic Deterioration|3
2839367|NCT02546986|9742162|P1|Treatment Period|Symptomatic Deterioration|4
2839368|NCT02546986|9742161|P2|Treatment Period|Adverse Event|6
2839369|NCT02546986|9742162|P1|Treatment Period|Adverse Event|14
2839370|NCT02546986|9742161|P2|Treatment Period|Progressive Disease|22
2839371|NCT02546986|9742162|P1|Treatment Period|Progressive Disease|20
2839372|NCT02546765|9742189|P4|Overall Study|Withdrawal by Subject|0
2839373|NCT02546765|9742190|P3|Overall Study|Withdrawal by Subject|0
2839374|NCT02546765|9742191|P2|Overall Study|Withdrawal by Subject|1
2839375|NCT02546765|9742192|P1|Overall Study|Withdrawal by Subject|0
2839376|NCT02546609|9742233|P3|Overall Study|travel or work schedule restriction|2
2839377|NCT02546609|9742234|P2|Overall Study|travel or work schedule restriction|0
2839378|NCT02546609|9742235|P1|Overall Study|travel or work schedule restriction|0
2839379|NCT02546609|9742233|P3|Overall Study|Lost to Follow-up|1
2839380|NCT02546609|9742234|P2|Overall Study|Lost to Follow-up|3
2839381|NCT02546609|9742235|P1|Overall Study|Lost to Follow-up|2
2839382|NCT02546609|9742233|P3|Overall Study|Protocol Violation|1
2839383|NCT02546609|9742234|P2|Overall Study|Protocol Violation|1
2839384|NCT02546609|9742235|P1|Overall Study|Protocol Violation|0
2839385|NCT02546609|9742233|P3|Overall Study|Adverse Event|1
2839386|NCT02546609|9742234|P2|Overall Study|Adverse Event|6
2839387|NCT02546609|9742235|P1|Overall Study|Adverse Event|0
2839388|NCT02546609|9742233|P3|Overall Study|Withdrawal by Subject|2
2839389|NCT02546609|9742234|P2|Overall Study|Withdrawal by Subject|1
2839390|NCT02546609|9742235|P1|Overall Study|Withdrawal by Subject|0
2839391|NCT02546544|9742315|P1|Overall Study|Withdrawal by Subject|1
2839392|NCT02546544|9742315|P1|Overall Study|Adverse Event|1
2839393|NCT02546544|9742315|P1|Overall Study|Disease Progression|14
2839394|NCT02546362|9742356|P1|12-week Treatment Period|Change in medication|1
2839395|NCT02546362|9742356|P1|12-week Treatment Period|Lost to Follow-up|2
2839396|NCT02546362|9742356|P1|12-week Treatment Period|Withdrawal by Subject|6
2839397|NCT02546362|9742356|P1|4-week Treatment Period|Change in medication|2
2839398|NCT02546362|9742356|P1|4-week Treatment Period|Lost to Follow-up|1
2839399|NCT02546323|9742377|P2|Overall Study|Met Withdrawal Criteria|14
2839400|NCT02546323|9742378|P1|Overall Study|Met Withdrawal Criteria|2
2839401|NCT02546323|9742377|P2|Overall Study|Non-compliance with Study Drug|2
2839402|NCT02546323|9742378|P1|Overall Study|Non-compliance with Study Drug|2
2839403|NCT02546323|9742377|P2|Overall Study|Lost to Follow-up|3
2839404|NCT02546323|9742378|P1|Overall Study|Lost to Follow-up|2
2839405|NCT02546323|9742377|P2|Overall Study|Patient Specific Reasons|2
2839406|NCT02546323|9742378|P1|Overall Study|Patient Specific Reasons|1
2839407|NCT02546323|9742377|P2|Overall Study|Adverse Event|11
2839408|NCT02546323|9742378|P1|Overall Study|Adverse Event|17
2839409|NCT02546323|9742377|P2|Overall Study|Eligibility Criteria not Fulfilled|1
2839410|NCT02546323|9742378|P1|Overall Study|Eligibility Criteria not Fulfilled|0
2839411|NCT02546323|9742377|P2|Overall Study|Withdrawal by Subject|33
2839412|NCT02546323|9742378|P1|Overall Study|Withdrawal by Subject|36
2839413|NCT02546193|9742398|P4|Overall Study|Not eligible at time of induction|0
2839414|NCT02546193|9742399|P3|Overall Study|Not eligible at time of induction|1
2839415|NCT02546193|9742400|P2|Overall Study|Not eligible at time of induction|6
2839416|NCT02546193|9742401|P1|Overall Study|Not eligible at time of induction|4
2839417|NCT02546193|9742398|P4|Overall Study|Withdrawal by Subject|0
2839418|NCT02546193|9742399|P3|Overall Study|Withdrawal by Subject|1
2839419|NCT02546193|9742400|P2|Overall Study|Withdrawal by Subject|0
2839420|NCT02546193|9742401|P1|Overall Study|Withdrawal by Subject|2
2839421|NCT02545868|9742438|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
2839422|NCT02545868|9742439|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
2839423|NCT02545868|9742440|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
2839424|NCT02545543|9742523|P2|Overall Study|Enrolment of subject at >1 study site|1
2839425|NCT02545543|9742524|P1|Overall Study|Enrolment of subject at >1 study site|1
2839426|NCT02545543|9742523|P2|Overall Study|Noncomplaince|0
2839427|NCT02545543|9742524|P1|Overall Study|Noncomplaince|1
2839428|NCT02545543|9742523|P2|Overall Study|Withdrawal by Subject|8
2839429|NCT02545543|9742524|P1|Overall Study|Withdrawal by Subject|9
2839430|NCT02545543|9742523|P2|Overall Study|Physician Decision|0
2839431|NCT02545543|9742524|P1|Overall Study|Physician Decision|3
2839432|NCT02545543|9742523|P2|Overall Study|Lost to Follow-up|25
2839433|NCT02545543|9742524|P1|Overall Study|Lost to Follow-up|67
2839434|NCT02545504|9742550|P2|Overall Study|Lost to Follow-up|2
2839435|NCT02545504|9742551|P1|Overall Study|Lost to Follow-up|2
2839436|NCT02545504|9742550|P2|Overall Study|Investigator's discretion|1
2839437|NCT02545504|9742551|P1|Overall Study|Investigator's discretion|3
2839438|NCT02545504|9742550|P2|Overall Study|Withdrew consent|11
2839439|NCT02545504|9742551|P1|Overall Study|Withdrew consent|9
2839440|NCT02545504|9742550|P2|Overall Study|Unknown reason|32
2839441|NCT02545504|9742551|P1|Overall Study|Unknown reason|30
2839442|NCT02545504|9742550|P2|Overall Study|Death|168
2839443|NCT02545504|9742551|P1|Overall Study|Death|174
2839444|NCT02545322|9742565|P1|Overall Study|Withdrawal by Subject|3
2839445|NCT02545270|9742573|P3|Overall Study|Videos being too similar to other|2
2839446|NCT02545270|9742574|P2|Overall Study|Videos being too similar to other|0
2839447|NCT02545270|9742575|P1|Overall Study|Videos being too similar to other|0
2839448|NCT02545270|9742573|P3|Overall Study|technical difficulties|0
2839449|NCT02545270|9742574|P2|Overall Study|technical difficulties|1
2839450|NCT02545270|9742575|P1|Overall Study|technical difficulties|0
2839451|NCT02545075|9742604|P2|Treatment|Completed treatment|12
2839452|NCT02545075|9742605|P1|Treatment|Completed treatment|40
2839453|NCT02545075|9742604|P2|Treatment|Participant drug toxicity|0
2839454|NCT02545075|9742605|P1|Treatment|Participant drug toxicity|1
2839455|NCT02545075|9742604|P2|Treatment|Death|0
2839456|NCT02545075|9742605|P1|Treatment|Death|1
2839457|NCT02545075|9742604|P2|Treatment|Adverse event not related to study drug|0
2839458|NCT02545075|9742605|P1|Treatment|Adverse event not related to study drug|1
2839459|NCT02545075|9742604|P2|Treatment|Withdrawal by Subject|0
2839460|NCT02545075|9742605|P1|Treatment|Withdrawal by Subject|1
2839461|NCT02545075|9742604|P2|Treatment|Participant dicontinued study treatment|9
2839462|NCT02545075|9742605|P1|Treatment|Participant dicontinued study treatment|7
2839463|NCT02545075|9742604|P2|Treatment|Disease progression|32
2839464|NCT02545075|9742605|P1|Treatment|Disease progression|71
2839465|NCT02545075|9742604|P2|Randomization|Withdrawal by Subject|6
2839466|NCT02545075|9742605|P1|Randomization|Withdrawal by Subject|0
2839467|NCT02545075|9742604|P2|Randomization|Lost to Follow-up|1
2839468|NCT02545075|9742605|P1|Randomization|Lost to Follow-up|0
2839469|NCT02544633|9742642|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
2839470|NCT02544633|9742643|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
2839471|NCT02544633|9742644|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
2839472|NCT02544633|9742645|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
2839473|NCT02544633|9742642|P4|Survival Follow-up Period|Withdrawal by Subject|0
2839474|NCT02544633|9742643|P3|Survival Follow-up Period|Withdrawal by Subject|1
2839475|NCT02544633|9742644|P2|Survival Follow-up Period|Withdrawal by Subject|0
2839476|NCT02544633|9742645|P1|Survival Follow-up Period|Withdrawal by Subject|4
2839477|NCT02544633|9742642|P4|Survival Follow-up Period|Lost to Follow-up|0
2839478|NCT02544633|9742643|P3|Survival Follow-up Period|Lost to Follow-up|1
2839479|NCT02544633|9742644|P2|Survival Follow-up Period|Lost to Follow-up|1
2839480|NCT02544633|9742645|P1|Survival Follow-up Period|Lost to Follow-up|0
2839481|NCT02544633|9742642|P4|Survival Follow-up Period|Death|9
2839482|NCT02544633|9742643|P3|Survival Follow-up Period|Death|3
2839483|NCT02544633|9742644|P2|Survival Follow-up Period|Death|14
2839484|NCT02544633|9742645|P1|Survival Follow-up Period|Death|12
2839485|NCT02544633|9742642|P4|Treatment Period|Clinical Disease Progression|1
2839486|NCT02544633|9742643|P3|Treatment Period|Clinical Disease Progression|0
2839487|NCT02544633|9742644|P2|Treatment Period|Clinical Disease Progression|0
2839488|NCT02544633|9742645|P1|Treatment Period|Clinical Disease Progression|0
2839489|NCT02544633|9742642|P4|Treatment Period|Non-compliance|0
2839490|NCT02544633|9742643|P3|Treatment Period|Non-compliance|1
2839491|NCT02544633|9742644|P2|Treatment Period|Non-compliance|0
2839492|NCT02544633|9742645|P1|Treatment Period|Non-compliance|0
2839493|NCT02544633|9742642|P4|Treatment Period|Death|0
2839494|NCT02544633|9742643|P3|Treatment Period|Death|1
2839495|NCT02544633|9742644|P2|Treatment Period|Death|0
2839496|NCT02544633|9742645|P1|Treatment Period|Death|0
2839497|NCT02544633|9742642|P4|Treatment Period|Lost to Follow-up|0
2839498|NCT02544633|9742643|P3|Treatment Period|Lost to Follow-up|0
2839499|NCT02544633|9742644|P2|Treatment Period|Lost to Follow-up|1
2839500|NCT02544633|9742645|P1|Treatment Period|Lost to Follow-up|0
2839501|NCT02544633|9742642|P4|Treatment Period|Withdrawal by Subject|0
2839502|NCT02544633|9742643|P3|Treatment Period|Withdrawal by Subject|0
2839503|NCT02544633|9742644|P2|Treatment Period|Withdrawal by Subject|0
2839504|NCT02544633|9742645|P1|Treatment Period|Withdrawal by Subject|1
2839505|NCT02544633|9742642|P4|Treatment Period|Global Deterioration of Health|1
2839506|NCT02544633|9742643|P3|Treatment Period|Global Deterioration of Health|0
2839507|NCT02544633|9742644|P2|Treatment Period|Global Deterioration of Health|3
2839508|NCT02544633|9742645|P1|Treatment Period|Global Deterioration of Health|3
2839509|NCT02544633|9742642|P4|Treatment Period|Lack of Efficacy|5
2839510|NCT02544633|9742643|P3|Treatment Period|Lack of Efficacy|5
2839511|NCT02544633|9742644|P2|Treatment Period|Lack of Efficacy|11
2839512|NCT02544633|9742645|P1|Treatment Period|Lack of Efficacy|17
2839513|NCT02544633|9742642|P4|Treatment Period|Adverse Event|5
2839514|NCT02544633|9742643|P3|Treatment Period|Adverse Event|0
2839515|NCT02544633|9742644|P2|Treatment Period|Adverse Event|4
2839516|NCT02544633|9742645|P1|Treatment Period|Adverse Event|7
2839517|NCT02544633|9742642|P4|Treatment Period|Patient Still on Treatment/Study|0
2839518|NCT02544633|9742643|P3|Treatment Period|Patient Still on Treatment/Study|1
2839519|NCT02544633|9742644|P2|Treatment Period|Patient Still on Treatment/Study|1
2839520|NCT02544633|9742645|P1|Treatment Period|Patient Still on Treatment/Study|0
2839521|NCT02544451|9742729|P3|Overall Study|Other|0
2839522|NCT02544451|9742730|P2|Overall Study|Other|4
2839523|NCT02544451|9742731|P1|Overall Study|Other|4
2839524|NCT02544451|9742729|P3|Overall Study|Physician Decision|0
2839525|NCT02544451|9742730|P2|Overall Study|Physician Decision|0
2839526|NCT02544451|9742731|P1|Overall Study|Physician Decision|4
2839527|NCT02544451|9742729|P3|Overall Study|Lost to Follow-up|0
2839528|NCT02544451|9742730|P2|Overall Study|Lost to Follow-up|0
2839529|NCT02544451|9742731|P1|Overall Study|Lost to Follow-up|2
2839530|NCT02544451|9742729|P3|Overall Study|Withdrawal of consent (not due to AE)|1
2839531|NCT02544451|9742730|P2|Overall Study|Withdrawal of consent (not due to AE)|2
2839532|NCT02544451|9742731|P1|Overall Study|Withdrawal of consent (not due to AE)|3
2839533|NCT02544451|9742729|P3|Overall Study|Adverse Event|0
2839534|NCT02544451|9742730|P2|Overall Study|Adverse Event|6
2839535|NCT02544451|9742731|P1|Overall Study|Adverse Event|1
2839536|NCT02544152|9742776|P2|Overall Study|Other|0
2839537|NCT02544152|9742777|P1|Overall Study|Other|1
2839538|NCT02544152|9742776|P2|Overall Study|Withdrawal by Subject|3
2839539|NCT02544152|9742777|P1|Overall Study|Withdrawal by Subject|0
2839540|NCT02544152|9742776|P2|Overall Study|Adverse Event|4
2839541|NCT02544152|9742777|P1|Overall Study|Adverse Event|0
2839542|NCT02544074|9742820|P21|Overall Study|Tablet error|0
2839543|NCT02544074|9742821|P20|Overall Study|Tablet error|0
2839544|NCT02544074|9742822|P19|Overall Study|Tablet error|0
2839545|NCT02544074|9742823|P18|Overall Study|Tablet error|0
2839546|NCT02544074|9742824|P17|Overall Study|Tablet error|0
2839547|NCT02544074|9742825|P16|Overall Study|Tablet error|0
2839548|NCT02544074|9742826|P15|Overall Study|Tablet error|0
2839549|NCT02544074|9742827|P14|Overall Study|Tablet error|0
2839550|NCT02544074|9742828|P13|Overall Study|Tablet error|0
2839551|NCT02544074|9742829|P12|Overall Study|Tablet error|0
2839552|NCT02544074|9742830|P11|Overall Study|Tablet error|0
2839553|NCT02544074|9742831|P10|Overall Study|Tablet error|1
2839554|NCT02544074|9742832|P9|Overall Study|Tablet error|0
2839555|NCT02544074|9742833|P8|Overall Study|Tablet error|0
2839556|NCT02544074|9742834|P7|Overall Study|Tablet error|0
2839557|NCT02544074|9742835|P6|Overall Study|Tablet error|1
2839558|NCT02544074|9742836|P5|Overall Study|Tablet error|0
2839559|NCT02544074|9742837|P4|Overall Study|Tablet error|0
2839560|NCT02544074|9742838|P3|Overall Study|Tablet error|0
2839561|NCT02544074|9742839|P2|Overall Study|Tablet error|0
2839562|NCT02544074|9742840|P1|Overall Study|Tablet error|0
2839563|NCT02544074|9742820|P21|Overall Study|Withdrawal by Subject|0
2839564|NCT02544074|9742821|P20|Overall Study|Withdrawal by Subject|0
2839565|NCT02544074|9742822|P19|Overall Study|Withdrawal by Subject|0
2839566|NCT02544074|9742823|P18|Overall Study|Withdrawal by Subject|0
2839567|NCT02544074|9742824|P17|Overall Study|Withdrawal by Subject|0
2839568|NCT02544074|9742825|P16|Overall Study|Withdrawal by Subject|0
2839569|NCT02544074|9742826|P15|Overall Study|Withdrawal by Subject|0
2839570|NCT02544074|9742827|P14|Overall Study|Withdrawal by Subject|0
2839571|NCT02544074|9742828|P13|Overall Study|Withdrawal by Subject|0
2839572|NCT02544074|9742829|P12|Overall Study|Withdrawal by Subject|0
2839573|NCT02544074|9742830|P11|Overall Study|Withdrawal by Subject|0
2839574|NCT02544074|9742831|P10|Overall Study|Withdrawal by Subject|0
2839575|NCT02544074|9742832|P9|Overall Study|Withdrawal by Subject|0
2839576|NCT02544074|9742833|P8|Overall Study|Withdrawal by Subject|0
2839577|NCT02544074|9742834|P7|Overall Study|Withdrawal by Subject|0
2839578|NCT02544074|9742835|P6|Overall Study|Withdrawal by Subject|0
2839579|NCT02544074|9742836|P5|Overall Study|Withdrawal by Subject|0
2839580|NCT02544074|9742837|P4|Overall Study|Withdrawal by Subject|0
2839581|NCT02544074|9742838|P3|Overall Study|Withdrawal by Subject|0
2839582|NCT02544074|9742839|P2|Overall Study|Withdrawal by Subject|1
2839583|NCT02544074|9742840|P1|Overall Study|Withdrawal by Subject|0
2839584|NCT02543918|9742876|P2|Overall Study|Adverse Event|1
2839585|NCT02543918|9742877|P1|Overall Study|Adverse Event|1
2839586|NCT02543918|9742876|P2|Overall Study|Withdrawal by Subject|1
2839587|NCT02543918|9742877|P1|Overall Study|Withdrawal by Subject|1
2839588|NCT02543918|9742876|P2|Overall Study|Lost to Follow-up|1
2839589|NCT02543918|9742877|P1|Overall Study|Lost to Follow-up|1
2839590|NCT02543918|9742876|P2|Overall Study|Never treated|1
2839591|NCT02543918|9742877|P1|Overall Study|Never treated|0
2839592|NCT02543892|9742891|P8|Had Immunology Data|Withdrawal by Subject|0
2839593|NCT02543892|9742892|P7|Had Immunology Data|Withdrawal by Subject|1
2839594|NCT02543892|9742893|P6|Had Immunology Data|Withdrawal by Subject|0
2839595|NCT02543892|9742894|P5|Had Immunology Data|Withdrawal by Subject|0
2839596|NCT02543892|9742895|P4|Had Immunology Data|Withdrawal by Subject|0
2839597|NCT02543892|9742896|P3|Had Immunology Data|Withdrawal by Subject|0
2839598|NCT02543892|9742897|P2|Had Immunology Data|Withdrawal by Subject|0
2839599|NCT02543892|9742898|P1|Had Immunology Data|Withdrawal by Subject|0
2839600|NCT02543892|9742891|P8|Received Vaccination 2|Adverse Event|0
2839601|NCT02543892|9742892|P7|Received Vaccination 2|Adverse Event|0
2839602|NCT02543892|9742893|P6|Received Vaccination 2|Adverse Event|0
2839603|NCT02543892|9742894|P5|Received Vaccination 2|Adverse Event|0
2839604|NCT02543892|9742895|P4|Received Vaccination 2|Adverse Event|0
2839605|NCT02543892|9742896|P3|Received Vaccination 2|Adverse Event|0
2839606|NCT02543892|9742897|P2|Received Vaccination 2|Adverse Event|1
2839607|NCT02543892|9742898|P1|Received Vaccination 2|Adverse Event|0
2839608|NCT02543892|9742891|P8|Received Vaccination 2|Physician Decision|0
2839609|NCT02543892|9742892|P7|Received Vaccination 2|Physician Decision|0
2839610|NCT02543892|9742893|P6|Received Vaccination 2|Physician Decision|1
2839611|NCT02543892|9742894|P5|Received Vaccination 2|Physician Decision|0
2839612|NCT02543892|9742895|P4|Received Vaccination 2|Physician Decision|0
2839613|NCT02543892|9742896|P3|Received Vaccination 2|Physician Decision|0
2839614|NCT02543892|9742897|P2|Received Vaccination 2|Physician Decision|0
2839615|NCT02543892|9742898|P1|Received Vaccination 2|Physician Decision|0
2839616|NCT02543892|9742891|P8|Received Vaccination 2|Withdrawal by Subject|1
2839617|NCT02543892|9742892|P7|Received Vaccination 2|Withdrawal by Subject|0
2839618|NCT02543892|9742893|P6|Received Vaccination 2|Withdrawal by Subject|0
2839619|NCT02543892|9742894|P5|Received Vaccination 2|Withdrawal by Subject|0
2839620|NCT02543892|9742895|P4|Received Vaccination 2|Withdrawal by Subject|0
2839621|NCT02543892|9742896|P3|Received Vaccination 2|Withdrawal by Subject|0
2839622|NCT02543892|9742897|P2|Received Vaccination 2|Withdrawal by Subject|0
2839623|NCT02543892|9742898|P1|Received Vaccination 2|Withdrawal by Subject|1
2839624|NCT02543801|9742948|P4|Overall Study|Protocol Violation|0
2839625|NCT02543801|9742949|P3|Overall Study|Protocol Violation|0
2839626|NCT02543801|9742950|P2|Overall Study|Protocol Violation|2
2839627|NCT02543801|9742951|P1|Overall Study|Protocol Violation|1
2839628|NCT02543528|9742980|P5|Extended Wear Period|Withdrawal by Subject|0
2839629|NCT02543528|9742981|P4|Extended Wear Period|Withdrawal by Subject|5
2839630|NCT02543528|9742982|P3|Extended Wear Period|Withdrawal by Subject|4
2839631|NCT02543528|9742983|P2|Extended Wear Period|Withdrawal by Subject|9
2839632|NCT02543528|9742984|P1|Extended Wear Period|Withdrawal by Subject|10
2839633|NCT02543528|9742980|P5|Extended Wear Period|Lost to Follow-up|0
2839634|NCT02543528|9742981|P4|Extended Wear Period|Lost to Follow-up|1
2839635|NCT02543528|9742982|P3|Extended Wear Period|Lost to Follow-up|2
2839636|NCT02543528|9742983|P2|Extended Wear Period|Lost to Follow-up|1
2839637|NCT02543528|9742984|P1|Extended Wear Period|Lost to Follow-up|0
2839638|NCT02543528|9742980|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
2839639|NCT02543528|9742981|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
2839640|NCT02543528|9742982|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
2839641|NCT02543528|9742983|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
2839642|NCT02543528|9742984|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
2839643|NCT02543528|9742980|P5|Extended Wear Period|Missed too many scheduled visits|0
2839644|NCT02543528|9742981|P4|Extended Wear Period|Missed too many scheduled visits|3
2839645|NCT02543528|9742982|P3|Extended Wear Period|Missed too many scheduled visits|1
2839646|NCT02543528|9742983|P2|Extended Wear Period|Missed too many scheduled visits|0
2839647|NCT02543528|9742984|P1|Extended Wear Period|Missed too many scheduled visits|0
2839648|NCT02543528|9742980|P5|Extended Wear Period|Adverse Event|0
2839649|NCT02543528|9742981|P4|Extended Wear Period|Adverse Event|3
2839650|NCT02543528|9742982|P3|Extended Wear Period|Adverse Event|16
2839651|NCT02543528|9742983|P2|Extended Wear Period|Adverse Event|11
2839652|NCT02543528|9742984|P1|Extended Wear Period|Adverse Event|17
2839653|NCT02543528|9742980|P5|Adaptation Period|Adverse Event|2
2839654|NCT02543528|9742981|P4|Adaptation Period|Adverse Event|0
2839655|NCT02543528|9742982|P3|Adaptation Period|Adverse Event|0
2839656|NCT02543528|9742983|P2|Adaptation Period|Adverse Event|0
2839657|NCT02543528|9742984|P1|Adaptation Period|Adverse Event|0
2839658|NCT02543528|9742980|P5|Adaptation Period|Lost to Follow-up|14
2839659|NCT02543528|9742981|P4|Adaptation Period|Lost to Follow-up|0
2839660|NCT02543528|9742982|P3|Adaptation Period|Lost to Follow-up|0
2839661|NCT02543528|9742983|P2|Adaptation Period|Lost to Follow-up|0
2839662|NCT02543528|9742984|P1|Adaptation Period|Lost to Follow-up|0
2839663|NCT02543528|9742980|P5|Adaptation Period|Lens Handling Difficultes|8
2839664|NCT02543528|9742981|P4|Adaptation Period|Lens Handling Difficultes|0
2839665|NCT02543528|9742982|P3|Adaptation Period|Lens Handling Difficultes|0
2839666|NCT02543528|9742983|P2|Adaptation Period|Lens Handling Difficultes|0
2839667|NCT02543528|9742984|P1|Adaptation Period|Lens Handling Difficultes|0
2839668|NCT02543528|9742980|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
2839669|NCT02543528|9742981|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
2839670|NCT02543528|9742982|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
2839671|NCT02543528|9742983|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
2839672|NCT02543528|9742984|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
2839673|NCT02543346|9743017|P4|Second Priming Visit|Adverse Event|0
2839674|NCT02543346|9743018|P3|Second Priming Visit|Adverse Event|0
2839675|NCT02543346|9743019|P2|Second Priming Visit|Adverse Event|0
2839676|NCT02543346|9743020|P1|Second Priming Visit|Adverse Event|1
2839677|NCT02543346|9743017|P4|Second Priming Visit|Withdrawal by Subject|2
2839678|NCT02543346|9743018|P3|Second Priming Visit|Withdrawal by Subject|2
2839679|NCT02543346|9743019|P2|Second Priming Visit|Withdrawal by Subject|2
2839680|NCT02543346|9743020|P1|Second Priming Visit|Withdrawal by Subject|0
2839681|NCT02543294|9743046|P1|Overall Study|Withdrawal by Subject|7
2839682|NCT02543294|9743046|P1|Overall Study|Physician Decision|2
2839683|NCT02543294|9743046|P1|Overall Study|Lost to Follow-up|3
2839684|NCT02542943|9743054|P3|Overall Study|Withdrawal by Subject|0
2839685|NCT02542943|9743055|P2|Overall Study|Withdrawal by Subject|1
2839686|NCT02542943|9743056|P1|Overall Study|Withdrawal by Subject|0
2839687|NCT02542943|9743054|P3|Overall Study|Lost to Follow-up|0
2839688|NCT02542943|9743055|P2|Overall Study|Lost to Follow-up|0
2839689|NCT02542943|9743056|P1|Overall Study|Lost to Follow-up|1
2839690|NCT02542865|9743083|P2|Overall Study|Withdrawal by Subject|0
2839691|NCT02542865|9743084|P1|Overall Study|Withdrawal by Subject|16
2839692|NCT02542865|9743083|P2|Overall Study|Identified as screen failure|0
2839693|NCT02542865|9743084|P1|Overall Study|Identified as screen failure|1
2839694|NCT02542631|9743147|P2|Overall Study|Used Prohibited Medication|1
2839695|NCT02542631|9743148|P1|Overall Study|Used Prohibited Medication|2
2839696|NCT02542631|9743147|P2|Overall Study|Other|1
2839697|NCT02542631|9743148|P1|Overall Study|Other|2
2839698|NCT02542631|9743147|P2|Overall Study|Death|2
2839699|NCT02542631|9743148|P1|Overall Study|Death|1
2839700|NCT02542631|9743147|P2|Overall Study|Lost to Follow-up|5
2839701|NCT02542631|9743148|P1|Overall Study|Lost to Follow-up|6
2839702|NCT02542631|9743147|P2|Overall Study|Physician Decision|4
2839703|NCT02542631|9743148|P1|Overall Study|Physician Decision|6
2839704|NCT02542631|9743147|P2|Overall Study|Protocol Violation|1
2839705|NCT02542631|9743148|P1|Overall Study|Protocol Violation|1
2839706|NCT02542631|9743147|P2|Overall Study|Withdrawal by Subject|16
2839707|NCT02542631|9743148|P1|Overall Study|Withdrawal by Subject|11
2839708|NCT02542631|9743147|P2|Overall Study|Sponsor Termination|0
2839709|NCT02542631|9743148|P1|Overall Study|Sponsor Termination|1
2839710|NCT02542631|9743147|P2|Overall Study|Adverse Event|1
2839711|NCT02542631|9743148|P1|Overall Study|Adverse Event|1
2839712|NCT02542605|9743170|P3|Part B: Randomization Phase|Withdrawal by Subject|1
2839713|NCT02542605|9743171|P2|Part B: Randomization Phase|Withdrawal by Subject|0
2839714|NCT02542605|9743172|P1|Part B: Randomization Phase|Withdrawal by Subject|0
2839715|NCT02542605|9743170|P3|Part B: Challenge Phase|Sponsor decision|0
2839716|NCT02542605|9743171|P2|Part B: Challenge Phase|Sponsor decision|0
2839717|NCT02542605|9743172|P1|Part B: Challenge Phase|Sponsor decision|1
2839718|NCT02542072|9743262|P2|Second Intervention (1 Month)|Lens discomfort|0
2839719|NCT02542072|9743263|P1|Second Intervention (1 Month)|Lens discomfort|1
2839720|NCT02542072|9743262|P2|Second Intervention (1 Month)|Lost to Follow-up|0
2839721|NCT02542072|9743263|P1|Second Intervention (1 Month)|Lost to Follow-up|1
2839722|NCT02542072|9743262|P2|First Intervention (1 Month)|Protocol Violation|0
2839723|NCT02542072|9743263|P1|First Intervention (1 Month)|Protocol Violation|1
2839724|NCT02542072|9743262|P2|First Intervention (1 Month)|Lens discomfort|2
2839725|NCT02542072|9743263|P1|First Intervention (1 Month)|Lens discomfort|1
2839726|NCT02542072|9743262|P2|First Intervention (1 Month)|Lost to Follow-up|0
2839727|NCT02542072|9743263|P1|First Intervention (1 Month)|Lost to Follow-up|2
2839728|NCT02542072|9743262|P2|First Intervention (1 Month)|Adverse Event|1
2839729|NCT02542072|9743263|P1|First Intervention (1 Month)|Adverse Event|1
2839730|NCT02541903|9743387|P1|Overall Study|Death|1
2839731|NCT02541669|9743408|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
2839732|NCT02541669|9743409|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
2839733|NCT02541669|9743410|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
2839734|NCT02541669|9743411|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
2839735|NCT02541669|9743412|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
2839736|NCT02541604|9743459|P12|Overall Study|Medical condition may jeopardize safety|0
2839737|NCT02541604|9743460|P11|Overall Study|Medical condition may jeopardize safety|0
2839738|NCT02541604|9743461|P10|Overall Study|Medical condition may jeopardize safety|0
2839739|NCT02541604|9743462|P9|Overall Study|Medical condition may jeopardize safety|0
2839740|NCT02541604|9743463|P8|Overall Study|Medical condition may jeopardize safety|1
2839741|NCT02541604|9743464|P7|Overall Study|Medical condition may jeopardize safety|0
2839742|NCT02541604|9743465|P6|Overall Study|Medical condition may jeopardize safety|0
2839743|NCT02541604|9743466|P5|Overall Study|Medical condition may jeopardize safety|0
2839744|NCT02541604|9743467|P4|Overall Study|Medical condition may jeopardize safety|0
2839745|NCT02541604|9743468|P3|Overall Study|Medical condition may jeopardize safety|0
2839746|NCT02541604|9743469|P2|Overall Study|Medical condition may jeopardize safety|0
2839747|NCT02541604|9743470|P1|Overall Study|Medical condition may jeopardize safety|0
2839748|NCT02541604|9743459|P12|Overall Study|Study Terminated by Sponsor|0
2839749|NCT02541604|9743460|P11|Overall Study|Study Terminated by Sponsor|0
2839750|NCT02541604|9743461|P10|Overall Study|Study Terminated by Sponsor|0
2839751|NCT02541604|9743462|P9|Overall Study|Study Terminated by Sponsor|0
2839752|NCT02541604|9743463|P8|Overall Study|Study Terminated by Sponsor|0
2839753|NCT02541604|9743464|P7|Overall Study|Study Terminated by Sponsor|0
2839754|NCT02541604|9743465|P6|Overall Study|Study Terminated by Sponsor|0
2839755|NCT02541604|9743466|P5|Overall Study|Study Terminated by Sponsor|0
2839756|NCT02541604|9743467|P4|Overall Study|Study Terminated by Sponsor|1
2839757|NCT02541604|9743468|P3|Overall Study|Study Terminated by Sponsor|2
2839758|NCT02541604|9743469|P2|Overall Study|Study Terminated by Sponsor|4
2839759|NCT02541604|9743470|P1|Overall Study|Study Terminated by Sponsor|1
2839760|NCT02541604|9743459|P12|Overall Study|Withdrawal by Subject|0
2839761|NCT02541604|9743460|P11|Overall Study|Withdrawal by Subject|0
2839762|NCT02541604|9743461|P10|Overall Study|Withdrawal by Subject|0
2839763|NCT02541604|9743462|P9|Overall Study|Withdrawal by Subject|1
2839764|NCT02541604|9743463|P8|Overall Study|Withdrawal by Subject|0
2839765|NCT02541604|9743464|P7|Overall Study|Withdrawal by Subject|0
2839766|NCT02541604|9743465|P6|Overall Study|Withdrawal by Subject|1
2839767|NCT02541604|9743466|P5|Overall Study|Withdrawal by Subject|1
2839768|NCT02541604|9743467|P4|Overall Study|Withdrawal by Subject|0
2839769|NCT02541604|9743468|P3|Overall Study|Withdrawal by Subject|1
2839770|NCT02541604|9743469|P2|Overall Study|Withdrawal by Subject|0
2839771|NCT02541604|9743470|P1|Overall Study|Withdrawal by Subject|2
2839772|NCT02541604|9743459|P12|Overall Study|Lost to Follow-up|0
2839773|NCT02541604|9743460|P11|Overall Study|Lost to Follow-up|0
2839774|NCT02541604|9743461|P10|Overall Study|Lost to Follow-up|0
2839775|NCT02541604|9743462|P9|Overall Study|Lost to Follow-up|0
2839776|NCT02541604|9743463|P8|Overall Study|Lost to Follow-up|0
2839777|NCT02541604|9743464|P7|Overall Study|Lost to Follow-up|1
2839778|NCT02541604|9743465|P6|Overall Study|Lost to Follow-up|1
2839779|NCT02541604|9743466|P5|Overall Study|Lost to Follow-up|0
2839780|NCT02541604|9743467|P4|Overall Study|Lost to Follow-up|0
2839781|NCT02541604|9743468|P3|Overall Study|Lost to Follow-up|1
2839782|NCT02541604|9743469|P2|Overall Study|Lost to Follow-up|0
2839783|NCT02541604|9743470|P1|Overall Study|Lost to Follow-up|2
2839784|NCT02541604|9743459|P12|Overall Study|Death|3
2839785|NCT02541604|9743460|P11|Overall Study|Death|2
2839786|NCT02541604|9743461|P10|Overall Study|Death|4
2839787|NCT02541604|9743462|P9|Overall Study|Death|3
2839788|NCT02541604|9743463|P8|Overall Study|Death|9
2839789|NCT02541604|9743464|P7|Overall Study|Death|9
2839790|NCT02541604|9743465|P6|Overall Study|Death|8
2839791|NCT02541604|9743466|P5|Overall Study|Death|9
2839792|NCT02541604|9743467|P4|Overall Study|Death|2
2839793|NCT02541604|9743468|P3|Overall Study|Death|7
2839794|NCT02541604|9743469|P2|Overall Study|Death|5
2839795|NCT02541604|9743470|P1|Overall Study|Death|6
2839796|NCT02540850|9743585|P3|Overall Study|Lost to Follow-up|34
2839797|NCT02540850|9743586|P2|Overall Study|Lost to Follow-up|66
2839798|NCT02540850|9743587|P1|Overall Study|Lost to Follow-up|69
2839799|NCT02540668|9743628|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
2839800|NCT02540668|9743629|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
2839801|NCT02540538|9743660|P3|Overall Study|Pregnancy|0
2839802|NCT02540538|9743661|P2|Overall Study|Pregnancy|1
2839803|NCT02540538|9743662|P1|Overall Study|Pregnancy|0
2839804|NCT02540356|9743730|P2|Overall Study|Terminated due to disease progression|0
2839805|NCT02540356|9743731|P1|Overall Study|Terminated due to disease progression|1
2839806|NCT02540291|9743766|P4|Overall Study|Other|0
2839807|NCT02540291|9743767|P3|Overall Study|Other|1
2839808|NCT02540291|9743768|P2|Overall Study|Other|0
2839809|NCT02540291|9743769|P1|Overall Study|Other|0
2839810|NCT02540291|9743766|P4|Overall Study|Study Terminated By Sponsor|0
2839811|NCT02540291|9743767|P3|Overall Study|Study Terminated By Sponsor|0
2839812|NCT02540291|9743768|P2|Overall Study|Study Terminated By Sponsor|0
2839813|NCT02540291|9743769|P1|Overall Study|Study Terminated By Sponsor|1
2839814|NCT02540291|9743766|P4|Overall Study|Withdrawal Of Consent|0
2839815|NCT02540291|9743767|P3|Overall Study|Withdrawal Of Consent|0
2839816|NCT02540291|9743768|P2|Overall Study|Withdrawal Of Consent|1
2839817|NCT02540291|9743769|P1|Overall Study|Withdrawal Of Consent|0
2839818|NCT02540291|9743766|P4|Overall Study|Lost to Follow-up|0
2839819|NCT02540291|9743767|P3|Overall Study|Lost to Follow-up|1
2839820|NCT02540291|9743768|P2|Overall Study|Lost to Follow-up|0
2839821|NCT02540291|9743769|P1|Overall Study|Lost to Follow-up|0
2839822|NCT02540291|9743766|P4|Overall Study|Death|7
2839823|NCT02540291|9743767|P3|Overall Study|Death|5
2839824|NCT02540291|9743768|P2|Overall Study|Death|7
2839825|NCT02540291|9743769|P1|Overall Study|Death|7
2839826|NCT02540265|9743804|P3|Overall Study|Lost to Follow-up|1
2839827|NCT02540265|9743805|P2|Overall Study|Lost to Follow-up|0
2839828|NCT02540265|9743806|P1|Overall Study|Lost to Follow-up|0
2839829|NCT02540213|9743861|P1|Overall Study|Enrolled but not treated|2
2839830|NCT02540213|9743861|P1|Overall Study|Consent withdrawn|7
2839831|NCT02540213|9743861|P1|Overall Study|Lack of Efficacy|6
2839832|NCT02540213|9743861|P1|Overall Study|Kidney transplant|3
2839833|NCT02540213|9743861|P1|Overall Study|Administrative reasons|3
2839834|NCT02540213|9743861|P1|Overall Study|Death/adverse event|18
2839835|NCT02540083|9743882|P1|Overall Study|Withdrawal by Subject|16
2839836|NCT02539797|9743923|P3|Overall Study|Lost to Follow-up|0
2839837|NCT02539797|9743924|P2|Overall Study|Lost to Follow-up|1
2839838|NCT02539797|9743925|P1|Overall Study|Lost to Follow-up|0
2839839|NCT02539368|9743977|P5|Overall Study|Missing|0
2839840|NCT02539368|9743978|P4|Overall Study|Missing|0
2839841|NCT02539368|9743979|P3|Overall Study|Missing|0
2839842|NCT02539368|9743980|P2|Overall Study|Missing|3
2839843|NCT02539368|9743981|P1|Overall Study|Missing|10
2839844|NCT02539368|9743977|P5|Overall Study|Other|3
2839845|NCT02539368|9743978|P4|Overall Study|Other|1
2839846|NCT02539368|9743979|P3|Overall Study|Other|24
2839847|NCT02539368|9743980|P2|Overall Study|Other|18
2839848|NCT02539368|9743981|P1|Overall Study|Other|145
2839849|NCT02539368|9743977|P5|Overall Study|Participant Non-compliant|0
2839850|NCT02539368|9743978|P4|Overall Study|Participant Non-compliant|1
2839851|NCT02539368|9743979|P3|Overall Study|Participant Non-compliant|1
2839852|NCT02539368|9743980|P2|Overall Study|Participant Non-compliant|2
2839853|NCT02539368|9743981|P1|Overall Study|Participant Non-compliant|13
2839854|NCT02539368|9743977|P5|Overall Study|Adverse Event|3
2839855|NCT02539368|9743978|P4|Overall Study|Adverse Event|0
2839856|NCT02539368|9743979|P3|Overall Study|Adverse Event|9
2839857|NCT02539368|9743980|P2|Overall Study|Adverse Event|5
2839858|NCT02539368|9743981|P1|Overall Study|Adverse Event|44
2839859|NCT02539368|9743977|P5|Overall Study|Lost to Follow-up|3
2839860|NCT02539368|9743978|P4|Overall Study|Lost to Follow-up|4
2839861|NCT02539368|9743979|P3|Overall Study|Lost to Follow-up|16
2839862|NCT02539368|9743980|P2|Overall Study|Lost to Follow-up|21
2839863|NCT02539368|9743981|P1|Overall Study|Lost to Follow-up|96
2839864|NCT02539368|9743977|P5|Overall Study|Physician Decision|2
2839865|NCT02539368|9743978|P4|Overall Study|Physician Decision|0
2839866|NCT02539368|9743979|P3|Overall Study|Physician Decision|7
2839867|NCT02539368|9743980|P2|Overall Study|Physician Decision|15
2839868|NCT02539368|9743981|P1|Overall Study|Physician Decision|49
2839869|NCT02539368|9743977|P5|Overall Study|Withdrawal by Subject|3
2839870|NCT02539368|9743978|P4|Overall Study|Withdrawal by Subject|1
2839871|NCT02539368|9743979|P3|Overall Study|Withdrawal by Subject|9
2839872|NCT02539368|9743980|P2|Overall Study|Withdrawal by Subject|35
2839873|NCT02539368|9743981|P1|Overall Study|Withdrawal by Subject|44
2839874|NCT02539368|9743977|P5|Overall Study|Death|0
2839875|NCT02539368|9743978|P4|Overall Study|Death|0
2839876|NCT02539368|9743979|P3|Overall Study|Death|1
2839877|NCT02539368|9743980|P2|Overall Study|Death|2
2839878|NCT02539368|9743981|P1|Overall Study|Death|4
2839879|NCT02539225|9744114|P2|Part B|Physician Decision|9
2839880|NCT02539225|9744115|P1|Part B|Physician Decision|0
2839881|NCT02539225|9744114|P2|Part B|Withdrawal by Subject|3
2839882|NCT02539225|9744115|P1|Part B|Withdrawal by Subject|0
2839883|NCT02539225|9744114|P2|Part B|Adverse Event|4
2839884|NCT02539225|9744115|P1|Part B|Adverse Event|4
2839885|NCT02539225|9744114|P2|Pre Treatment for Part B|Physician Decision|0
2839886|NCT02539225|9744115|P1|Pre Treatment for Part B|Physician Decision|2
2839887|NCT02539225|9744114|P2|Pre Treatment for Part B|Withdrawal by Subject|0
2839888|NCT02539225|9744115|P1|Pre Treatment for Part B|Withdrawal by Subject|1
2839889|NCT02539225|9744114|P2|Pre Treatment for Part B|Adverse Event|1
2839890|NCT02539225|9744115|P1|Pre Treatment for Part B|Adverse Event|1
2839891|NCT02539225|9744114|P2|Pre Treatment for Part B|Progressive disease|1
2839892|NCT02539225|9744115|P1|Pre Treatment for Part B|Progressive disease|1
2839893|NCT02539225|9744114|P2|Part A|Did Not Receive study Drug|1
2839894|NCT02539225|9744115|P1|Part A|Did Not Receive study Drug|1
2839895|NCT02539225|9744114|P2|Part A|Physician Decision|7
2839896|NCT02539225|9744115|P1|Part A|Physician Decision|4
2839897|NCT02539225|9744114|P2|Part A|Withdrawal by Subject|4
2839898|NCT02539225|9744115|P1|Part A|Withdrawal by Subject|2
2839899|NCT02539225|9744114|P2|Part A|Adverse Event|4
2839900|NCT02539225|9744115|P1|Part A|Adverse Event|13
2839901|NCT02539134|9744142|P6|Overall Study|Lost to Follow-up|0
2839902|NCT02539134|9744143|P5|Overall Study|Lost to Follow-up|0
2839903|NCT02539134|9744144|P4|Overall Study|Lost to Follow-up|0
2839904|NCT02539134|9744145|P3|Overall Study|Lost to Follow-up|0
2839905|NCT02539134|9744146|P2|Overall Study|Lost to Follow-up|0
2839906|NCT02539134|9744147|P1|Overall Study|Lost to Follow-up|1
2839907|NCT02538965|9744216|P1|Follow-Up Period|Withdrawal by Parent|4
2839908|NCT02538965|9744216|P1|Follow-Up Period|Other = Death due to disease progression|13
2839909|NCT02538965|9744216|P1|Treatment Period|Physician Decision|2
2839910|NCT02538965|9744216|P1|Treatment Period|Disease Progression|1
2839911|NCT02538965|9744216|P1|Treatment Period|Treatment Failure|9
2839912|NCT02538965|9744216|P1|Treatment Period|Withdrawal by Parent/Guardian|2
2839913|NCT02538965|9744216|P1|Treatment Period|Adverse Event|2
2839914|NCT02538965|9744216|P1|Treatment Period|Other = Death due to disease progression|1
2839915|NCT02538666|9744262|P3|Overall Study|Withdrew Consent|1
2839916|NCT02538666|9744263|P2|Overall Study|Withdrew Consent|1
2839917|NCT02538666|9744264|P1|Overall Study|Withdrew Consent|0
2839918|NCT02538666|9744262|P3|Overall Study|no longer meets study criteria|0
2839919|NCT02538666|9744263|P2|Overall Study|no longer meets study criteria|0
2839920|NCT02538666|9744264|P1|Overall Study|no longer meets study criteria|1
2839921|NCT02538666|9744262|P3|Overall Study|Disease progression|0
2839922|NCT02538666|9744263|P2|Overall Study|Disease progression|0
2839923|NCT02538666|9744264|P1|Overall Study|Disease progression|1
2839924|NCT02538471|9744294|P1|Overall Study|Progression of disease|2
2839925|NCT02538107|9744330|P1|Overall Study|Not recorded|7
2839926|NCT02538107|9744330|P1|Overall Study|Other|7
2839927|NCT02538107|9744330|P1|Overall Study|Surgery|1
2839928|NCT02538107|9744330|P1|Overall Study|Adverse Event|4
2839929|NCT02538107|9744330|P1|Overall Study|Administrative reason|5
2839930|NCT02538107|9744330|P1|Overall Study|Death|4
2839931|NCT02538107|9744330|P1|Overall Study|Withdrawal by Subject|17
2839932|NCT02538107|9744330|P1|Overall Study|No further treatment necessary|18
2839933|NCT02538107|9744330|P1|Overall Study|Administration of other ESA|11
2839934|NCT02538107|9744330|P1|Overall Study|Necessity of dialysis|20
2839935|NCT02538107|9744330|P1|Overall Study|Missing|5
2839936|NCT02538107|9744330|P1|Overall Study|Did not receive any Mircera dose|11
2839937|NCT02538094|9744350|P2|Washout (4 Weeks)|Withdrawal by Subject|1
2839938|NCT02538094|9744351|P1|Washout (4 Weeks)|Withdrawal by Subject|0
2839939|NCT02538094|9744350|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
2839940|NCT02538094|9744351|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
2839941|NCT02538029|9744381|P3|Overall Study|unable to complete cognitive assessments|1
2839942|NCT02538029|9744382|P2|Overall Study|unable to complete cognitive assessments|0
2839943|NCT02538029|9744383|P1|Overall Study|unable to complete cognitive assessments|1
2839944|NCT02537574|9744450|P3|Overall Study|Noncompliance with Protocol|1
2839945|NCT02537574|9744451|P2|Overall Study|Noncompliance with Protocol|0
2839946|NCT02537574|9744452|P1|Overall Study|Noncompliance with Protocol|0
2839947|NCT02537574|9744450|P3|Overall Study|Subject did not want last Vivitrol Injec|1
2839948|NCT02537574|9744451|P2|Overall Study|Subject did not want last Vivitrol Injec|0
2839949|NCT02537574|9744452|P1|Overall Study|Subject did not want last Vivitrol Injec|0
2839950|NCT02537574|9744450|P3|Overall Study|Transportation Issues|1
2839951|NCT02537574|9744451|P2|Overall Study|Transportation Issues|0
2839952|NCT02537574|9744452|P1|Overall Study|Transportation Issues|0
2839953|NCT02537574|9744450|P3|Overall Study|Failed Naloxone Challenge|0
2839954|NCT02537574|9744451|P2|Overall Study|Failed Naloxone Challenge|1
2839955|NCT02537574|9744452|P1|Overall Study|Failed Naloxone Challenge|0
2839956|NCT02537574|9744450|P3|Overall Study|Incarceration|0
2839957|NCT02537574|9744451|P2|Overall Study|Incarceration|1
2839958|NCT02537574|9744452|P1|Overall Study|Incarceration|0
2839959|NCT02537574|9744450|P3|Overall Study|Patient not Stable|0
2839960|NCT02537574|9744451|P2|Overall Study|Patient not Stable|1
2839961|NCT02537574|9744452|P1|Overall Study|Patient not Stable|0
2839962|NCT02537574|9744450|P3|Overall Study|Duplicate Patient|0
2839963|NCT02537574|9744451|P2|Overall Study|Duplicate Patient|0
2839964|NCT02537574|9744452|P1|Overall Study|Duplicate Patient|1
2839965|NCT02537574|9744450|P3|Overall Study|Lack of Efficacy|15
2839966|NCT02537574|9744451|P2|Overall Study|Lack of Efficacy|16
2839967|NCT02537574|9744452|P1|Overall Study|Lack of Efficacy|14
2839968|NCT02537574|9744450|P3|Overall Study|Withdrawal by Subject|29
2839969|NCT02537574|9744451|P2|Overall Study|Withdrawal by Subject|27
2839970|NCT02537574|9744452|P1|Overall Study|Withdrawal by Subject|37
2839971|NCT02537574|9744450|P3|Overall Study|Protocol Violation|3
2839972|NCT02537574|9744451|P2|Overall Study|Protocol Violation|2
2839973|NCT02537574|9744452|P1|Overall Study|Protocol Violation|4
2839974|NCT02537574|9744450|P3|Overall Study|Physician Decision|0
2839975|NCT02537574|9744451|P2|Overall Study|Physician Decision|0
2839976|NCT02537574|9744452|P1|Overall Study|Physician Decision|2
2839977|NCT02537574|9744450|P3|Overall Study|Noncompliance with study drug|1
2839978|NCT02537574|9744451|P2|Overall Study|Noncompliance with study drug|1
2839979|NCT02537574|9744452|P1|Overall Study|Noncompliance with study drug|0
2839980|NCT02537574|9744450|P3|Overall Study|Lost to Follow-up|55
2839981|NCT02537574|9744451|P2|Overall Study|Lost to Follow-up|51
2839982|NCT02537574|9744452|P1|Overall Study|Lost to Follow-up|40
2839983|NCT02537574|9744450|P3|Overall Study|Adverse Event|2
2839984|NCT02537574|9744451|P2|Overall Study|Adverse Event|3
2839985|NCT02537574|9744452|P1|Overall Study|Adverse Event|1
2839986|NCT02537522|9744478|P4|Phase II - Period 1 Bilateral|Adverse Event|1
2839987|NCT02537522|9744479|P3|Phase II - Period 1 Bilateral|Adverse Event|0
2839988|NCT02537522|9744480|P2|Phase II - Period 1 Bilateral|Adverse Event|0
2839989|NCT02537522|9744481|P1|Phase II - Period 1 Bilateral|Adverse Event|0
2839990|NCT02537522|9744478|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
2839991|NCT02537522|9744479|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
2839992|NCT02537522|9744480|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
2839993|NCT02537522|9744481|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
2839994|NCT02537522|9744478|P4|Phase I - Contralateral|incorrect randomization|0
2839995|NCT02537522|9744479|P3|Phase I - Contralateral|incorrect randomization|0
2839996|NCT02537522|9744480|P2|Phase I - Contralateral|incorrect randomization|1
2839997|NCT02537522|9744481|P1|Phase I - Contralateral|incorrect randomization|0
2839998|NCT02537522|9744478|P4|Phase I - Contralateral|Withdrawal by Subject|0
2839999|NCT02537522|9744479|P3|Phase I - Contralateral|Withdrawal by Subject|0
2840000|NCT02537522|9744480|P2|Phase I - Contralateral|Withdrawal by Subject|1
2840001|NCT02537522|9744481|P1|Phase I - Contralateral|Withdrawal by Subject|0
2840002|NCT02537522|9744478|P4|Phase I - Contralateral|Subject no longer eligible|0
2840003|NCT02537522|9744479|P3|Phase I - Contralateral|Subject no longer eligible|0
2840004|NCT02537522|9744480|P2|Phase I - Contralateral|Subject no longer eligible|7
2840005|NCT02537522|9744481|P1|Phase I - Contralateral|Subject no longer eligible|15
2840006|NCT02537431|9744498|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
2840007|NCT02537015|9744527|P1|Overall Study|Other Miscellaneous Reasons|1
2840008|NCT02537015|9744527|P1|Overall Study|Withdrawal by Subject|2
2840009|NCT02537015|9744527|P1|Overall Study|Adverse Event|3
2840010|NCT02536976|9744533|P2|Overall Study|Physician Decision|1
2840011|NCT02536976|9744534|P1|Overall Study|Physician Decision|0
2840012|NCT02536781|9744546|P2|Overall Study|Lost to Follow-up|0
2840013|NCT02536781|9744547|P1|Overall Study|Lost to Follow-up|2
2840014|NCT02536664|9744557|P2|Overall Study|Missing|20
2840015|NCT02536664|9744558|P1|Overall Study|Missing|53
2840016|NCT02536664|9744557|P2|Overall Study|Other|24
2840017|NCT02536664|9744558|P1|Overall Study|Other|18
2840018|NCT02536664|9744557|P2|Overall Study|Withdrawal by Subject|5
2840019|NCT02536664|9744558|P1|Overall Study|Withdrawal by Subject|8
2840020|NCT02536664|9744557|P2|Overall Study|Intolerability|6
2840021|NCT02536664|9744558|P1|Overall Study|Intolerability|8
2840022|NCT02536664|9744557|P2|Overall Study|Death due to other reason|2
2840023|NCT02536664|9744558|P1|Overall Study|Death due to other reason|3
2840024|NCT02536664|9744557|P2|Overall Study|Death due to lymphoma|1
2840025|NCT02536664|9744558|P1|Overall Study|Death due to lymphoma|2
2840026|NCT02536664|9744557|P2|Overall Study|Progression|18
2840027|NCT02536664|9744558|P1|Overall Study|Progression|13
2840028|NCT02536664|9744557|P2|Overall Study|Inadequate completion of documentation|4
2840029|NCT02536664|9744558|P1|Overall Study|Inadequate completion of documentation|2
2840030|NCT02536339|9744576|P1|Overall Study|Death|20
2840031|NCT02536339|9744576|P1|Overall Study|Withdrawal by Subject|3
2840032|NCT02536339|9744576|P1|Overall Study|Lost to Follow-up|2
2840033|NCT02536339|9744576|P1|Overall Study|Treatment Ongoing|2
2840034|NCT02536339|9744576|P1|Overall Study|In Survival Follow-Up|4
2840035|NCT02536313|9744602|P2|Overall Study|Lack of Efficacy|1
2840036|NCT02536313|9744603|P1|Overall Study|Lack of Efficacy|0
2840037|NCT02535741|9744672|P1|Overall Study|Missing data|6
2840038|NCT02535741|9744672|P1|Overall Study|Exclusion criteria: Bilateral implant|4
2840039|NCT02535741|9744672|P1|Overall Study|Lost to Follow-up|10
2840040|NCT02535741|9744672|P1|Overall Study|Withdrawal by Subject|9
2840041|NCT02535741|9744672|P1|Overall Study|Adverse Event|3
2840042|NCT02535715|9744680|P3|Overall Study|Withdrawal by Subject|1
2840043|NCT02535715|9744681|P2|Overall Study|Withdrawal by Subject|0
2840044|NCT02535715|9744682|P1|Overall Study|Withdrawal by Subject|0
2840045|NCT02535416|9744711|P9|Overall Study|Family bereavement overseas|0
2840046|NCT02535416|9744712|P8|Overall Study|Family bereavement overseas|0
2840047|NCT02535416|9744713|P7|Overall Study|Family bereavement overseas|0
2840048|NCT02535416|9744714|P6|Overall Study|Family bereavement overseas|0
2840049|NCT02535416|9744715|P5|Overall Study|Family bereavement overseas|0
2840050|NCT02535416|9744716|P4|Overall Study|Family bereavement overseas|0
2840051|NCT02535416|9744717|P3|Overall Study|Family bereavement overseas|0
2840052|NCT02535416|9744718|P2|Overall Study|Family bereavement overseas|0
2840053|NCT02535416|9744719|P1|Overall Study|Family bereavement overseas|1
2840054|NCT02535364|9744771|P1|12-Month Follow-up Period|Subject transferred to hospice|1
2840055|NCT02535364|9744771|P1|12-Month Follow-up Period|Subject received alternative therapy|2
2840056|NCT02535364|9744771|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
2840057|NCT02535364|9744771|P1|12-Month Follow-up Period|Death|5
2840058|NCT02535364|9744771|P1|12-Month Follow-up Period|Disease progression|22
2840059|NCT02535364|9744771|P1|Study Treatment|Study placed on clinical hold by FDA|1
2840060|NCT02535364|9744771|P1|Study Treatment|Death|1
2840061|NCT02535364|9744771|P1|Part B Screening|Change in diagnosis, no longer eligible|2
2840062|NCT02535364|9744771|P1|Part B Screening|Adverse Event|1
2840063|NCT02535364|9744771|P1|Part B Screening|Withdrawal by Subject|1
2840064|NCT02535364|9744771|P1|Part B Screening|Physician Decision|1
2840065|NCT02535364|9744771|P1|Part B Screening|Death|2
2840066|NCT02535364|9744771|P1|Part B Screening|Unable to manufacture JCAR015|3
2840067|NCT02535364|9744771|P1|Part B Screening|Study placed on clinical hold by FDA|7
2840068|NCT02535364|9744771|P1|Part A Screening Through Leukapheresis|Disease progression|1
2840069|NCT02535364|9744771|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
2840070|NCT02535364|9744771|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
2840071|NCT02534935|9744856|P3|Overall Study|Lost to Follow-up|1
2840072|NCT02534935|9744857|P2|Overall Study|Lost to Follow-up|1
2840073|NCT02534935|9744858|P1|Overall Study|Lost to Follow-up|0
2840074|NCT02534935|9744856|P3|Overall Study|Adverse Event|0
2840075|NCT02534935|9744857|P2|Overall Study|Adverse Event|2
2840076|NCT02534935|9744858|P1|Overall Study|Adverse Event|0
2840077|NCT02534935|9744856|P3|Overall Study|No longer meets the eligibility criteria|0
2840078|NCT02534935|9744857|P2|Overall Study|No longer meets the eligibility criteria|3
2840079|NCT02534935|9744858|P1|Overall Study|No longer meets the eligibility criteria|0
2840080|NCT02534935|9744856|P3|Overall Study|Withdrawal by Subject|3
2840081|NCT02534935|9744857|P2|Overall Study|Withdrawal by Subject|3
2840082|NCT02534935|9744858|P1|Overall Study|Withdrawal by Subject|0
2840083|NCT02534935|9744856|P3|Overall Study|No longer willing to participate|1
2840084|NCT02534935|9744857|P2|Overall Study|No longer willing to participate|1
2840085|NCT02534935|9744858|P1|Overall Study|No longer willing to participate|0
2840086|NCT02534896|9745019|P3|Overall Study|Insufficient therapeutic response|0
2840087|NCT02534896|9745020|P2|Overall Study|Insufficient therapeutic response|0
2840088|NCT02534896|9745021|P1|Overall Study|Insufficient therapeutic response|2
2840089|NCT02534896|9745019|P3|Overall Study|Adverse Event|1
2840090|NCT02534896|9745020|P2|Overall Study|Adverse Event|1
2840091|NCT02534896|9745021|P1|Overall Study|Adverse Event|2
2840092|NCT02534883|9745040|P2|Overall Study|Early Termination|3
2840093|NCT02534883|9745041|P1|Overall Study|Early Termination|8
2840094|NCT02534493|9745057|P1|Overall Study|Withdrawal by Subject|1
2840095|NCT02534493|9745057|P1|Overall Study|Lost to Follow-up|1
2840096|NCT02534350|9745068|P2|Overall Study|Withdrew Consent|0
2840097|NCT02534350|9745069|P1|Overall Study|Withdrew Consent|2
2840098|NCT02534350|9745068|P2|Overall Study|Protocol Violation|0
2840099|NCT02534350|9745069|P1|Overall Study|Protocol Violation|1
2840100|NCT02534350|9745068|P2|Overall Study|Randomized But Not Treated|0
2840101|NCT02534350|9745069|P1|Overall Study|Randomized But Not Treated|1
2840102|NCT02534324|9745083|P2|Overall Study|Adverse Event|0
2840103|NCT02534324|9745084|P1|Overall Study|Adverse Event|1
2840104|NCT02534324|9745083|P2|Overall Study|Lost to Follow-up|7
2840105|NCT02534324|9745084|P1|Overall Study|Lost to Follow-up|20
2840106|NCT02534324|9745083|P2|Overall Study|Protocol Violation|1
2840107|NCT02534324|9745084|P1|Overall Study|Protocol Violation|4
2840108|NCT02533999|9745103|P2|Overall Study|Randomized but intervention not received|1
2840109|NCT02533999|9745104|P1|Overall Study|Randomized but intervention not received|0
2840110|NCT02533999|9745103|P2|Overall Study|Adverse Event|1
2840111|NCT02533999|9745104|P1|Overall Study|Adverse Event|0
2840112|NCT02533999|9745103|P2|Overall Study|Protocol Violation|0
2840113|NCT02533999|9745104|P1|Overall Study|Protocol Violation|3
2840114|NCT02533999|9745103|P2|Overall Study|Lost to Follow-up|5
2840115|NCT02533999|9745104|P1|Overall Study|Lost to Follow-up|3
2840116|NCT02533570|9745155|P3|Overall Study|Adverse Event|1
2840117|NCT02533570|9745156|P2|Overall Study|Adverse Event|1
2840118|NCT02533570|9745157|P1|Overall Study|Adverse Event|0
2840119|NCT02533531|9745168|P1|Overall Study|Device did not turn on|1
2840120|NCT02533453|9745231|P1|Overall Study|Withdrawal by Subject|2
2840121|NCT02533453|9745231|P1|Overall Study|Protocol Violation|1
2840122|NCT02533453|9745231|P1|Overall Study|Adverse Event|6
2840123|NCT02533401|9745240|P1|Overall Study|Violation of Selection Criteria|1
2840124|NCT02533401|9745240|P1|Overall Study|Lost to Follow-up|1
2840125|NCT02533401|9745240|P1|Overall Study|Insufficient Response/Progressed Disease|1
2840126|NCT02533401|9745240|P1|Overall Study|Death|5
2840127|NCT02533401|9745240|P1|Overall Study|Adverse Event/Intercurrent Disease|3
2840128|NCT02533375|9745248|P1|Overall Study|Adverse Event|2
2840129|NCT02533375|9745248|P1|Overall Study|Lack of Efficacy|3
2840130|NCT02533258|9745280|P1|Overall Study|Lack of Efficacy|2
2840131|NCT02533258|9745280|P1|Overall Study|Progression of pleural effusion|1
2840132|NCT02533258|9745280|P1|Overall Study|Economic factor|1
2840133|NCT02533258|9745280|P1|Overall Study|Other|1
2840134|NCT02533258|9745280|P1|Overall Study|Death|2
2840135|NCT02533258|9745280|P1|Overall Study|Adverse Event|1
2840136|NCT02532972|9745421|P1|Overall Study|Withdrawal by Subject|1
2840137|NCT02532855|9745438|P2|Overall Study|Withdrawal by Subject|8
2840138|NCT02532855|9745439|P1|Overall Study|Withdrawal by Subject|4
2840139|NCT02532855|9745438|P2|Overall Study|Lost to Follow-up|3
2840140|NCT02532855|9745439|P1|Overall Study|Lost to Follow-up|4
2840141|NCT02532764|9745473|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2840142|NCT02532764|9745474|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2840143|NCT02532764|9745475|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2840144|NCT02532764|9745476|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840145|NCT02532764|9745477|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840146|NCT02532764|9745478|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840147|NCT02532764|9745479|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840148|NCT02532764|9745480|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840149|NCT02532764|9745481|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840150|NCT02532764|9745482|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2840151|NCT02532647|9745633|P3|Overall Study|Did not receive trial medication|1
2840152|NCT02532647|9745634|P2|Overall Study|Did not receive trial medication|0
2840153|NCT02532647|9745635|P1|Overall Study|Did not receive trial medication|1
2840154|NCT02532543|9745653|P4|Overall Study|Lost to Follow-up|0
2840155|NCT02532543|9745654|P3|Overall Study|Lost to Follow-up|1
2840156|NCT02532543|9745655|P2|Overall Study|Lost to Follow-up|0
2840157|NCT02532543|9745656|P1|Overall Study|Lost to Follow-up|0
2840158|NCT02532465|9745692|P2|Overall Study|Lack of Efficacy|1
2840159|NCT02532465|9745693|P1|Overall Study|Lack of Efficacy|0
2840160|NCT02532465|9745692|P2|Overall Study|Protocol Violation|0
2840161|NCT02532465|9745693|P1|Overall Study|Protocol Violation|1
2840162|NCT02532374|9745703|P1|Overall Study|Physician Decision|1
2840163|NCT02532374|9745703|P1|Overall Study|Withdrawal by Subject|1
2840164|NCT02532283|9745729|P2|Overall Study|Withdrawal by Subject|3
2840165|NCT02532283|9745730|P1|Overall Study|Withdrawal by Subject|8
2840166|NCT02532283|9745729|P2|Overall Study|Lost to Follow-up|1
2840167|NCT02532283|9745730|P1|Overall Study|Lost to Follow-up|0
2840168|NCT02532283|9745729|P2|Overall Study|Death|0
2840169|NCT02532283|9745730|P1|Overall Study|Death|1
2840170|NCT02532283|9745729|P2|Overall Study|Adverse Event|1
2840171|NCT02532283|9745730|P1|Overall Study|Adverse Event|0
2840172|NCT02532179|9745772|P1|Overall Study|Subject received depot steroid injection|1
2840173|NCT02532179|9745772|P1|Overall Study|Pregnancy|1
2840174|NCT02532179|9745772|P1|Overall Study|Lost to Follow-up|1
2840175|NCT02531802|9745837|P21|Received Vaccination 2|Withdrawal by Subject|0
2840176|NCT02531802|9745838|P20|Received Vaccination 2|Withdrawal by Subject|1
2840177|NCT02531802|9745839|P19|Received Vaccination 2|Withdrawal by Subject|1
2840178|NCT02531802|9745840|P18|Received Vaccination 2|Withdrawal by Subject|1
2840179|NCT02531802|9745841|P17|Received Vaccination 2|Withdrawal by Subject|0
2840180|NCT02531802|9745842|P16|Received Vaccination 2|Withdrawal by Subject|0
2840181|NCT02531802|9745843|P15|Received Vaccination 2|Withdrawal by Subject|1
2840182|NCT02531802|9745844|P14|Received Vaccination 2|Withdrawal by Subject|1
2840183|NCT02531802|9745845|P13|Received Vaccination 2|Withdrawal by Subject|1
2840184|NCT02531802|9745846|P12|Received Vaccination 2|Withdrawal by Subject|0
2840185|NCT02531802|9745847|P11|Received Vaccination 2|Withdrawal by Subject|1
2840186|NCT02531802|9745848|P10|Received Vaccination 2|Withdrawal by Subject|0
2840187|NCT02531802|9745849|P9|Received Vaccination 2|Withdrawal by Subject|0
2840188|NCT02531802|9745850|P8|Received Vaccination 2|Withdrawal by Subject|0
2840189|NCT02531802|9745851|P7|Received Vaccination 2|Withdrawal by Subject|0
2840190|NCT02531802|9745852|P6|Received Vaccination 2|Withdrawal by Subject|0
2840191|NCT02531802|9745853|P5|Received Vaccination 2|Withdrawal by Subject|0
2840192|NCT02531802|9745854|P4|Received Vaccination 2|Withdrawal by Subject|0
2840193|NCT02531802|9745855|P3|Received Vaccination 2|Withdrawal by Subject|0
2840194|NCT02531802|9745856|P2|Received Vaccination 2|Withdrawal by Subject|0
2840195|NCT02531802|9745857|P1|Received Vaccination 2|Withdrawal by Subject|0
2840196|NCT02531802|9745837|P21|Received Vaccination 2|Adverse Event|1
2840197|NCT02531802|9745838|P20|Received Vaccination 2|Adverse Event|0
2840198|NCT02531802|9745839|P19|Received Vaccination 2|Adverse Event|1
2840199|NCT02531802|9745840|P18|Received Vaccination 2|Adverse Event|2
2840200|NCT02531802|9745841|P17|Received Vaccination 2|Adverse Event|0
2840201|NCT02531802|9745842|P16|Received Vaccination 2|Adverse Event|0
2840202|NCT02531802|9745843|P15|Received Vaccination 2|Adverse Event|0
2840203|NCT02531802|9745844|P14|Received Vaccination 2|Adverse Event|0
2840204|NCT02531802|9745845|P13|Received Vaccination 2|Adverse Event|0
2840205|NCT02531802|9745846|P12|Received Vaccination 2|Adverse Event|0
2840206|NCT02531802|9745847|P11|Received Vaccination 2|Adverse Event|0
2840207|NCT02531802|9745848|P10|Received Vaccination 2|Adverse Event|0
2840208|NCT02531802|9745849|P9|Received Vaccination 2|Adverse Event|0
2840209|NCT02531802|9745850|P8|Received Vaccination 2|Adverse Event|0
2840210|NCT02531802|9745851|P7|Received Vaccination 2|Adverse Event|0
2840211|NCT02531802|9745852|P6|Received Vaccination 2|Adverse Event|2
2840212|NCT02531802|9745853|P5|Received Vaccination 2|Adverse Event|0
2840213|NCT02531802|9745854|P4|Received Vaccination 2|Adverse Event|0
2840214|NCT02531802|9745855|P3|Received Vaccination 2|Adverse Event|0
2840215|NCT02531802|9745856|P2|Received Vaccination 2|Adverse Event|0
2840216|NCT02531802|9745857|P1|Received Vaccination 2|Adverse Event|0
2840217|NCT02531802|9745837|P21|Received Vaccination 2|Physician Decision|0
2840218|NCT02531802|9745838|P20|Received Vaccination 2|Physician Decision|0
2840219|NCT02531802|9745839|P19|Received Vaccination 2|Physician Decision|0
2840220|NCT02531802|9745840|P18|Received Vaccination 2|Physician Decision|1
2840221|NCT02531802|9745841|P17|Received Vaccination 2|Physician Decision|0
2840222|NCT02531802|9745842|P16|Received Vaccination 2|Physician Decision|0
2840223|NCT02531802|9745843|P15|Received Vaccination 2|Physician Decision|0
2840224|NCT02531802|9745844|P14|Received Vaccination 2|Physician Decision|1
2840225|NCT02531802|9745845|P13|Received Vaccination 2|Physician Decision|0
2840226|NCT02531802|9745846|P12|Received Vaccination 2|Physician Decision|0
2840227|NCT02531802|9745847|P11|Received Vaccination 2|Physician Decision|0
2840228|NCT02531802|9745848|P10|Received Vaccination 2|Physician Decision|2
2840229|NCT02531802|9745849|P9|Received Vaccination 2|Physician Decision|0
2840230|NCT02531802|9745850|P8|Received Vaccination 2|Physician Decision|0
2840231|NCT02531802|9745851|P7|Received Vaccination 2|Physician Decision|0
2840232|NCT02531802|9745852|P6|Received Vaccination 2|Physician Decision|1
2840233|NCT02531802|9745853|P5|Received Vaccination 2|Physician Decision|0
2840234|NCT02531802|9745854|P4|Received Vaccination 2|Physician Decision|0
2840235|NCT02531802|9745855|P3|Received Vaccination 2|Physician Decision|0
2840236|NCT02531802|9745856|P2|Received Vaccination 2|Physician Decision|0
2840237|NCT02531802|9745857|P1|Received Vaccination 2|Physician Decision|0
2840238|NCT02531802|9745837|P21|Received Vaccination 2|Medication interfering with study taken|0
2840239|NCT02531802|9745838|P20|Received Vaccination 2|Medication interfering with study taken|0
2840240|NCT02531802|9745839|P19|Received Vaccination 2|Medication interfering with study taken|1
2840241|NCT02531802|9745840|P18|Received Vaccination 2|Medication interfering with study taken|0
2840242|NCT02531802|9745841|P17|Received Vaccination 2|Medication interfering with study taken|0
2840243|NCT02531802|9745842|P16|Received Vaccination 2|Medication interfering with study taken|0
2840244|NCT02531802|9745843|P15|Received Vaccination 2|Medication interfering with study taken|0
2840245|NCT02531802|9745844|P14|Received Vaccination 2|Medication interfering with study taken|0
2840246|NCT02531802|9745845|P13|Received Vaccination 2|Medication interfering with study taken|1
2840247|NCT02531802|9745846|P12|Received Vaccination 2|Medication interfering with study taken|0
2840248|NCT02531802|9745847|P11|Received Vaccination 2|Medication interfering with study taken|1
2840249|NCT02531802|9745848|P10|Received Vaccination 2|Medication interfering with study taken|1
2840250|NCT02531802|9745849|P9|Received Vaccination 2|Medication interfering with study taken|0
2840251|NCT02531802|9745850|P8|Received Vaccination 2|Medication interfering with study taken|0
2840252|NCT02531802|9745851|P7|Received Vaccination 2|Medication interfering with study taken|0
2840253|NCT02531802|9745852|P6|Received Vaccination 2|Medication interfering with study taken|0
2840254|NCT02531802|9745853|P5|Received Vaccination 2|Medication interfering with study taken|0
2840255|NCT02531802|9745854|P4|Received Vaccination 2|Medication interfering with study taken|0
2840256|NCT02531802|9745855|P3|Received Vaccination 2|Medication interfering with study taken|1
2840257|NCT02531802|9745856|P2|Received Vaccination 2|Medication interfering with study taken|0
2840258|NCT02531802|9745857|P1|Received Vaccination 2|Medication interfering with study taken|0
2840259|NCT02531698|9746289|P2|Overall Study|Lost to Follow-up|0
2840260|NCT02531698|9746290|P1|Overall Study|Lost to Follow-up|1
2840261|NCT02531698|9746289|P2|Overall Study|Protocol Violation|0
2840262|NCT02531698|9746290|P1|Overall Study|Protocol Violation|2
2840263|NCT02531698|9746289|P2|Overall Study|Withdrawal by Subject|1
2840264|NCT02531698|9746290|P1|Overall Study|Withdrawal by Subject|6
2840265|NCT02531698|9746289|P2|Overall Study|Adverse Event|1
2840266|NCT02531698|9746290|P1|Overall Study|Adverse Event|2
2840267|NCT02531646|9746537|P3|Overall Study|equip. image processing issue|0
2840268|NCT02531646|9746538|P2|Overall Study|equip. image processing issue|1
2840269|NCT02531646|9746539|P1|Overall Study|equip. image processing issue|5
2840270|NCT02531633|9746558|P10|Part B (104 Weeks)|Lost to Follow-up|0
2840271|NCT02531633|9746559|P9|Part B (104 Weeks)|Lost to Follow-up|0
2840272|NCT02531633|9746560|P8|Part B (104 Weeks)|Lost to Follow-up|1
2840273|NCT02531633|9746561|P7|Part B (104 Weeks)|Lost to Follow-up|0
2840274|NCT02531633|9746562|P6|Part B (104 Weeks)|Lost to Follow-up|0
2840275|NCT02531633|9746563|P5|Part B (104 Weeks)|Lost to Follow-up|0
2840276|NCT02531633|9746564|P4|Part B (104 Weeks)|Lost to Follow-up|0
2840277|NCT02531633|9746565|P3|Part B (104 Weeks)|Lost to Follow-up|0
2840278|NCT02531633|9746566|P2|Part B (104 Weeks)|Lost to Follow-up|0
2840279|NCT02531633|9746567|P1|Part B (104 Weeks)|Lost to Follow-up|0
2840280|NCT02531633|9746558|P10|Part B (104 Weeks)|Sponsor request|4
2840281|NCT02531633|9746559|P9|Part B (104 Weeks)|Sponsor request|5
2840282|NCT02531633|9746560|P8|Part B (104 Weeks)|Sponsor request|3
2840283|NCT02531633|9746561|P7|Part B (104 Weeks)|Sponsor request|5
2840284|NCT02531633|9746562|P6|Part B (104 Weeks)|Sponsor request|8
2840285|NCT02531633|9746563|P5|Part B (104 Weeks)|Sponsor request|0
2840286|NCT02531633|9746564|P4|Part B (104 Weeks)|Sponsor request|0
2840287|NCT02531633|9746565|P3|Part B (104 Weeks)|Sponsor request|0
2840288|NCT02531633|9746566|P2|Part B (104 Weeks)|Sponsor request|0
2840289|NCT02531633|9746567|P1|Part B (104 Weeks)|Sponsor request|0
2840290|NCT02531633|9746558|P10|Part A (52 Weeks)|Other|0
2840291|NCT02531633|9746559|P9|Part A (52 Weeks)|Other|0
2840292|NCT02531633|9746560|P8|Part A (52 Weeks)|Other|0
2840293|NCT02531633|9746561|P7|Part A (52 Weeks)|Other|0
2840294|NCT02531633|9746562|P6|Part A (52 Weeks)|Other|0
2840295|NCT02531633|9746563|P5|Part A (52 Weeks)|Other|0
2840296|NCT02531633|9746564|P4|Part A (52 Weeks)|Other|0
2840297|NCT02531633|9746565|P3|Part A (52 Weeks)|Other|0
2840298|NCT02531633|9746566|P2|Part A (52 Weeks)|Other|0
2840299|NCT02531633|9746567|P1|Part A (52 Weeks)|Other|2
2840300|NCT02531633|9746558|P10|Part A (52 Weeks)|Withdrawal by Subject|0
2840301|NCT02531633|9746559|P9|Part A (52 Weeks)|Withdrawal by Subject|0
2840302|NCT02531633|9746560|P8|Part A (52 Weeks)|Withdrawal by Subject|0
2840303|NCT02531633|9746561|P7|Part A (52 Weeks)|Withdrawal by Subject|0
2840304|NCT02531633|9746562|P6|Part A (52 Weeks)|Withdrawal by Subject|0
2840305|NCT02531633|9746563|P5|Part A (52 Weeks)|Withdrawal by Subject|3
2840306|NCT02531633|9746564|P4|Part A (52 Weeks)|Withdrawal by Subject|3
2840307|NCT02531633|9746565|P3|Part A (52 Weeks)|Withdrawal by Subject|1
2840308|NCT02531633|9746566|P2|Part A (52 Weeks)|Withdrawal by Subject|6
2840309|NCT02531633|9746567|P1|Part A (52 Weeks)|Withdrawal by Subject|6
2840310|NCT02531633|9746558|P10|Part A (52 Weeks)|Physician Decision|0
2840311|NCT02531633|9746559|P9|Part A (52 Weeks)|Physician Decision|0
2840312|NCT02531633|9746560|P8|Part A (52 Weeks)|Physician Decision|0
2840313|NCT02531633|9746561|P7|Part A (52 Weeks)|Physician Decision|0
2840314|NCT02531633|9746562|P6|Part A (52 Weeks)|Physician Decision|0
2840315|NCT02531633|9746563|P5|Part A (52 Weeks)|Physician Decision|0
2840316|NCT02531633|9746564|P4|Part A (52 Weeks)|Physician Decision|1
2840317|NCT02531633|9746565|P3|Part A (52 Weeks)|Physician Decision|3
2840318|NCT02531633|9746566|P2|Part A (52 Weeks)|Physician Decision|4
2840319|NCT02531633|9746567|P1|Part A (52 Weeks)|Physician Decision|1
2840320|NCT02531633|9746558|P10|Part A (52 Weeks)|Lost to Follow-up|0
2840321|NCT02531633|9746559|P9|Part A (52 Weeks)|Lost to Follow-up|0
2840322|NCT02531633|9746560|P8|Part A (52 Weeks)|Lost to Follow-up|0
2840323|NCT02531633|9746561|P7|Part A (52 Weeks)|Lost to Follow-up|0
2840324|NCT02531633|9746562|P6|Part A (52 Weeks)|Lost to Follow-up|0
2840325|NCT02531633|9746563|P5|Part A (52 Weeks)|Lost to Follow-up|1
2840326|NCT02531633|9746564|P4|Part A (52 Weeks)|Lost to Follow-up|0
2840327|NCT02531633|9746565|P3|Part A (52 Weeks)|Lost to Follow-up|0
2840328|NCT02531633|9746566|P2|Part A (52 Weeks)|Lost to Follow-up|0
2840329|NCT02531633|9746567|P1|Part A (52 Weeks)|Lost to Follow-up|0
2840330|NCT02531633|9746558|P10|Part A (52 Weeks)|Protocol Violation|0
2840331|NCT02531633|9746559|P9|Part A (52 Weeks)|Protocol Violation|0
2840332|NCT02531633|9746560|P8|Part A (52 Weeks)|Protocol Violation|0
2840333|NCT02531633|9746561|P7|Part A (52 Weeks)|Protocol Violation|0
2840334|NCT02531633|9746562|P6|Part A (52 Weeks)|Protocol Violation|0
2840335|NCT02531633|9746563|P5|Part A (52 Weeks)|Protocol Violation|0
2840336|NCT02531633|9746564|P4|Part A (52 Weeks)|Protocol Violation|0
2840337|NCT02531633|9746565|P3|Part A (52 Weeks)|Protocol Violation|0
2840338|NCT02531633|9746566|P2|Part A (52 Weeks)|Protocol Violation|0
2840339|NCT02531633|9746567|P1|Part A (52 Weeks)|Protocol Violation|1
2840340|NCT02531633|9746558|P10|Part A (52 Weeks)|Sponsor request|0
2840341|NCT02531633|9746559|P9|Part A (52 Weeks)|Sponsor request|0
2840342|NCT02531633|9746560|P8|Part A (52 Weeks)|Sponsor request|0
2840343|NCT02531633|9746561|P7|Part A (52 Weeks)|Sponsor request|0
2840344|NCT02531633|9746562|P6|Part A (52 Weeks)|Sponsor request|0
2840345|NCT02531633|9746563|P5|Part A (52 Weeks)|Sponsor request|19
2840346|NCT02531633|9746564|P4|Part A (52 Weeks)|Sponsor request|18
2840347|NCT02531633|9746565|P3|Part A (52 Weeks)|Sponsor request|18
2840348|NCT02531633|9746566|P2|Part A (52 Weeks)|Sponsor request|24
2840349|NCT02531633|9746567|P1|Part A (52 Weeks)|Sponsor request|24
2840350|NCT02531438|9747046|P2|Overall Study|Randomized with Exclusion Criteria|0
2840351|NCT02531438|9747047|P1|Overall Study|Randomized with Exclusion Criteria|1
2840352|NCT02531438|9747046|P2|Overall Study|Missed EOT/PTE Visit|2
2840353|NCT02531438|9747047|P1|Overall Study|Missed EOT/PTE Visit|5
2840354|NCT02531438|9747046|P2|Overall Study|Randomized, but Not Treated|0
2840355|NCT02531438|9747047|P1|Overall Study|Randomized, but Not Treated|4
2840356|NCT02531438|9747046|P2|Overall Study|Death|3
2840357|NCT02531438|9747047|P1|Overall Study|Death|6
2840358|NCT02531438|9747046|P2|Overall Study|Physician Decision|1
2840359|NCT02531438|9747047|P1|Overall Study|Physician Decision|0
2840360|NCT02531438|9747046|P2|Overall Study|Withdrawal by Subject|8
2840361|NCT02531438|9747047|P1|Overall Study|Withdrawal by Subject|7
2840362|NCT02531438|9747046|P2|Overall Study|Lost to Follow-up|3
2840363|NCT02531438|9747047|P1|Overall Study|Lost to Follow-up|0
2840364|NCT02531438|9747046|P2|Overall Study|Adverse Event|9
2840365|NCT02531438|9747047|P1|Overall Study|Adverse Event|7
2840366|NCT02531373|9747066|P9|Overall Study|Withdrawal by Subject|0
2840367|NCT02531373|9747067|P8|Overall Study|Withdrawal by Subject|0
2840368|NCT02531373|9747068|P7|Overall Study|Withdrawal by Subject|0
2840369|NCT02531373|9747069|P6|Overall Study|Withdrawal by Subject|0
2840370|NCT02531373|9747070|P5|Overall Study|Withdrawal by Subject|3
2840371|NCT02531373|9747071|P4|Overall Study|Withdrawal by Subject|0
2840372|NCT02531373|9747072|P3|Overall Study|Withdrawal by Subject|0
2840373|NCT02531373|9747073|P2|Overall Study|Withdrawal by Subject|0
2840374|NCT02531373|9747074|P1|Overall Study|Withdrawal by Subject|0
2840375|NCT02531373|9747066|P9|Overall Study|Withdrawal by Parent/Guardian|3
2840376|NCT02531373|9747067|P8|Overall Study|Withdrawal by Parent/Guardian|1
2840377|NCT02531373|9747068|P7|Overall Study|Withdrawal by Parent/Guardian|4
2840378|NCT02531373|9747069|P6|Overall Study|Withdrawal by Parent/Guardian|3
2840379|NCT02531373|9747070|P5|Overall Study|Withdrawal by Parent/Guardian|0
2840380|NCT02531373|9747071|P4|Overall Study|Withdrawal by Parent/Guardian|0
2840381|NCT02531373|9747072|P3|Overall Study|Withdrawal by Parent/Guardian|0
2840382|NCT02531373|9747073|P2|Overall Study|Withdrawal by Parent/Guardian|0
2840383|NCT02531373|9747074|P1|Overall Study|Withdrawal by Parent/Guardian|0
2840384|NCT02531373|9747066|P9|Overall Study|Protocol Violation|1
2840385|NCT02531373|9747067|P8|Overall Study|Protocol Violation|0
2840386|NCT02531373|9747068|P7|Overall Study|Protocol Violation|1
2840387|NCT02531373|9747069|P6|Overall Study|Protocol Violation|1
2840388|NCT02531373|9747070|P5|Overall Study|Protocol Violation|0
2840389|NCT02531373|9747071|P4|Overall Study|Protocol Violation|0
2840390|NCT02531373|9747072|P3|Overall Study|Protocol Violation|0
2840391|NCT02531373|9747073|P2|Overall Study|Protocol Violation|0
2840392|NCT02531373|9747074|P1|Overall Study|Protocol Violation|0
2840393|NCT02531373|9747066|P9|Overall Study|Physician Decision|0
2840394|NCT02531373|9747067|P8|Overall Study|Physician Decision|0
2840395|NCT02531373|9747068|P7|Overall Study|Physician Decision|0
2840396|NCT02531373|9747069|P6|Overall Study|Physician Decision|1
2840397|NCT02531373|9747070|P5|Overall Study|Physician Decision|2
2840398|NCT02531373|9747071|P4|Overall Study|Physician Decision|0
2840399|NCT02531373|9747072|P3|Overall Study|Physician Decision|0
2840400|NCT02531373|9747073|P2|Overall Study|Physician Decision|0
2840401|NCT02531373|9747074|P1|Overall Study|Physician Decision|0
2840402|NCT02531373|9747066|P9|Overall Study|Lost to Follow-up|0
2840403|NCT02531373|9747067|P8|Overall Study|Lost to Follow-up|0
2840404|NCT02531373|9747068|P7|Overall Study|Lost to Follow-up|2
2840405|NCT02531373|9747069|P6|Overall Study|Lost to Follow-up|2
2840406|NCT02531373|9747070|P5|Overall Study|Lost to Follow-up|0
2840407|NCT02531373|9747071|P4|Overall Study|Lost to Follow-up|0
2840408|NCT02531373|9747072|P3|Overall Study|Lost to Follow-up|0
2840409|NCT02531373|9747073|P2|Overall Study|Lost to Follow-up|0
2840410|NCT02531373|9747074|P1|Overall Study|Lost to Follow-up|0
2840411|NCT02531373|9747066|P9|Overall Study|Lack of Efficacy|5
2840412|NCT02531373|9747067|P8|Overall Study|Lack of Efficacy|8
2840413|NCT02531373|9747068|P7|Overall Study|Lack of Efficacy|4
2840414|NCT02531373|9747069|P6|Overall Study|Lack of Efficacy|2
2840415|NCT02531373|9747070|P5|Overall Study|Lack of Efficacy|3
2840416|NCT02531373|9747071|P4|Overall Study|Lack of Efficacy|0
2840417|NCT02531373|9747072|P3|Overall Study|Lack of Efficacy|0
2840418|NCT02531373|9747073|P2|Overall Study|Lack of Efficacy|0
2840419|NCT02531373|9747074|P1|Overall Study|Lack of Efficacy|0
2840420|NCT02531035|9747148|P2|Overall Study|Randomized, not treated|1
2840421|NCT02531035|9747149|P1|Overall Study|Randomized, not treated|2
2840422|NCT02531035|9747148|P2|Overall Study|Lost to Follow-up|10
2840423|NCT02531035|9747149|P1|Overall Study|Lost to Follow-up|8
2840424|NCT02531035|9747148|P2|Overall Study|Withdrawal by Subject|32
2840425|NCT02531035|9747149|P1|Overall Study|Withdrawal by Subject|42
2840426|NCT02531035|9747148|P2|Overall Study|Other|2
2840427|NCT02531035|9747149|P1|Overall Study|Other|3
2840428|NCT02531035|9747148|P2|Overall Study|Adverse Event|45
2840429|NCT02531035|9747149|P1|Overall Study|Adverse Event|16
2840430|NCT02531035|9747148|P2|Overall Study|Physician Decision|0
2840431|NCT02531035|9747149|P1|Overall Study|Physician Decision|1
2840432|NCT02531035|9747148|P2|Overall Study|Noncompliance with study drug|3
2840433|NCT02531035|9747149|P1|Overall Study|Noncompliance with study drug|8
2840434|NCT02531035|9747148|P2|Overall Study|Protocol Violation|1
2840435|NCT02531035|9747149|P1|Overall Study|Protocol Violation|1
2840436|NCT02531035|9747148|P2|Overall Study|Death|1
2840437|NCT02531035|9747149|P1|Overall Study|Death|0
2840438|NCT02530970|9747174|P1|Overall Study|Relocation|3
2840439|NCT02530970|9747174|P1|Overall Study|Change in Provider|5
2840440|NCT02530970|9747174|P1|Overall Study|Explant|2
2840441|NCT02530970|9747174|P1|Overall Study|Insurance|2
2840442|NCT02530970|9747174|P1|Overall Study|Hospitalization|1
2840443|NCT02530970|9747174|P1|Overall Study|Death|6
2840444|NCT02530970|9747174|P1|Overall Study|Withdrawal by Subject|14
2840445|NCT02530970|9747174|P1|Overall Study|Physician Decision|5
2840446|NCT02530970|9747174|P1|Overall Study|Lost to Follow-up|88
2840447|NCT02530970|9747174|P1|Overall Study|Adverse Event|8
2840448|NCT02530671|9747181|P2|Overall Study|Withdrawal by Subject|0
2840449|NCT02530671|9747182|P1|Overall Study|Withdrawal by Subject|1
2840450|NCT02530671|9747181|P2|Overall Study|Lost to Follow-up|0
2840451|NCT02530671|9747182|P1|Overall Study|Lost to Follow-up|2
2840452|NCT02530385|9747260|P2|Overall Study|Withdrawal by Subject|1
2840453|NCT02530385|9747261|P1|Overall Study|Withdrawal by Subject|0
2840454|NCT02530125|9747324|P1|Followed for Survival for 2 Years|Early termination of study|3
2840455|NCT02530125|9747324|P1|Completed Treatment|Early termination of study|1
2840456|NCT02529995|9747338|P2|Part B|Discontinued Study|5
2840457|NCT02529995|9747339|P1|Part B|Discontinued Study|6
2840458|NCT02529995|9747338|P2|Part B|Ongoing Study at Data Cut-off|7
2840459|NCT02529995|9747339|P1|Part B|Ongoing Study at Data Cut-off|0
2840460|NCT02529995|9747338|P2|Part A|Discontinued Study|0
2840461|NCT02529995|9747339|P1|Part A|Discontinued Study|1
2840462|NCT02529995|9747338|P2|Part A|Ongoing Study at Data Cut-off|16
2840463|NCT02529995|9747339|P1|Part A|Ongoing Study at Data Cut-off|14
2840464|NCT02529553|9747382|P9|Overall Study|Withdrawal by Subject|0
2840465|NCT02529553|9747383|P8|Overall Study|Withdrawal by Subject|1
2840466|NCT02529553|9747384|P7|Overall Study|Withdrawal by Subject|0
2840467|NCT02529553|9747385|P6|Overall Study|Withdrawal by Subject|1
2840468|NCT02529553|9747386|P5|Overall Study|Withdrawal by Subject|0
2840469|NCT02529553|9747387|P4|Overall Study|Withdrawal by Subject|0
2840470|NCT02529553|9747388|P3|Overall Study|Withdrawal by Subject|0
2840471|NCT02529553|9747389|P2|Overall Study|Withdrawal by Subject|0
2840472|NCT02529553|9747390|P1|Overall Study|Withdrawal by Subject|0
2840473|NCT02529553|9747382|P9|Overall Study|Physician Decision|0
2840474|NCT02529553|9747383|P8|Overall Study|Physician Decision|0
2840475|NCT02529553|9747384|P7|Overall Study|Physician Decision|0
2840476|NCT02529553|9747385|P6|Overall Study|Physician Decision|0
2840477|NCT02529553|9747386|P5|Overall Study|Physician Decision|1
2840478|NCT02529553|9747387|P4|Overall Study|Physician Decision|0
2840479|NCT02529553|9747388|P3|Overall Study|Physician Decision|0
2840480|NCT02529553|9747389|P2|Overall Study|Physician Decision|1
2840481|NCT02529553|9747390|P1|Overall Study|Physician Decision|0
2840482|NCT02529553|9747382|P9|Overall Study|Progressive Disease|3
2840483|NCT02529553|9747383|P8|Overall Study|Progressive Disease|5
2840484|NCT02529553|9747384|P7|Overall Study|Progressive Disease|3
2840485|NCT02529553|9747385|P6|Overall Study|Progressive Disease|3
2840486|NCT02529553|9747386|P5|Overall Study|Progressive Disease|2
2840487|NCT02529553|9747387|P4|Overall Study|Progressive Disease|3
2840488|NCT02529553|9747388|P3|Overall Study|Progressive Disease|1
2840489|NCT02529553|9747389|P2|Overall Study|Progressive Disease|0
2840490|NCT02529553|9747390|P1|Overall Study|Progressive Disease|1
2840491|NCT02529488|9747429|P1|Overall Study|Death|3
2840492|NCT02529488|9747429|P1|Overall Study|Adverse Event|1
2840493|NCT02529137|9747437|P1|Overall Study|Discontinuation for different reasons|8
2840494|NCT02528643|9747474|P2|Overall Study|No End of Study Information Available|0
2840495|NCT02528643|9747475|P1|Overall Study|No End of Study Information Available|1
2840496|NCT02528643|9747474|P2|Overall Study|Miscellaneous|1
2840497|NCT02528643|9747475|P1|Overall Study|Miscellaneous|0
2840498|NCT02528643|9747474|P2|Overall Study|Withdrawal by Subject|7
2840499|NCT02528643|9747475|P1|Overall Study|Withdrawal by Subject|0
2840500|NCT02528643|9747474|P2|Overall Study|Lost to Follow-up|1
2840501|NCT02528643|9747475|P1|Overall Study|Lost to Follow-up|0
2840502|NCT02528643|9747474|P2|Overall Study|Death|76
2840503|NCT02528643|9747475|P1|Overall Study|Death|38
2840504|NCT02528331|9747517|P1|Overall Study|Withdrawal by Subject|2
2840505|NCT02528305|9747585|P1|Overall Study|Physician Decision|1
2840506|NCT02528305|9747585|P1|Overall Study|Adverse Event|1
2840507|NCT02528305|9747585|P1|Overall Study|Withdrawal by Subject|1
2840508|NCT02528253|9747632|P5|Overall Study|Withdrawn Due to Pregnancy|1
2840509|NCT02528253|9747633|P4|Overall Study|Withdrawn Due to Pregnancy|0
2840510|NCT02528253|9747634|P3|Overall Study|Withdrawn Due to Pregnancy|0
2840511|NCT02528253|9747635|P2|Overall Study|Withdrawn Due to Pregnancy|1
2840512|NCT02528253|9747636|P1|Overall Study|Withdrawn Due to Pregnancy|0
2840513|NCT02528253|9747632|P5|Overall Study|Protocol Violation|4
2840514|NCT02528253|9747633|P4|Overall Study|Protocol Violation|0
2840515|NCT02528253|9747634|P3|Overall Study|Protocol Violation|4
2840516|NCT02528253|9747635|P2|Overall Study|Protocol Violation|2
2840517|NCT02528253|9747636|P1|Overall Study|Protocol Violation|1
2840518|NCT02528253|9747632|P5|Overall Study|Withdrawal by Subject|73
2840519|NCT02528253|9747633|P4|Overall Study|Withdrawal by Subject|48
2840520|NCT02528253|9747634|P3|Overall Study|Withdrawal by Subject|29
2840521|NCT02528253|9747635|P2|Overall Study|Withdrawal by Subject|20
2840522|NCT02528253|9747636|P1|Overall Study|Withdrawal by Subject|25
2840523|NCT02528253|9747632|P5|Overall Study|Other|76
2840524|NCT02528253|9747633|P4|Overall Study|Other|52
2840525|NCT02528253|9747634|P3|Overall Study|Other|58
2840526|NCT02528253|9747635|P2|Overall Study|Other|22
2840527|NCT02528253|9747636|P1|Overall Study|Other|21
2840528|NCT02528253|9747632|P5|Overall Study|Lost to Follow-up|34
2840529|NCT02528253|9747633|P4|Overall Study|Lost to Follow-up|16
2840530|NCT02528253|9747634|P3|Overall Study|Lost to Follow-up|31
2840531|NCT02528253|9747635|P2|Overall Study|Lost to Follow-up|9
2840532|NCT02528253|9747636|P1|Overall Study|Lost to Follow-up|16
2840533|NCT02528253|9747632|P5|Overall Study|Insufficient clinical response|16
2840534|NCT02528253|9747633|P4|Overall Study|Insufficient clinical response|12
2840535|NCT02528253|9747634|P3|Overall Study|Insufficient clinical response|13
2840536|NCT02528253|9747635|P2|Overall Study|Insufficient clinical response|10
2840537|NCT02528253|9747636|P1|Overall Study|Insufficient clinical response|7
2840538|NCT02528253|9747632|P5|Overall Study|Death|1
2840539|NCT02528253|9747633|P4|Overall Study|Death|0
2840540|NCT02528253|9747634|P3|Overall Study|Death|1
2840541|NCT02528253|9747635|P2|Overall Study|Death|2
2840542|NCT02528253|9747636|P1|Overall Study|Death|2
2840543|NCT02528253|9747632|P5|Overall Study|Adverse Event|18
2840544|NCT02528253|9747633|P4|Overall Study|Adverse Event|8
2840545|NCT02528253|9747634|P3|Overall Study|Adverse Event|4
2840546|NCT02528253|9747635|P2|Overall Study|Adverse Event|4
2840547|NCT02528253|9747636|P1|Overall Study|Adverse Event|3
2840548|NCT02528214|9747929|P2|Overall Study|Other than specified above|1
2840549|NCT02528214|9747930|P1|Overall Study|Other than specified above|0
2840550|NCT02528214|9747929|P2|Overall Study|Adverse Event|1
2840551|NCT02528214|9747930|P1|Overall Study|Adverse Event|0
2840552|NCT02528214|9747929|P2|Overall Study|Protocol Violation|1
2840553|NCT02528214|9747930|P1|Overall Study|Protocol Violation|0
2840554|NCT02528188|9747965|P3|Overall Study|Randomized but not treated|12
2840555|NCT02528188|9747966|P2|Overall Study|Randomized but not treated|7
2840556|NCT02528188|9747967|P1|Overall Study|Randomized but not treated|6
2840557|NCT02528188|9747965|P3|Overall Study|Other|74
2840558|NCT02528188|9747966|P2|Overall Study|Other|91
2840559|NCT02528188|9747967|P1|Overall Study|Other|89
2840560|NCT02528188|9747965|P3|Overall Study|Death|0
2840561|NCT02528188|9747966|P2|Overall Study|Death|4
2840562|NCT02528188|9747967|P1|Overall Study|Death|4
2840563|NCT02528188|9747965|P3|Overall Study|Lost to Follow-up|31
2840564|NCT02528188|9747966|P2|Overall Study|Lost to Follow-up|21
2840565|NCT02528188|9747967|P1|Overall Study|Lost to Follow-up|25
2840566|NCT02528188|9747965|P3|Overall Study|Withdrawal by Subject|100
2840567|NCT02528188|9747966|P2|Overall Study|Withdrawal by Subject|104
2840568|NCT02528188|9747967|P1|Overall Study|Withdrawal by Subject|97
2840569|NCT02528188|9747965|P3|Overall Study|Lack of Efficacy|22
2840570|NCT02528188|9747966|P2|Overall Study|Lack of Efficacy|21
2840571|NCT02528188|9747967|P1|Overall Study|Lack of Efficacy|19
2840572|NCT02528188|9747965|P3|Overall Study|Protocol Violation|4
2840573|NCT02528188|9747966|P2|Overall Study|Protocol Violation|6
2840574|NCT02528188|9747967|P1|Overall Study|Protocol Violation|4
2840575|NCT02528188|9747965|P3|Overall Study|Adverse Event|8
2840576|NCT02528188|9747966|P2|Overall Study|Adverse Event|22
2840577|NCT02528188|9747967|P1|Overall Study|Adverse Event|23
2840578|NCT02527434|9748242|P3|Overall Study|Site closure|0
2840579|NCT02527434|9748243|P2|Overall Study|Site closure|0
2840580|NCT02527434|9748244|P1|Overall Study|Site closure|1
2840581|NCT02527434|9748242|P3|Overall Study|Reason Not Specified|0
2840582|NCT02527434|9748243|P2|Overall Study|Reason Not Specified|0
2840583|NCT02527434|9748244|P1|Overall Study|Reason Not Specified|1
2840584|NCT02527434|9748242|P3|Overall Study|Withdrawal by Subject|3
2840585|NCT02527434|9748243|P2|Overall Study|Withdrawal by Subject|3
2840586|NCT02527434|9748244|P1|Overall Study|Withdrawal by Subject|5
2840587|NCT02527434|9748242|P3|Overall Study|Death|17
2840588|NCT02527434|9748243|P2|Overall Study|Death|6
2840589|NCT02527434|9748244|P1|Overall Study|Death|19
2840590|NCT02527434|9748242|P3|Overall Study|Lost to Follow-up|0
2840591|NCT02527434|9748243|P2|Overall Study|Lost to Follow-up|2
2840592|NCT02527434|9748244|P1|Overall Study|Lost to Follow-up|2
2840593|NCT02527161|9748302|P1|Overall Study|Consent violation|4
2840594|NCT02527161|9748302|P1|Overall Study|MRI contraindication|2
2840595|NCT02527161|9748302|P1|Overall Study|Delay in or unfit for surgery|5
2840596|NCT02527161|9748302|P1|Overall Study|Exclusion RA diagnosis|1
2840597|NCT02527161|9748302|P1|Overall Study|Exclusion for excessive deformity|1
2840598|NCT02527161|9748302|P1|Overall Study|Exclusion for BMI|2
2840599|NCT02527161|9748302|P1|Overall Study|Shape Match not used in surgery|2
2840600|NCT02527161|9748302|P1|Overall Study|Withdrawal by Subject|6
2840601|NCT02527161|9748302|P1|Overall Study|Failed MRI|39
2840602|NCT02527148|9748321|P2|Overall Study|Did not receive study intervention|0
2840603|NCT02527148|9748322|P1|Overall Study|Did not receive study intervention|1
2840604|NCT02526693|9748342|P2|Overall Study|Physician Decision|1
2840605|NCT02526693|9748343|P1|Overall Study|Physician Decision|3
2840606|NCT02526550|9748372|P1|Overall Study|Lost to Follow-up|1
2840607|NCT02526524|9748384|P6|Overall Study|Sponsor Decision|0
2840608|NCT02526524|9748385|P5|Overall Study|Sponsor Decision|0
2840609|NCT02526524|9748386|P4|Overall Study|Sponsor Decision|0
2840610|NCT02526524|9748387|P3|Overall Study|Sponsor Decision|0
2840611|NCT02526524|9748388|P2|Overall Study|Sponsor Decision|0
2840612|NCT02526524|9748389|P1|Overall Study|Sponsor Decision|1
2840613|NCT02526524|9748384|P6|Overall Study|Physician Decision|0
2840614|NCT02526524|9748385|P5|Overall Study|Physician Decision|1
2840615|NCT02526524|9748386|P4|Overall Study|Physician Decision|0
2840616|NCT02526524|9748387|P3|Overall Study|Physician Decision|0
2840617|NCT02526524|9748388|P2|Overall Study|Physician Decision|0
2840618|NCT02526524|9748389|P1|Overall Study|Physician Decision|0
2840619|NCT02526524|9748384|P6|Overall Study|Loss of Glucose Control|0
2840620|NCT02526524|9748385|P5|Overall Study|Loss of Glucose Control|2
2840621|NCT02526524|9748386|P4|Overall Study|Loss of Glucose Control|0
2840622|NCT02526524|9748387|P3|Overall Study|Loss of Glucose Control|3
2840623|NCT02526524|9748388|P2|Overall Study|Loss of Glucose Control|0
2840624|NCT02526524|9748389|P1|Overall Study|Loss of Glucose Control|0
2840625|NCT02526524|9748384|P6|Overall Study|Protocol Violation|3
2840626|NCT02526524|9748385|P5|Overall Study|Protocol Violation|4
2840627|NCT02526524|9748386|P4|Overall Study|Protocol Violation|3
2840628|NCT02526524|9748387|P3|Overall Study|Protocol Violation|5
2840629|NCT02526524|9748388|P2|Overall Study|Protocol Violation|1
2840630|NCT02526524|9748389|P1|Overall Study|Protocol Violation|3
2840631|NCT02526524|9748384|P6|Overall Study|Lost to Follow-up|5
2840632|NCT02526524|9748385|P5|Overall Study|Lost to Follow-up|2
2840633|NCT02526524|9748386|P4|Overall Study|Lost to Follow-up|1
2840634|NCT02526524|9748387|P3|Overall Study|Lost to Follow-up|8
2840635|NCT02526524|9748388|P2|Overall Study|Lost to Follow-up|3
2840636|NCT02526524|9748389|P1|Overall Study|Lost to Follow-up|2
2840637|NCT02526524|9748384|P6|Overall Study|Adverse Event|8
2840638|NCT02526524|9748385|P5|Overall Study|Adverse Event|6
2840639|NCT02526524|9748386|P4|Overall Study|Adverse Event|2
2840640|NCT02526524|9748387|P3|Overall Study|Adverse Event|4
2840641|NCT02526524|9748388|P2|Overall Study|Adverse Event|2
2840642|NCT02526524|9748389|P1|Overall Study|Adverse Event|3
2840643|NCT02526524|9748384|P6|Overall Study|Withdrawal by Subject|5
2840644|NCT02526524|9748385|P5|Overall Study|Withdrawal by Subject|9
2840645|NCT02526524|9748386|P4|Overall Study|Withdrawal by Subject|1
2840646|NCT02526524|9748387|P3|Overall Study|Withdrawal by Subject|6
2840647|NCT02526524|9748388|P2|Overall Study|Withdrawal by Subject|3
2840648|NCT02526524|9748389|P1|Overall Study|Withdrawal by Subject|3
2840649|NCT02526290|9748403|P1|Overall Study|Physician Decision|1
2840650|NCT02526290|9748403|P1|Overall Study|Withdrawal by Subject|4
2840651|NCT02526290|9748403|P1|Overall Study|Adverse Event|3
2840652|NCT02525874|9748435|P1|Overall Study|New lesions in Brain|1
2840653|NCT02525874|9748435|P1|Overall Study|Alternative Treatment for MS|2
2840654|NCT02525874|9748435|P1|Overall Study|Disease relapse|4
2840655|NCT02525874|9748435|P1|Overall Study|Disease progression, defined by protocol|2
2840656|NCT02525874|9748435|P1|Overall Study|Lost to Follow-up|7
2840657|NCT02525874|9748435|P1|Overall Study|Adverse Event|17
2840658|NCT02525874|9748435|P1|Overall Study|Non-compliance with study drug|3
2840659|NCT02525874|9748435|P1|Overall Study|Consent withdrawn|22
2840660|NCT02525874|9748435|P1|Overall Study|Investigator Decision|1
2840661|NCT02525874|9748435|P1|Overall Study|Other|1
2840662|NCT02525744|9748448|P4|Period 5|Physician Decision|0
2840663|NCT02525744|9748449|P3|Period 5|Physician Decision|0
2840664|NCT02525744|9748450|P2|Period 5|Physician Decision|0
2840665|NCT02525744|9748451|P1|Period 5|Physician Decision|1
2840666|NCT02525744|9748448|P4|Period 4|Withdrawal by Subject|0
2840667|NCT02525744|9748449|P3|Period 4|Withdrawal by Subject|0
2840668|NCT02525744|9748450|P2|Period 4|Withdrawal by Subject|0
2840669|NCT02525744|9748451|P1|Period 4|Withdrawal by Subject|1
2840670|NCT02525744|9748448|P4|Period 3|Adverse Event|0
2840671|NCT02525744|9748449|P3|Period 3|Adverse Event|0
2840672|NCT02525744|9748450|P2|Period 3|Adverse Event|1
2840673|NCT02525744|9748451|P1|Period 3|Adverse Event|0
2840674|NCT02525744|9748448|P4|Period 1|Physician Decision|0
2840675|NCT02525744|9748449|P3|Period 1|Physician Decision|1
2840676|NCT02525744|9748450|P2|Period 1|Physician Decision|0
2840677|NCT02525744|9748451|P1|Period 1|Physician Decision|0
2840678|NCT02525627|9748487|P2|Overall Study|Site terminated|10
2840679|NCT02525627|9748488|P1|Overall Study|Site terminated|11
2840680|NCT02525627|9748487|P2|Overall Study|Death|0
2840681|NCT02525627|9748488|P1|Overall Study|Death|1
2840682|NCT02525627|9748487|P2|Overall Study|Withdrawal by Subject|2
2840683|NCT02525627|9748488|P1|Overall Study|Withdrawal by Subject|1
2840684|NCT02525627|9748487|P2|Overall Study|Revision|1
2840685|NCT02525627|9748488|P1|Overall Study|Revision|1
2840686|NCT02525588|9748500|P2|Overall Study|Adverse Event|1
2840687|NCT02525588|9748501|P1|Overall Study|Adverse Event|0
2840688|NCT02525588|9748500|P2|Overall Study|Withdrawal by Subject|1
2840689|NCT02525588|9748501|P1|Overall Study|Withdrawal by Subject|1
2840690|NCT02525588|9748500|P2|Overall Study|Lost to Follow-up|0
2840691|NCT02525588|9748501|P1|Overall Study|Lost to Follow-up|2
2840692|NCT02525588|9748500|P2|Overall Study|Death|1
2840693|NCT02525588|9748501|P1|Overall Study|Death|3
2840694|NCT02525094|9748613|P2|Overall Study|Not Treated|1
2840695|NCT02525094|9748614|P1|Overall Study|Not Treated|1
2840696|NCT02525094|9748613|P2|Overall Study|Withdrawal by Subject|6
2840697|NCT02525094|9748614|P1|Overall Study|Withdrawal by Subject|5
2840698|NCT02525094|9748613|P2|Overall Study|Lost to Follow-up|1
2840699|NCT02525094|9748614|P1|Overall Study|Lost to Follow-up|2
2840700|NCT02524665|9748677|P1|Overall Study|Lost to Follow-up|1
2840701|NCT02524288|9748728|P1|Overall Study|Physician Decision|2
2840702|NCT02524288|9748728|P1|Overall Study|Pregnancy|22
2840703|NCT02524288|9748728|P1|Overall Study|Withdrawal by Subject|76
2840704|NCT02524288|9748728|P1|Overall Study|Subject Moved|32
2840705|NCT02524288|9748728|P1|Overall Study|Study Terminated By Sponsor|1417
2840706|NCT02524288|9748728|P1|Overall Study|Site Discontinued Study Participation|1
2840707|NCT02524288|9748728|P1|Overall Study|Screen Failure|2
2840708|NCT02524288|9748728|P1|Overall Study|Protocol Violation|6
2840709|NCT02524288|9748728|P1|Overall Study|Pregnancy Wish|6
2840710|NCT02524288|9748728|P1|Overall Study|Non-Compliance With Study Drug|14
2840711|NCT02524288|9748728|P1|Overall Study|Non-Compliance With Protocol|32
2840712|NCT02524288|9748728|P1|Overall Study|Lost to Follow-up|216
2840713|NCT02524288|9748728|P1|Overall Study|Adverse Event|115
2840714|NCT02524158|9748738|P2|6-month Assessment|Lost to Follow-up|20
2840715|NCT02524158|9748739|P1|6-month Assessment|Lost to Follow-up|21
2840716|NCT02524158|9748738|P2|6-month Assessment|Withdrawal by Subject|1
2840717|NCT02524158|9748739|P1|6-month Assessment|Withdrawal by Subject|1
2840718|NCT02524158|9748738|P2|12-weeks Assessment|Lost to Follow-up|12
2840719|NCT02524158|9748739|P1|12-weeks Assessment|Lost to Follow-up|18
2840720|NCT02524158|9748738|P2|12-weeks Assessment|Withdrawal by Subject|1
2840721|NCT02524158|9748739|P1|12-weeks Assessment|Withdrawal by Subject|1
2840722|NCT02524145|9748781|P3|Overall Study|Withdrawal by Subject|3
2840723|NCT02524145|9748782|P2|Overall Study|Withdrawal by Subject|2
2840724|NCT02524145|9748783|P1|Overall Study|Withdrawal by Subject|2
2840725|NCT02522884|9748880|P1|Overall Study|Missed 12-month Follow-up|9
2840726|NCT02522884|9748880|P1|Overall Study|Death|3
2840727|NCT02522884|9748880|P1|Overall Study|Withdrawal by Subject|6
2840728|NCT02522728|9748887|P2|Overall Study|Did not receive randomized study device|1
2840729|NCT02522728|9748888|P1|Overall Study|Did not receive randomized study device|0
2840730|NCT02522728|9748887|P2|Overall Study|Adverse Event|1
2840731|NCT02522728|9748888|P1|Overall Study|Adverse Event|2
2840732|NCT02522728|9748887|P2|Overall Study|Death|3
2840733|NCT02522728|9748888|P1|Overall Study|Death|4
2840734|NCT02522728|9748887|P2|Overall Study|Withdrawal by Subject|6
2840735|NCT02522728|9748888|P1|Overall Study|Withdrawal by Subject|6
2840736|NCT02522624|9748904|P2|Overall Study|Technical failure|0
2840737|NCT02522624|9748905|P1|Overall Study|Technical failure|1
2840738|NCT02522403|9748940|P2|Overall Study|Withdrawal by Subject|4
2840739|NCT02522403|9748941|P1|Overall Study|Withdrawal by Subject|2
2840740|NCT02522403|9748940|P2|Overall Study|Lost to Follow-up|2
2840741|NCT02522403|9748941|P1|Overall Study|Lost to Follow-up|2
2840742|NCT02522377|9748953|P2|Overall Study|Remission Achieved|0
2840743|NCT02522377|9748954|P1|Overall Study|Remission Achieved|3
2840744|NCT02522377|9748953|P2|Overall Study|Withdrawal by Subject|0
2840745|NCT02522377|9748954|P1|Overall Study|Withdrawal by Subject|1
2840746|NCT02522325|9748970|P2|Overall Study|Adverse Event|1
2840747|NCT02522325|9748971|P1|Overall Study|Adverse Event|0
2840748|NCT02522299|9748979|P2|Overall Study|Withdrawal by Subject|0
2840749|NCT02522299|9748980|P1|Overall Study|Withdrawal by Subject|2
2840750|NCT02522299|9748979|P2|Overall Study|Physician Decision|1
2840751|NCT02522299|9748980|P1|Overall Study|Physician Decision|0
2840752|NCT02522299|9748979|P2|Overall Study|Adverse Event|0
2840753|NCT02522299|9748980|P1|Overall Study|Adverse Event|2
2840754|NCT02522286|9749063|P4|Overall Study|Withdrawal by Subject|3
2840755|NCT02522286|9749064|P3|Overall Study|Withdrawal by Subject|0
2840756|NCT02522286|9749065|P2|Overall Study|Withdrawal by Subject|0
2840757|NCT02522286|9749066|P1|Overall Study|Withdrawal by Subject|3
2840758|NCT02521948|9749092|P1|Overall Study|Did not attend one or both follow-ups|6
2840759|NCT02521948|9749092|P1|Overall Study|Lost to Follow-up|1
2840760|NCT02521948|9749092|P1|Overall Study|Death|4
2840761|NCT02521948|9749092|P1|Overall Study|Adverse Event|2
2840762|NCT02521376|9749138|P4|Overall Study|Enrolled, But Not Treated|0
2840763|NCT02521376|9749139|P3|Overall Study|Enrolled, But Not Treated|0
2840764|NCT02521376|9749140|P2|Overall Study|Enrolled, But Not Treated|0
2840765|NCT02521376|9749141|P1|Overall Study|Enrolled, But Not Treated|1
2840766|NCT02520726|9749182|P2|Overall Study|Lost to Follow-up|2
2840767|NCT02520726|9749183|P1|Overall Study|Lost to Follow-up|3
2840768|NCT02520531|9749193|P2|Overall Study|Not study device|0
2840769|NCT02520531|9749194|P1|Overall Study|Not study device|1
2840770|NCT02520531|9749193|P2|Overall Study|Withdrawal by Subject|0
2840771|NCT02520531|9749194|P1|Overall Study|Withdrawal by Subject|1
2840772|NCT02520531|9749193|P2|Overall Study|Meet exclusion criterion|1
2840773|NCT02520531|9749194|P1|Overall Study|Meet exclusion criterion|0
2840774|NCT02520531|9749193|P2|Overall Study|Lost to Follow-up|1
2840775|NCT02520531|9749194|P1|Overall Study|Lost to Follow-up|1
2840776|NCT02520531|9749193|P2|Overall Study|Death|2
2840777|NCT02520531|9749194|P1|Overall Study|Death|1
2840778|NCT02520531|9749193|P2|Overall Study|Revision of study device components|2
2840779|NCT02520531|9749194|P1|Overall Study|Revision of study device components|2
2840780|NCT02520388|9749279|P2|Overall Study|Other (reason not defined)|4
2840781|NCT02520388|9749280|P1|Overall Study|Other (reason not defined)|4
2840782|NCT02520388|9749279|P2|Overall Study|Lost to Follow-up|2
2840783|NCT02520388|9749280|P1|Overall Study|Lost to Follow-up|3
2840784|NCT02520388|9749279|P2|Overall Study|Adverse Event|4
2840785|NCT02520388|9749280|P1|Overall Study|Adverse Event|1
2840786|NCT02520388|9749279|P2|Overall Study|Subject or parent/guardian request|6
2840787|NCT02520388|9749280|P1|Overall Study|Subject or parent/guardian request|0
2840788|NCT02520388|9749279|P2|Overall Study|Physician Decision|0
2840789|NCT02520388|9749280|P1|Overall Study|Physician Decision|1
2840790|NCT02520310|9749288|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
2840791|NCT02520310|9749288|P1|AT 3 Year Clinical Follow-up|Death|2
2840792|NCT02520310|9749288|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
2840793|NCT02520310|9749288|P1|At 6 Months Clinical Follow-up|Death|1
2840794|NCT02520284|9749462|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2840795|NCT02520284|9749463|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2840796|NCT02520284|9749464|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
2840797|NCT02520284|9749462|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
2840798|NCT02520284|9749463|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
2840799|NCT02520284|9749464|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
2840800|NCT02520284|9749462|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
2840801|NCT02520284|9749463|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
2840802|NCT02520284|9749464|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
2840803|NCT02520284|9749462|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
2840804|NCT02520284|9749463|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
2840805|NCT02520284|9749464|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
2840806|NCT02520284|9749462|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2840807|NCT02520284|9749463|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
2840808|NCT02520284|9749464|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2840809|NCT02520284|9749462|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
2840810|NCT02520284|9749463|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2840811|NCT02520284|9749464|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2840812|NCT02520284|9749462|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
2840813|NCT02520284|9749463|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2840814|NCT02520284|9749464|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2840815|NCT02520284|9749462|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
2840816|NCT02520284|9749463|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
2840817|NCT02520284|9749464|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
2840818|NCT02520284|9749462|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
2840819|NCT02520284|9749463|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2840820|NCT02520284|9749464|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2840821|NCT02520284|9749462|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2840822|NCT02520284|9749463|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2840823|NCT02520284|9749464|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2840824|NCT02520284|9749462|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
2840825|NCT02520284|9749463|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
2840826|NCT02520284|9749464|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
2840827|NCT02520089|9749498|P2|Overall Study|Lost to Follow-up|4
2840828|NCT02520089|9749499|P1|Overall Study|Lost to Follow-up|3
2840829|NCT02519855|9749509|P2|Overall Study|Lost to Follow-up|3
2840830|NCT02519855|9749510|P1|Overall Study|Lost to Follow-up|3
2840831|NCT02519855|9749509|P2|Overall Study|Adverse Event|1
2840832|NCT02519855|9749510|P1|Overall Study|Adverse Event|0
2840833|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
2840834|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2840835|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2840836|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
2840837|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2840838|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2840839|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
2840840|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2840841|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2840842|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
2840843|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2840844|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2840845|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Death|1
2840846|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Death|0
2840847|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Death|0
2840848|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
2840849|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2840850|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2840851|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
2840852|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2840853|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2840854|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Adverse Event|1
2840855|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Adverse Event|0
2840856|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Adverse Event|0
2840857|NCT02519842|9749528|P3|Optional Extension: Cycles 2-6|Physician Decision|5
2840858|NCT02519842|9749529|P2|Optional Extension: Cycles 2-6|Physician Decision|0
2840859|NCT02519842|9749530|P1|Optional Extension: Cycles 2-6|Physician Decision|0
2840860|NCT02519842|9749528|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
2840861|NCT02519842|9749529|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
2840862|NCT02519842|9749530|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
2840863|NCT02519842|9749528|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2840864|NCT02519842|9749529|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
2840865|NCT02519842|9749530|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2840866|NCT02519842|9749528|P3|Base Study: Cycle 1|Adverse Event|0
2840867|NCT02519842|9749529|P2|Base Study: Cycle 1|Adverse Event|0
2840868|NCT02519842|9749530|P1|Base Study: Cycle 1|Adverse Event|1
2840869|NCT02519842|9749528|P3|Base Study: Cycle 1|Screening Failure|0
2840870|NCT02519842|9749529|P2|Base Study: Cycle 1|Screening Failure|1
2840871|NCT02519842|9749530|P1|Base Study: Cycle 1|Screening Failure|1
2840872|NCT02519712|9749549|P1|Overall Study|Accruals are donors|2
2840873|NCT02519712|9749549|P1|Overall Study|Disease Progression|1
2840874|NCT02519712|9749549|P1|Overall Study|Disease Relapse|1
2840875|NCT02519595|9749556|P3|Overall Study|Protocol Violation|16
2840876|NCT02519595|9749557|P2|Overall Study|Protocol Violation|22
2840877|NCT02519595|9749558|P1|Overall Study|Protocol Violation|8
2840878|NCT02519504|9749583|P2|Overall Study|Did not participate in direct testing|86
2840879|NCT02519504|9749584|P1|Overall Study|Did not participate in direct testing|95
2840880|NCT02519504|9749583|P2|Overall Study|Ineligible for direct testing|12
2840881|NCT02519504|9749584|P1|Overall Study|Ineligible for direct testing|12
2840882|NCT02519504|9749583|P2|Overall Study|Protocol Violation|5
2840883|NCT02519504|9749584|P1|Overall Study|Protocol Violation|6
2840884|NCT02518971|9749789|P2|Overall Study|eligibility criteria no longer met|3
2840885|NCT02518971|9749790|P1|Overall Study|eligibility criteria no longer met|6
2840886|NCT02518971|9749789|P2|Overall Study|medication lost in mail|1
2840887|NCT02518971|9749790|P1|Overall Study|medication lost in mail|0
2840888|NCT02518971|9749789|P2|Overall Study|Side effects|0
2840889|NCT02518971|9749790|P1|Overall Study|Side effects|1
2840890|NCT02518971|9749789|P2|Overall Study|Withdrawal by Subject|5
2840891|NCT02518971|9749790|P1|Overall Study|Withdrawal by Subject|4
2840892|NCT02518971|9749789|P2|Overall Study|Protocol Violation|4
2840893|NCT02518971|9749790|P1|Overall Study|Protocol Violation|6
2840894|NCT02518971|9749789|P2|Overall Study|Physician Decision|6
2840895|NCT02518971|9749790|P1|Overall Study|Physician Decision|6
2840896|NCT02518971|9749789|P2|Overall Study|Lost to Follow-up|1
2840897|NCT02518971|9749790|P1|Overall Study|Lost to Follow-up|0
2840898|NCT02518919|9749810|P3|Overall Study|Protocol Violation|2
2840899|NCT02518919|9749811|P2|Overall Study|Protocol Violation|1
2840900|NCT02518919|9749812|P1|Overall Study|Protocol Violation|1
2840901|NCT02518685|9749842|P2|Overall Study|Lost to Follow-up|4
2840902|NCT02518685|9749843|P1|Overall Study|Lost to Follow-up|1
2840903|NCT02518685|9749842|P2|Overall Study|Physician Decision|0
2840904|NCT02518685|9749843|P1|Overall Study|Physician Decision|1
2840905|NCT02518685|9749842|P2|Overall Study|Pregnancy|0
2840906|NCT02518685|9749843|P1|Overall Study|Pregnancy|1
2840907|NCT02518685|9749842|P2|Overall Study|relocation, study fatigue|2
2840908|NCT02518685|9749843|P1|Overall Study|relocation, study fatigue|7
2840909|NCT02518685|9749842|P2|Overall Study|Withdrawal by Subject|3
2840910|NCT02518685|9749843|P1|Overall Study|Withdrawal by Subject|10
2840911|NCT02518685|9749842|P2|Overall Study|Adverse Event|1
2840912|NCT02518685|9749843|P1|Overall Study|Adverse Event|29
2840913|NCT02518620|9749852|P2|Overall Study|Relocation|1
2840914|NCT02518620|9749853|P1|Overall Study|Relocation|2
2840915|NCT02518620|9749852|P2|Overall Study|Pregnancy|0
2840916|NCT02518620|9749853|P1|Overall Study|Pregnancy|1
2840917|NCT02518620|9749852|P2|Overall Study|Pregnancy Wish|0
2840918|NCT02518620|9749853|P1|Overall Study|Pregnancy Wish|3
2840919|NCT02518620|9749852|P2|Overall Study|Death|0
2840920|NCT02518620|9749853|P1|Overall Study|Death|1
2840921|NCT02518620|9749852|P2|Overall Study|Withdrawal by Subject|9
2840922|NCT02518620|9749853|P1|Overall Study|Withdrawal by Subject|17
2840923|NCT02518620|9749852|P2|Overall Study|Lost to Follow-up|1
2840924|NCT02518620|9749853|P1|Overall Study|Lost to Follow-up|1
2840925|NCT02518620|9749852|P2|Overall Study|Sponsor's Decision|3
2840926|NCT02518620|9749853|P1|Overall Study|Sponsor's Decision|0
2840927|NCT02518620|9749852|P2|Overall Study|Physician Decision|1
2840928|NCT02518620|9749853|P1|Overall Study|Physician Decision|1
2840929|NCT02518620|9749852|P2|Overall Study|Non-Compliance with Study Drug|0
2840930|NCT02518620|9749853|P1|Overall Study|Non-Compliance with Study Drug|1
2840931|NCT02518620|9749852|P2|Overall Study|Lack of Efficacy|0
2840932|NCT02518620|9749853|P1|Overall Study|Lack of Efficacy|2
2840933|NCT02518620|9749852|P2|Overall Study|Adverse Event|11
2840934|NCT02518620|9749853|P1|Overall Study|Adverse Event|23
2840935|NCT02518464|9749876|P1|Overall Study|Adverse Event|2
2840936|NCT02518113|9749897|P4|Overall Study|Progressive Disease|0
2840937|NCT02518113|9749898|P3|Overall Study|Progressive Disease|3
2840938|NCT02518113|9749899|P2|Overall Study|Progressive Disease|2
2840939|NCT02518113|9749900|P1|Overall Study|Progressive Disease|1
2840940|NCT02518113|9749897|P4|Overall Study|Physician Decision|0
2840941|NCT02518113|9749898|P3|Overall Study|Physician Decision|0
2840942|NCT02518113|9749899|P2|Overall Study|Physician Decision|1
2840943|NCT02518113|9749900|P1|Overall Study|Physician Decision|0
2840944|NCT02518113|9749897|P4|Overall Study|Death|0
2840945|NCT02518113|9749898|P3|Overall Study|Death|0
2840946|NCT02518113|9749899|P2|Overall Study|Death|2
2840947|NCT02518113|9749900|P1|Overall Study|Death|1
2840948|NCT02518113|9749897|P4|Overall Study|Adverse Event|0
2840949|NCT02518113|9749898|P3|Overall Study|Adverse Event|1
2840950|NCT02518113|9749899|P2|Overall Study|Adverse Event|0
2840951|NCT02518113|9749900|P1|Overall Study|Adverse Event|1
2840952|NCT02518048|9749941|P1|Overall Study|Withdrawal by Subject|1
2840953|NCT02517866|9749967|P3|Overall Study|Reason not specified|0
2840954|NCT02517866|9749968|P2|Overall Study|Reason not specified|0
2840955|NCT02517866|9749969|P1|Overall Study|Reason not specified|2
2840956|NCT02517866|9749967|P3|Overall Study|Investigator Decision|0
2840957|NCT02517866|9749968|P2|Overall Study|Investigator Decision|1
2840958|NCT02517866|9749969|P1|Overall Study|Investigator Decision|2
2840959|NCT02517866|9749967|P3|Overall Study|Voluntary Withdrawal|0
2840960|NCT02517866|9749968|P2|Overall Study|Voluntary Withdrawal|2
2840961|NCT02517866|9749969|P1|Overall Study|Voluntary Withdrawal|2
2840962|NCT02517866|9749967|P3|Overall Study|Lost to Follow-up|0
2840963|NCT02517866|9749968|P2|Overall Study|Lost to Follow-up|0
2840964|NCT02517866|9749969|P1|Overall Study|Lost to Follow-up|1
2840965|NCT02517866|9749967|P3|Overall Study|Significant Protocol Deviation|0
2840966|NCT02517866|9749968|P2|Overall Study|Significant Protocol Deviation|1
2840967|NCT02517866|9749969|P1|Overall Study|Significant Protocol Deviation|4
2840968|NCT02517866|9749967|P3|Overall Study|Pretreatment Event/Adverse Event|0
2840969|NCT02517866|9749968|P2|Overall Study|Pretreatment Event/Adverse Event|2
2840970|NCT02517866|9749969|P1|Overall Study|Pretreatment Event/Adverse Event|9
2840971|NCT02517541|9750040|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
2840972|NCT02517541|9750040|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
2840973|NCT02517541|9750040|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
2840974|NCT02517541|9750040|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
2840975|NCT02517541|9750040|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
2840976|NCT02517541|9750040|P1|Baseline Period (Own Product)|Protocol Violation|1
2840977|NCT02517528|9750046|P1|Overall Study|Withdrawal by Subject|1
2840978|NCT02517515|9750056|P2|Overall Study|Other|0
2840979|NCT02517515|9750057|P1|Overall Study|Other|1
2840980|NCT02517515|9750056|P2|Overall Study|Lost to Follow-up|0
2840981|NCT02517515|9750057|P1|Overall Study|Lost to Follow-up|1
2840982|NCT02517515|9750056|P2|Overall Study|Withdrew Consent|1
2840983|NCT02517515|9750057|P1|Overall Study|Withdrew Consent|0
2840984|NCT02517515|9750056|P2|Overall Study|Adverse Event|1
2840985|NCT02517515|9750057|P1|Overall Study|Adverse Event|0
2840986|NCT02517463|9750074|P2|Overall Study|Lost to Follow-up|2
2840987|NCT02517463|9750075|P1|Overall Study|Lost to Follow-up|5
2840988|NCT02517268|9750087|P2|Overall Study|Withdrawal by Subject|0
2840989|NCT02517268|9750088|P1|Overall Study|Withdrawal by Subject|1
2840990|NCT02516982|9750140|P4|Overall Study|Did not install the app|47
2840991|NCT02516982|9750141|P3|Overall Study|Did not install the app|46
2840992|NCT02516982|9750142|P2|Overall Study|Did not install the app|0
2840993|NCT02516982|9750143|P1|Overall Study|Did not install the app|0
2840994|NCT02516982|9750140|P4|Overall Study|Protocol Violation|1
2840995|NCT02516982|9750141|P3|Overall Study|Protocol Violation|1
2840996|NCT02516982|9750142|P2|Overall Study|Protocol Violation|0
2840997|NCT02516982|9750143|P1|Overall Study|Protocol Violation|0
2840998|NCT02516982|9750140|P4|Overall Study|Withdrawal by Subject|2
2840999|NCT02516982|9750141|P3|Overall Study|Withdrawal by Subject|1
2841000|NCT02516982|9750142|P2|Overall Study|Withdrawal by Subject|0
2841001|NCT02516982|9750143|P1|Overall Study|Withdrawal by Subject|0
2841002|NCT02516982|9750140|P4|Overall Study|Called in to antenatal appointment|0
2841003|NCT02516982|9750141|P3|Overall Study|Called in to antenatal appointment|0
2841004|NCT02516982|9750142|P2|Overall Study|Called in to antenatal appointment|35
2841005|NCT02516982|9750143|P1|Overall Study|Called in to antenatal appointment|32
2841006|NCT02516605|9750170|P5|Overall Study|Withdrawal by Subject|0
2841007|NCT02516605|9750171|P4|Overall Study|Withdrawal by Subject|1
2841008|NCT02516605|9750172|P3|Overall Study|Withdrawal by Subject|0
2841009|NCT02516605|9750173|P2|Overall Study|Withdrawal by Subject|0
2841010|NCT02516605|9750174|P1|Overall Study|Withdrawal by Subject|0
2841011|NCT02516605|9750170|P5|Overall Study|Protocol Violation|1
2841012|NCT02516605|9750171|P4|Overall Study|Protocol Violation|0
2841013|NCT02516605|9750172|P3|Overall Study|Protocol Violation|0
2841014|NCT02516605|9750173|P2|Overall Study|Protocol Violation|0
2841015|NCT02516605|9750174|P1|Overall Study|Protocol Violation|0
2841016|NCT02516592|9750245|P2|Overall Study|Death|1
2841017|NCT02516592|9750246|P1|Overall Study|Death|1
2841018|NCT02516592|9750245|P2|Overall Study|Abnormal test procedure result|0
2841019|NCT02516592|9750246|P1|Overall Study|Abnormal test procedure result|1
2841020|NCT02516592|9750245|P2|Overall Study|Adverse Event|2
2841021|NCT02516592|9750246|P1|Overall Study|Adverse Event|1
2841022|NCT02516592|9750245|P2|Overall Study|Patient/guardian decision|1
2841023|NCT02516592|9750246|P1|Overall Study|Patient/guardian decision|2
2841024|NCT02516592|9750245|P2|Overall Study|Lost to Follow-up|3
2841025|NCT02516592|9750246|P1|Overall Study|Lost to Follow-up|2
2841026|NCT02516592|9750245|P2|Overall Study|Protocol deviation|4
2841027|NCT02516592|9750246|P1|Overall Study|Protocol deviation|4
2841028|NCT02516592|9750245|P2|Overall Study|Patient withdrew consent|2
2841029|NCT02516592|9750246|P1|Overall Study|Patient withdrew consent|5
2841030|NCT02516410|9750268|P2|Overall Study|Withdrawal by Subject|1
2841031|NCT02516410|9750269|P1|Overall Study|Withdrawal by Subject|0
2841032|NCT02516410|9750268|P2|Overall Study|Adverse Event|1
2841033|NCT02516410|9750269|P1|Overall Study|Adverse Event|0
2841034|NCT02516306|9750298|P2|Period 2: Day 8 - 91|Protocol Violation|2
2841035|NCT02516306|9750299|P1|Period 2: Day 8 - 91|Protocol Violation|1
2841036|NCT02516202|9750308|P3|Overall Study|Stopped Follow-up|1
2841037|NCT02516202|9750309|P2|Overall Study|Stopped Follow-up|0
2841038|NCT02516202|9750310|P1|Overall Study|Stopped Follow-up|0
2841039|NCT02516202|9750308|P3|Overall Study|Lost to Follow-up|1
2841040|NCT02516202|9750309|P2|Overall Study|Lost to Follow-up|1
2841041|NCT02516202|9750310|P1|Overall Study|Lost to Follow-up|1
2841042|NCT02516202|9750308|P3|Overall Study|Withdrawal by Subject|1
2841043|NCT02516202|9750309|P2|Overall Study|Withdrawal by Subject|0
2841044|NCT02516202|9750310|P1|Overall Study|Withdrawal by Subject|1
2841045|NCT02516163|9750336|P1|Overall Study|MRI contraindication exclusion|6
2841046|NCT02516163|9750336|P1|Overall Study|Data not recorded|2
2841047|NCT02516163|9750336|P1|Overall Study|Use of incorrect measurement technique|5
2841048|NCT02516163|9750336|P1|Overall Study|Unfit/delay in surgery|3
2841049|NCT02516163|9750336|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
2841050|NCT02516163|9750336|P1|Overall Study|Withdrawal by Subject|1
2841051|NCT02516098|9750350|P2|Period 2|Withdrawal by Subject|1
2841052|NCT02516098|9750351|P1|Period 2|Withdrawal by Subject|0
2841053|NCT02516098|9750350|P2|Washout After Period 1|Adverse Event|1
2841054|NCT02516098|9750351|P1|Washout After Period 1|Adverse Event|0
2841055|NCT02516098|9750350|P2|Period 1|Protocol Violation|0
2841056|NCT02516098|9750351|P1|Period 1|Protocol Violation|1
2841057|NCT02515994|9750365|P2|Overall Study|Withdrawal by Subject|0
2841058|NCT02515994|9750366|P1|Overall Study|Withdrawal by Subject|2
2841059|NCT02515994|9750365|P2|Overall Study|Adverse Event|1
2841060|NCT02515994|9750366|P1|Overall Study|Adverse Event|3
2841061|NCT02515994|9750365|P2|Overall Study|No Longer Meets Eligibility Criteria|1
2841062|NCT02515994|9750366|P1|Overall Study|No Longer Meets Eligibility Criteria|2
2841063|NCT02515994|9750365|P2|Overall Study|Protocol Violation|5
2841064|NCT02515994|9750366|P1|Overall Study|Protocol Violation|3
2841065|NCT02515942|9750381|P3|Overall Study|Withdrawal by Subject|2
2841066|NCT02515942|9750382|P2|Overall Study|Withdrawal by Subject|3
2841067|NCT02515942|9750383|P1|Overall Study|Withdrawal by Subject|0
2841068|NCT02515942|9750381|P3|Overall Study|Lost to Follow-up|0
2841069|NCT02515942|9750382|P2|Overall Study|Lost to Follow-up|0
2841070|NCT02515942|9750383|P1|Overall Study|Lost to Follow-up|2
2841071|NCT02515942|9750381|P3|Overall Study|Lack of Efficacy|1
2841072|NCT02515942|9750382|P2|Overall Study|Lack of Efficacy|0
2841073|NCT02515942|9750383|P1|Overall Study|Lack of Efficacy|0
2841074|NCT02515942|9750381|P3|Overall Study|Death|1
2841075|NCT02515942|9750382|P2|Overall Study|Death|0
2841076|NCT02515942|9750383|P1|Overall Study|Death|0
2841077|NCT02515942|9750381|P3|Overall Study|Adverse Event|0
2841078|NCT02515942|9750382|P2|Overall Study|Adverse Event|0
2841079|NCT02515942|9750383|P1|Overall Study|Adverse Event|5
2841080|NCT02515669|9750449|P4|48 Week Open-Label Phase|Other|0
2841081|NCT02515669|9750450|P3|48 Week Open-Label Phase|Other|1
2841082|NCT02515669|9750451|P2|48 Week Open-Label Phase|Other|0
2841083|NCT02515669|9750452|P1|48 Week Open-Label Phase|Other|0
2841084|NCT02515331|9750537|P3|Overall Study|Adverse Event|0
2841085|NCT02515331|9750538|P2|Overall Study|Adverse Event|0
2841086|NCT02515331|9750539|P1|Overall Study|Adverse Event|2
2841087|NCT02515331|9750537|P3|Overall Study|Protocol deviation|3
2841088|NCT02515331|9750538|P2|Overall Study|Protocol deviation|0
2841089|NCT02515331|9750539|P1|Overall Study|Protocol deviation|0
2841090|NCT02515331|9750537|P3|Overall Study|Withdrawal by Subject|1
2841091|NCT02515331|9750538|P2|Overall Study|Withdrawal by Subject|0
2841092|NCT02515331|9750539|P1|Overall Study|Withdrawal by Subject|0
2841093|NCT02515279|9750560|P1|Overall Study|Other|22
2841094|NCT02515279|9750560|P1|Overall Study|End-of-treatment visit not attended|17
2841095|NCT02515279|9750560|P1|Overall Study|Withdrawal by Subject|18
2841096|NCT02515279|9750560|P1|Overall Study|Lost to Follow-up|9
2841097|NCT02515279|9750560|P1|Overall Study|Lack of Efficacy|31
2841098|NCT02515279|9750560|P1|Overall Study|Adverse Event|7
2841099|NCT02515097|9750579|P2|Overall Study|Adverse Event|1
2841100|NCT02515097|9750580|P1|Overall Study|Adverse Event|2
2841101|NCT02515097|9750579|P2|Overall Study|Withdrawal by Subject|3
2841102|NCT02515097|9750580|P1|Overall Study|Withdrawal by Subject|1
2841103|NCT02515097|9750579|P2|Overall Study|Lost to Follow-up|2
2841104|NCT02515097|9750580|P1|Overall Study|Lost to Follow-up|4
2841105|NCT02515045|9750601|P3|Overall Study|Lost to Follow-up|1
2841106|NCT02515045|9750602|P2|Overall Study|Lost to Follow-up|1
2841107|NCT02515045|9750603|P1|Overall Study|Lost to Follow-up|0
2841108|NCT02515045|9750601|P3|Overall Study|Adverse Event|3
2841109|NCT02515045|9750602|P2|Overall Study|Adverse Event|3
2841110|NCT02515045|9750603|P1|Overall Study|Adverse Event|0
2841111|NCT02514772|9750640|P2|Overall Study|Withdrawal by Subject|1
2841112|NCT02514772|9750641|P1|Overall Study|Withdrawal by Subject|2
2841113|NCT02514772|9750640|P2|Overall Study|Death|1
2841114|NCT02514772|9750641|P1|Overall Study|Death|0
2841115|NCT02514772|9750640|P2|Overall Study|Adverse Event|0
2841116|NCT02514772|9750641|P1|Overall Study|Adverse Event|1
2841117|NCT02514577|9750655|P2|Overall Study|Adverse Event|1
2841118|NCT02514577|9750656|P1|Overall Study|Adverse Event|1
2841119|NCT02514577|9750655|P2|Overall Study|Withdrawal by Subject|6
2841120|NCT02514577|9750656|P1|Overall Study|Withdrawal by Subject|6
2841121|NCT02514577|9750655|P2|Overall Study|Protocol Violation|0
2841122|NCT02514577|9750656|P1|Overall Study|Protocol Violation|1
2841123|NCT02514577|9750655|P2|Overall Study|Lost to Follow-up|6
2841124|NCT02514577|9750656|P1|Overall Study|Lost to Follow-up|6
2841125|NCT02514551|9750666|P2|Overall Study|Participant Never Treated|2
2841126|NCT02514551|9750667|P1|Overall Study|Participant Never Treated|0
2841127|NCT02514551|9750666|P2|Overall Study|Lost to Follow-up|1
2841128|NCT02514551|9750667|P1|Overall Study|Lost to Follow-up|0
2841129|NCT02514473|9750684|P2|Overall Study|Other|1
2841130|NCT02514473|9750685|P1|Overall Study|Other|1
2841131|NCT02514473|9750684|P2|Overall Study|Lost to Follow-up|1
2841132|NCT02514473|9750685|P1|Overall Study|Lost to Follow-up|0
2841133|NCT02514473|9750684|P2|Overall Study|Withdrawal by Subject|1
2841134|NCT02514473|9750685|P1|Overall Study|Withdrawal by Subject|2
2841135|NCT02514473|9750684|P2|Overall Study|Adverse Event|2
2841136|NCT02514473|9750685|P1|Overall Study|Adverse Event|0
2841137|NCT02514174|9750726|P1|Overall Study|Treated off study with Afatinib.|1
2841138|NCT02514174|9750726|P1|Overall Study|Treatment change|1
2841139|NCT02514174|9750726|P1|Overall Study|Progressive disease|11
2841140|NCT02514174|9750726|P1|Overall Study|Study closed by sponsor|9
2841141|NCT02514174|9750726|P1|Overall Study|Adverse Event|2
2841142|NCT02514174|9750726|P1|Overall Study|Patient refused to continue medication|1
2841143|NCT02514122|9750737|P2|Overall Study|Withdrawal by Subject|0
2841144|NCT02514122|9750738|P1|Overall Study|Withdrawal by Subject|2
2841145|NCT02513823|9750785|P1|Overall Study|Physician Decision|1
2841146|NCT02513823|9750785|P1|Overall Study|Lost to Follow-up|4
2841147|NCT02513771|9750792|P2|Overall Study|Not being able to get to clinic|0
2841148|NCT02513771|9750793|P1|Overall Study|Not being able to get to clinic|1
2841149|NCT02513771|9750792|P2|Overall Study|Lost to Follow-up|1
2841150|NCT02513771|9750793|P1|Overall Study|Lost to Follow-up|1
2841151|NCT02513745|9750831|P2|Overall Study|Criteria at time of surgery not met.|3
2841152|NCT02513745|9750832|P1|Overall Study|Criteria at time of surgery not met.|3
2841153|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Labor Reasons|0
2841154|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Labor Reasons|0
2841155|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Labor Reasons|0
2841156|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Labor Reasons|1
2841157|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Labor Reasons|0
2841158|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Labor Reasons|0
2841159|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2841160|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2841161|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2841162|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
2841163|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2841164|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2841165|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Subject move out of town|0
2841166|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Subject move out of town|0
2841167|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Subject move out of town|0
2841168|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Subject move out of town|1
2841169|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Subject move out of town|0
2841170|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Subject move out of town|0
2841171|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Death|0
2841172|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Death|0
2841173|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Death|0
2841174|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Death|1
2841175|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Death|0
2841176|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Death|0
2841177|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Physician Decision|0
2841178|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Physician Decision|0
2841179|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Physician Decision|0
2841180|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Physician Decision|0
2841181|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Physician Decision|0
2841182|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Physician Decision|2
2841183|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Adverse Event|0
2841184|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Adverse Event|0
2841185|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Adverse Event|0
2841186|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Adverse Event|4
2841187|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Adverse Event|1
2841188|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Adverse Event|1
2841189|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
2841190|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
2841191|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
2841192|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
2841193|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
2841194|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
2841195|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2841196|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2841197|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2841198|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
2841199|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
2841200|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
2841201|NCT02513550|9751086|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2841202|NCT02513550|9751087|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2841203|NCT02513550|9751088|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2841204|NCT02513550|9751089|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
2841205|NCT02513550|9751090|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
2841206|NCT02513550|9751091|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
2841207|NCT02513550|9751086|P6|Double Blind Treatment Period|Death|0
2841208|NCT02513550|9751087|P5|Double Blind Treatment Period|Death|0
2841209|NCT02513550|9751088|P4|Double Blind Treatment Period|Death|0
2841210|NCT02513550|9751089|P3|Double Blind Treatment Period|Death|2
2841211|NCT02513550|9751090|P2|Double Blind Treatment Period|Death|0
2841212|NCT02513550|9751091|P1|Double Blind Treatment Period|Death|1
2841213|NCT02513550|9751086|P6|Double Blind Treatment Period|Due to personal business|0
2841214|NCT02513550|9751087|P5|Double Blind Treatment Period|Due to personal business|0
2841215|NCT02513550|9751088|P4|Double Blind Treatment Period|Due to personal business|0
2841216|NCT02513550|9751089|P3|Double Blind Treatment Period|Due to personal business|1
2841217|NCT02513550|9751090|P2|Double Blind Treatment Period|Due to personal business|0
2841218|NCT02513550|9751091|P1|Double Blind Treatment Period|Due to personal business|2
2841219|NCT02513550|9751086|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2841220|NCT02513550|9751087|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2841221|NCT02513550|9751088|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2841222|NCT02513550|9751089|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
2841223|NCT02513550|9751090|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2841224|NCT02513550|9751091|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2841225|NCT02513550|9751086|P6|Double Blind Treatment Period|Site terminated by sponsor|0
2841226|NCT02513550|9751087|P5|Double Blind Treatment Period|Site terminated by sponsor|0
2841227|NCT02513550|9751088|P4|Double Blind Treatment Period|Site terminated by sponsor|0
2841228|NCT02513550|9751089|P3|Double Blind Treatment Period|Site terminated by sponsor|3
2841229|NCT02513550|9751090|P2|Double Blind Treatment Period|Site terminated by sponsor|1
2841230|NCT02513550|9751091|P1|Double Blind Treatment Period|Site terminated by sponsor|1
2841231|NCT02513550|9751086|P6|Double Blind Treatment Period|Physician Decision|0
2841232|NCT02513550|9751087|P5|Double Blind Treatment Period|Physician Decision|0
2841233|NCT02513550|9751088|P4|Double Blind Treatment Period|Physician Decision|0
2841234|NCT02513550|9751089|P3|Double Blind Treatment Period|Physician Decision|4
2841235|NCT02513550|9751090|P2|Double Blind Treatment Period|Physician Decision|0
2841236|NCT02513550|9751091|P1|Double Blind Treatment Period|Physician Decision|2
2841237|NCT02513550|9751086|P6|Double Blind Treatment Period|Protocol Violation|0
2841238|NCT02513550|9751087|P5|Double Blind Treatment Period|Protocol Violation|0
2841239|NCT02513550|9751088|P4|Double Blind Treatment Period|Protocol Violation|0
2841240|NCT02513550|9751089|P3|Double Blind Treatment Period|Protocol Violation|4
2841241|NCT02513550|9751090|P2|Double Blind Treatment Period|Protocol Violation|1
2841242|NCT02513550|9751091|P1|Double Blind Treatment Period|Protocol Violation|1
2841243|NCT02513550|9751086|P6|Double Blind Treatment Period|Lack of Efficacy|0
2841244|NCT02513550|9751087|P5|Double Blind Treatment Period|Lack of Efficacy|0
2841245|NCT02513550|9751088|P4|Double Blind Treatment Period|Lack of Efficacy|0
2841246|NCT02513550|9751089|P3|Double Blind Treatment Period|Lack of Efficacy|6
2841247|NCT02513550|9751090|P2|Double Blind Treatment Period|Lack of Efficacy|5
2841248|NCT02513550|9751091|P1|Double Blind Treatment Period|Lack of Efficacy|4
2841249|NCT02513550|9751086|P6|Double Blind Treatment Period|Lost to Follow-up|1
2841250|NCT02513550|9751087|P5|Double Blind Treatment Period|Lost to Follow-up|0
2841251|NCT02513550|9751088|P4|Double Blind Treatment Period|Lost to Follow-up|0
2841252|NCT02513550|9751089|P3|Double Blind Treatment Period|Lost to Follow-up|11
2841253|NCT02513550|9751090|P2|Double Blind Treatment Period|Lost to Follow-up|7
2841254|NCT02513550|9751091|P1|Double Blind Treatment Period|Lost to Follow-up|9
2841255|NCT02513550|9751086|P6|Double Blind Treatment Period|Adverse Event|0
2841256|NCT02513550|9751087|P5|Double Blind Treatment Period|Adverse Event|1
2841257|NCT02513550|9751088|P4|Double Blind Treatment Period|Adverse Event|0
2841258|NCT02513550|9751089|P3|Double Blind Treatment Period|Adverse Event|17
2841259|NCT02513550|9751090|P2|Double Blind Treatment Period|Adverse Event|13
2841260|NCT02513550|9751091|P1|Double Blind Treatment Period|Adverse Event|5
2841261|NCT02513550|9751086|P6|Double Blind Treatment Period|Withdrawal by Subject|0
2841262|NCT02513550|9751087|P5|Double Blind Treatment Period|Withdrawal by Subject|0
2841263|NCT02513550|9751088|P4|Double Blind Treatment Period|Withdrawal by Subject|0
2841264|NCT02513550|9751089|P3|Double Blind Treatment Period|Withdrawal by Subject|25
2841265|NCT02513550|9751090|P2|Double Blind Treatment Period|Withdrawal by Subject|11
2841266|NCT02513550|9751091|P1|Double Blind Treatment Period|Withdrawal by Subject|11
2841267|NCT02513459|9751183|P1|Overall Study|Surgery planned-- not done|1
2841268|NCT02513459|9751183|P1|Overall Study|Reproductive plans|1
2841269|NCT02513459|9751183|P1|Overall Study|Lack of response|1
2841270|NCT02513459|9751183|P1|Overall Study|Subject decision|2
2841271|NCT02513459|9751183|P1|Overall Study|Pregnancy|2
2841272|NCT02513459|9751183|P1|Overall Study|Loss of efficacy|2
2841273|NCT02513459|9751183|P1|Overall Study|Withdrew consent|5
2841274|NCT02513459|9751183|P1|Overall Study|Adverse Event|7
2841275|NCT02513160|9751240|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2841276|NCT02513160|9751241|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2841277|NCT02513160|9751242|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
2841278|NCT02513160|9751243|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2841279|NCT02513160|9751240|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2841280|NCT02513160|9751241|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2841281|NCT02513160|9751242|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2841282|NCT02513160|9751243|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
2841283|NCT02513160|9751240|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2841284|NCT02513160|9751241|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2841285|NCT02513160|9751242|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2841286|NCT02513160|9751243|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
2841287|NCT02513160|9751240|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2841288|NCT02513160|9751241|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2841289|NCT02513160|9751242|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2841290|NCT02513160|9751243|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
2841291|NCT02513160|9751240|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
2841292|NCT02513160|9751241|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
2841293|NCT02513160|9751242|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2841294|NCT02513160|9751243|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2841295|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2841296|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2841297|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2841298|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
2841299|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2841300|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2841301|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2841302|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
2841303|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2841304|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2841305|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2841306|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
2841307|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2841308|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2841309|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2841310|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
2841311|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2841312|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2841313|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2841314|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
2841315|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2841316|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2841317|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2841318|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
2841319|NCT02513160|9751240|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2841320|NCT02513160|9751241|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2841321|NCT02513160|9751242|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2841322|NCT02513160|9751243|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
2841323|NCT02513095|9751301|P2|Overall Study|Stampede resulted in transfers out of ER|16
2841324|NCT02513095|9751302|P1|Overall Study|Stampede resulted in transfers out of ER|14
2841325|NCT02512861|9751348|P2|Overall Study|Withdrawal by Subject|1
2841326|NCT02512861|9751349|P1|Overall Study|Withdrawal by Subject|0
2841327|NCT02512861|9751348|P2|Overall Study|Physician Decision|1
2841328|NCT02512861|9751349|P1|Overall Study|Physician Decision|3
2841329|NCT02512861|9751348|P2|Overall Study|Protocol Violation|7
2841330|NCT02512861|9751349|P1|Overall Study|Protocol Violation|3
2841331|NCT02512302|9751627|P10|Period 4|Adverse Event|0
2841332|NCT02512302|9751628|P9|Period 4|Adverse Event|0
2841333|NCT02512302|9751629|P8|Period 4|Adverse Event|0
2841334|NCT02512302|9751630|P7|Period 4|Adverse Event|1
2841335|NCT02512302|9751631|P6|Period 4|Adverse Event|0
2841336|NCT02512302|9751632|P5|Period 4|Adverse Event|0
2841337|NCT02512302|9751633|P4|Period 4|Adverse Event|0
2841338|NCT02512302|9751634|P3|Period 4|Adverse Event|0
2841339|NCT02512302|9751635|P2|Period 4|Adverse Event|0
2841340|NCT02512302|9751636|P1|Period 4|Adverse Event|0
2841341|NCT02512302|9751627|P10|Period 3|Lost to Follow-up|0
2841342|NCT02512302|9751628|P9|Period 3|Lost to Follow-up|0
2841343|NCT02512302|9751629|P8|Period 3|Lost to Follow-up|0
2841344|NCT02512302|9751630|P7|Period 3|Lost to Follow-up|0
2841345|NCT02512302|9751631|P6|Period 3|Lost to Follow-up|0
2841346|NCT02512302|9751632|P5|Period 3|Lost to Follow-up|0
2841347|NCT02512302|9751633|P4|Period 3|Lost to Follow-up|0
2841348|NCT02512302|9751634|P3|Period 3|Lost to Follow-up|1
2841349|NCT02512302|9751635|P2|Period 3|Lost to Follow-up|0
2841350|NCT02512302|9751636|P1|Period 3|Lost to Follow-up|0
2841351|NCT02512302|9751627|P10|Period 2|Adverse Event|1
2841352|NCT02512302|9751628|P9|Period 2|Adverse Event|0
2841353|NCT02512302|9751629|P8|Period 2|Adverse Event|0
2841354|NCT02512302|9751630|P7|Period 2|Adverse Event|0
2841355|NCT02512302|9751631|P6|Period 2|Adverse Event|0
2841356|NCT02512302|9751632|P5|Period 2|Adverse Event|0
2841357|NCT02512302|9751633|P4|Period 2|Adverse Event|0
2841358|NCT02512302|9751634|P3|Period 2|Adverse Event|0
2841359|NCT02512302|9751635|P2|Period 2|Adverse Event|0
2841360|NCT02512302|9751636|P1|Period 2|Adverse Event|0
2841361|NCT02512302|9751627|P10|Period 1|Adverse Event|0
2841362|NCT02512302|9751628|P9|Period 1|Adverse Event|0
2841363|NCT02512302|9751629|P8|Period 1|Adverse Event|0
2841364|NCT02512302|9751630|P7|Period 1|Adverse Event|0
2841365|NCT02512302|9751631|P6|Period 1|Adverse Event|0
2841366|NCT02512302|9751632|P5|Period 1|Adverse Event|0
2841367|NCT02512302|9751633|P4|Period 1|Adverse Event|0
2841368|NCT02512302|9751634|P3|Period 1|Adverse Event|0
2841369|NCT02512302|9751635|P2|Period 1|Adverse Event|1
2841370|NCT02512302|9751636|P1|Period 1|Adverse Event|0
2841371|NCT02512068|9751752|P2|Overall Study|Reason Not Specified|5
2841372|NCT02512068|9751753|P1|Overall Study|Reason Not Specified|3
2841373|NCT02512068|9751752|P2|Overall Study|Lack of Efficacy|1
2841374|NCT02512068|9751753|P1|Overall Study|Lack of Efficacy|0
2841375|NCT02512068|9751752|P2|Overall Study|Voluntary Withdrawal|1
2841376|NCT02512068|9751753|P1|Overall Study|Voluntary Withdrawal|0
2841377|NCT02512068|9751752|P2|Overall Study|Major Protocol Deviation|0
2841378|NCT02512068|9751753|P1|Overall Study|Major Protocol Deviation|1
2841379|NCT02512068|9751752|P2|Overall Study|Pretreatment Event/Adverse Event|6
2841380|NCT02512068|9751753|P1|Overall Study|Pretreatment Event/Adverse Event|8
2841381|NCT02512042|9751779|P2|Overall Study|Other|11
2841382|NCT02512042|9751780|P1|Overall Study|Other|11
2841383|NCT02512042|9751779|P2|Overall Study|Lost to Follow-up|2
2841384|NCT02512042|9751780|P1|Overall Study|Lost to Follow-up|5
2841385|NCT02512042|9751779|P2|Overall Study|Non-compliance with study drug|2
2841386|NCT02512042|9751780|P1|Overall Study|Non-compliance with study drug|1
2841387|NCT02512042|9751779|P2|Overall Study|Withdrawal by Subject|6
2841388|NCT02512042|9751780|P1|Overall Study|Withdrawal by Subject|6
2841389|NCT02512042|9751779|P2|Overall Study|Adverse Event|4
2841390|NCT02512042|9751780|P1|Overall Study|Adverse Event|0
2841391|NCT02511782|9751789|P3|Overall Study|Withdrawal by Subject|0
2841392|NCT02511782|9751790|P2|Overall Study|Withdrawal by Subject|0
2841393|NCT02511782|9751791|P1|Overall Study|Withdrawal by Subject|1
2841394|NCT02511678|9751810|P1|Overall Study|Received Radiation Treatment|1
2841395|NCT02511678|9751810|P1|Overall Study|Protocol Violation|1
2841396|NCT02511678|9751810|P1|Overall Study|Biopsy was Negative|1
2841397|NCT02511678|9751810|P1|Overall Study|Required Radiofrequency Ablation|1
2841398|NCT02511678|9751810|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
2841399|NCT02511678|9751810|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
2841400|NCT02511678|9751810|P1|Overall Study|Adverse Event|1
2841401|NCT02511678|9751810|P1|Overall Study|Death|19
2841402|NCT02511678|9751810|P1|Overall Study|Lost to Follow-up|4
2841403|NCT02511678|9751810|P1|Overall Study|Withdrawal by Subject|2
2841404|NCT02511431|9751864|P6|Treatment|Lost to Follow-up|1
2841405|NCT02511431|9751865|P5|Treatment|Lost to Follow-up|0
2841406|NCT02511431|9751866|P4|Treatment|Lost to Follow-up|0
2841407|NCT02511431|9751867|P3|Treatment|Lost to Follow-up|1
2841408|NCT02511431|9751868|P2|Treatment|Lost to Follow-up|0
2841409|NCT02511431|9751869|P1|Treatment|Lost to Follow-up|0
2841410|NCT02511184|9751896|P2|Overall Study|Withdrawal by Subject|1
2841411|NCT02511184|9751897|P1|Overall Study|Withdrawal by Subject|0
2841412|NCT02511184|9751896|P2|Overall Study|Study terminated by sponsor|5
2841413|NCT02511184|9751897|P1|Overall Study|Study terminated by sponsor|1
2841414|NCT02511184|9751896|P2|Overall Study|Lost to Follow-up|1
2841415|NCT02511184|9751897|P1|Overall Study|Lost to Follow-up|0
2841416|NCT02511184|9751896|P2|Overall Study|Death|0
2841417|NCT02511184|9751897|P1|Overall Study|Death|1
2841418|NCT02510820|9751947|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2841419|NCT02510820|9751948|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2841420|NCT02510820|9751947|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
2841421|NCT02510820|9751948|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
2841422|NCT02510664|9751989|P3|Overall Study|Time Constraints|0
2841423|NCT02510664|9751990|P2|Overall Study|Time Constraints|1
2841424|NCT02510664|9751991|P1|Overall Study|Time Constraints|1
2841425|NCT02510664|9751989|P3|Overall Study|Provider Retired/No Time to Reschedule|0
2841426|NCT02510664|9751990|P2|Overall Study|Provider Retired/No Time to Reschedule|10
2841427|NCT02510664|9751991|P1|Overall Study|Provider Retired/No Time to Reschedule|10
2841428|NCT02510664|9751989|P3|Overall Study|Transferred Care|0
2841429|NCT02510664|9751990|P2|Overall Study|Transferred Care|9
2841430|NCT02510664|9751991|P1|Overall Study|Transferred Care|9
2841431|NCT02510014|9752033|P2|Treatment Period|Incarceration, pregnancy, misc|5
2841432|NCT02510014|9752034|P1|Treatment Period|Incarceration, pregnancy, misc|29
2841433|NCT02510014|9752033|P2|Treatment Period|Protocol Violation|4
2841434|NCT02510014|9752034|P1|Treatment Period|Protocol Violation|4
2841435|NCT02510014|9752033|P2|Treatment Period|Withdrawn by the investigator|1
2841436|NCT02510014|9752034|P1|Treatment Period|Withdrawn by the investigator|7
2841437|NCT02510014|9752033|P2|Treatment Period|Withdrawal by Subject|24
2841438|NCT02510014|9752034|P1|Treatment Period|Withdrawal by Subject|67
2841439|NCT02510014|9752033|P2|Treatment Period|Physician Decision|0
2841440|NCT02510014|9752034|P1|Treatment Period|Physician Decision|5
2841441|NCT02510014|9752033|P2|Treatment Period|Lost to Follow-up|19
2841442|NCT02510014|9752034|P1|Treatment Period|Lost to Follow-up|80
2841443|NCT02510014|9752033|P2|Treatment Period|Withdrawal symptoms|0
2841444|NCT02510014|9752034|P1|Treatment Period|Withdrawal symptoms|3
2841445|NCT02510014|9752033|P2|Treatment Period|Adverse Event|4
2841446|NCT02510014|9752034|P1|Treatment Period|Adverse Event|11
2841447|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Other|1
2841448|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Other|19
2841449|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
2841450|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
2841451|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
2841452|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
2841453|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
2841454|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
2841455|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
2841456|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
2841457|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
2841458|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
2841459|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
2841460|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
2841461|NCT02510014|9752033|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2841462|NCT02510014|9752034|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2841463|NCT02509117|9752137|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
2841464|NCT02509117|9752138|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841465|NCT02509117|9752139|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841466|NCT02509117|9752140|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841467|NCT02509117|9752141|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841468|NCT02509117|9752142|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841469|NCT02509117|9752143|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841470|NCT02509117|9752144|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841471|NCT02509117|9752145|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841472|NCT02509117|9752146|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2841473|NCT02509117|9752137|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
2841474|NCT02509117|9752138|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841475|NCT02509117|9752139|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841476|NCT02509117|9752140|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841477|NCT02509117|9752141|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841478|NCT02509117|9752142|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841479|NCT02509117|9752143|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841480|NCT02509117|9752144|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841481|NCT02509117|9752145|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841482|NCT02509117|9752146|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2841483|NCT02509117|9752137|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841484|NCT02509117|9752138|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841485|NCT02509117|9752139|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841486|NCT02509117|9752140|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841487|NCT02509117|9752141|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841488|NCT02509117|9752142|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841489|NCT02509117|9752143|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841490|NCT02509117|9752144|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841491|NCT02509117|9752145|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
2841492|NCT02509117|9752146|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2841493|NCT02509078|9752357|P2|Overall Study|Protocol Violation|1
2841494|NCT02509078|9752358|P1|Overall Study|Protocol Violation|1
2841495|NCT02508935|9752501|P1|Overall Study|Trial terminated by sponsor|5
2841496|NCT02508935|9752501|P1|Overall Study|Physician Decision|1
2841497|NCT02508935|9752501|P1|Overall Study|Protocol Violation|1
2841498|NCT02508935|9752501|P1|Overall Study|Adverse Event|3
2841499|NCT02508935|9752501|P1|Overall Study|Emesis|3
2841500|NCT02508935|9752501|P1|Overall Study|Pain Score <4|1
2841501|NCT02508935|9752501|P1|Overall Study|Withdrawal by Caregiver|8
2841502|NCT02508935|9752501|P1|Overall Study|Withdrawal by Subject|1
2841503|NCT02508701|9752517|P4|Overall Study|Lost to Follow-up|3
2841504|NCT02508701|9752518|P3|Overall Study|Lost to Follow-up|5
2841505|NCT02508701|9752519|P2|Overall Study|Lost to Follow-up|5
2841506|NCT02508701|9752520|P1|Overall Study|Lost to Follow-up|9
2841507|NCT02508194|9752605|P2|Overall Study|Principal Investigator Decision|2
2841508|NCT02508194|9752606|P1|Overall Study|Principal Investigator Decision|1
2841509|NCT02508194|9752605|P2|Overall Study|Error in Randomization|3
2841510|NCT02508194|9752606|P1|Overall Study|Error in Randomization|1
2841511|NCT02508194|9752605|P2|Overall Study|Withdrawal by Subject|18
2841512|NCT02508194|9752606|P1|Overall Study|Withdrawal by Subject|20
2841513|NCT02508194|9752605|P2|Overall Study|Lost to Follow-up|18
2841514|NCT02508194|9752606|P1|Overall Study|Lost to Follow-up|25
2841515|NCT02508194|9752605|P2|Overall Study|Death|3
2841516|NCT02508194|9752606|P1|Overall Study|Death|5
2841517|NCT02508116|9752646|P2|Overall Study|Physician Decision|0
2841518|NCT02508116|9752647|P1|Overall Study|Physician Decision|2
2841519|NCT02508116|9752646|P2|Overall Study|Protocol Violation|2
2841520|NCT02508116|9752647|P1|Overall Study|Protocol Violation|1
2841521|NCT02508116|9752646|P2|Overall Study|Withdrawal by Subject|2
2841522|NCT02508116|9752647|P1|Overall Study|Withdrawal by Subject|3
2841523|NCT02508116|9752646|P2|Overall Study|Lost to Follow-up|3
2841524|NCT02508116|9752647|P1|Overall Study|Lost to Follow-up|2
2841525|NCT02507973|9752674|P1|Overall Study|Adverse Event|1
2841526|NCT02507752|9752680|P1|Overall Study|Participant didn't perform visit Week 24|1
2841527|NCT02507752|9752680|P1|Overall Study|Participant didn't perform visit Week 12|1
2841528|NCT02507752|9752680|P1|Overall Study|Infusion reaction at first infusion|1
2841529|NCT02507752|9752680|P1|Overall Study|Lost to Follow-up|7
2841530|NCT02507752|9752680|P1|Overall Study|Protocol Violation|6
2841531|NCT02507752|9752680|P1|Overall Study|Adverse Event|1
2841532|NCT02507375|9752724|P2|Overall Study|Adverse Event|1
2841533|NCT02507375|9752725|P1|Overall Study|Adverse Event|0
2841534|NCT02507375|9752724|P2|Overall Study|Refused treatment|1
2841535|NCT02507375|9752725|P1|Overall Study|Refused treatment|0
2841536|NCT02507375|9752724|P2|Overall Study|Death|1
2841537|NCT02507375|9752725|P1|Overall Study|Death|0
2841538|NCT02507375|9752724|P2|Overall Study|Progressive Disease|5
2841539|NCT02507375|9752725|P1|Overall Study|Progressive Disease|4
2841540|NCT02507349|9752744|P2|Overall Study|Lost to Follow-up|144
2841541|NCT02507349|9752745|P1|Overall Study|Lost to Follow-up|174
2841542|NCT02507349|9752744|P2|Overall Study|Withdrawal by Subject|1
2841543|NCT02507349|9752745|P1|Overall Study|Withdrawal by Subject|1
2841544|NCT02507349|9752744|P2|Overall Study|Death|16
2841545|NCT02507349|9752745|P1|Overall Study|Death|12
2841546|NCT02507219|9752769|P6|Overall Study|Withdrawal by Subject|0
2841547|NCT02507219|9752770|P5|Overall Study|Withdrawal by Subject|1
2841548|NCT02507219|9752771|P4|Overall Study|Withdrawal by Subject|0
2841549|NCT02507219|9752772|P3|Overall Study|Withdrawal by Subject|0
2841550|NCT02507219|9752773|P2|Overall Study|Withdrawal by Subject|0
2841551|NCT02507219|9752774|P1|Overall Study|Withdrawal by Subject|0
2841552|NCT02507219|9752769|P6|Overall Study|Physician Decision|0
2841553|NCT02507219|9752770|P5|Overall Study|Physician Decision|0
2841554|NCT02507219|9752771|P4|Overall Study|Physician Decision|0
2841555|NCT02507219|9752772|P3|Overall Study|Physician Decision|0
2841556|NCT02507219|9752773|P2|Overall Study|Physician Decision|0
2841557|NCT02507219|9752774|P1|Overall Study|Physician Decision|1
2841558|NCT02506881|9752803|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
2841559|NCT02506881|9752804|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
2841560|NCT02506881|9752805|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
2841561|NCT02506881|9752806|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
2841562|NCT02506881|9752803|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2841563|NCT02506881|9752804|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2841564|NCT02506881|9752805|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2841565|NCT02506881|9752806|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2841566|NCT02506881|9752803|P4|First Intervention (Day 1)|Protocol Violation|0
2841567|NCT02506881|9752804|P3|First Intervention (Day 1)|Protocol Violation|1
2841568|NCT02506881|9752805|P2|First Intervention (Day 1)|Protocol Violation|0
2841569|NCT02506881|9752806|P1|First Intervention (Day 1)|Protocol Violation|0
2841570|NCT02506816|9752879|P1|Overall Study|Adverse Event|3
2841571|NCT02506257|9753005|P4|Overall Study|Protocol Violation|0
2841572|NCT02506257|9753006|P3|Overall Study|Protocol Violation|1
2841573|NCT02506257|9753007|P2|Overall Study|Protocol Violation|0
2841574|NCT02506257|9753008|P1|Overall Study|Protocol Violation|0
2841575|NCT02506257|9753005|P4|Overall Study|Adverse Event|0
2841576|NCT02506257|9753006|P3|Overall Study|Adverse Event|3
2841577|NCT02506257|9753007|P2|Overall Study|Adverse Event|2
2841578|NCT02506257|9753008|P1|Overall Study|Adverse Event|0
2841579|NCT02506101|9753040|P2|Overall Study|No enrollment and staff unavailability|0
2841580|NCT02506101|9753041|P1|Overall Study|No enrollment and staff unavailability|1
2841581|NCT02506101|9753040|P2|Overall Study|Transportation issues|0
2841582|NCT02506101|9753041|P1|Overall Study|Transportation issues|1
2841583|NCT02506036|9753057|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
2841584|NCT02506036|9753058|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
2841585|NCT02506036|9753057|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
2841586|NCT02506036|9753058|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
2841587|NCT02506036|9753057|P2|First Intervention (4-6 Weeks)|Death|0
2841588|NCT02506036|9753058|P1|First Intervention (4-6 Weeks)|Death|1
2841589|NCT02505945|9753066|P2|Overall Study|Lost to Follow-up|1
2841590|NCT02505945|9753067|P1|Overall Study|Lost to Follow-up|6
2841591|NCT02505945|9753066|P2|Overall Study|Physician Decision|1
2841592|NCT02505945|9753067|P1|Overall Study|Physician Decision|2
2841593|NCT02505945|9753066|P2|Overall Study|Adverse Event|0
2841594|NCT02505945|9753067|P1|Overall Study|Adverse Event|1
2841595|NCT02505945|9753066|P2|Overall Study|Withdrawal by Subject|2
2841596|NCT02505945|9753067|P1|Overall Study|Withdrawal by Subject|13
2841597|NCT02505867|9753088|P2|Overall Study|Lack of Efficacy|6
2841598|NCT02505867|9753089|P1|Overall Study|Lack of Efficacy|6
2841599|NCT02505542|9753095|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
2841600|NCT02505542|9753096|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
2841601|NCT02505542|9753097|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
2841602|NCT02505542|9753098|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
2841603|NCT02505542|9753095|P4|Part B: Double-Blind Period|Miscalculation|0
2841604|NCT02505542|9753096|P3|Part B: Double-Blind Period|Miscalculation|0
2841605|NCT02505542|9753097|P2|Part B: Double-Blind Period|Miscalculation|1
2841606|NCT02505542|9753098|P1|Part B: Double-Blind Period|Miscalculation|0
2841607|NCT02505542|9753095|P4|Part B: Double-Blind Period|Lack of Efficacy|0
2841608|NCT02505542|9753096|P3|Part B: Double-Blind Period|Lack of Efficacy|0
2841609|NCT02505542|9753097|P2|Part B: Double-Blind Period|Lack of Efficacy|1
2841610|NCT02505542|9753098|P1|Part B: Double-Blind Period|Lack of Efficacy|0
2841611|NCT02505542|9753095|P4|Part B: Double-Blind Period|Patient was moved from the country|1
2841612|NCT02505542|9753096|P3|Part B: Double-Blind Period|Patient was moved from the country|0
2841613|NCT02505542|9753097|P2|Part B: Double-Blind Period|Patient was moved from the country|0
2841614|NCT02505542|9753098|P1|Part B: Double-Blind Period|Patient was moved from the country|0
2841615|NCT02505542|9753095|P4|Part B: Double-Blind Period|Week 94 missed|0
2841616|NCT02505542|9753096|P3|Part B: Double-Blind Period|Week 94 missed|1
2841617|NCT02505542|9753097|P2|Part B: Double-Blind Period|Week 94 missed|0
2841618|NCT02505542|9753098|P1|Part B: Double-Blind Period|Week 94 missed|0
2841619|NCT02505542|9753095|P4|Part B: Double-Blind Period|Planning pregnancy|0
2841620|NCT02505542|9753096|P3|Part B: Double-Blind Period|Planning pregnancy|0
2841621|NCT02505542|9753097|P2|Part B: Double-Blind Period|Planning pregnancy|1
2841622|NCT02505542|9753098|P1|Part B: Double-Blind Period|Planning pregnancy|0
2841623|NCT02505542|9753095|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
2841624|NCT02505542|9753096|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
2841625|NCT02505542|9753097|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
2841626|NCT02505542|9753098|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
2841627|NCT02505542|9753095|P4|Part B: Double-Blind Period|Lost to Follow-up|1
2841628|NCT02505542|9753096|P3|Part B: Double-Blind Period|Lost to Follow-up|0
2841629|NCT02505542|9753097|P2|Part B: Double-Blind Period|Lost to Follow-up|0
2841630|NCT02505542|9753098|P1|Part B: Double-Blind Period|Lost to Follow-up|0
2841631|NCT02505542|9753095|P4|Part B: Double-Blind Period|Adverse Event|3
2841632|NCT02505542|9753096|P3|Part B: Double-Blind Period|Adverse Event|1
2841633|NCT02505542|9753097|P2|Part B: Double-Blind Period|Adverse Event|0
2841634|NCT02505542|9753098|P1|Part B: Double-Blind Period|Adverse Event|0
2841635|NCT02505542|9753095|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2841636|NCT02505542|9753096|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2841637|NCT02505542|9753097|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2841638|NCT02505542|9753098|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
2841639|NCT02505542|9753095|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2841640|NCT02505542|9753096|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2841641|NCT02505542|9753097|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2841642|NCT02505542|9753098|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
2841643|NCT02505542|9753095|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2841644|NCT02505542|9753096|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2841645|NCT02505542|9753097|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2841646|NCT02505542|9753098|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
2841647|NCT02505542|9753095|P4|Part A: Open-Label Period|Non-compliance|0
2841648|NCT02505542|9753096|P3|Part A: Open-Label Period|Non-compliance|0
2841649|NCT02505542|9753097|P2|Part A: Open-Label Period|Non-compliance|0
2841650|NCT02505542|9753098|P1|Part A: Open-Label Period|Non-compliance|1
2841651|NCT02505542|9753095|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
2841652|NCT02505542|9753096|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
2841653|NCT02505542|9753097|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
2841654|NCT02505542|9753098|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
2841655|NCT02505542|9753095|P4|Part A: Open-Label Period|Medical monitor decision|0
2841656|NCT02505542|9753096|P3|Part A: Open-Label Period|Medical monitor decision|0
2841657|NCT02505542|9753097|P2|Part A: Open-Label Period|Medical monitor decision|0
2841658|NCT02505542|9753098|P1|Part A: Open-Label Period|Medical monitor decision|1
2841659|NCT02505542|9753095|P4|Part A: Open-Label Period|Sponsor directive|0
2841660|NCT02505542|9753096|P3|Part A: Open-Label Period|Sponsor directive|0
2841661|NCT02505542|9753097|P2|Part A: Open-Label Period|Sponsor directive|0
2841662|NCT02505542|9753098|P1|Part A: Open-Label Period|Sponsor directive|1
2841663|NCT02505542|9753095|P4|Part A: Open-Label Period|Pregnancy|0
2841664|NCT02505542|9753096|P3|Part A: Open-Label Period|Pregnancy|0
2841665|NCT02505542|9753097|P2|Part A: Open-Label Period|Pregnancy|0
2841666|NCT02505542|9753098|P1|Part A: Open-Label Period|Pregnancy|2
2841667|NCT02505542|9753095|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2841668|NCT02505542|9753096|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2841669|NCT02505542|9753097|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2841670|NCT02505542|9753098|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
2841671|NCT02505542|9753095|P4|Part A: Open-Label Period|New medical history available|0
2841672|NCT02505542|9753096|P3|Part A: Open-Label Period|New medical history available|0
2841673|NCT02505542|9753097|P2|Part A: Open-Label Period|New medical history available|0
2841674|NCT02505542|9753098|P1|Part A: Open-Label Period|New medical history available|1
2841675|NCT02505542|9753095|P4|Part A: Open-Label Period|Withdrawal by Subject|0
2841676|NCT02505542|9753096|P3|Part A: Open-Label Period|Withdrawal by Subject|0
2841677|NCT02505542|9753097|P2|Part A: Open-Label Period|Withdrawal by Subject|0
2841678|NCT02505542|9753098|P1|Part A: Open-Label Period|Withdrawal by Subject|27
2841679|NCT02505542|9753095|P4|Part A: Open-Label Period|Lost to Follow-up|0
2841680|NCT02505542|9753096|P3|Part A: Open-Label Period|Lost to Follow-up|0
2841681|NCT02505542|9753097|P2|Part A: Open-Label Period|Lost to Follow-up|0
2841682|NCT02505542|9753098|P1|Part A: Open-Label Period|Lost to Follow-up|5
2841683|NCT02505542|9753095|P4|Part A: Open-Label Period|Protocol Violation|0
2841684|NCT02505542|9753096|P3|Part A: Open-Label Period|Protocol Violation|0
2841685|NCT02505542|9753097|P2|Part A: Open-Label Period|Protocol Violation|0
2841686|NCT02505542|9753098|P1|Part A: Open-Label Period|Protocol Violation|1
2841687|NCT02505542|9753095|P4|Part A: Open-Label Period|Lack of Efficacy|0
2841688|NCT02505542|9753096|P3|Part A: Open-Label Period|Lack of Efficacy|0
2841689|NCT02505542|9753097|P2|Part A: Open-Label Period|Lack of Efficacy|0
2841690|NCT02505542|9753098|P1|Part A: Open-Label Period|Lack of Efficacy|5
2841691|NCT02505542|9753095|P4|Part A: Open-Label Period|Adverse Event|0
2841692|NCT02505542|9753096|P3|Part A: Open-Label Period|Adverse Event|0
2841693|NCT02505542|9753097|P2|Part A: Open-Label Period|Adverse Event|0
2841694|NCT02505542|9753098|P1|Part A: Open-Label Period|Adverse Event|31
2841695|NCT02505334|9753206|P2|Extension Treatment Period|Unclassified|0
2841696|NCT02505334|9753207|P1|Extension Treatment Period|Unclassified|3
2841697|NCT02505334|9753206|P2|Extension Treatment Period|Withdrawal by Subject|0
2841698|NCT02505334|9753207|P1|Extension Treatment Period|Withdrawal by Subject|6
2841699|NCT02505334|9753206|P2|Extension Treatment Period|Lack of Efficacy|0
2841700|NCT02505334|9753207|P1|Extension Treatment Period|Lack of Efficacy|4
2841701|NCT02505334|9753206|P2|Extension Treatment Period|Adverse Event|0
2841702|NCT02505334|9753207|P1|Extension Treatment Period|Adverse Event|5
2841703|NCT02505334|9753206|P2|Main Treatment Period|Unclassified|10
2841704|NCT02505334|9753207|P1|Main Treatment Period|Unclassified|4
2841705|NCT02505334|9753206|P2|Main Treatment Period|Withdrawal by Subject|8
2841706|NCT02505334|9753207|P1|Main Treatment Period|Withdrawal by Subject|1
2841707|NCT02505334|9753206|P2|Main Treatment Period|Protocol Violation|1
2841708|NCT02505334|9753207|P1|Main Treatment Period|Protocol Violation|0
2841709|NCT02505334|9753206|P2|Main Treatment Period|Lack of Efficacy|17
2841710|NCT02505334|9753207|P1|Main Treatment Period|Lack of Efficacy|7
2841711|NCT02505334|9753206|P2|Main Treatment Period|Adverse Event|3
2841712|NCT02505334|9753207|P1|Main Treatment Period|Adverse Event|3
2841713|NCT02505217|9753334|P2|Overall Study|Withdrawal by Subject|2
2841714|NCT02505217|9753335|P1|Overall Study|Withdrawal by Subject|1
2841715|NCT02504892|9753354|P1|Overall Study|Adverse event-pneumonitis|2
2841716|NCT02504827|9753361|P1|Overall Study|Could not produce sputum|1
2841717|NCT02504671|9753400|P6|Overall Study|Protocol defined stopping criteria|3
2841718|NCT02504671|9753401|P5|Overall Study|Protocol defined stopping criteria|3
2841719|NCT02504671|9753402|P4|Overall Study|Protocol defined stopping criteria|5
2841720|NCT02504671|9753403|P3|Overall Study|Protocol defined stopping criteria|3
2841721|NCT02504671|9753404|P2|Overall Study|Protocol defined stopping criteria|4
2841722|NCT02504671|9753405|P1|Overall Study|Protocol defined stopping criteria|7
2841723|NCT02504671|9753400|P6|Overall Study|Lost to Follow-up|1
2841724|NCT02504671|9753401|P5|Overall Study|Lost to Follow-up|0
2841725|NCT02504671|9753402|P4|Overall Study|Lost to Follow-up|0
2841726|NCT02504671|9753403|P3|Overall Study|Lost to Follow-up|2
2841727|NCT02504671|9753404|P2|Overall Study|Lost to Follow-up|0
2841728|NCT02504671|9753405|P1|Overall Study|Lost to Follow-up|0
2841729|NCT02504671|9753400|P6|Overall Study|Protocol Violation|1
2841730|NCT02504671|9753401|P5|Overall Study|Protocol Violation|0
2841731|NCT02504671|9753402|P4|Overall Study|Protocol Violation|0
2841732|NCT02504671|9753403|P3|Overall Study|Protocol Violation|0
2841733|NCT02504671|9753404|P2|Overall Study|Protocol Violation|1
2841734|NCT02504671|9753405|P1|Overall Study|Protocol Violation|2
2841735|NCT02504671|9753400|P6|Overall Study|Adverse Event|2
2841736|NCT02504671|9753401|P5|Overall Study|Adverse Event|0
2841737|NCT02504671|9753402|P4|Overall Study|Adverse Event|1
2841738|NCT02504671|9753403|P3|Overall Study|Adverse Event|0
2841739|NCT02504671|9753404|P2|Overall Study|Adverse Event|1
2841740|NCT02504671|9753405|P1|Overall Study|Adverse Event|1
2841741|NCT02504671|9753400|P6|Overall Study|Lack of Efficacy|4
2841742|NCT02504671|9753401|P5|Overall Study|Lack of Efficacy|4
2841743|NCT02504671|9753402|P4|Overall Study|Lack of Efficacy|0
2841744|NCT02504671|9753403|P3|Overall Study|Lack of Efficacy|1
2841745|NCT02504671|9753404|P2|Overall Study|Lack of Efficacy|3
2841746|NCT02504671|9753405|P1|Overall Study|Lack of Efficacy|1
2841747|NCT02504671|9753400|P6|Overall Study|Withdrawal by Subject|3
2841748|NCT02504671|9753401|P5|Overall Study|Withdrawal by Subject|5
2841749|NCT02504671|9753402|P4|Overall Study|Withdrawal by Subject|4
2841750|NCT02504671|9753403|P3|Overall Study|Withdrawal by Subject|4
2841751|NCT02504671|9753404|P2|Overall Study|Withdrawal by Subject|5
2841752|NCT02504671|9753405|P1|Overall Study|Withdrawal by Subject|1
2841753|NCT02504541|9753577|P1|Overall Study|Multiple|5
2841754|NCT02504541|9753577|P1|Overall Study|Other|2
2841755|NCT02504541|9753577|P1|Overall Study|Termination by Sponsor|1
2841756|NCT02504541|9753577|P1|Overall Study|Protocol Violation|2
2841757|NCT02504541|9753577|P1|Overall Study|Met Stopping Criteria|1
2841758|NCT02504541|9753577|P1|Overall Study|Lost to Follow-up|1
2841759|NCT02504541|9753577|P1|Overall Study|Withdrawal by Subject|4
2841760|NCT02504541|9753577|P1|Overall Study|Adverse Event|4
2841761|NCT02504502|9753583|P2|Crossover to Enhanced Report|Lost to Follow-up|0
2841762|NCT02504502|9753584|P1|Crossover to Enhanced Report|Lost to Follow-up|5
2841763|NCT02504502|9753583|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
2841764|NCT02504502|9753584|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
2841765|NCT02504424|9753590|P1|Overall Study|Withdrawal by Subject|2
2841766|NCT02504320|9753599|P4|Treatment Period 3|Adverse Event|0
2841767|NCT02504320|9753600|P3|Treatment Period 3|Adverse Event|1
2841768|NCT02504320|9753601|P2|Treatment Period 3|Adverse Event|0
2841769|NCT02504320|9753602|P1|Treatment Period 3|Adverse Event|0
2841770|NCT02504320|9753599|P4|Treatment Period 3|Positive Drug Screen|1
2841771|NCT02504320|9753600|P3|Treatment Period 3|Positive Drug Screen|0
2841772|NCT02504320|9753601|P2|Treatment Period 3|Positive Drug Screen|0
2841773|NCT02504320|9753602|P1|Treatment Period 3|Positive Drug Screen|0
2841774|NCT02504320|9753599|P4|Treatment Period 2|Positive Drug Screen|0
2841775|NCT02504320|9753600|P3|Treatment Period 2|Positive Drug Screen|0
2841776|NCT02504320|9753601|P2|Treatment Period 2|Positive Drug Screen|1
2841777|NCT02504320|9753602|P1|Treatment Period 2|Positive Drug Screen|0
2841778|NCT02504320|9753599|P4|Treatment Period 1|Positive Drug Screen|0
2841779|NCT02504320|9753600|P3|Treatment Period 1|Positive Drug Screen|1
2841780|NCT02504320|9753601|P2|Treatment Period 1|Positive Drug Screen|0
2841781|NCT02504320|9753602|P1|Treatment Period 1|Positive Drug Screen|0
2841782|NCT02504294|9753622|P2|Overall Study|Lost to Follow-up|7
2841783|NCT02504294|9753623|P1|Overall Study|Lost to Follow-up|6
2841784|NCT02504294|9753622|P2|Overall Study|Physician Decision|2
2841785|NCT02504294|9753623|P1|Overall Study|Physician Decision|1
2841786|NCT02504294|9753622|P2|Overall Study|Protocol Violation|26
2841787|NCT02504294|9753623|P1|Overall Study|Protocol Violation|27
2841788|NCT02504294|9753622|P2|Overall Study|Withdrawal by Subject|1
2841789|NCT02504294|9753623|P1|Overall Study|Withdrawal by Subject|7
2841790|NCT02504294|9753622|P2|Overall Study|Adverse Event|12
2841791|NCT02504294|9753623|P1|Overall Study|Adverse Event|15
2841792|NCT02504268|9753633|P2|Overall Study|Not Disclosed|0
2841793|NCT02504268|9753634|P1|Overall Study|Not Disclosed|1
2841794|NCT02504268|9753633|P2|Overall Study|Poor/Non-Compliance|2
2841795|NCT02504268|9753634|P1|Overall Study|Poor/Non-Compliance|3
2841796|NCT02504268|9753633|P2|Overall Study|Lack of Efficacy|35
2841797|NCT02504268|9753634|P1|Overall Study|Lack of Efficacy|11
2841798|NCT02504268|9753633|P2|Overall Study|No Longer Meets Study Criteria|3
2841799|NCT02504268|9753634|P1|Overall Study|No Longer Meets Study Criteria|2
2841800|NCT02504268|9753633|P2|Overall Study|Subject Request to Discontinue|3
2841801|NCT02504268|9753634|P1|Overall Study|Subject Request to Discontinue|11
2841802|NCT02504268|9753633|P2|Overall Study|Death|1
2841803|NCT02504268|9753634|P1|Overall Study|Death|1
2841804|NCT02504268|9753633|P2|Overall Study|Lost to Follow-up|6
2841805|NCT02504268|9753634|P1|Overall Study|Lost to Follow-up|3
2841806|NCT02504268|9753633|P2|Overall Study|Pregnancy|0
2841807|NCT02504268|9753634|P1|Overall Study|Pregnancy|2
2841808|NCT02504268|9753633|P2|Overall Study|Withdrawal of Consent|10
2841809|NCT02504268|9753634|P1|Overall Study|Withdrawal of Consent|11
2841810|NCT02504268|9753633|P2|Overall Study|Adverse Event|8
2841811|NCT02504268|9753634|P1|Overall Study|Adverse Event|18
2841812|NCT02503865|9753669|P3|Overall Study|Refused treatment|2
2841813|NCT02503865|9753670|P2|Overall Study|Refused treatment|39
2841814|NCT02503865|9753671|P1|Overall Study|Refused treatment|4
2841815|NCT02503865|9753669|P3|Overall Study|Moved out of area|0
2841816|NCT02503865|9753670|P2|Overall Study|Moved out of area|8
2841817|NCT02503865|9753671|P1|Overall Study|Moved out of area|1
2841818|NCT02503787|9753716|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
2841819|NCT02503787|9753716|P1|Implant to 3 Month Endpoint|Adverse Event|2
2841820|NCT02503787|9753716|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
2841821|NCT02503787|9753716|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
2841822|NCT02503787|9753716|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
2841823|NCT02503787|9753716|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
2841824|NCT02503787|9753716|P1|Enrollment|Unable to be programmed|1
2841825|NCT02503787|9753716|P1|Enrollment|Inability to implant system|1
2841826|NCT02503787|9753716|P1|Enrollment|Protocol Violation|1
2841827|NCT02503787|9753716|P1|Enrollment|Adverse Event|1
2841828|NCT02503787|9753716|P1|Enrollment|Study closure|1
2841829|NCT02503787|9753716|P1|Enrollment|Lost to Follow-up|1
2841830|NCT02503787|9753716|P1|Enrollment|Insurance issue|2
2841831|NCT02503787|9753716|P1|Enrollment|Physician Decision|2
2841832|NCT02503787|9753716|P1|Enrollment|Inclusion/exclusion criteria not met|4
2841833|NCT02503787|9753716|P1|Enrollment|Withdrawal by Subject|6
2841834|NCT02503540|9753733|P1|Overall Study|Withdrawal by Subject|1
2841835|NCT02503540|9753733|P1|Overall Study|Death|2
2841836|NCT02503501|9753754|P2|Overall Study|Withdrawal by Subject|2
2841837|NCT02503501|9753755|P1|Overall Study|Withdrawal by Subject|0
2841838|NCT02503501|9753754|P2|Overall Study|Protocol Violation|1
2841839|NCT02503501|9753755|P1|Overall Study|Protocol Violation|0
2841840|NCT02503501|9753754|P2|Overall Study|Physician Decision|0
2841841|NCT02503501|9753755|P1|Overall Study|Physician Decision|1
2841842|NCT02503215|9753804|P1|Overall Study|Unable to use positive airway pressure|2
2841843|NCT02503215|9753804|P1|Overall Study|Unable to wear compression stockings|1
2841844|NCT02503202|9753815|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
2841845|NCT02503202|9753816|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
2841846|NCT02503202|9753817|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
2841847|NCT02503202|9753818|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
2841848|NCT02503202|9753819|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
2841849|NCT02503202|9753815|P5|Extension: Month 6 to 24|Physician Decision|0
2841850|NCT02503202|9753816|P4|Extension: Month 6 to 24|Physician Decision|3
2841851|NCT02503202|9753817|P3|Extension: Month 6 to 24|Physician Decision|1
2841852|NCT02503202|9753818|P2|Extension: Month 6 to 24|Physician Decision|0
2841853|NCT02503202|9753819|P1|Extension: Month 6 to 24|Physician Decision|1
2841854|NCT02503202|9753815|P5|Extension: Month 6 to 24|Lost to Follow-up|1
2841855|NCT02503202|9753816|P4|Extension: Month 6 to 24|Lost to Follow-up|10
2841856|NCT02503202|9753817|P3|Extension: Month 6 to 24|Lost to Follow-up|6
2841857|NCT02503202|9753818|P2|Extension: Month 6 to 24|Lost to Follow-up|8
2841858|NCT02503202|9753819|P1|Extension: Month 6 to 24|Lost to Follow-up|4
2841859|NCT02503202|9753815|P5|Extension: Month 6 to 24|Death|0
2841860|NCT02503202|9753816|P4|Extension: Month 6 to 24|Death|0
2841861|NCT02503202|9753817|P3|Extension: Month 6 to 24|Death|0
2841862|NCT02503202|9753818|P2|Extension: Month 6 to 24|Death|0
2841863|NCT02503202|9753819|P1|Extension: Month 6 to 24|Death|1
2841864|NCT02503202|9753815|P5|Extension: Month 6 to 24|Protocol Violation|0
2841865|NCT02503202|9753816|P4|Extension: Month 6 to 24|Protocol Violation|1
2841866|NCT02503202|9753817|P3|Extension: Month 6 to 24|Protocol Violation|0
2841867|NCT02503202|9753818|P2|Extension: Month 6 to 24|Protocol Violation|0
2841868|NCT02503202|9753819|P1|Extension: Month 6 to 24|Protocol Violation|0
2841869|NCT02503202|9753815|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
2841870|NCT02503202|9753816|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
2841871|NCT02503202|9753817|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
2841872|NCT02503202|9753818|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
2841873|NCT02503202|9753819|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
2841874|NCT02503202|9753815|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
2841875|NCT02503202|9753816|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
2841876|NCT02503202|9753817|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
2841877|NCT02503202|9753818|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
2841878|NCT02503202|9753819|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
2841879|NCT02503202|9753815|P5|Base Study: Up to Month 6|Physician Decision|1
2841880|NCT02503202|9753816|P4|Base Study: Up to Month 6|Physician Decision|0
2841881|NCT02503202|9753817|P3|Base Study: Up to Month 6|Physician Decision|0
2841882|NCT02503202|9753818|P2|Base Study: Up to Month 6|Physician Decision|0
2841883|NCT02503202|9753819|P1|Base Study: Up to Month 6|Physician Decision|0
2841884|NCT02503202|9753815|P5|Base Study: Up to Month 6|Lost to Follow-up|1
2841885|NCT02503202|9753816|P4|Base Study: Up to Month 6|Lost to Follow-up|5
2841886|NCT02503202|9753817|P3|Base Study: Up to Month 6|Lost to Follow-up|10
2841887|NCT02503202|9753818|P2|Base Study: Up to Month 6|Lost to Follow-up|8
2841888|NCT02503202|9753819|P1|Base Study: Up to Month 6|Lost to Follow-up|11
2841889|NCT02503202|9753815|P5|Base Study: Up to Month 6|Death|0
2841890|NCT02503202|9753816|P4|Base Study: Up to Month 6|Death|0
2841891|NCT02503202|9753817|P3|Base Study: Up to Month 6|Death|0
2841892|NCT02503202|9753818|P2|Base Study: Up to Month 6|Death|1
2841893|NCT02503202|9753819|P1|Base Study: Up to Month 6|Death|1
2841894|NCT02503085|9753861|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2841895|NCT02503085|9753862|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2841896|NCT02503085|9753863|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2841897|NCT02503085|9753864|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2841898|NCT02502864|9753903|P1|Overall Study|Withdrawal by Subject|1
2841899|NCT02502734|9753912|P2|Washout Period|Adverse Event|0
2841900|NCT02502734|9753913|P1|Washout Period|Adverse Event|1
2841901|NCT02502734|9753912|P2|Double-blind Treatment Period 1|Adverse Event|0
2841902|NCT02502734|9753913|P1|Double-blind Treatment Period 1|Adverse Event|1
2841903|NCT02502526|9753924|P3|Overall Study|Enrollment suspension|1
2841904|NCT02502526|9753925|P2|Overall Study|Enrollment suspension|1
2841905|NCT02502526|9753926|P1|Overall Study|Enrollment suspension|4
2841906|NCT02502526|9753924|P3|Overall Study|Disqualified due to cataract grading|1
2841907|NCT02502526|9753925|P2|Overall Study|Disqualified due to cataract grading|0
2841908|NCT02502526|9753926|P1|Overall Study|Disqualified due to cataract grading|0
2841909|NCT02502526|9753924|P3|Overall Study|Withdrawal by Subject|1
2841910|NCT02502526|9753925|P2|Overall Study|Withdrawal by Subject|1
2841911|NCT02502526|9753926|P1|Overall Study|Withdrawal by Subject|0
2841912|NCT02502526|9753924|P3|Overall Study|Lost to Follow-up|3
2841913|NCT02502526|9753925|P2|Overall Study|Lost to Follow-up|2
2841914|NCT02502526|9753926|P1|Overall Study|Lost to Follow-up|2
2841915|NCT02502149|9754023|P5|Intermediate|Discontinued prematurely|0
2841916|NCT02502149|9754024|P4|Intermediate|Discontinued prematurely|0
2841917|NCT02502149|9754025|P3|Intermediate|Discontinued prematurely|0
2841918|NCT02502149|9754026|P2|Intermediate|Discontinued prematurely|0
2841919|NCT02502149|9754027|P1|Intermediate|Discontinued prematurely|1
2841920|NCT02501629|9754167|P2|Overall Study|Subject did not return to site|1
2841921|NCT02501629|9754168|P1|Overall Study|Subject did not return to site|0
2841922|NCT02501629|9754167|P2|Overall Study|Withdrawal by Subject|5
2841923|NCT02501629|9754168|P1|Overall Study|Withdrawal by Subject|3
2841924|NCT02501629|9754167|P2|Overall Study|Early termination by sponsor|0
2841925|NCT02501629|9754168|P1|Overall Study|Early termination by sponsor|1
2841926|NCT02501629|9754167|P2|Overall Study|Withdrawn from study by sponsor|0
2841927|NCT02501629|9754168|P1|Overall Study|Withdrawn from study by sponsor|1
2841928|NCT02501629|9754167|P2|Overall Study|Death|1
2841929|NCT02501629|9754168|P1|Overall Study|Death|0
2841930|NCT02501161|9754201|P2|Overall Study|Other|0
2841931|NCT02501161|9754202|P1|Overall Study|Other|3
2841932|NCT02501161|9754201|P2|Overall Study|Withdrawal by Subject|15
2841933|NCT02501161|9754202|P1|Overall Study|Withdrawal by Subject|10
2841934|NCT02501161|9754201|P2|Overall Study|Lost to Follow-up|4
2841935|NCT02501161|9754202|P1|Overall Study|Lost to Follow-up|7
2841936|NCT02501161|9754201|P2|Overall Study|Adverse Event|6
2841937|NCT02501161|9754202|P1|Overall Study|Adverse Event|2
2841938|NCT02500979|9754326|P2|Period 2|Change in risk|0
2841939|NCT02500979|9754327|P1|Period 2|Change in risk|1
2841940|NCT02500979|9754326|P2|Period 1|Subject decision|0
2841941|NCT02500979|9754327|P1|Period 1|Subject decision|2
2841942|NCT02500979|9754326|P2|Period 1|Adverse Event|0
2841943|NCT02500979|9754327|P1|Period 1|Adverse Event|1
2841944|NCT02500979|9754326|P2|Period 1|Severe non-compliance to protocol|1
2841945|NCT02500979|9754327|P1|Period 1|Severe non-compliance to protocol|0
2841946|NCT02500979|9754326|P2|Period 1|Hyperglycemia|0
2841947|NCT02500979|9754327|P1|Period 1|Hyperglycemia|1
2841948|NCT02500901|9754361|P1|Overall Study|Disease ProgressionDD|2
2841949|NCT02500758|9754383|P2|Second Intervention (2 Minutes)|Protocol Violation|1
2841950|NCT02500758|9754384|P1|Second Intervention (2 Minutes)|Protocol Violation|1
2841951|NCT02500758|9754383|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
2841952|NCT02500758|9754384|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
2841953|NCT02500758|9754383|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
2841954|NCT02500758|9754384|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
2841955|NCT02500758|9754383|P2|Washout (1 Week)|Lost to Follow-up|2
2841956|NCT02500758|9754384|P1|Washout (1 Week)|Lost to Follow-up|2
2841957|NCT02500758|9754383|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
2841958|NCT02500758|9754384|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
2841959|NCT02500732|9754394|P2|Overall Study|Physician Decision|1
2841960|NCT02500732|9754395|P1|Overall Study|Physician Decision|0
2841961|NCT02500706|9754412|P3|Overall Study|Unclassified|1
2841962|NCT02500706|9754413|P2|Overall Study|Unclassified|0
2841963|NCT02500706|9754414|P1|Overall Study|Unclassified|0
2841964|NCT02500706|9754412|P3|Overall Study|Withdrawal by Subject|4
2841965|NCT02500706|9754413|P2|Overall Study|Withdrawal by Subject|6
2841966|NCT02500706|9754414|P1|Overall Study|Withdrawal by Subject|4
2841967|NCT02500706|9754412|P3|Overall Study|Lost to Follow-up|1
2841968|NCT02500706|9754413|P2|Overall Study|Lost to Follow-up|1
2841969|NCT02500706|9754414|P1|Overall Study|Lost to Follow-up|0
2841970|NCT02500706|9754412|P3|Overall Study|Adverse Event|1
2841971|NCT02500706|9754413|P2|Overall Study|Adverse Event|0
2841972|NCT02500706|9754414|P1|Overall Study|Adverse Event|0
2841973|NCT02500641|9754568|P2|Overall Study|Non compliance to study drug|1
2841974|NCT02500641|9754569|P1|Overall Study|Non compliance to study drug|0
2841975|NCT02500641|9754568|P2|Overall Study|Sponsor decision|0
2841976|NCT02500641|9754569|P1|Overall Study|Sponsor decision|1
2841977|NCT02500641|9754568|P2|Overall Study|Lost to Follow-up|0
2841978|NCT02500641|9754569|P1|Overall Study|Lost to Follow-up|1
2841979|NCT02500641|9754568|P2|Overall Study|Protocol Violation|2
2841980|NCT02500641|9754569|P1|Overall Study|Protocol Violation|1
2841981|NCT02500641|9754568|P2|Overall Study|Unable to follow study procedures|2
2841982|NCT02500641|9754569|P1|Overall Study|Unable to follow study procedures|3
2841983|NCT02500641|9754568|P2|Overall Study|Withdrawal by Subject|5
2841984|NCT02500641|9754569|P1|Overall Study|Withdrawal by Subject|4
2841985|NCT02500641|9754568|P2|Overall Study|Adverse Event|2
2841986|NCT02500641|9754569|P1|Overall Study|Adverse Event|0
2841987|NCT02500537|9754590|P2|Overall Study|Withdrawal by Subject|0
2841988|NCT02500537|9754591|P1|Overall Study|Withdrawal by Subject|1
2841989|NCT02500537|9754590|P2|Overall Study|Lost to Follow-up|1
2841990|NCT02500537|9754591|P1|Overall Study|Lost to Follow-up|0
2841991|NCT02500537|9754590|P2|Overall Study|Death|0
2841992|NCT02500537|9754591|P1|Overall Study|Death|2
2841993|NCT02500056|9754660|P2|Overall Study|Death|1
2841994|NCT02500056|9754661|P1|Overall Study|Death|3
2841995|NCT02500056|9754660|P2|Overall Study|Recurrence|0
2841996|NCT02500056|9754661|P1|Overall Study|Recurrence|1
2841997|NCT02500056|9754660|P2|Overall Study|Lost to Follow-up|7
2841998|NCT02500056|9754661|P1|Overall Study|Lost to Follow-up|3
2841999|NCT02499952|9754671|P1|Overall Study|Death|9
2842000|NCT02499952|9754671|P1|Overall Study|Lost to Follow-up|1
2842001|NCT02499900|9754680|P2|Extension Study Period|Other|2
2842002|NCT02499900|9754681|P1|Extension Study Period|Other|0
2842003|NCT02499900|9754680|P2|Extension Study Period|Lost to Follow-up|5
2842004|NCT02499900|9754681|P1|Extension Study Period|Lost to Follow-up|2
2842005|NCT02499900|9754680|P2|Extension Study Period|Pregnancy|2
2842006|NCT02499900|9754681|P1|Extension Study Period|Pregnancy|1
2842007|NCT02499900|9754680|P2|Extension Study Period|Physician Decision|5
2842008|NCT02499900|9754681|P1|Extension Study Period|Physician Decision|2
2842009|NCT02499900|9754680|P2|Extension Study Period|Withdrawal by Subject|2
2842010|NCT02499900|9754681|P1|Extension Study Period|Withdrawal by Subject|5
2842011|NCT02499900|9754680|P2|Extension Study Period|Adverse Event|4
2842012|NCT02499900|9754681|P1|Extension Study Period|Adverse Event|2
2842013|NCT02499900|9754680|P2|Completed Core, Continued Into Extension|Personal motivation|0
2842014|NCT02499900|9754681|P1|Completed Core, Continued Into Extension|Personal motivation|1
2842015|NCT02499900|9754680|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
2842016|NCT02499900|9754681|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
2842017|NCT02499900|9754680|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
2842018|NCT02499900|9754681|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
2842019|NCT02499900|9754680|P2|Completed Core, Continued Into Extension|Physician Decision|0
2842020|NCT02499900|9754681|P1|Completed Core, Continued Into Extension|Physician Decision|1
2842021|NCT02499900|9754680|P2|Core Study Period|Death|1
2842022|NCT02499900|9754681|P1|Core Study Period|Death|0
2842023|NCT02499900|9754680|P2|Core Study Period|Adverse Event|14
2842024|NCT02499900|9754681|P1|Core Study Period|Adverse Event|18
2842025|NCT02499900|9754680|P2|Core Study Period|Withdrawal by Subject|10
2842026|NCT02499900|9754681|P1|Core Study Period|Withdrawal by Subject|11
2842027|NCT02499900|9754680|P2|Core Study Period|Protocol Violation|0
2842028|NCT02499900|9754681|P1|Core Study Period|Protocol Violation|3
2842029|NCT02499900|9754680|P2|Core Study Period|Pregnancy|0
2842030|NCT02499900|9754681|P1|Core Study Period|Pregnancy|1
2842031|NCT02499900|9754680|P2|Core Study Period|Per sponsor request|1
2842032|NCT02499900|9754681|P1|Core Study Period|Per sponsor request|0
2842033|NCT02499900|9754680|P2|Core Study Period|Lost to Follow-up|2
2842034|NCT02499900|9754681|P1|Core Study Period|Lost to Follow-up|1
2842035|NCT02499900|9754680|P2|Core Study Period|Other|4
2842036|NCT02499900|9754681|P1|Core Study Period|Other|1
2842037|NCT02499783|9754712|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
2842038|NCT02499783|9754713|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2842039|NCT02499783|9754714|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2842040|NCT02499783|9754712|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
2842041|NCT02499783|9754713|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2842042|NCT02499783|9754714|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2842043|NCT02499783|9754712|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
2842044|NCT02499783|9754713|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2842045|NCT02499783|9754714|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2842046|NCT02499783|9754712|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
2842047|NCT02499783|9754713|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
2842048|NCT02499783|9754714|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
2842049|NCT02499783|9754712|P3|DB Period: Weeks 0-8|Other|0
2842050|NCT02499783|9754713|P2|DB Period: Weeks 0-8|Other|1
2842051|NCT02499783|9754714|P1|DB Period: Weeks 0-8|Other|1
2842052|NCT02499783|9754712|P3|DB Period: Weeks 0-8|Withdrew Consent|0
2842053|NCT02499783|9754713|P2|DB Period: Weeks 0-8|Withdrew Consent|0
2842054|NCT02499783|9754714|P1|DB Period: Weeks 0-8|Withdrew Consent|1
2842055|NCT02499783|9754712|P3|DB Period: Weeks 0-8|Adverse Event|0
2842056|NCT02499783|9754713|P2|DB Period: Weeks 0-8|Adverse Event|6
2842057|NCT02499783|9754714|P1|DB Period: Weeks 0-8|Adverse Event|8
2842058|NCT02499783|9754712|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
2842059|NCT02499783|9754713|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2842060|NCT02499783|9754714|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2842061|NCT02499783|9754712|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2842062|NCT02499783|9754713|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2842063|NCT02499783|9754714|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
2842064|NCT02499783|9754712|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
2842065|NCT02499783|9754713|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
2842066|NCT02499783|9754714|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
2842067|NCT02499575|9754772|P2|Overall Study|Protocol Violation|1
2842068|NCT02499575|9754773|P1|Overall Study|Protocol Violation|0
2842069|NCT02499406|9754783|P1|Overall Study|missed 3 treatment sessions|4
2842070|NCT02499263|9754804|P1|Overall Study|Pregnancy|1
2842071|NCT02499263|9754804|P1|Overall Study|Participant's decision|3
2842072|NCT02499263|9754804|P1|Overall Study|Adverse Events/Serious Adverse Events|11
2842073|NCT02499263|9754804|P1|Overall Study|investigator's judgment|12
2842074|NCT02499263|9754804|P1|Overall Study|Lack of Efficacy|22
2842075|NCT02499263|9754804|P1|Overall Study|Participant's withdrawal of consent|4
2842076|NCT02499263|9754804|P1|Overall Study|Lost to Follow-up|9
2842077|NCT02499172|9754841|P4|Overall Study|Lost to Follow-up|0
2842078|NCT02499172|9754842|P3|Overall Study|Lost to Follow-up|0
2842079|NCT02499172|9754843|P2|Overall Study|Lost to Follow-up|64
2842080|NCT02499172|9754844|P1|Overall Study|Lost to Follow-up|65
2842081|NCT02499172|9754841|P4|Overall Study|Financial reason|436
2842082|NCT02499172|9754842|P3|Overall Study|Financial reason|523
2842083|NCT02499172|9754843|P2|Overall Study|Financial reason|0
2842084|NCT02499172|9754844|P1|Overall Study|Financial reason|0
2842085|NCT02499159|9754856|P2|30-Day Follow-Up Phone Call|Other|0
2842086|NCT02499159|9754857|P1|30-Day Follow-Up Phone Call|Other|1
2842087|NCT02499159|9754856|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
2842088|NCT02499159|9754857|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
2842089|NCT02499159|9754856|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
2842090|NCT02499159|9754857|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
2842091|NCT02499159|9754856|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2842092|NCT02499159|9754857|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2842093|NCT02499159|9754856|P2|Randomization|Protocol Violation|1
2842094|NCT02499159|9754857|P1|Randomization|Protocol Violation|1
2842095|NCT02499146|9754881|P1|Overall Study|Began other treatment/therapy|13
2842096|NCT02499146|9754881|P1|Overall Study|Ongoing at date of cut-off|9
2842097|NCT02499146|9754881|P1|Overall Study|Other|2
2842098|NCT02499146|9754881|P1|Overall Study|Withdrawal by Subject|1
2842099|NCT02499146|9754881|P1|Overall Study|Lost to Follow-up|1
2842100|NCT02499120|9754921|P2|Overall Study|Ongoing on study|11
2842101|NCT02499120|9754922|P1|Overall Study|Ongoing on study|15
2842102|NCT02499120|9754921|P2|Overall Study|Other|0
2842103|NCT02499120|9754922|P1|Overall Study|Other|1
2842104|NCT02499120|9754921|P2|Overall Study|Withdrawal by Subject|5
2842105|NCT02499120|9754922|P1|Overall Study|Withdrawal by Subject|2
2842106|NCT02499120|9754921|P2|Overall Study|Participant refused further follow-up|0
2842107|NCT02499120|9754922|P1|Overall Study|Participant refused further follow-up|1
2842108|NCT02499120|9754921|P2|Overall Study|Lost to Follow-up|2
2842109|NCT02499120|9754922|P1|Overall Study|Lost to Follow-up|1
2842110|NCT02499120|9754921|P2|Overall Study|Death|42
2842111|NCT02499120|9754922|P1|Overall Study|Death|45
2842112|NCT02499029|9754953|P2|Overall Study|Death|0
2842113|NCT02499029|9754954|P1|Overall Study|Death|1
2842114|NCT02499029|9754953|P2|Overall Study|Physician Decision|1
2842115|NCT02499029|9754954|P1|Overall Study|Physician Decision|2
2842116|NCT02499029|9754953|P2|Overall Study|Lost to Follow-up|2
2842117|NCT02499029|9754954|P1|Overall Study|Lost to Follow-up|2
2842118|NCT02498821|9754981|P2|Overall Study|Screen failure|5
2842119|NCT02498821|9754982|P1|Overall Study|Screen failure|3
2842120|NCT02498678|9755026|P2|Overall Study|interference from the surgical team|2
2842121|NCT02498678|9755027|P1|Overall Study|interference from the surgical team|0
2842122|NCT02498652|9755043|P2|Overall Study|Protocol Violation|1
2842123|NCT02498652|9755044|P1|Overall Study|Protocol Violation|0
2842124|NCT02498418|9755172|P3|Overall Study|Participant taken prohibited medication|1
2842125|NCT02498418|9755173|P2|Overall Study|Participant taken prohibited medication|1
2842126|NCT02498418|9755174|P1|Overall Study|Participant taken prohibited medication|0
2842127|NCT02498418|9755172|P3|Overall Study|Lost to Follow-up|1
2842128|NCT02498418|9755173|P2|Overall Study|Lost to Follow-up|1
2842129|NCT02498418|9755174|P1|Overall Study|Lost to Follow-up|0
2842130|NCT02498418|9755172|P3|Overall Study|Withdrawal by Subject|3
2842131|NCT02498418|9755173|P2|Overall Study|Withdrawal by Subject|0
2842132|NCT02498418|9755174|P1|Overall Study|Withdrawal by Subject|2
2842133|NCT02498418|9755172|P3|Overall Study|Lack of Efficacy|1
2842134|NCT02498418|9755173|P2|Overall Study|Lack of Efficacy|0
2842135|NCT02498418|9755174|P1|Overall Study|Lack of Efficacy|0
2842136|NCT02498236|9755198|P8|Overall Study|Withdrawal by Subject|0
2842137|NCT02498236|9755199|P7|Overall Study|Withdrawal by Subject|0
2842138|NCT02498236|9755200|P6|Overall Study|Withdrawal by Subject|0
2842139|NCT02498236|9755201|P5|Overall Study|Withdrawal by Subject|1
2842140|NCT02498236|9755202|P4|Overall Study|Withdrawal by Subject|0
2842141|NCT02498236|9755203|P3|Overall Study|Withdrawal by Subject|0
2842142|NCT02498236|9755204|P2|Overall Study|Withdrawal by Subject|0
2842143|NCT02498236|9755205|P1|Overall Study|Withdrawal by Subject|0
2842144|NCT02498236|9755198|P8|Overall Study|Equipment failure|0
2842145|NCT02498236|9755199|P7|Overall Study|Equipment failure|1
2842146|NCT02498236|9755200|P6|Overall Study|Equipment failure|0
2842147|NCT02498236|9755201|P5|Overall Study|Equipment failure|0
2842148|NCT02498236|9755202|P4|Overall Study|Equipment failure|0
2842149|NCT02498236|9755203|P3|Overall Study|Equipment failure|0
2842150|NCT02498236|9755204|P2|Overall Study|Equipment failure|0
2842151|NCT02498236|9755205|P1|Overall Study|Equipment failure|0
2842152|NCT02498236|9755198|P8|Overall Study|Did not show for testing|1
2842153|NCT02498236|9755199|P7|Overall Study|Did not show for testing|0
2842154|NCT02498236|9755200|P6|Overall Study|Did not show for testing|0
2842155|NCT02498236|9755201|P5|Overall Study|Did not show for testing|0
2842156|NCT02498236|9755202|P4|Overall Study|Did not show for testing|0
2842157|NCT02498236|9755203|P3|Overall Study|Did not show for testing|0
2842158|NCT02498236|9755204|P2|Overall Study|Did not show for testing|0
2842159|NCT02498236|9755205|P1|Overall Study|Did not show for testing|1
2842160|NCT02497976|9755236|P2|Overall Study|Moved out of area|1
2842161|NCT02497976|9755237|P1|Overall Study|Moved out of area|0
2842162|NCT02497976|9755236|P2|Overall Study|Withdrawal by Subject|0
2842163|NCT02497976|9755237|P1|Overall Study|Withdrawal by Subject|2
2842164|NCT02497781|9755332|P2|Overall Study|Lost to Follow-up|1
2842165|NCT02497781|9755333|P1|Overall Study|Lost to Follow-up|1
2842166|NCT02497781|9755332|P2|Overall Study|Randomised but not treated|1
2842167|NCT02497781|9755333|P1|Overall Study|Randomised but not treated|1
2842168|NCT02497781|9755332|P2|Overall Study|Lack of Efficacy|1
2842169|NCT02497781|9755333|P1|Overall Study|Lack of Efficacy|0
2842170|NCT02497781|9755332|P2|Overall Study|Withdrawal by Subject|0
2842171|NCT02497781|9755333|P1|Overall Study|Withdrawal by Subject|2
2842172|NCT02497755|9755396|P2|Overall Study|Protocol Violation|0
2842173|NCT02497755|9755397|P1|Overall Study|Protocol Violation|1
2842174|NCT02497469|9755412|P2|Overall Study|Reason not Specified|6
2842175|NCT02497469|9755413|P1|Overall Study|Reason not Specified|6
2842176|NCT02497469|9755412|P2|Overall Study|Lack of Efficacy|40
2842177|NCT02497469|9755413|P1|Overall Study|Lack of Efficacy|86
2842178|NCT02497469|9755412|P2|Overall Study|Pregnancy|1
2842179|NCT02497469|9755413|P1|Overall Study|Pregnancy|1
2842180|NCT02497469|9755412|P2|Overall Study|Voluntary Withdrawal|41
2842181|NCT02497469|9755413|P1|Overall Study|Voluntary Withdrawal|39
2842182|NCT02497469|9755412|P2|Overall Study|Lost to Follow-up|4
2842183|NCT02497469|9755413|P1|Overall Study|Lost to Follow-up|14
2842184|NCT02497469|9755412|P2|Overall Study|Significant Protocol Deviation|5
2842185|NCT02497469|9755413|P1|Overall Study|Significant Protocol Deviation|4
2842186|NCT02497469|9755412|P2|Overall Study|Leukopenia or Lymphopenia|0
2842187|NCT02497469|9755413|P1|Overall Study|Leukopenia or Lymphopenia|1
2842188|NCT02497469|9755412|P2|Overall Study|Pretreatment Event/Adverse Event|16
2842189|NCT02497469|9755413|P1|Overall Study|Pretreatment Event/Adverse Event|18
2842190|NCT02497469|9755412|P2|Overall Study|Randomized but not Treated|2
2842191|NCT02497469|9755413|P1|Overall Study|Randomized but not Treated|0
2842192|NCT02497391|9755423|P6|Period 3 (14 Days)|Withdrawal by Subject|0
2842193|NCT02497391|9755424|P5|Period 3 (14 Days)|Withdrawal by Subject|0
2842194|NCT02497391|9755425|P4|Period 3 (14 Days)|Withdrawal by Subject|0
2842195|NCT02497391|9755426|P3|Period 3 (14 Days)|Withdrawal by Subject|1
2842196|NCT02497391|9755427|P2|Period 3 (14 Days)|Withdrawal by Subject|0
2842197|NCT02497391|9755428|P1|Period 3 (14 Days)|Withdrawal by Subject|0
2842198|NCT02497391|9755423|P6|Period 3 (14 Days)|Sponsor Decision|0
2842199|NCT02497391|9755424|P5|Period 3 (14 Days)|Sponsor Decision|1
2842200|NCT02497391|9755425|P4|Period 3 (14 Days)|Sponsor Decision|0
2842201|NCT02497391|9755426|P3|Period 3 (14 Days)|Sponsor Decision|0
2842202|NCT02497391|9755427|P2|Period 3 (14 Days)|Sponsor Decision|0
2842203|NCT02497391|9755428|P1|Period 3 (14 Days)|Sponsor Decision|0
2842204|NCT02497391|9755423|P6|Period 3 (14 Days)|Adverse Event|0
2842205|NCT02497391|9755424|P5|Period 3 (14 Days)|Adverse Event|0
2842206|NCT02497391|9755425|P4|Period 3 (14 Days)|Adverse Event|0
2842207|NCT02497391|9755426|P3|Period 3 (14 Days)|Adverse Event|0
2842208|NCT02497391|9755427|P2|Period 3 (14 Days)|Adverse Event|1
2842209|NCT02497391|9755428|P1|Period 3 (14 Days)|Adverse Event|0
2842210|NCT02497391|9755423|P6|Period 2 (14 Days)|Sponsor Decision|3
2842211|NCT02497391|9755424|P5|Period 2 (14 Days)|Sponsor Decision|2
2842212|NCT02497391|9755425|P4|Period 2 (14 Days)|Sponsor Decision|3
2842213|NCT02497391|9755426|P3|Period 2 (14 Days)|Sponsor Decision|2
2842214|NCT02497391|9755427|P2|Period 2 (14 Days)|Sponsor Decision|1
2842215|NCT02497391|9755428|P1|Period 2 (14 Days)|Sponsor Decision|3
2842216|NCT02497391|9755423|P6|Period 2 (14 Days)|Withdrawal by Subject|0
2842217|NCT02497391|9755424|P5|Period 2 (14 Days)|Withdrawal by Subject|0
2842218|NCT02497391|9755425|P4|Period 2 (14 Days)|Withdrawal by Subject|0
2842219|NCT02497391|9755426|P3|Period 2 (14 Days)|Withdrawal by Subject|1
2842220|NCT02497391|9755427|P2|Period 2 (14 Days)|Withdrawal by Subject|0
2842221|NCT02497391|9755428|P1|Period 2 (14 Days)|Withdrawal by Subject|1
2842222|NCT02497287|9755439|P1|Follow-up Phase (4 Week)|Other|1
2842223|NCT02497287|9755439|P1|Follow-up Phase (4 Week)|Adverse Event|3
2842224|NCT02497287|9755439|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
2842225|NCT02497287|9755439|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
2842226|NCT02497287|9755439|P1|Follow-up Phase (4 Week)|PI Decision|12
2842227|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
2842228|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Death|2
2842229|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
2842230|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
2842231|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
2842232|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
2842233|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Other|21
2842234|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
2842235|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
2842236|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
2842237|NCT02497287|9755439|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
2842238|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
2842239|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Protocol Violation|1
2842240|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
2842241|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Other|13
2842242|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
2842243|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
2842244|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Adverse Event|52
2842245|NCT02497287|9755439|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
2842246|NCT02496702|9755532|P2|Overall Study|Only partially tested|2
2842247|NCT02496702|9755533|P1|Overall Study|Only partially tested|0
2842248|NCT02496702|9755532|P2|Overall Study|Lost to Follow-up|6
2842249|NCT02496702|9755533|P1|Overall Study|Lost to Follow-up|8
2842250|NCT02496533|9755555|P2|Overall Study|Late for radiologic testing|2
2842251|NCT02496533|9755556|P1|Overall Study|Late for radiologic testing|0
2842252|NCT02496533|9755555|P2|Overall Study|Patient did not complete all measures|4
2842253|NCT02496533|9755556|P1|Overall Study|Patient did not complete all measures|0
2842254|NCT02496533|9755555|P2|Overall Study|Lack of data on outcome|0
2842255|NCT02496533|9755556|P1|Overall Study|Lack of data on outcome|3
2842256|NCT02496221|9755568|P2|Treatment Period 2 - 4 Days|Physician Decision|0
2842257|NCT02496221|9755569|P1|Treatment Period 2 - 4 Days|Physician Decision|1
2842258|NCT02496221|9755568|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
2842259|NCT02496221|9755569|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
2842260|NCT02496221|9755568|P2|Treatment Period 2 - 4 Days|Adverse Event|1
2842261|NCT02496221|9755569|P1|Treatment Period 2 - 4 Days|Adverse Event|0
2842262|NCT02496091|9755603|P1|Overall Study|Eligibility criteria not fulfilled|2
2842263|NCT02496039|9755612|P1|Overall Study|Protocol Violation|1
2842264|NCT02496039|9755612|P1|Overall Study|Adverse Event|3
2842265|NCT02496000|9755627|P3|Overall Study|undetermined|0
2842266|NCT02496000|9755628|P2|Overall Study|undetermined|1
2842267|NCT02496000|9755629|P1|Overall Study|undetermined|0
2842268|NCT02496000|9755627|P3|Overall Study|Non-compliance or lack of cooperation|0
2842269|NCT02496000|9755628|P2|Overall Study|Non-compliance or lack of cooperation|2
2842270|NCT02496000|9755629|P1|Overall Study|Non-compliance or lack of cooperation|0
2842271|NCT02496000|9755627|P3|Overall Study|Protocol Violation|1
2842272|NCT02496000|9755628|P2|Overall Study|Protocol Violation|0
2842273|NCT02496000|9755629|P1|Overall Study|Protocol Violation|0
2842274|NCT02496000|9755627|P3|Overall Study|Lost to Follow-up|1
2842275|NCT02496000|9755628|P2|Overall Study|Lost to Follow-up|0
2842276|NCT02496000|9755629|P1|Overall Study|Lost to Follow-up|1
2842277|NCT02496000|9755627|P3|Overall Study|Withdrawal by Subject|0
2842278|NCT02496000|9755628|P2|Overall Study|Withdrawal by Subject|2
2842279|NCT02496000|9755629|P1|Overall Study|Withdrawal by Subject|1
2842280|NCT02495948|9755650|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2842281|NCT02495948|9755651|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2842282|NCT02495948|9755650|P2|Period 1, First 30 Days of Wear|Adverse Event|1
2842283|NCT02495948|9755651|P1|Period 1, First 30 Days of Wear|Adverse Event|0
2842284|NCT02495844|9755660|P2|Overall Study|Hepatitis Positivity|1
2842285|NCT02495844|9755661|P1|Overall Study|Hepatitis Positivity|0
2842286|NCT02495844|9755660|P2|Overall Study|AE, non-fatal|1
2842287|NCT02495844|9755661|P1|Overall Study|AE, non-fatal|0
2842288|NCT02495844|9755660|P2|Overall Study|Lack of Efficacy|2
2842289|NCT02495844|9755661|P1|Overall Study|Lack of Efficacy|1
2842290|NCT02495233|9755784|P2|Overall Study|Miscellaneous|1
2842291|NCT02495233|9755785|P1|Overall Study|Miscellaneous|0
2842292|NCT02495168|9755814|P3|Overall Study|Lack of Efficacy|3
2842293|NCT02495168|9755815|P2|Overall Study|Lack of Efficacy|0
2842294|NCT02495168|9755816|P1|Overall Study|Lack of Efficacy|0
2842295|NCT02495168|9755814|P3|Overall Study|Adverse Event|3
2842296|NCT02495168|9755815|P2|Overall Study|Adverse Event|8
2842297|NCT02495168|9755816|P1|Overall Study|Adverse Event|4
2842298|NCT02495168|9755814|P3|Overall Study|Protocol Violation|1
2842299|NCT02495168|9755815|P2|Overall Study|Protocol Violation|10
2842300|NCT02495168|9755816|P1|Overall Study|Protocol Violation|0
2842301|NCT02495168|9755814|P3|Overall Study|Withdrawal by Subject|2
2842302|NCT02495168|9755815|P2|Overall Study|Withdrawal by Subject|4
2842303|NCT02495168|9755816|P1|Overall Study|Withdrawal by Subject|1
2842304|NCT02495168|9755814|P3|Overall Study|Lost to Follow-up|1
2842305|NCT02495168|9755815|P2|Overall Study|Lost to Follow-up|6
2842306|NCT02495168|9755816|P1|Overall Study|Lost to Follow-up|10
2842307|NCT02495168|9755814|P3|Overall Study|Physician Decision|0
2842308|NCT02495168|9755815|P2|Overall Study|Physician Decision|1
2842309|NCT02495168|9755816|P1|Overall Study|Physician Decision|1
2842310|NCT02495168|9755814|P3|Overall Study|Did not Complete Final Visit On Time|2
2842311|NCT02495168|9755815|P2|Overall Study|Did not Complete Final Visit On Time|3
2842312|NCT02495168|9755816|P1|Overall Study|Did not Complete Final Visit On Time|4
2842313|NCT02495168|9755814|P3|Overall Study|Other than Specified|5
2842314|NCT02495168|9755815|P2|Overall Study|Other than Specified|22
2842315|NCT02495168|9755816|P1|Overall Study|Other than Specified|18
2842316|NCT02495025|9755875|P2|Overall Study|Withdrawal by Subject|0
2842317|NCT02495025|9755876|P1|Overall Study|Withdrawal by Subject|5
2842318|NCT02495025|9755875|P2|Overall Study|Lost to Follow-up|14
2842319|NCT02495025|9755876|P1|Overall Study|Lost to Follow-up|21
2842320|NCT02494596|9755928|P3|Overall Study|Refused Treatment|0
2842321|NCT02494596|9755929|P2|Overall Study|Refused Treatment|1
2842322|NCT02494596|9755930|P1|Overall Study|Refused Treatment|0
2842323|NCT02494596|9755928|P3|Overall Study|Adverse Event|0
2842324|NCT02494596|9755929|P2|Overall Study|Adverse Event|1
2842325|NCT02494596|9755930|P1|Overall Study|Adverse Event|0
2842326|NCT02494596|9755928|P3|Overall Study|Insufficient Therapeutic Response|1
2842327|NCT02494596|9755929|P2|Overall Study|Insufficient Therapeutic Response|3
2842328|NCT02494596|9755930|P1|Overall Study|Insufficient Therapeutic Response|3
2842329|NCT02494583|9755958|P3|Overall Study|Ongoing in Study|34
2842330|NCT02494583|9755959|P2|Overall Study|Ongoing in Study|51
2842331|NCT02494583|9755960|P1|Overall Study|Ongoing in Study|56
2842332|NCT02494583|9755958|P3|Overall Study|Withdrawal by Subject|15
2842333|NCT02494583|9755959|P2|Overall Study|Withdrawal by Subject|15
2842334|NCT02494583|9755960|P1|Overall Study|Withdrawal by Subject|3
2842335|NCT02494583|9755958|P3|Overall Study|Protocol Violation|0
2842336|NCT02494583|9755959|P2|Overall Study|Protocol Violation|2
2842337|NCT02494583|9755960|P1|Overall Study|Protocol Violation|1
2842338|NCT02494583|9755958|P3|Overall Study|Lost to Follow-up|0
2842339|NCT02494583|9755959|P2|Overall Study|Lost to Follow-up|0
2842340|NCT02494583|9755960|P1|Overall Study|Lost to Follow-up|1
2842341|NCT02494583|9755958|P3|Overall Study|Death|201
2842342|NCT02494583|9755959|P2|Overall Study|Death|189
2842343|NCT02494583|9755960|P1|Overall Study|Death|195
2842344|NCT02494401|9756058|P2|Overall Study|Withdrawal by Subject|2
2842345|NCT02494401|9756059|P1|Overall Study|Withdrawal by Subject|3
2842346|NCT02494401|9756058|P2|Overall Study|Lost to Follow-up|25
2842347|NCT02494401|9756059|P1|Overall Study|Lost to Follow-up|22
2842348|NCT02494206|9756111|P1|Overall Study|Disease Progression|1
2842349|NCT02494206|9756111|P1|Overall Study|Adverse Event|1
2842350|NCT02493946|9756165|P3|Open Label Period|Site error|1
2842351|NCT02493946|9756166|P2|Open Label Period|Site error|0
2842352|NCT02493946|9756167|P1|Open Label Period|Site error|0
2842353|NCT02493946|9756165|P3|Open Label Period|Pregnancy|3
2842354|NCT02493946|9756166|P2|Open Label Period|Pregnancy|0
2842355|NCT02493946|9756167|P1|Open Label Period|Pregnancy|0
2842356|NCT02493946|9756165|P3|Open Label Period|Investigator decision, non-availability|1
2842357|NCT02493946|9756166|P2|Open Label Period|Investigator decision, non-availability|0
2842358|NCT02493946|9756167|P1|Open Label Period|Investigator decision, non-availability|0
2842359|NCT02493946|9756165|P3|Open Label Period|Investigator decision, non-compliance|2
2842360|NCT02493946|9756166|P2|Open Label Period|Investigator decision, non-compliance|0
2842361|NCT02493946|9756167|P1|Open Label Period|Investigator decision, non-compliance|0
2842362|NCT02493946|9756165|P3|Open Label Period|Lost to Follow-up|1
2842363|NCT02493946|9756166|P2|Open Label Period|Lost to Follow-up|0
2842364|NCT02493946|9756167|P1|Open Label Period|Lost to Follow-up|0
2842365|NCT02493946|9756165|P3|Open Label Period|Adverse Event|4
2842366|NCT02493946|9756166|P2|Open Label Period|Adverse Event|0
2842367|NCT02493946|9756167|P1|Open Label Period|Adverse Event|0
2842368|NCT02493946|9756165|P3|Open Label Period|Withdrawal by Subject|74
2842369|NCT02493946|9756166|P2|Open Label Period|Withdrawal by Subject|0
2842370|NCT02493946|9756167|P1|Open Label Period|Withdrawal by Subject|0
2842371|NCT02493946|9756165|P3|DB Period|Withdrawal by Subject|0
2842372|NCT02493946|9756166|P2|DB Period|Withdrawal by Subject|5
2842373|NCT02493946|9756167|P1|DB Period|Withdrawal by Subject|8
2842374|NCT02493868|9756200|P2|Follow-up Phase|Other|1
2842375|NCT02493868|9756201|P1|Follow-up Phase|Other|2
2842376|NCT02493868|9756200|P2|Follow-up Phase|Investigator Decision|1
2842377|NCT02493868|9756201|P1|Follow-up Phase|Investigator Decision|5
2842378|NCT02493868|9756200|P2|Follow-up Phase|Withdrawal by Subject|0
2842379|NCT02493868|9756201|P1|Follow-up Phase|Withdrawal by Subject|3
2842380|NCT02493868|9756200|P2|Follow-up Phase|Lost to Follow-up|0
2842381|NCT02493868|9756201|P1|Follow-up Phase|Lost to Follow-up|1
2842382|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Other|9
2842383|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Other|4
2842384|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
2842385|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
2842386|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
2842387|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
2842388|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
2842389|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
2842390|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2842391|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2842392|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
2842393|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
2842394|NCT02493868|9756200|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
2842395|NCT02493868|9756201|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
2842396|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Other|2
2842397|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Other|10
2842398|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
2842399|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
2842400|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
2842401|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
2842402|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
2842403|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
2842404|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
2842405|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
2842406|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
2842407|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
2842408|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
2842409|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
2842410|NCT02493868|9756200|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
2842411|NCT02493868|9756201|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
2842412|NCT02493868|9756200|P2|Induction Phase: DE Participants|Other|0
2842413|NCT02493868|9756201|P1|Induction Phase: DE Participants|Other|8
2842414|NCT02493868|9756200|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
2842415|NCT02493868|9756201|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
2842416|NCT02493868|9756200|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
2842417|NCT02493868|9756201|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
2842418|NCT02493868|9756200|P2|Induction Phase: DE Participants|Protocol Violation|0
2842419|NCT02493868|9756201|P1|Induction Phase: DE Participants|Protocol Violation|2
2842420|NCT02493868|9756200|P2|Induction Phase: DE Participants|Lack of Efficacy|0
2842421|NCT02493868|9756201|P1|Induction Phase: DE Participants|Lack of Efficacy|2
2842422|NCT02493868|9756200|P2|Induction Phase: DE Participants|Lost to Follow-up|0
2842423|NCT02493868|9756201|P1|Induction Phase: DE Participants|Lost to Follow-up|1
2842424|NCT02493868|9756200|P2|Induction Phase: DE Participants|Adverse Event|0
2842425|NCT02493868|9756201|P1|Induction Phase: DE Participants|Adverse Event|22
2842426|NCT02493855|9756250|P3|Overall Study|Withdrawal by Subject|0
2842427|NCT02493855|9756251|P2|Overall Study|Withdrawal by Subject|0
2842428|NCT02493855|9756252|P1|Overall Study|Withdrawal by Subject|1
2842429|NCT02493855|9756250|P3|Overall Study|Adverse Event|0
2842430|NCT02493855|9756251|P2|Overall Study|Adverse Event|1
2842431|NCT02493855|9756252|P1|Overall Study|Adverse Event|0
2842432|NCT02493855|9756250|P3|Overall Study|Non-compliance|0
2842433|NCT02493855|9756251|P2|Overall Study|Non-compliance|0
2842434|NCT02493855|9756252|P1|Overall Study|Non-compliance|1
2842435|NCT02493777|9756262|P2|Overall Study|Lost to Follow-up|1
2842436|NCT02493777|9756263|P1|Overall Study|Lost to Follow-up|0
2842437|NCT02493764|9756273|P2|Overall Study|Withdrawal by Subject|7
2842438|NCT02493764|9756274|P1|Overall Study|Withdrawal by Subject|11
2842439|NCT02493764|9756273|P2|Overall Study|Withdrawal parent/guardian|1
2842440|NCT02493764|9756274|P1|Overall Study|Withdrawal parent/guardian|0
2842441|NCT02493764|9756273|P2|Overall Study|Participant moved|5
2842442|NCT02493764|9756274|P1|Overall Study|Participant moved|17
2842443|NCT02493764|9756273|P2|Overall Study|Physician Decision|1
2842444|NCT02493764|9756274|P1|Overall Study|Physician Decision|1
2842445|NCT02493764|9756273|P2|Overall Study|Protocol Violation|7
2842446|NCT02493764|9756274|P1|Overall Study|Protocol Violation|6
2842447|NCT02493764|9756273|P2|Overall Study|Lost to Follow-up|1
2842448|NCT02493764|9756274|P1|Overall Study|Lost to Follow-up|2
2842449|NCT02493764|9756273|P2|Overall Study|Death|58
2842450|NCT02493764|9756274|P1|Overall Study|Death|44
2842451|NCT02493764|9756273|P2|Overall Study|Adverse Event|2
2842452|NCT02493764|9756274|P1|Overall Study|Adverse Event|2
2842453|NCT02493751|9756324|P2|Overall Study|Ongoing|23
2842454|NCT02493751|9756325|P1|Overall Study|Ongoing|11
2842455|NCT02493751|9756324|P2|Overall Study|Withdrawal by Subject|5
2842456|NCT02493751|9756325|P1|Overall Study|Withdrawal by Subject|2
2842457|NCT02493751|9756324|P2|Overall Study|Lost to Follow-up|1
2842458|NCT02493751|9756325|P1|Overall Study|Lost to Follow-up|0
2842459|NCT02493517|9756356|P2|Overall Study|Missed study visit|1
2842460|NCT02493517|9756357|P1|Overall Study|Missed study visit|0
2842461|NCT02493517|9756356|P2|Overall Study|Adverse Event|2
2842462|NCT02493517|9756357|P1|Overall Study|Adverse Event|0
2842463|NCT02493517|9756356|P2|Overall Study|Withdrawal by Subject|2
2842464|NCT02493517|9756357|P1|Overall Study|Withdrawal by Subject|1
2842465|NCT02493517|9756356|P2|Overall Study|Protocol Violation|2
2842466|NCT02493517|9756357|P1|Overall Study|Protocol Violation|1
2842467|NCT02493127|9756422|P2|Overall Study|Lost to Follow-up|1
2842468|NCT02493127|9756423|P1|Overall Study|Lost to Follow-up|1
2842469|NCT02493062|9756441|P1|Overall Study|Physician Decision|12
2842470|NCT02492984|9756464|P2|Overall Study|Withdrawal by Subject|0
2842471|NCT02492984|9756465|P1|Overall Study|Withdrawal by Subject|1
2842472|NCT02492984|9756464|P2|Overall Study|Protocol Violation|0
2842473|NCT02492984|9756465|P1|Overall Study|Protocol Violation|1
2842474|NCT02492984|9756464|P2|Overall Study|Adverse Event|0
2842475|NCT02492984|9756465|P1|Overall Study|Adverse Event|1
2842476|NCT02492958|9756489|P4|Overall Study|Adverse Event|0
2842477|NCT02492958|9756490|P3|Overall Study|Adverse Event|1
2842478|NCT02492958|9756491|P2|Overall Study|Adverse Event|0
2842479|NCT02492958|9756492|P1|Overall Study|Adverse Event|1
2842480|NCT02492958|9756489|P4|Overall Study|Withdrawal by Subject|0
2842481|NCT02492958|9756490|P3|Overall Study|Withdrawal by Subject|1
2842482|NCT02492958|9756491|P2|Overall Study|Withdrawal by Subject|0
2842483|NCT02492958|9756492|P1|Overall Study|Withdrawal by Subject|0
2842484|NCT02492880|9756578|P1|Overall Study|Protocol Violation|1
2842485|NCT02492880|9756578|P1|Overall Study|Lost to Follow-up|1
2842486|NCT02492841|9756585|P3|Overall Study|Lost to Follow-up|35
2842487|NCT02492841|9756586|P2|Overall Study|Lost to Follow-up|31
2842488|NCT02492841|9756587|P1|Overall Study|Lost to Follow-up|34
2842489|NCT02492763|9756606|P4|Overall Study|Study Terminated by Sponsor|10
2842490|NCT02492763|9756607|P3|Overall Study|Study Terminated by Sponsor|6
2842491|NCT02492763|9756608|P2|Overall Study|Study Terminated by Sponsor|10
2842492|NCT02492763|9756609|P1|Overall Study|Study Terminated by Sponsor|13
2842493|NCT02492763|9756606|P4|Overall Study|Screen Failure|1
2842494|NCT02492763|9756607|P3|Overall Study|Screen Failure|0
2842495|NCT02492763|9756608|P2|Overall Study|Screen Failure|0
2842496|NCT02492763|9756609|P1|Overall Study|Screen Failure|0
2842497|NCT02492763|9756606|P4|Overall Study|Non-Compliance With Study Drug|0
2842498|NCT02492763|9756607|P3|Overall Study|Non-Compliance With Study Drug|0
2842499|NCT02492763|9756608|P2|Overall Study|Non-Compliance With Study Drug|1
2842500|NCT02492763|9756609|P1|Overall Study|Non-Compliance With Study Drug|0
2842501|NCT02492763|9756606|P4|Overall Study|Lost to Follow-up|0
2842502|NCT02492763|9756607|P3|Overall Study|Lost to Follow-up|1
2842503|NCT02492763|9756608|P2|Overall Study|Lost to Follow-up|0
2842504|NCT02492763|9756609|P1|Overall Study|Lost to Follow-up|0
2842505|NCT02492763|9756606|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
2842506|NCT02492763|9756607|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
2842507|NCT02492763|9756608|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
2842508|NCT02492763|9756609|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
2842509|NCT02492763|9756606|P4|Overall Study|Death|0
2842510|NCT02492763|9756607|P3|Overall Study|Death|1
2842511|NCT02492763|9756608|P2|Overall Study|Death|0
2842512|NCT02492763|9756609|P1|Overall Study|Death|0
2842513|NCT02492763|9756606|P4|Overall Study|Adverse Event|2
2842514|NCT02492763|9756607|P3|Overall Study|Adverse Event|1
2842515|NCT02492763|9756608|P2|Overall Study|Adverse Event|1
2842516|NCT02492763|9756609|P1|Overall Study|Adverse Event|3
2842517|NCT02492763|9756606|P4|Overall Study|Withdrawal by Subject|0
2842518|NCT02492763|9756607|P3|Overall Study|Withdrawal by Subject|1
2842519|NCT02492763|9756608|P2|Overall Study|Withdrawal by Subject|2
2842520|NCT02492763|9756609|P1|Overall Study|Withdrawal by Subject|0
2842521|NCT02492165|9756714|P4|Overall Study|Withdrawal by Subject|0
2842522|NCT02492165|9756715|P3|Overall Study|Withdrawal by Subject|0
2842523|NCT02492165|9756716|P2|Overall Study|Withdrawal by Subject|1
2842524|NCT02492165|9756717|P1|Overall Study|Withdrawal by Subject|0
2842525|NCT02492100|9756739|P1|Overall Study|Death|1
2842526|NCT02491892|9756768|P2|Overall Study|Lost to Follow-up|0
2842527|NCT02491892|9756769|P1|Overall Study|Lost to Follow-up|1
2842528|NCT02491892|9756768|P2|Overall Study|Refused Treatment|0
2842529|NCT02491892|9756769|P1|Overall Study|Refused Treatment|1
2842530|NCT02491892|9756768|P2|Overall Study|Lack of Efficacy|36
2842531|NCT02491892|9756769|P1|Overall Study|Lack of Efficacy|37
2842532|NCT02491892|9756768|P2|Overall Study|Death|1
2842533|NCT02491892|9756769|P1|Overall Study|Death|1
2842534|NCT02491892|9756768|P2|Overall Study|Adverse Event|1
2842535|NCT02491892|9756769|P1|Overall Study|Adverse Event|1
2842536|NCT02491684|9756815|P2|Treatment Phase|Investigator and Sponsor decision|1
2842537|NCT02491684|9756816|P1|Treatment Phase|Investigator and Sponsor decision|0
2842538|NCT02491684|9756815|P2|Treatment Phase|Incorrect randomisation|0
2842539|NCT02491684|9756816|P1|Treatment Phase|Incorrect randomisation|1
2842540|NCT02491684|9756815|P2|Treatment Phase|Adverse Event|2
2842541|NCT02491684|9756816|P1|Treatment Phase|Adverse Event|2
2842542|NCT02491463|9756854|P4|Overall Study|Lost to Follow-up|0
2842543|NCT02491463|9756855|P3|Overall Study|Lost to Follow-up|3
2842544|NCT02491463|9756856|P2|Overall Study|Lost to Follow-up|3
2842545|NCT02491463|9756857|P1|Overall Study|Lost to Follow-up|0
2842546|NCT02491463|9756854|P4|Overall Study|Migrated/moved from study area|1
2842547|NCT02491463|9756855|P3|Overall Study|Migrated/moved from study area|1
2842548|NCT02491463|9756856|P2|Overall Study|Migrated/moved from study area|5
2842549|NCT02491463|9756857|P1|Overall Study|Migrated/moved from study area|1
2842550|NCT02491463|9756854|P4|Overall Study|Withdrawal by Subject|0
2842551|NCT02491463|9756855|P3|Overall Study|Withdrawal by Subject|0
2842552|NCT02491463|9756856|P2|Overall Study|Withdrawal by Subject|2
2842553|NCT02491463|9756857|P1|Overall Study|Withdrawal by Subject|1
2842554|NCT02491411|9756960|P1|Overall Study|Physician Decision|4
2842555|NCT02491073|9756991|P2|Overall Study|screen failure|0
2842556|NCT02491073|9756992|P1|Overall Study|screen failure|1
2842557|NCT02490475|9757044|P4|Period 2: Extension Phase|Adverse Event|0
2842558|NCT02490475|9757045|P3|Period 2: Extension Phase|Adverse Event|1
2842559|NCT02490475|9757046|P2|Period 2: Extension Phase|Adverse Event|0
2842560|NCT02490475|9757047|P1|Period 2: Extension Phase|Adverse Event|0
2842561|NCT02490475|9757044|P4|Period 2: Extension Phase|Refused Treatment|1
2842562|NCT02490475|9757045|P3|Period 2: Extension Phase|Refused Treatment|0
2842563|NCT02490475|9757046|P2|Period 2: Extension Phase|Refused Treatment|0
2842564|NCT02490475|9757047|P1|Period 2: Extension Phase|Refused Treatment|0
2842565|NCT02490475|9757044|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2842566|NCT02490475|9757045|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
2842567|NCT02490475|9757046|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2842568|NCT02490475|9757047|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
2842569|NCT02490475|9757044|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
2842570|NCT02490475|9757045|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
2842571|NCT02490475|9757046|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2842572|NCT02490475|9757047|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2842573|NCT02490475|9757044|P4|Period 1: First 6 Cycles|Refused Treatment|0
2842574|NCT02490475|9757045|P3|Period 1: First 6 Cycles|Refused Treatment|0
2842575|NCT02490475|9757046|P2|Period 1: First 6 Cycles|Refused Treatment|0
2842576|NCT02490475|9757047|P1|Period 1: First 6 Cycles|Refused Treatment|1
2842577|NCT02490475|9757044|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2842578|NCT02490475|9757045|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2842579|NCT02490475|9757046|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
2842580|NCT02490475|9757047|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2842581|NCT02490475|9757044|P4|Period 1: First 6 Cycles|Adverse Event|1
2842582|NCT02490475|9757045|P3|Period 1: First 6 Cycles|Adverse Event|0
2842583|NCT02490475|9757046|P2|Period 1: First 6 Cycles|Adverse Event|1
2842584|NCT02490475|9757047|P1|Period 1: First 6 Cycles|Adverse Event|2
2842585|NCT02490371|9757125|P2|Overall Study|Lost to Follow-up|1
2842586|NCT02490371|9757126|P1|Overall Study|Lost to Follow-up|1
2842587|NCT02489981|9757153|P1|Overall Study|Other than listed|28
2842588|NCT02489981|9757153|P1|Overall Study|Lost to Follow-up|31
2842589|NCT02489981|9757153|P1|Overall Study|Improved|31
2842590|NCT02489981|9757153|P1|Overall Study|Insufficient effectiveness|16
2842591|NCT02489981|9757153|P1|Overall Study|Adverse Event|21
2842592|NCT02489968|9757160|P6|Double-blind Treatment Period|Other than specified above|0
2842593|NCT02489968|9757161|P5|Double-blind Treatment Period|Other than specified above|1
2842594|NCT02489968|9757162|P4|Double-blind Treatment Period|Other than specified above|0
2842595|NCT02489968|9757163|P3|Double-blind Treatment Period|Other than specified above|0
2842596|NCT02489968|9757164|P2|Double-blind Treatment Period|Other than specified above|0
2842597|NCT02489968|9757165|P1|Double-blind Treatment Period|Other than specified above|0
2842598|NCT02489968|9757160|P6|Double-blind Treatment Period|Withdrawal by Subject|2
2842599|NCT02489968|9757161|P5|Double-blind Treatment Period|Withdrawal by Subject|0
2842600|NCT02489968|9757162|P4|Double-blind Treatment Period|Withdrawal by Subject|2
2842601|NCT02489968|9757163|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2842602|NCT02489968|9757164|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2842603|NCT02489968|9757165|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2842604|NCT02489968|9757160|P6|Double-blind Treatment Period|Protocol Violation|1
2842605|NCT02489968|9757161|P5|Double-blind Treatment Period|Protocol Violation|1
2842606|NCT02489968|9757162|P4|Double-blind Treatment Period|Protocol Violation|0
2842607|NCT02489968|9757163|P3|Double-blind Treatment Period|Protocol Violation|0
2842608|NCT02489968|9757164|P2|Double-blind Treatment Period|Protocol Violation|0
2842609|NCT02489968|9757165|P1|Double-blind Treatment Period|Protocol Violation|0
2842610|NCT02489968|9757160|P6|Double-blind Treatment Period|Adverse Event|5
2842611|NCT02489968|9757161|P5|Double-blind Treatment Period|Adverse Event|4
2842612|NCT02489968|9757162|P4|Double-blind Treatment Period|Adverse Event|6
2842613|NCT02489968|9757163|P3|Double-blind Treatment Period|Adverse Event|2
2842614|NCT02489968|9757164|P2|Double-blind Treatment Period|Adverse Event|0
2842615|NCT02489968|9757165|P1|Double-blind Treatment Period|Adverse Event|0
2842616|NCT02489968|9757160|P6|Open-label Treatment Period|Other than specified above|0
2842617|NCT02489968|9757161|P5|Open-label Treatment Period|Other than specified above|0
2842618|NCT02489968|9757162|P4|Open-label Treatment Period|Other than specified above|0
2842619|NCT02489968|9757163|P3|Open-label Treatment Period|Other than specified above|0
2842620|NCT02489968|9757164|P2|Open-label Treatment Period|Other than specified above|189
2842621|NCT02489968|9757165|P1|Open-label Treatment Period|Other than specified above|204
2842622|NCT02489968|9757160|P6|Open-label Treatment Period|Withdrawal by Subject|0
2842623|NCT02489968|9757161|P5|Open-label Treatment Period|Withdrawal by Subject|0
2842624|NCT02489968|9757162|P4|Open-label Treatment Period|Withdrawal by Subject|0
2842625|NCT02489968|9757163|P3|Open-label Treatment Period|Withdrawal by Subject|0
2842626|NCT02489968|9757164|P2|Open-label Treatment Period|Withdrawal by Subject|7
2842627|NCT02489968|9757165|P1|Open-label Treatment Period|Withdrawal by Subject|4
2842628|NCT02489968|9757160|P6|Open-label Treatment Period|Lost to Follow-up|0
2842629|NCT02489968|9757161|P5|Open-label Treatment Period|Lost to Follow-up|0
2842630|NCT02489968|9757162|P4|Open-label Treatment Period|Lost to Follow-up|0
2842631|NCT02489968|9757163|P3|Open-label Treatment Period|Lost to Follow-up|0
2842632|NCT02489968|9757164|P2|Open-label Treatment Period|Lost to Follow-up|3
2842633|NCT02489968|9757165|P1|Open-label Treatment Period|Lost to Follow-up|0
2842634|NCT02489968|9757160|P6|Open-label Treatment Period|Protocol Violation|0
2842635|NCT02489968|9757161|P5|Open-label Treatment Period|Protocol Violation|0
2842636|NCT02489968|9757162|P4|Open-label Treatment Period|Protocol Violation|0
2842637|NCT02489968|9757163|P3|Open-label Treatment Period|Protocol Violation|0
2842638|NCT02489968|9757164|P2|Open-label Treatment Period|Protocol Violation|2
2842639|NCT02489968|9757165|P1|Open-label Treatment Period|Protocol Violation|2
2842640|NCT02489968|9757160|P6|Open-label Treatment Period|Adverse Event|0
2842641|NCT02489968|9757161|P5|Open-label Treatment Period|Adverse Event|0
2842642|NCT02489968|9757162|P4|Open-label Treatment Period|Adverse Event|0
2842643|NCT02489968|9757163|P3|Open-label Treatment Period|Adverse Event|0
2842644|NCT02489968|9757164|P2|Open-label Treatment Period|Adverse Event|7
2842645|NCT02489968|9757165|P1|Open-label Treatment Period|Adverse Event|14
2842646|NCT02489799|9757179|P2|Overall Study|Death|1
2842647|NCT02489799|9757180|P1|Overall Study|Death|0
2842648|NCT02489799|9757179|P2|Overall Study|Withdrawal by Subject|1
2842649|NCT02489799|9757180|P1|Overall Study|Withdrawal by Subject|1
2842650|NCT02489799|9757179|P2|Overall Study|Failure to Maintain Eligibility|6
2842651|NCT02489799|9757180|P1|Overall Study|Failure to Maintain Eligibility|4
2842652|NCT02489799|9757179|P2|Overall Study|Lost to Follow-up|1
2842653|NCT02489799|9757180|P1|Overall Study|Lost to Follow-up|4
2842654|NCT02489773|9757206|P2|Overall Study|Leave the country or the state|1
2842655|NCT02489773|9757207|P1|Overall Study|Leave the country or the state|1
2842656|NCT02489773|9757206|P2|Overall Study|Withdrawal by Subject|0
2842657|NCT02489773|9757207|P1|Overall Study|Withdrawal by Subject|1
2842658|NCT02489773|9757206|P2|Overall Study|Physician Decision|0
2842659|NCT02489773|9757207|P1|Overall Study|Physician Decision|1
2842660|NCT02489773|9757206|P2|Overall Study|Lost to Follow-up|1
2842661|NCT02489773|9757207|P1|Overall Study|Lost to Follow-up|4
2842662|NCT02489500|9757217|P2|Overall Study|Death|1
2842663|NCT02489500|9757218|P1|Overall Study|Death|1
2842664|NCT02489344|9757236|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
2842665|NCT02489344|9757236|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
2842666|NCT02489344|9757236|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
2842667|NCT02489344|9757236|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
2842668|NCT02489279|9757278|P2|Overall Study|Lost to Follow-up|10
2842669|NCT02489279|9757279|P1|Overall Study|Lost to Follow-up|12
2842670|NCT02488980|9757320|P3|Overall Study|Protocol Violation|2
2842671|NCT02488980|9757321|P2|Overall Study|Protocol Violation|2
2842672|NCT02488980|9757322|P1|Overall Study|Protocol Violation|2
2842673|NCT02488915|9757339|P1|Overall Study|Withdrawal by Subject|1
2842674|NCT02488915|9757339|P1|Overall Study|Lost to Follow-up|4
2842675|NCT02488915|9757339|P1|Overall Study|Death|21
2842676|NCT02488824|9757357|P2|Overall Study|Adverse Event|1
2842677|NCT02488824|9757358|P1|Overall Study|Adverse Event|1
2842678|NCT02488681|9757372|P1|Overall Study|Implant unsuccessful|7
2842679|NCT02488330|9757376|P1|Overall Study|Study Termination by Sponsor|4
2842680|NCT02488330|9757376|P1|Overall Study|Disease Progression|3
2842681|NCT02488330|9757376|P1|Overall Study|Death|2
2842682|NCT02488330|9757376|P1|Overall Study|Physician Decision|2
2842683|NCT02488330|9757376|P1|Overall Study|Adverse Event|1
2842684|NCT02488239|9757397|P1|Overall Study|Did not undergo implant procedure|1
2842685|NCT02488239|9757397|P1|Overall Study|Consent ineligible|1
2842686|NCT02488239|9757397|P1|Overall Study|Physician Decision|2
2842687|NCT02488239|9757397|P1|Overall Study|Withdrawal by Subject|3
2842688|NCT02488239|9757397|P1|Overall Study|Death|3
2842689|NCT02488005|9757414|P1|Overall Study|Lost to Follow-up|2
2842690|NCT02487979|9757424|P1|Overall Study|Progressive Disease|17
2842691|NCT02487979|9757424|P1|Overall Study|Withdrawal by Subject|2
2842692|NCT02487979|9757424|P1|Overall Study|Physician Decision|2
2842693|NCT02487810|9757436|P2|Overall Study|Withdrawal by Subject|0
2842694|NCT02487810|9757437|P1|Overall Study|Withdrawal by Subject|1
2842695|NCT02487771|9757469|P2|Overall Study|Withdrawal by Subject|5
2842696|NCT02487771|9757470|P1|Overall Study|Withdrawal by Subject|3
2842697|NCT02487771|9757469|P2|Overall Study|Moved out of area|6
2842698|NCT02487771|9757470|P1|Overall Study|Moved out of area|5
2842699|NCT02487771|9757469|P2|Overall Study|Lost to Follow-up|3
2842700|NCT02487771|9757470|P1|Overall Study|Lost to Follow-up|2
2842701|NCT02487498|9757636|P2|Period: Period 2|Physician Decision|0
2842702|NCT02487498|9757637|P1|Period: Period 2|Physician Decision|1
2842703|NCT02487498|9757636|P2|Period: Period 2|Death|1
2842704|NCT02487498|9757637|P1|Period: Period 2|Death|0
2842705|NCT02487498|9757636|P2|Period: Period 2|Lost to Follow-up|1
2842706|NCT02487498|9757637|P1|Period: Period 2|Lost to Follow-up|1
2842707|NCT02487498|9757636|P2|Period: Period 2|Subject/guardian decision|1
2842708|NCT02487498|9757637|P1|Period: Period 2|Subject/guardian decision|2
2842709|NCT02487498|9757636|P2|Period: Period 2|Adverse Event|2
2842710|NCT02487498|9757637|P1|Period: Period 2|Adverse Event|2
2842711|NCT02487498|9757636|P2|Period: Washout|Non-compliance with study treatment|1
2842712|NCT02487498|9757637|P1|Period: Washout|Non-compliance with study treatment|0
2842713|NCT02487498|9757636|P2|Period: Washout|Physician Decision|0
2842714|NCT02487498|9757637|P1|Period: Washout|Physician Decision|1
2842715|NCT02487498|9757636|P2|Period: Washout|Lack of Efficacy|1
2842716|NCT02487498|9757637|P1|Period: Washout|Lack of Efficacy|1
2842717|NCT02487498|9757636|P2|Period: Washout|Subject/guardian decision|5
2842718|NCT02487498|9757637|P1|Period: Washout|Subject/guardian decision|0
2842719|NCT02487498|9757636|P2|Period: Period 1|Protocol deviation|0
2842720|NCT02487498|9757637|P1|Period: Period 1|Protocol deviation|1
2842721|NCT02487498|9757636|P2|Period: Period 1|Physician Decision|1
2842722|NCT02487498|9757637|P1|Period: Period 1|Physician Decision|0
2842723|NCT02487498|9757636|P2|Period: Period 1|Lack of Efficacy|0
2842724|NCT02487498|9757637|P1|Period: Period 1|Lack of Efficacy|1
2842725|NCT02487498|9757636|P2|Period: Period 1|Lost to Follow-up|2
2842726|NCT02487498|9757637|P1|Period: Period 1|Lost to Follow-up|0
2842727|NCT02487498|9757636|P2|Period: Period 1|Subject/guardian decision|4
2842728|NCT02487498|9757637|P1|Period: Period 1|Subject/guardian decision|2
2842729|NCT02487498|9757636|P2|Period: Period 1|Adverse Event|4
2842730|NCT02487498|9757637|P1|Period: Period 1|Adverse Event|2
2842731|NCT02487472|9757660|P1|Overall Study|Other|2
2842732|NCT02487472|9757660|P1|Overall Study|Did not complete telephonic interviews|9
2842733|NCT02487446|9757676|P2|Period 2|Adverse Event|2
2842734|NCT02487446|9757677|P1|Period 2|Adverse Event|6
2842735|NCT02487446|9757676|P2|Period 2|Withdrawal by Subject|1
2842736|NCT02487446|9757677|P1|Period 2|Withdrawal by Subject|1
2842737|NCT02487446|9757676|P2|Period 2|Lost to Follow-up|1
2842738|NCT02487446|9757677|P1|Period 2|Lost to Follow-up|1
2842739|NCT02487446|9757676|P2|Period 2|Protocol deviation|1
2842740|NCT02487446|9757677|P1|Period 2|Protocol deviation|0
2842741|NCT02487446|9757676|P2|Washout|Adverse Event|2
2842742|NCT02487446|9757677|P1|Washout|Adverse Event|2
2842743|NCT02487446|9757676|P2|Washout|Withdrawal by Subject|4
2842744|NCT02487446|9757677|P1|Washout|Withdrawal by Subject|1
2842745|NCT02487446|9757676|P2|Washout|Lost to Follow-up|2
2842746|NCT02487446|9757677|P1|Washout|Lost to Follow-up|0
2842747|NCT02487446|9757676|P2|Period 1|Adverse Event|5
2842748|NCT02487446|9757677|P1|Period 1|Adverse Event|5
2842749|NCT02487446|9757676|P2|Period 1|Withdrawal by Subject|0
2842750|NCT02487446|9757677|P1|Period 1|Withdrawal by Subject|2
2842751|NCT02487446|9757676|P2|Period 1|Lost to Follow-up|0
2842752|NCT02487446|9757677|P1|Period 1|Lost to Follow-up|2
2842753|NCT02487446|9757676|P2|Period 1|Protocol deviation|2
2842754|NCT02487446|9757677|P1|Period 1|Protocol deviation|3
2842755|NCT02487446|9757676|P2|Period 1|Lack of Efficacy|0
2842756|NCT02487446|9757677|P1|Period 1|Lack of Efficacy|1
2842757|NCT02487446|9757676|P2|Period 1|Physician Decision|1
2842758|NCT02487446|9757677|P1|Period 1|Physician Decision|0
2842759|NCT02487199|9757757|P2|Overall Study|Withdrew Consent|1
2842760|NCT02487199|9757758|P1|Overall Study|Withdrew Consent|0
2842761|NCT02487030|9757783|P7|Overall Study|Death|0
2842762|NCT02487030|9757784|P6|Overall Study|Death|0
2842763|NCT02487030|9757785|P5|Overall Study|Death|1
2842764|NCT02487030|9757786|P4|Overall Study|Death|0
2842765|NCT02487030|9757787|P3|Overall Study|Death|0
2842766|NCT02487030|9757788|P2|Overall Study|Death|0
2842767|NCT02487030|9757789|P1|Overall Study|Death|0
2842768|NCT02487030|9757783|P7|Overall Study|Adverse Event|0
2842769|NCT02487030|9757784|P6|Overall Study|Adverse Event|0
2842770|NCT02487030|9757785|P5|Overall Study|Adverse Event|0
2842771|NCT02487030|9757786|P4|Overall Study|Adverse Event|1
2842772|NCT02487030|9757787|P3|Overall Study|Adverse Event|0
2842773|NCT02487030|9757788|P2|Overall Study|Adverse Event|0
2842774|NCT02487030|9757789|P1|Overall Study|Adverse Event|0
2842775|NCT02487030|9757783|P7|Overall Study|Lost to Follow-up|0
2842776|NCT02487030|9757784|P6|Overall Study|Lost to Follow-up|1
2842777|NCT02487030|9757785|P5|Overall Study|Lost to Follow-up|0
2842778|NCT02487030|9757786|P4|Overall Study|Lost to Follow-up|1
2842779|NCT02487030|9757787|P3|Overall Study|Lost to Follow-up|1
2842780|NCT02487030|9757788|P2|Overall Study|Lost to Follow-up|0
2842781|NCT02487030|9757789|P1|Overall Study|Lost to Follow-up|0
2842782|NCT02487030|9757783|P7|Overall Study|Lack of Efficacy|0
2842783|NCT02487030|9757784|P6|Overall Study|Lack of Efficacy|0
2842784|NCT02487030|9757785|P5|Overall Study|Lack of Efficacy|1
2842785|NCT02487030|9757786|P4|Overall Study|Lack of Efficacy|0
2842786|NCT02487030|9757787|P3|Overall Study|Lack of Efficacy|1
2842787|NCT02487030|9757788|P2|Overall Study|Lack of Efficacy|4
2842788|NCT02487030|9757789|P1|Overall Study|Lack of Efficacy|2
2842789|NCT02486952|9757820|P1|Overall Study|Other|2
2842790|NCT02486952|9757820|P1|Overall Study|Lost to Follow-up|26
2842791|NCT02486952|9757820|P1|Overall Study|Lack of Efficacy|3
2842792|NCT02486952|9757820|P1|Overall Study|Death|15
2842793|NCT02486952|9757820|P1|Overall Study|Adverse Event|1
2842794|NCT02486952|9757820|P1|Overall Study|Not Started Induction Therapy|3
2842795|NCT02486796|9757838|P2|Overall Study|Physician Decision|0
2842796|NCT02486796|9757839|P1|Overall Study|Physician Decision|1
2842797|NCT02486796|9757838|P2|Overall Study|Withdrawal by Subject|1
2842798|NCT02486796|9757839|P1|Overall Study|Withdrawal by Subject|1
2842799|NCT02486757|9757851|P1|Overall Study|Lost to Follow-up|1
2842800|NCT02486692|9757857|P2|Overall Study|did not login for randomization|7
2842801|NCT02486692|9757858|P1|Overall Study|did not login for randomization|4
2842802|NCT02486653|9757870|P2|Overall Study|surgery cancelled|1
2842803|NCT02486653|9757871|P1|Overall Study|surgery cancelled|4
2842804|NCT02486653|9757870|P2|Overall Study|Protocol Violation|0
2842805|NCT02486653|9757871|P1|Overall Study|Protocol Violation|1
2842806|NCT02486653|9757870|P2|Overall Study|Withdrawal by Subject|3
2842807|NCT02486653|9757871|P1|Overall Study|Withdrawal by Subject|1
2842808|NCT02486627|9757895|P2|Overall Study|Lost to Follow-up|3
2842809|NCT02486627|9757896|P1|Overall Study|Lost to Follow-up|1
2842810|NCT02486627|9757895|P2|Overall Study|Significant Participant Noncompliance|1
2842811|NCT02486627|9757896|P1|Overall Study|Significant Participant Noncompliance|1
2842812|NCT02486627|9757895|P2|Overall Study|Consent Withdrawn by Participant|3
2842813|NCT02486627|9757896|P1|Overall Study|Consent Withdrawn by Participant|4
2842814|NCT02486627|9757895|P2|Overall Study|Other Unspecified|2
2842815|NCT02486627|9757896|P1|Overall Study|Other Unspecified|0
2842816|NCT02486627|9757895|P2|Overall Study|Death|0
2842817|NCT02486627|9757896|P1|Overall Study|Death|1
2842818|NCT02486302|9757913|P1|Overall Study|Not treated|3
2842819|NCT02486302|9757913|P1|Overall Study|Excluded due to legal reasons|8
2842820|NCT02486302|9757913|P1|Overall Study|Documentation not completed|255
2842821|NCT02486302|9757913|P1|Overall Study|Discontinued prematurely|410
2842822|NCT02485925|9757993|P1|Overall Study|Lost to Follow-up|11
2842823|NCT02485925|9757993|P1|Overall Study|Death|1
2842824|NCT02485925|9757993|P1|Overall Study|Withdrawal by Subject|3
2842825|NCT02485717|9758025|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
2842826|NCT02485717|9758026|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
2842827|NCT02485717|9758027|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
2842828|NCT02485717|9758025|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
2842829|NCT02485717|9758026|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
2842830|NCT02485717|9758027|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
2842831|NCT02485717|9758025|P3|Overall Study|Withdrawal by Subject|1
2842832|NCT02485717|9758026|P2|Overall Study|Withdrawal by Subject|0
2842833|NCT02485717|9758027|P1|Overall Study|Withdrawal by Subject|0
2842834|NCT02485717|9758025|P3|Overall Study|Lost to Follow-up|0
2842835|NCT02485717|9758026|P2|Overall Study|Lost to Follow-up|0
2842836|NCT02485717|9758027|P1|Overall Study|Lost to Follow-up|6
2842837|NCT02485704|9758042|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
2842838|NCT02485704|9758043|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
2842839|NCT02485704|9758042|P2|Overall Study|Withdrawal by Subject|3
2842840|NCT02485704|9758043|P1|Overall Study|Withdrawal by Subject|0
2842841|NCT02485704|9758042|P2|Overall Study|Lost to Follow-up|5
2842842|NCT02485704|9758043|P1|Overall Study|Lost to Follow-up|4
2842843|NCT02485483|9758091|P2|Overall Study|Discontinued after baseline|0
2842844|NCT02485483|9758092|P1|Overall Study|Discontinued after baseline|39
2842845|NCT02485483|9758091|P2|Overall Study|Depression at baseline|0
2842846|NCT02485483|9758092|P1|Overall Study|Depression at baseline|15
2842847|NCT02485353|9758107|P1|Overall Study|Disease Progression|1
2842848|NCT02485353|9758107|P1|Overall Study|Death|1
2842849|NCT02485301|9758114|P2|Overall Study|Other|4
2842850|NCT02485301|9758115|P1|Overall Study|Other|3
2842851|NCT02485301|9758114|P2|Overall Study|Lost to Follow-up|17
2842852|NCT02485301|9758115|P1|Overall Study|Lost to Follow-up|17
2842853|NCT02485301|9758114|P2|Overall Study|Migrated/moved from study area|19
2842854|NCT02485301|9758115|P1|Overall Study|Migrated/moved from study area|10
2842855|NCT02485301|9758114|P2|Overall Study|Withdrawal by Subject|7
2842856|NCT02485301|9758115|P1|Overall Study|Withdrawal by Subject|6
2842857|NCT02485301|9758114|P2|Overall Study|Protocol Violation|1
2842858|NCT02485301|9758115|P1|Overall Study|Protocol Violation|0
2842859|NCT02485301|9758114|P2|Overall Study|Serious Adverse Events|1
2842860|NCT02485301|9758115|P1|Overall Study|Serious Adverse Events|2
2842861|NCT02485158|9758165|P1|Overall Study|expected drug side effect|1
2842862|NCT02485158|9758165|P1|Overall Study|Withdrawal by Subject|3
2842863|NCT02484911|9758254|P2|Overall Study|Protocol Violation|1
2842864|NCT02484911|9758255|P1|Overall Study|Protocol Violation|2
2842865|NCT02484911|9758254|P2|Overall Study|Withdrawal by Subject|1
2842866|NCT02484911|9758255|P1|Overall Study|Withdrawal by Subject|2
2842867|NCT02484729|9758345|P10|Overall Study|Failure of IntelliCap Error|1
2842868|NCT02484729|9758346|P9|Overall Study|Failure of IntelliCap Error|0
2842869|NCT02484729|9758347|P8|Overall Study|Failure of IntelliCap Error|0
2842870|NCT02484729|9758348|P7|Overall Study|Failure of IntelliCap Error|0
2842871|NCT02484729|9758349|P6|Overall Study|Failure of IntelliCap Error|0
2842872|NCT02484729|9758350|P5|Overall Study|Failure of IntelliCap Error|0
2842873|NCT02484729|9758351|P4|Overall Study|Failure of IntelliCap Error|0
2842874|NCT02484729|9758352|P3|Overall Study|Failure of IntelliCap Error|0
2842875|NCT02484729|9758353|P2|Overall Study|Failure of IntelliCap Error|0
2842876|NCT02484729|9758354|P1|Overall Study|Failure of IntelliCap Error|0
2842877|NCT02484651|9758552|P2|Overall Study|Time of the procedure less than 90 min.|2
2842878|NCT02484651|9758553|P1|Overall Study|Time of the procedure less than 90 min.|1
2842879|NCT02484651|9758552|P2|Overall Study|BIS monitoring failed.|1
2842880|NCT02484651|9758553|P1|Overall Study|BIS monitoring failed.|1
2842881|NCT02484651|9758552|P2|Overall Study|Patients' data files were corrupted.|1
2842882|NCT02484651|9758553|P1|Overall Study|Patients' data files were corrupted.|1
2842883|NCT02483975|9758587|P2|Overall Study|Physician Decision|0
2842884|NCT02483975|9758588|P1|Overall Study|Physician Decision|2
2842885|NCT02483975|9758587|P2|Overall Study|Lost to Follow-up|1
2842886|NCT02483975|9758588|P1|Overall Study|Lost to Follow-up|0
2842887|NCT02483975|9758587|P2|Overall Study|Adverse Event|1
2842888|NCT02483975|9758588|P1|Overall Study|Adverse Event|0
2842889|NCT02483611|9758626|P3|Overall Study|Protocol Violation|1
2842890|NCT02483611|9758627|P2|Overall Study|Protocol Violation|0
2842891|NCT02483611|9758628|P1|Overall Study|Protocol Violation|0
2842892|NCT02483585|9758725|P2|Open-label Treatment Phase|Lost to Follow-up|5
2842893|NCT02483585|9758726|P1|Open-label Treatment Phase|Lost to Follow-up|3
2842894|NCT02483585|9758725|P2|Open-label Treatment Phase|Withdrawal by Subject|14
2842895|NCT02483585|9758726|P1|Open-label Treatment Phase|Withdrawal by Subject|18
2842896|NCT02483585|9758725|P2|Open-label Treatment Phase|Decision by Sponsor|1
2842897|NCT02483585|9758726|P1|Open-label Treatment Phase|Decision by Sponsor|0
2842898|NCT02483585|9758725|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
2842899|NCT02483585|9758726|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
2842900|NCT02483585|9758725|P2|Double-blind Treatment Phase|Lost to Follow-up|2
2842901|NCT02483585|9758726|P1|Double-blind Treatment Phase|Lost to Follow-up|3
2842902|NCT02483585|9758725|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
2842903|NCT02483585|9758726|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
2842904|NCT02483585|9758725|P2|Double-blind Treatment Phase|Decision by Sponsor|1
2842905|NCT02483585|9758726|P1|Double-blind Treatment Phase|Decision by Sponsor|1
2842906|NCT02483572|9758748|P2|Overall Study|Physician Decision|1
2842907|NCT02483572|9758749|P1|Overall Study|Physician Decision|0
2842908|NCT02483572|9758748|P2|Overall Study|Lost to Follow-up|0
2842909|NCT02483572|9758749|P1|Overall Study|Lost to Follow-up|1
2842910|NCT02483572|9758748|P2|Overall Study|Withdrawal by Subject|0
2842911|NCT02483572|9758749|P1|Overall Study|Withdrawal by Subject|1
2842912|NCT02483533|9758763|P2|Overall Study|Lack of Efficacy|50
2842913|NCT02483533|9758764|P1|Overall Study|Lack of Efficacy|50
2842914|NCT02483416|9758774|P2|Overall Study|Treatment stop|0
2842915|NCT02483416|9758775|P1|Overall Study|Treatment stop|3
2842916|NCT02483416|9758774|P2|Overall Study|Other reason|1
2842917|NCT02483416|9758775|P1|Overall Study|Other reason|0
2842918|NCT02482935|9758830|P2|Period 1|Withdrawal by Subject|0
2842919|NCT02482935|9758831|P1|Period 1|Withdrawal by Subject|1
2842920|NCT02482805|9758859|P3|Overall Study|Lost to Follow-up|0
2842921|NCT02482805|9758860|P2|Overall Study|Lost to Follow-up|4
2842922|NCT02482805|9758861|P1|Overall Study|Lost to Follow-up|4
2842923|NCT02482571|9758980|P1|Overall Study|Withdrawal by Subject|4
2842924|NCT02482571|9758980|P1|Overall Study|Scanner or Respiract failure|3
2842925|NCT02482571|9758980|P1|Overall Study|Adverse Event|1
2842926|NCT02482428|9758992|P5|Overall Study|subject/guardian decision|2
2842927|NCT02482428|9758993|P4|Overall Study|subject/guardian decision|0
2842928|NCT02482428|9758994|P3|Overall Study|subject/guardian decision|0
2842929|NCT02482428|9758995|P2|Overall Study|subject/guardian decision|2
2842930|NCT02482428|9758996|P1|Overall Study|subject/guardian decision|4
2842931|NCT02482428|9758992|P5|Overall Study|protocol deviation|0
2842932|NCT02482428|9758993|P4|Overall Study|protocol deviation|0
2842933|NCT02482428|9758994|P3|Overall Study|protocol deviation|0
2842934|NCT02482428|9758995|P2|Overall Study|protocol deviation|1
2842935|NCT02482428|9758996|P1|Overall Study|protocol deviation|1
2842936|NCT02482428|9758992|P5|Overall Study|Physician Decision|1
2842937|NCT02482428|9758993|P4|Overall Study|Physician Decision|0
2842938|NCT02482428|9758994|P3|Overall Study|Physician Decision|0
2842939|NCT02482428|9758995|P2|Overall Study|Physician Decision|0
2842940|NCT02482428|9758996|P1|Overall Study|Physician Decision|0
2842941|NCT02482428|9758992|P5|Overall Study|Lost to Follow-up|4
2842942|NCT02482428|9758993|P4|Overall Study|Lost to Follow-up|2
2842943|NCT02482428|9758994|P3|Overall Study|Lost to Follow-up|1
2842944|NCT02482428|9758995|P2|Overall Study|Lost to Follow-up|9
2842945|NCT02482428|9758996|P1|Overall Study|Lost to Follow-up|4
2842946|NCT02482298|9759019|P3|Overall Study|Lost to Follow-up|0
2842947|NCT02482298|9759020|P2|Overall Study|Lost to Follow-up|1
2842948|NCT02482298|9759021|P1|Overall Study|Lost to Follow-up|0
2842949|NCT02482298|9759019|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
2842950|NCT02482298|9759020|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2842951|NCT02482298|9759021|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2842952|NCT02482298|9759019|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
2842953|NCT02482298|9759020|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
2842954|NCT02482298|9759021|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
2842955|NCT02482298|9759019|P3|Overall Study|Withdrawal by Subject|2
2842956|NCT02482298|9759020|P2|Overall Study|Withdrawal by Subject|1
2842957|NCT02482298|9759021|P1|Overall Study|Withdrawal by Subject|2
2842958|NCT02482233|9759043|P2|Overall Study|Lost to Follow-up|1
2842959|NCT02482233|9759044|P1|Overall Study|Lost to Follow-up|1
2842960|NCT02482129|9759080|P2|Overall Study|Criteria not met|0
2842961|NCT02482129|9759081|P1|Overall Study|Criteria not met|1
2842962|NCT02482129|9759080|P2|Overall Study|Withdrawal by Subject|0
2842963|NCT02482129|9759081|P1|Overall Study|Withdrawal by Subject|2
2842964|NCT02482129|9759080|P2|Overall Study|Adverse Event|0
2842965|NCT02482129|9759081|P1|Overall Study|Adverse Event|1
2842966|NCT02482129|9759080|P2|Overall Study|Criteria not met-prior to treatment|0
2842967|NCT02482129|9759081|P1|Overall Study|Criteria not met-prior to treatment|1
2842968|NCT02482129|9759080|P2|Overall Study|Unable to draw blood-prior to treatment|0
2842969|NCT02482129|9759081|P1|Overall Study|Unable to draw blood-prior to treatment|1
2842970|NCT02482129|9759080|P2|Overall Study|Withdrawal by subject-prior to treatment|1
2842971|NCT02482129|9759081|P1|Overall Study|Withdrawal by subject-prior to treatment|0
2842972|NCT02482129|9759080|P2|Overall Study|Adverse Event-prior to treatment|1
2842973|NCT02482129|9759081|P1|Overall Study|Adverse Event-prior to treatment|0
2842974|NCT02481934|9759108|P1|Overall Study|Death|2
2842975|NCT02481830|9759115|P2|Overall Study|Participant not eligible for trial|1
2842976|NCT02481830|9759116|P1|Overall Study|Participant not eligible for trial|0
2842977|NCT02481830|9759115|P2|Overall Study|Disease Progression|1
2842978|NCT02481830|9759116|P1|Overall Study|Disease Progression|1
2842979|NCT02481830|9759115|P2|Overall Study|Withdrawal by Subject|14
2842980|NCT02481830|9759116|P1|Overall Study|Withdrawal by Subject|0
2842981|NCT02481830|9759115|P2|Overall Study|No longer meets Study Criteria|4
2842982|NCT02481830|9759116|P1|Overall Study|No longer meets Study Criteria|1
2842983|NCT02481050|9759278|P1|Overall Study|Other|3
2842984|NCT02481050|9759278|P1|Overall Study|Withdrawal by Subject|7
2842985|NCT02481050|9759278|P1|Overall Study|Disease Progression|47
2842986|NCT02481050|9759278|P1|Overall Study|Adverse Event|1
2842987|NCT02480764|9759305|P3|Overall Study|Reason not Specified|0
2842988|NCT02480764|9759306|P2|Overall Study|Reason not Specified|1
2842989|NCT02480764|9759307|P1|Overall Study|Reason not Specified|0
2842990|NCT02480764|9759305|P3|Overall Study|Lack of Efficacy|3
2842991|NCT02480764|9759306|P2|Overall Study|Lack of Efficacy|3
2842992|NCT02480764|9759307|P1|Overall Study|Lack of Efficacy|0
2842993|NCT02480764|9759305|P3|Overall Study|Voluntary Withdrawal|10
2842994|NCT02480764|9759306|P2|Overall Study|Voluntary Withdrawal|5
2842995|NCT02480764|9759307|P1|Overall Study|Voluntary Withdrawal|6
2842996|NCT02480764|9759305|P3|Overall Study|Lost to Follow-up|2
2842997|NCT02480764|9759306|P2|Overall Study|Lost to Follow-up|1
2842998|NCT02480764|9759307|P1|Overall Study|Lost to Follow-up|0
2842999|NCT02480764|9759305|P3|Overall Study|Major Protocol Deviation|3
2843000|NCT02480764|9759306|P2|Overall Study|Major Protocol Deviation|4
2843001|NCT02480764|9759307|P1|Overall Study|Major Protocol Deviation|1
2843002|NCT02480764|9759305|P3|Overall Study|Pretreatment Event/Adverse Event|3
2843003|NCT02480764|9759306|P2|Overall Study|Pretreatment Event/Adverse Event|6
2843004|NCT02480764|9759307|P1|Overall Study|Pretreatment Event/Adverse Event|3
2843005|NCT02480712|9759333|P1|Overall Study|Lack of Efficacy|1
2843006|NCT02480712|9759333|P1|Overall Study|Death|1
2843007|NCT02480712|9759333|P1|Overall Study|Withdrew Consent|3
2843008|NCT02480712|9759333|P1|Overall Study|Lost to Follow-up|5
2843009|NCT02480712|9759333|P1|Overall Study|Enrolled but Never Treated|1
2843010|NCT02480621|9759352|P2|Follow Up|Lost to Follow-up|2
2843011|NCT02480621|9759353|P1|Follow Up|Lost to Follow-up|4
2843012|NCT02480621|9759352|P2|Randomization|Surgeon did not give intervention|1
2843013|NCT02480621|9759353|P1|Randomization|Surgeon did not give intervention|0
2843014|NCT02480621|9759352|P2|Randomization|Withdrawal by Subject|0
2843015|NCT02480621|9759353|P1|Randomization|Withdrawal by Subject|1
2843016|NCT02480153|9759430|P3|Period 3: Week 52 Dosing to Week 78|Death|0
2843017|NCT02480153|9759431|P2|Period 3: Week 52 Dosing to Week 78|Death|1
2843018|NCT02480153|9759432|P1|Period 3: Week 52 Dosing to Week 78|Death|0
2843019|NCT02480153|9759430|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
2843020|NCT02480153|9759431|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2843021|NCT02480153|9759432|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2843022|NCT02480153|9759430|P3|Period 3: Week 52 Dosing to Week 78|Other|1
2843023|NCT02480153|9759431|P2|Period 3: Week 52 Dosing to Week 78|Other|0
2843024|NCT02480153|9759432|P1|Period 3: Week 52 Dosing to Week 78|Other|0
2843025|NCT02480153|9759430|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
2843026|NCT02480153|9759431|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
2843027|NCT02480153|9759432|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
2843028|NCT02480153|9759430|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
2843029|NCT02480153|9759431|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
2843030|NCT02480153|9759432|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
2843031|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2843032|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
2843033|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2843034|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2843035|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2843036|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
2843037|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
2843038|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
2843039|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
2843040|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
2843041|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
2843042|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
2843043|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2843044|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
2843045|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2843046|NCT02480153|9759430|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
2843047|NCT02480153|9759431|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
2843048|NCT02480153|9759432|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
2843049|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2843050|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
2843051|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2843052|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
2843053|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
2843054|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
2843055|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
2843056|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
2843057|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
2843058|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
2843059|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
2843060|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
2843061|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
2843062|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
2843063|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
2843064|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2843065|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
2843066|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2843067|NCT02480153|9759430|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2843068|NCT02480153|9759431|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
2843069|NCT02480153|9759432|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2843070|NCT02480010|9759609|P2|Overall Study|Refused Treatment|3
2843071|NCT02480010|9759610|P1|Overall Study|Refused Treatment|0
2843072|NCT02480010|9759609|P2|Overall Study|Insufficient therapeutic response|29
2843073|NCT02480010|9759610|P1|Overall Study|Insufficient therapeutic response|31
2843074|NCT02480010|9759609|P2|Overall Study|Death|0
2843075|NCT02480010|9759610|P1|Overall Study|Death|1
2843076|NCT02480010|9759609|P2|Overall Study|Adverse Event|1
2843077|NCT02480010|9759610|P1|Overall Study|Adverse Event|3
2843078|NCT02479880|9759656|P2|Overall Study|Pregnancy|1
2843079|NCT02479880|9759657|P1|Overall Study|Pregnancy|0
2843080|NCT02479880|9759656|P2|Overall Study|Study Terminated by Sponsor|12
2843081|NCT02479880|9759657|P1|Overall Study|Study Terminated by Sponsor|13
2843082|NCT02479412|9759681|P9|Overall Study|Randomization to wrong PK sampling group|0
2843083|NCT02479412|9759682|P8|Overall Study|Randomization to wrong PK sampling group|0
2843084|NCT02479412|9759683|P7|Overall Study|Randomization to wrong PK sampling group|0
2843085|NCT02479412|9759684|P6|Overall Study|Randomization to wrong PK sampling group|0
2843086|NCT02479412|9759685|P5|Overall Study|Randomization to wrong PK sampling group|1
2843087|NCT02479412|9759686|P4|Overall Study|Randomization to wrong PK sampling group|0
2843088|NCT02479412|9759687|P3|Overall Study|Randomization to wrong PK sampling group|0
2843089|NCT02479412|9759688|P2|Overall Study|Randomization to wrong PK sampling group|0
2843090|NCT02479412|9759689|P1|Overall Study|Randomization to wrong PK sampling group|0
2843091|NCT02479412|9759681|P9|Overall Study|Study-specific withdrawal criteria|1
2843092|NCT02479412|9759682|P8|Overall Study|Study-specific withdrawal criteria|1
2843093|NCT02479412|9759683|P7|Overall Study|Study-specific withdrawal criteria|0
2843094|NCT02479412|9759684|P6|Overall Study|Study-specific withdrawal criteria|0
2843095|NCT02479412|9759685|P5|Overall Study|Study-specific withdrawal criteria|0
2843096|NCT02479412|9759686|P4|Overall Study|Study-specific withdrawal criteria|1
2843097|NCT02479412|9759687|P3|Overall Study|Study-specific withdrawal criteria|1
2843098|NCT02479412|9759688|P2|Overall Study|Study-specific withdrawal criteria|0
2843099|NCT02479412|9759689|P1|Overall Study|Study-specific withdrawal criteria|0
2843100|NCT02479412|9759681|P9|Overall Study|Adverse Event|0
2843101|NCT02479412|9759682|P8|Overall Study|Adverse Event|0
2843102|NCT02479412|9759683|P7|Overall Study|Adverse Event|0
2843103|NCT02479412|9759684|P6|Overall Study|Adverse Event|0
2843104|NCT02479412|9759685|P5|Overall Study|Adverse Event|0
2843105|NCT02479412|9759686|P4|Overall Study|Adverse Event|0
2843106|NCT02479412|9759687|P3|Overall Study|Adverse Event|1
2843107|NCT02479412|9759688|P2|Overall Study|Adverse Event|0
2843108|NCT02479412|9759689|P1|Overall Study|Adverse Event|0
2843109|NCT02479139|9759766|P6|Overall Study|Other Miscellaneous Reasons|0
2843110|NCT02479139|9759767|P5|Overall Study|Other Miscellaneous Reasons|1
2843111|NCT02479139|9759768|P4|Overall Study|Other Miscellaneous Reasons|1
2843112|NCT02479139|9759769|P3|Overall Study|Other Miscellaneous Reasons|1
2843113|NCT02479139|9759770|P2|Overall Study|Other Miscellaneous Reasons|0
2843114|NCT02479139|9759771|P1|Overall Study|Other Miscellaneous Reasons|1
2843115|NCT02479139|9759766|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
2843116|NCT02479139|9759767|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
2843117|NCT02479139|9759768|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
2843118|NCT02479139|9759769|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
2843119|NCT02479139|9759770|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
2843120|NCT02479139|9759771|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
2843121|NCT02479139|9759766|P6|Overall Study|Withdrew Consent|1
2843122|NCT02479139|9759767|P5|Overall Study|Withdrew Consent|1
2843123|NCT02479139|9759768|P4|Overall Study|Withdrew Consent|4
2843124|NCT02479139|9759769|P3|Overall Study|Withdrew Consent|1
2843125|NCT02479139|9759770|P2|Overall Study|Withdrew Consent|6
2843126|NCT02479139|9759771|P1|Overall Study|Withdrew Consent|5
2843127|NCT02479139|9759766|P6|Overall Study|Lost to Follow-up|5
2843128|NCT02479139|9759767|P5|Overall Study|Lost to Follow-up|3
2843129|NCT02479139|9759768|P4|Overall Study|Lost to Follow-up|2
2843130|NCT02479139|9759769|P3|Overall Study|Lost to Follow-up|4
2843131|NCT02479139|9759770|P2|Overall Study|Lost to Follow-up|4
2843132|NCT02479139|9759771|P1|Overall Study|Lost to Follow-up|2
2843133|NCT02478632|9759804|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
2843134|NCT02478632|9759805|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
2843135|NCT02478632|9759804|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
2843136|NCT02478632|9759805|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
2843137|NCT02478632|9759804|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
2843138|NCT02478632|9759805|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
2843139|NCT02478398|9759842|P2|Overall Study|Withdrawal By Participant|4
2843140|NCT02478398|9759843|P1|Overall Study|Withdrawal By Participant|10
2843141|NCT02478398|9759842|P2|Overall Study|Withdrawal By Parent/Guardian|6
2843142|NCT02478398|9759843|P1|Overall Study|Withdrawal By Parent/Guardian|9
2843143|NCT02478398|9759842|P2|Overall Study|Protocol Violation|1
2843144|NCT02478398|9759843|P1|Overall Study|Protocol Violation|3
2843145|NCT02478398|9759842|P2|Overall Study|Non-Compliance With Study Drug|1
2843146|NCT02478398|9759843|P1|Overall Study|Non-Compliance With Study Drug|5
2843147|NCT02478398|9759842|P2|Overall Study|Lost to Follow-up|4
2843148|NCT02478398|9759843|P1|Overall Study|Lost to Follow-up|5
2843149|NCT02478398|9759842|P2|Overall Study|Adverse Event|5
2843150|NCT02478398|9759843|P1|Overall Study|Adverse Event|20
2843151|NCT02478372|9759863|P2|Overall Study|Death|2
2843152|NCT02478372|9759864|P1|Overall Study|Death|0
2843153|NCT02478372|9759863|P2|Overall Study|Lost to Follow-up|4
2843154|NCT02478372|9759864|P1|Overall Study|Lost to Follow-up|1
2843155|NCT02478372|9759863|P2|Overall Study|Protocol Violation|8
2843156|NCT02478372|9759864|P1|Overall Study|Protocol Violation|12
2843157|NCT02478359|9759888|P2|Overall Study|Disenrolled from health plan|65
2843158|NCT02478359|9759889|P1|Overall Study|Disenrolled from health plan|106
2843159|NCT02478164|9759961|P1|Overall Study|Withdrawal by Subject|1
2843160|NCT02478164|9759961|P1|Overall Study|Adverse Event|1
2843161|NCT02478164|9759961|P1|Overall Study|Lack of Efficacy|13
2843162|NCT02477618|9759974|P2|Overall Study|Left Study Site for Rehabilitation|1
2843163|NCT02477618|9759975|P1|Overall Study|Left Study Site for Rehabilitation|0
2843164|NCT02477618|9759974|P2|Overall Study|Transferred Away from Study Site|0
2843165|NCT02477618|9759975|P1|Overall Study|Transferred Away from Study Site|1
2843166|NCT02477618|9759974|P2|Overall Study|Adverse Event|1
2843167|NCT02477618|9759975|P1|Overall Study|Adverse Event|1
2843168|NCT02477618|9759974|P2|Overall Study|Died in Double-Blind Treatment Period|11
2843169|NCT02477618|9759975|P1|Overall Study|Died in Double-Blind Treatment Period|11
2843170|NCT02477618|9759974|P2|Overall Study|Completed Visits but Discontinued Drug|1
2843171|NCT02477618|9759975|P1|Overall Study|Completed Visits but Discontinued Drug|2
2843172|NCT02477605|9759999|P2|Overall Study|Administered gas during surgery|1
2843173|NCT02477605|9760000|P1|Overall Study|Administered gas during surgery|0
2843174|NCT02477605|9759999|P2|Overall Study|Withdrawal by Subject|1
2843175|NCT02477605|9760000|P1|Overall Study|Withdrawal by Subject|0
2843176|NCT02477605|9759999|P2|Overall Study|Lost to Follow-up|2
2843177|NCT02477605|9760000|P1|Overall Study|Lost to Follow-up|0
2843178|NCT02477605|9759999|P2|Overall Study|Discontinued prior to treatment|0
2843179|NCT02477605|9760000|P1|Overall Study|Discontinued prior to treatment|1
2843180|NCT02477553|9760016|P2|Overall Study|patient deceased|0
2843181|NCT02477553|9760017|P1|Overall Study|patient deceased|1
2843182|NCT02477553|9760016|P2|Overall Study|MD advised against screening|3
2843183|NCT02477553|9760017|P1|Overall Study|MD advised against screening|1
2843184|NCT02477553|9760016|P2|Overall Study|Elevated risk for CRC|2
2843185|NCT02477553|9760017|P1|Overall Study|Elevated risk for CRC|2
2843186|NCT02477553|9760016|P2|Overall Study|Technical issues with intervention|0
2843187|NCT02477553|9760017|P1|Overall Study|Technical issues with intervention|2
2843188|NCT02477553|9760016|P2|Overall Study|Workup consistent w/CRC|1
2843189|NCT02477553|9760017|P1|Overall Study|Workup consistent w/CRC|1
2843190|NCT02477553|9760016|P2|Overall Study|No MD visit|1
2843191|NCT02477553|9760017|P1|Overall Study|No MD visit|1
2843192|NCT02477553|9760016|P2|Overall Study|Screening up-to-date|13
2843193|NCT02477553|9760017|P1|Overall Study|Screening up-to-date|12
2843194|NCT02477527|9760037|P1|Overall Study|Screen Failure|3
2843195|NCT02477527|9760037|P1|Overall Study|Withdrawal by Subject|1
2843196|NCT02477527|9760037|P1|Overall Study|Lost to Follow-up|2
2843197|NCT02477332|9760051|P6|Overall Study|Withdrawal by Subject|0
2843198|NCT02477332|9760052|P5|Overall Study|Withdrawal by Subject|1
2843199|NCT02477332|9760053|P4|Overall Study|Withdrawal by Subject|2
2843200|NCT02477332|9760054|P3|Overall Study|Withdrawal by Subject|1
2843201|NCT02477332|9760055|P2|Overall Study|Withdrawal by Subject|3
2843202|NCT02477332|9760056|P1|Overall Study|Withdrawal by Subject|0
2843203|NCT02477332|9760051|P6|Overall Study|Physician Decision|1
2843204|NCT02477332|9760052|P5|Overall Study|Physician Decision|0
2843205|NCT02477332|9760053|P4|Overall Study|Physician Decision|3
2843206|NCT02477332|9760054|P3|Overall Study|Physician Decision|1
2843207|NCT02477332|9760055|P2|Overall Study|Physician Decision|0
2843208|NCT02477332|9760056|P1|Overall Study|Physician Decision|0
2843209|NCT02477332|9760051|P6|Overall Study|Lost to Follow-up|0
2843210|NCT02477332|9760052|P5|Overall Study|Lost to Follow-up|0
2843211|NCT02477332|9760053|P4|Overall Study|Lost to Follow-up|0
2843212|NCT02477332|9760054|P3|Overall Study|Lost to Follow-up|2
2843213|NCT02477332|9760055|P2|Overall Study|Lost to Follow-up|0
2843214|NCT02477332|9760056|P1|Overall Study|Lost to Follow-up|0
2843215|NCT02477332|9760051|P6|Overall Study|Technical problems|0
2843216|NCT02477332|9760052|P5|Overall Study|Technical problems|0
2843217|NCT02477332|9760053|P4|Overall Study|Technical problems|0
2843218|NCT02477332|9760054|P3|Overall Study|Technical problems|1
2843219|NCT02477332|9760055|P2|Overall Study|Technical problems|0
2843220|NCT02477332|9760056|P1|Overall Study|Technical problems|0
2843221|NCT02477332|9760051|P6|Overall Study|Protocol Violation|1
2843222|NCT02477332|9760052|P5|Overall Study|Protocol Violation|1
2843223|NCT02477332|9760053|P4|Overall Study|Protocol Violation|3
2843224|NCT02477332|9760054|P3|Overall Study|Protocol Violation|3
2843225|NCT02477332|9760055|P2|Overall Study|Protocol Violation|0
2843226|NCT02477332|9760056|P1|Overall Study|Protocol Violation|2
2843227|NCT02477332|9760051|P6|Overall Study|Pregnancy|0
2843228|NCT02477332|9760052|P5|Overall Study|Pregnancy|0
2843229|NCT02477332|9760053|P4|Overall Study|Pregnancy|1
2843230|NCT02477332|9760054|P3|Overall Study|Pregnancy|0
2843231|NCT02477332|9760055|P2|Overall Study|Pregnancy|0
2843232|NCT02477332|9760056|P1|Overall Study|Pregnancy|0
2843233|NCT02477332|9760051|P6|Overall Study|Non-compliance with study treatment|0
2843234|NCT02477332|9760052|P5|Overall Study|Non-compliance with study treatment|0
2843235|NCT02477332|9760053|P4|Overall Study|Non-compliance with study treatment|0
2843236|NCT02477332|9760054|P3|Overall Study|Non-compliance with study treatment|2
2843237|NCT02477332|9760055|P2|Overall Study|Non-compliance with study treatment|1
2843238|NCT02477332|9760056|P1|Overall Study|Non-compliance with study treatment|0
2843239|NCT02477332|9760051|P6|Overall Study|Lack of Efficacy|1
2843240|NCT02477332|9760052|P5|Overall Study|Lack of Efficacy|1
2843241|NCT02477332|9760053|P4|Overall Study|Lack of Efficacy|2
2843242|NCT02477332|9760054|P3|Overall Study|Lack of Efficacy|1
2843243|NCT02477332|9760055|P2|Overall Study|Lack of Efficacy|2
2843244|NCT02477332|9760056|P1|Overall Study|Lack of Efficacy|1
2843245|NCT02477332|9760051|P6|Overall Study|Adverse Event|2
2843246|NCT02477332|9760052|P5|Overall Study|Adverse Event|1
2843247|NCT02477332|9760053|P4|Overall Study|Adverse Event|2
2843248|NCT02477332|9760054|P3|Overall Study|Adverse Event|1
2843249|NCT02477332|9760055|P2|Overall Study|Adverse Event|1
2843250|NCT02477332|9760056|P1|Overall Study|Adverse Event|0
2843251|NCT02477215|9760148|P3|Fixed Dose Phase|Physician Decision|0
2843252|NCT02477215|9760149|P2|Fixed Dose Phase|Physician Decision|7
2843253|NCT02477215|9760150|P1|Fixed Dose Phase|Physician Decision|0
2843254|NCT02477215|9760148|P3|Dose Escalation Phase|Physician Decision|0
2843255|NCT02477215|9760149|P2|Dose Escalation Phase|Physician Decision|2
2843256|NCT02477215|9760150|P1|Dose Escalation Phase|Physician Decision|1
2843257|NCT02477020|9760166|P2|Overall Study|Lack of Efficacy|5
2843258|NCT02477020|9760167|P1|Overall Study|Lack of Efficacy|14
2843259|NCT02477020|9760166|P2|Overall Study|Reason not Specified|1
2843260|NCT02477020|9760167|P1|Overall Study|Reason not Specified|3
2843261|NCT02477020|9760166|P2|Overall Study|Voluntary Withdrawal|16
2843262|NCT02477020|9760167|P1|Overall Study|Voluntary Withdrawal|7
2843263|NCT02477020|9760166|P2|Overall Study|Pretreatment Event/Adverse Event|6
2843264|NCT02477020|9760167|P1|Overall Study|Pretreatment Event/Adverse Event|6
2843265|NCT02476994|9760197|P2|Overall Study|Based on feedback from FDA|0
2843266|NCT02476994|9760198|P1|Overall Study|Based on feedback from FDA|1
2843267|NCT02476617|9760267|P1|Overall Study|Lost to Follow-up|1
2843268|NCT02476617|9760267|P1|Overall Study|Adverse Event|1
2843269|NCT02476578|9760273|P2|Overall Study|Lost to Follow-up|13
2843270|NCT02476578|9760274|P1|Overall Study|Lost to Follow-up|6
2843271|NCT02476578|9760273|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
2843272|NCT02476578|9760274|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
2843273|NCT02476422|9760336|P2|Overall Study|Subject/guardian decision|1
2843274|NCT02476422|9760337|P1|Overall Study|Subject/guardian decision|0
2843275|NCT02476175|9760378|P1|Overall Study|Adverse Event|2
2843276|NCT02476006|9760402|P1|Overall Study|Enrolled but not treated|4
2843277|NCT02476006|9760402|P1|Overall Study|Protocol Violation|1
2843278|NCT02476006|9760402|P1|Overall Study|Excluded from study|1
2843279|NCT02476006|9760402|P1|Overall Study|Switched to commercial drug|4
2843280|NCT02476006|9760402|P1|Overall Study|Study ended treatment not available|4
2843281|NCT02476006|9760402|P1|Overall Study|Physician Decision|5
2843282|NCT02476006|9760402|P1|Overall Study|Lost to Follow-up|5
2843283|NCT02476006|9760402|P1|Overall Study|Sponsor decision|6
2843284|NCT02476006|9760402|P1|Overall Study|Poor compliance to study protocol|3
2843285|NCT02476006|9760402|P1|Overall Study|Adverse Event|41
2843286|NCT02476006|9760402|P1|Overall Study|Participant did not wish to continue|39
2843287|NCT02476006|9760402|P1|Overall Study|Pregnancy|1
2843288|NCT02476006|9760402|P1|Overall Study|Lack of treatment efficacy|2
2843289|NCT02476006|9760402|P1|Overall Study|Death|4
2843290|NCT02475980|9760416|P1|Overall Study|Withdrawal by Subject|1
2843291|NCT02475980|9760416|P1|Overall Study|Lost to Follow-up|4
2843292|NCT02475733|9760442|P2|Overall Study|Physician Decision|0
2843293|NCT02475733|9760443|P1|Overall Study|Physician Decision|1
2843294|NCT02475733|9760442|P2|Overall Study|Withdrawal by Subject|0
2843295|NCT02475733|9760443|P1|Overall Study|Withdrawal by Subject|1
2843296|NCT02475655|9760500|P2|Overall Study|Lost to Follow-up|1
2843297|NCT02475655|9760501|P1|Overall Study|Lost to Follow-up|0
2843298|NCT02475629|9760560|P1|Overall Study|Subject non-compliance|1
2843299|NCT02475629|9760560|P1|Overall Study|Lost to Follow-up|1
2843300|NCT02475629|9760560|P1|Overall Study|Withdrawal by Subject|1
2843301|NCT02475629|9760560|P1|Overall Study|Physician Decision|1
2843302|NCT02475629|9760560|P1|Overall Study|Death|4
2843303|NCT02475629|9760560|P1|Overall Study|Adverse Event|1
2843304|NCT02475564|9760583|P2|Overall Study|Intense Menstrual bleeding|0
2843305|NCT02475564|9760584|P1|Overall Study|Intense Menstrual bleeding|1
2843306|NCT02475564|9760583|P2|Overall Study|Lost to Follow-up|1
2843307|NCT02475564|9760584|P1|Overall Study|Lost to Follow-up|2
2843308|NCT02475564|9760583|P2|Overall Study|Withdrawal by Subject|0
2843309|NCT02475564|9760584|P1|Overall Study|Withdrawal by Subject|1
2843310|NCT02475395|9760596|P2|Overall Study|Protocol Violation|3
2843311|NCT02475395|9760597|P1|Overall Study|Protocol Violation|30
2843312|NCT02475278|9760607|P1|Overall Study|Reason Not Specified|1
2843313|NCT02475278|9760607|P1|Overall Study|Lost to Follow-up|1
2843314|NCT02475265|9760618|P1|Overall Study|Withdrawal by Subject|2
2843315|NCT02475265|9760618|P1|Overall Study|Physician Decision|1
2843316|NCT02474589|9760669|P2|Overall Study|Inability to complete study procedures|1
2843317|NCT02474589|9760670|P1|Overall Study|Inability to complete study procedures|5
2843318|NCT02474589|9760669|P2|Overall Study|Withdrawal by Subject|0
2843319|NCT02474589|9760670|P1|Overall Study|Withdrawal by Subject|4
2843320|NCT02474589|9760669|P2|Overall Study|Protocol Violation|1
2843321|NCT02474589|9760670|P1|Overall Study|Protocol Violation|4
2843322|NCT02474589|9760669|P2|Overall Study|Lost to Follow-up|1
2843323|NCT02474589|9760670|P1|Overall Study|Lost to Follow-up|6
2843324|NCT02474589|9760669|P2|Overall Study|Adverse Event|2
2843325|NCT02474589|9760670|P1|Overall Study|Adverse Event|6
2843326|NCT02474082|9760729|P2|Overall Study|Protocol deviation|1
2843327|NCT02474082|9760730|P1|Overall Study|Protocol deviation|0
2843328|NCT02474082|9760729|P2|Overall Study|Non-compliance with study treatment|2
2843329|NCT02474082|9760730|P1|Overall Study|Non-compliance with study treatment|0
2843330|NCT02474082|9760729|P2|Overall Study|Participant/guardian decision|2
2843331|NCT02474082|9760730|P1|Overall Study|Participant/guardian decision|1
2843332|NCT02474082|9760729|P2|Overall Study|Dose tapering not achieved|4
2843333|NCT02474082|9760730|P1|Overall Study|Dose tapering not achieved|0
2843334|NCT02474082|9760729|P2|Overall Study|Lost to Follow-up|2
2843335|NCT02474082|9760730|P1|Overall Study|Lost to Follow-up|2
2843336|NCT02474082|9760729|P2|Overall Study|Withdrawal of informed consent|11
2843337|NCT02474082|9760730|P1|Overall Study|Withdrawal of informed consent|1
2843338|NCT02474082|9760729|P2|Overall Study|Adverse Event|32
2843339|NCT02474082|9760730|P1|Overall Study|Adverse Event|2
2843340|NCT02474069|9760764|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2843341|NCT02474069|9760765|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2843342|NCT02474069|9760766|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
2843343|NCT02474069|9760764|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
2843344|NCT02474069|9760765|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2843345|NCT02474069|9760766|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2843346|NCT02474069|9760764|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
2843347|NCT02474069|9760765|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
2843348|NCT02474069|9760766|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
2843349|NCT02474069|9760764|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
2843350|NCT02474069|9760765|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
2843351|NCT02474069|9760766|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
2843352|NCT02474069|9760764|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
2843353|NCT02474069|9760765|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
2843354|NCT02474069|9760766|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
2843355|NCT02474069|9760764|P3|Selection Phase (SP)|Withdrawal by Subject|0
2843356|NCT02474069|9760765|P2|Selection Phase (SP)|Withdrawal by Subject|0
2843357|NCT02474069|9760766|P1|Selection Phase (SP)|Withdrawal by Subject|3
2843358|NCT02474069|9760764|P3|Selection Phase (SP)|Technical Problem|0
2843359|NCT02474069|9760765|P2|Selection Phase (SP)|Technical Problem|0
2843360|NCT02474069|9760766|P1|Selection Phase (SP)|Technical Problem|1
2843361|NCT02474069|9760764|P3|Selection Phase (SP)|No longer requires treatment|0
2843362|NCT02474069|9760765|P2|Selection Phase (SP)|No longer requires treatment|0
2843363|NCT02474069|9760766|P1|Selection Phase (SP)|No longer requires treatment|1
2843364|NCT02474069|9760764|P3|Selection Phase (SP)|Protocol Violation|0
2843365|NCT02474069|9760765|P2|Selection Phase (SP)|Protocol Violation|0
2843366|NCT02474069|9760766|P1|Selection Phase (SP)|Protocol Violation|1
2843367|NCT02474069|9760764|P3|Selection Phase (SP)|Physician Decision|0
2843368|NCT02474069|9760765|P2|Selection Phase (SP)|Physician Decision|0
2843369|NCT02474069|9760766|P1|Selection Phase (SP)|Physician Decision|1
2843370|NCT02474069|9760764|P3|Selection Phase (SP)|Lost to Follow-up|0
2843371|NCT02474069|9760765|P2|Selection Phase (SP)|Lost to Follow-up|0
2843372|NCT02474069|9760766|P1|Selection Phase (SP)|Lost to Follow-up|4
2843373|NCT02474069|9760764|P3|Selection Phase (SP)|Lack of Efficacy|0
2843374|NCT02474069|9760765|P2|Selection Phase (SP)|Lack of Efficacy|0
2843375|NCT02474069|9760766|P1|Selection Phase (SP)|Lack of Efficacy|1
2843376|NCT02474069|9760764|P3|Selection Phase (SP)|Adverse Event|0
2843377|NCT02474069|9760765|P2|Selection Phase (SP)|Adverse Event|0
2843378|NCT02474069|9760766|P1|Selection Phase (SP)|Adverse Event|8
2843379|NCT02473965|9760799|P2|Overall Study|Physician Decision|2
2843380|NCT02473965|9760800|P1|Overall Study|Physician Decision|0
2843381|NCT02473965|9760799|P2|Overall Study|Withdrawal by Subject|3
2843382|NCT02473965|9760800|P1|Overall Study|Withdrawal by Subject|2
2843383|NCT02473965|9760799|P2|Overall Study|MG worsening|1
2843384|NCT02473965|9760800|P1|Overall Study|MG worsening|4
2843385|NCT02473965|9760799|P2|Overall Study|Adverse Event|4
2843386|NCT02473965|9760800|P1|Overall Study|Adverse Event|6
2843387|NCT02473952|9760812|P2|Overall Study|Withdrawal by Subject|6
2843388|NCT02473952|9760813|P1|Overall Study|Withdrawal by Subject|0
2843389|NCT02473952|9760812|P2|Overall Study|Adverse Event|2
2843390|NCT02473952|9760813|P1|Overall Study|Adverse Event|2
2843391|NCT02473640|9760853|P1|Treatment Period 1|Adverse Event|1
2843392|NCT02473523|9760862|P1|Overall Study|Lost to Follow-up|1
2843393|NCT02473523|9760862|P1|Overall Study|Death|1
2843394|NCT02473510|9760883|P2|Overall Study|Lost to Follow-up|2
2843395|NCT02473510|9760884|P1|Overall Study|Lost to Follow-up|1
2843396|NCT02473471|9760898|P1|Overall Study|Lost to Follow-up|1
2843397|NCT02473471|9760898|P1|Overall Study|poor oral hygiene|2
2843398|NCT02473445|9760929|P1|Overall Study|Sponsor Decision|20
2843399|NCT02473445|9760929|P1|Overall Study|Withdrawal by Subject|2
2843400|NCT02473367|9760935|P1|Period 4|Lost to Follow-up|1
2843401|NCT02473367|9760935|P1|Wait 1|Withdrawal by Subject|1
2843402|NCT02473289|9760955|P2|Overall Study|Other|0
2843403|NCT02473289|9760956|P1|Overall Study|Other|2
2843404|NCT02473289|9760955|P2|Overall Study|Treatment Unblinded + Adverse event|1
2843405|NCT02473289|9760956|P1|Overall Study|Treatment Unblinded + Adverse event|0
2843406|NCT02473289|9760955|P2|Overall Study|Withdrawal of consent|7
2843407|NCT02473289|9760956|P1|Overall Study|Withdrawal of consent|6
2843408|NCT02473289|9760955|P2|Overall Study|Protocol Violation|1
2843409|NCT02473289|9760956|P1|Overall Study|Protocol Violation|0
2843410|NCT02473289|9760955|P2|Overall Study|Lost to Follow-up|1
2843411|NCT02473289|9760956|P1|Overall Study|Lost to Follow-up|1
2843412|NCT02473289|9760955|P2|Overall Study|Adverse Event|3
2843413|NCT02473289|9760956|P1|Overall Study|Adverse Event|2
2843414|NCT02472977|9760981|P3|Overall Study|Subject request to discontinue treatment|0
2843415|NCT02472977|9760982|P2|Overall Study|Subject request to discontinue treatment|1
2843416|NCT02472977|9760983|P1|Overall Study|Subject request to discontinue treatment|0
2843417|NCT02472977|9760981|P3|Overall Study|Study drug toxicity|2
2843418|NCT02472977|9760982|P2|Overall Study|Study drug toxicity|0
2843419|NCT02472977|9760983|P1|Overall Study|Study drug toxicity|2
2843420|NCT02472977|9760981|P3|Overall Study|Withdrawal by Subject|0
2843421|NCT02472977|9760982|P2|Overall Study|Withdrawal by Subject|1
2843422|NCT02472977|9760983|P1|Overall Study|Withdrawal by Subject|0
2843423|NCT02472977|9760981|P3|Overall Study|Disease progression|6
2843424|NCT02472977|9760982|P2|Overall Study|Disease progression|25
2843425|NCT02472977|9760983|P1|Overall Study|Disease progression|4
2843426|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
2843427|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
2843428|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
2843429|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
2843430|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
2843431|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
2843432|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Physician Decision|1
2843433|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Physician Decision|1
2843434|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Death|1
2843435|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Death|0
2843436|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Disease Progression|56
2843437|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Disease Progression|52
2843438|NCT02472964|9761008|P2|Part 2 (Week 24-week 48)|Adverse Event|2
2843439|NCT02472964|9761009|P1|Part 2 (Week 24-week 48)|Adverse Event|4
2843440|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Other|1
2843441|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Other|2
2843442|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
2843443|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
2843444|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
2843445|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
2843446|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Physician Decision|1
2843447|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Physician Decision|3
2843448|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Death|6
2843449|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Death|3
2843450|NCT02472964|9761008|P2|Part 1 (up to Week 24)|disease progression|47
2843451|NCT02472964|9761009|P1|Part 1 (up to Week 24)|disease progression|58
2843452|NCT02472964|9761008|P2|Part 1 (up to Week 24)|Adverse Event|4
2843453|NCT02472964|9761009|P1|Part 1 (up to Week 24)|Adverse Event|2
2843454|NCT02472886|9761018|P3|Overall Study|Lack of Efficacy|1
2843455|NCT02472886|9761019|P2|Overall Study|Lack of Efficacy|2
2843456|NCT02472886|9761020|P1|Overall Study|Lack of Efficacy|0
2843457|NCT02472847|9761048|P2|Overall Study|Withdrawal by Subject|5
2843458|NCT02472847|9761049|P1|Overall Study|Withdrawal by Subject|1
2843459|NCT02472795|9761060|P5|Overall Study|Withdrawal by Subject|1
2843460|NCT02472795|9761061|P4|Overall Study|Withdrawal by Subject|0
2843461|NCT02472795|9761062|P3|Overall Study|Withdrawal by Subject|0
2843462|NCT02472795|9761063|P2|Overall Study|Withdrawal by Subject|0
2843463|NCT02472795|9761064|P1|Overall Study|Withdrawal by Subject|0
2843464|NCT02472795|9761060|P5|Overall Study|Adverse Event|2
2843465|NCT02472795|9761061|P4|Overall Study|Adverse Event|0
2843466|NCT02472795|9761062|P3|Overall Study|Adverse Event|0
2843467|NCT02472795|9761063|P2|Overall Study|Adverse Event|1
2843468|NCT02472795|9761064|P1|Overall Study|Adverse Event|0
2843469|NCT02472756|9761096|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
2843470|NCT02472756|9761096|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
2843471|NCT02472756|9761096|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
2843472|NCT02472756|9761096|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
2843473|NCT02472756|9761096|P1|Induction (Approximately 6 Months)|Adverse Event|1
2843474|NCT02472652|9761117|P1|Overall Study|Lost to Follow-up|1
2843475|NCT02472639|9761124|P2|Overall Study|Physician Decision|3
2843476|NCT02472639|9761125|P1|Overall Study|Physician Decision|4
2843477|NCT02472405|9761181|P1|Overall Study|Adverse Event|1
2843478|NCT02472405|9761181|P1|Overall Study|Lost to Follow-up|9
2843479|NCT02472366|9761189|P2|Overall Study|Lost to Follow-up|0
2843480|NCT02472366|9761190|P1|Overall Study|Lost to Follow-up|1
2843481|NCT02472353|9761206|P2|Overall Study|Study Termination|4
2843482|NCT02472353|9761207|P1|Overall Study|Study Termination|1
2843483|NCT02472353|9761206|P2|Overall Study|Withdrawal by Subject|1
2843484|NCT02472353|9761207|P1|Overall Study|Withdrawal by Subject|2
2843485|NCT02472353|9761206|P2|Overall Study|Lost to Follow-up|1
2843486|NCT02472353|9761207|P1|Overall Study|Lost to Follow-up|1
2843487|NCT02472145|9761244|P3|Overall Study|Other|43
2843488|NCT02472145|9761245|P2|Overall Study|Other|45
2843489|NCT02472145|9761246|P1|Overall Study|Other|0
2843490|NCT02472145|9761244|P3|Overall Study|Sponsor decision|2
2843491|NCT02472145|9761245|P2|Overall Study|Sponsor decision|3
2843492|NCT02472145|9761246|P1|Overall Study|Sponsor decision|0
2843493|NCT02472145|9761244|P3|Overall Study|Withdrawal by Subject|13
2843494|NCT02472145|9761245|P2|Overall Study|Withdrawal by Subject|9
2843495|NCT02472145|9761246|P1|Overall Study|Withdrawal by Subject|0
2843496|NCT02472145|9761244|P3|Overall Study|Lost to Follow-up|0
2843497|NCT02472145|9761245|P2|Overall Study|Lost to Follow-up|1
2843498|NCT02472145|9761246|P1|Overall Study|Lost to Follow-up|0
2843499|NCT02472145|9761244|P3|Overall Study|Death|99
2843500|NCT02472145|9761245|P2|Overall Study|Death|101
2843501|NCT02472145|9761246|P1|Overall Study|Death|10
2843502|NCT02471755|9761267|P2|Overall Study|Lost to Follow-up|1
2843503|NCT02471755|9761268|P1|Overall Study|Lost to Follow-up|0
2843504|NCT02471755|9761267|P2|Overall Study|Withdrawal by Subject|0
2843505|NCT02471755|9761268|P1|Overall Study|Withdrawal by Subject|1
2843506|NCT02471612|9761297|P1|Overall Study|Lost to Follow-up|2
2843507|NCT02471404|9761328|P3|Overall Study|Other reasons not specified|12
2843508|NCT02471404|9761329|P2|Overall Study|Other reasons not specified|7
2843509|NCT02471404|9761330|P1|Overall Study|Other reasons not specified|10
2843510|NCT02471404|9761328|P3|Overall Study|Withdrawal by Subject|5
2843511|NCT02471404|9761329|P2|Overall Study|Withdrawal by Subject|4
2843512|NCT02471404|9761330|P1|Overall Study|Withdrawal by Subject|8
2843513|NCT02471404|9761328|P3|Overall Study|Protocol Violation|0
2843514|NCT02471404|9761329|P2|Overall Study|Protocol Violation|0
2843515|NCT02471404|9761330|P1|Overall Study|Protocol Violation|1
2843516|NCT02471404|9761328|P3|Overall Study|Lost to Follow-up|3
2843517|NCT02471404|9761329|P2|Overall Study|Lost to Follow-up|1
2843518|NCT02471404|9761330|P1|Overall Study|Lost to Follow-up|1
2843519|NCT02471404|9761328|P3|Overall Study|Failure to Meet Randomization Criteria|1
2843520|NCT02471404|9761329|P2|Overall Study|Failure to Meet Randomization Criteria|0
2843521|NCT02471404|9761330|P1|Overall Study|Failure to Meet Randomization Criteria|2
2843522|NCT02471404|9761328|P3|Overall Study|Developed Study Withdrawal Criteria|2
2843523|NCT02471404|9761329|P2|Overall Study|Developed Study Withdrawal Criteria|1
2843524|NCT02471404|9761330|P1|Overall Study|Developed Study Withdrawal Criteria|4
2843525|NCT02471404|9761328|P3|Overall Study|Adverse Event|2
2843526|NCT02471404|9761329|P2|Overall Study|Adverse Event|1
2843527|NCT02471404|9761330|P1|Overall Study|Adverse Event|7
2843528|NCT02471183|9761362|P1|Extended Treatment Period|Lack of Efficacy|1
2843529|NCT02471183|9761362|P1|Main Treatment Period|Withdrawal by Subject|1
2843530|NCT02471183|9761362|P1|Main Treatment Period|Adverse Event|1
2843531|NCT02470806|9761397|P2|Overall Study|Lack of Efficacy|15
2843532|NCT02470806|9761398|P1|Overall Study|Lack of Efficacy|5
2843533|NCT02470806|9761397|P2|Overall Study|Withdrawal by Subject|10
2843534|NCT02470806|9761398|P1|Overall Study|Withdrawal by Subject|3
2843535|NCT02470806|9761397|P2|Overall Study|Physician Decision|3
2843536|NCT02470806|9761398|P1|Overall Study|Physician Decision|0
2843537|NCT02470806|9761397|P2|Overall Study|Protocol Violation|11
2843538|NCT02470806|9761398|P1|Overall Study|Protocol Violation|4
2843539|NCT02470806|9761397|P2|Overall Study|Adverse Event|2
2843540|NCT02470806|9761398|P1|Overall Study|Adverse Event|5
2843541|NCT02470806|9761397|P2|Overall Study|Lost to Follow-up|1
2843542|NCT02470806|9761398|P1|Overall Study|Lost to Follow-up|1
2843543|NCT02470429|9761458|P2|Overall Study|Withdrawal by Subject|0
2843544|NCT02470429|9761459|P1|Overall Study|Withdrawal by Subject|1
2843545|NCT02470429|9761458|P2|Overall Study|Adverse Event|0
2843546|NCT02470429|9761459|P1|Overall Study|Adverse Event|1
2843547|NCT02470403|9761477|P5|Overall Study|Subject/guardian decision|0
2843548|NCT02470403|9761478|P4|Overall Study|Subject/guardian decision|4
2843549|NCT02470403|9761479|P3|Overall Study|Subject/guardian decision|0
2843550|NCT02470403|9761480|P2|Overall Study|Subject/guardian decision|0
2843551|NCT02470403|9761481|P1|Overall Study|Subject/guardian decision|1
2843552|NCT02470403|9761477|P5|Overall Study|Lost to Follow-up|0
2843553|NCT02470403|9761478|P4|Overall Study|Lost to Follow-up|0
2843554|NCT02470403|9761479|P3|Overall Study|Lost to Follow-up|0
2843555|NCT02470403|9761480|P2|Overall Study|Lost to Follow-up|1
2843556|NCT02470403|9761481|P1|Overall Study|Lost to Follow-up|0
2843557|NCT02470403|9761477|P5|Overall Study|Adverse Event|0
2843558|NCT02470403|9761478|P4|Overall Study|Adverse Event|0
2843559|NCT02470403|9761479|P3|Overall Study|Adverse Event|0
2843560|NCT02470403|9761480|P2|Overall Study|Adverse Event|0
2843561|NCT02470403|9761481|P1|Overall Study|Adverse Event|1
2843562|NCT02469961|9761561|P2|Overall Study|Physician Decision|1
2843563|NCT02469961|9761562|P1|Overall Study|Physician Decision|4
2843564|NCT02469896|9761576|P2|Overall Study|Withdrawal by Subject|0
2843565|NCT02469896|9761577|P1|Overall Study|Withdrawal by Subject|2
2843566|NCT02469623|9761647|P1|Overall Study|Death|3
2843567|NCT02469623|9761647|P1|Overall Study|Withdrawal by Subject|2
2843568|NCT02469623|9761647|P1|Overall Study|Lost to Follow-up|4
2843569|NCT02469623|9761647|P1|Overall Study|Not consented for long-term follow-up|4
2843570|NCT02469610|9761654|P2|Overall Study|exclusion criteria|1
2843571|NCT02469610|9761655|P1|Overall Study|exclusion criteria|2
2843572|NCT02469610|9761654|P2|Overall Study|Lost to Follow-up|0
2843573|NCT02469610|9761655|P1|Overall Study|Lost to Follow-up|1
2843574|NCT02469610|9761654|P2|Overall Study|Death|0
2843575|NCT02469610|9761655|P1|Overall Study|Death|1
2843576|NCT02469415|9761682|P1|Overall Study|Investigational agent placed on hold|2
2843577|NCT02469415|9761682|P1|Overall Study|Withdrawal by Subject|1
2843578|NCT02469298|9761690|P4|Overall Study|Withdrawal by Subject|1
2843579|NCT02469298|9761691|P3|Overall Study|Withdrawal by Subject|0
2843580|NCT02469298|9761692|P2|Overall Study|Withdrawal by Subject|0
2843581|NCT02469298|9761693|P1|Overall Study|Withdrawal by Subject|0
2843582|NCT02469298|9761690|P4|Overall Study|Physician Decision|1
2843583|NCT02469298|9761691|P3|Overall Study|Physician Decision|0
2843584|NCT02469298|9761692|P2|Overall Study|Physician Decision|0
2843585|NCT02469298|9761693|P1|Overall Study|Physician Decision|0
2843586|NCT02469298|9761690|P4|Overall Study|Lost to Follow-up|0
2843587|NCT02469298|9761691|P3|Overall Study|Lost to Follow-up|1
2843588|NCT02469298|9761692|P2|Overall Study|Lost to Follow-up|0
2843589|NCT02469298|9761693|P1|Overall Study|Lost to Follow-up|1
2843590|NCT02469298|9761690|P4|Overall Study|Protocol Violation|0
2843591|NCT02469298|9761691|P3|Overall Study|Protocol Violation|1
2843592|NCT02469298|9761692|P2|Overall Study|Protocol Violation|1
2843593|NCT02469298|9761693|P1|Overall Study|Protocol Violation|0
2843594|NCT02469246|9761833|P2|Double-Blind Phase|Lost to Follow-up|5
2843595|NCT02469246|9761834|P1|Double-Blind Phase|Lost to Follow-up|9
2843596|NCT02469246|9761833|P2|Double-Blind Phase|Withdrew Consent|25
2843597|NCT02469246|9761834|P1|Double-Blind Phase|Withdrew Consent|25
2843598|NCT02469246|9761833|P2|Double-Blind Phase|Protocol Violation|1
2843599|NCT02469246|9761834|P1|Double-Blind Phase|Protocol Violation|1
2843600|NCT02469246|9761833|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2843601|NCT02469246|9761834|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
2843602|NCT02469246|9761833|P2|Double-Blind Phase|Investigator's Discretion|8
2843603|NCT02469246|9761834|P1|Double-Blind Phase|Investigator's Discretion|8
2843604|NCT02469246|9761833|P2|Double-Blind Phase|Lack of Efficacy|1
2843605|NCT02469246|9761834|P1|Double-Blind Phase|Lack of Efficacy|2
2843606|NCT02469246|9761833|P2|Double-Blind Phase|Death|0
2843607|NCT02469246|9761834|P1|Double-Blind Phase|Death|2
2843608|NCT02469246|9761833|P2|Double-Blind Phase|Adverse Event|9
2843609|NCT02469246|9761834|P1|Double-Blind Phase|Adverse Event|12
2843610|NCT02469246|9761833|P2|Double-Blind Phase|Randomized and Never Treated|6
2843611|NCT02469246|9761834|P1|Double-Blind Phase|Randomized and Never Treated|5
2843612|NCT02469168|9761866|P2|Overall Study|Trial closed|0
2843613|NCT02469168|9761867|P1|Overall Study|Trial closed|1
2843614|NCT02469064|9761887|P2|Overall Study|Request not to receive intervention.|3
2843615|NCT02469064|9761888|P1|Overall Study|Request not to receive intervention.|1
2843616|NCT02468934|9761896|P1|Overall Study|Screen Failure|3
2843617|NCT02468934|9761896|P1|Overall Study|Withdrawal by Subject|4
2843618|NCT02468674|9761947|P9|Overall Study|Protocol Deviation|1
2843619|NCT02468674|9761948|P8|Overall Study|Protocol Deviation|1
2843620|NCT02468674|9761949|P7|Overall Study|Protocol Deviation|0
2843621|NCT02468674|9761950|P6|Overall Study|Protocol Deviation|0
2843622|NCT02468674|9761951|P5|Overall Study|Protocol Deviation|0
2843623|NCT02468674|9761952|P4|Overall Study|Protocol Deviation|0
2843624|NCT02468674|9761953|P3|Overall Study|Protocol Deviation|0
2843625|NCT02468674|9761954|P2|Overall Study|Protocol Deviation|0
2843626|NCT02468674|9761955|P1|Overall Study|Protocol Deviation|0
2843627|NCT02468674|9761947|P9|Overall Study|Patient/Guardian Decision|1
2843628|NCT02468674|9761948|P8|Overall Study|Patient/Guardian Decision|2
2843629|NCT02468674|9761949|P7|Overall Study|Patient/Guardian Decision|0
2843630|NCT02468674|9761950|P6|Overall Study|Patient/Guardian Decision|0
2843631|NCT02468674|9761951|P5|Overall Study|Patient/Guardian Decision|1
2843632|NCT02468674|9761952|P4|Overall Study|Patient/Guardian Decision|0
2843633|NCT02468674|9761953|P3|Overall Study|Patient/Guardian Decision|0
2843634|NCT02468674|9761954|P2|Overall Study|Patient/Guardian Decision|0
2843635|NCT02468674|9761955|P1|Overall Study|Patient/Guardian Decision|0
2843636|NCT02468674|9761947|P9|Overall Study|Physician Decision|0
2843637|NCT02468674|9761948|P8|Overall Study|Physician Decision|0
2843638|NCT02468674|9761949|P7|Overall Study|Physician Decision|1
2843639|NCT02468674|9761950|P6|Overall Study|Physician Decision|0
2843640|NCT02468674|9761951|P5|Overall Study|Physician Decision|0
2843641|NCT02468674|9761952|P4|Overall Study|Physician Decision|0
2843642|NCT02468674|9761953|P3|Overall Study|Physician Decision|0
2843643|NCT02468674|9761954|P2|Overall Study|Physician Decision|0
2843644|NCT02468674|9761955|P1|Overall Study|Physician Decision|0
2843645|NCT02468674|9761947|P9|Overall Study|Lost to Follow-up|1
2843646|NCT02468674|9761948|P8|Overall Study|Lost to Follow-up|1
2843647|NCT02468674|9761949|P7|Overall Study|Lost to Follow-up|0
2843648|NCT02468674|9761950|P6|Overall Study|Lost to Follow-up|0
2843649|NCT02468674|9761951|P5|Overall Study|Lost to Follow-up|0
2843650|NCT02468674|9761952|P4|Overall Study|Lost to Follow-up|0
2843651|NCT02468674|9761953|P3|Overall Study|Lost to Follow-up|0
2843652|NCT02468674|9761954|P2|Overall Study|Lost to Follow-up|0
2843653|NCT02468674|9761955|P1|Overall Study|Lost to Follow-up|1
2843654|NCT02468674|9761947|P9|Overall Study|Adverse Event|0
2843655|NCT02468674|9761948|P8|Overall Study|Adverse Event|0
2843656|NCT02468674|9761949|P7|Overall Study|Adverse Event|0
2843657|NCT02468674|9761950|P6|Overall Study|Adverse Event|1
2843658|NCT02468674|9761951|P5|Overall Study|Adverse Event|0
2843659|NCT02468674|9761952|P4|Overall Study|Adverse Event|1
2843660|NCT02468674|9761953|P3|Overall Study|Adverse Event|0
2843661|NCT02468674|9761954|P2|Overall Study|Adverse Event|0
2843662|NCT02468674|9761955|P1|Overall Study|Adverse Event|0
2843663|NCT02468648|9762011|P1|Overall Study|Death|1
2843664|NCT02468414|9762059|P2|Overall Study|Screen Failure|0
2843665|NCT02468414|9762060|P1|Overall Study|Screen Failure|1
2843666|NCT02468414|9762059|P2|Overall Study|Poor in-vitro secreting TARGTs|0
2843667|NCT02468414|9762060|P1|Overall Study|Poor in-vitro secreting TARGTs|1
2843668|NCT02468414|9762059|P2|Overall Study|Early Study Termination by Sponsor|0
2843669|NCT02468414|9762060|P1|Overall Study|Early Study Termination by Sponsor|1
2843670|NCT02468193|9762066|P1|Overall Study|Subject/ Guardian decision|2
2843671|NCT02468193|9762066|P1|Overall Study|Adverse Event|4
2843672|NCT02466659|9762341|P2|Overall Study|Lost to Follow-up|2
2843673|NCT02466659|9762342|P1|Overall Study|Lost to Follow-up|5
2843674|NCT02466555|9762350|P1|Overall Study|Lost to Follow-up|2
2843675|NCT02466516|9762362|P5|Overall Study|Lost to Follow-up|0
2843676|NCT02466516|9762363|P4|Overall Study|Lost to Follow-up|0
2843677|NCT02466516|9762364|P3|Overall Study|Lost to Follow-up|1
2843678|NCT02466516|9762365|P2|Overall Study|Lost to Follow-up|0
2843679|NCT02466516|9762366|P1|Overall Study|Lost to Follow-up|2
2843680|NCT02466516|9762362|P5|Overall Study|Withdrew Consent|0
2843681|NCT02466516|9762363|P4|Overall Study|Withdrew Consent|0
2843682|NCT02466516|9762364|P3|Overall Study|Withdrew Consent|0
2843683|NCT02466516|9762365|P2|Overall Study|Withdrew Consent|0
2843684|NCT02466516|9762366|P1|Overall Study|Withdrew Consent|1
2843685|NCT02466516|9762362|P5|Overall Study|Adverse Event|0
2843686|NCT02466516|9762363|P4|Overall Study|Adverse Event|0
2843687|NCT02466516|9762364|P3|Overall Study|Adverse Event|0
2843688|NCT02466516|9762365|P2|Overall Study|Adverse Event|1
2843689|NCT02466516|9762366|P1|Overall Study|Adverse Event|1
2843690|NCT02466425|9762385|P2|Overall Study|Withdrawal by Parent/Guardian|0
2843691|NCT02466425|9762386|P1|Overall Study|Withdrawal by Parent/Guardian|2
2843692|NCT02466425|9762385|P2|Overall Study|Other|3
2843693|NCT02466425|9762386|P1|Overall Study|Other|1
2843694|NCT02466425|9762385|P2|Overall Study|Withdrawal by Subject|1
2843695|NCT02466425|9762386|P1|Overall Study|Withdrawal by Subject|0
2843696|NCT02466425|9762385|P2|Overall Study|Protocol Violation|0
2843697|NCT02466425|9762386|P1|Overall Study|Protocol Violation|1
2843698|NCT02466425|9762385|P2|Overall Study|Lost to Follow-up|0
2843699|NCT02466425|9762386|P1|Overall Study|Lost to Follow-up|3
2843700|NCT02466425|9762385|P2|Overall Study|Lack of Efficacy|1
2843701|NCT02466425|9762386|P1|Overall Study|Lack of Efficacy|4
2843702|NCT02466425|9762385|P2|Overall Study|Adverse Event|11
2843703|NCT02466425|9762386|P1|Overall Study|Adverse Event|3
2843704|NCT02465931|9762424|P2|Overall Study|Withdrawal by Subject|0
2843705|NCT02465931|9762425|P1|Overall Study|Withdrawal by Subject|1
2843706|NCT02465931|9762424|P2|Overall Study|Protocol Violation|0
2843707|NCT02465931|9762425|P1|Overall Study|Protocol Violation|1
2843708|NCT02465931|9762424|P2|Overall Study|Lost to Follow-up|11
2843709|NCT02465931|9762425|P1|Overall Study|Lost to Follow-up|9
2843710|NCT02465866|9762431|P4|Period 3|Withdrawal by Subject|0
2843711|NCT02465866|9762432|P3|Period 3|Withdrawal by Subject|0
2843712|NCT02465866|9762433|P2|Period 3|Withdrawal by Subject|1
2843713|NCT02465866|9762434|P1|Period 3|Withdrawal by Subject|0
2843714|NCT02465528|9762524|P4|Overall Study|Physician Decision|0
2843715|NCT02465528|9762525|P3|Overall Study|Physician Decision|1
2843716|NCT02465528|9762526|P2|Overall Study|Physician Decision|0
2843717|NCT02465528|9762527|P1|Overall Study|Physician Decision|0
2843718|NCT02465528|9762524|P4|Overall Study|Adverse Event|1
2843719|NCT02465528|9762525|P3|Overall Study|Adverse Event|0
2843720|NCT02465528|9762526|P2|Overall Study|Adverse Event|0
2843721|NCT02465528|9762527|P1|Overall Study|Adverse Event|0
2843722|NCT02465528|9762524|P4|Overall Study|Withdrawal by Subject|0
2843723|NCT02465528|9762525|P3|Overall Study|Withdrawal by Subject|2
2843724|NCT02465528|9762526|P2|Overall Study|Withdrawal by Subject|0
2843725|NCT02465528|9762527|P1|Overall Study|Withdrawal by Subject|0
2843726|NCT02465528|9762524|P4|Overall Study|Study terminated by sponsor|0
2843727|NCT02465528|9762525|P3|Overall Study|Study terminated by sponsor|0
2843728|NCT02465528|9762526|P2|Overall Study|Study terminated by sponsor|2
2843729|NCT02465528|9762527|P1|Overall Study|Study terminated by sponsor|1
2843730|NCT02465528|9762524|P4|Overall Study|Progressive disease|4
2843731|NCT02465528|9762525|P3|Overall Study|Progressive disease|9
2843732|NCT02465528|9762526|P2|Overall Study|Progressive disease|2
2843733|NCT02465528|9762527|P1|Overall Study|Progressive disease|0
2843734|NCT02465515|9762560|P2|Overall Study|Lost to Follow-up|51
2843735|NCT02465515|9762561|P1|Overall Study|Lost to Follow-up|68
2843736|NCT02465515|9762560|P2|Overall Study|Physician Decision|12
2843737|NCT02465515|9762561|P1|Overall Study|Physician Decision|8
2843738|NCT02465515|9762560|P2|Overall Study|Withdrawal by Subject|43
2843739|NCT02465515|9762561|P1|Overall Study|Withdrawal by Subject|74
2843740|NCT02465515|9762560|P2|Overall Study|Investigator site closed|5
2843741|NCT02465515|9762561|P1|Overall Study|Investigator site closed|4
2843742|NCT02465489|9762607|P1|Overall Study|Adverse Event|5
2843743|NCT02465463|9762636|P2|Overall Study|Protocol Violation|0
2843744|NCT02465463|9762637|P1|Overall Study|Protocol Violation|1
2843745|NCT02465463|9762636|P2|Overall Study|Death|0
2843746|NCT02465463|9762637|P1|Overall Study|Death|1
2843747|NCT02465463|9762636|P2|Overall Study|Lost to Follow-up|1
2843748|NCT02465463|9762637|P1|Overall Study|Lost to Follow-up|2
2843749|NCT02465437|9762685|P4|Overall Study|Adverse Event|0
2843750|NCT02465437|9762686|P3|Overall Study|Adverse Event|0
2843751|NCT02465437|9762687|P2|Overall Study|Adverse Event|1
2843752|NCT02465437|9762688|P1|Overall Study|Adverse Event|0
2843753|NCT02465437|9762685|P4|Overall Study|Withdrawal by Subject|1
2843754|NCT02465437|9762686|P3|Overall Study|Withdrawal by Subject|0
2843755|NCT02465437|9762687|P2|Overall Study|Withdrawal by Subject|0
2843756|NCT02465437|9762688|P1|Overall Study|Withdrawal by Subject|1
2843757|NCT02465437|9762685|P4|Overall Study|Physician Decision|0
2843758|NCT02465437|9762686|P3|Overall Study|Physician Decision|1
2843759|NCT02465437|9762687|P2|Overall Study|Physician Decision|0
2843760|NCT02465437|9762688|P1|Overall Study|Physician Decision|0
2843761|NCT02465203|9762748|P3|Overall Study|Patient/guardian decision|1
2843762|NCT02465203|9762749|P2|Overall Study|Patient/guardian decision|1
2843763|NCT02465203|9762750|P1|Overall Study|Patient/guardian decision|1
2843764|NCT02465203|9762748|P3|Overall Study|New therapy for study indication|0
2843765|NCT02465203|9762749|P2|Overall Study|New therapy for study indication|0
2843766|NCT02465203|9762750|P1|Overall Study|New therapy for study indication|4
2843767|NCT02465203|9762748|P3|Overall Study|Study terminated by sponsor|11
2843768|NCT02465203|9762749|P2|Overall Study|Study terminated by sponsor|34
2843769|NCT02465203|9762750|P1|Overall Study|Study terminated by sponsor|50
2843770|NCT02465203|9762748|P3|Overall Study|Protocol Violation|1
2843771|NCT02465203|9762749|P2|Overall Study|Protocol Violation|1
2843772|NCT02465203|9762750|P1|Overall Study|Protocol Violation|1
2843773|NCT02463409|9762910|P1|Overall Study|Screen failure|1
2843774|NCT02463409|9762910|P1|Overall Study|Withdrawal by Subject|1
2843775|NCT02463331|9762918|P2|Overall Study|Physician Decision|0
2843776|NCT02463331|9762919|P1|Overall Study|Physician Decision|3
2843777|NCT02463331|9762918|P2|Overall Study|Lack of Efficacy|0
2843778|NCT02463331|9762919|P1|Overall Study|Lack of Efficacy|6
2843779|NCT02463331|9762918|P2|Overall Study|Pregnancy|3
2843780|NCT02463331|9762919|P1|Overall Study|Pregnancy|2
2843781|NCT02463331|9762918|P2|Overall Study|Lost to Follow-up|1
2843782|NCT02463331|9762919|P1|Overall Study|Lost to Follow-up|1
2843783|NCT02463331|9762918|P2|Overall Study|Adverse Event|2
2843784|NCT02463331|9762919|P1|Overall Study|Adverse Event|4
2843785|NCT02463097|9762935|P1|Overall Study|Withdrawal by Subject|1
2843786|NCT02463071|9762944|P3|Overall Study|Lost to Follow-up|1
2843787|NCT02463071|9762945|P2|Overall Study|Lost to Follow-up|0
2843788|NCT02463071|9762946|P1|Overall Study|Lost to Follow-up|0
2843789|NCT02463071|9762944|P3|Overall Study|Protocol Violation|0
2843790|NCT02463071|9762945|P2|Overall Study|Protocol Violation|2
2843791|NCT02463071|9762946|P1|Overall Study|Protocol Violation|0
2843792|NCT02463071|9762944|P3|Overall Study|Reason not specified|4
2843793|NCT02463071|9762945|P2|Overall Study|Reason not specified|9
2843794|NCT02463071|9762946|P1|Overall Study|Reason not specified|7
2843795|NCT02463071|9762944|P3|Overall Study|Eligibility criteria not fulfilled|0
2843796|NCT02463071|9762945|P2|Overall Study|Eligibility criteria not fulfilled|0
2843797|NCT02463071|9762946|P1|Overall Study|Eligibility criteria not fulfilled|1
2843798|NCT02463071|9762944|P3|Overall Study|Death|0
2843799|NCT02463071|9762945|P2|Overall Study|Death|0
2843800|NCT02463071|9762946|P1|Overall Study|Death|1
2843801|NCT02463071|9762944|P3|Overall Study|Adverse Event|1
2843802|NCT02463071|9762945|P2|Overall Study|Adverse Event|5
2843803|NCT02463071|9762946|P1|Overall Study|Adverse Event|3
2843804|NCT02462759|9762974|P3|Part 1: Double Blind|Death|0
2843805|NCT02462759|9762975|P2|Part 1: Double Blind|Death|0
2843806|NCT02462759|9762976|P1|Part 1: Double Blind|Death|1
2843807|NCT02462720|9763024|P2|Part 2|Protocol Violation|1
2843808|NCT02462720|9763025|P1|Part 2|Protocol Violation|0
2843809|NCT02462720|9763024|P2|Part 2|Withdrawal by Subject|0
2843810|NCT02462720|9763025|P1|Part 2|Withdrawal by Subject|1
2843811|NCT02462473|9763035|P1|Overall Study|Other|3
2843812|NCT02462473|9763035|P1|Overall Study|Death|1
2843813|NCT02462083|9763115|P1|Overall Study|Other than specified|45
2843814|NCT02462083|9763115|P1|Overall Study|Worsening condition|16
2843815|NCT02462083|9763115|P1|Overall Study|Adverse Event|33
2843816|NCT02462083|9763115|P1|Overall Study|Protocol Violation|6
2843817|NCT02462083|9763115|P1|Overall Study|Pregnancy|1
2843818|NCT02462083|9763115|P1|Overall Study|Lack of Efficacy|151
2843819|NCT02462083|9763115|P1|Overall Study|Lost to Follow-up|41
2843820|NCT02462083|9763115|P1|Overall Study|Withdrawal by Subject|87
2843821|NCT02462083|9763115|P1|Overall Study|Sponsor request|39
2843822|NCT02462057|9763124|P5|Overall Study|Joined HealthyFood Before Intervention|17
2843823|NCT02462057|9763125|P4|Overall Study|Joined HealthyFood Before Intervention|16
2843824|NCT02462057|9763126|P3|Overall Study|Joined HealthyFood Before Intervention|23
2843825|NCT02462057|9763127|P2|Overall Study|Joined HealthyFood Before Intervention|13
2843826|NCT02462057|9763128|P1|Overall Study|Joined HealthyFood Before Intervention|22
2843827|NCT02462057|9763124|P5|Overall Study|Left Vitality|33
2843828|NCT02462057|9763125|P4|Overall Study|Left Vitality|35
2843829|NCT02462057|9763126|P3|Overall Study|Left Vitality|23
2843830|NCT02462057|9763127|P2|Overall Study|Left Vitality|27
2843831|NCT02462057|9763128|P1|Overall Study|Left Vitality|32
2843832|NCT02461758|9763174|P4|Overall Study|Lost to Follow-up|0
2843833|NCT02461758|9763175|P3|Overall Study|Lost to Follow-up|1
2843834|NCT02461758|9763176|P2|Overall Study|Lost to Follow-up|1
2843835|NCT02461758|9763177|P1|Overall Study|Lost to Follow-up|0
2843836|NCT02461628|9763218|P2|Overall Study|Refused to complete survey|7
2843837|NCT02461628|9763219|P1|Overall Study|Refused to complete survey|4
2843838|NCT02461589|9763243|P10|Overall Study|Withdrawal from trial before exposure|1
2843839|NCT02461589|9763244|P9|Overall Study|Withdrawal from trial before exposure|0
2843840|NCT02461589|9763245|P8|Overall Study|Withdrawal from trial before exposure|0
2843841|NCT02461589|9763246|P7|Overall Study|Withdrawal from trial before exposure|0
2843842|NCT02461589|9763247|P6|Overall Study|Withdrawal from trial before exposure|0
2843843|NCT02461589|9763248|P5|Overall Study|Withdrawal from trial before exposure|0
2843844|NCT02461589|9763249|P4|Overall Study|Withdrawal from trial before exposure|0
2843845|NCT02461589|9763250|P3|Overall Study|Withdrawal from trial before exposure|0
2843846|NCT02461589|9763251|P2|Overall Study|Withdrawal from trial before exposure|0
2843847|NCT02461589|9763252|P1|Overall Study|Withdrawal from trial before exposure|0
2843848|NCT02461589|9763243|P10|Overall Study|Missing follow-up information|0
2843849|NCT02461589|9763244|P9|Overall Study|Missing follow-up information|0
2843850|NCT02461589|9763245|P8|Overall Study|Missing follow-up information|0
2843851|NCT02461589|9763246|P7|Overall Study|Missing follow-up information|1
2843852|NCT02461589|9763247|P6|Overall Study|Missing follow-up information|0
2843853|NCT02461589|9763248|P5|Overall Study|Missing follow-up information|0
2843854|NCT02461589|9763249|P4|Overall Study|Missing follow-up information|0
2843855|NCT02461589|9763250|P3|Overall Study|Missing follow-up information|0
2843856|NCT02461589|9763251|P2|Overall Study|Missing follow-up information|1
2843857|NCT02461589|9763252|P1|Overall Study|Missing follow-up information|1
2843858|NCT02461589|9763243|P10|Overall Study|Unclassified|2
2843859|NCT02461589|9763244|P9|Overall Study|Unclassified|0
2843860|NCT02461589|9763245|P8|Overall Study|Unclassified|0
2843861|NCT02461589|9763246|P7|Overall Study|Unclassified|1
2843862|NCT02461589|9763247|P6|Overall Study|Unclassified|0
2843863|NCT02461589|9763248|P5|Overall Study|Unclassified|0
2843864|NCT02461589|9763249|P4|Overall Study|Unclassified|0
2843865|NCT02461589|9763250|P3|Overall Study|Unclassified|0
2843866|NCT02461589|9763251|P2|Overall Study|Unclassified|0
2843867|NCT02461589|9763252|P1|Overall Study|Unclassified|0
2843868|NCT02461589|9763243|P10|Overall Study|Death|0
2843869|NCT02461589|9763244|P9|Overall Study|Death|0
2843870|NCT02461589|9763245|P8|Overall Study|Death|1
2843871|NCT02461589|9763246|P7|Overall Study|Death|0
2843872|NCT02461589|9763247|P6|Overall Study|Death|0
2843873|NCT02461589|9763248|P5|Overall Study|Death|0
2843874|NCT02461589|9763249|P4|Overall Study|Death|0
2843875|NCT02461589|9763250|P3|Overall Study|Death|0
2843876|NCT02461589|9763251|P2|Overall Study|Death|0
2843877|NCT02461589|9763252|P1|Overall Study|Death|0
2843878|NCT02461589|9763243|P10|Overall Study|Lost to Follow-up|1
2843879|NCT02461589|9763244|P9|Overall Study|Lost to Follow-up|3
2843880|NCT02461589|9763245|P8|Overall Study|Lost to Follow-up|1
2843881|NCT02461589|9763246|P7|Overall Study|Lost to Follow-up|3
2843882|NCT02461589|9763247|P6|Overall Study|Lost to Follow-up|1
2843883|NCT02461589|9763248|P5|Overall Study|Lost to Follow-up|1
2843884|NCT02461589|9763249|P4|Overall Study|Lost to Follow-up|3
2843885|NCT02461589|9763250|P3|Overall Study|Lost to Follow-up|2
2843886|NCT02461589|9763251|P2|Overall Study|Lost to Follow-up|0
2843887|NCT02461589|9763252|P1|Overall Study|Lost to Follow-up|0
2843888|NCT02461589|9763243|P10|Overall Study|Withdrawal by Subject|1
2843889|NCT02461589|9763244|P9|Overall Study|Withdrawal by Subject|3
2843890|NCT02461589|9763245|P8|Overall Study|Withdrawal by Subject|3
2843891|NCT02461589|9763246|P7|Overall Study|Withdrawal by Subject|1
2843892|NCT02461589|9763247|P6|Overall Study|Withdrawal by Subject|2
2843893|NCT02461589|9763248|P5|Overall Study|Withdrawal by Subject|1
2843894|NCT02461589|9763249|P4|Overall Study|Withdrawal by Subject|2
2843895|NCT02461589|9763250|P3|Overall Study|Withdrawal by Subject|3
2843896|NCT02461589|9763251|P2|Overall Study|Withdrawal by Subject|1
2843897|NCT02461589|9763252|P1|Overall Study|Withdrawal by Subject|5
2843898|NCT02461290|9763385|P1|Overall Study|Lost to Follow-up|3
2843899|NCT02461290|9763385|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
2843900|NCT02461160|9763405|P13|Overall Study|Lost to Follow-up|0
2843901|NCT02461160|9763406|P12|Overall Study|Lost to Follow-up|0
2843902|NCT02461160|9763407|P11|Overall Study|Lost to Follow-up|0
2843903|NCT02461160|9763408|P10|Overall Study|Lost to Follow-up|0
2843904|NCT02461160|9763409|P9|Overall Study|Lost to Follow-up|0
2843905|NCT02461160|9763410|P8|Overall Study|Lost to Follow-up|1
2843906|NCT02461160|9763411|P7|Overall Study|Lost to Follow-up|0
2843907|NCT02461160|9763412|P6|Overall Study|Lost to Follow-up|0
2843908|NCT02461160|9763413|P5|Overall Study|Lost to Follow-up|0
2843909|NCT02461160|9763414|P4|Overall Study|Lost to Follow-up|0
2843910|NCT02461160|9763415|P3|Overall Study|Lost to Follow-up|0
2843911|NCT02461160|9763416|P2|Overall Study|Lost to Follow-up|0
2843912|NCT02461160|9763417|P1|Overall Study|Lost to Follow-up|0
2843913|NCT02461134|9763628|P1|Overall Study|Adverse Event|1
2843914|NCT02460991|9763636|P2|Overall Study|Withdrawal by Subject|2
2843915|NCT02460991|9763637|P1|Overall Study|Withdrawal by Subject|0
2843916|NCT02460978|9763654|P3|Overall Study|Pregnancy|2
2843917|NCT02460978|9763655|P2|Overall Study|Pregnancy|0
2843918|NCT02460978|9763656|P1|Overall Study|Pregnancy|0
2843919|NCT02460978|9763654|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
2843920|NCT02460978|9763655|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
2843921|NCT02460978|9763656|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
2843922|NCT02460978|9763654|P3|Overall Study|Protocol Violation|1
2843923|NCT02460978|9763655|P2|Overall Study|Protocol Violation|1
2843924|NCT02460978|9763656|P1|Overall Study|Protocol Violation|1
2843925|NCT02460978|9763654|P3|Overall Study|Lost to Follow-up|1
2843926|NCT02460978|9763655|P2|Overall Study|Lost to Follow-up|3
2843927|NCT02460978|9763656|P1|Overall Study|Lost to Follow-up|2
2843928|NCT02460978|9763654|P3|Overall Study|Withdrawal by Subject|14
2843929|NCT02460978|9763655|P2|Overall Study|Withdrawal by Subject|5
2843930|NCT02460978|9763656|P1|Overall Study|Withdrawal by Subject|5
2843931|NCT02460978|9763654|P3|Overall Study|Adverse Event|11
2843932|NCT02460978|9763655|P2|Overall Study|Adverse Event|11
2843933|NCT02460978|9763656|P1|Overall Study|Adverse Event|17
2843934|NCT02460822|9763682|P1|Overall Study|Withdrawal by Subject|1
2843935|NCT02460575|9763693|P2|Overall Study|Lost to Follow-up|0
2843936|NCT02460575|9763694|P1|Overall Study|Lost to Follow-up|1
2843937|NCT02460562|9763704|P2|Overall Study|Lost to Follow-up|16
2843938|NCT02460562|9763705|P1|Overall Study|Lost to Follow-up|15
2843939|NCT02460380|9763721|P2|Overall Study|Withdrawal by Subject|5
2843940|NCT02460380|9763722|P1|Overall Study|Withdrawal by Subject|10
2843941|NCT02460159|9763758|P2|Overall Study|Withdrawal by Subject|0
2843942|NCT02460159|9763759|P1|Overall Study|Withdrawal by Subject|2
2843943|NCT02460159|9763758|P2|Overall Study|Adverse Event|1
2843944|NCT02460159|9763759|P1|Overall Study|Adverse Event|4
2843945|NCT02459951|9763787|P1|Overall Study|Unable to meet holding requirement|1
2843946|NCT02459899|9763798|P4|Overall Study|Withdrawal by Subject|0
2843947|NCT02459899|9763799|P3|Overall Study|Withdrawal by Subject|0
2843948|NCT02459899|9763800|P2|Overall Study|Withdrawal by Subject|3
2843949|NCT02459899|9763801|P1|Overall Study|Withdrawal by Subject|1
2843950|NCT02459899|9763798|P4|Overall Study|Non-compliance with the treatment|1
2843951|NCT02459899|9763799|P3|Overall Study|Non-compliance with the treatment|0
2843952|NCT02459899|9763800|P2|Overall Study|Non-compliance with the treatment|0
2843953|NCT02459899|9763801|P1|Overall Study|Non-compliance with the treatment|0
2843954|NCT02459899|9763798|P4|Overall Study|Lost to Follow-up|1
2843955|NCT02459899|9763799|P3|Overall Study|Lost to Follow-up|0
2843956|NCT02459899|9763800|P2|Overall Study|Lost to Follow-up|2
2843957|NCT02459899|9763801|P1|Overall Study|Lost to Follow-up|1
2843958|NCT02459899|9763798|P4|Overall Study|Adverse Event|0
2843959|NCT02459899|9763799|P3|Overall Study|Adverse Event|0
2843960|NCT02459899|9763800|P2|Overall Study|Adverse Event|1
2843961|NCT02459899|9763801|P1|Overall Study|Adverse Event|1
2843962|NCT02459665|9763835|P4|Overall Study|Withdrawal by Subject|2
2843963|NCT02459665|9763836|P3|Overall Study|Withdrawal by Subject|1
2843964|NCT02459665|9763837|P2|Overall Study|Withdrawal by Subject|1
2843965|NCT02459665|9763838|P1|Overall Study|Withdrawal by Subject|0
2843966|NCT02459418|9763869|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
2843967|NCT02459418|9763870|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
2843968|NCT02459418|9763869|P2|Overall Study|Elevated Creatine Kinase|0
2843969|NCT02459418|9763870|P1|Overall Study|Elevated Creatine Kinase|1
2843970|NCT02459418|9763869|P2|Overall Study|Withdrawal by Subject|1
2843971|NCT02459418|9763870|P1|Overall Study|Withdrawal by Subject|1
2843972|NCT02459418|9763869|P2|Overall Study|Adverse Event|1
2843973|NCT02459418|9763870|P1|Overall Study|Adverse Event|0
2843974|NCT02459418|9763869|P2|Overall Study|Endometrial thickness of >5 mm|0
2843975|NCT02459418|9763870|P1|Overall Study|Endometrial thickness of >5 mm|1
2843976|NCT02459418|9763869|P2|Overall Study|Physician Decision|2
2843977|NCT02459418|9763870|P1|Overall Study|Physician Decision|0
2843978|NCT02459418|9763869|P2|Overall Study|Protocol Violation|2
2843979|NCT02459418|9763870|P1|Overall Study|Protocol Violation|0
2843980|NCT02459418|9763869|P2|Overall Study|Exclusion Criteria|0
2843981|NCT02459418|9763870|P1|Overall Study|Exclusion Criteria|4
2843982|NCT02459093|9763917|P2|Overall Study|Lost to Follow-up|7
2843983|NCT02459093|9763918|P1|Overall Study|Lost to Follow-up|6
2843984|NCT02459093|9763917|P2|Overall Study|Protocol Violation|11
2843985|NCT02459093|9763918|P1|Overall Study|Protocol Violation|6
2843986|NCT02458469|9763963|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
2843987|NCT02458469|9763964|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2843988|NCT02458469|9763965|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2843989|NCT02458469|9763966|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2843990|NCT02458469|9763967|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2843991|NCT02458469|9763968|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2843992|NCT02458469|9763963|P6|First Intervention (2 Weeks)|Physician Decision|0
2843993|NCT02458469|9763964|P5|First Intervention (2 Weeks)|Physician Decision|0
2843994|NCT02458469|9763965|P4|First Intervention (2 Weeks)|Physician Decision|0
2843995|NCT02458469|9763966|P3|First Intervention (2 Weeks)|Physician Decision|0
2843996|NCT02458469|9763967|P2|First Intervention (2 Weeks)|Physician Decision|0
2843997|NCT02458469|9763968|P1|First Intervention (2 Weeks)|Physician Decision|1
2843998|NCT02458469|9763963|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
2843999|NCT02458469|9763964|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
2844000|NCT02458469|9763965|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
2844001|NCT02458469|9763966|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
2844002|NCT02458469|9763967|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
2844003|NCT02458469|9763968|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
2844004|NCT02458287|9764014|P4|Overall Study|Relocated Out of State|1
2844005|NCT02458287|9764015|P3|Overall Study|Relocated Out of State|0
2844006|NCT02458287|9764016|P2|Overall Study|Relocated Out of State|0
2844007|NCT02458287|9764017|P1|Overall Study|Relocated Out of State|0
2844008|NCT02458287|9764014|P4|Overall Study|Withdrawal by Subject|1
2844009|NCT02458287|9764015|P3|Overall Study|Withdrawal by Subject|2
2844010|NCT02458287|9764016|P2|Overall Study|Withdrawal by Subject|2
2844011|NCT02458287|9764017|P1|Overall Study|Withdrawal by Subject|0
2844012|NCT02458287|9764014|P4|Overall Study|Protocol Violation|0
2844013|NCT02458287|9764015|P3|Overall Study|Protocol Violation|0
2844014|NCT02458287|9764016|P2|Overall Study|Protocol Violation|1
2844015|NCT02458287|9764017|P1|Overall Study|Protocol Violation|0
2844016|NCT02458287|9764014|P4|Overall Study|Lost to Follow-up|0
2844017|NCT02458287|9764015|P3|Overall Study|Lost to Follow-up|1
2844018|NCT02458287|9764016|P2|Overall Study|Lost to Follow-up|1
2844019|NCT02458287|9764017|P1|Overall Study|Lost to Follow-up|0
2844020|NCT02458287|9764014|P4|Overall Study|Adverse Event|1
2844021|NCT02458287|9764015|P3|Overall Study|Adverse Event|0
2844022|NCT02458287|9764016|P2|Overall Study|Adverse Event|0
2844023|NCT02458287|9764017|P1|Overall Study|Adverse Event|0
2844024|NCT02457910|9764068|P6|Overall Study|Death|0
2844025|NCT02457910|9764069|P5|Overall Study|Death|0
2844026|NCT02457910|9764070|P4|Overall Study|Death|0
2844027|NCT02457910|9764071|P3|Overall Study|Death|1
2844028|NCT02457910|9764072|P2|Overall Study|Death|0
2844029|NCT02457910|9764073|P1|Overall Study|Death|0
2844030|NCT02457910|9764068|P6|Overall Study|Other complicating illness|1
2844031|NCT02457910|9764069|P5|Overall Study|Other complicating illness|0
2844032|NCT02457910|9764070|P4|Overall Study|Other complicating illness|0
2844033|NCT02457910|9764071|P3|Overall Study|Other complicating illness|0
2844034|NCT02457910|9764072|P2|Overall Study|Other complicating illness|0
2844035|NCT02457910|9764073|P1|Overall Study|Other complicating illness|0
2844036|NCT02457910|9764068|P6|Overall Study|Disease progression|6
2844037|NCT02457910|9764069|P5|Overall Study|Disease progression|4
2844038|NCT02457910|9764070|P4|Overall Study|Disease progression|1
2844039|NCT02457910|9764071|P3|Overall Study|Disease progression|1
2844040|NCT02457910|9764072|P2|Overall Study|Disease progression|3
2844041|NCT02457910|9764073|P1|Overall Study|Disease progression|3
2844042|NCT02457910|9764068|P6|Overall Study|Adverse Event|3
2844043|NCT02457910|9764069|P5|Overall Study|Adverse Event|1
2844044|NCT02457910|9764070|P4|Overall Study|Adverse Event|1
2844045|NCT02457910|9764071|P3|Overall Study|Adverse Event|1
2844046|NCT02457910|9764072|P2|Overall Study|Adverse Event|2
2844047|NCT02457910|9764073|P1|Overall Study|Adverse Event|0
2844048|NCT02457910|9764068|P6|Overall Study|Withdrawal by Subject|1
2844049|NCT02457910|9764069|P5|Overall Study|Withdrawal by Subject|0
2844050|NCT02457910|9764070|P4|Overall Study|Withdrawal by Subject|0
2844051|NCT02457910|9764071|P3|Overall Study|Withdrawal by Subject|0
2844052|NCT02457910|9764072|P2|Overall Study|Withdrawal by Subject|0
2844053|NCT02457910|9764073|P1|Overall Study|Withdrawal by Subject|0
2844054|NCT02457819|9764097|P1|Overall Study|Adverse Event|33
2844055|NCT02457819|9764097|P1|Overall Study|Lack of Efficacy|19
2844056|NCT02457819|9764097|P1|Overall Study|Lost to Follow-up|10
2844057|NCT02457819|9764097|P1|Overall Study|non compliance with study drug|4
2844058|NCT02457819|9764097|P1|Overall Study|Protocol Violation|1
2844059|NCT02457819|9764097|P1|Overall Study|Withdrawal by Subject|24
2844060|NCT02457819|9764097|P1|Overall Study|reason not given|8
2844061|NCT02457793|9764109|P6|Overall Study|Physician Decision|3
2844062|NCT02457793|9764110|P5|Overall Study|Physician Decision|1
2844063|NCT02457793|9764111|P4|Overall Study|Physician Decision|1
2844064|NCT02457793|9764112|P3|Overall Study|Physician Decision|1
2844065|NCT02457793|9764113|P2|Overall Study|Physician Decision|0
2844066|NCT02457793|9764114|P1|Overall Study|Physician Decision|1
2844067|NCT02457793|9764109|P6|Overall Study|Adverse Event|0
2844068|NCT02457793|9764110|P5|Overall Study|Adverse Event|0
2844069|NCT02457793|9764111|P4|Overall Study|Adverse Event|1
2844070|NCT02457793|9764112|P3|Overall Study|Adverse Event|0
2844071|NCT02457793|9764113|P2|Overall Study|Adverse Event|0
2844072|NCT02457793|9764114|P1|Overall Study|Adverse Event|0
2844073|NCT02457793|9764109|P6|Overall Study|Withdrawal by Subject|2
2844074|NCT02457793|9764110|P5|Overall Study|Withdrawal by Subject|2
2844075|NCT02457793|9764111|P4|Overall Study|Withdrawal by Subject|2
2844076|NCT02457793|9764112|P3|Overall Study|Withdrawal by Subject|2
2844077|NCT02457793|9764113|P2|Overall Study|Withdrawal by Subject|4
2844078|NCT02457793|9764114|P1|Overall Study|Withdrawal by Subject|0
2844079|NCT02457793|9764109|P6|Overall Study|Reason not specified|1
2844080|NCT02457793|9764110|P5|Overall Study|Reason not specified|1
2844081|NCT02457793|9764111|P4|Overall Study|Reason not specified|1
2844082|NCT02457793|9764112|P3|Overall Study|Reason not specified|0
2844083|NCT02457793|9764113|P2|Overall Study|Reason not specified|0
2844084|NCT02457793|9764114|P1|Overall Study|Reason not specified|0
2844085|NCT02457637|9764258|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
2844086|NCT02457611|9764265|P1|Overall Study|Lost to Follow-up|3
2844087|NCT02457546|9764279|P2|Overall Study|Adverse Event|1
2844088|NCT02457546|9764280|P1|Overall Study|Adverse Event|0
2844089|NCT02457546|9764279|P2|Overall Study|Lost to Follow-up|1
2844090|NCT02457546|9764280|P1|Overall Study|Lost to Follow-up|4
2844091|NCT02457546|9764279|P2|Overall Study|Refused to complete study/procedures|1
2844092|NCT02457546|9764280|P1|Overall Study|Refused to complete study/procedures|1
2844093|NCT02457546|9764279|P2|Overall Study|Other reasons|1
2844094|NCT02457546|9764280|P1|Overall Study|Other reasons|4
2844095|NCT02457247|9764335|P4|Period 2|Voluntary Withdrawal|0
2844096|NCT02457247|9764336|P3|Period 2|Voluntary Withdrawal|0
2844097|NCT02457247|9764337|P2|Period 2|Voluntary Withdrawal|1
2844098|NCT02457247|9764338|P1|Period 2|Voluntary Withdrawal|1
2844099|NCT02457247|9764335|P4|Period 2|Lost to Follow-up|0
2844100|NCT02457247|9764336|P3|Period 2|Lost to Follow-up|0
2844101|NCT02457247|9764337|P2|Period 2|Lost to Follow-up|1
2844102|NCT02457247|9764338|P1|Period 2|Lost to Follow-up|0
2844103|NCT02457247|9764335|P4|Period 2|Significant Protocol Deviation|0
2844104|NCT02457247|9764336|P3|Period 2|Significant Protocol Deviation|0
2844105|NCT02457247|9764337|P2|Period 2|Significant Protocol Deviation|0
2844106|NCT02457247|9764338|P1|Period 2|Significant Protocol Deviation|1
2844107|NCT02457247|9764335|P4|Period 2|Pretreatment Event/Adverse Event|0
2844108|NCT02457247|9764336|P3|Period 2|Pretreatment Event/Adverse Event|0
2844109|NCT02457247|9764337|P2|Period 2|Pretreatment Event/Adverse Event|1
2844110|NCT02457247|9764338|P1|Period 2|Pretreatment Event/Adverse Event|0
2844111|NCT02457247|9764335|P4|Period 1|Voluntary Withdrawal|0
2844112|NCT02457247|9764336|P3|Period 1|Voluntary Withdrawal|0
2844113|NCT02457247|9764337|P2|Period 1|Voluntary Withdrawal|0
2844114|NCT02457247|9764338|P1|Period 1|Voluntary Withdrawal|1
2844115|NCT02457247|9764335|P4|Period 1|Significant Protocol Deviation|0
2844116|NCT02457247|9764336|P3|Period 1|Significant Protocol Deviation|0
2844117|NCT02457247|9764337|P2|Period 1|Significant Protocol Deviation|1
2844118|NCT02457247|9764338|P1|Period 1|Significant Protocol Deviation|1
2844119|NCT02457247|9764335|P4|Period 1|Pretreatment Event/Adverse Event|0
2844120|NCT02457247|9764336|P3|Period 1|Pretreatment Event/Adverse Event|0
2844121|NCT02457247|9764337|P2|Period 1|Pretreatment Event/Adverse Event|1
2844122|NCT02457247|9764338|P1|Period 1|Pretreatment Event/Adverse Event|0
2844123|NCT02457195|9764358|P1|Overall Study|Withdrawal by Subject|4
2844124|NCT02457195|9764358|P1|Overall Study|Protocol Violation|2
2844125|NCT02457195|9764358|P1|Overall Study|Adverse Event|3
2844126|NCT02457182|9764364|P2|Overall Study|Lost to Follow-up|0
2844127|NCT02457182|9764365|P1|Overall Study|Lost to Follow-up|1
2844128|NCT02457065|9764383|P2|Overall Study|Lost to Follow-up|11
2844129|NCT02457065|9764384|P1|Overall Study|Lost to Follow-up|9
2844130|NCT02456740|9764406|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2844131|NCT02456740|9764407|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2844132|NCT02456740|9764408|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2844133|NCT02456740|9764409|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2844134|NCT02456740|9764410|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
2844135|NCT02456740|9764411|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2844136|NCT02456740|9764412|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2844137|NCT02456740|9764413|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2844138|NCT02456740|9764414|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2844139|NCT02456740|9764406|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844140|NCT02456740|9764407|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
2844141|NCT02456740|9764408|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844142|NCT02456740|9764409|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844143|NCT02456740|9764410|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844144|NCT02456740|9764411|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844145|NCT02456740|9764412|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844146|NCT02456740|9764413|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844147|NCT02456740|9764414|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
2844148|NCT02456740|9764406|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2844149|NCT02456740|9764407|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2844150|NCT02456740|9764408|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2844151|NCT02456740|9764409|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2844152|NCT02456740|9764410|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
2844153|NCT02456740|9764411|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
2844154|NCT02456740|9764412|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2844155|NCT02456740|9764413|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2844156|NCT02456740|9764414|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2844157|NCT02456740|9764406|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
2844158|NCT02456740|9764407|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844159|NCT02456740|9764408|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844160|NCT02456740|9764409|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844161|NCT02456740|9764410|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
2844162|NCT02456740|9764411|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
2844163|NCT02456740|9764412|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844164|NCT02456740|9764413|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844165|NCT02456740|9764414|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2844166|NCT02456740|9764406|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844167|NCT02456740|9764407|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844168|NCT02456740|9764408|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844169|NCT02456740|9764409|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844170|NCT02456740|9764410|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844171|NCT02456740|9764411|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2844172|NCT02456740|9764412|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
2844173|NCT02456740|9764413|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
2844174|NCT02456740|9764414|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
2844175|NCT02456740|9764406|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844176|NCT02456740|9764407|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844177|NCT02456740|9764408|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844178|NCT02456740|9764409|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844179|NCT02456740|9764410|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844180|NCT02456740|9764411|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2844181|NCT02456740|9764412|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
2844182|NCT02456740|9764413|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
2844183|NCT02456740|9764414|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
2844184|NCT02456740|9764406|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844185|NCT02456740|9764407|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844186|NCT02456740|9764408|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844187|NCT02456740|9764409|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844188|NCT02456740|9764410|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844189|NCT02456740|9764411|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2844190|NCT02456740|9764412|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2844191|NCT02456740|9764413|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2844192|NCT02456740|9764414|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2844193|NCT02456662|9764438|P2|Overall Study|Lost to Follow-up|1
2844194|NCT02456662|9764439|P1|Overall Study|Lost to Follow-up|2
2844195|NCT02456103|9764445|P1|Overall Study|Withdrawal by Subject|24
2844196|NCT02456103|9764445|P1|Overall Study|Lost to Follow-up|1
2844197|NCT02456103|9764445|P1|Overall Study|Abnormal Laboratory Value|2
2844198|NCT02456103|9764445|P1|Overall Study|Adverse Event|5
2844199|NCT02456103|9764445|P1|Overall Study|Protocol Violation|1
2844200|NCT02456103|9764445|P1|Overall Study|Required prohibited medications|5
2844201|NCT02456103|9764445|P1|Overall Study|Physician Decision|1
2844202|NCT02456103|9764445|P1|Overall Study|Study Closure|207
2844203|NCT02455518|9764458|P4|Overall Study|Protocol Violation|3
2844204|NCT02455518|9764459|P3|Overall Study|Protocol Violation|1
2844205|NCT02455518|9764460|P2|Overall Study|Protocol Violation|1
2844206|NCT02455518|9764461|P1|Overall Study|Protocol Violation|0
2844207|NCT02455388|9764483|P3|Overall Study|Withdrawal by Subject|7
2844208|NCT02455388|9764484|P2|Overall Study|Withdrawal by Subject|0
2844209|NCT02455388|9764485|P1|Overall Study|Withdrawal by Subject|0
2844210|NCT02455388|9764483|P3|Overall Study|Protocol Violation|4
2844211|NCT02455388|9764484|P2|Overall Study|Protocol Violation|0
2844212|NCT02455388|9764485|P1|Overall Study|Protocol Violation|1
2844213|NCT02455336|9764496|P2|Overall Study|Non-responder to treatment|0
2844214|NCT02455336|9764497|P1|Overall Study|Non-responder to treatment|2
2844215|NCT02455336|9764496|P2|Overall Study|Adverse Event|0
2844216|NCT02455336|9764497|P1|Overall Study|Adverse Event|3
2844217|NCT02455336|9764496|P2|Overall Study|Withdrawal by Subject|2
2844218|NCT02455336|9764497|P1|Overall Study|Withdrawal by Subject|0
2844219|NCT02455076|9764512|P5|Outpatient|Lost to Follow-up|12
2844220|NCT02455076|9764513|P4|Outpatient|Lost to Follow-up|1
2844221|NCT02455076|9764514|P3|Outpatient|Lost to Follow-up|0
2844222|NCT02455076|9764515|P2|Outpatient|Lost to Follow-up|0
2844223|NCT02455076|9764516|P1|Outpatient|Lost to Follow-up|0
2844224|NCT02455076|9764512|P5|Outpatient|Adverse Event|0
2844225|NCT02455076|9764513|P4|Outpatient|Adverse Event|5
2844226|NCT02455076|9764514|P3|Outpatient|Adverse Event|0
2844227|NCT02455076|9764515|P2|Outpatient|Adverse Event|0
2844228|NCT02455076|9764516|P1|Outpatient|Adverse Event|0
2844229|NCT02455076|9764512|P5|Inpatient|Adverse Event|0
2844230|NCT02455076|9764513|P4|Inpatient|Adverse Event|0
2844231|NCT02455076|9764514|P3|Inpatient|Adverse Event|0
2844232|NCT02455076|9764515|P2|Inpatient|Adverse Event|0
2844233|NCT02455076|9764516|P1|Inpatient|Adverse Event|3
2844234|NCT02455076|9764512|P5|Inpatient|Discharged <24 h after admission|0
2844235|NCT02455076|9764513|P4|Inpatient|Discharged <24 h after admission|0
2844236|NCT02455076|9764514|P3|Inpatient|Discharged <24 h after admission|0
2844237|NCT02455076|9764515|P2|Inpatient|Discharged <24 h after admission|1
2844238|NCT02455076|9764516|P1|Inpatient|Discharged <24 h after admission|0
2844239|NCT02455076|9764512|P5|Inpatient|Withdrawal by Subject|0
2844240|NCT02455076|9764513|P4|Inpatient|Withdrawal by Subject|0
2844241|NCT02455076|9764514|P3|Inpatient|Withdrawal by Subject|0
2844242|NCT02455076|9764515|P2|Inpatient|Withdrawal by Subject|0
2844243|NCT02455076|9764516|P1|Inpatient|Withdrawal by Subject|1
2844244|NCT02455050|9764602|P4|Treatment Period 2|Lost to Follow-up|1
2844245|NCT02455050|9764603|P3|Treatment Period 2|Lost to Follow-up|2
2844246|NCT02455050|9764604|P2|Treatment Period 2|Lost to Follow-up|0
2844247|NCT02455050|9764605|P1|Treatment Period 2|Lost to Follow-up|1
2844248|NCT02455050|9764602|P4|Treatment Period 1|Lost to Follow-up|2
2844249|NCT02455050|9764603|P3|Treatment Period 1|Lost to Follow-up|1
2844250|NCT02455050|9764604|P2|Treatment Period 1|Lost to Follow-up|1
2844251|NCT02455050|9764605|P1|Treatment Period 1|Lost to Follow-up|1
2844252|NCT02454959|9764669|P1|Overall Study|Adverse Event|2
2844253|NCT02454959|9764669|P1|Overall Study|Withdrawal by Subject|3
2844254|NCT02454959|9764669|P1|Overall Study|Physician Decision|1
2844255|NCT02454959|9764669|P1|Overall Study|Protocol-Specified Criteria|3
2844256|NCT02454933|9764689|P2|Overall Study|Withdrawal by Subject|2
2844257|NCT02454933|9764690|P1|Overall Study|Withdrawal by Subject|0
2844258|NCT02454933|9764689|P2|Overall Study|Adverse Event|1
2844259|NCT02454933|9764690|P1|Overall Study|Adverse Event|1
2844260|NCT02454933|9764689|P2|Overall Study|Progressive disease|5
2844261|NCT02454933|9764690|P1|Overall Study|Progressive disease|7
2844262|NCT02454608|9764698|P3|Open Label Period|Withdrawal by Subject|8
2844263|NCT02454608|9764699|P2|Open Label Period|Withdrawal by Subject|0
2844264|NCT02454608|9764700|P1|Open Label Period|Withdrawal by Subject|0
2844265|NCT02454608|9764698|P3|Open Label Period|Lost to Follow-up|11
2844266|NCT02454608|9764699|P2|Open Label Period|Lost to Follow-up|0
2844267|NCT02454608|9764700|P1|Open Label Period|Lost to Follow-up|0
2844268|NCT02454608|9764698|P3|Double-Blind Period|Lack of Efficacy|0
2844269|NCT02454608|9764699|P2|Double-Blind Period|Lack of Efficacy|2
2844270|NCT02454608|9764700|P1|Double-Blind Period|Lack of Efficacy|0
2844271|NCT02454530|9764723|P2|Overall Study|Lost to Follow-up|4
2844272|NCT02454530|9764724|P1|Overall Study|Lost to Follow-up|4
2844273|NCT02454530|9764723|P2|Overall Study|Death|41
2844274|NCT02454530|9764724|P1|Overall Study|Death|2
2844275|NCT02454530|9764723|P2|Overall Study|Missing information|69
2844276|NCT02454530|9764724|P1|Overall Study|Missing information|56
2844277|NCT02454530|9764723|P2|Overall Study|Other|13
2844278|NCT02454530|9764724|P1|Overall Study|Other|8
2844279|NCT02454478|9764761|P1|Overall Study|Incomplete DLT Evaluation|1
2844280|NCT02454101|9764855|P2|Overall Study|Lost to Follow-up|4
2844281|NCT02454101|9764856|P1|Overall Study|Lost to Follow-up|3
2844282|NCT02454101|9764855|P2|Overall Study|Adverse Event|3
2844283|NCT02454101|9764856|P1|Overall Study|Adverse Event|2
2844284|NCT02453841|9764878|P1|Overall Study|Unable to obtain blood samples|2
2844285|NCT02453841|9764878|P1|Overall Study|Protocol Violation|1
2844286|NCT02453711|9764901|P9|Overall Study|Unclassified|0
2844287|NCT02453711|9764902|P8|Overall Study|Unclassified|0
2844288|NCT02453711|9764903|P7|Overall Study|Unclassified|0
2844289|NCT02453711|9764904|P6|Overall Study|Unclassified|0
2844290|NCT02453711|9764905|P5|Overall Study|Unclassified|0
2844291|NCT02453711|9764906|P4|Overall Study|Unclassified|0
2844292|NCT02453711|9764907|P3|Overall Study|Unclassified|1
2844293|NCT02453711|9764908|P2|Overall Study|Unclassified|0
2844294|NCT02453711|9764909|P1|Overall Study|Unclassified|1
2844295|NCT02453711|9764901|P9|Overall Study|Death|0
2844296|NCT02453711|9764902|P8|Overall Study|Death|0
2844297|NCT02453711|9764903|P7|Overall Study|Death|1
2844298|NCT02453711|9764904|P6|Overall Study|Death|0
2844299|NCT02453711|9764905|P5|Overall Study|Death|0
2844300|NCT02453711|9764906|P4|Overall Study|Death|0
2844301|NCT02453711|9764907|P3|Overall Study|Death|0
2844302|NCT02453711|9764908|P2|Overall Study|Death|0
2844303|NCT02453711|9764909|P1|Overall Study|Death|0
2844304|NCT02453711|9764901|P9|Overall Study|Lost to Follow-up|6
2844305|NCT02453711|9764902|P8|Overall Study|Lost to Follow-up|6
2844306|NCT02453711|9764903|P7|Overall Study|Lost to Follow-up|2
2844307|NCT02453711|9764904|P6|Overall Study|Lost to Follow-up|5
2844308|NCT02453711|9764905|P5|Overall Study|Lost to Follow-up|1
2844309|NCT02453711|9764906|P4|Overall Study|Lost to Follow-up|3
2844310|NCT02453711|9764907|P3|Overall Study|Lost to Follow-up|2
2844311|NCT02453711|9764908|P2|Overall Study|Lost to Follow-up|3
2844312|NCT02453711|9764909|P1|Overall Study|Lost to Follow-up|5
2844313|NCT02453711|9764901|P9|Overall Study|Withdrawal by Subject|7
2844314|NCT02453711|9764902|P8|Overall Study|Withdrawal by Subject|1
2844315|NCT02453711|9764903|P7|Overall Study|Withdrawal by Subject|0
2844316|NCT02453711|9764904|P6|Overall Study|Withdrawal by Subject|1
2844317|NCT02453711|9764905|P5|Overall Study|Withdrawal by Subject|1
2844318|NCT02453711|9764906|P4|Overall Study|Withdrawal by Subject|4
2844319|NCT02453711|9764907|P3|Overall Study|Withdrawal by Subject|6
2844320|NCT02453711|9764908|P2|Overall Study|Withdrawal by Subject|4
2844321|NCT02453711|9764909|P1|Overall Study|Withdrawal by Subject|5
2844322|NCT02453685|9765253|P2|Overall Study|Unclassified|2
2844323|NCT02453685|9765254|P1|Overall Study|Unclassified|4
2844324|NCT02453685|9765253|P2|Overall Study|Withdrawal by Subject|4
2844325|NCT02453685|9765254|P1|Overall Study|Withdrawal by Subject|8
2844326|NCT02453685|9765253|P2|Overall Study|Lost to Follow-up|1
2844327|NCT02453685|9765254|P1|Overall Study|Lost to Follow-up|0
2844328|NCT02453685|9765253|P2|Overall Study|Protocol Violation|4
2844329|NCT02453685|9765254|P1|Overall Study|Protocol Violation|7
2844330|NCT02453685|9765253|P2|Overall Study|Adverse Event|1
2844331|NCT02453685|9765254|P1|Overall Study|Adverse Event|0
2844332|NCT02453555|9765312|P6|Extension Period|Withdrawal by Subject|0
2844333|NCT02453555|9765313|P5|Extension Period|Withdrawal by Subject|0
2844334|NCT02453555|9765314|P4|Extension Period|Withdrawal by Subject|0
2844335|NCT02453555|9765315|P3|Extension Period|Withdrawal by Subject|1
2844336|NCT02453555|9765316|P2|Extension Period|Withdrawal by Subject|0
2844337|NCT02453555|9765317|P1|Extension Period|Withdrawal by Subject|0
2844338|NCT02453555|9765312|P6|Extension Period|Protocol Violation|0
2844339|NCT02453555|9765313|P5|Extension Period|Protocol Violation|0
2844340|NCT02453555|9765314|P4|Extension Period|Protocol Violation|0
2844341|NCT02453555|9765315|P3|Extension Period|Protocol Violation|1
2844342|NCT02453555|9765316|P2|Extension Period|Protocol Violation|0
2844343|NCT02453555|9765317|P1|Extension Period|Protocol Violation|0
2844344|NCT02453555|9765312|P6|Extension Period|Adverse Event|1
2844345|NCT02453555|9765313|P5|Extension Period|Adverse Event|1
2844346|NCT02453555|9765314|P4|Extension Period|Adverse Event|2
2844347|NCT02453555|9765315|P3|Extension Period|Adverse Event|1
2844348|NCT02453555|9765316|P2|Extension Period|Adverse Event|0
2844349|NCT02453555|9765317|P1|Extension Period|Adverse Event|0
2844350|NCT02453555|9765312|P6|24-week Double-blind Treatment Period|Other than specified above|0
2844351|NCT02453555|9765313|P5|24-week Double-blind Treatment Period|Other than specified above|0
2844352|NCT02453555|9765314|P4|24-week Double-blind Treatment Period|Other than specified above|0
2844353|NCT02453555|9765315|P3|24-week Double-blind Treatment Period|Other than specified above|0
2844354|NCT02453555|9765316|P2|24-week Double-blind Treatment Period|Other than specified above|3
2844355|NCT02453555|9765317|P1|24-week Double-blind Treatment Period|Other than specified above|0
2844356|NCT02453555|9765312|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2844357|NCT02453555|9765313|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2844358|NCT02453555|9765314|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2844359|NCT02453555|9765315|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2844360|NCT02453555|9765316|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
2844361|NCT02453555|9765317|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
2844362|NCT02453555|9765312|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
2844363|NCT02453555|9765313|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
2844364|NCT02453555|9765314|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
2844365|NCT02453555|9765315|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
2844366|NCT02453555|9765316|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
2844367|NCT02453555|9765317|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
2844368|NCT02453555|9765312|P6|24-week Double-blind Treatment Period|Adverse Event|0
2844369|NCT02453555|9765313|P5|24-week Double-blind Treatment Period|Adverse Event|0
2844370|NCT02453555|9765314|P4|24-week Double-blind Treatment Period|Adverse Event|0
2844371|NCT02453555|9765315|P3|24-week Double-blind Treatment Period|Adverse Event|0
2844372|NCT02453555|9765316|P2|24-week Double-blind Treatment Period|Adverse Event|0
2844373|NCT02453555|9765317|P1|24-week Double-blind Treatment Period|Adverse Event|2
2844374|NCT02453386|9765333|P3|Overall Study|Other|1
2844375|NCT02453386|9765334|P2|Overall Study|Other|0
2844376|NCT02453386|9765335|P1|Overall Study|Other|1
2844377|NCT02453386|9765333|P3|Overall Study|Lost to Follow-up|1
2844378|NCT02453386|9765334|P2|Overall Study|Lost to Follow-up|0
2844379|NCT02453386|9765335|P1|Overall Study|Lost to Follow-up|0
2844380|NCT02453386|9765333|P3|Overall Study|Sponsor Terminated by Investigator|2
2844381|NCT02453386|9765334|P2|Overall Study|Sponsor Terminated by Investigator|1
2844382|NCT02453386|9765335|P1|Overall Study|Sponsor Terminated by Investigator|0
2844383|NCT02453386|9765333|P3|Overall Study|Subject Terminated by Sponsor|1
2844384|NCT02453386|9765334|P2|Overall Study|Subject Terminated by Sponsor|1
2844385|NCT02453386|9765335|P1|Overall Study|Subject Terminated by Sponsor|1
2844386|NCT02453386|9765333|P3|Overall Study|Sponsor Terminated Study|11
2844387|NCT02453386|9765334|P2|Overall Study|Sponsor Terminated Study|8
2844388|NCT02453386|9765335|P1|Overall Study|Sponsor Terminated Study|14
2844389|NCT02453386|9765333|P3|Overall Study|Withdrawal by Subject|9
2844390|NCT02453386|9765334|P2|Overall Study|Withdrawal by Subject|9
2844391|NCT02453386|9765335|P1|Overall Study|Withdrawal by Subject|10
2844392|NCT02453386|9765333|P3|Overall Study|Protocol Violation|1
2844393|NCT02453386|9765334|P2|Overall Study|Protocol Violation|0
2844394|NCT02453386|9765335|P1|Overall Study|Protocol Violation|1
2844395|NCT02453386|9765333|P3|Overall Study|Adverse Event|15
2844396|NCT02453386|9765334|P2|Overall Study|Adverse Event|30
2844397|NCT02453386|9765335|P1|Overall Study|Adverse Event|22
2844398|NCT02453321|9765399|P3|Overall Study|Deep Venous Thrombosis|0
2844399|NCT02453321|9765400|P2|Overall Study|Deep Venous Thrombosis|1
2844400|NCT02453321|9765401|P1|Overall Study|Deep Venous Thrombosis|0
2844401|NCT02453321|9765399|P3|Overall Study|Weakness|2
2844402|NCT02453321|9765400|P2|Overall Study|Weakness|1
2844403|NCT02453321|9765401|P1|Overall Study|Weakness|1
2844404|NCT02453282|9765421|P3|Overall Study|Other|1
2844405|NCT02453282|9765422|P2|Overall Study|Other|1
2844406|NCT02453282|9765423|P1|Overall Study|Other|1
2844407|NCT02453282|9765421|P3|Overall Study|Participants ongoing at data cut-off|62
2844408|NCT02453282|9765422|P2|Overall Study|Participants ongoing at data cut-off|84
2844409|NCT02453282|9765423|P1|Overall Study|Participants ongoing at data cut-off|85
2844410|NCT02453282|9765421|P3|Overall Study|Withdrawal by Subject|11
2844411|NCT02453282|9765422|P2|Overall Study|Withdrawal by Subject|10
2844412|NCT02453282|9765423|P1|Overall Study|Withdrawal by Subject|12
2844413|NCT02453282|9765421|P3|Overall Study|Lost to Follow-up|2
2844414|NCT02453282|9765422|P2|Overall Study|Lost to Follow-up|0
2844415|NCT02453282|9765423|P1|Overall Study|Lost to Follow-up|1
2844416|NCT02453282|9765421|P3|Overall Study|Death|296
2844417|NCT02453282|9765422|P2|Overall Study|Death|277
2844418|NCT02453282|9765423|P1|Overall Study|Death|275
2844419|NCT02453256|9765504|P2|Open Label Period|Withdrawal by Subject|1
2844420|NCT02453256|9765505|P1|Open Label Period|Withdrawal by Subject|5
2844421|NCT02453256|9765504|P2|Open Label Period|Other|2
2844422|NCT02453256|9765505|P1|Open Label Period|Other|0
2844423|NCT02453256|9765504|P2|Open Label Period|Lost to Follow-up|0
2844424|NCT02453256|9765505|P1|Open Label Period|Lost to Follow-up|1
2844425|NCT02453256|9765504|P2|Open Label Period|Death|1
2844426|NCT02453256|9765505|P1|Open Label Period|Death|0
2844427|NCT02453256|9765504|P2|Open Label Period|Adverse Event|3
2844428|NCT02453256|9765505|P1|Open Label Period|Adverse Event|1
2844429|NCT02453256|9765504|P2|Double Blind Period|Other|1
2844430|NCT02453256|9765505|P1|Double Blind Period|Other|0
2844431|NCT02453256|9765504|P2|Double Blind Period|Withdrawal by Subject|5
2844432|NCT02453256|9765505|P1|Double Blind Period|Withdrawal by Subject|9
2844433|NCT02453256|9765504|P2|Double Blind Period|Adverse Event|2
2844434|NCT02453256|9765505|P1|Double Blind Period|Adverse Event|3
2844435|NCT02453256|9765504|P2|Double Blind Period|Death|1
2844436|NCT02453256|9765505|P1|Double Blind Period|Death|1
2844437|NCT02453048|9765630|P5|Overall Study|Lost to Follow-up|0
2844438|NCT02453048|9765631|P4|Overall Study|Lost to Follow-up|0
2844439|NCT02453048|9765632|P3|Overall Study|Lost to Follow-up|2
2844440|NCT02453048|9765633|P2|Overall Study|Lost to Follow-up|1
2844441|NCT02453048|9765634|P1|Overall Study|Lost to Follow-up|0
2844442|NCT02453048|9765630|P5|Overall Study|Only part of initial 6 mo. study|6
2844443|NCT02453048|9765631|P4|Overall Study|Only part of initial 6 mo. study|0
2844444|NCT02453048|9765632|P3|Overall Study|Only part of initial 6 mo. study|0
2844445|NCT02453048|9765633|P2|Overall Study|Only part of initial 6 mo. study|0
2844446|NCT02453048|9765634|P1|Overall Study|Only part of initial 6 mo. study|0
2844447|NCT02452892|9765694|P4|Follow-up|Subject left town on Day 42|0
2844448|NCT02452892|9765695|P3|Follow-up|Subject left town on Day 42|0
2844449|NCT02452892|9765696|P2|Follow-up|Subject left town on Day 42|0
2844450|NCT02452892|9765697|P1|Follow-up|Subject left town on Day 42|1
2844451|NCT02452892|9765694|P4|Follow-up|Withdrawal by Subject|1
2844452|NCT02452892|9765695|P3|Follow-up|Withdrawal by Subject|0
2844453|NCT02452892|9765696|P2|Follow-up|Withdrawal by Subject|0
2844454|NCT02452892|9765697|P1|Follow-up|Withdrawal by Subject|0
2844455|NCT02452892|9765694|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2844456|NCT02452892|9765695|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2844457|NCT02452892|9765696|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2844458|NCT02452892|9765697|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
2844459|NCT02452892|9765694|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
2844460|NCT02452892|9765695|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2844461|NCT02452892|9765696|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2844462|NCT02452892|9765697|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2844463|NCT02452892|9765694|P4|Week 1 Initial Randommization|Lost to Follow-up|0
2844464|NCT02452892|9765695|P3|Week 1 Initial Randommization|Lost to Follow-up|1
2844465|NCT02452892|9765696|P2|Week 1 Initial Randommization|Lost to Follow-up|0
2844466|NCT02452892|9765697|P1|Week 1 Initial Randommization|Lost to Follow-up|0
2844467|NCT02452892|9765694|P4|Week 1 Initial Randommization|Adverse Event|0
2844468|NCT02452892|9765695|P3|Week 1 Initial Randommization|Adverse Event|0
2844469|NCT02452892|9765696|P2|Week 1 Initial Randommization|Adverse Event|0
2844470|NCT02452892|9765697|P1|Week 1 Initial Randommization|Adverse Event|1
2844471|NCT02452554|9765732|P6|Overall Study|Never Received Treatment|0
2844472|NCT02452554|9765733|P5|Overall Study|Never Received Treatment|0
2844473|NCT02452554|9765734|P4|Overall Study|Never Received Treatment|0
2844474|NCT02452554|9765735|P3|Overall Study|Never Received Treatment|0
2844475|NCT02452554|9765736|P2|Overall Study|Never Received Treatment|0
2844476|NCT02452554|9765737|P1|Overall Study|Never Received Treatment|1
2844477|NCT02452554|9765732|P6|Overall Study|Ineligible|0
2844478|NCT02452554|9765733|P5|Overall Study|Ineligible|0
2844479|NCT02452554|9765734|P4|Overall Study|Ineligible|0
2844480|NCT02452554|9765735|P3|Overall Study|Ineligible|0
2844481|NCT02452554|9765736|P2|Overall Study|Ineligible|1
2844482|NCT02452554|9765737|P1|Overall Study|Ineligible|0
2844483|NCT02452554|9765732|P6|Overall Study|Withdrawal by Subject|1
2844484|NCT02452554|9765733|P5|Overall Study|Withdrawal by Subject|0
2844485|NCT02452554|9765734|P4|Overall Study|Withdrawal by Subject|0
2844486|NCT02452554|9765735|P3|Overall Study|Withdrawal by Subject|2
2844487|NCT02452554|9765736|P2|Overall Study|Withdrawal by Subject|0
2844488|NCT02452554|9765737|P1|Overall Study|Withdrawal by Subject|1
2844489|NCT02452554|9765732|P6|Overall Study|Physician Decision|0
2844490|NCT02452554|9765733|P5|Overall Study|Physician Decision|0
2844491|NCT02452554|9765734|P4|Overall Study|Physician Decision|0
2844492|NCT02452554|9765735|P3|Overall Study|Physician Decision|0
2844493|NCT02452554|9765736|P2|Overall Study|Physician Decision|1
2844494|NCT02452554|9765737|P1|Overall Study|Physician Decision|0
2844495|NCT02452554|9765732|P6|Overall Study|Lack of Efficacy|8
2844496|NCT02452554|9765733|P5|Overall Study|Lack of Efficacy|5
2844497|NCT02452554|9765734|P4|Overall Study|Lack of Efficacy|1
2844498|NCT02452554|9765735|P3|Overall Study|Lack of Efficacy|9
2844499|NCT02452554|9765736|P2|Overall Study|Lack of Efficacy|14
2844500|NCT02452554|9765737|P1|Overall Study|Lack of Efficacy|13
2844501|NCT02452554|9765732|P6|Overall Study|Death|0
2844502|NCT02452554|9765733|P5|Overall Study|Death|0
2844503|NCT02452554|9765734|P4|Overall Study|Death|0
2844504|NCT02452554|9765735|P3|Overall Study|Death|0
2844505|NCT02452554|9765736|P2|Overall Study|Death|1
2844506|NCT02452554|9765737|P1|Overall Study|Death|2
2844507|NCT02452463|9765790|P3|Overall Study|Withdrawal by Subject|0
2844508|NCT02452463|9765791|P2|Overall Study|Withdrawal by Subject|1
2844509|NCT02452463|9765792|P1|Overall Study|Withdrawal by Subject|0
2844510|NCT02452463|9765790|P3|Overall Study|Recommended by DSMB|0
2844511|NCT02452463|9765791|P2|Overall Study|Recommended by DSMB|1
2844512|NCT02452463|9765792|P1|Overall Study|Recommended by DSMB|0
2844513|NCT02452463|9765790|P3|Overall Study|Study Suspended|0
2844514|NCT02452463|9765791|P2|Overall Study|Study Suspended|0
2844515|NCT02452463|9765792|P1|Overall Study|Study Suspended|1
2844516|NCT02452463|9765790|P3|Overall Study|Death|0
2844517|NCT02452463|9765791|P2|Overall Study|Death|0
2844518|NCT02452463|9765792|P1|Overall Study|Death|1
2844519|NCT02452424|9765835|P11|Overall Study|Adverse Event|1
2844520|NCT02452424|9765836|P10|Overall Study|Adverse Event|0
2844521|NCT02452424|9765837|P9|Overall Study|Adverse Event|0
2844522|NCT02452424|9765838|P8|Overall Study|Adverse Event|0
2844523|NCT02452424|9765839|P7|Overall Study|Adverse Event|0
2844524|NCT02452424|9765840|P6|Overall Study|Adverse Event|0
2844525|NCT02452424|9765841|P5|Overall Study|Adverse Event|0
2844526|NCT02452424|9765842|P4|Overall Study|Adverse Event|0
2844527|NCT02452424|9765843|P3|Overall Study|Adverse Event|0
2844528|NCT02452424|9765844|P2|Overall Study|Adverse Event|0
2844529|NCT02452424|9765845|P1|Overall Study|Adverse Event|0
2844530|NCT02452424|9765835|P11|Overall Study|Progressive disease (per RECIST)|0
2844531|NCT02452424|9765836|P10|Overall Study|Progressive disease (per RECIST)|0
2844532|NCT02452424|9765837|P9|Overall Study|Progressive disease (per RECIST)|2
2844533|NCT02452424|9765838|P8|Overall Study|Progressive disease (per RECIST)|0
2844534|NCT02452424|9765839|P7|Overall Study|Progressive disease (per RECIST)|0
2844535|NCT02452424|9765840|P6|Overall Study|Progressive disease (per RECIST)|0
2844536|NCT02452424|9765841|P5|Overall Study|Progressive disease (per RECIST)|0
2844537|NCT02452424|9765842|P4|Overall Study|Progressive disease (per RECIST)|0
2844538|NCT02452424|9765843|P3|Overall Study|Progressive disease (per RECIST)|0
2844539|NCT02452424|9765844|P2|Overall Study|Progressive disease (per RECIST)|0
2844540|NCT02452424|9765845|P1|Overall Study|Progressive disease (per RECIST)|0
2844541|NCT02452424|9765835|P11|Overall Study|Other|1
2844542|NCT02452424|9765836|P10|Overall Study|Other|0
2844543|NCT02452424|9765837|P9|Overall Study|Other|0
2844544|NCT02452424|9765838|P8|Overall Study|Other|3
2844545|NCT02452424|9765839|P7|Overall Study|Other|4
2844546|NCT02452424|9765840|P6|Overall Study|Other|1
2844547|NCT02452424|9765841|P5|Overall Study|Other|0
2844548|NCT02452424|9765842|P4|Overall Study|Other|0
2844549|NCT02452424|9765843|P3|Overall Study|Other|1
2844550|NCT02452424|9765844|P2|Overall Study|Other|0
2844551|NCT02452424|9765845|P1|Overall Study|Other|0
2844552|NCT02452424|9765835|P11|Overall Study|Withdrawal by Subject|0
2844553|NCT02452424|9765836|P10|Overall Study|Withdrawal by Subject|1
2844554|NCT02452424|9765837|P9|Overall Study|Withdrawal by Subject|1
2844555|NCT02452424|9765838|P8|Overall Study|Withdrawal by Subject|0
2844556|NCT02452424|9765839|P7|Overall Study|Withdrawal by Subject|1
2844557|NCT02452424|9765840|P6|Overall Study|Withdrawal by Subject|0
2844558|NCT02452424|9765841|P5|Overall Study|Withdrawal by Subject|0
2844559|NCT02452424|9765842|P4|Overall Study|Withdrawal by Subject|2
2844560|NCT02452424|9765843|P3|Overall Study|Withdrawal by Subject|3
2844561|NCT02452424|9765844|P2|Overall Study|Withdrawal by Subject|0
2844562|NCT02452424|9765845|P1|Overall Study|Withdrawal by Subject|0
2844563|NCT02452424|9765835|P11|Overall Study|Lost to Follow-up|0
2844564|NCT02452424|9765836|P10|Overall Study|Lost to Follow-up|0
2844565|NCT02452424|9765837|P9|Overall Study|Lost to Follow-up|0
2844566|NCT02452424|9765838|P8|Overall Study|Lost to Follow-up|0
2844567|NCT02452424|9765839|P7|Overall Study|Lost to Follow-up|0
2844568|NCT02452424|9765840|P6|Overall Study|Lost to Follow-up|0
2844569|NCT02452424|9765841|P5|Overall Study|Lost to Follow-up|0
2844570|NCT02452424|9765842|P4|Overall Study|Lost to Follow-up|0
2844571|NCT02452424|9765843|P3|Overall Study|Lost to Follow-up|1
2844572|NCT02452424|9765844|P2|Overall Study|Lost to Follow-up|1
2844573|NCT02452424|9765845|P1|Overall Study|Lost to Follow-up|0
2844574|NCT02452424|9765835|P11|Overall Study|Death|0
2844575|NCT02452424|9765836|P10|Overall Study|Death|1
2844576|NCT02452424|9765837|P9|Overall Study|Death|3
2844577|NCT02452424|9765838|P8|Overall Study|Death|1
2844578|NCT02452424|9765839|P7|Overall Study|Death|5
2844579|NCT02452424|9765840|P6|Overall Study|Death|0
2844580|NCT02452424|9765841|P5|Overall Study|Death|2
2844581|NCT02452424|9765842|P4|Overall Study|Death|6
2844582|NCT02452424|9765843|P3|Overall Study|Death|2
2844583|NCT02452424|9765844|P2|Overall Study|Death|2
2844584|NCT02452424|9765845|P1|Overall Study|Death|2
2844585|NCT02452320|9765888|P2|Overall Study|Adverse Event|1
2844586|NCT02452320|9765889|P1|Overall Study|Adverse Event|0
2844587|NCT02452190|9765901|P2|Overall Study|Death|1
2844588|NCT02452190|9765902|P1|Overall Study|Death|0
2844589|NCT02452190|9765901|P2|Overall Study|Participant traveled abroad|0
2844590|NCT02452190|9765902|P1|Overall Study|Participant traveled abroad|1
2844591|NCT02452190|9765901|P2|Overall Study|Noncompliance with study drug|0
2844592|NCT02452190|9765902|P1|Overall Study|Noncompliance with study drug|1
2844593|NCT02452190|9765901|P2|Overall Study|Withdrawal by Subject|11
2844594|NCT02452190|9765902|P1|Overall Study|Withdrawal by Subject|20
2844595|NCT02452190|9765901|P2|Overall Study|Adverse Event|5
2844596|NCT02452190|9765902|P1|Overall Study|Adverse Event|2
2844597|NCT02452190|9765901|P2|Overall Study|Lost to Follow-up|3
2844598|NCT02452190|9765902|P1|Overall Study|Lost to Follow-up|4
2844599|NCT02452190|9765901|P2|Overall Study|Lack of Efficacy|1
2844600|NCT02452190|9765902|P1|Overall Study|Lack of Efficacy|3
2844601|NCT02452190|9765901|P2|Overall Study|Investigator's Decision|0
2844602|NCT02452190|9765902|P1|Overall Study|Investigator's Decision|2
2844603|NCT02452190|9765901|P2|Overall Study|Pregnancy|0
2844604|NCT02452190|9765902|P1|Overall Study|Pregnancy|1
2844605|NCT02452190|9765901|P2|Overall Study|Withdrawal by Sponsor|3
2844606|NCT02452190|9765902|P1|Overall Study|Withdrawal by Sponsor|1
2844607|NCT02452047|9765940|P3|Overall Study|Withdrawal by Subject|0
2844608|NCT02452047|9765941|P2|Overall Study|Withdrawal by Subject|0
2844609|NCT02452047|9765942|P1|Overall Study|Withdrawal by Subject|1
2844610|NCT02452047|9765940|P3|Overall Study|Lost to Follow-up|0
2844611|NCT02452047|9765941|P2|Overall Study|Lost to Follow-up|1
2844612|NCT02452047|9765942|P1|Overall Study|Lost to Follow-up|1
2844613|NCT02452047|9765940|P3|Overall Study|Physician Decision|0
2844614|NCT02452047|9765941|P2|Overall Study|Physician Decision|0
2844615|NCT02452047|9765942|P1|Overall Study|Physician Decision|1
2844616|NCT02452047|9765940|P3|Overall Study|Death|1
2844617|NCT02452047|9765941|P2|Overall Study|Death|3
2844618|NCT02452047|9765942|P1|Overall Study|Death|1
2844619|NCT02452047|9765940|P3|Overall Study|Adverse Event|1
2844620|NCT02452047|9765941|P2|Overall Study|Adverse Event|1
2844621|NCT02452047|9765942|P1|Overall Study|Adverse Event|0
2844622|NCT02452034|9766007|P6|Overall Study|Withdrawn by Parent/Guardian|0
2844623|NCT02452034|9766008|P5|Overall Study|Withdrawn by Parent/Guardian|0
2844624|NCT02452034|9766009|P4|Overall Study|Withdrawn by Parent/Guardian|0
2844625|NCT02452034|9766010|P3|Overall Study|Withdrawn by Parent/Guardian|0
2844626|NCT02452034|9766011|P2|Overall Study|Withdrawn by Parent/Guardian|0
2844627|NCT02452034|9766012|P1|Overall Study|Withdrawn by Parent/Guardian|1
2844628|NCT02452034|9766007|P6|Overall Study|Screen Failure|0
2844629|NCT02452034|9766008|P5|Overall Study|Screen Failure|0
2844630|NCT02452034|9766009|P4|Overall Study|Screen Failure|1
2844631|NCT02452034|9766010|P3|Overall Study|Screen Failure|0
2844632|NCT02452034|9766011|P2|Overall Study|Screen Failure|0
2844633|NCT02452034|9766012|P1|Overall Study|Screen Failure|1
2844634|NCT02452034|9766007|P6|Overall Study|Protocol Violation|1
2844635|NCT02452034|9766008|P5|Overall Study|Protocol Violation|0
2844636|NCT02452034|9766009|P4|Overall Study|Protocol Violation|0
2844637|NCT02452034|9766010|P3|Overall Study|Protocol Violation|0
2844638|NCT02452034|9766011|P2|Overall Study|Protocol Violation|0
2844639|NCT02452034|9766012|P1|Overall Study|Protocol Violation|0
2844640|NCT02452034|9766007|P6|Overall Study|Physician Decision|0
2844641|NCT02452034|9766008|P5|Overall Study|Physician Decision|0
2844642|NCT02452034|9766009|P4|Overall Study|Physician Decision|0
2844643|NCT02452034|9766010|P3|Overall Study|Physician Decision|1
2844644|NCT02452034|9766011|P2|Overall Study|Physician Decision|1
2844645|NCT02452034|9766012|P1|Overall Study|Physician Decision|0
2844646|NCT02452034|9766007|P6|Overall Study|Death|1
2844647|NCT02452034|9766008|P5|Overall Study|Death|1
2844648|NCT02452034|9766009|P4|Overall Study|Death|0
2844649|NCT02452034|9766010|P3|Overall Study|Death|0
2844650|NCT02452034|9766011|P2|Overall Study|Death|0
2844651|NCT02452034|9766012|P1|Overall Study|Death|0
2844652|NCT02452034|9766007|P6|Overall Study|Adverse Event|1
2844653|NCT02452034|9766008|P5|Overall Study|Adverse Event|0
2844654|NCT02452034|9766009|P4|Overall Study|Adverse Event|0
2844655|NCT02452034|9766010|P3|Overall Study|Adverse Event|0
2844656|NCT02452034|9766011|P2|Overall Study|Adverse Event|0
2844657|NCT02452034|9766012|P1|Overall Study|Adverse Event|0
2844658|NCT02451943|9766085|P2|Overall Study|Lost to Follow-up|4
2844659|NCT02451943|9766086|P1|Overall Study|Lost to Follow-up|3
2844660|NCT02451943|9766085|P2|Overall Study|Withdrawal by Subject|16
2844661|NCT02451943|9766086|P1|Overall Study|Withdrawal by Subject|13
2844662|NCT02451943|9766085|P2|Overall Study|On Treatment|4
2844663|NCT02451943|9766086|P1|Overall Study|On Treatment|4
2844664|NCT02451917|9766114|P2|First Intervention (24 Weeks)|Adverse Event|2
2844665|NCT02451917|9766115|P1|First Intervention (24 Weeks)|Adverse Event|0
2844666|NCT02451917|9766114|P2|First Intervention (24 Weeks)|Death|1
2844667|NCT02451917|9766115|P1|First Intervention (24 Weeks)|Death|0
2844668|NCT02451917|9766114|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
2844669|NCT02451917|9766115|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
2844670|NCT02451670|9766157|P2|Overall Study|Did not have qualifying follow-up visit.|696
2844671|NCT02451670|9766158|P1|Overall Study|Did not have qualifying follow-up visit.|714
2844672|NCT02451358|9766177|P4|Overall Study|Protocol Violation|0
2844673|NCT02451358|9766178|P3|Overall Study|Protocol Violation|1
2844674|NCT02451358|9766179|P2|Overall Study|Protocol Violation|1
2844675|NCT02451358|9766180|P1|Overall Study|Protocol Violation|0
2844676|NCT02451358|9766177|P4|Overall Study|Withdrawal by Subject|0
2844677|NCT02451358|9766178|P3|Overall Study|Withdrawal by Subject|0
2844678|NCT02451358|9766179|P2|Overall Study|Withdrawal by Subject|1
2844679|NCT02451358|9766180|P1|Overall Study|Withdrawal by Subject|1
2844680|NCT02451137|9766268|P2|Overall Study|Other than specified above|3
2844681|NCT02451137|9766269|P1|Overall Study|Other than specified above|2
2844682|NCT02451137|9766268|P2|Overall Study|Withdrawal by Subject|63
2844683|NCT02451137|9766269|P1|Overall Study|Withdrawal by Subject|40
2844684|NCT02451137|9766268|P2|Overall Study|Sponsor decision|25
2844685|NCT02451137|9766269|P1|Overall Study|Sponsor decision|13
2844686|NCT02451137|9766268|P2|Overall Study|Physician Decision|5
2844687|NCT02451137|9766269|P1|Overall Study|Physician Decision|6
2844688|NCT02451137|9766268|P2|Overall Study|Lost to Follow-up|61
2844689|NCT02451137|9766269|P1|Overall Study|Lost to Follow-up|53
2844690|NCT02451137|9766268|P2|Overall Study|Investigator's decision|19
2844691|NCT02451137|9766269|P1|Overall Study|Investigator's decision|23
2844692|NCT02451137|9766268|P2|Overall Study|Hypoglycemia|1
2844693|NCT02451137|9766269|P1|Overall Study|Hypoglycemia|2
2844694|NCT02451137|9766268|P2|Overall Study|Participant decision:discontinue insulin|43
2844695|NCT02451137|9766269|P1|Overall Study|Participant decision:discontinue insulin|41
2844696|NCT02451137|9766268|P2|Overall Study|Lack of Efficacy|9
2844697|NCT02451137|9766269|P1|Overall Study|Lack of Efficacy|4
2844698|NCT02451137|9766268|P2|Overall Study|Adverse Event|42
2844699|NCT02451137|9766269|P1|Overall Study|Adverse Event|43
2844700|NCT02451137|9766268|P2|Overall Study|Randomized but not treated|27
2844701|NCT02451137|9766269|P1|Overall Study|Randomized but not treated|19
2844702|NCT02451124|9766299|P1|Overall Study|Withdrawal by Subject|1
2844703|NCT02451007|9766310|P1|Overall Study|Disease Progression|2
2844704|NCT02451007|9766310|P1|Overall Study|Adverse Event|1
2844705|NCT02451007|9766310|P1|Overall Study|Withdrawal by Subject|4
2844706|NCT02450552|9766349|P3|Overall Study|Physician Decision|1
2844707|NCT02450552|9766350|P2|Overall Study|Physician Decision|0
2844708|NCT02450552|9766351|P1|Overall Study|Physician Decision|1
2844709|NCT02450552|9766349|P3|Overall Study|Withdrawal by Subject|4
2844710|NCT02450552|9766350|P2|Overall Study|Withdrawal by Subject|0
2844711|NCT02450552|9766351|P1|Overall Study|Withdrawal by Subject|4
2844712|NCT02450539|9766394|P2|Overall Study|On study treatment/follow up|25
2844713|NCT02450539|9766395|P1|Overall Study|On study treatment/follow up|27
2844714|NCT02450539|9766394|P2|Overall Study|Lost to Follow-up|1
2844715|NCT02450539|9766395|P1|Overall Study|Lost to Follow-up|4
2844716|NCT02450539|9766394|P2|Overall Study|Withdrawal by Subject|7
2844717|NCT02450539|9766395|P1|Overall Study|Withdrawal by Subject|19
2844718|NCT02450526|9766419|P5|OL Period (Cycles 2-5)|Protocol Violation|7
2844719|NCT02450526|9766420|P4|OL Period (Cycles 2-5)|Protocol Violation|0
2844720|NCT02450526|9766421|P3|OL Period (Cycles 2-5)|Protocol Violation|0
2844721|NCT02450526|9766422|P2|OL Period (Cycles 2-5)|Protocol Violation|0
2844722|NCT02450526|9766423|P1|OL Period (Cycles 2-5)|Protocol Violation|0
2844723|NCT02450526|9766419|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
2844724|NCT02450526|9766420|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
2844725|NCT02450526|9766421|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
2844726|NCT02450526|9766422|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
2844727|NCT02450526|9766423|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
2844728|NCT02450526|9766419|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
2844729|NCT02450526|9766420|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2844730|NCT02450526|9766421|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2844731|NCT02450526|9766422|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2844732|NCT02450526|9766423|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2844733|NCT02450526|9766419|P5|OL Period (Cycles 2-5)|Adverse Event|2
2844734|NCT02450526|9766420|P4|OL Period (Cycles 2-5)|Adverse Event|0
2844735|NCT02450526|9766421|P3|OL Period (Cycles 2-5)|Adverse Event|0
2844736|NCT02450526|9766422|P2|OL Period (Cycles 2-5)|Adverse Event|0
2844737|NCT02450526|9766423|P1|OL Period (Cycles 2-5)|Adverse Event|0
2844738|NCT02450526|9766419|P5|DB Period (Cycle 1)|Protocol Violation|0
2844739|NCT02450526|9766420|P4|DB Period (Cycle 1)|Protocol Violation|1
2844740|NCT02450526|9766421|P3|DB Period (Cycle 1)|Protocol Violation|0
2844741|NCT02450526|9766422|P2|DB Period (Cycle 1)|Protocol Violation|0
2844742|NCT02450526|9766423|P1|DB Period (Cycle 1)|Protocol Violation|2
2844743|NCT02450526|9766419|P5|DB Period (Cycle 1)|Lost to Follow-up|0
2844744|NCT02450526|9766420|P4|DB Period (Cycle 1)|Lost to Follow-up|0
2844745|NCT02450526|9766421|P3|DB Period (Cycle 1)|Lost to Follow-up|0
2844746|NCT02450526|9766422|P2|DB Period (Cycle 1)|Lost to Follow-up|0
2844747|NCT02450526|9766423|P1|DB Period (Cycle 1)|Lost to Follow-up|1
2844748|NCT02450526|9766419|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
2844749|NCT02450526|9766420|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
2844750|NCT02450526|9766421|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
2844751|NCT02450526|9766422|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
2844752|NCT02450526|9766423|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
2844753|NCT02450526|9766419|P5|DB Period (Cycle 1)|Adverse Event|0
2844754|NCT02450526|9766420|P4|DB Period (Cycle 1)|Adverse Event|0
2844755|NCT02450526|9766421|P3|DB Period (Cycle 1)|Adverse Event|2
2844756|NCT02450526|9766422|P2|DB Period (Cycle 1)|Adverse Event|0
2844757|NCT02450526|9766423|P1|DB Period (Cycle 1)|Adverse Event|0
2844758|NCT02449915|9766525|P2|Overall Study|Abnormal preop lab|1
2844759|NCT02449915|9766526|P1|Overall Study|Abnormal preop lab|0
2844760|NCT02449915|9766525|P2|Overall Study|Intraoperative surgical findings|1
2844761|NCT02449915|9766526|P1|Overall Study|Intraoperative surgical findings|1
2844762|NCT02449915|9766525|P2|Overall Study|Withdrawal by Subject|2
2844763|NCT02449915|9766526|P1|Overall Study|Withdrawal by Subject|0
2844764|NCT02449915|9766525|P2|Overall Study|Exclusion criteria - drug use|0
2844765|NCT02449915|9766526|P1|Overall Study|Exclusion criteria - drug use|1
2844766|NCT02449902|9766534|P2|Overall Study|Withdrawal by Subject|1
2844767|NCT02449902|9766535|P1|Overall Study|Withdrawal by Subject|0
2844768|NCT02449902|9766534|P2|Overall Study|Adverse Event|1
2844769|NCT02449902|9766535|P1|Overall Study|Adverse Event|0
2844770|NCT02449889|9766562|P3|Overall Study|Protocol Violation|1
2844771|NCT02449889|9766563|P2|Overall Study|Protocol Violation|4
2844772|NCT02449889|9766564|P1|Overall Study|Protocol Violation|0
2844773|NCT02449889|9766562|P3|Overall Study|Adverse Event|0
2844774|NCT02449889|9766563|P2|Overall Study|Adverse Event|2
2844775|NCT02449889|9766564|P1|Overall Study|Adverse Event|1
2844776|NCT02449044|9766689|P1|Overall Study|Sponsor Discontinued Trial|3
2844777|NCT02449044|9766689|P1|Overall Study|Physician Decision|9
2844778|NCT02449044|9766689|P1|Overall Study|Met Withdrawal Criteria|7
2844779|NCT02449044|9766689|P1|Overall Study|Adverse Event|30
2844780|NCT02449044|9766689|P1|Overall Study|Withdrawal by Subject|13
2844781|NCT02449044|9766689|P1|Overall Study|Lost to Follow-up|2
2844782|NCT02449018|9766710|P2|Overall Study|Patient decision|0
2844783|NCT02449018|9766711|P1|Overall Study|Patient decision|2
2844784|NCT02449018|9766710|P2|Overall Study|Protocol deviation|0
2844785|NCT02449018|9766711|P1|Overall Study|Protocol deviation|4
2844786|NCT02449018|9766710|P2|Overall Study|Adverse Event|1
2844787|NCT02449018|9766711|P1|Overall Study|Adverse Event|5
2844788|NCT02449018|9766710|P2|Overall Study|Administrative problems|0
2844789|NCT02449018|9766711|P1|Overall Study|Administrative problems|1
2844790|NCT02449018|9766710|P2|Overall Study|Abnormal laboratory value|1
2844791|NCT02449018|9766711|P1|Overall Study|Abnormal laboratory value|0
2844792|NCT02448875|9766758|P3|Overall Study|Withdrawal by Subject|0
2844793|NCT02448875|9766759|P2|Overall Study|Withdrawal by Subject|0
2844794|NCT02448875|9766760|P1|Overall Study|Withdrawal by Subject|1
2844795|NCT02448875|9766758|P3|Overall Study|Investigator Decision|1
2844796|NCT02448875|9766759|P2|Overall Study|Investigator Decision|0
2844797|NCT02448875|9766760|P1|Overall Study|Investigator Decision|3
2844798|NCT02448875|9766758|P3|Overall Study|Lost to Follow-up|0
2844799|NCT02448875|9766759|P2|Overall Study|Lost to Follow-up|0
2844800|NCT02448875|9766760|P1|Overall Study|Lost to Follow-up|1
2844801|NCT02448875|9766758|P3|Overall Study|Adverse Event|0
2844802|NCT02448875|9766759|P2|Overall Study|Adverse Event|1
2844803|NCT02448875|9766760|P1|Overall Study|Adverse Event|2
2844804|NCT02448810|9766808|P8|Overall Study|Other (unspecified)|0
2844805|NCT02448810|9766809|P7|Overall Study|Other (unspecified)|2
2844806|NCT02448810|9766810|P6|Overall Study|Other (unspecified)|0
2844807|NCT02448810|9766811|P5|Overall Study|Other (unspecified)|0
2844808|NCT02448810|9766812|P4|Overall Study|Other (unspecified)|0
2844809|NCT02448810|9766813|P3|Overall Study|Other (unspecified)|0
2844810|NCT02448810|9766814|P2|Overall Study|Other (unspecified)|0
2844811|NCT02448810|9766815|P1|Overall Study|Other (unspecified)|0
2844812|NCT02448810|9766808|P8|Overall Study|Lost to Follow-up|0
2844813|NCT02448810|9766809|P7|Overall Study|Lost to Follow-up|0
2844814|NCT02448810|9766810|P6|Overall Study|Lost to Follow-up|0
2844815|NCT02448810|9766811|P5|Overall Study|Lost to Follow-up|0
2844816|NCT02448810|9766812|P4|Overall Study|Lost to Follow-up|0
2844817|NCT02448810|9766813|P3|Overall Study|Lost to Follow-up|0
2844818|NCT02448810|9766814|P2|Overall Study|Lost to Follow-up|1
2844819|NCT02448810|9766815|P1|Overall Study|Lost to Follow-up|0
2844820|NCT02448810|9766808|P8|Overall Study|Other (Progressive disease)|5
2844821|NCT02448810|9766809|P7|Overall Study|Other (Progressive disease)|14
2844822|NCT02448810|9766810|P6|Overall Study|Other (Progressive disease)|9
2844823|NCT02448810|9766811|P5|Overall Study|Other (Progressive disease)|23
2844824|NCT02448810|9766812|P4|Overall Study|Other (Progressive disease)|3
2844825|NCT02448810|9766813|P3|Overall Study|Other (Progressive disease)|0
2844826|NCT02448810|9766814|P2|Overall Study|Other (Progressive disease)|2
2844827|NCT02448810|9766815|P1|Overall Study|Other (Progressive disease)|2
2844828|NCT02448810|9766808|P8|Overall Study|Death|0
2844829|NCT02448810|9766809|P7|Overall Study|Death|0
2844830|NCT02448810|9766810|P6|Overall Study|Death|0
2844831|NCT02448810|9766811|P5|Overall Study|Death|1
2844832|NCT02448810|9766812|P4|Overall Study|Death|0
2844833|NCT02448810|9766813|P3|Overall Study|Death|1
2844834|NCT02448810|9766814|P2|Overall Study|Death|0
2844835|NCT02448810|9766815|P1|Overall Study|Death|1
2844836|NCT02448810|9766808|P8|Overall Study|Other (study terminated by sponsor)|1
2844837|NCT02448810|9766809|P7|Overall Study|Other (study terminated by sponsor)|2
2844838|NCT02448810|9766810|P6|Overall Study|Other (study terminated by sponsor)|2
2844839|NCT02448810|9766811|P5|Overall Study|Other (study terminated by sponsor)|4
2844840|NCT02448810|9766812|P4|Overall Study|Other (study terminated by sponsor)|0
2844841|NCT02448810|9766813|P3|Overall Study|Other (study terminated by sponsor)|0
2844842|NCT02448810|9766814|P2|Overall Study|Other (study terminated by sponsor)|0
2844843|NCT02448810|9766815|P1|Overall Study|Other (study terminated by sponsor)|0
2844844|NCT02448810|9766808|P8|Overall Study|Withdrawal by Subject|2
2844845|NCT02448810|9766809|P7|Overall Study|Withdrawal by Subject|0
2844846|NCT02448810|9766810|P6|Overall Study|Withdrawal by Subject|5
2844847|NCT02448810|9766811|P5|Overall Study|Withdrawal by Subject|3
2844848|NCT02448810|9766812|P4|Overall Study|Withdrawal by Subject|0
2844849|NCT02448810|9766813|P3|Overall Study|Withdrawal by Subject|1
2844850|NCT02448810|9766814|P2|Overall Study|Withdrawal by Subject|0
2844851|NCT02448810|9766815|P1|Overall Study|Withdrawal by Subject|0
2844852|NCT02448810|9766808|P8|Overall Study|Adverse Event|0
2844853|NCT02448810|9766809|P7|Overall Study|Adverse Event|0
2844854|NCT02448810|9766810|P6|Overall Study|Adverse Event|0
2844855|NCT02448810|9766811|P5|Overall Study|Adverse Event|0
2844856|NCT02448810|9766812|P4|Overall Study|Adverse Event|0
2844857|NCT02448810|9766813|P3|Overall Study|Adverse Event|1
2844858|NCT02448810|9766814|P2|Overall Study|Adverse Event|0
2844859|NCT02448810|9766815|P1|Overall Study|Adverse Event|0
2844860|NCT02448719|9766892|P11|Overall Study|Withdrawal by Subject|0
2844861|NCT02448719|9766893|P10|Overall Study|Withdrawal by Subject|0
2844862|NCT02448719|9766894|P9|Overall Study|Withdrawal by Subject|0
2844863|NCT02448719|9766895|P8|Overall Study|Withdrawal by Subject|0
2844864|NCT02448719|9766896|P7|Overall Study|Withdrawal by Subject|0
2844865|NCT02448719|9766897|P6|Overall Study|Withdrawal by Subject|0
2844866|NCT02448719|9766898|P5|Overall Study|Withdrawal by Subject|1
2844867|NCT02448719|9766899|P4|Overall Study|Withdrawal by Subject|0
2844868|NCT02448719|9766900|P3|Overall Study|Withdrawal by Subject|0
2844869|NCT02448719|9766901|P2|Overall Study|Withdrawal by Subject|0
2844870|NCT02448719|9766902|P1|Overall Study|Withdrawal by Subject|0
2844871|NCT02448706|9767126|P2|Overall Study|Protocol Violation|1
2844872|NCT02448706|9767127|P1|Overall Study|Protocol Violation|1
2844873|NCT02448706|9767126|P2|Overall Study|Withdrawal by Subject|3
2844874|NCT02448706|9767127|P1|Overall Study|Withdrawal by Subject|4
2844875|NCT02448563|9767177|P2|Overall Study|Withdrawal by Subject|1
2844876|NCT02448563|9767178|P1|Overall Study|Withdrawal by Subject|0
2844877|NCT02448563|9767177|P2|Overall Study|Lost to Follow-up|10
2844878|NCT02448563|9767178|P1|Overall Study|Lost to Follow-up|16
2844879|NCT02448537|9767200|P3|Overall Study|Withdrawal by Subject|1
2844880|NCT02448537|9767201|P2|Overall Study|Withdrawal by Subject|1
2844881|NCT02448537|9767202|P1|Overall Study|Withdrawal by Subject|1
2844882|NCT02448043|9767316|P2|Overall Study|Protocol Violation|2
2844883|NCT02448043|9767317|P1|Overall Study|Protocol Violation|1
2844884|NCT02448043|9767316|P2|Overall Study|Withdrawal by Subject|2
2844885|NCT02448043|9767317|P1|Overall Study|Withdrawal by Subject|2
2844886|NCT02447952|9767335|P1|Overall Study|Withdrawal by Subject|4
2844887|NCT02447952|9767335|P1|Overall Study|Physician Decision|1
2844888|NCT02447952|9767335|P1|Overall Study|Adverse Event|2
2844889|NCT02447887|9767392|P1|Overall Study|Study was terminated|3
2844890|NCT02447848|9767405|P1|Overall Study|Withdrawal by Subject|4
2844891|NCT02447848|9767405|P1|Overall Study|Lack of Efficacy|4
2844892|NCT02447848|9767405|P1|Overall Study|Patient discharged|3
2844893|NCT02447458|9767417|P6|Overall Study|Other|0
2844894|NCT02447458|9767418|P5|Overall Study|Other|0
2844895|NCT02447458|9767419|P4|Overall Study|Other|0
2844896|NCT02447458|9767420|P3|Overall Study|Other|1
2844897|NCT02447458|9767421|P2|Overall Study|Other|0
2844898|NCT02447458|9767422|P1|Overall Study|Other|0
2844899|NCT02447432|9767520|P2|Epoch 001|Lost to Follow-up|3
2844900|NCT02447432|9767521|P1|Epoch 001|Lost to Follow-up|1
2844901|NCT02447432|9767520|P2|Epoch 001|Migrated/moved from study area|5
2844902|NCT02447432|9767521|P1|Epoch 001|Migrated/moved from study area|3
2844903|NCT02447432|9767520|P2|Epoch 001|Withdrawal by Subject|4
2844904|NCT02447432|9767521|P1|Epoch 001|Withdrawal by Subject|0
2844905|NCT02447432|9767520|P2|Epoch 001|Adverse Event|1
2844906|NCT02447432|9767521|P1|Epoch 001|Adverse Event|1
2844907|NCT02447328|9767553|P1|Overall Study|Withdrawal by Subject|1
2844908|NCT02447250|9767557|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
2844909|NCT02447250|9767557|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
2844910|NCT02447250|9767557|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
2844911|NCT02447081|9767574|P1|Overall Study|unsuccessful implant procedure|10
2844912|NCT02447081|9767574|P1|Overall Study|Visit not completed|17
2844913|NCT02447081|9767574|P1|Overall Study|Lost to Follow-up|36
2844914|NCT02447081|9767574|P1|Overall Study|Death|161
2844915|NCT02447029|9767590|P2|Overall Study|Withdrawal by Subject|2
2844916|NCT02447029|9767591|P1|Overall Study|Withdrawal by Subject|3
2844917|NCT02446990|9767611|P2|Overall Study|Withdrawal by Subject|199
2844918|NCT02446990|9767612|P1|Overall Study|Withdrawal by Subject|231
2844919|NCT02446990|9767611|P2|Overall Study|Physician Decision|0
2844920|NCT02446990|9767612|P1|Overall Study|Physician Decision|1
2844921|NCT02446990|9767611|P2|Overall Study|Lost to Follow-up|1
2844922|NCT02446990|9767612|P1|Overall Study|Lost to Follow-up|3
2844923|NCT02446990|9767611|P2|Overall Study|Death|458
2844924|NCT02446990|9767612|P1|Overall Study|Death|485
2844925|NCT02446912|9767647|P3|Overall Study|Miscellaneous|4
2844926|NCT02446912|9767648|P2|Overall Study|Miscellaneous|2
2844927|NCT02446912|9767649|P1|Overall Study|Miscellaneous|2
2844928|NCT02446912|9767647|P3|Overall Study|Withdrawal by Subject|15
2844929|NCT02446912|9767648|P2|Overall Study|Withdrawal by Subject|15
2844930|NCT02446912|9767649|P1|Overall Study|Withdrawal by Subject|10
2844931|NCT02446912|9767647|P3|Overall Study|Severe non-compliance to protocol|1
2844932|NCT02446912|9767648|P2|Overall Study|Severe non-compliance to protocol|0
2844933|NCT02446912|9767649|P1|Overall Study|Severe non-compliance to protocol|1
2844934|NCT02446912|9767647|P3|Overall Study|Lost to Follow-up|2
2844935|NCT02446912|9767648|P2|Overall Study|Lost to Follow-up|0
2844936|NCT02446912|9767649|P1|Overall Study|Lost to Follow-up|0
2844937|NCT02446912|9767647|P3|Overall Study|Lack of Efficacy|7
2844938|NCT02446912|9767648|P2|Overall Study|Lack of Efficacy|4
2844939|NCT02446912|9767649|P1|Overall Study|Lack of Efficacy|1
2844940|NCT02446912|9767647|P3|Overall Study|Study-specific withdrawal criteria|0
2844941|NCT02446912|9767648|P2|Overall Study|Study-specific withdrawal criteria|0
2844942|NCT02446912|9767649|P1|Overall Study|Study-specific withdrawal criteria|1
2844943|NCT02446912|9767647|P3|Overall Study|Condition under investigation worsened|1
2844944|NCT02446912|9767648|P2|Overall Study|Condition under investigation worsened|1
2844945|NCT02446912|9767649|P1|Overall Study|Condition under investigation worsened|0
2844946|NCT02446912|9767647|P3|Overall Study|Adverse Event|5
2844947|NCT02446912|9767648|P2|Overall Study|Adverse Event|13
2844948|NCT02446912|9767649|P1|Overall Study|Adverse Event|3
2844949|NCT02446899|9767722|P2|Overall Study|Failure to Meet Randomization Criteria|2
2844950|NCT02446899|9767723|P1|Overall Study|Failure to Meet Randomization Criteria|0
2844951|NCT02446899|9767722|P2|Overall Study|Miscellaneous|4
2844952|NCT02446899|9767723|P1|Overall Study|Miscellaneous|5
2844953|NCT02446899|9767722|P2|Overall Study|Withdrawal by Subject|19
2844954|NCT02446899|9767723|P1|Overall Study|Withdrawal by Subject|11
2844955|NCT02446899|9767722|P2|Overall Study|Severe Non-Compliance to Protocol|1
2844956|NCT02446899|9767723|P1|Overall Study|Severe Non-Compliance to Protocol|0
2844957|NCT02446899|9767722|P2|Overall Study|Lost to Follow-up|3
2844958|NCT02446899|9767723|P1|Overall Study|Lost to Follow-up|1
2844959|NCT02446899|9767722|P2|Overall Study|Lack of Efficacy|8
2844960|NCT02446899|9767723|P1|Overall Study|Lack of Efficacy|2
2844961|NCT02446899|9767722|P2|Overall Study|Study Specific Withdrawal Criteria|0
2844962|NCT02446899|9767723|P1|Overall Study|Study Specific Withdrawal Criteria|1
2844963|NCT02446899|9767722|P2|Overall Study|Condition Under Investigation Worsened|4
2844964|NCT02446899|9767723|P1|Overall Study|Condition Under Investigation Worsened|1
2844965|NCT02446899|9767722|P2|Overall Study|Adverse Event|7
2844966|NCT02446899|9767723|P1|Overall Study|Adverse Event|4
2844967|NCT02446769|9767747|P3|Study Period|Randomized in Error|0
2844968|NCT02446769|9767748|P2|Study Period|Randomized in Error|2
2844969|NCT02446769|9767749|P1|Study Period|Randomized in Error|0
2844970|NCT02446769|9767747|P3|Screening Period|Screen Failure|0
2844971|NCT02446769|9767748|P2|Screening Period|Screen Failure|0
2844972|NCT02446769|9767749|P1|Screening Period|Screen Failure|11
2844973|NCT02446743|9767770|P2|Overall Study|Other|3
2844974|NCT02446743|9767771|P1|Overall Study|Other|2
2844975|NCT02446743|9767770|P2|Overall Study|Adverse Event|1
2844976|NCT02446743|9767771|P1|Overall Study|Adverse Event|1
2844977|NCT02446743|9767770|P2|Overall Study|Lost to Follow-up|0
2844978|NCT02446743|9767771|P1|Overall Study|Lost to Follow-up|1
2844979|NCT02446743|9767770|P2|Overall Study|Withdrawal by Subject|1
2844980|NCT02446743|9767771|P1|Overall Study|Withdrawal by Subject|1
2844981|NCT02446717|9767926|P5|Overall Study|Withdrew consent|0
2844982|NCT02446717|9767927|P4|Overall Study|Withdrew consent|1
2844983|NCT02446717|9767928|P3|Overall Study|Withdrew consent|0
2844984|NCT02446717|9767929|P2|Overall Study|Withdrew consent|0
2844985|NCT02446717|9767930|P1|Overall Study|Withdrew consent|0
2844986|NCT02446717|9767926|P5|Overall Study|Lost to Follow-up|1
2844987|NCT02446717|9767927|P4|Overall Study|Lost to Follow-up|0
2844988|NCT02446717|9767928|P3|Overall Study|Lost to Follow-up|1
2844989|NCT02446717|9767929|P2|Overall Study|Lost to Follow-up|1
2844990|NCT02446717|9767930|P1|Overall Study|Lost to Follow-up|0
2844991|NCT02446717|9767926|P5|Overall Study|Adverse Event|0
2844992|NCT02446717|9767927|P4|Overall Study|Adverse Event|0
2844993|NCT02446717|9767928|P3|Overall Study|Adverse Event|1
2844994|NCT02446717|9767929|P2|Overall Study|Adverse Event|0
2844995|NCT02446717|9767930|P1|Overall Study|Adverse Event|0
2844996|NCT02446691|9767957|P1|Overall Study|Protocol Violation|1
2844997|NCT02446691|9767957|P1|Overall Study|Lost to Follow-up|8
2844998|NCT02446691|9767957|P1|Overall Study|Withdrawal by Subject|2
2844999|NCT02446418|9768027|P2|Overall Study|Protocol defined stopping criteria reach|0
2845000|NCT02446418|9768028|P1|Overall Study|Protocol defined stopping criteria reach|1
2845001|NCT02446418|9768027|P2|Overall Study|Lack of Efficacy|0
2845002|NCT02446418|9768028|P1|Overall Study|Lack of Efficacy|2
2845003|NCT02446418|9768027|P2|Overall Study|Protocol Violation|2
2845004|NCT02446418|9768028|P1|Overall Study|Protocol Violation|1
2845005|NCT02446418|9768027|P2|Overall Study|Lost to Follow-up|2
2845006|NCT02446418|9768028|P1|Overall Study|Lost to Follow-up|2
2845007|NCT02446418|9768027|P2|Overall Study|Withdrawal by Subject|3
2845008|NCT02446418|9768028|P1|Overall Study|Withdrawal by Subject|3
2845009|NCT02446418|9768027|P2|Overall Study|Physician Decision|1
2845010|NCT02446418|9768028|P1|Overall Study|Physician Decision|5
2845011|NCT02446418|9768027|P2|Overall Study|Adverse Event|8
2845012|NCT02446418|9768028|P1|Overall Study|Adverse Event|4
2845013|NCT02446171|9768099|P4|Overall Study|Withdrawal by Subject|0
2845014|NCT02446171|9768100|P3|Overall Study|Withdrawal by Subject|2
2845015|NCT02446171|9768101|P2|Overall Study|Withdrawal by Subject|0
2845016|NCT02446171|9768102|P1|Overall Study|Withdrawal by Subject|0
2845017|NCT02446015|9768173|P2|Overall Study|Withdrawal by Subject|0
2845018|NCT02446015|9768174|P1|Overall Study|Withdrawal by Subject|1
2845019|NCT02446015|9768173|P2|Overall Study|Adverse Event|1
2845020|NCT02446015|9768174|P1|Overall Study|Adverse Event|0
2845021|NCT02445755|9768284|P1|Overall Study|Screen Failure|5
2845022|NCT02445755|9768284|P1|Overall Study|Protocol Violation|6
2845023|NCT02445755|9768284|P1|Overall Study|Withdrawal by Subject|2
2845024|NCT02445586|9768298|P1|Overall Study|Medical Condition|1
2845025|NCT02445586|9768298|P1|Overall Study|Protocol Violation|1
2845026|NCT02445586|9768298|P1|Overall Study|Disease Progression|10
2845027|NCT02445586|9768298|P1|Overall Study|Withdrawal by Subject|13
2845028|NCT02445586|9768298|P1|Overall Study|Death|14
2845029|NCT02445573|9768338|P2|Overall Study|Lost to Follow-up|1
2845030|NCT02445573|9768339|P1|Overall Study|Lost to Follow-up|0
2845031|NCT02445573|9768338|P2|Overall Study|Withdrawal by Subject|1
2845032|NCT02445573|9768339|P1|Overall Study|Withdrawal by Subject|1
2845033|NCT02444793|9768436|P4|Overall Study|Objective progression or relapse|3
2845034|NCT02444793|9768437|P3|Overall Study|Objective progression or relapse|2
2845035|NCT02444793|9768438|P2|Overall Study|Objective progression or relapse|1
2845036|NCT02444793|9768439|P1|Overall Study|Objective progression or relapse|9
2845037|NCT02444793|9768436|P4|Overall Study|Other|0
2845038|NCT02444793|9768437|P3|Overall Study|Other|2
2845039|NCT02444793|9768438|P2|Overall Study|Other|0
2845040|NCT02444793|9768439|P1|Overall Study|Other|0
2845041|NCT02444793|9768436|P4|Overall Study|Death|0
2845042|NCT02444793|9768437|P3|Overall Study|Death|0
2845043|NCT02444793|9768438|P2|Overall Study|Death|3
2845044|NCT02444793|9768439|P1|Overall Study|Death|0
2845045|NCT02444793|9768436|P4|Overall Study|Lost to Follow-up|0
2845046|NCT02444793|9768437|P3|Overall Study|Lost to Follow-up|0
2845047|NCT02444793|9768438|P2|Overall Study|Lost to Follow-up|2
2845048|NCT02444793|9768439|P1|Overall Study|Lost to Follow-up|2
2845049|NCT02444533|9768598|P2|Overall Study|Only gave post-procedure complications|2
2845050|NCT02444533|9768599|P1|Overall Study|Only gave post-procedure complications|2
2845051|NCT02444533|9768598|P2|Overall Study|Not able to complete forms|2
2845052|NCT02444533|9768599|P1|Overall Study|Not able to complete forms|0
2845053|NCT02444182|9768632|P2|Overall Study|Lost to Follow-up|4
2845054|NCT02444182|9768633|P1|Overall Study|Lost to Follow-up|0
2845055|NCT02444182|9768632|P2|Overall Study|non-compliance|1
2845056|NCT02444182|9768633|P1|Overall Study|non-compliance|2
2845057|NCT02443883|9768656|P4|Overall Study|Randomized, but never treated|1
2845058|NCT02443883|9768657|P3|Overall Study|Randomized, but never treated|1
2845059|NCT02443883|9768658|P2|Overall Study|Randomized, but never treated|0
2845060|NCT02443883|9768659|P1|Overall Study|Randomized, but never treated|2
2845061|NCT02443883|9768656|P4|Overall Study|Withdrawal by Subject|1
2845062|NCT02443883|9768657|P3|Overall Study|Withdrawal by Subject|2
2845063|NCT02443883|9768658|P2|Overall Study|Withdrawal by Subject|0
2845064|NCT02443883|9768659|P1|Overall Study|Withdrawal by Subject|1
2845065|NCT02443883|9768656|P4|Overall Study|Physician Decision|3
2845066|NCT02443883|9768657|P3|Overall Study|Physician Decision|0
2845067|NCT02443883|9768658|P2|Overall Study|Physician Decision|1
2845068|NCT02443883|9768659|P1|Overall Study|Physician Decision|2
2845069|NCT02443883|9768656|P4|Overall Study|Lost to Follow-up|0
2845070|NCT02443883|9768657|P3|Overall Study|Lost to Follow-up|0
2845071|NCT02443883|9768658|P2|Overall Study|Lost to Follow-up|2
2845072|NCT02443883|9768659|P1|Overall Study|Lost to Follow-up|1
2845073|NCT02443883|9768656|P4|Overall Study|Adverse Event|2
2845074|NCT02443883|9768657|P3|Overall Study|Adverse Event|1
2845075|NCT02443883|9768658|P2|Overall Study|Adverse Event|2
2845076|NCT02443883|9768659|P1|Overall Study|Adverse Event|0
2845077|NCT02443805|9768679|P2|Overall Study|Any other reason not above-mentioned|2
2845078|NCT02443805|9768680|P1|Overall Study|Any other reason not above-mentioned|3
2845079|NCT02443805|9768679|P2|Overall Study|Withdrawal by parent/guardian|5
2845080|NCT02443805|9768680|P1|Overall Study|Withdrawal by parent/guardian|3
2845081|NCT02443805|9768679|P2|Overall Study|Non-compliance with study drug|4
2845082|NCT02443805|9768680|P1|Overall Study|Non-compliance with study drug|6
2845083|NCT02443805|9768679|P2|Overall Study|Lack of Efficacy|1
2845084|NCT02443805|9768680|P1|Overall Study|Lack of Efficacy|1
2845085|NCT02443805|9768679|P2|Overall Study|Protocol Violation|4
2845086|NCT02443805|9768680|P1|Overall Study|Protocol Violation|2
2845087|NCT02443805|9768679|P2|Overall Study|Pregnancy|5
2845088|NCT02443805|9768680|P1|Overall Study|Pregnancy|6
2845089|NCT02443805|9768679|P2|Overall Study|Lost to Follow-up|14
2845090|NCT02443805|9768680|P1|Overall Study|Lost to Follow-up|19
2845091|NCT02443805|9768679|P2|Overall Study|Withdrawal by Subject|74
2845092|NCT02443805|9768680|P1|Overall Study|Withdrawal by Subject|73
2845093|NCT02443805|9768679|P2|Overall Study|Adverse Event|18
2845094|NCT02443805|9768680|P1|Overall Study|Adverse Event|100
2845095|NCT02443740|9768711|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845096|NCT02443740|9768712|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845097|NCT02443740|9768713|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845098|NCT02443740|9768714|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845099|NCT02443740|9768715|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845100|NCT02443740|9768716|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
2845101|NCT02443740|9768717|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845102|NCT02443740|9768718|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845103|NCT02443740|9768719|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845104|NCT02443740|9768720|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845105|NCT02443740|9768721|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2845106|NCT02443740|9768711|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
2845107|NCT02443740|9768712|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
2845108|NCT02443740|9768713|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
2845109|NCT02443740|9768714|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
2845110|NCT02443740|9768715|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
2845111|NCT02443740|9768716|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
2845112|NCT02443740|9768717|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
2845113|NCT02443740|9768718|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
2845114|NCT02443740|9768719|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
2845115|NCT02443740|9768720|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
2845116|NCT02443740|9768721|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
2845117|NCT02443740|9768711|P11|Intervention Period 1 (3 Days)|Adverse Event|0
2845118|NCT02443740|9768712|P10|Intervention Period 1 (3 Days)|Adverse Event|0
2845119|NCT02443740|9768713|P9|Intervention Period 1 (3 Days)|Adverse Event|0
2845120|NCT02443740|9768714|P8|Intervention Period 1 (3 Days)|Adverse Event|0
2845121|NCT02443740|9768715|P7|Intervention Period 1 (3 Days)|Adverse Event|0
2845122|NCT02443740|9768716|P6|Intervention Period 1 (3 Days)|Adverse Event|1
2845123|NCT02443740|9768717|P5|Intervention Period 1 (3 Days)|Adverse Event|0
2845124|NCT02443740|9768718|P4|Intervention Period 1 (3 Days)|Adverse Event|0
2845125|NCT02443740|9768719|P3|Intervention Period 1 (3 Days)|Adverse Event|0
2845126|NCT02443740|9768720|P2|Intervention Period 1 (3 Days)|Adverse Event|0
2845127|NCT02443740|9768721|P1|Intervention Period 1 (3 Days)|Adverse Event|0
2845128|NCT02443688|9768903|P3|Overall Study|Sponsor Request|0
2845129|NCT02443688|9768904|P2|Overall Study|Sponsor Request|1
2845130|NCT02443688|9768905|P1|Overall Study|Sponsor Request|2
2845131|NCT02443688|9768903|P3|Overall Study|Non-compliance with study drug|4
2845132|NCT02443688|9768904|P2|Overall Study|Non-compliance with study drug|2
2845133|NCT02443688|9768905|P1|Overall Study|Non-compliance with study drug|1
2845134|NCT02443688|9768903|P3|Overall Study|Withdrawal by Subject|4
2845135|NCT02443688|9768904|P2|Overall Study|Withdrawal by Subject|3
2845136|NCT02443688|9768905|P1|Overall Study|Withdrawal by Subject|3
2845137|NCT02443688|9768903|P3|Overall Study|Pregnancy|1
2845138|NCT02443688|9768904|P2|Overall Study|Pregnancy|0
2845139|NCT02443688|9768905|P1|Overall Study|Pregnancy|0
2845140|NCT02443688|9768903|P3|Overall Study|Physician Decision|1
2845141|NCT02443688|9768904|P2|Overall Study|Physician Decision|0
2845142|NCT02443688|9768905|P1|Overall Study|Physician Decision|3
2845143|NCT02443688|9768903|P3|Overall Study|Lost to Follow-up|0
2845144|NCT02443688|9768904|P2|Overall Study|Lost to Follow-up|0
2845145|NCT02443688|9768905|P1|Overall Study|Lost to Follow-up|1
2845146|NCT02443688|9768903|P3|Overall Study|Adverse Event|2
2845147|NCT02443688|9768904|P2|Overall Study|Adverse Event|3
2845148|NCT02443688|9768905|P1|Overall Study|Adverse Event|2
2845149|NCT02443402|9768984|P2|Overall Study|Screen Failure|2
2845150|NCT02443402|9768985|P1|Overall Study|Screen Failure|1
2845151|NCT02443402|9768984|P2|Overall Study|Withdrawal by Subject|1
2845152|NCT02443402|9768985|P1|Overall Study|Withdrawal by Subject|3
2845153|NCT02443298|9769047|P2|Overall Study|Withdrawal by Subject|2
2845154|NCT02443298|9769048|P1|Overall Study|Withdrawal by Subject|1
2845155|NCT02443298|9769047|P2|Overall Study|Adverse Event|3
2845156|NCT02443298|9769048|P1|Overall Study|Adverse Event|3
2845157|NCT02443103|9769068|P1|Overall Study|Noncompliance|1
2845158|NCT02443103|9769068|P1|Overall Study|Adverse Event|2
2845159|NCT02442830|9769081|P2|Overall Study|Technical Failure|1
2845160|NCT02442830|9769082|P1|Overall Study|Technical Failure|0
2845161|NCT02442804|9769092|P2|Overall Study|Adverse Event|0
2845162|NCT02442804|9769093|P1|Overall Study|Adverse Event|1
2845163|NCT02442804|9769092|P2|Overall Study|Withdrawal by Subject|1
2845164|NCT02442804|9769093|P1|Overall Study|Withdrawal by Subject|0
2845165|NCT02442349|9769198|P1|Overall Study|On-going Study at Data Cut-off|149
2845166|NCT02442349|9769198|P1|Overall Study|Withdrawal by Subject|8
2845167|NCT02442349|9769198|P1|Overall Study|Death|14
2845168|NCT02442310|9769203|P1|Overall Study|Withdrawal by Subject|1
2845169|NCT02442310|9769203|P1|Overall Study|Adverse Event|2
2845170|NCT02442284|9769225|P1|Overall Study|Other|1
2845171|NCT02442284|9769225|P1|Overall Study|Lost to Follow-up|3
2845172|NCT02442284|9769225|P1|Overall Study|Withdrew Consent|2
2845173|NCT02442284|9769225|P1|Overall Study|Adverse Event|1
2845174|NCT02442271|9769232|P1|Overall Study|Other|1
2845175|NCT02442271|9769232|P1|Overall Study|Lost to Follow-up|1
2845176|NCT02442271|9769232|P1|Overall Study|Withdrew Consent|1
2845177|NCT02442271|9769232|P1|Overall Study|Adverse Event|1
2845178|NCT02442206|9769258|P2|Period 2|Adverse Event|0
2845179|NCT02442206|9769259|P1|Period 2|Adverse Event|1
2845180|NCT02442206|9769258|P2|Period 1|COPD exacerbation|1
2845181|NCT02442206|9769259|P1|Period 1|COPD exacerbation|0
2845182|NCT02442206|9769258|P2|Period 1|withdrew consent|1
2845183|NCT02442206|9769259|P1|Period 1|withdrew consent|0
2845184|NCT02442206|9769258|P2|Period 1|Adverse Event|1
2845185|NCT02442206|9769259|P1|Period 1|Adverse Event|1
2845186|NCT02441946|9769291|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
2845187|NCT02441946|9769292|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
2845188|NCT02441946|9769293|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
2845189|NCT02441946|9769291|P3|Extension Period (8 Weeks)|Adverse Event|0
2845190|NCT02441946|9769292|P2|Extension Period (8 Weeks)|Adverse Event|0
2845191|NCT02441946|9769293|P1|Extension Period (8 Weeks)|Adverse Event|1
2845192|NCT02441946|9769291|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2845193|NCT02441946|9769292|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2845194|NCT02441946|9769293|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
2845195|NCT02441946|9769291|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2845196|NCT02441946|9769292|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2845197|NCT02441946|9769293|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
2845198|NCT02441946|9769291|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2845199|NCT02441946|9769292|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2845200|NCT02441946|9769293|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
2845201|NCT02441946|9769291|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2845202|NCT02441946|9769292|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2845203|NCT02441946|9769293|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
2845204|NCT02441946|9769291|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2845205|NCT02441946|9769292|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2845206|NCT02441946|9769293|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
2845207|NCT02441946|9769291|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2845208|NCT02441946|9769292|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
2845209|NCT02441946|9769293|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2845210|NCT02441946|9769291|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2845211|NCT02441946|9769292|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
2845212|NCT02441946|9769293|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2845213|NCT02441946|9769291|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2845214|NCT02441946|9769292|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2845215|NCT02441946|9769293|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
2845216|NCT02441946|9769291|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
2845217|NCT02441946|9769292|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2845218|NCT02441946|9769293|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2845219|NCT02441517|9769314|P1|Overall Study|Study Terminated by Sponsor|1
2845220|NCT02441517|9769314|P1|Overall Study|Withdrawal by Subject|2
2845221|NCT02441517|9769314|P1|Overall Study|Lost to Follow-up|1
2845222|NCT02441309|9769327|P3|Overall Study|Withdrawal by Subject|1
2845223|NCT02441309|9769328|P2|Overall Study|Withdrawal by Subject|0
2845224|NCT02441309|9769329|P1|Overall Study|Withdrawal by Subject|1
2845225|NCT02441309|9769327|P3|Overall Study|Adverse Event|0
2845226|NCT02441309|9769328|P2|Overall Study|Adverse Event|1
2845227|NCT02441309|9769329|P1|Overall Study|Adverse Event|0
2845228|NCT02441309|9769327|P3|Overall Study|Disease progression|2
2845229|NCT02441309|9769328|P2|Overall Study|Disease progression|1
2845230|NCT02441309|9769329|P1|Overall Study|Disease progression|2
2845231|NCT02441218|9769360|P2|Overall Study|Lost to Follow-up|1
2845232|NCT02441218|9769361|P1|Overall Study|Lost to Follow-up|2
2845233|NCT02441218|9769360|P2|Overall Study|Withdrawal by Subject|58
2845234|NCT02441218|9769361|P1|Overall Study|Withdrawal by Subject|73
2845235|NCT02441218|9769360|P2|Overall Study|Death|553
2845236|NCT02441218|9769361|P1|Overall Study|Death|503
2845237|NCT02441179|9769387|P2|Overall Study|Withdrawal by Subject|1
2845238|NCT02441179|9769388|P1|Overall Study|Withdrawal by Subject|1
2845239|NCT02441114|9769406|P1|Washout2|Withdrawal by Subject|4
2845240|NCT02441036|9769417|P5|Overall Study|No tissue resected|0
2845241|NCT02441036|9769418|P4|Overall Study|No tissue resected|1
2845242|NCT02441036|9769419|P3|Overall Study|No tissue resected|0
2845243|NCT02441036|9769420|P2|Overall Study|No tissue resected|1
2845244|NCT02441036|9769421|P1|Overall Study|No tissue resected|0
2845245|NCT02440789|9769448|P1|Overall Study|Not willing to adhere to reqs|1
2845246|NCT02440789|9769448|P1|Overall Study|Withdrawal by Subject|3
2845247|NCT02440594|9769523|P8|Overall Study|Administratively w/drawn|1
2845248|NCT02440594|9769524|P7|Overall Study|Administratively w/drawn|2
2845249|NCT02440594|9769525|P6|Overall Study|Administratively w/drawn|0
2845250|NCT02440594|9769526|P5|Overall Study|Administratively w/drawn|0
2845251|NCT02440594|9769527|P4|Overall Study|Administratively w/drawn|0
2845252|NCT02440594|9769528|P3|Overall Study|Administratively w/drawn|0
2845253|NCT02440594|9769529|P2|Overall Study|Administratively w/drawn|2
2845254|NCT02440594|9769530|P1|Overall Study|Administratively w/drawn|3
2845255|NCT02440594|9769523|P8|Overall Study|Withdrawal by Subject|7
2845256|NCT02440594|9769524|P7|Overall Study|Withdrawal by Subject|7
2845257|NCT02440594|9769525|P6|Overall Study|Withdrawal by Subject|2
2845258|NCT02440594|9769526|P5|Overall Study|Withdrawal by Subject|2
2845259|NCT02440594|9769527|P4|Overall Study|Withdrawal by Subject|38
2845260|NCT02440594|9769528|P3|Overall Study|Withdrawal by Subject|59
2845261|NCT02440594|9769529|P2|Overall Study|Withdrawal by Subject|67
2845262|NCT02440594|9769530|P1|Overall Study|Withdrawal by Subject|81
2845263|NCT02440594|9769523|P8|Overall Study|Cognitive Impairment/Communication Issue|0
2845264|NCT02440594|9769524|P7|Overall Study|Cognitive Impairment/Communication Issue|0
2845265|NCT02440594|9769525|P6|Overall Study|Cognitive Impairment/Communication Issue|1
2845266|NCT02440594|9769526|P5|Overall Study|Cognitive Impairment/Communication Issue|2
2845267|NCT02440594|9769527|P4|Overall Study|Cognitive Impairment/Communication Issue|4
2845268|NCT02440594|9769528|P3|Overall Study|Cognitive Impairment/Communication Issue|4
2845269|NCT02440594|9769529|P2|Overall Study|Cognitive Impairment/Communication Issue|6
2845270|NCT02440594|9769530|P1|Overall Study|Cognitive Impairment/Communication Issue|14
2845271|NCT02440594|9769523|P8|Overall Study|Lost to Follow-up|48
2845272|NCT02440594|9769524|P7|Overall Study|Lost to Follow-up|28
2845273|NCT02440594|9769525|P6|Overall Study|Lost to Follow-up|4
2845274|NCT02440594|9769526|P5|Overall Study|Lost to Follow-up|5
2845275|NCT02440594|9769527|P4|Overall Study|Lost to Follow-up|47
2845276|NCT02440594|9769528|P3|Overall Study|Lost to Follow-up|54
2845277|NCT02440594|9769529|P2|Overall Study|Lost to Follow-up|33
2845278|NCT02440594|9769530|P1|Overall Study|Lost to Follow-up|34
2845279|NCT02439320|9769647|P3|Overall Study|Randomization Failure|34
2845280|NCT02439320|9769648|P2|Overall Study|Randomization Failure|46
2845281|NCT02439320|9769649|P1|Overall Study|Randomization Failure|35
2845282|NCT02439320|9769647|P3|Overall Study|Sponsor Request|1
2845283|NCT02439320|9769648|P2|Overall Study|Sponsor Request|2
2845284|NCT02439320|9769649|P1|Overall Study|Sponsor Request|0
2845285|NCT02439320|9769647|P3|Overall Study|Physician Decision|0
2845286|NCT02439320|9769648|P2|Overall Study|Physician Decision|1
2845287|NCT02439320|9769649|P1|Overall Study|Physician Decision|2
2845288|NCT02439320|9769647|P3|Overall Study|Withdrawal by Subject|14
2845289|NCT02439320|9769648|P2|Overall Study|Withdrawal by Subject|16
2845290|NCT02439320|9769649|P1|Overall Study|Withdrawal by Subject|12
2845291|NCT02439320|9769647|P3|Overall Study|Pregnancy|1
2845292|NCT02439320|9769648|P2|Overall Study|Pregnancy|1
2845293|NCT02439320|9769649|P1|Overall Study|Pregnancy|0
2845294|NCT02439320|9769647|P3|Overall Study|Noncompliance with Protocol|7
2845295|NCT02439320|9769648|P2|Overall Study|Noncompliance with Protocol|11
2845296|NCT02439320|9769649|P1|Overall Study|Noncompliance with Protocol|10
2845297|NCT02439320|9769647|P3|Overall Study|Death|0
2845298|NCT02439320|9769648|P2|Overall Study|Death|1
2845299|NCT02439320|9769649|P1|Overall Study|Death|0
2845300|NCT02439320|9769647|P3|Overall Study|Lost to Follow-up|42
2845301|NCT02439320|9769648|P2|Overall Study|Lost to Follow-up|34
2845302|NCT02439320|9769649|P1|Overall Study|Lost to Follow-up|37
2845303|NCT02439320|9769647|P3|Overall Study|Adverse Event|0
2845304|NCT02439320|9769648|P2|Overall Study|Adverse Event|2
2845305|NCT02439320|9769649|P1|Overall Study|Adverse Event|0
2845306|NCT02439138|9769729|P1|Overall Study|PI decision to terminate the study|2
2845307|NCT02439138|9769729|P1|Overall Study|Adverse Event|1
2845308|NCT02438826|9769742|P2|Overall Study|Screen Failure|0
2845309|NCT02438826|9769743|P1|Overall Study|Screen Failure|2
2845310|NCT02438826|9769742|P2|Overall Study|Protocol Violation|2
2845311|NCT02438826|9769743|P1|Overall Study|Protocol Violation|1
2845312|NCT02438826|9769742|P2|Overall Study|Withdrawal by Subject|1
2845313|NCT02438826|9769743|P1|Overall Study|Withdrawal by Subject|1
2845314|NCT02438826|9769742|P2|Overall Study|Lack of Efficacy|0
2845315|NCT02438826|9769743|P1|Overall Study|Lack of Efficacy|1
2845316|NCT02438826|9769742|P2|Overall Study|Adverse Event|1
2845317|NCT02438826|9769743|P1|Overall Study|Adverse Event|1
2845318|NCT02438813|9769771|P1|Overall Study|Patients Not Treated/No EOT Visit|249
2845319|NCT02438813|9769771|P1|Overall Study|Study Ended by Sponsor|80
2845320|NCT02438813|9769771|P1|Overall Study|Patient Lost to Follow-Up|137
2845321|NCT02438813|9769771|P1|Overall Study|Patient Decision|59
2845322|NCT02438787|9769823|P3|Overall Study|Site terminated by sponsor|1
2845323|NCT02438787|9769824|P2|Overall Study|Site terminated by sponsor|0
2845324|NCT02438787|9769825|P1|Overall Study|Site terminated by sponsor|0
2845325|NCT02438787|9769823|P3|Overall Study|Other|0
2845326|NCT02438787|9769824|P2|Overall Study|Other|1
2845327|NCT02438787|9769825|P1|Overall Study|Other|0
2845328|NCT02438787|9769823|P3|Overall Study|Study discontinued by sponsor|69
2845329|NCT02438787|9769824|P2|Overall Study|Study discontinued by sponsor|72
2845330|NCT02438787|9769825|P1|Overall Study|Study discontinued by sponsor|64
2845331|NCT02438787|9769823|P3|Overall Study|Withdrawal by Subject|10
2845332|NCT02438787|9769824|P2|Overall Study|Withdrawal by Subject|7
2845333|NCT02438787|9769825|P1|Overall Study|Withdrawal by Subject|15
2845334|NCT02438787|9769823|P3|Overall Study|Protocol Violation|1
2845335|NCT02438787|9769824|P2|Overall Study|Protocol Violation|0
2845336|NCT02438787|9769825|P1|Overall Study|Protocol Violation|0
2845337|NCT02438787|9769823|P3|Overall Study|Lost to Follow-up|0
2845338|NCT02438787|9769824|P2|Overall Study|Lost to Follow-up|1
2845339|NCT02438787|9769825|P1|Overall Study|Lost to Follow-up|0
2845340|NCT02438787|9769823|P3|Overall Study|Lack of Efficacy|0
2845341|NCT02438787|9769824|P2|Overall Study|Lack of Efficacy|2
2845342|NCT02438787|9769825|P1|Overall Study|Lack of Efficacy|1
2845343|NCT02438787|9769823|P3|Overall Study|Adverse Event|2
2845344|NCT02438787|9769824|P2|Overall Study|Adverse Event|0
2845345|NCT02438787|9769825|P1|Overall Study|Adverse Event|1
2845346|NCT02438384|9769945|P3|Overall Study|Lost to Follow-up|4
2845347|NCT02438384|9769946|P2|Overall Study|Lost to Follow-up|6
2845348|NCT02438384|9769947|P1|Overall Study|Lost to Follow-up|8
2845349|NCT02438280|9769966|P2|Overall Study|Physician Decision|0
2845350|NCT02438280|9769967|P1|Overall Study|Physician Decision|1
2845351|NCT02438137|9769977|P2|Overall Study|Physician Decision|1
2845352|NCT02438137|9769978|P1|Overall Study|Physician Decision|0
2845353|NCT02438137|9769977|P2|Overall Study|Withdrawal by Subject|3
2845354|NCT02438137|9769978|P1|Overall Study|Withdrawal by Subject|4
2845355|NCT02438137|9769977|P2|Overall Study|Adverse Event|0
2845356|NCT02438137|9769978|P1|Overall Study|Adverse Event|1
2845357|NCT02438137|9769977|P2|Overall Study|Lost to Follow-up|2
2845358|NCT02438137|9769978|P1|Overall Study|Lost to Follow-up|3
2845359|NCT02437903|9769986|P1|Overall Study|Lost to Follow-up|3
2845360|NCT02437903|9769986|P1|Overall Study|Withdrawal by Subject|1
2845361|NCT02437903|9769986|P1|Overall Study|Adverse Event|1
2845362|NCT02437890|9769999|P5|Overall Study|Death|0
2845363|NCT02437890|9770000|P4|Overall Study|Death|2
2845364|NCT02437890|9770001|P3|Overall Study|Death|0
2845365|NCT02437890|9770002|P2|Overall Study|Death|0
2845366|NCT02437890|9770003|P1|Overall Study|Death|0
2845367|NCT02437890|9769999|P5|Overall Study|Withdrawal by Subject|5
2845368|NCT02437890|9770000|P4|Overall Study|Withdrawal by Subject|5
2845369|NCT02437890|9770001|P3|Overall Study|Withdrawal by Subject|6
2845370|NCT02437890|9770002|P2|Overall Study|Withdrawal by Subject|2
2845371|NCT02437890|9770003|P1|Overall Study|Withdrawal by Subject|1
2845372|NCT02437890|9769999|P5|Overall Study|Adverse Event|7
2845373|NCT02437890|9770000|P4|Overall Study|Adverse Event|11
2845374|NCT02437890|9770001|P3|Overall Study|Adverse Event|5
2845375|NCT02437890|9770002|P2|Overall Study|Adverse Event|9
2845376|NCT02437890|9770003|P1|Overall Study|Adverse Event|4
2845377|NCT02437890|9769999|P5|Overall Study|Lack of Efficacy|1
2845378|NCT02437890|9770000|P4|Overall Study|Lack of Efficacy|3
2845379|NCT02437890|9770001|P3|Overall Study|Lack of Efficacy|0
2845380|NCT02437890|9770002|P2|Overall Study|Lack of Efficacy|3
2845381|NCT02437890|9770003|P1|Overall Study|Lack of Efficacy|1
2845382|NCT02437890|9769999|P5|Overall Study|Unable to attend visit(s)|0
2845383|NCT02437890|9770000|P4|Overall Study|Unable to attend visit(s)|0
2845384|NCT02437890|9770001|P3|Overall Study|Unable to attend visit(s)|0
2845385|NCT02437890|9770002|P2|Overall Study|Unable to attend visit(s)|0
2845386|NCT02437890|9770003|P1|Overall Study|Unable to attend visit(s)|1
2845387|NCT02437890|9769999|P5|Overall Study|Physician Decision|0
2845388|NCT02437890|9770000|P4|Overall Study|Physician Decision|1
2845389|NCT02437890|9770001|P3|Overall Study|Physician Decision|0
2845390|NCT02437890|9770002|P2|Overall Study|Physician Decision|0
2845391|NCT02437890|9770003|P1|Overall Study|Physician Decision|0
2845392|NCT02437890|9769999|P5|Overall Study|Sponsor's decision|2
2845393|NCT02437890|9770000|P4|Overall Study|Sponsor's decision|0
2845394|NCT02437890|9770001|P3|Overall Study|Sponsor's decision|4
2845395|NCT02437890|9770002|P2|Overall Study|Sponsor's decision|1
2845396|NCT02437890|9770003|P1|Overall Study|Sponsor's decision|1
2845397|NCT02437890|9769999|P5|Overall Study|Non-compliance to study drug|1
2845398|NCT02437890|9770000|P4|Overall Study|Non-compliance to study drug|0
2845399|NCT02437890|9770001|P3|Overall Study|Non-compliance to study drug|0
2845400|NCT02437890|9770002|P2|Overall Study|Non-compliance to study drug|1
2845401|NCT02437890|9770003|P1|Overall Study|Non-compliance to study drug|0
2845402|NCT02437864|9770216|P2|Overall Study|Protocol Violation|0
2845403|NCT02437864|9770217|P1|Overall Study|Protocol Violation|4
2845404|NCT02437513|9770238|P1|Overall Study|Withdrawal by Subject|2
2845405|NCT02437409|9770263|P1|Overall Study|Screening failure|12
2845406|NCT02437409|9770263|P1|Overall Study|Withdrawal by Subject|3
2845407|NCT02437318|9770356|P2|Overall Study|Untreated|1
2845408|NCT02437318|9770357|P1|Overall Study|Untreated|0
2845409|NCT02437318|9770356|P2|Overall Study|Protocol Violation|6
2845410|NCT02437318|9770357|P1|Overall Study|Protocol Violation|5
2845411|NCT02437318|9770356|P2|Overall Study|Death|4
2845412|NCT02437318|9770357|P1|Overall Study|Death|4
2845413|NCT02437318|9770356|P2|Overall Study|Adverse Event|3
2845414|NCT02437318|9770357|P1|Overall Study|Adverse Event|14
2845415|NCT02437318|9770356|P2|Overall Study|Physician Decision|10
2845416|NCT02437318|9770357|P1|Overall Study|Physician Decision|11
2845417|NCT02437318|9770356|P2|Overall Study|Subject/guardian decision|10
2845418|NCT02437318|9770357|P1|Overall Study|Subject/guardian decision|22
2845419|NCT02437318|9770356|P2|Overall Study|Progressive disease|208
2845420|NCT02437318|9770357|P1|Overall Study|Progressive disease|173
2845421|NCT02437305|9770365|P2|Overall Study|Lost to Follow-up|12
2845422|NCT02437305|9770366|P1|Overall Study|Lost to Follow-up|18
2845423|NCT02437188|9770393|P2|Overall Study|Adverse Event|1
2845424|NCT02437188|9770394|P1|Overall Study|Adverse Event|0
2845425|NCT02437188|9770393|P2|Overall Study|Randomized but did not receive surgery|8
2845426|NCT02437188|9770394|P1|Overall Study|Randomized but did not receive surgery|4
2845427|NCT02437162|9770411|P3|Overall Study|Other|1
2845428|NCT02437162|9770412|P2|Overall Study|Other|0
2845429|NCT02437162|9770413|P1|Overall Study|Other|0
2845430|NCT02437162|9770411|P3|Overall Study|Death|0
2845431|NCT02437162|9770412|P2|Overall Study|Death|1
2845432|NCT02437162|9770413|P1|Overall Study|Death|0
2845433|NCT02437162|9770411|P3|Overall Study|Lost to Follow-up|1
2845434|NCT02437162|9770412|P2|Overall Study|Lost to Follow-up|0
2845435|NCT02437162|9770413|P1|Overall Study|Lost to Follow-up|1
2845436|NCT02437162|9770411|P3|Overall Study|Adverse Event|0
2845437|NCT02437162|9770412|P2|Overall Study|Adverse Event|1
2845438|NCT02437162|9770413|P1|Overall Study|Adverse Event|0
2845439|NCT02437162|9770411|P3|Overall Study|Withdrawal by Subject|9
2845440|NCT02437162|9770412|P2|Overall Study|Withdrawal by Subject|7
2845441|NCT02437162|9770413|P1|Overall Study|Withdrawal by Subject|13
2845442|NCT02437162|9770411|P3|Overall Study|Study discontinued by Sponsor|97
2845443|NCT02437162|9770412|P2|Overall Study|Study discontinued by Sponsor|98
2845444|NCT02437162|9770413|P1|Overall Study|Study discontinued by Sponsor|93
2845445|NCT02437162|9770411|P3|Overall Study|Randomized but not treated|1
2845446|NCT02437162|9770412|P2|Overall Study|Randomized but not treated|0
2845447|NCT02437162|9770413|P1|Overall Study|Randomized but not treated|0
2845448|NCT02437162|9770411|P3|Overall Study|Protocol Violation|0
2845449|NCT02437162|9770412|P2|Overall Study|Protocol Violation|1
2845450|NCT02437162|9770413|P1|Overall Study|Protocol Violation|0
2845451|NCT02436915|9770533|P2|Overall Study|Withdrawal by Subject|1
2845452|NCT02436915|9770534|P1|Overall Study|Withdrawal by Subject|0
2845453|NCT02436889|9770556|P2|Overall Study|Does not like/could not tolerate medicat|1
2845454|NCT02436889|9770557|P1|Overall Study|Does not like/could not tolerate medicat|0
2845455|NCT02436889|9770556|P2|Overall Study|No improvement in symptoms|0
2845456|NCT02436889|9770557|P1|Overall Study|No improvement in symptoms|1
2845457|NCT02436811|9770576|P3|Overall Study|Lost to Follow-up|7
2845458|NCT02436811|9770577|P2|Overall Study|Lost to Follow-up|9
2845459|NCT02436811|9770578|P1|Overall Study|Lost to Follow-up|2
2845460|NCT02436681|9770586|P1|Overall Study|Death|2
2845461|NCT02436681|9770586|P1|Overall Study|Withdrawal by Subject|2
2845462|NCT02436681|9770586|P1|Overall Study|Lost to Follow-up|10
2845463|NCT02436577|9770603|P6|Overall Study|Protocol Deviation|0
2845464|NCT02436577|9770604|P5|Overall Study|Protocol Deviation|0
2845465|NCT02436577|9770605|P4|Overall Study|Protocol Deviation|0
2845466|NCT02436577|9770606|P3|Overall Study|Protocol Deviation|0
2845467|NCT02436577|9770607|P2|Overall Study|Protocol Deviation|1
2845468|NCT02436577|9770608|P1|Overall Study|Protocol Deviation|0
2845469|NCT02436330|9770663|P2|Cohort 6|Withdrawal by Subject|1
2845470|NCT02436330|9770664|P1|Cohort 6|Withdrawal by Subject|1
2845471|NCT02436330|9770663|P2|Cohort 6|Lost to Follow-up|0
2845472|NCT02436330|9770664|P1|Cohort 6|Lost to Follow-up|2
2845473|NCT02436330|9770663|P2|Cohort 5|Withdrawal by Subject|2
2845474|NCT02436330|9770664|P1|Cohort 5|Withdrawal by Subject|3
2845475|NCT02436330|9770663|P2|Cohort 5|Lost to Follow-up|2
2845476|NCT02436330|9770664|P1|Cohort 5|Lost to Follow-up|3
2845477|NCT02436330|9770663|P2|Cohort 4|Withdrawal by Subject|0
2845478|NCT02436330|9770664|P1|Cohort 4|Withdrawal by Subject|1
2845479|NCT02436330|9770663|P2|Cohort 4|Lost to Follow-up|0
2845480|NCT02436330|9770664|P1|Cohort 4|Lost to Follow-up|1
2845481|NCT02436330|9770663|P2|Cohort 3|Withdrawal by Subject|0
2845482|NCT02436330|9770664|P1|Cohort 3|Withdrawal by Subject|4
2845483|NCT02436330|9770663|P2|Cohort 3|Lost to Follow-up|0
2845484|NCT02436330|9770664|P1|Cohort 3|Lost to Follow-up|1
2845485|NCT02436330|9770663|P2|Cohort 2|Withdrawal by Subject|3
2845486|NCT02436330|9770664|P1|Cohort 2|Withdrawal by Subject|2
2845487|NCT02436330|9770663|P2|Cohort 2|Lost to Follow-up|0
2845488|NCT02436330|9770664|P1|Cohort 2|Lost to Follow-up|2
2845489|NCT02436330|9770663|P2|Cohort 1|Withdrawal by Subject|1
2845490|NCT02436330|9770664|P1|Cohort 1|Withdrawal by Subject|0
2845491|NCT02436330|9770663|P2|Cohort 1|Lost to Follow-up|2
2845492|NCT02436330|9770664|P1|Cohort 1|Lost to Follow-up|5
2845493|NCT02436304|9770709|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
2845494|NCT02436304|9770710|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
2845495|NCT02436304|9770711|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
2845496|NCT02436304|9770709|P3|Overall Study|Withdrawal by Subject|0
2845497|NCT02436304|9770710|P2|Overall Study|Withdrawal by Subject|1
2845498|NCT02436304|9770711|P1|Overall Study|Withdrawal by Subject|0
2845499|NCT02436304|9770709|P3|Overall Study|Lost to Follow-up|0
2845500|NCT02436304|9770710|P2|Overall Study|Lost to Follow-up|1
2845501|NCT02436304|9770711|P1|Overall Study|Lost to Follow-up|0
2845502|NCT02436239|9770730|P4|Down-Taper Period|Withdrawal by Subject|2
2845503|NCT02436239|9770731|P3|Down-Taper Period|Withdrawal by Subject|1
2845504|NCT02436239|9770732|P2|Down-Taper Period|Withdrawal by Subject|4
2845505|NCT02436239|9770733|P1|Down-Taper Period|Withdrawal by Subject|4
2845506|NCT02436239|9770730|P4|Open-Lable Treatment Period|Other Reason|0
2845507|NCT02436239|9770731|P3|Open-Lable Treatment Period|Other Reason|0
2845508|NCT02436239|9770732|P2|Open-Lable Treatment Period|Other Reason|1
2845509|NCT02436239|9770733|P1|Open-Lable Treatment Period|Other Reason|1
2845510|NCT02436239|9770730|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
2845511|NCT02436239|9770731|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
2845512|NCT02436239|9770732|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
2845513|NCT02436239|9770733|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
2845514|NCT02436239|9770730|P4|Open-Lable Treatment Period|Protocol Violation|0
2845515|NCT02436239|9770731|P3|Open-Lable Treatment Period|Protocol Violation|1
2845516|NCT02436239|9770732|P2|Open-Lable Treatment Period|Protocol Violation|1
2845517|NCT02436239|9770733|P1|Open-Lable Treatment Period|Protocol Violation|0
2845518|NCT02436239|9770730|P4|Open-Lable Treatment Period|Lost to Follow-up|1
2845519|NCT02436239|9770731|P3|Open-Lable Treatment Period|Lost to Follow-up|4
2845520|NCT02436239|9770732|P2|Open-Lable Treatment Period|Lost to Follow-up|2
2845521|NCT02436239|9770733|P1|Open-Lable Treatment Period|Lost to Follow-up|4
2845522|NCT02436239|9770730|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
2845523|NCT02436239|9770731|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
2845524|NCT02436239|9770732|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
2845525|NCT02436239|9770733|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
2845526|NCT02436239|9770730|P4|Open-Lable Treatment Period|Lack of Efficacy|1
2845527|NCT02436239|9770731|P3|Open-Lable Treatment Period|Lack of Efficacy|6
2845528|NCT02436239|9770732|P2|Open-Lable Treatment Period|Lack of Efficacy|6
2845529|NCT02436239|9770733|P1|Open-Lable Treatment Period|Lack of Efficacy|1
2845530|NCT02436239|9770730|P4|Open-Lable Treatment Period|Adverse Event|2
2845531|NCT02436239|9770731|P3|Open-Lable Treatment Period|Adverse Event|4
2845532|NCT02436239|9770732|P2|Open-Lable Treatment Period|Adverse Event|3
2845533|NCT02436239|9770733|P1|Open-Lable Treatment Period|Adverse Event|12
2845534|NCT02436200|9770755|P1|Overall Study|Significant outlier|1
2845535|NCT02435966|9770774|P3|Overall Study|Withdrawal by Subject|0
2845536|NCT02435966|9770775|P2|Overall Study|Withdrawal by Subject|1
2845537|NCT02435966|9770776|P1|Overall Study|Withdrawal by Subject|0
2845538|NCT02435914|9770788|P4|Overall Study|Other Miscellaneous Reason|0
2845539|NCT02435914|9770789|P3|Overall Study|Other Miscellaneous Reason|1
2845540|NCT02435914|9770790|P2|Overall Study|Other Miscellaneous Reason|0
2845541|NCT02435914|9770791|P1|Overall Study|Other Miscellaneous Reason|0
2845542|NCT02435914|9770788|P4|Overall Study|Withdrawal by Subject|0
2845543|NCT02435914|9770789|P3|Overall Study|Withdrawal by Subject|0
2845544|NCT02435914|9770790|P2|Overall Study|Withdrawal by Subject|1
2845545|NCT02435914|9770791|P1|Overall Study|Withdrawal by Subject|0
2845546|NCT02435914|9770788|P4|Overall Study|Ocular Adverse Event|0
2845547|NCT02435914|9770789|P3|Overall Study|Ocular Adverse Event|0
2845548|NCT02435914|9770790|P2|Overall Study|Ocular Adverse Event|0
2845549|NCT02435914|9770791|P1|Overall Study|Ocular Adverse Event|1
2845550|NCT02435836|9770813|P1|Overall Study|AE of Worsening Schizophrenia|96
2845551|NCT02435836|9770813|P1|Overall Study|Met Withdrawal Criteria|7
2845552|NCT02435836|9770813|P1|Overall Study|Protocol Violation|6
2845553|NCT02435836|9770813|P1|Overall Study|Noncompliance|27
2845554|NCT02435836|9770813|P1|Overall Study|Sponsor discontinued trial|167
2845555|NCT02435836|9770813|P1|Overall Study|Adverse Event|44
2845556|NCT02435836|9770813|P1|Overall Study|Insufficient Clinical Response|26
2845557|NCT02435836|9770813|P1|Overall Study|Withdrawal by Subject|236
2845558|NCT02435836|9770813|P1|Overall Study|Lack of Efficacy|1
2845559|NCT02435836|9770813|P1|Overall Study|Lost to Follow-up|21
2845560|NCT02435433|9770872|P5|Overall Study|Lost to Follow-up|0
2845561|NCT02435433|9770873|P4|Overall Study|Lost to Follow-up|0
2845562|NCT02435433|9770874|P3|Overall Study|Lost to Follow-up|0
2845563|NCT02435433|9770875|P2|Overall Study|Lost to Follow-up|2
2845564|NCT02435433|9770876|P1|Overall Study|Lost to Follow-up|2
2845565|NCT02435433|9770872|P5|Overall Study|Withdrawal by Subject|0
2845566|NCT02435433|9770873|P4|Overall Study|Withdrawal by Subject|0
2845567|NCT02435433|9770874|P3|Overall Study|Withdrawal by Subject|0
2845568|NCT02435433|9770875|P2|Overall Study|Withdrawal by Subject|3
2845569|NCT02435433|9770876|P1|Overall Study|Withdrawal by Subject|2
2845570|NCT02435433|9770872|P5|Overall Study|On Treatment|0
2845571|NCT02435433|9770873|P4|Overall Study|On Treatment|0
2845572|NCT02435433|9770874|P3|Overall Study|On Treatment|0
2845573|NCT02435433|9770875|P2|Overall Study|On Treatment|0
2845574|NCT02435433|9770876|P1|Overall Study|On Treatment|11
2845575|NCT02435277|9770902|P4|Overall Study|Withdrawal by Subject|0
2845576|NCT02435277|9770903|P3|Overall Study|Withdrawal by Subject|0
2845577|NCT02435277|9770904|P2|Overall Study|Withdrawal by Subject|0
2845578|NCT02435277|9770905|P1|Overall Study|Withdrawal by Subject|1
2845579|NCT02435277|9770902|P4|Overall Study|Adverse Event|0
2845580|NCT02435277|9770903|P3|Overall Study|Adverse Event|0
2845581|NCT02435277|9770904|P2|Overall Study|Adverse Event|1
2845582|NCT02435277|9770905|P1|Overall Study|Adverse Event|1
2845583|NCT02435147|9770919|P1|Overall Study|non-evaluable DXA scan|11
2845584|NCT02435069|9770924|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
2845585|NCT02435069|9770925|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
2845586|NCT02435069|9770926|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
2845587|NCT02435069|9770927|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
2845588|NCT02435069|9770928|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
2845589|NCT02435069|9770924|P5|Dose Response - First Intervention|Adverse Event|0
2845590|NCT02435069|9770925|P4|Dose Response - First Intervention|Adverse Event|0
2845591|NCT02435069|9770926|P3|Dose Response - First Intervention|Adverse Event|1
2845592|NCT02435069|9770927|P2|Dose Response - First Intervention|Adverse Event|1
2845593|NCT02435069|9770928|P1|Dose Response - First Intervention|Adverse Event|0
2845594|NCT02434939|9770950|P2|Overall Study|Adverse Event|1
2845595|NCT02434939|9770951|P1|Overall Study|Adverse Event|0
2845596|NCT02434939|9770950|P2|Overall Study|Withdrawal by Subject|0
2845597|NCT02434939|9770951|P1|Overall Study|Withdrawal by Subject|3
2845598|NCT02434939|9770950|P2|Overall Study|Lack of Efficacy|48
2845599|NCT02434939|9770951|P1|Overall Study|Lack of Efficacy|34
2845600|NCT02434770|9770966|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
2845601|NCT02434770|9770967|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
2845602|NCT02434770|9770968|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
2845603|NCT02434770|9770966|P3|Week 18 to Week|Withdrawal by Subject|2
2845604|NCT02434770|9770967|P2|Week 18 to Week|Withdrawal by Subject|0
2845605|NCT02434770|9770968|P1|Week 18 to Week|Withdrawal by Subject|0
2845606|NCT02434770|9770966|P3|Week 18 to Week|Lost to Follow-up|1
2845607|NCT02434770|9770967|P2|Week 18 to Week|Lost to Follow-up|2
2845608|NCT02434770|9770968|P1|Week 18 to Week|Lost to Follow-up|2
2845609|NCT02434770|9770966|P3|Week 1 to Week 18|Death|0
2845610|NCT02434770|9770967|P2|Week 1 to Week 18|Death|0
2845611|NCT02434770|9770968|P1|Week 1 to Week 18|Death|1
2845612|NCT02434770|9770966|P3|Week 1 to Week 18|Relocated Out of Study Area|1
2845613|NCT02434770|9770967|P2|Week 1 to Week 18|Relocated Out of Study Area|0
2845614|NCT02434770|9770968|P1|Week 1 to Week 18|Relocated Out of Study Area|0
2845615|NCT02434770|9770966|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
2845616|NCT02434770|9770967|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
2845617|NCT02434770|9770968|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
2845618|NCT02434770|9770966|P3|Week 1 to Week 18|Withdrawal by Subject|5
2845619|NCT02434770|9770967|P2|Week 1 to Week 18|Withdrawal by Subject|12
2845620|NCT02434770|9770968|P1|Week 1 to Week 18|Withdrawal by Subject|6
2845621|NCT02434770|9770966|P3|Week 1 to Week 18|Lost to Follow-up|2
2845622|NCT02434770|9770967|P2|Week 1 to Week 18|Lost to Follow-up|0
2845623|NCT02434770|9770968|P1|Week 1 to Week 18|Lost to Follow-up|0
2845624|NCT02434471|9771118|P1|Overall Study|Physician Decision|9
2845625|NCT02434328|9771127|P2|Overall Study|Other|1
2845626|NCT02434328|9771128|P1|Overall Study|Other|4
2845627|NCT02434328|9771127|P2|Overall Study|Lost to Follow-up|6
2845628|NCT02434328|9771128|P1|Overall Study|Lost to Follow-up|1
2845629|NCT02434328|9771127|P2|Overall Study|Death|7
2845630|NCT02434328|9771128|P1|Overall Study|Death|4
2845631|NCT02434328|9771127|P2|Overall Study|Withdrawal by Subject|21
2845632|NCT02434328|9771128|P1|Overall Study|Withdrawal by Subject|12
2845633|NCT02434328|9771127|P2|Overall Study|Physician Decision|1
2845634|NCT02434328|9771128|P1|Overall Study|Physician Decision|0
2845635|NCT02434328|9771127|P2|Overall Study|Lack of Efficacy|2
2845636|NCT02434328|9771128|P1|Overall Study|Lack of Efficacy|0
2845637|NCT02434328|9771127|P2|Overall Study|Adverse Event|4
2845638|NCT02434328|9771128|P1|Overall Study|Adverse Event|9
2845639|NCT02433834|9771203|P1|Overall Study|Physician Decision|1
2845640|NCT02433834|9771203|P1|Overall Study|Adverse Event|6
2845641|NCT02433834|9771203|P1|Overall Study|Withdrawal by Subject|14
2845642|NCT02433834|9771203|P1|Overall Study|Lost to Follow-up|6
2845643|NCT02433834|9771203|P1|Overall Study|Protocol Violation|3
2845644|NCT02433834|9771203|P1|Overall Study|Protocol-specified criteria|7
2845645|NCT02433678|9771263|P2|Overall Study|Lost to Follow-up|2
2845646|NCT02433678|9771264|P1|Overall Study|Lost to Follow-up|1
2845647|NCT02433483|9771349|P1|Overall Study|Other antineoplastic therapy/HSCT|1
2845648|NCT02433483|9771349|P1|Overall Study|Unacceptable toxicity|1
2845649|NCT02433340|9771376|P4|Overall Study|Other|0
2845650|NCT02433340|9771377|P3|Overall Study|Other|0
2845651|NCT02433340|9771378|P2|Overall Study|Other|1
2845652|NCT02433340|9771379|P1|Overall Study|Other|0
2845653|NCT02433340|9771376|P4|Overall Study|Required Alternative/Prohibited Therapy|0
2845654|NCT02433340|9771377|P3|Overall Study|Required Alternative/Prohibited Therapy|0
2845655|NCT02433340|9771378|P2|Overall Study|Required Alternative/Prohibited Therapy|0
2845656|NCT02433340|9771379|P1|Overall Study|Required Alternative/Prohibited Therapy|1
2845657|NCT02433340|9771376|P4|Overall Study|Lost to Follow-up|0
2845658|NCT02433340|9771377|P3|Overall Study|Lost to Follow-up|0
2845659|NCT02433340|9771378|P2|Overall Study|Lost to Follow-up|1
2845660|NCT02433340|9771379|P1|Overall Study|Lost to Follow-up|0
2845661|NCT02433340|9771376|P4|Overall Study|Withdrawal by Subject|2
2845662|NCT02433340|9771377|P3|Overall Study|Withdrawal by Subject|1
2845663|NCT02433340|9771378|P2|Overall Study|Withdrawal by Subject|0
2845664|NCT02433340|9771379|P1|Overall Study|Withdrawal by Subject|1
2845665|NCT02433340|9771376|P4|Overall Study|Adverse Event|0
2845666|NCT02433340|9771377|P3|Overall Study|Adverse Event|1
2845667|NCT02433340|9771378|P2|Overall Study|Adverse Event|0
2845668|NCT02433340|9771379|P1|Overall Study|Adverse Event|0
2845669|NCT02433288|9772273|P2|Overall Study|Death|3
2845670|NCT02433288|9772274|P1|Overall Study|Death|0
2845671|NCT02433288|9772273|P2|Overall Study|Lost to Follow-up|14
2845672|NCT02433288|9772274|P1|Overall Study|Lost to Follow-up|2
2845673|NCT02433288|9772273|P2|Overall Study|Withdrawal by Subject|99
2845674|NCT02433288|9772274|P1|Overall Study|Withdrawal by Subject|101
2845675|NCT02433288|9772273|P2|Overall Study|Eligibility criteria not fullfilled|3
2845676|NCT02433288|9772274|P1|Overall Study|Eligibility criteria not fullfilled|7
2845677|NCT02433288|9772273|P2|Overall Study|Severe non-compliance to protocol|7
2845678|NCT02433288|9772274|P1|Overall Study|Severe non-compliance to protocol|13
2845679|NCT02433080|9772290|P2|Overall Study|Withdrawal by Subject|2
2845680|NCT02433080|9772291|P1|Overall Study|Withdrawal by Subject|0
2845681|NCT02433080|9772290|P2|Overall Study|Lost to Follow-up|2
2845682|NCT02433080|9772291|P1|Overall Study|Lost to Follow-up|1
2845683|NCT02432196|9772403|P1|Overall Study|On Study|20
2845684|NCT02432196|9772403|P1|Overall Study|Reoperation|3
2845685|NCT02432196|9772403|P1|Overall Study|Death|2
2845686|NCT02432196|9772403|P1|Overall Study|Not Implanted with Device|1
2845687|NCT02432144|9772411|P1|Overall Study|Participant Non-Compliance|1
2845688|NCT02432105|9772419|P3|Overall Study|Randomized in error|2
2845689|NCT02432105|9772420|P2|Overall Study|Randomized in error|0
2845690|NCT02432105|9772421|P1|Overall Study|Randomized in error|0
2845691|NCT02432105|9772419|P3|Overall Study|Culture positive for yeast|0
2845692|NCT02432105|9772420|P2|Overall Study|Culture positive for yeast|1
2845693|NCT02432105|9772421|P1|Overall Study|Culture positive for yeast|0
2845694|NCT02432105|9772419|P3|Overall Study|Withdrawal by Subject|1
2845695|NCT02432105|9772420|P2|Overall Study|Withdrawal by Subject|0
2845696|NCT02432105|9772421|P1|Overall Study|Withdrawal by Subject|1
2845697|NCT02432105|9772419|P3|Overall Study|Lost to Follow-up|0
2845698|NCT02432105|9772420|P2|Overall Study|Lost to Follow-up|1
2845699|NCT02432105|9772421|P1|Overall Study|Lost to Follow-up|1
2845700|NCT02432040|9772438|P2|Overall Study|Physician Decision|1
2845701|NCT02432040|9772439|P1|Overall Study|Physician Decision|1
2845702|NCT02432040|9772438|P2|Overall Study|Lost to Follow-up|5
2845703|NCT02432040|9772439|P1|Overall Study|Lost to Follow-up|4
2845704|NCT02432040|9772438|P2|Overall Study|Lack of Efficacy|0
2845705|NCT02432040|9772439|P1|Overall Study|Lack of Efficacy|3
2845706|NCT02431793|9772462|P3|Overall Study|Lost to Follow-up|104
2845707|NCT02431793|9772463|P2|Overall Study|Lost to Follow-up|122
2845708|NCT02431793|9772464|P1|Overall Study|Lost to Follow-up|101
2845709|NCT02431793|9772462|P3|Overall Study|Withdrawal by Subject|5
2845710|NCT02431793|9772463|P2|Overall Study|Withdrawal by Subject|5
2845711|NCT02431793|9772464|P1|Overall Study|Withdrawal by Subject|7
2845712|NCT02431793|9772462|P3|Overall Study|Ineligible doe to not filling Rx|8
2845713|NCT02431793|9772463|P2|Overall Study|Ineligible doe to not filling Rx|7
2845714|NCT02431793|9772464|P1|Overall Study|Ineligible doe to not filling Rx|11
2845715|NCT02431559|9772571|P4|Overall Study|Physician Decision|1
2845716|NCT02431559|9772572|P3|Overall Study|Physician Decision|0
2845717|NCT02431559|9772573|P2|Overall Study|Physician Decision|0
2845718|NCT02431559|9772574|P1|Overall Study|Physician Decision|0
2845719|NCT02431559|9772571|P4|Overall Study|Withdrawal by Subject|4
2845720|NCT02431559|9772572|P3|Overall Study|Withdrawal by Subject|0
2845721|NCT02431559|9772573|P2|Overall Study|Withdrawal by Subject|1
2845722|NCT02431559|9772574|P1|Overall Study|Withdrawal by Subject|0
2845723|NCT02431559|9772571|P4|Overall Study|Progressive disease|22
2845724|NCT02431559|9772572|P3|Overall Study|Progressive disease|4
2845725|NCT02431559|9772573|P2|Overall Study|Progressive disease|1
2845726|NCT02431559|9772574|P1|Overall Study|Progressive disease|2
2845727|NCT02431559|9772571|P4|Overall Study|Adverse Event|4
2845728|NCT02431559|9772572|P3|Overall Study|Adverse Event|0
2845729|NCT02431559|9772573|P2|Overall Study|Adverse Event|1
2845730|NCT02431559|9772574|P1|Overall Study|Adverse Event|0
2845731|NCT02431533|9772598|P2|Overall Study|Developed Exclusionary criteria|0
2845732|NCT02431533|9772599|P1|Overall Study|Developed Exclusionary criteria|1
2845733|NCT02431533|9772598|P2|Overall Study|Withdrawal by Subject|3
2845734|NCT02431533|9772599|P1|Overall Study|Withdrawal by Subject|1
2845735|NCT02431468|9772665|P3|Overall Study|noncompliance, investigator termination,|2
2845736|NCT02431468|9772666|P2|Overall Study|noncompliance, investigator termination,|2
2845737|NCT02431468|9772667|P1|Overall Study|noncompliance, investigator termination,|2
2845738|NCT02431468|9772665|P3|Overall Study|Withdrawal by Subject|2
2845739|NCT02431468|9772666|P2|Overall Study|Withdrawal by Subject|12
2845740|NCT02431468|9772667|P1|Overall Study|Withdrawal by Subject|4
2845741|NCT02431468|9772665|P3|Overall Study|Adverse Event|5
2845742|NCT02431468|9772666|P2|Overall Study|Adverse Event|4
2845743|NCT02431468|9772667|P1|Overall Study|Adverse Event|2
2845744|NCT02431260|9772758|P14|Overall Study|Other Unspecified|0
2845745|NCT02431260|9772759|P13|Overall Study|Other Unspecified|1
2845746|NCT02431260|9772760|P12|Overall Study|Other Unspecified|1
2845747|NCT02431260|9772761|P11|Overall Study|Other Unspecified|0
2845748|NCT02431260|9772762|P10|Overall Study|Other Unspecified|0
2845749|NCT02431260|9772763|P9|Overall Study|Other Unspecified|0
2845750|NCT02431260|9772764|P8|Overall Study|Other Unspecified|0
2845751|NCT02431260|9772765|P7|Overall Study|Other Unspecified|0
2845752|NCT02431260|9772766|P6|Overall Study|Other Unspecified|0
2845753|NCT02431260|9772767|P5|Overall Study|Other Unspecified|0
2845754|NCT02431260|9772768|P4|Overall Study|Other Unspecified|0
2845755|NCT02431260|9772769|P3|Overall Study|Other Unspecified|0
2845756|NCT02431260|9772770|P2|Overall Study|Other Unspecified|0
2845757|NCT02431260|9772771|P1|Overall Study|Other Unspecified|0
2845758|NCT02431260|9772758|P14|Overall Study|Physician Decision|0
2845759|NCT02431260|9772759|P13|Overall Study|Physician Decision|0
2845760|NCT02431260|9772760|P12|Overall Study|Physician Decision|0
2845761|NCT02431260|9772761|P11|Overall Study|Physician Decision|0
2845762|NCT02431260|9772762|P10|Overall Study|Physician Decision|0
2845763|NCT02431260|9772763|P9|Overall Study|Physician Decision|0
2845764|NCT02431260|9772764|P8|Overall Study|Physician Decision|0
2845765|NCT02431260|9772765|P7|Overall Study|Physician Decision|0
2845766|NCT02431260|9772766|P6|Overall Study|Physician Decision|1
2845767|NCT02431260|9772767|P5|Overall Study|Physician Decision|0
2845768|NCT02431260|9772768|P4|Overall Study|Physician Decision|0
2845769|NCT02431260|9772769|P3|Overall Study|Physician Decision|0
2845770|NCT02431260|9772770|P2|Overall Study|Physician Decision|0
2845771|NCT02431260|9772771|P1|Overall Study|Physician Decision|0
2845772|NCT02431260|9772758|P14|Overall Study|Study Terminated by the Sponsor|0
2845773|NCT02431260|9772759|P13|Overall Study|Study Terminated by the Sponsor|4
2845774|NCT02431260|9772760|P12|Overall Study|Study Terminated by the Sponsor|0
2845775|NCT02431260|9772761|P11|Overall Study|Study Terminated by the Sponsor|1
2845776|NCT02431260|9772762|P10|Overall Study|Study Terminated by the Sponsor|1
2845777|NCT02431260|9772763|P9|Overall Study|Study Terminated by the Sponsor|1
2845778|NCT02431260|9772764|P8|Overall Study|Study Terminated by the Sponsor|2
2845779|NCT02431260|9772765|P7|Overall Study|Study Terminated by the Sponsor|1
2845780|NCT02431260|9772766|P6|Overall Study|Study Terminated by the Sponsor|0
2845781|NCT02431260|9772767|P5|Overall Study|Study Terminated by the Sponsor|1
2845782|NCT02431260|9772768|P4|Overall Study|Study Terminated by the Sponsor|1
2845783|NCT02431260|9772769|P3|Overall Study|Study Terminated by the Sponsor|2
2845784|NCT02431260|9772770|P2|Overall Study|Study Terminated by the Sponsor|0
2845785|NCT02431260|9772771|P1|Overall Study|Study Terminated by the Sponsor|0
2845786|NCT02431260|9772758|P14|Overall Study|Lost to Follow-up|0
2845787|NCT02431260|9772759|P13|Overall Study|Lost to Follow-up|0
2845788|NCT02431260|9772760|P12|Overall Study|Lost to Follow-up|0
2845789|NCT02431260|9772761|P11|Overall Study|Lost to Follow-up|0
2845790|NCT02431260|9772762|P10|Overall Study|Lost to Follow-up|0
2845791|NCT02431260|9772763|P9|Overall Study|Lost to Follow-up|0
2845792|NCT02431260|9772764|P8|Overall Study|Lost to Follow-up|0
2845793|NCT02431260|9772765|P7|Overall Study|Lost to Follow-up|0
2845794|NCT02431260|9772766|P6|Overall Study|Lost to Follow-up|1
2845795|NCT02431260|9772767|P5|Overall Study|Lost to Follow-up|0
2845796|NCT02431260|9772768|P4|Overall Study|Lost to Follow-up|0
2845797|NCT02431260|9772769|P3|Overall Study|Lost to Follow-up|0
2845798|NCT02431260|9772770|P2|Overall Study|Lost to Follow-up|0
2845799|NCT02431260|9772771|P1|Overall Study|Lost to Follow-up|0
2845800|NCT02431260|9772758|P14|Overall Study|Death|1
2845801|NCT02431260|9772759|P13|Overall Study|Death|5
2845802|NCT02431260|9772760|P12|Overall Study|Death|2
2845803|NCT02431260|9772761|P11|Overall Study|Death|3
2845804|NCT02431260|9772762|P10|Overall Study|Death|6
2845805|NCT02431260|9772763|P9|Overall Study|Death|6
2845806|NCT02431260|9772764|P8|Overall Study|Death|1
2845807|NCT02431260|9772765|P7|Overall Study|Death|3
2845808|NCT02431260|9772766|P6|Overall Study|Death|2
2845809|NCT02431260|9772767|P5|Overall Study|Death|2
2845810|NCT02431260|9772768|P4|Overall Study|Death|4
2845811|NCT02431260|9772769|P3|Overall Study|Death|3
2845812|NCT02431260|9772770|P2|Overall Study|Death|4
2845813|NCT02431260|9772771|P1|Overall Study|Death|4
2845814|NCT02431260|9772758|P14|Overall Study|Subject Decision|0
2845815|NCT02431260|9772759|P13|Overall Study|Subject Decision|0
2845816|NCT02431260|9772760|P12|Overall Study|Subject Decision|1
2845817|NCT02431260|9772761|P11|Overall Study|Subject Decision|0
2845818|NCT02431260|9772762|P10|Overall Study|Subject Decision|1
2845819|NCT02431260|9772763|P9|Overall Study|Subject Decision|1
2845820|NCT02431260|9772764|P8|Overall Study|Subject Decision|0
2845821|NCT02431260|9772765|P7|Overall Study|Subject Decision|0
2845822|NCT02431260|9772766|P6|Overall Study|Subject Decision|0
2845823|NCT02431260|9772767|P5|Overall Study|Subject Decision|0
2845824|NCT02431260|9772768|P4|Overall Study|Subject Decision|0
2845825|NCT02431260|9772769|P3|Overall Study|Subject Decision|1
2845826|NCT02431260|9772770|P2|Overall Study|Subject Decision|1
2845827|NCT02431260|9772771|P1|Overall Study|Subject Decision|0
2845828|NCT02431247|9772864|P2|Overall Study|Non-compliance with study drug|0
2845829|NCT02431247|9772865|P1|Overall Study|Non-compliance with study drug|1
2845830|NCT02431247|9772864|P2|Overall Study|Ongoing|336
2845831|NCT02431247|9772865|P1|Overall Study|Ongoing|339
2845832|NCT02431247|9772864|P2|Overall Study|Other|1
2845833|NCT02431247|9772865|P1|Overall Study|Other|2
2845834|NCT02431247|9772864|P2|Overall Study|Withdrawal by Subject|6
2845835|NCT02431247|9772865|P1|Overall Study|Withdrawal by Subject|4
2845836|NCT02431247|9772864|P2|Overall Study|Physician Decision|0
2845837|NCT02431247|9772865|P1|Overall Study|Physician Decision|3
2845838|NCT02431247|9772864|P2|Overall Study|Adverse Event|15
2845839|NCT02431247|9772865|P1|Overall Study|Adverse Event|8
2845840|NCT02431247|9772864|P2|Overall Study|Lost to Follow-up|5
2845841|NCT02431247|9772865|P1|Overall Study|Lost to Follow-up|5
2845842|NCT02430870|9772958|P8|Part 2|Other Reason Not Specified|1
2845843|NCT02430870|9772959|P7|Part 2|Other Reason Not Specified|0
2845844|NCT02430870|9772960|P6|Part 2|Other Reason Not Specified|0
2845845|NCT02430870|9772961|P5|Part 2|Other Reason Not Specified|0
2845846|NCT02430870|9772962|P4|Part 2|Other Reason Not Specified|0
2845847|NCT02430870|9772963|P3|Part 2|Other Reason Not Specified|0
2845848|NCT02430870|9772964|P2|Part 2|Other Reason Not Specified|0
2845849|NCT02430870|9772965|P1|Part 2|Other Reason Not Specified|0
2845850|NCT02430870|9772958|P8|Part 2|Voluntary Withdrawal|0
2845851|NCT02430870|9772959|P7|Part 2|Voluntary Withdrawal|1
2845852|NCT02430870|9772960|P6|Part 2|Voluntary Withdrawal|0
2845853|NCT02430870|9772961|P5|Part 2|Voluntary Withdrawal|0
2845854|NCT02430870|9772962|P4|Part 2|Voluntary Withdrawal|0
2845855|NCT02430870|9772963|P3|Part 2|Voluntary Withdrawal|0
2845856|NCT02430870|9772964|P2|Part 2|Voluntary Withdrawal|0
2845857|NCT02430870|9772965|P1|Part 2|Voluntary Withdrawal|0
2845858|NCT02430532|9773052|P2|Overall Study|Adverse Event|1
2845859|NCT02430532|9773053|P1|Overall Study|Adverse Event|0
2845860|NCT02430532|9773052|P2|Overall Study|Consent Withdrawn|2
2845861|NCT02430532|9773053|P1|Overall Study|Consent Withdrawn|0
2845862|NCT02430532|9773052|P2|Overall Study|Sponsor Decision to Stop Study Early|25
2845863|NCT02430532|9773053|P1|Overall Study|Sponsor Decision to Stop Study Early|30
2845864|NCT02430311|9773094|P2|Part B|Death|0
2845865|NCT02430311|9773095|P1|Part B|Death|1
2845866|NCT02430311|9773094|P2|Part B|Adverse Event|0
2845867|NCT02430311|9773095|P1|Part B|Adverse Event|1
2845868|NCT02430311|9773094|P2|Part B|Withdrawal by Subject|2
2845869|NCT02430311|9773095|P1|Part B|Withdrawal by Subject|2
2845870|NCT02430311|9773094|P2|Part B|Meet study-specific withdrawal criteria|6
2845871|NCT02430311|9773095|P1|Part B|Meet study-specific withdrawal criteria|6
2845872|NCT02430311|9773094|P2|Part A|Withdrawal by Subject|0
2845873|NCT02430311|9773095|P1|Part A|Withdrawal by Subject|1
2845874|NCT02430311|9773094|P2|Part A|Adverse Event|1
2845875|NCT02430311|9773095|P1|Part A|Adverse Event|0
2845876|NCT02429856|9773149|P2|Overall Study|Withdrawal by Subject|1
2845877|NCT02429856|9773150|P1|Overall Study|Withdrawal by Subject|1
2845878|NCT02429856|9773149|P2|Overall Study|Lost to Follow-up|5
2845879|NCT02429856|9773150|P1|Overall Study|Lost to Follow-up|6
2845880|NCT02429856|9773149|P2|Overall Study|Death|13
2845881|NCT02429856|9773150|P1|Overall Study|Death|12
2845882|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
2845883|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
2845884|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2845885|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2845886|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
2845887|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
2845888|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
2845889|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
2845890|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
2845891|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
2845892|NCT02429791|9773168|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
2845893|NCT02429791|9773169|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
2845894|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
2845895|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
2845896|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
2845897|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
2845898|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
2845899|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2845900|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
2845901|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
2845902|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
2845903|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
2845904|NCT02429791|9773168|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
2845905|NCT02429791|9773169|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
2845906|NCT02429778|9773257|P2|Overall Study|Withdrawal by Subject|0
2845907|NCT02429778|9773258|P1|Overall Study|Withdrawal by Subject|5
2845908|NCT02429778|9773257|P2|Overall Study|Lost to Follow-up|0
2845909|NCT02429778|9773258|P1|Overall Study|Lost to Follow-up|2
2845910|NCT02429310|9773289|P2|Overall Study|Protocol Violation|1
2845911|NCT02429310|9773290|P1|Overall Study|Protocol Violation|1
2845912|NCT02429310|9773289|P2|Overall Study|Lost to Follow-up|2
2845913|NCT02429310|9773290|P1|Overall Study|Lost to Follow-up|1
2845914|NCT02429258|9773300|P2|Overall Study|Protocol Violation|1
2845915|NCT02429258|9773301|P1|Overall Study|Protocol Violation|0
2845916|NCT02429258|9773300|P2|Overall Study|Withdrawal by Subject|0
2845917|NCT02429258|9773301|P1|Overall Study|Withdrawal by Subject|2
2845918|NCT02428699|9773355|P2|Washout Period 1|Screen Failure|2
2845919|NCT02428699|9773356|P1|Washout Period 1|Screen Failure|1
2845920|NCT02428608|9773384|P1|Overall Study|various|16
2845921|NCT02428608|9773384|P1|Overall Study|Death|1
2845922|NCT02428608|9773384|P1|Overall Study|moved away|10
2845923|NCT02428608|9773384|P1|Overall Study|scheduling conflicts|15
2845924|NCT02428608|9773384|P1|Overall Study|Withdrawal by Subject|2
2845925|NCT02428608|9773384|P1|Overall Study|Lost to Follow-up|37
2845926|NCT02428608|9773384|P1|Overall Study|Pregnancy|2
2845927|NCT02428413|9773416|P2|Overall Study|Nurse Refusal|0
2845928|NCT02428413|9773417|P1|Overall Study|Nurse Refusal|1
2845929|NCT02428413|9773416|P2|Overall Study|Missed Cases|2
2845930|NCT02428413|9773417|P1|Overall Study|Missed Cases|1
2845931|NCT02428413|9773416|P2|Overall Study|Case Cancelled|0
2845932|NCT02428413|9773417|P1|Overall Study|Case Cancelled|2
2845933|NCT02428413|9773416|P2|Overall Study|Protocol Violation|2
2845934|NCT02428413|9773417|P1|Overall Study|Protocol Violation|1
2845935|NCT02428413|9773416|P2|Overall Study|Device to measure WAG malfunctioned|5
2845936|NCT02428413|9773417|P1|Overall Study|Device to measure WAG malfunctioned|3
2845937|NCT02428296|9773452|P1|Overall Study|Withdrawal by Subject|2
2845938|NCT02428296|9773452|P1|Overall Study|Adverse Event|7
2845939|NCT02428231|9773464|P2|Overall Study|Adverse Event|0
2845940|NCT02428231|9773465|P1|Overall Study|Adverse Event|3
2845941|NCT02428231|9773464|P2|Overall Study|Required Symptomatic Therapy|1
2845942|NCT02428231|9773465|P1|Overall Study|Required Symptomatic Therapy|0
2845943|NCT02428231|9773464|P2|Overall Study|Other|16
2845944|NCT02428231|9773465|P1|Overall Study|Other|10
2845945|NCT02427984|9773497|P3|Overall Study|Lost to Follow-up|18
2845946|NCT02427984|9773498|P2|Overall Study|Lost to Follow-up|5
2845947|NCT02427984|9773499|P1|Overall Study|Lost to Follow-up|13
2845948|NCT02427958|9773513|P1|Overall Study|Lack of Efficacy|1
2845949|NCT02427958|9773513|P1|Overall Study|Withdrawal by Subject|14
2845950|NCT02427958|9773513|P1|Overall Study|Lost to Follow-up|6
2845951|NCT02427958|9773513|P1|Overall Study|Pretreatment Event (PTE) or AE|3
2845952|NCT02427646|9773606|P2|Overall Study|Bothersome hand weakness|4
2845953|NCT02427646|9773607|P1|Overall Study|Bothersome hand weakness|2
2845954|NCT02427646|9773606|P2|Overall Study|Protocol Violation|3
2845955|NCT02427646|9773607|P1|Overall Study|Protocol Violation|3
2845956|NCT02427646|9773606|P2|Overall Study|Physician Decision|4
2845957|NCT02427646|9773607|P1|Overall Study|Physician Decision|1
2845958|NCT02427646|9773606|P2|Overall Study|Lack of Efficacy|3
2845959|NCT02427646|9773607|P1|Overall Study|Lack of Efficacy|2
2845960|NCT02427607|9773615|P1|Overall Study|Withdrawal by Subject|1
2845961|NCT02427477|9773621|P2|Period 1|Adverse Event|0
2845962|NCT02427477|9773622|P1|Period 1|Adverse Event|1
2845963|NCT02427399|9773635|P5|Overall Study|Protocol Violation|15
2845964|NCT02427399|9773636|P4|Overall Study|Protocol Violation|18
2845965|NCT02427399|9773637|P3|Overall Study|Protocol Violation|12
2845966|NCT02427399|9773638|P2|Overall Study|Protocol Violation|16
2845967|NCT02427399|9773639|P1|Overall Study|Protocol Violation|14
2845968|NCT02427100|9773663|P2|Overall Study|Lost to Follow-up|2
2845969|NCT02427100|9773664|P1|Overall Study|Lost to Follow-up|0
2845970|NCT02426918|9773675|P3|Overall Study|Other|9
2845971|NCT02426918|9773676|P2|Overall Study|Other|11
2845972|NCT02426918|9773677|P1|Overall Study|Other|9
2845973|NCT02426918|9773675|P3|Overall Study|Withdrawal by Subject|4
2845974|NCT02426918|9773676|P2|Overall Study|Withdrawal by Subject|5
2845975|NCT02426918|9773677|P1|Overall Study|Withdrawal by Subject|5
2845976|NCT02426918|9773675|P3|Overall Study|Physician Decision|1
2845977|NCT02426918|9773676|P2|Overall Study|Physician Decision|1
2845978|NCT02426918|9773677|P1|Overall Study|Physician Decision|1
2845979|NCT02426918|9773675|P3|Overall Study|Adverse Event|0
2845980|NCT02426918|9773676|P2|Overall Study|Adverse Event|2
2845981|NCT02426918|9773677|P1|Overall Study|Adverse Event|2
2845982|NCT02426658|9773712|P1|Overall Study|Patient expired before treatment|2
2845983|NCT02426658|9773712|P1|Overall Study|Withdrawal by Subject|1
2845984|NCT02426580|9773719|P2|Overall Study|Allergic to egg white|0
2845985|NCT02426580|9773720|P1|Overall Study|Allergic to egg white|1
2845986|NCT02426580|9773719|P2|Overall Study|Kidney transplant|0
2845987|NCT02426580|9773720|P1|Overall Study|Kidney transplant|3
2845988|NCT02426580|9773719|P2|Overall Study|transfer to hemodialysis|5
2845989|NCT02426580|9773720|P1|Overall Study|transfer to hemodialysis|5
2845990|NCT02426580|9773719|P2|Overall Study|Lost to Follow-up|9
2845991|NCT02426580|9773720|P1|Overall Study|Lost to Follow-up|0
2845992|NCT02426580|9773719|P2|Overall Study|Death|2
2845993|NCT02426580|9773720|P1|Overall Study|Death|2
2845994|NCT02426541|9773728|P2|Overall Study|Protocol Violation|0
2845995|NCT02426541|9773729|P1|Overall Study|Protocol Violation|1
2845996|NCT02426138|9773741|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
2845997|NCT02426138|9773742|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
2845998|NCT02426125|9773782|P2|Overall Study|Withdrawal by Subject|16
2845999|NCT02426125|9773783|P1|Overall Study|Withdrawal by Subject|16
2846000|NCT02426125|9773782|P2|Overall Study|Protocol Violation|0
2846001|NCT02426125|9773783|P1|Overall Study|Protocol Violation|1
2846002|NCT02426125|9773782|P2|Overall Study|Lost to Follow-up|10
2846003|NCT02426125|9773783|P1|Overall Study|Lost to Follow-up|12
2846004|NCT02425826|9773814|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
2846005|NCT02425826|9773815|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2846006|NCT02425826|9773816|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2846007|NCT02425826|9773814|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
2846008|NCT02425826|9773815|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
2846009|NCT02425826|9773816|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
2846010|NCT02425826|9773814|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
2846011|NCT02425826|9773815|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
2846012|NCT02425826|9773816|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
2846013|NCT02425826|9773814|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
2846014|NCT02425826|9773815|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
2846015|NCT02425826|9773816|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
2846016|NCT02425826|9773814|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
2846017|NCT02425826|9773815|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
2846018|NCT02425826|9773816|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
2846019|NCT02425826|9773814|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
2846020|NCT02425826|9773815|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
2846021|NCT02425826|9773816|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
2846022|NCT02425826|9773814|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
2846023|NCT02425826|9773815|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
2846024|NCT02425826|9773816|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
2846025|NCT02425826|9773814|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
2846026|NCT02425826|9773815|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
2846027|NCT02425826|9773816|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
2846028|NCT02425826|9773814|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2846029|NCT02425826|9773815|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
2846030|NCT02425826|9773816|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2846031|NCT02425826|9773814|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
2846032|NCT02425826|9773815|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
2846033|NCT02425826|9773816|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
2846034|NCT02425111|9773870|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
2846035|NCT02425111|9773870|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
2846036|NCT02425111|9773870|P1|Part A: Treatment Period|Lost to Follow-up|2
2846037|NCT02425111|9773870|P1|Part A: Treatment Period|Voluntary Withdrawal|4
2846038|NCT02425111|9773870|P1|Part A: Treatment Period|Lack of Efficacy|15
2846039|NCT02425111|9773870|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
2846040|NCT02425098|9773891|P2|Overall Study|Reason not Specified|1
2846041|NCT02425098|9773892|P1|Overall Study|Reason not Specified|0
2846042|NCT02425098|9773891|P2|Overall Study|Pregnancy|0
2846043|NCT02425098|9773892|P1|Overall Study|Pregnancy|2
2846044|NCT02425098|9773891|P2|Overall Study|Withdrawal by Subject|8
2846045|NCT02425098|9773892|P1|Overall Study|Withdrawal by Subject|4
2846046|NCT02425098|9773891|P2|Overall Study|Lost to Follow-up|7
2846047|NCT02425098|9773892|P1|Overall Study|Lost to Follow-up|7
2846048|NCT02424734|9774044|P3|Overall Study|Treatment stopped to be discharged home|0
2846049|NCT02424734|9774045|P2|Overall Study|Treatment stopped to be discharged home|2
2846050|NCT02424734|9774046|P1|Overall Study|Treatment stopped to be discharged home|2
2846051|NCT02424591|9774065|P2|Overall Study|Protocol Violation|3
2846052|NCT02424591|9774066|P1|Overall Study|Protocol Violation|2
2846053|NCT02424578|9774078|P2|Overall Study|Withdrawal by Subject|1
2846054|NCT02424578|9774079|P1|Overall Study|Withdrawal by Subject|0
2846055|NCT02424565|9774085|P2|Period 1 (D0)|Protocol Violation|1
2846056|NCT02424565|9774086|P1|Period 1 (D0)|Protocol Violation|0
2846057|NCT02424539|9774095|P3|Overall Study|Other: Reached stopping criteria|6
2846058|NCT02424539|9774096|P2|Overall Study|Other: Reached stopping criteria|7
2846059|NCT02424539|9774097|P1|Overall Study|Other: Reached stopping criteria|11
2846060|NCT02424539|9774095|P3|Overall Study|Withdrawal by Subject|0
2846061|NCT02424539|9774096|P2|Overall Study|Withdrawal by Subject|1
2846062|NCT02424539|9774097|P1|Overall Study|Withdrawal by Subject|3
2846063|NCT02424539|9774095|P3|Overall Study|Physician Decision|1
2846064|NCT02424539|9774096|P2|Overall Study|Physician Decision|0
2846065|NCT02424539|9774097|P1|Overall Study|Physician Decision|0
2846066|NCT02424539|9774095|P3|Overall Study|Adverse Event|1
2846067|NCT02424539|9774096|P2|Overall Study|Adverse Event|0
2846068|NCT02424539|9774097|P1|Overall Study|Adverse Event|0
2846069|NCT02424383|9774159|P1|Overall Study|Ineligible for Major Protocol Deviation|39
2846070|NCT02424383|9774159|P1|Overall Study|Other|7
2846071|NCT02424383|9774159|P1|Overall Study|Lost to Follow-up|81
2846072|NCT02424383|9774159|P1|Overall Study|Investigator's decision|44
2846073|NCT02424383|9774159|P1|Overall Study|Sponsor's decision|3
2846074|NCT02424383|9774159|P1|Overall Study|Death|170
2846075|NCT02424383|9774159|P1|Overall Study|Withdrawal by Subject|32
2846076|NCT02424344|9774183|P2|Overall Study|Adverse Event|8
2846077|NCT02424344|9774184|P1|Overall Study|Adverse Event|4
2846078|NCT02424344|9774183|P2|Overall Study|Lost to Follow-up|0
2846079|NCT02424344|9774184|P1|Overall Study|Lost to Follow-up|1
2846080|NCT02424344|9774183|P2|Overall Study|Withdrawal by Subject|1
2846081|NCT02424344|9774184|P1|Overall Study|Withdrawal by Subject|2
2846082|NCT02424344|9774183|P2|Overall Study|Lack of Efficacy|1
2846083|NCT02424344|9774184|P1|Overall Study|Lack of Efficacy|0
2846084|NCT02424149|9774202|P2|Overall Study|Withdrawal by Subject|1
2846085|NCT02424149|9774203|P1|Overall Study|Withdrawal by Subject|0
2846086|NCT02424149|9774202|P2|Overall Study|surgery cancelled|0
2846087|NCT02424149|9774203|P1|Overall Study|surgery cancelled|2
2846088|NCT02424097|9774219|P2|Overall Study|Lost to Follow-up|2
2846089|NCT02424097|9774220|P1|Overall Study|Lost to Follow-up|1
2846090|NCT02423798|9774275|P1|Overall Study|Withdrawal by Subject|3
2846091|NCT02423291|9774341|P1|Overall Study|Adverse Event|1
2846092|NCT02423291|9774341|P1|Overall Study|Lack of Efficacy|14
2846093|NCT02423109|9774371|P2|Lens 1|Adverse Event|0
2846094|NCT02423109|9774372|P1|Lens 1|Adverse Event|1
2846095|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
2846096|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2846097|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
2846098|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
2846099|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
2846100|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
2846101|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
2846102|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
2846103|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
2846104|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
2846105|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
2846106|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
2846107|NCT02422797|9774405|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
2846108|NCT02422797|9774406|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
2846109|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
2846110|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
2846111|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
2846112|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
2846113|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
2846114|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
2846115|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2846116|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2846117|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
2846118|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
2846119|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
2846120|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
2846121|NCT02422797|9774405|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
2846122|NCT02422797|9774406|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
2846123|NCT02422615|9774494|P2|Overall Study|Technical problems|1
2846124|NCT02422615|9774495|P1|Overall Study|Technical problems|0
2846125|NCT02422615|9774494|P2|Overall Study|Protocol Violation|1
2846126|NCT02422615|9774495|P1|Overall Study|Protocol Violation|1
2846127|NCT02422615|9774494|P2|Overall Study|Death|0
2846128|NCT02422615|9774495|P1|Overall Study|Death|2
2846129|NCT02422615|9774494|P2|Overall Study|Subject/guardian decision|5
2846130|NCT02422615|9774495|P1|Overall Study|Subject/guardian decision|21
2846131|NCT02422615|9774494|P2|Overall Study|Physician Decision|7
2846132|NCT02422615|9774495|P1|Overall Study|Physician Decision|22
2846133|NCT02422615|9774494|P2|Overall Study|Adverse Event|10
2846134|NCT02422615|9774495|P1|Overall Study|Adverse Event|41
2846135|NCT02422615|9774494|P2|Overall Study|Progressive disease|142
2846136|NCT02422615|9774495|P1|Overall Study|Progressive disease|193
2846137|NCT02422303|9774512|P2|Overall Study|Lost to Follow-up|1
2846138|NCT02422303|9774513|P1|Overall Study|Lost to Follow-up|1
2846139|NCT02422264|9774521|P2|Overall Study|Subject vaccinated outside of the study|1
2846140|NCT02422264|9774522|P1|Overall Study|Subject vaccinated outside of the study|0
2846141|NCT02422264|9774521|P2|Overall Study|Migrated/moved from study area|1
2846142|NCT02422264|9774522|P1|Overall Study|Migrated/moved from study area|3
2846143|NCT02422264|9774521|P2|Overall Study|Withdrawal by Subject|2
2846144|NCT02422264|9774522|P1|Overall Study|Withdrawal by Subject|1
2846145|NCT02422264|9774521|P2|Overall Study|Serious Adverse Event|0
2846146|NCT02422264|9774522|P1|Overall Study|Serious Adverse Event|1
2846147|NCT02422186|9774568|P2|Follow-up Phase (2 Weeks)|Other|0
2846148|NCT02422186|9774569|P1|Follow-up Phase (2 Weeks)|Other|3
2846149|NCT02422186|9774568|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
2846150|NCT02422186|9774569|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
2846151|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Other|0
2846152|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Other|1
2846153|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2846154|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
2846155|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2846156|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
2846157|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
2846158|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2846159|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2846160|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
2846161|NCT02422186|9774568|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2846162|NCT02422186|9774569|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2846163|NCT02421952|9774591|P1|Overall Study|Surgery cancelled|1
2846164|NCT02421952|9774591|P1|Overall Study|Subject uncooperative for baseline test|2
2846165|NCT02421952|9774591|P1|Overall Study|Failed seriation task|13
2846166|NCT02421952|9774591|P1|Overall Study|Diary Not Returned|93
2846167|NCT02421939|9774600|P2|Overall Study|Protocol deviation|1
2846168|NCT02421939|9774601|P1|Overall Study|Protocol deviation|1
2846169|NCT02421939|9774600|P2|Overall Study|Miscellaneous|5
2846170|NCT02421939|9774601|P1|Overall Study|Miscellaneous|4
2846171|NCT02421939|9774600|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
2846172|NCT02421939|9774601|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
2846173|NCT02421939|9774600|P2|Overall Study|Physician Decision|11
2846174|NCT02421939|9774601|P1|Overall Study|Physician Decision|11
2846175|NCT02421939|9774600|P2|Overall Study|Withdrawal by Subject|24
2846176|NCT02421939|9774601|P1|Overall Study|Withdrawal by Subject|5
2846177|NCT02421939|9774600|P2|Overall Study|Adverse Event|5
2846178|NCT02421939|9774601|P1|Overall Study|Adverse Event|28
2846179|NCT02421939|9774600|P2|Overall Study|Disease relapse|2
2846180|NCT02421939|9774601|P1|Overall Study|Disease relapse|33
2846181|NCT02421939|9774600|P2|Overall Study|Death|10
2846182|NCT02421939|9774601|P1|Overall Study|Death|36
2846183|NCT02421939|9774600|P2|Overall Study|Lack of Efficacy|31
2846184|NCT02421939|9774601|P1|Overall Study|Lack of Efficacy|21
2846185|NCT02421939|9774600|P2|Overall Study|Progressive disease|16
2846186|NCT02421939|9774601|P1|Overall Study|Progressive disease|70
2846187|NCT02421887|9774629|P2|Overall Study|Adverse Event|0
2846188|NCT02421887|9774630|P1|Overall Study|Adverse Event|2
2846189|NCT02421887|9774629|P2|Overall Study|Physician Decision|4
2846190|NCT02421887|9774630|P1|Overall Study|Physician Decision|2
2846191|NCT02421887|9774629|P2|Overall Study|Withdrawal by Subject|5
2846192|NCT02421887|9774630|P1|Overall Study|Withdrawal by Subject|8
2846193|NCT02421887|9774629|P2|Overall Study|Lost to Follow-up|0
2846194|NCT02421887|9774630|P1|Overall Study|Lost to Follow-up|5
2846195|NCT02421588|9774656|P2|Overall Study|Not treated|8
2846196|NCT02421588|9774657|P1|Overall Study|Not treated|2
2846197|NCT02421588|9774656|P2|Overall Study|Withdrawal by Subject|16
2846198|NCT02421588|9774657|P1|Overall Study|Withdrawal by Subject|14
2846199|NCT02421588|9774656|P2|Overall Study|Treatment-related AE|14
2846200|NCT02421588|9774657|P1|Overall Study|Treatment-related AE|10
2846201|NCT02421588|9774656|P2|Overall Study|Symptomatic deterioration|19
2846202|NCT02421588|9774657|P1|Overall Study|Symptomatic deterioration|13
2846203|NCT02421588|9774656|P2|Overall Study|Other reason not specified|1
2846204|NCT02421588|9774657|P1|Overall Study|Other reason not specified|3
2846205|NCT02421588|9774656|P2|Overall Study|Physician Decision|17
2846206|NCT02421588|9774657|P1|Overall Study|Physician Decision|8
2846207|NCT02421588|9774656|P2|Overall Study|Death|3
2846208|NCT02421588|9774657|P1|Overall Study|Death|11
2846209|NCT02421588|9774656|P2|Overall Study|Progressive disease|135
2846210|NCT02421588|9774657|P1|Overall Study|Progressive disease|152
2846211|NCT02421588|9774656|P2|Overall Study|Non-treatment-related AE|8
2846212|NCT02421588|9774657|P1|Overall Study|Non-treatment-related AE|8
2846213|NCT02421510|9774680|P3|Overall Study|Lost to Follow-up|0
2846214|NCT02421510|9774681|P2|Overall Study|Lost to Follow-up|1
2846215|NCT02421510|9774682|P1|Overall Study|Lost to Follow-up|1
2846216|NCT02421510|9774680|P3|Overall Study|Withdrawal by Subject|12
2846217|NCT02421510|9774681|P2|Overall Study|Withdrawal by Subject|18
2846218|NCT02421510|9774682|P1|Overall Study|Withdrawal by Subject|14
2846219|NCT02421510|9774680|P3|Overall Study|Pregnancy|0
2846220|NCT02421510|9774681|P2|Overall Study|Pregnancy|1
2846221|NCT02421510|9774682|P1|Overall Study|Pregnancy|1
2846222|NCT02421510|9774680|P3|Overall Study|Adverse Event|18
2846223|NCT02421510|9774681|P2|Overall Study|Adverse Event|10
2846224|NCT02421510|9774682|P1|Overall Study|Adverse Event|9
2846225|NCT02421510|9774680|P3|Overall Study|Physician Decision|3
2846226|NCT02421510|9774681|P2|Overall Study|Physician Decision|1
2846227|NCT02421510|9774682|P1|Overall Study|Physician Decision|1
2846228|NCT02421510|9774680|P3|Overall Study|Noncompliance with study drug|0
2846229|NCT02421510|9774681|P2|Overall Study|Noncompliance with study drug|0
2846230|NCT02421510|9774682|P1|Overall Study|Noncompliance with study drug|1
2846231|NCT02421510|9774680|P3|Overall Study|Death|0
2846232|NCT02421510|9774681|P2|Overall Study|Death|0
2846233|NCT02421510|9774682|P1|Overall Study|Death|1
2846234|NCT02421510|9774680|P3|Overall Study|Protocol Violation|0
2846235|NCT02421510|9774681|P2|Overall Study|Protocol Violation|2
2846236|NCT02421510|9774682|P1|Overall Study|Protocol Violation|1
2846237|NCT02421510|9774680|P3|Overall Study|Other|3
2846238|NCT02421510|9774681|P2|Overall Study|Other|2
2846239|NCT02421510|9774682|P1|Overall Study|Other|4
2846240|NCT02421419|9774714|P3|Overall Study|Physician Decision|1
2846241|NCT02421419|9774715|P2|Overall Study|Physician Decision|0
2846242|NCT02421419|9774716|P1|Overall Study|Physician Decision|0
2846243|NCT02421172|9774786|P5|Period 2|Patient/guardian decision|1
2846244|NCT02421172|9774787|P4|Period 2|Patient/guardian decision|2
2846245|NCT02421172|9774788|P3|Period 2|Patient/guardian decision|3
2846246|NCT02421172|9774789|P2|Period 2|Patient/guardian decision|0
2846247|NCT02421172|9774790|P1|Period 2|Patient/guardian decision|0
2846248|NCT02421172|9774786|P5|Period 2|Lost to Follow-up|0
2846249|NCT02421172|9774787|P4|Period 2|Lost to Follow-up|1
2846250|NCT02421172|9774788|P3|Period 2|Lost to Follow-up|0
2846251|NCT02421172|9774789|P2|Period 2|Lost to Follow-up|0
2846252|NCT02421172|9774790|P1|Period 2|Lost to Follow-up|0
2846253|NCT02421172|9774786|P5|Period 2|Adverse Event|0
2846254|NCT02421172|9774787|P4|Period 2|Adverse Event|0
2846255|NCT02421172|9774788|P3|Period 2|Adverse Event|4
2846256|NCT02421172|9774789|P2|Period 2|Adverse Event|0
2846257|NCT02421172|9774790|P1|Period 2|Adverse Event|0
2846258|NCT02421172|9774786|P5|Period 1|Patient/guardian decision|0
2846259|NCT02421172|9774787|P4|Period 1|Patient/guardian decision|0
2846260|NCT02421172|9774788|P3|Period 1|Patient/guardian decision|0
2846261|NCT02421172|9774789|P2|Period 1|Patient/guardian decision|1
2846262|NCT02421172|9774790|P1|Period 1|Patient/guardian decision|0
2846263|NCT02421172|9774786|P5|Period 1|Lost to Follow-up|0
2846264|NCT02421172|9774787|P4|Period 1|Lost to Follow-up|0
2846265|NCT02421172|9774788|P3|Period 1|Lost to Follow-up|0
2846266|NCT02421172|9774789|P2|Period 1|Lost to Follow-up|1
2846267|NCT02421172|9774790|P1|Period 1|Lost to Follow-up|3
2846268|NCT02421172|9774786|P5|Period 1|Adverse Event|0
2846269|NCT02421172|9774787|P4|Period 1|Adverse Event|0
2846270|NCT02421172|9774788|P3|Period 1|Adverse Event|0
2846271|NCT02421172|9774789|P2|Period 1|Adverse Event|0
2846272|NCT02421172|9774790|P1|Period 1|Adverse Event|1
2846273|NCT02421120|9774834|P1|Overall Study|Adverse Event|1
2846274|NCT02420821|9774876|P2|Overall Study|Death|116
2846275|NCT02420821|9774877|P1|Overall Study|Death|129
2846276|NCT02420821|9774876|P2|Overall Study|Withdrawal by Subject|17
2846277|NCT02420821|9774877|P1|Overall Study|Withdrawal by Subject|31
2846278|NCT02420821|9774876|P2|Overall Study|Physician Decision|2
2846279|NCT02420821|9774877|P1|Overall Study|Physician Decision|5
2846280|NCT02420821|9774876|P2|Overall Study|Non-compliance|2
2846281|NCT02420821|9774877|P1|Overall Study|Non-compliance|1
2846282|NCT02420821|9774876|P2|Overall Study|Lost to Follow-up|0
2846283|NCT02420821|9774877|P1|Overall Study|Lost to Follow-up|2
2846284|NCT02420353|9774947|P2|Overall Study|Withdrawal by Subject|1
2846285|NCT02420353|9774948|P1|Overall Study|Withdrawal by Subject|0
2846286|NCT02420327|9775040|P1|Overall Study|Protocol Violation|1
2846287|NCT02420327|9775040|P1|Overall Study|Lost to Follow-up|1
2846288|NCT02420327|9775040|P1|Overall Study|Withdrawal by Subject|6
2846289|NCT02420327|9775040|P1|Overall Study|Pregnancy|1
2846290|NCT02420327|9775040|P1|Overall Study|Adverse Event|7
2846291|NCT02420262|9775076|P2|Overall Study|Unclassified|1
2846292|NCT02420262|9775077|P1|Overall Study|Unclassified|0
2846293|NCT02420262|9775076|P2|Overall Study|Withdrawal by Subject|4
2846294|NCT02420262|9775077|P1|Overall Study|Withdrawal by Subject|1
2846295|NCT02420262|9775076|P2|Overall Study|Adverse Event|0
2846296|NCT02420262|9775077|P1|Overall Study|Adverse Event|1
2846297|NCT02420093|9775103|P2|Overall Study|Withdrawal by Subject|1
2846298|NCT02420093|9775104|P1|Overall Study|Withdrawal by Subject|1
2846299|NCT02419937|9775166|P2|Overall Study|Lost to Follow-up|0
2846300|NCT02419937|9775167|P1|Overall Study|Lost to Follow-up|1
2846301|NCT02419755|9775175|P2|Overall Study|Withdrawal by Subject|0
2846302|NCT02419755|9775176|P1|Overall Study|Withdrawal by Subject|1
2846303|NCT02419755|9775175|P2|Overall Study|Ineligible|0
2846304|NCT02419755|9775176|P1|Overall Study|Ineligible|1
2846305|NCT02419755|9775175|P2|Overall Study|Relapse|1
2846306|NCT02419755|9775176|P1|Overall Study|Relapse|0
2846307|NCT02419755|9775175|P2|Overall Study|Death|3
2846308|NCT02419755|9775176|P1|Overall Study|Death|1
2846309|NCT02419612|9775202|P2|Overall Study|Subject moved out of state|1
2846310|NCT02419612|9775203|P1|Overall Study|Subject moved out of state|0
2846311|NCT02419612|9775202|P2|Overall Study|Worsening of liver function|1
2846312|NCT02419612|9775203|P1|Overall Study|Worsening of liver function|0
2846313|NCT02419612|9775202|P2|Overall Study|Noncompliance With Study Drug|2
2846314|NCT02419612|9775203|P1|Overall Study|Noncompliance With Study Drug|0
2846315|NCT02419612|9775202|P2|Overall Study|Subject Request To Discontinue Treatment|1
2846316|NCT02419612|9775203|P1|Overall Study|Subject Request To Discontinue Treatment|1
2846317|NCT02419612|9775202|P2|Overall Study|Withdrawal by Subject|9
2846318|NCT02419612|9775203|P1|Overall Study|Withdrawal by Subject|9
2846319|NCT02419612|9775202|P2|Overall Study|Lost to Follow-up|6
2846320|NCT02419612|9775203|P1|Overall Study|Lost to Follow-up|6
2846321|NCT02419612|9775202|P2|Overall Study|Death|2
2846322|NCT02419612|9775203|P1|Overall Study|Death|0
2846323|NCT02419612|9775202|P2|Overall Study|Adverse Event|1
2846324|NCT02419612|9775203|P1|Overall Study|Adverse Event|1
2846325|NCT02419573|9775219|P2|Overall Study|Withdrawal by Subject|0
2846326|NCT02419573|9775220|P1|Overall Study|Withdrawal by Subject|1
2846327|NCT02419573|9775219|P2|Overall Study|Lost to Follow-up|0
2846328|NCT02419573|9775220|P1|Overall Study|Lost to Follow-up|3
2846329|NCT02419508|9775250|P2|Overall Study|Other - Reason not specified|1
2846330|NCT02419508|9775251|P1|Overall Study|Other - Reason not specified|0
2846331|NCT02419508|9775250|P2|Overall Study|Withdrawal by Subject|0
2846332|NCT02419508|9775251|P1|Overall Study|Withdrawal by Subject|1
2846333|NCT02419508|9775250|P2|Overall Study|Adverse Event|3
2846334|NCT02419508|9775251|P1|Overall Study|Adverse Event|9
2846335|NCT02419469|9775269|P1|Overall Study|Withdrawal by Subject|1
2846336|NCT02419313|9775273|P2|Second Intervention|Lost to Follow-up|0
2846337|NCT02419313|9775274|P1|Second Intervention|Lost to Follow-up|1
2846338|NCT02419313|9775273|P2|First Intervention|Lost to Follow-up|0
2846339|NCT02419313|9775274|P1|First Intervention|Lost to Follow-up|2
2846340|NCT02419001|9775286|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
2846341|NCT02419001|9775287|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
2846342|NCT02418910|9775297|P1|Overall Study|Withdrawal by Subject|4
2846343|NCT02418910|9775297|P1|Overall Study|Lost to Follow-up|3
2846344|NCT02418819|9775305|P4|Overall Study|No longer willing to participate|1
2846345|NCT02418819|9775306|P3|Overall Study|No longer willing to participate|2
2846346|NCT02418819|9775307|P2|Overall Study|No longer willing to participate|0
2846347|NCT02418819|9775308|P1|Overall Study|No longer willing to participate|0
2846348|NCT02418819|9775305|P4|Overall Study|No longer meets eligibility criteria|0
2846349|NCT02418819|9775306|P3|Overall Study|No longer meets eligibility criteria|1
2846350|NCT02418819|9775307|P2|Overall Study|No longer meets eligibility criteria|0
2846351|NCT02418819|9775308|P1|Overall Study|No longer meets eligibility criteria|0
2846352|NCT02418819|9775305|P4|Overall Study|Lost to Follow-up|0
2846353|NCT02418819|9775306|P3|Overall Study|Lost to Follow-up|0
2846354|NCT02418819|9775307|P2|Overall Study|Lost to Follow-up|0
2846355|NCT02418819|9775308|P1|Overall Study|Lost to Follow-up|1
2846356|NCT02418819|9775305|P4|Overall Study|Adverse Event|0
2846357|NCT02418819|9775306|P3|Overall Study|Adverse Event|1
2846358|NCT02418819|9775307|P2|Overall Study|Adverse Event|0
2846359|NCT02418819|9775308|P1|Overall Study|Adverse Event|0
2846360|NCT02418585|9775366|P2|Follow-up Phase (24 Weeks)|Other|2
2846361|NCT02418585|9775367|P1|Follow-up Phase (24 Weeks)|Other|3
2846362|NCT02418585|9775366|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
2846363|NCT02418585|9775367|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
2846364|NCT02418585|9775366|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2846365|NCT02418585|9775367|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
2846366|NCT02418585|9775366|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2846367|NCT02418585|9775367|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2846368|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
2846369|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
2846370|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
2846371|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
2846372|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
2846373|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
2846374|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
2846375|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
2846376|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2846377|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2846378|NCT02418585|9775366|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2846379|NCT02418585|9775367|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2846380|NCT02418468|9775423|P2|Overall Study|Withdrawal of informed consent|1
2846381|NCT02418468|9775424|P1|Overall Study|Withdrawal of informed consent|1
2846382|NCT02418468|9775423|P2|Overall Study|Adverse Event|0
2846383|NCT02418468|9775424|P1|Overall Study|Adverse Event|1
2846384|NCT02418455|9775430|P1|Continuation Period|Sponsor Decision|7
2846385|NCT02418455|9775430|P1|48-Week Treatment Period|Other- Not Specified|1
2846386|NCT02418182|9775473|P2|Overall Study|Lost to Follow-up|2
2846387|NCT02418182|9775474|P1|Overall Study|Lost to Follow-up|0
2846388|NCT02418182|9775473|P2|Overall Study|Unable to re-consent|15
2846389|NCT02418182|9775474|P1|Overall Study|Unable to re-consent|18
2846390|NCT02418156|9775486|P1|Overall Study|Subject refused to return|1
2846391|NCT02418156|9775486|P1|Overall Study|Withdrawal by Subject|1
2846392|NCT02418156|9775486|P1|Overall Study|Physician Decision|1
2846393|NCT02418156|9775486|P1|Overall Study|Death|2
2846394|NCT02418156|9775486|P1|Overall Study|Lost to Follow-up|12
2846395|NCT02418000|9775528|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
2846396|NCT02418000|9775529|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846397|NCT02418000|9775530|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846398|NCT02418000|9775531|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846399|NCT02418000|9775532|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846400|NCT02418000|9775528|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
2846401|NCT02418000|9775529|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2846402|NCT02418000|9775530|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2846403|NCT02418000|9775531|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2846404|NCT02418000|9775532|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2846405|NCT02418000|9775528|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846406|NCT02418000|9775529|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
2846407|NCT02418000|9775530|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846408|NCT02418000|9775531|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846409|NCT02418000|9775532|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846410|NCT02418000|9775528|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846411|NCT02418000|9775529|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846412|NCT02418000|9775530|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
2846413|NCT02418000|9775531|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846414|NCT02418000|9775532|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2846415|NCT02418000|9775528|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2846416|NCT02418000|9775529|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2846417|NCT02418000|9775530|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2846418|NCT02418000|9775531|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
2846419|NCT02418000|9775532|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2846420|NCT02418000|9775528|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2846421|NCT02418000|9775529|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2846422|NCT02418000|9775530|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2846423|NCT02418000|9775531|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
2846424|NCT02418000|9775532|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2846425|NCT02418000|9775528|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2846426|NCT02418000|9775529|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2846427|NCT02418000|9775530|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2846428|NCT02418000|9775531|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2846429|NCT02418000|9775532|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
2846430|NCT02418000|9775528|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2846431|NCT02418000|9775529|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2846432|NCT02418000|9775530|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2846433|NCT02418000|9775531|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2846434|NCT02418000|9775532|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
2846435|NCT02418000|9775528|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2846436|NCT02418000|9775529|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2846437|NCT02418000|9775530|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2846438|NCT02418000|9775531|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2846439|NCT02418000|9775532|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
2846440|NCT02417961|9775650|P1|Overall Study|Withdrawal by Subject|2
2846441|NCT02417961|9775650|P1|Overall Study|Lost to Follow-up|1
2846442|NCT02417961|9775650|P1|Overall Study|Adverse Event|1
2846443|NCT02417935|9775662|P2|Treatment Period|Physician Decision|1
2846444|NCT02417935|9775663|P1|Treatment Period|Physician Decision|3
2846445|NCT02417935|9775662|P2|Treatment Period|Withdrawal by Subject|3
2846446|NCT02417935|9775663|P1|Treatment Period|Withdrawal by Subject|3
2846447|NCT02417935|9775662|P2|Treatment Period|Protocol Violation|1
2846448|NCT02417935|9775663|P1|Treatment Period|Protocol Violation|2
2846449|NCT02417935|9775662|P2|Treatment Period|Entry Criteria not met|1
2846450|NCT02417935|9775663|P1|Treatment Period|Entry Criteria not met|0
2846451|NCT02417935|9775662|P2|Treatment Period|Lost to Follow-up|0
2846452|NCT02417935|9775663|P1|Treatment Period|Lost to Follow-up|1
2846453|NCT02417935|9775662|P2|Treatment Period|Adverse Event|10
2846454|NCT02417935|9775663|P1|Treatment Period|Adverse Event|12
2846455|NCT02417753|9775721|P1|Overall Study|Death|1
2846456|NCT02417441|9775741|P2|Overall Study|Inconclusive due to missing data|19
2846457|NCT02417441|9775742|P1|Overall Study|Inconclusive due to missing data|52
2846458|NCT02417246|9775810|P2|Phase 2 1st Generic Administered|Physician Decision|0
2846459|NCT02417246|9775811|P1|Phase 2 1st Generic Administered|Physician Decision|1
2846460|NCT02417246|9775810|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
2846461|NCT02417246|9775811|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
2846462|NCT02417246|9775810|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
2846463|NCT02417246|9775811|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
2846464|NCT02417246|9775810|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2846465|NCT02417246|9775811|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2846466|NCT02417233|9775834|P3|Overall Study|Mentally unstable|0
2846467|NCT02417233|9775835|P2|Overall Study|Mentally unstable|1
2846468|NCT02417233|9775836|P1|Overall Study|Mentally unstable|0
2846469|NCT02417233|9775834|P3|Overall Study|Relocation out of study area|1
2846470|NCT02417233|9775835|P2|Overall Study|Relocation out of study area|0
2846471|NCT02417233|9775836|P1|Overall Study|Relocation out of study area|1
2846472|NCT02417233|9775834|P3|Overall Study|Withdrawal by Subject|8
2846473|NCT02417233|9775835|P2|Overall Study|Withdrawal by Subject|1
2846474|NCT02417233|9775836|P1|Overall Study|Withdrawal by Subject|2
2846475|NCT02417233|9775834|P3|Overall Study|Protocol Violation|2
2846476|NCT02417233|9775835|P2|Overall Study|Protocol Violation|0
2846477|NCT02417233|9775836|P1|Overall Study|Protocol Violation|2
2846478|NCT02417233|9775834|P3|Overall Study|Lost to Follow-up|34
2846479|NCT02417233|9775835|P2|Overall Study|Lost to Follow-up|39
2846480|NCT02417233|9775836|P1|Overall Study|Lost to Follow-up|27
2846481|NCT02417233|9775834|P3|Overall Study|Death|14
2846482|NCT02417233|9775835|P2|Overall Study|Death|10
2846483|NCT02417233|9775836|P1|Overall Study|Death|4
2846484|NCT02417064|9775873|P3|Follow-up Phase (24 Weeks)|Other|3
2846485|NCT02417064|9775874|P2|Follow-up Phase (24 Weeks)|Other|2
2846486|NCT02417064|9775875|P1|Follow-up Phase (24 Weeks)|Other|2
2846487|NCT02417064|9775873|P3|Follow-up Phase (24 Weeks)|PI Decision|44
2846488|NCT02417064|9775874|P2|Follow-up Phase (24 Weeks)|PI Decision|29
2846489|NCT02417064|9775875|P1|Follow-up Phase (24 Weeks)|PI Decision|34
2846490|NCT02417064|9775873|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
2846491|NCT02417064|9775874|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
2846492|NCT02417064|9775875|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2846493|NCT02417064|9775873|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
2846494|NCT02417064|9775874|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
2846495|NCT02417064|9775875|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
2846496|NCT02417064|9775873|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
2846497|NCT02417064|9775874|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
2846498|NCT02417064|9775875|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
2846499|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Other|2
2846500|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Other|4
2846501|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Other|1
2846502|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2846503|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
2846504|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2846505|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2846506|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2846507|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
2846508|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2846509|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2846510|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2846511|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
2846512|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2846513|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2846514|NCT02417064|9775873|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2846515|NCT02417064|9775874|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
2846516|NCT02417064|9775875|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
2846517|NCT02416934|9775946|P2|Overall Study|re-operation|0
2846518|NCT02416934|9775947|P1|Overall Study|re-operation|1
2846519|NCT02416934|9775946|P2|Overall Study|surgery started late|1
2846520|NCT02416934|9775947|P1|Overall Study|surgery started late|0
2846521|NCT02416934|9775946|P2|Overall Study|Protocol Violation|1
2846522|NCT02416934|9775947|P1|Overall Study|Protocol Violation|0
2846523|NCT02416934|9775946|P2|Overall Study|recruited during continuing renewal proc|1
2846524|NCT02416934|9775947|P1|Overall Study|recruited during continuing renewal proc|0
2846525|NCT02416934|9775946|P2|Overall Study|Withdrawal by Subject|0
2846526|NCT02416934|9775947|P1|Overall Study|Withdrawal by Subject|1
2846527|NCT02416934|9775946|P2|Overall Study|Lost to Follow-up|2
2846528|NCT02416934|9775947|P1|Overall Study|Lost to Follow-up|0
2846529|NCT02416934|9775946|P2|Overall Study|given steroids|2
2846530|NCT02416934|9775947|P1|Overall Study|given steroids|1
2846531|NCT02416908|9775962|P4|Dose Escalation Phase|Withdrawal by Subject|0
2846532|NCT02416908|9775963|P3|Dose Escalation Phase|Withdrawal by Subject|1
2846533|NCT02416908|9775964|P2|Dose Escalation Phase|Withdrawal by Subject|0
2846534|NCT02416908|9775965|P1|Dose Escalation Phase|Withdrawal by Subject|0
2846535|NCT02416908|9775962|P4|Dose Escalation Phase|Adverse Event|0
2846536|NCT02416908|9775963|P3|Dose Escalation Phase|Adverse Event|3
2846537|NCT02416908|9775964|P2|Dose Escalation Phase|Adverse Event|0
2846538|NCT02416908|9775965|P1|Dose Escalation Phase|Adverse Event|0
2846539|NCT02416180|9775997|P1|Overall Study|Withdrawal by Subject|1
2846540|NCT02415959|9776013|P5|Overall Study|Protocol Violation|0
2846541|NCT02415959|9776014|P4|Overall Study|Protocol Violation|1
2846542|NCT02415959|9776015|P3|Overall Study|Protocol Violation|0
2846543|NCT02415959|9776016|P2|Overall Study|Protocol Violation|0
2846544|NCT02415959|9776017|P1|Overall Study|Protocol Violation|0
2846545|NCT02415959|9776013|P5|Overall Study|Adverse Event|0
2846546|NCT02415959|9776014|P4|Overall Study|Adverse Event|0
2846547|NCT02415959|9776015|P3|Overall Study|Adverse Event|0
2846548|NCT02415959|9776016|P2|Overall Study|Adverse Event|1
2846549|NCT02415959|9776017|P1|Overall Study|Adverse Event|0
2846550|NCT02415595|9776446|P4|Overall Study|Other|0
2846551|NCT02415595|9776447|P3|Overall Study|Other|1
2846552|NCT02415595|9776448|P2|Overall Study|Other|1
2846553|NCT02415595|9776449|P1|Overall Study|Other|0
2846554|NCT02415595|9776446|P4|Overall Study|Withdrawal by Subject|3
2846555|NCT02415595|9776447|P3|Overall Study|Withdrawal by Subject|1
2846556|NCT02415595|9776448|P2|Overall Study|Withdrawal by Subject|0
2846557|NCT02415595|9776449|P1|Overall Study|Withdrawal by Subject|4
2846558|NCT02415595|9776446|P4|Overall Study|Reached stopping criteria|0
2846559|NCT02415595|9776447|P3|Overall Study|Reached stopping criteria|1
2846560|NCT02415595|9776448|P2|Overall Study|Reached stopping criteria|1
2846561|NCT02415595|9776449|P1|Overall Study|Reached stopping criteria|0
2846562|NCT02415595|9776446|P4|Overall Study|Poor/Non-compliance|0
2846563|NCT02415595|9776447|P3|Overall Study|Poor/Non-compliance|1
2846564|NCT02415595|9776448|P2|Overall Study|Poor/Non-compliance|0
2846565|NCT02415595|9776449|P1|Overall Study|Poor/Non-compliance|1
2846566|NCT02415595|9776446|P4|Overall Study|Lost to Follow-up|1
2846567|NCT02415595|9776447|P3|Overall Study|Lost to Follow-up|1
2846568|NCT02415595|9776448|P2|Overall Study|Lost to Follow-up|3
2846569|NCT02415595|9776449|P1|Overall Study|Lost to Follow-up|1
2846570|NCT02415595|9776446|P4|Overall Study|Lack of Efficacy|0
2846571|NCT02415595|9776447|P3|Overall Study|Lack of Efficacy|0
2846572|NCT02415595|9776448|P2|Overall Study|Lack of Efficacy|4
2846573|NCT02415595|9776449|P1|Overall Study|Lack of Efficacy|4
2846574|NCT02415595|9776446|P4|Overall Study|Adverse Event|10
2846575|NCT02415595|9776447|P3|Overall Study|Adverse Event|5
2846576|NCT02415595|9776448|P2|Overall Study|Adverse Event|3
2846577|NCT02415595|9776449|P1|Overall Study|Adverse Event|1
2846578|NCT02415595|9776446|P4|Overall Study|Administrative reason by sponsor|39
2846579|NCT02415595|9776447|P3|Overall Study|Administrative reason by sponsor|41
2846580|NCT02415595|9776448|P2|Overall Study|Administrative reason by sponsor|40
2846581|NCT02415595|9776449|P1|Overall Study|Administrative reason by sponsor|39
2846582|NCT02415400|9776591|P4|Overall Study|Site closure; participant won't transfer|1
2846583|NCT02415400|9776592|P3|Overall Study|Site closure; participant won't transfer|0
2846584|NCT02415400|9776593|P2|Overall Study|Site closure; participant won't transfer|0
2846585|NCT02415400|9776594|P1|Overall Study|Site closure; participant won't transfer|0
2846586|NCT02415400|9776591|P4|Overall Study|Investigator decision|1
2846587|NCT02415400|9776592|P3|Overall Study|Investigator decision|1
2846588|NCT02415400|9776593|P2|Overall Study|Investigator decision|0
2846589|NCT02415400|9776594|P1|Overall Study|Investigator decision|0
2846590|NCT02415400|9776591|P4|Overall Study|Participant in jail|0
2846591|NCT02415400|9776592|P3|Overall Study|Participant in jail|1
2846592|NCT02415400|9776593|P2|Overall Study|Participant in jail|0
2846593|NCT02415400|9776594|P1|Overall Study|Participant in jail|0
2846594|NCT02415400|9776591|P4|Overall Study|Poor treatment monitoring|0
2846595|NCT02415400|9776592|P3|Overall Study|Poor treatment monitoring|1
2846596|NCT02415400|9776593|P2|Overall Study|Poor treatment monitoring|0
2846597|NCT02415400|9776594|P1|Overall Study|Poor treatment monitoring|0
2846598|NCT02415400|9776591|P4|Overall Study|State regulations prevent participation|0
2846599|NCT02415400|9776592|P3|Overall Study|State regulations prevent participation|1
2846600|NCT02415400|9776593|P2|Overall Study|State regulations prevent participation|0
2846601|NCT02415400|9776594|P1|Overall Study|State regulations prevent participation|0
2846602|NCT02415400|9776591|P4|Overall Study|Coagulation values cannot be set|0
2846603|NCT02415400|9776592|P3|Overall Study|Coagulation values cannot be set|1
2846604|NCT02415400|9776593|P2|Overall Study|Coagulation values cannot be set|0
2846605|NCT02415400|9776594|P1|Overall Study|Coagulation values cannot be set|0
2846606|NCT02415400|9776591|P4|Overall Study|Stroke and stroke rehabilitation|0
2846607|NCT02415400|9776592|P3|Overall Study|Stroke and stroke rehabilitation|1
2846608|NCT02415400|9776593|P2|Overall Study|Stroke and stroke rehabilitation|0
2846609|NCT02415400|9776594|P1|Overall Study|Stroke and stroke rehabilitation|0
2846610|NCT02415400|9776591|P4|Overall Study|No study drug on site|0
2846611|NCT02415400|9776592|P3|Overall Study|No study drug on site|0
2846612|NCT02415400|9776593|P2|Overall Study|No study drug on site|1
2846613|NCT02415400|9776594|P1|Overall Study|No study drug on site|0
2846614|NCT02415400|9776591|P4|Overall Study|Randomized in error|0
2846615|NCT02415400|9776592|P3|Overall Study|Randomized in error|0
2846616|NCT02415400|9776593|P2|Overall Study|Randomized in error|0
2846617|NCT02415400|9776594|P1|Overall Study|Randomized in error|2
2846618|NCT02415400|9776591|P4|Overall Study|Participant wanted home visits|0
2846619|NCT02415400|9776592|P3|Overall Study|Participant wanted home visits|0
2846620|NCT02415400|9776593|P2|Overall Study|Participant wanted home visits|0
2846621|NCT02415400|9776594|P1|Overall Study|Participant wanted home visits|1
2846622|NCT02415400|9776591|P4|Overall Study|Participant doesn't answer phone|0
2846623|NCT02415400|9776592|P3|Overall Study|Participant doesn't answer phone|0
2846624|NCT02415400|9776593|P2|Overall Study|Participant doesn't answer phone|0
2846625|NCT02415400|9776594|P1|Overall Study|Participant doesn't answer phone|1
2846626|NCT02415400|9776591|P4|Overall Study|Participant no longer meets criteria|1
2846627|NCT02415400|9776592|P3|Overall Study|Participant no longer meets criteria|0
2846628|NCT02415400|9776593|P2|Overall Study|Participant no longer meets criteria|0
2846629|NCT02415400|9776594|P1|Overall Study|Participant no longer meets criteria|2
2846630|NCT02415400|9776591|P4|Overall Study|Poor/Non-Compliance|4
2846631|NCT02415400|9776592|P3|Overall Study|Poor/Non-Compliance|3
2846632|NCT02415400|9776593|P2|Overall Study|Poor/Non-Compliance|1
2846633|NCT02415400|9776594|P1|Overall Study|Poor/Non-Compliance|0
2846634|NCT02415400|9776591|P4|Overall Study|Lost to Follow-up|5
2846635|NCT02415400|9776592|P3|Overall Study|Lost to Follow-up|2
2846636|NCT02415400|9776593|P2|Overall Study|Lost to Follow-up|3
2846637|NCT02415400|9776594|P1|Overall Study|Lost to Follow-up|3
2846638|NCT02415400|9776591|P4|Overall Study|Death|42
2846639|NCT02415400|9776592|P3|Overall Study|Death|35
2846640|NCT02415400|9776593|P2|Overall Study|Death|41
2846641|NCT02415400|9776594|P1|Overall Study|Death|39
2846642|NCT02415400|9776591|P4|Overall Study|Participant withdrew consent|21
2846643|NCT02415400|9776592|P3|Overall Study|Participant withdrew consent|30
2846644|NCT02415400|9776593|P2|Overall Study|Participant withdrew consent|12
2846645|NCT02415400|9776594|P1|Overall Study|Participant withdrew consent|14
2846646|NCT02415400|9776591|P4|Overall Study|Participant request to stop therapy|6
2846647|NCT02415400|9776592|P3|Overall Study|Participant request to stop therapy|8
2846648|NCT02415400|9776593|P2|Overall Study|Participant request to stop therapy|3
2846649|NCT02415400|9776594|P1|Overall Study|Participant request to stop therapy|4
2846650|NCT02415400|9776591|P4|Overall Study|Adverse Event|2
2846651|NCT02415400|9776592|P3|Overall Study|Adverse Event|1
2846652|NCT02415400|9776593|P2|Overall Study|Adverse Event|1
2846653|NCT02415400|9776594|P1|Overall Study|Adverse Event|0
2846654|NCT02415127|9776662|P2|Overall Study|Adverse Event|0
2846655|NCT02415127|9776663|P1|Overall Study|Adverse Event|1
2846656|NCT02414958|9776680|P3|Overall Study|Other than specified|5
2846657|NCT02414958|9776681|P2|Overall Study|Other than specified|4
2846658|NCT02414958|9776682|P1|Overall Study|Other than specified|4
2846659|NCT02414958|9776680|P3|Overall Study|Withdrawal by Subject|5
2846660|NCT02414958|9776681|P2|Overall Study|Withdrawal by Subject|3
2846661|NCT02414958|9776682|P1|Overall Study|Withdrawal by Subject|5
2846662|NCT02414958|9776680|P3|Overall Study|Lost to Follow-up|0
2846663|NCT02414958|9776681|P2|Overall Study|Lost to Follow-up|4
2846664|NCT02414958|9776682|P1|Overall Study|Lost to Follow-up|7
2846665|NCT02414958|9776680|P3|Overall Study|Protocol Violation|1
2846666|NCT02414958|9776681|P2|Overall Study|Protocol Violation|3
2846667|NCT02414958|9776682|P1|Overall Study|Protocol Violation|10
2846668|NCT02414958|9776680|P3|Overall Study|Adverse Event|3
2846669|NCT02414958|9776681|P2|Overall Study|Adverse Event|6
2846670|NCT02414958|9776682|P1|Overall Study|Adverse Event|6
2846671|NCT02414854|9776715|P4|Overall Study|Other than specified above|37
2846672|NCT02414854|9776716|P3|Overall Study|Other than specified above|17
2846673|NCT02414854|9776717|P2|Overall Study|Other than specified above|37
2846674|NCT02414854|9776718|P1|Overall Study|Other than specified above|12
2846675|NCT02414854|9776715|P4|Overall Study|Poor compliance to protocol|2
2846676|NCT02414854|9776716|P3|Overall Study|Poor compliance to protocol|2
2846677|NCT02414854|9776717|P2|Overall Study|Poor compliance to protocol|1
2846678|NCT02414854|9776718|P1|Overall Study|Poor compliance to protocol|1
2846679|NCT02414854|9776715|P4|Overall Study|Adverse Event|12
2846680|NCT02414854|9776716|P3|Overall Study|Adverse Event|1
2846681|NCT02414854|9776717|P2|Overall Study|Adverse Event|7
2846682|NCT02414854|9776718|P1|Overall Study|Adverse Event|9
2846683|NCT02414841|9776882|P2|Overall Study|Randomized But Not Treated|4
2846684|NCT02414841|9776883|P1|Overall Study|Randomized But Not Treated|6
2846685|NCT02414841|9776882|P2|Overall Study|Received a Kidney Transplant|4
2846686|NCT02414841|9776883|P1|Overall Study|Received a Kidney Transplant|13
2846687|NCT02414841|9776882|P2|Overall Study|Death|14
2846688|NCT02414841|9776883|P1|Overall Study|Death|17
2846689|NCT02414841|9776882|P2|Overall Study|Lost to Follow-up|6
2846690|NCT02414841|9776883|P1|Overall Study|Lost to Follow-up|13
2846691|NCT02414841|9776882|P2|Overall Study|Withdrawal by Subject|5
2846692|NCT02414841|9776883|P1|Overall Study|Withdrawal by Subject|7
2846693|NCT02414828|9776895|P4|Overall Study|Lost to Follow-up|2
2846694|NCT02414828|9776896|P3|Overall Study|Lost to Follow-up|1
2846695|NCT02414828|9776897|P2|Overall Study|Lost to Follow-up|1
2846696|NCT02414828|9776898|P1|Overall Study|Lost to Follow-up|0
2846697|NCT02414152|9776991|P1|Overall Study|Lack of Efficacy|1
2846698|NCT02414152|9776991|P1|Overall Study|Withdrawal by Subject|1
2846699|NCT02413996|9776997|P2|Overall Study|not comfortable with the intervention|2
2846700|NCT02413996|9776998|P1|Overall Study|not comfortable with the intervention|9
2846701|NCT02413593|9777043|P1|Overall Study|Adverse Event|1
2846702|NCT02413593|9777043|P1|Overall Study|Lost to Follow-up|3
2846703|NCT02413489|9777062|P3|Overall Study|Study Terminated By Sponsor|1
2846704|NCT02413489|9777063|P2|Overall Study|Study Terminated By Sponsor|13
2846705|NCT02413489|9777064|P1|Overall Study|Study Terminated By Sponsor|2
2846706|NCT02413489|9777062|P3|Overall Study|Withdrawal by Subject|0
2846707|NCT02413489|9777063|P2|Overall Study|Withdrawal by Subject|0
2846708|NCT02413489|9777064|P1|Overall Study|Withdrawal by Subject|2
2846709|NCT02413489|9777062|P3|Overall Study|Death|4
2846710|NCT02413489|9777063|P2|Overall Study|Death|3
2846711|NCT02413489|9777064|P1|Overall Study|Death|11
2846712|NCT02413398|9777105|P2|Overall Study|Other Eligibility criteria|2
2846713|NCT02413398|9777106|P1|Overall Study|Other Eligibility criteria|1
2846714|NCT02413398|9777105|P2|Overall Study|Withdrawal by Subject|1
2846715|NCT02413398|9777106|P1|Overall Study|Withdrawal by Subject|1
2846716|NCT02413398|9777105|P2|Overall Study|Lost to Follow-up|4
2846717|NCT02413398|9777106|P1|Overall Study|Lost to Follow-up|2
2846718|NCT02413372|9777121|P3|Follow-up|Subject unable to return for visit|1
2846719|NCT02413372|9777122|P2|Follow-up|Subject unable to return for visit|0
2846720|NCT02413372|9777123|P1|Follow-up|Subject unable to return for visit|0
2846721|NCT02413372|9777121|P3|Follow-up|Subject Withdrew Consent|1
2846722|NCT02413372|9777122|P2|Follow-up|Subject Withdrew Consent|0
2846723|NCT02413372|9777123|P1|Follow-up|Subject Withdrew Consent|1
2846724|NCT02413372|9777121|P3|Follow-up|Lost to Follow-up|0
2846725|NCT02413372|9777122|P2|Follow-up|Lost to Follow-up|1
2846726|NCT02413372|9777123|P1|Follow-up|Lost to Follow-up|1
2846727|NCT02413372|9777121|P3|Treatment|Withdrawal by Subject|0
2846728|NCT02413372|9777122|P2|Treatment|Withdrawal by Subject|0
2846729|NCT02413372|9777123|P1|Treatment|Withdrawal by Subject|1
2846730|NCT02413372|9777121|P3|Treatment|Lost to Follow-up|1
2846731|NCT02413372|9777122|P2|Treatment|Lost to Follow-up|2
2846732|NCT02413372|9777123|P1|Treatment|Lost to Follow-up|0
2846733|NCT02413346|9777172|P2|Overall Study|Other Miscellaneous Reasons|3
2846734|NCT02413346|9777173|P1|Overall Study|Other Miscellaneous Reasons|4
2846735|NCT02413346|9777172|P2|Overall Study|Protocol Violation|0
2846736|NCT02413346|9777173|P1|Overall Study|Protocol Violation|2
2846737|NCT02413346|9777172|P2|Overall Study|Lost to Follow-up|21
2846738|NCT02413346|9777173|P1|Overall Study|Lost to Follow-up|17
2846739|NCT02413346|9777172|P2|Overall Study|Withdrawal by Subject|40
2846740|NCT02413346|9777173|P1|Overall Study|Withdrawal by Subject|30
2846741|NCT02413346|9777172|P2|Overall Study|Adverse Event|6
2846742|NCT02413346|9777173|P1|Overall Study|Adverse Event|6
2846743|NCT02413333|9777183|P2|Period 2|Protocol Deviation|0
2846744|NCT02413333|9777184|P1|Period 2|Protocol Deviation|1
2846745|NCT02413333|9777183|P2|Period 1|Reason Not Specified|1
2846746|NCT02413333|9777184|P1|Period 1|Reason Not Specified|0
2846747|NCT02413333|9777183|P2|Period 1|Adverse Event|0
2846748|NCT02413333|9777184|P1|Period 1|Adverse Event|1
2846749|NCT02413294|9777192|P1|Overall Study|Withdrawal by Subject|1
2846750|NCT02413255|9777227|P17|Overall Study|Voluntary Withdrawal|0
2846751|NCT02413255|9777228|P16|Overall Study|Voluntary Withdrawal|0
2846752|NCT02413255|9777229|P15|Overall Study|Voluntary Withdrawal|1
2846753|NCT02413255|9777230|P14|Overall Study|Voluntary Withdrawal|0
2846754|NCT02413255|9777231|P13|Overall Study|Voluntary Withdrawal|0
2846755|NCT02413255|9777232|P12|Overall Study|Voluntary Withdrawal|0
2846756|NCT02413255|9777233|P11|Overall Study|Voluntary Withdrawal|0
2846757|NCT02413255|9777234|P10|Overall Study|Voluntary Withdrawal|0
2846758|NCT02413255|9777235|P9|Overall Study|Voluntary Withdrawal|0
2846759|NCT02413255|9777236|P8|Overall Study|Voluntary Withdrawal|0
2846760|NCT02413255|9777237|P7|Overall Study|Voluntary Withdrawal|0
2846761|NCT02413255|9777238|P6|Overall Study|Voluntary Withdrawal|0
2846762|NCT02413255|9777239|P5|Overall Study|Voluntary Withdrawal|0
2846763|NCT02413255|9777240|P4|Overall Study|Voluntary Withdrawal|0
2846764|NCT02413255|9777241|P3|Overall Study|Voluntary Withdrawal|0
2846765|NCT02413255|9777242|P2|Overall Study|Voluntary Withdrawal|0
2846766|NCT02413255|9777243|P1|Overall Study|Voluntary Withdrawal|0
2846767|NCT02413229|9777599|P8|Overall Study|Progressive Disease|1
2846768|NCT02413229|9777600|P7|Overall Study|Progressive Disease|0
2846769|NCT02413229|9777601|P6|Overall Study|Progressive Disease|0
2846770|NCT02413229|9777602|P5|Overall Study|Progressive Disease|0
2846771|NCT02413229|9777603|P4|Overall Study|Progressive Disease|0
2846772|NCT02413229|9777604|P3|Overall Study|Progressive Disease|0
2846773|NCT02413229|9777605|P2|Overall Study|Progressive Disease|0
2846774|NCT02413229|9777606|P1|Overall Study|Progressive Disease|0
2846775|NCT02413229|9777599|P8|Overall Study|Withdrawal by Subject|2
2846776|NCT02413229|9777600|P7|Overall Study|Withdrawal by Subject|0
2846777|NCT02413229|9777601|P6|Overall Study|Withdrawal by Subject|0
2846778|NCT02413229|9777602|P5|Overall Study|Withdrawal by Subject|1
2846779|NCT02413229|9777603|P4|Overall Study|Withdrawal by Subject|0
2846780|NCT02413229|9777604|P3|Overall Study|Withdrawal by Subject|0
2846781|NCT02413229|9777605|P2|Overall Study|Withdrawal by Subject|1
2846782|NCT02413229|9777606|P1|Overall Study|Withdrawal by Subject|1
2846783|NCT02413229|9777599|P8|Overall Study|Lost to Follow-up|0
2846784|NCT02413229|9777600|P7|Overall Study|Lost to Follow-up|0
2846785|NCT02413229|9777601|P6|Overall Study|Lost to Follow-up|0
2846786|NCT02413229|9777602|P5|Overall Study|Lost to Follow-up|2
2846787|NCT02413229|9777603|P4|Overall Study|Lost to Follow-up|0
2846788|NCT02413229|9777604|P3|Overall Study|Lost to Follow-up|1
2846789|NCT02413229|9777605|P2|Overall Study|Lost to Follow-up|0
2846790|NCT02413229|9777606|P1|Overall Study|Lost to Follow-up|0
2846791|NCT02413229|9777599|P8|Overall Study|Adverse Event|1
2846792|NCT02413229|9777600|P7|Overall Study|Adverse Event|0
2846793|NCT02413229|9777601|P6|Overall Study|Adverse Event|0
2846794|NCT02413229|9777602|P5|Overall Study|Adverse Event|0
2846795|NCT02413229|9777603|P4|Overall Study|Adverse Event|1
2846796|NCT02413229|9777604|P3|Overall Study|Adverse Event|0
2846797|NCT02413229|9777605|P2|Overall Study|Adverse Event|0
2846798|NCT02413229|9777606|P1|Overall Study|Adverse Event|0
2846799|NCT02412878|9777745|P2|Overall Study|Lost to Follow-up|3
2846800|NCT02412878|9777746|P1|Overall Study|Lost to Follow-up|2
2846801|NCT02412878|9777745|P2|Overall Study|Withdrawal by Subject|10
2846802|NCT02412878|9777746|P1|Overall Study|Withdrawal by Subject|19
2846803|NCT02412852|9777764|P4|Overall Study|Physician Decision|1
2846804|NCT02412852|9777765|P3|Overall Study|Physician Decision|0
2846805|NCT02412852|9777766|P2|Overall Study|Physician Decision|0
2846806|NCT02412852|9777767|P1|Overall Study|Physician Decision|0
2846807|NCT02412852|9777764|P4|Overall Study|Withdrawal by Subject|0
2846808|NCT02412852|9777765|P3|Overall Study|Withdrawal by Subject|0
2846809|NCT02412852|9777766|P2|Overall Study|Withdrawal by Subject|1
2846810|NCT02412852|9777767|P1|Overall Study|Withdrawal by Subject|0
2846811|NCT02412761|9777793|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
2846812|NCT02412761|9777794|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
2846813|NCT02412761|9777795|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
2846814|NCT02412761|9777796|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
2846815|NCT02412761|9777797|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
2846816|NCT02412761|9777798|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
2846817|NCT02412722|9777812|P6|Overall Study|Reason not Specified|6
2846818|NCT02412722|9777813|P5|Overall Study|Reason not Specified|2
2846819|NCT02412722|9777814|P4|Overall Study|Reason not Specified|1
2846820|NCT02412722|9777815|P3|Overall Study|Reason not Specified|2
2846821|NCT02412722|9777816|P2|Overall Study|Reason not Specified|0
2846822|NCT02412722|9777817|P1|Overall Study|Reason not Specified|3
2846823|NCT02412722|9777812|P6|Overall Study|Received drug in run-in and discontinued|0
2846824|NCT02412722|9777813|P5|Overall Study|Received drug in run-in and discontinued|0
2846825|NCT02412722|9777814|P4|Overall Study|Received drug in run-in and discontinued|0
2846826|NCT02412722|9777815|P3|Overall Study|Received drug in run-in and discontinued|0
2846827|NCT02412722|9777816|P2|Overall Study|Received drug in run-in and discontinued|2
2846828|NCT02412722|9777817|P1|Overall Study|Received drug in run-in and discontinued|0
2846829|NCT02412722|9777812|P6|Overall Study|Lost to Follow-up|0
2846830|NCT02412722|9777813|P5|Overall Study|Lost to Follow-up|1
2846831|NCT02412722|9777814|P4|Overall Study|Lost to Follow-up|0
2846832|NCT02412722|9777815|P3|Overall Study|Lost to Follow-up|0
2846833|NCT02412722|9777816|P2|Overall Study|Lost to Follow-up|0
2846834|NCT02412722|9777817|P1|Overall Study|Lost to Follow-up|0
2846835|NCT02412722|9777812|P6|Overall Study|Withdrawal by Subject|1
2846836|NCT02412722|9777813|P5|Overall Study|Withdrawal by Subject|1
2846837|NCT02412722|9777814|P4|Overall Study|Withdrawal by Subject|2
2846838|NCT02412722|9777815|P3|Overall Study|Withdrawal by Subject|1
2846839|NCT02412722|9777816|P2|Overall Study|Withdrawal by Subject|0
2846840|NCT02412722|9777817|P1|Overall Study|Withdrawal by Subject|2
2846841|NCT02412722|9777812|P6|Overall Study|Progressive Disease|3
2846842|NCT02412722|9777813|P5|Overall Study|Progressive Disease|3
2846843|NCT02412722|9777814|P4|Overall Study|Progressive Disease|9
2846844|NCT02412722|9777815|P3|Overall Study|Progressive Disease|4
2846845|NCT02412722|9777816|P2|Overall Study|Progressive Disease|4
2846846|NCT02412722|9777817|P1|Overall Study|Progressive Disease|6
2846847|NCT02412722|9777812|P6|Overall Study|Adverse Event|3
2846848|NCT02412722|9777813|P5|Overall Study|Adverse Event|0
2846849|NCT02412722|9777814|P4|Overall Study|Adverse Event|3
2846850|NCT02412722|9777815|P3|Overall Study|Adverse Event|0
2846851|NCT02412722|9777816|P2|Overall Study|Adverse Event|2
2846852|NCT02412722|9777817|P1|Overall Study|Adverse Event|0
2846853|NCT02412657|9777888|P3|Overall Study|Protocol Violation|3
2846854|NCT02412657|9777889|P2|Overall Study|Protocol Violation|2
2846855|NCT02412657|9777890|P1|Overall Study|Protocol Violation|0
2846856|NCT02412657|9777888|P3|Overall Study|Lost to Follow-up|0
2846857|NCT02412657|9777889|P2|Overall Study|Lost to Follow-up|0
2846858|NCT02412657|9777890|P1|Overall Study|Lost to Follow-up|1
2846859|NCT02412488|9777934|P1|Overall Study|Reveal LINQ explant|1
2846860|NCT02412488|9777934|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
2846861|NCT02412488|9777934|P1|Overall Study|Physician Decision|1
2846862|NCT02412488|9777934|P1|Overall Study|Withdrawal by Subject|5
2846863|NCT02412488|9777934|P1|Overall Study|Lost to Follow-up|10
2846864|NCT02412436|9777938|P1|Overall Study|Not Willing to Adhere to Requirements|1
2846865|NCT02412436|9777938|P1|Overall Study|Death|1
2846866|NCT02412436|9777938|P1|Overall Study|Unable to get to clinic|3
2846867|NCT02412436|9777938|P1|Overall Study|Lost to Follow-up|6
2846868|NCT02412436|9777938|P1|Overall Study|Protocol-mandated Discontinuation|7
2846869|NCT02412306|9777957|P5|Overall Study|Death|2
2846870|NCT02412306|9777958|P4|Overall Study|Death|0
2846871|NCT02412306|9777959|P3|Overall Study|Death|15
2846872|NCT02412306|9777960|P2|Overall Study|Death|7
2846873|NCT02412306|9777961|P1|Overall Study|Death|5
2846874|NCT02412306|9777957|P5|Overall Study|Withdrawal by Subject|0
2846875|NCT02412306|9777958|P4|Overall Study|Withdrawal by Subject|0
2846876|NCT02412306|9777959|P3|Overall Study|Withdrawal by Subject|1
2846877|NCT02412306|9777960|P2|Overall Study|Withdrawal by Subject|0
2846878|NCT02412306|9777961|P1|Overall Study|Withdrawal by Subject|0
2846879|NCT02412306|9777957|P5|Overall Study|Lost to Follow-up|0
2846880|NCT02412306|9777958|P4|Overall Study|Lost to Follow-up|0
2846881|NCT02412306|9777959|P3|Overall Study|Lost to Follow-up|0
2846882|NCT02412306|9777960|P2|Overall Study|Lost to Follow-up|1
2846883|NCT02412306|9777961|P1|Overall Study|Lost to Follow-up|0
2846884|NCT02412111|9778023|P3|Active Comparator Period (8 Weeks)|Other|2
2846885|NCT02412111|9778024|P2|Active Comparator Period (8 Weeks)|Other|0
2846886|NCT02412111|9778025|P1|Active Comparator Period (8 Weeks)|Other|0
2846887|NCT02412111|9778023|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
2846888|NCT02412111|9778024|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
2846889|NCT02412111|9778025|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
2846890|NCT02412111|9778023|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
2846891|NCT02412111|9778024|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2846892|NCT02412111|9778025|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2846893|NCT02412111|9778023|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
2846976|NCT02410343|9778462|P2|Core Period (24 Weeks)|Adverse Event|0
2846894|NCT02412111|9778024|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2846895|NCT02412111|9778025|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2846896|NCT02412111|9778023|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
2846897|NCT02412111|9778024|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
2846898|NCT02412111|9778025|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
2846899|NCT02412111|9778023|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2846900|NCT02412111|9778024|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2846901|NCT02412111|9778025|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
2846902|NCT02412111|9778023|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2846903|NCT02412111|9778024|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2846904|NCT02412111|9778025|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
2846905|NCT02411747|9778108|P2|Overall Study|Protocol Violation|4
2846906|NCT02411747|9778109|P1|Overall Study|Protocol Violation|2
2846907|NCT02411747|9778108|P2|Overall Study|Withdrawal by Subject|0
2846908|NCT02411747|9778109|P1|Overall Study|Withdrawal by Subject|1
2846909|NCT02411578|9778124|P2|Crossover Trial Phase|Pregnancy|1
2846910|NCT02411578|9778125|P1|Crossover Trial Phase|Pregnancy|0
2846911|NCT02411539|9778182|P2|Overall Study|Confounding medical condition|1
2846912|NCT02411539|9778183|P1|Overall Study|Confounding medical condition|0
2846913|NCT02411539|9778182|P2|Overall Study|Lost to Follow-up|0
2846914|NCT02411539|9778183|P1|Overall Study|Lost to Follow-up|2
2846915|NCT02411448|9778274|P3|Overall Study|Alive on study treatment|43
2846916|NCT02411448|9778275|P2|Overall Study|Alive on study treatment|64
2846917|NCT02411448|9778276|P1|Overall Study|Alive on study treatment|3
2846918|NCT02411448|9778274|P3|Overall Study|Did not receive study treatment|0
2846919|NCT02411448|9778275|P2|Overall Study|Did not receive study treatment|3
2846920|NCT02411448|9778276|P1|Overall Study|Did not receive study treatment|0
2846921|NCT02411448|9778274|P3|Overall Study|Other|0
2846922|NCT02411448|9778275|P2|Overall Study|Other|2
2846923|NCT02411448|9778276|P1|Overall Study|Other|0
2846924|NCT02411448|9778274|P3|Overall Study|Withdrawal by Subject|9
2846925|NCT02411448|9778275|P2|Overall Study|Withdrawal by Subject|14
2846926|NCT02411448|9778276|P1|Overall Study|Withdrawal by Subject|1
2846927|NCT02411396|9778305|P1|Overall Study|Death|10
2846928|NCT02411396|9778305|P1|Overall Study|Lost to Follow-up|31
2846929|NCT02411292|9778318|P1|Overall Study|Lost to Follow-up|3
2846930|NCT02411292|9778318|P1|Overall Study|Death|2
2846931|NCT02411292|9778318|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
2846932|NCT02411201|9778324|P1|Overall Study|Age group completed|2
2846933|NCT02411201|9778324|P1|Overall Study|Withdrawal by Subject|2
2846934|NCT02411201|9778324|P1|Overall Study|Adverse Event|2
2846935|NCT02411110|9778337|P2|Treatment Period 2|Personal Reasons|2
2846936|NCT02411110|9778338|P1|Treatment Period 2|Personal Reasons|0
2846937|NCT02411110|9778337|P2|Treatment Period 2|Lost to Follow-up|2
2846938|NCT02411110|9778338|P1|Treatment Period 2|Lost to Follow-up|0
2846939|NCT02411110|9778337|P2|Treatment Period 2|Adverse Event|0
2846940|NCT02411110|9778338|P1|Treatment Period 2|Adverse Event|1
2846941|NCT02411110|9778337|P2|Treatment Period 1|Other Miscellaneous Reasons|0
2846942|NCT02411110|9778338|P1|Treatment Period 1|Other Miscellaneous Reasons|2
2846943|NCT02411110|9778337|P2|Treatment Period 1|Personal Reasons|5
2846944|NCT02411110|9778338|P1|Treatment Period 1|Personal Reasons|2
2846945|NCT02411110|9778337|P2|Treatment Period 1|Lost to Follow-up|0
2846946|NCT02411110|9778338|P1|Treatment Period 1|Lost to Follow-up|1
2846947|NCT02411110|9778337|P2|Treatment Period 1|Adverse Event|2
2846948|NCT02411110|9778338|P1|Treatment Period 1|Adverse Event|4
2846949|NCT02411084|9778348|P2|Overall Study|Other reasons|5
2846950|NCT02411084|9778349|P1|Overall Study|Other reasons|0
2846951|NCT02411084|9778348|P2|Overall Study|Adverse Event|1
2846952|NCT02411084|9778349|P1|Overall Study|Adverse Event|2
2846953|NCT02411084|9778348|P2|Overall Study|Death|4
2846954|NCT02411084|9778349|P1|Overall Study|Death|5
2846955|NCT02411084|9778348|P2|Overall Study|Lack of Efficacy|3
2846956|NCT02411084|9778349|P1|Overall Study|Lack of Efficacy|6
2846957|NCT02410824|9778381|P2|First Intervention (One Week)|Headache|1
2846958|NCT02410824|9778382|P1|First Intervention (One Week)|Headache|0
2846959|NCT02410629|9778427|P2|Overall Study|Subject underwent heart surgery|1
2846960|NCT02410629|9778428|P1|Overall Study|Subject underwent heart surgery|0
2846961|NCT02410629|9778427|P2|Overall Study|Subject moved back to home country|1
2846962|NCT02410629|9778428|P1|Overall Study|Subject moved back to home country|0
2846963|NCT02410629|9778427|P2|Overall Study|Subject returned to work|0
2846964|NCT02410629|9778428|P1|Overall Study|Subject returned to work|1
2846965|NCT02410629|9778427|P2|Overall Study|Family cannot commit to the study|1
2846966|NCT02410629|9778428|P1|Overall Study|Family cannot commit to the study|2
2846967|NCT02410551|9778444|P1|Overall Study|FDA Clinical hold-patients taken off|2
2846968|NCT02410551|9778444|P1|Overall Study|Withdrawal by Subject|1
2846969|NCT02410551|9778444|P1|Overall Study|Adverse Event|1
2846970|NCT02410343|9778462|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
2846971|NCT02410343|9778463|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
2846972|NCT02410343|9778462|P2|Extension Period (12 Months)|Adverse Event|0
2846973|NCT02410343|9778463|P1|Extension Period (12 Months)|Adverse Event|1
2846974|NCT02410343|9778462|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
2846975|NCT02410343|9778463|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
2846977|NCT02410343|9778463|P1|Core Period (24 Weeks)|Adverse Event|1
2846978|NCT02410278|9778509|P3|Study Treatment Period|GSRS Threshold Not Met|0
2846979|NCT02410278|9778510|P2|Study Treatment Period|GSRS Threshold Not Met|1
2846980|NCT02410278|9778511|P1|Study Treatment Period|GSRS Threshold Not Met|0
2846981|NCT02410278|9778509|P3|Study Treatment Period|Other|0
2846982|NCT02410278|9778510|P2|Study Treatment Period|Other|3
2846983|NCT02410278|9778511|P1|Study Treatment Period|Other|0
2846984|NCT02410278|9778509|P3|Study Treatment Period|Withdrawal by Subject|0
2846985|NCT02410278|9778510|P2|Study Treatment Period|Withdrawal by Subject|1
2846986|NCT02410278|9778511|P1|Study Treatment Period|Withdrawal by Subject|0
2846987|NCT02410278|9778509|P3|Study Treatment Period|Physician Decision|1
2846988|NCT02410278|9778510|P2|Study Treatment Period|Physician Decision|0
2846989|NCT02410278|9778511|P1|Study Treatment Period|Physician Decision|0
2846990|NCT02410278|9778509|P3|Study Treatment Period|Adverse Event|3
2846991|NCT02410278|9778510|P2|Study Treatment Period|Adverse Event|6
2846992|NCT02410278|9778511|P1|Study Treatment Period|Adverse Event|0
2846993|NCT02410278|9778509|P3|Run-in Period|Pregnancy|0
2846994|NCT02410278|9778510|P2|Run-in Period|Pregnancy|0
2846995|NCT02410278|9778511|P1|Run-in Period|Pregnancy|1
2846996|NCT02410278|9778509|P3|Run-in Period|Withdrawal by Subject|0
2846997|NCT02410278|9778510|P2|Run-in Period|Withdrawal by Subject|0
2846998|NCT02410278|9778511|P1|Run-in Period|Withdrawal by Subject|1
2846999|NCT02410278|9778509|P3|Run-in Period|Lost to Follow-up|0
2847000|NCT02410278|9778510|P2|Run-in Period|Lost to Follow-up|0
2847001|NCT02410278|9778511|P1|Run-in Period|Lost to Follow-up|1
2847002|NCT02410278|9778509|P3|Run-in Period|GSRS Threshold Not Met|0
2847003|NCT02410278|9778510|P2|Run-in Period|GSRS Threshold Not Met|0
2847004|NCT02410278|9778511|P1|Run-in Period|GSRS Threshold Not Met|30
2847005|NCT02410278|9778509|P3|Run-in Period|Adverse Event|0
2847006|NCT02410278|9778510|P2|Run-in Period|Adverse Event|0
2847007|NCT02410278|9778511|P1|Run-in Period|Adverse Event|5
2847008|NCT02410252|9778536|P1|Overall Study|Physician Decision|2
2847009|NCT02410252|9778536|P1|Overall Study|Withdrawal by Subject|4
2847010|NCT02410200|9778549|P1|Overall Study|Adverse Event|2
2847011|NCT02409732|9778619|P1|Overall Study|Lost to Follow-up|2
2847012|NCT02409732|9778619|P1|Overall Study|Withdrawal by Subject|4
2847013|NCT02409719|9778629|P2|Overall Study|Lost to Follow-up|3
2847014|NCT02409719|9778630|P1|Overall Study|Lost to Follow-up|3
2847015|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2847016|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2847017|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
2847018|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2847019|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2847020|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2847021|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2847022|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2847023|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2847024|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2847025|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2847026|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
2847027|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
2847028|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
2847029|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2847030|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2847031|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2847032|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
2847033|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
2847034|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2847035|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
2847036|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
2847037|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
2847038|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
2847039|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
2847040|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2847041|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
2847042|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2847043|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2847044|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2847045|NCT02409667|9778640|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2847046|NCT02409667|9778641|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
2847047|NCT02409667|9778642|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
2847048|NCT02409667|9778643|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
2847049|NCT02409667|9778644|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2847050|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2847051|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2847052|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2847053|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2847054|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
2847055|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2847056|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2847057|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2847058|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2847059|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
2847060|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2847061|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2847062|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2847063|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2847064|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
2847065|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2847066|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2847067|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2847068|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2847069|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
2847070|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2847071|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2847072|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2847073|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2847074|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
2847075|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2847076|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2847077|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2847078|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2847079|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
2847080|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2847081|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2847082|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2847083|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2847084|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
2847085|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2847086|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2847087|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2847088|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2847089|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
2847090|NCT02409667|9778640|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2847091|NCT02409667|9778641|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2847092|NCT02409667|9778642|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2847093|NCT02409667|9778643|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2847094|NCT02409667|9778644|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
2847095|NCT02409355|9778706|P2|Overall Study|Study terminated by Sponsor|3
2847096|NCT02409355|9778707|P1|Overall Study|Study terminated by Sponsor|2
2847097|NCT02409355|9778706|P2|Overall Study|Death|1
2847098|NCT02409355|9778707|P1|Overall Study|Death|1
2847099|NCT02409355|9778706|P2|Overall Study|Withdrawal by Subject|0
2847100|NCT02409355|9778707|P1|Overall Study|Withdrawal by Subject|1
2847101|NCT02408523|9778799|P2|Overall Study|Did not satisfy extension conditions|1
2847102|NCT02408523|9778800|P1|Overall Study|Did not satisfy extension conditions|0
2847103|NCT02408523|9778799|P2|Overall Study|Sponsor request|0
2847104|NCT02408523|9778800|P1|Overall Study|Sponsor request|1
2847105|NCT02408523|9778799|P2|Overall Study|Withdrawal by Subject|1
2847106|NCT02408523|9778800|P1|Overall Study|Withdrawal by Subject|3
2847107|NCT02408523|9778799|P2|Overall Study|Lost to Follow-up|3
2847108|NCT02408523|9778800|P1|Overall Study|Lost to Follow-up|2
2847109|NCT02408523|9778799|P2|Overall Study|Protocol Violation|2
2847110|NCT02408523|9778800|P1|Overall Study|Protocol Violation|1
2847111|NCT02408523|9778799|P2|Overall Study|Lack of Efficacy|1
2847112|NCT02408523|9778800|P1|Overall Study|Lack of Efficacy|0
2847113|NCT02408523|9778799|P2|Overall Study|Adverse Event|10
2847114|NCT02408523|9778800|P1|Overall Study|Adverse Event|4
2847115|NCT02408068|9778891|P6|Treatment 3 (1.5 Days)|Adverse Event|0
2847116|NCT02408068|9778892|P5|Treatment 3 (1.5 Days)|Adverse Event|0
2847117|NCT02408068|9778893|P4|Treatment 3 (1.5 Days)|Adverse Event|0
2847118|NCT02408068|9778894|P3|Treatment 3 (1.5 Days)|Adverse Event|1
2847119|NCT02408068|9778895|P2|Treatment 3 (1.5 Days)|Adverse Event|0
2847120|NCT02408068|9778896|P1|Treatment 3 (1.5 Days)|Adverse Event|0
2847121|NCT02407704|9778923|P4|Overall Study|Withdrawal by Subject|0
2847122|NCT02407704|9778924|P3|Overall Study|Withdrawal by Subject|1
2847123|NCT02407704|9778925|P2|Overall Study|Withdrawal by Subject|0
2847124|NCT02407704|9778926|P1|Overall Study|Withdrawal by Subject|0
2847125|NCT02407704|9778923|P4|Overall Study|Protocol Violation|1
2847126|NCT02407704|9778924|P3|Overall Study|Protocol Violation|0
2847127|NCT02407704|9778925|P2|Overall Study|Protocol Violation|0
2847128|NCT02407704|9778926|P1|Overall Study|Protocol Violation|0
2847129|NCT02407704|9778923|P4|Overall Study|Lost to Follow-up|2
2847130|NCT02407704|9778924|P3|Overall Study|Lost to Follow-up|0
2847131|NCT02407704|9778925|P2|Overall Study|Lost to Follow-up|0
2847132|NCT02407704|9778926|P1|Overall Study|Lost to Follow-up|0
2847133|NCT02407249|9778960|P1|Overall Study|Not treated|13
2847134|NCT02407249|9778960|P1|Overall Study|Did not complete 12-month follow-up|13
2847135|NCT02407236|9778976|P8|Maintenance Study (44 Weeks)|Other|1
2847136|NCT02407236|9778977|P7|Maintenance Study (44 Weeks)|Other|2
2847137|NCT02407236|9778978|P6|Maintenance Study (44 Weeks)|Other|1
2847138|NCT02407236|9778979|P5|Maintenance Study (44 Weeks)|Other|1
2847139|NCT02407236|9778980|P4|Maintenance Study (44 Weeks)|Other|0
2847140|NCT02407236|9778981|P3|Maintenance Study (44 Weeks)|Other|0
2847141|NCT02407236|9778982|P2|Maintenance Study (44 Weeks)|Other|0
2847142|NCT02407236|9778983|P1|Maintenance Study (44 Weeks)|Other|0
2847143|NCT02407236|9778976|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
2847144|NCT02407236|9778977|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
2847145|NCT02407236|9778978|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
2847146|NCT02407236|9778979|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
2847147|NCT02407236|9778980|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
2847148|NCT02407236|9778981|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
2847149|NCT02407236|9778982|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
2847150|NCT02407236|9778983|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
2847151|NCT02407236|9778976|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
2847152|NCT02407236|9778977|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
2847153|NCT02407236|9778978|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
2847154|NCT02407236|9778979|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
2847155|NCT02407236|9778980|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
2847156|NCT02407236|9778981|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
2847157|NCT02407236|9778982|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
2847158|NCT02407236|9778983|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
2847159|NCT02407236|9778976|P8|Maintenance Study (44 Weeks)|Death|1
2847160|NCT02407236|9778977|P7|Maintenance Study (44 Weeks)|Death|0
2847161|NCT02407236|9778978|P6|Maintenance Study (44 Weeks)|Death|0
2847162|NCT02407236|9778979|P5|Maintenance Study (44 Weeks)|Death|0
2847163|NCT02407236|9778980|P4|Maintenance Study (44 Weeks)|Death|0
2847164|NCT02407236|9778981|P3|Maintenance Study (44 Weeks)|Death|0
2847165|NCT02407236|9778982|P2|Maintenance Study (44 Weeks)|Death|0
2847166|NCT02407236|9778983|P1|Maintenance Study (44 Weeks)|Death|0
2847167|NCT02407236|9778976|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2847168|NCT02407236|9778977|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2847169|NCT02407236|9778978|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2847170|NCT02407236|9778979|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2847171|NCT02407236|9778980|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2847172|NCT02407236|9778981|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2847173|NCT02407236|9778982|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2847174|NCT02407236|9778983|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2847175|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Other|0
2847176|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Other|0
2847177|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Other|0
2847178|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Other|0
2847179|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Other|0
2847180|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Other|5
2847181|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Other|1
2847182|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Other|2
2847183|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Physician Decision|0
2847184|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Physician Decision|0
2847185|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Physician Decision|0
2847186|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Physician Decision|0
2847187|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Physician Decision|0
2847188|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Physician Decision|0
2847189|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Physician Decision|1
2847190|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Physician Decision|1
2847191|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
2847192|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
2847193|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
2847194|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
2847195|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
2847196|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
2847197|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
2847198|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
2847199|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
2847200|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
2847201|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
2847202|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
2847203|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
2847204|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
2847205|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
2847206|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
2847207|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Death|0
2847208|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Death|0
2847209|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Death|0
2847210|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Death|0
2847211|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Death|0
2847212|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Death|1
2847213|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Death|0
2847214|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Death|0
2847215|NCT02407236|9778976|P8|Induction Study (8 Weeks)|Adverse Event|0
2847216|NCT02407236|9778977|P7|Induction Study (8 Weeks)|Adverse Event|0
2847217|NCT02407236|9778978|P6|Induction Study (8 Weeks)|Adverse Event|0
2847218|NCT02407236|9778979|P5|Induction Study (8 Weeks)|Adverse Event|0
2847219|NCT02407236|9778980|P4|Induction Study (8 Weeks)|Adverse Event|0
2847220|NCT02407236|9778981|P3|Induction Study (8 Weeks)|Adverse Event|1
2847221|NCT02407236|9778982|P2|Induction Study (8 Weeks)|Adverse Event|0
2847222|NCT02407236|9778983|P1|Induction Study (8 Weeks)|Adverse Event|3
2847223|NCT02407223|9779223|P3|Overall Study|Other|25
2847224|NCT02407223|9779224|P2|Overall Study|Other|27
2847225|NCT02407223|9779225|P1|Overall Study|Other|29
2847226|NCT02407223|9779223|P3|Overall Study|Subject Refused Further Study Treatment|0
2847227|NCT02407223|9779224|P2|Overall Study|Subject Refused Further Study Treatment|1
2847228|NCT02407223|9779225|P1|Overall Study|Subject Refused Further Study Treatment|0
2847229|NCT02407223|9779223|P3|Overall Study|Study Terminated by Sponsor|86
2847230|NCT02407223|9779224|P2|Overall Study|Study Terminated by Sponsor|80
2847231|NCT02407223|9779225|P1|Overall Study|Study Terminated by Sponsor|77
2847232|NCT02407223|9779223|P3|Overall Study|Withdrawal by Subject|4
2847233|NCT02407223|9779224|P2|Overall Study|Withdrawal by Subject|4
2847234|NCT02407223|9779225|P1|Overall Study|Withdrawal by Subject|2
2847235|NCT02407223|9779223|P3|Overall Study|Lost to Follow-up|2
2847236|NCT02407223|9779224|P2|Overall Study|Lost to Follow-up|0
2847237|NCT02407223|9779225|P1|Overall Study|Lost to Follow-up|1
2847238|NCT02407223|9779223|P3|Overall Study|Lack of Efficacy|4
2847239|NCT02407223|9779224|P2|Overall Study|Lack of Efficacy|6
2847240|NCT02407223|9779225|P1|Overall Study|Lack of Efficacy|6
2847241|NCT02407223|9779223|P3|Overall Study|Adverse Event|1
2847242|NCT02407223|9779224|P2|Overall Study|Adverse Event|0
2847243|NCT02407223|9779225|P1|Overall Study|Adverse Event|1
2847244|NCT02406677|9779358|P2|Overall Study|Withdrawal by Subject|0
2847245|NCT02406677|9779359|P1|Overall Study|Withdrawal by Subject|1
2847246|NCT02406677|9779358|P2|Overall Study|Discharged on prasugrel|587
2847247|NCT02406677|9779359|P1|Overall Study|Discharged on prasugrel|283
2847248|NCT02406677|9779358|P2|Overall Study|Discharged without P2Y12|3
2847249|NCT02406677|9779359|P1|Overall Study|Discharged without P2Y12|1
2847250|NCT02406677|9779358|P2|Overall Study|Death|8
2847251|NCT02406677|9779359|P1|Overall Study|Death|16
2847252|NCT02406612|9779373|P2|Overall Study|Guidewire Failure|1
2847253|NCT02406612|9779374|P1|Overall Study|Guidewire Failure|0
2847254|NCT02406612|9779373|P2|Overall Study|Intra-procedural Exclusion|3
2847255|NCT02406612|9779374|P1|Overall Study|Intra-procedural Exclusion|1
2847256|NCT02406612|9779373|P2|Overall Study|Screening Failure|0
2847257|NCT02406612|9779374|P1|Overall Study|Screening Failure|3
2847258|NCT02406586|9779389|P3|Overall Study|Withdrawal by Subject|0
2847259|NCT02406586|9779390|P2|Overall Study|Withdrawal by Subject|0
2847260|NCT02406586|9779391|P1|Overall Study|Withdrawal by Subject|1
2847261|NCT02406586|9779389|P3|Overall Study|Lost to Follow-up|2
2847262|NCT02406586|9779390|P2|Overall Study|Lost to Follow-up|4
2847263|NCT02406586|9779391|P1|Overall Study|Lost to Follow-up|0
2847264|NCT02406261|9779533|P2|Period 2|Withdrawal by Subject|1
2847265|NCT02406261|9779534|P1|Period 2|Withdrawal by Subject|0
2847266|NCT02406261|9779533|P2|Period 2|Protocol Violation|1
2847267|NCT02406261|9779534|P1|Period 2|Protocol Violation|0
2847268|NCT02406261|9779533|P2|Period 2|Physician Decision|1
2847269|NCT02406261|9779534|P1|Period 2|Physician Decision|0
2847270|NCT02406261|9779533|P2|Period 1|Adverse Event|0
2847271|NCT02406261|9779534|P1|Period 1|Adverse Event|1
2847272|NCT02406261|9779533|P2|Period 1|Lost to Follow-up|0
2847273|NCT02406261|9779534|P1|Period 1|Lost to Follow-up|2
2847274|NCT02406248|9779546|P1|Overall Study|Withdrawal by Subject|2
2847275|NCT02406248|9779546|P1|Overall Study|Death|7
2847276|NCT02406027|9779557|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847277|NCT02406027|9779558|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847278|NCT02406027|9779559|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
2847279|NCT02406027|9779560|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847280|NCT02406027|9779561|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847281|NCT02406027|9779562|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847282|NCT02406027|9779563|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2847283|NCT02406027|9779557|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847284|NCT02406027|9779558|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
2847285|NCT02406027|9779559|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847286|NCT02406027|9779560|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847287|NCT02406027|9779561|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847288|NCT02406027|9779562|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847289|NCT02406027|9779563|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2847290|NCT02406027|9779557|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
2847291|NCT02406027|9779558|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
2847292|NCT02406027|9779559|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
2847293|NCT02406027|9779560|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
2847294|NCT02406027|9779561|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2847295|NCT02406027|9779562|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2847296|NCT02406027|9779563|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2847297|NCT02406027|9779557|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
2847298|NCT02406027|9779558|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
2847299|NCT02406027|9779559|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
2847300|NCT02406027|9779560|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
2847301|NCT02406027|9779561|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
2847302|NCT02406027|9779562|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
2847303|NCT02406027|9779563|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
2847304|NCT02406027|9779557|P7|Open-label Phase (Period 2)|Physician Decision|1
2847305|NCT02406027|9779558|P6|Open-label Phase (Period 2)|Physician Decision|1
2847306|NCT02406027|9779559|P5|Open-label Phase (Period 2)|Physician Decision|0
2847307|NCT02406027|9779560|P4|Open-label Phase (Period 2)|Physician Decision|0
2847308|NCT02406027|9779561|P3|Open-label Phase (Period 2)|Physician Decision|0
2847309|NCT02406027|9779562|P2|Open-label Phase (Period 2)|Physician Decision|0
2847310|NCT02406027|9779563|P1|Open-label Phase (Period 2)|Physician Decision|0
2847311|NCT02406027|9779557|P7|Open-label Phase (Period 2)|Adverse Event|0
2847312|NCT02406027|9779558|P6|Open-label Phase (Period 2)|Adverse Event|0
2847313|NCT02406027|9779559|P5|Open-label Phase (Period 2)|Adverse Event|2
2847314|NCT02406027|9779560|P4|Open-label Phase (Period 2)|Adverse Event|2
2847315|NCT02406027|9779561|P3|Open-label Phase (Period 2)|Adverse Event|0
2847316|NCT02406027|9779562|P2|Open-label Phase (Period 2)|Adverse Event|0
2847317|NCT02406027|9779563|P1|Open-label Phase (Period 2)|Adverse Event|0
2847318|NCT02406027|9779557|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2847319|NCT02406027|9779558|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2847320|NCT02406027|9779559|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2847321|NCT02406027|9779560|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2847322|NCT02406027|9779561|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2847323|NCT02406027|9779562|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2847324|NCT02406027|9779563|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2847325|NCT02406027|9779557|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2847326|NCT02406027|9779558|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2847327|NCT02406027|9779559|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2847328|NCT02406027|9779560|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2847329|NCT02406027|9779561|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2847330|NCT02406027|9779562|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2847331|NCT02406027|9779563|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
2847332|NCT02406027|9779557|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2847333|NCT02406027|9779558|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2847334|NCT02406027|9779559|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2847335|NCT02406027|9779560|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2847336|NCT02406027|9779561|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
2847337|NCT02406027|9779562|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2847338|NCT02406027|9779563|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
2847339|NCT02406027|9779557|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2847340|NCT02406027|9779558|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2847341|NCT02406027|9779559|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2847342|NCT02406027|9779560|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2847343|NCT02406027|9779561|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
2847344|NCT02406027|9779562|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
2847345|NCT02406027|9779563|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2847346|NCT02405962|9779593|P2|Overall Study|A participant has moved to another place|1
2847347|NCT02405962|9779594|P1|Overall Study|A participant has moved to another place|0
2847348|NCT02405962|9779593|P2|Overall Study|Lost to Follow-up|4
2847349|NCT02405962|9779594|P1|Overall Study|Lost to Follow-up|1
2847350|NCT02405780|9779632|P4|Period II|Non-compliance with study procedures|4
2847351|NCT02405780|9779633|P3|Period II|Non-compliance with study procedures|7
2847352|NCT02405780|9779634|P2|Period II|Non-compliance with study procedures|2
2847353|NCT02405780|9779635|P1|Period II|Non-compliance with study procedures|5
2847354|NCT02405780|9779632|P4|Period II|Withdrawal by Subject|3
2847355|NCT02405780|9779633|P3|Period II|Withdrawal by Subject|0
2847356|NCT02405780|9779634|P2|Period II|Withdrawal by Subject|4
2847357|NCT02405780|9779635|P1|Period II|Withdrawal by Subject|7
2847358|NCT02405780|9779632|P4|Period II|Pregnancy|0
2847359|NCT02405780|9779633|P3|Period II|Pregnancy|1
2847360|NCT02405780|9779634|P2|Period II|Pregnancy|0
2847361|NCT02405780|9779635|P1|Period II|Pregnancy|0
2847362|NCT02405780|9779632|P4|Period II|Medical reason|0
2847363|NCT02405780|9779633|P3|Period II|Medical reason|0
2847364|NCT02405780|9779634|P2|Period II|Medical reason|1
2847365|NCT02405780|9779635|P1|Period II|Medical reason|0
2847366|NCT02405780|9779632|P4|Period II|Adverse Event|11
2847367|NCT02405780|9779633|P3|Period II|Adverse Event|4
2847368|NCT02405780|9779634|P2|Period II|Adverse Event|5
2847369|NCT02405780|9779635|P1|Period II|Adverse Event|3
2847370|NCT02405780|9779632|P4|Period I|Non-compliance with study procedures|11
2847371|NCT02405780|9779633|P3|Period I|Non-compliance with study procedures|8
2847372|NCT02405780|9779634|P2|Period I|Non-compliance with study procedures|6
2847373|NCT02405780|9779635|P1|Period I|Non-compliance with study procedures|8
2847374|NCT02405780|9779632|P4|Period I|Withdrawal by Subject|4
2847375|NCT02405780|9779633|P3|Period I|Withdrawal by Subject|3
2847376|NCT02405780|9779634|P2|Period I|Withdrawal by Subject|1
2847377|NCT02405780|9779635|P1|Period I|Withdrawal by Subject|9
2847378|NCT02405780|9779632|P4|Period I|Screening Failure|0
2847379|NCT02405780|9779633|P3|Period I|Screening Failure|1
2847380|NCT02405780|9779634|P2|Period I|Screening Failure|0
2847381|NCT02405780|9779635|P1|Period I|Screening Failure|1
2847382|NCT02405780|9779632|P4|Period I|Medical reasons|1
2847383|NCT02405780|9779633|P3|Period I|Medical reasons|0
2847384|NCT02405780|9779634|P2|Period I|Medical reasons|1
2847385|NCT02405780|9779635|P1|Period I|Medical reasons|1
2847386|NCT02405780|9779632|P4|Period I|Adverse Event|7
2847387|NCT02405780|9779633|P3|Period I|Adverse Event|3
2847388|NCT02405780|9779634|P2|Period I|Adverse Event|0
2847389|NCT02405780|9779635|P1|Period I|Adverse Event|8
2847390|NCT02405442|9779698|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2847391|NCT02405442|9779699|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2847392|NCT02405442|9779700|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2847393|NCT02405442|9779701|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
2847394|NCT02405442|9779698|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2847395|NCT02405442|9779699|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2847396|NCT02405442|9779700|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
2847397|NCT02405442|9779701|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2847398|NCT02405442|9779698|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2847399|NCT02405442|9779699|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2847400|NCT02405442|9779700|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
2847401|NCT02405442|9779701|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2847402|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2847403|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2847404|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
2847405|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2847406|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2847407|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2847408|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
2847409|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2847410|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2847411|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2847412|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
2847413|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2847414|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
2847415|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
2847416|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
2847417|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
2847418|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
2847419|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
2847420|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
2847421|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
2847422|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
2847423|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2847424|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2847425|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
2847426|NCT02405442|9779698|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
2847427|NCT02405442|9779699|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2847428|NCT02405442|9779700|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2847429|NCT02405442|9779701|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
2847430|NCT02405442|9779698|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2847431|NCT02405442|9779699|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2847432|NCT02405442|9779700|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
2847433|NCT02405442|9779701|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2847434|NCT02405442|9779698|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2847435|NCT02405442|9779699|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2847436|NCT02405442|9779700|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2847437|NCT02405442|9779701|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2847438|NCT02405442|9779698|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2847439|NCT02405442|9779699|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
2847440|NCT02405442|9779700|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
2847441|NCT02405442|9779701|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2847442|NCT02405442|9779698|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
2847443|NCT02405442|9779699|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
2847444|NCT02405442|9779700|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
2847445|NCT02405442|9779701|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
2847446|NCT02405091|9779755|P3|Overall Study|Physician Decision|0
2847447|NCT02405091|9779756|P2|Overall Study|Physician Decision|2
2847448|NCT02405091|9779757|P1|Overall Study|Physician Decision|2
2847449|NCT02405091|9779755|P3|Overall Study|Lost to Follow-up|0
2847450|NCT02405091|9779756|P2|Overall Study|Lost to Follow-up|6
2847451|NCT02405091|9779757|P1|Overall Study|Lost to Follow-up|5
2847452|NCT02405091|9779755|P3|Overall Study|Death|0
2847453|NCT02405091|9779756|P2|Overall Study|Death|1
2847454|NCT02405091|9779757|P1|Overall Study|Death|0
2847455|NCT02405091|9779755|P3|Overall Study|Withdrawal by Subject|0
2847456|NCT02405091|9779756|P2|Overall Study|Withdrawal by Subject|8
2847457|NCT02405091|9779757|P1|Overall Study|Withdrawal by Subject|4
2847458|NCT02405091|9779755|P3|Overall Study|Noncompliance|2
2847459|NCT02405091|9779756|P2|Overall Study|Noncompliance|6
2847460|NCT02405091|9779757|P1|Overall Study|Noncompliance|1
2847461|NCT02405091|9779755|P3|Overall Study|Protocol Violation|0
2847462|NCT02405091|9779756|P2|Overall Study|Protocol Violation|0
2847463|NCT02405091|9779757|P1|Overall Study|Protocol Violation|1
2847464|NCT02405091|9779755|P3|Overall Study|Adverse Event|0
2847465|NCT02405091|9779756|P2|Overall Study|Adverse Event|10
2847466|NCT02405091|9779757|P1|Overall Study|Adverse Event|16
2847467|NCT02404649|9779793|P2|Overall Study|Adverse Event|2
2847468|NCT02404649|9779794|P1|Overall Study|Adverse Event|1
2847469|NCT02404545|9779811|P2|Overall Study|Sponsor Termination|6
2847470|NCT02404545|9779812|P1|Overall Study|Sponsor Termination|6
2847471|NCT02404493|9779831|P2|Overall Study|Adverse Event|1
2847472|NCT02404493|9779832|P1|Overall Study|Adverse Event|1
2847473|NCT02404389|9780077|P5|Overall Study|Subject/guardian decision|1
2847474|NCT02404389|9780078|P4|Overall Study|Subject/guardian decision|1
2847475|NCT02404389|9780079|P3|Overall Study|Subject/guardian decision|0
2847476|NCT02404389|9780080|P2|Overall Study|Subject/guardian decision|0
2847477|NCT02404389|9780081|P1|Overall Study|Subject/guardian decision|1
2847478|NCT02404389|9780077|P5|Overall Study|Adverse Event|2
2847479|NCT02404389|9780078|P4|Overall Study|Adverse Event|0
2847480|NCT02404389|9780079|P3|Overall Study|Adverse Event|1
2847481|NCT02404389|9780080|P2|Overall Study|Adverse Event|0
2847482|NCT02404389|9780081|P1|Overall Study|Adverse Event|1
2847483|NCT02404350|9780121|P4|Overall Study|Due to Technical problems|1
2847484|NCT02404350|9780122|P3|Overall Study|Due to Technical problems|0
2847485|NCT02404350|9780123|P2|Overall Study|Due to Technical problems|0
2847486|NCT02404350|9780124|P1|Overall Study|Due to Technical problems|0
2847487|NCT02404350|9780121|P4|Overall Study|Due to Non-compliance with treatment|1
2847488|NCT02404350|9780122|P3|Overall Study|Due to Non-compliance with treatment|0
2847489|NCT02404350|9780123|P2|Overall Study|Due to Non-compliance with treatment|0
2847490|NCT02404350|9780124|P1|Overall Study|Due to Non-compliance with treatment|0
2847491|NCT02404350|9780121|P4|Overall Study|Withdrawal by Subject|19
2847492|NCT02404350|9780122|P3|Overall Study|Withdrawal by Subject|3
2847493|NCT02404350|9780123|P2|Overall Study|Withdrawal by Subject|3
2847494|NCT02404350|9780124|P1|Overall Study|Withdrawal by Subject|7
2847495|NCT02404350|9780121|P4|Overall Study|Pregnancy|1
2847496|NCT02404350|9780122|P3|Overall Study|Pregnancy|0
2847497|NCT02404350|9780123|P2|Overall Study|Pregnancy|0
2847498|NCT02404350|9780124|P1|Overall Study|Pregnancy|0
2847499|NCT02404350|9780121|P4|Overall Study|Physician Decision|2
2847500|NCT02404350|9780122|P3|Overall Study|Physician Decision|0
2847501|NCT02404350|9780123|P2|Overall Study|Physician Decision|0
2847502|NCT02404350|9780124|P1|Overall Study|Physician Decision|1
2847503|NCT02404350|9780121|P4|Overall Study|Lost to Follow-up|1
2847504|NCT02404350|9780122|P3|Overall Study|Lost to Follow-up|0
2847505|NCT02404350|9780123|P2|Overall Study|Lost to Follow-up|0
2847506|NCT02404350|9780124|P1|Overall Study|Lost to Follow-up|2
2847507|NCT02404350|9780121|P4|Overall Study|Lack of Efficacy|3
2847508|NCT02404350|9780122|P3|Overall Study|Lack of Efficacy|0
2847509|NCT02404350|9780123|P2|Overall Study|Lack of Efficacy|1
2847510|NCT02404350|9780124|P1|Overall Study|Lack of Efficacy|3
2847511|NCT02404350|9780121|P4|Overall Study|Adverse Event|9
2847512|NCT02404350|9780122|P3|Overall Study|Adverse Event|3
2847513|NCT02404350|9780123|P2|Overall Study|Adverse Event|2
2847514|NCT02404350|9780124|P1|Overall Study|Adverse Event|2
2847515|NCT02404220|9780206|P4|Overall Study|Enrolled but Never Treated|0
2847516|NCT02404220|9780207|P3|Overall Study|Enrolled but Never Treated|0
2847517|NCT02404220|9780208|P2|Overall Study|Enrolled but Never Treated|2
2847518|NCT02404220|9780209|P1|Overall Study|Enrolled but Never Treated|0
2847519|NCT02404220|9780206|P4|Overall Study|Withdrawal by Subject|0
2847520|NCT02404220|9780207|P3|Overall Study|Withdrawal by Subject|0
2847521|NCT02404220|9780208|P2|Overall Study|Withdrawal by Subject|1
2847522|NCT02404220|9780209|P1|Overall Study|Withdrawal by Subject|0
2847523|NCT02404220|9780206|P4|Overall Study|Study Terminated by Sponsor|1
2847524|NCT02404220|9780207|P3|Overall Study|Study Terminated by Sponsor|2
2847525|NCT02404220|9780208|P2|Overall Study|Study Terminated by Sponsor|0
2847526|NCT02404220|9780209|P1|Overall Study|Study Terminated by Sponsor|0
2847527|NCT02404220|9780206|P4|Overall Study|Progressive Disease|1
2847528|NCT02404220|9780207|P3|Overall Study|Progressive Disease|1
2847529|NCT02404220|9780208|P2|Overall Study|Progressive Disease|0
2847530|NCT02404220|9780209|P1|Overall Study|Progressive Disease|0
2847531|NCT02404220|9780206|P4|Overall Study|Death|8
2847532|NCT02404220|9780207|P3|Overall Study|Death|3
2847533|NCT02404220|9780208|P2|Overall Study|Death|5
2847534|NCT02404220|9780209|P1|Overall Study|Death|5
2847535|NCT02404220|9780206|P4|Overall Study|Adverse Event|0
2847536|NCT02404220|9780207|P3|Overall Study|Adverse Event|1
2847537|NCT02404220|9780208|P2|Overall Study|Adverse Event|0
2847538|NCT02404220|9780209|P1|Overall Study|Adverse Event|0
2847539|NCT02404103|9780245|P2|Overall Study|Lost to Follow-up|3
2847540|NCT02404103|9780246|P1|Overall Study|Lost to Follow-up|3
2847541|NCT02404103|9780245|P2|Overall Study|Adverse Event|0
2847542|NCT02404103|9780246|P1|Overall Study|Adverse Event|1
2847543|NCT02404025|9780266|P1|Overall Study|Lack of Efficacy|3
2847544|NCT02404025|9780266|P1|Overall Study|Adverse Event|1
2847545|NCT02403817|9780348|P2|Overall Study|Withdrawal by Subject|0
2847546|NCT02403817|9780349|P1|Overall Study|Withdrawal by Subject|5
2847547|NCT02403674|9780380|P2|Overall Study|Protocol Violation|2
2847548|NCT02403674|9780381|P1|Overall Study|Protocol Violation|4
2847549|NCT02403674|9780380|P2|Overall Study|Pregnancy|1
2847550|NCT02403674|9780381|P1|Overall Study|Pregnancy|1
2847551|NCT02403674|9780380|P2|Overall Study|Not treated with study drug|2
2847552|NCT02403674|9780381|P1|Overall Study|Not treated with study drug|4
2847553|NCT02403674|9780380|P2|Overall Study|Physician Decision|2
2847554|NCT02403674|9780381|P1|Overall Study|Physician Decision|2
2847555|NCT02403674|9780380|P2|Overall Study|Withdrawal by Subject|11
2847556|NCT02403674|9780381|P1|Overall Study|Withdrawal by Subject|8
2847557|NCT02403674|9780380|P2|Overall Study|Noncompliance with study drug|2
2847558|NCT02403674|9780381|P1|Overall Study|Noncompliance with study drug|1
2847559|NCT02403674|9780380|P2|Overall Study|Lost to Follow-up|7
2847560|NCT02403674|9780381|P1|Overall Study|Lost to Follow-up|6
2847561|NCT02403674|9780380|P2|Overall Study|Lack of Efficacy|10
2847562|NCT02403674|9780381|P1|Overall Study|Lack of Efficacy|18
2847563|NCT02403674|9780380|P2|Overall Study|Death|3
2847564|NCT02403674|9780381|P1|Overall Study|Death|1
2847565|NCT02403674|9780380|P2|Overall Study|Adverse Event|23
2847566|NCT02403674|9780381|P1|Overall Study|Adverse Event|10
2847567|NCT02403635|9780420|P1|Overall Study|Not eligible|9
2847568|NCT02403271|9780497|P2|Period 2|Other varied reasons|10
2847569|NCT02403271|9780498|P1|Period 2|Other varied reasons|0
2847570|NCT02403271|9780497|P2|Period 2|Study Terminated by Sponsor|14
2847571|NCT02403271|9780498|P1|Period 2|Study Terminated by Sponsor|0
2847572|NCT02403271|9780497|P2|Period 2|Lost to Follow-up|2
2847573|NCT02403271|9780498|P1|Period 2|Lost to Follow-up|0
2847574|NCT02403271|9780497|P2|Period 2|Death|84
2847575|NCT02403271|9780498|P1|Period 2|Death|0
2847576|NCT02403271|9780497|P2|Period 2|Withdrawal by Subject|14
2847577|NCT02403271|9780498|P1|Period 2|Withdrawal by Subject|0
2847578|NCT02403271|9780497|P2|Period 1|Other varied reasons|0
2847579|NCT02403271|9780498|P1|Period 1|Other varied reasons|1
2847580|NCT02403206|9780512|P2|Overall Study|Reason not given|4
2847581|NCT02403206|9780513|P1|Overall Study|Reason not given|2
2847582|NCT02403206|9780512|P2|Overall Study|Withdrawal by Subject|3
2847583|NCT02403206|9780513|P1|Overall Study|Withdrawal by Subject|3
2847584|NCT02403206|9780512|P2|Overall Study|Physician Decision|0
2847585|NCT02403206|9780513|P1|Overall Study|Physician Decision|2
2847586|NCT02403206|9780512|P2|Overall Study|Lost to Follow-up|3
2847587|NCT02403206|9780513|P1|Overall Study|Lost to Follow-up|4
2847588|NCT02403180|9780524|P2|Period 2 (5 Days)|Withdrawal by Subject|1
2847589|NCT02403180|9780525|P1|Period 2 (5 Days)|Withdrawal by Subject|0
2847590|NCT02403180|9780524|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
2847591|NCT02403180|9780525|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
2847592|NCT02402933|9780554|P1|Overall Study|Discontinued; Site Termination|10
2847593|NCT02402933|9780554|P1|Overall Study|Withdrawal by Subject|4
2847594|NCT02402322|9780598|P3|Follow-up|Withdrawal by Subject|24
2847595|NCT02402322|9780599|P2|Follow-up|Withdrawal by Subject|3
2847596|NCT02402322|9780600|P1|Follow-up|Withdrawal by Subject|6
2847597|NCT02402322|9780598|P3|Pretreatment|Withdrawal by Subject|1
2847598|NCT02402322|9780599|P2|Pretreatment|Withdrawal by Subject|1
2847599|NCT02402322|9780600|P1|Pretreatment|Withdrawal by Subject|3
2847600|NCT02402218|9780650|P3|Overall Study|Withdrawal by Subject|1
2847601|NCT02402218|9780651|P2|Overall Study|Withdrawal by Subject|1
2847602|NCT02402218|9780652|P1|Overall Study|Withdrawal by Subject|1
2847603|NCT02402218|9780650|P3|Overall Study|Adverse Event|1
2847604|NCT02402218|9780651|P2|Overall Study|Adverse Event|2
2847605|NCT02402218|9780652|P1|Overall Study|Adverse Event|0
2847606|NCT02402218|9780650|P3|Overall Study|Reinfection|1
2847607|NCT02402218|9780651|P2|Overall Study|Reinfection|0
2847608|NCT02402218|9780652|P1|Overall Study|Reinfection|0
2847609|NCT02402218|9780650|P3|Overall Study|Death|0
2847610|NCT02402218|9780651|P2|Overall Study|Death|0
2847611|NCT02402218|9780652|P1|Overall Study|Death|1
2847612|NCT02402218|9780650|P3|Overall Study|Lack of Efficacy|1
2847613|NCT02402218|9780651|P2|Overall Study|Lack of Efficacy|1
2847614|NCT02402218|9780652|P1|Overall Study|Lack of Efficacy|0
2847615|NCT02402218|9780650|P3|Overall Study|Did not pickup study medication|13
2847616|NCT02402218|9780651|P2|Overall Study|Did not pickup study medication|9
2847617|NCT02402218|9780652|P1|Overall Study|Did not pickup study medication|12
2847618|NCT02402166|9780675|P1|Overall Study|Lost to Follow-up|1
2847619|NCT02402166|9780675|P1|Overall Study|Withdrawal by Subject|2
2847620|NCT02402166|9780675|P1|Overall Study|Adverse Event|2
2847621|NCT02401867|9780732|P1|Analysis|Cervical assay could not be conducted|9
2847622|NCT02401867|9780732|P1|Specimen Collection|Didn't receive 1 or more tests|10
2847623|NCT02401529|9780767|P2|Overall Study|Protocol Violation|0
2847624|NCT02401529|9780768|P1|Overall Study|Protocol Violation|5
2847625|NCT02401529|9780767|P2|Overall Study|Physician Decision|6
2847626|NCT02401529|9780768|P1|Overall Study|Physician Decision|2
2847627|NCT02401529|9780767|P2|Overall Study|Lost to Follow-up|1
2847628|NCT02401529|9780768|P1|Overall Study|Lost to Follow-up|2
2847629|NCT02401412|9780835|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
2847630|NCT02401412|9780836|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
2847631|NCT02401412|9780835|P2|Overall Study|Subject withdrawal prior to intervention|1
2847632|NCT02401412|9780836|P1|Overall Study|Subject withdrawal prior to intervention|0
2847633|NCT02401412|9780835|P2|Overall Study|Withdrawal by Subject|4
2847634|NCT02401412|9780836|P1|Overall Study|Withdrawal by Subject|4
2847635|NCT02401412|9780835|P2|Overall Study|Discontinued Intervention|21
2847636|NCT02401412|9780836|P1|Overall Study|Discontinued Intervention|15
2847637|NCT02401412|9780835|P2|Overall Study|Lost to Follow-up|0
2847638|NCT02401412|9780836|P1|Overall Study|Lost to Follow-up|1
2847639|NCT02401256|9780844|P1|Overall Study|Withdrawal by Subject|12
2847640|NCT02401256|9780844|P1|Overall Study|Adverse Event|5
2847641|NCT02401230|9780853|P3|Overall Study|Lost to Follow-up|3
2847642|NCT02401230|9780854|P2|Overall Study|Lost to Follow-up|3
2847643|NCT02401230|9780855|P1|Overall Study|Lost to Follow-up|1
2847644|NCT02401230|9780853|P3|Overall Study|Withdrawal by Subject|1
2847645|NCT02401230|9780854|P2|Overall Study|Withdrawal by Subject|1
2847646|NCT02401230|9780855|P1|Overall Study|Withdrawal by Subject|2
2847647|NCT02401230|9780853|P3|Overall Study|Adverse Event|0
2847648|NCT02401230|9780854|P2|Overall Study|Adverse Event|2
2847649|NCT02401230|9780855|P1|Overall Study|Adverse Event|3
2847650|NCT02400905|9780934|P1|Overall Study|Subject refused visit|1
2847651|NCT02400905|9780934|P1|Overall Study|Death|3
2847652|NCT02400905|9780934|P1|Overall Study|Withdrawal by Subject|5
2847653|NCT02400905|9780934|P1|Overall Study|Lost to Follow-up|6
2847654|NCT02400905|9780934|P1|Overall Study|Ongoing Follow-up|256
2847655|NCT02400749|9780944|P2|Week 17 - 32|Adverse Event|1
2847656|NCT02400749|9780945|P1|Week 17 - 32|Adverse Event|2
2847657|NCT02400749|9780944|P2|Week 17 - 32|Withdrawal by Subject|2
2847658|NCT02400749|9780945|P1|Week 17 - 32|Withdrawal by Subject|3
2847659|NCT02400749|9780944|P2|Week 0 -16|Protocol Violation|0
2847660|NCT02400749|9780945|P1|Week 0 -16|Protocol Violation|1
2847661|NCT02400749|9780944|P2|Week 0 -16|Lost to Follow-up|0
2847662|NCT02400749|9780945|P1|Week 0 -16|Lost to Follow-up|2
2847663|NCT02400749|9780944|P2|Week 0 -16|Adverse Event|1
2847664|NCT02400749|9780945|P1|Week 0 -16|Adverse Event|3
2847665|NCT02400749|9780944|P2|Week 0 -16|Withdrawal by Subject|5
2847666|NCT02400749|9780945|P1|Week 0 -16|Withdrawal by Subject|5
2847667|NCT02400580|9780972|P2|Overall Study|Adverse Event|0
2847668|NCT02400580|9780973|P1|Overall Study|Adverse Event|1
2847669|NCT02400580|9780972|P2|Overall Study|Withdrawal by Subject|1
2847670|NCT02400580|9780973|P1|Overall Study|Withdrawal by Subject|1
2847671|NCT02400346|9780989|P1|Overall Study|Lost to Follow-up|1
2847672|NCT02400346|9780989|P1|Overall Study|Administrative or other reason(s)|2
2847673|NCT02400346|9780989|P1|Overall Study|Withdrawal by Subject|7
2847674|NCT02400346|9780989|P1|Overall Study|Non-compliance with IMP|1
2847675|NCT02400346|9780989|P1|Overall Study|Lack of Efficacy|9
2847676|NCT02400346|9780989|P1|Overall Study|Adverse Event|24
2847677|NCT02400333|9780997|P4|Overall Study|Protocol Violation|1
2847678|NCT02400333|9780998|P3|Overall Study|Protocol Violation|2
2847679|NCT02400333|9780999|P2|Overall Study|Protocol Violation|0
2847680|NCT02400333|9781000|P1|Overall Study|Protocol Violation|1
2847681|NCT02400333|9780997|P4|Overall Study|Withdrawal by Subject|1
2847682|NCT02400333|9780998|P3|Overall Study|Withdrawal by Subject|0
2847683|NCT02400333|9780999|P2|Overall Study|Withdrawal by Subject|1
2847684|NCT02400333|9781000|P1|Overall Study|Withdrawal by Subject|0
2847685|NCT02400307|9781060|P2|Overall Study|Enrolled and Never Dosed|0
2847686|NCT02400307|9781061|P1|Overall Study|Enrolled and Never Dosed|1
2847687|NCT02399254|9781115|P1|Overall Study|Physician Decision|2
2847688|NCT02399163|9781122|P1|Overall Study|Withdrawal by Participant|5
2847689|NCT02399163|9781122|P1|Overall Study|Protocol Deviation|2
2847690|NCT02399163|9781122|P1|Overall Study|Adverse Event|2
2847691|NCT02398227|9781177|P2|Overall Study|Removed from treatment and dropped out|0
2847692|NCT02398227|9781178|P1|Overall Study|Removed from treatment and dropped out|1
2847693|NCT02398227|9781177|P2|Overall Study|Withdrawal by Subject|6
2847694|NCT02398227|9781178|P1|Overall Study|Withdrawal by Subject|5
2847695|NCT02398227|9781177|P2|Overall Study|Lost to Follow-up|12
2847696|NCT02398227|9781178|P1|Overall Study|Lost to Follow-up|21
2847697|NCT02398188|9781188|P2|Overall Study|Withdrawal by Subject|16
2847698|NCT02398188|9781189|P1|Overall Study|Withdrawal by Subject|7
2847699|NCT02398188|9781188|P2|Overall Study|Pregnancy|0
2847700|NCT02398188|9781189|P1|Overall Study|Pregnancy|1
2847701|NCT02398188|9781188|P2|Overall Study|Sponsor Decision|1
2847702|NCT02398188|9781189|P1|Overall Study|Sponsor Decision|2
2847703|NCT02398188|9781188|P2|Overall Study|Protocol Violation|10
2847704|NCT02398188|9781189|P1|Overall Study|Protocol Violation|6
2847705|NCT02398188|9781188|P2|Overall Study|Non-compliance|4
2847706|NCT02398188|9781189|P1|Overall Study|Non-compliance|4
2847707|NCT02398188|9781188|P2|Overall Study|Lost to Follow-up|0
2847708|NCT02398188|9781189|P1|Overall Study|Lost to Follow-up|5
2847709|NCT02398188|9781188|P2|Overall Study|Adverse Event|3
2847710|NCT02398188|9781189|P1|Overall Study|Adverse Event|2
2847711|NCT02397915|9781207|P4|Period 1|Physician Decision|0
2847712|NCT02397915|9781208|P3|Period 1|Physician Decision|0
2847713|NCT02397915|9781209|P2|Period 1|Physician Decision|0
2847714|NCT02397915|9781210|P1|Period 1|Physician Decision|1
2847715|NCT02397915|9781207|P4|Period 1|Protocol Violation|0
2847716|NCT02397915|9781208|P3|Period 1|Protocol Violation|0
2847717|NCT02397915|9781209|P2|Period 1|Protocol Violation|1
2847718|NCT02397915|9781210|P1|Period 1|Protocol Violation|0
2847719|NCT02397837|9781262|P2|Overall Study|Physician Decision|1
2847720|NCT02397837|9781263|P1|Overall Study|Physician Decision|1
2847721|NCT02397837|9781262|P2|Overall Study|Withdrawal by Subject|5
2847722|NCT02397837|9781263|P1|Overall Study|Withdrawal by Subject|6
2847723|NCT02397694|9781358|P2|Open Label Extension Phase|Lost to Follow-up|0
2847724|NCT02397694|9781359|P1|Open Label Extension Phase|Lost to Follow-up|4
2847725|NCT02397694|9781358|P2|Open Label Extension Phase|Withdrew Consent|1
2847726|NCT02397694|9781359|P1|Open Label Extension Phase|Withdrew Consent|3
2847727|NCT02397694|9781358|P2|Open Label Extension Phase|Protocol Violation|0
2847728|NCT02397694|9781359|P1|Open Label Extension Phase|Protocol Violation|1
2847729|NCT02397694|9781358|P2|Double-Blinded Phase|Lost to Follow-up|1
2847730|NCT02397694|9781359|P1|Double-Blinded Phase|Lost to Follow-up|1
2847731|NCT02397694|9781358|P2|Double-Blinded Phase|Withdrawal by Subject|0
2847732|NCT02397694|9781359|P1|Double-Blinded Phase|Withdrawal by Subject|1
2847733|NCT02397694|9781358|P2|Double-Blinded Phase|Non-compliance with study drug|2
2847734|NCT02397694|9781359|P1|Double-Blinded Phase|Non-compliance with study drug|0
2847735|NCT02397694|9781358|P2|Double-Blinded Phase|Adverse Event|0
2847736|NCT02397694|9781359|P1|Double-Blinded Phase|Adverse Event|1
2847737|NCT02397655|9781397|P1|Overall Study|data not completed|1301
2847738|NCT02397473|9781408|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2847739|NCT02397473|9781409|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2847740|NCT02397473|9781408|P2|Post Treatment Follow-up Phase|Protocol Violation|0
2847741|NCT02397473|9781409|P1|Post Treatment Follow-up Phase|Protocol Violation|1
2847742|NCT02397473|9781408|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
2847743|NCT02397473|9781409|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
2847744|NCT02397473|9781408|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
2847745|NCT02397473|9781409|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
2847746|NCT02397473|9781408|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
2847747|NCT02397473|9781409|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
2847748|NCT02397473|9781408|P2|Treatment Phase|Withdrawal by Subject|1
2847749|NCT02397473|9781409|P1|Treatment Phase|Withdrawal by Subject|2
2847750|NCT02397473|9781408|P2|Treatment Phase|Lost to Follow-up|0
2847751|NCT02397473|9781409|P1|Treatment Phase|Lost to Follow-up|1
2847752|NCT02397473|9781408|P2|Treatment Phase|Lack of Efficacy|1
2847753|NCT02397473|9781409|P1|Treatment Phase|Lack of Efficacy|8
2847754|NCT02397473|9781408|P2|Treatment Phase|Adverse Event|2
2847755|NCT02397473|9781409|P1|Treatment Phase|Adverse Event|1
2847756|NCT02397096|9781468|P2|Study Extensions|Ongoing|202
2847757|NCT02397096|9781469|P1|Study Extensions|Ongoing|399
2847758|NCT02397096|9781468|P2|Week 24 to Week 48|Lost to Follow-up|0
2847759|NCT02397096|9781469|P1|Week 24 to Week 48|Lost to Follow-up|2
2847760|NCT02397096|9781468|P2|Week 24 to Week 48|Withdrawal by Subject|2
2847761|NCT02397096|9781469|P1|Week 24 to Week 48|Withdrawal by Subject|5
2847762|NCT02397096|9781468|P2|Week 24 to Week 48|Physician Decision|1
2847763|NCT02397096|9781469|P1|Week 24 to Week 48|Physician Decision|2
2847764|NCT02397096|9781468|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
2847765|NCT02397096|9781469|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
2847766|NCT02397096|9781468|P2|Week 24 to Week 48|Lack of Efficacy|1
2847767|NCT02397096|9781469|P1|Week 24 to Week 48|Lack of Efficacy|5
2847768|NCT02397096|9781468|P2|Week 24 to Week 48|Adverse Event|2
2847769|NCT02397096|9781469|P1|Week 24 to Week 48|Adverse Event|6
2847770|NCT02397096|9781468|P2|Day 1 to Week 24|Withdrawal by Subject|1
2847771|NCT02397096|9781469|P1|Day 1 to Week 24|Withdrawal by Subject|6
2847772|NCT02397096|9781468|P2|Day 1 to Week 24|Protocol Violation|4
2847773|NCT02397096|9781469|P1|Day 1 to Week 24|Protocol Violation|1
2847774|NCT02397096|9781468|P2|Day 1 to Week 24|Physician Decision|3
2847775|NCT02397096|9781469|P1|Day 1 to Week 24|Physician Decision|2
2847776|NCT02397096|9781468|P2|Day 1 to Week 24|Lost to Follow-up|4
2847777|NCT02397096|9781469|P1|Day 1 to Week 24|Lost to Follow-up|3
2847778|NCT02397096|9781468|P2|Day 1 to Week 24|Lack of Efficacy|1
2847779|NCT02397096|9781469|P1|Day 1 to Week 24|Lack of Efficacy|0
2847780|NCT02397096|9781468|P2|Day 1 to Week 24|Death|0
2847781|NCT02397096|9781469|P1|Day 1 to Week 24|Death|1
2847782|NCT02397096|9781468|P2|Day 1 to Week 24|Adverse Event|1
2847783|NCT02397096|9781469|P1|Day 1 to Week 24|Adverse Event|7
2847784|NCT02396953|9781502|P3|Overall Study|Personal Reasons|0
2847785|NCT02396953|9781503|P2|Overall Study|Personal Reasons|1
2847786|NCT02396953|9781504|P1|Overall Study|Personal Reasons|1
2847787|NCT02396953|9781502|P3|Overall Study|Insulin like Growth Factor-1 increased|2
2847788|NCT02396953|9781503|P2|Overall Study|Insulin like Growth Factor-1 increased|2
2847789|NCT02396953|9781504|P1|Overall Study|Insulin like Growth Factor-1 increased|3
2847790|NCT02396953|9781502|P3|Overall Study|Withdrawal by Subject|1
2847791|NCT02396953|9781503|P2|Overall Study|Withdrawal by Subject|0
2847792|NCT02396953|9781504|P1|Overall Study|Withdrawal by Subject|0
2847793|NCT02396537|9781579|P2|Overall Study|Protocol Violation|1
2847794|NCT02396537|9781580|P1|Overall Study|Protocol Violation|0
2847795|NCT02396420|9781592|P1|Overall Study|Death|1
2847796|NCT02396381|9781616|P2|Overall Study|Randomization/Screening Error|1
2847797|NCT02396381|9781617|P1|Overall Study|Randomization/Screening Error|3
2847798|NCT02396381|9781616|P2|Overall Study|Possible conflict of interest|0
2847799|NCT02396381|9781617|P1|Overall Study|Possible conflict of interest|1
2847800|NCT02396381|9781616|P2|Overall Study|Could not complete visit|0
2847801|NCT02396381|9781617|P1|Overall Study|Could not complete visit|1
2847802|NCT02396381|9781616|P2|Overall Study|Moved out of town/state|3
2847803|NCT02396381|9781617|P1|Overall Study|Moved out of town/state|1
2847804|NCT02396381|9781616|P2|Overall Study|Non-compliance with study procedures|0
2847805|NCT02396381|9781617|P1|Overall Study|Non-compliance with study procedures|1
2847806|NCT02396381|9781616|P2|Overall Study|Pregnancy|0
2847807|NCT02396381|9781617|P1|Overall Study|Pregnancy|2
2847808|NCT02396381|9781616|P2|Overall Study|Physician Decision|5
2847809|NCT02396381|9781617|P1|Overall Study|Physician Decision|5
2847810|NCT02396381|9781616|P2|Overall Study|Site terminated by sponsor|8
2847811|NCT02396381|9781617|P1|Overall Study|Site terminated by sponsor|7
2847812|NCT02396381|9781616|P2|Overall Study|Protocol Violation|0
2847813|NCT02396381|9781617|P1|Overall Study|Protocol Violation|1
2847814|NCT02396381|9781616|P2|Overall Study|Lost to Follow-up|31
2847815|NCT02396381|9781617|P1|Overall Study|Lost to Follow-up|49
2847816|NCT02396381|9781616|P2|Overall Study|Withdrawal by Subject|24
2847817|NCT02396381|9781617|P1|Overall Study|Withdrawal by Subject|33
2847818|NCT02396381|9781616|P2|Overall Study|Adverse Event|2
2847819|NCT02396381|9781617|P1|Overall Study|Adverse Event|3
2847820|NCT02396316|9781656|P2|Overall Study|Treatment unblinded|1
2847821|NCT02396316|9781657|P1|Overall Study|Treatment unblinded|0
2847822|NCT02396316|9781656|P2|Overall Study|Protocol Violation|1
2847823|NCT02396316|9781657|P1|Overall Study|Protocol Violation|0
2847824|NCT02396316|9781656|P2|Overall Study|Progressive disease|3
2847825|NCT02396316|9781657|P1|Overall Study|Progressive disease|6
2847826|NCT02396316|9781656|P2|Overall Study|Physician Decision|0
2847827|NCT02396316|9781657|P1|Overall Study|Physician Decision|1
2847828|NCT02396212|9781676|P1|Overall Study|Lack of Efficacy|2
2847829|NCT02396212|9781676|P1|Overall Study|Adverse Event|1
2847830|NCT02395822|9781783|P1|Overall Study|Death|1
2847831|NCT02395822|9781783|P1|Overall Study|Withdrawal by Subject|1
2847832|NCT02395666|9781804|P2|Overall Study|Withdrawal by Subject|1
2847833|NCT02395666|9781805|P1|Overall Study|Withdrawal by Subject|2
2847834|NCT02395666|9781804|P2|Overall Study|Lost to Follow-up|0
2847835|NCT02395666|9781805|P1|Overall Study|Lost to Follow-up|1
2847836|NCT02395666|9781804|P2|Overall Study|Physician Decision|0
2847837|NCT02395666|9781805|P1|Overall Study|Physician Decision|3
2847838|NCT02395653|9781819|P1|Overall Study|Lost to Follow-up|1
2847839|NCT02395653|9781819|P1|Overall Study|Withdrawal by Subject|1
2847840|NCT02395653|9781819|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
2847841|NCT02395653|9781819|P1|Overall Study|Investigator Decision at Screening|1
2847842|NCT02395653|9781819|P1|Overall Study|SSEC Application But With 0 Dose|1
2847843|NCT02395653|9781819|P1|Overall Study|Consent Withdrawn at Screening|1
2847844|NCT02395653|9781819|P1|Overall Study|Exclusion Criteria Met at Screening|4
2847845|NCT02395536|9781828|P2|Overall Study|Insurance issue|1
2847846|NCT02395536|9781829|P1|Overall Study|Insurance issue|0
2847847|NCT02395536|9781828|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
2847848|NCT02395536|9781829|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
2847849|NCT02395536|9781828|P2|Overall Study|Withdrawal by Subject|17
2847850|NCT02395536|9781829|P1|Overall Study|Withdrawal by Subject|9
2847851|NCT02395536|9781828|P2|Overall Study|Physician Decision|6
2847852|NCT02395536|9781829|P1|Overall Study|Physician Decision|4
2847853|NCT02395536|9781828|P2|Overall Study|Death|0
2847854|NCT02395536|9781829|P1|Overall Study|Death|2
2847855|NCT02395536|9781828|P2|Overall Study|Lost to Follow-up|4
2847856|NCT02395536|9781829|P1|Overall Study|Lost to Follow-up|4
2847857|NCT02395471|9781837|P2|Overall Study|Subject not eligible|0
2847858|NCT02395471|9781838|P1|Overall Study|Subject not eligible|1
2847859|NCT02395471|9781837|P2|Overall Study|Patient did not return for procedure|1
2847860|NCT02395471|9781838|P1|Overall Study|Patient did not return for procedure|0
2847861|NCT02395471|9781837|P2|Overall Study|Failure to swollow sponge twice|0
2847862|NCT02395471|9781838|P1|Overall Study|Failure to swollow sponge twice|1
2847863|NCT02395471|9781837|P2|Overall Study|Protocol Violation|1
2847864|NCT02395471|9781838|P1|Overall Study|Protocol Violation|0
2847865|NCT02395471|9781837|P2|Overall Study|Physician Decision|0
2847866|NCT02395471|9781838|P1|Overall Study|Physician Decision|1
2847867|NCT02395471|9781837|P2|Overall Study|Withdrawal by Subject|1
2847868|NCT02395471|9781838|P1|Overall Study|Withdrawal by Subject|2
2847869|NCT02395471|9781837|P2|Overall Study|Lost to Follow-up|0
2847870|NCT02395471|9781838|P1|Overall Study|Lost to Follow-up|2
2847871|NCT02395302|9781853|P1|Overall Study|Physician Decision|2
2847872|NCT02395302|9781853|P1|Overall Study|Withdrawal by Subject|2
2847873|NCT02395302|9781853|P1|Overall Study|Run In Failure|7
2847874|NCT02395302|9781853|P1|Overall Study|Screen Failure|3
2847875|NCT02395172|9781873|P2|Overall Study|Treatment ongoing|5
2847876|NCT02395172|9781874|P1|Overall Study|Treatment ongoing|49
2847877|NCT02395172|9781873|P2|Overall Study|Participants randomized but not treated|31
2847878|NCT02395172|9781874|P1|Overall Study|Participants randomized but not treated|3
2847879|NCT02395133|9781913|P4|Overall Study|Other than specified above|4
2847880|NCT02395133|9781914|P3|Overall Study|Other than specified above|2
2847881|NCT02395133|9781915|P2|Overall Study|Other than specified above|2
2847882|NCT02395133|9781916|P1|Overall Study|Other than specified above|5
2847883|NCT02395133|9781913|P4|Overall Study|Sponsor decision|1
2847884|NCT02395133|9781914|P3|Overall Study|Sponsor decision|0
2847885|NCT02395133|9781915|P2|Overall Study|Sponsor decision|0
2847886|NCT02395133|9781916|P1|Overall Study|Sponsor decision|2
2847887|NCT02395133|9781913|P4|Overall Study|Consent withdrawn with personal reason|3
2847888|NCT02395133|9781914|P3|Overall Study|Consent withdrawn with personal reason|0
2847889|NCT02395133|9781915|P2|Overall Study|Consent withdrawn with personal reason|1
2847890|NCT02395133|9781916|P1|Overall Study|Consent withdrawn with personal reason|0
2847891|NCT02395133|9781913|P4|Overall Study|Consent withdrawn with no reason given|2
2847892|NCT02395133|9781914|P3|Overall Study|Consent withdrawn with no reason given|0
2847893|NCT02395133|9781915|P2|Overall Study|Consent withdrawn with no reason given|3
2847894|NCT02395133|9781916|P1|Overall Study|Consent withdrawn with no reason given|1
2847895|NCT02395133|9781913|P4|Overall Study|Pregnancy|0
2847896|NCT02395133|9781914|P3|Overall Study|Pregnancy|3
2847897|NCT02395133|9781915|P2|Overall Study|Pregnancy|0
2847898|NCT02395133|9781916|P1|Overall Study|Pregnancy|0
2847899|NCT02395133|9781913|P4|Overall Study|Lost to Follow-up|0
2847900|NCT02395133|9781914|P3|Overall Study|Lost to Follow-up|1
2847901|NCT02395133|9781915|P2|Overall Study|Lost to Follow-up|1
2847902|NCT02395133|9781916|P1|Overall Study|Lost to Follow-up|0
2847903|NCT02395133|9781913|P4|Overall Study|Protocol Violation|3
2847904|NCT02395133|9781914|P3|Overall Study|Protocol Violation|0
2847905|NCT02395133|9781915|P2|Overall Study|Protocol Violation|1
2847906|NCT02395133|9781916|P1|Overall Study|Protocol Violation|1
2847907|NCT02395133|9781913|P4|Overall Study|Lack of Efficacy|1
2847908|NCT02395133|9781914|P3|Overall Study|Lack of Efficacy|1
2847909|NCT02395133|9781915|P2|Overall Study|Lack of Efficacy|0
2847910|NCT02395133|9781916|P1|Overall Study|Lack of Efficacy|1
2847911|NCT02395133|9781913|P4|Overall Study|Adverse Event|0
2847912|NCT02395133|9781914|P3|Overall Study|Adverse Event|3
2847913|NCT02395133|9781915|P2|Overall Study|Adverse Event|1
2847914|NCT02395133|9781916|P1|Overall Study|Adverse Event|4
2847915|NCT02395055|9782004|P2|Overall Study|Withdrawal by Subject|3
2847916|NCT02395055|9782005|P1|Overall Study|Withdrawal by Subject|7
2847917|NCT02395042|9782018|P3|Treatment 2 Period|Lack of Efficacy|0
2847918|NCT02395042|9782019|P2|Treatment 2 Period|Lack of Efficacy|1
2847919|NCT02395042|9782020|P1|Treatment 2 Period|Lack of Efficacy|1
2847920|NCT02395042|9782018|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
2847921|NCT02395042|9782019|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
2847922|NCT02395042|9782020|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
2847923|NCT02395042|9782018|P3|Treatment 1 Period|Lost to Follow-up|0
2847924|NCT02395042|9782019|P2|Treatment 1 Period|Lost to Follow-up|0
2847925|NCT02395042|9782020|P1|Treatment 1 Period|Lost to Follow-up|1
2847926|NCT02395042|9782018|P3|Treatment 1 Period|Lack of Efficacy|0
2847927|NCT02395042|9782019|P2|Treatment 1 Period|Lack of Efficacy|1
2847928|NCT02395042|9782020|P1|Treatment 1 Period|Lack of Efficacy|1
2847929|NCT02395042|9782018|P3|Treatment 1 Period|Adverse Event|1
2847930|NCT02395042|9782019|P2|Treatment 1 Period|Adverse Event|3
2847931|NCT02395042|9782020|P1|Treatment 1 Period|Adverse Event|1
2847932|NCT02394925|9782058|P1|Overall Study|Unsatisfactory Visual Response|5
2847933|NCT02394925|9782058|P1|Overall Study|No longer meet eligibility criteria|1
2847934|NCT02394925|9782058|P1|Overall Study|Protocol Violation|5
2847935|NCT02394925|9782058|P1|Overall Study|Lost to Follow-up|9
2847936|NCT02394925|9782058|P1|Overall Study|Lens handling difficulities|5
2847937|NCT02394925|9782058|P1|Overall Study|Lens Discomfort|3
2847938|NCT02394925|9782058|P1|Overall Study|Adverse Event|1
2847939|NCT02394808|9782068|P2|Period 2|Lost to Follow-up|0
2847940|NCT02394808|9782069|P1|Period 2|Lost to Follow-up|1
2847941|NCT02394808|9782068|P2|Period 1|Unsatisfactory lens fitting|1
2847942|NCT02394808|9782069|P1|Period 1|Unsatisfactory lens fitting|0
2847943|NCT02394756|9782077|P6|Period 2|Unsatisfactory Visual Response|0
2847944|NCT02394756|9782078|P5|Period 2|Unsatisfactory Visual Response|1
2847945|NCT02394756|9782079|P4|Period 2|Unsatisfactory Visual Response|0
2847946|NCT02394756|9782080|P3|Period 2|Unsatisfactory Visual Response|0
2847947|NCT02394756|9782081|P2|Period 2|Unsatisfactory Visual Response|0
2847948|NCT02394756|9782082|P1|Period 2|Unsatisfactory Visual Response|0
2847949|NCT02394756|9782077|P6|Period 1|Withdrawal by Subject|0
2847950|NCT02394756|9782078|P5|Period 1|Withdrawal by Subject|0
2847951|NCT02394756|9782079|P4|Period 1|Withdrawal by Subject|1
2847952|NCT02394756|9782080|P3|Period 1|Withdrawal by Subject|1
2847953|NCT02394756|9782081|P2|Period 1|Withdrawal by Subject|1
2847954|NCT02394756|9782082|P1|Period 1|Withdrawal by Subject|0
2847955|NCT02394756|9782077|P6|Period 1|Lens Discomfort|1
2847956|NCT02394756|9782078|P5|Period 1|Lens Discomfort|0
2847957|NCT02394756|9782079|P4|Period 1|Lens Discomfort|0
2847958|NCT02394756|9782080|P3|Period 1|Lens Discomfort|0
2847959|NCT02394756|9782081|P2|Period 1|Lens Discomfort|0
2847960|NCT02394756|9782082|P1|Period 1|Lens Discomfort|0
2847961|NCT02394730|9782095|P2|Overall Study|Withdrawal by Subject|1
2847962|NCT02394730|9782096|P1|Overall Study|Withdrawal by Subject|0
2847963|NCT02394730|9782095|P2|Overall Study|Lost to Follow-up|0
2847964|NCT02394730|9782096|P1|Overall Study|Lost to Follow-up|1
2847965|NCT02394665|9782133|P3|Overall Study|Physician Decision|0
2847966|NCT02394665|9782134|P2|Overall Study|Physician Decision|0
2847967|NCT02394665|9782135|P1|Overall Study|Physician Decision|1
2847968|NCT02394600|9782157|P2|Overall Study|Protocol Violation|0
2847969|NCT02394600|9782158|P1|Overall Study|Protocol Violation|1
2847970|NCT02394600|9782157|P2|Overall Study|Withdrawal by Subject|1
2847971|NCT02394600|9782158|P1|Overall Study|Withdrawal by Subject|0
2847972|NCT02394600|9782157|P2|Overall Study|Lost to Follow-up|1
2847973|NCT02394600|9782158|P1|Overall Study|Lost to Follow-up|0
2847974|NCT02394600|9782157|P2|Overall Study|Adverse Event|0
2847975|NCT02394600|9782158|P1|Overall Study|Adverse Event|3
2847976|NCT02394561|9782168|P2|Extension Phase|Lack of Efficacy|3
2847977|NCT02394561|9782169|P1|Extension Phase|Lack of Efficacy|3
2847978|NCT02394561|9782168|P2|Extension Phase|Withdrawal by Subject|5
2847979|NCT02394561|9782169|P1|Extension Phase|Withdrawal by Subject|0
2847980|NCT02394561|9782168|P2|Extension Phase|Physician Decision|2
2847981|NCT02394561|9782169|P1|Extension Phase|Physician Decision|0
2847982|NCT02394561|9782168|P2|Extension Phase|Lost to Follow-up|0
2847983|NCT02394561|9782169|P1|Extension Phase|Lost to Follow-up|1
2847984|NCT02394561|9782168|P2|Extension Phase|Protocol Violation|0
2847985|NCT02394561|9782169|P1|Extension Phase|Protocol Violation|1
2847986|NCT02394561|9782168|P2|Extension Phase|Death|1
2847987|NCT02394561|9782169|P1|Extension Phase|Death|0
2847988|NCT02394561|9782168|P2|Extension Phase|Adverse Event|1
2847989|NCT02394561|9782169|P1|Extension Phase|Adverse Event|6
2847990|NCT02394561|9782168|P2|CORE Phase|Lack of Efficacy|6
2847991|NCT02394561|9782169|P1|CORE Phase|Lack of Efficacy|1
2847992|NCT02394561|9782168|P2|CORE Phase|Withdrawal by Subject|2
2847993|NCT02394561|9782169|P1|CORE Phase|Withdrawal by Subject|2
2847994|NCT02394561|9782168|P2|CORE Phase|Physician Decision|1
2847995|NCT02394561|9782169|P1|CORE Phase|Physician Decision|1
2847996|NCT02394561|9782168|P2|CORE Phase|Lost to Follow-up|0
2847997|NCT02394561|9782169|P1|CORE Phase|Lost to Follow-up|1
2847998|NCT02394561|9782168|P2|CORE Phase|Pregnancy|0
2847999|NCT02394561|9782169|P1|CORE Phase|Pregnancy|1
2848000|NCT02394561|9782168|P2|CORE Phase|Death|1
2848001|NCT02394561|9782169|P1|CORE Phase|Death|0
2848002|NCT02394561|9782168|P2|CORE Phase|Adverse Event|9
2848003|NCT02394561|9782169|P1|CORE Phase|Adverse Event|7
2848004|NCT02394340|9782216|P1|Overall Study|Adverse Event|1
2848005|NCT02394340|9782216|P1|Overall Study|Failed drug screen test|1
2848006|NCT02393950|9782223|P2|Overall Study|Withdrawal by Subject|1
2848007|NCT02393950|9782224|P1|Overall Study|Withdrawal by Subject|0
2848008|NCT02393950|9782223|P2|Overall Study|Adverse Event|0
2848009|NCT02393950|9782224|P1|Overall Study|Adverse Event|1
2848010|NCT02393547|9782298|P1|Overall Study|Lost to Follow-up|1
2848011|NCT02393547|9782298|P1|Overall Study|Withdrawal by Subject|3
2848012|NCT02393547|9782298|P1|Overall Study|Adverse Event|2
2848013|NCT02393209|9782389|P4|Overall Study|Lost to Follow-up|0
2848014|NCT02393209|9782390|P3|Overall Study|Lost to Follow-up|0
2848015|NCT02393209|9782391|P2|Overall Study|Lost to Follow-up|1
2848016|NCT02393209|9782392|P1|Overall Study|Lost to Follow-up|0
2848017|NCT02393209|9782389|P4|Overall Study|Patient Seen by Another Oncologist|0
2848018|NCT02393209|9782390|P3|Overall Study|Patient Seen by Another Oncologist|0
2848019|NCT02393209|9782391|P2|Overall Study|Patient Seen by Another Oncologist|1
2848020|NCT02393209|9782392|P1|Overall Study|Patient Seen by Another Oncologist|0
2848021|NCT02393209|9782389|P4|Overall Study|Death from Legionella Infection|0
2848022|NCT02393209|9782390|P3|Overall Study|Death from Legionella Infection|0
2848023|NCT02393209|9782391|P2|Overall Study|Death from Legionella Infection|1
2848024|NCT02393209|9782392|P1|Overall Study|Death from Legionella Infection|0
2848025|NCT02393209|9782389|P4|Overall Study|Death due to Disease Progression|0
2848026|NCT02393209|9782390|P3|Overall Study|Death due to Disease Progression|0
2848027|NCT02393209|9782391|P2|Overall Study|Death due to Disease Progression|2
2848028|NCT02393209|9782392|P1|Overall Study|Death due to Disease Progression|2
2848029|NCT02393209|9782389|P4|Overall Study|Death|0
2848030|NCT02393209|9782390|P3|Overall Study|Death|0
2848031|NCT02393209|9782391|P2|Overall Study|Death|2
2848032|NCT02393209|9782392|P1|Overall Study|Death|2
2848033|NCT02393209|9782389|P4|Overall Study|Withdrawal by Patient|0
2848034|NCT02393209|9782390|P3|Overall Study|Withdrawal by Patient|0
2848035|NCT02393209|9782391|P2|Overall Study|Withdrawal by Patient|0
2848036|NCT02393209|9782392|P1|Overall Study|Withdrawal by Patient|1
2848037|NCT02393209|9782389|P4|Overall Study|Study Terminated by Sponsor|0
2848038|NCT02393209|9782390|P3|Overall Study|Study Terminated by Sponsor|0
2848039|NCT02393209|9782391|P2|Overall Study|Study Terminated by Sponsor|1
2848040|NCT02393209|9782392|P1|Overall Study|Study Terminated by Sponsor|1
2848041|NCT02392624|9782481|P3|Overall Study|Other|1
2848042|NCT02392624|9782482|P2|Overall Study|Other|1
2848043|NCT02392624|9782483|P1|Overall Study|Other|49
2848044|NCT02392624|9782481|P3|Overall Study|Sponsor/Investigator Decision|0
2848045|NCT02392624|9782482|P2|Overall Study|Sponsor/Investigator Decision|1
2848046|NCT02392624|9782483|P1|Overall Study|Sponsor/Investigator Decision|2
2848047|NCT02392624|9782481|P3|Overall Study|Protocol Violation|1
2848048|NCT02392624|9782482|P2|Overall Study|Protocol Violation|0
2848049|NCT02392624|9782483|P1|Overall Study|Protocol Violation|0
2848050|NCT02392624|9782481|P3|Overall Study|Pregnancy|0
2848051|NCT02392624|9782482|P2|Overall Study|Pregnancy|0
2848052|NCT02392624|9782483|P1|Overall Study|Pregnancy|1
2848053|NCT02392624|9782481|P3|Overall Study|Adverse Event|2
2848054|NCT02392624|9782482|P2|Overall Study|Adverse Event|1
2848055|NCT02392624|9782483|P1|Overall Study|Adverse Event|4
2848056|NCT02392624|9782481|P3|Overall Study|Withdrawal by Subject|9
2848057|NCT02392624|9782482|P2|Overall Study|Withdrawal by Subject|12
2848058|NCT02392624|9782483|P1|Overall Study|Withdrawal by Subject|15
2848059|NCT02392507|9782496|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|11
2848060|NCT02392507|9782496|P1|Maintenance Regimen|Death|1
2848061|NCT02392507|9782496|P1|Induction Regimen|Withdrawal by Subject|2
2848062|NCT02392507|9782496|P1|Induction Regimen|Physician Decision|1
2848063|NCT02392507|9782496|P1|Induction Regimen|On Study Treatment at Study Conclusion|11
2848064|NCT02392507|9782496|P1|Induction Regimen|Death|3
2848065|NCT02392481|9782535|P4|Overall Study|Withdrawal by Subject|0
2848066|NCT02392481|9782536|P3|Overall Study|Withdrawal by Subject|1
2848067|NCT02392481|9782537|P2|Overall Study|Withdrawal by Subject|0
2848068|NCT02392481|9782538|P1|Overall Study|Withdrawal by Subject|0
2848069|NCT02392481|9782535|P4|Overall Study|Adverse Event|2
2848070|NCT02392481|9782536|P3|Overall Study|Adverse Event|1
2848071|NCT02392481|9782537|P2|Overall Study|Adverse Event|0
2848072|NCT02392481|9782538|P1|Overall Study|Adverse Event|0
2848073|NCT02392403|9782560|P1|Overall Study|Withdrawal by Subject|1
2848074|NCT02392403|9782560|P1|Overall Study|Death|1
2848075|NCT02392403|9782560|P1|Overall Study|Adverse Event|1
2848076|NCT02392377|9782574|P2|Overall Study|Withdrawal by Subject|1
2848077|NCT02392377|9782575|P1|Overall Study|Withdrawal by Subject|0
2848078|NCT02392247|9782667|P1|Overall Study|Surgery cancelled; no data|1
2848079|NCT02392247|9782667|P1|Overall Study|Withdrawal by Subject|1
2848080|NCT02392234|9782678|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
2848081|NCT02392234|9782679|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
2848082|NCT02392234|9782680|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
2848083|NCT02392234|9782681|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
2848084|NCT02392234|9782682|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
2848085|NCT02392234|9782683|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
2848086|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2848087|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2848088|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2848089|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2848090|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2848091|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2848092|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Other|0
2848093|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Other|0
2848094|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Other|0
2848095|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Other|0
2848096|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Other|0
2848097|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Other|1
2848098|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
2848099|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
2848100|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
2848101|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
2848102|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
2848103|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
2848104|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
2848105|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
2848106|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
2848107|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
2848108|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
2848109|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
2848110|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2848111|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2848112|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2848113|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2848114|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2848115|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2848116|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2848117|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
2848118|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2848119|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2848120|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2848121|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2848122|NCT02392234|9782678|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
2848123|NCT02392234|9782679|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
2848124|NCT02392234|9782680|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
2848125|NCT02392234|9782681|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
2848126|NCT02392234|9782682|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
2848127|NCT02392234|9782683|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
2848128|NCT02392104|9782715|P1|Overall Study|INRs drawn by visiting nurse services|1
2848129|NCT02392104|9782715|P1|Overall Study|admitted to skilled nursing facility|3
2848130|NCT02392104|9782715|P1|Overall Study|INR goal range changed|1
2848131|NCT02392104|9782715|P1|Overall Study|transferred care to another doctor|2
2848132|NCT02392104|9782715|P1|Overall Study|bleeding event|1
2848133|NCT02392104|9782715|P1|Overall Study|discontinuation of warfarin|3
2848134|NCT02392000|9782726|P1|Overall Study|Lost to Follow-up|8
2848135|NCT02392000|9782726|P1|Overall Study|Withdrawal by Subject|1
2848136|NCT02392000|9782726|P1|Overall Study|Greater than mild sleep apnea exclusion|18
2848137|NCT02391948|9782752|P5|24-month Assessment|Not able to schedule visit in timeframe|8
2848138|NCT02391948|9782753|P4|24-month Assessment|Not able to schedule visit in timeframe|9
2848139|NCT02391948|9782754|P3|24-month Assessment|Not able to schedule visit in timeframe|2
2848140|NCT02391948|9782755|P2|24-month Assessment|Not able to schedule visit in timeframe|5
2848141|NCT02391948|9782756|P1|24-month Assessment|Not able to schedule visit in timeframe|8
2848142|NCT02391948|9782752|P5|24-month Assessment|Medical issue/illness|0
2848143|NCT02391948|9782753|P4|24-month Assessment|Medical issue/illness|0
2848144|NCT02391948|9782754|P3|24-month Assessment|Medical issue/illness|1
2848145|NCT02391948|9782755|P2|24-month Assessment|Medical issue/illness|0
2848146|NCT02391948|9782756|P1|24-month Assessment|Medical issue/illness|0
2848147|NCT02391948|9782752|P5|24-month Assessment|Lost to Follow-up|0
2848148|NCT02391948|9782753|P4|24-month Assessment|Lost to Follow-up|0
2848149|NCT02391948|9782754|P3|24-month Assessment|Lost to Follow-up|0
2848150|NCT02391948|9782755|P2|24-month Assessment|Lost to Follow-up|4
2848151|NCT02391948|9782756|P1|24-month Assessment|Lost to Follow-up|5
2848152|NCT02391948|9782752|P5|24-month Assessment|Withdrawal by Subject|1
2848153|NCT02391948|9782753|P4|24-month Assessment|Withdrawal by Subject|0
2848154|NCT02391948|9782754|P3|24-month Assessment|Withdrawal by Subject|0
2848155|NCT02391948|9782755|P2|24-month Assessment|Withdrawal by Subject|1
2848156|NCT02391948|9782756|P1|24-month Assessment|Withdrawal by Subject|1
2848157|NCT02391948|9782752|P5|24-month Assessment|Death|1
2848158|NCT02391948|9782753|P4|24-month Assessment|Death|0
2848159|NCT02391948|9782754|P3|24-month Assessment|Death|0
2848160|NCT02391948|9782755|P2|24-month Assessment|Death|0
2848161|NCT02391948|9782756|P1|24-month Assessment|Death|0
2848162|NCT02391948|9782752|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2848163|NCT02391948|9782753|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
2848164|NCT02391948|9782754|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2848165|NCT02391948|9782755|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
2848166|NCT02391948|9782756|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
2848167|NCT02391948|9782752|P5|18-month Assessment|Not able to schedule visit in timeframe|4
2848168|NCT02391948|9782753|P4|18-month Assessment|Not able to schedule visit in timeframe|1
2848169|NCT02391948|9782754|P3|18-month Assessment|Not able to schedule visit in timeframe|2
2848170|NCT02391948|9782755|P2|18-month Assessment|Not able to schedule visit in timeframe|3
2848171|NCT02391948|9782756|P1|18-month Assessment|Not able to schedule visit in timeframe|3
2848172|NCT02391948|9782752|P5|18-month Assessment|Lost to Follow-up|3
2848173|NCT02391948|9782753|P4|18-month Assessment|Lost to Follow-up|2
2848174|NCT02391948|9782754|P3|18-month Assessment|Lost to Follow-up|2
2848175|NCT02391948|9782755|P2|18-month Assessment|Lost to Follow-up|6
2848176|NCT02391948|9782756|P1|18-month Assessment|Lost to Follow-up|2
2848177|NCT02391948|9782752|P5|18-month Assessment|Withdrawal by Subject|0
2848178|NCT02391948|9782753|P4|18-month Assessment|Withdrawal by Subject|1
2848179|NCT02391948|9782754|P3|18-month Assessment|Withdrawal by Subject|0
2848180|NCT02391948|9782755|P2|18-month Assessment|Withdrawal by Subject|0
2848181|NCT02391948|9782756|P1|18-month Assessment|Withdrawal by Subject|1
2848182|NCT02391948|9782752|P5|18-month Assessment|Death|1
2848183|NCT02391948|9782753|P4|18-month Assessment|Death|1
2848184|NCT02391948|9782754|P3|18-month Assessment|Death|0
2848185|NCT02391948|9782755|P2|18-month Assessment|Death|0
2848186|NCT02391948|9782756|P1|18-month Assessment|Death|0
2848187|NCT02391948|9782752|P5|12-month Assessment|Not able to schedule visit in timeframe|1
2848188|NCT02391948|9782753|P4|12-month Assessment|Not able to schedule visit in timeframe|2
2848189|NCT02391948|9782754|P3|12-month Assessment|Not able to schedule visit in timeframe|0
2848190|NCT02391948|9782755|P2|12-month Assessment|Not able to schedule visit in timeframe|4
2848191|NCT02391948|9782756|P1|12-month Assessment|Not able to schedule visit in timeframe|2
2848192|NCT02391948|9782752|P5|12-month Assessment|Medical issue/illness|0
2848193|NCT02391948|9782753|P4|12-month Assessment|Medical issue/illness|1
2848194|NCT02391948|9782754|P3|12-month Assessment|Medical issue/illness|0
2848195|NCT02391948|9782755|P2|12-month Assessment|Medical issue/illness|1
2848196|NCT02391948|9782756|P1|12-month Assessment|Medical issue/illness|0
2848197|NCT02391948|9782752|P5|12-month Assessment|Lost to Follow-up|5
2848198|NCT02391948|9782753|P4|12-month Assessment|Lost to Follow-up|4
2848199|NCT02391948|9782754|P3|12-month Assessment|Lost to Follow-up|4
2848200|NCT02391948|9782755|P2|12-month Assessment|Lost to Follow-up|4
2848201|NCT02391948|9782756|P1|12-month Assessment|Lost to Follow-up|5
2848202|NCT02391948|9782752|P5|12-month Assessment|Withdrawal by Subject|0
2848203|NCT02391948|9782753|P4|12-month Assessment|Withdrawal by Subject|1
2848204|NCT02391948|9782754|P3|12-month Assessment|Withdrawal by Subject|0
2848205|NCT02391948|9782755|P2|12-month Assessment|Withdrawal by Subject|0
2848206|NCT02391948|9782756|P1|12-month Assessment|Withdrawal by Subject|1
2848207|NCT02391948|9782752|P5|12-month Assessment|Death|0
2848208|NCT02391948|9782753|P4|12-month Assessment|Death|1
2848209|NCT02391948|9782754|P3|12-month Assessment|Death|0
2848210|NCT02391948|9782755|P2|12-month Assessment|Death|0
2848211|NCT02391948|9782756|P1|12-month Assessment|Death|0
2848212|NCT02391948|9782752|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
2848213|NCT02391948|9782753|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
2848214|NCT02391948|9782754|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
2848215|NCT02391948|9782755|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
2848216|NCT02391948|9782756|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
2848217|NCT02391948|9782752|P5|6-month Assessment|Not able to schedule visit in timeframe|0
2848218|NCT02391948|9782753|P4|6-month Assessment|Not able to schedule visit in timeframe|5
2848219|NCT02391948|9782754|P3|6-month Assessment|Not able to schedule visit in timeframe|4
2848220|NCT02391948|9782755|P2|6-month Assessment|Not able to schedule visit in timeframe|8
2848221|NCT02391948|9782756|P1|6-month Assessment|Not able to schedule visit in timeframe|6
2848222|NCT02391948|9782752|P5|6-month Assessment|Medical issue/illness|0
2848223|NCT02391948|9782753|P4|6-month Assessment|Medical issue/illness|0
2848224|NCT02391948|9782754|P3|6-month Assessment|Medical issue/illness|0
2848225|NCT02391948|9782755|P2|6-month Assessment|Medical issue/illness|1
2848226|NCT02391948|9782756|P1|6-month Assessment|Medical issue/illness|1
2848227|NCT02391948|9782752|P5|6-month Assessment|Lost to Follow-up|1
2848228|NCT02391948|9782753|P4|6-month Assessment|Lost to Follow-up|3
2848229|NCT02391948|9782754|P3|6-month Assessment|Lost to Follow-up|2
2848230|NCT02391948|9782755|P2|6-month Assessment|Lost to Follow-up|5
2848231|NCT02391948|9782756|P1|6-month Assessment|Lost to Follow-up|4
2848232|NCT02391948|9782752|P5|6-month Assessment|Withdrawal by Subject|0
2848233|NCT02391948|9782753|P4|6-month Assessment|Withdrawal by Subject|2
2848234|NCT02391948|9782754|P3|6-month Assessment|Withdrawal by Subject|1
2848235|NCT02391948|9782755|P2|6-month Assessment|Withdrawal by Subject|0
2848236|NCT02391948|9782756|P1|6-month Assessment|Withdrawal by Subject|0
2848237|NCT02391948|9782752|P5|6-month Assessment|Death|1
2848238|NCT02391948|9782753|P4|6-month Assessment|Death|0
2848239|NCT02391948|9782754|P3|6-month Assessment|Death|0
2848240|NCT02391948|9782755|P2|6-month Assessment|Death|0
2848241|NCT02391948|9782756|P1|6-month Assessment|Death|0
2848242|NCT02391584|9782880|P2|12 Month (End of Study)|Lost to Follow-up|0
2848243|NCT02391584|9782881|P1|12 Month (End of Study)|Lost to Follow-up|2
2848244|NCT02391584|9782880|P2|6 Month|Withdrawal by Subject|0
2848245|NCT02391584|9782881|P1|6 Month|Withdrawal by Subject|1
2848246|NCT02391584|9782880|P2|3 Month|Lost to Follow-up|0
2848247|NCT02391584|9782881|P1|3 Month|Lost to Follow-up|1
2848248|NCT02391584|9782880|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
2848249|NCT02391584|9782881|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
2848250|NCT02391584|9782880|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
2848251|NCT02391584|9782881|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
2848252|NCT02391545|9782898|P2|Overall Study|Other Reasons|4
2848253|NCT02391545|9782899|P1|Overall Study|Other Reasons|6
2848254|NCT02391545|9782898|P2|Overall Study|Withdrawal by Subject|1
2848255|NCT02391545|9782899|P1|Overall Study|Withdrawal by Subject|0
2848256|NCT02391545|9782898|P2|Overall Study|Termination of study by sponsor|20
2848257|NCT02391545|9782899|P1|Overall Study|Termination of study by sponsor|20
2848258|NCT02391545|9782898|P2|Overall Study|Lost to Follow-up|1
2848259|NCT02391545|9782899|P1|Overall Study|Lost to Follow-up|0
2848260|NCT02391545|9782898|P2|Overall Study|Death|2
2848261|NCT02391545|9782899|P1|Overall Study|Death|0
2848262|NCT02391363|9782919|P2|Overall Study|Withdrawal by Subject|3
2848263|NCT02391363|9782920|P1|Overall Study|Withdrawal by Subject|6
2848264|NCT02391363|9782919|P2|Overall Study|Lost to Follow-up|5
2848265|NCT02391363|9782920|P1|Overall Study|Lost to Follow-up|5
2848266|NCT02391311|9782986|P2|Overall Study|deemed ineligible after baseline|1
2848267|NCT02391311|9782987|P1|Overall Study|deemed ineligible after baseline|1
2848268|NCT02391311|9782986|P2|Overall Study|Lost to Follow-up|1
2848269|NCT02391311|9782987|P1|Overall Study|Lost to Follow-up|2
2848270|NCT02391116|9782995|P1|Survival Follow-up|Switching to Other Therapy|1
2848271|NCT02391116|9782995|P1|Survival Follow-up|Withdrawal by Subject|3
2848272|NCT02391116|9782995|P1|Active Follow-up|Switching to Other Therapy|2
2848273|NCT02391116|9782995|P1|Active Follow-up|Withdrawal by Subject|1
2848274|NCT02391116|9782995|P1|Safety Follow-up|Deterioration of General Conditions|3
2848275|NCT02391116|9782995|P1|Safety Follow-up|No Follow Up|1
2848276|NCT02391116|9782995|P1|Safety Follow-up|Switching to Other Therapy|4
2848277|NCT02391116|9782995|P1|Safety Follow-up|Withdrawal by Subject|4
2848278|NCT02391116|9782995|P1|Safety Follow-up|Adverse Event|1
2848279|NCT02391116|9782995|P1|Treatment|AE with Clinical PD|3
2848280|NCT02391116|9782995|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
2848281|NCT02391116|9782995|P1|Treatment|Protocol Violation|1
2848282|NCT02391116|9782995|P1|Treatment|Withdrawal by Subject|1
2848283|NCT02391038|9783049|P3|Overall Study|Progressive disease|6
2848284|NCT02391038|9783050|P2|Overall Study|Progressive disease|3
2848285|NCT02391038|9783051|P1|Overall Study|Progressive disease|3
2848286|NCT02390557|9783195|P3|Wave 2|Survey non-respondent|23
2848287|NCT02390557|9783196|P2|Wave 2|Survey non-respondent|41
2848288|NCT02390557|9783197|P1|Wave 2|Survey non-respondent|72
2848289|NCT02390362|9783207|P2|Overall Study|Withdrawal by Subject|1
2848290|NCT02390362|9783208|P1|Overall Study|Withdrawal by Subject|0
2848291|NCT02390219|9783216|P1|Overall Study|Other|2
2848292|NCT02390219|9783216|P1|Overall Study|Lost to Follow-up|2
2848293|NCT02390219|9783216|P1|Overall Study|Withdrawal by Subject|1
2848294|NCT02390219|9783216|P1|Overall Study|Adverse Event|6
2848295|NCT02390219|9783216|P1|Overall Study|Physician Decision|1
2848296|NCT02390219|9783216|P1|Overall Study|Death|1
2848297|NCT02390167|9783226|P1|Overall Study|Lost to Follow-up|1
2848298|NCT02390076|9783248|P3|Overall Study|Lost to Follow-up|4
2848299|NCT02390076|9783249|P2|Overall Study|Lost to Follow-up|1
2848300|NCT02390076|9783250|P1|Overall Study|Lost to Follow-up|2
2848301|NCT02389894|9783279|P3|Overall Study|Lost to Follow-up|1
2848302|NCT02389894|9783280|P2|Overall Study|Lost to Follow-up|1
2848303|NCT02389894|9783281|P1|Overall Study|Lost to Follow-up|2
2848304|NCT02389894|9783279|P3|Overall Study|Withdrawal by Subject|5
2848305|NCT02389894|9783280|P2|Overall Study|Withdrawal by Subject|4
2848306|NCT02389894|9783281|P1|Overall Study|Withdrawal by Subject|2
2848307|NCT02389894|9783279|P3|Overall Study|Death|3
2848308|NCT02389894|9783280|P2|Overall Study|Death|5
2848309|NCT02389894|9783281|P1|Overall Study|Death|4
2848310|NCT02389829|9783413|P2|Overall Study|Lost to Follow-up|1
2848311|NCT02389829|9783414|P1|Overall Study|Lost to Follow-up|0
2848312|NCT02389816|9783429|P3|Overall Study|Reason not Specified|0
2848313|NCT02389816|9783430|P2|Overall Study|Reason not Specified|2
2848314|NCT02389816|9783431|P1|Overall Study|Reason not Specified|0
2848315|NCT02389816|9783429|P3|Overall Study|Non Compliance with Study Drug|1
2848316|NCT02389816|9783430|P2|Overall Study|Non Compliance with Study Drug|1
2848317|NCT02389816|9783431|P1|Overall Study|Non Compliance with Study Drug|1
2848318|NCT02389816|9783429|P3|Overall Study|Lack of Efficacy|0
2848319|NCT02389816|9783430|P2|Overall Study|Lack of Efficacy|0
2848320|NCT02389816|9783431|P1|Overall Study|Lack of Efficacy|1
2848321|NCT02389816|9783429|P3|Overall Study|Withdrawal of Consent|4
2848322|NCT02389816|9783430|P2|Overall Study|Withdrawal of Consent|4
2848323|NCT02389816|9783431|P1|Overall Study|Withdrawal of Consent|6
2848324|NCT02389816|9783429|P3|Overall Study|Lost to Follow-up|0
2848325|NCT02389816|9783430|P2|Overall Study|Lost to Follow-up|0
2848326|NCT02389816|9783431|P1|Overall Study|Lost to Follow-up|1
2848327|NCT02389816|9783429|P3|Overall Study|Major Protocol Deviation|0
2848328|NCT02389816|9783430|P2|Overall Study|Major Protocol Deviation|0
2848329|NCT02389816|9783431|P1|Overall Study|Major Protocol Deviation|1
2848330|NCT02389816|9783429|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
2848331|NCT02389816|9783430|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2848332|NCT02389816|9783431|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
2848333|NCT02389816|9783429|P3|Overall Study|Randomized but Not Treated|0
2848334|NCT02389816|9783430|P2|Overall Study|Randomized but Not Treated|0
2848335|NCT02389816|9783431|P1|Overall Study|Randomized but Not Treated|1
2848336|NCT02389764|9783463|P1|Overall Study|Lack of Efficacy|9
2848337|NCT02389621|9783498|P2|Posttreatment Period|Other - Miscellaneous|0
2848338|NCT02389621|9783499|P1|Posttreatment Period|Other - Miscellaneous|2
2848339|NCT02389621|9783498|P2|Posttreatment Period|Lost to Follow-up|1
2848340|NCT02389621|9783499|P1|Posttreatment Period|Lost to Follow-up|1
2848341|NCT02389621|9783498|P2|Posttreatment Period|Withdrawal by Subject|2
2848342|NCT02389621|9783499|P1|Posttreatment Period|Withdrawal by Subject|3
2848343|NCT02389621|9783498|P2|Posttreatment Period|Adverse Event|1
2848344|NCT02389621|9783499|P1|Posttreatment Period|Adverse Event|3
2848345|NCT02389621|9783498|P2|Treatment Period|Withdrawal by Subject|1
2848346|NCT02389621|9783499|P1|Treatment Period|Withdrawal by Subject|1
2848347|NCT02389452|9783529|P1|Overall Study|Enrolled but Not Eligible for Study|6
2848348|NCT02389452|9783529|P1|Overall Study|Withdrawal by Subject|5
2848349|NCT02389452|9783529|P1|Overall Study|Adverse Event|1
2848350|NCT02389452|9783529|P1|Overall Study|Lost to Follow-up|13
2848351|NCT02388997|9783641|P2|Overall Study|Tested positive for virus during run-in|1
2848352|NCT02388997|9783642|P1|Overall Study|Tested positive for virus during run-in|0
2848353|NCT02388997|9783641|P2|Overall Study|Lung function exclusion criteria|2
2848354|NCT02388997|9783642|P1|Overall Study|Lung function exclusion criteria|0
2848355|NCT02388997|9783641|P2|Overall Study|Withdrawal by Subject|1
2848356|NCT02388997|9783642|P1|Overall Study|Withdrawal by Subject|2
2848357|NCT02388997|9783641|P2|Overall Study|Adverse Event|2
2848358|NCT02388997|9783642|P1|Overall Study|Adverse Event|1
2848359|NCT02388932|9783660|P1|Overall Study|Death|1
2848360|NCT02388776|9783681|P1|Overall Study|Lost to Follow-up|1
2848361|NCT02388776|9783681|P1|Overall Study|Death|1
2848362|NCT02388763|9783686|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2848363|NCT02388763|9783687|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2848364|NCT02388763|9783686|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2848365|NCT02388763|9783687|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2848366|NCT02388737|9783701|P3|Overall Study|Reason Not Specified|4
2848367|NCT02388737|9783702|P2|Overall Study|Reason Not Specified|5
2848368|NCT02388737|9783703|P1|Overall Study|Reason Not Specified|5
2848369|NCT02388737|9783701|P3|Overall Study|Lack of Efficacy|3
2848370|NCT02388737|9783702|P2|Overall Study|Lack of Efficacy|0
2848371|NCT02388737|9783703|P1|Overall Study|Lack of Efficacy|3
2848372|NCT02388737|9783701|P3|Overall Study|Voluntary Withdrawal|17
2848373|NCT02388737|9783702|P2|Overall Study|Voluntary Withdrawal|18
2848374|NCT02388737|9783703|P1|Overall Study|Voluntary Withdrawal|10
2848375|NCT02388737|9783701|P3|Overall Study|Lost to Follow-up|4
2848376|NCT02388737|9783702|P2|Overall Study|Lost to Follow-up|1
2848377|NCT02388737|9783703|P1|Overall Study|Lost to Follow-up|5
2848378|NCT02388737|9783701|P3|Overall Study|Major Protocol Deviation|22
2848379|NCT02388737|9783702|P2|Overall Study|Major Protocol Deviation|25
2848380|NCT02388737|9783703|P1|Overall Study|Major Protocol Deviation|18
2848381|NCT02388737|9783701|P3|Overall Study|Pretreatment Event/Adverse Event|12
2848382|NCT02388737|9783702|P2|Overall Study|Pretreatment Event/Adverse Event|11
2848383|NCT02388737|9783703|P1|Overall Study|Pretreatment Event/Adverse Event|13
2848384|NCT02388724|9783737|P2|Overall Study|Randomized but not Treated|2
2848385|NCT02388724|9783738|P1|Overall Study|Randomized but not Treated|0
2848386|NCT02388724|9783737|P2|Overall Study|Voluntary Withdrawal|5
2848387|NCT02388724|9783738|P1|Overall Study|Voluntary Withdrawal|6
2848388|NCT02388724|9783737|P2|Overall Study|Pretreatment Event/Adverse Event|2
2848389|NCT02388724|9783738|P1|Overall Study|Pretreatment Event/Adverse Event|3
2848390|NCT02388724|9783737|P2|Overall Study|Major Protocol Deviation|3
2848391|NCT02388724|9783738|P1|Overall Study|Major Protocol Deviation|3
2848392|NCT02388724|9783737|P2|Overall Study|Reason not Specified|1
2848393|NCT02388724|9783738|P1|Overall Study|Reason not Specified|0
2848394|NCT02388347|9783784|P5|Overall Study|Withdrawal by Subject|0
2848395|NCT02388347|9783785|P4|Overall Study|Withdrawal by Subject|0
2848396|NCT02388347|9783786|P3|Overall Study|Withdrawal by Subject|1
2848397|NCT02388347|9783787|P2|Overall Study|Withdrawal by Subject|0
2848398|NCT02388347|9783788|P1|Overall Study|Withdrawal by Subject|0
2848399|NCT02388295|9783867|P3|Treatment Weeks 3 to 12|Adverse Event|0
2848400|NCT02388295|9783868|P2|Treatment Weeks 3 to 12|Adverse Event|1
2848401|NCT02388295|9783869|P1|Treatment Weeks 3 to 12|Adverse Event|1
2848402|NCT02388295|9783867|P3|Dose Escalation Week 2|Determined not eligible|1
2848403|NCT02388295|9783868|P2|Dose Escalation Week 2|Determined not eligible|1
2848404|NCT02388295|9783869|P1|Dose Escalation Week 2|Determined not eligible|1
2848405|NCT02388295|9783867|P3|Dose Escalation Week 2|Protocol Violation|0
2848406|NCT02388295|9783868|P2|Dose Escalation Week 2|Protocol Violation|1
2848407|NCT02388295|9783869|P1|Dose Escalation Week 2|Protocol Violation|0
2848408|NCT02388295|9783867|P3|Dose Escalation Week 1|Determined not eligible|1
2848409|NCT02388295|9783868|P2|Dose Escalation Week 1|Determined not eligible|1
2848410|NCT02388295|9783869|P1|Dose Escalation Week 1|Determined not eligible|1
2848411|NCT02388295|9783867|P3|Dose Escalation Week 1|Adverse Event|1
2848412|NCT02388295|9783868|P2|Dose Escalation Week 1|Adverse Event|2
2848413|NCT02388295|9783869|P1|Dose Escalation Week 1|Adverse Event|1
2848414|NCT02388269|9783887|P3|Overall Study|Screen Failure|10
2848415|NCT02388269|9783888|P2|Overall Study|Screen Failure|0
2848416|NCT02388269|9783889|P1|Overall Study|Screen Failure|0
2848417|NCT02388269|9783887|P3|Overall Study|Protocol Violation|0
2848418|NCT02388269|9783888|P2|Overall Study|Protocol Violation|0
2848419|NCT02388269|9783889|P1|Overall Study|Protocol Violation|2
2848420|NCT02388269|9783887|P3|Overall Study|no diary data|0
2848421|NCT02388269|9783888|P2|Overall Study|no diary data|0
2848422|NCT02388269|9783889|P1|Overall Study|no diary data|3
2848423|NCT02388269|9783887|P3|Overall Study|less than 50% stimulations|0
2848424|NCT02388269|9783888|P2|Overall Study|less than 50% stimulations|0
2848425|NCT02388269|9783889|P1|Overall Study|less than 50% stimulations|1
2848426|NCT02388269|9783887|P3|Overall Study|Withdrawal by Subject|0
2848427|NCT02388269|9783888|P2|Overall Study|Withdrawal by Subject|2
2848428|NCT02388269|9783889|P1|Overall Study|Withdrawal by Subject|1
2848429|NCT02388269|9783887|P3|Overall Study|Adverse Event|0
2848430|NCT02388269|9783888|P2|Overall Study|Adverse Event|0
2848431|NCT02388269|9783889|P1|Overall Study|Adverse Event|2
2848432|NCT02388191|9783921|P2|Overall Study|Patient did not receive IUD|0
2848433|NCT02388191|9783922|P1|Overall Study|Patient did not receive IUD|1
2848434|NCT02388074|9783936|P1|Overall Study|Sample Not Returned|1
2848435|NCT02388074|9783936|P1|Overall Study|Lost in Transit|2
2848436|NCT02387996|9783940|P1|Overall Study|Poor/Non-Compliance|1
2848437|NCT02387996|9783940|P1|Overall Study|Lost to Follow-up|1
2848438|NCT02387996|9783940|P1|Overall Study|Subject Withdrew Consent|1
2848439|NCT02387996|9783940|P1|Overall Study|Subject Request to Discontinue Treatment|9
2848440|NCT02387996|9783940|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
2848441|NCT02387996|9783940|P1|Overall Study|Study Drug Toxicity|14
2848442|NCT02387996|9783940|P1|Overall Study|Disease Progression|144
2848443|NCT02387983|9783951|P1|Overall Study|Withdrawal by Subject|2
2848444|NCT02387983|9783951|P1|Overall Study|Protocol Violation|1
2848445|NCT02387983|9783951|P1|Overall Study|Adverse Event|4
2848446|NCT02387970|9783965|P2|Overall Study|Did not complete 1-year follow up|2
2848447|NCT02387970|9783966|P1|Overall Study|Did not complete 1-year follow up|1
2848448|NCT02387957|9783987|P3|Overall Study|The study was discontinued|20
2848449|NCT02387957|9783988|P2|Overall Study|The study was discontinued|21
2848450|NCT02387957|9783989|P1|Overall Study|The study was discontinued|21
2848451|NCT02387762|9784060|P2|Overall Study|Withdrawal by Subject|0
2848452|NCT02387762|9784061|P1|Overall Study|Withdrawal by Subject|1
2848453|NCT02387580|9784093|P6|Overall Study|Withdrawal by Subject|0
2848454|NCT02387580|9784094|P5|Overall Study|Withdrawal by Subject|0
2848455|NCT02387580|9784095|P4|Overall Study|Withdrawal by Subject|1
2848456|NCT02387580|9784096|P3|Overall Study|Withdrawal by Subject|0
2848457|NCT02387580|9784097|P2|Overall Study|Withdrawal by Subject|0
2848458|NCT02387580|9784098|P1|Overall Study|Withdrawal by Subject|0
2848459|NCT02387372|9784191|P2|Overall Study|Not Treated|0
2848460|NCT02387372|9784192|P1|Overall Study|Not Treated|1
2848461|NCT02386345|9784302|P1|Overall Study|Did not complete 12-month follow-up|72
2848462|NCT02386345|9784302|P1|Overall Study|Repeat Procedure|10
2848463|NCT02386345|9784302|P1|Overall Study|Adverse Event|5
2848464|NCT02386345|9784302|P1|Overall Study|Lost to Follow-up|1
2848465|NCT02386345|9784302|P1|Overall Study|Not treated|14
2848466|NCT02386189|9784312|P2|Overall Study|Death|0
2848467|NCT02386189|9784313|P1|Overall Study|Death|1
2848468|NCT02386189|9784312|P2|Overall Study|Withdrawal by Subject|0
2848469|NCT02386189|9784313|P1|Overall Study|Withdrawal by Subject|1
2848470|NCT02386189|9784312|P2|Overall Study|Lost to Follow-up|3
2848471|NCT02386189|9784313|P1|Overall Study|Lost to Follow-up|2
2848472|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2848473|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2848474|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2848475|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
2848476|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
2848477|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Other|0
2848478|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Other|0
2848479|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Other|0
2848480|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Other|0
2848481|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Other|1
2848482|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2848483|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2848484|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2848485|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
2848486|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
2848487|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2848488|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2848489|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2848490|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
2848491|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2848492|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
2848493|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
2848494|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
2848495|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
2848496|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
2848497|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Adverse Event|0
2848498|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Adverse Event|0
2848499|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Adverse Event|0
2848500|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Adverse Event|1
2848501|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Adverse Event|2
2848502|NCT02386098|9784336|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2848503|NCT02386098|9784337|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2848504|NCT02386098|9784338|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2848505|NCT02386098|9784339|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
2848506|NCT02386098|9784340|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
2848507|NCT02385799|9784419|P2|Overall Study|Withdrawal by Subject|4
2848508|NCT02385799|9784420|P1|Overall Study|Withdrawal by Subject|0
2848509|NCT02385799|9784419|P2|Overall Study|Adverse Event|2
2848510|NCT02385799|9784420|P1|Overall Study|Adverse Event|4
2848511|NCT02385799|9784419|P2|Overall Study|Lost to Follow-up|2
2848512|NCT02385799|9784420|P1|Overall Study|Lost to Follow-up|1
2848513|NCT02385708|9784461|P2|Overall Study|Protocol Violation|1
2848514|NCT02385708|9784462|P1|Overall Study|Protocol Violation|1
2848515|NCT02385708|9784461|P2|Overall Study|Investigator decision|7
2848516|NCT02385708|9784462|P1|Overall Study|Investigator decision|5
2848517|NCT02385708|9784461|P2|Overall Study|Withdrawn - surgery canceled|5
2848518|NCT02385708|9784462|P1|Overall Study|Withdrawn - surgery canceled|2
2848519|NCT02385708|9784461|P2|Overall Study|Withdrawal by Subject|2
2848520|NCT02385708|9784462|P1|Overall Study|Withdrawal by Subject|0
2848521|NCT02385669|9784468|P1|Overall Study|Adverse Event|2
2848522|NCT02385526|9784476|P3|Overall Study|Protocol Violation|0
2848523|NCT02385526|9784477|P2|Overall Study|Protocol Violation|0
2848524|NCT02385526|9784478|P1|Overall Study|Protocol Violation|1
2848525|NCT02385526|9784476|P3|Overall Study|Physician Decision|0
2848526|NCT02385526|9784477|P2|Overall Study|Physician Decision|0
2848527|NCT02385526|9784478|P1|Overall Study|Physician Decision|1
2848528|NCT02385526|9784476|P3|Overall Study|Lost to Follow-up|0
2848529|NCT02385526|9784477|P2|Overall Study|Lost to Follow-up|1
2848530|NCT02385526|9784478|P1|Overall Study|Lost to Follow-up|0
2848531|NCT02385526|9784476|P3|Overall Study|Withdrawal by Subject|0
2848532|NCT02385526|9784477|P2|Overall Study|Withdrawal by Subject|2
2848533|NCT02385526|9784478|P1|Overall Study|Withdrawal by Subject|0
2848534|NCT02385084|9784486|P6|Period 2|Protocol Violation|0
2848535|NCT02385084|9784487|P5|Period 2|Protocol Violation|0
2848536|NCT02385084|9784488|P4|Period 2|Protocol Violation|0
2848537|NCT02385084|9784489|P3|Period 2|Protocol Violation|1
2848538|NCT02385084|9784490|P2|Period 2|Protocol Violation|0
2848539|NCT02385084|9784491|P1|Period 2|Protocol Violation|0
2848540|NCT02384993|9784504|P2|Overall Study|Adverse Event|1
2848541|NCT02384993|9784505|P1|Overall Study|Adverse Event|0
2848542|NCT02384941|9784531|P3|Overall Study|Other than specified above|1
2848543|NCT02384941|9784532|P2|Overall Study|Other than specified above|0
2848544|NCT02384941|9784533|P1|Overall Study|Other than specified above|4
2848545|NCT02384941|9784531|P3|Overall Study|Pregnancy|1
2848546|NCT02384941|9784532|P2|Overall Study|Pregnancy|0
2848547|NCT02384941|9784533|P1|Overall Study|Pregnancy|0
2848548|NCT02384941|9784531|P3|Overall Study|Withdrawal by Subject|20
2848549|NCT02384941|9784532|P2|Overall Study|Withdrawal by Subject|19
2848550|NCT02384941|9784533|P1|Overall Study|Withdrawal by Subject|26
2848551|NCT02384941|9784531|P3|Overall Study|Protocol Violation|0
2848552|NCT02384941|9784532|P2|Overall Study|Protocol Violation|0
2848553|NCT02384941|9784533|P1|Overall Study|Protocol Violation|3
2848554|NCT02384941|9784531|P3|Overall Study|Physician Decision|0
2848555|NCT02384941|9784532|P2|Overall Study|Physician Decision|1
2848556|NCT02384941|9784533|P1|Overall Study|Physician Decision|1
2848557|NCT02384941|9784531|P3|Overall Study|Non-Compliance With Study Drug|1
2848558|NCT02384941|9784532|P2|Overall Study|Non-Compliance With Study Drug|0
2848559|NCT02384941|9784533|P1|Overall Study|Non-Compliance With Study Drug|2
2848560|NCT02384941|9784531|P3|Overall Study|Lost to Follow-up|1
2848561|NCT02384941|9784532|P2|Overall Study|Lost to Follow-up|2
2848562|NCT02384941|9784533|P1|Overall Study|Lost to Follow-up|3
2848563|NCT02384941|9784531|P3|Overall Study|Adverse Event|17
2848564|NCT02384941|9784532|P2|Overall Study|Adverse Event|13
2848565|NCT02384941|9784533|P1|Overall Study|Adverse Event|11
2848566|NCT02384538|9784564|P2|Overall Study|Other|3
2848567|NCT02384538|9784565|P1|Overall Study|Other|1
2848568|NCT02384538|9784564|P2|Overall Study|Withdrew Consent|4
2848569|NCT02384538|9784565|P1|Overall Study|Withdrew Consent|0
2848570|NCT02384538|9784564|P2|Overall Study|Lack of Efficacy|4
2848571|NCT02384538|9784565|P1|Overall Study|Lack of Efficacy|4
2848572|NCT02384538|9784564|P2|Overall Study|Adverse Event|4
2848573|NCT02384538|9784565|P1|Overall Study|Adverse Event|1
2848574|NCT02384460|9784585|P2|Overall Study|Non-compliance|0
2848575|NCT02384460|9784586|P1|Overall Study|Non-compliance|1
2848576|NCT02384460|9784585|P2|Overall Study|Elective medical treatment|0
2848577|NCT02384460|9784586|P1|Overall Study|Elective medical treatment|1
2848578|NCT02384460|9784585|P2|Overall Study|Withdrawal by Subject|3
2848579|NCT02384460|9784586|P1|Overall Study|Withdrawal by Subject|0
2848580|NCT02384460|9784585|P2|Overall Study|Adverse Event|2
2848581|NCT02384460|9784586|P1|Overall Study|Adverse Event|5
2848582|NCT02384460|9784585|P2|Overall Study|Returned to previous therapeutic regimen|1
2848583|NCT02384460|9784586|P1|Overall Study|Returned to previous therapeutic regimen|0
2848584|NCT02384460|9784585|P2|Overall Study|Protocol Violation|1
2848585|NCT02384460|9784586|P1|Overall Study|Protocol Violation|0
2848586|NCT02384382|9784604|P1|Overall Study|Disease progression|16
2848587|NCT02384382|9784604|P1|Overall Study|Adverse Event|1
2848588|NCT02384382|9784604|P1|Overall Study|Death|1
2848589|NCT02384382|9784604|P1|Overall Study|Transitioned to study-NCT02960022|5
2848590|NCT02383966|9784676|P2|Overall Study|Randomized, but not treated|3
2848591|NCT02383966|9784677|P1|Overall Study|Randomized, but not treated|1
2848592|NCT02383966|9784676|P2|Overall Study|Ongoing at clinical cut-off date|4
2848593|NCT02383966|9784677|P1|Overall Study|Ongoing at clinical cut-off date|25
2848594|NCT02383940|9784697|P2|Overall Study|Other than specified above|0
2848595|NCT02383940|9784698|P1|Overall Study|Other than specified above|1
2848596|NCT02383940|9784697|P2|Overall Study|Randomized but not treated|0
2848597|NCT02383940|9784698|P1|Overall Study|Randomized but not treated|2
2848598|NCT02383940|9784697|P2|Overall Study|Withdrawal by Subject|1
2848599|NCT02383940|9784698|P1|Overall Study|Withdrawal by Subject|1
2848600|NCT02383940|9784697|P2|Overall Study|Physician Decision|0
2848601|NCT02383940|9784698|P1|Overall Study|Physician Decision|2
2848602|NCT02383940|9784697|P2|Overall Study|Lost to Follow-up|2
2848603|NCT02383940|9784698|P1|Overall Study|Lost to Follow-up|2
2848604|NCT02383940|9784697|P2|Overall Study|Adverse Event|0
2848605|NCT02383940|9784698|P1|Overall Study|Adverse Event|1
2848606|NCT02383862|9784714|P2|3 Month Follow up|Lost to Follow-up|21
2848607|NCT02383862|9784715|P1|3 Month Follow up|Lost to Follow-up|23
2848608|NCT02383758|9784748|P2|Overall Study|Withdrawal by Subject|2
2848609|NCT02383758|9784749|P1|Overall Study|Withdrawal by Subject|0
2848610|NCT02383589|9784777|P2|Overall Study|Non-compliance with study drug|1
2848611|NCT02383589|9784778|P1|Overall Study|Non-compliance with study drug|0
2848612|NCT02383589|9784777|P2|Overall Study|Withdrawal by Subject|5
2848613|NCT02383589|9784778|P1|Overall Study|Withdrawal by Subject|0
2848614|NCT02383589|9784777|P2|Overall Study|Lost to Follow-up|1
2848615|NCT02383589|9784778|P1|Overall Study|Lost to Follow-up|0
2848616|NCT02383589|9784777|P2|Overall Study|Adverse Event|3
2848617|NCT02383589|9784778|P1|Overall Study|Adverse Event|1
2848618|NCT02383576|9784801|P2|Overall Study|Administrative/Other|4
2848619|NCT02383576|9784802|P1|Overall Study|Administrative/Other|2
2848620|NCT02383576|9784801|P2|Overall Study|Investigator's Decision|1
2848621|NCT02383576|9784802|P1|Overall Study|Investigator's Decision|0
2848622|NCT02383576|9784801|P2|Overall Study|Withdrew Consent|6
2848623|NCT02383576|9784802|P1|Overall Study|Withdrew Consent|1
2848624|NCT02383576|9784801|P2|Overall Study|Lost to Follow-up|1
2848625|NCT02383576|9784802|P1|Overall Study|Lost to Follow-up|7
2848626|NCT02383576|9784801|P2|Overall Study|Death|33
2848627|NCT02383576|9784802|P1|Overall Study|Death|53
2848628|NCT02383472|9784818|P2|Overall Study|Withdrawal by Subject|1
2848629|NCT02383472|9784819|P1|Overall Study|Withdrawal by Subject|1
2848630|NCT02383433|9784833|P1|Overall Study|Disease progression|2
2848631|NCT02383355|9784852|P2|Overall Study|Adverse Event|0
2848632|NCT02383355|9784853|P1|Overall Study|Adverse Event|2
2848633|NCT02383056|9784869|P2|Overall Study|Lost to Follow-up|2
2848634|NCT02383056|9784870|P1|Overall Study|Lost to Follow-up|0
2848635|NCT02383056|9784869|P2|Overall Study|Adverse Event|0
2848636|NCT02383056|9784870|P1|Overall Study|Adverse Event|1
2848637|NCT02382991|9784896|P2|Overall Study|Withdrawal by Subject|1
2848638|NCT02382991|9784897|P1|Overall Study|Withdrawal by Subject|0
2848639|NCT02382991|9784896|P2|Overall Study|Lost to Follow-up|0
2848640|NCT02382991|9784897|P1|Overall Study|Lost to Follow-up|1
2848641|NCT02382991|9784896|P2|Overall Study|Adverse Event|2
2848642|NCT02382991|9784897|P1|Overall Study|Adverse Event|1
2848643|NCT02382640|9785024|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2848644|NCT02382640|9785025|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2848645|NCT02382640|9785026|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2848646|NCT02382640|9785027|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
2848647|NCT02382133|9785065|P1|Overall Study|pressure injury both sites|1
2848648|NCT02382133|9785065|P1|Overall Study|arterial catheter loss|4
2848649|NCT02382133|9785065|P1|Overall Study|Physician Decision|2
2848650|NCT02382133|9785065|P1|Overall Study|transfer out of ICU|4
2848651|NCT02382133|9785065|P1|Overall Study|Death|22
2848652|NCT02382016|9785072|P2|OL Extension Period|Withdrawal by Subject|0
2848653|NCT02382016|9785073|P1|OL Extension Period|Withdrawal by Subject|1
2848654|NCT02382016|9785072|P2|OL Extension Period|Death|0
2848655|NCT02382016|9785073|P1|OL Extension Period|Death|2
2848656|NCT02382016|9785072|P2|OL Extension Period|Physician Decision|0
2848657|NCT02382016|9785073|P1|OL Extension Period|Physician Decision|3
2848658|NCT02382016|9785072|P2|Open-label (OL) Treatment Period|Death|0
2848659|NCT02382016|9785073|P1|Open-label (OL) Treatment Period|Death|4
2848660|NCT02382016|9785072|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
2848661|NCT02382016|9785073|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
2848662|NCT02382016|9785072|P2|Open-label (OL) Treatment Period|Physician Decision|0
2848663|NCT02382016|9785073|P1|Open-label (OL) Treatment Period|Physician Decision|3
2848664|NCT02382016|9785072|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
2848665|NCT02382016|9785073|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
2848666|NCT02382016|9785072|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
2848667|NCT02382016|9785073|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
2848668|NCT02382016|9785072|P2|Double-blind (DB) Treatment Period|Physician Decision|0
2848669|NCT02382016|9785073|P1|Double-blind (DB) Treatment Period|Physician Decision|3
2848670|NCT02381795|9785097|P1|Overall Study|Study Terminated|2
2848671|NCT02381795|9785097|P1|Overall Study|Withdrawal by Subject|1
2848672|NCT02380859|9785205|P2|Overall Study|Withdrawal by Subject|0
2848673|NCT02380859|9785206|P1|Overall Study|Withdrawal by Subject|2
2848674|NCT02380742|9785242|P2|Overall Study|Withdrawal by Subject|0
2848675|NCT02380742|9785243|P1|Overall Study|Withdrawal by Subject|1
2848676|NCT02380287|9785263|P8|Overall Study|Adverse Event|0
2848677|NCT02380287|9785264|P7|Overall Study|Adverse Event|0
2848678|NCT02380287|9785265|P6|Overall Study|Adverse Event|0
2848679|NCT02380287|9785266|P5|Overall Study|Adverse Event|0
2848680|NCT02380287|9785267|P4|Overall Study|Adverse Event|0
2848681|NCT02380287|9785268|P3|Overall Study|Adverse Event|1
2848682|NCT02380287|9785269|P2|Overall Study|Adverse Event|0
2848683|NCT02380287|9785270|P1|Overall Study|Adverse Event|0
2848684|NCT02380248|9785286|P1|Overall Study|Withdrawal by Subject|3
2848685|NCT02380248|9785286|P1|Overall Study|Lost to Follow-up|11
2848686|NCT02379923|9785302|P1|Overall Study|Death|5
2848687|NCT02379728|9785331|P4|Overall Study|Protocol Violation|0
2848688|NCT02379728|9785332|P3|Overall Study|Protocol Violation|2
2848689|NCT02379728|9785333|P2|Overall Study|Protocol Violation|0
2848690|NCT02379728|9785334|P1|Overall Study|Protocol Violation|0
2848691|NCT02379728|9785331|P4|Overall Study|Withdrawal by Subject|3
2848692|NCT02379728|9785332|P3|Overall Study|Withdrawal by Subject|5
2848693|NCT02379728|9785333|P2|Overall Study|Withdrawal by Subject|0
2848694|NCT02379728|9785334|P1|Overall Study|Withdrawal by Subject|5
2848695|NCT02379728|9785331|P4|Overall Study|Lost to Follow-up|0
2848696|NCT02379728|9785332|P3|Overall Study|Lost to Follow-up|3
2848697|NCT02379728|9785333|P2|Overall Study|Lost to Follow-up|0
2848698|NCT02379728|9785334|P1|Overall Study|Lost to Follow-up|1
2848699|NCT02379637|9785390|P2|Overall Study|Withdrawal by Subject|0
2848700|NCT02379637|9785391|P1|Overall Study|Withdrawal by Subject|1
2848701|NCT02379637|9785390|P2|Overall Study|Adverse Event|0
2848702|NCT02379637|9785391|P1|Overall Study|Adverse Event|1
2848703|NCT02379637|9785390|P2|Overall Study|Protocol Violation|1
2848704|NCT02379637|9785391|P1|Overall Study|Protocol Violation|0
2848705|NCT02379390|9785430|P2|Overall Study|Study Termination|1
2848706|NCT02379390|9785431|P1|Overall Study|Study Termination|0
2848707|NCT02379390|9785430|P2|Overall Study|Investigator’s decision|0
2848708|NCT02379390|9785431|P1|Overall Study|Investigator’s decision|1
2848709|NCT02379390|9785430|P2|Overall Study|Adverse Event|1
2848710|NCT02379390|9785431|P1|Overall Study|Adverse Event|1
2848711|NCT02379221|9785459|P1|Overall Study|Lost to Follow-up|1
2848712|NCT02379091|9785495|P4|Overall Study|Lack of Efficacy|0
2848713|NCT02379091|9785496|P3|Overall Study|Lack of Efficacy|0
2848714|NCT02379091|9785497|P2|Overall Study|Lack of Efficacy|0
2848715|NCT02379091|9785498|P1|Overall Study|Lack of Efficacy|3
2848716|NCT02379091|9785495|P4|Overall Study|Study Termination|8
2848717|NCT02379091|9785496|P3|Overall Study|Study Termination|5
2848718|NCT02379091|9785497|P2|Overall Study|Study Termination|2
2848719|NCT02379091|9785498|P1|Overall Study|Study Termination|7
2848720|NCT02379091|9785495|P4|Overall Study|Voluntary Withdrawal|4
2848721|NCT02379091|9785496|P3|Overall Study|Voluntary Withdrawal|2
2848722|NCT02379091|9785497|P2|Overall Study|Voluntary Withdrawal|5
2848723|NCT02379091|9785498|P1|Overall Study|Voluntary Withdrawal|2
2848724|NCT02379091|9785495|P4|Overall Study|Lost to Follow-up|1
2848725|NCT02379091|9785496|P3|Overall Study|Lost to Follow-up|0
2848726|NCT02379091|9785497|P2|Overall Study|Lost to Follow-up|0
2848727|NCT02379091|9785498|P1|Overall Study|Lost to Follow-up|0
2848728|NCT02379091|9785495|P4|Overall Study|Principal Investigator Discretion|0
2848729|NCT02379091|9785496|P3|Overall Study|Principal Investigator Discretion|0
2848730|NCT02379091|9785497|P2|Overall Study|Principal Investigator Discretion|1
2848731|NCT02379091|9785498|P1|Overall Study|Principal Investigator Discretion|0
2848732|NCT02379091|9785495|P4|Overall Study|Pretreatment Event/Adverse Event|1
2848733|NCT02379091|9785496|P3|Overall Study|Pretreatment Event/Adverse Event|0
2848734|NCT02379091|9785497|P2|Overall Study|Pretreatment Event/Adverse Event|2
2848735|NCT02379091|9785498|P1|Overall Study|Pretreatment Event/Adverse Event|0
2848736|NCT02379052|9785536|P2|Overall Study|Subject was Incarcerated|1
2848737|NCT02379052|9785537|P1|Overall Study|Subject was Incarcerated|0
2848738|NCT02379052|9785536|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
2848739|NCT02379052|9785537|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
2848740|NCT02379052|9785536|P2|Overall Study|Lost to Follow-up|1
2848741|NCT02379052|9785537|P1|Overall Study|Lost to Follow-up|2
2848742|NCT02379052|9785536|P2|Overall Study|Withdrawal by Subject|0
2848743|NCT02379052|9785537|P1|Overall Study|Withdrawal by Subject|2
2848744|NCT02379052|9785536|P2|Overall Study|Physician Decision|1
2848745|NCT02379052|9785537|P1|Overall Study|Physician Decision|1
2848746|NCT02379052|9785536|P2|Overall Study|Adverse Event|1
2848747|NCT02379052|9785537|P1|Overall Study|Adverse Event|0
2848748|NCT02379052|9785536|P2|Overall Study|Protocol Violation|1
2848749|NCT02379052|9785537|P1|Overall Study|Protocol Violation|0
2848750|NCT02378961|9785579|P4|Overall Study|Death|0
2848751|NCT02378961|9785580|P3|Overall Study|Death|1
2848752|NCT02378961|9785581|P2|Overall Study|Death|0
2848753|NCT02378961|9785582|P1|Overall Study|Death|0
2848754|NCT02378961|9785579|P4|Overall Study|Lack of Efficacy|1
2848755|NCT02378961|9785580|P3|Overall Study|Lack of Efficacy|0
2848756|NCT02378961|9785581|P2|Overall Study|Lack of Efficacy|2
2848757|NCT02378961|9785582|P1|Overall Study|Lack of Efficacy|4
2848758|NCT02378935|9785619|P7|Overall Study|Death|0
2848759|NCT02378935|9785620|P6|Overall Study|Death|0
2848760|NCT02378935|9785621|P5|Overall Study|Death|0
2848761|NCT02378935|9785622|P4|Overall Study|Death|0
2848762|NCT02378935|9785623|P3|Overall Study|Death|1
2848763|NCT02378935|9785624|P2|Overall Study|Death|0
2848764|NCT02378935|9785625|P1|Overall Study|Death|0
2848765|NCT02378935|9785619|P7|Overall Study|Lack of Efficacy|0
2848766|NCT02378935|9785620|P6|Overall Study|Lack of Efficacy|0
2848767|NCT02378935|9785621|P5|Overall Study|Lack of Efficacy|0
2848768|NCT02378935|9785622|P4|Overall Study|Lack of Efficacy|6
2848769|NCT02378935|9785623|P3|Overall Study|Lack of Efficacy|2
2848770|NCT02378935|9785624|P2|Overall Study|Lack of Efficacy|0
2848771|NCT02378935|9785625|P1|Overall Study|Lack of Efficacy|10
2848772|NCT02378883|9785676|P1|12 Months Follow-Up|Death|2
2848773|NCT02378883|9785676|P1|12 Months Follow-Up|Lost to Follow-up|3
2848774|NCT02378883|9785676|P1|30 Day Follow-Up|Death|1
2848775|NCT02378883|9785676|P1|30 Day Follow-Up|Missed Visit|2
2848776|NCT02378883|9785676|P1|30 Day Follow-Up|Physician Decision|2
2848777|NCT02378883|9785676|P1|30 Day Follow-Up|Withdrawal by Subject|1
2848778|NCT02378883|9785676|P1|Enrollment|Attempt to use Apollo was not performed|3
2848779|NCT02378883|9785676|P1|Enrollment|Subject did not meet Inclusion criteria|6
2848780|NCT02378662|9785742|P2|Overall Study|Early Discontinuation|0
2848781|NCT02378662|9785743|P1|Overall Study|Early Discontinuation|2
2848782|NCT02378506|9785749|P1|Overall Study|Randomized But Not Treated|1
2848783|NCT02378506|9785749|P1|Overall Study|Adverse Event|14
2848784|NCT02378506|9785749|P1|Overall Study|Death|1
2848785|NCT02378506|9785749|P1|Overall Study|Protocol Violation|2
2848786|NCT02378506|9785749|P1|Overall Study|Withdrawal by Subject|4
2848787|NCT02378506|9785749|P1|Overall Study|Lack of Efficacy|3
2848788|NCT02378480|9785768|P2|Overall Study|Lost to Follow-up|18
2848789|NCT02378480|9785769|P1|Overall Study|Lost to Follow-up|10
2848790|NCT02378480|9785768|P2|Overall Study|Withdrawal by Subject|4
2848791|NCT02378480|9785769|P1|Overall Study|Withdrawal by Subject|9
2848792|NCT02378480|9785768|P2|Overall Study|Missed EOT/PTE Visit|2
2848793|NCT02378480|9785769|P1|Overall Study|Missed EOT/PTE Visit|1
2848794|NCT02378480|9785768|P2|Overall Study|Adverse Event|1
2848795|NCT02378480|9785769|P1|Overall Study|Adverse Event|0
2848796|NCT02378480|9785768|P2|Overall Study|Randomized, but Not Treated|4
2848797|NCT02378480|9785769|P1|Overall Study|Randomized, but Not Treated|6
2848798|NCT02378480|9785768|P2|Overall Study|Death|2
2848799|NCT02378480|9785769|P1|Overall Study|Death|1
2848800|NCT02378480|9785768|P2|Overall Study|Physician Decision|1
2848801|NCT02378480|9785769|P1|Overall Study|Physician Decision|1
2848802|NCT02378220|9785796|P2|Overall Study|Death|1
2848803|NCT02378220|9785797|P1|Overall Study|Death|6
2848804|NCT02377921|9785876|P2|Overall Study|Subject non-compliance|1
2848805|NCT02377921|9785877|P1|Overall Study|Subject non-compliance|1
2848806|NCT02377817|9785901|P2|Overall Study|Unrelated injury prevented lateral sleep|0
2848807|NCT02377817|9785902|P1|Overall Study|Unrelated injury prevented lateral sleep|1
2848808|NCT02377817|9785901|P2|Overall Study|Transportation/childcare barriers.|0
2848809|NCT02377817|9785902|P1|Overall Study|Transportation/childcare barriers.|2
2848810|NCT02377466|9785966|P2|Overall Study|Other: Randomized and not treated|2
2848811|NCT02377466|9785967|P1|Overall Study|Other: Randomized and not treated|0
2848812|NCT02377427|9786085|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2848813|NCT02377427|9786086|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2848814|NCT02377427|9786087|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
2848815|NCT02377427|9786088|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2848816|NCT02377427|9786089|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2848817|NCT02377427|9786085|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
2848818|NCT02377427|9786086|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
2848819|NCT02377427|9786087|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
2848820|NCT02377427|9786088|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
2848821|NCT02377427|9786089|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
2848822|NCT02377427|9786085|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2848823|NCT02377427|9786086|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2848824|NCT02377427|9786087|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2848825|NCT02377427|9786088|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2848826|NCT02377427|9786089|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
2848827|NCT02377427|9786085|P5|Part A (Up to Week 20)|Physician Decision|0
2848828|NCT02377427|9786086|P4|Part A (Up to Week 20)|Physician Decision|0
2848829|NCT02377427|9786087|P3|Part A (Up to Week 20)|Physician Decision|0
2848830|NCT02377427|9786088|P2|Part A (Up to Week 20)|Physician Decision|0
2848831|NCT02377427|9786089|P1|Part A (Up to Week 20)|Physician Decision|1
2848832|NCT02377362|9786162|P13|Part B Overall|Withdrawal by Subject|0
2848833|NCT02377362|9786163|P12|Part B Overall|Withdrawal by Subject|1
2848834|NCT02377362|9786164|P11|Part B Overall|Withdrawal by Subject|0
2848835|NCT02377362|9786165|P10|Part B Overall|Withdrawal by Subject|0
2848836|NCT02377362|9786166|P9|Part B Overall|Withdrawal by Subject|0
2848837|NCT02377362|9786167|P8|Part B Overall|Withdrawal by Subject|0
2848838|NCT02377362|9786168|P7|Part B Overall|Withdrawal by Subject|1
2848839|NCT02377362|9786169|P6|Part B Overall|Withdrawal by Subject|0
2848840|NCT02377362|9786170|P5|Part B Overall|Withdrawal by Subject|0
2848841|NCT02377362|9786171|P4|Part B Overall|Withdrawal by Subject|0
2848842|NCT02377362|9786172|P3|Part B Overall|Withdrawal by Subject|0
2848843|NCT02377362|9786173|P2|Part B Overall|Withdrawal by Subject|0
2848844|NCT02377362|9786174|P1|Part B Overall|Withdrawal by Subject|0
2848845|NCT02377362|9786162|P13|Part B Overall|Adverse Event|0
2848846|NCT02377362|9786163|P12|Part B Overall|Adverse Event|0
2848847|NCT02377362|9786164|P11|Part B Overall|Adverse Event|0
2848848|NCT02377362|9786165|P10|Part B Overall|Adverse Event|0
2848849|NCT02377362|9786166|P9|Part B Overall|Adverse Event|0
2848850|NCT02377362|9786167|P8|Part B Overall|Adverse Event|1
2848851|NCT02377362|9786168|P7|Part B Overall|Adverse Event|1
2848852|NCT02377362|9786169|P6|Part B Overall|Adverse Event|0
2848853|NCT02377362|9786170|P5|Part B Overall|Adverse Event|0
2848854|NCT02377362|9786171|P4|Part B Overall|Adverse Event|0
2848855|NCT02377362|9786172|P3|Part B Overall|Adverse Event|0
2848856|NCT02377362|9786173|P2|Part B Overall|Adverse Event|0
2848857|NCT02377362|9786174|P1|Part B Overall|Adverse Event|0
2848858|NCT02377362|9786162|P13|Part B Overall|Protocol Violation|0
2848859|NCT02377362|9786163|P12|Part B Overall|Protocol Violation|0
2848860|NCT02377362|9786164|P11|Part B Overall|Protocol Violation|0
2848861|NCT02377362|9786165|P10|Part B Overall|Protocol Violation|1
2848862|NCT02377362|9786166|P9|Part B Overall|Protocol Violation|0
2848863|NCT02377362|9786167|P8|Part B Overall|Protocol Violation|0
2848864|NCT02377362|9786168|P7|Part B Overall|Protocol Violation|0
2848865|NCT02377362|9786169|P6|Part B Overall|Protocol Violation|0
2848866|NCT02377362|9786170|P5|Part B Overall|Protocol Violation|0
2848867|NCT02377362|9786171|P4|Part B Overall|Protocol Violation|0
2848868|NCT02377362|9786172|P3|Part B Overall|Protocol Violation|0
2848869|NCT02377362|9786173|P2|Part B Overall|Protocol Violation|0
2848870|NCT02377362|9786174|P1|Part B Overall|Protocol Violation|0
2848871|NCT02377362|9786162|P13|Part A Third Treatment|Highest dose level 1200 not used|0
2848872|NCT02377362|9786163|P12|Part A Third Treatment|Highest dose level 1200 not used|0
2848873|NCT02377362|9786164|P11|Part A Third Treatment|Highest dose level 1200 not used|0
2848874|NCT02377362|9786165|P10|Part A Third Treatment|Highest dose level 1200 not used|0
2848875|NCT02377362|9786166|P9|Part A Third Treatment|Highest dose level 1200 not used|0
2848876|NCT02377362|9786167|P8|Part A Third Treatment|Highest dose level 1200 not used|0
2848877|NCT02377362|9786168|P7|Part A Third Treatment|Highest dose level 1200 not used|0
2848878|NCT02377362|9786169|P6|Part A Third Treatment|Highest dose level 1200 not used|4
2848879|NCT02377362|9786170|P5|Part A Third Treatment|Highest dose level 1200 not used|3
2848880|NCT02377362|9786171|P4|Part A Third Treatment|Highest dose level 1200 not used|4
2848881|NCT02377362|9786172|P3|Part A Third Treatment|Highest dose level 1200 not used|0
2848882|NCT02377362|9786173|P2|Part A Third Treatment|Highest dose level 1200 not used|0
2848883|NCT02377362|9786174|P1|Part A Third Treatment|Highest dose level 1200 not used|0
2848884|NCT02377362|9786162|P13|Part A Second Treatment|Protocol Violation|0
2848885|NCT02377362|9786163|P12|Part A Second Treatment|Protocol Violation|0
2848886|NCT02377362|9786164|P11|Part A Second Treatment|Protocol Violation|0
2848887|NCT02377362|9786165|P10|Part A Second Treatment|Protocol Violation|0
2848888|NCT02377362|9786166|P9|Part A Second Treatment|Protocol Violation|0
2848889|NCT02377362|9786167|P8|Part A Second Treatment|Protocol Violation|0
2848890|NCT02377362|9786168|P7|Part A Second Treatment|Protocol Violation|0
2848891|NCT02377362|9786169|P6|Part A Second Treatment|Protocol Violation|0
2848892|NCT02377362|9786170|P5|Part A Second Treatment|Protocol Violation|1
2848893|NCT02377362|9786171|P4|Part A Second Treatment|Protocol Violation|0
2848894|NCT02377362|9786172|P3|Part A Second Treatment|Protocol Violation|0
2848895|NCT02377362|9786173|P2|Part A Second Treatment|Protocol Violation|0
2848896|NCT02377362|9786174|P1|Part A Second Treatment|Protocol Violation|0
2848897|NCT02377349|9786383|P2|Overall Study|Other|1
2848898|NCT02377349|9786384|P1|Overall Study|Other|0
2848899|NCT02377349|9786383|P2|Overall Study|Lost to follow-up (complete vaccination)|5
2848900|NCT02377349|9786384|P1|Overall Study|Lost to follow-up (complete vaccination)|6
2848901|NCT02377349|9786383|P2|Overall Study|Lost to follow-up (partial vaccination)|0
2848902|NCT02377349|9786384|P1|Overall Study|Lost to follow-up (partial vaccination)|1
2848903|NCT02377349|9786383|P2|Overall Study|Withdrawal by Subject|3
2848904|NCT02377349|9786384|P1|Overall Study|Withdrawal by Subject|5
2848905|NCT02377349|9786383|P2|Overall Study|Protocol Violation|2
2848906|NCT02377349|9786384|P1|Overall Study|Protocol Violation|3
2848907|NCT02377349|9786383|P2|Overall Study|Serious Adverse Event|0
2848908|NCT02377349|9786384|P1|Overall Study|Serious Adverse Event|1
2848909|NCT02377063|9786422|P1|Overall Study|Non-compliance|5
2848910|NCT02376790|9786440|P3|Overall Study|Lost to Follow-up|12
2848911|NCT02376790|9786441|P2|Overall Study|Lost to Follow-up|10
2848912|NCT02376790|9786442|P1|Overall Study|Lost to Follow-up|15
2848913|NCT02376790|9786440|P3|Overall Study|Decision by Sponsor|4
2848914|NCT02376790|9786441|P2|Overall Study|Decision by Sponsor|1
2848915|NCT02376790|9786442|P1|Overall Study|Decision by Sponsor|2
2848916|NCT02376790|9786440|P3|Overall Study|Withdrawal by Subject|37
2848917|NCT02376790|9786441|P2|Overall Study|Withdrawal by Subject|36
2848918|NCT02376790|9786442|P1|Overall Study|Withdrawal by Subject|43
2848919|NCT02376166|9786633|P1|Overall Study|Discontinued metformin early|2
2848920|NCT02376166|9786633|P1|Overall Study|Adverse Event|1
2848921|NCT02375971|9786661|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
2848922|NCT02375971|9786662|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2848923|NCT02375971|9786663|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2848924|NCT02375971|9786661|P3|Follow-Up Phase (up to Day 169)|Death|4
2848925|NCT02375971|9786662|P2|Follow-Up Phase (up to Day 169)|Death|4
2848926|NCT02375971|9786663|P1|Follow-Up Phase (up to Day 169)|Death|4
2848927|NCT02375971|9786661|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2848928|NCT02375971|9786662|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
2848929|NCT02375971|9786663|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2848930|NCT02375971|9786661|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
2848931|NCT02375971|9786662|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
2848932|NCT02375971|9786663|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
2848933|NCT02375971|9786661|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
2848934|NCT02375971|9786662|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
2848935|NCT02375971|9786663|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
2848936|NCT02375971|9786661|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
2848937|NCT02375971|9786662|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2848938|NCT02375971|9786663|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2848939|NCT02375971|9786661|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
2848940|NCT02375971|9786662|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
2848941|NCT02375971|9786663|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
2848942|NCT02375971|9786661|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
2848943|NCT02375971|9786662|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2848944|NCT02375971|9786663|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2848945|NCT02375724|9786705|P2|Overall Study|Adverse Event|4
2848946|NCT02375724|9786706|P1|Overall Study|Adverse Event|2
2848947|NCT02375724|9786705|P2|Overall Study|Protocol Violation|0
2848948|NCT02375724|9786706|P1|Overall Study|Protocol Violation|1
2848949|NCT02375724|9786705|P2|Overall Study|Lost to Follow-up|0
2848950|NCT02375724|9786706|P1|Overall Study|Lost to Follow-up|1
2848951|NCT02375724|9786705|P2|Overall Study|Withdrawal by Subject|1
2848952|NCT02375724|9786706|P1|Overall Study|Withdrawal by Subject|1
2848953|NCT02375724|9786705|P2|Overall Study|Lack of Efficacy|1
2848954|NCT02375724|9786706|P1|Overall Study|Lack of Efficacy|1
2848955|NCT02375698|9786718|P2|Overall Study|Physician Decision|0
2848956|NCT02375698|9786719|P1|Overall Study|Physician Decision|2
2848957|NCT02375698|9786718|P2|Overall Study|Withdrawal by Subject|2
2848958|NCT02375698|9786719|P1|Overall Study|Withdrawal by Subject|0
2848959|NCT02375373|9786727|P1|Overall Study|Withdrawal by Subject|11
2848960|NCT02375347|9786731|P1|Overall Study|Protocol Violation|1
2848961|NCT02374957|9786737|P2|Overall Study|Patient did not complete forms correctly|0
2848962|NCT02374957|9786738|P1|Overall Study|Patient did not complete forms correctly|1
2848963|NCT02374671|9786767|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2848964|NCT02374671|9786768|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2848965|NCT02374671|9786769|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2848966|NCT02374671|9786767|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
2848967|NCT02374671|9786768|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
2848968|NCT02374671|9786769|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
2848969|NCT02374671|9786767|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
2848970|NCT02374671|9786768|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2848971|NCT02374671|9786769|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
2848972|NCT02374671|9786767|P3|Observation (Deferred Implantation)|Adverse Event|1
2848973|NCT02374671|9786768|P2|Observation (Deferred Implantation)|Adverse Event|0
2848974|NCT02374671|9786769|P1|Observation (Deferred Implantation)|Adverse Event|0
2848975|NCT02374671|9786767|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
2848976|NCT02374671|9786768|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
2848977|NCT02374671|9786769|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
2848978|NCT02374593|9786777|P2|Overall Study|non-compliant|0
2848979|NCT02374593|9786778|P1|Overall Study|non-compliant|2
2848980|NCT02374463|9786790|P2|Overall Study|Withdrawal by Subject|3
2848981|NCT02374463|9786791|P1|Overall Study|Withdrawal by Subject|3
2848982|NCT02374346|9786840|P1|Overall Study|operated or discharged during weekend|48
2848983|NCT02374307|9786848|P2|6-months Follow-up|Withdrawal by Subject|3
2848984|NCT02374307|9786849|P1|6-months Follow-up|Withdrawal by Subject|0
2848985|NCT02374307|9786848|P2|6-months Follow-up|Death|1
2848986|NCT02374307|9786849|P1|6-months Follow-up|Death|2
2848987|NCT02374307|9786848|P2|6-months Follow-up|Lost to Follow-up|2
2848988|NCT02374307|9786849|P1|6-months Follow-up|Lost to Follow-up|1
2848989|NCT02374307|9786848|P2|3-months Follow-up|Missed first follow-up|1
2848990|NCT02374307|9786849|P1|3-months Follow-up|Missed first follow-up|5
2848991|NCT02374307|9786848|P2|3-months Follow-up|Death|2
2848992|NCT02374307|9786849|P1|3-months Follow-up|Death|1
2848993|NCT02374307|9786848|P2|3-months Follow-up|Withdrawal by Subject|4
2848994|NCT02374307|9786849|P1|3-months Follow-up|Withdrawal by Subject|1
2848995|NCT02374307|9786848|P2|3-months Follow-up|Lost to Follow-up|2
2848996|NCT02374307|9786849|P1|3-months Follow-up|Lost to Follow-up|1
2848997|NCT02374255|9786880|P4|Overall Study|Withdrawal by Subject|0
2848998|NCT02374255|9786881|P3|Overall Study|Withdrawal by Subject|0
2848999|NCT02374255|9786882|P2|Overall Study|Withdrawal by Subject|0
2849000|NCT02374255|9786883|P1|Overall Study|Withdrawal by Subject|2
2849001|NCT02374099|9786984|P2|Overall Study|Study Terminated by Sponsor|4
2849002|NCT02374099|9786985|P1|Overall Study|Study Terminated by Sponsor|3
2849003|NCT02374099|9786984|P2|Overall Study|Randomized, but not treated|1
2849004|NCT02374099|9786985|P1|Overall Study|Randomized, but not treated|2
2849005|NCT02374099|9786984|P2|Overall Study|Miscellaneous|3
2849006|NCT02374099|9786985|P1|Overall Study|Miscellaneous|2
2849007|NCT02374099|9786984|P2|Overall Study|Withdrawal by Subject|1
2849008|NCT02374099|9786985|P1|Overall Study|Withdrawal by Subject|5
2849009|NCT02374099|9786984|P2|Overall Study|Progressive Disease|40
2849010|NCT02374099|9786985|P1|Overall Study|Progressive Disease|35
2849011|NCT02374099|9786984|P2|Overall Study|Adverse Event|0
2849012|NCT02374099|9786985|P1|Overall Study|Adverse Event|1
2849013|NCT02373202|9787093|P4|Overall Study|Other|0
2849014|NCT02373202|9787094|P3|Overall Study|Other|0
2849015|NCT02373202|9787095|P2|Overall Study|Other|1
2849016|NCT02373202|9787096|P1|Overall Study|Other|0
2849017|NCT02373202|9787093|P4|Overall Study|Lack of Efficacy|0
2849018|NCT02373202|9787094|P3|Overall Study|Lack of Efficacy|1
2849019|NCT02373202|9787095|P2|Overall Study|Lack of Efficacy|0
2849020|NCT02373202|9787096|P1|Overall Study|Lack of Efficacy|0
2849021|NCT02373202|9787093|P4|Overall Study|Adverse Event|1
2849022|NCT02373202|9787094|P3|Overall Study|Adverse Event|2
2849023|NCT02373202|9787095|P2|Overall Study|Adverse Event|5
2849024|NCT02373202|9787096|P1|Overall Study|Adverse Event|2
2849025|NCT02373098|9787171|P2|Overall Study|Adverse Event|0
2849026|NCT02373098|9787172|P1|Overall Study|Adverse Event|3
2849027|NCT02373098|9787171|P2|Overall Study|Withdrawal by Subject|0
2849028|NCT02373098|9787172|P1|Overall Study|Withdrawal by Subject|5
2849029|NCT02373098|9787171|P2|Overall Study|Protocol Violation|0
2849030|NCT02373098|9787172|P1|Overall Study|Protocol Violation|3
2849031|NCT02373098|9787171|P2|Overall Study|Lost to Follow-up|0
2849032|NCT02373098|9787172|P1|Overall Study|Lost to Follow-up|1
2849033|NCT02372799|9787200|P3|Down-taper Period|Lost to Follow-up|2
2849034|NCT02372799|9787201|P2|Down-taper Period|Lost to Follow-up|2
2849035|NCT02372799|9787202|P1|Down-taper Period|Lost to Follow-up|1
2849036|NCT02372799|9787200|P3|Treatment Period|Miscellaneous Reasons|0
2849037|NCT02372799|9787201|P2|Treatment Period|Miscellaneous Reasons|1
2849038|NCT02372799|9787202|P1|Treatment Period|Miscellaneous Reasons|1
2849039|NCT02372799|9787200|P3|Treatment Period|Non-compliance with study drug|4
2849040|NCT02372799|9787201|P2|Treatment Period|Non-compliance with study drug|4
2849041|NCT02372799|9787202|P1|Treatment Period|Non-compliance with study drug|4
2849042|NCT02372799|9787200|P3|Treatment Period|Protocol Violation|0
2849043|NCT02372799|9787201|P2|Treatment Period|Protocol Violation|0
2849044|NCT02372799|9787202|P1|Treatment Period|Protocol Violation|3
2849045|NCT02372799|9787200|P3|Treatment Period|Lost to Follow-up|3
2849046|NCT02372799|9787201|P2|Treatment Period|Lost to Follow-up|5
2849047|NCT02372799|9787202|P1|Treatment Period|Lost to Follow-up|11
2849048|NCT02372799|9787200|P3|Treatment Period|Withdrawal by Subject|2
2849049|NCT02372799|9787201|P2|Treatment Period|Withdrawal by Subject|10
2849050|NCT02372799|9787202|P1|Treatment Period|Withdrawal by Subject|10
2849051|NCT02372799|9787200|P3|Treatment Period|Insufficient therapeutic response|0
2849052|NCT02372799|9787201|P2|Treatment Period|Insufficient therapeutic response|2
2849053|NCT02372799|9787202|P1|Treatment Period|Insufficient therapeutic response|2
2849054|NCT02372799|9787200|P3|Treatment Period|Adverse Event|6
2849055|NCT02372799|9787201|P2|Treatment Period|Adverse Event|10
2849056|NCT02372799|9787202|P1|Treatment Period|Adverse Event|3
2849057|NCT02372396|9787231|P2|Overall Study|Lost to Follow-up|9
2849058|NCT02372396|9787232|P1|Overall Study|Lost to Follow-up|7
2849059|NCT02372253|9787256|P2|Overall Study|Non Compliance|0
2849060|NCT02372253|9787257|P1|Overall Study|Non Compliance|2
2849061|NCT02372071|9787302|P1|Overall Study|Protocol Violation|18
2849062|NCT02372058|9787307|P1|Overall Study|Withdrawal by Subject|3
2849063|NCT02371980|9787313|P5|Double-blind Period|Missing|0
2849064|NCT02371980|9787314|P4|Double-blind Period|Missing|0
2849065|NCT02371980|9787315|P3|Double-blind Period|Missing|0
2849066|NCT02371980|9787316|P2|Double-blind Period|Missing|1
2849067|NCT02371980|9787317|P1|Double-blind Period|Missing|0
2849068|NCT02371980|9787313|P5|Double-blind Period|Reason not Specified|1
2849069|NCT02371980|9787314|P4|Double-blind Period|Reason not Specified|2
2849070|NCT02371980|9787315|P3|Double-blind Period|Reason not Specified|3
2849071|NCT02371980|9787316|P2|Double-blind Period|Reason not Specified|3
2849072|NCT02371980|9787317|P1|Double-blind Period|Reason not Specified|0
2849073|NCT02371980|9787313|P5|Double-blind Period|Relapse|26
2849074|NCT02371980|9787314|P4|Double-blind Period|Relapse|25
2849075|NCT02371980|9787315|P3|Double-blind Period|Relapse|25
2849076|NCT02371980|9787316|P2|Double-blind Period|Relapse|50
2849077|NCT02371980|9787317|P1|Double-blind Period|Relapse|0
2849078|NCT02371980|9787313|P5|Double-blind Period|Voluntary Withdrawal|11
2849079|NCT02371980|9787314|P4|Double-blind Period|Voluntary Withdrawal|9
2849080|NCT02371980|9787315|P3|Double-blind Period|Voluntary Withdrawal|8
2849081|NCT02371980|9787316|P2|Double-blind Period|Voluntary Withdrawal|12
2849082|NCT02371980|9787317|P1|Double-blind Period|Voluntary Withdrawal|0
2849083|NCT02371980|9787313|P5|Double-blind Period|Lost to Follow-up|5
2849084|NCT02371980|9787314|P4|Double-blind Period|Lost to Follow-up|6
2849085|NCT02371980|9787315|P3|Double-blind Period|Lost to Follow-up|8
2849086|NCT02371980|9787316|P2|Double-blind Period|Lost to Follow-up|8
2849087|NCT02371980|9787317|P1|Double-blind Period|Lost to Follow-up|0
2849088|NCT02371980|9787313|P5|Double-blind Period|Noncompliance with Study Drug|3
2849089|NCT02371980|9787314|P4|Double-blind Period|Noncompliance with Study Drug|2
2849090|NCT02371980|9787315|P3|Double-blind Period|Noncompliance with Study Drug|2
2849091|NCT02371980|9787316|P2|Double-blind Period|Noncompliance with Study Drug|1
2849092|NCT02371980|9787317|P1|Double-blind Period|Noncompliance with Study Drug|0
2849093|NCT02371980|9787313|P5|Double-blind Period|Significant Protocol Deviation|3
2849094|NCT02371980|9787314|P4|Double-blind Period|Significant Protocol Deviation|3
2849095|NCT02371980|9787315|P3|Double-blind Period|Significant Protocol Deviation|7
2849096|NCT02371980|9787316|P2|Double-blind Period|Significant Protocol Deviation|2
2849097|NCT02371980|9787317|P1|Double-blind Period|Significant Protocol Deviation|0
2849098|NCT02371980|9787313|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
2849099|NCT02371980|9787314|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
2849100|NCT02371980|9787315|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
2849101|NCT02371980|9787316|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
2849102|NCT02371980|9787317|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
2849103|NCT02371980|9787313|P5|Open-label Period|Reason not Specified|0
2849104|NCT02371980|9787314|P4|Open-label Period|Reason not Specified|0
2849105|NCT02371980|9787315|P3|Open-label Period|Reason not Specified|0
2849106|NCT02371980|9787316|P2|Open-label Period|Reason not Specified|0
2849107|NCT02371980|9787317|P1|Open-label Period|Reason not Specified|9
2849108|NCT02371980|9787313|P5|Open-label Period|Did not Meet Randomization Criteria|0
2849109|NCT02371980|9787314|P4|Open-label Period|Did not Meet Randomization Criteria|0
2849110|NCT02371980|9787315|P3|Open-label Period|Did not Meet Randomization Criteria|0
2849111|NCT02371980|9787316|P2|Open-label Period|Did not Meet Randomization Criteria|0
2849112|NCT02371980|9787317|P1|Open-label Period|Did not Meet Randomization Criteria|162
2849113|NCT02371980|9787313|P5|Open-label Period|Lack of Efficacy|0
2849114|NCT02371980|9787314|P4|Open-label Period|Lack of Efficacy|0
2849115|NCT02371980|9787315|P3|Open-label Period|Lack of Efficacy|0
2849116|NCT02371980|9787316|P2|Open-label Period|Lack of Efficacy|0
2849117|NCT02371980|9787317|P1|Open-label Period|Lack of Efficacy|116
2849118|NCT02371980|9787313|P5|Open-label Period|Pregnancy|0
2849119|NCT02371980|9787314|P4|Open-label Period|Pregnancy|0
2849120|NCT02371980|9787315|P3|Open-label Period|Pregnancy|0
2849121|NCT02371980|9787316|P2|Open-label Period|Pregnancy|0
2849122|NCT02371980|9787317|P1|Open-label Period|Pregnancy|1
2849123|NCT02371980|9787313|P5|Open-label Period|Voluntary Withdrawal|0
2849124|NCT02371980|9787314|P4|Open-label Period|Voluntary Withdrawal|0
2849125|NCT02371980|9787315|P3|Open-label Period|Voluntary Withdrawal|0
2849126|NCT02371980|9787316|P2|Open-label Period|Voluntary Withdrawal|0
2849127|NCT02371980|9787317|P1|Open-label Period|Voluntary Withdrawal|91
2849128|NCT02371980|9787313|P5|Open-label Period|Lost to Follow-up|0
2849129|NCT02371980|9787314|P4|Open-label Period|Lost to Follow-up|0
2849130|NCT02371980|9787315|P3|Open-label Period|Lost to Follow-up|0
2849131|NCT02371980|9787316|P2|Open-label Period|Lost to Follow-up|0
2849132|NCT02371980|9787317|P1|Open-label Period|Lost to Follow-up|55
2849133|NCT02371980|9787313|P5|Open-label Period|Noncompliance with Study Drug|0
2849134|NCT02371980|9787314|P4|Open-label Period|Noncompliance with Study Drug|0
2849135|NCT02371980|9787315|P3|Open-label Period|Noncompliance with Study Drug|0
2849136|NCT02371980|9787316|P2|Open-label Period|Noncompliance with Study Drug|0
2849137|NCT02371980|9787317|P1|Open-label Period|Noncompliance with Study Drug|10
2849138|NCT02371980|9787313|P5|Open-label Period|Significant Protocol Deviation|0
2849139|NCT02371980|9787314|P4|Open-label Period|Significant Protocol Deviation|0
2849140|NCT02371980|9787315|P3|Open-label Period|Significant Protocol Deviation|0
2849141|NCT02371980|9787316|P2|Open-label Period|Significant Protocol Deviation|0
2849142|NCT02371980|9787317|P1|Open-label Period|Significant Protocol Deviation|19
2849143|NCT02371980|9787313|P5|Open-label Period|Pretreatment Event/Adverse Event|0
2849144|NCT02371980|9787314|P4|Open-label Period|Pretreatment Event/Adverse Event|0
2849145|NCT02371980|9787315|P3|Open-label Period|Pretreatment Event/Adverse Event|0
2849146|NCT02371980|9787316|P2|Open-label Period|Pretreatment Event/Adverse Event|0
2849147|NCT02371980|9787317|P1|Open-label Period|Pretreatment Event/Adverse Event|63
2849148|NCT02371759|9787377|P8|Overall Study|Withdrawal by Subject|1
2849149|NCT02371759|9787378|P7|Overall Study|Withdrawal by Subject|0
2849150|NCT02371759|9787379|P6|Overall Study|Withdrawal by Subject|0
2849151|NCT02371759|9787380|P5|Overall Study|Withdrawal by Subject|0
2849152|NCT02371759|9787381|P4|Overall Study|Withdrawal by Subject|0
2849153|NCT02371759|9787382|P3|Overall Study|Withdrawal by Subject|0
2849154|NCT02371759|9787383|P2|Overall Study|Withdrawal by Subject|0
2849155|NCT02371759|9787384|P1|Overall Study|Withdrawal by Subject|0
2849156|NCT02371759|9787377|P8|Overall Study|Protocol Violation|3
2849157|NCT02371759|9787378|P7|Overall Study|Protocol Violation|0
2849158|NCT02371759|9787379|P6|Overall Study|Protocol Violation|1
2849159|NCT02371759|9787380|P5|Overall Study|Protocol Violation|3
2849160|NCT02371759|9787381|P4|Overall Study|Protocol Violation|0
2849161|NCT02371759|9787382|P3|Overall Study|Protocol Violation|1
2849162|NCT02371759|9787383|P2|Overall Study|Protocol Violation|1
2849163|NCT02371759|9787384|P1|Overall Study|Protocol Violation|3
2849164|NCT02371746|9787601|P7|Overall Study|Consent withdrawn|1
2849165|NCT02371746|9787602|P6|Overall Study|Consent withdrawn|0
2849166|NCT02371746|9787603|P5|Overall Study|Consent withdrawn|0
2849167|NCT02371746|9787604|P4|Overall Study|Consent withdrawn|0
2849168|NCT02371746|9787605|P3|Overall Study|Consent withdrawn|0
2849169|NCT02371746|9787606|P2|Overall Study|Consent withdrawn|0
2849170|NCT02371746|9787607|P1|Overall Study|Consent withdrawn|0
2849171|NCT02371629|9787650|P2|Overall Study|Protocol deviation|1
2849172|NCT02371629|9787651|P1|Overall Study|Protocol deviation|0
2849173|NCT02371629|9787650|P2|Overall Study|Lack of Efficacy|2
2849174|NCT02371629|9787651|P1|Overall Study|Lack of Efficacy|0
2849175|NCT02371629|9787650|P2|Overall Study|Noncompliance with study treatment|0
2849176|NCT02371629|9787651|P1|Overall Study|Noncompliance with study treatment|1
2849177|NCT02371629|9787650|P2|Overall Study|Death|1
2849178|NCT02371629|9787651|P1|Overall Study|Death|1
2849179|NCT02371629|9787650|P2|Overall Study|Physician Decision|3
2849180|NCT02371629|9787651|P1|Overall Study|Physician Decision|2
2849181|NCT02371629|9787650|P2|Overall Study|Adverse Event|8
2849182|NCT02371629|9787651|P1|Overall Study|Adverse Event|8
2849183|NCT02371629|9787650|P2|Overall Study|Patient decision|10
2849184|NCT02371629|9787651|P1|Overall Study|Patient decision|14
2849185|NCT02371616|9787687|P2|Overall Study|Other (Not specified)|5
2849186|NCT02371616|9787688|P1|Overall Study|Other (Not specified)|1
2849187|NCT02371616|9787687|P2|Overall Study|Withdrawal of Consent|0
2849188|NCT02371616|9787688|P1|Overall Study|Withdrawal of Consent|1
2849189|NCT02371616|9787687|P2|Overall Study|Adverse Event|1
2849190|NCT02371616|9787688|P1|Overall Study|Adverse Event|0
2849191|NCT02371616|9787687|P2|Overall Study|Protocol Violation|1
2849192|NCT02371616|9787688|P1|Overall Study|Protocol Violation|2
2849193|NCT02371369|9787706|P2|Part 2|Death|1
2849194|NCT02371369|9787707|P1|Part 2|Death|0
2849195|NCT02371369|9787706|P2|Part 2|Physician Decision|0
2849196|NCT02371369|9787707|P1|Part 2|Physician Decision|1
2849197|NCT02371369|9787706|P2|Part 2|Withdrawal by Subject|1
2849198|NCT02371369|9787707|P1|Part 2|Withdrawal by Subject|5
2849199|NCT02371369|9787706|P2|Part 2|Adverse Event|2
2849200|NCT02371369|9787707|P1|Part 2|Adverse Event|3
2849201|NCT02371369|9787706|P2|Part 1|Protocol Violation|1
2849202|NCT02371369|9787707|P1|Part 1|Protocol Violation|0
2849203|NCT02371369|9787706|P2|Part 1|Disease progression|1
2849204|NCT02371369|9787707|P1|Part 1|Disease progression|0
2849205|NCT02371369|9787706|P2|Part 1|Withdrawal by Subject|6
2849206|NCT02371369|9787707|P1|Part 1|Withdrawal by Subject|1
2849207|NCT02371369|9787706|P2|Part 1|Adverse Event|0
2849208|NCT02371369|9787707|P1|Part 1|Adverse Event|8
2849209|NCT02371369|9787706|P2|Part 1|Physician Decision|3
2849210|NCT02371369|9787707|P1|Part 1|Physician Decision|0
2849211|NCT02370914|9787798|P1|Overall Study|Protocol Violation|2
2849212|NCT02370888|9787806|P1|Overall Study|did not meet chimerism criteria|6
2849213|NCT02370888|9787806|P1|Overall Study|disease progression|2
2849214|NCT02370667|9787817|P3|Overall Study|Lost to Follow-up|0
2849215|NCT02370667|9787818|P2|Overall Study|Lost to Follow-up|1
2849216|NCT02370667|9787819|P1|Overall Study|Lost to Follow-up|0
2849217|NCT02370641|9787883|P2|Overall Study|dropped study|2
2849218|NCT02370641|9787884|P1|Overall Study|dropped study|4
2849219|NCT02370615|9787892|P2|Overall Study|Adverse Event|0
2849220|NCT02370615|9787893|P1|Overall Study|Adverse Event|1
2849221|NCT02370602|9787936|P6|Overall Study|Pretreatment Event/Adverse Event|0
2849222|NCT02370602|9787937|P5|Overall Study|Pretreatment Event/Adverse Event|0
2849223|NCT02370602|9787938|P4|Overall Study|Pretreatment Event/Adverse Event|0
2849224|NCT02370602|9787939|P3|Overall Study|Pretreatment Event/Adverse Event|0
2849225|NCT02370602|9787940|P2|Overall Study|Pretreatment Event/Adverse Event|0
2849226|NCT02370602|9787941|P1|Overall Study|Pretreatment Event/Adverse Event|1
2849227|NCT02370537|9788035|P3|Part B|Withdrawal by Subject|0
2849228|NCT02370537|9788036|P2|Part B|Withdrawal by Subject|1
2849229|NCT02370537|9788037|P1|Part B|Withdrawal by Subject|0
2849230|NCT02370537|9788035|P3|Part B|Not randomised to receive treatment|259
2849231|NCT02370537|9788036|P2|Part B|Not randomised to receive treatment|2
2849232|NCT02370537|9788037|P1|Part B|Not randomised to receive treatment|1
2849233|NCT02370537|9788035|P3|Part A (Open-label Recruitment)|Adverse Event|1
2849234|NCT02370537|9788036|P2|Part A (Open-label Recruitment)|Adverse Event|0
2849235|NCT02370537|9788037|P1|Part A (Open-label Recruitment)|Adverse Event|0
2849236|NCT02370537|9788035|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2849237|NCT02370537|9788036|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
2849238|NCT02370537|9788037|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2849239|NCT02370498|9788086|P2|Overall Study|Ongoing In Trial|33
2849240|NCT02370498|9788087|P1|Overall Study|Ongoing In Trial|56
2849241|NCT02370498|9788086|P2|Overall Study|Withdrawal by Subject|11
2849242|NCT02370498|9788087|P1|Overall Study|Withdrawal by Subject|6
2849243|NCT02370498|9788086|P2|Overall Study|Protocol Violation|2
2849244|NCT02370498|9788087|P1|Overall Study|Protocol Violation|1
2849245|NCT02370498|9788086|P2|Overall Study|Lost to Follow-up|0
2849246|NCT02370498|9788087|P1|Overall Study|Lost to Follow-up|1
2849247|NCT02370498|9788086|P2|Overall Study|Death|242
2849248|NCT02370498|9788087|P1|Overall Study|Death|222
2849249|NCT02370498|9788086|P2|Overall Study|Adverse Event|8
2849250|NCT02370498|9788087|P1|Overall Study|Adverse Event|10
2849251|NCT02370420|9788141|P2|Overall Study|Lost to Follow-up|9
2849252|NCT02370420|9788142|P1|Overall Study|Lost to Follow-up|11
2849253|NCT02370420|9788141|P2|Overall Study|Physician Decision|3
2849254|NCT02370420|9788142|P1|Overall Study|Physician Decision|3
2849255|NCT02370394|9788179|P2|Overall Study|Withdrawal by Subject|1
2849256|NCT02370394|9788180|P1|Overall Study|Withdrawal by Subject|0
2849257|NCT02370394|9788179|P2|Overall Study|Lost to Follow-up|1
2849258|NCT02370394|9788180|P1|Overall Study|Lost to Follow-up|2
2849259|NCT02370251|9788194|P1|Overall Study|Death|4
2849260|NCT02370251|9788194|P1|Overall Study|Received less than 8 days of Omegaven|7
2849261|NCT02370160|9788200|P3|Overall Study|Death|1
2849262|NCT02370160|9788201|P2|Overall Study|Death|4
2849263|NCT02370160|9788202|P1|Overall Study|Death|3
2849264|NCT02370121|9788226|P2|Overall Study|Lost to Follow-up|1
2849265|NCT02370121|9788227|P1|Overall Study|Lost to Follow-up|1
2849266|NCT02370095|9788267|P2|Overall Study|Withdrawal by Subject|1
2849267|NCT02370095|9788268|P1|Overall Study|Withdrawal by Subject|0
2849268|NCT02370043|9788298|P6|Overall Study|Withdrawal by Subject|1
2849269|NCT02370043|9788299|P5|Overall Study|Withdrawal by Subject|1
2849270|NCT02370043|9788300|P4|Overall Study|Withdrawal by Subject|0
2849271|NCT02370043|9788301|P3|Overall Study|Withdrawal by Subject|0
2849272|NCT02370043|9788302|P2|Overall Study|Withdrawal by Subject|0
2849273|NCT02370043|9788303|P1|Overall Study|Withdrawal by Subject|0
2849274|NCT02369874|9788435|P3|Overall Study|Participant Ongoing|32
2849275|NCT02369874|9788436|P2|Overall Study|Participant Ongoing|45
2849276|NCT02369874|9788437|P1|Overall Study|Participant Ongoing|34
2849277|NCT02369874|9788435|P3|Overall Study|Miscellaneous|0
2849278|NCT02369874|9788436|P2|Overall Study|Miscellaneous|1
2849279|NCT02369874|9788437|P1|Overall Study|Miscellaneous|1
2849280|NCT02369874|9788435|P3|Overall Study|Withdrawal by Subject|27
2849281|NCT02369874|9788436|P2|Overall Study|Withdrawal by Subject|9
2849282|NCT02369874|9788437|P1|Overall Study|Withdrawal by Subject|7
2849283|NCT02369874|9788435|P3|Overall Study|Lost to Follow-up|2
2849284|NCT02369874|9788436|P2|Overall Study|Lost to Follow-up|2
2849285|NCT02369874|9788437|P1|Overall Study|Lost to Follow-up|2
2849286|NCT02369848|9788484|P1|Overall Study|Lost to Follow-up|1
2849287|NCT02369848|9788484|P1|Overall Study|Withdrawal by Subject|2
2849288|NCT02369848|9788484|P1|Overall Study|Death|1
2849289|NCT02369510|9788577|P3|Overall Study|Epidural Activation|5
2849290|NCT02369510|9788578|P2|Overall Study|Epidural Activation|1
2849291|NCT02369510|9788579|P1|Overall Study|Epidural Activation|1
2849292|NCT02369510|9788577|P3|Overall Study|Spilled Medication|1
2849293|NCT02369510|9788578|P2|Overall Study|Spilled Medication|2
2849294|NCT02369510|9788579|P1|Overall Study|Spilled Medication|1
2849295|NCT02369341|9788618|P2|Overall Study|Migrated/moved from study area|0
2849296|NCT02369341|9788619|P1|Overall Study|Migrated/moved from study area|1
2849297|NCT02368886|9788795|P4|Overall Study|Ineligible|1
2849298|NCT02368886|9788796|P3|Overall Study|Ineligible|0
2849299|NCT02368886|9788797|P2|Overall Study|Ineligible|0
2849300|NCT02368886|9788798|P1|Overall Study|Ineligible|0
2849301|NCT02368886|9788795|P4|Overall Study|Cancel|3
2849302|NCT02368886|9788796|P3|Overall Study|Cancel|1
2849303|NCT02368886|9788797|P2|Overall Study|Cancel|1
2849304|NCT02368886|9788798|P1|Overall Study|Cancel|1
2849305|NCT02368314|9788829|P2|Overall Study|Adverse Event|2
2849306|NCT02368314|9788830|P1|Overall Study|Adverse Event|1
2849307|NCT02368314|9788829|P2|Overall Study|Withdrawal by Subject|1
2849308|NCT02368314|9788830|P1|Overall Study|Withdrawal by Subject|2
2849309|NCT02368210|9788842|P2|Overall Study|Adverse Event|1
2849310|NCT02368210|9788843|P1|Overall Study|Adverse Event|0
2849311|NCT02368210|9788842|P2|Overall Study|Withdrawal by Subject|0
2849312|NCT02368210|9788843|P1|Overall Study|Withdrawal by Subject|1
2849313|NCT02367911|9788870|P2|Overall Study|Lost to Follow-up|2
2849314|NCT02367911|9788871|P1|Overall Study|Lost to Follow-up|2
2849315|NCT02367911|9788870|P2|Overall Study|Withdrawal by Subject|2
2849316|NCT02367911|9788871|P1|Overall Study|Withdrawal by Subject|3
2849317|NCT02367885|9788882|P3|Overall Study|Withdrawal by Subject|0
2849318|NCT02367885|9788883|P2|Overall Study|Withdrawal by Subject|0
2849319|NCT02367885|9788884|P1|Overall Study|Withdrawal by Subject|1
2849320|NCT02367885|9788882|P3|Overall Study|Lost to Follow-up|0
2849321|NCT02367885|9788883|P2|Overall Study|Lost to Follow-up|0
2849322|NCT02367885|9788884|P1|Overall Study|Lost to Follow-up|1
2849323|NCT02367833|9789127|P3|Overall Study|Withdrawal by Subject|0
2849324|NCT02367833|9789128|P2|Overall Study|Withdrawal by Subject|1
2849325|NCT02367833|9789129|P1|Overall Study|Withdrawal by Subject|1
2849326|NCT02367794|9789146|P3|Overall Study|Hypercalcemia prior to C1D1|1
2849327|NCT02367794|9789147|P2|Overall Study|Hypercalcemia prior to C1D1|0
2849328|NCT02367794|9789148|P1|Overall Study|Hypercalcemia prior to C1D1|0
2849329|NCT02367794|9789146|P3|Overall Study|Patient unable to receive carboplatin|1
2849330|NCT02367794|9789147|P2|Overall Study|Patient unable to receive carboplatin|0
2849331|NCT02367794|9789148|P1|Overall Study|Patient unable to receive carboplatin|0
2849332|NCT02367794|9789146|P3|Overall Study|Randomized in error|1
2849333|NCT02367794|9789147|P2|Overall Study|Randomized in error|0
2849334|NCT02367794|9789148|P1|Overall Study|Randomized in error|0
2849335|NCT02367794|9789146|P3|Overall Study|Brain metastasis|0
2849336|NCT02367794|9789147|P2|Overall Study|Brain metastasis|0
2849337|NCT02367794|9789148|P1|Overall Study|Brain metastasis|1
2849338|NCT02367794|9789146|P3|Overall Study|Withdrawal by Subject|14
2849339|NCT02367794|9789147|P2|Overall Study|Withdrawal by Subject|12
2849340|NCT02367794|9789148|P1|Overall Study|Withdrawal by Subject|25
2849341|NCT02367794|9789146|P3|Overall Study|Protocol Violation|1
2849342|NCT02367794|9789147|P2|Overall Study|Protocol Violation|0
2849343|NCT02367794|9789148|P1|Overall Study|Protocol Violation|1
2849344|NCT02367794|9789146|P3|Overall Study|Physician Decision|1
2849345|NCT02367794|9789147|P2|Overall Study|Physician Decision|3
2849346|NCT02367794|9789148|P1|Overall Study|Physician Decision|0
2849347|NCT02367794|9789146|P3|Overall Study|Lost to Follow-up|1
2849348|NCT02367794|9789147|P2|Overall Study|Lost to Follow-up|2
2849349|NCT02367794|9789148|P1|Overall Study|Lost to Follow-up|1
2849350|NCT02367794|9789146|P3|Overall Study|Death|229
2849351|NCT02367794|9789147|P2|Overall Study|Death|223
2849352|NCT02367794|9789148|P1|Overall Study|Death|230
2849353|NCT02367781|9789161|P2|Overall Study|Administrative-Change Facility|0
2849354|NCT02367781|9789162|P1|Overall Study|Administrative-Change Facility|1
2849355|NCT02367781|9789161|P2|Overall Study|Death Prior First Dose|0
2849356|NCT02367781|9789162|P1|Overall Study|Death Prior First Dose|1
2849357|NCT02367781|9789161|P2|Overall Study|Prolonged Hospitalization|0
2849358|NCT02367781|9789162|P1|Overall Study|Prolonged Hospitalization|1
2849359|NCT02367781|9789161|P2|Overall Study|On-going in study|88
2849360|NCT02367781|9789162|P1|Overall Study|On-going in study|214
2849361|NCT02367781|9789161|P2|Overall Study|Death|136
2849362|NCT02367781|9789162|P1|Overall Study|Death|240
2849363|NCT02367781|9789161|P2|Overall Study|Lost to Follow-up|1
2849364|NCT02367781|9789162|P1|Overall Study|Lost to Follow-up|0
2849365|NCT02367781|9789161|P2|Overall Study|Non-Compliance|0
2849366|NCT02367781|9789162|P1|Overall Study|Non-Compliance|1
2849367|NCT02367781|9789161|P2|Overall Study|Randomized in Error|4
2849368|NCT02367781|9789162|P1|Overall Study|Randomized in Error|5
2849369|NCT02367781|9789161|P2|Overall Study|Physician Decision|0
2849370|NCT02367781|9789162|P1|Overall Study|Physician Decision|1
2849371|NCT02367781|9789161|P2|Overall Study|Protocol Violation|1
2849372|NCT02367781|9789162|P1|Overall Study|Protocol Violation|0
2849373|NCT02367781|9789161|P2|Overall Study|Withdrawal by Subject|10
2849374|NCT02367781|9789162|P1|Overall Study|Withdrawal by Subject|19
2849375|NCT02367729|9789172|P2|Overall Study|Withdrawal by Subject|5
2849376|NCT02367729|9789173|P1|Overall Study|Withdrawal by Subject|0
2849377|NCT02367729|9789172|P2|Overall Study|Adverse Event|2
2849378|NCT02367729|9789173|P1|Overall Study|Adverse Event|1
2849379|NCT02367729|9789172|P2|Overall Study|Organic disorder diagnosed|1
2849380|NCT02367729|9789173|P1|Overall Study|Organic disorder diagnosed|2
2849381|NCT02367521|9789191|P2|Overall Study|unable to find transportation|0
2849382|NCT02367521|9789192|P1|Overall Study|unable to find transportation|2
2849383|NCT02367521|9789191|P2|Overall Study|severe headache after intervention|0
2849384|NCT02367521|9789192|P1|Overall Study|severe headache after intervention|2
2849385|NCT02367352|9789270|P3|Overall Study|Adverse Event|0
2849386|NCT02367352|9789271|P2|Overall Study|Adverse Event|0
2849387|NCT02367352|9789272|P1|Overall Study|Adverse Event|1
2849388|NCT02367352|9789270|P3|Overall Study|Participant Received Alternative Therapy|0
2849389|NCT02367352|9789271|P2|Overall Study|Participant Received Alternative Therapy|0
2849390|NCT02367352|9789272|P1|Overall Study|Participant Received Alternative Therapy|1
2849391|NCT02367352|9789270|P3|Overall Study|Progressive disease|0
2849392|NCT02367352|9789271|P2|Overall Study|Progressive disease|0
2849393|NCT02367352|9789272|P1|Overall Study|Progressive disease|7
2849394|NCT02367131|9789322|P1|Overall Study|Other than stated above|20
2849395|NCT02367131|9789322|P1|Overall Study|No change/progressive disease|78
2849396|NCT02367131|9789322|P1|Overall Study|Improvement/remission|2
2849397|NCT02367131|9789322|P1|Overall Study|Request by patient|54
2849398|NCT02367131|9789322|P1|Overall Study|No visit since the first visit|4
2849399|NCT02367131|9789322|P1|Overall Study|Adverse Event|64
2849400|NCT02366936|9789514|P1|Overall Study|Physician Decision|2
2849401|NCT02366936|9789514|P1|Overall Study|Lost to Follow-up|4
2849402|NCT02366936|9789514|P1|Overall Study|Withdrawal by Subject|2
2849403|NCT02366923|9789519|P1|Overall Study|High Astigmatism|3
2849404|NCT02366923|9789519|P1|Overall Study|Positive Slit Lamp Findings|2
2849405|NCT02366923|9789519|P1|Overall Study|Withdrawal by Subject|1
2849406|NCT02366910|9789532|P1|Overall Study|Screen Failure|3
2849407|NCT02366910|9789532|P1|Overall Study|Withdrawal by Subject|2
2849408|NCT02366767|9789580|P2|Overall Study|left for home after 1 day at camp|0
2849409|NCT02366767|9789581|P1|Overall Study|left for home after 1 day at camp|1
2849410|NCT02366689|9789594|P3|Overall Study|Pregnancy|1
2849411|NCT02366689|9789595|P2|Overall Study|Pregnancy|1
2849412|NCT02366689|9789596|P1|Overall Study|Pregnancy|0
2849413|NCT02366689|9789594|P3|Overall Study|Lost to Follow-up|0
2849414|NCT02366689|9789595|P2|Overall Study|Lost to Follow-up|2
2849415|NCT02366689|9789596|P1|Overall Study|Lost to Follow-up|3
2849416|NCT02366689|9789594|P3|Overall Study|Withdrawal by Subject|1
2849417|NCT02366689|9789595|P2|Overall Study|Withdrawal by Subject|0
2849418|NCT02366689|9789596|P1|Overall Study|Withdrawal by Subject|1
2849419|NCT02366637|9789648|P2|Second Intervention Period|Study Terminated by Sponsor|1
2849420|NCT02366637|9789649|P1|Second Intervention Period|Study Terminated by Sponsor|1
2849421|NCT02366637|9789648|P2|First Intervention Period|Study Terminated by Sponsor|4
2849422|NCT02366637|9789649|P1|First Intervention Period|Study Terminated by Sponsor|6
2849423|NCT02366637|9789648|P2|First Intervention Period|Adverse Event|1
2849424|NCT02366637|9789649|P1|First Intervention Period|Adverse Event|0
2849425|NCT02366468|9789675|P2|Overall Study|Other|2
2849426|NCT02366468|9789676|P1|Overall Study|Other|0
2849427|NCT02366468|9789675|P2|Overall Study|Death|2
2849428|NCT02366468|9789676|P1|Overall Study|Death|1
2849429|NCT02366468|9789675|P2|Overall Study|Lost to Follow-up|0
2849430|NCT02366468|9789676|P1|Overall Study|Lost to Follow-up|2
2849431|NCT02366468|9789675|P2|Overall Study|Withdrawal by Subject|5
2849432|NCT02366468|9789676|P1|Overall Study|Withdrawal by Subject|1
2849433|NCT02366468|9789675|P2|Overall Study|Adverse Event|0
2849434|NCT02366468|9789676|P1|Overall Study|Adverse Event|2
2849435|NCT02366195|9789707|P1|Overall Study|Death|26
2849436|NCT02366195|9789707|P1|Overall Study|Lost to Follow-up|1
2849437|NCT02366195|9789707|P1|Overall Study|Withdrawal by Subject|6
2849438|NCT02366195|9789707|P1|Overall Study|Continuing Study|79
2849439|NCT02365636|9789766|P3|Overall Study|Other|0
2849440|NCT02365636|9789767|P2|Overall Study|Other|0
2849441|NCT02365636|9789768|P1|Overall Study|Other|2
2849442|NCT02365636|9789766|P3|Overall Study|Lost to Follow-up|1
2849443|NCT02365636|9789767|P2|Overall Study|Lost to Follow-up|0
2849444|NCT02365636|9789768|P1|Overall Study|Lost to Follow-up|0
2849445|NCT02365636|9789766|P3|Overall Study|Protocol Violation|0
2849446|NCT02365636|9789767|P2|Overall Study|Protocol Violation|4
2849447|NCT02365636|9789768|P1|Overall Study|Protocol Violation|1
2849448|NCT02365636|9789766|P3|Overall Study|Adverse Event|2
2849449|NCT02365636|9789767|P2|Overall Study|Adverse Event|3
2849450|NCT02365636|9789768|P1|Overall Study|Adverse Event|3
2849451|NCT02365584|9789814|P2|Overall Study|Disease Progression|12
2849452|NCT02365584|9789815|P1|Overall Study|Disease Progression|9
2849453|NCT02365584|9789814|P2|Overall Study|Withdrawal by Subject|0
2849454|NCT02365584|9789815|P1|Overall Study|Withdrawal by Subject|1
2849455|NCT02365584|9789814|P2|Overall Study|Adverse Event|2
2849456|NCT02365584|9789815|P1|Overall Study|Adverse Event|2
2849457|NCT02365558|9789839|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
2849458|NCT02365558|9789840|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
2849459|NCT02365558|9789839|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
2849460|NCT02365558|9789840|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
2849461|NCT02365519|9789853|P3|Randomized and Treated|Withdrawal by Subject|1
2849462|NCT02365519|9789854|P2|Randomized and Treated|Withdrawal by Subject|1
2849463|NCT02365519|9789855|P1|Randomized and Treated|Withdrawal by Subject|0
2849464|NCT02365519|9789853|P3|Randomized and Treated|Adverse Event|0
2849465|NCT02365519|9789854|P2|Randomized and Treated|Adverse Event|1
2849466|NCT02365519|9789855|P1|Randomized and Treated|Adverse Event|0
2849467|NCT02365298|9789876|P2|Period 2|Protocol Violation|1
2849468|NCT02365298|9789877|P1|Period 2|Protocol Violation|0
2849469|NCT02365298|9789876|P2|Period 2|Test Article longer available|1
2849470|NCT02365298|9789877|P1|Period 2|Test Article longer available|0
2849471|NCT02365298|9789876|P2|Period 2|Discontinued at request of Sponsor|0
2849472|NCT02365298|9789877|P1|Period 2|Discontinued at request of Sponsor|1
2849473|NCT02365298|9789876|P2|Period 2|incorrect Rx dispensed|0
2849474|NCT02365298|9789877|P1|Period 2|incorrect Rx dispensed|1
2849475|NCT02365285|9789897|P4|Overall Study|Adverse Event|2
2849476|NCT02365285|9789898|P3|Overall Study|Adverse Event|0
2849477|NCT02365285|9789899|P2|Overall Study|Adverse Event|0
2849478|NCT02365285|9789900|P1|Overall Study|Adverse Event|0
2849479|NCT02365285|9789897|P4|Overall Study|Physician Decision|0
2849480|NCT02365285|9789898|P3|Overall Study|Physician Decision|1
2849481|NCT02365285|9789899|P2|Overall Study|Physician Decision|1
2849482|NCT02365285|9789900|P1|Overall Study|Physician Decision|0
2849483|NCT02365233|9789917|P3|Overall Study|IRB withheld the data|2
2849484|NCT02365233|9789918|P2|Overall Study|IRB withheld the data|2
2849485|NCT02365233|9789919|P1|Overall Study|IRB withheld the data|1
2849486|NCT02365207|9789927|P1|Overall Study|Physician Decision|1
2849487|NCT02365207|9789927|P1|Overall Study|Withdrawal by Subject|1
2849488|NCT02364999|9789933|P2|Overall Study|Randomized but did not receive treatment|3
2849489|NCT02364999|9789934|P1|Overall Study|Randomized but did not receive treatment|2
2849490|NCT02364999|9789933|P2|Overall Study|Other|1
2849491|NCT02364999|9789934|P1|Overall Study|Other|0
2849492|NCT02364999|9789933|P2|Overall Study|Withdrawal by Subject|14
2849493|NCT02364999|9789934|P1|Overall Study|Withdrawal by Subject|14
2849494|NCT02364999|9789933|P2|Overall Study|Protocol Violation|2
2849495|NCT02364999|9789934|P1|Overall Study|Protocol Violation|3
2849496|NCT02364999|9789933|P2|Overall Study|Lost to Follow-up|15
2849497|NCT02364999|9789934|P1|Overall Study|Lost to Follow-up|10
2849498|NCT02364999|9789933|P2|Overall Study|Death|138
2849499|NCT02364999|9789934|P1|Overall Study|Death|136
2849500|NCT02364947|9789960|P3|Overall Study|Death|0
2849501|NCT02364947|9789961|P2|Overall Study|Death|1
2849502|NCT02364947|9789962|P1|Overall Study|Death|0
2849503|NCT02364947|9789960|P3|Overall Study|Physician Decision|5
2849504|NCT02364947|9789961|P2|Overall Study|Physician Decision|2
2849505|NCT02364947|9789962|P1|Overall Study|Physician Decision|3
2849506|NCT02364947|9789960|P3|Overall Study|Protocol Violation|1
2849507|NCT02364947|9789961|P2|Overall Study|Protocol Violation|1
2849508|NCT02364947|9789962|P1|Overall Study|Protocol Violation|1
2849509|NCT02364947|9789960|P3|Overall Study|Adverse Event|11
2849510|NCT02364947|9789961|P2|Overall Study|Adverse Event|33
2849511|NCT02364947|9789962|P1|Overall Study|Adverse Event|45
2849512|NCT02364947|9789960|P3|Overall Study|Withdrawal by Subject|9
2849513|NCT02364947|9789961|P2|Overall Study|Withdrawal by Subject|8
2849514|NCT02364947|9789962|P1|Overall Study|Withdrawal by Subject|10
2849515|NCT02364388|9790131|P1|Overall Study|No Biopsy|2
2849516|NCT02364388|9790131|P1|Overall Study|No OA/US data|2
2849517|NCT02364388|9790131|P1|Overall Study|Technical Failure|3
2849518|NCT02364388|9790131|P1|Overall Study|Protocol Violation|1
2849519|NCT02364336|9790138|P2|Overall Study|Adverse Event|1
2849520|NCT02364336|9790139|P1|Overall Study|Adverse Event|0
2849521|NCT02364180|9790152|P1|Overall Study|Screen Fail|1
2849522|NCT02364037|9790165|P2|Overall Study|Lost to Follow-up|49
2849523|NCT02364037|9790166|P1|Overall Study|Lost to Follow-up|37
2849524|NCT02364037|9790165|P2|Overall Study|Withdrawal by Subject|4
2849525|NCT02364037|9790166|P1|Overall Study|Withdrawal by Subject|7
2849526|NCT02363959|9790180|P2|Overall Study|Medical instability|0
2849527|NCT02363959|9790181|P1|Overall Study|Medical instability|1
2849528|NCT02363946|9790210|P13|Overall Study|Lost to Follow-up|0
2849529|NCT02363946|9790211|P12|Overall Study|Lost to Follow-up|0
2849530|NCT02363946|9790212|P11|Overall Study|Lost to Follow-up|0
2849531|NCT02363946|9790213|P10|Overall Study|Lost to Follow-up|0
2849532|NCT02363946|9790214|P9|Overall Study|Lost to Follow-up|0
2849533|NCT02363946|9790215|P8|Overall Study|Lost to Follow-up|1
2849534|NCT02363946|9790216|P7|Overall Study|Lost to Follow-up|0
2849535|NCT02363946|9790217|P6|Overall Study|Lost to Follow-up|0
2849536|NCT02363946|9790218|P5|Overall Study|Lost to Follow-up|0
2849537|NCT02363946|9790219|P4|Overall Study|Lost to Follow-up|0
2849538|NCT02363946|9790220|P3|Overall Study|Lost to Follow-up|0
2849539|NCT02363946|9790221|P2|Overall Study|Lost to Follow-up|0
2849540|NCT02363946|9790222|P1|Overall Study|Lost to Follow-up|0
2849541|NCT02363478|9790451|P1|Overall Study|Adverse Event|4
2849542|NCT02363478|9790451|P1|Overall Study|Lost to Follow-up|4
2849543|NCT02363439|9790458|P1|Overall Study|Lack of Efficacy|4
2849544|NCT02363322|9790464|P2|Overall Study|Lost to Follow-up|0
2849545|NCT02363322|9790465|P1|Overall Study|Lost to Follow-up|1
2849546|NCT02362789|9790486|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
2849547|NCT02362789|9790487|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
2849548|NCT02362789|9790488|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
2849549|NCT02362789|9790486|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
2849550|NCT02362789|9790487|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
2849551|NCT02362789|9790488|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
2849552|NCT02362789|9790486|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
2849553|NCT02362789|9790487|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
2849554|NCT02362789|9790488|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
2849555|NCT02362789|9790486|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
2849556|NCT02362789|9790487|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
2849557|NCT02362789|9790488|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
2849558|NCT02362789|9790486|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2849559|NCT02362789|9790487|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2849560|NCT02362789|9790488|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
2849561|NCT02362646|9790497|P2|Overall Study|received transplant|14
2849562|NCT02362646|9790498|P1|Overall Study|received transplant|21
2849563|NCT02362646|9790497|P2|Overall Study|Withdrawal by Subject|2
2849564|NCT02362646|9790498|P1|Overall Study|Withdrawal by Subject|2
2849565|NCT02362646|9790497|P2|Overall Study|Death|8
2849566|NCT02362646|9790498|P1|Overall Study|Death|15
2849567|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
2849568|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
2849569|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
2849570|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
2849571|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
2849572|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
2849573|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
2849574|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
2849575|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
2849576|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
2849577|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
2849578|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
2849579|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
2849580|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
2849581|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
2849582|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
2849583|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
2849584|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
2849585|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
2849586|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
2849587|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
2849588|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
2849589|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
2849590|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
2849591|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
2849592|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
2849593|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
2849594|NCT02362503|9790530|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
2849595|NCT02362503|9790531|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
2849596|NCT02362503|9790532|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
2849597|NCT02362503|9790530|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2849598|NCT02362503|9790531|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
2849599|NCT02362503|9790532|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2849600|NCT02362503|9790530|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2849601|NCT02362503|9790531|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
2849602|NCT02362503|9790532|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2849603|NCT02362503|9790530|P3|Double-blind Period-Up to 8 Days|Death|0
2849604|NCT02362503|9790531|P2|Double-blind Period-Up to 8 Days|Death|1
2849605|NCT02362503|9790532|P1|Double-blind Period-Up to 8 Days|Death|1
2849606|NCT02362503|9790530|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
2849607|NCT02362503|9790531|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
2849608|NCT02362503|9790532|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
2849609|NCT02362425|9790561|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2849610|NCT02362425|9790562|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
2849611|NCT02362425|9790563|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2849612|NCT02362425|9790564|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2849613|NCT02362425|9790561|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
2849614|NCT02362425|9790562|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2849615|NCT02362425|9790563|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2849616|NCT02362425|9790564|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2849617|NCT02362425|9790561|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
2849618|NCT02362425|9790562|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2849619|NCT02362425|9790563|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2849620|NCT02362425|9790564|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2849621|NCT02362425|9790561|P4|Phase 1 (up to 6 Months)|Study closure|0
2849622|NCT02362425|9790562|P3|Phase 1 (up to 6 Months)|Study closure|0
2849623|NCT02362425|9790563|P2|Phase 1 (up to 6 Months)|Study closure|0
2849624|NCT02362425|9790564|P1|Phase 1 (up to 6 Months)|Study closure|9
2849625|NCT02362425|9790561|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2849626|NCT02362425|9790562|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2849627|NCT02362425|9790563|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2849628|NCT02362425|9790564|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
2849629|NCT02362425|9790561|P4|Phase 1 (up to 6 Months)|Screening failure|0
2849630|NCT02362425|9790562|P3|Phase 1 (up to 6 Months)|Screening failure|0
2849631|NCT02362425|9790563|P2|Phase 1 (up to 6 Months)|Screening failure|0
2849632|NCT02362425|9790564|P1|Phase 1 (up to 6 Months)|Screening failure|1
2849633|NCT02362425|9790561|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2849634|NCT02362425|9790562|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2849635|NCT02362425|9790563|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2849636|NCT02362425|9790564|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
2849637|NCT02362425|9790561|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2849638|NCT02362425|9790562|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2849639|NCT02362425|9790563|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2849640|NCT02362425|9790564|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
2849641|NCT02362412|9790682|P2|Treatment Period III|Lost to Follow-up|1
2849642|NCT02362412|9790683|P1|Treatment Period III|Lost to Follow-up|0
2849643|NCT02362360|9790717|P2|Period 1|Withdrawal by Subject|1
2849644|NCT02362360|9790718|P1|Period 1|Withdrawal by Subject|2
2849645|NCT02362360|9790717|P2|Period 1|Lack of Efficacy|0
2849646|NCT02362360|9790718|P1|Period 1|Lack of Efficacy|1
2849647|NCT02362282|9790735|P2|Overall Study|Withdrawal by Subject|0
2849648|NCT02362282|9790736|P1|Overall Study|Withdrawal by Subject|1
2849649|NCT02361762|9790753|P2|Overall Study|Lost to Follow-up|1
2849650|NCT02361762|9790754|P1|Overall Study|Lost to Follow-up|0
2849651|NCT02361762|9790753|P2|Overall Study|Withdrawal by Subject|1
2849652|NCT02361762|9790754|P1|Overall Study|Withdrawal by Subject|0
2849653|NCT02361580|9790805|P2|Overall Study|Lost to Follow-up|3
2849654|NCT02361580|9790806|P1|Overall Study|Lost to Follow-up|6
2849655|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
2849656|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
2849657|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2849658|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2849659|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
2849660|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
2849661|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
2849662|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
2849663|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
2849664|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
2849665|NCT02361216|9790835|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
2849666|NCT02361216|9790836|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
2849667|NCT02360995|9790851|P3|Overall Study|Withdrawal by Subject|0
2849668|NCT02360995|9790852|P2|Overall Study|Withdrawal by Subject|1
2849669|NCT02360995|9790853|P1|Overall Study|Withdrawal by Subject|0
2849670|NCT02360995|9790851|P3|Overall Study|Lost to Follow-up|2
2849671|NCT02360995|9790852|P2|Overall Study|Lost to Follow-up|0
2849672|NCT02360995|9790853|P1|Overall Study|Lost to Follow-up|2
2849673|NCT02360475|9790917|P4|Overall Study|Migrated/moved from study area|1
2849674|NCT02360475|9790918|P3|Overall Study|Migrated/moved from study area|0
2849675|NCT02360475|9790919|P2|Overall Study|Migrated/moved from study area|0
2849676|NCT02360475|9790920|P1|Overall Study|Migrated/moved from study area|0
2849677|NCT02360475|9790917|P4|Overall Study|Withdrawal by Subject|0
2849678|NCT02360475|9790918|P3|Overall Study|Withdrawal by Subject|2
2849679|NCT02360475|9790919|P2|Overall Study|Withdrawal by Subject|1
2849680|NCT02360475|9790920|P1|Overall Study|Withdrawal by Subject|0
2849681|NCT02360475|9790917|P4|Overall Study|Lost to Follow-up|4
2849682|NCT02360475|9790918|P3|Overall Study|Lost to Follow-up|6
2849683|NCT02360475|9790919|P2|Overall Study|Lost to Follow-up|12
2849684|NCT02360475|9790920|P1|Overall Study|Lost to Follow-up|4
2849685|NCT02360397|9790978|P1|Overall Study|Adverse Event|1
2849686|NCT02360397|9790978|P1|Overall Study|Incomplete screening|3
2849687|NCT02360293|9790987|P2|Overall Study|Excluded|0
2849688|NCT02360293|9790988|P1|Overall Study|Excluded|1
2849689|NCT02360293|9790987|P2|Overall Study|Withdrawal by Subject|1
2849690|NCT02360293|9790988|P1|Overall Study|Withdrawal by Subject|2
2849691|NCT02360293|9790987|P2|Overall Study|Lost to Follow-up|95
2849692|NCT02360293|9790988|P1|Overall Study|Lost to Follow-up|73
2849693|NCT02360280|9791002|P2|Overall Study|Lost to Follow-up|0
2849694|NCT02360280|9791003|P1|Overall Study|Lost to Follow-up|1
2849695|NCT02360280|9791002|P2|Overall Study|Adverse Event|1
2849696|NCT02360280|9791003|P1|Overall Study|Adverse Event|0
2849697|NCT02360280|9791002|P2|Overall Study|Withdrawal by Subject|0
2849698|NCT02360280|9791003|P1|Overall Study|Withdrawal by Subject|2
2849699|NCT02360228|9791018|P3|Overall Study|Unstable symptoms during screening|1
2849700|NCT02360228|9791019|P2|Overall Study|Unstable symptoms during screening|0
2849701|NCT02360228|9791020|P1|Overall Study|Unstable symptoms during screening|0
2849702|NCT02360228|9791018|P3|Overall Study|Self-discontinued medication|0
2849703|NCT02360228|9791019|P2|Overall Study|Self-discontinued medication|1
2849704|NCT02360228|9791020|P1|Overall Study|Self-discontinued medication|0
2849705|NCT02360228|9791018|P3|Overall Study|Withdrawal by Subject|0
2849706|NCT02360228|9791019|P2|Overall Study|Withdrawal by Subject|0
2849707|NCT02360228|9791020|P1|Overall Study|Withdrawal by Subject|1
2849708|NCT02360111|9791115|P1|Overall Study|Death|2
2849709|NCT02359903|9791186|P2|Overall Study|Adverse Event|2
2849710|NCT02359903|9791187|P1|Overall Study|Adverse Event|0
2849711|NCT02359890|9791195|P1|Overall Study|Never treated with study catheter|6
2849712|NCT02359890|9791195|P1|Overall Study|Not meeting eligibility|4
2849713|NCT02359877|9791206|P4|Overall Study|Adverse Event|1
2849714|NCT02359877|9791207|P3|Overall Study|Adverse Event|0
2849715|NCT02359877|9791208|P2|Overall Study|Adverse Event|0
2849716|NCT02359877|9791209|P1|Overall Study|Adverse Event|0
2849717|NCT02359877|9791206|P4|Overall Study|Withdrawal by Subject|2
2849718|NCT02359877|9791207|P3|Overall Study|Withdrawal by Subject|0
2849719|NCT02359877|9791208|P2|Overall Study|Withdrawal by Subject|0
2849720|NCT02359877|9791209|P1|Overall Study|Withdrawal by Subject|1
2849721|NCT02359851|9791259|P1|Overall Study|Disease progression|1
2849722|NCT02359851|9791259|P1|Overall Study|Death|1
2849723|NCT02359435|9791269|P2|Overall Study|Lost to Follow-up|4
2849724|NCT02359435|9791270|P1|Overall Study|Lost to Follow-up|4
2849725|NCT02359045|9791330|P2|Overall Study|Adverse Event|1
2849726|NCT02359045|9791331|P1|Overall Study|Adverse Event|0
2849727|NCT02359045|9791330|P2|Overall Study|Lost to Follow-up|1
2849728|NCT02359045|9791331|P1|Overall Study|Lost to Follow-up|1
2849729|NCT02359045|9791330|P2|Overall Study|Eligibility criteria not fulfilled|1
2849730|NCT02359045|9791331|P1|Overall Study|Eligibility criteria not fulfilled|3
2849731|NCT02358863|9791611|P1|Overall Study|Physician Decision|3
2849732|NCT02358668|9791618|P3|Overall Study|Withdrawal by Subject|0
2849733|NCT02358668|9791619|P2|Overall Study|Withdrawal by Subject|1
2849734|NCT02358668|9791620|P1|Overall Study|Withdrawal by Subject|0
2849735|NCT02358668|9791618|P3|Overall Study|Adverse Event|0
2849736|NCT02358668|9791619|P2|Overall Study|Adverse Event|0
2849737|NCT02358668|9791620|P1|Overall Study|Adverse Event|2
2849738|NCT02358473|9791769|P1|Overall Study|Physician Decision|2
2849739|NCT02358473|9791769|P1|Overall Study|Withdrawal by Subject|2
2849740|NCT02358473|9791769|P1|Overall Study|Adverse Event|3
2849741|NCT02358473|9791769|P1|Overall Study|Disease Progession|6
2849742|NCT02358343|9791783|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2849743|NCT02358343|9791784|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2849744|NCT02358343|9791785|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
2849745|NCT02358343|9791786|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2849746|NCT02358343|9791787|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2849747|NCT02358343|9791783|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2849748|NCT02358343|9791784|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2849749|NCT02358343|9791785|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2849750|NCT02358343|9791786|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2849751|NCT02358343|9791787|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2849752|NCT02358343|9791783|P5|Comparative Efficacy Trial / Observation|Death|0
2849753|NCT02358343|9791784|P4|Comparative Efficacy Trial / Observation|Death|0
2849754|NCT02358343|9791785|P3|Comparative Efficacy Trial / Observation|Death|2
2849755|NCT02358343|9791786|P2|Comparative Efficacy Trial / Observation|Death|0
2849756|NCT02358343|9791787|P1|Comparative Efficacy Trial / Observation|Death|0
2849757|NCT02358343|9791783|P5|Screening Intervention|Determined Ineligible|0
2849758|NCT02358343|9791784|P4|Screening Intervention|Determined Ineligible|0
2849759|NCT02358343|9791785|P3|Screening Intervention|Determined Ineligible|0
2849760|NCT02358343|9791786|P2|Screening Intervention|Determined Ineligible|6
2849761|NCT02358343|9791787|P1|Screening Intervention|Determined Ineligible|5
2849762|NCT02358343|9791783|P5|Screening Intervention|Withdrawal by Subject|0
2849763|NCT02358343|9791784|P4|Screening Intervention|Withdrawal by Subject|0
2849764|NCT02358343|9791785|P3|Screening Intervention|Withdrawal by Subject|0
2849765|NCT02358343|9791786|P2|Screening Intervention|Withdrawal by Subject|0
2849766|NCT02358343|9791787|P1|Screening Intervention|Withdrawal by Subject|1
2849767|NCT02358343|9791783|P5|Screening Intervention|Death|0
2849768|NCT02358343|9791784|P4|Screening Intervention|Death|0
2849769|NCT02358343|9791785|P3|Screening Intervention|Death|0
2849770|NCT02358343|9791786|P2|Screening Intervention|Death|2
2849771|NCT02358343|9791787|P1|Screening Intervention|Death|0
2849772|NCT02358044|9791843|P2|Overall Study|Withdrawal by Subject|4
2849773|NCT02358044|9791844|P1|Overall Study|Withdrawal by Subject|0
2849774|NCT02358044|9791843|P2|Overall Study|Physician Decision|1
2849775|NCT02358044|9791844|P1|Overall Study|Physician Decision|0
2849776|NCT02358044|9791843|P2|Overall Study|Lost to Follow-up|1
2849777|NCT02358044|9791844|P1|Overall Study|Lost to Follow-up|2
2849778|NCT02358044|9791843|P2|Overall Study|Adverse Event|1
2849779|NCT02358044|9791844|P1|Overall Study|Adverse Event|0
2849780|NCT02358031|9791863|P3|Overall Study|Ongoing in Study|33
2849781|NCT02358031|9791864|P2|Overall Study|Ongoing in Study|64
2849782|NCT02358031|9791865|P1|Overall Study|Ongoing in Study|61
2849783|NCT02358031|9791863|P3|Overall Study|Withdrawal by Subject|17
2849784|NCT02358031|9791864|P2|Overall Study|Withdrawal by Subject|12
2849785|NCT02358031|9791865|P1|Overall Study|Withdrawal by Subject|14
2849786|NCT02358031|9791863|P3|Overall Study|Lost to Follow-up|1
2849787|NCT02358031|9791864|P2|Overall Study|Lost to Follow-up|1
2849788|NCT02358031|9791865|P1|Overall Study|Lost to Follow-up|0
2849789|NCT02358031|9791863|P3|Overall Study|Death|249
2849790|NCT02358031|9791864|P2|Overall Study|Death|204
2849791|NCT02358031|9791865|P1|Overall Study|Death|226
2849792|NCT02357940|9791992|P2|Overall Study|Investigator's judgement|1
2849793|NCT02357940|9791993|P1|Overall Study|Investigator's judgement|0
2849794|NCT02357940|9791992|P2|Overall Study|Adverse Event|1
2849795|NCT02357940|9791993|P1|Overall Study|Adverse Event|0
2849796|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
2849797|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
2849798|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
2849799|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
2849800|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2849801|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2849802|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2849803|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2849804|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
2849805|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2849806|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
2849807|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2849808|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2849809|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2849810|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2849811|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2849812|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
2849813|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2849814|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2849815|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
2849816|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2849817|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
2849818|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
2849819|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2849820|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
2849821|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
2849822|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
2849823|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
2849824|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
2849825|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
2849826|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
2849827|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
2849828|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
2849829|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
2849830|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
2849831|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
2849832|NCT02357901|9792120|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
2849833|NCT02357901|9792121|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
2849834|NCT02357901|9792122|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
2849835|NCT02357901|9792123|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
2849836|NCT02357901|9792120|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2849837|NCT02357901|9792121|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2849838|NCT02357901|9792122|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2849839|NCT02357901|9792123|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
2849840|NCT02357576|9792211|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
2849841|NCT02357576|9792212|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
2849842|NCT02357576|9792211|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
2849843|NCT02357576|9792212|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
2849844|NCT02357576|9792211|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
2849845|NCT02357576|9792212|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
2849846|NCT02357576|9792211|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2849847|NCT02357576|9792212|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2849848|NCT02357576|9792211|P2|Treatment Period|Physician Decision|1
2849849|NCT02357576|9792212|P1|Treatment Period|Physician Decision|0
2849850|NCT02357576|9792211|P2|Treatment Period|Withdrawal by Subject|1
2849851|NCT02357576|9792212|P1|Treatment Period|Withdrawal by Subject|0
2849852|NCT02357459|9792253|P3|Overall Study|Job Commitments|1
2849853|NCT02357459|9792254|P2|Overall Study|Job Commitments|0
2849854|NCT02357459|9792255|P1|Overall Study|Job Commitments|0
2849855|NCT02357459|9792253|P3|Overall Study|Pre-planned Knee surgery|2
2849856|NCT02357459|9792254|P2|Overall Study|Pre-planned Knee surgery|0
2849857|NCT02357459|9792255|P1|Overall Study|Pre-planned Knee surgery|0
2849858|NCT02357459|9792253|P3|Overall Study|Incarceration|1
2849859|NCT02357459|9792254|P2|Overall Study|Incarceration|0
2849860|NCT02357459|9792255|P1|Overall Study|Incarceration|0
2849861|NCT02357459|9792253|P3|Overall Study|Instruction from PCP|0
2849862|NCT02357459|9792254|P2|Overall Study|Instruction from PCP|0
2849863|NCT02357459|9792255|P1|Overall Study|Instruction from PCP|1
2849864|NCT02357459|9792253|P3|Overall Study|Patient Relocated|0
2849865|NCT02357459|9792254|P2|Overall Study|Patient Relocated|0
2849866|NCT02357459|9792255|P1|Overall Study|Patient Relocated|2
2849867|NCT02357459|9792253|P3|Overall Study|Lack of Efficacy|4
2849868|NCT02357459|9792254|P2|Overall Study|Lack of Efficacy|4
2849869|NCT02357459|9792255|P1|Overall Study|Lack of Efficacy|7
2849870|NCT02357459|9792253|P3|Overall Study|Lost to Follow-up|0
2849871|NCT02357459|9792254|P2|Overall Study|Lost to Follow-up|3
2849872|NCT02357459|9792255|P1|Overall Study|Lost to Follow-up|1
2849873|NCT02357459|9792253|P3|Overall Study|Protocol Violation|0
2849874|NCT02357459|9792254|P2|Overall Study|Protocol Violation|1
2849875|NCT02357459|9792255|P1|Overall Study|Protocol Violation|1
2849876|NCT02357459|9792253|P3|Overall Study|Physician Decision|0
2849877|NCT02357459|9792254|P2|Overall Study|Physician Decision|2
2849878|NCT02357459|9792255|P1|Overall Study|Physician Decision|0
2849879|NCT02357459|9792253|P3|Overall Study|Withdrawal by Subject|3
2849880|NCT02357459|9792254|P2|Overall Study|Withdrawal by Subject|3
2849881|NCT02357459|9792255|P1|Overall Study|Withdrawal by Subject|5
2849882|NCT02357459|9792253|P3|Overall Study|Adverse Event|1
2849883|NCT02357459|9792254|P2|Overall Study|Adverse Event|1
2849884|NCT02357459|9792255|P1|Overall Study|Adverse Event|0
2849885|NCT02357420|9792301|P4|Overall Study|Lost to Follow-up|3
2849886|NCT02357420|9792302|P3|Overall Study|Lost to Follow-up|2
2849887|NCT02357420|9792303|P2|Overall Study|Lost to Follow-up|0
2849888|NCT02357420|9792304|P1|Overall Study|Lost to Follow-up|3
2849889|NCT02357420|9792301|P4|Overall Study|Withdrawn Consent|6
2849890|NCT02357420|9792302|P3|Overall Study|Withdrawn Consent|6
2849891|NCT02357420|9792303|P2|Overall Study|Withdrawn Consent|8
2849892|NCT02357420|9792304|P1|Overall Study|Withdrawn Consent|4
2849893|NCT02357420|9792301|P4|Overall Study|Protocol Non-compliance|1
2849894|NCT02357420|9792302|P3|Overall Study|Protocol Non-compliance|0
2849895|NCT02357420|9792303|P2|Overall Study|Protocol Non-compliance|0
2849896|NCT02357420|9792304|P1|Overall Study|Protocol Non-compliance|0
2849897|NCT02357420|9792301|P4|Overall Study|Prohibited Medication|0
2849898|NCT02357420|9792302|P3|Overall Study|Prohibited Medication|0
2849899|NCT02357420|9792303|P2|Overall Study|Prohibited Medication|1
2849900|NCT02357420|9792304|P1|Overall Study|Prohibited Medication|1
2849901|NCT02357420|9792301|P4|Overall Study|Investigator Decision|0
2849902|NCT02357420|9792302|P3|Overall Study|Investigator Decision|0
2849903|NCT02357420|9792303|P2|Overall Study|Investigator Decision|0
2849904|NCT02357420|9792304|P1|Overall Study|Investigator Decision|1
2849905|NCT02357420|9792301|P4|Overall Study|Adverse Event|9
2849906|NCT02357420|9792302|P3|Overall Study|Adverse Event|8
2849907|NCT02357420|9792303|P2|Overall Study|Adverse Event|3
2849908|NCT02357420|9792304|P1|Overall Study|Adverse Event|3
2849909|NCT02357342|9792365|P2|First 6 Months|Death|0
2849910|NCT02357342|9792366|P1|First 6 Months|Death|2
2849911|NCT02357147|9792414|P2|Maintenance Treatment Phase|Not Treated|0
2849912|NCT02357147|9792415|P1|Maintenance Treatment Phase|Not Treated|1
2849913|NCT02357147|9792414|P2|Maintenance Treatment Phase|Sponsor Decision|15
2849914|NCT02357147|9792415|P1|Maintenance Treatment Phase|Sponsor Decision|0
2849915|NCT02357147|9792414|P2|Maintenance Treatment Phase|Adverse Event|3
2849916|NCT02357147|9792415|P1|Maintenance Treatment Phase|Adverse Event|0
2849917|NCT02357147|9792414|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
2849918|NCT02357147|9792415|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
2849919|NCT02357147|9792414|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
2849920|NCT02357147|9792415|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
2849921|NCT02357147|9792414|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
2849922|NCT02357147|9792415|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
2849923|NCT02357147|9792414|P2|Combination Treatment Phase|Not treated|2
2849924|NCT02357147|9792415|P1|Combination Treatment Phase|Not treated|0
2849925|NCT02357147|9792414|P2|Combination Treatment Phase|Other|0
2849926|NCT02357147|9792415|P1|Combination Treatment Phase|Other|1
2849927|NCT02357147|9792414|P2|Combination Treatment Phase|Sponsor Decision|12
2849928|NCT02357147|9792415|P1|Combination Treatment Phase|Sponsor Decision|0
2849929|NCT02357147|9792414|P2|Combination Treatment Phase|Death|1
2849930|NCT02357147|9792415|P1|Combination Treatment Phase|Death|1
2849931|NCT02357147|9792414|P2|Combination Treatment Phase|Adverse Event|4
2849932|NCT02357147|9792415|P1|Combination Treatment Phase|Adverse Event|12
2849933|NCT02357147|9792414|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
2849934|NCT02357147|9792415|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
2849935|NCT02357147|9792414|P2|Combination Treatment Phase|Withdrawal by Subject|2
2849936|NCT02357147|9792415|P1|Combination Treatment Phase|Withdrawal by Subject|4
2849937|NCT02357147|9792414|P2|Combination Treatment Phase|Investigator Discretion|1
2849938|NCT02357147|9792415|P1|Combination Treatment Phase|Investigator Discretion|1
2849939|NCT02357147|9792414|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
2849940|NCT02357147|9792415|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
2849941|NCT02357147|9792414|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2849942|NCT02357147|9792415|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2849943|NCT02356783|9792448|P2|Overall Study|Lost to Follow-up|3
2849944|NCT02356783|9792449|P1|Overall Study|Lost to Follow-up|1
2849945|NCT02356588|9792459|P2|Overall Study|Protocol Violation|1
2849946|NCT02356588|9792460|P1|Overall Study|Protocol Violation|0
2849947|NCT02356588|9792459|P2|Overall Study|Withdrawal by Subject|0
2849948|NCT02356588|9792460|P1|Overall Study|Withdrawal by Subject|1
2849949|NCT02356588|9792459|P2|Overall Study|Adverse Event|2
2849950|NCT02356588|9792460|P1|Overall Study|Adverse Event|0
2849951|NCT02356588|9792459|P2|Overall Study|Lack of Efficacy|10
2849952|NCT02356588|9792460|P1|Overall Study|Lack of Efficacy|4
2849953|NCT02356562|9792577|P2|Overall Study|site closure|0
2849954|NCT02356562|9792578|P1|Overall Study|site closure|1
2849955|NCT02356562|9792577|P2|Overall Study|Re-entered treatment in a previous study|0
2849956|NCT02356562|9792578|P1|Overall Study|Re-entered treatment in a previous study|1
2849957|NCT02356562|9792577|P2|Overall Study|Withdrawal by Subject|1
2849958|NCT02356562|9792578|P1|Overall Study|Withdrawal by Subject|0
2849959|NCT02356211|9792607|P2|Overall Study|ineligible|8
2849960|NCT02356211|9792608|P1|Overall Study|ineligible|1
2849961|NCT02356211|9792607|P2|Overall Study|Withdrawal by Subject|2
2849962|NCT02356211|9792608|P1|Overall Study|Withdrawal by Subject|2
2849963|NCT02355743|9792672|P1|Overall Study|Lost to Follow-up|1
2849964|NCT02355743|9792672|P1|Overall Study|Withdrawal by Subject|1
2849965|NCT02355691|9792680|P2|Overall Study|Loss of Research Personnel|9
2849966|NCT02355691|9792681|P1|Overall Study|Loss of Research Personnel|7
2849967|NCT02355665|9792691|P2|Overall Study|Compliance, PI decision, move, eligible|3
2849968|NCT02355665|9792692|P1|Overall Study|Compliance, PI decision, move, eligible|6
2849969|NCT02355665|9792691|P2|Overall Study|Death|2
2849970|NCT02355665|9792692|P1|Overall Study|Death|4
2849971|NCT02355665|9792691|P2|Overall Study|Lost to Follow-up|103
2849972|NCT02355665|9792692|P1|Overall Study|Lost to Follow-up|131
2849973|NCT02355665|9792691|P2|Overall Study|Withdrawal by Subject|100
2849974|NCT02355665|9792692|P1|Overall Study|Withdrawal by Subject|90
2849975|NCT02355665|9792691|P2|Overall Study|Protocol Violation|0
2849976|NCT02355665|9792692|P1|Overall Study|Protocol Violation|2
2849977|NCT02355665|9792691|P2|Overall Study|Adverse Event|24
2849978|NCT02355665|9792692|P1|Overall Study|Adverse Event|16
2849979|NCT02355028|9793150|P2|Overall Study|Deemed ineligible after randomization|4
2849980|NCT02355028|9793151|P1|Overall Study|Deemed ineligible after randomization|8
2849981|NCT02355028|9793150|P2|Overall Study|Withdrawal by Subject|1
2849982|NCT02355028|9793151|P1|Overall Study|Withdrawal by Subject|1
2849983|NCT02355028|9793150|P2|Overall Study|Adverse Event|0
2849984|NCT02355028|9793151|P1|Overall Study|Adverse Event|2
2849985|NCT02354976|9793187|P3|Overall Study|Adverse Event|2
2849986|NCT02354976|9793188|P2|Overall Study|Adverse Event|0
2849987|NCT02354976|9793189|P1|Overall Study|Adverse Event|1
2849988|NCT02354976|9793187|P3|Overall Study|Study-specifc withdrawal criteria|0
2849989|NCT02354976|9793188|P2|Overall Study|Study-specifc withdrawal criteria|1
2849990|NCT02354976|9793189|P1|Overall Study|Study-specifc withdrawal criteria|0
2849991|NCT02354976|9793187|P3|Overall Study|Other - reason not specified|1
2849992|NCT02354976|9793188|P2|Overall Study|Other - reason not specified|0
2849993|NCT02354976|9793189|P1|Overall Study|Other - reason not specified|1
2849994|NCT02354690|9793252|P1|Overall Study|Physician Decision|1
2849995|NCT02354599|9793266|P6|Overall Study|Withdrawal by Subject|0
2849996|NCT02354599|9793267|P5|Overall Study|Withdrawal by Subject|0
2849997|NCT02354599|9793268|P4|Overall Study|Withdrawal by Subject|0
2849998|NCT02354599|9793269|P3|Overall Study|Withdrawal by Subject|0
2849999|NCT02354599|9793270|P2|Overall Study|Withdrawal by Subject|1
2850000|NCT02354599|9793271|P1|Overall Study|Withdrawal by Subject|1
2850001|NCT02354599|9793266|P6|Overall Study|Pretreatment Event/Adverse Event|1
2850002|NCT02354599|9793267|P5|Overall Study|Pretreatment Event/Adverse Event|0
2850003|NCT02354599|9793268|P4|Overall Study|Pretreatment Event/Adverse Event|0
2850004|NCT02354599|9793269|P3|Overall Study|Pretreatment Event/Adverse Event|0
2850005|NCT02354599|9793270|P2|Overall Study|Pretreatment Event/Adverse Event|0
2850006|NCT02354599|9793271|P1|Overall Study|Pretreatment Event/Adverse Event|0
2850007|NCT02354586|9793341|P1|Overall Study|Disease progression|116
2850008|NCT02354586|9793341|P1|Overall Study|Lost to Follow-up|6
2850009|NCT02354586|9793341|P1|Overall Study|Withdrawal by Subject|51
2850010|NCT02354586|9793341|P1|Overall Study|Death|168
2850011|NCT02354508|9793360|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
2850012|NCT02354508|9793361|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
2850013|NCT02354508|9793362|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
2850014|NCT02354508|9793360|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2850015|NCT02354508|9793361|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
2850016|NCT02354508|9793362|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2850017|NCT02354508|9793360|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2850018|NCT02354508|9793361|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2850019|NCT02354508|9793362|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
2850020|NCT02354508|9793360|P3|Period 2: Extension Phase|Physician Decision|1
2850021|NCT02354508|9793361|P2|Period 2: Extension Phase|Physician Decision|0
2850022|NCT02354508|9793362|P1|Period 2: Extension Phase|Physician Decision|5
2850023|NCT02354508|9793360|P3|Period 2: Extension Phase|Withdrawal by Subject|0
2850024|NCT02354508|9793361|P2|Period 2: Extension Phase|Withdrawal by Subject|1
2850025|NCT02354508|9793362|P1|Period 2: Extension Phase|Withdrawal by Subject|0
2850026|NCT02354508|9793360|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
2850027|NCT02354508|9793361|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
2850028|NCT02354508|9793362|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
2850029|NCT02354508|9793360|P3|Period 1: Core Phase|Withdrawal by Subject|2
2850030|NCT02354508|9793361|P2|Period 1: Core Phase|Withdrawal by Subject|1
2850031|NCT02354508|9793362|P1|Period 1: Core Phase|Withdrawal by Subject|0
2850032|NCT02354508|9793360|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
2850033|NCT02354508|9793361|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
2850034|NCT02354508|9793362|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
2850035|NCT02354508|9793360|P3|Period 1: Core Phase|Adverse Event|2
2850036|NCT02354508|9793361|P2|Period 1: Core Phase|Adverse Event|1
2850037|NCT02354508|9793362|P1|Period 1: Core Phase|Adverse Event|1
2850038|NCT02354417|9793464|P1|Overall Study|Physician Decision|1
2850039|NCT02354235|9793490|P2|Overall Study|Conflict with the stopping criteria|1
2850040|NCT02354235|9793491|P1|Overall Study|Conflict with the stopping criteria|0
2850041|NCT02354235|9793490|P2|Overall Study|Withdrawal by Subject|3
2850042|NCT02354235|9793491|P1|Overall Study|Withdrawal by Subject|1
2850043|NCT02354235|9793490|P2|Overall Study|Physician Decision|1
2850044|NCT02354235|9793491|P1|Overall Study|Physician Decision|0
2850045|NCT02354235|9793490|P2|Overall Study|Adverse Event|2
2850046|NCT02354235|9793491|P1|Overall Study|Adverse Event|2
2850047|NCT02354222|9793507|P2|Overall Study|Conflict with the stopping criteria|4
2850048|NCT02354222|9793508|P1|Overall Study|Conflict with the stopping criteria|0
2850049|NCT02354222|9793507|P2|Overall Study|Withdrawal by Subject|3
2850050|NCT02354222|9793508|P1|Overall Study|Withdrawal by Subject|2
2850051|NCT02354222|9793507|P2|Overall Study|Pregnancy|0
2850052|NCT02354222|9793508|P1|Overall Study|Pregnancy|1
2850053|NCT02354222|9793507|P2|Overall Study|Physician Decision|1
2850054|NCT02354222|9793508|P1|Overall Study|Physician Decision|1
2850055|NCT02354222|9793507|P2|Overall Study|Adverse Event|3
2850056|NCT02354222|9793508|P1|Overall Study|Adverse Event|0
2850057|NCT02353871|9793539|P2|Overall Study|Lost to Follow-up|0
2850058|NCT02353871|9793540|P1|Overall Study|Lost to Follow-up|2
2850059|NCT02353871|9793539|P2|Overall Study|Consent withdrawn|8
2850060|NCT02353871|9793540|P1|Overall Study|Consent withdrawn|1
2850061|NCT02353871|9793539|P2|Overall Study|Protocol deviation|1
2850062|NCT02353871|9793540|P1|Overall Study|Protocol deviation|0
2850063|NCT02353572|9793593|P1|Overall Study|Study terminated|2
2850064|NCT02353572|9793593|P1|Overall Study|Withdrawal by Subject|1
2850065|NCT02353468|9793597|P1|Overall Study|Study terminated|3
2850066|NCT02353442|9793603|P2|Overall Study|Withdrawal by Subject|4
2850067|NCT02353442|9793604|P1|Overall Study|Withdrawal by Subject|3
2850068|NCT02353169|9793659|P4|Overall Study|Pre-op medication|0
2850069|NCT02353169|9793660|P3|Overall Study|Pre-op medication|1
2850070|NCT02353169|9793661|P2|Overall Study|Pre-op medication|0
2850071|NCT02353169|9793662|P1|Overall Study|Pre-op medication|0
2850072|NCT02353169|9793659|P4|Overall Study|ECG data error|2
2850073|NCT02353169|9793660|P3|Overall Study|ECG data error|2
2850074|NCT02353169|9793661|P2|Overall Study|ECG data error|3
2850075|NCT02353169|9793662|P1|Overall Study|ECG data error|0
2850076|NCT02353169|9793659|P4|Overall Study|Inhalational induction|0
2850077|NCT02353169|9793660|P3|Overall Study|Inhalational induction|0
2850078|NCT02353169|9793661|P2|Overall Study|Inhalational induction|2
2850079|NCT02353169|9793662|P1|Overall Study|Inhalational induction|0
2850080|NCT02353169|9793659|P4|Overall Study|OR team declined|0
2850081|NCT02353169|9793660|P3|Overall Study|OR team declined|0
2850082|NCT02353169|9793661|P2|Overall Study|OR team declined|0
2850083|NCT02353169|9793662|P1|Overall Study|OR team declined|2
2850084|NCT02353169|9793659|P4|Overall Study|QTc > 450 msec|1
2850085|NCT02353169|9793660|P3|Overall Study|QTc > 450 msec|1
2850086|NCT02353169|9793661|P2|Overall Study|QTc > 450 msec|1
2850087|NCT02353169|9793662|P1|Overall Study|QTc > 450 msec|1
2850088|NCT02352948|9793754|P6|Overall Study|Other|0
2850089|NCT02352948|9793755|P5|Overall Study|Other|0
2850090|NCT02352948|9793756|P4|Overall Study|Other|0
2850091|NCT02352948|9793757|P3|Overall Study|Other|2
2850092|NCT02352948|9793758|P2|Overall Study|Other|0
2850093|NCT02352948|9793759|P1|Overall Study|Other|0
2850094|NCT02352948|9793754|P6|Overall Study|Eligibility criteria not fulfilled|0
2850095|NCT02352948|9793755|P5|Overall Study|Eligibility criteria not fulfilled|0
2850096|NCT02352948|9793756|P4|Overall Study|Eligibility criteria not fulfilled|1
2850097|NCT02352948|9793757|P3|Overall Study|Eligibility criteria not fulfilled|0
2850098|NCT02352948|9793758|P2|Overall Study|Eligibility criteria not fulfilled|1
2850099|NCT02352948|9793759|P1|Overall Study|Eligibility criteria not fulfilled|0
2850100|NCT02352948|9793754|P6|Overall Study|Withdrawal by Subject|4
2850101|NCT02352948|9793755|P5|Overall Study|Withdrawal by Subject|9
2850102|NCT02352948|9793756|P4|Overall Study|Withdrawal by Subject|23
2850103|NCT02352948|9793757|P3|Overall Study|Withdrawal by Subject|11
2850104|NCT02352948|9793758|P2|Overall Study|Withdrawal by Subject|10
2850105|NCT02352948|9793759|P1|Overall Study|Withdrawal by Subject|1
2850106|NCT02352948|9793754|P6|Overall Study|Lost to Follow-up|1
2850107|NCT02352948|9793755|P5|Overall Study|Lost to Follow-up|2
2850108|NCT02352948|9793756|P4|Overall Study|Lost to Follow-up|1
2850109|NCT02352948|9793757|P3|Overall Study|Lost to Follow-up|2
2850110|NCT02352948|9793758|P2|Overall Study|Lost to Follow-up|0
2850111|NCT02352948|9793759|P1|Overall Study|Lost to Follow-up|1
2850112|NCT02352948|9793754|P6|Overall Study|Death|44
2850113|NCT02352948|9793755|P5|Overall Study|Death|77
2850114|NCT02352948|9793756|P4|Overall Study|Death|74
2850115|NCT02352948|9793757|P3|Overall Study|Death|114
2850116|NCT02352948|9793758|P2|Overall Study|Death|48
2850117|NCT02352948|9793759|P1|Overall Study|Death|47
2850118|NCT02352779|9793847|P3|Overall Study|No Reason|1
2850119|NCT02352779|9793848|P2|Overall Study|No Reason|0
2850120|NCT02352779|9793849|P1|Overall Study|No Reason|0
2850121|NCT02352779|9793847|P3|Overall Study|Other Medical Reason|1
2850122|NCT02352779|9793848|P2|Overall Study|Other Medical Reason|0
2850123|NCT02352779|9793849|P1|Overall Study|Other Medical Reason|0
2850124|NCT02352779|9793847|P3|Overall Study|Absence of Symptoms|0
2850125|NCT02352779|9793848|P2|Overall Study|Absence of Symptoms|0
2850126|NCT02352779|9793849|P1|Overall Study|Absence of Symptoms|1
2850127|NCT02352779|9793847|P3|Overall Study|Study Related Symptoms|0
2850128|NCT02352779|9793848|P2|Overall Study|Study Related Symptoms|0
2850129|NCT02352779|9793849|P1|Overall Study|Study Related Symptoms|1
2850130|NCT02352779|9793847|P3|Overall Study|Changed Mind|0
2850131|NCT02352779|9793848|P2|Overall Study|Changed Mind|0
2850132|NCT02352779|9793849|P1|Overall Study|Changed Mind|1
2850133|NCT02352779|9793847|P3|Overall Study|Disliked Intervention|0
2850134|NCT02352779|9793848|P2|Overall Study|Disliked Intervention|0
2850135|NCT02352779|9793849|P1|Overall Study|Disliked Intervention|1
2850136|NCT02352779|9793847|P3|Overall Study|Feeling Overwhelmed|0
2850137|NCT02352779|9793848|P2|Overall Study|Feeling Overwhelmed|0
2850138|NCT02352779|9793849|P1|Overall Study|Feeling Overwhelmed|1
2850139|NCT02352779|9793847|P3|Overall Study|Too Many Forms|0
2850140|NCT02352779|9793848|P2|Overall Study|Too Many Forms|0
2850141|NCT02352779|9793849|P1|Overall Study|Too Many Forms|2
2850142|NCT02352779|9793847|P3|Overall Study|Personal Issues|0
2850143|NCT02352779|9793848|P2|Overall Study|Personal Issues|1
2850144|NCT02352779|9793849|P1|Overall Study|Personal Issues|1
2850145|NCT02352493|9793875|P18|Overall Study|Lost to Follow-up|0
2850146|NCT02352493|9793876|P17|Overall Study|Lost to Follow-up|0
2850147|NCT02352493|9793877|P16|Overall Study|Lost to Follow-up|0
2850148|NCT02352493|9793878|P15|Overall Study|Lost to Follow-up|0
2850149|NCT02352493|9793879|P14|Overall Study|Lost to Follow-up|2
2850150|NCT02352493|9793880|P13|Overall Study|Lost to Follow-up|1
2850151|NCT02352493|9793881|P12|Overall Study|Lost to Follow-up|0
2850152|NCT02352493|9793882|P11|Overall Study|Lost to Follow-up|0
2850153|NCT02352493|9793883|P10|Overall Study|Lost to Follow-up|1
2850154|NCT02352493|9793884|P9|Overall Study|Lost to Follow-up|0
2850155|NCT02352493|9793885|P8|Overall Study|Lost to Follow-up|0
2850156|NCT02352493|9793886|P7|Overall Study|Lost to Follow-up|0
2850157|NCT02352493|9793887|P6|Overall Study|Lost to Follow-up|0
2850158|NCT02352493|9793888|P5|Overall Study|Lost to Follow-up|0
2850159|NCT02352493|9793889|P4|Overall Study|Lost to Follow-up|0
2850160|NCT02352493|9793890|P3|Overall Study|Lost to Follow-up|0
2850161|NCT02352493|9793891|P2|Overall Study|Lost to Follow-up|0
2850162|NCT02352493|9793892|P1|Overall Study|Lost to Follow-up|0
2850163|NCT02352493|9793875|P18|Overall Study|Withdrawal by Subject|0
2850164|NCT02352493|9793876|P17|Overall Study|Withdrawal by Subject|0
2850165|NCT02352493|9793877|P16|Overall Study|Withdrawal by Subject|0
2850166|NCT02352493|9793878|P15|Overall Study|Withdrawal by Subject|1
2850167|NCT02352493|9793879|P14|Overall Study|Withdrawal by Subject|0
2850168|NCT02352493|9793880|P13|Overall Study|Withdrawal by Subject|0
2850169|NCT02352493|9793881|P12|Overall Study|Withdrawal by Subject|0
2850170|NCT02352493|9793882|P11|Overall Study|Withdrawal by Subject|0
2850171|NCT02352493|9793883|P10|Overall Study|Withdrawal by Subject|0
2850172|NCT02352493|9793884|P9|Overall Study|Withdrawal by Subject|1
2850173|NCT02352493|9793885|P8|Overall Study|Withdrawal by Subject|0
2850174|NCT02352493|9793886|P7|Overall Study|Withdrawal by Subject|0
2850175|NCT02352493|9793887|P6|Overall Study|Withdrawal by Subject|0
2850176|NCT02352493|9793888|P5|Overall Study|Withdrawal by Subject|0
2850177|NCT02352493|9793889|P4|Overall Study|Withdrawal by Subject|0
2850178|NCT02352493|9793890|P3|Overall Study|Withdrawal by Subject|0
2850179|NCT02352493|9793891|P2|Overall Study|Withdrawal by Subject|0
2850180|NCT02352493|9793892|P1|Overall Study|Withdrawal by Subject|0
2850181|NCT02352493|9793875|P18|Overall Study|Pregnancy|0
2850182|NCT02352493|9793876|P17|Overall Study|Pregnancy|0
2850183|NCT02352493|9793877|P16|Overall Study|Pregnancy|0
2850184|NCT02352493|9793878|P15|Overall Study|Pregnancy|0
2850185|NCT02352493|9793879|P14|Overall Study|Pregnancy|0
2850186|NCT02352493|9793880|P13|Overall Study|Pregnancy|0
2850187|NCT02352493|9793881|P12|Overall Study|Pregnancy|0
2850188|NCT02352493|9793882|P11|Overall Study|Pregnancy|0
2850189|NCT02352493|9793883|P10|Overall Study|Pregnancy|0
2850190|NCT02352493|9793884|P9|Overall Study|Pregnancy|1
2850191|NCT02352493|9793885|P8|Overall Study|Pregnancy|0
2850192|NCT02352493|9793886|P7|Overall Study|Pregnancy|1
2850193|NCT02352493|9793887|P6|Overall Study|Pregnancy|0
2850194|NCT02352493|9793888|P5|Overall Study|Pregnancy|0
2850195|NCT02352493|9793889|P4|Overall Study|Pregnancy|0
2850196|NCT02352493|9793890|P3|Overall Study|Pregnancy|0
2850197|NCT02352493|9793891|P2|Overall Study|Pregnancy|0
2850198|NCT02352493|9793892|P1|Overall Study|Pregnancy|0
2850199|NCT02351960|9794125|P2|Overall Study|Significant Protocol Deviation|5
2850200|NCT02351960|9794126|P1|Overall Study|Significant Protocol Deviation|0
2850201|NCT02351960|9794125|P2|Overall Study|Voluntary Withdrawal|4
2850202|NCT02351960|9794126|P1|Overall Study|Voluntary Withdrawal|5
2850203|NCT02351960|9794125|P2|Overall Study|Pretreatment Event/Adverse Event|3
2850204|NCT02351960|9794126|P1|Overall Study|Pretreatment Event/Adverse Event|6
2850205|NCT02351934|9794147|P2|Follow-Up|2 ERAS Components Noncompliant|4
2850206|NCT02351934|9794148|P1|Follow-Up|2 ERAS Components Noncompliant|0
2850207|NCT02351934|9794147|P2|Follow-Up|1 ERAS Component Noncompliant|6
2850208|NCT02351934|9794148|P1|Follow-Up|1 ERAS Component Noncompliant|0
2850209|NCT02351934|9794147|P2|Follow-Up|No documentation|0
2850210|NCT02351934|9794148|P1|Follow-Up|No documentation|2
2850211|NCT02351934|9794147|P2|Follow-Up|Hypotension|0
2850212|NCT02351934|9794148|P1|Follow-Up|Hypotension|3
2850213|NCT02351934|9794147|P2|Follow-Up|Early dismissal|0
2850214|NCT02351934|9794148|P1|Follow-Up|Early dismissal|3
2850215|NCT02351934|9794147|P2|Follow-Up|Acute Kidney Injury|0
2850216|NCT02351934|9794148|P1|Follow-Up|Acute Kidney Injury|1
2850217|NCT02351934|9794147|P2|Follow-Up|POD weight<pre-op weight|0
2850218|NCT02351934|9794148|P1|Follow-Up|POD weight<pre-op weight|3
2850219|NCT02351934|9794147|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
2850220|NCT02351934|9794148|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
2850221|NCT02351934|9794147|P2|Allocation|Hypotension preventing administration|0
2850222|NCT02351934|9794148|P1|Allocation|Hypotension preventing administration|2
2850223|NCT02351934|9794147|P2|Allocation|POD weight<pre-op weight|0
2850224|NCT02351934|9794148|P1|Allocation|POD weight<pre-op weight|3
2850225|NCT02351817|9794164|P2|Period 2|Protocol Violation|0
2850226|NCT02351817|9794165|P1|Period 2|Protocol Violation|1
2850227|NCT02351817|9794164|P2|Period 2|Adverse Event|2
2850228|NCT02351817|9794165|P1|Period 2|Adverse Event|0
2850229|NCT02351817|9794164|P2|Period 1|Lack of Efficacy|1
2850230|NCT02351817|9794165|P1|Period 1|Lack of Efficacy|0
2850231|NCT02351817|9794164|P2|Period 1|Adverse Event|2
2850232|NCT02351817|9794165|P1|Period 1|Adverse Event|1
2850233|NCT02351167|9794226|P3|Overall Study|Withdrawal by Subject|21
2850234|NCT02351167|9794227|P2|Overall Study|Withdrawal by Subject|18
2850235|NCT02351167|9794228|P1|Overall Study|Withdrawal by Subject|19
2850236|NCT02350478|9794384|P2|Overall Study|Lost to Follow-up|1
2850237|NCT02350478|9794385|P1|Overall Study|Lost to Follow-up|5
2850238|NCT02350309|9794407|P6|Treatment Period 4 (2 Days)|Death in the Family|1
2850239|NCT02350309|9794408|P5|Treatment Period 4 (2 Days)|Death in the Family|0
2850240|NCT02350309|9794409|P4|Treatment Period 4 (2 Days)|Death in the Family|0
2850241|NCT02350309|9794410|P3|Treatment Period 4 (2 Days)|Death in the Family|0
2850242|NCT02350309|9794411|P2|Treatment Period 4 (2 Days)|Death in the Family|0
2850243|NCT02350309|9794412|P1|Treatment Period 4 (2 Days)|Death in the Family|0
2850244|NCT02350309|9794407|P6|Treatment Period 1 (2 Days)|Physician Decision|0
2850245|NCT02350309|9794408|P5|Treatment Period 1 (2 Days)|Physician Decision|0
2850246|NCT02350309|9794409|P4|Treatment Period 1 (2 Days)|Physician Decision|0
2850247|NCT02350309|9794410|P3|Treatment Period 1 (2 Days)|Physician Decision|1
2850248|NCT02350309|9794411|P2|Treatment Period 1 (2 Days)|Physician Decision|0
2850249|NCT02350309|9794412|P1|Treatment Period 1 (2 Days)|Physician Decision|0
2850250|NCT02349789|9794451|P1|Overall Study|Withdrawal by Subject|2
2850251|NCT02349711|9794462|P2|Overall Study|Lost to Follow-up|1
2850252|NCT02349711|9794463|P1|Overall Study|Lost to Follow-up|1
2850253|NCT02349711|9794462|P2|Overall Study|Withdrawal by Subject|1
2850254|NCT02349711|9794463|P1|Overall Study|Withdrawal by Subject|2
2850255|NCT02349542|9794496|P1|Overall Study|Withdrawal by Subject|5
2850256|NCT02349451|9794520|P4|Overall Study|Withdrawal by Subject|1
2850257|NCT02349451|9794521|P3|Overall Study|Withdrawal by Subject|2
2850258|NCT02349451|9794522|P2|Overall Study|Withdrawal by Subject|1
2850259|NCT02349451|9794523|P1|Overall Study|Withdrawal by Subject|0
2850260|NCT02349412|9794572|P2|Overall Study|Withdrawal by Subject|7
2850261|NCT02349412|9794573|P1|Overall Study|Withdrawal by Subject|7
2850262|NCT02349360|9794589|P2|Overall Study|Withdrawal by Subject|1
2850263|NCT02349360|9794590|P1|Overall Study|Withdrawal by Subject|0
2850264|NCT02349295|9794601|P5|IR (Week 16-24)|Lack of Efficacy|1
2850265|NCT02349295|9794602|P4|IR (Week 16-24)|Lack of Efficacy|0
2850266|NCT02349295|9794603|P3|IR (Week 16-24)|Lack of Efficacy|0
2850267|NCT02349295|9794604|P2|IR (Week 16-24)|Lack of Efficacy|0
2850268|NCT02349295|9794605|P1|IR (Week 16-24)|Lack of Efficacy|0
2850269|NCT02349295|9794601|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2850270|NCT02349295|9794602|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2850271|NCT02349295|9794603|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2850272|NCT02349295|9794604|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2850273|NCT02349295|9794605|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2850274|NCT02349295|9794601|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2850275|NCT02349295|9794602|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2850276|NCT02349295|9794603|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2850277|NCT02349295|9794604|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2850278|NCT02349295|9794605|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
2850279|NCT02349295|9794601|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2850280|NCT02349295|9794602|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2850281|NCT02349295|9794603|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2850282|NCT02349295|9794604|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2850283|NCT02349295|9794605|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
2850284|NCT02349295|9794601|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2850285|NCT02349295|9794602|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2850286|NCT02349295|9794603|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
2850287|NCT02349295|9794604|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
2850288|NCT02349295|9794605|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
2850289|NCT02349295|9794601|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
2850290|NCT02349295|9794602|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
2850291|NCT02349295|9794603|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
2850292|NCT02349295|9794604|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
2850293|NCT02349295|9794605|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
2850294|NCT02349061|9794724|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
2850295|NCT02349061|9794725|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
2850296|NCT02349061|9794726|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
2850297|NCT02349061|9794724|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
2850298|NCT02349061|9794725|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
2850299|NCT02349061|9794726|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
2850300|NCT02349061|9794724|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
2850301|NCT02349061|9794725|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2850302|NCT02349061|9794726|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2850303|NCT02349061|9794724|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
2850304|NCT02349061|9794725|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
2850305|NCT02349061|9794726|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
2850306|NCT02349061|9794724|P3|Main Study: Week 24 to 56|Physician Decision|1
2850307|NCT02349061|9794725|P2|Main Study: Week 24 to 56|Physician Decision|0
2850308|NCT02349061|9794726|P1|Main Study: Week 24 to 56|Physician Decision|0
2850309|NCT02349061|9794724|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
2850310|NCT02349061|9794725|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
2850311|NCT02349061|9794726|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
2850312|NCT02349061|9794724|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
2850313|NCT02349061|9794725|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
2850314|NCT02349061|9794726|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
2850315|NCT02349061|9794724|P3|Main Study: Week 24 to 56|Adverse Event|1
2850316|NCT02349061|9794725|P2|Main Study: Week 24 to 56|Adverse Event|2
2850317|NCT02349061|9794726|P1|Main Study: Week 24 to 56|Adverse Event|0
2850318|NCT02349061|9794724|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2850319|NCT02349061|9794725|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2850320|NCT02349061|9794726|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
2850321|NCT02349061|9794724|P3|Main Study: PCP (Up to Week 24)|Other|0
2850322|NCT02349061|9794725|P2|Main Study: PCP (Up to Week 24)|Other|1
2850323|NCT02349061|9794726|P1|Main Study: PCP (Up to Week 24)|Other|1
2850324|NCT02349061|9794724|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
2850325|NCT02349061|9794725|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
2850326|NCT02349061|9794726|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
2850327|NCT02349061|9794724|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2850328|NCT02349061|9794725|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2850329|NCT02349061|9794726|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
2850330|NCT02349061|9794724|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
2850331|NCT02349061|9794725|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
2850332|NCT02349061|9794726|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
2850333|NCT02349048|9794746|P2|Overall Study|Lost to Follow-up|0
2850334|NCT02349048|9794747|P1|Overall Study|Lost to Follow-up|1
2850335|NCT02349048|9794746|P2|Overall Study|Withdrawal by Subject|0
2850336|NCT02349048|9794747|P1|Overall Study|Withdrawal by Subject|4
2850337|NCT02348840|9794808|P4|Overall Study|Withdrawal by Subject|0
2850338|NCT02348840|9794809|P3|Overall Study|Withdrawal by Subject|0
2850339|NCT02348840|9794810|P2|Overall Study|Withdrawal by Subject|1
2850340|NCT02348840|9794811|P1|Overall Study|Withdrawal by Subject|2
2850341|NCT02348723|9794825|P2|Overall Study|Adverse Event|1
2850342|NCT02348723|9794826|P1|Overall Study|Adverse Event|3
2850343|NCT02348723|9794825|P2|Overall Study|Reason other than specified|1
2850344|NCT02348723|9794826|P1|Overall Study|Reason other than specified|1
2850345|NCT02348723|9794825|P2|Overall Study|Consent withdrawn|3
2850346|NCT02348723|9794826|P1|Overall Study|Consent withdrawn|1
2850347|NCT02348723|9794825|P2|Overall Study|Lost to Follow-up|1
2850348|NCT02348723|9794826|P1|Overall Study|Lost to Follow-up|1
2850349|NCT02348723|9794825|P2|Overall Study|Non-compliant with Protocol|0
2850350|NCT02348723|9794826|P1|Overall Study|Non-compliant with Protocol|1
2850351|NCT02348723|9794825|P2|Overall Study|No ablation|20
2850352|NCT02348723|9794826|P1|Overall Study|No ablation|21
2850353|NCT02347943|9795053|P3|Overall Study|Study was cancelled|45
2850354|NCT02347943|9795054|P2|Overall Study|Study was cancelled|67
2850355|NCT02347943|9795055|P1|Overall Study|Study was cancelled|140
2850356|NCT02347787|9795065|P2|9 Month Follow-Up|Withdrawal by Subject|12
2850357|NCT02347787|9795066|P1|9 Month Follow-Up|Withdrawal by Subject|9
2850358|NCT02347787|9795065|P2|9 Month Follow-Up|Lost to Follow-up|59
2850359|NCT02347787|9795066|P1|9 Month Follow-Up|Lost to Follow-up|52
2850360|NCT02347787|9795065|P2|6 Month Follow-Up|Withdrawal by Subject|9
2850361|NCT02347787|9795066|P1|6 Month Follow-Up|Withdrawal by Subject|3
2850362|NCT02347787|9795065|P2|6 Month Follow-Up|Lost to Follow-up|47
2850363|NCT02347787|9795066|P1|6 Month Follow-Up|Lost to Follow-up|63
2850364|NCT02347774|9795128|P3|On Study Treatment|ranomized in error|1
2850365|NCT02347774|9795129|P2|On Study Treatment|ranomized in error|0
2850366|NCT02347774|9795130|P1|On Study Treatment|ranomized in error|0
2850367|NCT02347774|9795128|P3|On Study Treatment|Met Prolonged QT criteria|0
2850368|NCT02347774|9795129|P2|On Study Treatment|Met Prolonged QT criteria|0
2850369|NCT02347774|9795130|P1|On Study Treatment|Met Prolonged QT criteria|1
2850370|NCT02347774|9795128|P3|On Study Treatment|Lost to Follow-up|1
2850371|NCT02347774|9795129|P2|On Study Treatment|Lost to Follow-up|6
2850372|NCT02347774|9795130|P1|On Study Treatment|Lost to Follow-up|2
2850373|NCT02347774|9795128|P3|On Study Treatment|withdrew consent|12
2850374|NCT02347774|9795129|P2|On Study Treatment|withdrew consent|8
2850375|NCT02347774|9795130|P1|On Study Treatment|withdrew consent|9
2850376|NCT02347774|9795128|P3|On Study Treatment|Protocol Violation|1
2850377|NCT02347774|9795129|P2|On Study Treatment|Protocol Violation|0
2850378|NCT02347774|9795130|P1|On Study Treatment|Protocol Violation|0
2850379|NCT02347774|9795128|P3|On Study Treatment|non-complicance with study medication|0
2850380|NCT02347774|9795129|P2|On Study Treatment|non-complicance with study medication|2
2850381|NCT02347774|9795130|P1|On Study Treatment|non-complicance with study medication|0
2850382|NCT02347774|9795128|P3|On Study Treatment|Lack of Efficacy|2
2850383|NCT02347774|9795129|P2|On Study Treatment|Lack of Efficacy|0
2850384|NCT02347774|9795130|P1|On Study Treatment|Lack of Efficacy|3
2850385|NCT02347774|9795128|P3|On Study Treatment|Adverse Event|19
2850386|NCT02347774|9795129|P2|On Study Treatment|Adverse Event|15
2850387|NCT02347774|9795130|P1|On Study Treatment|Adverse Event|9
2850388|NCT02347774|9795128|P3|Study Participation|randomized in error|1
2850389|NCT02347774|9795129|P2|Study Participation|randomized in error|0
2850390|NCT02347774|9795130|P1|Study Participation|randomized in error|0
2850391|NCT02347774|9795128|P3|Study Participation|incarceration|0
2850392|NCT02347774|9795129|P2|Study Participation|incarceration|0
2850393|NCT02347774|9795130|P1|Study Participation|incarceration|1
2850394|NCT02347774|9795128|P3|Study Participation|non-compliance with study drug|0
2850395|NCT02347774|9795129|P2|Study Participation|non-compliance with study drug|1
2850396|NCT02347774|9795130|P1|Study Participation|non-compliance with study drug|0
2850397|NCT02347774|9795128|P3|Study Participation|Met Prolonged QT criteria|0
2850398|NCT02347774|9795129|P2|Study Participation|Met Prolonged QT criteria|0
2850399|NCT02347774|9795130|P1|Study Participation|Met Prolonged QT criteria|1
2850400|NCT02347774|9795128|P3|Study Participation|withdrew consent|1
2850401|NCT02347774|9795129|P2|Study Participation|withdrew consent|1
2850402|NCT02347774|9795130|P1|Study Participation|withdrew consent|1
2850403|NCT02347774|9795128|P3|Study Participation|Adverse Event|6
2850404|NCT02347774|9795129|P2|Study Participation|Adverse Event|4
2850405|NCT02347774|9795130|P1|Study Participation|Adverse Event|1
2850406|NCT02347774|9795128|P3|Study Participation|Withdrawal by Subject|15
2850407|NCT02347774|9795129|P2|Study Participation|Withdrawal by Subject|9
2850408|NCT02347774|9795130|P1|Study Participation|Withdrawal by Subject|8
2850409|NCT02347774|9795128|P3|Study Participation|Lost to Follow-up|2
2850410|NCT02347774|9795129|P2|Study Participation|Lost to Follow-up|6
2850411|NCT02347774|9795130|P1|Study Participation|Lost to Follow-up|3
2850412|NCT02347761|9795186|P3|On Study Treatment|Adverse Event|20
2850413|NCT02347761|9795187|P2|On Study Treatment|Adverse Event|8
2850414|NCT02347761|9795188|P1|On Study Treatment|Adverse Event|10
2850415|NCT02347761|9795186|P3|On Study Treatment|durg not working|1
2850416|NCT02347761|9795187|P2|On Study Treatment|durg not working|1
2850417|NCT02347761|9795188|P1|On Study Treatment|durg not working|0
2850418|NCT02347761|9795186|P3|On Study Treatment|investigator discretion|0
2850419|NCT02347761|9795187|P2|On Study Treatment|investigator discretion|0
2850420|NCT02347761|9795188|P1|On Study Treatment|investigator discretion|2
2850421|NCT02347761|9795186|P3|On Study Treatment|Lost to Follow-up|1
2850422|NCT02347761|9795187|P2|On Study Treatment|Lost to Follow-up|1
2850423|NCT02347761|9795188|P1|On Study Treatment|Lost to Follow-up|2
2850424|NCT02347761|9795186|P3|On Study Treatment|dissastisfaction with device|4
2850425|NCT02347761|9795187|P2|On Study Treatment|dissastisfaction with device|1
2850426|NCT02347761|9795188|P1|On Study Treatment|dissastisfaction with device|2
2850427|NCT02347761|9795186|P3|On Study Treatment|move/travel|5
2850428|NCT02347761|9795187|P2|On Study Treatment|move/travel|6
2850429|NCT02347761|9795188|P1|On Study Treatment|move/travel|2
2850430|NCT02347761|9795186|P3|On Study Treatment|Withdrawal by Subject|5
2850431|NCT02347761|9795187|P2|On Study Treatment|Withdrawal by Subject|3
2850432|NCT02347761|9795188|P1|On Study Treatment|Withdrawal by Subject|7
2850433|NCT02347761|9795186|P3|On Study Treatment|non-compliance with study medication|2
2850434|NCT02347761|9795187|P2|On Study Treatment|non-compliance with study medication|0
2850435|NCT02347761|9795188|P1|On Study Treatment|non-compliance with study medication|0
2850436|NCT02347761|9795186|P3|On Study Treatment|Lack of Efficacy|4
2850437|NCT02347761|9795187|P2|On Study Treatment|Lack of Efficacy|3
2850438|NCT02347761|9795188|P1|On Study Treatment|Lack of Efficacy|2
2850439|NCT02347761|9795186|P3|All Collected|moved/travel|0
2850440|NCT02347761|9795187|P2|All Collected|moved/travel|1
2850441|NCT02347761|9795188|P1|All Collected|moved/travel|0
2850442|NCT02347761|9795186|P3|All Collected|exacerbation of COPD|1
2850443|NCT02347761|9795187|P2|All Collected|exacerbation of COPD|0
2850444|NCT02347761|9795188|P1|All Collected|exacerbation of COPD|0
2850445|NCT02347761|9795186|P3|All Collected|instillation site pain|1
2850446|NCT02347761|9795187|P2|All Collected|instillation site pain|0
2850447|NCT02347761|9795188|P1|All Collected|instillation site pain|0
2850448|NCT02347761|9795186|P3|All Collected|invetigator disretion|0
2850449|NCT02347761|9795187|P2|All Collected|invetigator disretion|0
2850450|NCT02347761|9795188|P1|All Collected|invetigator disretion|2
2850451|NCT02347761|9795186|P3|All Collected|Withdrawal by Subject|22
2850452|NCT02347761|9795187|P2|All Collected|Withdrawal by Subject|11
2850453|NCT02347761|9795188|P1|All Collected|Withdrawal by Subject|11
2850454|NCT02347761|9795186|P3|All Collected|Lost to Follow-up|3
2850455|NCT02347761|9795187|P2|All Collected|Lost to Follow-up|2
2850456|NCT02347761|9795188|P1|All Collected|Lost to Follow-up|3
2850457|NCT02347761|9795186|P3|All Collected|Death|0
2850458|NCT02347761|9795187|P2|All Collected|Death|0
2850459|NCT02347761|9795188|P1|All Collected|Death|1
2850460|NCT02347657|9795249|P2|Overall Study|Other|3
2850461|NCT02347657|9795250|P1|Overall Study|Other|3
2850462|NCT02347657|9795249|P2|Overall Study|Randomized but not treated|0
2850463|NCT02347657|9795250|P1|Overall Study|Randomized but not treated|1
2850464|NCT02347657|9795249|P2|Overall Study|Withdrawal by Subject|7
2850465|NCT02347657|9795250|P1|Overall Study|Withdrawal by Subject|6
2850466|NCT02347657|9795249|P2|Overall Study|Adverse Event|4
2850467|NCT02347657|9795250|P1|Overall Study|Adverse Event|8
2850468|NCT02347657|9795249|P2|Overall Study|Physician Decision|1
2850469|NCT02347657|9795250|P1|Overall Study|Physician Decision|0
2850470|NCT02347332|9795328|P2|Overall Study|Switch Post-Trial program|1
2850471|NCT02347332|9795329|P1|Overall Study|Switch Post-Trial program|0
2850472|NCT02347332|9795328|P2|Overall Study|Protocol requirement|1
2850473|NCT02347332|9795329|P1|Overall Study|Protocol requirement|1
2850474|NCT02347332|9795328|P2|Overall Study|Withdrawal by Subject|14
2850475|NCT02347332|9795329|P1|Overall Study|Withdrawal by Subject|20
2850476|NCT02347332|9795328|P2|Overall Study|Physician Decision|3
2850477|NCT02347332|9795329|P1|Overall Study|Physician Decision|4
2850478|NCT02347332|9795328|P2|Overall Study|Lost to Follow-up|1
2850479|NCT02347332|9795329|P1|Overall Study|Lost to Follow-up|2
2850480|NCT02347332|9795328|P2|Overall Study|Protocol Violation|1
2850481|NCT02347332|9795329|P1|Overall Study|Protocol Violation|1
2850482|NCT02347332|9795328|P2|Overall Study|Death (Unknown, Various reasons)|6
2850483|NCT02347332|9795329|P1|Overall Study|Death (Unknown, Various reasons)|6
2850484|NCT02347332|9795328|P2|Overall Study|Adverse Event|41
2850485|NCT02347332|9795329|P1|Overall Study|Adverse Event|50
2850486|NCT02347332|9795328|P2|Overall Study|Progressive disease|159
2850487|NCT02347332|9795329|P1|Overall Study|Progressive disease|141
2850488|NCT02347332|9795328|P2|Overall Study|Not treated|2
2850489|NCT02347332|9795329|P1|Overall Study|Not treated|5
2850490|NCT02347189|9795343|P1|Overall Study|No primary outcome data available|2
2850491|NCT02347189|9795343|P1|Overall Study|No implant attempted of study device|9
2850492|NCT02347176|9795362|P4|Overall Study|Other|0
2850493|NCT02347176|9795363|P3|Overall Study|Other|2
2850494|NCT02347176|9795364|P2|Overall Study|Other|2
2850495|NCT02347176|9795365|P1|Overall Study|Other|1
2850496|NCT02347176|9795362|P4|Overall Study|Withdrawal by Subject|3
2850497|NCT02347176|9795363|P3|Overall Study|Withdrawal by Subject|5
2850498|NCT02347176|9795364|P2|Overall Study|Withdrawal by Subject|5
2850499|NCT02347176|9795365|P1|Overall Study|Withdrawal by Subject|9
2850500|NCT02347176|9795362|P4|Overall Study|Lost to Follow-up|1
2850501|NCT02347176|9795363|P3|Overall Study|Lost to Follow-up|1
2850502|NCT02347176|9795364|P2|Overall Study|Lost to Follow-up|3
2850503|NCT02347176|9795365|P1|Overall Study|Lost to Follow-up|2
2850504|NCT02347098|9795450|P2|Overall Study|no visit due to illness|1
2850505|NCT02347098|9795451|P1|Overall Study|no visit due to illness|2
2850506|NCT02347098|9795450|P2|Overall Study|Refuse Follow-up Visit|5
2850507|NCT02347098|9795451|P1|Overall Study|Refuse Follow-up Visit|1
2850508|NCT02347098|9795450|P2|Overall Study|Lost to Follow-up|2
2850509|NCT02347098|9795451|P1|Overall Study|Lost to Follow-up|2
2850510|NCT02347098|9795450|P2|Overall Study|Withdrawal by Subject|0
2850511|NCT02347098|9795451|P1|Overall Study|Withdrawal by Subject|1
2850512|NCT02347098|9795450|P2|Overall Study|Death|0
2850513|NCT02347098|9795451|P1|Overall Study|Death|1
2850514|NCT02347085|9795463|P1|Overall Study|Protocol Criteria|2
2850515|NCT02347085|9795463|P1|Overall Study|Lost to Follow-up|1
2850516|NCT02347085|9795463|P1|Overall Study|Withdrawal by Subject|4
2850517|NCT02347085|9795463|P1|Overall Study|Lack of Efficacy|1
2850518|NCT02347085|9795463|P1|Overall Study|Adverse Event|2
2850519|NCT02347072|9795485|P1|Overall Study|Disc due to Protocol-specified Criteria|6
2850520|NCT02347072|9795485|P1|Overall Study|Protocol Violation|1
2850521|NCT02347072|9795485|P1|Overall Study|Lost to Follow-up|2
2850522|NCT02347072|9795485|P1|Overall Study|Physician Decision|1
2850523|NCT02347072|9795485|P1|Overall Study|Withdrawal by Subject|6
2850524|NCT02347072|9795485|P1|Overall Study|Adverse Event|2
2850525|NCT02346877|9795519|P2|Overall Study|Missing|0
2850526|NCT02346877|9795520|P1|Overall Study|Missing|5
2850527|NCT02346877|9795519|P2|Overall Study|Sponsor Decision|0
2850528|NCT02346877|9795520|P1|Overall Study|Sponsor Decision|12
2850529|NCT02346877|9795519|P2|Overall Study|Administrative Decision|0
2850530|NCT02346877|9795520|P1|Overall Study|Administrative Decision|1
2850531|NCT02346877|9795519|P2|Overall Study|Adverse Event|0
2850532|NCT02346877|9795520|P1|Overall Study|Adverse Event|1
2850533|NCT02346721|9795530|P1|Overall Study|Lack of Efficacy|1
2850534|NCT02346721|9795530|P1|Overall Study|Withdrew Consent|3
2850535|NCT02346370|9795569|P3|Overall Study|Physician Decision|0
2850536|NCT02346370|9795570|P2|Overall Study|Physician Decision|1
2850537|NCT02346370|9795571|P1|Overall Study|Physician Decision|0
2850538|NCT02346370|9795569|P3|Overall Study|Radiologic progression|1
2850539|NCT02346370|9795570|P2|Overall Study|Radiologic progression|0
2850540|NCT02346370|9795571|P1|Overall Study|Radiologic progression|0
2850541|NCT02346370|9795569|P3|Overall Study|Sponsor discontinued study|2
2850542|NCT02346370|9795570|P2|Overall Study|Sponsor discontinued study|0
2850543|NCT02346370|9795571|P1|Overall Study|Sponsor discontinued study|5
2850544|NCT02346370|9795569|P3|Overall Study|Death|1
2850545|NCT02346370|9795570|P2|Overall Study|Death|3
2850546|NCT02346370|9795571|P1|Overall Study|Death|1
2850547|NCT02346370|9795569|P3|Overall Study|Withdrawal of consent|0
2850548|NCT02346370|9795570|P2|Overall Study|Withdrawal of consent|0
2850549|NCT02346370|9795571|P1|Overall Study|Withdrawal of consent|1
2850550|NCT02346370|9795569|P3|Overall Study|Not treated|0
2850551|NCT02346370|9795570|P2|Overall Study|Not treated|0
2850552|NCT02346370|9795571|P1|Overall Study|Not treated|1
2850553|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850554|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850555|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850556|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850557|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850558|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
2850559|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850560|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850561|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850562|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850563|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850564|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850565|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850566|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850567|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850568|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850569|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850570|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850571|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850572|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2851261|NCT02345226|9795944|P2|Double-Blind Phase|Lack of Efficacy|0
2850573|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850574|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850575|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850576|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2850577|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
2850578|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2850579|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
2850580|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850581|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850582|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2850583|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850584|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850585|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850586|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850587|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850588|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850589|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850590|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850591|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850592|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850593|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850594|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850595|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850596|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850597|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850598|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850599|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850600|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2850601|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2850602|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2850603|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
2850604|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850605|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2850606|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2850607|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850608|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850609|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850610|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850611|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850612|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850613|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850614|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850615|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850616|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850617|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850618|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850619|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850620|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850621|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850622|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850623|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850624|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2850625|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2850626|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2850627|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2850628|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850629|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
2850630|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2850631|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2850632|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850633|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850634|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850635|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850636|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850637|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850638|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850639|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850640|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850641|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850642|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850643|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850644|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850645|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850646|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850647|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850648|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2850649|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850650|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850651|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
2850652|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850653|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850654|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850655|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850656|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850657|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850658|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850659|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850660|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850661|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850662|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850663|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850664|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850665|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850666|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850667|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850668|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850669|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850670|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850671|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850672|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2850673|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850674|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850675|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2850676|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850677|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850678|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2850679|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850680|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850681|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850682|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850683|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850684|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850685|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850686|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850687|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850688|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850689|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850690|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850691|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850692|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850693|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850694|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850695|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850696|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2850697|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Death|0
2850698|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Death|0
2850699|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Death|1
2850700|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Death|0
2850701|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Death|1
2850702|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Death|1
2850703|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Death|0
2850704|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Death|0
2850705|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Death|0
2850706|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Death|0
2850707|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Death|0
2850708|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Death|0
2850709|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Death|0
2850710|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Death|0
2850711|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Death|0
2850712|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Death|0
2850713|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Death|0
2850714|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Death|0
2850715|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Death|0
2850716|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Death|0
2850717|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Death|0
2850718|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Death|0
2850719|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Death|0
2850720|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Death|0
2850721|NCT02346240|9795620|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2850722|NCT02346240|9795621|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2850723|NCT02346240|9795622|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
2850724|NCT02346240|9795623|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2850725|NCT02346240|9795624|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
2850726|NCT02346240|9795625|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
2850727|NCT02346240|9795626|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
2850728|NCT02346240|9795627|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850729|NCT02346240|9795628|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850730|NCT02346240|9795629|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850731|NCT02346240|9795630|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850732|NCT02346240|9795631|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850733|NCT02346240|9795632|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850734|NCT02346240|9795633|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850735|NCT02346240|9795634|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850736|NCT02346240|9795635|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850737|NCT02346240|9795636|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850738|NCT02346240|9795637|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850739|NCT02346240|9795638|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850740|NCT02346240|9795639|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850741|NCT02346240|9795640|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850742|NCT02346240|9795641|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850743|NCT02346240|9795642|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850744|NCT02346240|9795643|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2850745|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850746|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850747|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850748|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850749|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850750|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850751|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850752|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850753|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850754|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
2850755|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850756|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850757|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850758|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850759|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850760|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850761|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850762|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850763|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850764|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850765|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850766|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850767|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850768|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2850769|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850770|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850771|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850772|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850773|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850774|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850775|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850776|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850777|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850778|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
2850779|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850780|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850781|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850782|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850783|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850784|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850785|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850786|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850787|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850788|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850789|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850790|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850791|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850792|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2850793|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850794|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850795|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850796|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850797|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850798|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850799|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850800|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850801|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850802|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
2850803|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850804|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850805|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850806|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850807|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850808|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850809|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850810|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850811|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850812|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850813|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850814|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850815|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850816|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2850817|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850818|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850819|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850820|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850821|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850822|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850823|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850824|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850825|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850826|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850827|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850828|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850829|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850830|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|1
2850831|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850832|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850833|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850834|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850835|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850836|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850837|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850838|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850839|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2850840|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2851262|NCT02345226|9795945|P1|Double-Blind Phase|Lack of Efficacy|1
2850841|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850842|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850843|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850844|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850845|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850846|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850847|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850848|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850849|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850850|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850851|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850852|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850853|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850854|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850855|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
2850856|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850857|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850858|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850859|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850860|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850861|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850862|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850863|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850864|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2850865|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850866|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850867|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850868|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850869|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850870|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850871|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850872|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850873|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850874|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2850875|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2850876|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850877|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2850878|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850879|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850880|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2850881|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850882|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850883|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850884|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850885|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850886|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850887|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850888|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2850889|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850890|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850891|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850892|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850893|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850894|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850895|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850896|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850897|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850898|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850899|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850900|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850901|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850902|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850903|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850904|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850905|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850906|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
2850907|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850908|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850909|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850910|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850911|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850912|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2850913|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850914|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850915|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850916|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850917|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850918|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850919|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850920|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
2850921|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
2850922|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2850923|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2850924|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850925|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850926|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850927|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850928|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850929|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850930|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850931|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850932|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850933|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850934|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850935|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850936|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2850937|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850938|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850939|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850940|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850941|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850942|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850943|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850944|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850945|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2850946|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
2850947|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2850948|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850949|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2850950|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850951|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850952|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850953|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850954|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850955|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2850956|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850957|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850958|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850959|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850960|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2850961|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850962|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850963|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850964|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850965|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850966|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850967|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850968|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850969|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850970|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2850971|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850972|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850973|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850974|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850975|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850976|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850977|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850978|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850979|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850980|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850981|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850982|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850983|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850984|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2850985|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850986|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850987|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850988|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850989|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850990|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850991|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850992|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850993|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
2850994|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850995|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2850996|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850997|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850998|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2850999|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851000|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851001|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851002|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851003|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851004|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851005|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851006|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851007|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851008|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2851009|NCT02346240|9795620|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851010|NCT02346240|9795621|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851011|NCT02346240|9795622|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851012|NCT02346240|9795623|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851013|NCT02346240|9795624|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851014|NCT02346240|9795625|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851015|NCT02346240|9795626|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851016|NCT02346240|9795627|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2851017|NCT02346240|9795628|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2851018|NCT02346240|9795629|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2851019|NCT02346240|9795630|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2851020|NCT02346240|9795631|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851021|NCT02346240|9795632|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851022|NCT02346240|9795633|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851023|NCT02346240|9795634|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851024|NCT02346240|9795635|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2851025|NCT02346240|9795636|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2851026|NCT02346240|9795637|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851027|NCT02346240|9795638|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851028|NCT02346240|9795639|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851029|NCT02346240|9795640|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851030|NCT02346240|9795641|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851031|NCT02346240|9795642|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851032|NCT02346240|9795643|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2851033|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851034|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851035|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851036|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851037|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851038|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851263|NCT02345226|9795944|P2|Double-Blind Phase|Pregnancy|1
2851039|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851040|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851041|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851042|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851043|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851044|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851045|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851046|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851047|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851048|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851049|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851050|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851051|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851052|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851053|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851054|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
2851055|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851056|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2851057|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
2851058|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
2851059|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
2851060|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
2851061|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
2851062|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
2851063|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
2851064|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
2851065|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
2851066|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
2851067|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
2851068|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
2851069|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
2851070|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
2851071|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
2851072|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
2851073|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
2851074|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
2851075|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
2851076|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
2851077|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
2851078|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
2851079|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
2851080|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
2851081|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851082|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851083|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851084|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851085|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851086|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851087|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851088|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851089|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851090|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851091|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851092|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851093|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851094|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851095|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851096|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851097|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851098|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851099|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851100|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2851101|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2851102|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
2851103|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2851104|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
2851105|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851106|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851107|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851108|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851109|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851110|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851111|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851112|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851113|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851114|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851115|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851116|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851117|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851118|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851119|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851120|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851121|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851122|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851123|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851124|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2851125|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
2851126|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2851127|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
2851128|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2851129|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851130|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851131|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851132|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851133|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851134|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851135|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851136|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851137|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851138|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851139|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851140|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851141|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851142|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851143|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851144|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851145|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851146|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851147|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851148|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851149|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851150|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851151|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
2851152|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
2851153|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851154|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851155|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851156|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851157|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851158|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851159|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851160|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851161|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851162|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851163|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851164|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851165|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851166|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851167|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851168|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851169|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851170|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851171|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851172|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851173|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851174|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851175|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
2851176|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2851177|NCT02346240|9795620|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
2851178|NCT02346240|9795621|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
2851179|NCT02346240|9795622|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
2851180|NCT02346240|9795623|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
2851181|NCT02346240|9795624|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
2851182|NCT02346240|9795625|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
2851183|NCT02346240|9795626|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
2851184|NCT02346240|9795627|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
2851185|NCT02346240|9795628|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
2851186|NCT02346240|9795629|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
2851187|NCT02346240|9795630|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
2851188|NCT02346240|9795631|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
2851189|NCT02346240|9795632|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
2851190|NCT02346240|9795633|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
2851191|NCT02346240|9795634|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
2851192|NCT02346240|9795635|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
2851193|NCT02346240|9795636|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
2851194|NCT02346240|9795637|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
2851195|NCT02346240|9795638|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
2851196|NCT02346240|9795639|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
2851197|NCT02346240|9795640|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
2851198|NCT02346240|9795641|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
2851199|NCT02346240|9795642|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
2851200|NCT02346240|9795643|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
2851201|NCT02346136|9795682|P2|Overall Study|Study termination|18
2851202|NCT02346136|9795683|P1|Overall Study|Study termination|14
2851203|NCT02346136|9795682|P2|Overall Study|Death|0
2851204|NCT02346136|9795683|P1|Overall Study|Death|1
2851205|NCT02346136|9795682|P2|Overall Study|Withdrawal by Subject|5
2851206|NCT02346136|9795683|P1|Overall Study|Withdrawal by Subject|7
2851207|NCT02345889|9795719|P4|Overall Study|Cecum not intubated|0
2851208|NCT02345889|9795720|P3|Overall Study|Cecum not intubated|0
2851209|NCT02345889|9795721|P2|Overall Study|Cecum not intubated|0
2851210|NCT02345889|9795722|P1|Overall Study|Cecum not intubated|1
2851211|NCT02345889|9795719|P4|Overall Study|Ulcerative Colitis identified|0
2851212|NCT02345889|9795720|P3|Overall Study|Ulcerative Colitis identified|0
2851213|NCT02345889|9795721|P2|Overall Study|Ulcerative Colitis identified|0
2851214|NCT02345889|9795722|P1|Overall Study|Ulcerative Colitis identified|1
2851215|NCT02345889|9795719|P4|Overall Study|Recognized ineligible post-randomization|1
2851216|NCT02345889|9795720|P3|Overall Study|Recognized ineligible post-randomization|2
2851217|NCT02345889|9795721|P2|Overall Study|Recognized ineligible post-randomization|0
2851218|NCT02345889|9795722|P1|Overall Study|Recognized ineligible post-randomization|1
2851219|NCT02345889|9795719|P4|Overall Study|Polyposis identified during procedure|1
2851220|NCT02345889|9795720|P3|Overall Study|Polyposis identified during procedure|0
2851221|NCT02345889|9795721|P2|Overall Study|Polyposis identified during procedure|1
2851222|NCT02345889|9795722|P1|Overall Study|Polyposis identified during procedure|1
2851223|NCT02345889|9795719|P4|Overall Study|Inadequate Bowel Prep|14
2851224|NCT02345889|9795720|P3|Overall Study|Inadequate Bowel Prep|18
2851225|NCT02345889|9795721|P2|Overall Study|Inadequate Bowel Prep|16
2851226|NCT02345889|9795722|P1|Overall Study|Inadequate Bowel Prep|17
2851227|NCT02345512|9795809|P1|Overall Study|Withdrawal by Subject|1
2851228|NCT02345512|9795809|P1|Overall Study|Adverse Event|1
2851229|NCT02345330|9795903|P1|Overall Study|Progressive Disease|2
2851230|NCT02345330|9795903|P1|Overall Study|Death|1
2851231|NCT02345252|9795915|P2|Double-Blind Phase|Randomized but Never Treated|2
2851232|NCT02345252|9795916|P1|Double-Blind Phase|Randomized but Never Treated|0
2851233|NCT02345252|9795915|P2|Double-Blind Phase|Lost to Follow-up|10
2851234|NCT02345252|9795916|P1|Double-Blind Phase|Lost to Follow-up|8
2851235|NCT02345252|9795915|P2|Double-Blind Phase|Withdrew Consent|23
2851236|NCT02345252|9795916|P1|Double-Blind Phase|Withdrew Consent|21
2851237|NCT02345252|9795915|P2|Double-Blind Phase|Protocol Violation|1
2851238|NCT02345252|9795916|P1|Double-Blind Phase|Protocol Violation|2
2851239|NCT02345252|9795915|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
2851240|NCT02345252|9795916|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2851241|NCT02345252|9795915|P2|Double-Blind Phase|Investigator's Discretion|6
2851242|NCT02345252|9795916|P1|Double-Blind Phase|Investigator's Discretion|4
2851243|NCT02345252|9795915|P2|Double-Blind Phase|Lack of Efficacy|0
2851244|NCT02345252|9795916|P1|Double-Blind Phase|Lack of Efficacy|1
2851245|NCT02345252|9795915|P2|Double-Blind Phase|Death|2
2851246|NCT02345252|9795916|P1|Double-Blind Phase|Death|1
2851247|NCT02345252|9795915|P2|Double-Blind Phase|Adverse Event|3
2851248|NCT02345252|9795916|P1|Double-Blind Phase|Adverse Event|2
2851249|NCT02345226|9795944|P2|Open-Label Extension Phase|Lost to Follow-up|1
2851250|NCT02345226|9795945|P1|Open-Label Extension Phase|Lost to Follow-up|0
2851251|NCT02345226|9795944|P2|Double-Blind Phase|Randomized but Never Treated|4
2851252|NCT02345226|9795945|P1|Double-Blind Phase|Randomized but Never Treated|2
2851253|NCT02345226|9795944|P2|Double-Blind Phase|Lost to Follow-up|16
2851254|NCT02345226|9795945|P1|Double-Blind Phase|Lost to Follow-up|12
2851255|NCT02345226|9795944|P2|Double-Blind Phase|Withdrew Consent|39
2851256|NCT02345226|9795945|P1|Double-Blind Phase|Withdrew Consent|41
2851257|NCT02345226|9795944|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
2851258|NCT02345226|9795945|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2851259|NCT02345226|9795944|P2|Double-Blind Phase|Investigator's Discretion|3
2851260|NCT02345226|9795945|P1|Double-Blind Phase|Investigator's Discretion|4
2851264|NCT02345226|9795945|P1|Double-Blind Phase|Pregnancy|0
2851265|NCT02345226|9795944|P2|Double-Blind Phase|Death|0
2851266|NCT02345226|9795945|P1|Double-Blind Phase|Death|3
2851267|NCT02345226|9795944|P2|Double-Blind Phase|Adverse Event|6
2851268|NCT02345226|9795945|P1|Double-Blind Phase|Adverse Event|5
2851269|NCT02345161|9795977|P2|Overall Study|Lost to Follow-up|1
2851270|NCT02345161|9795978|P1|Overall Study|Lost to Follow-up|0
2851271|NCT02345161|9795977|P2|Overall Study|Physician Decision|4
2851272|NCT02345161|9795978|P1|Overall Study|Physician Decision|4
2851273|NCT02345161|9795977|P2|Overall Study|Adverse Event|19
2851274|NCT02345161|9795978|P1|Overall Study|Adverse Event|16
2851275|NCT02345161|9795977|P2|Overall Study|Withdrawal by Subject|33
2851276|NCT02345161|9795978|P1|Overall Study|Withdrawal by Subject|25
2851277|NCT02345070|9796083|P3|Overall Study|Other than specified above|7
2851278|NCT02345070|9796084|P2|Overall Study|Other than specified above|3
2851279|NCT02345070|9796085|P1|Overall Study|Other than specified above|6
2851280|NCT02345070|9796083|P3|Overall Study|Poor compliance to protocol|0
2851281|NCT02345070|9796084|P2|Overall Study|Poor compliance to protocol|0
2851282|NCT02345070|9796085|P1|Overall Study|Poor compliance to protocol|2
2851283|NCT02345070|9796083|P3|Overall Study|Adverse Event|16
2851284|NCT02345070|9796084|P2|Overall Study|Adverse Event|8
2851285|NCT02345070|9796085|P1|Overall Study|Adverse Event|12
2851286|NCT02344745|9796118|P2|Overall Study|Data collection sheets were lost|0
2851287|NCT02344745|9796119|P1|Overall Study|Data collection sheets were lost|2
2851288|NCT02344576|9796148|P4|6-Month Follow-Up|Lost to Follow-up|6
2851289|NCT02344576|9796149|P3|6-Month Follow-Up|Lost to Follow-up|13
2851290|NCT02344576|9796150|P2|6-Month Follow-Up|Lost to Follow-up|5
2851291|NCT02344576|9796151|P1|6-Month Follow-Up|Lost to Follow-up|4
2851292|NCT02344576|9796148|P4|6-Month Follow-Up|Withdrawal by Subject|2
2851293|NCT02344576|9796149|P3|6-Month Follow-Up|Withdrawal by Subject|1
2851294|NCT02344576|9796150|P2|6-Month Follow-Up|Withdrawal by Subject|0
2851295|NCT02344576|9796151|P1|6-Month Follow-Up|Withdrawal by Subject|1
2851296|NCT02344576|9796148|P4|6-Month Follow-Up|Death|0
2851297|NCT02344576|9796149|P3|6-Month Follow-Up|Death|0
2851298|NCT02344576|9796150|P2|6-Month Follow-Up|Death|14
2851299|NCT02344576|9796151|P1|6-Month Follow-Up|Death|14
2851300|NCT02344576|9796148|P4|1-Month Follow-Up|Lost to Follow-up|3
2851301|NCT02344576|9796149|P3|1-Month Follow-Up|Lost to Follow-up|11
2851302|NCT02344576|9796150|P2|1-Month Follow-Up|Lost to Follow-up|5
2851303|NCT02344576|9796151|P1|1-Month Follow-Up|Lost to Follow-up|2
2851304|NCT02344576|9796148|P4|1-Month Follow-Up|Withdrawal by Subject|10
2851305|NCT02344576|9796149|P3|1-Month Follow-Up|Withdrawal by Subject|8
2851306|NCT02344576|9796150|P2|1-Month Follow-Up|Withdrawal by Subject|14
2851307|NCT02344576|9796151|P1|1-Month Follow-Up|Withdrawal by Subject|3
2851308|NCT02344576|9796148|P4|1-Month Follow-Up|Death|0
2851309|NCT02344576|9796149|P3|1-Month Follow-Up|Death|0
2851310|NCT02344576|9796150|P2|1-Month Follow-Up|Death|8
2851311|NCT02344576|9796151|P1|1-Month Follow-Up|Death|13
2851312|NCT02344576|9796148|P4|Enrollment|Agreed to Medical Record Review Only|0
2851313|NCT02344576|9796149|P3|Enrollment|Agreed to Medical Record Review Only|0
2851314|NCT02344576|9796150|P2|Enrollment|Agreed to Medical Record Review Only|8
2851315|NCT02344576|9796151|P1|Enrollment|Agreed to Medical Record Review Only|7
2851316|NCT02344342|9796214|P4|Overall Study|Industry partner dropped out|10
2851317|NCT02344342|9796215|P3|Overall Study|Industry partner dropped out|14
2851318|NCT02344342|9796216|P2|Overall Study|Industry partner dropped out|9
2851319|NCT02344342|9796217|P1|Overall Study|Industry partner dropped out|11
2851320|NCT02344173|9796283|P1|12-month Visit|Lost to Follow-up|58
2851321|NCT02344173|9796283|P1|12-month Visit|Withdrawal by Subject|30
2851322|NCT02344173|9796283|P1|12-month Visit|Death|8
2851323|NCT02344173|9796283|P1|Procedure|Ablation Procedure Not Performed|7
2851324|NCT02344004|9796291|P2|Overall Study|Protocol Violation|0
2851325|NCT02344004|9796292|P1|Overall Study|Protocol Violation|1
2851326|NCT02344004|9796291|P2|Overall Study|Other Not Specified|0
2851327|NCT02344004|9796292|P1|Overall Study|Other Not Specified|12
2851328|NCT02344004|9796291|P2|Overall Study|Rescue Medication|0
2851329|NCT02344004|9796292|P1|Overall Study|Rescue Medication|2
2851330|NCT02344004|9796291|P2|Overall Study|Withdrawal by Subject|5
2851331|NCT02344004|9796292|P1|Overall Study|Withdrawal by Subject|22
2851332|NCT02344004|9796291|P2|Overall Study|Physician Decision|1
2851333|NCT02344004|9796292|P1|Overall Study|Physician Decision|4
2851334|NCT02344004|9796291|P2|Overall Study|Death|7
2851335|NCT02344004|9796292|P1|Overall Study|Death|9
2851336|NCT02344004|9796291|P2|Overall Study|Adverse Event|1
2851337|NCT02344004|9796292|P1|Overall Study|Adverse Event|11
2851338|NCT02343939|9796319|P9|Overall Study|Never Treated With ENTO|0
2851339|NCT02343939|9796320|P8|Overall Study|Never Treated With ENTO|2
2851340|NCT02343939|9796321|P7|Overall Study|Never Treated With ENTO|1
2851341|NCT02343939|9796322|P6|Overall Study|Never Treated With ENTO|0
2851342|NCT02343939|9796323|P5|Overall Study|Never Treated With ENTO|0
2851343|NCT02343939|9796324|P4|Overall Study|Never Treated With ENTO|0
2851344|NCT02343939|9796325|P3|Overall Study|Never Treated With ENTO|0
2851345|NCT02343939|9796326|P2|Overall Study|Never Treated With ENTO|0
2851346|NCT02343939|9796327|P1|Overall Study|Never Treated With ENTO|0
2851347|NCT02343939|9796319|P9|Overall Study|Adverse Event|0
2851348|NCT02343939|9796320|P8|Overall Study|Adverse Event|0
2851349|NCT02343939|9796321|P7|Overall Study|Adverse Event|0
2851350|NCT02343939|9796322|P6|Overall Study|Adverse Event|1
2851351|NCT02343939|9796323|P5|Overall Study|Adverse Event|0
2851352|NCT02343939|9796324|P4|Overall Study|Adverse Event|0
2851353|NCT02343939|9796325|P3|Overall Study|Adverse Event|0
2851354|NCT02343939|9796326|P2|Overall Study|Adverse Event|0
2851355|NCT02343939|9796327|P1|Overall Study|Adverse Event|0
2851356|NCT02343939|9796319|P9|Overall Study|Investigator's discretion|0
2851357|NCT02343939|9796320|P8|Overall Study|Investigator's discretion|0
2851358|NCT02343939|9796321|P7|Overall Study|Investigator's discretion|1
2851359|NCT02343939|9796322|P6|Overall Study|Investigator's discretion|0
2851360|NCT02343939|9796323|P5|Overall Study|Investigator's discretion|0
2851361|NCT02343939|9796324|P4|Overall Study|Investigator's discretion|1
2851362|NCT02343939|9796325|P3|Overall Study|Investigator's discretion|0
2851363|NCT02343939|9796326|P2|Overall Study|Investigator's discretion|0
2851364|NCT02343939|9796327|P1|Overall Study|Investigator's discretion|0
2851365|NCT02343939|9796319|P9|Overall Study|Treatment failure|0
2851366|NCT02343939|9796320|P8|Overall Study|Treatment failure|1
2851367|NCT02343939|9796321|P7|Overall Study|Treatment failure|2
2851368|NCT02343939|9796322|P6|Overall Study|Treatment failure|0
2851369|NCT02343939|9796323|P5|Overall Study|Treatment failure|0
2851370|NCT02343939|9796324|P4|Overall Study|Treatment failure|0
2851371|NCT02343939|9796325|P3|Overall Study|Treatment failure|0
2851372|NCT02343939|9796326|P2|Overall Study|Treatment failure|0
2851373|NCT02343939|9796327|P1|Overall Study|Treatment failure|0
2851374|NCT02343939|9796319|P9|Overall Study|Withdrew consent|6
2851375|NCT02343939|9796320|P8|Overall Study|Withdrew consent|8
2851376|NCT02343939|9796321|P7|Overall Study|Withdrew consent|0
2851377|NCT02343939|9796322|P6|Overall Study|Withdrew consent|0
2851378|NCT02343939|9796323|P5|Overall Study|Withdrew consent|2
2851379|NCT02343939|9796324|P4|Overall Study|Withdrew consent|2
2851380|NCT02343939|9796325|P3|Overall Study|Withdrew consent|1
2851381|NCT02343939|9796326|P2|Overall Study|Withdrew consent|6
2851382|NCT02343939|9796327|P1|Overall Study|Withdrew consent|3
2851383|NCT02343939|9796319|P9|Overall Study|Study terminated by sponsor|0
2851384|NCT02343939|9796320|P8|Overall Study|Study terminated by sponsor|4
2851385|NCT02343939|9796321|P7|Overall Study|Study terminated by sponsor|3
2851386|NCT02343939|9796322|P6|Overall Study|Study terminated by sponsor|5
2851387|NCT02343939|9796323|P5|Overall Study|Study terminated by sponsor|1
2851388|NCT02343939|9796324|P4|Overall Study|Study terminated by sponsor|1
2851389|NCT02343939|9796325|P3|Overall Study|Study terminated by sponsor|0
2851390|NCT02343939|9796326|P2|Overall Study|Study terminated by sponsor|27
2851391|NCT02343939|9796327|P1|Overall Study|Study terminated by sponsor|0
2851392|NCT02343939|9796319|P9|Overall Study|Death|1
2851393|NCT02343939|9796320|P8|Overall Study|Death|22
2851394|NCT02343939|9796321|P7|Overall Study|Death|8
2851395|NCT02343939|9796322|P6|Overall Study|Death|11
2851396|NCT02343939|9796323|P5|Overall Study|Death|5
2851397|NCT02343939|9796324|P4|Overall Study|Death|2
2851398|NCT02343939|9796325|P3|Overall Study|Death|4
2851399|NCT02343939|9796326|P2|Overall Study|Death|15
2851400|NCT02343939|9796327|P1|Overall Study|Death|0
2851401|NCT02343458|9796469|P4|Overall Study|Protocol Specified Criteria|8
2851402|NCT02343458|9796470|P3|Overall Study|Protocol Specified Criteria|14
2851403|NCT02343458|9796471|P2|Overall Study|Protocol Specified Criteria|13
2851404|NCT02343458|9796472|P1|Overall Study|Protocol Specified Criteria|17
2851405|NCT02343458|9796469|P4|Overall Study|Protocol Violation|2
2851406|NCT02343458|9796470|P3|Overall Study|Protocol Violation|2
2851407|NCT02343458|9796471|P2|Overall Study|Protocol Violation|5
2851408|NCT02343458|9796472|P1|Overall Study|Protocol Violation|2
2851409|NCT02343458|9796469|P4|Overall Study|Lost to Follow-up|1
2851410|NCT02343458|9796470|P3|Overall Study|Lost to Follow-up|3
2851411|NCT02343458|9796471|P2|Overall Study|Lost to Follow-up|5
2851412|NCT02343458|9796472|P1|Overall Study|Lost to Follow-up|5
2851413|NCT02343458|9796469|P4|Overall Study|Physician Decision|2
2851414|NCT02343458|9796470|P3|Overall Study|Physician Decision|2
2851415|NCT02343458|9796471|P2|Overall Study|Physician Decision|4
2851416|NCT02343458|9796472|P1|Overall Study|Physician Decision|1
2851417|NCT02343458|9796469|P4|Overall Study|Withdrawal by Subject|14
2851418|NCT02343458|9796470|P3|Overall Study|Withdrawal by Subject|23
2851419|NCT02343458|9796471|P2|Overall Study|Withdrawal by Subject|17
2851420|NCT02343458|9796472|P1|Overall Study|Withdrawal by Subject|18
2851421|NCT02343458|9796469|P4|Overall Study|Lack of Efficacy|8
2851422|NCT02343458|9796470|P3|Overall Study|Lack of Efficacy|4
2851423|NCT02343458|9796471|P2|Overall Study|Lack of Efficacy|8
2851424|NCT02343458|9796472|P1|Overall Study|Lack of Efficacy|3
2851425|NCT02343458|9796469|P4|Overall Study|Adverse Event|3
2851426|NCT02343458|9796470|P3|Overall Study|Adverse Event|15
2851427|NCT02343458|9796471|P2|Overall Study|Adverse Event|14
2851428|NCT02343458|9796472|P1|Overall Study|Adverse Event|15
2851429|NCT02343406|9796551|P5|Overall Study|Other, not specified|0
2851430|NCT02343406|9796552|P4|Overall Study|Other, not specified|4
2851431|NCT02343406|9796553|P3|Overall Study|Other, not specified|1
2851432|NCT02343406|9796554|P2|Overall Study|Other, not specified|1
2851433|NCT02343406|9796555|P1|Overall Study|Other, not specified|2
2851434|NCT02343406|9796551|P5|Overall Study|Other primary malignancy|0
2851435|NCT02343406|9796552|P4|Overall Study|Other primary malignancy|0
2851436|NCT02343406|9796553|P3|Overall Study|Other primary malignancy|0
2851437|NCT02343406|9796554|P2|Overall Study|Other primary malignancy|1
2851438|NCT02343406|9796555|P1|Overall Study|Other primary malignancy|0
2851439|NCT02343406|9796551|P5|Overall Study|Start of a new anti-cancer treatment|0
2851440|NCT02343406|9796552|P4|Overall Study|Start of a new anti-cancer treatment|1
2851441|NCT02343406|9796553|P3|Overall Study|Start of a new anti-cancer treatment|0
2851442|NCT02343406|9796554|P2|Overall Study|Start of a new anti-cancer treatment|1
2851443|NCT02343406|9796555|P1|Overall Study|Start of a new anti-cancer treatment|0
2851444|NCT02343406|9796551|P5|Overall Study|Death|0
2851445|NCT02343406|9796552|P4|Overall Study|Death|0
2851446|NCT02343406|9796553|P3|Overall Study|Death|0
2851447|NCT02343406|9796554|P2|Overall Study|Death|1
2851448|NCT02343406|9796555|P1|Overall Study|Death|2
2851449|NCT02343406|9796551|P5|Overall Study|Withdrawal by Subject|0
2851450|NCT02343406|9796552|P4|Overall Study|Withdrawal by Subject|3
2851451|NCT02343406|9796553|P3|Overall Study|Withdrawal by Subject|8
2851452|NCT02343406|9796554|P2|Overall Study|Withdrawal by Subject|4
2851453|NCT02343406|9796555|P1|Overall Study|Withdrawal by Subject|6
2851454|NCT02343406|9796551|P5|Overall Study|Adverse Event|0
2851455|NCT02343406|9796552|P4|Overall Study|Adverse Event|3
2851456|NCT02343406|9796553|P3|Overall Study|Adverse Event|6
2851457|NCT02343406|9796554|P2|Overall Study|Adverse Event|8
2851458|NCT02343406|9796555|P1|Overall Study|Adverse Event|6
2851459|NCT02343406|9796551|P5|Overall Study|Progressive disease|5
2851460|NCT02343406|9796552|P4|Overall Study|Progressive disease|15
2851461|NCT02343406|9796553|P3|Overall Study|Progressive disease|43
2851462|NCT02343406|9796554|P2|Overall Study|Progressive disease|70
2851463|NCT02343406|9796555|P1|Overall Study|Progressive disease|72
2851464|NCT02343263|9796623|P3|Overall Study|Physician Decision|1
2851465|NCT02343263|9796624|P2|Overall Study|Physician Decision|3
2851466|NCT02343263|9796625|P1|Overall Study|Physician Decision|5
2851467|NCT02343159|9796654|P3|Overall Study|Enrollment Error|0
2851468|NCT02343159|9796655|P2|Overall Study|Enrollment Error|0
2851469|NCT02343159|9796656|P1|Overall Study|Enrollment Error|1
2851470|NCT02343159|9796654|P3|Overall Study|Sponsor Decision|0
2851471|NCT02343159|9796655|P2|Overall Study|Sponsor Decision|1
2851472|NCT02343159|9796656|P1|Overall Study|Sponsor Decision|0
2851473|NCT02343159|9796654|P3|Overall Study|Adverse Event|2
2851474|NCT02343159|9796655|P2|Overall Study|Adverse Event|4
2851475|NCT02343159|9796656|P1|Overall Study|Adverse Event|4
2851476|NCT02343159|9796654|P3|Overall Study|Lost to Follow-up|2
2851477|NCT02343159|9796655|P2|Overall Study|Lost to Follow-up|2
2851478|NCT02343159|9796656|P1|Overall Study|Lost to Follow-up|0
2851479|NCT02343159|9796654|P3|Overall Study|Withdrawal by Subject|2
2851480|NCT02343159|9796655|P2|Overall Study|Withdrawal by Subject|0
2851481|NCT02343159|9796656|P1|Overall Study|Withdrawal by Subject|3
2851482|NCT02343159|9796654|P3|Overall Study|Physician Decision|1
2851483|NCT02343159|9796655|P2|Overall Study|Physician Decision|0
2851484|NCT02343159|9796656|P1|Overall Study|Physician Decision|2
2851485|NCT02343159|9796654|P3|Overall Study|Early Study Termination|23
2851486|NCT02343159|9796655|P2|Overall Study|Early Study Termination|19
2851487|NCT02343159|9796656|P1|Overall Study|Early Study Termination|16
2851488|NCT02343003|9796700|P2|Overall Study|terminated by sponsor|0
2851489|NCT02343003|9796701|P1|Overall Study|terminated by sponsor|2
2851490|NCT02343003|9796700|P2|Overall Study|exclusion criteria met|1
2851491|NCT02343003|9796701|P1|Overall Study|exclusion criteria met|1
2851492|NCT02343003|9796700|P2|Overall Study|Death|1
2851493|NCT02343003|9796701|P1|Overall Study|Death|0
2851494|NCT02343003|9796700|P2|Overall Study|Protocol Violation|0
2851495|NCT02343003|9796701|P1|Overall Study|Protocol Violation|1
2851496|NCT02343003|9796700|P2|Overall Study|Lost to Follow-up|1
2851497|NCT02343003|9796701|P1|Overall Study|Lost to Follow-up|5
2851498|NCT02343003|9796700|P2|Overall Study|Withdrawal by Subject|4
2851499|NCT02343003|9796701|P1|Overall Study|Withdrawal by Subject|9
2851500|NCT02342886|9796722|P5|Overall Study|Protocol Violation|0
2851501|NCT02342886|9796723|P4|Overall Study|Protocol Violation|2
2851502|NCT02342886|9796724|P3|Overall Study|Protocol Violation|0
2851503|NCT02342886|9796725|P2|Overall Study|Protocol Violation|0
2851504|NCT02342886|9796726|P1|Overall Study|Protocol Violation|0
2851505|NCT02342886|9796722|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
2851506|NCT02342886|9796723|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
2851507|NCT02342886|9796724|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
2851508|NCT02342886|9796725|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
2851509|NCT02342886|9796726|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
2851510|NCT02342886|9796722|P5|Overall Study|Pregnancy|0
2851511|NCT02342886|9796723|P4|Overall Study|Pregnancy|0
2851512|NCT02342886|9796724|P3|Overall Study|Pregnancy|2
2851513|NCT02342886|9796725|P2|Overall Study|Pregnancy|0
2851514|NCT02342886|9796726|P1|Overall Study|Pregnancy|0
2851515|NCT02342886|9796722|P5|Overall Study|Investigator/sponsor decision|1
2851516|NCT02342886|9796723|P4|Overall Study|Investigator/sponsor decision|3
2851517|NCT02342886|9796724|P3|Overall Study|Investigator/sponsor decision|0
2851518|NCT02342886|9796725|P2|Overall Study|Investigator/sponsor decision|2
2851519|NCT02342886|9796726|P1|Overall Study|Investigator/sponsor decision|0
2851520|NCT02342886|9796722|P5|Overall Study|Withdrawal by Subject|0
2851521|NCT02342886|9796723|P4|Overall Study|Withdrawal by Subject|1
2851522|NCT02342886|9796724|P3|Overall Study|Withdrawal by Subject|0
2851523|NCT02342886|9796725|P2|Overall Study|Withdrawal by Subject|1
2851524|NCT02342886|9796726|P1|Overall Study|Withdrawal by Subject|0
2851525|NCT02342886|9796722|P5|Overall Study|Death|1
2851526|NCT02342886|9796723|P4|Overall Study|Death|0
2851527|NCT02342886|9796724|P3|Overall Study|Death|1
2851528|NCT02342886|9796725|P2|Overall Study|Death|2
2851529|NCT02342886|9796726|P1|Overall Study|Death|1
2851530|NCT02342886|9796722|P5|Overall Study|Lost to Follow-up|0
2851531|NCT02342886|9796723|P4|Overall Study|Lost to Follow-up|0
2851532|NCT02342886|9796724|P3|Overall Study|Lost to Follow-up|0
2851533|NCT02342886|9796725|P2|Overall Study|Lost to Follow-up|0
2851534|NCT02342886|9796726|P1|Overall Study|Lost to Follow-up|1
2851535|NCT02342886|9796722|P5|Overall Study|Adverse event/specific toxicity|1
2851536|NCT02342886|9796723|P4|Overall Study|Adverse event/specific toxicity|2
2851537|NCT02342886|9796724|P3|Overall Study|Adverse event/specific toxicity|11
2851538|NCT02342886|9796725|P2|Overall Study|Adverse event/specific toxicity|3
2851539|NCT02342886|9796726|P1|Overall Study|Adverse event/specific toxicity|4
2851540|NCT02342886|9796722|P5|Overall Study|Late exclusion: rifampicin resistance|0
2851541|NCT02342886|9796723|P4|Overall Study|Late exclusion: rifampicin resistance|0
2851542|NCT02342886|9796724|P3|Overall Study|Late exclusion: rifampicin resistance|0
2851543|NCT02342886|9796725|P2|Overall Study|Late exclusion: rifampicin resistance|0
2851544|NCT02342886|9796726|P1|Overall Study|Late exclusion: rifampicin resistance|1
2851545|NCT02342886|9796722|P5|Overall Study|Treatment non-compliance|0
2851546|NCT02342886|9796723|P4|Overall Study|Treatment non-compliance|1
2851547|NCT02342886|9796724|P3|Overall Study|Treatment non-compliance|0
2851548|NCT02342886|9796725|P2|Overall Study|Treatment non-compliance|0
2851549|NCT02342886|9796726|P1|Overall Study|Treatment non-compliance|1
2851550|NCT02342743|9796743|P1|Treatment Period|Change in prophylactic medication|1
2851551|NCT02342743|9796743|P1|Treatment Period|Lost to Follow-up|8
2851552|NCT02342743|9796743|P1|Treatment Period|Withdrawal by Subject|2
2851553|NCT02342743|9796743|P1|Baseline Period|Screening failure regarding baseline|7
2851554|NCT02342743|9796743|P1|Baseline Period|Change in prophylactic medication|3
2851555|NCT02342743|9796743|P1|Baseline Period|Lost to Follow-up|2
2851556|NCT02342743|9796743|P1|Baseline Period|Withdrawal by Subject|3
2851557|NCT02342704|9796756|P2|Overall Study|Adverse Event|3
2851558|NCT02342704|9796757|P1|Overall Study|Adverse Event|1
2851559|NCT02342704|9796756|P2|Overall Study|Lost to Follow-up|1
2851560|NCT02342704|9796757|P1|Overall Study|Lost to Follow-up|2
2851561|NCT02342704|9796756|P2|Overall Study|Withdrawal by Subject|0
2851562|NCT02342704|9796757|P1|Overall Study|Withdrawal by Subject|1
2851563|NCT02342704|9796756|P2|Overall Study|Other|1
2851564|NCT02342704|9796757|P1|Overall Study|Other|0
2851565|NCT02342704|9796756|P2|Overall Study|Sponsor Termination|43
2851566|NCT02342704|9796757|P1|Overall Study|Sponsor Termination|49
2851567|NCT02342704|9796756|P2|Overall Study|Physician Decision|3
2851568|NCT02342704|9796757|P1|Overall Study|Physician Decision|0
2851569|NCT02342678|9796785|P2|Overall Study|Illness/medical reason|1
2851570|NCT02342678|9796786|P1|Overall Study|Illness/medical reason|1
2851571|NCT02342678|9796785|P2|Overall Study|Family illness/emergency|1
2851572|NCT02342678|9796786|P1|Overall Study|Family illness/emergency|0
2851573|NCT02342678|9796785|P2|Overall Study|Too busy to complete study|2
2851574|NCT02342678|9796786|P1|Overall Study|Too busy to complete study|0
2851575|NCT02342678|9796785|P2|Overall Study|Lost to Follow-up|1
2851576|NCT02342678|9796786|P1|Overall Study|Lost to Follow-up|0
2851577|NCT02342548|9796817|P3|Overall Study|Other|1
2851578|NCT02342548|9796818|P2|Overall Study|Other|1
2851579|NCT02342548|9796819|P1|Overall Study|Other|1
2851580|NCT02342548|9796817|P3|Overall Study|Withdrawal by Subject|4
2851581|NCT02342548|9796818|P2|Overall Study|Withdrawal by Subject|3
2851582|NCT02342548|9796819|P1|Overall Study|Withdrawal by Subject|1
2851583|NCT02342548|9796817|P3|Overall Study|Protocol Violation|0
2851584|NCT02342548|9796818|P2|Overall Study|Protocol Violation|1
2851585|NCT02342548|9796819|P1|Overall Study|Protocol Violation|0
2851586|NCT02342548|9796817|P3|Overall Study|Study terminated by sponsor|25
2851587|NCT02342548|9796818|P2|Overall Study|Study terminated by sponsor|39
2851588|NCT02342548|9796819|P1|Overall Study|Study terminated by sponsor|20
2851589|NCT02342548|9796817|P3|Overall Study|Lost to Follow-up|0
2851590|NCT02342548|9796818|P2|Overall Study|Lost to Follow-up|1
2851591|NCT02342548|9796819|P1|Overall Study|Lost to Follow-up|0
2851592|NCT02342548|9796817|P3|Overall Study|Adverse Event|13
2851593|NCT02342548|9796818|P2|Overall Study|Adverse Event|17
2851594|NCT02342548|9796819|P1|Overall Study|Adverse Event|12
2851595|NCT02342418|9796863|P2|Overall Study|Adverse Event|1
2851596|NCT02342418|9796864|P1|Overall Study|Adverse Event|0
2851597|NCT02342288|9797043|P2|Overall Study|coordinator not available|2
2851598|NCT02342288|9797044|P1|Overall Study|coordinator not available|0
2851599|NCT02342288|9797043|P2|Overall Study|subject cannot tolerate numbing drops|1
2851600|NCT02342288|9797044|P1|Overall Study|subject cannot tolerate numbing drops|0
2851601|NCT02342288|9797043|P2|Overall Study|coordinator contaminated with blood|1
2851602|NCT02342288|9797044|P1|Overall Study|coordinator contaminated with blood|0
2851603|NCT02342288|9797043|P2|Overall Study|Withdrawal by Subject|0
2851604|NCT02342288|9797044|P1|Overall Study|Withdrawal by Subject|1
2851605|NCT02342288|9797043|P2|Overall Study|anesthesia leak in system|0
2851606|NCT02342288|9797044|P1|Overall Study|anesthesia leak in system|1
2851607|NCT02342288|9797043|P2|Overall Study|no protocol anesthesiologist available|2
2851608|NCT02342288|9797044|P1|Overall Study|no protocol anesthesiologist available|3
2851609|NCT02342223|9797050|P1|Overall Study|Lost to Follow-up|1
2851610|NCT02342171|9797070|P2|Overall Study|Missing age data|1
2851611|NCT02342171|9797071|P1|Overall Study|Missing age data|0
2851612|NCT02342171|9797070|P2|Overall Study|Unknown outcome|1
2851613|NCT02342171|9797071|P1|Overall Study|Unknown outcome|0
2851614|NCT02342171|9797070|P2|Overall Study|Missing cycle treshold value|0
2851615|NCT02342171|9797071|P1|Overall Study|Missing cycle treshold value|1
2851616|NCT02342171|9797070|P2|Overall Study|Received favipiravir|0
2851617|NCT02342171|9797071|P1|Overall Study|Received favipiravir|10
2851618|NCT02342171|9797070|P2|Overall Study|Death|87
2851619|NCT02342171|9797071|P1|Overall Study|Death|4
2851620|NCT02341482|9797325|P1|Overall Study|Adverse Event|1
2851621|NCT02341456|9797354|P3|Overall Study|Physician Decision|0
2851622|NCT02341456|9797355|P2|Overall Study|Physician Decision|0
2851623|NCT02341456|9797356|P1|Overall Study|Physician Decision|1
2851624|NCT02341456|9797354|P3|Overall Study|Moved to local access programme.|1
2851625|NCT02341456|9797355|P2|Overall Study|Moved to local access programme.|1
2851626|NCT02341456|9797356|P1|Overall Study|Moved to local access programme.|0
2851627|NCT02341456|9797354|P3|Overall Study|Withdrawal by Subject|1
2851628|NCT02341456|9797355|P2|Overall Study|Withdrawal by Subject|1
2851629|NCT02341456|9797356|P1|Overall Study|Withdrawal by Subject|0
2851630|NCT02341456|9797354|P3|Overall Study|Death|1
2851631|NCT02341456|9797355|P2|Overall Study|Death|1
2851632|NCT02341456|9797356|P1|Overall Study|Death|1
2851633|NCT02341456|9797354|P3|Overall Study|Disease progression|1
2851634|NCT02341456|9797355|P2|Overall Study|Disease progression|3
2851635|NCT02341456|9797356|P1|Overall Study|Disease progression|2
2851636|NCT02341417|9797481|P3|Overall Study|Death|1
2851637|NCT02341417|9797482|P2|Overall Study|Death|0
2851638|NCT02341417|9797483|P1|Overall Study|Death|0
2851639|NCT02341417|9797481|P3|Overall Study|Decision by sponsor|0
2851640|NCT02341417|9797482|P2|Overall Study|Decision by sponsor|0
2851641|NCT02341417|9797483|P1|Overall Study|Decision by sponsor|2
2851642|NCT02341417|9797481|P3|Overall Study|Withdrawal by Subject|0
2851643|NCT02341417|9797482|P2|Overall Study|Withdrawal by Subject|2
2851644|NCT02341417|9797483|P1|Overall Study|Withdrawal by Subject|0
2851645|NCT02340975|9797548|P6|Overall Study|Other|6
2851646|NCT02340975|9797549|P5|Overall Study|Other|0
2851647|NCT02340975|9797550|P4|Overall Study|Other|2
2851648|NCT02340975|9797551|P3|Overall Study|Other|0
2851649|NCT02340975|9797552|P2|Overall Study|Other|4
2851650|NCT02340975|9797553|P1|Overall Study|Other|0
2851651|NCT02340975|9797548|P6|Overall Study|Withdrawal by Subject|0
2851652|NCT02340975|9797549|P5|Overall Study|Withdrawal by Subject|2
2851653|NCT02340975|9797550|P4|Overall Study|Withdrawal by Subject|3
2851654|NCT02340975|9797551|P3|Overall Study|Withdrawal by Subject|3
2851655|NCT02340975|9797552|P2|Overall Study|Withdrawal by Subject|0
2851656|NCT02340975|9797553|P1|Overall Study|Withdrawal by Subject|0
2851657|NCT02340975|9797548|P6|Overall Study|Lost to Follow-up|0
2851658|NCT02340975|9797549|P5|Overall Study|Lost to Follow-up|2
2851659|NCT02340975|9797550|P4|Overall Study|Lost to Follow-up|0
2851660|NCT02340975|9797551|P3|Overall Study|Lost to Follow-up|0
2851661|NCT02340975|9797552|P2|Overall Study|Lost to Follow-up|0
2851662|NCT02340975|9797553|P1|Overall Study|Lost to Follow-up|0
2851663|NCT02340975|9797548|P6|Overall Study|Death|13
2851664|NCT02340975|9797549|P5|Overall Study|Death|21
2851665|NCT02340975|9797550|P4|Overall Study|Death|7
2851666|NCT02340975|9797551|P3|Overall Study|Death|21
2851667|NCT02340975|9797552|P2|Overall Study|Death|23
2851668|NCT02340975|9797553|P1|Overall Study|Death|6
2851669|NCT02340962|9797667|P2|Overall Study|Lost to Follow-up|0
2851670|NCT02340962|9797668|P1|Overall Study|Lost to Follow-up|1
2851671|NCT02340819|9797688|P1|Overall Study|Discontinued with other reason|1
2851672|NCT02340819|9797688|P1|Overall Study|Withdrawal by Subject|2
2851673|NCT02340819|9797688|P1|Overall Study|Adverse Event|1
2851674|NCT02340806|9797717|P2|Overall Study|re-dose < 90 min of CSE|3
2851675|NCT02340806|9797718|P1|Overall Study|re-dose < 90 min of CSE|1
2851676|NCT02340806|9797717|P2|Overall Study|history of chronic pain medication|0
2851677|NCT02340806|9797718|P1|Overall Study|history of chronic pain medication|1
2851678|NCT02340806|9797717|P2|Overall Study|epidural catheter replaced|1
2851679|NCT02340806|9797718|P1|Overall Study|epidural catheter replaced|2
2851680|NCT02340806|9797717|P2|Overall Study|Protocol Violation|0
2851681|NCT02340806|9797718|P1|Overall Study|Protocol Violation|2
2851682|NCT02340780|9797744|P1|Overall Study|Ineligible|1
2851683|NCT02340663|9797799|P2|Overall Study|Withdrawal by Subject|1
2851684|NCT02340663|9797800|P1|Overall Study|Withdrawal by Subject|3
2851685|NCT02340663|9797799|P2|Overall Study|Protocol Violation|0
2851686|NCT02340663|9797800|P1|Overall Study|Protocol Violation|1
2851687|NCT02340663|9797799|P2|Overall Study|Lost to Follow-up|0
2851688|NCT02340663|9797800|P1|Overall Study|Lost to Follow-up|1
2851689|NCT02340520|9797856|P1|Overall Study|Withdrawal by Subject|1
2851690|NCT02340520|9797856|P1|Overall Study|Patient did not take drug as specified|1
2851691|NCT02340520|9797856|P1|Overall Study|Lost to Follow-up|1
2851692|NCT02340221|9797899|P2|Overall Study|Continued on study|290
2851693|NCT02340221|9797900|P1|Overall Study|Continued on study|140
2851694|NCT02340221|9797899|P2|Overall Study|Reason Not Specified|1
2851695|NCT02340221|9797900|P1|Overall Study|Reason Not Specified|0
2851696|NCT02340221|9797899|P2|Overall Study|Lost to Follow-up|3
2851697|NCT02340221|9797900|P1|Overall Study|Lost to Follow-up|2
2851698|NCT02340221|9797899|P2|Overall Study|Withdrawal by Participant|22
2851699|NCT02340221|9797900|P1|Overall Study|Withdrawal by Participant|14
2851700|NCT02340221|9797899|P2|Overall Study|Death|101
2851701|NCT02340221|9797900|P1|Overall Study|Death|58
2851702|NCT02340078|9797934|P1|Overall Study|Protocol Violation|1
2851703|NCT02340000|9797941|P2|Time Period 2|Lost to Follow-up|8
2851704|NCT02340000|9797942|P1|Time Period 2|Lost to Follow-up|10
2851705|NCT02340000|9797941|P2|Time Period 2|Withdrawal by Subject|7
2851706|NCT02340000|9797942|P1|Time Period 2|Withdrawal by Subject|9
2851707|NCT02340000|9797941|P2|Time Period 1|Lost to Follow-up|7
2851708|NCT02340000|9797942|P1|Time Period 1|Lost to Follow-up|6
2851709|NCT02340000|9797941|P2|Time Period 1|Withdrawal by Subject|8
2851710|NCT02340000|9797942|P1|Time Period 1|Withdrawal by Subject|6
2851711|NCT02339909|9797972|P3|Overall Study|Became ineligible after randomisation|71
2851712|NCT02339909|9797973|P2|Overall Study|Became ineligible after randomisation|63
2851713|NCT02339909|9797974|P1|Overall Study|Became ineligible after randomisation|89
2851714|NCT02339584|9798012|P2|Overall Study|Withdrawal by Subject|4
2851715|NCT02339584|9798013|P1|Overall Study|Withdrawal by Subject|2
2851716|NCT02339584|9798012|P2|Overall Study|Protocol Violation|1
2851717|NCT02339584|9798013|P1|Overall Study|Protocol Violation|1
2851718|NCT02339584|9798012|P2|Overall Study|Physician Decision|2
2851719|NCT02339584|9798013|P1|Overall Study|Physician Decision|1
2851720|NCT02339584|9798012|P2|Overall Study|Lack of Efficacy|1
2851721|NCT02339584|9798013|P1|Overall Study|Lack of Efficacy|0
2851722|NCT02339584|9798012|P2|Overall Study|Adverse Event|7
2851723|NCT02339584|9798013|P1|Overall Study|Adverse Event|11
2851724|NCT02339506|9798033|P2|Washout (Period 2)|Withdrawal by Subject|0
2851725|NCT02339506|9798034|P1|Washout (Period 2)|Withdrawal by Subject|2
2851726|NCT02339506|9798033|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
2851727|NCT02339506|9798034|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
2851728|NCT02339285|9798063|P3|Overall Study|Protocol Deviation|0
2851729|NCT02339285|9798064|P2|Overall Study|Protocol Deviation|1
2851730|NCT02339285|9798065|P1|Overall Study|Protocol Deviation|0
2851731|NCT02339285|9798063|P3|Overall Study|Lost to Follow-up|1
2851732|NCT02339285|9798064|P2|Overall Study|Lost to Follow-up|1
2851733|NCT02339285|9798065|P1|Overall Study|Lost to Follow-up|1
2851734|NCT02339285|9798063|P3|Overall Study|Withdrawal by Subject|1
2851735|NCT02339285|9798064|P2|Overall Study|Withdrawal by Subject|1
2851736|NCT02339285|9798065|P1|Overall Study|Withdrawal by Subject|0
2851737|NCT02339155|9798111|P2|Overall Study|Withdrawal by Subject|4
2851738|NCT02339155|9798112|P1|Overall Study|Withdrawal by Subject|4
2851739|NCT02339155|9798111|P2|Overall Study|Physician Decision|1
2851740|NCT02339155|9798112|P1|Overall Study|Physician Decision|2
2851741|NCT02339155|9798111|P2|Overall Study|Lost to Follow-up|9
2851742|NCT02339155|9798112|P1|Overall Study|Lost to Follow-up|8
2851743|NCT02339155|9798111|P2|Overall Study|Death|1
2851744|NCT02339155|9798112|P1|Overall Study|Death|1
2851745|NCT02339155|9798111|P2|Overall Study|Adverse Event|6
2851746|NCT02339155|9798112|P1|Overall Study|Adverse Event|0
2851747|NCT02338882|9798318|P2|Overall Study|Lost to Follow-up|3
2851748|NCT02338882|9798319|P1|Overall Study|Lost to Follow-up|6
2851749|NCT02338882|9798318|P2|Overall Study|Death|0
2851750|NCT02338882|9798319|P1|Overall Study|Death|1
2851751|NCT02338843|9798357|P2|Overall Study|Discontinued prior to randomizat|0
2851752|NCT02338843|9798358|P1|Overall Study|Discontinued prior to randomizat|1
2851753|NCT02338843|9798357|P2|Overall Study|Subject Recovered|2
2851754|NCT02338843|9798358|P1|Overall Study|Subject Recovered|0
2851755|NCT02338843|9798357|P2|Overall Study|Withdrawal by Subject|2
2851756|NCT02338843|9798358|P1|Overall Study|Withdrawal by Subject|0
2851757|NCT02338843|9798357|P2|Overall Study|Physician Decision|0
2851758|NCT02338843|9798358|P1|Overall Study|Physician Decision|1
2851759|NCT02338843|9798357|P2|Overall Study|Death|53
2851760|NCT02338843|9798358|P1|Overall Study|Death|40
2851761|NCT02338843|9798357|P2|Overall Study|Adverse Event|1
2851762|NCT02338843|9798358|P1|Overall Study|Adverse Event|2
2851763|NCT02338492|9798386|P1|Overall Study|Reason not captured above|6
2851764|NCT02338492|9798386|P1|Overall Study|Lost to Follow-up|4
2851765|NCT02338492|9798386|P1|Overall Study|Adverse Event|3
2851766|NCT02338492|9798386|P1|Overall Study|Death|32
2851767|NCT02338362|9798402|P2|Overall Study|Withdrawal by Subject|1
2851768|NCT02338362|9798403|P1|Overall Study|Withdrawal by Subject|1
2851769|NCT02338193|9798433|P3|Overall Study|intolerant of side effects|0
2851770|NCT02338193|9798434|P2|Overall Study|intolerant of side effects|0
2851771|NCT02338193|9798435|P1|Overall Study|intolerant of side effects|1
2851772|NCT02338193|9798433|P3|Overall Study|moved out of state|0
2851773|NCT02338193|9798434|P2|Overall Study|moved out of state|1
2851774|NCT02338193|9798435|P1|Overall Study|moved out of state|0
2851775|NCT02338193|9798433|P3|Overall Study|Noncompliant with visits|7
2851776|NCT02338193|9798434|P2|Overall Study|Noncompliant with visits|2
2851777|NCT02338193|9798435|P1|Overall Study|Noncompliant with visits|2
2851778|NCT02338193|9798433|P3|Overall Study|Pregnancy|1
2851779|NCT02338193|9798434|P2|Overall Study|Pregnancy|1
2851780|NCT02338193|9798435|P1|Overall Study|Pregnancy|0
2851781|NCT02338193|9798433|P3|Overall Study|Withdrawal by Subject|2
2851782|NCT02338193|9798434|P2|Overall Study|Withdrawal by Subject|0
2851783|NCT02338193|9798435|P1|Overall Study|Withdrawal by Subject|0
2851784|NCT02338154|9798488|P1|Overall Study|Missing Exit Reason on Exit Form|1
2851785|NCT02338154|9798488|P1|Overall Study|Patients Without Exit Form|47
2851786|NCT02338154|9798488|P1|Overall Study|Other Reason|3
2851787|NCT02338154|9798488|P1|Overall Study|Lost to Follow-up|8
2851788|NCT02338154|9798488|P1|Overall Study|Withdrawal by Subject or by Investigator|10
2851789|NCT02338154|9798488|P1|Overall Study|Valve Explant|11
2851790|NCT02338154|9798488|P1|Overall Study|Valve Implant Failure|17
2851791|NCT02338154|9798488|P1|Overall Study|Death|46
2851792|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Reason not specified|4
2851793|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Reason not specified|4
2851794|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Reason not specified|0
2851795|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
2851796|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
2851797|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
2851798|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2851799|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
2851800|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2851801|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
2851802|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
2851803|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
2851804|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
2851805|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
2851806|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
2851807|NCT02337946|9798612|P3|Protocol Treatment 2 Period|Adverse Event|9
2851808|NCT02337946|9798613|P2|Protocol Treatment 2 Period|Adverse Event|9
2851809|NCT02337946|9798614|P1|Protocol Treatment 2 Period|Adverse Event|0
2851810|NCT02337946|9798612|P3|In-between Period|Without Informed Consent|0
2851811|NCT02337946|9798613|P2|In-between Period|Without Informed Consent|0
2851812|NCT02337946|9798614|P1|In-between Period|Without Informed Consent|1
2851813|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Reason not specified|0
2851814|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Reason not specified|0
2851815|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Reason not specified|8
2851816|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2851817|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2851818|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
2851819|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2851820|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2851821|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
2851822|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2851823|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2851824|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
2851825|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
2851826|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
2851827|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
2851828|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2851829|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2851830|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
2851831|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
2851832|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
2851833|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
2851834|NCT02337946|9798612|P3|Protocol Treatment 1 Period|Adverse Event|0
2851835|NCT02337946|9798613|P2|Protocol Treatment 1 Period|Adverse Event|0
2851836|NCT02337946|9798614|P1|Protocol Treatment 1 Period|Adverse Event|7
2851837|NCT02337907|9798642|P6|Overall Study|Adverse Event|0
2851838|NCT02337907|9798643|P5|Overall Study|Adverse Event|4
2851839|NCT02337907|9798644|P4|Overall Study|Adverse Event|1
2851840|NCT02337907|9798645|P3|Overall Study|Adverse Event|1
2851841|NCT02337907|9798646|P2|Overall Study|Adverse Event|1
2851842|NCT02337907|9798647|P1|Overall Study|Adverse Event|1
2851843|NCT02337907|9798642|P6|Overall Study|Lost to Follow-up|1
2851844|NCT02337907|9798643|P5|Overall Study|Lost to Follow-up|0
2851845|NCT02337907|9798644|P4|Overall Study|Lost to Follow-up|0
2851846|NCT02337907|9798645|P3|Overall Study|Lost to Follow-up|0
2851847|NCT02337907|9798646|P2|Overall Study|Lost to Follow-up|0
2851848|NCT02337907|9798647|P1|Overall Study|Lost to Follow-up|0
2851849|NCT02337907|9798642|P6|Overall Study|Withdrawal by Subject|0
2851850|NCT02337907|9798643|P5|Overall Study|Withdrawal by Subject|5
2851851|NCT02337907|9798644|P4|Overall Study|Withdrawal by Subject|2
2851852|NCT02337907|9798645|P3|Overall Study|Withdrawal by Subject|0
2851853|NCT02337907|9798646|P2|Overall Study|Withdrawal by Subject|3
2851854|NCT02337907|9798647|P1|Overall Study|Withdrawal by Subject|2
2851855|NCT02337907|9798642|P6|Overall Study|Other than listed|0
2851856|NCT02337907|9798643|P5|Overall Study|Other than listed|1
2851857|NCT02337907|9798644|P4|Overall Study|Other than listed|1
2851858|NCT02337907|9798645|P3|Overall Study|Other than listed|0
2851859|NCT02337907|9798646|P2|Overall Study|Other than listed|0
2851860|NCT02337907|9798647|P1|Overall Study|Other than listed|1
2851861|NCT02337764|9798682|P1|Overall Study|Lack of Efficacy|2
2851862|NCT02337764|9798682|P1|Overall Study|Voluntary Withdrawal|12
2851863|NCT02337764|9798682|P1|Overall Study|Pretreatment Event/Adverse Event|46
2851864|NCT02337751|9798695|P2|Overall Study|Investigator's Judgement|0
2851865|NCT02337751|9798696|P1|Overall Study|Investigator's Judgement|1
2851866|NCT02337751|9798695|P2|Overall Study|Lack of Efficacy|5
2851867|NCT02337751|9798696|P1|Overall Study|Lack of Efficacy|2
2851868|NCT02337751|9798695|P2|Overall Study|Voluntary Withdrawal|8
2851869|NCT02337751|9798696|P1|Overall Study|Voluntary Withdrawal|6
2851870|NCT02337751|9798695|P2|Overall Study|Pretreatment Event/Adverse Event|3
2851871|NCT02337751|9798696|P1|Overall Study|Pretreatment Event/Adverse Event|2
2851872|NCT02337738|9798715|P3|Overall Study|Investigator's Judgment|3
2851873|NCT02337738|9798716|P2|Overall Study|Investigator's Judgment|1
2851874|NCT02337738|9798717|P1|Overall Study|Investigator's Judgment|1
2851875|NCT02337738|9798715|P3|Overall Study|Lack of Efficacy|0
2851876|NCT02337738|9798716|P2|Overall Study|Lack of Efficacy|4
2851877|NCT02337738|9798717|P1|Overall Study|Lack of Efficacy|2
2851878|NCT02337738|9798715|P3|Overall Study|Voluntary Withdrawal|2
2851879|NCT02337738|9798716|P2|Overall Study|Voluntary Withdrawal|5
2851880|NCT02337738|9798717|P1|Overall Study|Voluntary Withdrawal|10
2851881|NCT02337738|9798715|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
2851882|NCT02337738|9798716|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
2851883|NCT02337738|9798717|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
2851884|NCT02337738|9798715|P3|Overall Study|Pretreatment Event/Adverse Event|21
2851885|NCT02337738|9798716|P2|Overall Study|Pretreatment Event/Adverse Event|18
2851886|NCT02337738|9798717|P1|Overall Study|Pretreatment Event/Adverse Event|9
2851887|NCT02337738|9798715|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2851888|NCT02337738|9798716|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
2851889|NCT02337738|9798717|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2851890|NCT02337725|9798757|P2|Overall Study|Lack of Efficacy|0
2851891|NCT02337725|9798758|P1|Overall Study|Lack of Efficacy|4
2851892|NCT02337725|9798757|P2|Overall Study|Voluntary Withdrawal|3
2851893|NCT02337725|9798758|P1|Overall Study|Voluntary Withdrawal|14
2851894|NCT02337725|9798757|P2|Overall Study|Major Protocol Deviation|1
2851895|NCT02337725|9798758|P1|Overall Study|Major Protocol Deviation|0
2851896|NCT02337725|9798757|P2|Overall Study|Pretreatment Event/AE in Treatment|3
2851897|NCT02337725|9798758|P1|Overall Study|Pretreatment Event/AE in Treatment|8
2851898|NCT02337725|9798757|P2|Overall Study|Pretreatment Event/AE before Treatment|1
2851899|NCT02337725|9798758|P1|Overall Study|Pretreatment Event/AE before Treatment|0
2851900|NCT02337491|9798782|P2|Overall Study|On Treatment|0
2851901|NCT02337491|9798783|P1|Overall Study|On Treatment|2
2851902|NCT02337491|9798782|P2|Overall Study|Progressive Disease|28
2851903|NCT02337491|9798783|P1|Overall Study|Progressive Disease|44
2851904|NCT02337491|9798782|P2|Overall Study|Withdrawal by Subject|0
2851905|NCT02337491|9798783|P1|Overall Study|Withdrawal by Subject|3
2851906|NCT02337491|9798782|P2|Overall Study|Adverse Event|1
2851907|NCT02337491|9798783|P1|Overall Study|Adverse Event|0
2851908|NCT02337491|9798782|P2|Overall Study|Death|1
2851909|NCT02337491|9798783|P1|Overall Study|Death|1
2851910|NCT02337478|9798797|P1|Overall Study|Lack of Efficacy|5
2851911|NCT02337387|9798807|P4|Overall Study|Sponsor Decision to Terminate Study|3
2851912|NCT02337387|9798808|P3|Overall Study|Sponsor Decision to Terminate Study|3
2851913|NCT02337387|9798809|P2|Overall Study|Sponsor Decision to Terminate Study|7
2851914|NCT02337387|9798810|P1|Overall Study|Sponsor Decision to Terminate Study|14
2851915|NCT02337387|9798807|P4|Overall Study|Adverse Event|0
2851916|NCT02337387|9798808|P3|Overall Study|Adverse Event|0
2851917|NCT02337387|9798809|P2|Overall Study|Adverse Event|1
2851918|NCT02337387|9798810|P1|Overall Study|Adverse Event|0
2851919|NCT02337361|9798828|P2|6-month Follow-up|Lost to Follow-up|4
2851920|NCT02337361|9798829|P1|6-month Follow-up|Lost to Follow-up|2
2851921|NCT02337361|9798828|P2|3-month Follow-up|Lost to Follow-up|14
2851922|NCT02337361|9798829|P1|3-month Follow-up|Lost to Follow-up|19
2851923|NCT02336607|9798891|P4|Overall Study|Withdrawal by Subject|20
2851924|NCT02336607|9798892|P3|Overall Study|Withdrawal by Subject|0
2851925|NCT02336607|9798893|P2|Overall Study|Withdrawal by Subject|2
2851926|NCT02336607|9798894|P1|Overall Study|Withdrawal by Subject|0
2851927|NCT02336607|9798891|P4|Overall Study|Adverse Event|26
2851928|NCT02336607|9798892|P3|Overall Study|Adverse Event|2
2851929|NCT02336607|9798893|P2|Overall Study|Adverse Event|2
2851930|NCT02336607|9798894|P1|Overall Study|Adverse Event|0
2851931|NCT02336607|9798891|P4|Overall Study|Protocol Violation|3
2851932|NCT02336607|9798892|P3|Overall Study|Protocol Violation|1
2851933|NCT02336607|9798893|P2|Overall Study|Protocol Violation|1
2851934|NCT02336607|9798894|P1|Overall Study|Protocol Violation|0
2851935|NCT02336607|9798891|P4|Overall Study|Lost to Follow-up|21
2851936|NCT02336607|9798892|P3|Overall Study|Lost to Follow-up|0
2851937|NCT02336607|9798893|P2|Overall Study|Lost to Follow-up|1
2851938|NCT02336607|9798894|P1|Overall Study|Lost to Follow-up|2
2851939|NCT02336607|9798891|P4|Overall Study|Lack of Efficacy|2
2851940|NCT02336607|9798892|P3|Overall Study|Lack of Efficacy|0
2851941|NCT02336607|9798893|P2|Overall Study|Lack of Efficacy|0
2851942|NCT02336607|9798894|P1|Overall Study|Lack of Efficacy|1
2851943|NCT02336607|9798891|P4|Overall Study|Physician Decision|15
2851944|NCT02336607|9798892|P3|Overall Study|Physician Decision|3
2851945|NCT02336607|9798893|P2|Overall Study|Physician Decision|4
2851946|NCT02336607|9798894|P1|Overall Study|Physician Decision|1
2851947|NCT02336555|9798997|P2|Treatment Period 2 (28 Days)|Adverse Event|1
2851948|NCT02336555|9798998|P1|Treatment Period 2 (28 Days)|Adverse Event|0
2851949|NCT02336555|9798997|P2|Treatment Period 1 (28 Days)|Physician Decision|0
2851950|NCT02336555|9798998|P1|Treatment Period 1 (28 Days)|Physician Decision|2
2851951|NCT02336555|9798997|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2851952|NCT02336555|9798998|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2851953|NCT02336451|9799011|P5|Overall Study|Patient/guardian decision|1
2851954|NCT02336451|9799012|P4|Overall Study|Patient/guardian decision|2
2851955|NCT02336451|9799013|P3|Overall Study|Patient/guardian decision|0
2851956|NCT02336451|9799014|P2|Overall Study|Patient/guardian decision|4
2851957|NCT02336451|9799015|P1|Overall Study|Patient/guardian decision|2
2851958|NCT02336451|9799011|P5|Overall Study|Protocol Violation|0
2851959|NCT02336451|9799012|P4|Overall Study|Protocol Violation|0
2851960|NCT02336451|9799013|P3|Overall Study|Protocol Violation|0
2851961|NCT02336451|9799014|P2|Overall Study|Protocol Violation|0
2851962|NCT02336451|9799015|P1|Overall Study|Protocol Violation|1
2851963|NCT02336451|9799011|P5|Overall Study|Progressive disease|4
2851964|NCT02336451|9799012|P4|Overall Study|Progressive disease|14
2851965|NCT02336451|9799013|P3|Overall Study|Progressive disease|2
2851966|NCT02336451|9799014|P2|Overall Study|Progressive disease|26
2851967|NCT02336451|9799015|P1|Overall Study|Progressive disease|23
2851968|NCT02336451|9799011|P5|Overall Study|Physician Decision|3
2851969|NCT02336451|9799012|P4|Overall Study|Physician Decision|16
2851970|NCT02336451|9799013|P3|Overall Study|Physician Decision|7
2851971|NCT02336451|9799014|P2|Overall Study|Physician Decision|6
2851972|NCT02336451|9799015|P1|Overall Study|Physician Decision|9
2851973|NCT02336451|9799011|P5|Overall Study|Death|6
2851974|NCT02336451|9799012|P4|Overall Study|Death|6
2851975|NCT02336451|9799013|P3|Overall Study|Death|3
2851976|NCT02336451|9799014|P2|Overall Study|Death|2
2851977|NCT02336451|9799015|P1|Overall Study|Death|6
2851978|NCT02336451|9799011|P5|Overall Study|Adverse Event|4
2851979|NCT02336451|9799012|P4|Overall Study|Adverse Event|6
2851980|NCT02336451|9799013|P3|Overall Study|Adverse Event|0
2851981|NCT02336451|9799014|P2|Overall Study|Adverse Event|2
2851982|NCT02336451|9799015|P1|Overall Study|Adverse Event|1
2851983|NCT02336425|9799172|P4|Overall Study|Study terminated.|3
2851984|NCT02336425|9799173|P3|Overall Study|Study terminated.|3
2851985|NCT02336425|9799174|P2|Overall Study|Study terminated.|2
2851986|NCT02336425|9799175|P1|Overall Study|Study terminated.|2
2851987|NCT02336282|9799225|P1|Overall Study|Not enough time to complete sessions|2
2851988|NCT02336282|9799225|P1|Overall Study|Lost to Follow-up|1
2851989|NCT02336282|9799225|P1|Overall Study|Uncomfortable with technology|1
2851990|NCT02336282|9799225|P1|Overall Study|Unrelated illness|1
2851991|NCT02336178|9799249|P1|Overall Study|Other|1
2851992|NCT02336178|9799249|P1|Overall Study|Withdrawal by Subject|1
2851993|NCT02336178|9799249|P1|Overall Study|Protocol Violation|1
2851994|NCT02336178|9799249|P1|Overall Study|Lost to Follow-up|1
2851995|NCT02336165|9799340|P5|Overall Study|Other|0
2851996|NCT02336165|9799341|P4|Overall Study|Other|1
2851997|NCT02336165|9799342|P3|Overall Study|Other|0
2851998|NCT02336165|9799343|P2|Overall Study|Other|0
2851999|NCT02336165|9799344|P1|Overall Study|Other|1
2852000|NCT02336165|9799340|P5|Overall Study|Non-compliance|0
2852001|NCT02336165|9799341|P4|Overall Study|Non-compliance|1
2852002|NCT02336165|9799342|P3|Overall Study|Non-compliance|0
2852003|NCT02336165|9799343|P2|Overall Study|Non-compliance|0
2852004|NCT02336165|9799344|P1|Overall Study|Non-compliance|1
2852005|NCT02336165|9799340|P5|Overall Study|Progressive disease|19
2852006|NCT02336165|9799341|P4|Overall Study|Progressive disease|24
2852007|NCT02336165|9799342|P3|Overall Study|Progressive disease|27
2852008|NCT02336165|9799343|P2|Overall Study|Progressive disease|22
2852009|NCT02336165|9799344|P1|Overall Study|Progressive disease|23
2852010|NCT02336165|9799340|P5|Overall Study|Adverse Event|1
2852011|NCT02336165|9799341|P4|Overall Study|Adverse Event|4
2852012|NCT02336165|9799342|P3|Overall Study|Adverse Event|2
2852013|NCT02336165|9799343|P2|Overall Study|Adverse Event|1
2852014|NCT02336165|9799344|P1|Overall Study|Adverse Event|4
2852015|NCT02336165|9799340|P5|Overall Study|Withdrawal by Subject|1
2852016|NCT02336165|9799341|P4|Overall Study|Withdrawal by Subject|0
2852017|NCT02336165|9799342|P3|Overall Study|Withdrawal by Subject|1
2852018|NCT02336165|9799343|P2|Overall Study|Withdrawal by Subject|0
2852019|NCT02336165|9799344|P1|Overall Study|Withdrawal by Subject|0
2852020|NCT02336165|9799340|P5|Overall Study|Physician Decision|0
2852021|NCT02336165|9799341|P4|Overall Study|Physician Decision|1
2852022|NCT02336165|9799342|P3|Overall Study|Physician Decision|1
2852023|NCT02336165|9799343|P2|Overall Study|Physician Decision|2
2852024|NCT02336165|9799344|P1|Overall Study|Physician Decision|2
2852025|NCT02336165|9799340|P5|Overall Study|Death|1
2852026|NCT02336165|9799341|P4|Overall Study|Death|0
2852027|NCT02336165|9799342|P3|Overall Study|Death|0
2852028|NCT02336165|9799343|P2|Overall Study|Death|0
2852029|NCT02336165|9799344|P1|Overall Study|Death|3
2852030|NCT02336074|9799378|P2|Overall Study|Adverse Event|2
2852031|NCT02336074|9799379|P1|Overall Study|Adverse Event|0
2852032|NCT02335489|9799424|P1|Overall Study|Lack of Efficacy|1
2852033|NCT02335489|9799424|P1|Overall Study|Physician Decision|2
2852034|NCT02335489|9799424|P1|Overall Study|Withdrawal by Subject|2
2852035|NCT02335489|9799424|P1|Overall Study|Lost to Follow-up|1
2852036|NCT02335489|9799424|P1|Overall Study|Sponsor terminated study|4
2852037|NCT02335424|9799428|P1|Overall Study|Not treated|4
2852038|NCT02335424|9799428|P1|Overall Study|Physician Decision|3
2852039|NCT02335424|9799428|P1|Overall Study|Lost to Follow-up|2
2852040|NCT02335424|9799428|P1|Overall Study|Death|239
2852041|NCT02335424|9799428|P1|Overall Study|Adverse Event|25
2852042|NCT02335424|9799428|P1|Overall Study|Ongoing In Study|89
2852043|NCT02335424|9799428|P1|Overall Study|Withdrawal by Subject|12
2852044|NCT02335346|9799461|P1|Overall Study|Withdrawal by Subject|1
2852045|NCT02335346|9799461|P1|Overall Study|Adverse Event|11
2852046|NCT02334748|9799735|P1|Overall Study|Lack of Efficacy|4
2852047|NCT02334748|9799735|P1|Overall Study|Patient no longer required study drug|2
2852048|NCT02334748|9799735|P1|Overall Study|Inclusion in the CACZ8852306 study|1
2852049|NCT02334748|9799735|P1|Overall Study|Adverse Event|1
2852050|NCT02334423|9799766|P2|Overall Study|Protocol Violation|3
2852051|NCT02334423|9799767|P1|Overall Study|Protocol Violation|10
2852052|NCT02334384|9799781|P2|Overall Study|Lost to Follow-up|1
2852053|NCT02334384|9799782|P1|Overall Study|Lost to Follow-up|1
2852054|NCT02334306|9799794|P2|Double-blind Period|Withdrawal by Subject|1
2852055|NCT02334306|9799795|P1|Double-blind Period|Withdrawal by Subject|1
2852056|NCT02334306|9799794|P2|Double-blind Period|Adverse Event|1
2852057|NCT02334306|9799795|P1|Double-blind Period|Adverse Event|0
2852058|NCT02333630|9799851|P2|Overall Study|Lost to Follow-up|2
2852059|NCT02333630|9799852|P1|Overall Study|Lost to Follow-up|5
2852060|NCT02333487|9799867|P3|Overall Study|Adverse Event|0
2852061|NCT02333487|9799868|P2|Overall Study|Adverse Event|2
2852062|NCT02333487|9799869|P1|Overall Study|Adverse Event|0
2852063|NCT02333383|9799880|P1|Overall Study|Transfer to another hospital|2
2852064|NCT02333383|9799880|P1|Overall Study|Withdrawal by Subject|3
2852065|NCT02333383|9799880|P1|Overall Study|Lost to Follow-up|15
2852066|NCT02333383|9799880|P1|Overall Study|Adalimumab discontinuation|21
2852067|NCT02333331|9799894|P4|Overall Study|Patient/Guardian Decision|1
2852068|NCT02333331|9799895|P3|Overall Study|Patient/Guardian Decision|9
2852069|NCT02333331|9799896|P2|Overall Study|Patient/Guardian Decision|2
2852070|NCT02333331|9799897|P1|Overall Study|Patient/Guardian Decision|1
2852071|NCT02333331|9799894|P4|Overall Study|Protocol Deviation|1
2852072|NCT02333331|9799895|P3|Overall Study|Protocol Deviation|2
2852073|NCT02333331|9799896|P2|Overall Study|Protocol Deviation|3
2852074|NCT02333331|9799897|P1|Overall Study|Protocol Deviation|0
2852075|NCT02333331|9799894|P4|Overall Study|Physician Decision|0
2852076|NCT02333331|9799895|P3|Overall Study|Physician Decision|0
2852077|NCT02333331|9799896|P2|Overall Study|Physician Decision|1
2852078|NCT02333331|9799897|P1|Overall Study|Physician Decision|0
2852079|NCT02333331|9799894|P4|Overall Study|Lost to Follow-up|0
2852080|NCT02333331|9799895|P3|Overall Study|Lost to Follow-up|1
2852081|NCT02333331|9799896|P2|Overall Study|Lost to Follow-up|0
2852082|NCT02333331|9799897|P1|Overall Study|Lost to Follow-up|0
2852083|NCT02333331|9799894|P4|Overall Study|Death|0
2852084|NCT02333331|9799895|P3|Overall Study|Death|2
2852085|NCT02333331|9799896|P2|Overall Study|Death|0
2852086|NCT02333331|9799897|P1|Overall Study|Death|0
2852087|NCT02333331|9799894|P4|Overall Study|Adverse Event|1
2852088|NCT02333331|9799895|P3|Overall Study|Adverse Event|4
2852089|NCT02333331|9799896|P2|Overall Study|Adverse Event|0
2852090|NCT02333331|9799897|P1|Overall Study|Adverse Event|1
2852091|NCT02332889|9799941|P1|Overall Study|Physician Decision|1
2852092|NCT02332876|9799947|P2|Overall Study|Lost to Follow-up|1
2852093|NCT02332876|9799948|P1|Overall Study|Lost to Follow-up|1
2852094|NCT02332824|9799960|P6|Overall Study|Transfer|0
2852095|NCT02332824|9799961|P5|Overall Study|Transfer|0
2852096|NCT02332824|9799962|P4|Overall Study|Transfer|1
2852097|NCT02332824|9799963|P3|Overall Study|Transfer|1
2852098|NCT02332824|9799964|P2|Overall Study|Transfer|0
2852099|NCT02332824|9799965|P1|Overall Study|Transfer|0
2852100|NCT02332824|9799960|P6|Overall Study|Inconvenient schedule|0
2852101|NCT02332824|9799961|P5|Overall Study|Inconvenient schedule|0
2852102|NCT02332824|9799962|P4|Overall Study|Inconvenient schedule|0
2852103|NCT02332824|9799963|P3|Overall Study|Inconvenient schedule|0
2852104|NCT02332824|9799964|P2|Overall Study|Inconvenient schedule|1
2852105|NCT02332824|9799965|P1|Overall Study|Inconvenient schedule|1
2852106|NCT02332824|9799960|P6|Overall Study|Voluntary Withdrawal|0
2852107|NCT02332824|9799961|P5|Overall Study|Voluntary Withdrawal|0
2852108|NCT02332824|9799962|P4|Overall Study|Voluntary Withdrawal|0
2852109|NCT02332824|9799963|P3|Overall Study|Voluntary Withdrawal|0
2852110|NCT02332824|9799964|P2|Overall Study|Voluntary Withdrawal|0
2852111|NCT02332824|9799965|P1|Overall Study|Voluntary Withdrawal|1
2852112|NCT02332824|9799960|P6|Overall Study|Pretreatment Event/Adverse Event|1
2852113|NCT02332824|9799961|P5|Overall Study|Pretreatment Event/Adverse Event|4
2852114|NCT02332824|9799962|P4|Overall Study|Pretreatment Event/Adverse Event|1
2852115|NCT02332824|9799963|P3|Overall Study|Pretreatment Event/Adverse Event|1
2852116|NCT02332824|9799964|P2|Overall Study|Pretreatment Event/Adverse Event|0
2852117|NCT02332824|9799965|P1|Overall Study|Pretreatment Event/Adverse Event|4
2852118|NCT02332798|9800006|P3|Overall Study|Abnormal Laboratory Findings|0
2852119|NCT02332798|9800007|P2|Overall Study|Abnormal Laboratory Findings|0
2852120|NCT02332798|9800008|P1|Overall Study|Abnormal Laboratory Findings|1
2852121|NCT02332798|9800006|P3|Overall Study|Positive Urine Drug Test|0
2852122|NCT02332798|9800007|P2|Overall Study|Positive Urine Drug Test|1
2852123|NCT02332798|9800008|P1|Overall Study|Positive Urine Drug Test|0
2852124|NCT02332798|9800006|P3|Overall Study|Unwilling to Participate in Study|1
2852125|NCT02332798|9800007|P2|Overall Study|Unwilling to Participate in Study|1
2852126|NCT02332798|9800008|P1|Overall Study|Unwilling to Participate in Study|0
2852127|NCT02332720|9800081|P23|Part A and Part B|Withdrawal by Subject|0
2852128|NCT02332720|9800082|P22|Part A and Part B|Withdrawal by Subject|0
2852129|NCT02332720|9800083|P21|Part A and Part B|Withdrawal by Subject|0
2852130|NCT02332720|9800084|P20|Part A and Part B|Withdrawal by Subject|1
2852131|NCT02332720|9800085|P19|Part A and Part B|Withdrawal by Subject|0
2852132|NCT02332720|9800086|P18|Part A and Part B|Withdrawal by Subject|0
2852133|NCT02332720|9800087|P17|Part A and Part B|Withdrawal by Subject|0
2852134|NCT02332720|9800088|P16|Part A and Part B|Withdrawal by Subject|0
2852135|NCT02332720|9800089|P15|Part A and Part B|Withdrawal by Subject|0
2852136|NCT02332720|9800090|P14|Part A and Part B|Withdrawal by Subject|0
2852137|NCT02332720|9800091|P13|Part A and Part B|Withdrawal by Subject|0
2852138|NCT02332720|9800092|P12|Part A and Part B|Withdrawal by Subject|0
2852139|NCT02332720|9800093|P11|Part A and Part B|Withdrawal by Subject|0
2852140|NCT02332720|9800094|P10|Part A and Part B|Withdrawal by Subject|0
2852141|NCT02332720|9800095|P9|Part A and Part B|Withdrawal by Subject|0
2852142|NCT02332720|9800096|P8|Part A and Part B|Withdrawal by Subject|0
2852143|NCT02332720|9800097|P7|Part A and Part B|Withdrawal by Subject|0
2852144|NCT02332720|9800098|P6|Part A and Part B|Withdrawal by Subject|1
2852145|NCT02332720|9800099|P5|Part A and Part B|Withdrawal by Subject|0
2852146|NCT02332720|9800100|P4|Part A and Part B|Withdrawal by Subject|0
2852147|NCT02332720|9800101|P3|Part A and Part B|Withdrawal by Subject|0
2852148|NCT02332720|9800102|P2|Part A and Part B|Withdrawal by Subject|0
2852149|NCT02332720|9800103|P1|Part A and Part B|Withdrawal by Subject|0
2852150|NCT02332720|9800081|P23|Part A and Part B|Physician Decision|0
2852151|NCT02332720|9800082|P22|Part A and Part B|Physician Decision|0
2852152|NCT02332720|9800083|P21|Part A and Part B|Physician Decision|0
2852153|NCT02332720|9800084|P20|Part A and Part B|Physician Decision|0
2852154|NCT02332720|9800085|P19|Part A and Part B|Physician Decision|1
2852155|NCT02332720|9800086|P18|Part A and Part B|Physician Decision|0
2852156|NCT02332720|9800087|P17|Part A and Part B|Physician Decision|0
2852157|NCT02332720|9800088|P16|Part A and Part B|Physician Decision|0
2852158|NCT02332720|9800089|P15|Part A and Part B|Physician Decision|0
2852159|NCT02332720|9800090|P14|Part A and Part B|Physician Decision|0
2852160|NCT02332720|9800091|P13|Part A and Part B|Physician Decision|0
2852161|NCT02332720|9800092|P12|Part A and Part B|Physician Decision|0
2852162|NCT02332720|9800093|P11|Part A and Part B|Physician Decision|0
2852163|NCT02332720|9800094|P10|Part A and Part B|Physician Decision|0
2852164|NCT02332720|9800095|P9|Part A and Part B|Physician Decision|0
2852165|NCT02332720|9800096|P8|Part A and Part B|Physician Decision|0
2852166|NCT02332720|9800097|P7|Part A and Part B|Physician Decision|0
2852167|NCT02332720|9800098|P6|Part A and Part B|Physician Decision|0
2852168|NCT02332720|9800099|P5|Part A and Part B|Physician Decision|0
2852169|NCT02332720|9800100|P4|Part A and Part B|Physician Decision|0
2852170|NCT02332720|9800101|P3|Part A and Part B|Physician Decision|0
2852171|NCT02332720|9800102|P2|Part A and Part B|Physician Decision|0
2852172|NCT02332720|9800103|P1|Part A and Part B|Physician Decision|0
2852173|NCT02332720|9800081|P23|Part A and Part B|Adverse Event|0
2852174|NCT02332720|9800082|P22|Part A and Part B|Adverse Event|0
2852175|NCT02332720|9800083|P21|Part A and Part B|Adverse Event|0
2852176|NCT02332720|9800084|P20|Part A and Part B|Adverse Event|0
2852177|NCT02332720|9800085|P19|Part A and Part B|Adverse Event|0
2852178|NCT02332720|9800086|P18|Part A and Part B|Adverse Event|1
2852179|NCT02332720|9800087|P17|Part A and Part B|Adverse Event|0
2852180|NCT02332720|9800088|P16|Part A and Part B|Adverse Event|0
2852181|NCT02332720|9800089|P15|Part A and Part B|Adverse Event|0
2852182|NCT02332720|9800090|P14|Part A and Part B|Adverse Event|0
2852183|NCT02332720|9800091|P13|Part A and Part B|Adverse Event|0
2852184|NCT02332720|9800092|P12|Part A and Part B|Adverse Event|0
2852185|NCT02332720|9800093|P11|Part A and Part B|Adverse Event|0
2852186|NCT02332720|9800094|P10|Part A and Part B|Adverse Event|0
2852187|NCT02332720|9800095|P9|Part A and Part B|Adverse Event|0
2852188|NCT02332720|9800096|P8|Part A and Part B|Adverse Event|0
2852189|NCT02332720|9800097|P7|Part A and Part B|Adverse Event|0
2852190|NCT02332720|9800098|P6|Part A and Part B|Adverse Event|0
2852191|NCT02332720|9800099|P5|Part A and Part B|Adverse Event|0
2852192|NCT02332720|9800100|P4|Part A and Part B|Adverse Event|0
2852193|NCT02332720|9800101|P3|Part A and Part B|Adverse Event|0
2852194|NCT02332720|9800102|P2|Part A and Part B|Adverse Event|0
2852195|NCT02332720|9800103|P1|Part A and Part B|Adverse Event|0
2852196|NCT02332720|9800081|P23|Part A and Part B|Lost to Follow-up|0
2852197|NCT02332720|9800082|P22|Part A and Part B|Lost to Follow-up|0
2852198|NCT02332720|9800083|P21|Part A and Part B|Lost to Follow-up|0
2852199|NCT02332720|9800084|P20|Part A and Part B|Lost to Follow-up|0
2852200|NCT02332720|9800085|P19|Part A and Part B|Lost to Follow-up|0
2852201|NCT02332720|9800086|P18|Part A and Part B|Lost to Follow-up|0
2852202|NCT02332720|9800087|P17|Part A and Part B|Lost to Follow-up|0
2852203|NCT02332720|9800088|P16|Part A and Part B|Lost to Follow-up|1
2852204|NCT02332720|9800089|P15|Part A and Part B|Lost to Follow-up|0
2852205|NCT02332720|9800090|P14|Part A and Part B|Lost to Follow-up|0
2852206|NCT02332720|9800091|P13|Part A and Part B|Lost to Follow-up|0
2852207|NCT02332720|9800092|P12|Part A and Part B|Lost to Follow-up|0
2852208|NCT02332720|9800093|P11|Part A and Part B|Lost to Follow-up|0
2852209|NCT02332720|9800094|P10|Part A and Part B|Lost to Follow-up|0
2852210|NCT02332720|9800095|P9|Part A and Part B|Lost to Follow-up|0
2852211|NCT02332720|9800096|P8|Part A and Part B|Lost to Follow-up|1
2852212|NCT02332720|9800097|P7|Part A and Part B|Lost to Follow-up|1
2852213|NCT02332720|9800098|P6|Part A and Part B|Lost to Follow-up|2
2852214|NCT02332720|9800099|P5|Part A and Part B|Lost to Follow-up|0
2852215|NCT02332720|9800100|P4|Part A and Part B|Lost to Follow-up|0
2852216|NCT02332720|9800101|P3|Part A and Part B|Lost to Follow-up|0
2852217|NCT02332720|9800102|P2|Part A and Part B|Lost to Follow-up|0
2852218|NCT02332720|9800103|P1|Part A and Part B|Lost to Follow-up|1
2852219|NCT02332707|9800239|P18|Overall Study|Withdrawal by Subject|0
2852220|NCT02332707|9800240|P17|Overall Study|Withdrawal by Subject|0
2852221|NCT02332707|9800241|P16|Overall Study|Withdrawal by Subject|0
2852222|NCT02332707|9800242|P15|Overall Study|Withdrawal by Subject|0
2852223|NCT02332707|9800243|P14|Overall Study|Withdrawal by Subject|0
2852224|NCT02332707|9800244|P13|Overall Study|Withdrawal by Subject|0
2852225|NCT02332707|9800245|P12|Overall Study|Withdrawal by Subject|0
2852226|NCT02332707|9800246|P11|Overall Study|Withdrawal by Subject|0
2852227|NCT02332707|9800247|P10|Overall Study|Withdrawal by Subject|3
2852228|NCT02332707|9800248|P9|Overall Study|Withdrawal by Subject|0
2852229|NCT02332707|9800249|P8|Overall Study|Withdrawal by Subject|0
2852230|NCT02332707|9800250|P7|Overall Study|Withdrawal by Subject|0
2852231|NCT02332707|9800251|P6|Overall Study|Withdrawal by Subject|0
2852232|NCT02332707|9800252|P5|Overall Study|Withdrawal by Subject|0
2852233|NCT02332707|9800253|P4|Overall Study|Withdrawal by Subject|0
2852234|NCT02332707|9800254|P3|Overall Study|Withdrawal by Subject|1
2852235|NCT02332707|9800255|P2|Overall Study|Withdrawal by Subject|0
2852236|NCT02332707|9800256|P1|Overall Study|Withdrawal by Subject|0
2852237|NCT02332707|9800239|P18|Overall Study|Physician Decision|0
2852238|NCT02332707|9800240|P17|Overall Study|Physician Decision|0
2852239|NCT02332707|9800241|P16|Overall Study|Physician Decision|0
2852240|NCT02332707|9800242|P15|Overall Study|Physician Decision|0
2852241|NCT02332707|9800243|P14|Overall Study|Physician Decision|0
2852242|NCT02332707|9800244|P13|Overall Study|Physician Decision|1
2852243|NCT02332707|9800245|P12|Overall Study|Physician Decision|0
2852244|NCT02332707|9800246|P11|Overall Study|Physician Decision|0
2852245|NCT02332707|9800247|P10|Overall Study|Physician Decision|0
2852246|NCT02332707|9800248|P9|Overall Study|Physician Decision|0
2852247|NCT02332707|9800249|P8|Overall Study|Physician Decision|0
2852248|NCT02332707|9800250|P7|Overall Study|Physician Decision|0
2852249|NCT02332707|9800251|P6|Overall Study|Physician Decision|0
2852250|NCT02332707|9800252|P5|Overall Study|Physician Decision|0
2852251|NCT02332707|9800253|P4|Overall Study|Physician Decision|1
2852252|NCT02332707|9800254|P3|Overall Study|Physician Decision|0
2852253|NCT02332707|9800255|P2|Overall Study|Physician Decision|0
2852254|NCT02332707|9800256|P1|Overall Study|Physician Decision|0
2852255|NCT02332707|9800239|P18|Overall Study|Lost to Follow-up|0
2852256|NCT02332707|9800240|P17|Overall Study|Lost to Follow-up|0
2852257|NCT02332707|9800241|P16|Overall Study|Lost to Follow-up|0
2852258|NCT02332707|9800242|P15|Overall Study|Lost to Follow-up|0
2852259|NCT02332707|9800243|P14|Overall Study|Lost to Follow-up|0
2852260|NCT02332707|9800244|P13|Overall Study|Lost to Follow-up|3
2852261|NCT02332707|9800245|P12|Overall Study|Lost to Follow-up|0
2852262|NCT02332707|9800246|P11|Overall Study|Lost to Follow-up|2
2852263|NCT02332707|9800247|P10|Overall Study|Lost to Follow-up|0
2852264|NCT02332707|9800248|P9|Overall Study|Lost to Follow-up|0
2852265|NCT02332707|9800249|P8|Overall Study|Lost to Follow-up|0
2852266|NCT02332707|9800250|P7|Overall Study|Lost to Follow-up|0
2852267|NCT02332707|9800251|P6|Overall Study|Lost to Follow-up|1
2852268|NCT02332707|9800252|P5|Overall Study|Lost to Follow-up|0
2852269|NCT02332707|9800253|P4|Overall Study|Lost to Follow-up|0
2852270|NCT02332707|9800254|P3|Overall Study|Lost to Follow-up|0
2852271|NCT02332707|9800255|P2|Overall Study|Lost to Follow-up|0
2852272|NCT02332707|9800256|P1|Overall Study|Lost to Follow-up|0
2852273|NCT02332707|9800239|P18|Overall Study|Adverse Event|0
2852274|NCT02332707|9800240|P17|Overall Study|Adverse Event|0
2852275|NCT02332707|9800241|P16|Overall Study|Adverse Event|0
2852276|NCT02332707|9800242|P15|Overall Study|Adverse Event|0
2852277|NCT02332707|9800243|P14|Overall Study|Adverse Event|0
2852278|NCT02332707|9800244|P13|Overall Study|Adverse Event|1
2852279|NCT02332707|9800245|P12|Overall Study|Adverse Event|0
2852280|NCT02332707|9800246|P11|Overall Study|Adverse Event|0
2852281|NCT02332707|9800247|P10|Overall Study|Adverse Event|0
2852282|NCT02332707|9800248|P9|Overall Study|Adverse Event|0
2852283|NCT02332707|9800249|P8|Overall Study|Adverse Event|0
2852284|NCT02332707|9800250|P7|Overall Study|Adverse Event|0
2852285|NCT02332707|9800251|P6|Overall Study|Adverse Event|0
2852286|NCT02332707|9800252|P5|Overall Study|Adverse Event|0
2852287|NCT02332707|9800253|P4|Overall Study|Adverse Event|0
2852288|NCT02332707|9800254|P3|Overall Study|Adverse Event|0
2852289|NCT02332707|9800255|P2|Overall Study|Adverse Event|0
2852290|NCT02332707|9800256|P1|Overall Study|Adverse Event|0
2852291|NCT02332590|9800350|P2|Overall Study|Other than specified above|5
2852292|NCT02332590|9800351|P1|Overall Study|Other than specified above|6
2852293|NCT02332590|9800350|P2|Overall Study|Randomized but not treated|0
2852294|NCT02332590|9800351|P1|Overall Study|Randomized but not treated|1
2852295|NCT02332590|9800350|P2|Overall Study|Poor compliance to protocol|1
2852296|NCT02332590|9800351|P1|Overall Study|Poor compliance to protocol|3
2852297|NCT02332590|9800350|P2|Overall Study|Lack of Efficacy|2
2852298|NCT02332590|9800351|P1|Overall Study|Lack of Efficacy|4
2852299|NCT02332590|9800350|P2|Overall Study|Adverse Event|11
2852300|NCT02332590|9800351|P1|Overall Study|Adverse Event|15
2852301|NCT02332239|9800415|P2|Overall Study|Lost to Follow-up|6
2852302|NCT02332239|9800416|P1|Overall Study|Lost to Follow-up|4
2852303|NCT02331680|9800452|P3|Overall Study|Protocol Violation|3
2852304|NCT02331680|9800453|P2|Overall Study|Protocol Violation|0
2852305|NCT02331680|9800454|P1|Overall Study|Protocol Violation|0
2852306|NCT02331680|9800452|P3|Overall Study|Non-compliance with study drug|1
2852307|NCT02331680|9800453|P2|Overall Study|Non-compliance with study drug|0
2852308|NCT02331680|9800454|P1|Overall Study|Non-compliance with study drug|0
2852309|NCT02331680|9800452|P3|Overall Study|Met withdrawal criteria|5
2852310|NCT02331680|9800453|P2|Overall Study|Met withdrawal criteria|2
2852311|NCT02331680|9800454|P1|Overall Study|Met withdrawal criteria|2
2852312|NCT02331680|9800452|P3|Overall Study|Withdrawal by Subject|2
2852313|NCT02331680|9800453|P2|Overall Study|Withdrawal by Subject|1
2852314|NCT02331680|9800454|P1|Overall Study|Withdrawal by Subject|0
2852315|NCT02331680|9800452|P3|Overall Study|Physician Decision|2
2852316|NCT02331680|9800453|P2|Overall Study|Physician Decision|1
2852317|NCT02331680|9800454|P1|Overall Study|Physician Decision|1
2852318|NCT02331680|9800452|P3|Overall Study|Adverse Event|2
2852319|NCT02331680|9800453|P2|Overall Study|Adverse Event|0
2852320|NCT02331680|9800454|P1|Overall Study|Adverse Event|3
2852321|NCT02331446|9800484|P4|Overall Study|Lost before baseline analysis|0
2852322|NCT02331446|9800485|P3|Overall Study|Lost before baseline analysis|1
2852323|NCT02331446|9800486|P2|Overall Study|Lost before baseline analysis|1
2852324|NCT02331446|9800487|P1|Overall Study|Lost before baseline analysis|0
2852325|NCT02331446|9800484|P4|Overall Study|Physician Decision|1
2852326|NCT02331446|9800485|P3|Overall Study|Physician Decision|0
2852327|NCT02331446|9800486|P2|Overall Study|Physician Decision|1
2852328|NCT02331446|9800487|P1|Overall Study|Physician Decision|0
2852329|NCT02331446|9800484|P4|Overall Study|Disease|1
2852330|NCT02331446|9800485|P3|Overall Study|Disease|2
2852331|NCT02331446|9800486|P2|Overall Study|Disease|2
2852332|NCT02331446|9800487|P1|Overall Study|Disease|0
2852333|NCT02331446|9800484|P4|Overall Study|Personal Problem|0
2852334|NCT02331446|9800485|P3|Overall Study|Personal Problem|0
2852335|NCT02331446|9800486|P2|Overall Study|Personal Problem|0
2852336|NCT02331446|9800487|P1|Overall Study|Personal Problem|2
2852337|NCT02331446|9800484|P4|Overall Study|Lost to Follow-up|1
2852338|NCT02331446|9800485|P3|Overall Study|Lost to Follow-up|0
2852339|NCT02331446|9800486|P2|Overall Study|Lost to Follow-up|1
2852340|NCT02331446|9800487|P1|Overall Study|Lost to Follow-up|2
2852341|NCT02331368|9800563|P1|Overall Study|Withdrawal by Subject|3
2852342|NCT02330549|9800659|P2|Overall Study|Failure to meet randomization criteria|0
2852343|NCT02330549|9800660|P1|Overall Study|Failure to meet randomization criteria|1
2852344|NCT02330549|9800659|P2|Overall Study|Subject withdrew consent|1
2852345|NCT02330549|9800660|P1|Overall Study|Subject withdrew consent|2
2852346|NCT02330549|9800659|P2|Overall Study|Adverse Event|0
2852347|NCT02330549|9800660|P1|Overall Study|Adverse Event|1
2852348|NCT02330081|9800835|P1|Overall Study|Protocol Violation|6
2852349|NCT02330081|9800835|P1|Overall Study|Donation did not meet criteria|1
2852350|NCT02330081|9800835|P1|Overall Study|Adverse Event|1
2852351|NCT02330055|9800856|P2|Overall Study|participant did not sleep|1
2852352|NCT02330055|9800857|P1|Overall Study|participant did not sleep|0
2852353|NCT02330055|9800856|P2|Overall Study|data for less than 60 minutes|3
2852354|NCT02330055|9800857|P1|Overall Study|data for less than 60 minutes|3
2852355|NCT02330055|9800856|P2|Overall Study|participant forgot to wear device|5
2852356|NCT02330055|9800857|P1|Overall Study|participant forgot to wear device|5
2852357|NCT02330055|9800856|P2|Overall Study|technical issues|0
2852358|NCT02330055|9800857|P1|Overall Study|technical issues|2
2852359|NCT02329743|9800903|P3|Overall Study|Other|3
2852360|NCT02329743|9800904|P2|Overall Study|Other|2
2852361|NCT02329743|9800905|P1|Overall Study|Other|0
2852362|NCT02329743|9800903|P3|Overall Study|Withdrawal by Subject|1
2852363|NCT02329743|9800904|P2|Overall Study|Withdrawal by Subject|4
2852364|NCT02329743|9800905|P1|Overall Study|Withdrawal by Subject|4
2852365|NCT02329743|9800903|P3|Overall Study|Lost to Follow-up|1
2852366|NCT02329743|9800904|P2|Overall Study|Lost to Follow-up|0
2852367|NCT02329743|9800905|P1|Overall Study|Lost to Follow-up|1
2852368|NCT02329743|9800903|P3|Overall Study|Adverse Event|3
2852369|NCT02329743|9800904|P2|Overall Study|Adverse Event|1
2852370|NCT02329743|9800905|P1|Overall Study|Adverse Event|1
2852371|NCT02329730|9800920|P12|Overall Study|Withdrawal by Subject|0
2852372|NCT02329730|9800921|P11|Overall Study|Withdrawal by Subject|0
2852373|NCT02329730|9800922|P10|Overall Study|Withdrawal by Subject|1
2852374|NCT02329730|9800923|P9|Overall Study|Withdrawal by Subject|1
2852375|NCT02329730|9800924|P8|Overall Study|Withdrawal by Subject|1
2852376|NCT02329730|9800925|P7|Overall Study|Withdrawal by Subject|1
2852377|NCT02329730|9800926|P6|Overall Study|Withdrawal by Subject|0
2852378|NCT02329730|9800927|P5|Overall Study|Withdrawal by Subject|1
2852379|NCT02329730|9800928|P4|Overall Study|Withdrawal by Subject|0
2852380|NCT02329730|9800929|P3|Overall Study|Withdrawal by Subject|0
2852381|NCT02329730|9800930|P2|Overall Study|Withdrawal by Subject|0
2852382|NCT02329730|9800931|P1|Overall Study|Withdrawal by Subject|0
2852383|NCT02329730|9800920|P12|Overall Study|Protocol Violation|0
2852384|NCT02329730|9800921|P11|Overall Study|Protocol Violation|0
2852385|NCT02329730|9800922|P10|Overall Study|Protocol Violation|0
2852386|NCT02329730|9800923|P9|Overall Study|Protocol Violation|0
2852387|NCT02329730|9800924|P8|Overall Study|Protocol Violation|0
2852388|NCT02329730|9800925|P7|Overall Study|Protocol Violation|0
2852389|NCT02329730|9800926|P6|Overall Study|Protocol Violation|2
2852390|NCT02329730|9800927|P5|Overall Study|Protocol Violation|2
2852391|NCT02329730|9800928|P4|Overall Study|Protocol Violation|0
2852392|NCT02329730|9800929|P3|Overall Study|Protocol Violation|0
2852393|NCT02329730|9800930|P2|Overall Study|Protocol Violation|0
2852394|NCT02329730|9800931|P1|Overall Study|Protocol Violation|0
2852395|NCT02329431|9801042|P2|Overall Study|Lost to Follow-up|13
2852396|NCT02329431|9801043|P1|Overall Study|Lost to Follow-up|20
2852397|NCT02329223|9801062|P3|Overall Study|Adverse Event|0
2852398|NCT02329223|9801063|P2|Overall Study|Adverse Event|1
2852399|NCT02329223|9801064|P1|Overall Study|Adverse Event|0
2852400|NCT02329223|9801062|P3|Overall Study|Physician Decision|1
2852401|NCT02329223|9801063|P2|Overall Study|Physician Decision|0
2852402|NCT02329223|9801064|P1|Overall Study|Physician Decision|0
2852403|NCT02329223|9801062|P3|Overall Study|Withdrawal by Subject|5
2852404|NCT02329223|9801063|P2|Overall Study|Withdrawal by Subject|2
2852405|NCT02329223|9801064|P1|Overall Study|Withdrawal by Subject|1
2852406|NCT02328937|9801114|P6|Period 2|Adverse Event|0
2852407|NCT02328937|9801115|P5|Period 2|Adverse Event|0
2852408|NCT02328937|9801116|P4|Period 2|Adverse Event|0
2852409|NCT02328937|9801117|P3|Period 2|Adverse Event|1
2852410|NCT02328937|9801118|P2|Period 2|Adverse Event|0
2852411|NCT02328937|9801119|P1|Period 2|Adverse Event|0
2852412|NCT02328937|9801114|P6|Period 1|Lost to Follow-up|0
2852413|NCT02328937|9801115|P5|Period 1|Lost to Follow-up|0
2852414|NCT02328937|9801116|P4|Period 1|Lost to Follow-up|1
2852415|NCT02328937|9801117|P3|Period 1|Lost to Follow-up|0
2852416|NCT02328937|9801118|P2|Period 1|Lost to Follow-up|0
2852417|NCT02328937|9801119|P1|Period 1|Lost to Follow-up|0
2852418|NCT02328547|9801139|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
2852419|NCT02328547|9801140|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
2852420|NCT02328547|9801139|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
2852421|NCT02328547|9801140|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
2852422|NCT02328105|9801215|P1|Overall Study|Still On Study in Follow-Up|4
2852423|NCT02328105|9801215|P1|Overall Study|Withdrawal by Subject|1
2852424|NCT02328105|9801215|P1|Overall Study|Death|6
2852425|NCT02328040|9801220|P2|First Intervention (2 Days)|Withdrawal by Subject|1
2852426|NCT02328040|9801221|P1|First Intervention (2 Days)|Withdrawal by Subject|1
2852427|NCT02327325|9801273|P3|Overall Study|Excluded by Study Team|1
2852428|NCT02327325|9801274|P2|Overall Study|Excluded by Study Team|0
2852429|NCT02327325|9801275|P1|Overall Study|Excluded by Study Team|0
2852430|NCT02327325|9801273|P3|Overall Study|Withdrawal by Subject|4
2852431|NCT02327325|9801274|P2|Overall Study|Withdrawal by Subject|4
2852432|NCT02327325|9801275|P1|Overall Study|Withdrawal by Subject|1
2852433|NCT02327260|9801298|P3|Overall Study|cognitive concerns|0
2852434|NCT02327260|9801299|P2|Overall Study|cognitive concerns|0
2852435|NCT02327260|9801300|P1|Overall Study|cognitive concerns|1
2852436|NCT02327260|9801298|P3|Overall Study|non-adherence to protocol|0
2852437|NCT02327260|9801299|P2|Overall Study|non-adherence to protocol|0
2852438|NCT02327260|9801300|P1|Overall Study|non-adherence to protocol|2
2852439|NCT02327260|9801298|P3|Overall Study|invalid phone number|0
2852440|NCT02327260|9801299|P2|Overall Study|invalid phone number|1
2852441|NCT02327260|9801300|P1|Overall Study|invalid phone number|1
2852442|NCT02327260|9801298|P3|Overall Study|Lost to Follow-up|2
2852443|NCT02327260|9801299|P2|Overall Study|Lost to Follow-up|3
2852444|NCT02327260|9801300|P1|Overall Study|Lost to Follow-up|2
2852445|NCT02327169|9801347|P15|Overall Study|Lost to Follow-up|0
2852446|NCT02327169|9801348|P14|Overall Study|Lost to Follow-up|0
2852447|NCT02327169|9801349|P13|Overall Study|Lost to Follow-up|0
2852448|NCT02327169|9801350|P12|Overall Study|Lost to Follow-up|0
2852449|NCT02327169|9801351|P11|Overall Study|Lost to Follow-up|0
2852450|NCT02327169|9801352|P10|Overall Study|Lost to Follow-up|0
2852451|NCT02327169|9801353|P9|Overall Study|Lost to Follow-up|0
2852452|NCT02327169|9801354|P8|Overall Study|Lost to Follow-up|0
2852453|NCT02327169|9801355|P7|Overall Study|Lost to Follow-up|0
2852454|NCT02327169|9801356|P6|Overall Study|Lost to Follow-up|0
2852455|NCT02327169|9801357|P5|Overall Study|Lost to Follow-up|1
2852456|NCT02327169|9801358|P4|Overall Study|Lost to Follow-up|0
2852457|NCT02327169|9801359|P3|Overall Study|Lost to Follow-up|0
2852458|NCT02327169|9801360|P2|Overall Study|Lost to Follow-up|0
2852459|NCT02327169|9801361|P1|Overall Study|Lost to Follow-up|0
2852460|NCT02327169|9801347|P15|Overall Study|Withdrawal by Subject|3
2852461|NCT02327169|9801348|P14|Overall Study|Withdrawal by Subject|0
2852462|NCT02327169|9801349|P13|Overall Study|Withdrawal by Subject|0
2852463|NCT02327169|9801350|P12|Overall Study|Withdrawal by Subject|0
2852464|NCT02327169|9801351|P11|Overall Study|Withdrawal by Subject|0
2852465|NCT02327169|9801352|P10|Overall Study|Withdrawal by Subject|0
2852466|NCT02327169|9801353|P9|Overall Study|Withdrawal by Subject|0
2852467|NCT02327169|9801354|P8|Overall Study|Withdrawal by Subject|1
2852468|NCT02327169|9801355|P7|Overall Study|Withdrawal by Subject|0
2852469|NCT02327169|9801356|P6|Overall Study|Withdrawal by Subject|0
2852470|NCT02327169|9801357|P5|Overall Study|Withdrawal by Subject|1
2852471|NCT02327169|9801358|P4|Overall Study|Withdrawal by Subject|0
2852472|NCT02327169|9801359|P3|Overall Study|Withdrawal by Subject|0
2852473|NCT02327169|9801360|P2|Overall Study|Withdrawal by Subject|0
2852474|NCT02327169|9801361|P1|Overall Study|Withdrawal by Subject|1
2852475|NCT02327169|9801347|P15|Overall Study|Reason Not Specified|2
2852476|NCT02327169|9801348|P14|Overall Study|Reason Not Specified|0
2852477|NCT02327169|9801349|P13|Overall Study|Reason Not Specified|0
2852478|NCT02327169|9801350|P12|Overall Study|Reason Not Specified|1
2852479|NCT02327169|9801351|P11|Overall Study|Reason Not Specified|2
2852480|NCT02327169|9801352|P10|Overall Study|Reason Not Specified|1
2852481|NCT02327169|9801353|P9|Overall Study|Reason Not Specified|0
2852482|NCT02327169|9801354|P8|Overall Study|Reason Not Specified|0
2852483|NCT02327169|9801355|P7|Overall Study|Reason Not Specified|0
2852484|NCT02327169|9801356|P6|Overall Study|Reason Not Specified|0
2852485|NCT02327169|9801357|P5|Overall Study|Reason Not Specified|0
2852486|NCT02327169|9801358|P4|Overall Study|Reason Not Specified|0
2852487|NCT02327169|9801359|P3|Overall Study|Reason Not Specified|1
2852488|NCT02327169|9801360|P2|Overall Study|Reason Not Specified|0
2852489|NCT02327169|9801361|P1|Overall Study|Reason Not Specified|0
2852490|NCT02327169|9801347|P15|Overall Study|Symptomatic Deterioration|1
2852491|NCT02327169|9801348|P14|Overall Study|Symptomatic Deterioration|2
2852492|NCT02327169|9801349|P13|Overall Study|Symptomatic Deterioration|0
2852493|NCT02327169|9801350|P12|Overall Study|Symptomatic Deterioration|0
2852494|NCT02327169|9801351|P11|Overall Study|Symptomatic Deterioration|0
2852495|NCT02327169|9801352|P10|Overall Study|Symptomatic Deterioration|1
2852496|NCT02327169|9801353|P9|Overall Study|Symptomatic Deterioration|2
2852497|NCT02327169|9801354|P8|Overall Study|Symptomatic Deterioration|0
2852498|NCT02327169|9801355|P7|Overall Study|Symptomatic Deterioration|0
2852499|NCT02327169|9801356|P6|Overall Study|Symptomatic Deterioration|1
2852500|NCT02327169|9801357|P5|Overall Study|Symptomatic Deterioration|1
2852501|NCT02327169|9801358|P4|Overall Study|Symptomatic Deterioration|0
2852502|NCT02327169|9801359|P3|Overall Study|Symptomatic Deterioration|1
2852503|NCT02327169|9801360|P2|Overall Study|Symptomatic Deterioration|0
2852504|NCT02327169|9801361|P1|Overall Study|Symptomatic Deterioration|0
2852505|NCT02327169|9801347|P15|Overall Study|Adverse Event|1
2852506|NCT02327169|9801348|P14|Overall Study|Adverse Event|2
2852507|NCT02327169|9801349|P13|Overall Study|Adverse Event|0
2852508|NCT02327169|9801350|P12|Overall Study|Adverse Event|3
2852509|NCT02327169|9801351|P11|Overall Study|Adverse Event|0
2852510|NCT02327169|9801352|P10|Overall Study|Adverse Event|2
2852511|NCT02327169|9801353|P9|Overall Study|Adverse Event|0
2852512|NCT02327169|9801354|P8|Overall Study|Adverse Event|0
2852513|NCT02327169|9801355|P7|Overall Study|Adverse Event|0
2852514|NCT02327169|9801356|P6|Overall Study|Adverse Event|0
2852515|NCT02327169|9801357|P5|Overall Study|Adverse Event|1
2852516|NCT02327169|9801358|P4|Overall Study|Adverse Event|0
2852517|NCT02327169|9801359|P3|Overall Study|Adverse Event|1
2852518|NCT02327169|9801360|P2|Overall Study|Adverse Event|0
2852519|NCT02327169|9801361|P1|Overall Study|Adverse Event|2
2852520|NCT02327169|9801347|P15|Overall Study|Progressive Disease|3
2852521|NCT02327169|9801348|P14|Overall Study|Progressive Disease|3
2852522|NCT02327169|9801349|P13|Overall Study|Progressive Disease|1
2852523|NCT02327169|9801350|P12|Overall Study|Progressive Disease|3
2852524|NCT02327169|9801351|P11|Overall Study|Progressive Disease|4
2852525|NCT02327169|9801352|P10|Overall Study|Progressive Disease|4
2852526|NCT02327169|9801353|P9|Overall Study|Progressive Disease|4
2852527|NCT02327169|9801354|P8|Overall Study|Progressive Disease|3
2852528|NCT02327169|9801355|P7|Overall Study|Progressive Disease|3
2852529|NCT02327169|9801356|P6|Overall Study|Progressive Disease|3
2852530|NCT02327169|9801357|P5|Overall Study|Progressive Disease|4
2852531|NCT02327169|9801358|P4|Overall Study|Progressive Disease|3
2852532|NCT02327169|9801359|P3|Overall Study|Progressive Disease|4
2852533|NCT02327169|9801360|P2|Overall Study|Progressive Disease|3
2852534|NCT02327169|9801361|P1|Overall Study|Progressive Disease|1
2852535|NCT02327130|9801591|P1|Overall Study|Met exclusion criteria|3
2852536|NCT02327130|9801591|P1|Overall Study|Incorrectly place ventilator adaptor|1
2852537|NCT02327130|9801591|P1|Overall Study|Unable to provide breath sample|1
2852538|NCT02327130|9801591|P1|Overall Study|Physician Decision|2
2852539|NCT02327130|9801591|P1|Overall Study|Discharged in less than 5 days|5
2852540|NCT02327013|9801610|P5|Overall Study|Withdrawal before treatment|0
2852541|NCT02327013|9801611|P4|Overall Study|Withdrawal before treatment|0
2852542|NCT02327013|9801612|P3|Overall Study|Withdrawal before treatment|5
2852543|NCT02327013|9801613|P2|Overall Study|Withdrawal before treatment|1
2852544|NCT02327013|9801614|P1|Overall Study|Withdrawal before treatment|2
2852545|NCT02327013|9801610|P5|Overall Study|Protocol Violation|1
2852546|NCT02327013|9801611|P4|Overall Study|Protocol Violation|0
2852547|NCT02327013|9801612|P3|Overall Study|Protocol Violation|3
2852548|NCT02327013|9801613|P2|Overall Study|Protocol Violation|0
2852549|NCT02327013|9801614|P1|Overall Study|Protocol Violation|0
2852550|NCT02327013|9801610|P5|Overall Study|Administrative or other reason(s)|1
2852551|NCT02327013|9801611|P4|Overall Study|Administrative or other reason(s)|1
2852552|NCT02327013|9801612|P3|Overall Study|Administrative or other reason(s)|11
2852553|NCT02327013|9801613|P2|Overall Study|Administrative or other reason(s)|5
2852554|NCT02327013|9801614|P1|Overall Study|Administrative or other reason(s)|1
2852555|NCT02327013|9801610|P5|Overall Study|Lost to Follow-up|0
2852556|NCT02327013|9801611|P4|Overall Study|Lost to Follow-up|0
2852557|NCT02327013|9801612|P3|Overall Study|Lost to Follow-up|5
2852558|NCT02327013|9801613|P2|Overall Study|Lost to Follow-up|4
2852559|NCT02327013|9801614|P1|Overall Study|Lost to Follow-up|2
2852560|NCT02327013|9801610|P5|Overall Study|Withdrawal of Consent|0
2852561|NCT02327013|9801611|P4|Overall Study|Withdrawal of Consent|0
2852562|NCT02327013|9801612|P3|Overall Study|Withdrawal of Consent|3
2852563|NCT02327013|9801613|P2|Overall Study|Withdrawal of Consent|0
2852564|NCT02327013|9801614|P1|Overall Study|Withdrawal of Consent|1
2852565|NCT02327013|9801610|P5|Overall Study|Non-compliance with IMP|0
2852566|NCT02327013|9801611|P4|Overall Study|Non-compliance with IMP|0
2852567|NCT02327013|9801612|P3|Overall Study|Non-compliance with IMP|7
2852568|NCT02327013|9801613|P2|Overall Study|Non-compliance with IMP|2
2852569|NCT02327013|9801614|P1|Overall Study|Non-compliance with IMP|1
2852570|NCT02327013|9801610|P5|Overall Study|Lack of Efficacy|1
2852571|NCT02327013|9801611|P4|Overall Study|Lack of Efficacy|0
2852572|NCT02327013|9801612|P3|Overall Study|Lack of Efficacy|5
2852573|NCT02327013|9801613|P2|Overall Study|Lack of Efficacy|0
2852574|NCT02327013|9801614|P1|Overall Study|Lack of Efficacy|2
2852575|NCT02327013|9801610|P5|Overall Study|Adverse Event|1
2852576|NCT02327013|9801611|P4|Overall Study|Adverse Event|0
2852577|NCT02327013|9801612|P3|Overall Study|Adverse Event|3
2852578|NCT02327013|9801613|P2|Overall Study|Adverse Event|4
2852579|NCT02327013|9801614|P1|Overall Study|Adverse Event|4
2852580|NCT02326597|9801800|P2|Overall Study|Lost to Follow-up|32
2852581|NCT02326597|9801801|P1|Overall Study|Lost to Follow-up|42
2852582|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2852583|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2852584|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2852585|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852586|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852587|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852588|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852589|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852590|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852591|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852592|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852593|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852594|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852595|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852596|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2852597|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
2852598|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
2852599|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852600|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852601|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852602|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852603|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852604|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852605|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852606|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852607|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852608|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852609|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852610|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2852611|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2852612|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
2852613|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852614|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852615|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852616|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852617|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852618|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852619|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852620|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852621|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852622|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852623|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852624|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
2852625|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852626|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852627|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852628|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852629|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852630|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852631|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852632|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852633|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852634|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852635|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852636|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852637|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852638|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852639|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2852640|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2852641|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852642|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852643|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852644|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852645|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852646|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852647|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852648|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852649|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852650|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852651|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852652|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852653|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2852654|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2852655|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852656|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852657|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852658|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852659|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852660|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852661|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852662|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852663|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852664|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852665|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852666|NCT02326298|9801822|P14|Open-label Period (Week 48 to Week 144)|Death|0
2852667|NCT02326298|9801823|P13|Open-label Period (Week 48 to Week 144)|Death|0
2852668|NCT02326298|9801824|P12|Open-label Period (Week 48 to Week 144)|Death|1
2852669|NCT02326298|9801825|P11|Open-label Period (Week 48 to Week 144)|Death|0
2852670|NCT02326298|9801826|P10|Open-label Period (Week 48 to Week 144)|Death|0
2852671|NCT02326298|9801827|P9|Open-label Period (Week 48 to Week 144)|Death|0
2852672|NCT02326298|9801828|P8|Open-label Period (Week 48 to Week 144)|Death|0
2852673|NCT02326298|9801829|P7|Open-label Period (Week 48 to Week 144)|Death|0
2852674|NCT02326298|9801830|P6|Open-label Period (Week 48 to Week 144)|Death|0
2852675|NCT02326298|9801831|P5|Open-label Period (Week 48 to Week 144)|Death|0
2852676|NCT02326298|9801832|P4|Open-label Period (Week 48 to Week 144)|Death|0
2852677|NCT02326298|9801833|P3|Open-label Period (Week 48 to Week 144)|Death|0
2852678|NCT02326298|9801834|P2|Open-label Period (Week 48 to Week 144)|Death|0
2852679|NCT02326298|9801835|P1|Open-label Period (Week 48 to Week 144)|Death|0
2852680|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852681|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852682|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852683|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852684|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852685|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852686|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852687|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852688|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
2852689|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852690|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852691|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852692|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852693|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2852694|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852695|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852696|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852697|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852698|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852699|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852700|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2852701|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852702|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852703|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852704|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852705|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852706|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852707|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2852708|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852709|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852710|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852711|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852712|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852713|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852714|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2852715|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2852716|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852717|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852718|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852719|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852720|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852721|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2852722|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852723|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852724|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852725|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852726|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852727|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852728|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
2852729|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852730|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852731|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852732|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852733|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852734|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852735|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2852736|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852737|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852738|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852739|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852740|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852741|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852742|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852743|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2852744|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852745|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852746|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852747|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852748|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852749|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2852750|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852751|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852752|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852753|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852754|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852755|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852756|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852757|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852758|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
2852759|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852760|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852761|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852762|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852763|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2852764|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852765|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852766|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852767|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852768|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852769|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
2852770|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852771|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
2852772|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
2852773|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852774|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2853415|NCT02323646|9802645|P3|Treatment Course 1|Lost to Follow-up|2
2852775|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852776|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852777|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2852778|NCT02326298|9801822|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852779|NCT02326298|9801823|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852780|NCT02326298|9801824|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852781|NCT02326298|9801825|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852782|NCT02326298|9801826|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2852783|NCT02326298|9801827|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2852784|NCT02326298|9801828|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2852785|NCT02326298|9801829|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2852786|NCT02326298|9801830|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2852787|NCT02326298|9801831|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852788|NCT02326298|9801832|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852789|NCT02326298|9801833|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852790|NCT02326298|9801834|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852791|NCT02326298|9801835|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2852792|NCT02326298|9801822|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852793|NCT02326298|9801823|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852794|NCT02326298|9801824|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852795|NCT02326298|9801825|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852796|NCT02326298|9801826|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852797|NCT02326298|9801827|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852798|NCT02326298|9801828|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852799|NCT02326298|9801829|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852800|NCT02326298|9801830|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852801|NCT02326298|9801831|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852802|NCT02326298|9801832|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852803|NCT02326298|9801833|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
2852804|NCT02326298|9801834|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852805|NCT02326298|9801835|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2852806|NCT02326298|9801822|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852807|NCT02326298|9801823|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852808|NCT02326298|9801824|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852809|NCT02326298|9801825|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852810|NCT02326298|9801826|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852811|NCT02326298|9801827|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852812|NCT02326298|9801828|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852813|NCT02326298|9801829|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852814|NCT02326298|9801830|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852815|NCT02326298|9801831|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852816|NCT02326298|9801832|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852817|NCT02326298|9801833|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2852818|NCT02326298|9801834|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2852819|NCT02326298|9801835|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2852820|NCT02326298|9801822|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852821|NCT02326298|9801823|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852822|NCT02326298|9801824|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852823|NCT02326298|9801825|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852824|NCT02326298|9801826|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852825|NCT02326298|9801827|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852826|NCT02326298|9801828|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852827|NCT02326298|9801829|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852828|NCT02326298|9801830|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852829|NCT02326298|9801831|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852830|NCT02326298|9801832|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852831|NCT02326298|9801833|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2852832|NCT02326298|9801834|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2852833|NCT02326298|9801835|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2852834|NCT02326298|9801822|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852835|NCT02326298|9801823|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852836|NCT02326298|9801824|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852837|NCT02326298|9801825|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852838|NCT02326298|9801826|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852839|NCT02326298|9801827|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852840|NCT02326298|9801828|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852841|NCT02326298|9801829|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852842|NCT02326298|9801830|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852843|NCT02326298|9801831|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852844|NCT02326298|9801832|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852845|NCT02326298|9801833|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852846|NCT02326298|9801834|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2852847|NCT02326298|9801835|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
2852848|NCT02326298|9801822|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852849|NCT02326298|9801823|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852850|NCT02326298|9801824|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852851|NCT02326298|9801825|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852852|NCT02326298|9801826|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852853|NCT02326298|9801827|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852854|NCT02326298|9801828|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852855|NCT02326298|9801829|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852856|NCT02326298|9801830|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852857|NCT02326298|9801831|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852858|NCT02326298|9801832|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852859|NCT02326298|9801833|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2852860|NCT02326298|9801834|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852861|NCT02326298|9801835|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
2852862|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852863|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852864|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
2852865|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852866|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852867|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852868|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852869|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852870|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852871|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852872|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852873|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852874|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852875|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852876|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2852877|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852878|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852879|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852880|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
2852881|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852882|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852883|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852884|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852885|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852886|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852887|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852888|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852889|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852890|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852891|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2852892|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2852893|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852894|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2852895|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
2852896|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852897|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852898|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852899|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852900|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852901|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852902|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852903|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852904|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852905|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852906|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2852907|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2852908|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852909|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852910|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2852911|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852912|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852913|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852914|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852915|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852916|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852917|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852918|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852919|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852920|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852921|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2852922|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2852923|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852924|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
2852925|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852926|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
2852927|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852928|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852929|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852930|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852931|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852932|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852933|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852934|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852935|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852936|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2852937|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852938|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852939|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852940|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
2852941|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852942|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852943|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852944|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852945|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852946|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852947|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852948|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852949|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852950|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852951|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2852952|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852953|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852954|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2852955|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852956|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2852957|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852958|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852959|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852960|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852961|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852962|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852963|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852964|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852965|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852966|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2852967|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2852968|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852969|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2852970|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
2852971|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2852972|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852973|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852974|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852975|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852976|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852977|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852978|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852979|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852980|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852981|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2852982|NCT02326272|9801858|P15|Open-label Period (Week 48 to Week 144)|Death|0
2852983|NCT02326272|9801859|P14|Open-label Period (Week 48 to Week 144)|Death|0
2852984|NCT02326272|9801860|P13|Open-label Period (Week 48 to Week 144)|Death|1
2852985|NCT02326272|9801861|P12|Open-label Period (Week 48 to Week 144)|Death|0
2852986|NCT02326272|9801862|P11|Open-label Period (Week 48 to Week 144)|Death|0
2852987|NCT02326272|9801863|P10|Open-label Period (Week 48 to Week 144)|Death|0
2852988|NCT02326272|9801864|P9|Open-label Period (Week 48 to Week 144)|Death|0
2852989|NCT02326272|9801865|P8|Open-label Period (Week 48 to Week 144)|Death|0
2852990|NCT02326272|9801866|P7|Open-label Period (Week 48 to Week 144)|Death|0
2852991|NCT02326272|9801867|P6|Open-label Period (Week 48 to Week 144)|Death|0
2852992|NCT02326272|9801868|P5|Open-label Period (Week 48 to Week 144)|Death|0
2852993|NCT02326272|9801869|P4|Open-label Period (Week 48 to Week 144)|Death|0
2852994|NCT02326272|9801870|P3|Open-label Period (Week 48 to Week 144)|Death|0
2852995|NCT02326272|9801871|P2|Open-label Period (Week 48 to Week 144)|Death|0
2852996|NCT02326272|9801872|P1|Open-label Period (Week 48 to Week 144)|Death|0
2852997|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2852998|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2852999|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853000|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853001|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853002|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853003|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853004|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853005|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
2853006|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853007|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853008|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853009|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853010|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853011|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2853012|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853013|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853014|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853015|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853016|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853017|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853018|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853019|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853020|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853021|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
2853022|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853023|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853024|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853025|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853026|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2853027|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853028|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853029|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853030|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853031|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853032|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853033|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2853034|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2853035|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2853036|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2853037|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853038|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853039|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853040|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853041|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2853042|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853043|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853044|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853045|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853046|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853047|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853048|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
2853049|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853050|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853051|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853052|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853053|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853054|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853055|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853056|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2853057|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853058|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853059|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853060|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853061|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853062|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853063|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853064|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853065|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2853066|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853067|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853068|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853069|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853070|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853071|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2853072|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853073|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853074|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853075|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853076|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853077|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853078|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853079|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
2853080|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853081|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853082|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853083|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853084|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853085|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853086|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2853087|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853088|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853089|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853090|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853091|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853092|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2853093|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853094|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2853095|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2853096|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2853097|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853098|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2853099|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853100|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853101|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2853102|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853103|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853104|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853105|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853106|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853107|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853108|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853109|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2853110|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853111|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2853112|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853113|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853114|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853115|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853116|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2853117|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853118|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853119|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853120|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853121|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853122|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2853123|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2853124|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853125|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2853126|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
2853127|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853128|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853129|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853130|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853131|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2853132|NCT02326272|9801858|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853133|NCT02326272|9801859|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853134|NCT02326272|9801860|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853135|NCT02326272|9801861|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853136|NCT02326272|9801862|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853137|NCT02326272|9801863|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853138|NCT02326272|9801864|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2853139|NCT02326272|9801865|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2853140|NCT02326272|9801866|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2853141|NCT02326272|9801867|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
2853142|NCT02326272|9801868|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2853143|NCT02326272|9801869|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853144|NCT02326272|9801870|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853145|NCT02326272|9801871|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853146|NCT02326272|9801872|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2853147|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853148|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853149|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853150|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853151|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853152|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853153|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853154|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853155|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853156|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853157|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853158|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853159|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
2853160|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853161|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2853162|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853163|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853164|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853165|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853166|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853167|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853168|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853169|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853170|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853171|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853172|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853173|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853174|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
2853175|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853176|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2853177|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853178|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853179|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853180|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853181|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853182|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853183|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853184|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853185|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853186|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853187|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853188|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853189|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
2853190|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853191|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
2853192|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853193|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853194|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853195|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853196|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853197|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853198|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853199|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853200|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853201|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853202|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853203|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853204|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
2853205|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853206|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2853207|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853208|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853209|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853210|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853211|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853212|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853213|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853214|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853215|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853216|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853217|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853218|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2853219|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2853220|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2853221|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2853222|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853223|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853224|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853225|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853226|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853227|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853228|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853229|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853230|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853231|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853232|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853233|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853234|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2853235|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
2853236|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2853237|NCT02326272|9801858|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853238|NCT02326272|9801859|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853239|NCT02326272|9801860|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853240|NCT02326272|9801861|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853241|NCT02326272|9801862|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853242|NCT02326272|9801863|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853243|NCT02326272|9801864|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853244|NCT02326272|9801865|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853245|NCT02326272|9801866|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853246|NCT02326272|9801867|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853247|NCT02326272|9801868|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853248|NCT02326272|9801869|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853249|NCT02326272|9801870|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2853250|NCT02326272|9801871|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
2853251|NCT02326272|9801872|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
2853252|NCT02326220|9801909|P3|Open-label Treatment Period|Lost to Follow-up|1
2853253|NCT02326220|9801910|P2|Open-label Treatment Period|Lost to Follow-up|0
2853254|NCT02326220|9801911|P1|Open-label Treatment Period|Lost to Follow-up|0
2853255|NCT02326220|9801909|P3|Open-label Treatment Period|Withdrawal by Subject|1
2853256|NCT02326220|9801910|P2|Open-label Treatment Period|Withdrawal by Subject|0
2853257|NCT02326220|9801911|P1|Open-label Treatment Period|Withdrawal by Subject|0
2853258|NCT02326220|9801909|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2853259|NCT02326220|9801910|P2|Double-blind Treatment Period|Withdrawal by Subject|1
2853260|NCT02326220|9801911|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2853261|NCT02326220|9801909|P3|Double-blind Treatment Period|Protocol Violation|0
2853262|NCT02326220|9801910|P2|Double-blind Treatment Period|Protocol Violation|1
2853263|NCT02326220|9801911|P1|Double-blind Treatment Period|Protocol Violation|0
2853264|NCT02326220|9801909|P3|Double-blind Treatment Period|Adverse Event|0
2853265|NCT02326220|9801910|P2|Double-blind Treatment Period|Adverse Event|2
2853266|NCT02326220|9801911|P1|Double-blind Treatment Period|Adverse Event|1
2853267|NCT02326025|9801964|P2|Overall Study|Protocol Violation|1
2853268|NCT02326025|9801965|P1|Overall Study|Protocol Violation|0
2853269|NCT02326025|9801964|P2|Overall Study|Withdrawal by Subject|2
2853270|NCT02326025|9801965|P1|Overall Study|Withdrawal by Subject|0
2853271|NCT02326025|9801964|P2|Overall Study|Physician and Participant Decision|0
2853272|NCT02326025|9801965|P1|Overall Study|Physician and Participant Decision|1
2853273|NCT02326025|9801964|P2|Overall Study|Physician Decision|2
2853274|NCT02326025|9801965|P1|Overall Study|Physician Decision|1
2853275|NCT02326025|9801964|P2|Overall Study|Adverse Event|0
2853276|NCT02326025|9801965|P1|Overall Study|Adverse Event|3
2853277|NCT02325791|9802012|P4|Overall Study|Withdrawal by Subject|16
2853278|NCT02325791|9802013|P3|Overall Study|Withdrawal by Subject|8
2853279|NCT02325791|9802014|P2|Overall Study|Withdrawal by Subject|5
2853280|NCT02325791|9802015|P1|Overall Study|Withdrawal by Subject|0
2853281|NCT02325791|9802012|P4|Overall Study|Protocol Violation|0
2853282|NCT02325791|9802013|P3|Overall Study|Protocol Violation|1
2853283|NCT02325791|9802014|P2|Overall Study|Protocol Violation|0
2853284|NCT02325791|9802015|P1|Overall Study|Protocol Violation|0
2853285|NCT02325791|9802012|P4|Overall Study|Physician Decision|0
2853286|NCT02325791|9802013|P3|Overall Study|Physician Decision|1
2853287|NCT02325791|9802014|P2|Overall Study|Physician Decision|1
2853288|NCT02325791|9802015|P1|Overall Study|Physician Decision|0
2853289|NCT02325791|9802012|P4|Overall Study|Lost to Follow-up|9
2853290|NCT02325791|9802013|P3|Overall Study|Lost to Follow-up|14
2853291|NCT02325791|9802014|P2|Overall Study|Lost to Follow-up|15
2853292|NCT02325791|9802015|P1|Overall Study|Lost to Follow-up|0
2853293|NCT02325791|9802012|P4|Overall Study|Death|1
2853294|NCT02325791|9802013|P3|Overall Study|Death|0
2853295|NCT02325791|9802014|P2|Overall Study|Death|3
2853296|NCT02325791|9802015|P1|Overall Study|Death|0
2853297|NCT02325791|9802012|P4|Overall Study|Adverse Event|0
2853298|NCT02325791|9802013|P3|Overall Study|Adverse Event|1
2853299|NCT02325791|9802014|P2|Overall Study|Adverse Event|1
2853300|NCT02325791|9802015|P1|Overall Study|Adverse Event|0
2853301|NCT02325713|9802050|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853302|NCT02325713|9802051|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853303|NCT02325713|9802052|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853304|NCT02325713|9802053|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853305|NCT02325713|9802054|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853306|NCT02325713|9802055|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853307|NCT02325713|9802056|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
2853308|NCT02325713|9802057|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853309|NCT02325713|9802058|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853310|NCT02325713|9802059|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853311|NCT02325713|9802060|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853312|NCT02325713|9802061|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853313|NCT02325713|9802062|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853314|NCT02325713|9802063|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853315|NCT02325713|9802064|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853316|NCT02325713|9802065|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2853317|NCT02325713|9802050|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853318|NCT02325713|9802051|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853319|NCT02325713|9802052|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853320|NCT02325713|9802053|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853321|NCT02325713|9802054|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853322|NCT02325713|9802055|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853323|NCT02325713|9802056|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853324|NCT02325713|9802057|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853325|NCT02325713|9802058|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853326|NCT02325713|9802059|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853327|NCT02325713|9802060|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853328|NCT02325713|9802061|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853329|NCT02325713|9802062|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853330|NCT02325713|9802063|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853331|NCT02325713|9802064|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2853332|NCT02325713|9802065|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
2853333|NCT02325713|9802050|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853334|NCT02325713|9802051|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853335|NCT02325713|9802052|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853336|NCT02325713|9802053|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853337|NCT02325713|9802054|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853338|NCT02325713|9802055|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
2853339|NCT02325713|9802056|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853340|NCT02325713|9802057|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853341|NCT02325713|9802058|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853342|NCT02325713|9802059|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853343|NCT02325713|9802060|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853344|NCT02325713|9802061|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853345|NCT02325713|9802062|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853346|NCT02325713|9802063|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853347|NCT02325713|9802064|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853348|NCT02325713|9802065|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2853349|NCT02325518|9802179|P2|Overall Study|Withdrawal by Subject|1
2853350|NCT02325518|9802180|P1|Overall Study|Withdrawal by Subject|0
2853351|NCT02325518|9802179|P2|Overall Study|Physician Decision|1
2853352|NCT02325518|9802180|P1|Overall Study|Physician Decision|0
2853353|NCT02325518|9802179|P2|Overall Study|Adverse Event|1
2853354|NCT02325518|9802180|P1|Overall Study|Adverse Event|4
2853355|NCT02325219|9802192|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
2853356|NCT02325219|9802193|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
2853357|NCT02325219|9802194|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
2853358|NCT02325219|9802195|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
2853359|NCT02325219|9802196|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
2853360|NCT02325219|9802192|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2853361|NCT02325219|9802193|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2853362|NCT02325219|9802194|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2853363|NCT02325219|9802195|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
2853364|NCT02325219|9802196|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
2853365|NCT02325219|9802192|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
2853366|NCT02325219|9802193|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
2853367|NCT02325219|9802194|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
2853368|NCT02325219|9802195|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
2853369|NCT02325219|9802196|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
2853370|NCT02325219|9802192|P5|Controlled Period (Week 0 - 16)|Other|0
2853371|NCT02325219|9802193|P4|Controlled Period (Week 0 - 16)|Other|0
2853372|NCT02325219|9802194|P3|Controlled Period (Week 0 - 16)|Other|1
2853373|NCT02325219|9802195|P2|Controlled Period (Week 0 - 16)|Other|0
2853374|NCT02325219|9802196|P1|Controlled Period (Week 0 - 16)|Other|0
2853375|NCT02325219|9802192|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2853376|NCT02325219|9802193|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2853377|NCT02325219|9802194|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
2853378|NCT02325219|9802195|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
2853379|NCT02325219|9802196|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
2853380|NCT02325219|9802192|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
2853381|NCT02325219|9802193|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
2853382|NCT02325219|9802194|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
2853383|NCT02325219|9802195|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
2853384|NCT02325219|9802196|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
2853385|NCT02324842|9802388|P3|Overall Study|Lost to Follow-up|2
2853386|NCT02324842|9802389|P2|Overall Study|Lost to Follow-up|1
2853387|NCT02324842|9802390|P1|Overall Study|Lost to Follow-up|1
2853388|NCT02324699|9802419|P1|Overall Study|study terminated|1
2853389|NCT02324569|9802539|P2|Overall Study|Inconvenient Schedule|0
2853390|NCT02324569|9802540|P1|Overall Study|Inconvenient Schedule|2
2853391|NCT02324569|9802539|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
2853392|NCT02324569|9802540|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
2853393|NCT02324569|9802539|P2|Overall Study|Lack of Efficacy|3
2853394|NCT02324569|9802540|P1|Overall Study|Lack of Efficacy|2
2853395|NCT02324569|9802539|P2|Overall Study|Voluntary Withdrawal|6
2853396|NCT02324569|9802540|P1|Overall Study|Voluntary Withdrawal|3
2853397|NCT02324569|9802539|P2|Overall Study|Pretreatment Event/Adverse Event|10
2853398|NCT02324569|9802540|P1|Overall Study|Pretreatment Event/Adverse Event|9
2853399|NCT02324465|9802573|P2|Overall Study|device failure|1
2853400|NCT02324465|9802574|P1|Overall Study|device failure|0
2853401|NCT02324205|9802601|P1|Overall Study|Withdrawal by Subject|37
2853402|NCT02324049|9802632|P1|Part C|Study terminated|11
2853403|NCT02323646|9802645|P3|Treatment Course 2|Non-compliance|1
2853404|NCT02323646|9802646|P2|Treatment Course 2|Non-compliance|1
2853405|NCT02323646|9802647|P1|Treatment Course 2|Non-compliance|0
2853406|NCT02323646|9802645|P3|Treatment Course 2|Lost to Follow-up|1
2853407|NCT02323646|9802646|P2|Treatment Course 2|Lost to Follow-up|0
2853408|NCT02323646|9802647|P1|Treatment Course 2|Lost to Follow-up|0
2853409|NCT02323646|9802645|P3|Treatment Course 2|Adverse Event|1
2853410|NCT02323646|9802646|P2|Treatment Course 2|Adverse Event|0
2853411|NCT02323646|9802647|P1|Treatment Course 2|Adverse Event|1
2853412|NCT02323646|9802645|P3|Treatment Course 1|Withdrawal by Subject|0
2853413|NCT02323646|9802646|P2|Treatment Course 1|Withdrawal by Subject|2
2853414|NCT02323646|9802647|P1|Treatment Course 1|Withdrawal by Subject|0
2853416|NCT02323646|9802646|P2|Treatment Course 1|Lost to Follow-up|0
2853417|NCT02323646|9802647|P1|Treatment Course 1|Lost to Follow-up|1
2853418|NCT02323646|9802645|P3|Treatment Course 1|Heavy Bleeding|0
2853419|NCT02323646|9802646|P2|Treatment Course 1|Heavy Bleeding|1
2853420|NCT02323646|9802647|P1|Treatment Course 1|Heavy Bleeding|1
2853421|NCT02323646|9802645|P3|Treatment Course 1|Adverse Event|1
2853422|NCT02323646|9802646|P2|Treatment Course 1|Adverse Event|0
2853423|NCT02323646|9802647|P1|Treatment Course 1|Adverse Event|1
2853424|NCT02323204|9802695|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
2853425|NCT02323204|9802696|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
2853426|NCT02323204|9802697|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2853427|NCT02323204|9802698|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2853428|NCT02323204|9802695|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
2853429|NCT02323204|9802696|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
2853430|NCT02323204|9802697|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
2853431|NCT02323204|9802698|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
2853432|NCT02323204|9802695|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2853433|NCT02323204|9802696|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2853434|NCT02323204|9802697|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2853435|NCT02323204|9802698|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2853436|NCT02323204|9802695|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
2853437|NCT02323204|9802696|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
2853438|NCT02323204|9802697|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
2853439|NCT02323204|9802698|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
2853440|NCT02323204|9802695|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
2853441|NCT02323204|9802696|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2853442|NCT02323204|9802697|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
2853443|NCT02323204|9802698|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2853444|NCT02323204|9802695|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
2853445|NCT02323204|9802696|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2853446|NCT02323204|9802697|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
2853447|NCT02323204|9802698|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2853448|NCT02323204|9802695|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
2853449|NCT02323204|9802696|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
2853450|NCT02323204|9802697|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
2853451|NCT02323204|9802698|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
2853452|NCT02323204|9802695|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
2853453|NCT02323204|9802696|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
2853454|NCT02323204|9802697|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
2853455|NCT02323204|9802698|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
2853456|NCT02323204|9802695|P4|Baseline Survey Completion|Withdrawal by Subject|3
2853457|NCT02323204|9802696|P3|Baseline Survey Completion|Withdrawal by Subject|5
2853458|NCT02323204|9802697|P2|Baseline Survey Completion|Withdrawal by Subject|9
2853459|NCT02323204|9802698|P1|Baseline Survey Completion|Withdrawal by Subject|10
2853460|NCT02322892|9802771|P2|Overall Study|Protocol Violation|0
2853461|NCT02322892|9802772|P1|Overall Study|Protocol Violation|1
2853462|NCT02322892|9802771|P2|Overall Study|Met exclusion criteria|1
2853463|NCT02322892|9802772|P1|Overall Study|Met exclusion criteria|0
2853464|NCT02322892|9802771|P2|Overall Study|Surgery cancelled|2
2853465|NCT02322892|9802772|P1|Overall Study|Surgery cancelled|1
2853466|NCT02322879|9802788|P2|First Intervention|Physician Decision|0
2853467|NCT02322879|9802789|P1|First Intervention|Physician Decision|1
2853468|NCT02322866|9802797|P2|Overall Study|Other Miscellaneous Reasons|6
2853469|NCT02322866|9802798|P1|Overall Study|Other Miscellaneous Reasons|6
2853470|NCT02322866|9802797|P2|Overall Study|Lack of Efficacy|1
2853471|NCT02322866|9802798|P1|Overall Study|Lack of Efficacy|3
2853472|NCT02322866|9802797|P2|Overall Study|Noncompliance with Treatment|4
2853473|NCT02322866|9802798|P1|Overall Study|Noncompliance with Treatment|3
2853474|NCT02322866|9802797|P2|Overall Study|Protocol Violation|0
2853475|NCT02322866|9802798|P1|Overall Study|Protocol Violation|1
2853476|NCT02322866|9802797|P2|Overall Study|Lost to Follow-up|39
2853477|NCT02322866|9802798|P1|Overall Study|Lost to Follow-up|36
2853478|NCT02322866|9802797|P2|Overall Study|Withdrawal of Consent|25
2853479|NCT02322866|9802798|P1|Overall Study|Withdrawal of Consent|16
2853480|NCT02322866|9802797|P2|Overall Study|Adverse Event|11
2853481|NCT02322866|9802798|P1|Overall Study|Adverse Event|6
2853482|NCT02322814|9802825|P5|Overall Study|Withdrawal by Subject|3
2853483|NCT02322814|9802826|P4|Overall Study|Withdrawal by Subject|1
2853484|NCT02322814|9802827|P3|Overall Study|Withdrawal by Subject|2
2853485|NCT02322814|9802828|P2|Overall Study|Withdrawal by Subject|4
2853486|NCT02322814|9802829|P1|Overall Study|Withdrawal by Subject|5
2853487|NCT02322814|9802825|P5|Overall Study|Death|6
2853488|NCT02322814|9802826|P4|Overall Study|Death|10
2853489|NCT02322814|9802827|P3|Overall Study|Death|30
2853490|NCT02322814|9802828|P2|Overall Study|Death|22
2853491|NCT02322814|9802829|P1|Overall Study|Death|7
2853492|NCT02322814|9802825|P5|Overall Study|Protocol Violation|0
2853493|NCT02322814|9802826|P4|Overall Study|Protocol Violation|0
2853494|NCT02322814|9802827|P3|Overall Study|Protocol Violation|0
2853495|NCT02322814|9802828|P2|Overall Study|Protocol Violation|0
2853496|NCT02322814|9802829|P1|Overall Study|Protocol Violation|1
2853497|NCT02322814|9802825|P5|Overall Study|Other|0
2853498|NCT02322814|9802826|P4|Overall Study|Other|0
2853499|NCT02322814|9802827|P3|Overall Study|Other|0
2853500|NCT02322814|9802828|P2|Overall Study|Other|0
2853501|NCT02322814|9802829|P1|Overall Study|Other|2
2853502|NCT02322814|9802825|P5|Overall Study|Lost to Follow-up|0
2853503|NCT02322814|9802826|P4|Overall Study|Lost to Follow-up|0
2853504|NCT02322814|9802827|P3|Overall Study|Lost to Follow-up|1
2853505|NCT02322814|9802828|P2|Overall Study|Lost to Follow-up|2
2853506|NCT02322814|9802829|P1|Overall Study|Lost to Follow-up|1
2853507|NCT02322814|9802825|P5|Overall Study|Progressive Disease|0
2853508|NCT02322814|9802826|P4|Overall Study|Progressive Disease|1
2853509|NCT02322814|9802827|P3|Overall Study|Progressive Disease|0
2853510|NCT02322814|9802828|P2|Overall Study|Progressive Disease|2
2853511|NCT02322814|9802829|P1|Overall Study|Progressive Disease|0
2853512|NCT02322814|9802825|P5|Overall Study|Ongoing Study|22
2853513|NCT02322814|9802826|P4|Overall Study|Ongoing Study|20
2853514|NCT02322814|9802827|P3|Overall Study|Ongoing Study|14
2853515|NCT02322814|9802828|P2|Overall Study|Ongoing Study|13
2853516|NCT02322814|9802829|P1|Overall Study|Ongoing Study|0
2853517|NCT02322775|9802855|P2|Overall Study|Not willing to perform all FU visits|1
2853518|NCT02322775|9802856|P1|Overall Study|Not willing to perform all FU visits|0
2853519|NCT02322775|9802855|P2|Overall Study|Withdrawal by Subject|4
2853520|NCT02322775|9802856|P1|Overall Study|Withdrawal by Subject|3
2853521|NCT02322775|9802855|P2|Overall Study|Protocol Violation|0
2853522|NCT02322775|9802856|P1|Overall Study|Protocol Violation|1
2853523|NCT02322775|9802855|P2|Overall Study|Lost to Follow-up|1
2853524|NCT02322775|9802856|P1|Overall Study|Lost to Follow-up|0
2853525|NCT02322775|9802855|P2|Overall Study|Adverse Event|0
2853526|NCT02322775|9802856|P1|Overall Study|Adverse Event|1
2853527|NCT02322749|9802882|P6|Period 3|Withdrawal by Subject|0
2853528|NCT02322749|9802883|P5|Period 3|Withdrawal by Subject|0
2853529|NCT02322749|9802884|P4|Period 3|Withdrawal by Subject|0
2853530|NCT02322749|9802885|P3|Period 3|Withdrawal by Subject|1
2853531|NCT02322749|9802886|P2|Period 3|Withdrawal by Subject|0
2853532|NCT02322749|9802887|P1|Period 3|Withdrawal by Subject|0
2853533|NCT02322749|9802882|P6|Period 2|Withdrawal by Subject|0
2853534|NCT02322749|9802883|P5|Period 2|Withdrawal by Subject|0
2853535|NCT02322749|9802884|P4|Period 2|Withdrawal by Subject|1
2853536|NCT02322749|9802885|P3|Period 2|Withdrawal by Subject|0
2853537|NCT02322749|9802886|P2|Period 2|Withdrawal by Subject|0
2853538|NCT02322749|9802887|P1|Period 2|Withdrawal by Subject|0
2853539|NCT02322749|9802882|P6|Period 2|Adverse Event|0
2853540|NCT02322749|9802883|P5|Period 2|Adverse Event|0
2853541|NCT02322749|9802884|P4|Period 2|Adverse Event|1
2853542|NCT02322749|9802885|P3|Period 2|Adverse Event|0
2853543|NCT02322749|9802886|P2|Period 2|Adverse Event|0
2853544|NCT02322749|9802887|P1|Period 2|Adverse Event|0
2853545|NCT02322710|9802912|P2|Overall Study|Protocol Violation|25
2853546|NCT02322710|9802913|P1|Overall Study|Protocol Violation|20
2853547|NCT02322710|9802912|P2|Overall Study|No efficacy assessment post-baseline|1
2853548|NCT02322710|9802913|P1|Overall Study|No efficacy assessment post-baseline|0
2853549|NCT02322411|9802926|P2|Overall Study|Lost to Follow-up|7
2853550|NCT02322411|9802927|P1|Overall Study|Lost to Follow-up|4
2853551|NCT02322281|9802971|P3|Overall Study|Miscellaneous|4
2853552|NCT02322281|9802972|P2|Overall Study|Miscellaneous|0
2853553|NCT02322281|9802973|P1|Overall Study|Miscellaneous|0
2853554|NCT02322281|9802971|P3|Overall Study|Missing|1
2853555|NCT02322281|9802972|P2|Overall Study|Missing|0
2853556|NCT02322281|9802973|P1|Overall Study|Missing|0
2853557|NCT02322281|9802971|P3|Overall Study|Study Terminated by Sponsor|0
2853558|NCT02322281|9802972|P2|Overall Study|Study Terminated by Sponsor|0
2853559|NCT02322281|9802973|P1|Overall Study|Study Terminated by Sponsor|2
2853560|NCT02322281|9802971|P3|Overall Study|Physician Decision|5
2853561|NCT02322281|9802972|P2|Overall Study|Physician Decision|0
2853562|NCT02322281|9802973|P1|Overall Study|Physician Decision|2
2853563|NCT02322281|9802971|P3|Overall Study|Withdrawal by Subject|6
2853564|NCT02322281|9802972|P2|Overall Study|Withdrawal by Subject|1
2853565|NCT02322281|9802973|P1|Overall Study|Withdrawal by Subject|1
2853566|NCT02322281|9802971|P3|Overall Study|Death|3
2853567|NCT02322281|9802972|P2|Overall Study|Death|3
2853568|NCT02322281|9802973|P1|Overall Study|Death|3
2853569|NCT02322281|9802971|P3|Overall Study|Adverse Event|6
2853570|NCT02322281|9802972|P2|Overall Study|Adverse Event|4
2853571|NCT02322281|9802973|P1|Overall Study|Adverse Event|3
2853572|NCT02322281|9802971|P3|Overall Study|Progressive Disease|49
2853573|NCT02322281|9802972|P2|Overall Study|Progressive Disease|14
2853574|NCT02322281|9802973|P1|Overall Study|Progressive Disease|42
2853575|NCT02322229|9802994|P1|Overall Study|Physician Decision|2
2853576|NCT02322216|9803006|P2|Overall Study|Withdrawal by Subject|4
2853577|NCT02322216|9803007|P1|Overall Study|Withdrawal by Subject|1
2853578|NCT02322216|9803006|P2|Overall Study|Adverse Event|0
2853579|NCT02322216|9803007|P1|Overall Study|Adverse Event|1
2853580|NCT02322190|9803014|P2|Overall Study|Death on study|0
2853581|NCT02322190|9803015|P1|Overall Study|Death on study|1
2853582|NCT02321930|9803023|P1|Overall Study|Lost to Follow-up|1
2853583|NCT02321800|9803033|P2|Overall Study|Other, Miscellaneous|1
2853584|NCT02321800|9803034|P1|Overall Study|Other, Miscellaneous|3
2853585|NCT02321800|9803033|P2|Overall Study|Adverse Event|3
2853586|NCT02321800|9803034|P1|Overall Study|Adverse Event|2
2853587|NCT02321800|9803033|P2|Overall Study|Lost to Follow-up|4
2853588|NCT02321800|9803034|P1|Overall Study|Lost to Follow-up|10
2853589|NCT02321800|9803033|P2|Overall Study|Protocol Violation|0
2853590|NCT02321800|9803034|P1|Overall Study|Protocol Violation|1
2853591|NCT02321800|9803033|P2|Overall Study|Death|0
2853592|NCT02321800|9803034|P1|Overall Study|Death|1
2853593|NCT02321800|9803033|P2|Overall Study|Withdrawal by Subject|3
2853594|NCT02321800|9803034|P1|Overall Study|Withdrawal by Subject|3
2853595|NCT02321462|9803123|P2|Overall Study|Subject withdrawn before any treatment|1
2853596|NCT02321462|9803124|P1|Overall Study|Subject withdrawn before any treatment|1
2853597|NCT02321462|9803123|P2|Overall Study|Withdrawal by Subject|2
2853598|NCT02321462|9803124|P1|Overall Study|Withdrawal by Subject|5
2853599|NCT02321436|9803146|P2|Overall Study|Lost to Follow-up|1
2853600|NCT02321436|9803147|P1|Overall Study|Lost to Follow-up|0
2853601|NCT02321436|9803146|P2|Overall Study|Withdrawal by Subject|0
2853602|NCT02321436|9803147|P1|Overall Study|Withdrawal by Subject|1
2853603|NCT02321319|9803163|P1|Overall Study|Product discontinued|5
2853604|NCT02321098|9803195|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
2853605|NCT02321098|9803196|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
2853606|NCT02321098|9803197|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
2853607|NCT02321098|9803195|P3|Additional 15 Months Treatment|Lost to Follow-up|1
2853608|NCT02321098|9803196|P2|Additional 15 Months Treatment|Lost to Follow-up|0
2853609|NCT02321098|9803197|P1|Additional 15 Months Treatment|Lost to Follow-up|0
2853610|NCT02321098|9803195|P3|Additional 15 Months Treatment|Lack of Efficacy|6
2853611|NCT02321098|9803196|P2|Additional 15 Months Treatment|Lack of Efficacy|0
2853612|NCT02321098|9803197|P1|Additional 15 Months Treatment|Lack of Efficacy|0
2853613|NCT02321098|9803195|P3|12 Weeks Treament|Lost to Follow-up|0
2853614|NCT02321098|9803196|P2|12 Weeks Treament|Lost to Follow-up|1
2853615|NCT02321098|9803197|P1|12 Weeks Treament|Lost to Follow-up|1
2853616|NCT02320903|9803209|P3|Overall Study|Lost to Follow-up|5
2853617|NCT02320903|9803210|P2|Overall Study|Lost to Follow-up|5
2853618|NCT02320903|9803211|P1|Overall Study|Lost to Follow-up|0
2853619|NCT02320903|9803209|P3|Overall Study|Exited therapy; no longer eligible|2
2853620|NCT02320903|9803210|P2|Overall Study|Exited therapy; no longer eligible|2
2853621|NCT02320903|9803211|P1|Overall Study|Exited therapy; no longer eligible|8
2853622|NCT02320903|9803209|P3|Overall Study|Withdrawal by Subject|9
2853623|NCT02320903|9803210|P2|Overall Study|Withdrawal by Subject|9
2853624|NCT02320903|9803211|P1|Overall Study|Withdrawal by Subject|0
2853625|NCT02320721|9803336|P2|Overall Study|Other than specified above|20
2853626|NCT02320721|9803337|P1|Overall Study|Other than specified above|15
2853627|NCT02320721|9803336|P2|Overall Study|Hypoglycemia|0
2853628|NCT02320721|9803337|P1|Overall Study|Hypoglycemia|1
2853629|NCT02320721|9803336|P2|Overall Study|Randomized but not treated|1
2853630|NCT02320721|9803337|P1|Overall Study|Randomized but not treated|0
2853631|NCT02320721|9803336|P2|Overall Study|Poor compliance to protocol|7
2853632|NCT02320721|9803337|P1|Overall Study|Poor compliance to protocol|3
2853633|NCT02320721|9803336|P2|Overall Study|Lack of Efficacy|0
2853634|NCT02320721|9803337|P1|Overall Study|Lack of Efficacy|2
2853635|NCT02320721|9803336|P2|Overall Study|Adverse Event|6
2853636|NCT02320721|9803337|P1|Overall Study|Adverse Event|6
2853637|NCT02320487|9803392|P1|Overall Study|Adverse Event|11
2853638|NCT02320487|9803392|P1|Overall Study|Death|3
2853639|NCT02320487|9803392|P1|Overall Study|Withdrawal by Subject|1
2853640|NCT02320487|9803392|P1|Overall Study|Physician Decision|5
2853641|NCT02320487|9803392|P1|Overall Study|Reason not Specified|1
2853642|NCT02320396|9803412|P2|Overall Study|Withdrawal by Subject|0
2853643|NCT02320396|9803413|P1|Overall Study|Withdrawal by Subject|2
2853644|NCT02320396|9803412|P2|Overall Study|Protocol Violation|1
2853645|NCT02320396|9803413|P1|Overall Study|Protocol Violation|0
2853646|NCT02320396|9803412|P2|Overall Study|Pregnancy|1
2853647|NCT02320396|9803413|P1|Overall Study|Pregnancy|0
2853648|NCT02320396|9803412|P2|Overall Study|Adverse Event|2
2853649|NCT02320396|9803413|P1|Overall Study|Adverse Event|2
2853650|NCT02320149|9803455|P2|Overall Study|Other Miscellaneous Reasons|3
2853651|NCT02320149|9803456|P1|Overall Study|Other Miscellaneous Reasons|2
2853652|NCT02320149|9803455|P2|Overall Study|Lack of Efficacy|1
2853653|NCT02320149|9803456|P1|Overall Study|Lack of Efficacy|0
2853654|NCT02320149|9803455|P2|Overall Study|Noncompliance with Study Treatment|2
2853655|NCT02320149|9803456|P1|Overall Study|Noncompliance with Study Treatment|7
2853656|NCT02320149|9803455|P2|Overall Study|Protocol Violation|1
2853657|NCT02320149|9803456|P1|Overall Study|Protocol Violation|2
2853658|NCT02320149|9803455|P2|Overall Study|Lost to Follow-up|34
2853659|NCT02320149|9803456|P1|Overall Study|Lost to Follow-up|21
2853660|NCT02320149|9803455|P2|Overall Study|Withdrawal of Consent|32
2853661|NCT02320149|9803456|P1|Overall Study|Withdrawal of Consent|28
2853662|NCT02320149|9803455|P2|Overall Study|Adverse Event|7
2853663|NCT02320149|9803456|P1|Overall Study|Adverse Event|3
2853664|NCT02319668|9803563|P2|Overall Study|Other (Not specified)|2
2853665|NCT02319668|9803564|P1|Overall Study|Other (Not specified)|0
2853666|NCT02319642|9803578|P2|Overall Study|Withdrawal by Subject|1
2853667|NCT02319642|9803579|P1|Overall Study|Withdrawal by Subject|1
2853668|NCT02319642|9803578|P2|Overall Study|Lack of Efficacy|1
2853669|NCT02319642|9803579|P1|Overall Study|Lack of Efficacy|1
2853670|NCT02319642|9803578|P2|Overall Study|Adverse Event|4
2853671|NCT02319642|9803579|P1|Overall Study|Adverse Event|2
2853672|NCT02319525|9803599|P2|Overall Study|Withdrawal by Subject|1
2853673|NCT02319525|9803600|P1|Overall Study|Withdrawal by Subject|2
2853674|NCT02319148|9803642|P4|Second Intervention Period|Other|1
2853675|NCT02319148|9803643|P3|Second Intervention Period|Other|0
2853676|NCT02319148|9803644|P2|Second Intervention Period|Other|0
2853677|NCT02319148|9803645|P1|Second Intervention Period|Other|0
2853678|NCT02319148|9803642|P4|Second Intervention Period|No longer willing to participate|0
2853679|NCT02319148|9803643|P3|Second Intervention Period|No longer willing to participate|0
2853680|NCT02319148|9803644|P2|Second Intervention Period|No longer willing to participate|1
2853681|NCT02319148|9803645|P1|Second Intervention Period|No longer willing to participate|0
2853682|NCT02319148|9803642|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
2853683|NCT02319148|9803643|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
2853684|NCT02319148|9803644|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
2853685|NCT02319148|9803645|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
2853686|NCT02319044|9803708|P3|Overall Study|Not treated|2
2853687|NCT02319044|9803709|P2|Overall Study|Not treated|2
2853688|NCT02319044|9803710|P1|Overall Study|Not treated|0
2853689|NCT02319044|9803708|P3|Overall Study|Study specific discontinuation criteria|1
2853690|NCT02319044|9803709|P2|Overall Study|Study specific discontinuation criteria|2
2853691|NCT02319044|9803710|P1|Overall Study|Study specific discontinuation criteria|2
2853692|NCT02319044|9803708|P3|Overall Study|Adverse Event|8
2853693|NCT02319044|9803709|P2|Overall Study|Adverse Event|2
2853694|NCT02319044|9803710|P1|Overall Study|Adverse Event|17
2853695|NCT02319044|9803708|P3|Overall Study|Condition under investigation worsened|46
2853696|NCT02319044|9803709|P2|Overall Study|Condition under investigation worsened|50
2853697|NCT02319044|9803710|P1|Overall Study|Condition under investigation worsened|100
2853698|NCT02319044|9803708|P3|Overall Study|Withdrawal by Subject|6
2853699|NCT02319044|9803709|P2|Overall Study|Withdrawal by Subject|3
2853700|NCT02319044|9803710|P1|Overall Study|Withdrawal by Subject|3
2853701|NCT02319044|9803708|P3|Overall Study|Death, PI/sponsor decision, med history|4
2853702|NCT02319044|9803709|P2|Overall Study|Death, PI/sponsor decision, med history|1
2853703|NCT02319044|9803710|P1|Overall Study|Death, PI/sponsor decision, med history|0
2853704|NCT02319031|9803766|P2|Treatment Period|Death|0
2853705|NCT02319031|9803767|P1|Treatment Period|Death|1
2853706|NCT02318940|9803831|P2|Overall Study|lost the record|0
2853707|NCT02318940|9803832|P1|Overall Study|lost the record|1
2853708|NCT02318797|9803874|P2|Overall Study|Lost to Follow-up|96
2853709|NCT02318797|9803875|P1|Overall Study|Lost to Follow-up|85
2853710|NCT02318797|9803874|P2|Overall Study|Death|6
2853711|NCT02318797|9803875|P1|Overall Study|Death|3
2853712|NCT02318693|9803915|P2|Overall Study|Protocol Violation|1
2853713|NCT02318693|9803916|P1|Overall Study|Protocol Violation|0
2853714|NCT02318667|9803930|P1|Overall Study|Protocol Violation|2
2853715|NCT02318667|9803930|P1|Overall Study|Lack of Efficacy|6
2853716|NCT02318667|9803930|P1|Overall Study|Adverse Event|1
2853717|NCT02318602|9803949|P3|Overall Study|Guardian decision to withdraw|1
2853718|NCT02318602|9803950|P2|Overall Study|Guardian decision to withdraw|0
2853719|NCT02318602|9803951|P1|Overall Study|Guardian decision to withdraw|0
2853720|NCT02318602|9803949|P3|Overall Study|Death|0
2853721|NCT02318602|9803950|P2|Overall Study|Death|0
2853722|NCT02318602|9803951|P1|Overall Study|Death|1
2853723|NCT02318602|9803949|P3|Overall Study|Withdrawal by Subject|0
2853724|NCT02318602|9803950|P2|Overall Study|Withdrawal by Subject|3
2853725|NCT02318602|9803951|P1|Overall Study|Withdrawal by Subject|0
2853726|NCT02318602|9803949|P3|Overall Study|Adverse Event|1
2853727|NCT02318602|9803950|P2|Overall Study|Adverse Event|1
2853728|NCT02318602|9803951|P1|Overall Study|Adverse Event|0
2853729|NCT02318329|9803992|P10|Overall Study|Other|1
2853730|NCT02318329|9803993|P9|Overall Study|Other|1
2853731|NCT02318329|9803994|P8|Overall Study|Other|0
2853732|NCT02318329|9803995|P7|Overall Study|Other|0
2853733|NCT02318329|9803996|P6|Overall Study|Other|0
2853734|NCT02318329|9803997|P5|Overall Study|Other|0
2853735|NCT02318329|9803998|P4|Overall Study|Other|0
2853736|NCT02318329|9803999|P3|Overall Study|Other|1
2853737|NCT02318329|9804000|P2|Overall Study|Other|1
2853738|NCT02318329|9804001|P1|Overall Study|Other|1
2853739|NCT02318329|9803992|P10|Overall Study|Withdrawal by Subject|6
2853740|NCT02318329|9803993|P9|Overall Study|Withdrawal by Subject|0
2853741|NCT02318329|9803994|P8|Overall Study|Withdrawal by Subject|0
2853742|NCT02318329|9803995|P7|Overall Study|Withdrawal by Subject|0
2853743|NCT02318329|9803996|P6|Overall Study|Withdrawal by Subject|0
2853744|NCT02318329|9803997|P5|Overall Study|Withdrawal by Subject|0
2853745|NCT02318329|9803998|P4|Overall Study|Withdrawal by Subject|0
2853746|NCT02318329|9803999|P3|Overall Study|Withdrawal by Subject|0
2853747|NCT02318329|9804000|P2|Overall Study|Withdrawal by Subject|0
2853748|NCT02318329|9804001|P1|Overall Study|Withdrawal by Subject|0
2853749|NCT02318329|9803992|P10|Overall Study|Lost to Follow-up|1
2853750|NCT02318329|9803993|P9|Overall Study|Lost to Follow-up|0
2853751|NCT02318329|9803994|P8|Overall Study|Lost to Follow-up|0
2853752|NCT02318329|9803995|P7|Overall Study|Lost to Follow-up|0
2853753|NCT02318329|9803996|P6|Overall Study|Lost to Follow-up|0
2853754|NCT02318329|9803997|P5|Overall Study|Lost to Follow-up|0
2853755|NCT02318329|9803998|P4|Overall Study|Lost to Follow-up|0
2853756|NCT02318329|9803999|P3|Overall Study|Lost to Follow-up|0
2853757|NCT02318329|9804000|P2|Overall Study|Lost to Follow-up|0
2853758|NCT02318329|9804001|P1|Overall Study|Lost to Follow-up|0
2853759|NCT02318329|9803992|P10|Overall Study|Death|5
2853760|NCT02318329|9803993|P9|Overall Study|Death|0
2853761|NCT02318329|9803994|P8|Overall Study|Death|0
2853762|NCT02318329|9803995|P7|Overall Study|Death|0
2853763|NCT02318329|9803996|P6|Overall Study|Death|0
2853764|NCT02318329|9803997|P5|Overall Study|Death|0
2853765|NCT02318329|9803998|P4|Overall Study|Death|0
2853766|NCT02318329|9803999|P3|Overall Study|Death|0
2853767|NCT02318329|9804000|P2|Overall Study|Death|0
2853768|NCT02318329|9804001|P1|Overall Study|Death|0
2853769|NCT02318329|9803992|P10|Overall Study|Progressive Disease|39
2853770|NCT02318329|9803993|P9|Overall Study|Progressive Disease|5
2853771|NCT02318329|9803994|P8|Overall Study|Progressive Disease|1
2853772|NCT02318329|9803995|P7|Overall Study|Progressive Disease|1
2853773|NCT02318329|9803996|P6|Overall Study|Progressive Disease|3
2853774|NCT02318329|9803997|P5|Overall Study|Progressive Disease|3
2853775|NCT02318329|9803998|P4|Overall Study|Progressive Disease|3
2853776|NCT02318329|9803999|P3|Overall Study|Progressive Disease|2
2853777|NCT02318329|9804000|P2|Overall Study|Progressive Disease|3
2853778|NCT02318329|9804001|P1|Overall Study|Progressive Disease|2
2853779|NCT02317809|9804086|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
2853780|NCT02317809|9804087|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
2853781|NCT02317809|9804086|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
2853782|NCT02317809|9804087|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
2853783|NCT02317614|9804175|P2|Overall Study|Death|1
2853784|NCT02317614|9804176|P1|Overall Study|Death|1
2853785|NCT02317614|9804175|P2|Overall Study|Withdrawal by Subject|0
2853786|NCT02317614|9804176|P1|Overall Study|Withdrawal by Subject|1
2853787|NCT02317614|9804175|P2|Overall Study|Lost to Follow-up|1
2853788|NCT02317614|9804176|P1|Overall Study|Lost to Follow-up|1
2853789|NCT02317575|9804192|P5|Period 1|Withdrawal by Subject|0
2853790|NCT02317575|9804193|P4|Period 1|Withdrawal by Subject|0
2853791|NCT02317575|9804194|P3|Period 1|Withdrawal by Subject|0
2853792|NCT02317575|9804195|P2|Period 1|Withdrawal by Subject|0
2853793|NCT02317575|9804196|P1|Period 1|Withdrawal by Subject|1
2853794|NCT02317575|9804192|P5|Period 1|Difficulty with venous cannulation|0
2853795|NCT02317575|9804193|P4|Period 1|Difficulty with venous cannulation|0
2853796|NCT02317575|9804194|P3|Period 1|Difficulty with venous cannulation|0
2853797|NCT02317575|9804195|P2|Period 1|Difficulty with venous cannulation|1
2853798|NCT02317575|9804196|P1|Period 1|Difficulty with venous cannulation|0
2853799|NCT02317510|9804231|P2|Overall Study|Adverse Event|1
2853800|NCT02317510|9804232|P1|Overall Study|Adverse Event|0
2853801|NCT02317016|9804264|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
2853802|NCT02317016|9804264|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
2853803|NCT02317016|9804264|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
2853804|NCT02317016|9804264|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
2853805|NCT02317016|9804264|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
2853806|NCT02317016|9804264|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
2853807|NCT02317016|9804264|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
2853808|NCT02316847|9804292|P2|Overall Study|Withdrawn due to termination by Sponsor|67
2853809|NCT02316847|9804293|P1|Overall Study|Withdrawn due to termination by Sponsor|7
2853810|NCT02316847|9804292|P2|Overall Study|Noncompliance with study drug|3
2853811|NCT02316847|9804293|P1|Overall Study|Noncompliance with study drug|0
2853812|NCT02316847|9804292|P2|Overall Study|Withdrawal by Subject|9
2853813|NCT02316847|9804293|P1|Overall Study|Withdrawal by Subject|2
2853814|NCT02316847|9804292|P2|Overall Study|Pregnancy|1
2853815|NCT02316847|9804293|P1|Overall Study|Pregnancy|0
2853816|NCT02316847|9804292|P2|Overall Study|Physician Decision|1
2853817|NCT02316847|9804293|P1|Overall Study|Physician Decision|0
2853818|NCT02316847|9804292|P2|Overall Study|Lost to Follow-up|2
2853819|NCT02316847|9804293|P1|Overall Study|Lost to Follow-up|0
2853820|NCT02316847|9804292|P2|Overall Study|Adverse Event|3
2853821|NCT02316847|9804293|P1|Overall Study|Adverse Event|0
2853822|NCT02316769|9804304|P2|Overall Study|Withdrawal by Subject|0
2853823|NCT02316769|9804305|P1|Overall Study|Withdrawal by Subject|1
2853824|NCT02316769|9804304|P2|Overall Study|Physician Decision|0
2853825|NCT02316769|9804305|P1|Overall Study|Physician Decision|1
2853826|NCT02316717|9804316|P3|Overall Study|TBC|0
2853827|NCT02316717|9804317|P2|Overall Study|TBC|0
2853828|NCT02316717|9804318|P1|Overall Study|TBC|1
2853829|NCT02316717|9804316|P3|Overall Study|Physician Decision|0
2853830|NCT02316717|9804317|P2|Overall Study|Physician Decision|1
2853831|NCT02316717|9804318|P1|Overall Study|Physician Decision|0
2853832|NCT02316717|9804316|P3|Overall Study|Death|1
2853833|NCT02316717|9804317|P2|Overall Study|Death|0
2853834|NCT02316717|9804318|P1|Overall Study|Death|0
2853835|NCT02316717|9804316|P3|Overall Study|Withdrawal by Subject|1
2853836|NCT02316717|9804317|P2|Overall Study|Withdrawal by Subject|1
2853837|NCT02316717|9804318|P1|Overall Study|Withdrawal by Subject|2
2853838|NCT02316717|9804316|P3|Overall Study|Protocol Violation|0
2853839|NCT02316717|9804317|P2|Overall Study|Protocol Violation|0
2853840|NCT02316717|9804318|P1|Overall Study|Protocol Violation|2
2853841|NCT02316717|9804316|P3|Overall Study|Non compliance|0
2853842|NCT02316717|9804317|P2|Overall Study|Non compliance|1
2853843|NCT02316717|9804318|P1|Overall Study|Non compliance|3
2853844|NCT02316717|9804316|P3|Overall Study|Lost to Follow-up|1
2853845|NCT02316717|9804317|P2|Overall Study|Lost to Follow-up|2
2853846|NCT02316717|9804318|P1|Overall Study|Lost to Follow-up|1
2853847|NCT02316717|9804316|P3|Overall Study|Adverse Event|0
2853848|NCT02316717|9804317|P2|Overall Study|Adverse Event|2
2853849|NCT02316717|9804318|P1|Overall Study|Adverse Event|2
2853850|NCT02316613|9804455|P1|Overall Study|Did not met selection criteria|14
2853851|NCT02316613|9804455|P1|Overall Study|No data and duplicate cases|5
2853852|NCT02316613|9804455|P1|Overall Study|Participant moved/changed medical team|11
2853853|NCT02316613|9804455|P1|Overall Study|Lymphoma transformation|2
2853854|NCT02316613|9804455|P1|Overall Study|Lost to Follow-up|9
2853855|NCT02316613|9804455|P1|Overall Study|Death|63
2853856|NCT02316548|9804494|P2|Overall Study|Protocol Violation|1
2853857|NCT02316548|9804495|P1|Overall Study|Protocol Violation|0
2853858|NCT02316353|9804625|P2|Overall Study|Withdrawal by Subject|2
2853859|NCT02316353|9804626|P1|Overall Study|Withdrawal by Subject|6
2853860|NCT02316353|9804625|P2|Overall Study|Adverse Event|3
2853861|NCT02316353|9804626|P1|Overall Study|Adverse Event|1
2853862|NCT02316353|9804625|P2|Overall Study|Pregnancy|3
2853863|NCT02316353|9804626|P1|Overall Study|Pregnancy|1
2853864|NCT02316171|9804646|P4|Overall Study|difficulties with urinary catheter|0
2853865|NCT02316171|9804647|P3|Overall Study|difficulties with urinary catheter|0
2853866|NCT02316171|9804648|P2|Overall Study|difficulties with urinary catheter|0
2853867|NCT02316171|9804649|P1|Overall Study|difficulties with urinary catheter|1
2853868|NCT02315664|9804713|P2|Overall Study|Withdrawal by Subject|3
2853869|NCT02315664|9804714|P1|Overall Study|Withdrawal by Subject|0
2853870|NCT02315664|9804713|P2|Overall Study|Lost to Follow-up|1
2853871|NCT02315664|9804714|P1|Overall Study|Lost to Follow-up|1
2853872|NCT02315560|9804734|P1|Overall Study|noncompliance by subjects|3
2853873|NCT02314923|9804993|P10|Overall Study|Participant relocation|0
2853874|NCT02314923|9804994|P9|Overall Study|Participant relocation|0
2853875|NCT02314923|9804995|P8|Overall Study|Participant relocation|1
2853876|NCT02314923|9804996|P7|Overall Study|Participant relocation|0
2853877|NCT02314923|9804997|P6|Overall Study|Participant relocation|0
2853878|NCT02314923|9804998|P5|Overall Study|Participant relocation|0
2853879|NCT02314923|9804999|P4|Overall Study|Participant relocation|0
2853880|NCT02314923|9805000|P3|Overall Study|Participant relocation|0
2853881|NCT02314923|9805001|P2|Overall Study|Participant relocation|0
2853882|NCT02314923|9805002|P1|Overall Study|Participant relocation|1
2853883|NCT02314923|9804993|P10|Overall Study|Screen failure|0
2853884|NCT02314923|9804994|P9|Overall Study|Screen failure|0
2853885|NCT02314923|9804995|P8|Overall Study|Screen failure|0
2853886|NCT02314923|9804996|P7|Overall Study|Screen failure|1
2853887|NCT02314923|9804997|P6|Overall Study|Screen failure|0
2853888|NCT02314923|9804998|P5|Overall Study|Screen failure|0
2853889|NCT02314923|9804999|P4|Overall Study|Screen failure|0
2853890|NCT02314923|9805000|P3|Overall Study|Screen failure|0
2853891|NCT02314923|9805001|P2|Overall Study|Screen failure|0
2853892|NCT02314923|9805002|P1|Overall Study|Screen failure|0
2853893|NCT02314923|9804993|P10|Overall Study|Participant unavailable|0
2853894|NCT02314923|9804994|P9|Overall Study|Participant unavailable|0
2853895|NCT02314923|9804995|P8|Overall Study|Participant unavailable|0
2853896|NCT02314923|9804996|P7|Overall Study|Participant unavailable|0
2853897|NCT02314923|9804997|P6|Overall Study|Participant unavailable|1
2853898|NCT02314923|9804998|P5|Overall Study|Participant unavailable|0
2853899|NCT02314923|9804999|P4|Overall Study|Participant unavailable|0
2853900|NCT02314923|9805000|P3|Overall Study|Participant unavailable|0
2853901|NCT02314923|9805001|P2|Overall Study|Participant unavailable|0
2853902|NCT02314923|9805002|P1|Overall Study|Participant unavailable|0
2853903|NCT02314923|9804993|P10|Overall Study|Physician Decision|0
2853904|NCT02314923|9804994|P9|Overall Study|Physician Decision|0
2853905|NCT02314923|9804995|P8|Overall Study|Physician Decision|0
2853906|NCT02314923|9804996|P7|Overall Study|Physician Decision|0
2853907|NCT02314923|9804997|P6|Overall Study|Physician Decision|0
2853908|NCT02314923|9804998|P5|Overall Study|Physician Decision|0
2853909|NCT02314923|9804999|P4|Overall Study|Physician Decision|0
2853910|NCT02314923|9805000|P3|Overall Study|Physician Decision|0
2853911|NCT02314923|9805001|P2|Overall Study|Physician Decision|1
2853912|NCT02314923|9805002|P1|Overall Study|Physician Decision|0
2853913|NCT02314923|9804993|P10|Overall Study|Withdrawal by Subject|0
2853914|NCT02314923|9804994|P9|Overall Study|Withdrawal by Subject|0
2853915|NCT02314923|9804995|P8|Overall Study|Withdrawal by Subject|0
2853916|NCT02314923|9804996|P7|Overall Study|Withdrawal by Subject|1
2853917|NCT02314923|9804997|P6|Overall Study|Withdrawal by Subject|0
2853918|NCT02314923|9804998|P5|Overall Study|Withdrawal by Subject|1
2853919|NCT02314923|9804999|P4|Overall Study|Withdrawal by Subject|0
2853920|NCT02314923|9805000|P3|Overall Study|Withdrawal by Subject|1
2853921|NCT02314923|9805001|P2|Overall Study|Withdrawal by Subject|0
2853922|NCT02314923|9805002|P1|Overall Study|Withdrawal by Subject|0
2853923|NCT02314923|9804993|P10|Overall Study|Lost to Follow-up|0
2853924|NCT02314923|9804994|P9|Overall Study|Lost to Follow-up|2
2853925|NCT02314923|9804995|P8|Overall Study|Lost to Follow-up|4
2853926|NCT02314923|9804996|P7|Overall Study|Lost to Follow-up|3
2853927|NCT02314923|9804997|P6|Overall Study|Lost to Follow-up|0
2853928|NCT02314923|9804998|P5|Overall Study|Lost to Follow-up|0
2853929|NCT02314923|9804999|P4|Overall Study|Lost to Follow-up|0
2853930|NCT02314923|9805000|P3|Overall Study|Lost to Follow-up|1
2853931|NCT02314923|9805001|P2|Overall Study|Lost to Follow-up|3
2853932|NCT02314923|9805002|P1|Overall Study|Lost to Follow-up|2
2853933|NCT02314923|9804993|P10|Overall Study|Death|0
2853934|NCT02314923|9804994|P9|Overall Study|Death|0
2853935|NCT02314923|9804995|P8|Overall Study|Death|0
2853936|NCT02314923|9804996|P7|Overall Study|Death|0
2853937|NCT02314923|9804997|P6|Overall Study|Death|0
2853938|NCT02314923|9804998|P5|Overall Study|Death|0
2853939|NCT02314923|9804999|P4|Overall Study|Death|1
2853940|NCT02314923|9805000|P3|Overall Study|Death|0
2853941|NCT02314923|9805001|P2|Overall Study|Death|0
2853942|NCT02314923|9805002|P1|Overall Study|Death|0
2853943|NCT02314637|9805101|P2|Overall Study|Other Reason|0
2853944|NCT02314637|9805102|P1|Overall Study|Other Reason|1
2853945|NCT02314637|9805101|P2|Overall Study|Withdrawal by Subject|4
2853946|NCT02314637|9805102|P1|Overall Study|Withdrawal by Subject|5
2853947|NCT02314637|9805101|P2|Overall Study|Physician Decision|2
2853948|NCT02314637|9805102|P1|Overall Study|Physician Decision|5
2853949|NCT02314637|9805101|P2|Overall Study|Lack of Efficacy|0
2853950|NCT02314637|9805102|P1|Overall Study|Lack of Efficacy|1
2853951|NCT02314637|9805101|P2|Overall Study|Adverse Event|8
2853952|NCT02314637|9805102|P1|Overall Study|Adverse Event|4
2853953|NCT02314247|9805173|P3|Overall Study|Progression of Disease|0
2853954|NCT02314247|9805174|P2|Overall Study|Progression of Disease|2
2853955|NCT02314247|9805175|P1|Overall Study|Progression of Disease|6
2853956|NCT02314247|9805173|P3|Overall Study|Withdrawal by Subject|1
2853957|NCT02314247|9805174|P2|Overall Study|Withdrawal by Subject|3
2853958|NCT02314247|9805175|P1|Overall Study|Withdrawal by Subject|1
2853959|NCT02314247|9805173|P3|Overall Study|Adverse Event|0
2853960|NCT02314247|9805174|P2|Overall Study|Adverse Event|1
2853961|NCT02314247|9805175|P1|Overall Study|Adverse Event|2
2853962|NCT02314143|9805200|P3|Overall Study|Withdrawal by Subject|1
2853963|NCT02314143|9805201|P2|Overall Study|Withdrawal by Subject|0
2853964|NCT02314143|9805202|P1|Overall Study|Withdrawal by Subject|1
2853965|NCT02314143|9805200|P3|Overall Study|Physician Decision|0
2853966|NCT02314143|9805201|P2|Overall Study|Physician Decision|1
2853967|NCT02314143|9805202|P1|Overall Study|Physician Decision|2
2853968|NCT02314143|9805200|P3|Overall Study|Other (Study Closed/Terminated)|4
2853969|NCT02314143|9805201|P2|Overall Study|Other (Study Closed/Terminated)|3
2853970|NCT02314143|9805202|P1|Overall Study|Other (Study Closed/Terminated)|5
2853971|NCT02314143|9805200|P3|Overall Study|Adverse Event|4
2853972|NCT02314143|9805201|P2|Overall Study|Adverse Event|6
2853973|NCT02314143|9805202|P1|Overall Study|Adverse Event|0
2853974|NCT02314117|9805248|P2|Overall Study|No post-discontinuation follow-up|19
2853975|NCT02314117|9805249|P1|Overall Study|No post-discontinuation follow-up|21
2853976|NCT02314117|9805248|P2|Overall Study|Withdrawal by Subject|2
2853977|NCT02314117|9805249|P1|Overall Study|Withdrawal by Subject|2
2853978|NCT02314117|9805248|P2|Overall Study|On Treatment|6
2853979|NCT02314117|9805249|P1|Overall Study|On Treatment|10
2853980|NCT02314117|9805248|P2|Overall Study|Lost to Follow-up|11
2853981|NCT02314117|9805249|P1|Overall Study|Lost to Follow-up|8
2853982|NCT02314052|9805302|P6|Cycle One|Adverse Event|0
2853983|NCT02314052|9805303|P5|Cycle One|Adverse Event|0
2853984|NCT02314052|9805304|P4|Cycle One|Adverse Event|1
2853985|NCT02314052|9805305|P3|Cycle One|Adverse Event|0
2853986|NCT02314052|9805306|P2|Cycle One|Adverse Event|0
2853987|NCT02314052|9805307|P1|Cycle One|Adverse Event|0
2853988|NCT02314026|9805375|P1|Overall Study|Protocol Violation|28
2853989|NCT02313909|9805393|P2|Overall Study|Lost to Follow-up|17
2853990|NCT02313909|9805394|P1|Overall Study|Lost to Follow-up|24
2853991|NCT02313909|9805393|P2|Overall Study|Consent withdrawn by participant|33
2853992|NCT02313909|9805394|P1|Overall Study|Consent withdrawn by participant|33
2853993|NCT02313766|9805417|P3|Overall Study|Adverse Event|0
2853994|NCT02313766|9805418|P2|Overall Study|Adverse Event|1
2853995|NCT02313766|9805419|P1|Overall Study|Adverse Event|0
2853996|NCT02313766|9805417|P3|Overall Study|Lost to Follow-up|0
2853997|NCT02313766|9805418|P2|Overall Study|Lost to Follow-up|2
2853998|NCT02313766|9805419|P1|Overall Study|Lost to Follow-up|0
2853999|NCT02313766|9805417|P3|Overall Study|surgery cancelled|0
2854000|NCT02313766|9805418|P2|Overall Study|surgery cancelled|0
2854001|NCT02313766|9805419|P1|Overall Study|surgery cancelled|1
2854002|NCT02313558|9805456|P2|Overall Study|Lost to Follow-up|4
2854003|NCT02313558|9805457|P1|Overall Study|Lost to Follow-up|4
2854004|NCT02313558|9805456|P2|Overall Study|Withdrawal by Subject|0
2854005|NCT02313558|9805457|P1|Overall Study|Withdrawal by Subject|2
2854006|NCT02313233|9805503|P2|Overall Study|Administrative reason|1
2854007|NCT02313233|9805504|P1|Overall Study|Administrative reason|1
2854008|NCT02313233|9805503|P2|Overall Study|Withdrawal by Subject|2
2854009|NCT02313233|9805504|P1|Overall Study|Withdrawal by Subject|1
2854010|NCT02313155|9805526|P2|Overall Study|Lost to Follow-up|1
2854011|NCT02313155|9805527|P1|Overall Study|Lost to Follow-up|0
2854012|NCT02312934|9805577|P2|Overall Study|Physician Decision|0
2854013|NCT02312934|9805578|P1|Overall Study|Physician Decision|1
2854014|NCT02312934|9805577|P2|Overall Study|Lost to Follow-up|0
2854015|NCT02312934|9805578|P1|Overall Study|Lost to Follow-up|1
2854016|NCT02312856|9805590|P1|Overall Study|Lost to Follow-up|3
2854017|NCT02312856|9805590|P1|Overall Study|Death|1
2854018|NCT02312687|9805674|P1|Overall Study|Other, Not Specified|1
2854019|NCT02312219|9805733|P2|Overall Study|Not randomized. Ineligible|1
2854020|NCT02312219|9805734|P1|Overall Study|Not randomized. Ineligible|0
2854021|NCT02312219|9805733|P2|Overall Study|Other|1
2854022|NCT02312219|9805734|P1|Overall Study|Other|0
2854023|NCT02312219|9805733|P2|Overall Study|could not schedule imaging in time|2
2854024|NCT02312219|9805734|P1|Overall Study|could not schedule imaging in time|0
2854025|NCT02312219|9805733|P2|Overall Study|Withdrawal by Subject|2
2854026|NCT02312219|9805734|P1|Overall Study|Withdrawal by Subject|1
2854027|NCT02312206|9805744|P2|Overall Study|Subject missed 3 consecutive tx visits|1
2854028|NCT02312206|9805745|P1|Overall Study|Subject missed 3 consecutive tx visits|0
2854029|NCT02312206|9805744|P2|Overall Study|Patient transferred to hospice|1
2854030|NCT02312206|9805745|P1|Overall Study|Patient transferred to hospice|0
2854031|NCT02312206|9805744|P2|Overall Study|Patient progression and new therapy|0
2854032|NCT02312206|9805745|P1|Overall Study|Patient progression and new therapy|1
2854033|NCT02312206|9805744|P2|Overall Study|Disease Progression|0
2854034|NCT02312206|9805745|P1|Overall Study|Disease Progression|1
2854035|NCT02312206|9805744|P2|Overall Study|Study Terminated by Sponsor|74
2854036|NCT02312206|9805745|P1|Overall Study|Study Terminated by Sponsor|81
2854037|NCT02312206|9805744|P2|Overall Study|Death|36
2854038|NCT02312206|9805745|P1|Overall Study|Death|30
2854039|NCT02312206|9805744|P2|Overall Study|Physician Decision|6
2854040|NCT02312206|9805745|P1|Overall Study|Physician Decision|7
2854041|NCT02312206|9805744|P2|Overall Study|Withdrawal by Subject|6
2854042|NCT02312206|9805745|P1|Overall Study|Withdrawal by Subject|7
2854043|NCT02312206|9805744|P2|Overall Study|Adverse Event|6
2854044|NCT02312206|9805745|P1|Overall Study|Adverse Event|3
2854045|NCT02312063|9805768|P2|Overall Study|Withdrawal by Subject|1
2854046|NCT02312063|9805769|P1|Overall Study|Withdrawal by Subject|0
2854047|NCT02311894|9805822|P1|Overall Study|Withdrawal by Subject|1
2854048|NCT02311894|9805822|P1|Overall Study|Adverse Event|1
2854049|NCT02311894|9805822|P1|Overall Study|Lost to Follow-up|1
2854050|NCT02311894|9805822|P1|Overall Study|Discontinued in error|1
2854051|NCT02311881|9805834|P3|Overall Study|Serious Adverse Event|0
2854052|NCT02311881|9805835|P2|Overall Study|Serious Adverse Event|1
2854053|NCT02311881|9805836|P1|Overall Study|Serious Adverse Event|0
2854054|NCT02311881|9805834|P3|Overall Study|Participant taking another medication|1
2854055|NCT02311881|9805835|P2|Overall Study|Participant taking another medication|0
2854056|NCT02311881|9805836|P1|Overall Study|Participant taking another medication|0
2854057|NCT02311881|9805834|P3|Overall Study|Medical Monitor Discretion|1
2854058|NCT02311881|9805835|P2|Overall Study|Medical Monitor Discretion|0
2854059|NCT02311881|9805836|P1|Overall Study|Medical Monitor Discretion|0
2854060|NCT02311881|9805834|P3|Overall Study|Physician Decision|1
2854061|NCT02311881|9805835|P2|Overall Study|Physician Decision|0
2854062|NCT02311881|9805836|P1|Overall Study|Physician Decision|0
2854063|NCT02311881|9805834|P3|Overall Study|Non-Compliance|2
2854064|NCT02311881|9805835|P2|Overall Study|Non-Compliance|0
2854065|NCT02311881|9805836|P1|Overall Study|Non-Compliance|1
2854066|NCT02311881|9805834|P3|Overall Study|Protocol Deviation|0
2854067|NCT02311881|9805835|P2|Overall Study|Protocol Deviation|0
2854068|NCT02311881|9805836|P1|Overall Study|Protocol Deviation|1
2854069|NCT02311881|9805834|P3|Overall Study|Sponsor Decision|1
2854070|NCT02311881|9805835|P2|Overall Study|Sponsor Decision|1
2854071|NCT02311881|9805836|P1|Overall Study|Sponsor Decision|1
2854072|NCT02311881|9805834|P3|Overall Study|Withdrawal by Subject|4
2854073|NCT02311881|9805835|P2|Overall Study|Withdrawal by Subject|1
2854074|NCT02311881|9805836|P1|Overall Study|Withdrawal by Subject|3
2854075|NCT02311881|9805834|P3|Overall Study|Subject has border line pregnancy test|0
2854076|NCT02311881|9805835|P2|Overall Study|Subject has border line pregnancy test|0
2854077|NCT02311881|9805836|P1|Overall Study|Subject has border line pregnancy test|1
2854078|NCT02311881|9805834|P3|Overall Study|Lack of Efficacy|0
2854079|NCT02311881|9805835|P2|Overall Study|Lack of Efficacy|2
2854080|NCT02311881|9805836|P1|Overall Study|Lack of Efficacy|1
2854081|NCT02311881|9805834|P3|Overall Study|Other|1
2854082|NCT02311881|9805835|P2|Overall Study|Other|0
2854083|NCT02311881|9805836|P1|Overall Study|Other|0
2854084|NCT02311881|9805834|P3|Overall Study|Withdrawal of consent|17
2854085|NCT02311881|9805835|P2|Overall Study|Withdrawal of consent|16
2854086|NCT02311881|9805836|P1|Overall Study|Withdrawal of consent|14
2854087|NCT02311881|9805834|P3|Overall Study|Protocol Violation|3
2854088|NCT02311881|9805835|P2|Overall Study|Protocol Violation|2
2854089|NCT02311881|9805836|P1|Overall Study|Protocol Violation|1
2854090|NCT02311881|9805834|P3|Overall Study|Lost to Follow-up|2
2854091|NCT02311881|9805835|P2|Overall Study|Lost to Follow-up|3
2854092|NCT02311881|9805836|P1|Overall Study|Lost to Follow-up|3
2854093|NCT02311881|9805834|P3|Overall Study|Adverse Event|8
2854094|NCT02311881|9805835|P2|Overall Study|Adverse Event|15
2854095|NCT02311881|9805836|P1|Overall Study|Adverse Event|7
2854096|NCT02311881|9805834|P3|Overall Study|Did not meet the study criteria|0
2854097|NCT02311881|9805835|P2|Overall Study|Did not meet the study criteria|2
2854098|NCT02311881|9805836|P1|Overall Study|Did not meet the study criteria|2
2854099|NCT02311478|9805871|P1|Overall Study|Failed IUD Insertion|1
2854100|NCT02311478|9805871|P1|Overall Study|Lost to Follow-up|5
2854101|NCT02311478|9805871|P1|Overall Study|Withdrawal by Subject|1
2854102|NCT02311153|9805894|P2|Overall Study|Lost to Follow-up|7
2854103|NCT02311153|9805895|P1|Overall Study|Lost to Follow-up|5
2854104|NCT02310789|9805911|P1|Overall Study|Adverse Event|1
2854105|NCT02310763|9805923|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2854106|NCT02310763|9805924|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2854107|NCT02310763|9805925|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2854108|NCT02310763|9805923|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
2854109|NCT02310763|9805924|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
2854110|NCT02310763|9805925|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
2854111|NCT02310763|9805923|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2854112|NCT02310763|9805924|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2854113|NCT02310763|9805925|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
2854114|NCT02310763|9805923|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2854115|NCT02310763|9805924|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2854116|NCT02310763|9805925|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
2854117|NCT02310763|9805923|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2854118|NCT02310763|9805924|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2854119|NCT02310763|9805925|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2854120|NCT02310750|9806128|P16|HP Washout 2|Lost to Follow-up|0
2854121|NCT02310750|9806129|P15|HP Washout 2|Lost to Follow-up|0
2854122|NCT02310750|9806130|P14|HP Washout 2|Lost to Follow-up|0
2854123|NCT02310750|9806131|P13|HP Washout 2|Lost to Follow-up|0
2854124|NCT02310750|9806132|P12|HP Washout 2|Lost to Follow-up|0
2854125|NCT02310750|9806133|P11|HP Washout 2|Lost to Follow-up|0
2854126|NCT02310750|9806134|P10|HP Washout 2|Lost to Follow-up|0
2854127|NCT02310750|9806135|P9|HP Washout 2|Lost to Follow-up|0
2854128|NCT02310750|9806136|P8|HP Washout 2|Lost to Follow-up|0
2854129|NCT02310750|9806137|P7|HP Washout 2|Lost to Follow-up|7
2854130|NCT02310750|9806138|P6|HP Washout 2|Lost to Follow-up|0
2854131|NCT02310750|9806139|P5|HP Washout 2|Lost to Follow-up|1
2854132|NCT02310750|9806140|P4|HP Washout 2|Lost to Follow-up|0
2854133|NCT02310750|9806141|P3|HP Washout 2|Lost to Follow-up|0
2854134|NCT02310750|9806142|P2|HP Washout 2|Lost to Follow-up|0
2854135|NCT02310750|9806143|P1|HP Washout 2|Lost to Follow-up|0
2854136|NCT02310750|9806128|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854137|NCT02310750|9806129|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854138|NCT02310750|9806130|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854139|NCT02310750|9806131|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854140|NCT02310750|9806132|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854141|NCT02310750|9806133|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854142|NCT02310750|9806134|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854143|NCT02310750|9806135|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2854144|NCT02310750|9806136|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2854145|NCT02310750|9806137|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854146|NCT02310750|9806138|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854147|NCT02310750|9806139|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854148|NCT02310750|9806140|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854149|NCT02310750|9806141|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854150|NCT02310750|9806142|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854151|NCT02310750|9806143|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2854152|NCT02310750|9806128|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854153|NCT02310750|9806129|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854154|NCT02310750|9806130|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854155|NCT02310750|9806131|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854156|NCT02310750|9806132|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854157|NCT02310750|9806133|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854158|NCT02310750|9806134|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2854159|NCT02310750|9806135|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2854160|NCT02310750|9806136|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2854161|NCT02310750|9806137|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854162|NCT02310750|9806138|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854163|NCT02310750|9806139|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854164|NCT02310750|9806140|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854165|NCT02310750|9806141|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854166|NCT02310750|9806142|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854167|NCT02310750|9806143|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2854168|NCT02310750|9806128|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854169|NCT02310750|9806129|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854170|NCT02310750|9806130|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854171|NCT02310750|9806131|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854172|NCT02310750|9806132|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854173|NCT02310750|9806133|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854174|NCT02310750|9806134|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
2854175|NCT02310750|9806135|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854176|NCT02310750|9806136|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854177|NCT02310750|9806137|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854178|NCT02310750|9806138|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854179|NCT02310750|9806139|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854180|NCT02310750|9806140|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854181|NCT02310750|9806141|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854182|NCT02310750|9806142|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854183|NCT02310750|9806143|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2854184|NCT02310750|9806128|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854185|NCT02310750|9806129|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854186|NCT02310750|9806130|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854187|NCT02310750|9806131|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854188|NCT02310750|9806132|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854189|NCT02310750|9806133|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854190|NCT02310750|9806134|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2854191|NCT02310750|9806135|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
2854192|NCT02310750|9806136|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854193|NCT02310750|9806137|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854194|NCT02310750|9806138|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
2854195|NCT02310750|9806139|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854196|NCT02310750|9806140|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2854197|NCT02310750|9806141|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854198|NCT02310750|9806142|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854199|NCT02310750|9806143|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2854200|NCT02310750|9806128|P16|HP Washout 1|Lost to Follow-up|0
2854201|NCT02310750|9806129|P15|HP Washout 1|Lost to Follow-up|0
2854202|NCT02310750|9806130|P14|HP Washout 1|Lost to Follow-up|0
2854203|NCT02310750|9806131|P13|HP Washout 1|Lost to Follow-up|0
2854204|NCT02310750|9806132|P12|HP Washout 1|Lost to Follow-up|0
2854205|NCT02310750|9806133|P11|HP Washout 1|Lost to Follow-up|0
2854206|NCT02310750|9806134|P10|HP Washout 1|Lost to Follow-up|0
2854207|NCT02310750|9806135|P9|HP Washout 1|Lost to Follow-up|0
2854208|NCT02310750|9806136|P8|HP Washout 1|Lost to Follow-up|0
2854209|NCT02310750|9806137|P7|HP Washout 1|Lost to Follow-up|3
2854210|NCT02310750|9806138|P6|HP Washout 1|Lost to Follow-up|2
2854211|NCT02310750|9806139|P5|HP Washout 1|Lost to Follow-up|2
2854212|NCT02310750|9806140|P4|HP Washout 1|Lost to Follow-up|1
2854213|NCT02310750|9806141|P3|HP Washout 1|Lost to Follow-up|1
2854214|NCT02310750|9806142|P2|HP Washout 1|Lost to Follow-up|0
2854215|NCT02310750|9806143|P1|HP Washout 1|Lost to Follow-up|0
2854216|NCT02310750|9806128|P16|HP Period 1|Withdrawal by Subject|0
2854217|NCT02310750|9806129|P15|HP Period 1|Withdrawal by Subject|0
2854218|NCT02310750|9806130|P14|HP Period 1|Withdrawal by Subject|0
2854219|NCT02310750|9806131|P13|HP Period 1|Withdrawal by Subject|0
2854220|NCT02310750|9806132|P12|HP Period 1|Withdrawal by Subject|0
2854221|NCT02310750|9806133|P11|HP Period 1|Withdrawal by Subject|0
2854222|NCT02310750|9806134|P10|HP Period 1|Withdrawal by Subject|0
2854223|NCT02310750|9806135|P9|HP Period 1|Withdrawal by Subject|0
2854224|NCT02310750|9806136|P8|HP Period 1|Withdrawal by Subject|0
2854225|NCT02310750|9806137|P7|HP Period 1|Withdrawal by Subject|0
2854226|NCT02310750|9806138|P6|HP Period 1|Withdrawal by Subject|0
2854227|NCT02310750|9806139|P5|HP Period 1|Withdrawal by Subject|0
2854228|NCT02310750|9806140|P4|HP Period 1|Withdrawal by Subject|1
2854229|NCT02310750|9806141|P3|HP Period 1|Withdrawal by Subject|0
2854230|NCT02310750|9806142|P2|HP Period 1|Withdrawal by Subject|0
2854231|NCT02310750|9806143|P1|HP Period 1|Withdrawal by Subject|1
2854232|NCT02310750|9806128|P16|HP Period 1|Lost to Follow-up|0
2854233|NCT02310750|9806129|P15|HP Period 1|Lost to Follow-up|0
2854234|NCT02310750|9806130|P14|HP Period 1|Lost to Follow-up|0
2854235|NCT02310750|9806131|P13|HP Period 1|Lost to Follow-up|0
2854236|NCT02310750|9806132|P12|HP Period 1|Lost to Follow-up|0
2854237|NCT02310750|9806133|P11|HP Period 1|Lost to Follow-up|0
2854238|NCT02310750|9806134|P10|HP Period 1|Lost to Follow-up|0
2854239|NCT02310750|9806135|P9|HP Period 1|Lost to Follow-up|0
2854240|NCT02310750|9806136|P8|HP Period 1|Lost to Follow-up|0
2854241|NCT02310750|9806137|P7|HP Period 1|Lost to Follow-up|1
2854242|NCT02310750|9806138|P6|HP Period 1|Lost to Follow-up|0
2854243|NCT02310750|9806139|P5|HP Period 1|Lost to Follow-up|0
2854244|NCT02310750|9806140|P4|HP Period 1|Lost to Follow-up|0
2854245|NCT02310750|9806141|P3|HP Period 1|Lost to Follow-up|0
2854246|NCT02310750|9806142|P2|HP Period 1|Lost to Follow-up|0
2854247|NCT02310750|9806143|P1|HP Period 1|Lost to Follow-up|0
2854248|NCT02310646|9806584|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
2854249|NCT02310646|9806585|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
2854250|NCT02310646|9806584|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
2854251|NCT02310646|9806585|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
2854252|NCT02310581|9806613|P4|Overall Study|Withdrawal by Subject|1
2854253|NCT02310581|9806614|P3|Overall Study|Withdrawal by Subject|0
2854254|NCT02310581|9806615|P2|Overall Study|Withdrawal by Subject|1
2854255|NCT02310581|9806616|P1|Overall Study|Withdrawal by Subject|2
2854256|NCT02310581|9806613|P4|Overall Study|Adverse Event|0
2854257|NCT02310581|9806614|P3|Overall Study|Adverse Event|1
2854258|NCT02310581|9806615|P2|Overall Study|Adverse Event|1
2854259|NCT02310581|9806616|P1|Overall Study|Adverse Event|1
2854260|NCT02310568|9806655|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
2854261|NCT02310568|9806656|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
2854262|NCT02310568|9806657|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
2854263|NCT02310568|9806658|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
2854264|NCT02310568|9806659|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
2854265|NCT02310568|9806655|P5|Stage 2 (4 Weeks)|Protocol Violation|0
2854266|NCT02310568|9806656|P4|Stage 2 (4 Weeks)|Protocol Violation|1
2854267|NCT02310568|9806657|P3|Stage 2 (4 Weeks)|Protocol Violation|0
2854268|NCT02310568|9806658|P2|Stage 2 (4 Weeks)|Protocol Violation|0
2854269|NCT02310568|9806659|P1|Stage 2 (4 Weeks)|Protocol Violation|0
2854270|NCT02310568|9806655|P5|Stage 2 (4 Weeks)|Adverse Event|1
2854271|NCT02310568|9806656|P4|Stage 2 (4 Weeks)|Adverse Event|1
2854272|NCT02310568|9806657|P3|Stage 2 (4 Weeks)|Adverse Event|0
2854273|NCT02310568|9806658|P2|Stage 2 (4 Weeks)|Adverse Event|0
2854274|NCT02310568|9806659|P1|Stage 2 (4 Weeks)|Adverse Event|0
2854275|NCT02310568|9806655|P5|Stage 2 (4 Weeks)|Other|0
2854276|NCT02310568|9806656|P4|Stage 2 (4 Weeks)|Other|0
2854277|NCT02310568|9806657|P3|Stage 2 (4 Weeks)|Other|1
2854278|NCT02310568|9806658|P2|Stage 2 (4 Weeks)|Other|1
2854279|NCT02310568|9806659|P1|Stage 2 (4 Weeks)|Other|0
2854280|NCT02310568|9806655|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2854281|NCT02310568|9806656|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2854282|NCT02310568|9806657|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2854283|NCT02310568|9806658|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2854284|NCT02310568|9806659|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2854285|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2854286|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
2854287|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2854288|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2854289|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2854290|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2854291|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
2854292|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2854293|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2854294|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2854295|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
2854296|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
2854297|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
2854298|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
2854299|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
2854300|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|Other|0
2854301|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|Other|0
2854302|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|Other|0
2854303|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|Other|1
2854304|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|Other|1
2854305|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2854306|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2854307|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2854308|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2854309|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
2854310|NCT02310568|9806655|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
2854311|NCT02310568|9806656|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2854312|NCT02310568|9806657|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2854313|NCT02310568|9806658|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2854314|NCT02310568|9806659|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2854315|NCT02310126|9806739|P2|Period 1 (15 Minutes)|Protocol Violation|1
2854316|NCT02310126|9806740|P1|Period 1 (15 Minutes)|Protocol Violation|0
2854317|NCT02310126|9806739|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
2854318|NCT02310126|9806740|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
2854319|NCT02310100|9806746|P1|Overall Study|Lost to Follow-up|2
2854320|NCT02310100|9806746|P1|Overall Study|Visit compliance|1
2854321|NCT02310100|9806746|P1|Overall Study|Unapproved ablation operator|1
2854322|NCT02310100|9806746|P1|Overall Study|Enrollment closure|1
2854323|NCT02310100|9806746|P1|Overall Study|Withdrawal by Subject|10
2854324|NCT02310100|9806746|P1|Overall Study|Physician Decision|3
2854325|NCT02309723|9806754|P3|Overall Study|Withdrawal by Subject|24
2854326|NCT02309723|9806755|P2|Overall Study|Withdrawal by Subject|23
2854327|NCT02309723|9806756|P1|Overall Study|Withdrawal by Subject|24
2854328|NCT02309411|9806799|P3|Overall Study|Withdrawal by Subject|0
2854329|NCT02309411|9806800|P2|Overall Study|Withdrawal by Subject|1
2854330|NCT02309411|9806801|P1|Overall Study|Withdrawal by Subject|1
2854331|NCT02309411|9806799|P3|Overall Study|Physician Decision|0
2854332|NCT02309411|9806800|P2|Overall Study|Physician Decision|0
2854333|NCT02309411|9806801|P1|Overall Study|Physician Decision|1
2854334|NCT02309359|9806825|P5|Overall Study|Other|2
2854335|NCT02309359|9806826|P4|Overall Study|Other|3
2854336|NCT02309359|9806827|P3|Overall Study|Other|2
2854337|NCT02309359|9806828|P2|Overall Study|Other|0
2854338|NCT02309359|9806829|P1|Overall Study|Other|2
2854339|NCT02309359|9806825|P5|Overall Study|Lost to Follow-up|0
2854340|NCT02309359|9806826|P4|Overall Study|Lost to Follow-up|1
2854341|NCT02309359|9806827|P3|Overall Study|Lost to Follow-up|0
2854342|NCT02309359|9806828|P2|Overall Study|Lost to Follow-up|0
2854343|NCT02309359|9806829|P1|Overall Study|Lost to Follow-up|0
2854344|NCT02309359|9806825|P5|Overall Study|Lack of Efficacy|3
2854345|NCT02309359|9806826|P4|Overall Study|Lack of Efficacy|0
2854346|NCT02309359|9806827|P3|Overall Study|Lack of Efficacy|0
2854347|NCT02309359|9806828|P2|Overall Study|Lack of Efficacy|1
2854348|NCT02309359|9806829|P1|Overall Study|Lack of Efficacy|3
2854349|NCT02309359|9806825|P5|Overall Study|Withdrawal by Subject|0
2854350|NCT02309359|9806826|P4|Overall Study|Withdrawal by Subject|4
2854351|NCT02309359|9806827|P3|Overall Study|Withdrawal by Subject|4
2854352|NCT02309359|9806828|P2|Overall Study|Withdrawal by Subject|2
2854353|NCT02309359|9806829|P1|Overall Study|Withdrawal by Subject|2
2854354|NCT02309359|9806825|P5|Overall Study|Death|0
2854355|NCT02309359|9806826|P4|Overall Study|Death|0
2854356|NCT02309359|9806827|P3|Overall Study|Death|0
2854357|NCT02309359|9806828|P2|Overall Study|Death|0
2854358|NCT02309359|9806829|P1|Overall Study|Death|1
2854359|NCT02309359|9806825|P5|Overall Study|Adverse Event|4
2854360|NCT02309359|9806826|P4|Overall Study|Adverse Event|4
2854361|NCT02309359|9806827|P3|Overall Study|Adverse Event|5
2854362|NCT02309359|9806828|P2|Overall Study|Adverse Event|5
2854363|NCT02309359|9806829|P1|Overall Study|Adverse Event|4
2854364|NCT02309294|9806956|P1|Overall Study|Withdrawal by Subject|2
2854365|NCT02309112|9806963|P3|Overall Study|Lost to Follow-up|0
2854366|NCT02309112|9806964|P2|Overall Study|Lost to Follow-up|1
2854367|NCT02309112|9806965|P1|Overall Study|Lost to Follow-up|0
2854368|NCT02309112|9806963|P3|Overall Study|Withdrawal by Subject|1
2854369|NCT02309112|9806964|P2|Overall Study|Withdrawal by Subject|0
2854370|NCT02309112|9806965|P1|Overall Study|Withdrawal by Subject|1
2854371|NCT02309099|9806988|P2|Overall Study|Adverse Event|0
2854372|NCT02309099|9806989|P1|Overall Study|Adverse Event|2
2854373|NCT02308748|9807060|P10|Period 5|Adverse Event|0
2854374|NCT02308748|9807061|P9|Period 5|Adverse Event|1
2854375|NCT02308748|9807062|P8|Period 5|Adverse Event|0
2854376|NCT02308748|9807063|P7|Period 5|Adverse Event|0
2854377|NCT02308748|9807064|P6|Period 5|Adverse Event|0
2854378|NCT02308748|9807065|P5|Period 5|Adverse Event|0
2854379|NCT02308748|9807066|P4|Period 5|Adverse Event|0
2854380|NCT02308748|9807067|P3|Period 5|Adverse Event|0
2854381|NCT02308748|9807068|P2|Period 5|Adverse Event|0
2854382|NCT02308748|9807069|P1|Period 5|Adverse Event|1
2854383|NCT02308748|9807060|P10|Period 3|Protocol Violation|1
2854384|NCT02308748|9807061|P9|Period 3|Protocol Violation|0
2854385|NCT02308748|9807062|P8|Period 3|Protocol Violation|0
2854386|NCT02308748|9807063|P7|Period 3|Protocol Violation|0
2854387|NCT02308748|9807064|P6|Period 3|Protocol Violation|0
2854388|NCT02308748|9807065|P5|Period 3|Protocol Violation|0
2854389|NCT02308748|9807066|P4|Period 3|Protocol Violation|0
2854390|NCT02308748|9807067|P3|Period 3|Protocol Violation|0
2854391|NCT02308748|9807068|P2|Period 3|Protocol Violation|0
2854392|NCT02308748|9807069|P1|Period 3|Protocol Violation|0
2854393|NCT02308748|9807060|P10|Period 2|Adverse Event|0
2854394|NCT02308748|9807061|P9|Period 2|Adverse Event|0
2854395|NCT02308748|9807062|P8|Period 2|Adverse Event|1
2854396|NCT02308748|9807063|P7|Period 2|Adverse Event|0
2854397|NCT02308748|9807064|P6|Period 2|Adverse Event|0
2854398|NCT02308748|9807065|P5|Period 2|Adverse Event|0
2854399|NCT02308748|9807066|P4|Period 2|Adverse Event|0
2854400|NCT02308748|9807067|P3|Period 2|Adverse Event|0
2854401|NCT02308748|9807068|P2|Period 2|Adverse Event|0
2854402|NCT02308748|9807069|P1|Period 2|Adverse Event|0
2854403|NCT02308748|9807060|P10|Period 1|Withdrawal by Subject|0
2854404|NCT02308748|9807061|P9|Period 1|Withdrawal by Subject|0
2854405|NCT02308748|9807062|P8|Period 1|Withdrawal by Subject|0
2854406|NCT02308748|9807063|P7|Period 1|Withdrawal by Subject|0
2854407|NCT02308748|9807064|P6|Period 1|Withdrawal by Subject|0
2854408|NCT02308748|9807065|P5|Period 1|Withdrawal by Subject|0
2854409|NCT02308748|9807066|P4|Period 1|Withdrawal by Subject|0
2854410|NCT02308748|9807067|P3|Period 1|Withdrawal by Subject|1
2854411|NCT02308748|9807068|P2|Period 1|Withdrawal by Subject|0
2854412|NCT02308748|9807069|P1|Period 1|Withdrawal by Subject|0
2854413|NCT02308696|9807083|P2|Overall Study|Moved to a Higher Level of Care|6
2854414|NCT02308696|9807084|P1|Overall Study|Moved to a Higher Level of Care|17
2854415|NCT02308696|9807083|P2|Overall Study|Death|4
2854416|NCT02308696|9807084|P1|Overall Study|Death|8
2854417|NCT02308696|9807083|P2|Overall Study|Lost to Follow-up|21
2854418|NCT02308696|9807084|P1|Overall Study|Lost to Follow-up|28
2854419|NCT02308540|9807118|P6|Overall Study|Lost to Follow-up|1
2854420|NCT02308540|9807119|P5|Overall Study|Lost to Follow-up|0
2854421|NCT02308540|9807120|P4|Overall Study|Lost to Follow-up|0
2854422|NCT02308540|9807121|P3|Overall Study|Lost to Follow-up|0
2854423|NCT02308540|9807122|P2|Overall Study|Lost to Follow-up|0
2854424|NCT02308540|9807123|P1|Overall Study|Lost to Follow-up|0
2854425|NCT02308228|9807212|P2|Overall Study|Withdrawal by Subject|3
2854426|NCT02308228|9807213|P1|Overall Study|Withdrawal by Subject|5
2854427|NCT02308228|9807212|P2|Overall Study|Adverse Event|4
2854428|NCT02308228|9807213|P1|Overall Study|Adverse Event|3
2854429|NCT02308163|9807242|P5|Overall Study|Miscellaneous|5
2854430|NCT02308163|9807243|P4|Overall Study|Miscellaneous|0
2854431|NCT02308163|9807244|P3|Overall Study|Miscellaneous|1
2854432|NCT02308163|9807245|P2|Overall Study|Miscellaneous|2
2854433|NCT02308163|9807246|P1|Overall Study|Miscellaneous|2
2854434|NCT02308163|9807242|P5|Overall Study|Lab data met discontinuation criteria|0
2854435|NCT02308163|9807243|P4|Overall Study|Lab data met discontinuation criteria|2
2854436|NCT02308163|9807244|P3|Overall Study|Lab data met discontinuation criteria|0
2854437|NCT02308163|9807245|P2|Overall Study|Lab data met discontinuation criteria|0
2854438|NCT02308163|9807246|P1|Overall Study|Lab data met discontinuation criteria|3
2854439|NCT02308163|9807242|P5|Overall Study|Protocol Violation|5
2854440|NCT02308163|9807243|P4|Overall Study|Protocol Violation|2
2854441|NCT02308163|9807244|P3|Overall Study|Protocol Violation|3
2854442|NCT02308163|9807245|P2|Overall Study|Protocol Violation|3
2854443|NCT02308163|9807246|P1|Overall Study|Protocol Violation|3
2854444|NCT02308163|9807242|P5|Overall Study|Withdrawal of consent|6
2854445|NCT02308163|9807243|P4|Overall Study|Withdrawal of consent|2
2854446|NCT02308163|9807244|P3|Overall Study|Withdrawal of consent|0
2854447|NCT02308163|9807245|P2|Overall Study|Withdrawal of consent|3
2854448|NCT02308163|9807246|P1|Overall Study|Withdrawal of consent|2
2854449|NCT02308163|9807242|P5|Overall Study|Lack of Efficacy|6
2854450|NCT02308163|9807243|P4|Overall Study|Lack of Efficacy|4
2854451|NCT02308163|9807244|P3|Overall Study|Lack of Efficacy|8
2854452|NCT02308163|9807245|P2|Overall Study|Lack of Efficacy|3
2854453|NCT02308163|9807246|P1|Overall Study|Lack of Efficacy|11
2854454|NCT02308163|9807242|P5|Overall Study|Adverse Event|11
2854455|NCT02308163|9807243|P4|Overall Study|Adverse Event|2
2854456|NCT02308163|9807244|P3|Overall Study|Adverse Event|2
2854457|NCT02308163|9807245|P2|Overall Study|Adverse Event|5
2854458|NCT02308163|9807246|P1|Overall Study|Adverse Event|9
2854459|NCT02308163|9807242|P5|Overall Study|Not fulfill eligible criteria|1
2854460|NCT02308163|9807243|P4|Overall Study|Not fulfill eligible criteria|1
2854461|NCT02308163|9807244|P3|Overall Study|Not fulfill eligible criteria|0
2854462|NCT02308163|9807245|P2|Overall Study|Not fulfill eligible criteria|2
2854463|NCT02308163|9807246|P1|Overall Study|Not fulfill eligible criteria|1
2854464|NCT02308124|9807556|P3|Overall Study|Adverse Event|2
2854465|NCT02308124|9807557|P2|Overall Study|Adverse Event|2
2854466|NCT02308124|9807558|P1|Overall Study|Adverse Event|0
2854467|NCT02308124|9807556|P3|Overall Study|Lost to Follow-up|6
2854468|NCT02308124|9807557|P2|Overall Study|Lost to Follow-up|6
2854469|NCT02308124|9807558|P1|Overall Study|Lost to Follow-up|6
2854470|NCT02308020|9807584|P6|Overall Study|On treatment|0
2854471|NCT02308020|9807585|P5|Overall Study|On treatment|0
2854472|NCT02308020|9807586|P4|Overall Study|On treatment|0
2854473|NCT02308020|9807587|P3|Overall Study|On treatment|0
2854474|NCT02308020|9807588|P2|Overall Study|On treatment|3
2854475|NCT02308020|9807589|P1|Overall Study|On treatment|0
2854476|NCT02308020|9807584|P6|Overall Study|Withdrawal by Subject|0
2854477|NCT02308020|9807585|P5|Overall Study|Withdrawal by Subject|2
2854478|NCT02308020|9807586|P4|Overall Study|Withdrawal by Subject|3
2854479|NCT02308020|9807587|P3|Overall Study|Withdrawal by Subject|0
2854480|NCT02308020|9807588|P2|Overall Study|Withdrawal by Subject|4
2854481|NCT02308020|9807589|P1|Overall Study|Withdrawal by Subject|0
2854482|NCT02308020|9807584|P6|Overall Study|Physician Decision|1
2854483|NCT02308020|9807585|P5|Overall Study|Physician Decision|0
2854484|NCT02308020|9807586|P4|Overall Study|Physician Decision|0
2854485|NCT02308020|9807587|P3|Overall Study|Physician Decision|0
2854486|NCT02308020|9807588|P2|Overall Study|Physician Decision|0
2854487|NCT02308020|9807589|P1|Overall Study|Physician Decision|0
2854488|NCT02308020|9807584|P6|Overall Study|Protocol Violation|0
2854489|NCT02308020|9807585|P5|Overall Study|Protocol Violation|0
2854490|NCT02308020|9807586|P4|Overall Study|Protocol Violation|0
2854491|NCT02308020|9807587|P3|Overall Study|Protocol Violation|1
2854492|NCT02308020|9807588|P2|Overall Study|Protocol Violation|0
2854493|NCT02308020|9807589|P1|Overall Study|Protocol Violation|0
2854494|NCT02308020|9807584|P6|Overall Study|Adverse Event|1
2854495|NCT02308020|9807585|P5|Overall Study|Adverse Event|0
2854496|NCT02308020|9807586|P4|Overall Study|Adverse Event|1
2854497|NCT02308020|9807587|P3|Overall Study|Adverse Event|0
2854498|NCT02308020|9807588|P2|Overall Study|Adverse Event|5
2854499|NCT02308020|9807589|P1|Overall Study|Adverse Event|3
2854500|NCT02307682|9807690|P3|Overall Study|Other|0
2854501|NCT02307682|9807691|P2|Overall Study|Other|1
2854502|NCT02307682|9807692|P1|Overall Study|Other|1
2854503|NCT02307682|9807690|P3|Overall Study|Protocol Deviation|2
2854504|NCT02307682|9807691|P2|Overall Study|Protocol Deviation|0
2854505|NCT02307682|9807692|P1|Overall Study|Protocol Deviation|0
2854506|NCT02307682|9807690|P3|Overall Study|Lost to Follow-up|6
2854507|NCT02307682|9807691|P2|Overall Study|Lost to Follow-up|5
2854508|NCT02307682|9807692|P1|Overall Study|Lost to Follow-up|1
2854509|NCT02307682|9807690|P3|Overall Study|Death|12
2854510|NCT02307682|9807691|P2|Overall Study|Death|7
2854511|NCT02307682|9807692|P1|Overall Study|Death|9
2854512|NCT02307682|9807690|P3|Overall Study|Withdrawal by Subject|23
2854513|NCT02307682|9807691|P2|Overall Study|Withdrawal by Subject|34
2854514|NCT02307682|9807692|P1|Overall Study|Withdrawal by Subject|26
2854515|NCT02307682|9807690|P3|Overall Study|Progressive Disease|0
2854516|NCT02307682|9807691|P2|Overall Study|Progressive Disease|0
2854517|NCT02307682|9807692|P1|Overall Study|Progressive Disease|1
2854518|NCT02307682|9807690|P3|Overall Study|Physician Decision|8
2854519|NCT02307682|9807691|P2|Overall Study|Physician Decision|2
2854520|NCT02307682|9807692|P1|Overall Study|Physician Decision|2
2854521|NCT02307682|9807690|P3|Overall Study|Lack of Efficacy|1
2854522|NCT02307682|9807691|P2|Overall Study|Lack of Efficacy|0
2854523|NCT02307682|9807692|P1|Overall Study|Lack of Efficacy|1
2854524|NCT02307682|9807690|P3|Overall Study|Adverse Event|12
2854525|NCT02307682|9807691|P2|Overall Study|Adverse Event|8
2854526|NCT02307682|9807692|P1|Overall Study|Adverse Event|9
2854527|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
2854528|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
2854529|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2854530|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2854531|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2854532|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2854533|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2854534|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2854535|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
2854536|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
2854537|NCT02307513|9807808|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
2854538|NCT02307513|9807809|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
2854539|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2854540|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2854541|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
2854542|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
2854543|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
2854544|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
2854545|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
2854546|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
2854547|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
2854548|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
2854549|NCT02307513|9807808|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
2854550|NCT02307513|9807809|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
2854551|NCT02307266|9807860|P3|Overall Study|Lost to Follow-up|0
2854552|NCT02307266|9807861|P2|Overall Study|Lost to Follow-up|0
2854553|NCT02307266|9807862|P1|Overall Study|Lost to Follow-up|3
2854554|NCT02307266|9807860|P3|Overall Study|Withdrawal by Subject|1
2854555|NCT02307266|9807861|P2|Overall Study|Withdrawal by Subject|0
2854556|NCT02307266|9807862|P1|Overall Study|Withdrawal by Subject|2
2854557|NCT02307266|9807860|P3|Overall Study|Adverse Event|5
2854558|NCT02307266|9807861|P2|Overall Study|Adverse Event|1
2854559|NCT02307266|9807862|P1|Overall Study|Adverse Event|3
2854560|NCT02306850|9807887|P1|Overall Study|Lack of Efficacy|2
2854561|NCT02306694|9807909|P1|Overall Study|Lost to Follow-up|1
2854562|NCT02306694|9807909|P1|Overall Study|Withdrawal by Subject|3
2854563|NCT02306265|9807919|P1|Overall Study|Withdrawal by Subject|1
2854564|NCT02305888|9807928|P3|Overall Study|Adverse Event|0
2854565|NCT02305888|9807929|P2|Overall Study|Adverse Event|1
2854566|NCT02305888|9807930|P1|Overall Study|Adverse Event|0
2854567|NCT02305888|9807928|P3|Overall Study|Lost to Follow-up|1
2854568|NCT02305888|9807929|P2|Overall Study|Lost to Follow-up|0
2854569|NCT02305888|9807930|P1|Overall Study|Lost to Follow-up|0
2854570|NCT02305797|9807949|P2|Overall Study|Reason not collected|1
2854571|NCT02305797|9807950|P1|Overall Study|Reason not collected|0
2854572|NCT02305797|9807949|P2|Overall Study|Noncompliance|12
2854573|NCT02305797|9807950|P1|Overall Study|Noncompliance|14
2854574|NCT02305797|9807949|P2|Overall Study|Pregnancy|2
2854575|NCT02305797|9807950|P1|Overall Study|Pregnancy|0
2854576|NCT02305797|9807949|P2|Overall Study|Lost to Follow-up|11
2854577|NCT02305797|9807950|P1|Overall Study|Lost to Follow-up|5
2854578|NCT02305797|9807949|P2|Overall Study|Lack of Efficacy|0
2854579|NCT02305797|9807950|P1|Overall Study|Lack of Efficacy|6
2854580|NCT02305797|9807949|P2|Overall Study|Withdrawal by Subject|10
2854581|NCT02305797|9807950|P1|Overall Study|Withdrawal by Subject|9
2854582|NCT02305797|9807949|P2|Overall Study|Adverse Event|2
2854583|NCT02305797|9807950|P1|Overall Study|Adverse Event|11
2854584|NCT02305758|9807960|P2|Overall Study|Other, not specified|1
2854585|NCT02305758|9807961|P1|Overall Study|Other, not specified|2
2854586|NCT02305758|9807960|P2|Overall Study|Study Terminated by Sponsor|34
2854587|NCT02305758|9807961|P1|Overall Study|Study Terminated by Sponsor|21
2854588|NCT02305758|9807960|P2|Overall Study|Lost to Follow-up|1
2854589|NCT02305758|9807961|P1|Overall Study|Lost to Follow-up|6
2854590|NCT02305758|9807960|P2|Overall Study|Withdrew consent|2
2854591|NCT02305758|9807961|P1|Overall Study|Withdrew consent|9
2854592|NCT02305758|9807960|P2|Overall Study|Death|27
2854593|NCT02305758|9807961|P1|Overall Study|Death|27
2854594|NCT02305446|9807979|P1|Overall Study|Adverse Event|1
2854595|NCT02305381|9807987|P3|Overall Study|Unclassified|7
2854596|NCT02305381|9807988|P2|Overall Study|Unclassified|5
2854597|NCT02305381|9807989|P1|Overall Study|Unclassified|5
2854598|NCT02305238|9808102|P3|Overall Study|Required procedure failed|0
2854599|NCT02305238|9808103|P2|Overall Study|Required procedure failed|1
2854600|NCT02305238|9808104|P1|Overall Study|Required procedure failed|0
2854601|NCT02305238|9808102|P3|Overall Study|Randomized failure|8
2854602|NCT02305238|9808103|P2|Overall Study|Randomized failure|0
2854603|NCT02305238|9808104|P1|Overall Study|Randomized failure|0
2854604|NCT02305238|9808102|P3|Overall Study|Withdrawal by Subject|0
2854605|NCT02305238|9808103|P2|Overall Study|Withdrawal by Subject|4
2854606|NCT02305238|9808104|P1|Overall Study|Withdrawal by Subject|3
2854607|NCT02305238|9808102|P3|Overall Study|Adverse Event|0
2854608|NCT02305238|9808103|P2|Overall Study|Adverse Event|2
2854609|NCT02305238|9808104|P1|Overall Study|Adverse Event|4
2854610|NCT02305238|9808102|P3|Overall Study|Physician Decision|0
2854611|NCT02305238|9808103|P2|Overall Study|Physician Decision|1
2854612|NCT02305238|9808104|P1|Overall Study|Physician Decision|2
2854613|NCT02305238|9808102|P3|Overall Study|Protocol Violation|0
2854614|NCT02305238|9808103|P2|Overall Study|Protocol Violation|3
2854615|NCT02305238|9808104|P1|Overall Study|Protocol Violation|0
2854616|NCT02305238|9808102|P3|Overall Study|Logistical difficulties|0
2854617|NCT02305238|9808103|P2|Overall Study|Logistical difficulties|3
2854618|NCT02305238|9808104|P1|Overall Study|Logistical difficulties|1
2854619|NCT02305238|9808102|P3|Overall Study|Progressive disease|0
2854620|NCT02305238|9808103|P2|Overall Study|Progressive disease|4
2854621|NCT02305238|9808104|P1|Overall Study|Progressive disease|4
2854622|NCT02305238|9808102|P3|Overall Study|Death|0
2854623|NCT02305238|9808103|P2|Overall Study|Death|1
2854624|NCT02305238|9808104|P1|Overall Study|Death|2
2854625|NCT02304926|9808136|P2|Overall Study|Lost to Follow-up|1
2854626|NCT02304926|9808137|P1|Overall Study|Lost to Follow-up|2
2854627|NCT02304705|9808183|P2|Overall Study|Lost to Follow-up|2
2854628|NCT02304705|9808184|P1|Overall Study|Lost to Follow-up|0
2854629|NCT02304705|9808183|P2|Overall Study|Death|1
2854630|NCT02304705|9808184|P1|Overall Study|Death|0
2854631|NCT02304705|9808183|P2|Overall Study|Physician Decision|4
2854632|NCT02304705|9808184|P1|Overall Study|Physician Decision|2
2854633|NCT02304705|9808183|P2|Overall Study|Withdrawal by Subject|0
2854634|NCT02304705|9808184|P1|Overall Study|Withdrawal by Subject|2
2854635|NCT02304484|9808190|P1|Overall Study|Lost to Follow-up|2
2854636|NCT02304484|9808190|P1|Overall Study|Withdrawal by Subject|14
2854637|NCT02304484|9808190|P1|Overall Study|Death|9
2854638|NCT02303704|9808273|P2|Overall Study|Protocol Violation|9
2854639|NCT02303704|9808274|P1|Overall Study|Protocol Violation|5
2854640|NCT02303574|9808302|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854641|NCT02303574|9808303|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854642|NCT02303574|9808304|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
2854643|NCT02303574|9808305|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854644|NCT02303574|9808306|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854645|NCT02303574|9808307|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854646|NCT02303574|9808308|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854647|NCT02303574|9808309|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854648|NCT02303574|9808310|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854649|NCT02303574|9808311|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2854650|NCT02303574|9808302|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854651|NCT02303574|9808303|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854652|NCT02303574|9808304|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854653|NCT02303574|9808305|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854654|NCT02303574|9808306|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854655|NCT02303574|9808307|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854656|NCT02303574|9808308|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854657|NCT02303574|9808309|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
2854658|NCT02303574|9808310|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854659|NCT02303574|9808311|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2854660|NCT02303262|9808532|P1|Overall Study|Withdrawal by Subject|2
2854661|NCT02303041|9808540|P2|Overall Study|Adverse Event|2
2854662|NCT02303041|9808541|P1|Overall Study|Adverse Event|1
2854663|NCT02302859|9808557|P2|Overall Study|Withdrawal by Subject|1
2854664|NCT02302859|9808558|P1|Overall Study|Withdrawal by Subject|0
2854665|NCT02302859|9808557|P2|Overall Study|Lost Phone|1
2854666|NCT02302859|9808558|P1|Overall Study|Lost Phone|1
2854667|NCT02302846|9808564|P1|Overall Study|Withdrawal by Subject|1
2854668|NCT02302807|9808570|P2|Overall Study|Physician Decision|1
2854669|NCT02302807|9808571|P1|Overall Study|Physician Decision|0
2854670|NCT02302807|9808570|P2|Overall Study|Study Terminated By Sponsor|64
2854671|NCT02302807|9808571|P1|Overall Study|Study Terminated By Sponsor|35
2854672|NCT02302807|9808570|P2|Overall Study|Death|385
2854673|NCT02302807|9808571|P1|Overall Study|Death|397
2854674|NCT02302807|9808570|P2|Overall Study|Lost to Follow-up|6
2854675|NCT02302807|9808571|P1|Overall Study|Lost to Follow-up|4
2854676|NCT02302807|9808570|P2|Overall Study|Withdrawal by Subject|11
2854677|NCT02302807|9808571|P1|Overall Study|Withdrawal by Subject|28
2854678|NCT02302716|9808618|P2|Overall Study|Protocol Violation|1
2854679|NCT02302716|9808619|P1|Overall Study|Protocol Violation|0
2854680|NCT02302716|9808618|P2|Overall Study|Withdrawal by Subject|7
2854681|NCT02302716|9808619|P1|Overall Study|Withdrawal by Subject|13
2854682|NCT02302716|9808618|P2|Overall Study|Physician Decision|4
2854683|NCT02302716|9808619|P1|Overall Study|Physician Decision|3
2854684|NCT02302716|9808618|P2|Overall Study|Lost to Follow-up|4
2854685|NCT02302716|9808619|P1|Overall Study|Lost to Follow-up|2
2854686|NCT02302716|9808618|P2|Overall Study|Lack of Efficacy|1
2854687|NCT02302716|9808619|P1|Overall Study|Lack of Efficacy|0
2854688|NCT02302716|9808618|P2|Overall Study|Death|1
2854689|NCT02302716|9808619|P1|Overall Study|Death|0
2854690|NCT02302716|9808618|P2|Overall Study|Adverse Event|1
2854691|NCT02302716|9808619|P1|Overall Study|Adverse Event|1
2854692|NCT02302339|9808667|P4|Overall Study|Withdrawal by Subject|0
2854693|NCT02302339|9808668|P3|Overall Study|Withdrawal by Subject|1
2854694|NCT02302339|9808669|P2|Overall Study|Withdrawal by Subject|2
2854695|NCT02302339|9808670|P1|Overall Study|Withdrawal by Subject|0
2854696|NCT02302339|9808667|P4|Overall Study|Lost to Follow-up|0
2854697|NCT02302339|9808668|P3|Overall Study|Lost to Follow-up|0
2854698|NCT02302339|9808669|P2|Overall Study|Lost to Follow-up|0
2854699|NCT02302339|9808670|P1|Overall Study|Lost to Follow-up|1
2854700|NCT02302222|9808703|P2|Overall Study|Withdrawn prior to any treatment|1
2854701|NCT02302222|9808704|P1|Overall Study|Withdrawn prior to any treatment|0
2854702|NCT02302222|9808703|P2|Overall Study|Treatment discontinued before day 5|1
2854703|NCT02302222|9808704|P1|Overall Study|Treatment discontinued before day 5|0
2854704|NCT02302222|9808703|P2|Overall Study|Lost to Follow-up|0
2854705|NCT02302222|9808704|P1|Overall Study|Lost to Follow-up|1
2854706|NCT02302222|9808703|P2|Overall Study|Physician Decision|4
2854707|NCT02302222|9808704|P1|Overall Study|Physician Decision|0
2854708|NCT02302066|9808743|P4|Overall Study|Reason Not Specified|1
2854709|NCT02302066|9808744|P3|Overall Study|Reason Not Specified|9
2854710|NCT02302066|9808745|P2|Overall Study|Reason Not Specified|1
2854711|NCT02302066|9808746|P1|Overall Study|Reason Not Specified|1
2854712|NCT02302066|9808743|P4|Overall Study|Pregnancy|0
2854713|NCT02302066|9808744|P3|Overall Study|Pregnancy|12
2854714|NCT02302066|9808745|P2|Overall Study|Pregnancy|10
2854715|NCT02302066|9808746|P1|Overall Study|Pregnancy|2
2854716|NCT02302066|9808743|P4|Overall Study|Withdrawal by Subject|33
2854717|NCT02302066|9808744|P3|Overall Study|Withdrawal by Subject|124
2854718|NCT02302066|9808745|P2|Overall Study|Withdrawal by Subject|58
2854719|NCT02302066|9808746|P1|Overall Study|Withdrawal by Subject|25
2854720|NCT02302066|9808743|P4|Overall Study|Lost to Follow-up|7
2854721|NCT02302066|9808744|P3|Overall Study|Lost to Follow-up|24
2854722|NCT02302066|9808745|P2|Overall Study|Lost to Follow-up|5
2854723|NCT02302066|9808746|P1|Overall Study|Lost to Follow-up|4
2854724|NCT02302066|9808743|P4|Overall Study|Adverse Event|0
2854725|NCT02302066|9808744|P3|Overall Study|Adverse Event|3
2854726|NCT02302066|9808745|P2|Overall Study|Adverse Event|1
2854727|NCT02302066|9808746|P1|Overall Study|Adverse Event|1
2854728|NCT02301988|9808790|P2|Overall Study|Adverse Event|1
2854729|NCT02301988|9808791|P1|Overall Study|Adverse Event|1
2854730|NCT02301988|9808790|P2|Overall Study|Death|0
2854731|NCT02301988|9808791|P1|Overall Study|Death|1
2854732|NCT02301988|9808790|P2|Overall Study|Lack of Efficacy|2
2854733|NCT02301988|9808791|P1|Overall Study|Lack of Efficacy|3
2854734|NCT02301988|9808790|P2|Overall Study|Unknown Reason|3
2854735|NCT02301988|9808791|P1|Overall Study|Unknown Reason|1
2854736|NCT02301988|9808790|P2|Overall Study|Physician Decision|2
2854737|NCT02301988|9808791|P1|Overall Study|Physician Decision|2
2854738|NCT02301988|9808790|P2|Overall Study|Withdrawal by Subject|1
2854739|NCT02301988|9808791|P1|Overall Study|Withdrawal by Subject|2
2854740|NCT02301975|9808824|P3|Overall Study|Withdrawal by Subject|11
2854741|NCT02301975|9808825|P2|Overall Study|Withdrawal by Subject|12
2854742|NCT02301975|9808826|P1|Overall Study|Withdrawal by Subject|15
2854743|NCT02301975|9808824|P3|Overall Study|Physician Decision|3
2854744|NCT02301975|9808825|P2|Overall Study|Physician Decision|2
2854745|NCT02301975|9808826|P1|Overall Study|Physician Decision|4
2854746|NCT02301975|9808824|P3|Overall Study|Lost to Follow-up|2
2854747|NCT02301975|9808825|P2|Overall Study|Lost to Follow-up|2
2854748|NCT02301975|9808826|P1|Overall Study|Lost to Follow-up|0
2854749|NCT02301975|9808824|P3|Overall Study|Protocol Violation|3
2854750|NCT02301975|9808825|P2|Overall Study|Protocol Violation|5
2854751|NCT02301975|9808826|P1|Overall Study|Protocol Violation|3
2854752|NCT02301975|9808824|P3|Overall Study|Lack of Efficacy|1
2854753|NCT02301975|9808825|P2|Overall Study|Lack of Efficacy|1
2854754|NCT02301975|9808826|P1|Overall Study|Lack of Efficacy|1
2854755|NCT02301975|9808824|P3|Overall Study|Adverse Event|2
2854756|NCT02301975|9808825|P2|Overall Study|Adverse Event|3
2854757|NCT02301975|9808826|P1|Overall Study|Adverse Event|8
2854758|NCT02301936|9808854|P2|Overall Study|Lost to Follow-up|0
2854759|NCT02301936|9808855|P1|Overall Study|Lost to Follow-up|1
2854760|NCT02301897|9808880|P3|Treatment Course 2|Other Miscellaneous Reasons|0
2854761|NCT02301897|9808881|P2|Treatment Course 2|Other Miscellaneous Reasons|0
2854762|NCT02301897|9808882|P1|Treatment Course 2|Other Miscellaneous Reasons|1
2854763|NCT02301897|9808880|P3|Treatment Course 2|Withdrawal by Subject|0
2854764|NCT02301897|9808881|P2|Treatment Course 2|Withdrawal by Subject|2
2854765|NCT02301897|9808882|P1|Treatment Course 2|Withdrawal by Subject|0
2854766|NCT02301897|9808880|P3|Treatment Course 2|Pregnancy|1
2854767|NCT02301897|9808881|P2|Treatment Course 2|Pregnancy|1
2854768|NCT02301897|9808882|P1|Treatment Course 2|Pregnancy|0
2854769|NCT02301897|9808880|P3|Treatment Course 2|Lost to Follow-up|0
2854770|NCT02301897|9808881|P2|Treatment Course 2|Lost to Follow-up|2
2854771|NCT02301897|9808882|P1|Treatment Course 2|Lost to Follow-up|0
2854772|NCT02301897|9808880|P3|Treatment Course 1|Other Miscellaneous Reasons|0
2854773|NCT02301897|9808881|P2|Treatment Course 1|Other Miscellaneous Reasons|0
2854774|NCT02301897|9808882|P1|Treatment Course 1|Other Miscellaneous Reasons|1
2854775|NCT02301897|9808880|P3|Treatment Course 1|Withdrawal by Subject|2
2854776|NCT02301897|9808881|P2|Treatment Course 1|Withdrawal by Subject|0
2854777|NCT02301897|9808882|P1|Treatment Course 1|Withdrawal by Subject|0
2854778|NCT02301897|9808880|P3|Treatment Course 1|Withdrawal by Sponsor|2
2854779|NCT02301897|9808881|P2|Treatment Course 1|Withdrawal by Sponsor|0
2854780|NCT02301897|9808882|P1|Treatment Course 1|Withdrawal by Sponsor|0
2854781|NCT02301897|9808880|P3|Treatment Course 1|Lost to Follow-up|1
2854782|NCT02301897|9808881|P2|Treatment Course 1|Lost to Follow-up|2
2854783|NCT02301897|9808882|P1|Treatment Course 1|Lost to Follow-up|1
2854784|NCT02301897|9808880|P3|Treatment Course 1|Adverse Event|0
2854785|NCT02301897|9808881|P2|Treatment Course 1|Adverse Event|1
2854786|NCT02301897|9808882|P1|Treatment Course 1|Adverse Event|1
2854787|NCT02301897|9808880|P3|Treatment Course 1|Non-Compliance|1
2854788|NCT02301897|9808881|P2|Treatment Course 1|Non-Compliance|0
2854789|NCT02301897|9808882|P1|Treatment Course 1|Non-Compliance|0
2854790|NCT02301624|9808948|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
2854791|NCT02301624|9808949|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
2854792|NCT02301624|9808948|P2|Open-label Maintenance Phase|Death|1
2854793|NCT02301624|9808949|P1|Open-label Maintenance Phase|Death|2
2854794|NCT02301624|9808948|P2|Open-label Maintenance Phase|Physician Decision|3
2854795|NCT02301624|9808949|P1|Open-label Maintenance Phase|Physician Decision|3
2854796|NCT02301624|9808948|P2|Open-label Maintenance Phase|Adverse Event|5
2854797|NCT02301624|9808949|P1|Open-label Maintenance Phase|Adverse Event|2
2854798|NCT02301624|9808948|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
2854799|NCT02301624|9808949|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
2854800|NCT02301624|9808948|P2|Blind Induction Phase|Withdrawal by Subject|0
2854801|NCT02301624|9808949|P1|Blind Induction Phase|Withdrawal by Subject|1
2854802|NCT02301429|9808958|P1|Overall Study|not acceptable vascular anatomy|3
2854803|NCT02301403|9809004|P2|Overall Study|Withdrawal by Subject|41
2854804|NCT02301403|9809005|P1|Overall Study|Withdrawal by Subject|28
2854805|NCT02301390|9809013|P2|Overall Study|study terminated|0
2854806|NCT02301390|9809014|P1|Overall Study|study terminated|2
2854807|NCT02301390|9809013|P2|Overall Study|Missed multiple visits|1
2854808|NCT02301390|9809014|P1|Overall Study|Missed multiple visits|1
2854809|NCT02301390|9809013|P2|Overall Study|Procedure not completed|4
2854810|NCT02301390|9809014|P1|Overall Study|Procedure not completed|0
2854811|NCT02301390|9809013|P2|Overall Study|Death|2
2854812|NCT02301390|9809014|P1|Overall Study|Death|2
2854813|NCT02301390|9809013|P2|Overall Study|Lost to Follow-up|1
2854814|NCT02301390|9809014|P1|Overall Study|Lost to Follow-up|0
2854815|NCT02301390|9809013|P2|Overall Study|Physician Decision|0
2854816|NCT02301390|9809014|P1|Overall Study|Physician Decision|1
2854817|NCT02301390|9809013|P2|Overall Study|Protocol Violation|0
2854818|NCT02301390|9809014|P1|Overall Study|Protocol Violation|1
2854819|NCT02301390|9809013|P2|Overall Study|Withdrawal by Subject|5
2854820|NCT02301390|9809014|P1|Overall Study|Withdrawal by Subject|3
2854821|NCT02301169|9809055|P2|Overall Study|Adverse Event|0
2854822|NCT02301169|9809056|P1|Overall Study|Adverse Event|1
2854823|NCT02301143|9809070|P2|Investigator's Choice|Unresectable Surgery|1
2854824|NCT02301143|9809071|P1|Investigator's Choice|Unresectable Surgery|0
2854825|NCT02301143|9809070|P2|Investigator's Choice|Other|1
2854826|NCT02301143|9809071|P1|Investigator's Choice|Other|0
2854827|NCT02301143|9809070|P2|Investigator's Choice|Symptomatic Deterioration|1
2854828|NCT02301143|9809071|P1|Investigator's Choice|Symptomatic Deterioration|0
2854829|NCT02301143|9809070|P2|Investigator's Choice|Noncompliance With Study Drug|1
2854830|NCT02301143|9809071|P1|Investigator's Choice|Noncompliance With Study Drug|0
2854831|NCT02301143|9809070|P2|Investigator's Choice|Progressive Disease|3
2854832|NCT02301143|9809071|P1|Investigator's Choice|Progressive Disease|0
2854833|NCT02301143|9809070|P2|Investigator's Choice|Adverse Event|3
2854834|NCT02301143|9809071|P1|Investigator's Choice|Adverse Event|0
2854835|NCT02301143|9809070|P2|Induction Period|Other|0
2854836|NCT02301143|9809071|P1|Induction Period|Other|1
2854837|NCT02301143|9809070|P2|Induction Period|Protocol Violation|0
2854838|NCT02301143|9809071|P1|Induction Period|Protocol Violation|2
2854839|NCT02301143|9809070|P2|Induction Period|Symptomatic Deterioration|0
2854840|NCT02301143|9809071|P1|Induction Period|Symptomatic Deterioration|2
2854841|NCT02301143|9809070|P2|Induction Period|Physician Decision|0
2854842|NCT02301143|9809071|P1|Induction Period|Physician Decision|4
2854843|NCT02301143|9809070|P2|Induction Period|Noncompliance with Study Drug|0
2854844|NCT02301143|9809071|P1|Induction Period|Noncompliance with Study Drug|1
2854845|NCT02301143|9809070|P2|Induction Period|Withdrawal by Subject|0
2854846|NCT02301143|9809071|P1|Induction Period|Withdrawal by Subject|3
2854847|NCT02301143|9809070|P2|Induction Period|Progressive Disease|0
2854848|NCT02301143|9809071|P1|Induction Period|Progressive Disease|8
2854849|NCT02301143|9809070|P2|Induction Period|Adverse Event|0
2854850|NCT02301143|9809071|P1|Induction Period|Adverse Event|22
2854851|NCT02301143|9809070|P2|Induction Period|Death|0
2854852|NCT02301143|9809071|P1|Induction Period|Death|1
2854853|NCT02301143|9809070|P2|Induction Period|Enrolled But Not Treated|0
2854854|NCT02301143|9809071|P1|Induction Period|Enrolled But Not Treated|1
2854855|NCT02300610|9809115|P3|Overall Study|Withdrawal by Subject|1
2854856|NCT02300610|9809116|P2|Overall Study|Withdrawal by Subject|0
2854857|NCT02300610|9809117|P1|Overall Study|Withdrawal by Subject|1
2854858|NCT02300558|9809132|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
2854859|NCT02300558|9809132|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
2854860|NCT02300558|9809132|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
2854861|NCT02300558|9809132|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
2854862|NCT02300311|9809145|P2|Overall Study|Refused to continue taking medication|0
2854863|NCT02300311|9809146|P1|Overall Study|Refused to continue taking medication|18
2854864|NCT02300311|9809145|P2|Overall Study|Other than the reason specified|0
2854865|NCT02300311|9809146|P1|Overall Study|Other than the reason specified|1
2854866|NCT02300298|9809158|P2|Disposition for Docetaxel|other adverse event|4
2854867|NCT02300298|9809159|P1|Disposition for Docetaxel|other adverse event|0
2854868|NCT02300298|9809158|P2|Disposition for Docetaxel|Progressive disease|6
2854869|NCT02300298|9809159|P1|Disposition for Docetaxel|Progressive disease|0
2854870|NCT02300298|9809158|P2|Disposition for Nintedanib|Progressive disease|0
2854871|NCT02300298|9809159|P1|Disposition for Nintedanib|Progressive disease|10
2854872|NCT02300129|9809169|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2854873|NCT02300129|9809170|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2854874|NCT02300129|9809171|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2854875|NCT02300129|9809172|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
2854876|NCT02300129|9809169|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
2854877|NCT02300129|9809170|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2854878|NCT02300129|9809171|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2854879|NCT02300129|9809172|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2854880|NCT02300129|9809169|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2854881|NCT02300129|9809170|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2854882|NCT02300129|9809171|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
2854883|NCT02300129|9809172|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2854884|NCT02300103|9809182|P1|Overall Study|Withdrew Consent|2
2854885|NCT02300103|9809182|P1|Overall Study|Protocol Violation|1
2854886|NCT02300103|9809182|P1|Overall Study|Lack of Efficacy|3
2854887|NCT02299934|9809262|P1|Overall Study|Termination of study|13
2854888|NCT02299635|9809312|P1|Overall Study|Other|3
2854889|NCT02299635|9809312|P1|Overall Study|Withdrawal by Subject|2
2854890|NCT02299635|9809312|P1|Overall Study|Objective progression or relapse|10
2854891|NCT02299635|9809312|P1|Overall Study|Global deterioration of health status|1
2854892|NCT02299635|9809312|P1|Overall Study|Death|1
2854893|NCT02299635|9809312|P1|Overall Study|Adverse Event|2
2854894|NCT02299427|9809352|P2|Overall Study|not adherent to dog website use|0
2854895|NCT02299427|9809353|P1|Overall Study|not adherent to dog website use|21
2854896|NCT02299427|9809352|P2|Overall Study|Lost to Follow-up|3
2854897|NCT02299427|9809353|P1|Overall Study|Lost to Follow-up|1
2854898|NCT02299427|9809352|P2|Overall Study|Withdrawal by Subject|0
2854899|NCT02299427|9809353|P1|Overall Study|Withdrawal by Subject|1
2854900|NCT02299388|9809363|P2|Overall Study|Withdrawal by Subject|1
2854901|NCT02299388|9809364|P1|Overall Study|Withdrawal by Subject|0
2854902|NCT02299375|9809374|P2|Overall Study|Withdrawal by Subject|4
2854903|NCT02299375|9809375|P1|Overall Study|Withdrawal by Subject|1
2854904|NCT02299375|9809374|P2|Overall Study|Physician Decision|1
2854905|NCT02299375|9809375|P1|Overall Study|Physician Decision|1
2854906|NCT02299375|9809374|P2|Overall Study|Lost to Follow-up|2
2854907|NCT02299375|9809375|P1|Overall Study|Lost to Follow-up|0
2854908|NCT02299375|9809374|P2|Overall Study|Other: Study closed/terminated|55
2854909|NCT02299375|9809375|P1|Overall Study|Other: Study closed/terminated|66
2854910|NCT02299375|9809374|P2|Overall Study|Other: Met stopping criteria|0
2854911|NCT02299375|9809375|P1|Overall Study|Other: Met stopping criteria|1
2854912|NCT02299375|9809374|P2|Overall Study|Protocol Violation|3
2854913|NCT02299375|9809375|P1|Overall Study|Protocol Violation|1
2854914|NCT02299375|9809374|P2|Overall Study|Lack of Efficacy|3
2854915|NCT02299375|9809375|P1|Overall Study|Lack of Efficacy|1
2854916|NCT02299375|9809374|P2|Overall Study|Adverse Event, non-fatal|9
2854917|NCT02299375|9809375|P1|Overall Study|Adverse Event, non-fatal|8
2854918|NCT02299375|9809374|P2|Overall Study|Adverse Event, serious fatal|3
2854919|NCT02299375|9809375|P1|Overall Study|Adverse Event, serious fatal|1
2854920|NCT02299336|9809434|P1|Overall Study|Lost to Follow-up|1
2854921|NCT02299336|9809434|P1|Overall Study|Death|1
2854922|NCT02299336|9809434|P1|Overall Study|Adverse Event|1
2854923|NCT02299336|9809434|P1|Overall Study|Withdrawal by Subject|11
2854924|NCT02299206|9809469|P1|Overall Study|Withdrawal by Subject|1
2854925|NCT02299206|9809469|P1|Overall Study|Lost to Follow-up|1
2854926|NCT02299076|9809530|P2|Overall Study|Fraudulent Entries|14
2854927|NCT02299076|9809531|P1|Overall Study|Fraudulent Entries|20
2854928|NCT02298946|9809552|P2|Overall Study|Unevaluable|1
2854929|NCT02298946|9809553|P1|Overall Study|Unevaluable|2
2854930|NCT02298946|9809552|P2|Overall Study|Did not receive treatment|0
2854931|NCT02298946|9809553|P1|Overall Study|Did not receive treatment|2
2854932|NCT02298868|9809581|P1|Overall Study|Patient underwent transplant|1
2854933|NCT02298868|9809581|P1|Overall Study|Death|1
2854934|NCT02298868|9809581|P1|Overall Study|Adverse Event|1
2854935|NCT02298192|9809652|P2|Overall Study|Adverse Event|2
2854936|NCT02298192|9809653|P1|Overall Study|Adverse Event|6
2854937|NCT02298192|9809652|P2|Overall Study|Lost to Follow-up|1
2854938|NCT02298192|9809653|P1|Overall Study|Lost to Follow-up|2
2854939|NCT02298192|9809652|P2|Overall Study|Withdrawal by Subject|1
2854940|NCT02298192|9809653|P1|Overall Study|Withdrawal by Subject|6
2854941|NCT02298192|9809652|P2|Overall Study|Withdrawal criteria|0
2854942|NCT02298192|9809653|P1|Overall Study|Withdrawal criteria|2
2854943|NCT02298192|9809652|P2|Overall Study|Unclassified|2
2854944|NCT02298192|9809653|P1|Overall Study|Unclassified|3
2854945|NCT02298179|9809677|P12|Overall Study|Lost to Follow-up|0
2854946|NCT02298179|9809678|P11|Overall Study|Lost to Follow-up|0
2854947|NCT02298179|9809679|P10|Overall Study|Lost to Follow-up|0
2854948|NCT02298179|9809680|P9|Overall Study|Lost to Follow-up|0
2854949|NCT02298179|9809681|P8|Overall Study|Lost to Follow-up|1
2854950|NCT02298179|9809682|P7|Overall Study|Lost to Follow-up|0
2854951|NCT02298179|9809683|P6|Overall Study|Lost to Follow-up|0
2854952|NCT02298179|9809684|P5|Overall Study|Lost to Follow-up|0
2854953|NCT02298179|9809685|P4|Overall Study|Lost to Follow-up|0
2854954|NCT02298179|9809686|P3|Overall Study|Lost to Follow-up|1
2854955|NCT02298179|9809687|P2|Overall Study|Lost to Follow-up|0
2854956|NCT02298179|9809688|P1|Overall Study|Lost to Follow-up|0
2854957|NCT02297841|9809930|P1|Overall Study|Protocol Violation|7
2854958|NCT02297841|9809930|P1|Overall Study|Withdrawal by Subject|1
2854959|NCT02297815|9809936|P2|Overall Study|Lost to Follow-up|140
2854960|NCT02297815|9809937|P1|Overall Study|Lost to Follow-up|236
2854961|NCT02297516|9809955|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
2854962|NCT02297516|9809956|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
2854963|NCT02297516|9809955|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
2854964|NCT02297516|9809956|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
2854965|NCT02297516|9809955|P2|Single Treatment Phase (6 Months)|Medical reason|0
2854966|NCT02297516|9809956|P1|Single Treatment Phase (6 Months)|Medical reason|1
2854967|NCT02297503|9809977|P2|Overall Study|Medical reason|1
2854968|NCT02297503|9809978|P1|Overall Study|Medical reason|0
2854969|NCT02297503|9809977|P2|Overall Study|Lost to Follow-up|1
2854970|NCT02297503|9809978|P1|Overall Study|Lost to Follow-up|0
2854971|NCT02297503|9809977|P2|Overall Study|Pregnancy|1
2854972|NCT02297503|9809978|P1|Overall Study|Pregnancy|0
2854973|NCT02297503|9809977|P2|Overall Study|Protocol Violation|0
2854974|NCT02297503|9809978|P1|Overall Study|Protocol Violation|1
2854975|NCT02297503|9809977|P2|Overall Study|Withdrawal by Subject|1
2854976|NCT02297503|9809978|P1|Overall Study|Withdrawal by Subject|1
2854977|NCT02297412|9810005|P2|Overall Study|Canceled|1
2854978|NCT02297412|9810006|P1|Overall Study|Canceled|1
2854979|NCT02296931|9810067|P2|Overall Study|Protocol Violation|2
2854980|NCT02296931|9810068|P1|Overall Study|Protocol Violation|0
2854981|NCT02296892|9810077|P3|Overall Study|Lost to Follow-up|1
2854982|NCT02296892|9810078|P2|Overall Study|Lost to Follow-up|0
2854983|NCT02296892|9810079|P1|Overall Study|Lost to Follow-up|5
2854984|NCT02296892|9810077|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
2854985|NCT02296892|9810078|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
2854986|NCT02296892|9810079|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
2854987|NCT02296840|9810098|P2|Overall Study|Lost to Follow-up|17
2854988|NCT02296840|9810099|P1|Overall Study|Lost to Follow-up|6
2854989|NCT02296840|9810098|P2|Overall Study|Protocol Violation|1
2854990|NCT02296840|9810099|P1|Overall Study|Protocol Violation|2
2854991|NCT02296840|9810098|P2|Overall Study|Adverse Event|1
2854992|NCT02296840|9810099|P1|Overall Study|Adverse Event|1
2854993|NCT02296476|9810207|P3|Overall Study|Disease Progression|2
2854994|NCT02296476|9810208|P2|Overall Study|Disease Progression|4
2854995|NCT02296476|9810209|P1|Overall Study|Disease Progression|6
2854996|NCT02296424|9810264|P4|Part 2|Lost to Follow-up|0
2854997|NCT02296424|9810265|P3|Part 2|Lost to Follow-up|1
2854998|NCT02296424|9810266|P2|Part 2|Lost to Follow-up|0
2854999|NCT02296424|9810267|P1|Part 2|Lost to Follow-up|0
2855000|NCT02296424|9810264|P4|Part 2|Adverse Event|0
2855001|NCT02296424|9810265|P3|Part 2|Adverse Event|1
2855002|NCT02296424|9810266|P2|Part 2|Adverse Event|0
2855003|NCT02296424|9810267|P1|Part 2|Adverse Event|0
2855004|NCT02296424|9810264|P4|Part 2|Lack of Efficacy|0
2855005|NCT02296424|9810265|P3|Part 2|Lack of Efficacy|1
2855006|NCT02296424|9810266|P2|Part 2|Lack of Efficacy|0
2855007|NCT02296424|9810267|P1|Part 2|Lack of Efficacy|0
2855008|NCT02296424|9810264|P4|Part 1|16 directly started part II|0
2855009|NCT02296424|9810265|P3|Part 1|16 directly started part II|0
2855010|NCT02296424|9810266|P2|Part 1|16 directly started part II|0
2855011|NCT02296424|9810267|P1|Part 1|16 directly started part II|16
2855012|NCT02296424|9810264|P4|Part 1|Lack of Efficacy|0
2855013|NCT02296424|9810265|P3|Part 1|Lack of Efficacy|0
2855014|NCT02296424|9810266|P2|Part 1|Lack of Efficacy|17
2855015|NCT02296424|9810267|P1|Part 1|Lack of Efficacy|5
2855016|NCT02296424|9810264|P4|Part 1|Adverse Event|0
2855017|NCT02296424|9810265|P3|Part 1|Adverse Event|0
2855018|NCT02296424|9810266|P2|Part 1|Adverse Event|11
2855019|NCT02296424|9810267|P1|Part 1|Adverse Event|2
2855020|NCT02296424|9810264|P4|Part 1|Study terminated by sponsor|0
2855021|NCT02296424|9810265|P3|Part 1|Study terminated by sponsor|0
2855022|NCT02296424|9810266|P2|Part 1|Study terminated by sponsor|1
2855023|NCT02296424|9810267|P1|Part 1|Study terminated by sponsor|0
2855024|NCT02296424|9810264|P4|Part 1|Withdrawal by Subject|0
2855025|NCT02296424|9810265|P3|Part 1|Withdrawal by Subject|0
2855026|NCT02296424|9810266|P2|Part 1|Withdrawal by Subject|2
2855027|NCT02296424|9810267|P1|Part 1|Withdrawal by Subject|0
2855028|NCT02296424|9810264|P4|Part 1|Protocol Violation|0
2855029|NCT02296424|9810265|P3|Part 1|Protocol Violation|0
2855030|NCT02296424|9810266|P2|Part 1|Protocol Violation|1
2855031|NCT02296424|9810267|P1|Part 1|Protocol Violation|0
2855032|NCT02296424|9810264|P4|Part 1|New therapy for study indication|0
2855033|NCT02296424|9810265|P3|Part 1|New therapy for study indication|0
2855034|NCT02296424|9810266|P2|Part 1|New therapy for study indication|1
2855035|NCT02296424|9810267|P1|Part 1|New therapy for study indication|0
2855036|NCT02296320|9810292|P3|Overall Study|Not - specified|1
2855037|NCT02296320|9810293|P2|Overall Study|Not - specified|0
2855038|NCT02296320|9810294|P1|Overall Study|Not - specified|0
2855039|NCT02296320|9810292|P3|Overall Study|Not treated|0
2855040|NCT02296320|9810293|P2|Overall Study|Not treated|0
2855041|NCT02296320|9810294|P1|Overall Study|Not treated|2
2855042|NCT02296320|9810292|P3|Overall Study|Lost to Follow-up|7
2855043|NCT02296320|9810293|P2|Overall Study|Lost to Follow-up|2
2855044|NCT02296320|9810294|P1|Overall Study|Lost to Follow-up|5
2855045|NCT02296320|9810292|P3|Overall Study|Death|27
2855046|NCT02296320|9810293|P2|Overall Study|Death|3
2855047|NCT02296320|9810294|P1|Overall Study|Death|24
2855048|NCT02296320|9810292|P3|Overall Study|Withdrawal by Subject|2
2855049|NCT02296320|9810293|P2|Overall Study|Withdrawal by Subject|0
2855050|NCT02296320|9810294|P1|Overall Study|Withdrawal by Subject|4
2855051|NCT02296242|9810333|P5|Overall Study|Lack of Efficacy|3
2855052|NCT02296242|9810334|P4|Overall Study|Lack of Efficacy|0
2855053|NCT02296242|9810335|P3|Overall Study|Lack of Efficacy|0
2855054|NCT02296242|9810336|P2|Overall Study|Lack of Efficacy|0
2855055|NCT02296242|9810337|P1|Overall Study|Lack of Efficacy|0
2855056|NCT02296242|9810333|P5|Overall Study|Adverse Event|0
2855057|NCT02296242|9810334|P4|Overall Study|Adverse Event|1
2855058|NCT02296242|9810335|P3|Overall Study|Adverse Event|0
2855059|NCT02296242|9810336|P2|Overall Study|Adverse Event|0
2855060|NCT02296242|9810337|P1|Overall Study|Adverse Event|0
2855061|NCT02296242|9810333|P5|Overall Study|Alternative Treatment|0
2855062|NCT02296242|9810334|P4|Overall Study|Alternative Treatment|1
2855063|NCT02296242|9810335|P3|Overall Study|Alternative Treatment|0
2855064|NCT02296242|9810336|P2|Overall Study|Alternative Treatment|0
2855065|NCT02296242|9810337|P1|Overall Study|Alternative Treatment|0
2855066|NCT02296242|9810333|P5|Overall Study|Physician Decision|0
2855067|NCT02296242|9810334|P4|Overall Study|Physician Decision|1
2855068|NCT02296242|9810335|P3|Overall Study|Physician Decision|0
2855069|NCT02296242|9810336|P2|Overall Study|Physician Decision|1
2855070|NCT02296242|9810337|P1|Overall Study|Physician Decision|0
2855071|NCT02296242|9810333|P5|Overall Study|Screened for Other Protocol|0
2855072|NCT02296242|9810334|P4|Overall Study|Screened for Other Protocol|0
2855073|NCT02296242|9810335|P3|Overall Study|Screened for Other Protocol|0
2855074|NCT02296242|9810336|P2|Overall Study|Screened for Other Protocol|1
2855075|NCT02296242|9810337|P1|Overall Study|Screened for Other Protocol|0
2855076|NCT02296242|9810333|P5|Overall Study|Need for Hydroxyurea|0
2855077|NCT02296242|9810334|P4|Overall Study|Need for Hydroxyurea|0
2855078|NCT02296242|9810335|P3|Overall Study|Need for Hydroxyurea|0
2855079|NCT02296242|9810336|P2|Overall Study|Need for Hydroxyurea|0
2855080|NCT02296242|9810337|P1|Overall Study|Need for Hydroxyurea|2
2855081|NCT02296242|9810333|P5|Overall Study|Lost to Follow-up|0
2855082|NCT02296242|9810334|P4|Overall Study|Lost to Follow-up|0
2855083|NCT02296242|9810335|P3|Overall Study|Lost to Follow-up|0
2855084|NCT02296242|9810336|P2|Overall Study|Lost to Follow-up|0
2855085|NCT02296242|9810337|P1|Overall Study|Lost to Follow-up|1
2855086|NCT02296242|9810333|P5|Overall Study|At Least 3 Drug Interruptions|1
2855087|NCT02296242|9810334|P4|Overall Study|At Least 3 Drug Interruptions|1
2855088|NCT02296242|9810335|P3|Overall Study|At Least 3 Drug Interruptions|1
2855089|NCT02296242|9810336|P2|Overall Study|At Least 3 Drug Interruptions|0
2855090|NCT02296242|9810337|P1|Overall Study|At Least 3 Drug Interruptions|0
2855091|NCT02296242|9810333|P5|Overall Study|Patient Condition Changed|1
2855092|NCT02296242|9810334|P4|Overall Study|Patient Condition Changed|0
2855093|NCT02296242|9810335|P3|Overall Study|Patient Condition Changed|2
2855094|NCT02296242|9810336|P2|Overall Study|Patient Condition Changed|0
2855095|NCT02296242|9810337|P1|Overall Study|Patient Condition Changed|0
2855096|NCT02296242|9810333|P5|Overall Study|Unacceptable Toxicity|1
2855097|NCT02296242|9810334|P4|Overall Study|Unacceptable Toxicity|0
2855098|NCT02296242|9810335|P3|Overall Study|Unacceptable Toxicity|0
2855099|NCT02296242|9810336|P2|Overall Study|Unacceptable Toxicity|0
2855100|NCT02296242|9810337|P1|Overall Study|Unacceptable Toxicity|0
2855101|NCT02296242|9810333|P5|Overall Study|Disease Progression|11
2855102|NCT02296242|9810334|P4|Overall Study|Disease Progression|8
2855103|NCT02296242|9810335|P3|Overall Study|Disease Progression|2
2855104|NCT02296242|9810336|P2|Overall Study|Disease Progression|3
2855105|NCT02296242|9810337|P1|Overall Study|Disease Progression|1
2855106|NCT02296242|9810333|P5|Overall Study|Withdrawal by Subject|3
2855107|NCT02296242|9810334|P4|Overall Study|Withdrawal by Subject|1
2855108|NCT02296242|9810335|P3|Overall Study|Withdrawal by Subject|1
2855109|NCT02296242|9810336|P2|Overall Study|Withdrawal by Subject|0
2855110|NCT02296242|9810337|P1|Overall Study|Withdrawal by Subject|0
2855111|NCT02296242|9810333|P5|Overall Study|Death|1
2855112|NCT02296242|9810334|P4|Overall Study|Death|1
2855113|NCT02296242|9810335|P3|Overall Study|Death|1
2855114|NCT02296242|9810336|P2|Overall Study|Death|1
2855115|NCT02296242|9810337|P1|Overall Study|Death|1
2855116|NCT02296138|9810365|P2|Overall Study|Other than specified|13
2855117|NCT02296138|9810366|P1|Overall Study|Other than specified|15
2855118|NCT02296138|9810365|P2|Overall Study|Patients with data irregularities|11
2855119|NCT02296138|9810366|P1|Overall Study|Patients with data irregularities|10
2855120|NCT02296138|9810365|P2|Overall Study|Not Treated|1
2855121|NCT02296138|9810366|P1|Overall Study|Not Treated|1
2855122|NCT02296138|9810365|P2|Overall Study|Withdrawal by Subject|131
2855123|NCT02296138|9810366|P1|Overall Study|Withdrawal by Subject|184
2855124|NCT02296138|9810365|P2|Overall Study|Lost to Follow-up|12
2855125|NCT02296138|9810366|P1|Overall Study|Lost to Follow-up|9
2855126|NCT02296138|9810365|P2|Overall Study|Protocol Violation|36
2855127|NCT02296138|9810366|P1|Overall Study|Protocol Violation|35
2855128|NCT02296138|9810365|P2|Overall Study|Lack of Efficacy|37
2855129|NCT02296138|9810366|P1|Overall Study|Lack of Efficacy|59
2855130|NCT02296138|9810365|P2|Overall Study|Adverse Event|259
2855131|NCT02296138|9810366|P1|Overall Study|Adverse Event|348
2855132|NCT02296125|9810382|P4|Overall Study|Any reason not specifically recorded|0
2855133|NCT02296125|9810383|P3|Overall Study|Any reason not specifically recorded|0
2855134|NCT02296125|9810384|P2|Overall Study|Any reason not specifically recorded|3
2855135|NCT02296125|9810385|P1|Overall Study|Any reason not specifically recorded|3
2855136|NCT02296125|9810382|P4|Overall Study|Condition under investigation worsened|39
2855137|NCT02296125|9810383|P3|Overall Study|Condition under investigation worsened|24
2855138|NCT02296125|9810384|P2|Overall Study|Condition under investigation worsened|151
2855139|NCT02296125|9810385|P1|Overall Study|Condition under investigation worsened|87
2855140|NCT02296125|9810382|P4|Overall Study|Severe non-compliance to protocol|0
2855141|NCT02296125|9810383|P3|Overall Study|Severe non-compliance to protocol|0
2855142|NCT02296125|9810384|P2|Overall Study|Severe non-compliance to protocol|1
2855143|NCT02296125|9810385|P1|Overall Study|Severe non-compliance to protocol|0
2855144|NCT02296125|9810382|P4|Overall Study|Adverse Event|4
2855145|NCT02296125|9810383|P3|Overall Study|Adverse Event|9
2855146|NCT02296125|9810384|P2|Overall Study|Adverse Event|50
2855147|NCT02296125|9810385|P1|Overall Study|Adverse Event|36
2855148|NCT02296125|9810382|P4|Overall Study|Withdrawal by Subject|1
2855149|NCT02296125|9810383|P3|Overall Study|Withdrawal by Subject|5
2855150|NCT02296125|9810384|P2|Overall Study|Withdrawal by Subject|8
2855151|NCT02296125|9810385|P1|Overall Study|Withdrawal by Subject|12
2855152|NCT02296112|9810437|P1|Overall Study|Began an alternate therapy|1
2855153|NCT02296112|9810437|P1|Overall Study|Toxicity|1
2855154|NCT02296112|9810437|P1|Overall Study|Disease progression|7
2855155|NCT02295995|9810479|P2|Overall Study|Lost to Follow-up|1
2855156|NCT02295995|9810480|P1|Overall Study|Lost to Follow-up|5
2855157|NCT02295774|9810491|P1|Overall Study|Withdrawal by Subject|2
2855158|NCT02295774|9810491|P1|Overall Study|Physician Decision|1
2855159|NCT02295644|9810500|P4|Overall Study|Did not meet inclusion criterion|2
2855160|NCT02295644|9810501|P3|Overall Study|Did not meet inclusion criterion|1
2855161|NCT02295644|9810502|P2|Overall Study|Did not meet inclusion criterion|0
2855162|NCT02295644|9810503|P1|Overall Study|Did not meet inclusion criterion|0
2855163|NCT02295280|9810552|P2|Overall Study|Adverse Event|1
2855164|NCT02295280|9810553|P1|Overall Study|Adverse Event|0
2855165|NCT02295020|9810561|P2|Overall Study|Withdrawal by Subject|2
2855166|NCT02295020|9810562|P1|Overall Study|Withdrawal by Subject|3
2855167|NCT02295020|9810561|P2|Overall Study|Adverse Event|1
2855168|NCT02295020|9810562|P1|Overall Study|Adverse Event|0
2855169|NCT02294786|9810594|P2|Overall Study|Death|3
2855170|NCT02294786|9810595|P1|Overall Study|Death|2
2855171|NCT02294786|9810594|P2|Overall Study|Adverse Event|1
2855172|NCT02294786|9810595|P1|Overall Study|Adverse Event|1
2855173|NCT02294786|9810594|P2|Overall Study|Protocol Violation|0
2855174|NCT02294786|9810595|P1|Overall Study|Protocol Violation|1
2855175|NCT02294786|9810594|P2|Overall Study|Lost to Follow-up|2
2855176|NCT02294786|9810595|P1|Overall Study|Lost to Follow-up|1
2855177|NCT02294786|9810594|P2|Overall Study|Physician Decision|7
2855178|NCT02294786|9810595|P1|Overall Study|Physician Decision|6
2855179|NCT02294786|9810594|P2|Overall Study|Withdrawal by Subject|1
2855180|NCT02294786|9810595|P1|Overall Study|Withdrawal by Subject|0
2855181|NCT02294773|9810642|P2|Overall Study|Withdrawal by Subject|2
2855182|NCT02294773|9810643|P1|Overall Study|Withdrawal by Subject|0
2855183|NCT02294734|9810659|P2|Overall Study|Withdrawal by Subject|2
2855184|NCT02294734|9810660|P1|Overall Study|Withdrawal by Subject|4
2855185|NCT02294734|9810659|P2|Overall Study|Physician Decision|1
2855186|NCT02294734|9810660|P1|Overall Study|Physician Decision|2
2855187|NCT02294734|9810659|P2|Overall Study|Lost to Follow-up|0
2855188|NCT02294734|9810660|P1|Overall Study|Lost to Follow-up|2
2855189|NCT02294734|9810659|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
2855190|NCT02294734|9810660|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
2855191|NCT02294734|9810659|P2|Overall Study|Adverse Event|5
2855192|NCT02294734|9810660|P1|Overall Study|Adverse Event|5
2855193|NCT02294682|9810712|P2|Overall Study|Could not swallow pills|0
2855194|NCT02294682|9810713|P1|Overall Study|Could not swallow pills|1
2855195|NCT02294604|9810756|P3|Overall Study|Culture contamination|0
2855196|NCT02294604|9810757|P2|Overall Study|Culture contamination|2
2855197|NCT02294604|9810758|P1|Overall Study|Culture contamination|1
2855198|NCT02294604|9810756|P3|Overall Study|Did not provide samples for culture|0
2855199|NCT02294604|9810757|P2|Overall Study|Did not provide samples for culture|1
2855200|NCT02294604|9810758|P1|Overall Study|Did not provide samples for culture|0
2855201|NCT02294474|9810777|P2|Overall Study|Other than specified above|12
2855202|NCT02294474|9810778|P1|Overall Study|Other than specified above|12
2855203|NCT02294474|9810777|P2|Overall Study|Protocol Violation|2
2855204|NCT02294474|9810778|P1|Overall Study|Protocol Violation|4
2855205|NCT02294474|9810777|P2|Overall Study|Lack of Efficacy|1
2855206|NCT02294474|9810778|P1|Overall Study|Lack of Efficacy|2
2855207|NCT02294474|9810777|P2|Overall Study|Adverse Event|7
2855208|NCT02294474|9810778|P1|Overall Study|Adverse Event|7
2855209|NCT02294461|9810802|P2|Overall Study|Miscellaneous|32
2855210|NCT02294461|9810803|P1|Overall Study|Miscellaneous|11
2855211|NCT02294461|9810802|P2|Overall Study|Adverse Event|10
2855212|NCT02294461|9810803|P1|Overall Study|Adverse Event|11
2855213|NCT02294461|9810802|P2|Overall Study|Disease Progression|39
2855214|NCT02294461|9810803|P1|Overall Study|Disease Progression|23
2855215|NCT02294461|9810802|P2|Overall Study|Withdrawal by Subject|45
2855216|NCT02294461|9810803|P1|Overall Study|Withdrawal by Subject|14
2855217|NCT02294461|9810802|P2|Overall Study|Protocol Violation|2
2855218|NCT02294461|9810803|P1|Overall Study|Protocol Violation|0
2855219|NCT02294461|9810802|P2|Overall Study|Death|3
2855220|NCT02294461|9810803|P1|Overall Study|Death|3
2855221|NCT02294396|9810859|P4|Overall Study|Miscellaneous|2
2855222|NCT02294396|9810860|P3|Overall Study|Miscellaneous|5
2855223|NCT02294396|9810861|P2|Overall Study|Miscellaneous|0
2855224|NCT02294396|9810862|P1|Overall Study|Miscellaneous|2
2855225|NCT02294396|9810859|P4|Overall Study|Protocol Deviation|1
2855226|NCT02294396|9810860|P3|Overall Study|Protocol Deviation|2
2855227|NCT02294396|9810861|P2|Overall Study|Protocol Deviation|2
2855228|NCT02294396|9810862|P1|Overall Study|Protocol Deviation|3
2855229|NCT02294396|9810859|P4|Overall Study|Lost to Follow-up|1
2855230|NCT02294396|9810860|P3|Overall Study|Lost to Follow-up|1
2855231|NCT02294396|9810861|P2|Overall Study|Lost to Follow-up|0
2855232|NCT02294396|9810862|P1|Overall Study|Lost to Follow-up|0
2855233|NCT02294396|9810859|P4|Overall Study|Withdrawal by Subject|8
2855234|NCT02294396|9810860|P3|Overall Study|Withdrawal by Subject|6
2855235|NCT02294396|9810861|P2|Overall Study|Withdrawal by Subject|6
2855236|NCT02294396|9810862|P1|Overall Study|Withdrawal by Subject|8
2855320|NCT02293538|9811153|P1|Overall Study|Withdrawal by Subject|0
2855237|NCT02294396|9810859|P4|Overall Study|Electrocardiogram adviser's judgment|1
2855238|NCT02294396|9810860|P3|Overall Study|Electrocardiogram adviser's judgment|0
2855239|NCT02294396|9810861|P2|Overall Study|Electrocardiogram adviser's judgment|0
2855240|NCT02294396|9810862|P1|Overall Study|Electrocardiogram adviser's judgment|1
2855241|NCT02294396|9810859|P4|Overall Study|Adverse Event|24
2855242|NCT02294396|9810860|P3|Overall Study|Adverse Event|21
2855243|NCT02294396|9810861|P2|Overall Study|Adverse Event|25
2855244|NCT02294396|9810862|P1|Overall Study|Adverse Event|26
2855245|NCT02294318|9810934|P2|Overall Study|Not exposed to intervention|2
2855246|NCT02294318|9810935|P1|Overall Study|Not exposed to intervention|0
2855247|NCT02294318|9810934|P2|Overall Study|Worsening of drinking|0
2855248|NCT02294318|9810935|P1|Overall Study|Worsening of drinking|3
2855249|NCT02294227|9810954|P3|Overall Study|Adverse Event|2
2855250|NCT02294227|9810955|P2|Overall Study|Adverse Event|8
2855251|NCT02294227|9810956|P1|Overall Study|Adverse Event|6
2855252|NCT02294227|9810954|P3|Overall Study|Lack of Efficacy|8
2855253|NCT02294227|9810955|P2|Overall Study|Lack of Efficacy|12
2855254|NCT02294227|9810956|P1|Overall Study|Lack of Efficacy|11
2855255|NCT02294227|9810954|P3|Overall Study|Lost to Follow-up|0
2855256|NCT02294227|9810955|P2|Overall Study|Lost to Follow-up|0
2855257|NCT02294227|9810956|P1|Overall Study|Lost to Follow-up|1
2855258|NCT02294227|9810954|P3|Overall Study|Physician Decision|1
2855259|NCT02294227|9810955|P2|Overall Study|Physician Decision|2
2855260|NCT02294227|9810956|P1|Overall Study|Physician Decision|1
2855261|NCT02294227|9810954|P3|Overall Study|Subject/Guardian Decision|7
2855262|NCT02294227|9810955|P2|Overall Study|Subject/Guardian Decision|3
2855263|NCT02294227|9810956|P1|Overall Study|Subject/Guardian Decision|6
2855264|NCT02294227|9810954|P3|Overall Study|Death|1
2855265|NCT02294227|9810955|P2|Overall Study|Death|0
2855266|NCT02294227|9810956|P1|Overall Study|Death|0
2855267|NCT02294175|9810982|P2|Overall Study|wound healed|2
2855268|NCT02294175|9810983|P1|Overall Study|wound healed|0
2855269|NCT02294175|9810982|P2|Overall Study|Lost to Follow-up|1
2855270|NCT02294175|9810983|P1|Overall Study|Lost to Follow-up|0
2855271|NCT02294175|9810982|P2|Overall Study|Protocol Violation|0
2855272|NCT02294175|9810983|P1|Overall Study|Protocol Violation|1
2855273|NCT02294175|9810982|P2|Overall Study|pt taking excluded medication|1
2855274|NCT02294175|9810983|P1|Overall Study|pt taking excluded medication|3
2855275|NCT02294175|9810982|P2|Overall Study|Withdrawal by Subject|2
2855276|NCT02294175|9810983|P1|Overall Study|Withdrawal by Subject|1
2855277|NCT02294019|9811007|P1|Overall Study|Withdrawal by Subject|1
2855278|NCT02294019|9811007|P1|Overall Study|Other|1
2855279|NCT02294019|9811007|P1|Overall Study|Lost to Follow-up|31
2855280|NCT02294019|9811007|P1|Overall Study|Protocol Violation|68
2855281|NCT02294019|9811007|P1|Overall Study|Adverse Event|2
2855282|NCT02293902|9811015|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2855283|NCT02293902|9811016|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2855284|NCT02293902|9811017|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2855285|NCT02293902|9811018|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2855286|NCT02293902|9811019|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2855287|NCT02293902|9811015|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
2855288|NCT02293902|9811016|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2855289|NCT02293902|9811017|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2855290|NCT02293902|9811018|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
2855291|NCT02293902|9811019|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
2855292|NCT02293902|9811015|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2855293|NCT02293902|9811016|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2855294|NCT02293902|9811017|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2855295|NCT02293902|9811018|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2855296|NCT02293902|9811019|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
2855297|NCT02293902|9811015|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2855298|NCT02293902|9811016|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2855299|NCT02293902|9811017|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
2855300|NCT02293902|9811018|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
2855301|NCT02293902|9811019|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
2855302|NCT02293902|9811015|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
2855303|NCT02293902|9811016|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
2855304|NCT02293902|9811017|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
2855305|NCT02293902|9811018|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
2855306|NCT02293902|9811019|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
2855307|NCT02293863|9811081|P3|Overall Study|Reason Not Specified|2
2855308|NCT02293863|9811082|P2|Overall Study|Reason Not Specified|2
2855309|NCT02293863|9811083|P1|Overall Study|Reason Not Specified|0
2855310|NCT02293863|9811081|P3|Overall Study|Withdrawal by Subject|1
2855311|NCT02293863|9811082|P2|Overall Study|Withdrawal by Subject|3
2855312|NCT02293863|9811083|P1|Overall Study|Withdrawal by Subject|3
2855313|NCT02293863|9811081|P3|Overall Study|Lost to Follow-up|2
2855314|NCT02293863|9811082|P2|Overall Study|Lost to Follow-up|2
2855315|NCT02293863|9811083|P1|Overall Study|Lost to Follow-up|2
2855316|NCT02293863|9811081|P3|Overall Study|Death|4
2855317|NCT02293863|9811082|P2|Overall Study|Death|6
2855318|NCT02293863|9811083|P1|Overall Study|Death|4
2855319|NCT02293538|9811152|P2|Overall Study|Withdrawal by Subject|1
2855321|NCT02293538|9811152|P2|Overall Study|Lost to Follow-up|0
2855322|NCT02293538|9811153|P1|Overall Study|Lost to Follow-up|1
2855323|NCT02293538|9811152|P2|Overall Study|Adverse Event|1
2855324|NCT02293538|9811153|P1|Overall Study|Adverse Event|0
2855325|NCT02293460|9811183|P1|Overall Study|Withdrawal by Subject|1
2855326|NCT02293460|9811183|P1|Overall Study|Adverse Event|2
2855327|NCT02293460|9811183|P1|Overall Study|Lack of Efficacy|2
2855328|NCT02293460|9811183|P1|Overall Study|Protocol Violation|1
2855329|NCT02293395|9811189|P2|Overall Study|Withdrawal by Subject|7
2855330|NCT02293395|9811190|P1|Overall Study|Withdrawal by Subject|8
2855331|NCT02293395|9811189|P2|Overall Study|Lost to Follow-up|0
2855332|NCT02293395|9811190|P1|Overall Study|Lost to Follow-up|1
2855333|NCT02292927|9811203|P2|Overall Study|Protocol Violation|7
2855334|NCT02292927|9811204|P1|Overall Study|Protocol Violation|13
2855335|NCT02292849|9811221|P3|Overall Study|Physician Decision|0
2855336|NCT02292849|9811222|P2|Overall Study|Physician Decision|0
2855337|NCT02292849|9811223|P1|Overall Study|Physician Decision|4
2855338|NCT02292849|9811221|P3|Overall Study|Lost to Follow-up|2
2855339|NCT02292849|9811222|P2|Overall Study|Lost to Follow-up|2
2855340|NCT02292849|9811223|P1|Overall Study|Lost to Follow-up|0
2855341|NCT02292771|9811233|P2|Overall Study|Lost to Follow-up|1
2855342|NCT02292771|9811234|P1|Overall Study|Lost to Follow-up|2
2855343|NCT02292771|9811233|P2|Overall Study|Withdrawal by Subject|1
2855344|NCT02292771|9811234|P1|Overall Study|Withdrawal by Subject|2
2855345|NCT02292719|9811357|P6|Overall Study|Subject enrolled in new study.|0
2855346|NCT02292719|9811358|P5|Overall Study|Subject enrolled in new study.|0
2855347|NCT02292719|9811359|P4|Overall Study|Subject enrolled in new study.|0
2855348|NCT02292719|9811360|P3|Overall Study|Subject enrolled in new study.|1
2855349|NCT02292719|9811361|P2|Overall Study|Subject enrolled in new study.|0
2855350|NCT02292719|9811362|P1|Overall Study|Subject enrolled in new study.|0
2855351|NCT02292719|9811357|P6|Overall Study|Withdrawal by Subject|0
2855352|NCT02292719|9811358|P5|Overall Study|Withdrawal by Subject|1
2855353|NCT02292719|9811359|P4|Overall Study|Withdrawal by Subject|1
2855354|NCT02292719|9811360|P3|Overall Study|Withdrawal by Subject|0
2855355|NCT02292719|9811361|P2|Overall Study|Withdrawal by Subject|0
2855356|NCT02292719|9811362|P1|Overall Study|Withdrawal by Subject|0
2855357|NCT02292446|9811425|P1|Overall Study|Withdrawal by Subject|3
2855358|NCT02292446|9811425|P1|Overall Study|Subject/guardian decision|2
2855359|NCT02292446|9811425|P1|Overall Study|Disease progression|2
2855360|NCT02292446|9811425|P1|Overall Study|Death|1
2855361|NCT02292446|9811425|P1|Overall Study|Adverse Event|12
2855362|NCT02292212|9811514|P1|ViE Phase|Protocol Violation|2
2855363|NCT02292212|9811514|P1|ViE Phase|Withdrawal by Subject|1
2855364|NCT02291913|9811583|P1|Overall Study|Protocol Violation|1
2855365|NCT02291913|9811583|P1|Overall Study|Withdrawal by Subject|1
2855366|NCT02291913|9811583|P1|Overall Study|Physician Decision|1
2855367|NCT02291913|9811583|P1|Overall Study|Death|2
2855368|NCT02291913|9811583|P1|Overall Study|Adverse Event|11
2855369|NCT02291913|9811583|P1|Overall Study|Progressive Disease|32
2855370|NCT02291861|9811596|P4|Overall Study|Other|1
2855371|NCT02291861|9811597|P3|Overall Study|Other|0
2855372|NCT02291861|9811598|P2|Overall Study|Other|0
2855373|NCT02291861|9811599|P1|Overall Study|Other|0
2855374|NCT02291861|9811596|P4|Overall Study|Lost to Follow-up|0
2855375|NCT02291861|9811597|P3|Overall Study|Lost to Follow-up|4
2855376|NCT02291861|9811598|P2|Overall Study|Lost to Follow-up|1
2855377|NCT02291861|9811599|P1|Overall Study|Lost to Follow-up|2
2855378|NCT02291861|9811596|P4|Overall Study|Noncompliance|1
2855379|NCT02291861|9811597|P3|Overall Study|Noncompliance|2
2855380|NCT02291861|9811598|P2|Overall Study|Noncompliance|1
2855381|NCT02291861|9811599|P1|Overall Study|Noncompliance|1
2855382|NCT02291861|9811596|P4|Overall Study|Withdrawal by Subject|4
2855383|NCT02291861|9811597|P3|Overall Study|Withdrawal by Subject|1
2855384|NCT02291861|9811598|P2|Overall Study|Withdrawal by Subject|2
2855385|NCT02291861|9811599|P1|Overall Study|Withdrawal by Subject|1
2855386|NCT02291861|9811596|P4|Overall Study|Protocol Violation|1
2855387|NCT02291861|9811597|P3|Overall Study|Protocol Violation|0
2855388|NCT02291861|9811598|P2|Overall Study|Protocol Violation|0
2855389|NCT02291861|9811599|P1|Overall Study|Protocol Violation|1
2855390|NCT02291861|9811596|P4|Overall Study|Death|1
2855391|NCT02291861|9811597|P3|Overall Study|Death|1
2855392|NCT02291861|9811598|P2|Overall Study|Death|0
2855393|NCT02291861|9811599|P1|Overall Study|Death|0
2855394|NCT02291861|9811596|P4|Overall Study|Adverse Event|2
2855395|NCT02291861|9811597|P3|Overall Study|Adverse Event|1
2855396|NCT02291861|9811598|P2|Overall Study|Adverse Event|4
2855397|NCT02291861|9811599|P1|Overall Study|Adverse Event|2
2855398|NCT02291679|9811662|P3|Overall Study|Other|2
2855399|NCT02291679|9811663|P2|Overall Study|Other|4
2855400|NCT02291679|9811664|P1|Overall Study|Other|2
2855401|NCT02291679|9811662|P3|Overall Study|Insufficient Therapeutic Response|7
2855402|NCT02291679|9811663|P2|Overall Study|Insufficient Therapeutic Response|5
2855403|NCT02291679|9811664|P1|Overall Study|Insufficient Therapeutic Response|5
2855404|NCT02291679|9811662|P3|Overall Study|Lost to Follow-up|9
2855405|NCT02291679|9811663|P2|Overall Study|Lost to Follow-up|10
2855406|NCT02291679|9811664|P1|Overall Study|Lost to Follow-up|12
2855407|NCT02291679|9811662|P3|Overall Study|Withdrew Consent|15
2855408|NCT02291679|9811663|P2|Overall Study|Withdrew Consent|10
2855409|NCT02291679|9811664|P1|Overall Study|Withdrew Consent|18
2855410|NCT02291679|9811662|P3|Overall Study|Protocol Violation|7
2855411|NCT02291679|9811663|P2|Overall Study|Protocol Violation|1
2855412|NCT02291679|9811664|P1|Overall Study|Protocol Violation|5
2855413|NCT02291679|9811662|P3|Overall Study|Adverse Event|19
2855414|NCT02291679|9811663|P2|Overall Study|Adverse Event|12
2855415|NCT02291679|9811664|P1|Overall Study|Adverse Event|2
2855416|NCT02291549|9811695|P2|Overall Study|Withdrawal by Subject|1
2855417|NCT02291549|9811696|P1|Overall Study|Withdrawal by Subject|0
2855418|NCT02291549|9811695|P2|Overall Study|Lost to Follow-up|0
2855419|NCT02291549|9811696|P1|Overall Study|Lost to Follow-up|1
2855420|NCT02291510|9811718|P4|Overall Study|Adverse Event|1
2855421|NCT02291510|9811719|P3|Overall Study|Adverse Event|0
2855422|NCT02291510|9811720|P2|Overall Study|Adverse Event|0
2855423|NCT02291510|9811721|P1|Overall Study|Adverse Event|0
2855424|NCT02291419|9811737|P2|Overall Study|Early study termination|5
2855425|NCT02291419|9811738|P1|Overall Study|Early study termination|1
2855426|NCT02291237|9811756|P2|Overall Study|Subject Required Prohibited Medication|0
2855427|NCT02291237|9811757|P1|Overall Study|Subject Required Prohibited Medication|2
2855428|NCT02291237|9811756|P2|Overall Study|Lost to Follow-up|2
2855429|NCT02291237|9811757|P1|Overall Study|Lost to Follow-up|0
2855430|NCT02291237|9811756|P2|Overall Study|Withdrew Consent|11
2855431|NCT02291237|9811757|P1|Overall Study|Withdrew Consent|11
2855432|NCT02291237|9811756|P2|Overall Study|Investigator's Discretion|3
2855433|NCT02291237|9811757|P1|Overall Study|Investigator's Discretion|0
2855434|NCT02291237|9811756|P2|Overall Study|Adverse Event|3
2855435|NCT02291237|9811757|P1|Overall Study|Adverse Event|1
2855436|NCT02291237|9811756|P2|Overall Study|Study Terminated by Sponsor|67
2855437|NCT02291237|9811757|P1|Overall Study|Study Terminated by Sponsor|72
2855438|NCT02291029|9811779|P6|Overall Study|Adverse Event|0
2855439|NCT02291029|9811780|P5|Overall Study|Adverse Event|0
2855440|NCT02291029|9811781|P4|Overall Study|Adverse Event|0
2855441|NCT02291029|9811782|P3|Overall Study|Adverse Event|0
2855442|NCT02291029|9811783|P2|Overall Study|Adverse Event|1
2855443|NCT02291029|9811784|P1|Overall Study|Adverse Event|0
2855444|NCT02291029|9811779|P6|Overall Study|Withdrawal by Subject|0
2855445|NCT02291029|9811780|P5|Overall Study|Withdrawal by Subject|0
2855446|NCT02291029|9811781|P4|Overall Study|Withdrawal by Subject|0
2855447|NCT02291029|9811782|P3|Overall Study|Withdrawal by Subject|1
2855448|NCT02291029|9811783|P2|Overall Study|Withdrawal by Subject|0
2855449|NCT02291029|9811784|P1|Overall Study|Withdrawal by Subject|0
2855450|NCT02290925|9811855|P2|Second Period of 3 Months|insulin started|1
2855451|NCT02290925|9811856|P1|Second Period of 3 Months|insulin started|0
2855452|NCT02290925|9811855|P2|Second Period of 3 Months|Lost to Follow-up|3
2855453|NCT02290925|9811856|P1|Second Period of 3 Months|Lost to Follow-up|1
2855454|NCT02290925|9811855|P2|First Period of Three Months|Insulin Started|1
2855455|NCT02290925|9811856|P1|First Period of Three Months|Insulin Started|1
2855456|NCT02290925|9811855|P2|First Period of Three Months|Death|0
2855457|NCT02290925|9811856|P1|First Period of Three Months|Death|1
2855458|NCT02290925|9811855|P2|First Period of Three Months|Lost to Follow-up|1
2855459|NCT02290925|9811856|P1|First Period of Three Months|Lost to Follow-up|2
2855460|NCT02290873|9811871|P3|Overall Study|Protocol Violation|1
2855461|NCT02290873|9811872|P2|Overall Study|Protocol Violation|0
2855462|NCT02290873|9811873|P1|Overall Study|Protocol Violation|0
2855463|NCT02290873|9811871|P3|Overall Study|Esophagogastroduodenoscopy was added|0
2855464|NCT02290873|9811872|P2|Overall Study|Esophagogastroduodenoscopy was added|0
2855465|NCT02290873|9811873|P1|Overall Study|Esophagogastroduodenoscopy was added|1
2855466|NCT02290873|9811871|P3|Overall Study|Nellcor device error|0
2855467|NCT02290873|9811872|P2|Overall Study|Nellcor device error|0
2855468|NCT02290873|9811873|P1|Overall Study|Nellcor device error|1
2855469|NCT02290873|9811871|P3|Overall Study|Withdrawal by Subject|1
2855470|NCT02290873|9811872|P2|Overall Study|Withdrawal by Subject|1
2855471|NCT02290873|9811873|P1|Overall Study|Withdrawal by Subject|0
2855472|NCT02290821|9811892|P2|Overall Study|Lost to Follow-up|2
2855473|NCT02290821|9811893|P1|Overall Study|Lost to Follow-up|3
2855474|NCT02290821|9811892|P2|Overall Study|Unable or unwilling to cooperate with|0
2855475|NCT02290821|9811893|P1|Overall Study|Unable or unwilling to cooperate with|2
2855476|NCT02290821|9811892|P2|Overall Study|Withdrawal by Subject|1
2855477|NCT02290821|9811893|P1|Overall Study|Withdrawal by Subject|1
2855478|NCT02290691|9811901|P2|Overall Study|Lost to Follow-up|7
2855479|NCT02290691|9811902|P1|Overall Study|Lost to Follow-up|7
2855480|NCT02290691|9811901|P2|Overall Study|Withdrawal by Subject|1
2855481|NCT02290691|9811902|P1|Overall Study|Withdrawal by Subject|1
2855482|NCT02290691|9811901|P2|Overall Study|Noncompliance|1
2855483|NCT02290691|9811902|P1|Overall Study|Noncompliance|0
2855484|NCT02290431|9812015|P1|Overall Study|Physician Decision|2
2855485|NCT02290431|9812015|P1|Overall Study|Study terminated by Sponsor|1
2855486|NCT02290431|9812015|P1|Overall Study|Progressive disease|4
2855487|NCT02290431|9812015|P1|Overall Study|Adverse Event|20
2855488|NCT02290340|9812038|P4|Overall Study|Other|1
2855489|NCT02290340|9812039|P3|Overall Study|Other|0
2855490|NCT02290340|9812040|P2|Overall Study|Other|0
2855491|NCT02290340|9812041|P1|Overall Study|Other|1
2855492|NCT02290340|9812038|P4|Overall Study|Withdrawal by Subject|0
2855493|NCT02290340|9812039|P3|Overall Study|Withdrawal by Subject|0
2855494|NCT02290340|9812040|P2|Overall Study|Withdrawal by Subject|0
2855495|NCT02290340|9812041|P1|Overall Study|Withdrawal by Subject|1
2855496|NCT02290340|9812038|P4|Overall Study|Lost to Follow-up|1
2855497|NCT02290340|9812039|P3|Overall Study|Lost to Follow-up|0
2855498|NCT02290340|9812040|P2|Overall Study|Lost to Follow-up|0
2855499|NCT02290340|9812041|P1|Overall Study|Lost to Follow-up|0
2855500|NCT02290223|9812086|P2|12 Months|Refusal|1
2855501|NCT02290223|9812087|P1|12 Months|Refusal|0
2855502|NCT02290223|9812086|P2|12 Months|Lost to Follow-up|10
2855503|NCT02290223|9812087|P1|12 Months|Lost to Follow-up|16
2855504|NCT02290223|9812086|P2|6 Months|deceased (not related to study)|0
2855505|NCT02290223|9812087|P1|6 Months|deceased (not related to study)|2
2855506|NCT02290223|9812086|P2|6 Months|Withdrawal by Subject|0
2855507|NCT02290223|9812087|P1|6 Months|Withdrawal by Subject|5
2855508|NCT02290223|9812086|P2|6 Months|Lost to Follow-up|6
2855509|NCT02290223|9812087|P1|6 Months|Lost to Follow-up|9
2855510|NCT02289963|9812202|P2|Overall Study|Other than specified above|2
2855511|NCT02289963|9812203|P1|Overall Study|Other than specified above|0
2855512|NCT02289963|9812202|P2|Overall Study|End treatment visit outside visit window|4
2855513|NCT02289963|9812203|P1|Overall Study|End treatment visit outside visit window|0
2855514|NCT02289963|9812202|P2|Overall Study|Last injection missed|2
2855515|NCT02289963|9812203|P1|Overall Study|Last injection missed|2
2855516|NCT02289963|9812202|P2|Overall Study|Withdrawal by Subject|0
2855517|NCT02289963|9812203|P1|Overall Study|Withdrawal by Subject|1
2855518|NCT02289963|9812202|P2|Overall Study|Poor compliance to protocol|0
2855519|NCT02289963|9812203|P1|Overall Study|Poor compliance to protocol|1
2855520|NCT02289963|9812202|P2|Overall Study|Adverse Event|2
2855521|NCT02289963|9812203|P1|Overall Study|Adverse Event|1
2855522|NCT02289898|9812254|P3|Overall Study|Other|10
2855523|NCT02289898|9812255|P2|Overall Study|Other|7
2855524|NCT02289898|9812256|P1|Overall Study|Other|8
2855525|NCT02289898|9812254|P3|Overall Study|Use of another anticancer therapy|1
2855526|NCT02289898|9812255|P2|Overall Study|Use of another anticancer therapy|0
2855527|NCT02289898|9812256|P1|Overall Study|Use of another anticancer therapy|0
2855528|NCT02289898|9812254|P3|Overall Study|Disease progression|34
2855529|NCT02289898|9812255|P2|Overall Study|Disease progression|28
2855530|NCT02289898|9812256|P1|Overall Study|Disease progression|34
2855531|NCT02289898|9812254|P3|Overall Study|Adverse Event|5
2855532|NCT02289898|9812255|P2|Overall Study|Adverse Event|5
2855533|NCT02289898|9812256|P1|Overall Study|Adverse Event|3
2855534|NCT02289898|9812254|P3|Overall Study|Withdrawal by Subject|1
2855535|NCT02289898|9812255|P2|Overall Study|Withdrawal by Subject|4
2855536|NCT02289898|9812256|P1|Overall Study|Withdrawal by Subject|0
2855537|NCT02289898|9812254|P3|Overall Study|Physician Decision|2
2855538|NCT02289898|9812255|P2|Overall Study|Physician Decision|5
2855539|NCT02289898|9812256|P1|Overall Study|Physician Decision|2
2855540|NCT02289898|9812254|P3|Overall Study|Death|3
2855541|NCT02289898|9812255|P2|Overall Study|Death|4
2855542|NCT02289898|9812256|P1|Overall Study|Death|5
2855543|NCT02289833|9812265|P2|Overall Study|Death|16
2855544|NCT02289833|9812266|P1|Overall Study|Death|23
2855545|NCT02289833|9812265|P2|Overall Study|Lost to Follow-up|0
2855546|NCT02289833|9812266|P1|Overall Study|Lost to Follow-up|4
2855547|NCT02289833|9812265|P2|Overall Study|Study discontinuation|1
2855548|NCT02289833|9812266|P1|Overall Study|Study discontinuation|0
2855549|NCT02289820|9812302|P7|Overall Study|withdrawal of consent|0
2855550|NCT02289820|9812303|P6|Overall Study|withdrawal of consent|0
2855551|NCT02289820|9812304|P5|Overall Study|withdrawal of consent|0
2855552|NCT02289820|9812305|P4|Overall Study|withdrawal of consent|0
2855553|NCT02289820|9812306|P3|Overall Study|withdrawal of consent|0
2855554|NCT02289820|9812307|P2|Overall Study|withdrawal of consent|1
2855555|NCT02289820|9812308|P1|Overall Study|withdrawal of consent|0
2855556|NCT02289820|9812302|P7|Overall Study|Lost to Follow-up|1
2855557|NCT02289820|9812303|P6|Overall Study|Lost to Follow-up|1
2855558|NCT02289820|9812304|P5|Overall Study|Lost to Follow-up|0
2855559|NCT02289820|9812305|P4|Overall Study|Lost to Follow-up|1
2855560|NCT02289820|9812306|P3|Overall Study|Lost to Follow-up|3
2855561|NCT02289820|9812307|P2|Overall Study|Lost to Follow-up|0
2855562|NCT02289820|9812308|P1|Overall Study|Lost to Follow-up|0
2855563|NCT02289820|9812302|P7|Overall Study|Death|0
2855564|NCT02289820|9812303|P6|Overall Study|Death|0
2855565|NCT02289820|9812304|P5|Overall Study|Death|0
2855566|NCT02289820|9812305|P4|Overall Study|Death|0
2855567|NCT02289820|9812306|P3|Overall Study|Death|1
2855568|NCT02289820|9812307|P2|Overall Study|Death|0
2855569|NCT02289820|9812308|P1|Overall Study|Death|0
2855570|NCT02289820|9812302|P7|Overall Study|Withdrawal by Subject|1
2855571|NCT02289820|9812303|P6|Overall Study|Withdrawal by Subject|0
2855572|NCT02289820|9812304|P5|Overall Study|Withdrawal by Subject|0
2855573|NCT02289820|9812305|P4|Overall Study|Withdrawal by Subject|1
2855574|NCT02289820|9812306|P3|Overall Study|Withdrawal by Subject|2
2855575|NCT02289820|9812307|P2|Overall Study|Withdrawal by Subject|1
2855576|NCT02289820|9812308|P1|Overall Study|Withdrawal by Subject|2
2855577|NCT02289742|9812426|P4|Third Wear Period|Reason not given|1
2855578|NCT02289742|9812427|P3|Third Wear Period|Reason not given|0
2855579|NCT02289742|9812428|P2|Third Wear Period|Reason not given|0
2855580|NCT02289742|9812429|P1|Third Wear Period|Reason not given|0
2855581|NCT02289742|9812426|P4|Third Wear Period|Adverse Event|0
2855582|NCT02289742|9812427|P3|Third Wear Period|Adverse Event|0
2855583|NCT02289742|9812428|P2|Third Wear Period|Adverse Event|1
2855584|NCT02289742|9812429|P1|Third Wear Period|Adverse Event|0
2855585|NCT02289742|9812426|P4|First Wear Period|Other prior to treatment|1
2855586|NCT02289742|9812427|P3|First Wear Period|Other prior to treatment|0
2855587|NCT02289742|9812428|P2|First Wear Period|Other prior to treatment|0
2855588|NCT02289742|9812429|P1|First Wear Period|Other prior to treatment|0
2855589|NCT02289742|9812426|P4|First Wear Period|Adverse Event|0
2855590|NCT02289742|9812427|P3|First Wear Period|Adverse Event|1
2855591|NCT02289742|9812428|P2|First Wear Period|Adverse Event|0
2855592|NCT02289742|9812429|P1|First Wear Period|Adverse Event|0
2855593|NCT02289742|9812426|P4|First Wear Period|Adverse event prior to treatment|0
2855594|NCT02289742|9812427|P3|First Wear Period|Adverse event prior to treatment|0
2855595|NCT02289742|9812428|P2|First Wear Period|Adverse event prior to treatment|1
2855596|NCT02289742|9812429|P1|First Wear Period|Adverse event prior to treatment|0
2855597|NCT02289729|9812446|P1|Overall Study|Death|1
2855598|NCT02289729|9812446|P1|Overall Study|Withdrawal by Subject|1
2855599|NCT02289729|9812446|P1|Overall Study|Very Narrow Therapeutic Margin|1
2855600|NCT02289729|9812446|P1|Overall Study|Lack of Efficacy|3
2855601|NCT02289690|9812510|P10|Overall Study|Other|1
2855602|NCT02289690|9812511|P9|Overall Study|Other|3
2855603|NCT02289690|9812512|P8|Overall Study|Other|2
2855604|NCT02289690|9812513|P7|Overall Study|Other|1
2855605|NCT02289690|9812514|P6|Overall Study|Other|0
2855606|NCT02289690|9812515|P5|Overall Study|Other|1
2855607|NCT02289690|9812516|P4|Overall Study|Other|1
2855608|NCT02289690|9812517|P3|Overall Study|Other|0
2855609|NCT02289690|9812518|P2|Overall Study|Other|0
2855610|NCT02289690|9812519|P1|Overall Study|Other|0
2855611|NCT02289690|9812510|P10|Overall Study|Sponsor Discontinued Study|15
2855612|NCT02289690|9812511|P9|Overall Study|Sponsor Discontinued Study|7
2855613|NCT02289690|9812512|P8|Overall Study|Sponsor Discontinued Study|9
2855614|NCT02289690|9812513|P7|Overall Study|Sponsor Discontinued Study|0
2855615|NCT02289690|9812514|P6|Overall Study|Sponsor Discontinued Study|0
2855616|NCT02289690|9812515|P5|Overall Study|Sponsor Discontinued Study|0
2855617|NCT02289690|9812516|P4|Overall Study|Sponsor Discontinued Study|0
2855618|NCT02289690|9812517|P3|Overall Study|Sponsor Discontinued Study|0
2855619|NCT02289690|9812518|P2|Overall Study|Sponsor Discontinued Study|0
2855620|NCT02289690|9812519|P1|Overall Study|Sponsor Discontinued Study|0
2855621|NCT02289690|9812510|P10|Overall Study|Death|41
2855622|NCT02289690|9812511|P9|Overall Study|Death|45
2855623|NCT02289690|9812512|P8|Overall Study|Death|49
2855624|NCT02289690|9812513|P7|Overall Study|Death|0
2855625|NCT02289690|9812514|P6|Overall Study|Death|0
2855626|NCT02289690|9812515|P5|Overall Study|Death|0
2855627|NCT02289690|9812516|P4|Overall Study|Death|0
2855628|NCT02289690|9812517|P3|Overall Study|Death|0
2855629|NCT02289690|9812518|P2|Overall Study|Death|0
2855630|NCT02289690|9812519|P1|Overall Study|Death|0
2855631|NCT02289690|9812510|P10|Overall Study|Lost to Follow-up|2
2855632|NCT02289690|9812511|P9|Overall Study|Lost to Follow-up|0
2855633|NCT02289690|9812512|P8|Overall Study|Lost to Follow-up|1
2855634|NCT02289690|9812513|P7|Overall Study|Lost to Follow-up|0
2855635|NCT02289690|9812514|P6|Overall Study|Lost to Follow-up|0
2855636|NCT02289690|9812515|P5|Overall Study|Lost to Follow-up|0
2855637|NCT02289690|9812516|P4|Overall Study|Lost to Follow-up|0
2855638|NCT02289690|9812517|P3|Overall Study|Lost to Follow-up|0
2855639|NCT02289690|9812518|P2|Overall Study|Lost to Follow-up|0
2855640|NCT02289690|9812519|P1|Overall Study|Lost to Follow-up|0
2855641|NCT02289690|9812510|P10|Overall Study|Progressive Disease, Per Protocol|0
2855642|NCT02289690|9812511|P9|Overall Study|Progressive Disease, Per Protocol|0
2855643|NCT02289690|9812512|P8|Overall Study|Progressive Disease, Per Protocol|0
2855644|NCT02289690|9812513|P7|Overall Study|Progressive Disease, Per Protocol|2
2855645|NCT02289690|9812514|P6|Overall Study|Progressive Disease, Per Protocol|13
2855646|NCT02289690|9812515|P5|Overall Study|Progressive Disease, Per Protocol|5
2855647|NCT02289690|9812516|P4|Overall Study|Progressive Disease, Per Protocol|2
2855648|NCT02289690|9812517|P3|Overall Study|Progressive Disease, Per Protocol|3
2855649|NCT02289690|9812518|P2|Overall Study|Progressive Disease, Per Protocol|2
2855650|NCT02289690|9812519|P1|Overall Study|Progressive Disease, Per Protocol|3
2855651|NCT02289690|9812510|P10|Overall Study|Withdrawal by Subject|2
2855652|NCT02289690|9812511|P9|Overall Study|Withdrawal by Subject|4
2855653|NCT02289690|9812512|P8|Overall Study|Withdrawal by Subject|0
2855654|NCT02289690|9812513|P7|Overall Study|Withdrawal by Subject|0
2855655|NCT02289690|9812514|P6|Overall Study|Withdrawal by Subject|1
2855656|NCT02289690|9812515|P5|Overall Study|Withdrawal by Subject|1
2855657|NCT02289690|9812516|P4|Overall Study|Withdrawal by Subject|0
2855658|NCT02289690|9812517|P3|Overall Study|Withdrawal by Subject|0
2855659|NCT02289690|9812518|P2|Overall Study|Withdrawal by Subject|0
2855660|NCT02289690|9812519|P1|Overall Study|Withdrawal by Subject|1
2855661|NCT02289690|9812510|P10|Overall Study|Adverse Event Related to Progression|0
2855662|NCT02289690|9812511|P9|Overall Study|Adverse Event Related to Progression|0
2855663|NCT02289690|9812512|P8|Overall Study|Adverse Event Related to Progression|0
2855664|NCT02289690|9812513|P7|Overall Study|Adverse Event Related to Progression|1
2855665|NCT02289690|9812514|P6|Overall Study|Adverse Event Related to Progression|0
2855666|NCT02289690|9812515|P5|Overall Study|Adverse Event Related to Progression|1
2855667|NCT02289690|9812516|P4|Overall Study|Adverse Event Related to Progression|0
2855668|NCT02289690|9812517|P3|Overall Study|Adverse Event Related to Progression|1
2855669|NCT02289690|9812518|P2|Overall Study|Adverse Event Related to Progression|1
2855670|NCT02289690|9812519|P1|Overall Study|Adverse Event Related to Progression|0
2855671|NCT02289469|9812607|P2|Overall Study|Unable to match a control|0
2855672|NCT02289469|9812608|P1|Overall Study|Unable to match a control|6
2855673|NCT02289456|9812616|P1|Monotherapy Period|Miscellaneous|1
2855674|NCT02289456|9812616|P1|Monotherapy Period|Study Terminated by Sponsor|2
2855675|NCT02289456|9812616|P1|Monotherapy Period|Withdrawal by Subject|2
2855676|NCT02289456|9812616|P1|Monotherapy Period|Symptomatic Deterioration|1
2855677|NCT02289456|9812616|P1|Monotherapy Period|Progressive Disease (PD)|8
2855678|NCT02289456|9812616|P1|Monotherapy Period|Adverse Event|1
2855679|NCT02289456|9812616|P1|Monotherapy Period|Death|1
2855680|NCT02289456|9812616|P1|Induction Period|Miscellaneous|1
2855681|NCT02289456|9812616|P1|Induction Period|Withdrawal by Subject|2
2855682|NCT02289456|9812616|P1|Induction Period|Symptomatic Deterioration|4
2855683|NCT02289456|9812616|P1|Induction Period|Progressive Disease (PD)|4
2855684|NCT02289456|9812616|P1|Induction Period|Adverse Event|11
2855685|NCT02289456|9812616|P1|Induction Period|Death|2
2855686|NCT02289417|9812639|P9|Extension Phase Weeks 52-104|Miscellaneous|0
2855687|NCT02289417|9812640|P8|Extension Phase Weeks 52-104|Miscellaneous|1
2855688|NCT02289417|9812641|P7|Extension Phase Weeks 52-104|Miscellaneous|0
2855689|NCT02289417|9812642|P6|Extension Phase Weeks 52-104|Miscellaneous|0
2855690|NCT02289417|9812643|P5|Extension Phase Weeks 52-104|Miscellaneous|0
2855691|NCT02289417|9812644|P4|Extension Phase Weeks 52-104|Miscellaneous|0
2855692|NCT02289417|9812645|P3|Extension Phase Weeks 52-104|Miscellaneous|0
2855693|NCT02289417|9812646|P2|Extension Phase Weeks 52-104|Miscellaneous|0
2855694|NCT02289417|9812647|P1|Extension Phase Weeks 52-104|Miscellaneous|0
2855695|NCT02289417|9812639|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
2855696|NCT02289417|9812640|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
2855697|NCT02289417|9812641|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855698|NCT02289417|9812642|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855699|NCT02289417|9812643|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855700|NCT02289417|9812644|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855701|NCT02289417|9812645|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855702|NCT02289417|9812646|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855703|NCT02289417|9812647|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2855704|NCT02289417|9812639|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
2855705|NCT02289417|9812640|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
2855706|NCT02289417|9812641|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855707|NCT02289417|9812642|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855708|NCT02289417|9812643|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855709|NCT02289417|9812644|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855710|NCT02289417|9812645|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855711|NCT02289417|9812646|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855712|NCT02289417|9812647|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
2855713|NCT02289417|9812639|P9|Extension Phase Weeks 52-104|Adverse Event|3
2855714|NCT02289417|9812640|P8|Extension Phase Weeks 52-104|Adverse Event|2
2855715|NCT02289417|9812641|P7|Extension Phase Weeks 52-104|Adverse Event|0
2855716|NCT02289417|9812642|P6|Extension Phase Weeks 52-104|Adverse Event|0
2855717|NCT02289417|9812643|P5|Extension Phase Weeks 52-104|Adverse Event|0
2855718|NCT02289417|9812644|P4|Extension Phase Weeks 52-104|Adverse Event|0
2855719|NCT02289417|9812645|P3|Extension Phase Weeks 52-104|Adverse Event|0
2855720|NCT02289417|9812646|P2|Extension Phase Weeks 52-104|Adverse Event|0
2855721|NCT02289417|9812647|P1|Extension Phase Weeks 52-104|Adverse Event|0
2855722|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855723|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855724|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2855725|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855726|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855727|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2855728|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855729|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855730|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2855731|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855732|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855733|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
2855734|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855735|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855736|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855737|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855738|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855739|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2855740|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855741|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855742|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855743|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2855744|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2855745|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855746|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2855747|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855748|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2855749|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2855750|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2855751|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2855752|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
2855753|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
2855754|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
2855755|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
2855756|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
2855757|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2855758|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855759|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855760|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855761|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855762|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855763|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855764|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
2855765|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855766|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
2855767|NCT02289417|9812639|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
2855768|NCT02289417|9812640|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
2855769|NCT02289417|9812641|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
2855770|NCT02289417|9812642|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
2855771|NCT02289417|9812643|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
2855772|NCT02289417|9812644|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
2855773|NCT02289417|9812645|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
2855774|NCT02289417|9812646|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
2855775|NCT02289417|9812647|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
2855776|NCT02289417|9812639|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855777|NCT02289417|9812640|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855778|NCT02289417|9812641|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855779|NCT02289417|9812642|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855780|NCT02289417|9812643|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855781|NCT02289417|9812644|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855782|NCT02289417|9812645|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855783|NCT02289417|9812646|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2855784|NCT02289417|9812647|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
2855785|NCT02289417|9812639|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855786|NCT02289417|9812640|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855787|NCT02289417|9812641|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855788|NCT02289417|9812642|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855789|NCT02289417|9812643|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855790|NCT02289417|9812644|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855791|NCT02289417|9812645|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855792|NCT02289417|9812646|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
2855793|NCT02289417|9812647|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2855794|NCT02289417|9812639|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855795|NCT02289417|9812640|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855796|NCT02289417|9812641|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855797|NCT02289417|9812642|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855798|NCT02289417|9812643|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855799|NCT02289417|9812644|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2855800|NCT02289417|9812645|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
2855801|NCT02289417|9812646|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
2855802|NCT02289417|9812647|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
2855803|NCT02289417|9812639|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855804|NCT02289417|9812640|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855805|NCT02289417|9812641|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855806|NCT02289417|9812642|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855807|NCT02289417|9812643|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855808|NCT02289417|9812644|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855809|NCT02289417|9812645|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
2855810|NCT02289417|9812646|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2855811|NCT02289417|9812647|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
2855812|NCT02289352|9812696|P3|Overall Study|Withdrawal by Subject|0
2855813|NCT02289352|9812697|P2|Overall Study|Withdrawal by Subject|1
2855814|NCT02289352|9812698|P1|Overall Study|Withdrawal by Subject|1
2855815|NCT02289079|9812765|P2|Overall Study|Lost to Follow-up|1
2855816|NCT02289079|9812766|P1|Overall Study|Lost to Follow-up|0
2855817|NCT02289079|9812765|P2|Overall Study|Physician Decision|0
2855818|NCT02289079|9812766|P1|Overall Study|Physician Decision|2
2855819|NCT02288559|9812795|P4|Overall Study|Reason Not Specified|0
2855820|NCT02288559|9812796|P3|Overall Study|Reason Not Specified|3
2855821|NCT02288559|9812797|P2|Overall Study|Reason Not Specified|0
2855822|NCT02288559|9812798|P1|Overall Study|Reason Not Specified|0
2855823|NCT02288559|9812795|P4|Overall Study|Withdrawal by Subject|1
2855824|NCT02288559|9812796|P3|Overall Study|Withdrawal by Subject|2
2855825|NCT02288559|9812797|P2|Overall Study|Withdrawal by Subject|0
2855826|NCT02288559|9812798|P1|Overall Study|Withdrawal by Subject|0
2855827|NCT02288559|9812795|P4|Overall Study|Lost to Follow-up|1
2855828|NCT02288559|9812796|P3|Overall Study|Lost to Follow-up|0
2855829|NCT02288559|9812797|P2|Overall Study|Lost to Follow-up|0
2855830|NCT02288559|9812798|P1|Overall Study|Lost to Follow-up|0
2855831|NCT02288559|9812795|P4|Overall Study|Death|0
2855832|NCT02288559|9812796|P3|Overall Study|Death|1
2855833|NCT02288559|9812797|P2|Overall Study|Death|0
2855834|NCT02288559|9812798|P1|Overall Study|Death|0
2855835|NCT02288559|9812795|P4|Overall Study|Adverse Event|0
2855836|NCT02288559|9812796|P3|Overall Study|Adverse Event|5
2855837|NCT02288559|9812797|P2|Overall Study|Adverse Event|1
2855838|NCT02288559|9812798|P1|Overall Study|Adverse Event|1
2855839|NCT02288325|9812849|P3|Double-blind Treatment Period|Multiple Reasons|2
2855840|NCT02288325|9812850|P2|Double-blind Treatment Period|Multiple Reasons|8
2855841|NCT02288325|9812851|P1|Double-blind Treatment Period|Multiple Reasons|0
2855842|NCT02288325|9812849|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
2855843|NCT02288325|9812850|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
2855844|NCT02288325|9812851|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
2855845|NCT02288325|9812849|P3|Double-blind Treatment Period|Protocol Violation|2
2855846|NCT02288325|9812850|P2|Double-blind Treatment Period|Protocol Violation|1
2855847|NCT02288325|9812851|P1|Double-blind Treatment Period|Protocol Violation|0
2855848|NCT02288325|9812849|P3|Double-blind Treatment Period|Lost to Follow-up|5
2855849|NCT02288325|9812850|P2|Double-blind Treatment Period|Lost to Follow-up|4
2855850|NCT02288325|9812851|P1|Double-blind Treatment Period|Lost to Follow-up|0
2855851|NCT02288325|9812849|P3|Double-blind Treatment Period|Withdrawal of Consent|8
2855852|NCT02288325|9812850|P2|Double-blind Treatment Period|Withdrawal of Consent|8
2855853|NCT02288325|9812851|P1|Double-blind Treatment Period|Withdrawal of Consent|0
2855854|NCT02288325|9812849|P3|Double-blind Treatment Period|Adverse Event|5
2855855|NCT02288325|9812850|P2|Double-blind Treatment Period|Adverse Event|2
2855856|NCT02288325|9812851|P1|Double-blind Treatment Period|Adverse Event|0
2855857|NCT02288325|9812849|P3|Stabilization Period|Reason not Specified|0
2855858|NCT02288325|9812850|P2|Stabilization Period|Reason not Specified|0
2855859|NCT02288325|9812851|P1|Stabilization Period|Reason not Specified|15
2855860|NCT02288325|9812849|P3|Stabilization Period|Non-Compliance With Study Drug|0
2855861|NCT02288325|9812850|P2|Stabilization Period|Non-Compliance With Study Drug|0
2855862|NCT02288325|9812851|P1|Stabilization Period|Non-Compliance With Study Drug|5
2855863|NCT02288325|9812849|P3|Stabilization Period|Protocol Violation|0
2855864|NCT02288325|9812850|P2|Stabilization Period|Protocol Violation|0
2855865|NCT02288325|9812851|P1|Stabilization Period|Protocol Violation|8
2855866|NCT02288325|9812849|P3|Stabilization Period|Lost to Follow-up|0
2855867|NCT02288325|9812850|P2|Stabilization Period|Lost to Follow-up|0
2855868|NCT02288325|9812851|P1|Stabilization Period|Lost to Follow-up|12
2855869|NCT02288325|9812849|P3|Stabilization Period|Withdrawal of Consent|0
2855870|NCT02288325|9812850|P2|Stabilization Period|Withdrawal of Consent|0
2855871|NCT02288325|9812851|P1|Stabilization Period|Withdrawal of Consent|23
2855872|NCT02288325|9812849|P3|Stabilization Period|Lack of Efficacy|0
2855873|NCT02288325|9812850|P2|Stabilization Period|Lack of Efficacy|0
2855874|NCT02288325|9812851|P1|Stabilization Period|Lack of Efficacy|22
2855875|NCT02288325|9812849|P3|Stabilization Period|Adverse Event|0
2855876|NCT02288325|9812850|P2|Stabilization Period|Adverse Event|0
2855877|NCT02288325|9812851|P1|Stabilization Period|Adverse Event|13
2855878|NCT02288325|9812849|P3|Run-in Period|Reason not Specified|0
2855879|NCT02288325|9812850|P2|Run-in Period|Reason not Specified|0
2855880|NCT02288325|9812851|P1|Run-in Period|Reason not Specified|8
2855881|NCT02288325|9812849|P3|Run-in Period|Non-Compliance With Study Drug|0
2855882|NCT02288325|9812850|P2|Run-in Period|Non-Compliance With Study Drug|0
2855883|NCT02288325|9812851|P1|Run-in Period|Non-Compliance With Study Drug|3
2855884|NCT02288325|9812849|P3|Run-in Period|Protocol Violation|0
2855885|NCT02288325|9812850|P2|Run-in Period|Protocol Violation|0
2855886|NCT02288325|9812851|P1|Run-in Period|Protocol Violation|17
2855887|NCT02288325|9812849|P3|Run-in Period|Lost to Follow-up|0
2855888|NCT02288325|9812850|P2|Run-in Period|Lost to Follow-up|0
2855889|NCT02288325|9812851|P1|Run-in Period|Lost to Follow-up|25
2855890|NCT02288325|9812849|P3|Run-in Period|Withdrawal of Consent|0
2855891|NCT02288325|9812850|P2|Run-in Period|Withdrawal of Consent|0
2855892|NCT02288325|9812851|P1|Run-in Period|Withdrawal of Consent|28
2855893|NCT02288325|9812849|P3|Run-in Period|Lack of Efficacy|0
2855894|NCT02288325|9812850|P2|Run-in Period|Lack of Efficacy|0
2855895|NCT02288325|9812851|P1|Run-in Period|Lack of Efficacy|16
2855896|NCT02288325|9812849|P3|Run-in Period|Adverse Event|0
2855897|NCT02288325|9812850|P2|Run-in Period|Adverse Event|0
2855898|NCT02288325|9812851|P1|Run-in Period|Adverse Event|48
2855899|NCT02288312|9812861|P3|Overall Study|Pregnancy|0
2855900|NCT02288312|9812862|P2|Overall Study|Pregnancy|0
2855901|NCT02288312|9812863|P1|Overall Study|Pregnancy|1
2855902|NCT02288182|9812903|P2|Overall Study|Lost to Follow-up|1
2855903|NCT02288182|9812904|P1|Overall Study|Lost to Follow-up|0
2855904|NCT02288182|9812903|P2|Overall Study|Adverse Event|1
2855905|NCT02288182|9812904|P1|Overall Study|Adverse Event|0
2855906|NCT02288091|9812916|P1|Overall Study|Screen fail|7
2855907|NCT02288091|9812916|P1|Overall Study|Lost to Follow-up|1
2855908|NCT02287922|9812928|P4|Overall Study|Other|0
2855909|NCT02287922|9812929|P3|Overall Study|Other|2
2855910|NCT02287922|9812930|P2|Overall Study|Other|0
2855911|NCT02287922|9812931|P1|Overall Study|Other|1
2855912|NCT02287922|9812928|P4|Overall Study|Sponsor's decision|1
2855913|NCT02287922|9812929|P3|Overall Study|Sponsor's decision|0
2855914|NCT02287922|9812930|P2|Overall Study|Sponsor's decision|0
2855915|NCT02287922|9812931|P1|Overall Study|Sponsor's decision|0
2855916|NCT02287922|9812928|P4|Overall Study|Lost to Follow-up|0
2855917|NCT02287922|9812929|P3|Overall Study|Lost to Follow-up|1
2855918|NCT02287922|9812930|P2|Overall Study|Lost to Follow-up|0
2855919|NCT02287922|9812931|P1|Overall Study|Lost to Follow-up|0
2855920|NCT02287922|9812928|P4|Overall Study|Withdrawal by Subject|2
2855921|NCT02287922|9812929|P3|Overall Study|Withdrawal by Subject|1
2855922|NCT02287922|9812930|P2|Overall Study|Withdrawal by Subject|1
2855923|NCT02287922|9812931|P1|Overall Study|Withdrawal by Subject|1
2855924|NCT02287922|9812928|P4|Overall Study|Adverse Event|4
2855925|NCT02287922|9812929|P3|Overall Study|Adverse Event|3
2855926|NCT02287922|9812930|P2|Overall Study|Adverse Event|1
2855927|NCT02287922|9812931|P1|Overall Study|Adverse Event|1
2855928|NCT02287896|9813022|P2|Second Injection Visit|Withdrawal by Subject|1
2855929|NCT02287896|9813023|P1|Second Injection Visit|Withdrawal by Subject|0
2855930|NCT02287883|9813041|P2|Overall Study|Non-response to survey|237
2855931|NCT02287883|9813042|P1|Overall Study|Non-response to survey|229
2855932|NCT02287883|9813041|P2|Overall Study|No longer eligible|182
2855933|NCT02287883|9813042|P1|Overall Study|No longer eligible|222
2855934|NCT02287883|9813041|P2|Overall Study|Death|7
2855935|NCT02287883|9813042|P1|Overall Study|Death|8
2855936|NCT02287623|9813244|P2|Overall Study|Protocol Violation|1
2855937|NCT02287623|9813245|P1|Overall Study|Protocol Violation|0
2855938|NCT02287610|9813261|P1|Overall Study|Excluded-investigator non-responsiveness|5
2855939|NCT02287610|9813261|P1|Overall Study|Withdrawal by Subject|8
2855940|NCT02287610|9813261|P1|Overall Study|Lost to Follow-up|3
2855941|NCT02287467|9813296|P2|Overall Study|Protocol Violation|9
2855942|NCT02287467|9813297|P1|Overall Study|Protocol Violation|12
2855943|NCT02287402|9813345|P1|Follow-up|Voluntary Withdrawal|2
2855944|NCT02287402|9813345|P1|Follow-up|Lost to Follow-up|1
2855945|NCT02287402|9813345|P1|Treatment Period|Voluntary Withdrawal|10
2855946|NCT02287402|9813345|P1|Treatment Period|Adverse Event|17
2855947|NCT02287038|9813450|P2|Overall Study|Abnormal ECG after starting medication|0
2855948|NCT02287038|9813451|P1|Overall Study|Abnormal ECG after starting medication|1
2855949|NCT02287038|9813450|P2|Overall Study|Nausea after starting medication|0
2855950|NCT02287038|9813451|P1|Overall Study|Nausea after starting medication|1
2855951|NCT02287038|9813450|P2|Overall Study|Anxiety after starting medication|1
2855952|NCT02287038|9813451|P1|Overall Study|Anxiety after starting medication|0
2855953|NCT02287038|9813450|P2|Overall Study|Stopped attending appointments|2
2855954|NCT02287038|9813451|P1|Overall Study|Stopped attending appointments|3
2855955|NCT02287025|9813461|P2|Overall Study|Screening failed|1
2855956|NCT02287025|9813462|P1|Overall Study|Screening failed|1
2855957|NCT02287025|9813461|P2|Overall Study|Withdrawal by Subject|2
2855958|NCT02287025|9813462|P1|Overall Study|Withdrawal by Subject|2
2855959|NCT02287025|9813461|P2|Overall Study|Adverse Event|4
2855960|NCT02287025|9813462|P1|Overall Study|Adverse Event|2
2855961|NCT02287025|9813461|P2|Overall Study|Progression of disease|2
2855962|NCT02287025|9813462|P1|Overall Study|Progression of disease|3
2855963|NCT02287025|9813461|P2|Overall Study|Not treated|0
2855964|NCT02287025|9813462|P1|Overall Study|Not treated|2
2855965|NCT02286960|9813473|P2|Overall Study|Lost to Follow-up|3
2855966|NCT02286960|9813474|P1|Overall Study|Lost to Follow-up|3
2855967|NCT02286947|9813486|P1|Overall Study|Withdrawal by Subject|2
2855968|NCT02286895|9813528|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
2855969|NCT02286895|9813529|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
2855970|NCT02286895|9813528|P2|Assessed for Measles Seroconversion|Missing measurement|3
2855971|NCT02286895|9813529|P1|Assessed for Measles Seroconversion|Missing measurement|6
2855972|NCT02286895|9813528|P2|Assessed for Measles Seroconversion|Protocol Violation|4
2855973|NCT02286895|9813529|P1|Assessed for Measles Seroconversion|Protocol Violation|1
2855974|NCT02286713|9813573|P2|Six Month Follow-Up|Lost to Follow-up|27
2855975|NCT02286713|9813574|P1|Six Month Follow-Up|Lost to Follow-up|30
2855976|NCT02286713|9813573|P2|Six Month Follow-Up|Death|0
2855977|NCT02286713|9813574|P1|Six Month Follow-Up|Death|2
2855978|NCT02286713|9813573|P2|Three Month Follow-Up|Withdrawal by Subject|1
2855979|NCT02286713|9813574|P1|Three Month Follow-Up|Withdrawal by Subject|1
2855980|NCT02286713|9813573|P2|Three Month Follow-Up|Lost to Follow-up|24
2855981|NCT02286713|9813574|P1|Three Month Follow-Up|Lost to Follow-up|26
2855982|NCT02286713|9813573|P2|Three Month Follow-Up|Death|1
2855983|NCT02286713|9813574|P1|Three Month Follow-Up|Death|1
2855984|NCT02286713|9813573|P2|One Week Follow-Up|Withdrawal by Subject|3
2855985|NCT02286713|9813574|P1|One Week Follow-Up|Withdrawal by Subject|6
2855986|NCT02286713|9813573|P2|One Week Follow-Up|Lost to Follow-up|21
2855987|NCT02286713|9813574|P1|One Week Follow-Up|Lost to Follow-up|17
2855988|NCT02286713|9813573|P2|One Week Follow-Up|Death|0
2855989|NCT02286713|9813574|P1|One Week Follow-Up|Death|1
2855990|NCT02286466|9813755|P2|Overall Study|Declined Clinician Assessment|1
2855991|NCT02286466|9813756|P1|Overall Study|Declined Clinician Assessment|0
2855992|NCT02286466|9813755|P2|Overall Study|Lost to Follow-up|4
2855993|NCT02286466|9813756|P1|Overall Study|Lost to Follow-up|1
2855994|NCT02286466|9813755|P2|Overall Study|Withdrawal by Subject|2
2855995|NCT02286466|9813756|P1|Overall Study|Withdrawal by Subject|5
2855996|NCT02286466|9813755|P2|Overall Study|Death|3
2855997|NCT02286466|9813756|P1|Overall Study|Death|1
2855998|NCT02286193|9813768|P1|Overall Study|Referred: Declined service|38
2855999|NCT02286193|9813768|P1|Overall Study|Referred: unable to reach/resource sent|104
2856000|NCT02286193|9813768|P1|Overall Study|Referred: CRS unable to make contact|62
2856001|NCT02286102|9813775|P2|Overall Study|Screen Failure|1
2856002|NCT02286102|9813776|P1|Overall Study|Screen Failure|1
2856003|NCT02285998|9813788|P2|Overall Study|Other Reasons|10
2856004|NCT02285998|9813789|P1|Overall Study|Other Reasons|7
2856005|NCT02285998|9813788|P2|Overall Study|Withdrawal by Subject|61
2856006|NCT02285998|9813789|P1|Overall Study|Withdrawal by Subject|53
2856007|NCT02285998|9813788|P2|Overall Study|Lost to Follow-up|172
2856008|NCT02285998|9813789|P1|Overall Study|Lost to Follow-up|176
2856009|NCT02285998|9813788|P2|Overall Study|Physician Decision|2
2856010|NCT02285998|9813789|P1|Overall Study|Physician Decision|1
2856011|NCT02285998|9813788|P2|Overall Study|Adverse Event|8
2856012|NCT02285998|9813789|P1|Overall Study|Adverse Event|9
2856013|NCT02285920|9813817|P4|Overall Study|Death|1
2856014|NCT02285920|9813818|P3|Overall Study|Death|2
2856015|NCT02285920|9813819|P2|Overall Study|Death|0
2856016|NCT02285920|9813820|P1|Overall Study|Death|2
2856017|NCT02285920|9813817|P4|Overall Study|Dialysis discontinuation|0
2856018|NCT02285920|9813818|P3|Overall Study|Dialysis discontinuation|0
2856019|NCT02285920|9813819|P2|Overall Study|Dialysis discontinuation|1
2856020|NCT02285920|9813820|P1|Overall Study|Dialysis discontinuation|0
2856021|NCT02285920|9813817|P4|Overall Study|Transfer to non-participating unit|0
2856022|NCT02285920|9813818|P3|Overall Study|Transfer to non-participating unit|0
2856023|NCT02285920|9813819|P2|Overall Study|Transfer to non-participating unit|1
2856024|NCT02285920|9813820|P1|Overall Study|Transfer to non-participating unit|0
2856025|NCT02285920|9813817|P4|Overall Study|Change to peritoneal dialysis|0
2856026|NCT02285920|9813818|P3|Overall Study|Change to peritoneal dialysis|1
2856027|NCT02285920|9813819|P2|Overall Study|Change to peritoneal dialysis|0
2856028|NCT02285920|9813820|P1|Overall Study|Change to peritoneal dialysis|0
2856029|NCT02285920|9813817|P4|Overall Study|Kidney transplantation|0
2856030|NCT02285920|9813818|P3|Overall Study|Kidney transplantation|2
2856031|NCT02285920|9813819|P2|Overall Study|Kidney transplantation|2
2856032|NCT02285920|9813820|P1|Overall Study|Kidney transplantation|2
2856033|NCT02285855|9813910|P2|Overall Study|Withdrawal by Subject|1
2856034|NCT02285855|9813911|P1|Overall Study|Withdrawal by Subject|2
2856035|NCT02285777|9813919|P2|Overall Study|Lost to Follow-up|2
2856036|NCT02285777|9813920|P1|Overall Study|Lost to Follow-up|4
2856037|NCT02285777|9813919|P2|Overall Study|Withdrawal by Subject|1
2856038|NCT02285777|9813920|P1|Overall Study|Withdrawal by Subject|1
2856039|NCT02285270|9814001|P1|Overall Study|Determined to be ineligible|1
2856040|NCT02285270|9814001|P1|Overall Study|Physician Decision|3
2856041|NCT02285270|9814001|P1|Overall Study|Lost to Follow-up|1
2856042|NCT02285153|9814009|P2|Overall Study|Adverse Event|0
2856043|NCT02285153|9814010|P1|Overall Study|Adverse Event|1
2856044|NCT02285062|9814024|P2|Overall Study|Lost to Follow-up|5
2856045|NCT02285062|9814025|P1|Overall Study|Lost to Follow-up|8
2856046|NCT02285062|9814024|P2|Overall Study|Death|62
2856047|NCT02285062|9814025|P1|Overall Study|Death|58
2856048|NCT02285062|9814024|P2|Overall Study|Withdrawal by Subject|17
2856049|NCT02285062|9814025|P1|Overall Study|Withdrawal by Subject|12
2856050|NCT02285010|9814073|P2|Overall Study|Not spinal anesthesia|1
2856051|NCT02285010|9814074|P1|Overall Study|Not spinal anesthesia|3
2856052|NCT02285010|9814073|P2|Overall Study|not abdominal hysterectomy|0
2856053|NCT02285010|9814074|P1|Overall Study|not abdominal hysterectomy|2
2856054|NCT02284906|9814091|P3|Overall Study|Reason not Specified|0
2856055|NCT02284906|9814092|P2|Overall Study|Reason not Specified|1
2856056|NCT02284906|9814093|P1|Overall Study|Reason not Specified|1
2856057|NCT02284906|9814091|P3|Overall Study|Study Termination|14
2856058|NCT02284906|9814092|P2|Overall Study|Study Termination|11
2856059|NCT02284906|9814093|P1|Overall Study|Study Termination|0
2856060|NCT02284906|9814091|P3|Overall Study|Voluntary Withdrawal|5
2856061|NCT02284906|9814092|P2|Overall Study|Voluntary Withdrawal|4
2856062|NCT02284906|9814093|P1|Overall Study|Voluntary Withdrawal|2
2856063|NCT02284906|9814091|P3|Overall Study|Major Protocol Deviation|0
2856064|NCT02284906|9814092|P2|Overall Study|Major Protocol Deviation|1
2856065|NCT02284906|9814093|P1|Overall Study|Major Protocol Deviation|0
2856066|NCT02284906|9814091|P3|Overall Study|Pretreatment Event/Adverse Event|0
2856067|NCT02284906|9814092|P2|Overall Study|Pretreatment Event/Adverse Event|1
2856068|NCT02284906|9814093|P1|Overall Study|Pretreatment Event/Adverse Event|0
2856069|NCT02284893|9814106|P2|52 Week (Long Term)|Non-Compliance|3
2856070|NCT02284893|9814107|P1|52 Week (Long Term)|Non-Compliance|2
2856071|NCT02284893|9814106|P2|52 Week (Long Term)|Lost to Follow-up|2
2856072|NCT02284893|9814107|P1|52 Week (Long Term)|Lost to Follow-up|2
2856073|NCT02284893|9814106|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
2856074|NCT02284893|9814107|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
2856075|NCT02284893|9814106|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
2856076|NCT02284893|9814107|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
2856077|NCT02284893|9814106|P2|52 Week (Long Term)|Adverse Event|1
2856078|NCT02284893|9814107|P1|52 Week (Long Term)|Adverse Event|3
2856079|NCT02284893|9814106|P2|26 Week (Short Term)|Other|1
2856080|NCT02284893|9814107|P1|26 Week (Short Term)|Other|1
2856081|NCT02284893|9814106|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
2856082|NCT02284893|9814107|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
2856083|NCT02284893|9814106|P2|26 Week (Short Term)|Lost to Follow-up|1
2856084|NCT02284893|9814107|P1|26 Week (Short Term)|Lost to Follow-up|3
2856085|NCT02284893|9814106|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
2856086|NCT02284893|9814107|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
2856087|NCT02284893|9814106|P2|26 Week (Short Term)|Discontinuation by the subject|2
2856088|NCT02284893|9814107|P1|26 Week (Short Term)|Discontinuation by the subject|2
2856089|NCT02284893|9814106|P2|26 Week (Short Term)|Adverse Event|9
2856090|NCT02284893|9814107|P1|26 Week (Short Term)|Adverse Event|1
2856091|NCT02284568|9814184|P3|Overall Study|Withdrew before taking study drug|0
2856092|NCT02284568|9814185|P2|Overall Study|Withdrew before taking study drug|1
2856093|NCT02284568|9814186|P1|Overall Study|Withdrew before taking study drug|0
2856094|NCT02284568|9814184|P3|Overall Study|Other|0
2856095|NCT02284568|9814185|P2|Overall Study|Other|2
2856096|NCT02284568|9814186|P1|Overall Study|Other|1
2856097|NCT02284568|9814184|P3|Overall Study|Lack of Efficacy|0
2856098|NCT02284568|9814185|P2|Overall Study|Lack of Efficacy|7
2856099|NCT02284568|9814186|P1|Overall Study|Lack of Efficacy|4
2856100|NCT02284568|9814184|P3|Overall Study|Lost to Follow-up|0
2856101|NCT02284568|9814185|P2|Overall Study|Lost to Follow-up|3
2856102|NCT02284568|9814186|P1|Overall Study|Lost to Follow-up|0
2856103|NCT02284568|9814184|P3|Overall Study|Sponsor requested patient stop treatment|90
2856104|NCT02284568|9814185|P2|Overall Study|Sponsor requested patient stop treatment|0
2856105|NCT02284568|9814186|P1|Overall Study|Sponsor requested patient stop treatment|0
2856106|NCT02284568|9814184|P3|Overall Study|Protocol Violation|0
2856107|NCT02284568|9814185|P2|Overall Study|Protocol Violation|1
2856108|NCT02284568|9814186|P1|Overall Study|Protocol Violation|0
2856109|NCT02284568|9814184|P3|Overall Study|Noncompliance|0
2856110|NCT02284568|9814185|P2|Overall Study|Noncompliance|0
2856111|NCT02284568|9814186|P1|Overall Study|Noncompliance|1
2856112|NCT02284568|9814184|P3|Overall Study|Noncompliance with study drug admin|0
2856113|NCT02284568|9814185|P2|Overall Study|Noncompliance with study drug admin|2
2856114|NCT02284568|9814186|P1|Overall Study|Noncompliance with study drug admin|1
2856115|NCT02284568|9814184|P3|Overall Study|Withdrawal by Subject|1
2856116|NCT02284568|9814185|P2|Overall Study|Withdrawal by Subject|21
2856117|NCT02284568|9814186|P1|Overall Study|Withdrawal by Subject|22
2856118|NCT02284568|9814184|P3|Overall Study|Adverse Event|4
2856119|NCT02284568|9814185|P2|Overall Study|Adverse Event|9
2856120|NCT02284568|9814186|P1|Overall Study|Adverse Event|2
2856121|NCT02284373|9814280|P3|Overall Study|Lost to Follow-up|0
2856122|NCT02284373|9814281|P2|Overall Study|Lost to Follow-up|1
2856123|NCT02284373|9814282|P1|Overall Study|Lost to Follow-up|0
2856124|NCT02284373|9814280|P3|Overall Study|Other|0
2856125|NCT02284373|9814281|P2|Overall Study|Other|1
2856126|NCT02284373|9814282|P1|Overall Study|Other|0
2856127|NCT02284373|9814280|P3|Overall Study|Withdrawal by Subject|0
2856128|NCT02284373|9814281|P2|Overall Study|Withdrawal by Subject|1
2856129|NCT02284373|9814282|P1|Overall Study|Withdrawal by Subject|0
2856130|NCT02284347|9814290|P1|Overall Study|Withdrawn prior to treatment|1
2856131|NCT02284347|9814290|P1|Overall Study|Lost to Follow-up|2
2856132|NCT02284243|9814298|P2|Overall Study|Adverse Event|0
2856133|NCT02284243|9814299|P1|Overall Study|Adverse Event|1
2856134|NCT02284243|9814298|P2|Overall Study|Lack of Efficacy|3
2856135|NCT02284243|9814299|P1|Overall Study|Lack of Efficacy|3
2856136|NCT02284178|9814319|P2|Overall Study|Met exclusion criteria|54
2856137|NCT02284178|9814320|P1|Overall Study|Met exclusion criteria|49
2856138|NCT02284009|9814363|P2|Overall Study|Withdrawal by Subject|5
2856139|NCT02284009|9814364|P1|Overall Study|Withdrawal by Subject|2
2856140|NCT02284009|9814363|P2|Overall Study|Physician Decision|2
2856141|NCT02284009|9814364|P1|Overall Study|Physician Decision|0
2856142|NCT02284009|9814363|P2|Overall Study|Lost to Follow-up|3
2856143|NCT02284009|9814364|P1|Overall Study|Lost to Follow-up|1
2856144|NCT02284009|9814363|P2|Overall Study|Adverse Event|0
2856145|NCT02284009|9814364|P1|Overall Study|Adverse Event|3
2856146|NCT02283788|9814463|P4|Overall Study|Withdrawal by Subject|1
2856147|NCT02283788|9814464|P3|Overall Study|Withdrawal by Subject|0
2856148|NCT02283788|9814465|P2|Overall Study|Withdrawal by Subject|1
2856149|NCT02283788|9814466|P1|Overall Study|Withdrawal by Subject|0
2856150|NCT02283788|9814463|P4|Overall Study|Adverse Event|1
2856151|NCT02283788|9814464|P3|Overall Study|Adverse Event|5
2856152|NCT02283788|9814465|P2|Overall Study|Adverse Event|3
2856153|NCT02283788|9814466|P1|Overall Study|Adverse Event|1
2856154|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Physician Decision|2
2856155|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Physician Decision|1
2856156|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
2856157|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
2856158|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
2856159|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
2856160|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
2856161|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
2856162|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
2856163|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
2856164|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2856165|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2856166|NCT02283762|9814478|P2|Long-term Extension Phase (LTE)|Adverse Event|6
2856167|NCT02283762|9814479|P1|Long-term Extension Phase (LTE)|Adverse Event|2
2856168|NCT02283762|9814478|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
2856169|NCT02283762|9814479|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
2856170|NCT02283762|9814478|P2|Main Treatment Phase (MT)|Pregnancy|1
2856171|NCT02283762|9814479|P1|Main Treatment Phase (MT)|Pregnancy|0
2856172|NCT02283762|9814478|P2|Main Treatment Phase (MT)|Physician Decision|1
2856173|NCT02283762|9814479|P1|Main Treatment Phase (MT)|Physician Decision|1
2856174|NCT02283762|9814478|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
2856175|NCT02283762|9814479|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
2856176|NCT02283762|9814478|P2|Main Treatment Phase (MT)|Adverse Event|9
2856177|NCT02283762|9814479|P1|Main Treatment Phase (MT)|Adverse Event|9
2856178|NCT02283658|9814503|P1|Overall Study|Withdrawal by Subject|1
2856179|NCT02283411|9814525|P1|Overall Study|Screen Failed|28
2856180|NCT02283411|9814525|P1|Overall Study|Withdrawal by Subject|3
2856181|NCT02283268|9814533|P1|Overall Study|Withdrawal by Subject|1
2856182|NCT02282982|9814594|P1|Overall Study|Other, not specified|18
2856183|NCT02282982|9814594|P1|Overall Study|Palivizumab is ended|11
2856184|NCT02282982|9814594|P1|Overall Study|Lack of product|156
2856185|NCT02282982|9814594|P1|Overall Study|Death|4
2856186|NCT02282982|9814594|P1|Overall Study|Withdrew consent|2
2856187|NCT02282982|9814594|P1|Overall Study|Lost to Follow-up|15
2856188|NCT02282813|9814622|P3|Overall Study|Administrative reasons|0
2856189|NCT02282813|9814623|P2|Overall Study|Administrative reasons|1
2856190|NCT02282813|9814624|P1|Overall Study|Administrative reasons|0
2856191|NCT02282813|9814622|P3|Overall Study|Lack of Efficacy|0
2856192|NCT02282813|9814623|P2|Overall Study|Lack of Efficacy|0
2856193|NCT02282813|9814624|P1|Overall Study|Lack of Efficacy|1
2856194|NCT02282813|9814622|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
2856195|NCT02282813|9814623|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
2856196|NCT02282813|9814624|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
2856197|NCT02282813|9814622|P3|Overall Study|Lost to Follow-up|1
2856198|NCT02282813|9814623|P2|Overall Study|Lost to Follow-up|0
2856199|NCT02282813|9814624|P1|Overall Study|Lost to Follow-up|2
2856200|NCT02282813|9814622|P3|Overall Study|Physician Decision|1
2856201|NCT02282813|9814623|P2|Overall Study|Physician Decision|3
2856202|NCT02282813|9814624|P1|Overall Study|Physician Decision|0
2856203|NCT02282813|9814622|P3|Overall Study|Subject non-compliance|0
2856204|NCT02282813|9814623|P2|Overall Study|Subject non-compliance|4
2856205|NCT02282813|9814624|P1|Overall Study|Subject non-compliance|1
2856206|NCT02282813|9814622|P3|Overall Study|Adverse Event|1
2856207|NCT02282813|9814623|P2|Overall Study|Adverse Event|10
2856208|NCT02282813|9814624|P1|Overall Study|Adverse Event|3
2856209|NCT02282813|9814622|P3|Overall Study|Withdrawal by Subject|0
2856210|NCT02282813|9814623|P2|Overall Study|Withdrawal by Subject|5
2856211|NCT02282813|9814624|P1|Overall Study|Withdrawal by Subject|4
2856212|NCT02282631|9814670|P2|Overall Study|Lost to Follow-up|0
2856213|NCT02282631|9814671|P1|Overall Study|Lost to Follow-up|2
2856214|NCT02282605|9814712|P3|Overall Study|negative SA result on Day -1|0
2856215|NCT02282605|9814713|P2|Overall Study|negative SA result on Day -1|0
2856216|NCT02282605|9814714|P1|Overall Study|negative SA result on Day -1|3
2856217|NCT02282527|9814736|P2|Overall Study|Lack of home health aid|0
2856218|NCT02282527|9814737|P1|Overall Study|Lack of home health aid|1
2856219|NCT02282527|9814736|P2|Overall Study|Lost to Follow-up|1
2856220|NCT02282527|9814737|P1|Overall Study|Lost to Follow-up|0
2856221|NCT02282293|9814749|P2|Overall Study|Moved out of study area|1
2856222|NCT02282293|9814750|P1|Overall Study|Moved out of study area|0
2856223|NCT02282293|9814749|P2|Overall Study|Unable to comply with study procedures|0
2856224|NCT02282293|9814750|P1|Overall Study|Unable to comply with study procedures|1
2856225|NCT02282293|9814749|P2|Overall Study|Lost to Follow-up|2
2856226|NCT02282293|9814750|P1|Overall Study|Lost to Follow-up|2
2856227|NCT02282020|9814787|P2|Overall Study|Withdrew Consent Prior to Dosing|12
2856228|NCT02282020|9814788|P1|Overall Study|Withdrew Consent Prior to Dosing|0
2856229|NCT02282020|9814787|P2|Overall Study|Developed Discontinuation Criteria|3
2856230|NCT02282020|9814788|P1|Overall Study|Developed Discontinuation Criteria|1
2856231|NCT02282020|9814787|P2|Overall Study|Severe Non-compliance to Protocol|0
2856232|NCT02282020|9814788|P1|Overall Study|Severe Non-compliance to Protocol|1
2856233|NCT02282020|9814787|P2|Overall Study|Miscellaneous|17
2856234|NCT02282020|9814788|P1|Overall Study|Miscellaneous|4
2856235|NCT02282020|9814787|P2|Overall Study|Withdrawal by Subject|10
2856236|NCT02282020|9814788|P1|Overall Study|Withdrawal by Subject|5
2856237|NCT02282020|9814787|P2|Overall Study|Adverse Event|15
2856238|NCT02282020|9814788|P1|Overall Study|Adverse Event|13
2856239|NCT02282020|9814787|P2|Overall Study|Objective Disease Progression|30
2856240|NCT02282020|9814788|P1|Overall Study|Objective Disease Progression|111
2856241|NCT02281773|9814847|P5|Overall Study|Other Reason|1
2856242|NCT02281773|9814848|P4|Overall Study|Other Reason|3
2856243|NCT02281773|9814849|P3|Overall Study|Other Reason|2
2856244|NCT02281773|9814850|P2|Overall Study|Other Reason|4
2856245|NCT02281773|9814851|P1|Overall Study|Other Reason|0
2856246|NCT02281773|9814847|P5|Overall Study|Withdrawal by Subject|8
2856247|NCT02281773|9814848|P4|Overall Study|Withdrawal by Subject|6
2856248|NCT02281773|9814849|P3|Overall Study|Withdrawal by Subject|6
2856249|NCT02281773|9814850|P2|Overall Study|Withdrawal by Subject|8
2856250|NCT02281773|9814851|P1|Overall Study|Withdrawal by Subject|2
2856251|NCT02281773|9814847|P5|Overall Study|Lost to Follow-up|10
2856252|NCT02281773|9814848|P4|Overall Study|Lost to Follow-up|2
2856253|NCT02281773|9814849|P3|Overall Study|Lost to Follow-up|6
2856254|NCT02281773|9814850|P2|Overall Study|Lost to Follow-up|2
2856255|NCT02281773|9814851|P1|Overall Study|Lost to Follow-up|2
2856256|NCT02281773|9814847|P5|Overall Study|Protocol Violation|2
2856257|NCT02281773|9814848|P4|Overall Study|Protocol Violation|2
2856258|NCT02281773|9814849|P3|Overall Study|Protocol Violation|0
2856259|NCT02281773|9814850|P2|Overall Study|Protocol Violation|0
2856260|NCT02281773|9814851|P1|Overall Study|Protocol Violation|1
2856261|NCT02281773|9814847|P5|Overall Study|Adverse Event|9
2856262|NCT02281773|9814848|P4|Overall Study|Adverse Event|8
2856263|NCT02281773|9814849|P3|Overall Study|Adverse Event|4
2856264|NCT02281773|9814850|P2|Overall Study|Adverse Event|1
2856265|NCT02281773|9814851|P1|Overall Study|Adverse Event|6
2856266|NCT02281552|9814939|P2|Overall Study|Adverse Event|9
2856267|NCT02281552|9814940|P1|Overall Study|Adverse Event|3
2856268|NCT02281552|9814939|P2|Overall Study|Insufficient clinical response|1
2856269|NCT02281552|9814940|P1|Overall Study|Insufficient clinical response|0
2856270|NCT02281552|9814939|P2|Overall Study|Medication error|0
2856271|NCT02281552|9814940|P1|Overall Study|Medication error|1
2856272|NCT02281357|9815033|P2|Overall Study|Withdrawal by Subject|3
2856273|NCT02281357|9815034|P1|Overall Study|Withdrawal by Subject|4
2856274|NCT02281357|9815033|P2|Overall Study|Lost to Follow-up|0
2856275|NCT02281357|9815034|P1|Overall Study|Lost to Follow-up|1
2856276|NCT02281357|9815033|P2|Overall Study|Adverse Event|1
2856277|NCT02281357|9815034|P1|Overall Study|Adverse Event|2
2856278|NCT02281318|9815048|P2|Overall Study|Withdrawal by Subject|2
2856279|NCT02281318|9815049|P1|Overall Study|Withdrawal by Subject|6
2856280|NCT02281318|9815048|P2|Overall Study|Physician Decision|0
2856281|NCT02281318|9815049|P1|Overall Study|Physician Decision|2
2856282|NCT02281318|9815048|P2|Overall Study|Lost to Follow-up|1
2856283|NCT02281318|9815049|P1|Overall Study|Lost to Follow-up|2
2856284|NCT02281318|9815048|P2|Overall Study|Lack of Efficacy|0
2856285|NCT02281318|9815049|P1|Overall Study|Lack of Efficacy|2
2856286|NCT02281318|9815048|P2|Overall Study|Adverse Event|2
2856287|NCT02281318|9815049|P1|Overall Study|Adverse Event|2
2856288|NCT02280863|9815095|P2|Integrated Platform|Met stopping criteria|1
2856289|NCT02280863|9815096|P1|Integrated Platform|Met stopping criteria|0
2856290|NCT02280499|9815180|P1|Overall Study|Adverse Event|5
2856291|NCT02280499|9815180|P1|Overall Study|Lost to Follow-up|42
2856292|NCT02280499|9815180|P1|Overall Study|Death|14
2856293|NCT02280473|9815188|P2|Overall Study|Lost to Follow-up|1
2856294|NCT02280473|9815189|P1|Overall Study|Lost to Follow-up|0
2856295|NCT02280473|9815188|P2|Overall Study|Lack of Efficacy|1
2856296|NCT02280473|9815189|P1|Overall Study|Lack of Efficacy|0
2856297|NCT02280473|9815188|P2|Overall Study|Adverse Event|1
2856298|NCT02280473|9815189|P1|Overall Study|Adverse Event|1
2856299|NCT02280421|9815205|P2|Washout (2 Weeks)|Withdrawal by Subject|0
2856300|NCT02280421|9815206|P1|Washout (2 Weeks)|Withdrawal by Subject|1
2856301|NCT02280421|9815205|P2|Washout (2 Weeks)|Adverse Event|1
2856302|NCT02280421|9815206|P1|Washout (2 Weeks)|Adverse Event|0
2856303|NCT02280408|9815272|P4|Overall Study|Lost to Follow-up|0
2856304|NCT02280408|9815273|P3|Overall Study|Lost to Follow-up|0
2856305|NCT02280408|9815274|P2|Overall Study|Lost to Follow-up|2
2856306|NCT02280408|9815275|P1|Overall Study|Lost to Follow-up|0
2856307|NCT02280304|9815347|P2|Overall Study|Lost to Follow-up|8
2856308|NCT02280304|9815348|P1|Overall Study|Lost to Follow-up|7
2856309|NCT02280291|9815369|P4|Overall Study|Other|0
2856310|NCT02280291|9815370|P3|Overall Study|Other|0
2856311|NCT02280291|9815371|P2|Overall Study|Other|1
2856312|NCT02280291|9815372|P1|Overall Study|Other|1
2856313|NCT02280291|9815369|P4|Overall Study|Protocol Violation|0
2856314|NCT02280291|9815370|P3|Overall Study|Protocol Violation|0
2856315|NCT02280291|9815371|P2|Overall Study|Protocol Violation|0
2856316|NCT02280291|9815372|P1|Overall Study|Protocol Violation|1
2856317|NCT02280291|9815369|P4|Overall Study|Lost to Follow-up|8
2856318|NCT02280291|9815370|P3|Overall Study|Lost to Follow-up|3
2856319|NCT02280291|9815371|P2|Overall Study|Lost to Follow-up|1
2856320|NCT02280291|9815372|P1|Overall Study|Lost to Follow-up|2
2856321|NCT02280187|9815406|P1|Overall Study|Lost to Follow-up|218
2856322|NCT02280096|9815434|P2|Overall Study|Lack of attachment|1
2856323|NCT02280096|9815435|P1|Overall Study|Lack of attachment|0
2856324|NCT02280096|9815434|P2|Overall Study|Functional neurological disorder|0
2856325|NCT02280096|9815435|P1|Overall Study|Functional neurological disorder|1
2856326|NCT02280096|9815434|P2|Overall Study|Pregnancy|0
2856327|NCT02280096|9815435|P1|Overall Study|Pregnancy|1
2856328|NCT02280044|9815465|P2|Overall Study|Planned alternate|2
2856329|NCT02280044|9815466|P1|Overall Study|Planned alternate|0
2856330|NCT02279862|9815476|P2|Overall Study|Withdrawal by Subject|0
2856331|NCT02279862|9815477|P1|Overall Study|Withdrawal by Subject|1
2856332|NCT02279862|9815476|P2|Overall Study|Other|2
2856333|NCT02279862|9815477|P1|Overall Study|Other|1
2856334|NCT02279862|9815476|P2|Overall Study|Study closed by sponsor|13
2856335|NCT02279862|9815477|P1|Overall Study|Study closed by sponsor|16
2856336|NCT02279862|9815476|P2|Overall Study|Disease progression|2
2856337|NCT02279862|9815477|P1|Overall Study|Disease progression|5
2856338|NCT02279862|9815476|P2|Overall Study|Administrative reason by sponsor|1
2856339|NCT02279862|9815477|P1|Overall Study|Administrative reason by sponsor|0
2856340|NCT02279862|9815476|P2|Overall Study|No longer meets criteria|1
2856341|NCT02279862|9815477|P1|Overall Study|No longer meets criteria|0
2856342|NCT02279862|9815476|P2|Overall Study|Study drug toxicity|6
2856343|NCT02279862|9815477|P1|Overall Study|Study drug toxicity|3
2856344|NCT02279732|9815495|P2|Overall Study|Other|3
2856345|NCT02279732|9815496|P1|Overall Study|Other|3
2856346|NCT02279732|9815495|P2|Overall Study|Other|67
2856347|NCT02279732|9815496|P1|Overall Study|Other|53
2856348|NCT02279732|9815495|P2|Overall Study|Subject Requested to Discontinue|1
2856349|NCT02279732|9815496|P1|Overall Study|Subject Requested to Discontinue|0
2856350|NCT02279732|9815495|P2|Overall Study|Maximum Clinical Benefit|0
2856351|NCT02279732|9815496|P1|Overall Study|Maximum Clinical Benefit|1
2856352|NCT02279732|9815495|P2|Overall Study|Lost to Follow-up|1
2856353|NCT02279732|9815496|P1|Overall Study|Lost to Follow-up|0
2856354|NCT02279732|9815495|P2|Overall Study|Study Drug Toxicity|0
2856355|NCT02279732|9815496|P1|Overall Study|Study Drug Toxicity|2
2856356|NCT02279732|9815495|P2|Overall Study|Administrative Reason By Sponsor|2
2856357|NCT02279732|9815496|P1|Overall Study|Administrative Reason By Sponsor|0
2856358|NCT02279732|9815495|P2|Overall Study|Adverse Event|2
2856359|NCT02279732|9815496|P1|Overall Study|Adverse Event|1
2856360|NCT02279732|9815495|P2|Overall Study|Withdrawal by Subject|7
2856361|NCT02279732|9815496|P1|Overall Study|Withdrawal by Subject|2
2856362|NCT02279732|9815495|P2|Overall Study|Disease Progression|3
2856363|NCT02279732|9815496|P1|Overall Study|Disease Progression|13
2856364|NCT02279732|9815495|P2|Overall Study|Death|20
2856365|NCT02279732|9815496|P1|Overall Study|Death|23
2856366|NCT02279498|9815588|P2|Overall Study|Undefined|1
2856367|NCT02279498|9815589|P1|Overall Study|Undefined|2
2856368|NCT02279498|9815588|P2|Overall Study|Withdrawal by Subject|2
2856369|NCT02279498|9815589|P1|Overall Study|Withdrawal by Subject|9
2856370|NCT02279498|9815588|P2|Overall Study|Lost to Follow-up|1
2856371|NCT02279498|9815589|P1|Overall Study|Lost to Follow-up|0
2856372|NCT02279498|9815588|P2|Overall Study|Lack of Efficacy|0
2856373|NCT02279498|9815589|P1|Overall Study|Lack of Efficacy|4
2856374|NCT02279498|9815588|P2|Overall Study|Adverse Event|0
2856375|NCT02279498|9815589|P1|Overall Study|Adverse Event|3
2856376|NCT02279420|9815598|P1|Overall Study|Lost to Follow-up|23
2856377|NCT02279407|9815606|P4|Overall Study|Adverse Event|0
2856378|NCT02279407|9815607|P3|Overall Study|Adverse Event|2
2856379|NCT02279407|9815608|P2|Overall Study|Adverse Event|1
2856380|NCT02279407|9815609|P1|Overall Study|Adverse Event|1
2856381|NCT02279407|9815606|P4|Overall Study|Withdrawal by Subject|1
2856382|NCT02279407|9815607|P3|Overall Study|Withdrawal by Subject|1
2856383|NCT02279407|9815608|P2|Overall Study|Withdrawal by Subject|0
2856384|NCT02279407|9815609|P1|Overall Study|Withdrawal by Subject|1
2856385|NCT02279407|9815606|P4|Overall Study|Couldn't swallow IP; noncompliance|0
2856386|NCT02279407|9815607|P3|Overall Study|Couldn't swallow IP; noncompliance|2
2856387|NCT02279407|9815608|P2|Overall Study|Couldn't swallow IP; noncompliance|0
2856388|NCT02279407|9815609|P1|Overall Study|Couldn't swallow IP; noncompliance|0
2856389|NCT02279173|9815620|P1|Overall Study|Enrolled But Did Not Receive Treatment|1
2856390|NCT02279173|9815620|P1|Overall Study|Lost to Follow-up|3
2856391|NCT02279173|9815620|P1|Overall Study|Decision by Sponsor|4
2856392|NCT02279173|9815620|P1|Overall Study|Withdrawal by Subject|17
2856393|NCT02279173|9815620|P1|Overall Study|Protocol-specified Criteria|64
2856394|NCT02279173|9815620|P1|Overall Study|Ongoing|78
2856395|NCT02279043|9815669|P3|Overall Study|Lost to Follow-up|0
2856396|NCT02279043|9815670|P2|Overall Study|Lost to Follow-up|88
2856397|NCT02279043|9815671|P1|Overall Study|Lost to Follow-up|46
2856398|NCT02279043|9815669|P3|Overall Study|Post-rand. exclusion - not eligible|0
2856399|NCT02279043|9815670|P2|Overall Study|Post-rand. exclusion - not eligible|1
2856400|NCT02279043|9815671|P1|Overall Study|Post-rand. exclusion - not eligible|1
2856401|NCT02278952|9815701|P1|Overall Study|Insufficient Sample|6
2856402|NCT02278939|9815713|P2|Overall Study|family emergency unable to commit|0
2856403|NCT02278939|9815714|P1|Overall Study|family emergency unable to commit|2
2856404|NCT02278939|9815713|P2|Overall Study|death in family|0
2856405|NCT02278939|9815714|P1|Overall Study|death in family|1
2856406|NCT02278939|9815713|P2|Overall Study|Lost to Follow-up|1
2856407|NCT02278939|9815714|P1|Overall Study|Lost to Follow-up|1
2856408|NCT02278939|9815713|P2|Overall Study|lack of time|0
2856409|NCT02278939|9815714|P1|Overall Study|lack of time|1
2856410|NCT02278614|9815742|P2|Overall Study|left eye was not eligible|0
2856411|NCT02278614|9815743|P1|Overall Study|left eye was not eligible|1
2856412|NCT02278614|9815742|P2|Overall Study|Adverse Event|0
2856413|NCT02278614|9815743|P1|Overall Study|Adverse Event|1
2856414|NCT02278614|9815742|P2|Overall Study|Withdrawal by Subject|5
2856415|NCT02278614|9815743|P1|Overall Study|Withdrawal by Subject|3
2856416|NCT02278471|9815777|P2|Overall Study|Withdrawal by Subject|3
2856417|NCT02278471|9815778|P1|Overall Study|Withdrawal by Subject|0
2856418|NCT02278471|9815777|P2|Overall Study|Death|2
2856419|NCT02278471|9815778|P1|Overall Study|Death|2
2856420|NCT02278471|9815777|P2|Overall Study|Lost to Follow-up|15
2856421|NCT02278471|9815778|P1|Overall Study|Lost to Follow-up|6
2856422|NCT02278328|9815794|P3|Neuropsych Screening|incomplete consent|2
2856423|NCT02278328|9815795|P2|Neuropsych Screening|incomplete consent|0
2856424|NCT02278328|9815796|P1|Neuropsych Screening|incomplete consent|0
2856425|NCT02278328|9815794|P3|Neuropsych Screening|Withdrawal by Subject|0
2856426|NCT02278328|9815795|P2|Neuropsych Screening|Withdrawal by Subject|1
2856427|NCT02278328|9815796|P1|Neuropsych Screening|Withdrawal by Subject|0
2856428|NCT02278328|9815794|P3|Neuropsych Screening|found ineligible on neuropsych|0
2856429|NCT02278328|9815795|P2|Neuropsych Screening|found ineligible on neuropsych|0
2856430|NCT02278328|9815796|P1|Neuropsych Screening|found ineligible on neuropsych|1
2856431|NCT02278263|9815809|P3|Overall Study|Protocol Violation|9
2856432|NCT02278263|9815810|P2|Overall Study|Protocol Violation|0
2856433|NCT02278263|9815811|P1|Overall Study|Protocol Violation|7
2856434|NCT02278120|9815856|P2|Overall Study|Protocol Violation|2
2856435|NCT02278120|9815857|P1|Overall Study|Protocol Violation|0
2856436|NCT02278120|9815856|P2|Overall Study|Lost to Follow-up|0
2856437|NCT02278120|9815857|P1|Overall Study|Lost to Follow-up|2
2856438|NCT02278120|9815856|P2|Overall Study|Death|3
2856439|NCT02278120|9815857|P1|Overall Study|Death|3
2856440|NCT02278120|9815856|P2|Overall Study|Physician Decision|19
2856441|NCT02278120|9815857|P1|Overall Study|Physician Decision|8
2856442|NCT02278120|9815856|P2|Overall Study|Adverse Event|10
2856443|NCT02278120|9815857|P1|Overall Study|Adverse Event|12
2856444|NCT02278120|9815856|P2|Overall Study|Patient/guardian decision|8
2856445|NCT02278120|9815857|P1|Overall Study|Patient/guardian decision|14
2856446|NCT02278120|9815856|P2|Overall Study|Progressive disease|174
2856447|NCT02278120|9815857|P1|Overall Study|Progressive disease|122
2856448|NCT02278003|9815873|P2|Overall Study|Recognition task improperly completed|0
2856449|NCT02278003|9815874|P1|Overall Study|Recognition task improperly completed|7
2856450|NCT02278003|9815873|P2|Overall Study|Not Treated|0
2856451|NCT02278003|9815874|P1|Overall Study|Not Treated|1
2856452|NCT02278003|9815873|P2|Overall Study|Withdrawal by Subject|0
2856453|NCT02278003|9815874|P1|Overall Study|Withdrawal by Subject|11
2856454|NCT02277990|9815884|P2|Overall Study|Had other reason|32
2856455|NCT02277990|9815885|P1|Overall Study|Had other reason|26
2856456|NCT02277990|9815884|P2|Overall Study|Lost to Follow-up|69
2856457|NCT02277990|9815885|P1|Overall Study|Lost to Follow-up|66
2856458|NCT02277990|9815884|P2|Overall Study|Physician Decision|34
2856459|NCT02277990|9815885|P1|Overall Study|Physician Decision|40
2856460|NCT02277990|9815884|P2|Overall Study|Withdrawal by Subject|53
2856461|NCT02277990|9815885|P1|Overall Study|Withdrawal by Subject|64
2856462|NCT02277990|9815884|P2|Overall Study|Death|188
2856463|NCT02277990|9815885|P1|Overall Study|Death|170
2856464|NCT02277769|9815913|P3|Overall Study|Other than specified above|5
2856465|NCT02277769|9815914|P2|Overall Study|Other than specified above|8
2856466|NCT02277769|9815915|P1|Overall Study|Other than specified above|12
2856467|NCT02277769|9815913|P3|Overall Study|Adverse Event|4
2856468|NCT02277769|9815914|P2|Overall Study|Adverse Event|2
2856469|NCT02277769|9815915|P1|Overall Study|Adverse Event|14
2856470|NCT02277769|9815913|P3|Overall Study|Lack of Efficacy|4
2856471|NCT02277769|9815914|P2|Overall Study|Lack of Efficacy|0
2856472|NCT02277769|9815915|P1|Overall Study|Lack of Efficacy|17
2856473|NCT02277769|9815913|P3|Overall Study|Protocol Violation|5
2856474|NCT02277769|9815914|P2|Overall Study|Protocol Violation|3
2856475|NCT02277769|9815915|P1|Overall Study|Protocol Violation|3
2856476|NCT02277743|9815986|P3|Overall Study|Other than specified above|16
2856477|NCT02277743|9815987|P2|Overall Study|Other than specified above|5
2856478|NCT02277743|9815988|P1|Overall Study|Other than specified above|18
2856479|NCT02277743|9815986|P3|Overall Study|Lack of Efficacy|3
2856480|NCT02277743|9815987|P2|Overall Study|Lack of Efficacy|4
2856481|NCT02277743|9815988|P1|Overall Study|Lack of Efficacy|11
2856482|NCT02277743|9815986|P3|Overall Study|Adverse Event|6
2856483|NCT02277743|9815987|P2|Overall Study|Adverse Event|6
2856484|NCT02277743|9815988|P1|Overall Study|Adverse Event|10
2856485|NCT02277743|9815986|P3|Overall Study|Protocol Violation|1
2856486|NCT02277743|9815987|P2|Overall Study|Protocol Violation|1
2856487|NCT02277743|9815988|P1|Overall Study|Protocol Violation|1
2856488|NCT02277691|9816056|P1|Overall Study|Used Other Antihypertensive Drug|1
2856489|NCT02277691|9816056|P1|Overall Study|Lack of Efficacy|5
2856490|NCT02277691|9816056|P1|Overall Study|Voluntary Withdrawal|7
2856491|NCT02277691|9816056|P1|Overall Study|Pretreatment Event/Adverse Event|33
2856492|NCT02277119|9816130|P3|Overall Study|Protocol Violation|7
2856493|NCT02277119|9816131|P2|Overall Study|Protocol Violation|3
2856494|NCT02277119|9816132|P1|Overall Study|Protocol Violation|2
2856495|NCT02277119|9816130|P3|Overall Study|Lack of Efficacy|1
2856496|NCT02277119|9816131|P2|Overall Study|Lack of Efficacy|1
2856497|NCT02277119|9816132|P1|Overall Study|Lack of Efficacy|1
2856498|NCT02276872|9816170|P3|Overall Study|Adverse Event|0
2856499|NCT02276872|9816171|P2|Overall Study|Adverse Event|0
2856500|NCT02276872|9816172|P1|Overall Study|Adverse Event|1
2856501|NCT02276807|9816248|P2|Overall Study|Lost to Follow-up|10
2856502|NCT02276807|9816249|P1|Overall Study|Lost to Follow-up|10
2856503|NCT02276807|9816248|P2|Overall Study|Withdrawal by Subject|7
2856504|NCT02276807|9816249|P1|Overall Study|Withdrawal by Subject|8
2856505|NCT02276612|9816284|P2|Overall Study|Lost to Follow-up|0
2856506|NCT02276612|9816285|P1|Overall Study|Lost to Follow-up|1
2856507|NCT02276612|9816284|P2|Overall Study|Withdrew Consent|0
2856508|NCT02276612|9816285|P1|Overall Study|Withdrew Consent|1
2856509|NCT02276612|9816284|P2|Overall Study|Pregnancy|0
2856510|NCT02276612|9816285|P1|Overall Study|Pregnancy|1
2856511|NCT02276612|9816284|P2|Overall Study|Death|0
2856512|NCT02276612|9816285|P1|Overall Study|Death|1
2856513|NCT02276560|9816308|P3|Overall Study|Adverse Event|0
2856514|NCT02276560|9816309|P2|Overall Study|Adverse Event|0
2856515|NCT02276560|9816310|P1|Overall Study|Adverse Event|1
2856516|NCT02276482|9816320|P2|Overall Study|Reason not specified|1
2856517|NCT02276482|9816321|P1|Overall Study|Reason not specified|0
2856518|NCT02276482|9816320|P2|Overall Study|Gram-negative infection|0
2856519|NCT02276482|9816321|P1|Overall Study|Gram-negative infection|1
2856520|NCT02276482|9816320|P2|Overall Study|Withdrawal by Subject|0
2856521|NCT02276482|9816321|P1|Overall Study|Withdrawal by Subject|1
2856522|NCT02276482|9816320|P2|Overall Study|Adverse Event|0
2856523|NCT02276482|9816321|P1|Overall Study|Adverse Event|1
2856524|NCT02276222|9816456|P2|Overall Study|subject withdrew after randomization|0
2856525|NCT02276222|9816457|P1|Overall Study|subject withdrew after randomization|1
2856526|NCT02276222|9816456|P2|Overall Study|sheduling conflict|0
2856527|NCT02276222|9816457|P1|Overall Study|sheduling conflict|1
2856528|NCT02276222|9816456|P2|Overall Study|Physician Decision|1
2856529|NCT02276222|9816457|P1|Overall Study|Physician Decision|2
2856530|NCT02276222|9816456|P2|Overall Study|Lost to Follow-up|5
2856531|NCT02276222|9816457|P1|Overall Study|Lost to Follow-up|15
2856532|NCT02276222|9816456|P2|Overall Study|sponsor decision|3
2856533|NCT02276222|9816457|P1|Overall Study|sponsor decision|0
2856534|NCT02276222|9816456|P2|Overall Study|non compliance with study medication|2
2856535|NCT02276222|9816457|P1|Overall Study|non compliance with study medication|6
2856536|NCT02276222|9816456|P2|Overall Study|Withdrawal by Subject|33
2856537|NCT02276222|9816457|P1|Overall Study|Withdrawal by Subject|79
2856538|NCT02276222|9816456|P2|Overall Study|Protocol Violation|2
2856539|NCT02276222|9816457|P1|Overall Study|Protocol Violation|3
2856540|NCT02276222|9816456|P2|Overall Study|Lack of Efficacy|3
2856541|NCT02276222|9816457|P1|Overall Study|Lack of Efficacy|13
2856542|NCT02276222|9816456|P2|Overall Study|Death|4
2856543|NCT02276222|9816457|P1|Overall Study|Death|3
2856544|NCT02276222|9816456|P2|Overall Study|Adverse Event|11
2856545|NCT02276222|9816457|P1|Overall Study|Adverse Event|62
2856546|NCT02276053|9816481|P1|Overall Study|Patient needs to increase baseline AED|1
2856547|NCT02276053|9816481|P1|Overall Study|Patient does not meet selection criteria|3
2856548|NCT02276053|9816481|P1|Overall Study|Withdrawal by Subject|1
2856549|NCT02276053|9816481|P1|Overall Study|Lack of Efficacy|2
2856550|NCT02276053|9816481|P1|Overall Study|Adverse Event|5
2856551|NCT02276053|9816481|P1|Overall Study|Death|2
2856552|NCT02276040|9816497|P1|Overall Study|Physician Decision|15
2856553|NCT02275780|9816508|P2|Extension Study: up to 192 Weeks|Ongoing|233
2856554|NCT02275780|9816509|P1|Extension Study: up to 192 Weeks|Ongoing|260
2856555|NCT02275780|9816508|P2|Base Study: 96 Weeks|Randomized not treated|1
2856556|NCT02275780|9816509|P1|Base Study: 96 Weeks|Randomized not treated|2
2856557|NCT02275780|9816508|P2|Base Study: 96 Weeks|Pregnancy|1
2856558|NCT02275780|9816509|P1|Base Study: 96 Weeks|Pregnancy|2
2856559|NCT02275780|9816508|P2|Base Study: 96 Weeks|Physician Decision|4
2856560|NCT02275780|9816509|P1|Base Study: 96 Weeks|Physician Decision|2
2856561|NCT02275780|9816508|P2|Base Study: 96 Weeks|Noncompliance with drug|6
2856562|NCT02275780|9816509|P1|Base Study: 96 Weeks|Noncompliance with drug|9
2856563|NCT02275780|9816508|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
2856564|NCT02275780|9816509|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
2856565|NCT02275780|9816508|P2|Base Study: 96 Weeks|Protocol Violation|6
2856566|NCT02275780|9816509|P1|Base Study: 96 Weeks|Protocol Violation|1
2856567|NCT02275780|9816508|P2|Base Study: 96 Weeks|Lost to Follow-up|24
2856568|NCT02275780|9816509|P1|Base Study: 96 Weeks|Lost to Follow-up|28
2856569|NCT02275780|9816508|P2|Base Study: 96 Weeks|Lack of Efficacy|32
2856570|NCT02275780|9816509|P1|Base Study: 96 Weeks|Lack of Efficacy|21
2856571|NCT02275780|9816508|P2|Base Study: 96 Weeks|Death|1
2856572|NCT02275780|9816509|P1|Base Study: 96 Weeks|Death|3
2856573|NCT02275780|9816508|P2|Base Study: 96 Weeks|Adverse Event|14
2856574|NCT02275780|9816509|P1|Base Study: 96 Weeks|Adverse Event|6
2856575|NCT02275611|9816565|P4|Inpatient Withdrawal|Withdrawal by Subject|0
2856576|NCT02275611|9816566|P3|Inpatient Withdrawal|Withdrawal by Subject|0
2856577|NCT02275611|9816567|P2|Inpatient Withdrawal|Withdrawal by Subject|0
2856578|NCT02275611|9816568|P1|Inpatient Withdrawal|Withdrawal by Subject|1
2856579|NCT02275546|9816580|P2|Treatment Period 2|Protocol Violation|1
2856580|NCT02275546|9816581|P1|Treatment Period 2|Protocol Violation|0
2856581|NCT02275546|9816580|P2|Treatment Period 2|Withdrawal by Subject|1
2856582|NCT02275546|9816581|P1|Treatment Period 2|Withdrawal by Subject|2
2856583|NCT02275481|9816591|P2|Overall Study|Physician Decision|1
2856584|NCT02275481|9816592|P1|Overall Study|Physician Decision|0
2856585|NCT02275481|9816591|P2|Overall Study|all other reasons combined|1
2856586|NCT02275481|9816592|P1|Overall Study|all other reasons combined|2
2856587|NCT02275481|9816591|P2|Overall Study|Withdrawal by Subject|0
2856588|NCT02275481|9816592|P1|Overall Study|Withdrawal by Subject|3
2856589|NCT02275481|9816591|P2|Overall Study|Lost to Follow-up|0
2856590|NCT02275481|9816592|P1|Overall Study|Lost to Follow-up|2
2856591|NCT02275481|9816591|P2|Overall Study|Death|1
2856592|NCT02275481|9816592|P1|Overall Study|Death|2
2856593|NCT02275364|9816598|P2|Period 1|Other reason|0
2856594|NCT02275364|9816599|P1|Period 1|Other reason|1
2856595|NCT02275364|9816598|P2|Period 1|Withdrawal by Subject|0
2856596|NCT02275364|9816599|P1|Period 1|Withdrawal by Subject|1
2856597|NCT02275338|9816628|P1|Overall Study|Does not meet entry criteria|1
2856598|NCT02275338|9816628|P1|Overall Study|Reason not specified|5
2856599|NCT02275338|9816628|P1|Overall Study|Ineligible to start Phase 2|4
2856600|NCT02275338|9816628|P1|Overall Study|Disease progression (death)|1
2856601|NCT02275338|9816628|P1|Overall Study|Withdrawal by Subject|4
2856602|NCT02275338|9816628|P1|Overall Study|Lack of Efficacy|3
2856603|NCT02275338|9816628|P1|Overall Study|Adverse Event|15
2856604|NCT02275117|9816677|P5|Overall Study|Other|2
2856605|NCT02275117|9816678|P4|Overall Study|Other|0
2856606|NCT02275117|9816679|P3|Overall Study|Other|0
2856607|NCT02275117|9816680|P2|Overall Study|Other|0
2856608|NCT02275117|9816681|P1|Overall Study|Other|1
2856609|NCT02275117|9816677|P5|Overall Study|Study Burden|7
2856610|NCT02275117|9816678|P4|Overall Study|Study Burden|5
2856611|NCT02275117|9816679|P3|Overall Study|Study Burden|7
2856612|NCT02275117|9816680|P2|Overall Study|Study Burden|4
2856613|NCT02275117|9816681|P1|Overall Study|Study Burden|5
2856614|NCT02275117|9816677|P5|Overall Study|Worsening of Study Indication|0
2856615|NCT02275117|9816678|P4|Overall Study|Worsening of Study Indication|0
2856616|NCT02275117|9816679|P3|Overall Study|Worsening of Study Indication|2
2856617|NCT02275117|9816680|P2|Overall Study|Worsening of Study Indication|1
2856618|NCT02275117|9816681|P1|Overall Study|Worsening of Study Indication|0
2856619|NCT02275117|9816677|P5|Overall Study|Terminated by Sponsor|4
2856620|NCT02275117|9816678|P4|Overall Study|Terminated by Sponsor|6
2856621|NCT02275117|9816679|P3|Overall Study|Terminated by Sponsor|4
2856622|NCT02275117|9816680|P2|Overall Study|Terminated by Sponsor|4
2856623|NCT02275117|9816681|P1|Overall Study|Terminated by Sponsor|4
2856624|NCT02275117|9816677|P5|Overall Study|Withdrawal by Subject|3
2856625|NCT02275117|9816678|P4|Overall Study|Withdrawal by Subject|3
2856626|NCT02275117|9816679|P3|Overall Study|Withdrawal by Subject|7
2856627|NCT02275117|9816680|P2|Overall Study|Withdrawal by Subject|4
2856628|NCT02275117|9816681|P1|Overall Study|Withdrawal by Subject|6
2856629|NCT02275117|9816677|P5|Overall Study|Protocol Violation|0
2856630|NCT02275117|9816678|P4|Overall Study|Protocol Violation|1
2856631|NCT02275117|9816679|P3|Overall Study|Protocol Violation|1
2856632|NCT02275117|9816680|P2|Overall Study|Protocol Violation|0
2856633|NCT02275117|9816681|P1|Overall Study|Protocol Violation|1
2856634|NCT02275117|9816677|P5|Overall Study|Physician Decision|1
2856635|NCT02275117|9816678|P4|Overall Study|Physician Decision|0
2856636|NCT02275117|9816679|P3|Overall Study|Physician Decision|1
2856637|NCT02275117|9816680|P2|Overall Study|Physician Decision|1
2856638|NCT02275117|9816681|P1|Overall Study|Physician Decision|0
2856639|NCT02275117|9816677|P5|Overall Study|Lost to Follow-up|8
2856640|NCT02275117|9816678|P4|Overall Study|Lost to Follow-up|16
2856641|NCT02275117|9816679|P3|Overall Study|Lost to Follow-up|15
2856642|NCT02275117|9816680|P2|Overall Study|Lost to Follow-up|16
2856643|NCT02275117|9816681|P1|Overall Study|Lost to Follow-up|11
2856644|NCT02275117|9816677|P5|Overall Study|Lack of Efficacy|10
2856645|NCT02275117|9816678|P4|Overall Study|Lack of Efficacy|2
2856646|NCT02275117|9816679|P3|Overall Study|Lack of Efficacy|5
2856647|NCT02275117|9816680|P2|Overall Study|Lack of Efficacy|7
2856648|NCT02275117|9816681|P1|Overall Study|Lack of Efficacy|6
2856649|NCT02275117|9816677|P5|Overall Study|Adverse Event|1
2856650|NCT02275117|9816678|P4|Overall Study|Adverse Event|0
2856651|NCT02275117|9816679|P3|Overall Study|Adverse Event|0
2856652|NCT02275117|9816680|P2|Overall Study|Adverse Event|0
2856653|NCT02275117|9816681|P1|Overall Study|Adverse Event|0
2856654|NCT02275052|9816788|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
2856655|NCT02275052|9816789|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2856656|NCT02275052|9816790|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2856657|NCT02275052|9816791|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2856658|NCT02275052|9816788|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
2856659|NCT02275052|9816789|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2856660|NCT02275052|9816790|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2856661|NCT02275052|9816791|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2856662|NCT02275052|9816788|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
2856663|NCT02275052|9816789|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2856664|NCT02275052|9816790|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2856665|NCT02275052|9816791|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2856666|NCT02275052|9816788|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
2856667|NCT02275052|9816789|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
2856668|NCT02275052|9816790|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2856669|NCT02275052|9816791|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2856670|NCT02275052|9816788|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
2856671|NCT02275052|9816789|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
2856672|NCT02275052|9816790|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
2856673|NCT02275052|9816791|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
2856674|NCT02275052|9816788|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
2856675|NCT02275052|9816789|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
2856676|NCT02275052|9816790|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
2856677|NCT02275052|9816791|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
2856678|NCT02275052|9816788|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2856679|NCT02275052|9816789|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2856680|NCT02275052|9816790|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2856681|NCT02275052|9816791|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
2856682|NCT02275052|9816788|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2856683|NCT02275052|9816789|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2856684|NCT02275052|9816790|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2856685|NCT02275052|9816791|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
2856686|NCT02275052|9816788|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2856687|NCT02275052|9816789|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2856688|NCT02275052|9816790|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
2856689|NCT02275052|9816791|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
2856690|NCT02275052|9816788|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2856691|NCT02275052|9816789|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2856692|NCT02275052|9816790|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
2856693|NCT02275052|9816791|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2856694|NCT02275052|9816788|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2856695|NCT02275052|9816789|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2856696|NCT02275052|9816790|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2856697|NCT02275052|9816791|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2856698|NCT02274948|9816805|P2|Overall Study|Left the area|3
2856699|NCT02274948|9816806|P1|Overall Study|Left the area|4
2856700|NCT02274948|9816805|P2|Overall Study|Stopped on family Practitioner advice|5
2856701|NCT02274948|9816806|P1|Overall Study|Stopped on family Practitioner advice|2
2856702|NCT02274948|9816805|P2|Overall Study|Withdrawal by Subject|58
2856703|NCT02274948|9816806|P1|Overall Study|Withdrawal by Subject|64
2856704|NCT02274948|9816805|P2|Overall Study|Lost to Follow-up|25
2856705|NCT02274948|9816806|P1|Overall Study|Lost to Follow-up|28
2856706|NCT02274857|9816849|P2|Overall Study|Other|0
2856707|NCT02274857|9816850|P1|Overall Study|Other|2
2856708|NCT02274857|9816849|P2|Overall Study|Withdrawal by Subject|2
2856709|NCT02274857|9816850|P1|Overall Study|Withdrawal by Subject|11
2856710|NCT02274857|9816849|P2|Overall Study|Trial screen failure|2
2856711|NCT02274857|9816850|P1|Overall Study|Trial screen failure|0
2856712|NCT02274857|9816849|P2|Overall Study|Physician Decision|0
2856713|NCT02274857|9816850|P1|Overall Study|Physician Decision|2
2856714|NCT02274857|9816849|P2|Overall Study|Lost to Follow-up|0
2856715|NCT02274857|9816850|P1|Overall Study|Lost to Follow-up|3
2856716|NCT02274857|9816849|P2|Overall Study|Death|2
2856717|NCT02274857|9816850|P1|Overall Study|Death|1
2856718|NCT02274857|9816849|P2|Overall Study|Adverse Event|0
2856719|NCT02274857|9816850|P1|Overall Study|Adverse Event|1
2856720|NCT02274792|9816863|P1|Overall Study|Sponsor Decision|2
2856721|NCT02274792|9816863|P1|Overall Study|Protocol Specified Criteria|2
2856722|NCT02274792|9816863|P1|Overall Study|Lost to Follow-up|8
2856723|NCT02274792|9816863|P1|Overall Study|Withdrawal by Subject|13
2856724|NCT02274766|9816873|P2|Overall Study|Adverse Event|1
2856725|NCT02274766|9816874|P1|Overall Study|Adverse Event|0
2856726|NCT02274766|9816873|P2|Overall Study|Subject Unwilling to Proceed|1
2856727|NCT02274766|9816874|P1|Overall Study|Subject Unwilling to Proceed|0
2856728|NCT02274766|9816873|P2|Overall Study|Did Not Receive Study Drug|1
2856729|NCT02274766|9816874|P1|Overall Study|Did Not Receive Study Drug|1
2856730|NCT02274766|9816873|P2|Overall Study|Withdrawal by Subject|6
2856731|NCT02274766|9816874|P1|Overall Study|Withdrawal by Subject|3
2856732|NCT02274558|9816941|P3|Overall Study|Physician Decision|1
2856733|NCT02274558|9816942|P2|Overall Study|Physician Decision|2
2856734|NCT02274558|9816943|P1|Overall Study|Physician Decision|0
2856735|NCT02274558|9816941|P3|Overall Study|Lost to Follow-up|1
2856736|NCT02274558|9816942|P2|Overall Study|Lost to Follow-up|1
2856737|NCT02274558|9816943|P1|Overall Study|Lost to Follow-up|2
2856738|NCT02274558|9816941|P3|Overall Study|Death|1
2856739|NCT02274558|9816942|P2|Overall Study|Death|0
2856740|NCT02274558|9816943|P1|Overall Study|Death|0
2856741|NCT02274558|9816941|P3|Overall Study|Withdrawal by Subject|4
2856742|NCT02274558|9816942|P2|Overall Study|Withdrawal by Subject|5
2856743|NCT02274558|9816943|P1|Overall Study|Withdrawal by Subject|1
2856744|NCT02274558|9816941|P3|Overall Study|Non-compliance|0
2856745|NCT02274558|9816942|P2|Overall Study|Non-compliance|1
2856746|NCT02274558|9816943|P1|Overall Study|Non-compliance|2
2856747|NCT02274558|9816941|P3|Overall Study|Adverse Event|2
2856748|NCT02274558|9816942|P2|Overall Study|Adverse Event|4
2856749|NCT02274558|9816943|P1|Overall Study|Adverse Event|2
2856750|NCT02274493|9816957|P1|Overall Study|Withdrawal by Subject|1
2856751|NCT02274311|9816964|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
2856752|NCT02273973|9816972|P2|Overall Study|Reason not specified|1
2856753|NCT02273973|9816973|P1|Overall Study|Reason not specified|0
2856754|NCT02273973|9816972|P2|Overall Study|Physician Decision|1
2856755|NCT02273973|9816973|P1|Overall Study|Physician Decision|0
2856756|NCT02273973|9816972|P2|Overall Study|Lost to Follow-up|1
2856757|NCT02273973|9816973|P1|Overall Study|Lost to Follow-up|0
2856758|NCT02273973|9816972|P2|Overall Study|Progression of disease|2
2856759|NCT02273973|9816973|P1|Overall Study|Progression of disease|0
2856760|NCT02273973|9816972|P2|Overall Study|Protocol Violation|0
2856761|NCT02273973|9816973|P1|Overall Study|Protocol Violation|1
2856762|NCT02273973|9816972|P2|Overall Study|Non-compliance|0
2856763|NCT02273973|9816973|P1|Overall Study|Non-compliance|1
2856764|NCT02273973|9816972|P2|Overall Study|Death|0
2856765|NCT02273973|9816973|P1|Overall Study|Death|1
2856766|NCT02273973|9816972|P2|Overall Study|Withdrawal by Subject|3
2856767|NCT02273973|9816973|P1|Overall Study|Withdrawal by Subject|2
2856768|NCT02273973|9816972|P2|Overall Study|Adverse Event|0
2856769|NCT02273973|9816973|P1|Overall Study|Adverse Event|4
2856770|NCT02273960|9817017|P4|Long Term Extension|Death|1
2856771|NCT02273960|9817018|P3|Long Term Extension|Death|0
2856772|NCT02273960|9817019|P2|Long Term Extension|Death|0
2856773|NCT02273960|9817020|P1|Long Term Extension|Death|0
2856774|NCT02273960|9817017|P4|Short Term Period|ST complete, not entering LTE|5
2856775|NCT02273960|9817018|P3|Short Term Period|ST complete, not entering LTE|4
2856776|NCT02273960|9817019|P2|Short Term Period|ST complete, not entering LTE|6
2856777|NCT02273960|9817020|P1|Short Term Period|ST complete, not entering LTE|4
2856778|NCT02273960|9817017|P4|Short Term Period|Lack of Efficacy|1
2856779|NCT02273960|9817018|P3|Short Term Period|Lack of Efficacy|0
2856780|NCT02273960|9817019|P2|Short Term Period|Lack of Efficacy|0
2856781|NCT02273960|9817020|P1|Short Term Period|Lack of Efficacy|0
2856782|NCT02273960|9817017|P4|Short Term Period|Lost to Follow-up|0
2856783|NCT02273960|9817018|P3|Short Term Period|Lost to Follow-up|0
2856784|NCT02273960|9817019|P2|Short Term Period|Lost to Follow-up|0
2856785|NCT02273960|9817020|P1|Short Term Period|Lost to Follow-up|1
2856786|NCT02273908|9817064|P2|Overall Study|Withdrawal by Subject|2
2856787|NCT02273908|9817065|P1|Overall Study|Withdrawal by Subject|4
2856788|NCT02273908|9817064|P2|Overall Study|Did not meet entrance criteria|2
2856789|NCT02273908|9817065|P1|Overall Study|Did not meet entrance criteria|3
2856790|NCT02273908|9817064|P2|Overall Study|Lost to Follow-up|1
2856791|NCT02273908|9817065|P1|Overall Study|Lost to Follow-up|10
2856792|NCT02273908|9817064|P2|Overall Study|Adverse Event|0
2856793|NCT02273908|9817065|P1|Overall Study|Adverse Event|16
2856794|NCT02273752|9817087|P1|Overall Study|Trial was terminated early|2
2856795|NCT02273180|9817178|P2|Overall Study|Other than specified above|10
2856796|NCT02273180|9817179|P1|Overall Study|Other than specified above|21
2856797|NCT02273180|9817178|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
2856798|NCT02273180|9817179|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
2856799|NCT02273180|9817178|P2|Overall Study|Randomized but not treated|0
2856800|NCT02273180|9817179|P1|Overall Study|Randomized but not treated|1
2856801|NCT02273180|9817178|P2|Overall Study|Protocol Violation|7
2856802|NCT02273180|9817179|P1|Overall Study|Protocol Violation|1
2856803|NCT02273180|9817178|P2|Overall Study|Lack of Efficacy|0
2856804|NCT02273180|9817179|P1|Overall Study|Lack of Efficacy|1
2856805|NCT02273180|9817178|P2|Overall Study|Adverse Event|2
2856806|NCT02273180|9817179|P1|Overall Study|Adverse Event|2
2856807|NCT02273167|9817204|P3|Overall Study|Various|8
2856808|NCT02273167|9817205|P2|Overall Study|Various|9
2856809|NCT02273167|9817206|P1|Overall Study|Various|10
2856810|NCT02273167|9817204|P3|Overall Study|Withdrawal by Subject|11
2856811|NCT02273167|9817205|P2|Overall Study|Withdrawal by Subject|12
2856812|NCT02273167|9817206|P1|Overall Study|Withdrawal by Subject|10
2856813|NCT02273167|9817204|P3|Overall Study|Lost to Follow-up|1
2856814|NCT02273167|9817205|P2|Overall Study|Lost to Follow-up|1
2856815|NCT02273167|9817206|P1|Overall Study|Lost to Follow-up|0
2856816|NCT02273167|9817204|P3|Overall Study|Protocol Violation|1
2856817|NCT02273167|9817205|P2|Overall Study|Protocol Violation|1
2856818|NCT02273167|9817206|P1|Overall Study|Protocol Violation|3
2856819|NCT02273167|9817204|P3|Overall Study|Adverse Event|0
2856820|NCT02273167|9817205|P2|Overall Study|Adverse Event|0
2856821|NCT02273167|9817206|P1|Overall Study|Adverse Event|1
2856822|NCT02273141|9817231|P2|Overall Study|Various|6
2856823|NCT02273141|9817232|P1|Overall Study|Various|6
2856824|NCT02273141|9817231|P2|Overall Study|Withdrawal by Subject|15
2856825|NCT02273141|9817232|P1|Overall Study|Withdrawal by Subject|10
2856826|NCT02273141|9817231|P2|Overall Study|Lost to Follow-up|3
2856827|NCT02273141|9817232|P1|Overall Study|Lost to Follow-up|1
2856828|NCT02273141|9817231|P2|Overall Study|Adverse Event|1
2856829|NCT02273141|9817232|P1|Overall Study|Adverse Event|0
2856830|NCT02273050|9817305|P3|Overall Study|Protocol Violation|4
2856831|NCT02273050|9817306|P2|Overall Study|Protocol Violation|1
2856832|NCT02273050|9817307|P1|Overall Study|Protocol Violation|3
2856833|NCT02273050|9817305|P3|Overall Study|Lost to Follow-up|3
2856834|NCT02273050|9817306|P2|Overall Study|Lost to Follow-up|2
2856835|NCT02273050|9817307|P1|Overall Study|Lost to Follow-up|0
2856836|NCT02273050|9817305|P3|Overall Study|Withdrawal by Subject|16
2856837|NCT02273050|9817306|P2|Overall Study|Withdrawal by Subject|14
2856838|NCT02273050|9817307|P1|Overall Study|Withdrawal by Subject|17
2856839|NCT02273050|9817305|P3|Overall Study|Lack of Efficacy|1
2856840|NCT02273050|9817306|P2|Overall Study|Lack of Efficacy|1
2856841|NCT02273050|9817307|P1|Overall Study|Lack of Efficacy|0
2856842|NCT02273050|9817305|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
2856843|NCT02273050|9817306|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
2856844|NCT02273050|9817307|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
2856845|NCT02273050|9817305|P3|Overall Study|Death|1
2856846|NCT02273050|9817306|P2|Overall Study|Death|0
2856847|NCT02273050|9817307|P1|Overall Study|Death|0
2856848|NCT02273050|9817305|P3|Overall Study|Adverse Event|3
2856849|NCT02273050|9817306|P2|Overall Study|Adverse Event|3
2856850|NCT02273050|9817307|P1|Overall Study|Adverse Event|4
2856851|NCT02273037|9817335|P2|Overall Study|Other complication|0
2856852|NCT02273037|9817336|P1|Overall Study|Other complication|2
2856853|NCT02273037|9817335|P2|Overall Study|Multiple delivery|2
2856854|NCT02273037|9817336|P1|Overall Study|Multiple delivery|2
2856855|NCT02273037|9817335|P2|Overall Study|Breech delivery|3
2856856|NCT02273037|9817336|P1|Overall Study|Breech delivery|2
2856857|NCT02273037|9817335|P2|Overall Study|Delivered before monitoring initiated|3
2856858|NCT02273037|9817336|P1|Overall Study|Delivered before monitoring initiated|1
2856859|NCT02273037|9817335|P2|Overall Study|Lost to Follow-up|0
2856860|NCT02273037|9817336|P1|Overall Study|Lost to Follow-up|1
2856861|NCT02272985|9817346|P1|Overall Study|kidney transplantation|1
2856862|NCT02272985|9817346|P1|Overall Study|hip fracture|1
2856863|NCT02272985|9817346|P1|Overall Study|Withdrawal by Subject|1
2856864|NCT02272816|9817351|P1|Overall Study|Adverse Event|1
2856865|NCT02272803|9817359|P2|Overall Study|Withdrawal by Subject|0
2856866|NCT02272803|9817360|P1|Overall Study|Withdrawal by Subject|1
2856867|NCT02272803|9817359|P2|Overall Study|Poor/non-compliance|1
2856868|NCT02272803|9817360|P1|Overall Study|Poor/non-compliance|0
2856869|NCT02272803|9817359|P2|Overall Study|Subject moved to care facility|1
2856870|NCT02272803|9817360|P1|Overall Study|Subject moved to care facility|0
2856871|NCT02272803|9817359|P2|Overall Study|Maximum clinical benefit|1
2856872|NCT02272803|9817360|P1|Overall Study|Maximum clinical benefit|1
2856873|NCT02272803|9817359|P2|Overall Study|Subj request to discontinue study trt|4
2856874|NCT02272803|9817360|P1|Overall Study|Subj request to discontinue study trt|1
2856875|NCT02272803|9817359|P2|Overall Study|Study drug toxicity|4
2856876|NCT02272803|9817360|P1|Overall Study|Study drug toxicity|1
2856877|NCT02272803|9817359|P2|Overall Study|Adverse Event unrelated to study drug|4
2856878|NCT02272803|9817360|P1|Overall Study|Adverse Event unrelated to study drug|1
2856879|NCT02272803|9817359|P2|Overall Study|Disease progression|2
2856880|NCT02272803|9817360|P1|Overall Study|Disease progression|4
2856881|NCT02272790|9817377|P6|Overall Study|Physician Decision|0
2856882|NCT02272790|9817378|P5|Overall Study|Physician Decision|0
2856883|NCT02272790|9817379|P4|Overall Study|Physician Decision|0
2856884|NCT02272790|9817380|P3|Overall Study|Physician Decision|0
2856885|NCT02272790|9817381|P2|Overall Study|Physician Decision|1
2856886|NCT02272790|9817382|P1|Overall Study|Physician Decision|0
2856887|NCT02272777|9817518|P2|Overall Study|Other|0
2856888|NCT02272777|9817519|P1|Overall Study|Other|2
2856889|NCT02272777|9817518|P2|Overall Study|Lost to Follow-up|0
2856890|NCT02272777|9817519|P1|Overall Study|Lost to Follow-up|2
2856891|NCT02272777|9817518|P2|Overall Study|Withdrawal by Subject|3
2856892|NCT02272777|9817519|P1|Overall Study|Withdrawal by Subject|0
2856893|NCT02272777|9817518|P2|Overall Study|Adverse Event|1
2856894|NCT02272777|9817519|P1|Overall Study|Adverse Event|0
2856895|NCT02272725|9817527|P2|Overall Study|equipment malfunction|0
2856896|NCT02272725|9817528|P1|Overall Study|equipment malfunction|2
2856897|NCT02272413|9817545|P2|Post-switch Period|Other than listed|5
2856898|NCT02272413|9817546|P1|Post-switch Period|Other than listed|4
2856899|NCT02272413|9817545|P2|Post-switch Period|Study terminated by sponsor|11
2856900|NCT02272413|9817546|P1|Post-switch Period|Study terminated by sponsor|8
2856901|NCT02272413|9817545|P2|Post-switch Period|Progressive disease|21
2856902|NCT02272413|9817546|P1|Post-switch Period|Progressive disease|21
2856903|NCT02272413|9817545|P2|Post-switch Period|Physician Decision|1
2856904|NCT02272413|9817546|P1|Post-switch Period|Physician Decision|1
2856905|NCT02272413|9817545|P2|Post-switch Period|Withdrawal by Subject|2
2856906|NCT02272413|9817546|P1|Post-switch Period|Withdrawal by Subject|1
2856907|NCT02272413|9817545|P2|Post-switch Period|Death|2
2856908|NCT02272413|9817546|P1|Post-switch Period|Death|3
2856909|NCT02272413|9817545|P2|Post-switch Period|Adverse Event|4
2856910|NCT02272413|9817546|P1|Post-switch Period|Adverse Event|4
2856911|NCT02272413|9817545|P2|Pre-switch Period|Other than listed|11
2856912|NCT02272413|9817546|P1|Pre-switch Period|Other than listed|10
2856913|NCT02272413|9817545|P2|Pre-switch Period|Protocol Violation|0
2856914|NCT02272413|9817546|P1|Pre-switch Period|Protocol Violation|1
2856915|NCT02272413|9817545|P2|Pre-switch Period|Lost to Follow-up|2
2856916|NCT02272413|9817546|P1|Pre-switch Period|Lost to Follow-up|0
2856917|NCT02272413|9817545|P2|Pre-switch Period|Progressive disease|173
2856918|NCT02272413|9817546|P1|Pre-switch Period|Progressive disease|185
2856919|NCT02272413|9817545|P2|Pre-switch Period|Physician Decision|18
2856920|NCT02272413|9817546|P1|Pre-switch Period|Physician Decision|6
2856921|NCT02272413|9817545|P2|Pre-switch Period|Withdrawal by Subject|15
2856922|NCT02272413|9817546|P1|Pre-switch Period|Withdrawal by Subject|27
2856923|NCT02272413|9817545|P2|Pre-switch Period|Death|26
2856924|NCT02272413|9817546|P1|Pre-switch Period|Death|26
2856925|NCT02272413|9817545|P2|Pre-switch Period|Adverse Event|37
2856926|NCT02272413|9817546|P1|Pre-switch Period|Adverse Event|38
2856927|NCT02272413|9817545|P2|Randomized Through Treatment Start|Not treated|5
2856928|NCT02272413|9817546|P1|Randomized Through Treatment Start|Not treated|3
2856929|NCT02271984|9817577|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856930|NCT02271984|9817578|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856931|NCT02271984|9817579|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856932|NCT02271984|9817580|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856933|NCT02271984|9817581|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2856934|NCT02271984|9817582|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856935|NCT02271984|9817583|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2856936|NCT02271984|9817584|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856937|NCT02271984|9817585|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856938|NCT02271984|9817586|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856939|NCT02271984|9817587|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856940|NCT02271984|9817588|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2856941|NCT02271945|9817677|P2|Overall Study|Other|1
2856942|NCT02271945|9817678|P1|Overall Study|Other|1
2856943|NCT02271945|9817677|P2|Overall Study|Withdrawal by Subject|1
2856944|NCT02271945|9817678|P1|Overall Study|Withdrawal by Subject|1
2856945|NCT02271945|9817677|P2|Overall Study|Death|3
2856946|NCT02271945|9817678|P1|Overall Study|Death|3
2856947|NCT02271880|9817721|P2|Overall Study|Premature discontinuation of study|4
2856948|NCT02271880|9817722|P1|Overall Study|Premature discontinuation of study|3
2856949|NCT02271854|9817752|P1|Overall Study|Lost to Follow-up|1
2856950|NCT02271854|9817752|P1|Overall Study|Unable or unwilling to cooperate with st|1
2856951|NCT02271854|9817752|P1|Overall Study|Withdrawal by Subject|2
2856952|NCT02271529|9817792|P1|Overall Study|Withdrawal by Subject|1
2856953|NCT02270983|9817913|P3|Overall Study|moved away from study site|0
2856954|NCT02270983|9817914|P2|Overall Study|moved away from study site|1
2856955|NCT02270983|9817915|P1|Overall Study|moved away from study site|0
2856956|NCT02270983|9817913|P3|Overall Study|study procedure non-compliance|0
2856957|NCT02270983|9817914|P2|Overall Study|study procedure non-compliance|0
2856958|NCT02270983|9817915|P1|Overall Study|study procedure non-compliance|1
2856959|NCT02270983|9817913|P3|Overall Study|family emergency|0
2856960|NCT02270983|9817914|P2|Overall Study|family emergency|1
2856961|NCT02270983|9817915|P1|Overall Study|family emergency|0
2856962|NCT02270983|9817913|P3|Overall Study|Protocol Violation|1
2856963|NCT02270983|9817914|P2|Overall Study|Protocol Violation|1
2856964|NCT02270983|9817915|P1|Overall Study|Protocol Violation|1
2856965|NCT02270983|9817913|P3|Overall Study|Lost to Follow-up|2
2856966|NCT02270983|9817914|P2|Overall Study|Lost to Follow-up|1
2856967|NCT02270983|9817915|P1|Overall Study|Lost to Follow-up|1
2856968|NCT02270983|9817913|P3|Overall Study|Withdrawal by Subject|2
2856969|NCT02270983|9817914|P2|Overall Study|Withdrawal by Subject|0
2856970|NCT02270983|9817915|P1|Overall Study|Withdrawal by Subject|1
2856971|NCT02270983|9817913|P3|Overall Study|Lack of Efficacy|1
2856972|NCT02270983|9817914|P2|Overall Study|Lack of Efficacy|1
2856973|NCT02270983|9817915|P1|Overall Study|Lack of Efficacy|2
2856974|NCT02270983|9817913|P3|Overall Study|Adverse Event|6
2856975|NCT02270983|9817914|P2|Overall Study|Adverse Event|2
2856976|NCT02270983|9817915|P1|Overall Study|Adverse Event|3
2856977|NCT02270944|9817940|P2|Overall Study|Withdrawal by Subject|1
2856978|NCT02270944|9817941|P1|Overall Study|Withdrawal by Subject|2
2856979|NCT02270944|9817940|P2|Overall Study|Lost to Follow-up|4
2856980|NCT02270944|9817941|P1|Overall Study|Lost to Follow-up|9
2856981|NCT02270684|9817959|P2|Overall Study|Study terminated|0
2856982|NCT02270684|9817960|P1|Overall Study|Study terminated|1
2856983|NCT02270684|9817959|P2|Overall Study|Lost to Follow-up|3
2856984|NCT02270684|9817960|P1|Overall Study|Lost to Follow-up|0
2856985|NCT02270671|9817968|P2|Overall Study|Lost to Follow-up|1
2856986|NCT02270671|9817969|P1|Overall Study|Lost to Follow-up|2
2856987|NCT02270671|9817968|P2|Overall Study|Missed Post-intervention Data Collection|2
2856988|NCT02270671|9817969|P1|Overall Study|Missed Post-intervention Data Collection|2
2856989|NCT02270671|9817968|P2|Overall Study|Protocol Violation|1
2856990|NCT02270671|9817969|P1|Overall Study|Protocol Violation|0
2856991|NCT02270671|9817968|P2|Overall Study|Withdrawal by Subject|1
2856992|NCT02270671|9817969|P1|Overall Study|Withdrawal by Subject|1
2856993|NCT02270515|9817994|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
2856994|NCT02270515|9817994|P1|Intervention Period 3: 12-18 Months|Death|3
2856995|NCT02270515|9817994|P1|Intervention Period 3: 12-18 Months|Received transplant|2
2856996|NCT02270515|9817994|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
2856997|NCT02270515|9817994|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
2856998|NCT02270515|9817994|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
2856999|NCT02270515|9817994|P1|Intervention Period 2: 6-12 Months|Death|5
2857000|NCT02270515|9817994|P1|Intervention Period 2: 6-12 Months|Received transplant|1
2857001|NCT02270515|9817994|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
2857002|NCT02270515|9817994|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
2857003|NCT02270515|9817994|P1|Intervention Period 1: 0-6 Months|Death|7
2857004|NCT02270515|9817994|P1|Intervention Period 1: 0-6 Months|Received transplant|3
2857005|NCT02270515|9817994|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
2857006|NCT02270515|9817994|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
2857007|NCT02269943|9818053|P2|Follow-Up Survival Period|Alive|8
2857008|NCT02269943|9818054|P1|Follow-Up Survival Period|Alive|2
2857009|NCT02269943|9818053|P2|Follow-Up Survival Period|Lost to Follow-up|2
2857010|NCT02269943|9818054|P1|Follow-Up Survival Period|Lost to Follow-up|0
2857011|NCT02269943|9818053|P2|Follow-Up Survival Period|Death|16
2857012|NCT02269943|9818054|P1|Follow-Up Survival Period|Death|3
2857013|NCT02269943|9818053|P2|Treatment Period|Symptomatic Deterioration|2
2857014|NCT02269943|9818054|P1|Treatment Period|Symptomatic Deterioration|0
2857015|NCT02269943|9818053|P2|Treatment Period|Progressive Disease|17
2857016|NCT02269943|9818054|P1|Treatment Period|Progressive Disease|5
2857017|NCT02269943|9818053|P2|Treatment Period|Adverse Event|10
2857018|NCT02269943|9818054|P1|Treatment Period|Adverse Event|1
2857019|NCT02269943|9818053|P2|Treatment Period|Death|1
2857020|NCT02269943|9818054|P1|Treatment Period|Death|0
2857021|NCT02269917|9818084|P2|Overall Study|Randomized but not treated|5
2857022|NCT02269917|9818085|P1|Overall Study|Randomized but not treated|3
2857023|NCT02269917|9818084|P2|Overall Study|Non-compliance with study drug|0
2857024|NCT02269917|9818085|P1|Overall Study|Non-compliance with study drug|2
2857025|NCT02269917|9818084|P2|Overall Study|Adverse Event|4
2857026|NCT02269917|9818085|P1|Overall Study|Adverse Event|11
2857027|NCT02269917|9818084|P2|Overall Study|Withdrawal by Subject|8
2857028|NCT02269917|9818085|P1|Overall Study|Withdrawal by Subject|9
2857029|NCT02269917|9818084|P2|Overall Study|Other|3
2857030|NCT02269917|9818085|P1|Overall Study|Other|6
2857031|NCT02269917|9818084|P2|Overall Study|Ongoing|360
2857032|NCT02269917|9818085|P1|Overall Study|Ongoing|731
2857033|NCT02269917|9818084|P2|Overall Study|Lost to Follow-up|3
2857034|NCT02269917|9818085|P1|Overall Study|Lost to Follow-up|4
2857035|NCT02269787|9818138|P2|Overall Study|Incapacitated|1
2857036|NCT02269787|9818139|P1|Overall Study|Incapacitated|0
2857037|NCT02269787|9818138|P2|Overall Study|Death|3
2857038|NCT02269787|9818139|P1|Overall Study|Death|2
2857039|NCT02269787|9818138|P2|Overall Study|Lost to Follow-up|6
2857040|NCT02269787|9818139|P1|Overall Study|Lost to Follow-up|20
2857041|NCT02269709|9818145|P1|Six Month Follow-up|Lost to Follow-up|12
2857042|NCT02269709|9818145|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
2857043|NCT02269709|9818145|P1|Time of Enrollment|Withdrawal by Subject|3
2857044|NCT02269657|9818150|P1|Overall Study|Protocol Violation|3
2857045|NCT02269475|9818187|P2|Overall Study|Withdrawal by Subject|1
2857046|NCT02269475|9818188|P1|Overall Study|Withdrawal by Subject|0
2857047|NCT02269475|9818187|P2|Overall Study|Meet Exclusion Criteria No. 17|0
2857048|NCT02269475|9818188|P1|Overall Study|Meet Exclusion Criteria No. 17|3
2857049|NCT02269423|9818203|P4|Overall Study|Discontinued due to change in residence|1
2857050|NCT02269423|9818204|P3|Overall Study|Discontinued due to change in residence|0
2857051|NCT02269423|9818205|P2|Overall Study|Discontinued due to change in residence|1
2857052|NCT02269423|9818206|P1|Overall Study|Discontinued due to change in residence|0
2857053|NCT02269241|9818268|P1|Overall Study|Screening failures|546
2857054|NCT02269241|9818268|P1|Overall Study|Several reasons not classified|53
2857055|NCT02269241|9818268|P1|Overall Study|At the specific request of the sponsor|20
2857056|NCT02269241|9818268|P1|Overall Study|Adverse Event|113
2857057|NCT02269241|9818268|P1|Overall Study|Development of an exclusion criteria|16
2857058|NCT02269241|9818268|P1|Overall Study|Wish for pregnancy|5
2857059|NCT02269241|9818268|P1|Overall Study|Pregnancy|15
2857060|NCT02269241|9818268|P1|Overall Study|Physician Decision|7
2857061|NCT02269241|9818268|P1|Overall Study|Protocol Violation|1
2857062|NCT02269241|9818268|P1|Overall Study|Withdrawal by Subject|155
2857063|NCT02269241|9818268|P1|Overall Study|Lost to Follow-up|269
2857064|NCT02269098|9818282|P2|Overall Study|Lost to Follow-up|9
2857065|NCT02269098|9818283|P1|Overall Study|Lost to Follow-up|14
2857066|NCT02268864|9818344|P3|Overall Study|Death|0
2857067|NCT02268864|9818345|P2|Overall Study|Death|1
2857068|NCT02268864|9818346|P1|Overall Study|Death|0
2857069|NCT02268864|9818344|P3|Overall Study|Withdrawal by Subject|0
2857070|NCT02268864|9818345|P2|Overall Study|Withdrawal by Subject|0
2857071|NCT02268864|9818346|P1|Overall Study|Withdrawal by Subject|2
2857072|NCT02268812|9818372|P4|Overall Study|Other|3
2857073|NCT02268812|9818373|P3|Overall Study|Other|1
2857074|NCT02268812|9818374|P2|Overall Study|Other|4
2857075|NCT02268812|9818375|P1|Overall Study|Other|5
2857076|NCT02268812|9818372|P4|Overall Study|Physician Decision|1
2857077|NCT02268812|9818373|P3|Overall Study|Physician Decision|0
2857078|NCT02268812|9818374|P2|Overall Study|Physician Decision|1
2857079|NCT02268812|9818375|P1|Overall Study|Physician Decision|3
2857080|NCT02268812|9818372|P4|Overall Study|Withdrawal by Subject|0
2857081|NCT02268812|9818373|P3|Overall Study|Withdrawal by Subject|0
2857082|NCT02268812|9818374|P2|Overall Study|Withdrawal by Subject|1
2857083|NCT02268812|9818375|P1|Overall Study|Withdrawal by Subject|0
2857084|NCT02268812|9818372|P4|Overall Study|Protocol deviation|0
2857085|NCT02268812|9818373|P3|Overall Study|Protocol deviation|1
2857086|NCT02268812|9818374|P2|Overall Study|Protocol deviation|0
2857087|NCT02268812|9818375|P1|Overall Study|Protocol deviation|0
2857088|NCT02268812|9818372|P4|Overall Study|Adverse Event|10
2857089|NCT02268812|9818373|P3|Overall Study|Adverse Event|7
2857090|NCT02268812|9818374|P2|Overall Study|Adverse Event|26
2857091|NCT02268812|9818375|P1|Overall Study|Adverse Event|8
2857092|NCT02268786|9818407|P2|Overall Study|Protocol Violation|0
2857093|NCT02268786|9818408|P1|Overall Study|Protocol Violation|1
2857094|NCT02268786|9818407|P2|Overall Study|Thaw Failure|4
2857095|NCT02268786|9818408|P1|Overall Study|Thaw Failure|6
2857096|NCT02268786|9818407|P2|Overall Study|Withdrawal by Subject|14
2857097|NCT02268786|9818408|P1|Overall Study|Withdrawal by Subject|7
2857098|NCT02268786|9818407|P2|Overall Study|No Euploid Embryos available|0
2857099|NCT02268786|9818408|P1|Overall Study|No Euploid Embryos available|42
2857100|NCT02268526|9818417|P3|Overall Study|Subject/guardian decision|3
2857101|NCT02268526|9818418|P2|Overall Study|Subject/guardian decision|7
2857102|NCT02268526|9818419|P1|Overall Study|Subject/guardian decision|0
2857103|NCT02268526|9818417|P3|Overall Study|Physician Decision|1
2857104|NCT02268526|9818418|P2|Overall Study|Physician Decision|0
2857105|NCT02268526|9818419|P1|Overall Study|Physician Decision|0
2857106|NCT02268526|9818417|P3|Overall Study|protocol deviation|0
2857107|NCT02268526|9818418|P2|Overall Study|protocol deviation|1
2857108|NCT02268526|9818419|P1|Overall Study|protocol deviation|0
2857109|NCT02268526|9818417|P3|Overall Study|Death|0
2857110|NCT02268526|9818418|P2|Overall Study|Death|11
2857111|NCT02268526|9818419|P1|Overall Study|Death|1
2857112|NCT02268526|9818417|P3|Overall Study|Adverse Event|1
2857113|NCT02268526|9818418|P2|Overall Study|Adverse Event|2
2857114|NCT02268526|9818419|P1|Overall Study|Adverse Event|0
2857115|NCT02268396|9818440|P1|Overall Study|2 Subjects no Day 29 Assessment|2
2857116|NCT02268396|9818440|P1|Overall Study|Protocol-Specified Criteria|2
2857117|NCT02268396|9818440|P1|Overall Study|Lost to Follow-up|2
2857118|NCT02268396|9818440|P1|Overall Study|Withdrawal by Subject|1
2857119|NCT02268396|9818440|P1|Overall Study|Administrative|2
2857120|NCT02268396|9818440|P1|Overall Study|Adverse Event|3
2857121|NCT02268214|9818452|P3|Overall Study|Not entering long-term period|5
2857122|NCT02268214|9818453|P2|Overall Study|Not entering long-term period|3
2857123|NCT02268214|9818454|P1|Overall Study|Not entering long-term period|2
2857124|NCT02268214|9818452|P3|Overall Study|Other reasons|3
2857125|NCT02268214|9818453|P2|Overall Study|Other reasons|3
2857126|NCT02268214|9818454|P1|Overall Study|Other reasons|7
2857127|NCT02268214|9818452|P3|Overall Study|Poor/non-compliance|2
2857128|NCT02268214|9818453|P2|Overall Study|Poor/non-compliance|1
2857129|NCT02268214|9818454|P1|Overall Study|Poor/non-compliance|2
2857130|NCT02268214|9818452|P3|Overall Study|Subject request to discontinue treatment|6
2857131|NCT02268214|9818453|P2|Overall Study|Subject request to discontinue treatment|8
2857132|NCT02268214|9818454|P1|Overall Study|Subject request to discontinue treatment|10
2857133|NCT02268214|9818452|P3|Overall Study|Withdrawal by Subject|10
2857134|NCT02268214|9818453|P2|Overall Study|Withdrawal by Subject|5
2857135|NCT02268214|9818454|P1|Overall Study|Withdrawal by Subject|4
2857136|NCT02268214|9818452|P3|Overall Study|Adverse Event|9
2857137|NCT02268214|9818453|P2|Overall Study|Adverse Event|14
2857138|NCT02268214|9818454|P1|Overall Study|Adverse Event|11
2857139|NCT02268214|9818452|P3|Overall Study|Lack of Efficacy|2
2857140|NCT02268214|9818453|P2|Overall Study|Lack of Efficacy|0
2857141|NCT02268214|9818454|P1|Overall Study|Lack of Efficacy|1
2857142|NCT02268214|9818452|P3|Overall Study|Lost to Follow-up|4
2857143|NCT02268214|9818453|P2|Overall Study|Lost to Follow-up|3
2857144|NCT02268214|9818454|P1|Overall Study|Lost to Follow-up|3
2857145|NCT02268214|9818452|P3|Overall Study|Pregnancy|1
2857146|NCT02268214|9818453|P2|Overall Study|Pregnancy|2
2857147|NCT02268214|9818454|P1|Overall Study|Pregnancy|2
2857148|NCT02268214|9818452|P3|Overall Study|Subject no longer meets study criteria|0
2857149|NCT02268214|9818453|P2|Overall Study|Subject no longer meets study criteria|2
2857150|NCT02268214|9818454|P1|Overall Study|Subject no longer meets study criteria|0
2857151|NCT02268058|9818501|P4|Overall Study|Protocol Violation|0
2857152|NCT02268058|9818502|P3|Overall Study|Protocol Violation|0
2857153|NCT02268058|9818503|P2|Overall Study|Protocol Violation|0
2857154|NCT02268058|9818504|P1|Overall Study|Protocol Violation|1
2857155|NCT02268045|9818528|P2|Overall Study|Protocol Violation|1
2857156|NCT02268045|9818529|P1|Overall Study|Protocol Violation|1
2857157|NCT02268045|9818528|P2|Overall Study|Physician Decision|1
2857158|NCT02268045|9818529|P1|Overall Study|Physician Decision|0
2857159|NCT02268045|9818528|P2|Overall Study|Withdrawal by Subject|6
2857160|NCT02268045|9818529|P1|Overall Study|Withdrawal by Subject|2
2857161|NCT02268045|9818528|P2|Overall Study|Adverse Event|7
2857162|NCT02268045|9818529|P1|Overall Study|Adverse Event|7
2857163|NCT02268045|9818528|P2|Overall Study|Disease Progression|1
2857164|NCT02268045|9818529|P1|Overall Study|Disease Progression|2
2857165|NCT02268045|9818528|P2|Overall Study|Death|4
2857166|NCT02268045|9818529|P1|Overall Study|Death|4
2857167|NCT02267824|9818571|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
2857168|NCT02267824|9818572|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
2857169|NCT02267824|9818571|P2|Overall Study|Protocol Violation|0
2857170|NCT02267824|9818572|P1|Overall Study|Protocol Violation|3
2857171|NCT02267824|9818571|P2|Overall Study|Lost to Follow-up|0
2857172|NCT02267824|9818572|P1|Overall Study|Lost to Follow-up|4
2857173|NCT02267824|9818571|P2|Overall Study|Pregnancy|1
2857174|NCT02267824|9818572|P1|Overall Study|Pregnancy|1
2857175|NCT02267746|9818594|P3|Overall Study|Death|1
2857176|NCT02267746|9818595|P2|Overall Study|Death|0
2857177|NCT02267746|9818596|P1|Overall Study|Death|1
2857178|NCT02267746|9818594|P3|Overall Study|Protocol Violation|1
2857179|NCT02267746|9818595|P2|Overall Study|Protocol Violation|2
2857180|NCT02267746|9818596|P1|Overall Study|Protocol Violation|1
2857181|NCT02267746|9818594|P3|Overall Study|Lack of Efficacy|15
2857182|NCT02267746|9818595|P2|Overall Study|Lack of Efficacy|11
2857183|NCT02267746|9818596|P1|Overall Study|Lack of Efficacy|11
2857184|NCT02267746|9818594|P3|Overall Study|Protocol Violation|3
2857185|NCT02267746|9818595|P2|Overall Study|Protocol Violation|7
2857186|NCT02267746|9818596|P1|Overall Study|Protocol Violation|8
2857187|NCT02267746|9818594|P3|Overall Study|Adverse Event|1
2857188|NCT02267746|9818595|P2|Overall Study|Adverse Event|2
2857189|NCT02267746|9818596|P1|Overall Study|Adverse Event|0
2857190|NCT02267317|9818680|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2857191|NCT02267317|9818681|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2857192|NCT02267317|9818682|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2857193|NCT02267317|9818683|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2857194|NCT02267317|9818684|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2857195|NCT02267317|9818685|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
2857196|NCT02267317|9818680|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2857197|NCT02267317|9818681|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2857198|NCT02267317|9818682|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2857199|NCT02267317|9818683|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2857200|NCT02267317|9818684|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2857201|NCT02267317|9818685|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
2857202|NCT02267278|9818735|P1|Overall Study|prescribed prohibited medication|1
2857203|NCT02267278|9818735|P1|Overall Study|Developed new cancer diagnoses|2
2857204|NCT02267278|9818735|P1|Overall Study|transformation to acute leukemia (AML)|1
2857205|NCT02267278|9818735|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
2857206|NCT02267187|9818759|P1|Overall Study|Screen fail|3
2857207|NCT02267187|9818759|P1|Overall Study|Physician Decision|2
2857208|NCT02267135|9818767|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
2857209|NCT02267135|9818768|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
2857210|NCT02267135|9818767|P2|Period 2 (Randomized Set)|Adverse Event|0
2857211|NCT02267135|9818768|P1|Period 2 (Randomized Set)|Adverse Event|2
2857212|NCT02267135|9818767|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
2857213|NCT02267135|9818768|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
2857214|NCT02267135|9818767|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
2857215|NCT02267135|9818768|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
2857216|NCT02267135|9818767|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
2857217|NCT02267135|9818768|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
2857218|NCT02266875|9818812|P2|Overall Study|Lost to Follow-up|0
2857219|NCT02266875|9818813|P1|Overall Study|Lost to Follow-up|2
2857220|NCT02266875|9818812|P2|Overall Study|Withdrawal by Subject|0
2857221|NCT02266875|9818813|P1|Overall Study|Withdrawal by Subject|9
2857222|NCT02266706|9818878|P9|Overall Study|Enrollment in another study|0
2857223|NCT02266706|9818879|P8|Overall Study|Enrollment in another study|0
2857224|NCT02266706|9818880|P7|Overall Study|Enrollment in another study|0
2857225|NCT02266706|9818881|P6|Overall Study|Enrollment in another study|0
2857226|NCT02266706|9818882|P5|Overall Study|Enrollment in another study|0
2857227|NCT02266706|9818883|P4|Overall Study|Enrollment in another study|1
2857228|NCT02266706|9818884|P3|Overall Study|Enrollment in another study|0
2857229|NCT02266706|9818885|P2|Overall Study|Enrollment in another study|0
2857230|NCT02266706|9818886|P1|Overall Study|Enrollment in another study|0
2857231|NCT02266706|9818878|P9|Overall Study|Screen failure|0
2857232|NCT02266706|9818879|P8|Overall Study|Screen failure|0
2857233|NCT02266706|9818880|P7|Overall Study|Screen failure|1
2857234|NCT02266706|9818881|P6|Overall Study|Screen failure|1
2857235|NCT02266706|9818882|P5|Overall Study|Screen failure|0
2857236|NCT02266706|9818883|P4|Overall Study|Screen failure|0
2857237|NCT02266706|9818884|P3|Overall Study|Screen failure|0
2857238|NCT02266706|9818885|P2|Overall Study|Screen failure|0
2857239|NCT02266706|9818886|P1|Overall Study|Screen failure|0
2857240|NCT02266706|9818878|P9|Overall Study|Withdrawal by Subject|0
2857241|NCT02266706|9818879|P8|Overall Study|Withdrawal by Subject|0
2857242|NCT02266706|9818880|P7|Overall Study|Withdrawal by Subject|0
2857243|NCT02266706|9818881|P6|Overall Study|Withdrawal by Subject|1
2857244|NCT02266706|9818882|P5|Overall Study|Withdrawal by Subject|0
2857245|NCT02266706|9818883|P4|Overall Study|Withdrawal by Subject|0
2857246|NCT02266706|9818884|P3|Overall Study|Withdrawal by Subject|1
2857247|NCT02266706|9818885|P2|Overall Study|Withdrawal by Subject|1
2857248|NCT02266706|9818886|P1|Overall Study|Withdrawal by Subject|0
2857249|NCT02266381|9819118|P3|Overall Study|Physician Decision|4
2857250|NCT02266381|9819119|P2|Overall Study|Physician Decision|5
2857251|NCT02266381|9819120|P1|Overall Study|Physician Decision|3
2857252|NCT02266225|9819170|P1|Overall Study|Withdrawal by Subject|13
2857253|NCT02266225|9819170|P1|Overall Study|Death|1
2857254|NCT02266225|9819170|P1|Overall Study|Lost to Follow-up|2
2857255|NCT02265952|9819227|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
2857256|NCT02265952|9819228|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2857257|NCT02265952|9819227|P2|Open Label Extension (OLE) Period|Physician Decision|7
2857258|NCT02265952|9819228|P1|Open Label Extension (OLE) Period|Physician Decision|0
2857259|NCT02265796|9819271|P2|Overall Study|Withdrawal by Subject|1
2857260|NCT02265796|9819272|P1|Overall Study|Withdrawal by Subject|1
2857261|NCT02265796|9819271|P2|Overall Study|started on excluded medication|0
2857262|NCT02265796|9819272|P1|Overall Study|started on excluded medication|1
2857263|NCT02265796|9819271|P2|Overall Study|Death|0
2857264|NCT02265796|9819272|P1|Overall Study|Death|1
2857265|NCT02265744|9819291|P5|Overall Study|Pregnancy|0
2857266|NCT02265744|9819292|P4|Overall Study|Pregnancy|1
2857267|NCT02265744|9819293|P3|Overall Study|Pregnancy|1
2857268|NCT02265744|9819294|P2|Overall Study|Pregnancy|2
2857269|NCT02265744|9819295|P1|Overall Study|Pregnancy|1
2857270|NCT02265744|9819291|P5|Overall Study|Subject no longer meets study criteria|1
2857271|NCT02265744|9819292|P4|Overall Study|Subject no longer meets study criteria|0
2857272|NCT02265744|9819293|P3|Overall Study|Subject no longer meets study criteria|0
2857273|NCT02265744|9819294|P2|Overall Study|Subject no longer meets study criteria|0
2857274|NCT02265744|9819295|P1|Overall Study|Subject no longer meets study criteria|0
2857275|NCT02265744|9819291|P5|Overall Study|Administrative reason by sponsor|3
2857276|NCT02265744|9819292|P4|Overall Study|Administrative reason by sponsor|3
2857277|NCT02265744|9819293|P3|Overall Study|Administrative reason by sponsor|2
2857278|NCT02265744|9819294|P2|Overall Study|Administrative reason by sponsor|2
2857279|NCT02265744|9819295|P1|Overall Study|Administrative reason by sponsor|3
2857280|NCT02265744|9819291|P5|Overall Study|Reason not provided by Investigator|0
2857281|NCT02265744|9819292|P4|Overall Study|Reason not provided by Investigator|2
2857282|NCT02265744|9819293|P3|Overall Study|Reason not provided by Investigator|0
2857283|NCT02265744|9819294|P2|Overall Study|Reason not provided by Investigator|0
2857284|NCT02265744|9819295|P1|Overall Study|Reason not provided by Investigator|1
2857285|NCT02265744|9819291|P5|Overall Study|Lack of Efficacy|5
2857286|NCT02265744|9819292|P4|Overall Study|Lack of Efficacy|4
2857287|NCT02265744|9819293|P3|Overall Study|Lack of Efficacy|3
2857288|NCT02265744|9819294|P2|Overall Study|Lack of Efficacy|4
2857289|NCT02265744|9819295|P1|Overall Study|Lack of Efficacy|2
2857290|NCT02265744|9819291|P5|Overall Study|Adverse Event|2
2857291|NCT02265744|9819292|P4|Overall Study|Adverse Event|8
2857292|NCT02265744|9819293|P3|Overall Study|Adverse Event|9
2857293|NCT02265744|9819294|P2|Overall Study|Adverse Event|4
2857294|NCT02265744|9819295|P1|Overall Study|Adverse Event|8
2857295|NCT02265744|9819291|P5|Overall Study|Participant request to discontinue|0
2857296|NCT02265744|9819292|P4|Overall Study|Participant request to discontinue|0
2857297|NCT02265744|9819293|P3|Overall Study|Participant request to discontinue|2
2857298|NCT02265744|9819294|P2|Overall Study|Participant request to discontinue|2
2857299|NCT02265744|9819295|P1|Overall Study|Participant request to discontinue|2
2857300|NCT02265744|9819291|P5|Overall Study|Withdrawal by Subject|0
2857301|NCT02265744|9819292|P4|Overall Study|Withdrawal by Subject|2
2857302|NCT02265744|9819293|P3|Overall Study|Withdrawal by Subject|0
2857303|NCT02265744|9819294|P2|Overall Study|Withdrawal by Subject|0
2857304|NCT02265744|9819295|P1|Overall Study|Withdrawal by Subject|2
2857305|NCT02265744|9819291|P5|Overall Study|Death|0
2857306|NCT02265744|9819292|P4|Overall Study|Death|2
2857307|NCT02265744|9819293|P3|Overall Study|Death|0
2857308|NCT02265744|9819294|P2|Overall Study|Death|0
2857309|NCT02265744|9819295|P1|Overall Study|Death|0
2857310|NCT02265744|9819291|P5|Overall Study|Lost to Follow-up|0
2857311|NCT02265744|9819292|P4|Overall Study|Lost to Follow-up|1
2857312|NCT02265744|9819293|P3|Overall Study|Lost to Follow-up|0
2857313|NCT02265744|9819294|P2|Overall Study|Lost to Follow-up|0
2857314|NCT02265744|9819295|P1|Overall Study|Lost to Follow-up|0
2857315|NCT02265744|9819291|P5|Overall Study|Poor/Non-compliance|2
2857316|NCT02265744|9819292|P4|Overall Study|Poor/Non-compliance|0
2857317|NCT02265744|9819293|P3|Overall Study|Poor/Non-compliance|0
2857318|NCT02265744|9819294|P2|Overall Study|Poor/Non-compliance|1
2857319|NCT02265744|9819295|P1|Overall Study|Poor/Non-compliance|1
2857320|NCT02265705|9819474|P7|Follow-up Period|Withdrawal by Subject|1
2857321|NCT02265705|9819475|P6|Follow-up Period|Withdrawal by Subject|0
2857322|NCT02265705|9819476|P5|Follow-up Period|Withdrawal by Subject|0
2857323|NCT02265705|9819477|P4|Follow-up Period|Withdrawal by Subject|0
2857324|NCT02265705|9819478|P3|Follow-up Period|Withdrawal by Subject|0
2857325|NCT02265705|9819479|P2|Follow-up Period|Withdrawal by Subject|0
2857326|NCT02265705|9819480|P1|Follow-up Period|Withdrawal by Subject|0
2857327|NCT02265705|9819474|P7|Follow-up Period|Physician Decision|1
2857328|NCT02265705|9819475|P6|Follow-up Period|Physician Decision|0
2857329|NCT02265705|9819476|P5|Follow-up Period|Physician Decision|0
2857330|NCT02265705|9819477|P4|Follow-up Period|Physician Decision|0
2857331|NCT02265705|9819478|P3|Follow-up Period|Physician Decision|0
2857332|NCT02265705|9819479|P2|Follow-up Period|Physician Decision|0
2857333|NCT02265705|9819480|P1|Follow-up Period|Physician Decision|0
2857334|NCT02265705|9819474|P7|Follow-up Period|Adverse Event|3
2857335|NCT02265705|9819475|P6|Follow-up Period|Adverse Event|0
2857336|NCT02265705|9819476|P5|Follow-up Period|Adverse Event|0
2857337|NCT02265705|9819477|P4|Follow-up Period|Adverse Event|0
2857338|NCT02265705|9819478|P3|Follow-up Period|Adverse Event|0
2857339|NCT02265705|9819479|P2|Follow-up Period|Adverse Event|0
2857340|NCT02265705|9819480|P1|Follow-up Period|Adverse Event|0
2857341|NCT02265705|9819474|P7|Follow-up Period|Sponsor Decision|6
2857342|NCT02265705|9819475|P6|Follow-up Period|Sponsor Decision|1
2857343|NCT02265705|9819476|P5|Follow-up Period|Sponsor Decision|0
2857344|NCT02265705|9819477|P4|Follow-up Period|Sponsor Decision|0
2857345|NCT02265705|9819478|P3|Follow-up Period|Sponsor Decision|0
2857346|NCT02265705|9819479|P2|Follow-up Period|Sponsor Decision|0
2857347|NCT02265705|9819480|P1|Follow-up Period|Sponsor Decision|0
2857348|NCT02265705|9819474|P7|Open Label Period|Withdrawal by Subject|0
2857349|NCT02265705|9819475|P6|Open Label Period|Withdrawal by Subject|0
2857350|NCT02265705|9819476|P5|Open Label Period|Withdrawal by Subject|2
2857351|NCT02265705|9819477|P4|Open Label Period|Withdrawal by Subject|0
2857352|NCT02265705|9819478|P3|Open Label Period|Withdrawal by Subject|0
2857353|NCT02265705|9819479|P2|Open Label Period|Withdrawal by Subject|0
2857354|NCT02265705|9819480|P1|Open Label Period|Withdrawal by Subject|0
2857355|NCT02265705|9819474|P7|Open Label Period|Physician Decision|0
2857356|NCT02265705|9819475|P6|Open Label Period|Physician Decision|0
2857357|NCT02265705|9819476|P5|Open Label Period|Physician Decision|1
2857358|NCT02265705|9819477|P4|Open Label Period|Physician Decision|0
2857359|NCT02265705|9819478|P3|Open Label Period|Physician Decision|0
2857360|NCT02265705|9819479|P2|Open Label Period|Physician Decision|0
2857361|NCT02265705|9819480|P1|Open Label Period|Physician Decision|0
2857362|NCT02265705|9819474|P7|Open Label Period|Adverse Event|0
2857363|NCT02265705|9819475|P6|Open Label Period|Adverse Event|0
2857364|NCT02265705|9819476|P5|Open Label Period|Adverse Event|2
2857365|NCT02265705|9819477|P4|Open Label Period|Adverse Event|2
2857366|NCT02265705|9819478|P3|Open Label Period|Adverse Event|0
2857367|NCT02265705|9819479|P2|Open Label Period|Adverse Event|0
2857368|NCT02265705|9819480|P1|Open Label Period|Adverse Event|0
2857369|NCT02265705|9819474|P7|Rescue Period|Lack of Efficacy|0
2857370|NCT02265705|9819475|P6|Rescue Period|Lack of Efficacy|0
2857371|NCT02265705|9819476|P5|Rescue Period|Lack of Efficacy|0
2857372|NCT02265705|9819477|P4|Rescue Period|Lack of Efficacy|0
2857373|NCT02265705|9819478|P3|Rescue Period|Lack of Efficacy|1
2857374|NCT02265705|9819479|P2|Rescue Period|Lack of Efficacy|0
2857375|NCT02265705|9819480|P1|Rescue Period|Lack of Efficacy|0
2857376|NCT02265705|9819474|P7|Rescue Period|Death|0
2857377|NCT02265705|9819475|P6|Rescue Period|Death|0
2857378|NCT02265705|9819476|P5|Rescue Period|Death|0
2857379|NCT02265705|9819477|P4|Rescue Period|Death|0
2857380|NCT02265705|9819478|P3|Rescue Period|Death|1
2857381|NCT02265705|9819479|P2|Rescue Period|Death|0
2857382|NCT02265705|9819480|P1|Rescue Period|Death|0
2857383|NCT02265705|9819474|P7|Rescue Period|Withdrawal by Subject|0
2857384|NCT02265705|9819475|P6|Rescue Period|Withdrawal by Subject|0
2857385|NCT02265705|9819476|P5|Rescue Period|Withdrawal by Subject|0
2857386|NCT02265705|9819477|P4|Rescue Period|Withdrawal by Subject|0
2857387|NCT02265705|9819478|P3|Rescue Period|Withdrawal by Subject|1
2857388|NCT02265705|9819479|P2|Rescue Period|Withdrawal by Subject|0
2857389|NCT02265705|9819480|P1|Rescue Period|Withdrawal by Subject|0
2857390|NCT02265705|9819474|P7|Treatment Period Week 0-24|Lack of Efficacy|0
2857391|NCT02265705|9819475|P6|Treatment Period Week 0-24|Lack of Efficacy|0
2857392|NCT02265705|9819476|P5|Treatment Period Week 0-24|Lack of Efficacy|0
2857393|NCT02265705|9819477|P4|Treatment Period Week 0-24|Lack of Efficacy|0
2857394|NCT02265705|9819478|P3|Treatment Period Week 0-24|Lack of Efficacy|0
2857395|NCT02265705|9819479|P2|Treatment Period Week 0-24|Lack of Efficacy|1
2857396|NCT02265705|9819480|P1|Treatment Period Week 0-24|Lack of Efficacy|0
2857397|NCT02265705|9819474|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
2857398|NCT02265705|9819475|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
2857399|NCT02265705|9819476|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
2857400|NCT02265705|9819477|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
2857401|NCT02265705|9819478|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
2857402|NCT02265705|9819479|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
2857403|NCT02265705|9819480|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
2857404|NCT02265705|9819474|P7|Treatment Period Week 0-24|Physician Decision|0
2857405|NCT02265705|9819475|P6|Treatment Period Week 0-24|Physician Decision|0
2857406|NCT02265705|9819476|P5|Treatment Period Week 0-24|Physician Decision|0
2857407|NCT02265705|9819477|P4|Treatment Period Week 0-24|Physician Decision|0
2857408|NCT02265705|9819478|P3|Treatment Period Week 0-24|Physician Decision|0
2857409|NCT02265705|9819479|P2|Treatment Period Week 0-24|Physician Decision|0
2857410|NCT02265705|9819480|P1|Treatment Period Week 0-24|Physician Decision|1
2857411|NCT02265705|9819474|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
2857412|NCT02265705|9819475|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
2857413|NCT02265705|9819476|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
2857414|NCT02265705|9819477|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
2857415|NCT02265705|9819478|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
2857416|NCT02265705|9819479|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
2857417|NCT02265705|9819480|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
2857418|NCT02265705|9819474|P7|Treatment Period Week 0-24|Adverse Event|0
2857419|NCT02265705|9819475|P6|Treatment Period Week 0-24|Adverse Event|0
2857420|NCT02265705|9819476|P5|Treatment Period Week 0-24|Adverse Event|0
2857421|NCT02265705|9819477|P4|Treatment Period Week 0-24|Adverse Event|0
2857422|NCT02265705|9819478|P3|Treatment Period Week 0-24|Adverse Event|0
2857423|NCT02265705|9819479|P2|Treatment Period Week 0-24|Adverse Event|2
2857424|NCT02265705|9819480|P1|Treatment Period Week 0-24|Adverse Event|3
2857425|NCT02265510|9819519|P14|Overall Study|Study Terminated by Sponsor|2
2857426|NCT02265510|9819520|P13|Overall Study|Study Terminated by Sponsor|1
2857427|NCT02265510|9819521|P12|Overall Study|Study Terminated by Sponsor|4
2857428|NCT02265510|9819522|P11|Overall Study|Study Terminated by Sponsor|1
2857429|NCT02265510|9819523|P10|Overall Study|Study Terminated by Sponsor|2
2857430|NCT02265510|9819524|P9|Overall Study|Study Terminated by Sponsor|1
2857431|NCT02265510|9819525|P8|Overall Study|Study Terminated by Sponsor|1
2857432|NCT02265510|9819526|P7|Overall Study|Study Terminated by Sponsor|1
2857433|NCT02265510|9819527|P6|Overall Study|Study Terminated by Sponsor|1
2857434|NCT02265510|9819528|P5|Overall Study|Study Terminated by Sponsor|0
2857435|NCT02265510|9819529|P4|Overall Study|Study Terminated by Sponsor|0
2857436|NCT02265510|9819530|P3|Overall Study|Study Terminated by Sponsor|0
2857437|NCT02265510|9819531|P2|Overall Study|Study Terminated by Sponsor|0
2857438|NCT02265510|9819532|P1|Overall Study|Study Terminated by Sponsor|0
2857439|NCT02265510|9819519|P14|Overall Study|Other|0
2857440|NCT02265510|9819520|P13|Overall Study|Other|0
2857441|NCT02265510|9819521|P12|Overall Study|Other|0
2857442|NCT02265510|9819522|P11|Overall Study|Other|0
2857443|NCT02265510|9819523|P10|Overall Study|Other|0
2857444|NCT02265510|9819524|P9|Overall Study|Other|0
2857445|NCT02265510|9819525|P8|Overall Study|Other|0
2857446|NCT02265510|9819526|P7|Overall Study|Other|0
2857447|NCT02265510|9819527|P6|Overall Study|Other|0
2857448|NCT02265510|9819528|P5|Overall Study|Other|0
2857449|NCT02265510|9819529|P4|Overall Study|Other|0
2857450|NCT02265510|9819530|P3|Overall Study|Other|0
2857451|NCT02265510|9819531|P2|Overall Study|Other|1
2857452|NCT02265510|9819532|P1|Overall Study|Other|0
2857453|NCT02265510|9819519|P14|Overall Study|Lost to Follow-up|2
2857454|NCT02265510|9819520|P13|Overall Study|Lost to Follow-up|0
2857455|NCT02265510|9819521|P12|Overall Study|Lost to Follow-up|0
2857456|NCT02265510|9819522|P11|Overall Study|Lost to Follow-up|0
2857457|NCT02265510|9819523|P10|Overall Study|Lost to Follow-up|2
2857458|NCT02265510|9819524|P9|Overall Study|Lost to Follow-up|0
2857459|NCT02265510|9819525|P8|Overall Study|Lost to Follow-up|0
2857460|NCT02265510|9819526|P7|Overall Study|Lost to Follow-up|0
2857461|NCT02265510|9819527|P6|Overall Study|Lost to Follow-up|0
2857462|NCT02265510|9819528|P5|Overall Study|Lost to Follow-up|1
2857463|NCT02265510|9819529|P4|Overall Study|Lost to Follow-up|0
2857464|NCT02265510|9819530|P3|Overall Study|Lost to Follow-up|0
2857465|NCT02265510|9819531|P2|Overall Study|Lost to Follow-up|0
2857466|NCT02265510|9819532|P1|Overall Study|Lost to Follow-up|0
2857467|NCT02265510|9819519|P14|Overall Study|Death|6
2857468|NCT02265510|9819520|P13|Overall Study|Death|7
2857469|NCT02265510|9819521|P12|Overall Study|Death|12
2857470|NCT02265510|9819522|P11|Overall Study|Death|4
2857471|NCT02265510|9819523|P10|Overall Study|Death|3
2857472|NCT02265510|9819524|P9|Overall Study|Death|3
2857473|NCT02265510|9819525|P8|Overall Study|Death|1
2857474|NCT02265510|9819526|P7|Overall Study|Death|2
2857475|NCT02265510|9819527|P6|Overall Study|Death|3
2857476|NCT02265510|9819528|P5|Overall Study|Death|1
2857477|NCT02265510|9819529|P4|Overall Study|Death|2
2857478|NCT02265510|9819530|P3|Overall Study|Death|2
2857479|NCT02265510|9819531|P2|Overall Study|Death|0
2857480|NCT02265510|9819532|P1|Overall Study|Death|2
2857481|NCT02265510|9819519|P14|Overall Study|Disease Progression|0
2857482|NCT02265510|9819520|P13|Overall Study|Disease Progression|0
2857483|NCT02265510|9819521|P12|Overall Study|Disease Progression|0
2857484|NCT02265510|9819522|P11|Overall Study|Disease Progression|0
2857485|NCT02265510|9819523|P10|Overall Study|Disease Progression|0
2857486|NCT02265510|9819524|P9|Overall Study|Disease Progression|0
2857487|NCT02265510|9819525|P8|Overall Study|Disease Progression|0
2857488|NCT02265510|9819526|P7|Overall Study|Disease Progression|0
2857489|NCT02265510|9819527|P6|Overall Study|Disease Progression|0
2857490|NCT02265510|9819528|P5|Overall Study|Disease Progression|1
2857491|NCT02265510|9819529|P4|Overall Study|Disease Progression|1
2857492|NCT02265510|9819530|P3|Overall Study|Disease Progression|2
2857493|NCT02265510|9819531|P2|Overall Study|Disease Progression|1
2857494|NCT02265510|9819532|P1|Overall Study|Disease Progression|0
2857495|NCT02265510|9819519|P14|Overall Study|Withdrawal by Subject|0
2857496|NCT02265510|9819520|P13|Overall Study|Withdrawal by Subject|1
2857497|NCT02265510|9819521|P12|Overall Study|Withdrawal by Subject|0
2857498|NCT02265510|9819522|P11|Overall Study|Withdrawal by Subject|0
2857499|NCT02265510|9819523|P10|Overall Study|Withdrawal by Subject|0
2857500|NCT02265510|9819524|P9|Overall Study|Withdrawal by Subject|0
2857501|NCT02265510|9819525|P8|Overall Study|Withdrawal by Subject|2
2857502|NCT02265510|9819526|P7|Overall Study|Withdrawal by Subject|0
2857503|NCT02265510|9819527|P6|Overall Study|Withdrawal by Subject|2
2857504|NCT02265510|9819528|P5|Overall Study|Withdrawal by Subject|0
2857505|NCT02265510|9819529|P4|Overall Study|Withdrawal by Subject|1
2857506|NCT02265510|9819530|P3|Overall Study|Withdrawal by Subject|2
2857507|NCT02265510|9819531|P2|Overall Study|Withdrawal by Subject|1
2857508|NCT02265510|9819532|P1|Overall Study|Withdrawal by Subject|1
2857509|NCT02265237|9819632|P4|As Treated (Overall Study)|Other|1
2857510|NCT02265237|9819633|P3|As Treated (Overall Study)|Other|3
2857511|NCT02265237|9819634|P2|As Treated (Overall Study)|Other|0
2857512|NCT02265237|9819635|P1|As Treated (Overall Study)|Other|2
2857513|NCT02265237|9819632|P4|As Treated (Overall Study)|Lost to Follow-up|0
2857514|NCT02265237|9819633|P3|As Treated (Overall Study)|Lost to Follow-up|6
2857515|NCT02265237|9819634|P2|As Treated (Overall Study)|Lost to Follow-up|2
2857516|NCT02265237|9819635|P1|As Treated (Overall Study)|Lost to Follow-up|1
2857517|NCT02265237|9819632|P4|As Treated (Overall Study)|Withdrawal by Subject|0
2857518|NCT02265237|9819633|P3|As Treated (Overall Study)|Withdrawal by Subject|1
2857519|NCT02265237|9819634|P2|As Treated (Overall Study)|Withdrawal by Subject|0
2857520|NCT02265237|9819635|P1|As Treated (Overall Study)|Withdrawal by Subject|1
2857521|NCT02265237|9819632|P4|As Treated (Overall Study)|Adverse Event|0
2857522|NCT02265237|9819633|P3|As Treated (Overall Study)|Adverse Event|0
2857523|NCT02265237|9819634|P2|As Treated (Overall Study)|Adverse Event|1
2857524|NCT02265237|9819635|P1|As Treated (Overall Study)|Adverse Event|1
2857525|NCT02264821|9819665|P3|Overall Study|Protocol Violation|6
2857526|NCT02264821|9819666|P2|Overall Study|Protocol Violation|3
2857527|NCT02264821|9819667|P1|Overall Study|Protocol Violation|1
2857528|NCT02264574|9819680|P2|Overall Study|various other reasons|3
2857529|NCT02264574|9819681|P1|Overall Study|various other reasons|0
2857530|NCT02264574|9819680|P2|Overall Study|Withdrawal by Subject|5
2857531|NCT02264574|9819681|P1|Overall Study|Withdrawal by Subject|6
2857532|NCT02263547|9819751|P1|Overall Study|Lost to Follow-up|2
2857533|NCT02263547|9819751|P1|Overall Study|Adverse Event|1
2857534|NCT02263365|9819758|P2|Overall Study|Physician Decision|18
2857535|NCT02263365|9819759|P1|Overall Study|Physician Decision|22
2857536|NCT02263326|9819773|P2|Overall Study|Lost to Follow-up|1
2857537|NCT02263326|9819774|P1|Overall Study|Lost to Follow-up|1
2857538|NCT02262754|9819868|P3|Overall Study|Other|2
2857539|NCT02262754|9819869|P2|Overall Study|Other|0
2857540|NCT02262754|9819870|P1|Overall Study|Other|4
2857541|NCT02262754|9819868|P3|Overall Study|Withdrawal by Subject|1
2857542|NCT02262754|9819869|P2|Overall Study|Withdrawal by Subject|0
2857543|NCT02262754|9819870|P1|Overall Study|Withdrawal by Subject|1
2857544|NCT02262754|9819868|P3|Overall Study|Protocol Violation|0
2857545|NCT02262754|9819869|P2|Overall Study|Protocol Violation|0
2857546|NCT02262754|9819870|P1|Overall Study|Protocol Violation|1
2857547|NCT02262754|9819868|P3|Overall Study|Study terminated by sponsor|4
2857548|NCT02262754|9819869|P2|Overall Study|Study terminated by sponsor|4
2857549|NCT02262754|9819870|P1|Overall Study|Study terminated by sponsor|5
2857550|NCT02262754|9819868|P3|Overall Study|No longer meets eligibility criteria|0
2857551|NCT02262754|9819869|P2|Overall Study|No longer meets eligibility criteria|1
2857552|NCT02262754|9819870|P1|Overall Study|No longer meets eligibility criteria|0
2857553|NCT02262754|9819868|P3|Overall Study|Lost to Follow-up|1
2857554|NCT02262754|9819869|P2|Overall Study|Lost to Follow-up|0
2857555|NCT02262754|9819870|P1|Overall Study|Lost to Follow-up|0
2857556|NCT02262754|9819868|P3|Overall Study|Lack of Efficacy|1
2857557|NCT02262754|9819869|P2|Overall Study|Lack of Efficacy|0
2857558|NCT02262754|9819870|P1|Overall Study|Lack of Efficacy|2
2857559|NCT02262754|9819868|P3|Overall Study|Adverse Event|0
2857560|NCT02262754|9819869|P2|Overall Study|Adverse Event|4
2857561|NCT02262754|9819870|P1|Overall Study|Adverse Event|3
2857562|NCT02262728|9819945|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
2857563|NCT02262728|9819946|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
2857564|NCT02262728|9819945|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
2857565|NCT02262728|9819946|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
2857566|NCT02262728|9819945|P2|Follow-up Phase (3 Years)|Death|1
2857567|NCT02262728|9819946|P1|Follow-up Phase (3 Years)|Death|0
2857568|NCT02262377|9819978|P2|Overall Study|Withdrawal by Subject|0
2857569|NCT02262377|9819979|P1|Overall Study|Withdrawal by Subject|4
2857570|NCT02262377|9819978|P2|Overall Study|Found ineligible after enrollment|0
2857571|NCT02262377|9819979|P1|Overall Study|Found ineligible after enrollment|3
2857572|NCT02262377|9819978|P2|Overall Study|Lost to Follow-up|6
2857573|NCT02262377|9819979|P1|Overall Study|Lost to Follow-up|5
2857574|NCT02262364|9819994|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
2857575|NCT02262260|9820003|P2|Overall Study|Protocol deviation|5
2857576|NCT02262260|9820004|P1|Overall Study|Protocol deviation|2
2857577|NCT02262260|9820003|P2|Overall Study|Lost to Follow-up|2
2857578|NCT02262260|9820004|P1|Overall Study|Lost to Follow-up|1
2857579|NCT02262260|9820003|P2|Overall Study|Withdrawal of consent|2
2857580|NCT02262260|9820004|P1|Overall Study|Withdrawal of consent|4
2857581|NCT02262260|9820003|P2|Overall Study|Adverse Event|1
2857582|NCT02262260|9820004|P1|Overall Study|Adverse Event|4
2857583|NCT02261974|9820062|P2|Overall Study|Adverse Event|0
2857584|NCT02261974|9820063|P1|Overall Study|Adverse Event|1
2857585|NCT02261974|9820062|P2|Overall Study|Lost to Follow-up|0
2857586|NCT02261974|9820063|P1|Overall Study|Lost to Follow-up|2
2857587|NCT02261974|9820062|P2|Overall Study|Received partial treatment; FU to 1 mo|1
2857588|NCT02261974|9820063|P1|Overall Study|Received partial treatment; FU to 1 mo|3
2857589|NCT02261974|9820062|P2|Overall Study|Missed treatment cut-off date|3
2857590|NCT02261974|9820063|P1|Overall Study|Missed treatment cut-off date|6
2857591|NCT02261974|9820062|P2|Overall Study|Pregnancy|1
2857592|NCT02261974|9820063|P1|Overall Study|Pregnancy|0
2857593|NCT02261974|9820062|P2|Overall Study|Withdrawal by Subject|2
2857594|NCT02261974|9820063|P1|Overall Study|Withdrawal by Subject|3
2857595|NCT02261493|9820127|P3|Overall Study|Adverse Event|0
2857596|NCT02261493|9820128|P2|Overall Study|Adverse Event|1
2857597|NCT02261493|9820129|P1|Overall Study|Adverse Event|0
2857598|NCT02261493|9820127|P3|Overall Study|Lack of Efficacy|0
2857599|NCT02261493|9820128|P2|Overall Study|Lack of Efficacy|1
2857600|NCT02261493|9820129|P1|Overall Study|Lack of Efficacy|0
2857601|NCT02261493|9820127|P3|Overall Study|Pregnancy|0
2857602|NCT02261493|9820128|P2|Overall Study|Pregnancy|2
2857603|NCT02261493|9820129|P1|Overall Study|Pregnancy|1
2857604|NCT02261493|9820127|P3|Overall Study|Lost to Follow-up|8
2857605|NCT02261493|9820128|P2|Overall Study|Lost to Follow-up|27
2857606|NCT02261493|9820129|P1|Overall Study|Lost to Follow-up|14
2857607|NCT02261493|9820127|P3|Overall Study|Personal Reasons|16
2857608|NCT02261493|9820128|P2|Overall Study|Personal Reasons|14
2857609|NCT02261493|9820129|P1|Overall Study|Personal Reasons|14
2857610|NCT02261493|9820127|P3|Overall Study|Protocol Violation|0
2857611|NCT02261493|9820128|P2|Overall Study|Protocol Violation|0
2857612|NCT02261493|9820129|P1|Overall Study|Protocol Violation|1
2857613|NCT02261493|9820127|P3|Overall Study|Undisclosed alcohol abuse|0
2857614|NCT02261493|9820128|P2|Overall Study|Undisclosed alcohol abuse|1
2857615|NCT02261493|9820129|P1|Overall Study|Undisclosed alcohol abuse|0
2857616|NCT02261493|9820127|P3|Overall Study|Physician Decision|0
2857617|NCT02261493|9820128|P2|Overall Study|Physician Decision|1
2857618|NCT02261493|9820129|P1|Overall Study|Physician Decision|0
2857619|NCT02261493|9820127|P3|Overall Study|Noncompliance|2
2857620|NCT02261493|9820128|P2|Overall Study|Noncompliance|0
2857621|NCT02261493|9820129|P1|Overall Study|Noncompliance|0
2857622|NCT02261467|9820157|P2|Overall Study|Adverse Event|1
2857623|NCT02261467|9820158|P1|Overall Study|Adverse Event|1
2857624|NCT02261467|9820157|P2|Overall Study|Lost to Follow-up|13
2857625|NCT02261467|9820158|P1|Overall Study|Lost to Follow-up|2
2857626|NCT02261467|9820157|P2|Overall Study|Personal Reasons|22
2857627|NCT02261467|9820158|P1|Overall Study|Personal Reasons|17
2857628|NCT02261467|9820157|P2|Overall Study|Protocol Violation|1
2857629|NCT02261467|9820158|P1|Overall Study|Protocol Violation|0
2857630|NCT02261467|9820157|P2|Overall Study|Enrolled in Error|0
2857631|NCT02261467|9820158|P1|Overall Study|Enrolled in Error|1
2857632|NCT02260986|9820200|P3|Overall Study|Pregnancy|0
2857633|NCT02260986|9820201|P2|Overall Study|Pregnancy|0
2857634|NCT02260986|9820202|P1|Overall Study|Pregnancy|2
2857635|NCT02260986|9820200|P3|Overall Study|Lost to Follow-up|3
2857636|NCT02260986|9820201|P2|Overall Study|Lost to Follow-up|0
2857637|NCT02260986|9820202|P1|Overall Study|Lost to Follow-up|4
2857638|NCT02260986|9820200|P3|Overall Study|Lack of investigation product supply|1
2857639|NCT02260986|9820201|P2|Overall Study|Lack of investigation product supply|0
2857640|NCT02260986|9820202|P1|Overall Study|Lack of investigation product supply|2
2857641|NCT02260986|9820200|P3|Overall Study|Incorrect randomization|0
2857642|NCT02260986|9820201|P2|Overall Study|Incorrect randomization|1
2857643|NCT02260986|9820202|P1|Overall Study|Incorrect randomization|0
2857644|NCT02260986|9820200|P3|Overall Study|Withdrawal by Subject|9
2857645|NCT02260986|9820201|P2|Overall Study|Withdrawal by Subject|4
2857646|NCT02260986|9820202|P1|Overall Study|Withdrawal by Subject|17
2857647|NCT02260986|9820200|P3|Overall Study|Car accident|1
2857648|NCT02260986|9820201|P2|Overall Study|Car accident|0
2857649|NCT02260986|9820202|P1|Overall Study|Car accident|0
2857650|NCT02260986|9820200|P3|Overall Study|Protocol Violation|16
2857651|NCT02260986|9820201|P2|Overall Study|Protocol Violation|5
2857652|NCT02260986|9820202|P1|Overall Study|Protocol Violation|14
2857653|NCT02260986|9820200|P3|Overall Study|Lack of Efficacy|0
2857654|NCT02260986|9820201|P2|Overall Study|Lack of Efficacy|3
2857655|NCT02260986|9820202|P1|Overall Study|Lack of Efficacy|27
2857656|NCT02260986|9820200|P3|Overall Study|Adverse Event|11
2857657|NCT02260986|9820201|P2|Overall Study|Adverse Event|0
2857658|NCT02260986|9820202|P1|Overall Study|Adverse Event|24
2857659|NCT02260934|9820320|P2|Overall Study|Site error|1
2857660|NCT02260934|9820321|P1|Overall Study|Site error|0
2857661|NCT02260934|9820320|P2|Overall Study|Participant Relocated|0
2857662|NCT02260934|9820321|P1|Overall Study|Participant Relocated|1
2857663|NCT02260934|9820320|P2|Overall Study|Withdrawal by Subject|2
2857664|NCT02260934|9820321|P1|Overall Study|Withdrawal by Subject|0
2857665|NCT02260934|9820320|P2|Overall Study|Lost to Follow-up|1
2857666|NCT02260934|9820321|P1|Overall Study|Lost to Follow-up|2
2857667|NCT02260882|9820359|P2|Overall Study|Protocol Violation|1
2857668|NCT02260882|9820360|P1|Overall Study|Protocol Violation|0
2857669|NCT02260817|9820384|P2|Overall Study|Protocol Violation|14
2857670|NCT02260817|9820385|P1|Overall Study|Protocol Violation|0
2857671|NCT02260817|9820384|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
2857672|NCT02260817|9820385|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
2857673|NCT02260817|9820384|P2|Overall Study|Observation, no biopsy|1
2857674|NCT02260817|9820385|P1|Overall Study|Observation, no biopsy|0
2857675|NCT02260817|9820384|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
2857676|NCT02260817|9820385|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
2857677|NCT02260817|9820384|P2|Overall Study|Lost to Follow-up|14
2857678|NCT02260817|9820385|P1|Overall Study|Lost to Follow-up|0
2857679|NCT02260791|9820433|P2|Overall Study|Protocol deviation|3
2857680|NCT02260791|9820434|P1|Overall Study|Protocol deviation|2
2857681|NCT02260791|9820433|P2|Overall Study|Screen failure|1
2857682|NCT02260791|9820434|P1|Overall Study|Screen failure|0
2857683|NCT02260791|9820433|P2|Overall Study|Withdrawal by Subject|16
2857684|NCT02260791|9820434|P1|Overall Study|Withdrawal by Subject|11
2857685|NCT02260791|9820433|P2|Overall Study|Death|0
2857686|NCT02260791|9820434|P1|Overall Study|Death|1
2857687|NCT02260791|9820433|P2|Overall Study|Adverse Event|9
2857688|NCT02260791|9820434|P1|Overall Study|Adverse Event|13
2857689|NCT02260791|9820433|P2|Overall Study|Lack of Efficacy|1
2857690|NCT02260791|9820434|P1|Overall Study|Lack of Efficacy|2
2857691|NCT02260791|9820433|P2|Overall Study|Lost to Follow-up|4
2857692|NCT02260791|9820434|P1|Overall Study|Lost to Follow-up|4
2857693|NCT02260648|9820473|P3|Overall Study|Discontinue Due to Study Termination|7
2857694|NCT02260648|9820474|P2|Overall Study|Discontinue Due to Study Termination|12
2857695|NCT02260648|9820475|P1|Overall Study|Discontinue Due to Study Termination|13
2857696|NCT02260648|9820473|P3|Overall Study|Protocol Violation|0
2857697|NCT02260648|9820474|P2|Overall Study|Protocol Violation|0
2857698|NCT02260648|9820475|P1|Overall Study|Protocol Violation|1
2857699|NCT02260648|9820473|P3|Overall Study|Withdrawal by Subject|0
2857700|NCT02260648|9820474|P2|Overall Study|Withdrawal by Subject|1
2857701|NCT02260648|9820475|P1|Overall Study|Withdrawal by Subject|1
2857702|NCT02260648|9820473|P3|Overall Study|Adverse Event|1
2857703|NCT02260648|9820474|P2|Overall Study|Adverse Event|0
2857704|NCT02260648|9820475|P1|Overall Study|Adverse Event|3
2857705|NCT02260635|9820503|P2|Open-Label Extension|Withdrawal by Subject|0
2857706|NCT02260635|9820504|P1|Open-Label Extension|Withdrawal by Subject|1
2857707|NCT02260635|9820503|P2|Open-Label Extension|Study Termination|25
2857708|NCT02260635|9820504|P1|Open-Label Extension|Study Termination|25
2857709|NCT02260635|9820503|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
2857710|NCT02260635|9820504|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
2857711|NCT02260492|9820556|P3|Overall Study|Withdrawal by Subject|2
2857712|NCT02260492|9820557|P2|Overall Study|Withdrawal by Subject|2
2857713|NCT02260492|9820558|P1|Overall Study|Withdrawal by Subject|3
2857714|NCT02260492|9820556|P3|Overall Study|Physician Decision|1
2857715|NCT02260492|9820557|P2|Overall Study|Physician Decision|0
2857716|NCT02260492|9820558|P1|Overall Study|Physician Decision|2
2857717|NCT02260492|9820556|P3|Overall Study|Lost to Follow-up|0
2857718|NCT02260492|9820557|P2|Overall Study|Lost to Follow-up|9
2857719|NCT02260492|9820558|P1|Overall Study|Lost to Follow-up|12
2857720|NCT02260492|9820556|P3|Overall Study|Death|0
2857721|NCT02260492|9820557|P2|Overall Study|Death|1
2857722|NCT02260492|9820558|P1|Overall Study|Death|0
2857723|NCT02260492|9820556|P3|Overall Study|Adverse Event|2
2857724|NCT02260492|9820557|P2|Overall Study|Adverse Event|1
2857725|NCT02260492|9820558|P1|Overall Study|Adverse Event|6
2857726|NCT02260388|9820591|P4|Overall Study|Lost to Follow-up|4
2857727|NCT02260388|9820592|P3|Overall Study|Lost to Follow-up|3
2857728|NCT02260388|9820593|P2|Overall Study|Lost to Follow-up|8
2857729|NCT02260388|9820594|P1|Overall Study|Lost to Follow-up|2
2857730|NCT02260180|9820623|P3|Overall Study|Adverse Event|1
2857731|NCT02260180|9820624|P2|Overall Study|Adverse Event|0
2857732|NCT02260180|9820625|P1|Overall Study|Adverse Event|2
2857733|NCT02260154|9820636|P1|Overall Study|Screening failure|2
2857734|NCT02259582|9820676|P3|Overall Study|Lack of Subject Adherence to Protocol|1
2857735|NCT02259582|9820677|P2|Overall Study|Lack of Subject Adherence to Protocol|1
2857736|NCT02259582|9820678|P1|Overall Study|Lack of Subject Adherence to Protocol|1
2857737|NCT02259582|9820676|P3|Overall Study|Disease progression|17
2857738|NCT02259582|9820677|P2|Overall Study|Disease progression|15
2857739|NCT02259582|9820678|P1|Overall Study|Disease progression|14
2857740|NCT02259582|9820676|P3|Overall Study|Withdrawal by Subject|1
2857741|NCT02259582|9820677|P2|Overall Study|Withdrawal by Subject|0
2857742|NCT02259582|9820678|P1|Overall Study|Withdrawal by Subject|0
2857743|NCT02259582|9820676|P3|Overall Study|Adverse Event|1
2857744|NCT02259582|9820677|P2|Overall Study|Adverse Event|0
2857745|NCT02259582|9820678|P1|Overall Study|Adverse Event|1
2857746|NCT02259582|9820676|P3|Overall Study|Death|1
2857747|NCT02259582|9820677|P2|Overall Study|Death|0
2857748|NCT02259582|9820678|P1|Overall Study|Death|0
2857749|NCT02259582|9820676|P3|Overall Study|Physician Decision|0
2857750|NCT02259582|9820677|P2|Overall Study|Physician Decision|1
2857751|NCT02259582|9820678|P1|Overall Study|Physician Decision|0
2857752|NCT02259400|9820688|P2|Overall Study|Death|2
2857753|NCT02259400|9820689|P1|Overall Study|Death|0
2857754|NCT02259348|9820721|P1|Overall Study|Death|4
2857755|NCT02259348|9820721|P1|Overall Study|Donors|6
2857756|NCT02259114|9820738|P5|Overall Study|Not Treated|0
2857757|NCT02259114|9820739|P4|Overall Study|Not Treated|0
2857758|NCT02259114|9820740|P3|Overall Study|Not Treated|0
2857759|NCT02259114|9820741|P2|Overall Study|Not Treated|0
2857760|NCT02259114|9820742|P1|Overall Study|Not Treated|1
2857761|NCT02259114|9820738|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
2857762|NCT02259114|9820739|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
2857763|NCT02259114|9820740|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
2857764|NCT02259114|9820741|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
2857765|NCT02259114|9820742|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
2857766|NCT02259114|9820738|P5|Overall Study|Withdrawal by Subject|0
2857767|NCT02259114|9820739|P4|Overall Study|Withdrawal by Subject|1
2857768|NCT02259114|9820740|P3|Overall Study|Withdrawal by Subject|1
2857769|NCT02259114|9820741|P2|Overall Study|Withdrawal by Subject|0
2857770|NCT02259114|9820742|P1|Overall Study|Withdrawal by Subject|0
2857771|NCT02259114|9820738|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2857772|NCT02259114|9820739|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2857773|NCT02259114|9820740|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
2857774|NCT02259114|9820741|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2857775|NCT02259114|9820742|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2857776|NCT02259114|9820738|P5|Overall Study|Death|0
2857777|NCT02259114|9820739|P4|Overall Study|Death|0
2857778|NCT02259114|9820740|P3|Overall Study|Death|1
2857779|NCT02259114|9820741|P2|Overall Study|Death|0
2857780|NCT02259114|9820742|P1|Overall Study|Death|3
2857781|NCT02259114|9820738|P5|Overall Study|Adverse Event|1
2857782|NCT02259114|9820739|P4|Overall Study|Adverse Event|0
2857783|NCT02259114|9820740|P3|Overall Study|Adverse Event|0
2857784|NCT02259114|9820741|P2|Overall Study|Adverse Event|1
2857785|NCT02259114|9820742|P1|Overall Study|Adverse Event|2
2857786|NCT02259114|9820738|P5|Overall Study|Progressive Disease|5
2857787|NCT02259114|9820739|P4|Overall Study|Progressive Disease|2
2857788|NCT02259114|9820740|P3|Overall Study|Progressive Disease|10
2857789|NCT02259114|9820741|P2|Overall Study|Progressive Disease|2
2857790|NCT02259114|9820742|P1|Overall Study|Progressive Disease|14
2857791|NCT02259088|9820801|P2|Overall Study|Subject/guardian decision|8
2857792|NCT02259088|9820802|P1|Overall Study|Subject/guardian decision|8
2857793|NCT02259088|9820801|P2|Overall Study|Protocol deviation|0
2857794|NCT02259088|9820802|P1|Overall Study|Protocol deviation|5
2857795|NCT02259088|9820801|P2|Overall Study|Physician Decision|2
2857796|NCT02259088|9820802|P1|Overall Study|Physician Decision|5
2857797|NCT02259088|9820801|P2|Overall Study|Death|0
2857798|NCT02259088|9820802|P1|Overall Study|Death|2
2857799|NCT02259088|9820801|P2|Overall Study|Lost to Follow-up|0
2857800|NCT02259088|9820802|P1|Overall Study|Lost to Follow-up|2
2857801|NCT02259088|9820801|P2|Overall Study|Adverse Event|4
2857802|NCT02259088|9820802|P1|Overall Study|Adverse Event|6
2857803|NCT02259010|9820847|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
2857804|NCT02258542|9820876|P4|Overall Study|Eligibility criteria not fulfilled|0
2857805|NCT02258542|9820877|P3|Overall Study|Eligibility criteria not fulfilled|0
2857806|NCT02258542|9820878|P2|Overall Study|Eligibility criteria not fulfilled|2
2857807|NCT02258542|9820879|P1|Overall Study|Eligibility criteria not fulfilled|0
2857808|NCT02258542|9820876|P4|Overall Study|Protocol Violation|0
2857809|NCT02258542|9820877|P3|Overall Study|Protocol Violation|0
2857810|NCT02258542|9820878|P2|Overall Study|Protocol Violation|2
2857811|NCT02258542|9820879|P1|Overall Study|Protocol Violation|1
2857812|NCT02258542|9820876|P4|Overall Study|Adverse Event|0
2857813|NCT02258542|9820877|P3|Overall Study|Adverse Event|0
2857814|NCT02258542|9820878|P2|Overall Study|Adverse Event|4
2857815|NCT02258542|9820879|P1|Overall Study|Adverse Event|3
2857816|NCT02258542|9820876|P4|Overall Study|Death|1
2857817|NCT02258542|9820877|P3|Overall Study|Death|0
2857818|NCT02258542|9820878|P2|Overall Study|Death|4
2857819|NCT02258542|9820879|P1|Overall Study|Death|5
2857820|NCT02258542|9820876|P4|Overall Study|Lost to Follow-up|2
2857821|NCT02258542|9820877|P3|Overall Study|Lost to Follow-up|1
2857822|NCT02258542|9820878|P2|Overall Study|Lost to Follow-up|12
2857823|NCT02258542|9820879|P1|Overall Study|Lost to Follow-up|5
2857824|NCT02258542|9820876|P4|Overall Study|Withdrawal by Subject|1
2857825|NCT02258542|9820877|P3|Overall Study|Withdrawal by Subject|7
2857826|NCT02258542|9820878|P2|Overall Study|Withdrawal by Subject|20
2857827|NCT02258542|9820879|P1|Overall Study|Withdrawal by Subject|20
2857828|NCT02258542|9820876|P4|Overall Study|study specific discount. criteria|0
2857829|NCT02258542|9820877|P3|Overall Study|study specific discount. criteria|0
2857830|NCT02258542|9820878|P2|Overall Study|study specific discount. criteria|1
2857831|NCT02258542|9820879|P1|Overall Study|study specific discount. criteria|1
2857832|NCT02258542|9820876|P4|Overall Study|eg. not made to the visit|1
2857833|NCT02258542|9820877|P3|Overall Study|eg. not made to the visit|0
2857834|NCT02258542|9820878|P2|Overall Study|eg. not made to the visit|4
2857835|NCT02258542|9820879|P1|Overall Study|eg. not made to the visit|7
2857836|NCT02258529|9821103|P1|Overall Study|Adverse Event|1
2857837|NCT02258529|9821103|P1|Overall Study|Study Terminated by Sponsor|9
2857838|NCT02258334|9821192|P4|Overall Study|Adverse Event|0
2857839|NCT02258334|9821193|P3|Overall Study|Adverse Event|0
2857840|NCT02258334|9821194|P2|Overall Study|Adverse Event|0
2857841|NCT02258334|9821195|P1|Overall Study|Adverse Event|1
2857842|NCT02257918|9821269|P3|Overall Study|Pregnancy|1
2857843|NCT02257918|9821270|P2|Overall Study|Pregnancy|0
2857844|NCT02257918|9821271|P1|Overall Study|Pregnancy|0
2857845|NCT02257918|9821269|P3|Overall Study|Withdrawal by Subject|1
2857846|NCT02257918|9821270|P2|Overall Study|Withdrawal by Subject|0
2857847|NCT02257918|9821271|P1|Overall Study|Withdrawal by Subject|0
2857848|NCT02257918|9821269|P3|Overall Study|Lost to Follow-up|0
2857849|NCT02257918|9821270|P2|Overall Study|Lost to Follow-up|1
2857850|NCT02257918|9821271|P1|Overall Study|Lost to Follow-up|4
2857851|NCT02257684|9821321|P1|Overall Study|Sponsor's Decision|1
2857852|NCT02257684|9821321|P1|Overall Study|Lack of Efficacy|1
2857853|NCT02257684|9821321|P1|Overall Study|Adverse Event|2
2857854|NCT02257632|9821331|P2|Overall Study|Adverse Event|2
2857855|NCT02257632|9821332|P1|Overall Study|Adverse Event|1
2857856|NCT02257632|9821331|P2|Overall Study|Withdrawal by Subject|1
2857857|NCT02257632|9821332|P1|Overall Study|Withdrawal by Subject|0
2857858|NCT02257489|9821381|P9|Overall Study|Withdrawal by Subject|0
2857859|NCT02257489|9821382|P8|Overall Study|Withdrawal by Subject|0
2857860|NCT02257489|9821383|P7|Overall Study|Withdrawal by Subject|0
2857861|NCT02257489|9821384|P6|Overall Study|Withdrawal by Subject|0
2857862|NCT02257489|9821385|P5|Overall Study|Withdrawal by Subject|0
2857863|NCT02257489|9821386|P4|Overall Study|Withdrawal by Subject|1
2857864|NCT02257489|9821387|P3|Overall Study|Withdrawal by Subject|0
2857865|NCT02257489|9821388|P2|Overall Study|Withdrawal by Subject|0
2857866|NCT02257489|9821389|P1|Overall Study|Withdrawal by Subject|0
2857867|NCT02257385|9821425|P2|Overall Study|Withdrawal by Subject|4
2857868|NCT02257385|9821426|P1|Overall Study|Withdrawal by Subject|4
2857869|NCT02257385|9821425|P2|Overall Study|Lost to Follow-up|1
2857870|NCT02257385|9821426|P1|Overall Study|Lost to Follow-up|0
2857871|NCT02257385|9821425|P2|Overall Study|Protocol Violation|7
2857872|NCT02257385|9821426|P1|Overall Study|Protocol Violation|5
2857873|NCT02257385|9821425|P2|Overall Study|Lack of Efficacy|2
2857874|NCT02257385|9821426|P1|Overall Study|Lack of Efficacy|1
2857875|NCT02257385|9821425|P2|Overall Study|Adverse Event|8
2857876|NCT02257385|9821426|P1|Overall Study|Adverse Event|12
2857877|NCT02257372|9821436|P2|Overall Study|Withdrew consent|0
2857878|NCT02257372|9821437|P1|Overall Study|Withdrew consent|1
2857879|NCT02257372|9821436|P2|Overall Study|Lost to Follow-up|1
2857880|NCT02257372|9821437|P1|Overall Study|Lost to Follow-up|0
2857881|NCT02257372|9821436|P2|Overall Study|Protocol Violation|1
2857882|NCT02257372|9821437|P1|Overall Study|Protocol Violation|1
2857883|NCT02257372|9821436|P2|Overall Study|Lack of Efficacy|1
2857884|NCT02257372|9821437|P1|Overall Study|Lack of Efficacy|2
2857885|NCT02257372|9821436|P2|Overall Study|Adverse Event|7
2857886|NCT02257372|9821437|P1|Overall Study|Adverse Event|3
2857887|NCT02256982|9821454|P2|Overall Study|Disease Progression|1
2857888|NCT02256982|9821455|P1|Overall Study|Disease Progression|0
2857889|NCT02256969|9821464|P3|Overall Study|Screenfailed or withdrew|1
2857890|NCT02256969|9821465|P2|Overall Study|Screenfailed or withdrew|1
2857891|NCT02256969|9821466|P1|Overall Study|Screenfailed or withdrew|2
2857892|NCT02256917|9821483|P1|Prophylactic Treatment Phase II|Discontinued medication|1
2857893|NCT02256917|9821483|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
2857894|NCT02256917|9821483|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
2857895|NCT02256917|9821483|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
2857896|NCT02256917|9821483|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
2857897|NCT02256891|9821504|P2|Overall Study|Equipment Malfunction|1
2857898|NCT02256891|9821505|P1|Overall Study|Equipment Malfunction|0
2857899|NCT02256891|9821504|P2|Overall Study|Screen Fail|4
2857900|NCT02256891|9821505|P1|Overall Study|Screen Fail|5
2857901|NCT02256891|9821504|P2|Overall Study|Physician Decision|3
2857902|NCT02256891|9821505|P1|Overall Study|Physician Decision|7
2857903|NCT02256891|9821504|P2|Overall Study|Lost to Follow-up|3
2857904|NCT02256891|9821505|P1|Overall Study|Lost to Follow-up|0
2857905|NCT02256891|9821504|P2|Overall Study|Death|2
2857906|NCT02256891|9821505|P1|Overall Study|Death|0
2857907|NCT02256839|9821531|P2|Overall Study|Did not meet Eligibility Criteria|3
2857908|NCT02256839|9821532|P1|Overall Study|Did not meet Eligibility Criteria|2
2857909|NCT02256553|9821538|P1|Period III|Adverse Event|3
2857910|NCT02256553|9821538|P1|Period II|Subject Moved|1
2857911|NCT02256553|9821538|P1|Period II|Adverse Event|1
2857912|NCT02256553|9821538|P1|Period I|Protocol Violation|1
2857913|NCT02256553|9821538|P1|Period I|Adverse Event|5
2857914|NCT02256540|9821547|P3|Overall Study|Back pain preventing exercise|1
2857915|NCT02256540|9821548|P2|Overall Study|Back pain preventing exercise|0
2857916|NCT02256540|9821549|P1|Overall Study|Back pain preventing exercise|0
2857917|NCT02256540|9821547|P3|Overall Study|Withdrawal by Subject|1
2857918|NCT02256540|9821548|P2|Overall Study|Withdrawal by Subject|1
2857919|NCT02256540|9821549|P1|Overall Study|Withdrawal by Subject|0
2857920|NCT02256488|9821567|P4|Overall Study|Withdrawal by Subject|2
2857921|NCT02256488|9821568|P3|Overall Study|Withdrawal by Subject|0
2857922|NCT02256488|9821569|P2|Overall Study|Withdrawal by Subject|0
2857923|NCT02256488|9821570|P1|Overall Study|Withdrawal by Subject|1
2857924|NCT02256488|9821567|P4|Overall Study|OTHER|1
2857925|NCT02256488|9821568|P3|Overall Study|OTHER|1
2857926|NCT02256488|9821569|P2|Overall Study|OTHER|0
2857927|NCT02256488|9821570|P1|Overall Study|OTHER|1
2857928|NCT02256488|9821567|P4|Overall Study|Lost to Follow-up|3
2857929|NCT02256488|9821568|P3|Overall Study|Lost to Follow-up|9
2857930|NCT02256488|9821569|P2|Overall Study|Lost to Follow-up|6
2857931|NCT02256488|9821570|P1|Overall Study|Lost to Follow-up|6
2857932|NCT02256436|9821586|P2|Overall Study|Ongoing in Study|67
2857933|NCT02256436|9821587|P1|Overall Study|Ongoing in Study|108
2857934|NCT02256436|9821586|P2|Overall Study|Withdrawal by Subject|30
2857935|NCT02256436|9821587|P1|Overall Study|Withdrawal by Subject|7
2857936|NCT02256436|9821586|P2|Overall Study|Protocol Violation|0
2857937|NCT02256436|9821587|P1|Overall Study|Protocol Violation|1
2857938|NCT02256436|9821586|P2|Overall Study|Physician Decision|3
2857939|NCT02256436|9821587|P1|Overall Study|Physician Decision|1
2857940|NCT02256436|9821586|P2|Overall Study|Lost to Follow-up|1
2857941|NCT02256436|9821587|P1|Overall Study|Lost to Follow-up|1
2857942|NCT02256436|9821586|P2|Overall Study|Death|158
2857943|NCT02256436|9821587|P1|Overall Study|Death|137
2857944|NCT02256436|9821586|P2|Overall Study|Adverse Event|13
2857945|NCT02256436|9821587|P1|Overall Study|Adverse Event|15
2857946|NCT02256267|9821647|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
2857947|NCT02256267|9821647|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
2857948|NCT02255981|9821720|P1|Overall Study|Withdrawal by Subject|1
2857949|NCT02255981|9821720|P1|Overall Study|Lost to Follow-up|3
2857950|NCT02255760|9821735|P5|Overall Study|Lost to Follow-up|0
2857951|NCT02255760|9821736|P4|Overall Study|Lost to Follow-up|0
2857952|NCT02255760|9821737|P3|Overall Study|Lost to Follow-up|0
2857953|NCT02255760|9821738|P2|Overall Study|Lost to Follow-up|1
2857954|NCT02255760|9821739|P1|Overall Study|Lost to Follow-up|0
2857955|NCT02255565|9821794|P3|Overall Study|Withdrawal by Subject|0
2857956|NCT02255565|9821795|P2|Overall Study|Withdrawal by Subject|1
2857957|NCT02255565|9821796|P1|Overall Study|Withdrawal by Subject|0
2857958|NCT02255461|9821860|P5|Overall Study|Not meet dose reduction BSA requirement|0
2857959|NCT02255461|9821861|P4|Overall Study|Not meet dose reduction BSA requirement|0
2857960|NCT02255461|9821862|P3|Overall Study|Not meet dose reduction BSA requirement|0
2857961|NCT02255461|9821863|P2|Overall Study|Not meet dose reduction BSA requirement|1
2857962|NCT02255461|9821864|P1|Overall Study|Not meet dose reduction BSA requirement|0
2857963|NCT02255461|9821860|P5|Overall Study|Withdrawal by Subject|1
2857964|NCT02255461|9821861|P4|Overall Study|Withdrawal by Subject|0
2857965|NCT02255461|9821862|P3|Overall Study|Withdrawal by Subject|1
2857966|NCT02255461|9821863|P2|Overall Study|Withdrawal by Subject|0
2857967|NCT02255461|9821864|P1|Overall Study|Withdrawal by Subject|0
2857968|NCT02255461|9821860|P5|Overall Study|Adverse Event|1
2857969|NCT02255461|9821861|P4|Overall Study|Adverse Event|0
2857970|NCT02255461|9821862|P3|Overall Study|Adverse Event|0
2857971|NCT02255461|9821863|P2|Overall Study|Adverse Event|1
2857972|NCT02255461|9821864|P1|Overall Study|Adverse Event|0
2857973|NCT02255279|9821947|P2|Overall Study|Withdrawal by Subject|6
2857974|NCT02255279|9821948|P1|Overall Study|Withdrawal by Subject|3
2857975|NCT02255279|9821947|P2|Overall Study|Protocol Violation|1
2857976|NCT02255279|9821948|P1|Overall Study|Protocol Violation|0
2857977|NCT02255279|9821947|P2|Overall Study|Lost to Follow-up|2
2857978|NCT02255279|9821948|P1|Overall Study|Lost to Follow-up|2
2857979|NCT02255149|9822001|P1|Overall Study|Implant Failure|1
2857980|NCT02255149|9822001|P1|Overall Study|Withdrawal by PI|1
2857981|NCT02255149|9822001|P1|Overall Study|Withdrawal by Subject|1
2857982|NCT02255149|9822001|P1|Overall Study|Lost to Follow-up|2
2857983|NCT02255097|9822017|P1|Overall Study|Treatment Ongoing|36
2857984|NCT02255097|9822017|P1|Overall Study|Allocated but not treated|1
2857985|NCT02255097|9822017|P1|Overall Study|Withdrawal by Subject|2
2857986|NCT02255097|9822017|P1|Overall Study|Progressive Disease|80
2857987|NCT02255097|9822017|P1|Overall Study|Physician Decision|1
2857988|NCT02255097|9822017|P1|Overall Study|Lost to Follow-up|1
2857989|NCT02255097|9822017|P1|Overall Study|Death|2
2857990|NCT02255097|9822017|P1|Overall Study|Excluded Medication|1
2857991|NCT02255097|9822017|P1|Overall Study|Complete Response|1
2857992|NCT02255097|9822017|P1|Overall Study|Clinical Progression|23
2857993|NCT02255097|9822017|P1|Overall Study|Adverse Event|24
2857994|NCT02254772|9822038|P1|Overall Study|Withdrawal by Subject|1
2857995|NCT02254772|9822038|P1|Overall Study|Ineligible|1
2857996|NCT02254681|9822044|P1|Overall Study|Lack of Efficacy|6
2857997|NCT02254551|9822054|P1|Dose Escalation|Dose-limiting toxicity|2
2857998|NCT02254551|9822054|P1|Dose Escalation|Physician Decision|1
2857999|NCT02254486|9822064|P2|Overall Study|Various|12
2858000|NCT02254486|9822065|P1|Overall Study|Various|12
2858001|NCT02254486|9822064|P2|Overall Study|GFR<60mL/min|21
2858002|NCT02254486|9822065|P1|Overall Study|GFR<60mL/min|16
2858003|NCT02254486|9822064|P2|Overall Study|Withdrawal by Subject|15
2858004|NCT02254486|9822065|P1|Overall Study|Withdrawal by Subject|17
2858005|NCT02254486|9822064|P2|Overall Study|Protocol Violation|2
2858006|NCT02254486|9822065|P1|Overall Study|Protocol Violation|1
2858007|NCT02254486|9822064|P2|Overall Study|Lost to Follow-up|4
2858008|NCT02254486|9822065|P1|Overall Study|Lost to Follow-up|2
2858009|NCT02254486|9822064|P2|Overall Study|Lack of Efficacy|0
2858010|NCT02254486|9822065|P1|Overall Study|Lack of Efficacy|1
2858011|NCT02254486|9822064|P2|Overall Study|Adverse Event|1
2858012|NCT02254486|9822065|P1|Overall Study|Adverse Event|1
2858013|NCT02254460|9822104|P2|Overall Study|Adverse Event|0
2858014|NCT02254460|9822105|P1|Overall Study|Adverse Event|1
2858015|NCT02254421|9822113|P2|Overall Study|Withdrew Consent|1
2858016|NCT02254421|9822114|P1|Overall Study|Withdrew Consent|1
2858017|NCT02254421|9822113|P2|Overall Study|Death|2
2858018|NCT02254421|9822114|P1|Overall Study|Death|0
2858019|NCT02254421|9822113|P2|Overall Study|Randomized but Not Treated|0
2858020|NCT02254421|9822114|P1|Overall Study|Randomized but Not Treated|1
2858021|NCT02254408|9822128|P2|Overall Study|Lost to Follow-up|0
2858022|NCT02254408|9822129|P1|Overall Study|Lost to Follow-up|1
2858023|NCT02254408|9822128|P2|Overall Study|Withdrawal by Subject|3
2858024|NCT02254408|9822129|P1|Overall Study|Withdrawal by Subject|3
2858025|NCT02254408|9822128|P2|Overall Study|Investigator's Discretion|1
2858026|NCT02254408|9822129|P1|Overall Study|Investigator's Discretion|0
2858027|NCT02254408|9822128|P2|Overall Study|Death|3
2858028|NCT02254408|9822129|P1|Overall Study|Death|2
2858029|NCT02254408|9822128|P2|Overall Study|Adverse Event|0
2858030|NCT02254408|9822129|P1|Overall Study|Adverse Event|1
2858031|NCT02254408|9822128|P2|Overall Study|Randomized But Not Treated|3
2858032|NCT02254408|9822129|P1|Overall Study|Randomized But Not Treated|1
2858033|NCT02254304|9822141|P2|Overall Study|Personal decision|0
2858034|NCT02254304|9822142|P1|Overall Study|Personal decision|1
2858035|NCT02254304|9822141|P2|Overall Study|Personal causes|1
2858036|NCT02254304|9822142|P1|Overall Study|Personal causes|4
2858037|NCT02254304|9822141|P2|Overall Study|Injection site pain and Injection fear|0
2858038|NCT02254304|9822142|P1|Overall Study|Injection site pain and Injection fear|1
2858039|NCT02254304|9822141|P2|Overall Study|Withdrawal by Subject|0
2858040|NCT02254304|9822142|P1|Overall Study|Withdrawal by Subject|3
2858041|NCT02254304|9822141|P2|Overall Study|Protocol Violation|0
2858042|NCT02254304|9822142|P1|Overall Study|Protocol Violation|1
2858043|NCT02254304|9822141|P2|Overall Study|Lost to Follow-up|2
2858044|NCT02254304|9822142|P1|Overall Study|Lost to Follow-up|2
2858045|NCT02254304|9822141|P2|Overall Study|Adverse Event|1
2858046|NCT02254304|9822142|P1|Overall Study|Adverse Event|2
2858047|NCT02254291|9822202|P3|Overall Study|Missing follow-up information|1
2858048|NCT02254291|9822203|P2|Overall Study|Missing follow-up information|0
2858049|NCT02254291|9822204|P1|Overall Study|Missing follow-up information|0
2858050|NCT02254291|9822202|P3|Overall Study|Withdrawal by Subject|1
2858051|NCT02254291|9822203|P2|Overall Study|Withdrawal by Subject|3
2858052|NCT02254291|9822204|P1|Overall Study|Withdrawal by Subject|0
2858053|NCT02253654|9822261|P2|Overall Study|Did Not Receive Study Treatment|1
2858054|NCT02253654|9822262|P1|Overall Study|Did Not Receive Study Treatment|4
2858055|NCT02253654|9822261|P2|Overall Study|Death|7
2858056|NCT02253654|9822262|P1|Overall Study|Death|4
2858057|NCT02253654|9822261|P2|Overall Study|Lost to Follow-up|5
2858058|NCT02253654|9822262|P1|Overall Study|Lost to Follow-up|2
2858059|NCT02253654|9822261|P2|Overall Study|Decision by Sponsor|1
2858060|NCT02253654|9822262|P1|Overall Study|Decision by Sponsor|1
2858061|NCT02253654|9822261|P2|Overall Study|Withdrawal by Subject|4
2858062|NCT02253654|9822262|P1|Overall Study|Withdrawal by Subject|12
2858063|NCT02253433|9822288|P2|Overall Study|Medical or Other Concerns|2
2858064|NCT02253433|9822289|P1|Overall Study|Medical or Other Concerns|1
2858065|NCT02253433|9822288|P2|Overall Study|Too Busy|4
2858066|NCT02253433|9822289|P1|Overall Study|Too Busy|0
2858067|NCT02253433|9822288|P2|Overall Study|Unstable Housing/Homeless|7
2858068|NCT02253433|9822289|P1|Overall Study|Unstable Housing/Homeless|0
2858069|NCT02253433|9822288|P2|Overall Study|Uncomfortable with home visitors|3
2858070|NCT02253433|9822289|P1|Overall Study|Uncomfortable with home visitors|0
2858071|NCT02253433|9822288|P2|Overall Study|Out of Study Area|7
2858072|NCT02253433|9822289|P1|Overall Study|Out of Study Area|2
2858073|NCT02253433|9822288|P2|Overall Study|No Longer Interested|15
2858074|NCT02253433|9822289|P1|Overall Study|No Longer Interested|3
2858075|NCT02253433|9822288|P2|Overall Study|Death|1
2858076|NCT02253433|9822289|P1|Overall Study|Death|1
2858077|NCT02253433|9822288|P2|Overall Study|Unable to Contact|16
2858078|NCT02253433|9822289|P1|Overall Study|Unable to Contact|9
2858079|NCT02253147|9822548|P1|Overall Study|Withdrawal by Subject|1
2858080|NCT02253147|9822548|P1|Overall Study|Lost to Follow-up|2
2858081|NCT02253147|9822548|P1|Overall Study|Conditional re-treatment at W52|5
2858082|NCT02253147|9822548|P1|Overall Study|Did not consent to study extension|9
2858083|NCT02253147|9822548|P1|Overall Study|Protocol Violation|30
2858084|NCT02252965|9822582|P2|Overall Study|Other|5
2858085|NCT02252965|9822583|P1|Overall Study|Other|4
2858086|NCT02252965|9822582|P2|Overall Study|Withdrawal by Subject|9
2858087|NCT02252965|9822583|P1|Overall Study|Withdrawal by Subject|7
2858088|NCT02252965|9822582|P2|Overall Study|Lack of Efficacy|2
2858089|NCT02252965|9822583|P1|Overall Study|Lack of Efficacy|0
2858090|NCT02252965|9822582|P2|Overall Study|Protocol Violation|5
2858091|NCT02252965|9822583|P1|Overall Study|Protocol Violation|4
2858092|NCT02252965|9822582|P2|Overall Study|Lost to Follow-up|8
2858093|NCT02252965|9822583|P1|Overall Study|Lost to Follow-up|16
2858094|NCT02252965|9822582|P2|Overall Study|Adverse Event|14
2858095|NCT02252965|9822583|P1|Overall Study|Adverse Event|9
2858096|NCT02252939|9822610|P1|Overall Study|Lost to Follow-up|3
2858097|NCT02252536|9822667|P2|Overall Study|Lost to Follow-up|3
2858098|NCT02252536|9822668|P1|Overall Study|Lost to Follow-up|5
2858099|NCT02252406|9822729|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
2858100|NCT02252406|9822730|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
2858101|NCT02252406|9822729|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2858102|NCT02252406|9822730|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2858103|NCT02252406|9822729|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
2858104|NCT02252406|9822730|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
2858105|NCT02252406|9822729|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
2858106|NCT02252406|9822730|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
2858107|NCT02252406|9822729|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
2858108|NCT02252406|9822730|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
2858109|NCT02252211|9822788|P3|Overall Study|Serious Adverse Event During Screening|1
2858110|NCT02252211|9822789|P2|Overall Study|Serious Adverse Event During Screening|0
2858111|NCT02252211|9822790|P1|Overall Study|Serious Adverse Event During Screening|1
2858112|NCT02252211|9822788|P3|Overall Study|Withdrawal by Subject|0
2858113|NCT02252211|9822789|P2|Overall Study|Withdrawal by Subject|0
2858114|NCT02252211|9822790|P1|Overall Study|Withdrawal by Subject|1
2858115|NCT02252211|9822788|P3|Overall Study|Progressive disease|0
2858116|NCT02252211|9822789|P2|Overall Study|Progressive disease|2
2858117|NCT02252211|9822790|P1|Overall Study|Progressive disease|3
2858118|NCT02252211|9822788|P3|Overall Study|Adverse Event|0
2858119|NCT02252211|9822789|P2|Overall Study|Adverse Event|1
2858120|NCT02252211|9822790|P1|Overall Study|Adverse Event|0
2858121|NCT02252172|9822827|P2|Overall Study|Ongoing|298
2858122|NCT02252172|9822828|P1|Overall Study|Ongoing|276
2858123|NCT02252172|9822827|P2|Overall Study|Lost to Follow-up|1
2858124|NCT02252172|9822828|P1|Overall Study|Lost to Follow-up|3
2858125|NCT02252146|9822840|P1|Overall Study|Inability to travel to study site|1
2858126|NCT02252146|9822840|P1|Overall Study|Entered hospice care|1
2858127|NCT02252146|9822840|P1|Overall Study|Lack of Efficacy|4
2858128|NCT02252042|9822853|P2|Overall Study|Ongoing in study|35
2858129|NCT02252042|9822854|P1|Overall Study|Ongoing in study|64
2858130|NCT02252042|9822853|P2|Overall Study|Withdrawal by Subject|20
2858131|NCT02252042|9822854|P1|Overall Study|Withdrawal by Subject|13
2858132|NCT02252042|9822853|P2|Overall Study|Physician Decision|1
2858133|NCT02252042|9822854|P1|Overall Study|Physician Decision|0
2858134|NCT02252042|9822853|P2|Overall Study|Death|192
2858135|NCT02252042|9822854|P1|Overall Study|Death|170
2858136|NCT02252016|9822894|P2|Overall Study|Withdrawal by Subject|2
2858137|NCT02252016|9822895|P1|Overall Study|Withdrawal by Subject|0
2858138|NCT02252016|9822894|P2|Overall Study|Physician Decision|0
2858139|NCT02252016|9822895|P1|Overall Study|Physician Decision|1
2858140|NCT02252016|9822894|P2|Overall Study|Lost to Follow-up|1
2858141|NCT02252016|9822895|P1|Overall Study|Lost to Follow-up|2
2858142|NCT02251990|9822909|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
2858143|NCT02251990|9822910|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
2858144|NCT02251990|9822909|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
2858145|NCT02251990|9822910|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
2858146|NCT02251990|9822909|P2|Period 1 (Double-blind [DB])|Not Treated|0
2858147|NCT02251990|9822910|P1|Period 1 (Double-blind [DB])|Not Treated|1
2858148|NCT02251990|9822909|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
2858149|NCT02251990|9822910|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
2858150|NCT02251990|9822909|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
2858151|NCT02251990|9822910|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
2858152|NCT02251990|9822909|P2|Period 1 (Double-blind [DB])|Adverse Event|1
2858153|NCT02251990|9822910|P1|Period 1 (Double-blind [DB])|Adverse Event|1
2858154|NCT02251912|9822938|P2|Overall Study|Adverse Event|2
2858155|NCT02251912|9822939|P1|Overall Study|Adverse Event|0
2858156|NCT02251912|9822938|P2|Overall Study|Withdrawal by Subject|3
2858157|NCT02251912|9822939|P1|Overall Study|Withdrawal by Subject|2
2858158|NCT02251717|9822968|P2|Overall Study|Withdrew Consent|0
2858159|NCT02251717|9822969|P1|Overall Study|Withdrew Consent|1
2858160|NCT02251717|9822968|P2|Overall Study|Adverse Event|1
2858161|NCT02251717|9822969|P1|Overall Study|Adverse Event|0
2858162|NCT02251652|9822981|P1|Overall Study|Withdrawal by Subject|1
2858163|NCT02251275|9823037|P5|Overall Study|Withdrawal by Subject|0
2858164|NCT02251275|9823038|P4|Overall Study|Withdrawal by Subject|1
2858165|NCT02251275|9823039|P3|Overall Study|Withdrawal by Subject|35
2858166|NCT02251275|9823040|P2|Overall Study|Withdrawal by Subject|51
2858167|NCT02251275|9823041|P1|Overall Study|Withdrawal by Subject|25
2858168|NCT02251275|9823037|P5|Overall Study|Protocol Deviation|0
2858169|NCT02251275|9823038|P4|Overall Study|Protocol Deviation|0
2858170|NCT02251275|9823039|P3|Overall Study|Protocol Deviation|1
2858171|NCT02251275|9823040|P2|Overall Study|Protocol Deviation|0
2858172|NCT02251275|9823041|P1|Overall Study|Protocol Deviation|0
2858173|NCT02251275|9823037|P5|Overall Study|Physician Decision|1
2858174|NCT02251275|9823038|P4|Overall Study|Physician Decision|0
2858175|NCT02251275|9823039|P3|Overall Study|Physician Decision|26
2858176|NCT02251275|9823040|P2|Overall Study|Physician Decision|30
2858177|NCT02251275|9823041|P1|Overall Study|Physician Decision|19
2858178|NCT02251275|9823037|P5|Overall Study|Lost to Follow-up|0
2858179|NCT02251275|9823038|P4|Overall Study|Lost to Follow-up|0
2858180|NCT02251275|9823039|P3|Overall Study|Lost to Follow-up|4
2858181|NCT02251275|9823040|P2|Overall Study|Lost to Follow-up|6
2858182|NCT02251275|9823041|P1|Overall Study|Lost to Follow-up|5
2858183|NCT02251275|9823037|P5|Overall Study|Adverse Event|0
2858184|NCT02251275|9823038|P4|Overall Study|Adverse Event|0
2858185|NCT02251275|9823039|P3|Overall Study|Adverse Event|28
2858186|NCT02251275|9823040|P2|Overall Study|Adverse Event|60
2858187|NCT02251275|9823041|P1|Overall Study|Adverse Event|23
2858188|NCT02250443|9823114|P1|Overall Study|Adverse Event|3
2858189|NCT02250443|9823114|P1|Overall Study|Administrative problems|7
2858190|NCT02250326|9823143|P3|Follow-Up Period|Lost to Follow-up|3
2858191|NCT02250326|9823144|P2|Follow-Up Period|Lost to Follow-up|1
2858192|NCT02250326|9823145|P1|Follow-Up Period|Lost to Follow-up|1
2858193|NCT02250326|9823143|P3|Follow-Up Period|Unknown or Missing|3
2858194|NCT02250326|9823144|P2|Follow-Up Period|Unknown or Missing|3
2858195|NCT02250326|9823145|P1|Follow-Up Period|Unknown or Missing|2
2858196|NCT02250326|9823143|P3|Follow-Up Period|Death|32
2858197|NCT02250326|9823144|P2|Follow-Up Period|Death|26
2858198|NCT02250326|9823145|P1|Follow-Up Period|Death|46
2858199|NCT02250326|9823143|P3|Treatment Period|Randomized or assigned; not treated|1
2858200|NCT02250326|9823144|P2|Treatment Period|Randomized or assigned; not treated|1
2858201|NCT02250326|9823145|P1|Treatment Period|Randomized or assigned; not treated|2
2858202|NCT02250326|9823143|P3|Treatment Period|Miscellaneous|7
2858203|NCT02250326|9823144|P2|Treatment Period|Miscellaneous|2
2858204|NCT02250326|9823145|P1|Treatment Period|Miscellaneous|8
2858205|NCT02250326|9823143|P3|Treatment Period|Withdrawal by Subject|4
2858206|NCT02250326|9823144|P2|Treatment Period|Withdrawal by Subject|5
2858207|NCT02250326|9823145|P1|Treatment Period|Withdrawal by Subject|11
2858208|NCT02250326|9823143|P3|Treatment Period|Symptomatic Deterioration|10
2858209|NCT02250326|9823144|P2|Treatment Period|Symptomatic Deterioration|4
2858210|NCT02250326|9823145|P1|Treatment Period|Symptomatic Deterioration|9
2858211|NCT02250326|9823143|P3|Treatment Period|Progressive Disease|45
2858212|NCT02250326|9823144|P2|Treatment Period|Progressive Disease|36
2858213|NCT02250326|9823145|P1|Treatment Period|Progressive Disease|42
2858214|NCT02250326|9823143|P3|Treatment Period|Adverse Event|8
2858215|NCT02250326|9823144|P2|Treatment Period|Adverse Event|4
2858216|NCT02250326|9823145|P1|Treatment Period|Adverse Event|8
2858217|NCT02250326|9823143|P3|Treatment Period|Death|2
2858218|NCT02250326|9823144|P2|Treatment Period|Death|12
2858219|NCT02250326|9823145|P1|Treatment Period|Death|1
2858220|NCT02250274|9823178|P2|Overall Study|Insufficient blood draw amount|6
2858221|NCT02250274|9823179|P1|Overall Study|Insufficient blood draw amount|7
2858222|NCT02250183|9823195|P1|Overall Study|Lost to Follow-up|1
2858223|NCT02250183|9823195|P1|Overall Study|Adverse Event|5
2858224|NCT02250183|9823195|P1|Overall Study|Withdrawal by Subject|2
2858225|NCT02249949|9823204|P1|Overall Study|Cancelled prior to treatment|2
2858226|NCT02249832|9823211|P1|Overall Study|Lost to Follow-up|10
2858227|NCT02249832|9823211|P1|Overall Study|Withdrawal by Subject|3
2858228|NCT02249767|9823255|P3|Overall Study|Did not use medication|8
2858229|NCT02249767|9823256|P2|Overall Study|Did not use medication|9
2858230|NCT02249767|9823257|P1|Overall Study|Did not use medication|8
2858231|NCT02249182|9823323|P5|Treatment Phase|Lost to Follow-up|0
2858232|NCT02249182|9823324|P4|Treatment Phase|Lost to Follow-up|0
2858233|NCT02249182|9823325|P3|Treatment Phase|Lost to Follow-up|0
2858234|NCT02249182|9823326|P2|Treatment Phase|Lost to Follow-up|0
2858235|NCT02249182|9823327|P1|Treatment Phase|Lost to Follow-up|4
2858236|NCT02248974|9823477|P2|1-Month Follow-Up|Lost to Follow-up|3
2858237|NCT02248974|9823478|P1|1-Month Follow-Up|Lost to Follow-up|2
2858238|NCT02248974|9823477|P2|1-Week Follow-Up|Lost to Follow-up|8
2858239|NCT02248974|9823478|P1|1-Week Follow-Up|Lost to Follow-up|0
2858240|NCT02248974|9823477|P2|1-Week Follow-Up|Withdrawal by Subject|2
2858241|NCT02248974|9823478|P1|1-Week Follow-Up|Withdrawal by Subject|0
2858242|NCT02248974|9823477|P2|1-Week Follow-Up|Timing: implanted before survey|2
2858243|NCT02248974|9823478|P1|1-Week Follow-Up|Timing: implanted before survey|0
2858244|NCT02248974|9823477|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
2858245|NCT02248974|9823478|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
2858246|NCT02248974|9823477|P2|1-Week Follow-Up|Excluded because of age|1
2858247|NCT02248974|9823478|P1|1-Week Follow-Up|Excluded because of age|0
2858248|NCT02248974|9823477|P2|1-Week Follow-Up|Death|1
2858249|NCT02248974|9823478|P1|1-Week Follow-Up|Death|1
2858250|NCT02248974|9823477|P2|1-Week Follow-Up|Cognitive Difficulty|0
2858251|NCT02248974|9823478|P1|1-Week Follow-Up|Cognitive Difficulty|1
2858252|NCT02248974|9823477|P2|1-Week Follow-Up|Transferred to another facility|0
2858253|NCT02248974|9823478|P1|1-Week Follow-Up|Transferred to another facility|1
2858254|NCT02248974|9823477|P2|1-Week Follow-Up|Enrolled in another study|1
2858255|NCT02248974|9823478|P1|1-Week Follow-Up|Enrolled in another study|1
2858256|NCT02248974|9823477|P2|1-Week Follow-Up|Became ineligible for LVAD|1
2858257|NCT02248974|9823478|P1|1-Week Follow-Up|Became ineligible for LVAD|4
2858258|NCT02248974|9823477|P2|1-Day Follow-Up|Enrolled in another study|0
2858259|NCT02248974|9823478|P1|1-Day Follow-Up|Enrolled in another study|1
2858260|NCT02248974|9823477|P2|1-Day Follow-Up|Withdrawal by Subject|0
2858261|NCT02248974|9823478|P1|1-Day Follow-Up|Withdrawal by Subject|5
2858262|NCT02248974|9823477|P2|1-Day Follow-Up|Lost to Follow-up|0
2858263|NCT02248974|9823478|P1|1-Day Follow-Up|Lost to Follow-up|4
2858264|NCT02248961|9823556|P2|Overall Study|Unmet inclusion/exclusion criteria|0
2858265|NCT02248961|9823557|P1|Overall Study|Unmet inclusion/exclusion criteria|1
2858266|NCT02248961|9823556|P2|Overall Study|Withdrawal by Subject|2
2858267|NCT02248961|9823557|P1|Overall Study|Withdrawal by Subject|1
2858268|NCT02248961|9823556|P2|Overall Study|Adverse Event|0
2858269|NCT02248961|9823557|P1|Overall Study|Adverse Event|1
2858270|NCT02248857|9823592|P3|6 Month|Death|0
2858271|NCT02248857|9823593|P2|6 Month|Death|0
2858272|NCT02248857|9823594|P1|6 Month|Death|1
2858273|NCT02248857|9823592|P3|6 Month|Withdrawal by Subject|2
2858274|NCT02248857|9823593|P2|6 Month|Withdrawal by Subject|2
2858275|NCT02248857|9823594|P1|6 Month|Withdrawal by Subject|0
2858276|NCT02248857|9823592|P3|6 Month|Partially completed, unable to finish|0
2858277|NCT02248857|9823593|P2|6 Month|Partially completed, unable to finish|1
2858278|NCT02248857|9823594|P1|6 Month|Partially completed, unable to finish|0
2858279|NCT02248857|9823592|P3|6 Month|Lost to Follow-up|15
2858280|NCT02248857|9823593|P2|6 Month|Lost to Follow-up|26
2858281|NCT02248857|9823594|P1|6 Month|Lost to Follow-up|27
2858282|NCT02248857|9823592|P3|3 Month|Partially completed, unable to finish|1
2858283|NCT02248857|9823593|P2|3 Month|Partially completed, unable to finish|2
2858284|NCT02248857|9823594|P1|3 Month|Partially completed, unable to finish|2
2858285|NCT02248857|9823592|P3|3 Month|Unable to reach for 3 month|26
2858286|NCT02248857|9823593|P2|3 Month|Unable to reach for 3 month|29
2858287|NCT02248857|9823594|P1|3 Month|Unable to reach for 3 month|35
2858288|NCT02248857|9823592|P3|3 Month|Withdrawal by Subject|4
2858289|NCT02248857|9823593|P2|3 Month|Withdrawal by Subject|3
2858290|NCT02248857|9823594|P1|3 Month|Withdrawal by Subject|9
2858291|NCT02248818|9823631|P9|Randomised Study|Administrative - randomization error|0
2858292|NCT02248818|9823632|P8|Randomised Study|Administrative - randomization error|0
2858293|NCT02248818|9823633|P7|Randomised Study|Administrative - randomization error|0
2858294|NCT02248818|9823634|P6|Randomised Study|Administrative - randomization error|8
2858295|NCT02248818|9823635|P5|Randomised Study|Administrative - randomization error|0
2858296|NCT02248818|9823636|P4|Randomised Study|Administrative - randomization error|0
2858297|NCT02248818|9823637|P3|Randomised Study|Administrative - randomization error|0
2858298|NCT02248818|9823638|P2|Randomised Study|Administrative - randomization error|0
2858299|NCT02248818|9823639|P1|Randomised Study|Administrative - randomization error|0
2858300|NCT02248818|9823631|P9|Screening|Lost to Follow-up|7
2858301|NCT02248818|9823632|P8|Screening|Lost to Follow-up|0
2858302|NCT02248818|9823633|P7|Screening|Lost to Follow-up|0
2858303|NCT02248818|9823634|P6|Screening|Lost to Follow-up|0
2858304|NCT02248818|9823635|P5|Screening|Lost to Follow-up|0
2858305|NCT02248818|9823636|P4|Screening|Lost to Follow-up|0
2858306|NCT02248818|9823637|P3|Screening|Lost to Follow-up|0
2858307|NCT02248818|9823638|P2|Screening|Lost to Follow-up|0
2858308|NCT02248818|9823639|P1|Screening|Lost to Follow-up|0
2858309|NCT02248818|9823631|P9|Screening|Withdrawal by Subject|6
2858310|NCT02248818|9823632|P8|Screening|Withdrawal by Subject|0
2858311|NCT02248818|9823633|P7|Screening|Withdrawal by Subject|0
2858312|NCT02248818|9823634|P6|Screening|Withdrawal by Subject|0
2858313|NCT02248818|9823635|P5|Screening|Withdrawal by Subject|0
2858314|NCT02248818|9823636|P4|Screening|Withdrawal by Subject|0
2858315|NCT02248818|9823637|P3|Screening|Withdrawal by Subject|0
2858316|NCT02248818|9823638|P2|Screening|Withdrawal by Subject|0
2858317|NCT02248818|9823639|P1|Screening|Withdrawal by Subject|0
2858318|NCT02248818|9823631|P9|Screening|Physician Decision|73
2858319|NCT02248818|9823632|P8|Screening|Physician Decision|0
2858320|NCT02248818|9823633|P7|Screening|Physician Decision|0
2858321|NCT02248818|9823634|P6|Screening|Physician Decision|0
2858322|NCT02248818|9823635|P5|Screening|Physician Decision|0
2858323|NCT02248818|9823636|P4|Screening|Physician Decision|0
2858324|NCT02248818|9823637|P3|Screening|Physician Decision|0
2858325|NCT02248818|9823638|P2|Screening|Physician Decision|0
2858326|NCT02248818|9823639|P1|Screening|Physician Decision|0
2858327|NCT02248818|9823631|P9|Screening|Study fully enrolled|14
2858328|NCT02248818|9823632|P8|Screening|Study fully enrolled|0
2858329|NCT02248818|9823633|P7|Screening|Study fully enrolled|0
2858330|NCT02248818|9823634|P6|Screening|Study fully enrolled|0
2858331|NCT02248818|9823635|P5|Screening|Study fully enrolled|0
2858332|NCT02248818|9823636|P4|Screening|Study fully enrolled|0
2858333|NCT02248818|9823637|P3|Screening|Study fully enrolled|0
2858334|NCT02248818|9823638|P2|Screening|Study fully enrolled|0
2858335|NCT02248818|9823639|P1|Screening|Study fully enrolled|0
2858336|NCT02248818|9823631|P9|Screening|Protocol Violation|7
2858337|NCT02248818|9823632|P8|Screening|Protocol Violation|0
2858338|NCT02248818|9823633|P7|Screening|Protocol Violation|0
2858339|NCT02248818|9823634|P6|Screening|Protocol Violation|0
2858340|NCT02248818|9823635|P5|Screening|Protocol Violation|0
2858341|NCT02248818|9823636|P4|Screening|Protocol Violation|0
2858342|NCT02248818|9823637|P3|Screening|Protocol Violation|0
2858343|NCT02248818|9823638|P2|Screening|Protocol Violation|0
2858344|NCT02248818|9823639|P1|Screening|Protocol Violation|0
2858345|NCT02248675|9823854|P2|Overall Study|Lost to Follow-up|1
2858346|NCT02248675|9823855|P1|Overall Study|Lost to Follow-up|3
2858347|NCT02248649|9823882|P2|Overall Study|Lost to Follow-up|10
2858348|NCT02248649|9823883|P1|Overall Study|Lost to Follow-up|14
2858349|NCT02248649|9823882|P2|Overall Study|Death|11
2858350|NCT02248649|9823883|P1|Overall Study|Death|7
2858351|NCT02248480|9823908|P2|Overall Study|Other:Physician Decision|1
2858352|NCT02248480|9823909|P1|Overall Study|Other:Physician Decision|0
2858353|NCT02248480|9823908|P2|Overall Study|Entry Criteria Not Met|1
2858354|NCT02248480|9823909|P1|Overall Study|Entry Criteria Not Met|0
2858355|NCT02248480|9823908|P2|Overall Study|Withdrawal by Subject|4
2858356|NCT02248480|9823909|P1|Overall Study|Withdrawal by Subject|2
2858357|NCT02248480|9823908|P2|Overall Study|Adverse Event|2
2858358|NCT02248480|9823909|P1|Overall Study|Adverse Event|11
2858359|NCT02248480|9823908|P2|Overall Study|Lack of Efficacy|6
2858360|NCT02248480|9823909|P1|Overall Study|Lack of Efficacy|4
2858361|NCT02247960|9823976|P2|Catheter Removed|Lost to Follow-up|10
2858362|NCT02247960|9823977|P1|Catheter Removed|Lost to Follow-up|7
2858363|NCT02247960|9823976|P2|Patient Consent and Randomization|Withdrawal by Subject|4
2858364|NCT02247960|9823977|P1|Patient Consent and Randomization|Withdrawal by Subject|0
2858365|NCT02247960|9823976|P2|Patient Consent and Randomization|Physician Decision|2
2858366|NCT02247960|9823977|P1|Patient Consent and Randomization|Physician Decision|2
2858367|NCT02247804|9823990|P3|Treatment Period 3|Reason not Specified|3
2858368|NCT02247804|9823991|P2|Treatment Period 3|Reason not Specified|1
2858369|NCT02247804|9823992|P1|Treatment Period 3|Reason not Specified|2
2858370|NCT02247804|9823990|P3|Treatment Period 3|Personal Reasons|2
2858371|NCT02247804|9823991|P2|Treatment Period 3|Personal Reasons|3
2858372|NCT02247804|9823992|P1|Treatment Period 3|Personal Reasons|4
2858373|NCT02247804|9823990|P3|Treatment Period 3|Lost to Follow-up|2
2858374|NCT02247804|9823991|P2|Treatment Period 3|Lost to Follow-up|2
2858375|NCT02247804|9823992|P1|Treatment Period 3|Lost to Follow-up|1
2858376|NCT02247804|9823990|P3|Treatment Period 3|Lack of Efficacy|0
2858377|NCT02247804|9823991|P2|Treatment Period 3|Lack of Efficacy|1
2858378|NCT02247804|9823992|P1|Treatment Period 3|Lack of Efficacy|0
2858379|NCT02247804|9823990|P3|Treatment Period 3|Adverse Event|3
2858380|NCT02247804|9823991|P2|Treatment Period 3|Adverse Event|3
2858381|NCT02247804|9823992|P1|Treatment Period 3|Adverse Event|4
2858382|NCT02247804|9823990|P3|Treatment Period 2|Reason not Specified|2
2858383|NCT02247804|9823991|P2|Treatment Period 2|Reason not Specified|0
2858384|NCT02247804|9823992|P1|Treatment Period 2|Reason not Specified|0
2858385|NCT02247804|9823990|P3|Treatment Period 2|Personal Reasons|1
2858386|NCT02247804|9823991|P2|Treatment Period 2|Personal Reasons|1
2858387|NCT02247804|9823992|P1|Treatment Period 2|Personal Reasons|2
2858388|NCT02247804|9823990|P3|Treatment Period 2|Lost to Follow-up|1
2858389|NCT02247804|9823991|P2|Treatment Period 2|Lost to Follow-up|1
2858390|NCT02247804|9823992|P1|Treatment Period 2|Lost to Follow-up|0
2858391|NCT02247804|9823990|P3|Treatment Period 2|Lack of Efficacy|1
2858392|NCT02247804|9823991|P2|Treatment Period 2|Lack of Efficacy|0
2858393|NCT02247804|9823992|P1|Treatment Period 2|Lack of Efficacy|0
2858394|NCT02247804|9823990|P3|Treatment Period 2|Adverse Event|3
2858395|NCT02247804|9823991|P2|Treatment Period 2|Adverse Event|3
2858396|NCT02247804|9823992|P1|Treatment Period 2|Adverse Event|6
2858397|NCT02247804|9823990|P3|Treatment Period 1|Randomized but not Treated|1
2858398|NCT02247804|9823991|P2|Treatment Period 1|Randomized but not Treated|1
2858399|NCT02247804|9823992|P1|Treatment Period 1|Randomized but not Treated|5
2858400|NCT02247804|9823990|P3|Treatment Period 1|Protocol Deviation|1
2858401|NCT02247804|9823991|P2|Treatment Period 1|Protocol Deviation|0
2858402|NCT02247804|9823992|P1|Treatment Period 1|Protocol Deviation|0
2858403|NCT02247804|9823990|P3|Treatment Period 1|Personal Reasons|2
2858404|NCT02247804|9823991|P2|Treatment Period 1|Personal Reasons|1
2858405|NCT02247804|9823992|P1|Treatment Period 1|Personal Reasons|7
2858406|NCT02247804|9823990|P3|Treatment Period 1|Lost to Follow-up|2
2858407|NCT02247804|9823991|P2|Treatment Period 1|Lost to Follow-up|0
2858408|NCT02247804|9823992|P1|Treatment Period 1|Lost to Follow-up|1
2858409|NCT02247804|9823990|P3|Treatment Period 1|Lack of Efficacy|2
2858410|NCT02247804|9823991|P2|Treatment Period 1|Lack of Efficacy|0
2858411|NCT02247804|9823992|P1|Treatment Period 1|Lack of Efficacy|0
2858412|NCT02247804|9823990|P3|Treatment Period 1|Adverse Event|0
2858413|NCT02247804|9823991|P2|Treatment Period 1|Adverse Event|2
2858414|NCT02247804|9823992|P1|Treatment Period 1|Adverse Event|9
2858415|NCT02247531|9824050|P3|Overall Study|Unspecified Reason|4
2858416|NCT02247531|9824051|P2|Overall Study|Unspecified Reason|3
2858417|NCT02247531|9824052|P1|Overall Study|Unspecified Reason|2
2858418|NCT02247531|9824050|P3|Overall Study|Physician Decision|2
2858419|NCT02247531|9824051|P2|Overall Study|Physician Decision|2
2858420|NCT02247531|9824052|P1|Overall Study|Physician Decision|0
2858421|NCT02247531|9824050|P3|Overall Study|Study Terminated by Sponsor|62
2858422|NCT02247531|9824051|P2|Overall Study|Study Terminated by Sponsor|66
2858423|NCT02247531|9824052|P1|Overall Study|Study Terminated by Sponsor|64
2858424|NCT02247531|9824050|P3|Overall Study|Withdrawal by Subject|25
2858425|NCT02247531|9824051|P2|Overall Study|Withdrawal by Subject|31
2858426|NCT02247531|9824052|P1|Overall Study|Withdrawal by Subject|26
2858427|NCT02247531|9824050|P3|Overall Study|Non-compliance|0
2858428|NCT02247531|9824051|P2|Overall Study|Non-compliance|2
2858429|NCT02247531|9824052|P1|Overall Study|Non-compliance|2
2858430|NCT02247531|9824050|P3|Overall Study|Lost to Follow-up|3
2858431|NCT02247531|9824051|P2|Overall Study|Lost to Follow-up|8
2858432|NCT02247531|9824052|P1|Overall Study|Lost to Follow-up|1
2858433|NCT02247531|9824050|P3|Overall Study|Death|5
2858434|NCT02247531|9824051|P2|Overall Study|Death|9
2858435|NCT02247531|9824052|P1|Overall Study|Death|8
2858436|NCT02247531|9824050|P3|Overall Study|Adverse Event|9
2858437|NCT02247531|9824051|P2|Overall Study|Adverse Event|4
2858438|NCT02247531|9824052|P1|Overall Study|Adverse Event|3
2858439|NCT02247479|9824102|P3|Overall Study|Unspecified Reason|2
2858440|NCT02247479|9824103|P2|Overall Study|Unspecified Reason|5
2858441|NCT02247479|9824104|P1|Overall Study|Unspecified Reason|2
2858442|NCT02247479|9824102|P3|Overall Study|Physician Decision|2
2858443|NCT02247479|9824103|P2|Overall Study|Physician Decision|0
2858444|NCT02247479|9824104|P1|Overall Study|Physician Decision|1
2858445|NCT02247479|9824102|P3|Overall Study|Study Terminated by Sponsor|94
2858446|NCT02247479|9824103|P2|Overall Study|Study Terminated by Sponsor|88
2858447|NCT02247479|9824104|P1|Overall Study|Study Terminated by Sponsor|98
2858448|NCT02247479|9824102|P3|Overall Study|Withdrawal by Subject|24
2858449|NCT02247479|9824103|P2|Overall Study|Withdrawal by Subject|29
2858450|NCT02247479|9824104|P1|Overall Study|Withdrawal by Subject|25
2858451|NCT02247479|9824102|P3|Overall Study|Non-compliance|1
2858452|NCT02247479|9824103|P2|Overall Study|Non-compliance|0
2858453|NCT02247479|9824104|P1|Overall Study|Non-compliance|0
2858454|NCT02247479|9824102|P3|Overall Study|Lost to Follow-up|1
2858455|NCT02247479|9824103|P2|Overall Study|Lost to Follow-up|3
2858456|NCT02247479|9824104|P1|Overall Study|Lost to Follow-up|3
2858457|NCT02247479|9824102|P3|Overall Study|Death|6
2858458|NCT02247479|9824103|P2|Overall Study|Death|4
2858459|NCT02247479|9824104|P1|Overall Study|Death|5
2858460|NCT02247479|9824102|P3|Overall Study|Adverse Event|8
2858461|NCT02247479|9824103|P2|Overall Study|Adverse Event|9
2858462|NCT02247479|9824104|P1|Overall Study|Adverse Event|8
2858463|NCT02247466|9824153|P2|Overall Study|Procedure changed to open surgery|3
2858464|NCT02247466|9824154|P1|Overall Study|Procedure changed to open surgery|0
2858465|NCT02247440|9824172|P1|Overall Study|Lack of Efficacy|3
2858466|NCT02247440|9824172|P1|Overall Study|Withdrawal by Subject|1
2858467|NCT02247401|9824185|P3|Overall Study|Lost to Follow-up|1
2858468|NCT02247401|9824186|P2|Overall Study|Lost to Follow-up|1
2858469|NCT02247401|9824187|P1|Overall Study|Lost to Follow-up|1
2858470|NCT02247401|9824185|P3|Overall Study|Withdrawal by Subject|1
2858471|NCT02247401|9824186|P2|Overall Study|Withdrawal by Subject|1
2858472|NCT02247401|9824187|P1|Overall Study|Withdrawal by Subject|4
2858473|NCT02247401|9824185|P3|Overall Study|Adverse Event|0
2858474|NCT02247401|9824186|P2|Overall Study|Adverse Event|0
2858475|NCT02247401|9824187|P1|Overall Study|Adverse Event|1
2858476|NCT02247011|9824234|P1|Overall Study|Poor quality of radiological results|125
2858477|NCT02246998|9824255|P4|Overall Study|Randomized but Never Dosed|1
2858478|NCT02246998|9824256|P3|Overall Study|Randomized but Never Dosed|2
2858479|NCT02246998|9824257|P2|Overall Study|Randomized but Never Dosed|2
2858480|NCT02246998|9824258|P1|Overall Study|Randomized but Never Dosed|1
2858481|NCT02246998|9824255|P4|Overall Study|Lost to Follow-up|1
2858482|NCT02246998|9824256|P3|Overall Study|Lost to Follow-up|0
2858483|NCT02246998|9824257|P2|Overall Study|Lost to Follow-up|0
2858484|NCT02246998|9824258|P1|Overall Study|Lost to Follow-up|1
2858485|NCT02246998|9824255|P4|Overall Study|Adverse Event|0
2858486|NCT02246998|9824256|P3|Overall Study|Adverse Event|1
2858487|NCT02246998|9824257|P2|Overall Study|Adverse Event|1
2858488|NCT02246998|9824258|P1|Overall Study|Adverse Event|0
2858489|NCT02246777|9824368|P1|Overall Study|Change of residence|1
2858490|NCT02246777|9824368|P1|Overall Study|Adverse Event|2
2858491|NCT02246764|9824384|P3|Overall Study|Protocol Violation|1
2858492|NCT02246764|9824385|P2|Overall Study|Protocol Violation|1
2858493|NCT02246764|9824386|P1|Overall Study|Protocol Violation|2
2858494|NCT02246764|9824384|P3|Overall Study|Physician Decision|1
2858495|NCT02246764|9824385|P2|Overall Study|Physician Decision|2
2858496|NCT02246764|9824386|P1|Overall Study|Physician Decision|0
2858497|NCT02246764|9824384|P3|Overall Study|Disallowed Concomitant Medication|0
2858498|NCT02246764|9824385|P2|Overall Study|Disallowed Concomitant Medication|0
2858499|NCT02246764|9824386|P1|Overall Study|Disallowed Concomitant Medication|1
2858500|NCT02246764|9824384|P3|Overall Study|Withdrawal by Subject|1
2858501|NCT02246764|9824385|P2|Overall Study|Withdrawal by Subject|0
2858502|NCT02246764|9824386|P1|Overall Study|Withdrawal by Subject|0
2858503|NCT02246764|9824384|P3|Overall Study|Adverse Event|1
2858504|NCT02246764|9824385|P2|Overall Study|Adverse Event|29
2858505|NCT02246764|9824386|P1|Overall Study|Adverse Event|15
2858506|NCT02246673|9824399|P5|Overall Study|Protocol Violation|0
2858507|NCT02246673|9824400|P4|Overall Study|Protocol Violation|1
2858508|NCT02246673|9824401|P3|Overall Study|Protocol Violation|0
2858509|NCT02246673|9824402|P2|Overall Study|Protocol Violation|0
2858510|NCT02246673|9824403|P1|Overall Study|Protocol Violation|0
2858511|NCT02246673|9824399|P5|Overall Study|Lost to Follow-up|0
2858512|NCT02246673|9824400|P4|Overall Study|Lost to Follow-up|1
2858513|NCT02246673|9824401|P3|Overall Study|Lost to Follow-up|0
2858514|NCT02246673|9824402|P2|Overall Study|Lost to Follow-up|0
2858515|NCT02246673|9824403|P1|Overall Study|Lost to Follow-up|0
2858516|NCT02246673|9824399|P5|Overall Study|Withdrawal by Subject|1
2858517|NCT02246673|9824400|P4|Overall Study|Withdrawal by Subject|0
2858518|NCT02246673|9824401|P3|Overall Study|Withdrawal by Subject|0
2858519|NCT02246673|9824402|P2|Overall Study|Withdrawal by Subject|0
2858520|NCT02246673|9824403|P1|Overall Study|Withdrawal by Subject|0
2858521|NCT02246673|9824399|P5|Overall Study|Sponsor Decision|0
2858522|NCT02246673|9824400|P4|Overall Study|Sponsor Decision|0
2858523|NCT02246673|9824401|P3|Overall Study|Sponsor Decision|0
2858524|NCT02246673|9824402|P2|Overall Study|Sponsor Decision|0
2858525|NCT02246673|9824403|P1|Overall Study|Sponsor Decision|1
2858526|NCT02246660|9824511|P3|Overall Study|Death|1
2858527|NCT02246660|9824512|P2|Overall Study|Death|0
2858528|NCT02246660|9824513|P1|Overall Study|Death|0
2858529|NCT02246660|9824511|P3|Overall Study|Withdrawal by Subject|0
2858530|NCT02246660|9824512|P2|Overall Study|Withdrawal by Subject|1
2858531|NCT02246660|9824513|P1|Overall Study|Withdrawal by Subject|0
2858532|NCT02246647|9824523|P2|Overall Study|Withdrawal by Subject|1
2858533|NCT02246647|9824524|P1|Overall Study|Withdrawal by Subject|1
2858534|NCT02246621|9824558|P2|Overall Study|On Study Treatment/ Follow Up|133
2858535|NCT02246621|9824559|P1|Overall Study|On Study Treatment/ Follow Up|257
2858536|NCT02246621|9824558|P2|Overall Study|Lost to Follow-up|1
2858537|NCT02246621|9824559|P1|Overall Study|Lost to Follow-up|3
2858538|NCT02246621|9824558|P2|Overall Study|Withdrawal by Subject|14
2858539|NCT02246621|9824559|P1|Overall Study|Withdrawal by Subject|36
2858540|NCT02246582|9824596|P2|Overall Study|Withdrawal by Subject|4
2858541|NCT02246582|9824597|P1|Overall Study|Withdrawal by Subject|3
2858542|NCT02246439|9824605|P2|Overall Study|Withdrawal by Subject|0
2858543|NCT02246439|9824606|P1|Overall Study|Withdrawal by Subject|1
2858544|NCT02246439|9824605|P2|Overall Study|Unkonwn|3
2858545|NCT02246439|9824606|P1|Overall Study|Unkonwn|1
2858546|NCT02246439|9824605|P2|Overall Study|Physician Decision|1
2858547|NCT02246439|9824606|P1|Overall Study|Physician Decision|0
2858548|NCT02246439|9824605|P2|Overall Study|Protocol Violation|2
2858549|NCT02246439|9824606|P1|Overall Study|Protocol Violation|0
2858550|NCT02246439|9824605|P2|Overall Study|Lost to Follow-up|5
2858551|NCT02246439|9824606|P1|Overall Study|Lost to Follow-up|7
2858552|NCT02246439|9824605|P2|Overall Study|Adverse Event|0
2858553|NCT02246439|9824606|P1|Overall Study|Adverse Event|3
2858554|NCT02246218|9824657|P2|Overall Study|Lost to Follow-up|0
2858555|NCT02246218|9824658|P1|Overall Study|Lost to Follow-up|1
2858556|NCT02246218|9824657|P2|Overall Study|Adverse Event|1
2858557|NCT02246218|9824658|P1|Overall Study|Adverse Event|1
2858558|NCT02246218|9824657|P2|Overall Study|Stopping Rule: Liver Transplant|4
2858559|NCT02246218|9824658|P1|Overall Study|Stopping Rule: Liver Transplant|2
2858560|NCT02246218|9824657|P2|Overall Study|Withdrawal by Parent/Guardian|1
2858561|NCT02246218|9824658|P1|Overall Study|Withdrawal by Parent/Guardian|0
2858562|NCT02246166|9824718|P2|Overall Study|Protocol Violation|0
2858563|NCT02246166|9824719|P1|Overall Study|Protocol Violation|1
2858564|NCT02246114|9824755|P2|Overall Study|miscarriage|0
2858565|NCT02246114|9824756|P1|Overall Study|miscarriage|1
2858566|NCT02245737|9824807|P3|Overall Study|Sponsor Decision|432
2858567|NCT02245737|9824808|P2|Overall Study|Sponsor Decision|430
2858568|NCT02245737|9824809|P1|Overall Study|Sponsor Decision|445
2858569|NCT02245737|9824807|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
2858570|NCT02245737|9824808|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
2858571|NCT02245737|9824809|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
2858572|NCT02245737|9824807|P3|Overall Study|Withdrawal by Subject|44
2858573|NCT02245737|9824808|P2|Overall Study|Withdrawal by Subject|41
2858574|NCT02245737|9824809|P1|Overall Study|Withdrawal by Subject|40
2858575|NCT02245737|9824807|P3|Overall Study|Protocol Violation|3
2858576|NCT02245737|9824808|P2|Overall Study|Protocol Violation|2
2858577|NCT02245737|9824809|P1|Overall Study|Protocol Violation|3
2858578|NCT02245737|9824807|P3|Overall Study|Physician Decision|6
2858579|NCT02245737|9824808|P2|Overall Study|Physician Decision|3
2858580|NCT02245737|9824809|P1|Overall Study|Physician Decision|6
2858581|NCT02245737|9824807|P3|Overall Study|Other-determined by Investigator|10
2858582|NCT02245737|9824808|P2|Overall Study|Other-determined by Investigator|10
2858583|NCT02245737|9824809|P1|Overall Study|Other-determined by Investigator|9
2858584|NCT02245737|9824807|P3|Overall Study|Lost to Follow-up|4
2858585|NCT02245737|9824808|P2|Overall Study|Lost to Follow-up|5
2858586|NCT02245737|9824809|P1|Overall Study|Lost to Follow-up|2
2858587|NCT02245737|9824807|P3|Overall Study|Initiation of Symptomatic AD medication|0
2858588|NCT02245737|9824808|P2|Overall Study|Initiation of Symptomatic AD medication|0
2858589|NCT02245737|9824809|P1|Overall Study|Initiation of Symptomatic AD medication|2
2858590|NCT02245737|9824807|P3|Overall Study|Eligibility Criteria No Longer Met|4
2858591|NCT02245737|9824808|P2|Overall Study|Eligibility Criteria No Longer Met|4
2858592|NCT02245737|9824809|P1|Overall Study|Eligibility Criteria No Longer Met|2
2858593|NCT02245737|9824807|P3|Overall Study|Death|4
2858594|NCT02245737|9824808|P2|Overall Study|Death|4
2858595|NCT02245737|9824809|P1|Overall Study|Death|2
2858596|NCT02245737|9824807|P3|Overall Study|Condition Worsened|9
2858597|NCT02245737|9824808|P2|Overall Study|Condition Worsened|10
2858598|NCT02245737|9824809|P1|Overall Study|Condition Worsened|9
2858599|NCT02245737|9824807|P3|Overall Study|Adverse Event|33
2858600|NCT02245737|9824808|P2|Overall Study|Adverse Event|26
2858601|NCT02245737|9824809|P1|Overall Study|Adverse Event|23
2858602|NCT02245412|9824867|P3|Follow-Up Period|Other - Terminated by Sponsor|1
2858603|NCT02245412|9824868|P2|Follow-Up Period|Other - Terminated by Sponsor|0
2858604|NCT02245412|9824869|P1|Follow-Up Period|Other - Terminated by Sponsor|0
2858605|NCT02245412|9824867|P3|Follow-Up Period|Physician Decision|0
2858606|NCT02245412|9824868|P2|Follow-Up Period|Physician Decision|0
2858607|NCT02245412|9824869|P1|Follow-Up Period|Physician Decision|1
2858608|NCT02245412|9824867|P3|Follow-Up Period|Death|1
2858609|NCT02245412|9824868|P2|Follow-Up Period|Death|2
2858610|NCT02245412|9824869|P1|Follow-Up Period|Death|4
2858611|NCT02245412|9824867|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
2858612|NCT02245412|9824868|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
2858613|NCT02245412|9824869|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
2858614|NCT02245412|9824867|P3|Treatment Period|Withdrawal by Subject|0
2858615|NCT02245412|9824868|P2|Treatment Period|Withdrawal by Subject|1
2858616|NCT02245412|9824869|P1|Treatment Period|Withdrawal by Subject|2
2858617|NCT02245412|9824867|P3|Treatment Period|Physician Decision|0
2858618|NCT02245412|9824868|P2|Treatment Period|Physician Decision|1
2858619|NCT02245412|9824869|P1|Treatment Period|Physician Decision|1
2858620|NCT02245412|9824867|P3|Treatment Period|Death|0
2858621|NCT02245412|9824868|P2|Treatment Period|Death|1
2858622|NCT02245412|9824869|P1|Treatment Period|Death|1
2858623|NCT02244996|9824916|P2|Overall Study|Lack of Efficacy|6
2858624|NCT02244996|9824917|P1|Overall Study|Lack of Efficacy|2
2858625|NCT02244944|9824929|P1|Overall Study|Study Terminated|1
2858626|NCT02244944|9824929|P1|Overall Study|Withdrawal by Subject|1
2858627|NCT02244619|9824960|P2|Overall Study|Did not receive study intervention|21
2858628|NCT02244619|9824961|P1|Overall Study|Did not receive study intervention|8
2858629|NCT02244580|9824979|P1|Overall Study|No cancer tissues available|241
2858630|NCT02244424|9824989|P2|Overall Study|Lost to Follow-up|10
2858631|NCT02244424|9824990|P1|Overall Study|Lost to Follow-up|20
2858632|NCT02243696|9825009|P1|Overall Study|Study Terminated for EP PASSION|961
2858633|NCT02243696|9825009|P1|Overall Study|Subject Withdrawn by Investigator|273
2858634|NCT02243696|9825009|P1|Overall Study|Subject No Longer has Study System|42
2858635|NCT02243696|9825009|P1|Overall Study|Lost to Follow-up|57
2858636|NCT02243696|9825009|P1|Overall Study|Withdrawal by Subject|79
2858637|NCT02243696|9825009|P1|Overall Study|Death|282
2858638|NCT02243371|9825045|P2|Overall Study|Withdrawal by Subject|2
2858639|NCT02243371|9825046|P1|Overall Study|Withdrawal by Subject|0
2858640|NCT02243371|9825045|P2|Overall Study|Lack of Clinical Benefit|1
2858641|NCT02243371|9825046|P1|Overall Study|Lack of Clinical Benefit|0
2858642|NCT02243371|9825045|P2|Overall Study|Adverse Event (unrelated)|1
2858643|NCT02243371|9825046|P1|Overall Study|Adverse Event (unrelated)|0
2858644|NCT02243371|9825045|P2|Overall Study|Death (unrelated)|4
2858645|NCT02243371|9825046|P1|Overall Study|Death (unrelated)|2
2858646|NCT02243371|9825045|P2|Overall Study|Progressive Disease (clinic & radio)|24
2858647|NCT02243371|9825046|P1|Overall Study|Progressive Disease (clinic & radio)|35
2858648|NCT02243306|9825066|P2|Overall Study|Physician Decision|1
2858649|NCT02243306|9825067|P1|Overall Study|Physician Decision|0
2858650|NCT02243306|9825066|P2|Overall Study|Other: Reached stopping criteria|1
2858651|NCT02243306|9825067|P1|Overall Study|Other: Reached stopping criteria|0
2858652|NCT02243306|9825066|P2|Overall Study|Adverse Event|1
2858653|NCT02243306|9825067|P1|Overall Study|Adverse Event|0
2858654|NCT02243293|9825142|P22|Overall Study|Randomized but did'nt receive study drug|0
2858655|NCT02243293|9825143|P21|Overall Study|Randomized but did'nt receive study drug|0
2858656|NCT02243293|9825144|P20|Overall Study|Randomized but did'nt receive study drug|1
2858657|NCT02243293|9825145|P19|Overall Study|Randomized but did'nt receive study drug|0
2858658|NCT02243293|9825146|P18|Overall Study|Randomized but did'nt receive study drug|0
2858659|NCT02243293|9825147|P17|Overall Study|Randomized but did'nt receive study drug|0
2858660|NCT02243293|9825148|P16|Overall Study|Randomized but did'nt receive study drug|0
2858661|NCT02243293|9825149|P15|Overall Study|Randomized but did'nt receive study drug|0
2858662|NCT02243293|9825150|P14|Overall Study|Randomized but did'nt receive study drug|0
2858663|NCT02243293|9825151|P13|Overall Study|Randomized but did'nt receive study drug|0
2858664|NCT02243293|9825152|P12|Overall Study|Randomized but did'nt receive study drug|0
2858665|NCT02243293|9825153|P11|Overall Study|Randomized but did'nt receive study drug|0
2858666|NCT02243293|9825154|P10|Overall Study|Randomized but did'nt receive study drug|1
2858667|NCT02243293|9825155|P9|Overall Study|Randomized but did'nt receive study drug|0
2858668|NCT02243293|9825156|P8|Overall Study|Randomized but did'nt receive study drug|0
2858669|NCT02243293|9825157|P7|Overall Study|Randomized but did'nt receive study drug|0
2858670|NCT02243293|9825158|P6|Overall Study|Randomized but did'nt receive study drug|0
2858671|NCT02243293|9825159|P5|Overall Study|Randomized but did'nt receive study drug|1
2858672|NCT02243293|9825160|P4|Overall Study|Randomized but did'nt receive study drug|0
2858673|NCT02243293|9825161|P3|Overall Study|Randomized but did'nt receive study drug|0
2858674|NCT02243293|9825162|P2|Overall Study|Randomized but did'nt receive study drug|0
2858675|NCT02243293|9825163|P1|Overall Study|Randomized but did'nt receive study drug|0
2858676|NCT02243293|9825142|P22|Overall Study|Enrolled into a Re-treatment Study|0
2858677|NCT02243293|9825143|P21|Overall Study|Enrolled into a Re-treatment Study|0
2858678|NCT02243293|9825144|P20|Overall Study|Enrolled into a Re-treatment Study|0
2858679|NCT02243293|9825145|P19|Overall Study|Enrolled into a Re-treatment Study|0
2858680|NCT02243293|9825146|P18|Overall Study|Enrolled into a Re-treatment Study|0
2858681|NCT02243293|9825147|P17|Overall Study|Enrolled into a Re-treatment Study|0
2858682|NCT02243293|9825148|P16|Overall Study|Enrolled into a Re-treatment Study|0
2858683|NCT02243293|9825149|P15|Overall Study|Enrolled into a Re-treatment Study|1
2858684|NCT02243293|9825150|P14|Overall Study|Enrolled into a Re-treatment Study|0
2858685|NCT02243293|9825151|P13|Overall Study|Enrolled into a Re-treatment Study|0
2858686|NCT02243293|9825152|P12|Overall Study|Enrolled into a Re-treatment Study|0
2858687|NCT02243293|9825153|P11|Overall Study|Enrolled into a Re-treatment Study|0
2858688|NCT02243293|9825154|P10|Overall Study|Enrolled into a Re-treatment Study|0
2858689|NCT02243293|9825155|P9|Overall Study|Enrolled into a Re-treatment Study|0
2858690|NCT02243293|9825156|P8|Overall Study|Enrolled into a Re-treatment Study|0
2858691|NCT02243293|9825157|P7|Overall Study|Enrolled into a Re-treatment Study|0
2858692|NCT02243293|9825158|P6|Overall Study|Enrolled into a Re-treatment Study|0
2858693|NCT02243293|9825159|P5|Overall Study|Enrolled into a Re-treatment Study|0
2858694|NCT02243293|9825160|P4|Overall Study|Enrolled into a Re-treatment Study|0
2858695|NCT02243293|9825161|P3|Overall Study|Enrolled into a Re-treatment Study|0
2858696|NCT02243293|9825162|P2|Overall Study|Enrolled into a Re-treatment Study|0
2858697|NCT02243293|9825163|P1|Overall Study|Enrolled into a Re-treatment Study|0
2858698|NCT02243293|9825142|P22|Overall Study|Lost to Follow-up|2
2858699|NCT02243293|9825143|P21|Overall Study|Lost to Follow-up|1
2858700|NCT02243293|9825144|P20|Overall Study|Lost to Follow-up|0
2858701|NCT02243293|9825145|P19|Overall Study|Lost to Follow-up|0
2858702|NCT02243293|9825146|P18|Overall Study|Lost to Follow-up|1
2858703|NCT02243293|9825147|P17|Overall Study|Lost to Follow-up|3
2858704|NCT02243293|9825148|P16|Overall Study|Lost to Follow-up|0
2858705|NCT02243293|9825149|P15|Overall Study|Lost to Follow-up|0
2858706|NCT02243293|9825150|P14|Overall Study|Lost to Follow-up|0
2858707|NCT02243293|9825151|P13|Overall Study|Lost to Follow-up|0
2858708|NCT02243293|9825152|P12|Overall Study|Lost to Follow-up|2
2858709|NCT02243293|9825153|P11|Overall Study|Lost to Follow-up|0
2858710|NCT02243293|9825154|P10|Overall Study|Lost to Follow-up|0
2858711|NCT02243293|9825155|P9|Overall Study|Lost to Follow-up|0
2858712|NCT02243293|9825156|P8|Overall Study|Lost to Follow-up|0
2858713|NCT02243293|9825157|P7|Overall Study|Lost to Follow-up|3
2858714|NCT02243293|9825158|P6|Overall Study|Lost to Follow-up|0
2858715|NCT02243293|9825159|P5|Overall Study|Lost to Follow-up|0
2858716|NCT02243293|9825160|P4|Overall Study|Lost to Follow-up|1
2858717|NCT02243293|9825161|P3|Overall Study|Lost to Follow-up|1
2858718|NCT02243293|9825162|P2|Overall Study|Lost to Follow-up|1
2858719|NCT02243293|9825163|P1|Overall Study|Lost to Follow-up|0
2858720|NCT02243293|9825142|P22|Overall Study|Withdrawal by Subject|1
2858721|NCT02243293|9825143|P21|Overall Study|Withdrawal by Subject|0
2858722|NCT02243293|9825144|P20|Overall Study|Withdrawal by Subject|0
2858723|NCT02243293|9825145|P19|Overall Study|Withdrawal by Subject|0
2858724|NCT02243293|9825146|P18|Overall Study|Withdrawal by Subject|0
2858725|NCT02243293|9825147|P17|Overall Study|Withdrawal by Subject|0
2858726|NCT02243293|9825148|P16|Overall Study|Withdrawal by Subject|0
2858727|NCT02243293|9825149|P15|Overall Study|Withdrawal by Subject|0
2858728|NCT02243293|9825150|P14|Overall Study|Withdrawal by Subject|0
2858729|NCT02243293|9825151|P13|Overall Study|Withdrawal by Subject|0
2858730|NCT02243293|9825152|P12|Overall Study|Withdrawal by Subject|1
2858731|NCT02243293|9825153|P11|Overall Study|Withdrawal by Subject|0
2858732|NCT02243293|9825154|P10|Overall Study|Withdrawal by Subject|1
2858733|NCT02243293|9825155|P9|Overall Study|Withdrawal by Subject|0
2858734|NCT02243293|9825156|P8|Overall Study|Withdrawal by Subject|0
2858735|NCT02243293|9825157|P7|Overall Study|Withdrawal by Subject|0
2858736|NCT02243293|9825158|P6|Overall Study|Withdrawal by Subject|0
2858737|NCT02243293|9825159|P5|Overall Study|Withdrawal by Subject|0
2858738|NCT02243293|9825160|P4|Overall Study|Withdrawal by Subject|0
2858739|NCT02243293|9825161|P3|Overall Study|Withdrawal by Subject|0
2858740|NCT02243293|9825162|P2|Overall Study|Withdrawal by Subject|0
2858741|NCT02243293|9825163|P1|Overall Study|Withdrawal by Subject|1
2858742|NCT02243293|9825142|P22|Overall Study|Adverse Event|0
2858743|NCT02243293|9825143|P21|Overall Study|Adverse Event|1
2858744|NCT02243293|9825144|P20|Overall Study|Adverse Event|0
2858745|NCT02243293|9825145|P19|Overall Study|Adverse Event|0
2858746|NCT02243293|9825146|P18|Overall Study|Adverse Event|0
2858747|NCT02243293|9825147|P17|Overall Study|Adverse Event|0
2858748|NCT02243293|9825148|P16|Overall Study|Adverse Event|1
2858749|NCT02243293|9825149|P15|Overall Study|Adverse Event|0
2858750|NCT02243293|9825150|P14|Overall Study|Adverse Event|0
2858751|NCT02243293|9825151|P13|Overall Study|Adverse Event|0
2858752|NCT02243293|9825152|P12|Overall Study|Adverse Event|0
2858753|NCT02243293|9825153|P11|Overall Study|Adverse Event|0
2858754|NCT02243293|9825154|P10|Overall Study|Adverse Event|0
2858755|NCT02243293|9825155|P9|Overall Study|Adverse Event|0
2858756|NCT02243293|9825156|P8|Overall Study|Adverse Event|0
2858757|NCT02243293|9825157|P7|Overall Study|Adverse Event|0
2858758|NCT02243293|9825158|P6|Overall Study|Adverse Event|0
2858759|NCT02243293|9825159|P5|Overall Study|Adverse Event|0
2858760|NCT02243293|9825160|P4|Overall Study|Adverse Event|0
2858761|NCT02243293|9825161|P3|Overall Study|Adverse Event|0
2858762|NCT02243293|9825162|P2|Overall Study|Adverse Event|0
2858763|NCT02243293|9825163|P1|Overall Study|Adverse Event|1
2858764|NCT02243280|9825262|P11|Treated|Lost to Follow-up|2
2858765|NCT02243280|9825263|P10|Treated|Lost to Follow-up|0
2858766|NCT02243280|9825264|P9|Treated|Lost to Follow-up|1
2858767|NCT02243280|9825265|P8|Treated|Lost to Follow-up|0
2858768|NCT02243280|9825266|P7|Treated|Lost to Follow-up|0
2858769|NCT02243280|9825267|P6|Treated|Lost to Follow-up|0
2858770|NCT02243280|9825268|P5|Treated|Lost to Follow-up|0
2858771|NCT02243280|9825269|P4|Treated|Lost to Follow-up|0
2858772|NCT02243280|9825270|P3|Treated|Lost to Follow-up|0
2858773|NCT02243280|9825271|P2|Treated|Lost to Follow-up|0
2858774|NCT02243280|9825272|P1|Treated|Lost to Follow-up|0
2858775|NCT02243280|9825262|P11|Treated|Adverse Event|1
2858776|NCT02243280|9825263|P10|Treated|Adverse Event|0
2858777|NCT02243280|9825264|P9|Treated|Adverse Event|0
2858778|NCT02243280|9825265|P8|Treated|Adverse Event|0
2858779|NCT02243280|9825266|P7|Treated|Adverse Event|0
2858780|NCT02243280|9825267|P6|Treated|Adverse Event|0
2858781|NCT02243280|9825268|P5|Treated|Adverse Event|0
2858782|NCT02243280|9825269|P4|Treated|Adverse Event|0
2858783|NCT02243280|9825270|P3|Treated|Adverse Event|0
2858784|NCT02243280|9825271|P2|Treated|Adverse Event|0
2858785|NCT02243280|9825272|P1|Treated|Adverse Event|1
2858786|NCT02243202|9825327|P4|Overall Study|Randomized but not received treatment|1
2858787|NCT02243202|9825328|P3|Overall Study|Randomized but not received treatment|0
2858788|NCT02243202|9825329|P2|Overall Study|Randomized but not received treatment|0
2858789|NCT02243202|9825330|P1|Overall Study|Randomized but not received treatment|0
2858790|NCT02243202|9825327|P4|Overall Study|Other|2
2858791|NCT02243202|9825328|P3|Overall Study|Other|1
2858792|NCT02243202|9825329|P2|Overall Study|Other|3
2858793|NCT02243202|9825330|P1|Overall Study|Other|1
2858794|NCT02243202|9825327|P4|Overall Study|Withdrawal by Subject|4
2858795|NCT02243202|9825328|P3|Overall Study|Withdrawal by Subject|4
2858796|NCT02243202|9825329|P2|Overall Study|Withdrawal by Subject|6
2858797|NCT02243202|9825330|P1|Overall Study|Withdrawal by Subject|7
2858798|NCT02243202|9825327|P4|Overall Study|Protocol Violation|1
2858799|NCT02243202|9825328|P3|Overall Study|Protocol Violation|2
2858800|NCT02243202|9825329|P2|Overall Study|Protocol Violation|1
2858801|NCT02243202|9825330|P1|Overall Study|Protocol Violation|3
2858802|NCT02243202|9825327|P4|Overall Study|Lost to Follow-up|11
2858803|NCT02243202|9825328|P3|Overall Study|Lost to Follow-up|14
2858804|NCT02243202|9825329|P2|Overall Study|Lost to Follow-up|9
2858805|NCT02243202|9825330|P1|Overall Study|Lost to Follow-up|9
2858806|NCT02243202|9825327|P4|Overall Study|Adverse Event|4
2858807|NCT02243202|9825328|P3|Overall Study|Adverse Event|10
2858808|NCT02243202|9825329|P2|Overall Study|Adverse Event|6
2858809|NCT02243202|9825330|P1|Overall Study|Adverse Event|5
2858810|NCT02243176|9825366|P2|Overall Study|Adverse Event|2
2858811|NCT02243176|9825367|P1|Overall Study|Adverse Event|2
2858812|NCT02243176|9825366|P2|Overall Study|Withdrawal by Subject|7
2858813|NCT02243176|9825367|P1|Overall Study|Withdrawal by Subject|8
2858814|NCT02243176|9825366|P2|Overall Study|Protocol Violation|1
2858815|NCT02243176|9825367|P1|Overall Study|Protocol Violation|2
2858816|NCT02243176|9825366|P2|Overall Study|protocol specified withdrawal critera|3
2858817|NCT02243176|9825367|P1|Overall Study|protocol specified withdrawal critera|1
2858818|NCT02243176|9825366|P2|Overall Study|Other reason|2
2858819|NCT02243176|9825367|P1|Overall Study|Other reason|1
2858820|NCT02243046|9825392|P3|Overall Study|Lost to Follow-up|4
2858821|NCT02243046|9825393|P2|Overall Study|Lost to Follow-up|1
2858822|NCT02243046|9825394|P1|Overall Study|Lost to Follow-up|1
2858823|NCT02242942|9825461|P3|Overall Study|On-going in Study|11
2858824|NCT02242942|9825462|P2|Overall Study|On-going in Study|186
2858825|NCT02242942|9825463|P1|Overall Study|On-going in Study|190
2858826|NCT02242942|9825461|P3|Overall Study|Withdrawal by Subject|0
2858827|NCT02242942|9825462|P2|Overall Study|Withdrawal by Subject|10
2858828|NCT02242942|9825463|P1|Overall Study|Withdrawal by Subject|8
2858829|NCT02242942|9825461|P3|Overall Study|Physician Decision|0
2858830|NCT02242942|9825462|P2|Overall Study|Physician Decision|0
2858831|NCT02242942|9825463|P1|Overall Study|Physician Decision|1
2858832|NCT02242942|9825461|P3|Overall Study|Death|2
2858833|NCT02242942|9825462|P2|Overall Study|Death|20
2858834|NCT02242942|9825463|P1|Overall Study|Death|17
2858835|NCT02242903|9825497|P7|Overall Study|Withdrawal by Subject|0
2858836|NCT02242903|9825498|P6|Overall Study|Withdrawal by Subject|0
2858837|NCT02242903|9825499|P5|Overall Study|Withdrawal by Subject|0
2858838|NCT02242903|9825500|P4|Overall Study|Withdrawal by Subject|0
2858839|NCT02242903|9825501|P3|Overall Study|Withdrawal by Subject|0
2858840|NCT02242903|9825502|P2|Overall Study|Withdrawal by Subject|0
2858841|NCT02242903|9825503|P1|Overall Study|Withdrawal by Subject|1
2858842|NCT02242643|9825533|P2|Overall Study|Withdrawal by subject at Visit 2|1
2858843|NCT02242643|9825534|P1|Overall Study|Withdrawal by subject at Visit 2|0
2858844|NCT02242643|9825533|P2|Overall Study|Language barrier|0
2858845|NCT02242643|9825534|P1|Overall Study|Language barrier|1
2858846|NCT02242643|9825533|P2|Overall Study|Protocol requirements not followed|0
2858847|NCT02242643|9825534|P1|Overall Study|Protocol requirements not followed|1
2858848|NCT02242643|9825533|P2|Overall Study|Consent withdrawal by parent|0
2858849|NCT02242643|9825534|P1|Overall Study|Consent withdrawal by parent|1
2858850|NCT02242643|9825533|P2|Overall Study|Non-compliance|0
2858851|NCT02242643|9825534|P1|Overall Study|Non-compliance|1
2858852|NCT02242643|9825533|P2|Overall Study|Child placed in foster care by family|1
2858853|NCT02242643|9825534|P1|Overall Study|Child placed in foster care by family|0
2858854|NCT02242643|9825533|P2|Overall Study|Lost to Follow-up|61
2858855|NCT02242643|9825534|P1|Overall Study|Lost to Follow-up|54
2858856|NCT02242643|9825533|P2|Overall Study|Migrated/moved from study area|3
2858857|NCT02242643|9825534|P1|Overall Study|Migrated/moved from study area|1
2858858|NCT02242643|9825533|P2|Overall Study|Withdrawal by Subject|10
2858859|NCT02242643|9825534|P1|Overall Study|Withdrawal by Subject|15
2858860|NCT02242643|9825533|P2|Overall Study|Protocol Violation|2
2858861|NCT02242643|9825534|P1|Overall Study|Protocol Violation|1
2858862|NCT02242487|9825589|P2|Overall Study|Withdrawal by Subject|19
2858863|NCT02242487|9825590|P1|Overall Study|Withdrawal by Subject|37
2858864|NCT02242487|9825589|P2|Overall Study|Other - Miscellaneous|6
2858865|NCT02242487|9825590|P1|Overall Study|Other - Miscellaneous|4
2858866|NCT02242487|9825589|P2|Overall Study|Lost to Follow-up|1
2858867|NCT02242487|9825590|P1|Overall Study|Lost to Follow-up|2
2858868|NCT02242487|9825589|P2|Overall Study|Protocol Violation|0
2858869|NCT02242487|9825590|P1|Overall Study|Protocol Violation|2
2858870|NCT02242487|9825589|P2|Overall Study|Lack of Efficacy|6
2858871|NCT02242487|9825590|P1|Overall Study|Lack of Efficacy|4
2858872|NCT02242487|9825589|P2|Overall Study|Adverse Event|15
2858873|NCT02242487|9825590|P1|Overall Study|Adverse Event|13
2858874|NCT02242305|9825606|P2|Overall Study|Lost to Follow-up|0
2858875|NCT02242305|9825607|P1|Overall Study|Lost to Follow-up|2
2858876|NCT02242305|9825606|P2|Overall Study|Subject withdraws inform consent|4
2858877|NCT02242305|9825607|P1|Overall Study|Subject withdraws inform consent|0
2858878|NCT02242305|9825606|P2|Overall Study|Non-compliance dosing regimen or visit|2
2858879|NCT02242305|9825607|P1|Overall Study|Non-compliance dosing regimen or visit|2
2858880|NCT02242305|9825606|P2|Overall Study|Adverse Event|0
2858881|NCT02242305|9825607|P1|Overall Study|Adverse Event|1
2858882|NCT02242305|9825606|P2|Overall Study|Without spasm-like pain during 3 weeks|4
2858883|NCT02242305|9825607|P1|Overall Study|Without spasm-like pain during 3 weeks|1
2858884|NCT02242201|9825628|P3|Overall Study|preoperative opioid consumption|0
2858885|NCT02242201|9825629|P2|Overall Study|preoperative opioid consumption|1
2858886|NCT02242201|9825630|P1|Overall Study|preoperative opioid consumption|0
2858887|NCT02242201|9825628|P3|Overall Study|postponed surgery|1
2858888|NCT02242201|9825629|P2|Overall Study|postponed surgery|0
2858889|NCT02242201|9825630|P1|Overall Study|postponed surgery|0
2858890|NCT02242201|9825628|P3|Overall Study|changed surgical procedure|0
2858891|NCT02242201|9825629|P2|Overall Study|changed surgical procedure|0
2858892|NCT02242201|9825630|P1|Overall Study|changed surgical procedure|1
2858893|NCT02242201|9825628|P3|Overall Study|planned post-op anticoagulation|0
2858894|NCT02242201|9825629|P2|Overall Study|planned post-op anticoagulation|0
2858895|NCT02242201|9825630|P1|Overall Study|planned post-op anticoagulation|1
2858896|NCT02242201|9825628|P3|Overall Study|preoperative identified neuropathy|0
2858897|NCT02242201|9825629|P2|Overall Study|preoperative identified neuropathy|0
2858898|NCT02242201|9825630|P1|Overall Study|preoperative identified neuropathy|2
2858899|NCT02241889|9825668|P6|Overall Study|Withdrawal by Subject|1
2858900|NCT02241889|9825669|P5|Overall Study|Withdrawal by Subject|0
2858901|NCT02241889|9825670|P4|Overall Study|Withdrawal by Subject|0
2858902|NCT02241889|9825671|P3|Overall Study|Withdrawal by Subject|0
2858903|NCT02241889|9825672|P2|Overall Study|Withdrawal by Subject|0
2858904|NCT02241889|9825673|P1|Overall Study|Withdrawal by Subject|0
2858905|NCT02241889|9825668|P6|Overall Study|device issues|0
2858906|NCT02241889|9825669|P5|Overall Study|device issues|0
2858907|NCT02241889|9825670|P4|Overall Study|device issues|0
2858908|NCT02241889|9825671|P3|Overall Study|device issues|1
2858909|NCT02241889|9825672|P2|Overall Study|device issues|0
2858910|NCT02241889|9825673|P1|Overall Study|device issues|0
2858911|NCT02241785|9825708|P1|Overall Study|Adverse Event|1
2858912|NCT02241785|9825708|P1|Overall Study|Lost to Follow-up|2
2858913|NCT02241785|9825708|P1|Overall Study|Withdrawal by Subject|1
2858914|NCT02241785|9825708|P1|Overall Study|Sponsor Termination|43
2858915|NCT02241733|9825718|P2|Overall Study|Death|2
2858916|NCT02241733|9825719|P1|Overall Study|Death|0
2858917|NCT02241733|9825718|P2|Overall Study|Withdrawal by Subject|2
2858918|NCT02241733|9825719|P1|Overall Study|Withdrawal by Subject|0
2858919|NCT02241733|9825718|P2|Overall Study|Physician Decision|2
2858920|NCT02241733|9825719|P1|Overall Study|Physician Decision|6
2858921|NCT02241733|9825718|P2|Overall Study|Lost to Follow-up|4
2858922|NCT02241733|9825719|P1|Overall Study|Lost to Follow-up|9
2858923|NCT02241551|9825758|P2|Overall Study|Adverse Event|0
2858924|NCT02241551|9825759|P1|Overall Study|Adverse Event|1
2858925|NCT02241512|9825781|P2|Overall Study|Pump malfunction, drug not delivered|0
2858926|NCT02241512|9825782|P1|Overall Study|Pump malfunction, drug not delivered|1
2858927|NCT02241187|9825798|P1|Overall Study|Protocol closed due to lack of accrual.|2
2858928|NCT02240693|9825830|P5|Overall Study|Other than specified|0
2858929|NCT02240693|9825831|P4|Overall Study|Other than specified|0
2858930|NCT02240693|9825832|P3|Overall Study|Other than specified|2
2858931|NCT02240693|9825833|P2|Overall Study|Other than specified|0
2858932|NCT02240693|9825834|P1|Overall Study|Other than specified|0
2858933|NCT02240693|9825830|P5|Overall Study|Withdrawal by Subject|0
2858934|NCT02240693|9825831|P4|Overall Study|Withdrawal by Subject|1
2858935|NCT02240693|9825832|P3|Overall Study|Withdrawal by Subject|2
2858936|NCT02240693|9825833|P2|Overall Study|Withdrawal by Subject|0
2858937|NCT02240693|9825834|P1|Overall Study|Withdrawal by Subject|0
2858938|NCT02240693|9825830|P5|Overall Study|Adverse Event|1
2858939|NCT02240693|9825831|P4|Overall Study|Adverse Event|0
2858940|NCT02240693|9825832|P3|Overall Study|Adverse Event|0
2858941|NCT02240693|9825833|P2|Overall Study|Adverse Event|0
2858942|NCT02240693|9825834|P1|Overall Study|Adverse Event|0
2858943|NCT02240680|9825870|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2858944|NCT02240680|9825871|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
2858945|NCT02240680|9825872|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2858946|NCT02240680|9825873|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2858947|NCT02240680|9825870|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2858948|NCT02240680|9825871|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
2858949|NCT02240680|9825872|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2858950|NCT02240680|9825873|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2859035|NCT02239679|9826199|P3|Overall Study|Withdrawal by Subject|1
2858951|NCT02240680|9825870|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
2858952|NCT02240680|9825871|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
2858953|NCT02240680|9825872|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2858954|NCT02240680|9825873|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2858955|NCT02240680|9825870|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
2858956|NCT02240680|9825871|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
2858957|NCT02240680|9825872|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
2858958|NCT02240680|9825873|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
2858959|NCT02240680|9825870|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2858960|NCT02240680|9825871|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2858961|NCT02240680|9825872|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
2858962|NCT02240680|9825873|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
2858963|NCT02240680|9825870|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2858964|NCT02240680|9825871|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2858965|NCT02240680|9825872|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2858966|NCT02240680|9825873|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
2858967|NCT02240680|9825870|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2858968|NCT02240680|9825871|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2858969|NCT02240680|9825872|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
2858970|NCT02240680|9825873|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
2858971|NCT02240680|9825870|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
2858972|NCT02240680|9825871|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
2858973|NCT02240680|9825872|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
2858974|NCT02240680|9825873|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
2858975|NCT02240628|9825927|P2|Overall Study|Physician Decision|5
2858976|NCT02240628|9825928|P1|Overall Study|Physician Decision|6
2858977|NCT02240368|9825962|P3|Overall Study|Entropy failed to detect more than 50%|1
2858978|NCT02240368|9825963|P2|Overall Study|Entropy failed to detect more than 50%|0
2858979|NCT02240368|9825964|P1|Overall Study|Entropy failed to detect more than 50%|0
2858980|NCT02240368|9825962|P3|Overall Study|Surgery lasted less then 20 minutes|0
2858981|NCT02240368|9825963|P2|Overall Study|Surgery lasted less then 20 minutes|0
2858982|NCT02240368|9825964|P1|Overall Study|Surgery lasted less then 20 minutes|1
2858983|NCT02240121|9825996|P2|Overall Study|Other than specified|3
2858984|NCT02240121|9825997|P1|Overall Study|Other than specified|1
2858985|NCT02240121|9825996|P2|Overall Study|Lost to Follow-up|4
2858986|NCT02240121|9825997|P1|Overall Study|Lost to Follow-up|3
2858987|NCT02240121|9825996|P2|Overall Study|Withdrawal by Subject|2
2858988|NCT02240121|9825997|P1|Overall Study|Withdrawal by Subject|6
2858989|NCT02240121|9825996|P2|Overall Study|Adverse Event|4
2858990|NCT02240121|9825997|P1|Overall Study|Adverse Event|2
2858991|NCT02240121|9825996|P2|Overall Study|Pregnancy|0
2858992|NCT02240121|9825997|P1|Overall Study|Pregnancy|1
2858993|NCT02240121|9825996|P2|Overall Study|Site closed|1
2858994|NCT02240121|9825997|P1|Overall Study|Site closed|1
2858995|NCT02240121|9825996|P2|Overall Study|Lack of Efficacy|3
2858996|NCT02240121|9825997|P1|Overall Study|Lack of Efficacy|2
2858997|NCT02240121|9825996|P2|Overall Study|Change in protocol interpretation|0
2858998|NCT02240121|9825997|P1|Overall Study|Change in protocol interpretation|1
2858999|NCT02240121|9825996|P2|Overall Study|Physician Decision|1
2859000|NCT02240121|9825997|P1|Overall Study|Physician Decision|0
2859001|NCT02240121|9825996|P2|Overall Study|Protocol Violation|2
2859002|NCT02240121|9825997|P1|Overall Study|Protocol Violation|1
2859003|NCT02240108|9826025|P2|Overall Study|StudyTerminated by Sponsor|1
2859004|NCT02240108|9826026|P1|Overall Study|StudyTerminated by Sponsor|0
2859005|NCT02240108|9826025|P2|Overall Study|Withdrawal by Subject|9
2859006|NCT02240108|9826026|P1|Overall Study|Withdrawal by Subject|4
2859007|NCT02240108|9826025|P2|Overall Study|Pregnancy|0
2859008|NCT02240108|9826026|P1|Overall Study|Pregnancy|1
2859009|NCT02240108|9826025|P2|Overall Study|Adverse Event|9
2859010|NCT02240108|9826026|P1|Overall Study|Adverse Event|1
2859011|NCT02240108|9826025|P2|Overall Study|Other than specified|6
2859012|NCT02240108|9826026|P1|Overall Study|Other than specified|8
2859013|NCT02239978|9826081|P2|Overall Study|Withdrawal by Subject|0
2859014|NCT02239978|9826082|P1|Overall Study|Withdrawal by Subject|2
2859015|NCT02239939|9826099|P2|Overall Study|Lost to Follow-up|1
2859016|NCT02239939|9826100|P1|Overall Study|Lost to Follow-up|0
2859017|NCT02239939|9826099|P2|Overall Study|Withdrawal by Subject|1
2859018|NCT02239939|9826100|P1|Overall Study|Withdrawal by Subject|1
2859019|NCT02239939|9826099|P2|Overall Study|Adverse Event|0
2859020|NCT02239939|9826100|P1|Overall Study|Adverse Event|1
2859021|NCT02239926|9826116|P2|Overall Study|Withdrawal by Subject|1
2859022|NCT02239926|9826117|P1|Overall Study|Withdrawal by Subject|0
2859023|NCT02239692|9826179|P2|Overall Study|Other reason|0
2859024|NCT02239692|9826180|P1|Overall Study|Other reason|1
2859025|NCT02239692|9826179|P2|Overall Study|Withdrawal by Subject|5
2859026|NCT02239692|9826180|P1|Overall Study|Withdrawal by Subject|3
2859027|NCT02239692|9826179|P2|Overall Study|Lost to Follow-up|4
2859028|NCT02239692|9826180|P1|Overall Study|Lost to Follow-up|1
2859029|NCT02239692|9826179|P2|Overall Study|Physician Decision|1
2859030|NCT02239692|9826180|P1|Overall Study|Physician Decision|0
2859031|NCT02239692|9826179|P2|Overall Study|Adverse Event|1
2859032|NCT02239692|9826180|P1|Overall Study|Adverse Event|0
2859033|NCT02239692|9826179|P2|Overall Study|Incomplete colonoscopy|2
2859034|NCT02239692|9826180|P1|Overall Study|Incomplete colonoscopy|1
2861389|NCT02203149|9836222|P2|Part 2|Death|0
2859036|NCT02239679|9826200|P2|Overall Study|Withdrawal by Subject|3
2859037|NCT02239679|9826201|P1|Overall Study|Withdrawal by Subject|2
2859038|NCT02239679|9826199|P3|Overall Study|Lost to Follow-up|0
2859039|NCT02239679|9826200|P2|Overall Study|Lost to Follow-up|0
2859040|NCT02239679|9826201|P1|Overall Study|Lost to Follow-up|1
2859041|NCT02239640|9826413|P1|Overall Study|Death|142
2859042|NCT02239640|9826413|P1|Overall Study|Lost to Follow-up|72
2859043|NCT02239640|9826413|P1|Overall Study|Withdrawal by Subject|3
2859044|NCT02239601|9826425|P2|Overall Study|Protocol Violation|2
2859045|NCT02239601|9826426|P1|Overall Study|Protocol Violation|4
2859046|NCT02239601|9826425|P2|Overall Study|Withdrawal by Subject|4
2859047|NCT02239601|9826426|P1|Overall Study|Withdrawal by Subject|3
2859048|NCT02239536|9826479|P2|Overall Study|Non-neoplastic polyp|17
2859049|NCT02239536|9826480|P1|Overall Study|Non-neoplastic polyp|23
2859050|NCT02239510|9826490|P2|Overall Study|Lost to Follow-up|1
2859051|NCT02239510|9826491|P1|Overall Study|Lost to Follow-up|2
2859052|NCT02239328|9826513|P1|Overall Study|Equipment or website malfunction|2
2859053|NCT02239328|9826513|P1|Overall Study|Benign disease noted at time of surgery|6
2859054|NCT02239120|9826538|P2|Overall Study|Lost to Follow-up|14
2859055|NCT02239120|9826539|P1|Overall Study|Lost to Follow-up|19
2859056|NCT02239120|9826538|P2|Overall Study|Death|58
2859057|NCT02239120|9826539|P1|Overall Study|Death|56
2859058|NCT02239094|9826563|P1|Overall Study|Remitted before started|1
2859059|NCT02239094|9826563|P1|Overall Study|Withdrawal by Subject|1
2859060|NCT02238483|9826618|P2|Overall Study|Illness in family member|0
2859061|NCT02238483|9826619|P1|Overall Study|Illness in family member|1
2859062|NCT02238483|9826618|P2|Overall Study|Completion status not recorded|1
2859063|NCT02238483|9826619|P1|Overall Study|Completion status not recorded|1
2859064|NCT02238483|9826618|P2|Overall Study|Withdrawn due to physician decision|0
2859065|NCT02238483|9826619|P1|Overall Study|Withdrawn due to physician decision|1
2859066|NCT02238483|9826618|P2|Overall Study|Adverse Event|3
2859067|NCT02238483|9826619|P1|Overall Study|Adverse Event|7
2859068|NCT02238483|9826618|P2|Overall Study|Death|0
2859069|NCT02238483|9826619|P1|Overall Study|Death|1
2859070|NCT02238483|9826618|P2|Overall Study|Protocol Violation|2
2859071|NCT02238483|9826619|P1|Overall Study|Protocol Violation|1
2859072|NCT02238483|9826618|P2|Overall Study|Lost to Follow-up|1
2859073|NCT02238483|9826619|P1|Overall Study|Lost to Follow-up|1
2859074|NCT02238483|9826618|P2|Overall Study|Withdrawal by Subject|7
2859075|NCT02238483|9826619|P1|Overall Study|Withdrawal by Subject|2
2859076|NCT02238379|9826657|P2|Overall Study|Lost to Follow-up|0
2859077|NCT02238379|9826658|P1|Overall Study|Lost to Follow-up|1
2859078|NCT02238080|9826684|P1|Overall Study|Other|4
2859079|NCT02238080|9826684|P1|Overall Study|Withdrawal by Subject|2
2859080|NCT02238080|9826684|P1|Overall Study|Treatment interrupted|6
2859081|NCT02238080|9826684|P1|Overall Study|Death|13
2859082|NCT02238067|9826698|P1|Overall Study|Not completed survey at Month 6|45
2859083|NCT02237911|9826769|P3|Overall Study|Lost to Follow-up|1
2859084|NCT02237911|9826770|P2|Overall Study|Lost to Follow-up|1
2859085|NCT02237911|9826771|P1|Overall Study|Lost to Follow-up|3
2859086|NCT02237911|9826769|P3|Overall Study|Withdrawal by Subject|2
2859087|NCT02237911|9826770|P2|Overall Study|Withdrawal by Subject|7
2859088|NCT02237911|9826771|P1|Overall Study|Withdrawal by Subject|4
2859089|NCT02237196|9826811|P4|Overall Study|Site Error|2
2859090|NCT02237196|9826812|P3|Overall Study|Site Error|0
2859091|NCT02237196|9826813|P2|Overall Study|Site Error|2
2859092|NCT02237196|9826814|P1|Overall Study|Site Error|1
2859093|NCT02237196|9826811|P4|Overall Study|Withdrawal by Subject|1
2859094|NCT02237196|9826812|P3|Overall Study|Withdrawal by Subject|4
2859095|NCT02237196|9826813|P2|Overall Study|Withdrawal by Subject|1
2859096|NCT02237196|9826814|P1|Overall Study|Withdrawal by Subject|1
2859097|NCT02237196|9826811|P4|Overall Study|Pregnancy|1
2859098|NCT02237196|9826812|P3|Overall Study|Pregnancy|1
2859099|NCT02237196|9826813|P2|Overall Study|Pregnancy|0
2859100|NCT02237196|9826814|P1|Overall Study|Pregnancy|0
2859101|NCT02237196|9826811|P4|Overall Study|Physician Decision|1
2859102|NCT02237196|9826812|P3|Overall Study|Physician Decision|0
2859103|NCT02237196|9826813|P2|Overall Study|Physician Decision|0
2859104|NCT02237196|9826814|P1|Overall Study|Physician Decision|2
2859105|NCT02237196|9826811|P4|Overall Study|Lost to Follow-up|6
2859106|NCT02237196|9826812|P3|Overall Study|Lost to Follow-up|4
2859107|NCT02237196|9826813|P2|Overall Study|Lost to Follow-up|2
2859108|NCT02237196|9826814|P1|Overall Study|Lost to Follow-up|4
2859109|NCT02237196|9826811|P4|Overall Study|Adverse Event|0
2859110|NCT02237196|9826812|P3|Overall Study|Adverse Event|1
2859111|NCT02237196|9826813|P2|Overall Study|Adverse Event|1
2859112|NCT02237196|9826814|P1|Overall Study|Adverse Event|0
2859113|NCT02237118|9826858|P2|Overall Study|consent withdrawn|0
2859114|NCT02237118|9826859|P1|Overall Study|consent withdrawn|1
2859115|NCT02237118|9826858|P2|Overall Study|Protocol Violation|1
2859116|NCT02237118|9826859|P1|Overall Study|Protocol Violation|0
2859117|NCT02236611|9826896|P2|Overall Study|Withdrew consent|4
2859118|NCT02236611|9826897|P1|Overall Study|Withdrew consent|9
2859119|NCT02236611|9826896|P2|Overall Study|Protocol deviation|5
2859120|NCT02236611|9826897|P1|Overall Study|Protocol deviation|3
2859121|NCT02236611|9826896|P2|Overall Study|Lost to Follow-up|2
2859122|NCT02236611|9826897|P1|Overall Study|Lost to Follow-up|0
2859123|NCT02236611|9826896|P2|Overall Study|Lack of Efficacy|7
2859124|NCT02236611|9826897|P1|Overall Study|Lack of Efficacy|4
2861390|NCT02203149|9836223|P1|Part 2|Death|0
2859125|NCT02236611|9826896|P2|Overall Study|Adverse Event|16
2859126|NCT02236611|9826897|P1|Overall Study|Adverse Event|10
2859127|NCT02236598|9826905|P2|Overall Study|Withdrawal by Subject|1
2859128|NCT02236598|9826906|P1|Overall Study|Withdrawal by Subject|0
2859129|NCT02236598|9826905|P2|Overall Study|Adverse Event|1
2859130|NCT02236598|9826906|P1|Overall Study|Adverse Event|0
2859131|NCT02236559|9826920|P2|Overall Study|Withdrawal by Subject|0
2859132|NCT02236559|9826921|P1|Overall Study|Withdrawal by Subject|1
2859133|NCT02236559|9826920|P2|Overall Study|Physician Decision|1
2859134|NCT02236559|9826921|P1|Overall Study|Physician Decision|1
2859135|NCT02236559|9826920|P2|Overall Study|Subject Did Not Consent|2
2859136|NCT02236559|9826921|P1|Overall Study|Subject Did Not Consent|4
2859137|NCT02236559|9826920|P2|Overall Study|Did not Meet Inclusion|3
2859138|NCT02236559|9826921|P1|Overall Study|Did not Meet Inclusion|3
2859139|NCT02236559|9826920|P2|Overall Study|Met Exclusion|6
2859140|NCT02236559|9826921|P1|Overall Study|Met Exclusion|3
2859141|NCT02236520|9826958|P4|Overall Study|Pregnancy|0
2859142|NCT02236520|9826959|P3|Overall Study|Pregnancy|0
2859143|NCT02236520|9826960|P2|Overall Study|Pregnancy|0
2859144|NCT02236520|9826961|P1|Overall Study|Pregnancy|1
2859145|NCT02236520|9826958|P4|Overall Study|Withdrawal by Subject|1
2859146|NCT02236520|9826959|P3|Overall Study|Withdrawal by Subject|0
2859147|NCT02236520|9826960|P2|Overall Study|Withdrawal by Subject|0
2859148|NCT02236520|9826961|P1|Overall Study|Withdrawal by Subject|1
2859149|NCT02236520|9826958|P4|Overall Study|Physician Decision|0
2859150|NCT02236520|9826959|P3|Overall Study|Physician Decision|0
2859151|NCT02236520|9826960|P2|Overall Study|Physician Decision|5
2859152|NCT02236520|9826961|P1|Overall Study|Physician Decision|0
2859153|NCT02236130|9826988|P2|Overall Study|Lost to Follow-up|12
2859154|NCT02236130|9826989|P1|Overall Study|Lost to Follow-up|7
2859155|NCT02235454|9827039|P1|Overall Study|Withdrawal by Subject|2
2859156|NCT02235311|9827045|P2|Overall Study|Protocol Violation|1
2859157|NCT02235311|9827046|P1|Overall Study|Protocol Violation|0
2859158|NCT02235311|9827045|P2|Overall Study|Lost to Follow-up|1
2859159|NCT02235311|9827046|P1|Overall Study|Lost to Follow-up|0
2859160|NCT02235077|9827064|P2|Overall Study|Physician Decision|1
2859161|NCT02235077|9827065|P1|Overall Study|Physician Decision|0
2859162|NCT02235077|9827064|P2|Overall Study|Withdrawal by Subject|5
2859163|NCT02235077|9827065|P1|Overall Study|Withdrawal by Subject|8
2859164|NCT02235077|9827064|P2|Overall Study|Lost to Follow-up|6
2859165|NCT02235077|9827065|P1|Overall Study|Lost to Follow-up|5
2859166|NCT02235077|9827064|P2|Overall Study|Death|7
2859167|NCT02235077|9827065|P1|Overall Study|Death|5
2859168|NCT02234843|9827130|P10|Overall Study|Lost to Follow-up|0
2859169|NCT02234843|9827131|P9|Overall Study|Lost to Follow-up|0
2859170|NCT02234843|9827132|P8|Overall Study|Lost to Follow-up|0
2859171|NCT02234843|9827133|P7|Overall Study|Lost to Follow-up|1
2859172|NCT02234843|9827134|P6|Overall Study|Lost to Follow-up|0
2859173|NCT02234843|9827135|P5|Overall Study|Lost to Follow-up|0
2859174|NCT02234843|9827136|P4|Overall Study|Lost to Follow-up|0
2859175|NCT02234843|9827137|P3|Overall Study|Lost to Follow-up|0
2859176|NCT02234843|9827138|P2|Overall Study|Lost to Follow-up|1
2859177|NCT02234843|9827139|P1|Overall Study|Lost to Follow-up|0
2859178|NCT02234843|9827130|P10|Overall Study|Non-compliance with study drug|0
2859179|NCT02234843|9827131|P9|Overall Study|Non-compliance with study drug|0
2859180|NCT02234843|9827132|P8|Overall Study|Non-compliance with study drug|0
2859181|NCT02234843|9827133|P7|Overall Study|Non-compliance with study drug|1
2859182|NCT02234843|9827134|P6|Overall Study|Non-compliance with study drug|1
2859183|NCT02234843|9827135|P5|Overall Study|Non-compliance with study drug|0
2859184|NCT02234843|9827136|P4|Overall Study|Non-compliance with study drug|0
2859185|NCT02234843|9827137|P3|Overall Study|Non-compliance with study drug|0
2859186|NCT02234843|9827138|P2|Overall Study|Non-compliance with study drug|0
2859187|NCT02234843|9827139|P1|Overall Study|Non-compliance with study drug|1
2859188|NCT02234843|9827130|P10|Overall Study|Adverse Event|0
2859189|NCT02234843|9827131|P9|Overall Study|Adverse Event|1
2859190|NCT02234843|9827132|P8|Overall Study|Adverse Event|0
2859191|NCT02234843|9827133|P7|Overall Study|Adverse Event|0
2859192|NCT02234843|9827134|P6|Overall Study|Adverse Event|1
2859193|NCT02234843|9827135|P5|Overall Study|Adverse Event|2
2859194|NCT02234843|9827136|P4|Overall Study|Adverse Event|3
2859195|NCT02234843|9827137|P3|Overall Study|Adverse Event|1
2859196|NCT02234843|9827138|P2|Overall Study|Adverse Event|1
2859197|NCT02234843|9827139|P1|Overall Study|Adverse Event|5
2859198|NCT02234843|9827130|P10|Overall Study|Physician Decision|0
2859199|NCT02234843|9827131|P9|Overall Study|Physician Decision|0
2859200|NCT02234843|9827132|P8|Overall Study|Physician Decision|1
2859201|NCT02234843|9827133|P7|Overall Study|Physician Decision|0
2859202|NCT02234843|9827134|P6|Overall Study|Physician Decision|0
2859203|NCT02234843|9827135|P5|Overall Study|Physician Decision|0
2859204|NCT02234843|9827136|P4|Overall Study|Physician Decision|1
2859205|NCT02234843|9827137|P3|Overall Study|Physician Decision|0
2859206|NCT02234843|9827138|P2|Overall Study|Physician Decision|1
2859207|NCT02234843|9827139|P1|Overall Study|Physician Decision|4
2859208|NCT02234843|9827130|P10|Overall Study|Other|0
2859209|NCT02234843|9827131|P9|Overall Study|Other|0
2859210|NCT02234843|9827132|P8|Overall Study|Other|1
2859211|NCT02234843|9827133|P7|Overall Study|Other|0
2859212|NCT02234843|9827134|P6|Overall Study|Other|1
2859213|NCT02234843|9827135|P5|Overall Study|Other|0
2859214|NCT02234843|9827136|P4|Overall Study|Other|1
2859215|NCT02234843|9827137|P3|Overall Study|Other|0
2859216|NCT02234843|9827138|P2|Overall Study|Other|2
2859217|NCT02234843|9827139|P1|Overall Study|Other|0
2859218|NCT02234843|9827130|P10|Overall Study|Recovery|0
2859219|NCT02234843|9827131|P9|Overall Study|Recovery|0
2859220|NCT02234843|9827132|P8|Overall Study|Recovery|0
2859221|NCT02234843|9827133|P7|Overall Study|Recovery|0
2859222|NCT02234843|9827134|P6|Overall Study|Recovery|0
2859223|NCT02234843|9827135|P5|Overall Study|Recovery|0
2859224|NCT02234843|9827136|P4|Overall Study|Recovery|0
2859225|NCT02234843|9827137|P3|Overall Study|Recovery|0
2859226|NCT02234843|9827138|P2|Overall Study|Recovery|0
2859227|NCT02234843|9827139|P1|Overall Study|Recovery|1
2859228|NCT02234843|9827130|P10|Overall Study|Withdrawal by Subject|0
2859229|NCT02234843|9827131|P9|Overall Study|Withdrawal by Subject|0
2859230|NCT02234843|9827132|P8|Overall Study|Withdrawal by Subject|0
2859231|NCT02234843|9827133|P7|Overall Study|Withdrawal by Subject|0
2859232|NCT02234843|9827134|P6|Overall Study|Withdrawal by Subject|7
2859233|NCT02234843|9827135|P5|Overall Study|Withdrawal by Subject|0
2859234|NCT02234843|9827136|P4|Overall Study|Withdrawal by Subject|0
2859235|NCT02234843|9827137|P3|Overall Study|Withdrawal by Subject|1
2859236|NCT02234843|9827138|P2|Overall Study|Withdrawal by Subject|1
2859237|NCT02234843|9827139|P1|Overall Study|Withdrawal by Subject|5
2859238|NCT02234843|9827130|P10|Overall Study|Patient convenience|0
2859239|NCT02234843|9827131|P9|Overall Study|Patient convenience|0
2859240|NCT02234843|9827132|P8|Overall Study|Patient convenience|0
2859241|NCT02234843|9827133|P7|Overall Study|Patient convenience|0
2859242|NCT02234843|9827134|P6|Overall Study|Patient convenience|1
2859243|NCT02234843|9827135|P5|Overall Study|Patient convenience|0
2859244|NCT02234843|9827136|P4|Overall Study|Patient convenience|0
2859245|NCT02234843|9827137|P3|Overall Study|Patient convenience|0
2859246|NCT02234843|9827138|P2|Overall Study|Patient convenience|0
2859247|NCT02234843|9827139|P1|Overall Study|Patient convenience|2
2859248|NCT02234843|9827130|P10|Overall Study|Efficacy outcome reached|0
2859249|NCT02234843|9827131|P9|Overall Study|Efficacy outcome reached|0
2859250|NCT02234843|9827132|P8|Overall Study|Efficacy outcome reached|0
2859251|NCT02234843|9827133|P7|Overall Study|Efficacy outcome reached|0
2859252|NCT02234843|9827134|P6|Overall Study|Efficacy outcome reached|2
2859253|NCT02234843|9827135|P5|Overall Study|Efficacy outcome reached|0
2859254|NCT02234843|9827136|P4|Overall Study|Efficacy outcome reached|0
2859255|NCT02234843|9827137|P3|Overall Study|Efficacy outcome reached|0
2859256|NCT02234843|9827138|P2|Overall Study|Efficacy outcome reached|0
2859257|NCT02234843|9827139|P1|Overall Study|Efficacy outcome reached|2
2859258|NCT02234843|9827130|P10|Overall Study|Protocol Violation|0
2859259|NCT02234843|9827131|P9|Overall Study|Protocol Violation|0
2859260|NCT02234843|9827132|P8|Overall Study|Protocol Violation|0
2859261|NCT02234843|9827133|P7|Overall Study|Protocol Violation|0
2859262|NCT02234843|9827134|P6|Overall Study|Protocol Violation|0
2859263|NCT02234843|9827135|P5|Overall Study|Protocol Violation|0
2859264|NCT02234843|9827136|P4|Overall Study|Protocol Violation|0
2859265|NCT02234843|9827137|P3|Overall Study|Protocol Violation|1
2859266|NCT02234843|9827138|P2|Overall Study|Protocol Violation|0
2859267|NCT02234843|9827139|P1|Overall Study|Protocol Violation|1
2859268|NCT02234843|9827130|P10|Overall Study|Death|0
2859269|NCT02234843|9827131|P9|Overall Study|Death|0
2859270|NCT02234843|9827132|P8|Overall Study|Death|0
2859271|NCT02234843|9827133|P7|Overall Study|Death|0
2859272|NCT02234843|9827134|P6|Overall Study|Death|0
2859273|NCT02234843|9827135|P5|Overall Study|Death|0
2859274|NCT02234843|9827136|P4|Overall Study|Death|0
2859275|NCT02234843|9827137|P3|Overall Study|Death|0
2859276|NCT02234843|9827138|P2|Overall Study|Death|0
2859277|NCT02234843|9827139|P1|Overall Study|Death|1
2859278|NCT02234622|9827297|P2|Overall Study|Lost to Follow-up|14
2859279|NCT02234622|9827298|P1|Overall Study|Lost to Follow-up|27
2859280|NCT02234622|9827297|P2|Overall Study|Withdrawal by Subject|22
2859281|NCT02234622|9827298|P1|Overall Study|Withdrawal by Subject|16
2859282|NCT02234479|9827407|P2|Overall Study|Withdrawal by Subject|3
2859283|NCT02234479|9827408|P1|Overall Study|Withdrawal by Subject|1
2859284|NCT02234362|9827418|P1|Overall Study|Withdrawal by Subject|3
2859285|NCT02234362|9827418|P1|Overall Study|Lost to Follow-up|6
2859286|NCT02234362|9827418|P1|Overall Study|Not eligible after first screening visit|17
2859287|NCT02234284|9827437|P2|Overall Study|Lost to Follow-up|7
2859288|NCT02234284|9827438|P1|Overall Study|Lost to Follow-up|20
2859289|NCT02234284|9827437|P2|Overall Study|Withdrawal by Subject|0
2859290|NCT02234284|9827438|P1|Overall Study|Withdrawal by Subject|1
2859291|NCT02234284|9827437|P2|Overall Study|Death|2
2859292|NCT02234284|9827438|P1|Overall Study|Death|4
2859293|NCT02234141|9827497|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
2859294|NCT02234141|9827498|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
2859295|NCT02234141|9827499|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
2859296|NCT02234141|9827500|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
2859297|NCT02234141|9827501|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
2859298|NCT02234141|9827502|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
2859299|NCT02234141|9827503|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
2859300|NCT02234141|9827497|P7|Long-Term Treatment Period|Withdrew Consent|0
2859301|NCT02234141|9827498|P6|Long-Term Treatment Period|Withdrew Consent|0
2859302|NCT02234141|9827499|P5|Long-Term Treatment Period|Withdrew Consent|0
2859303|NCT02234141|9827500|P4|Long-Term Treatment Period|Withdrew Consent|0
2859304|NCT02234141|9827501|P3|Long-Term Treatment Period|Withdrew Consent|1
2859305|NCT02234141|9827502|P2|Long-Term Treatment Period|Withdrew Consent|1
2859306|NCT02234141|9827503|P1|Long-Term Treatment Period|Withdrew Consent|0
2859307|NCT02234141|9827497|P7|Long-Term Treatment Period|Adverse Event|1
2859308|NCT02234141|9827498|P6|Long-Term Treatment Period|Adverse Event|1
2859309|NCT02234141|9827499|P5|Long-Term Treatment Period|Adverse Event|1
2859310|NCT02234141|9827500|P4|Long-Term Treatment Period|Adverse Event|0
2859311|NCT02234141|9827501|P3|Long-Term Treatment Period|Adverse Event|5
2859312|NCT02234141|9827502|P2|Long-Term Treatment Period|Adverse Event|0
2859313|NCT02234141|9827503|P1|Long-Term Treatment Period|Adverse Event|4
2859314|NCT02234141|9827497|P7|Long-Term Treatment Period|Investigator's discretion|1
2859315|NCT02234141|9827498|P6|Long-Term Treatment Period|Investigator's discretion|0
2859316|NCT02234141|9827499|P5|Long-Term Treatment Period|Investigator's discretion|0
2859317|NCT02234141|9827500|P4|Long-Term Treatment Period|Investigator's discretion|0
2859318|NCT02234141|9827501|P3|Long-Term Treatment Period|Investigator's discretion|2
2859319|NCT02234141|9827502|P2|Long-Term Treatment Period|Investigator's discretion|3
2859320|NCT02234141|9827503|P1|Long-Term Treatment Period|Investigator's discretion|1
2859321|NCT02234141|9827497|P7|Long-Term Treatment Period|Death|0
2859322|NCT02234141|9827498|P6|Long-Term Treatment Period|Death|1
2859323|NCT02234141|9827499|P5|Long-Term Treatment Period|Death|0
2859324|NCT02234141|9827500|P4|Long-Term Treatment Period|Death|0
2859325|NCT02234141|9827501|P3|Long-Term Treatment Period|Death|0
2859326|NCT02234141|9827502|P2|Long-Term Treatment Period|Death|0
2859327|NCT02234141|9827503|P1|Long-Term Treatment Period|Death|0
2859328|NCT02234141|9827497|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
2859329|NCT02234141|9827498|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
2859330|NCT02234141|9827499|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
2859331|NCT02234141|9827500|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
2859332|NCT02234141|9827501|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
2859333|NCT02234141|9827502|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
2859334|NCT02234141|9827503|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
2859335|NCT02234141|9827497|P7|Treatment Period (24 Weeks)|Adverse Event|0
2859336|NCT02234141|9827498|P6|Treatment Period (24 Weeks)|Adverse Event|0
2859337|NCT02234141|9827499|P5|Treatment Period (24 Weeks)|Adverse Event|0
2859338|NCT02234141|9827500|P4|Treatment Period (24 Weeks)|Adverse Event|3
2859339|NCT02234141|9827501|P3|Treatment Period (24 Weeks)|Adverse Event|2
2859340|NCT02234141|9827502|P2|Treatment Period (24 Weeks)|Adverse Event|1
2859341|NCT02234141|9827503|P1|Treatment Period (24 Weeks)|Adverse Event|3
2859342|NCT02234141|9827497|P7|Treatment Period (24 Weeks)|Death|0
2859343|NCT02234141|9827498|P6|Treatment Period (24 Weeks)|Death|0
2859344|NCT02234141|9827499|P5|Treatment Period (24 Weeks)|Death|0
2859345|NCT02234141|9827500|P4|Treatment Period (24 Weeks)|Death|1
2859346|NCT02234141|9827501|P3|Treatment Period (24 Weeks)|Death|0
2859347|NCT02234141|9827502|P2|Treatment Period (24 Weeks)|Death|2
2859348|NCT02234141|9827503|P1|Treatment Period (24 Weeks)|Death|1
2859349|NCT02234141|9827497|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
2859350|NCT02234141|9827498|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
2859351|NCT02234141|9827499|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
2859352|NCT02234141|9827500|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
2859353|NCT02234141|9827501|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
2859354|NCT02234141|9827502|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
2859355|NCT02234141|9827503|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
2859356|NCT02234141|9827497|P7|Treatment Period (24 Weeks)|Protocol Violation|0
2859357|NCT02234141|9827498|P6|Treatment Period (24 Weeks)|Protocol Violation|0
2859358|NCT02234141|9827499|P5|Treatment Period (24 Weeks)|Protocol Violation|0
2859359|NCT02234141|9827500|P4|Treatment Period (24 Weeks)|Protocol Violation|1
2859360|NCT02234141|9827501|P3|Treatment Period (24 Weeks)|Protocol Violation|0
2859361|NCT02234141|9827502|P2|Treatment Period (24 Weeks)|Protocol Violation|0
2859362|NCT02234141|9827503|P1|Treatment Period (24 Weeks)|Protocol Violation|0
2859363|NCT02233803|9827649|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
2859364|NCT02233803|9827650|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
2859365|NCT02233803|9827649|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
2859366|NCT02233803|9827650|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
2859367|NCT02233803|9827649|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
2859368|NCT02233803|9827650|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
2859369|NCT02233803|9827649|P2|Washout Period (4-Wks)|Physician Decision|0
2859370|NCT02233803|9827650|P1|Washout Period (4-Wks)|Physician Decision|1
2859371|NCT02233803|9827649|P2|Washout Period (4-Wks)|Lost to Follow-up|1
2859372|NCT02233803|9827650|P1|Washout Period (4-Wks)|Lost to Follow-up|0
2859373|NCT02233803|9827649|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
2859374|NCT02233803|9827650|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
2859375|NCT02233803|9827649|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
2859376|NCT02233803|9827650|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
2859377|NCT02233803|9827649|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
2859378|NCT02233803|9827650|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
2859379|NCT02233803|9827649|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
2859380|NCT02233803|9827650|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
2859381|NCT02233738|9827683|P2|Overall Study|Did not return after Baseline|2
2859382|NCT02233738|9827684|P1|Overall Study|Did not return after Baseline|3
2859383|NCT02233738|9827683|P2|Overall Study|Withdrawal by Subject|1
2859384|NCT02233738|9827684|P1|Overall Study|Withdrawal by Subject|0
2859385|NCT02233738|9827683|P2|Overall Study|Death|1
2859386|NCT02233738|9827684|P1|Overall Study|Death|0
2859387|NCT02233738|9827683|P2|Overall Study|Lost to Follow-up|12
2859388|NCT02233738|9827684|P1|Overall Study|Lost to Follow-up|5
2859389|NCT02233647|9827854|P1|Overall Study|Adverse Event|1
2859390|NCT02233543|9827883|P2|Period 2|COPD exacerbation|0
2859391|NCT02233543|9827884|P1|Period 2|COPD exacerbation|1
2859392|NCT02233543|9827883|P2|Period 2|Participant required other treatment.|1
2859393|NCT02233543|9827884|P1|Period 2|Participant required other treatment.|0
2859394|NCT02233543|9827883|P2|Period 2|Adverse Event|0
2859395|NCT02233543|9827884|P1|Period 2|Adverse Event|1
2859396|NCT02233543|9827883|P2|Period 1|Participants required other treatment.|3
2859397|NCT02233543|9827884|P1|Period 1|Participants required other treatment.|2
2859398|NCT02233543|9827883|P2|Period 1|Withdrawal by Subject|0
2859399|NCT02233543|9827884|P1|Period 1|Withdrawal by Subject|1
2859400|NCT02233309|9827934|P1|Overall Study|Physician Decision|5
2859401|NCT02232984|9827968|P1|Overall Study|Protocol Violation|1
2859402|NCT02232984|9827968|P1|Overall Study|not disclosed by site|7
2859403|NCT02232984|9827968|P1|Overall Study|Device implant unsuccessful|53
2859404|NCT02232984|9827968|P1|Overall Study|Investigator withdrawal|10
2859405|NCT02232984|9827968|P1|Overall Study|Death|1
2859406|NCT02232984|9827968|P1|Overall Study|Withdrawal by Subject|5
2859407|NCT02232880|9827977|P1|Overall Study|study stopped prior to randomization|1
2859408|NCT02232698|9827986|P2|Overall Study|Withdrawal by Subject|11
2859409|NCT02232698|9827987|P1|Overall Study|Withdrawal by Subject|0
2859410|NCT02232698|9827986|P2|Overall Study|Allocated to control group|3
2859411|NCT02232698|9827987|P1|Overall Study|Allocated to control group|0
2859412|NCT02232698|9827986|P2|Overall Study|Non-compliance with study device|4
2859413|NCT02232698|9827987|P1|Overall Study|Non-compliance with study device|1
2859414|NCT02232698|9827986|P2|Overall Study|Had device-associated symptoms|0
2859415|NCT02232698|9827987|P1|Overall Study|Had device-associated symptoms|7
2859416|NCT02232698|9827986|P2|Overall Study|Met exclusion criteria|1
2859417|NCT02232698|9827987|P1|Overall Study|Met exclusion criteria|1
2859418|NCT02232698|9827986|P2|Overall Study|Pregnancy|1
2859419|NCT02232698|9827987|P1|Overall Study|Pregnancy|1
2859420|NCT02232425|9828010|P2|Overall Study|Lack of Efficacy|0
2859421|NCT02232425|9828011|P1|Overall Study|Lack of Efficacy|1
2859422|NCT02232425|9828010|P2|Overall Study|Withdrawal by Subject|6
2859423|NCT02232425|9828011|P1|Overall Study|Withdrawal by Subject|5
2859424|NCT02232425|9828010|P2|Overall Study|Adverse Event|0
2859425|NCT02232425|9828011|P1|Overall Study|Adverse Event|2
2859426|NCT02232425|9828010|P2|Overall Study|Lost to Follow-up|2
2859427|NCT02232425|9828011|P1|Overall Study|Lost to Follow-up|6
2859428|NCT02232243|9828044|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2859429|NCT02232243|9828045|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
2859430|NCT02232243|9828046|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2859431|NCT02232178|9828058|P3|Overall Study|surgical complication|0
2859432|NCT02232178|9828059|P2|Overall Study|surgical complication|0
2859433|NCT02232178|9828060|P1|Overall Study|surgical complication|1
2859434|NCT02232178|9828058|P3|Overall Study|ineligibility|1
2859435|NCT02232178|9828059|P2|Overall Study|ineligibility|0
2859436|NCT02232178|9828060|P1|Overall Study|ineligibility|0
2859437|NCT02232178|9828058|P3|Overall Study|Lost to Follow-up|0
2859438|NCT02232178|9828059|P2|Overall Study|Lost to Follow-up|1
2859439|NCT02232178|9828060|P1|Overall Study|Lost to Follow-up|0
2859440|NCT02232074|9828090|P2|Overall Study|deemed ineligible|1
2859441|NCT02232074|9828091|P1|Overall Study|deemed ineligible|0
2859442|NCT02232074|9828090|P2|Overall Study|No legal concerns at baseline|41
2859443|NCT02232074|9828091|P1|Overall Study|No legal concerns at baseline|36
2859444|NCT02232074|9828090|P2|Overall Study|Withdrawal by Subject|3
2859445|NCT02232074|9828091|P1|Overall Study|Withdrawal by Subject|5
2859446|NCT02231918|9828158|P3|Overall Study|Adverse Event|1
2859447|NCT02231918|9828159|P2|Overall Study|Adverse Event|0
2859448|NCT02231918|9828160|P1|Overall Study|Adverse Event|0
2859449|NCT02231918|9828158|P3|Overall Study|Withdrawal by Subject|0
2859450|NCT02231918|9828159|P2|Overall Study|Withdrawal by Subject|1
2859451|NCT02231918|9828160|P1|Overall Study|Withdrawal by Subject|0
2859452|NCT02231892|9828225|P3|Overall Study|Could not find reliable motor hotspot|1
2859453|NCT02231892|9828226|P2|Overall Study|Could not find reliable motor hotspot|0
2859454|NCT02231892|9828227|P1|Overall Study|Could not find reliable motor hotspot|0
2859455|NCT02231892|9828225|P3|Overall Study|Could not find motor threshold|1
2859456|NCT02231892|9828226|P2|Overall Study|Could not find motor threshold|0
2859457|NCT02231892|9828227|P1|Overall Study|Could not find motor threshold|2
2859458|NCT02231892|9828225|P3|Overall Study|Participant motor threshold was >83%|9
2859459|NCT02231892|9828226|P2|Overall Study|Participant motor threshold was >83%|0
2859460|NCT02231892|9828227|P1|Overall Study|Participant motor threshold was >83%|0
2859461|NCT02231892|9828225|P3|Overall Study|Motor activity when stimulating ante ACC|12
2859462|NCT02231892|9828226|P2|Overall Study|Motor activity when stimulating ante ACC|7
2859463|NCT02231892|9828227|P1|Overall Study|Motor activity when stimulating ante ACC|4
2859464|NCT02231892|9828225|P3|Overall Study|Physician Decision|4
2859465|NCT02231892|9828226|P2|Overall Study|Physician Decision|2
2859466|NCT02231892|9828227|P1|Overall Study|Physician Decision|0
2859467|NCT02231892|9828225|P3|Overall Study|Withdrawal by Subject|15
2859468|NCT02231892|9828226|P2|Overall Study|Withdrawal by Subject|3
2859469|NCT02231892|9828227|P1|Overall Study|Withdrawal by Subject|4
2859470|NCT02231892|9828225|P3|Overall Study|Lost to Follow-up|3
2859471|NCT02231892|9828226|P2|Overall Study|Lost to Follow-up|0
2859472|NCT02231892|9828227|P1|Overall Study|Lost to Follow-up|1
2859473|NCT02231762|9828244|P4|Maintenance Phase|Adverse Event|2
2859474|NCT02231762|9828245|P3|Maintenance Phase|Adverse Event|1
2859475|NCT02231762|9828246|P2|Maintenance Phase|Adverse Event|0
2859476|NCT02231762|9828247|P1|Maintenance Phase|Adverse Event|0
2859477|NCT02231762|9828244|P4|Maintenance Phase|Disease progression|3
2859478|NCT02231762|9828245|P3|Maintenance Phase|Disease progression|4
2859479|NCT02231762|9828246|P2|Maintenance Phase|Disease progression|3
2859480|NCT02231762|9828247|P1|Maintenance Phase|Disease progression|0
2859481|NCT02231762|9828244|P4|Combination Phase|Protocol Violation|0
2859482|NCT02231762|9828245|P3|Combination Phase|Protocol Violation|0
2859483|NCT02231762|9828246|P2|Combination Phase|Protocol Violation|0
2859484|NCT02231762|9828247|P1|Combination Phase|Protocol Violation|1
2859485|NCT02231762|9828244|P4|Combination Phase|Did not meet inclusion criteria|0
2859486|NCT02231762|9828245|P3|Combination Phase|Did not meet inclusion criteria|0
2859487|NCT02231762|9828246|P2|Combination Phase|Did not meet inclusion criteria|0
2859488|NCT02231762|9828247|P1|Combination Phase|Did not meet inclusion criteria|1
2859489|NCT02231762|9828244|P4|Combination Phase|Disease Progression|0
2859490|NCT02231762|9828245|P3|Combination Phase|Disease Progression|0
2859491|NCT02231762|9828246|P2|Combination Phase|Disease Progression|0
2859492|NCT02231762|9828247|P1|Combination Phase|Disease Progression|6
2859493|NCT02231762|9828244|P4|Combination Phase|Withdrawal by Subject|0
2859494|NCT02231762|9828245|P3|Combination Phase|Withdrawal by Subject|0
2859495|NCT02231762|9828246|P2|Combination Phase|Withdrawal by Subject|0
2859496|NCT02231762|9828247|P1|Combination Phase|Withdrawal by Subject|2
2859497|NCT02231762|9828244|P4|Combination Phase|Adverse Event|0
2859498|NCT02231762|9828245|P3|Combination Phase|Adverse Event|0
2859499|NCT02231762|9828246|P2|Combination Phase|Adverse Event|0
2859500|NCT02231762|9828247|P1|Combination Phase|Adverse Event|10
2859501|NCT02231749|9828280|P2|Overall Study|No longer meets Study Criteria|0
2859502|NCT02231749|9828281|P1|Overall Study|No longer meets Study Criteria|1
2859503|NCT02231749|9828280|P2|Overall Study|other|8
2859504|NCT02231749|9828281|P1|Overall Study|other|0
2859505|NCT02231749|9828280|P2|Overall Study|Pregnancy|0
2859506|NCT02231749|9828281|P1|Overall Study|Pregnancy|1
2859507|NCT02231749|9828280|P2|Overall Study|Poor/Non-Compliance|3
2859508|NCT02231749|9828281|P1|Overall Study|Poor/Non-Compliance|0
2859509|NCT02231749|9828280|P2|Overall Study|Maximum Clinical Benefit|8
2859510|NCT02231749|9828281|P1|Overall Study|Maximum Clinical Benefit|5
2859511|NCT02231749|9828280|P2|Overall Study|Lost to Follow-up|2
2859512|NCT02231749|9828281|P1|Overall Study|Lost to Follow-up|1
2859513|NCT02231749|9828280|P2|Overall Study|Participant withdrew Consent|15
2859514|NCT02231749|9828281|P1|Overall Study|Participant withdrew Consent|8
2859515|NCT02231749|9828280|P2|Overall Study|Participant's request to discontinue|21
2859516|NCT02231749|9828281|P1|Overall Study|Participant's request to discontinue|10
2859517|NCT02231749|9828280|P2|Overall Study|AE unrelated to Study drug|31
2859518|NCT02231749|9828281|P1|Overall Study|AE unrelated to Study drug|32
2859519|NCT02231749|9828280|P2|Overall Study|Death|1
2859520|NCT02231749|9828281|P1|Overall Study|Death|1
2859521|NCT02231749|9828280|P2|Overall Study|Study Drug Toxicity|63
2859522|NCT02231749|9828281|P1|Overall Study|Study Drug Toxicity|134
2859523|NCT02231749|9828280|P2|Overall Study|Disease progression|297
2859524|NCT02231749|9828281|P1|Overall Study|Disease progression|229
2859525|NCT02231580|9828299|P2|Overall Study|Adverse Event|0
2859526|NCT02231580|9828300|P1|Overall Study|Adverse Event|5
2859527|NCT02231164|9828417|P2|Overall Study|Withdrawal by Subject|2
2859528|NCT02231164|9828418|P1|Overall Study|Withdrawal by Subject|1
2859529|NCT02231164|9828417|P2|Overall Study|Lack of Efficacy|3
2859530|NCT02231164|9828418|P1|Overall Study|Lack of Efficacy|4
2859531|NCT02231164|9828417|P2|Overall Study|Adverse Event|1
2859532|NCT02231164|9828418|P1|Overall Study|Adverse Event|1
2859533|NCT02230956|9828446|P3|Overall Study|Other Miscellaneous Reason|2
2859534|NCT02230956|9828447|P2|Overall Study|Other Miscellaneous Reason|1
2859535|NCT02230956|9828448|P1|Overall Study|Other Miscellaneous Reason|0
2859536|NCT02230956|9828446|P3|Overall Study|Protocol Violation|1
2859537|NCT02230956|9828447|P2|Overall Study|Protocol Violation|1
2859538|NCT02230956|9828448|P1|Overall Study|Protocol Violation|0
2859539|NCT02230956|9828446|P3|Overall Study|Personal Reasons|1
2859540|NCT02230956|9828447|P2|Overall Study|Personal Reasons|1
2859541|NCT02230956|9828448|P1|Overall Study|Personal Reasons|2
2859542|NCT02230956|9828446|P3|Overall Study|Lost to Follow-up|2
2859543|NCT02230956|9828447|P2|Overall Study|Lost to Follow-up|1
2859544|NCT02230956|9828448|P1|Overall Study|Lost to Follow-up|1
2859545|NCT02230956|9828446|P3|Overall Study|Lack of Efficacy|1
2859546|NCT02230956|9828447|P2|Overall Study|Lack of Efficacy|1
2859547|NCT02230956|9828448|P1|Overall Study|Lack of Efficacy|1
2859548|NCT02230956|9828446|P3|Overall Study|Adverse Event|0
2859549|NCT02230956|9828447|P2|Overall Study|Adverse Event|1
2859550|NCT02230956|9828448|P1|Overall Study|Adverse Event|1
2859551|NCT02230904|9828470|P2|Overall Study|Safety follow up could not take place|1
2859552|NCT02230904|9828471|P1|Overall Study|Safety follow up could not take place|0
2859553|NCT02230683|9828504|P1|Overall Study|Adverse Event|1
2859554|NCT02230670|9828521|P2|Overall Study|Progression to Child-Pugh C|2
2859555|NCT02230670|9828522|P1|Overall Study|Progression to Child-Pugh C|1
2859556|NCT02230670|9828521|P2|Overall Study|Protocol Violation|1
2859557|NCT02230670|9828522|P1|Overall Study|Protocol Violation|0
2859558|NCT02230670|9828521|P2|Overall Study|Physician Decision|1
2859559|NCT02230670|9828522|P1|Overall Study|Physician Decision|0
2859560|NCT02230670|9828521|P2|Overall Study|Withdrawal by Subject|2
2859561|NCT02230670|9828522|P1|Overall Study|Withdrawal by Subject|2
2859562|NCT02230670|9828521|P2|Overall Study|Adverse Event|2
2859563|NCT02230670|9828522|P1|Overall Study|Adverse Event|1
2859564|NCT02230384|9828608|P2|Phase 2 - Switch|Adverse Event|0
2859565|NCT02230384|9828609|P1|Phase 2 - Switch|Adverse Event|2
2859566|NCT02230384|9828608|P2|Phase 2 - Switch|Lost to Follow-up|0
2859567|NCT02230384|9828609|P1|Phase 2 - Switch|Lost to Follow-up|1
2859568|NCT02230384|9828608|P2|Phase 2 - Switch|Withdrawal by Subject|1
2859569|NCT02230384|9828609|P1|Phase 2 - Switch|Withdrawal by Subject|0
2859570|NCT02230384|9828608|P2|Phase 1|Physician Decision|1
2859571|NCT02230384|9828609|P1|Phase 1|Physician Decision|0
2859572|NCT02230384|9828608|P2|Phase 1|Lost to Follow-up|0
2859573|NCT02230384|9828609|P1|Phase 1|Lost to Follow-up|1
2859574|NCT02230332|9828629|P2|Overall Study|Protocol Violation|0
2859575|NCT02230332|9828630|P1|Overall Study|Protocol Violation|1
2859576|NCT02230332|9828629|P2|Overall Study|Lost to Follow-up|0
2859577|NCT02230332|9828630|P1|Overall Study|Lost to Follow-up|1
2859578|NCT02230332|9828629|P2|Overall Study|Adverse Event|1
2859579|NCT02230332|9828630|P1|Overall Study|Adverse Event|2
2859580|NCT02230306|9828646|P1|Overall Study|Did not receive study treatment|1
2859581|NCT02230085|9828657|P1|Overall Study|Withdrawal by Subject|3
2859582|NCT02230085|9828657|P1|Overall Study|Physician Decision|1
2859583|NCT02229864|9828661|P1|3 - Year Visit|Death|2
2859584|NCT02229864|9828661|P1|2 - Year Visit|Missed Visits|1
2859585|NCT02229539|9828716|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
2859586|NCT02229539|9828717|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
2859587|NCT02229539|9828718|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
2859588|NCT02229539|9828716|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
2859589|NCT02229539|9828717|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2859590|NCT02229539|9828718|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2859591|NCT02229539|9828716|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2859592|NCT02229539|9828717|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2859593|NCT02229539|9828718|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
2859594|NCT02229539|9828716|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2859595|NCT02229539|9828717|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2859596|NCT02229539|9828718|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
2859597|NCT02229539|9828716|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
2859598|NCT02229539|9828717|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2859599|NCT02229539|9828718|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2859600|NCT02229539|9828716|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
2859601|NCT02229539|9828717|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
2859602|NCT02229539|9828718|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
2859603|NCT02229539|9828716|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
2859604|NCT02229539|9828717|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2859605|NCT02229539|9828718|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2859606|NCT02229539|9828716|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
2859607|NCT02229539|9828717|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2859608|NCT02229539|9828718|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2859609|NCT02229539|9828716|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2859610|NCT02229539|9828717|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
2859611|NCT02229539|9828718|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2859612|NCT02229396|9828849|P3|Overall Study|Withdrew; No Record on Termination Page|1
2859613|NCT02229396|9828850|P2|Overall Study|Withdrew; No Record on Termination Page|0
2859614|NCT02229396|9828851|P1|Overall Study|Withdrew; No Record on Termination Page|2
2859615|NCT02229396|9828849|P3|Overall Study|Study-Specific Withdrawal Criteria|3
2859616|NCT02229396|9828850|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2859617|NCT02229396|9828851|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2859618|NCT02229396|9828849|P3|Overall Study|Withdrawal by Subject|41
2859619|NCT02229396|9828850|P2|Overall Study|Withdrawal by Subject|28
2859620|NCT02229396|9828851|P1|Overall Study|Withdrawal by Subject|42
2859621|NCT02229396|9828849|P3|Overall Study|Other|15
2859622|NCT02229396|9828850|P2|Overall Study|Other|18
2859623|NCT02229396|9828851|P1|Overall Study|Other|10
2859624|NCT02229396|9828849|P3|Overall Study|Patient Incorrectly Randomized|1
2859625|NCT02229396|9828850|P2|Overall Study|Patient Incorrectly Randomized|0
2859626|NCT02229396|9828851|P1|Overall Study|Patient Incorrectly Randomized|0
2859627|NCT02229396|9828849|P3|Overall Study|Protocol Violation|0
2859628|NCT02229396|9828850|P2|Overall Study|Protocol Violation|1
2859629|NCT02229396|9828851|P1|Overall Study|Protocol Violation|2
2859630|NCT02229396|9828849|P3|Overall Study|Lost to Follow-up|21
2859631|NCT02229396|9828850|P2|Overall Study|Lost to Follow-up|14
2859632|NCT02229396|9828851|P1|Overall Study|Lost to Follow-up|14
2859633|NCT02229396|9828849|P3|Overall Study|Death|1
2859634|NCT02229396|9828850|P2|Overall Study|Death|3
2859635|NCT02229396|9828851|P1|Overall Study|Death|2
2859636|NCT02229396|9828849|P3|Overall Study|Adverse Event|12
2859637|NCT02229396|9828850|P2|Overall Study|Adverse Event|12
2859638|NCT02229396|9828851|P1|Overall Study|Adverse Event|6
2859639|NCT02229383|9828882|P2|Overall Study|Other|8
2859640|NCT02229383|9828883|P1|Overall Study|Other|3
2859641|NCT02229383|9828882|P2|Overall Study|Did not receive treatment|0
2859642|NCT02229383|9828883|P1|Overall Study|Did not receive treatment|1
2859643|NCT02229383|9828882|P2|Overall Study|Withdrawal by Subject|6
2859644|NCT02229383|9828883|P1|Overall Study|Withdrawal by Subject|4
2859645|NCT02229383|9828882|P2|Overall Study|Lost to Follow-up|3
2859646|NCT02229383|9828883|P1|Overall Study|Lost to Follow-up|5
2859647|NCT02229383|9828882|P2|Overall Study|Death|1
2859648|NCT02229383|9828883|P1|Overall Study|Death|0
2859649|NCT02229383|9828882|P2|Overall Study|Adverse Event|4
2859650|NCT02229383|9828883|P1|Overall Study|Adverse Event|7
2859651|NCT02229227|9828908|P2|Overall Study|Physician Decision|12
2859652|NCT02229227|9828909|P1|Overall Study|Physician Decision|5
2859653|NCT02229227|9828908|P2|Overall Study|Other|1
2859654|NCT02229227|9828909|P1|Overall Study|Other|0
2859655|NCT02229227|9828908|P2|Overall Study|Withdrawal by Subject|12
2859656|NCT02229227|9828909|P1|Overall Study|Withdrawal by Subject|8
2859657|NCT02229227|9828908|P2|Overall Study|Study terminated by sponsor|11
2859658|NCT02229227|9828909|P1|Overall Study|Study terminated by sponsor|11
2859659|NCT02229227|9828908|P2|Overall Study|Lost to Follow-up|3
2859660|NCT02229227|9828909|P1|Overall Study|Lost to Follow-up|3
2859661|NCT02229227|9828908|P2|Overall Study|Protocol defined stopping criteria|3
2859662|NCT02229227|9828909|P1|Overall Study|Protocol defined stopping criteria|1
2859663|NCT02229227|9828908|P2|Overall Study|Protocol Violation|8
2859664|NCT02229227|9828909|P1|Overall Study|Protocol Violation|6
2859665|NCT02229227|9828908|P2|Overall Study|Lack of Efficacy|3
2859666|NCT02229227|9828909|P1|Overall Study|Lack of Efficacy|3
2859667|NCT02229227|9828908|P2|Overall Study|Adverse Event|9
2859668|NCT02229227|9828909|P1|Overall Study|Adverse Event|14
2859669|NCT02229214|9828994|P2|Overall Study|Withdrawal by Subject|0
2859670|NCT02229214|9828995|P1|Overall Study|Withdrawal by Subject|4
2859671|NCT02229214|9828994|P2|Overall Study|Adverse Event|0
2859672|NCT02229214|9828995|P1|Overall Study|Adverse Event|2
2859673|NCT02228980|9829019|P4|Overall Study|Withdrawal by Subject|3
2859674|NCT02228980|9829020|P3|Overall Study|Withdrawal by Subject|2
2859675|NCT02228980|9829021|P2|Overall Study|Withdrawal by Subject|3
2859676|NCT02228980|9829022|P1|Overall Study|Withdrawal by Subject|3
2859677|NCT02228980|9829019|P4|Overall Study|Protocol Violation|0
2859678|NCT02228980|9829020|P3|Overall Study|Protocol Violation|0
2859679|NCT02228980|9829021|P2|Overall Study|Protocol Violation|0
2859680|NCT02228980|9829022|P1|Overall Study|Protocol Violation|7
2859681|NCT02228980|9829019|P4|Overall Study|Adverse Event|0
2859682|NCT02228980|9829020|P3|Overall Study|Adverse Event|0
2859683|NCT02228980|9829021|P2|Overall Study|Adverse Event|0
2859684|NCT02228980|9829022|P1|Overall Study|Adverse Event|14
2859685|NCT02228967|9829046|P2|Overall Study|Withdrawal by Subject|18
2859686|NCT02228967|9829047|P1|Overall Study|Withdrawal by Subject|13
2859687|NCT02228967|9829046|P2|Overall Study|Lost to Follow-up|142
2859688|NCT02228967|9829047|P1|Overall Study|Lost to Follow-up|146
2859689|NCT02228720|9829092|P1|Open Label - Day 30|Lost to Follow-up|1
2859690|NCT02228460|9829124|P1|Overall Study|Lost to Follow-up|1
2859691|NCT02228460|9829124|P1|Overall Study|Adverse Event|1
2859692|NCT02228395|9829147|P3|First Intervention Period|Unable to comply with study dates|1
2859693|NCT02228395|9829148|P2|First Intervention Period|Unable to comply with study dates|1
2859694|NCT02228395|9829149|P1|First Intervention Period|Unable to comply with study dates|0
2859695|NCT02228395|9829147|P3|First Intervention Period|No longer willing to participate|0
2859696|NCT02228395|9829148|P2|First Intervention Period|No longer willing to participate|0
2859697|NCT02228395|9829149|P1|First Intervention Period|No longer willing to participate|1
2859698|NCT02227862|9829235|P2|Overall Study|Lost to Follow-up|2
2859699|NCT02227862|9829236|P1|Overall Study|Lost to Follow-up|1
2859700|NCT02227862|9829235|P2|Overall Study|Withdrawal by Subject|6
2859701|NCT02227862|9829236|P1|Overall Study|Withdrawal by Subject|7
2859702|NCT02227862|9829235|P2|Overall Study|Adverse Event|3
2859703|NCT02227862|9829236|P1|Overall Study|Adverse Event|4
2859704|NCT02227862|9829235|P2|Overall Study|Other|2
2859705|NCT02227862|9829236|P1|Overall Study|Other|0
2859706|NCT02227862|9829235|P2|Overall Study|Protocol Violation|9
2859707|NCT02227862|9829236|P1|Overall Study|Protocol Violation|7
2859708|NCT02227849|9829266|P1|Overall Study|Withdrawal by Subject|3
2859709|NCT02227849|9829266|P1|Overall Study|Physician Decision|1
2859710|NCT02227849|9829266|P1|Overall Study|Adverse Event|4
2859711|NCT02227784|9829297|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
2859712|NCT02227784|9829298|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2859713|NCT02227784|9829299|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2859714|NCT02227784|9829300|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2859715|NCT02227784|9829301|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2859716|NCT02227784|9829297|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
2859717|NCT02227784|9829298|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2859718|NCT02227784|9829299|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2859719|NCT02227784|9829300|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2859720|NCT02227784|9829301|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2859721|NCT02227784|9829297|P5|Open-Label Extension Phase (OLE)|Death|1
2859722|NCT02227784|9829298|P4|Open-Label Extension Phase (OLE)|Death|0
2859723|NCT02227784|9829299|P3|Open-Label Extension Phase (OLE)|Death|0
2859724|NCT02227784|9829300|P2|Open-Label Extension Phase (OLE)|Death|0
2859725|NCT02227784|9829301|P1|Open-Label Extension Phase (OLE)|Death|0
2859726|NCT02227784|9829297|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
2859727|NCT02227784|9829298|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
2859728|NCT02227784|9829299|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
2859729|NCT02227784|9829300|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
2859730|NCT02227784|9829301|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
2859731|NCT02227784|9829297|P5|Double-Blind Phase|Withdrawal by Subject|0
2859732|NCT02227784|9829298|P4|Double-Blind Phase|Withdrawal by Subject|2
2859733|NCT02227784|9829299|P3|Double-Blind Phase|Withdrawal by Subject|5
2859734|NCT02227784|9829300|P2|Double-Blind Phase|Withdrawal by Subject|1
2859735|NCT02227784|9829301|P1|Double-Blind Phase|Withdrawal by Subject|2
2859736|NCT02227784|9829297|P5|Double-Blind Phase|Sponsor Decision|0
2859737|NCT02227784|9829298|P4|Double-Blind Phase|Sponsor Decision|32
2859738|NCT02227784|9829299|P3|Double-Blind Phase|Sponsor Decision|14
2859739|NCT02227784|9829300|P2|Double-Blind Phase|Sponsor Decision|15
2859740|NCT02227784|9829301|P1|Double-Blind Phase|Sponsor Decision|34
2859741|NCT02227784|9829297|P5|Double-Blind Phase|Protocol Violation|0
2859742|NCT02227784|9829298|P4|Double-Blind Phase|Protocol Violation|1
2859743|NCT02227784|9829299|P3|Double-Blind Phase|Protocol Violation|1
2859744|NCT02227784|9829300|P2|Double-Blind Phase|Protocol Violation|0
2859745|NCT02227784|9829301|P1|Double-Blind Phase|Protocol Violation|0
2859746|NCT02227784|9829297|P5|Double-Blind Phase|Physician Decision|0
2859747|NCT02227784|9829298|P4|Double-Blind Phase|Physician Decision|1
2859748|NCT02227784|9829299|P3|Double-Blind Phase|Physician Decision|0
2859749|NCT02227784|9829300|P2|Double-Blind Phase|Physician Decision|0
2859750|NCT02227784|9829301|P1|Double-Blind Phase|Physician Decision|1
2859751|NCT02227784|9829297|P5|Double-Blind Phase|Adverse Event|0
2859752|NCT02227784|9829298|P4|Double-Blind Phase|Adverse Event|3
2859753|NCT02227784|9829299|P3|Double-Blind Phase|Adverse Event|1
2859754|NCT02227784|9829300|P2|Double-Blind Phase|Adverse Event|2
2859755|NCT02227784|9829301|P1|Double-Blind Phase|Adverse Event|3
2859756|NCT02227368|9829430|P2|Overall Study|Adverse Event|0
2859757|NCT02227368|9829431|P1|Overall Study|Adverse Event|1
2859758|NCT02227368|9829430|P2|Overall Study|Lost to Follow-up|0
2859759|NCT02227368|9829431|P1|Overall Study|Lost to Follow-up|1
2859760|NCT02227368|9829430|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
2859761|NCT02227368|9829431|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
2859762|NCT02227238|9829487|P2|Overall Study|Lost to Follow-up|5
2859763|NCT02227238|9829488|P1|Overall Study|Lost to Follow-up|7
2859764|NCT02227238|9829487|P2|Overall Study|Physician Decision|9
2859765|NCT02227238|9829488|P1|Overall Study|Physician Decision|0
2859766|NCT02227238|9829487|P2|Overall Study|Withdrawal by Subject|4
2859767|NCT02227238|9829488|P1|Overall Study|Withdrawal by Subject|5
2859768|NCT02227238|9829487|P2|Overall Study|Protocol Violation|8
2859769|NCT02227238|9829488|P1|Overall Study|Protocol Violation|7
2859770|NCT02227238|9829487|P2|Overall Study|Lack of Efficacy|22
2859771|NCT02227238|9829488|P1|Overall Study|Lack of Efficacy|10
2859772|NCT02227238|9829487|P2|Overall Study|Adverse Event|18
2859773|NCT02227238|9829488|P1|Overall Study|Adverse Event|8
2859774|NCT02227238|9829487|P2|Overall Study|Other: Reached stopping criteria|1
2859775|NCT02227238|9829488|P1|Overall Study|Other: Reached stopping criteria|0
2859776|NCT02227147|9829554|P2|Follow-up Period|Other|5
2859777|NCT02227147|9829555|P1|Follow-up Period|Other|3
2859778|NCT02227147|9829554|P2|Controlled Treatment Period|Other|0
2859779|NCT02227147|9829555|P1|Controlled Treatment Period|Other|2
2859780|NCT02227147|9829554|P2|Controlled Treatment Period|Adverse Event|3
2859781|NCT02227147|9829555|P1|Controlled Treatment Period|Adverse Event|4
2859782|NCT02227108|9829582|P1|Overall Study|Adverse Event|6
2859783|NCT02227108|9829582|P1|Overall Study|Investigator discretion|1
2859784|NCT02227108|9829582|P1|Overall Study|Initiation of alternative therapy|2
2859785|NCT02227108|9829582|P1|Overall Study|Progressive disease|17
2859786|NCT02227108|9829582|P1|Overall Study|Other|3
2859787|NCT02227108|9829582|P1|Overall Study|Did not receive treatment|2
2859788|NCT02226653|9829621|P2|Treatment Period 5 Fed State|Adverse Event|1
2859789|NCT02226653|9829622|P1|Treatment Period 5 Fed State|Adverse Event|0
2859790|NCT02226653|9829621|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
2859791|NCT02226653|9829622|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
2859792|NCT02226562|9829646|P2|Overall Study|Lost to Follow-up|1
2859793|NCT02226562|9829647|P1|Overall Study|Lost to Follow-up|0
2859794|NCT02226549|9829665|P2|Overall Study|Lost to Follow-up|1
2859795|NCT02226549|9829666|P1|Overall Study|Lost to Follow-up|0
2859796|NCT02226549|9829665|P2|Overall Study|Randomized but Never Treated|0
2859797|NCT02226549|9829666|P1|Overall Study|Randomized but Never Treated|1
2859798|NCT02226198|9829676|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2859799|NCT02226198|9829677|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
2859800|NCT02226198|9829678|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2859801|NCT02226198|9829676|P3|Lead-in Phase|Protocol Violation|0
2859802|NCT02226198|9829677|P2|Lead-in Phase|Protocol Violation|0
2859803|NCT02226198|9829678|P1|Lead-in Phase|Protocol Violation|1
2859804|NCT02226172|9829751|P1|Overall Study|Adverse Event|6
2859805|NCT02226172|9829751|P1|Overall Study|Study terminated by sponsor|1
2859806|NCT02226172|9829751|P1|Overall Study|Death|1
2859807|NCT02226172|9829751|P1|Overall Study|Other|5
2859808|NCT02226172|9829751|P1|Overall Study|Participant refused further follow-up|4
2859809|NCT02226120|9829782|P1|Overall Study|missing treatment disposition pages|2
2859810|NCT02226120|9829782|P1|Overall Study|Protocol deviation|1
2859811|NCT02226120|9829782|P1|Overall Study|Non-compliance with study drug|10
2859812|NCT02226120|9829782|P1|Overall Study|Withdrawal by parent/guardian|36
2859813|NCT02226120|9829782|P1|Overall Study|Physician Decision|21
2859814|NCT02226120|9829782|P1|Overall Study|Lost to Follow-up|13
2859815|NCT02226120|9829782|P1|Overall Study|Technical problems|4
2859816|NCT02226120|9829782|P1|Overall Study|Study terminated by sponsor|1
2859817|NCT02226120|9829782|P1|Overall Study|Death|172
2859818|NCT02226120|9829782|P1|Overall Study|Adverse Event|60
2859819|NCT02226003|9829789|P3|Overall Study|Withdrawal by Subject|3
2859820|NCT02226003|9829790|P2|Overall Study|Withdrawal by Subject|0
2859821|NCT02226003|9829791|P1|Overall Study|Withdrawal by Subject|0
2859822|NCT02226003|9829789|P3|Overall Study|Lost to Follow-up|3
2859823|NCT02226003|9829790|P2|Overall Study|Lost to Follow-up|1
2859824|NCT02226003|9829791|P1|Overall Study|Lost to Follow-up|2
2859825|NCT02225743|9829847|P1|Overall Study|Withdrawal by Subject|18
2859826|NCT02225587|9829853|P2|Overall Study|Withdrawal by Subject|28
2859827|NCT02225587|9829854|P1|Overall Study|Withdrawal by Subject|13
2859828|NCT02225587|9829853|P2|Overall Study|Participant Moved|0
2859829|NCT02225587|9829854|P1|Overall Study|Participant Moved|1
2859830|NCT02225587|9829853|P2|Overall Study|Protocol Violation|0
2859831|NCT02225587|9829854|P1|Overall Study|Protocol Violation|1
2859832|NCT02225587|9829853|P2|Overall Study|Physician Decision|0
2859833|NCT02225587|9829854|P1|Overall Study|Physician Decision|2
2859834|NCT02225587|9829853|P2|Overall Study|Non-Compliance With Study Drug|0
2859835|NCT02225587|9829854|P1|Overall Study|Non-Compliance With Study Drug|1
2859836|NCT02225587|9829853|P2|Overall Study|Lost to Follow-up|5
2859837|NCT02225587|9829854|P1|Overall Study|Lost to Follow-up|5
2859838|NCT02225587|9829853|P2|Overall Study|Adverse Event|5
2859839|NCT02225587|9829854|P1|Overall Study|Adverse Event|5
2859840|NCT02225353|9829883|P3|Overall Study|Protocol Violation|12
2859841|NCT02225353|9829884|P2|Overall Study|Protocol Violation|5
2859842|NCT02225353|9829885|P1|Overall Study|Protocol Violation|4
2859843|NCT02225353|9829883|P3|Overall Study|Lost to Follow-up|3
2859844|NCT02225353|9829884|P2|Overall Study|Lost to Follow-up|1
2859845|NCT02225353|9829885|P1|Overall Study|Lost to Follow-up|0
2859846|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
2859847|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
2859848|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
2859849|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
2859850|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
2859851|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
2859852|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
2859853|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
2859854|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
2859855|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
2859856|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Death|0
2859857|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Death|1
2859858|NCT02224846|9829926|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
2859859|NCT02224846|9829927|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
2859860|NCT02224846|9829926|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
2859861|NCT02224846|9829927|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
2859862|NCT02224846|9829926|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
2859863|NCT02224846|9829927|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
2859864|NCT02224846|9829926|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
2859865|NCT02224846|9829927|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
2859866|NCT02224846|9829926|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
2859867|NCT02224846|9829927|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
2859868|NCT02224846|9829926|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
2859869|NCT02224846|9829927|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
2859870|NCT02224846|9829926|P2|Period 1 (Month 3)|Sponsor Decision|1
2859871|NCT02224846|9829927|P1|Period 1 (Month 3)|Sponsor Decision|2
2859872|NCT02224846|9829926|P2|Period 1 (Month 3)|Withdrawal by Subject|18
2859873|NCT02224846|9829927|P1|Period 1 (Month 3)|Withdrawal by Subject|8
2859874|NCT02224846|9829926|P2|Period 1 (Month 3)|Protocol Violation|8
2859875|NCT02224846|9829927|P1|Period 1 (Month 3)|Protocol Violation|4
2859876|NCT02224846|9829926|P2|Period 1 (Month 3)|Lost to Follow-up|8
2859877|NCT02224846|9829927|P1|Period 1 (Month 3)|Lost to Follow-up|3
2859878|NCT02224846|9829926|P2|Period 1 (Month 3)|Adverse Event|1
2859879|NCT02224846|9829927|P1|Period 1 (Month 3)|Adverse Event|2
2859880|NCT02224755|9829957|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
2859881|NCT02224755|9829958|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
2859882|NCT02224755|9829957|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2859883|NCT02224755|9829958|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2859884|NCT02224755|9829957|P2|Two Year Follow up Post-implant|Heart transplant|119
2859885|NCT02224755|9829958|P1|Two Year Follow up Post-implant|Heart transplant|137
2859886|NCT02224755|9829957|P2|Two Year Follow up Post-implant|Death|98
2859887|NCT02224755|9829958|P1|Two Year Follow up Post-implant|Death|103
2859888|NCT02224755|9829957|P2|Randomization to Device Implant|Withdrawn prior to implant|1
2859889|NCT02224755|9829958|P1|Randomization to Device Implant|Withdrawn prior to implant|7
2859890|NCT02224703|9829993|P3|Overall Study|Lack of Efficacy|0
2859891|NCT02224703|9829994|P2|Overall Study|Lack of Efficacy|0
2859892|NCT02224703|9829995|P1|Overall Study|Lack of Efficacy|1
2859893|NCT02224703|9829993|P3|Overall Study|Withdrawn by parent/guardian|0
2859894|NCT02224703|9829994|P2|Overall Study|Withdrawn by parent/guardian|1
2859895|NCT02224703|9829995|P1|Overall Study|Withdrawn by parent/guardian|0
2859896|NCT02224703|9829993|P3|Overall Study|Advised by medical monitor|0
2859897|NCT02224703|9829994|P2|Overall Study|Advised by medical monitor|0
2859898|NCT02224703|9829995|P1|Overall Study|Advised by medical monitor|1
2859899|NCT02224703|9829993|P3|Overall Study|Withdrawn by investigator|0
2859900|NCT02224703|9829994|P2|Overall Study|Withdrawn by investigator|0
2859901|NCT02224703|9829995|P1|Overall Study|Withdrawn by investigator|1
2859902|NCT02224703|9829993|P3|Overall Study|Adverse Event|0
2859903|NCT02224703|9829994|P2|Overall Study|Adverse Event|5
2859904|NCT02224703|9829995|P1|Overall Study|Adverse Event|0
2859905|NCT02224690|9830014|P2|Overall Study|Did not meet eligibility criteria|0
2859906|NCT02224690|9830015|P1|Overall Study|Did not meet eligibility criteria|1
2859907|NCT02224690|9830014|P2|Overall Study|Use of G-tube|0
2859908|NCT02224690|9830015|P1|Overall Study|Use of G-tube|1
2859909|NCT02224690|9830014|P2|Overall Study|Met Withdrawal Criteria|0
2859910|NCT02224690|9830015|P1|Overall Study|Met Withdrawal Criteria|4
2859911|NCT02224690|9830014|P2|Overall Study|Adverse Event|1
2859912|NCT02224690|9830015|P1|Overall Study|Adverse Event|8
2859913|NCT02224664|9830027|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
2859914|NCT02224664|9830028|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
2859915|NCT02224664|9830029|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2859916|NCT02224664|9830030|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2859917|NCT02224664|9830031|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2859918|NCT02224664|9830027|P5|Dose Escalation Period (21 Days)|Adverse Event|7
2859919|NCT02224664|9830028|P4|Dose Escalation Period (21 Days)|Adverse Event|2
2859920|NCT02224664|9830029|P3|Dose Escalation Period (21 Days)|Adverse Event|2
2859921|NCT02224664|9830030|P2|Dose Escalation Period (21 Days)|Adverse Event|0
2859922|NCT02224664|9830031|P1|Dose Escalation Period (21 Days)|Adverse Event|0
2859923|NCT02224664|9830027|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2859924|NCT02224664|9830028|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2859925|NCT02224664|9830029|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2859926|NCT02224664|9830030|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2859927|NCT02224664|9830031|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
2859928|NCT02224638|9830113|P2|Overall Study|Adverse Event|1
2859929|NCT02224638|9830114|P1|Overall Study|Adverse Event|1
2859930|NCT02224625|9830122|P1|Sensitization|Adverse Event|55
2859931|NCT02224625|9830122|P1|Irritation|Adverse Event|6
2859932|NCT02224599|9830143|P1|Overall Study|Progression of Disease|1
2859933|NCT02224599|9830143|P1|Overall Study|Physician Decision|1
2859934|NCT02224560|9830152|P3|Overall Study|Withdrawn by Investigator|0
2859935|NCT02224560|9830153|P2|Overall Study|Withdrawn by Investigator|1
2859936|NCT02224560|9830154|P1|Overall Study|Withdrawn by Investigator|1
2859937|NCT02224560|9830152|P3|Overall Study|Adverse Event|1
2859938|NCT02224560|9830153|P2|Overall Study|Adverse Event|1
2859939|NCT02224560|9830154|P1|Overall Study|Adverse Event|4
2859940|NCT02224560|9830152|P3|Overall Study|Met Withdrawal Criteria|0
2859941|NCT02224560|9830153|P2|Overall Study|Met Withdrawal Criteria|0
2859942|NCT02224560|9830154|P1|Overall Study|Met Withdrawal Criteria|1
2859943|NCT02224560|9830152|P3|Overall Study|Withdrawal by Subject|1
2859944|NCT02224560|9830153|P2|Overall Study|Withdrawal by Subject|0
2859945|NCT02224560|9830154|P1|Overall Study|Withdrawal by Subject|2
2859946|NCT02224560|9830152|P3|Overall Study|Protocol Deviation|0
2859947|NCT02224560|9830153|P2|Overall Study|Protocol Deviation|0
2859948|NCT02224560|9830154|P1|Overall Study|Protocol Deviation|1
2859949|NCT02224274|9830202|P2|Overall Study|Death|0
2859950|NCT02224274|9830203|P1|Overall Study|Death|1
2859951|NCT02224157|9830215|P2|Overall Study|Adverse Event|3
2859952|NCT02224157|9830216|P1|Overall Study|Adverse Event|1
2859953|NCT02224157|9830215|P2|Overall Study|Death|1
2859954|NCT02224157|9830216|P1|Overall Study|Death|1
2859955|NCT02224157|9830215|P2|Overall Study|Lost to Follow-up|35
2859956|NCT02224157|9830216|P1|Overall Study|Lost to Follow-up|27
2859957|NCT02224157|9830215|P2|Overall Study|Eligibility criteria not fulfilled|8
2859958|NCT02224157|9830216|P1|Overall Study|Eligibility criteria not fulfilled|4
2859959|NCT02224157|9830215|P2|Overall Study|Prematurely closed site|2
2859960|NCT02224157|9830216|P1|Overall Study|Prematurely closed site|4
2859961|NCT02224157|9830215|P2|Overall Study|Subject decision|50
2859962|NCT02224157|9830216|P1|Overall Study|Subject decision|58
2859963|NCT02224157|9830215|P2|Overall Study|Other|10
2859964|NCT02224157|9830216|P1|Overall Study|Other|13
2859965|NCT02224157|9830215|P2|Overall Study|Severe non-compliance to protocol|2
2859966|NCT02224157|9830216|P1|Overall Study|Severe non-compliance to protocol|2
2859967|NCT02224053|9830240|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
2859968|NCT02224053|9830240|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
2859969|NCT02224053|9830240|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
2859970|NCT02224053|9830240|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
2859971|NCT02224053|9830240|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
2859972|NCT02223858|9830286|P2|Overall Study|Refused|9
2859973|NCT02223858|9830287|P1|Overall Study|Refused|9
2859974|NCT02223858|9830286|P2|Overall Study|Withdrawal by Subject|5
2859975|NCT02223858|9830287|P1|Overall Study|Withdrawal by Subject|8
2859976|NCT02223858|9830286|P2|Overall Study|Lost to Follow-up|11
2859977|NCT02223858|9830287|P1|Overall Study|Lost to Follow-up|6
2859978|NCT02223858|9830286|P2|Overall Study|Death|1
2859979|NCT02223858|9830287|P1|Overall Study|Death|1
2859980|NCT02223793|9830300|P3|Overall Study|Moved/studycenter unable to participate|8
2859981|NCT02223793|9830301|P2|Overall Study|Moved/studycenter unable to participate|6
2859982|NCT02223793|9830302|P1|Overall Study|Moved/studycenter unable to participate|4
2859983|NCT02223793|9830300|P3|Overall Study|Withdrawal by Subject|3
2859984|NCT02223793|9830301|P2|Overall Study|Withdrawal by Subject|2
2859985|NCT02223793|9830302|P1|Overall Study|Withdrawal by Subject|3
2859986|NCT02223793|9830300|P3|Overall Study|Lost to Follow-up|2
2859987|NCT02223793|9830301|P2|Overall Study|Lost to Follow-up|1
2859988|NCT02223793|9830302|P1|Overall Study|Lost to Follow-up|10
2859989|NCT02223754|9830315|P2|Period 2|Test Article No Longer Available|1
2859990|NCT02223754|9830316|P1|Period 2|Test Article No Longer Available|0
2859991|NCT02223754|9830315|P2|Period 2|Lost to Follow-up|0
2859992|NCT02223754|9830316|P1|Period 2|Lost to Follow-up|1
2859993|NCT02223754|9830315|P2|Period 2|Lens Discomfort|1
2859994|NCT02223754|9830316|P1|Period 2|Lens Discomfort|1
2859995|NCT02223754|9830315|P2|Period 2|Protocol Violation|0
2859996|NCT02223754|9830316|P1|Period 2|Protocol Violation|1
2859997|NCT02223754|9830315|P2|Period 2|Adverse Event|1
2859998|NCT02223754|9830316|P1|Period 2|Adverse Event|0
2859999|NCT02223754|9830315|P2|Period 1|Unsatisfactory Visual Response|1
2860000|NCT02223754|9830316|P1|Period 1|Unsatisfactory Visual Response|0
2860001|NCT02223754|9830315|P2|Period 1|Test Article No Longer Available|5
2860002|NCT02223754|9830316|P1|Period 1|Test Article No Longer Available|1
2860003|NCT02223754|9830315|P2|Period 1|Withdrawal by Subject|4
2860004|NCT02223754|9830316|P1|Period 1|Withdrawal by Subject|0
2860005|NCT02223754|9830315|P2|Period 1|Protocol Violation|4
2860006|NCT02223754|9830316|P1|Period 1|Protocol Violation|2
2860007|NCT02223754|9830315|P2|Period 1|Lost to Follow-up|1
2860008|NCT02223754|9830316|P1|Period 1|Lost to Follow-up|0
2860009|NCT02223754|9830315|P2|Period 1|Adverse Event|0
2860010|NCT02223754|9830316|P1|Period 1|Adverse Event|1
2860011|NCT02223715|9830336|P1|Overall Study|Lost to Follow-up|73
2860012|NCT02223715|9830336|P1|Overall Study|Death|31
2860013|NCT02223390|9830474|P2|Overall Study|Lost to Follow-up|4
2860014|NCT02223390|9830475|P1|Overall Study|Lost to Follow-up|9
2860015|NCT02223364|9830486|P3|Overall Study|Physician Decision|0
2860016|NCT02223364|9830487|P2|Overall Study|Physician Decision|0
2860017|NCT02223364|9830488|P1|Overall Study|Physician Decision|1
2860018|NCT02223364|9830486|P3|Overall Study|subject expired before surgery|0
2860019|NCT02223364|9830487|P2|Overall Study|subject expired before surgery|0
2860020|NCT02223364|9830488|P1|Overall Study|subject expired before surgery|1
2860021|NCT02223364|9830486|P3|Overall Study|Protocol Violation|3
2860022|NCT02223364|9830487|P2|Overall Study|Protocol Violation|0
2860023|NCT02223364|9830488|P1|Overall Study|Protocol Violation|3
2860024|NCT02222818|9830664|P2|Period 1|Eligibility criteria not met|3
2860025|NCT02222818|9830665|P1|Period 1|Eligibility criteria not met|0
2860026|NCT02222714|9830677|P5|Overall Study|Withdrawal by Subject|1
2860027|NCT02222714|9830678|P4|Overall Study|Withdrawal by Subject|0
2860028|NCT02222714|9830679|P3|Overall Study|Withdrawal by Subject|1
2860029|NCT02222714|9830680|P2|Overall Study|Withdrawal by Subject|0
2860030|NCT02222714|9830681|P1|Overall Study|Withdrawal by Subject|0
2860031|NCT02222714|9830677|P5|Overall Study|Death|6
2860032|NCT02222714|9830678|P4|Overall Study|Death|4
2860033|NCT02222714|9830679|P3|Overall Study|Death|3
2860034|NCT02222714|9830680|P2|Overall Study|Death|2
2860035|NCT02222714|9830681|P1|Overall Study|Death|0
2860036|NCT02222558|9830720|P6|Period 3|Withdrawal by Subject|1
2860037|NCT02222558|9830721|P5|Period 3|Withdrawal by Subject|0
2860038|NCT02222558|9830722|P4|Period 3|Withdrawal by Subject|0
2860039|NCT02222558|9830723|P3|Period 3|Withdrawal by Subject|0
2860040|NCT02222558|9830724|P2|Period 3|Withdrawal by Subject|0
2860041|NCT02222558|9830725|P1|Period 3|Withdrawal by Subject|0
2860042|NCT02222558|9830720|P6|Period 1: Single Dose|Withdrawal by Subject|0
2860043|NCT02222558|9830721|P5|Period 1: Single Dose|Withdrawal by Subject|0
2860044|NCT02222558|9830722|P4|Period 1: Single Dose|Withdrawal by Subject|0
2860045|NCT02222558|9830723|P3|Period 1: Single Dose|Withdrawal by Subject|0
2860046|NCT02222558|9830724|P2|Period 1: Single Dose|Withdrawal by Subject|0
2860047|NCT02222558|9830725|P1|Period 1: Single Dose|Withdrawal by Subject|4
2860048|NCT02222493|9830741|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
2860049|NCT02222493|9830742|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
2860050|NCT02222493|9830741|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
2860051|NCT02222493|9830742|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
2860052|NCT02222493|9830741|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
2860053|NCT02222493|9830742|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
2860054|NCT02222493|9830741|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
2860055|NCT02222493|9830742|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
2860056|NCT02222493|9830741|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
2860057|NCT02222493|9830742|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
2860058|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
2860059|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
2860060|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2860061|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2860062|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
2860063|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
2860064|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
2860065|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
2860066|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
2860067|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
2860068|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
2860069|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
2860070|NCT02222493|9830741|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
2860071|NCT02222493|9830742|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
2860072|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
2860073|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
2860074|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
2860075|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
2860076|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
2860077|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
2860078|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
2860079|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
2860080|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
2860081|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
2860082|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
2860083|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
2860084|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
2860085|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
2860086|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
2860087|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
2860088|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
2860089|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
2860090|NCT02222493|9830741|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2860091|NCT02222493|9830742|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2860092|NCT02222246|9830893|P2|Overall Study|Physician Decision|1
2860093|NCT02222246|9830894|P1|Overall Study|Physician Decision|0
2860094|NCT02222246|9830893|P2|Overall Study|No Emergency Department Visits|26
2860095|NCT02222246|9830894|P1|Overall Study|No Emergency Department Visits|27
2860096|NCT02222207|9830922|P1|Overall Study|Adverse Event|1
2860097|NCT02222207|9830922|P1|Overall Study|Other reasons|2
2860098|NCT02222207|9830922|P1|Overall Study|Death|1
2860099|NCT02221882|9830969|P6|Overall Study|Death|0
2860100|NCT02221882|9830970|P5|Overall Study|Death|0
2860101|NCT02221882|9830971|P4|Overall Study|Death|0
2860102|NCT02221882|9830972|P3|Overall Study|Death|0
2860103|NCT02221882|9830973|P2|Overall Study|Death|1
2860104|NCT02221882|9830974|P1|Overall Study|Death|0
2860105|NCT02221882|9830969|P6|Overall Study|Withdrawal by Subject|2
2860106|NCT02221882|9830970|P5|Overall Study|Withdrawal by Subject|2
2860107|NCT02221882|9830971|P4|Overall Study|Withdrawal by Subject|2
2860108|NCT02221882|9830972|P3|Overall Study|Withdrawal by Subject|4
2860109|NCT02221882|9830973|P2|Overall Study|Withdrawal by Subject|0
2860110|NCT02221882|9830974|P1|Overall Study|Withdrawal by Subject|0
2860111|NCT02221674|9831041|P3|Overall Study|Lost to Follow-up|0
2860112|NCT02221674|9831042|P2|Overall Study|Lost to Follow-up|0
2860113|NCT02221674|9831043|P1|Overall Study|Lost to Follow-up|1
2860114|NCT02221648|9831059|P2|Overall Study|Withdrawal by Subject|3
2860115|NCT02221648|9831060|P1|Overall Study|Withdrawal by Subject|3
2860116|NCT02221284|9831078|P1|Overall Study|Protocol Deviation|5
2860117|NCT02221284|9831078|P1|Overall Study|Case Report Forms Uncollected|56
2860118|NCT02221037|9831110|P4|Overall Study|Physician Decision|0
2860119|NCT02221037|9831111|P3|Overall Study|Physician Decision|1
2860120|NCT02221037|9831112|P2|Overall Study|Physician Decision|0
2860121|NCT02221037|9831113|P1|Overall Study|Physician Decision|0
2860122|NCT02220998|9831199|P2|Overall Study|Lost to Follow-up|4
2860123|NCT02220998|9831200|P1|Overall Study|Lost to Follow-up|4
2860124|NCT02220998|9831199|P2|Overall Study|Lack of Efficacy|5
2860125|NCT02220998|9831200|P1|Overall Study|Lack of Efficacy|0
2860126|NCT02220998|9831199|P2|Overall Study|Death|0
2860127|NCT02220998|9831200|P1|Overall Study|Death|2
2860128|NCT02220998|9831199|P2|Overall Study|Randomized but Never Treated|2
2860129|NCT02220998|9831200|P1|Overall Study|Randomized but Never Treated|1
2860130|NCT02220920|9831218|P2|Overall Study|Conflict with the stopping criteria|2
2860131|NCT02220920|9831219|P1|Overall Study|Conflict with the stopping criteria|1
2860132|NCT02220920|9831218|P2|Overall Study|Withdrawal by Subject|0
2860133|NCT02220920|9831219|P1|Overall Study|Withdrawal by Subject|1
2860134|NCT02220920|9831218|P2|Overall Study|Lack of Efficacy|1
2860135|NCT02220920|9831219|P1|Overall Study|Lack of Efficacy|0
2860136|NCT02220920|9831218|P2|Overall Study|Adverse Event|0
2860137|NCT02220920|9831219|P1|Overall Study|Adverse Event|1
2860138|NCT02220907|9831233|P1|Overall Study|Conflict with the stopping criteria|1
2860139|NCT02220907|9831233|P1|Overall Study|Withdrawal by Subject|2
2860140|NCT02220907|9831233|P1|Overall Study|Physician Decision|1
2860141|NCT02220907|9831233|P1|Overall Study|Adverse Event|7
2860142|NCT02220894|9831242|P2|Overall Study|Ongoing in Study|183
2860143|NCT02220894|9831243|P1|Overall Study|Ongoing in Study|265
2860144|NCT02220894|9831242|P2|Overall Study|Withdrawal by Subject|13
2860145|NCT02220894|9831243|P1|Overall Study|Withdrawal by Subject|2
2860146|NCT02220894|9831242|P2|Overall Study|Withdrawal by Parent/Guardian|1
2860147|NCT02220894|9831243|P1|Overall Study|Withdrawal by Parent/Guardian|0
2860148|NCT02220894|9831242|P2|Overall Study|Lost to Follow-up|2
2860149|NCT02220894|9831243|P1|Overall Study|Lost to Follow-up|0
2860150|NCT02220894|9831242|P2|Overall Study|Death|368
2860151|NCT02220894|9831243|P1|Overall Study|Death|252
2860152|NCT02220894|9831242|P2|Overall Study|Adverse Event|70
2860153|NCT02220894|9831243|P1|Overall Study|Adverse Event|118
2860154|NCT02220855|9831269|P1|Overall Study|Withdrawal by Subject|1
2860155|NCT02220855|9831269|P1|Overall Study|Disease Progression|5
2860156|NCT02220855|9831269|P1|Overall Study|Adverse Event|8
2860157|NCT02220764|9831279|P2|Overall Study|Death|0
2860158|NCT02220764|9831280|P1|Overall Study|Death|1
2860159|NCT02220764|9831279|P2|Overall Study|Lost to Follow-up|1
2860160|NCT02220764|9831280|P1|Overall Study|Lost to Follow-up|3
2860161|NCT02220725|9831294|P4|Overall Study|Withdrawal by Subject|1
2860162|NCT02220725|9831295|P3|Overall Study|Withdrawal by Subject|0
2860163|NCT02220725|9831296|P2|Overall Study|Withdrawal by Subject|0
2860164|NCT02220725|9831297|P1|Overall Study|Withdrawal by Subject|0
2860165|NCT02220725|9831294|P4|Overall Study|Lost to Follow-up|1
2860166|NCT02220725|9831295|P3|Overall Study|Lost to Follow-up|0
2860167|NCT02220725|9831296|P2|Overall Study|Lost to Follow-up|0
2860168|NCT02220725|9831297|P1|Overall Study|Lost to Follow-up|0
2860169|NCT02220205|9831327|P2|Overall Study|Withdrawal by Subject|0
2860170|NCT02220205|9831328|P1|Overall Study|Withdrawal by Subject|1
2860171|NCT02219932|9831353|P2|Overall Study|Adverse Event|21
2860172|NCT02219932|9831354|P1|Overall Study|Adverse Event|23
2860173|NCT02219932|9831353|P2|Overall Study|Lost to Follow-up|2
2860174|NCT02219932|9831354|P1|Overall Study|Lost to Follow-up|4
2860175|NCT02219932|9831353|P2|Overall Study|Pregnancy|0
2860176|NCT02219932|9831354|P1|Overall Study|Pregnancy|1
2860177|NCT02219932|9831353|P2|Overall Study|Protocol Violation|6
2860178|NCT02219932|9831354|P1|Overall Study|Protocol Violation|10
2860179|NCT02219932|9831353|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
2860180|NCT02219932|9831354|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
2860181|NCT02219932|9831353|P2|Overall Study|Consent Withdrawn|7
2860182|NCT02219932|9831354|P1|Overall Study|Consent Withdrawn|11
2860183|NCT02219932|9831353|P2|Overall Study|Investigator Decision|1
2860184|NCT02219932|9831354|P1|Overall Study|Investigator Decision|0
2860185|NCT02219932|9831353|P2|Overall Study|Death|1
2860186|NCT02219932|9831354|P1|Overall Study|Death|1
2860187|NCT02219932|9831353|P2|Overall Study|Other|11
2860188|NCT02219932|9831354|P1|Overall Study|Other|5
2860189|NCT02219685|9831370|P2|Blinded Treatment Phase|Withdrew Consent|0
2860190|NCT02219685|9831371|P1|Blinded Treatment Phase|Withdrew Consent|1
2860191|NCT02219685|9831370|P2|Blinded Treatment Phase|Lost to Follow-up|0
2860192|NCT02219685|9831371|P1|Blinded Treatment Phase|Lost to Follow-up|1
2860193|NCT02219477|9831477|P3|Overall Study|Withdrawal by Subject|0
2860194|NCT02219477|9831478|P2|Overall Study|Withdrawal by Subject|1
2860195|NCT02219477|9831479|P1|Overall Study|Withdrawal by Subject|0
2860196|NCT02219477|9831477|P3|Overall Study|Adverse Event|1
2860197|NCT02219477|9831478|P2|Overall Study|Adverse Event|1
2860198|NCT02219477|9831479|P1|Overall Study|Adverse Event|0
2860199|NCT02219464|9831507|P2|Overall Study|catheter malfunction|0
2860200|NCT02219464|9831508|P1|Overall Study|catheter malfunction|1
2860201|NCT02219464|9831507|P2|Overall Study|case cancelled|0
2860202|NCT02219464|9831508|P1|Overall Study|case cancelled|1
2860203|NCT02219464|9831507|P2|Overall Study|Withdrawal by Subject|0
2860204|NCT02219464|9831508|P1|Overall Study|Withdrawal by Subject|1
2860205|NCT02219308|9831529|P2|Overall Study|Withdrawal by Subject|2
2860206|NCT02219308|9831530|P1|Overall Study|Withdrawal by Subject|1
2860207|NCT02219087|9831690|P2|Overall Study|Randomization envelope pulled out of seq|1
2860208|NCT02219087|9831691|P1|Overall Study|Randomization envelope pulled out of seq|0
2860209|NCT02219048|9831711|P2|Overall Study|Other|1
2860210|NCT02219048|9831712|P1|Overall Study|Other|0
2860211|NCT02219048|9831711|P2|Overall Study|Withdrawal by Subject|0
2860212|NCT02219048|9831712|P1|Overall Study|Withdrawal by Subject|2
2860213|NCT02219048|9831711|P2|Overall Study|Study terminated by sponsor|15
2860214|NCT02219048|9831712|P1|Overall Study|Study terminated by sponsor|16
2860215|NCT02219048|9831711|P2|Overall Study|No longer meets eligibility criteria|0
2860216|NCT02219048|9831712|P1|Overall Study|No longer meets eligibility criteria|1
2860217|NCT02219048|9831711|P2|Overall Study|Adverse Event|5
2860218|NCT02219048|9831712|P1|Overall Study|Adverse Event|2
2860219|NCT02219009|9831738|P2|Overall Study|Physician Decision|1
2860220|NCT02219009|9831739|P1|Overall Study|Physician Decision|0
2860221|NCT02219009|9831738|P2|Overall Study|Protocol deviation|0
2860222|NCT02219009|9831739|P1|Overall Study|Protocol deviation|1
2860223|NCT02219009|9831738|P2|Overall Study|Lost to Follow-up|2
2860224|NCT02219009|9831739|P1|Overall Study|Lost to Follow-up|2
2860225|NCT02219009|9831738|P2|Overall Study|Adverse Event|4
2860226|NCT02219009|9831739|P1|Overall Study|Adverse Event|2
2860227|NCT02219009|9831738|P2|Overall Study|Withdrawal by Subject|1
2860228|NCT02219009|9831739|P1|Overall Study|Withdrawal by Subject|5
2860229|NCT02218736|9831751|P2|Overall Study|Protocol Violation|0
2860230|NCT02218736|9831752|P1|Overall Study|Protocol Violation|2
2860231|NCT02218736|9831751|P2|Overall Study|Withdrawal by Subject|9
2860232|NCT02218736|9831752|P1|Overall Study|Withdrawal by Subject|10
2860233|NCT02218697|9831764|P2|Overall Study|Withdrawal by Subject|3
2860234|NCT02218697|9831765|P1|Overall Study|Withdrawal by Subject|2
2860235|NCT02218697|9831764|P2|Overall Study|Unwilling to be vaccinated in left arm|1
2860236|NCT02218697|9831765|P1|Overall Study|Unwilling to be vaccinated in left arm|0
2860237|NCT02218697|9831764|P2|Overall Study|Adverse Event|2
2860238|NCT02218697|9831765|P1|Overall Study|Adverse Event|0
2860239|NCT02218541|9831805|P2|Overall Study|Implant Failure|1
2860240|NCT02218541|9831806|P1|Overall Study|Implant Failure|4
2860241|NCT02218541|9831805|P2|Overall Study|Lost to Follow-up|1
2860242|NCT02218541|9831806|P1|Overall Study|Lost to Follow-up|2
2860243|NCT02218372|9831852|P2|Overall Study|Withdrawal by Parent/Guardian|1
2860244|NCT02218372|9831853|P1|Overall Study|Withdrawal by Parent/Guardian|0
2860245|NCT02218372|9831852|P2|Overall Study|Randomized but did not receive treatment|3
2860246|NCT02218372|9831853|P1|Overall Study|Randomized but did not receive treatment|2
2860247|NCT02218372|9831852|P2|Overall Study|Miscellaneous|1
2860248|NCT02218372|9831853|P1|Overall Study|Miscellaneous|2
2860249|NCT02218372|9831852|P2|Overall Study|Adverse Event|1
2860250|NCT02218372|9831853|P1|Overall Study|Adverse Event|1
2860251|NCT02218268|9831933|P2|24 Hour Washout|Physician Decision|9
2860252|NCT02218268|9831934|P1|24 Hour Washout|Physician Decision|11
2860253|NCT02218216|9831946|P3|Overall Study|Study terminated before completed|0
2860254|NCT02218216|9831947|P2|Overall Study|Study terminated before completed|0
2860255|NCT02218216|9831948|P1|Overall Study|Study terminated before completed|6
2860256|NCT02218008|9832001|P6|Stage 2 (S2)|Lost to Follow-up|1
2860257|NCT02218008|9832002|P5|Stage 2 (S2)|Lost to Follow-up|0
2860258|NCT02218008|9832003|P4|Stage 2 (S2)|Lost to Follow-up|0
2860259|NCT02218008|9832004|P3|Stage 2 (S2)|Lost to Follow-up|0
2860260|NCT02218008|9832005|P2|Stage 2 (S2)|Lost to Follow-up|0
2860261|NCT02218008|9832006|P1|Stage 2 (S2)|Lost to Follow-up|0
2860262|NCT02218008|9832001|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2860263|NCT02218008|9832002|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2860264|NCT02218008|9832003|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
2860265|NCT02218008|9832004|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2860266|NCT02218008|9832005|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2860267|NCT02218008|9832006|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2860268|NCT02218008|9832001|P6|Stage 2 (S2)|Lack of Efficacy|2
2860269|NCT02218008|9832002|P5|Stage 2 (S2)|Lack of Efficacy|0
2860270|NCT02218008|9832003|P4|Stage 2 (S2)|Lack of Efficacy|0
2860271|NCT02218008|9832004|P3|Stage 2 (S2)|Lack of Efficacy|0
2860272|NCT02218008|9832005|P2|Stage 2 (S2)|Lack of Efficacy|0
2860273|NCT02218008|9832006|P1|Stage 2 (S2)|Lack of Efficacy|0
2860274|NCT02218008|9832001|P6|Stage 2 (S2)|Withdrawal by Subject|0
2860275|NCT02218008|9832002|P5|Stage 2 (S2)|Withdrawal by Subject|1
2860276|NCT02218008|9832003|P4|Stage 2 (S2)|Withdrawal by Subject|1
2860277|NCT02218008|9832004|P3|Stage 2 (S2)|Withdrawal by Subject|0
2860278|NCT02218008|9832005|P2|Stage 2 (S2)|Withdrawal by Subject|0
2860279|NCT02218008|9832006|P1|Stage 2 (S2)|Withdrawal by Subject|0
2860280|NCT02218008|9832001|P6|Stage 2 (S2)|Adverse Event|3
2860281|NCT02218008|9832002|P5|Stage 2 (S2)|Adverse Event|3
2860282|NCT02218008|9832003|P4|Stage 2 (S2)|Adverse Event|2
2860283|NCT02218008|9832004|P3|Stage 2 (S2)|Adverse Event|0
2860284|NCT02218008|9832005|P2|Stage 2 (S2)|Adverse Event|0
2860285|NCT02218008|9832006|P1|Stage 2 (S2)|Adverse Event|0
2860286|NCT02218008|9832001|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2860287|NCT02218008|9832002|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2860288|NCT02218008|9832003|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2860289|NCT02218008|9832004|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2860290|NCT02218008|9832005|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2860291|NCT02218008|9832006|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
2860292|NCT02218008|9832001|P6|Stage 1 (S1)|Protocol Violation|0
2860293|NCT02218008|9832002|P5|Stage 1 (S1)|Protocol Violation|0
2860294|NCT02218008|9832003|P4|Stage 1 (S1)|Protocol Violation|0
2860295|NCT02218008|9832004|P3|Stage 1 (S1)|Protocol Violation|1
2860296|NCT02218008|9832005|P2|Stage 1 (S1)|Protocol Violation|0
2860297|NCT02218008|9832006|P1|Stage 1 (S1)|Protocol Violation|0
2860298|NCT02218008|9832001|P6|Stage 1 (S1)|Pregnancy|0
2860299|NCT02218008|9832002|P5|Stage 1 (S1)|Pregnancy|0
2860300|NCT02218008|9832003|P4|Stage 1 (S1)|Pregnancy|0
2860301|NCT02218008|9832004|P3|Stage 1 (S1)|Pregnancy|1
2860302|NCT02218008|9832005|P2|Stage 1 (S1)|Pregnancy|0
2860303|NCT02218008|9832006|P1|Stage 1 (S1)|Pregnancy|0
2860304|NCT02218008|9832001|P6|Stage 1 (S1)|Non-compliance; drug use|0
2860305|NCT02218008|9832002|P5|Stage 1 (S1)|Non-compliance; drug use|0
2860306|NCT02218008|9832003|P4|Stage 1 (S1)|Non-compliance; drug use|0
2860307|NCT02218008|9832004|P3|Stage 1 (S1)|Non-compliance; drug use|0
2860308|NCT02218008|9832005|P2|Stage 1 (S1)|Non-compliance; drug use|0
2860309|NCT02218008|9832006|P1|Stage 1 (S1)|Non-compliance; drug use|1
2860310|NCT02218008|9832001|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
2860311|NCT02218008|9832002|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
2860312|NCT02218008|9832003|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
2860313|NCT02218008|9832004|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
2860314|NCT02218008|9832005|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
2860315|NCT02218008|9832006|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
2860316|NCT02218008|9832001|P6|Stage 1 (S1)|Lost to Follow-up|0
2860317|NCT02218008|9832002|P5|Stage 1 (S1)|Lost to Follow-up|0
2860318|NCT02218008|9832003|P4|Stage 1 (S1)|Lost to Follow-up|0
2860319|NCT02218008|9832004|P3|Stage 1 (S1)|Lost to Follow-up|1
2860320|NCT02218008|9832005|P2|Stage 1 (S1)|Lost to Follow-up|0
2860321|NCT02218008|9832006|P1|Stage 1 (S1)|Lost to Follow-up|3
2860322|NCT02218008|9832001|P6|Stage 1 (S1)|Lack of Efficacy|0
2860323|NCT02218008|9832002|P5|Stage 1 (S1)|Lack of Efficacy|0
2860324|NCT02218008|9832003|P4|Stage 1 (S1)|Lack of Efficacy|0
2860325|NCT02218008|9832004|P3|Stage 1 (S1)|Lack of Efficacy|0
2860326|NCT02218008|9832005|P2|Stage 1 (S1)|Lack of Efficacy|0
2860327|NCT02218008|9832006|P1|Stage 1 (S1)|Lack of Efficacy|3
2860328|NCT02218008|9832001|P6|Stage 1 (S1)|Withdrawal by Subject|0
2860329|NCT02218008|9832002|P5|Stage 1 (S1)|Withdrawal by Subject|0
2860330|NCT02218008|9832003|P4|Stage 1 (S1)|Withdrawal by Subject|0
2860331|NCT02218008|9832004|P3|Stage 1 (S1)|Withdrawal by Subject|1
2860332|NCT02218008|9832005|P2|Stage 1 (S1)|Withdrawal by Subject|1
2860333|NCT02218008|9832006|P1|Stage 1 (S1)|Withdrawal by Subject|6
2860334|NCT02218008|9832001|P6|Stage 1 (S1)|Adverse Event|0
2860335|NCT02218008|9832002|P5|Stage 1 (S1)|Adverse Event|0
2860336|NCT02218008|9832003|P4|Stage 1 (S1)|Adverse Event|0
2860337|NCT02218008|9832004|P3|Stage 1 (S1)|Adverse Event|11
2860338|NCT02218008|9832005|P2|Stage 1 (S1)|Adverse Event|5
2860339|NCT02218008|9832006|P1|Stage 1 (S1)|Adverse Event|6
2860340|NCT02217982|9832052|P2|Overall Study|Adverse Event|1
2860341|NCT02217982|9832053|P1|Overall Study|Adverse Event|0
2860342|NCT02217982|9832052|P2|Overall Study|Trial discontinued|0
2860343|NCT02217982|9832053|P1|Overall Study|Trial discontinued|1
2860344|NCT02217878|9832136|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
2860345|NCT02217878|9832137|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
2860346|NCT02217878|9832136|P2|Overall Study|required morphine due to chest pain|2
2860347|NCT02217878|9832137|P1|Overall Study|required morphine due to chest pain|1
2860348|NCT02217566|9832235|P1|Overall Study|Early study termination|6
2860349|NCT02217566|9832235|P1|Overall Study|Death|3
2860350|NCT02217566|9832235|P1|Overall Study|Lost to Follow-up|2
2860351|NCT02217527|9832246|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
2860352|NCT02217527|9832247|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
2860353|NCT02217527|9832246|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
2860354|NCT02217527|9832247|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
2860355|NCT02217475|9832260|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
2860356|NCT02217475|9832261|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2860357|NCT02217475|9832262|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2860358|NCT02217475|9832260|P3|Treatment Period 2 (Year 2)|Physician Decision|2
2860359|NCT02217475|9832261|P2|Treatment Period 2 (Year 2)|Physician Decision|0
2860360|NCT02217475|9832262|P1|Treatment Period 2 (Year 2)|Physician Decision|0
2860361|NCT02217475|9832260|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2860362|NCT02217475|9832261|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
2860363|NCT02217475|9832262|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2860364|NCT02217475|9832260|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
2860365|NCT02217475|9832261|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
2860366|NCT02217475|9832262|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
2860367|NCT02217475|9832260|P3|Treatment Period 2 (Year 2)|Adverse Event|5
2860368|NCT02217475|9832261|P2|Treatment Period 2 (Year 2)|Adverse Event|1
2860369|NCT02217475|9832262|P1|Treatment Period 2 (Year 2)|Adverse Event|0
2860370|NCT02217475|9832260|P3|Discontinued After Period 1|Physician Decision|1
2860371|NCT02217475|9832261|P2|Discontinued After Period 1|Physician Decision|0
2860372|NCT02217475|9832262|P1|Discontinued After Period 1|Physician Decision|0
2860373|NCT02217475|9832260|P3|Discontinued After Period 1|Participant Withdrew Consent|2
2860374|NCT02217475|9832261|P2|Discontinued After Period 1|Participant Withdrew Consent|1
2860375|NCT02217475|9832262|P1|Discontinued After Period 1|Participant Withdrew Consent|1
2860376|NCT02217475|9832260|P3|Discontinued After Period 1|Adverse Event|0
2860377|NCT02217475|9832261|P2|Discontinued After Period 1|Adverse Event|2
2860378|NCT02217475|9832262|P1|Discontinued After Period 1|Adverse Event|1
2860379|NCT02217475|9832260|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
2860380|NCT02217475|9832261|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2860381|NCT02217475|9832262|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2860382|NCT02217475|9832260|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
2860383|NCT02217475|9832261|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
2860384|NCT02217475|9832262|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
2860385|NCT02217475|9832260|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2860386|NCT02217475|9832261|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2860387|NCT02217475|9832262|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
2860388|NCT02217475|9832260|P3|Treatment Period 1 (Year 1)|Adverse Event|9
2860389|NCT02217475|9832261|P2|Treatment Period 1 (Year 1)|Adverse Event|5
2860390|NCT02217475|9832262|P1|Treatment Period 1 (Year 1)|Adverse Event|4
2860391|NCT02217475|9832260|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2860392|NCT02217475|9832261|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
2860393|NCT02217475|9832262|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2860394|NCT02217436|9832379|P2|Overall Study|Incomplete data|1
2860395|NCT02217436|9832380|P1|Overall Study|Incomplete data|0
2860396|NCT02217436|9832379|P2|Overall Study|Protocol Violation|1
2860397|NCT02217436|9832380|P1|Overall Study|Protocol Violation|1
2860398|NCT02217410|9832391|P3|Overall Study|Physician Decision|0
2860399|NCT02217410|9832392|P2|Overall Study|Physician Decision|3
2860400|NCT02217410|9832393|P1|Overall Study|Physician Decision|1
2860401|NCT02217410|9832391|P3|Overall Study|Lack of Efficacy|0
2860402|NCT02217410|9832392|P2|Overall Study|Lack of Efficacy|1
2860403|NCT02217410|9832393|P1|Overall Study|Lack of Efficacy|0
2860404|NCT02217410|9832391|P3|Overall Study|Lost to Follow-up|1
2860405|NCT02217410|9832392|P2|Overall Study|Lost to Follow-up|0
2860406|NCT02217410|9832393|P1|Overall Study|Lost to Follow-up|0
2860407|NCT02217410|9832391|P3|Overall Study|Withdrawal by Subject|2
2860408|NCT02217410|9832392|P2|Overall Study|Withdrawal by Subject|0
2860409|NCT02217410|9832393|P1|Overall Study|Withdrawal by Subject|0
2860410|NCT02217410|9832391|P3|Overall Study|Graft Loss|2
2860411|NCT02217410|9832392|P2|Overall Study|Graft Loss|0
2860412|NCT02217410|9832393|P1|Overall Study|Graft Loss|0
2860413|NCT02217280|9832416|P1|Overall Study|Post-consent sceen fail|2
2860414|NCT02217280|9832416|P1|Overall Study|Withdrawal by Subject|2
2860415|NCT02216812|9832423|P2|Overall Study|Lost to Follow-up|5
2860416|NCT02216812|9832424|P1|Overall Study|Lost to Follow-up|10
2860417|NCT02216773|9832440|P2|Overall Study|Abandoned|3
2860418|NCT02216773|9832441|P1|Overall Study|Abandoned|4
2860419|NCT02216773|9832440|P2|Overall Study|Insufficient FLRV|0
2860420|NCT02216773|9832441|P1|Overall Study|Insufficient FLRV|4
2860421|NCT02216773|9832440|P2|Overall Study|Disease progression|2
2860422|NCT02216773|9832441|P1|Overall Study|Disease progression|4
2860423|NCT02216591|9832462|P2|Overall Study|Lost to Follow-up|1
2860424|NCT02216591|9832463|P1|Overall Study|Lost to Follow-up|0
2860425|NCT02216526|9832476|P3|Overall Study|Hospitalization|3
2860426|NCT02216526|9832477|P2|Overall Study|Hospitalization|1
2860427|NCT02216526|9832478|P1|Overall Study|Hospitalization|2
2860428|NCT02216526|9832476|P3|Overall Study|Protocol Violation|2
2860429|NCT02216526|9832477|P2|Overall Study|Protocol Violation|0
2860430|NCT02216526|9832478|P1|Overall Study|Protocol Violation|2
2860431|NCT02216526|9832476|P3|Overall Study|Death|3
2860432|NCT02216526|9832477|P2|Overall Study|Death|1
2860433|NCT02216526|9832478|P1|Overall Study|Death|0
2860434|NCT02216526|9832476|P3|Overall Study|Adverse Event|0
2860435|NCT02216526|9832477|P2|Overall Study|Adverse Event|1
2860436|NCT02216526|9832478|P1|Overall Study|Adverse Event|1
2860437|NCT02216357|9832596|P2|Overall Study|Inclusion or exclusion criteria not met|1
2860438|NCT02216357|9832597|P1|Overall Study|Inclusion or exclusion criteria not met|2
2860439|NCT02216214|9832623|P2|Overall Study|Miscellaneous|1
2860440|NCT02216214|9832624|P1|Overall Study|Miscellaneous|1
2860441|NCT02216214|9832623|P2|Overall Study|Study Terminated By Sponsor|1
2860442|NCT02216214|9832624|P1|Overall Study|Study Terminated By Sponsor|0
2860443|NCT02216214|9832623|P2|Overall Study|Withdrawal by Subject|20
2860444|NCT02216214|9832624|P1|Overall Study|Withdrawal by Subject|22
2860445|NCT02216214|9832623|P2|Overall Study|Protocol Violation|2
2860446|NCT02216214|9832624|P1|Overall Study|Protocol Violation|4
2860447|NCT02216214|9832623|P2|Overall Study|Lost to Follow-up|2
2860448|NCT02216214|9832624|P1|Overall Study|Lost to Follow-up|3
2860449|NCT02216214|9832623|P2|Overall Study|Lack of Efficacy|2
2860450|NCT02216214|9832624|P1|Overall Study|Lack of Efficacy|2
2860451|NCT02216214|9832623|P2|Overall Study|Adverse Event|8
2860452|NCT02216214|9832624|P1|Overall Study|Adverse Event|10
2860453|NCT02216214|9832623|P2|Overall Study|Randomized Never Received Study Drug|0
2860454|NCT02216214|9832624|P1|Overall Study|Randomized Never Received Study Drug|1
2860455|NCT02216123|9832695|P2|Overall Study|Withdrawal by Subject|0
2860456|NCT02216123|9832696|P1|Overall Study|Withdrawal by Subject|2
2860457|NCT02216123|9832695|P2|Overall Study|Lost to Follow-up|2
2860458|NCT02216123|9832696|P1|Overall Study|Lost to Follow-up|4
2860459|NCT02215967|9832789|P4|Overall Study|Patient did not get CAR T-Cells|0
2860460|NCT02215967|9832790|P3|Overall Study|Patient did not get CAR T-Cells|1
2860461|NCT02215967|9832791|P2|Overall Study|Patient did not get CAR T-Cells|0
2860462|NCT02215967|9832792|P1|Overall Study|Patient did not get CAR T-Cells|0
2860463|NCT02215967|9832789|P4|Overall Study|Patient became ineligible for treatment|3
2860464|NCT02215967|9832790|P3|Overall Study|Patient became ineligible for treatment|0
2860465|NCT02215967|9832791|P2|Overall Study|Patient became ineligible for treatment|0
2860466|NCT02215967|9832792|P1|Overall Study|Patient became ineligible for treatment|0
2860467|NCT02215954|9832813|P3|Overall Study|Not exposed|3
2860468|NCT02215954|9832814|P2|Overall Study|Not exposed|1
2860469|NCT02215954|9832815|P1|Overall Study|Not exposed|1
2860470|NCT02215954|9832813|P3|Overall Study|Withdrawal by Subject|2
2860471|NCT02215954|9832814|P2|Overall Study|Withdrawal by Subject|0
2860472|NCT02215954|9832815|P1|Overall Study|Withdrawal by Subject|0
2860473|NCT02215954|9832813|P3|Overall Study|Adverse Event|1
2860474|NCT02215954|9832814|P2|Overall Study|Adverse Event|0
2860475|NCT02215954|9832815|P1|Overall Study|Adverse Event|0
2860476|NCT02215616|9832839|P4|Overall Study|Other than specified|1
2860477|NCT02215616|9832840|P3|Overall Study|Other than specified|1
2860478|NCT02215616|9832841|P2|Overall Study|Other than specified|0
2860479|NCT02215616|9832842|P1|Overall Study|Other than specified|1
2860480|NCT02215616|9832839|P4|Overall Study|Lost to Follow-up|1
2860481|NCT02215616|9832840|P3|Overall Study|Lost to Follow-up|0
2860482|NCT02215616|9832841|P2|Overall Study|Lost to Follow-up|1
2860483|NCT02215616|9832842|P1|Overall Study|Lost to Follow-up|1
2860484|NCT02215616|9832839|P4|Overall Study|Protocol Violation|0
2860485|NCT02215616|9832840|P3|Overall Study|Protocol Violation|0
2860486|NCT02215616|9832841|P2|Overall Study|Protocol Violation|2
2860487|NCT02215616|9832842|P1|Overall Study|Protocol Violation|0
2860488|NCT02215616|9832839|P4|Overall Study|Non-compliance|0
2860489|NCT02215616|9832840|P3|Overall Study|Non-compliance|1
2860490|NCT02215616|9832841|P2|Overall Study|Non-compliance|2
2860491|NCT02215616|9832842|P1|Overall Study|Non-compliance|0
2860492|NCT02215616|9832839|P4|Overall Study|Withdrawal by Subject|5
2860493|NCT02215616|9832840|P3|Overall Study|Withdrawal by Subject|2
2860494|NCT02215616|9832841|P2|Overall Study|Withdrawal by Subject|8
2860495|NCT02215616|9832842|P1|Overall Study|Withdrawal by Subject|1
2860496|NCT02215616|9832839|P4|Overall Study|Adverse Event|2
2860497|NCT02215616|9832840|P3|Overall Study|Adverse Event|9
2860498|NCT02215616|9832841|P2|Overall Study|Adverse Event|4
2860499|NCT02215616|9832842|P1|Overall Study|Adverse Event|7
2860500|NCT02215616|9832839|P4|Overall Study|Death|0
2860501|NCT02215616|9832840|P3|Overall Study|Death|0
2860502|NCT02215616|9832841|P2|Overall Study|Death|0
2860503|NCT02215616|9832842|P1|Overall Study|Death|1
2860504|NCT02215616|9832839|P4|Overall Study|Sponsor requested to stop study drug|4
2860505|NCT02215616|9832840|P3|Overall Study|Sponsor requested to stop study drug|1
2860506|NCT02215616|9832841|P2|Overall Study|Sponsor requested to stop study drug|0
2860507|NCT02215616|9832842|P1|Overall Study|Sponsor requested to stop study drug|0
2860508|NCT02215252|9832864|P3|Overall Study|Other|1
2860509|NCT02215252|9832865|P2|Overall Study|Other|1
2860510|NCT02215252|9832866|P1|Overall Study|Other|0
2860511|NCT02215252|9832864|P3|Overall Study|Withdrawal by Subject|0
2860512|NCT02215252|9832865|P2|Overall Study|Withdrawal by Subject|0
2860513|NCT02215252|9832866|P1|Overall Study|Withdrawal by Subject|1
2860514|NCT02215252|9832864|P3|Overall Study|Protocol Violation|0
2860515|NCT02215252|9832865|P2|Overall Study|Protocol Violation|1
2860516|NCT02215252|9832866|P1|Overall Study|Protocol Violation|0
2860517|NCT02215252|9832864|P3|Overall Study|Does not Meet Entrance Criteria|0
2860518|NCT02215252|9832865|P2|Overall Study|Does not Meet Entrance Criteria|1
2860519|NCT02215252|9832866|P1|Overall Study|Does not Meet Entrance Criteria|0
2860520|NCT02215252|9832864|P3|Overall Study|Lost to Follow-up|1
2860521|NCT02215252|9832865|P2|Overall Study|Lost to Follow-up|0
2860522|NCT02215252|9832866|P1|Overall Study|Lost to Follow-up|0
2860523|NCT02215252|9832864|P3|Overall Study|Adverse Event|2
2860524|NCT02215252|9832865|P2|Overall Study|Adverse Event|5
2860525|NCT02215252|9832866|P1|Overall Study|Adverse Event|1
2860526|NCT02214225|9833020|P3|Overall Study|randomized in error, not vaccinated|1
2860527|NCT02214225|9833021|P2|Overall Study|randomized in error, not vaccinated|1
2860528|NCT02214225|9833022|P1|Overall Study|randomized in error, not vaccinated|2
2860529|NCT02214225|9833020|P3|Overall Study|Death|1
2860530|NCT02214225|9833021|P2|Overall Study|Death|0
2860531|NCT02214225|9833022|P1|Overall Study|Death|5
2860532|NCT02214225|9833020|P3|Overall Study|Withdrawal by Subject|2
2860533|NCT02214225|9833021|P2|Overall Study|Withdrawal by Subject|0
2860534|NCT02214225|9833022|P1|Overall Study|Withdrawal by Subject|2
2860535|NCT02214225|9833020|P3|Overall Study|Lost to Follow-up|18
2860536|NCT02214225|9833021|P2|Overall Study|Lost to Follow-up|18
2860537|NCT02214225|9833022|P1|Overall Study|Lost to Follow-up|46
2860538|NCT02214186|9833081|P2|Overall Study|Protocol Violation|1
2860539|NCT02214186|9833082|P1|Overall Study|Protocol Violation|1
2860540|NCT02214186|9833081|P2|Overall Study|Lost to Follow-up|1
2860541|NCT02214186|9833082|P1|Overall Study|Lost to Follow-up|1
2860542|NCT02214121|9833150|P3|Part B|Lost to Follow-up|1
2860543|NCT02214121|9833151|P2|Part B|Lost to Follow-up|0
2860544|NCT02214121|9833152|P1|Part B|Lost to Follow-up|0
2860545|NCT02214121|9833150|P3|Part B|Dev. of study-specific withdrawal crit.|0
2860546|NCT02214121|9833151|P2|Part B|Dev. of study-specific withdrawal crit.|2
2860547|NCT02214121|9833152|P1|Part B|Dev. of study-specific withdrawal crit.|0
2860548|NCT02214121|9833150|P3|Part B|Patient decision|0
2860549|NCT02214121|9833151|P2|Part B|Patient decision|1
2860550|NCT02214121|9833152|P1|Part B|Patient decision|0
2860551|NCT02214121|9833150|P3|Part A|Other|0
2860552|NCT02214121|9833151|P2|Part A|Other|0
2860553|NCT02214121|9833152|P1|Part A|Other|1
2860554|NCT02214121|9833150|P3|Part A|Dev. of study-specific withdrawal crit.|0
2860555|NCT02214121|9833151|P2|Part A|Dev. of study-specific withdrawal crit.|0
2860556|NCT02214121|9833152|P1|Part A|Dev. of study-specific withdrawal crit.|4
2860557|NCT02214121|9833150|P3|Part A|Patient decision|0
2860558|NCT02214121|9833151|P2|Part A|Patient decision|0
2860559|NCT02214121|9833152|P1|Part A|Patient decision|2
2860560|NCT02213666|9833261|P1|Overall Study|Withdrawal by Subject|1
2860561|NCT02213510|9833267|P2|Overall Study|Lost to Follow-up|0
2860562|NCT02213510|9833268|P1|Overall Study|Lost to Follow-up|1
2860563|NCT02213510|9833267|P2|Overall Study|Death|1
2860564|NCT02213510|9833268|P1|Overall Study|Death|0
2860565|NCT02213263|9833296|P2|Overall Study|Adverse Event|3
2860566|NCT02213263|9833297|P1|Overall Study|Adverse Event|1
2860567|NCT02213263|9833296|P2|Overall Study|Protocol Violation|1
2860568|NCT02213263|9833297|P1|Overall Study|Protocol Violation|0
2860569|NCT02213263|9833296|P2|Overall Study|Progressive disease|14
2860570|NCT02213263|9833297|P1|Overall Study|Progressive disease|20
2860571|NCT02213263|9833296|P2|Overall Study|No longer willing to participate|4
2860572|NCT02213263|9833297|P1|Overall Study|No longer willing to participate|3
2860573|NCT02213263|9833296|P2|Overall Study|Lost to Follow-up|1
2860574|NCT02213263|9833297|P1|Overall Study|Lost to Follow-up|0
2860575|NCT02213263|9833296|P2|Overall Study|Insufficient clinical response|3
2860576|NCT02213263|9833297|P1|Overall Study|Insufficient clinical response|4
2860577|NCT02213198|9833365|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
2860578|NCT02213198|9833366|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
2860579|NCT02213198|9833365|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
2860580|NCT02213198|9833366|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
2860581|NCT02213198|9833365|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
2860582|NCT02213198|9833366|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
2860583|NCT02213198|9833365|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
2860584|NCT02213198|9833366|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
2860585|NCT02213198|9833365|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
2860586|NCT02213198|9833366|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
2860587|NCT02213198|9833365|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2860588|NCT02213198|9833366|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2860589|NCT02213198|9833365|P2|Baseline|incarcerated,violent|1
2860590|NCT02213198|9833366|P1|Baseline|incarcerated,violent|0
2860591|NCT02213198|9833365|P2|Baseline|Lost to Follow-up|21
2860592|NCT02213198|9833366|P1|Baseline|Lost to Follow-up|40
2860593|NCT02213198|9833365|P2|Baseline|transferred out of clinic|9
2860594|NCT02213198|9833366|P1|Baseline|transferred out of clinic|7
2860595|NCT02213198|9833365|P2|Baseline|Withdrawal by Subject|11
2860596|NCT02213198|9833366|P1|Baseline|Withdrawal by Subject|34
2860597|NCT02213198|9833365|P2|Baseline|No show for intake|9
2860598|NCT02213198|9833366|P1|Baseline|No show for intake|7
2860599|NCT02213094|9833376|P2|Overall Study|Adverse Event|0
2860600|NCT02213094|9833377|P1|Overall Study|Adverse Event|1
2860601|NCT02213055|9833385|P2|Overall Study|Did not Return to School|0
2860602|NCT02213055|9833386|P1|Overall Study|Did not Return to School|5
2860603|NCT02213055|9833385|P2|Overall Study|Did not meet Inclusion Criteria|0
2860604|NCT02213055|9833386|P1|Overall Study|Did not meet Inclusion Criteria|6
2860605|NCT02213055|9833385|P2|Overall Study|Had another Treatment during the Study|0
2860606|NCT02213055|9833386|P1|Overall Study|Had another Treatment during the Study|3
2860607|NCT02213055|9833385|P2|Overall Study|Did not have Live Lice|0
2860608|NCT02213055|9833386|P1|Overall Study|Did not have Live Lice|8
2860609|NCT02213055|9833385|P2|Overall Study|Documentation Issue during Study|0
2860610|NCT02213055|9833386|P1|Overall Study|Documentation Issue during Study|10
2860611|NCT02213055|9833385|P2|Overall Study|Documentation Issue at Enrollment|0
2860612|NCT02213055|9833386|P1|Overall Study|Documentation Issue at Enrollment|1
2860613|NCT02213055|9833385|P2|Overall Study|Protocol was not Followed during Study|0
2860614|NCT02213055|9833386|P1|Overall Study|Protocol was not Followed during Study|1
2860615|NCT02213055|9833385|P2|Overall Study|Protocol was not Followed at Enrollment|0
2860616|NCT02213055|9833386|P1|Overall Study|Protocol was not Followed at Enrollment|5
2860617|NCT02212678|9833418|P1|Overall Study|Adverse Event|1
2860618|NCT02212457|9833428|P6|Overall Study|Other|1
2860619|NCT02212457|9833429|P5|Overall Study|Other|0
2860620|NCT02212457|9833430|P4|Overall Study|Other|1
2860621|NCT02212457|9833431|P3|Overall Study|Other|2
2860622|NCT02212457|9833432|P2|Overall Study|Other|1
2860623|NCT02212457|9833433|P1|Overall Study|Other|2
2860624|NCT02212457|9833428|P6|Overall Study|Protocol Violation|3
2860625|NCT02212457|9833429|P5|Overall Study|Protocol Violation|2
2860626|NCT02212457|9833430|P4|Overall Study|Protocol Violation|1
2860627|NCT02212457|9833431|P3|Overall Study|Protocol Violation|0
2860628|NCT02212457|9833432|P2|Overall Study|Protocol Violation|1
2860629|NCT02212457|9833433|P1|Overall Study|Protocol Violation|2
2860630|NCT02212457|9833428|P6|Overall Study|Lost to Follow-up|4
2860631|NCT02212457|9833429|P5|Overall Study|Lost to Follow-up|8
2860632|NCT02212457|9833430|P4|Overall Study|Lost to Follow-up|1
2860633|NCT02212457|9833431|P3|Overall Study|Lost to Follow-up|4
2860634|NCT02212457|9833432|P2|Overall Study|Lost to Follow-up|7
2860635|NCT02212457|9833433|P1|Overall Study|Lost to Follow-up|6
2860636|NCT02212457|9833428|P6|Overall Study|Withdrawal by Subject|4
2860637|NCT02212457|9833429|P5|Overall Study|Withdrawal by Subject|5
2860638|NCT02212457|9833430|P4|Overall Study|Withdrawal by Subject|6
2860639|NCT02212457|9833431|P3|Overall Study|Withdrawal by Subject|8
2860640|NCT02212457|9833432|P2|Overall Study|Withdrawal by Subject|10
2860641|NCT02212457|9833433|P1|Overall Study|Withdrawal by Subject|8
2860642|NCT02212457|9833428|P6|Overall Study|Adverse Event|1
2860643|NCT02212457|9833429|P5|Overall Study|Adverse Event|0
2860644|NCT02212457|9833430|P4|Overall Study|Adverse Event|2
2860645|NCT02212457|9833431|P3|Overall Study|Adverse Event|2
2860646|NCT02212457|9833432|P2|Overall Study|Adverse Event|2
2860647|NCT02212457|9833433|P1|Overall Study|Adverse Event|1
2860648|NCT02212301|9833557|P2|Period 1|Lost to Follow-up|1
2860649|NCT02212301|9833558|P1|Period 1|Lost to Follow-up|0
2860650|NCT02212197|9833569|P3|Overall Study|Need for radiotherapy|0
2860651|NCT02212197|9833570|P2|Overall Study|Need for radiotherapy|0
2860652|NCT02212197|9833571|P1|Overall Study|Need for radiotherapy|1
2860653|NCT02211638|9833624|P1|Overall Study|Protocol Violation|692
2860654|NCT02211638|9833624|P1|Overall Study|Case Report Forms Uncollected|291
2860655|NCT02211313|9833658|P2|Overall Study|No Follow up Questionnaires|1
2860656|NCT02211313|9833659|P1|Overall Study|No Follow up Questionnaires|1
2860657|NCT02211313|9833658|P2|Overall Study|Treatment Failure|2
2860658|NCT02211313|9833659|P1|Overall Study|Treatment Failure|5
2860659|NCT02211261|9833676|P11|Overall Study|Lost to Follow-up|0
2860660|NCT02211261|9833677|P10|Overall Study|Lost to Follow-up|0
2860661|NCT02211261|9833678|P9|Overall Study|Lost to Follow-up|0
2860662|NCT02211261|9833679|P8|Overall Study|Lost to Follow-up|1
2860663|NCT02211261|9833680|P7|Overall Study|Lost to Follow-up|0
2860664|NCT02211261|9833681|P6|Overall Study|Lost to Follow-up|0
2860665|NCT02211261|9833682|P5|Overall Study|Lost to Follow-up|0
2860666|NCT02211261|9833683|P4|Overall Study|Lost to Follow-up|0
2860667|NCT02211261|9833684|P3|Overall Study|Lost to Follow-up|0
2860668|NCT02211261|9833685|P2|Overall Study|Lost to Follow-up|0
2860669|NCT02211261|9833686|P1|Overall Study|Lost to Follow-up|0
2860670|NCT02211261|9833676|P11|Overall Study|Other|0
2860671|NCT02211261|9833677|P10|Overall Study|Other|2
2860672|NCT02211261|9833678|P9|Overall Study|Other|0
2860673|NCT02211261|9833679|P8|Overall Study|Other|0
2860674|NCT02211261|9833680|P7|Overall Study|Other|0
2860675|NCT02211261|9833681|P6|Overall Study|Other|1
2860676|NCT02211261|9833682|P5|Overall Study|Other|0
2860677|NCT02211261|9833683|P4|Overall Study|Other|0
2860678|NCT02211261|9833684|P3|Overall Study|Other|0
2860679|NCT02211261|9833685|P2|Overall Study|Other|0
2860680|NCT02211261|9833686|P1|Overall Study|Other|0
2860681|NCT02211261|9833676|P11|Overall Study|Withdrawal by Subject|0
2860682|NCT02211261|9833677|P10|Overall Study|Withdrawal by Subject|0
2860683|NCT02211261|9833678|P9|Overall Study|Withdrawal by Subject|0
2860684|NCT02211261|9833679|P8|Overall Study|Withdrawal by Subject|0
2860685|NCT02211261|9833680|P7|Overall Study|Withdrawal by Subject|0
2860686|NCT02211261|9833681|P6|Overall Study|Withdrawal by Subject|0
2860687|NCT02211261|9833682|P5|Overall Study|Withdrawal by Subject|2
2860688|NCT02211261|9833683|P4|Overall Study|Withdrawal by Subject|0
2860689|NCT02211261|9833684|P3|Overall Study|Withdrawal by Subject|1
2860690|NCT02211261|9833685|P2|Overall Study|Withdrawal by Subject|0
2860691|NCT02211261|9833686|P1|Overall Study|Withdrawal by Subject|0
2860692|NCT02211131|9833809|P2|Overall Study|Continuing on Study|60
2860693|NCT02211131|9833810|P1|Overall Study|Continuing on Study|49
2860694|NCT02211131|9833809|P2|Overall Study|Withdrawal by Subject|4
2860695|NCT02211131|9833810|P1|Overall Study|Withdrawal by Subject|3
2860696|NCT02211131|9833809|P2|Overall Study|Decision by Sponsor|1
2860697|NCT02211131|9833810|P1|Overall Study|Decision by Sponsor|1
2860698|NCT02211131|9833809|P2|Overall Study|Lost to Follow-up|0
2860699|NCT02211131|9833810|P1|Overall Study|Lost to Follow-up|1
2860700|NCT02211131|9833809|P2|Overall Study|Death|11
2860701|NCT02211131|9833810|P1|Overall Study|Death|20
2860702|NCT02211014|9833844|P2|Overall Study|In agreement with patient, no benefit|1
2860703|NCT02211014|9833845|P1|Overall Study|In agreement with patient, no benefit|0
2860704|NCT02211014|9833844|P2|Overall Study|Withdrawal by Subject|1
2860705|NCT02211014|9833845|P1|Overall Study|Withdrawal by Subject|0
2860706|NCT02211014|9833844|P2|Overall Study|Started another cancer therapy|0
2860707|NCT02211014|9833845|P1|Overall Study|Started another cancer therapy|1
2860708|NCT02211014|9833844|P2|Overall Study|Physician Decision|2
2860709|NCT02211014|9833845|P1|Overall Study|Physician Decision|1
2860710|NCT02211014|9833844|P2|Overall Study|Adverse Event|2
2860711|NCT02211014|9833845|P1|Overall Study|Adverse Event|0
2860712|NCT02210780|9833871|P2|Overall Study|Other than specified above|1
2860713|NCT02210780|9833872|P1|Overall Study|Other than specified above|0
2860714|NCT02210780|9833871|P2|Overall Study|Protocol Violation|0
2860715|NCT02210780|9833872|P1|Overall Study|Protocol Violation|1
2860716|NCT02210780|9833871|P2|Overall Study|Physician Decision|0
2860717|NCT02210780|9833872|P1|Overall Study|Physician Decision|1
2860718|NCT02210780|9833871|P2|Overall Study|Withdrawal by Subject|1
2860719|NCT02210780|9833872|P1|Overall Study|Withdrawal by Subject|1
2860720|NCT02210780|9833871|P2|Overall Study|Lost to Follow-up|1
2860721|NCT02210780|9833872|P1|Overall Study|Lost to Follow-up|2
2860722|NCT02210780|9833871|P2|Overall Study|Adverse Event|5
2860723|NCT02210780|9833872|P1|Overall Study|Adverse Event|0
2860724|NCT02210689|9833901|P3|Overall Study|Other|8
2860725|NCT02210689|9833902|P2|Overall Study|Other|21
2860726|NCT02210689|9833903|P1|Overall Study|Other|25
2860727|NCT02210689|9833901|P3|Overall Study|Negative Nugent score at baseline|2
2860728|NCT02210689|9833902|P2|Overall Study|Negative Nugent score at baseline|2
2860729|NCT02210689|9833903|P1|Overall Study|Negative Nugent score at baseline|6
2860730|NCT02210689|9833901|P3|Overall Study|Prohibited medication|1
2860731|NCT02210689|9833902|P2|Overall Study|Prohibited medication|8
2860732|NCT02210689|9833903|P1|Overall Study|Prohibited medication|2
2860733|NCT02210689|9833901|P3|Overall Study|Lack of Efficacy|5
2860734|NCT02210689|9833902|P2|Overall Study|Lack of Efficacy|1
2860735|NCT02210689|9833903|P1|Overall Study|Lack of Efficacy|0
2860736|NCT02210689|9833901|P3|Overall Study|Pregnancy|0
2860737|NCT02210689|9833902|P2|Overall Study|Pregnancy|1
2860738|NCT02210689|9833903|P1|Overall Study|Pregnancy|0
2860739|NCT02210689|9833901|P3|Overall Study|Lost to Follow-up|5
2860740|NCT02210689|9833902|P2|Overall Study|Lost to Follow-up|9
2860741|NCT02210689|9833903|P1|Overall Study|Lost to Follow-up|11
2860742|NCT02210689|9833901|P3|Overall Study|Protocol Violation|0
2860743|NCT02210689|9833902|P2|Overall Study|Protocol Violation|0
2860744|NCT02210689|9833903|P1|Overall Study|Protocol Violation|1
2860745|NCT02210689|9833901|P3|Overall Study|Adverse Event|0
2860746|NCT02210689|9833902|P2|Overall Study|Adverse Event|1
2860747|NCT02210689|9833903|P1|Overall Study|Adverse Event|0
2860748|NCT02210689|9833901|P3|Overall Study|Withdrawal by Subject|2
2860749|NCT02210689|9833902|P2|Overall Study|Withdrawal by Subject|4
2860750|NCT02210689|9833903|P1|Overall Study|Withdrawal by Subject|7
2860751|NCT02210208|9833911|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
2860752|NCT02210208|9833911|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
2860753|NCT02210208|9833911|P1|Period A (Graft Site)|Withdrawal by Subject|1
2860754|NCT02210091|9833931|P2|Overall Study|Withdrawal by Sponsor|1
2860755|NCT02210091|9833932|P1|Overall Study|Withdrawal by Sponsor|0
2860756|NCT02210091|9833931|P2|Overall Study|Physician Decision|1
2860757|NCT02210091|9833932|P1|Overall Study|Physician Decision|0
2860758|NCT02210000|9834019|P2|Overall Study|Physician Decision|1
2860759|NCT02210000|9834020|P1|Overall Study|Physician Decision|0
2860760|NCT02210000|9834019|P2|Overall Study|Lost to Follow-up|2
2860761|NCT02210000|9834020|P1|Overall Study|Lost to Follow-up|0
2860762|NCT02210000|9834019|P2|Overall Study|Adverse Event|5
2860763|NCT02210000|9834020|P1|Overall Study|Adverse Event|1
2860764|NCT02210000|9834019|P2|Overall Study|Withdrawal by Subject|1
2860765|NCT02210000|9834020|P1|Overall Study|Withdrawal by Subject|7
2860766|NCT02210000|9834019|P2|Overall Study|Study Terminated|12
2860767|NCT02210000|9834020|P1|Overall Study|Study Terminated|11
2860768|NCT02209766|9834046|P5|Overall Study|Withdrawal by Subject|0
2860769|NCT02209766|9834047|P4|Overall Study|Withdrawal by Subject|1
2860770|NCT02209766|9834048|P3|Overall Study|Withdrawal by Subject|0
2860771|NCT02209766|9834049|P2|Overall Study|Withdrawal by Subject|0
2860772|NCT02209766|9834050|P1|Overall Study|Withdrawal by Subject|0
2860773|NCT02209597|9834109|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
2860774|NCT02209597|9834109|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
2860775|NCT02209597|9834109|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
2860776|NCT02209597|9834109|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
2860777|NCT02209506|9834154|P5|Overall Study|Withdrawal by Subject|1
2860778|NCT02209506|9834155|P4|Overall Study|Withdrawal by Subject|0
2860779|NCT02209506|9834156|P3|Overall Study|Withdrawal by Subject|0
2860780|NCT02209506|9834157|P2|Overall Study|Withdrawal by Subject|0
2860781|NCT02209506|9834158|P1|Overall Study|Withdrawal by Subject|0
2860782|NCT02209454|9834233|P2|Second Period|Adverse Event|0
2860783|NCT02209454|9834234|P1|Second Period|Adverse Event|1
2860784|NCT02209181|9834284|P4|Overall Study|Withdrawal by Subject|0
2860785|NCT02209181|9834285|P3|Overall Study|Withdrawal by Subject|0
2860786|NCT02209181|9834286|P2|Overall Study|Withdrawal by Subject|1
2860787|NCT02209181|9834287|P1|Overall Study|Withdrawal by Subject|0
2860788|NCT02209181|9834284|P4|Overall Study|Adverse Event|0
2860789|NCT02209181|9834285|P3|Overall Study|Adverse Event|1
2860790|NCT02209181|9834286|P2|Overall Study|Adverse Event|0
2860791|NCT02209181|9834287|P1|Overall Study|Adverse Event|1
2860792|NCT02208999|9834458|P1|Overall Study|Lost to Follow-up|1
2860793|NCT02208843|9834480|P1|Overall Study|Switched to commercial afatinib|20
2860794|NCT02208843|9834480|P1|Overall Study|Withdrawal by Subject|1
2860795|NCT02208843|9834480|P1|Overall Study|Protocol Violation|1
2860796|NCT02208843|9834480|P1|Overall Study|Adverse Event|12
2860797|NCT02208843|9834480|P1|Overall Study|Progression disease according to RECIST|24
2860798|NCT02208843|9834480|P1|Overall Study|Clinical symptoms of progression|2
2860799|NCT02208089|9834532|P2|Overall Study|Lost to Follow-up|0
2860800|NCT02208089|9834533|P1|Overall Study|Lost to Follow-up|6
2860801|NCT02208089|9834532|P2|Overall Study|Withdrawal by Subject|0
2860802|NCT02208089|9834533|P1|Overall Study|Withdrawal by Subject|1
2860803|NCT02208063|9834549|P2|Overall Study|Lost to Follow-up|0
2860804|NCT02208063|9834550|P1|Overall Study|Lost to Follow-up|1
2860805|NCT02208063|9834549|P2|Overall Study|Withdrawal by Subject|2
2860806|NCT02208063|9834550|P1|Overall Study|Withdrawal by Subject|5
2860807|NCT02208063|9834549|P2|Overall Study|Not Specified in report|4
2860808|NCT02208063|9834550|P1|Overall Study|Not Specified in report|3
2860809|NCT02208063|9834549|P2|Overall Study|Death|5
2860810|NCT02208063|9834550|P1|Overall Study|Death|3
2860811|NCT02207907|9834629|P2|Overall Study|Pregnancy|1
2860812|NCT02207907|9834630|P1|Overall Study|Pregnancy|0
2860813|NCT02207907|9834629|P2|Overall Study|Did not meet study criteria|0
2860814|NCT02207907|9834630|P1|Overall Study|Did not meet study criteria|3
2860815|NCT02207907|9834629|P2|Overall Study|Withdrawal by Subject|6
2860816|NCT02207907|9834630|P1|Overall Study|Withdrawal by Subject|5
2860817|NCT02207907|9834629|P2|Overall Study|Lost to Follow-up|1
2860818|NCT02207907|9834630|P1|Overall Study|Lost to Follow-up|3
2860819|NCT02207829|9834648|P2|Overall Study|Withdrew consent|14
2860820|NCT02207829|9834649|P1|Overall Study|Withdrew consent|18
2860821|NCT02207829|9834648|P2|Overall Study|Protocol deviation|4
2860822|NCT02207829|9834649|P1|Overall Study|Protocol deviation|5
2860823|NCT02207829|9834648|P2|Overall Study|Lost to Follow-up|2
2860824|NCT02207829|9834649|P1|Overall Study|Lost to Follow-up|2
2860825|NCT02207829|9834648|P2|Overall Study|Lack of Efficacy|5
2860826|NCT02207829|9834649|P1|Overall Study|Lack of Efficacy|7
2860827|NCT02207829|9834648|P2|Overall Study|Adverse Event|9
2860828|NCT02207829|9834649|P1|Overall Study|Adverse Event|10
2860829|NCT02207816|9834658|P3|Overall Study|Other|4
2860830|NCT02207816|9834659|P2|Overall Study|Other|2
2860831|NCT02207816|9834660|P1|Overall Study|Other|1
2860832|NCT02207816|9834658|P3|Overall Study|Lost to Follow-up|1
2860833|NCT02207816|9834659|P2|Overall Study|Lost to Follow-up|9
2860834|NCT02207816|9834660|P1|Overall Study|Lost to Follow-up|3
2860835|NCT02207816|9834658|P3|Overall Study|Migrated/Moved From Study Area|51
2860836|NCT02207816|9834659|P2|Overall Study|Migrated/Moved From Study Area|60
2860837|NCT02207816|9834660|P1|Overall Study|Migrated/Moved From Study Area|41
2860838|NCT02207816|9834658|P3|Overall Study|Withdrawal by Subject|7
2860839|NCT02207816|9834659|P2|Overall Study|Withdrawal by Subject|9
2860840|NCT02207816|9834660|P1|Overall Study|Withdrawal by Subject|4
2860841|NCT02207816|9834658|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
2860842|NCT02207816|9834659|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
2860843|NCT02207816|9834660|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
2860844|NCT02207816|9834658|P3|Overall Study|Serious Adverse Event|2
2860845|NCT02207816|9834659|P2|Overall Study|Serious Adverse Event|5
2860846|NCT02207816|9834660|P1|Overall Study|Serious Adverse Event|0
2860847|NCT02207725|9834818|P4|Overall Study|Did Not Receive Treatment|1
2860848|NCT02207725|9834819|P3|Overall Study|Did Not Receive Treatment|1
2860849|NCT02207725|9834820|P2|Overall Study|Did Not Receive Treatment|1
2860850|NCT02207725|9834821|P1|Overall Study|Did Not Receive Treatment|0
2860851|NCT02207634|9834851|P2|Overall Study|Lost to Follow-up|0
2860852|NCT02207634|9834852|P1|Overall Study|Lost to Follow-up|1
2860853|NCT02207634|9834851|P2|Overall Study|Withdrawal by Subject|31
2860854|NCT02207634|9834852|P1|Overall Study|Withdrawal by Subject|21
2860855|NCT02207621|9834867|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
2860856|NCT02207621|9834868|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
2860857|NCT02207621|9834869|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
2860858|NCT02207621|9834867|P3|Overall Study|Death|0
2860859|NCT02207621|9834868|P2|Overall Study|Death|0
2860860|NCT02207621|9834869|P1|Overall Study|Death|2
2860861|NCT02207621|9834867|P3|Overall Study|Protocol Violation|6
2860862|NCT02207621|9834868|P2|Overall Study|Protocol Violation|10
2860863|NCT02207621|9834869|P1|Overall Study|Protocol Violation|4
2860864|NCT02207621|9834867|P3|Overall Study|Physician Decision|2
2860865|NCT02207621|9834868|P2|Overall Study|Physician Decision|2
2860866|NCT02207621|9834869|P1|Overall Study|Physician Decision|1
2860867|NCT02207621|9834867|P3|Overall Study|Disallowed Concurrent Medication|2
2860868|NCT02207621|9834868|P2|Overall Study|Disallowed Concurrent Medication|5
2860869|NCT02207621|9834869|P1|Overall Study|Disallowed Concurrent Medication|2
2860870|NCT02207621|9834867|P3|Overall Study|Lack of Efficacy|4
2860871|NCT02207621|9834868|P2|Overall Study|Lack of Efficacy|2
2860872|NCT02207621|9834869|P1|Overall Study|Lack of Efficacy|10
2860873|NCT02207621|9834867|P3|Overall Study|Lost to Follow-up|3
2860874|NCT02207621|9834868|P2|Overall Study|Lost to Follow-up|0
2860875|NCT02207621|9834869|P1|Overall Study|Lost to Follow-up|1
2860876|NCT02207621|9834867|P3|Overall Study|Non-Compliant|1
2860877|NCT02207621|9834868|P2|Overall Study|Non-Compliant|3
2860878|NCT02207621|9834869|P1|Overall Study|Non-Compliant|3
2860879|NCT02207621|9834867|P3|Overall Study|Withdrawal by Subject|13
2860880|NCT02207621|9834868|P2|Overall Study|Withdrawal by Subject|9
2860881|NCT02207621|9834869|P1|Overall Study|Withdrawal by Subject|9
2860882|NCT02207621|9834867|P3|Overall Study|Adverse Event|132
2860883|NCT02207621|9834868|P2|Overall Study|Adverse Event|15
2860884|NCT02207621|9834869|P1|Overall Study|Adverse Event|71
2860885|NCT02207608|9834882|P2|Overall Study|Adverse Event|0
2860886|NCT02207608|9834883|P1|Overall Study|Adverse Event|1
2860887|NCT02207556|9834909|P2|Overall Study|Death|5
2860888|NCT02207556|9834910|P1|Overall Study|Death|0
2860889|NCT02207556|9834909|P2|Overall Study|Withdrawal by Subject|0
2860890|NCT02207556|9834910|P1|Overall Study|Withdrawal by Subject|1
2860891|NCT02207556|9834909|P2|Overall Study|Physician Decision|0
2860892|NCT02207556|9834910|P1|Overall Study|Physician Decision|1
2860893|NCT02207530|9834915|P1|Overall Study|Adverse Event|8
2860894|NCT02207530|9834915|P1|Overall Study|Patient decision to stop study treatment|5
2860895|NCT02207530|9834915|P1|Overall Study|Worsening condition under investigation|78
2860896|NCT02207491|9834929|P2|Overall Study|Protocol Violation|5
2860897|NCT02207491|9834930|P1|Overall Study|Protocol Violation|3
2860898|NCT02207491|9834929|P2|Overall Study|Physician Decision|0
2860899|NCT02207491|9834930|P1|Overall Study|Physician Decision|2
2860900|NCT02207491|9834929|P2|Overall Study|Lack of Efficacy|0
2860901|NCT02207491|9834930|P1|Overall Study|Lack of Efficacy|3
2860902|NCT02207491|9834929|P2|Overall Study|Lost to Follow-up|1
2860903|NCT02207491|9834930|P1|Overall Study|Lost to Follow-up|0
2860904|NCT02207491|9834929|P2|Overall Study|Non-compliant|1
2860905|NCT02207491|9834930|P1|Overall Study|Non-compliant|0
2860906|NCT02207491|9834929|P2|Overall Study|Withdrawal by Subject|2
2860907|NCT02207491|9834930|P1|Overall Study|Withdrawal by Subject|3
2860908|NCT02207491|9834929|P2|Overall Study|Adverse Event|4
2860909|NCT02207491|9834930|P1|Overall Study|Adverse Event|20
2860910|NCT02207413|9834955|P6|Overall Study|Migrated/moved from study area|0
2860911|NCT02207413|9834956|P5|Overall Study|Migrated/moved from study area|1
2860912|NCT02207413|9834957|P4|Overall Study|Migrated/moved from study area|0
2860913|NCT02207413|9834958|P3|Overall Study|Migrated/moved from study area|0
2860914|NCT02207413|9834959|P2|Overall Study|Migrated/moved from study area|0
2860915|NCT02207413|9834960|P1|Overall Study|Migrated/moved from study area|0
2860916|NCT02207413|9834955|P6|Overall Study|Adverse Event|1
2860917|NCT02207413|9834956|P5|Overall Study|Adverse Event|2
2860918|NCT02207413|9834957|P4|Overall Study|Adverse Event|0
2860919|NCT02207413|9834958|P3|Overall Study|Adverse Event|0
2860920|NCT02207413|9834959|P2|Overall Study|Adverse Event|0
2860921|NCT02207413|9834960|P1|Overall Study|Adverse Event|0
2860922|NCT02207413|9834955|P6|Overall Study|Lost to Follow-up|5
2860923|NCT02207413|9834956|P5|Overall Study|Lost to Follow-up|1
2860924|NCT02207413|9834957|P4|Overall Study|Lost to Follow-up|1
2860925|NCT02207413|9834958|P3|Overall Study|Lost to Follow-up|0
2860926|NCT02207413|9834959|P2|Overall Study|Lost to Follow-up|0
2860927|NCT02207413|9834960|P1|Overall Study|Lost to Follow-up|0
2860928|NCT02207413|9834955|P6|Overall Study|Withdrawal by Subject|7
2860929|NCT02207413|9834956|P5|Overall Study|Withdrawal by Subject|3
2860930|NCT02207413|9834957|P4|Overall Study|Withdrawal by Subject|0
2860931|NCT02207413|9834958|P3|Overall Study|Withdrawal by Subject|0
2860932|NCT02207413|9834959|P2|Overall Study|Withdrawal by Subject|0
2860933|NCT02207413|9834960|P1|Overall Study|Withdrawal by Subject|1
2860934|NCT02207400|9835056|P2|Overall Study|Positive Urine Pregnancy Test|1
2860935|NCT02207400|9835057|P1|Overall Study|Positive Urine Pregnancy Test|0
2860936|NCT02207400|9835056|P2|Overall Study|Withdrawal by Subject|4
2860937|NCT02207400|9835057|P1|Overall Study|Withdrawal by Subject|8
2860938|NCT02207400|9835056|P2|Overall Study|Protocol Violation|1
2860939|NCT02207400|9835057|P1|Overall Study|Protocol Violation|1
2860940|NCT02207400|9835056|P2|Overall Study|Lost to Follow-up|7
2860941|NCT02207400|9835057|P1|Overall Study|Lost to Follow-up|6
2860942|NCT02207400|9835056|P2|Overall Study|Adverse Event|1
2860943|NCT02207400|9835057|P1|Overall Study|Adverse Event|1
2860944|NCT02207374|9835078|P3|Overall Study|Missing follow-up information|1
2860945|NCT02207374|9835079|P2|Overall Study|Missing follow-up information|1
2860946|NCT02207374|9835080|P1|Overall Study|Missing follow-up information|0
2860947|NCT02207374|9835078|P3|Overall Study|Death|1
2860948|NCT02207374|9835079|P2|Overall Study|Death|0
2860949|NCT02207374|9835080|P1|Overall Study|Death|1
2860950|NCT02207374|9835078|P3|Overall Study|Withdrawal by Subject|4
2860951|NCT02207374|9835079|P2|Overall Study|Withdrawal by Subject|9
2860952|NCT02207374|9835080|P1|Overall Study|Withdrawal by Subject|5
2860953|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
2860954|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
2860955|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
2860956|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
2860957|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
2860958|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
2860959|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
2860960|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
2860961|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
2860962|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860963|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860964|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
2860965|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860966|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860967|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860968|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860969|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860970|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2860971|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860972|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860973|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
2860974|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860975|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860976|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860977|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860978|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860979|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2860980|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
2860981|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
2860982|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
2860983|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860984|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860985|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860986|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860987|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860988|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2860989|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
2860990|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
2860991|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
2860992|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860993|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860994|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860995|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860996|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860997|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2860998|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
2860999|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
2861000|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861001|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861002|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861003|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861004|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861005|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861006|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2861007|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861008|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
2861009|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861010|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861011|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861012|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861013|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861014|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861015|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2861016|NCT02207244|9835144|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
2861017|NCT02207244|9835145|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
2861018|NCT02207244|9835146|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
2861019|NCT02207244|9835147|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861020|NCT02207244|9835148|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861021|NCT02207244|9835149|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861022|NCT02207244|9835150|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861023|NCT02207244|9835151|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861024|NCT02207244|9835152|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2861025|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861026|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861027|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861028|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861029|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861030|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
2861031|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861032|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861033|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
2861034|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861035|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861036|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861037|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
2861038|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861039|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
2861040|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861041|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861042|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2861043|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861044|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861045|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861046|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
2861047|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
2861048|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
2861049|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861050|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861051|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2861052|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861053|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861054|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861055|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
2861056|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
2861057|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
2861058|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861059|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861060|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2861061|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861062|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861063|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861064|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
2861065|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861066|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861067|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861068|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861069|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2861070|NCT02207244|9835144|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861071|NCT02207244|9835145|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861072|NCT02207244|9835146|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861073|NCT02207244|9835147|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
2861074|NCT02207244|9835148|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
2861075|NCT02207244|9835149|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861076|NCT02207244|9835150|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861077|NCT02207244|9835151|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861078|NCT02207244|9835152|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2861079|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Other|0
2861080|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Other|0
2861081|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Other|0
2861082|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Other|0
2861083|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Other|0
2861084|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Other|0
2861085|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Other|0
2861086|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Other|1
2861087|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Other|0
2861088|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861089|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861090|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861091|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861092|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861093|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861094|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
2861095|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
2861096|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2861097|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861098|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861099|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861100|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861101|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861102|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861103|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2861104|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
2861105|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2861106|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861107|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861108|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861109|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861110|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861111|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861112|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861113|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
2861114|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
2861115|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861116|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861117|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861118|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861119|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861120|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2861121|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
2861122|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
2861123|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2861124|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861125|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861126|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861127|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861128|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861129|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861130|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
2861131|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861132|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
2861133|NCT02207244|9835144|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861134|NCT02207244|9835145|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861135|NCT02207244|9835146|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861136|NCT02207244|9835147|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861137|NCT02207244|9835148|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861138|NCT02207244|9835149|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2861139|NCT02207244|9835150|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
2861140|NCT02207244|9835151|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
2861141|NCT02207244|9835152|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2861142|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
2861143|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
2861144|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
2861145|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Other|3
2861146|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Other|2
2861147|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Other|0
2861148|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2861149|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
2861150|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2861151|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
2861152|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
2861153|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
2861154|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
2861155|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
2861156|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
2861157|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
2861158|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
2861159|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
2861160|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
2861161|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
2861162|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
2861163|NCT02207231|9835193|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
2861164|NCT02207231|9835194|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
2861165|NCT02207231|9835195|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
2861166|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
2861167|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
2861168|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
2861169|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2861170|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861171|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2861172|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
2861173|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2861174|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
2861175|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2861176|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2861177|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2861178|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
2861179|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2861180|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
2861181|NCT02207231|9835193|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2861182|NCT02207231|9835194|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
2861183|NCT02207231|9835195|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2861184|NCT02207088|9835227|P1|Overall Study|Adverse Event|2
2861185|NCT02206828|9835233|P1|Overall Study|Lost to Follow-up|7
2861186|NCT02206620|9835269|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
2861187|NCT02206620|9835270|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
2861188|NCT02206620|9835269|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2861189|NCT02206620|9835270|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2861190|NCT02206607|9835286|P5|Second Intervention Period|Insufficient Clinical Response|0
2861191|NCT02206607|9835287|P4|Second Intervention Period|Insufficient Clinical Response|1
2861192|NCT02206607|9835288|P3|Second Intervention Period|Insufficient Clinical Response|0
2861193|NCT02206607|9835289|P2|Second Intervention Period|Insufficient Clinical Response|0
2861194|NCT02206607|9835290|P1|Second Intervention Period|Insufficient Clinical Response|0
2861195|NCT02206607|9835286|P5|Open-Label Run-In|Withdrawal by Subject|0
2861196|NCT02206607|9835287|P4|Open-Label Run-In|Withdrawal by Subject|0
2861197|NCT02206607|9835288|P3|Open-Label Run-In|Withdrawal by Subject|0
2861198|NCT02206607|9835289|P2|Open-Label Run-In|Withdrawal by Subject|0
2861199|NCT02206607|9835290|P1|Open-Label Run-In|Withdrawal by Subject|3
2861200|NCT02206152|9835353|P1|Pre-Randomization|Withdrawal by Subject|2
2861201|NCT02205814|9835380|P4|Overall Study|not compliant with study procedures|0
2861202|NCT02205814|9835381|P3|Overall Study|not compliant with study procedures|1
2861203|NCT02205814|9835382|P2|Overall Study|not compliant with study procedures|0
2861204|NCT02205814|9835383|P1|Overall Study|not compliant with study procedures|0
2861205|NCT02205814|9835380|P4|Overall Study|Withdrawal by Subject|1
2861206|NCT02205814|9835381|P3|Overall Study|Withdrawal by Subject|2
2861207|NCT02205814|9835382|P2|Overall Study|Withdrawal by Subject|1
2861208|NCT02205814|9835383|P1|Overall Study|Withdrawal by Subject|0
2861209|NCT02205814|9835380|P4|Overall Study|Protocol Violation|1
2861210|NCT02205814|9835381|P3|Overall Study|Protocol Violation|0
2861211|NCT02205814|9835382|P2|Overall Study|Protocol Violation|0
2861212|NCT02205814|9835383|P1|Overall Study|Protocol Violation|1
2861213|NCT02205814|9835380|P4|Overall Study|Physician Decision|0
2861214|NCT02205814|9835381|P3|Overall Study|Physician Decision|1
2861215|NCT02205814|9835382|P2|Overall Study|Physician Decision|0
2861216|NCT02205814|9835383|P1|Overall Study|Physician Decision|0
2861217|NCT02205814|9835380|P4|Overall Study|Lack of Efficacy|1
2861218|NCT02205814|9835381|P3|Overall Study|Lack of Efficacy|1
2861219|NCT02205814|9835382|P2|Overall Study|Lack of Efficacy|0
2861220|NCT02205814|9835383|P1|Overall Study|Lack of Efficacy|1
2861221|NCT02205814|9835380|P4|Overall Study|Lost to Follow-up|1
2861222|NCT02205814|9835381|P3|Overall Study|Lost to Follow-up|0
2861223|NCT02205814|9835382|P2|Overall Study|Lost to Follow-up|0
2861224|NCT02205814|9835383|P1|Overall Study|Lost to Follow-up|0
2861225|NCT02205476|9835436|P2|Overall Study|Study termination by Sponsor|3
2861226|NCT02205476|9835437|P1|Overall Study|Study termination by Sponsor|7
2861227|NCT02205333|9835476|P9|Overall Study|Withdrawal by Subject|0
2861228|NCT02205333|9835477|P8|Overall Study|Withdrawal by Subject|0
2861229|NCT02205333|9835478|P7|Overall Study|Withdrawal by Subject|2
2861230|NCT02205333|9835479|P6|Overall Study|Withdrawal by Subject|0
2861231|NCT02205333|9835480|P5|Overall Study|Withdrawal by Subject|0
2861232|NCT02205333|9835481|P4|Overall Study|Withdrawal by Subject|1
2861233|NCT02205333|9835482|P3|Overall Study|Withdrawal by Subject|0
2861234|NCT02205333|9835483|P2|Overall Study|Withdrawal by Subject|0
2861235|NCT02205333|9835484|P1|Overall Study|Withdrawal by Subject|1
2861236|NCT02205333|9835476|P9|Overall Study|Death|0
2861237|NCT02205333|9835477|P8|Overall Study|Death|2
2861238|NCT02205333|9835478|P7|Overall Study|Death|3
2861239|NCT02205333|9835479|P6|Overall Study|Death|3
2861240|NCT02205333|9835480|P5|Overall Study|Death|5
2861241|NCT02205333|9835481|P4|Overall Study|Death|6
2861242|NCT02205333|9835482|P3|Overall Study|Death|2
2861243|NCT02205333|9835483|P2|Overall Study|Death|6
2861244|NCT02205333|9835484|P1|Overall Study|Death|5
2861245|NCT02204982|9835670|P2|Overall Study|Termination of Study bySponsor|1
2861246|NCT02204982|9835671|P1|Overall Study|Termination of Study bySponsor|0
2861247|NCT02204982|9835670|P2|Overall Study|Protocol-Specified Disease Progression|4
2861248|NCT02204982|9835671|P1|Overall Study|Protocol-Specified Disease Progression|0
2861249|NCT02204982|9835670|P2|Overall Study|Physician Decision|2
2861250|NCT02204982|9835671|P1|Overall Study|Physician Decision|0
2861251|NCT02204982|9835670|P2|Overall Study|Adverse Event and Investigator decision|0
2861252|NCT02204982|9835671|P1|Overall Study|Adverse Event and Investigator decision|1
2861253|NCT02204982|9835670|P2|Overall Study|Adverse Event|0
2861254|NCT02204982|9835671|P1|Overall Study|Adverse Event|1
2861255|NCT02204982|9835670|P2|Overall Study|Withdrawal by Subject|0
2861256|NCT02204982|9835671|P1|Overall Study|Withdrawal by Subject|1
2861257|NCT02204982|9835670|P2|Overall Study|Patient ineligible-medical monitor|0
2861258|NCT02204982|9835671|P1|Overall Study|Patient ineligible-medical monitor|1
2861259|NCT02204917|9835679|P1|Overall Study|Protocol Violation|1
2861260|NCT02204579|9835716|P1|Overall Study|Screen failures|2
2861261|NCT02204449|9835774|P2|Overall Study|Withdrawal by Subject|1
2861262|NCT02204449|9835775|P1|Overall Study|Withdrawal by Subject|0
2861263|NCT02204449|9835774|P2|Overall Study|Death|1
2861264|NCT02204449|9835775|P1|Overall Study|Death|0
2861265|NCT02204449|9835774|P2|Overall Study|Lost to Follow-up|9
2861266|NCT02204449|9835775|P1|Overall Study|Lost to Follow-up|7
2861267|NCT02204410|9835785|P1|Overall Study|Withdrawal by Subject|3
2861268|NCT02204410|9835785|P1|Overall Study|Protocol Violation|1
2861269|NCT02204410|9835785|P1|Overall Study|Physician Decision|2
2861270|NCT02204410|9835785|P1|Overall Study|Lost to Follow-up|5
2861271|NCT02204371|9835790|P1|Overall Study|Adverse Event|1
2861272|NCT02204319|9835813|P1|Overall Study|Withdrawal by Subject|2
2861273|NCT02204319|9835813|P1|Overall Study|Pregnancy|1
2861274|NCT02204007|9835874|P2|Overall Study|Surgery Canceled|1
2861275|NCT02204007|9835875|P1|Overall Study|Surgery Canceled|1
2861276|NCT02203916|9835886|P3|Overall Study|Reason Not Specified|1
2861277|NCT02203916|9835887|P2|Overall Study|Reason Not Specified|2
2861278|NCT02203916|9835888|P1|Overall Study|Reason Not Specified|0
2861279|NCT02203916|9835886|P3|Overall Study|Lack of Efficacy|0
2861280|NCT02203916|9835887|P2|Overall Study|Lack of Efficacy|0
2861281|NCT02203916|9835888|P1|Overall Study|Lack of Efficacy|3
2861282|NCT02203916|9835886|P3|Overall Study|Voluntary Withdrawal|8
2861283|NCT02203916|9835887|P2|Overall Study|Voluntary Withdrawal|3
2861284|NCT02203916|9835888|P1|Overall Study|Voluntary Withdrawal|3
2861285|NCT02203916|9835886|P3|Overall Study|Lost to Follow-up|0
2861286|NCT02203916|9835887|P2|Overall Study|Lost to Follow-up|1
2861287|NCT02203916|9835888|P1|Overall Study|Lost to Follow-up|0
2861288|NCT02203916|9835886|P3|Overall Study|Major Protocol Deviation|0
2861289|NCT02203916|9835887|P2|Overall Study|Major Protocol Deviation|1
2861290|NCT02203916|9835888|P1|Overall Study|Major Protocol Deviation|1
2861291|NCT02203916|9835886|P3|Overall Study|Pretreatment Event/Adverse Event|2
2861292|NCT02203916|9835887|P2|Overall Study|Pretreatment Event/Adverse Event|3
2861293|NCT02203916|9835888|P1|Overall Study|Pretreatment Event/Adverse Event|1
2861294|NCT02203851|9835908|P1|Overall Study|Other|1
2861295|NCT02203851|9835908|P1|Overall Study|Withdrawal by Subject|6
2861296|NCT02203851|9835908|P1|Overall Study|Lost to Follow-up|4
2861297|NCT02203838|9835946|P4|Overall Study|Other|0
2861298|NCT02203838|9835947|P3|Overall Study|Other|0
2861299|NCT02203838|9835948|P2|Overall Study|Other|0
2861300|NCT02203838|9835949|P1|Overall Study|Other|1
2861301|NCT02203838|9835946|P4|Overall Study|Physician Decision|3
2861302|NCT02203838|9835947|P3|Overall Study|Physician Decision|2
2861303|NCT02203838|9835948|P2|Overall Study|Physician Decision|0
2861304|NCT02203838|9835949|P1|Overall Study|Physician Decision|27
2861305|NCT02203838|9835946|P4|Overall Study|Withdrawal by Subject|11
2861306|NCT02203838|9835947|P3|Overall Study|Withdrawal by Subject|8
2861307|NCT02203838|9835948|P2|Overall Study|Withdrawal by Subject|10
2861308|NCT02203838|9835949|P1|Overall Study|Withdrawal by Subject|83
2861309|NCT02203838|9835946|P4|Overall Study|Protocol Violation|0
2861310|NCT02203838|9835947|P3|Overall Study|Protocol Violation|0
2861311|NCT02203838|9835948|P2|Overall Study|Protocol Violation|3
2861312|NCT02203838|9835949|P1|Overall Study|Protocol Violation|7
2861313|NCT02203838|9835946|P4|Overall Study|Lost to Follow-up|1
2861314|NCT02203838|9835947|P3|Overall Study|Lost to Follow-up|2
2861315|NCT02203838|9835948|P2|Overall Study|Lost to Follow-up|3
2861316|NCT02203838|9835949|P1|Overall Study|Lost to Follow-up|39
2861317|NCT02203838|9835946|P4|Overall Study|Adverse Event|2
2861318|NCT02203838|9835947|P3|Overall Study|Adverse Event|3
2861319|NCT02203838|9835948|P2|Overall Study|Adverse Event|6
2861320|NCT02203838|9835949|P1|Overall Study|Adverse Event|46
2861321|NCT02203838|9835946|P4|Overall Study|Lack of Efficacy|1
2861322|NCT02203838|9835947|P3|Overall Study|Lack of Efficacy|1
2861323|NCT02203838|9835948|P2|Overall Study|Lack of Efficacy|0
2861324|NCT02203838|9835949|P1|Overall Study|Lack of Efficacy|7
2861325|NCT02203721|9836029|P2|Overall Study|Illness|1
2861326|NCT02203721|9836030|P1|Overall Study|Illness|0
2861327|NCT02203721|9836029|P2|Overall Study|Death|2
2861328|NCT02203721|9836030|P1|Overall Study|Death|0
2861329|NCT02203721|9836029|P2|Overall Study|Lost to Follow-up|0
2861330|NCT02203721|9836030|P1|Overall Study|Lost to Follow-up|1
2861331|NCT02203357|9836130|P3|Overall Study|Lost to Follow-up|70
2861332|NCT02203357|9836131|P2|Overall Study|Lost to Follow-up|66
2861333|NCT02203357|9836132|P1|Overall Study|Lost to Follow-up|58
2861334|NCT02203331|9836155|P6|Overall Study|Lost to Follow-up|0
2861335|NCT02203331|9836156|P5|Overall Study|Lost to Follow-up|1
2861336|NCT02203331|9836157|P4|Overall Study|Lost to Follow-up|0
2861337|NCT02203331|9836158|P3|Overall Study|Lost to Follow-up|0
2861338|NCT02203331|9836159|P2|Overall Study|Lost to Follow-up|0
2861339|NCT02203331|9836160|P1|Overall Study|Lost to Follow-up|0
2861340|NCT02203331|9836155|P6|Overall Study|Protocol Violation|0
2861341|NCT02203331|9836156|P5|Overall Study|Protocol Violation|1
2861342|NCT02203331|9836157|P4|Overall Study|Protocol Violation|1
2861343|NCT02203331|9836158|P3|Overall Study|Protocol Violation|0
2861344|NCT02203331|9836159|P2|Overall Study|Protocol Violation|2
2861345|NCT02203331|9836160|P1|Overall Study|Protocol Violation|0
2861346|NCT02203331|9836155|P6|Overall Study|Lack of Efficacy|1
2861347|NCT02203331|9836156|P5|Overall Study|Lack of Efficacy|0
2861348|NCT02203331|9836157|P4|Overall Study|Lack of Efficacy|0
2861349|NCT02203331|9836158|P3|Overall Study|Lack of Efficacy|1
2861350|NCT02203331|9836159|P2|Overall Study|Lack of Efficacy|2
2861351|NCT02203331|9836160|P1|Overall Study|Lack of Efficacy|0
2861352|NCT02203331|9836155|P6|Overall Study|Other Reasons|0
2861353|NCT02203331|9836156|P5|Overall Study|Other Reasons|0
2861354|NCT02203331|9836157|P4|Overall Study|Other Reasons|2
2861355|NCT02203331|9836158|P3|Overall Study|Other Reasons|0
2861356|NCT02203331|9836159|P2|Overall Study|Other Reasons|2
2861357|NCT02203331|9836160|P1|Overall Study|Other Reasons|1
2861358|NCT02203331|9836155|P6|Overall Study|Adverse Event|3
2861359|NCT02203331|9836156|P5|Overall Study|Adverse Event|3
2861360|NCT02203331|9836157|P4|Overall Study|Adverse Event|4
2861361|NCT02203331|9836158|P3|Overall Study|Adverse Event|3
2861362|NCT02203331|9836159|P2|Overall Study|Adverse Event|8
2861363|NCT02203331|9836160|P1|Overall Study|Adverse Event|4
2861364|NCT02203331|9836155|P6|Overall Study|Withdrawal by Subject|3
2861365|NCT02203331|9836156|P5|Overall Study|Withdrawal by Subject|0
2861366|NCT02203331|9836157|P4|Overall Study|Withdrawal by Subject|0
2861367|NCT02203331|9836158|P3|Overall Study|Withdrawal by Subject|1
2861368|NCT02203331|9836159|P2|Overall Study|Withdrawal by Subject|0
2861369|NCT02203331|9836160|P1|Overall Study|Withdrawal by Subject|1
2861370|NCT02203331|9836155|P6|Overall Study|Pregnancy|0
2861371|NCT02203331|9836156|P5|Overall Study|Pregnancy|2
2861372|NCT02203331|9836157|P4|Overall Study|Pregnancy|0
2861373|NCT02203331|9836158|P3|Overall Study|Pregnancy|0
2861374|NCT02203331|9836159|P2|Overall Study|Pregnancy|0
2861375|NCT02203331|9836160|P1|Overall Study|Pregnancy|1
2861376|NCT02203149|9836219|P5|Part 2|Adverse Event|1
2861377|NCT02203149|9836220|P4|Part 2|Adverse Event|1
2861378|NCT02203149|9836221|P3|Part 2|Adverse Event|0
2861379|NCT02203149|9836222|P2|Part 2|Adverse Event|0
2861380|NCT02203149|9836223|P1|Part 2|Adverse Event|0
2861381|NCT02203149|9836219|P5|Part 2|Withdrawal by Subject|0
2861382|NCT02203149|9836220|P4|Part 2|Withdrawal by Subject|1
2861383|NCT02203149|9836221|P3|Part 2|Withdrawal by Subject|0
2861384|NCT02203149|9836222|P2|Part 2|Withdrawal by Subject|0
2861385|NCT02203149|9836223|P1|Part 2|Withdrawal by Subject|0
2861386|NCT02203149|9836219|P5|Part 2|Death|0
2861387|NCT02203149|9836220|P4|Part 2|Death|1
2861388|NCT02203149|9836221|P3|Part 2|Death|1
2861391|NCT02203149|9836219|P5|Part 1|Adverse Event|0
2861392|NCT02203149|9836220|P4|Part 1|Adverse Event|0
2861393|NCT02203149|9836221|P3|Part 1|Adverse Event|0
2861394|NCT02203149|9836222|P2|Part 1|Adverse Event|1
2861395|NCT02203149|9836223|P1|Part 1|Adverse Event|0
2861396|NCT02203071|9836258|P2|Overall Study|Lost to Follow-up|1
2861397|NCT02203071|9836259|P1|Overall Study|Lost to Follow-up|3
2861398|NCT02203032|9836275|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
2861399|NCT02203032|9836276|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
2861400|NCT02203032|9836277|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
2861401|NCT02203032|9836278|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
2861402|NCT02203032|9836275|P4|Blinded Phase (Week 16 to Week 44)|Death|1
2861403|NCT02203032|9836276|P3|Blinded Phase (Week 16 to Week 44)|Death|0
2861404|NCT02203032|9836277|P2|Blinded Phase (Week 16 to Week 44)|Death|0
2861405|NCT02203032|9836278|P1|Blinded Phase (Week 16 to Week 44)|Death|0
2861406|NCT02203032|9836275|P4|Blinded Phase (Week 16 to Week 44)|Other|15
2861407|NCT02203032|9836276|P3|Blinded Phase (Week 16 to Week 44)|Other|1
2861408|NCT02203032|9836277|P2|Blinded Phase (Week 16 to Week 44)|Other|4
2861409|NCT02203032|9836278|P1|Blinded Phase (Week 16 to Week 44)|Other|0
2861410|NCT02203032|9836275|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
2861411|NCT02203032|9836276|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
2861412|NCT02203032|9836277|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
2861413|NCT02203032|9836278|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
2861414|NCT02203032|9836275|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
2861415|NCT02203032|9836276|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
2861416|NCT02203032|9836277|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
2861417|NCT02203032|9836278|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
2861418|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2861419|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2861420|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2861421|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
2861422|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
2861423|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
2861424|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
2861425|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
2861426|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2861427|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2861428|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2861429|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
2861430|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2861431|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2861432|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2861433|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
2861434|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2861435|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2861436|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2861437|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
2861438|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2861439|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2861440|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2861441|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
2861442|NCT02203032|9836275|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2861443|NCT02203032|9836276|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2861444|NCT02203032|9836277|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2861445|NCT02203032|9836278|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
2861446|NCT02202980|9836321|P14|Overall Study|Withdrew Consent|0
2861447|NCT02202980|9836322|P13|Overall Study|Withdrew Consent|0
2861448|NCT02202980|9836323|P12|Overall Study|Withdrew Consent|0
2861449|NCT02202980|9836324|P11|Overall Study|Withdrew Consent|0
2861450|NCT02202980|9836325|P10|Overall Study|Withdrew Consent|0
2861451|NCT02202980|9836326|P9|Overall Study|Withdrew Consent|1
2861452|NCT02202980|9836327|P8|Overall Study|Withdrew Consent|0
2861453|NCT02202980|9836328|P7|Overall Study|Withdrew Consent|0
2861454|NCT02202980|9836329|P6|Overall Study|Withdrew Consent|0
2861455|NCT02202980|9836330|P5|Overall Study|Withdrew Consent|0
2861456|NCT02202980|9836331|P4|Overall Study|Withdrew Consent|0
2861457|NCT02202980|9836332|P3|Overall Study|Withdrew Consent|2
2861458|NCT02202980|9836333|P2|Overall Study|Withdrew Consent|1
2861459|NCT02202980|9836334|P1|Overall Study|Withdrew Consent|0
2861460|NCT02202980|9836321|P14|Overall Study|Lost to Follow-up|0
2861461|NCT02202980|9836322|P13|Overall Study|Lost to Follow-up|1
2861462|NCT02202980|9836323|P12|Overall Study|Lost to Follow-up|0
2861463|NCT02202980|9836324|P11|Overall Study|Lost to Follow-up|0
2861464|NCT02202980|9836325|P10|Overall Study|Lost to Follow-up|0
2861465|NCT02202980|9836326|P9|Overall Study|Lost to Follow-up|1
2861466|NCT02202980|9836327|P8|Overall Study|Lost to Follow-up|1
2861467|NCT02202980|9836328|P7|Overall Study|Lost to Follow-up|0
2861468|NCT02202980|9836329|P6|Overall Study|Lost to Follow-up|0
2861469|NCT02202980|9836330|P5|Overall Study|Lost to Follow-up|0
2861470|NCT02202980|9836331|P4|Overall Study|Lost to Follow-up|1
2861471|NCT02202980|9836332|P3|Overall Study|Lost to Follow-up|1
2861472|NCT02202980|9836333|P2|Overall Study|Lost to Follow-up|1
2861473|NCT02202980|9836334|P1|Overall Study|Lost to Follow-up|0
2861474|NCT02202980|9836321|P14|Overall Study|Protocol Violation|0
2861475|NCT02202980|9836322|P13|Overall Study|Protocol Violation|0
2861476|NCT02202980|9836323|P12|Overall Study|Protocol Violation|0
2861477|NCT02202980|9836324|P11|Overall Study|Protocol Violation|0
2861478|NCT02202980|9836325|P10|Overall Study|Protocol Violation|0
2861479|NCT02202980|9836326|P9|Overall Study|Protocol Violation|0
2861480|NCT02202980|9836327|P8|Overall Study|Protocol Violation|0
2861481|NCT02202980|9836328|P7|Overall Study|Protocol Violation|0
2861482|NCT02202980|9836329|P6|Overall Study|Protocol Violation|0
2861483|NCT02202980|9836330|P5|Overall Study|Protocol Violation|3
2861484|NCT02202980|9836331|P4|Overall Study|Protocol Violation|3
2861485|NCT02202980|9836332|P3|Overall Study|Protocol Violation|0
2861486|NCT02202980|9836333|P2|Overall Study|Protocol Violation|0
2861487|NCT02202980|9836334|P1|Overall Study|Protocol Violation|0
2861488|NCT02202980|9836321|P14|Overall Study|Lack of Efficacy|0
2861489|NCT02202980|9836322|P13|Overall Study|Lack of Efficacy|10
2861490|NCT02202980|9836323|P12|Overall Study|Lack of Efficacy|3
2861491|NCT02202980|9836324|P11|Overall Study|Lack of Efficacy|0
2861492|NCT02202980|9836325|P10|Overall Study|Lack of Efficacy|0
2861493|NCT02202980|9836326|P9|Overall Study|Lack of Efficacy|2
2861494|NCT02202980|9836327|P8|Overall Study|Lack of Efficacy|2
2861495|NCT02202980|9836328|P7|Overall Study|Lack of Efficacy|11
2861496|NCT02202980|9836329|P6|Overall Study|Lack of Efficacy|1
2861497|NCT02202980|9836330|P5|Overall Study|Lack of Efficacy|3
2861498|NCT02202980|9836331|P4|Overall Study|Lack of Efficacy|0
2861499|NCT02202980|9836332|P3|Overall Study|Lack of Efficacy|7
2861500|NCT02202980|9836333|P2|Overall Study|Lack of Efficacy|0
2861501|NCT02202980|9836334|P1|Overall Study|Lack of Efficacy|1
2861502|NCT02202850|9836422|P2|Overall Study|Lost to Follow-up|1
2861503|NCT02202850|9836423|P1|Overall Study|Lost to Follow-up|7
2861504|NCT02202850|9836422|P2|Overall Study|Enbrel treatment discontinued|3
2861505|NCT02202850|9836423|P1|Overall Study|Enbrel treatment discontinued|15
2861506|NCT02202850|9836422|P2|Overall Study|Other|2
2861507|NCT02202850|9836423|P1|Overall Study|Other|2
2861508|NCT02202837|9836475|P2|Overall Study|Lost to Follow-up|1
2861509|NCT02202837|9836476|P1|Overall Study|Lost to Follow-up|7
2861510|NCT02202837|9836475|P2|Overall Study|Other|0
2861511|NCT02202837|9836476|P1|Overall Study|Other|10
2861512|NCT02202837|9836475|P2|Overall Study|Enbrel treatment discontinued|4
2861513|NCT02202837|9836476|P1|Overall Study|Enbrel treatment discontinued|36
2861514|NCT02202785|9836527|P3|Overall Study|Reason not Specified|13
2861515|NCT02202785|9836528|P2|Overall Study|Reason not Specified|7
2861516|NCT02202785|9836529|P1|Overall Study|Reason not Specified|10
2861517|NCT02202785|9836527|P3|Overall Study|Lost to Follow-up|0
2861518|NCT02202785|9836528|P2|Overall Study|Lost to Follow-up|1
2861519|NCT02202785|9836529|P1|Overall Study|Lost to Follow-up|0
2861520|NCT02202785|9836527|P3|Overall Study|Withdrawal by Subject|0
2861521|NCT02202785|9836528|P2|Overall Study|Withdrawal by Subject|1
2861522|NCT02202785|9836529|P1|Overall Study|Withdrawal by Subject|0
2861523|NCT02202785|9836527|P3|Overall Study|Study Terminated by Sponsor|4
2861524|NCT02202785|9836528|P2|Overall Study|Study Terminated by Sponsor|6
2861525|NCT02202785|9836529|P1|Overall Study|Study Terminated by Sponsor|1
2861526|NCT02202759|9836566|P3|Overall Study|Reason not Specified|10
2861527|NCT02202759|9836567|P2|Overall Study|Reason not Specified|11
2861528|NCT02202759|9836568|P1|Overall Study|Reason not Specified|4
2861529|NCT02202759|9836566|P3|Overall Study|Withdrawal by Subject|1
2861530|NCT02202759|9836567|P2|Overall Study|Withdrawal by Subject|1
2861531|NCT02202759|9836568|P1|Overall Study|Withdrawal by Subject|2
2861532|NCT02202759|9836566|P3|Overall Study|Study Terminated by Sponsor|3
2861533|NCT02202759|9836567|P2|Overall Study|Study Terminated by Sponsor|3
2861534|NCT02202759|9836568|P1|Overall Study|Study Terminated by Sponsor|3
2861535|NCT02202616|9836602|P1|Overall Study|Unsatisfactory therapeutic effect|1
2861536|NCT02202616|9836602|P1|Overall Study|Abnormal test procedure result|1
2861537|NCT02202616|9836602|P1|Overall Study|Administrative problems|6
2861538|NCT02202616|9836602|P1|Overall Study|Lost to Follow-up|6
2861539|NCT02202616|9836602|P1|Overall Study|Patient withdrew consent|12
2861540|NCT02202616|9836602|P1|Overall Study|Protocol deviation|18
2861541|NCT02202616|9836602|P1|Overall Study|Adverse Event|32
2861542|NCT02202616|9836602|P1|Overall Study|Screen failed|24
2861543|NCT02202538|9836613|P1|Overall Study|Investigator Decision|1
2861544|NCT02202538|9836613|P1|Overall Study|Did not meet all inclusion criteria|2
2861545|NCT02202538|9836613|P1|Overall Study|Withdrawal by Subject|5
2861546|NCT02202499|9836627|P3|Overall Study|Auto accident|0
2861547|NCT02202499|9836628|P2|Overall Study|Auto accident|0
2861548|NCT02202499|9836629|P1|Overall Study|Auto accident|1
2861549|NCT02202499|9836627|P3|Overall Study|Declined before randomization|0
2861550|NCT02202499|9836628|P2|Overall Study|Declined before randomization|0
2861551|NCT02202499|9836629|P1|Overall Study|Declined before randomization|1
2861552|NCT02202499|9836627|P3|Overall Study|Moved from area|1
2861553|NCT02202499|9836628|P2|Overall Study|Moved from area|0
2861554|NCT02202499|9836629|P1|Overall Study|Moved from area|0
2861555|NCT02202499|9836627|P3|Overall Study|Cancer diagnosis|1
2861556|NCT02202499|9836628|P2|Overall Study|Cancer diagnosis|0
2861557|NCT02202499|9836629|P1|Overall Study|Cancer diagnosis|0
2861558|NCT02202434|9836656|P4|Overall Study|Other|1
2861559|NCT02202434|9836657|P3|Overall Study|Other|0
2861560|NCT02202434|9836658|P2|Overall Study|Other|0
2861561|NCT02202434|9836659|P1|Overall Study|Other|1
2861562|NCT02202434|9836656|P4|Overall Study|Visit Missed|5
2861563|NCT02202434|9836657|P3|Overall Study|Visit Missed|0
2861564|NCT02202434|9836658|P2|Overall Study|Visit Missed|12
2861565|NCT02202434|9836659|P1|Overall Study|Visit Missed|21
2861566|NCT02202434|9836656|P4|Overall Study|Completed Study|0
2861567|NCT02202434|9836657|P3|Overall Study|Completed Study|0
2861568|NCT02202434|9836658|P2|Overall Study|Completed Study|0
2861569|NCT02202434|9836659|P1|Overall Study|Completed Study|1
2861570|NCT02202434|9836656|P4|Overall Study|Withdrawal by Subject|4
2861571|NCT02202434|9836657|P3|Overall Study|Withdrawal by Subject|1
2861572|NCT02202434|9836658|P2|Overall Study|Withdrawal by Subject|14
2861573|NCT02202434|9836659|P1|Overall Study|Withdrawal by Subject|13
2861574|NCT02202434|9836656|P4|Overall Study|Physician Decision|0
2861575|NCT02202434|9836657|P3|Overall Study|Physician Decision|0
2861576|NCT02202434|9836658|P2|Overall Study|Physician Decision|3
2861577|NCT02202434|9836659|P1|Overall Study|Physician Decision|2
2861578|NCT02202434|9836656|P4|Overall Study|Lost to Follow-up|0
2861579|NCT02202434|9836657|P3|Overall Study|Lost to Follow-up|1
2861580|NCT02202434|9836658|P2|Overall Study|Lost to Follow-up|1
2861581|NCT02202434|9836659|P1|Overall Study|Lost to Follow-up|1
2861582|NCT02202434|9836656|P4|Overall Study|Death|27
2861583|NCT02202434|9836657|P3|Overall Study|Death|13
2861584|NCT02202434|9836658|P2|Overall Study|Death|39
2861585|NCT02202434|9836659|P1|Overall Study|Death|70
2861586|NCT02202317|9836783|P1|Overall Study|Lost to Follow-up|1
2861587|NCT02202161|9836810|P8|Overall Study|Withdrawal by Subject|0
2861588|NCT02202161|9836811|P7|Overall Study|Withdrawal by Subject|0
2861589|NCT02202161|9836812|P6|Overall Study|Withdrawal by Subject|0
2861590|NCT02202161|9836813|P5|Overall Study|Withdrawal by Subject|1
2861591|NCT02202161|9836814|P4|Overall Study|Withdrawal by Subject|0
2861592|NCT02202161|9836815|P3|Overall Study|Withdrawal by Subject|0
2861593|NCT02202161|9836816|P2|Overall Study|Withdrawal by Subject|0
2861594|NCT02202161|9836817|P1|Overall Study|Withdrawal by Subject|0
2861595|NCT02202161|9836810|P8|Overall Study|Physician Decision|3
2861596|NCT02202161|9836811|P7|Overall Study|Physician Decision|0
2861597|NCT02202161|9836812|P6|Overall Study|Physician Decision|0
2861598|NCT02202161|9836813|P5|Overall Study|Physician Decision|0
2861599|NCT02202161|9836814|P4|Overall Study|Physician Decision|0
2861600|NCT02202161|9836815|P3|Overall Study|Physician Decision|0
2861601|NCT02202161|9836816|P2|Overall Study|Physician Decision|0
2861602|NCT02202161|9836817|P1|Overall Study|Physician Decision|0
2861603|NCT02202161|9836810|P8|Overall Study|Did not meet continuation criteria|3
2861604|NCT02202161|9836811|P7|Overall Study|Did not meet continuation criteria|0
2861605|NCT02202161|9836812|P6|Overall Study|Did not meet continuation criteria|0
2861606|NCT02202161|9836813|P5|Overall Study|Did not meet continuation criteria|0
2861607|NCT02202161|9836814|P4|Overall Study|Did not meet continuation criteria|0
2861608|NCT02202161|9836815|P3|Overall Study|Did not meet continuation criteria|0
2861609|NCT02202161|9836816|P2|Overall Study|Did not meet continuation criteria|0
2861610|NCT02202161|9836817|P1|Overall Study|Did not meet continuation criteria|0
2861611|NCT02202161|9836810|P8|Overall Study|Adverse Event|0
2861612|NCT02202161|9836811|P7|Overall Study|Adverse Event|0
2861613|NCT02202161|9836812|P6|Overall Study|Adverse Event|1
2861614|NCT02202161|9836813|P5|Overall Study|Adverse Event|0
2861615|NCT02202161|9836814|P4|Overall Study|Adverse Event|0
2861616|NCT02202161|9836815|P3|Overall Study|Adverse Event|0
2861617|NCT02202161|9836816|P2|Overall Study|Adverse Event|1
2861618|NCT02202161|9836817|P1|Overall Study|Adverse Event|1
2861619|NCT02202109|9836977|P2|Overall Study|Withdrawal by Subject|0
2861620|NCT02202109|9836978|P1|Overall Study|Withdrawal by Subject|2
2861621|NCT02202109|9836977|P2|Overall Study|Lost to Follow-up|87
2861622|NCT02202109|9836978|P1|Overall Study|Lost to Follow-up|88
2861623|NCT02202031|9836995|P2|Overall Study|Intolerance/Lack of Improvement|0
2861624|NCT02202031|9836996|P1|Overall Study|Intolerance/Lack of Improvement|3
2861625|NCT02202031|9836995|P2|Overall Study|Illness/Medical Reason|2
2861626|NCT02202031|9836996|P1|Overall Study|Illness/Medical Reason|0
2861627|NCT02202031|9836995|P2|Overall Study|Too Busy|3
2861628|NCT02202031|9836996|P1|Overall Study|Too Busy|1
2861629|NCT02202031|9836995|P2|Overall Study|Lost to Follow-up|0
2861630|NCT02202031|9836996|P1|Overall Study|Lost to Follow-up|1
2861631|NCT02201953|9837044|P2|Overall Study|Death|3
2861632|NCT02201953|9837045|P1|Overall Study|Death|0
2861633|NCT02201953|9837044|P2|Overall Study|Adverse Event|5
2861634|NCT02201953|9837045|P1|Overall Study|Adverse Event|0
2861635|NCT02201953|9837044|P2|Overall Study|Withdrew Consent|5
2861636|NCT02201953|9837045|P1|Overall Study|Withdrew Consent|2
2861637|NCT02201953|9837044|P2|Overall Study|Lost to Follow-up|8
2861638|NCT02201953|9837045|P1|Overall Study|Lost to Follow-up|8
2861639|NCT02201953|9837044|P2|Overall Study|Lack of Efficacy|30
2861640|NCT02201953|9837045|P1|Overall Study|Lack of Efficacy|9
2861641|NCT02201953|9837044|P2|Overall Study|Randomized but Never Treated|5
2861642|NCT02201953|9837045|P1|Overall Study|Randomized but Never Treated|1
2861643|NCT02201940|9837063|P2|Overall Study|Adverse Event|1
2861644|NCT02201940|9837064|P1|Overall Study|Adverse Event|0
2861645|NCT02201940|9837063|P2|Overall Study|Death|0
2861646|NCT02201940|9837064|P1|Overall Study|Death|1
2861647|NCT02201940|9837063|P2|Overall Study|Investigator's Discretion|1
2861648|NCT02201940|9837064|P1|Overall Study|Investigator's Discretion|1
2861649|NCT02201940|9837063|P2|Overall Study|Withdrew Consent|1
2861650|NCT02201940|9837064|P1|Overall Study|Withdrew Consent|2
2861651|NCT02201940|9837063|P2|Overall Study|Lost to Follow-up|0
2861652|NCT02201940|9837064|P1|Overall Study|Lost to Follow-up|5
2861653|NCT02201940|9837063|P2|Overall Study|Lack of Efficacy|113
2861654|NCT02201940|9837064|P1|Overall Study|Lack of Efficacy|2
2861655|NCT02201940|9837063|P2|Overall Study|Randomized/Enrolled but Never Treated|0
2861656|NCT02201940|9837064|P1|Overall Study|Randomized/Enrolled but Never Treated|1
2861657|NCT02201901|9837083|P3|Overall Study|Adverse Event|0
2861658|NCT02201901|9837084|P2|Overall Study|Adverse Event|1
2861659|NCT02201901|9837085|P1|Overall Study|Adverse Event|1
2861660|NCT02201901|9837083|P3|Overall Study|Withdrew Consent|2
2861661|NCT02201901|9837084|P2|Overall Study|Withdrew Consent|0
2861662|NCT02201901|9837085|P1|Overall Study|Withdrew Consent|2
2861663|NCT02201901|9837083|P3|Overall Study|Lost to Follow-up|2
2861664|NCT02201901|9837084|P2|Overall Study|Lost to Follow-up|3
2861665|NCT02201901|9837085|P1|Overall Study|Lost to Follow-up|2
2861666|NCT02201901|9837083|P3|Overall Study|Death|3
2861667|NCT02201901|9837084|P2|Overall Study|Death|3
2861668|NCT02201901|9837085|P1|Overall Study|Death|3
2861669|NCT02201901|9837083|P3|Overall Study|Lack of Efficacy|6
2861670|NCT02201901|9837084|P2|Overall Study|Lack of Efficacy|1
2861671|NCT02201901|9837085|P1|Overall Study|Lack of Efficacy|7
2861672|NCT02201901|9837083|P3|Overall Study|Randomized but never treated|0
2861673|NCT02201901|9837084|P2|Overall Study|Randomized but never treated|1
2861674|NCT02201901|9837085|P1|Overall Study|Randomized but never treated|0
2861675|NCT02201784|9837116|P2|Overall Study|Failure to achieve adequate block|0
2861676|NCT02201784|9837117|P1|Overall Study|Failure to achieve adequate block|2
2861677|NCT02201771|9837134|P3|Overall Study|Protocol Violation|10
2861678|NCT02201771|9837135|P2|Overall Study|Protocol Violation|8
2861679|NCT02201771|9837136|P1|Overall Study|Protocol Violation|10
2861680|NCT02201771|9837134|P3|Overall Study|Death|0
2861681|NCT02201771|9837135|P2|Overall Study|Death|2
2861682|NCT02201771|9837136|P1|Overall Study|Death|3
2861683|NCT02201524|9837163|P4|Overall Study|Other|0
2861684|NCT02201524|9837164|P3|Overall Study|Other|0
2861685|NCT02201524|9837165|P2|Overall Study|Other|1
2861686|NCT02201524|9837166|P1|Overall Study|Other|1
2861687|NCT02201524|9837163|P4|Overall Study|Withdrawal by Subject|1
2861688|NCT02201524|9837164|P3|Overall Study|Withdrawal by Subject|1
2861689|NCT02201524|9837165|P2|Overall Study|Withdrawal by Subject|0
2861690|NCT02201524|9837166|P1|Overall Study|Withdrawal by Subject|0
2861691|NCT02201524|9837163|P4|Overall Study|Protocol Violation|1
2861692|NCT02201524|9837164|P3|Overall Study|Protocol Violation|0
2861693|NCT02201524|9837165|P2|Overall Study|Protocol Violation|0
2861694|NCT02201524|9837166|P1|Overall Study|Protocol Violation|0
2861695|NCT02201524|9837163|P4|Overall Study|No longer meets eligibility criteria|2
2861696|NCT02201524|9837164|P3|Overall Study|No longer meets eligibility criteria|0
2861697|NCT02201524|9837165|P2|Overall Study|No longer meets eligibility criteria|0
2861698|NCT02201524|9837166|P1|Overall Study|No longer meets eligibility criteria|0
2861699|NCT02201524|9837163|P4|Overall Study|Lost to Follow-up|0
2861700|NCT02201524|9837164|P3|Overall Study|Lost to Follow-up|2
2861701|NCT02201524|9837165|P2|Overall Study|Lost to Follow-up|0
2861702|NCT02201524|9837166|P1|Overall Study|Lost to Follow-up|0
2861703|NCT02201524|9837163|P4|Overall Study|Insufficient clinical response|0
2861704|NCT02201524|9837164|P3|Overall Study|Insufficient clinical response|0
2861705|NCT02201524|9837165|P2|Overall Study|Insufficient clinical response|0
2861706|NCT02201524|9837166|P1|Overall Study|Insufficient clinical response|1
2861707|NCT02201524|9837163|P4|Overall Study|Adverse Event|0
2861708|NCT02201524|9837164|P3|Overall Study|Adverse Event|1
2861709|NCT02201524|9837165|P2|Overall Study|Adverse Event|2
2861710|NCT02201524|9837166|P1|Overall Study|Adverse Event|0
2861711|NCT02201329|9837291|P1|Overall Study|Withdrawal by Subject|2
2861712|NCT02201329|9837291|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
2861713|NCT02201290|9837299|P1|Overall Study|Adverse Event|1
2861714|NCT02201290|9837299|P1|Overall Study|Lack of Efficacy|2
2861715|NCT02201290|9837299|P1|Overall Study|Withdrawal by Subject|2
2861716|NCT02201277|9837305|P2|Overall Study|Physician Decision|0
2861717|NCT02201277|9837306|P1|Overall Study|Physician Decision|1
2861718|NCT02201277|9837305|P2|Overall Study|Failed retrieval|0
2861719|NCT02201277|9837306|P1|Overall Study|Failed retrieval|1
2861720|NCT02201277|9837305|P2|Overall Study|Lost to Follow-up|1
2861721|NCT02201277|9837306|P1|Overall Study|Lost to Follow-up|2
2861722|NCT02201277|9837305|P2|Overall Study|Death|4
2861723|NCT02201277|9837306|P1|Overall Study|Death|3
2861724|NCT02200770|9837396|P2|Open-label Period (OLP)|Participants ongoing|162
2861725|NCT02200770|9837397|P1|Open-label Period (OLP)|Participants ongoing|51
2861726|NCT02200770|9837396|P2|Randomized-controlled Period (RCP)|Other|2
2861727|NCT02200770|9837397|P1|Randomized-controlled Period (RCP)|Other|1
2861728|NCT02200770|9837396|P2|Randomized-controlled Period (RCP)|Not treated|1
2861729|NCT02200770|9837397|P1|Randomized-controlled Period (RCP)|Not treated|0
2861730|NCT02200770|9837396|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2861731|NCT02200770|9837397|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2861732|NCT02200770|9837396|P2|Randomized-controlled Period (RCP)|Adverse Event|2
2861733|NCT02200770|9837397|P1|Randomized-controlled Period (RCP)|Adverse Event|0
2861734|NCT02200614|9837428|P2|Follow-up Period|personal reason|72
2861735|NCT02200614|9837429|P1|Follow-up Period|personal reason|81
2861736|NCT02200614|9837428|P2|Follow-up Period|Other|28
2861737|NCT02200614|9837429|P1|Follow-up Period|Other|23
2861738|NCT02200614|9837428|P2|Follow-up Period|Lost to Follow-up|12
2861739|NCT02200614|9837429|P1|Follow-up Period|Lost to Follow-up|6
2861740|NCT02200614|9837428|P2|Follow-up Period|Death|51
2861741|NCT02200614|9837429|P1|Follow-up Period|Death|64
2861742|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Study drug never administered|0
2861743|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Study drug never administered|1
2861744|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Personal reason|78
2861745|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Personal reason|68
2861746|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Protocol deviation|7
2861747|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Protocol deviation|13
2861748|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Judgment of the investigator|91
2861749|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Judgment of the investigator|54
2861750|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Confirmed metastasis|129
2861751|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Confirmed metastasis|112
2861752|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Other reason|2
2861753|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Other reason|6
2861754|NCT02200614|9837428|P2|Treatment Period to Primary Completion|Adverse Event|47
2861755|NCT02200614|9837429|P1|Treatment Period to Primary Completion|Adverse Event|86
2861756|NCT02200510|9837461|P2|Overall Study|potential COI - joined study team|0
2861757|NCT02200510|9837462|P1|Overall Study|potential COI - joined study team|1
2861758|NCT02200510|9837461|P2|Overall Study|Lost to Follow-up|1
2861759|NCT02200510|9837462|P1|Overall Study|Lost to Follow-up|7
2861760|NCT02200510|9837461|P2|Overall Study|Protocol Violation|1
2861761|NCT02200510|9837462|P1|Overall Study|Protocol Violation|0
2861762|NCT02200510|9837461|P2|Overall Study|Death|1
2861763|NCT02200510|9837462|P1|Overall Study|Death|1
2861764|NCT02200211|9837487|P4|Overall Study|Withdrawal by Subject|0
2861765|NCT02200211|9837488|P3|Overall Study|Withdrawal by Subject|0
2861766|NCT02200211|9837489|P2|Overall Study|Withdrawal by Subject|0
2861767|NCT02200211|9837490|P1|Overall Study|Withdrawal by Subject|1
2861768|NCT02200211|9837487|P4|Overall Study|Lost to Follow-up|2
2861769|NCT02200211|9837488|P3|Overall Study|Lost to Follow-up|1
2861770|NCT02200211|9837489|P2|Overall Study|Lost to Follow-up|7
2861771|NCT02200211|9837490|P1|Overall Study|Lost to Follow-up|7
2861772|NCT02200042|9837603|P2|Overall Study|Withdrawal by Subject|1
2861773|NCT02200042|9837604|P1|Overall Study|Withdrawal by Subject|0
2861774|NCT02199795|9837633|P2|Overall Study|withdrew due to shoulder pain|0
2861775|NCT02199795|9837634|P1|Overall Study|withdrew due to shoulder pain|1
2861776|NCT02199795|9837633|P2|Overall Study|no longer met inclusion criteria|0
2861777|NCT02199795|9837634|P1|Overall Study|no longer met inclusion criteria|1
2861778|NCT02199509|9837675|P2|Overall Study|Misunderstood titration schedule|0
2861779|NCT02199509|9837676|P1|Overall Study|Misunderstood titration schedule|1
2861780|NCT02199509|9837675|P2|Overall Study|Suicidal Ideation|1
2861781|NCT02199509|9837676|P1|Overall Study|Suicidal Ideation|0
2861782|NCT02199080|9837699|P1|Overall Study|Protocol Violation|12
2861783|NCT02199028|9837724|P2|Week 3|Adverse Event|0
2861784|NCT02199028|9837725|P1|Week 3|Adverse Event|1
2861785|NCT02199028|9837724|P2|Week 1|Adverse Event|0
2861786|NCT02199028|9837725|P1|Week 1|Adverse Event|1
2861787|NCT02198963|9837734|P1|Overall Study|Withdrawal by Subject|6
2861788|NCT02198963|9837734|P1|Overall Study|Adverse Event|1
2861789|NCT02198651|9837758|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2861790|NCT02198651|9837759|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
2861791|NCT02198651|9837760|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2861792|NCT02198651|9837761|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2861793|NCT02198651|9837762|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2861794|NCT02198651|9837758|P5|Open-label Rescue Period|Withdrew consent|0
2861795|NCT02198651|9837759|P4|Open-label Rescue Period|Withdrew consent|2
2861796|NCT02198651|9837760|P3|Open-label Rescue Period|Withdrew consent|0
2861797|NCT02198651|9837761|P2|Open-label Rescue Period|Withdrew consent|0
2861798|NCT02198651|9837762|P1|Open-label Rescue Period|Withdrew consent|0
2861799|NCT02198651|9837758|P5|Double-blind Period|Other, not specified|0
2861800|NCT02198651|9837759|P4|Double-blind Period|Other, not specified|0
2861801|NCT02198651|9837760|P3|Double-blind Period|Other, not specified|1
2861802|NCT02198651|9837761|P2|Double-blind Period|Other, not specified|4
2861803|NCT02198651|9837762|P1|Double-blind Period|Other, not specified|0
2861804|NCT02198651|9837758|P5|Double-blind Period|Adverse Event|0
2861805|NCT02198651|9837759|P4|Double-blind Period|Adverse Event|0
2861806|NCT02198651|9837760|P3|Double-blind Period|Adverse Event|0
2861807|NCT02198651|9837761|P2|Double-blind Period|Adverse Event|1
2861808|NCT02198651|9837762|P1|Double-blind Period|Adverse Event|0
2861809|NCT02198651|9837758|P5|Double-blind Period|Withdrew consent|0
2861810|NCT02198651|9837759|P4|Double-blind Period|Withdrew consent|0
2861811|NCT02198651|9837760|P3|Double-blind Period|Withdrew consent|0
2861812|NCT02198651|9837761|P2|Double-blind Period|Withdrew consent|4
2861813|NCT02198651|9837762|P1|Double-blind Period|Withdrew consent|0
2861814|NCT02198651|9837758|P5|Lead-in Period|Other, not specified|0
2861815|NCT02198651|9837759|P4|Lead-in Period|Other, not specified|0
2861816|NCT02198651|9837760|P3|Lead-in Period|Other, not specified|0
2861817|NCT02198651|9837761|P2|Lead-in Period|Other, not specified|0
2861818|NCT02198651|9837762|P1|Lead-in Period|Other, not specified|22
2861819|NCT02198651|9837758|P5|Lead-in Period|Adverse Event|0
2861820|NCT02198651|9837759|P4|Lead-in Period|Adverse Event|0
2861821|NCT02198651|9837760|P3|Lead-in Period|Adverse Event|0
2861822|NCT02198651|9837761|P2|Lead-in Period|Adverse Event|0
2861823|NCT02198651|9837762|P1|Lead-in Period|Adverse Event|2
2861824|NCT02198651|9837758|P5|Lead-in Period|Withdrew consent|0
2861825|NCT02198651|9837759|P4|Lead-in Period|Withdrew consent|0
2861826|NCT02198651|9837760|P3|Lead-in Period|Withdrew consent|0
2861827|NCT02198651|9837761|P2|Lead-in Period|Withdrew consent|0
2861828|NCT02198651|9837762|P1|Lead-in Period|Withdrew consent|13
2861829|NCT02198235|9837863|P3|Overall Study|Lost to Follow-up|2
2861830|NCT02198235|9837864|P2|Overall Study|Lost to Follow-up|2
2861831|NCT02198235|9837865|P1|Overall Study|Lost to Follow-up|3
2861832|NCT02198040|9837885|P3|Overall Study|Withdrawal by Subject|1
2861833|NCT02198040|9837886|P2|Overall Study|Withdrawal by Subject|0
2861834|NCT02198040|9837887|P1|Overall Study|Withdrawal by Subject|0
2861835|NCT02198040|9837885|P3|Overall Study|Work reasons|0
2861836|NCT02198040|9837886|P2|Overall Study|Work reasons|1
2861837|NCT02198040|9837887|P1|Overall Study|Work reasons|0
2861838|NCT02197806|9837917|P4|Overall Study|Adverse Event|1
2861839|NCT02197806|9837918|P3|Overall Study|Adverse Event|0
2861840|NCT02197806|9837919|P2|Overall Study|Adverse Event|1
2861841|NCT02197806|9837920|P1|Overall Study|Adverse Event|0
2861842|NCT02197572|9837935|P1|Overall Study|Reason Not Specified|4
2861843|NCT02197572|9837935|P1|Overall Study|Adverse Event|3
2861844|NCT02197572|9837935|P1|Overall Study|Withdrawal by Subject|9
2861845|NCT02197572|9837935|P1|Overall Study|Progressive Disease|28
2861846|NCT02197520|9837952|P2|Period 2|Withdrawal by Subject|0
2861847|NCT02197520|9837953|P1|Period 2|Withdrawal by Subject|1
2861848|NCT02197520|9837952|P2|Period 2|Adverse Event|2
2861849|NCT02197520|9837953|P1|Period 2|Adverse Event|0
2861850|NCT02197520|9837952|P2|Period 1|Withdrawal by Subject|0
2861851|NCT02197520|9837953|P1|Period 1|Withdrawal by Subject|1
2861852|NCT02197377|9837999|P2|Overall Study|Insertion Failure|3
2861853|NCT02197377|9838000|P1|Overall Study|Insertion Failure|0
2861854|NCT02197247|9838021|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
2861855|NCT02197247|9838021|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
2861856|NCT02197247|9838021|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
2861857|NCT02197247|9838021|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
2861858|NCT02197247|9838021|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
2861859|NCT02197247|9838021|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
2861860|NCT02197247|9838021|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
2861861|NCT02197247|9838021|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
2861862|NCT02197234|9838066|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
2861863|NCT02197234|9838066|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
2861864|NCT02197234|9838066|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
2861865|NCT02197234|9838066|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
2861866|NCT02197234|9838066|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
2861867|NCT02197234|9838066|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
2861868|NCT02197234|9838066|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
2861869|NCT02197130|9838088|P3|Overall Study|Other|3
2861870|NCT02197130|9838089|P2|Overall Study|Other|0
2861871|NCT02197130|9838090|P1|Overall Study|Other|1
2861872|NCT02197130|9838088|P3|Overall Study|Withdrawal by Subject|4
2861873|NCT02197130|9838089|P2|Overall Study|Withdrawal by Subject|3
2861874|NCT02197130|9838090|P1|Overall Study|Withdrawal by Subject|0
2861875|NCT02197130|9838088|P3|Overall Study|Does not meet entrance criteria|1
2861876|NCT02197130|9838089|P2|Overall Study|Does not meet entrance criteria|0
2861877|NCT02197130|9838090|P1|Overall Study|Does not meet entrance criteria|0
2861878|NCT02197130|9838088|P3|Overall Study|Lost to Follow-up|1
2861879|NCT02197130|9838089|P2|Overall Study|Lost to Follow-up|0
2861880|NCT02197130|9838090|P1|Overall Study|Lost to Follow-up|2
2861881|NCT02197130|9838088|P3|Overall Study|Death|0
2861882|NCT02197130|9838089|P2|Overall Study|Death|1
2861883|NCT02197130|9838090|P1|Overall Study|Death|0
2861884|NCT02197130|9838088|P3|Overall Study|Adverse Event|23
2861885|NCT02197130|9838089|P2|Overall Study|Adverse Event|4
2861886|NCT02197130|9838090|P1|Overall Study|Adverse Event|13
2861887|NCT02196714|9838336|P4|Overall Study|Protocol Violation|0
2861888|NCT02196714|9838337|P3|Overall Study|Protocol Violation|1
2861889|NCT02196714|9838338|P2|Overall Study|Protocol Violation|0
2861890|NCT02196714|9838339|P1|Overall Study|Protocol Violation|0
2861891|NCT02196701|9838461|P1|Overall Study|Non-adherence to Protocol|1
2861892|NCT02196701|9838461|P1|Overall Study|Lost to Follow-up|1
2861893|NCT02196701|9838461|P1|Overall Study|Adverse Event|1
2861894|NCT02196675|9838535|P3|Overall Study|Death|1
2861895|NCT02196675|9838536|P2|Overall Study|Death|0
2861896|NCT02196675|9838537|P1|Overall Study|Death|0
2861897|NCT02196675|9838535|P3|Overall Study|Protocol Violation|0
2861898|NCT02196675|9838536|P2|Overall Study|Protocol Violation|1
2861899|NCT02196675|9838537|P1|Overall Study|Protocol Violation|0
2861900|NCT02196675|9838535|P3|Overall Study|Intra-operative surgical exclusion|0
2861901|NCT02196675|9838536|P2|Overall Study|Intra-operative surgical exclusion|1
2861902|NCT02196675|9838537|P1|Overall Study|Intra-operative surgical exclusion|1
2861903|NCT02196675|9838535|P3|Overall Study|Withdrawal by Subject|0
2861904|NCT02196675|9838536|P2|Overall Study|Withdrawal by Subject|0
2861905|NCT02196675|9838537|P1|Overall Study|Withdrawal by Subject|1
2861906|NCT02196506|9838559|P4|Phase A+|Participant withdrawn by investigator|1
2861907|NCT02196506|9838560|P3|Phase A+|Participant withdrawn by investigator|0
2861908|NCT02196506|9838561|P2|Phase A+|Participant withdrawn by investigator|0
2861909|NCT02196506|9838562|P1|Phase A+|Participant withdrawn by investigator|0
2861910|NCT02196506|9838559|P4|Phase A+|Lost to Follow-up|6
2861911|NCT02196506|9838560|P3|Phase A+|Lost to Follow-up|0
2861912|NCT02196506|9838561|P2|Phase A+|Lost to Follow-up|0
2861913|NCT02196506|9838562|P1|Phase A+|Lost to Follow-up|0
2861914|NCT02196506|9838559|P4|Phase A+|Adverse Event|1
2861915|NCT02196506|9838560|P3|Phase A+|Adverse Event|0
2861916|NCT02196506|9838561|P2|Phase A+|Adverse Event|0
2861917|NCT02196506|9838562|P1|Phase A+|Adverse Event|0
2861918|NCT02196506|9838559|P4|Phase A+|Withdrawal by Participant|5
2861919|NCT02196506|9838560|P3|Phase A+|Withdrawal by Participant|0
2861920|NCT02196506|9838561|P2|Phase A+|Withdrawal by Participant|0
2861921|NCT02196506|9838562|P1|Phase A+|Withdrawal by Participant|0
2861922|NCT02196506|9838559|P4|Phase A+|Participant Met Withdrawal Criteria|1
2861923|NCT02196506|9838560|P3|Phase A+|Participant Met Withdrawal Criteria|0
2861924|NCT02196506|9838561|P2|Phase A+|Participant Met Withdrawal Criteria|0
2861925|NCT02196506|9838562|P1|Phase A+|Participant Met Withdrawal Criteria|0
2861926|NCT02196506|9838559|P4|Phase B|Lost to Follow-up|0
2861927|NCT02196506|9838560|P3|Phase B|Lost to Follow-up|1
2861928|NCT02196506|9838561|P2|Phase B|Lost to Follow-up|2
2861929|NCT02196506|9838562|P1|Phase B|Lost to Follow-up|0
2861930|NCT02196506|9838559|P4|Phase B|Adverse Event|0
2861931|NCT02196506|9838560|P3|Phase B|Adverse Event|1
2861932|NCT02196506|9838561|P2|Phase B|Adverse Event|4
2861933|NCT02196506|9838562|P1|Phase B|Adverse Event|0
2861934|NCT02196506|9838559|P4|Phase B|Withdrawal by Participant|0
2861935|NCT02196506|9838560|P3|Phase B|Withdrawal by Participant|1
2861936|NCT02196506|9838561|P2|Phase B|Withdrawal by Participant|8
2861937|NCT02196506|9838562|P1|Phase B|Withdrawal by Participant|0
2861938|NCT02196506|9838559|P4|Phase B|Lack of Efficacy|0
2861939|NCT02196506|9838560|P3|Phase B|Lack of Efficacy|2
2861940|NCT02196506|9838561|P2|Phase B|Lack of Efficacy|1
2861941|NCT02196506|9838562|P1|Phase B|Lack of Efficacy|0
2861942|NCT02196506|9838559|P4|Phase B|Participant Met Withdrawal Criteria|0
2861943|NCT02196506|9838560|P3|Phase B|Participant Met Withdrawal Criteria|1
2861944|NCT02196506|9838561|P2|Phase B|Participant Met Withdrawal Criteria|0
2861945|NCT02196506|9838562|P1|Phase B|Participant Met Withdrawal Criteria|0
2861946|NCT02196506|9838559|P4|Phase A|Participant withdrawn by investigator|0
2861947|NCT02196506|9838560|P3|Phase A|Participant withdrawn by investigator|0
2861948|NCT02196506|9838561|P2|Phase A|Participant withdrawn by investigator|0
2861949|NCT02196506|9838562|P1|Phase A|Participant withdrawn by investigator|10
2861950|NCT02196506|9838559|P4|Phase A|Protocol deviation|0
2861951|NCT02196506|9838560|P3|Phase A|Protocol deviation|0
2861952|NCT02196506|9838561|P2|Phase A|Protocol deviation|0
2861953|NCT02196506|9838562|P1|Phase A|Protocol deviation|12
2861954|NCT02196506|9838559|P4|Phase A|Lost to Follow-up|0
2861955|NCT02196506|9838560|P3|Phase A|Lost to Follow-up|0
2861956|NCT02196506|9838561|P2|Phase A|Lost to Follow-up|0
2861957|NCT02196506|9838562|P1|Phase A|Lost to Follow-up|9
2861958|NCT02196506|9838559|P4|Phase A|Adverse Event|0
2861959|NCT02196506|9838560|P3|Phase A|Adverse Event|0
2861960|NCT02196506|9838561|P2|Phase A|Adverse Event|0
2861961|NCT02196506|9838562|P1|Phase A|Adverse Event|22
2861962|NCT02196506|9838559|P4|Phase A|Withdrawal by Subject|0
2861963|NCT02196506|9838560|P3|Phase A|Withdrawal by Subject|0
2861964|NCT02196506|9838561|P2|Phase A|Withdrawal by Subject|0
2861965|NCT02196506|9838562|P1|Phase A|Withdrawal by Subject|34
2861966|NCT02196506|9838559|P4|Phase A|Participant Met Withdrawal Criteria|0
2861967|NCT02196506|9838560|P3|Phase A|Participant Met Withdrawal Criteria|0
2861968|NCT02196506|9838561|P2|Phase A|Participant Met Withdrawal Criteria|0
2861969|NCT02196506|9838562|P1|Phase A|Participant Met Withdrawal Criteria|34
2861970|NCT02196259|9838577|P3|Overall Study|Partial data analysis|0
2861971|NCT02196259|9838578|P2|Overall Study|Partial data analysis|3
2861972|NCT02196259|9838579|P1|Overall Study|Partial data analysis|0
2861973|NCT02196259|9838577|P3|Overall Study|Researcher choice|1
2861974|NCT02196259|9838578|P2|Overall Study|Researcher choice|0
2861975|NCT02196259|9838579|P1|Overall Study|Researcher choice|0
2861976|NCT02196077|9838607|P1|Overall Study|Protocol Violation|24
2861977|NCT02196077|9838607|P1|Overall Study|Lost to Follow-up|3
2861978|NCT02196077|9838607|P1|Overall Study|Physician Decision|1
2861979|NCT02196077|9838607|P1|Overall Study|Withdrawal by Subject|14
2861980|NCT02196077|9838607|P1|Overall Study|Lack of Efficacy|1
2861981|NCT02196077|9838607|P1|Overall Study|Adverse Event|4
2861982|NCT02195986|9838657|P3|Overall Study|Non-compliance|0
2861983|NCT02195986|9838658|P2|Overall Study|Non-compliance|1
2861984|NCT02195986|9838659|P1|Overall Study|Non-compliance|0
2861985|NCT02195986|9838657|P3|Overall Study|Protocol Violation|1
2861986|NCT02195986|9838658|P2|Overall Study|Protocol Violation|1
2861987|NCT02195986|9838659|P1|Overall Study|Protocol Violation|0
2861988|NCT02195986|9838657|P3|Overall Study|Family Emergency|1
2861989|NCT02195986|9838658|P2|Overall Study|Family Emergency|0
2861990|NCT02195986|9838659|P1|Overall Study|Family Emergency|0
2861991|NCT02195986|9838657|P3|Overall Study|Withdrawal by Subject|0
2861992|NCT02195986|9838658|P2|Overall Study|Withdrawal by Subject|3
2861993|NCT02195986|9838659|P1|Overall Study|Withdrawal by Subject|0
2861994|NCT02195986|9838657|P3|Overall Study|Adverse Event|0
2861995|NCT02195986|9838658|P2|Overall Study|Adverse Event|0
2861996|NCT02195986|9838659|P1|Overall Study|Adverse Event|3
2861997|NCT02195869|9838682|P1|Overall Study|Noncompliance with study drug|2
2861998|NCT02195869|9838682|P1|Overall Study|Study Terminated by Sponsor|7
2861999|NCT02195869|9838682|P1|Overall Study|Physician Decision|4
2862000|NCT02195869|9838682|P1|Overall Study|Withdrawal by Subject|7
2862001|NCT02195869|9838682|P1|Overall Study|Adverse Event|15
2862002|NCT02195869|9838682|P1|Overall Study|Malignancy Progression/relapse|2
2862003|NCT02195869|9838682|P1|Overall Study|cGVHD Progression|5
2862004|NCT02195700|9838704|P2|Overall Study|Lost to Follow-up|1
2862005|NCT02195700|9838705|P1|Overall Study|Lost to Follow-up|1
2862006|NCT02195700|9838704|P2|Overall Study|Withdrawal by Subject|2
2862007|NCT02195700|9838705|P1|Overall Study|Withdrawal by Subject|3
2862008|NCT02195700|9838704|P2|Overall Study|Adverse Event|2
2862009|NCT02195700|9838705|P1|Overall Study|Adverse Event|1
2862010|NCT02195700|9838704|P2|Overall Study|Noncompliance|0
2862011|NCT02195700|9838705|P1|Overall Study|Noncompliance|1
2862012|NCT02195700|9838704|P2|Overall Study|Protocol Violation|2
2862013|NCT02195700|9838705|P1|Overall Study|Protocol Violation|0
2862014|NCT02195687|9838727|P2|Overall Study|Lost to Follow-up|1
2862015|NCT02195687|9838728|P1|Overall Study|Lost to Follow-up|4
2862016|NCT02195687|9838727|P2|Overall Study|Personal Reasons|1
2862017|NCT02195687|9838728|P1|Overall Study|Personal Reasons|1
2862018|NCT02195583|9838753|P1|Overall Study|Other Reason|2
2862019|NCT02195583|9838753|P1|Overall Study|Adverse Event|2
2862020|NCT02195583|9838753|P1|Overall Study|Withdrawal by Subject|4
2862021|NCT02195583|9838753|P1|Overall Study|Lost to Follow-up|1
2862022|NCT02195531|9838788|P3|Overall Study|Withdrawal by Subject|1
2862023|NCT02195531|9838789|P2|Overall Study|Withdrawal by Subject|1
2862024|NCT02195531|9838790|P1|Overall Study|Withdrawal by Subject|1
2862025|NCT02195518|9838815|P1|Overall Study|Lost to Follow-up|1
2862026|NCT02195518|9838815|P1|Overall Study|Withdrawal by Subject|1
2862027|NCT02195518|9838815|P1|Overall Study|Pregnancy|2
2862028|NCT02195518|9838815|P1|Overall Study|Protocol Violation|4
2862029|NCT02195518|9838815|P1|Overall Study|Adverse Event|1
2862030|NCT02195479|9838838|P2|Overall Study|Ongoing|297
2862031|NCT02195479|9838839|P1|Overall Study|Ongoing|291
2862032|NCT02195479|9838838|P2|Overall Study|Other|2
2862033|NCT02195479|9838839|P1|Overall Study|Other|2
2862034|NCT02195479|9838838|P2|Overall Study|Withdrawal by Subject|6
2862035|NCT02195479|9838839|P1|Overall Study|Withdrawal by Subject|11
2862036|NCT02195479|9838838|P2|Overall Study|Physician Decision|0
2862037|NCT02195479|9838839|P1|Overall Study|Physician Decision|1
2862038|NCT02195479|9838838|P2|Overall Study|Death|45
2862039|NCT02195479|9838839|P1|Overall Study|Death|48
2862040|NCT02195479|9838838|P2|Overall Study|Lost to Follow-up|0
2862041|NCT02195479|9838839|P1|Overall Study|Lost to Follow-up|3
2862042|NCT02195427|9838877|P2|Overall Study|Conditional re-treatment at W52|1
2862043|NCT02195427|9838878|P1|Overall Study|Conditional re-treatment at W52|2
2862044|NCT02195427|9838877|P2|Overall Study|Protocol Violation|14
2862045|NCT02195427|9838878|P1|Overall Study|Protocol Violation|7
2862046|NCT02195427|9838877|P2|Overall Study|Lost to Follow-up|1
2862047|NCT02195427|9838878|P1|Overall Study|Lost to Follow-up|0
2862048|NCT02195427|9838877|P2|Overall Study|Withdrawal by Subject|2
2862049|NCT02195427|9838878|P1|Overall Study|Withdrawal by Subject|4
2862050|NCT02195427|9838877|P2|Overall Study|Did not consent to study extension|9
2862051|NCT02195427|9838878|P1|Overall Study|Did not consent to study extension|13
2862052|NCT02195011|9839243|P2|Overall Study|Withdrawal by Subject|0
2862053|NCT02195011|9839244|P1|Overall Study|Withdrawal by Subject|3
2862054|NCT02195011|9839243|P2|Overall Study|Progressive Disease|1
2862055|NCT02195011|9839244|P1|Overall Study|Progressive Disease|18
2862056|NCT02195011|9839243|P2|Overall Study|Adverse Event|0
2862057|NCT02195011|9839244|P1|Overall Study|Adverse Event|4
2862058|NCT02194998|9839260|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2862059|NCT02194998|9839261|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2862060|NCT02194998|9839262|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2862061|NCT02194998|9839263|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2862062|NCT02194998|9839260|P4|On-HCV Treatment|Did not pick up study medication|0
2862063|NCT02194998|9839261|P3|On-HCV Treatment|Did not pick up study medication|0
2862064|NCT02194998|9839262|P2|On-HCV Treatment|Did not pick up study medication|1
2862065|NCT02194998|9839263|P1|On-HCV Treatment|Did not pick up study medication|0
2862066|NCT02194933|9839327|P2|Overall Study|Lack of Efficacy|2
2862067|NCT02194933|9839328|P1|Overall Study|Lack of Efficacy|1
2862068|NCT02194933|9839327|P2|Overall Study|Withdrawal by Subject|2
2862069|NCT02194933|9839328|P1|Overall Study|Withdrawal by Subject|0
2862070|NCT02194933|9839327|P2|Overall Study|Participant met withdrawal criteria|3
2862071|NCT02194933|9839328|P1|Overall Study|Participant met withdrawal criteria|1
2862072|NCT02194933|9839327|P2|Overall Study|Lost to Follow-up|2
2862073|NCT02194933|9839328|P1|Overall Study|Lost to Follow-up|1
2862074|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Other|16
2862075|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Other|24
2862076|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
2862077|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
2862162|NCT02193074|9839799|P2|Overall Study|Withdrawal by Subject|2
2862078|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2862079|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2862080|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
2862081|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
2862082|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Death|3
2862083|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Death|1
2862084|NCT02194699|9839382|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
2862085|NCT02194699|9839383|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
2862086|NCT02194699|9839382|P2|Randomised|Duplicate patient|1
2862087|NCT02194699|9839383|P1|Randomised|Duplicate patient|2
2862088|NCT02194699|9839382|P2|Randomised|Without potential for 52 weeks of IP|5
2862089|NCT02194699|9839383|P1|Randomised|Without potential for 52 weeks of IP|5
2862090|NCT02194699|9839382|P2|Randomised|Did not receive treatment|5
2862091|NCT02194699|9839383|P1|Randomised|Did not receive treatment|1
2862092|NCT02194621|9839491|P3|Overall Study|Withdrawal by Subject|7
2862093|NCT02194621|9839492|P2|Overall Study|Withdrawal by Subject|4
2862094|NCT02194621|9839493|P1|Overall Study|Withdrawal by Subject|4
2862095|NCT02194621|9839491|P3|Overall Study|6 withdrew prior to randomization|2
2862096|NCT02194621|9839492|P2|Overall Study|6 withdrew prior to randomization|2
2862097|NCT02194621|9839493|P1|Overall Study|6 withdrew prior to randomization|2
2862098|NCT02194062|9839526|P3|Overall Study|Lost to Follow-up|5
2862099|NCT02194062|9839527|P2|Overall Study|Lost to Follow-up|2
2862100|NCT02194062|9839528|P1|Overall Study|Lost to Follow-up|2
2862101|NCT02193880|9839539|P1|Overall Study|patients did not collect enough HPC|3
2862102|NCT02193867|9839544|P1|Overall Study|Sponsor Study Termination|2
2862103|NCT02193867|9839544|P1|Overall Study|Death|2
2862104|NCT02193828|9839562|P4|Overall Study|Withdrawal by Subject|1
2862105|NCT02193828|9839563|P3|Overall Study|Withdrawal by Subject|1
2862106|NCT02193828|9839564|P2|Overall Study|Withdrawal by Subject|0
2862107|NCT02193828|9839565|P1|Overall Study|Withdrawal by Subject|0
2862108|NCT02193776|9839642|P4|Overall Study|Adverse event/Specific toxicity|2
2862109|NCT02193776|9839643|P3|Overall Study|Adverse event/Specific toxicity|2
2862110|NCT02193776|9839644|P2|Overall Study|Adverse event/Specific toxicity|5
2862111|NCT02193776|9839645|P1|Overall Study|Adverse event/Specific toxicity|5
2862112|NCT02193776|9839642|P4|Overall Study|Death|0
2862113|NCT02193776|9839643|P3|Overall Study|Death|0
2862114|NCT02193776|9839644|P2|Overall Study|Death|0
2862115|NCT02193776|9839645|P1|Overall Study|Death|1
2862116|NCT02193776|9839642|P4|Overall Study|Investigator/Sponsor decision|0
2862117|NCT02193776|9839643|P3|Overall Study|Investigator/Sponsor decision|0
2862118|NCT02193776|9839644|P2|Overall Study|Investigator/Sponsor decision|1
2862119|NCT02193776|9839645|P1|Overall Study|Investigator/Sponsor decision|1
2862120|NCT02193776|9839642|P4|Overall Study|Failure to comply with protocol|0
2862121|NCT02193776|9839643|P3|Overall Study|Failure to comply with protocol|0
2862122|NCT02193776|9839644|P2|Overall Study|Failure to comply with protocol|1
2862123|NCT02193776|9839645|P1|Overall Study|Failure to comply with protocol|0
2862124|NCT02193776|9839642|P4|Overall Study|Consent withdrawn|0
2862125|NCT02193776|9839643|P3|Overall Study|Consent withdrawn|0
2862126|NCT02193776|9839644|P2|Overall Study|Consent withdrawn|0
2862127|NCT02193776|9839645|P1|Overall Study|Consent withdrawn|1
2862128|NCT02193178|9839672|P1|Overall Study|Dry eyes|1
2862129|NCT02193178|9839672|P1|Overall Study|Lost to Follow-up|1
2862130|NCT02193165|9839722|P3|6 Week Product Use|Lost to Follow-up|0
2862131|NCT02193165|9839723|P2|6 Week Product Use|Lost to Follow-up|1
2862132|NCT02193165|9839724|P1|6 Week Product Use|Lost to Follow-up|0
2862133|NCT02193165|9839722|P3|4 Week Product Use|Lost to Follow-up|1
2862134|NCT02193165|9839723|P2|4 Week Product Use|Lost to Follow-up|1
2862135|NCT02193165|9839724|P1|4 Week Product Use|Lost to Follow-up|1
2862136|NCT02193087|9839751|P4|Overall Study|Did Not Receive Any Vaccination|1
2862137|NCT02193087|9839752|P3|Overall Study|Did Not Receive Any Vaccination|0
2862138|NCT02193087|9839753|P2|Overall Study|Did Not Receive Any Vaccination|3
2862139|NCT02193087|9839754|P1|Overall Study|Did Not Receive Any Vaccination|2
2862140|NCT02193087|9839751|P4|Overall Study|Other Reason Not Specified|9
2862141|NCT02193087|9839752|P3|Overall Study|Other Reason Not Specified|1
2862142|NCT02193087|9839753|P2|Overall Study|Other Reason Not Specified|2
2862143|NCT02193087|9839754|P1|Overall Study|Other Reason Not Specified|7
2862144|NCT02193087|9839751|P4|Overall Study|Withdrawal by Subject|19
2862145|NCT02193087|9839752|P3|Overall Study|Withdrawal by Subject|1
2862146|NCT02193087|9839753|P2|Overall Study|Withdrawal by Subject|3
2862147|NCT02193087|9839754|P1|Overall Study|Withdrawal by Subject|10
2862148|NCT02193087|9839751|P4|Overall Study|Protocol Violation|2
2862149|NCT02193087|9839752|P3|Overall Study|Protocol Violation|1
2862150|NCT02193087|9839753|P2|Overall Study|Protocol Violation|0
2862151|NCT02193087|9839754|P1|Overall Study|Protocol Violation|2
2862152|NCT02193087|9839751|P4|Overall Study|Lost to Follow-up|37
2862153|NCT02193087|9839752|P3|Overall Study|Lost to Follow-up|4
2862154|NCT02193087|9839753|P2|Overall Study|Lost to Follow-up|6
2862155|NCT02193087|9839754|P1|Overall Study|Lost to Follow-up|14
2862156|NCT02193087|9839751|P4|Overall Study|Adverse Event|11
2862157|NCT02193087|9839752|P3|Overall Study|Adverse Event|0
2862158|NCT02193087|9839753|P2|Overall Study|Adverse Event|0
2862159|NCT02193087|9839754|P1|Overall Study|Adverse Event|2
2862160|NCT02193074|9839799|P2|Overall Study|Adverse Event|13
2862161|NCT02193074|9839800|P1|Overall Study|Adverse Event|16
2862163|NCT02193074|9839800|P1|Overall Study|Withdrawal by Subject|1
2862164|NCT02192905|9839832|P1|Overall Study|Lost to Follow-up|1
2862165|NCT02192606|9839896|P2|Overall Study|3D equipment rep unable to join|1
2862166|NCT02192606|9839897|P1|Overall Study|3D equipment rep unable to join|0
2862167|NCT02192606|9839896|P2|Overall Study|Physician Decision|2
2862168|NCT02192606|9839897|P1|Overall Study|Physician Decision|1
2862169|NCT02192606|9839896|P2|Overall Study|surgery type was changed|1
2862170|NCT02192606|9839897|P1|Overall Study|surgery type was changed|1
2862171|NCT02192190|9839945|P6|Overall Study|Inadequate Pain Relief|0
2862172|NCT02192190|9839946|P5|Overall Study|Inadequate Pain Relief|0
2862173|NCT02192190|9839947|P4|Overall Study|Inadequate Pain Relief|0
2862174|NCT02192190|9839948|P3|Overall Study|Inadequate Pain Relief|1
2862175|NCT02192190|9839949|P2|Overall Study|Inadequate Pain Relief|1
2862176|NCT02192190|9839950|P1|Overall Study|Inadequate Pain Relief|0
2862177|NCT02192190|9839945|P6|Overall Study|Positive Drug Screen|0
2862178|NCT02192190|9839946|P5|Overall Study|Positive Drug Screen|0
2862179|NCT02192190|9839947|P4|Overall Study|Positive Drug Screen|1
2862180|NCT02192190|9839948|P3|Overall Study|Positive Drug Screen|0
2862181|NCT02192190|9839949|P2|Overall Study|Positive Drug Screen|0
2862182|NCT02192190|9839950|P1|Overall Study|Positive Drug Screen|0
2862183|NCT02192190|9839945|P6|Overall Study|Could not Keep Visit Schedule|0
2862184|NCT02192190|9839946|P5|Overall Study|Could not Keep Visit Schedule|0
2862185|NCT02192190|9839947|P4|Overall Study|Could not Keep Visit Schedule|0
2862186|NCT02192190|9839948|P3|Overall Study|Could not Keep Visit Schedule|0
2862187|NCT02192190|9839949|P2|Overall Study|Could not Keep Visit Schedule|0
2862188|NCT02192190|9839950|P1|Overall Study|Could not Keep Visit Schedule|1
2862189|NCT02192190|9839945|P6|Overall Study|Withdrawal by Subject|3
2862190|NCT02192190|9839946|P5|Overall Study|Withdrawal by Subject|5
2862191|NCT02192190|9839947|P4|Overall Study|Withdrawal by Subject|1
2862192|NCT02192190|9839948|P3|Overall Study|Withdrawal by Subject|2
2862193|NCT02192190|9839949|P2|Overall Study|Withdrawal by Subject|1
2862194|NCT02192190|9839950|P1|Overall Study|Withdrawal by Subject|4
2862195|NCT02192190|9839945|P6|Overall Study|Terminated by Sponsor|23
2862196|NCT02192190|9839946|P5|Overall Study|Terminated by Sponsor|21
2862197|NCT02192190|9839947|P4|Overall Study|Terminated by Sponsor|23
2862198|NCT02192190|9839948|P3|Overall Study|Terminated by Sponsor|20
2862199|NCT02192190|9839949|P2|Overall Study|Terminated by Sponsor|23
2862200|NCT02192190|9839950|P1|Overall Study|Terminated by Sponsor|43
2862201|NCT02192190|9839945|P6|Overall Study|Physician Decision|0
2862202|NCT02192190|9839946|P5|Overall Study|Physician Decision|0
2862203|NCT02192190|9839947|P4|Overall Study|Physician Decision|0
2862204|NCT02192190|9839948|P3|Overall Study|Physician Decision|0
2862205|NCT02192190|9839949|P2|Overall Study|Physician Decision|0
2862206|NCT02192190|9839950|P1|Overall Study|Physician Decision|2
2862207|NCT02192190|9839945|P6|Overall Study|Lost to Follow-up|3
2862208|NCT02192190|9839946|P5|Overall Study|Lost to Follow-up|4
2862209|NCT02192190|9839947|P4|Overall Study|Lost to Follow-up|1
2862210|NCT02192190|9839948|P3|Overall Study|Lost to Follow-up|2
2862211|NCT02192190|9839949|P2|Overall Study|Lost to Follow-up|3
2862212|NCT02192190|9839950|P1|Overall Study|Lost to Follow-up|3
2862213|NCT02192190|9839945|P6|Overall Study|Adverse Event|0
2862214|NCT02192190|9839946|P5|Overall Study|Adverse Event|0
2862215|NCT02192190|9839947|P4|Overall Study|Adverse Event|0
2862216|NCT02192190|9839948|P3|Overall Study|Adverse Event|0
2862217|NCT02192190|9839949|P2|Overall Study|Adverse Event|1
2862218|NCT02192190|9839950|P1|Overall Study|Adverse Event|1
2862219|NCT02192164|9839994|P1|Overall Study|Did not meet the exclusion criteria|1
2862220|NCT02192164|9839994|P1|Overall Study|Physician Decision|4
2862221|NCT02192164|9839994|P1|Overall Study|Withdrawal by Subject|1
2862222|NCT02192164|9839994|P1|Overall Study|Other|8
2862223|NCT02192099|9840010|P1|Overall Study|Miscellaneous Reasons|5
2862224|NCT02192099|9840010|P1|Overall Study|Withdrawal by Subject|11
2862225|NCT02192099|9840010|P1|Overall Study|Study Terminated by Sponsor|32
2862226|NCT02192099|9840010|P1|Overall Study|Protocol Violation|8
2862227|NCT02192099|9840010|P1|Overall Study|Pregnancy|1
2862228|NCT02192099|9840010|P1|Overall Study|Physician Decision|1
2862229|NCT02192099|9840010|P1|Overall Study|Lost to Follow-up|2
2862230|NCT02192099|9840010|P1|Overall Study|Adverse Event|1
2862231|NCT02191618|9840039|P1|Overall Study|Missed Visit|4
2862232|NCT02191618|9840039|P1|Overall Study|Withdrawal by Subject|3
2862233|NCT02191605|9840049|P5|Overall Study|Lost to Follow-up|4
2862234|NCT02191605|9840050|P4|Overall Study|Lost to Follow-up|3
2862235|NCT02191605|9840051|P3|Overall Study|Lost to Follow-up|7
2862236|NCT02191605|9840052|P2|Overall Study|Lost to Follow-up|4
2862237|NCT02191605|9840053|P1|Overall Study|Lost to Follow-up|9
2862238|NCT02191579|9840072|P2|Treatment 2|Multiple Reasons Specified|25
2862239|NCT02191579|9840073|P1|Treatment 2|Multiple Reasons Specified|0
2862240|NCT02191579|9840072|P2|Treatment 1|Multiple Reasons Specified|58
2862241|NCT02191579|9840073|P1|Treatment 1|Multiple Reasons Specified|27
2862242|NCT02191397|9840087|P2|Overall Study|Withdrawal by Subject|27
2862243|NCT02191397|9840088|P1|Overall Study|Withdrawal by Subject|22
2862244|NCT02191397|9840087|P2|Overall Study|Physician Decision|3
2862245|NCT02191397|9840088|P1|Overall Study|Physician Decision|8
2862246|NCT02191397|9840087|P2|Overall Study|Lost to Follow-up|11
2862247|NCT02191397|9840088|P1|Overall Study|Lost to Follow-up|10
2862248|NCT02191397|9840087|P2|Overall Study|Met protocol-defined stopping criteria|4
2862249|NCT02191397|9840088|P1|Overall Study|Met protocol-defined stopping criteria|5
2862250|NCT02191397|9840087|P2|Overall Study|Protocol Violation|3
2862251|NCT02191397|9840088|P1|Overall Study|Protocol Violation|0
2862252|NCT02191397|9840087|P2|Overall Study|Lack of Efficacy|5
2862253|NCT02191397|9840088|P1|Overall Study|Lack of Efficacy|10
2862254|NCT02191397|9840087|P2|Overall Study|Adverse Event|17
2862255|NCT02191397|9840088|P1|Overall Study|Adverse Event|28
2862256|NCT02191267|9840149|P3|Overall Study|Withdrawal by Subject|0
2862257|NCT02191267|9840150|P2|Overall Study|Withdrawal by Subject|0
2862258|NCT02191267|9840151|P1|Overall Study|Withdrawal by Subject|1
2862259|NCT02191137|9840162|P1|Follow-up|Adverse Event|1
2862260|NCT02191137|9840162|P1|Follow-up|Ongoing/unknown|2
2862261|NCT02191137|9840162|P1|Follow-up|Lost to Follow-up|2
2862262|NCT02191137|9840162|P1|Treatment|Other|1
2862263|NCT02191137|9840162|P1|Treatment|Adverse Event|2
2862264|NCT02191137|9840162|P1|Treatment|Withdrawal by Subject|3
2862265|NCT02191137|9840162|P1|Treatment|Death|4
2862266|NCT02191046|9840192|P2|Overall Study|low compliance|1
2862267|NCT02191046|9840193|P1|Overall Study|low compliance|5
2862268|NCT02190721|9840224|P3|Overall Study|Patient was out of the city|0
2862269|NCT02190721|9840225|P2|Overall Study|Patient was out of the city|1
2862270|NCT02190721|9840226|P1|Overall Study|Patient was out of the city|0
2862271|NCT02190604|9840349|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862272|NCT02190604|9840350|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862273|NCT02190604|9840351|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862274|NCT02190604|9840352|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862275|NCT02190604|9840353|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862276|NCT02190604|9840354|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
2862277|NCT02190604|9840355|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862278|NCT02190604|9840356|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862279|NCT02190604|9840357|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862280|NCT02190604|9840358|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862281|NCT02190604|9840359|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862282|NCT02190604|9840360|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862283|NCT02190604|9840361|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862284|NCT02190604|9840362|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862285|NCT02190604|9840363|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862286|NCT02190604|9840364|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862287|NCT02190604|9840365|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862288|NCT02190604|9840366|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862289|NCT02190604|9840367|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2862290|NCT02190604|9840349|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862291|NCT02190604|9840350|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862292|NCT02190604|9840351|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862293|NCT02190604|9840352|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862294|NCT02190604|9840353|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
2862295|NCT02190604|9840354|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862296|NCT02190604|9840355|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862297|NCT02190604|9840356|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862298|NCT02190604|9840357|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862299|NCT02190604|9840358|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862300|NCT02190604|9840359|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862301|NCT02190604|9840360|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862302|NCT02190604|9840361|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862303|NCT02190604|9840362|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862304|NCT02190604|9840363|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862305|NCT02190604|9840364|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862306|NCT02190604|9840365|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862307|NCT02190604|9840366|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862308|NCT02190604|9840367|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2862309|NCT02190591|9840558|P2|Overall Study|face presentation so she was ineligible|1
2862310|NCT02190591|9840559|P1|Overall Study|face presentation so she was ineligible|0
2862311|NCT02190591|9840558|P2|Overall Study|did not use peanut ball as instructed|2
2862312|NCT02190591|9840559|P1|Overall Study|did not use peanut ball as instructed|0
2862313|NCT02190591|9840558|P2|Overall Study|Protocol Violation|0
2862314|NCT02190591|9840559|P1|Overall Study|Protocol Violation|1
2862315|NCT02190591|9840558|P2|Overall Study|Withdrawal by Subject|8
2862316|NCT02190591|9840559|P1|Overall Study|Withdrawal by Subject|1
2862317|NCT02190435|9840582|P2|Overall Study|3 consented screen fails|0
2862318|NCT02190435|9840583|P1|Overall Study|3 consented screen fails|3
2862319|NCT02190435|9840582|P2|Overall Study|First 12 patients were lead-ins|0
2862320|NCT02190435|9840583|P1|Overall Study|First 12 patients were lead-ins|12
2862321|NCT02190279|9840594|P3|Overall Study|Screening failure|1
2862322|NCT02190279|9840595|P2|Overall Study|Screening failure|0
2862323|NCT02190279|9840596|P1|Overall Study|Screening failure|0
2862324|NCT02190279|9840594|P3|Overall Study|Refused further treatment|1
2862325|NCT02190279|9840595|P2|Overall Study|Refused further treatment|0
2862326|NCT02190279|9840596|P1|Overall Study|Refused further treatment|0
2862327|NCT02190279|9840594|P3|Overall Study|Lost to Follow-up|0
2862328|NCT02190279|9840595|P2|Overall Study|Lost to Follow-up|0
2862329|NCT02190279|9840596|P1|Overall Study|Lost to Follow-up|2
2862330|NCT02190279|9840594|P3|Overall Study|Withdrawal consent|1
2862331|NCT02190279|9840595|P2|Overall Study|Withdrawal consent|0
2862332|NCT02190279|9840596|P1|Overall Study|Withdrawal consent|1
2862333|NCT02189941|9840635|P3|Overall Study|Non-compliance|1
2862334|NCT02189941|9840636|P2|Overall Study|Non-compliance|0
2862335|NCT02189941|9840637|P1|Overall Study|Non-compliance|0
2862336|NCT02189863|9840665|P2|First 2 Weeks|Motion Sickness|2
2862337|NCT02189863|9840666|P1|First 2 Weeks|Motion Sickness|4
2862338|NCT02189837|9840681|P4|Overall Study|Sponsor Decision|1
2862339|NCT02189837|9840682|P3|Overall Study|Sponsor Decision|0
2862340|NCT02189837|9840683|P2|Overall Study|Sponsor Decision|0
2862341|NCT02189837|9840684|P1|Overall Study|Sponsor Decision|0
2862342|NCT02189837|9840681|P4|Overall Study|Withdrawal by Subject|1
2862343|NCT02189837|9840682|P3|Overall Study|Withdrawal by Subject|3
2862344|NCT02189837|9840683|P2|Overall Study|Withdrawal by Subject|1
2862345|NCT02189837|9840684|P1|Overall Study|Withdrawal by Subject|2
2862346|NCT02189759|9840714|P4|Overall Study|Lost to Follow-up|5
2862347|NCT02189759|9840715|P3|Overall Study|Lost to Follow-up|2
2862348|NCT02189759|9840716|P2|Overall Study|Lost to Follow-up|0
2862349|NCT02189759|9840717|P1|Overall Study|Lost to Follow-up|0
2862350|NCT02189473|9840753|P2|Overall Study|Lost to Follow-up|2
2862351|NCT02189473|9840754|P1|Overall Study|Lost to Follow-up|1
2862352|NCT02189473|9840753|P2|Overall Study|Death|23
2862353|NCT02189473|9840754|P1|Overall Study|Death|22
2862354|NCT02189252|9840802|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2862355|NCT02189252|9840803|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2862356|NCT02189252|9840804|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
2862357|NCT02189252|9840805|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2862358|NCT02189252|9840802|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2862359|NCT02189252|9840803|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2862360|NCT02189252|9840804|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
2862361|NCT02189252|9840805|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2862362|NCT02188849|9840864|P2|Overall Study|Lost to Follow-up|8
2862363|NCT02188849|9840865|P1|Overall Study|Lost to Follow-up|3
2862364|NCT02188784|9840879|P2|Overall Study|Physician Decision|3
2862365|NCT02188784|9840880|P1|Overall Study|Physician Decision|2
2862366|NCT02188784|9840879|P2|Overall Study|Withdrawal by Subject|9
2862367|NCT02188784|9840880|P1|Overall Study|Withdrawal by Subject|3
2862368|NCT02188784|9840879|P2|Overall Study|Lost to Follow-up|0
2862369|NCT02188784|9840880|P1|Overall Study|Lost to Follow-up|1
2862370|NCT02188784|9840879|P2|Overall Study|Death|1
2862371|NCT02188784|9840880|P1|Overall Study|Death|3
2862372|NCT02188589|9840896|P1|Overall Study|Withdrawal by Subject|5
2862373|NCT02187861|9840928|P4|Overall Study|Other|1
2862374|NCT02187861|9840929|P3|Overall Study|Other|7
2862375|NCT02187861|9840930|P2|Overall Study|Other|1
2862376|NCT02187861|9840931|P1|Overall Study|Other|0
2862377|NCT02187861|9840928|P4|Overall Study|Withdrawal by Subject|3
2862378|NCT02187861|9840929|P3|Overall Study|Withdrawal by Subject|3
2862379|NCT02187861|9840930|P2|Overall Study|Withdrawal by Subject|0
2862380|NCT02187861|9840931|P1|Overall Study|Withdrawal by Subject|0
2862381|NCT02187861|9840928|P4|Overall Study|Progressive Disease|22
2862382|NCT02187861|9840929|P3|Overall Study|Progressive Disease|19
2862383|NCT02187861|9840930|P2|Overall Study|Progressive Disease|42
2862384|NCT02187861|9840931|P1|Overall Study|Progressive Disease|4
2862385|NCT02187861|9840928|P4|Overall Study|Physician Decision|3
2862386|NCT02187861|9840929|P3|Overall Study|Physician Decision|0
2862387|NCT02187861|9840930|P2|Overall Study|Physician Decision|1
2862388|NCT02187861|9840931|P1|Overall Study|Physician Decision|0
2862389|NCT02187861|9840928|P4|Overall Study|Death|2
2862390|NCT02187861|9840929|P3|Overall Study|Death|1
2862391|NCT02187861|9840930|P2|Overall Study|Death|3
2862392|NCT02187861|9840931|P1|Overall Study|Death|0
2862393|NCT02187861|9840928|P4|Overall Study|Adverse Event|1
2862394|NCT02187861|9840929|P3|Overall Study|Adverse Event|2
2862395|NCT02187861|9840930|P2|Overall Study|Adverse Event|1
2862396|NCT02187861|9840931|P1|Overall Study|Adverse Event|2
2862397|NCT02187809|9841027|P1|Overall Study|The study was terminated|3
2862398|NCT02187783|9841037|P1|Overall Study|Study terminated by sponsor|1
2862399|NCT02187783|9841037|P1|Overall Study|Withdrawal by Subject|9
2862400|NCT02187783|9841037|P1|Overall Study|Physician Decision|2
2862401|NCT02187783|9841037|P1|Overall Study|Protocol Violation|3
2862402|NCT02187783|9841037|P1|Overall Study|Progressive disease|80
2862403|NCT02187783|9841037|P1|Overall Study|Death|3
2862404|NCT02187783|9841037|P1|Overall Study|Adverse Event|8
2862405|NCT02187744|9841048|P2|Treatment|Participant refused continued treatment|1
2862406|NCT02187744|9841049|P1|Treatment|Participant refused continued treatment|1
2862407|NCT02187744|9841048|P2|Treatment|Other|0
2862408|NCT02187744|9841049|P1|Treatment|Other|2
2862409|NCT02187744|9841048|P2|Treatment|Lost to Follow-up|1
2862410|NCT02187744|9841049|P1|Treatment|Lost to Follow-up|0
2862411|NCT02187744|9841048|P2|Treatment|Related adverse event, not serious|2
2862412|NCT02187744|9841049|P1|Treatment|Related adverse event, not serious|0
2862413|NCT02187744|9841048|P2|Treatment|Related adverse event, serious non-fatal|1
2862414|NCT02187744|9841049|P1|Treatment|Related adverse event, serious non-fatal|0
2862415|NCT02187744|9841048|P2|Treatment|Death|0
2862416|NCT02187744|9841049|P1|Treatment|Death|1
2862417|NCT02187744|9841048|P2|Study|Related adverse event, serious non-fatal|1
2862418|NCT02187744|9841049|P1|Study|Related adverse event, serious non-fatal|0
2862419|NCT02187744|9841048|P2|Study|Death|0
2862420|NCT02187744|9841049|P1|Study|Death|1
2862421|NCT02187744|9841048|P2|Study|Related adverse event, not serious|2
2862422|NCT02187744|9841049|P1|Study|Related adverse event, not serious|0
2862423|NCT02187744|9841048|P2|Study|Lost to Follow-up|2
2862424|NCT02187744|9841049|P1|Study|Lost to Follow-up|0
2862425|NCT02187744|9841048|P2|Study|Other|1
2862426|NCT02187744|9841049|P1|Study|Other|2
2862427|NCT02187744|9841048|P2|Study|Participant refused further follow-up|0
2862428|NCT02187744|9841049|P1|Study|Participant refused further follow-up|1
2862429|NCT02187172|9841067|P2|Overall Study|Physician Decision|1
2862430|NCT02187172|9841068|P1|Overall Study|Physician Decision|1
2862431|NCT02187172|9841067|P2|Overall Study|Adverse Event|1
2862432|NCT02187172|9841068|P1|Overall Study|Adverse Event|0
2862433|NCT02187172|9841067|P2|Overall Study|Lack of Efficacy|2
2862434|NCT02187172|9841068|P1|Overall Study|Lack of Efficacy|1
2862435|NCT02187172|9841067|P2|Overall Study|Lost to Follow-up|2
2862436|NCT02187172|9841068|P1|Overall Study|Lost to Follow-up|1
2862437|NCT02187055|9841235|P3|Overall Study|Death|0
2862438|NCT02187055|9841236|P2|Overall Study|Death|0
2862439|NCT02187055|9841237|P1|Overall Study|Death|2
2862440|NCT02187055|9841235|P3|Overall Study|Adverse Event|36
2862441|NCT02187055|9841236|P2|Overall Study|Adverse Event|26
2862442|NCT02187055|9841237|P1|Overall Study|Adverse Event|21
2862443|NCT02187055|9841235|P3|Overall Study|Withdrawal by Subject|11
2862444|NCT02187055|9841236|P2|Overall Study|Withdrawal by Subject|11
2862445|NCT02187055|9841237|P1|Overall Study|Withdrawal by Subject|11
2862446|NCT02187055|9841235|P3|Overall Study|Pregnancy|0
2862447|NCT02187055|9841236|P2|Overall Study|Pregnancy|1
2862448|NCT02187055|9841237|P1|Overall Study|Pregnancy|3
2862449|NCT02187055|9841235|P3|Overall Study|Protocol Violation|4
2862450|NCT02187055|9841236|P2|Overall Study|Protocol Violation|9
2862451|NCT02187055|9841237|P1|Overall Study|Protocol Violation|9
2862452|NCT02187055|9841235|P3|Overall Study|Other|3
2862453|NCT02187055|9841236|P2|Overall Study|Other|6
2862454|NCT02187055|9841237|P1|Overall Study|Other|5
2862455|NCT02187055|9841235|P3|Overall Study|No longer willing to participate|10
2862456|NCT02187055|9841236|P2|Overall Study|No longer willing to participate|8
2862457|NCT02187055|9841237|P1|Overall Study|No longer willing to participate|6
2862458|NCT02187055|9841235|P3|Overall Study|No longer meets eligibility criteria|0
2862459|NCT02187055|9841236|P2|Overall Study|No longer meets eligibility criteria|2
2862460|NCT02187055|9841237|P1|Overall Study|No longer meets eligibility criteria|0
2862461|NCT02187055|9841235|P3|Overall Study|Lost to Follow-up|3
2862462|NCT02187055|9841236|P2|Overall Study|Lost to Follow-up|7
2862463|NCT02187055|9841237|P1|Overall Study|Lost to Follow-up|2
2862464|NCT02187055|9841235|P3|Overall Study|Lack of Efficacy|7
2862465|NCT02187055|9841236|P2|Overall Study|Lack of Efficacy|3
2862466|NCT02187055|9841237|P1|Overall Study|Lack of Efficacy|10
2862467|NCT02187042|9841337|P2|Overall Study|Progressive disease|8
2862468|NCT02187042|9841338|P1|Overall Study|Progressive disease|4
2862469|NCT02187042|9841337|P2|Overall Study|Doctor choice|0
2862470|NCT02187042|9841338|P1|Overall Study|Doctor choice|1
2862471|NCT02187042|9841337|P2|Overall Study|Participant choice|0
2862472|NCT02187042|9841338|P1|Overall Study|Participant choice|1
2862473|NCT02187042|9841337|P2|Overall Study|Toxicity|5
2862474|NCT02187042|9841338|P1|Overall Study|Toxicity|6
2862475|NCT02187042|9841337|P2|Overall Study|Death|1
2862476|NCT02187042|9841338|P1|Overall Study|Death|1
2862477|NCT02187029|9841384|P4|Overall Study|Withdrawal by Subject|0
2862478|NCT02187029|9841385|P3|Overall Study|Withdrawal by Subject|0
2862479|NCT02187029|9841386|P2|Overall Study|Withdrawal by Subject|0
2862480|NCT02187029|9841387|P1|Overall Study|Withdrawal by Subject|1
2862481|NCT02187029|9841384|P4|Overall Study|Study Terminated by Sponsor|3
2862482|NCT02187029|9841385|P3|Overall Study|Study Terminated by Sponsor|10
2862483|NCT02187029|9841386|P2|Overall Study|Study Terminated by Sponsor|0
2862484|NCT02187029|9841387|P1|Overall Study|Study Terminated by Sponsor|0
2862485|NCT02187029|9841384|P4|Overall Study|Adverse Event|0
2862486|NCT02187029|9841385|P3|Overall Study|Adverse Event|1
2862487|NCT02187029|9841386|P2|Overall Study|Adverse Event|1
2862488|NCT02187029|9841387|P1|Overall Study|Adverse Event|0
2862489|NCT02186873|9841509|P2|Overall Study|Withdrawal by Subject|2
2862490|NCT02186873|9841510|P1|Overall Study|Withdrawal by Subject|7
2862491|NCT02186873|9841509|P2|Overall Study|Lost to Follow-up|2
2862492|NCT02186873|9841510|P1|Overall Study|Lost to Follow-up|1
2862493|NCT02186873|9841509|P2|Overall Study|Lack of Efficacy|1
2862494|NCT02186873|9841510|P1|Overall Study|Lack of Efficacy|0
2862495|NCT02186873|9841509|P2|Overall Study|Adverse Event|3
2862496|NCT02186873|9841510|P1|Overall Study|Adverse Event|1
2862497|NCT02186834|9841533|P6|Treatment at RP2D|Died prior to treatment|1
2862498|NCT02186834|9841534|P5|Treatment at RP2D|Died prior to treatment|0
2862499|NCT02186834|9841535|P4|Treatment at RP2D|Died prior to treatment|0
2862500|NCT02186834|9841536|P3|Treatment at RP2D|Died prior to treatment|0
2862501|NCT02186834|9841537|P2|Treatment at RP2D|Died prior to treatment|0
2862502|NCT02186834|9841538|P1|Treatment at RP2D|Died prior to treatment|0
2862503|NCT02186834|9841533|P6|Dose Escalation|Death|0
2862504|NCT02186834|9841534|P5|Dose Escalation|Death|0
2862505|NCT02186834|9841535|P4|Dose Escalation|Death|1
2862506|NCT02186834|9841536|P3|Dose Escalation|Death|0
2862507|NCT02186834|9841537|P2|Dose Escalation|Death|0
2862508|NCT02186834|9841538|P1|Dose Escalation|Death|0
2862509|NCT02186652|9841574|P2|Overall Study|Lost to Follow-up|0
2862510|NCT02186652|9841575|P1|Overall Study|Lost to Follow-up|2
2862511|NCT02186561|9841608|P1|1- Year Post Index Procedure Visit|Missed|1
2862512|NCT02186561|9841608|P1|1- Year Post Index Procedure Visit|Death|1
2862513|NCT02186561|9841608|P1|30-Day Post Index Procedure Visit|Death|1
2862514|NCT02186561|9841608|P1|Enrollment|Investigator Withdrew Consent|1
2862515|NCT02186561|9841608|P1|Enrollment|Withdrawal by Subject|2
2862516|NCT02186561|9841608|P1|Enrollment|Insurance Denial|2
2862517|NCT02186561|9841608|P1|Enrollment|Enrollment Cap Reached|5
2862518|NCT02186561|9841608|P1|Enrollment|Did Not Meet Inclusion Criteria|46
2862519|NCT02186301|9841628|P3|Overall Study|Other|1
2862520|NCT02186301|9841629|P2|Overall Study|Other|0
2862521|NCT02186301|9841630|P1|Overall Study|Other|0
2862522|NCT02186301|9841628|P3|Overall Study|Missing|2
2862523|NCT02186301|9841629|P2|Overall Study|Missing|0
2862524|NCT02186301|9841630|P1|Overall Study|Missing|0
2862525|NCT02186301|9841628|P3|Overall Study|Protocol Deviation|0
2862526|NCT02186301|9841629|P2|Overall Study|Protocol Deviation|2
2862527|NCT02186301|9841630|P1|Overall Study|Protocol Deviation|0
2862528|NCT02186301|9841628|P3|Overall Study|Study Terminated by Sponsor|11
2862529|NCT02186301|9841629|P2|Overall Study|Study Terminated by Sponsor|0
2862530|NCT02186301|9841630|P1|Overall Study|Study Terminated by Sponsor|1
2862531|NCT02186301|9841628|P3|Overall Study|Physician Decision|1
2862532|NCT02186301|9841629|P2|Overall Study|Physician Decision|0
2862533|NCT02186301|9841630|P1|Overall Study|Physician Decision|1
2862534|NCT02186301|9841628|P3|Overall Study|Withdrawal by Subject|3
2862535|NCT02186301|9841629|P2|Overall Study|Withdrawal by Subject|1
2862536|NCT02186301|9841630|P1|Overall Study|Withdrawal by Subject|5
2862537|NCT02186301|9841628|P3|Overall Study|Death|0
2862538|NCT02186301|9841629|P2|Overall Study|Death|0
2862539|NCT02186301|9841630|P1|Overall Study|Death|1
2862540|NCT02186301|9841628|P3|Overall Study|Adverse Event|5
2862541|NCT02186301|9841629|P2|Overall Study|Adverse Event|5
2862542|NCT02186301|9841630|P1|Overall Study|Adverse Event|5
2862543|NCT02186301|9841628|P3|Overall Study|Progressive Disease|27
2862544|NCT02186301|9841629|P2|Overall Study|Progressive Disease|22
2862545|NCT02186301|9841630|P1|Overall Study|Progressive Disease|7
2862546|NCT02186223|9841646|P1|Overall Study|Device in place less than 48 hours|9
2862547|NCT02186223|9841646|P1|Overall Study|Death|3
2862548|NCT02186223|9841646|P1|Overall Study|Unable to obtain femoral access|3
2862549|NCT02186223|9841646|P1|Overall Study|Not eligible for device placement|6
2862550|NCT02186171|9841668|P2|Overall Study|Protocol-specified Criteria|2
2862551|NCT02186171|9841669|P1|Overall Study|Protocol-specified Criteria|0
2862552|NCT02186171|9841668|P2|Overall Study|Death|2
2862553|NCT02186171|9841669|P1|Overall Study|Death|1
2862554|NCT02186171|9841668|P2|Overall Study|Lost to Follow-up|2
2862555|NCT02186171|9841669|P1|Overall Study|Lost to Follow-up|2
2862556|NCT02186171|9841668|P2|Overall Study|Withdrawal by Subject|9
2862557|NCT02186171|9841669|P1|Overall Study|Withdrawal by Subject|1
2862558|NCT02185534|9841706|P6|First Washout Period|Protocol Violation|1
2862559|NCT02185534|9841707|P5|First Washout Period|Protocol Violation|0
2862560|NCT02185534|9841708|P4|First Washout Period|Protocol Violation|0
2862561|NCT02185534|9841709|P3|First Washout Period|Protocol Violation|0
2862562|NCT02185534|9841710|P2|First Washout Period|Protocol Violation|0
2862563|NCT02185534|9841711|P1|First Washout Period|Protocol Violation|0
2862564|NCT02185534|9841706|P6|First Washout Period|Withdrawal by Subject|0
2862565|NCT02185534|9841707|P5|First Washout Period|Withdrawal by Subject|1
2862566|NCT02185534|9841708|P4|First Washout Period|Withdrawal by Subject|0
2862567|NCT02185534|9841709|P3|First Washout Period|Withdrawal by Subject|0
2862568|NCT02185534|9841710|P2|First Washout Period|Withdrawal by Subject|0
2862569|NCT02185534|9841711|P1|First Washout Period|Withdrawal by Subject|1
2862570|NCT02185534|9841706|P6|First Period|Withdrawal by Subject|0
2862571|NCT02185534|9841707|P5|First Period|Withdrawal by Subject|0
2862572|NCT02185534|9841708|P4|First Period|Withdrawal by Subject|1
2862573|NCT02185534|9841709|P3|First Period|Withdrawal by Subject|0
2862574|NCT02185534|9841710|P2|First Period|Withdrawal by Subject|0
2862575|NCT02185534|9841711|P1|First Period|Withdrawal by Subject|0
2862576|NCT02185521|9841726|P1|Overall Study|Protocol Violation|1
2862577|NCT02185521|9841726|P1|Overall Study|Withdrawal by Subject|1
2862578|NCT02185040|9841819|P7|Active Treatment Extension Phase|Lost to Follow-up|2
2862579|NCT02185040|9841820|P6|Active Treatment Extension Phase|Lost to Follow-up|0
2862580|NCT02185040|9841821|P5|Active Treatment Extension Phase|Lost to Follow-up|0
2862581|NCT02185040|9841822|P4|Active Treatment Extension Phase|Lost to Follow-up|0
2862582|NCT02185040|9841823|P3|Active Treatment Extension Phase|Lost to Follow-up|0
2862583|NCT02185040|9841824|P2|Active Treatment Extension Phase|Lost to Follow-up|0
2862584|NCT02185040|9841825|P1|Active Treatment Extension Phase|Lost to Follow-up|0
2862585|NCT02185040|9841819|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
2862586|NCT02185040|9841820|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
2862587|NCT02185040|9841821|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
2862588|NCT02185040|9841822|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
2862589|NCT02185040|9841823|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
2862590|NCT02185040|9841824|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
2862591|NCT02185040|9841825|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
2862592|NCT02185040|9841819|P7|Active Treatment Extension Phase|Adverse Event|4
2862593|NCT02185040|9841820|P6|Active Treatment Extension Phase|Adverse Event|1
2862594|NCT02185040|9841821|P5|Active Treatment Extension Phase|Adverse Event|0
2862595|NCT02185040|9841822|P4|Active Treatment Extension Phase|Adverse Event|0
2862596|NCT02185040|9841823|P3|Active Treatment Extension Phase|Adverse Event|0
2862597|NCT02185040|9841824|P2|Active Treatment Extension Phase|Adverse Event|0
2862598|NCT02185040|9841825|P1|Active Treatment Extension Phase|Adverse Event|0
2862599|NCT02185040|9841819|P7|Active Treatment Extension Phase|Miscellaneous|0
2862600|NCT02185040|9841820|P6|Active Treatment Extension Phase|Miscellaneous|1
2862601|NCT02185040|9841821|P5|Active Treatment Extension Phase|Miscellaneous|0
2862602|NCT02185040|9841822|P4|Active Treatment Extension Phase|Miscellaneous|0
2862603|NCT02185040|9841823|P3|Active Treatment Extension Phase|Miscellaneous|0
2862604|NCT02185040|9841824|P2|Active Treatment Extension Phase|Miscellaneous|0
2862605|NCT02185040|9841825|P1|Active Treatment Extension Phase|Miscellaneous|0
2862606|NCT02185040|9841819|P7|Part 1 Treatment Phase|Lost to Follow-up|0
2862607|NCT02185040|9841820|P6|Part 1 Treatment Phase|Lost to Follow-up|0
2862608|NCT02185040|9841821|P5|Part 1 Treatment Phase|Lost to Follow-up|0
2862609|NCT02185040|9841822|P4|Part 1 Treatment Phase|Lost to Follow-up|0
2862610|NCT02185040|9841823|P3|Part 1 Treatment Phase|Lost to Follow-up|0
2862611|NCT02185040|9841824|P2|Part 1 Treatment Phase|Lost to Follow-up|1
2862612|NCT02185040|9841825|P1|Part 1 Treatment Phase|Lost to Follow-up|0
2862613|NCT02185040|9841819|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
2862614|NCT02185040|9841820|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
2862615|NCT02185040|9841821|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
2862616|NCT02185040|9841822|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
2862617|NCT02185040|9841823|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
2862618|NCT02185040|9841824|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
2862619|NCT02185040|9841825|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
2862620|NCT02185040|9841819|P7|Part 1 Treatment Phase|Adverse Event|0
2862621|NCT02185040|9841820|P6|Part 1 Treatment Phase|Adverse Event|0
2862622|NCT02185040|9841821|P5|Part 1 Treatment Phase|Adverse Event|3
2862623|NCT02185040|9841822|P4|Part 1 Treatment Phase|Adverse Event|2
2862624|NCT02185040|9841823|P3|Part 1 Treatment Phase|Adverse Event|0
2862625|NCT02185040|9841824|P2|Part 1 Treatment Phase|Adverse Event|0
2862626|NCT02185040|9841825|P1|Part 1 Treatment Phase|Adverse Event|1
2862627|NCT02185040|9841819|P7|Part 1 Treatment Phase|Miscellaneous|0
2862628|NCT02185040|9841820|P6|Part 1 Treatment Phase|Miscellaneous|0
2862629|NCT02185040|9841821|P5|Part 1 Treatment Phase|Miscellaneous|0
2862630|NCT02185040|9841822|P4|Part 1 Treatment Phase|Miscellaneous|0
2862631|NCT02185040|9841823|P3|Part 1 Treatment Phase|Miscellaneous|1
2862632|NCT02185040|9841824|P2|Part 1 Treatment Phase|Miscellaneous|0
2862633|NCT02185040|9841825|P1|Part 1 Treatment Phase|Miscellaneous|0
2862634|NCT02185014|9841879|P1|Overall Study|Other|4
2862635|NCT02185014|9841879|P1|Overall Study|Subject Noncompliance|1
2862636|NCT02185014|9841879|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
2862637|NCT02185014|9841879|P1|Overall Study|Lack of Efficacy|14
2862638|NCT02185014|9841879|P1|Overall Study|Lost to Follow-up|4
2862639|NCT02185014|9841879|P1|Overall Study|Withdrew Consent|8
2862640|NCT02185014|9841879|P1|Overall Study|Adverse Event|18
2862641|NCT02184988|9841883|P1|Overall Study|Lost to Follow-up|32
2862642|NCT02184988|9841883|P1|Overall Study|various other reasons|9
2862643|NCT02184988|9841883|P1|Overall Study|work scheduling issues|4
2862644|NCT02184988|9841883|P1|Overall Study|moving away/travelling/unable to complet|6
2862645|NCT02184988|9841883|P1|Overall Study|Adverse Event|2
2862646|NCT02184988|9841883|P1|Overall Study|Pregnancy|2
2862647|NCT02184611|9841941|P2|Overall Study|Protocol defined stopping criteria|1
2862648|NCT02184611|9841942|P1|Overall Study|Protocol defined stopping criteria|0
2862649|NCT02184611|9841941|P2|Overall Study|Protocol Violation|1
2862650|NCT02184611|9841942|P1|Overall Study|Protocol Violation|1
2862651|NCT02184611|9841941|P2|Overall Study|Adverse Event|5
2862652|NCT02184611|9841942|P1|Overall Study|Adverse Event|4
2862653|NCT02184611|9841941|P2|Overall Study|Withdrawal by Subject|6
2862654|NCT02184611|9841942|P1|Overall Study|Withdrawal by Subject|5
2862655|NCT02184611|9841941|P2|Overall Study|Lack of Efficacy|15
2862656|NCT02184611|9841942|P1|Overall Study|Lack of Efficacy|11
2862657|NCT02184572|9841978|P2|Overall Study|Withdrawal by Subject|9
2862658|NCT02184572|9841979|P1|Overall Study|Withdrawal by Subject|14
2862659|NCT02184572|9841978|P2|Overall Study|Traveling Outside The Country|0
2862660|NCT02184572|9841979|P1|Overall Study|Traveling Outside The Country|1
2862661|NCT02184572|9841978|P2|Overall Study|2nd blooddraw & diary card incomplete|0
2862662|NCT02184572|9841979|P1|Overall Study|2nd blooddraw & diary card incomplete|1
2862663|NCT02184572|9841978|P2|Overall Study|Loss Of Kaiser Insurance|0
2862664|NCT02184572|9841979|P1|Overall Study|Loss Of Kaiser Insurance|1
2862665|NCT02184572|9841978|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
2862666|NCT02184572|9841979|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
2862667|NCT02184572|9841978|P2|Overall Study|Lost to Follow-up|21
2862668|NCT02184572|9841979|P1|Overall Study|Lost to Follow-up|29
2862669|NCT02184455|9842040|P1|Overall Study|Lost to Follow-up|1
2862670|NCT02184442|9842051|P2|Overall Study|Withdrawal by Subject|11
2862671|NCT02184442|9842052|P1|Overall Study|Withdrawal by Subject|3
2862672|NCT02184442|9842051|P2|Overall Study|Death|65
2862673|NCT02184442|9842052|P1|Overall Study|Death|61
2862674|NCT02184195|9842072|P2|Overall Study|Other|2
2862675|NCT02184195|9842073|P1|Overall Study|Other|0
2862676|NCT02184195|9842072|P2|Overall Study|Lost to Follow-up|2
2862677|NCT02184195|9842073|P1|Overall Study|Lost to Follow-up|0
2862678|NCT02184195|9842072|P2|Overall Study|Death|29
2862679|NCT02184195|9842073|P1|Overall Study|Death|40
2862680|NCT02184195|9842072|P2|Overall Study|Eligibility criteria not fulfilled|1
2862681|NCT02184195|9842073|P1|Overall Study|Eligibility criteria not fulfilled|0
2862682|NCT02184195|9842072|P2|Overall Study|Patient decision|1
2862683|NCT02184195|9842073|P1|Overall Study|Patient decision|3
2862684|NCT02184143|9842099|P2|Overall Study|Death|0
2862685|NCT02184143|9842100|P1|Overall Study|Death|1
2862686|NCT02184143|9842099|P2|Overall Study|Lost to Follow-up|3
2862687|NCT02184143|9842100|P1|Overall Study|Lost to Follow-up|5
2862688|NCT02184143|9842099|P2|Overall Study|Withdrawal by Subject|4
2862689|NCT02184143|9842100|P1|Overall Study|Withdrawal by Subject|4
2862690|NCT02183675|9842129|P6|Treatment Period 2 (10 Days)|Adverse Event|2
2862691|NCT02183675|9842130|P5|Treatment Period 2 (10 Days)|Adverse Event|0
2862692|NCT02183675|9842131|P4|Treatment Period 2 (10 Days)|Adverse Event|0
2862693|NCT02183675|9842132|P3|Treatment Period 2 (10 Days)|Adverse Event|0
2862694|NCT02183675|9842133|P2|Treatment Period 2 (10 Days)|Adverse Event|0
2862695|NCT02183675|9842134|P1|Treatment Period 2 (10 Days)|Adverse Event|0
2862696|NCT02183519|9842158|P2|Overall Study|Did not respond to cough inducter|3
2862697|NCT02183519|9842159|P1|Overall Study|Did not respond to cough inducter|0
2862698|NCT02183519|9842158|P2|Overall Study|computer error|0
2862699|NCT02183519|9842159|P1|Overall Study|computer error|3
2862700|NCT02182999|9842167|P2|Overall Study|Physician Decision|0
2862701|NCT02182999|9842168|P1|Overall Study|Physician Decision|1
2862702|NCT02182999|9842167|P2|Overall Study|Adverse Event|3
2862703|NCT02182999|9842168|P1|Overall Study|Adverse Event|4
2862704|NCT02182973|9842184|P2|Overall Study|Withdrawal by Subject|0
2862705|NCT02182973|9842185|P1|Overall Study|Withdrawal by Subject|3
2862706|NCT02182895|9842197|P2|Overall Study|Discharged from hospital within 24 hours|4
2862707|NCT02182895|9842198|P1|Overall Study|Discharged from hospital within 24 hours|2
2862708|NCT02182843|9842218|P1|Overall Study|Adverse Event|1
2862709|NCT02182843|9842218|P1|Overall Study|Lost to Follow-up|2
2862710|NCT02182843|9842218|P1|Overall Study|Withdrawal by Subject|7
2862711|NCT02182830|9842225|P2|Overall Study|Lost to Follow-up|3
2862712|NCT02182830|9842226|P1|Overall Study|Lost to Follow-up|3
2862713|NCT02182830|9842225|P2|Overall Study|Consent withdrawn|8
2862714|NCT02182830|9842226|P1|Overall Study|Consent withdrawn|8
2862715|NCT02182830|9842225|P2|Overall Study|Trial stopped, reason missing|3
2862716|NCT02182830|9842226|P1|Overall Study|Trial stopped, reason missing|3
2862717|NCT02182830|9842225|P2|Overall Study|Not Treated|1
2862718|NCT02182830|9842226|P1|Overall Study|Not Treated|1
2862719|NCT02182440|9842267|P4|Overall Study|different, e.g adm other hospital|10
2862720|NCT02182440|9842268|P3|Overall Study|different, e.g adm other hospital|3
2862721|NCT02182440|9842269|P2|Overall Study|different, e.g adm other hospital|3
2862722|NCT02182440|9842270|P1|Overall Study|different, e.g adm other hospital|12
2862723|NCT02182440|9842267|P4|Overall Study|Withdrawal by Subject|4
2862724|NCT02182440|9842268|P3|Overall Study|Withdrawal by Subject|3
2862725|NCT02182440|9842269|P2|Overall Study|Withdrawal by Subject|1
2862726|NCT02182440|9842270|P1|Overall Study|Withdrawal by Subject|1
2862727|NCT02182440|9842267|P4|Overall Study|Physician Decision|0
2862728|NCT02182440|9842268|P3|Overall Study|Physician Decision|0
2862729|NCT02182440|9842269|P2|Overall Study|Physician Decision|0
2862730|NCT02182440|9842270|P1|Overall Study|Physician Decision|1
2862731|NCT02182440|9842267|P4|Overall Study|Protocol Violation|0
2862732|NCT02182440|9842268|P3|Overall Study|Protocol Violation|0
2862733|NCT02182440|9842269|P2|Overall Study|Protocol Violation|1
2862734|NCT02182440|9842270|P1|Overall Study|Protocol Violation|0
2862735|NCT02182440|9842267|P4|Overall Study|Death|16
2862736|NCT02182440|9842268|P3|Overall Study|Death|5
2862737|NCT02182440|9842269|P2|Overall Study|Death|8
2862738|NCT02182440|9842270|P1|Overall Study|Death|31
2862739|NCT02182440|9842267|P4|Overall Study|Adverse Event|0
2862740|NCT02182440|9842268|P3|Overall Study|Adverse Event|0
2862741|NCT02182440|9842269|P2|Overall Study|Adverse Event|1
2862742|NCT02182440|9842270|P1|Overall Study|Adverse Event|0
2862743|NCT02181842|9842309|P1|Overall Study|Case Report Forms Uncollected|2
2862744|NCT02181816|9842326|P1|Overall Study|Protocol Deviation|21
2862745|NCT02181816|9842326|P1|Overall Study|Case Report Forms Uncollected|38
2862746|NCT02181803|9842341|P9|Overall Study|Adverse Event|0
2862747|NCT02181803|9842342|P8|Overall Study|Adverse Event|0
2862748|NCT02181803|9842343|P7|Overall Study|Adverse Event|1
2862749|NCT02181803|9842344|P6|Overall Study|Adverse Event|0
2862750|NCT02181803|9842345|P5|Overall Study|Adverse Event|0
2862751|NCT02181803|9842346|P4|Overall Study|Adverse Event|1
2862752|NCT02181803|9842347|P3|Overall Study|Adverse Event|0
2862753|NCT02181803|9842348|P2|Overall Study|Adverse Event|2
2862754|NCT02181803|9842349|P1|Overall Study|Adverse Event|0
2862755|NCT02181803|9842341|P9|Overall Study|Physician Decision|0
2862756|NCT02181803|9842342|P8|Overall Study|Physician Decision|1
2862757|NCT02181803|9842343|P7|Overall Study|Physician Decision|0
2862758|NCT02181803|9842344|P6|Overall Study|Physician Decision|0
2862759|NCT02181803|9842345|P5|Overall Study|Physician Decision|0
2862760|NCT02181803|9842346|P4|Overall Study|Physician Decision|1
2862761|NCT02181803|9842347|P3|Overall Study|Physician Decision|0
2862762|NCT02181803|9842348|P2|Overall Study|Physician Decision|0
2862763|NCT02181803|9842349|P1|Overall Study|Physician Decision|0
2862764|NCT02181803|9842341|P9|Overall Study|Withdrawal by Subject|0
2862765|NCT02181803|9842342|P8|Overall Study|Withdrawal by Subject|0
2862766|NCT02181803|9842343|P7|Overall Study|Withdrawal by Subject|0
2862767|NCT02181803|9842344|P6|Overall Study|Withdrawal by Subject|0
2862768|NCT02181803|9842345|P5|Overall Study|Withdrawal by Subject|0
2862769|NCT02181803|9842346|P4|Overall Study|Withdrawal by Subject|0
2862770|NCT02181803|9842347|P3|Overall Study|Withdrawal by Subject|0
2862771|NCT02181803|9842348|P2|Overall Study|Withdrawal by Subject|2
2862772|NCT02181803|9842349|P1|Overall Study|Withdrawal by Subject|0
2862773|NCT02181790|9842500|P2|Overall Study|study terminated|0
2862774|NCT02181790|9842501|P1|Overall Study|study terminated|2
2862775|NCT02181738|9842513|P4|Overall Study|Patient Return to Home Country|0
2862776|NCT02181738|9842514|P3|Overall Study|Patient Return to Home Country|0
2862777|NCT02181738|9842515|P2|Overall Study|Patient Return to Home Country|1
2862778|NCT02181738|9842516|P1|Overall Study|Patient Return to Home Country|0
2862779|NCT02181738|9842513|P4|Overall Study|Lost to Follow-up|0
2862780|NCT02181738|9842514|P3|Overall Study|Lost to Follow-up|2
2862781|NCT02181738|9842515|P2|Overall Study|Lost to Follow-up|4
2862782|NCT02181738|9842516|P1|Overall Study|Lost to Follow-up|0
2862783|NCT02181738|9842513|P4|Overall Study|Subject Withdrew Consent|1
2862784|NCT02181738|9842514|P3|Overall Study|Subject Withdrew Consent|2
2862785|NCT02181738|9842515|P2|Overall Study|Subject Withdrew Consent|3
2862786|NCT02181738|9842516|P1|Overall Study|Subject Withdrew Consent|1
2862787|NCT02181738|9842513|P4|Overall Study|Death|1
2862788|NCT02181738|9842514|P3|Overall Study|Death|6
2862789|NCT02181738|9842515|P2|Overall Study|Death|1
2862790|NCT02181738|9842516|P1|Overall Study|Death|1
2862791|NCT02181673|9842557|P3|Week 24-Week 60|Physician Decision|1
2862792|NCT02181673|9842558|P2|Week 24-Week 60|Physician Decision|0
2862793|NCT02181673|9842559|P1|Week 24-Week 60|Physician Decision|0
2862794|NCT02181673|9842557|P3|Week 24-Week 60|Lost to Follow-up|1
2862795|NCT02181673|9842558|P2|Week 24-Week 60|Lost to Follow-up|0
2862796|NCT02181673|9842559|P1|Week 24-Week 60|Lost to Follow-up|0
2862797|NCT02181673|9842557|P3|Week 24-Week 60|Lack of Efficacy|1
2862798|NCT02181673|9842558|P2|Week 24-Week 60|Lack of Efficacy|0
2862799|NCT02181673|9842559|P1|Week 24-Week 60|Lack of Efficacy|0
2862800|NCT02181673|9842557|P3|Week 24-Week 60|Pregnancy|1
2862801|NCT02181673|9842558|P2|Week 24-Week 60|Pregnancy|0
2862802|NCT02181673|9842559|P1|Week 24-Week 60|Pregnancy|0
2862803|NCT02181673|9842557|P3|Week 24-Week 60|Withdrawal by Subject|2
2862804|NCT02181673|9842558|P2|Week 24-Week 60|Withdrawal by Subject|2
2862805|NCT02181673|9842559|P1|Week 24-Week 60|Withdrawal by Subject|0
2862806|NCT02181673|9842557|P3|Week 24-Week 60|Other|1
2862807|NCT02181673|9842558|P2|Week 24-Week 60|Other|2
2862808|NCT02181673|9842559|P1|Week 24-Week 60|Other|0
2862809|NCT02181673|9842557|P3|Week 24-Week 60|Adverse Event|10
2862810|NCT02181673|9842558|P2|Week 24-Week 60|Adverse Event|4
2862811|NCT02181673|9842559|P1|Week 24-Week 60|Adverse Event|0
2862812|NCT02181673|9842557|P3|Up to Week 24|Randomized not Treated|1
2862813|NCT02181673|9842558|P2|Up to Week 24|Randomized not Treated|0
2862814|NCT02181673|9842559|P1|Up to Week 24|Randomized not Treated|0
2862815|NCT02181673|9842557|P3|Up to Week 24|Other|3
2862816|NCT02181673|9842558|P2|Up to Week 24|Other|0
2862817|NCT02181673|9842559|P1|Up to Week 24|Other|2
2862818|NCT02181673|9842557|P3|Up to Week 24|Withdrawal by Subject|1
2862819|NCT02181673|9842558|P2|Up to Week 24|Withdrawal by Subject|0
2862820|NCT02181673|9842559|P1|Up to Week 24|Withdrawal by Subject|10
2862821|NCT02181673|9842557|P3|Up to Week 24|Physician Decision|3
2862822|NCT02181673|9842558|P2|Up to Week 24|Physician Decision|0
2862823|NCT02181673|9842559|P1|Up to Week 24|Physician Decision|0
2862824|NCT02181673|9842557|P3|Up to Week 24|Lost to Follow-up|0
2862825|NCT02181673|9842558|P2|Up to Week 24|Lost to Follow-up|0
2862826|NCT02181673|9842559|P1|Up to Week 24|Lost to Follow-up|1
2862827|NCT02181673|9842557|P3|Up to Week 24|Lack of Efficacy|0
2862828|NCT02181673|9842558|P2|Up to Week 24|Lack of Efficacy|0
2862829|NCT02181673|9842559|P1|Up to Week 24|Lack of Efficacy|1
2862830|NCT02181673|9842557|P3|Up to Week 24|Death|0
2862831|NCT02181673|9842558|P2|Up to Week 24|Death|0
2862832|NCT02181673|9842559|P1|Up to Week 24|Death|1
2862833|NCT02181673|9842557|P3|Up to Week 24|Adverse Event|3
2862834|NCT02181673|9842558|P2|Up to Week 24|Adverse Event|0
2862835|NCT02181673|9842559|P1|Up to Week 24|Adverse Event|2
2862836|NCT02181634|9842586|P1|Overall Study|Patient opted to proceed to surgery|1
2862837|NCT02181634|9842586|P1|Overall Study|Symptomatic progression|1
2862838|NCT02181634|9842586|P1|Overall Study|Max number of dose reduction|1
2862839|NCT02181634|9842586|P1|Overall Study|Ineligible|1
2862840|NCT02181634|9842586|P1|Overall Study|Treatment delayed greater than 4 weeks|3
2862841|NCT02181634|9842586|P1|Overall Study|Death|2
2862842|NCT02181634|9842586|P1|Overall Study|Withdrawal by Subject|5
2862843|NCT02181634|9842586|P1|Overall Study|Physician Decision|8
2862844|NCT02181634|9842586|P1|Overall Study|Adverse Event|17
2862845|NCT02181634|9842586|P1|Overall Study|Lack of Efficacy|33
2862846|NCT02181504|9842635|P3|Overall Study|Adverse Event|1
2862847|NCT02181504|9842636|P2|Overall Study|Adverse Event|1
2862848|NCT02181504|9842637|P1|Overall Study|Adverse Event|1
2862849|NCT02181413|9842676|P2|Overall Study|Lost to Follow-up|1
2862850|NCT02181413|9842677|P1|Overall Study|Lost to Follow-up|0
2862851|NCT02181413|9842676|P2|Overall Study|Ongoing Study Treatment|1
2862852|NCT02181413|9842677|P1|Overall Study|Ongoing Study Treatment|0
2862853|NCT02181413|9842676|P2|Overall Study|Reason Not Specified|20
2862854|NCT02181413|9842677|P1|Overall Study|Reason Not Specified|19
2862855|NCT02181413|9842676|P2|Overall Study|Withdrawal by Subject|8
2862856|NCT02181413|9842677|P1|Overall Study|Withdrawal by Subject|5
2862857|NCT02181413|9842676|P2|Overall Study|Progressive Disease|143
2862858|NCT02181413|9842677|P1|Overall Study|Progressive Disease|121
2862859|NCT02181413|9842676|P2|Overall Study|Adverse Event|24
2862860|NCT02181413|9842677|P1|Overall Study|Adverse Event|7
2862861|NCT02181296|9842722|P2|Overall Study|Lost to Follow-up|6
2862862|NCT02181296|9842723|P1|Overall Study|Lost to Follow-up|7
2862863|NCT02180724|9842865|P2|Overall Study|Ongoing Study|11
2862864|NCT02180724|9842866|P1|Overall Study|Ongoing Study|78
2862865|NCT02180724|9842865|P2|Overall Study|Withdrawal by Subject|2
2862866|NCT02180724|9842866|P1|Overall Study|Withdrawal by Subject|1
2862867|NCT02180724|9842865|P2|Overall Study|Lost to Follow-up|0
2862868|NCT02180724|9842866|P1|Overall Study|Lost to Follow-up|1
2862869|NCT02180724|9842865|P2|Overall Study|Death|1
2862870|NCT02180724|9842866|P1|Overall Study|Death|12
2862871|NCT02180659|9842880|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
2862872|NCT02180659|9842881|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
2862873|NCT02180659|9842880|P2|Overall Study|Withdrawal by Subject|2
2862874|NCT02180659|9842881|P1|Overall Study|Withdrawal by Subject|0
2862875|NCT02180659|9842880|P2|Overall Study|Subject incarcerated during conduct|0
2862876|NCT02180659|9842881|P1|Overall Study|Subject incarcerated during conduct|1
2862877|NCT02180659|9842880|P2|Overall Study|Lost to Follow-up|2
2862878|NCT02180659|9842881|P1|Overall Study|Lost to Follow-up|4
2862879|NCT02180659|9842880|P2|Overall Study|Adverse Event|0
2862880|NCT02180659|9842881|P1|Overall Study|Adverse Event|1
2862881|NCT02180438|9842916|P1|Overall Study|Lost to Follow-up|1
2862882|NCT02180165|9842940|P4|Overall Study|Withdrawal by Subject|1
2862883|NCT02180165|9842941|P3|Overall Study|Withdrawal by Subject|2
2862884|NCT02180165|9842942|P2|Overall Study|Withdrawal by Subject|0
2862885|NCT02180165|9842943|P1|Overall Study|Withdrawal by Subject|3
2862886|NCT02180165|9842940|P4|Overall Study|Physician Decision|0
2862887|NCT02180165|9842941|P3|Overall Study|Physician Decision|5
2862888|NCT02180165|9842942|P2|Overall Study|Physician Decision|0
2862889|NCT02180165|9842943|P1|Overall Study|Physician Decision|1
2862890|NCT02180165|9842940|P4|Overall Study|Lack of Efficacy|2
2862891|NCT02180165|9842941|P3|Overall Study|Lack of Efficacy|3
2862892|NCT02180165|9842942|P2|Overall Study|Lack of Efficacy|1
2862893|NCT02180165|9842943|P1|Overall Study|Lack of Efficacy|0
2862894|NCT02180165|9842940|P4|Overall Study|Adverse Event|3
2862895|NCT02180165|9842941|P3|Overall Study|Adverse Event|18
2862896|NCT02180165|9842942|P2|Overall Study|Adverse Event|0
2862897|NCT02180165|9842943|P1|Overall Study|Adverse Event|7
2862898|NCT02180165|9842940|P4|Overall Study|Not Treated|0
2862899|NCT02180165|9842941|P3|Overall Study|Not Treated|1
2862900|NCT02180165|9842942|P2|Overall Study|Not Treated|0
2862901|NCT02180165|9842943|P1|Overall Study|Not Treated|0
2862902|NCT02180061|9843031|P2|Overall Study|Physician Decision|0
2862903|NCT02180061|9843032|P1|Overall Study|Physician Decision|1
2862904|NCT02180061|9843031|P2|Overall Study|Progressive Disease|5
2862905|NCT02180061|9843032|P1|Overall Study|Progressive Disease|15
2862906|NCT02180061|9843031|P2|Overall Study|Clinical Progression|1
2862907|NCT02180061|9843032|P1|Overall Study|Clinical Progression|5
2862908|NCT02180061|9843031|P2|Overall Study|Adverse Event|2
2862909|NCT02180061|9843032|P1|Overall Study|Adverse Event|4
2862910|NCT02179918|9843051|P5|Overall Study|Subject refused further follow-up|1
2862911|NCT02179918|9843052|P4|Overall Study|Subject refused further follow-up|0
2862912|NCT02179918|9843053|P3|Overall Study|Subject refused further follow-up|0
2862913|NCT02179918|9843054|P2|Overall Study|Subject refused further follow-up|1
2862914|NCT02179918|9843055|P1|Overall Study|Subject refused further follow-up|0
2862915|NCT02179918|9843051|P5|Overall Study|Other|1
2862916|NCT02179918|9843052|P4|Overall Study|Other|0
2862917|NCT02179918|9843053|P3|Overall Study|Other|0
2862918|NCT02179918|9843054|P2|Overall Study|Other|1
2862919|NCT02179918|9843055|P1|Overall Study|Other|0
2862920|NCT02179918|9843051|P5|Overall Study|Progressive Disease|6
2862921|NCT02179918|9843052|P4|Overall Study|Progressive Disease|2
2862922|NCT02179918|9843053|P3|Overall Study|Progressive Disease|1
2862923|NCT02179918|9843054|P2|Overall Study|Progressive Disease|1
2862924|NCT02179918|9843055|P1|Overall Study|Progressive Disease|4
2862925|NCT02179918|9843051|P5|Overall Study|Lost to Follow-up|0
2862926|NCT02179918|9843052|P4|Overall Study|Lost to Follow-up|0
2862927|NCT02179918|9843053|P3|Overall Study|Lost to Follow-up|1
2862928|NCT02179918|9843054|P2|Overall Study|Lost to Follow-up|0
2862929|NCT02179918|9843055|P1|Overall Study|Lost to Follow-up|0
2862930|NCT02179918|9843051|P5|Overall Study|Death|0
2862931|NCT02179918|9843052|P4|Overall Study|Death|1
2862932|NCT02179918|9843053|P3|Overall Study|Death|0
2862933|NCT02179918|9843054|P2|Overall Study|Death|0
2862934|NCT02179918|9843055|P1|Overall Study|Death|0
2862935|NCT02179398|9843259|P2|Overall Study|Lost to Follow-up|1
2862936|NCT02179398|9843260|P1|Overall Study|Lost to Follow-up|0
2862937|NCT02179398|9843259|P2|Overall Study|Lack of obligatory data|3
2862938|NCT02179398|9843260|P1|Overall Study|Lack of obligatory data|3
2862939|NCT02179190|9843278|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
2862940|NCT02179190|9843278|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
2862941|NCT02179190|9843278|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
2862942|NCT02179190|9843278|P1|Follow-Up Post Barrel VRD Implanted|Death|3
2862943|NCT02179190|9843278|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
2862944|NCT02179190|9843278|P1|Enrollment|Exit Prior to Device Attempt|11
2862945|NCT02179177|9843291|P2|Overall Study|Withdrawal by Subject|1
2862946|NCT02179177|9843292|P1|Overall Study|Withdrawal by Subject|1
2862947|NCT02179177|9843291|P2|Overall Study|Lost to Follow-up|1
2862948|NCT02179177|9843292|P1|Overall Study|Lost to Follow-up|1
2862949|NCT02178995|9843332|P9|Open Label|Adverse Event|0
2862950|NCT02178995|9843333|P8|Open Label|Adverse Event|0
2862951|NCT02178995|9843334|P7|Open Label|Adverse Event|0
2862952|NCT02178995|9843335|P6|Open Label|Adverse Event|0
2862953|NCT02178995|9843336|P5|Open Label|Adverse Event|0
2862954|NCT02178995|9843337|P4|Open Label|Adverse Event|0
2862955|NCT02178995|9843338|P3|Open Label|Adverse Event|0
2862956|NCT02178995|9843339|P2|Open Label|Adverse Event|0
2862957|NCT02178995|9843340|P1|Open Label|Adverse Event|2
2862958|NCT02178995|9843332|P9|Double Blind|Lost to Follow-up|0
2862959|NCT02178995|9843333|P8|Double Blind|Lost to Follow-up|1
2862960|NCT02178995|9843334|P7|Double Blind|Lost to Follow-up|0
2862961|NCT02178995|9843335|P6|Double Blind|Lost to Follow-up|0
2862962|NCT02178995|9843336|P5|Double Blind|Lost to Follow-up|0
2862963|NCT02178995|9843337|P4|Double Blind|Lost to Follow-up|0
2862964|NCT02178995|9843338|P3|Double Blind|Lost to Follow-up|0
2862965|NCT02178995|9843339|P2|Double Blind|Lost to Follow-up|1
2862966|NCT02178995|9843340|P1|Double Blind|Lost to Follow-up|0
2862967|NCT02178995|9843332|P9|Double Blind|Adverse Event|1
2862968|NCT02178995|9843333|P8|Double Blind|Adverse Event|1
2862969|NCT02178995|9843334|P7|Double Blind|Adverse Event|0
2862970|NCT02178995|9843335|P6|Double Blind|Adverse Event|1
2862971|NCT02178995|9843336|P5|Double Blind|Adverse Event|0
2862972|NCT02178995|9843337|P4|Double Blind|Adverse Event|0
2862973|NCT02178995|9843338|P3|Double Blind|Adverse Event|0
2862974|NCT02178995|9843339|P2|Double Blind|Adverse Event|0
2862975|NCT02178995|9843340|P1|Double Blind|Adverse Event|0
2862976|NCT02178787|9843448|P2|Overall Study|Physician Decision|0
2862977|NCT02178787|9843449|P1|Overall Study|Physician Decision|1
2862978|NCT02178787|9843448|P2|Overall Study|No TCD window|7
2862979|NCT02178787|9843449|P1|Overall Study|No TCD window|3
2862980|NCT02178787|9843448|P2|Overall Study|Withdrawal by Subject|2
2862981|NCT02178787|9843449|P1|Overall Study|Withdrawal by Subject|0
2862982|NCT02178787|9843448|P2|Overall Study|Lost to Follow-up|0
2862983|NCT02178787|9843449|P1|Overall Study|Lost to Follow-up|1
2862984|NCT02178722|9843462|P5|Overall Study|Participants Ongoing in study|74
2862985|NCT02178722|9843463|P4|Overall Study|Participants Ongoing in study|2
2862986|NCT02178722|9843464|P3|Overall Study|Participants Ongoing in study|4
2862987|NCT02178722|9843465|P2|Overall Study|Participants Ongoing in study|1
2862988|NCT02178722|9843466|P1|Overall Study|Participants Ongoing in study|1
2862989|NCT02178722|9843462|P5|Overall Study|Other Unspecified|1
2862990|NCT02178722|9843463|P4|Overall Study|Other Unspecified|0
2862991|NCT02178722|9843464|P3|Overall Study|Other Unspecified|0
2862992|NCT02178722|9843465|P2|Overall Study|Other Unspecified|0
2862993|NCT02178722|9843466|P1|Overall Study|Other Unspecified|0
2862994|NCT02178722|9843462|P5|Overall Study|Physician Decision|2
2862995|NCT02178722|9843463|P4|Overall Study|Physician Decision|0
2862996|NCT02178722|9843464|P3|Overall Study|Physician Decision|0
2862997|NCT02178722|9843465|P2|Overall Study|Physician Decision|0
2862998|NCT02178722|9843466|P1|Overall Study|Physician Decision|0
2862999|NCT02178722|9843462|P5|Overall Study|Study Terminated by Sponsor|65
2863000|NCT02178722|9843463|P4|Overall Study|Study Terminated by Sponsor|3
2863001|NCT02178722|9843464|P3|Overall Study|Study Terminated by Sponsor|2
2863002|NCT02178722|9843465|P2|Overall Study|Study Terminated by Sponsor|6
2863003|NCT02178722|9843466|P1|Overall Study|Study Terminated by Sponsor|1
2863004|NCT02178722|9843462|P5|Overall Study|Lost to Follow-up|11
2863005|NCT02178722|9843463|P4|Overall Study|Lost to Follow-up|2
2863006|NCT02178722|9843464|P3|Overall Study|Lost to Follow-up|0
2863007|NCT02178722|9843465|P2|Overall Study|Lost to Follow-up|0
2863008|NCT02178722|9843466|P1|Overall Study|Lost to Follow-up|0
2863009|NCT02178722|9843462|P5|Overall Study|Death|199
2863010|NCT02178722|9843463|P4|Overall Study|Death|11
2863011|NCT02178722|9843464|P3|Overall Study|Death|12
2863012|NCT02178722|9843465|P2|Overall Study|Death|13
2863013|NCT02178722|9843466|P1|Overall Study|Death|2
2863014|NCT02178722|9843462|P5|Overall Study|Participant decision|30
2863015|NCT02178722|9843463|P4|Overall Study|Participant decision|2
2863016|NCT02178722|9843464|P3|Overall Study|Participant decision|0
2863017|NCT02178722|9843465|P2|Overall Study|Participant decision|0
2863018|NCT02178722|9843466|P1|Overall Study|Participant decision|0
2863019|NCT02178709|9843478|P1|Overall Study|Disease Progression|5
2863020|NCT02178709|9843478|P1|Overall Study|Physician Decision|2
2863021|NCT02178709|9843478|P1|Overall Study|Withdrawal by Subject|2
2863022|NCT02178709|9843478|P1|Overall Study|Death|2
2863023|NCT02178709|9843478|P1|Overall Study|Adverse Event|5
2863024|NCT02178592|9843505|P2|Overall Study|Physician Decision|0
2863025|NCT02178592|9843506|P1|Overall Study|Physician Decision|1
2863026|NCT02178592|9843505|P2|Overall Study|Lost to Follow-up|3
2863027|NCT02178592|9843506|P1|Overall Study|Lost to Follow-up|11
2863028|NCT02178592|9843505|P2|Overall Study|Withdrawal by Subject|1
2863029|NCT02178592|9843506|P1|Overall Study|Withdrawal by Subject|3
2863030|NCT02178592|9843505|P2|Overall Study|Protocol Violation|2
2863031|NCT02178592|9843506|P1|Overall Study|Protocol Violation|3
2863032|NCT02178592|9843505|P2|Overall Study|Lack of Efficacy|1
2863033|NCT02178592|9843506|P1|Overall Study|Lack of Efficacy|1
2863034|NCT02178592|9843505|P2|Overall Study|Adverse Event|2
2863035|NCT02178592|9843506|P1|Overall Study|Adverse Event|0
2863036|NCT02178553|9843534|P2|Overall Study|Technical problem with injection|3
2863037|NCT02178553|9843535|P1|Overall Study|Technical problem with injection|1
2863038|NCT02178553|9843534|P2|Overall Study|Physician Decision|4
2863039|NCT02178553|9843535|P1|Overall Study|Physician Decision|0
2863040|NCT02178553|9843534|P2|Overall Study|Did not proceed to open thoracotomy|3
2863041|NCT02178553|9843535|P1|Overall Study|Did not proceed to open thoracotomy|7
2863042|NCT02178475|9843554|P1|Overall Study|Protocol-specified Criteria|99
2863043|NCT02178475|9843554|P1|Overall Study|Death|13
2863044|NCT02178475|9843554|P1|Overall Study|Lost to Follow-up|10
2863045|NCT02178475|9843554|P1|Overall Study|Withdrawal by Subject|7
2863046|NCT02178059|9843581|P2|Washout|Physician Decision|0
2863047|NCT02178059|9843582|P1|Washout|Physician Decision|1
2863048|NCT02177942|9843600|P2|Overall Study|Withdrawal by Subject|81
2863049|NCT02177942|9843601|P1|Overall Study|Withdrawal by Subject|71
2863050|NCT02177942|9843600|P2|Overall Study|Protocol Violation|6
2863051|NCT02177942|9843601|P1|Overall Study|Protocol Violation|4
2863052|NCT02177942|9843600|P2|Overall Study|Lost to Follow-up|1
2863053|NCT02177942|9843601|P1|Overall Study|Lost to Follow-up|1
2863054|NCT02177942|9843600|P2|Overall Study|Adverse Event|0
2863055|NCT02177942|9843601|P1|Overall Study|Adverse Event|1
2863056|NCT02177812|9843632|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
2863057|NCT02177812|9843633|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
2863058|NCT02177812|9843634|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
2863059|NCT02177812|9843635|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
2863060|NCT02177812|9843636|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
2863061|NCT02177812|9843637|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
2863062|NCT02177812|9843638|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
2863063|NCT02177812|9843639|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
2863064|NCT02177812|9843640|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
2863065|NCT02177812|9843632|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863066|NCT02177812|9843633|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863067|NCT02177812|9843634|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
2863068|NCT02177812|9843635|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
2863069|NCT02177812|9843636|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863070|NCT02177812|9843637|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863071|NCT02177812|9843638|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863072|NCT02177812|9843639|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863073|NCT02177812|9843640|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
2863074|NCT02177812|9843632|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863075|NCT02177812|9843633|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2863076|NCT02177812|9843634|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
2863077|NCT02177812|9843635|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2863078|NCT02177812|9843636|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863079|NCT02177812|9843637|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863080|NCT02177812|9843638|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863081|NCT02177812|9843639|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863082|NCT02177812|9843640|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2863083|NCT02177786|9843857|P4|Overall Study|Missing study completion status|0
2863084|NCT02177786|9843858|P3|Overall Study|Missing study completion status|0
2863085|NCT02177786|9843859|P2|Overall Study|Missing study completion status|1
2863086|NCT02177786|9843860|P1|Overall Study|Missing study completion status|0
2863087|NCT02177786|9843857|P4|Overall Study|Progressive Disease|0
2863088|NCT02177786|9843858|P3|Overall Study|Progressive Disease|0
2863089|NCT02177786|9843859|P2|Overall Study|Progressive Disease|1
2863090|NCT02177786|9843860|P1|Overall Study|Progressive Disease|0
2863091|NCT02177786|9843857|P4|Overall Study|Protocol Violation|0
2863092|NCT02177786|9843858|P3|Overall Study|Protocol Violation|2
2863093|NCT02177786|9843859|P2|Overall Study|Protocol Violation|0
2863094|NCT02177786|9843860|P1|Overall Study|Protocol Violation|0
2863095|NCT02177786|9843857|P4|Overall Study|Non-Compliance with Study Drug|1
2863096|NCT02177786|9843858|P3|Overall Study|Non-Compliance with Study Drug|0
2863097|NCT02177786|9843859|P2|Overall Study|Non-Compliance with Study Drug|1
2863098|NCT02177786|9843860|P1|Overall Study|Non-Compliance with Study Drug|0
2863099|NCT02177786|9843857|P4|Overall Study|Lost to Follow-up|2
2863100|NCT02177786|9843858|P3|Overall Study|Lost to Follow-up|2
2863101|NCT02177786|9843859|P2|Overall Study|Lost to Follow-up|0
2863102|NCT02177786|9843860|P1|Overall Study|Lost to Follow-up|0
2863103|NCT02177786|9843857|P4|Overall Study|Death|1
2863104|NCT02177786|9843858|P3|Overall Study|Death|1
2863105|NCT02177786|9843859|P2|Overall Study|Death|1
2863106|NCT02177786|9843860|P1|Overall Study|Death|1
2863107|NCT02177786|9843857|P4|Overall Study|Adverse Event|3
2863108|NCT02177786|9843858|P3|Overall Study|Adverse Event|2
2863109|NCT02177786|9843859|P2|Overall Study|Adverse Event|1
2863110|NCT02177786|9843860|P1|Overall Study|Adverse Event|1
2863111|NCT02177786|9843857|P4|Overall Study|Progression to End Stage Renal Disease|1
2863112|NCT02177786|9843858|P3|Overall Study|Progression to End Stage Renal Disease|2
2863113|NCT02177786|9843859|P2|Overall Study|Progression to End Stage Renal Disease|3
2863114|NCT02177786|9843860|P1|Overall Study|Progression to End Stage Renal Disease|2
2863115|NCT02177786|9843857|P4|Overall Study|Withdrew Consent|5
2863116|NCT02177786|9843858|P3|Overall Study|Withdrew Consent|9
2863117|NCT02177786|9843859|P2|Overall Study|Withdrew Consent|6
2863118|NCT02177786|9843860|P1|Overall Study|Withdrew Consent|2
2863119|NCT02177266|9843883|P2|Overall Study|Withdrawal by Subject|0
2863120|NCT02177266|9843884|P1|Overall Study|Withdrawal by Subject|1
2863121|NCT02177266|9843883|P2|Overall Study|Adverse Event|1
2863122|NCT02177266|9843884|P1|Overall Study|Adverse Event|0
2863123|NCT02177136|9843906|P3|Overall Study|Protocol Violation|1
2863124|NCT02177136|9843907|P2|Overall Study|Protocol Violation|0
2863125|NCT02177136|9843908|P1|Overall Study|Protocol Violation|0
2863126|NCT02177136|9843906|P3|Overall Study|Adverse Event|3
2863127|NCT02177136|9843907|P2|Overall Study|Adverse Event|2
2863128|NCT02177136|9843908|P1|Overall Study|Adverse Event|3
2863129|NCT02177136|9843906|P3|Overall Study|Discontinued due to pruritus|0
2863130|NCT02177136|9843907|P2|Overall Study|Discontinued due to pruritus|3
2863131|NCT02177136|9843908|P1|Overall Study|Discontinued due to pruritus|1
2863132|NCT02177136|9843906|P3|Overall Study|Withdrawal by Subject|0
2863133|NCT02177136|9843907|P2|Overall Study|Withdrawal by Subject|0
2863134|NCT02177136|9843908|P1|Overall Study|Withdrawal by Subject|2
2863135|NCT02177032|9843941|P4|Overall Study|Withdrawal by Subject|0
2863136|NCT02177032|9843942|P3|Overall Study|Withdrawal by Subject|1
2863137|NCT02177032|9843943|P2|Overall Study|Withdrawal by Subject|0
2863138|NCT02177032|9843944|P1|Overall Study|Withdrawal by Subject|1
2863139|NCT02177032|9843941|P4|Overall Study|OTHER|0
2863140|NCT02177032|9843942|P3|Overall Study|OTHER|1
2863141|NCT02177032|9843943|P2|Overall Study|OTHER|0
2863142|NCT02177032|9843944|P1|Overall Study|OTHER|2
2863143|NCT02177032|9843941|P4|Overall Study|Lost to Follow-up|0
2863144|NCT02177032|9843942|P3|Overall Study|Lost to Follow-up|0
2863145|NCT02177032|9843943|P2|Overall Study|Lost to Follow-up|2
2863146|NCT02177032|9843944|P1|Overall Study|Lost to Follow-up|0
2863147|NCT02177032|9843941|P4|Overall Study|ADMINISTRATIVE REASON|0
2863148|NCT02177032|9843942|P3|Overall Study|ADMINISTRATIVE REASON|1
2863149|NCT02177032|9843943|P2|Overall Study|ADMINISTRATIVE REASON|0
2863150|NCT02177032|9843944|P1|Overall Study|ADMINISTRATIVE REASON|2
2863151|NCT02176655|9843982|P1|Overall Study|Subjects did not treat|6
2863152|NCT02176642|9844005|P2|Overall Study|Withdrawal by Subject|1
2863153|NCT02176642|9844006|P1|Overall Study|Withdrawal by Subject|0
2863154|NCT02176525|9844036|P8|Overall Study|not treated|0
2863155|NCT02176525|9844037|P7|Overall Study|not treated|0
2863156|NCT02176525|9844038|P6|Overall Study|not treated|1
2863157|NCT02176525|9844039|P5|Overall Study|not treated|0
2863158|NCT02176525|9844040|P4|Overall Study|not treated|0
2863159|NCT02176525|9844041|P3|Overall Study|not treated|0
2863160|NCT02176525|9844042|P2|Overall Study|not treated|0
2863161|NCT02176525|9844043|P1|Overall Study|not treated|1
2863162|NCT02176525|9844036|P8|Overall Study|Adverse Event|0
2863163|NCT02176525|9844037|P7|Overall Study|Adverse Event|1
2863164|NCT02176525|9844038|P6|Overall Study|Adverse Event|0
2863165|NCT02176525|9844039|P5|Overall Study|Adverse Event|1
2863166|NCT02176525|9844040|P4|Overall Study|Adverse Event|1
2863167|NCT02176525|9844041|P3|Overall Study|Adverse Event|0
2863168|NCT02176525|9844042|P2|Overall Study|Adverse Event|0
2863169|NCT02176525|9844043|P1|Overall Study|Adverse Event|0
2863170|NCT02176421|9844259|P1|Overall Study|Adverse Event|1
2863171|NCT02176421|9844259|P1|Overall Study|Lost to Follow-up|4
2863172|NCT02176356|9844291|P1|Overall Study|Other Miscellaneous Reasons|2
2863173|NCT02176356|9844291|P1|Overall Study|Personal Reasons|3
2863174|NCT02176356|9844291|P1|Overall Study|Lost to Follow-up|4
2863175|NCT02176356|9844291|P1|Overall Study|Screen Failure|14
2863176|NCT02176291|9844321|P2|Overall Study|Withdrawal by Subject|0
2863177|NCT02176291|9844322|P1|Overall Study|Withdrawal by Subject|2
2863178|NCT02176291|9844321|P2|Overall Study|non compliance with protocol|0
2863179|NCT02176291|9844322|P1|Overall Study|non compliance with protocol|2
2863180|NCT02176291|9844321|P2|Overall Study|Death|0
2863181|NCT02176291|9844322|P1|Overall Study|Death|1
2863182|NCT02176226|9844330|P1|Overall Study|Withdrew prior to treatment|6
2863183|NCT02176226|9844330|P1|Overall Study|Lost to Follow-up|3
2863184|NCT02176018|9844356|P2|Overall Study|Withdrawal by Subject|2
2863185|NCT02176018|9844357|P1|Overall Study|Withdrawal by Subject|1
2863186|NCT02176018|9844356|P2|Overall Study|Protocol Violation|1
2863187|NCT02176018|9844357|P1|Overall Study|Protocol Violation|1
2863188|NCT02176018|9844356|P2|Overall Study|Lost to Follow-up|1
2863189|NCT02176018|9844357|P1|Overall Study|Lost to Follow-up|3
2863190|NCT02176018|9844356|P2|Overall Study|Adverse Event|2
2863191|NCT02176018|9844357|P1|Overall Study|Adverse Event|0
2863192|NCT02175966|9844441|P2|Follow-up Period|Lack of Efficacy|6
2863193|NCT02175966|9844442|P1|Follow-up Period|Lack of Efficacy|10
2863194|NCT02175771|9844470|P9|Treatment Period|Other|0
2863195|NCT02175771|9844471|P8|Treatment Period|Other|2
2863196|NCT02175771|9844472|P7|Treatment Period|Other|0
2863197|NCT02175771|9844473|P6|Treatment Period|Other|0
2863198|NCT02175771|9844474|P5|Treatment Period|Other|1
2863199|NCT02175771|9844475|P4|Treatment Period|Other|3
2863200|NCT02175771|9844476|P3|Treatment Period|Other|0
2863201|NCT02175771|9844477|P2|Treatment Period|Other|1
2863202|NCT02175771|9844478|P1|Treatment Period|Other|0
2863203|NCT02175771|9844470|P9|Treatment Period|Lack of Efficacy|0
2863204|NCT02175771|9844471|P8|Treatment Period|Lack of Efficacy|1
2863205|NCT02175771|9844472|P7|Treatment Period|Lack of Efficacy|0
2863206|NCT02175771|9844473|P6|Treatment Period|Lack of Efficacy|1
2863207|NCT02175771|9844474|P5|Treatment Period|Lack of Efficacy|0
2863208|NCT02175771|9844475|P4|Treatment Period|Lack of Efficacy|0
2863209|NCT02175771|9844476|P3|Treatment Period|Lack of Efficacy|0
2863210|NCT02175771|9844477|P2|Treatment Period|Lack of Efficacy|0
2863211|NCT02175771|9844478|P1|Treatment Period|Lack of Efficacy|0
2863212|NCT02175771|9844470|P9|Treatment Period|Lost to Follow-up|2
2863213|NCT02175771|9844471|P8|Treatment Period|Lost to Follow-up|2
2863214|NCT02175771|9844472|P7|Treatment Period|Lost to Follow-up|1
2863215|NCT02175771|9844473|P6|Treatment Period|Lost to Follow-up|2
2863216|NCT02175771|9844474|P5|Treatment Period|Lost to Follow-up|1
2863217|NCT02175771|9844475|P4|Treatment Period|Lost to Follow-up|3
2863218|NCT02175771|9844476|P3|Treatment Period|Lost to Follow-up|1
2863219|NCT02175771|9844477|P2|Treatment Period|Lost to Follow-up|3
2863220|NCT02175771|9844478|P1|Treatment Period|Lost to Follow-up|0
2863221|NCT02175771|9844470|P9|Treatment Period|Disease progression|0
2863222|NCT02175771|9844471|P8|Treatment Period|Disease progression|2
2863223|NCT02175771|9844472|P7|Treatment Period|Disease progression|0
2863224|NCT02175771|9844473|P6|Treatment Period|Disease progression|0
2863225|NCT02175771|9844474|P5|Treatment Period|Disease progression|0
2863226|NCT02175771|9844475|P4|Treatment Period|Disease progression|0
2863227|NCT02175771|9844476|P3|Treatment Period|Disease progression|0
2863228|NCT02175771|9844477|P2|Treatment Period|Disease progression|0
2863229|NCT02175771|9844478|P1|Treatment Period|Disease progression|0
2863230|NCT02175771|9844470|P9|Treatment Period|Protocol Violation|0
2863231|NCT02175771|9844471|P8|Treatment Period|Protocol Violation|1
2863232|NCT02175771|9844472|P7|Treatment Period|Protocol Violation|0
2863233|NCT02175771|9844473|P6|Treatment Period|Protocol Violation|0
2863234|NCT02175771|9844474|P5|Treatment Period|Protocol Violation|0
2863235|NCT02175771|9844475|P4|Treatment Period|Protocol Violation|0
2863236|NCT02175771|9844476|P3|Treatment Period|Protocol Violation|0
2863237|NCT02175771|9844477|P2|Treatment Period|Protocol Violation|0
2863238|NCT02175771|9844478|P1|Treatment Period|Protocol Violation|0
2863239|NCT02175771|9844470|P9|Treatment Period|Noncompliance|1
2863240|NCT02175771|9844471|P8|Treatment Period|Noncompliance|0
2863241|NCT02175771|9844472|P7|Treatment Period|Noncompliance|0
2863242|NCT02175771|9844473|P6|Treatment Period|Noncompliance|0
2863243|NCT02175771|9844474|P5|Treatment Period|Noncompliance|0
2863244|NCT02175771|9844475|P4|Treatment Period|Noncompliance|0
2863245|NCT02175771|9844476|P3|Treatment Period|Noncompliance|2
2863246|NCT02175771|9844477|P2|Treatment Period|Noncompliance|1
2863247|NCT02175771|9844478|P1|Treatment Period|Noncompliance|0
2863248|NCT02175771|9844470|P9|Treatment Period|Withdrawal by Subject|2
2863249|NCT02175771|9844471|P8|Treatment Period|Withdrawal by Subject|9
2863250|NCT02175771|9844472|P7|Treatment Period|Withdrawal by Subject|2
2863251|NCT02175771|9844473|P6|Treatment Period|Withdrawal by Subject|4
2863252|NCT02175771|9844474|P5|Treatment Period|Withdrawal by Subject|2
2863253|NCT02175771|9844475|P4|Treatment Period|Withdrawal by Subject|6
2863254|NCT02175771|9844476|P3|Treatment Period|Withdrawal by Subject|3
2863255|NCT02175771|9844477|P2|Treatment Period|Withdrawal by Subject|9
2863256|NCT02175771|9844478|P1|Treatment Period|Withdrawal by Subject|0
2863257|NCT02175771|9844470|P9|Treatment Period|Adverse Event|1
2863258|NCT02175771|9844471|P8|Treatment Period|Adverse Event|0
2863259|NCT02175771|9844472|P7|Treatment Period|Adverse Event|2
2863260|NCT02175771|9844473|P6|Treatment Period|Adverse Event|3
2863261|NCT02175771|9844474|P5|Treatment Period|Adverse Event|1
2863262|NCT02175771|9844475|P4|Treatment Period|Adverse Event|1
2863263|NCT02175771|9844476|P3|Treatment Period|Adverse Event|1
2863264|NCT02175771|9844477|P2|Treatment Period|Adverse Event|2
2863265|NCT02175771|9844478|P1|Treatment Period|Adverse Event|0
2863266|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Other|0
2863267|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Other|0
2863268|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Other|0
2863269|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Other|0
2863270|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Other|0
2863271|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Other|0
2863272|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Other|0
2863273|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Other|0
2863274|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Other|8
2863275|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863276|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863277|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863278|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863279|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863280|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863281|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863282|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2863283|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2863284|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863285|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863286|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863287|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863288|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863289|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863290|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863291|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2863292|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
2863293|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Adverse Event|0
2863294|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Adverse Event|0
2863295|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Adverse Event|0
2863296|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2863297|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2863298|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2863299|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2863300|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2863301|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Adverse Event|9
2863302|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863303|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863304|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863305|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863306|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863307|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863308|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863309|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2863310|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
2863311|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863312|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863313|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863314|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863315|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863316|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863317|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863318|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2863319|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
2863320|NCT02175771|9844470|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863321|NCT02175771|9844471|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863322|NCT02175771|9844472|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863323|NCT02175771|9844473|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863324|NCT02175771|9844474|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863325|NCT02175771|9844475|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863326|NCT02175771|9844476|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863327|NCT02175771|9844477|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2863328|NCT02175771|9844478|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
2863329|NCT02175758|9844542|P6|Treatment Phase|Adverse Event|0
2863330|NCT02175758|9844543|P5|Treatment Phase|Adverse Event|1
2863331|NCT02175758|9844544|P4|Treatment Phase|Adverse Event|0
2863332|NCT02175758|9844545|P3|Treatment Phase|Adverse Event|0
2863333|NCT02175758|9844546|P2|Treatment Phase|Adverse Event|0
2863334|NCT02175758|9844547|P1|Treatment Phase|Adverse Event|0
2863335|NCT02175758|9844542|P6|Treatment Phase|Lost to Follow-up|0
2863336|NCT02175758|9844543|P5|Treatment Phase|Lost to Follow-up|0
2863337|NCT02175758|9844544|P4|Treatment Phase|Lost to Follow-up|0
2863338|NCT02175758|9844545|P3|Treatment Phase|Lost to Follow-up|0
2863339|NCT02175758|9844546|P2|Treatment Phase|Lost to Follow-up|1
2863340|NCT02175758|9844547|P1|Treatment Phase|Lost to Follow-up|0
2863341|NCT02175745|9844650|P1|Overall Study|Not Eligible|1
2863342|NCT02175368|9844689|P1|Overall Study|Lost to Follow-up|1
2863343|NCT02175277|9844694|P1|Overall Study|Protocol-specified Criteria|1
2863344|NCT02175225|9844700|P2|Overall Study|Study drug not administered|2
2863345|NCT02175225|9844701|P1|Overall Study|Study drug not administered|1
2863346|NCT02175225|9844700|P2|Overall Study|Lost to Follow-up|7
2863347|NCT02175225|9844701|P1|Overall Study|Lost to Follow-up|6
2863348|NCT02175225|9844700|P2|Overall Study|Withdrawal by Subject|2
2863349|NCT02175225|9844701|P1|Overall Study|Withdrawal by Subject|1
2863350|NCT02175199|9844752|P2|Overall Study|Sponsor Decision|0
2863351|NCT02175199|9844753|P1|Overall Study|Sponsor Decision|1
2863352|NCT02175199|9844752|P2|Overall Study|Randomized in Error|0
2863353|NCT02175199|9844753|P1|Overall Study|Randomized in Error|1
2863354|NCT02175199|9844752|P2|Overall Study|Withdrawal by Subject|5
2863355|NCT02175199|9844753|P1|Overall Study|Withdrawal by Subject|1
2863356|NCT02175121|9844767|P5|Overall Study|Time issues|0
2863357|NCT02175121|9844768|P4|Overall Study|Time issues|0
2863358|NCT02175121|9844769|P3|Overall Study|Time issues|1
2863359|NCT02175121|9844770|P2|Overall Study|Time issues|0
2863360|NCT02175121|9844771|P1|Overall Study|Time issues|0
2863361|NCT02175121|9844767|P5|Overall Study|Schedule conflict|0
2863362|NCT02175121|9844768|P4|Overall Study|Schedule conflict|0
2863363|NCT02175121|9844769|P3|Overall Study|Schedule conflict|1
2863364|NCT02175121|9844770|P2|Overall Study|Schedule conflict|0
2863365|NCT02175121|9844771|P1|Overall Study|Schedule conflict|0
2863366|NCT02175121|9844767|P5|Overall Study|Personal emergency|1
2863367|NCT02175121|9844768|P4|Overall Study|Personal emergency|0
2863368|NCT02175121|9844769|P3|Overall Study|Personal emergency|0
2863369|NCT02175121|9844770|P2|Overall Study|Personal emergency|0
2863370|NCT02175121|9844771|P1|Overall Study|Personal emergency|0
2863371|NCT02175121|9844767|P5|Overall Study|Lost to Follow-up|0
2863372|NCT02175121|9844768|P4|Overall Study|Lost to Follow-up|1
2863373|NCT02175121|9844769|P3|Overall Study|Lost to Follow-up|0
2863374|NCT02175121|9844770|P2|Overall Study|Lost to Follow-up|1
2863375|NCT02175121|9844771|P1|Overall Study|Lost to Follow-up|0
2863376|NCT02175121|9844767|P5|Overall Study|Lack of Efficacy|0
2863377|NCT02175121|9844768|P4|Overall Study|Lack of Efficacy|0
2863378|NCT02175121|9844769|P3|Overall Study|Lack of Efficacy|0
2863379|NCT02175121|9844770|P2|Overall Study|Lack of Efficacy|0
2863380|NCT02175121|9844771|P1|Overall Study|Lack of Efficacy|1
2863381|NCT02174861|9844898|P1|Overall Study|Lost to Follow-up|26
2863382|NCT02174861|9844898|P1|Overall Study|Withdrawal by Subject|124
2863383|NCT02174861|9844898|P1|Overall Study|Decision by sponsor|8
2863384|NCT02174848|9844912|P2|Overall Study|Unable to comply with study requirements|0
2863385|NCT02174848|9844913|P1|Overall Study|Unable to comply with study requirements|1
2863386|NCT02174848|9844912|P2|Overall Study|Worsening of disease|1
2863387|NCT02174848|9844913|P1|Overall Study|Worsening of disease|1
2863388|NCT02174848|9844912|P2|Overall Study|Lost to Follow-up|1
2863389|NCT02174848|9844913|P1|Overall Study|Lost to Follow-up|0
2863390|NCT02174848|9844912|P2|Overall Study|Withdrawal by Subject|3
2863391|NCT02174848|9844913|P1|Overall Study|Withdrawal by Subject|3
2863392|NCT02174848|9844912|P2|Overall Study|Adverse Event|1
2863393|NCT02174848|9844913|P1|Overall Study|Adverse Event|2
2863394|NCT02174731|9844934|P2|Overall Study|Missing|0
2863395|NCT02174731|9844935|P1|Overall Study|Missing|2
2863396|NCT02174731|9844934|P2|Overall Study|Incorrect enrolment before randomization|1
2863397|NCT02174731|9844935|P1|Overall Study|Incorrect enrolment before randomization|0
2863398|NCT02174731|9844934|P2|Overall Study|Participant decision|64
2863399|NCT02174731|9844935|P1|Overall Study|Participant decision|67
2863400|NCT02174627|9844957|P2|Overall Study|Participant decision|128
2863401|NCT02174627|9844958|P1|Overall Study|Participant decision|84
2863402|NCT02174627|9844957|P2|Overall Study|Incorrect enrolment before randomization|1
2863403|NCT02174627|9844958|P1|Overall Study|Incorrect enrolment before randomization|0
2863404|NCT02174627|9844957|P2|Overall Study|Missing|1
2863405|NCT02174627|9844958|P1|Overall Study|Missing|0
2863406|NCT02174523|9844986|P2|Overall Study|Withdrawal by Subject|0
2863407|NCT02174523|9844987|P1|Overall Study|Withdrawal by Subject|1
2863408|NCT02174276|9845055|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
2863409|NCT02174276|9845056|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2863410|NCT02174276|9845057|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
2863411|NCT02174276|9845058|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2863412|NCT02174276|9845055|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
2863413|NCT02174276|9845056|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
2863414|NCT02174276|9845057|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
2863415|NCT02174276|9845058|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
2863416|NCT02174276|9845055|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2863417|NCT02174276|9845056|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
2863418|NCT02174276|9845057|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2863419|NCT02174276|9845058|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2863420|NCT02174276|9845055|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2863421|NCT02174276|9845056|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
2863422|NCT02174276|9845057|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
2863423|NCT02174276|9845058|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2863424|NCT02174276|9845055|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2863425|NCT02174276|9845056|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
2863426|NCT02174276|9845057|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2863427|NCT02174276|9845058|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2863428|NCT02174276|9845055|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2863429|NCT02174276|9845056|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2863430|NCT02174276|9845057|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2863431|NCT02174276|9845058|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
2863432|NCT02173769|9845165|P1|Overall Study|Protocol Violation|4
2863433|NCT02173704|9845178|P2|Overall Study|Withdrawal by Subject|4
2863434|NCT02173704|9845179|P1|Overall Study|Withdrawal by Subject|9
2863435|NCT02173704|9845178|P2|Overall Study|Protocol Violation|0
2863436|NCT02173704|9845179|P1|Overall Study|Protocol Violation|1
2863437|NCT02173704|9845178|P2|Overall Study|Other|0
2863438|NCT02173704|9845179|P1|Overall Study|Other|1
2863439|NCT02173704|9845178|P2|Overall Study|Lost to Follow-up|0
2863440|NCT02173704|9845179|P1|Overall Study|Lost to Follow-up|1
2863441|NCT02173704|9845178|P2|Overall Study|Adverse Event|0
2863442|NCT02173704|9845179|P1|Overall Study|Adverse Event|1
2863443|NCT02173548|9845205|P2|Overall Study|Withdrawal by Subject|0
2863444|NCT02173548|9845206|P1|Overall Study|Withdrawal by Subject|1
2863445|NCT02173548|9845205|P2|Overall Study|Lost to Follow-up|2
2863446|NCT02173548|9845206|P1|Overall Study|Lost to Follow-up|0
2863447|NCT02173379|9845338|P2|Overall Study|Withdrawn by the physician|1
2863448|NCT02173379|9845339|P1|Overall Study|Withdrawn by the physician|0
2863449|NCT02173379|9845338|P2|Overall Study|Death|1
2863450|NCT02173379|9845339|P1|Overall Study|Death|1
2863451|NCT02173379|9845338|P2|Overall Study|Physician Decision|1
2863452|NCT02173379|9845339|P1|Overall Study|Physician Decision|4
2863453|NCT02173379|9845338|P2|Overall Study|Withdrawal by Subject|4
2863454|NCT02173379|9845339|P1|Overall Study|Withdrawal by Subject|1
2863455|NCT02173379|9845338|P2|Overall Study|Lost to Follow-up|0
2863456|NCT02173379|9845339|P1|Overall Study|Lost to Follow-up|3
2863457|NCT02173158|9845405|P1|Efficacy Phase|Adverse Event|1
2863458|NCT02173054|9845422|P3|Overall Study|Withdrawal by Subject|1
2863459|NCT02173054|9845423|P2|Overall Study|Withdrawal by Subject|0
2863460|NCT02173054|9845424|P1|Overall Study|Withdrawal by Subject|0
2863461|NCT02173054|9845422|P3|Overall Study|lack of compliance|0
2863462|NCT02173054|9845423|P2|Overall Study|lack of compliance|0
2863463|NCT02173054|9845424|P1|Overall Study|lack of compliance|1
2863464|NCT02172664|9845480|P2|Overall Study|Moved out of area|1
2863465|NCT02172664|9845481|P1|Overall Study|Moved out of area|1
2863466|NCT02172664|9845480|P2|Overall Study|Death|1
2863467|NCT02172664|9845481|P1|Overall Study|Death|1
2863468|NCT02172664|9845480|P2|Overall Study|Lost to Follow-up|4
2863469|NCT02172664|9845481|P1|Overall Study|Lost to Follow-up|4
2863470|NCT02172625|9845490|P2|Overall Study|car accident|1
2863471|NCT02172625|9845491|P1|Overall Study|car accident|0
2863472|NCT02172625|9845490|P2|Overall Study|Pregnancy|1
2863473|NCT02172625|9845491|P1|Overall Study|Pregnancy|0
2863474|NCT02172625|9845490|P2|Overall Study|Adverse Event|1
2863475|NCT02172625|9845491|P1|Overall Study|Adverse Event|0
2863476|NCT02172040|9845513|P4|Overall Study|Family emergency abroad|1
2863477|NCT02172040|9845514|P3|Overall Study|Family emergency abroad|0
2863478|NCT02172040|9845515|P2|Overall Study|Family emergency abroad|0
2863479|NCT02172040|9845516|P1|Overall Study|Family emergency abroad|0
2863480|NCT02172040|9845513|P4|Overall Study|Not available for Day 13 & 14 visits|0
2863481|NCT02172040|9845514|P3|Overall Study|Not available for Day 13 & 14 visits|1
2863482|NCT02172040|9845515|P2|Overall Study|Not available for Day 13 & 14 visits|0
2863483|NCT02172040|9845516|P1|Overall Study|Not available for Day 13 & 14 visits|0
2863484|NCT02172040|9845513|P4|Overall Study|Withdrawal by Subject|0
2863485|NCT02172040|9845514|P3|Overall Study|Withdrawal by Subject|1
2863486|NCT02172040|9845515|P2|Overall Study|Withdrawal by Subject|0
2863487|NCT02172040|9845516|P1|Overall Study|Withdrawal by Subject|0
2863488|NCT02172040|9845513|P4|Overall Study|Protocol Violation|0
2863489|NCT02172040|9845514|P3|Overall Study|Protocol Violation|0
2863490|NCT02172040|9845515|P2|Overall Study|Protocol Violation|1
2863491|NCT02172040|9845516|P1|Overall Study|Protocol Violation|0
2863492|NCT02172040|9845513|P4|Overall Study|Adverse Event|0
2863493|NCT02172040|9845514|P3|Overall Study|Adverse Event|0
2863494|NCT02172040|9845515|P2|Overall Study|Adverse Event|2
2863495|NCT02172040|9845516|P1|Overall Study|Adverse Event|0
2863496|NCT02171260|9845679|P4|Overall Study|Evidence of progressive disease|4
2863497|NCT02171260|9845680|P3|Overall Study|Evidence of progressive disease|4
2863498|NCT02171260|9845681|P2|Overall Study|Evidence of progressive disease|6
2863499|NCT02171260|9845682|P1|Overall Study|Evidence of progressive disease|4
2863500|NCT02171260|9845679|P4|Overall Study|Withdrawal by Subject|0
2863501|NCT02171260|9845680|P3|Overall Study|Withdrawal by Subject|0
2863502|NCT02171260|9845681|P2|Overall Study|Withdrawal by Subject|0
2863503|NCT02171260|9845682|P1|Overall Study|Withdrawal by Subject|1
2863504|NCT02171260|9845679|P4|Overall Study|Physician Decision|0
2863505|NCT02171260|9845680|P3|Overall Study|Physician Decision|1
2863506|NCT02171260|9845681|P2|Overall Study|Physician Decision|0
2863507|NCT02171260|9845682|P1|Overall Study|Physician Decision|1
2863508|NCT02171260|9845679|P4|Overall Study|Death|1
2863509|NCT02171260|9845680|P3|Overall Study|Death|0
2863510|NCT02171260|9845681|P2|Overall Study|Death|0
2863511|NCT02171260|9845682|P1|Overall Study|Death|0
2863512|NCT02171130|9845818|P1|Overall Study|Met Exclusion Criteria|1
2863513|NCT02171130|9845818|P1|Overall Study|Lost to Follow-up|1
2863514|NCT02171130|9845818|P1|Overall Study|Physician Decision|1
2863515|NCT02171130|9845818|P1|Overall Study|Withdrawal by Subject|3
2863516|NCT02171130|9845818|P1|Overall Study|Discontinued; Site Termination|5
2863517|NCT02171130|9845818|P1|Overall Study|Discontinued; Clinical Material Issue|16
2863518|NCT02171130|9845818|P1|Overall Study|Death|1
2863519|NCT02170779|9845859|P2|Overall Study|Lost to Follow-up|1
2863520|NCT02170779|9845860|P1|Overall Study|Lost to Follow-up|0
2863521|NCT02170779|9845859|P2|Overall Study|Withdrawal by Subject|0
2863522|NCT02170779|9845860|P1|Overall Study|Withdrawal by Subject|1
2863523|NCT02170727|9845884|P2|Overall Study|Withdrawal by Subject|0
2863524|NCT02170727|9845885|P1|Overall Study|Withdrawal by Subject|2
2863525|NCT02170727|9845884|P2|Overall Study|Lost to Follow-up|0
2863526|NCT02170727|9845885|P1|Overall Study|Lost to Follow-up|1
2863527|NCT02170688|9845916|P5|Overall Study|Physician Decision|0
2863528|NCT02170688|9845917|P4|Overall Study|Physician Decision|0
2863529|NCT02170688|9845918|P3|Overall Study|Physician Decision|1
2863530|NCT02170688|9845919|P2|Overall Study|Physician Decision|0
2863531|NCT02170688|9845920|P1|Overall Study|Physician Decision|0
2863532|NCT02170688|9845916|P5|Overall Study|Full dose not received|0
2863533|NCT02170688|9845917|P4|Overall Study|Full dose not received|0
2863534|NCT02170688|9845918|P3|Overall Study|Full dose not received|0
2863535|NCT02170688|9845919|P2|Overall Study|Full dose not received|1
2863536|NCT02170688|9845920|P1|Overall Study|Full dose not received|0
2863537|NCT02170688|9845916|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
2863538|NCT02170688|9845917|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
2863539|NCT02170688|9845918|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
2863540|NCT02170688|9845919|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
2863541|NCT02170688|9845920|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
2863542|NCT02170389|9846006|P1|Overall Study|Study terminated prior to start of treat|1
2863543|NCT02170298|9846071|P2|Overall Study|unblinded, rerandomized to intervention|0
2863544|NCT02170298|9846072|P1|Overall Study|unblinded, rerandomized to intervention|1
2863545|NCT02170298|9846071|P2|Overall Study|Withdrawal by Subject|1
2863546|NCT02170298|9846072|P1|Overall Study|Withdrawal by Subject|0
2863547|NCT02170207|9846109|P1|Overall Study|Case report forms unavailable|5
2863548|NCT02170077|9846120|P3|Overall Study|Exacerbation of seizures|1
2863549|NCT02170077|9846121|P2|Overall Study|Exacerbation of seizures|2
2863550|NCT02170077|9846122|P1|Overall Study|Exacerbation of seizures|0
2863551|NCT02170077|9846120|P3|Overall Study|Exclusion criteria|5
2863552|NCT02170077|9846121|P2|Overall Study|Exclusion criteria|2
2863553|NCT02170077|9846122|P1|Overall Study|Exclusion criteria|2
2863554|NCT02170077|9846120|P3|Overall Study|Lost to Follow-up|0
2863555|NCT02170077|9846121|P2|Overall Study|Lost to Follow-up|1
2863556|NCT02170077|9846122|P1|Overall Study|Lost to Follow-up|0
2863557|NCT02170077|9846120|P3|Overall Study|Adverse Event|4
2863558|NCT02170077|9846121|P2|Overall Study|Adverse Event|4
2863559|NCT02170077|9846122|P1|Overall Study|Adverse Event|4
2863560|NCT02170077|9846120|P3|Overall Study|Withdrawal by Subject|2
2863561|NCT02170077|9846121|P2|Overall Study|Withdrawal by Subject|4
2863562|NCT02170077|9846122|P1|Overall Study|Withdrawal by Subject|3
2863563|NCT02170064|9846133|P3|Overall Study|Physician Decision|0
2863564|NCT02170064|9846134|P2|Overall Study|Physician Decision|1
2863565|NCT02170064|9846135|P1|Overall Study|Physician Decision|1
2863566|NCT02170064|9846133|P3|Overall Study|Withdrawal by Subject|1
2863567|NCT02170064|9846134|P2|Overall Study|Withdrawal by Subject|1
2863568|NCT02170064|9846135|P1|Overall Study|Withdrawal by Subject|5
2863569|NCT02170025|9846151|P2|Overall Study|Adverse Event|0
2863570|NCT02170025|9846152|P1|Overall Study|Adverse Event|2
2863571|NCT02169674|9846196|P2|Overall Study|Lost to Follow-up|1
2863572|NCT02169674|9846197|P1|Overall Study|Lost to Follow-up|0
2863573|NCT02169674|9846196|P2|Overall Study|Seroprotected|76
2863574|NCT02169674|9846197|P1|Overall Study|Seroprotected|30
2863575|NCT02169674|9846196|P2|Overall Study|Withdrawal by Subject|1
2863576|NCT02169674|9846197|P1|Overall Study|Withdrawal by Subject|2
2863577|NCT02169505|9846211|P1|Overall Study|Withdrawal by Subject|1
2863578|NCT02169414|9846339|P4|Overall Study|Adverse Event|0
2863579|NCT02169414|9846340|P3|Overall Study|Adverse Event|0
2863580|NCT02169414|9846341|P2|Overall Study|Adverse Event|1
2863581|NCT02169414|9846342|P1|Overall Study|Adverse Event|0
2863582|NCT02169414|9846339|P4|Overall Study|Withdrawal by Subject|0
2863583|NCT02169414|9846340|P3|Overall Study|Withdrawal by Subject|0
2863584|NCT02169414|9846341|P2|Overall Study|Withdrawal by Subject|0
2863585|NCT02169414|9846342|P1|Overall Study|Withdrawal by Subject|1
2863586|NCT02169336|9846383|P3|Overall Study|Subject declined to continue dosing|1
2863587|NCT02169336|9846384|P2|Overall Study|Subject declined to continue dosing|0
2863588|NCT02169336|9846385|P1|Overall Study|Subject declined to continue dosing|0
2863589|NCT02169336|9846383|P3|Overall Study|Physician Decision|1
2863590|NCT02169336|9846384|P2|Overall Study|Physician Decision|0
2863591|NCT02169336|9846385|P1|Overall Study|Physician Decision|0
2863592|NCT02169336|9846383|P3|Overall Study|Withdrawal by Subject|0
2863593|NCT02169336|9846384|P2|Overall Study|Withdrawal by Subject|0
2863594|NCT02169336|9846385|P1|Overall Study|Withdrawal by Subject|1
2863595|NCT02169336|9846383|P3|Overall Study|Adverse Event|1
2863596|NCT02169336|9846384|P2|Overall Study|Adverse Event|3
2863597|NCT02169336|9846385|P1|Overall Study|Adverse Event|2
2863598|NCT02169336|9846383|P3|Overall Study|Lack of Efficacy|0
2863599|NCT02169336|9846384|P2|Overall Study|Lack of Efficacy|1
2863600|NCT02169336|9846385|P1|Overall Study|Lack of Efficacy|1
2863601|NCT02169271|9846395|P2|Overall Study|Protocol Violation|2
2863602|NCT02169271|9846396|P1|Overall Study|Protocol Violation|1
2863603|NCT02169219|9846418|P1|Overall Study|Lack of Efficacy|6
2863604|NCT02168946|9846444|P2|Overall Study|Subject unable to come back for visits|0
2863605|NCT02168946|9846445|P1|Overall Study|Subject unable to come back for visits|1
2863606|NCT02168946|9846444|P2|Overall Study|Lost to Follow-up|0
2863607|NCT02168946|9846445|P1|Overall Study|Lost to Follow-up|3
2863608|NCT02168946|9846444|P2|Overall Study|Adverse Event|5
2863609|NCT02168946|9846445|P1|Overall Study|Adverse Event|8
2863610|NCT02168842|9846504|P2|Overall Study|Physician Decision|2
2863611|NCT02168842|9846505|P1|Overall Study|Physician Decision|1
2863612|NCT02168842|9846504|P2|Overall Study|Death|1
2863613|NCT02168842|9846505|P1|Overall Study|Death|2
2863614|NCT02168842|9846504|P2|Overall Study|Lost to Follow-up|2
2863615|NCT02168842|9846505|P1|Overall Study|Lost to Follow-up|0
2863616|NCT02168842|9846504|P2|Overall Study|Withdrawal by Subject|3
2863617|NCT02168842|9846505|P1|Overall Study|Withdrawal by Subject|5
2863618|NCT02168816|9846563|P2|Overall Study|Lost to Follow-up|2
2863619|NCT02168816|9846564|P1|Overall Study|Lost to Follow-up|2
2863620|NCT02168803|9846575|P3|Overall Study|Sponsor Decision|1
2863621|NCT02168803|9846576|P2|Overall Study|Sponsor Decision|0
2863622|NCT02168803|9846577|P1|Overall Study|Sponsor Decision|0
2863623|NCT02168803|9846575|P3|Overall Study|Death|1
2863624|NCT02168803|9846576|P2|Overall Study|Death|0
2863625|NCT02168803|9846577|P1|Overall Study|Death|0
2863626|NCT02168803|9846575|P3|Overall Study|Adverse Event|1
2863627|NCT02168803|9846576|P2|Overall Study|Adverse Event|1
2863628|NCT02168803|9846577|P1|Overall Study|Adverse Event|0
2863629|NCT02168803|9846575|P3|Overall Study|Physician Decision|0
2863630|NCT02168803|9846576|P2|Overall Study|Physician Decision|1
2863631|NCT02168803|9846577|P1|Overall Study|Physician Decision|0
2863632|NCT02168803|9846575|P3|Overall Study|Withdrawal by Subject|2
2863633|NCT02168803|9846576|P2|Overall Study|Withdrawal by Subject|1
2863634|NCT02168803|9846577|P1|Overall Study|Withdrawal by Subject|1
2863635|NCT02168803|9846575|P3|Overall Study|Lost to Follow-up|1
2863636|NCT02168803|9846576|P2|Overall Study|Lost to Follow-up|0
2863637|NCT02168803|9846577|P1|Overall Study|Lost to Follow-up|1
2863638|NCT02168777|9846607|P3|Overall Study|Other reason|0
2863639|NCT02168777|9846608|P2|Overall Study|Other reason|1
2863640|NCT02168777|9846609|P1|Overall Study|Other reason|0
2863641|NCT02168777|9846607|P3|Overall Study|Clinical disease progression|2
2863642|NCT02168777|9846608|P2|Overall Study|Clinical disease progression|1
2863643|NCT02168777|9846609|P1|Overall Study|Clinical disease progression|0
2863644|NCT02168777|9846607|P3|Overall Study|Radiological disease progression|5
2863645|NCT02168777|9846608|P2|Overall Study|Radiological disease progression|5
2863646|NCT02168777|9846609|P1|Overall Study|Radiological disease progression|0
2863647|NCT02168777|9846607|P3|Overall Study|Disease recurrence|1
2863648|NCT02168777|9846608|P2|Overall Study|Disease recurrence|0
2863649|NCT02168777|9846609|P1|Overall Study|Disease recurrence|0
2863650|NCT02168777|9846607|P3|Overall Study|Adverse Event|1
2863651|NCT02168777|9846608|P2|Overall Study|Adverse Event|0
2863652|NCT02168777|9846609|P1|Overall Study|Adverse Event|1
2863653|NCT02168777|9846607|P3|Overall Study|Withdrawal by Subject|2
2863654|NCT02168777|9846608|P2|Overall Study|Withdrawal by Subject|0
2863655|NCT02168777|9846609|P1|Overall Study|Withdrawal by Subject|1
2863656|NCT02168491|9846705|P1|Overall Study|Withdrawal by Subject|1
2863657|NCT02168478|9846711|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
2863658|NCT02168478|9846711|P1|Overall Study|Did Not Consent to Participation|2
2863659|NCT02168478|9846711|P1|Overall Study|Withdrawal by Subject|1
2863660|NCT02168439|9846717|P2|Overall Study|Protocol Violation|2
2863661|NCT02168439|9846718|P1|Overall Study|Protocol Violation|0
2863662|NCT02168387|9846736|P2|Overall Study|Death|0
2863663|NCT02168387|9846737|P1|Overall Study|Death|1
2863664|NCT02168387|9846736|P2|Overall Study|Planned exubation|3
2863665|NCT02168387|9846737|P1|Overall Study|Planned exubation|6
2863666|NCT02168270|9846769|P1|Overall Study|Lack of Efficacy|4
2863667|NCT02168101|9846796|P3|Overall Study|Death|1
2863668|NCT02168101|9846797|P2|Overall Study|Death|2
2863669|NCT02168101|9846798|P1|Overall Study|Death|2
2863670|NCT02167893|9846817|P1|Overall Study|Case report forms not collected|68
2863671|NCT02167893|9846817|P1|Overall Study|Investigator health reasons|10
2863672|NCT02167893|9846817|P1|Overall Study|Investigator transferred|85
2863673|NCT02167451|9846849|P1|Overall Study|Withdrawal by Subject|1
2863674|NCT02167256|9846866|P2|Overall Study|Study partner unable to participate|0
2863675|NCT02167256|9846867|P1|Overall Study|Study partner unable to participate|1
2863676|NCT02167256|9846866|P2|Overall Study|non-compliance|0
2863677|NCT02167256|9846867|P1|Overall Study|non-compliance|3
2863678|NCT02167256|9846866|P2|Overall Study|Withdrawal by Subject|4
2863679|NCT02167256|9846867|P1|Overall Study|Withdrawal by Subject|4
2863680|NCT02167256|9846866|P2|Overall Study|Adverse Event|6
2863681|NCT02167256|9846867|P1|Overall Study|Adverse Event|13
2863682|NCT02167139|9846900|P4|Transition-extension|Lost to Follow-up|0
2863683|NCT02167139|9846901|P3|Transition-extension|Lost to Follow-up|0
2863684|NCT02167139|9846902|P2|Transition-extension|Lost to Follow-up|0
2863685|NCT02167139|9846903|P1|Transition-extension|Lost to Follow-up|1
2863686|NCT02167139|9846900|P4|Transition-extension|Other|0
2863687|NCT02167139|9846901|P3|Transition-extension|Other|1
2863688|NCT02167139|9846902|P2|Transition-extension|Other|0
2863689|NCT02167139|9846903|P1|Transition-extension|Other|1
2863690|NCT02167139|9846900|P4|Transition-extension|Lack of Efficacy|1
2863691|NCT02167139|9846901|P3|Transition-extension|Lack of Efficacy|1
2863692|NCT02167139|9846902|P2|Transition-extension|Lack of Efficacy|0
2863693|NCT02167139|9846903|P1|Transition-extension|Lack of Efficacy|0
2863694|NCT02167139|9846900|P4|Transition-extension|Withdrawal by Subject|1
2863695|NCT02167139|9846901|P3|Transition-extension|Withdrawal by Subject|4
2863696|NCT02167139|9846902|P2|Transition-extension|Withdrawal by Subject|0
2863697|NCT02167139|9846903|P1|Transition-extension|Withdrawal by Subject|2
2863698|NCT02167139|9846900|P4|Transition-extension|Adverse Event|3
2863699|NCT02167139|9846901|P3|Transition-extension|Adverse Event|2
2863700|NCT02167139|9846902|P2|Transition-extension|Adverse Event|0
2863701|NCT02167139|9846903|P1|Transition-extension|Adverse Event|2
2863702|NCT02167139|9846900|P4|Randomised, Double-blind|Other|0
2863703|NCT02167139|9846901|P3|Randomised, Double-blind|Other|0
2863704|NCT02167139|9846902|P2|Randomised, Double-blind|Other|0
2863705|NCT02167139|9846903|P1|Randomised, Double-blind|Other|3
2863706|NCT02167139|9846900|P4|Randomised, Double-blind|Lack of Efficacy|0
2863707|NCT02167139|9846901|P3|Randomised, Double-blind|Lack of Efficacy|0
2863708|NCT02167139|9846902|P2|Randomised, Double-blind|Lack of Efficacy|2
2863709|NCT02167139|9846903|P1|Randomised, Double-blind|Lack of Efficacy|1
2863710|NCT02167139|9846900|P4|Randomised, Double-blind|Adverse Event|0
2863711|NCT02167139|9846901|P3|Randomised, Double-blind|Adverse Event|0
2863712|NCT02167139|9846902|P2|Randomised, Double-blind|Adverse Event|9
2863713|NCT02167139|9846903|P1|Randomised, Double-blind|Adverse Event|2
2863714|NCT02167139|9846900|P4|Randomised, Double-blind|Withdrawal by Subject|0
2863715|NCT02167139|9846901|P3|Randomised, Double-blind|Withdrawal by Subject|0
2863716|NCT02167139|9846902|P2|Randomised, Double-blind|Withdrawal by Subject|8
2863717|NCT02167139|9846903|P1|Randomised, Double-blind|Withdrawal by Subject|11
2863718|NCT02167035|9846938|P2|Overall Study|Randomized to incorrect Study Medication|1
2863719|NCT02167035|9846939|P1|Overall Study|Randomized to incorrect Study Medication|0
2863720|NCT02167035|9846938|P2|Overall Study|Lost to Follow-up|3
2863721|NCT02167035|9846939|P1|Overall Study|Lost to Follow-up|3
2863722|NCT02167035|9846938|P2|Overall Study|Adverse Event|2
2863723|NCT02167035|9846939|P1|Overall Study|Adverse Event|2
2863724|NCT02166697|9846947|P1|Overall Study|Protocol Violation|347
2863725|NCT02166606|9846956|P1|Overall Study|Enrolled after End of Enrollment|4
2863726|NCT02166606|9846956|P1|Overall Study|Device upgrade|1
2863727|NCT02166606|9846956|P1|Overall Study|Physician Decision|1
2863728|NCT02166606|9846956|P1|Overall Study|Withdrawal by Subject|1
2863729|NCT02166606|9846956|P1|Overall Study|Lost to Follow-up|30
2863730|NCT02166606|9846956|P1|Overall Study|Protocol Violation|7
2863731|NCT02166606|9846956|P1|Overall Study|Death|31
2863732|NCT02166606|9846956|P1|Overall Study|Adverse Event|3
2863733|NCT02166476|9846963|P2|Overall Study|Unable to Come for Visit|3
2863734|NCT02166476|9846964|P1|Overall Study|Unable to Come for Visit|0
2863735|NCT02166476|9846963|P2|Overall Study|Physician Decision|0
2863736|NCT02166476|9846964|P1|Overall Study|Physician Decision|1
2863737|NCT02166476|9846963|P2|Overall Study|Lost to Follow-up|10
2863738|NCT02166476|9846964|P1|Overall Study|Lost to Follow-up|5
2863739|NCT02166476|9846963|P2|Overall Study|Adverse Event|3
2863740|NCT02166476|9846964|P1|Overall Study|Adverse Event|3
2863741|NCT02166476|9846963|P2|Overall Study|Withdrawal by Subject|7
2863742|NCT02166476|9846964|P1|Overall Study|Withdrawal by Subject|5
2863743|NCT02165826|9847028|P3|Down-Titration Period|Reason Not Specified|2
2863744|NCT02165826|9847029|P2|Down-Titration Period|Reason Not Specified|0
2863745|NCT02165826|9847030|P1|Down-Titration Period|Reason Not Specified|1
2863746|NCT02165826|9847028|P3|Down-Titration Period|Voluntary Withdrawal|2
2863747|NCT02165826|9847029|P2|Down-Titration Period|Voluntary Withdrawal|1
2863748|NCT02165826|9847030|P1|Down-Titration Period|Voluntary Withdrawal|2
2863749|NCT02165826|9847028|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
2863750|NCT02165826|9847029|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
2863751|NCT02165826|9847030|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
2863752|NCT02165826|9847028|P3|Main Treatment Period|Did Not Receive Study Drug|0
2863753|NCT02165826|9847029|P2|Main Treatment Period|Did Not Receive Study Drug|2
2863754|NCT02165826|9847030|P1|Main Treatment Period|Did Not Receive Study Drug|0
2863755|NCT02165826|9847028|P3|Main Treatment Period|Reason Not Specified|16
2863756|NCT02165826|9847029|P2|Main Treatment Period|Reason Not Specified|5
2863757|NCT02165826|9847030|P1|Main Treatment Period|Reason Not Specified|8
2863758|NCT02165826|9847028|P3|Main Treatment Period|Lack of Efficacy|0
2863759|NCT02165826|9847029|P2|Main Treatment Period|Lack of Efficacy|0
2863760|NCT02165826|9847030|P1|Main Treatment Period|Lack of Efficacy|2
2863761|NCT02165826|9847028|P3|Main Treatment Period|Voluntary Withdrawal|21
2863762|NCT02165826|9847029|P2|Main Treatment Period|Voluntary Withdrawal|23
2863763|NCT02165826|9847030|P1|Main Treatment Period|Voluntary Withdrawal|23
2863764|NCT02165826|9847028|P3|Main Treatment Period|Lost to Follow-up|1
2863765|NCT02165826|9847029|P2|Main Treatment Period|Lost to Follow-up|2
2863766|NCT02165826|9847030|P1|Main Treatment Period|Lost to Follow-up|4
2863767|NCT02165826|9847028|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
2863768|NCT02165826|9847029|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
2863769|NCT02165826|9847030|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
2863770|NCT02165826|9847028|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
2863771|NCT02165826|9847029|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
2863772|NCT02165826|9847030|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
2863773|NCT02165735|9847098|P2|Overall Study|Protocol Violation|1
2863774|NCT02165735|9847099|P1|Overall Study|Protocol Violation|0
2863775|NCT02165735|9847098|P2|Overall Study|Participant indicated lack of time|3
2863776|NCT02165735|9847099|P1|Overall Study|Participant indicated lack of time|1
2863777|NCT02165735|9847098|P2|Overall Study|Withdrawal by Subject|0
2863778|NCT02165735|9847099|P1|Overall Study|Withdrawal by Subject|3
2863779|NCT02165735|9847098|P2|Overall Study|Lost to Follow-up|10
2863780|NCT02165735|9847099|P1|Overall Study|Lost to Follow-up|12
2863781|NCT02165202|9847164|P2|Injection Phase|Participant unwilling to comply|0
2863782|NCT02165202|9847165|P1|Injection Phase|Participant unwilling to comply|1
2863783|NCT02165202|9847164|P2|Injection Phase|No longer interested|1
2863784|NCT02165202|9847165|P1|Injection Phase|No longer interested|0
2863785|NCT02165202|9847164|P2|Injection Phase|Study Product related Toxicity|0
2863786|NCT02165202|9847165|P1|Injection Phase|Study Product related Toxicity|1
2863787|NCT02165202|9847164|P2|Injection Phase|End of Study|1
2863788|NCT02165202|9847165|P1|Injection Phase|End of Study|2
2863789|NCT02165202|9847164|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
2863790|NCT02165202|9847165|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
2863791|NCT02165202|9847164|P2|Injection Phase|Unable to attend within Visit Window|0
2863792|NCT02165202|9847165|P1|Injection Phase|Unable to attend within Visit Window|1
2863793|NCT02165202|9847164|P2|Injection Phase|Reactive HIV or HIV Suspected|2
2863794|NCT02165202|9847165|P1|Injection Phase|Reactive HIV or HIV Suspected|0
2863795|NCT02165202|9847164|P2|Injection Phase|Abnormal Lab Value|1
2863796|NCT02165202|9847165|P1|Injection Phase|Abnormal Lab Value|5
2863797|NCT02165202|9847164|P2|Oral Phase|Abnormal EKG|1
2863798|NCT02165202|9847165|P1|Oral Phase|Abnormal EKG|0
2863799|NCT02165202|9847164|P2|Oral Phase|Relocated, no follow-up planned|0
2863800|NCT02165202|9847165|P1|Oral Phase|Relocated, no follow-up planned|1
2863801|NCT02165202|9847164|P2|Oral Phase|CMC advised termination|0
2863802|NCT02165202|9847165|P1|Oral Phase|CMC advised termination|1
2863803|NCT02165202|9847164|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
2863804|NCT02165202|9847165|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
2863805|NCT02165202|9847164|P2|Oral Phase|Clinical reasons|0
2863806|NCT02165202|9847165|P1|Oral Phase|Clinical reasons|1
2863807|NCT02165202|9847164|P2|Oral Phase|Unable to contact Participant|1
2863808|NCT02165202|9847165|P1|Oral Phase|Unable to contact Participant|1
2863809|NCT02165202|9847164|P2|Oral Phase|Study product Related Toxicity|0
2863810|NCT02165202|9847165|P1|Oral Phase|Study product Related Toxicity|1
2863811|NCT02165202|9847164|P2|Oral Phase|Refused further participation|1
2863812|NCT02165202|9847165|P1|Oral Phase|Refused further participation|5
2863813|NCT02164981|9847202|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2863814|NCT02164981|9847203|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
2863815|NCT02164981|9847204|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2863816|NCT02164981|9847202|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
2863817|NCT02164981|9847203|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
2863818|NCT02164981|9847204|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
2863819|NCT02164981|9847202|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2863820|NCT02164981|9847203|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
2863821|NCT02164981|9847204|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2863822|NCT02164981|9847202|P3|Started|Adverse Event|0
2863823|NCT02164981|9847203|P2|Started|Adverse Event|2
2863824|NCT02164981|9847204|P1|Started|Adverse Event|1
2863825|NCT02164981|9847202|P3|Started|Protocol Violation|0
2863826|NCT02164981|9847203|P2|Started|Protocol Violation|0
2863827|NCT02164981|9847204|P1|Started|Protocol Violation|2
2863828|NCT02164981|9847202|P3|Started|Withdrawal by Subject|0
2863829|NCT02164981|9847203|P2|Started|Withdrawal by Subject|1
2863830|NCT02164981|9847204|P1|Started|Withdrawal by Subject|2
2863831|NCT02164929|9847277|P4|Overall Study|Failed regional block|0
2863832|NCT02164929|9847278|P3|Overall Study|Failed regional block|1
2863833|NCT02164929|9847279|P2|Overall Study|Failed regional block|0
2863834|NCT02164929|9847280|P1|Overall Study|Failed regional block|0
2863835|NCT02164929|9847277|P4|Overall Study|Converted to open procedure|2
2863836|NCT02164929|9847278|P3|Overall Study|Converted to open procedure|0
2863837|NCT02164929|9847279|P2|Overall Study|Converted to open procedure|0
2863838|NCT02164929|9847280|P1|Overall Study|Converted to open procedure|1
2863839|NCT02164916|9847324|P2|Overall Study|Not eligible|5
2863840|NCT02164916|9847325|P1|Overall Study|Not eligible|2
2863841|NCT02164916|9847324|P2|Overall Study|Reason under review|6
2863842|NCT02164916|9847325|P1|Overall Study|Reason under review|1
2863843|NCT02164916|9847324|P2|Overall Study|Not protocol specified|1
2863844|NCT02164916|9847325|P1|Overall Study|Not protocol specified|5
2863845|NCT02164916|9847324|P2|Overall Study|Progression|26
2863846|NCT02164916|9847325|P1|Overall Study|Progression|37
2863847|NCT02164916|9847324|P2|Overall Study|Refusal unrelated to adverse event|7
2863848|NCT02164916|9847325|P1|Overall Study|Refusal unrelated to adverse event|3
2863849|NCT02164916|9847324|P2|Overall Study|Death|1
2863850|NCT02164916|9847325|P1|Overall Study|Death|1
2863851|NCT02164916|9847324|P2|Overall Study|Adverse Event|8
2863852|NCT02164916|9847325|P1|Overall Study|Adverse Event|3
2863853|NCT02164864|9847345|P3|Overall Study|Other than stated|14
2863854|NCT02164864|9847346|P2|Overall Study|Other than stated|4
2863855|NCT02164864|9847347|P1|Overall Study|Other than stated|3
2863856|NCT02164864|9847345|P3|Overall Study|Consent withdrawn, not due to AE|56
2863857|NCT02164864|9847346|P2|Overall Study|Consent withdrawn, not due to AE|8
2863858|NCT02164864|9847347|P1|Overall Study|Consent withdrawn, not due to AE|21
2863859|NCT02164864|9847345|P3|Overall Study|Lost to Follow-up|2
2863860|NCT02164864|9847346|P2|Overall Study|Lost to Follow-up|3
2863861|NCT02164864|9847347|P1|Overall Study|Lost to Follow-up|4
2863862|NCT02164864|9847345|P3|Overall Study|Protocol Violation|1
2863863|NCT02164864|9847346|P2|Overall Study|Protocol Violation|4
2863864|NCT02164864|9847347|P1|Overall Study|Protocol Violation|2
2863865|NCT02164864|9847345|P3|Overall Study|Other Adverse Event (AE)|49
2863866|NCT02164864|9847346|P2|Overall Study|Other Adverse Event (AE)|32
2863867|NCT02164864|9847347|P1|Overall Study|Other Adverse Event (AE)|52
2863868|NCT02164864|9847345|P3|Overall Study|Other pre-existing disease worsening|9
2863869|NCT02164864|9847346|P2|Overall Study|Other pre-existing disease worsening|4
2863870|NCT02164864|9847347|P1|Overall Study|Other pre-existing disease worsening|6
2863871|NCT02164864|9847345|P3|Overall Study|Trial disease worsening|1
2863872|NCT02164864|9847346|P2|Overall Study|Trial disease worsening|5
2863873|NCT02164864|9847347|P1|Overall Study|Trial disease worsening|7
2863874|NCT02164539|9847422|P7|Treatment Phase C (1 Week)|Physician Decision|1
2863875|NCT02164539|9847423|P6|Treatment Phase C (1 Week)|Physician Decision|0
2863876|NCT02164539|9847424|P5|Treatment Phase C (1 Week)|Physician Decision|0
2863877|NCT02164539|9847425|P4|Treatment Phase C (1 Week)|Physician Decision|0
2863878|NCT02164539|9847426|P3|Treatment Phase C (1 Week)|Physician Decision|0
2863879|NCT02164539|9847427|P2|Treatment Phase C (1 Week)|Physician Decision|0
2863880|NCT02164539|9847428|P1|Treatment Phase C (1 Week)|Physician Decision|0
2863881|NCT02164539|9847422|P7|Treatment Phase C (1 Week)|Adverse Event|1
2863882|NCT02164539|9847423|P6|Treatment Phase C (1 Week)|Adverse Event|0
2863883|NCT02164539|9847424|P5|Treatment Phase C (1 Week)|Adverse Event|0
2863884|NCT02164539|9847425|P4|Treatment Phase C (1 Week)|Adverse Event|0
2863885|NCT02164539|9847426|P3|Treatment Phase C (1 Week)|Adverse Event|0
2863886|NCT02164539|9847427|P2|Treatment Phase C (1 Week)|Adverse Event|0
2863887|NCT02164539|9847428|P1|Treatment Phase C (1 Week)|Adverse Event|0
2863888|NCT02164539|9847422|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863889|NCT02164539|9847423|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863890|NCT02164539|9847424|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863891|NCT02164539|9847425|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863892|NCT02164539|9847426|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863893|NCT02164539|9847427|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2863894|NCT02164539|9847428|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
2863895|NCT02164539|9847422|P7|Treatment Phase B (1 Week)|Physician Decision|1
2863896|NCT02164539|9847423|P6|Treatment Phase B (1 Week)|Physician Decision|0
2863897|NCT02164539|9847424|P5|Treatment Phase B (1 Week)|Physician Decision|1
2863898|NCT02164539|9847425|P4|Treatment Phase B (1 Week)|Physician Decision|0
2863899|NCT02164539|9847426|P3|Treatment Phase B (1 Week)|Physician Decision|0
2863900|NCT02164539|9847427|P2|Treatment Phase B (1 Week)|Physician Decision|0
2863901|NCT02164539|9847428|P1|Treatment Phase B (1 Week)|Physician Decision|0
2863902|NCT02164539|9847422|P7|Treatment Phase B (1 Week)|Adverse Event|0
2863903|NCT02164539|9847423|P6|Treatment Phase B (1 Week)|Adverse Event|0
2863904|NCT02164539|9847424|P5|Treatment Phase B (1 Week)|Adverse Event|2
2863905|NCT02164539|9847425|P4|Treatment Phase B (1 Week)|Adverse Event|0
2863906|NCT02164539|9847426|P3|Treatment Phase B (1 Week)|Adverse Event|0
2863907|NCT02164539|9847427|P2|Treatment Phase B (1 Week)|Adverse Event|0
2863908|NCT02164539|9847428|P1|Treatment Phase B (1 Week)|Adverse Event|0
2863909|NCT02164539|9847422|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2863910|NCT02164539|9847423|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2863911|NCT02164539|9847424|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
2863912|NCT02164539|9847425|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2863913|NCT02164539|9847426|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2863914|NCT02164539|9847427|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2863915|NCT02164539|9847428|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2863916|NCT02164513|9847476|P3|Overall Study|Other: Reason not provided by site|0
2863917|NCT02164513|9847477|P2|Overall Study|Other: Reason not provided by site|0
2863918|NCT02164513|9847478|P1|Overall Study|Other: Reason not provided by site|1
2863919|NCT02164513|9847476|P3|Overall Study|Withdrawal by Subject|130
2863920|NCT02164513|9847477|P2|Overall Study|Withdrawal by Subject|261
2863921|NCT02164513|9847478|P1|Overall Study|Withdrawal by Subject|192
2863922|NCT02164513|9847476|P3|Overall Study|Physician Decision|28
2863923|NCT02164513|9847477|P2|Overall Study|Physician Decision|57
2863924|NCT02164513|9847478|P1|Overall Study|Physician Decision|47
2863925|NCT02164513|9847476|P3|Overall Study|Lost to Follow-up|22
2863926|NCT02164513|9847477|P2|Overall Study|Lost to Follow-up|36
2863927|NCT02164513|9847478|P1|Overall Study|Lost to Follow-up|30
2863928|NCT02164513|9847476|P3|Overall Study|Other: Study Closed or terminated|4
2863929|NCT02164513|9847477|P2|Overall Study|Other: Study Closed or terminated|2
2863930|NCT02164513|9847478|P1|Overall Study|Other: Study Closed or terminated|5
2863931|NCT02164513|9847476|P3|Overall Study|Adverse Event|111
2863932|NCT02164513|9847477|P2|Overall Study|Adverse Event|180
2863933|NCT02164513|9847478|P1|Overall Study|Adverse Event|162
2863934|NCT02164383|9847515|P2|Overall Study|Lost to Follow-up|0
2863935|NCT02164383|9847516|P1|Overall Study|Lost to Follow-up|1
2863936|NCT02164318|9847526|P4|Overall Study|Withdrawal by Subject|1
2863937|NCT02164318|9847527|P3|Overall Study|Withdrawal by Subject|0
2863938|NCT02164318|9847528|P2|Overall Study|Withdrawal by Subject|1
2863939|NCT02164318|9847529|P1|Overall Study|Withdrawal by Subject|0
2863940|NCT02163993|9847564|P5|Post-treatment Period|Withdrawal by Subject|2
2863941|NCT02163993|9847565|P4|Post-treatment Period|Withdrawal by Subject|1
2863942|NCT02163993|9847566|P3|Post-treatment Period|Withdrawal by Subject|0
2863943|NCT02163993|9847567|P2|Post-treatment Period|Withdrawal by Subject|4
2863944|NCT02163993|9847568|P1|Post-treatment Period|Withdrawal by Subject|2
2863945|NCT02163993|9847564|P5|Post-treatment Period|Protocol Violation|1
2863946|NCT02163993|9847565|P4|Post-treatment Period|Protocol Violation|0
2863947|NCT02163993|9847566|P3|Post-treatment Period|Protocol Violation|0
2863948|NCT02163993|9847567|P2|Post-treatment Period|Protocol Violation|0
2863949|NCT02163993|9847568|P1|Post-treatment Period|Protocol Violation|0
2863950|NCT02163993|9847564|P5|Post-treatment Period|Lost to Follow-up|0
2863951|NCT02163993|9847565|P4|Post-treatment Period|Lost to Follow-up|1
2863952|NCT02163993|9847566|P3|Post-treatment Period|Lost to Follow-up|3
2863953|NCT02163993|9847567|P2|Post-treatment Period|Lost to Follow-up|2
2863954|NCT02163993|9847568|P1|Post-treatment Period|Lost to Follow-up|2
2863955|NCT02163993|9847564|P5|Post-treatment Period|Adverse Event|0
2863956|NCT02163993|9847565|P4|Post-treatment Period|Adverse Event|0
2863957|NCT02163993|9847566|P3|Post-treatment Period|Adverse Event|1
2863958|NCT02163993|9847567|P2|Post-treatment Period|Adverse Event|0
2863959|NCT02163993|9847568|P1|Post-treatment Period|Adverse Event|0
2863960|NCT02163993|9847564|P5|Treatment Period|Not treated|2
2863961|NCT02163993|9847565|P4|Treatment Period|Not treated|1
2863962|NCT02163993|9847566|P3|Treatment Period|Not treated|0
2863963|NCT02163993|9847567|P2|Treatment Period|Not treated|0
2863964|NCT02163993|9847568|P1|Treatment Period|Not treated|1
2863965|NCT02163993|9847564|P5|Treatment Period|Withdrawal by Subject|1
2863966|NCT02163993|9847565|P4|Treatment Period|Withdrawal by Subject|4
2863967|NCT02163993|9847566|P3|Treatment Period|Withdrawal by Subject|1
2863968|NCT02163993|9847567|P2|Treatment Period|Withdrawal by Subject|4
2863969|NCT02163993|9847568|P1|Treatment Period|Withdrawal by Subject|6
2863970|NCT02163993|9847564|P5|Treatment Period|Protocol Violation|2
2863971|NCT02163993|9847565|P4|Treatment Period|Protocol Violation|1
2863972|NCT02163993|9847566|P3|Treatment Period|Protocol Violation|0
2863973|NCT02163993|9847567|P2|Treatment Period|Protocol Violation|1
2863974|NCT02163993|9847568|P1|Treatment Period|Protocol Violation|2
2863975|NCT02163993|9847564|P5|Treatment Period|Physician Decision|0
2863976|NCT02163993|9847565|P4|Treatment Period|Physician Decision|0
2863977|NCT02163993|9847566|P3|Treatment Period|Physician Decision|0
2863978|NCT02163993|9847567|P2|Treatment Period|Physician Decision|0
2863979|NCT02163993|9847568|P1|Treatment Period|Physician Decision|1
2863980|NCT02163993|9847564|P5|Treatment Period|Lost to Follow-up|1
2863981|NCT02163993|9847565|P4|Treatment Period|Lost to Follow-up|3
2863982|NCT02163993|9847566|P3|Treatment Period|Lost to Follow-up|1
2863983|NCT02163993|9847567|P2|Treatment Period|Lost to Follow-up|3
2863984|NCT02163993|9847568|P1|Treatment Period|Lost to Follow-up|2
2863985|NCT02163993|9847564|P5|Treatment Period|Adverse Event|1
2863986|NCT02163993|9847565|P4|Treatment Period|Adverse Event|0
2863987|NCT02163993|9847566|P3|Treatment Period|Adverse Event|0
2863988|NCT02163993|9847567|P2|Treatment Period|Adverse Event|1
2863989|NCT02163993|9847568|P1|Treatment Period|Adverse Event|0
2863990|NCT02163915|9847671|P5|Overall Study|Physician Decision|0
2863991|NCT02163915|9847672|P4|Overall Study|Physician Decision|1
2863992|NCT02163915|9847673|P3|Overall Study|Physician Decision|0
2863993|NCT02163915|9847674|P2|Overall Study|Physician Decision|0
2863994|NCT02163915|9847675|P1|Overall Study|Physician Decision|0
2863995|NCT02163915|9847671|P5|Overall Study|Study termination|2
2863996|NCT02163915|9847672|P4|Overall Study|Study termination|0
2863997|NCT02163915|9847673|P3|Overall Study|Study termination|0
2863998|NCT02163915|9847674|P2|Overall Study|Study termination|0
2863999|NCT02163915|9847675|P1|Overall Study|Study termination|1
2864000|NCT02163915|9847671|P5|Overall Study|Withdrawal by Subject|2
2864001|NCT02163915|9847672|P4|Overall Study|Withdrawal by Subject|2
2864002|NCT02163915|9847673|P3|Overall Study|Withdrawal by Subject|2
2864003|NCT02163915|9847674|P2|Overall Study|Withdrawal by Subject|0
2864004|NCT02163915|9847675|P1|Overall Study|Withdrawal by Subject|2
2864005|NCT02163902|9847730|P2|Overall Study|Administrative Decision|2
2864006|NCT02163902|9847731|P1|Overall Study|Administrative Decision|2
2864007|NCT02163902|9847730|P2|Overall Study|Lost to Follow-up|7
2864008|NCT02163902|9847731|P1|Overall Study|Lost to Follow-up|6
2864009|NCT02163902|9847730|P2|Overall Study|Subject's Request|4
2864010|NCT02163902|9847731|P1|Overall Study|Subject's Request|3
2864011|NCT02163733|9847757|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
2864012|NCT02163733|9847758|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
2864013|NCT02163733|9847759|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
2864014|NCT02163733|9847757|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
2864015|NCT02163733|9847758|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
2864016|NCT02163733|9847759|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
2864017|NCT02163538|9847861|P2|Overall Study|Physician Decision|1
2864018|NCT02163538|9847862|P1|Overall Study|Physician Decision|0
2864019|NCT02163538|9847861|P2|Overall Study|Protocol Violation|0
2864020|NCT02163538|9847862|P1|Overall Study|Protocol Violation|1
2864021|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Various reasons|16
2864022|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
2864023|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Subject Compliance|17
2864024|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Death|8
2864025|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Protocol Violation|2
2864026|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
2864027|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Physician Decision|8
2864028|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
2864029|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
2864030|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
2864031|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Hypokalemia|9
2864032|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
2864033|NCT02163499|9847878|P1|Extended Dosing Phase: ZS|Adverse Event|51
2864034|NCT02163499|9847878|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
2864035|NCT02163499|9847878|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
2864036|NCT02163499|9847878|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
2864037|NCT02163499|9847878|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
2864038|NCT02163499|9847878|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
2864039|NCT02163447|9847906|P3|Overall Study|Became HIV infected at time of delivery|0
2864040|NCT02163447|9847907|P2|Overall Study|Became HIV infected at time of delivery|0
2864041|NCT02163447|9847908|P1|Overall Study|Became HIV infected at time of delivery|1
2864042|NCT02163447|9847906|P3|Overall Study|Moved out of study area|2
2864043|NCT02163447|9847907|P2|Overall Study|Moved out of study area|3
2864044|NCT02163447|9847908|P1|Overall Study|Moved out of study area|2
2864045|NCT02163447|9847906|P3|Overall Study|Lost to Follow-up|0
2864046|NCT02163447|9847907|P2|Overall Study|Lost to Follow-up|3
2864047|NCT02163447|9847908|P1|Overall Study|Lost to Follow-up|1
2864048|NCT02163447|9847906|P3|Overall Study|Withdrawal by Subject|1
2864049|NCT02163447|9847907|P2|Overall Study|Withdrawal by Subject|0
2864050|NCT02163447|9847908|P1|Overall Study|Withdrawal by Subject|2
2864051|NCT02163395|9847948|P1|Overall Study|Adverse Event|1
2864052|NCT02163395|9847948|P1|Overall Study|Lost to Follow-up|3
2864053|NCT02163395|9847948|P1|Overall Study|Withdrawal by Subject|1
2864054|NCT02163187|9847957|P2|Overall Study|Progressive disease|0
2864055|NCT02163187|9847958|P1|Overall Study|Progressive disease|1
2864056|NCT02163187|9847957|P2|Overall Study|Device removed|0
2864057|NCT02163187|9847958|P1|Overall Study|Device removed|1
2864058|NCT02162862|9847993|P3|Overall Study|Subject did not feel the med was needed|4
2864059|NCT02162862|9847994|P2|Overall Study|Subject did not feel the med was needed|0
2864060|NCT02162862|9847995|P1|Overall Study|Subject did not feel the med was needed|0
2864061|NCT02162862|9847993|P3|Overall Study|Lost to Follow-up|0
2864062|NCT02162862|9847994|P2|Overall Study|Lost to Follow-up|11
2864063|NCT02162862|9847995|P1|Overall Study|Lost to Follow-up|0
2864064|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Stable Disease|1
2864065|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Stable Disease|0
2864066|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
2864067|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
2864068|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
2864069|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
2864070|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Death|1
2864071|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Death|2
2864072|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Adverse Event|3
2864073|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Adverse Event|3
2864074|NCT02162771|9848008|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
2864075|NCT02162771|9848009|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
2864076|NCT02162771|9848008|P2|Core Study Period (Part 2)|Death|0
2864077|NCT02162771|9848009|P1|Core Study Period (Part 2)|Death|1
2864078|NCT02162771|9848008|P2|Core Study Period (Part 2)|Physician Decision|2
2864079|NCT02162771|9848009|P1|Core Study Period (Part 2)|Physician Decision|0
2864080|NCT02162771|9848008|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
2864081|NCT02162771|9848009|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
2864082|NCT02162771|9848008|P2|Core Study Period (Part 2)|Adverse Event|1
2864083|NCT02162771|9848009|P1|Core Study Period (Part 2)|Adverse Event|4
2864084|NCT02162771|9848008|P2|Core Study Period (Part 2)|Progressive Disease|3
2864085|NCT02162771|9848009|P1|Core Study Period (Part 2)|Progressive Disease|2
2864086|NCT02162758|9848023|P2|Overall Study|Study termination|1
2864087|NCT02162758|9848024|P1|Overall Study|Study termination|0
2864088|NCT02161757|9848159|P3|Treatment Through Study Completion|Death|1
2864089|NCT02161757|9848160|P2|Treatment Through Study Completion|Death|1
2864090|NCT02161757|9848161|P1|Treatment Through Study Completion|Death|2
2864091|NCT02161757|9848159|P3|Treatment Through Study Completion|Other|12
2864092|NCT02161757|9848160|P2|Treatment Through Study Completion|Other|19
2864093|NCT02161757|9848161|P1|Treatment Through Study Completion|Other|20
2864094|NCT02161757|9848159|P3|Treatment Through Study Completion|Lost to Follow-up|4
2864095|NCT02161757|9848160|P2|Treatment Through Study Completion|Lost to Follow-up|2
2864096|NCT02161757|9848161|P1|Treatment Through Study Completion|Lost to Follow-up|7
2864097|NCT02161757|9848159|P3|Treatment Through Study Completion|Withdrawal by Subject|20
2864098|NCT02161757|9848160|P2|Treatment Through Study Completion|Withdrawal by Subject|19
2864099|NCT02161757|9848161|P1|Treatment Through Study Completion|Withdrawal by Subject|27
2864100|NCT02161757|9848159|P3|Treatment Through Study Completion|Protocol Violation|2
2864101|NCT02161757|9848160|P2|Treatment Through Study Completion|Protocol Violation|1
2864102|NCT02161757|9848161|P1|Treatment Through Study Completion|Protocol Violation|0
2864103|NCT02161757|9848159|P3|Treatment Through Study Completion|Adverse Event|0
2864104|NCT02161757|9848160|P2|Treatment Through Study Completion|Adverse Event|1
2864105|NCT02161757|9848161|P1|Treatment Through Study Completion|Adverse Event|1
2864106|NCT02161757|9848159|P3|Randomised Through Start Treatment|Did not receive treatment|0
2864107|NCT02161757|9848160|P2|Randomised Through Start Treatment|Did not receive treatment|2
2864108|NCT02161757|9848161|P1|Randomised Through Start Treatment|Did not receive treatment|3
2864109|NCT02161731|9848219|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
2864110|NCT02161731|9848220|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
2864111|NCT02161731|9848219|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
2864112|NCT02161731|9848220|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
2864113|NCT02161575|9848248|P1|Overall Study|Adverse Event|2
2864114|NCT02161575|9848248|P1|Overall Study|Lack of Efficacy|1
2864115|NCT02161575|9848248|P1|Overall Study|Protocol Violation|8
2864116|NCT02161562|9848268|P2|Overall Study|Participant moved out of province|0
2864117|NCT02161562|9848269|P1|Overall Study|Participant moved out of province|1
2864118|NCT02161562|9848268|P2|Overall Study|Withdrew due to being out of the country|0
2864119|NCT02161562|9848269|P1|Overall Study|Withdrew due to being out of the country|1
2864120|NCT02161562|9848268|P2|Overall Study|Participant moved back to home country|0
2864121|NCT02161562|9848269|P1|Overall Study|Participant moved back to home country|1
2864122|NCT02161562|9848268|P2|Overall Study|Adverse Event|1
2864123|NCT02161562|9848269|P1|Overall Study|Adverse Event|1
2864124|NCT02161562|9848268|P2|Overall Study|Lack of Efficacy|1
2864125|NCT02161562|9848269|P1|Overall Study|Lack of Efficacy|4
2864126|NCT02161562|9848268|P2|Overall Study|Lost to Follow-up|1
2864127|NCT02161562|9848269|P1|Overall Study|Lost to Follow-up|3
2864128|NCT02161562|9848268|P2|Overall Study|Pregnancy|2
2864129|NCT02161562|9848269|P1|Overall Study|Pregnancy|1
2864130|NCT02161562|9848268|P2|Overall Study|Protocol Violation|4
2864131|NCT02161562|9848269|P1|Overall Study|Protocol Violation|9
2864132|NCT02161562|9848268|P2|Overall Study|Withdrawal by Subject|8
2864133|NCT02161562|9848269|P1|Overall Study|Withdrawal by Subject|5
2864134|NCT02161549|9848297|P2|Overall Study|Physician Decision|2
2864135|NCT02161549|9848298|P1|Overall Study|Physician Decision|6
2864136|NCT02161458|9848346|P4|Overall Study|Lost to Follow-up|0
2864137|NCT02161458|9848347|P3|Overall Study|Lost to Follow-up|1
2864138|NCT02161458|9848348|P2|Overall Study|Lost to Follow-up|2
2864139|NCT02161458|9848349|P1|Overall Study|Lost to Follow-up|0
2864140|NCT02161458|9848346|P4|Overall Study|Withdrawal by Subject|0
2864141|NCT02161458|9848347|P3|Overall Study|Withdrawal by Subject|4
2864142|NCT02161458|9848348|P2|Overall Study|Withdrawal by Subject|4
2864143|NCT02161458|9848349|P1|Overall Study|Withdrawal by Subject|0
2864144|NCT02161406|9848361|P2|Overall Study|relocation|1
2864145|NCT02161406|9848362|P1|Overall Study|relocation|0
2864146|NCT02161406|9848361|P2|Overall Study|Lack of Efficacy|1
2864147|NCT02161406|9848362|P1|Overall Study|Lack of Efficacy|1
2864148|NCT02161406|9848361|P2|Overall Study|investigator withdrew subject|1
2864149|NCT02161406|9848362|P1|Overall Study|investigator withdrew subject|3
2864150|NCT02161406|9848361|P2|Overall Study|Withdrawal by Subject|4
2864151|NCT02161406|9848362|P1|Overall Study|Withdrawal by Subject|2
2864152|NCT02161406|9848361|P2|Overall Study|Lost to Follow-up|1
2864153|NCT02161406|9848362|P1|Overall Study|Lost to Follow-up|2
2864154|NCT02161406|9848361|P2|Overall Study|Death|1
2864155|NCT02161406|9848362|P1|Overall Study|Death|2
2864156|NCT02161185|9848436|P1|Treatment Phase|Administrative/Other|7
2864157|NCT02161146|9848446|P5|Overall Study|Other Miscellaneous Reasons|0
2864158|NCT02161146|9848447|P4|Overall Study|Other Miscellaneous Reasons|0
2864159|NCT02161146|9848448|P3|Overall Study|Other Miscellaneous Reasons|0
2864160|NCT02161146|9848449|P2|Overall Study|Other Miscellaneous Reasons|1
2864161|NCT02161146|9848450|P1|Overall Study|Other Miscellaneous Reasons|0
2864162|NCT02161146|9848446|P5|Overall Study|Personal Reasons|1
2864163|NCT02161146|9848447|P4|Overall Study|Personal Reasons|2
2864164|NCT02161146|9848448|P3|Overall Study|Personal Reasons|0
2864165|NCT02161146|9848449|P2|Overall Study|Personal Reasons|1
2864166|NCT02161146|9848450|P1|Overall Study|Personal Reasons|0
2864167|NCT02161146|9848446|P5|Overall Study|Lost to Follow-up|0
2864168|NCT02161146|9848447|P4|Overall Study|Lost to Follow-up|0
2864169|NCT02161146|9848448|P3|Overall Study|Lost to Follow-up|0
2864170|NCT02161146|9848449|P2|Overall Study|Lost to Follow-up|1
2864171|NCT02161146|9848450|P1|Overall Study|Lost to Follow-up|0
2864172|NCT02161146|9848446|P5|Overall Study|Adverse Event|0
2864173|NCT02161146|9848447|P4|Overall Study|Adverse Event|1
2864174|NCT02161146|9848448|P3|Overall Study|Adverse Event|0
2864175|NCT02161146|9848449|P2|Overall Study|Adverse Event|1
2864176|NCT02161146|9848450|P1|Overall Study|Adverse Event|1
2864177|NCT02161016|9848463|P1|Overall Study|withdrawn by IRB|1
2864178|NCT02160977|9848494|P2|Six Months After Surgery|Lost to Follow-up|1
2864179|NCT02160977|9848495|P1|Six Months After Surgery|Lost to Follow-up|2
2864180|NCT02160977|9848494|P2|Three Months After Surgery|Lost to Follow-up|2
2864181|NCT02160977|9848495|P1|Three Months After Surgery|Lost to Follow-up|0
2864182|NCT02160977|9848494|P2|Six Weeks After Surgery|Lost to Follow-up|0
2864183|NCT02160977|9848495|P1|Six Weeks After Surgery|Lost to Follow-up|1
2864184|NCT02160899|9848511|P6|Overall Study|Adverse Event or Serious Adverse Event|0
2864185|NCT02160899|9848512|P5|Overall Study|Adverse Event or Serious Adverse Event|2
2864186|NCT02160899|9848513|P4|Overall Study|Adverse Event or Serious Adverse Event|1
2864187|NCT02160899|9848514|P3|Overall Study|Adverse Event or Serious Adverse Event|0
2864188|NCT02160899|9848515|P2|Overall Study|Adverse Event or Serious Adverse Event|1
2864189|NCT02160899|9848516|P1|Overall Study|Adverse Event or Serious Adverse Event|0
2864190|NCT02160626|9848578|P3|Overall Study|Withdrawal by Subject|0
2864191|NCT02160626|9848579|P2|Overall Study|Withdrawal by Subject|1
2864192|NCT02160626|9848580|P1|Overall Study|Withdrawal by Subject|0
2864193|NCT02160626|9848578|P3|Overall Study|Schedule not conducive to study visits|1
2864194|NCT02160626|9848579|P2|Overall Study|Schedule not conducive to study visits|0
2864195|NCT02160626|9848580|P1|Overall Study|Schedule not conducive to study visits|0
2864196|NCT02160626|9848578|P3|Overall Study|Adverse Event|0
2864197|NCT02160626|9848579|P2|Overall Study|Adverse Event|0
2864198|NCT02160626|9848580|P1|Overall Study|Adverse Event|1
2864199|NCT02160314|9848603|P2|Overall Study|Lost to Follow-up|1
2864200|NCT02160314|9848604|P1|Overall Study|Lost to Follow-up|0
2864201|NCT02160314|9848603|P2|Overall Study|Withdrawal by Subject|2
2864202|NCT02160314|9848604|P1|Overall Study|Withdrawal by Subject|1
2864203|NCT02160314|9848603|P2|Overall Study|Protocol Violation|4
2864204|NCT02160314|9848604|P1|Overall Study|Protocol Violation|0
2864205|NCT02160314|9848603|P2|Overall Study|Adverse Event|6
2864206|NCT02160314|9848604|P1|Overall Study|Adverse Event|0
2864207|NCT02160145|9848639|P3|Randomized Double-blind Period|Physician Decision|5
2864208|NCT02160145|9848640|P2|Randomized Double-blind Period|Physician Decision|7
2864209|NCT02160145|9848641|P1|Randomized Double-blind Period|Physician Decision|0
2864210|NCT02160145|9848639|P3|Randomized Double-blind Period|Lost to Follow-up|3
2864211|NCT02160145|9848640|P2|Randomized Double-blind Period|Lost to Follow-up|1
2864212|NCT02160145|9848641|P1|Randomized Double-blind Period|Lost to Follow-up|0
2864213|NCT02160145|9848639|P3|Randomized Double-blind Period|Subject decision|20
2864214|NCT02160145|9848640|P2|Randomized Double-blind Period|Subject decision|21
2864215|NCT02160145|9848641|P1|Randomized Double-blind Period|Subject decision|0
2864216|NCT02160145|9848639|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2864217|NCT02160145|9848640|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2864218|NCT02160145|9848641|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
2864219|NCT02160145|9848639|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
2864220|NCT02160145|9848640|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
2864221|NCT02160145|9848641|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
2864222|NCT02160041|9848654|P1|Overall Study|study terminated by by sponsor|1
2864223|NCT02160041|9848654|P1|Overall Study|Withdrawal by Subject|8
2864224|NCT02160041|9848654|P1|Overall Study|Physician Decision|3
2864225|NCT02160041|9848654|P1|Overall Study|non-compliance with study|1
2864226|NCT02160041|9848654|P1|Overall Study|Protocol Violation|1
2864227|NCT02160041|9848654|P1|Overall Study|disease progression|57
2864228|NCT02160041|9848654|P1|Overall Study|Death|2
2864229|NCT02160041|9848654|P1|Overall Study|Adverse Event|11
2864230|NCT02160002|9848666|P2|Overall Study|Withdrawal by Subject|1
2864231|NCT02160002|9848667|P1|Overall Study|Withdrawal by Subject|2
2864232|NCT02159950|9848714|P2|Overall Study|Progression|1
2864233|NCT02159950|9848715|P1|Overall Study|Progression|0
2864234|NCT02159950|9848714|P2|Overall Study|Adverse Event|1
2864235|NCT02159950|9848715|P1|Overall Study|Adverse Event|0
2864236|NCT02159807|9848774|P3|Overall Study|elevated blood pressure|1
2864237|NCT02159807|9848775|P2|Overall Study|elevated blood pressure|0
2864238|NCT02159807|9848776|P1|Overall Study|elevated blood pressure|0
2864239|NCT02159807|9848774|P3|Overall Study|No CSF|1
2864240|NCT02159807|9848775|P2|Overall Study|No CSF|1
2864241|NCT02159807|9848776|P1|Overall Study|No CSF|1
2864242|NCT02159807|9848774|P3|Overall Study|Adverse Event|1
2864243|NCT02159807|9848775|P2|Overall Study|Adverse Event|0
2864244|NCT02159807|9848776|P1|Overall Study|Adverse Event|0
2864245|NCT02159729|9848797|P2|Overall Study|Other Unspecified|1
2864246|NCT02159729|9848798|P1|Overall Study|Other Unspecified|3
2864247|NCT02159729|9848797|P2|Overall Study|Non compliance|0
2864248|NCT02159729|9848798|P1|Overall Study|Non compliance|2
2864249|NCT02159729|9848797|P2|Overall Study|Lost to Follow-up|9
2864250|NCT02159729|9848798|P1|Overall Study|Lost to Follow-up|24
2864251|NCT02159729|9848797|P2|Overall Study|Subject's Request|10
2864252|NCT02159729|9848798|P1|Overall Study|Subject's Request|13
2864253|NCT02159729|9848797|P2|Overall Study|Adverse Event|1
2864254|NCT02159729|9848798|P1|Overall Study|Adverse Event|0
2864255|NCT02159521|9848825|P1|Overall Study|Other than specified|1
2864256|NCT02159521|9848825|P1|Overall Study|Death|1
2864257|NCT02159521|9848825|P1|Overall Study|Lost to Follow-up|6
2864258|NCT02159521|9848825|P1|Overall Study|Withdrawal by Subject|7
2864259|NCT02159521|9848825|P1|Overall Study|Enrolled but not treated|3
2864260|NCT02159482|9848846|P1|Overall Study|Physician Decision|3
2864261|NCT02159482|9848846|P1|Overall Study|Withdrawal by Subject|2
2864262|NCT02159469|9848851|P1|Overall Study|Multiple|29
2864263|NCT02159469|9848851|P1|Overall Study|Other|1
2864264|NCT02159469|9848851|P1|Overall Study|Met Stopping Criteria|3
2864265|NCT02159469|9848851|P1|Overall Study|Sponsor's request|2
2864266|NCT02159469|9848851|P1|Overall Study|Lost to Follow-up|1
2864267|NCT02159469|9848851|P1|Overall Study|Withdrawal by Subject|9
2864268|NCT02159469|9848851|P1|Overall Study|Non-compliance|2
2864269|NCT02159469|9848851|P1|Overall Study|Adverse Event|5
2864270|NCT02159469|9848851|P1|Overall Study|Missing Completion status|1
2864271|NCT02159365|9848856|P1|Overall Study|Lost to Follow-up|1
2864272|NCT02159365|9848856|P1|Overall Study|Death|1
2864273|NCT02159365|9848856|P1|Overall Study|Subject withdrew consent|3
2864274|NCT02159365|9848856|P1|Overall Study|Subject request to discontinue treatment|3
2864275|NCT02159365|9848856|P1|Overall Study|Maximum clinical benefit|3
2864276|NCT02159365|9848856|P1|Overall Study|Study drug toxicity|7
2864277|NCT02159365|9848856|P1|Overall Study|Adverse Event unrelated to study drug|9
2864278|NCT02159365|9848856|P1|Overall Study|Administrative reason by Sponsor|9
2864279|NCT02159365|9848856|P1|Overall Study|Other reasons|11
2864280|NCT02159365|9848856|P1|Overall Study|Disease Progression|23
2864281|NCT02159352|9848863|P2|Overall Study|Withdrawal by Subject|1
2864282|NCT02159352|9848864|P1|Overall Study|Withdrawal by Subject|0
2864283|NCT02159352|9848863|P2|Overall Study|Adverse Event|1
2864284|NCT02159352|9848864|P1|Overall Study|Adverse Event|3
2864285|NCT02159183|9848916|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
2864286|NCT02159183|9848917|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
2864287|NCT02159183|9848916|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
2864288|NCT02159183|9848917|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
2864289|NCT02159183|9848916|P2|Analysis After the 36 Months Follow-up|Death|1
2864290|NCT02159183|9848917|P1|Analysis After the 36 Months Follow-up|Death|0
2864291|NCT02159183|9848916|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
2864292|NCT02159183|9848917|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
2864293|NCT02159183|9848916|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
2864294|NCT02159183|9848917|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
2864295|NCT02159053|9848990|P3|Overall Study|Participants/guardian decision|6
2864296|NCT02159053|9848991|P2|Overall Study|Participants/guardian decision|10
2864297|NCT02159053|9848992|P1|Overall Study|Participants/guardian decision|8
2864298|NCT02159053|9848990|P3|Overall Study|Adverse Event|5
2864299|NCT02159053|9848991|P2|Overall Study|Adverse Event|6
2864300|NCT02159053|9848992|P1|Overall Study|Adverse Event|7
2864301|NCT02159053|9848990|P3|Overall Study|Lack of Efficacy|7
2864302|NCT02159053|9848991|P2|Overall Study|Lack of Efficacy|4
2864303|NCT02159053|9848992|P1|Overall Study|Lack of Efficacy|3
2864304|NCT02159053|9848990|P3|Overall Study|Physician Decision|1
2864305|NCT02159053|9848991|P2|Overall Study|Physician Decision|1
2864306|NCT02159053|9848992|P1|Overall Study|Physician Decision|0
2864307|NCT02159053|9848990|P3|Overall Study|Death|1
2864308|NCT02159053|9848991|P2|Overall Study|Death|0
2864309|NCT02159053|9848992|P1|Overall Study|Death|2
2864310|NCT02159040|9849029|P1|Overall Study|Death|1
2864311|NCT02158975|9849042|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
2864312|NCT02158936|9849052|P2|Overall Study|Lost to Follow-up|1
2864313|NCT02158936|9849053|P1|Overall Study|Lost to Follow-up|0
2864314|NCT02158936|9849052|P2|Overall Study|Physician Decision|13
2864315|NCT02158936|9849053|P1|Overall Study|Physician Decision|15
2864316|NCT02158936|9849052|P2|Overall Study|Withdrawal by Subject|16
2864317|NCT02158936|9849053|P1|Overall Study|Withdrawal by Subject|15
2864318|NCT02158936|9849052|P2|Overall Study|Adverse Event|24
2864319|NCT02158936|9849053|P1|Overall Study|Adverse Event|39
2864320|NCT02158936|9849052|P2|Overall Study|Azacitidine tx discontinued|46
2864321|NCT02158936|9849053|P1|Overall Study|Azacitidine tx discontinued|53
2864322|NCT02158936|9849052|P2|Overall Study|Study closed/ terminated|77
2864323|NCT02158936|9849053|P1|Overall Study|Study closed/ terminated|57
2864324|NCT02158884|9849095|P1|12 Month Assessment|Missed SMFA|17
2864325|NCT02158884|9849095|P1|6 Month Assessment|Missed SMFA|20
2864326|NCT02158884|9849095|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
2864327|NCT02158884|9849095|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
2864328|NCT02158884|9849095|P1|Baseline Assessment|Missed SMFA|1
2864329|NCT02158884|9849095|P1|Baseline Assessment|Missed performance assessment|3
2864330|NCT02158806|9849130|P2|Overall Study|Transferred to palliative care|1
2864331|NCT02158806|9849131|P1|Overall Study|Transferred to palliative care|0
2864332|NCT02158806|9849130|P2|Overall Study|Moved out of area|1
2864333|NCT02158806|9849131|P1|Overall Study|Moved out of area|0
2864334|NCT02158806|9849130|P2|Overall Study|Lost to Follow-up|3
2864335|NCT02158806|9849131|P1|Overall Study|Lost to Follow-up|0
2864336|NCT02158806|9849130|P2|Overall Study|Withdrawal by Subject|0
2864337|NCT02158806|9849131|P1|Overall Study|Withdrawal by Subject|2
2864338|NCT02158806|9849130|P2|Overall Study|Death|0
2864339|NCT02158806|9849131|P1|Overall Study|Death|2
2864340|NCT02158728|9849151|P1|Overall Study|no qualified dataset|24
2864341|NCT02158728|9849151|P1|Overall Study|no procedure according to CIP done|3
2864342|NCT02158663|9849157|P2|Overall Study|Withdrawal by Subject|4
2864343|NCT02158663|9849158|P1|Overall Study|Withdrawal by Subject|5
2864344|NCT02158546|9849181|P4|Overall Study|Site Excluded|4
2864345|NCT02158546|9849182|P3|Overall Study|Site Excluded|3
2864346|NCT02158546|9849183|P2|Overall Study|Site Excluded|5
2864347|NCT02158546|9849184|P1|Overall Study|Site Excluded|5
2864348|NCT02158546|9849181|P4|Overall Study|Lost to Follow-up|1
2864349|NCT02158546|9849182|P3|Overall Study|Lost to Follow-up|0
2864350|NCT02158546|9849183|P2|Overall Study|Lost to Follow-up|4
2864351|NCT02158546|9849184|P1|Overall Study|Lost to Follow-up|5
2864352|NCT02158546|9849181|P4|Overall Study|Withdrawal by Subject|0
2864353|NCT02158546|9849182|P3|Overall Study|Withdrawal by Subject|1
2864354|NCT02158546|9849183|P2|Overall Study|Withdrawal by Subject|2
2864355|NCT02158546|9849184|P1|Overall Study|Withdrawal by Subject|6
2864356|NCT02158546|9849181|P4|Overall Study|Adverse Event|0
2864357|NCT02158546|9849182|P3|Overall Study|Adverse Event|0
2864358|NCT02158546|9849183|P2|Overall Study|Adverse Event|2
2864359|NCT02158546|9849184|P1|Overall Study|Adverse Event|2
2864360|NCT02158546|9849181|P4|Overall Study|Lack of Efficacy|0
2864361|NCT02158546|9849182|P3|Overall Study|Lack of Efficacy|0
2864362|NCT02158546|9849183|P2|Overall Study|Lack of Efficacy|1
2864363|NCT02158546|9849184|P1|Overall Study|Lack of Efficacy|1
2864364|NCT02158546|9849181|P4|Overall Study|Failure to meet eligibility criteria|0
2864365|NCT02158546|9849182|P3|Overall Study|Failure to meet eligibility criteria|0
2864366|NCT02158546|9849183|P2|Overall Study|Failure to meet eligibility criteria|1
2864367|NCT02158546|9849184|P1|Overall Study|Failure to meet eligibility criteria|0
2864368|NCT02158546|9849181|P4|Overall Study|Non-compliance|1
2864369|NCT02158546|9849182|P3|Overall Study|Non-compliance|0
2864370|NCT02158546|9849183|P2|Overall Study|Non-compliance|1
2864371|NCT02158546|9849184|P1|Overall Study|Non-compliance|0
2864372|NCT02158546|9849181|P4|Overall Study|Physician Decision|0
2864373|NCT02158546|9849182|P3|Overall Study|Physician Decision|0
2864374|NCT02158546|9849183|P2|Overall Study|Physician Decision|1
2864375|NCT02158546|9849184|P1|Overall Study|Physician Decision|0
2864376|NCT02158533|9849203|P6|Stage 2|Non-adherence with study visits|1
2864377|NCT02158533|9849204|P5|Stage 2|Non-adherence with study visits|0
2864378|NCT02158533|9849205|P4|Stage 2|Non-adherence with study visits|0
2864379|NCT02158533|9849206|P3|Stage 2|Non-adherence with study visits|0
2864380|NCT02158533|9849207|P2|Stage 2|Non-adherence with study visits|0
2864381|NCT02158533|9849208|P1|Stage 2|Non-adherence with study visits|0
2864382|NCT02158533|9849203|P6|Stage 2|Psychiatrist decision to try new tx|0
2864383|NCT02158533|9849204|P5|Stage 2|Psychiatrist decision to try new tx|0
2864384|NCT02158533|9849205|P4|Stage 2|Psychiatrist decision to try new tx|1
2864385|NCT02158533|9849206|P3|Stage 2|Psychiatrist decision to try new tx|0
2864386|NCT02158533|9849207|P2|Stage 2|Psychiatrist decision to try new tx|0
2864387|NCT02158533|9849208|P1|Stage 2|Psychiatrist decision to try new tx|0
2864388|NCT02158533|9849203|P6|Stage 2|Pregnancy|0
2864389|NCT02158533|9849204|P5|Stage 2|Pregnancy|0
2864390|NCT02158533|9849205|P4|Stage 2|Pregnancy|1
2864391|NCT02158533|9849206|P3|Stage 2|Pregnancy|0
2864392|NCT02158533|9849207|P2|Stage 2|Pregnancy|0
2864393|NCT02158533|9849208|P1|Stage 2|Pregnancy|0
2864394|NCT02158533|9849203|P6|Stage 2|Physician Decision|0
2864395|NCT02158533|9849204|P5|Stage 2|Physician Decision|1
2864396|NCT02158533|9849205|P4|Stage 2|Physician Decision|0
2864397|NCT02158533|9849206|P3|Stage 2|Physician Decision|0
2864398|NCT02158533|9849207|P2|Stage 2|Physician Decision|0
2864399|NCT02158533|9849208|P1|Stage 2|Physician Decision|0
2864400|NCT02158533|9849203|P6|Stage 2|Withdrawal by Subject|2
2864401|NCT02158533|9849204|P5|Stage 2|Withdrawal by Subject|1
2864402|NCT02158533|9849205|P4|Stage 2|Withdrawal by Subject|0
2864403|NCT02158533|9849206|P3|Stage 2|Withdrawal by Subject|0
2864404|NCT02158533|9849207|P2|Stage 2|Withdrawal by Subject|0
2864405|NCT02158533|9849208|P1|Stage 2|Withdrawal by Subject|0
2864406|NCT02158533|9849203|P6|Stage 2|Lost to Follow-up|2
2864407|NCT02158533|9849204|P5|Stage 2|Lost to Follow-up|1
2864408|NCT02158533|9849205|P4|Stage 2|Lost to Follow-up|1
2864409|NCT02158533|9849206|P3|Stage 2|Lost to Follow-up|0
2864410|NCT02158533|9849207|P2|Stage 2|Lost to Follow-up|0
2864411|NCT02158533|9849208|P1|Stage 2|Lost to Follow-up|0
2864412|NCT02158533|9849203|P6|Stage 2|Lack of Efficacy|0
2864413|NCT02158533|9849204|P5|Stage 2|Lack of Efficacy|1
2864414|NCT02158533|9849205|P4|Stage 2|Lack of Efficacy|0
2864415|NCT02158533|9849206|P3|Stage 2|Lack of Efficacy|0
2864416|NCT02158533|9849207|P2|Stage 2|Lack of Efficacy|0
2864417|NCT02158533|9849208|P1|Stage 2|Lack of Efficacy|0
2864418|NCT02158533|9849203|P6|Stage 2|Adverse Event|1
2864419|NCT02158533|9849204|P5|Stage 2|Adverse Event|0
2864420|NCT02158533|9849205|P4|Stage 2|Adverse Event|0
2864421|NCT02158533|9849206|P3|Stage 2|Adverse Event|0
2864422|NCT02158533|9849207|P2|Stage 2|Adverse Event|0
2864423|NCT02158533|9849208|P1|Stage 2|Adverse Event|0
2864424|NCT02158533|9849203|P6|Stage 1|Non-compliance with study visits|0
2864425|NCT02158533|9849204|P5|Stage 1|Non-compliance with study visits|0
2864426|NCT02158533|9849205|P4|Stage 1|Non-compliance with study visits|0
2864427|NCT02158533|9849206|P3|Stage 1|Non-compliance with study visits|0
2864428|NCT02158533|9849207|P2|Stage 1|Non-compliance with study visits|0
2864429|NCT02158533|9849208|P1|Stage 1|Non-compliance with study visits|1
2864430|NCT02158533|9849203|P6|Stage 1|Failure to Meet Eligibility Criteria|0
2864431|NCT02158533|9849204|P5|Stage 1|Failure to Meet Eligibility Criteria|0
2864432|NCT02158533|9849205|P4|Stage 1|Failure to Meet Eligibility Criteria|0
2864433|NCT02158533|9849206|P3|Stage 1|Failure to Meet Eligibility Criteria|0
2864434|NCT02158533|9849207|P2|Stage 1|Failure to Meet Eligibility Criteria|1
2864435|NCT02158533|9849208|P1|Stage 1|Failure to Meet Eligibility Criteria|0
2864436|NCT02158533|9849203|P6|Stage 1|Lost to Follow-up|0
2864437|NCT02158533|9849204|P5|Stage 1|Lost to Follow-up|0
2864438|NCT02158533|9849205|P4|Stage 1|Lost to Follow-up|0
2864439|NCT02158533|9849206|P3|Stage 1|Lost to Follow-up|0
2864440|NCT02158533|9849207|P2|Stage 1|Lost to Follow-up|1
2864441|NCT02158533|9849208|P1|Stage 1|Lost to Follow-up|3
2864442|NCT02158533|9849203|P6|Stage 1|Lack of Efficacy|0
2864443|NCT02158533|9849204|P5|Stage 1|Lack of Efficacy|0
2864444|NCT02158533|9849205|P4|Stage 1|Lack of Efficacy|0
2864445|NCT02158533|9849206|P3|Stage 1|Lack of Efficacy|0
2864446|NCT02158533|9849207|P2|Stage 1|Lack of Efficacy|0
2864447|NCT02158533|9849208|P1|Stage 1|Lack of Efficacy|1
2864448|NCT02158533|9849203|P6|Stage 1|Withdrawal by Subject|0
2864449|NCT02158533|9849204|P5|Stage 1|Withdrawal by Subject|0
2864450|NCT02158533|9849205|P4|Stage 1|Withdrawal by Subject|0
2864451|NCT02158533|9849206|P3|Stage 1|Withdrawal by Subject|1
2864452|NCT02158533|9849207|P2|Stage 1|Withdrawal by Subject|2
2864453|NCT02158533|9849208|P1|Stage 1|Withdrawal by Subject|3
2864454|NCT02158533|9849203|P6|Stage 1|Adverse Event|0
2864455|NCT02158533|9849204|P5|Stage 1|Adverse Event|0
2864456|NCT02158533|9849205|P4|Stage 1|Adverse Event|0
2864457|NCT02158533|9849206|P3|Stage 1|Adverse Event|7
2864458|NCT02158533|9849207|P2|Stage 1|Adverse Event|4
2864459|NCT02158533|9849208|P1|Stage 1|Adverse Event|6
2864460|NCT02158442|9849284|P2|Overall Study|Perfusion staff not available|0
2864461|NCT02158442|9849285|P1|Overall Study|Perfusion staff not available|1
2864462|NCT02158442|9849284|P2|Overall Study|Withdrawal by Subject|0
2864463|NCT02158442|9849285|P1|Overall Study|Withdrawal by Subject|1
2864464|NCT02158364|9849291|P1|Overall Study|Protocol Deviation|50
2864465|NCT02158364|9849291|P1|Overall Study|Case report forms uncollected|10
2864466|NCT02158247|9849309|P1|Overall Study|Invisible vocal cords|5
2864467|NCT02158091|9849328|P3|Overall Study|DLT|0
2864468|NCT02158091|9849329|P2|Overall Study|DLT|1
2864469|NCT02158091|9849330|P1|Overall Study|DLT|2
2864470|NCT02158039|9849338|P1|Overall Study|Screen Failure|9
2864471|NCT02158039|9849338|P1|Overall Study|Withdrawal by Subject|1
2864472|NCT02157948|9849345|P2|Overall Study|Decision by Sponsor|1
2864473|NCT02157948|9849346|P1|Overall Study|Decision by Sponsor|0
2864474|NCT02157948|9849345|P2|Overall Study|Protocol Specified Criteria|1
2864475|NCT02157948|9849346|P1|Overall Study|Protocol Specified Criteria|2
2864476|NCT02157948|9849345|P2|Overall Study|Lost to Follow-up|2
2864477|NCT02157948|9849346|P1|Overall Study|Lost to Follow-up|3
2864478|NCT02157948|9849345|P2|Overall Study|Withdrawal by Subject|5
2864479|NCT02157948|9849346|P1|Overall Study|Withdrawal by Subject|4
2864480|NCT02157935|9849358|P2|Overall Study|Adverse Event|5
2864481|NCT02157935|9849359|P1|Overall Study|Adverse Event|3
2864482|NCT02157935|9849358|P2|Overall Study|Death|4
2864483|NCT02157935|9849359|P1|Overall Study|Death|4
2864484|NCT02157935|9849358|P2|Overall Study|Lack of Efficacy|1
2864485|NCT02157935|9849359|P1|Overall Study|Lack of Efficacy|0
2864486|NCT02157935|9849358|P2|Overall Study|Other|12
2864487|NCT02157935|9849359|P1|Overall Study|Other|5
2864488|NCT02157935|9849358|P2|Overall Study|Progressive disease|2
2864489|NCT02157935|9849359|P1|Overall Study|Progressive disease|0
2864490|NCT02157935|9849358|P2|Overall Study|Protocol Violation|0
2864491|NCT02157935|9849359|P1|Overall Study|Protocol Violation|1
2864492|NCT02157935|9849358|P2|Overall Study|Screen failure|2
2864493|NCT02157935|9849359|P1|Overall Study|Screen failure|1
2864494|NCT02157935|9849358|P2|Overall Study|Withdrawal by Subject|39
2864495|NCT02157935|9849359|P1|Overall Study|Withdrawal by Subject|25
2864496|NCT02157883|9849385|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
2864497|NCT02157883|9849385|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
2864498|NCT02157883|9849385|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
2864499|NCT02157883|9849385|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
2864500|NCT02157883|9849385|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
2864501|NCT02157779|9849416|P2|Overall Study|Need for alternative treatment|0
2864502|NCT02157779|9849417|P1|Overall Study|Need for alternative treatment|1
2864503|NCT02157779|9849416|P2|Overall Study|Medical Issue|0
2864504|NCT02157779|9849417|P1|Overall Study|Medical Issue|1
2864505|NCT02157779|9849416|P2|Overall Study|Moved|0
2864506|NCT02157779|9849417|P1|Overall Study|Moved|1
2864507|NCT02157779|9849416|P2|Overall Study|No response to outreach after Baseline|1
2864508|NCT02157779|9849417|P1|Overall Study|No response to outreach after Baseline|1
2864509|NCT02157779|9849416|P2|Overall Study|Withdrawal by Subject|1
2864510|NCT02157779|9849417|P1|Overall Study|Withdrawal by Subject|4
2864511|NCT02157779|9849416|P2|Overall Study|Failure to comply - Missed Sessions|5
2864512|NCT02157779|9849417|P1|Overall Study|Failure to comply - Missed Sessions|8
2864513|NCT02157779|9849416|P2|Overall Study|Logistical|4
2864514|NCT02157779|9849417|P1|Overall Study|Logistical|8
2864515|NCT02157623|9849441|P2|Overall Study|Physician Decision|3
2864516|NCT02157623|9849442|P1|Overall Study|Physician Decision|4
2864517|NCT02157519|9849450|P2|Overall Study|Lost to Follow-up|0
2864518|NCT02157519|9849451|P1|Overall Study|Lost to Follow-up|1
2864519|NCT02157519|9849450|P2|Overall Study|Withdrawal by Subject|0
2864520|NCT02157519|9849451|P1|Overall Study|Withdrawal by Subject|7
2864521|NCT02157519|9849450|P2|Overall Study|Death|1
2864522|NCT02157519|9849451|P1|Overall Study|Death|3
2864523|NCT02157506|9849474|P5|Overall Study|Lost to Follow-up|0
2864524|NCT02157506|9849475|P4|Overall Study|Lost to Follow-up|0
2864525|NCT02157506|9849476|P3|Overall Study|Lost to Follow-up|1
2864526|NCT02157506|9849477|P2|Overall Study|Lost to Follow-up|0
2864527|NCT02157506|9849478|P1|Overall Study|Lost to Follow-up|0
2864528|NCT02157506|9849474|P5|Overall Study|Adverse Event|0
2864529|NCT02157506|9849475|P4|Overall Study|Adverse Event|0
2864530|NCT02157506|9849476|P3|Overall Study|Adverse Event|0
2864531|NCT02157506|9849477|P2|Overall Study|Adverse Event|1
2864532|NCT02157506|9849478|P1|Overall Study|Adverse Event|0
2864533|NCT02157376|9849537|P2|Overall Study|Investigator's misjudgement|2
2864534|NCT02157376|9849538|P1|Overall Study|Investigator's misjudgement|1
2864535|NCT02157376|9849537|P2|Overall Study|Not treated|3
2864536|NCT02157376|9849538|P1|Overall Study|Not treated|8
2864537|NCT02157376|9849537|P2|Overall Study|Withdrawal by Subject|8
2864538|NCT02157376|9849538|P1|Overall Study|Withdrawal by Subject|3
2864539|NCT02157376|9849537|P2|Overall Study|Eligibility criteria not fulfilled|1
2864540|NCT02157376|9849538|P1|Overall Study|Eligibility criteria not fulfilled|0
2864541|NCT02157376|9849537|P2|Overall Study|Death|4
2864542|NCT02157376|9849538|P1|Overall Study|Death|10
2864543|NCT02157298|9849548|P2|Overall Study|Withdrawal by Subject|0
2864544|NCT02157298|9849549|P1|Overall Study|Withdrawal by Subject|1
2864545|NCT02157298|9849548|P2|Overall Study|Poor/Non-compliance|0
2864546|NCT02157298|9849549|P1|Overall Study|Poor/Non-compliance|1
2864547|NCT02157298|9849548|P2|Overall Study|Subject no longer meets study criteria|2
2864548|NCT02157298|9849549|P1|Overall Study|Subject no longer meets study criteria|1
2864549|NCT02157298|9849548|P2|Overall Study|Adverse Event|0
2864550|NCT02157298|9849549|P1|Overall Study|Adverse Event|1
2864551|NCT02157116|9849588|P1|Overall Study|Failed Screening|2
2864552|NCT02157116|9849588|P1|Overall Study|Physician Decision|3
2864553|NCT02157116|9849588|P1|Overall Study|Withdrawal by Subject|4
2864554|NCT02156804|9849603|P1|Overall Study|Withdrawal by Subject|1
2864555|NCT02156492|9849614|P3|Period 3|Adverse Event|0
2864556|NCT02156492|9849615|P2|Period 3|Adverse Event|1
2864557|NCT02156492|9849616|P1|Period 3|Adverse Event|0
2864558|NCT02156492|9849614|P3|Period 1|No Reason Given|0
2864559|NCT02156492|9849615|P2|Period 1|No Reason Given|1
2864560|NCT02156492|9849616|P1|Period 1|No Reason Given|0
2864561|NCT02156466|9849642|P5|Overall Study|Quantiferon Positivity|0
2864562|NCT02156466|9849643|P4|Overall Study|Quantiferon Positivity|1
2864563|NCT02156466|9849644|P3|Overall Study|Quantiferon Positivity|0
2864564|NCT02156466|9849645|P2|Overall Study|Quantiferon Positivity|0
2864565|NCT02156466|9849646|P1|Overall Study|Quantiferon Positivity|0
2864566|NCT02156466|9849642|P5|Overall Study|Adverse Event|0
2864567|NCT02156466|9849643|P4|Overall Study|Adverse Event|1
2864568|NCT02156466|9849644|P3|Overall Study|Adverse Event|1
2864569|NCT02156466|9849645|P2|Overall Study|Adverse Event|0
2864570|NCT02156466|9849646|P1|Overall Study|Adverse Event|0
2864571|NCT02156271|9849827|P2|Overall Study|Physician Decision|3
2864572|NCT02156271|9849828|P1|Overall Study|Physician Decision|4
2864573|NCT02156076|9849881|P4|Follow-up Period|Withdrawal by Subject|0
2864574|NCT02156076|9849882|P3|Follow-up Period|Withdrawal by Subject|0
2864575|NCT02156076|9849883|P2|Follow-up Period|Withdrawal by Subject|0
2864576|NCT02156076|9849884|P1|Follow-up Period|Withdrawal by Subject|1
2864577|NCT02156076|9849881|P4|Treatment Period|Adverse Event|1
2864578|NCT02156076|9849882|P3|Treatment Period|Adverse Event|0
2864579|NCT02156076|9849883|P2|Treatment Period|Adverse Event|0
2864580|NCT02156076|9849884|P1|Treatment Period|Adverse Event|0
2864581|NCT02156076|9849881|P4|Treatment Period|Subject request to discontinue treatment|0
2864582|NCT02156076|9849882|P3|Treatment Period|Subject request to discontinue treatment|0
2864583|NCT02156076|9849883|P2|Treatment Period|Subject request to discontinue treatment|1
2864584|NCT02156076|9849884|P1|Treatment Period|Subject request to discontinue treatment|0
2864585|NCT02156076|9849881|P4|Treatment Period|Withdrawal by Subject|0
2864586|NCT02156076|9849882|P3|Treatment Period|Withdrawal by Subject|1
2864587|NCT02156076|9849883|P2|Treatment Period|Withdrawal by Subject|0
2864588|NCT02156076|9849884|P1|Treatment Period|Withdrawal by Subject|0
2864589|NCT02156076|9849881|P4|Treatment Period|Lost to Follow-up|1
2864590|NCT02156076|9849882|P3|Treatment Period|Lost to Follow-up|0
2864591|NCT02156076|9849883|P2|Treatment Period|Lost to Follow-up|0
2864592|NCT02156076|9849884|P1|Treatment Period|Lost to Follow-up|0
2864593|NCT02156076|9849881|P4|Treatment Period|Poor/non-compliance|0
2864594|NCT02156076|9849882|P3|Treatment Period|Poor/non-compliance|0
2864595|NCT02156076|9849883|P2|Treatment Period|Poor/non-compliance|1
2864596|NCT02156076|9849884|P1|Treatment Period|Poor/non-compliance|0
2864597|NCT02156076|9849881|P4|Treatment Period|no longer meets study criteria|0
2864598|NCT02156076|9849882|P3|Treatment Period|no longer meets study criteria|1
2864599|NCT02156076|9849883|P2|Treatment Period|no longer meets study criteria|0
2864600|NCT02156076|9849884|P1|Treatment Period|no longer meets study criteria|0
2864601|NCT02155985|9849941|P3|Overall Study|Lost to Follow-up|0
2864602|NCT02155985|9849942|P2|Overall Study|Lost to Follow-up|0
2864603|NCT02155985|9849943|P1|Overall Study|Lost to Follow-up|1
2864604|NCT02155985|9849941|P3|Overall Study|Withdrawal by Subject|1
2864605|NCT02155985|9849942|P2|Overall Study|Withdrawal by Subject|0
2864606|NCT02155985|9849943|P1|Overall Study|Withdrawal by Subject|0
2864607|NCT02155881|9850010|P2|Overall Study|Inappropriately randomized|2
2864608|NCT02155881|9850011|P1|Overall Study|Inappropriately randomized|2
2864609|NCT02155881|9850010|P2|Overall Study|Withdrawal by Subject|2
2864610|NCT02155881|9850011|P1|Overall Study|Withdrawal by Subject|0
2864611|NCT02155738|9850035|P4|Overall Study|Missing critical information|1
2864612|NCT02155738|9850036|P3|Overall Study|Missing critical information|0
2864613|NCT02155738|9850037|P2|Overall Study|Missing critical information|0
2864614|NCT02155738|9850038|P1|Overall Study|Missing critical information|1
2864615|NCT02155712|9850058|P2|Primary Objective|Withdrawal by Subject|0
2864616|NCT02155712|9850059|P1|Primary Objective|Withdrawal by Subject|21
2864617|NCT02155712|9850058|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
2864618|NCT02155712|9850059|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
2864619|NCT02155712|9850058|P2|Primary Objective|No 2-Year Forms but not Terminated|0
2864620|NCT02155712|9850059|P1|Primary Objective|No 2-Year Forms but not Terminated|13
2864621|NCT02155712|9850058|P2|Primary Objective|Lost to Follow-up|0
2864622|NCT02155712|9850059|P1|Primary Objective|Lost to Follow-up|22
2864623|NCT02155712|9850058|P2|Primary Objective|Death|0
2864624|NCT02155712|9850059|P1|Primary Objective|Death|3
2864625|NCT02155660|9850069|P4|Overall Study|Withdrawal by Subject|21
2864626|NCT02155660|9850070|P3|Overall Study|Withdrawal by Subject|24
2864627|NCT02155660|9850071|P2|Overall Study|Withdrawal by Subject|31
2864628|NCT02155660|9850072|P1|Overall Study|Withdrawal by Subject|28
2864629|NCT02155660|9850069|P4|Overall Study|Death|19
2864630|NCT02155660|9850070|P3|Overall Study|Death|17
2864631|NCT02155660|9850071|P2|Overall Study|Death|19
2864632|NCT02155660|9850072|P1|Overall Study|Death|17
2864633|NCT02155660|9850069|P4|Overall Study|Lost to Follow-up|8
2864634|NCT02155660|9850070|P3|Overall Study|Lost to Follow-up|5
2864635|NCT02155660|9850071|P2|Overall Study|Lost to Follow-up|6
2864636|NCT02155660|9850072|P1|Overall Study|Lost to Follow-up|3
2864637|NCT02155660|9850069|P4|Overall Study|Adverse Event|1
2864638|NCT02155660|9850070|P3|Overall Study|Adverse Event|3
2864639|NCT02155660|9850071|P2|Overall Study|Adverse Event|6
2864640|NCT02155660|9850072|P1|Overall Study|Adverse Event|2
2864641|NCT02155660|9850069|P4|Overall Study|Severe non-compliance|1
2864642|NCT02155660|9850070|P3|Overall Study|Severe non-compliance|0
2864643|NCT02155660|9850071|P2|Overall Study|Severe non-compliance|4
2864644|NCT02155660|9850072|P1|Overall Study|Severe non-compliance|0
2864645|NCT02155660|9850069|P4|Overall Study|Study-specific withdrawal criteria|1
2864646|NCT02155660|9850070|P3|Overall Study|Study-specific withdrawal criteria|1
2864647|NCT02155660|9850071|P2|Overall Study|Study-specific withdrawal criteria|1
2864648|NCT02155660|9850072|P1|Overall Study|Study-specific withdrawal criteria|0
2864649|NCT02155660|9850069|P4|Overall Study|Other Reason|10
2864650|NCT02155660|9850070|P3|Overall Study|Other Reason|10
2864651|NCT02155660|9850071|P2|Overall Study|Other Reason|6
2864652|NCT02155660|9850072|P1|Overall Study|Other Reason|8
2864653|NCT02155608|9850155|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2864654|NCT02155608|9850156|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2864655|NCT02155608|9850155|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
2864656|NCT02155608|9850156|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
2864657|NCT02155322|9850253|P1|Overall Study|Withdrawal by Subject|4
2864658|NCT02155322|9850253|P1|Overall Study|Relapse/Recurrence|8
2864659|NCT02155322|9850253|P1|Overall Study|Physician Decision|1
2864660|NCT02155322|9850253|P1|Overall Study|Adverse Event|1
2864661|NCT02155309|9850260|P3|Overall Study|Protocol Violation|1
2864662|NCT02155309|9850261|P2|Overall Study|Protocol Violation|0
2864663|NCT02155309|9850262|P1|Overall Study|Protocol Violation|0
2864664|NCT02155283|9850269|P1|Overall Study|Protocol Violation|3
2864665|NCT02155283|9850269|P1|Overall Study|Withdrawal by Subject|1
2864666|NCT02155283|9850269|P1|Overall Study|Lost to Follow-up|3
2864667|NCT02154581|9850445|P2|Overall Study|Lost to Follow-up|8
2864668|NCT02154581|9850446|P1|Overall Study|Lost to Follow-up|7
2864669|NCT02154425|9850471|P1|Screening Period|Adverse Event|1
2864670|NCT02154347|9850516|P2|Open-label Period|Withdrawal by Subject|1
2864671|NCT02154347|9850517|P1|Open-label Period|Withdrawal by Subject|0
2864672|NCT02154347|9850516|P2|Open-label Period|Protocol Violation|1
2864673|NCT02154347|9850517|P1|Open-label Period|Protocol Violation|0
2864674|NCT02154347|9850516|P2|Open-label Period|Lack of Efficacy|19
2864675|NCT02154347|9850517|P1|Open-label Period|Lack of Efficacy|4
2864676|NCT02154347|9850516|P2|Open-label Period|Adverse Event|4
2864677|NCT02154347|9850517|P1|Open-label Period|Adverse Event|3
2864678|NCT02154347|9850516|P2|Double-blind Period|Withdrawal by Subject|1
2864679|NCT02154347|9850517|P1|Double-blind Period|Withdrawal by Subject|1
2864680|NCT02154347|9850516|P2|Double-blind Period|Physician Decision|1
2864681|NCT02154347|9850517|P1|Double-blind Period|Physician Decision|0
2864682|NCT02154347|9850516|P2|Double-blind Period|Lack of Efficacy|0
2864683|NCT02154347|9850517|P1|Double-blind Period|Lack of Efficacy|1
2864684|NCT02154347|9850516|P2|Double-blind Period|Adverse Event|2
2864685|NCT02154347|9850517|P1|Double-blind Period|Adverse Event|1
2864686|NCT02154139|9850540|P1|Overall Study|Investigator transferred|3
2864687|NCT02154139|9850540|P1|Overall Study|Other|2
2864688|NCT02154139|9850540|P1|Overall Study|Injection not administered|2
2864689|NCT02154087|9850548|P1|Overall Study|Study Termination|1
2864690|NCT02154061|9850554|P2|Overall Study|enrolled but not vaccinated|0
2864691|NCT02154061|9850555|P1|Overall Study|enrolled but not vaccinated|1
2864692|NCT02154061|9850554|P2|Overall Study|Pregnancy|0
2864693|NCT02154061|9850555|P1|Overall Study|Pregnancy|1
2864694|NCT02153918|9850602|P1|Overall Study|Refused further treatment|1
2864695|NCT02153905|9850613|P2|Overall Study|Death|0
2864696|NCT02153905|9850614|P1|Overall Study|Death|1
2864697|NCT02153827|9850632|P2|Overall Study|Lost to Follow-up|9
2864698|NCT02153827|9850633|P1|Overall Study|Lost to Follow-up|3
2864699|NCT02153788|9850649|P2|Overall Study|Physician Decision|1
2864700|NCT02153788|9850650|P1|Overall Study|Physician Decision|2
2864701|NCT02153736|9850670|P2|Overall Study|Withdrawal by Subject|1
2864702|NCT02153736|9850671|P1|Overall Study|Withdrawal by Subject|0
2864703|NCT02153736|9850670|P2|Overall Study|Death|1
2864704|NCT02153736|9850671|P1|Overall Study|Death|0
2864705|NCT02153736|9850670|P2|Overall Study|Medical status change made ineligible|0
2864706|NCT02153736|9850671|P1|Overall Study|Medical status change made ineligible|1
2864707|NCT02153736|9850670|P2|Overall Study|Lost to Follow-up|0
2864708|NCT02153736|9850671|P1|Overall Study|Lost to Follow-up|1
2864709|NCT02153398|9850898|P5|Overall Study|Adverse Event|0
2864710|NCT02153398|9850899|P4|Overall Study|Adverse Event|1
2864711|NCT02153398|9850900|P3|Overall Study|Adverse Event|1
2864712|NCT02153398|9850901|P2|Overall Study|Adverse Event|0
2864713|NCT02153398|9850902|P1|Overall Study|Adverse Event|0
2864714|NCT02153398|9850898|P5|Overall Study|Withdrawal by Subject|0
2864715|NCT02153398|9850899|P4|Overall Study|Withdrawal by Subject|0
2864716|NCT02153398|9850900|P3|Overall Study|Withdrawal by Subject|0
2864717|NCT02153398|9850901|P2|Overall Study|Withdrawal by Subject|0
2864718|NCT02153398|9850902|P1|Overall Study|Withdrawal by Subject|1
2864719|NCT02153359|9851024|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
2864720|NCT02153359|9851025|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
2864721|NCT02153346|9851059|P1|Overall Study|Lost to Follow-up|11
2864722|NCT02153112|9851076|P10|Overall Study|Reason not Specified|1
2864723|NCT02153112|9851077|P9|Overall Study|Reason not Specified|1
2864724|NCT02153112|9851078|P8|Overall Study|Reason not Specified|0
2864725|NCT02153112|9851079|P7|Overall Study|Reason not Specified|0
2864726|NCT02153112|9851080|P6|Overall Study|Reason not Specified|0
2864727|NCT02153112|9851081|P5|Overall Study|Reason not Specified|0
2864728|NCT02153112|9851082|P4|Overall Study|Reason not Specified|0
2864729|NCT02153112|9851083|P3|Overall Study|Reason not Specified|0
2864730|NCT02153112|9851084|P2|Overall Study|Reason not Specified|0
2864731|NCT02153112|9851085|P1|Overall Study|Reason not Specified|0
2864732|NCT02153112|9851076|P10|Overall Study|Withdrawal by Subject|12
2864733|NCT02153112|9851077|P9|Overall Study|Withdrawal by Subject|13
2864734|NCT02153112|9851078|P8|Overall Study|Withdrawal by Subject|2
2864735|NCT02153112|9851079|P7|Overall Study|Withdrawal by Subject|7
2864736|NCT02153112|9851080|P6|Overall Study|Withdrawal by Subject|1
2864737|NCT02153112|9851081|P5|Overall Study|Withdrawal by Subject|1
2864738|NCT02153112|9851082|P4|Overall Study|Withdrawal by Subject|2
2864739|NCT02153112|9851083|P3|Overall Study|Withdrawal by Subject|2
2864740|NCT02153112|9851084|P2|Overall Study|Withdrawal by Subject|1
2864741|NCT02153112|9851085|P1|Overall Study|Withdrawal by Subject|3
2864742|NCT02153112|9851076|P10|Overall Study|Lost to Follow-up|1
2864743|NCT02153112|9851077|P9|Overall Study|Lost to Follow-up|1
2864744|NCT02153112|9851078|P8|Overall Study|Lost to Follow-up|0
2864745|NCT02153112|9851079|P7|Overall Study|Lost to Follow-up|1
2864746|NCT02153112|9851080|P6|Overall Study|Lost to Follow-up|1
2864747|NCT02153112|9851081|P5|Overall Study|Lost to Follow-up|2
2864748|NCT02153112|9851082|P4|Overall Study|Lost to Follow-up|0
2864749|NCT02153112|9851083|P3|Overall Study|Lost to Follow-up|0
2864750|NCT02153112|9851084|P2|Overall Study|Lost to Follow-up|1
2864751|NCT02153112|9851085|P1|Overall Study|Lost to Follow-up|1
2864752|NCT02153112|9851076|P10|Overall Study|Adverse Event|0
2864753|NCT02153112|9851077|P9|Overall Study|Adverse Event|0
2864754|NCT02153112|9851078|P8|Overall Study|Adverse Event|0
2864755|NCT02153112|9851079|P7|Overall Study|Adverse Event|0
2864756|NCT02153112|9851080|P6|Overall Study|Adverse Event|0
2864757|NCT02153112|9851081|P5|Overall Study|Adverse Event|0
2864758|NCT02153112|9851082|P4|Overall Study|Adverse Event|0
2864759|NCT02153112|9851083|P3|Overall Study|Adverse Event|1
2864760|NCT02153112|9851084|P2|Overall Study|Adverse Event|0
2864761|NCT02153112|9851085|P1|Overall Study|Adverse Event|0
2864762|NCT02153086|9851424|P1|Overall Study|Other|2
2864763|NCT02153086|9851424|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
2864764|NCT02153073|9851438|P1|Overall Study|Protocol Deviation|68
2864765|NCT02153073|9851438|P1|Overall Study|Case Report Forms Uncollected|230
2864766|NCT02152631|9851453|P2|Overall Study|On Treatment|3
2864767|NCT02152631|9851454|P1|Overall Study|On Treatment|19
2864768|NCT02152631|9851453|P2|Overall Study|Lost to Follow-up|1
2864769|NCT02152631|9851454|P1|Overall Study|Lost to Follow-up|0
2864770|NCT02152631|9851453|P2|Overall Study|Physician Decision|2
2864771|NCT02152631|9851454|P1|Overall Study|Physician Decision|1
2864772|NCT02152631|9851453|P2|Overall Study|Noncompliance with study drug|0
2864773|NCT02152631|9851454|P1|Overall Study|Noncompliance with study drug|1
2864774|NCT02152631|9851453|P2|Overall Study|Withdrawal by Subject|16
2864775|NCT02152631|9851454|P1|Overall Study|Withdrawal by Subject|13
2864776|NCT02152631|9851453|P2|Overall Study|Adverse Event|4
2864777|NCT02152631|9851454|P1|Overall Study|Adverse Event|32
2864778|NCT02152605|9851473|P2|Overall Study|Withdrew consent|2
2864779|NCT02152605|9851474|P1|Overall Study|Withdrew consent|4
2864780|NCT02152605|9851473|P2|Overall Study|Lost to Follow-up|0
2864781|NCT02152605|9851474|P1|Overall Study|Lost to Follow-up|1
2864782|NCT02152605|9851473|P2|Overall Study|Protocol deviation|4
2864783|NCT02152605|9851474|P1|Overall Study|Protocol deviation|1
2864784|NCT02152605|9851473|P2|Overall Study|Lack of Efficacy|4
2864785|NCT02152605|9851474|P1|Overall Study|Lack of Efficacy|7
2864786|NCT02152605|9851473|P2|Overall Study|Adverse Event|8
2864787|NCT02152605|9851474|P1|Overall Study|Adverse Event|6
2864788|NCT02152566|9851484|P1|Overall Study|Withdrawal by Subject|2
2864789|NCT02152566|9851484|P1|Overall Study|Lost to Follow-up|1
2864790|NCT02152384|9851497|P2|Period 1|Adverse Event|1
2864791|NCT02152384|9851498|P1|Period 1|Adverse Event|1
2864792|NCT02152384|9851497|P2|Period 1|Withdrawal by Subject|1
2864793|NCT02152384|9851498|P1|Period 1|Withdrawal by Subject|0
2864794|NCT02152371|9851518|P2|Overall Study|Reason Not Given|1
2864795|NCT02152371|9851519|P1|Overall Study|Reason Not Given|0
2864796|NCT02152371|9851518|P2|Overall Study|Physician Decision|2
2864797|NCT02152371|9851519|P1|Overall Study|Physician Decision|0
2864798|NCT02152371|9851518|P2|Overall Study|Lack of Efficacy|1
2864799|NCT02152371|9851519|P1|Overall Study|Lack of Efficacy|0
2864800|NCT02152371|9851518|P2|Overall Study|Lost to Follow-up|0
2864801|NCT02152371|9851519|P1|Overall Study|Lost to Follow-up|1
2864802|NCT02152371|9851518|P2|Overall Study|Protocol Violation|3
2864803|NCT02152371|9851519|P1|Overall Study|Protocol Violation|2
2864804|NCT02152371|9851518|P2|Overall Study|Withdrawal by Subject|7
2864805|NCT02152371|9851519|P1|Overall Study|Withdrawal by Subject|3
2864806|NCT02152371|9851518|P2|Overall Study|Adverse Event|2
2864807|NCT02152371|9851519|P1|Overall Study|Adverse Event|6
2864808|NCT02152345|9851557|P2|Overall Study|Withdrawal by Subject|1
2864809|NCT02152345|9851558|P1|Overall Study|Withdrawal by Subject|2
2864810|NCT02152345|9851557|P2|Overall Study|Case Cancellations|4
2864811|NCT02152345|9851558|P1|Overall Study|Case Cancellations|2
2864812|NCT02152137|9851570|P1|Overall Study|Originally assigned to Arm B|3
2864813|NCT02152137|9851570|P1|Overall Study|Withdrawal by Subject|1
2864814|NCT02152007|9851578|P1|Overall Study|Withdrawal by Subject|1
2864815|NCT02151981|9851639|P2|Overall Study|Eligibility criteria not fulfilled|1
2864816|NCT02151981|9851640|P1|Overall Study|Eligibility criteria not fulfilled|0
2864817|NCT02151981|9851639|P2|Overall Study|Ongoing Study at Data Cut-off|95
2864818|NCT02151981|9851640|P1|Overall Study|Ongoing Study at Data Cut-off|224
2864819|NCT02151981|9851639|P2|Overall Study|Withdrawal by Subject|18
2864820|NCT02151981|9851640|P1|Overall Study|Withdrawal by Subject|19
2864821|NCT02151981|9851639|P2|Overall Study|Lost to Follow-up|0
2864822|NCT02151981|9851640|P1|Overall Study|Lost to Follow-up|1
2864823|NCT02151981|9851639|P2|Overall Study|Death|26
2864824|NCT02151981|9851640|P1|Overall Study|Death|35
2864825|NCT02151851|9851677|P2|Overall Study|Adverse Event|28
2864826|NCT02151851|9851678|P1|Overall Study|Adverse Event|6
2864827|NCT02151851|9851677|P2|Overall Study|Subject entered into study in error|1
2864828|NCT02151851|9851678|P1|Overall Study|Subject entered into study in error|0
2864829|NCT02151851|9851677|P2|Overall Study|Low compliance to study visits|1
2864830|NCT02151851|9851678|P1|Overall Study|Low compliance to study visits|0
2864831|NCT02151851|9851677|P2|Overall Study|Medical impairment|0
2864832|NCT02151851|9851678|P1|Overall Study|Medical impairment|1
2864833|NCT02151851|9851677|P2|Overall Study|Withdrawal by Subject|5
2864834|NCT02151851|9851678|P1|Overall Study|Withdrawal by Subject|2
2864835|NCT02151851|9851677|P2|Overall Study|Protocol Violation|1
2864836|NCT02151851|9851678|P1|Overall Study|Protocol Violation|0
2864837|NCT02151851|9851677|P2|Overall Study|Lack of Efficacy|94
2864838|NCT02151851|9851678|P1|Overall Study|Lack of Efficacy|67
2864839|NCT02151786|9851690|P1|Overall Study|Unavailability of Information|8
2864840|NCT02151786|9851690|P1|Overall Study|Randomized, not Treated|1
2864841|NCT02151786|9851690|P1|Overall Study|Outside the Contract Period|1
2864842|NCT02151786|9851690|P1|Overall Study|Unavailability of Case Report Form|26
2864843|NCT02151773|9851701|P1|Overall Study|Protocol Deviation|64
2864844|NCT02151682|9851708|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
2864845|NCT02151682|9851709|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2864846|NCT02151682|9851710|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2864847|NCT02151682|9851711|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2864848|NCT02151682|9851712|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2864849|NCT02151682|9851713|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2864850|NCT02151682|9851708|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
2864851|NCT02151682|9851709|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2864852|NCT02151682|9851710|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2864853|NCT02151682|9851711|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2864854|NCT02151682|9851712|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2864855|NCT02151682|9851713|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2864856|NCT02151682|9851708|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
2864857|NCT02151682|9851709|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
2864858|NCT02151682|9851710|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
2864859|NCT02151682|9851711|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
2864860|NCT02151682|9851712|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
2864861|NCT02151682|9851713|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
2864862|NCT02151682|9851708|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
2864863|NCT02151682|9851709|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2864864|NCT02151682|9851710|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2864865|NCT02151682|9851711|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2864866|NCT02151682|9851712|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2864867|NCT02151682|9851713|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2864868|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2864869|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2864870|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2864871|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
2864872|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2864873|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2864874|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Various other|0
2864875|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Various other|0
2864876|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Various other|0
2864877|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Various other|6
2864878|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Various other|0
2864879|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Various other|0
2864880|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Missing|0
2864881|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Missing|0
2864882|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Missing|1
2864883|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Missing|0
2864884|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Missing|0
2864885|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Missing|0
2864886|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
2864887|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
2864888|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
2864889|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
2864890|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
2864891|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
2864892|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2864893|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2864894|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2864895|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
2864896|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2864897|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2864898|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2864899|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2864900|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2864901|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
2864902|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2864903|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2864904|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2864905|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2864906|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2864907|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2864908|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2864909|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2864910|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Death|0
2864911|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Death|0
2864912|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Death|2
2864913|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Death|0
2864914|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Death|0
2864915|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Death|0
2864916|NCT02151682|9851708|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
2864917|NCT02151682|9851709|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
2864918|NCT02151682|9851710|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
2864919|NCT02151682|9851711|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
2864920|NCT02151682|9851712|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
2864921|NCT02151682|9851713|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
2864922|NCT02151682|9851708|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2864923|NCT02151682|9851709|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2864924|NCT02151682|9851710|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2864925|NCT02151682|9851711|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2864926|NCT02151682|9851712|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2864927|NCT02151682|9851713|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
2864928|NCT02151682|9851708|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2864929|NCT02151682|9851709|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2864930|NCT02151682|9851710|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2864931|NCT02151682|9851711|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2864932|NCT02151682|9851712|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2864933|NCT02151682|9851713|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2864934|NCT02151682|9851708|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2864935|NCT02151682|9851709|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2864936|NCT02151682|9851710|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2864937|NCT02151682|9851711|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2864938|NCT02151682|9851712|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
2864939|NCT02151682|9851713|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2864940|NCT02151682|9851708|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2864941|NCT02151682|9851709|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2864942|NCT02151682|9851710|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2864943|NCT02151682|9851711|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2864944|NCT02151682|9851712|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
2864945|NCT02151682|9851713|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2864946|NCT02151682|9851708|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2864947|NCT02151682|9851709|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2864948|NCT02151682|9851710|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2864949|NCT02151682|9851711|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2864950|NCT02151682|9851712|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
2864951|NCT02151682|9851713|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2864952|NCT02151643|9851763|P5|Overall Study|High Ferritin levels|1
2864953|NCT02151643|9851764|P4|Overall Study|High Ferritin levels|2
2864954|NCT02151643|9851765|P3|Overall Study|High Ferritin levels|2
2864955|NCT02151643|9851766|P2|Overall Study|High Ferritin levels|3
2864956|NCT02151643|9851767|P1|Overall Study|High Ferritin levels|3
2864957|NCT02151643|9851763|P5|Overall Study|Hyperphosphataemia|1
2864958|NCT02151643|9851764|P4|Overall Study|Hyperphosphataemia|0
2864959|NCT02151643|9851765|P3|Overall Study|Hyperphosphataemia|0
2864960|NCT02151643|9851766|P2|Overall Study|Hyperphosphataemia|0
2864961|NCT02151643|9851767|P1|Overall Study|Hyperphosphataemia|1
2864962|NCT02151643|9851763|P5|Overall Study|Withdrawal by Subject|1
2864963|NCT02151643|9851764|P4|Overall Study|Withdrawal by Subject|1
2864964|NCT02151643|9851765|P3|Overall Study|Withdrawal by Subject|1
2864965|NCT02151643|9851766|P2|Overall Study|Withdrawal by Subject|1
2864966|NCT02151643|9851767|P1|Overall Study|Withdrawal by Subject|0
2864967|NCT02151643|9851763|P5|Overall Study|Adverse Event|0
2864968|NCT02151643|9851764|P4|Overall Study|Adverse Event|4
2864969|NCT02151643|9851765|P3|Overall Study|Adverse Event|1
2864970|NCT02151643|9851766|P2|Overall Study|Adverse Event|0
2864971|NCT02151643|9851767|P1|Overall Study|Adverse Event|2
2864972|NCT02151591|9851806|P2|Overall Study|Lost to Follow-up|3
2864973|NCT02151591|9851807|P1|Overall Study|Lost to Follow-up|6
2864974|NCT02151461|9851878|P4|Overall Study|Treatment discontinuation|0
2864975|NCT02151461|9851879|P3|Overall Study|Treatment discontinuation|1
2864976|NCT02151461|9851880|P2|Overall Study|Treatment discontinuation|0
2864977|NCT02151461|9851881|P1|Overall Study|Treatment discontinuation|0
2864978|NCT02151461|9851878|P4|Overall Study|Withdrawal by Subject|1
2864979|NCT02151461|9851879|P3|Overall Study|Withdrawal by Subject|1
2864980|NCT02151461|9851880|P2|Overall Study|Withdrawal by Subject|0
2864981|NCT02151461|9851881|P1|Overall Study|Withdrawal by Subject|1
2864982|NCT02151461|9851878|P4|Overall Study|Lost to Follow-up|1
2864983|NCT02151461|9851879|P3|Overall Study|Lost to Follow-up|1
2864984|NCT02151461|9851880|P2|Overall Study|Lost to Follow-up|0
2864985|NCT02151461|9851881|P1|Overall Study|Lost to Follow-up|0
2864986|NCT02151461|9851878|P4|Overall Study|Adverse Event|2
2864987|NCT02151461|9851879|P3|Overall Study|Adverse Event|0
2864988|NCT02151461|9851880|P2|Overall Study|Adverse Event|1
2864989|NCT02151461|9851881|P1|Overall Study|Adverse Event|5
2864990|NCT02151266|9852013|P3|Overall Study|Not able to exercise|4
2864991|NCT02151266|9852014|P2|Overall Study|Not able to exercise|5
2864992|NCT02151266|9852015|P1|Overall Study|Not able to exercise|4
2864993|NCT02151266|9852013|P3|Overall Study|Did NOT receive intervention|2
2864994|NCT02151266|9852014|P2|Overall Study|Did NOT receive intervention|6
2864995|NCT02151266|9852015|P1|Overall Study|Did NOT receive intervention|3
2864996|NCT02151266|9852013|P3|Overall Study|Lost to Follow-up|1
2864997|NCT02151266|9852014|P2|Overall Study|Lost to Follow-up|4
2864998|NCT02151266|9852015|P1|Overall Study|Lost to Follow-up|1
2864999|NCT02151149|9852058|P2|Follow-Up Period|Death|34
2865000|NCT02151149|9852059|P1|Follow-Up Period|Death|37
2865001|NCT02151149|9852058|P2|Follow-Up Period|Lost to Follow-up|3
2865002|NCT02151149|9852059|P1|Follow-Up Period|Lost to Follow-up|2
2865003|NCT02151149|9852058|P2|Treatment Period|Participants randomized but not treated|2
2865004|NCT02151149|9852059|P1|Treatment Period|Participants randomized but not treated|3
2865005|NCT02151149|9852058|P2|Treatment Period|Miscellaneous|7
2865006|NCT02151149|9852059|P1|Treatment Period|Miscellaneous|8
2865007|NCT02151149|9852058|P2|Treatment Period|Withdrawal by Subject|11
2865008|NCT02151149|9852059|P1|Treatment Period|Withdrawal by Subject|13
2865009|NCT02151149|9852058|P2|Treatment Period|Symptomatic Deterioration|10
2865010|NCT02151149|9852059|P1|Treatment Period|Symptomatic Deterioration|2
2865011|NCT02151149|9852058|P2|Treatment Period|Progressive Disease|24
2865012|NCT02151149|9852059|P1|Treatment Period|Progressive Disease|25
2865013|NCT02151149|9852058|P2|Treatment Period|Adverse Event|14
2865014|NCT02151149|9852059|P1|Treatment Period|Adverse Event|17
2865015|NCT02151149|9852058|P2|Treatment Period|Death|3
2865016|NCT02151149|9852059|P1|Treatment Period|Death|2
2865017|NCT02151110|9852091|P8|Overall Study|Lost to Follow-up|2
2865018|NCT02151110|9852092|P7|Overall Study|Lost to Follow-up|0
2865019|NCT02151110|9852093|P6|Overall Study|Lost to Follow-up|0
2865020|NCT02151110|9852094|P5|Overall Study|Lost to Follow-up|0
2865021|NCT02151110|9852095|P4|Overall Study|Lost to Follow-up|0
2865022|NCT02151110|9852096|P3|Overall Study|Lost to Follow-up|0
2865023|NCT02151110|9852097|P2|Overall Study|Lost to Follow-up|0
2865024|NCT02151110|9852098|P1|Overall Study|Lost to Follow-up|0
2865025|NCT02151110|9852091|P8|Overall Study|Withdrawal by Subject|1
2865026|NCT02151110|9852092|P7|Overall Study|Withdrawal by Subject|0
2865027|NCT02151110|9852093|P6|Overall Study|Withdrawal by Subject|0
2865028|NCT02151110|9852094|P5|Overall Study|Withdrawal by Subject|0
2865029|NCT02151110|9852095|P4|Overall Study|Withdrawal by Subject|0
2865030|NCT02151110|9852096|P3|Overall Study|Withdrawal by Subject|0
2865031|NCT02151110|9852097|P2|Overall Study|Withdrawal by Subject|0
2865032|NCT02151110|9852098|P1|Overall Study|Withdrawal by Subject|0
2865033|NCT02151058|9852191|P3|Overall Study|Lost to Follow-up|2
2865034|NCT02151058|9852192|P2|Overall Study|Lost to Follow-up|0
2865035|NCT02151058|9852193|P1|Overall Study|Lost to Follow-up|1
2865036|NCT02151058|9852191|P3|Overall Study|Withdrawal by Subject|3
2865037|NCT02151058|9852192|P2|Overall Study|Withdrawal by Subject|1
2865038|NCT02151058|9852193|P1|Overall Study|Withdrawal by Subject|1
2865039|NCT02150954|9852227|P2|Overall Study|Protocol Violation|0
2865040|NCT02150954|9852228|P1|Overall Study|Protocol Violation|1
2865041|NCT02150863|9852253|P3|Overall Study|Lost to Follow-up|0
2865042|NCT02150863|9852254|P2|Overall Study|Lost to Follow-up|1
2865043|NCT02150863|9852255|P1|Overall Study|Lost to Follow-up|0
2865044|NCT02150343|9852501|P4|Overall Study|Other|2
2865045|NCT02150343|9852502|P3|Overall Study|Other|0
2865046|NCT02150343|9852503|P2|Overall Study|Other|6
2865047|NCT02150343|9852504|P1|Overall Study|Other|2
2865048|NCT02150343|9852501|P4|Overall Study|Lost to Follow-up|3
2865049|NCT02150343|9852502|P3|Overall Study|Lost to Follow-up|2
2865050|NCT02150343|9852503|P2|Overall Study|Lost to Follow-up|4
2865051|NCT02150343|9852504|P1|Overall Study|Lost to Follow-up|4
2865052|NCT02150343|9852501|P4|Overall Study|Withdrawal by Subject|4
2865053|NCT02150343|9852502|P3|Overall Study|Withdrawal by Subject|9
2865054|NCT02150343|9852503|P2|Overall Study|Withdrawal by Subject|10
2865055|NCT02150343|9852504|P1|Overall Study|Withdrawal by Subject|13
2865056|NCT02150343|9852501|P4|Overall Study|Adverse Event|1
2865057|NCT02150343|9852502|P3|Overall Study|Adverse Event|1
2865058|NCT02150343|9852503|P2|Overall Study|Adverse Event|0
2865059|NCT02150343|9852504|P1|Overall Study|Adverse Event|2
2865060|NCT02150213|9852542|P1|Overall Study|Withdrawal by Subject|1
2865061|NCT02150213|9852542|P1|Overall Study|Lost to Follow-up|1
2865062|NCT02150057|9852561|P2|Overall Study|Lost to Follow-up|4
2865063|NCT02150057|9852562|P1|Overall Study|Lost to Follow-up|6
2865064|NCT02149875|9852577|P3|Overall Study|Physician Decision|2
2865065|NCT02149875|9852578|P2|Overall Study|Physician Decision|2
2865066|NCT02149875|9852579|P1|Overall Study|Physician Decision|1
2865067|NCT02149875|9852577|P3|Overall Study|Withdrawal by Subject|2
2865068|NCT02149875|9852578|P2|Overall Study|Withdrawal by Subject|2
2865069|NCT02149875|9852579|P1|Overall Study|Withdrawal by Subject|3
2865070|NCT02149875|9852577|P3|Overall Study|Lost to Follow-up|5
2865071|NCT02149875|9852578|P2|Overall Study|Lost to Follow-up|4
2865072|NCT02149875|9852579|P1|Overall Study|Lost to Follow-up|3
2865073|NCT02149836|9852590|P1|Overall Study|Withdrawal by Subject|1
2865074|NCT02149420|9852617|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2865075|NCT02149420|9852618|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2865076|NCT02149420|9852619|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
2865077|NCT02149420|9852617|P3|Core Study|Administrative problems|2
2865078|NCT02149420|9852618|P2|Core Study|Administrative problems|1
2865079|NCT02149420|9852619|P1|Core Study|Administrative problems|0
2865080|NCT02149264|9852687|P1|Overall Study|Protocol Violation|1
2865081|NCT02149264|9852687|P1|Overall Study|Physician Decision|3
2865082|NCT02149264|9852687|P1|Overall Study|Adverse Event|7
2865083|NCT02149264|9852687|P1|Overall Study|Withdrawal by Subject|9
2865084|NCT02149199|9852703|P3|Overall Study|Adverse Event|9
2865085|NCT02149199|9852704|P2|Overall Study|Adverse Event|15
2865086|NCT02149199|9852705|P1|Overall Study|Adverse Event|6
2865087|NCT02149199|9852703|P3|Overall Study|Death|1
2865088|NCT02149199|9852704|P2|Overall Study|Death|0
2865089|NCT02149199|9852705|P1|Overall Study|Death|0
2865090|NCT02149199|9852703|P3|Overall Study|Lost to Follow-up|11
2865091|NCT02149199|9852704|P2|Overall Study|Lost to Follow-up|12
2865092|NCT02149199|9852705|P1|Overall Study|Lost to Follow-up|3
2865093|NCT02149199|9852703|P3|Overall Study|Protocol Violation|15
2865094|NCT02149199|9852704|P2|Overall Study|Protocol Violation|13
2865095|NCT02149199|9852705|P1|Overall Study|Protocol Violation|16
2865096|NCT02149199|9852703|P3|Overall Study|Withdrawal by Subject|77
2865097|NCT02149199|9852704|P2|Overall Study|Withdrawal by Subject|93
2865098|NCT02149199|9852705|P1|Overall Study|Withdrawal by Subject|75
2865099|NCT02149199|9852703|P3|Overall Study|Eligibility criteria not fulfilled|8
2865100|NCT02149199|9852704|P2|Overall Study|Eligibility criteria not fulfilled|14
2865101|NCT02149199|9852705|P1|Overall Study|Eligibility criteria not fulfilled|9
2865102|NCT02149199|9852703|P3|Overall Study|Other|20
2865103|NCT02149199|9852704|P2|Overall Study|Other|25
2865104|NCT02149199|9852705|P1|Overall Study|Other|20
2865105|NCT02149199|9852703|P3|Overall Study|Study specific withdrawal criteria|6
2865106|NCT02149199|9852704|P2|Overall Study|Study specific withdrawal criteria|21
2865107|NCT02149199|9852705|P1|Overall Study|Study specific withdrawal criteria|4
2865108|NCT02149108|9852784|P2|Overall Study|Lost to Follow-up|0
2865109|NCT02149108|9852785|P1|Overall Study|Lost to Follow-up|1
2865110|NCT02149108|9852784|P2|Overall Study|Refusal to continue trial medication|11
2865111|NCT02149108|9852785|P1|Overall Study|Refusal to continue trial medication|15
2865112|NCT02149108|9852784|P2|Overall Study|Other not defined above|2
2865113|NCT02149108|9852785|P1|Overall Study|Other not defined above|0
2865114|NCT02149108|9852784|P2|Overall Study|Other Adverse Event (AE)|18
2865115|NCT02149108|9852785|P1|Overall Study|Other Adverse Event (AE)|8
2865116|NCT02149108|9852784|P2|Overall Study|Worsening/adverse event cancer disease|32
2865117|NCT02149108|9852785|P1|Overall Study|Worsening/adverse event cancer disease|31
2865118|NCT02149108|9852784|P2|Overall Study|Progressive Disease (PD)|318
2865119|NCT02149108|9852785|P1|Overall Study|Progressive Disease (PD)|324
2865120|NCT02149108|9852784|P2|Overall Study|Not treated|2
2865121|NCT02149108|9852785|P1|Overall Study|Not treated|1
2865122|NCT02148952|9852799|P2|Follow-Up|Withdrawal by Subject|48
2865123|NCT02148952|9852800|P1|Follow-Up|Withdrawal by Subject|46
2865124|NCT02148952|9852799|P2|Follow-Up|Lost to Follow-up|231
2865125|NCT02148952|9852800|P1|Follow-Up|Lost to Follow-up|219
2865126|NCT02148952|9852799|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
2865127|NCT02148952|9852800|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
2865128|NCT02148952|9852799|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
2865129|NCT02148952|9852800|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
2865130|NCT02148718|9852883|P1|Overall Study|Discontinued Study Prematurely|5
2865131|NCT02148718|9852883|P1|Overall Study|Protocol Violation|26
2865132|NCT02148445|9852931|P2|Overall Study|Death|3
2865133|NCT02148445|9852932|P1|Overall Study|Death|1
2865134|NCT02148250|9852983|P2|Screening|Withdrawal by Subject|0
2865135|NCT02148250|9852984|P1|Screening|Withdrawal by Subject|5
2865136|NCT02148133|9852998|P1|Overall Study|Protocol-defined stopping criteria|2
2865137|NCT02148133|9852998|P1|Overall Study|Protocol deviation|1
2865138|NCT02148133|9852998|P1|Overall Study|Lack of Efficacy|1
2865139|NCT02148133|9852998|P1|Overall Study|Investigator discretion|1
2865140|NCT02147691|9853074|P2|Overall Study|Lost to Follow-up|1
2865141|NCT02147691|9853075|P1|Overall Study|Lost to Follow-up|0
2865142|NCT02147691|9853074|P2|Overall Study|Adverse Event|0
2865143|NCT02147691|9853075|P1|Overall Study|Adverse Event|2
2865144|NCT02147691|9853074|P2|Overall Study|Withdrawal by Subject|0
2865145|NCT02147691|9853075|P1|Overall Study|Withdrawal by Subject|2
2865146|NCT02147587|9853134|P2|Overall Study|Lack of Efficacy|1
2865147|NCT02147587|9853135|P1|Overall Study|Lack of Efficacy|2
2865148|NCT02147587|9853134|P2|Overall Study|Adverse Event|4
2865149|NCT02147587|9853135|P1|Overall Study|Adverse Event|9
2865150|NCT02147561|9853155|P1|Overall Study|Subjects who didn’t receive BOTOX|1
2865151|NCT02147561|9853155|P1|Overall Study|Lost to Follow-up|3
2865152|NCT02147353|9853176|P2|Overall Study|medication noncompliance|0
2865153|NCT02147353|9853177|P1|Overall Study|medication noncompliance|3
2865154|NCT02147353|9853176|P2|Overall Study|unable to make visits|0
2865155|NCT02147353|9853177|P1|Overall Study|unable to make visits|4
2865156|NCT02147353|9853176|P2|Overall Study|Lost to Follow-up|0
2865157|NCT02147353|9853177|P1|Overall Study|Lost to Follow-up|2
2865158|NCT02147288|9853210|P10|Overall Study|complications from concurrent hernia rep|0
2865159|NCT02147288|9853211|P9|Overall Study|complications from concurrent hernia rep|0
2865160|NCT02147288|9853212|P8|Overall Study|complications from concurrent hernia rep|0
2865161|NCT02147288|9853213|P7|Overall Study|complications from concurrent hernia rep|0
2865162|NCT02147288|9853214|P6|Overall Study|complications from concurrent hernia rep|0
2865163|NCT02147288|9853215|P5|Overall Study|complications from concurrent hernia rep|0
2865164|NCT02147288|9853216|P4|Overall Study|complications from concurrent hernia rep|0
2865165|NCT02147288|9853217|P3|Overall Study|complications from concurrent hernia rep|0
2865166|NCT02147288|9853218|P2|Overall Study|complications from concurrent hernia rep|1
2865167|NCT02147288|9853219|P1|Overall Study|complications from concurrent hernia rep|0
2865168|NCT02147288|9853210|P10|Overall Study|post-operative hematoma|0
2865169|NCT02147288|9853211|P9|Overall Study|post-operative hematoma|0
2865170|NCT02147288|9853212|P8|Overall Study|post-operative hematoma|0
2865171|NCT02147288|9853213|P7|Overall Study|post-operative hematoma|0
2865172|NCT02147288|9853214|P6|Overall Study|post-operative hematoma|0
2865173|NCT02147288|9853215|P5|Overall Study|post-operative hematoma|0
2865174|NCT02147288|9853216|P4|Overall Study|post-operative hematoma|0
2865175|NCT02147288|9853217|P3|Overall Study|post-operative hematoma|0
2865176|NCT02147288|9853218|P2|Overall Study|post-operative hematoma|1
2865177|NCT02147288|9853219|P1|Overall Study|post-operative hematoma|1
2865178|NCT02147197|9853228|P3|Overall Study|Other Miscellaneous Reasons|3
2865179|NCT02147197|9853229|P2|Overall Study|Other Miscellaneous Reasons|0
2865180|NCT02147197|9853230|P1|Overall Study|Other Miscellaneous Reasons|1
2865181|NCT02147197|9853228|P3|Overall Study|Protocol Violation|3
2865182|NCT02147197|9853229|P2|Overall Study|Protocol Violation|0
2865183|NCT02147197|9853230|P1|Overall Study|Protocol Violation|1
2865184|NCT02147197|9853228|P3|Overall Study|Lost to Follow-up|1
2865185|NCT02147197|9853229|P2|Overall Study|Lost to Follow-up|3
2865186|NCT02147197|9853230|P1|Overall Study|Lost to Follow-up|2
2865187|NCT02147197|9853228|P3|Overall Study|Withdrawal of Consent|2
2865188|NCT02147197|9853229|P2|Overall Study|Withdrawal of Consent|3
2865189|NCT02147197|9853230|P1|Overall Study|Withdrawal of Consent|4
2865190|NCT02147197|9853228|P3|Overall Study|Adverse Event|0
2865191|NCT02147197|9853229|P2|Overall Study|Adverse Event|0
2865192|NCT02147197|9853230|P1|Overall Study|Adverse Event|1
2865193|NCT02147184|9853249|P2|Overall Study|Other|0
2865194|NCT02147184|9853250|P1|Overall Study|Other|1
2865195|NCT02147184|9853249|P2|Overall Study|Physician Decision|2
2865196|NCT02147184|9853250|P1|Overall Study|Physician Decision|0
2865197|NCT02147184|9853249|P2|Overall Study|Moved out of state|3
2865198|NCT02147184|9853250|P1|Overall Study|Moved out of state|3
2865199|NCT02147184|9853249|P2|Overall Study|Pregnancy|0
2865200|NCT02147184|9853250|P1|Overall Study|Pregnancy|6
2865201|NCT02147184|9853249|P2|Overall Study|Study Burden|7
2865202|NCT02147184|9853250|P1|Overall Study|Study Burden|11
2865203|NCT02147184|9853249|P2|Overall Study|Lost to Follow-up|15
2865204|NCT02147184|9853250|P1|Overall Study|Lost to Follow-up|28
2865205|NCT02147158|9853274|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2865206|NCT02147158|9853275|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2865207|NCT02147158|9853276|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
2865208|NCT02147158|9853277|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2865209|NCT02147158|9853278|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
2865210|NCT02147158|9853279|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2865211|NCT02147158|9853274|P6|Off-Treatment Interval 2|Protocol Violation|0
2865212|NCT02147158|9853275|P5|Off-Treatment Interval 2|Protocol Violation|0
2865213|NCT02147158|9853276|P4|Off-Treatment Interval 2|Protocol Violation|1
2865214|NCT02147158|9853277|P3|Off-Treatment Interval 2|Protocol Violation|0
2865215|NCT02147158|9853278|P2|Off-Treatment Interval 2|Protocol Violation|0
2865216|NCT02147158|9853279|P1|Off-Treatment Interval 2|Protocol Violation|0
2865217|NCT02147158|9853274|P6|Off-Treatment Interval 2|Lost to Follow-up|2
2865218|NCT02147158|9853275|P5|Off-Treatment Interval 2|Lost to Follow-up|2
2865219|NCT02147158|9853276|P4|Off-Treatment Interval 2|Lost to Follow-up|2
2865220|NCT02147158|9853277|P3|Off-Treatment Interval 2|Lost to Follow-up|3
2865221|NCT02147158|9853278|P2|Off-Treatment Interval 2|Lost to Follow-up|0
2865222|NCT02147158|9853279|P1|Off-Treatment Interval 2|Lost to Follow-up|0
2865223|NCT02147158|9853274|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
2865224|NCT02147158|9853275|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
2865225|NCT02147158|9853276|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
2865226|NCT02147158|9853277|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
2865227|NCT02147158|9853278|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
2865228|NCT02147158|9853279|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
2865229|NCT02147158|9853274|P6|Off-Treatment Interval 2|Lack of Efficacy|0
2865230|NCT02147158|9853275|P5|Off-Treatment Interval 2|Lack of Efficacy|0
2865231|NCT02147158|9853276|P4|Off-Treatment Interval 2|Lack of Efficacy|0
2865232|NCT02147158|9853277|P3|Off-Treatment Interval 2|Lack of Efficacy|1
2865233|NCT02147158|9853278|P2|Off-Treatment Interval 2|Lack of Efficacy|1
2865234|NCT02147158|9853279|P1|Off-Treatment Interval 2|Lack of Efficacy|0
2865235|NCT02147158|9853274|P6|Treatment Course 2|Lost to Follow-up|1
2865236|NCT02147158|9853275|P5|Treatment Course 2|Lost to Follow-up|0
2865237|NCT02147158|9853276|P4|Treatment Course 2|Lost to Follow-up|1
2865238|NCT02147158|9853277|P3|Treatment Course 2|Lost to Follow-up|1
2865239|NCT02147158|9853278|P2|Treatment Course 2|Lost to Follow-up|0
2865240|NCT02147158|9853279|P1|Treatment Course 2|Lost to Follow-up|1
2865241|NCT02147158|9853274|P6|Treatment Course 2|Withdrawal of Consent|0
2865242|NCT02147158|9853275|P5|Treatment Course 2|Withdrawal of Consent|0
2865243|NCT02147158|9853276|P4|Treatment Course 2|Withdrawal of Consent|3
2865244|NCT02147158|9853277|P3|Treatment Course 2|Withdrawal of Consent|2
2865245|NCT02147158|9853278|P2|Treatment Course 2|Withdrawal of Consent|1
2865246|NCT02147158|9853279|P1|Treatment Course 2|Withdrawal of Consent|0
2865247|NCT02147158|9853274|P6|Treatment Course 2|Adverse Event|1
2865248|NCT02147158|9853275|P5|Treatment Course 2|Adverse Event|0
2865249|NCT02147158|9853276|P4|Treatment Course 2|Adverse Event|1
2865250|NCT02147158|9853277|P3|Treatment Course 2|Adverse Event|2
2865251|NCT02147158|9853278|P2|Treatment Course 2|Adverse Event|4
2865252|NCT02147158|9853279|P1|Treatment Course 2|Adverse Event|0
2865253|NCT02147158|9853274|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2865254|NCT02147158|9853275|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2865255|NCT02147158|9853276|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2865256|NCT02147158|9853277|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
2865257|NCT02147158|9853278|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2865258|NCT02147158|9853279|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2865259|NCT02147158|9853274|P6|Off-Treatment Interval 1|Lack of Efficacy|0
2865260|NCT02147158|9853275|P5|Off-Treatment Interval 1|Lack of Efficacy|1
2865261|NCT02147158|9853276|P4|Off-Treatment Interval 1|Lack of Efficacy|0
2865262|NCT02147158|9853277|P3|Off-Treatment Interval 1|Lack of Efficacy|2
2865263|NCT02147158|9853278|P2|Off-Treatment Interval 1|Lack of Efficacy|0
2865264|NCT02147158|9853279|P1|Off-Treatment Interval 1|Lack of Efficacy|0
2865265|NCT02147158|9853274|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
2865266|NCT02147158|9853275|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
2865267|NCT02147158|9853276|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
2865268|NCT02147158|9853277|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
2865269|NCT02147158|9853278|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
2865270|NCT02147158|9853279|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
2865271|NCT02147158|9853274|P6|Off-Treatment Interval 1|Protocol Violation|0
2865272|NCT02147158|9853275|P5|Off-Treatment Interval 1|Protocol Violation|1
2865273|NCT02147158|9853276|P4|Off-Treatment Interval 1|Protocol Violation|0
2865274|NCT02147158|9853277|P3|Off-Treatment Interval 1|Protocol Violation|2
2865275|NCT02147158|9853278|P2|Off-Treatment Interval 1|Protocol Violation|0
2865276|NCT02147158|9853279|P1|Off-Treatment Interval 1|Protocol Violation|1
2865277|NCT02147158|9853274|P6|Off-Treatment Interval 1|Lost to Follow-up|2
2865278|NCT02147158|9853275|P5|Off-Treatment Interval 1|Lost to Follow-up|4
2865279|NCT02147158|9853276|P4|Off-Treatment Interval 1|Lost to Follow-up|2
2865280|NCT02147158|9853277|P3|Off-Treatment Interval 1|Lost to Follow-up|3
2865281|NCT02147158|9853278|P2|Off-Treatment Interval 1|Lost to Follow-up|1
2865282|NCT02147158|9853279|P1|Off-Treatment Interval 1|Lost to Follow-up|2
2865283|NCT02147158|9853274|P6|Off-Treatment Interval 1|Adverse Event|0
2865284|NCT02147158|9853275|P5|Off-Treatment Interval 1|Adverse Event|0
2865285|NCT02147158|9853276|P4|Off-Treatment Interval 1|Adverse Event|1
2865286|NCT02147158|9853277|P3|Off-Treatment Interval 1|Adverse Event|0
2865287|NCT02147158|9853278|P2|Off-Treatment Interval 1|Adverse Event|0
2865288|NCT02147158|9853279|P1|Off-Treatment Interval 1|Adverse Event|1
2865289|NCT02147158|9853274|P6|Treatment Course 1|Withdrawal of Consent|2
2865290|NCT02147158|9853275|P5|Treatment Course 1|Withdrawal of Consent|3
2865291|NCT02147158|9853276|P4|Treatment Course 1|Withdrawal of Consent|5
2865292|NCT02147158|9853277|P3|Treatment Course 1|Withdrawal of Consent|1
2865293|NCT02147158|9853278|P2|Treatment Course 1|Withdrawal of Consent|1
2865294|NCT02147158|9853279|P1|Treatment Course 1|Withdrawal of Consent|1
2865295|NCT02147158|9853274|P6|Treatment Course 1|Protocol Violation|0
2865296|NCT02147158|9853275|P5|Treatment Course 1|Protocol Violation|0
2865297|NCT02147158|9853276|P4|Treatment Course 1|Protocol Violation|1
2865298|NCT02147158|9853277|P3|Treatment Course 1|Protocol Violation|1
2865299|NCT02147158|9853278|P2|Treatment Course 1|Protocol Violation|0
2865300|NCT02147158|9853279|P1|Treatment Course 1|Protocol Violation|0
2865301|NCT02147158|9853274|P6|Treatment Course 1|Lost to Follow-up|4
2865302|NCT02147158|9853275|P5|Treatment Course 1|Lost to Follow-up|2
2865303|NCT02147158|9853276|P4|Treatment Course 1|Lost to Follow-up|3
2865304|NCT02147158|9853277|P3|Treatment Course 1|Lost to Follow-up|3
2865305|NCT02147158|9853278|P2|Treatment Course 1|Lost to Follow-up|4
2865306|NCT02147158|9853279|P1|Treatment Course 1|Lost to Follow-up|2
2865307|NCT02147158|9853274|P6|Treatment Course 1|Adverse Event|2
2865308|NCT02147158|9853275|P5|Treatment Course 1|Adverse Event|1
2865309|NCT02147158|9853276|P4|Treatment Course 1|Adverse Event|4
2865310|NCT02147158|9853277|P3|Treatment Course 1|Adverse Event|3
2865311|NCT02147158|9853278|P2|Treatment Course 1|Adverse Event|4
2865312|NCT02147158|9853279|P1|Treatment Course 1|Adverse Event|1
2865313|NCT02147132|9853308|P4|Overall Study|Lost to Follow-up|0
2865314|NCT02147132|9853309|P3|Overall Study|Lost to Follow-up|0
2865315|NCT02147132|9853310|P2|Overall Study|Lost to Follow-up|0
2865316|NCT02147132|9853311|P1|Overall Study|Lost to Follow-up|1
2865317|NCT02147093|9853331|P2|Period 2|Protocol Violation|0
2865318|NCT02147093|9853332|P1|Period 2|Protocol Violation|2
2865319|NCT02147093|9853331|P2|Period 1|Lost to Follow-up|1
2865320|NCT02147093|9853332|P1|Period 1|Lost to Follow-up|0
2865321|NCT02147067|9853342|P2|Overall Study|Withdrawal by Subject|2
2865322|NCT02147067|9853343|P1|Overall Study|Withdrawal by Subject|2
2865323|NCT02146599|9853369|P1|Overall Study|Failed to meet inclusion criteria|5
2865324|NCT02146365|9853388|P8|Overall Study|Other|0
2865325|NCT02146365|9853389|P7|Overall Study|Other|0
2865326|NCT02146365|9853390|P6|Overall Study|Other|0
2865327|NCT02146365|9853391|P5|Overall Study|Other|0
2865328|NCT02146365|9853392|P4|Overall Study|Other|1
2865329|NCT02146365|9853393|P3|Overall Study|Other|2
2865330|NCT02146365|9853394|P2|Overall Study|Other|0
2865331|NCT02146365|9853395|P1|Overall Study|Other|1
2865332|NCT02146365|9853388|P8|Overall Study|Unable to Comply with Protocol|0
2865333|NCT02146365|9853389|P7|Overall Study|Unable to Comply with Protocol|0
2865334|NCT02146365|9853390|P6|Overall Study|Unable to Comply with Protocol|0
2865335|NCT02146365|9853391|P5|Overall Study|Unable to Comply with Protocol|0
2865336|NCT02146365|9853392|P4|Overall Study|Unable to Comply with Protocol|0
2865337|NCT02146365|9853393|P3|Overall Study|Unable to Comply with Protocol|1
2865338|NCT02146365|9853394|P2|Overall Study|Unable to Comply with Protocol|1
2865339|NCT02146365|9853395|P1|Overall Study|Unable to Comply with Protocol|0
2865340|NCT02146365|9853388|P8|Overall Study|Withdrawal by Subject|0
2865341|NCT02146365|9853389|P7|Overall Study|Withdrawal by Subject|0
2865342|NCT02146365|9853390|P6|Overall Study|Withdrawal by Subject|0
2865343|NCT02146365|9853391|P5|Overall Study|Withdrawal by Subject|1
2865344|NCT02146365|9853392|P4|Overall Study|Withdrawal by Subject|5
2865345|NCT02146365|9853393|P3|Overall Study|Withdrawal by Subject|1
2865346|NCT02146365|9853394|P2|Overall Study|Withdrawal by Subject|2
2865347|NCT02146365|9853395|P1|Overall Study|Withdrawal by Subject|1
2865348|NCT02146365|9853388|P8|Overall Study|Lost to Follow-up|1
2865349|NCT02146365|9853389|P7|Overall Study|Lost to Follow-up|0
2865350|NCT02146365|9853390|P6|Overall Study|Lost to Follow-up|1
2865351|NCT02146365|9853391|P5|Overall Study|Lost to Follow-up|1
2865352|NCT02146365|9853392|P4|Overall Study|Lost to Follow-up|3
2865353|NCT02146365|9853393|P3|Overall Study|Lost to Follow-up|3
2865354|NCT02146365|9853394|P2|Overall Study|Lost to Follow-up|1
2865355|NCT02146365|9853395|P1|Overall Study|Lost to Follow-up|2
2865356|NCT02146352|9853521|P1|Overall Study|Patient entered hospice care|1
2865357|NCT02146352|9853521|P1|Overall Study|Death|1
2865358|NCT02146326|9853539|P4|Overall Study|Unable to complete interview|6
2865359|NCT02146326|9853540|P3|Overall Study|Unable to complete interview|10
2865360|NCT02146326|9853541|P2|Overall Study|Unable to complete interview|0
2865361|NCT02146326|9853542|P1|Overall Study|Unable to complete interview|0
2865362|NCT02146326|9853539|P4|Overall Study|Death|4
2865363|NCT02146326|9853540|P3|Overall Study|Death|4
2865364|NCT02146326|9853541|P2|Overall Study|Death|0
2865365|NCT02146326|9853542|P1|Overall Study|Death|0
2865366|NCT02146326|9853539|P4|Overall Study|Incarcerated|8
2865367|NCT02146326|9853540|P3|Overall Study|Incarcerated|3
2865368|NCT02146326|9853541|P2|Overall Study|Incarcerated|0
2865369|NCT02146326|9853542|P1|Overall Study|Incarcerated|0
2865370|NCT02146326|9853539|P4|Overall Study|Separated from mental health center|0
2865371|NCT02146326|9853540|P3|Overall Study|Separated from mental health center|0
2865372|NCT02146326|9853541|P2|Overall Study|Separated from mental health center|33
2865373|NCT02146326|9853542|P1|Overall Study|Separated from mental health center|23
2865374|NCT02146326|9853539|P4|Overall Study|Withdrawal by Subject|11
2865375|NCT02146326|9853540|P3|Overall Study|Withdrawal by Subject|15
2865376|NCT02146326|9853541|P2|Overall Study|Withdrawal by Subject|1
2865377|NCT02146326|9853542|P1|Overall Study|Withdrawal by Subject|2
2865378|NCT02146326|9853539|P4|Overall Study|Lost to Follow-up|19
2865379|NCT02146326|9853540|P3|Overall Study|Lost to Follow-up|11
2865380|NCT02146326|9853541|P2|Overall Study|Lost to Follow-up|3
2865381|NCT02146326|9853542|P1|Overall Study|Lost to Follow-up|3
2865382|NCT02146274|9853704|P1|Overall Study|Protocol Violation|73
2865383|NCT02146248|9853711|P1|Overall Study|Withdrawal by Subject|2
2865384|NCT02146131|9853721|P2|Overall Study|Physician Decision|56
2865385|NCT02146131|9853722|P1|Overall Study|Physician Decision|61
2865386|NCT02146105|9853728|P1|Overall Study|Withdrawal by Subject|5
2865387|NCT02146105|9853728|P1|Overall Study|Adverse Event|1
2865388|NCT02145468|9853779|P2|Overall Study|Withdrawal by Subject|8
2865389|NCT02145468|9853780|P1|Overall Study|Withdrawal by Subject|5
2865390|NCT02145429|9853838|P2|Overall Study|Withdrawal by Subject|3
2865391|NCT02145429|9853839|P1|Overall Study|Withdrawal by Subject|8
2865392|NCT02145429|9853838|P2|Overall Study|Lost to Follow-up|3
2865393|NCT02145429|9853839|P1|Overall Study|Lost to Follow-up|4
2865394|NCT02145429|9853838|P2|Overall Study|Death|5
2865395|NCT02145429|9853839|P1|Overall Study|Death|4
2865396|NCT02145390|9853870|P1|Overall Study|Withdrawal by Subject|1
2865397|NCT02145182|9853919|P2|Overall Study|Withdrawal by Subject|4
2865398|NCT02145182|9853920|P1|Overall Study|Withdrawal by Subject|5
2865399|NCT02145182|9853919|P2|Overall Study|Pre-transplant Withdrawal|2
2865400|NCT02145182|9853920|P1|Overall Study|Pre-transplant Withdrawal|0
2865401|NCT02145182|9853919|P2|Overall Study|Lost to Follow-up|2
2865402|NCT02145182|9853920|P1|Overall Study|Lost to Follow-up|2
2865403|NCT02145182|9853919|P2|Overall Study|Death|7
2865404|NCT02145182|9853920|P1|Overall Study|Death|7
2865405|NCT02145182|9853919|P2|Overall Study|Adverse Event|1
2865406|NCT02145182|9853920|P1|Overall Study|Adverse Event|4
2865407|NCT02145156|9853953|P3|Overall Study|No match to vaccination records|41
2865408|NCT02145156|9853954|P2|Overall Study|No match to vaccination records|52
2865409|NCT02145156|9853955|P1|Overall Study|No match to vaccination records|60
2865410|NCT02145026|9854005|P1|Overall Study|Physician Decision|4
2865411|NCT02145026|9854005|P1|Overall Study|Withdrawal by Subject|2
2865412|NCT02145026|9854005|P1|Overall Study|Death|4
2865413|NCT02145026|9854005|P1|Overall Study|Adverse Event|2
2865414|NCT02144701|9854036|P2|Overall Study|development of relapse, GVHD or death|3
2865415|NCT02144701|9854037|P1|Overall Study|development of relapse, GVHD or death|9
2865416|NCT02144610|9854064|P2|Overall Study|Other|1
2865417|NCT02144610|9854065|P1|Overall Study|Other|0
2865418|NCT02144610|9854064|P2|Overall Study|Study Discontinuation by Sponsor|14
2865419|NCT02144610|9854065|P1|Overall Study|Study Discontinuation by Sponsor|19
2865420|NCT02144610|9854064|P2|Overall Study|Death|2
2865421|NCT02144610|9854065|P1|Overall Study|Death|2
2865422|NCT02144610|9854064|P2|Overall Study|Withdrawal by Subject|5
2865423|NCT02144610|9854065|P1|Overall Study|Withdrawal by Subject|1
2865424|NCT02144610|9854064|P2|Overall Study|Physician Decision|0
2865425|NCT02144610|9854065|P1|Overall Study|Physician Decision|1
2865426|NCT02144337|9854106|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
2865427|NCT02144337|9854107|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
2865428|NCT02144337|9854106|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
2865429|NCT02144337|9854107|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
2865430|NCT02144337|9854106|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
2865431|NCT02144337|9854107|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
2865432|NCT02144337|9854106|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
2865433|NCT02144337|9854107|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
2865434|NCT02144337|9854106|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2865435|NCT02144337|9854107|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2865436|NCT02144285|9854127|P10|Overall Study|Withdrawal by Subject|0
2865437|NCT02144285|9854128|P9|Overall Study|Withdrawal by Subject|0
2865438|NCT02144285|9854129|P8|Overall Study|Withdrawal by Subject|0
2865439|NCT02144285|9854130|P7|Overall Study|Withdrawal by Subject|0
2865440|NCT02144285|9854131|P6|Overall Study|Withdrawal by Subject|0
2865441|NCT02144285|9854132|P5|Overall Study|Withdrawal by Subject|1
2865442|NCT02144285|9854133|P4|Overall Study|Withdrawal by Subject|0
2865443|NCT02144285|9854134|P3|Overall Study|Withdrawal by Subject|0
2865444|NCT02144285|9854135|P2|Overall Study|Withdrawal by Subject|0
2865445|NCT02144285|9854136|P1|Overall Study|Withdrawal by Subject|0
2865446|NCT02144220|9854262|P1|Overall Study|Protocol Violation|1
2865447|NCT02144220|9854262|P1|Overall Study|Withdrawal by Subject|2
2865448|NCT02144220|9854262|P1|Overall Study|Physician Decision|3
2865449|NCT02144220|9854262|P1|Overall Study|Lack of Efficacy|4
2865450|NCT02144220|9854262|P1|Overall Study|technology incompatibility|9
2865451|NCT02144077|9854281|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
2865452|NCT02144077|9854282|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
2865453|NCT02144077|9854281|P2|Overall Study|Death|1
2865454|NCT02144077|9854282|P1|Overall Study|Death|0
2865455|NCT02144077|9854281|P2|Overall Study|Protocol Violation|2
2865456|NCT02144077|9854282|P1|Overall Study|Protocol Violation|1
2865457|NCT02144077|9854281|P2|Overall Study|Lost to Follow-up|2
2865458|NCT02144077|9854282|P1|Overall Study|Lost to Follow-up|2
2865459|NCT02144077|9854281|P2|Overall Study|Adverse Event|3
2865460|NCT02144077|9854282|P1|Overall Study|Adverse Event|2
2865461|NCT02144077|9854281|P2|Overall Study|Withdrawal by Subject|3
2865462|NCT02144077|9854282|P1|Overall Study|Withdrawal by Subject|3
2865463|NCT02144012|9854300|P2|Overall Study|Other|0
2865464|NCT02144012|9854301|P1|Overall Study|Other|3
2865465|NCT02144012|9854300|P2|Overall Study|Study Terminated by Sponsor|12
2865466|NCT02144012|9854301|P1|Overall Study|Study Terminated by Sponsor|18
2865467|NCT02144012|9854300|P2|Overall Study|Withdrawal by Subject|3
2865468|NCT02144012|9854301|P1|Overall Study|Withdrawal by Subject|11
2865469|NCT02144012|9854300|P2|Overall Study|Death|0
2865470|NCT02144012|9854301|P1|Overall Study|Death|1
2865471|NCT02144012|9854300|P2|Overall Study|Adverse Event|0
2865472|NCT02144012|9854301|P1|Overall Study|Adverse Event|1
2865473|NCT02143947|9854338|P2|Overall Study|Lost to Follow-up|2
2865474|NCT02143947|9854339|P1|Overall Study|Lost to Follow-up|4
2865475|NCT02143843|9854351|P1|Overall Study|Withdrawal by Subject|2
2865476|NCT02143843|9854351|P1|Overall Study|Lack of Efficacy|2
2865477|NCT02143843|9854351|P1|Overall Study|Adverse Event|8
2865478|NCT02143778|9854356|P1|Overall Study|Device malfunction|1
2865479|NCT02143778|9854356|P1|Overall Study|Withdrawal by Subject|2
2865480|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Other|7
2865481|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Other|7
2865482|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Other|4
2865483|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Other|3
2865484|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2865485|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2865486|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2865487|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2865488|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
2865489|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2865490|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2865491|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
2865492|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2865493|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
2865494|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2865495|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
2865496|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
2865497|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
2865498|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
2865499|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
2865500|NCT02143713|9854365|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
2865501|NCT02143713|9854366|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2865502|NCT02143713|9854367|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
2865503|NCT02143713|9854368|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2865504|NCT02143713|9854365|P4|Treatment Period (6 Months)|Lack of Efficacy|1
2865505|NCT02143713|9854366|P3|Treatment Period (6 Months)|Lack of Efficacy|0
2865506|NCT02143713|9854367|P2|Treatment Period (6 Months)|Lack of Efficacy|0
2865507|NCT02143713|9854368|P1|Treatment Period (6 Months)|Lack of Efficacy|1
2865508|NCT02143713|9854365|P4|Treatment Period (6 Months)|Exclusionary Medication|0
2865509|NCT02143713|9854366|P3|Treatment Period (6 Months)|Exclusionary Medication|0
2865510|NCT02143713|9854367|P2|Treatment Period (6 Months)|Exclusionary Medication|0
2865511|NCT02143713|9854368|P1|Treatment Period (6 Months)|Exclusionary Medication|2
2865512|NCT02143713|9854365|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
2865513|NCT02143713|9854366|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2865514|NCT02143713|9854367|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2865515|NCT02143713|9854368|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2865516|NCT02143713|9854365|P4|Treatment Period (6 Months)|Other|2
2865517|NCT02143713|9854366|P3|Treatment Period (6 Months)|Other|3
2865518|NCT02143713|9854367|P2|Treatment Period (6 Months)|Other|0
2865519|NCT02143713|9854368|P1|Treatment Period (6 Months)|Other|3
2865520|NCT02143713|9854365|P4|Treatment Period (6 Months)|Non-compliance|3
2865521|NCT02143713|9854366|P3|Treatment Period (6 Months)|Non-compliance|0
2865522|NCT02143713|9854367|P2|Treatment Period (6 Months)|Non-compliance|0
2865523|NCT02143713|9854368|P1|Treatment Period (6 Months)|Non-compliance|1
2865524|NCT02143713|9854365|P4|Treatment Period (6 Months)|Pregnancy|0
2865525|NCT02143713|9854366|P3|Treatment Period (6 Months)|Pregnancy|2
2865526|NCT02143713|9854367|P2|Treatment Period (6 Months)|Pregnancy|2
2865527|NCT02143713|9854368|P1|Treatment Period (6 Months)|Pregnancy|0
2865528|NCT02143713|9854365|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2865529|NCT02143713|9854366|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2865530|NCT02143713|9854367|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2865531|NCT02143713|9854368|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2865532|NCT02143713|9854365|P4|Treatment Period (6 Months)|Lost to Follow-up|3
2865533|NCT02143713|9854366|P3|Treatment Period (6 Months)|Lost to Follow-up|4
2865534|NCT02143713|9854367|P2|Treatment Period (6 Months)|Lost to Follow-up|0
2865535|NCT02143713|9854368|P1|Treatment Period (6 Months)|Lost to Follow-up|3
2865536|NCT02143713|9854365|P4|Treatment Period (6 Months)|Adverse Event|9
2865537|NCT02143713|9854366|P3|Treatment Period (6 Months)|Adverse Event|8
2865538|NCT02143713|9854367|P2|Treatment Period (6 Months)|Adverse Event|8
2865539|NCT02143713|9854368|P1|Treatment Period (6 Months)|Adverse Event|7
2865540|NCT02143713|9854365|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
2865541|NCT02143713|9854366|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
2865542|NCT02143713|9854367|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
2865543|NCT02143713|9854368|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
2865544|NCT02143583|9854449|P3|Overall Study|husband illness|1
2865545|NCT02143583|9854450|P2|Overall Study|husband illness|0
2865546|NCT02143583|9854451|P1|Overall Study|husband illness|0
2865547|NCT02143583|9854449|P3|Overall Study|Withdrawal by Subject|1
2865548|NCT02143583|9854450|P2|Overall Study|Withdrawal by Subject|0
2865549|NCT02143583|9854451|P1|Overall Study|Withdrawal by Subject|1
2865550|NCT02143141|9854474|P2|Overall Study|pain scores at 24 hours not collected|0
2865551|NCT02143141|9854475|P1|Overall Study|pain scores at 24 hours not collected|1
2865552|NCT02143102|9854487|P2|Overall Study|Lost to Follow-up|0
2865553|NCT02143102|9854488|P1|Overall Study|Lost to Follow-up|11
2865554|NCT02143024|9854498|P2|Overall Study|Withdrawal by Subject|0
2865555|NCT02143024|9854499|P1|Overall Study|Withdrawal by Subject|1
2865556|NCT02143024|9854498|P2|Overall Study|Lost to Follow-up|1
2865557|NCT02143024|9854499|P1|Overall Study|Lost to Follow-up|1
2865558|NCT02142894|9854505|P1|Overall Study|Protocol Violation|8
2865559|NCT02142738|9854511|P2|Overall Study|Ongoing in Study|82
2865560|NCT02142738|9854512|P1|Overall Study|Ongoing in Study|107
2865561|NCT02142738|9854511|P2|Overall Study|Withdrawal by Subject|5
2865562|NCT02142738|9854512|P1|Overall Study|Withdrawal by Subject|5
2865563|NCT02142738|9854511|P2|Overall Study|Progressive Disease|1
2865564|NCT02142738|9854512|P1|Overall Study|Progressive Disease|0
2865565|NCT02142738|9854511|P2|Overall Study|Death|55
2865566|NCT02142738|9854512|P1|Overall Study|Death|33
2865567|NCT02142738|9854511|P2|Overall Study|Adverse Event|8
2865568|NCT02142738|9854512|P1|Overall Study|Adverse Event|9
2865569|NCT02142712|9854525|P4|Overall Study|Lost to Follow-up|0
2865570|NCT02142712|9854526|P3|Overall Study|Lost to Follow-up|1
2865571|NCT02142712|9854527|P2|Overall Study|Lost to Follow-up|1
2865572|NCT02142712|9854528|P1|Overall Study|Lost to Follow-up|1
2865573|NCT02142504|9854551|P3|Overall Study|Reason Not Specified|4
2865574|NCT02142504|9854552|P2|Overall Study|Reason Not Specified|5
2865575|NCT02142504|9854553|P1|Overall Study|Reason Not Specified|4
2865576|NCT02142504|9854551|P3|Overall Study|Physician Decision|3
2865577|NCT02142504|9854552|P2|Overall Study|Physician Decision|1
2865578|NCT02142504|9854553|P1|Overall Study|Physician Decision|0
2865579|NCT02142504|9854551|P3|Overall Study|Pregnancy|2
2865580|NCT02142504|9854552|P2|Overall Study|Pregnancy|4
2865581|NCT02142504|9854553|P1|Overall Study|Pregnancy|4
2865582|NCT02142504|9854551|P3|Overall Study|Withdrawal by Subject|11
2865583|NCT02142504|9854552|P2|Overall Study|Withdrawal by Subject|9
2865584|NCT02142504|9854553|P1|Overall Study|Withdrawal by Subject|7
2865585|NCT02142504|9854551|P3|Overall Study|Lost to Follow-up|17
2865586|NCT02142504|9854552|P2|Overall Study|Lost to Follow-up|19
2865587|NCT02142504|9854553|P1|Overall Study|Lost to Follow-up|12
2865588|NCT02142504|9854551|P3|Overall Study|Adverse Event|4
2865589|NCT02142504|9854552|P2|Overall Study|Adverse Event|3
2865590|NCT02142504|9854553|P1|Overall Study|Adverse Event|2
2865591|NCT02142504|9854551|P3|Overall Study|Protocol Violation|2
2865592|NCT02142504|9854552|P2|Overall Study|Protocol Violation|1
2865593|NCT02142504|9854553|P1|Overall Study|Protocol Violation|2
2865594|NCT02142387|9854641|P2|Overall Study|occurred not at home|2474
2865595|NCT02142387|9854642|P1|Overall Study|occurred not at home|298
2865596|NCT02142387|9854641|P2|Overall Study|incomplete data|9
2865597|NCT02142387|9854642|P1|Overall Study|incomplete data|1
2865598|NCT02142387|9854641|P2|Overall Study|witnessed by paramedic|917
2865599|NCT02142387|9854642|P1|Overall Study|witnessed by paramedic|139
2865600|NCT02142387|9854641|P2|Overall Study|CPR not performed|473
2865601|NCT02142387|9854642|P1|Overall Study|CPR not performed|74
2865602|NCT02142387|9854641|P2|Overall Study|non-cardiac etiology|3431
2865603|NCT02142387|9854642|P1|Overall Study|non-cardiac etiology|504
2865604|NCT02142387|9854641|P2|Overall Study|<19 years old|326
2865605|NCT02142387|9854642|P1|Overall Study|<19 years old|49
2865606|NCT02142283|9854755|P2|Overall Study|Withdrawal by Subject|3
2865607|NCT02142283|9854756|P1|Overall Study|Withdrawal by Subject|1
2865608|NCT02142283|9854755|P2|Overall Study|Death|18
2865609|NCT02142283|9854756|P1|Overall Study|Death|20
2865610|NCT02141997|9854865|P4|Overall Study|Other|0
2865611|NCT02141997|9854866|P3|Overall Study|Other|0
2865612|NCT02141997|9854867|P2|Overall Study|Other|4
2865613|NCT02141997|9854868|P1|Overall Study|Other|1
2865614|NCT02141997|9854865|P4|Overall Study|Withdrew consent|0
2865615|NCT02141997|9854866|P3|Overall Study|Withdrew consent|3
2865616|NCT02141997|9854867|P2|Overall Study|Withdrew consent|0
2865617|NCT02141997|9854868|P1|Overall Study|Withdrew consent|1
2865618|NCT02141997|9854865|P4|Overall Study|Participant noncompliance|0
2865619|NCT02141997|9854866|P3|Overall Study|Participant noncompliance|0
2865620|NCT02141997|9854867|P2|Overall Study|Participant noncompliance|0
2865621|NCT02141997|9854868|P1|Overall Study|Participant noncompliance|1
2865622|NCT02141997|9854865|P4|Overall Study|Adverse Event|1
2865623|NCT02141997|9854866|P3|Overall Study|Adverse Event|0
2865624|NCT02141997|9854867|P2|Overall Study|Adverse Event|2
2865625|NCT02141997|9854868|P1|Overall Study|Adverse Event|0
2865626|NCT02141984|9854906|P1|Overall Study|Lack of Efficacy|2
2865627|NCT02141854|9854925|P6|Treatment Period|Lost to Follow-up|1
2865628|NCT02141854|9854926|P5|Treatment Period|Lost to Follow-up|0
2865629|NCT02141854|9854927|P4|Treatment Period|Lost to Follow-up|1
2865630|NCT02141854|9854928|P3|Treatment Period|Lost to Follow-up|1
2865631|NCT02141854|9854929|P2|Treatment Period|Lost to Follow-up|1
2865632|NCT02141854|9854930|P1|Treatment Period|Lost to Follow-up|0
2865633|NCT02141854|9854925|P6|Treatment Period|Disease progression|18
2865634|NCT02141854|9854926|P5|Treatment Period|Disease progression|0
2865635|NCT02141854|9854927|P4|Treatment Period|Disease progression|3
2865636|NCT02141854|9854928|P3|Treatment Period|Disease progression|1
2865637|NCT02141854|9854929|P2|Treatment Period|Disease progression|2
2865638|NCT02141854|9854930|P1|Treatment Period|Disease progression|0
2865639|NCT02141854|9854925|P6|Treatment Period|Withdrawal by Subject|7
2865640|NCT02141854|9854926|P5|Treatment Period|Withdrawal by Subject|4
2865641|NCT02141854|9854927|P4|Treatment Period|Withdrawal by Subject|3
2865642|NCT02141854|9854928|P3|Treatment Period|Withdrawal by Subject|3
2865643|NCT02141854|9854929|P2|Treatment Period|Withdrawal by Subject|2
2865644|NCT02141854|9854930|P1|Treatment Period|Withdrawal by Subject|0
2865645|NCT02141854|9854925|P6|Treatment Period|Adverse Event|2
2865646|NCT02141854|9854926|P5|Treatment Period|Adverse Event|2
2865647|NCT02141854|9854927|P4|Treatment Period|Adverse Event|0
2865648|NCT02141854|9854928|P3|Treatment Period|Adverse Event|2
2865649|NCT02141854|9854929|P2|Treatment Period|Adverse Event|2
2865650|NCT02141854|9854930|P1|Treatment Period|Adverse Event|0
2865651|NCT02141854|9854925|P6|Treatment Period|Other|2
2865652|NCT02141854|9854926|P5|Treatment Period|Other|1
2865653|NCT02141854|9854927|P4|Treatment Period|Other|0
2865654|NCT02141854|9854928|P3|Treatment Period|Other|2
2865655|NCT02141854|9854929|P2|Treatment Period|Other|1
2865656|NCT02141854|9854930|P1|Treatment Period|Other|0
2865657|NCT02141854|9854925|P6|Treatment Period|Pregnancy|0
2865658|NCT02141854|9854926|P5|Treatment Period|Pregnancy|0
2865659|NCT02141854|9854927|P4|Treatment Period|Pregnancy|0
2865660|NCT02141854|9854928|P3|Treatment Period|Pregnancy|0
2865661|NCT02141854|9854929|P2|Treatment Period|Pregnancy|1
2865662|NCT02141854|9854930|P1|Treatment Period|Pregnancy|0
2865663|NCT02141854|9854925|P6|Treatment Period|Lack of Efficacy|7
2865664|NCT02141854|9854926|P5|Treatment Period|Lack of Efficacy|1
2865665|NCT02141854|9854927|P4|Treatment Period|Lack of Efficacy|1
2865666|NCT02141854|9854928|P3|Treatment Period|Lack of Efficacy|0
2865667|NCT02141854|9854929|P2|Treatment Period|Lack of Efficacy|0
2865668|NCT02141854|9854930|P1|Treatment Period|Lack of Efficacy|0
2865669|NCT02141854|9854925|P6|Treatment Period|Noncompliance|0
2865670|NCT02141854|9854926|P5|Treatment Period|Noncompliance|0
2865671|NCT02141854|9854927|P4|Treatment Period|Noncompliance|1
2865672|NCT02141854|9854928|P3|Treatment Period|Noncompliance|0
2865673|NCT02141854|9854929|P2|Treatment Period|Noncompliance|0
2865674|NCT02141854|9854930|P1|Treatment Period|Noncompliance|0
2865675|NCT02141854|9854925|P6|Treatment Period|Protocol Violation|1
2865676|NCT02141854|9854926|P5|Treatment Period|Protocol Violation|2
2865677|NCT02141854|9854927|P4|Treatment Period|Protocol Violation|2
2865678|NCT02141854|9854928|P3|Treatment Period|Protocol Violation|0
2865679|NCT02141854|9854929|P2|Treatment Period|Protocol Violation|1
2865680|NCT02141854|9854930|P1|Treatment Period|Protocol Violation|0
2865681|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865682|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865683|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865684|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865685|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865686|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2865687|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865688|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865689|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865690|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865691|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865692|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
2865693|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2865694|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2865695|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2865696|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2865697|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2865698|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Adverse Event|10
2865699|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Other|0
2865700|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Other|0
2865701|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Other|0
2865702|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Other|0
2865703|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Other|0
2865704|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Other|14
2865705|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865706|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865707|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865708|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865709|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865710|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
2865711|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865712|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865713|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865714|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865715|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865716|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
2865717|NCT02141854|9854925|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865718|NCT02141854|9854926|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865719|NCT02141854|9854927|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865720|NCT02141854|9854928|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865721|NCT02141854|9854929|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865722|NCT02141854|9854930|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
2865723|NCT02141659|9854988|P6|Overall Study|Pretreatment Event/ Adverse Event|1
2865724|NCT02141659|9854989|P5|Overall Study|Pretreatment Event/ Adverse Event|2
2865725|NCT02141659|9854990|P4|Overall Study|Pretreatment Event/ Adverse Event|0
2865726|NCT02141659|9854991|P3|Overall Study|Pretreatment Event/ Adverse Event|0
2865727|NCT02141659|9854992|P2|Overall Study|Pretreatment Event/ Adverse Event|0
2865728|NCT02141659|9854993|P1|Overall Study|Pretreatment Event/ Adverse Event|0
2865729|NCT02141659|9854988|P6|Overall Study|Lack of Efficacy|1
2865730|NCT02141659|9854989|P5|Overall Study|Lack of Efficacy|0
2865731|NCT02141659|9854990|P4|Overall Study|Lack of Efficacy|0
2865732|NCT02141659|9854991|P3|Overall Study|Lack of Efficacy|0
2865733|NCT02141659|9854992|P2|Overall Study|Lack of Efficacy|0
2865734|NCT02141659|9854993|P1|Overall Study|Lack of Efficacy|0
2865735|NCT02141659|9854988|P6|Overall Study|Major Protocol Deviation|0
2865736|NCT02141659|9854989|P5|Overall Study|Major Protocol Deviation|0
2865737|NCT02141659|9854990|P4|Overall Study|Major Protocol Deviation|0
2865738|NCT02141659|9854991|P3|Overall Study|Major Protocol Deviation|0
2865739|NCT02141659|9854992|P2|Overall Study|Major Protocol Deviation|1
2865740|NCT02141659|9854993|P1|Overall Study|Major Protocol Deviation|0
2865741|NCT02141633|9855049|P2|Overall Study|Physician Decision|0
2865742|NCT02141633|9855050|P1|Overall Study|Physician Decision|1
2865743|NCT02141620|9855058|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
2865744|NCT02141620|9855059|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
2865745|NCT02141516|9855151|P3|Overall Study|Other|0
2865746|NCT02141516|9855152|P2|Overall Study|Other|3
2865747|NCT02141516|9855153|P1|Overall Study|Other|0
2865748|NCT02141516|9855151|P3|Overall Study|Lost to Follow-up|0
2865749|NCT02141516|9855152|P2|Overall Study|Lost to Follow-up|1
2865750|NCT02141516|9855153|P1|Overall Study|Lost to Follow-up|0
2865751|NCT02141516|9855151|P3|Overall Study|Adverse Event|0
2865752|NCT02141516|9855152|P2|Overall Study|Adverse Event|1
2865753|NCT02141516|9855153|P1|Overall Study|Adverse Event|0
2865754|NCT02141490|9855204|P3|Overall Study|Screening failures|0
2865755|NCT02141490|9855205|P2|Overall Study|Screening failures|0
2865756|NCT02141490|9855206|P1|Overall Study|Screening failures|4
2865757|NCT02141399|9855251|P1|Overall Study|Failure to meet eligibility criteria|14
2865758|NCT02141399|9855251|P1|Overall Study|Withdrawal by Subject|238
2865759|NCT02141399|9855251|P1|Overall Study|Protocol Violation|38
2865760|NCT02141399|9855251|P1|Overall Study|Pregnancy|3
2865761|NCT02141399|9855251|P1|Overall Study|Physician Decision|17
2865762|NCT02141399|9855251|P1|Overall Study|Other|45
2865763|NCT02141399|9855251|P1|Overall Study|Non-compliance with study drug|18
2865764|NCT02141399|9855251|P1|Overall Study|Lost to Follow-up|151
2865765|NCT02141399|9855251|P1|Overall Study|Lack of Efficacy|62
2865766|NCT02141399|9855251|P1|Overall Study|Adverse Event|158
2865767|NCT02141360|9855257|P3|Overall Study|Study Terminated before Visit|0
2865768|NCT02141360|9855258|P2|Overall Study|Study Terminated before Visit|0
2865769|NCT02141360|9855259|P1|Overall Study|Study Terminated before Visit|1
2865770|NCT02141360|9855257|P3|Overall Study|Withdrawal by Subject|0
2865771|NCT02141360|9855258|P2|Overall Study|Withdrawal by Subject|0
2865772|NCT02141360|9855259|P1|Overall Study|Withdrawal by Subject|6
2865773|NCT02141295|9855270|P3|Overall Study|Withdrawal by Subject|4
2865774|NCT02141295|9855271|P2|Overall Study|Withdrawal by Subject|9
2865775|NCT02141295|9855272|P1|Overall Study|Withdrawal by Subject|0
2865776|NCT02141295|9855270|P3|Overall Study|Reason not specified|10
2865777|NCT02141295|9855271|P2|Overall Study|Reason not specified|9
2865778|NCT02141295|9855272|P1|Overall Study|Reason not specified|0
2865779|NCT02141295|9855270|P3|Overall Study|Progressive disease|50
2865780|NCT02141295|9855271|P2|Overall Study|Progressive disease|32
2865781|NCT02141295|9855272|P1|Overall Study|Progressive disease|3
2865782|NCT02141295|9855270|P3|Overall Study|Non-compliance|0
2865783|NCT02141295|9855271|P2|Overall Study|Non-compliance|1
2865784|NCT02141295|9855272|P1|Overall Study|Non-compliance|0
2865785|NCT02141295|9855270|P3|Overall Study|Study terminated by sponsor|6
2865786|NCT02141295|9855271|P2|Overall Study|Study terminated by sponsor|6
2865787|NCT02141295|9855272|P1|Overall Study|Study terminated by sponsor|0
2865788|NCT02141295|9855270|P3|Overall Study|Physician Decision|14
2865789|NCT02141295|9855271|P2|Overall Study|Physician Decision|19
2865790|NCT02141295|9855272|P1|Overall Study|Physician Decision|2
2865791|NCT02141295|9855270|P3|Overall Study|Adverse Event|11
2865792|NCT02141295|9855271|P2|Overall Study|Adverse Event|18
2865793|NCT02141295|9855272|P1|Overall Study|Adverse Event|1
2865794|NCT02141217|9855308|P2|Overall Study|Surgical Intervention|1
2865795|NCT02141217|9855309|P1|Overall Study|Surgical Intervention|1
2865796|NCT02141217|9855308|P2|Overall Study|Physician Decision|0
2865797|NCT02141217|9855309|P1|Overall Study|Physician Decision|1
2865798|NCT02141217|9855308|P2|Overall Study|Lost to Follow-up|1
2865799|NCT02141217|9855309|P1|Overall Study|Lost to Follow-up|1
2865800|NCT02141217|9855308|P2|Overall Study|Withdrawal by Subject|0
2865801|NCT02141217|9855309|P1|Overall Study|Withdrawal by Subject|6
2865802|NCT02141217|9855308|P2|Overall Study|Protocol Violation|4
2865803|NCT02141217|9855309|P1|Overall Study|Protocol Violation|1
2865804|NCT02141217|9855308|P2|Overall Study|Adverse Event|2
2865805|NCT02141217|9855309|P1|Overall Study|Adverse Event|1
2865806|NCT02140775|9855371|P2|Overall Study|Withdrawal by Subject|7
2865807|NCT02140775|9855372|P1|Overall Study|Withdrawal by Subject|30
2865808|NCT02140762|9855384|P2|Overall Study|Other|1
2865809|NCT02140762|9855385|P1|Overall Study|Other|0
2865810|NCT02140762|9855384|P2|Overall Study|Withdrawal by Subject|4
2865811|NCT02140762|9855385|P1|Overall Study|Withdrawal by Subject|6
2865812|NCT02140762|9855384|P2|Overall Study|Protocol Violation|1
2865813|NCT02140762|9855385|P1|Overall Study|Protocol Violation|1
2865814|NCT02140762|9855384|P2|Overall Study|Lost to Follow-up|5
2865815|NCT02140762|9855385|P1|Overall Study|Lost to Follow-up|9
2865816|NCT02140762|9855384|P2|Overall Study|Adverse Event|1
2865817|NCT02140762|9855385|P1|Overall Study|Adverse Event|1
2865818|NCT02140645|9855451|P6|Overall Study|Not linked|70896
2865819|NCT02140645|9855452|P5|Overall Study|Not linked|3286
2865820|NCT02140645|9855453|P4|Overall Study|Not linked|13833
2865821|NCT02140645|9855454|P3|Overall Study|Not linked|4236
2865822|NCT02140645|9855455|P2|Overall Study|Not linked|61654
2865823|NCT02140645|9855456|P1|Overall Study|Not linked|5489
2865824|NCT02140567|9855554|P1|Overall Study|Problems with recording equipment|6
2865825|NCT02140411|9855559|P1|Overall Study|Adverse Event|1
2865826|NCT02140164|9855579|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
2865827|NCT02140060|9855600|P6|Overall Study|Lack of Efficacy|0
2865828|NCT02140060|9855601|P5|Overall Study|Lack of Efficacy|0
2865829|NCT02140060|9855602|P4|Overall Study|Lack of Efficacy|1
2865830|NCT02140060|9855603|P3|Overall Study|Lack of Efficacy|0
2865831|NCT02140060|9855604|P2|Overall Study|Lack of Efficacy|0
2865832|NCT02140060|9855605|P1|Overall Study|Lack of Efficacy|0
2865833|NCT02140060|9855600|P6|Overall Study|Adverse Event|1
2865834|NCT02140060|9855601|P5|Overall Study|Adverse Event|1
2865835|NCT02140060|9855602|P4|Overall Study|Adverse Event|1
2865836|NCT02140060|9855603|P3|Overall Study|Adverse Event|0
2865837|NCT02140060|9855604|P2|Overall Study|Adverse Event|0
2865838|NCT02140060|9855605|P1|Overall Study|Adverse Event|0
2865839|NCT02139982|9855630|P10|Overall Study|Lack of Efficacy|0
2865840|NCT02139982|9855631|P9|Overall Study|Lack of Efficacy|0
2865841|NCT02139982|9855632|P8|Overall Study|Lack of Efficacy|0
2865842|NCT02139982|9855633|P7|Overall Study|Lack of Efficacy|0
2865843|NCT02139982|9855634|P6|Overall Study|Lack of Efficacy|0
2865844|NCT02139982|9855635|P5|Overall Study|Lack of Efficacy|0
2865845|NCT02139982|9855636|P4|Overall Study|Lack of Efficacy|1
2865846|NCT02139982|9855637|P3|Overall Study|Lack of Efficacy|0
2865847|NCT02139982|9855638|P2|Overall Study|Lack of Efficacy|1
2865848|NCT02139982|9855639|P1|Overall Study|Lack of Efficacy|0
2865849|NCT02139943|9855684|P3|Overall Study|eGFR Withdrawal Criteria|1
2865850|NCT02139943|9855685|P2|Overall Study|eGFR Withdrawal Criteria|0
2865851|NCT02139943|9855686|P1|Overall Study|eGFR Withdrawal Criteria|0
2865852|NCT02139943|9855684|P3|Overall Study|Participant in Poor Compliance|1
2865853|NCT02139943|9855685|P2|Overall Study|Participant in Poor Compliance|0
2865854|NCT02139943|9855686|P1|Overall Study|Participant in Poor Compliance|1
2865855|NCT02139943|9855684|P3|Overall Study|Participant wishes to discontinue|0
2865856|NCT02139943|9855685|P2|Overall Study|Participant wishes to discontinue|0
2865857|NCT02139943|9855686|P1|Overall Study|Participant wishes to discontinue|2
2865858|NCT02139943|9855684|P3|Overall Study|Other|1
2865859|NCT02139943|9855685|P2|Overall Study|Other|0
2865860|NCT02139943|9855686|P1|Overall Study|Other|0
2865861|NCT02139943|9855684|P3|Overall Study|Withdrawal by Subject|0
2865862|NCT02139943|9855685|P2|Overall Study|Withdrawal by Subject|3
2865863|NCT02139943|9855686|P1|Overall Study|Withdrawal by Subject|4
2865864|NCT02139943|9855684|P3|Overall Study|Lost to Follow-up|2
2865865|NCT02139943|9855685|P2|Overall Study|Lost to Follow-up|2
2865866|NCT02139943|9855686|P1|Overall Study|Lost to Follow-up|3
2865867|NCT02139943|9855684|P3|Overall Study|Adverse Event|2
2865868|NCT02139943|9855685|P2|Overall Study|Adverse Event|1
2865869|NCT02139943|9855686|P1|Overall Study|Adverse Event|0
2865870|NCT02139644|9855711|P6|Treatment Period|Other|1
2865871|NCT02139644|9855712|P5|Treatment Period|Other|0
2865872|NCT02139644|9855713|P4|Treatment Period|Other|1
2865873|NCT02139644|9855714|P3|Treatment Period|Other|1
2865874|NCT02139644|9855715|P2|Treatment Period|Other|3
2865875|NCT02139644|9855716|P1|Treatment Period|Other|0
2865876|NCT02139644|9855711|P6|Treatment Period|Lack of Efficacy|4
2865877|NCT02139644|9855712|P5|Treatment Period|Lack of Efficacy|1
2865878|NCT02139644|9855713|P4|Treatment Period|Lack of Efficacy|0
2865879|NCT02139644|9855714|P3|Treatment Period|Lack of Efficacy|1
2865880|NCT02139644|9855715|P2|Treatment Period|Lack of Efficacy|0
2865881|NCT02139644|9855716|P1|Treatment Period|Lack of Efficacy|0
2865882|NCT02139644|9855711|P6|Treatment Period|Lost to Follow-up|1
2865883|NCT02139644|9855712|P5|Treatment Period|Lost to Follow-up|1
2865884|NCT02139644|9855713|P4|Treatment Period|Lost to Follow-up|1
2865885|NCT02139644|9855714|P3|Treatment Period|Lost to Follow-up|1
2865886|NCT02139644|9855715|P2|Treatment Period|Lost to Follow-up|0
2865887|NCT02139644|9855716|P1|Treatment Period|Lost to Follow-up|0
2865888|NCT02139644|9855711|P6|Treatment Period|Disease progression|2
2865889|NCT02139644|9855712|P5|Treatment Period|Disease progression|1
2865890|NCT02139644|9855713|P4|Treatment Period|Disease progression|1
2865891|NCT02139644|9855714|P3|Treatment Period|Disease progression|0
2865892|NCT02139644|9855715|P2|Treatment Period|Disease progression|0
2865893|NCT02139644|9855716|P1|Treatment Period|Disease progression|0
2865894|NCT02139644|9855711|P6|Treatment Period|Protocol Violation|1
2865895|NCT02139644|9855712|P5|Treatment Period|Protocol Violation|1
2865896|NCT02139644|9855713|P4|Treatment Period|Protocol Violation|1
2865897|NCT02139644|9855714|P3|Treatment Period|Protocol Violation|0
2865898|NCT02139644|9855715|P2|Treatment Period|Protocol Violation|0
2865899|NCT02139644|9855716|P1|Treatment Period|Protocol Violation|0
2865900|NCT02139644|9855711|P6|Treatment Period|Non-compliance|0
2865901|NCT02139644|9855712|P5|Treatment Period|Non-compliance|0
2865902|NCT02139644|9855713|P4|Treatment Period|Non-compliance|1
2865903|NCT02139644|9855714|P3|Treatment Period|Non-compliance|0
2865904|NCT02139644|9855715|P2|Treatment Period|Non-compliance|0
2865905|NCT02139644|9855716|P1|Treatment Period|Non-compliance|0
2865906|NCT02139644|9855711|P6|Treatment Period|Withdrawal by Subject|2
2865907|NCT02139644|9855712|P5|Treatment Period|Withdrawal by Subject|3
2865908|NCT02139644|9855713|P4|Treatment Period|Withdrawal by Subject|2
2865909|NCT02139644|9855714|P3|Treatment Period|Withdrawal by Subject|2
2865910|NCT02139644|9855715|P2|Treatment Period|Withdrawal by Subject|0
2865911|NCT02139644|9855716|P1|Treatment Period|Withdrawal by Subject|0
2865912|NCT02139644|9855711|P6|Treatment Period|Adverse Event|6
2865913|NCT02139644|9855712|P5|Treatment Period|Adverse Event|1
2865914|NCT02139644|9855713|P4|Treatment Period|Adverse Event|2
2865915|NCT02139644|9855714|P3|Treatment Period|Adverse Event|3
2865916|NCT02139644|9855715|P2|Treatment Period|Adverse Event|0
2865917|NCT02139644|9855716|P1|Treatment Period|Adverse Event|0
2865918|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Other|0
2865919|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Other|0
2865920|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Other|0
2865921|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Other|0
2865922|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Other|0
2865923|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Other|6
2865924|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2865925|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2865926|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2865927|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2865928|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2865929|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Adverse Event|3
2865930|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865931|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865932|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865933|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865934|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2865935|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
2865936|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865937|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865938|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865939|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865940|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2865941|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
2865942|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865943|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865944|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865945|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865946|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2865947|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
2865948|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865949|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865950|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865951|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865952|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2865953|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
2865954|NCT02139644|9855711|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865955|NCT02139644|9855712|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865956|NCT02139644|9855713|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865957|NCT02139644|9855714|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865958|NCT02139644|9855715|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2865959|NCT02139644|9855716|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
2865960|NCT02139592|9855768|P1|Overall Study|Case Report Forms Uncollected|8
2865961|NCT02139306|9855794|P2|Overall Study|Protocol Violation|0
2865962|NCT02139306|9855795|P1|Overall Study|Protocol Violation|4
2865963|NCT02139306|9855794|P2|Overall Study|Other Unspecified|3
2865964|NCT02139306|9855795|P1|Overall Study|Other Unspecified|2
2865965|NCT02139306|9855794|P2|Overall Study|Physician Decision|1
2865966|NCT02139306|9855795|P1|Overall Study|Physician Decision|0
2865967|NCT02139306|9855794|P2|Overall Study|Adverse Event|4
2865968|NCT02139306|9855795|P1|Overall Study|Adverse Event|3
2865969|NCT02139306|9855794|P2|Overall Study|Withdrawal by Subject|6
2865970|NCT02139306|9855795|P1|Overall Study|Withdrawal by Subject|4
2865971|NCT02139124|9855865|P5|Overall Study|Lost to Follow-up|4
2865972|NCT02139124|9855866|P4|Overall Study|Lost to Follow-up|5
2865973|NCT02139124|9855867|P3|Overall Study|Lost to Follow-up|0
2865974|NCT02139124|9855868|P2|Overall Study|Lost to Follow-up|2
2865975|NCT02139124|9855869|P1|Overall Study|Lost to Follow-up|3
2865976|NCT02139124|9855865|P5|Overall Study|subject moved|0
2865977|NCT02139124|9855866|P4|Overall Study|subject moved|0
2865978|NCT02139124|9855867|P3|Overall Study|subject moved|0
2865979|NCT02139124|9855868|P2|Overall Study|subject moved|0
2865980|NCT02139124|9855869|P1|Overall Study|subject moved|1
2865981|NCT02139124|9855865|P5|Overall Study|incarceration|0
2865982|NCT02139124|9855866|P4|Overall Study|incarceration|0
2865983|NCT02139124|9855867|P3|Overall Study|incarceration|1
2865984|NCT02139124|9855868|P2|Overall Study|incarceration|0
2865985|NCT02139124|9855869|P1|Overall Study|incarceration|0
2865986|NCT02139124|9855865|P5|Overall Study|non-compliant|0
2865987|NCT02139124|9855866|P4|Overall Study|non-compliant|2
2865988|NCT02139124|9855867|P3|Overall Study|non-compliant|0
2865989|NCT02139124|9855868|P2|Overall Study|non-compliant|0
2865990|NCT02139124|9855869|P1|Overall Study|non-compliant|1
2865991|NCT02139124|9855865|P5|Overall Study|Protocol Violation|1
2865992|NCT02139124|9855866|P4|Overall Study|Protocol Violation|1
2865993|NCT02139124|9855867|P3|Overall Study|Protocol Violation|0
2865994|NCT02139124|9855868|P2|Overall Study|Protocol Violation|0
2865995|NCT02139124|9855869|P1|Overall Study|Protocol Violation|0
2865996|NCT02139124|9855865|P5|Overall Study|Withdrawal by Subject|3
2865997|NCT02139124|9855866|P4|Overall Study|Withdrawal by Subject|2
2865998|NCT02139124|9855867|P3|Overall Study|Withdrawal by Subject|2
2865999|NCT02139124|9855868|P2|Overall Study|Withdrawal by Subject|2
2866000|NCT02139124|9855869|P1|Overall Study|Withdrawal by Subject|2
2866001|NCT02139124|9855865|P5|Overall Study|Adverse Event|5
2866002|NCT02139124|9855866|P4|Overall Study|Adverse Event|2
2866003|NCT02139124|9855867|P3|Overall Study|Adverse Event|1
2866004|NCT02139124|9855868|P2|Overall Study|Adverse Event|0
2866005|NCT02139124|9855869|P1|Overall Study|Adverse Event|2
2866006|NCT02139046|9855886|P5|Overall Study|Other Miscellaneous Reasons|12
2866007|NCT02139046|9855887|P4|Overall Study|Other Miscellaneous Reasons|9
2866008|NCT02139046|9855888|P3|Overall Study|Other Miscellaneous Reasons|4
2866009|NCT02139046|9855889|P2|Overall Study|Other Miscellaneous Reasons|9
2866010|NCT02139046|9855890|P1|Overall Study|Other Miscellaneous Reasons|10
2866011|NCT02139046|9855886|P5|Overall Study|Withdrawal due to a Gout Flare|1
2866012|NCT02139046|9855887|P4|Overall Study|Withdrawal due to a Gout Flare|0
2866013|NCT02139046|9855888|P3|Overall Study|Withdrawal due to a Gout Flare|1
2866014|NCT02139046|9855889|P2|Overall Study|Withdrawal due to a Gout Flare|1
2866015|NCT02139046|9855890|P1|Overall Study|Withdrawal due to a Gout Flare|1
2866016|NCT02139046|9855886|P5|Overall Study|Lack of Efficacy|2
2866017|NCT02139046|9855887|P4|Overall Study|Lack of Efficacy|1
2866018|NCT02139046|9855888|P3|Overall Study|Lack of Efficacy|2
2866019|NCT02139046|9855889|P2|Overall Study|Lack of Efficacy|1
2866020|NCT02139046|9855890|P1|Overall Study|Lack of Efficacy|0
2866021|NCT02139046|9855886|P5|Overall Study|Voluntary Withdrawal|16
2866022|NCT02139046|9855887|P4|Overall Study|Voluntary Withdrawal|15
2866023|NCT02139046|9855888|P3|Overall Study|Voluntary Withdrawal|10
2866024|NCT02139046|9855889|P2|Overall Study|Voluntary Withdrawal|8
2866025|NCT02139046|9855890|P1|Overall Study|Voluntary Withdrawal|20
2866026|NCT02139046|9855886|P5|Overall Study|Lost to Follow-up|13
2866027|NCT02139046|9855887|P4|Overall Study|Lost to Follow-up|18
2866028|NCT02139046|9855888|P3|Overall Study|Lost to Follow-up|16
2866029|NCT02139046|9855889|P2|Overall Study|Lost to Follow-up|16
2866030|NCT02139046|9855890|P1|Overall Study|Lost to Follow-up|13
2866031|NCT02139046|9855886|P5|Overall Study|Major Protocol Deviation|6
2866032|NCT02139046|9855887|P4|Overall Study|Major Protocol Deviation|12
2866033|NCT02139046|9855888|P3|Overall Study|Major Protocol Deviation|16
2866034|NCT02139046|9855889|P2|Overall Study|Major Protocol Deviation|10
2866035|NCT02139046|9855890|P1|Overall Study|Major Protocol Deviation|9
2866036|NCT02139046|9855886|P5|Overall Study|Pretreatment Event/Adverse Event|7
2866037|NCT02139046|9855887|P4|Overall Study|Pretreatment Event/Adverse Event|13
2866038|NCT02139046|9855888|P3|Overall Study|Pretreatment Event/Adverse Event|10
2866039|NCT02139046|9855889|P2|Overall Study|Pretreatment Event/Adverse Event|9
2866040|NCT02139046|9855890|P1|Overall Study|Pretreatment Event/Adverse Event|9
2866041|NCT02138916|9855931|P3|Overall Study|Adverse Event|3
2866042|NCT02138916|9855932|P2|Overall Study|Adverse Event|4
2866043|NCT02138916|9855933|P1|Overall Study|Adverse Event|4
2866044|NCT02138916|9855931|P3|Overall Study|Lost to Follow-up|3
2866045|NCT02138916|9855932|P2|Overall Study|Lost to Follow-up|2
2866046|NCT02138916|9855933|P1|Overall Study|Lost to Follow-up|4
2866047|NCT02138916|9855931|P3|Overall Study|Severe non-compliance|1
2866048|NCT02138916|9855932|P2|Overall Study|Severe non-compliance|2
2866049|NCT02138916|9855933|P1|Overall Study|Severe non-compliance|1
2866050|NCT02138916|9855931|P3|Overall Study|incorrect enrolment|0
2866051|NCT02138916|9855932|P2|Overall Study|incorrect enrolment|1
2866052|NCT02138916|9855933|P1|Overall Study|incorrect enrolment|1
2866053|NCT02138916|9855931|P3|Overall Study|Study specific withdrawal criteria|1
2866054|NCT02138916|9855932|P2|Overall Study|Study specific withdrawal criteria|0
2866055|NCT02138916|9855933|P1|Overall Study|Study specific withdrawal criteria|0
2866056|NCT02138916|9855931|P3|Overall Study|Withdrawal by Subject|32
2866057|NCT02138916|9855932|P2|Overall Study|Withdrawal by Subject|31
2866058|NCT02138916|9855933|P1|Overall Study|Withdrawal by Subject|27
2866059|NCT02138916|9855931|P3|Overall Study|Death|12
2866060|NCT02138916|9855932|P2|Overall Study|Death|11
2866061|NCT02138916|9855933|P1|Overall Study|Death|14
2866062|NCT02138916|9855931|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
2866063|NCT02138916|9855932|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
2866064|NCT02138916|9855933|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
2866065|NCT02138890|9855996|P2|Overall Study|Adverse Event|0
2866066|NCT02138890|9855997|P1|Overall Study|Adverse Event|1
2866067|NCT02138838|9856039|P2|Overall Study|Withdrawal by Subject|5
2866068|NCT02138838|9856040|P1|Overall Study|Withdrawal by Subject|1
2866069|NCT02138838|9856039|P2|Overall Study|Study Closure|6
2866070|NCT02138838|9856040|P1|Overall Study|Study Closure|7
2866071|NCT02138825|9856058|P2|Safety Follow-up|withdrawn due to lung transplant|1
2866072|NCT02138825|9856059|P1|Safety Follow-up|withdrawn due to lung transplant|0
2866073|NCT02138825|9856058|P2|Safety Follow-up|treatment unblinded|1
2866074|NCT02138825|9856059|P1|Safety Follow-up|treatment unblinded|0
2866075|NCT02138825|9856058|P2|Safety Follow-up|too unwell to attend the visit|1
2866076|NCT02138825|9856059|P1|Safety Follow-up|too unwell to attend the visit|0
2866077|NCT02138825|9856058|P2|Safety Follow-up|progressive disease|2
2866078|NCT02138825|9856059|P1|Safety Follow-up|progressive disease|0
2866079|NCT02138825|9856058|P2|Safety Follow-up|logistical difficulties|1
2866080|NCT02138825|9856059|P1|Safety Follow-up|logistical difficulties|0
2866081|NCT02138825|9856058|P2|Safety Follow-up|withdrawal by PI|0
2866082|NCT02138825|9856059|P1|Safety Follow-up|withdrawal by PI|1
2866083|NCT02138825|9856058|P2|Safety Follow-up|clinic worsening|0
2866084|NCT02138825|9856059|P1|Safety Follow-up|clinic worsening|1
2866085|NCT02138825|9856058|P2|Safety Follow-up|Withdrawal by Subject|3
2866086|NCT02138825|9856059|P1|Safety Follow-up|Withdrawal by Subject|5
2866087|NCT02138825|9856058|P2|Safety Follow-up|Death|5
2866088|NCT02138825|9856059|P1|Safety Follow-up|Death|11
2866089|NCT02138825|9856058|P2|Safety Follow-up|Adverse Event|3
2866090|NCT02138825|9856059|P1|Safety Follow-up|Adverse Event|4
2866091|NCT02138825|9856058|P2|Long-term Extension|Study termination by sponsor|38
2866092|NCT02138825|9856059|P1|Long-term Extension|Study termination by sponsor|32
2866093|NCT02138825|9856058|P2|Main Study Treatment|Medical decision|0
2866094|NCT02138825|9856059|P1|Main Study Treatment|Medical decision|1
2866095|NCT02138825|9856058|P2|Main Study Treatment|Withdrawal by Subject|1
2866096|NCT02138825|9856059|P1|Main Study Treatment|Withdrawal by Subject|3
2866097|NCT02138825|9856058|P2|Main Study Treatment|Study terminated by sponsor|9
2866098|NCT02138825|9856059|P1|Main Study Treatment|Study terminated by sponsor|10
2866099|NCT02138825|9856058|P2|Main Study Treatment|Sponsor decision|18
2866100|NCT02138825|9856059|P1|Main Study Treatment|Sponsor decision|12
2866101|NCT02138825|9856058|P2|Main Study Treatment|Protocol Violation|2
2866102|NCT02138825|9856059|P1|Main Study Treatment|Protocol Violation|2
2866103|NCT02138825|9856058|P2|Main Study Treatment|Death|2
2866104|NCT02138825|9856059|P1|Main Study Treatment|Death|1
2866105|NCT02138825|9856058|P2|Main Study Treatment|Adverse Event|3
2866106|NCT02138825|9856059|P1|Main Study Treatment|Adverse Event|11
2866107|NCT02138786|9856076|P3|Overall Study|Non-Compliance|1
2866108|NCT02138786|9856077|P2|Overall Study|Non-Compliance|0
2866109|NCT02138786|9856078|P1|Overall Study|Non-Compliance|0
2866110|NCT02138786|9856076|P3|Overall Study|Sponsor Terminated Study|1
2866111|NCT02138786|9856077|P2|Overall Study|Sponsor Terminated Study|1
2866112|NCT02138786|9856078|P1|Overall Study|Sponsor Terminated Study|0
2866113|NCT02138786|9856076|P3|Overall Study|Patient's Wish|0
2866114|NCT02138786|9856077|P2|Overall Study|Patient's Wish|2
2866115|NCT02138786|9856078|P1|Overall Study|Patient's Wish|0
2866116|NCT02138786|9856076|P3|Overall Study|Withdrawal by Subject|0
2866117|NCT02138786|9856077|P2|Overall Study|Withdrawal by Subject|2
2866118|NCT02138786|9856078|P1|Overall Study|Withdrawal by Subject|1
2866119|NCT02138786|9856076|P3|Overall Study|Disease Progression|3
2866120|NCT02138786|9856077|P2|Overall Study|Disease Progression|1
2866121|NCT02138786|9856078|P1|Overall Study|Disease Progression|1
2866122|NCT02138786|9856076|P3|Overall Study|Death|2
2866123|NCT02138786|9856077|P2|Overall Study|Death|7
2866124|NCT02138786|9856078|P1|Overall Study|Death|1
2866125|NCT02138786|9856076|P3|Overall Study|Adverse Event|1
2866126|NCT02138786|9856077|P2|Overall Study|Adverse Event|2
2866127|NCT02138786|9856078|P1|Overall Study|Adverse Event|0
2866128|NCT02138747|9856095|P4|Treatment Period 2|Other - Miscellaneous|0
2866129|NCT02138747|9856096|P3|Treatment Period 2|Other - Miscellaneous|0
2866130|NCT02138747|9856097|P2|Treatment Period 2|Other - Miscellaneous|0
2866131|NCT02138747|9856098|P1|Treatment Period 2|Other - Miscellaneous|3
2866132|NCT02138747|9856095|P4|Treatment Period 2|Withdrawal by Subject|2
2866133|NCT02138747|9856096|P3|Treatment Period 2|Withdrawal by Subject|1
2866134|NCT02138747|9856097|P2|Treatment Period 2|Withdrawal by Subject|4
2866135|NCT02138747|9856098|P1|Treatment Period 2|Withdrawal by Subject|5
2866136|NCT02138747|9856095|P4|Treatment Period 2|Protocol Violation|0
2866137|NCT02138747|9856096|P3|Treatment Period 2|Protocol Violation|0
2866138|NCT02138747|9856097|P2|Treatment Period 2|Protocol Violation|0
2866139|NCT02138747|9856098|P1|Treatment Period 2|Protocol Violation|1
2866140|NCT02138747|9856095|P4|Treatment Period 2|Lost to Follow-up|0
2866141|NCT02138747|9856096|P3|Treatment Period 2|Lost to Follow-up|0
2866142|NCT02138747|9856097|P2|Treatment Period 2|Lost to Follow-up|0
2866143|NCT02138747|9856098|P1|Treatment Period 2|Lost to Follow-up|2
2866144|NCT02138747|9856095|P4|Treatment Period 2|Adverse Event|1
2866145|NCT02138747|9856096|P3|Treatment Period 2|Adverse Event|1
2866146|NCT02138747|9856097|P2|Treatment Period 2|Adverse Event|3
2866147|NCT02138747|9856098|P1|Treatment Period 2|Adverse Event|6
2866148|NCT02138747|9856095|P4|Treatment Period 1|Other - Miscellaneous|0
2866149|NCT02138747|9856096|P3|Treatment Period 1|Other - Miscellaneous|0
2866150|NCT02138747|9856097|P2|Treatment Period 1|Other - Miscellaneous|4
2866151|NCT02138747|9856098|P1|Treatment Period 1|Other - Miscellaneous|2
2866152|NCT02138747|9856095|P4|Treatment Period 1|Withdrawal by Subject|3
2866153|NCT02138747|9856096|P3|Treatment Period 1|Withdrawal by Subject|1
2866154|NCT02138747|9856097|P2|Treatment Period 1|Withdrawal by Subject|4
2866155|NCT02138747|9856098|P1|Treatment Period 1|Withdrawal by Subject|8
2866156|NCT02138747|9856095|P4|Treatment Period 1|Protocol Violation|0
2866157|NCT02138747|9856096|P3|Treatment Period 1|Protocol Violation|0
2866158|NCT02138747|9856097|P2|Treatment Period 1|Protocol Violation|2
2866159|NCT02138747|9856098|P1|Treatment Period 1|Protocol Violation|0
2866160|NCT02138747|9856095|P4|Treatment Period 1|Lost to Follow-up|0
2866161|NCT02138747|9856096|P3|Treatment Period 1|Lost to Follow-up|1
2866162|NCT02138747|9856097|P2|Treatment Period 1|Lost to Follow-up|1
2866163|NCT02138747|9856098|P1|Treatment Period 1|Lost to Follow-up|0
2866164|NCT02138747|9856095|P4|Treatment Period 1|Adverse Event|1
2866165|NCT02138747|9856096|P3|Treatment Period 1|Adverse Event|2
2866166|NCT02138747|9856097|P2|Treatment Period 1|Adverse Event|14
2866167|NCT02138747|9856098|P1|Treatment Period 1|Adverse Event|10
2866168|NCT02138253|9856172|P2|Overall Study|Withdrawal by Subject|0
2866169|NCT02138253|9856173|P1|Overall Study|Withdrawal by Subject|1
2866170|NCT02138253|9856172|P2|Overall Study|Non compliance|0
2866171|NCT02138253|9856173|P1|Overall Study|Non compliance|1
2866172|NCT02138253|9856172|P2|Overall Study|Physician Decision|0
2866173|NCT02138253|9856173|P1|Overall Study|Physician Decision|2
2866174|NCT02138253|9856172|P2|Overall Study|Lost to Follow-up|1
2866175|NCT02138253|9856173|P1|Overall Study|Lost to Follow-up|2
2866176|NCT02138253|9856172|P2|Overall Study|Adverse Event|3
2866177|NCT02138253|9856173|P1|Overall Study|Adverse Event|3
2866178|NCT02138136|9856245|P1|Overall Study|Withdrawn by Sponsor|5
2866179|NCT02138136|9856245|P1|Overall Study|Lost to Follow-up|32
2866180|NCT02138136|9856245|P1|Overall Study|Withdrawal by Subject|36
2866181|NCT02138136|9856245|P1|Overall Study|Adverse Event|18
2866182|NCT02138136|9856245|P1|Overall Study|Pregnancy|2
2866183|NCT02138136|9856245|P1|Overall Study|Lack of Efficacy|35
2866184|NCT02138136|9856245|P1|Overall Study|Physician Decision|7
2866185|NCT02138136|9856245|P1|Overall Study|Protocol Violation|4
2866186|NCT02138110|9856252|P1|Overall Scaffold Implantation|Death|3
2866187|NCT02138110|9856252|P1|Enrolled for Scaffold Implantation|Physician Decision|1
2866188|NCT02137785|9856484|P2|Overall Study|subject moved out of state|0
2866189|NCT02137785|9856485|P1|Overall Study|subject moved out of state|1
2866190|NCT02137785|9856484|P2|Overall Study|Withdrawal by Subject|4
2866191|NCT02137785|9856485|P1|Overall Study|Withdrawal by Subject|1
2866192|NCT02137785|9856484|P2|Overall Study|Lost to Follow-up|0
2866193|NCT02137785|9856485|P1|Overall Study|Lost to Follow-up|1
2866194|NCT02137772|9856593|P2|Overall Study|Not treated|2
2866195|NCT02137772|9856594|P1|Overall Study|Not treated|3
2866196|NCT02137772|9856593|P2|Overall Study|Non-compliance with study drug|0
2866197|NCT02137772|9856594|P1|Overall Study|Non-compliance with study drug|1
2866198|NCT02137772|9856593|P2|Overall Study|Withdrawal by Subject|17
2866199|NCT02137772|9856594|P1|Overall Study|Withdrawal by Subject|28
2866200|NCT02137772|9856593|P2|Overall Study|Physician Decision|5
2866201|NCT02137772|9856594|P1|Overall Study|Physician Decision|15
2866202|NCT02137772|9856593|P2|Overall Study|Lost to Follow-up|4
2866203|NCT02137772|9856594|P1|Overall Study|Lost to Follow-up|8
2866204|NCT02137772|9856593|P2|Overall Study|Death|44
2866205|NCT02137772|9856594|P1|Overall Study|Death|71
2866206|NCT02137772|9856593|P2|Overall Study|Adverse Event|3
2866207|NCT02137772|9856594|P1|Overall Study|Adverse Event|6
2866208|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Other Reason|1
2866209|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Other Reason|1
2866210|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Other Reason|1
2866211|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Other Reason|0
2866212|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Other Reason|0
2866213|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
2866214|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
2866215|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
2866216|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
2866217|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
2866218|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
2866219|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
2866220|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
2866221|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
2866222|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
2866223|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Physician Decision|0
2866224|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Physician Decision|1
2866225|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Physician Decision|0
2866226|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Physician Decision|0
2866227|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Physician Decision|0
2866228|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
2866229|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
2866230|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
2866231|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2866232|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2866233|NCT02137226|9856852|P5|Period 2 (Re - Randomization)|Adverse Event|4
2866234|NCT02137226|9856853|P4|Period 2 (Re - Randomization)|Adverse Event|1
2866235|NCT02137226|9856854|P3|Period 2 (Re - Randomization)|Adverse Event|3
2866236|NCT02137226|9856855|P2|Period 2 (Re - Randomization)|Adverse Event|0
2866237|NCT02137226|9856856|P1|Period 2 (Re - Randomization)|Adverse Event|0
2866238|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Other Reason|0
2866239|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Other Reason|0
2866240|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Other Reason|0
2866241|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Other Reason|3
2866242|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Other Reason|1
2866243|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
2866244|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
2866245|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
2866246|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
2866247|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
2866248|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
2866249|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
2866250|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
2866251|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
2866252|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
2866253|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Physician Decision|0
2866254|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Physician Decision|0
2866255|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Physician Decision|0
2866256|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Physician Decision|3
2866257|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Physician Decision|1
2866258|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2866259|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2866260|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2866261|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
2866262|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
2866263|NCT02137226|9856852|P5|Period 1 (Initial Randomization)|Adverse Event|0
2866264|NCT02137226|9856853|P4|Period 1 (Initial Randomization)|Adverse Event|0
2866265|NCT02137226|9856854|P3|Period 1 (Initial Randomization)|Adverse Event|0
2866266|NCT02137226|9856855|P2|Period 1 (Initial Randomization)|Adverse Event|3
2866267|NCT02137226|9856856|P1|Period 1 (Initial Randomization)|Adverse Event|3
2866268|NCT02136914|9856874|P2|Overall Study|Death|1
2866269|NCT02136914|9856875|P1|Overall Study|Death|0
2866270|NCT02136914|9856874|P2|Overall Study|Lack of Efficacy|0
2866271|NCT02136914|9856875|P1|Overall Study|Lack of Efficacy|1
2866272|NCT02136914|9856874|P2|Overall Study|Did Not Receive Study Drug|0
2866273|NCT02136914|9856875|P1|Overall Study|Did Not Receive Study Drug|2
2866274|NCT02136914|9856874|P2|Overall Study|Lost to Follow-up|1
2866275|NCT02136914|9856875|P1|Overall Study|Lost to Follow-up|1
2866276|NCT02136914|9856874|P2|Overall Study|Subject Unwilling to Proceed|2
2866277|NCT02136914|9856875|P1|Overall Study|Subject Unwilling to Proceed|7
2866278|NCT02136914|9856874|P2|Overall Study|Withdrawal by Subject|10
2866279|NCT02136914|9856875|P1|Overall Study|Withdrawal by Subject|3
2866280|NCT02136914|9856874|P2|Overall Study|Sponsor's Decision to Stop the Study|7
2866281|NCT02136914|9856875|P1|Overall Study|Sponsor's Decision to Stop the Study|7
2866282|NCT02136680|9856895|P2|Overall Study|Study ended before interview due|3
2866283|NCT02136680|9856896|P1|Overall Study|Study ended before interview due|6
2866284|NCT02136680|9856895|P2|Overall Study|Unable to schedule|16
2866285|NCT02136680|9856896|P1|Overall Study|Unable to schedule|17
2866286|NCT02136680|9856895|P2|Overall Study|Moved away|4
2866287|NCT02136680|9856896|P1|Overall Study|Moved away|5
2866288|NCT02136680|9856895|P2|Overall Study|No longer receiving care at clinic|5
2866289|NCT02136680|9856896|P1|Overall Study|No longer receiving care at clinic|3
2866290|NCT02136680|9856895|P2|Overall Study|No Longer Interested|1
2866291|NCT02136680|9856896|P1|Overall Study|No Longer Interested|1
2866292|NCT02136134|9856971|P2|Overall Study|Subjects randomized but not treated|8
2866293|NCT02136134|9856972|P1|Overall Study|Subjects randomized but not treated|10
2866294|NCT02136134|9856971|P2|Overall Study|Ongoing|207
2866295|NCT02136134|9856972|P1|Overall Study|Ongoing|185
2866296|NCT02136134|9856971|P2|Overall Study|Other|3
2866297|NCT02136134|9856972|P1|Overall Study|Other|3
2866298|NCT02136134|9856971|P2|Overall Study|Withdrawal by Subject|4
2866299|NCT02136134|9856972|P1|Overall Study|Withdrawal by Subject|14
2866300|NCT02136134|9856971|P2|Overall Study|Death|29
2866301|NCT02136134|9856972|P1|Overall Study|Death|35
2866302|NCT02135848|9857034|P2|Overall Study|Withdrawal by Subject|1
2866303|NCT02135848|9857035|P1|Overall Study|Withdrawal by Subject|1
2866304|NCT02135848|9857034|P2|Overall Study|Adverse Event|0
2866305|NCT02135848|9857035|P1|Overall Study|Adverse Event|2
2866306|NCT02135692|9857093|P1|Overall Study|Withdrawal by Subject|15
2866307|NCT02135692|9857093|P1|Overall Study|Lost to Follow-up|4
2866308|NCT02135692|9857093|P1|Overall Study|Study closed/terminated|153
2866309|NCT02135692|9857093|P1|Overall Study|Product commercially available|159
2866310|NCT02135692|9857093|P1|Overall Study|Subject met Liver Stopping Criteria|1
2866311|NCT02135692|9857093|P1|Overall Study|Protocol Violation|2
2866312|NCT02135692|9857093|P1|Overall Study|Lack of Efficacy|2
2866313|NCT02135692|9857093|P1|Overall Study|Adverse Event|3
2866314|NCT02135614|9857112|P2|Overall Study|Lost to Follow-up|0
2866315|NCT02135614|9857113|P1|Overall Study|Lost to Follow-up|3
2866316|NCT02135614|9857112|P2|Overall Study|Withdrew Consent|2
2866317|NCT02135614|9857113|P1|Overall Study|Withdrew Consent|2
2866318|NCT02135614|9857112|P2|Overall Study|Investigator's Discretion|1
2866319|NCT02135614|9857113|P1|Overall Study|Investigator's Discretion|0
2866320|NCT02135614|9857112|P2|Overall Study|Death|0
2866321|NCT02135614|9857113|P1|Overall Study|Death|1
2866322|NCT02135614|9857112|P2|Overall Study|Adverse Event|1
2866323|NCT02135614|9857113|P1|Overall Study|Adverse Event|0
2866324|NCT02135614|9857112|P2|Overall Study|Randomized but Not Treated|1
2866325|NCT02135614|9857113|P1|Overall Study|Randomized but Not Treated|2
2866326|NCT02135445|9857127|P2|Overall Study|Withdrawal by Subject|0
2866327|NCT02135445|9857128|P1|Overall Study|Withdrawal by Subject|1
2866328|NCT02135445|9857127|P2|Overall Study|Lost to Follow-up|0
2866329|NCT02135445|9857128|P1|Overall Study|Lost to Follow-up|1
2866330|NCT02135107|9857213|P4|Maintenance Therapy Period|Other|8
2866331|NCT02135107|9857214|P3|Maintenance Therapy Period|Other|7
2866332|NCT02135107|9857215|P2|Maintenance Therapy Period|Other|0
2866333|NCT02135107|9857216|P1|Maintenance Therapy Period|Other|0
2866334|NCT02135107|9857213|P4|Maintenance Therapy Period|Pregnancy|1
2866335|NCT02135107|9857214|P3|Maintenance Therapy Period|Pregnancy|0
2866336|NCT02135107|9857215|P2|Maintenance Therapy Period|Pregnancy|0
2866337|NCT02135107|9857216|P1|Maintenance Therapy Period|Pregnancy|0
2866338|NCT02135107|9857213|P4|Maintenance Therapy Period|Withdrawal by Subject|4
2866339|NCT02135107|9857214|P3|Maintenance Therapy Period|Withdrawal by Subject|5
2866340|NCT02135107|9857215|P2|Maintenance Therapy Period|Withdrawal by Subject|0
2866341|NCT02135107|9857216|P1|Maintenance Therapy Period|Withdrawal by Subject|0
2866342|NCT02135107|9857213|P4|Maintenance Therapy Period|Adverse Event|7
2866343|NCT02135107|9857214|P3|Maintenance Therapy Period|Adverse Event|3
2866344|NCT02135107|9857215|P2|Maintenance Therapy Period|Adverse Event|0
2866345|NCT02135107|9857216|P1|Maintenance Therapy Period|Adverse Event|0
2866346|NCT02135107|9857213|P4|Treatment Period|Other|0
2866347|NCT02135107|9857214|P3|Treatment Period|Other|0
2866348|NCT02135107|9857215|P2|Treatment Period|Other|24
2866349|NCT02135107|9857216|P1|Treatment Period|Other|115
2866350|NCT02135107|9857213|P4|Treatment Period|Pregnancy|0
2866351|NCT02135107|9857214|P3|Treatment Period|Pregnancy|0
2866352|NCT02135107|9857215|P2|Treatment Period|Pregnancy|0
2866353|NCT02135107|9857216|P1|Treatment Period|Pregnancy|1
2866354|NCT02135107|9857213|P4|Treatment Period|Adverse Event|0
2866355|NCT02135107|9857214|P3|Treatment Period|Adverse Event|0
2866356|NCT02135107|9857215|P2|Treatment Period|Adverse Event|2
2866357|NCT02135107|9857216|P1|Treatment Period|Adverse Event|5
2866358|NCT02135107|9857213|P4|Treatment Period|Withdrawal by Subject|0
2866359|NCT02135107|9857214|P3|Treatment Period|Withdrawal by Subject|0
2866360|NCT02135107|9857215|P2|Treatment Period|Withdrawal by Subject|0
2866361|NCT02135107|9857216|P1|Treatment Period|Withdrawal by Subject|11
2866362|NCT02135029|9857262|P3|Overall Study|Death|0
2866363|NCT02135029|9857263|P2|Overall Study|Death|1
2866364|NCT02135029|9857264|P1|Overall Study|Death|0
2866365|NCT02135029|9857262|P3|Overall Study|Other|0
2866366|NCT02135029|9857263|P2|Overall Study|Other|1
2866367|NCT02135029|9857264|P1|Overall Study|Other|0
2866368|NCT02135029|9857262|P3|Overall Study|Withdrawal by Subject|1
2866369|NCT02135029|9857263|P2|Overall Study|Withdrawal by Subject|0
2866370|NCT02135029|9857264|P1|Overall Study|Withdrawal by Subject|2
2866371|NCT02135029|9857262|P3|Overall Study|Lost to Follow-up|0
2866372|NCT02135029|9857263|P2|Overall Study|Lost to Follow-up|1
2866373|NCT02135029|9857264|P1|Overall Study|Lost to Follow-up|0
2866374|NCT02135029|9857262|P3|Overall Study|Adverse Event|2
2866375|NCT02135029|9857263|P2|Overall Study|Adverse Event|2
2866376|NCT02135029|9857264|P1|Overall Study|Adverse Event|2
2866377|NCT02134977|9857369|P1|Overall Study|Protocol Deviation|102
2866378|NCT02134925|9857403|P2|Overall Study|Cancel|6
2866379|NCT02134925|9857404|P1|Overall Study|Cancel|1
2866380|NCT02134925|9857403|P2|Overall Study|Withdrawal by Subject|0
2866381|NCT02134925|9857404|P1|Overall Study|Withdrawal by Subject|1
2866382|NCT02134587|9857445|P1|Overall Study|Did not completed all meetings|30
2866383|NCT02134015|9857584|P2|Overall Study|Withdrawal by Subject|7
2866384|NCT02134015|9857585|P1|Overall Study|Withdrawal by Subject|3
2866385|NCT02134015|9857584|P2|Overall Study|Adverse Event|10
2866386|NCT02134015|9857585|P1|Overall Study|Adverse Event|9
2866387|NCT02134015|9857584|P2|Overall Study|Study terminated by sponsor|3
2866388|NCT02134015|9857585|P1|Overall Study|Study terminated by sponsor|2
2866389|NCT02134015|9857584|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
2866390|NCT02134015|9857585|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
2866391|NCT02134015|9857584|P2|Overall Study|Clinical progression|7
2866392|NCT02134015|9857585|P1|Overall Study|Clinical progression|14
2866393|NCT02134015|9857584|P2|Overall Study|Reason not provided|2
2866394|NCT02134015|9857585|P1|Overall Study|Reason not provided|1
2866395|NCT02134015|9857584|P2|Overall Study|Death|1
2866396|NCT02134015|9857585|P1|Overall Study|Death|2
2866397|NCT02134015|9857584|P2|Overall Study|Protocol Violation|1
2866398|NCT02134015|9857585|P1|Overall Study|Protocol Violation|0
2866399|NCT02133742|9857621|P1|Period 2:Dose Expansion Phase (903 Days)|Ongoing at date of cutoff|41
2866400|NCT02133742|9857621|P1|Period 2:Dose Expansion Phase (903 Days)|Death|5
2866401|NCT02133742|9857621|P1|Period 2:Dose Expansion Phase (903 Days)|Other|2
2866402|NCT02133742|9857621|P1|Period 2:Dose Expansion Phase (903 Days)|Lost to Follow-up|4
2866403|NCT02133664|9857640|P2|Overall Study|Adverse Event|6
2866404|NCT02133664|9857641|P1|Overall Study|Adverse Event|3
2866405|NCT02133664|9857640|P2|Overall Study|Lost to Follow-up|1
2866406|NCT02133664|9857641|P1|Overall Study|Lost to Follow-up|2
2866407|NCT02133508|9857657|P1|Overall Study|Lost to Follow-up|2
2866408|NCT02133508|9857657|P1|Overall Study|Death|12
2866409|NCT02133508|9857657|P1|Overall Study|Decision of Investigator or Sponsor|1
2866410|NCT02133352|9857665|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
2866411|NCT02133131|9857696|P7|Overall Study|Protocol Violation|1
2866412|NCT02133131|9857697|P6|Overall Study|Protocol Violation|0
2866413|NCT02133131|9857698|P5|Overall Study|Protocol Violation|0
2866414|NCT02133131|9857699|P4|Overall Study|Protocol Violation|0
2866415|NCT02133131|9857700|P3|Overall Study|Protocol Violation|0
2866416|NCT02133131|9857701|P2|Overall Study|Protocol Violation|0
2866417|NCT02133131|9857702|P1|Overall Study|Protocol Violation|0
2866418|NCT02133131|9857696|P7|Overall Study|Ongoing in study|11
2866419|NCT02133131|9857697|P6|Overall Study|Ongoing in study|14
2866420|NCT02133131|9857698|P5|Overall Study|Ongoing in study|15
2866421|NCT02133131|9857699|P4|Overall Study|Ongoing in study|0
2866422|NCT02133131|9857700|P3|Overall Study|Ongoing in study|0
2866423|NCT02133131|9857701|P2|Overall Study|Ongoing in study|0
2866424|NCT02133131|9857702|P1|Overall Study|Ongoing in study|0
2866425|NCT02133131|9857696|P7|Overall Study|Status not recorded|0
2866426|NCT02133131|9857697|P6|Overall Study|Status not recorded|0
2866427|NCT02133131|9857698|P5|Overall Study|Status not recorded|0
2866428|NCT02133131|9857699|P4|Overall Study|Status not recorded|4
2866429|NCT02133131|9857700|P3|Overall Study|Status not recorded|1
2866430|NCT02133131|9857701|P2|Overall Study|Status not recorded|5
2866431|NCT02133131|9857702|P1|Overall Study|Status not recorded|4
2866432|NCT02133131|9857696|P7|Overall Study|Lost to Follow-up|0
2866433|NCT02133131|9857697|P6|Overall Study|Lost to Follow-up|0
2866434|NCT02133131|9857698|P5|Overall Study|Lost to Follow-up|0
2866435|NCT02133131|9857699|P4|Overall Study|Lost to Follow-up|1
2866436|NCT02133131|9857700|P3|Overall Study|Lost to Follow-up|0
2866437|NCT02133131|9857701|P2|Overall Study|Lost to Follow-up|0
2866438|NCT02133131|9857702|P1|Overall Study|Lost to Follow-up|1
2866439|NCT02133131|9857696|P7|Overall Study|Adverse Event|0
2866440|NCT02133131|9857697|P6|Overall Study|Adverse Event|0
2866441|NCT02133131|9857698|P5|Overall Study|Adverse Event|0
2866442|NCT02133131|9857699|P4|Overall Study|Adverse Event|1
2866443|NCT02133131|9857700|P3|Overall Study|Adverse Event|0
2866444|NCT02133131|9857701|P2|Overall Study|Adverse Event|0
2866445|NCT02133131|9857702|P1|Overall Study|Adverse Event|0
2866446|NCT02133001|9857756|P2|Follow-Up Phase (Day 26-81)|Other|1
2866447|NCT02133001|9857757|P1|Follow-Up Phase (Day 26-81)|Other|0
2866448|NCT02133001|9857756|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2866449|NCT02133001|9857757|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2866450|NCT02133001|9857756|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2866451|NCT02133001|9857757|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2866452|NCT02133001|9857756|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
2866453|NCT02133001|9857757|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
2866454|NCT02133001|9857756|P2|Double Blind (Day 1-25)|Other|2
2866455|NCT02133001|9857757|P1|Double Blind (Day 1-25)|Other|2
2866456|NCT02133001|9857756|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
2866457|NCT02133001|9857757|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
2866458|NCT02133001|9857756|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
2866459|NCT02133001|9857757|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
2866460|NCT02133001|9857756|P2|Double Blind (Day 1-25)|Adverse Event|5
2866461|NCT02133001|9857757|P1|Double Blind (Day 1-25)|Adverse Event|1
2866462|NCT02132949|9857805|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
2866463|NCT02132949|9857806|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
2866464|NCT02132949|9857805|P2|Adjuvant Treatment Period|Protocol Deviation|0
2866465|NCT02132949|9857806|P1|Adjuvant Treatment Period|Protocol Deviation|1
2866466|NCT02132949|9857805|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
2866467|NCT02132949|9857806|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
2866468|NCT02132949|9857805|P2|Adjuvant Treatment Period|Physician Decision|0
2866469|NCT02132949|9857806|P1|Adjuvant Treatment Period|Physician Decision|1
2866470|NCT02132949|9857805|P2|Adjuvant Treatment Period|Disease Relapse|1
2866471|NCT02132949|9857806|P1|Adjuvant Treatment Period|Disease Relapse|0
2866472|NCT02132949|9857805|P2|Adjuvant Treatment Period|Disease Progression|1
2866473|NCT02132949|9857806|P1|Adjuvant Treatment Period|Disease Progression|0
2866474|NCT02132949|9857805|P2|Adjuvant Treatment Period|Reason unspecified|1
2866475|NCT02132949|9857806|P1|Adjuvant Treatment Period|Reason unspecified|0
2866476|NCT02132949|9857805|P2|Adjuvant Treatment Period|Adverse Event|6
2866477|NCT02132949|9857806|P1|Adjuvant Treatment Period|Adverse Event|4
2866478|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
2866479|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
2866480|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Adverse Event|3
2866481|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Adverse Event|6
2866482|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Disease Progression|1
2866483|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Disease Progression|1
2866484|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
2866485|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
2866486|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Physician Decision|0
2866487|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Physician Decision|2
2866488|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
2866489|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
2866490|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Reason unspecified|1
2866491|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Reason unspecified|3
2866492|NCT02132949|9857805|P2|Neoadjuvant Treatment Period|Early surgery|3
2866493|NCT02132949|9857806|P1|Neoadjuvant Treatment Period|Early surgery|4
2866494|NCT02132767|9857918|P2|Overall Study|Lost to Follow-up|4
2866495|NCT02132767|9857919|P1|Overall Study|Lost to Follow-up|4
2866496|NCT02132767|9857918|P2|Overall Study|Withdrawal by Subject|9
2866497|NCT02132767|9857919|P1|Overall Study|Withdrawal by Subject|10
2866498|NCT02132767|9857918|P2|Overall Study|Death|2
2866499|NCT02132767|9857919|P1|Overall Study|Death|3
2866500|NCT02132637|9857941|P2|Study Period 2 (Crossover)|Physician Decision|0
2866501|NCT02132637|9857942|P1|Study Period 2 (Crossover)|Physician Decision|2
2866502|NCT02132637|9857941|P2|Study Period 2 (Crossover)|Adverse Event|1
2866503|NCT02132637|9857942|P1|Study Period 2 (Crossover)|Adverse Event|0
2866504|NCT02132637|9857941|P2|Study Period 1|Physician Decision|0
2866505|NCT02132637|9857942|P1|Study Period 1|Physician Decision|1
2866506|NCT02132637|9857941|P2|Study Period 1|Withdrawal by Subject|4
2866507|NCT02132637|9857942|P1|Study Period 1|Withdrawal by Subject|0
2866508|NCT02132611|9857966|P1|Overall Study|Death|2
2866509|NCT02132247|9858017|P2|Overall Study|Protocol Violation|0
2866510|NCT02132247|9858018|P1|Overall Study|Protocol Violation|1
2866511|NCT02132195|9858033|P3|Rescue Therapy|Adverse Event|2
2866512|NCT02132195|9858034|P2|Rescue Therapy|Adverse Event|0
2866513|NCT02132195|9858035|P1|Rescue Therapy|Adverse Event|0
2866514|NCT02132195|9858033|P3|Rescue Therapy|Withdrawal by Subject|1
2866515|NCT02132195|9858034|P2|Rescue Therapy|Withdrawal by Subject|0
2866516|NCT02132195|9858035|P1|Rescue Therapy|Withdrawal by Subject|0
2866517|NCT02132195|9858033|P3|Rescue Therapy|Physician Decision|1
2866518|NCT02132195|9858034|P2|Rescue Therapy|Physician Decision|0
2866519|NCT02132195|9858035|P1|Rescue Therapy|Physician Decision|0
2866520|NCT02132195|9858033|P3|Rescue Therapy|Relapsed|7
2866521|NCT02132195|9858034|P2|Rescue Therapy|Relapsed|0
2866522|NCT02132195|9858035|P1|Rescue Therapy|Relapsed|0
2866523|NCT02132195|9858033|P3|Initial Assignment|Relapsed|0
2866524|NCT02132195|9858034|P2|Initial Assignment|Relapsed|0
2866525|NCT02132195|9858035|P1|Initial Assignment|Relapsed|14
2866526|NCT02132117|9858066|P2|Overall Study|Other Miscellaneous Reasons|0
2866527|NCT02132117|9858067|P1|Overall Study|Other Miscellaneous Reasons|2
2866528|NCT02132117|9858066|P2|Overall Study|Personal Reasons|2
2866529|NCT02132117|9858067|P1|Overall Study|Personal Reasons|1
2866530|NCT02132117|9858066|P2|Overall Study|Lost to Follow-up|2
2866531|NCT02132117|9858067|P1|Overall Study|Lost to Follow-up|2
2866532|NCT02132117|9858066|P2|Overall Study|Adverse Event|1
2866533|NCT02132117|9858067|P1|Overall Study|Adverse Event|6
2866534|NCT02131766|9858083|P1|Overall Study|Withdrawal by Subject|4
2866535|NCT02131662|9858099|P5|Overall Study|Not treated|3
2866536|NCT02131662|9858100|P4|Overall Study|Not treated|2
2866537|NCT02131662|9858101|P3|Overall Study|Not treated|2
2866538|NCT02131662|9858102|P2|Overall Study|Not treated|0
2866539|NCT02131662|9858103|P1|Overall Study|Not treated|2
2866540|NCT02131662|9858099|P5|Overall Study|Lost to Follow-up|0
2866541|NCT02131662|9858100|P4|Overall Study|Lost to Follow-up|9
2866542|NCT02131662|9858101|P3|Overall Study|Lost to Follow-up|0
2866543|NCT02131662|9858102|P2|Overall Study|Lost to Follow-up|3
2866544|NCT02131662|9858103|P1|Overall Study|Lost to Follow-up|1
2866545|NCT02131662|9858099|P5|Overall Study|Withdrawal by Subject|6
2866546|NCT02131662|9858100|P4|Overall Study|Withdrawal by Subject|5
2866547|NCT02131662|9858101|P3|Overall Study|Withdrawal by Subject|1
2866548|NCT02131662|9858102|P2|Overall Study|Withdrawal by Subject|5
2866549|NCT02131662|9858103|P1|Overall Study|Withdrawal by Subject|1
2866550|NCT02131662|9858099|P5|Overall Study|Lack of Efficacy|1
2866551|NCT02131662|9858100|P4|Overall Study|Lack of Efficacy|0
2866552|NCT02131662|9858101|P3|Overall Study|Lack of Efficacy|0
2866553|NCT02131662|9858102|P2|Overall Study|Lack of Efficacy|0
2866554|NCT02131662|9858103|P1|Overall Study|Lack of Efficacy|1
2866555|NCT02131662|9858099|P5|Overall Study|Wish for pregnancy|1
2866556|NCT02131662|9858100|P4|Overall Study|Wish for pregnancy|0
2866557|NCT02131662|9858101|P3|Overall Study|Wish for pregnancy|0
2866558|NCT02131662|9858102|P2|Overall Study|Wish for pregnancy|0
2866559|NCT02131662|9858103|P1|Overall Study|Wish for pregnancy|0
2866560|NCT02131662|9858099|P5|Overall Study|Pregnancy|0
2866561|NCT02131662|9858100|P4|Overall Study|Pregnancy|1
2866562|NCT02131662|9858101|P3|Overall Study|Pregnancy|0
2866563|NCT02131662|9858102|P2|Overall Study|Pregnancy|1
2866564|NCT02131662|9858103|P1|Overall Study|Pregnancy|0
2866565|NCT02131662|9858099|P5|Overall Study|Adverse Event|3
2866566|NCT02131662|9858100|P4|Overall Study|Adverse Event|1
2866567|NCT02131662|9858101|P3|Overall Study|Adverse Event|1
2866568|NCT02131662|9858102|P2|Overall Study|Adverse Event|1
2866569|NCT02131662|9858103|P1|Overall Study|Adverse Event|0
2866570|NCT02131662|9858099|P5|Overall Study|Other|4
2866571|NCT02131662|9858100|P4|Overall Study|Other|3
2866572|NCT02131662|9858101|P3|Overall Study|Other|3
2866573|NCT02131662|9858102|P2|Overall Study|Other|4
2866574|NCT02131662|9858103|P1|Overall Study|Other|2
2866575|NCT02131662|9858099|P5|Overall Study|Protocol Violation|0
2866576|NCT02131662|9858100|P4|Overall Study|Protocol Violation|0
2866577|NCT02131662|9858101|P3|Overall Study|Protocol Violation|0
2866578|NCT02131662|9858102|P2|Overall Study|Protocol Violation|0
2866579|NCT02131662|9858103|P1|Overall Study|Protocol Violation|1
2866580|NCT02131636|9858149|P2|Overall Study|Adverse Event|1
2866581|NCT02131636|9858150|P1|Overall Study|Adverse Event|4
2866582|NCT02131636|9858149|P2|Overall Study|Lost to Follow-up|0
2866583|NCT02131636|9858150|P1|Overall Study|Lost to Follow-up|4
2866584|NCT02131636|9858149|P2|Overall Study|Personal Reasons|4
2866585|NCT02131636|9858150|P1|Overall Study|Personal Reasons|4
2866586|NCT02131532|9858166|P1|Overall Study|Other health conditions|2
2866587|NCT02131532|9858166|P1|Overall Study|Physician Decision|1
2866588|NCT02131532|9858166|P1|Overall Study|Withdrawal by Subject|1
2866589|NCT02131324|9858258|P2|Overall Study|Lost to Follow-up|1
2866590|NCT02131324|9858259|P1|Overall Study|Lost to Follow-up|1
2866591|NCT02131324|9858258|P2|Overall Study|Withdrawal by Subject|2
2866592|NCT02131324|9858259|P1|Overall Study|Withdrawal by Subject|1
2866593|NCT02131311|9858265|P1|Overall Study|Lost to Follow-up|1
2866594|NCT02131311|9858265|P1|Overall Study|Protocol Violation|1
2866595|NCT02131311|9858265|P1|Overall Study|Adverse Event|2
2866596|NCT02131272|9858277|P2|Overall Study|Withdrawal Criteria|0
2866597|NCT02131272|9858278|P1|Overall Study|Withdrawal Criteria|1
2866598|NCT02131272|9858277|P2|Overall Study|Withdrawal by Subject|1
2866599|NCT02131272|9858278|P1|Overall Study|Withdrawal by Subject|0
2866600|NCT02131272|9858277|P2|Overall Study|Withdrawal by parent|1
2866601|NCT02131272|9858278|P1|Overall Study|Withdrawal by parent|0
2866602|NCT02131259|9858296|P1|Overall Study|Missing|3
2866603|NCT02131259|9858296|P1|Overall Study|Progressive disease/AE/other|1
2866604|NCT02131259|9858296|P1|Overall Study|AE/other|1
2866605|NCT02131259|9858296|P1|Overall Study|AE/lost to follow-up|1
2866606|NCT02131259|9858296|P1|Overall Study|Progressive disease/other|2
2866607|NCT02131259|9858296|P1|Overall Study|Progressive disease/relocation|1
2866608|NCT02131259|9858296|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
2866609|NCT02131259|9858296|P1|Overall Study|Other|63
2866610|NCT02131259|9858296|P1|Overall Study|Relocation|32
2866611|NCT02131259|9858296|P1|Overall Study|Lost to Follow-up|7
2866612|NCT02131259|9858296|P1|Overall Study|Adverse Event|341
2866613|NCT02131259|9858296|P1|Overall Study|Progressive disease|751
2866614|NCT02131233|9858303|P2|Overall Study|Withdrawal by Subject|11
2866615|NCT02131233|9858304|P1|Overall Study|Withdrawal by Subject|18
2866616|NCT02131233|9858303|P2|Overall Study|Pregnancy|0
2866617|NCT02131233|9858304|P1|Overall Study|Pregnancy|4
2866618|NCT02131233|9858303|P2|Overall Study|Physician Decision|0
2866619|NCT02131233|9858304|P1|Overall Study|Physician Decision|7
2866620|NCT02131233|9858303|P2|Overall Study|Non-Compliance With Study Drug|5
2866621|NCT02131233|9858304|P1|Overall Study|Non-Compliance With Study Drug|8
2866622|NCT02131233|9858303|P2|Overall Study|Lost to Follow-up|13
2866623|NCT02131233|9858304|P1|Overall Study|Lost to Follow-up|14
2866624|NCT02131233|9858303|P2|Overall Study|Lack of Efficacy|3
2866625|NCT02131233|9858304|P1|Overall Study|Lack of Efficacy|6
2866626|NCT02131233|9858303|P2|Overall Study|Death|1
2866627|NCT02131233|9858304|P1|Overall Study|Death|0
2866628|NCT02131233|9858303|P2|Overall Study|Adverse Event|6
2866629|NCT02131233|9858304|P1|Overall Study|Adverse Event|7
2866630|NCT02131233|9858303|P2|Overall Study|Not Treated|3
2866631|NCT02131233|9858304|P1|Overall Study|Not Treated|2
2866632|NCT02131155|9858338|P2|Overall Study|Study early termination|10
2866633|NCT02131155|9858339|P1|Overall Study|Study early termination|20
2866634|NCT02131155|9858338|P2|Overall Study|Refused to continue study medication|0
2866635|NCT02131155|9858339|P1|Overall Study|Refused to continue study medication|1
2866636|NCT02131155|9858338|P2|Overall Study|Primary tumour recurrence|1
2866637|NCT02131155|9858339|P1|Overall Study|Primary tumour recurrence|2
2866638|NCT02131155|9858338|P2|Overall Study|Treatment completed|0
2866639|NCT02131155|9858339|P1|Overall Study|Treatment completed|1
2866640|NCT02131155|9858338|P2|Overall Study|Adverse Event|0
2866641|NCT02131155|9858339|P1|Overall Study|Adverse Event|1
2866642|NCT02131129|9858353|P2|Overall Study|Withdrawal by Subject|0
2866643|NCT02131129|9858354|P1|Overall Study|Withdrawal by Subject|1
2866644|NCT02131064|9858372|P2|Overall Study|Other|2
2866645|NCT02131064|9858373|P1|Overall Study|Other|2
2866646|NCT02131064|9858372|P2|Overall Study|Withdrawal by Subject|18
2866647|NCT02131064|9858373|P1|Overall Study|Withdrawal by Subject|14
2866648|NCT02131064|9858372|P2|Overall Study|Lost to Follow-up|8
2866649|NCT02131064|9858373|P1|Overall Study|Lost to Follow-up|4
2866650|NCT02131064|9858372|P2|Overall Study|Death|6
2866651|NCT02131064|9858373|P1|Overall Study|Death|5
2866652|NCT02130986|9858442|P2|Overall Study|Lost to Follow-up|160
2866653|NCT02130986|9858443|P1|Overall Study|Lost to Follow-up|151
2866654|NCT02130986|9858442|P2|Overall Study|Withdrawal by Subject|4
2866655|NCT02130986|9858443|P1|Overall Study|Withdrawal by Subject|4
2866656|NCT02130765|9858457|P4|Overall Study|Did not receive treatment|0
2866657|NCT02130765|9858458|P3|Overall Study|Did not receive treatment|0
2866658|NCT02130765|9858459|P2|Overall Study|Did not receive treatment|0
2866659|NCT02130765|9858460|P1|Overall Study|Did not receive treatment|4
2866660|NCT02130570|9858706|P2|Overall Study|Part of practice that discontinued study|5
2866661|NCT02130570|9858707|P1|Overall Study|Part of practice that discontinued study|0
2866662|NCT02130570|9858706|P2|Overall Study|Withdrawal by Subject|3
2866663|NCT02130570|9858707|P1|Overall Study|Withdrawal by Subject|6
2866664|NCT02130570|9858706|P2|Overall Study|Death|5
2866665|NCT02130570|9858707|P1|Overall Study|Death|3
2866666|NCT02130557|9858725|P2|Overall Study|Ongoing|255
2866667|NCT02130557|9858726|P1|Overall Study|Ongoing|260
2866668|NCT02130557|9858725|P2|Overall Study|Deceased|6
2866669|NCT02130557|9858726|P1|Overall Study|Deceased|1
2866670|NCT02130557|9858725|P2|Overall Study|Lost to Follow-up|2
2866671|NCT02130557|9858726|P1|Overall Study|Lost to Follow-up|2
2866672|NCT02130557|9858725|P2|Overall Study|Withdrawal by Subject|2
2866673|NCT02130557|9858726|P1|Overall Study|Withdrawal by Subject|5
2866674|NCT02130557|9858725|P2|Overall Study|Randomized, not treated|3
2866675|NCT02130557|9858726|P1|Overall Study|Randomized, not treated|0
2866676|NCT02130284|9858758|P1|Overall Study|Screen Failure|1
2866677|NCT02130284|9858758|P1|Overall Study|Subject was screened as backup for study|3
2866678|NCT02130284|9858758|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
2866679|NCT02130284|9858758|P1|Overall Study|Subject Withdrew Consent|1
2866680|NCT02130284|9858758|P1|Overall Study|Withdrawal by Subject|3
2866681|NCT02130193|9858784|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2866682|NCT02130193|9858785|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2866683|NCT02130193|9858786|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
2866684|NCT02130193|9858784|P3|Part B: 52-week Double-blind Period|Physician Decision|1
2866685|NCT02130193|9858785|P2|Part B: 52-week Double-blind Period|Physician Decision|0
2866686|NCT02130193|9858786|P1|Part B: 52-week Double-blind Period|Physician Decision|0
2866687|NCT02130193|9858784|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
2866688|NCT02130193|9858785|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
2866689|NCT02130193|9858786|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
2866690|NCT02130193|9858784|P3|Part B: 52-week Double-blind Period|Adverse Event|3
2866691|NCT02130193|9858785|P2|Part B: 52-week Double-blind Period|Adverse Event|5
2866692|NCT02130193|9858786|P1|Part B: 52-week Double-blind Period|Adverse Event|0
2866693|NCT02130024|9858867|P2|Overall Study|Subject Withdrew Consent|14
2866694|NCT02130024|9858868|P1|Overall Study|Subject Withdrew Consent|6
2866695|NCT02130024|9858867|P2|Overall Study|Site Administration Problems|0
2866696|NCT02130024|9858868|P1|Overall Study|Site Administration Problems|1
2866697|NCT02130024|9858867|P2|Overall Study|Protocol Deviation|0
2866698|NCT02130024|9858868|P1|Overall Study|Protocol Deviation|4
2866699|NCT02130024|9858867|P2|Overall Study|Physician Decision|3
2866700|NCT02130024|9858868|P1|Overall Study|Physician Decision|1
2866701|NCT02130024|9858867|P2|Overall Study|Lost to Follow-up|1
2866702|NCT02130024|9858868|P1|Overall Study|Lost to Follow-up|1
2866703|NCT02130024|9858867|P2|Overall Study|Death|2
2866704|NCT02130024|9858868|P1|Overall Study|Death|2
2866705|NCT02130024|9858867|P2|Overall Study|Adverse Event|11
2866706|NCT02130024|9858868|P1|Overall Study|Adverse Event|10
2866707|NCT02129777|9858905|P7|Open-Label Period|Study Termination|39
2866708|NCT02129777|9858906|P6|Open-Label Period|Study Termination|10
2866709|NCT02129777|9858907|P5|Open-Label Period|Study Termination|0
2866710|NCT02129777|9858908|P4|Open-Label Period|Study Termination|0
2866711|NCT02129777|9858909|P3|Open-Label Period|Study Termination|0
2866712|NCT02129777|9858910|P2|Open-Label Period|Study Termination|0
2866713|NCT02129777|9858911|P1|Open-Label Period|Study Termination|0
2866714|NCT02129777|9858905|P7|Open-Label Period|Withdrawal by Subject|3
2866715|NCT02129777|9858906|P6|Open-Label Period|Withdrawal by Subject|1
2866716|NCT02129777|9858907|P5|Open-Label Period|Withdrawal by Subject|0
2866717|NCT02129777|9858908|P4|Open-Label Period|Withdrawal by Subject|0
2866718|NCT02129777|9858909|P3|Open-Label Period|Withdrawal by Subject|0
2866719|NCT02129777|9858910|P2|Open-Label Period|Withdrawal by Subject|0
2866720|NCT02129777|9858911|P1|Open-Label Period|Withdrawal by Subject|0
2866721|NCT02129777|9858905|P7|Open-Label Period|Lost to Follow-up|1
2866722|NCT02129777|9858906|P6|Open-Label Period|Lost to Follow-up|1
2866723|NCT02129777|9858907|P5|Open-Label Period|Lost to Follow-up|0
2866724|NCT02129777|9858908|P4|Open-Label Period|Lost to Follow-up|0
2866725|NCT02129777|9858909|P3|Open-Label Period|Lost to Follow-up|0
2866726|NCT02129777|9858910|P2|Open-Label Period|Lost to Follow-up|0
2866727|NCT02129777|9858911|P1|Open-Label Period|Lost to Follow-up|0
2866728|NCT02129777|9858905|P7|Open-Label Period|Lack of Efficacy|5
2866729|NCT02129777|9858906|P6|Open-Label Period|Lack of Efficacy|0
2866730|NCT02129777|9858907|P5|Open-Label Period|Lack of Efficacy|0
2866731|NCT02129777|9858908|P4|Open-Label Period|Lack of Efficacy|0
2866732|NCT02129777|9858909|P3|Open-Label Period|Lack of Efficacy|0
2866733|NCT02129777|9858910|P2|Open-Label Period|Lack of Efficacy|0
2866734|NCT02129777|9858911|P1|Open-Label Period|Lack of Efficacy|0
2866735|NCT02129777|9858905|P7|Double-Blind Period|Other|0
2866736|NCT02129777|9858906|P6|Double-Blind Period|Other|0
2866737|NCT02129777|9858907|P5|Double-Blind Period|Other|0
2866738|NCT02129777|9858908|P4|Double-Blind Period|Other|0
2866739|NCT02129777|9858909|P3|Double-Blind Period|Other|0
2866740|NCT02129777|9858910|P2|Double-Blind Period|Other|2
2866741|NCT02129777|9858911|P1|Double-Blind Period|Other|1
2866742|NCT02129777|9858905|P7|Double-Blind Period|Lack of Efficacy|0
2866743|NCT02129777|9858906|P6|Double-Blind Period|Lack of Efficacy|0
2866744|NCT02129777|9858907|P5|Double-Blind Period|Lack of Efficacy|2
2866745|NCT02129777|9858908|P4|Double-Blind Period|Lack of Efficacy|3
2866746|NCT02129777|9858909|P3|Double-Blind Period|Lack of Efficacy|0
2866747|NCT02129777|9858910|P2|Double-Blind Period|Lack of Efficacy|1
2866748|NCT02129777|9858911|P1|Double-Blind Period|Lack of Efficacy|3
2866749|NCT02129777|9858905|P7|Double-Blind Period|Pregnancy|0
2866750|NCT02129777|9858906|P6|Double-Blind Period|Pregnancy|0
2866751|NCT02129777|9858907|P5|Double-Blind Period|Pregnancy|1
2866752|NCT02129777|9858908|P4|Double-Blind Period|Pregnancy|0
2866753|NCT02129777|9858909|P3|Double-Blind Period|Pregnancy|0
2866754|NCT02129777|9858910|P2|Double-Blind Period|Pregnancy|0
2866755|NCT02129777|9858911|P1|Double-Blind Period|Pregnancy|0
2866756|NCT02129777|9858905|P7|Double-Blind Period|Withdrawal by Subject|0
2866757|NCT02129777|9858906|P6|Double-Blind Period|Withdrawal by Subject|0
2866758|NCT02129777|9858907|P5|Double-Blind Period|Withdrawal by Subject|3
2866759|NCT02129777|9858908|P4|Double-Blind Period|Withdrawal by Subject|2
2866760|NCT02129777|9858909|P3|Double-Blind Period|Withdrawal by Subject|3
2866761|NCT02129777|9858910|P2|Double-Blind Period|Withdrawal by Subject|4
2866762|NCT02129777|9858911|P1|Double-Blind Period|Withdrawal by Subject|2
2866763|NCT02129777|9858905|P7|Double-Blind Period|Lost to Follow-up|0
2866764|NCT02129777|9858906|P6|Double-Blind Period|Lost to Follow-up|0
2866765|NCT02129777|9858907|P5|Double-Blind Period|Lost to Follow-up|0
2866766|NCT02129777|9858908|P4|Double-Blind Period|Lost to Follow-up|2
2866767|NCT02129777|9858909|P3|Double-Blind Period|Lost to Follow-up|1
2866768|NCT02129777|9858910|P2|Double-Blind Period|Lost to Follow-up|1
2866769|NCT02129777|9858911|P1|Double-Blind Period|Lost to Follow-up|1
2866770|NCT02129777|9858905|P7|Double-Blind Period|Adverse Event|0
2866771|NCT02129777|9858906|P6|Double-Blind Period|Adverse Event|0
2866772|NCT02129777|9858907|P5|Double-Blind Period|Adverse Event|1
2866773|NCT02129777|9858908|P4|Double-Blind Period|Adverse Event|0
2866774|NCT02129777|9858909|P3|Double-Blind Period|Adverse Event|0
2866775|NCT02129777|9858910|P2|Double-Blind Period|Adverse Event|0
2866776|NCT02129777|9858911|P1|Double-Blind Period|Adverse Event|0
2866777|NCT02129608|9859078|P3|Overall Study|Withdrawal by Subject|2
2866778|NCT02129608|9859079|P2|Overall Study|Withdrawal by Subject|0
2866779|NCT02129608|9859080|P1|Overall Study|Withdrawal by Subject|0
2866780|NCT02129608|9859078|P3|Overall Study|Lost to Follow-up|1
2866781|NCT02129608|9859079|P2|Overall Study|Lost to Follow-up|1
2866782|NCT02129608|9859080|P1|Overall Study|Lost to Follow-up|0
2866783|NCT02129205|9859137|P10|Overall Study|Other|0
2866784|NCT02129205|9859138|P9|Overall Study|Other|1
2866785|NCT02129205|9859139|P8|Overall Study|Other|2
2866786|NCT02129205|9859140|P7|Overall Study|Other|3
2866787|NCT02129205|9859141|P6|Overall Study|Other|3
2866788|NCT02129205|9859142|P5|Overall Study|Other|2
2866789|NCT02129205|9859143|P4|Overall Study|Other|0
2866790|NCT02129205|9859144|P3|Overall Study|Other|0
2866791|NCT02129205|9859145|P2|Overall Study|Other|0
2866792|NCT02129205|9859146|P1|Overall Study|Other|1
2866793|NCT02129205|9859137|P10|Overall Study|Withdrawal by Subject|0
2866794|NCT02129205|9859138|P9|Overall Study|Withdrawal by Subject|1
2866795|NCT02129205|9859139|P8|Overall Study|Withdrawal by Subject|0
2866796|NCT02129205|9859140|P7|Overall Study|Withdrawal by Subject|1
2866797|NCT02129205|9859141|P6|Overall Study|Withdrawal by Subject|1
2866798|NCT02129205|9859142|P5|Overall Study|Withdrawal by Subject|1
2866799|NCT02129205|9859143|P4|Overall Study|Withdrawal by Subject|0
2866800|NCT02129205|9859144|P3|Overall Study|Withdrawal by Subject|0
2866801|NCT02129205|9859145|P2|Overall Study|Withdrawal by Subject|0
2866802|NCT02129205|9859146|P1|Overall Study|Withdrawal by Subject|0
2866803|NCT02129192|9859299|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
2866804|NCT02129192|9859300|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
2866805|NCT02129062|9859317|P1|Overall Study|Disease Progression|2
2866806|NCT02129062|9859317|P1|Overall Study|Death|1
2866807|NCT02128997|9859324|P2|Overall Study|Lost to Follow-up|11
2866808|NCT02128997|9859325|P1|Overall Study|Lost to Follow-up|6
2866809|NCT02128932|9859340|P3|Overall Study|No reason for withdrawal|7
2866810|NCT02128932|9859341|P2|Overall Study|No reason for withdrawal|11
2866811|NCT02128932|9859342|P1|Overall Study|No reason for withdrawal|12
2866812|NCT02128932|9859340|P3|Overall Study|Lost to Follow-up|1
2866813|NCT02128932|9859341|P2|Overall Study|Lost to Follow-up|1
2866814|NCT02128932|9859342|P1|Overall Study|Lost to Follow-up|2
2866815|NCT02128932|9859340|P3|Overall Study|Death|2
2866816|NCT02128932|9859341|P2|Overall Study|Death|0
2866817|NCT02128932|9859342|P1|Overall Study|Death|2
2866818|NCT02128932|9859340|P3|Overall Study|Withdrawal by Subject|8
2866819|NCT02128932|9859341|P2|Overall Study|Withdrawal by Subject|7
2866820|NCT02128932|9859342|P1|Overall Study|Withdrawal by Subject|11
2866821|NCT02128763|9859399|P2|Overall Study|Lost to Follow-up|16
2866822|NCT02128763|9859400|P1|Overall Study|Lost to Follow-up|19
2866823|NCT02128763|9859399|P2|Overall Study|Death|0
2866824|NCT02128763|9859400|P1|Overall Study|Death|1
2866825|NCT02128724|9859446|P4|Overall Study|Withdrawal by Subject|1
2866826|NCT02128724|9859447|P3|Overall Study|Withdrawal by Subject|0
2866827|NCT02128724|9859448|P2|Overall Study|Withdrawal by Subject|0
2866828|NCT02128724|9859449|P1|Overall Study|Withdrawal by Subject|0
2866829|NCT02128724|9859446|P4|Overall Study|Physician Decision|2
2866830|NCT02128724|9859447|P3|Overall Study|Physician Decision|0
2866831|NCT02128724|9859448|P2|Overall Study|Physician Decision|0
2866832|NCT02128724|9859449|P1|Overall Study|Physician Decision|0
2866833|NCT02128724|9859446|P4|Overall Study|Adverse Event|0
2866834|NCT02128724|9859447|P3|Overall Study|Adverse Event|0
2866835|NCT02128724|9859448|P2|Overall Study|Adverse Event|1
2866836|NCT02128724|9859449|P1|Overall Study|Adverse Event|0
2866837|NCT02128724|9859446|P4|Overall Study|Death|0
2866838|NCT02128724|9859447|P3|Overall Study|Death|0
2866839|NCT02128724|9859448|P2|Overall Study|Death|0
2866840|NCT02128724|9859449|P1|Overall Study|Death|1
2866841|NCT02128542|9859504|P2|Overall Study|Withdrew Consent|0
2866842|NCT02128542|9859505|P1|Overall Study|Withdrew Consent|1
2866843|NCT02128542|9859504|P2|Overall Study|Lost to Follow-up|0
2866844|NCT02128542|9859505|P1|Overall Study|Lost to Follow-up|3
2866845|NCT02128490|9859523|P5|Overall Study|Other Miscellaneous Reasons|1
2866846|NCT02128490|9859524|P4|Overall Study|Other Miscellaneous Reasons|1
2866847|NCT02128490|9859525|P3|Overall Study|Other Miscellaneous Reasons|2
2866848|NCT02128490|9859526|P2|Overall Study|Other Miscellaneous Reasons|0
2866849|NCT02128490|9859527|P1|Overall Study|Other Miscellaneous Reasons|0
2866850|NCT02128490|9859523|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
2866851|NCT02128490|9859524|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
2866852|NCT02128490|9859525|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
2866853|NCT02128490|9859526|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
2866854|NCT02128490|9859527|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
2866855|NCT02128490|9859523|P5|Overall Study|Lack of Efficacy|0
2866856|NCT02128490|9859524|P4|Overall Study|Lack of Efficacy|0
2866857|NCT02128490|9859525|P3|Overall Study|Lack of Efficacy|0
2866858|NCT02128490|9859526|P2|Overall Study|Lack of Efficacy|1
2866859|NCT02128490|9859527|P1|Overall Study|Lack of Efficacy|0
2866860|NCT02128490|9859523|P5|Overall Study|Voluntary Withdrawal|2
2866861|NCT02128490|9859524|P4|Overall Study|Voluntary Withdrawal|1
2866862|NCT02128490|9859525|P3|Overall Study|Voluntary Withdrawal|1
2866863|NCT02128490|9859526|P2|Overall Study|Voluntary Withdrawal|3
2866864|NCT02128490|9859527|P1|Overall Study|Voluntary Withdrawal|3
2866865|NCT02128490|9859523|P5|Overall Study|Lost to Follow-up|1
2866866|NCT02128490|9859524|P4|Overall Study|Lost to Follow-up|1
2866867|NCT02128490|9859525|P3|Overall Study|Lost to Follow-up|1
2866868|NCT02128490|9859526|P2|Overall Study|Lost to Follow-up|0
2866869|NCT02128490|9859527|P1|Overall Study|Lost to Follow-up|0
2866870|NCT02128490|9859523|P5|Overall Study|Major Protocol Deviation|2
2866871|NCT02128490|9859524|P4|Overall Study|Major Protocol Deviation|2
2866872|NCT02128490|9859525|P3|Overall Study|Major Protocol Deviation|0
2866873|NCT02128490|9859526|P2|Overall Study|Major Protocol Deviation|2
2866874|NCT02128490|9859527|P1|Overall Study|Major Protocol Deviation|1
2866875|NCT02128490|9859523|P5|Overall Study|Pretreatment Event/Adverse Event|0
2866876|NCT02128490|9859524|P4|Overall Study|Pretreatment Event/Adverse Event|1
2866877|NCT02128490|9859525|P3|Overall Study|Pretreatment Event/Adverse Event|1
2866878|NCT02128490|9859526|P2|Overall Study|Pretreatment Event/Adverse Event|0
2866879|NCT02128490|9859527|P1|Overall Study|Pretreatment Event/Adverse Event|1
2866880|NCT02128269|9859549|P1|Treatment Period|Physician Decision|1
2866881|NCT02128269|9859549|P1|Treatment Period|Adverse Event|1
2866882|NCT02128217|9859555|P2|Overall Study|Lost to Follow-up|1
2866883|NCT02128217|9859556|P1|Overall Study|Lost to Follow-up|0
2866884|NCT02127970|9859604|P2|Overall Study|Subject Withdrew Consent|3
2866885|NCT02127970|9859605|P1|Overall Study|Subject Withdrew Consent|5
2866886|NCT02127970|9859604|P2|Overall Study|Pregnancy|1
2866887|NCT02127970|9859605|P1|Overall Study|Pregnancy|0
2866888|NCT02127970|9859604|P2|Overall Study|Reason not Specified|7
2866889|NCT02127970|9859605|P1|Overall Study|Reason not Specified|4
2866890|NCT02127970|9859604|P2|Overall Study|Lost to Follow-up|14
2866891|NCT02127970|9859605|P1|Overall Study|Lost to Follow-up|14
2866892|NCT02127970|9859604|P2|Overall Study|Death|1
2866893|NCT02127970|9859605|P1|Overall Study|Death|1
2866894|NCT02127970|9859604|P2|Overall Study|Adverse Event|1
2866895|NCT02127970|9859605|P1|Overall Study|Adverse Event|2
2866896|NCT02127931|9859627|P1|Overall Study|Glitch in Game|1
2866897|NCT02127372|9859746|P2|Overall Study|Withdrawal by Subject|0
2866898|NCT02127372|9859747|P1|Overall Study|Withdrawal by Subject|1
2866899|NCT02127307|9859757|P1|Overall Study|Other than specified above|169
2866900|NCT02127307|9859757|P1|Overall Study|Death|101
2866901|NCT02127307|9859757|P1|Overall Study|Lost to Follow-up|2
2866902|NCT02127307|9859757|P1|Overall Study|Protocol Violation|36
2866903|NCT02127281|9859763|P2|Overall Study|Lost to Follow-up|0
2866904|NCT02127281|9859764|P1|Overall Study|Lost to Follow-up|1
2866905|NCT02126969|9859792|P2|Overall Study|Withdrawal by Subject|2
2866906|NCT02126969|9859793|P1|Overall Study|Withdrawal by Subject|1
2866907|NCT02126839|9859803|P2|Overall Study|Other|5
2866908|NCT02126839|9859804|P1|Overall Study|Other|5
2866909|NCT02126839|9859803|P2|Overall Study|Lost to Follow-up|4
2866910|NCT02126839|9859804|P1|Overall Study|Lost to Follow-up|1
2866911|NCT02126839|9859803|P2|Overall Study|Sponsor request|1
2866912|NCT02126839|9859804|P1|Overall Study|Sponsor request|0
2866913|NCT02126839|9859803|P2|Overall Study|Protocol Violation|3
2866914|NCT02126839|9859804|P1|Overall Study|Protocol Violation|2
2866915|NCT02126839|9859803|P2|Overall Study|Withdrawal by parent/guardian|0
2866916|NCT02126839|9859804|P1|Overall Study|Withdrawal by parent/guardian|1
2866917|NCT02126839|9859803|P2|Overall Study|Withdrawal by Subject|0
2866918|NCT02126839|9859804|P1|Overall Study|Withdrawal by Subject|1
2866919|NCT02126839|9859803|P2|Overall Study|Adverse Event|1
2866920|NCT02126839|9859804|P1|Overall Study|Adverse Event|0
2866921|NCT02126826|9859821|P7|Overall Study|Withdrawal by Subject|0
2866922|NCT02126826|9859822|P6|Overall Study|Withdrawal by Subject|0
2866923|NCT02126826|9859823|P5|Overall Study|Withdrawal by Subject|0
2866924|NCT02126826|9859824|P4|Overall Study|Withdrawal by Subject|1
2866925|NCT02126826|9859825|P3|Overall Study|Withdrawal by Subject|0
2866926|NCT02126826|9859826|P2|Overall Study|Withdrawal by Subject|0
2866927|NCT02126826|9859827|P1|Overall Study|Withdrawal by Subject|0
2866928|NCT02126670|9859895|P4|Overall Study|Withdrawal by Subject|1
2866929|NCT02126670|9859896|P3|Overall Study|Withdrawal by Subject|0
2866930|NCT02126670|9859897|P2|Overall Study|Withdrawal by Subject|0
2866931|NCT02126670|9859898|P1|Overall Study|Withdrawal by Subject|1
2866932|NCT02125877|9859950|P2|Overall Study|Adverse Event|4
2866933|NCT02125877|9859951|P1|Overall Study|Adverse Event|6
2866934|NCT02125877|9859950|P2|Overall Study|Protocol deviation|1
2866935|NCT02125877|9859951|P1|Overall Study|Protocol deviation|4
2866936|NCT02125877|9859950|P2|Overall Study|Withdrawal by Subject|1
2866937|NCT02125877|9859951|P1|Overall Study|Withdrawal by Subject|2
2866938|NCT02125877|9859950|P2|Overall Study|Participant/guardian decision|2
2866939|NCT02125877|9859951|P1|Overall Study|Participant/guardian decision|0
2866940|NCT02125877|9859950|P2|Overall Study|Administrative problems|1
2866941|NCT02125877|9859951|P1|Overall Study|Administrative problems|0
2866942|NCT02125877|9859950|P2|Overall Study|Death|1
2866943|NCT02125877|9859951|P1|Overall Study|Death|0
2866944|NCT02125877|9859950|P2|Overall Study|Physician Decision|0
2866945|NCT02125877|9859951|P1|Overall Study|Physician Decision|1
2866946|NCT02125838|9859981|P2|Overall Study|Lost to Follow-up|4
2866947|NCT02125838|9859982|P1|Overall Study|Lost to Follow-up|4
2866948|NCT02125734|9860000|P2|Period 2|Adverse Event|1
2866949|NCT02125734|9860001|P1|Period 2|Adverse Event|0
2866950|NCT02125604|9860011|P1|Overall Study|Adverse Event|20
2866951|NCT02125604|9860011|P1|Overall Study|Consent Withdrawn|4
2866952|NCT02125604|9860011|P1|Overall Study|Lost to Follow-up|2
2866953|NCT02125604|9860011|P1|Overall Study|Investigator Decision|1
2866954|NCT02125604|9860011|P1|Overall Study|Other|4
2866955|NCT02125461|9860027|P2|Overall Study|Death|115
2866956|NCT02125461|9860028|P1|Overall Study|Death|180
2866957|NCT02125461|9860027|P2|Overall Study|Lost to Follow-up|0
2866958|NCT02125461|9860028|P1|Overall Study|Lost to Follow-up|1
2866959|NCT02125461|9860027|P2|Overall Study|Withdrawal by Subject|14
2866960|NCT02125461|9860028|P1|Overall Study|Withdrawal by Subject|22
2866961|NCT02125279|9860083|P1|Overall Study|Lost to Follow-up|4
2866962|NCT02125279|9860083|P1|Overall Study|Protocol Violation|1
2866963|NCT02125279|9860083|P1|Overall Study|Withdrawal by Subject|6
2866964|NCT02125279|9860083|P1|Overall Study|Lack of Efficacy|2
2866965|NCT02124811|9860127|P2|Overall Study|Withdrawal by Subject|0
2866966|NCT02124811|9860128|P1|Overall Study|Withdrawal by Subject|1
2866967|NCT02124811|9860127|P2|Overall Study|Early termination|2
2866968|NCT02124811|9860128|P1|Overall Study|Early termination|2
2866969|NCT02124798|9860144|P1|Overall Study|Lost to Follow-up|1
2866970|NCT02124798|9860144|P1|Overall Study|Adverse Event|3
2866971|NCT02124564|9860156|P1|Treatment Period|Withdrawal by Subject|2
2866972|NCT02124564|9860156|P1|Treatment Period|Lack of Efficacy|3
2866973|NCT02124564|9860156|P1|Treatment Period|Adverse Event|2
2866974|NCT02124265|9860221|P1|Overall Study|Adverse Event|1
2866975|NCT02124161|9860227|P2|Overall Study|Lost to Follow-up|4
2866976|NCT02124161|9860228|P1|Overall Study|Lost to Follow-up|3
2866977|NCT02124161|9860227|P2|Overall Study|No longer meets eligibility criteria|4
2866978|NCT02124161|9860228|P1|Overall Study|No longer meets eligibility criteria|5
2866979|NCT02124161|9860227|P2|Overall Study|Does not meet entrance criteria|3
2866980|NCT02124161|9860228|P1|Overall Study|Does not meet entrance criteria|2
2866981|NCT02124161|9860227|P2|Overall Study|Adverse Event|0
2866982|NCT02124161|9860228|P1|Overall Study|Adverse Event|2
2866983|NCT02124161|9860227|P2|Overall Study|Withdrawal by Subject|2
2866984|NCT02124161|9860228|P1|Overall Study|Withdrawal by Subject|1
2866985|NCT02124161|9860227|P2|Overall Study|Protocol Violation|1
2866986|NCT02124161|9860228|P1|Overall Study|Protocol Violation|2
2866987|NCT02124161|9860227|P2|Overall Study|Death|0
2866988|NCT02124161|9860228|P1|Overall Study|Death|1
2866989|NCT02124161|9860227|P2|Overall Study|Other unspecified|1
2866990|NCT02124161|9860228|P1|Overall Study|Other unspecified|0
2866991|NCT02123966|9860303|P1|Overall Study|Intercurrent Illness|1
2866992|NCT02123576|9860345|P2|Overall Study|Adverse Event|0
2866993|NCT02123576|9860346|P1|Overall Study|Adverse Event|1
2866994|NCT02123511|9860364|P2|Overall Study|Ineligible|1
2866995|NCT02123511|9860365|P1|Overall Study|Ineligible|0
2866996|NCT02123511|9860364|P2|Overall Study|Incomplete data|3
2866997|NCT02123511|9860365|P1|Overall Study|Incomplete data|1
2866998|NCT02123511|9860364|P2|Overall Study|Cancelled treatment|0
2866999|NCT02123511|9860365|P1|Overall Study|Cancelled treatment|1
2867000|NCT02123472|9860389|P2|Period 2 (7 Days)|Withdrawal by Subject|1
2867001|NCT02123472|9860390|P1|Period 2 (7 Days)|Withdrawal by Subject|0
2867002|NCT02123459|9860400|P2|Washout Period (1 Day)|Adverse Event|0
2867003|NCT02123459|9860401|P1|Washout Period (1 Day)|Adverse Event|1
2867004|NCT02123446|9860411|P2|Washout Period (1 Day)|Physician Decision|0
2867005|NCT02123446|9860412|P1|Washout Period (1 Day)|Physician Decision|1
2867006|NCT02123251|9860453|P2|Overall Study|Switched Managed Care Organization (MCO)|4
2867007|NCT02123251|9860454|P1|Overall Study|Switched Managed Care Organization (MCO)|4
2867008|NCT02123251|9860453|P2|Overall Study|Lost Medicaid eligibility|22
2867009|NCT02123251|9860454|P1|Overall Study|Lost Medicaid eligibility|29
2867010|NCT02123251|9860453|P2|Overall Study|Withdrawal by Subject|3
2867011|NCT02123251|9860454|P1|Overall Study|Withdrawal by Subject|0
2867012|NCT02123251|9860453|P2|Overall Study|Death|1
2867013|NCT02123251|9860454|P1|Overall Study|Death|1
2867014|NCT02123134|9860480|P2|Overall Study|Administrative decision|1
2867015|NCT02123134|9860481|P1|Overall Study|Administrative decision|0
2867016|NCT02123134|9860480|P2|Overall Study|Withdrawal of consent|2
2867017|NCT02123134|9860481|P1|Overall Study|Withdrawal of consent|3
2867018|NCT02122887|9860538|P2|Overall Study|Withdrawal by Subject|2
2867019|NCT02122887|9860539|P1|Overall Study|Withdrawal by Subject|20
2867020|NCT02122783|9860577|P2|Overall Study|Adverse Event|1
2867021|NCT02122783|9860578|P1|Overall Study|Adverse Event|0
2867022|NCT02122770|9860592|P6|Part B: Standard of Care|Progressive Disease|8
2867023|NCT02122770|9860593|P5|Part B: Standard of Care|Progressive Disease|10
2867024|NCT02122770|9860594|P4|Part B: Standard of Care|Progressive Disease|0
2867025|NCT02122770|9860595|P3|Part B: Standard of Care|Progressive Disease|0
2867026|NCT02122770|9860596|P2|Part B: Standard of Care|Progressive Disease|0
2867027|NCT02122770|9860597|P1|Part B: Standard of Care|Progressive Disease|0
2867028|NCT02122770|9860592|P6|Part B: Standard of Care|Symptomatic Deterioration|0
2867029|NCT02122770|9860593|P5|Part B: Standard of Care|Symptomatic Deterioration|5
2867030|NCT02122770|9860594|P4|Part B: Standard of Care|Symptomatic Deterioration|0
2867031|NCT02122770|9860595|P3|Part B: Standard of Care|Symptomatic Deterioration|0
2867032|NCT02122770|9860596|P2|Part B: Standard of Care|Symptomatic Deterioration|0
2867033|NCT02122770|9860597|P1|Part B: Standard of Care|Symptomatic Deterioration|0
2867034|NCT02122770|9860592|P6|Part B: Standard of Care|Withdrawal by Subject|2
2867035|NCT02122770|9860593|P5|Part B: Standard of Care|Withdrawal by Subject|4
2867036|NCT02122770|9860594|P4|Part B: Standard of Care|Withdrawal by Subject|0
2867037|NCT02122770|9860595|P3|Part B: Standard of Care|Withdrawal by Subject|0
2867038|NCT02122770|9860596|P2|Part B: Standard of Care|Withdrawal by Subject|0
2867039|NCT02122770|9860597|P1|Part B: Standard of Care|Withdrawal by Subject|0
2867040|NCT02122770|9860592|P6|Part B: Standard of Care|Other|2
2867041|NCT02122770|9860593|P5|Part B: Standard of Care|Other|0
2867042|NCT02122770|9860594|P4|Part B: Standard of Care|Other|0
2867043|NCT02122770|9860595|P3|Part B: Standard of Care|Other|0
2867044|NCT02122770|9860596|P2|Part B: Standard of Care|Other|0
2867045|NCT02122770|9860597|P1|Part B: Standard of Care|Other|0
2867046|NCT02122770|9860592|P6|Part B: Standard of Care|Adverse Event|1
2867047|NCT02122770|9860593|P5|Part B: Standard of Care|Adverse Event|4
2867048|NCT02122770|9860594|P4|Part B: Standard of Care|Adverse Event|0
2867049|NCT02122770|9860595|P3|Part B: Standard of Care|Adverse Event|0
2867050|NCT02122770|9860596|P2|Part B: Standard of Care|Adverse Event|0
2867051|NCT02122770|9860597|P1|Part B: Standard of Care|Adverse Event|0
2867052|NCT02122770|9860592|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2867053|NCT02122770|9860593|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2867054|NCT02122770|9860594|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2867055|NCT02122770|9860595|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2867056|NCT02122770|9860596|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
2867057|NCT02122770|9860597|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2867058|NCT02122770|9860592|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2867059|NCT02122770|9860593|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2867060|NCT02122770|9860594|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2867061|NCT02122770|9860595|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2867062|NCT02122770|9860596|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
2867063|NCT02122770|9860597|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2867064|NCT02122770|9860592|P6|Part A: Drug-drug Interaction 2|Other|0
2867065|NCT02122770|9860593|P5|Part A: Drug-drug Interaction 2|Other|0
2867066|NCT02122770|9860594|P4|Part A: Drug-drug Interaction 2|Other|0
2867067|NCT02122770|9860595|P3|Part A: Drug-drug Interaction 2|Other|1
2867068|NCT02122770|9860596|P2|Part A: Drug-drug Interaction 2|Other|0
2867069|NCT02122770|9860597|P1|Part A: Drug-drug Interaction 2|Other|0
2867070|NCT02122770|9860592|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
2867071|NCT02122770|9860593|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
2867072|NCT02122770|9860594|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
2867073|NCT02122770|9860595|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
2867074|NCT02122770|9860596|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
2867075|NCT02122770|9860597|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
2867076|NCT02122380|9860717|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
2867077|NCT02122380|9860718|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
2867078|NCT02122380|9860717|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
2867079|NCT02122380|9860718|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
2867080|NCT02122380|9860717|P2|Washout (8 Weeks)|Lost to Follow-up|0
2867081|NCT02122380|9860718|P1|Washout (8 Weeks)|Lost to Follow-up|1
2867082|NCT02122380|9860717|P2|First Intervention (30 Days)|Physician Decision|1
2867083|NCT02122380|9860718|P1|First Intervention (30 Days)|Physician Decision|0
2867084|NCT02122380|9860717|P2|First Intervention (30 Days)|Adverse Event|0
2867085|NCT02122380|9860718|P1|First Intervention (30 Days)|Adverse Event|1
2867086|NCT02122146|9860757|P8|Part 1: Dose Escalation|Other|2
2867087|NCT02122146|9860758|P7|Part 1: Dose Escalation|Other|1
2867088|NCT02122146|9860759|P6|Part 1: Dose Escalation|Other|1
2867089|NCT02122146|9860760|P5|Part 1: Dose Escalation|Other|0
2867090|NCT02122146|9860761|P4|Part 1: Dose Escalation|Other|0
2867091|NCT02122146|9860762|P3|Part 1: Dose Escalation|Other|0
2867092|NCT02122146|9860763|P2|Part 1: Dose Escalation|Other|0
2867093|NCT02122146|9860764|P1|Part 1: Dose Escalation|Other|1
2867094|NCT02122146|9860757|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
2867095|NCT02122146|9860758|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
2867096|NCT02122146|9860759|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
2867097|NCT02122146|9860760|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
2867098|NCT02122146|9860761|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
2867099|NCT02122146|9860762|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
2867100|NCT02122146|9860763|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
2867101|NCT02122146|9860764|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
2867102|NCT02122146|9860757|P8|Part 1: Dose Escalation|Lost to Follow-up|0
2867103|NCT02122146|9860758|P7|Part 1: Dose Escalation|Lost to Follow-up|0
2867104|NCT02122146|9860759|P6|Part 1: Dose Escalation|Lost to Follow-up|0
2867105|NCT02122146|9860760|P5|Part 1: Dose Escalation|Lost to Follow-up|1
2867106|NCT02122146|9860761|P4|Part 1: Dose Escalation|Lost to Follow-up|0
2867107|NCT02122146|9860762|P3|Part 1: Dose Escalation|Lost to Follow-up|1
2867108|NCT02122146|9860763|P2|Part 1: Dose Escalation|Lost to Follow-up|0
2867109|NCT02122146|9860764|P1|Part 1: Dose Escalation|Lost to Follow-up|0
2867110|NCT02122146|9860757|P8|Part 1: Dose Escalation|Death|0
2867111|NCT02122146|9860758|P7|Part 1: Dose Escalation|Death|0
2867112|NCT02122146|9860759|P6|Part 1: Dose Escalation|Death|0
2867113|NCT02122146|9860760|P5|Part 1: Dose Escalation|Death|0
2867114|NCT02122146|9860761|P4|Part 1: Dose Escalation|Death|0
2867115|NCT02122146|9860762|P3|Part 1: Dose Escalation|Death|1
2867116|NCT02122146|9860763|P2|Part 1: Dose Escalation|Death|1
2867117|NCT02122146|9860764|P1|Part 1: Dose Escalation|Death|0
2867118|NCT02121847|9861038|P1|Overall Study|Adverse Event|2
2867119|NCT02121847|9861038|P1|Overall Study|Administrative Reasons|1
2867120|NCT02121834|9861064|P7|Overall Study|Lost to Follow-up|0
2867121|NCT02121834|9861065|P6|Overall Study|Lost to Follow-up|0
2867122|NCT02121834|9861066|P5|Overall Study|Lost to Follow-up|0
2867123|NCT02121834|9861067|P4|Overall Study|Lost to Follow-up|0
2867124|NCT02121834|9861068|P3|Overall Study|Lost to Follow-up|1
2867125|NCT02121834|9861069|P2|Overall Study|Lost to Follow-up|0
2867126|NCT02121834|9861070|P1|Overall Study|Lost to Follow-up|0
2867127|NCT02121834|9861064|P7|Overall Study|Withdrawal by Subject|0
2867128|NCT02121834|9861065|P6|Overall Study|Withdrawal by Subject|0
2867129|NCT02121834|9861066|P5|Overall Study|Withdrawal by Subject|0
2867130|NCT02121834|9861067|P4|Overall Study|Withdrawal by Subject|0
2867131|NCT02121834|9861068|P3|Overall Study|Withdrawal by Subject|1
2867132|NCT02121834|9861069|P2|Overall Study|Withdrawal by Subject|1
2867133|NCT02121834|9861070|P1|Overall Study|Withdrawal by Subject|0
2867134|NCT02121834|9861064|P7|Overall Study|Protocol Violation|0
2867135|NCT02121834|9861065|P6|Overall Study|Protocol Violation|0
2867136|NCT02121834|9861066|P5|Overall Study|Protocol Violation|0
2867137|NCT02121834|9861067|P4|Overall Study|Protocol Violation|0
2867138|NCT02121834|9861068|P3|Overall Study|Protocol Violation|0
2867139|NCT02121834|9861069|P2|Overall Study|Protocol Violation|1
2867140|NCT02121834|9861070|P1|Overall Study|Protocol Violation|0
2867141|NCT02121808|9861096|P1|Overall Study|Technical problem|3
2867142|NCT02121795|9861107|P2|Open-Label Phase|Lost to Follow-up|0
2867143|NCT02121795|9861108|P1|Open-Label Phase|Lost to Follow-up|1
2867144|NCT02121795|9861107|P2|Open-Label Phase|Withdrawal by Subject|2
2867145|NCT02121795|9861108|P1|Open-Label Phase|Withdrawal by Subject|3
2867146|NCT02121795|9861107|P2|Open-Label Phase|Physician Decision|8
2867147|NCT02121795|9861108|P1|Open-Label Phase|Physician Decision|8
2867148|NCT02121795|9861107|P2|Double-Blind Phase|Death|1
2867149|NCT02121795|9861108|P1|Double-Blind Phase|Death|1
2867150|NCT02121795|9861107|P2|Double-Blind Phase|Protocol Violation|3
2867151|NCT02121795|9861108|P1|Double-Blind Phase|Protocol Violation|0
2867152|NCT02121795|9861107|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2867153|NCT02121795|9861108|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
2867154|NCT02121795|9861107|P2|Double-Blind Phase|Adverse Event|0
2867155|NCT02121795|9861108|P1|Double-Blind Phase|Adverse Event|5
2867156|NCT02121795|9861107|P2|Double-Blind Phase|Physician Decision|5
2867157|NCT02121795|9861108|P1|Double-Blind Phase|Physician Decision|2
2867158|NCT02121795|9861107|P2|Double-Blind Phase|Lost to Follow-up|4
2867159|NCT02121795|9861108|P1|Double-Blind Phase|Lost to Follow-up|7
2867160|NCT02121795|9861107|P2|Double-Blind Phase|Withdrawal by Subject|16
2867161|NCT02121795|9861108|P1|Double-Blind Phase|Withdrawal by Subject|19
2867162|NCT02121795|9861107|P2|Double-Blind Phase|Randomized but Never Treated|4
2867163|NCT02121795|9861108|P1|Double-Blind Phase|Randomized but Never Treated|1
2867164|NCT02121756|9861136|P2|Overall Study|Physician Decision|1
2867165|NCT02121756|9861137|P1|Overall Study|Physician Decision|2
2867166|NCT02121756|9861136|P2|Overall Study|Protocol Violation|1
2867167|NCT02121756|9861137|P1|Overall Study|Protocol Violation|1
2867168|NCT02121756|9861136|P2|Overall Study|Adverse Event|0
2867169|NCT02121756|9861137|P1|Overall Study|Adverse Event|3
2867170|NCT02121535|9861174|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
2867171|NCT02121535|9861175|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
2867172|NCT02121535|9861174|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
2867173|NCT02121535|9861175|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
2867174|NCT02121522|9861198|P1|Overall Study|Adverse Event|1
2867175|NCT02121509|9861205|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
2867176|NCT02121509|9861206|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
2867177|NCT02121509|9861207|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
2867178|NCT02121509|9861208|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
2867179|NCT02121509|9861205|P4|Washout Period (35 Days)|Withdrawal by Subject|0
2867180|NCT02121509|9861206|P3|Washout Period (35 Days)|Withdrawal by Subject|0
2867181|NCT02121509|9861207|P2|Washout Period (35 Days)|Withdrawal by Subject|3
2867182|NCT02121509|9861208|P1|Washout Period (35 Days)|Withdrawal by Subject|0
2867183|NCT02121509|9861205|P4|Washout Period (35 Days)|Adverse Event|0
2867184|NCT02121509|9861206|P3|Washout Period (35 Days)|Adverse Event|0
2867185|NCT02121509|9861207|P2|Washout Period (35 Days)|Adverse Event|1
2867186|NCT02121509|9861208|P1|Washout Period (35 Days)|Adverse Event|1
2867187|NCT02121210|9861279|P2|Overall Study|Other than specified above|2
2867188|NCT02121210|9861280|P1|Overall Study|Other than specified above|0
2867189|NCT02121210|9861279|P2|Overall Study|Lack of Efficacy|0
2867190|NCT02121210|9861280|P1|Overall Study|Lack of Efficacy|2
2867191|NCT02121210|9861279|P2|Overall Study|Adverse Event|7
2867192|NCT02121210|9861280|P1|Overall Study|Adverse Event|5
2867193|NCT02120950|9861305|P3|Overall Study|Lost to Follow-up|1
2867194|NCT02120950|9861306|P2|Overall Study|Lost to Follow-up|2
2867195|NCT02120950|9861307|P1|Overall Study|Lost to Follow-up|0
2867196|NCT02120950|9861305|P3|Overall Study|Other reasons|1
2867197|NCT02120950|9861306|P2|Overall Study|Other reasons|4
2867198|NCT02120950|9861307|P1|Overall Study|Other reasons|5
2867199|NCT02120950|9861305|P3|Overall Study|Protocol Violation|7
2867200|NCT02120950|9861306|P2|Overall Study|Protocol Violation|1
2867201|NCT02120950|9861307|P1|Overall Study|Protocol Violation|1
2867202|NCT02120950|9861305|P3|Overall Study|Withdrawal by Subject|2
2867203|NCT02120950|9861306|P2|Overall Study|Withdrawal by Subject|3
2867204|NCT02120950|9861307|P1|Overall Study|Withdrawal by Subject|6
2867205|NCT02120950|9861305|P3|Overall Study|Death|1
2867206|NCT02120950|9861306|P2|Overall Study|Death|0
2867207|NCT02120950|9861307|P1|Overall Study|Death|3
2867208|NCT02120950|9861305|P3|Overall Study|Adverse Event|3
2867209|NCT02120950|9861306|P2|Overall Study|Adverse Event|4
2867210|NCT02120950|9861307|P1|Overall Study|Adverse Event|5
2867211|NCT02120898|9861343|P3|Overall Study|Lost to Follow-up|1
2867212|NCT02120898|9861344|P2|Overall Study|Lost to Follow-up|0
2867213|NCT02120898|9861345|P1|Overall Study|Lost to Follow-up|0
2867214|NCT02120898|9861343|P3|Overall Study|Protocol Violation|0
2867215|NCT02120898|9861344|P2|Overall Study|Protocol Violation|2
2867216|NCT02120898|9861345|P1|Overall Study|Protocol Violation|1
2867217|NCT02120898|9861343|P3|Overall Study|Adverse Event|1
2867218|NCT02120898|9861344|P2|Overall Study|Adverse Event|2
2867219|NCT02120898|9861345|P1|Overall Study|Adverse Event|1
2867220|NCT02120898|9861343|P3|Overall Study|Non-compliance with study drug|0
2867221|NCT02120898|9861344|P2|Overall Study|Non-compliance with study drug|0
2867222|NCT02120898|9861345|P1|Overall Study|Non-compliance with study drug|3
2867223|NCT02120898|9861343|P3|Overall Study|Withdrawal by Subject|2
2867224|NCT02120898|9861344|P2|Overall Study|Withdrawal by Subject|2
2867225|NCT02120898|9861345|P1|Overall Study|Withdrawal by Subject|4
2867226|NCT02120833|9861367|P2|Overall Study|Lost to Follow-up|1
2867227|NCT02120833|9861368|P1|Overall Study|Lost to Follow-up|1
2867228|NCT02120833|9861367|P2|Overall Study|Withdrawal by Subject|0
2867229|NCT02120833|9861368|P1|Overall Study|Withdrawal by Subject|2
2867230|NCT02120833|9861367|P2|Overall Study|Adverse Event|0
2867231|NCT02120833|9861368|P1|Overall Study|Adverse Event|1
2867232|NCT02120794|9861522|P1|Overall Study|Due to insurance coverage|1
2867233|NCT02120794|9861522|P1|Overall Study|Physician Decision|4
2867234|NCT02120794|9861522|P1|Overall Study|Adverse Event|10
2867235|NCT02120794|9861522|P1|Overall Study|Withdrawal by Subject|43
2867236|NCT02120664|9861546|P5|Overall Study|Withdrawal by Subject|0
2867237|NCT02120664|9861547|P4|Overall Study|Withdrawal by Subject|1
2867238|NCT02120664|9861548|P3|Overall Study|Withdrawal by Subject|0
2867239|NCT02120664|9861549|P2|Overall Study|Withdrawal by Subject|0
2867240|NCT02120664|9861550|P1|Overall Study|Withdrawal by Subject|0
2867241|NCT02120625|9861568|P1|Overall Study|Physician Decision|2
2867242|NCT02120456|9861584|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
2867243|NCT02120456|9861585|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867244|NCT02120456|9861586|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867245|NCT02120456|9861587|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867246|NCT02120456|9861588|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867247|NCT02120456|9861589|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867248|NCT02120456|9861590|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867249|NCT02120456|9861591|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867250|NCT02120456|9861592|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2867251|NCT02120456|9861584|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
2867252|NCT02120456|9861585|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
2867253|NCT02120456|9861586|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
2867254|NCT02120456|9861587|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
2867255|NCT02120456|9861588|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
2867256|NCT02120456|9861589|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
2867257|NCT02120456|9861590|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
2867258|NCT02120456|9861591|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
2867259|NCT02120456|9861592|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
2867260|NCT02120456|9861584|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
2867261|NCT02120456|9861585|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
2867262|NCT02120456|9861586|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
2867263|NCT02120456|9861587|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
2867264|NCT02120456|9861588|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
2867265|NCT02120456|9861589|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
2867266|NCT02120456|9861590|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
2867267|NCT02120456|9861591|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
2867268|NCT02120456|9861592|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
2867269|NCT02120417|9861626|P2|Overall Study|Other unspecified|4
2867270|NCT02120417|9861627|P1|Overall Study|Other unspecified|5
2867271|NCT02120417|9861626|P2|Overall Study|Physician Decision|3
2867272|NCT02120417|9861627|P1|Overall Study|Physician Decision|2
2867273|NCT02120417|9861626|P2|Overall Study|Noncompliance with study treatment|2
2867274|NCT02120417|9861627|P1|Overall Study|Noncompliance with study treatment|0
2867275|NCT02120417|9861626|P2|Overall Study|Disease progression|45
2867276|NCT02120417|9861627|P1|Overall Study|Disease progression|41
2867277|NCT02120417|9861626|P2|Overall Study|Participant decision|4
2867278|NCT02120417|9861627|P1|Overall Study|Participant decision|4
2867279|NCT02120417|9861626|P2|Overall Study|Adverse Event|9
2867280|NCT02120417|9861627|P1|Overall Study|Adverse Event|3
2867281|NCT02120417|9861626|P2|Overall Study|Death|1
2867282|NCT02120417|9861627|P1|Overall Study|Death|5
2867283|NCT02120300|9861649|P4|Overall Study|Lost to Follow-up|0
2867284|NCT02120300|9861650|P3|Overall Study|Lost to Follow-up|0
2867285|NCT02120300|9861651|P2|Overall Study|Lost to Follow-up|0
2867286|NCT02120300|9861652|P1|Overall Study|Lost to Follow-up|1
2867287|NCT02120300|9861649|P4|Overall Study|Lack of Efficacy|1
2867288|NCT02120300|9861650|P3|Overall Study|Lack of Efficacy|0
2867289|NCT02120300|9861651|P2|Overall Study|Lack of Efficacy|0
2867290|NCT02120300|9861652|P1|Overall Study|Lack of Efficacy|0
2867291|NCT02120300|9861649|P4|Overall Study|Enrolled but Never Treated|0
2867292|NCT02120300|9861650|P3|Overall Study|Enrolled but Never Treated|0
2867293|NCT02120300|9861651|P2|Overall Study|Enrolled but Never Treated|0
2867294|NCT02120300|9861652|P1|Overall Study|Enrolled but Never Treated|2
2867295|NCT02120157|9861723|P2|Overall Study|Graft Failure before Day 100|0
2867296|NCT02120157|9861724|P1|Overall Study|Graft Failure before Day 100|2
2867297|NCT02120157|9861723|P2|Overall Study|Death|2
2867298|NCT02120157|9861724|P1|Overall Study|Death|4
2867299|NCT02120027|9861734|P2|Overall Study|Withdrawal by Subject|25
2867300|NCT02120027|9861735|P1|Overall Study|Withdrawal by Subject|33
2867301|NCT02120027|9861734|P2|Overall Study|Study terminated by Sponsor|47
2867302|NCT02120027|9861735|P1|Overall Study|Study terminated by Sponsor|45
2867303|NCT02120027|9861734|P2|Overall Study|Protocol Violation|21
2867304|NCT02120027|9861735|P1|Overall Study|Protocol Violation|18
2867305|NCT02120027|9861734|P2|Overall Study|Physician Decision|3
2867306|NCT02120027|9861735|P1|Overall Study|Physician Decision|4
2867307|NCT02120027|9861734|P2|Overall Study|Other|0
2867308|NCT02120027|9861735|P1|Overall Study|Other|4
2867309|NCT02120027|9861734|P2|Overall Study|Lost to Follow-up|13
2867310|NCT02120027|9861735|P1|Overall Study|Lost to Follow-up|5
2867311|NCT02120027|9861734|P2|Overall Study|Lack of Efficacy|5
2867312|NCT02120027|9861735|P1|Overall Study|Lack of Efficacy|3
2867313|NCT02120027|9861734|P2|Overall Study|Adverse Event|5
2867314|NCT02120027|9861735|P1|Overall Study|Adverse Event|4
2867315|NCT02119936|9861760|P1|Overall Study|Lost to Follow-up|10
2867316|NCT02119676|9861794|P4|Overall Study|Did not receive study med|5
2867317|NCT02119676|9861795|P3|Overall Study|Did not receive study med|4
2867318|NCT02119676|9861796|P2|Overall Study|Did not receive study med|2
2867319|NCT02119676|9861797|P1|Overall Study|Did not receive study med|2
2867320|NCT02119676|9861794|P4|Overall Study|Other, unspecified|4
2867321|NCT02119676|9861795|P3|Overall Study|Other, unspecified|3
2867322|NCT02119676|9861796|P2|Overall Study|Other, unspecified|1
2867323|NCT02119676|9861797|P1|Overall Study|Other, unspecified|2
2867324|NCT02119676|9861794|P4|Overall Study|Protocol deviation|0
2867325|NCT02119676|9861795|P3|Overall Study|Protocol deviation|1
2867326|NCT02119676|9861796|P2|Overall Study|Protocol deviation|0
2867327|NCT02119676|9861797|P1|Overall Study|Protocol deviation|0
2867328|NCT02119676|9861794|P4|Overall Study|Lost to Follow-up|0
2867329|NCT02119676|9861795|P3|Overall Study|Lost to Follow-up|1
2867330|NCT02119676|9861796|P2|Overall Study|Lost to Follow-up|0
2867331|NCT02119676|9861797|P1|Overall Study|Lost to Follow-up|0
2867332|NCT02119676|9861794|P4|Overall Study|Noncompliance|0
2867333|NCT02119676|9861795|P3|Overall Study|Noncompliance|0
2867334|NCT02119676|9861796|P2|Overall Study|Noncompliance|1
2867335|NCT02119676|9861797|P1|Overall Study|Noncompliance|0
2867336|NCT02119676|9861794|P4|Overall Study|Death|1
2867337|NCT02119676|9861795|P3|Overall Study|Death|2
2867338|NCT02119676|9861796|P2|Overall Study|Death|3
2867339|NCT02119676|9861797|P1|Overall Study|Death|9
2867340|NCT02119676|9861794|P4|Overall Study|Physician Decision|2
2867341|NCT02119676|9861795|P3|Overall Study|Physician Decision|3
2867342|NCT02119676|9861796|P2|Overall Study|Physician Decision|2
2867343|NCT02119676|9861797|P1|Overall Study|Physician Decision|4
2867344|NCT02119676|9861794|P4|Overall Study|Patient decision, inc. consent withdrawn|6
2867345|NCT02119676|9861795|P3|Overall Study|Patient decision, inc. consent withdrawn|5
2867346|NCT02119676|9861796|P2|Overall Study|Patient decision, inc. consent withdrawn|5
2867347|NCT02119676|9861797|P1|Overall Study|Patient decision, inc. consent withdrawn|4
2867348|NCT02119676|9861794|P4|Overall Study|Disease progression|73
2867349|NCT02119676|9861795|P3|Overall Study|Disease progression|68
2867350|NCT02119676|9861796|P2|Overall Study|Disease progression|55
2867351|NCT02119676|9861797|P1|Overall Study|Disease progression|53
2867352|NCT02119676|9861794|P4|Overall Study|Adverse Event|10
2867353|NCT02119676|9861795|P3|Overall Study|Adverse Event|10
2867354|NCT02119676|9861796|P2|Overall Study|Adverse Event|17
2867355|NCT02119676|9861797|P1|Overall Study|Adverse Event|9
2867356|NCT02119663|9861829|P2|Overall Study|Study Terminated by the Sponsor|4
2867357|NCT02119663|9861830|P1|Overall Study|Study Terminated by the Sponsor|3
2867358|NCT02119663|9861829|P2|Overall Study|Subject decision|1
2867359|NCT02119663|9861830|P1|Overall Study|Subject decision|0
2867360|NCT02119663|9861829|P2|Overall Study|Other unspecified|0
2867361|NCT02119663|9861830|P1|Overall Study|Other unspecified|2
2867362|NCT02119663|9861829|P2|Overall Study|Physician Decision|2
2867363|NCT02119663|9861830|P1|Overall Study|Physician Decision|1
2867364|NCT02119663|9861829|P2|Overall Study|Death|2
2867365|NCT02119663|9861830|P1|Overall Study|Death|3
2867366|NCT02119663|9861829|P2|Overall Study|Adverse Event|5
2867367|NCT02119663|9861830|P1|Overall Study|Adverse Event|5
2867368|NCT02119663|9861829|P2|Overall Study|Disease progression|27
2867369|NCT02119663|9861830|P1|Overall Study|Disease progression|26
2867370|NCT02119650|9861848|P2|Overall Study|Multiple reasons for termination|1
2867371|NCT02119650|9861849|P1|Overall Study|Multiple reasons for termination|2
2867372|NCT02119650|9861848|P2|Overall Study|Physician Decision|2
2867373|NCT02119650|9861849|P1|Overall Study|Physician Decision|0
2867374|NCT02119650|9861848|P2|Overall Study|Study terminated by the sponsor|0
2867375|NCT02119650|9861849|P1|Overall Study|Study terminated by the sponsor|1
2867376|NCT02119650|9861848|P2|Overall Study|Noncompliance with study treatment|1
2867377|NCT02119650|9861849|P1|Overall Study|Noncompliance with study treatment|1
2867378|NCT02119650|9861848|P2|Overall Study|Death|1
2867379|NCT02119650|9861849|P1|Overall Study|Death|5
2867380|NCT02119650|9861848|P2|Overall Study|Disease progression|14
2867381|NCT02119650|9861849|P1|Overall Study|Disease progression|11
2867382|NCT02119650|9861848|P2|Overall Study|Subject decision|3
2867383|NCT02119650|9861849|P1|Overall Study|Subject decision|2
2867384|NCT02119650|9861848|P2|Overall Study|Adverse Event|4
2867385|NCT02119650|9861849|P1|Overall Study|Adverse Event|3
2867386|NCT02119325|9861884|P2|Washout Period 1|Adverse Event|1
2867387|NCT02119325|9861885|P1|Washout Period 1|Adverse Event|0
2867388|NCT02119299|9861929|P1|Overall Study|Pregnancy|1
2867389|NCT02119299|9861929|P1|Overall Study|Lack of Efficacy|1
2867390|NCT02119299|9861929|P1|Overall Study|Withdrawal by Subject|7
2867391|NCT02119286|9861943|P3|Overall Study|Withdrawal by Subject|0
2867392|NCT02119286|9861944|P2|Overall Study|Withdrawal by Subject|1
2867393|NCT02119286|9861945|P1|Overall Study|Withdrawal by Subject|4
2867394|NCT02119286|9861943|P3|Overall Study|Lost to Follow-up|1
2867395|NCT02119286|9861944|P2|Overall Study|Lost to Follow-up|0
2867396|NCT02119286|9861945|P1|Overall Study|Lost to Follow-up|2
2867397|NCT02119286|9861943|P3|Overall Study|Lack of Efficacy|4
2867398|NCT02119286|9861944|P2|Overall Study|Lack of Efficacy|3
2867399|NCT02119286|9861945|P1|Overall Study|Lack of Efficacy|11
2867400|NCT02119286|9861943|P3|Overall Study|Adverse Event|2
2867401|NCT02119286|9861944|P2|Overall Study|Adverse Event|7
2867402|NCT02119286|9861945|P1|Overall Study|Adverse Event|9
2867403|NCT02119260|9861963|P7|Overall Study|Withdrew consent|0
2867404|NCT02119260|9861964|P6|Overall Study|Withdrew consent|0
2867405|NCT02119260|9861965|P5|Overall Study|Withdrew consent|0
2867406|NCT02119260|9861966|P4|Overall Study|Withdrew consent|0
2867407|NCT02119260|9861967|P3|Overall Study|Withdrew consent|1
2867408|NCT02119260|9861968|P2|Overall Study|Withdrew consent|1
2867409|NCT02119260|9861969|P1|Overall Study|Withdrew consent|0
2867410|NCT02119260|9861963|P7|Overall Study|Adverse Event|0
2867411|NCT02119260|9861964|P6|Overall Study|Adverse Event|0
2867412|NCT02119260|9861965|P5|Overall Study|Adverse Event|0
2867413|NCT02119260|9861966|P4|Overall Study|Adverse Event|0
2867414|NCT02119260|9861967|P3|Overall Study|Adverse Event|0
2867415|NCT02119260|9861968|P2|Overall Study|Adverse Event|0
2867416|NCT02119260|9861969|P1|Overall Study|Adverse Event|1
2867417|NCT02119156|9862042|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
2867418|NCT02119156|9862043|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
2867419|NCT02119156|9862044|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
2867420|NCT02119156|9862042|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2867421|NCT02119156|9862043|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2867422|NCT02119156|9862044|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
2867423|NCT02119156|9862042|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
2867424|NCT02119156|9862043|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
2867425|NCT02119156|9862044|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
2867426|NCT02119156|9862042|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2867427|NCT02119156|9862043|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2867428|NCT02119156|9862044|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
2867429|NCT02119156|9862042|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
2867430|NCT02119156|9862043|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2867431|NCT02119156|9862044|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2867432|NCT02119104|9862102|P1|Overall Study|Protocol Violation|16
2867433|NCT02119026|9862108|P2|2nd-line Treatment|Adverse Event|1
2867434|NCT02119026|9862109|P1|2nd-line Treatment|Adverse Event|4
2867435|NCT02119026|9862108|P2|2nd-line Treatment|Withdrawal by Subject|1
2867436|NCT02119026|9862109|P1|2nd-line Treatment|Withdrawal by Subject|3
2867437|NCT02119026|9862108|P2|2nd-line Treatment|Lost to Follow-up|0
2867438|NCT02119026|9862109|P1|2nd-line Treatment|Lost to Follow-up|2
2867439|NCT02119026|9862108|P2|1st-line Treatment|Death|1
2867440|NCT02119026|9862109|P1|1st-line Treatment|Death|2
2867441|NCT02119026|9862108|P2|1st-line Treatment|Surgery of metastases|1
2867442|NCT02119026|9862109|P1|1st-line Treatment|Surgery of metastases|2
2867443|NCT02119026|9862108|P2|1st-line Treatment|Patient condition or compliance|4
2867444|NCT02119026|9862109|P1|1st-line Treatment|Patient condition or compliance|6
2867445|NCT02119026|9862108|P2|1st-line Treatment|Withdrawal by Subject|10
2867446|NCT02119026|9862109|P1|1st-line Treatment|Withdrawal by Subject|4
2867447|NCT02119026|9862108|P2|1st-line Treatment|Physician Decision|8
2867448|NCT02119026|9862109|P1|1st-line Treatment|Physician Decision|3
2867449|NCT02119026|9862108|P2|1st-line Treatment|Adverse Event|14
2867450|NCT02119026|9862109|P1|1st-line Treatment|Adverse Event|9
2867451|NCT02118961|9862133|P2|Overall Study|Withdrawal by Subject|0
2867452|NCT02118961|9862134|P1|Overall Study|Withdrawal by Subject|1
2867453|NCT02118896|9862162|P10|Overall Study|Miscellaneous|0
2867454|NCT02118896|9862163|P9|Overall Study|Miscellaneous|0
2867455|NCT02118896|9862164|P8|Overall Study|Miscellaneous|0
2867456|NCT02118896|9862165|P7|Overall Study|Miscellaneous|0
2867457|NCT02118896|9862166|P6|Overall Study|Miscellaneous|4
2867458|NCT02118896|9862167|P5|Overall Study|Miscellaneous|0
2867459|NCT02118896|9862168|P4|Overall Study|Miscellaneous|2
2867460|NCT02118896|9862169|P3|Overall Study|Miscellaneous|0
2867461|NCT02118896|9862170|P2|Overall Study|Miscellaneous|2
2867462|NCT02118896|9862171|P1|Overall Study|Miscellaneous|1
2867463|NCT02118896|9862162|P10|Overall Study|Prohibited medication|0
2867464|NCT02118896|9862163|P9|Overall Study|Prohibited medication|0
2867465|NCT02118896|9862164|P8|Overall Study|Prohibited medication|0
2867466|NCT02118896|9862165|P7|Overall Study|Prohibited medication|0
2867467|NCT02118896|9862166|P6|Overall Study|Prohibited medication|3
2867468|NCT02118896|9862167|P5|Overall Study|Prohibited medication|1
2867469|NCT02118896|9862168|P4|Overall Study|Prohibited medication|0
2867470|NCT02118896|9862169|P3|Overall Study|Prohibited medication|0
2867471|NCT02118896|9862170|P2|Overall Study|Prohibited medication|0
2867472|NCT02118896|9862171|P1|Overall Study|Prohibited medication|0
2867473|NCT02118896|9862162|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
2867474|NCT02118896|9862163|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
2867475|NCT02118896|9862164|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
2867476|NCT02118896|9862165|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
2867477|NCT02118896|9862166|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
2867478|NCT02118896|9862167|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
2867479|NCT02118896|9862168|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
2867480|NCT02118896|9862169|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
2867481|NCT02118896|9862170|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
2867482|NCT02118896|9862171|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
2867483|NCT02118896|9862162|P10|Overall Study|Lost to Follow-up|0
2867484|NCT02118896|9862163|P9|Overall Study|Lost to Follow-up|0
2867485|NCT02118896|9862164|P8|Overall Study|Lost to Follow-up|0
2867486|NCT02118896|9862165|P7|Overall Study|Lost to Follow-up|0
2867487|NCT02118896|9862166|P6|Overall Study|Lost to Follow-up|1
2867488|NCT02118896|9862167|P5|Overall Study|Lost to Follow-up|2
2867489|NCT02118896|9862168|P4|Overall Study|Lost to Follow-up|0
2867490|NCT02118896|9862169|P3|Overall Study|Lost to Follow-up|1
2867491|NCT02118896|9862170|P2|Overall Study|Lost to Follow-up|2
2867492|NCT02118896|9862171|P1|Overall Study|Lost to Follow-up|1
2867493|NCT02118896|9862162|P10|Overall Study|Pregnancy|0
2867494|NCT02118896|9862163|P9|Overall Study|Pregnancy|0
2867495|NCT02118896|9862164|P8|Overall Study|Pregnancy|0
2867496|NCT02118896|9862165|P7|Overall Study|Pregnancy|1
2867497|NCT02118896|9862166|P6|Overall Study|Pregnancy|3
2867498|NCT02118896|9862167|P5|Overall Study|Pregnancy|1
2867499|NCT02118896|9862168|P4|Overall Study|Pregnancy|0
2867500|NCT02118896|9862169|P3|Overall Study|Pregnancy|0
2867501|NCT02118896|9862170|P2|Overall Study|Pregnancy|1
2867502|NCT02118896|9862171|P1|Overall Study|Pregnancy|1
2867503|NCT02118896|9862162|P10|Overall Study|Non-compliance|0
2867504|NCT02118896|9862163|P9|Overall Study|Non-compliance|0
2867505|NCT02118896|9862164|P8|Overall Study|Non-compliance|1
2867506|NCT02118896|9862165|P7|Overall Study|Non-compliance|0
2867507|NCT02118896|9862166|P6|Overall Study|Non-compliance|1
2867508|NCT02118896|9862167|P5|Overall Study|Non-compliance|0
2867509|NCT02118896|9862168|P4|Overall Study|Non-compliance|5
2867510|NCT02118896|9862169|P3|Overall Study|Non-compliance|1
2867511|NCT02118896|9862170|P2|Overall Study|Non-compliance|1
2867512|NCT02118896|9862171|P1|Overall Study|Non-compliance|2
2867513|NCT02118896|9862162|P10|Overall Study|Consent withdrawn|0
2867514|NCT02118896|9862163|P9|Overall Study|Consent withdrawn|0
2867515|NCT02118896|9862164|P8|Overall Study|Consent withdrawn|0
2867516|NCT02118896|9862165|P7|Overall Study|Consent withdrawn|0
2867517|NCT02118896|9862166|P6|Overall Study|Consent withdrawn|4
2867518|NCT02118896|9862167|P5|Overall Study|Consent withdrawn|1
2867519|NCT02118896|9862168|P4|Overall Study|Consent withdrawn|4
2867520|NCT02118896|9862169|P3|Overall Study|Consent withdrawn|3
2867521|NCT02118896|9862170|P2|Overall Study|Consent withdrawn|0
2867522|NCT02118896|9862171|P1|Overall Study|Consent withdrawn|2
2867523|NCT02118896|9862162|P10|Overall Study|Adverse Event|0
2867524|NCT02118896|9862163|P9|Overall Study|Adverse Event|4
2867525|NCT02118896|9862164|P8|Overall Study|Adverse Event|1
2867526|NCT02118896|9862165|P7|Overall Study|Adverse Event|1
2867527|NCT02118896|9862166|P6|Overall Study|Adverse Event|9
2867528|NCT02118896|9862167|P5|Overall Study|Adverse Event|5
2867529|NCT02118896|9862168|P4|Overall Study|Adverse Event|5
2867530|NCT02118896|9862169|P3|Overall Study|Adverse Event|4
2867531|NCT02118896|9862170|P2|Overall Study|Adverse Event|4
2867532|NCT02118896|9862171|P1|Overall Study|Adverse Event|5
2867533|NCT02118896|9862162|P10|Overall Study|Death|0
2867534|NCT02118896|9862163|P9|Overall Study|Death|0
2867535|NCT02118896|9862164|P8|Overall Study|Death|0
2867536|NCT02118896|9862165|P7|Overall Study|Death|0
2867537|NCT02118896|9862166|P6|Overall Study|Death|1
2867538|NCT02118896|9862167|P5|Overall Study|Death|3
2867539|NCT02118896|9862168|P4|Overall Study|Death|6
2867540|NCT02118896|9862169|P3|Overall Study|Death|4
2867541|NCT02118896|9862170|P2|Overall Study|Death|0
2867542|NCT02118896|9862171|P1|Overall Study|Death|4
2867543|NCT02118792|9862261|P2|Overall Study|Randomised but not treated|0
2867544|NCT02118792|9862262|P1|Overall Study|Randomised but not treated|1
2867545|NCT02118792|9862261|P2|Overall Study|Other|6
2867546|NCT02118792|9862262|P1|Overall Study|Other|1
2867547|NCT02118792|9862261|P2|Overall Study|Withdrawal by parent/guardian|20
2867548|NCT02118792|9862262|P1|Overall Study|Withdrawal by parent/guardian|14
2867549|NCT02118792|9862261|P2|Overall Study|Adverse Event|4
2867550|NCT02118792|9862262|P1|Overall Study|Adverse Event|5
2867551|NCT02118792|9862261|P2|Overall Study|Lost to Follow-up|4
2867552|NCT02118792|9862262|P1|Overall Study|Lost to Follow-up|4
2867553|NCT02118792|9862261|P2|Overall Study|Withdrawal by Subject|3
2867554|NCT02118792|9862262|P1|Overall Study|Withdrawal by Subject|6
2867555|NCT02118766|9862304|P2|Overall Study|Other|1
2867556|NCT02118766|9862305|P1|Overall Study|Other|3
2867557|NCT02118766|9862304|P2|Overall Study|Withdrawal by parent/guardian|18
2867558|NCT02118766|9862305|P1|Overall Study|Withdrawal by parent/guardian|12
2867559|NCT02118766|9862304|P2|Overall Study|Lost to Follow-up|4
2867560|NCT02118766|9862305|P1|Overall Study|Lost to Follow-up|5
2867561|NCT02118766|9862304|P2|Overall Study|Withdrawal by Subject|6
2867562|NCT02118766|9862305|P1|Overall Study|Withdrawal by Subject|3
2867563|NCT02118766|9862304|P2|Overall Study|Adverse Event|2
2867564|NCT02118766|9862305|P1|Overall Study|Adverse Event|7
2867565|NCT02118714|9862327|P1|Overall Study|Protocol Violation|1
2867566|NCT02118714|9862327|P1|Overall Study|Lost to Follow-up|2
2867567|NCT02118597|9862352|P1|Overall Study|Investigator's decision|1
2867568|NCT02118597|9862352|P1|Overall Study|Serious Adverse Event|1
2867569|NCT02118597|9862352|P1|Overall Study|Sponsor terminated the study|14
2867570|NCT02118428|9862383|P3|Overall Study|Screen Failure or Became Inelegible|1
2867571|NCT02118428|9862384|P2|Overall Study|Screen Failure or Became Inelegible|0
2867572|NCT02118428|9862385|P1|Overall Study|Screen Failure or Became Inelegible|1
2867573|NCT02118428|9862383|P3|Overall Study|Lost to Follow-up|0
2867574|NCT02118428|9862384|P2|Overall Study|Lost to Follow-up|1
2867575|NCT02118428|9862385|P1|Overall Study|Lost to Follow-up|3
2867576|NCT02118428|9862383|P3|Overall Study|Death|0
2867577|NCT02118428|9862384|P2|Overall Study|Death|5
2867578|NCT02118428|9862385|P1|Overall Study|Death|7
2867579|NCT02118428|9862383|P3|Overall Study|Withdrawal by Subject|0
2867580|NCT02118428|9862384|P2|Overall Study|Withdrawal by Subject|2
2867581|NCT02118428|9862385|P1|Overall Study|Withdrawal by Subject|2
2867582|NCT02118428|9862383|P3|Overall Study|Physician Decision|0
2867583|NCT02118428|9862384|P2|Overall Study|Physician Decision|1
2867584|NCT02118428|9862385|P1|Overall Study|Physician Decision|0
2867585|NCT02117687|9862455|P2|Overall Study|Other Reasons|1
2867586|NCT02117687|9862456|P1|Overall Study|Other Reasons|1
2867587|NCT02117687|9862455|P2|Overall Study|Adverse Event|2
2867588|NCT02117687|9862456|P1|Overall Study|Adverse Event|0
2867589|NCT02117687|9862455|P2|Overall Study|Lost to Follow-up|1
2867590|NCT02117687|9862456|P1|Overall Study|Lost to Follow-up|0
2867591|NCT02117648|9862488|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
2867592|NCT02117648|9862488|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
2867593|NCT02117648|9862488|P1|Abemaciclib Safety-Extension Phase|Death|3
2867594|NCT02117648|9862488|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
2867595|NCT02117648|9862488|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
2867596|NCT02117648|9862488|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
2867597|NCT02117648|9862488|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
2867598|NCT02117648|9862488|P1|Abemaciclib + Clarithromycin Period 2|Death|1
2867599|NCT02117648|9862488|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
2867600|NCT02117648|9862488|P1|Abemaciclib Alone Period 1|Adverse Event|1
2867601|NCT02117648|9862488|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
2867602|NCT02117570|9862501|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2867603|NCT02117570|9862502|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
2867604|NCT02117570|9862503|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2867605|NCT02117570|9862501|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2867606|NCT02117570|9862502|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2867607|NCT02117570|9862503|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
2867608|NCT02117570|9862501|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
2867609|NCT02117570|9862502|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2867610|NCT02117570|9862503|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2867611|NCT02117570|9862501|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
2867612|NCT02117570|9862502|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
2867613|NCT02117570|9862503|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
2867614|NCT02117570|9862501|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
2867615|NCT02117570|9862502|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2867616|NCT02117570|9862503|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2867617|NCT02117570|9862501|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
2867618|NCT02117570|9862502|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2867619|NCT02117570|9862503|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2867620|NCT02117570|9862501|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
2867621|NCT02117570|9862502|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
2867622|NCT02117570|9862503|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
2867623|NCT02117544|9862553|P2|Period 1|Lost to follow-up (prior to treatment)|0
2867624|NCT02117544|9862554|P1|Period 1|Lost to follow-up (prior to treatment)|2
2867625|NCT02117479|9862569|P2|Overall Study|Other unspecified|7
2867626|NCT02117479|9862570|P1|Overall Study|Other unspecified|11
2867627|NCT02117479|9862569|P2|Overall Study|Physician Decision|2
2867628|NCT02117479|9862570|P1|Overall Study|Physician Decision|7
2867629|NCT02117479|9862569|P2|Overall Study|Study terminated by the sponsor|6
2867630|NCT02117479|9862570|P1|Overall Study|Study terminated by the sponsor|4
2867631|NCT02117479|9862569|P2|Overall Study|Noncompliance with study treatment|0
2867632|NCT02117479|9862570|P1|Overall Study|Noncompliance with study treatment|1
2867633|NCT02117479|9862569|P2|Overall Study|Disease progression|108
2867634|NCT02117479|9862570|P1|Overall Study|Disease progression|104
2867635|NCT02117479|9862569|P2|Overall Study|Subject decision|9
2867636|NCT02117479|9862570|P1|Overall Study|Subject decision|8
2867637|NCT02117479|9862569|P2|Overall Study|Adverse Event|16
2867638|NCT02117479|9862570|P1|Overall Study|Adverse Event|8
2867639|NCT02117479|9862569|P2|Overall Study|Death|8
2867640|NCT02117479|9862570|P1|Overall Study|Death|13
2867641|NCT02117427|9862589|P3|Overall Study|Death|0
2867642|NCT02117427|9862590|P2|Overall Study|Death|1
2867643|NCT02117427|9862591|P1|Overall Study|Death|0
2867644|NCT02117427|9862589|P3|Overall Study|No longer meets inclusion criteria|0
2867645|NCT02117427|9862590|P2|Overall Study|No longer meets inclusion criteria|1
2867646|NCT02117427|9862591|P1|Overall Study|No longer meets inclusion criteria|0
2867647|NCT02117427|9862589|P3|Overall Study|Physician Decision|0
2867648|NCT02117427|9862590|P2|Overall Study|Physician Decision|2
2867649|NCT02117427|9862591|P1|Overall Study|Physician Decision|0
2867650|NCT02117427|9862589|P3|Overall Study|Permanent need for exogenous ESA Tx|0
2867651|NCT02117427|9862590|P2|Overall Study|Permanent need for exogenous ESA Tx|1
2867652|NCT02117427|9862591|P1|Overall Study|Permanent need for exogenous ESA Tx|3
2867653|NCT02117427|9862589|P3|Overall Study|Permanent need for exogenous EPO Tx|0
2867654|NCT02117427|9862590|P2|Overall Study|Permanent need for exogenous EPO Tx|0
2867655|NCT02117427|9862591|P1|Overall Study|Permanent need for exogenous EPO Tx|2
2867656|NCT02117414|9862601|P2|Overall Study|Withdrawal by Subject|4
2867657|NCT02117414|9862602|P1|Overall Study|Withdrawal by Subject|10
2867658|NCT02117414|9862601|P2|Overall Study|Death|2
2867659|NCT02117414|9862602|P1|Overall Study|Death|5
2867660|NCT02117349|9862622|P2|Overall Study|Death|0
2867661|NCT02117349|9862623|P1|Overall Study|Death|1
2867662|NCT02117349|9862622|P2|Overall Study|Lost to Follow-up|1
2867663|NCT02117349|9862623|P1|Overall Study|Lost to Follow-up|1
2867664|NCT02117349|9862622|P2|Overall Study|Withdrawal by Subject|0
2867665|NCT02117349|9862623|P1|Overall Study|Withdrawal by Subject|1
2867666|NCT02117050|9862659|P1|Overall Study|Subject Enrolled but not Dosed|1
2867667|NCT02117024|9862673|P2|Overall Study|Physician Decision|2
2867668|NCT02117024|9862674|P1|Overall Study|Physician Decision|0
2867669|NCT02117024|9862673|P2|Overall Study|Patient took treatment break|1
2867670|NCT02117024|9862674|P1|Overall Study|Patient took treatment break|0
2867671|NCT02117024|9862673|P2|Overall Study|Patient returned to primary oncologist|1
2867672|NCT02117024|9862674|P1|Overall Study|Patient returned to primary oncologist|0
2867673|NCT02117024|9862673|P2|Overall Study|Randomized in Error|0
2867674|NCT02117024|9862674|P1|Overall Study|Randomized in Error|1
2867675|NCT02117024|9862673|P2|Overall Study|Adverse Event|2
2867676|NCT02117024|9862674|P1|Overall Study|Adverse Event|1
2867677|NCT02117024|9862673|P2|Overall Study|Protocol Violation|0
2867678|NCT02117024|9862674|P1|Overall Study|Protocol Violation|1
2867679|NCT02117024|9862673|P2|Overall Study|Withdrawal by Subject|1
2867680|NCT02117024|9862674|P1|Overall Study|Withdrawal by Subject|3
2867681|NCT02117024|9862673|P2|Overall Study|Death|0
2867682|NCT02117024|9862674|P1|Overall Study|Death|5
2867683|NCT02117024|9862673|P2|Overall Study|Significant Clinical Progression|4
2867684|NCT02117024|9862674|P1|Overall Study|Significant Clinical Progression|7
2867685|NCT02117024|9862673|P2|Overall Study|Progressive Disease|9
2867686|NCT02117024|9862674|P1|Overall Study|Progressive Disease|26
2867687|NCT02116972|9862701|P3|Overall Study|scheduling conflicts and relocation|6
2867688|NCT02116972|9862702|P2|Overall Study|scheduling conflicts and relocation|3
2867689|NCT02116972|9862703|P1|Overall Study|scheduling conflicts and relocation|3
2867690|NCT02116972|9862701|P3|Overall Study|Lack of Efficacy|5
2867691|NCT02116972|9862702|P2|Overall Study|Lack of Efficacy|6
2867692|NCT02116972|9862703|P1|Overall Study|Lack of Efficacy|6
2867693|NCT02116972|9862701|P3|Overall Study|Lost to Follow-up|1
2867694|NCT02116972|9862702|P2|Overall Study|Lost to Follow-up|3
2867695|NCT02116972|9862703|P1|Overall Study|Lost to Follow-up|4
2867696|NCT02116972|9862701|P3|Overall Study|Protocol Violation|1
2867697|NCT02116972|9862702|P2|Overall Study|Protocol Violation|0
2867698|NCT02116972|9862703|P1|Overall Study|Protocol Violation|1
2867699|NCT02116972|9862701|P3|Overall Study|Withdrawal by Subject|5
2867700|NCT02116972|9862702|P2|Overall Study|Withdrawal by Subject|1
2867701|NCT02116972|9862703|P1|Overall Study|Withdrawal by Subject|1
2867702|NCT02116972|9862701|P3|Overall Study|Adverse Event|1
2867703|NCT02116972|9862702|P2|Overall Study|Adverse Event|4
2867704|NCT02116972|9862703|P1|Overall Study|Adverse Event|4
2867705|NCT02116803|9862735|P2|Overall Study|Death|0
2867706|NCT02116803|9862736|P1|Overall Study|Death|1
2867707|NCT02116803|9862735|P2|Overall Study|Study terminated by sponsor|1
2867708|NCT02116803|9862736|P1|Overall Study|Study terminated by sponsor|2
2867709|NCT02116803|9862735|P2|Overall Study|Progressive disease|0
2867710|NCT02116803|9862736|P1|Overall Study|Progressive disease|4
2867711|NCT02116803|9862735|P2|Overall Study|Physician Decision|0
2867712|NCT02116803|9862736|P1|Overall Study|Physician Decision|1
2867713|NCT02116803|9862735|P2|Overall Study|Adverse Event|1
2867714|NCT02116803|9862736|P1|Overall Study|Adverse Event|2
2867715|NCT02116660|9862744|P2|Overall Study|Organization reason|0
2867716|NCT02116660|9862745|P1|Overall Study|Organization reason|1
2867717|NCT02116660|9862744|P2|Overall Study|Withdrawal by Subject|2
2867718|NCT02116660|9862745|P1|Overall Study|Withdrawal by Subject|0
2867719|NCT02116660|9862744|P2|Overall Study|Adverse Event|1
2867720|NCT02116660|9862745|P1|Overall Study|Adverse Event|1
2867721|NCT02116660|9862744|P2|Overall Study|Deteriorating renal function|1
2867722|NCT02116660|9862745|P1|Overall Study|Deteriorating renal function|0
2867723|NCT02116621|9862789|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
2867724|NCT02116621|9862790|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
2867725|NCT02116621|9862789|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
2867726|NCT02116621|9862790|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
2867727|NCT02116621|9862789|P2|Twelve Month Follow-up|Lost to Follow-up|1
2867728|NCT02116621|9862790|P1|Twelve Month Follow-up|Lost to Follow-up|0
2867729|NCT02116621|9862789|P2|Twelve Month Follow-up|Withdrawal by Subject|0
2867730|NCT02116621|9862790|P1|Twelve Month Follow-up|Withdrawal by Subject|1
2867731|NCT02116621|9862789|P2|Six Month Follow-up|Did not complete follow-up survey|1
2867732|NCT02116621|9862790|P1|Six Month Follow-up|Did not complete follow-up survey|1
2867733|NCT02116621|9862789|P2|Six Month Follow-up|Lost to Follow-up|1
2867734|NCT02116621|9862790|P1|Six Month Follow-up|Lost to Follow-up|2
2867735|NCT02116621|9862789|P2|Six Month Follow-up|Withdrawal by Subject|1
2867736|NCT02116621|9862790|P1|Six Month Follow-up|Withdrawal by Subject|1
2867737|NCT02116621|9862789|P2|Three Month Follow-up|Did not complete follow-up survey|4
2867738|NCT02116621|9862790|P1|Three Month Follow-up|Did not complete follow-up survey|14
2867739|NCT02116621|9862789|P2|Three Month Follow-up|Lost to Follow-up|1
2867740|NCT02116621|9862790|P1|Three Month Follow-up|Lost to Follow-up|0
2867741|NCT02116621|9862789|P2|Three Month Follow-up|Withdrawal by Subject|1
2867742|NCT02116621|9862790|P1|Three Month Follow-up|Withdrawal by Subject|4
2867743|NCT02116621|9862789|P2|Three Month Follow-up|Death|1
2867744|NCT02116621|9862790|P1|Three Month Follow-up|Death|1
2867745|NCT02116621|9862789|P2|Baseline|Withdrawal by Subject|4
2867746|NCT02116621|9862790|P1|Baseline|Withdrawal by Subject|0
2867747|NCT02116582|9862878|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
2867748|NCT02116582|9862878|P1|Overall Study|Lost to Follow-up|1
2867749|NCT02116582|9862878|P1|Overall Study|Other: Miscellaneous|11
2867750|NCT02116582|9862878|P1|Overall Study|Withdrawal by Subject|8
2867751|NCT02116582|9862878|P1|Overall Study|Protocol Violation|3
2867752|NCT02116582|9862878|P1|Overall Study|Progressive Disease|148
2867753|NCT02116582|9862878|P1|Overall Study|Death|9
2867754|NCT02116582|9862878|P1|Overall Study|Adverse Event|22
2867755|NCT02116582|9862878|P1|Overall Study|Enrolled but Never Received Study Drug|1
2867756|NCT02116530|9862888|P2|Overall Study|Other Medical Problems|2
2867757|NCT02116530|9862889|P1|Overall Study|Other Medical Problems|2
2867758|NCT02116530|9862888|P2|Overall Study|Lost to Follow-up|0
2867759|NCT02116530|9862889|P1|Overall Study|Lost to Follow-up|1
2867760|NCT02116530|9862888|P2|Overall Study|Physician Decision|0
2867761|NCT02116530|9862889|P1|Overall Study|Physician Decision|1
2867762|NCT02116530|9862888|P2|Overall Study|Adverse Event|0
2867763|NCT02116530|9862889|P1|Overall Study|Adverse Event|4
2867764|NCT02116530|9862888|P2|Overall Study|Withdrawal by Subject|2
2867765|NCT02116530|9862889|P1|Overall Study|Withdrawal by Subject|1
2867766|NCT02116361|9862907|P4|Overall Study|Investigator Decision - Relapse|5
2867767|NCT02116361|9862908|P3|Overall Study|Investigator Decision - Relapse|8
2867768|NCT02116361|9862909|P2|Overall Study|Investigator Decision - Relapse|7
2867769|NCT02116361|9862910|P1|Overall Study|Investigator Decision - Relapse|9
2867770|NCT02116361|9862907|P4|Overall Study|Personal Reasons|9
2867771|NCT02116361|9862908|P3|Overall Study|Personal Reasons|4
2867772|NCT02116361|9862909|P2|Overall Study|Personal Reasons|6
2867773|NCT02116361|9862910|P1|Overall Study|Personal Reasons|6
2867774|NCT02116361|9862907|P4|Overall Study|Lost to Follow-up|5
2867775|NCT02116361|9862908|P3|Overall Study|Lost to Follow-up|7
2867776|NCT02116361|9862909|P2|Overall Study|Lost to Follow-up|5
2867777|NCT02116361|9862910|P1|Overall Study|Lost to Follow-up|4
2867778|NCT02116361|9862907|P4|Overall Study|Lack of Efficacy|3
2867779|NCT02116361|9862908|P3|Overall Study|Lack of Efficacy|4
2867780|NCT02116361|9862909|P2|Overall Study|Lack of Efficacy|7
2867781|NCT02116361|9862910|P1|Overall Study|Lack of Efficacy|5
2867782|NCT02116361|9862907|P4|Overall Study|Other Reasons|3
2867783|NCT02116361|9862908|P3|Overall Study|Other Reasons|3
2867784|NCT02116361|9862909|P2|Overall Study|Other Reasons|3
2867785|NCT02116361|9862910|P1|Overall Study|Other Reasons|3
2867786|NCT02116361|9862907|P4|Overall Study|Adverse Event|3
2867787|NCT02116361|9862908|P3|Overall Study|Adverse Event|0
2867788|NCT02116361|9862909|P2|Overall Study|Adverse Event|0
2867789|NCT02116361|9862910|P1|Overall Study|Adverse Event|1
2867790|NCT02116361|9862907|P4|Overall Study|Physician Decision|0
2867791|NCT02116361|9862908|P3|Overall Study|Physician Decision|0
2867792|NCT02116361|9862909|P2|Overall Study|Physician Decision|3
2867793|NCT02116361|9862910|P1|Overall Study|Physician Decision|2
2867794|NCT02116361|9862907|P4|Overall Study|Protocol Violation|2
2867795|NCT02116361|9862908|P3|Overall Study|Protocol Violation|0
2867796|NCT02116361|9862909|P2|Overall Study|Protocol Violation|0
2867797|NCT02116361|9862910|P1|Overall Study|Protocol Violation|1
2867798|NCT02116361|9862907|P4|Overall Study|Pregnancy|1
2867799|NCT02116361|9862908|P3|Overall Study|Pregnancy|0
2867800|NCT02116361|9862909|P2|Overall Study|Pregnancy|0
2867801|NCT02116361|9862910|P1|Overall Study|Pregnancy|0
2867802|NCT02116309|9862947|P2|Overall Study|Lost to Follow-up|1
2867803|NCT02116309|9862948|P1|Overall Study|Lost to Follow-up|0
2867804|NCT02115815|9862980|P7|Overall Study|Missed appointment, randomized in error|0
2867805|NCT02115815|9862981|P6|Overall Study|Missed appointment, randomized in error|1
2867806|NCT02115815|9862982|P5|Overall Study|Missed appointment, randomized in error|0
2867807|NCT02115815|9862983|P4|Overall Study|Missed appointment, randomized in error|0
2867808|NCT02115815|9862984|P3|Overall Study|Missed appointment, randomized in error|0
2867809|NCT02115815|9862985|P2|Overall Study|Missed appointment, randomized in error|0
2867810|NCT02115815|9862986|P1|Overall Study|Missed appointment, randomized in error|0
2867811|NCT02115815|9862980|P7|Overall Study|Not enough drug to dose participant|0
2867812|NCT02115815|9862981|P6|Overall Study|Not enough drug to dose participant|1
2867813|NCT02115815|9862982|P5|Overall Study|Not enough drug to dose participant|0
2867814|NCT02115815|9862983|P4|Overall Study|Not enough drug to dose participant|0
2867815|NCT02115815|9862984|P3|Overall Study|Not enough drug to dose participant|0
2867816|NCT02115815|9862985|P2|Overall Study|Not enough drug to dose participant|0
2867817|NCT02115815|9862986|P1|Overall Study|Not enough drug to dose participant|0
2867818|NCT02115815|9862980|P7|Overall Study|Withdrawal by Subject|0
2867819|NCT02115815|9862981|P6|Overall Study|Withdrawal by Subject|0
2867820|NCT02115815|9862982|P5|Overall Study|Withdrawal by Subject|0
2867821|NCT02115815|9862983|P4|Overall Study|Withdrawal by Subject|0
2867822|NCT02115815|9862984|P3|Overall Study|Withdrawal by Subject|0
2867823|NCT02115815|9862985|P2|Overall Study|Withdrawal by Subject|0
2867824|NCT02115815|9862986|P1|Overall Study|Withdrawal by Subject|2
2867825|NCT02115607|9863128|P1|Overall Study|Withdrawal by Subject|1
2867826|NCT02115386|9863154|P1|Overall Study|Administrative - trial was terminated|6
2867827|NCT02115386|9863154|P1|Overall Study|Protocol Violation|1
2867828|NCT02115321|9863257|P2|Overall Study|Death|0
2867829|NCT02115321|9863258|P1|Overall Study|Death|1
2867830|NCT02115308|9863280|P2|Overall Study|Safety Screening|2
2867831|NCT02115308|9863281|P1|Overall Study|Safety Screening|2
2867832|NCT02115269|9863297|P1|Overall Study|Didn't take study drug|2
2867833|NCT02115269|9863297|P1|Overall Study|Withdrawal by Subject|2
2867834|NCT02115269|9863297|P1|Overall Study|Moved to another city|7
2867835|NCT02115269|9863297|P1|Overall Study|Did not complete patient diary|3
2867836|NCT02115269|9863297|P1|Overall Study|Lost to Follow-up|43
2867837|NCT02115256|9863317|P2|Overall Study|Withdrawal by Subject|1
2867838|NCT02115256|9863318|P1|Overall Study|Withdrawal by Subject|0
2867839|NCT02115113|9863330|P3|Participants Randomized|Death|0
2867840|NCT02115113|9863331|P2|Participants Randomized|Death|0
2867841|NCT02115113|9863332|P1|Participants Randomized|Death|1
2867842|NCT02115113|9863330|P3|Participants Randomized|Lost to Follow-up|0
2867843|NCT02115113|9863331|P2|Participants Randomized|Lost to Follow-up|0
2867844|NCT02115113|9863332|P1|Participants Randomized|Lost to Follow-up|1
2867845|NCT02115113|9863330|P3|Participants in Run-in Period|Withdrawal by Subject|3
2867846|NCT02115113|9863331|P2|Participants in Run-in Period|Withdrawal by Subject|0
2867847|NCT02115113|9863332|P1|Participants in Run-in Period|Withdrawal by Subject|0
2867848|NCT02115113|9863330|P3|Participants in Run-in Period|Lost to Follow-up|5
2867849|NCT02115113|9863331|P2|Participants in Run-in Period|Lost to Follow-up|0
2867850|NCT02115113|9863332|P1|Participants in Run-in Period|Lost to Follow-up|0
2867851|NCT02115113|9863330|P3|Participants in Run-in Period|Administrative problems|1
2867852|NCT02115113|9863331|P2|Participants in Run-in Period|Administrative problems|0
2867853|NCT02115113|9863332|P1|Participants in Run-in Period|Administrative problems|0
2867854|NCT02115113|9863330|P3|Participants in Run-in Period|Death|1
2867855|NCT02115113|9863331|P2|Participants in Run-in Period|Death|0
2867856|NCT02115113|9863332|P1|Participants in Run-in Period|Death|0
2867857|NCT02114931|9863364|P2|Overall Study|Other|1
2867858|NCT02114931|9863365|P1|Overall Study|Other|2
2867859|NCT02114931|9863364|P2|Overall Study|Physician Decision|2
2867860|NCT02114931|9863365|P1|Overall Study|Physician Decision|1
2867861|NCT02114931|9863364|P2|Overall Study|Lost to Follow-up|3
2867862|NCT02114931|9863365|P1|Overall Study|Lost to Follow-up|3
2867863|NCT02114931|9863364|P2|Overall Study|Adverse Event|6
2867864|NCT02114931|9863365|P1|Overall Study|Adverse Event|4
2867865|NCT02114931|9863364|P2|Overall Study|Withdrawal by Subject|18
2867866|NCT02114931|9863365|P1|Overall Study|Withdrawal by Subject|15
2867867|NCT02114892|9863381|P2|Overall Study|Lost to Follow-up|2
2867868|NCT02114892|9863382|P1|Overall Study|Lost to Follow-up|1
2867869|NCT02114697|9863418|P2|Overall Study|Study terminated|4
2867870|NCT02114697|9863419|P1|Overall Study|Study terminated|5
2867871|NCT02114684|9863427|P2|Overall Study|Patient Incarcerated|0
2867872|NCT02114684|9863428|P1|Overall Study|Patient Incarcerated|1
2867873|NCT02114684|9863427|P2|Overall Study|Rifampicin resistant on culture|1
2867874|NCT02114684|9863428|P1|Overall Study|Rifampicin resistant on culture|0
2867875|NCT02114684|9863427|P2|Overall Study|Relocation|1
2867876|NCT02114684|9863428|P1|Overall Study|Relocation|3
2867877|NCT02114684|9863427|P2|Overall Study|Withdrawal by Subject|2
2867878|NCT02114684|9863428|P1|Overall Study|Withdrawal by Subject|1
2867879|NCT02114684|9863427|P2|Overall Study|Lost to Follow-up|2
2867880|NCT02114684|9863428|P1|Overall Study|Lost to Follow-up|1
2867881|NCT02114684|9863427|P2|Overall Study|Death|4
2867882|NCT02114684|9863428|P1|Overall Study|Death|6
2867883|NCT02114515|9863446|P2|Overall Study|Other|61
2867884|NCT02114515|9863447|P1|Overall Study|Other|65
2867885|NCT02114515|9863446|P2|Overall Study|Withdrawal by Subject|22
2867886|NCT02114515|9863447|P1|Overall Study|Withdrawal by Subject|4
2867887|NCT02114515|9863446|P2|Overall Study|Death|12
2867888|NCT02114515|9863447|P1|Overall Study|Death|12
2867889|NCT02114515|9863446|P2|Overall Study|Lost to Follow-up|55
2867890|NCT02114515|9863447|P1|Overall Study|Lost to Follow-up|52
2867891|NCT02114385|9863493|P2|Overall Study|Lost to Follow-up|6
2867892|NCT02114385|9863494|P1|Overall Study|Lost to Follow-up|0
2867893|NCT02114385|9863493|P2|Overall Study|Withdrawal by Subject|2
2867894|NCT02114385|9863494|P1|Overall Study|Withdrawal by Subject|3
2867895|NCT02114268|9863535|P6|Overall Study|Withdrawn by site due to noncompliance|0
2867896|NCT02114268|9863536|P5|Overall Study|Withdrawn by site due to noncompliance|0
2867897|NCT02114268|9863537|P4|Overall Study|Withdrawn by site due to noncompliance|0
2867898|NCT02114268|9863538|P3|Overall Study|Withdrawn by site due to noncompliance|0
2867899|NCT02114268|9863539|P2|Overall Study|Withdrawn by site due to noncompliance|0
2867900|NCT02114268|9863540|P1|Overall Study|Withdrawn by site due to noncompliance|1
2867901|NCT02114268|9863535|P6|Overall Study|Withdrawal by Subject|1
2867902|NCT02114268|9863536|P5|Overall Study|Withdrawal by Subject|0
2867903|NCT02114268|9863537|P4|Overall Study|Withdrawal by Subject|0
2867904|NCT02114268|9863538|P3|Overall Study|Withdrawal by Subject|0
2867905|NCT02114268|9863539|P2|Overall Study|Withdrawal by Subject|0
2867906|NCT02114268|9863540|P1|Overall Study|Withdrawal by Subject|1
2867907|NCT02114268|9863535|P6|Overall Study|Lost to Follow-up|2
2867908|NCT02114268|9863536|P5|Overall Study|Lost to Follow-up|0
2867909|NCT02114268|9863537|P4|Overall Study|Lost to Follow-up|0
2867910|NCT02114268|9863538|P3|Overall Study|Lost to Follow-up|1
2867911|NCT02114268|9863539|P2|Overall Study|Lost to Follow-up|1
2867912|NCT02114268|9863540|P1|Overall Study|Lost to Follow-up|4
2867913|NCT02114203|9863609|P3|Overall Study|Withdrawal by Subject|0
2867914|NCT02114203|9863610|P2|Overall Study|Withdrawal by Subject|1
2867915|NCT02114203|9863611|P1|Overall Study|Withdrawal by Subject|0
2867916|NCT02114203|9863609|P3|Overall Study|Adverse Event|0
2867917|NCT02114203|9863610|P2|Overall Study|Adverse Event|1
2867918|NCT02114203|9863611|P1|Overall Study|Adverse Event|0
2867919|NCT02114177|9863645|P2|Overall Study|Other|1
2867920|NCT02114177|9863646|P1|Overall Study|Other|2
2867921|NCT02114177|9863645|P2|Overall Study|Withdrawal by Subject|1
2867922|NCT02114177|9863646|P1|Overall Study|Withdrawal by Subject|6
2867923|NCT02114177|9863645|P2|Overall Study|Lost to Follow-up|2
2867924|NCT02114177|9863646|P1|Overall Study|Lost to Follow-up|1
2867925|NCT02114151|9863670|P1|Overall Study|Withdrawal by Subject|5
2867926|NCT02114151|9863670|P1|Overall Study|Lost to Follow-up|1
2867927|NCT02114151|9863670|P1|Overall Study|Death|1
2867928|NCT02113956|9863687|P2|3 Month Post-intervention|Lost to Follow-up|2
2867929|NCT02113956|9863688|P1|3 Month Post-intervention|Lost to Follow-up|4
2867930|NCT02113956|9863687|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
2867931|NCT02113956|9863688|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
2867932|NCT02113956|9863687|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
2867933|NCT02113956|9863688|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
2867934|NCT02113579|9863722|P2|Overall Study|Lost to Follow-up|2
2867935|NCT02113579|9863723|P1|Overall Study|Lost to Follow-up|6
2867936|NCT02113579|9863722|P2|Overall Study|Withdrawal by Subject|2
2867937|NCT02113579|9863723|P1|Overall Study|Withdrawal by Subject|3
2867938|NCT02113579|9863722|P2|Overall Study|Adverse Event|0
2867939|NCT02113579|9863723|P1|Overall Study|Adverse Event|1
2867940|NCT02113449|9863747|P1|Overall Study|Adverse Event|4
2867941|NCT02113436|9863763|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
2867942|NCT02113436|9863764|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
2867943|NCT02113436|9863765|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
2867944|NCT02113436|9863766|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
2867945|NCT02113436|9863763|P4|Period 2: 16 Weeks|Physician Decision|0
2867946|NCT02113436|9863764|P3|Period 2: 16 Weeks|Physician Decision|2
2867947|NCT02113436|9863765|P2|Period 2: 16 Weeks|Physician Decision|0
2867948|NCT02113436|9863766|P1|Period 2: 16 Weeks|Physician Decision|0
2867949|NCT02113436|9863763|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
2867950|NCT02113436|9863764|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
2867951|NCT02113436|9863765|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2867952|NCT02113436|9863766|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2867953|NCT02113436|9863763|P4|Period 2: 16 Weeks|Adverse Event|5
2867954|NCT02113436|9863764|P3|Period 2: 16 Weeks|Adverse Event|4
2867955|NCT02113436|9863765|P2|Period 2: 16 Weeks|Adverse Event|0
2867956|NCT02113436|9863766|P1|Period 2: 16 Weeks|Adverse Event|0
2867957|NCT02113436|9863763|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
2867958|NCT02113436|9863764|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
2867959|NCT02113436|9863765|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
2867960|NCT02113436|9863766|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
2867961|NCT02113436|9863763|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2867962|NCT02113436|9863764|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2867963|NCT02113436|9863765|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
2867964|NCT02113436|9863766|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
2867965|NCT02113436|9863763|P4|Period 1: 8 Weeks|Protocol Violation|0
2867966|NCT02113436|9863764|P3|Period 1: 8 Weeks|Protocol Violation|0
2867967|NCT02113436|9863765|P2|Period 1: 8 Weeks|Protocol Violation|0
2867968|NCT02113436|9863766|P1|Period 1: 8 Weeks|Protocol Violation|1
2867969|NCT02113436|9863763|P4|Period 1: 8 Weeks|Adverse Event|0
2867970|NCT02113436|9863764|P3|Period 1: 8 Weeks|Adverse Event|0
2867971|NCT02113436|9863765|P2|Period 1: 8 Weeks|Adverse Event|0
2867972|NCT02113436|9863766|P1|Period 1: 8 Weeks|Adverse Event|1
2867973|NCT02113189|9863817|P3|Overall Study|Lost to follow up|3
2867974|NCT02113189|9863818|P2|Overall Study|Lost to follow up|1
2867975|NCT02113189|9863819|P1|Overall Study|Lost to follow up|2
2867976|NCT02113124|9863835|P2|Overall Study|Unable to retrieve blood sample|1
2867977|NCT02113124|9863836|P1|Overall Study|Unable to retrieve blood sample|1
2867978|NCT02113007|9863842|P1|Overall Study|Progressive disease|2
2867979|NCT02112994|9863848|P3|Overall Study|Withdrawal by Subject|1
2867980|NCT02112994|9863849|P2|Overall Study|Withdrawal by Subject|0
2867981|NCT02112994|9863850|P1|Overall Study|Withdrawal by Subject|0
2867982|NCT02112994|9863848|P3|Overall Study|Liver Transplant|0
2867983|NCT02112994|9863849|P2|Overall Study|Liver Transplant|1
2867984|NCT02112994|9863850|P1|Overall Study|Liver Transplant|0
2867985|NCT02112994|9863848|P3|Overall Study|Pregnancy|1
2867986|NCT02112994|9863849|P2|Overall Study|Pregnancy|1
2867987|NCT02112994|9863850|P1|Overall Study|Pregnancy|0
2867988|NCT02112994|9863848|P3|Overall Study|Progressive Disease|1
2867989|NCT02112994|9863849|P2|Overall Study|Progressive Disease|0
2867990|NCT02112994|9863850|P1|Overall Study|Progressive Disease|0
2867991|NCT02112877|9863868|P2|Overall Study|Visit Missed|6
2867992|NCT02112877|9863869|P1|Overall Study|Visit Missed|1
2867993|NCT02112877|9863868|P2|Overall Study|Withdrawal by Subject|7
2867994|NCT02112877|9863869|P1|Overall Study|Withdrawal by Subject|1
2867995|NCT02112448|9863948|P2|Overall Study|required heparin so could not use ketoro|0
2867996|NCT02112448|9863949|P1|Overall Study|required heparin so could not use ketoro|1
2867997|NCT02112448|9863948|P2|Overall Study|Physician Decision|6
2867998|NCT02112448|9863949|P1|Overall Study|Physician Decision|4
2867999|NCT02112448|9863948|P2|Overall Study|Protocol Violation|2
2868000|NCT02112448|9863949|P1|Overall Study|Protocol Violation|1
2868001|NCT02112448|9863948|P2|Overall Study|lab values precluding use of ketorolac|2
2868002|NCT02112448|9863949|P1|Overall Study|lab values precluding use of ketorolac|2
2868003|NCT02112045|9863982|P2|Overall Study|Withdrawal by Subject|0
2868004|NCT02112045|9863983|P1|Overall Study|Withdrawal by Subject|1
2868005|NCT02111993|9864003|P2|Overall Study|Physician Decision|4
2868006|NCT02111993|9864004|P1|Overall Study|Physician Decision|5
2868007|NCT02111811|9864045|P2|Follow up Period (Aim 2)|Death|0
2868008|NCT02111811|9864046|P1|Follow up Period (Aim 2)|Death|2
2868009|NCT02111811|9864045|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
2868010|NCT02111811|9864046|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
2868011|NCT02111811|9864045|P2|Treatment Phase|Death|0
2868012|NCT02111811|9864046|P1|Treatment Phase|Death|2
2868013|NCT02111811|9864045|P2|Treatment Phase|Lost to Follow-up|18
2868014|NCT02111811|9864046|P1|Treatment Phase|Lost to Follow-up|22
2868015|NCT02111785|9864059|P4|Overall Study|Death|0
2868016|NCT02111785|9864060|P3|Overall Study|Death|0
2868017|NCT02111785|9864061|P2|Overall Study|Death|1
2868018|NCT02111785|9864062|P1|Overall Study|Death|0
2868019|NCT02111603|9864124|P1|Overall Study|Withdrawal by Subject|1
2868020|NCT02111564|9864135|P2|Overall Study|Withdrawal by Subject|20
2868021|NCT02111564|9864136|P1|Overall Study|Withdrawal by Subject|20
2868022|NCT02111564|9864135|P2|Overall Study|Lost to Follow-up|3
2868023|NCT02111564|9864136|P1|Overall Study|Lost to Follow-up|2
2868024|NCT02111564|9864135|P2|Overall Study|Death|120
2868025|NCT02111564|9864136|P1|Overall Study|Death|109
2868026|NCT02111369|9864175|P1|Overall Study|Withdrawal by Subject|1
2868027|NCT02111369|9864175|P1|Overall Study|Lost to Follow-up|2
2868028|NCT02111213|9864199|P2|Overall Study|Lost to Follow-up|4
2868029|NCT02111213|9864200|P1|Overall Study|Lost to Follow-up|3
2868030|NCT02111213|9864199|P2|Overall Study|Withdrawal by Subject|2
2868031|NCT02111213|9864200|P1|Overall Study|Withdrawal by Subject|3
2868032|NCT02111174|9864244|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
2868033|NCT02111174|9864245|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
2868034|NCT02111174|9864244|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
2868035|NCT02111174|9864245|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
2868036|NCT02111174|9864244|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
2868037|NCT02111174|9864245|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
2868038|NCT02111174|9864244|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
2868039|NCT02111174|9864245|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
2868040|NCT02111096|9864274|P3|Overall Study|Withdrawal by Subject|8
2868041|NCT02111096|9864275|P2|Overall Study|Withdrawal by Subject|2
2868042|NCT02111096|9864276|P1|Overall Study|Withdrawal by Subject|4
2868043|NCT02111096|9864274|P3|Overall Study|Terminated by Sponsor|54
2868044|NCT02111096|9864275|P2|Overall Study|Terminated by Sponsor|35
2868045|NCT02111096|9864276|P1|Overall Study|Terminated by Sponsor|53
2868046|NCT02111096|9864274|P3|Overall Study|Protocol Violation|1
2868047|NCT02111096|9864275|P2|Overall Study|Protocol Violation|0
2868048|NCT02111096|9864276|P1|Overall Study|Protocol Violation|1
2868049|NCT02111096|9864274|P3|Overall Study|Physician Decision|0
2868050|NCT02111096|9864275|P2|Overall Study|Physician Decision|1
2868051|NCT02111096|9864276|P1|Overall Study|Physician Decision|0
2868052|NCT02111096|9864274|P3|Overall Study|Lost to Follow Up|1
2868053|NCT02111096|9864275|P2|Overall Study|Lost to Follow Up|1
2868054|NCT02111096|9864276|P1|Overall Study|Lost to Follow Up|1
2868055|NCT02111096|9864274|P3|Overall Study|Non-Compliance with Study Drug|0
2868056|NCT02111096|9864275|P2|Overall Study|Non-Compliance with Study Drug|1
2868057|NCT02111096|9864276|P1|Overall Study|Non-Compliance with Study Drug|1
2868058|NCT02111096|9864274|P3|Overall Study|Adverse Event|2
2868059|NCT02111096|9864275|P2|Overall Study|Adverse Event|1
2868060|NCT02111096|9864276|P1|Overall Study|Adverse Event|4
2868061|NCT02111083|9864324|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
2868062|NCT02111083|9864325|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
2868063|NCT02110901|9864345|P2|Overall Study|received a kidney transplant|0
2868064|NCT02110901|9864346|P1|Overall Study|received a kidney transplant|5
2868065|NCT02110901|9864345|P2|Overall Study|Withdrawal by Subject|3
2868066|NCT02110901|9864346|P1|Overall Study|Withdrawal by Subject|7
2868067|NCT02110901|9864345|P2|Overall Study|Lost to Follow-up|8
2868068|NCT02110901|9864346|P1|Overall Study|Lost to Follow-up|12
2868069|NCT02110901|9864345|P2|Overall Study|Death|3
2868070|NCT02110901|9864346|P1|Overall Study|Death|6
2868071|NCT02110706|9864360|P2|Overall Study|Patients who didn't receive 2nd infusion|1
2868072|NCT02110706|9864361|P1|Overall Study|Patients who didn't receive 2nd infusion|3
2868073|NCT02110706|9864360|P2|Overall Study|Adverse Event|3
2868074|NCT02110706|9864361|P1|Overall Study|Adverse Event|2
2868075|NCT02110693|9864373|P2|Overall Study|Other|0
2868076|NCT02110693|9864374|P1|Overall Study|Other|1
2868077|NCT02110693|9864373|P2|Overall Study|technical difficulties|4
2868078|NCT02110693|9864374|P1|Overall Study|technical difficulties|6
2868079|NCT02110693|9864373|P2|Overall Study|skipped assessment|18
2868080|NCT02110693|9864374|P1|Overall Study|skipped assessment|15
2868081|NCT02110693|9864373|P2|Overall Study|Withdrawal by Subject|7
2868082|NCT02110693|9864374|P1|Overall Study|Withdrawal by Subject|6
2868083|NCT02110238|9864455|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
2868084|NCT02110238|9864456|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
2868085|NCT02110238|9864455|P2|14 Week Blinded Extension Phase|Protocol Violation|3
2868086|NCT02110238|9864456|P1|14 Week Blinded Extension Phase|Protocol Violation|2
2868087|NCT02110238|9864455|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
2868088|NCT02110238|9864456|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
2868089|NCT02110238|9864455|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
2868090|NCT02110238|9864456|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
2868091|NCT02110238|9864455|P2|14 Week Blinded Extension Phase|Adverse Event|1
2868092|NCT02110238|9864456|P1|14 Week Blinded Extension Phase|Adverse Event|1
2868093|NCT02110238|9864455|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
2868094|NCT02110238|9864456|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
2868095|NCT02110238|9864455|P2|12 Week Pivotal Phase|Protocol Violation|1
2868096|NCT02110238|9864456|P1|12 Week Pivotal Phase|Protocol Violation|0
2868097|NCT02110238|9864455|P2|12 Week Pivotal Phase|Physician Decision|2
2868098|NCT02110238|9864456|P1|12 Week Pivotal Phase|Physician Decision|0
2868099|NCT02110238|9864455|P2|12 Week Pivotal Phase|Lost to Follow-up|0
2868100|NCT02110238|9864456|P1|12 Week Pivotal Phase|Lost to Follow-up|2
2868101|NCT02110238|9864455|P2|12 Week Pivotal Phase|Lack of Efficacy|3
2868102|NCT02110238|9864456|P1|12 Week Pivotal Phase|Lack of Efficacy|2
2868103|NCT02110238|9864455|P2|12 Week Pivotal Phase|Adverse Event|0
2868104|NCT02110238|9864456|P1|12 Week Pivotal Phase|Adverse Event|3
2868105|NCT02110225|9864465|P3|Overall Study|Lost to Follow-up|0
2868106|NCT02110225|9864466|P2|Overall Study|Lost to Follow-up|1
2868107|NCT02110225|9864467|P1|Overall Study|Lost to Follow-up|0
2868108|NCT02109562|9864577|P3|Overall Study|Physician Decision|5
2868109|NCT02109562|9864578|P2|Overall Study|Physician Decision|4
2868110|NCT02109562|9864579|P1|Overall Study|Physician Decision|3
2868111|NCT02109562|9864577|P3|Overall Study|Withdrawal by Subject|21
2868112|NCT02109562|9864578|P2|Overall Study|Withdrawal by Subject|25
2868113|NCT02109562|9864579|P1|Overall Study|Withdrawal by Subject|20
2868114|NCT02109562|9864577|P3|Overall Study|Protocol Violation|1
2868115|NCT02109562|9864578|P2|Overall Study|Protocol Violation|3
2868116|NCT02109562|9864579|P1|Overall Study|Protocol Violation|0
2868117|NCT02109562|9864577|P3|Overall Study|Lost to Follow-up|1
2868118|NCT02109562|9864578|P2|Overall Study|Lost to Follow-up|0
2868119|NCT02109562|9864579|P1|Overall Study|Lost to Follow-up|1
2868120|NCT02109562|9864577|P3|Overall Study|Adverse Event|3
2868121|NCT02109562|9864578|P2|Overall Study|Adverse Event|2
2868122|NCT02109562|9864579|P1|Overall Study|Adverse Event|0
2868123|NCT02109562|9864577|P3|Overall Study|Insufficient clinical response|4
2868124|NCT02109562|9864578|P2|Overall Study|Insufficient clinical response|0
2868125|NCT02109562|9864579|P1|Overall Study|Insufficient clinical response|2
2868126|NCT02109484|9864606|P8|Overall Study|Moved away from study area|1
2868127|NCT02109484|9864607|P7|Overall Study|Moved away from study area|1
2868128|NCT02109484|9864608|P6|Overall Study|Moved away from study area|0
2868129|NCT02109484|9864609|P5|Overall Study|Moved away from study area|0
2868130|NCT02109484|9864610|P4|Overall Study|Moved away from study area|0
2868131|NCT02109484|9864611|P3|Overall Study|Moved away from study area|0
2868132|NCT02109484|9864612|P2|Overall Study|Moved away from study area|0
2868133|NCT02109484|9864613|P1|Overall Study|Moved away from study area|0
2868134|NCT02109484|9864606|P8|Overall Study|Death|2
2868135|NCT02109484|9864607|P7|Overall Study|Death|0
2868136|NCT02109484|9864608|P6|Overall Study|Death|0
2868137|NCT02109484|9864609|P5|Overall Study|Death|0
2868138|NCT02109484|9864610|P4|Overall Study|Death|0
2868139|NCT02109484|9864611|P3|Overall Study|Death|0
2868140|NCT02109484|9864612|P2|Overall Study|Death|0
2868141|NCT02109484|9864613|P1|Overall Study|Death|0
2868142|NCT02109484|9864606|P8|Overall Study|Physician Decision|0
2868143|NCT02109484|9864607|P7|Overall Study|Physician Decision|0
2868144|NCT02109484|9864608|P6|Overall Study|Physician Decision|0
2868145|NCT02109484|9864609|P5|Overall Study|Physician Decision|2
2868146|NCT02109484|9864610|P4|Overall Study|Physician Decision|0
2868147|NCT02109484|9864611|P3|Overall Study|Physician Decision|0
2868148|NCT02109484|9864612|P2|Overall Study|Physician Decision|0
2868149|NCT02109484|9864613|P1|Overall Study|Physician Decision|0
2868150|NCT02109484|9864606|P8|Overall Study|Withdrawal by Subject|0
2868151|NCT02109484|9864607|P7|Overall Study|Withdrawal by Subject|1
2868152|NCT02109484|9864608|P6|Overall Study|Withdrawal by Subject|1
2868153|NCT02109484|9864609|P5|Overall Study|Withdrawal by Subject|1
2868154|NCT02109484|9864610|P4|Overall Study|Withdrawal by Subject|0
2868155|NCT02109484|9864611|P3|Overall Study|Withdrawal by Subject|0
2868156|NCT02109484|9864612|P2|Overall Study|Withdrawal by Subject|0
2868157|NCT02109484|9864613|P1|Overall Study|Withdrawal by Subject|0
2868158|NCT02109484|9864606|P8|Overall Study|Lost to Follow-up|0
2868159|NCT02109484|9864607|P7|Overall Study|Lost to Follow-up|1
2868160|NCT02109484|9864608|P6|Overall Study|Lost to Follow-up|0
2868161|NCT02109484|9864609|P5|Overall Study|Lost to Follow-up|1
2868162|NCT02109484|9864610|P4|Overall Study|Lost to Follow-up|1
2868163|NCT02109484|9864611|P3|Overall Study|Lost to Follow-up|0
2868164|NCT02109484|9864612|P2|Overall Study|Lost to Follow-up|0
2868165|NCT02109484|9864613|P1|Overall Study|Lost to Follow-up|0
2868166|NCT02109445|9864669|P1|Overall Study|Adverse Event|1
2868167|NCT02109445|9864669|P1|Overall Study|Symptomatic deterioration|2
2868168|NCT02109432|9864702|P1|Overall Study|Withdrawal by Subject|1
2868169|NCT02109172|9864712|P6|Overall Study|Death|0
2868170|NCT02109172|9864713|P5|Overall Study|Death|1
2868171|NCT02109172|9864714|P4|Overall Study|Death|0
2868172|NCT02109172|9864715|P3|Overall Study|Death|0
2868173|NCT02109172|9864716|P2|Overall Study|Death|0
2868174|NCT02109172|9864717|P1|Overall Study|Death|0
2868175|NCT02109172|9864712|P6|Overall Study|Adverse Event|1
2868176|NCT02109172|9864713|P5|Overall Study|Adverse Event|0
2868177|NCT02109172|9864714|P4|Overall Study|Adverse Event|0
2868178|NCT02109172|9864715|P3|Overall Study|Adverse Event|1
2868179|NCT02109172|9864716|P2|Overall Study|Adverse Event|0
2868180|NCT02109172|9864717|P1|Overall Study|Adverse Event|0
2868181|NCT02109172|9864712|P6|Overall Study|Withdrawal by Subject|0
2868182|NCT02109172|9864713|P5|Overall Study|Withdrawal by Subject|0
2868183|NCT02109172|9864714|P4|Overall Study|Withdrawal by Subject|1
2868184|NCT02109172|9864715|P3|Overall Study|Withdrawal by Subject|0
2868185|NCT02109172|9864716|P2|Overall Study|Withdrawal by Subject|0
2868186|NCT02109172|9864717|P1|Overall Study|Withdrawal by Subject|1
2868187|NCT02109133|9864738|P2|Overall Study|Lost to Follow-up|0
2868188|NCT02109133|9864739|P1|Overall Study|Lost to Follow-up|1
2868189|NCT02109107|9864751|P1|Overall Study|Lost to Follow-up|2
2868190|NCT02109042|9864758|P1|Overall Study|Sponsor Decision|15
2868191|NCT02109029|9864767|P6|Part B|Adverse Event|1
2868192|NCT02109029|9864768|P5|Part B|Adverse Event|1
2868193|NCT02109029|9864769|P4|Part B|Adverse Event|0
2868194|NCT02109029|9864770|P3|Part B|Adverse Event|0
2868195|NCT02109029|9864771|P2|Part B|Adverse Event|0
2868196|NCT02109029|9864772|P1|Part B|Adverse Event|0
2868197|NCT02108951|9864801|P1|Overall Study|Study Terminated by Sponsor|14
2868198|NCT02108951|9864801|P1|Overall Study|Patient's/guardian's decision|1
2868199|NCT02108951|9864801|P1|Overall Study|Lost to Follow-up|1
2868200|NCT02108912|9864820|P2|Overall Study|high blood pressure|0
2868201|NCT02108912|9864821|P1|Overall Study|high blood pressure|1
2868202|NCT02108912|9864820|P2|Overall Study|lack of transportation|0
2868203|NCT02108912|9864821|P1|Overall Study|lack of transportation|1
2868204|NCT02108912|9864820|P2|Overall Study|Lost to Follow-up|1
2868205|NCT02108912|9864821|P1|Overall Study|Lost to Follow-up|1
2868206|NCT02108652|9864850|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
2868207|NCT02108652|9864850|P1|Overall Study|Withdrawal by Subject|8
2868208|NCT02108652|9864850|P1|Overall Study|Lost to Follow-up|2
2868209|NCT02108652|9864850|P1|Overall Study|Death|226
2868210|NCT02107898|9865028|P2|Overall Study|Randomized but not treated|1
2868211|NCT02107898|9865029|P1|Overall Study|Randomized but not treated|0
2868212|NCT02107898|9865028|P2|Overall Study|Consent withdrawn by participant|1
2868213|NCT02107898|9865029|P1|Overall Study|Consent withdrawn by participant|2
2868214|NCT02107898|9865028|P2|Overall Study|Participant moved|2
2868215|NCT02107898|9865029|P1|Overall Study|Participant moved|0
2868216|NCT02107898|9865028|P2|Overall Study|Poor compliance to protocol|1
2868217|NCT02107898|9865029|P1|Overall Study|Poor compliance to protocol|0
2868218|NCT02107898|9865028|P2|Overall Study|Adverse Event|7
2868219|NCT02107898|9865029|P1|Overall Study|Adverse Event|4
2868220|NCT02107859|9865081|P1|Overall Study|Other than specified|3
2868221|NCT02107859|9865081|P1|Overall Study|Study closure|41
2868222|NCT02107859|9865081|P1|Overall Study|Adverse Event|3
2868223|NCT02107859|9865081|P1|Overall Study|Withdrawal by Subject|14
2868224|NCT02107703|9865097|P2|Overall Study|On study treatment/follow up|152
2868225|NCT02107703|9865098|P1|Overall Study|On study treatment/follow up|319
2868226|NCT02107703|9865097|P2|Overall Study|Lost to Follow-up|4
2868227|NCT02107703|9865098|P1|Overall Study|Lost to Follow-up|6
2868228|NCT02107703|9865097|P2|Overall Study|Withdrawal by Subject|19
2868229|NCT02107703|9865098|P1|Overall Study|Withdrawal by Subject|36
2868230|NCT02107482|9865130|P1|Overall Study|Lack of Efficacy|1
2868231|NCT02107482|9865130|P1|Overall Study|Lost to Follow-up|1
2868232|NCT02107482|9865130|P1|Overall Study|inconveinence|2
2868233|NCT02107443|9865138|P2|Overall Study|Withdrawal: Personal Issues|3
2868234|NCT02107443|9865139|P1|Overall Study|Withdrawal: Personal Issues|0
2868235|NCT02107443|9865138|P2|Overall Study|Withdrawal: Disease Progression|2
2868236|NCT02107443|9865139|P1|Overall Study|Withdrawal: Disease Progression|4
2868237|NCT02107443|9865138|P2|Overall Study|Withdrawal: Other Medical|5
2868238|NCT02107443|9865139|P1|Overall Study|Withdrawal: Other Medical|9
2868239|NCT02107443|9865138|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
2868240|NCT02107443|9865139|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
2868241|NCT02107443|9865138|P2|Overall Study|Withdrawal: Too Time Consuming|6
2868242|NCT02107443|9865139|P1|Overall Study|Withdrawal: Too Time Consuming|3
2868243|NCT02107443|9865138|P2|Overall Study|Withdrawal: Too Many Forms|1
2868244|NCT02107443|9865139|P1|Overall Study|Withdrawal: Too Many Forms|3
2868245|NCT02107443|9865138|P2|Overall Study|Withdrawal: Changed MD/Facility|3
2868246|NCT02107443|9865139|P1|Overall Study|Withdrawal: Changed MD/Facility|1
2868247|NCT02107443|9865138|P2|Overall Study|Withdrawal: Changed Mind|0
2868248|NCT02107443|9865139|P1|Overall Study|Withdrawal: Changed Mind|2
2868249|NCT02107443|9865138|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
2868250|NCT02107443|9865139|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
2868251|NCT02107443|9865138|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
2868252|NCT02107443|9865139|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
2868253|NCT02107443|9865138|P2|Overall Study|Registered but Not Eligible|1
2868254|NCT02107443|9865139|P1|Overall Study|Registered but Not Eligible|0
2868255|NCT02107443|9865138|P2|Overall Study|Study Protocol Violation|1
2868256|NCT02107443|9865139|P1|Overall Study|Study Protocol Violation|3
2868257|NCT02107443|9865138|P2|Overall Study|Death|30
2868258|NCT02107443|9865139|P1|Overall Study|Death|42
2868259|NCT02107313|9865186|P2|Overall Study|One participant did not do the FED cohor|1
2868260|NCT02107313|9865187|P1|Overall Study|One participant did not do the FED cohor|0
2868261|NCT02107274|9865208|P2|Control Phase|Adverse Event|1
2868262|NCT02107274|9865209|P1|Control Phase|Adverse Event|0
2868263|NCT02107274|9865208|P2|Control Phase|Death|0
2868264|NCT02107274|9865209|P1|Control Phase|Death|2
2868265|NCT02107274|9865208|P2|Control Phase|Lost to Follow-up|1
2868266|NCT02107274|9865209|P1|Control Phase|Lost to Follow-up|1
2868267|NCT02107274|9865208|P2|Treatment vs. Placebo|Lost to Follow-up|2
2868268|NCT02107274|9865209|P1|Treatment vs. Placebo|Lost to Follow-up|0
2868269|NCT02107274|9865208|P2|Treatment vs. Placebo|Adverse Event|0
2868270|NCT02107274|9865209|P1|Treatment vs. Placebo|Adverse Event|3
2868271|NCT02107196|9865223|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
2868272|NCT02107196|9865224|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
2868273|NCT02107196|9865223|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
2868274|NCT02107196|9865224|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
2868275|NCT02107196|9865223|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
2868276|NCT02107196|9865224|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
2868277|NCT02107196|9865223|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
2868278|NCT02107196|9865224|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
2868279|NCT02107196|9865223|P2|12-week Treatment Period|Reason Missing|8
2868280|NCT02107196|9865224|P1|12-week Treatment Period|Reason Missing|11
2868281|NCT02107196|9865223|P2|12-week Treatment Period|Protocol Violation|8
2868282|NCT02107196|9865224|P1|12-week Treatment Period|Protocol Violation|7
2868283|NCT02107196|9865223|P2|12-week Treatment Period|Withdrawal by Subject|12
2868284|NCT02107196|9865224|P1|12-week Treatment Period|Withdrawal by Subject|15
2868285|NCT02107196|9865223|P2|12-week Treatment Period|Physician Decision|1
2868286|NCT02107196|9865224|P1|12-week Treatment Period|Physician Decision|0
2868287|NCT02107196|9865223|P2|12-week Treatment Period|Lost to Follow-up|6
2868288|NCT02107196|9865224|P1|12-week Treatment Period|Lost to Follow-up|3
2868289|NCT02107196|9865223|P2|12-week Treatment Period|Lack of Efficacy|1
2868290|NCT02107196|9865224|P1|12-week Treatment Period|Lack of Efficacy|2
2868291|NCT02107196|9865223|P2|12-week Treatment Period|Adverse Event|3
2868292|NCT02107196|9865224|P1|12-week Treatment Period|Adverse Event|6
2868293|NCT02107131|9865239|P2|Overall Study|Protocol Violation|4
2868294|NCT02107131|9865240|P1|Overall Study|Protocol Violation|0
2868295|NCT02107131|9865239|P2|Overall Study|Death|1
2868296|NCT02107131|9865240|P1|Overall Study|Death|0
2868297|NCT02107131|9865239|P2|Overall Study|mental instability|0
2868298|NCT02107131|9865240|P1|Overall Study|mental instability|1
2868299|NCT02107131|9865239|P2|Overall Study|Withdrawal by Subject|0
2868300|NCT02107131|9865240|P1|Overall Study|Withdrawal by Subject|2
2868301|NCT02107131|9865239|P2|Overall Study|Physician Decision|0
2868302|NCT02107131|9865240|P1|Overall Study|Physician Decision|1
2868303|NCT02107131|9865239|P2|Overall Study|Lost to Follow-up|4
2868304|NCT02107131|9865240|P1|Overall Study|Lost to Follow-up|4
2868305|NCT02107092|9865252|P1|Overall Study|Expected progression of CKD|12
2868306|NCT02107092|9865252|P1|Overall Study|Adverse Event|7
2868307|NCT02107092|9865252|P1|Overall Study|Withdrawal by Subject|9
2868308|NCT02107092|9865252|P1|Overall Study|Lost to Follow-up|2
2868309|NCT02107092|9865252|P1|Overall Study|Physician Decision|3
2868310|NCT02107092|9865252|P1|Overall Study|Met ECG withdrawal criteria|3
2868311|NCT02107092|9865252|P1|Overall Study|Hypo-or hyperkalemia|2
2868312|NCT02107092|9865252|P1|Overall Study|Subject compliance|3
2868313|NCT02107092|9865252|P1|Overall Study|Miscellaneous|3
2868314|NCT02107014|9865257|P1|Overall Study|Withdrew before drug: moving interstate|1
2868315|NCT02106975|9865327|P2|Overall Study|Death|39
2868316|NCT02106975|9865328|P1|Overall Study|Death|25
2868317|NCT02106923|9865388|P6|Overall Study|Protocol Violation|1
2868318|NCT02106923|9865389|P5|Overall Study|Protocol Violation|0
2868319|NCT02106923|9865390|P4|Overall Study|Protocol Violation|0
2868320|NCT02106923|9865391|P3|Overall Study|Protocol Violation|0
2868321|NCT02106923|9865392|P2|Overall Study|Protocol Violation|0
2868322|NCT02106923|9865393|P1|Overall Study|Protocol Violation|0
2868323|NCT02106884|9865439|P2|Overall Study|Change of diagnosis/exclusion|1
2868324|NCT02106884|9865440|P1|Overall Study|Change of diagnosis/exclusion|0
2868325|NCT02106832|9865464|P4|Overall Study|Technical problems|0
2868326|NCT02106832|9865465|P3|Overall Study|Technical problems|0
2868327|NCT02106832|9865466|P2|Overall Study|Technical problems|1
2868328|NCT02106832|9865467|P1|Overall Study|Technical problems|0
2868329|NCT02106832|9865464|P4|Overall Study|Withdrawal by Subject|7
2868330|NCT02106832|9865465|P3|Overall Study|Withdrawal by Subject|10
2868331|NCT02106832|9865466|P2|Overall Study|Withdrawal by Subject|17
2868332|NCT02106832|9865467|P1|Overall Study|Withdrawal by Subject|17
2868333|NCT02106832|9865464|P4|Overall Study|Protocol Violation|1
2868334|NCT02106832|9865465|P3|Overall Study|Protocol Violation|0
2868335|NCT02106832|9865466|P2|Overall Study|Protocol Violation|0
2868336|NCT02106832|9865467|P1|Overall Study|Protocol Violation|0
2868337|NCT02106832|9865464|P4|Overall Study|Physician Decision|0
2868338|NCT02106832|9865465|P3|Overall Study|Physician Decision|0
2868339|NCT02106832|9865466|P2|Overall Study|Physician Decision|0
2868340|NCT02106832|9865467|P1|Overall Study|Physician Decision|1
2868341|NCT02106832|9865464|P4|Overall Study|Lost to Follow-up|3
2868342|NCT02106832|9865465|P3|Overall Study|Lost to Follow-up|1
2868343|NCT02106832|9865466|P2|Overall Study|Lost to Follow-up|1
2868344|NCT02106832|9865467|P1|Overall Study|Lost to Follow-up|0
2868345|NCT02106832|9865464|P4|Overall Study|Deterioration of general conditions|0
2868346|NCT02106832|9865465|P3|Overall Study|Deterioration of general conditions|1
2868347|NCT02106832|9865466|P2|Overall Study|Deterioration of general conditions|0
2868348|NCT02106832|9865467|P1|Overall Study|Deterioration of general conditions|0
2868349|NCT02106832|9865464|P4|Overall Study|Death|4
2868350|NCT02106832|9865465|P3|Overall Study|Death|1
2868351|NCT02106832|9865466|P2|Overall Study|Death|4
2868352|NCT02106832|9865467|P1|Overall Study|Death|4
2868353|NCT02106832|9865464|P4|Overall Study|Adverse Event|0
2868354|NCT02106832|9865465|P3|Overall Study|Adverse Event|3
2868355|NCT02106832|9865466|P2|Overall Study|Adverse Event|2
2868356|NCT02106832|9865467|P1|Overall Study|Adverse Event|1
2868357|NCT02106455|9865534|P1|Overall Study|Protocol Deviation|2
2868358|NCT02106455|9865534|P1|Overall Study|Case Report Form Uncollected|6
2868359|NCT02106442|9865548|P1|Overall Study|Protocol Deviation|30
2868360|NCT02106442|9865548|P1|Overall Study|Case Report Forms Uncollected|7
2868361|NCT02106403|9865566|P6|Follow-Up Visit 3|Other Reason|1
2868362|NCT02106403|9865567|P5|Follow-Up Visit 3|Other Reason|0
2868363|NCT02106403|9865568|P4|Follow-Up Visit 3|Other Reason|0
2868364|NCT02106403|9865569|P3|Follow-Up Visit 3|Other Reason|0
2868365|NCT02106403|9865570|P2|Follow-Up Visit 3|Other Reason|0
2868366|NCT02106403|9865571|P1|Follow-Up Visit 3|Other Reason|0
2868367|NCT02106390|9865594|P3|Overall Study|Protocol Violation|0
2868368|NCT02106390|9865595|P2|Overall Study|Protocol Violation|1
2868369|NCT02106390|9865596|P1|Overall Study|Protocol Violation|0
2868370|NCT02106390|9865594|P3|Overall Study|Adverse Event|1
2868371|NCT02106390|9865595|P2|Overall Study|Adverse Event|2
2868372|NCT02106390|9865596|P1|Overall Study|Adverse Event|0
2868373|NCT02106390|9865594|P3|Overall Study|Other: Unspecified|2
2868374|NCT02106390|9865595|P2|Overall Study|Other: Unspecified|4
2868375|NCT02106390|9865596|P1|Overall Study|Other: Unspecified|1
2868376|NCT02106390|9865594|P3|Overall Study|Other: Administrative Reason|12
2868377|NCT02106390|9865595|P2|Overall Study|Other: Administrative Reason|5
2868378|NCT02106390|9865596|P1|Overall Study|Other: Administrative Reason|8
2868379|NCT02106390|9865594|P3|Overall Study|Lost to Follow-up|13
2868380|NCT02106390|9865595|P2|Overall Study|Lost to Follow-up|20
2868381|NCT02106390|9865596|P1|Overall Study|Lost to Follow-up|25
2868382|NCT02106390|9865594|P3|Overall Study|Withdrawal by Subject|15
2868383|NCT02106390|9865595|P2|Overall Study|Withdrawal by Subject|16
2868384|NCT02106390|9865596|P1|Overall Study|Withdrawal by Subject|15
2868385|NCT02106351|9865673|P3|Treatment Cycle 4|Other|0
2868386|NCT02106351|9865674|P2|Treatment Cycle 4|Other|1
2868387|NCT02106351|9865675|P1|Treatment Cycle 4|Other|0
2868388|NCT02106351|9865673|P3|Treatment Cycle 4|Consent withdrawn|2
2868389|NCT02106351|9865674|P2|Treatment Cycle 4|Consent withdrawn|0
2868390|NCT02106351|9865675|P1|Treatment Cycle 4|Consent withdrawn|0
2868391|NCT02106351|9865673|P3|Treatment Cycle 3|Other|3
2868392|NCT02106351|9865674|P2|Treatment Cycle 3|Other|2
2868393|NCT02106351|9865675|P1|Treatment Cycle 3|Other|0
2868394|NCT02106351|9865673|P3|Treatment Cycle 3|Lost to Follow-up|0
2868395|NCT02106351|9865674|P2|Treatment Cycle 3|Lost to Follow-up|1
2868396|NCT02106351|9865675|P1|Treatment Cycle 3|Lost to Follow-up|0
2868397|NCT02106351|9865673|P3|Treatment Cycle 3|Consent withdrawn|2
2868398|NCT02106351|9865674|P2|Treatment Cycle 3|Consent withdrawn|0
2868399|NCT02106351|9865675|P1|Treatment Cycle 3|Consent withdrawn|0
2868400|NCT02106351|9865673|P3|Treatment Cycle 3|Adverse Event|0
2868401|NCT02106351|9865674|P2|Treatment Cycle 3|Adverse Event|1
2868402|NCT02106351|9865675|P1|Treatment Cycle 3|Adverse Event|0
2868403|NCT02106351|9865673|P3|Treatment Cycle 2|Other|2
2868404|NCT02106351|9865674|P2|Treatment Cycle 2|Other|2
2868405|NCT02106351|9865675|P1|Treatment Cycle 2|Other|0
2868406|NCT02106351|9865673|P3|Treatment Cycle 2|Consent withdrawn|1
2868407|NCT02106351|9865674|P2|Treatment Cycle 2|Consent withdrawn|1
2868408|NCT02106351|9865675|P1|Treatment Cycle 2|Consent withdrawn|0
2868409|NCT02106351|9865673|P3|Treatment Cycle 2|Adverse Event|0
2868410|NCT02106351|9865674|P2|Treatment Cycle 2|Adverse Event|2
2868411|NCT02106351|9865675|P1|Treatment Cycle 2|Adverse Event|0
2868412|NCT02106351|9865673|P3|Treatment Cycle 1|Randomised but not treated|1
2868413|NCT02106351|9865674|P2|Treatment Cycle 1|Randomised but not treated|0
2868414|NCT02106351|9865675|P1|Treatment Cycle 1|Randomised but not treated|1
2868415|NCT02106351|9865673|P3|Treatment Cycle 1|Other|1
2868416|NCT02106351|9865674|P2|Treatment Cycle 1|Other|3
2868417|NCT02106351|9865675|P1|Treatment Cycle 1|Other|0
2868418|NCT02106351|9865673|P3|Treatment Cycle 1|Lost to Follow-up|0
2868419|NCT02106351|9865674|P2|Treatment Cycle 1|Lost to Follow-up|0
2868420|NCT02106351|9865675|P1|Treatment Cycle 1|Lost to Follow-up|1
2868421|NCT02106351|9865673|P3|Treatment Cycle 1|Consent withdrawn|2
2868422|NCT02106351|9865674|P2|Treatment Cycle 1|Consent withdrawn|0
2868423|NCT02106351|9865675|P1|Treatment Cycle 1|Consent withdrawn|1
2868424|NCT02106351|9865673|P3|Treatment Cycle 1|Adverse Event|0
2868425|NCT02106351|9865674|P2|Treatment Cycle 1|Adverse Event|0
2868426|NCT02106351|9865675|P1|Treatment Cycle 1|Adverse Event|2
2868427|NCT02106325|9865718|P2|Phase 3|Lost to Follow-up|1
2868428|NCT02106325|9865719|P1|Phase 3|Lost to Follow-up|2
2868429|NCT02106325|9865718|P2|Phase 2|Lost to Follow-up|3
2868430|NCT02106325|9865719|P1|Phase 2|Lost to Follow-up|2
2868431|NCT02106325|9865718|P2|Phase 1|Lost to Follow-up|2
2868432|NCT02106325|9865719|P1|Phase 1|Lost to Follow-up|2
2868433|NCT02106156|9865744|P3|Overall Study|Relocation/Change of Physician|0
2868434|NCT02106156|9865745|P2|Overall Study|Relocation/Change of Physician|1
2868435|NCT02106156|9865746|P1|Overall Study|Relocation/Change of Physician|40
2868436|NCT02106156|9865744|P3|Overall Study|Hospitalization/Surgical Intervention|0
2868437|NCT02106156|9865745|P2|Overall Study|Hospitalization/Surgical Intervention|0
2868438|NCT02106156|9865746|P1|Overall Study|Hospitalization/Surgical Intervention|6
2868439|NCT02106156|9865744|P3|Overall Study|Change of Laboratory Parameter|0
2868440|NCT02106156|9865745|P2|Overall Study|Change of Laboratory Parameter|0
2868441|NCT02106156|9865746|P1|Overall Study|Change of Laboratory Parameter|10
2868442|NCT02106156|9865744|P3|Overall Study|Unplanned Event|0
2868443|NCT02106156|9865745|P2|Overall Study|Unplanned Event|2
2868444|NCT02106156|9865746|P1|Overall Study|Unplanned Event|82
2868445|NCT02106156|9865744|P3|Overall Study|Lost to Follow-up|0
2868446|NCT02106156|9865745|P2|Overall Study|Lost to Follow-up|8
2868447|NCT02106156|9865746|P1|Overall Study|Lost to Follow-up|451
2868448|NCT02106156|9865744|P3|Overall Study|Patients Request|0
2868449|NCT02106156|9865745|P2|Overall Study|Patients Request|9
2868450|NCT02106156|9865746|P1|Overall Study|Patients Request|307
2868451|NCT02106156|9865744|P3|Overall Study|Lack of Compliance|0
2868452|NCT02106156|9865745|P2|Overall Study|Lack of Compliance|7
2868453|NCT02106156|9865746|P1|Overall Study|Lack of Compliance|211
2868454|NCT02106156|9865744|P3|Overall Study|Concomitant Disease|0
2868455|NCT02106156|9865745|P2|Overall Study|Concomitant Disease|2
2868456|NCT02106156|9865746|P1|Overall Study|Concomitant Disease|74
2868457|NCT02106156|9865744|P3|Overall Study|Lack of Virological Response|0
2868458|NCT02106156|9865745|P2|Overall Study|Lack of Virological Response|8
2868459|NCT02106156|9865746|P1|Overall Study|Lack of Virological Response|1044
2868460|NCT02106156|9865744|P3|Overall Study|Lack of Tolerability|0
2868461|NCT02106156|9865745|P2|Overall Study|Lack of Tolerability|3
2868462|NCT02106156|9865746|P1|Overall Study|Lack of Tolerability|305
2868463|NCT02106156|9865744|P3|Overall Study|Patient Died|0
2868464|NCT02106156|9865745|P2|Overall Study|Patient Died|0
2868465|NCT02106156|9865746|P1|Overall Study|Patient Died|19
2868466|NCT02105987|9865770|P6|Continuation Phase|Protocol Violation|0
2868467|NCT02105987|9865771|P5|Continuation Phase|Protocol Violation|1
2868468|NCT02105987|9865772|P4|Continuation Phase|Protocol Violation|0
2868469|NCT02105987|9865773|P3|Continuation Phase|Protocol Violation|0
2868470|NCT02105987|9865774|P2|Continuation Phase|Protocol Violation|0
2868471|NCT02105987|9865775|P1|Continuation Phase|Protocol Violation|0
2868472|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
2868473|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
2868474|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
2868475|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
2868476|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
2868477|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
2868478|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2868479|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2868480|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
2868481|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2868482|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2868483|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2868484|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
2868485|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
2868486|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
2868487|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
2868488|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
2868489|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
2868490|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2868491|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2868492|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
2868493|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
2868494|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2868495|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2868496|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868497|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868498|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
2868499|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
2868500|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868501|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868502|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
2868503|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
2868504|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
2868505|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
2868506|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
2868507|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
2868508|NCT02105987|9865770|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
2868509|NCT02105987|9865771|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
2868510|NCT02105987|9865772|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
2868511|NCT02105987|9865773|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
2868512|NCT02105987|9865774|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
2868513|NCT02105987|9865775|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
2868514|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2868515|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2868516|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2868517|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2868518|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
2868519|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2868520|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
2868521|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
2868522|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
2868523|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
2868524|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
2868525|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
2868526|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2868527|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2868528|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2868529|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2868530|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2868531|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2868532|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868533|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868534|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868535|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2868536|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
2868537|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
2868538|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
2868539|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
2868540|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
2868541|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
2868542|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
2868543|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
2868544|NCT02105987|9865770|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
2868545|NCT02105987|9865771|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
2868546|NCT02105987|9865772|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
2868547|NCT02105987|9865773|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
2868548|NCT02105987|9865774|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
2868549|NCT02105987|9865775|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
2868550|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
2868551|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
2868552|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
2868553|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
2868554|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
2868555|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
2868556|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
2868557|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2868558|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2868559|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
2868560|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
2868561|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
2868562|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
2868563|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
2868564|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
2868565|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
2868566|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
2868567|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
2868568|NCT02105974|9865829|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
2868569|NCT02105974|9865830|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
2868570|NCT02105974|9865831|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
2868571|NCT02105974|9865829|P3|2 Week Run-in Period|Investigator discretion|0
2868572|NCT02105974|9865830|P2|2 Week Run-in Period|Investigator discretion|0
2868573|NCT02105974|9865831|P1|2 Week Run-in Period|Investigator discretion|8
2868574|NCT02105974|9865829|P3|2 Week Run-in Period|Withdrew consent|0
2868575|NCT02105974|9865830|P2|2 Week Run-in Period|Withdrew consent|0
2868576|NCT02105974|9865831|P1|2 Week Run-in Period|Withdrew consent|23
2868577|NCT02105974|9865829|P3|2 Week Run-in Period|Lost to Follow-up|0
2868578|NCT02105974|9865830|P2|2 Week Run-in Period|Lost to Follow-up|0
2868579|NCT02105974|9865831|P1|2 Week Run-in Period|Lost to Follow-up|2
2868580|NCT02105974|9865829|P3|2 Week Run-in Period|Study closed/terminated|0
2868581|NCT02105974|9865830|P2|2 Week Run-in Period|Study closed/terminated|0
2868582|NCT02105974|9865831|P1|2 Week Run-in Period|Study closed/terminated|1
2868583|NCT02105974|9865829|P3|2 Week Run-in Period|Adverse Event|0
2868584|NCT02105974|9865830|P2|2 Week Run-in Period|Adverse Event|0
2868585|NCT02105974|9865831|P1|2 Week Run-in Period|Adverse Event|6
2868586|NCT02105974|9865829|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2868587|NCT02105974|9865830|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2868588|NCT02105974|9865831|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
2868589|NCT02105974|9865829|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
2868590|NCT02105974|9865830|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
2868591|NCT02105974|9865831|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
2868592|NCT02105961|9865844|P3|Overall Study|Withdrawal by Subject|11
2868593|NCT02105961|9865845|P2|Overall Study|Withdrawal by Subject|7
2868594|NCT02105961|9865846|P1|Overall Study|Withdrawal by Subject|15
2868595|NCT02105961|9865844|P3|Overall Study|Physician Decision|2
2868596|NCT02105961|9865845|P2|Overall Study|Physician Decision|3
2868597|NCT02105961|9865846|P1|Overall Study|Physician Decision|3
2868598|NCT02105961|9865844|P3|Overall Study|Lost to Follow-up|1
2868599|NCT02105961|9865845|P2|Overall Study|Lost to Follow-up|0
2868600|NCT02105961|9865846|P1|Overall Study|Lost to Follow-up|2
2868601|NCT02105961|9865844|P3|Overall Study|Lack of Efficacy|3
2868602|NCT02105961|9865845|P2|Overall Study|Lack of Efficacy|0
2868603|NCT02105961|9865846|P1|Overall Study|Lack of Efficacy|3
2868604|NCT02105961|9865844|P3|Overall Study|Adverse Event|13
2868605|NCT02105961|9865845|P2|Overall Study|Adverse Event|7
2868606|NCT02105961|9865846|P1|Overall Study|Adverse Event|18
2868607|NCT02105948|9865870|P4|Overall Study|Withdrawal by Subject|11
2868608|NCT02105948|9865871|P3|Overall Study|Withdrawal by Subject|10
2868609|NCT02105948|9865872|P2|Overall Study|Withdrawal by Subject|10
2868610|NCT02105948|9865873|P1|Overall Study|Withdrawal by Subject|15
2868611|NCT02105948|9865870|P4|Overall Study|Physician Decision|2
2868612|NCT02105948|9865871|P3|Overall Study|Physician Decision|2
2868613|NCT02105948|9865872|P2|Overall Study|Physician Decision|2
2868614|NCT02105948|9865873|P1|Overall Study|Physician Decision|2
2868615|NCT02105948|9865870|P4|Overall Study|Lost to Follow-up|1
2868616|NCT02105948|9865871|P3|Overall Study|Lost to Follow-up|2
2868617|NCT02105948|9865872|P2|Overall Study|Lost to Follow-up|0
2868618|NCT02105948|9865873|P1|Overall Study|Lost to Follow-up|0
2868619|NCT02105948|9865870|P4|Overall Study|Lack of Efficacy|2
2868620|NCT02105948|9865871|P3|Overall Study|Lack of Efficacy|3
2868621|NCT02105948|9865872|P2|Overall Study|Lack of Efficacy|1
2868622|NCT02105948|9865873|P1|Overall Study|Lack of Efficacy|0
2868623|NCT02105948|9865870|P4|Overall Study|Adverse Event|11
2868624|NCT02105948|9865871|P3|Overall Study|Adverse Event|11
2868625|NCT02105948|9865872|P2|Overall Study|Adverse Event|7
2868626|NCT02105948|9865873|P1|Overall Study|Adverse Event|10
2868627|NCT02105701|9865914|P4|Overall Study|Death|0
2868628|NCT02105701|9865915|P3|Overall Study|Death|0
2868629|NCT02105701|9865916|P2|Overall Study|Death|0
2868630|NCT02105701|9865917|P1|Overall Study|Death|1
2868631|NCT02105701|9865914|P4|Overall Study|Withdrawal by Subject|1
2868632|NCT02105701|9865915|P3|Overall Study|Withdrawal by Subject|0
2868633|NCT02105701|9865916|P2|Overall Study|Withdrawal by Subject|1
2868634|NCT02105701|9865917|P1|Overall Study|Withdrawal by Subject|2
2868635|NCT02105701|9865914|P4|Overall Study|Protocol Violation|0
2868636|NCT02105701|9865915|P3|Overall Study|Protocol Violation|1
2868637|NCT02105701|9865916|P2|Overall Study|Protocol Violation|0
2868638|NCT02105701|9865917|P1|Overall Study|Protocol Violation|0
2868639|NCT02105701|9865914|P4|Overall Study|Lost to Follow-up|1
2868640|NCT02105701|9865915|P3|Overall Study|Lost to Follow-up|2
2868641|NCT02105701|9865916|P2|Overall Study|Lost to Follow-up|0
2868642|NCT02105701|9865917|P1|Overall Study|Lost to Follow-up|1
2868643|NCT02105688|9865941|P2|Part B: Observational Follow-up|Physician Decision|1
2868644|NCT02105688|9865942|P1|Part B: Observational Follow-up|Physician Decision|3
2868645|NCT02105688|9865941|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
2868646|NCT02105688|9865942|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
2868647|NCT02105688|9865941|P2|Part B: Observational Follow-up|Lost to Follow-up|15
2868648|NCT02105688|9865942|P1|Part B: Observational Follow-up|Lost to Follow-up|23
2868649|NCT02105688|9865941|P2|Part B: Observational Follow-up|Death|1
2868650|NCT02105688|9865942|P1|Part B: Observational Follow-up|Death|2
2868651|NCT02105688|9865941|P2|Part A: Double-Blind|Withdrawal by Subject|2
2868652|NCT02105688|9865942|P1|Part A: Double-Blind|Withdrawal by Subject|4
2868653|NCT02105688|9865941|P2|Part A: Double-Blind|Status Unknown|2
2868654|NCT02105688|9865942|P1|Part A: Double-Blind|Status Unknown|0
2868655|NCT02105688|9865941|P2|Part A: Double-Blind|Physician Decision|1
2868656|NCT02105688|9865942|P1|Part A: Double-Blind|Physician Decision|0
2868657|NCT02105688|9865941|P2|Part A: Double-Blind|Lost to Follow-up|11
2868658|NCT02105688|9865942|P1|Part A: Double-Blind|Lost to Follow-up|15
2868659|NCT02105688|9865941|P2|Part A: Double-Blind|Death|1
2868660|NCT02105688|9865942|P1|Part A: Double-Blind|Death|0
2868661|NCT02105688|9865941|P2|Part A: Double-Blind|Adverse Event|0
2868662|NCT02105688|9865942|P1|Part A: Double-Blind|Adverse Event|1
2868663|NCT02105662|9865955|P1|Overall Study|Withdrawal by Subject|1
2868664|NCT02105662|9865955|P1|Overall Study|Lost to Follow-up|5
2868665|NCT02105636|9865964|P2|Overall Study|Not Reported|0
2868666|NCT02105636|9865965|P1|Overall Study|Not Reported|3
2868667|NCT02105636|9865964|P2|Overall Study|Reason Not Specified|2
2868668|NCT02105636|9865965|P1|Overall Study|Reason Not Specified|0
2868669|NCT02105636|9865964|P2|Overall Study|Poor/Non-compliance|1
2868670|NCT02105636|9865965|P1|Overall Study|Poor/Non-compliance|0
2868671|NCT02105636|9865964|P2|Overall Study|Maximum Clinical Benefit|1
2868672|NCT02105636|9865965|P1|Overall Study|Maximum Clinical Benefit|1
2868673|NCT02105636|9865964|P2|Overall Study|Subject Withdrew Consent|1
2868674|NCT02105636|9865965|P1|Overall Study|Subject Withdrew Consent|4
2868675|NCT02105636|9865964|P2|Overall Study|Subject Request to Discontinue Treatment|6
2868676|NCT02105636|9865965|P1|Overall Study|Subject Request to Discontinue Treatment|4
2868677|NCT02105636|9865964|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
2868678|NCT02105636|9865965|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
2868679|NCT02105636|9865964|P2|Overall Study|Study Drug Toxicity|11
2868680|NCT02105636|9865965|P1|Overall Study|Study Drug Toxicity|9
2868681|NCT02105636|9865964|P2|Overall Study|Disease Progression|83
2868682|NCT02105636|9865965|P1|Overall Study|Disease Progression|162
2868683|NCT02105467|9866008|P2|Period 3|Lost to Follow-up|1
2868684|NCT02105467|9866009|P1|Period 3|Lost to Follow-up|0
2868685|NCT02105467|9866008|P2|Period 2|Withdrawal by Subject|2
2868686|NCT02105467|9866009|P1|Period 2|Withdrawal by Subject|0
2868687|NCT02105467|9866008|P2|Period 2|Death|0
2868688|NCT02105467|9866009|P1|Period 2|Death|1
2868689|NCT02105467|9866008|P2|Period 2|Lost to Follow-up|0
2868690|NCT02105467|9866009|P1|Period 2|Lost to Follow-up|1
2868691|NCT02105467|9866008|P2|Period 1|Death|0
2868692|NCT02105467|9866009|P1|Period 1|Death|1
2868693|NCT02105467|9866008|P2|Period 1|Lost to Follow-up|0
2868694|NCT02105467|9866009|P1|Period 1|Lost to Follow-up|1
2868695|NCT02105454|9866021|P1|Overall Study|Withdrawal by Subject|1
2868696|NCT02105285|9866133|P3|Overall Study|Withdrawal by Subject|0
2868697|NCT02105285|9866134|P2|Overall Study|Withdrawal by Subject|0
2868698|NCT02105285|9866135|P1|Overall Study|Withdrawal by Subject|1
2868699|NCT02105285|9866133|P3|Overall Study|Protocol Violation|0
2868700|NCT02105285|9866134|P2|Overall Study|Protocol Violation|1
2868701|NCT02105285|9866135|P1|Overall Study|Protocol Violation|0
2868702|NCT02105285|9866133|P3|Overall Study|Adverse Event|0
2868703|NCT02105285|9866134|P2|Overall Study|Adverse Event|1
2868704|NCT02105285|9866135|P1|Overall Study|Adverse Event|1
2868705|NCT02105272|9866154|P2|Overall Study|Withdrawal by Subject|0
2868706|NCT02105272|9866155|P1|Overall Study|Withdrawal by Subject|2
2868707|NCT02105272|9866154|P2|Overall Study|Protocol Violation|0
2868708|NCT02105272|9866155|P1|Overall Study|Protocol Violation|2
2868709|NCT02105272|9866154|P2|Overall Study|Physician Decision|1
2868710|NCT02105272|9866155|P1|Overall Study|Physician Decision|0
2868711|NCT02105272|9866154|P2|Overall Study|Adverse Event|2
2868712|NCT02105272|9866155|P1|Overall Study|Adverse Event|1
2868713|NCT02105116|9866184|P1|Overall Study|Death|1
2868714|NCT02105116|9866184|P1|Overall Study|not eligible for step 2 of trial|5
2868715|NCT02105012|9866191|P1|Overall Study|Lack of Efficacy|1
2868716|NCT02105012|9866191|P1|Overall Study|Adverse Event|1
2868717|NCT02105012|9866191|P1|Overall Study|Physician Decision|3
2868718|NCT02105012|9866191|P1|Overall Study|Protocol Violation|4
2868719|NCT02105012|9866191|P1|Overall Study|Lost to Follow-up|4
2868720|NCT02105012|9866191|P1|Overall Study|Protocol Specified Criteria|9
2868721|NCT02105012|9866191|P1|Overall Study|Withdrawal by Subject|11
2868722|NCT02104947|9866225|P2|Overall Study|Other than stated above|3
2868723|NCT02104947|9866226|P1|Overall Study|Other than stated above|2
2868724|NCT02104947|9866225|P2|Overall Study|Adverse Event|38
2868725|NCT02104947|9866226|P1|Overall Study|Adverse Event|57
2868726|NCT02104947|9866225|P2|Overall Study|Protocol Violation|8
2868727|NCT02104947|9866226|P1|Overall Study|Protocol Violation|6
2868728|NCT02104947|9866225|P2|Overall Study|Lost to Follow-up|4
2868729|NCT02104947|9866226|P1|Overall Study|Lost to Follow-up|4
2868730|NCT02104947|9866225|P2|Overall Study|Withdrawal by Subject|3
2868731|NCT02104947|9866226|P1|Overall Study|Withdrawal by Subject|10
2868732|NCT02104895|9866244|P2|Overall Study|Withdrawal by Subject|14
2868733|NCT02104895|9866245|P1|Overall Study|Withdrawal by Subject|0
2868734|NCT02104804|9866285|P2|Overall Study|Withdrawal by Subject|12
2868735|NCT02104804|9866286|P1|Overall Study|Withdrawal by Subject|4
2868736|NCT02104804|9866285|P2|Overall Study|Adverse Event|3
2868737|NCT02104804|9866286|P1|Overall Study|Adverse Event|4
2868738|NCT02104804|9866285|P2|Overall Study|Protocol Violation|1
2868739|NCT02104804|9866286|P1|Overall Study|Protocol Violation|0
2868740|NCT02104804|9866285|P2|Overall Study|Other listed|1
2868741|NCT02104804|9866286|P1|Overall Study|Other listed|2
2868742|NCT02104804|9866285|P2|Overall Study|Study specific discontinuation criteria|1
2868743|NCT02104804|9866286|P1|Overall Study|Study specific discontinuation criteria|6
2868744|NCT02104804|9866285|P2|Overall Study|Did not take study medication|1
2868745|NCT02104804|9866286|P1|Overall Study|Did not take study medication|0
2868746|NCT02104765|9866309|P7|Overall Study|Withdrawal by Subject|1
2868747|NCT02104765|9866310|P6|Overall Study|Withdrawal by Subject|0
2868748|NCT02104765|9866311|P5|Overall Study|Withdrawal by Subject|1
2868749|NCT02104765|9866312|P4|Overall Study|Withdrawal by Subject|1
2868750|NCT02104765|9866313|P3|Overall Study|Withdrawal by Subject|0
2868751|NCT02104765|9866314|P2|Overall Study|Withdrawal by Subject|0
2868752|NCT02104765|9866315|P1|Overall Study|Withdrawal by Subject|0
2868753|NCT02104765|9866309|P7|Overall Study|Lost to Follow-up|0
2868754|NCT02104765|9866310|P6|Overall Study|Lost to Follow-up|0
2868755|NCT02104765|9866311|P5|Overall Study|Lost to Follow-up|0
2868756|NCT02104765|9866312|P4|Overall Study|Lost to Follow-up|0
2868757|NCT02104765|9866313|P3|Overall Study|Lost to Follow-up|1
2868758|NCT02104765|9866314|P2|Overall Study|Lost to Follow-up|0
2868759|NCT02104765|9866315|P1|Overall Study|Lost to Follow-up|0
2868760|NCT02104752|9866343|P2|Overall Study|Weight gain; unrelated anxiety|2
2868761|NCT02104752|9866344|P1|Overall Study|Weight gain; unrelated anxiety|0
2868762|NCT02104752|9866343|P2|Overall Study|Withdrawal by Subject|0
2868763|NCT02104752|9866344|P1|Overall Study|Withdrawal by Subject|1
2868764|NCT02104583|9866427|P5|Overall Study|Randomized but Never Treated|0
2868765|NCT02104583|9866428|P4|Overall Study|Randomized but Never Treated|1
2868766|NCT02104583|9866429|P3|Overall Study|Randomized but Never Treated|0
2868767|NCT02104583|9866430|P2|Overall Study|Randomized but Never Treated|0
2868768|NCT02104583|9866431|P1|Overall Study|Randomized but Never Treated|0
2868769|NCT02104583|9866427|P5|Overall Study|Lost to Follow-up|0
2868770|NCT02104583|9866428|P4|Overall Study|Lost to Follow-up|0
2868771|NCT02104583|9866429|P3|Overall Study|Lost to Follow-up|0
2868772|NCT02104583|9866430|P2|Overall Study|Lost to Follow-up|0
2868773|NCT02104583|9866431|P1|Overall Study|Lost to Follow-up|1
2868774|NCT02104583|9866427|P5|Overall Study|Adverse Event|1
2868775|NCT02104583|9866428|P4|Overall Study|Adverse Event|6
2868776|NCT02104583|9866429|P3|Overall Study|Adverse Event|6
2868777|NCT02104583|9866430|P2|Overall Study|Adverse Event|3
2868778|NCT02104583|9866431|P1|Overall Study|Adverse Event|3
2868779|NCT02104583|9866427|P5|Overall Study|Protocol Violation|0
2868780|NCT02104583|9866428|P4|Overall Study|Protocol Violation|0
2868781|NCT02104583|9866429|P3|Overall Study|Protocol Violation|1
2868782|NCT02104583|9866430|P2|Overall Study|Protocol Violation|0
2868783|NCT02104583|9866431|P1|Overall Study|Protocol Violation|0
2868784|NCT02104583|9866427|P5|Overall Study|Investigator's Discretion|0
2868785|NCT02104583|9866428|P4|Overall Study|Investigator's Discretion|0
2868786|NCT02104583|9866429|P3|Overall Study|Investigator's Discretion|0
2868787|NCT02104583|9866430|P2|Overall Study|Investigator's Discretion|0
2868788|NCT02104583|9866431|P1|Overall Study|Investigator's Discretion|1
2868789|NCT02104583|9866427|P5|Overall Study|Withdrew Consent|1
2868790|NCT02104583|9866428|P4|Overall Study|Withdrew Consent|2
2868791|NCT02104583|9866429|P3|Overall Study|Withdrew Consent|0
2868792|NCT02104583|9866430|P2|Overall Study|Withdrew Consent|2
2868793|NCT02104583|9866431|P1|Overall Study|Withdrew Consent|3
2868794|NCT02104583|9866427|P5|Overall Study|Subject required prohibited medication|1
2868795|NCT02104583|9866428|P4|Overall Study|Subject required prohibited medication|0
2868796|NCT02104583|9866429|P3|Overall Study|Subject required prohibited medication|1
2868797|NCT02104583|9866430|P2|Overall Study|Subject required prohibited medication|1
2868798|NCT02104583|9866431|P1|Overall Study|Subject required prohibited medication|0
2868799|NCT02104583|9866427|P5|Overall Study|Subject required cardiac ablation|4
2868800|NCT02104583|9866428|P4|Overall Study|Subject required cardiac ablation|5
2868801|NCT02104583|9866429|P3|Overall Study|Subject required cardiac ablation|4
2868802|NCT02104583|9866430|P2|Overall Study|Subject required cardiac ablation|4
2868803|NCT02104583|9866431|P1|Overall Study|Subject required cardiac ablation|6
2868804|NCT02104583|9866427|P5|Overall Study|Death|5
2868805|NCT02104583|9866428|P4|Overall Study|Death|3
2868806|NCT02104583|9866429|P3|Overall Study|Death|3
2868807|NCT02104583|9866430|P2|Overall Study|Death|1
2868808|NCT02104583|9866431|P1|Overall Study|Death|2
2868809|NCT02104583|9866427|P5|Overall Study|New ICD or CRT-D implanted|0
2868810|NCT02104583|9866428|P4|Overall Study|New ICD or CRT-D implanted|0
2868811|NCT02104583|9866429|P3|Overall Study|New ICD or CRT-D implanted|1
2868812|NCT02104583|9866430|P2|Overall Study|New ICD or CRT-D implanted|0
2868813|NCT02104583|9866431|P1|Overall Study|New ICD or CRT-D implanted|2
2868814|NCT02104505|9866494|P2|Second Intervention (14 Days)|Adverse Event|0
2868815|NCT02104505|9866495|P1|Second Intervention (14 Days)|Adverse Event|2
2868816|NCT02104505|9866494|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2868817|NCT02104505|9866495|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2868818|NCT02104505|9866494|P2|First Intervention (14 Days)|exclusionary condition|1
2868819|NCT02104505|9866495|P1|First Intervention (14 Days)|exclusionary condition|0
2868820|NCT02104505|9866494|P2|First Intervention (14 Days)|Lost to Follow-up|1
2868821|NCT02104505|9866495|P1|First Intervention (14 Days)|Lost to Follow-up|0
2868822|NCT02104505|9866494|P2|First Intervention (14 Days)|Withdrawal by Subject|1
2868823|NCT02104505|9866495|P1|First Intervention (14 Days)|Withdrawal by Subject|0
2868824|NCT02104505|9866494|P2|First Intervention (14 Days)|Adverse Event|0
2868825|NCT02104505|9866495|P1|First Intervention (14 Days)|Adverse Event|2
2868826|NCT02104180|9866567|P2|Overall Study|Protocol Violation|0
2868827|NCT02104180|9866568|P1|Overall Study|Protocol Violation|1
2868828|NCT02103439|9866598|P2|Overall Study|Withdrawal by Subject|1
2868829|NCT02103439|9866599|P1|Overall Study|Withdrawal by Subject|3
2868830|NCT02103439|9866598|P2|Overall Study|Adverse Event|2
2868831|NCT02103439|9866599|P1|Overall Study|Adverse Event|0
2868832|NCT02103062|9866758|P2|Overall Study|Death|1
2868833|NCT02103062|9866759|P1|Overall Study|Death|0
2868834|NCT02103062|9866758|P2|Overall Study|Progressive Disease|20
2868835|NCT02103062|9866759|P1|Overall Study|Progressive Disease|17
2868836|NCT02103062|9866758|P2|Overall Study|Adverse Event|2
2868837|NCT02103062|9866759|P1|Overall Study|Adverse Event|1
2868838|NCT02102724|9866852|P2|Overall Study|surgery for brain aneurysm|1
2868839|NCT02102724|9866853|P1|Overall Study|surgery for brain aneurysm|1
2868840|NCT02102724|9866852|P2|Overall Study|Lost to Follow-up|0
2868841|NCT02102724|9866853|P1|Overall Study|Lost to Follow-up|1
2868842|NCT02102490|9866859|P1|Overall Study|Lost to Follow-up|1
2868843|NCT02102490|9866859|P1|Overall Study|Death|6
2868844|NCT02102464|9866873|P3|Randomized Study|Withdrawal by Subject|0
2868845|NCT02102464|9866874|P2|Randomized Study|Withdrawal by Subject|1
2868846|NCT02102464|9866875|P1|Randomized Study|Withdrawal by Subject|0
2868847|NCT02102399|9866894|P2|Overall Study|Withdrawal by Subject|4
2868848|NCT02102399|9866895|P1|Overall Study|Withdrawal by Subject|6
2868849|NCT02102204|9866965|P1|Overall Study|Ongoing|5
2868850|NCT02102204|9866965|P1|Overall Study|Sponsor Decision|5
2868851|NCT02102204|9866965|P1|Overall Study|Lost to Follow-up|65
2868852|NCT02102204|9866965|P1|Overall Study|Death|92
2868853|NCT02102204|9866965|P1|Overall Study|Withdrawal by Subject|137
2868854|NCT02101983|9866985|P2|Overall Study|Physician Decision|0
2868855|NCT02101983|9866986|P1|Overall Study|Physician Decision|1
2868856|NCT02101359|9867082|P2|Overall Study|Protocol Violation|2
2868857|NCT02101359|9867083|P1|Overall Study|Protocol Violation|0
2868858|NCT02101359|9867082|P2|Overall Study|Lost to Follow-up|0
2868859|NCT02101359|9867083|P1|Overall Study|Lost to Follow-up|1
2868860|NCT02101359|9867082|P2|Overall Study|Withdrawal by Subject|4
2868861|NCT02101359|9867083|P1|Overall Study|Withdrawal by Subject|5
2868862|NCT02101359|9867082|P2|Overall Study|Not included|13
2868863|NCT02101359|9867083|P1|Overall Study|Not included|23
2868864|NCT02101294|9867089|P1|Overall Study|Lost to Follow-up|6
2868865|NCT02101294|9867089|P1|Overall Study|Withdrawal by Subject|5
2868866|NCT02101281|9867098|P2|Overall Study|Adverse Event|1
2868867|NCT02101281|9867099|P1|Overall Study|Adverse Event|0
2868868|NCT02101112|9867152|P6|Overall Study|Withdrawal by Subject|0
2868869|NCT02101112|9867153|P5|Overall Study|Withdrawal by Subject|1
2868870|NCT02101112|9867154|P4|Overall Study|Withdrawal by Subject|0
2868871|NCT02101112|9867155|P3|Overall Study|Withdrawal by Subject|0
2868872|NCT02101112|9867156|P2|Overall Study|Withdrawal by Subject|0
2868873|NCT02101112|9867157|P1|Overall Study|Withdrawal by Subject|0
2868874|NCT02101112|9867152|P6|Overall Study|Adverse Event|0
2868875|NCT02101112|9867153|P5|Overall Study|Adverse Event|0
2868876|NCT02101112|9867154|P4|Overall Study|Adverse Event|0
2868877|NCT02101112|9867155|P3|Overall Study|Adverse Event|1
2868878|NCT02101112|9867156|P2|Overall Study|Adverse Event|0
2868879|NCT02101112|9867157|P1|Overall Study|Adverse Event|0
2868880|NCT02101021|9867187|P5|Overall Study|Study Terminated by Sponsor|1
2868881|NCT02101021|9867188|P4|Overall Study|Study Terminated by Sponsor|1
2868882|NCT02101021|9867189|P3|Overall Study|Study Terminated by Sponsor|1
2868883|NCT02101021|9867190|P2|Overall Study|Study Terminated by Sponsor|0
2868884|NCT02101021|9867191|P1|Overall Study|Study Terminated by Sponsor|1
2868885|NCT02101021|9867187|P5|Overall Study|Lost to Follow-up|0
2868886|NCT02101021|9867188|P4|Overall Study|Lost to Follow-up|0
2868887|NCT02101021|9867189|P3|Overall Study|Lost to Follow-up|0
2868888|NCT02101021|9867190|P2|Overall Study|Lost to Follow-up|0
2868889|NCT02101021|9867191|P1|Overall Study|Lost to Follow-up|1
2868890|NCT02101021|9867187|P5|Overall Study|Withdrew Consent from study|0
2868891|NCT02101021|9867188|P4|Overall Study|Withdrew Consent from study|2
2868892|NCT02101021|9867189|P3|Overall Study|Withdrew Consent from study|0
2868893|NCT02101021|9867190|P2|Overall Study|Withdrew Consent from study|1
2868894|NCT02101021|9867191|P1|Overall Study|Withdrew Consent from study|1
2868895|NCT02101021|9867187|P5|Overall Study|Death|3
2868896|NCT02101021|9867188|P4|Overall Study|Death|0
2868897|NCT02101021|9867189|P3|Overall Study|Death|6
2868898|NCT02101021|9867190|P2|Overall Study|Death|3
2868899|NCT02101021|9867191|P1|Overall Study|Death|4
2868900|NCT02100969|9867238|P1|Overall Study|Did not pass screening phase|1
2868901|NCT02100839|9867257|P2|Multiple Ascending Dose|Withdrawal by Subject|0
2868902|NCT02100839|9867258|P1|Multiple Ascending Dose|Withdrawal by Subject|2
2868903|NCT02100839|9867257|P2|Multiple Ascending Dose|Adverse Event|0
2868904|NCT02100839|9867258|P1|Multiple Ascending Dose|Adverse Event|2
2868905|NCT02100813|9867289|P8|Overall Study|Adverse Event|1
2868906|NCT02100813|9867290|P7|Overall Study|Adverse Event|0
2868907|NCT02100813|9867291|P6|Overall Study|Adverse Event|0
2868908|NCT02100813|9867292|P5|Overall Study|Adverse Event|0
2868909|NCT02100813|9867293|P4|Overall Study|Adverse Event|0
2868910|NCT02100813|9867294|P3|Overall Study|Adverse Event|0
2868911|NCT02100813|9867295|P2|Overall Study|Adverse Event|0
2868912|NCT02100813|9867296|P1|Overall Study|Adverse Event|0
2868913|NCT02100670|9867324|P4|Overall Study|Withdrawal by Subject|0
2868914|NCT02100670|9867325|P3|Overall Study|Withdrawal by Subject|0
2868915|NCT02100670|9867326|P2|Overall Study|Withdrawal by Subject|0
2868916|NCT02100670|9867327|P1|Overall Study|Withdrawal by Subject|1
2868917|NCT02100670|9867324|P4|Overall Study|Physician Decision|0
2868918|NCT02100670|9867325|P3|Overall Study|Physician Decision|0
2868919|NCT02100670|9867326|P2|Overall Study|Physician Decision|1
2868920|NCT02100670|9867327|P1|Overall Study|Physician Decision|0
2868921|NCT02100670|9867324|P4|Overall Study|Poor Efficacy|0
2868922|NCT02100670|9867325|P3|Overall Study|Poor Efficacy|0
2868923|NCT02100670|9867326|P2|Overall Study|Poor Efficacy|1
2868924|NCT02100670|9867327|P1|Overall Study|Poor Efficacy|0
2868925|NCT02100670|9867324|P4|Overall Study|No swelling no pain|0
2868926|NCT02100670|9867325|P3|Overall Study|No swelling no pain|0
2868927|NCT02100670|9867326|P2|Overall Study|No swelling no pain|0
2868928|NCT02100670|9867327|P1|Overall Study|No swelling no pain|1
2868929|NCT02100670|9867324|P4|Overall Study|Withdrawal of Consent|0
2868930|NCT02100670|9867325|P3|Overall Study|Withdrawal of Consent|1
2868931|NCT02100670|9867326|P2|Overall Study|Withdrawal of Consent|1
2868932|NCT02100670|9867327|P1|Overall Study|Withdrawal of Consent|0
2868933|NCT02100670|9867324|P4|Overall Study|Protocol Violation|1
2868934|NCT02100670|9867325|P3|Overall Study|Protocol Violation|0
2868935|NCT02100670|9867326|P2|Overall Study|Protocol Violation|1
2868936|NCT02100670|9867327|P1|Overall Study|Protocol Violation|0
2868937|NCT02100670|9867324|P4|Overall Study|Lost to Follow-up|0
2868938|NCT02100670|9867325|P3|Overall Study|Lost to Follow-up|0
2868939|NCT02100670|9867326|P2|Overall Study|Lost to Follow-up|0
2868940|NCT02100670|9867327|P1|Overall Study|Lost to Follow-up|1
2868941|NCT02100670|9867324|P4|Overall Study|Adverse Event|0
2868942|NCT02100670|9867325|P3|Overall Study|Adverse Event|3
2868943|NCT02100670|9867326|P2|Overall Study|Adverse Event|3
2868944|NCT02100670|9867327|P1|Overall Study|Adverse Event|10
2868945|NCT02100644|9867387|P3|LTG Escalation Phase|Withdrawal by Subject|0
2868946|NCT02100644|9867388|P2|LTG Escalation Phase|Withdrawal by Subject|0
2868947|NCT02100644|9867389|P1|LTG Escalation Phase|Withdrawal by Subject|3
2868948|NCT02100644|9867387|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2868949|NCT02100644|9867388|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2868950|NCT02100644|9867389|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
2868951|NCT02100644|9867387|P3|LTG Escalation Phase|Adverse Event|0
2868952|NCT02100644|9867388|P2|LTG Escalation Phase|Adverse Event|0
2868953|NCT02100644|9867389|P1|LTG Escalation Phase|Adverse Event|9
2868954|NCT02100514|9867414|P5|Extension Period|Withdrew consent|0
2868955|NCT02100514|9867415|P4|Extension Period|Withdrew consent|0
2868956|NCT02100514|9867416|P3|Extension Period|Withdrew consent|2
2868957|NCT02100514|9867417|P2|Extension Period|Withdrew consent|0
2868958|NCT02100514|9867418|P1|Extension Period|Withdrew consent|0
2868959|NCT02100514|9867414|P5|Treatment Period|Other|0
2868960|NCT02100514|9867415|P4|Treatment Period|Other|0
2868961|NCT02100514|9867416|P3|Treatment Period|Other|0
2868962|NCT02100514|9867417|P2|Treatment Period|Other|11
2868963|NCT02100514|9867418|P1|Treatment Period|Other|9
2868964|NCT02100514|9867414|P5|Treatment Period|Withdrawal by Subject|0
2868965|NCT02100514|9867415|P4|Treatment Period|Withdrawal by Subject|0
2868966|NCT02100514|9867416|P3|Treatment Period|Withdrawal by Subject|0
2868967|NCT02100514|9867417|P2|Treatment Period|Withdrawal by Subject|37
2868968|NCT02100514|9867418|P1|Treatment Period|Withdrawal by Subject|12
2868969|NCT02100514|9867414|P5|Treatment Period|Protocol Violation|0
2868970|NCT02100514|9867415|P4|Treatment Period|Protocol Violation|0
2868971|NCT02100514|9867416|P3|Treatment Period|Protocol Violation|0
2868972|NCT02100514|9867417|P2|Treatment Period|Protocol Violation|1
2868973|NCT02100514|9867418|P1|Treatment Period|Protocol Violation|1
2868974|NCT02100514|9867414|P5|Treatment Period|Did Not Meet Entrance Criteria|0
2868975|NCT02100514|9867415|P4|Treatment Period|Did Not Meet Entrance Criteria|0
2868976|NCT02100514|9867416|P3|Treatment Period|Did Not Meet Entrance Criteria|0
2868977|NCT02100514|9867417|P2|Treatment Period|Did Not Meet Entrance Criteria|1
2868978|NCT02100514|9867418|P1|Treatment Period|Did Not Meet Entrance Criteria|0
2868979|NCT02100514|9867414|P5|Treatment Period|Lost to Follow-up|0
2868980|NCT02100514|9867415|P4|Treatment Period|Lost to Follow-up|0
2868981|NCT02100514|9867416|P3|Treatment Period|Lost to Follow-up|0
2868982|NCT02100514|9867417|P2|Treatment Period|Lost to Follow-up|17
2868983|NCT02100514|9867418|P1|Treatment Period|Lost to Follow-up|5
2868984|NCT02100514|9867414|P5|Treatment Period|Death|0
2868985|NCT02100514|9867415|P4|Treatment Period|Death|0
2868986|NCT02100514|9867416|P3|Treatment Period|Death|0
2868987|NCT02100514|9867417|P2|Treatment Period|Death|2
2868988|NCT02100514|9867418|P1|Treatment Period|Death|2
2868989|NCT02100514|9867414|P5|Treatment Period|Adverse Event|0
2868990|NCT02100514|9867415|P4|Treatment Period|Adverse Event|0
2868991|NCT02100514|9867416|P3|Treatment Period|Adverse Event|0
2868992|NCT02100514|9867417|P2|Treatment Period|Adverse Event|5
2868993|NCT02100514|9867418|P1|Treatment Period|Adverse Event|0
2868994|NCT02100475|9867486|P2|Overall Study|Withdrawal criteria|0
2868995|NCT02100475|9867487|P1|Overall Study|Withdrawal criteria|1
2868996|NCT02100475|9867486|P2|Overall Study|Unclassified|2
2868997|NCT02100475|9867487|P1|Overall Study|Unclassified|1
2868998|NCT02100319|9867518|P1|Overall Study|Protocol Deviation|5
2868999|NCT02100319|9867518|P1|Overall Study|Case Report Forms Uncollected|11
2869000|NCT02100228|9867546|P2|Overall Study|Death|1
2869001|NCT02100228|9867547|P1|Overall Study|Death|1
2869002|NCT02100228|9867546|P2|Overall Study|Adverse Event|12
2869003|NCT02100228|9867547|P1|Overall Study|Adverse Event|16
2869004|NCT02100228|9867546|P2|Overall Study|Withdrawal by Subject|37
2869005|NCT02100228|9867547|P1|Overall Study|Withdrawal by Subject|27
2869006|NCT02100228|9867546|P2|Overall Study|Lost to Follow-up|1
2869007|NCT02100228|9867547|P1|Overall Study|Lost to Follow-up|0
2869008|NCT02100228|9867546|P2|Overall Study|Non-compliance|3
2869009|NCT02100228|9867547|P1|Overall Study|Non-compliance|0
2869010|NCT02100228|9867546|P2|Overall Study|Inclusion/Exclusion criteria not met|16
2869011|NCT02100228|9867547|P1|Overall Study|Inclusion/Exclusion criteria not met|12
2869012|NCT02100228|9867546|P2|Overall Study|Administrative reason|1
2869013|NCT02100228|9867547|P1|Overall Study|Administrative reason|0
2869014|NCT02100228|9867546|P2|Overall Study|Other|19
2869015|NCT02100228|9867547|P1|Overall Study|Other|19
2869016|NCT02100124|9867583|P3|Overall Study|Withdrawal by Subject|0
2869017|NCT02100124|9867584|P2|Overall Study|Withdrawal by Subject|0
2869018|NCT02100124|9867585|P1|Overall Study|Withdrawal by Subject|1
2869019|NCT02100124|9867583|P3|Overall Study|Lost to Follow-up|3
2869020|NCT02100124|9867584|P2|Overall Study|Lost to Follow-up|11
2869021|NCT02100124|9867585|P1|Overall Study|Lost to Follow-up|5
2869022|NCT02099838|9867615|P2|Overall Study|Withdrawal by Subject|1
2869023|NCT02099838|9867616|P1|Overall Study|Withdrawal by Subject|0
2869024|NCT02099838|9867615|P2|Overall Study|Lost to Follow-up|1
2869025|NCT02099838|9867616|P1|Overall Study|Lost to Follow-up|3
2869026|NCT02099838|9867615|P2|Overall Study|Death|0
2869027|NCT02099838|9867616|P1|Overall Study|Death|1
2869028|NCT02099708|9867661|P1|Overall Study|Other|29
2869029|NCT02099708|9867661|P1|Overall Study|Lost to Follow-up|141
2869030|NCT02099708|9867661|P1|Overall Study|Data Not Available|30
2869031|NCT02099682|9867672|P1|Overall Study|Other|29
2869032|NCT02099682|9867672|P1|Overall Study|Lost to Follow-up|31
2869033|NCT02099682|9867672|P1|Overall Study|Data Not Available|51
2869034|NCT02099344|9867698|P2|Overall Study|Physician Decision|0
2869035|NCT02099344|9867699|P1|Overall Study|Physician Decision|1
2869036|NCT02099110|9867736|P5|Overall Study|Physician Decision|1
2869037|NCT02099110|9867737|P4|Overall Study|Physician Decision|2
2869038|NCT02099110|9867738|P3|Overall Study|Physician Decision|1
2869039|NCT02099110|9867739|P2|Overall Study|Physician Decision|0
2869040|NCT02099110|9867740|P1|Overall Study|Physician Decision|3
2869041|NCT02099110|9867736|P5|Overall Study|Non-compliance with study drug|1
2869042|NCT02099110|9867737|P4|Overall Study|Non-compliance with study drug|0
2869043|NCT02099110|9867738|P3|Overall Study|Non-compliance with study drug|0
2869044|NCT02099110|9867739|P2|Overall Study|Non-compliance with study drug|0
2869045|NCT02099110|9867740|P1|Overall Study|Non-compliance with study drug|2
2869046|NCT02099110|9867736|P5|Overall Study|Screen failure|1
2869047|NCT02099110|9867737|P4|Overall Study|Screen failure|0
2869048|NCT02099110|9867738|P3|Overall Study|Screen failure|0
2869049|NCT02099110|9867739|P2|Overall Study|Screen failure|0
2869050|NCT02099110|9867740|P1|Overall Study|Screen failure|0
2869051|NCT02099110|9867736|P5|Overall Study|Death|0
2869052|NCT02099110|9867737|P4|Overall Study|Death|0
2869053|NCT02099110|9867738|P3|Overall Study|Death|0
2869054|NCT02099110|9867739|P2|Overall Study|Death|1
2869055|NCT02099110|9867740|P1|Overall Study|Death|0
2869056|NCT02099110|9867736|P5|Overall Study|Lost to Follow-up|6
2869057|NCT02099110|9867737|P4|Overall Study|Lost to Follow-up|5
2869058|NCT02099110|9867738|P3|Overall Study|Lost to Follow-up|11
2869059|NCT02099110|9867739|P2|Overall Study|Lost to Follow-up|12
2869060|NCT02099110|9867740|P1|Overall Study|Lost to Follow-up|6
2869061|NCT02099110|9867736|P5|Overall Study|Adverse Event|2
2869062|NCT02099110|9867737|P4|Overall Study|Adverse Event|3
2869063|NCT02099110|9867738|P3|Overall Study|Adverse Event|2
2869064|NCT02099110|9867739|P2|Overall Study|Adverse Event|5
2869065|NCT02099110|9867740|P1|Overall Study|Adverse Event|3
2869066|NCT02099110|9867736|P5|Overall Study|Withdrawal by Subject|13
2869067|NCT02099110|9867737|P4|Overall Study|Withdrawal by Subject|9
2869068|NCT02099110|9867738|P3|Overall Study|Withdrawal by Subject|13
2869069|NCT02099110|9867739|P2|Overall Study|Withdrawal by Subject|11
2869070|NCT02099110|9867740|P1|Overall Study|Withdrawal by Subject|7
2869071|NCT02099110|9867736|P5|Overall Study|Participant moved|2
2869072|NCT02099110|9867737|P4|Overall Study|Participant moved|0
2869073|NCT02099110|9867738|P3|Overall Study|Participant moved|1
2869074|NCT02099110|9867739|P2|Overall Study|Participant moved|1
2869075|NCT02099110|9867740|P1|Overall Study|Participant moved|1
2869076|NCT02099110|9867736|P5|Overall Study|Protocol Violation|1
2869077|NCT02099110|9867737|P4|Overall Study|Protocol Violation|3
2869078|NCT02099110|9867738|P3|Overall Study|Protocol Violation|0
2869079|NCT02099110|9867739|P2|Overall Study|Protocol Violation|1
2869080|NCT02099110|9867740|P1|Overall Study|Protocol Violation|2
2869081|NCT02098746|9867841|P1|Overall Study|Data Not Available After Treatment|1
2869082|NCT02098746|9867841|P1|Overall Study|Enrolled 15 Days After the First Dose|1
2869083|NCT02098746|9867841|P1|Overall Study|Other Miscellaneous Reasons|1
2869084|NCT02098746|9867841|P1|Overall Study|Changes of Investigator|2
2869085|NCT02098733|9867849|P1|Overall Study|Lost to Follow-up|5
2869086|NCT02098733|9867849|P1|Overall Study|Data Not Available|5
2869087|NCT02098395|9867863|P4|Overall Study|Unclassified|2
2869088|NCT02098395|9867864|P3|Overall Study|Unclassified|3
2869089|NCT02098395|9867865|P2|Overall Study|Unclassified|0
2869090|NCT02098395|9867866|P1|Overall Study|Unclassified|0
2869091|NCT02098395|9867863|P4|Overall Study|Lost to Follow-up|3
2869092|NCT02098395|9867864|P3|Overall Study|Lost to Follow-up|0
2869093|NCT02098395|9867865|P2|Overall Study|Lost to Follow-up|1
2869094|NCT02098395|9867866|P1|Overall Study|Lost to Follow-up|2
2869095|NCT02098395|9867863|P4|Overall Study|Adverse Event|2
2869096|NCT02098395|9867864|P3|Overall Study|Adverse Event|34
2869097|NCT02098395|9867865|P2|Overall Study|Adverse Event|19
2869098|NCT02098395|9867866|P1|Overall Study|Adverse Event|12
2869099|NCT02098395|9867863|P4|Overall Study|Withdrawal by Subject|13
2869100|NCT02098395|9867864|P3|Overall Study|Withdrawal by Subject|5
2869101|NCT02098395|9867865|P2|Overall Study|Withdrawal by Subject|10
2869102|NCT02098395|9867866|P1|Overall Study|Withdrawal by Subject|10
2869103|NCT02098395|9867863|P4|Overall Study|Protocol Violation|7
2869104|NCT02098395|9867864|P3|Overall Study|Protocol Violation|0
2869105|NCT02098395|9867865|P2|Overall Study|Protocol Violation|2
2869106|NCT02098395|9867866|P1|Overall Study|Protocol Violation|2
2869107|NCT02098369|9867887|P3|Overall Study|Other|1
2869108|NCT02098369|9867888|P2|Overall Study|Other|2
2869109|NCT02098369|9867889|P1|Overall Study|Other|0
2869110|NCT02098369|9867887|P3|Overall Study|Death|1
2869111|NCT02098369|9867888|P2|Overall Study|Death|1
2869112|NCT02098369|9867889|P1|Overall Study|Death|1
2869113|NCT02098369|9867887|P3|Overall Study|Lost to Follow-up|3
2869114|NCT02098369|9867888|P2|Overall Study|Lost to Follow-up|1
2869115|NCT02098369|9867889|P1|Overall Study|Lost to Follow-up|5
2869116|NCT02098369|9867887|P3|Overall Study|Withdrawal by Subject|0
2869117|NCT02098369|9867888|P2|Overall Study|Withdrawal by Subject|5
2869118|NCT02098369|9867889|P1|Overall Study|Withdrawal by Subject|1
2869119|NCT02098109|9867927|P2|Overall Study|Protocol Violation|0
2869120|NCT02098109|9867928|P1|Overall Study|Protocol Violation|3
2869121|NCT02097823|9868006|P2|Overall Study|Withdrawal by Subject|1
2869122|NCT02097823|9868007|P1|Overall Study|Withdrawal by Subject|1
2869123|NCT02097745|9868022|P1|Overall Study|Reason Not Specified|96
2869124|NCT02097745|9868022|P1|Overall Study|Administrative/Other|27
2869125|NCT02097745|9868022|P1|Overall Study|Failure to Return|14
2869126|NCT02097745|9868022|P1|Overall Study|Death|16
2869127|NCT02097745|9868022|P1|Overall Study|Adverse Event|25
2869128|NCT02097719|9868060|P2|Overall Study|Adverse Event|0
2869129|NCT02097719|9868061|P1|Overall Study|Adverse Event|2
2869130|NCT02097719|9868060|P2|Overall Study|Lost to Follow-up|1
2869131|NCT02097719|9868061|P1|Overall Study|Lost to Follow-up|0
2869132|NCT02097719|9868060|P2|Overall Study|Subject Withdrew Consent|0
2869133|NCT02097719|9868061|P1|Overall Study|Subject Withdrew Consent|1
2869134|NCT02097472|9868126|P8|Received Vaccination 2|Adverse Event|0
2869135|NCT02097472|9868127|P7|Received Vaccination 2|Adverse Event|1
2869136|NCT02097472|9868128|P6|Received Vaccination 2|Adverse Event|0
2869137|NCT02097472|9868129|P5|Received Vaccination 2|Adverse Event|0
2869138|NCT02097472|9868130|P4|Received Vaccination 2|Adverse Event|0
2869139|NCT02097472|9868131|P3|Received Vaccination 2|Adverse Event|0
2869140|NCT02097472|9868132|P2|Received Vaccination 2|Adverse Event|0
2869141|NCT02097472|9868133|P1|Received Vaccination 2|Adverse Event|0
2869142|NCT02097290|9868564|P1|Overall Study|Attempt|8
2869143|NCT02097290|9868564|P1|Overall Study|Total Withdrawals|3
2869144|NCT02097290|9868564|P1|Overall Study|Death|6
2869145|NCT02097277|9868579|P5|Overall Study|Adverse Event|0
2869146|NCT02097277|9868580|P4|Overall Study|Adverse Event|2
2869147|NCT02097277|9868581|P3|Overall Study|Adverse Event|1
2869148|NCT02097277|9868582|P2|Overall Study|Adverse Event|0
2869149|NCT02097277|9868583|P1|Overall Study|Adverse Event|0
2869150|NCT02097277|9868579|P5|Overall Study|Withdrawal by Subject|0
2869151|NCT02097277|9868580|P4|Overall Study|Withdrawal by Subject|1
2869152|NCT02097277|9868581|P3|Overall Study|Withdrawal by Subject|0
2869153|NCT02097277|9868582|P2|Overall Study|Withdrawal by Subject|1
2869154|NCT02097277|9868583|P1|Overall Study|Withdrawal by Subject|2
2869155|NCT02097277|9868579|P5|Overall Study|Lost to Follow-up|0
2869156|NCT02097277|9868580|P4|Overall Study|Lost to Follow-up|0
2869157|NCT02097277|9868581|P3|Overall Study|Lost to Follow-up|1
2869158|NCT02097277|9868582|P2|Overall Study|Lost to Follow-up|1
2869159|NCT02097277|9868583|P1|Overall Study|Lost to Follow-up|0
2869160|NCT02097277|9868579|P5|Overall Study|Subject request to discontinue treatment|1
2869161|NCT02097277|9868580|P4|Overall Study|Subject request to discontinue treatment|0
2869162|NCT02097277|9868581|P3|Overall Study|Subject request to discontinue treatment|0
2869163|NCT02097277|9868582|P2|Overall Study|Subject request to discontinue treatment|0
2869164|NCT02097277|9868583|P1|Overall Study|Subject request to discontinue treatment|0
2869165|NCT02097277|9868579|P5|Overall Study|Subject no longer meets study criteria|0
2869166|NCT02097277|9868580|P4|Overall Study|Subject no longer meets study criteria|1
2869167|NCT02097277|9868581|P3|Overall Study|Subject no longer meets study criteria|0
2869168|NCT02097277|9868582|P2|Overall Study|Subject no longer meets study criteria|1
2869169|NCT02097277|9868583|P1|Overall Study|Subject no longer meets study criteria|0
2869170|NCT02097238|9868666|P1|Overall Study|Progressive Disease|17
2869171|NCT02097238|9868666|P1|Overall Study|Physician Decision|1
2869172|NCT02097238|9868666|P1|Overall Study|Death|1
2869173|NCT02097134|9868675|P1|Overall Study|Refusal of Further Protocol Therapy|1
2869174|NCT02097134|9868675|P1|Overall Study|Progressive Disease|3
2869175|NCT02097134|9868675|P1|Overall Study|Non-Protocol Therapy|1
2869176|NCT02097134|9868675|P1|Overall Study|Physician Decision|4
2869177|NCT02097108|9868683|P1|Overall Study|patient was abroad for 6 months|1
2869178|NCT02097108|9868683|P1|Overall Study|Adverse Event|1
2869179|NCT02097056|9868690|P1|Overall Study|Other|2
2869180|NCT02097056|9868690|P1|Overall Study|Adverse Event|37
2869181|NCT02097056|9868690|P1|Overall Study|Lost to Follow-up|2
2869182|NCT02097056|9868690|P1|Overall Study|Withdrawal by Subject|15
2869183|NCT02097056|9868690|P1|Overall Study|Protocol Violation|2
2869184|NCT02097030|9868698|P2|First Intervention (3 Days)|Visual Acuity|1
2869185|NCT02097030|9868699|P1|First Intervention (3 Days)|Visual Acuity|0
2869186|NCT02097030|9868698|P2|First Intervention (3 Days)|Lost to Follow-up|0
2869187|NCT02097030|9868699|P1|First Intervention (3 Days)|Lost to Follow-up|1
2869188|NCT02096952|9868760|P1|Overall Study|Adverse Event|1
2869189|NCT02096900|9868766|P2|Overall Study|Surgery cancelled- medication received|1
2869190|NCT02096900|9868767|P1|Overall Study|Surgery cancelled- medication received|1
2869191|NCT02096900|9868766|P2|Overall Study|Did not receive medication|1
2869192|NCT02096900|9868767|P1|Overall Study|Did not receive medication|3
2869193|NCT02096835|9868819|P3|Overall Study|Lost to Follow-up|1
2869194|NCT02096835|9868820|P2|Overall Study|Lost to Follow-up|0
2869195|NCT02096835|9868821|P1|Overall Study|Lost to Follow-up|1
2869196|NCT02096835|9868819|P3|Overall Study|converted to open procedures|0
2869197|NCT02096835|9868820|P2|Overall Study|converted to open procedures|0
2869198|NCT02096835|9868821|P1|Overall Study|converted to open procedures|1
2869199|NCT02096835|9868819|P3|Overall Study|Withdrawal by Subject|0
2869200|NCT02096835|9868820|P2|Overall Study|Withdrawal by Subject|0
2869201|NCT02096835|9868821|P1|Overall Study|Withdrawal by Subject|1
2869202|NCT02096744|9868838|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
2869203|NCT02096744|9868839|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
2869204|NCT02096744|9868838|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
2869205|NCT02096744|9868839|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
2869206|NCT02096744|9868838|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
2869207|NCT02096744|9868839|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
2869208|NCT02096705|9868893|P2|Follow-up|Subjects not reporting status|2
2869209|NCT02096705|9868894|P1|Follow-up|Subjects not reporting status|1
2869210|NCT02096705|9868893|P2|Follow-up|Adverse Event|2
2869211|NCT02096705|9868894|P1|Follow-up|Adverse Event|2
2869212|NCT02096705|9868893|P2|Follow-up|Withdrawal by Subject|0
2869213|NCT02096705|9868894|P1|Follow-up|Withdrawal by Subject|1
2869214|NCT02096705|9868893|P2|Treatment|Other|1
2869215|NCT02096705|9868894|P1|Treatment|Other|1
2869216|NCT02096705|9868893|P2|Treatment|Withdrawal by Subject|0
2869217|NCT02096705|9868894|P1|Treatment|Withdrawal by Subject|1
2869218|NCT02096705|9868893|P2|Treatment|Subject request to discontinue treatment|1
2869219|NCT02096705|9868894|P1|Treatment|Subject request to discontinue treatment|1
2869220|NCT02096705|9868893|P2|Treatment|Adverse Event|3
2869221|NCT02096705|9868894|P1|Treatment|Adverse Event|6
2869222|NCT02096588|9868937|P2|Overall Study|Withdrawal by Subject|1
2869223|NCT02096588|9868938|P1|Overall Study|Withdrawal by Subject|0
2869224|NCT02096588|9868937|P2|Overall Study|Lack of Efficacy|0
2869225|NCT02096588|9868938|P1|Overall Study|Lack of Efficacy|2
2869226|NCT02096471|9868964|P1|Overall Study|Non-Compliant|2
2869227|NCT02096471|9868964|P1|Overall Study|Withdrawal by Subject|3
2869228|NCT02096471|9868964|P1|Overall Study|Lack of Efficacy|7
2869229|NCT02096471|9868964|P1|Overall Study|Adverse Event|1
2869230|NCT02096263|9868982|P3|Overall Study|Withdrawal by Subject|8
2869231|NCT02096263|9868983|P2|Overall Study|Withdrawal by Subject|7
2869232|NCT02096263|9868984|P1|Overall Study|Withdrawal by Subject|5
2869233|NCT02096263|9868982|P3|Overall Study|Protocol Violation|8
2869234|NCT02096263|9868983|P2|Overall Study|Protocol Violation|2
2869235|NCT02096263|9868984|P1|Overall Study|Protocol Violation|7
2869236|NCT02096263|9868982|P3|Overall Study|Sponsor study termination|1
2869237|NCT02096263|9868983|P2|Overall Study|Sponsor study termination|0
2869238|NCT02096263|9868984|P1|Overall Study|Sponsor study termination|0
2869239|NCT02096263|9868982|P3|Overall Study|Other|6
2869240|NCT02096263|9868983|P2|Overall Study|Other|9
2869241|NCT02096263|9868984|P1|Overall Study|Other|7
2869242|NCT02096263|9868982|P3|Overall Study|Lost to Follow-up|15
2869243|NCT02096263|9868983|P2|Overall Study|Lost to Follow-up|18
2869244|NCT02096263|9868984|P1|Overall Study|Lost to Follow-up|14
2869245|NCT02096263|9868982|P3|Overall Study|Adverse Event|1
2869246|NCT02096263|9868983|P2|Overall Study|Adverse Event|0
2869247|NCT02096263|9868984|P1|Overall Study|Adverse Event|1
2869248|NCT02096042|9869172|P3|Overall Study|Disease Progression|0
2869249|NCT02096042|9869173|P2|Overall Study|Disease Progression|0
2869250|NCT02096042|9869174|P1|Overall Study|Disease Progression|1
2869251|NCT02096003|9869196|P2|Overall Study|additional surgery|1
2869252|NCT02096003|9869197|P1|Overall Study|additional surgery|2
2869253|NCT02096003|9869196|P2|Overall Study|Protocol Violation|2
2869254|NCT02096003|9869197|P1|Overall Study|Protocol Violation|0
2869255|NCT02095951|9869213|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
2869256|NCT02095951|9869214|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
2869257|NCT02095873|9869234|P2|Second Intervention (8 Weeks)|Protocol Violation|0
2869258|NCT02095873|9869235|P1|Second Intervention (8 Weeks)|Protocol Violation|1
2869259|NCT02095873|9869234|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2869260|NCT02095873|9869235|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2869261|NCT02095873|9869234|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
2869262|NCT02095873|9869235|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
2869263|NCT02095691|9869247|P1|Overall Study|Physician Decision|1
2869264|NCT02095535|9869279|P1|Recruitment|Protocol Violation|2
2869265|NCT02095223|9869301|P2|Overall Study|Withdrawal by Subject|0
2869266|NCT02095223|9869302|P1|Overall Study|Withdrawal by Subject|1
2869267|NCT02095197|9869312|P2|Overall Study|Lost to Follow-up|3
2869268|NCT02095197|9869313|P1|Overall Study|Lost to Follow-up|0
2869269|NCT02095158|9869325|P1|Overall Study|Other Miscellaneous Reasons|1
2869270|NCT02095158|9869325|P1|Overall Study|Protocol Violation|1
2869271|NCT02095158|9869325|P1|Overall Study|Personal Reasons|35
2869272|NCT02095158|9869325|P1|Overall Study|Lost to Follow-up|20
2869273|NCT02095158|9869325|P1|Overall Study|Pregnancy|1
2869274|NCT02095158|9869325|P1|Overall Study|Lack of Efficacy|3
2869275|NCT02095158|9869325|P1|Overall Study|Adverse Event|14
2869276|NCT02095145|9869332|P2|Overall Study|Withdrawal by Subject|0
2869277|NCT02095145|9869333|P1|Overall Study|Withdrawal by Subject|1
2869278|NCT02095106|9869379|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2869279|NCT02095106|9869380|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2869280|NCT02094937|9869396|P4|12 Weeks in Period 2|Randomized incorrectly|0
2869281|NCT02094937|9869397|P3|12 Weeks in Period 2|Randomized incorrectly|0
2869282|NCT02094937|9869398|P2|12 Weeks in Period 2|Randomized incorrectly|1
2869283|NCT02094937|9869399|P1|12 Weeks in Period 2|Randomized incorrectly|0
2869284|NCT02094937|9869396|P4|12 Weeks in Period 2|Withdrawal by Subject|0
2869285|NCT02094937|9869397|P3|12 Weeks in Period 2|Withdrawal by Subject|2
2869286|NCT02094937|9869398|P2|12 Weeks in Period 2|Withdrawal by Subject|2
2869287|NCT02094937|9869399|P1|12 Weeks in Period 2|Withdrawal by Subject|0
2869288|NCT02094937|9869396|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
2869289|NCT02094937|9869397|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
2869290|NCT02094937|9869398|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
2869291|NCT02094937|9869399|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
2869292|NCT02094937|9869396|P4|12 Weeks in Period 2|Lack of Efficacy|0
2869293|NCT02094937|9869397|P3|12 Weeks in Period 2|Lack of Efficacy|0
2869294|NCT02094937|9869398|P2|12 Weeks in Period 2|Lack of Efficacy|1
2869295|NCT02094937|9869399|P1|12 Weeks in Period 2|Lack of Efficacy|0
2869296|NCT02094937|9869396|P4|12 Weeks in Period 2|Adverse Event|1
2869297|NCT02094937|9869397|P3|12 Weeks in Period 2|Adverse Event|4
2869298|NCT02094937|9869398|P2|12 Weeks in Period 2|Adverse Event|2
2869299|NCT02094937|9869399|P1|12 Weeks in Period 2|Adverse Event|0
2869300|NCT02094937|9869396|P4|8 Weeks in Period 1|Withdrawal by Subject|0
2869301|NCT02094937|9869397|P3|8 Weeks in Period 1|Withdrawal by Subject|0
2869302|NCT02094937|9869398|P2|8 Weeks in Period 1|Withdrawal by Subject|0
2869303|NCT02094937|9869399|P1|8 Weeks in Period 1|Withdrawal by Subject|4
2869304|NCT02094937|9869396|P4|8 Weeks in Period 1|Physician Decision|0
2869305|NCT02094937|9869397|P3|8 Weeks in Period 1|Physician Decision|0
2869306|NCT02094937|9869398|P2|8 Weeks in Period 1|Physician Decision|0
2869307|NCT02094937|9869399|P1|8 Weeks in Period 1|Physician Decision|1
2869308|NCT02094937|9869396|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
2869309|NCT02094937|9869397|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
2869310|NCT02094937|9869398|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
2869311|NCT02094937|9869399|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
2869312|NCT02094937|9869396|P4|8 Weeks in Period 1|Protocol Violation|0
2869313|NCT02094937|9869397|P3|8 Weeks in Period 1|Protocol Violation|0
2869314|NCT02094937|9869398|P2|8 Weeks in Period 1|Protocol Violation|0
2869315|NCT02094937|9869399|P1|8 Weeks in Period 1|Protocol Violation|2
2869316|NCT02094937|9869396|P4|8 Weeks in Period 1|Lack of Efficacy|0
2869317|NCT02094937|9869397|P3|8 Weeks in Period 1|Lack of Efficacy|0
2869318|NCT02094937|9869398|P2|8 Weeks in Period 1|Lack of Efficacy|0
2869319|NCT02094937|9869399|P1|8 Weeks in Period 1|Lack of Efficacy|3
2869320|NCT02094937|9869396|P4|8 Weeks in Period 1|Adverse Event|0
2869321|NCT02094937|9869397|P3|8 Weeks in Period 1|Adverse Event|0
2869322|NCT02094937|9869398|P2|8 Weeks in Period 1|Adverse Event|0
2869323|NCT02094937|9869399|P1|8 Weeks in Period 1|Adverse Event|9
2869324|NCT02094898|9869429|P1|Overall Study|Lack of Efficacy|1
2869325|NCT02094898|9869429|P1|Overall Study|Adverse Event|2
2869326|NCT02094898|9869429|P1|Overall Study|Clinical Worsening|2
2869327|NCT02094885|9869476|P2|Overall Study|Withdrawn due to age|0
2869328|NCT02094885|9869477|P1|Overall Study|Withdrawn due to age|1
2869329|NCT02094885|9869476|P2|Overall Study|Death|5
2869330|NCT02094885|9869477|P1|Overall Study|Death|1
2869331|NCT02094677|9869500|P2|Overall Study|Screening|1
2869332|NCT02094677|9869501|P1|Overall Study|Screening|3
2869333|NCT02094612|9869580|P2|Overall Study|Never started ADHD medication|23
2869334|NCT02094612|9869581|P1|Overall Study|Never started ADHD medication|32
2869335|NCT02094612|9869580|P2|Overall Study|Lost to Follow-up|47
2869336|NCT02094612|9869581|P1|Overall Study|Lost to Follow-up|47
2869337|NCT02094573|9869601|P2|Overall Study|Ongoing|76
2869338|NCT02094573|9869602|P1|Overall Study|Ongoing|64
2869339|NCT02094573|9869601|P2|Overall Study|Randomized but not treated|0
2869340|NCT02094573|9869602|P1|Overall Study|Randomized but not treated|3
2869341|NCT02094573|9869601|P2|Overall Study|Withdrawal by Subject|4
2869342|NCT02094573|9869602|P1|Overall Study|Withdrawal by Subject|2
2869343|NCT02094573|9869601|P2|Overall Study|Non-compliance with study drug|1
2869344|NCT02094573|9869602|P1|Overall Study|Non-compliance with study drug|0
2869345|NCT02094573|9869601|P2|Overall Study|Death|1
2869346|NCT02094573|9869602|P1|Overall Study|Death|7
2869347|NCT02094573|9869601|P2|Overall Study|Adverse Event|9
2869348|NCT02094573|9869602|P1|Overall Study|Adverse Event|3
2869349|NCT02094573|9869601|P2|Overall Study|Clinical Progressive Disease|3
2869350|NCT02094573|9869602|P1|Overall Study|Clinical Progressive Disease|4
2869351|NCT02094573|9869601|P2|Overall Study|Documented Progressive Disease|16
2869352|NCT02094573|9869602|P1|Overall Study|Documented Progressive Disease|29
2869353|NCT02094300|9869684|P1|Overall Study|Still be eligible for follow-up|3
2869354|NCT02094300|9869684|P1|Overall Study|Lost to Follow-up|10
2869355|NCT02094300|9869684|P1|Overall Study|Death|7
2869356|NCT02094261|9869688|P1|Overall Study|Ongoing Study at Data Cut-off|181
2869357|NCT02094261|9869688|P1|Overall Study|Withdrawal by Subject|4
2869358|NCT02094261|9869688|P1|Overall Study|Lost to Follow-up|1
2869359|NCT02094261|9869688|P1|Overall Study|Death|24
2869360|NCT02093923|9869730|P5|Overall Study|Screen failure after randomization|0
2869361|NCT02093923|9869731|P4|Overall Study|Screen failure after randomization|1
2869362|NCT02093923|9869732|P3|Overall Study|Screen failure after randomization|0
2869363|NCT02093923|9869733|P2|Overall Study|Screen failure after randomization|0
2869364|NCT02093923|9869734|P1|Overall Study|Screen failure after randomization|0
2869365|NCT02093923|9869730|P5|Overall Study|Lost to Follow-up|0
2869366|NCT02093923|9869731|P4|Overall Study|Lost to Follow-up|1
2869367|NCT02093923|9869732|P3|Overall Study|Lost to Follow-up|0
2869368|NCT02093923|9869733|P2|Overall Study|Lost to Follow-up|0
2869369|NCT02093923|9869734|P1|Overall Study|Lost to Follow-up|0
2869370|NCT02093897|9869789|P1|Overall Study|Adverse event, non-fatal|1
2869371|NCT02093897|9869789|P1|Overall Study|Planned age group closure - no's reached|17
2869372|NCT02093897|9869789|P1|Overall Study|Physician Decision|1
2869373|NCT02093689|9869892|P3|Overall Study|Physician Decision|0
2869374|NCT02093689|9869893|P2|Overall Study|Physician Decision|0
2869375|NCT02093689|9869894|P1|Overall Study|Physician Decision|4
2869376|NCT02093663|9869900|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
2869377|NCT02093663|9869901|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2869378|NCT02093663|9869902|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2869379|NCT02093663|9869903|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2869380|NCT02093663|9869904|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2869381|NCT02093663|9869900|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2869382|NCT02093663|9869901|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2869383|NCT02093663|9869902|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2869384|NCT02093663|9869903|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2869385|NCT02093663|9869904|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2869386|NCT02093663|9869900|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
2869387|NCT02093663|9869901|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
2869388|NCT02093663|9869902|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2869389|NCT02093663|9869903|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2869390|NCT02093663|9869904|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2869391|NCT02093663|9869900|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
2869392|NCT02093663|9869901|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
2869393|NCT02093663|9869902|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2869394|NCT02093663|9869903|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2869395|NCT02093663|9869904|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2869396|NCT02093663|9869900|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2869397|NCT02093663|9869901|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2869398|NCT02093663|9869902|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
2869399|NCT02093663|9869903|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2869400|NCT02093663|9869904|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2869401|NCT02093663|9869900|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2869402|NCT02093663|9869901|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2869403|NCT02093663|9869902|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
2869404|NCT02093663|9869903|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2869405|NCT02093663|9869904|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2869406|NCT02093663|9869900|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2869407|NCT02093663|9869901|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2869408|NCT02093663|9869902|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2869409|NCT02093663|9869903|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
2869410|NCT02093663|9869904|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
2869411|NCT02093663|9869900|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2869412|NCT02093663|9869901|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2869413|NCT02093663|9869902|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2869414|NCT02093663|9869903|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2869415|NCT02093663|9869904|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
2869416|NCT02093663|9869900|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2869417|NCT02093663|9869901|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2869418|NCT02093663|9869902|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2869419|NCT02093663|9869903|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2869420|NCT02093663|9869904|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
2869421|NCT02093520|9869933|P2|Overall Study|Not treated|22
2869422|NCT02093520|9869934|P1|Overall Study|Not treated|6
2869423|NCT02093390|9869946|P2|Overall Study|Withdrawal by Subject|1
2869424|NCT02093390|9869947|P1|Overall Study|Withdrawal by Subject|0
2869425|NCT02093351|9869986|P4|Part B|Death|1
2869426|NCT02093351|9869987|P3|Part B|Death|0
2869427|NCT02093351|9869988|P2|Part B|Death|0
2869428|NCT02093351|9869989|P1|Part B|Death|0
2869429|NCT02093351|9869986|P4|Part B|Adverse Event|2
2869430|NCT02093351|9869987|P3|Part B|Adverse Event|0
2869431|NCT02093351|9869988|P2|Part B|Adverse Event|0
2869432|NCT02093351|9869989|P1|Part B|Adverse Event|0
2869433|NCT02093351|9869986|P4|Part B|Condition under investigation worsened|39
2869434|NCT02093351|9869987|P3|Part B|Condition under investigation worsened|0
2869435|NCT02093351|9869988|P2|Part B|Condition under investigation worsened|0
2869436|NCT02093351|9869989|P1|Part B|Condition under investigation worsened|0
2869437|NCT02093351|9869986|P4|Part B|Lack of therapeutic response|12
2869438|NCT02093351|9869987|P3|Part B|Lack of therapeutic response|0
2869439|NCT02093351|9869988|P2|Part B|Lack of therapeutic response|0
2869440|NCT02093351|9869989|P1|Part B|Lack of therapeutic response|0
2869441|NCT02093351|9869986|P4|Part B|Adverse event + disease progression|1
2869442|NCT02093351|9869987|P3|Part B|Adverse event + disease progression|0
2869443|NCT02093351|9869988|P2|Part B|Adverse event + disease progression|0
2869444|NCT02093351|9869989|P1|Part B|Adverse event + disease progression|0
2869445|NCT02093351|9869986|P4|Part B|Complete response|1
2869446|NCT02093351|9869987|P3|Part B|Complete response|0
2869447|NCT02093351|9869988|P2|Part B|Complete response|0
2869448|NCT02093351|9869989|P1|Part B|Complete response|0
2869449|NCT02093351|9869986|P4|Part B|Disease progression|4
2869450|NCT02093351|9869987|P3|Part B|Disease progression|0
2869451|NCT02093351|9869988|P2|Part B|Disease progression|0
2869452|NCT02093351|9869989|P1|Part B|Disease progression|0
2869453|NCT02093351|9869986|P4|Part B|Patient decision|3
2869454|NCT02093351|9869987|P3|Part B|Patient decision|0
2869455|NCT02093351|9869988|P2|Part B|Patient decision|0
2869456|NCT02093351|9869989|P1|Part B|Patient decision|0
2869457|NCT02093351|9869986|P4|Part A|Death|0
2869458|NCT02093351|9869987|P3|Part A|Death|0
2869459|NCT02093351|9869988|P2|Part A|Death|1
2869460|NCT02093351|9869989|P1|Part A|Death|0
2869461|NCT02093351|9869986|P4|Part A|Condition under investigation worsened|0
2869462|NCT02093351|9869987|P3|Part A|Condition under investigation worsened|2
2869463|NCT02093351|9869988|P2|Part A|Condition under investigation worsened|0
2869464|NCT02093351|9869989|P1|Part A|Condition under investigation worsened|2
2869465|NCT02093351|9869986|P4|Part A|Adverse Event|0
2869466|NCT02093351|9869987|P3|Part A|Adverse Event|1
2869467|NCT02093351|9869988|P2|Part A|Adverse Event|1
2869468|NCT02093351|9869989|P1|Part A|Adverse Event|0
2869469|NCT02093221|9870046|P5|Overall Study|Study termination|7
2869470|NCT02093221|9870047|P4|Overall Study|Study termination|6
2869471|NCT02093221|9870048|P3|Overall Study|Study termination|4
2869472|NCT02093221|9870049|P2|Overall Study|Study termination|5
2869473|NCT02093221|9870050|P1|Overall Study|Study termination|6
2869474|NCT02093221|9870046|P5|Overall Study|Protocol Violation|0
2869475|NCT02093221|9870047|P4|Overall Study|Protocol Violation|0
2869476|NCT02093221|9870048|P3|Overall Study|Protocol Violation|0
2869477|NCT02093221|9870049|P2|Overall Study|Protocol Violation|1
2869478|NCT02093221|9870050|P1|Overall Study|Protocol Violation|0
2869479|NCT02093221|9870046|P5|Overall Study|Death|0
2869480|NCT02093221|9870047|P4|Overall Study|Death|0
2869481|NCT02093221|9870048|P3|Overall Study|Death|0
2869482|NCT02093221|9870049|P2|Overall Study|Death|1
2869483|NCT02093221|9870050|P1|Overall Study|Death|0
2869484|NCT02093221|9870046|P5|Overall Study|Lost to Follow-up|0
2869485|NCT02093221|9870047|P4|Overall Study|Lost to Follow-up|1
2869486|NCT02093221|9870048|P3|Overall Study|Lost to Follow-up|1
2869487|NCT02093221|9870049|P2|Overall Study|Lost to Follow-up|0
2869488|NCT02093221|9870050|P1|Overall Study|Lost to Follow-up|2
2869489|NCT02093221|9870046|P5|Overall Study|Withdrawal by Subject|1
2869490|NCT02093221|9870047|P4|Overall Study|Withdrawal by Subject|1
2869491|NCT02093221|9870048|P3|Overall Study|Withdrawal by Subject|4
2869492|NCT02093221|9870049|P2|Overall Study|Withdrawal by Subject|1
2869493|NCT02093221|9870050|P1|Overall Study|Withdrawal by Subject|1
2869494|NCT02093221|9870046|P5|Overall Study|Adverse Event|0
2869495|NCT02093221|9870047|P4|Overall Study|Adverse Event|0
2869496|NCT02093221|9870048|P3|Overall Study|Adverse Event|0
2869497|NCT02093221|9870049|P2|Overall Study|Adverse Event|0
2869498|NCT02093221|9870050|P1|Overall Study|Adverse Event|1
2869499|NCT02093026|9870087|P1|Overall Study|Other|157
2869500|NCT02093026|9870087|P1|Overall Study|Death|10
2869501|NCT02093026|9870087|P1|Overall Study|Adverse Event|26
2869502|NCT02092961|9870109|P3|Overall Study|Adverse Event|0
2869503|NCT02092961|9870110|P2|Overall Study|Adverse Event|4
2869504|NCT02092961|9870111|P1|Overall Study|Adverse Event|2
2869505|NCT02092961|9870109|P3|Overall Study|Dev. of study specific discont. criteria|0
2869506|NCT02092961|9870110|P2|Overall Study|Dev. of study specific discont. criteria|0
2869507|NCT02092961|9870111|P1|Overall Study|Dev. of study specific discont. criteria|3
2869508|NCT02092961|9870109|P3|Overall Study|Lack of therapeutic response|3
2869509|NCT02092961|9870110|P2|Overall Study|Lack of therapeutic response|1
2869510|NCT02092961|9870111|P1|Overall Study|Lack of therapeutic response|2
2869511|NCT02092961|9870109|P3|Overall Study|Study stopped|12
2869512|NCT02092961|9870110|P2|Overall Study|Study stopped|9
2869513|NCT02092961|9870111|P1|Overall Study|Study stopped|13
2869514|NCT02092961|9870109|P3|Overall Study|Not reported|1
2869515|NCT02092961|9870110|P2|Overall Study|Not reported|0
2869516|NCT02092961|9870111|P1|Overall Study|Not reported|1
2869517|NCT02092909|9870136|P4|Overall Study|Miscellaneous|1
2869518|NCT02092909|9870137|P3|Overall Study|Miscellaneous|2
2869519|NCT02092909|9870138|P2|Overall Study|Miscellaneous|1
2869520|NCT02092909|9870139|P1|Overall Study|Miscellaneous|1
2869521|NCT02092909|9870136|P4|Overall Study|Study terminated by Sponsor|2
2869522|NCT02092909|9870137|P3|Overall Study|Study terminated by Sponsor|0
2869523|NCT02092909|9870138|P2|Overall Study|Study terminated by Sponsor|0
2869524|NCT02092909|9870139|P1|Overall Study|Study terminated by Sponsor|0
2869525|NCT02092909|9870136|P4|Overall Study|Withdrawal by Subject|1
2869526|NCT02092909|9870137|P3|Overall Study|Withdrawal by Subject|2
2869527|NCT02092909|9870138|P2|Overall Study|Withdrawal by Subject|0
2869528|NCT02092909|9870139|P1|Overall Study|Withdrawal by Subject|0
2869529|NCT02092909|9870136|P4|Overall Study|Lack of Efficacy|0
2869530|NCT02092909|9870137|P3|Overall Study|Lack of Efficacy|1
2869531|NCT02092909|9870138|P2|Overall Study|Lack of Efficacy|2
2869532|NCT02092909|9870139|P1|Overall Study|Lack of Efficacy|0
2869533|NCT02092909|9870136|P4|Overall Study|Adverse Event|2
2869534|NCT02092909|9870137|P3|Overall Study|Adverse Event|4
2869535|NCT02092909|9870138|P2|Overall Study|Adverse Event|0
2869536|NCT02092909|9870139|P1|Overall Study|Adverse Event|0
2869537|NCT02092662|9870180|P2|Overall Study|Lost to Follow-up|0
2869538|NCT02092662|9870181|P1|Overall Study|Lost to Follow-up|13
2869539|NCT02092389|9870240|P1|Overall Study|Other|5
2869540|NCT02092389|9870240|P1|Overall Study|Adverse Event|1
2869541|NCT02092350|9870252|P2|Overall Study|Withdrawal by Subject|2
2869542|NCT02092350|9870253|P1|Overall Study|Withdrawal by Subject|2
2869543|NCT02092350|9870252|P2|Overall Study|Screen Failure|0
2869544|NCT02092350|9870253|P1|Overall Study|Screen Failure|1
2869545|NCT02092350|9870252|P2|Overall Study|Physician Decision|1
2869546|NCT02092350|9870253|P1|Overall Study|Physician Decision|1
2869547|NCT02092350|9870252|P2|Overall Study|Protocol Violation|0
2869548|NCT02092350|9870253|P1|Overall Study|Protocol Violation|1
2869549|NCT02092350|9870252|P2|Overall Study|Lost to Follow-up|1
2869550|NCT02092350|9870253|P1|Overall Study|Lost to Follow-up|3
2869551|NCT02092350|9870252|P2|Overall Study|Death|5
2869552|NCT02092350|9870253|P1|Overall Study|Death|2
2869553|NCT02092350|9870252|P2|Overall Study|Adverse Event|3
2869554|NCT02092350|9870253|P1|Overall Study|Adverse Event|0
2869555|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
2869556|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
2869557|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
2869558|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Protocol Violation|11
2869559|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Pregnancy|1
2869560|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Physician Decision|10
2869561|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
2869562|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
2869563|NCT02092285|9870281|P1|Maintenance Phase & Follow-up|Adverse Event|22
2869564|NCT02092285|9870281|P1|Induction Phase|Lack of Efficacy|14
2869565|NCT02092285|9870281|P1|Induction Phase|Withdrawal by Subject|2
2869566|NCT02092285|9870281|P1|Induction Phase|Relapse/Recurrence|7
2869567|NCT02092285|9870281|P1|Induction Phase|Pregnancy|1
2869568|NCT02092285|9870281|P1|Induction Phase|Physician Decision|4
2869569|NCT02092285|9870281|P1|Induction Phase|Adverse Event|7
2869570|NCT02092220|9870285|P2|Period 2|Nausea, Anxiety, Inconvenience|1
2869571|NCT02092220|9870286|P1|Period 2|Nausea, Anxiety, Inconvenience|0
2869572|NCT02092220|9870285|P2|Period 2|Severe Hypoglycaemia|0
2869573|NCT02092220|9870286|P1|Period 2|Severe Hypoglycaemia|1
2869574|NCT02092220|9870285|P2|Period 1|Unrelated Illness|2
2869575|NCT02092220|9870286|P1|Period 1|Unrelated Illness|0
2869576|NCT02092116|9870359|P2|Overall Study|Adverse Event|1
2869577|NCT02092116|9870360|P1|Overall Study|Adverse Event|0
2869578|NCT02092116|9870359|P2|Overall Study|Withdrawal by Subject|3
2869579|NCT02092116|9870360|P1|Overall Study|Withdrawal by Subject|0
2869580|NCT02092025|9870369|P1|Overall Study|Protocol Deviation|24
2869581|NCT02092025|9870369|P1|Overall Study|Case Report Forms Uncollected|44
2869582|NCT02091986|9870378|P3|Overall Study|Adverse Event|2
2869583|NCT02091986|9870379|P2|Overall Study|Adverse Event|0
2869584|NCT02091986|9870380|P1|Overall Study|Adverse Event|0
2869585|NCT02091986|9870378|P3|Overall Study|Withdrawal by Subject|3
2869586|NCT02091986|9870379|P2|Overall Study|Withdrawal by Subject|8
2869587|NCT02091986|9870380|P1|Overall Study|Withdrawal by Subject|4
2869588|NCT02091986|9870378|P3|Overall Study|Lost to Follow-up|0
2869589|NCT02091986|9870379|P2|Overall Study|Lost to Follow-up|0
2869590|NCT02091986|9870380|P1|Overall Study|Lost to Follow-up|1
2869591|NCT02091986|9870378|P3|Overall Study|7 rand in error 1 patient decision|3
2869592|NCT02091986|9870379|P2|Overall Study|7 rand in error 1 patient decision|3
2869593|NCT02091986|9870380|P1|Overall Study|7 rand in error 1 patient decision|2
2869594|NCT02091960|9870427|P1|Overall Study|On Study at Data Cut-off|12
2869595|NCT02091960|9870427|P1|Overall Study|Miscellaneous Reasons|31
2869596|NCT02091960|9870427|P1|Overall Study|Withdrawal by Subject|1
2869597|NCT02091960|9870427|P1|Overall Study|Death|7
2869598|NCT02091921|9870438|P1|Overall Study|Adverse Event|3
2869599|NCT02091869|9870447|P2|Overall Study|Withdrawal by Subject|3
2869600|NCT02091869|9870448|P1|Overall Study|Withdrawal by Subject|0
2869601|NCT02091752|9870489|P1|Overall Study|Adverse Event|1
2869602|NCT02091752|9870489|P1|Overall Study|Study terminated by Sponsor|2
2869603|NCT02091739|9870503|P5|EP: 48 Weeks|Withdrawal by Subject|6
2869604|NCT02091739|9870504|P4|EP: 48 Weeks|Withdrawal by Subject|2
2869605|NCT02091739|9870505|P3|EP: 48 Weeks|Withdrawal by Subject|0
2869606|NCT02091739|9870506|P2|EP: 48 Weeks|Withdrawal by Subject|0
2869607|NCT02091739|9870507|P1|EP: 48 Weeks|Withdrawal by Subject|0
2869608|NCT02091739|9870503|P5|EP: 48 Weeks|Adverse Event|6
2869609|NCT02091739|9870504|P4|EP: 48 Weeks|Adverse Event|2
2869610|NCT02091739|9870505|P3|EP: 48 Weeks|Adverse Event|0
2869611|NCT02091739|9870506|P2|EP: 48 Weeks|Adverse Event|0
2869612|NCT02091739|9870507|P1|EP: 48 Weeks|Adverse Event|0
2869613|NCT02091739|9870503|P5|EP: 48 Weeks|Death|2
2869614|NCT02091739|9870504|P4|EP: 48 Weeks|Death|3
2869615|NCT02091739|9870505|P3|EP: 48 Weeks|Death|0
2869616|NCT02091739|9870506|P2|EP: 48 Weeks|Death|0
2869617|NCT02091739|9870507|P1|EP: 48 Weeks|Death|0
2869618|NCT02091739|9870503|P5|EP: 48 Weeks|Other|0
2869619|NCT02091739|9870504|P4|EP: 48 Weeks|Other|1
2869620|NCT02091739|9870505|P3|EP: 48 Weeks|Other|0
2869621|NCT02091739|9870506|P2|EP: 48 Weeks|Other|0
2869622|NCT02091739|9870507|P1|EP: 48 Weeks|Other|0
2869623|NCT02091739|9870503|P5|MP: 16 Weeks|Lost to Follow-up|0
2869624|NCT02091739|9870504|P4|MP: 16 Weeks|Lost to Follow-up|0
2869625|NCT02091739|9870505|P3|MP: 16 Weeks|Lost to Follow-up|1
2869626|NCT02091739|9870506|P2|MP: 16 Weeks|Lost to Follow-up|0
2869627|NCT02091739|9870507|P1|MP: 16 Weeks|Lost to Follow-up|0
2869628|NCT02091739|9870503|P5|MP: 16 Weeks|Withdrawal by Subject|0
2869629|NCT02091739|9870504|P4|MP: 16 Weeks|Withdrawal by Subject|0
2869630|NCT02091739|9870505|P3|MP: 16 Weeks|Withdrawal by Subject|0
2869631|NCT02091739|9870506|P2|MP: 16 Weeks|Withdrawal by Subject|4
2869632|NCT02091739|9870507|P1|MP: 16 Weeks|Withdrawal by Subject|3
2869633|NCT02091739|9870503|P5|MP: 16 Weeks|Adverse Event|0
2869634|NCT02091739|9870504|P4|MP: 16 Weeks|Adverse Event|0
2869635|NCT02091739|9870505|P3|MP: 16 Weeks|Adverse Event|1
2869636|NCT02091739|9870506|P2|MP: 16 Weeks|Adverse Event|1
2869637|NCT02091739|9870507|P1|MP: 16 Weeks|Adverse Event|1
2869638|NCT02091726|9870526|P1|Overall Study|Lost to Follow-up|6
2869639|NCT02091440|9870549|P1|Overall Study|Death|2
2869640|NCT02091414|9870559|P1|Overall Study|Death|2
2869641|NCT02091414|9870559|P1|Overall Study|Withdrawal by Subject|2
2869642|NCT02091375|9870573|P2|Overall Study|Withdrawn by the investigator|0
2869643|NCT02091375|9870574|P1|Overall Study|Withdrawn by the investigator|1
2869644|NCT02091375|9870573|P2|Overall Study|Withdrawal by Subject|1
2869645|NCT02091375|9870574|P1|Overall Study|Withdrawal by Subject|0
2869646|NCT02091375|9870573|P2|Overall Study|Lost to Follow-up|1
2869647|NCT02091375|9870574|P1|Overall Study|Lost to Follow-up|0
2869648|NCT02091375|9870573|P2|Overall Study|Adverse Event|1
2869649|NCT02091375|9870574|P1|Overall Study|Adverse Event|8
2869650|NCT02091362|9870604|P2|Period 2|Withdrawal by Subject|1
2869651|NCT02091362|9870605|P1|Period 2|Withdrawal by Subject|1
2869652|NCT02091362|9870604|P2|Period 2|Lost to Follow-up|1
2869653|NCT02091362|9870605|P1|Period 2|Lost to Follow-up|0
2869654|NCT02091362|9870604|P2|Period 2|Adverse Event|0
2869655|NCT02091362|9870605|P1|Period 2|Adverse Event|1
2869656|NCT02091362|9870604|P2|Wash-out|Withdrawal by Subject|2
2869657|NCT02091362|9870605|P1|Wash-out|Withdrawal by Subject|0
2869658|NCT02091362|9870604|P2|Wash-out|Lost to Follow-up|1
2869659|NCT02091362|9870605|P1|Wash-out|Lost to Follow-up|1
2869660|NCT02091362|9870604|P2|Period 1|Adverse Event|0
2869661|NCT02091362|9870605|P1|Period 1|Adverse Event|2
2869662|NCT02091362|9870604|P2|Period 1|Lost to Follow-up|1
2869663|NCT02091362|9870605|P1|Period 1|Lost to Follow-up|0
2869664|NCT02091362|9870604|P2|Period 1|Withdrawal by Subject|3
2869665|NCT02091362|9870605|P1|Period 1|Withdrawal by Subject|2
2869666|NCT02091362|9870604|P2|Period 1|Protocol Violation|0
2869667|NCT02091362|9870605|P1|Period 1|Protocol Violation|1
2869668|NCT02091284|9870627|P2|Overall Study|unreliable data|0
2869669|NCT02091284|9870628|P1|Overall Study|unreliable data|1
2869670|NCT02091284|9870627|P2|Overall Study|Withdrawal by Subject|1
2869671|NCT02091284|9870628|P1|Overall Study|Withdrawal by Subject|2
2869672|NCT02091206|9870650|P4|Taper Period|Lost to Follow-up|1
2869673|NCT02091206|9870651|P3|Taper Period|Lost to Follow-up|0
2869674|NCT02091206|9870652|P2|Taper Period|Lost to Follow-up|0
2869675|NCT02091206|9870653|P1|Taper Period|Lost to Follow-up|0
2869676|NCT02091206|9870650|P4|Taper Period|Participant refused study drug|1
2869677|NCT02091206|9870651|P3|Taper Period|Participant refused study drug|0
2869678|NCT02091206|9870652|P2|Taper Period|Participant refused study drug|0
2869679|NCT02091206|9870653|P1|Taper Period|Participant refused study drug|1
2869680|NCT02091206|9870650|P4|Treatment Period|Met withdrawal criteria|0
2869681|NCT02091206|9870651|P3|Treatment Period|Met withdrawal criteria|1
2869682|NCT02091206|9870652|P2|Treatment Period|Met withdrawal criteria|0
2869683|NCT02091206|9870653|P1|Treatment Period|Met withdrawal criteria|0
2869684|NCT02091206|9870650|P4|Treatment Period|Adverse Event|0
2869685|NCT02091206|9870651|P3|Treatment Period|Adverse Event|0
2869686|NCT02091206|9870652|P2|Treatment Period|Adverse Event|1
2869687|NCT02091206|9870653|P1|Treatment Period|Adverse Event|0
2869688|NCT02091167|9870672|P2|Overall Study|Lost to Follow-up|2
2869689|NCT02091167|9870673|P1|Overall Study|Lost to Follow-up|0
2869690|NCT02090855|9870686|P1|Overall Study|no evaluable Standard of Truth results|2
2869691|NCT02090764|9870699|P2|Overall Study|Lost to Follow-up|2
2869692|NCT02090764|9870700|P1|Overall Study|Lost to Follow-up|2
2869693|NCT02090764|9870699|P2|Overall Study|Intercurrent illness and other|1
2869694|NCT02090764|9870700|P1|Overall Study|Intercurrent illness and other|1
2869695|NCT02090764|9870699|P2|Overall Study|Withdrawal by Subject|1
2869696|NCT02090764|9870700|P1|Overall Study|Withdrawal by Subject|2
2869697|NCT02090764|9870699|P2|Overall Study|Lack of Efficacy|13
2869698|NCT02090764|9870700|P1|Overall Study|Lack of Efficacy|0
2869699|NCT02090764|9870699|P2|Overall Study|Adverse Event|3
2869700|NCT02090764|9870700|P1|Overall Study|Adverse Event|1
2869701|NCT02090725|9870706|P1|Overall Study|participants moved from area|3
2869702|NCT02090725|9870706|P1|Overall Study|Withdrawal by Subject|1
2869703|NCT02090426|9870712|P2|Overall Study|Lost to Follow-up|6
2869704|NCT02090426|9870713|P1|Overall Study|Lost to Follow-up|12
2869705|NCT02090413|9870744|P3|Overall Study|Lost to Follow-up|0
2869706|NCT02090413|9870745|P2|Overall Study|Lost to Follow-up|1
2869707|NCT02090413|9870746|P1|Overall Study|Lost to Follow-up|1
2869708|NCT02090413|9870744|P3|Overall Study|Other|0
2869709|NCT02090413|9870745|P2|Overall Study|Other|1
2869710|NCT02090413|9870746|P1|Overall Study|Other|2
2869711|NCT02090413|9870744|P3|Overall Study|Investigator Decision|0
2869712|NCT02090413|9870745|P2|Overall Study|Investigator Decision|1
2869713|NCT02090413|9870746|P1|Overall Study|Investigator Decision|1
2869714|NCT02090413|9870744|P3|Overall Study|Withdrawal by Subject|2
2869715|NCT02090413|9870745|P2|Overall Study|Withdrawal by Subject|2
2869716|NCT02090413|9870746|P1|Overall Study|Withdrawal by Subject|2
2869717|NCT02090413|9870744|P3|Overall Study|Flushing event|1
2869718|NCT02090413|9870745|P2|Overall Study|Flushing event|0
2869719|NCT02090413|9870746|P1|Overall Study|Flushing event|2
2869720|NCT02090413|9870744|P3|Overall Study|Adverse Event|20
2869721|NCT02090413|9870745|P2|Overall Study|Adverse Event|15
2869722|NCT02090413|9870746|P1|Overall Study|Adverse Event|11
2869723|NCT02090283|9870823|P3|Overall Study|Protocol Violation|0
2869724|NCT02090283|9870824|P2|Overall Study|Protocol Violation|0
2869725|NCT02090283|9870825|P1|Overall Study|Protocol Violation|2
2869726|NCT02090283|9870823|P3|Overall Study|Adverse Event|0
2869727|NCT02090283|9870824|P2|Overall Study|Adverse Event|1
2869728|NCT02090283|9870825|P1|Overall Study|Adverse Event|1
2869729|NCT02090283|9870823|P3|Overall Study|Lost to Follow-up|3
2869730|NCT02090283|9870824|P2|Overall Study|Lost to Follow-up|2
2869731|NCT02090283|9870825|P1|Overall Study|Lost to Follow-up|2
2869732|NCT02090283|9870823|P3|Overall Study|Sponsor Terminated Study|1
2869733|NCT02090283|9870824|P2|Overall Study|Sponsor Terminated Study|6
2869734|NCT02090283|9870825|P1|Overall Study|Sponsor Terminated Study|6
2869735|NCT02090283|9870823|P3|Overall Study|Withdrawal by Subject|6
2869736|NCT02090283|9870824|P2|Overall Study|Withdrawal by Subject|6
2869737|NCT02090283|9870825|P1|Overall Study|Withdrawal by Subject|6
2869738|NCT02089997|9870859|P1|Overall Study|Protocol Violation|147
2869739|NCT02089997|9870859|P1|Overall Study|Case report forms uncollected|99
2869740|NCT02089737|9870874|P1|Overall Study|Not treated|1
2869741|NCT02089737|9870874|P1|Overall Study|Survey form not completed|5
2869742|NCT02089347|9870899|P2|Overall Study|Protocol Violation|0
2869743|NCT02089347|9870900|P1|Overall Study|Protocol Violation|1
2869744|NCT02088957|9870942|P2|Overall Study|Lack of Efficacy|0
2869745|NCT02088957|9870943|P1|Overall Study|Lack of Efficacy|1
2869746|NCT02088905|9870961|P2|Overall Study|Withdrawal by Subject|1
2869747|NCT02088905|9870962|P1|Overall Study|Withdrawal by Subject|5
2869748|NCT02088177|9871033|P1|Overall Study|Lost to Follow-up|3
2869749|NCT02088073|9871043|P5|Maintanance Phase|Subject compliance|0
2869750|NCT02088073|9871044|P4|Maintanance Phase|Subject compliance|0
2869751|NCT02088073|9871045|P3|Maintanance Phase|Subject compliance|0
2869752|NCT02088073|9871046|P2|Maintanance Phase|Subject compliance|1
2869753|NCT02088073|9871047|P1|Maintanance Phase|Subject compliance|0
2869754|NCT02088073|9871043|P5|Maintanance Phase|Met ECG withdrawal criteria|2
2869755|NCT02088073|9871044|P4|Maintanance Phase|Met ECG withdrawal criteria|0
2869756|NCT02088073|9871045|P3|Maintanance Phase|Met ECG withdrawal criteria|1
2869757|NCT02088073|9871046|P2|Maintanance Phase|Met ECG withdrawal criteria|0
2869758|NCT02088073|9871047|P1|Maintanance Phase|Met ECG withdrawal criteria|0
2869759|NCT02088073|9871043|P5|Maintanance Phase|Miscellaneous|1
2869760|NCT02088073|9871044|P4|Maintanance Phase|Miscellaneous|2
2869761|NCT02088073|9871045|P3|Maintanance Phase|Miscellaneous|1
2869762|NCT02088073|9871046|P2|Maintanance Phase|Miscellaneous|2
2869763|NCT02088073|9871047|P1|Maintanance Phase|Miscellaneous|0
2869764|NCT02088073|9871043|P5|Maintanance Phase|Hypo- or hyperkalemia|1
2869765|NCT02088073|9871044|P4|Maintanance Phase|Hypo- or hyperkalemia|3
2869766|NCT02088073|9871045|P3|Maintanance Phase|Hypo- or hyperkalemia|0
2869767|NCT02088073|9871046|P2|Maintanance Phase|Hypo- or hyperkalemia|3
2869768|NCT02088073|9871047|P1|Maintanance Phase|Hypo- or hyperkalemia|0
2869769|NCT02088073|9871043|P5|Maintanance Phase|Sponsor's decision|1
2869770|NCT02088073|9871044|P4|Maintanance Phase|Sponsor's decision|2
2869771|NCT02088073|9871045|P3|Maintanance Phase|Sponsor's decision|0
2869772|NCT02088073|9871046|P2|Maintanance Phase|Sponsor's decision|2
2869773|NCT02088073|9871047|P1|Maintanance Phase|Sponsor's decision|0
2869774|NCT02088073|9871043|P5|Maintanance Phase|Physician Decision|1
2869775|NCT02088073|9871044|P4|Maintanance Phase|Physician Decision|0
2869776|NCT02088073|9871045|P3|Maintanance Phase|Physician Decision|0
2869777|NCT02088073|9871046|P2|Maintanance Phase|Physician Decision|0
2869778|NCT02088073|9871047|P1|Maintanance Phase|Physician Decision|0
2869779|NCT02088073|9871043|P5|Maintanance Phase|Adverse Event|1
2869780|NCT02088073|9871044|P4|Maintanance Phase|Adverse Event|0
2869781|NCT02088073|9871045|P3|Maintanance Phase|Adverse Event|3
2869782|NCT02088073|9871046|P2|Maintanance Phase|Adverse Event|0
2869783|NCT02088073|9871047|P1|Maintanance Phase|Adverse Event|0
2869784|NCT02088073|9871043|P5|Maintanance Phase|Withdrawal by Subject|0
2869785|NCT02088073|9871044|P4|Maintanance Phase|Withdrawal by Subject|0
2869786|NCT02088073|9871045|P3|Maintanance Phase|Withdrawal by Subject|0
2869787|NCT02088073|9871046|P2|Maintanance Phase|Withdrawal by Subject|2
2869788|NCT02088073|9871047|P1|Maintanance Phase|Withdrawal by Subject|0
2869789|NCT02088073|9871043|P5|Acute Phase|Hyperkalemia|0
2869790|NCT02088073|9871044|P4|Acute Phase|Hyperkalemia|0
2869791|NCT02088073|9871045|P3|Acute Phase|Hyperkalemia|0
2869792|NCT02088073|9871046|P2|Acute Phase|Hyperkalemia|0
2869793|NCT02088073|9871047|P1|Acute Phase|Hyperkalemia|2
2869794|NCT02088073|9871043|P5|Acute Phase|Withdrawal by Subject|0
2869795|NCT02088073|9871044|P4|Acute Phase|Withdrawal by Subject|0
2869796|NCT02088073|9871045|P3|Acute Phase|Withdrawal by Subject|0
2869797|NCT02088073|9871046|P2|Acute Phase|Withdrawal by Subject|0
2869798|NCT02088073|9871047|P1|Acute Phase|Withdrawal by Subject|5
2869799|NCT02087943|9871121|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
2869800|NCT02087943|9871122|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
2869801|NCT02087943|9871123|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
2869802|NCT02087943|9871124|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
2869803|NCT02087943|9871125|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
2869804|NCT02087943|9871121|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
2869805|NCT02087943|9871122|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2869806|NCT02087943|9871123|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2869807|NCT02087943|9871124|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2869808|NCT02087943|9871125|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2869809|NCT02087943|9871121|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2869810|NCT02087943|9871122|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2869811|NCT02087943|9871123|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
2869812|NCT02087943|9871124|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2869813|NCT02087943|9871125|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2869814|NCT02087943|9871121|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2869815|NCT02087943|9871122|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2869816|NCT02087943|9871123|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2869817|NCT02087943|9871124|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
2869818|NCT02087943|9871125|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2869819|NCT02087943|9871121|P5|Active Treatment Phase Week 12-24|Adverse Event|1
2869820|NCT02087943|9871122|P4|Active Treatment Phase Week 12-24|Adverse Event|0
2869821|NCT02087943|9871123|P3|Active Treatment Phase Week 12-24|Adverse Event|2
2869822|NCT02087943|9871124|P2|Active Treatment Phase Week 12-24|Adverse Event|1
2869823|NCT02087943|9871125|P1|Active Treatment Phase Week 12-24|Adverse Event|0
2869824|NCT02087943|9871121|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2869825|NCT02087943|9871122|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2869826|NCT02087943|9871123|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2869827|NCT02087943|9871124|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
2869828|NCT02087943|9871125|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2869829|NCT02087943|9871121|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2869830|NCT02087943|9871122|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2869831|NCT02087943|9871123|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2869832|NCT02087943|9871124|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2869833|NCT02087943|9871125|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2869834|NCT02087943|9871121|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2869835|NCT02087943|9871122|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2869836|NCT02087943|9871123|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2869837|NCT02087943|9871124|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2869838|NCT02087943|9871125|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
2869839|NCT02087943|9871121|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2869840|NCT02087943|9871122|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2869841|NCT02087943|9871123|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
2869842|NCT02087943|9871124|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
2869843|NCT02087943|9871125|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
2869844|NCT02087943|9871121|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2869845|NCT02087943|9871122|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2869846|NCT02087943|9871123|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
2869847|NCT02087943|9871124|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
2869848|NCT02087943|9871125|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
2869849|NCT02087904|9871153|P4|Overall Study|Lost to Follow-up|2
2869850|NCT02087904|9871154|P3|Overall Study|Lost to Follow-up|2
2869851|NCT02087904|9871155|P2|Overall Study|Lost to Follow-up|4
2869852|NCT02087904|9871156|P1|Overall Study|Lost to Follow-up|0
2869853|NCT02087904|9871153|P4|Overall Study|Withdrawal by Subject|4
2869854|NCT02087904|9871154|P3|Overall Study|Withdrawal by Subject|7
2869855|NCT02087904|9871155|P2|Overall Study|Withdrawal by Subject|3
2869856|NCT02087904|9871156|P1|Overall Study|Withdrawal by Subject|8
2869857|NCT02087904|9871153|P4|Overall Study|Other|4
2869858|NCT02087904|9871154|P3|Overall Study|Other|4
2869859|NCT02087904|9871155|P2|Overall Study|Other|2
2869860|NCT02087904|9871156|P1|Overall Study|Other|6
2869861|NCT02087904|9871153|P4|Overall Study|Lack of Efficacy|2
2869862|NCT02087904|9871154|P3|Overall Study|Lack of Efficacy|3
2869863|NCT02087904|9871155|P2|Overall Study|Lack of Efficacy|6
2869864|NCT02087904|9871156|P1|Overall Study|Lack of Efficacy|3
2869865|NCT02087904|9871153|P4|Overall Study|Adverse Event|12
2869866|NCT02087904|9871154|P3|Overall Study|Adverse Event|4
2869867|NCT02087904|9871155|P2|Overall Study|Adverse Event|4
2869868|NCT02087904|9871156|P1|Overall Study|Adverse Event|8
2869869|NCT02087904|9871153|P4|Overall Study|Did Not Receive Study Drug|1
2869870|NCT02087904|9871154|P3|Overall Study|Did Not Receive Study Drug|2
2869871|NCT02087904|9871155|P2|Overall Study|Did Not Receive Study Drug|0
2869872|NCT02087904|9871156|P1|Overall Study|Did Not Receive Study Drug|0
2869873|NCT02087774|9871272|P2|Overall Study|Were absent day of data collection|20
2869874|NCT02087774|9871273|P1|Overall Study|Were absent day of data collection|8
2869875|NCT02087670|9871293|P2|Overall Study|Withdrawal by Subject|2
2869876|NCT02087670|9871294|P1|Overall Study|Withdrawal by Subject|3
2869877|NCT02087423|9871330|P3|Overall Study|Terminated from study at final DCO|25
2869878|NCT02087423|9871331|P2|Overall Study|Terminated from study at final DCO|36
2869879|NCT02087423|9871332|P1|Overall Study|Terminated from study at final DCO|23
2869880|NCT02087423|9871330|P3|Overall Study|Lost to Follow-up|0
2869881|NCT02087423|9871331|P2|Overall Study|Lost to Follow-up|2
2869882|NCT02087423|9871332|P1|Overall Study|Lost to Follow-up|0
2869883|NCT02087423|9871330|P3|Overall Study|Death|40
2869884|NCT02087423|9871331|P2|Overall Study|Death|207
2869885|NCT02087423|9871332|P1|Overall Study|Death|68
2869886|NCT02087423|9871330|P3|Overall Study|Withdrawal by Subject|3
2869887|NCT02087423|9871331|P2|Overall Study|Withdrawal by Subject|20
2869888|NCT02087423|9871332|P1|Overall Study|Withdrawal by Subject|20
2869889|NCT02087241|9871361|P4|Overall Study|Study Terminated by Sponsor|4
2869890|NCT02087241|9871362|P3|Overall Study|Study Terminated by Sponsor|0
2869891|NCT02087241|9871363|P2|Overall Study|Study Terminated by Sponsor|2
2869892|NCT02087241|9871364|P1|Overall Study|Study Terminated by Sponsor|0
2869893|NCT02087241|9871361|P4|Overall Study|Progressive Disease|1
2869894|NCT02087241|9871362|P3|Overall Study|Progressive Disease|0
2869895|NCT02087241|9871363|P2|Overall Study|Progressive Disease|0
2869896|NCT02087241|9871364|P1|Overall Study|Progressive Disease|0
2869897|NCT02087241|9871361|P4|Overall Study|Withdrawal by Subject|1
2869898|NCT02087241|9871362|P3|Overall Study|Withdrawal by Subject|0
2869899|NCT02087241|9871363|P2|Overall Study|Withdrawal by Subject|0
2869900|NCT02087241|9871364|P1|Overall Study|Withdrawal by Subject|1
2869901|NCT02087241|9871361|P4|Overall Study|Death|1
2869902|NCT02087241|9871362|P3|Overall Study|Death|1
2869903|NCT02087241|9871363|P2|Overall Study|Death|1
2869904|NCT02087241|9871364|P1|Overall Study|Death|2
2869905|NCT02087176|9871390|P1|Overall Study|Study Terminated by Sponsor|2
2869906|NCT02087176|9871390|P1|Overall Study|Censored|19
2869907|NCT02087176|9871390|P1|Overall Study|Death|10
2869908|NCT02087176|9871390|P1|Overall Study|Withdrawal by Subject|1
2869909|NCT02087150|9871403|P3|Overall Study|Pt moved out of town|0
2869910|NCT02087150|9871404|P2|Overall Study|Pt moved out of town|1
2869911|NCT02087150|9871405|P1|Overall Study|Pt moved out of town|0
2869912|NCT02087150|9871403|P3|Overall Study|Other|0
2869913|NCT02087150|9871404|P2|Overall Study|Other|0
2869914|NCT02087150|9871405|P1|Overall Study|Other|1
2869915|NCT02087150|9871403|P3|Overall Study|F/U not completed w/in study window|1
2869916|NCT02087150|9871404|P2|Overall Study|F/U not completed w/in study window|0
2869917|NCT02087150|9871405|P1|Overall Study|F/U not completed w/in study window|0
2869918|NCT02087150|9871403|P3|Overall Study|Procedure not done|0
2869919|NCT02087150|9871404|P2|Overall Study|Procedure not done|13
2869920|NCT02087150|9871405|P1|Overall Study|Procedure not done|1
2869921|NCT02087150|9871403|P3|Overall Study|Physician Decision|0
2869922|NCT02087150|9871404|P2|Overall Study|Physician Decision|1
2869923|NCT02087150|9871405|P1|Overall Study|Physician Decision|0
2869924|NCT02087150|9871403|P3|Overall Study|Withdrawal by Subject|3
2869925|NCT02087150|9871404|P2|Overall Study|Withdrawal by Subject|5
2869926|NCT02087150|9871405|P1|Overall Study|Withdrawal by Subject|2
2869927|NCT02087150|9871403|P3|Overall Study|Lost to Follow-up|7
2869928|NCT02087150|9871404|P2|Overall Study|Lost to Follow-up|13
2869929|NCT02087150|9871405|P1|Overall Study|Lost to Follow-up|6
2869930|NCT02087150|9871403|P3|Overall Study|Death|0
2869931|NCT02087150|9871404|P2|Overall Study|Death|1
2869932|NCT02087150|9871405|P1|Overall Study|Death|0
2869933|NCT02087085|9871424|P2|Overall Study|Other Miscellaneous Reasons|4
2869934|NCT02087085|9871425|P1|Overall Study|Other Miscellaneous Reasons|3
2869935|NCT02087085|9871424|P2|Overall Study|Study Terminated by Sponsor|80
2869936|NCT02087085|9871425|P1|Overall Study|Study Terminated by Sponsor|87
2869937|NCT02087085|9871424|P2|Overall Study|Protocol Violation|0
2869938|NCT02087085|9871425|P1|Overall Study|Protocol Violation|1
2869939|NCT02087085|9871424|P2|Overall Study|Withdrawal by Subject|11
2869940|NCT02087085|9871425|P1|Overall Study|Withdrawal by Subject|9
2869941|NCT02087085|9871424|P2|Overall Study|Lost to Follow-up|4
2869942|NCT02087085|9871425|P1|Overall Study|Lost to Follow-up|6
2869943|NCT02087085|9871424|P2|Overall Study|Lack of Efficacy|3
2869944|NCT02087085|9871425|P1|Overall Study|Lack of Efficacy|4
2869945|NCT02087085|9871424|P2|Overall Study|Adverse Event|14
2869946|NCT02087085|9871425|P1|Overall Study|Adverse Event|10
2869947|NCT02087059|9871435|P1|Overall Study|Lost to Follow-up|1
2869948|NCT02087059|9871435|P1|Overall Study|Adverse Event|5
2869949|NCT02087059|9871435|P1|Overall Study|Disease Progression|1
2869950|NCT02086591|9871491|P1|Overall Study|protocol terminated|3
2869951|NCT02086591|9871491|P1|Overall Study|Withdrawal by Subject|1
2869952|NCT02086591|9871491|P1|Overall Study|Adverse Event|1
2869953|NCT02086565|9871499|P2|Overall Study|withdrawn by research team|2
2869954|NCT02086565|9871500|P1|Overall Study|withdrawn by research team|2
2869955|NCT02086565|9871499|P2|Overall Study|Death|2
2869956|NCT02086565|9871500|P1|Overall Study|Death|3
2869957|NCT02086565|9871499|P2|Overall Study|Withdrawal by Subject|1
2869958|NCT02086565|9871500|P1|Overall Study|Withdrawal by Subject|2
2869959|NCT02086565|9871499|P2|Overall Study|Lost to Follow-up|7
2869960|NCT02086565|9871500|P1|Overall Study|Lost to Follow-up|9
2869961|NCT02086552|9871514|P1|Overall Study|Withdrawal by Subject|1
2869962|NCT02086162|9871523|P2|Overall Study|Death|0
2869963|NCT02086162|9871524|P1|Overall Study|Death|1
2869964|NCT02086162|9871523|P2|Overall Study|Lost to Follow-up|2
2869965|NCT02086162|9871524|P1|Overall Study|Lost to Follow-up|4
2869966|NCT02086162|9871523|P2|Overall Study|moved|1
2869967|NCT02086162|9871524|P1|Overall Study|moved|1
2869968|NCT02086162|9871523|P2|Overall Study|Withdrawal by Subject|4
2869969|NCT02086162|9871524|P1|Overall Study|Withdrawal by Subject|4
2869970|NCT02086110|9871536|P2|Overall Study|Withdrawal by Subject|1
2869971|NCT02086110|9871537|P1|Overall Study|Withdrawal by Subject|1
2869972|NCT02085785|9871548|P2|Overall Study|Lost to Follow-up|1
2869973|NCT02085785|9871549|P1|Overall Study|Lost to Follow-up|0
2869974|NCT02085785|9871548|P2|Overall Study|Withdrawal by Subject|1
2869975|NCT02085785|9871549|P1|Overall Study|Withdrawal by Subject|2
2869976|NCT02085252|9871698|P2|Overall Study|Reason Unknown|1
2869977|NCT02085252|9871699|P1|Overall Study|Reason Unknown|0
2869978|NCT02085252|9871698|P2|Overall Study|Reason Not Specified|1
2869979|NCT02085252|9871699|P1|Overall Study|Reason Not Specified|0
2869980|NCT02085252|9871698|P2|Overall Study|Discontinuation Due to Patient Decision|1
2869981|NCT02085252|9871699|P1|Overall Study|Discontinuation Due to Patient Decision|0
2869982|NCT02085252|9871698|P2|Overall Study|Adverse Event|1
2869983|NCT02085252|9871699|P1|Overall Study|Adverse Event|0
2869984|NCT02085252|9871698|P2|Overall Study|Withdrawal of Consent|0
2869985|NCT02085252|9871699|P1|Overall Study|Withdrawal of Consent|1
2869986|NCT02085161|9871723|P4|Overall Study|Other Reason|1
2869987|NCT02085161|9871724|P3|Overall Study|Other Reason|1
2869988|NCT02085161|9871725|P2|Overall Study|Other Reason|0
2869989|NCT02085161|9871726|P1|Overall Study|Other Reason|1
2869990|NCT02085161|9871723|P4|Overall Study|Withdrawal by Subject|3
2869991|NCT02085161|9871724|P3|Overall Study|Withdrawal by Subject|0
2869992|NCT02085161|9871725|P2|Overall Study|Withdrawal by Subject|4
2869993|NCT02085161|9871726|P1|Overall Study|Withdrawal by Subject|2
2869994|NCT02085161|9871723|P4|Overall Study|Protocol Violation|1
2869995|NCT02085161|9871724|P3|Overall Study|Protocol Violation|0
2869996|NCT02085161|9871725|P2|Overall Study|Protocol Violation|1
2869997|NCT02085161|9871726|P1|Overall Study|Protocol Violation|0
2869998|NCT02085161|9871723|P4|Overall Study|Adverse Event|5
2869999|NCT02085161|9871724|P3|Overall Study|Adverse Event|4
2870000|NCT02085161|9871725|P2|Overall Study|Adverse Event|5
2870001|NCT02085161|9871726|P1|Overall Study|Adverse Event|8
2870002|NCT02085161|9871723|P4|Overall Study|Not Treated|0
2870003|NCT02085161|9871724|P3|Overall Study|Not Treated|0
2870004|NCT02085161|9871725|P2|Overall Study|Not Treated|0
2870005|NCT02085161|9871726|P1|Overall Study|Not Treated|1
2870006|NCT02085135|9871767|P2|Overall Study|Lack of Efficacy|0
2870007|NCT02085135|9871768|P1|Overall Study|Lack of Efficacy|2
2870008|NCT02085135|9871767|P2|Overall Study|Withdrawal by Subject|0
2870009|NCT02085135|9871768|P1|Overall Study|Withdrawal by Subject|3
2870010|NCT02085135|9871767|P2|Overall Study|Lost to Follow-up|2
2870011|NCT02085135|9871768|P1|Overall Study|Lost to Follow-up|2
2870012|NCT02085135|9871767|P2|Overall Study|Adverse Event|7
2870013|NCT02085135|9871768|P1|Overall Study|Adverse Event|4
2870014|NCT02084238|9871840|P1|Overall Study|Lost to Follow-up|2
2870015|NCT02084134|9871865|P2|Overall Study|Death|1
2870016|NCT02084134|9871866|P1|Overall Study|Death|0
2870017|NCT02084134|9871865|P2|Overall Study|Protocol Violation|2
2870018|NCT02084134|9871866|P1|Overall Study|Protocol Violation|4
2870019|NCT02084082|9871876|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2870020|NCT02084082|9871877|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870021|NCT02084082|9871878|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870022|NCT02084082|9871879|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870023|NCT02084082|9871876|P4|Washout Period 1 (35 Days)|Adverse Event|1
2870024|NCT02084082|9871877|P3|Washout Period 1 (35 Days)|Adverse Event|1
2870025|NCT02084082|9871878|P2|Washout Period 1 (35 Days)|Adverse Event|0
2870026|NCT02084082|9871879|P1|Washout Period 1 (35 Days)|Adverse Event|0
2870027|NCT02084056|9871920|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870028|NCT02084056|9871921|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870029|NCT02084056|9871922|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2870030|NCT02084056|9871923|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2870031|NCT02084056|9871920|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2870032|NCT02084056|9871921|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2870033|NCT02084056|9871922|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2870034|NCT02084056|9871923|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2870035|NCT02083965|9871955|P2|Treatment Period|Other|0
2870036|NCT02083965|9871956|P1|Treatment Period|Other|1
2870037|NCT02083653|9872051|P3|Overall Study|Reason Missing|4
2870038|NCT02083653|9872052|P2|Overall Study|Reason Missing|0
2870039|NCT02083653|9872053|P1|Overall Study|Reason Missing|0
2870040|NCT02083653|9872051|P3|Overall Study|Other Events|2
2870041|NCT02083653|9872052|P2|Overall Study|Other Events|2
2870042|NCT02083653|9872053|P1|Overall Study|Other Events|0
2870043|NCT02083653|9872051|P3|Overall Study|Withdrawal by Subject|2
2870044|NCT02083653|9872052|P2|Overall Study|Withdrawal by Subject|1
2870045|NCT02083653|9872053|P1|Overall Study|Withdrawal by Subject|2
2870046|NCT02083653|9872051|P3|Overall Study|Progressive Disease|63
2870047|NCT02083653|9872052|P2|Overall Study|Progressive Disease|73
2870048|NCT02083653|9872053|P1|Overall Study|Progressive Disease|65
2870049|NCT02083653|9872051|P3|Overall Study|Death|2
2870050|NCT02083653|9872052|P2|Overall Study|Death|2
2870051|NCT02083653|9872053|P1|Overall Study|Death|2
2870052|NCT02083653|9872051|P3|Overall Study|Lost to Follow-up|0
2870053|NCT02083653|9872052|P2|Overall Study|Lost to Follow-up|0
2870054|NCT02083653|9872053|P1|Overall Study|Lost to Follow-up|1
2870055|NCT02083653|9872051|P3|Overall Study|Adverse Event|4
2870056|NCT02083653|9872052|P2|Overall Study|Adverse Event|5
2870057|NCT02083653|9872053|P1|Overall Study|Adverse Event|12
2870058|NCT02083653|9872051|P3|Overall Study|Randomized but not Treated|7
2870059|NCT02083653|9872052|P2|Overall Study|Randomized but not Treated|2
2870060|NCT02083653|9872053|P1|Overall Study|Randomized but not Treated|0
2870061|NCT02083380|9872121|P3|Overall Study|Other|6
2870062|NCT02083380|9872122|P2|Overall Study|Other|4
2870063|NCT02083380|9872123|P1|Overall Study|Other|8
2870064|NCT02083380|9872121|P3|Overall Study|Lost to Follow-up|3
2870065|NCT02083380|9872122|P2|Overall Study|Lost to Follow-up|3
2870066|NCT02083380|9872123|P1|Overall Study|Lost to Follow-up|5
2870067|NCT02083380|9872121|P3|Overall Study|Adverse Event|1
2870068|NCT02083380|9872122|P2|Overall Study|Adverse Event|0
2870069|NCT02083380|9872123|P1|Overall Study|Adverse Event|0
2870070|NCT02083380|9872121|P3|Overall Study|Physician Decision|3
2870071|NCT02083380|9872122|P2|Overall Study|Physician Decision|6
2870072|NCT02083380|9872123|P1|Overall Study|Physician Decision|1
2870073|NCT02083380|9872121|P3|Overall Study|Withdrawal by Subject|7
2870074|NCT02083380|9872122|P2|Overall Study|Withdrawal by Subject|3
2870075|NCT02083380|9872123|P1|Overall Study|Withdrawal by Subject|9
2870076|NCT02083380|9872121|P3|Overall Study|Lack of Efficacy|64
2870077|NCT02083380|9872122|P2|Overall Study|Lack of Efficacy|79
2870078|NCT02083380|9872123|P1|Overall Study|Lack of Efficacy|68
2870079|NCT02083185|9872228|P3|Overall Study|Did not Receive Study Drug|0
2870080|NCT02083185|9872229|P2|Overall Study|Did not Receive Study Drug|2
2870081|NCT02083185|9872230|P1|Overall Study|Did not Receive Study Drug|0
2870082|NCT02083185|9872228|P3|Overall Study|Study Terminated by Sponsor|0
2870083|NCT02083185|9872229|P2|Overall Study|Study Terminated by Sponsor|1
2870084|NCT02083185|9872230|P1|Overall Study|Study Terminated by Sponsor|0
2870085|NCT02083185|9872228|P3|Overall Study|Reason not Specified|5
2870086|NCT02083185|9872229|P2|Overall Study|Reason not Specified|6
2870087|NCT02083185|9872230|P1|Overall Study|Reason not Specified|9
2870088|NCT02083185|9872228|P3|Overall Study|Death|1
2870089|NCT02083185|9872229|P2|Overall Study|Death|2
2870090|NCT02083185|9872230|P1|Overall Study|Death|2
2870091|NCT02083185|9872228|P3|Overall Study|Withdrawal by Subject|1
2870092|NCT02083185|9872229|P2|Overall Study|Withdrawal by Subject|15
2870093|NCT02083185|9872230|P1|Overall Study|Withdrawal by Subject|9
2870094|NCT02083185|9872228|P3|Overall Study|Lost to Follow-up|0
2870095|NCT02083185|9872229|P2|Overall Study|Lost to Follow-up|3
2870096|NCT02083185|9872230|P1|Overall Study|Lost to Follow-up|0
2870097|NCT02082977|9872335|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870098|NCT02082977|9872336|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870099|NCT02082977|9872337|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
2870100|NCT02082977|9872338|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870101|NCT02082977|9872339|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870102|NCT02082977|9872340|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870103|NCT02082977|9872341|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870104|NCT02082977|9872342|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870105|NCT02082977|9872343|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870106|NCT02082977|9872344|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2870107|NCT02082977|9872335|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
2870108|NCT02082977|9872336|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
2870109|NCT02082977|9872337|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
2870110|NCT02082977|9872338|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
2870111|NCT02082977|9872339|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
2870112|NCT02082977|9872340|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
2870113|NCT02082977|9872341|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
2870114|NCT02082977|9872342|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
2870115|NCT02082977|9872343|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
2870116|NCT02082977|9872344|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
2870117|NCT02082977|9872335|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870118|NCT02082977|9872336|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870119|NCT02082977|9872337|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870120|NCT02082977|9872338|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870121|NCT02082977|9872339|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
2870122|NCT02082977|9872340|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870123|NCT02082977|9872341|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870124|NCT02082977|9872342|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870125|NCT02082977|9872343|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870126|NCT02082977|9872344|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2870127|NCT02082977|9872335|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870128|NCT02082977|9872336|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870129|NCT02082977|9872337|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
2870130|NCT02082977|9872338|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870131|NCT02082977|9872339|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870132|NCT02082977|9872340|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870133|NCT02082977|9872341|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870134|NCT02082977|9872342|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870135|NCT02082977|9872343|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870136|NCT02082977|9872344|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2870137|NCT02082977|9872335|P10|Part 1 (Up to 3.2 Years)|Death|0
2870138|NCT02082977|9872336|P9|Part 1 (Up to 3.2 Years)|Death|1
2870139|NCT02082977|9872337|P8|Part 1 (Up to 3.2 Years)|Death|0
2870140|NCT02082977|9872338|P7|Part 1 (Up to 3.2 Years)|Death|2
2870141|NCT02082977|9872339|P6|Part 1 (Up to 3.2 Years)|Death|1
2870142|NCT02082977|9872340|P5|Part 1 (Up to 3.2 Years)|Death|0
2870143|NCT02082977|9872341|P4|Part 1 (Up to 3.2 Years)|Death|0
2870144|NCT02082977|9872342|P3|Part 1 (Up to 3.2 Years)|Death|0
2870145|NCT02082977|9872343|P2|Part 1 (Up to 3.2 Years)|Death|0
2870146|NCT02082977|9872344|P1|Part 1 (Up to 3.2 Years)|Death|1
2870147|NCT02082912|9872598|P2|Overall Study|Physician Decision|1
2870148|NCT02082912|9872599|P1|Overall Study|Physician Decision|0
2870149|NCT02082522|9872634|P2|Overall Study|Chemotherapy change|3
2870150|NCT02082522|9872635|P1|Overall Study|Chemotherapy change|1
2870151|NCT02082522|9872634|P2|Overall Study|Disease progression|2
2870152|NCT02082522|9872635|P1|Overall Study|Disease progression|2
2870153|NCT02082522|9872634|P2|Overall Study|Physician Decision|1
2870154|NCT02082522|9872635|P1|Overall Study|Physician Decision|3
2870155|NCT02082522|9872634|P2|Overall Study|Lost to Follow-up|0
2870156|NCT02082522|9872635|P1|Overall Study|Lost to Follow-up|1
2870157|NCT02082522|9872634|P2|Overall Study|Death|0
2870158|NCT02082522|9872635|P1|Overall Study|Death|1
2870159|NCT02082522|9872634|P2|Overall Study|Withdrawal by Subject|4
2870160|NCT02082522|9872635|P1|Overall Study|Withdrawal by Subject|2
2870161|NCT02082522|9872634|P2|Overall Study|Sponsor termination|3
2870162|NCT02082522|9872635|P1|Overall Study|Sponsor termination|5
2870163|NCT02082483|9872685|P2|Overall Study|Death|3
2870164|NCT02082483|9872686|P1|Overall Study|Death|2
2870165|NCT02082483|9872685|P2|Overall Study|Physician Decision|1
2870166|NCT02082483|9872686|P1|Overall Study|Physician Decision|1
2870167|NCT02082483|9872685|P2|Overall Study|Withdrawal by Subject|1
2870168|NCT02082483|9872686|P1|Overall Study|Withdrawal by Subject|2
2870169|NCT02082483|9872685|P2|Overall Study|Lost to Follow-up|1
2870170|NCT02082483|9872686|P1|Overall Study|Lost to Follow-up|1
2870171|NCT02082340|9872738|P2|Overall Study|Lost to Follow-up|1
2870172|NCT02082340|9872739|P1|Overall Study|Lost to Follow-up|1
2870173|NCT02082262|9872749|P1|Overall Study|Adverse Event|48
2870174|NCT02082262|9872749|P1|Overall Study|Withdrawal by Subject|3
2870175|NCT02082184|9872755|P2|Overall Study|Subject non-compliance|1
2870176|NCT02082184|9872756|P1|Overall Study|Subject non-compliance|0
2870177|NCT02082184|9872755|P2|Overall Study|Lost to Follow-up|2
2870178|NCT02082184|9872756|P1|Overall Study|Lost to Follow-up|0
2870179|NCT02082184|9872755|P2|Overall Study|Protocol Violation|6
2870180|NCT02082184|9872756|P1|Overall Study|Protocol Violation|0
2870181|NCT02082184|9872755|P2|Overall Study|Withdrawal by Subject|2
2870182|NCT02082184|9872756|P1|Overall Study|Withdrawal by Subject|3
2870183|NCT02082184|9872755|P2|Overall Study|Device associated symptoms|0
2870184|NCT02082184|9872756|P1|Overall Study|Device associated symptoms|5
2870185|NCT02082184|9872755|P2|Overall Study|Medical diagnosis|2
2870186|NCT02082184|9872756|P1|Overall Study|Medical diagnosis|1
2870187|NCT02082184|9872755|P2|Overall Study|Adverse Event|0
2870188|NCT02082184|9872756|P1|Overall Study|Adverse Event|1
2870189|NCT02082158|9872781|P6|Overall Study|Failed Fit-testing|7
2870190|NCT02082158|9872782|P5|Overall Study|Failed Fit-testing|3
2870191|NCT02082158|9872783|P4|Overall Study|Failed Fit-testing|4
2870192|NCT02082158|9872784|P3|Overall Study|Failed Fit-testing|14
2870193|NCT02082158|9872785|P2|Overall Study|Failed Fit-testing|8
2870194|NCT02082158|9872786|P1|Overall Study|Failed Fit-testing|8
2870195|NCT02082158|9872781|P6|Overall Study|Withdrawal by Subject|0
2870196|NCT02082158|9872782|P5|Overall Study|Withdrawal by Subject|1
2870197|NCT02082158|9872783|P4|Overall Study|Withdrawal by Subject|0
2870198|NCT02082158|9872784|P3|Overall Study|Withdrawal by Subject|0
2870199|NCT02082158|9872785|P2|Overall Study|Withdrawal by Subject|0
2870200|NCT02082158|9872786|P1|Overall Study|Withdrawal by Subject|0
2870201|NCT02081859|9872840|P2|Overall Study|Other reasons|0
2870202|NCT02081859|9872841|P1|Overall Study|Other reasons|2
2870203|NCT02081859|9872840|P2|Overall Study|< 4 embryos|23
2870204|NCT02081859|9872841|P1|Overall Study|< 4 embryos|27
2870205|NCT02081859|9872840|P2|Overall Study|Unanticipated freeze all cycle|6
2870206|NCT02081859|9872841|P1|Overall Study|Unanticipated freeze all cycle|2
2870207|NCT02081859|9872840|P2|Overall Study|No sperm|0
2870208|NCT02081859|9872841|P1|Overall Study|No sperm|1
2870209|NCT02081859|9872840|P2|Overall Study|No fertilization|2
2870210|NCT02081859|9872841|P1|Overall Study|No fertilization|2
2870211|NCT02081846|9872851|P2|Overall Study|invalid consent|0
2870212|NCT02081846|9872852|P1|Overall Study|invalid consent|1
2870213|NCT02081846|9872851|P2|Overall Study|Withdrawal by Subject|0
2870214|NCT02081846|9872852|P1|Overall Study|Withdrawal by Subject|1
2870215|NCT02081690|9873021|P1|Overall Study|Withdrawal by Subject|1
2870216|NCT02081690|9873021|P1|Overall Study|Physician Decision|3
2870217|NCT02081690|9873021|P1|Overall Study|Death|3
2870218|NCT02081677|9873032|P4|Overall Study|Unsatisfactory Lens Fitting|0
2870219|NCT02081677|9873033|P3|Overall Study|Unsatisfactory Lens Fitting|0
2870220|NCT02081677|9873034|P2|Overall Study|Unsatisfactory Lens Fitting|1
2870221|NCT02081677|9873035|P1|Overall Study|Unsatisfactory Lens Fitting|0
2870222|NCT02081677|9873032|P4|Overall Study|Not comfortable with lens care system|0
2870223|NCT02081677|9873033|P3|Overall Study|Not comfortable with lens care system|0
2870224|NCT02081677|9873034|P2|Overall Study|Not comfortable with lens care system|0
2870225|NCT02081677|9873035|P1|Overall Study|Not comfortable with lens care system|1
2870226|NCT02081677|9873032|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2870227|NCT02081677|9873033|P3|Overall Study|No Longer Meets Eligibility Criteria|1
2870228|NCT02081677|9873034|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2870229|NCT02081677|9873035|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2870230|NCT02081677|9873032|P4|Overall Study|Adverse Event|0
2870231|NCT02081677|9873033|P3|Overall Study|Adverse Event|1
2870232|NCT02081677|9873034|P2|Overall Study|Adverse Event|0
2870233|NCT02081677|9873035|P1|Overall Study|Adverse Event|0
2870234|NCT02081599|9873127|P2|Period 2：Open-label Period|Withdrawal by Subject|0
2870235|NCT02081599|9873128|P1|Period 2：Open-label Period|Withdrawal by Subject|2
2870236|NCT02081599|9873127|P2|Period 2：Open-label Period|Physician Decision|0
2870237|NCT02081599|9873128|P1|Period 2：Open-label Period|Physician Decision|1
2870238|NCT02081599|9873127|P2|Period 2：Open-label Period|Lack of Efficacy|4
2870239|NCT02081599|9873128|P1|Period 2：Open-label Period|Lack of Efficacy|2
2870240|NCT02081599|9873127|P2|Period 2：Open-label Period|Adverse Event|0
2870241|NCT02081599|9873128|P1|Period 2：Open-label Period|Adverse Event|1
2870242|NCT02081599|9873127|P2|Period 1：Double-blind Period|stopping criteria|0
2870243|NCT02081599|9873128|P1|Period 1：Double-blind Period|stopping criteria|1
2870244|NCT02081599|9873127|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
2870245|NCT02081599|9873128|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
2870246|NCT02081599|9873127|P2|Period 1：Double-blind Period|Protocol Violation|1
2870247|NCT02081599|9873128|P1|Period 1：Double-blind Period|Protocol Violation|0
2870248|NCT02081599|9873127|P2|Period 1：Double-blind Period|Physician Decision|0
2870249|NCT02081599|9873128|P1|Period 1：Double-blind Period|Physician Decision|1
2870250|NCT02081599|9873127|P2|Period 1：Double-blind Period|Lack of Efficacy|1
2870251|NCT02081599|9873128|P1|Period 1：Double-blind Period|Lack of Efficacy|2
2870252|NCT02081599|9873127|P2|Period 1：Double-blind Period|Adverse Event|0
2870253|NCT02081599|9873128|P1|Period 1：Double-blind Period|Adverse Event|3
2870254|NCT02081586|9873146|P4|Overall Study|Head injury not related to study|0
2870255|NCT02081586|9873147|P3|Overall Study|Head injury not related to study|1
2870256|NCT02081586|9873148|P2|Overall Study|Head injury not related to study|0
2870257|NCT02081586|9873149|P1|Overall Study|Head injury not related to study|0
2870258|NCT02081586|9873146|P4|Overall Study|Lost to Follow-up|1
2870259|NCT02081586|9873147|P3|Overall Study|Lost to Follow-up|0
2870260|NCT02081586|9873148|P2|Overall Study|Lost to Follow-up|1
2870261|NCT02081586|9873149|P1|Overall Study|Lost to Follow-up|0
2870262|NCT02081417|9873215|P2|Overall Study|Did not start treatment|21
2870263|NCT02081417|9873216|P1|Overall Study|Did not start treatment|17
2870264|NCT02081417|9873215|P2|Overall Study|Admitted to Residential Treatment|0
2870265|NCT02081417|9873216|P1|Overall Study|Admitted to Residential Treatment|2
2870266|NCT02081417|9873215|P2|Overall Study|Withdrawal by Subject|0
2870267|NCT02081417|9873216|P1|Overall Study|Withdrawal by Subject|4
2870268|NCT02081417|9873215|P2|Overall Study|Death|3
2870269|NCT02081417|9873216|P1|Overall Study|Death|4
2870270|NCT02081417|9873215|P2|Overall Study|Incarcerated|2
2870271|NCT02081417|9873216|P1|Overall Study|Incarcerated|2
2870272|NCT02081417|9873215|P2|Overall Study|Moved Away|2
2870273|NCT02081417|9873216|P1|Overall Study|Moved Away|1
2870274|NCT02081417|9873215|P2|Overall Study|Lost to Follow-up|23
2870275|NCT02081417|9873216|P1|Overall Study|Lost to Follow-up|26
2870276|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Further reasons|0
2870277|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Further reasons|0
2870278|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Further reasons|4
2870279|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Further reasons|3
2870280|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Technical Problems|0
2870281|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Technical Problems|0
2870282|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Technical Problems|1
2870283|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Technical Problems|1
2870284|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
2870285|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
2870286|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
2870287|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
2870288|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Adverse Event|0
2870289|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Adverse Event|0
2870290|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Adverse Event|0
2870291|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Adverse Event|1
2870292|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2870293|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2870294|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
2870295|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
2870296|NCT02081391|9873236|P4|24-hour Treatment and Trial Completion|Physician Decision|0
2870297|NCT02081391|9873237|P3|24-hour Treatment and Trial Completion|Physician Decision|0
2870298|NCT02081391|9873238|P2|24-hour Treatment and Trial Completion|Physician Decision|5
2870299|NCT02081391|9873239|P1|24-hour Treatment and Trial Completion|Physician Decision|10
2870300|NCT02081391|9873236|P4|12-hour Treatment|Further reasons|0
2870301|NCT02081391|9873237|P3|12-hour Treatment|Further reasons|0
2870302|NCT02081391|9873238|P2|12-hour Treatment|Further reasons|1
2870303|NCT02081391|9873239|P1|12-hour Treatment|Further reasons|2
2870304|NCT02081391|9873236|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
2870305|NCT02081391|9873237|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
2870306|NCT02081391|9873238|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
2870307|NCT02081391|9873239|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
2870308|NCT02081391|9873236|P4|12-hour Treatment|Adverse Event|0
2870309|NCT02081391|9873237|P3|12-hour Treatment|Adverse Event|0
2870310|NCT02081391|9873238|P2|12-hour Treatment|Adverse Event|2
2870311|NCT02081391|9873239|P1|12-hour Treatment|Adverse Event|4
2870312|NCT02081391|9873236|P4|12-hour Treatment|Lack of Efficacy|0
2870313|NCT02081391|9873237|P3|12-hour Treatment|Lack of Efficacy|0
2870314|NCT02081391|9873238|P2|12-hour Treatment|Lack of Efficacy|0
2870315|NCT02081391|9873239|P1|12-hour Treatment|Lack of Efficacy|3
2870316|NCT02081391|9873236|P4|12-hour Treatment|Physician Decision|0
2870317|NCT02081391|9873237|P3|12-hour Treatment|Physician Decision|0
2870318|NCT02081391|9873238|P2|12-hour Treatment|Physician Decision|1
2870319|NCT02081391|9873239|P1|12-hour Treatment|Physician Decision|4
2870320|NCT02081391|9873236|P4|12-hour Treatment|Withdrawal by Subject|0
2870321|NCT02081391|9873237|P3|12-hour Treatment|Withdrawal by Subject|0
2870322|NCT02081391|9873238|P2|12-hour Treatment|Withdrawal by Subject|2
2870323|NCT02081391|9873239|P1|12-hour Treatment|Withdrawal by Subject|3
2870324|NCT02081183|9873333|P2|Overall Study|Other|3
2870325|NCT02081183|9873334|P1|Overall Study|Other|3
2870326|NCT02081183|9873333|P2|Overall Study|Protocol Violation|0
2870327|NCT02081183|9873334|P1|Overall Study|Protocol Violation|1
2870328|NCT02081183|9873333|P2|Overall Study|Lost to Follow-up|1
2870329|NCT02081183|9873334|P1|Overall Study|Lost to Follow-up|0
2870330|NCT02081079|9873350|P2|Overall Study|Lost to Follow-up|0
2870331|NCT02081079|9873351|P1|Overall Study|Lost to Follow-up|1
2870332|NCT02081079|9873350|P2|Overall Study|Lack of Efficacy|2
2870333|NCT02081079|9873351|P1|Overall Study|Lack of Efficacy|3
2870334|NCT02081001|9873424|P12|Overall Study|Adverse Event|0
2870335|NCT02081001|9873425|P11|Overall Study|Adverse Event|0
2870336|NCT02081001|9873426|P10|Overall Study|Adverse Event|0
2870337|NCT02081001|9873427|P9|Overall Study|Adverse Event|0
2870338|NCT02081001|9873428|P8|Overall Study|Adverse Event|0
2870339|NCT02081001|9873429|P7|Overall Study|Adverse Event|0
2870340|NCT02081001|9873430|P6|Overall Study|Adverse Event|0
2870341|NCT02081001|9873431|P5|Overall Study|Adverse Event|1
2870342|NCT02081001|9873432|P4|Overall Study|Adverse Event|0
2870343|NCT02081001|9873433|P3|Overall Study|Adverse Event|0
2870344|NCT02081001|9873434|P2|Overall Study|Adverse Event|0
2870345|NCT02081001|9873435|P1|Overall Study|Adverse Event|0
2870346|NCT02080871|9873499|P1|Overall Study|Lost to Follow-up|1
2870347|NCT02080871|9873499|P1|Overall Study|Death|1
2870348|NCT02080832|9873583|P3|Overall Study|Lost to Follow-up|2
2870349|NCT02080832|9873584|P2|Overall Study|Lost to Follow-up|2
2870350|NCT02080832|9873585|P1|Overall Study|Lost to Follow-up|0
2870351|NCT02080832|9873583|P3|Overall Study|Excluded from analysis by MRI|14
2870352|NCT02080832|9873584|P2|Overall Study|Excluded from analysis by MRI|10
2870353|NCT02080832|9873585|P1|Overall Study|Excluded from analysis by MRI|9
2870354|NCT02080481|9873657|P2|Overall Study|Never received a block.|0
2870355|NCT02080481|9873658|P1|Overall Study|Never received a block.|1
2870356|NCT02080260|9873844|P1|Overall Study|Withdrawal by Subject|1
2870357|NCT02080260|9873844|P1|Overall Study|Death|18
2870358|NCT02080091|9873861|P1|Overall Study|Other|1
2870359|NCT02080091|9873861|P1|Overall Study|Withdrawal by Subject|1
2870360|NCT02080091|9873861|P1|Overall Study|Death|1
2870361|NCT02080091|9873861|P1|Overall Study|Study Terminated|22
2870362|NCT02079909|9873889|P3|Overall Study|Relocation etc.|3
2870363|NCT02079909|9873890|P2|Overall Study|Relocation etc.|2
2870364|NCT02079909|9873891|P1|Overall Study|Relocation etc.|2
2870365|NCT02079909|9873889|P3|Overall Study|Physician Decision|1
2870366|NCT02079909|9873890|P2|Overall Study|Physician Decision|1
2870367|NCT02079909|9873891|P1|Overall Study|Physician Decision|0
2870368|NCT02079909|9873889|P3|Overall Study|Protocol Violation|1
2870369|NCT02079909|9873890|P2|Overall Study|Protocol Violation|1
2870370|NCT02079909|9873891|P1|Overall Study|Protocol Violation|0
2870371|NCT02079909|9873889|P3|Overall Study|Lack of Efficacy|1
2870372|NCT02079909|9873890|P2|Overall Study|Lack of Efficacy|0
2870373|NCT02079909|9873891|P1|Overall Study|Lack of Efficacy|0
2870374|NCT02079909|9873889|P3|Overall Study|Death|0
2870375|NCT02079909|9873890|P2|Overall Study|Death|2
2870376|NCT02079909|9873891|P1|Overall Study|Death|2
2870377|NCT02079909|9873889|P3|Overall Study|Lost to Follow-up|1
2870378|NCT02079909|9873890|P2|Overall Study|Lost to Follow-up|3
2870379|NCT02079909|9873891|P1|Overall Study|Lost to Follow-up|2
2870380|NCT02079909|9873889|P3|Overall Study|Withdrawal by Subject|4
2870381|NCT02079909|9873890|P2|Overall Study|Withdrawal by Subject|17
2870382|NCT02079909|9873891|P1|Overall Study|Withdrawal by Subject|9
2870383|NCT02079909|9873889|P3|Overall Study|Adverse Event|7
2870384|NCT02079909|9873890|P2|Overall Study|Adverse Event|23
2870385|NCT02079909|9873891|P1|Overall Study|Adverse Event|23
2870386|NCT02079844|9873908|P3|Treatment Period 2|Voluntary Withdrawal|0
2870387|NCT02079844|9873909|P2|Treatment Period 2|Voluntary Withdrawal|1
2870388|NCT02079844|9873910|P1|Treatment Period 2|Voluntary Withdrawal|0
2870389|NCT02079844|9873908|P3|Treatment Period 1|Voluntary Withdrawal|2
2870390|NCT02079844|9873909|P2|Treatment Period 1|Voluntary Withdrawal|0
2870391|NCT02079844|9873910|P1|Treatment Period 1|Voluntary Withdrawal|0
2870392|NCT02079805|9873968|P2|Overall Study|Voluntary Withdrawal|1
2870393|NCT02079805|9873969|P1|Overall Study|Voluntary Withdrawal|0
2870394|NCT02079805|9873968|P2|Overall Study|Pretreatment Event/Adverse Event|1
2870395|NCT02079805|9873969|P1|Overall Study|Pretreatment Event/Adverse Event|0
2870396|NCT02079649|9873991|P4|Overall Study|Randomization error (prior to treatment)|0
2870397|NCT02079649|9873992|P3|Overall Study|Randomization error (prior to treatment)|1
2870398|NCT02079649|9873993|P2|Overall Study|Randomization error (prior to treatment)|0
2870399|NCT02079649|9873994|P1|Overall Study|Randomization error (prior to treatment)|1
2870400|NCT02079649|9873991|P4|Overall Study|Withdrawal by Subject|1
2870401|NCT02079649|9873992|P3|Overall Study|Withdrawal by Subject|0
2870402|NCT02079649|9873993|P2|Overall Study|Withdrawal by Subject|0
2870403|NCT02079649|9873994|P1|Overall Study|Withdrawal by Subject|0
2870404|NCT02079649|9873991|P4|Overall Study|Lost to Follow-up|1
2870405|NCT02079649|9873992|P3|Overall Study|Lost to Follow-up|0
2870406|NCT02079649|9873993|P2|Overall Study|Lost to Follow-up|0
2870407|NCT02079649|9873994|P1|Overall Study|Lost to Follow-up|0
2870408|NCT02079610|9874011|P2|Overall Study|Withdrawal by Subject|1
2870409|NCT02079610|9874012|P1|Overall Study|Withdrawal by Subject|1
2870410|NCT02079532|9874022|P1|Overall Study|Other|3
2870411|NCT02079532|9874022|P1|Overall Study|Inclusion into ReFIRST|3
2870412|NCT02079532|9874022|P1|Overall Study|Administrative problems|1
2870413|NCT02079532|9874022|P1|Overall Study|Withdrawal by Subject|1
2870414|NCT02079532|9874022|P1|Overall Study|Protocol Violation|3
2870415|NCT02079532|9874022|P1|Overall Study|Lack of Efficacy|9
2870416|NCT02079532|9874022|P1|Overall Study|Additional or changed therapy|2
2870417|NCT02079532|9874022|P1|Overall Study|Adverse Event|7
2870418|NCT02079519|9874044|P1|Overall Study|Adverse Event|1
2870419|NCT02079519|9874044|P1|Overall Study|Disease Progression|9
2870420|NCT02079246|9874057|P2|OLEX-MEM|Other: Moved to nursing home|3
2870421|NCT02079246|9874058|P1|OLEX-MEM|Other: Moved to nursing home|0
2870422|NCT02079246|9874057|P2|OLEX-MEM|Lost to Follow-up|1
2870423|NCT02079246|9874058|P1|OLEX-MEM|Lost to Follow-up|0
2870424|NCT02079246|9874057|P2|OLEX-MEM|Protocol Violation|2
2870425|NCT02079246|9874058|P1|OLEX-MEM|Protocol Violation|0
2870426|NCT02079246|9874057|P2|OLEX-MEM|Withdrawal by Subject|7
2870427|NCT02079246|9874058|P1|OLEX-MEM|Withdrawal by Subject|0
2870428|NCT02079246|9874057|P2|OLEX-MEM|Adverse Event|6
2870429|NCT02079246|9874058|P1|OLEX-MEM|Adverse Event|0
2870430|NCT02079246|9874057|P2|OLEX|Other: Withdrawal of caregiver consent|0
2870431|NCT02079246|9874058|P1|OLEX|Other: Withdrawal of caregiver consent|1
2870432|NCT02079246|9874057|P2|OLEX|Other: Moved to nursing home|0
2870433|NCT02079246|9874058|P1|OLEX|Other: Moved to nursing home|1
2870434|NCT02079246|9874057|P2|OLEX|Other: Worsening of condition|0
2870435|NCT02079246|9874058|P1|OLEX|Other: Worsening of condition|1
2870436|NCT02079246|9874057|P2|OLEX|Other: Coordinator decision|0
2870437|NCT02079246|9874058|P1|OLEX|Other: Coordinator decision|1
2870438|NCT02079246|9874057|P2|OLEX|Other: Caregiver unavailable|0
2870439|NCT02079246|9874058|P1|OLEX|Other: Caregiver unavailable|3
2870440|NCT02079246|9874057|P2|OLEX|Other: Insufficient compliance|0
2870441|NCT02079246|9874058|P1|OLEX|Other: Insufficient compliance|2
2870442|NCT02079246|9874057|P2|OLEX|Other: Disallowed medication|0
2870443|NCT02079246|9874058|P1|OLEX|Other: Disallowed medication|8
2870444|NCT02079246|9874057|P2|OLEX|Results of the lead-in studies|0
2870445|NCT02079246|9874058|P1|OLEX|Results of the lead-in studies|58
2870446|NCT02079246|9874057|P2|OLEX|Lack of Efficacy|0
2870447|NCT02079246|9874058|P1|OLEX|Lack of Efficacy|3
2870448|NCT02079246|9874057|P2|OLEX|Protocol Violation|0
2870449|NCT02079246|9874058|P1|OLEX|Protocol Violation|6
2870450|NCT02079246|9874057|P2|OLEX|Lost to Follow-up|0
2870451|NCT02079246|9874058|P1|OLEX|Lost to Follow-up|6
2870452|NCT02079246|9874057|P2|OLEX|Withdrawal by Subject|0
2870453|NCT02079246|9874058|P1|OLEX|Withdrawal by Subject|60
2870454|NCT02079246|9874057|P2|OLEX|Adverse Event|0
2870455|NCT02079246|9874058|P1|OLEX|Adverse Event|66
2870456|NCT02079246|9874057|P2|OLEX|Death|0
2870457|NCT02079246|9874058|P1|OLEX|Death|11
2870458|NCT02079246|9874057|P2|OLEX|Withdrawal before treatment|0
2870459|NCT02079246|9874058|P1|OLEX|Withdrawal before treatment|1
2870460|NCT02079077|9874077|P2|Overall Study|Became STIs Positive|2
2870461|NCT02079077|9874078|P1|Overall Study|Became STIs Positive|1
2870462|NCT02079077|9874077|P2|Overall Study|Lost to Follow-up|7
2870463|NCT02079077|9874078|P1|Overall Study|Lost to Follow-up|5
2870464|NCT02078960|9874101|P3|Follow-up Period|Lost to Follow-up|0
2870465|NCT02078960|9874102|P2|Follow-up Period|Lost to Follow-up|1
2870466|NCT02078960|9874103|P1|Follow-up Period|Lost to Follow-up|0
2870467|NCT02078960|9874101|P3|Follow-up Period|Death|0
2870468|NCT02078960|9874102|P2|Follow-up Period|Death|0
2870469|NCT02078960|9874103|P1|Follow-up Period|Death|2
2870470|NCT02078960|9874101|P3|Treatment Period|Death|1
2870471|NCT02078960|9874102|P2|Treatment Period|Death|0
2870472|NCT02078960|9874103|P1|Treatment Period|Death|0
2870473|NCT02078960|9874101|P3|Treatment Period|Adverse Event|0
2870474|NCT02078960|9874102|P2|Treatment Period|Adverse Event|0
2870475|NCT02078960|9874103|P1|Treatment Period|Adverse Event|1
2870476|NCT02078960|9874101|P3|Treatment Period|Withdrawal by Subject|1
2870477|NCT02078960|9874102|P2|Treatment Period|Withdrawal by Subject|1
2870478|NCT02078960|9874103|P1|Treatment Period|Withdrawal by Subject|0
2870479|NCT02078960|9874101|P3|Treatment Period|Disease progression - blast phase|0
2870480|NCT02078960|9874102|P2|Treatment Period|Disease progression - blast phase|0
2870481|NCT02078960|9874103|P1|Treatment Period|Disease progression - blast phase|1
2870482|NCT02078960|9874101|P3|Treatment Period|Disease progression - accelerated phase|0
2870483|NCT02078960|9874102|P2|Treatment Period|Disease progression - accelerated phase|1
2870484|NCT02078960|9874103|P1|Treatment Period|Disease progression - accelerated phase|0
2870485|NCT02078960|9874101|P3|Treatment Period|Lack of Efficacy|0
2870486|NCT02078960|9874102|P2|Treatment Period|Lack of Efficacy|1
2870487|NCT02078960|9874103|P1|Treatment Period|Lack of Efficacy|0
2870488|NCT02078960|9874101|P3|Treatment Period|Other|1
2870489|NCT02078960|9874102|P2|Treatment Period|Other|0
2870490|NCT02078960|9874103|P1|Treatment Period|Other|0
2870491|NCT02078817|9874137|P1|Overall Study|Withdrawal by Subject|1
2870492|NCT02078752|9874159|P10|Overall Study|Study terminated by sponsor|5
2870493|NCT02078752|9874160|P9|Overall Study|Study terminated by sponsor|0
2870494|NCT02078752|9874161|P8|Overall Study|Study terminated by sponsor|0
2870495|NCT02078752|9874162|P7|Overall Study|Study terminated by sponsor|0
2870496|NCT02078752|9874163|P6|Overall Study|Study terminated by sponsor|0
2870497|NCT02078752|9874164|P5|Overall Study|Study terminated by sponsor|0
2870498|NCT02078752|9874165|P4|Overall Study|Study terminated by sponsor|0
2870499|NCT02078752|9874166|P3|Overall Study|Study terminated by sponsor|0
2870500|NCT02078752|9874167|P2|Overall Study|Study terminated by sponsor|0
2870501|NCT02078752|9874168|P1|Overall Study|Study terminated by sponsor|0
2870502|NCT02078752|9874159|P10|Overall Study|Other|0
2870503|NCT02078752|9874160|P9|Overall Study|Other|0
2870504|NCT02078752|9874161|P8|Overall Study|Other|1
2870505|NCT02078752|9874162|P7|Overall Study|Other|0
2870506|NCT02078752|9874163|P6|Overall Study|Other|0
2870507|NCT02078752|9874164|P5|Overall Study|Other|1
2870508|NCT02078752|9874165|P4|Overall Study|Other|0
2870509|NCT02078752|9874166|P3|Overall Study|Other|0
2870510|NCT02078752|9874167|P2|Overall Study|Other|3
2870511|NCT02078752|9874168|P1|Overall Study|Other|0
2870512|NCT02078752|9874159|P10|Overall Study|Withdrawal by Subject|1
2870513|NCT02078752|9874160|P9|Overall Study|Withdrawal by Subject|0
2870514|NCT02078752|9874161|P8|Overall Study|Withdrawal by Subject|1
2870515|NCT02078752|9874162|P7|Overall Study|Withdrawal by Subject|2
2870516|NCT02078752|9874163|P6|Overall Study|Withdrawal by Subject|3
2870517|NCT02078752|9874164|P5|Overall Study|Withdrawal by Subject|0
2870518|NCT02078752|9874165|P4|Overall Study|Withdrawal by Subject|1
2870519|NCT02078752|9874166|P3|Overall Study|Withdrawal by Subject|1
2870520|NCT02078752|9874167|P2|Overall Study|Withdrawal by Subject|1
2870521|NCT02078752|9874168|P1|Overall Study|Withdrawal by Subject|1
2870522|NCT02078752|9874159|P10|Overall Study|Lost to Follow-up|0
2870523|NCT02078752|9874160|P9|Overall Study|Lost to Follow-up|0
2870524|NCT02078752|9874161|P8|Overall Study|Lost to Follow-up|0
2870525|NCT02078752|9874162|P7|Overall Study|Lost to Follow-up|0
2870526|NCT02078752|9874163|P6|Overall Study|Lost to Follow-up|0
2870527|NCT02078752|9874164|P5|Overall Study|Lost to Follow-up|0
2870528|NCT02078752|9874165|P4|Overall Study|Lost to Follow-up|1
2870529|NCT02078752|9874166|P3|Overall Study|Lost to Follow-up|0
2870530|NCT02078752|9874167|P2|Overall Study|Lost to Follow-up|0
2870531|NCT02078752|9874168|P1|Overall Study|Lost to Follow-up|1
2870532|NCT02078752|9874159|P10|Overall Study|Death|4
2870533|NCT02078752|9874160|P9|Overall Study|Death|0
2870534|NCT02078752|9874161|P8|Overall Study|Death|1
2870535|NCT02078752|9874162|P7|Overall Study|Death|0
2870536|NCT02078752|9874163|P6|Overall Study|Death|1
2870537|NCT02078752|9874164|P5|Overall Study|Death|0
2870538|NCT02078752|9874165|P4|Overall Study|Death|0
2870539|NCT02078752|9874166|P3|Overall Study|Death|0
2870540|NCT02078752|9874167|P2|Overall Study|Death|3
2870541|NCT02078752|9874168|P1|Overall Study|Death|0
2870542|NCT02078713|9874444|P4|Overall Study|Enrolled twice|0
2870543|NCT02078713|9874445|P3|Overall Study|Enrolled twice|0
2870544|NCT02078713|9874446|P2|Overall Study|Enrolled twice|1
2870545|NCT02078713|9874447|P1|Overall Study|Enrolled twice|0
2870546|NCT02078713|9874444|P4|Overall Study|Pregnant at baseline|0
2870547|NCT02078713|9874445|P3|Overall Study|Pregnant at baseline|0
2870548|NCT02078713|9874446|P2|Overall Study|Pregnant at baseline|5
2870549|NCT02078713|9874447|P1|Overall Study|Pregnant at baseline|3
2870550|NCT02078713|9874444|P4|Overall Study|Lost to Follow-up|0
2870551|NCT02078713|9874445|P3|Overall Study|Lost to Follow-up|0
2870552|NCT02078713|9874446|P2|Overall Study|Lost to Follow-up|55
2870553|NCT02078713|9874447|P1|Overall Study|Lost to Follow-up|49
2870554|NCT02078219|9874532|P5|Overall Study|Adverse Event|0
2870555|NCT02078219|9874533|P4|Overall Study|Adverse Event|1
2870556|NCT02078219|9874534|P3|Overall Study|Adverse Event|3
2870557|NCT02078219|9874535|P2|Overall Study|Adverse Event|1
2870558|NCT02078219|9874536|P1|Overall Study|Adverse Event|1
2870559|NCT02078219|9874532|P5|Overall Study|Death|0
2870560|NCT02078219|9874533|P4|Overall Study|Death|1
2870561|NCT02078219|9874534|P3|Overall Study|Death|0
2870562|NCT02078219|9874535|P2|Overall Study|Death|0
2870563|NCT02078219|9874536|P1|Overall Study|Death|0
2870564|NCT02078219|9874532|P5|Overall Study|Protocol Violation|0
2870565|NCT02078219|9874533|P4|Overall Study|Protocol Violation|1
2870566|NCT02078219|9874534|P3|Overall Study|Protocol Violation|0
2870567|NCT02078219|9874535|P2|Overall Study|Protocol Violation|0
2870568|NCT02078219|9874536|P1|Overall Study|Protocol Violation|0
2870569|NCT02078219|9874532|P5|Overall Study|Withdrawal by Subject|1
2870570|NCT02078219|9874533|P4|Overall Study|Withdrawal by Subject|1
2870571|NCT02078219|9874534|P3|Overall Study|Withdrawal by Subject|0
2870572|NCT02078219|9874535|P2|Overall Study|Withdrawal by Subject|1
2870573|NCT02078219|9874536|P1|Overall Study|Withdrawal by Subject|0
2870574|NCT02078219|9874532|P5|Overall Study|Other|1
2870575|NCT02078219|9874533|P4|Overall Study|Other|0
2870576|NCT02078219|9874534|P3|Overall Study|Other|3
2870577|NCT02078219|9874535|P2|Overall Study|Other|2
2870578|NCT02078219|9874536|P1|Overall Study|Other|2
2870579|NCT02077374|9874586|P2|Overall Study|Protocol Violation|1
2870580|NCT02077374|9874587|P1|Overall Study|Protocol Violation|0
2870581|NCT02077374|9874586|P2|Overall Study|Withdrawal by Subject|1
2870582|NCT02077374|9874587|P1|Overall Study|Withdrawal by Subject|0
2870583|NCT02077140|9874608|P5|Overall Study|Withdrawal by Subject|2
2870584|NCT02077140|9874609|P4|Overall Study|Withdrawal by Subject|2
2870585|NCT02077140|9874610|P3|Overall Study|Withdrawal by Subject|0
2870586|NCT02077140|9874611|P2|Overall Study|Withdrawal by Subject|1
2870587|NCT02077140|9874612|P1|Overall Study|Withdrawal by Subject|0
2870588|NCT02077140|9874608|P5|Overall Study|Lost to Follow-up|3
2870589|NCT02077140|9874609|P4|Overall Study|Lost to Follow-up|2
2870590|NCT02077140|9874610|P3|Overall Study|Lost to Follow-up|2
2870591|NCT02077140|9874611|P2|Overall Study|Lost to Follow-up|1
2870592|NCT02077140|9874612|P1|Overall Study|Lost to Follow-up|4
2870593|NCT02076334|9874890|P4|Overall Study|muscle soreness|1
2870594|NCT02076334|9874891|P3|Overall Study|muscle soreness|0
2870595|NCT02076334|9874892|P2|Overall Study|muscle soreness|0
2870596|NCT02076334|9874893|P1|Overall Study|muscle soreness|0
2870597|NCT02076334|9874890|P4|Overall Study|Lost to Follow-up|0
2870598|NCT02076334|9874891|P3|Overall Study|Lost to Follow-up|1
2870599|NCT02076334|9874892|P2|Overall Study|Lost to Follow-up|1
2870600|NCT02076334|9874893|P1|Overall Study|Lost to Follow-up|0
2870601|NCT02076334|9874890|P4|Overall Study|Protocol Violation|0
2870602|NCT02076334|9874891|P3|Overall Study|Protocol Violation|0
2870603|NCT02076334|9874892|P2|Overall Study|Protocol Violation|0
2870604|NCT02076334|9874893|P1|Overall Study|Protocol Violation|1
2870605|NCT02076178|9874926|P2|Injection Phase|Lost to Follow-up|1
2870606|NCT02076178|9874927|P1|Injection Phase|Lost to Follow-up|0
2870607|NCT02076178|9874926|P2|Injection Phase|Physician Decision|3
2870608|NCT02076178|9874927|P1|Injection Phase|Physician Decision|0
2870609|NCT02076178|9874926|P2|Injection Phase|Withdrawal by Subject|3
2870610|NCT02076178|9874927|P1|Injection Phase|Withdrawal by Subject|0
2870611|NCT02076178|9874926|P2|Injection Phase|Protocol defined stopping criteria|0
2870612|NCT02076178|9874927|P1|Injection Phase|Protocol defined stopping criteria|1
2870613|NCT02076178|9874926|P2|Oral Phase|Physician Decision|1
2870614|NCT02076178|9874927|P1|Oral Phase|Physician Decision|0
2870615|NCT02076178|9874926|P2|Oral Phase|Withdrawal by Subject|4
2870616|NCT02076178|9874927|P1|Oral Phase|Withdrawal by Subject|0
2870617|NCT02076178|9874926|P2|Oral Phase|Adverse Event|7
2870618|NCT02076178|9874927|P1|Oral Phase|Adverse Event|0
2870619|NCT02076165|9874961|P2|Overall Study|Refused follow-up assessment|1
2870620|NCT02076165|9874962|P1|Overall Study|Refused follow-up assessment|1
2870621|NCT02076165|9874961|P2|Overall Study|Lost to Follow-up|5
2870622|NCT02076165|9874962|P1|Overall Study|Lost to Follow-up|7
2870623|NCT02076022|9875032|P2|Overall Study|Withdrawal by Subject|0
2870624|NCT02076022|9875033|P1|Overall Study|Withdrawal by Subject|2
2870625|NCT02076009|9875045|P2|Overall Study|Subjects randomized but not treated|3
2870626|NCT02076009|9875046|P1|Overall Study|Subjects randomized but not treated|2
2870627|NCT02076009|9875045|P2|Overall Study|Ongoing|249
2870628|NCT02076009|9875046|P1|Overall Study|Ongoing|226
2870629|NCT02076009|9875045|P2|Overall Study|Progressive disease|0
2870630|NCT02076009|9875046|P1|Overall Study|Progressive disease|1
2870631|NCT02076009|9875045|P2|Overall Study|Lost to Follow-up|1
2870632|NCT02076009|9875046|P1|Overall Study|Lost to Follow-up|1
2870633|NCT02076009|9875045|P2|Overall Study|Withdrawal by Subject|3
2870634|NCT02076009|9875046|P1|Overall Study|Withdrawal by Subject|9
2870635|NCT02076009|9875045|P2|Overall Study|Death|30
2870636|NCT02076009|9875046|P1|Overall Study|Death|44
2870637|NCT02075840|9875068|P2|Overall Study|Ongoing at CCOD|82
2870638|NCT02075840|9875069|P1|Overall Study|Ongoing at CCOD|99
2870639|NCT02075840|9875068|P2|Overall Study|Physician Decision|3
2870640|NCT02075840|9875069|P1|Overall Study|Physician Decision|1
2870641|NCT02075840|9875068|P2|Overall Study|Lost to Follow-up|2
2870642|NCT02075840|9875069|P1|Overall Study|Lost to Follow-up|3
2870643|NCT02075840|9875068|P2|Overall Study|Death|40
2870644|NCT02075840|9875069|P1|Overall Study|Death|35
2870645|NCT02075840|9875068|P2|Overall Study|Adverse Event|2
2870646|NCT02075840|9875069|P1|Overall Study|Adverse Event|0
2870647|NCT02075840|9875068|P2|Overall Study|Reason not specified|0
2870648|NCT02075840|9875069|P1|Overall Study|Reason not specified|1
2870649|NCT02075840|9875068|P2|Overall Study|Withdrawal by Subject|22
2870650|NCT02075840|9875069|P1|Overall Study|Withdrawal by Subject|13
2870651|NCT02075658|9875125|P2|Overall Study|Physician Decision|2
2870652|NCT02075658|9875126|P1|Overall Study|Physician Decision|2
2870653|NCT02075632|9875136|P2|Overall Study|Withdrawal by Subject|1
2870654|NCT02075632|9875137|P1|Overall Study|Withdrawal by Subject|0
2870655|NCT02075632|9875136|P2|Overall Study|Lost to Follow-up|3
2870656|NCT02075632|9875137|P1|Overall Study|Lost to Follow-up|0
2870657|NCT02075632|9875136|P2|Overall Study|Adverse Event|1
2870658|NCT02075632|9875137|P1|Overall Study|Adverse Event|1
2870659|NCT02075606|9875147|P1|Overall Study|Increasing Symptoms|1
2870660|NCT02075606|9875147|P1|Overall Study|Symptom management|1
2870661|NCT02075606|9875147|P1|Overall Study|Investigator's decision|1
2870662|NCT02075606|9875147|P1|Overall Study|Death|1
2870663|NCT02075606|9875147|P1|Overall Study|Withdrawal by Subject|1
2870664|NCT02075606|9875147|P1|Overall Study|Adverse Event|5
2870665|NCT02075541|9875171|P2|Overall Study|Other- unable to perform study procedure|0
2870666|NCT02075541|9875172|P1|Overall Study|Other- unable to perform study procedure|1
2870667|NCT02075541|9875171|P2|Overall Study|Sponsor study termination|1
2870668|NCT02075541|9875172|P1|Overall Study|Sponsor study termination|0
2870669|NCT02075541|9875171|P2|Overall Study|Withdrawal by Subject|3
2870670|NCT02075541|9875172|P1|Overall Study|Withdrawal by Subject|1
2870671|NCT02075541|9875171|P2|Overall Study|Protocol Violation|0
2870672|NCT02075541|9875172|P1|Overall Study|Protocol Violation|1
2870673|NCT02075541|9875171|P2|Overall Study|Serious Adverse Event|4
2870674|NCT02075541|9875172|P1|Overall Study|Serious Adverse Event|1
2870675|NCT02075515|9875221|P3|Overall Study|Lost to Follow-up|6
2870676|NCT02075515|9875222|P2|Overall Study|Lost to Follow-up|3
2870677|NCT02075515|9875223|P1|Overall Study|Lost to Follow-up|1
2870678|NCT02075515|9875221|P3|Overall Study|Withdrawal by Subject|1
2870679|NCT02075515|9875222|P2|Overall Study|Withdrawal by Subject|0
2870680|NCT02075515|9875223|P1|Overall Study|Withdrawal by Subject|2
2870681|NCT02075515|9875221|P3|Overall Study|Non-Serious Adverse Event|0
2870682|NCT02075515|9875222|P2|Overall Study|Non-Serious Adverse Event|1
2870683|NCT02075515|9875223|P1|Overall Study|Non-Serious Adverse Event|0
2870684|NCT02075515|9875221|P3|Overall Study|Serious Adverse Event|1
2870685|NCT02075515|9875222|P2|Overall Study|Serious Adverse Event|1
2870686|NCT02075515|9875223|P1|Overall Study|Serious Adverse Event|1
2870687|NCT02075476|9875260|P2|Overall Study|Lost to Follow-up|3
2870688|NCT02075476|9875261|P1|Overall Study|Lost to Follow-up|1
2870689|NCT02075476|9875260|P2|Overall Study|Death|2
2870690|NCT02075476|9875261|P1|Overall Study|Death|2
2870691|NCT02075463|9875271|P1|Overall Study|Withdrawal by Subject|1
2870692|NCT02075463|9875271|P1|Overall Study|Par. reached stopping criteria|4
2870693|NCT02075463|9875271|P1|Overall Study|Adverse Event|3
2870694|NCT02075320|9875321|P1|Overall Study|Withdrawal by Subject|2
2870695|NCT02075255|9875331|P3|Overall Study|Death|0
2870696|NCT02075255|9875332|P2|Overall Study|Death|2
2870697|NCT02075255|9875333|P1|Overall Study|Death|0
2870698|NCT02075255|9875331|P3|Overall Study|Adverse Event|1
2870699|NCT02075255|9875332|P2|Overall Study|Adverse Event|0
2870700|NCT02075255|9875333|P1|Overall Study|Adverse Event|0
2870701|NCT02075255|9875331|P3|Overall Study|Lost to Follow-up|1
2870702|NCT02075255|9875332|P2|Overall Study|Lost to Follow-up|0
2870703|NCT02075255|9875333|P1|Overall Study|Lost to Follow-up|0
2870704|NCT02075255|9875331|P3|Overall Study|Withdrawal by Subject|0
2870705|NCT02075255|9875332|P2|Overall Study|Withdrawal by Subject|1
2870706|NCT02075255|9875333|P1|Overall Study|Withdrawal by Subject|4
2870707|NCT02075255|9875331|P3|Overall Study|Study specific withdrawal criteria|1
2870708|NCT02075255|9875332|P2|Overall Study|Study specific withdrawal criteria|1
2870709|NCT02075255|9875333|P1|Overall Study|Study specific withdrawal criteria|0
2870710|NCT02075203|9875443|P3|Overall Study|participant refused to use contraception|0
2870711|NCT02075203|9875444|P2|Overall Study|participant refused to use contraception|0
2870712|NCT02075203|9875445|P1|Overall Study|participant refused to use contraception|1
2870713|NCT02075203|9875443|P3|Overall Study|Adverse Event|0
2870714|NCT02075203|9875444|P2|Overall Study|Adverse Event|0
2870715|NCT02075203|9875445|P1|Overall Study|Adverse Event|1
2870716|NCT02075203|9875443|P3|Overall Study|Withdrawal by Subject|1
2870717|NCT02075203|9875444|P2|Overall Study|Withdrawal by Subject|0
2870718|NCT02075203|9875445|P1|Overall Study|Withdrawal by Subject|1
2870719|NCT02075073|9875486|P3|Overall Study|Withdrawal by Subject|0
2870720|NCT02075073|9875487|P2|Overall Study|Withdrawal by Subject|1
2870721|NCT02075073|9875488|P1|Overall Study|Withdrawal by Subject|0
2870722|NCT02075008|9875510|P1|Overall Study|Study terminated by Sponsor|159
2870723|NCT02075008|9875510|P1|Overall Study|Withdrawal by Subject|6
2870724|NCT02075008|9875510|P1|Overall Study|Adverse Event|5
2870725|NCT02075008|9875510|P1|Overall Study|Death|1
2870726|NCT02075008|9875510|P1|Overall Study|Lack of Efficacy|1
2870727|NCT02075008|9875510|P1|Overall Study|Lost to Follow-up|1
2870728|NCT02075008|9875510|P1|Overall Study|Physician Decision|1
2870729|NCT02075008|9875510|P1|Overall Study|Pregnancy|1
2870730|NCT02075008|9875510|P1|Overall Study|Technical problems|1
2870731|NCT02074982|9875533|P2|Overall Study|Death|2
2870732|NCT02074982|9875534|P1|Overall Study|Death|0
2870733|NCT02074982|9875533|P2|Overall Study|Subject/guardian decision|24
2870734|NCT02074982|9875534|P1|Overall Study|Subject/guardian decision|15
2870735|NCT02074982|9875533|P2|Overall Study|Technical problems|2
2870736|NCT02074982|9875534|P1|Overall Study|Technical problems|0
2870737|NCT02074982|9875533|P2|Overall Study|Protocol deviation|3
2870738|NCT02074982|9875534|P1|Overall Study|Protocol deviation|4
2870739|NCT02074982|9875533|P2|Overall Study|Pregnancy|2
2870740|NCT02074982|9875534|P1|Overall Study|Pregnancy|1
2870741|NCT02074982|9875533|P2|Overall Study|Physician Decision|1
2870742|NCT02074982|9875534|P1|Overall Study|Physician Decision|1
2870743|NCT02074982|9875533|P2|Overall Study|Non-compliance with study treatment|2
2870744|NCT02074982|9875534|P1|Overall Study|Non-compliance with study treatment|0
2870745|NCT02074982|9875533|P2|Overall Study|Lost to Follow-up|10
2870746|NCT02074982|9875534|P1|Overall Study|Lost to Follow-up|9
2870747|NCT02074982|9875533|P2|Overall Study|Lack of Efficacy|1
2870748|NCT02074982|9875534|P1|Overall Study|Lack of Efficacy|6
2870749|NCT02074982|9875533|P2|Overall Study|Adverse Event|7
2870750|NCT02074982|9875534|P1|Overall Study|Adverse Event|15
2870751|NCT02074553|9875581|P8|Washout Period 3|Physician Decision|1
2870752|NCT02074553|9875582|P7|Washout Period 3|Physician Decision|0
2870753|NCT02074553|9875583|P6|Washout Period 3|Physician Decision|0
2870754|NCT02074553|9875584|P5|Washout Period 3|Physician Decision|0
2870755|NCT02074553|9875585|P4|Washout Period 3|Physician Decision|0
2870756|NCT02074553|9875586|P3|Washout Period 3|Physician Decision|0
2870757|NCT02074553|9875587|P2|Washout Period 3|Physician Decision|0
2870758|NCT02074553|9875588|P1|Washout Period 3|Physician Decision|0
2870759|NCT02074553|9875581|P8|Washout Period 2|Lost to Follow-up|0
2870760|NCT02074553|9875582|P7|Washout Period 2|Lost to Follow-up|0
2870761|NCT02074553|9875583|P6|Washout Period 2|Lost to Follow-up|0
2870762|NCT02074553|9875584|P5|Washout Period 2|Lost to Follow-up|0
2870763|NCT02074553|9875585|P4|Washout Period 2|Lost to Follow-up|0
2870764|NCT02074553|9875586|P3|Washout Period 2|Lost to Follow-up|1
2870765|NCT02074553|9875587|P2|Washout Period 2|Lost to Follow-up|0
2870766|NCT02074553|9875588|P1|Washout Period 2|Lost to Follow-up|0
2870767|NCT02074553|9875581|P8|Washout Period 2|Physician Decision|0
2870768|NCT02074553|9875582|P7|Washout Period 2|Physician Decision|0
2870769|NCT02074553|9875583|P6|Washout Period 2|Physician Decision|1
2870770|NCT02074553|9875584|P5|Washout Period 2|Physician Decision|0
2870771|NCT02074553|9875585|P4|Washout Period 2|Physician Decision|0
2870772|NCT02074553|9875586|P3|Washout Period 2|Physician Decision|0
2870773|NCT02074553|9875587|P2|Washout Period 2|Physician Decision|0
2870774|NCT02074553|9875588|P1|Washout Period 2|Physician Decision|0
2870775|NCT02074553|9875581|P8|Washout Period 2|Adverse Event|0
2870776|NCT02074553|9875582|P7|Washout Period 2|Adverse Event|1
2870777|NCT02074553|9875583|P6|Washout Period 2|Adverse Event|0
2870778|NCT02074553|9875584|P5|Washout Period 2|Adverse Event|0
2870779|NCT02074553|9875585|P4|Washout Period 2|Adverse Event|0
2870780|NCT02074553|9875586|P3|Washout Period 2|Adverse Event|0
2870781|NCT02074553|9875587|P2|Washout Period 2|Adverse Event|0
2870782|NCT02074553|9875588|P1|Washout Period 2|Adverse Event|0
2870783|NCT02074553|9875581|P8|Washout Period 1|Other|0
2870784|NCT02074553|9875582|P7|Washout Period 1|Other|0
2870785|NCT02074553|9875583|P6|Washout Period 1|Other|1
2870786|NCT02074553|9875584|P5|Washout Period 1|Other|0
2870787|NCT02074553|9875585|P4|Washout Period 1|Other|0
2870788|NCT02074553|9875586|P3|Washout Period 1|Other|0
2870789|NCT02074553|9875587|P2|Washout Period 1|Other|0
2870790|NCT02074553|9875588|P1|Washout Period 1|Other|0
2870791|NCT02074553|9875581|P8|Washout Period 1|Physician Decision|0
2870792|NCT02074553|9875582|P7|Washout Period 1|Physician Decision|0
2870793|NCT02074553|9875583|P6|Washout Period 1|Physician Decision|0
2870794|NCT02074553|9875584|P5|Washout Period 1|Physician Decision|0
2870795|NCT02074553|9875585|P4|Washout Period 1|Physician Decision|1
2870796|NCT02074553|9875586|P3|Washout Period 1|Physician Decision|0
2870797|NCT02074553|9875587|P2|Washout Period 1|Physician Decision|0
2870798|NCT02074553|9875588|P1|Washout Period 1|Physician Decision|0
2870799|NCT02074553|9875581|P8|Washout Period 1|Adverse Event|0
2870800|NCT02074553|9875582|P7|Washout Period 1|Adverse Event|0
2870801|NCT02074553|9875583|P6|Washout Period 1|Adverse Event|0
2870802|NCT02074553|9875584|P5|Washout Period 1|Adverse Event|0
2870803|NCT02074553|9875585|P4|Washout Period 1|Adverse Event|0
2870804|NCT02074553|9875586|P3|Washout Period 1|Adverse Event|0
2870805|NCT02074553|9875587|P2|Washout Period 1|Adverse Event|0
2870806|NCT02074553|9875588|P1|Washout Period 1|Adverse Event|1
2870807|NCT02074553|9875581|P8|Intervention Period 1|Family Emergency|0
2870808|NCT02074553|9875582|P7|Intervention Period 1|Family Emergency|0
2870809|NCT02074553|9875583|P6|Intervention Period 1|Family Emergency|0
2870810|NCT02074553|9875584|P5|Intervention Period 1|Family Emergency|0
2870811|NCT02074553|9875585|P4|Intervention Period 1|Family Emergency|1
2870812|NCT02074553|9875586|P3|Intervention Period 1|Family Emergency|0
2870813|NCT02074553|9875587|P2|Intervention Period 1|Family Emergency|0
2870814|NCT02074553|9875588|P1|Intervention Period 1|Family Emergency|0
2870815|NCT02074514|9875770|P2|Overall Study|Withdrew Consent|1
2870816|NCT02074514|9875771|P1|Overall Study|Withdrew Consent|0
2870817|NCT02074514|9875770|P2|Overall Study|Lost to Follow-up|1
2870818|NCT02074514|9875771|P1|Overall Study|Lost to Follow-up|0
2870819|NCT02074514|9875770|P2|Overall Study|Lack of Efficacy|2
2870820|NCT02074514|9875771|P1|Overall Study|Lack of Efficacy|3
2870821|NCT02074059|9875912|P6|Overall Study|Death|1
2870822|NCT02074059|9875913|P5|Overall Study|Death|1
2870823|NCT02074059|9875914|P4|Overall Study|Death|0
2870824|NCT02074059|9875915|P3|Overall Study|Death|0
2870825|NCT02074059|9875916|P2|Overall Study|Death|0
2870826|NCT02074059|9875917|P1|Overall Study|Death|0
2870827|NCT02073929|9875961|P2|Overall Study|Withdrawal by Subject|1
2870828|NCT02073929|9875962|P1|Overall Study|Withdrawal by Subject|0
2870829|NCT02073929|9875961|P2|Overall Study|Adverse Event|1
2870830|NCT02073929|9875962|P1|Overall Study|Adverse Event|2
2870831|NCT02073929|9875961|P2|Overall Study|Lost to Follow-up|1
2870832|NCT02073929|9875962|P1|Overall Study|Lost to Follow-up|2
2870833|NCT02073682|9875999|P2|Overall Study|ID: Benefit/Risk Judgment|46
2870834|NCT02073682|9876000|P1|Overall Study|ID: Benefit/Risk Judgment|32
2870835|NCT02073682|9875999|P2|Overall Study|Lost to Follow-up|1
2870836|NCT02073682|9876000|P1|Overall Study|Lost to Follow-up|1
2870837|NCT02073682|9875999|P2|Overall Study|PD: Inconvenience of Dosing|78
2870838|NCT02073682|9876000|P1|Overall Study|PD: Inconvenience of Dosing|21
2870839|NCT02073682|9875999|P2|Overall Study|No reason provided|9
2870840|NCT02073682|9876000|P1|Overall Study|No reason provided|11
2870841|NCT02073682|9875999|P2|Overall Study|Adverse Event|62
2870842|NCT02073682|9876000|P1|Overall Study|Adverse Event|79
2870843|NCT02073682|9875999|P2|Overall Study|Protocol Violation|0
2870844|NCT02073682|9876000|P1|Overall Study|Protocol Violation|1
2870845|NCT02073682|9875999|P2|Overall Study|Cancer Progression|33
2870846|NCT02073682|9876000|P1|Overall Study|Cancer Progression|53
2870847|NCT02073682|9875999|P2|Overall Study|Start of New Chemotherapy Regimen|3
2870848|NCT02073682|9876000|P1|Overall Study|Start of New Chemotherapy Regimen|6
2870849|NCT02073682|9875999|P2|Overall Study|Withdrawal by Subject|8
2870850|NCT02073682|9876000|P1|Overall Study|Withdrawal by Subject|6
2870851|NCT02073682|9875999|P2|Overall Study|Surgery/Medical Procedure|1
2870852|NCT02073682|9876000|P1|Overall Study|Surgery/Medical Procedure|3
2870853|NCT02073682|9875999|P2|Overall Study|Platelet Count <50,000/mL|2
2870854|NCT02073682|9876000|P1|Overall Study|Platelet Count <50,000/mL|1
2870855|NCT02073682|9875999|P2|Overall Study|Prohibited Concomitant Medication Use|1
2870856|NCT02073682|9876000|P1|Overall Study|Prohibited Concomitant Medication Use|0
2870857|NCT02073682|9875999|P2|Overall Study|ID: Palliative Treatment Only|7
2870858|NCT02073682|9876000|P1|Overall Study|ID: Palliative Treatment Only|10
2870859|NCT02073682|9875999|P2|Overall Study|ID: Patient Noncompliance|2
2870860|NCT02073682|9876000|P1|Overall Study|ID: Patient Noncompliance|1
2870861|NCT02073682|9875999|P2|Overall Study|Cancer Cured|15
2870862|NCT02073682|9876000|P1|Overall Study|Cancer Cured|10
2870863|NCT02073682|9875999|P2|Overall Study|Death|100
2870864|NCT02073682|9876000|P1|Overall Study|Death|86
2870865|NCT02073682|9875999|P2|Overall Study|Low Creatinine Clearance|2
2870866|NCT02073682|9876000|P1|Overall Study|Low Creatinine Clearance|1
2870867|NCT02073656|9876018|P1|Primary Study|Withdrew Consent|1
2870868|NCT02073656|9876018|P1|Primary Study|Death|1
2870869|NCT02073656|9876018|P1|Primary Study|Lost to Follow-up|6
2870870|NCT02073643|9876034|P1|Overall Study|Lost to Follow-up|24
2870871|NCT02073565|9876045|P2|Cohort C|Lost to Follow-up|2
2870872|NCT02073565|9876046|P1|Cohort C|Lost to Follow-up|0
2870873|NCT02073565|9876045|P2|Cohort C|Withdrawal by Subject|2
2870874|NCT02073565|9876046|P1|Cohort C|Withdrawal by Subject|0
2870875|NCT02073565|9876045|P2|Cohort B|Withdrawal by Subject|2
2870876|NCT02073565|9876046|P1|Cohort B|Withdrawal by Subject|1
2870877|NCT02073565|9876045|P2|Cohort A|Withdrawal by Subject|0
2870878|NCT02073565|9876046|P1|Cohort A|Withdrawal by Subject|1
2870879|NCT02072980|9876166|P2|Period 2, Second Wear|Adverse Event|1
2870880|NCT02072980|9876167|P1|Period 2, Second Wear|Adverse Event|0
2870881|NCT02072941|9876175|P2|Overall Study|Removed by Study Staff|2
2870882|NCT02072941|9876176|P1|Overall Study|Removed by Study Staff|2
2870883|NCT02072941|9876175|P2|Overall Study|Death|2
2870884|NCT02072941|9876176|P1|Overall Study|Death|3
2870885|NCT02072941|9876175|P2|Overall Study|Lost to Follow-up|4
2870886|NCT02072941|9876176|P1|Overall Study|Lost to Follow-up|4
2870887|NCT02072941|9876175|P2|Overall Study|Withdrawal by Subject|21
2870888|NCT02072941|9876176|P1|Overall Study|Withdrawal by Subject|29
2870889|NCT02072824|9876191|P3|Overall Study|Adverse Event|1
2870890|NCT02072824|9876192|P2|Overall Study|Adverse Event|0
2870891|NCT02072824|9876193|P1|Overall Study|Adverse Event|0
2870892|NCT02072824|9876191|P3|Overall Study|Medication error|0
2870893|NCT02072824|9876192|P2|Overall Study|Medication error|1
2870894|NCT02072824|9876193|P1|Overall Study|Medication error|0
2870895|NCT02072824|9876191|P3|Overall Study|No longer willing to participate|1
2870896|NCT02072824|9876192|P2|Overall Study|No longer willing to participate|0
2870897|NCT02072824|9876193|P1|Overall Study|No longer willing to participate|1
2870898|NCT02072824|9876191|P3|Overall Study|Insufficient clinical response|1
2870899|NCT02072824|9876192|P2|Overall Study|Insufficient clinical response|0
2870900|NCT02072824|9876193|P1|Overall Study|Insufficient clinical response|1
2870901|NCT02072668|9876228|P2|Second Intervention|Lost to Follow-up|0
2870902|NCT02072668|9876229|P1|Second Intervention|Lost to Follow-up|1
2870903|NCT02072434|9876269|P2|Overall Study|Lost to Follow-up|1
2870904|NCT02072434|9876270|P1|Overall Study|Lost to Follow-up|0
2870905|NCT02072434|9876269|P2|Overall Study|Other|29
2870906|NCT02072434|9876270|P1|Overall Study|Other|14
2870907|NCT02072434|9876269|P2|Overall Study|Withdrawal by Subject|29
2870908|NCT02072434|9876270|P1|Overall Study|Withdrawal by Subject|17
2870909|NCT02072434|9876269|P2|Overall Study|Adverse Event|6
2870910|NCT02072434|9876270|P1|Overall Study|Adverse Event|7
2870911|NCT02072434|9876269|P2|Overall Study|Adverse event, serious fatal|6
2870912|NCT02072434|9876270|P1|Overall Study|Adverse event, serious fatal|1
2870913|NCT02072434|9876269|P2|Overall Study|Physician Decision|10
2870914|NCT02072434|9876270|P1|Overall Study|Physician Decision|5
2870915|NCT02072434|9876269|P2|Overall Study|Protocol Violation|9
2870916|NCT02072434|9876270|P1|Overall Study|Protocol Violation|10
2870917|NCT02072226|9876290|P2|Overall Study|Patient Withdrawal of Consent|0
2870918|NCT02072226|9876291|P1|Overall Study|Patient Withdrawal of Consent|1
2870919|NCT02072226|9876290|P2|Overall Study|Death|0
2870920|NCT02072226|9876291|P1|Overall Study|Death|1
2870921|NCT02072226|9876290|P2|Overall Study|Patient Non-compliance|3
2870922|NCT02072226|9876291|P1|Overall Study|Patient Non-compliance|2
2870923|NCT02072226|9876290|P2|Overall Study|Lost to Follow-up|7
2870924|NCT02072226|9876291|P1|Overall Study|Lost to Follow-up|11
2870925|NCT02072174|9876321|P2|Overall Study|Non-compliance with protocol requirement|0
2870926|NCT02072174|9876322|P1|Overall Study|Non-compliance with protocol requirement|2
2870927|NCT02072174|9876321|P2|Overall Study|Physician Decision|1
2870928|NCT02072174|9876322|P1|Overall Study|Physician Decision|0
2870929|NCT02072174|9876321|P2|Overall Study|Protocol Violation|23
2870930|NCT02072174|9876322|P1|Overall Study|Protocol Violation|16
2870931|NCT02072174|9876321|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
2870932|NCT02072174|9876322|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
2870933|NCT02072096|9876346|P2|Overall Study|Lost to Follow-up|0
2870934|NCT02072096|9876347|P1|Overall Study|Lost to Follow-up|1
2870935|NCT02072096|9876346|P2|Overall Study|Study Terminated by Sponsor|30
2870936|NCT02072096|9876347|P1|Overall Study|Study Terminated by Sponsor|43
2870937|NCT02072096|9876346|P2|Overall Study|Physician Decision|1
2870938|NCT02072096|9876347|P1|Overall Study|Physician Decision|0
2870939|NCT02072096|9876346|P2|Overall Study|Death|0
2870940|NCT02072096|9876347|P1|Overall Study|Death|2
2870941|NCT02072096|9876346|P2|Overall Study|No Reason Provided|2
2870942|NCT02072096|9876347|P1|Overall Study|No Reason Provided|4
2870943|NCT02072096|9876346|P2|Overall Study|Adverse Event|2
2870944|NCT02072096|9876347|P1|Overall Study|Adverse Event|5
2870945|NCT02072096|9876346|P2|Overall Study|Withdrawal by Subject|7
2870946|NCT02072096|9876347|P1|Overall Study|Withdrawal by Subject|5
2870947|NCT02072096|9876346|P2|Overall Study|Protocol Violation|7
2870948|NCT02072096|9876347|P1|Overall Study|Protocol Violation|7
2870949|NCT02072096|9876346|P2|Overall Study|Lack of Efficacy|29
2870950|NCT02072096|9876347|P1|Overall Study|Lack of Efficacy|18
2870951|NCT02071849|9876382|P1|2-year Extended Follow-up|Adverse Event|1
2870952|NCT02071849|9876382|P1|6-month Primary Endpoint|Adverse Event|1
2870953|NCT02071849|9876382|P1|6-month Primary Endpoint|Did not receive device|4
2870954|NCT02071771|9876448|P2|Period 1: First 10 Days|Unavailable lens power|0
2870955|NCT02071771|9876449|P1|Period 1: First 10 Days|Unavailable lens power|1
2870956|NCT02071771|9876448|P2|Period 1: First 10 Days|Unacceptable lens fit|0
2870957|NCT02071771|9876449|P1|Period 1: First 10 Days|Unacceptable lens fit|1
2870958|NCT02071706|9876457|P1|Overall Study|Withdrawal by Subject|2
2870959|NCT02071706|9876457|P1|Overall Study|Adverse Event|1
2870960|NCT02071290|9876473|P2|Overall Study|Physician Decision|1
2870961|NCT02071290|9876474|P1|Overall Study|Physician Decision|0
2870962|NCT02071290|9876473|P2|Overall Study|Protocol Violation|5
2870963|NCT02071290|9876474|P1|Overall Study|Protocol Violation|3
2870964|NCT02071290|9876473|P2|Overall Study|Withdrawal by Subject|1
2870965|NCT02071290|9876474|P1|Overall Study|Withdrawal by Subject|0
2870966|NCT02071290|9876473|P2|Overall Study|Death|0
2870967|NCT02071290|9876474|P1|Overall Study|Death|1
2870968|NCT02071225|9876528|P1|Overall Study|Death|25
2870969|NCT02071225|9876528|P1|Overall Study|Lost to Follow-up|2
2870970|NCT02071225|9876528|P1|Overall Study|Protocol Deviation|1
2870971|NCT02071225|9876528|P1|Overall Study|Withdrawal of Consent|2
2870972|NCT02071082|9876584|P2|Overall Study|Lost to Follow-up|1
2870973|NCT02071082|9876585|P1|Overall Study|Lost to Follow-up|1
2870974|NCT02071082|9876584|P2|Overall Study|Withdrew Consent|4
2870975|NCT02071082|9876585|P1|Overall Study|Withdrew Consent|0
2870976|NCT02071082|9876584|P2|Overall Study|Adverse Event|1
2870977|NCT02071082|9876585|P1|Overall Study|Adverse Event|0
2870978|NCT02071082|9876584|P2|Overall Study|Enrolled and Never Treated|1
2870979|NCT02071082|9876585|P1|Overall Study|Enrolled and Never Treated|1
2870980|NCT02070991|9876615|P2|Overall Study|Withdrawal by Subject|0
2870981|NCT02070991|9876616|P1|Overall Study|Withdrawal by Subject|1
2870982|NCT02070991|9876615|P2|Overall Study|Death|0
2870983|NCT02070991|9876616|P1|Overall Study|Death|2
2870984|NCT02070978|9876639|P3|Overall Study|Terminated by Sponsor|39
2870985|NCT02070978|9876640|P2|Overall Study|Terminated by Sponsor|40
2870986|NCT02070978|9876641|P1|Overall Study|Terminated by Sponsor|33
2870987|NCT02070978|9876639|P3|Overall Study|Un-specified|2
2870988|NCT02070978|9876640|P2|Overall Study|Un-specified|2
2870989|NCT02070978|9876641|P1|Overall Study|Un-specified|3
2870990|NCT02070978|9876639|P3|Overall Study|Death|2
2870991|NCT02070978|9876640|P2|Overall Study|Death|0
2870992|NCT02070978|9876641|P1|Overall Study|Death|0
2870993|NCT02070978|9876639|P3|Overall Study|Lack of Efficacy|0
2870994|NCT02070978|9876640|P2|Overall Study|Lack of Efficacy|1
2870995|NCT02070978|9876641|P1|Overall Study|Lack of Efficacy|0
2870996|NCT02070978|9876639|P3|Overall Study|Protocol Violation|3
2870997|NCT02070978|9876640|P2|Overall Study|Protocol Violation|0
2870998|NCT02070978|9876641|P1|Overall Study|Protocol Violation|1
2870999|NCT02070978|9876639|P3|Overall Study|Withdrawal by Subject|3
2871000|NCT02070978|9876640|P2|Overall Study|Withdrawal by Subject|5
2871001|NCT02070978|9876641|P1|Overall Study|Withdrawal by Subject|3
2871002|NCT02070978|9876639|P3|Overall Study|Lost to Follow-up|4
2871003|NCT02070978|9876640|P2|Overall Study|Lost to Follow-up|3
2871004|NCT02070978|9876641|P1|Overall Study|Lost to Follow-up|1
2871005|NCT02070978|9876639|P3|Overall Study|Adverse Event|0
2871006|NCT02070978|9876640|P2|Overall Study|Adverse Event|2
2871007|NCT02070978|9876641|P1|Overall Study|Adverse Event|6
2871008|NCT02070965|9876703|P3|Overall Study|Subject moved|0
2871009|NCT02070965|9876704|P2|Overall Study|Subject moved|0
2871010|NCT02070965|9876705|P1|Overall Study|Subject moved|1
2871011|NCT02070965|9876703|P3|Overall Study|Withdrawal by Subject|1
2871012|NCT02070965|9876704|P2|Overall Study|Withdrawal by Subject|1
2871013|NCT02070965|9876705|P1|Overall Study|Withdrawal by Subject|1
2871014|NCT02070965|9876703|P3|Overall Study|Lost to Follow-up|0
2871015|NCT02070965|9876704|P2|Overall Study|Lost to Follow-up|1
2871016|NCT02070965|9876705|P1|Overall Study|Lost to Follow-up|0
2871017|NCT02070757|9876715|P2|Overall Study|Discharged from Study Hospital|2
2871018|NCT02070757|9876716|P1|Overall Study|Discharged from Study Hospital|2
2871019|NCT02070757|9876715|P2|Overall Study|Investigator Decision|2
2871020|NCT02070757|9876716|P1|Overall Study|Investigator Decision|0
2871021|NCT02070757|9876715|P2|Overall Study|Withdrawal by Subject|3
2871022|NCT02070757|9876716|P1|Overall Study|Withdrawal by Subject|1
2871023|NCT02070757|9876715|P2|Overall Study|Protocol Violation|4
2871024|NCT02070757|9876716|P1|Overall Study|Protocol Violation|0
2871025|NCT02070757|9876715|P2|Overall Study|Lost to Follow-up|4
2871026|NCT02070757|9876716|P1|Overall Study|Lost to Follow-up|7
2871027|NCT02070757|9876715|P2|Overall Study|Adverse Event|99
2871028|NCT02070757|9876716|P1|Overall Study|Adverse Event|107
2871029|NCT02070744|9876750|P5|OLE Phase (48 Weeks)|Other|1
2871030|NCT02070744|9876751|P4|OLE Phase (48 Weeks)|Other|0
2871031|NCT02070744|9876752|P3|OLE Phase (48 Weeks)|Other|0
2871032|NCT02070744|9876753|P2|OLE Phase (48 Weeks)|Other|0
2871033|NCT02070744|9876754|P1|OLE Phase (48 Weeks)|Other|0
2871034|NCT02070744|9876750|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
2871035|NCT02070744|9876751|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2871036|NCT02070744|9876752|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2871037|NCT02070744|9876753|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2871038|NCT02070744|9876754|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2871039|NCT02070744|9876750|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
2871040|NCT02070744|9876751|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
2871041|NCT02070744|9876752|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
2871042|NCT02070744|9876753|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
2871043|NCT02070744|9876754|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
2871044|NCT02070588|9876837|P3|Overall Study|Adverse Event|0
2871045|NCT02070588|9876838|P2|Overall Study|Adverse Event|0
2871046|NCT02070588|9876839|P1|Overall Study|Adverse Event|1
2871047|NCT02070588|9876837|P3|Overall Study|Writhdrawal due to early termination|0
2871048|NCT02070588|9876838|P2|Overall Study|Writhdrawal due to early termination|0
2871049|NCT02070588|9876839|P1|Overall Study|Writhdrawal due to early termination|9
2871050|NCT02070588|9876837|P3|Overall Study|Withdrawal by Subject|0
2871051|NCT02070588|9876838|P2|Overall Study|Withdrawal by Subject|1
2871052|NCT02070588|9876839|P1|Overall Study|Withdrawal by Subject|29
2871053|NCT02070484|9876855|P2|Overall Study|Withdrawal by Subject|0
2871054|NCT02070484|9876856|P1|Overall Study|Withdrawal by Subject|1
2871055|NCT02070380|9876878|P4|Second Injection|Protocol Violation|5
2871056|NCT02070380|9876879|P3|Second Injection|Protocol Violation|1
2871057|NCT02070380|9876880|P2|Second Injection|Protocol Violation|1
2871058|NCT02070380|9876881|P1|Second Injection|Protocol Violation|0
2871059|NCT02070380|9876878|P4|Second Injection|Image sets missing or technically inadeq|0
2871060|NCT02070380|9876879|P3|Second Injection|Image sets missing or technically inadeq|0
2871061|NCT02070380|9876880|P2|Second Injection|Image sets missing or technically inadeq|1
2871062|NCT02070380|9876881|P1|Second Injection|Image sets missing or technically inadeq|0
2871063|NCT02070380|9876878|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
2871064|NCT02070380|9876879|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
2871065|NCT02070380|9876880|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
2871066|NCT02070380|9876881|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
2871067|NCT02069392|9877013|P2|Overall Study|Withdrawal by Subject|2
2871068|NCT02069392|9877014|P1|Overall Study|Withdrawal by Subject|4
2871069|NCT02069379|9877038|P4|Second Treatment Arm|Lost to Follow-up|0
2871070|NCT02069379|9877039|P3|Second Treatment Arm|Lost to Follow-up|1
2871071|NCT02069379|9877040|P2|Second Treatment Arm|Lost to Follow-up|0
2871072|NCT02069379|9877041|P1|Second Treatment Arm|Lost to Follow-up|0
2871073|NCT02069379|9877038|P4|Washout Period (4 Weeks)|Unrelated event|0
2871074|NCT02069379|9877039|P3|Washout Period (4 Weeks)|Unrelated event|0
2871075|NCT02069379|9877040|P2|Washout Period (4 Weeks)|Unrelated event|1
2871076|NCT02069379|9877041|P1|Washout Period (4 Weeks)|Unrelated event|0
2871077|NCT02069379|9877038|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
2871078|NCT02069379|9877039|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
2871079|NCT02069379|9877040|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
2871080|NCT02069379|9877041|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
2871081|NCT02069379|9877038|P4|First Treatment Arm|Lost to Follow-up|0
2871082|NCT02069379|9877039|P3|First Treatment Arm|Lost to Follow-up|1
2871083|NCT02069379|9877040|P2|First Treatment Arm|Lost to Follow-up|1
2871084|NCT02069379|9877041|P1|First Treatment Arm|Lost to Follow-up|0
2871085|NCT02069379|9877038|P4|Baseline Measurements|Ineligible based on initial assessments|2
2871086|NCT02069379|9877039|P3|Baseline Measurements|Ineligible based on initial assessments|0
2871087|NCT02069379|9877040|P2|Baseline Measurements|Ineligible based on initial assessments|0
2871088|NCT02069379|9877041|P1|Baseline Measurements|Ineligible based on initial assessments|2
2871089|NCT02069379|9877038|P4|Baseline Measurements|Lost to Follow-up|0
2871090|NCT02069379|9877039|P3|Baseline Measurements|Lost to Follow-up|0
2871091|NCT02069379|9877040|P2|Baseline Measurements|Lost to Follow-up|0
2871092|NCT02069379|9877041|P1|Baseline Measurements|Lost to Follow-up|1
2871093|NCT02069093|9877128|P1|Overall Study|Adverse Event|10
2871094|NCT02069093|9877128|P1|Overall Study|Abnormal laboratory values|1
2871095|NCT02069093|9877128|P1|Overall Study|Withdrawal by Subject|2
2871096|NCT02069093|9877128|P1|Overall Study|Administrative problems|1
2871097|NCT02069093|9877128|P1|Overall Study|Death|1
2871098|NCT02069093|9877128|P1|Overall Study|New cancer therapy|1
2871099|NCT02069093|9877128|P1|Overall Study|Disease progression|14
2871100|NCT02068768|9877178|P1|Overall Study|Early Termination by Sponsor|2
2871101|NCT02068768|9877178|P1|Overall Study|Lost to Follow-up|5
2871102|NCT02068599|9877187|P3|Overall Study|Noncompliance|1
2871103|NCT02068599|9877188|P2|Overall Study|Noncompliance|0
2871104|NCT02068599|9877189|P1|Overall Study|Noncompliance|0
2871105|NCT02068599|9877187|P3|Overall Study|Lack of Efficacy|3
2871106|NCT02068599|9877188|P2|Overall Study|Lack of Efficacy|0
2871107|NCT02068599|9877189|P1|Overall Study|Lack of Efficacy|0
2871108|NCT02068599|9877187|P3|Overall Study|Lost to Follow-up|0
2871109|NCT02068599|9877188|P2|Overall Study|Lost to Follow-up|0
2871110|NCT02068599|9877189|P1|Overall Study|Lost to Follow-up|1
2871111|NCT02068599|9877187|P3|Overall Study|Protocol Violation|3
2871112|NCT02068599|9877188|P2|Overall Study|Protocol Violation|2
2871113|NCT02068599|9877189|P1|Overall Study|Protocol Violation|4
2871114|NCT02068599|9877187|P3|Overall Study|Withdrawal by Subject|5
2871115|NCT02068599|9877188|P2|Overall Study|Withdrawal by Subject|7
2871116|NCT02068599|9877189|P1|Overall Study|Withdrawal by Subject|2
2871117|NCT02068599|9877187|P3|Overall Study|Adverse Event|1
2871118|NCT02068599|9877188|P2|Overall Study|Adverse Event|1
2871119|NCT02068599|9877189|P1|Overall Study|Adverse Event|4
2871120|NCT02068547|9877229|P2|Overall Study|Physician Decision|0
2871121|NCT02068547|9877230|P1|Overall Study|Physician Decision|1
2871122|NCT02068547|9877229|P2|Overall Study|Lost to Follow-up|3
2871123|NCT02068547|9877230|P1|Overall Study|Lost to Follow-up|3
2871124|NCT02068508|9877240|P1|Overall Study|Protocol Violation|4
2871125|NCT02068508|9877240|P1|Overall Study|Patient did not visit the study site|1
2871126|NCT02068508|9877240|P1|Overall Study|Case report forms uncollected|27
2871127|NCT02068495|9877250|P1|Overall Study|Protocol Deviation|49
2871128|NCT02068495|9877250|P1|Overall Study|Case Report Forms Uncollected|60
2871129|NCT02068443|9877262|P3|Overall Study|Other Reason Not Specified|0
2871130|NCT02068443|9877263|P2|Overall Study|Other Reason Not Specified|0
2871131|NCT02068443|9877264|P1|Overall Study|Other Reason Not Specified|1
2871132|NCT02068443|9877262|P3|Overall Study|Lack of Efficacy|0
2871133|NCT02068443|9877263|P2|Overall Study|Lack of Efficacy|1
2871134|NCT02068443|9877264|P1|Overall Study|Lack of Efficacy|2
2871135|NCT02068443|9877262|P3|Overall Study|Voluntary Withdrawal|1
2871136|NCT02068443|9877263|P2|Overall Study|Voluntary Withdrawal|0
2871137|NCT02068443|9877264|P1|Overall Study|Voluntary Withdrawal|4
2871138|NCT02068443|9877262|P3|Overall Study|Pretreatment Event/Adverse Event|2
2871139|NCT02068443|9877263|P2|Overall Study|Pretreatment Event/Adverse Event|5
2871140|NCT02068443|9877264|P1|Overall Study|Pretreatment Event/Adverse Event|0
2871141|NCT02068222|9877299|P1|Overall Study|Lost to Follow-up|1
2871142|NCT02067728|9877330|P2|6 Month Measurements|Unable to attend|97
2871143|NCT02067728|9877331|P1|6 Month Measurements|Unable to attend|114
2871144|NCT02067728|9877330|P2|6 Month Follow up Survey|Lost to Follow-up|60
2871145|NCT02067728|9877331|P1|6 Month Follow up Survey|Lost to Follow-up|48
2871146|NCT02067728|9877330|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
2871147|NCT02067728|9877331|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
2871148|NCT02067676|9877365|P6|Overall Study|Withdrawal by Subject|0
2871149|NCT02067676|9877366|P5|Overall Study|Withdrawal by Subject|0
2871150|NCT02067676|9877367|P4|Overall Study|Withdrawal by Subject|0
2871151|NCT02067676|9877368|P3|Overall Study|Withdrawal by Subject|0
2871152|NCT02067676|9877369|P2|Overall Study|Withdrawal by Subject|0
2871153|NCT02067676|9877370|P1|Overall Study|Withdrawal by Subject|1
2871154|NCT02067663|9877410|P2|Overall Study|Lost to Follow-up|14
2871155|NCT02067663|9877411|P1|Overall Study|Lost to Follow-up|13
2871156|NCT02067533|9877510|P2|Overall Study|Lost to Follow-up|2
2871157|NCT02067533|9877511|P1|Overall Study|Lost to Follow-up|4
2871158|NCT02067104|9877562|P2|Overall Study|Study termination due to low accrual|5
2871159|NCT02067104|9877563|P1|Overall Study|Study termination due to low accrual|4
2871160|NCT02066922|9877586|P1|Overall Study|Adverse Event|1
2871161|NCT02066467|9877638|P1|Overall Study|Not defined|4
2871162|NCT02066467|9877638|P1|Overall Study|Physician Decision|2
2871163|NCT02066467|9877638|P1|Overall Study|Withdrawal by Subject|16
2871164|NCT02066467|9877638|P1|Overall Study|Adverse Event|20
2871165|NCT02066467|9877638|P1|Overall Study|Lost to Follow-up|51
2871166|NCT02066467|9877638|P1|Overall Study|Death|54
2871167|NCT02066467|9877638|P1|Overall Study|Consent ineligible|1
2871168|NCT02066467|9877638|P1|Overall Study|Attempted to implant withoput success|43
2871169|NCT02066467|9877638|P1|Overall Study|Did not undergo implant procedure|24
2871170|NCT02066415|9877647|P3|Overall Study|Lost to Follow-up|2
2871171|NCT02066415|9877648|P2|Overall Study|Lost to Follow-up|2
2871172|NCT02066415|9877649|P1|Overall Study|Lost to Follow-up|7
2871173|NCT02066415|9877647|P3|Overall Study|Withdrawal by Subject|4
2871174|NCT02066415|9877648|P2|Overall Study|Withdrawal by Subject|1
2871175|NCT02066415|9877649|P1|Overall Study|Withdrawal by Subject|9
2871176|NCT02066415|9877647|P3|Overall Study|Decision by Sponsor|2
2871177|NCT02066415|9877648|P2|Overall Study|Decision by Sponsor|4
2871178|NCT02066415|9877649|P1|Overall Study|Decision by Sponsor|5
2871179|NCT02066402|9877674|P2|Overall Study|Protocol driven decision point|1
2871180|NCT02066402|9877675|P1|Overall Study|Protocol driven decision point|0
2871181|NCT02066402|9877674|P2|Overall Study|Progressive disease-clinical progression|1
2871182|NCT02066402|9877675|P1|Overall Study|Progressive disease-clinical progression|0
2871183|NCT02066402|9877674|P2|Overall Study|Withdrawal by Subject|11
2871184|NCT02066402|9877675|P1|Overall Study|Withdrawal by Subject|14
2871185|NCT02066402|9877674|P2|Overall Study|Lost to Follow-up|8
2871186|NCT02066402|9877675|P1|Overall Study|Lost to Follow-up|11
2871187|NCT02066402|9877674|P2|Overall Study|Adverse Event|2
2871188|NCT02066402|9877675|P1|Overall Study|Adverse Event|1
2871189|NCT02066389|9877707|P6|Overall Study|Randomized in Error|1
2871190|NCT02066389|9877708|P5|Overall Study|Randomized in Error|0
2871191|NCT02066389|9877709|P4|Overall Study|Randomized in Error|0
2871192|NCT02066389|9877710|P3|Overall Study|Randomized in Error|0
2871193|NCT02066389|9877711|P2|Overall Study|Randomized in Error|0
2871194|NCT02066389|9877712|P1|Overall Study|Randomized in Error|0
2871195|NCT02066389|9877707|P6|Overall Study|Lost to Follow-up|1
2871196|NCT02066389|9877708|P5|Overall Study|Lost to Follow-up|1
2871197|NCT02066389|9877709|P4|Overall Study|Lost to Follow-up|1
2871198|NCT02066389|9877710|P3|Overall Study|Lost to Follow-up|0
2871199|NCT02066389|9877711|P2|Overall Study|Lost to Follow-up|0
2871200|NCT02066389|9877712|P1|Overall Study|Lost to Follow-up|0
2871201|NCT02066389|9877707|P6|Overall Study|Withdrawal by Subject|2
2871202|NCT02066389|9877708|P5|Overall Study|Withdrawal by Subject|1
2871203|NCT02066389|9877709|P4|Overall Study|Withdrawal by Subject|1
2871204|NCT02066389|9877710|P3|Overall Study|Withdrawal by Subject|5
2871205|NCT02066389|9877711|P2|Overall Study|Withdrawal by Subject|0
2871206|NCT02066389|9877712|P1|Overall Study|Withdrawal by Subject|4
2871207|NCT02066389|9877707|P6|Overall Study|Adverse Event|1
2871208|NCT02066389|9877708|P5|Overall Study|Adverse Event|5
2871209|NCT02066389|9877709|P4|Overall Study|Adverse Event|1
2871210|NCT02066389|9877710|P3|Overall Study|Adverse Event|1
2871211|NCT02066389|9877711|P2|Overall Study|Adverse Event|1
2871212|NCT02066389|9877712|P1|Overall Study|Adverse Event|1
2871213|NCT02066311|9877762|P1|Overall Study|Withdrawal by Subject|1
2871214|NCT02066311|9877762|P1|Overall Study|Adverse Event|4
2871215|NCT02066298|9877772|P6|Overall Study|Physician Decision|0
2871216|NCT02066298|9877773|P5|Overall Study|Physician Decision|1
2871217|NCT02066298|9877774|P4|Overall Study|Physician Decision|0
2871218|NCT02066298|9877775|P3|Overall Study|Physician Decision|1
2871219|NCT02066298|9877776|P2|Overall Study|Physician Decision|0
2871220|NCT02066298|9877777|P1|Overall Study|Physician Decision|0
2871221|NCT02066298|9877772|P6|Overall Study|Withdrawal by Subject|8
2871222|NCT02066298|9877773|P5|Overall Study|Withdrawal by Subject|5
2871223|NCT02066298|9877774|P4|Overall Study|Withdrawal by Subject|4
2871224|NCT02066298|9877775|P3|Overall Study|Withdrawal by Subject|6
2871225|NCT02066298|9877776|P2|Overall Study|Withdrawal by Subject|6
2871226|NCT02066298|9877777|P1|Overall Study|Withdrawal by Subject|6
2871227|NCT02066298|9877772|P6|Overall Study|Lost to Follow-up|4
2871228|NCT02066298|9877773|P5|Overall Study|Lost to Follow-up|3
2871229|NCT02066298|9877774|P4|Overall Study|Lost to Follow-up|2
2871230|NCT02066298|9877775|P3|Overall Study|Lost to Follow-up|3
2871231|NCT02066298|9877776|P2|Overall Study|Lost to Follow-up|2
2871232|NCT02066298|9877777|P1|Overall Study|Lost to Follow-up|3
2871233|NCT02066233|9877801|P2|EG Scan II (Day 1)|difficulty intubating subject|6
2871234|NCT02066233|9877802|P1|EG Scan II (Day 1)|difficulty intubating subject|6
2871235|NCT02066181|9877812|P2|Overall Study|Withdrawal by Subject|1
2871236|NCT02066181|9877813|P1|Overall Study|Withdrawal by Subject|1
2871237|NCT02066129|9877835|P2|Overall Study|Physician Decision|1
2871238|NCT02066129|9877836|P1|Overall Study|Physician Decision|1
2871239|NCT02066129|9877835|P2|Overall Study|Lack of Efficacy|10
2871240|NCT02066129|9877836|P1|Overall Study|Lack of Efficacy|8
2871241|NCT02066129|9877835|P2|Overall Study|Withdrawal by Subject|10
2871242|NCT02066129|9877836|P1|Overall Study|Withdrawal by Subject|7
2871243|NCT02066129|9877835|P2|Overall Study|Lost to Follow-up|12
2871244|NCT02066129|9877836|P1|Overall Study|Lost to Follow-up|13
2871245|NCT02066051|9877850|P1|Overall Study|Subject developed active GVHD|1
2871246|NCT02065895|9877855|P6|Overall Study|Scheduling conflicts|0
2871247|NCT02065895|9877856|P5|Overall Study|Scheduling conflicts|0
2871248|NCT02065895|9877857|P4|Overall Study|Scheduling conflicts|0
2871249|NCT02065895|9877858|P3|Overall Study|Scheduling conflicts|0
2871250|NCT02065895|9877859|P2|Overall Study|Scheduling conflicts|1
2871251|NCT02065895|9877860|P1|Overall Study|Scheduling conflicts|0
2871252|NCT02065895|9877855|P6|Overall Study|Protocol Violation|0
2871253|NCT02065895|9877856|P5|Overall Study|Protocol Violation|0
2871254|NCT02065895|9877857|P4|Overall Study|Protocol Violation|1
2871255|NCT02065895|9877858|P3|Overall Study|Protocol Violation|0
2871256|NCT02065895|9877859|P2|Overall Study|Protocol Violation|0
2871257|NCT02065895|9877860|P1|Overall Study|Protocol Violation|1
2871258|NCT02065791|9877879|P2|Overall Study|Lost to Follow-up|9
2871259|NCT02065791|9877880|P1|Overall Study|Lost to Follow-up|13
2871260|NCT02065791|9877879|P2|Overall Study|Withdrawal by Subject|5
2871261|NCT02065791|9877880|P1|Overall Study|Withdrawal by Subject|11
2871262|NCT02065791|9877879|P2|Overall Study|Closed Site|1
2871263|NCT02065791|9877880|P1|Overall Study|Closed Site|1
2871264|NCT02065518|9877904|P4|Overall Study|Withdrawal by Subject|2
2871265|NCT02065518|9877905|P3|Overall Study|Withdrawal by Subject|9
2871266|NCT02065518|9877906|P2|Overall Study|Withdrawal by Subject|4
2871267|NCT02065518|9877907|P1|Overall Study|Withdrawal by Subject|3
2871268|NCT02065518|9877904|P4|Overall Study|Lost to Follow-up|3
2871269|NCT02065518|9877905|P3|Overall Study|Lost to Follow-up|0
2871270|NCT02065518|9877906|P2|Overall Study|Lost to Follow-up|4
2871271|NCT02065518|9877907|P1|Overall Study|Lost to Follow-up|3
2871272|NCT02065336|9877973|P10|Extension Phase|Study Terminated by Sponsor|8
2871273|NCT02065336|9877974|P9|Extension Phase|Study Terminated by Sponsor|2
2871274|NCT02065336|9877975|P8|Extension Phase|Study Terminated by Sponsor|0
2871275|NCT02065336|9877976|P7|Extension Phase|Study Terminated by Sponsor|0
2871276|NCT02065336|9877977|P6|Extension Phase|Study Terminated by Sponsor|0
2871277|NCT02065336|9877978|P5|Extension Phase|Study Terminated by Sponsor|0
2871278|NCT02065336|9877979|P4|Extension Phase|Study Terminated by Sponsor|0
2871279|NCT02065336|9877980|P3|Extension Phase|Study Terminated by Sponsor|0
2871280|NCT02065336|9877981|P2|Extension Phase|Study Terminated by Sponsor|0
2871281|NCT02065336|9877982|P1|Extension Phase|Study Terminated by Sponsor|0
2871282|NCT02064920|9878242|P2|Overall Study|Withdrawal by Subject|3
2871283|NCT02064920|9878243|P1|Overall Study|Withdrawal by Subject|1
2871284|NCT02064920|9878242|P2|Overall Study|Technical Problems|1
2871285|NCT02064920|9878243|P1|Overall Study|Technical Problems|0
2871286|NCT02064920|9878242|P2|Overall Study|Physician Decision|1
2871287|NCT02064920|9878243|P1|Overall Study|Physician Decision|0
2871288|NCT02064920|9878242|P2|Overall Study|Adverse Event|4
2871289|NCT02064920|9878243|P1|Overall Study|Adverse Event|0
2871290|NCT02064894|9878273|P3|Overall Study|Withdrawal by Subject|115
2871291|NCT02064894|9878274|P2|Overall Study|Withdrawal by Subject|102
2871292|NCT02064894|9878275|P1|Overall Study|Withdrawal by Subject|43
2871293|NCT02064868|9878288|P2|Overall Study|Technical Problems or Missing|2
2871294|NCT02064868|9878289|P1|Overall Study|Technical Problems or Missing|5
2871295|NCT02064868|9878288|P2|Overall Study|Withdrawal by Subject|3
2871296|NCT02064868|9878289|P1|Overall Study|Withdrawal by Subject|14
2871297|NCT02064868|9878288|P2|Overall Study|Physician Decision|0
2871298|NCT02064868|9878289|P1|Overall Study|Physician Decision|1
2871299|NCT02064868|9878288|P2|Overall Study|Lost to Follow-up|8
2871300|NCT02064868|9878289|P1|Overall Study|Lost to Follow-up|14
2871301|NCT02064816|9878309|P2|Overall Study|Other|3
2871302|NCT02064816|9878310|P1|Overall Study|Other|1
2871303|NCT02064816|9878309|P2|Overall Study|Therapeutic failure|1
2871304|NCT02064816|9878310|P1|Overall Study|Therapeutic failure|0
2871305|NCT02064816|9878309|P2|Overall Study|Lost to Follow-up|1
2871306|NCT02064816|9878310|P1|Overall Study|Lost to Follow-up|2
2871307|NCT02064816|9878309|P2|Overall Study|Withdrawal by Subject|1
2871308|NCT02064816|9878310|P1|Overall Study|Withdrawal by Subject|2
2871309|NCT02064816|9878309|P2|Overall Study|Adverse Event|2
2871310|NCT02064816|9878310|P1|Overall Study|Adverse Event|3
2871311|NCT02064439|9878351|P3|Overall Study|Other|7
2871312|NCT02064439|9878352|P2|Overall Study|Other|2
2871313|NCT02064439|9878353|P1|Overall Study|Other|2
2871314|NCT02064439|9878351|P3|Overall Study|Safety outcome reached|10
2871315|NCT02064439|9878352|P2|Overall Study|Safety outcome reached|20
2871316|NCT02064439|9878353|P1|Overall Study|Safety outcome reached|12
2871317|NCT02064439|9878351|P3|Overall Study|Efficacy outcome reached|57
2871318|NCT02064439|9878352|P2|Overall Study|Efficacy outcome reached|16
2871319|NCT02064439|9878353|P1|Overall Study|Efficacy outcome reached|18
2871320|NCT02064439|9878351|P3|Overall Study|Logistical difficulties|2
2871321|NCT02064439|9878352|P2|Overall Study|Logistical difficulties|5
2871322|NCT02064439|9878353|P1|Overall Study|Logistical difficulties|6
2871323|NCT02064439|9878351|P3|Overall Study|Physician Decision|1
2871324|NCT02064439|9878352|P2|Overall Study|Physician Decision|1
2871325|NCT02064439|9878353|P1|Overall Study|Physician Decision|0
2871326|NCT02064439|9878351|P3|Overall Study|Non-compliance with study medication|23
2871327|NCT02064439|9878352|P2|Overall Study|Non-compliance with study medication|19
2871328|NCT02064439|9878353|P1|Overall Study|Non-compliance with study medication|21
2871329|NCT02064439|9878351|P3|Overall Study|Lost to Follow-up|4
2871330|NCT02064439|9878352|P2|Overall Study|Lost to Follow-up|3
2871331|NCT02064439|9878353|P1|Overall Study|Lost to Follow-up|1
2871332|NCT02064439|9878351|P3|Overall Study|Protocol Violation|3
2871333|NCT02064439|9878352|P2|Overall Study|Protocol Violation|5
2871334|NCT02064439|9878353|P1|Overall Study|Protocol Violation|3
2871335|NCT02064439|9878351|P3|Overall Study|Withdrawal by Subject|26
2871336|NCT02064439|9878352|P2|Overall Study|Withdrawal by Subject|18
2871337|NCT02064439|9878353|P1|Overall Study|Withdrawal by Subject|29
2871338|NCT02064439|9878351|P3|Overall Study|Death|3
2871339|NCT02064439|9878352|P2|Overall Study|Death|2
2871340|NCT02064439|9878353|P1|Overall Study|Death|0
2871341|NCT02064439|9878351|P3|Overall Study|Adverse Event|46
2871342|NCT02064439|9878352|P2|Overall Study|Adverse Event|47
2871343|NCT02064439|9878353|P1|Overall Study|Adverse Event|51
2871344|NCT02064387|9878381|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|8
2871345|NCT02064387|9878382|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871346|NCT02064387|9878383|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871347|NCT02064387|9878384|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871348|NCT02064387|9878385|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871349|NCT02064387|9878386|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871350|NCT02064387|9878387|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871351|NCT02064387|9878388|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871352|NCT02064387|9878389|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871353|NCT02064387|9878390|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871354|NCT02064387|9878391|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871355|NCT02064387|9878381|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|1
2871356|NCT02064387|9878382|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871357|NCT02064387|9878383|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871358|NCT02064387|9878384|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871359|NCT02064387|9878385|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871360|NCT02064387|9878386|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871361|NCT02064387|9878387|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871362|NCT02064387|9878388|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871363|NCT02064387|9878389|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871364|NCT02064387|9878390|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871365|NCT02064387|9878391|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2871366|NCT02064387|9878381|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Death|4
2871367|NCT02064387|9878382|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871368|NCT02064387|9878383|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871369|NCT02064387|9878384|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871370|NCT02064387|9878385|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871371|NCT02064387|9878386|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871372|NCT02064387|9878387|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871373|NCT02064387|9878388|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871374|NCT02064387|9878389|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871375|NCT02064387|9878390|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871376|NCT02064387|9878391|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2871377|NCT02064387|9878381|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871378|NCT02064387|9878382|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871379|NCT02064387|9878383|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|1
2871380|NCT02064387|9878384|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871381|NCT02064387|9878385|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871382|NCT02064387|9878386|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871383|NCT02064387|9878387|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871384|NCT02064387|9878388|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871385|NCT02064387|9878389|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871386|NCT02064387|9878390|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871387|NCT02064387|9878391|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2871388|NCT02064387|9878381|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871389|NCT02064387|9878382|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871390|NCT02064387|9878383|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871391|NCT02064387|9878384|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|1
2871392|NCT02064387|9878385|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871393|NCT02064387|9878386|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871394|NCT02064387|9878387|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871395|NCT02064387|9878388|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871396|NCT02064387|9878389|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871397|NCT02064387|9878390|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871398|NCT02064387|9878391|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2871399|NCT02064387|9878381|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871400|NCT02064387|9878382|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871401|NCT02064387|9878383|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871402|NCT02064387|9878384|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|1
2871403|NCT02064387|9878385|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871404|NCT02064387|9878386|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871405|NCT02064387|9878387|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871406|NCT02064387|9878388|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871407|NCT02064387|9878389|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871408|NCT02064387|9878390|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871409|NCT02064387|9878391|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2871410|NCT02064387|9878381|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871411|NCT02064387|9878382|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
2871412|NCT02064387|9878383|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871413|NCT02064387|9878384|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
2871414|NCT02064387|9878385|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871415|NCT02064387|9878386|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871416|NCT02064387|9878387|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871417|NCT02064387|9878388|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871418|NCT02064387|9878389|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871419|NCT02064387|9878390|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871420|NCT02064387|9878391|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2871421|NCT02064231|9878706|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2871422|NCT02064231|9878707|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2871588|NCT02061280|9879691|P1|Overall Study|Lost to Follow-up|5
2871423|NCT02064231|9878708|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2871424|NCT02064231|9878709|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2871425|NCT02064231|9878706|P4|First Test Period (Test A or Test C)|Adverse Event|0
2871426|NCT02064231|9878707|P3|First Test Period (Test A or Test C)|Adverse Event|1
2871427|NCT02064231|9878708|P2|First Test Period (Test A or Test C)|Adverse Event|0
2871428|NCT02064231|9878709|P1|First Test Period (Test A or Test C)|Adverse Event|1
2871429|NCT02064231|9878706|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2871430|NCT02064231|9878707|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2871431|NCT02064231|9878708|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2871432|NCT02064231|9878709|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2871433|NCT02064231|9878706|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
2871434|NCT02064231|9878707|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
2871435|NCT02064231|9878708|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
2871436|NCT02064231|9878709|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
2871437|NCT02064205|9878721|P1|Overall Study|Withdrawal by Subject|1
2871438|NCT02064166|9878739|P2|Overall Study|Adverse Event|0
2871439|NCT02064166|9878740|P1|Overall Study|Adverse Event|1
2871440|NCT02063880|9878770|P2|Overall Study|Ineligible|2
2871441|NCT02063880|9878771|P1|Overall Study|Ineligible|0
2871442|NCT02063880|9878770|P2|Overall Study|Lost to Follow-up|7
2871443|NCT02063880|9878771|P1|Overall Study|Lost to Follow-up|7
2871444|NCT02063880|9878770|P2|Overall Study|Death|18
2871445|NCT02063880|9878771|P1|Overall Study|Death|21
2871446|NCT02063854|9878809|P7|Overall Study|Did Not Receive Study Drug|0
2871447|NCT02063854|9878810|P6|Overall Study|Did Not Receive Study Drug|1
2871448|NCT02063854|9878811|P5|Overall Study|Did Not Receive Study Drug|0
2871449|NCT02063854|9878812|P4|Overall Study|Did Not Receive Study Drug|0
2871450|NCT02063854|9878813|P3|Overall Study|Did Not Receive Study Drug|0
2871451|NCT02063854|9878814|P2|Overall Study|Did Not Receive Study Drug|0
2871452|NCT02063854|9878815|P1|Overall Study|Did Not Receive Study Drug|0
2871453|NCT02063854|9878809|P7|Overall Study|Reason Not Specified|0
2871454|NCT02063854|9878810|P6|Overall Study|Reason Not Specified|0
2871455|NCT02063854|9878811|P5|Overall Study|Reason Not Specified|0
2871456|NCT02063854|9878812|P4|Overall Study|Reason Not Specified|0
2871457|NCT02063854|9878813|P3|Overall Study|Reason Not Specified|0
2871458|NCT02063854|9878814|P2|Overall Study|Reason Not Specified|0
2871459|NCT02063854|9878815|P1|Overall Study|Reason Not Specified|1
2871460|NCT02063854|9878809|P7|Overall Study|Surgical Dental Work Performed/Planned|1
2871461|NCT02063854|9878810|P6|Overall Study|Surgical Dental Work Performed/Planned|6
2871462|NCT02063854|9878811|P5|Overall Study|Surgical Dental Work Performed/Planned|1
2871463|NCT02063854|9878812|P4|Overall Study|Surgical Dental Work Performed/Planned|1
2871464|NCT02063854|9878813|P3|Overall Study|Surgical Dental Work Performed/Planned|6
2871465|NCT02063854|9878814|P2|Overall Study|Surgical Dental Work Performed/Planned|2
2871466|NCT02063854|9878815|P1|Overall Study|Surgical Dental Work Performed/Planned|5
2871467|NCT02063854|9878809|P7|Overall Study|Voluntary Withdrawal|1
2871468|NCT02063854|9878810|P6|Overall Study|Voluntary Withdrawal|6
2871469|NCT02063854|9878811|P5|Overall Study|Voluntary Withdrawal|3
2871470|NCT02063854|9878812|P4|Overall Study|Voluntary Withdrawal|1
2871471|NCT02063854|9878813|P3|Overall Study|Voluntary Withdrawal|8
2871472|NCT02063854|9878814|P2|Overall Study|Voluntary Withdrawal|0
2871473|NCT02063854|9878815|P1|Overall Study|Voluntary Withdrawal|2
2871474|NCT02063854|9878809|P7|Overall Study|Major Protocol Deviation|0
2871475|NCT02063854|9878810|P6|Overall Study|Major Protocol Deviation|0
2871476|NCT02063854|9878811|P5|Overall Study|Major Protocol Deviation|0
2871477|NCT02063854|9878812|P4|Overall Study|Major Protocol Deviation|0
2871478|NCT02063854|9878813|P3|Overall Study|Major Protocol Deviation|3
2871479|NCT02063854|9878814|P2|Overall Study|Major Protocol Deviation|0
2871480|NCT02063854|9878815|P1|Overall Study|Major Protocol Deviation|0
2871481|NCT02063854|9878809|P7|Overall Study|Pretreatment Event/Adverse Event|4
2871482|NCT02063854|9878810|P6|Overall Study|Pretreatment Event/Adverse Event|18
2871483|NCT02063854|9878811|P5|Overall Study|Pretreatment Event/Adverse Event|7
2871484|NCT02063854|9878812|P4|Overall Study|Pretreatment Event/Adverse Event|8
2871485|NCT02063854|9878813|P3|Overall Study|Pretreatment Event/Adverse Event|13
2871486|NCT02063854|9878814|P2|Overall Study|Pretreatment Event/Adverse Event|10
2871487|NCT02063854|9878815|P1|Overall Study|Pretreatment Event/Adverse Event|13
2871488|NCT02063737|9878899|P2|Overall Study|Lost to Follow-up|4
2871489|NCT02063737|9878900|P1|Overall Study|Lost to Follow-up|11
2871490|NCT02063724|9878932|P1|Overall Study|Disease progression|1
2871491|NCT02063698|9878940|P2|Overall Study|did not complete booklet for days 2-8|2
2871492|NCT02063698|9878941|P1|Overall Study|did not complete booklet for days 2-8|1
2871493|NCT02063672|9878965|P2|Overall Study|Withdrawal by Subject|2
2871494|NCT02063672|9878966|P1|Overall Study|Withdrawal by Subject|2
2871495|NCT02063672|9878965|P2|Overall Study|Lost to Follow-up|3
2871496|NCT02063672|9878966|P1|Overall Study|Lost to Follow-up|1
2871497|NCT02063672|9878965|P2|Overall Study|Death|3
2871498|NCT02063672|9878966|P1|Overall Study|Death|5
2871499|NCT02063672|9878965|P2|Overall Study|Ongoing Follow-up|14
2871500|NCT02063672|9878966|P1|Overall Study|Ongoing Follow-up|27
2871501|NCT02063659|9879013|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
2871502|NCT02063659|9879014|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
2871503|NCT02063659|9879015|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
2871504|NCT02063659|9879016|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
2871505|NCT02063659|9879013|P4|Open-Label Extension Period (OLE)|Adverse Event|7
2871506|NCT02063659|9879014|P3|Open-Label Extension Period (OLE)|Adverse Event|0
2871507|NCT02063659|9879015|P2|Open-Label Extension Period (OLE)|Adverse Event|0
2871508|NCT02063659|9879016|P1|Open-Label Extension Period (OLE)|Adverse Event|0
2871509|NCT02063659|9879013|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
2871510|NCT02063659|9879014|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2871511|NCT02063659|9879015|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2871512|NCT02063659|9879016|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2871513|NCT02063659|9879013|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2871514|NCT02063659|9879014|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2871515|NCT02063659|9879015|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2871516|NCT02063659|9879016|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2871517|NCT02063659|9879013|P4|Open-Label Extension Period (OLE)|Physician Decision|1
2871518|NCT02063659|9879014|P3|Open-Label Extension Period (OLE)|Physician Decision|0
2871519|NCT02063659|9879015|P2|Open-Label Extension Period (OLE)|Physician Decision|0
2871520|NCT02063659|9879016|P1|Open-Label Extension Period (OLE)|Physician Decision|0
2871521|NCT02063659|9879013|P4|Double-Blind Treatment Period|Withdrawal of consent|0
2871522|NCT02063659|9879014|P3|Double-Blind Treatment Period|Withdrawal of consent|3
2871523|NCT02063659|9879015|P2|Double-Blind Treatment Period|Withdrawal of consent|1
2871524|NCT02063659|9879016|P1|Double-Blind Treatment Period|Withdrawal of consent|0
2871525|NCT02063659|9879013|P4|Double-Blind Treatment Period|Physician Decision|0
2871526|NCT02063659|9879014|P3|Double-Blind Treatment Period|Physician Decision|0
2871527|NCT02063659|9879015|P2|Double-Blind Treatment Period|Physician Decision|0
2871528|NCT02063659|9879016|P1|Double-Blind Treatment Period|Physician Decision|1
2871529|NCT02063659|9879013|P4|Double-Blind Treatment Period|Adverse Event|0
2871530|NCT02063659|9879014|P3|Double-Blind Treatment Period|Adverse Event|0
2871531|NCT02063659|9879015|P2|Double-Blind Treatment Period|Adverse Event|2
2871532|NCT02063659|9879016|P1|Double-Blind Treatment Period|Adverse Event|1
2871533|NCT02063217|9879099|P3|Overall Study|Withdrawal by Subject|0
2871534|NCT02063217|9879100|P2|Overall Study|Withdrawal by Subject|0
2871535|NCT02063217|9879101|P1|Overall Study|Withdrawal by Subject|1
2871536|NCT02062879|9879177|P2|Overall Study|Withdrawal by Subject|1
2871537|NCT02062879|9879178|P1|Overall Study|Withdrawal by Subject|4
2871538|NCT02062658|9879214|P1|Overall Study|Lack of Efficacy|1
2871539|NCT02062658|9879214|P1|Overall Study|Withdrawal by Subject|1
2871540|NCT02062645|9879218|P1|Overall Study|Lost to Follow-up|5
2871541|NCT02062645|9879218|P1|Overall Study|Protocol Violation|8
2871542|NCT02062645|9879218|P1|Overall Study|Adverse Event|2
2871543|NCT02062632|9879226|P1|Overall Study|No treatment data|1
2871544|NCT02062450|9879267|P1|Overall Study|No follow-up visit|124
2871545|NCT02062437|9879281|P1|Overall Study|Pt. couldn't come due to med. condition|1
2871546|NCT02062437|9879281|P1|Overall Study|Death|2
2871547|NCT02062437|9879281|P1|Overall Study|Patient not available for the 2y visit|18
2871548|NCT02062437|9879281|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
2871549|NCT02062398|9879290|P1|Overall Study|Implant removal|1
2871550|NCT02062385|9879302|P4|Overall Study|Lost to Follow-up|0
2871551|NCT02062385|9879303|P3|Overall Study|Lost to Follow-up|1
2871552|NCT02062385|9879304|P2|Overall Study|Lost to Follow-up|0
2871553|NCT02062385|9879305|P1|Overall Study|Lost to Follow-up|0
2871554|NCT02062385|9879302|P4|Overall Study|Death|1
2871555|NCT02062385|9879303|P3|Overall Study|Death|0
2871556|NCT02062385|9879304|P2|Overall Study|Death|0
2871557|NCT02062385|9879305|P1|Overall Study|Death|0
2871558|NCT02062385|9879302|P4|Overall Study|Withdrawn by parent/guardian|8
2871559|NCT02062385|9879303|P3|Overall Study|Withdrawn by parent/guardian|9
2871560|NCT02062385|9879304|P2|Overall Study|Withdrawn by parent/guardian|41
2871561|NCT02062385|9879305|P1|Overall Study|Withdrawn by parent/guardian|46
2871562|NCT02062385|9879302|P4|Overall Study|Moved|0
2871563|NCT02062385|9879303|P3|Overall Study|Moved|1
2871564|NCT02062385|9879304|P2|Overall Study|Moved|11
2871565|NCT02062385|9879305|P1|Overall Study|Moved|10
2871566|NCT02062385|9879302|P4|Overall Study|Incomplete EPI by database lock|0
2871567|NCT02062385|9879303|P3|Overall Study|Incomplete EPI by database lock|0
2871568|NCT02062385|9879304|P2|Overall Study|Incomplete EPI by database lock|0
2871569|NCT02062385|9879305|P1|Overall Study|Incomplete EPI by database lock|2
2871570|NCT02062385|9879302|P4|Overall Study|Protocol Violation|0
2871571|NCT02062385|9879303|P3|Overall Study|Protocol Violation|0
2871572|NCT02062385|9879304|P2|Overall Study|Protocol Violation|0
2871573|NCT02062385|9879305|P1|Overall Study|Protocol Violation|1
2871574|NCT02062385|9879302|P4|Overall Study|Adverse Event|0
2871575|NCT02062385|9879303|P3|Overall Study|Adverse Event|1
2871576|NCT02062385|9879304|P2|Overall Study|Adverse Event|13
2871577|NCT02062385|9879305|P1|Overall Study|Adverse Event|19
2871578|NCT02062151|9879349|P1|Overall Study|screen failure|1
2871579|NCT02061592|9879509|P2|Period 2|Lost to Follow-up|1
2871580|NCT02061592|9879510|P1|Period 2|Lost to Follow-up|0
2871581|NCT02061592|9879509|P2|Period 1|Protocol Violation|0
2871582|NCT02061592|9879510|P1|Period 1|Protocol Violation|1
2871583|NCT02061592|9879509|P2|Period 1|Withdrawal by Subject|0
2871584|NCT02061592|9879510|P1|Period 1|Withdrawal by Subject|1
2871585|NCT02061540|9879522|P1|Overall Study|Withdrawal by Subject|2
2871586|NCT02061540|9879522|P1|Overall Study|Adverse Event|2
2871587|NCT02061280|9879690|P2|Overall Study|Lost to Follow-up|1
2871589|NCT02061280|9879690|P2|Overall Study|Withdrawal by Subject|2
2871590|NCT02061280|9879691|P1|Overall Study|Withdrawal by Subject|1
2871591|NCT02061280|9879690|P2|Overall Study|moved out of state|1
2871592|NCT02061280|9879691|P1|Overall Study|moved out of state|0
2871593|NCT02061280|9879690|P2|Overall Study|Protocol Violation|8
2871594|NCT02061280|9879691|P1|Overall Study|Protocol Violation|12
2871595|NCT02061202|9879723|P2|Overall Study|Lost to Follow-up|1
2871596|NCT02061202|9879724|P1|Overall Study|Lost to Follow-up|1
2871597|NCT02060383|9879863|P5|Extension Phase|Protocol Violation|1
2871598|NCT02060383|9879864|P4|Extension Phase|Protocol Violation|0
2871599|NCT02060383|9879865|P3|Extension Phase|Protocol Violation|0
2871600|NCT02060383|9879866|P2|Extension Phase|Protocol Violation|0
2871601|NCT02060383|9879867|P1|Extension Phase|Protocol Violation|0
2871602|NCT02060383|9879863|P5|Extension Phase|Death|1
2871603|NCT02060383|9879864|P4|Extension Phase|Death|0
2871604|NCT02060383|9879865|P3|Extension Phase|Death|1
2871605|NCT02060383|9879866|P2|Extension Phase|Death|0
2871606|NCT02060383|9879867|P1|Extension Phase|Death|0
2871607|NCT02060383|9879863|P5|Extension Phase|Administrative problems|0
2871608|NCT02060383|9879864|P4|Extension Phase|Administrative problems|0
2871609|NCT02060383|9879865|P3|Extension Phase|Administrative problems|0
2871610|NCT02060383|9879866|P2|Extension Phase|Administrative problems|0
2871611|NCT02060383|9879867|P1|Extension Phase|Administrative problems|1
2871612|NCT02060383|9879863|P5|Extension Phase|Withdrawal by Subject|2
2871613|NCT02060383|9879864|P4|Extension Phase|Withdrawal by Subject|0
2871614|NCT02060383|9879865|P3|Extension Phase|Withdrawal by Subject|0
2871615|NCT02060383|9879866|P2|Extension Phase|Withdrawal by Subject|1
2871616|NCT02060383|9879867|P1|Extension Phase|Withdrawal by Subject|0
2871617|NCT02060383|9879863|P5|Extension Phase|Adverse Event|1
2871618|NCT02060383|9879864|P4|Extension Phase|Adverse Event|0
2871619|NCT02060383|9879865|P3|Extension Phase|Adverse Event|2
2871620|NCT02060383|9879866|P2|Extension Phase|Adverse Event|1
2871621|NCT02060383|9879867|P1|Extension Phase|Adverse Event|1
2871622|NCT02060383|9879863|P5|Extension Phase|Unsatisfactory therapeutic effect|2
2871623|NCT02060383|9879864|P4|Extension Phase|Unsatisfactory therapeutic effect|2
2871624|NCT02060383|9879865|P3|Extension Phase|Unsatisfactory therapeutic effect|0
2871625|NCT02060383|9879866|P2|Extension Phase|Unsatisfactory therapeutic effect|1
2871626|NCT02060383|9879867|P1|Extension Phase|Unsatisfactory therapeutic effect|1
2871627|NCT02060383|9879863|P5|Core Phase|Withdrawal by Subject|2
2871628|NCT02060383|9879864|P4|Core Phase|Withdrawal by Subject|4
2871629|NCT02060383|9879865|P3|Core Phase|Withdrawal by Subject|0
2871630|NCT02060383|9879866|P2|Core Phase|Withdrawal by Subject|0
2871631|NCT02060383|9879867|P1|Core Phase|Withdrawal by Subject|0
2871632|NCT02060383|9879863|P5|Core Phase|Protocol Violation|0
2871633|NCT02060383|9879864|P4|Core Phase|Protocol Violation|1
2871634|NCT02060383|9879865|P3|Core Phase|Protocol Violation|0
2871635|NCT02060383|9879866|P2|Core Phase|Protocol Violation|0
2871636|NCT02060383|9879867|P1|Core Phase|Protocol Violation|0
2871637|NCT02060383|9879863|P5|Core Phase|Administrative problems|0
2871638|NCT02060383|9879864|P4|Core Phase|Administrative problems|0
2871639|NCT02060383|9879865|P3|Core Phase|Administrative problems|0
2871640|NCT02060383|9879866|P2|Core Phase|Administrative problems|1
2871641|NCT02060383|9879867|P1|Core Phase|Administrative problems|0
2871642|NCT02060383|9879863|P5|Core Phase|Adverse Event|6
2871643|NCT02060383|9879864|P4|Core Phase|Adverse Event|2
2871644|NCT02060383|9879865|P3|Core Phase|Adverse Event|0
2871645|NCT02060383|9879866|P2|Core Phase|Adverse Event|0
2871646|NCT02060383|9879867|P1|Core Phase|Adverse Event|2
2871647|NCT02060383|9879863|P5|Core Phase|Unsatisfactory therapeutic effect|0
2871648|NCT02060383|9879864|P4|Core Phase|Unsatisfactory therapeutic effect|0
2871649|NCT02060383|9879865|P3|Core Phase|Unsatisfactory therapeutic effect|0
2871650|NCT02060383|9879866|P2|Core Phase|Unsatisfactory therapeutic effect|5
2871651|NCT02060383|9879867|P1|Core Phase|Unsatisfactory therapeutic effect|1
2871652|NCT02060370|9879893|P1|Overall Study|Physician Decision|1
2871653|NCT02059980|9879932|P2|Overall Study|Lost to Follow-up|1
2871654|NCT02059980|9879933|P1|Overall Study|Lost to Follow-up|2
2871655|NCT02059434|9879978|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
2871656|NCT02059434|9879979|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871657|NCT02059434|9879980|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871658|NCT02059434|9879981|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871659|NCT02059434|9879982|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871660|NCT02059434|9879983|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871661|NCT02059434|9879984|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871662|NCT02059434|9879985|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871663|NCT02059434|9879986|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2871664|NCT02059434|9879978|P9|Washout Between Periods 7 and 8|Adverse Event|1
2871665|NCT02059434|9879979|P8|Washout Between Periods 7 and 8|Adverse Event|0
2871666|NCT02059434|9879980|P7|Washout Between Periods 7 and 8|Adverse Event|0
2871667|NCT02059434|9879981|P6|Washout Between Periods 7 and 8|Adverse Event|0
2871668|NCT02059434|9879982|P5|Washout Between Periods 7 and 8|Adverse Event|0
2871669|NCT02059434|9879983|P4|Washout Between Periods 7 and 8|Adverse Event|0
2871670|NCT02059434|9879984|P3|Washout Between Periods 7 and 8|Adverse Event|0
2871671|NCT02059434|9879985|P2|Washout Between Periods 7 and 8|Adverse Event|0
2871672|NCT02059434|9879986|P1|Washout Between Periods 7 and 8|Adverse Event|0
2871673|NCT02059434|9879978|P9|Washout Between Periods 6 and 7|Physician Decision|1
2871674|NCT02059434|9879979|P8|Washout Between Periods 6 and 7|Physician Decision|0
2871675|NCT02059434|9879980|P7|Washout Between Periods 6 and 7|Physician Decision|0
2871676|NCT02059434|9879981|P6|Washout Between Periods 6 and 7|Physician Decision|0
2871677|NCT02059434|9879982|P5|Washout Between Periods 6 and 7|Physician Decision|0
2871678|NCT02059434|9879983|P4|Washout Between Periods 6 and 7|Physician Decision|0
2871679|NCT02059434|9879984|P3|Washout Between Periods 6 and 7|Physician Decision|0
2871680|NCT02059434|9879985|P2|Washout Between Periods 6 and 7|Physician Decision|0
2871681|NCT02059434|9879986|P1|Washout Between Periods 6 and 7|Physician Decision|0
2871682|NCT02059434|9879978|P9|Washout Between Periods 4 and 5|Adverse Event|1
2871683|NCT02059434|9879979|P8|Washout Between Periods 4 and 5|Adverse Event|0
2871684|NCT02059434|9879980|P7|Washout Between Periods 4 and 5|Adverse Event|0
2871685|NCT02059434|9879981|P6|Washout Between Periods 4 and 5|Adverse Event|0
2871686|NCT02059434|9879982|P5|Washout Between Periods 4 and 5|Adverse Event|0
2871687|NCT02059434|9879983|P4|Washout Between Periods 4 and 5|Adverse Event|0
2871688|NCT02059434|9879984|P3|Washout Between Periods 4 and 5|Adverse Event|0
2871689|NCT02059434|9879985|P2|Washout Between Periods 4 and 5|Adverse Event|0
2871690|NCT02059434|9879986|P1|Washout Between Periods 4 and 5|Adverse Event|0
2871691|NCT02059434|9879978|P9|Washout Between Periods 1 and 2|Physician Decision|0
2871692|NCT02059434|9879979|P8|Washout Between Periods 1 and 2|Physician Decision|1
2871693|NCT02059434|9879980|P7|Washout Between Periods 1 and 2|Physician Decision|0
2871694|NCT02059434|9879981|P6|Washout Between Periods 1 and 2|Physician Decision|0
2871695|NCT02059434|9879982|P5|Washout Between Periods 1 and 2|Physician Decision|0
2871696|NCT02059434|9879983|P4|Washout Between Periods 1 and 2|Physician Decision|0
2871697|NCT02059434|9879984|P3|Washout Between Periods 1 and 2|Physician Decision|0
2871698|NCT02059434|9879985|P2|Washout Between Periods 1 and 2|Physician Decision|0
2871699|NCT02059434|9879986|P1|Washout Between Periods 1 and 2|Physician Decision|0
2871700|NCT02059408|9880051|P3|Overall Study|Did not get tested|358
2871701|NCT02059408|9880052|P2|Overall Study|Did not get tested|330
2871702|NCT02059408|9880053|P1|Overall Study|Did not get tested|0
2871703|NCT02059395|9880072|P2|Overall Study|Lost to Follow-up|4
2871704|NCT02059395|9880073|P1|Overall Study|Lost to Follow-up|2
2871705|NCT02059291|9880088|P25|Epoch 4|Lack of Efficacy|0
2871706|NCT02059291|9880089|P24|Epoch 4|Lack of Efficacy|1
2871707|NCT02059291|9880090|P23|Epoch 4|Lack of Efficacy|0
2871708|NCT02059291|9880091|P22|Epoch 4|Lack of Efficacy|0
2871709|NCT02059291|9880092|P21|Epoch 4|Lack of Efficacy|0
2871710|NCT02059291|9880093|P20|Epoch 4|Lack of Efficacy|0
2871711|NCT02059291|9880094|P19|Epoch 4|Lack of Efficacy|0
2871712|NCT02059291|9880095|P18|Epoch 4|Lack of Efficacy|0
2871713|NCT02059291|9880096|P17|Epoch 4|Lack of Efficacy|0
2871714|NCT02059291|9880097|P16|Epoch 4|Lack of Efficacy|0
2871715|NCT02059291|9880098|P15|Epoch 4|Lack of Efficacy|0
2871716|NCT02059291|9880099|P14|Epoch 4|Lack of Efficacy|0
2871717|NCT02059291|9880100|P13|Epoch 4|Lack of Efficacy|0
2871718|NCT02059291|9880101|P12|Epoch 4|Lack of Efficacy|0
2871719|NCT02059291|9880102|P11|Epoch 4|Lack of Efficacy|0
2871720|NCT02059291|9880103|P10|Epoch 4|Lack of Efficacy|0
2871721|NCT02059291|9880104|P9|Epoch 4|Lack of Efficacy|0
2871722|NCT02059291|9880105|P8|Epoch 4|Lack of Efficacy|0
2871723|NCT02059291|9880106|P7|Epoch 4|Lack of Efficacy|0
2871724|NCT02059291|9880107|P6|Epoch 4|Lack of Efficacy|0
2871725|NCT02059291|9880108|P5|Epoch 4|Lack of Efficacy|0
2871726|NCT02059291|9880109|P4|Epoch 4|Lack of Efficacy|0
2871727|NCT02059291|9880110|P3|Epoch 4|Lack of Efficacy|0
2871728|NCT02059291|9880111|P2|Epoch 4|Lack of Efficacy|0
2871729|NCT02059291|9880112|P1|Epoch 4|Lack of Efficacy|0
2871730|NCT02059291|9880088|P25|Epoch 4|Withdrawal by Subject|0
2871731|NCT02059291|9880089|P24|Epoch 4|Withdrawal by Subject|0
2871732|NCT02059291|9880090|P23|Epoch 4|Withdrawal by Subject|0
2871733|NCT02059291|9880091|P22|Epoch 4|Withdrawal by Subject|0
2871734|NCT02059291|9880092|P21|Epoch 4|Withdrawal by Subject|1
2871735|NCT02059291|9880093|P20|Epoch 4|Withdrawal by Subject|0
2871736|NCT02059291|9880094|P19|Epoch 4|Withdrawal by Subject|0
2871737|NCT02059291|9880095|P18|Epoch 4|Withdrawal by Subject|0
2871738|NCT02059291|9880096|P17|Epoch 4|Withdrawal by Subject|0
2871739|NCT02059291|9880097|P16|Epoch 4|Withdrawal by Subject|0
2871740|NCT02059291|9880098|P15|Epoch 4|Withdrawal by Subject|0
2871741|NCT02059291|9880099|P14|Epoch 4|Withdrawal by Subject|0
2871742|NCT02059291|9880100|P13|Epoch 4|Withdrawal by Subject|0
2871743|NCT02059291|9880101|P12|Epoch 4|Withdrawal by Subject|0
2871744|NCT02059291|9880102|P11|Epoch 4|Withdrawal by Subject|0
2871745|NCT02059291|9880103|P10|Epoch 4|Withdrawal by Subject|0
2871746|NCT02059291|9880104|P9|Epoch 4|Withdrawal by Subject|0
2871747|NCT02059291|9880105|P8|Epoch 4|Withdrawal by Subject|0
2871748|NCT02059291|9880106|P7|Epoch 4|Withdrawal by Subject|0
2871749|NCT02059291|9880107|P6|Epoch 4|Withdrawal by Subject|0
2871750|NCT02059291|9880108|P5|Epoch 4|Withdrawal by Subject|0
2871751|NCT02059291|9880109|P4|Epoch 4|Withdrawal by Subject|0
2871752|NCT02059291|9880110|P3|Epoch 4|Withdrawal by Subject|0
2871753|NCT02059291|9880111|P2|Epoch 4|Withdrawal by Subject|0
2871754|NCT02059291|9880112|P1|Epoch 4|Withdrawal by Subject|0
2871755|NCT02059291|9880088|P25|Epoch 4|Pregnancy|0
2871756|NCT02059291|9880089|P24|Epoch 4|Pregnancy|0
2871757|NCT02059291|9880090|P23|Epoch 4|Pregnancy|0
2871758|NCT02059291|9880091|P22|Epoch 4|Pregnancy|0
2871759|NCT02059291|9880092|P21|Epoch 4|Pregnancy|0
2871760|NCT02059291|9880093|P20|Epoch 4|Pregnancy|0
2871761|NCT02059291|9880094|P19|Epoch 4|Pregnancy|0
2871762|NCT02059291|9880095|P18|Epoch 4|Pregnancy|0
2871763|NCT02059291|9880096|P17|Epoch 4|Pregnancy|1
2871764|NCT02059291|9880097|P16|Epoch 4|Pregnancy|0
2871765|NCT02059291|9880098|P15|Epoch 4|Pregnancy|0
2871766|NCT02059291|9880099|P14|Epoch 4|Pregnancy|0
2871767|NCT02059291|9880100|P13|Epoch 4|Pregnancy|0
2871768|NCT02059291|9880101|P12|Epoch 4|Pregnancy|0
2871769|NCT02059291|9880102|P11|Epoch 4|Pregnancy|0
2871770|NCT02059291|9880103|P10|Epoch 4|Pregnancy|0
2871771|NCT02059291|9880104|P9|Epoch 4|Pregnancy|0
2871772|NCT02059291|9880105|P8|Epoch 4|Pregnancy|0
2871773|NCT02059291|9880106|P7|Epoch 4|Pregnancy|0
2871774|NCT02059291|9880107|P6|Epoch 4|Pregnancy|0
2871775|NCT02059291|9880108|P5|Epoch 4|Pregnancy|0
2871776|NCT02059291|9880109|P4|Epoch 4|Pregnancy|0
2871777|NCT02059291|9880110|P3|Epoch 4|Pregnancy|0
2871778|NCT02059291|9880111|P2|Epoch 4|Pregnancy|0
2871779|NCT02059291|9880112|P1|Epoch 4|Pregnancy|0
2871780|NCT02059291|9880088|P25|Epoch 4|Adverse Event|0
2871781|NCT02059291|9880089|P24|Epoch 4|Adverse Event|0
2871782|NCT02059291|9880090|P23|Epoch 4|Adverse Event|1
2871783|NCT02059291|9880091|P22|Epoch 4|Adverse Event|0
2871784|NCT02059291|9880092|P21|Epoch 4|Adverse Event|0
2871785|NCT02059291|9880093|P20|Epoch 4|Adverse Event|0
2871786|NCT02059291|9880094|P19|Epoch 4|Adverse Event|0
2871787|NCT02059291|9880095|P18|Epoch 4|Adverse Event|0
2871788|NCT02059291|9880096|P17|Epoch 4|Adverse Event|1
2871789|NCT02059291|9880097|P16|Epoch 4|Adverse Event|0
2871790|NCT02059291|9880098|P15|Epoch 4|Adverse Event|0
2871791|NCT02059291|9880099|P14|Epoch 4|Adverse Event|0
2871792|NCT02059291|9880100|P13|Epoch 4|Adverse Event|0
2871793|NCT02059291|9880101|P12|Epoch 4|Adverse Event|0
2871794|NCT02059291|9880102|P11|Epoch 4|Adverse Event|0
2871795|NCT02059291|9880103|P10|Epoch 4|Adverse Event|0
2871796|NCT02059291|9880104|P9|Epoch 4|Adverse Event|0
2871797|NCT02059291|9880105|P8|Epoch 4|Adverse Event|0
2871798|NCT02059291|9880106|P7|Epoch 4|Adverse Event|0
2871799|NCT02059291|9880107|P6|Epoch 4|Adverse Event|0
2871800|NCT02059291|9880108|P5|Epoch 4|Adverse Event|0
2871801|NCT02059291|9880109|P4|Epoch 4|Adverse Event|0
2871802|NCT02059291|9880110|P3|Epoch 4|Adverse Event|0
2871803|NCT02059291|9880111|P2|Epoch 4|Adverse Event|0
2871804|NCT02059291|9880112|P1|Epoch 4|Adverse Event|0
2871805|NCT02059291|9880088|P25|Epoch 3|Withdrawal by Subject|0
2871806|NCT02059291|9880089|P24|Epoch 3|Withdrawal by Subject|0
2871807|NCT02059291|9880090|P23|Epoch 3|Withdrawal by Subject|0
2871808|NCT02059291|9880091|P22|Epoch 3|Withdrawal by Subject|0
2871809|NCT02059291|9880092|P21|Epoch 3|Withdrawal by Subject|0
2871810|NCT02059291|9880093|P20|Epoch 3|Withdrawal by Subject|0
2871811|NCT02059291|9880094|P19|Epoch 3|Withdrawal by Subject|0
2871812|NCT02059291|9880095|P18|Epoch 3|Withdrawal by Subject|0
2871813|NCT02059291|9880096|P17|Epoch 3|Withdrawal by Subject|0
2871814|NCT02059291|9880097|P16|Epoch 3|Withdrawal by Subject|1
2871815|NCT02059291|9880098|P15|Epoch 3|Withdrawal by Subject|0
2871816|NCT02059291|9880099|P14|Epoch 3|Withdrawal by Subject|0
2871817|NCT02059291|9880100|P13|Epoch 3|Withdrawal by Subject|0
2871818|NCT02059291|9880101|P12|Epoch 3|Withdrawal by Subject|0
2871819|NCT02059291|9880102|P11|Epoch 3|Withdrawal by Subject|0
2871820|NCT02059291|9880103|P10|Epoch 3|Withdrawal by Subject|0
2871821|NCT02059291|9880104|P9|Epoch 3|Withdrawal by Subject|0
2871822|NCT02059291|9880105|P8|Epoch 3|Withdrawal by Subject|0
2871823|NCT02059291|9880106|P7|Epoch 3|Withdrawal by Subject|0
2871824|NCT02059291|9880107|P6|Epoch 3|Withdrawal by Subject|0
2871825|NCT02059291|9880108|P5|Epoch 3|Withdrawal by Subject|0
2871826|NCT02059291|9880109|P4|Epoch 3|Withdrawal by Subject|0
2871827|NCT02059291|9880110|P3|Epoch 3|Withdrawal by Subject|0
2871828|NCT02059291|9880111|P2|Epoch 3|Withdrawal by Subject|0
2871829|NCT02059291|9880112|P1|Epoch 3|Withdrawal by Subject|0
2871830|NCT02059291|9880088|P25|Epoch 3|Lack of Efficacy|0
2871831|NCT02059291|9880089|P24|Epoch 3|Lack of Efficacy|0
2871832|NCT02059291|9880090|P23|Epoch 3|Lack of Efficacy|0
2871833|NCT02059291|9880091|P22|Epoch 3|Lack of Efficacy|0
2871834|NCT02059291|9880092|P21|Epoch 3|Lack of Efficacy|0
2871835|NCT02059291|9880093|P20|Epoch 3|Lack of Efficacy|0
2871836|NCT02059291|9880094|P19|Epoch 3|Lack of Efficacy|0
2871837|NCT02059291|9880095|P18|Epoch 3|Lack of Efficacy|0
2871838|NCT02059291|9880096|P17|Epoch 3|Lack of Efficacy|0
2871839|NCT02059291|9880097|P16|Epoch 3|Lack of Efficacy|3
2871840|NCT02059291|9880098|P15|Epoch 3|Lack of Efficacy|0
2871841|NCT02059291|9880099|P14|Epoch 3|Lack of Efficacy|0
2871842|NCT02059291|9880100|P13|Epoch 3|Lack of Efficacy|0
2871843|NCT02059291|9880101|P12|Epoch 3|Lack of Efficacy|0
2871844|NCT02059291|9880102|P11|Epoch 3|Lack of Efficacy|0
2871845|NCT02059291|9880103|P10|Epoch 3|Lack of Efficacy|0
2871846|NCT02059291|9880104|P9|Epoch 3|Lack of Efficacy|0
2871847|NCT02059291|9880105|P8|Epoch 3|Lack of Efficacy|0
2871848|NCT02059291|9880106|P7|Epoch 3|Lack of Efficacy|0
2871849|NCT02059291|9880107|P6|Epoch 3|Lack of Efficacy|0
2871850|NCT02059291|9880108|P5|Epoch 3|Lack of Efficacy|0
2871851|NCT02059291|9880109|P4|Epoch 3|Lack of Efficacy|0
2871852|NCT02059291|9880110|P3|Epoch 3|Lack of Efficacy|0
2871853|NCT02059291|9880111|P2|Epoch 3|Lack of Efficacy|0
2871854|NCT02059291|9880112|P1|Epoch 3|Lack of Efficacy|0
2871855|NCT02059291|9880088|P25|Epoch 3|Adverse Event|0
2871856|NCT02059291|9880089|P24|Epoch 3|Adverse Event|0
2871857|NCT02059291|9880090|P23|Epoch 3|Adverse Event|0
2871858|NCT02059291|9880091|P22|Epoch 3|Adverse Event|0
2871859|NCT02059291|9880092|P21|Epoch 3|Adverse Event|0
2871860|NCT02059291|9880093|P20|Epoch 3|Adverse Event|0
2871861|NCT02059291|9880094|P19|Epoch 3|Adverse Event|0
2871862|NCT02059291|9880095|P18|Epoch 3|Adverse Event|0
2871863|NCT02059291|9880096|P17|Epoch 3|Adverse Event|0
2871864|NCT02059291|9880097|P16|Epoch 3|Adverse Event|1
2871865|NCT02059291|9880098|P15|Epoch 3|Adverse Event|0
2871866|NCT02059291|9880099|P14|Epoch 3|Adverse Event|0
2871867|NCT02059291|9880100|P13|Epoch 3|Adverse Event|0
2871868|NCT02059291|9880101|P12|Epoch 3|Adverse Event|0
2871869|NCT02059291|9880102|P11|Epoch 3|Adverse Event|0
2871870|NCT02059291|9880103|P10|Epoch 3|Adverse Event|0
2871871|NCT02059291|9880104|P9|Epoch 3|Adverse Event|0
2871872|NCT02059291|9880105|P8|Epoch 3|Adverse Event|0
2871873|NCT02059291|9880106|P7|Epoch 3|Adverse Event|0
2871874|NCT02059291|9880107|P6|Epoch 3|Adverse Event|0
2871875|NCT02059291|9880108|P5|Epoch 3|Adverse Event|0
2871876|NCT02059291|9880109|P4|Epoch 3|Adverse Event|0
2871877|NCT02059291|9880110|P3|Epoch 3|Adverse Event|0
2871878|NCT02059291|9880111|P2|Epoch 3|Adverse Event|0
2871879|NCT02059291|9880112|P1|Epoch 3|Adverse Event|0
2871880|NCT02059291|9880088|P25|Epoch 3|Physician Decision|0
2871881|NCT02059291|9880089|P24|Epoch 3|Physician Decision|0
2871882|NCT02059291|9880090|P23|Epoch 3|Physician Decision|0
2871883|NCT02059291|9880091|P22|Epoch 3|Physician Decision|0
2871884|NCT02059291|9880092|P21|Epoch 3|Physician Decision|0
2871885|NCT02059291|9880093|P20|Epoch 3|Physician Decision|0
2871886|NCT02059291|9880094|P19|Epoch 3|Physician Decision|0
2871887|NCT02059291|9880095|P18|Epoch 3|Physician Decision|0
2871888|NCT02059291|9880096|P17|Epoch 3|Physician Decision|0
2871889|NCT02059291|9880097|P16|Epoch 3|Physician Decision|1
2871890|NCT02059291|9880098|P15|Epoch 3|Physician Decision|0
2871891|NCT02059291|9880099|P14|Epoch 3|Physician Decision|1
2871892|NCT02059291|9880100|P13|Epoch 3|Physician Decision|0
2871893|NCT02059291|9880101|P12|Epoch 3|Physician Decision|0
2871894|NCT02059291|9880102|P11|Epoch 3|Physician Decision|0
2871895|NCT02059291|9880103|P10|Epoch 3|Physician Decision|0
2871896|NCT02059291|9880104|P9|Epoch 3|Physician Decision|0
2871897|NCT02059291|9880105|P8|Epoch 3|Physician Decision|0
2871898|NCT02059291|9880106|P7|Epoch 3|Physician Decision|0
2871899|NCT02059291|9880107|P6|Epoch 3|Physician Decision|0
2871900|NCT02059291|9880108|P5|Epoch 3|Physician Decision|0
2871901|NCT02059291|9880109|P4|Epoch 3|Physician Decision|0
2871902|NCT02059291|9880110|P3|Epoch 3|Physician Decision|0
2871903|NCT02059291|9880111|P2|Epoch 3|Physician Decision|0
2871904|NCT02059291|9880112|P1|Epoch 3|Physician Decision|0
2871905|NCT02059291|9880088|P25|Epoch 2|Withdrawal by Subject|0
2871906|NCT02059291|9880089|P24|Epoch 2|Withdrawal by Subject|0
2871907|NCT02059291|9880090|P23|Epoch 2|Withdrawal by Subject|0
2871908|NCT02059291|9880091|P22|Epoch 2|Withdrawal by Subject|0
2871909|NCT02059291|9880092|P21|Epoch 2|Withdrawal by Subject|0
2871910|NCT02059291|9880093|P20|Epoch 2|Withdrawal by Subject|0
2871911|NCT02059291|9880094|P19|Epoch 2|Withdrawal by Subject|0
2871912|NCT02059291|9880095|P18|Epoch 2|Withdrawal by Subject|0
2871913|NCT02059291|9880096|P17|Epoch 2|Withdrawal by Subject|0
2871914|NCT02059291|9880097|P16|Epoch 2|Withdrawal by Subject|0
2871915|NCT02059291|9880098|P15|Epoch 2|Withdrawal by Subject|0
2871916|NCT02059291|9880099|P14|Epoch 2|Withdrawal by Subject|0
2871917|NCT02059291|9880100|P13|Epoch 2|Withdrawal by Subject|0
2871918|NCT02059291|9880101|P12|Epoch 2|Withdrawal by Subject|0
2871919|NCT02059291|9880102|P11|Epoch 2|Withdrawal by Subject|0
2871920|NCT02059291|9880103|P10|Epoch 2|Withdrawal by Subject|0
2871921|NCT02059291|9880104|P9|Epoch 2|Withdrawal by Subject|1
2871922|NCT02059291|9880105|P8|Epoch 2|Withdrawal by Subject|0
2871923|NCT02059291|9880106|P7|Epoch 2|Withdrawal by Subject|0
2871924|NCT02059291|9880107|P6|Epoch 2|Withdrawal by Subject|1
2871925|NCT02059291|9880108|P5|Epoch 2|Withdrawal by Subject|0
2871926|NCT02059291|9880109|P4|Epoch 2|Withdrawal by Subject|0
2871927|NCT02059291|9880110|P3|Epoch 2|Withdrawal by Subject|0
2871928|NCT02059291|9880111|P2|Epoch 2|Withdrawal by Subject|1
2871929|NCT02059291|9880112|P1|Epoch 2|Withdrawal by Subject|0
2871930|NCT02059291|9880088|P25|Epoch 2|Adverse Event|0
2871931|NCT02059291|9880089|P24|Epoch 2|Adverse Event|0
2871932|NCT02059291|9880090|P23|Epoch 2|Adverse Event|0
2871933|NCT02059291|9880091|P22|Epoch 2|Adverse Event|0
2871934|NCT02059291|9880092|P21|Epoch 2|Adverse Event|0
2871935|NCT02059291|9880093|P20|Epoch 2|Adverse Event|0
2871936|NCT02059291|9880094|P19|Epoch 2|Adverse Event|0
2871937|NCT02059291|9880095|P18|Epoch 2|Adverse Event|0
2871938|NCT02059291|9880096|P17|Epoch 2|Adverse Event|0
2871939|NCT02059291|9880097|P16|Epoch 2|Adverse Event|0
2871940|NCT02059291|9880098|P15|Epoch 2|Adverse Event|0
2871941|NCT02059291|9880099|P14|Epoch 2|Adverse Event|0
2871942|NCT02059291|9880100|P13|Epoch 2|Adverse Event|0
2871943|NCT02059291|9880101|P12|Epoch 2|Adverse Event|0
2871944|NCT02059291|9880102|P11|Epoch 2|Adverse Event|0
2871945|NCT02059291|9880103|P10|Epoch 2|Adverse Event|0
2871946|NCT02059291|9880104|P9|Epoch 2|Adverse Event|1
2871947|NCT02059291|9880105|P8|Epoch 2|Adverse Event|1
2871948|NCT02059291|9880106|P7|Epoch 2|Adverse Event|0
2871949|NCT02059291|9880107|P6|Epoch 2|Adverse Event|0
2871950|NCT02059291|9880108|P5|Epoch 2|Adverse Event|0
2871951|NCT02059291|9880109|P4|Epoch 2|Adverse Event|1
2871952|NCT02059291|9880110|P3|Epoch 2|Adverse Event|1
2871953|NCT02059291|9880111|P2|Epoch 2|Adverse Event|0
2871954|NCT02059291|9880112|P1|Epoch 2|Adverse Event|0
2871955|NCT02059291|9880088|P25|Epoch 2|Lack of Efficacy|0
2871956|NCT02059291|9880089|P24|Epoch 2|Lack of Efficacy|0
2871957|NCT02059291|9880090|P23|Epoch 2|Lack of Efficacy|0
2871958|NCT02059291|9880091|P22|Epoch 2|Lack of Efficacy|0
2871959|NCT02059291|9880092|P21|Epoch 2|Lack of Efficacy|0
2871960|NCT02059291|9880093|P20|Epoch 2|Lack of Efficacy|0
2871961|NCT02059291|9880094|P19|Epoch 2|Lack of Efficacy|0
2871962|NCT02059291|9880095|P18|Epoch 2|Lack of Efficacy|0
2871963|NCT02059291|9880096|P17|Epoch 2|Lack of Efficacy|0
2871964|NCT02059291|9880097|P16|Epoch 2|Lack of Efficacy|0
2871965|NCT02059291|9880098|P15|Epoch 2|Lack of Efficacy|0
2871966|NCT02059291|9880099|P14|Epoch 2|Lack of Efficacy|0
2871967|NCT02059291|9880100|P13|Epoch 2|Lack of Efficacy|0
2871968|NCT02059291|9880101|P12|Epoch 2|Lack of Efficacy|0
2871969|NCT02059291|9880102|P11|Epoch 2|Lack of Efficacy|0
2871970|NCT02059291|9880103|P10|Epoch 2|Lack of Efficacy|0
2871971|NCT02059291|9880104|P9|Epoch 2|Lack of Efficacy|0
2871972|NCT02059291|9880105|P8|Epoch 2|Lack of Efficacy|0
2871973|NCT02059291|9880106|P7|Epoch 2|Lack of Efficacy|0
2871974|NCT02059291|9880107|P6|Epoch 2|Lack of Efficacy|1
2871975|NCT02059291|9880108|P5|Epoch 2|Lack of Efficacy|0
2871976|NCT02059291|9880109|P4|Epoch 2|Lack of Efficacy|1
2871977|NCT02059291|9880110|P3|Epoch 2|Lack of Efficacy|0
2871978|NCT02059291|9880111|P2|Epoch 2|Lack of Efficacy|0
2871979|NCT02059291|9880112|P1|Epoch 2|Lack of Efficacy|0
2871980|NCT02059278|9880166|P2|Overall Study|Ran out of IP and decided to discontinue|0
2871981|NCT02059278|9880167|P1|Overall Study|Ran out of IP and decided to discontinue|1
2871982|NCT02059278|9880166|P2|Overall Study|Withdrawal by Subject|3
2871983|NCT02059278|9880167|P1|Overall Study|Withdrawal by Subject|0
2871984|NCT02059278|9880166|P2|Overall Study|Lost to Follow-up|0
2871985|NCT02059278|9880167|P1|Overall Study|Lost to Follow-up|1
2871986|NCT02059278|9880166|P2|Overall Study|Adverse Event|1
2871987|NCT02059278|9880167|P1|Overall Study|Adverse Event|1
2871988|NCT02059265|9880181|P1|Overall Study|Ineligible|4
2871989|NCT02059187|9880200|P2|Overall Study|Withdrawal by Subject|8
2871990|NCT02059187|9880201|P1|Overall Study|Withdrawal by Subject|12
2871991|NCT02059187|9880200|P2|Overall Study|Protocol Violation|0
2871992|NCT02059187|9880201|P1|Overall Study|Protocol Violation|1
2871993|NCT02059187|9880200|P2|Overall Study|Physician Decision|2
2871994|NCT02059187|9880201|P1|Overall Study|Physician Decision|1
2871995|NCT02059187|9880200|P2|Overall Study|Non-compliance with study drug|0
2871996|NCT02059187|9880201|P1|Overall Study|Non-compliance with study drug|1
2871997|NCT02059187|9880200|P2|Overall Study|Lost to Follow-up|8
2871998|NCT02059187|9880201|P1|Overall Study|Lost to Follow-up|9
2871999|NCT02059187|9880200|P2|Overall Study|Death|1
2872000|NCT02059187|9880201|P1|Overall Study|Death|1
2872001|NCT02059187|9880200|P2|Overall Study|Adverse Event|3
2872002|NCT02059187|9880201|P1|Overall Study|Adverse Event|0
2872003|NCT02059174|9880227|P2|Period 3|Physician Decision|0
2872004|NCT02059174|9880228|P1|Period 3|Physician Decision|1
2872005|NCT02059174|9880227|P2|Period 2|Protocol Violation|0
2872006|NCT02059174|9880228|P1|Period 2|Protocol Violation|1
2872007|NCT02059174|9880227|P2|Period 2|Withdrawal by Subject|2
2872008|NCT02059174|9880228|P1|Period 2|Withdrawal by Subject|0
2872009|NCT02059174|9880227|P2|Period 1|Withdrawal by Subject|2
2872010|NCT02059174|9880228|P1|Period 1|Withdrawal by Subject|0
2872011|NCT02059161|9880252|P2|Overall Study|Non-compliance with study drug|2
2872012|NCT02059161|9880253|P1|Overall Study|Non-compliance with study drug|6
2872013|NCT02059161|9880252|P2|Overall Study|Randomized in error, no study drug|1
2872014|NCT02059161|9880253|P1|Overall Study|Randomized in error, no study drug|0
2872015|NCT02059161|9880252|P2|Overall Study|Withdrawal by Subject|13
2872016|NCT02059161|9880253|P1|Overall Study|Withdrawal by Subject|16
2872017|NCT02059161|9880252|P2|Overall Study|Protocol Violation|1
2872018|NCT02059161|9880253|P1|Overall Study|Protocol Violation|1
2872019|NCT02059161|9880252|P2|Overall Study|Physician Decision|4
2872020|NCT02059161|9880253|P1|Overall Study|Physician Decision|4
2872021|NCT02059161|9880252|P2|Overall Study|Lost to Follow-up|12
2872022|NCT02059161|9880253|P1|Overall Study|Lost to Follow-up|20
2872023|NCT02059161|9880252|P2|Overall Study|Adverse Event|6
2872024|NCT02059161|9880253|P1|Overall Study|Adverse Event|2
2872025|NCT02059161|9880252|P2|Overall Study|Pregnancy|2
2872026|NCT02059161|9880253|P1|Overall Study|Pregnancy|0
2872027|NCT02059148|9880313|P6|Treatment 1|Protocol Violation|1
2872028|NCT02059148|9880314|P5|Treatment 1|Protocol Violation|0
2872029|NCT02059148|9880315|P4|Treatment 1|Protocol Violation|0
2872030|NCT02059148|9880316|P3|Treatment 1|Protocol Violation|0
2872031|NCT02059148|9880317|P2|Treatment 1|Protocol Violation|0
2872032|NCT02059148|9880318|P1|Treatment 1|Protocol Violation|0
2872033|NCT02059135|9880337|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
2872034|NCT02059135|9880338|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
2872035|NCT02059135|9880337|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
2872036|NCT02059135|9880338|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
2872037|NCT02059135|9880337|P2|Neonatal Follow-up (Safety Population)|Death|2
2872038|NCT02059135|9880338|P1|Neonatal Follow-up (Safety Population)|Death|3
2872039|NCT02059135|9880337|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
2872040|NCT02059135|9880338|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
2872041|NCT02059135|9880337|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
2872042|NCT02059135|9880338|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
2872043|NCT02059135|9880337|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
2872044|NCT02059135|9880338|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
2872045|NCT02059135|9880337|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
2872046|NCT02059135|9880338|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
2872047|NCT02059135|9880337|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
2872048|NCT02059135|9880338|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
2872049|NCT02059005|9880374|P2|Overall Study|Inpatient|1
2872050|NCT02059005|9880375|P1|Overall Study|Inpatient|0
2872051|NCT02059005|9880374|P2|Overall Study|Incarceration|1
2872052|NCT02059005|9880375|P1|Overall Study|Incarceration|0
2872053|NCT02059005|9880374|P2|Overall Study|Lost to Follow-up|19
2872054|NCT02059005|9880375|P1|Overall Study|Lost to Follow-up|19
2872055|NCT02059005|9880374|P2|Overall Study|Death|3
2872056|NCT02059005|9880375|P1|Overall Study|Death|1
2872057|NCT02058992|9880385|P1|Overall Study|CRF Uncollected|20
2872058|NCT02058992|9880385|P1|Overall Study|Protocol Violation|92
2872059|NCT02058992|9880385|P1|Overall Study|Lost to Follow-up|4
2872060|NCT02058966|9880394|P1|First Intervention|Withdrawal by Subject|1
2872061|NCT02058966|9880394|P1|Open-Label Methamphetamine|Adverse Event|1
2872062|NCT02058940|9880421|P1|Overall Study|Discharged from Critical Care Unit|1
2872063|NCT02058849|9880445|P2|Overall Study|Withdrawal by Subject|0
2872064|NCT02058849|9880446|P1|Overall Study|Withdrawal by Subject|4
2872065|NCT02058849|9880445|P2|Overall Study|Lost to Follow-up|0
2872066|NCT02058849|9880446|P1|Overall Study|Lost to Follow-up|1
2872067|NCT02058849|9880445|P2|Overall Study|Death|0
2872068|NCT02058849|9880446|P1|Overall Study|Death|1
2872069|NCT02058849|9880445|P2|Overall Study|Hospitalization|1
2872070|NCT02058849|9880446|P1|Overall Study|Hospitalization|1
2872071|NCT02058836|9880474|P2|Overall Study|Withdrawal by Subject|1
2872072|NCT02058836|9880475|P1|Overall Study|Withdrawal by Subject|1
2872073|NCT02058628|9880505|P2|Overall Study|Non compliance|0
2872074|NCT02058628|9880506|P1|Overall Study|Non compliance|1
2872075|NCT02058628|9880505|P2|Overall Study|A lot of time for study for participant|0
2872076|NCT02058628|9880506|P1|Overall Study|A lot of time for study for participant|1
2872077|NCT02058628|9880505|P2|Overall Study|The visit date was not in timeline|1
2872078|NCT02058628|9880506|P1|Overall Study|The visit date was not in timeline|0
2872079|NCT02058628|9880505|P2|Overall Study|Not in time schedule|1
2872080|NCT02058628|9880506|P1|Overall Study|Not in time schedule|0
2872081|NCT02058628|9880505|P2|Overall Study|Lost to Follow-up|4
2872082|NCT02058628|9880506|P1|Overall Study|Lost to Follow-up|2
2872083|NCT02058628|9880505|P2|Overall Study|Withdrawal by Subject|2
2872084|NCT02058628|9880506|P1|Overall Study|Withdrawal by Subject|2
2872085|NCT02058628|9880505|P2|Overall Study|Adverse Event|0
2872086|NCT02058628|9880506|P1|Overall Study|Adverse Event|1
2872087|NCT02058589|9880538|P2|Overall Study|Withdrawal by Subject|1
2872088|NCT02058589|9880539|P1|Overall Study|Withdrawal by Subject|0
2872089|NCT02058589|9880538|P2|Overall Study|Non-Serious Adverse Event|0
2872090|NCT02058589|9880539|P1|Overall Study|Non-Serious Adverse Event|1
2872091|NCT02058589|9880538|P2|Overall Study|Serious Adverse Event|1
2872092|NCT02058589|9880539|P1|Overall Study|Serious Adverse Event|1
2872093|NCT02058563|9880581|P2|Overall Study|Other (patient incarcerated)|1
2872094|NCT02058563|9880582|P1|Overall Study|Other (patient incarcerated)|0
2872095|NCT02058563|9880581|P2|Overall Study|Consent Withdrawal|1
2872096|NCT02058563|9880582|P1|Overall Study|Consent Withdrawal|1
2872097|NCT02058563|9880581|P2|Overall Study|Other (vaccinated later as new subject)|0
2872098|NCT02058563|9880582|P1|Overall Study|Other (vaccinated later as new subject)|1
2872099|NCT02058563|9880581|P2|Overall Study|Lost to Follow-up|22
2872100|NCT02058563|9880582|P1|Overall Study|Lost to Follow-up|26
2872101|NCT02058537|9880618|P1|Overall Study|Withdrawal by Subject|1
2872102|NCT02058498|9880629|P1|Overall Study|Withdrawal by Subject|4
2872103|NCT02058368|9880637|P2|Overall Study|Withdrawal by Subject|26
2872104|NCT02058368|9880638|P1|Overall Study|Withdrawal by Subject|22
2872105|NCT02058368|9880637|P2|Overall Study|Physician Decision|3
2872106|NCT02058368|9880638|P1|Overall Study|Physician Decision|2
2872107|NCT02058368|9880637|P2|Overall Study|Lost to Follow-up|0
2872108|NCT02058368|9880638|P1|Overall Study|Lost to Follow-up|2
2872109|NCT02058368|9880637|P2|Overall Study|Protocol Violation|4
2872110|NCT02058368|9880638|P1|Overall Study|Protocol Violation|0
2872111|NCT02058368|9880637|P2|Overall Study|Lack of Efficacy|1
2872112|NCT02058368|9880638|P1|Overall Study|Lack of Efficacy|0
2872113|NCT02058368|9880637|P2|Overall Study|Adverse Event|20
2872114|NCT02058368|9880638|P1|Overall Study|Adverse Event|15
2872115|NCT02058290|9880690|P2|Overall Study|Withdrawal by Subject|1
2872116|NCT02058290|9880691|P1|Overall Study|Withdrawal by Subject|0
2872117|NCT02058290|9880690|P2|Overall Study|Didn't meet intraoperative criteria|7
2872118|NCT02058290|9880691|P1|Overall Study|Didn't meet intraoperative criteria|8
2872119|NCT02058290|9880690|P2|Overall Study|Physician Decision|0
2872120|NCT02058290|9880691|P1|Overall Study|Physician Decision|1
2872121|NCT02058290|9880690|P2|Overall Study|Protocol Violation|1
2872122|NCT02058290|9880691|P1|Overall Study|Protocol Violation|2
2872123|NCT02058160|9880718|P2|Overall Study|Other than specified above|6
2872124|NCT02058160|9880719|P1|Overall Study|Other than specified above|12
2872125|NCT02058160|9880718|P2|Overall Study|Lost to Follow-up|0
2872126|NCT02058160|9880719|P1|Overall Study|Lost to Follow-up|1
2872127|NCT02058160|9880718|P2|Overall Study|Adverse Event|3
2872128|NCT02058160|9880719|P1|Overall Study|Adverse Event|12
2872129|NCT02058160|9880718|P2|Overall Study|Poor compliance to protocol|1
2872130|NCT02058160|9880719|P1|Overall Study|Poor compliance to protocol|4
2872131|NCT02058160|9880718|P2|Overall Study|Randomized but not treated|4
2872132|NCT02058160|9880719|P1|Overall Study|Randomized but not treated|2
2872133|NCT02058147|9880756|P3|Overall Study|Other than specified|0
2872134|NCT02058147|9880757|P2|Overall Study|Other than specified|9
2872135|NCT02058147|9880758|P1|Overall Study|Other than specified|8
2872136|NCT02058147|9880756|P3|Overall Study|Poor compliance to protocol|4
2872137|NCT02058147|9880757|P2|Overall Study|Poor compliance to protocol|9
2872138|NCT02058147|9880758|P1|Overall Study|Poor compliance to protocol|8
2872139|NCT02058147|9880756|P3|Overall Study|Lack of Efficacy|3
2872140|NCT02058147|9880757|P2|Overall Study|Lack of Efficacy|0
2872141|NCT02058147|9880758|P1|Overall Study|Lack of Efficacy|1
2872142|NCT02058147|9880756|P3|Overall Study|Adverse Event|21
2872143|NCT02058147|9880757|P2|Overall Study|Adverse Event|9
2872144|NCT02058147|9880758|P1|Overall Study|Adverse Event|12
2872145|NCT02058147|9880756|P3|Overall Study|Randomized but not treated|1
2872146|NCT02058147|9880757|P2|Overall Study|Randomized but not treated|0
2872147|NCT02058147|9880758|P1|Overall Study|Randomized but not treated|0
2872148|NCT02058108|9880809|P2|Overall Study|Protocol Violation|1
2872149|NCT02058108|9880810|P1|Overall Study|Protocol Violation|0
2872150|NCT02058108|9880809|P2|Overall Study|Administrative problems|3
2872151|NCT02058108|9880810|P1|Overall Study|Administrative problems|3
2872152|NCT02058108|9880809|P2|Overall Study|Withdrawal by Subject|0
2872153|NCT02058108|9880810|P1|Overall Study|Withdrawal by Subject|1
2872154|NCT02058108|9880809|P2|Overall Study|No longer requires study drug|1
2872155|NCT02058108|9880810|P1|Overall Study|No longer requires study drug|0
2872156|NCT02058108|9880809|P2|Overall Study|Unsatisfactory therapeutic effect|4
2872157|NCT02058108|9880810|P1|Overall Study|Unsatisfactory therapeutic effect|37
2872158|NCT02058108|9880809|P2|Overall Study|Abnormal Laboratory Values|1
2872159|NCT02058108|9880810|P1|Overall Study|Abnormal Laboratory Values|0
2872160|NCT02058095|9880836|P2|Overall Study|Adverse Event|0
2872161|NCT02058095|9880837|P1|Overall Study|Adverse Event|1
2872162|NCT02058069|9880847|P1|Overall Study|Withdrawal by Subject|6
2872163|NCT02058069|9880847|P1|Overall Study|Exclusion due to implant size|5
2872164|NCT02057874|9880906|P1|Overall Study|participant did not return for scan|1
2872165|NCT02057835|9880924|P10|Overall Study|Withdrawal by Subject|0
2872166|NCT02057835|9880925|P9|Overall Study|Withdrawal by Subject|0
2872167|NCT02057835|9880926|P8|Overall Study|Withdrawal by Subject|0
2872168|NCT02057835|9880927|P7|Overall Study|Withdrawal by Subject|0
2872169|NCT02057835|9880928|P6|Overall Study|Withdrawal by Subject|0
2872170|NCT02057835|9880929|P5|Overall Study|Withdrawal by Subject|0
2872171|NCT02057835|9880930|P4|Overall Study|Withdrawal by Subject|0
2872172|NCT02057835|9880931|P3|Overall Study|Withdrawal by Subject|0
2872173|NCT02057835|9880932|P2|Overall Study|Withdrawal by Subject|2
2872174|NCT02057835|9880933|P1|Overall Study|Withdrawal by Subject|0
2872175|NCT02057757|9881012|P2|Overall Study|Non-compliance|0
2872176|NCT02057757|9881013|P1|Overall Study|Non-compliance|1
2872177|NCT02057757|9881012|P2|Overall Study|Lost to Follow-up|3
2872178|NCT02057757|9881013|P1|Overall Study|Lost to Follow-up|8
2872179|NCT02057757|9881012|P2|Overall Study|Death|0
2872180|NCT02057757|9881013|P1|Overall Study|Death|2
2872181|NCT02057757|9881012|P2|Overall Study|Withdrawal by Subject|5
2872182|NCT02057757|9881013|P1|Overall Study|Withdrawal by Subject|3
2872183|NCT02057692|9881067|P4|Overall Study|Lost to Follow-up|1
2872184|NCT02057692|9881068|P3|Overall Study|Lost to Follow-up|0
2872185|NCT02057692|9881069|P2|Overall Study|Lost to Follow-up|0
2872186|NCT02057692|9881070|P1|Overall Study|Lost to Follow-up|0
2872187|NCT02057692|9881067|P4|Overall Study|Adverse Event|0
2872188|NCT02057692|9881068|P3|Overall Study|Adverse Event|0
2872189|NCT02057692|9881069|P2|Overall Study|Adverse Event|0
2872190|NCT02057692|9881070|P1|Overall Study|Adverse Event|1
2872191|NCT02057575|9881116|P4|Overall Study|Protocol Violation|0
2872192|NCT02057575|9881117|P3|Overall Study|Protocol Violation|0
2872193|NCT02057575|9881118|P2|Overall Study|Protocol Violation|1
2872194|NCT02057575|9881119|P1|Overall Study|Protocol Violation|0
2872195|NCT02057575|9881116|P4|Overall Study|Dissallowed Concurrent Medication|0
2872196|NCT02057575|9881117|P3|Overall Study|Dissallowed Concurrent Medication|0
2872197|NCT02057575|9881118|P2|Overall Study|Dissallowed Concurrent Medication|1
2872198|NCT02057575|9881119|P1|Overall Study|Dissallowed Concurrent Medication|0
2872199|NCT02057575|9881116|P4|Overall Study|Withdrawal by Subject|0
2872200|NCT02057575|9881117|P3|Overall Study|Withdrawal by Subject|0
2872201|NCT02057575|9881118|P2|Overall Study|Withdrawal by Subject|0
2872202|NCT02057575|9881119|P1|Overall Study|Withdrawal by Subject|1
2872203|NCT02057575|9881116|P4|Overall Study|Adverse Event|1
2872204|NCT02057575|9881117|P3|Overall Study|Adverse Event|0
2872205|NCT02057575|9881118|P2|Overall Study|Adverse Event|2
2872206|NCT02057575|9881119|P1|Overall Study|Adverse Event|0
2872207|NCT02057549|9881131|P2|Overall Study|Withdrawal by Subject|0
2872208|NCT02057549|9881132|P1|Overall Study|Withdrawal by Subject|1
2872209|NCT02057549|9881131|P2|Overall Study|Physician Decision|0
2872210|NCT02057549|9881132|P1|Overall Study|Physician Decision|1
2872211|NCT02057549|9881131|P2|Overall Study|Lost to Follow-up|0
2872212|NCT02057549|9881132|P1|Overall Study|Lost to Follow-up|1
2872213|NCT02057458|9881152|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2872214|NCT02057458|9881153|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2872215|NCT02057458|9881154|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
2872216|NCT02057458|9881152|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2872217|NCT02057458|9881153|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2872218|NCT02057458|9881154|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
2872219|NCT02057458|9881152|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
2872220|NCT02057458|9881153|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
2872221|NCT02057458|9881154|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
2872222|NCT02057406|9881192|P3|Overall Study|Patient transportation issues|1
2872223|NCT02057406|9881193|P2|Overall Study|Patient transportation issues|0
2872224|NCT02057406|9881194|P1|Overall Study|Patient transportation issues|0
2872225|NCT02057406|9881192|P3|Overall Study|Protocol Violation|0
2872226|NCT02057406|9881193|P2|Overall Study|Protocol Violation|1
2872227|NCT02057406|9881194|P1|Overall Study|Protocol Violation|0
2872228|NCT02057406|9881192|P3|Overall Study|Death|0
2872229|NCT02057406|9881193|P2|Overall Study|Death|0
2872230|NCT02057406|9881194|P1|Overall Study|Death|1
2872231|NCT02057406|9881192|P3|Overall Study|Lost to Follow-up|1
2872232|NCT02057406|9881193|P2|Overall Study|Lost to Follow-up|0
2872233|NCT02057406|9881194|P1|Overall Study|Lost to Follow-up|0
2872234|NCT02057406|9881192|P3|Overall Study|Withdrawal by Subject|0
2872235|NCT02057406|9881193|P2|Overall Study|Withdrawal by Subject|2
2872236|NCT02057406|9881194|P1|Overall Study|Withdrawal by Subject|0
2872237|NCT02057406|9881192|P3|Overall Study|Physician Decision|2
2872238|NCT02057406|9881193|P2|Overall Study|Physician Decision|0
2872239|NCT02057406|9881194|P1|Overall Study|Physician Decision|0
2872240|NCT02057393|9881205|P1|Overall Study|Patient did not meet criteria|1
2872241|NCT02057393|9881205|P1|Overall Study|Withdrawal by Subject|1
2872242|NCT02057250|9881226|P5|Extension Phase|Other than specified above|7
2872243|NCT02057250|9881227|P4|Extension Phase|Other than specified above|0
2872244|NCT02057250|9881228|P3|Extension Phase|Other than specified above|0
2872245|NCT02057250|9881229|P2|Extension Phase|Other than specified above|0
2872246|NCT02057250|9881230|P1|Extension Phase|Other than specified above|0
2872247|NCT02057250|9881226|P5|Extension Phase|Entered in this period but not treated|4
2872248|NCT02057250|9881227|P4|Extension Phase|Entered in this period but not treated|0
2872249|NCT02057250|9881228|P3|Extension Phase|Entered in this period but not treated|0
2872250|NCT02057250|9881229|P2|Extension Phase|Entered in this period but not treated|0
2872251|NCT02057250|9881230|P1|Extension Phase|Entered in this period but not treated|0
2872252|NCT02057250|9881226|P5|Extension Phase|Lack of Efficacy|10
2872253|NCT02057250|9881227|P4|Extension Phase|Lack of Efficacy|0
2872254|NCT02057250|9881228|P3|Extension Phase|Lack of Efficacy|0
2872255|NCT02057250|9881229|P2|Extension Phase|Lack of Efficacy|0
2872256|NCT02057250|9881230|P1|Extension Phase|Lack of Efficacy|0
2872257|NCT02057250|9881226|P5|Extension Phase|Adverse Event|15
2872258|NCT02057250|9881227|P4|Extension Phase|Adverse Event|0
2872259|NCT02057250|9881228|P3|Extension Phase|Adverse Event|0
2872260|NCT02057250|9881229|P2|Extension Phase|Adverse Event|0
2872261|NCT02057250|9881230|P1|Extension Phase|Adverse Event|0
2872262|NCT02057250|9881226|P5|AID Assessment Phase|Other than specified above|0
2872263|NCT02057250|9881227|P4|AID Assessment Phase|Other than specified above|1
2872264|NCT02057250|9881228|P3|AID Assessment Phase|Other than specified above|1
2872265|NCT02057250|9881229|P2|AID Assessment Phase|Other than specified above|1
2872266|NCT02057250|9881230|P1|AID Assessment Phase|Other than specified above|1
2872267|NCT02057250|9881226|P5|AID Assessment Phase|Adverse Event|0
2872268|NCT02057250|9881227|P4|AID Assessment Phase|Adverse Event|1
2872269|NCT02057250|9881228|P3|AID Assessment Phase|Adverse Event|6
2872270|NCT02057250|9881229|P2|AID Assessment Phase|Adverse Event|2
2872271|NCT02057250|9881230|P1|AID Assessment Phase|Adverse Event|3
2872272|NCT02057198|9881251|P3|Overall Study|Discharged early; lost to followup|0
2872273|NCT02057198|9881252|P2|Overall Study|Discharged early; lost to followup|1
2872274|NCT02057198|9881253|P1|Overall Study|Discharged early; lost to followup|0
2872275|NCT02057198|9881251|P3|Overall Study|Death|1
2872276|NCT02057198|9881252|P2|Overall Study|Death|0
2872277|NCT02057198|9881253|P1|Overall Study|Death|0
2872278|NCT02057068|9881278|P2|Overall Study|Lost to Follow-up|2
2872279|NCT02057068|9881279|P1|Overall Study|Lost to Follow-up|2
2872280|NCT02057068|9881278|P2|Overall Study|Carepartner (CP) Health|2
2872281|NCT02057068|9881279|P1|Overall Study|Carepartner (CP) Health|4
2872282|NCT02057068|9881278|P2|Overall Study|Caregiver (CG) Health|2
2872283|NCT02057068|9881279|P1|Overall Study|Caregiver (CG) Health|0
2872284|NCT02057068|9881278|P2|Overall Study|Withdrawal by Subject|2
2872285|NCT02057068|9881279|P1|Overall Study|Withdrawal by Subject|2
2872286|NCT02056834|9881308|P1|Overall Study|Lost to Follow-up|7
2872287|NCT02056652|9881329|P2|Overall Study|Lost to Follow-up|3
2872288|NCT02056652|9881330|P1|Overall Study|Lost to Follow-up|0
2872289|NCT02056652|9881329|P2|Overall Study|Withdrawal by Subject|0
2872290|NCT02056652|9881330|P1|Overall Study|Withdrawal by Subject|1
2872291|NCT02056626|9881367|P4|Overall Study|patient did not follow directions|0
2872292|NCT02056626|9881368|P3|Overall Study|patient did not follow directions|0
2872293|NCT02056626|9881369|P2|Overall Study|patient did not follow directions|1
2872294|NCT02056626|9881370|P1|Overall Study|patient did not follow directions|3
2872295|NCT02056392|9881405|P6|Overall Study|Withdrawal by Subject|0
2872296|NCT02056392|9881406|P5|Overall Study|Withdrawal by Subject|1
2872297|NCT02056392|9881407|P4|Overall Study|Withdrawal by Subject|0
2872298|NCT02056392|9881408|P3|Overall Study|Withdrawal by Subject|0
2872299|NCT02056392|9881409|P2|Overall Study|Withdrawal by Subject|0
2872300|NCT02056392|9881410|P1|Overall Study|Withdrawal by Subject|1
2872301|NCT02056392|9881405|P6|Overall Study|Protocol Violation|0
2872302|NCT02056392|9881406|P5|Overall Study|Protocol Violation|0
2872303|NCT02056392|9881407|P4|Overall Study|Protocol Violation|0
2872304|NCT02056392|9881408|P3|Overall Study|Protocol Violation|1
2872305|NCT02056392|9881409|P2|Overall Study|Protocol Violation|0
2872306|NCT02056392|9881410|P1|Overall Study|Protocol Violation|1
2872307|NCT02056392|9881405|P6|Overall Study|Lost to Follow-up|0
2872308|NCT02056392|9881406|P5|Overall Study|Lost to Follow-up|0
2872309|NCT02056392|9881407|P4|Overall Study|Lost to Follow-up|0
2872310|NCT02056392|9881408|P3|Overall Study|Lost to Follow-up|2
2872311|NCT02056392|9881409|P2|Overall Study|Lost to Follow-up|1
2872312|NCT02056392|9881410|P1|Overall Study|Lost to Follow-up|0
2872313|NCT02056340|9881447|P2|Overall Study|Withdrawal by Subject|6
2872314|NCT02056340|9881448|P1|Overall Study|Withdrawal by Subject|2
2872315|NCT02056340|9881447|P2|Overall Study|Lost to Follow-up|5
2872316|NCT02056340|9881448|P1|Overall Study|Lost to Follow-up|5
2872317|NCT02055976|9881478|P9|Overall Study|Lost to Follow-up|0
2872318|NCT02055976|9881479|P8|Overall Study|Lost to Follow-up|0
2872319|NCT02055976|9881480|P7|Overall Study|Lost to Follow-up|0
2872320|NCT02055976|9881481|P6|Overall Study|Lost to Follow-up|0
2872321|NCT02055976|9881482|P5|Overall Study|Lost to Follow-up|0
2872322|NCT02055976|9881483|P4|Overall Study|Lost to Follow-up|1
2872323|NCT02055976|9881484|P3|Overall Study|Lost to Follow-up|0
2872324|NCT02055976|9881485|P2|Overall Study|Lost to Follow-up|0
2872325|NCT02055976|9881486|P1|Overall Study|Lost to Follow-up|0
2872326|NCT02055976|9881478|P9|Overall Study|Does not meet entrance criteria|0
2872327|NCT02055976|9881479|P8|Overall Study|Does not meet entrance criteria|0
2872328|NCT02055976|9881480|P7|Overall Study|Does not meet entrance criteria|1
2872329|NCT02055976|9881481|P6|Overall Study|Does not meet entrance criteria|0
2872330|NCT02055976|9881482|P5|Overall Study|Does not meet entrance criteria|0
2872331|NCT02055976|9881483|P4|Overall Study|Does not meet entrance criteria|0
2872332|NCT02055976|9881484|P3|Overall Study|Does not meet entrance criteria|0
2872333|NCT02055976|9881485|P2|Overall Study|Does not meet entrance criteria|0
2872334|NCT02055976|9881486|P1|Overall Study|Does not meet entrance criteria|0
2872335|NCT02055976|9881478|P9|Overall Study|Adverse Event|0
2872336|NCT02055976|9881479|P8|Overall Study|Adverse Event|0
2872337|NCT02055976|9881480|P7|Overall Study|Adverse Event|1
2872338|NCT02055976|9881481|P6|Overall Study|Adverse Event|1
2872339|NCT02055976|9881482|P5|Overall Study|Adverse Event|0
2872340|NCT02055976|9881483|P4|Overall Study|Adverse Event|0
2872341|NCT02055976|9881484|P3|Overall Study|Adverse Event|0
2872342|NCT02055976|9881485|P2|Overall Study|Adverse Event|0
2872343|NCT02055976|9881486|P1|Overall Study|Adverse Event|0
2872344|NCT02055976|9881478|P9|Overall Study|Other|0
2872345|NCT02055976|9881479|P8|Overall Study|Other|0
2872346|NCT02055976|9881480|P7|Overall Study|Other|0
2872347|NCT02055976|9881481|P6|Overall Study|Other|0
2872348|NCT02055976|9881482|P5|Overall Study|Other|0
2872349|NCT02055976|9881483|P4|Overall Study|Other|0
2872350|NCT02055976|9881484|P3|Overall Study|Other|1
2872351|NCT02055976|9881485|P2|Overall Study|Other|0
2872352|NCT02055976|9881486|P1|Overall Study|Other|0
2872353|NCT02055820|9881915|P10|Phase II: Expansion|Death|0
2872354|NCT02055820|9881916|P9|Phase II: Expansion|Death|0
2872355|NCT02055820|9881917|P8|Phase II: Expansion|Death|0
2872356|NCT02055820|9881918|P7|Phase II: Expansion|Death|0
2872357|NCT02055820|9881919|P6|Phase II: Expansion|Death|0
2872358|NCT02055820|9881920|P5|Phase II: Expansion|Death|15
2872359|NCT02055820|9881921|P4|Phase II: Expansion|Death|0
2872360|NCT02055820|9881922|P3|Phase II: Expansion|Death|0
2872361|NCT02055820|9881923|P2|Phase II: Expansion|Death|0
2872362|NCT02055820|9881924|P1|Phase II: Expansion|Death|0
2872363|NCT02055820|9881915|P10|Phase II: Expansion|Withdrawal by Subject|0
2872364|NCT02055820|9881916|P9|Phase II: Expansion|Withdrawal by Subject|0
2872365|NCT02055820|9881917|P8|Phase II: Expansion|Withdrawal by Subject|0
2872366|NCT02055820|9881918|P7|Phase II: Expansion|Withdrawal by Subject|0
2872367|NCT02055820|9881919|P6|Phase II: Expansion|Withdrawal by Subject|0
2872368|NCT02055820|9881920|P5|Phase II: Expansion|Withdrawal by Subject|10
2872369|NCT02055820|9881921|P4|Phase II: Expansion|Withdrawal by Subject|0
2872370|NCT02055820|9881922|P3|Phase II: Expansion|Withdrawal by Subject|0
2872371|NCT02055820|9881923|P2|Phase II: Expansion|Withdrawal by Subject|0
2872372|NCT02055820|9881924|P1|Phase II: Expansion|Withdrawal by Subject|0
2872373|NCT02055820|9881915|P10|Phase II: Expansion|Lost to Follow-up|0
2872374|NCT02055820|9881916|P9|Phase II: Expansion|Lost to Follow-up|0
2872375|NCT02055820|9881917|P8|Phase II: Expansion|Lost to Follow-up|0
2872376|NCT02055820|9881918|P7|Phase II: Expansion|Lost to Follow-up|0
2872377|NCT02055820|9881919|P6|Phase II: Expansion|Lost to Follow-up|0
2872378|NCT02055820|9881920|P5|Phase II: Expansion|Lost to Follow-up|3
2872379|NCT02055820|9881921|P4|Phase II: Expansion|Lost to Follow-up|0
2872380|NCT02055820|9881922|P3|Phase II: Expansion|Lost to Follow-up|0
2872381|NCT02055820|9881923|P2|Phase II: Expansion|Lost to Follow-up|0
2872382|NCT02055820|9881924|P1|Phase II: Expansion|Lost to Follow-up|0
2872383|NCT02055820|9881915|P10|Phase II: Expansion|Participants still in study|0
2872384|NCT02055820|9881916|P9|Phase II: Expansion|Participants still in study|0
2872385|NCT02055820|9881917|P8|Phase II: Expansion|Participants still in study|0
2872386|NCT02055820|9881918|P7|Phase II: Expansion|Participants still in study|0
2872387|NCT02055820|9881919|P6|Phase II: Expansion|Participants still in study|0
2872388|NCT02055820|9881920|P5|Phase II: Expansion|Participants still in study|177
2872389|NCT02055820|9881921|P4|Phase II: Expansion|Participants still in study|0
2872390|NCT02055820|9881922|P3|Phase II: Expansion|Participants still in study|0
2872391|NCT02055820|9881923|P2|Phase II: Expansion|Participants still in study|0
2872392|NCT02055820|9881924|P1|Phase II: Expansion|Participants still in study|0
2872393|NCT02055820|9881915|P10|Phase II: Expansion|Unspecified Reason|0
2872394|NCT02055820|9881916|P9|Phase II: Expansion|Unspecified Reason|0
2872395|NCT02055820|9881917|P8|Phase II: Expansion|Unspecified Reason|0
2872396|NCT02055820|9881918|P7|Phase II: Expansion|Unspecified Reason|0
2872397|NCT02055820|9881919|P6|Phase II: Expansion|Unspecified Reason|0
2872398|NCT02055820|9881920|P5|Phase II: Expansion|Unspecified Reason|3
2872399|NCT02055820|9881921|P4|Phase II: Expansion|Unspecified Reason|0
2872400|NCT02055820|9881922|P3|Phase II: Expansion|Unspecified Reason|0
2872401|NCT02055820|9881923|P2|Phase II: Expansion|Unspecified Reason|0
2872402|NCT02055820|9881924|P1|Phase II: Expansion|Unspecified Reason|0
2872403|NCT02055820|9881915|P10|Phase I: Dose-Finding|Participants still in study|6
2872404|NCT02055820|9881916|P9|Phase I: Dose-Finding|Participants still in study|6
2872405|NCT02055820|9881917|P8|Phase I: Dose-Finding|Participants still in study|6
2872406|NCT02055820|9881918|P7|Phase I: Dose-Finding|Participants still in study|7
2872407|NCT02055820|9881919|P6|Phase I: Dose-Finding|Participants still in study|6
2872408|NCT02055820|9881920|P5|Phase I: Dose-Finding|Participants still in study|0
2872409|NCT02055820|9881921|P4|Phase I: Dose-Finding|Participants still in study|4
2872410|NCT02055820|9881922|P3|Phase I: Dose-Finding|Participants still in study|7
2872411|NCT02055820|9881923|P2|Phase I: Dose-Finding|Participants still in study|3
2872412|NCT02055820|9881924|P1|Phase I: Dose-Finding|Participants still in study|6
2872413|NCT02055820|9881915|P10|Phase I: Dose-Finding|Death|0
2872414|NCT02055820|9881916|P9|Phase I: Dose-Finding|Death|0
2872415|NCT02055820|9881917|P8|Phase I: Dose-Finding|Death|0
2872416|NCT02055820|9881918|P7|Phase I: Dose-Finding|Death|0
2872417|NCT02055820|9881919|P6|Phase I: Dose-Finding|Death|0
2872418|NCT02055820|9881920|P5|Phase I: Dose-Finding|Death|0
2872419|NCT02055820|9881921|P4|Phase I: Dose-Finding|Death|2
2872420|NCT02055820|9881922|P3|Phase I: Dose-Finding|Death|1
2872421|NCT02055820|9881923|P2|Phase I: Dose-Finding|Death|0
2872422|NCT02055820|9881924|P1|Phase I: Dose-Finding|Death|1
2872423|NCT02055820|9881915|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
2872424|NCT02055820|9881916|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
2872425|NCT02055820|9881917|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
2872426|NCT02055820|9881918|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
2872427|NCT02055820|9881919|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
2872428|NCT02055820|9881920|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
2872429|NCT02055820|9881921|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
2872430|NCT02055820|9881922|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
2872431|NCT02055820|9881923|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
2872432|NCT02055820|9881924|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
2872433|NCT02055365|9882057|P1|Overall Study|Prematurely Withdrawn|1
2872434|NCT02055352|9882070|P2|Overall Study|Reason unknown|5
2872435|NCT02055352|9882071|P1|Overall Study|Reason unknown|1
2872436|NCT02055352|9882070|P2|Overall Study|Withdrawal of informed consent|0
2872437|NCT02055352|9882071|P1|Overall Study|Withdrawal of informed consent|1
2872438|NCT02055352|9882070|P2|Overall Study|AE, study drug would be detrimental|3
2872439|NCT02055352|9882071|P1|Overall Study|AE, study drug would be detrimental|1
2872440|NCT02055352|9882070|P2|Overall Study|Use of prohibited treatment|3
2872441|NCT02055352|9882071|P1|Overall Study|Use of prohibited treatment|0
2872442|NCT02055352|9882070|P2|Overall Study|Patient decision|1
2872443|NCT02055352|9882071|P1|Overall Study|Patient decision|1
2872444|NCT02055352|9882070|P2|Overall Study|Death|2
2872445|NCT02055352|9882071|P1|Overall Study|Death|1
2872446|NCT02055352|9882070|P2|Overall Study|Poor compliance|1
2872447|NCT02055352|9882071|P1|Overall Study|Poor compliance|1
2872448|NCT02055352|9882070|P2|Overall Study|Non-eligible|1
2872449|NCT02055352|9882071|P1|Overall Study|Non-eligible|0
2872450|NCT02055352|9882070|P2|Overall Study|Adverse Event|1
2872451|NCT02055352|9882071|P1|Overall Study|Adverse Event|0
2872452|NCT02055118|9882088|P3|Overall Study|Withdrawal by Subject|0
2872453|NCT02055118|9882089|P2|Overall Study|Withdrawal by Subject|2
2872454|NCT02055118|9882090|P1|Overall Study|Withdrawal by Subject|0
2872455|NCT02054910|9882149|P2|Overall Study|Lost to Follow-up|1
2872456|NCT02054910|9882150|P1|Overall Study|Lost to Follow-up|4
2872457|NCT02054897|9882169|P3|Overall Study|Randomized but not exposed|0
2872458|NCT02054897|9882170|P2|Overall Study|Randomized but not exposed|0
2872459|NCT02054897|9882171|P1|Overall Study|Randomized but not exposed|1
2872460|NCT02054897|9882169|P3|Overall Study|Lost to Follow-up|7
2872461|NCT02054897|9882170|P2|Overall Study|Lost to Follow-up|2
2872462|NCT02054897|9882171|P1|Overall Study|Lost to Follow-up|4
2872463|NCT02054897|9882169|P3|Overall Study|Missing follow-up information|3
2872464|NCT02054897|9882170|P2|Overall Study|Missing follow-up information|5
2872465|NCT02054897|9882171|P1|Overall Study|Missing follow-up information|3
2872466|NCT02054897|9882169|P3|Overall Study|Withdrawal by Subject|2
2872467|NCT02054897|9882170|P2|Overall Study|Withdrawal by Subject|0
2872468|NCT02054897|9882171|P1|Overall Study|Withdrawal by Subject|2
2872469|NCT02054715|9882218|P2|Follow-up 2|Treatment Change or Delay|0
2872470|NCT02054715|9882219|P1|Follow-up 2|Treatment Change or Delay|1
2872471|NCT02054715|9882218|P2|Follow-up 2|No Reason|0
2872472|NCT02054715|9882219|P1|Follow-up 2|No Reason|2
2872473|NCT02054715|9882218|P2|Follow-up 2|Changed Mind|1
2872474|NCT02054715|9882219|P1|Follow-up 2|Changed Mind|0
2872475|NCT02054715|9882218|P2|Follow-up 2|Changed MD/Facility|1
2872476|NCT02054715|9882219|P1|Follow-up 2|Changed MD/Facility|0
2872477|NCT02054715|9882218|P2|Follow-up 2|Hospitalization|2
2872478|NCT02054715|9882219|P1|Follow-up 2|Hospitalization|0
2872479|NCT02054715|9882218|P2|Follow-up 2|Death|3
2872480|NCT02054715|9882219|P1|Follow-up 2|Death|3
2872481|NCT02054715|9882218|P2|Follow-up 2|Ineligible|5
2872482|NCT02054715|9882219|P1|Follow-up 2|Ineligible|4
2872483|NCT02054715|9882218|P2|Follow-up 2|Followup Not Completed|4
2872484|NCT02054715|9882219|P1|Follow-up 2|Followup Not Completed|3
2872485|NCT02054715|9882218|P2|Follow-up 2|Refused|2
2872486|NCT02054715|9882219|P1|Follow-up 2|Refused|3
2872487|NCT02054715|9882218|P2|Follow-up 2|Lost to Followup|1
2872488|NCT02054715|9882219|P1|Follow-up 2|Lost to Followup|3
2872489|NCT02054715|9882218|P2|Baseline/Follow-up 1|Changed Mind|0
2872490|NCT02054715|9882219|P1|Baseline/Follow-up 1|Changed Mind|1
2872491|NCT02054715|9882218|P2|Baseline/Follow-up 1|Hospitalization|0
2872492|NCT02054715|9882219|P1|Baseline/Follow-up 1|Hospitalization|1
2872493|NCT02054715|9882218|P2|Baseline/Follow-up 1|Ineligible|0
2872494|NCT02054715|9882219|P1|Baseline/Follow-up 1|Ineligible|3
2872495|NCT02054715|9882218|P2|Baseline/Follow-up 1|Overwhelmed|0
2872496|NCT02054715|9882219|P1|Baseline/Follow-up 1|Overwhelmed|2
2872497|NCT02054715|9882218|P2|Baseline/Follow-up 1|No Reason|1
2872498|NCT02054715|9882219|P1|Baseline/Follow-up 1|No Reason|0
2872499|NCT02054715|9882218|P2|Baseline/Follow-up 1|Disliked Procedure|1
2872500|NCT02054715|9882219|P1|Baseline/Follow-up 1|Disliked Procedure|0
2872501|NCT02054715|9882218|P2|Baseline/Follow-up 1|Changed MD/Facility|1
2872502|NCT02054715|9882219|P1|Baseline/Follow-up 1|Changed MD/Facility|0
2872503|NCT02054715|9882218|P2|Baseline/Follow-up 1|Medical|1
2872504|NCT02054715|9882219|P1|Baseline/Follow-up 1|Medical|0
2872505|NCT02054715|9882218|P2|Baseline/Follow-up 1|Refused|3
2872506|NCT02054715|9882219|P1|Baseline/Follow-up 1|Refused|1
2872507|NCT02054702|9882233|P2|Overall Study|Withdrawal by Subject|4
2872508|NCT02054702|9882234|P1|Overall Study|Withdrawal by Subject|14
2872509|NCT02054702|9882233|P2|Overall Study|Physician Decision|1
2872510|NCT02054702|9882234|P1|Overall Study|Physician Decision|0
2872511|NCT02054702|9882233|P2|Overall Study|Met Withdrawal Criteria|1
2872512|NCT02054702|9882234|P1|Overall Study|Met Withdrawal Criteria|4
2872513|NCT02054702|9882233|P2|Overall Study|Adverse Event|1
2872514|NCT02054702|9882234|P1|Overall Study|Adverse Event|3
2872515|NCT02054702|9882233|P2|Overall Study|Lost to Follow-up|5
2872516|NCT02054702|9882234|P1|Overall Study|Lost to Follow-up|3
2872517|NCT02054520|9882291|P6|Overall Study|Study terminated by Sponsor|0
2872518|NCT02054520|9882292|P5|Overall Study|Study terminated by Sponsor|0
2872519|NCT02054520|9882293|P4|Overall Study|Study terminated by Sponsor|1
2872520|NCT02054520|9882294|P3|Overall Study|Study terminated by Sponsor|2
2872521|NCT02054520|9882295|P2|Overall Study|Study terminated by Sponsor|0
2872522|NCT02054520|9882296|P1|Overall Study|Study terminated by Sponsor|0
2872523|NCT02054520|9882291|P6|Overall Study|Physician Decision|1
2872524|NCT02054520|9882292|P5|Overall Study|Physician Decision|0
2872525|NCT02054520|9882293|P4|Overall Study|Physician Decision|1
2872526|NCT02054520|9882294|P3|Overall Study|Physician Decision|0
2872527|NCT02054520|9882295|P2|Overall Study|Physician Decision|1
2872528|NCT02054520|9882296|P1|Overall Study|Physician Decision|0
2872529|NCT02054520|9882291|P6|Overall Study|Withdrawal by Subject|0
2872530|NCT02054520|9882292|P5|Overall Study|Withdrawal by Subject|1
2872531|NCT02054520|9882293|P4|Overall Study|Withdrawal by Subject|2
2872532|NCT02054520|9882294|P3|Overall Study|Withdrawal by Subject|0
2872533|NCT02054520|9882295|P2|Overall Study|Withdrawal by Subject|0
2872534|NCT02054520|9882296|P1|Overall Study|Withdrawal by Subject|1
2872535|NCT02054520|9882291|P6|Overall Study|Lack of Efficacy|2
2872536|NCT02054520|9882292|P5|Overall Study|Lack of Efficacy|3
2872537|NCT02054520|9882293|P4|Overall Study|Lack of Efficacy|1
2872538|NCT02054520|9882294|P3|Overall Study|Lack of Efficacy|2
2872539|NCT02054520|9882295|P2|Overall Study|Lack of Efficacy|0
2872540|NCT02054520|9882296|P1|Overall Study|Lack of Efficacy|7
2872541|NCT02054520|9882291|P6|Overall Study|Adverse Event|0
2872542|NCT02054520|9882292|P5|Overall Study|Adverse Event|1
2872543|NCT02054520|9882293|P4|Overall Study|Adverse Event|1
2872544|NCT02054520|9882294|P3|Overall Study|Adverse Event|2
2872545|NCT02054520|9882295|P2|Overall Study|Adverse Event|4
2872546|NCT02054520|9882296|P1|Overall Study|Adverse Event|1
2872547|NCT02054481|9882320|P4|Overall Study|Other reason|0
2872548|NCT02054481|9882321|P3|Overall Study|Other reason|2
2872549|NCT02054481|9882322|P2|Overall Study|Other reason|1
2872550|NCT02054481|9882323|P1|Overall Study|Other reason|2
2872551|NCT02054481|9882320|P4|Overall Study|Lost to Follow-up|0
2872552|NCT02054481|9882321|P3|Overall Study|Lost to Follow-up|0
2872553|NCT02054481|9882322|P2|Overall Study|Lost to Follow-up|0
2872554|NCT02054481|9882323|P1|Overall Study|Lost to Follow-up|1
2872555|NCT02054481|9882320|P4|Overall Study|Adverse Event|1
2872556|NCT02054481|9882321|P3|Overall Study|Adverse Event|0
2872557|NCT02054481|9882322|P2|Overall Study|Adverse Event|1
2872558|NCT02054481|9882323|P1|Overall Study|Adverse Event|1
2872559|NCT02054325|9882384|P2|Overall Study|Lost to Follow-up|5
2872560|NCT02054325|9882385|P1|Overall Study|Lost to Follow-up|8
2872561|NCT02054130|9882412|P4|Overall Study|Missed dose|10
2872562|NCT02054130|9882413|P3|Overall Study|Missed dose|7
2872563|NCT02054130|9882414|P2|Overall Study|Missed dose|6
2872564|NCT02054130|9882415|P1|Overall Study|Missed dose|4
2872565|NCT02054130|9882412|P4|Overall Study|Lost to Follow-up|2
2872566|NCT02054130|9882413|P3|Overall Study|Lost to Follow-up|1
2872567|NCT02054130|9882414|P2|Overall Study|Lost to Follow-up|0
2872568|NCT02054130|9882415|P1|Overall Study|Lost to Follow-up|0
2872569|NCT02054130|9882412|P4|Overall Study|Death|0
2872570|NCT02054130|9882413|P3|Overall Study|Death|0
2872571|NCT02054130|9882414|P2|Overall Study|Death|1
2872572|NCT02054130|9882415|P1|Overall Study|Death|0
2872573|NCT02054130|9882412|P4|Overall Study|Withdrawal by Subject|10
2872574|NCT02054130|9882413|P3|Overall Study|Withdrawal by Subject|7
2872575|NCT02054130|9882414|P2|Overall Study|Withdrawal by Subject|4
2872576|NCT02054130|9882415|P1|Overall Study|Withdrawal by Subject|4
2872577|NCT02053753|9882509|P2|Overall Study|Lost to Follow-up|3
2872578|NCT02053753|9882510|P1|Overall Study|Lost to Follow-up|4
2872579|NCT02053753|9882509|P2|Overall Study|Decision by Sponsor|1
2872580|NCT02053753|9882510|P1|Overall Study|Decision by Sponsor|1
2872581|NCT02053753|9882509|P2|Overall Study|Withdrawal by Subject|4
2872582|NCT02053753|9882510|P1|Overall Study|Withdrawal by Subject|2
2872583|NCT02053610|9882534|P2|Overall Study|Violation of Selection Criteria|0
2872584|NCT02053610|9882535|P1|Overall Study|Violation of Selection Criteria|1
2872585|NCT02053610|9882534|P2|Overall Study|Insufficient Therapeutic Response|1
2872586|NCT02053610|9882535|P1|Overall Study|Insufficient Therapeutic Response|1
2872587|NCT02053610|9882534|P2|Overall Study|Did not Receive Treatment|2
2872588|NCT02053610|9882535|P1|Overall Study|Did not Receive Treatment|4
2872589|NCT02053610|9882534|P2|Overall Study|Refused treatment/Did not cooperate|3
2872590|NCT02053610|9882535|P1|Overall Study|Refused treatment/Did not cooperate|1
2872591|NCT02053610|9882534|P2|Overall Study|Disease Progression|3
2872592|NCT02053610|9882535|P1|Overall Study|Disease Progression|2
2872593|NCT02053610|9882534|P2|Overall Study|Administrative/Other|1
2872594|NCT02053610|9882535|P1|Overall Study|Administrative/Other|1
2872595|NCT02053610|9882534|P2|Overall Study|Death|5
2872596|NCT02053610|9882535|P1|Overall Study|Death|5
2872597|NCT02053610|9882534|P2|Overall Study|Withdrew Consent|9
2872598|NCT02053610|9882535|P1|Overall Study|Withdrew Consent|2
2872599|NCT02053610|9882534|P2|Overall Study|Adverse Event/Intercurrent Illness|43
2872600|NCT02053610|9882535|P1|Overall Study|Adverse Event/Intercurrent Illness|25
2872601|NCT02053493|9882567|P2|Overall Study|Withdrawal by Subject|1
2872602|NCT02053493|9882568|P1|Overall Study|Withdrawal by Subject|1
2872603|NCT02053168|9882617|P1|Overall Study|Lost to Follow-up|1
2872604|NCT02053168|9882617|P1|Overall Study|Physician Decision|1
2872605|NCT02053168|9882617|P1|Overall Study|Withdrawal by Subject|1
2872606|NCT02052596|9882696|P2|Safety Phase|Lost due to Crohn`s disease|1
2872607|NCT02052596|9882697|P1|Safety Phase|Lost due to Crohn`s disease|0
2872608|NCT02052596|9882696|P2|Safety Phase|Enrolled in error|0
2872609|NCT02052596|9882697|P1|Safety Phase|Enrolled in error|1
2872610|NCT02052596|9882696|P2|Safety Phase|Withdrawal by Subject|11
2872611|NCT02052596|9882697|P1|Safety Phase|Withdrawal by Subject|8
2872612|NCT02052596|9882696|P2|Safety Phase|Protocol Violation|2
2872613|NCT02052596|9882697|P1|Safety Phase|Protocol Violation|1
2872614|NCT02052596|9882696|P2|Safety Phase|Lost to Follow-up|18
2872615|NCT02052596|9882697|P1|Safety Phase|Lost to Follow-up|11
2872616|NCT02052596|9882696|P2|Safety Phase|Adverse Event|3
2872617|NCT02052596|9882697|P1|Safety Phase|Adverse Event|6
2872618|NCT02052596|9882696|P2|Active Phase|Lost due to Crohn`s disease|1
2872619|NCT02052596|9882697|P1|Active Phase|Lost due to Crohn`s disease|0
2872620|NCT02052596|9882696|P2|Active Phase|Enrolled in error|0
2872621|NCT02052596|9882697|P1|Active Phase|Enrolled in error|1
2872622|NCT02052596|9882696|P2|Active Phase|Withdrawal by Subject|4
2872623|NCT02052596|9882697|P1|Active Phase|Withdrawal by Subject|3
2872624|NCT02052596|9882696|P2|Active Phase|Protocol Violation|2
2872625|NCT02052596|9882697|P1|Active Phase|Protocol Violation|1
2872626|NCT02052596|9882696|P2|Active Phase|Lost to Follow-up|11
2872627|NCT02052596|9882697|P1|Active Phase|Lost to Follow-up|8
2872628|NCT02052596|9882696|P2|Active Phase|Adverse Event|2
2872629|NCT02052596|9882697|P1|Active Phase|Adverse Event|3
2872630|NCT02052466|9882727|P1|Overall Study|Acromial fracture|1
2872631|NCT02052466|9882727|P1|Overall Study|Withdrawal by Subject|1
2872632|NCT02052440|9882744|P2|Overall Study|Withdrawal by Subject|1
2872633|NCT02052440|9882745|P1|Overall Study|Withdrawal by Subject|0
2872634|NCT02052414|9882757|P1|Overall Study|Withdrawal by Subject|3
2872635|NCT02052414|9882757|P1|Overall Study|Lack of Efficacy|2
2872636|NCT02052414|9882757|P1|Overall Study|Adverse Event|12
2872637|NCT02052011|9882792|P2|Overall Study|Withdrawal by Subject|2
2872638|NCT02052011|9882793|P1|Overall Study|Withdrawal by Subject|1
2872639|NCT02052011|9882792|P2|Overall Study|Lost to Follow-up|0
2872640|NCT02052011|9882793|P1|Overall Study|Lost to Follow-up|3
2872641|NCT02051296|9882948|P2|Overall Study|withdraw prior to treatment|7
2872642|NCT02051296|9882949|P1|Overall Study|withdraw prior to treatment|7
2872643|NCT02051296|9882948|P2|Overall Study|Lost to Follow-up|2
2872644|NCT02051296|9882949|P1|Overall Study|Lost to Follow-up|1
2872645|NCT02050321|9883005|P1|Overall Study|Adverse Event|1
2872646|NCT02050321|9883005|P1|Overall Study|Withdrawal by Subject|1
2872647|NCT02050048|9883021|P2|Overall Study|Ineligible after ERCP|1
2872648|NCT02050048|9883022|P1|Overall Study|Ineligible after ERCP|4
2872649|NCT02050048|9883021|P2|Overall Study|Death|0
2872650|NCT02050048|9883022|P1|Overall Study|Death|1
2872651|NCT02050048|9883021|P2|Overall Study|Lost to Follow-up|1
2872652|NCT02050048|9883022|P1|Overall Study|Lost to Follow-up|0
2872653|NCT02049957|9883037|P9|Overall Study|Physician Decision|0
2872654|NCT02049957|9883038|P8|Overall Study|Physician Decision|0
2872655|NCT02049957|9883039|P7|Overall Study|Physician Decision|0
2872656|NCT02049957|9883040|P6|Overall Study|Physician Decision|1
2872657|NCT02049957|9883041|P5|Overall Study|Physician Decision|0
2872658|NCT02049957|9883042|P4|Overall Study|Physician Decision|0
2872659|NCT02049957|9883043|P3|Overall Study|Physician Decision|0
2872660|NCT02049957|9883044|P2|Overall Study|Physician Decision|0
2872661|NCT02049957|9883045|P1|Overall Study|Physician Decision|0
2872662|NCT02049957|9883037|P9|Overall Study|Withdrawal by Subject|1
2872663|NCT02049957|9883038|P8|Overall Study|Withdrawal by Subject|3
2872664|NCT02049957|9883039|P7|Overall Study|Withdrawal by Subject|0
2872665|NCT02049957|9883040|P6|Overall Study|Withdrawal by Subject|2
2872666|NCT02049957|9883041|P5|Overall Study|Withdrawal by Subject|0
2872667|NCT02049957|9883042|P4|Overall Study|Withdrawal by Subject|1
2872668|NCT02049957|9883043|P3|Overall Study|Withdrawal by Subject|0
2872669|NCT02049957|9883044|P2|Overall Study|Withdrawal by Subject|0
2872670|NCT02049957|9883045|P1|Overall Study|Withdrawal by Subject|0
2872671|NCT02049957|9883037|P9|Overall Study|Study Terminated by Sponsor|0
2872672|NCT02049957|9883038|P8|Overall Study|Study Terminated by Sponsor|0
2872673|NCT02049957|9883039|P7|Overall Study|Study Terminated by Sponsor|1
2872674|NCT02049957|9883040|P6|Overall Study|Study Terminated by Sponsor|0
2872675|NCT02049957|9883041|P5|Overall Study|Study Terminated by Sponsor|0
2872676|NCT02049957|9883042|P4|Overall Study|Study Terminated by Sponsor|0
2872677|NCT02049957|9883043|P3|Overall Study|Study Terminated by Sponsor|0
2872678|NCT02049957|9883044|P2|Overall Study|Study Terminated by Sponsor|1
2872679|NCT02049957|9883045|P1|Overall Study|Study Terminated by Sponsor|0
2872680|NCT02049957|9883037|P9|Overall Study|Adverse Event|1
2872681|NCT02049957|9883038|P8|Overall Study|Adverse Event|6
2872682|NCT02049957|9883039|P7|Overall Study|Adverse Event|0
2872683|NCT02049957|9883040|P6|Overall Study|Adverse Event|5
2872684|NCT02049957|9883041|P5|Overall Study|Adverse Event|0
2872685|NCT02049957|9883042|P4|Overall Study|Adverse Event|0
2872686|NCT02049957|9883043|P3|Overall Study|Adverse Event|1
2872687|NCT02049957|9883044|P2|Overall Study|Adverse Event|1
2872688|NCT02049957|9883045|P1|Overall Study|Adverse Event|1
2872689|NCT02049957|9883037|P9|Overall Study|Progressive Disease|6
2872690|NCT02049957|9883038|P8|Overall Study|Progressive Disease|26
2872691|NCT02049957|9883039|P7|Overall Study|Progressive Disease|7
2872692|NCT02049957|9883040|P6|Overall Study|Progressive Disease|35
2872693|NCT02049957|9883041|P5|Overall Study|Progressive Disease|6
2872694|NCT02049957|9883042|P4|Overall Study|Progressive Disease|2
2872695|NCT02049957|9883043|P3|Overall Study|Progressive Disease|2
2872696|NCT02049957|9883044|P2|Overall Study|Progressive Disease|4
2872697|NCT02049957|9883045|P1|Overall Study|Progressive Disease|5
2872698|NCT02049814|9883137|P2|Overall Study|Voluntary withdrawal|8
2872699|NCT02049814|9883138|P1|Overall Study|Voluntary withdrawal|9
2872700|NCT02049814|9883137|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
2872701|NCT02049814|9883138|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
2872702|NCT02049814|9883137|P2|Overall Study|Study Termination|1
2872703|NCT02049814|9883138|P1|Overall Study|Study Termination|0
2872704|NCT02049814|9883137|P2|Overall Study|Serious Protocol Violation|7
2872705|NCT02049814|9883138|P1|Overall Study|Serious Protocol Violation|5
2872706|NCT02049814|9883137|P2|Overall Study|Lost to Follow-up|3
2872707|NCT02049814|9883138|P1|Overall Study|Lost to Follow-up|2
2872708|NCT02049814|9883137|P2|Overall Study|Pregnancy|0
2872709|NCT02049814|9883138|P1|Overall Study|Pregnancy|1
2872710|NCT02049814|9883137|P2|Overall Study|Reason not Specified|3
2872711|NCT02049814|9883138|P1|Overall Study|Reason not Specified|4
2872712|NCT02049450|9883187|P1|Overall Study|Patients/guardian decision|1
2872713|NCT02049450|9883187|P1|Overall Study|Withdrawal by Subject|1
2872714|NCT02049450|9883187|P1|Overall Study|Adverse Event|2
2872715|NCT02048904|9883236|P1|Overall Study|Physician Decision|70
2872716|NCT02048904|9883236|P1|Overall Study|Withdrawal by Subject|7
2872717|NCT02048241|9883281|P2|Overall Study|Withdrawal by Subject|1
2872718|NCT02048241|9883282|P1|Overall Study|Withdrawal by Subject|0
2872719|NCT02048072|9883288|P1|Overall Study|Lost to Follow-up|1
2872720|NCT02048072|9883288|P1|Overall Study|Adverse Event|3
2872721|NCT02047903|9883327|P1|Overall Study|Not Treated|9
2872722|NCT02047903|9883327|P1|Overall Study|Reason not listed|6
2872723|NCT02047903|9883327|P1|Overall Study|Lost to Follow-up|4
2872724|NCT02047903|9883327|P1|Overall Study|Withdrawal by Subject|16
2872725|NCT02047903|9883327|P1|Overall Study|Serious adverse event|10
2872726|NCT02047903|9883327|P1|Overall Study|Adverse Event|14
2872727|NCT02047253|9883382|P1|Overall Study|Lost to Follow-up|8
2872728|NCT02047227|9883392|P2|Overall Study|Other|9
2872729|NCT02047227|9883393|P1|Overall Study|Other|10
2872730|NCT02047227|9883392|P2|Overall Study|All embryos discarded|11
2872731|NCT02047227|9883393|P1|Overall Study|All embryos discarded|12
2872732|NCT02047227|9883392|P2|Overall Study|Intention to freeze all embryos|0
2872733|NCT02047227|9883393|P1|Overall Study|Intention to freeze all embryos|1
2872734|NCT02047227|9883392|P2|Overall Study|No fertilization|51
2872735|NCT02047227|9883393|P1|Overall Study|No fertilization|61
2872736|NCT02047227|9883392|P2|Overall Study|No oocytes retrieved|20
2872737|NCT02047227|9883393|P1|Overall Study|No oocytes retrieved|21
2872738|NCT02047227|9883392|P2|Overall Study|Lack of ovarian response to stimulation|32
2872739|NCT02047227|9883393|P1|Overall Study|Lack of ovarian response to stimulation|35
2872740|NCT02047227|9883392|P2|Overall Study|Spontaneous pregnancy|0
2872741|NCT02047227|9883393|P1|Overall Study|Spontaneous pregnancy|1
2872742|NCT02047227|9883392|P2|Overall Study|Protocol Violation|0
2872743|NCT02047227|9883393|P1|Overall Study|Protocol Violation|1
2872744|NCT02047227|9883392|P2|Overall Study|Lost to Follow-up|3
2872745|NCT02047227|9883393|P1|Overall Study|Lost to Follow-up|0
2872746|NCT02047227|9883392|P2|Overall Study|Adverse Event|4
2872747|NCT02047227|9883393|P1|Overall Study|Adverse Event|2
2872748|NCT02047110|9883413|P4|OLE Treatment Period|Other than specified|0
2872749|NCT02047110|9883414|P3|OLE Treatment Period|Other than specified|1
2872750|NCT02047110|9883415|P2|OLE Treatment Period|Other than specified|0
2872751|NCT02047110|9883416|P1|OLE Treatment Period|Other than specified|0
2872752|NCT02047110|9883413|P4|Escape Treatment Period|Other than specified|1
2872753|NCT02047110|9883414|P3|Escape Treatment Period|Other than specified|0
2872754|NCT02047110|9883415|P2|Escape Treatment Period|Other than specified|2
2872755|NCT02047110|9883416|P1|Escape Treatment Period|Other than specified|1
2872756|NCT02047110|9883413|P4|Escape Treatment Period|Adverse Event|0
2872757|NCT02047110|9883414|P3|Escape Treatment Period|Adverse Event|2
2872758|NCT02047110|9883415|P2|Escape Treatment Period|Adverse Event|2
2872759|NCT02047110|9883416|P1|Escape Treatment Period|Adverse Event|1
2872760|NCT02047110|9883413|P4|Escape Treatment Period|Withdrawal by Subject|1
2872761|NCT02047110|9883414|P3|Escape Treatment Period|Withdrawal by Subject|1
2872762|NCT02047110|9883415|P2|Escape Treatment Period|Withdrawal by Subject|2
2872763|NCT02047110|9883416|P1|Escape Treatment Period|Withdrawal by Subject|1
2872764|NCT02047110|9883413|P4|DB (Week 12 up to Week 24)|Other than specified|0
2872765|NCT02047110|9883414|P3|DB (Week 12 up to Week 24)|Other than specified|1
2872766|NCT02047110|9883415|P2|DB (Week 12 up to Week 24)|Other than specified|1
2872767|NCT02047110|9883416|P1|DB (Week 12 up to Week 24)|Other than specified|0
2872768|NCT02047110|9883413|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2872769|NCT02047110|9883414|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2872770|NCT02047110|9883415|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
2872771|NCT02047110|9883416|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2872772|NCT02047110|9883413|P4|DB Treatment Period up to Week 24|Other than specified|1
2872773|NCT02047110|9883414|P3|DB Treatment Period up to Week 24|Other than specified|3
2872774|NCT02047110|9883415|P2|DB Treatment Period up to Week 24|Other than specified|2
2872775|NCT02047110|9883416|P1|DB Treatment Period up to Week 24|Other than specified|1
2872776|NCT02047110|9883413|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2872777|NCT02047110|9883414|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2872778|NCT02047110|9883415|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2872779|NCT02047110|9883416|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2872780|NCT02047110|9883413|P4|DB Treatment Period up to Week 24|Protocol Violation|0
2872781|NCT02047110|9883414|P3|DB Treatment Period up to Week 24|Protocol Violation|0
2872782|NCT02047110|9883415|P2|DB Treatment Period up to Week 24|Protocol Violation|0
2872783|NCT02047110|9883416|P1|DB Treatment Period up to Week 24|Protocol Violation|1
2872784|NCT02047110|9883413|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
2872785|NCT02047110|9883414|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
2872786|NCT02047110|9883415|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
2872787|NCT02047110|9883416|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
2872788|NCT02047110|9883413|P4|DB Treatment Period up to Week 24|Adverse Event|0
2872789|NCT02047110|9883414|P3|DB Treatment Period up to Week 24|Adverse Event|0
2872790|NCT02047110|9883415|P2|DB Treatment Period up to Week 24|Adverse Event|0
2872791|NCT02047110|9883416|P1|DB Treatment Period up to Week 24|Adverse Event|1
2872792|NCT02047045|9883459|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
2872793|NCT02047045|9883460|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
2872794|NCT02047045|9883459|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
2872795|NCT02047045|9883460|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
2872796|NCT02047045|9883459|P2|Treatment Period (8 Weeks )|Adverse Event|1
2872797|NCT02047045|9883460|P1|Treatment Period (8 Weeks )|Adverse Event|2
2872798|NCT02047045|9883459|P2|Baseline|Withdrawal by Subject|15
2872799|NCT02047045|9883460|P1|Baseline|Withdrawal by Subject|8
2872800|NCT02046993|9883524|P2|Overall Study|Lost to Follow-up|1
2872801|NCT02046993|9883525|P1|Overall Study|Lost to Follow-up|1
2872802|NCT02046993|9883524|P2|Overall Study|Withdrawal by Subject|10
2872803|NCT02046993|9883525|P1|Overall Study|Withdrawal by Subject|2
2872804|NCT02046616|9883597|P1|8-Week FU Period|Lost to Follow-up|1
2872805|NCT02046616|9883597|P1|24-Week Treatment Period|Other|1
2872806|NCT02046616|9883597|P1|24-Week Treatment Period|Physician Decision|3
2872807|NCT02046616|9883597|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
2872808|NCT02046616|9883597|P1|24-Week Treatment Period|Any Other Adverse Event|13
2872809|NCT02046616|9883597|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
2872810|NCT02046603|9883619|P2|Overall Study|Adverse Event|1
2872811|NCT02046603|9883620|P1|Overall Study|Adverse Event|0
2872812|NCT02046603|9883619|P2|Overall Study|Death|1
2872813|NCT02046603|9883620|P1|Overall Study|Death|0
2872814|NCT02046603|9883619|P2|Overall Study|Lost to Follow-up|2
2872815|NCT02046603|9883620|P1|Overall Study|Lost to Follow-up|1
2872816|NCT02046603|9883619|P2|Overall Study|Physician Decision|1
2872817|NCT02046603|9883620|P1|Overall Study|Physician Decision|2
2872818|NCT02046603|9883619|P2|Overall Study|Participant/legal guardian decision|3
2872819|NCT02046603|9883620|P1|Overall Study|Participant/legal guardian decision|1
2872820|NCT02046603|9883619|P2|Overall Study|Protocol Violation|1
2872821|NCT02046603|9883620|P1|Overall Study|Protocol Violation|0
2872822|NCT02046603|9883619|P2|Overall Study|Other|66
2872823|NCT02046603|9883620|P1|Overall Study|Other|11
2872824|NCT02046564|9883699|P2|Overall Study|Subject met withdrawal criteria|5
2872825|NCT02046564|9883700|P1|Overall Study|Subject met withdrawal criteria|2
2872826|NCT02046564|9883699|P2|Overall Study|Withdrawal by Subject|10
2872827|NCT02046564|9883700|P1|Overall Study|Withdrawal by Subject|4
2872828|NCT02046564|9883699|P2|Overall Study|Protocol Violation|1
2872829|NCT02046564|9883700|P1|Overall Study|Protocol Violation|3
2872830|NCT02046564|9883699|P2|Overall Study|Physician Decision|1
2872831|NCT02046564|9883700|P1|Overall Study|Physician Decision|0
2872832|NCT02046564|9883699|P2|Overall Study|Adverse Event|3
2872833|NCT02046564|9883700|P1|Overall Study|Adverse Event|6
2872834|NCT02046369|9883748|P2|Overall Study|non compliance|0
2872835|NCT02046369|9883749|P1|Overall Study|non compliance|1
2872836|NCT02046369|9883748|P2|Overall Study|never received study drug|1
2872837|NCT02046369|9883749|P1|Overall Study|never received study drug|0
2872838|NCT02046369|9883748|P2|Overall Study|Withdrawal by Subject|6
2872839|NCT02046369|9883749|P1|Overall Study|Withdrawal by Subject|3
2872840|NCT02046369|9883748|P2|Overall Study|Protocol Violation|2
2872841|NCT02046369|9883749|P1|Overall Study|Protocol Violation|1
2872842|NCT02046369|9883748|P2|Overall Study|Lost to Follow-up|3
2872843|NCT02046369|9883749|P1|Overall Study|Lost to Follow-up|3
2872844|NCT02046369|9883748|P2|Overall Study|Lack of Efficacy|3
2872845|NCT02046369|9883749|P1|Overall Study|Lack of Efficacy|3
2872846|NCT02046369|9883748|P2|Overall Study|Adverse Event|3
2872847|NCT02046369|9883749|P1|Overall Study|Adverse Event|3
2872848|NCT02046226|9883793|P1|Overall Study|Lost to Follow-up|7
2872849|NCT02046148|9883841|P2|Overall Study|Withdrawal by Subject|2
2872850|NCT02046148|9883842|P1|Overall Study|Withdrawal by Subject|0
2872851|NCT02046148|9883841|P2|Overall Study|Lost to Follow-up|1
2872852|NCT02046148|9883842|P1|Overall Study|Lost to Follow-up|1
2872853|NCT02046122|9883902|P1|Overall Study|Withdrawal by Subject|1
2872854|NCT02046122|9883902|P1|Overall Study|Physician Decision|8
2872855|NCT02046070|9883912|P3|Overall Study|Reason not Specified|6
2872856|NCT02046070|9883913|P2|Overall Study|Reason not Specified|4
2872857|NCT02046070|9883914|P1|Overall Study|Reason not Specified|4
2872858|NCT02046070|9883912|P3|Overall Study|Study Terminated by Sponsor|1
2872859|NCT02046070|9883913|P2|Overall Study|Study Terminated by Sponsor|1
2872860|NCT02046070|9883914|P1|Overall Study|Study Terminated by Sponsor|1
2872861|NCT02046070|9883912|P3|Overall Study|Withdrawal by Subject|6
2872862|NCT02046070|9883913|P2|Overall Study|Withdrawal by Subject|2
2872863|NCT02046070|9883914|P1|Overall Study|Withdrawal by Subject|1
2872864|NCT02046070|9883912|P3|Overall Study|Adverse Event|17
2872865|NCT02046070|9883913|P2|Overall Study|Adverse Event|10
2872866|NCT02046070|9883914|P1|Overall Study|Adverse Event|8
2872867|NCT02046070|9883912|P3|Overall Study|Progressive Disease|40
2872868|NCT02046070|9883913|P2|Overall Study|Progressive Disease|11
2872869|NCT02046070|9883914|P1|Overall Study|Progressive Disease|18
2872870|NCT02045979|9883974|P3|Overall Study|not specified above|0
2872871|NCT02045979|9883975|P2|Overall Study|not specified above|1
2872872|NCT02045979|9883976|P1|Overall Study|not specified above|0
2872873|NCT02045979|9883974|P3|Overall Study|Informed Consent Withdrawn|1
2872874|NCT02045979|9883975|P2|Overall Study|Informed Consent Withdrawn|0
2872875|NCT02045979|9883976|P1|Overall Study|Informed Consent Withdrawn|2
2872876|NCT02045875|9884013|P2|Overall Study|Withdrawal by Subject|3
2872877|NCT02045875|9884014|P1|Overall Study|Withdrawal by Subject|4
2872878|NCT02045875|9884013|P2|Overall Study|Lost to Follow-up|0
2872879|NCT02045875|9884014|P1|Overall Study|Lost to Follow-up|3
2872880|NCT02045862|9884025|P3|Overall Study|Lost to Follow-up|6
2872881|NCT02045862|9884026|P2|Overall Study|Lost to Follow-up|2
2872882|NCT02045862|9884027|P1|Overall Study|Lost to Follow-up|1
2872883|NCT02045862|9884025|P3|Overall Study|Adverse Event|27
2872884|NCT02045862|9884026|P2|Overall Study|Adverse Event|5
2872885|NCT02045862|9884027|P1|Overall Study|Adverse Event|7
2872886|NCT02045862|9884025|P3|Overall Study|Randomized but not Received Study Drug|8
2872887|NCT02045862|9884026|P2|Overall Study|Randomized but not Received Study Drug|2
2872888|NCT02045862|9884027|P1|Overall Study|Randomized but not Received Study Drug|0
2872889|NCT02045862|9884025|P3|Overall Study|Lack of Efficacy|13
2872890|NCT02045862|9884026|P2|Overall Study|Lack of Efficacy|4
2872891|NCT02045862|9884027|P1|Overall Study|Lack of Efficacy|8
2872892|NCT02045862|9884025|P3|Overall Study|Protocol Violation|6
2872893|NCT02045862|9884026|P2|Overall Study|Protocol Violation|0
2872894|NCT02045862|9884027|P1|Overall Study|Protocol Violation|0
2872895|NCT02045862|9884025|P3|Overall Study|Withdrawal by Patient|57
2872896|NCT02045862|9884026|P2|Overall Study|Withdrawal by Patient|27
2872897|NCT02045862|9884027|P1|Overall Study|Withdrawal by Patient|18
2872898|NCT02045862|9884025|P3|Overall Study|Miscellaneous|8
2872899|NCT02045862|9884026|P2|Overall Study|Miscellaneous|0
2872900|NCT02045862|9884027|P1|Overall Study|Miscellaneous|5
2872901|NCT02045862|9884025|P3|Overall Study|Death|1
2872902|NCT02045862|9884026|P2|Overall Study|Death|0
2872903|NCT02045862|9884027|P1|Overall Study|Death|0
2872904|NCT02045836|9884208|P2|Overall Study|Migrated from study area|2
2872905|NCT02045836|9884209|P1|Overall Study|Migrated from study area|0
2872906|NCT02045836|9884208|P2|Overall Study|Lost to Follow-up|7
2872907|NCT02045836|9884209|P1|Overall Study|Lost to Follow-up|4
2872908|NCT02045836|9884208|P2|Overall Study|Withdrawal by Subject|1
2872909|NCT02045836|9884209|P1|Overall Study|Withdrawal by Subject|1
2872910|NCT02045836|9884208|P2|Overall Study|Adverse Event|4
2872911|NCT02045836|9884209|P1|Overall Study|Adverse Event|4
2872912|NCT02045797|9884241|P3|Overall Study|Withdrawal by Subject|0
2872913|NCT02045797|9884242|P2|Overall Study|Withdrawal by Subject|2
2872914|NCT02045797|9884243|P1|Overall Study|Withdrawal by Subject|1
2872915|NCT02045797|9884241|P3|Overall Study|Physician Decision|0
2872916|NCT02045797|9884242|P2|Overall Study|Physician Decision|1
2872917|NCT02045797|9884243|P1|Overall Study|Physician Decision|0
2872918|NCT02045797|9884241|P3|Overall Study|Lost to Follow-up|1
2872919|NCT02045797|9884242|P2|Overall Study|Lost to Follow-up|3
2872920|NCT02045797|9884243|P1|Overall Study|Lost to Follow-up|2
2872921|NCT02045797|9884241|P3|Overall Study|Lack of Efficacy|0
2872922|NCT02045797|9884242|P2|Overall Study|Lack of Efficacy|0
2872923|NCT02045797|9884243|P1|Overall Study|Lack of Efficacy|1
2872924|NCT02045797|9884241|P3|Overall Study|Adverse Event|0
2872925|NCT02045797|9884242|P2|Overall Study|Adverse Event|1
2872926|NCT02045797|9884243|P1|Overall Study|Adverse Event|3
2872927|NCT02045732|9884388|P2|Overall Study|At the discretion of the investigator|1
2872928|NCT02045732|9884389|P1|Overall Study|At the discretion of the investigator|1
2872929|NCT02045433|9884426|P1|Overall Study|Withdrawal by Subject|1
2872930|NCT02045212|9884458|P2|Overall Study|Finished 13 weeks, chose not to extend|0
2872931|NCT02045212|9884459|P1|Overall Study|Finished 13 weeks, chose not to extend|1
2872932|NCT02045212|9884458|P2|Overall Study|Withdrawal by Subject|0
2872933|NCT02045212|9884459|P1|Overall Study|Withdrawal by Subject|1
2872934|NCT02045212|9884458|P2|Overall Study|Adverse Event|1
2872935|NCT02045212|9884459|P1|Overall Study|Adverse Event|0
2872936|NCT02045095|9884524|P7|Overall Study|Adverse Event|0
2872937|NCT02045095|9884525|P6|Overall Study|Adverse Event|2
2872938|NCT02045095|9884526|P5|Overall Study|Adverse Event|0
2872939|NCT02045095|9884527|P4|Overall Study|Adverse Event|0
2872940|NCT02045095|9884528|P3|Overall Study|Adverse Event|1
2872941|NCT02045095|9884529|P2|Overall Study|Adverse Event|1
2872942|NCT02045095|9884530|P1|Overall Study|Adverse Event|0
2872943|NCT02045095|9884524|P7|Overall Study|Withdrawal by Subject|0
2872944|NCT02045095|9884525|P6|Overall Study|Withdrawal by Subject|0
2872945|NCT02045095|9884526|P5|Overall Study|Withdrawal by Subject|3
2872946|NCT02045095|9884527|P4|Overall Study|Withdrawal by Subject|0
2872947|NCT02045095|9884528|P3|Overall Study|Withdrawal by Subject|0
2872948|NCT02045095|9884529|P2|Overall Study|Withdrawal by Subject|0
2872949|NCT02045095|9884530|P1|Overall Study|Withdrawal by Subject|0
2872950|NCT02045095|9884524|P7|Overall Study|Progressive Disease|1
2872951|NCT02045095|9884525|P6|Overall Study|Progressive Disease|4
2872952|NCT02045095|9884526|P5|Overall Study|Progressive Disease|2
2872953|NCT02045095|9884527|P4|Overall Study|Progressive Disease|4
2872954|NCT02045095|9884528|P3|Overall Study|Progressive Disease|2
2872955|NCT02045095|9884529|P2|Overall Study|Progressive Disease|3
2872956|NCT02045095|9884530|P1|Overall Study|Progressive Disease|3
2872957|NCT02045095|9884524|P7|Overall Study|Other|0
2872958|NCT02045095|9884525|P6|Overall Study|Other|2
2872959|NCT02045095|9884526|P5|Overall Study|Other|0
2872960|NCT02045095|9884527|P4|Overall Study|Other|0
2872961|NCT02045095|9884528|P3|Overall Study|Other|1
2872962|NCT02045095|9884529|P2|Overall Study|Other|0
2872963|NCT02045095|9884530|P1|Overall Study|Other|0
2872964|NCT02044874|9884688|P3|Overall Study|Other|8
2872965|NCT02044874|9884689|P2|Overall Study|Other|3
2872966|NCT02044874|9884690|P1|Overall Study|Other|7
2872967|NCT02044874|9884688|P3|Overall Study|Sponsor Decision|1
2872968|NCT02044874|9884689|P2|Overall Study|Sponsor Decision|1
2872969|NCT02044874|9884690|P1|Overall Study|Sponsor Decision|0
2872970|NCT02044874|9884688|P3|Overall Study|Lost to Follow-up|21
2872971|NCT02044874|9884689|P2|Overall Study|Lost to Follow-up|27
2872972|NCT02044874|9884690|P1|Overall Study|Lost to Follow-up|10
2872973|NCT02044874|9884688|P3|Overall Study|Physician Decision|1
2872974|NCT02044874|9884689|P2|Overall Study|Physician Decision|2
2872975|NCT02044874|9884690|P1|Overall Study|Physician Decision|0
2872976|NCT02044874|9884688|P3|Overall Study|Withdrawal by Subject|23
2872977|NCT02044874|9884689|P2|Overall Study|Withdrawal by Subject|16
2872978|NCT02044874|9884690|P1|Overall Study|Withdrawal by Subject|8
2872979|NCT02044874|9884688|P3|Overall Study|Adverse Event|6
2872980|NCT02044874|9884689|P2|Overall Study|Adverse Event|6
2872981|NCT02044874|9884690|P1|Overall Study|Adverse Event|5
2872982|NCT02044848|9884712|P2|Overall Study|Administrative Problems|3
2872983|NCT02044848|9884713|P1|Overall Study|Administrative Problems|2
2872984|NCT02044822|9884719|P1|Overall Study|Lost to Follow-up|1
2872985|NCT02044822|9884719|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
2872986|NCT02044822|9884719|P1|Overall Study|Withdrew Consent|3
2872987|NCT02044822|9884719|P1|Overall Study|Investigator's Discretion|10
2872988|NCT02044822|9884719|P1|Overall Study|Study Terminated by Sponsor|77
2872989|NCT02044510|9884761|P2|Overall Study|Adverse Event|2
2872990|NCT02044510|9884762|P1|Overall Study|Adverse Event|1
2872991|NCT02044458|9884770|P2|Overall Study|Protocol Violation|8
2872992|NCT02044458|9884771|P1|Overall Study|Protocol Violation|3
2872993|NCT02044302|9884857|P2|Overall Study|study terminated|0
2872994|NCT02044302|9884858|P1|Overall Study|study terminated|2
2872995|NCT02044159|9884866|P2|Overall Study|Nurse declined to give study drug|0
2872996|NCT02044159|9884867|P1|Overall Study|Nurse declined to give study drug|1
2872997|NCT02044159|9884866|P2|Overall Study|No longer eligible, drug not given|0
2872998|NCT02044159|9884867|P1|Overall Study|No longer eligible, drug not given|1
2872999|NCT02044159|9884866|P2|Overall Study|Consent declined (deferred consent)|4
2873000|NCT02044159|9884867|P1|Overall Study|Consent declined (deferred consent)|2
2873001|NCT02044094|9884880|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
2873002|NCT02044094|9884880|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
2873003|NCT02044094|9884880|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
2873004|NCT02044094|9884880|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
2873005|NCT02044094|9884880|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
2873006|NCT02044094|9884880|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
2873007|NCT02044094|9884880|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
2873008|NCT02044094|9884880|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
2873009|NCT02043938|9884937|P1|Overall Study|Investigator decision|1
2873010|NCT02043938|9884937|P1|Overall Study|No show by subject|1
2873011|NCT02043938|9884937|P1|Overall Study|Unable to place EEG sensors on patient|1
2873012|NCT02043938|9884937|P1|Overall Study|Withdrawal by Subject|7
2873013|NCT02043782|9884992|P6|Period 1|Adverse Event|0
2873014|NCT02043782|9884993|P5|Period 1|Adverse Event|0
2873015|NCT02043782|9884994|P4|Period 1|Adverse Event|0
2873016|NCT02043782|9884995|P3|Period 1|Adverse Event|1
2873017|NCT02043782|9884996|P2|Period 1|Adverse Event|0
2873018|NCT02043782|9884997|P1|Period 1|Adverse Event|0
2873019|NCT02043678|9885040|P2|Overall Study|Ongoing with treatment|104
2873020|NCT02043678|9885041|P1|Overall Study|Ongoing with treatment|87
2873021|NCT02043678|9885040|P2|Overall Study|Withdrawal by Subject|13
2873022|NCT02043678|9885041|P1|Overall Study|Withdrawal by Subject|10
2873023|NCT02043678|9885040|P2|Overall Study|Protocol-driven decision point|45
2873024|NCT02043678|9885041|P1|Overall Study|Protocol-driven decision point|53
2873025|NCT02043678|9885040|P2|Overall Study|Radiological PD|67
2873026|NCT02043678|9885041|P1|Overall Study|Radiological PD|78
2873027|NCT02043678|9885040|P2|Overall Study|Clinical PD|112
2873028|NCT02043678|9885041|P1|Overall Study|Clinical PD|88
2873029|NCT02043678|9885040|P2|Overall Study|Other|8
2873030|NCT02043678|9885041|P1|Overall Study|Other|15
2873031|NCT02043678|9885040|P2|Overall Study|Lost to Follow-up|1
2873032|NCT02043678|9885041|P1|Overall Study|Lost to Follow-up|1
2873033|NCT02043678|9885040|P2|Overall Study|AE without clinical PD|31
2873034|NCT02043678|9885041|P1|Overall Study|AE without clinical PD|41
2873035|NCT02043678|9885040|P2|Overall Study|AE with clinical progressive disease(PD)|15
2873036|NCT02043678|9885041|P1|Overall Study|AE with clinical progressive disease(PD)|17
2873037|NCT02043678|9885040|P2|Overall Study|Never treated|9
2873038|NCT02043678|9885041|P1|Overall Study|Never treated|11
2873039|NCT02043509|9885077|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
2873040|NCT02043509|9885078|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
2873041|NCT02043509|9885077|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
2873042|NCT02043509|9885078|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
2873043|NCT02043509|9885077|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
2873044|NCT02043509|9885078|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
2873045|NCT02043509|9885077|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
2873046|NCT02043509|9885078|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
2873047|NCT02043366|9885166|P6|Overall Study|Lost to Follow-up|2
2873048|NCT02043366|9885167|P5|Overall Study|Lost to Follow-up|2
2873049|NCT02043366|9885168|P4|Overall Study|Lost to Follow-up|2
2873050|NCT02043366|9885169|P3|Overall Study|Lost to Follow-up|2
2873051|NCT02043366|9885170|P2|Overall Study|Lost to Follow-up|2
2873052|NCT02043366|9885171|P1|Overall Study|Lost to Follow-up|2
2873053|NCT02043301|9885194|P3|Overall Study|Discontinued|0
2873054|NCT02043301|9885195|P2|Overall Study|Discontinued|1
2873055|NCT02043301|9885196|P1|Overall Study|Discontinued|0
2873056|NCT02043132|9885293|P2|Overall Study|screen failures|8
2873057|NCT02043132|9885294|P1|Overall Study|screen failures|4
2873058|NCT02043132|9885293|P2|Overall Study|Lost to Follow-up|1
2873059|NCT02043132|9885294|P1|Overall Study|Lost to Follow-up|1
2873060|NCT02043015|9885314|P1|Overall Study|Incarceration|1
2873061|NCT02043015|9885314|P1|Overall Study|Participant moved away from study city|4
2873062|NCT02043015|9885314|P1|Overall Study|Removed once target enrollment reached|15
2873063|NCT02043015|9885314|P1|Overall Study|Withdrawal by Subject|4
2873064|NCT02043015|9885314|P1|Overall Study|Lost to Follow-up|4
2873065|NCT02042950|9885327|P1|Overall Study|Progressive Disease|4
2873066|NCT02042924|9885333|P1|Overall Study|Early Death|1
2873067|NCT02042443|9885381|P2|Overall Study|Not eligible/not analyzable|6
2873068|NCT02042443|9885382|P1|Overall Study|Not eligible/not analyzable|3
2873069|NCT02042443|9885381|P2|Overall Study|not protocol specified|1
2873070|NCT02042443|9885382|P1|Overall Study|not protocol specified|1
2873071|NCT02042443|9885381|P2|Overall Study|Progression|17
2873072|NCT02042443|9885382|P1|Overall Study|Progression|21
2873073|NCT02042443|9885381|P2|Overall Study|Withdrawal by Subject|1
2873074|NCT02042443|9885382|P1|Overall Study|Withdrawal by Subject|0
2873075|NCT02042443|9885381|P2|Overall Study|Adverse Event|1
2873076|NCT02042443|9885382|P1|Overall Study|Adverse Event|2
2873077|NCT02042404|9885394|P2|Overall Study|Inability to meet time requirements|0
2873078|NCT02042404|9885395|P1|Overall Study|Inability to meet time requirements|1
2873079|NCT02042404|9885394|P2|Overall Study|Unrelated Adverse Event|0
2873080|NCT02042404|9885395|P1|Overall Study|Unrelated Adverse Event|3
2873081|NCT02042404|9885394|P2|Overall Study|Death|0
2873082|NCT02042404|9885395|P1|Overall Study|Death|1
2873083|NCT02042014|9885433|P1|Overall Study|Physician Decision|7
2873084|NCT02042014|9885433|P1|Overall Study|Adverse Event|1
2873085|NCT02041962|9885439|P2|Overall Study|Withdrawal by Subject|11
2873086|NCT02041962|9885440|P1|Overall Study|Withdrawal by Subject|0
2873087|NCT02041962|9885439|P2|Overall Study|Lost to Follow-up|32
2873088|NCT02041962|9885440|P1|Overall Study|Lost to Follow-up|37
2873089|NCT02041962|9885439|P2|Overall Study|Death|1
2873090|NCT02041962|9885440|P1|Overall Study|Death|1
2873091|NCT02041962|9885439|P2|Overall Study|Lost Aetna Coverage|40
2873092|NCT02041962|9885440|P1|Overall Study|Lost Aetna Coverage|43
2873093|NCT02041702|9885450|P2|Overall Study|Cardiac Resynchronization Therapy|0
2873094|NCT02041702|9885451|P1|Overall Study|Cardiac Resynchronization Therapy|1
2873095|NCT02041702|9885450|P2|Overall Study|Patient not confirmed as MRI compatible|0
2873096|NCT02041702|9885451|P1|Overall Study|Patient not confirmed as MRI compatible|1
2873097|NCT02041702|9885450|P2|Overall Study|Withdrawal by Subject|3
2873098|NCT02041702|9885451|P1|Overall Study|Withdrawal by Subject|4
2873099|NCT02041702|9885450|P2|Overall Study|Death|0
2873100|NCT02041702|9885451|P1|Overall Study|Death|4
2873101|NCT02041702|9885450|P2|Overall Study|Lost to Follow-up|6
2873102|NCT02041702|9885451|P1|Overall Study|Lost to Follow-up|1
2873103|NCT02041533|9885466|P2|Overall Study|Randomized, not treated|7
2873104|NCT02041533|9885467|P1|Overall Study|Randomized, not treated|4
2873105|NCT02041533|9885466|P2|Overall Study|Completed max number of chemo cycles|29
2873106|NCT02041533|9885467|P1|Overall Study|Completed max number of chemo cycles|0
2873107|NCT02041533|9885466|P2|Overall Study|Other reasons|1
2873108|NCT02041533|9885467|P1|Overall Study|Other reasons|0
2873109|NCT02041533|9885466|P2|Overall Study|Poor/non-compliance|0
2873110|NCT02041533|9885467|P1|Overall Study|Poor/non-compliance|1
2873111|NCT02041533|9885466|P2|Overall Study|Maximum clinical benefit|18
2873112|NCT02041533|9885467|P1|Overall Study|Maximum clinical benefit|0
2873113|NCT02041533|9885466|P2|Overall Study|Withdrawal by Subject|1
2873114|NCT02041533|9885467|P1|Overall Study|Withdrawal by Subject|2
2873115|NCT02041533|9885466|P2|Overall Study|Subject request to discontinue treatment|9
2873116|NCT02041533|9885467|P1|Overall Study|Subject request to discontinue treatment|5
2873117|NCT02041533|9885466|P2|Overall Study|Adverse Event unrelated to study drug|21
2873118|NCT02041533|9885467|P1|Overall Study|Adverse Event unrelated to study drug|20
2873119|NCT02041533|9885466|P2|Overall Study|Death|0
2873120|NCT02041533|9885467|P1|Overall Study|Death|1
2873121|NCT02041533|9885466|P2|Overall Study|Study drug toxicity|30
2873122|NCT02041533|9885467|P1|Overall Study|Study drug toxicity|27
2873123|NCT02041533|9885466|P2|Overall Study|Disease Progression|142
2873124|NCT02041533|9885467|P1|Overall Study|Disease Progression|168
2873125|NCT02041520|9885489|P2|Overall Study|Hypothiroidism identified during follow-|1
2873126|NCT02041520|9885490|P1|Overall Study|Hypothiroidism identified during follow-|0
2873127|NCT02041520|9885489|P2|Overall Study|Lost to Follow-up|1
2873128|NCT02041520|9885490|P1|Overall Study|Lost to Follow-up|0
2873129|NCT02041520|9885489|P2|Overall Study|Protocol Violation|0
2873130|NCT02041520|9885490|P1|Overall Study|Protocol Violation|1
2873131|NCT02041520|9885489|P2|Overall Study|Withdrawal by Subject|4
2873132|NCT02041520|9885490|P1|Overall Study|Withdrawal by Subject|3
2873133|NCT02041520|9885489|P2|Overall Study|Adverse Event|1
2873134|NCT02041520|9885490|P1|Overall Study|Adverse Event|2
2873135|NCT02041286|9885533|P1|Overall Study|Adverse Event|1
2873136|NCT02041104|9885568|P2|Overall Study|discomfort during OGTT|3
2873137|NCT02041104|9885569|P1|Overall Study|discomfort during OGTT|0
2873138|NCT02041104|9885568|P2|Overall Study|Lost to Follow-up|4
2873139|NCT02041104|9885569|P1|Overall Study|Lost to Follow-up|1
2873140|NCT02041091|9885609|P2|Optional Safety Extension Period|Lost to Follow-up|3
2873141|NCT02041091|9885610|P1|Optional Safety Extension Period|Lost to Follow-up|2
2873142|NCT02041091|9885609|P2|Optional Safety Extension Period|Sponsor Decision|74
2873143|NCT02041091|9885610|P1|Optional Safety Extension Period|Sponsor Decision|70
2873144|NCT02041091|9885609|P2|Optional Safety Extension Period|Physician Decision|1
2873145|NCT02041091|9885610|P1|Optional Safety Extension Period|Physician Decision|2
2873146|NCT02041091|9885609|P2|Optional Safety Extension Period|Protocol Violation|0
2873147|NCT02041091|9885610|P1|Optional Safety Extension Period|Protocol Violation|2
2873148|NCT02041091|9885609|P2|Optional Safety Extension Period|Withdrawal by Subject|2
2873149|NCT02041091|9885610|P1|Optional Safety Extension Period|Withdrawal by Subject|5
2873150|NCT02041091|9885609|P2|Optional Safety Extension Period|Adverse Event|2
2873151|NCT02041091|9885610|P1|Optional Safety Extension Period|Adverse Event|4
2873152|NCT02041091|9885609|P2|Treatment|Lost to Follow-up|0
2873153|NCT02041091|9885610|P1|Treatment|Lost to Follow-up|1
2873154|NCT02041091|9885609|P2|Treatment|Sponsor Decision|16
2873155|NCT02041091|9885610|P1|Treatment|Sponsor Decision|15
2873156|NCT02041091|9885609|P2|Treatment|Physician Decision|0
2873157|NCT02041091|9885610|P1|Treatment|Physician Decision|1
2873158|NCT02041091|9885609|P2|Treatment|Withdrawal by Subject|4
2873159|NCT02041091|9885610|P1|Treatment|Withdrawal by Subject|2
2873160|NCT02041091|9885609|P2|Treatment|Adverse Event|3
2873161|NCT02041091|9885610|P1|Treatment|Adverse Event|3
2873162|NCT02040870|9885632|P1|Overall Study|Death|13
2873163|NCT02040870|9885632|P1|Overall Study|Lost to Follow-up|3
2873164|NCT02040870|9885632|P1|Overall Study|Subject/guardian decision|10
2873165|NCT02040870|9885632|P1|Overall Study|Physician Decision|6
2873166|NCT02040870|9885632|P1|Overall Study|Progressive disease|58
2873167|NCT02040870|9885632|P1|Overall Study|Adverse Event|7
2873168|NCT02040870|9885632|P1|Overall Study|Completed treatment phase|6
2873169|NCT02040844|9885656|P3|Overall Study|Concomitant medication|1
2873170|NCT02040844|9885657|P2|Overall Study|Concomitant medication|3
2873171|NCT02040844|9885658|P1|Overall Study|Concomitant medication|1
2873172|NCT02040844|9885656|P3|Overall Study|Non-specified|5
2873173|NCT02040844|9885657|P2|Overall Study|Non-specified|2
2873174|NCT02040844|9885658|P1|Overall Study|Non-specified|8
2873175|NCT02040844|9885656|P3|Overall Study|Missing|2
2873176|NCT02040844|9885657|P2|Overall Study|Missing|3
2873177|NCT02040844|9885658|P1|Overall Study|Missing|13
2873178|NCT02040844|9885656|P3|Overall Study|Lost to Follow-up|13
2873179|NCT02040844|9885657|P2|Overall Study|Lost to Follow-up|9
2873180|NCT02040844|9885658|P1|Overall Study|Lost to Follow-up|12
2873181|NCT02040844|9885656|P3|Overall Study|Withdrawal by Subject|25
2873182|NCT02040844|9885657|P2|Overall Study|Withdrawal by Subject|22
2873183|NCT02040844|9885658|P1|Overall Study|Withdrawal by Subject|16
2873184|NCT02040844|9885656|P3|Overall Study|Adverse Event|1
2873185|NCT02040844|9885657|P2|Overall Study|Adverse Event|0
2873186|NCT02040844|9885658|P1|Overall Study|Adverse Event|0
2873187|NCT02040805|9885683|P2|Overall Study|Withdrawal by Subject|41
2873188|NCT02040805|9885684|P1|Overall Study|Withdrawal by Subject|28
2873189|NCT02040805|9885683|P2|Overall Study|Lost to Follow-up|9
2873190|NCT02040805|9885684|P1|Overall Study|Lost to Follow-up|14
2873191|NCT02040779|9885720|P3|Overall Study|Lack of Efficacy|0
2873192|NCT02040779|9885721|P2|Overall Study|Lack of Efficacy|2
2873193|NCT02040779|9885722|P1|Overall Study|Lack of Efficacy|4
2873194|NCT02040779|9885720|P3|Overall Study|Lost to Follow-up|1
2873195|NCT02040779|9885721|P2|Overall Study|Lost to Follow-up|2
2873196|NCT02040779|9885722|P1|Overall Study|Lost to Follow-up|1
2873197|NCT02040779|9885720|P3|Overall Study|Protocol Violation|0
2873198|NCT02040779|9885721|P2|Overall Study|Protocol Violation|1
2873199|NCT02040779|9885722|P1|Overall Study|Protocol Violation|2
2873200|NCT02040779|9885720|P3|Overall Study|Non-compliance|0
2873201|NCT02040779|9885721|P2|Overall Study|Non-compliance|1
2873202|NCT02040779|9885722|P1|Overall Study|Non-compliance|0
2873203|NCT02040779|9885720|P3|Overall Study|Withdrawal by Subject|3
2873204|NCT02040779|9885721|P2|Overall Study|Withdrawal by Subject|1
2873205|NCT02040779|9885722|P1|Overall Study|Withdrawal by Subject|4
2873206|NCT02040779|9885720|P3|Overall Study|Adverse Event|0
2873207|NCT02040779|9885721|P2|Overall Study|Adverse Event|0
2873208|NCT02040779|9885722|P1|Overall Study|Adverse Event|1
2873209|NCT02040766|9885762|P5|Overall Study|Lack of Efficacy|5
2873210|NCT02040766|9885763|P4|Overall Study|Lack of Efficacy|6
2873211|NCT02040766|9885764|P3|Overall Study|Lack of Efficacy|4
2873212|NCT02040766|9885765|P2|Overall Study|Lack of Efficacy|3
2873213|NCT02040766|9885766|P1|Overall Study|Lack of Efficacy|6
2873214|NCT02040766|9885762|P5|Overall Study|Not reported|0
2873215|NCT02040766|9885763|P4|Overall Study|Not reported|0
2873216|NCT02040766|9885764|P3|Overall Study|Not reported|0
2873217|NCT02040766|9885765|P2|Overall Study|Not reported|0
2873218|NCT02040766|9885766|P1|Overall Study|Not reported|1
2873219|NCT02040766|9885762|P5|Overall Study|Lost to Follow-up|4
2873220|NCT02040766|9885763|P4|Overall Study|Lost to Follow-up|1
2873221|NCT02040766|9885764|P3|Overall Study|Lost to Follow-up|3
2873222|NCT02040766|9885765|P2|Overall Study|Lost to Follow-up|1
2873223|NCT02040766|9885766|P1|Overall Study|Lost to Follow-up|4
2873224|NCT02040766|9885762|P5|Overall Study|Protocol Violation|0
2873225|NCT02040766|9885763|P4|Overall Study|Protocol Violation|3
2873226|NCT02040766|9885764|P3|Overall Study|Protocol Violation|2
2873227|NCT02040766|9885765|P2|Overall Study|Protocol Violation|1
2873228|NCT02040766|9885766|P1|Overall Study|Protocol Violation|2
2873229|NCT02040766|9885762|P5|Overall Study|Non-compliance|0
2873230|NCT02040766|9885763|P4|Overall Study|Non-compliance|0
2873231|NCT02040766|9885764|P3|Overall Study|Non-compliance|0
2873232|NCT02040766|9885765|P2|Overall Study|Non-compliance|1
2873233|NCT02040766|9885766|P1|Overall Study|Non-compliance|0
2873234|NCT02040766|9885762|P5|Overall Study|Withdrawal by Subject|2
2873235|NCT02040766|9885763|P4|Overall Study|Withdrawal by Subject|3
2873236|NCT02040766|9885764|P3|Overall Study|Withdrawal by Subject|2
2873237|NCT02040766|9885765|P2|Overall Study|Withdrawal by Subject|3
2873238|NCT02040766|9885766|P1|Overall Study|Withdrawal by Subject|4
2873239|NCT02040766|9885762|P5|Overall Study|Adverse Event|2
2873240|NCT02040766|9885763|P4|Overall Study|Adverse Event|0
2873241|NCT02040766|9885764|P3|Overall Study|Adverse Event|1
2873242|NCT02040766|9885765|P2|Overall Study|Adverse Event|1
2873243|NCT02040766|9885766|P1|Overall Study|Adverse Event|1
2873244|NCT02040584|9885819|P2|Overall Study|Immunosuppressant/prohibited med use|10
2873245|NCT02040584|9885820|P1|Overall Study|Immunosuppressant/prohibited med use|7
2873246|NCT02040584|9885819|P2|Overall Study|Transplant rejection/retransplant|1
2873247|NCT02040584|9885820|P1|Overall Study|Transplant rejection/retransplant|0
2873248|NCT02040584|9885819|P2|Overall Study|Death|3
2873249|NCT02040584|9885820|P1|Overall Study|Death|6
2873250|NCT02040584|9885819|P2|Overall Study|Unsatisfactory therapeutic effect|1
2873251|NCT02040584|9885820|P1|Overall Study|Unsatisfactory therapeutic effect|0
2873252|NCT02040584|9885819|P2|Overall Study|Protocol Violation|11
2873253|NCT02040584|9885820|P1|Overall Study|Protocol Violation|9
2873254|NCT02040584|9885819|P2|Overall Study|Adverse Event|6
2873255|NCT02040584|9885820|P1|Overall Study|Adverse Event|13
2873256|NCT02040532|9885853|P1|Overall Study|Withdrawal by Subject|3
2873257|NCT02040532|9885853|P1|Overall Study|Adverse Event|4
2873258|NCT02040532|9885853|P1|Overall Study|Physician Decision|4
2873259|NCT02040532|9885853|P1|Overall Study|Lost to Follow-up|1
2873260|NCT02040428|9885866|P2|Overall Study|Withdrawal by Subject|1
2873261|NCT02040428|9885867|P1|Overall Study|Withdrawal by Subject|1
2873262|NCT02040428|9885866|P2|Overall Study|Death|3
2873263|NCT02040428|9885867|P1|Overall Study|Death|4
2873264|NCT02039908|9885945|P4|Phase 2-School Year|Withdrawal by Subject|5
2873265|NCT02039908|9885946|P3|Phase 2-School Year|Withdrawal by Subject|8
2873266|NCT02039908|9885947|P2|Phase 2-School Year|Withdrawal by Subject|0
2873267|NCT02039908|9885948|P1|Phase 2-School Year|Withdrawal by Subject|0
2873268|NCT02039908|9885945|P4|Phase 2-School Year|Protocol Violation|0
2873269|NCT02039908|9885946|P3|Phase 2-School Year|Protocol Violation|3
2873270|NCT02039908|9885947|P2|Phase 2-School Year|Protocol Violation|0
2873271|NCT02039908|9885948|P1|Phase 2-School Year|Protocol Violation|0
2873272|NCT02039908|9885945|P4|Phase 2-School Year|Lost to Follow-up|3
2873273|NCT02039908|9885946|P3|Phase 2-School Year|Lost to Follow-up|1
2873274|NCT02039908|9885947|P2|Phase 2-School Year|Lost to Follow-up|0
2873275|NCT02039908|9885948|P1|Phase 2-School Year|Lost to Follow-up|0
2873276|NCT02039908|9885945|P4|Phase 1-Summer|Protocol Violation|0
2873277|NCT02039908|9885946|P3|Phase 1-Summer|Protocol Violation|0
2873278|NCT02039908|9885947|P2|Phase 1-Summer|Protocol Violation|0
2873279|NCT02039908|9885948|P1|Phase 1-Summer|Protocol Violation|6
2873280|NCT02039908|9885945|P4|Phase 1-Summer|Withdrawal by Subject|0
2873281|NCT02039908|9885946|P3|Phase 1-Summer|Withdrawal by Subject|0
2873282|NCT02039908|9885947|P2|Phase 1-Summer|Withdrawal by Subject|6
2873283|NCT02039908|9885948|P1|Phase 1-Summer|Withdrawal by Subject|7
2873284|NCT02039856|9885962|P2|Overall Study|Withdrawal by Subject|618
2873285|NCT02039856|9885963|P1|Overall Study|Withdrawal by Subject|1573
2873286|NCT02039856|9885962|P2|Overall Study|Lost to Follow-up|206
2873287|NCT02039856|9885963|P1|Overall Study|Lost to Follow-up|388
2873288|NCT02039856|9885962|P2|Overall Study|Partial survey completion|26
2873289|NCT02039856|9885963|P1|Overall Study|Partial survey completion|61
2873290|NCT02039856|9885962|P2|Overall Study|Death|3
2873291|NCT02039856|9885963|P1|Overall Study|Death|5
2873292|NCT02039778|9885995|P1|Overall Study|Never started the protocol treatment|1
2873293|NCT02039778|9885995|P1|Overall Study|Withdrawal by Subject|1
2873294|NCT02039778|9885995|P1|Overall Study|Death|2
2873295|NCT02039687|9886018|P4|Overall Study|treatment assignment could not be confir|0
2873296|NCT02039687|9886019|P3|Overall Study|treatment assignment could not be confir|2
2873297|NCT02039687|9886020|P2|Overall Study|treatment assignment could not be confir|0
2873298|NCT02039687|9886021|P1|Overall Study|treatment assignment could not be confir|0
2873299|NCT02039687|9886018|P4|Overall Study|Withdrawal by Subject|0
2873300|NCT02039687|9886019|P3|Overall Study|Withdrawal by Subject|0
2873301|NCT02039687|9886020|P2|Overall Study|Withdrawal by Subject|1
2873302|NCT02039687|9886021|P1|Overall Study|Withdrawal by Subject|0
2873303|NCT02039687|9886018|P4|Overall Study|Adverse Event|0
2873304|NCT02039687|9886019|P3|Overall Study|Adverse Event|1
2873305|NCT02039687|9886020|P2|Overall Study|Adverse Event|0
2873306|NCT02039687|9886021|P1|Overall Study|Adverse Event|0
2873307|NCT02039674|9886061|P14|Overall Study|Ongoing in Study|3
2873308|NCT02039674|9886062|P13|Overall Study|Ongoing in Study|33
2873309|NCT02039674|9886063|P12|Overall Study|Ongoing in Study|34
2873310|NCT02039674|9886064|P11|Overall Study|Ongoing in Study|1
2873311|NCT02039674|9886065|P10|Overall Study|Ongoing in Study|6
2873312|NCT02039674|9886066|P9|Overall Study|Ongoing in Study|1
2873313|NCT02039674|9886067|P8|Overall Study|Ongoing in Study|0
2873314|NCT02039674|9886068|P7|Overall Study|Ongoing in Study|2
2873315|NCT02039674|9886069|P6|Overall Study|Ongoing in Study|1
2873316|NCT02039674|9886070|P5|Overall Study|Ongoing in Study|3
2873317|NCT02039674|9886071|P4|Overall Study|Ongoing in Study|2
2873318|NCT02039674|9886072|P3|Overall Study|Ongoing in Study|3
2873319|NCT02039674|9886073|P2|Overall Study|Ongoing in Study|2
2873320|NCT02039674|9886074|P1|Overall Study|Ongoing in Study|5
2873321|NCT02039674|9886061|P14|Overall Study|Withdrawal by Subject|2
2873322|NCT02039674|9886062|P13|Overall Study|Withdrawal by Subject|5
2873323|NCT02039674|9886063|P12|Overall Study|Withdrawal by Subject|3
2873324|NCT02039674|9886064|P11|Overall Study|Withdrawal by Subject|1
2873325|NCT02039674|9886065|P10|Overall Study|Withdrawal by Subject|2
2873326|NCT02039674|9886066|P9|Overall Study|Withdrawal by Subject|0
2873327|NCT02039674|9886067|P8|Overall Study|Withdrawal by Subject|0
2873328|NCT02039674|9886068|P7|Overall Study|Withdrawal by Subject|0
2873329|NCT02039674|9886069|P6|Overall Study|Withdrawal by Subject|0
2873330|NCT02039674|9886070|P5|Overall Study|Withdrawal by Subject|1
2873331|NCT02039674|9886071|P4|Overall Study|Withdrawal by Subject|0
2873332|NCT02039674|9886072|P3|Overall Study|Withdrawal by Subject|1
2873333|NCT02039674|9886073|P2|Overall Study|Withdrawal by Subject|2
2873334|NCT02039674|9886074|P1|Overall Study|Withdrawal by Subject|0
2873335|NCT02039674|9886061|P14|Overall Study|Progressive Disease|16
2873336|NCT02039674|9886062|P13|Overall Study|Progressive Disease|18
2873337|NCT02039674|9886063|P12|Overall Study|Progressive Disease|17
2873338|NCT02039674|9886064|P11|Overall Study|Progressive Disease|0
2873339|NCT02039674|9886065|P10|Overall Study|Progressive Disease|2
2873340|NCT02039674|9886066|P9|Overall Study|Progressive Disease|7
2873341|NCT02039674|9886067|P8|Overall Study|Progressive Disease|3
2873342|NCT02039674|9886068|P7|Overall Study|Progressive Disease|1
2873343|NCT02039674|9886069|P6|Overall Study|Progressive Disease|10
2873344|NCT02039674|9886070|P5|Overall Study|Progressive Disease|8
2873345|NCT02039674|9886071|P4|Overall Study|Progressive Disease|7
2873346|NCT02039674|9886072|P3|Overall Study|Progressive Disease|6
2873347|NCT02039674|9886073|P2|Overall Study|Progressive Disease|7
2873348|NCT02039674|9886074|P1|Overall Study|Progressive Disease|6
2873349|NCT02039674|9886061|P14|Overall Study|Physician Decision|0
2873350|NCT02039674|9886062|P13|Overall Study|Physician Decision|0
2873351|NCT02039674|9886063|P12|Overall Study|Physician Decision|1
2873352|NCT02039674|9886064|P11|Overall Study|Physician Decision|0
2873353|NCT02039674|9886065|P10|Overall Study|Physician Decision|0
2873354|NCT02039674|9886066|P9|Overall Study|Physician Decision|0
2873355|NCT02039674|9886067|P8|Overall Study|Physician Decision|0
2873356|NCT02039674|9886068|P7|Overall Study|Physician Decision|0
2873357|NCT02039674|9886069|P6|Overall Study|Physician Decision|0
2873358|NCT02039674|9886070|P5|Overall Study|Physician Decision|0
2873359|NCT02039674|9886071|P4|Overall Study|Physician Decision|0
2873360|NCT02039674|9886072|P3|Overall Study|Physician Decision|0
2873361|NCT02039674|9886073|P2|Overall Study|Physician Decision|0
2873362|NCT02039674|9886074|P1|Overall Study|Physician Decision|0
2873363|NCT02039674|9886061|P14|Overall Study|Lost to Follow-up|0
2873364|NCT02039674|9886062|P13|Overall Study|Lost to Follow-up|1
2873365|NCT02039674|9886063|P12|Overall Study|Lost to Follow-up|0
2873366|NCT02039674|9886064|P11|Overall Study|Lost to Follow-up|0
2873367|NCT02039674|9886065|P10|Overall Study|Lost to Follow-up|0
2873368|NCT02039674|9886066|P9|Overall Study|Lost to Follow-up|0
2873369|NCT02039674|9886067|P8|Overall Study|Lost to Follow-up|0
2873370|NCT02039674|9886068|P7|Overall Study|Lost to Follow-up|0
2873371|NCT02039674|9886069|P6|Overall Study|Lost to Follow-up|0
2873372|NCT02039674|9886070|P5|Overall Study|Lost to Follow-up|0
2873373|NCT02039674|9886071|P4|Overall Study|Lost to Follow-up|0
2873374|NCT02039674|9886072|P3|Overall Study|Lost to Follow-up|0
2873375|NCT02039674|9886073|P2|Overall Study|Lost to Follow-up|0
2873376|NCT02039674|9886074|P1|Overall Study|Lost to Follow-up|0
2873377|NCT02039674|9886061|P14|Overall Study|Excluded Medication|3
2873378|NCT02039674|9886062|P13|Overall Study|Excluded Medication|4
2873379|NCT02039674|9886063|P12|Overall Study|Excluded Medication|2
2873380|NCT02039674|9886064|P11|Overall Study|Excluded Medication|4
2873381|NCT02039674|9886065|P10|Overall Study|Excluded Medication|2
2873382|NCT02039674|9886066|P9|Overall Study|Excluded Medication|2
2873383|NCT02039674|9886067|P8|Overall Study|Excluded Medication|0
2873384|NCT02039674|9886068|P7|Overall Study|Excluded Medication|0
2873385|NCT02039674|9886069|P6|Overall Study|Excluded Medication|1
2873386|NCT02039674|9886070|P5|Overall Study|Excluded Medication|0
2873387|NCT02039674|9886071|P4|Overall Study|Excluded Medication|1
2873388|NCT02039674|9886072|P3|Overall Study|Excluded Medication|0
2873389|NCT02039674|9886073|P2|Overall Study|Excluded Medication|1
2873390|NCT02039674|9886074|P1|Overall Study|Excluded Medication|1
2873391|NCT02039674|9886061|P14|Overall Study|Death|8
2873392|NCT02039674|9886062|P13|Overall Study|Death|0
2873393|NCT02039674|9886063|P12|Overall Study|Death|1
2873394|NCT02039674|9886064|P11|Overall Study|Death|1
2873395|NCT02039674|9886065|P10|Overall Study|Death|0
2873396|NCT02039674|9886066|P9|Overall Study|Death|0
2873397|NCT02039674|9886067|P8|Overall Study|Death|0
2873398|NCT02039674|9886068|P7|Overall Study|Death|0
2873399|NCT02039674|9886069|P6|Overall Study|Death|0
2873400|NCT02039674|9886070|P5|Overall Study|Death|0
2873401|NCT02039674|9886071|P4|Overall Study|Death|2
2873402|NCT02039674|9886072|P3|Overall Study|Death|1
2873403|NCT02039674|9886073|P2|Overall Study|Death|0
2873404|NCT02039674|9886074|P1|Overall Study|Death|0
2873405|NCT02039674|9886061|P14|Overall Study|Adverse Event|1
2873406|NCT02039674|9886062|P13|Overall Study|Adverse Event|2
2873407|NCT02039674|9886063|P12|Overall Study|Adverse Event|2
2873408|NCT02039674|9886064|P11|Overall Study|Adverse Event|0
2873409|NCT02039674|9886065|P10|Overall Study|Adverse Event|0
2873410|NCT02039674|9886066|P9|Overall Study|Adverse Event|2
2873411|NCT02039674|9886067|P8|Overall Study|Adverse Event|0
2873412|NCT02039674|9886068|P7|Overall Study|Adverse Event|0
2873413|NCT02039674|9886069|P6|Overall Study|Adverse Event|0
2873414|NCT02039674|9886070|P5|Overall Study|Adverse Event|0
2873415|NCT02039674|9886071|P4|Overall Study|Adverse Event|1
2873416|NCT02039674|9886072|P3|Overall Study|Adverse Event|1
2873417|NCT02039674|9886073|P2|Overall Study|Adverse Event|0
2873418|NCT02039674|9886074|P1|Overall Study|Adverse Event|0
2873419|NCT02039505|9886116|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
2873420|NCT02039505|9886117|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873421|NCT02039505|9886118|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873422|NCT02039505|9886119|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873423|NCT02039505|9886120|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873424|NCT02039505|9886121|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873425|NCT02039505|9886122|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2873426|NCT02039505|9886116|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
2873427|NCT02039505|9886117|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873428|NCT02039505|9886118|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873429|NCT02039505|9886119|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873430|NCT02039505|9886120|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873431|NCT02039505|9886121|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873432|NCT02039505|9886122|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2873433|NCT02039505|9886116|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
2873434|NCT02039505|9886117|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873435|NCT02039505|9886118|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873436|NCT02039505|9886119|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873437|NCT02039505|9886120|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873438|NCT02039505|9886121|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873439|NCT02039505|9886122|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2873440|NCT02039505|9886116|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
2873441|NCT02039505|9886117|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873442|NCT02039505|9886118|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873443|NCT02039505|9886119|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873444|NCT02039505|9886120|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873445|NCT02039505|9886121|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873446|NCT02039505|9886122|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2873447|NCT02039505|9886116|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873448|NCT02039505|9886117|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873449|NCT02039505|9886118|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873450|NCT02039505|9886119|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
2873451|NCT02039505|9886120|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873452|NCT02039505|9886121|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873453|NCT02039505|9886122|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2873454|NCT02039505|9886116|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2873455|NCT02039505|9886117|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
2873456|NCT02039505|9886118|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
2873457|NCT02039505|9886119|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
2873458|NCT02039505|9886120|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2873459|NCT02039505|9886121|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2873460|NCT02039505|9886122|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2873461|NCT02039505|9886116|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2873462|NCT02039505|9886117|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2873463|NCT02039505|9886118|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2873464|NCT02039505|9886119|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
2873465|NCT02039505|9886120|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2873466|NCT02039505|9886121|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2873467|NCT02039505|9886122|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2873468|NCT02039505|9886116|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2873469|NCT02039505|9886117|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
2873470|NCT02039505|9886118|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
2873471|NCT02039505|9886119|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
2873472|NCT02039505|9886120|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2873473|NCT02039505|9886121|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2873474|NCT02039505|9886122|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2873475|NCT02039505|9886116|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873476|NCT02039505|9886117|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873477|NCT02039505|9886118|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873478|NCT02039505|9886119|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873479|NCT02039505|9886120|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873480|NCT02039505|9886121|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2873481|NCT02039505|9886122|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
2873482|NCT02039505|9886116|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2873483|NCT02039505|9886117|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2873484|NCT02039505|9886118|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2873485|NCT02039505|9886119|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2873486|NCT02039505|9886120|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
2873487|NCT02039505|9886121|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2873488|NCT02039505|9886122|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2873489|NCT02039505|9886116|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2873490|NCT02039505|9886117|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2873491|NCT02039505|9886118|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2873492|NCT02039505|9886119|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2873493|NCT02039505|9886120|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
2873494|NCT02039505|9886121|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
2873495|NCT02039505|9886122|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
2873496|NCT02039427|9886198|P4|Overall Study|Steroid Use|0
2873497|NCT02039427|9886199|P3|Overall Study|Steroid Use|0
2873498|NCT02039427|9886200|P2|Overall Study|Steroid Use|0
2873499|NCT02039427|9886201|P1|Overall Study|Steroid Use|1
2873500|NCT02039427|9886198|P4|Overall Study|Loss of follow - up|4
2873501|NCT02039427|9886199|P3|Overall Study|Loss of follow - up|2
2873502|NCT02039427|9886200|P2|Overall Study|Loss of follow - up|0
2873503|NCT02039427|9886201|P1|Overall Study|Loss of follow - up|1
2873504|NCT02039427|9886198|P4|Overall Study|Cancellation of surgery|0
2873505|NCT02039427|9886199|P3|Overall Study|Cancellation of surgery|1
2873506|NCT02039427|9886200|P2|Overall Study|Cancellation of surgery|0
2873507|NCT02039427|9886201|P1|Overall Study|Cancellation of surgery|0
2873508|NCT02039427|9886198|P4|Overall Study|Withdrawal on concent|1
2873509|NCT02039427|9886199|P3|Overall Study|Withdrawal on concent|0
2873510|NCT02039427|9886200|P2|Overall Study|Withdrawal on concent|0
2873511|NCT02039427|9886201|P1|Overall Study|Withdrawal on concent|0
2873512|NCT02039427|9886198|P4|Overall Study|Duration of surgery > 3h|0
2873513|NCT02039427|9886199|P3|Overall Study|Duration of surgery > 3h|0
2873514|NCT02039427|9886200|P2|Overall Study|Duration of surgery > 3h|1
2873515|NCT02039427|9886201|P1|Overall Study|Duration of surgery > 3h|1
2873516|NCT02039414|9886221|P2|Overall Study|Protocol Violation|1
2873517|NCT02039414|9886222|P1|Overall Study|Protocol Violation|3
2873518|NCT02039414|9886221|P2|Overall Study|Lost to Follow-up|0
2873519|NCT02039414|9886222|P1|Overall Study|Lost to Follow-up|2
2873520|NCT02039414|9886221|P2|Overall Study|Delivered|1
2873521|NCT02039414|9886222|P1|Overall Study|Delivered|1
2873522|NCT02039375|9886234|P1|Overall Study|Lost to Follow-up|2
2873523|NCT02039219|9886245|P2|Follow up|Adverse Event|1
2873524|NCT02039219|9886246|P1|Follow up|Adverse Event|0
2873525|NCT02039219|9886245|P2|Treatment|Death|0
2873526|NCT02039219|9886246|P1|Treatment|Death|1
2873527|NCT02039219|9886245|P2|Treatment|Protocol Violation|0
2873528|NCT02039219|9886246|P1|Treatment|Protocol Violation|1
2873529|NCT02039219|9886245|P2|Treatment|Lost to Follow-up|1
2873530|NCT02039219|9886246|P1|Treatment|Lost to Follow-up|0
2873531|NCT02039219|9886245|P2|Treatment|Physician Decision|0
2873532|NCT02039219|9886246|P1|Treatment|Physician Decision|1
2873533|NCT02039219|9886245|P2|Treatment|Adverse Event|1
2873534|NCT02039219|9886246|P1|Treatment|Adverse Event|0
2873535|NCT02039219|9886245|P2|Treatment|Withdrawal by Subject|0
2873536|NCT02039219|9886246|P1|Treatment|Withdrawal by Subject|1
2873537|NCT02038959|9886295|P2|Overall Study|Withdrawal by Subject|8
2873538|NCT02038959|9886296|P1|Overall Study|Withdrawal by Subject|6
2873539|NCT02038946|9886322|P1|Overall Study|Other reasons|1
2873540|NCT02038946|9886322|P1|Overall Study|Lost to Follow-up|2
2873541|NCT02038946|9886322|P1|Overall Study|Withdrawal by Subject|3
2873542|NCT02038946|9886322|P1|Overall Study|Death|5
2873543|NCT02038933|9886333|P1|Follow-up|Disease Progression|2
2873544|NCT02038933|9886333|P1|Follow-up|Withdrawal by Subject|1
2873545|NCT02038933|9886333|P1|Follow-up|Lost to Follow-up|1
2873546|NCT02038933|9886333|P1|Follow-up|Adverse event unrelated to study drug|4
2873547|NCT02038933|9886333|P1|Follow-up|Death|11
2873548|NCT02038933|9886333|P1|Treatment|Withdrawal by Subject|1
2873549|NCT02038933|9886333|P1|Treatment|Disease Progression|101
2873550|NCT02038933|9886333|P1|Treatment|Study Drug Toxicity|4
2873551|NCT02038933|9886333|P1|Treatment|Adverse Event Unrelated to Study Drug|6
2873552|NCT02038933|9886333|P1|Treatment|Lost to Follow-up|1
2873553|NCT02038933|9886333|P1|Treatment|No longer meets study criteria|1
2873554|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
2873555|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2873556|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2873557|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2873558|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2873559|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2873560|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
2873561|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2873562|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2873563|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2873564|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2873565|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2873566|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
2873567|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2873568|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2873569|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2873570|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2873571|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2873572|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
2873573|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2873574|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2873575|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2873576|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2873577|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2873578|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
2873579|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2873580|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2873581|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2873582|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2873583|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2873584|NCT02038920|9886354|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
2873585|NCT02038920|9886355|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2873586|NCT02038920|9886356|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2873587|NCT02038920|9886357|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2873588|NCT02038920|9886358|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2873589|NCT02038920|9886359|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2873590|NCT02038920|9886354|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2873591|NCT02038920|9886355|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
2873592|NCT02038920|9886356|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
2873593|NCT02038920|9886357|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
2873594|NCT02038920|9886358|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2873595|NCT02038920|9886359|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2873596|NCT02038920|9886354|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2873597|NCT02038920|9886355|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2873598|NCT02038920|9886356|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2873599|NCT02038920|9886357|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
2873600|NCT02038920|9886358|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2873601|NCT02038920|9886359|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2873602|NCT02038920|9886354|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2873603|NCT02038920|9886355|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2873604|NCT02038920|9886356|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
2873605|NCT02038920|9886357|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2873606|NCT02038920|9886358|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2873607|NCT02038920|9886359|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2873608|NCT02038920|9886354|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2873609|NCT02038920|9886355|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2873610|NCT02038920|9886356|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2873611|NCT02038920|9886357|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2873612|NCT02038920|9886358|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2873613|NCT02038920|9886359|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2873614|NCT02038920|9886354|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2873615|NCT02038920|9886355|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2873616|NCT02038920|9886356|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2873617|NCT02038920|9886357|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2873618|NCT02038920|9886358|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2873619|NCT02038920|9886359|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
2873620|NCT02038920|9886354|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2873621|NCT02038920|9886355|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2873622|NCT02038920|9886356|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2873623|NCT02038920|9886357|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2873624|NCT02038920|9886358|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
2873625|NCT02038920|9886359|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
2873626|NCT02038907|9886436|P14|Overall Study|Withdrawal by Subject|0
2873627|NCT02038907|9886437|P13|Overall Study|Withdrawal by Subject|0
2873628|NCT02038907|9886438|P12|Overall Study|Withdrawal by Subject|0
2873629|NCT02038907|9886439|P11|Overall Study|Withdrawal by Subject|1
2873630|NCT02038907|9886440|P10|Overall Study|Withdrawal by Subject|0
2873631|NCT02038907|9886441|P9|Overall Study|Withdrawal by Subject|0
2873632|NCT02038907|9886442|P8|Overall Study|Withdrawal by Subject|0
2873633|NCT02038907|9886443|P7|Overall Study|Withdrawal by Subject|0
2873634|NCT02038907|9886444|P6|Overall Study|Withdrawal by Subject|0
2873635|NCT02038907|9886445|P5|Overall Study|Withdrawal by Subject|0
2873636|NCT02038907|9886446|P4|Overall Study|Withdrawal by Subject|0
2873637|NCT02038907|9886447|P3|Overall Study|Withdrawal by Subject|0
2873638|NCT02038907|9886448|P2|Overall Study|Withdrawal by Subject|0
2873639|NCT02038907|9886449|P1|Overall Study|Withdrawal by Subject|0
2873640|NCT02038907|9886436|P14|Overall Study|Protocol Violation|0
2873641|NCT02038907|9886437|P13|Overall Study|Protocol Violation|0
2873642|NCT02038907|9886438|P12|Overall Study|Protocol Violation|0
2873643|NCT02038907|9886439|P11|Overall Study|Protocol Violation|1
2873644|NCT02038907|9886440|P10|Overall Study|Protocol Violation|0
2873645|NCT02038907|9886441|P9|Overall Study|Protocol Violation|0
2873646|NCT02038907|9886442|P8|Overall Study|Protocol Violation|0
2873647|NCT02038907|9886443|P7|Overall Study|Protocol Violation|0
2873648|NCT02038907|9886444|P6|Overall Study|Protocol Violation|0
2873649|NCT02038907|9886445|P5|Overall Study|Protocol Violation|0
2873650|NCT02038907|9886446|P4|Overall Study|Protocol Violation|0
2873651|NCT02038907|9886447|P3|Overall Study|Protocol Violation|0
2873652|NCT02038907|9886448|P2|Overall Study|Protocol Violation|0
2873653|NCT02038907|9886449|P1|Overall Study|Protocol Violation|0
2873654|NCT02038881|9886980|P3|Overall Study|incarcerated|0
2873655|NCT02038881|9886981|P2|Overall Study|incarcerated|0
2873656|NCT02038881|9886982|P1|Overall Study|incarcerated|1
2873657|NCT02038881|9886980|P3|Overall Study|Lost to Follow-up|0
2873658|NCT02038881|9886981|P2|Overall Study|Lost to Follow-up|0
2873659|NCT02038881|9886982|P1|Overall Study|Lost to Follow-up|2
2873660|NCT02038881|9886980|P3|Overall Study|Withdrawal by Subject|1
2873661|NCT02038881|9886981|P2|Overall Study|Withdrawal by Subject|0
2873662|NCT02038881|9886982|P1|Overall Study|Withdrawal by Subject|0
2873663|NCT02038829|9887055|P12|Treatment Period 6|Adverse Event|0
2873664|NCT02038829|9887056|P11|Treatment Period 6|Adverse Event|0
2873665|NCT02038829|9887057|P10|Treatment Period 6|Adverse Event|0
2873666|NCT02038829|9887058|P9|Treatment Period 6|Adverse Event|0
2873667|NCT02038829|9887059|P8|Treatment Period 6|Adverse Event|0
2873668|NCT02038829|9887060|P7|Treatment Period 6|Adverse Event|0
2873669|NCT02038829|9887061|P6|Treatment Period 6|Adverse Event|0
2873670|NCT02038829|9887062|P5|Treatment Period 6|Adverse Event|0
2873671|NCT02038829|9887063|P4|Treatment Period 6|Adverse Event|0
2873672|NCT02038829|9887064|P3|Treatment Period 6|Adverse Event|1
2873673|NCT02038829|9887065|P2|Treatment Period 6|Adverse Event|0
2873674|NCT02038829|9887066|P1|Treatment Period 6|Adverse Event|0
2873675|NCT02038829|9887055|P12|Washout Period 4|Adverse Event|0
2873676|NCT02038829|9887056|P11|Washout Period 4|Adverse Event|0
2873677|NCT02038829|9887057|P10|Washout Period 4|Adverse Event|0
2873678|NCT02038829|9887058|P9|Washout Period 4|Adverse Event|0
2873679|NCT02038829|9887059|P8|Washout Period 4|Adverse Event|0
2873680|NCT02038829|9887060|P7|Washout Period 4|Adverse Event|1
2873681|NCT02038829|9887061|P6|Washout Period 4|Adverse Event|0
2873682|NCT02038829|9887062|P5|Washout Period 4|Adverse Event|0
2873683|NCT02038829|9887063|P4|Washout Period 4|Adverse Event|0
2873684|NCT02038829|9887064|P3|Washout Period 4|Adverse Event|0
2873685|NCT02038829|9887065|P2|Washout Period 4|Adverse Event|0
2873686|NCT02038829|9887066|P1|Washout Period 4|Adverse Event|0
2873687|NCT02038829|9887055|P12|Treatment Period 4|Adverse Event|0
2873688|NCT02038829|9887056|P11|Treatment Period 4|Adverse Event|0
2873689|NCT02038829|9887057|P10|Treatment Period 4|Adverse Event|0
2873690|NCT02038829|9887058|P9|Treatment Period 4|Adverse Event|0
2873691|NCT02038829|9887059|P8|Treatment Period 4|Adverse Event|0
2873692|NCT02038829|9887060|P7|Treatment Period 4|Adverse Event|0
2873693|NCT02038829|9887061|P6|Treatment Period 4|Adverse Event|0
2873694|NCT02038829|9887062|P5|Treatment Period 4|Adverse Event|0
2873695|NCT02038829|9887063|P4|Treatment Period 4|Adverse Event|0
2873696|NCT02038829|9887064|P3|Treatment Period 4|Adverse Event|0
2873697|NCT02038829|9887065|P2|Treatment Period 4|Adverse Event|1
2873698|NCT02038829|9887066|P1|Treatment Period 4|Adverse Event|0
2873699|NCT02038829|9887055|P12|Washout Period 2|Withdrawal by Subject|0
2873700|NCT02038829|9887056|P11|Washout Period 2|Withdrawal by Subject|0
2873701|NCT02038829|9887057|P10|Washout Period 2|Withdrawal by Subject|0
2873702|NCT02038829|9887058|P9|Washout Period 2|Withdrawal by Subject|0
2873703|NCT02038829|9887059|P8|Washout Period 2|Withdrawal by Subject|0
2873704|NCT02038829|9887060|P7|Washout Period 2|Withdrawal by Subject|0
2873705|NCT02038829|9887061|P6|Washout Period 2|Withdrawal by Subject|1
2873706|NCT02038829|9887062|P5|Washout Period 2|Withdrawal by Subject|0
2873707|NCT02038829|9887063|P4|Washout Period 2|Withdrawal by Subject|0
2873708|NCT02038829|9887064|P3|Washout Period 2|Withdrawal by Subject|0
2873709|NCT02038829|9887065|P2|Washout Period 2|Withdrawal by Subject|0
2873710|NCT02038829|9887066|P1|Washout Period 2|Withdrawal by Subject|0
2873711|NCT02038829|9887055|P12|Washout Period 2|Adverse Event|0
2873712|NCT02038829|9887056|P11|Washout Period 2|Adverse Event|0
2873713|NCT02038829|9887057|P10|Washout Period 2|Adverse Event|0
2873714|NCT02038829|9887058|P9|Washout Period 2|Adverse Event|1
2873715|NCT02038829|9887059|P8|Washout Period 2|Adverse Event|0
2873716|NCT02038829|9887060|P7|Washout Period 2|Adverse Event|0
2873717|NCT02038829|9887061|P6|Washout Period 2|Adverse Event|0
2873718|NCT02038829|9887062|P5|Washout Period 2|Adverse Event|0
2873719|NCT02038829|9887063|P4|Washout Period 2|Adverse Event|0
2873720|NCT02038829|9887064|P3|Washout Period 2|Adverse Event|0
2873721|NCT02038829|9887065|P2|Washout Period 2|Adverse Event|0
2873722|NCT02038829|9887066|P1|Washout Period 2|Adverse Event|0
2873723|NCT02038829|9887055|P12|Treatment Period 2|Withdrawal by Subject|0
2873724|NCT02038829|9887056|P11|Treatment Period 2|Withdrawal by Subject|0
2873725|NCT02038829|9887057|P10|Treatment Period 2|Withdrawal by Subject|0
2873726|NCT02038829|9887058|P9|Treatment Period 2|Withdrawal by Subject|0
2873727|NCT02038829|9887059|P8|Treatment Period 2|Withdrawal by Subject|0
2873728|NCT02038829|9887060|P7|Treatment Period 2|Withdrawal by Subject|0
2873729|NCT02038829|9887061|P6|Treatment Period 2|Withdrawal by Subject|0
2873730|NCT02038829|9887062|P5|Treatment Period 2|Withdrawal by Subject|0
2873731|NCT02038829|9887063|P4|Treatment Period 2|Withdrawal by Subject|0
2873732|NCT02038829|9887064|P3|Treatment Period 2|Withdrawal by Subject|0
2873733|NCT02038829|9887065|P2|Treatment Period 2|Withdrawal by Subject|0
2873734|NCT02038829|9887066|P1|Treatment Period 2|Withdrawal by Subject|1
2873735|NCT02038829|9887055|P12|Treatment Period 2|Adverse Event|0
2873736|NCT02038829|9887056|P11|Treatment Period 2|Adverse Event|1
2873737|NCT02038829|9887057|P10|Treatment Period 2|Adverse Event|0
2873738|NCT02038829|9887058|P9|Treatment Period 2|Adverse Event|0
2873739|NCT02038829|9887059|P8|Treatment Period 2|Adverse Event|0
2873740|NCT02038829|9887060|P7|Treatment Period 2|Adverse Event|0
2873741|NCT02038829|9887061|P6|Treatment Period 2|Adverse Event|0
2873742|NCT02038829|9887062|P5|Treatment Period 2|Adverse Event|0
2873743|NCT02038829|9887063|P4|Treatment Period 2|Adverse Event|0
2873744|NCT02038829|9887064|P3|Treatment Period 2|Adverse Event|0
2873745|NCT02038829|9887065|P2|Treatment Period 2|Adverse Event|0
2873746|NCT02038829|9887066|P1|Treatment Period 2|Adverse Event|0
2873747|NCT02038829|9887055|P12|Washout Period 1|Death|0
2873748|NCT02038829|9887056|P11|Washout Period 1|Death|0
2873749|NCT02038829|9887057|P10|Washout Period 1|Death|0
2873750|NCT02038829|9887058|P9|Washout Period 1|Death|0
2873751|NCT02038829|9887059|P8|Washout Period 1|Death|0
2873752|NCT02038829|9887060|P7|Washout Period 1|Death|0
2873753|NCT02038829|9887061|P6|Washout Period 1|Death|0
2873754|NCT02038829|9887062|P5|Washout Period 1|Death|1
2873755|NCT02038829|9887063|P4|Washout Period 1|Death|0
2873756|NCT02038829|9887064|P3|Washout Period 1|Death|0
2873757|NCT02038829|9887065|P2|Washout Period 1|Death|0
2873758|NCT02038829|9887066|P1|Washout Period 1|Death|0
2873759|NCT02038790|9887100|P2|Day 0 - First Treatment|Withdrawal by Subject|1
2873760|NCT02038790|9887101|P1|Day 0 - First Treatment|Withdrawal by Subject|1
2873761|NCT02038764|9887137|P5|Overall Study|Other|0
2873762|NCT02038764|9887138|P4|Overall Study|Other|0
2873763|NCT02038764|9887139|P3|Overall Study|Other|1
2873764|NCT02038764|9887140|P2|Overall Study|Other|0
2873765|NCT02038764|9887141|P1|Overall Study|Other|1
2873766|NCT02038764|9887137|P5|Overall Study|Withdrawal by Subject|1
2873767|NCT02038764|9887138|P4|Overall Study|Withdrawal by Subject|0
2873768|NCT02038764|9887139|P3|Overall Study|Withdrawal by Subject|0
2873769|NCT02038764|9887140|P2|Overall Study|Withdrawal by Subject|0
2873770|NCT02038764|9887141|P1|Overall Study|Withdrawal by Subject|0
2873771|NCT02038764|9887137|P5|Overall Study|Lost to Follow-up|0
2873772|NCT02038764|9887138|P4|Overall Study|Lost to Follow-up|0
2873773|NCT02038764|9887139|P3|Overall Study|Lost to Follow-up|0
2873774|NCT02038764|9887140|P2|Overall Study|Lost to Follow-up|1
2873775|NCT02038764|9887141|P1|Overall Study|Lost to Follow-up|0
2873776|NCT02038764|9887137|P5|Overall Study|Adverse Event|0
2873777|NCT02038764|9887138|P4|Overall Study|Adverse Event|0
2873778|NCT02038764|9887139|P3|Overall Study|Adverse Event|1
2873779|NCT02038764|9887140|P2|Overall Study|Adverse Event|0
2873780|NCT02038764|9887141|P1|Overall Study|Adverse Event|0
2873781|NCT02038647|9887243|P2|Overall Study|Ongoing at Datacut|10
2873782|NCT02038647|9887244|P1|Overall Study|Ongoing at Datacut|9
2873783|NCT02038647|9887243|P2|Overall Study|Not Reported|1
2873784|NCT02038647|9887244|P1|Overall Study|Not Reported|0
2873785|NCT02038647|9887243|P2|Overall Study|Withdrawal by Subject|2
2873786|NCT02038647|9887244|P1|Overall Study|Withdrawal by Subject|5
2873787|NCT02038647|9887243|P2|Overall Study|Symptomatic Deterioration|7
2873788|NCT02038647|9887244|P1|Overall Study|Symptomatic Deterioration|7
2873789|NCT02038647|9887243|P2|Overall Study|Adverse Event|10
2873790|NCT02038647|9887244|P1|Overall Study|Adverse Event|18
2873791|NCT02038647|9887243|P2|Overall Study|Progressive Disease|59
2873792|NCT02038647|9887244|P1|Overall Study|Progressive Disease|50
2873793|NCT02038543|9887307|P4|Overall Study|Withdrawal by Subject|1
2873794|NCT02038543|9887308|P3|Overall Study|Withdrawal by Subject|0
2873795|NCT02038543|9887309|P2|Overall Study|Withdrawal by Subject|0
2873796|NCT02038543|9887310|P1|Overall Study|Withdrawal by Subject|0
2873797|NCT02038543|9887307|P4|Overall Study|Screen Failure|1
2873798|NCT02038543|9887308|P3|Overall Study|Screen Failure|0
2873799|NCT02038543|9887309|P2|Overall Study|Screen Failure|0
2873800|NCT02038543|9887310|P1|Overall Study|Screen Failure|0
2873801|NCT02038153|9887335|P1|Overall Study|Withdrawal by Subject|1
2873802|NCT02038075|9887342|P2|Overall Study|Withdrawal by Subject|0
2873803|NCT02038075|9887343|P1|Overall Study|Withdrawal by Subject|3
2873804|NCT02038049|9887351|P2|Overall Study|Lost to Follow-up|0
2873805|NCT02038049|9887352|P1|Overall Study|Lost to Follow-up|1
2873806|NCT02038010|9887381|P4|Follow Up|Other|0
2873807|NCT02038010|9887382|P3|Follow Up|Other|0
2873808|NCT02038010|9887383|P2|Follow Up|Other|0
2873809|NCT02038010|9887384|P1|Follow Up|Other|3
2873810|NCT02038010|9887381|P4|Follow Up|Death|0
2873811|NCT02038010|9887382|P3|Follow Up|Death|0
2873812|NCT02038010|9887383|P2|Follow Up|Death|3
2873813|NCT02038010|9887384|P1|Follow Up|Death|4
2873814|NCT02038010|9887381|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2873815|NCT02038010|9887382|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2873816|NCT02038010|9887383|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2873817|NCT02038010|9887384|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2873818|NCT02038010|9887381|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2873819|NCT02038010|9887382|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2873820|NCT02038010|9887383|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
2873821|NCT02038010|9887384|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2873822|NCT02038010|9887381|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2873823|NCT02038010|9887382|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2873824|NCT02038010|9887383|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2873825|NCT02038010|9887384|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
2873826|NCT02038010|9887381|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2873827|NCT02038010|9887382|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2873828|NCT02038010|9887383|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
2873829|NCT02038010|9887384|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2873830|NCT02037984|9887411|P8|Overall Study|Withdrawal by Subject|1
2873831|NCT02037984|9887412|P7|Overall Study|Withdrawal by Subject|0
2873832|NCT02037984|9887413|P6|Overall Study|Withdrawal by Subject|3
2873833|NCT02037984|9887414|P5|Overall Study|Withdrawal by Subject|1
2873834|NCT02037984|9887415|P4|Overall Study|Withdrawal by Subject|1
2873835|NCT02037984|9887416|P3|Overall Study|Withdrawal by Subject|0
2873836|NCT02037984|9887417|P2|Overall Study|Withdrawal by Subject|0
2873837|NCT02037984|9887418|P1|Overall Study|Withdrawal by Subject|0
2873838|NCT02037984|9887411|P8|Overall Study|Withdrawal by Parent/Guardian|2
2873839|NCT02037984|9887412|P7|Overall Study|Withdrawal by Parent/Guardian|4
2873840|NCT02037984|9887413|P6|Overall Study|Withdrawal by Parent/Guardian|1
2873841|NCT02037984|9887414|P5|Overall Study|Withdrawal by Parent/Guardian|5
2873842|NCT02037984|9887415|P4|Overall Study|Withdrawal by Parent/Guardian|2
2873843|NCT02037984|9887416|P3|Overall Study|Withdrawal by Parent/Guardian|3
2873844|NCT02037984|9887417|P2|Overall Study|Withdrawal by Parent/Guardian|0
2873845|NCT02037984|9887418|P1|Overall Study|Withdrawal by Parent/Guardian|0
2873846|NCT02037984|9887411|P8|Overall Study|Technical Problems|2
2873847|NCT02037984|9887412|P7|Overall Study|Technical Problems|4
2873848|NCT02037984|9887413|P6|Overall Study|Technical Problems|3
2873849|NCT02037984|9887414|P5|Overall Study|Technical Problems|2
2873850|NCT02037984|9887415|P4|Overall Study|Technical Problems|3
2873851|NCT02037984|9887416|P3|Overall Study|Technical Problems|3
2873852|NCT02037984|9887417|P2|Overall Study|Technical Problems|0
2873853|NCT02037984|9887418|P1|Overall Study|Technical Problems|0
2873854|NCT02037984|9887411|P8|Overall Study|Protocol Violation|0
2873855|NCT02037984|9887412|P7|Overall Study|Protocol Violation|2
2873856|NCT02037984|9887413|P6|Overall Study|Protocol Violation|1
2873857|NCT02037984|9887414|P5|Overall Study|Protocol Violation|0
2873858|NCT02037984|9887415|P4|Overall Study|Protocol Violation|0
2873859|NCT02037984|9887416|P3|Overall Study|Protocol Violation|0
2873860|NCT02037984|9887417|P2|Overall Study|Protocol Violation|0
2873861|NCT02037984|9887418|P1|Overall Study|Protocol Violation|0
2873862|NCT02037984|9887411|P8|Overall Study|Physician Decision|0
2873863|NCT02037984|9887412|P7|Overall Study|Physician Decision|1
2873864|NCT02037984|9887413|P6|Overall Study|Physician Decision|0
2873865|NCT02037984|9887414|P5|Overall Study|Physician Decision|0
2873866|NCT02037984|9887415|P4|Overall Study|Physician Decision|0
2873867|NCT02037984|9887416|P3|Overall Study|Physician Decision|0
2873868|NCT02037984|9887417|P2|Overall Study|Physician Decision|0
2873869|NCT02037984|9887418|P1|Overall Study|Physician Decision|0
2873870|NCT02037984|9887411|P8|Overall Study|Lost to Follow-up|4
2873871|NCT02037984|9887412|P7|Overall Study|Lost to Follow-up|2
2873872|NCT02037984|9887413|P6|Overall Study|Lost to Follow-up|2
2873873|NCT02037984|9887414|P5|Overall Study|Lost to Follow-up|2
2873874|NCT02037984|9887415|P4|Overall Study|Lost to Follow-up|5
2873875|NCT02037984|9887416|P3|Overall Study|Lost to Follow-up|3
2873876|NCT02037984|9887417|P2|Overall Study|Lost to Follow-up|0
2873877|NCT02037984|9887418|P1|Overall Study|Lost to Follow-up|1
2873878|NCT02037984|9887411|P8|Overall Study|Lack of Efficacy|3
2873879|NCT02037984|9887412|P7|Overall Study|Lack of Efficacy|4
2873880|NCT02037984|9887413|P6|Overall Study|Lack of Efficacy|2
2873881|NCT02037984|9887414|P5|Overall Study|Lack of Efficacy|2
2873882|NCT02037984|9887415|P4|Overall Study|Lack of Efficacy|10
2873883|NCT02037984|9887416|P3|Overall Study|Lack of Efficacy|3
2873884|NCT02037984|9887417|P2|Overall Study|Lack of Efficacy|0
2873885|NCT02037984|9887418|P1|Overall Study|Lack of Efficacy|0
2873886|NCT02037568|9887563|P2|Overall Study|Patient did not receive transplant|1
2873887|NCT02037568|9887564|P1|Overall Study|Patient did not receive transplant|0
2873888|NCT02037568|9887563|P2|Overall Study|Screen Failure|1
2873889|NCT02037568|9887564|P1|Overall Study|Screen Failure|3
2873890|NCT02037568|9887563|P2|Overall Study|Lost to Follow-up|13
2873891|NCT02037568|9887564|P1|Overall Study|Lost to Follow-up|16
2873892|NCT02037568|9887563|P2|Overall Study|Withdrawal by Subject|24
2873893|NCT02037568|9887564|P1|Overall Study|Withdrawal by Subject|17
2873894|NCT02037477|9887599|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2873895|NCT02037477|9887600|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
2873896|NCT02037477|9887601|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2873897|NCT02037477|9887602|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2873898|NCT02037165|9887729|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
2873899|NCT02037165|9887730|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2873900|NCT02037165|9887731|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2873901|NCT02037165|9887732|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2873902|NCT02037165|9887733|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2873903|NCT02036775|9887793|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
2873904|NCT02036775|9887794|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2873905|NCT02036775|9887795|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2873906|NCT02036775|9887796|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2873907|NCT02036775|9887797|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2873908|NCT02036775|9887798|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2873909|NCT02036645|9887848|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873910|NCT02036645|9887849|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873911|NCT02036645|9887850|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873912|NCT02036645|9887851|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873913|NCT02036645|9887852|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873914|NCT02036645|9887853|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873915|NCT02036645|9887854|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873916|NCT02036645|9887855|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873917|NCT02036645|9887856|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
2873918|NCT02036645|9887857|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873919|NCT02036645|9887858|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873920|NCT02036645|9887859|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2873921|NCT02036645|9887848|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873922|NCT02036645|9887849|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873923|NCT02036645|9887850|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873924|NCT02036645|9887851|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873925|NCT02036645|9887852|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873926|NCT02036645|9887853|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
2873927|NCT02036645|9887854|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873928|NCT02036645|9887855|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873929|NCT02036645|9887856|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873930|NCT02036645|9887857|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873931|NCT02036645|9887858|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873932|NCT02036645|9887859|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2873933|NCT02036580|9887964|P3|Overall Study|Adverse Event|0
2873934|NCT02036580|9887965|P2|Overall Study|Adverse Event|0
2873935|NCT02036580|9887966|P1|Overall Study|Adverse Event|1
2873936|NCT02036580|9887964|P3|Overall Study|Withdrawal by Subject|0
2873937|NCT02036580|9887965|P2|Overall Study|Withdrawal by Subject|1
2873938|NCT02036580|9887966|P1|Overall Study|Withdrawal by Subject|0
2873939|NCT02036515|9887987|P3|Overall Study|Hyperglycemia|1
2873940|NCT02036515|9887988|P2|Overall Study|Hyperglycemia|0
2873941|NCT02036515|9887989|P1|Overall Study|Hyperglycemia|0
2873942|NCT02036515|9887987|P3|Overall Study|Withdrawal by Subject|9
2873943|NCT02036515|9887988|P2|Overall Study|Withdrawal by Subject|7
2873944|NCT02036515|9887989|P1|Overall Study|Withdrawal by Subject|4
2873945|NCT02036515|9887987|P3|Overall Study|Screen failure|0
2873946|NCT02036515|9887988|P2|Overall Study|Screen failure|2
2873947|NCT02036515|9887989|P1|Overall Study|Screen failure|0
2873948|NCT02036515|9887987|P3|Overall Study|Non-compliance with study drug|2
2873949|NCT02036515|9887988|P2|Overall Study|Non-compliance with study drug|0
2873950|NCT02036515|9887989|P1|Overall Study|Non-compliance with study drug|0
2873951|NCT02036515|9887987|P3|Overall Study|Lost to Follow-up|0
2873952|NCT02036515|9887988|P2|Overall Study|Lost to Follow-up|2
2873953|NCT02036515|9887989|P1|Overall Study|Lost to Follow-up|0
2873954|NCT02036515|9887987|P3|Overall Study|Adverse Event|2
2873955|NCT02036515|9887988|P2|Overall Study|Adverse Event|1
2873956|NCT02036515|9887989|P1|Overall Study|Adverse Event|1
2873957|NCT02036294|9888090|P2|Overall Study|Withdrawal by Subject|3
2873958|NCT02036294|9888091|P1|Overall Study|Withdrawal by Subject|2
2873959|NCT02036294|9888090|P2|Overall Study|Death|8
2873960|NCT02036294|9888091|P1|Overall Study|Death|7
2873961|NCT02035748|9888107|P1|Overall Study|Progressive Disease|1
2873962|NCT02035748|9888107|P1|Overall Study|Withdrawal by Subject|6
2873963|NCT02035748|9888107|P1|Overall Study|Physician Decision|3
2873964|NCT02035748|9888107|P1|Overall Study|Lost to Follow-up|2
2873965|NCT02035748|9888107|P1|Overall Study|Death|3
2873966|NCT02035748|9888107|P1|Overall Study|Adverse Event|5
2873967|NCT02035696|9888121|P4|Overall Study|Withdrawal by Subject|1
2873968|NCT02035696|9888122|P3|Overall Study|Withdrawal by Subject|2
2873969|NCT02035696|9888123|P2|Overall Study|Withdrawal by Subject|0
2873970|NCT02035696|9888124|P1|Overall Study|Withdrawal by Subject|3
2873971|NCT02035696|9888121|P4|Overall Study|Lost to Follow-up|2
2873972|NCT02035696|9888122|P3|Overall Study|Lost to Follow-up|1
2873973|NCT02035696|9888123|P2|Overall Study|Lost to Follow-up|3
2873974|NCT02035696|9888124|P1|Overall Study|Lost to Follow-up|0
2873975|NCT02035553|9888180|P2|Overall Study|Other Reason|4
2873976|NCT02035553|9888181|P1|Overall Study|Other Reason|0
2873977|NCT02035553|9888180|P2|Overall Study|Lost to Follow-up|1
2873978|NCT02035553|9888181|P1|Overall Study|Lost to Follow-up|0
2873979|NCT02035553|9888180|P2|Overall Study|Non-compliance with Study Drug|1
2873980|NCT02035553|9888181|P1|Overall Study|Non-compliance with Study Drug|0
2873981|NCT02035553|9888180|P2|Overall Study|Withdrawal by Subject|7
2873982|NCT02035553|9888181|P1|Overall Study|Withdrawal by Subject|4
2873983|NCT02035553|9888180|P2|Overall Study|Lack of Efficacy|1
2873984|NCT02035553|9888181|P1|Overall Study|Lack of Efficacy|1
2873985|NCT02035553|9888180|P2|Overall Study|Physician Decision|2
2873986|NCT02035553|9888181|P1|Overall Study|Physician Decision|3
2873987|NCT02035553|9888180|P2|Overall Study|Adverse Event|6
2873988|NCT02035553|9888181|P1|Overall Study|Adverse Event|10
2873989|NCT02035553|9888180|P2|Overall Study|Death (See All-Cause Mortality Table)|1
2873990|NCT02035553|9888181|P1|Overall Study|Death (See All-Cause Mortality Table)|0
2873991|NCT02035475|9888187|P1|Overall Study|Equipment Error|1
2873992|NCT02035475|9888187|P1|Overall Study|Physician Decision|1
2873993|NCT02035475|9888187|P1|Overall Study|Withdrawal by Subject|4
2873994|NCT02035332|9888198|P1|Overall Study|Procedure Aborted due to Uterine Width|1
2873995|NCT02035267|9888208|P4|Overall Study|Other unspecified|0
2873996|NCT02035267|9888209|P3|Overall Study|Other unspecified|0
2873997|NCT02035267|9888210|P2|Overall Study|Other unspecified|1
2873998|NCT02035267|9888211|P1|Overall Study|Other unspecified|0
2873999|NCT02035267|9888208|P4|Overall Study|Lost to Follow-up|1
2874000|NCT02035267|9888209|P3|Overall Study|Lost to Follow-up|0
2874001|NCT02035267|9888210|P2|Overall Study|Lost to Follow-up|0
2874002|NCT02035267|9888211|P1|Overall Study|Lost to Follow-up|0
2874003|NCT02035267|9888208|P4|Overall Study|Adverse Event|0
2874004|NCT02035267|9888209|P3|Overall Study|Adverse Event|1
2874005|NCT02035267|9888210|P2|Overall Study|Adverse Event|0
2874006|NCT02035267|9888211|P1|Overall Study|Adverse Event|0
2874007|NCT02035267|9888208|P4|Overall Study|Withdrawal consent-subject convenience|0
2874008|NCT02035267|9888209|P3|Overall Study|Withdrawal consent-subject convenience|1
2874009|NCT02035267|9888210|P2|Overall Study|Withdrawal consent-subject convenience|0
2874010|NCT02035267|9888211|P1|Overall Study|Withdrawal consent-subject convenience|0
2874011|NCT02035202|9888242|P3|Overall Study|Lost to Follow-up|2
2874012|NCT02035202|9888243|P2|Overall Study|Lost to Follow-up|16
2874013|NCT02035202|9888244|P1|Overall Study|Lost to Follow-up|8
2874014|NCT02034916|9888260|P2|Overall Study|Study terminated by sponsor|5
2874015|NCT02034916|9888261|P1|Overall Study|Study terminated by sponsor|4
2874016|NCT02034916|9888260|P2|Overall Study|Lost to Follow-up|1
2874017|NCT02034916|9888261|P1|Overall Study|Lost to Follow-up|4
2874018|NCT02034916|9888260|P2|Overall Study|Withdrawal by Subject|1
2874019|NCT02034916|9888261|P1|Overall Study|Withdrawal by Subject|2
2874020|NCT02034916|9888260|P2|Overall Study|Death|28
2874021|NCT02034916|9888261|P1|Overall Study|Death|39
2874022|NCT02034877|9888298|P2|Overall Study|No Longer Willing to Participate|3
2874023|NCT02034877|9888299|P1|Overall Study|No Longer Willing to Participate|0
2874024|NCT02034877|9888298|P2|Overall Study|Lost to Follow-up|3
2874025|NCT02034877|9888299|P1|Overall Study|Lost to Follow-up|0
2874026|NCT02034799|9888317|P2|Overall Study|Death|1
2874027|NCT02034799|9888318|P1|Overall Study|Death|2
2874028|NCT02034799|9888317|P2|Overall Study|Lost to Follow-up|1
2874029|NCT02034799|9888318|P1|Overall Study|Lost to Follow-up|0
2874030|NCT02034799|9888317|P2|Overall Study|Withdrawal by Subject|2
2874031|NCT02034799|9888318|P1|Overall Study|Withdrawal by Subject|0
2874032|NCT02034708|9888332|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
2874033|NCT02034708|9888333|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
2874034|NCT02034708|9888332|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2874035|NCT02034708|9888333|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2874036|NCT02034708|9888332|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
2874037|NCT02034708|9888333|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
2874038|NCT02034708|9888332|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
2874039|NCT02034708|9888333|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
2874040|NCT02034591|9888344|P6|Overall Study|Withdrawal by Subject|0
2874041|NCT02034591|9888345|P5|Overall Study|Withdrawal by Subject|1
2874042|NCT02034591|9888346|P4|Overall Study|Withdrawal by Subject|0
2874043|NCT02034591|9888347|P3|Overall Study|Withdrawal by Subject|0
2874044|NCT02034591|9888348|P2|Overall Study|Withdrawal by Subject|0
2874045|NCT02034591|9888349|P1|Overall Study|Withdrawal by Subject|0
2874046|NCT02034565|9888404|P2|Overall Study|Adverse Event|0
2874047|NCT02034565|9888405|P1|Overall Study|Adverse Event|1
2874048|NCT02034552|9888422|P3|Overall Study|Clinical progression|9
2874049|NCT02034552|9888423|P2|Overall Study|Clinical progression|7
2874050|NCT02034552|9888424|P1|Overall Study|Clinical progression|5
2874051|NCT02034552|9888422|P3|Overall Study|Non-compliance with study drug|1
2874052|NCT02034552|9888423|P2|Overall Study|Non-compliance with study drug|0
2874053|NCT02034552|9888424|P1|Overall Study|Non-compliance with study drug|0
2874054|NCT02034552|9888422|P3|Overall Study|Withdrawal by Subject|1
2874055|NCT02034552|9888423|P2|Overall Study|Withdrawal by Subject|1
2874056|NCT02034552|9888424|P1|Overall Study|Withdrawal by Subject|2
2874057|NCT02034552|9888422|P3|Overall Study|AE associated with disease progression|0
2874058|NCT02034552|9888423|P2|Overall Study|AE associated with disease progression|1
2874059|NCT02034552|9888424|P1|Overall Study|AE associated with disease progression|0
2874060|NCT02034552|9888422|P3|Overall Study|AE not assoc. with disease progression|2
2874061|NCT02034552|9888423|P2|Overall Study|AE not assoc. with disease progression|4
2874062|NCT02034552|9888424|P1|Overall Study|AE not assoc. with disease progression|1
2874063|NCT02034552|9888422|P3|Overall Study|Radiological progression|4
2874064|NCT02034552|9888423|P2|Overall Study|Radiological progression|5
2874065|NCT02034552|9888424|P1|Overall Study|Radiological progression|3
2874066|NCT02034552|9888422|P3|Overall Study|Never treated|0
2874067|NCT02034552|9888423|P2|Overall Study|Never treated|2
2874068|NCT02034552|9888424|P1|Overall Study|Never treated|3
2874069|NCT02034513|9888455|P2|Overall Study|Unclassified|1
2874070|NCT02034513|9888456|P1|Overall Study|Unclassified|0
2874071|NCT02034513|9888455|P2|Overall Study|Withdrawal by Subject|25
2874072|NCT02034513|9888456|P1|Overall Study|Withdrawal by Subject|25
2874073|NCT02034513|9888455|P2|Overall Study|Protocol Violation|10
2874074|NCT02034513|9888456|P1|Overall Study|Protocol Violation|7
2874075|NCT02034513|9888455|P2|Overall Study|Pregnancy|3
2874076|NCT02034513|9888456|P1|Overall Study|Pregnancy|0
2874077|NCT02034513|9888455|P2|Overall Study|Lost to Follow-up|7
2874078|NCT02034513|9888456|P1|Overall Study|Lost to Follow-up|6
2874079|NCT02034513|9888455|P2|Overall Study|Lack of Efficacy|1
2874080|NCT02034513|9888456|P1|Overall Study|Lack of Efficacy|0
2874081|NCT02034513|9888455|P2|Overall Study|Adverse Event|10
2874082|NCT02034513|9888456|P1|Overall Study|Adverse Event|11
2874083|NCT02034474|9888474|P2|Overall Study|Withdrawal by Subject|2
2874084|NCT02034474|9888475|P1|Overall Study|Withdrawal by Subject|1
2874085|NCT02034474|9888474|P2|Overall Study|Adverse Event|2
2874086|NCT02034474|9888475|P1|Overall Study|Adverse Event|3
2874087|NCT02034162|9888491|P3|Double-blind|Withdrawal by Subject|0
2874088|NCT02034162|9888492|P2|Double-blind|Withdrawal by Subject|7
2874089|NCT02034162|9888493|P1|Double-blind|Withdrawal by Subject|5
2874090|NCT02034162|9888491|P3|Double-blind|Protocol Violation|0
2874091|NCT02034162|9888492|P2|Double-blind|Protocol Violation|1
2874092|NCT02034162|9888493|P1|Double-blind|Protocol Violation|0
2874093|NCT02034162|9888491|P3|Double-blind|Physician Decision|0
2874094|NCT02034162|9888492|P2|Double-blind|Physician Decision|0
2874095|NCT02034162|9888493|P1|Double-blind|Physician Decision|1
2874096|NCT02034162|9888491|P3|Double-blind|Lost to Follow-up|0
2874097|NCT02034162|9888492|P2|Double-blind|Lost to Follow-up|0
2874098|NCT02034162|9888493|P1|Double-blind|Lost to Follow-up|3
2874099|NCT02034123|9888539|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874100|NCT02034123|9888540|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874101|NCT02034123|9888541|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874102|NCT02034123|9888542|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874103|NCT02034123|9888543|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874104|NCT02034123|9888544|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874105|NCT02034123|9888545|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874106|NCT02034123|9888546|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874107|NCT02034123|9888547|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874108|NCT02034123|9888548|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874109|NCT02034123|9888549|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874110|NCT02034123|9888550|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874111|NCT02034123|9888551|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874112|NCT02034123|9888552|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2874113|NCT02034123|9888553|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2874114|NCT02034123|9888554|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874115|NCT02034123|9888555|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874116|NCT02034123|9888556|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2874117|NCT02034123|9888539|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874118|NCT02034123|9888540|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874119|NCT02034123|9888541|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874120|NCT02034123|9888542|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874121|NCT02034123|9888543|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874122|NCT02034123|9888544|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874123|NCT02034123|9888545|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874124|NCT02034123|9888546|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874125|NCT02034123|9888547|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874126|NCT02034123|9888548|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
2874127|NCT02034123|9888549|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874128|NCT02034123|9888550|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874129|NCT02034123|9888551|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874130|NCT02034123|9888552|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874131|NCT02034123|9888553|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874132|NCT02034123|9888554|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874133|NCT02034123|9888555|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874134|NCT02034123|9888556|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2874135|NCT02034123|9888539|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874136|NCT02034123|9888540|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874137|NCT02034123|9888541|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874138|NCT02034123|9888542|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874139|NCT02034123|9888543|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874140|NCT02034123|9888544|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874141|NCT02034123|9888545|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874142|NCT02034123|9888546|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874143|NCT02034123|9888547|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874144|NCT02034123|9888548|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874145|NCT02034123|9888549|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874146|NCT02034123|9888550|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874147|NCT02034123|9888551|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874148|NCT02034123|9888552|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874149|NCT02034123|9888553|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
2874150|NCT02034123|9888554|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874151|NCT02034123|9888555|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874152|NCT02034123|9888556|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2874153|NCT02034123|9888539|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874154|NCT02034123|9888540|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874155|NCT02034123|9888541|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874156|NCT02034123|9888542|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874157|NCT02034123|9888543|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874158|NCT02034123|9888544|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874159|NCT02034123|9888545|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874160|NCT02034123|9888546|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874161|NCT02034123|9888547|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874162|NCT02034123|9888548|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2874163|NCT02034123|9888549|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2874164|NCT02034123|9888550|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874165|NCT02034123|9888551|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874166|NCT02034123|9888552|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2874167|NCT02034123|9888553|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874168|NCT02034123|9888554|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874169|NCT02034123|9888555|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874170|NCT02034123|9888556|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2874171|NCT02034058|9888875|P1|Overall Study|Death|3
2874172|NCT02034006|9888896|P1|Overall Study|Pregnancy|1
2874173|NCT02034006|9888896|P1|Overall Study|Death|1
2874174|NCT02034006|9888896|P1|Overall Study|Lost to Follow-up|5
2874175|NCT02034006|9888896|P1|Overall Study|Withdrawal by Subject|7
2874176|NCT02033889|9888947|P3|Overall Study|Withdrawal by Subject|13
2874177|NCT02033889|9888948|P2|Overall Study|Withdrawal by Subject|10
2874178|NCT02033889|9888949|P1|Overall Study|Withdrawal by Subject|18
2874179|NCT02033889|9888947|P3|Overall Study|Participant moved|0
2874180|NCT02033889|9888948|P2|Overall Study|Participant moved|1
2874181|NCT02033889|9888949|P1|Overall Study|Participant moved|0
2874182|NCT02033889|9888947|P3|Overall Study|Physician Decision|1
2874183|NCT02033889|9888948|P2|Overall Study|Physician Decision|1
2874184|NCT02033889|9888949|P1|Overall Study|Physician Decision|0
2874185|NCT02033889|9888947|P3|Overall Study|Non-Compliance With Study Drug|0
2874186|NCT02033889|9888948|P2|Overall Study|Non-Compliance With Study Drug|0
2874187|NCT02033889|9888949|P1|Overall Study|Non-Compliance With Study Drug|1
2874188|NCT02033889|9888947|P3|Overall Study|Lost to Follow-up|6
2874189|NCT02033889|9888948|P2|Overall Study|Lost to Follow-up|5
2874190|NCT02033889|9888949|P1|Overall Study|Lost to Follow-up|8
2874191|NCT02033889|9888947|P3|Overall Study|Excluded Medication|0
2874192|NCT02033889|9888948|P2|Overall Study|Excluded Medication|1
2874193|NCT02033889|9888949|P1|Overall Study|Excluded Medication|1
2874194|NCT02033889|9888947|P3|Overall Study|Death|2
2874195|NCT02033889|9888948|P2|Overall Study|Death|1
2874196|NCT02033889|9888949|P1|Overall Study|Death|3
2874197|NCT02033889|9888947|P3|Overall Study|Adverse Event|3
2874198|NCT02033889|9888948|P2|Overall Study|Adverse Event|1
2874199|NCT02033889|9888949|P1|Overall Study|Adverse Event|3
2874200|NCT02033850|9889126|P2|Overall Study|unrelated medical reason|1
2874201|NCT02033850|9889127|P1|Overall Study|unrelated medical reason|1
2874202|NCT02033850|9889126|P2|Overall Study|Death|0
2874203|NCT02033850|9889127|P1|Overall Study|Death|1
2874204|NCT02033759|9889151|P2|Overall Study|Protocol Violation|1
2874205|NCT02033759|9889152|P1|Overall Study|Protocol Violation|1
2874206|NCT02033759|9889151|P2|Overall Study|Withdrawal by Subject|1
2874207|NCT02033759|9889152|P1|Overall Study|Withdrawal by Subject|2
2874208|NCT02033369|9889212|P2|Overall Study|Protocol Violation|0
2874209|NCT02033369|9889213|P1|Overall Study|Protocol Violation|2
2874210|NCT02033369|9889212|P2|Overall Study|Lost to Follow-up|0
2874211|NCT02033369|9889213|P1|Overall Study|Lost to Follow-up|1
2874212|NCT02033369|9889212|P2|Overall Study|Withdrawal by Subject|1
2874213|NCT02033369|9889213|P1|Overall Study|Withdrawal by Subject|1
2874214|NCT02033369|9889212|P2|Overall Study|Not a good demographic match|2
2874215|NCT02033369|9889213|P1|Overall Study|Not a good demographic match|0
2874216|NCT02033369|9889212|P2|Overall Study|Physician Decision|2
2874217|NCT02033369|9889213|P1|Overall Study|Physician Decision|1
2874218|NCT02032901|9889307|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
2874219|NCT02032901|9889308|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
2874220|NCT02032901|9889307|P2|Treatment Period (12 Weeks)|Pregnancy|0
2874221|NCT02032901|9889308|P1|Treatment Period (12 Weeks)|Pregnancy|1
2874222|NCT02032888|9889332|P3|Follow-up Period|Other|0
2874223|NCT02032888|9889333|P2|Follow-up Period|Other|0
2874224|NCT02032888|9889334|P1|Follow-up Period|Other|1
2874225|NCT02032888|9889332|P3|Follow-up Period|Death|0
2874226|NCT02032888|9889333|P2|Follow-up Period|Death|1
2874227|NCT02032888|9889334|P1|Follow-up Period|Death|1
2874228|NCT02032888|9889332|P3|Follow-up Period|Lost to Follow-up|0
2874229|NCT02032888|9889333|P2|Follow-up Period|Lost to Follow-up|1
2874230|NCT02032888|9889334|P1|Follow-up Period|Lost to Follow-up|1
2874231|NCT02032888|9889332|P3|Treatment Period|Other|0
2874232|NCT02032888|9889333|P2|Treatment Period|Other|1
2874233|NCT02032888|9889334|P1|Treatment Period|Other|1
2874234|NCT02032888|9889332|P3|Treatment Period|Poor compliance/noncompliance|0
2874235|NCT02032888|9889333|P2|Treatment Period|Poor compliance/noncompliance|1
2874236|NCT02032888|9889334|P1|Treatment Period|Poor compliance/noncompliance|1
2874237|NCT02032875|9889365|P2|Follow-up Period|Virologic Relapse|10
2874238|NCT02032875|9889366|P1|Follow-up Period|Virologic Relapse|3
2874239|NCT02032875|9889365|P2|Follow-up Period|Death|1
2874240|NCT02032875|9889366|P1|Follow-up Period|Death|0
2874241|NCT02032875|9889365|P2|Treatment Period|Liver transplant, Treatment extension|3
2874242|NCT02032875|9889366|P1|Treatment Period|Liver transplant, Treatment extension|0
2874243|NCT02032875|9889365|P2|Treatment Period|Liver transplant, No extension needed|1
2874244|NCT02032875|9889366|P1|Treatment Period|Liver transplant, No extension needed|0
2874245|NCT02032875|9889365|P2|Treatment Period|Adverse Event|0
2874246|NCT02032875|9889366|P1|Treatment Period|Adverse Event|1
2874247|NCT02032706|9889409|P1|Overall Study|Protocol Violation|1
2874248|NCT02032706|9889409|P1|Overall Study|Did not qualify|5
2874249|NCT02032407|9889466|P1|Overall Study|Other Miscellaneous Reasons|2
2874250|NCT02032407|9889466|P1|Overall Study|Pregnancy|1
2874251|NCT02032407|9889466|P1|Overall Study|Lost to Follow-up|2
2874252|NCT02032238|9889479|P2|Overall Study|Lost to Follow-up|0
2874253|NCT02032238|9889480|P1|Overall Study|Lost to Follow-up|2
2874254|NCT02031679|9889521|P2|Overall Study|Lack of Efficacy|1
2874255|NCT02031679|9889522|P1|Overall Study|Lack of Efficacy|0
2874256|NCT02031679|9889521|P2|Overall Study|Protocol Violation|1
2874257|NCT02031679|9889522|P1|Overall Study|Protocol Violation|0
2874258|NCT02031640|9889537|P6|Double-blind Treatment Period|Lost to Follow-up|0
2874259|NCT02031640|9889538|P5|Double-blind Treatment Period|Lost to Follow-up|1
2874260|NCT02031640|9889539|P4|Double-blind Treatment Period|Lost to Follow-up|0
2874261|NCT02031640|9889540|P3|Double-blind Treatment Period|Lost to Follow-up|0
2874262|NCT02031640|9889541|P2|Double-blind Treatment Period|Lost to Follow-up|3
2874263|NCT02031640|9889542|P1|Double-blind Treatment Period|Lost to Follow-up|0
2874264|NCT02031640|9889537|P6|Double-blind Treatment Period|Withdrawal by Subject|1
2874265|NCT02031640|9889538|P5|Double-blind Treatment Period|Withdrawal by Subject|1
2874266|NCT02031640|9889539|P4|Double-blind Treatment Period|Withdrawal by Subject|1
2874267|NCT02031640|9889540|P3|Double-blind Treatment Period|Withdrawal by Subject|3
2874268|NCT02031640|9889541|P2|Double-blind Treatment Period|Withdrawal by Subject|2
2874269|NCT02031640|9889542|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2874270|NCT02031640|9889537|P6|Double-blind Treatment Period|Adverse Event|0
2874271|NCT02031640|9889538|P5|Double-blind Treatment Period|Adverse Event|0
2874272|NCT02031640|9889539|P4|Double-blind Treatment Period|Adverse Event|2
2874273|NCT02031640|9889540|P3|Double-blind Treatment Period|Adverse Event|0
2874274|NCT02031640|9889541|P2|Double-blind Treatment Period|Adverse Event|0
2874275|NCT02031640|9889542|P1|Double-blind Treatment Period|Adverse Event|0
2874276|NCT02031640|9889537|P6|Double-blind Treatment Period|Non-compliance|0
2874277|NCT02031640|9889538|P5|Double-blind Treatment Period|Non-compliance|1
2874278|NCT02031640|9889539|P4|Double-blind Treatment Period|Non-compliance|1
2874279|NCT02031640|9889540|P3|Double-blind Treatment Period|Non-compliance|0
2874280|NCT02031640|9889541|P2|Double-blind Treatment Period|Non-compliance|1
2874281|NCT02031640|9889542|P1|Double-blind Treatment Period|Non-compliance|0
2874282|NCT02031640|9889537|P6|Double-blind Treatment Period|Lack of Efficacy|1
2874283|NCT02031640|9889538|P5|Double-blind Treatment Period|Lack of Efficacy|5
2874284|NCT02031640|9889539|P4|Double-blind Treatment Period|Lack of Efficacy|2
2874285|NCT02031640|9889540|P3|Double-blind Treatment Period|Lack of Efficacy|3
2874286|NCT02031640|9889541|P2|Double-blind Treatment Period|Lack of Efficacy|14
2874287|NCT02031640|9889542|P1|Double-blind Treatment Period|Lack of Efficacy|0
2874288|NCT02031640|9889537|P6|Double-blind Treatment Period|Protocol deviation|1
2874289|NCT02031640|9889538|P5|Double-blind Treatment Period|Protocol deviation|3
2874290|NCT02031640|9889539|P4|Double-blind Treatment Period|Protocol deviation|1
2874291|NCT02031640|9889540|P3|Double-blind Treatment Period|Protocol deviation|0
2874292|NCT02031640|9889541|P2|Double-blind Treatment Period|Protocol deviation|2
2874293|NCT02031640|9889542|P1|Double-blind Treatment Period|Protocol deviation|0
2874294|NCT02031640|9889537|P6|Run-In Period|Various administrative reasons|0
2874295|NCT02031640|9889538|P5|Run-In Period|Various administrative reasons|0
2874296|NCT02031640|9889539|P4|Run-In Period|Various administrative reasons|0
2874297|NCT02031640|9889540|P3|Run-In Period|Various administrative reasons|0
2874298|NCT02031640|9889541|P2|Run-In Period|Various administrative reasons|0
2874299|NCT02031640|9889542|P1|Run-In Period|Various administrative reasons|17
2874300|NCT02031640|9889537|P6|Run-In Period|Randomization criteria not met|0
2874301|NCT02031640|9889538|P5|Run-In Period|Randomization criteria not met|0
2874302|NCT02031640|9889539|P4|Run-In Period|Randomization criteria not met|0
2874303|NCT02031640|9889540|P3|Run-In Period|Randomization criteria not met|0
2874304|NCT02031640|9889541|P2|Run-In Period|Randomization criteria not met|0
2874305|NCT02031640|9889542|P1|Run-In Period|Randomization criteria not met|85
2874306|NCT02031640|9889537|P6|Run-In Period|Exclusion criteria met|0
2874307|NCT02031640|9889538|P5|Run-In Period|Exclusion criteria met|0
2874308|NCT02031640|9889539|P4|Run-In Period|Exclusion criteria met|0
2874309|NCT02031640|9889540|P3|Run-In Period|Exclusion criteria met|0
2874310|NCT02031640|9889541|P2|Run-In Period|Exclusion criteria met|0
2874311|NCT02031640|9889542|P1|Run-In Period|Exclusion criteria met|8
2874312|NCT02031640|9889537|P6|Run-In Period|Inclusion criteria not met|0
2874313|NCT02031640|9889538|P5|Run-In Period|Inclusion criteria not met|0
2874314|NCT02031640|9889539|P4|Run-In Period|Inclusion criteria not met|0
2874315|NCT02031640|9889540|P3|Run-In Period|Inclusion criteria not met|0
2874316|NCT02031640|9889541|P2|Run-In Period|Inclusion criteria not met|0
2874317|NCT02031640|9889542|P1|Run-In Period|Inclusion criteria not met|38
2874318|NCT02031640|9889537|P6|Run-In Period|Withdrawal by Subject|0
2874319|NCT02031640|9889538|P5|Run-In Period|Withdrawal by Subject|0
2874320|NCT02031640|9889539|P4|Run-In Period|Withdrawal by Subject|0
2874321|NCT02031640|9889540|P3|Run-In Period|Withdrawal by Subject|0
2874322|NCT02031640|9889541|P2|Run-In Period|Withdrawal by Subject|0
2874323|NCT02031640|9889542|P1|Run-In Period|Withdrawal by Subject|17
2874324|NCT02031640|9889537|P6|Run-In Period|Adverse Event|0
2874325|NCT02031640|9889538|P5|Run-In Period|Adverse Event|0
2874326|NCT02031640|9889539|P4|Run-In Period|Adverse Event|0
2874327|NCT02031640|9889540|P3|Run-In Period|Adverse Event|0
2874328|NCT02031640|9889541|P2|Run-In Period|Adverse Event|0
2874329|NCT02031640|9889542|P1|Run-In Period|Adverse Event|4
2874330|NCT02031640|9889537|P6|Screening Period|Enrollment closed|0
2874331|NCT02031640|9889538|P5|Screening Period|Enrollment closed|0
2874332|NCT02031640|9889539|P4|Screening Period|Enrollment closed|0
2874333|NCT02031640|9889540|P3|Screening Period|Enrollment closed|0
2874334|NCT02031640|9889541|P2|Screening Period|Enrollment closed|0
2874335|NCT02031640|9889542|P1|Screening Period|Enrollment closed|26
2874336|NCT02031640|9889537|P6|Screening Period|Lost to Follow-up|0
2874337|NCT02031640|9889538|P5|Screening Period|Lost to Follow-up|0
2874338|NCT02031640|9889539|P4|Screening Period|Lost to Follow-up|0
2874339|NCT02031640|9889540|P3|Screening Period|Lost to Follow-up|0
2874340|NCT02031640|9889541|P2|Screening Period|Lost to Follow-up|0
2874341|NCT02031640|9889542|P1|Screening Period|Lost to Follow-up|14
2874342|NCT02031640|9889537|P6|Screening Period|Exclusion criteria met|0
2874343|NCT02031640|9889538|P5|Screening Period|Exclusion criteria met|0
2874344|NCT02031640|9889539|P4|Screening Period|Exclusion criteria met|0
2874345|NCT02031640|9889540|P3|Screening Period|Exclusion criteria met|0
2874346|NCT02031640|9889541|P2|Screening Period|Exclusion criteria met|0
2874347|NCT02031640|9889542|P1|Screening Period|Exclusion criteria met|30
2874348|NCT02031640|9889537|P6|Screening Period|Inclusion criteria not met|0
2874349|NCT02031640|9889538|P5|Screening Period|Inclusion criteria not met|0
2874350|NCT02031640|9889539|P4|Screening Period|Inclusion criteria not met|0
2874351|NCT02031640|9889540|P3|Screening Period|Inclusion criteria not met|0
2874352|NCT02031640|9889541|P2|Screening Period|Inclusion criteria not met|0
2874353|NCT02031640|9889542|P1|Screening Period|Inclusion criteria not met|312
2874354|NCT02031640|9889537|P6|Screening Period|Withdrawal by Subject|0
2874355|NCT02031640|9889538|P5|Screening Period|Withdrawal by Subject|0
2874356|NCT02031640|9889539|P4|Screening Period|Withdrawal by Subject|0
2874357|NCT02031640|9889540|P3|Screening Period|Withdrawal by Subject|0
2874358|NCT02031640|9889541|P2|Screening Period|Withdrawal by Subject|0
2874359|NCT02031640|9889542|P1|Screening Period|Withdrawal by Subject|29
2874360|NCT02031640|9889537|P6|Screening Period|Adverse Event|0
2874361|NCT02031640|9889538|P5|Screening Period|Adverse Event|0
2874362|NCT02031640|9889539|P4|Screening Period|Adverse Event|0
2874363|NCT02031640|9889540|P3|Screening Period|Adverse Event|0
2874364|NCT02031640|9889541|P2|Screening Period|Adverse Event|0
2874365|NCT02031640|9889542|P1|Screening Period|Adverse Event|1
2874366|NCT02031471|9889585|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
2874367|NCT02031471|9889585|P1|Long Term Extension (LTE) Period|Adverse Event|1
2874368|NCT02031471|9889585|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
2874369|NCT02031471|9889585|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
2874370|NCT02031471|9889585|P1|24 Week Treatment Period|Protocol Violation|1
2874371|NCT02031471|9889585|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
2874372|NCT02031471|9889585|P1|24 Week Treatment Period|Adverse Event|6
2874373|NCT02031458|9889618|P3|Baseline to May 8, 2015|Lost to Follow-up|2
2874374|NCT02031458|9889619|P2|Baseline to May 8, 2015|Lost to Follow-up|1
2874375|NCT02031458|9889620|P1|Baseline to May 8, 2015|Lost to Follow-up|1
2874376|NCT02031458|9889618|P3|Baseline to May 8, 2015|On Treatment|73
2874377|NCT02031458|9889619|P2|Baseline to May 8, 2015|On Treatment|81
2874378|NCT02031458|9889620|P1|Baseline to May 8, 2015|On Treatment|43
2874379|NCT02031458|9889618|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
2874380|NCT02031458|9889619|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
2874381|NCT02031458|9889620|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
2874382|NCT02031458|9889618|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
2874383|NCT02031458|9889619|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
2874384|NCT02031458|9889620|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
2874385|NCT02031458|9889618|P3|Baseline to May 8, 2015|Unknown Reason|2
2874386|NCT02031458|9889619|P2|Baseline to May 8, 2015|Unknown Reason|1
2874387|NCT02031458|9889620|P1|Baseline to May 8, 2015|Unknown Reason|0
2874388|NCT02031458|9889618|P3|Baseline to May 8, 2015|Physician Decision|0
2874389|NCT02031458|9889619|P2|Baseline to May 8, 2015|Physician Decision|1
2874390|NCT02031458|9889620|P1|Baseline to May 8, 2015|Physician Decision|0
2874391|NCT02031458|9889618|P3|Baseline to May 8, 2015|Protocol Violation|0
2874392|NCT02031458|9889619|P2|Baseline to May 8, 2015|Protocol Violation|4
2874393|NCT02031458|9889620|P1|Baseline to May 8, 2015|Protocol Violation|7
2874394|NCT02031458|9889618|P3|Baseline to May 8, 2015|Death|100
2874395|NCT02031458|9889619|P2|Baseline to May 8, 2015|Death|87
2874396|NCT02031458|9889620|P1|Baseline to May 8, 2015|Death|36
2874397|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
2874398|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
2874399|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
2874400|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
2874401|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
2874402|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
2874403|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
2874404|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
2874405|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
2874406|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
2874407|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
2874408|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
2874409|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2874410|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2874411|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
2874412|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
2874413|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
2874414|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
2874415|NCT02031458|9889618|P3|May 8, 2015 to January 11, 2019|Death|198
2874416|NCT02031458|9889619|P2|May 8, 2015 to January 11, 2019|Death|193
2874417|NCT02031458|9889620|P1|May 8, 2015 to January 11, 2019|Death|89
2874418|NCT02031432|9889714|P1|Overall Study|Death|10
2874419|NCT02031432|9889714|P1|Overall Study|Inclusion/Exclusion criteria not met|5
2874420|NCT02031432|9889714|P1|Overall Study|Lost to Follow-up|1
2874421|NCT02031432|9889714|P1|Overall Study|Withdrawal by Subject|5
2874422|NCT02031432|9889714|P1|Overall Study|Adverse Event|8
2874423|NCT02031432|9889714|P1|Overall Study|Withdrawn as forbidden meds required|1
2874424|NCT02031432|9889714|P1|Overall Study|Cancer Progression|2
2874425|NCT02031432|9889714|P1|Overall Study|Lack of Efficacy|5
2874426|NCT02031432|9889714|P1|Overall Study|Protocol Violation|1
2874427|NCT02031302|9889741|P2|Overall Study|Lost to Follow-up|0
2874428|NCT02031302|9889742|P1|Overall Study|Lost to Follow-up|4
2874429|NCT02031302|9889741|P2|Overall Study|Missed Follow Up|0
2874430|NCT02031302|9889742|P1|Overall Study|Missed Follow Up|27
2874431|NCT02031302|9889741|P2|Overall Study|Not treated with study valve system|0
2874432|NCT02031302|9889742|P1|Overall Study|Not treated with study valve system|18
2874433|NCT02031302|9889741|P2|Overall Study|Death|0
2874434|NCT02031302|9889742|P1|Overall Study|Death|115
2874435|NCT02031276|9889763|P3|Period 3 Open-label Risankizumab SC|Other|1
2874436|NCT02031276|9889764|P2|Period 3 Open-label Risankizumab SC|Other|0
2874437|NCT02031276|9889765|P1|Period 3 Open-label Risankizumab SC|Other|0
2874438|NCT02031276|9889763|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2874439|NCT02031276|9889764|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2874440|NCT02031276|9889765|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2874441|NCT02031276|9889763|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2874442|NCT02031276|9889764|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2874443|NCT02031276|9889765|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
2874444|NCT02031276|9889763|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
2874445|NCT02031276|9889764|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
2874446|NCT02031276|9889765|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
2874447|NCT02031276|9889763|P3|Period 2 Open-label Risankizumab IV|Other|1
2874448|NCT02031276|9889764|P2|Period 2 Open-label Risankizumab IV|Other|2
2874449|NCT02031276|9889765|P1|Period 2 Open-label Risankizumab IV|Other|0
2874450|NCT02031276|9889763|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2874451|NCT02031276|9889764|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2874452|NCT02031276|9889765|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
2874453|NCT02031276|9889763|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
2874454|NCT02031276|9889764|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
2874455|NCT02031276|9889765|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
2874456|NCT02031276|9889763|P3|Period 1 Double-blind IV|Other|0
2874457|NCT02031276|9889764|P2|Period 1 Double-blind IV|Other|1
2874458|NCT02031276|9889765|P1|Period 1 Double-blind IV|Other|0
2874459|NCT02031276|9889763|P3|Period 1 Double-blind IV|Adverse Event|1
2874460|NCT02031276|9889764|P2|Period 1 Double-blind IV|Adverse Event|5
2874461|NCT02031276|9889765|P1|Period 1 Double-blind IV|Adverse Event|6
2874462|NCT02031237|9889799|P3|Overall Study|Alternate Treatment Given|3
2874463|NCT02031237|9889800|P2|Overall Study|Alternate Treatment Given|0
2874464|NCT02031237|9889801|P1|Overall Study|Alternate Treatment Given|0
2874465|NCT02031237|9889799|P3|Overall Study|Protocol Violation|0
2874466|NCT02031237|9889800|P2|Overall Study|Protocol Violation|6
2874467|NCT02031237|9889801|P1|Overall Study|Protocol Violation|2
2874468|NCT02031237|9889799|P3|Overall Study|Withdrawal by Subject|0
2874469|NCT02031237|9889800|P2|Overall Study|Withdrawal by Subject|2
2874470|NCT02031237|9889801|P1|Overall Study|Withdrawal by Subject|2
2874471|NCT02031237|9889799|P3|Overall Study|Physician Decision|0
2874472|NCT02031237|9889800|P2|Overall Study|Physician Decision|1
2874473|NCT02031237|9889801|P1|Overall Study|Physician Decision|0
2874474|NCT02031237|9889799|P3|Overall Study|Death|0
2874475|NCT02031237|9889800|P2|Overall Study|Death|5
2874476|NCT02031237|9889801|P1|Overall Study|Death|1
2874477|NCT02030847|9889808|P1|Overall Study|Withdrawal by Subject|1
2874478|NCT02030847|9889808|P1|Overall Study|Physician Decision|3
2874479|NCT02030847|9889808|P1|Overall Study|New Cancer Therapy|8
2874480|NCT02030847|9889808|P1|Overall Study|Disease Progression|15
2874481|NCT02030847|9889808|P1|Overall Study|Death|10
2874482|NCT02030821|9889817|P4|Overall Study|Physician Decision|2
2874483|NCT02030821|9889818|P3|Overall Study|Physician Decision|5
2874484|NCT02030821|9889819|P2|Overall Study|Physician Decision|2
2874485|NCT02030821|9889820|P1|Overall Study|Physician Decision|2
2874486|NCT02030600|9889848|P2|Treatment Period 2|Unclassified|0
2874487|NCT02030600|9889849|P1|Treatment Period 2|Unclassified|1
2874488|NCT02030600|9889848|P2|Treatment Period 2|Withdrawal by Subject|9
2874489|NCT02030600|9889849|P1|Treatment Period 2|Withdrawal by Subject|13
2874490|NCT02030600|9889848|P2|Treatment Period 2|Protocol Violation|2
2874491|NCT02030600|9889849|P1|Treatment Period 2|Protocol Violation|1
2874492|NCT02030600|9889848|P2|Treatment Period 2|Lost to Follow-up|2
2874493|NCT02030600|9889849|P1|Treatment Period 2|Lost to Follow-up|4
2874494|NCT02030600|9889848|P2|Treatment Period 2|Lack of Efficacy|1
2874495|NCT02030600|9889849|P1|Treatment Period 2|Lack of Efficacy|2
2874496|NCT02030600|9889848|P2|Treatment Period 2|Adverse Event|4
2874497|NCT02030600|9889849|P1|Treatment Period 2|Adverse Event|4
2874498|NCT02030600|9889848|P2|Treatment Period 1|Unclassified|0
2874499|NCT02030600|9889849|P1|Treatment Period 1|Unclassified|1
2874500|NCT02030600|9889848|P2|Treatment Period 1|Casebook Unsigned|0
2874501|NCT02030600|9889849|P1|Treatment Period 1|Casebook Unsigned|1
2874502|NCT02030600|9889848|P2|Treatment Period 1|Withdrawal by Subject|17
2874503|NCT02030600|9889849|P1|Treatment Period 1|Withdrawal by Subject|13
2874504|NCT02030600|9889848|P2|Treatment Period 1|Protocol Violation|17
2874505|NCT02030600|9889849|P1|Treatment Period 1|Protocol Violation|22
2874506|NCT02030600|9889848|P2|Treatment Period 1|Lost to Follow-up|3
2874507|NCT02030600|9889849|P1|Treatment Period 1|Lost to Follow-up|11
2874508|NCT02030600|9889848|P2|Treatment Period 1|Lack of Efficacy|1
2874509|NCT02030600|9889849|P1|Treatment Period 1|Lack of Efficacy|0
2874510|NCT02030600|9889848|P2|Treatment Period 1|Adverse Event|7
2874511|NCT02030600|9889849|P1|Treatment Period 1|Adverse Event|5
2874512|NCT02030535|9889870|P1|Washout Period 1 (21 Days)|Adverse Event|1
2874513|NCT02030405|9889938|P1|Overall Study|Lost to Follow-up|1
2874514|NCT02030405|9889938|P1|Overall Study|Withdrawal by Subject|1
2874515|NCT02030119|9889949|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
2874516|NCT02030119|9889950|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
2874517|NCT02030119|9889951|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
2874518|NCT02030119|9889952|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
2874519|NCT02030119|9889949|P4|Overall Study|Withdrawal by Subject|3
2874520|NCT02030119|9889950|P3|Overall Study|Withdrawal by Subject|5
2874521|NCT02030119|9889951|P2|Overall Study|Withdrawal by Subject|1
2874522|NCT02030119|9889952|P1|Overall Study|Withdrawal by Subject|3
2874523|NCT02030041|9889990|P3|Overall Study|Withdrawal by Subject|1
2874524|NCT02030041|9889991|P2|Overall Study|Withdrawal by Subject|2
2874525|NCT02030041|9889992|P1|Overall Study|Withdrawal by Subject|2
2874526|NCT02029989|9890005|P2|Overall Study|Protocol Violation|0
2874527|NCT02029989|9890006|P1|Overall Study|Protocol Violation|1
2874528|NCT02029989|9890005|P2|Overall Study|Death|1
2874529|NCT02029989|9890006|P1|Overall Study|Death|0
2874530|NCT02029989|9890005|P2|Overall Study|Lost to Follow-up|7
2874531|NCT02029989|9890006|P1|Overall Study|Lost to Follow-up|9
2874532|NCT02029989|9890005|P2|Overall Study|Physician Decision|0
2874533|NCT02029989|9890006|P1|Overall Study|Physician Decision|2
2874534|NCT02029989|9890005|P2|Overall Study|Change of location|3
2874535|NCT02029989|9890006|P1|Overall Study|Change of location|2
2874536|NCT02029989|9890005|P2|Overall Study|Withdrawal: Fear of needles|0
2874537|NCT02029989|9890006|P1|Overall Study|Withdrawal: Fear of needles|1
2874538|NCT02029989|9890005|P2|Overall Study|Withdrawal by Subject|0
2874539|NCT02029989|9890006|P1|Overall Study|Withdrawal by Subject|1
2874540|NCT02029846|9890029|P2|Overall Study|n=1 each arm|1
2874541|NCT02029846|9890030|P1|Overall Study|n=1 each arm|1
2874542|NCT02029638|9890068|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
2874543|NCT02029638|9890069|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
2874544|NCT02029638|9890070|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
2874545|NCT02029638|9890068|P3|Overall Study|Death|1
2874546|NCT02029638|9890069|P2|Overall Study|Death|0
2874547|NCT02029638|9890070|P1|Overall Study|Death|0
2874548|NCT02029521|9890099|P2|Overall Study|Withdrawal by Subject|1
2874549|NCT02029521|9890100|P1|Overall Study|Withdrawal by Subject|1
2874550|NCT02029521|9890099|P2|Overall Study|Protocol Violation|0
2874551|NCT02029521|9890100|P1|Overall Study|Protocol Violation|1
2874552|NCT02029417|9890198|P1|Overall Study|Adverse Event|1
2874553|NCT02029417|9890198|P1|Overall Study|Death|1
2874554|NCT02029274|9890207|P4|Overall Study|Adverse Event|2
2874555|NCT02029274|9890208|P3|Overall Study|Adverse Event|2
2874556|NCT02029274|9890209|P2|Overall Study|Adverse Event|0
2874557|NCT02029274|9890210|P1|Overall Study|Adverse Event|1
2874558|NCT02029235|9890242|P2|Overall Study|Non-compliance with study meds or diary|1
2874559|NCT02029235|9890243|P1|Overall Study|Non-compliance with study meds or diary|4
2874560|NCT02028871|9890275|P2|Overall Study|Current Illness|0
2874561|NCT02028871|9890276|P1|Overall Study|Current Illness|1
2874562|NCT02028871|9890275|P2|Overall Study|IV placement difficulty|0
2874563|NCT02028871|9890276|P1|Overall Study|IV placement difficulty|1
2874564|NCT02028871|9890275|P2|Overall Study|Withdrawal by Subject|2
2874565|NCT02028871|9890276|P1|Overall Study|Withdrawal by Subject|1
2874566|NCT02028871|9890275|P2|Overall Study|Positive urine drug screen|1
2874567|NCT02028871|9890276|P1|Overall Study|Positive urine drug screen|1
2874568|NCT02028767|9890373|P2|Treatment Period 2|Reason other than those specified above|0
2874569|NCT02028767|9890374|P1|Treatment Period 2|Reason other than those specified above|1
2874570|NCT02028767|9890373|P2|Treatment Period 2|Non compliant with protocol|0
2874571|NCT02028767|9890374|P1|Treatment Period 2|Non compliant with protocol|1
2874572|NCT02028715|9890407|P2|Overall Study|Did not complete satisfaction surveys|2
2874573|NCT02028715|9890408|P1|Overall Study|Did not complete satisfaction surveys|2
2874574|NCT02028715|9890407|P2|Overall Study|Physician Decision|0
2874575|NCT02028715|9890408|P1|Overall Study|Physician Decision|1
2874576|NCT02028715|9890407|P2|Overall Study|Adverse Event|2
2874577|NCT02028715|9890408|P1|Overall Study|Adverse Event|2
2874578|NCT02028169|9890620|P1|Overall Study|Concomitant Medication Usage|1
2874579|NCT02028169|9890620|P1|Overall Study|Cessation of Drug|1
2874580|NCT02028169|9890620|P1|Overall Study|Adverse Event|1
2874581|NCT02028169|9890620|P1|Overall Study|Withdrawal by Subject|2
2874582|NCT02028169|9890620|P1|Overall Study|Lack of Efficacy|2
2874583|NCT02028169|9890620|P1|Overall Study|Lost to Follow-up|21
2874584|NCT02028065|9890646|P3|Treatment Through Study Completion|Adverse Event|5
2874585|NCT02028065|9890647|P2|Treatment Through Study Completion|Adverse Event|3
2874586|NCT02028065|9890648|P1|Treatment Through Study Completion|Adverse Event|3
2874587|NCT02028065|9890646|P3|Treatment Through Study Completion|Withdrawal by Subject|3
2874588|NCT02028065|9890647|P2|Treatment Through Study Completion|Withdrawal by Subject|4
2874589|NCT02028065|9890648|P1|Treatment Through Study Completion|Withdrawal by Subject|5
2874590|NCT02028065|9890646|P3|Treatment Through Study Completion|Protocol Violation|0
2874591|NCT02028065|9890647|P2|Treatment Through Study Completion|Protocol Violation|4
2874592|NCT02028065|9890648|P1|Treatment Through Study Completion|Protocol Violation|1
2874593|NCT02028065|9890646|P3|Treatment Through Study Completion|Physician Decision|0
2874594|NCT02028065|9890647|P2|Treatment Through Study Completion|Physician Decision|0
2874595|NCT02028065|9890648|P1|Treatment Through Study Completion|Physician Decision|1
2874596|NCT02028065|9890646|P3|Treatment Through Study Completion|Lost to Follow-up|6
2874597|NCT02028065|9890647|P2|Treatment Through Study Completion|Lost to Follow-up|4
2874598|NCT02028065|9890648|P1|Treatment Through Study Completion|Lost to Follow-up|2
2874599|NCT02028065|9890646|P3|Randomization Through Start Treatment|Not treated|3
2874600|NCT02028065|9890647|P2|Randomization Through Start Treatment|Not treated|3
2874601|NCT02028065|9890648|P1|Randomization Through Start Treatment|Not treated|1
2874602|NCT02027844|9890675|P3|Overall Study|Incomlete data|0
2874603|NCT02027844|9890676|P2|Overall Study|Incomlete data|0
2874604|NCT02027844|9890677|P1|Overall Study|Incomlete data|2
2874605|NCT02027844|9890675|P3|Overall Study|Protocol Violation|0
2874606|NCT02027844|9890676|P2|Overall Study|Protocol Violation|2
2874607|NCT02027844|9890677|P1|Overall Study|Protocol Violation|0
2874608|NCT02027844|9890675|P3|Overall Study|Lost to Follow-up|1
2874609|NCT02027844|9890676|P2|Overall Study|Lost to Follow-up|2
2874610|NCT02027844|9890677|P1|Overall Study|Lost to Follow-up|0
2874611|NCT02027844|9890675|P3|Overall Study|Withdrawal by Subject|1
2874612|NCT02027844|9890676|P2|Overall Study|Withdrawal by Subject|2
2874613|NCT02027844|9890677|P1|Overall Study|Withdrawal by Subject|3
2874614|NCT02027701|9890694|P1|Overall Study|Withdrawal by Subject|3
2874615|NCT02027701|9890694|P1|Overall Study|Physician Decision|2
2874616|NCT02027701|9890694|P1|Overall Study|Lack of Efficacy|8
2874617|NCT02027701|9890694|P1|Overall Study|Adverse Event|3
2874618|NCT02027623|9890712|P2|Overall Study|Withdrawal by Subject|9
2874619|NCT02027623|9890713|P1|Overall Study|Withdrawal by Subject|6
2874620|NCT02027623|9890712|P2|Overall Study|Lost to Follow-up|3
2874621|NCT02027623|9890713|P1|Overall Study|Lost to Follow-up|3
2874622|NCT02027558|9890805|P2|Overall Study|Refused assessment|0
2874623|NCT02027558|9890806|P1|Overall Study|Refused assessment|3
2874624|NCT02027558|9890805|P2|Overall Study|Lost to Follow-up|1
2874625|NCT02027558|9890806|P1|Overall Study|Lost to Follow-up|4
2874626|NCT02027558|9890805|P2|Overall Study|Withdrawal by Subject|0
2874627|NCT02027558|9890806|P1|Overall Study|Withdrawal by Subject|2
2874628|NCT02027558|9890805|P2|Overall Study|Death|1
2874629|NCT02027558|9890806|P1|Overall Study|Death|0
2874630|NCT02027545|9890824|P2|Overall Study|Failed to attend study visit|0
2874631|NCT02027545|9890825|P1|Overall Study|Failed to attend study visit|2
2874632|NCT02027545|9890824|P2|Overall Study|Failed to sign HIPAA|2
2874633|NCT02027545|9890825|P1|Overall Study|Failed to sign HIPAA|0
2874634|NCT02027428|9890837|P3|Survival Follow-up|Lost to Follow-up|0
2874635|NCT02027428|9890838|P2|Survival Follow-up|Lost to Follow-up|1
2874636|NCT02027428|9890839|P1|Survival Follow-up|Lost to Follow-up|0
2874637|NCT02027428|9890837|P3|Survival Follow-up|Death|30
2874638|NCT02027428|9890838|P2|Survival Follow-up|Death|47
2874639|NCT02027428|9890839|P1|Survival Follow-up|Death|0
2874640|NCT02027428|9890837|P3|Maintenance|Other|3
2874641|NCT02027428|9890838|P2|Maintenance|Other|6
2874642|NCT02027428|9890839|P1|Maintenance|Other|0
2874643|NCT02027428|9890837|P3|Maintenance|Protocol Violation|1
2874644|NCT02027428|9890838|P2|Maintenance|Protocol Violation|0
2874645|NCT02027428|9890839|P1|Maintenance|Protocol Violation|0
2874646|NCT02027428|9890837|P3|Maintenance|Withdrawal by Subject|5
2874647|NCT02027428|9890838|P2|Maintenance|Withdrawal by Subject|6
2874648|NCT02027428|9890839|P1|Maintenance|Withdrawal by Subject|0
2874649|NCT02027428|9890837|P3|Maintenance|Symptomatic deterioration|1
2874650|NCT02027428|9890838|P2|Maintenance|Symptomatic deterioration|4
2874651|NCT02027428|9890839|P1|Maintenance|Symptomatic deterioration|0
2874652|NCT02027428|9890837|P3|Maintenance|Progressive disease|47
2874653|NCT02027428|9890838|P2|Maintenance|Progressive disease|84
2874654|NCT02027428|9890839|P1|Maintenance|Progressive disease|0
2874655|NCT02027428|9890837|P3|Maintenance|Adverse Event|1
2874656|NCT02027428|9890838|P2|Maintenance|Adverse Event|21
2874657|NCT02027428|9890839|P1|Maintenance|Adverse Event|0
2874658|NCT02027428|9890837|P3|Maintenance|Death|2
2874659|NCT02027428|9890838|P2|Maintenance|Death|3
2874660|NCT02027428|9890839|P1|Maintenance|Death|0
2874661|NCT02027428|9890837|P3|Induction|Induction treatment ongoing|0
2874662|NCT02027428|9890838|P2|Induction|Induction treatment ongoing|0
2874663|NCT02027428|9890839|P1|Induction|Induction treatment ongoing|4
2874664|NCT02027428|9890837|P3|Induction|Protocol Violation|0
2874665|NCT02027428|9890838|P2|Induction|Protocol Violation|0
2874666|NCT02027428|9890839|P1|Induction|Protocol Violation|1
2874667|NCT02027428|9890837|P3|Induction|Study terminated by sponsor|0
2874668|NCT02027428|9890838|P2|Induction|Study terminated by sponsor|0
2874669|NCT02027428|9890839|P1|Induction|Study terminated by sponsor|12
2874670|NCT02027428|9890837|P3|Induction|Other|0
2874671|NCT02027428|9890838|P2|Induction|Other|0
2874672|NCT02027428|9890839|P1|Induction|Other|14
2874673|NCT02027428|9890837|P3|Induction|Symptomatic deterioration|0
2874674|NCT02027428|9890838|P2|Induction|Symptomatic deterioration|0
2874675|NCT02027428|9890839|P1|Induction|Symptomatic deterioration|16
2874676|NCT02027428|9890837|P3|Induction|Death|0
2874677|NCT02027428|9890838|P2|Induction|Death|0
2874678|NCT02027428|9890839|P1|Induction|Death|21
2874679|NCT02027428|9890837|P3|Induction|Withdrawal by Subject|0
2874680|NCT02027428|9890838|P2|Induction|Withdrawal by Subject|0
2874681|NCT02027428|9890839|P1|Induction|Withdrawal by Subject|22
2874682|NCT02027428|9890837|P3|Induction|Adverse Event|0
2874683|NCT02027428|9890838|P2|Induction|Adverse Event|0
2874684|NCT02027428|9890839|P1|Induction|Adverse Event|51
2874685|NCT02027428|9890837|P3|Induction|Progressive disease|0
2874686|NCT02027428|9890838|P2|Induction|Progressive disease|0
2874687|NCT02027428|9890839|P1|Induction|Progressive disease|77
2874688|NCT02027428|9890837|P3|Induction|Never treated|0
2874689|NCT02027428|9890838|P2|Induction|Never treated|0
2874690|NCT02027428|9890839|P1|Induction|Never treated|7
2874691|NCT02027402|9890877|P2|Overall Study|Withdrawal by Subject|1
2874692|NCT02027402|9890878|P1|Overall Study|Withdrawal by Subject|4
2874693|NCT02027376|9890890|P3|Overall Study|Death|0
2874694|NCT02027376|9890891|P2|Overall Study|Death|0
2874695|NCT02027376|9890892|P1|Overall Study|Death|1
2874696|NCT02027311|9890918|P2|Overall Study|Protocol Violation|2
2874697|NCT02027311|9890919|P1|Overall Study|Protocol Violation|3
2874698|NCT02027025|9890939|P3|Overall Study|Sponsor's decision|0
2874699|NCT02027025|9890940|P2|Overall Study|Sponsor's decision|1
2874700|NCT02027025|9890941|P1|Overall Study|Sponsor's decision|0
2874701|NCT02027025|9890939|P3|Overall Study|Withdrawal by Subject|0
2874702|NCT02027025|9890940|P2|Overall Study|Withdrawal by Subject|1
2874703|NCT02027025|9890941|P1|Overall Study|Withdrawal by Subject|0
2874704|NCT02027025|9890939|P3|Overall Study|Lost to Follow-up|0
2874705|NCT02027025|9890940|P2|Overall Study|Lost to Follow-up|2
2874706|NCT02027025|9890941|P1|Overall Study|Lost to Follow-up|0
2874707|NCT02027025|9890939|P3|Overall Study|Protocol Violation|0
2874708|NCT02027025|9890940|P2|Overall Study|Protocol Violation|0
2874709|NCT02027025|9890941|P1|Overall Study|Protocol Violation|1
2874710|NCT02027025|9890939|P3|Overall Study|Adverse Event|1
2874711|NCT02027025|9890940|P2|Overall Study|Adverse Event|1
2874712|NCT02027025|9890941|P1|Overall Study|Adverse Event|0
2874713|NCT02026258|9890991|P2|Recieved Allocated Intervention|Lost to Follow-up|1
2874714|NCT02026258|9890992|P1|Recieved Allocated Intervention|Lost to Follow-up|0
2874715|NCT02026258|9890991|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
2874716|NCT02026258|9890992|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
2874717|NCT02026258|9890991|P2|Randomized|Presence of periodontal disease|1
2874718|NCT02026258|9890992|P1|Randomized|Presence of periodontal disease|1
2874719|NCT02026258|9890991|P2|Randomized|Change in treatment plan|0
2874720|NCT02026258|9890992|P1|Randomized|Change in treatment plan|1
2874721|NCT02026258|9890991|P2|Randomized|Did not start treatment|1
2874722|NCT02026258|9890992|P1|Randomized|Did not start treatment|2
2874723|NCT02026141|9891026|P2|Overall Study|Protocol Violation|1
2874724|NCT02026141|9891027|P1|Overall Study|Protocol Violation|0
2874725|NCT02026063|9891035|P2|Overall Study|Reason not Specified|7
2874726|NCT02026063|9891036|P1|Overall Study|Reason not Specified|2
2874727|NCT02026063|9891035|P2|Overall Study|Lost to Follow-up|1
2874728|NCT02026063|9891036|P1|Overall Study|Lost to Follow-up|0
2874729|NCT02026063|9891035|P2|Overall Study|Lack of Efficacy|4
2874730|NCT02026063|9891036|P1|Overall Study|Lack of Efficacy|0
2874731|NCT02026063|9891035|P2|Overall Study|Adverse Event|20
2874732|NCT02026063|9891036|P1|Overall Study|Adverse Event|5
2874733|NCT02026063|9891035|P2|Overall Study|Withdrawal of Consent|6
2874734|NCT02026063|9891036|P1|Overall Study|Withdrawal of Consent|1
2874735|NCT02026063|9891035|P2|Overall Study|Noncompliance with Study Drug|1
2874736|NCT02026063|9891036|P1|Overall Study|Noncompliance with Study Drug|1
2874737|NCT02026063|9891035|P2|Overall Study|Physician Decision|10
2874738|NCT02026063|9891036|P1|Overall Study|Physician Decision|0
2874739|NCT02026011|9891048|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
2874740|NCT02026011|9891049|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
2874741|NCT02026011|9891048|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
2874742|NCT02026011|9891049|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
2874743|NCT02026011|9891048|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
2874744|NCT02026011|9891049|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
2874745|NCT02026011|9891048|P2|Allocation 1 (First Set of Medication)|Side Effects|0
2874746|NCT02026011|9891049|P1|Allocation 1 (First Set of Medication)|Side Effects|6
2874747|NCT02025907|9891075|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
2874748|NCT02025907|9891076|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
2874749|NCT02025907|9891075|P2|Overall Study|Adverse Event|1
2874750|NCT02025907|9891076|P1|Overall Study|Adverse Event|3
2874751|NCT02025907|9891075|P2|Overall Study|Lost to Follow-up|2
2874752|NCT02025907|9891076|P1|Overall Study|Lost to Follow-up|2
2874753|NCT02025907|9891075|P2|Overall Study|Physician Decision|0
2874754|NCT02025907|9891076|P1|Overall Study|Physician Decision|2
2874755|NCT02025907|9891075|P2|Overall Study|Protocol Violation|0
2874756|NCT02025907|9891076|P1|Overall Study|Protocol Violation|2
2874757|NCT02025907|9891075|P2|Overall Study|Withdrawal by Subject|8
2874758|NCT02025907|9891076|P1|Overall Study|Withdrawal by Subject|15
2874759|NCT02025907|9891075|P2|Overall Study|Lack of Efficacy|0
2874760|NCT02025907|9891076|P1|Overall Study|Lack of Efficacy|1
2874761|NCT02025725|9891104|P2|Overall Study|Post-dose QTcB > 270 msec|1
2874762|NCT02025725|9891105|P1|Overall Study|Post-dose QTcB > 270 msec|0
2874763|NCT02025725|9891104|P2|Overall Study|Withdrawal by Subject|2
2874764|NCT02025725|9891105|P1|Overall Study|Withdrawal by Subject|3
2874765|NCT02025725|9891104|P2|Overall Study|Protocol Violation|1
2874766|NCT02025725|9891105|P1|Overall Study|Protocol Violation|1
2874767|NCT02025725|9891104|P2|Overall Study|Lost to Follow-up|0
2874768|NCT02025725|9891105|P1|Overall Study|Lost to Follow-up|2
2874769|NCT02025725|9891104|P2|Overall Study|Adverse Event|0
2874770|NCT02025725|9891105|P1|Overall Study|Adverse Event|5
2874771|NCT02025621|9891142|P2|Overall Study|Surgery initiated before infusion|3
2874772|NCT02025621|9891143|P1|Overall Study|Surgery initiated before infusion|3
2874773|NCT02025621|9891142|P2|Overall Study|No longer eligible|15
2874774|NCT02025621|9891143|P1|Overall Study|No longer eligible|10
2874775|NCT02025621|9891142|P2|Overall Study|Death|1
2874776|NCT02025621|9891143|P1|Overall Study|Death|0
2874777|NCT02025621|9891142|P2|Overall Study|Withdrawal by Subject|0
2874778|NCT02025621|9891143|P1|Overall Study|Withdrawal by Subject|1
2874779|NCT02025530|9891163|P2|Overall Study|No longer met elligibility criteria|1
2874780|NCT02025530|9891164|P1|Overall Study|No longer met elligibility criteria|5
2874781|NCT02025205|9891176|P2|Overall Study|Death|1
2874782|NCT02025205|9891177|P1|Overall Study|Death|0
2874783|NCT02025205|9891176|P2|Overall Study|Protocol Violation|1
2874784|NCT02025205|9891177|P1|Overall Study|Protocol Violation|2
2874785|NCT02025205|9891176|P2|Overall Study|Withdrawal by Subject|1
2874786|NCT02025205|9891177|P1|Overall Study|Withdrawal by Subject|1
2874787|NCT02025179|9891221|P3|Overall Study|Lost to Follow-up|1
2874788|NCT02025179|9891222|P2|Overall Study|Lost to Follow-up|0
2874789|NCT02025179|9891223|P1|Overall Study|Lost to Follow-up|0
2874790|NCT02024971|9891273|P1|Overall Study|Lost to Follow-up|6
2874791|NCT02024971|9891273|P1|Overall Study|Data Not Available|30
2874792|NCT02024932|9891286|P6|Overall Study|Abnormal laboratory value|0
2874793|NCT02024932|9891287|P5|Overall Study|Abnormal laboratory value|0
2874794|NCT02024932|9891288|P4|Overall Study|Abnormal laboratory value|2
2874795|NCT02024932|9891289|P3|Overall Study|Abnormal laboratory value|0
2874796|NCT02024932|9891290|P2|Overall Study|Abnormal laboratory value|0
2874797|NCT02024932|9891291|P1|Overall Study|Abnormal laboratory value|0
2874798|NCT02024932|9891286|P6|Overall Study|Adverse Event|0
2874799|NCT02024932|9891287|P5|Overall Study|Adverse Event|2
2874800|NCT02024932|9891288|P4|Overall Study|Adverse Event|0
2874801|NCT02024932|9891289|P3|Overall Study|Adverse Event|0
2874802|NCT02024932|9891290|P2|Overall Study|Adverse Event|3
2874803|NCT02024932|9891291|P1|Overall Study|Adverse Event|2
2874804|NCT02024867|9891350|P2|Overall Study|Lost to Follow-up|4
2874805|NCT02024867|9891351|P1|Overall Study|Lost to Follow-up|6
2874806|NCT02024867|9891350|P2|Overall Study|Protocol Violation|3
2874807|NCT02024867|9891351|P1|Overall Study|Protocol Violation|3
2874808|NCT02024750|9891369|P2|Overall Study|Withdrawal by Subject|1
2874809|NCT02024750|9891370|P1|Overall Study|Withdrawal by Subject|2
2874810|NCT02024698|9891391|P2|First Intervention (7 Days)|Withdrawal by Subject|1
2874811|NCT02024698|9891392|P1|First Intervention (7 Days)|Withdrawal by Subject|0
2874812|NCT02023879|9891502|P3|Extension Open Label Treatment|Other than specified above|2
2874813|NCT02023879|9891503|P2|Extension Open Label Treatment|Other than specified above|7
2874814|NCT02023879|9891504|P1|Extension Open Label Treatment|Other than specified above|2
2874815|NCT02023879|9891502|P3|Extension Open Label Treatment|Participant moved|0
2874816|NCT02023879|9891503|P2|Extension Open Label Treatment|Participant moved|2
2874817|NCT02023879|9891504|P1|Extension Open Label Treatment|Participant moved|1
2874818|NCT02023879|9891502|P3|Extension Open Label Treatment|Poor compliance to protocol|0
2874819|NCT02023879|9891503|P2|Extension Open Label Treatment|Poor compliance to protocol|1
2874820|NCT02023879|9891504|P1|Extension Open Label Treatment|Poor compliance to protocol|1
2874821|NCT02023879|9891502|P3|Extension Open Label Treatment|Adverse Event|3
2874822|NCT02023879|9891503|P2|Extension Open Label Treatment|Adverse Event|7
2874823|NCT02023879|9891504|P1|Extension Open Label Treatment|Adverse Event|1
2874824|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2874825|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
2874826|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2874827|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2874828|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2874829|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
2874830|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2874831|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
2874832|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2874833|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2874834|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
2874835|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2874836|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
2874837|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
2874838|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
2874839|NCT02023879|9891502|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
2874840|NCT02023879|9891503|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2874841|NCT02023879|9891504|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2874842|NCT02023866|9891593|P1|Overall Study|Withdrawal by Subject|1
2874843|NCT02023866|9891593|P1|Overall Study|Adverse Event|3
2874844|NCT02023866|9891593|P1|Overall Study|Non-compliance|2
2874845|NCT02023697|9891615|P3|Long-term Follow-up Period|Other unspecified|5
2874846|NCT02023697|9891616|P2|Long-term Follow-up Period|Other unspecified|3
2874847|NCT02023697|9891617|P1|Long-term Follow-up Period|Other unspecified|6
2874848|NCT02023697|9891615|P3|Long-term Follow-up Period|Technical problems|1
2874849|NCT02023697|9891616|P2|Long-term Follow-up Period|Technical problems|0
2874850|NCT02023697|9891617|P1|Long-term Follow-up Period|Technical problems|0
2874851|NCT02023697|9891615|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
2874852|NCT02023697|9891616|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
2874853|NCT02023697|9891617|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
2874854|NCT02023697|9891615|P3|Long-term Follow-up Period|Lost to Follow-up|1
2874855|NCT02023697|9891616|P2|Long-term Follow-up Period|Lost to Follow-up|0
2874856|NCT02023697|9891617|P1|Long-term Follow-up Period|Lost to Follow-up|1
2874857|NCT02023697|9891615|P3|Long-term Follow-up Period|Withdrawal by Subject|0
2874858|NCT02023697|9891616|P2|Long-term Follow-up Period|Withdrawal by Subject|3
2874859|NCT02023697|9891617|P1|Long-term Follow-up Period|Withdrawal by Subject|6
2874860|NCT02023697|9891615|P3|Long-term Follow-up Period|Death|4
2874861|NCT02023697|9891616|P2|Long-term Follow-up Period|Death|6
2874862|NCT02023697|9891617|P1|Long-term Follow-up Period|Death|9
2874863|NCT02023697|9891615|P3|Active Follow-up Period|Death|87
2874864|NCT02023697|9891616|P2|Active Follow-up Period|Death|82
2874865|NCT02023697|9891617|P1|Active Follow-up Period|Death|83
2874866|NCT02023697|9891615|P3|Active Follow-up Period|Radiological progression|1
2874867|NCT02023697|9891616|P2|Active Follow-up Period|Radiological progression|0
2874868|NCT02023697|9891617|P1|Active Follow-up Period|Radiological progression|0
2874869|NCT02023697|9891615|P3|Active Follow-up Period|Clinical progression|1
2874870|NCT02023697|9891616|P2|Active Follow-up Period|Clinical progression|2
2874871|NCT02023697|9891617|P1|Active Follow-up Period|Clinical progression|0
2874872|NCT02023697|9891615|P3|Active Follow-up Period|Other unspecified|1
2874873|NCT02023697|9891616|P2|Active Follow-up Period|Other unspecified|0
2874874|NCT02023697|9891617|P1|Active Follow-up Period|Other unspecified|2
2874875|NCT02023697|9891615|P3|Active Follow-up Period|Deterioration of general condition|1
2874876|NCT02023697|9891616|P2|Active Follow-up Period|Deterioration of general condition|1
2874877|NCT02023697|9891617|P1|Active Follow-up Period|Deterioration of general condition|1
2874878|NCT02023697|9891615|P3|Active Follow-up Period|Lost to Follow-up|1
2874879|NCT02023697|9891616|P2|Active Follow-up Period|Lost to Follow-up|1
2874880|NCT02023697|9891617|P1|Active Follow-up Period|Lost to Follow-up|1
2874881|NCT02023697|9891615|P3|Active Follow-up Period|Withdrawal by Subject|7
2874882|NCT02023697|9891616|P2|Active Follow-up Period|Withdrawal by Subject|13
2874883|NCT02023697|9891617|P1|Active Follow-up Period|Withdrawal by Subject|5
2874884|NCT02023697|9891615|P3|Treatment Period|Physician Decision|1
2874885|NCT02023697|9891616|P2|Treatment Period|Physician Decision|0
2874886|NCT02023697|9891617|P1|Treatment Period|Physician Decision|0
2874887|NCT02023697|9891615|P3|Treatment Period|Safety outcome reached|0
2874888|NCT02023697|9891616|P2|Treatment Period|Safety outcome reached|1
2874889|NCT02023697|9891617|P1|Treatment Period|Safety outcome reached|0
2874890|NCT02023697|9891615|P3|Treatment Period|Withdrawal by Subject|13
2874891|NCT02023697|9891616|P2|Treatment Period|Withdrawal by Subject|5
2874892|NCT02023697|9891617|P1|Treatment Period|Withdrawal by Subject|4
2874893|NCT02023697|9891615|P3|Treatment Period|Clinical progression|28
2874894|NCT02023697|9891616|P2|Treatment Period|Clinical progression|8
2874895|NCT02023697|9891617|P1|Treatment Period|Clinical progression|10
2874896|NCT02023697|9891615|P3|Treatment Period|Logistical difficulties|1
2874897|NCT02023697|9891616|P2|Treatment Period|Logistical difficulties|1
2874898|NCT02023697|9891617|P1|Treatment Period|Logistical difficulties|1
2874899|NCT02023697|9891615|P3|Treatment Period|Adverse Event|23
2874900|NCT02023697|9891616|P2|Treatment Period|Adverse Event|25
2874901|NCT02023697|9891617|P1|Treatment Period|Adverse Event|13
2874902|NCT02023697|9891615|P3|Treatment Period|Never Treated|10
2874903|NCT02023697|9891616|P2|Treatment Period|Never Treated|6
2874904|NCT02023697|9891617|P1|Treatment Period|Never Treated|5
2874905|NCT02023697|9891615|P3|Treatment Period|Radiological progression|26
2874906|NCT02023697|9891616|P2|Treatment Period|Radiological progression|17
2874907|NCT02023697|9891617|P1|Treatment Period|Radiological progression|13
2874908|NCT02023268|9891730|P2|Overall Study|Withdrawal by Subject|1
2874909|NCT02023268|9891731|P1|Overall Study|Withdrawal by Subject|0
2874910|NCT02023268|9891730|P2|Overall Study|Adverse Event|2
2874911|NCT02023268|9891731|P1|Overall Study|Adverse Event|0
2874912|NCT02023268|9891730|P2|Overall Study|Lack of Efficacy|1
2874913|NCT02023268|9891731|P1|Overall Study|Lack of Efficacy|0
2874914|NCT02023242|9891739|P2|Overall Study|Death|1
2874915|NCT02023242|9891740|P1|Overall Study|Death|0
2874916|NCT02023242|9891739|P2|Overall Study|Lost to Follow-up|1
2874917|NCT02023242|9891740|P1|Overall Study|Lost to Follow-up|3
2874918|NCT02023151|9891754|P1|Overall Study|Lost to Follow-up|4
2874919|NCT02023112|9891824|P2|Overall Study|Withdrawal by Subject|1
2874920|NCT02023112|9891825|P1|Overall Study|Withdrawal by Subject|2
2874921|NCT02023099|9891846|P3|Overall Study|Non-treatment-emergent Fatal AE|1
2874922|NCT02023099|9891847|P2|Overall Study|Non-treatment-emergent Fatal AE|0
2874923|NCT02023099|9891848|P1|Overall Study|Non-treatment-emergent Fatal AE|0
2874924|NCT02023099|9891846|P3|Overall Study|Withdrawn Consent|1
2874925|NCT02023099|9891847|P2|Overall Study|Withdrawn Consent|0
2874926|NCT02023099|9891848|P1|Overall Study|Withdrawn Consent|3
2874927|NCT02023099|9891846|P3|Overall Study|Non-fatal Adverse Event (AE)|1
2874928|NCT02023099|9891847|P2|Overall Study|Non-fatal Adverse Event (AE)|0
2874929|NCT02023099|9891848|P1|Overall Study|Non-fatal Adverse Event (AE)|0
2874930|NCT02022748|9891871|P3|Overall Study|Withdrawal by Subject|0
2874931|NCT02022748|9891872|P2|Overall Study|Withdrawal by Subject|1
2874932|NCT02022748|9891873|P1|Overall Study|Withdrawal by Subject|0
2874933|NCT02022748|9891871|P3|Overall Study|Adverse Event|0
2874934|NCT02022748|9891872|P2|Overall Study|Adverse Event|1
2874935|NCT02022748|9891873|P1|Overall Study|Adverse Event|1
2874936|NCT02022670|9891899|P3|Overall Study|Adverse Event|1
2874937|NCT02022670|9891900|P2|Overall Study|Adverse Event|0
2874938|NCT02022670|9891901|P1|Overall Study|Adverse Event|1
2874939|NCT02022657|9891915|P6|Overall Study|Physician Decision|1
2874940|NCT02022657|9891916|P5|Overall Study|Physician Decision|0
2874941|NCT02022657|9891917|P4|Overall Study|Physician Decision|0
2874942|NCT02022657|9891918|P3|Overall Study|Physician Decision|0
2874943|NCT02022657|9891919|P2|Overall Study|Physician Decision|0
2874944|NCT02022657|9891920|P1|Overall Study|Physician Decision|0
2874945|NCT02022657|9891915|P6|Overall Study|Withdrawal by Subject|0
2874946|NCT02022657|9891916|P5|Overall Study|Withdrawal by Subject|0
2874947|NCT02022657|9891917|P4|Overall Study|Withdrawal by Subject|0
2874948|NCT02022657|9891918|P3|Overall Study|Withdrawal by Subject|1
2874949|NCT02022657|9891919|P2|Overall Study|Withdrawal by Subject|0
2874950|NCT02022657|9891920|P1|Overall Study|Withdrawal by Subject|2
2874951|NCT02022007|9891970|P3|Overall Study|Noncompliant|1
2874952|NCT02022007|9891971|P2|Overall Study|Noncompliant|0
2874953|NCT02022007|9891972|P1|Overall Study|Noncompliant|0
2874954|NCT02022007|9891970|P3|Overall Study|Withdrawal by Subject|1
2874955|NCT02022007|9891971|P2|Overall Study|Withdrawal by Subject|1
2874956|NCT02022007|9891972|P1|Overall Study|Withdrawal by Subject|1
2874957|NCT02021656|9892055|P1|Overall Study|Withdrew Consent|2
2874958|NCT02021656|9892055|P1|Overall Study|Lost to Follow-up|1
2874959|NCT02021656|9892055|P1|Overall Study|Lack of Efficacy|2
2874960|NCT02021656|9892055|P1|Overall Study|Adverse Event|1
2874961|NCT02021643|9892075|P4|Overall Study|Withdrew Consent|0
2874962|NCT02021643|9892076|P3|Overall Study|Withdrew Consent|0
2874963|NCT02021643|9892077|P2|Overall Study|Withdrew Consent|1
2874964|NCT02021643|9892078|P1|Overall Study|Withdrew Consent|0
2874965|NCT02021643|9892075|P4|Overall Study|Lost to Follow-up|0
2874966|NCT02021643|9892076|P3|Overall Study|Lost to Follow-up|0
2874967|NCT02021643|9892077|P2|Overall Study|Lost to Follow-up|1
2874968|NCT02021643|9892078|P1|Overall Study|Lost to Follow-up|0
2874969|NCT02021643|9892075|P4|Overall Study|Lack of Efficacy|12
2874970|NCT02021643|9892076|P3|Overall Study|Lack of Efficacy|0
2874971|NCT02021643|9892077|P2|Overall Study|Lack of Efficacy|6
2874972|NCT02021643|9892078|P1|Overall Study|Lack of Efficacy|7
2874973|NCT02021643|9892075|P4|Overall Study|Investigator's Discretion|0
2874974|NCT02021643|9892076|P3|Overall Study|Investigator's Discretion|0
2874975|NCT02021643|9892077|P2|Overall Study|Investigator's Discretion|0
2874976|NCT02021643|9892078|P1|Overall Study|Investigator's Discretion|1
2874977|NCT02021643|9892075|P4|Overall Study|Death|0
2874978|NCT02021643|9892076|P3|Overall Study|Death|0
2874979|NCT02021643|9892077|P2|Overall Study|Death|1
2874980|NCT02021643|9892078|P1|Overall Study|Death|0
2874981|NCT02021643|9892075|P4|Overall Study|Adverse Event|0
2874982|NCT02021643|9892076|P3|Overall Study|Adverse Event|0
2874983|NCT02021643|9892077|P2|Overall Study|Adverse Event|1
2874984|NCT02021643|9892078|P1|Overall Study|Adverse Event|0
2874985|NCT02021643|9892075|P4|Overall Study|Enrolled but Never Treated|0
2874986|NCT02021643|9892076|P3|Overall Study|Enrolled but Never Treated|0
2874987|NCT02021643|9892077|P2|Overall Study|Enrolled but Never Treated|0
2874988|NCT02021643|9892078|P1|Overall Study|Enrolled but Never Treated|1
2874989|NCT02021565|9892120|P2|3-month Follow-up|Protocol Violation|2
2874990|NCT02021565|9892121|P1|3-month Follow-up|Protocol Violation|3
2874991|NCT02021565|9892120|P2|3-month Follow-up|Withdrawal by Subject|0
2874992|NCT02021565|9892121|P1|3-month Follow-up|Withdrawal by Subject|4
2874993|NCT02021565|9892120|P2|3-month Follow-up|Death|0
2874994|NCT02021565|9892121|P1|3-month Follow-up|Death|3
2874995|NCT02021565|9892120|P2|Baseline Through Intervention|Lost to Follow-up|2
2874996|NCT02021565|9892121|P1|Baseline Through Intervention|Lost to Follow-up|4
2874997|NCT02021565|9892120|P2|Baseline Through Intervention|Protocol Violation|7
2874998|NCT02021565|9892121|P1|Baseline Through Intervention|Protocol Violation|0
2874999|NCT02021565|9892120|P2|Baseline Through Intervention|Withdrawal by Subject|8
2875000|NCT02021565|9892121|P1|Baseline Through Intervention|Withdrawal by Subject|8
2875001|NCT02021565|9892120|P2|Baseline Through Intervention|Death|1
2875002|NCT02021565|9892121|P1|Baseline Through Intervention|Death|0
2875003|NCT02021331|9892141|P2|Overall Study|Adverse Event|2
2875004|NCT02021331|9892142|P1|Overall Study|Adverse Event|0
2875005|NCT02021292|9892154|P2|Overall Study|Death|1
2875006|NCT02021292|9892155|P1|Overall Study|Death|0
2875007|NCT02021292|9892154|P2|Overall Study|Lost to Follow-up|1
2875008|NCT02021292|9892155|P1|Overall Study|Lost to Follow-up|0
2875009|NCT02021292|9892154|P2|Overall Study|Physician Decision|1
2875010|NCT02021292|9892155|P1|Overall Study|Physician Decision|0
2875011|NCT02020941|9892181|P1|Overall Study|Disease Progression|4
2875012|NCT02020941|9892181|P1|Overall Study|Withdrawal by Subject|1
2875013|NCT02020941|9892181|P1|Overall Study|Physician Decision|2
2875014|NCT02020941|9892181|P1|Overall Study|Adverse Event|1
2875015|NCT02020889|9892192|P2|Overall Study|Withdrawal by Subject|2
2875016|NCT02020889|9892193|P1|Overall Study|Withdrawal by Subject|3
2875017|NCT02020889|9892192|P2|Overall Study|Physician Decision|0
2875018|NCT02020889|9892193|P1|Overall Study|Physician Decision|2
2875019|NCT02020889|9892192|P2|Overall Study|Lost to Follow-up|0
2875020|NCT02020889|9892193|P1|Overall Study|Lost to Follow-up|1
2875021|NCT02020889|9892192|P2|Overall Study|Lack of Efficacy|0
2875022|NCT02020889|9892193|P1|Overall Study|Lack of Efficacy|1
2875023|NCT02020889|9892192|P2|Overall Study|Adverse Event|1
2875024|NCT02020889|9892193|P1|Overall Study|Adverse Event|0
2875025|NCT02020863|9892247|P1|Overall Study|Team chose not to place an a line|1
2875026|NCT02020863|9892247|P1|Overall Study|Discovery of Metastatic disease|4
2875027|NCT02020616|9892277|P7|Overall Study|Lack of Efficacy|0
2875028|NCT02020616|9892278|P6|Overall Study|Lack of Efficacy|0
2875029|NCT02020616|9892279|P5|Overall Study|Lack of Efficacy|1
2875030|NCT02020616|9892280|P4|Overall Study|Lack of Efficacy|0
2875031|NCT02020616|9892281|P3|Overall Study|Lack of Efficacy|0
2875032|NCT02020616|9892282|P2|Overall Study|Lack of Efficacy|0
2875033|NCT02020616|9892283|P1|Overall Study|Lack of Efficacy|0
2875034|NCT02020616|9892277|P7|Overall Study|Randomized in Error|0
2875035|NCT02020616|9892278|P6|Overall Study|Randomized in Error|0
2875036|NCT02020616|9892279|P5|Overall Study|Randomized in Error|0
2875037|NCT02020616|9892280|P4|Overall Study|Randomized in Error|1
2875038|NCT02020616|9892281|P3|Overall Study|Randomized in Error|0
2875039|NCT02020616|9892282|P2|Overall Study|Randomized in Error|0
2875040|NCT02020616|9892283|P1|Overall Study|Randomized in Error|0
2875041|NCT02020616|9892277|P7|Overall Study|Early Termination Criteria Met|0
2875042|NCT02020616|9892278|P6|Overall Study|Early Termination Criteria Met|1
2875043|NCT02020616|9892279|P5|Overall Study|Early Termination Criteria Met|0
2875044|NCT02020616|9892280|P4|Overall Study|Early Termination Criteria Met|0
2875045|NCT02020616|9892281|P3|Overall Study|Early Termination Criteria Met|1
2875046|NCT02020616|9892282|P2|Overall Study|Early Termination Criteria Met|0
2875047|NCT02020616|9892283|P1|Overall Study|Early Termination Criteria Met|0
2875048|NCT02020616|9892277|P7|Overall Study|Lost to Follow-up|0
2875049|NCT02020616|9892278|P6|Overall Study|Lost to Follow-up|1
2875050|NCT02020616|9892279|P5|Overall Study|Lost to Follow-up|1
2875051|NCT02020616|9892280|P4|Overall Study|Lost to Follow-up|1
2875052|NCT02020616|9892281|P3|Overall Study|Lost to Follow-up|0
2875053|NCT02020616|9892282|P2|Overall Study|Lost to Follow-up|1
2875054|NCT02020616|9892283|P1|Overall Study|Lost to Follow-up|0
2875055|NCT02020616|9892277|P7|Overall Study|Withdrawal by Subject|1
2875056|NCT02020616|9892278|P6|Overall Study|Withdrawal by Subject|1
2875057|NCT02020616|9892279|P5|Overall Study|Withdrawal by Subject|0
2875058|NCT02020616|9892280|P4|Overall Study|Withdrawal by Subject|0
2875059|NCT02020616|9892281|P3|Overall Study|Withdrawal by Subject|1
2875060|NCT02020616|9892282|P2|Overall Study|Withdrawal by Subject|0
2875061|NCT02020616|9892283|P1|Overall Study|Withdrawal by Subject|0
2875062|NCT02020616|9892277|P7|Overall Study|Physician Decision|2
2875063|NCT02020616|9892278|P6|Overall Study|Physician Decision|1
2875064|NCT02020616|9892279|P5|Overall Study|Physician Decision|0
2875065|NCT02020616|9892280|P4|Overall Study|Physician Decision|0
2875066|NCT02020616|9892281|P3|Overall Study|Physician Decision|0
2875067|NCT02020616|9892282|P2|Overall Study|Physician Decision|0
2875068|NCT02020616|9892283|P1|Overall Study|Physician Decision|0
2875069|NCT02020616|9892277|P7|Overall Study|Adverse Event|1
2875070|NCT02020616|9892278|P6|Overall Study|Adverse Event|1
2875071|NCT02020616|9892279|P5|Overall Study|Adverse Event|0
2875072|NCT02020616|9892280|P4|Overall Study|Adverse Event|0
2875073|NCT02020616|9892281|P3|Overall Study|Adverse Event|0
2875074|NCT02020616|9892282|P2|Overall Study|Adverse Event|0
2875075|NCT02020616|9892283|P1|Overall Study|Adverse Event|0
2875076|NCT02020577|9892376|P2|Overall Study|Other than stated above|1
2875077|NCT02020577|9892377|P1|Overall Study|Other than stated above|0
2875078|NCT02020577|9892376|P2|Overall Study|Withdrawal by Subject|1
2875079|NCT02020577|9892377|P1|Overall Study|Withdrawal by Subject|0
2875080|NCT02020577|9892376|P2|Overall Study|Other AE or clinical progression|15
2875081|NCT02020577|9892377|P1|Overall Study|Other AE or clinical progression|0
2875082|NCT02020577|9892376|P2|Overall Study|Progressive disease|38
2875083|NCT02020577|9892377|P1|Overall Study|Progressive disease|3
2875084|NCT02020512|9892404|P1|Overall Study|Protocol Violation|4
2875085|NCT02020512|9892404|P1|Overall Study|Lost to Follow-up|3
2875086|NCT02020512|9892404|P1|Overall Study|Adverse Event|1
2875087|NCT02020031|9892483|P2|Overall Study|Physician Decision|1
2875088|NCT02020031|9892484|P1|Overall Study|Physician Decision|1
2875089|NCT02019979|9892505|P1|Overall Study|study terminated|14
2875090|NCT02019927|9892521|P6|Overall Study|Lost to Follow-up|1
2875091|NCT02019927|9892522|P5|Overall Study|Lost to Follow-up|3
2875092|NCT02019927|9892523|P4|Overall Study|Lost to Follow-up|2
2875093|NCT02019927|9892524|P3|Overall Study|Lost to Follow-up|1
2875094|NCT02019927|9892525|P2|Overall Study|Lost to Follow-up|4
2875095|NCT02019927|9892526|P1|Overall Study|Lost to Follow-up|2
2875096|NCT02019719|9892626|P5|Overall Study|Physician Decision|0
2875097|NCT02019719|9892627|P4|Overall Study|Physician Decision|0
2875098|NCT02019719|9892628|P3|Overall Study|Physician Decision|0
2875099|NCT02019719|9892629|P2|Overall Study|Physician Decision|0
2875100|NCT02019719|9892630|P1|Overall Study|Physician Decision|2
2875101|NCT02019719|9892626|P5|Overall Study|Protocol defined stopping criteria|1
2875102|NCT02019719|9892627|P4|Overall Study|Protocol defined stopping criteria|1
2875103|NCT02019719|9892628|P3|Overall Study|Protocol defined stopping criteria|0
2875104|NCT02019719|9892629|P2|Overall Study|Protocol defined stopping criteria|0
2875105|NCT02019719|9892630|P1|Overall Study|Protocol defined stopping criteria|2
2875106|NCT02019719|9892626|P5|Overall Study|Protocol Violation|0
2875107|NCT02019719|9892627|P4|Overall Study|Protocol Violation|0
2875108|NCT02019719|9892628|P3|Overall Study|Protocol Violation|0
2875109|NCT02019719|9892629|P2|Overall Study|Protocol Violation|1
2875110|NCT02019719|9892630|P1|Overall Study|Protocol Violation|1
2875111|NCT02019719|9892626|P5|Overall Study|Adverse Event|1
2875112|NCT02019719|9892627|P4|Overall Study|Adverse Event|1
2875113|NCT02019719|9892628|P3|Overall Study|Adverse Event|0
2875114|NCT02019719|9892629|P2|Overall Study|Adverse Event|0
2875115|NCT02019719|9892630|P1|Overall Study|Adverse Event|1
2875116|NCT02019667|9892727|P2|2nd Intervention (6 Months)|Physician Decision|1
2875117|NCT02019667|9892728|P1|2nd Intervention (6 Months)|Physician Decision|0
2875118|NCT02019667|9892727|P2|2nd Intervention (6 Months)|Adverse Event|1
2875119|NCT02019667|9892728|P1|2nd Intervention (6 Months)|Adverse Event|0
2875120|NCT02019667|9892727|P2|First Intervention (6 Months)|Adverse Event|1
2875121|NCT02019667|9892728|P1|First Intervention (6 Months)|Adverse Event|0
2875122|NCT02019602|9892748|P2|Screening Period|Adverse Event|0
2875123|NCT02019602|9892749|P1|Screening Period|Adverse Event|1
2875124|NCT02019602|9892748|P2|Screening Period|Ineligibility|0
2875125|NCT02019602|9892749|P1|Screening Period|Ineligibility|4
2875126|NCT02019550|9892778|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
2875127|NCT02019550|9892779|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
2875128|NCT02019472|9892820|P3|Overall Study|Other|6
2875129|NCT02019472|9892821|P2|Overall Study|Other|8
2875130|NCT02019472|9892822|P1|Overall Study|Other|3
2875131|NCT02019472|9892820|P3|Overall Study|Withdrawal by Subject|11
2875132|NCT02019472|9892821|P2|Overall Study|Withdrawal by Subject|10
2875133|NCT02019472|9892822|P1|Overall Study|Withdrawal by Subject|11
2875134|NCT02019472|9892820|P3|Overall Study|Pregnancy|2
2875135|NCT02019472|9892821|P2|Overall Study|Pregnancy|2
2875136|NCT02019472|9892822|P1|Overall Study|Pregnancy|1
2875137|NCT02019472|9892820|P3|Overall Study|Physician Decision|0
2875138|NCT02019472|9892821|P2|Overall Study|Physician Decision|2
2875139|NCT02019472|9892822|P1|Overall Study|Physician Decision|1
2875140|NCT02019472|9892820|P3|Overall Study|Lost to Follow-up|1
2875141|NCT02019472|9892821|P2|Overall Study|Lost to Follow-up|2
2875142|NCT02019472|9892822|P1|Overall Study|Lost to Follow-up|0
2875143|NCT02019472|9892820|P3|Overall Study|Lack of Efficacy|4
2875144|NCT02019472|9892821|P2|Overall Study|Lack of Efficacy|4
2875145|NCT02019472|9892822|P1|Overall Study|Lack of Efficacy|7
2875146|NCT02019472|9892820|P3|Overall Study|Death|1
2875147|NCT02019472|9892821|P2|Overall Study|Death|1
2875148|NCT02019472|9892822|P1|Overall Study|Death|0
2875149|NCT02019472|9892820|P3|Overall Study|Adverse Event|17
2875150|NCT02019472|9892821|P2|Overall Study|Adverse Event|23
2875151|NCT02019472|9892822|P1|Overall Study|Adverse Event|14
2875152|NCT02019420|9892845|P2|Overall Study|Transferred to other care facility|1
2875153|NCT02019420|9892846|P1|Overall Study|Transferred to other care facility|1
2875154|NCT02019420|9892845|P2|Overall Study|Death|99
2875155|NCT02019420|9892846|P1|Overall Study|Death|104
2875156|NCT02019420|9892845|P2|Overall Study|At request of sponsor or investigator|1
2875157|NCT02019420|9892846|P1|Overall Study|At request of sponsor or investigator|0
2875158|NCT02019420|9892845|P2|Overall Study|Withdrawal by Subject|3
2875159|NCT02019420|9892846|P1|Overall Study|Withdrawal by Subject|1
2875160|NCT02019420|9892845|P2|Overall Study|Did not receive study drug|2
2875161|NCT02019420|9892846|P1|Overall Study|Did not receive study drug|2
2875162|NCT02019277|9892874|P1|Overall Study|Adverse Event|1
2875163|NCT02019277|9892874|P1|Overall Study|Did no Cooperate|1
2875164|NCT02019277|9892874|P1|Overall Study|Death|7
2875165|NCT02019277|9892874|P1|Overall Study|Withdrawal by Subject|3
2875166|NCT02019264|9892893|P2|Overall Study|Missing|11
2875167|NCT02019264|9892894|P1|Overall Study|Missing|14
2875168|NCT02019264|9892893|P2|Overall Study|Administrative reason|28
2875169|NCT02019264|9892894|P1|Overall Study|Administrative reason|36
2875170|NCT02019264|9892893|P2|Overall Study|Withdrawal by Subject|117
2875171|NCT02019264|9892894|P1|Overall Study|Withdrawal by Subject|142
2875172|NCT02019264|9892893|P2|Overall Study|Lost to Follow-up|47
2875173|NCT02019264|9892894|P1|Overall Study|Lost to Follow-up|50
2875174|NCT02019264|9892893|P2|Overall Study|Not treated|4
2875175|NCT02019264|9892894|P1|Overall Study|Not treated|6
2875176|NCT02019108|9892930|P2|Overall Study|Lost to Follow-up|7
2875177|NCT02019108|9892931|P1|Overall Study|Lost to Follow-up|5
2875178|NCT02018887|9892973|P11|Part C: Cohort 8 Overall|Physician Decision|1
2875179|NCT02018887|9892974|P10|Part C: Cohort 8 Overall|Physician Decision|0
2875180|NCT02018887|9892975|P9|Part C: Cohort 8 Overall|Physician Decision|2
2875181|NCT02018887|9892976|P8|Part C: Cohort 8 Overall|Physician Decision|0
2875182|NCT02018887|9892977|P7|Part C: Cohort 8 Overall|Physician Decision|0
2875183|NCT02018887|9892978|P6|Part C: Cohort 8 Overall|Physician Decision|0
2875184|NCT02018887|9892979|P5|Part C: Cohort 8 Overall|Physician Decision|0
2875185|NCT02018887|9892980|P4|Part C: Cohort 8 Overall|Physician Decision|0
2875186|NCT02018887|9892981|P3|Part C: Cohort 8 Overall|Physician Decision|0
2875187|NCT02018887|9892982|P2|Part C: Cohort 8 Overall|Physician Decision|0
2875188|NCT02018887|9892983|P1|Part C: Cohort 8 Overall|Physician Decision|0
2875189|NCT02018887|9892973|P11|Part C: Cohort 8 Overall|Adverse Event|0
2875190|NCT02018887|9892974|P10|Part C: Cohort 8 Overall|Adverse Event|3
2875191|NCT02018887|9892975|P9|Part C: Cohort 8 Overall|Adverse Event|1
2875192|NCT02018887|9892976|P8|Part C: Cohort 8 Overall|Adverse Event|0
2875193|NCT02018887|9892977|P7|Part C: Cohort 8 Overall|Adverse Event|0
2875194|NCT02018887|9892978|P6|Part C: Cohort 8 Overall|Adverse Event|0
2875195|NCT02018887|9892979|P5|Part C: Cohort 8 Overall|Adverse Event|0
2875196|NCT02018887|9892980|P4|Part C: Cohort 8 Overall|Adverse Event|0
2875197|NCT02018887|9892981|P3|Part C: Cohort 8 Overall|Adverse Event|0
2875198|NCT02018887|9892982|P2|Part C: Cohort 8 Overall|Adverse Event|0
2875199|NCT02018887|9892983|P1|Part C: Cohort 8 Overall|Adverse Event|0
2875200|NCT02018887|9892973|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875201|NCT02018887|9892974|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875202|NCT02018887|9892975|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875203|NCT02018887|9892976|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
2875204|NCT02018887|9892977|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
2875205|NCT02018887|9892978|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875206|NCT02018887|9892979|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
2875207|NCT02018887|9892980|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875208|NCT02018887|9892981|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875209|NCT02018887|9892982|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875210|NCT02018887|9892983|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
2875211|NCT02018887|9892973|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875212|NCT02018887|9892974|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875213|NCT02018887|9892975|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875214|NCT02018887|9892976|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875215|NCT02018887|9892977|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875216|NCT02018887|9892978|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875217|NCT02018887|9892979|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875218|NCT02018887|9892980|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875219|NCT02018887|9892981|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875220|NCT02018887|9892982|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2875221|NCT02018887|9892983|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
2875222|NCT02018822|9893072|P3|Overall Study|Lost to Follow-up|5
2875223|NCT02018822|9893073|P2|Overall Study|Lost to Follow-up|6
2875224|NCT02018822|9893074|P1|Overall Study|Lost to Follow-up|6
2875225|NCT02018822|9893072|P3|Overall Study|Physician Decision|1
2875226|NCT02018822|9893073|P2|Overall Study|Physician Decision|1
2875227|NCT02018822|9893074|P1|Overall Study|Physician Decision|0
2875228|NCT02018822|9893072|P3|Overall Study|filling replaced by crown|0
2875229|NCT02018822|9893073|P2|Overall Study|filling replaced by crown|1
2875230|NCT02018822|9893074|P1|Overall Study|filling replaced by crown|0
2875231|NCT02018562|9893154|P2|Overall Study|Discharged prior to study completion|0
2875232|NCT02018562|9893155|P1|Overall Study|Discharged prior to study completion|1
2875233|NCT02018562|9893154|P2|Overall Study|Withdrawal by Subject|0
2875234|NCT02018562|9893155|P1|Overall Study|Withdrawal by Subject|2
2875235|NCT02018458|9893173|P1|Overall Study|Death|4
2875236|NCT02018042|9893200|P1|Overall Study|Withdrawal by Subject|1
2875237|NCT02017964|9893206|P1|Overall Study|Patient deemed ineligible|1
2875238|NCT02017899|9893220|P6|Overall Study|Withdrawal by Subject|0
2875239|NCT02017899|9893221|P5|Overall Study|Withdrawal by Subject|1
2875240|NCT02017899|9893222|P4|Overall Study|Withdrawal by Subject|1
2875241|NCT02017899|9893223|P3|Overall Study|Withdrawal by Subject|0
2875242|NCT02017899|9893224|P2|Overall Study|Withdrawal by Subject|0
2875243|NCT02017899|9893225|P1|Overall Study|Withdrawal by Subject|0
2875244|NCT02017860|9893299|P1|Overall Study|Withdrawal by Subject|1
2875245|NCT02017860|9893299|P1|Overall Study|Adverse Event|1
2875246|NCT02017535|9893318|P4|Overall Study|Withdrawal by Subject|0
2875247|NCT02017535|9893319|P3|Overall Study|Withdrawal by Subject|0
2875248|NCT02017535|9893320|P2|Overall Study|Withdrawal by Subject|0
2875249|NCT02017535|9893321|P1|Overall Study|Withdrawal by Subject|1
2875250|NCT02017522|9893343|P1|Overall Study|Withdrawal by Subject|1
2875251|NCT02017223|9893361|P1|Overall Study|Algorithm problems|2
2875252|NCT02017015|9893416|P1|Overall Study|Physician Decision|2
2875253|NCT02017015|9893416|P1|Overall Study|Non-compliance with study drug|2
2875254|NCT02017015|9893416|P1|Overall Study|Progressive Disease|31
2875255|NCT02017015|9893416|P1|Overall Study|Death|4
2875256|NCT02017015|9893416|P1|Overall Study|Withdrawal by Subject|21
2875257|NCT02017015|9893416|P1|Overall Study|Adverse Event|9
2875258|NCT02016898|9893441|P2|Overall Study|Lost to Follow-up|4
2875259|NCT02016898|9893442|P1|Overall Study|Lost to Follow-up|4
2875260|NCT02016898|9893441|P2|Overall Study|Death|1
2875261|NCT02016898|9893442|P1|Overall Study|Death|1
2875262|NCT02016716|9893499|P3|Overall Study|Lost to Follow-up|1
2875263|NCT02016716|9893500|P2|Overall Study|Lost to Follow-up|2
2875264|NCT02016716|9893501|P1|Overall Study|Lost to Follow-up|1
2875265|NCT02016716|9893499|P3|Overall Study|Protocol-specified Criteria|0
2875266|NCT02016716|9893500|P2|Overall Study|Protocol-specified Criteria|1
2875267|NCT02016716|9893501|P1|Overall Study|Protocol-specified Criteria|0
2875268|NCT02016716|9893499|P3|Overall Study|Withdrawal by Subject|5
2875269|NCT02016716|9893500|P2|Overall Study|Withdrawal by Subject|5
2875270|NCT02016716|9893501|P1|Overall Study|Withdrawal by Subject|5
2875271|NCT02016690|9893522|P1|Overall Study|Hospitalized for RSV at study start|3
2875272|NCT02016690|9893522|P1|Overall Study|Did not meet inclusion criteria|13
2875273|NCT02016690|9893522|P1|Overall Study|Excluded from SAS: Ineligible for study|2
2875274|NCT02016690|9893522|P1|Overall Study|Excluded from SAS: Early treatment|2
2875275|NCT02016690|9893522|P1|Overall Study|Excluded from SAS: Duplication|2
2875276|NCT02016690|9893522|P1|Overall Study|Excluded from SAS: Enrollment violation|2
2875277|NCT02016625|9893535|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
2875278|NCT02016625|9893536|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
2875279|NCT02016625|9893535|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
2875280|NCT02016625|9893536|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
2875281|NCT02016625|9893535|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
2875282|NCT02016625|9893536|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
2875283|NCT02016482|9893591|P2|Period B|Required Alternative/Prohibited Therapy|2
2875284|NCT02016482|9893592|P1|Period B|Required Alternative/Prohibited Therapy|0
2875285|NCT02016482|9893591|P2|Period B|Other|0
2875286|NCT02016482|9893592|P1|Period B|Other|4
2875287|NCT02016482|9893591|P2|Period B|Lack of Efficacy|4
2875288|NCT02016482|9893592|P1|Period B|Lack of Efficacy|6
2875289|NCT02016482|9893591|P2|Period B|Lost to Follow-up|0
2875290|NCT02016482|9893592|P1|Period B|Lost to Follow-up|2
2875291|NCT02016482|9893591|P2|Period B|Withdrawal by Subject|1
2875292|NCT02016482|9893592|P1|Period B|Withdrawal by Subject|1
2875293|NCT02016482|9893591|P2|Period A|Required Alternative/Prohibited Therapy|1
2875294|NCT02016482|9893592|P1|Period A|Required Alternative/Prohibited Therapy|0
2875295|NCT02016482|9893591|P2|Period A|Protocol Violation|1
2875296|NCT02016482|9893592|P1|Period A|Protocol Violation|0
2875297|NCT02016482|9893591|P2|Period A|Other|0
2875298|NCT02016482|9893592|P1|Period A|Other|3
2875299|NCT02016482|9893591|P2|Period A|Lack of Efficacy|1
2875300|NCT02016482|9893592|P1|Period A|Lack of Efficacy|2
2875301|NCT02016482|9893591|P2|Period A|Lost to Follow-up|3
2875302|NCT02016482|9893592|P1|Period A|Lost to Follow-up|3
2875303|NCT02016482|9893591|P2|Period A|Withdrawal by Subject|4
2875304|NCT02016482|9893592|P1|Period A|Withdrawal by Subject|3
2875305|NCT02016482|9893591|P2|Period A|Adverse Event|5
2875306|NCT02016482|9893592|P1|Period A|Adverse Event|3
2875307|NCT02016300|9893682|P2|Overall Study|Lost to Follow-up|3
2875308|NCT02016300|9893683|P1|Overall Study|Lost to Follow-up|0
2875309|NCT02016183|9893714|P1|Overall Study|Protocol Violation|52
2875310|NCT02016183|9893714|P1|Overall Study|Case Report Forms Uncollected|13
2875311|NCT02016170|9893724|P3|Overall Study|Protocol Violation|0
2875312|NCT02016170|9893725|P2|Overall Study|Protocol Violation|0
2875313|NCT02016170|9893726|P1|Overall Study|Protocol Violation|1
2875314|NCT02016170|9893724|P3|Overall Study|Adverse Event|0
2875315|NCT02016170|9893725|P2|Overall Study|Adverse Event|1
2875316|NCT02016170|9893726|P1|Overall Study|Adverse Event|1
2875317|NCT02016105|9893737|P6|EXTENSION PERIOD|Lost to Follow-up|2
2875318|NCT02016105|9893738|P5|EXTENSION PERIOD|Lost to Follow-up|0
2875319|NCT02016105|9893739|P4|EXTENSION PERIOD|Lost to Follow-up|0
2875320|NCT02016105|9893740|P3|EXTENSION PERIOD|Lost to Follow-up|0
2875321|NCT02016105|9893741|P2|EXTENSION PERIOD|Lost to Follow-up|0
2875322|NCT02016105|9893742|P1|EXTENSION PERIOD|Lost to Follow-up|0
2875323|NCT02016105|9893737|P6|EXTENSION PERIOD|Non-compliance with study indication|0
2875324|NCT02016105|9893738|P5|EXTENSION PERIOD|Non-compliance with study indication|1
2875325|NCT02016105|9893739|P4|EXTENSION PERIOD|Non-compliance with study indication|0
2875326|NCT02016105|9893740|P3|EXTENSION PERIOD|Non-compliance with study indication|0
2875327|NCT02016105|9893741|P2|EXTENSION PERIOD|Non-compliance with study indication|0
2875328|NCT02016105|9893742|P1|EXTENSION PERIOD|Non-compliance with study indication|0
2875329|NCT02016105|9893737|P6|EXTENSION PERIOD|Withdrawal by Subject|2
2875330|NCT02016105|9893738|P5|EXTENSION PERIOD|Withdrawal by Subject|2
2875331|NCT02016105|9893739|P4|EXTENSION PERIOD|Withdrawal by Subject|2
2875332|NCT02016105|9893740|P3|EXTENSION PERIOD|Withdrawal by Subject|2
2875333|NCT02016105|9893741|P2|EXTENSION PERIOD|Withdrawal by Subject|0
2875334|NCT02016105|9893742|P1|EXTENSION PERIOD|Withdrawal by Subject|0
2875335|NCT02016105|9893737|P6|EXTENSION PERIOD|Adverse Event|0
2875336|NCT02016105|9893738|P5|EXTENSION PERIOD|Adverse Event|1
2875337|NCT02016105|9893739|P4|EXTENSION PERIOD|Adverse Event|0
2875338|NCT02016105|9893740|P3|EXTENSION PERIOD|Adverse Event|2
2875339|NCT02016105|9893741|P2|EXTENSION PERIOD|Adverse Event|0
2875340|NCT02016105|9893742|P1|EXTENSION PERIOD|Adverse Event|0
2875341|NCT02016105|9893737|P6|EXTENSION PERIOD|Lack of Efficacy|1
2875342|NCT02016105|9893738|P5|EXTENSION PERIOD|Lack of Efficacy|1
2875343|NCT02016105|9893739|P4|EXTENSION PERIOD|Lack of Efficacy|3
2875344|NCT02016105|9893740|P3|EXTENSION PERIOD|Lack of Efficacy|1
2875345|NCT02016105|9893741|P2|EXTENSION PERIOD|Lack of Efficacy|0
2875346|NCT02016105|9893742|P1|EXTENSION PERIOD|Lack of Efficacy|0
2875347|NCT02016105|9893737|P6|EXTENSION PERIOD|New therapy for study indication|1
2875348|NCT02016105|9893738|P5|EXTENSION PERIOD|New therapy for study indication|1
2875349|NCT02016105|9893739|P4|EXTENSION PERIOD|New therapy for study indication|0
2875350|NCT02016105|9893740|P3|EXTENSION PERIOD|New therapy for study indication|0
2875351|NCT02016105|9893741|P2|EXTENSION PERIOD|New therapy for study indication|0
2875352|NCT02016105|9893742|P1|EXTENSION PERIOD|New therapy for study indication|0
2875353|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
2875354|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
2875355|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
2875356|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
2875357|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
2875358|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
2875359|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
2875360|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
2875361|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
2875362|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
2875363|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
2875364|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
2875365|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Adverse Event|1
2875366|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Adverse Event|0
2875367|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Adverse Event|4
2875368|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Adverse Event|0
2875369|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Adverse Event|0
2875370|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Adverse Event|0
2875371|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Death|1
2875372|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Death|0
2875373|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Death|0
2875374|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Death|0
2875375|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Death|0
2875376|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Death|0
2875377|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Pregnancy|1
2875378|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Pregnancy|0
2875379|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Pregnancy|0
2875380|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Pregnancy|0
2875381|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Pregnancy|0
2875382|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Pregnancy|0
2875383|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
2875384|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
2875385|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
2875386|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
2875387|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
2875388|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
2875389|NCT02016105|9893737|P6|TREATMENT PERIOD 2|Non compliance study medication|1
2875390|NCT02016105|9893738|P5|TREATMENT PERIOD 2|Non compliance study medication|0
2875391|NCT02016105|9893739|P4|TREATMENT PERIOD 2|Non compliance study medication|0
2875392|NCT02016105|9893740|P3|TREATMENT PERIOD 2|Non compliance study medication|0
2875393|NCT02016105|9893741|P2|TREATMENT PERIOD 2|Non compliance study medication|0
2875394|NCT02016105|9893742|P1|TREATMENT PERIOD 2|Non compliance study medication|0
2875395|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
2875396|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
2875397|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
2875398|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
2875399|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
2875400|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
2875401|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
2875402|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
2875403|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
2875404|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
2875405|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
2875406|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
2875407|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Adverse Event|0
2875408|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Adverse Event|0
2875409|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Adverse Event|0
2875410|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Adverse Event|0
2875411|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Adverse Event|5
2875412|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Adverse Event|3
2875413|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Pregnancy|0
2875414|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Pregnancy|0
2875415|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Pregnancy|0
2875416|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Pregnancy|0
2875417|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Pregnancy|1
2875418|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Pregnancy|0
2875419|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
2875420|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
2875421|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
2875422|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
2875423|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
2875424|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
2875425|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Physician Decision|0
2875426|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Physician Decision|0
2875427|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Physician Decision|0
2875428|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Physician Decision|0
2875429|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Physician Decision|2
2875430|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Physician Decision|0
2875431|NCT02016105|9893737|P6|TREATMENT PERIOD 1|Protocol Violation|0
2875432|NCT02016105|9893738|P5|TREATMENT PERIOD 1|Protocol Violation|0
2875433|NCT02016105|9893739|P4|TREATMENT PERIOD 1|Protocol Violation|0
2875434|NCT02016105|9893740|P3|TREATMENT PERIOD 1|Protocol Violation|0
2875435|NCT02016105|9893741|P2|TREATMENT PERIOD 1|Protocol Violation|8
2875436|NCT02016105|9893742|P1|TREATMENT PERIOD 1|Protocol Violation|2
2875437|NCT02015793|9893801|P2|Overall Study|Withdrawal by Subject|1
2875438|NCT02015793|9893802|P1|Overall Study|Withdrawal by Subject|1
2875439|NCT02015793|9893801|P2|Overall Study|Adverse Event|3
2875440|NCT02015793|9893802|P1|Overall Study|Adverse Event|3
2875441|NCT02015754|9893832|P1|Overall Study|Lost to Follow-up|1
2875442|NCT02015754|9893832|P1|Overall Study|Change in treatment modality|5
2875443|NCT02015754|9893832|P1|Overall Study|Disease progression|5
2875444|NCT02015676|9893852|P3|Overall Study|Disease progression|1
2875445|NCT02015676|9893853|P2|Overall Study|Disease progression|1
2875446|NCT02015676|9893854|P1|Overall Study|Disease progression|3
2875447|NCT02015676|9893852|P3|Overall Study|Death|0
2875448|NCT02015676|9893853|P2|Overall Study|Death|1
2875449|NCT02015676|9893854|P1|Overall Study|Death|0
2875450|NCT02015676|9893852|P3|Overall Study|Administrative reasons|1
2875451|NCT02015676|9893853|P2|Overall Study|Administrative reasons|3
2875452|NCT02015676|9893854|P1|Overall Study|Administrative reasons|0
2875453|NCT02015676|9893852|P3|Overall Study|Withdrawal by Subject|1
2875454|NCT02015676|9893853|P2|Overall Study|Withdrawal by Subject|7
2875455|NCT02015676|9893854|P1|Overall Study|Withdrawal by Subject|1
2875456|NCT02015676|9893852|P3|Overall Study|Protocol Violation|0
2875457|NCT02015676|9893853|P2|Overall Study|Protocol Violation|0
2875458|NCT02015676|9893854|P1|Overall Study|Protocol Violation|1
2875459|NCT02015676|9893852|P3|Overall Study|Lack of Efficacy|0
2875460|NCT02015676|9893853|P2|Overall Study|Lack of Efficacy|4
2875461|NCT02015676|9893854|P1|Overall Study|Lack of Efficacy|2
2875462|NCT02015676|9893852|P3|Overall Study|Adverse Event|0
2875463|NCT02015676|9893853|P2|Overall Study|Adverse Event|18
2875464|NCT02015676|9893854|P1|Overall Study|Adverse Event|2
2875465|NCT02015663|9893870|P2|Overall Study|Administrative problems|11
2875466|NCT02015663|9893871|P1|Overall Study|Administrative problems|10
2875467|NCT02015663|9893870|P2|Overall Study|Adverse Event|0
2875468|NCT02015663|9893871|P1|Overall Study|Adverse Event|3
2875469|NCT02015663|9893870|P2|Overall Study|Protocol Violation|1
2875470|NCT02015663|9893871|P1|Overall Study|Protocol Violation|0
2875471|NCT02015663|9893870|P2|Overall Study|Withdrawal by Subject|0
2875472|NCT02015663|9893871|P1|Overall Study|Withdrawal by Subject|1
2875473|NCT02015663|9893870|P2|Overall Study|unsatisfactory therapeutic effect|0
2875474|NCT02015663|9893871|P1|Overall Study|unsatisfactory therapeutic effect|1
2875475|NCT02015637|9893902|P2|Overall Study|Did not take study drug|0
2875476|NCT02015637|9893903|P1|Overall Study|Did not take study drug|2
2875477|NCT02015637|9893902|P2|Overall Study|Adverse Event|0
2875478|NCT02015637|9893903|P1|Overall Study|Adverse Event|3
2875479|NCT02015637|9893902|P2|Overall Study|Lost to Follow-up|5
2875480|NCT02015637|9893903|P1|Overall Study|Lost to Follow-up|3
2875481|NCT02015546|9893914|P3|Overall Study|Screem Failure|3
2875482|NCT02015546|9893915|P2|Overall Study|Screem Failure|1
2875483|NCT02015546|9893916|P1|Overall Study|Screem Failure|2
2875484|NCT02015546|9893914|P3|Overall Study|Withdrawal by Subject|1
2875485|NCT02015546|9893915|P2|Overall Study|Withdrawal by Subject|1
2875486|NCT02015546|9893916|P1|Overall Study|Withdrawal by Subject|1
2875487|NCT02015481|9893948|P1|Overall Study|Death|1
2875488|NCT02015221|9893981|P2|Overall Study|Lost to Follow-up|0
2875489|NCT02015221|9893982|P1|Overall Study|Lost to Follow-up|1
2875490|NCT02015221|9893981|P2|Overall Study|Withdrawal by Subject|6
2875491|NCT02015221|9893982|P1|Overall Study|Withdrawal by Subject|8
2875492|NCT02015195|9893995|P7|Overall Study|Adverse Event|0
2875493|NCT02015195|9893996|P6|Overall Study|Adverse Event|0
2875494|NCT02015195|9893997|P5|Overall Study|Adverse Event|0
2875495|NCT02015195|9893998|P4|Overall Study|Adverse Event|1
2875496|NCT02015195|9893999|P3|Overall Study|Adverse Event|0
2875497|NCT02015195|9894000|P2|Overall Study|Adverse Event|0
2875498|NCT02015195|9894001|P1|Overall Study|Adverse Event|0
2875499|NCT02015104|9894024|P2|Overall Study|Withdrew consent prior to treatment|1
2875500|NCT02015104|9894025|P1|Overall Study|Withdrew consent prior to treatment|0
2875501|NCT02015104|9894024|P2|Overall Study|Withdrew consent after first dose drug|0
2875502|NCT02015104|9894025|P1|Overall Study|Withdrew consent after first dose drug|1
2875503|NCT02015065|9894042|P3|Overall Study|Death on study|1
2875504|NCT02015065|9894043|P2|Overall Study|Death on study|2
2875505|NCT02015065|9894044|P1|Overall Study|Death on study|1
2875506|NCT02015039|9894066|P2|Overall Study|Not eligible|1
2875507|NCT02015039|9894067|P1|Overall Study|Not eligible|0
2875508|NCT02014740|9894087|P2|Overall Study|Withdrawal by Subject|1
2875509|NCT02014740|9894088|P1|Overall Study|Withdrawal by Subject|2
2875510|NCT02014740|9894087|P2|Overall Study|Lost to Follow-up|4
2875511|NCT02014740|9894088|P1|Overall Study|Lost to Follow-up|4
2875512|NCT02014584|9894096|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2875513|NCT02014584|9894097|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
2875514|NCT02014584|9894098|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2875515|NCT02014584|9894099|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2875516|NCT02014584|9894100|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2875517|NCT02014584|9894101|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2875518|NCT02014584|9894096|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2875519|NCT02014584|9894097|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2875520|NCT02014584|9894098|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
2875521|NCT02014584|9894099|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
2875522|NCT02014584|9894100|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2875523|NCT02014584|9894101|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2875524|NCT02014584|9894096|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2875525|NCT02014584|9894097|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2875526|NCT02014584|9894098|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2875527|NCT02014584|9894099|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
2875528|NCT02014584|9894100|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2875529|NCT02014584|9894101|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2875530|NCT02014584|9894096|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2875531|NCT02014584|9894097|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2875532|NCT02014584|9894098|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2875533|NCT02014584|9894099|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2875534|NCT02014584|9894100|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
2875535|NCT02014584|9894101|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
2875536|NCT02014584|9894096|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
2875537|NCT02014584|9894097|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
2875538|NCT02014584|9894098|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
2875539|NCT02014584|9894099|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
2875540|NCT02014584|9894100|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
2875541|NCT02014584|9894101|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
2875542|NCT02014558|9894231|P13|Overall Study|Miscellaneous|1
2875543|NCT02014558|9894232|P12|Overall Study|Miscellaneous|11
2875544|NCT02014558|9894233|P11|Overall Study|Miscellaneous|12
2875545|NCT02014558|9894234|P10|Overall Study|Miscellaneous|3
2875546|NCT02014558|9894235|P9|Overall Study|Miscellaneous|1
2875547|NCT02014558|9894236|P8|Overall Study|Miscellaneous|1
2875548|NCT02014558|9894237|P7|Overall Study|Miscellaneous|0
2875549|NCT02014558|9894238|P6|Overall Study|Miscellaneous|1
2875550|NCT02014558|9894239|P5|Overall Study|Miscellaneous|0
2875551|NCT02014558|9894240|P4|Overall Study|Miscellaneous|1
2875552|NCT02014558|9894241|P3|Overall Study|Miscellaneous|1
2875553|NCT02014558|9894242|P2|Overall Study|Miscellaneous|1
2875554|NCT02014558|9894243|P1|Overall Study|Miscellaneous|2
2875555|NCT02014558|9894231|P13|Overall Study|Withdrawal by Subject|0
2875556|NCT02014558|9894232|P12|Overall Study|Withdrawal by Subject|10
2875557|NCT02014558|9894233|P11|Overall Study|Withdrawal by Subject|6
2875558|NCT02014558|9894234|P10|Overall Study|Withdrawal by Subject|2
2875559|NCT02014558|9894235|P9|Overall Study|Withdrawal by Subject|0
2875560|NCT02014558|9894236|P8|Overall Study|Withdrawal by Subject|0
2875561|NCT02014558|9894237|P7|Overall Study|Withdrawal by Subject|0
2875562|NCT02014558|9894238|P6|Overall Study|Withdrawal by Subject|0
2875563|NCT02014558|9894239|P5|Overall Study|Withdrawal by Subject|1
2875564|NCT02014558|9894240|P4|Overall Study|Withdrawal by Subject|0
2875565|NCT02014558|9894241|P3|Overall Study|Withdrawal by Subject|0
2875566|NCT02014558|9894242|P2|Overall Study|Withdrawal by Subject|0
2875567|NCT02014558|9894243|P1|Overall Study|Withdrawal by Subject|0
2875568|NCT02014558|9894231|P13|Overall Study|Progressive Disease|6
2875569|NCT02014558|9894232|P12|Overall Study|Progressive Disease|31
2875570|NCT02014558|9894233|P11|Overall Study|Progressive Disease|22
2875571|NCT02014558|9894234|P10|Overall Study|Progressive Disease|6
2875572|NCT02014558|9894235|P9|Overall Study|Progressive Disease|5
2875573|NCT02014558|9894236|P8|Overall Study|Progressive Disease|6
2875574|NCT02014558|9894237|P7|Overall Study|Progressive Disease|1
2875575|NCT02014558|9894238|P6|Overall Study|Progressive Disease|2
2875576|NCT02014558|9894239|P5|Overall Study|Progressive Disease|1
2875577|NCT02014558|9894240|P4|Overall Study|Progressive Disease|1
2875578|NCT02014558|9894241|P3|Overall Study|Progressive Disease|1
2875579|NCT02014558|9894242|P2|Overall Study|Progressive Disease|0
2875580|NCT02014558|9894243|P1|Overall Study|Progressive Disease|1
2875581|NCT02014558|9894231|P13|Overall Study|Lost to Follow-up|0
2875582|NCT02014558|9894232|P12|Overall Study|Lost to Follow-up|0
2875583|NCT02014558|9894233|P11|Overall Study|Lost to Follow-up|1
2875584|NCT02014558|9894234|P10|Overall Study|Lost to Follow-up|0
2875585|NCT02014558|9894235|P9|Overall Study|Lost to Follow-up|0
2875586|NCT02014558|9894236|P8|Overall Study|Lost to Follow-up|0
2875587|NCT02014558|9894237|P7|Overall Study|Lost to Follow-up|0
2875588|NCT02014558|9894238|P6|Overall Study|Lost to Follow-up|0
2875589|NCT02014558|9894239|P5|Overall Study|Lost to Follow-up|0
2875590|NCT02014558|9894240|P4|Overall Study|Lost to Follow-up|0
2875591|NCT02014558|9894241|P3|Overall Study|Lost to Follow-up|0
2875592|NCT02014558|9894242|P2|Overall Study|Lost to Follow-up|0
2875593|NCT02014558|9894243|P1|Overall Study|Lost to Follow-up|0
2875594|NCT02014558|9894231|P13|Overall Study|Lack of Efficacy|5
2875595|NCT02014558|9894232|P12|Overall Study|Lack of Efficacy|8
2875596|NCT02014558|9894233|P11|Overall Study|Lack of Efficacy|16
2875597|NCT02014558|9894234|P10|Overall Study|Lack of Efficacy|3
2875598|NCT02014558|9894235|P9|Overall Study|Lack of Efficacy|3
2875599|NCT02014558|9894236|P8|Overall Study|Lack of Efficacy|3
2875600|NCT02014558|9894237|P7|Overall Study|Lack of Efficacy|1
2875601|NCT02014558|9894238|P6|Overall Study|Lack of Efficacy|0
2875602|NCT02014558|9894239|P5|Overall Study|Lack of Efficacy|0
2875603|NCT02014558|9894240|P4|Overall Study|Lack of Efficacy|1
2875604|NCT02014558|9894241|P3|Overall Study|Lack of Efficacy|1
2875605|NCT02014558|9894242|P2|Overall Study|Lack of Efficacy|2
2875606|NCT02014558|9894243|P1|Overall Study|Lack of Efficacy|1
2875607|NCT02014558|9894231|P13|Overall Study|Death|2
2875608|NCT02014558|9894232|P12|Overall Study|Death|19
2875609|NCT02014558|9894233|P11|Overall Study|Death|5
2875610|NCT02014558|9894234|P10|Overall Study|Death|5
2875611|NCT02014558|9894235|P9|Overall Study|Death|2
2875612|NCT02014558|9894236|P8|Overall Study|Death|1
2875613|NCT02014558|9894237|P7|Overall Study|Death|1
2875614|NCT02014558|9894238|P6|Overall Study|Death|0
2875615|NCT02014558|9894239|P5|Overall Study|Death|0
2875616|NCT02014558|9894240|P4|Overall Study|Death|0
2875617|NCT02014558|9894241|P3|Overall Study|Death|0
2875618|NCT02014558|9894242|P2|Overall Study|Death|0
2875619|NCT02014558|9894243|P1|Overall Study|Death|1
2875620|NCT02014558|9894231|P13|Overall Study|Adverse Event|3
2875621|NCT02014558|9894232|P12|Overall Study|Adverse Event|21
2875622|NCT02014558|9894233|P11|Overall Study|Adverse Event|5
2875623|NCT02014558|9894234|P10|Overall Study|Adverse Event|2
2875624|NCT02014558|9894235|P9|Overall Study|Adverse Event|2
2875625|NCT02014558|9894236|P8|Overall Study|Adverse Event|0
2875626|NCT02014558|9894237|P7|Overall Study|Adverse Event|0
2875627|NCT02014558|9894238|P6|Overall Study|Adverse Event|0
2875628|NCT02014558|9894239|P5|Overall Study|Adverse Event|1
2875629|NCT02014558|9894240|P4|Overall Study|Adverse Event|0
2875630|NCT02014558|9894241|P3|Overall Study|Adverse Event|0
2875631|NCT02014558|9894242|P2|Overall Study|Adverse Event|0
2875632|NCT02014558|9894243|P1|Overall Study|Adverse Event|0
2875633|NCT02014558|9894231|P13|Overall Study|Never Received Study Drug|0
2875634|NCT02014558|9894232|P12|Overall Study|Never Received Study Drug|2
2875635|NCT02014558|9894233|P11|Overall Study|Never Received Study Drug|2
2875636|NCT02014558|9894234|P10|Overall Study|Never Received Study Drug|0
2875637|NCT02014558|9894235|P9|Overall Study|Never Received Study Drug|2
2875638|NCT02014558|9894236|P8|Overall Study|Never Received Study Drug|0
2875639|NCT02014558|9894237|P7|Overall Study|Never Received Study Drug|1
2875640|NCT02014558|9894238|P6|Overall Study|Never Received Study Drug|0
2875641|NCT02014558|9894239|P5|Overall Study|Never Received Study Drug|1
2875642|NCT02014558|9894240|P4|Overall Study|Never Received Study Drug|0
2875643|NCT02014558|9894241|P3|Overall Study|Never Received Study Drug|0
2875644|NCT02014558|9894242|P2|Overall Study|Never Received Study Drug|0
2875645|NCT02014558|9894243|P1|Overall Study|Never Received Study Drug|0
2875646|NCT02014480|9894608|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
2875647|NCT02014480|9894609|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2875648|NCT02014480|9894610|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2875649|NCT02014480|9894611|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2875650|NCT02014480|9894612|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2875651|NCT02014480|9894613|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2875652|NCT02014480|9894608|P6|Treatment Period 3 (14 Days)|Adverse Event|1
2875653|NCT02014480|9894609|P5|Treatment Period 3 (14 Days)|Adverse Event|0
2875654|NCT02014480|9894610|P4|Treatment Period 3 (14 Days)|Adverse Event|0
2875655|NCT02014480|9894611|P3|Treatment Period 3 (14 Days)|Adverse Event|1
2875656|NCT02014480|9894612|P2|Treatment Period 3 (14 Days)|Adverse Event|0
2875657|NCT02014480|9894613|P1|Treatment Period 3 (14 Days)|Adverse Event|0
2875658|NCT02014480|9894608|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2875659|NCT02014480|9894609|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2875660|NCT02014480|9894610|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2875661|NCT02014480|9894611|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2875662|NCT02014480|9894612|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2875663|NCT02014480|9894613|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2875664|NCT02014480|9894608|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
2875665|NCT02014480|9894609|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
2875666|NCT02014480|9894610|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
2875667|NCT02014480|9894611|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
2875668|NCT02014480|9894612|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
2875669|NCT02014480|9894613|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
2875670|NCT02014480|9894608|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2875671|NCT02014480|9894609|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2875672|NCT02014480|9894610|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2875673|NCT02014480|9894611|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2875674|NCT02014480|9894612|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2875675|NCT02014480|9894613|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2875676|NCT02014480|9894608|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2875677|NCT02014480|9894609|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2875678|NCT02014480|9894610|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2875679|NCT02014480|9894611|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2875680|NCT02014480|9894612|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2875681|NCT02014480|9894613|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2875682|NCT02014480|9894608|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2875771|NCT02014116|9894891|P6|Overall Study|Adverse Event|0
2875683|NCT02014480|9894609|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2875684|NCT02014480|9894610|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2875685|NCT02014480|9894611|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
2875686|NCT02014480|9894612|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2875687|NCT02014480|9894613|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2875688|NCT02014467|9894632|P2|Overall Study|Withdrawal by Subject|4
2875689|NCT02014467|9894633|P1|Overall Study|Withdrawal by Subject|16
2875690|NCT02014467|9894632|P2|Overall Study|Physician Decision|3
2875691|NCT02014467|9894633|P1|Overall Study|Physician Decision|2
2875692|NCT02014467|9894632|P2|Overall Study|Protocol Violation|0
2875693|NCT02014467|9894633|P1|Overall Study|Protocol Violation|3
2875694|NCT02014467|9894632|P2|Overall Study|Adverse Event|0
2875695|NCT02014467|9894633|P1|Overall Study|Adverse Event|4
2875696|NCT02014441|9894693|P1|Overall Study|Withdrawal by Subject|12
2875697|NCT02014402|9894789|P4|Overall Study|Lost to Follow-up|2
2875698|NCT02014402|9894790|P3|Overall Study|Lost to Follow-up|1
2875699|NCT02014402|9894791|P2|Overall Study|Lost to Follow-up|0
2875700|NCT02014402|9894792|P1|Overall Study|Lost to Follow-up|0
2875701|NCT02014402|9894789|P4|Overall Study|Subject did not have transportation|0
2875702|NCT02014402|9894790|P3|Overall Study|Subject did not have transportation|0
2875703|NCT02014402|9894791|P2|Overall Study|Subject did not have transportation|1
2875704|NCT02014402|9894792|P1|Overall Study|Subject did not have transportation|0
2875705|NCT02014402|9894789|P4|Overall Study|Withdrawal by Subject|1
2875706|NCT02014402|9894790|P3|Overall Study|Withdrawal by Subject|2
2875707|NCT02014402|9894791|P2|Overall Study|Withdrawal by Subject|2
2875708|NCT02014402|9894792|P1|Overall Study|Withdrawal by Subject|1
2875709|NCT02014402|9894789|P4|Overall Study|Adverse Event|0
2875710|NCT02014402|9894790|P3|Overall Study|Adverse Event|0
2875711|NCT02014402|9894791|P2|Overall Study|Adverse Event|0
2875712|NCT02014402|9894792|P1|Overall Study|Adverse Event|1
2875713|NCT02014376|9894822|P3|Overall Study|Lost to Follow-up|0
2875714|NCT02014376|9894823|P2|Overall Study|Lost to Follow-up|0
2875715|NCT02014376|9894824|P1|Overall Study|Lost to Follow-up|2
2875716|NCT02014376|9894822|P3|Overall Study|Adverse Event|0
2875717|NCT02014376|9894823|P2|Overall Study|Adverse Event|1
2875718|NCT02014376|9894824|P1|Overall Study|Adverse Event|1
2875719|NCT02014272|9894860|P2|Intervention Period 1|Adverse Event|1
2875720|NCT02014272|9894861|P1|Intervention Period 1|Adverse Event|0
2875721|NCT02014272|9894860|P2|Intervention Period 1|Withdrawal by Subject|0
2875722|NCT02014272|9894861|P1|Intervention Period 1|Withdrawal by Subject|1
2875723|NCT02014116|9894888|P9|Overall Study|Physician Decision|1
2875724|NCT02014116|9894889|P8|Overall Study|Physician Decision|0
2875725|NCT02014116|9894890|P7|Overall Study|Physician Decision|0
2875726|NCT02014116|9894891|P6|Overall Study|Physician Decision|0
2875727|NCT02014116|9894892|P5|Overall Study|Physician Decision|0
2875728|NCT02014116|9894893|P4|Overall Study|Physician Decision|0
2875729|NCT02014116|9894894|P3|Overall Study|Physician Decision|0
2875730|NCT02014116|9894895|P2|Overall Study|Physician Decision|0
2875731|NCT02014116|9894896|P1|Overall Study|Physician Decision|0
2875732|NCT02014116|9894888|P9|Overall Study|Withdrawal Caregiver Decision|0
2875733|NCT02014116|9894889|P8|Overall Study|Withdrawal Caregiver Decision|0
2875734|NCT02014116|9894890|P7|Overall Study|Withdrawal Caregiver Decision|0
2875735|NCT02014116|9894891|P6|Overall Study|Withdrawal Caregiver Decision|1
2875736|NCT02014116|9894892|P5|Overall Study|Withdrawal Caregiver Decision|0
2875737|NCT02014116|9894893|P4|Overall Study|Withdrawal Caregiver Decision|0
2875738|NCT02014116|9894894|P3|Overall Study|Withdrawal Caregiver Decision|0
2875739|NCT02014116|9894895|P2|Overall Study|Withdrawal Caregiver Decision|0
2875740|NCT02014116|9894896|P1|Overall Study|Withdrawal Caregiver Decision|0
2875741|NCT02014116|9894888|P9|Overall Study|Withdrawal by Subject|0
2875742|NCT02014116|9894889|P8|Overall Study|Withdrawal by Subject|0
2875743|NCT02014116|9894890|P7|Overall Study|Withdrawal by Subject|0
2875744|NCT02014116|9894891|P6|Overall Study|Withdrawal by Subject|1
2875745|NCT02014116|9894892|P5|Overall Study|Withdrawal by Subject|0
2875746|NCT02014116|9894893|P4|Overall Study|Withdrawal by Subject|1
2875747|NCT02014116|9894894|P3|Overall Study|Withdrawal by Subject|1
2875748|NCT02014116|9894895|P2|Overall Study|Withdrawal by Subject|0
2875749|NCT02014116|9894896|P1|Overall Study|Withdrawal by Subject|0
2875750|NCT02014116|9894888|P9|Overall Study|Death|1
2875751|NCT02014116|9894889|P8|Overall Study|Death|1
2875752|NCT02014116|9894890|P7|Overall Study|Death|0
2875753|NCT02014116|9894891|P6|Overall Study|Death|0
2875754|NCT02014116|9894892|P5|Overall Study|Death|0
2875755|NCT02014116|9894893|P4|Overall Study|Death|0
2875756|NCT02014116|9894894|P3|Overall Study|Death|0
2875757|NCT02014116|9894895|P2|Overall Study|Death|0
2875758|NCT02014116|9894896|P1|Overall Study|Death|0
2875759|NCT02014116|9894888|P9|Overall Study|Lost to Follow-up|1
2875760|NCT02014116|9894889|P8|Overall Study|Lost to Follow-up|0
2875761|NCT02014116|9894890|P7|Overall Study|Lost to Follow-up|0
2875762|NCT02014116|9894891|P6|Overall Study|Lost to Follow-up|1
2875763|NCT02014116|9894892|P5|Overall Study|Lost to Follow-up|0
2875764|NCT02014116|9894893|P4|Overall Study|Lost to Follow-up|0
2875765|NCT02014116|9894894|P3|Overall Study|Lost to Follow-up|0
2875766|NCT02014116|9894895|P2|Overall Study|Lost to Follow-up|0
2875767|NCT02014116|9894896|P1|Overall Study|Lost to Follow-up|0
2875768|NCT02014116|9894888|P9|Overall Study|Adverse Event|0
2875769|NCT02014116|9894889|P8|Overall Study|Adverse Event|1
2875770|NCT02014116|9894890|P7|Overall Study|Adverse Event|0
2875772|NCT02014116|9894892|P5|Overall Study|Adverse Event|1
2875773|NCT02014116|9894893|P4|Overall Study|Adverse Event|0
2875774|NCT02014116|9894894|P3|Overall Study|Adverse Event|0
2875775|NCT02014116|9894895|P2|Overall Study|Adverse Event|0
2875776|NCT02014116|9894896|P1|Overall Study|Adverse Event|0
2875777|NCT02014116|9894888|P9|Overall Study|Progressive Disease|7
2875778|NCT02014116|9894889|P8|Overall Study|Progressive Disease|3
2875779|NCT02014116|9894890|P7|Overall Study|Progressive Disease|1
2875780|NCT02014116|9894891|P6|Overall Study|Progressive Disease|13
2875781|NCT02014116|9894892|P5|Overall Study|Progressive Disease|1
2875782|NCT02014116|9894893|P4|Overall Study|Progressive Disease|6
2875783|NCT02014116|9894894|P3|Overall Study|Progressive Disease|2
2875784|NCT02014116|9894895|P2|Overall Study|Progressive Disease|4
2875785|NCT02014116|9894896|P1|Overall Study|Progressive Disease|3
2875786|NCT02013830|9894961|P1|Overall Study|Refused treatment|1
2875787|NCT02013830|9894961|P1|Overall Study|Insufficient therapeutic response|25
2875788|NCT02013830|9894961|P1|Overall Study|Death|1
2875789|NCT02013830|9894961|P1|Overall Study|Adverse Event|3
2875790|NCT02013817|9894972|P1|Overall Study|Other|9
2875791|NCT02013817|9894972|P1|Overall Study|Death|2
2875792|NCT02013817|9894972|P1|Overall Study|Withdrawal by Subject|4
2875793|NCT02013817|9894972|P1|Overall Study|Adverse Event|12
2875794|NCT02013791|9894990|P9|Period 1|Other Miscellaneous Reasons|0
2875795|NCT02013791|9894991|P8|Period 1|Other Miscellaneous Reasons|0
2875796|NCT02013791|9894992|P7|Period 1|Other Miscellaneous Reasons|0
2875797|NCT02013791|9894993|P6|Period 1|Other Miscellaneous Reasons|0
2875798|NCT02013791|9894994|P5|Period 1|Other Miscellaneous Reasons|0
2875799|NCT02013791|9894995|P4|Period 1|Other Miscellaneous Reasons|0
2875800|NCT02013791|9894996|P3|Period 1|Other Miscellaneous Reasons|0
2875801|NCT02013791|9894997|P2|Period 1|Other Miscellaneous Reasons|2
2875802|NCT02013791|9894998|P1|Period 1|Other Miscellaneous Reasons|0
2875803|NCT02013791|9894990|P9|Period 1|Lost to Follow-up|0
2875804|NCT02013791|9894991|P8|Period 1|Lost to Follow-up|1
2875805|NCT02013791|9894992|P7|Period 1|Lost to Follow-up|1
2875806|NCT02013791|9894993|P6|Period 1|Lost to Follow-up|0
2875807|NCT02013791|9894994|P5|Period 1|Lost to Follow-up|0
2875808|NCT02013791|9894995|P4|Period 1|Lost to Follow-up|1
2875809|NCT02013791|9894996|P3|Period 1|Lost to Follow-up|0
2875810|NCT02013791|9894997|P2|Period 1|Lost to Follow-up|0
2875811|NCT02013791|9894998|P1|Period 1|Lost to Follow-up|0
2875812|NCT02013778|9895019|P1|Overall Study|Adverse Event|1
2875813|NCT02013778|9895019|P1|Overall Study|Physician Decision|1
2875814|NCT02013778|9895019|P1|Overall Study|Withdrawal by Subject|1
2875815|NCT02013778|9895019|P1|Overall Study|Death|4
2875816|NCT02013765|9895023|P1|Overall Study|Trial was terminated by sponsor|1
2875817|NCT02013687|9895037|P4|Overall Study|Missed visits due to patient travel|0
2875818|NCT02013687|9895038|P3|Overall Study|Missed visits due to patient travel|1
2875819|NCT02013687|9895039|P2|Overall Study|Missed visits due to patient travel|0
2875820|NCT02013687|9895040|P1|Overall Study|Missed visits due to patient travel|0
2875821|NCT02013687|9895037|P4|Overall Study|Withdrawal by Subject|1
2875822|NCT02013687|9895038|P3|Overall Study|Withdrawal by Subject|0
2875823|NCT02013687|9895039|P2|Overall Study|Withdrawal by Subject|0
2875824|NCT02013687|9895040|P1|Overall Study|Withdrawal by Subject|0
2875825|NCT02013687|9895037|P4|Overall Study|Protocol Violation|1
2875826|NCT02013687|9895038|P3|Overall Study|Protocol Violation|0
2875827|NCT02013687|9895039|P2|Overall Study|Protocol Violation|0
2875828|NCT02013687|9895040|P1|Overall Study|Protocol Violation|0
2875829|NCT02013687|9895037|P4|Overall Study|Lost to Follow-up|0
2875830|NCT02013687|9895038|P3|Overall Study|Lost to Follow-up|1
2875831|NCT02013687|9895039|P2|Overall Study|Lost to Follow-up|0
2875832|NCT02013687|9895040|P1|Overall Study|Lost to Follow-up|0
2875833|NCT02013674|9895072|P2|Overall Study|Lost to Follow-up|0
2875834|NCT02013674|9895073|P1|Overall Study|Lost to Follow-up|1
2875835|NCT02013674|9895072|P2|Overall Study|Death|1
2875836|NCT02013674|9895073|P1|Overall Study|Death|0
2875837|NCT02013622|9895123|P1|Overall Study|Lack of Efficacy|1
2875838|NCT02013622|9895123|P1|Overall Study|Protocol Deviation|1
2875839|NCT02013622|9895123|P1|Overall Study|Withdrawal by Subject|6
2875840|NCT02013622|9895123|P1|Overall Study|Met Withdrawal Criteria|3
2875841|NCT02013622|9895123|P1|Overall Study|Adverse Event|3
2875842|NCT02013622|9895123|P1|Overall Study|Lost to Follow-up|10
2875843|NCT02013609|9895143|P1|Overall Study|Met Withdrawal Criteria|3
2875844|NCT02013609|9895143|P1|Overall Study|Adverse Event|3
2875845|NCT02013609|9895143|P1|Overall Study|Lost to Follow-up|3
2875846|NCT02013609|9895143|P1|Overall Study|Withdrawal by Subject|9
2875847|NCT02013544|9895168|P2|Overall Study|Entry criteria not met/non-compliance|3
2875848|NCT02013544|9895169|P1|Overall Study|Entry criteria not met/non-compliance|2
2875849|NCT02013544|9895168|P2|Overall Study|Physician Decision|1
2875850|NCT02013544|9895169|P1|Overall Study|Physician Decision|0
2875851|NCT02013544|9895168|P2|Overall Study|Withdrawal by Subject|8
2875852|NCT02013544|9895169|P1|Overall Study|Withdrawal by Subject|2
2875853|NCT02013544|9895168|P2|Overall Study|Lost to Follow-up|3
2875854|NCT02013544|9895169|P1|Overall Study|Lost to Follow-up|2
2875855|NCT02013544|9895168|P2|Overall Study|Adverse Event|5
2875856|NCT02013544|9895169|P1|Overall Study|Adverse Event|5
2875857|NCT02013531|9895191|P1|Overall Study|Withdrawal by Subject|1
2875858|NCT02013531|9895191|P1|Overall Study|Met Withdrawal Criteria|1
2875859|NCT02013531|9895191|P1|Overall Study|Lost to Follow-up|3
2875860|NCT02013388|9895227|P8|Overall Study|work emergency|0
2875861|NCT02013388|9895228|P7|Overall Study|work emergency|0
2875862|NCT02013388|9895229|P6|Overall Study|work emergency|0
2875863|NCT02013388|9895230|P5|Overall Study|work emergency|1
2875864|NCT02013388|9895231|P4|Overall Study|work emergency|0
2875865|NCT02013388|9895232|P3|Overall Study|work emergency|0
2875866|NCT02013388|9895233|P2|Overall Study|work emergency|0
2875867|NCT02013388|9895234|P1|Overall Study|work emergency|1
2875868|NCT02013375|9895268|P1|Overall Study|Did not engraft|1
2875869|NCT02013375|9895268|P1|Overall Study|Did not engraft|1
2875870|NCT02013206|9895298|P2|Overall Study|Other reasons off treatment|2
2875871|NCT02013206|9895299|P1|Overall Study|Other reasons off treatment|5
2875872|NCT02013206|9895298|P2|Overall Study|Death|2
2875873|NCT02013206|9895299|P1|Overall Study|Death|1
2875874|NCT02013206|9895298|P2|Overall Study|Patient non-compliance|0
2875875|NCT02013206|9895299|P1|Overall Study|Patient non-compliance|1
2875876|NCT02013206|9895298|P2|Overall Study|Patient refusal|0
2875877|NCT02013206|9895299|P1|Overall Study|Patient refusal|2
2875878|NCT02013206|9895298|P2|Overall Study|Adverse Event|0
2875879|NCT02013206|9895299|P1|Overall Study|Adverse Event|1
2875880|NCT02013206|9895298|P2|Overall Study|Symptomatic deterioration|1
2875881|NCT02013206|9895299|P1|Overall Study|Symptomatic deterioration|3
2875882|NCT02013206|9895298|P2|Overall Study|Progressive disease (PD)|17
2875883|NCT02013206|9895299|P1|Overall Study|Progressive disease (PD)|14
2875884|NCT02013167|9895330|P2|Overall Study|Death|160
2875885|NCT02013167|9895331|P1|Overall Study|Death|85
2875886|NCT02013167|9895330|P2|Overall Study|Lost to Follow-up|1
2875887|NCT02013167|9895331|P1|Overall Study|Lost to Follow-up|0
2875888|NCT02013167|9895330|P2|Overall Study|Sponsor Decision|3
2875889|NCT02013167|9895331|P1|Overall Study|Sponsor Decision|1
2875890|NCT02013167|9895330|P2|Overall Study|Withdrawal by Subject|14
2875891|NCT02013167|9895331|P1|Overall Study|Withdrawal by Subject|15
2875892|NCT02012959|9895407|P5|Treatment Phase A|Adverse Event|0
2875893|NCT02012959|9895408|P4|Treatment Phase A|Adverse Event|0
2875894|NCT02012959|9895409|P3|Treatment Phase A|Adverse Event|0
2875895|NCT02012959|9895410|P2|Treatment Phase A|Adverse Event|0
2875896|NCT02012959|9895411|P1|Treatment Phase A|Adverse Event|2
2875897|NCT02012686|9895424|P2|Overall Study|electrocardiography monitoring noise|1
2875898|NCT02012686|9895425|P1|Overall Study|electrocardiography monitoring noise|0
2875899|NCT02012686|9895424|P2|Overall Study|muscle contraction|1
2875900|NCT02012686|9895425|P1|Overall Study|muscle contraction|0
2875901|NCT02012491|9895487|P2|Overall Study|Withdrawal by Subject|0
2875902|NCT02012491|9895488|P1|Overall Study|Withdrawal by Subject|1
2875903|NCT02012491|9895487|P2|Overall Study|Protocol Violation|1
2875904|NCT02012491|9895488|P1|Overall Study|Protocol Violation|0
2875905|NCT02012491|9895487|P2|Overall Study|Lost to Follow-up|0
2875906|NCT02012491|9895488|P1|Overall Study|Lost to Follow-up|1
2875907|NCT02012452|9895506|P2|Overall Study|Withdrawal by Subject|0
2875908|NCT02012452|9895507|P1|Overall Study|Withdrawal by Subject|4
2875909|NCT02012452|9895506|P2|Overall Study|Lost to Follow-up|1
2875910|NCT02012452|9895507|P1|Overall Study|Lost to Follow-up|2
2875911|NCT02012218|9895550|P5|Overall Study|Protocol Deviation|0
2875912|NCT02012218|9895551|P4|Overall Study|Protocol Deviation|0
2875913|NCT02012218|9895552|P3|Overall Study|Protocol Deviation|0
2875914|NCT02012218|9895553|P2|Overall Study|Protocol Deviation|0
2875915|NCT02012218|9895554|P1|Overall Study|Protocol Deviation|1
2875916|NCT02012218|9895550|P5|Overall Study|Protocol Specified|0
2875917|NCT02012218|9895551|P4|Overall Study|Protocol Specified|0
2875918|NCT02012218|9895552|P3|Overall Study|Protocol Specified|0
2875919|NCT02012218|9895553|P2|Overall Study|Protocol Specified|0
2875920|NCT02012218|9895554|P1|Overall Study|Protocol Specified|1
2875921|NCT02012218|9895550|P5|Overall Study|Lost to Follow-up|0
2875922|NCT02012218|9895551|P4|Overall Study|Lost to Follow-up|0
2875923|NCT02012218|9895552|P3|Overall Study|Lost to Follow-up|1
2875924|NCT02012218|9895553|P2|Overall Study|Lost to Follow-up|1
2875925|NCT02012218|9895554|P1|Overall Study|Lost to Follow-up|0
2875926|NCT02012218|9895550|P5|Overall Study|Adverse Event|0
2875927|NCT02012218|9895551|P4|Overall Study|Adverse Event|1
2875928|NCT02012218|9895552|P3|Overall Study|Adverse Event|0
2875929|NCT02012218|9895553|P2|Overall Study|Adverse Event|0
2875930|NCT02012218|9895554|P1|Overall Study|Adverse Event|1
2875931|NCT02012218|9895550|P5|Overall Study|Withdrawal by Subject|1
2875932|NCT02012218|9895551|P4|Overall Study|Withdrawal by Subject|1
2875933|NCT02012218|9895552|P3|Overall Study|Withdrawal by Subject|1
2875934|NCT02012218|9895553|P2|Overall Study|Withdrawal by Subject|0
2875935|NCT02012218|9895554|P1|Overall Study|Withdrawal by Subject|1
2875936|NCT02011945|9895578|P3|Overall Study|Sub-Optimal Response to dasatinib|0
2875937|NCT02011945|9895579|P2|Overall Study|Sub-Optimal Response to dasatinib|0
2875938|NCT02011945|9895580|P1|Overall Study|Sub-Optimal Response to dasatinib|1
2875939|NCT02011945|9895578|P3|Overall Study|Proceeded to stem cell transplant|1
2875940|NCT02011945|9895579|P2|Overall Study|Proceeded to stem cell transplant|0
2875941|NCT02011945|9895580|P1|Overall Study|Proceeded to stem cell transplant|0
2875942|NCT02011945|9895578|P3|Overall Study|No Longer Meets Study Criteria|0
2875943|NCT02011945|9895579|P2|Overall Study|No Longer Meets Study Criteria|0
2875944|NCT02011945|9895580|P1|Overall Study|No Longer Meets Study Criteria|1
2875945|NCT02011945|9895578|P3|Overall Study|Treatment Failure|6
2875946|NCT02011945|9895579|P2|Overall Study|Treatment Failure|7
2875947|NCT02011945|9895580|P1|Overall Study|Treatment Failure|0
2875948|NCT02011945|9895578|P3|Overall Study|Study Drug Toxicity|1
2875949|NCT02011945|9895579|P2|Overall Study|Study Drug Toxicity|0
2875950|NCT02011945|9895580|P1|Overall Study|Study Drug Toxicity|0
2875951|NCT02011945|9895578|P3|Overall Study|Adverse Event unrelated to Drug|1
2875952|NCT02011945|9895579|P2|Overall Study|Adverse Event unrelated to Drug|2
2875953|NCT02011945|9895580|P1|Overall Study|Adverse Event unrelated to Drug|0
2875954|NCT02011945|9895578|P3|Overall Study|Participant requested to Discontinue|1
2875955|NCT02011945|9895579|P2|Overall Study|Participant requested to Discontinue|1
2875956|NCT02011945|9895580|P1|Overall Study|Participant requested to Discontinue|0
2875957|NCT02011893|9895657|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
2875958|NCT02011893|9895658|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2875959|NCT02011893|9895659|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2875960|NCT02011893|9895657|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
2875961|NCT02011893|9895658|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2875962|NCT02011893|9895659|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2875963|NCT02011893|9895657|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
2875964|NCT02011893|9895658|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2875965|NCT02011893|9895659|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2875966|NCT02011893|9895657|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
2875967|NCT02011893|9895658|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
2875968|NCT02011893|9895659|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
2875969|NCT02011893|9895657|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2875970|NCT02011893|9895658|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2875971|NCT02011893|9895659|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
2875972|NCT02011893|9895657|P3|Enrollment to Randomization|Screening Failure|0
2875973|NCT02011893|9895658|P2|Enrollment to Randomization|Screening Failure|0
2875974|NCT02011893|9895659|P1|Enrollment to Randomization|Screening Failure|29
2875975|NCT02011893|9895657|P3|Enrollment to Randomization|Withdrawal by Subject|0
2875976|NCT02011893|9895658|P2|Enrollment to Randomization|Withdrawal by Subject|0
2875977|NCT02011893|9895659|P1|Enrollment to Randomization|Withdrawal by Subject|21
2875978|NCT02011893|9895657|P3|Enrollment to Randomization|Physician Decision|0
2875979|NCT02011893|9895658|P2|Enrollment to Randomization|Physician Decision|0
2875980|NCT02011893|9895659|P1|Enrollment to Randomization|Physician Decision|10
2875981|NCT02011893|9895657|P3|Enrollment to Randomization|Adverse Event|0
2875982|NCT02011893|9895658|P2|Enrollment to Randomization|Adverse Event|0
2875983|NCT02011893|9895659|P1|Enrollment to Randomization|Adverse Event|2
2875984|NCT02011542|9895670|P1|Overall Study|Physician Decision|1
2875985|NCT02011113|9895801|P1|Overall Study|Study terminated by sponsor|11
2875986|NCT02011113|9895801|P1|Overall Study|Investigator's judgement- DP|3
2875987|NCT02011113|9895801|P1|Overall Study|Insufficient effect of Pomalidomide|1
2875988|NCT02011113|9895801|P1|Overall Study|Death|1
2875989|NCT02011113|9895801|P1|Overall Study|Disease Progression (DP)|16
2875990|NCT02011113|9895801|P1|Overall Study|Adverse Event|4
2875991|NCT02010775|9895833|P5|Overall Study|Personal Reasons|4
2875992|NCT02010775|9895834|P4|Overall Study|Personal Reasons|2
2875993|NCT02010775|9895835|P3|Overall Study|Personal Reasons|1
2875994|NCT02010775|9895836|P2|Overall Study|Personal Reasons|3
2875995|NCT02010775|9895837|P1|Overall Study|Personal Reasons|3
2875996|NCT02010775|9895833|P5|Overall Study|Lost to Follow-up|1
2875997|NCT02010775|9895834|P4|Overall Study|Lost to Follow-up|1
2875998|NCT02010775|9895835|P3|Overall Study|Lost to Follow-up|0
2875999|NCT02010775|9895836|P2|Overall Study|Lost to Follow-up|0
2876000|NCT02010775|9895837|P1|Overall Study|Lost to Follow-up|2
2876001|NCT02010775|9895833|P5|Overall Study|Pregnancy|0
2876002|NCT02010775|9895834|P4|Overall Study|Pregnancy|0
2876003|NCT02010775|9895835|P3|Overall Study|Pregnancy|2
2876004|NCT02010775|9895836|P2|Overall Study|Pregnancy|0
2876005|NCT02010775|9895837|P1|Overall Study|Pregnancy|0
2876006|NCT02010775|9895833|P5|Overall Study|Adverse Event|1
2876007|NCT02010775|9895834|P4|Overall Study|Adverse Event|0
2876008|NCT02010775|9895835|P3|Overall Study|Adverse Event|0
2876009|NCT02010775|9895836|P2|Overall Study|Adverse Event|0
2876010|NCT02010775|9895837|P1|Overall Study|Adverse Event|0
2876011|NCT02010684|9895878|P2|Overall Study|Withdrawal by Subject|5
2876012|NCT02010684|9895879|P1|Overall Study|Withdrawal by Subject|4
2876013|NCT02010684|9895878|P2|Overall Study|Lost to Follow-up|18
2876014|NCT02010684|9895879|P1|Overall Study|Lost to Follow-up|8
2876015|NCT02010632|9895901|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
2876016|NCT02010632|9895902|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
2876017|NCT02010567|9895913|P5|Overall Study|Adverse Event|1
2876018|NCT02010567|9895914|P4|Overall Study|Adverse Event|0
2876019|NCT02010567|9895915|P3|Overall Study|Adverse Event|1
2876020|NCT02010567|9895916|P2|Overall Study|Adverse Event|0
2876021|NCT02010567|9895917|P1|Overall Study|Adverse Event|0
2876022|NCT02010255|9895969|P14|Overall Study|Randomized but Not Treated|1
2876023|NCT02010255|9895970|P13|Overall Study|Randomized but Not Treated|0
2876024|NCT02010255|9895971|P12|Overall Study|Randomized but Not Treated|0
2876025|NCT02010255|9895972|P11|Overall Study|Randomized but Not Treated|0
2876026|NCT02010255|9895973|P10|Overall Study|Randomized but Not Treated|0
2876027|NCT02010255|9895974|P9|Overall Study|Randomized but Not Treated|0
2876028|NCT02010255|9895975|P8|Overall Study|Randomized but Not Treated|0
2876029|NCT02010255|9895976|P7|Overall Study|Randomized but Not Treated|0
2876030|NCT02010255|9895977|P6|Overall Study|Randomized but Not Treated|0
2876031|NCT02010255|9895978|P5|Overall Study|Randomized but Not Treated|0
2876032|NCT02010255|9895979|P4|Overall Study|Randomized but Not Treated|0
2876033|NCT02010255|9895980|P3|Overall Study|Randomized but Not Treated|0
2876034|NCT02010255|9895981|P2|Overall Study|Randomized but Not Treated|0
2876035|NCT02010255|9895982|P1|Overall Study|Randomized but Not Treated|0
2876036|NCT02010255|9895969|P14|Overall Study|Lost to Follow-up|0
2876037|NCT02010255|9895970|P13|Overall Study|Lost to Follow-up|0
2876038|NCT02010255|9895971|P12|Overall Study|Lost to Follow-up|0
2876039|NCT02010255|9895972|P11|Overall Study|Lost to Follow-up|0
2876040|NCT02010255|9895973|P10|Overall Study|Lost to Follow-up|0
2876041|NCT02010255|9895974|P9|Overall Study|Lost to Follow-up|0
2876042|NCT02010255|9895975|P8|Overall Study|Lost to Follow-up|0
2876043|NCT02010255|9895976|P7|Overall Study|Lost to Follow-up|0
2876044|NCT02010255|9895977|P6|Overall Study|Lost to Follow-up|0
2876045|NCT02010255|9895978|P5|Overall Study|Lost to Follow-up|1
2876046|NCT02010255|9895979|P4|Overall Study|Lost to Follow-up|0
2876047|NCT02010255|9895980|P3|Overall Study|Lost to Follow-up|1
2876048|NCT02010255|9895981|P2|Overall Study|Lost to Follow-up|0
2876049|NCT02010255|9895982|P1|Overall Study|Lost to Follow-up|0
2876050|NCT02010255|9895969|P14|Overall Study|Adverse Event|0
2876051|NCT02010255|9895970|P13|Overall Study|Adverse Event|0
2876052|NCT02010255|9895971|P12|Overall Study|Adverse Event|0
2876053|NCT02010255|9895972|P11|Overall Study|Adverse Event|0
2876054|NCT02010255|9895973|P10|Overall Study|Adverse Event|0
2876055|NCT02010255|9895974|P9|Overall Study|Adverse Event|0
2876056|NCT02010255|9895975|P8|Overall Study|Adverse Event|0
2876057|NCT02010255|9895976|P7|Overall Study|Adverse Event|0
2876058|NCT02010255|9895977|P6|Overall Study|Adverse Event|0
2876059|NCT02010255|9895978|P5|Overall Study|Adverse Event|0
2876060|NCT02010255|9895979|P4|Overall Study|Adverse Event|0
2876061|NCT02010255|9895980|P3|Overall Study|Adverse Event|0
2876062|NCT02010255|9895981|P2|Overall Study|Adverse Event|0
2876063|NCT02010255|9895982|P1|Overall Study|Adverse Event|1
2876064|NCT02010255|9895969|P14|Overall Study|Withdrew Consent|0
2876065|NCT02010255|9895970|P13|Overall Study|Withdrew Consent|0
2876066|NCT02010255|9895971|P12|Overall Study|Withdrew Consent|0
2876067|NCT02010255|9895972|P11|Overall Study|Withdrew Consent|0
2876068|NCT02010255|9895973|P10|Overall Study|Withdrew Consent|0
2876069|NCT02010255|9895974|P9|Overall Study|Withdrew Consent|0
2876070|NCT02010255|9895975|P8|Overall Study|Withdrew Consent|0
2876071|NCT02010255|9895976|P7|Overall Study|Withdrew Consent|0
2876072|NCT02010255|9895977|P6|Overall Study|Withdrew Consent|0
2876073|NCT02010255|9895978|P5|Overall Study|Withdrew Consent|0
2876074|NCT02010255|9895979|P4|Overall Study|Withdrew Consent|1
2876075|NCT02010255|9895980|P3|Overall Study|Withdrew Consent|0
2876076|NCT02010255|9895981|P2|Overall Study|Withdrew Consent|0
2876077|NCT02010255|9895982|P1|Overall Study|Withdrew Consent|1
2876078|NCT02010255|9895969|P14|Overall Study|Lack of Efficacy|0
2876079|NCT02010255|9895970|P13|Overall Study|Lack of Efficacy|0
2876080|NCT02010255|9895971|P12|Overall Study|Lack of Efficacy|0
2876081|NCT02010255|9895972|P11|Overall Study|Lack of Efficacy|1
2876082|NCT02010255|9895973|P10|Overall Study|Lack of Efficacy|0
2876083|NCT02010255|9895974|P9|Overall Study|Lack of Efficacy|0
2876084|NCT02010255|9895975|P8|Overall Study|Lack of Efficacy|0
2876085|NCT02010255|9895976|P7|Overall Study|Lack of Efficacy|0
2876086|NCT02010255|9895977|P6|Overall Study|Lack of Efficacy|0
2876087|NCT02010255|9895978|P5|Overall Study|Lack of Efficacy|1
2876088|NCT02010255|9895979|P4|Overall Study|Lack of Efficacy|1
2876089|NCT02010255|9895980|P3|Overall Study|Lack of Efficacy|2
2876090|NCT02010255|9895981|P2|Overall Study|Lack of Efficacy|1
2876091|NCT02010255|9895982|P1|Overall Study|Lack of Efficacy|4
2876092|NCT02010255|9895969|P14|Overall Study|Death|0
2876093|NCT02010255|9895970|P13|Overall Study|Death|0
2876094|NCT02010255|9895971|P12|Overall Study|Death|1
2876095|NCT02010255|9895972|P11|Overall Study|Death|1
2876096|NCT02010255|9895973|P10|Overall Study|Death|0
2876097|NCT02010255|9895974|P9|Overall Study|Death|1
2876098|NCT02010255|9895975|P8|Overall Study|Death|1
2876099|NCT02010255|9895976|P7|Overall Study|Death|1
2876100|NCT02010255|9895977|P6|Overall Study|Death|0
2876101|NCT02010255|9895978|P5|Overall Study|Death|2
2876102|NCT02010255|9895979|P4|Overall Study|Death|4
2876103|NCT02010255|9895980|P3|Overall Study|Death|4
2876104|NCT02010255|9895981|P2|Overall Study|Death|1
2876105|NCT02010255|9895982|P1|Overall Study|Death|0
2876106|NCT02009878|9896430|P3|Overall Study|Participant Met Withdrawal Criteria|0
2876107|NCT02009878|9896431|P2|Overall Study|Participant Met Withdrawal Criteria|1
2876108|NCT02009878|9896432|P1|Overall Study|Participant Met Withdrawal Criteria|0
2876109|NCT02009865|9896466|P2|Overall Study|Withdrawal by Subject|1
2876110|NCT02009865|9896467|P1|Overall Study|Withdrawal by Subject|1
2876111|NCT02009865|9896466|P2|Overall Study|Protocol Violation|2
2876112|NCT02009865|9896467|P1|Overall Study|Protocol Violation|0
2876113|NCT02009865|9896466|P2|Overall Study|Adverse Event|2
2876114|NCT02009865|9896467|P1|Overall Study|Adverse Event|0
2876115|NCT02009722|9896483|P2|Overall Study|Did not receive intervention|1
2876116|NCT02009722|9896484|P1|Overall Study|Did not receive intervention|0
2876117|NCT02009722|9896483|P2|Overall Study|Protocol Violation|2
2876118|NCT02009722|9896484|P1|Overall Study|Protocol Violation|1
2876119|NCT02009696|9896508|P1|Overall Study|Withdrawal by Subject|2
2876120|NCT02009163|9896525|P3|Randomized-withdrawal Period|Other|5
2876121|NCT02009163|9896526|P2|Randomized-withdrawal Period|Other|9
2876122|NCT02009163|9896527|P1|Randomized-withdrawal Period|Other|0
2876123|NCT02009163|9896525|P3|Randomized-withdrawal Period|Pregnancy|2
2876124|NCT02009163|9896526|P2|Randomized-withdrawal Period|Pregnancy|0
2876125|NCT02009163|9896527|P1|Randomized-withdrawal Period|Pregnancy|0
2876126|NCT02009163|9896525|P3|Randomized-withdrawal Period|Protocol Violation|2
2876127|NCT02009163|9896526|P2|Randomized-withdrawal Period|Protocol Violation|1
2876128|NCT02009163|9896527|P1|Randomized-withdrawal Period|Protocol Violation|0
2876129|NCT02009163|9896525|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
2876130|NCT02009163|9896526|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
2876131|NCT02009163|9896527|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
2876132|NCT02009163|9896525|P3|Randomized-withdrawal Period|Adverse Event|6
2876133|NCT02009163|9896526|P2|Randomized-withdrawal Period|Adverse Event|0
2876134|NCT02009163|9896527|P1|Randomized-withdrawal Period|Adverse Event|0
2876135|NCT02009163|9896525|P3|Randomized-withdrawal Period|Lost to Follow-up|6
2876136|NCT02009163|9896526|P2|Randomized-withdrawal Period|Lost to Follow-up|13
2876137|NCT02009163|9896527|P1|Randomized-withdrawal Period|Lost to Follow-up|0
2876138|NCT02009163|9896525|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
2876139|NCT02009163|9896526|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
2876140|NCT02009163|9896527|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
2876141|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Other|0
2876142|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Other|0
2876143|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Other|13
2876144|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Pregnancy|0
2876145|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Pregnancy|0
2876146|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Pregnancy|1
2876147|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Protocol Violation|0
2876148|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Protocol Violation|0
2876149|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Protocol Violation|10
2876150|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
2876151|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
2876152|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
2876153|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Adverse Event|0
2876154|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Adverse Event|0
2876155|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Adverse Event|22
2876156|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2876157|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2876158|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
2876159|NCT02009163|9896525|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2876160|NCT02009163|9896526|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2876161|NCT02009163|9896527|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
2876162|NCT02009046|9896562|P2|Overall Study|Lost to Follow-up|206
2876163|NCT02009046|9896563|P1|Overall Study|Lost to Follow-up|256
2876164|NCT02008916|9896623|P3|Week 16 - 156|Physician Decision|0
2876165|NCT02008916|9896624|P2|Week 16 - 156|Physician Decision|1
2876166|NCT02008916|9896625|P1|Week 16 - 156|Physician Decision|0
2876167|NCT02008916|9896623|P3|Week 16 - 156|Pregnancy|0
2876168|NCT02008916|9896624|P2|Week 16 - 156|Pregnancy|1
2876169|NCT02008916|9896625|P1|Week 16 - 156|Pregnancy|0
2876170|NCT02008916|9896623|P3|Week 16 - 156|Lack of Efficacy|2
2876171|NCT02008916|9896624|P2|Week 16 - 156|Lack of Efficacy|5
2876172|NCT02008916|9896625|P1|Week 16 - 156|Lack of Efficacy|3
2876173|NCT02008916|9896623|P3|Week 16 - 156|Lost to Follow-up|0
2876174|NCT02008916|9896624|P2|Week 16 - 156|Lost to Follow-up|0
2876175|NCT02008916|9896625|P1|Week 16 - 156|Lost to Follow-up|5
2876176|NCT02008916|9896623|P3|Week 16 - 156|No longer requires treatment|0
2876177|NCT02008916|9896624|P2|Week 16 - 156|No longer requires treatment|1
2876178|NCT02008916|9896625|P1|Week 16 - 156|No longer requires treatment|0
2876179|NCT02008916|9896623|P3|Week 16 - 156|Withdrawal by Subject|5
2876180|NCT02008916|9896624|P2|Week 16 - 156|Withdrawal by Subject|3
2876181|NCT02008916|9896625|P1|Week 16 - 156|Withdrawal by Subject|7
2876182|NCT02008916|9896623|P3|Week 16 - 156|Adverse Event|3
2876183|NCT02008916|9896624|P2|Week 16 - 156|Adverse Event|2
2876184|NCT02008916|9896625|P1|Week 16 - 156|Adverse Event|4
2876185|NCT02008916|9896623|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
2876186|NCT02008916|9896624|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
2876187|NCT02008916|9896625|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
2876188|NCT02008890|9896661|P5|Extension Period|Adverse Event|2
2876189|NCT02008890|9896662|P4|Extension Period|Adverse Event|0
2876190|NCT02008890|9896663|P3|Extension Period|Adverse Event|0
2876191|NCT02008890|9896664|P2|Extension Period|Adverse Event|3
2876192|NCT02008890|9896665|P1|Extension Period|Adverse Event|1
2876193|NCT02008890|9896661|P5|Extension Period|Lost to Follow-up|0
2876194|NCT02008890|9896662|P4|Extension Period|Lost to Follow-up|0
2876195|NCT02008890|9896663|P3|Extension Period|Lost to Follow-up|0
2876196|NCT02008890|9896664|P2|Extension Period|Lost to Follow-up|0
2876197|NCT02008890|9896665|P1|Extension Period|Lost to Follow-up|1
2876198|NCT02008890|9896661|P5|Extension Period|Withdrawal by Subject|2
2876199|NCT02008890|9896662|P4|Extension Period|Withdrawal by Subject|4
2876200|NCT02008890|9896663|P3|Extension Period|Withdrawal by Subject|0
2876201|NCT02008890|9896664|P2|Extension Period|Withdrawal by Subject|2
2876202|NCT02008890|9896665|P1|Extension Period|Withdrawal by Subject|3
2876203|NCT02008890|9896661|P5|Period 2|Lost to Follow-up|0
2876204|NCT02008890|9896662|P4|Period 2|Lost to Follow-up|0
2876205|NCT02008890|9896663|P3|Period 2|Lost to Follow-up|1
2876206|NCT02008890|9896664|P2|Period 2|Lost to Follow-up|0
2876207|NCT02008890|9896665|P1|Period 2|Lost to Follow-up|0
2876208|NCT02008890|9896661|P5|Period 2|Physician Decision|1
2876209|NCT02008890|9896662|P4|Period 2|Physician Decision|2
2876210|NCT02008890|9896663|P3|Period 2|Physician Decision|0
2876211|NCT02008890|9896664|P2|Period 2|Physician Decision|0
2876212|NCT02008890|9896665|P1|Period 2|Physician Decision|4
2876213|NCT02008890|9896661|P5|Period 2|Withdrawal by Subject|2
2876214|NCT02008890|9896662|P4|Period 2|Withdrawal by Subject|7
2876215|NCT02008890|9896663|P3|Period 2|Withdrawal by Subject|0
2876216|NCT02008890|9896664|P2|Period 2|Withdrawal by Subject|8
2876217|NCT02008890|9896665|P1|Period 2|Withdrawal by Subject|11
2876218|NCT02008890|9896661|P5|Period 2|Adverse Event|5
2876219|NCT02008890|9896662|P4|Period 2|Adverse Event|5
2876220|NCT02008890|9896663|P3|Period 2|Adverse Event|0
2876221|NCT02008890|9896664|P2|Period 2|Adverse Event|7
2876222|NCT02008890|9896665|P1|Period 2|Adverse Event|12
2876223|NCT02008890|9896661|P5|Period 1|Adverse Event|0
2876224|NCT02008890|9896662|P4|Period 1|Adverse Event|0
2876225|NCT02008890|9896663|P3|Period 1|Adverse Event|6
2876226|NCT02008890|9896664|P2|Period 1|Adverse Event|8
2876227|NCT02008890|9896665|P1|Period 1|Adverse Event|6
2876228|NCT02008890|9896661|P5|Period 1|Physician Decision|0
2876229|NCT02008890|9896662|P4|Period 1|Physician Decision|0
2876230|NCT02008890|9896663|P3|Period 1|Physician Decision|1
2876231|NCT02008890|9896664|P2|Period 1|Physician Decision|0
2876232|NCT02008890|9896665|P1|Period 1|Physician Decision|1
2876233|NCT02008890|9896661|P5|Period 1|Pregnancy|0
2876234|NCT02008890|9896662|P4|Period 1|Pregnancy|0
2876235|NCT02008890|9896663|P3|Period 1|Pregnancy|0
2876236|NCT02008890|9896664|P2|Period 1|Pregnancy|0
2876237|NCT02008890|9896665|P1|Period 1|Pregnancy|1
2876238|NCT02008890|9896661|P5|Period 1|Withdrawal by Subject|0
2876239|NCT02008890|9896662|P4|Period 1|Withdrawal by Subject|0
2876240|NCT02008890|9896663|P3|Period 1|Withdrawal by Subject|5
2876241|NCT02008890|9896664|P2|Period 1|Withdrawal by Subject|7
2876242|NCT02008890|9896665|P1|Period 1|Withdrawal by Subject|7
2876243|NCT02008877|9896701|P3|Overall Study|Inevaluable|0
2876244|NCT02008877|9896702|P2|Overall Study|Inevaluable|1
2876245|NCT02008877|9896703|P1|Overall Study|Inevaluable|0
2876246|NCT02008773|9896722|P4|Overall Study|Lost to Follow-up|2
2876247|NCT02008773|9896723|P3|Overall Study|Lost to Follow-up|3
2876248|NCT02008773|9896724|P2|Overall Study|Lost to Follow-up|1
2876249|NCT02008773|9896725|P1|Overall Study|Lost to Follow-up|0
2876250|NCT02008773|9896722|P4|Overall Study|Withdrawal by Subject|6
2876251|NCT02008773|9896723|P3|Overall Study|Withdrawal by Subject|7
2876252|NCT02008773|9896724|P2|Overall Study|Withdrawal by Subject|4
2876253|NCT02008773|9896725|P1|Overall Study|Withdrawal by Subject|8
2876254|NCT02008773|9896722|P4|Overall Study|Medication Non-compliance|2
2876255|NCT02008773|9896723|P3|Overall Study|Medication Non-compliance|3
2876256|NCT02008773|9896724|P2|Overall Study|Medication Non-compliance|1
2876257|NCT02008773|9896725|P1|Overall Study|Medication Non-compliance|2
2876258|NCT02008773|9896722|P4|Overall Study|Adverse Event|2
2876259|NCT02008773|9896723|P3|Overall Study|Adverse Event|1
2876260|NCT02008773|9896724|P2|Overall Study|Adverse Event|3
2876261|NCT02008773|9896725|P1|Overall Study|Adverse Event|3
2876262|NCT02008565|9896791|P4|Overall Study|Protocol Violation|0
2876263|NCT02008565|9896792|P3|Overall Study|Protocol Violation|2
2876264|NCT02008565|9896793|P2|Overall Study|Protocol Violation|1
2876265|NCT02008565|9896794|P1|Overall Study|Protocol Violation|1
2876266|NCT02008526|9896855|P3|Overall Study|Lost to Follow-up|6
2876267|NCT02008526|9896856|P2|Overall Study|Lost to Follow-up|9
2876268|NCT02008526|9896857|P1|Overall Study|Lost to Follow-up|5
2876269|NCT02008526|9896855|P3|Overall Study|Withdrawal by Subject|2
2876270|NCT02008526|9896856|P2|Overall Study|Withdrawal by Subject|3
2876271|NCT02008526|9896857|P1|Overall Study|Withdrawal by Subject|3
2876272|NCT02008526|9896855|P3|Overall Study|Death|1
2876273|NCT02008526|9896856|P2|Overall Study|Death|2
2876274|NCT02008526|9896857|P1|Overall Study|Death|0
2876275|NCT02008370|9896868|P1|Overall Study|Lost to Follow-up|7
2876276|NCT02008318|9896876|P2|Overall Study|Withdrawal by Subject|0
2876277|NCT02008318|9896877|P1|Overall Study|Withdrawal by Subject|3
2876278|NCT02008318|9896876|P2|Overall Study|Protocol Violation|1
2876279|NCT02008318|9896877|P1|Overall Study|Protocol Violation|1
2876280|NCT02008318|9896876|P2|Overall Study|Progressive Disease|0
2876281|NCT02008318|9896877|P1|Overall Study|Progressive Disease|2
2876282|NCT02008318|9896876|P2|Overall Study|Physician Decision|0
2876283|NCT02008318|9896877|P1|Overall Study|Physician Decision|2
2876284|NCT02008318|9896876|P2|Overall Study|Adverse Event|0
2876285|NCT02008318|9896877|P1|Overall Study|Adverse Event|4
2876286|NCT02008227|9896898|P2|Overall Study|Study Terminated By Sponsor|83
2876287|NCT02008227|9896899|P1|Overall Study|Study Terminated By Sponsor|44
2876288|NCT02008227|9896898|P2|Overall Study|Withdrawal by Subject|36
2876289|NCT02008227|9896899|P1|Overall Study|Withdrawal by Subject|67
2876290|NCT02008227|9896898|P2|Overall Study|Death|485
2876291|NCT02008227|9896899|P1|Overall Study|Death|494
2876292|NCT02008227|9896898|P2|Overall Study|Lost to Follow-up|9
2876293|NCT02008227|9896899|P1|Overall Study|Lost to Follow-up|7
2876294|NCT02007954|9896987|P1|Overall Study|Death|1
2876295|NCT02007954|9896987|P1|Overall Study|Disease progression and unrelated AE|1
2876296|NCT02007954|9896987|P1|Overall Study|Switch in treatment modality|2
2876297|NCT02007954|9896987|P1|Overall Study|Received liver transplant|3
2876298|NCT02007720|9897006|P2|Overall Study|patient followd less than 165 days|5
2876299|NCT02007720|9897007|P1|Overall Study|patient followd less than 165 days|11
2876300|NCT02007720|9897006|P2|Overall Study|technical problem|2
2876301|NCT02007720|9897007|P1|Overall Study|technical problem|4
2876302|NCT02007720|9897006|P2|Overall Study|study terminated by sponsor|54
2876303|NCT02007720|9897007|P1|Overall Study|study terminated by sponsor|58
2876304|NCT02007720|9897006|P2|Overall Study|Withdrawal by Subject|11
2876305|NCT02007720|9897007|P1|Overall Study|Withdrawal by Subject|9
2876306|NCT02007577|9897042|P2|Overall Study|Withdrawal by Subject|1
2876307|NCT02007577|9897043|P1|Overall Study|Withdrawal by Subject|0
2876308|NCT02007577|9897042|P2|Overall Study|Adverse Event|0
2876309|NCT02007577|9897043|P1|Overall Study|Adverse Event|1
2876310|NCT02007512|9897055|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2876311|NCT02007512|9897056|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2876312|NCT02007512|9897057|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
2876313|NCT02007512|9897058|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2876314|NCT02007512|9897055|P4|Open Label Treatment Period|Disease progression|11
2876315|NCT02007512|9897056|P3|Open Label Treatment Period|Disease progression|0
2876316|NCT02007512|9897057|P2|Open Label Treatment Period|Disease progression|17
2876317|NCT02007512|9897058|P1|Open Label Treatment Period|Disease progression|0
2876318|NCT02007512|9897055|P4|Open Label Treatment Period|Other|1
2876319|NCT02007512|9897056|P3|Open Label Treatment Period|Other|0
2876320|NCT02007512|9897057|P2|Open Label Treatment Period|Other|0
2876321|NCT02007512|9897058|P1|Open Label Treatment Period|Other|0
2876322|NCT02007512|9897055|P4|Open Label Treatment Period|Adverse Event|0
2876323|NCT02007512|9897056|P3|Open Label Treatment Period|Adverse Event|0
2876324|NCT02007512|9897057|P2|Open Label Treatment Period|Adverse Event|1
2876325|NCT02007512|9897058|P1|Open Label Treatment Period|Adverse Event|0
2876326|NCT02007512|9897055|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
2876327|NCT02007512|9897056|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
2876328|NCT02007512|9897057|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
2876329|NCT02007512|9897058|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
2876330|NCT02007512|9897055|P4|Double Blind Treatment Period|Other|2
2876331|NCT02007512|9897056|P3|Double Blind Treatment Period|Other|1
2876332|NCT02007512|9897057|P2|Double Blind Treatment Period|Other|0
2876333|NCT02007512|9897058|P1|Double Blind Treatment Period|Other|0
2876334|NCT02007512|9897055|P4|Double Blind Treatment Period|Protocol Violation|1
2876335|NCT02007512|9897056|P3|Double Blind Treatment Period|Protocol Violation|0
2876336|NCT02007512|9897057|P2|Double Blind Treatment Period|Protocol Violation|0
2876337|NCT02007512|9897058|P1|Double Blind Treatment Period|Protocol Violation|0
2876338|NCT02007512|9897055|P4|Double Blind Treatment Period|Withdrawal by Subject|3
2876339|NCT02007512|9897056|P3|Double Blind Treatment Period|Withdrawal by Subject|3
2876340|NCT02007512|9897057|P2|Double Blind Treatment Period|Withdrawal by Subject|2
2876341|NCT02007512|9897058|P1|Double Blind Treatment Period|Withdrawal by Subject|4
2876342|NCT02007512|9897055|P4|Double Blind Treatment Period|Disease progression|51
2876343|NCT02007512|9897056|P3|Double Blind Treatment Period|Disease progression|45
2876344|NCT02007512|9897057|P2|Double Blind Treatment Period|Disease progression|49
2876345|NCT02007512|9897058|P1|Double Blind Treatment Period|Disease progression|44
2876346|NCT02007512|9897055|P4|Double Blind Treatment Period|Death|0
2876347|NCT02007512|9897056|P3|Double Blind Treatment Period|Death|0
2876348|NCT02007512|9897057|P2|Double Blind Treatment Period|Death|0
2876349|NCT02007512|9897058|P1|Double Blind Treatment Period|Death|1
2876350|NCT02007512|9897055|P4|Double Blind Treatment Period|Adverse Event|2
2876351|NCT02007512|9897056|P3|Double Blind Treatment Period|Adverse Event|6
2876352|NCT02007512|9897057|P2|Double Blind Treatment Period|Adverse Event|2
2876353|NCT02007512|9897058|P1|Double Blind Treatment Period|Adverse Event|4
2876354|NCT02007434|9897136|P8|Overall Study|Non-compliance|0
2876355|NCT02007434|9897137|P7|Overall Study|Non-compliance|0
2876356|NCT02007434|9897138|P6|Overall Study|Non-compliance|0
2876357|NCT02007434|9897139|P5|Overall Study|Non-compliance|0
2876358|NCT02007434|9897140|P4|Overall Study|Non-compliance|0
2876359|NCT02007434|9897141|P3|Overall Study|Non-compliance|1
2876360|NCT02007434|9897142|P2|Overall Study|Non-compliance|0
2876361|NCT02007434|9897143|P1|Overall Study|Non-compliance|1
2876362|NCT02007434|9897136|P8|Overall Study|Lost to Follow-up|0
2876363|NCT02007434|9897137|P7|Overall Study|Lost to Follow-up|0
2876364|NCT02007434|9897138|P6|Overall Study|Lost to Follow-up|0
2876365|NCT02007434|9897139|P5|Overall Study|Lost to Follow-up|0
2876366|NCT02007434|9897140|P4|Overall Study|Lost to Follow-up|0
2876367|NCT02007434|9897141|P3|Overall Study|Lost to Follow-up|0
2876368|NCT02007434|9897142|P2|Overall Study|Lost to Follow-up|1
2876369|NCT02007434|9897143|P1|Overall Study|Lost to Follow-up|0
2876370|NCT02007278|9897274|P2|Overall Study|Mis-randomization|1
2876371|NCT02007278|9897275|P1|Overall Study|Mis-randomization|1
2876372|NCT02007278|9897274|P2|Overall Study|Incorrect medication administration|0
2876373|NCT02007278|9897275|P1|Overall Study|Incorrect medication administration|1
2876374|NCT02007278|9897274|P2|Overall Study|Ingestion of drugs not allowed in study|1
2876375|NCT02007278|9897275|P1|Overall Study|Ingestion of drugs not allowed in study|0
2876376|NCT02007278|9897274|P2|Overall Study|Failure to comply with an eligibility|1
2876377|NCT02007278|9897275|P1|Overall Study|Failure to comply with an eligibility|0
2876378|NCT02007252|9897297|P2|Overall Study|Adverse Event|4
2876379|NCT02007252|9897298|P1|Overall Study|Adverse Event|7
2876380|NCT02007252|9897297|P2|Overall Study|Abnormal laboratory value(s)|0
2876381|NCT02007252|9897298|P1|Overall Study|Abnormal laboratory value(s)|1
2876382|NCT02007252|9897297|P2|Overall Study|Administrative problems|7
2876383|NCT02007252|9897298|P1|Overall Study|Administrative problems|3
2876384|NCT02007109|9897311|P1|Overall Study|Excluded - Age<7yo|9
2876385|NCT02007109|9897311|P1|Overall Study|Diary not returned or excluded|102
2876386|NCT02007096|9897320|P2|Overall Study|no mesh placed|1
2876387|NCT02007096|9897321|P1|Overall Study|no mesh placed|0
2876388|NCT02007096|9897320|P2|Overall Study|converted to open surgery|1
2876389|NCT02007096|9897321|P1|Overall Study|converted to open surgery|1
2876390|NCT02007096|9897320|P2|Overall Study|did not follow postoperative protocol|11
2876391|NCT02007096|9897321|P1|Overall Study|did not follow postoperative protocol|8
2876392|NCT02007096|9897320|P2|Overall Study|did not inject saline|3
2876393|NCT02007096|9897321|P1|Overall Study|did not inject saline|0
2876394|NCT02007096|9897320|P2|Overall Study|medication not available|0
2876395|NCT02007096|9897321|P1|Overall Study|medication not available|2
2876396|NCT02007070|9897333|P1|Overall Study|Progressive Disease|21
2876397|NCT02007070|9897333|P1|Overall Study|Physician Decision|1
2876398|NCT02007070|9897333|P1|Overall Study|Protocol Violation|2
2876399|NCT02007070|9897333|P1|Overall Study|Death|1
2876400|NCT02007070|9897333|P1|Overall Study|Clinical Progression|4
2876401|NCT02007070|9897333|P1|Overall Study|Adverse Event|4
2876402|NCT02006979|9897354|P2|Overall Study|Protocol Violation|1
2876403|NCT02006979|9897355|P1|Overall Study|Protocol Violation|0
2876404|NCT02006979|9897354|P2|Overall Study|Withdrawal by Subject|1
2876405|NCT02006979|9897355|P1|Overall Study|Withdrawal by Subject|1
2876406|NCT02006758|9897401|P1|Overall Study|Other|2
2876407|NCT02006758|9897401|P1|Overall Study|Procedurally excluded|1
2876408|NCT02006758|9897401|P1|Overall Study|Withdrawal by Subject|4
2876409|NCT02006758|9897401|P1|Overall Study|Lost to Follow-up|4
2876410|NCT02006758|9897401|P1|Overall Study|Death|1
2876411|NCT02006758|9897401|P1|Overall Study|Protocol Violation|1
2876412|NCT02006732|9897432|P4|Overall Study|Withdrawal by Subject|1
2876413|NCT02006732|9897433|P3|Overall Study|Withdrawal by Subject|4
2876414|NCT02006732|9897434|P2|Overall Study|Withdrawal by Subject|0
2876415|NCT02006732|9897435|P1|Overall Study|Withdrawal by Subject|3
2876416|NCT02006732|9897432|P4|Overall Study|Lost to Follow-up|0
2876417|NCT02006732|9897433|P3|Overall Study|Lost to Follow-up|0
2876418|NCT02006732|9897434|P2|Overall Study|Lost to Follow-up|1
2876419|NCT02006732|9897435|P1|Overall Study|Lost to Follow-up|0
2876420|NCT02006732|9897432|P4|Overall Study|Protocol Violation|0
2876421|NCT02006732|9897433|P3|Overall Study|Protocol Violation|0
2876422|NCT02006732|9897434|P2|Overall Study|Protocol Violation|1
2876423|NCT02006732|9897435|P1|Overall Study|Protocol Violation|1
2876424|NCT02006732|9897432|P4|Overall Study|Lack of Efficacy|1
2876425|NCT02006732|9897433|P3|Overall Study|Lack of Efficacy|1
2876426|NCT02006732|9897434|P2|Overall Study|Lack of Efficacy|3
2876427|NCT02006732|9897435|P1|Overall Study|Lack of Efficacy|6
2876428|NCT02006732|9897432|P4|Overall Study|Adverse Event|2
2876429|NCT02006732|9897433|P3|Overall Study|Adverse Event|4
2876430|NCT02006732|9897434|P2|Overall Study|Adverse Event|7
2876431|NCT02006732|9897435|P1|Overall Study|Adverse Event|10
2876432|NCT02006719|9897475|P2|Overall Study|Other/Unknown|1
2876433|NCT02006719|9897476|P1|Overall Study|Other/Unknown|0
2876434|NCT02006719|9897475|P2|Overall Study|Adverse Event|1
2876435|NCT02006719|9897476|P1|Overall Study|Adverse Event|1
2876436|NCT02006719|9897475|P2|Overall Study|Protocol Violation|0
2876437|NCT02006719|9897476|P1|Overall Study|Protocol Violation|2
2876438|NCT02006719|9897475|P2|Overall Study|Lost to Follow-up|1
2876439|NCT02006719|9897476|P1|Overall Study|Lost to Follow-up|5
2876440|NCT02006719|9897475|P2|Overall Study|Withdrawal by Subject|2
2876441|NCT02006719|9897476|P1|Overall Study|Withdrawal by Subject|10
2876442|NCT02006706|9897506|P1|Overall Study|Lost to Follow-up|1
2876443|NCT02006693|9897513|P2|Overall Study|Patient Decision|0
2876444|NCT02006693|9897514|P1|Overall Study|Patient Decision|4
2876445|NCT02006693|9897513|P2|Overall Study|Lost to Follow-up|1
2876446|NCT02006693|9897514|P1|Overall Study|Lost to Follow-up|4
2876447|NCT02006693|9897513|P2|Overall Study|Death|2
2876448|NCT02006693|9897514|P1|Overall Study|Death|2
2876449|NCT02006693|9897513|P2|Overall Study|XEN Implant Explantation|1
2876450|NCT02006693|9897514|P1|Overall Study|XEN Implant Explantation|0
2876451|NCT02006693|9897513|P2|Overall Study|Another Glaucoma-related Surgery|1
2876452|NCT02006693|9897514|P1|Overall Study|Another Glaucoma-related Surgery|12
2876453|NCT02006693|9897513|P2|Overall Study|No Reason Specified|8
2876454|NCT02006693|9897514|P1|Overall Study|No Reason Specified|6
2876455|NCT02006667|9897526|P1|Overall Study|Withdrawal by Subject|1
2876456|NCT02006667|9897526|P1|Overall Study|Death|2
2876457|NCT02006667|9897526|P1|Overall Study|Adverse Event|3
2876458|NCT02006654|9897538|P2|Overall Study|moving out of state|1
2876459|NCT02006654|9897539|P1|Overall Study|moving out of state|0
2876460|NCT02006654|9897538|P2|Overall Study|disallowed medication|0
2876461|NCT02006654|9897539|P1|Overall Study|disallowed medication|1
2876462|NCT02006654|9897538|P2|Overall Study|mood disorder|1
2876463|NCT02006654|9897539|P1|Overall Study|mood disorder|0
2876464|NCT02006654|9897538|P2|Overall Study|faecal incontinence|1
2876465|NCT02006654|9897539|P1|Overall Study|faecal incontinence|0
2876466|NCT02006654|9897538|P2|Overall Study|worsening cognitive condition|1
2876467|NCT02006654|9897539|P1|Overall Study|worsening cognitive condition|0
2876468|NCT02006654|9897538|P2|Overall Study|insufficient compliance|0
2876469|NCT02006654|9897539|P1|Overall Study|insufficient compliance|1
2876470|NCT02006654|9897538|P2|Overall Study|patient's will|1
2876471|NCT02006654|9897539|P1|Overall Study|patient's will|2
2876472|NCT02006654|9897538|P2|Overall Study|Lost to Follow-up|0
2876473|NCT02006654|9897539|P1|Overall Study|Lost to Follow-up|1
2876474|NCT02006654|9897538|P2|Overall Study|Protocol Violation|8
2876475|NCT02006654|9897539|P1|Overall Study|Protocol Violation|5
2876476|NCT02006654|9897538|P2|Overall Study|Withdrawal by Subject|12
2876477|NCT02006654|9897539|P1|Overall Study|Withdrawal by Subject|14
2876478|NCT02006654|9897538|P2|Overall Study|Death|0
2876479|NCT02006654|9897539|P1|Overall Study|Death|1
2876480|NCT02006654|9897538|P2|Overall Study|Adverse Event|17
2876481|NCT02006654|9897539|P1|Overall Study|Adverse Event|16
2876482|NCT02006654|9897538|P2|Overall Study|Withdrawal before treatment|2
2876483|NCT02006654|9897539|P1|Overall Study|Withdrawal before treatment|4
2876484|NCT02006641|9897568|P3|Overall Study|Other reason: protocol non-compliance|1
2876485|NCT02006641|9897569|P2|Overall Study|Other reason: protocol non-compliance|0
2876486|NCT02006641|9897570|P1|Overall Study|Other reason: protocol non-compliance|0
2876487|NCT02006641|9897568|P3|Overall Study|Other reason: caregiver impossibility|1
2876488|NCT02006641|9897569|P2|Overall Study|Other reason: caregiver impossibility|0
2876489|NCT02006641|9897570|P1|Overall Study|Other reason: caregiver impossibility|0
2876490|NCT02006641|9897568|P3|Overall Study|Other reason: hospitalisation|0
2876491|NCT02006641|9897569|P2|Overall Study|Other reason: hospitalisation|1
2876492|NCT02006641|9897570|P1|Overall Study|Other reason: hospitalisation|0
2876493|NCT02006641|9897568|P3|Overall Study|Other reason: patient's wife has died|1
2876494|NCT02006641|9897569|P2|Overall Study|Other reason: patient's wife has died|0
2876495|NCT02006641|9897570|P1|Overall Study|Other reason: patient's wife has died|0
2876496|NCT02006641|9897568|P3|Overall Study|Other reason: caregiver in hospital|0
2876497|NCT02006641|9897569|P2|Overall Study|Other reason: caregiver in hospital|1
2876498|NCT02006641|9897570|P1|Overall Study|Other reason: caregiver in hospital|0
2876499|NCT02006641|9897568|P3|Overall Study|Other reason: patient has moved|1
2876500|NCT02006641|9897569|P2|Overall Study|Other reason: patient has moved|0
2876501|NCT02006641|9897570|P1|Overall Study|Other reason: patient has moved|1
2876502|NCT02006641|9897568|P3|Overall Study|Other reason:patient didn't want to come|1
2876503|NCT02006641|9897569|P2|Overall Study|Other reason:patient didn't want to come|0
2876504|NCT02006641|9897570|P1|Overall Study|Other reason:patient didn't want to come|0
2876505|NCT02006641|9897568|P3|Overall Study|Other reason: patient didn't show up|0
2876506|NCT02006641|9897569|P2|Overall Study|Other reason: patient didn't show up|0
2876507|NCT02006641|9897570|P1|Overall Study|Other reason: patient didn't show up|1
2876508|NCT02006641|9897568|P3|Overall Study|Withdrawal by Subject|11
2876509|NCT02006641|9897569|P2|Overall Study|Withdrawal by Subject|12
2876510|NCT02006641|9897570|P1|Overall Study|Withdrawal by Subject|7
2876511|NCT02006641|9897568|P3|Overall Study|Lost to Follow-up|0
2876512|NCT02006641|9897569|P2|Overall Study|Lost to Follow-up|1
2876513|NCT02006641|9897570|P1|Overall Study|Lost to Follow-up|0
2876514|NCT02006641|9897568|P3|Overall Study|Protocol Violation|2
2876515|NCT02006641|9897569|P2|Overall Study|Protocol Violation|2
2876516|NCT02006641|9897570|P1|Overall Study|Protocol Violation|0
2876517|NCT02006641|9897568|P3|Overall Study|Adverse Event|15
2876518|NCT02006641|9897569|P2|Overall Study|Adverse Event|11
2876519|NCT02006641|9897570|P1|Overall Study|Adverse Event|15
2876520|NCT02006641|9897568|P3|Overall Study|Withdrawal before treatment|3
2876521|NCT02006641|9897569|P2|Overall Study|Withdrawal before treatment|5
2876522|NCT02006641|9897570|P1|Overall Study|Withdrawal before treatment|2
2876523|NCT02006628|9897610|P2|Overall Study|Withdrawal by Subject|1
2876524|NCT02006628|9897611|P1|Overall Study|Withdrawal by Subject|2
2876525|NCT02006628|9897610|P2|Overall Study|Adverse Event|1
2876526|NCT02006628|9897611|P1|Overall Study|Adverse Event|1
2876527|NCT02006576|9897636|P3|Overall Study|Screen Failure, too sick, other|13
2876528|NCT02006576|9897637|P2|Overall Study|Screen Failure, too sick, other|1
2876529|NCT02006576|9897638|P1|Overall Study|Screen Failure, too sick, other|13
2876530|NCT02006576|9897636|P3|Overall Study|Lost to Follow-up|1
2876531|NCT02006576|9897637|P2|Overall Study|Lost to Follow-up|0
2876532|NCT02006576|9897638|P1|Overall Study|Lost to Follow-up|1
2876533|NCT02006576|9897636|P3|Overall Study|Death|1
2876534|NCT02006576|9897637|P2|Overall Study|Death|0
2876535|NCT02006576|9897638|P1|Overall Study|Death|0
2876536|NCT02006576|9897636|P3|Overall Study|Withdrawal by Subject|2
2876537|NCT02006576|9897637|P2|Overall Study|Withdrawal by Subject|6
2876538|NCT02006576|9897638|P1|Overall Study|Withdrawal by Subject|4
2876539|NCT02006121|9897721|P2|Open Label Phase|Non-compliance with study drug|0
2876540|NCT02006121|9897722|P1|Open Label Phase|Non-compliance with study drug|3
2876541|NCT02006121|9897721|P2|Open Label Phase|Withdrawal by Subject|0
2876542|NCT02006121|9897722|P1|Open Label Phase|Withdrawal by Subject|3
2876543|NCT02006121|9897721|P2|Open Label Phase|Protocol Violation|0
2876544|NCT02006121|9897722|P1|Open Label Phase|Protocol Violation|2
2876545|NCT02006121|9897721|P2|Open Label Phase|Lack of Efficacy|0
2876546|NCT02006121|9897722|P1|Open Label Phase|Lack of Efficacy|2
2876547|NCT02006121|9897721|P2|Open Label Phase|Adverse Event|0
2876548|NCT02006121|9897722|P1|Open Label Phase|Adverse Event|15
2876549|NCT02006121|9897721|P2|Double Blind Phase|Inconvenience of infusion system|1
2876550|NCT02006121|9897722|P1|Double Blind Phase|Inconvenience of infusion system|0
2876551|NCT02006121|9897721|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
2876552|NCT02006121|9897722|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
2876553|NCT02006121|9897721|P2|Double Blind Phase|Non-compliance with study drug|3
2876554|NCT02006121|9897722|P1|Double Blind Phase|Non-compliance with study drug|1
2876555|NCT02006121|9897721|P2|Double Blind Phase|Withdrawal by Subject|4
2876556|NCT02006121|9897722|P1|Double Blind Phase|Withdrawal by Subject|3
2876557|NCT02006121|9897721|P2|Double Blind Phase|Lack of Efficacy|16
2876558|NCT02006121|9897722|P1|Double Blind Phase|Lack of Efficacy|1
2876559|NCT02006121|9897721|P2|Double Blind Phase|Adverse Event|0
2876560|NCT02006121|9897722|P1|Double Blind Phase|Adverse Event|6
2876561|NCT02005887|9897755|P2|Overall Study|Protocol Violation|2
2876562|NCT02005887|9897756|P1|Overall Study|Protocol Violation|0
2876563|NCT02005692|9897774|P1|Overall Study|Discharged earlier than anticipated|5
2876564|NCT02005692|9897774|P1|Overall Study|Withdrawal by Subject|1
2876565|NCT02005692|9897774|P1|Overall Study|Protocol Violation|1
2876566|NCT02005627|9897781|P2|Overall Study|Withdrawal by Subject|2
2876567|NCT02005627|9897782|P1|Overall Study|Withdrawal by Subject|1
2876568|NCT02005627|9897781|P2|Overall Study|Lost to Follow-up|2
2876569|NCT02005627|9897782|P1|Overall Study|Lost to Follow-up|1
2876570|NCT02005562|9897811|P2|Overall Study|Physician Decision|1
2876571|NCT02005562|9897812|P1|Overall Study|Physician Decision|0
2876572|NCT02005562|9897811|P2|Overall Study|No transplant|4
2876573|NCT02005562|9897812|P1|Overall Study|No transplant|1
2876574|NCT02005562|9897811|P2|Overall Study|Withdrawal by Subject|2
2876575|NCT02005562|9897812|P1|Overall Study|Withdrawal by Subject|2
2876576|NCT02005562|9897811|P2|Overall Study|Graft loss|6
2876577|NCT02005562|9897812|P1|Overall Study|Graft loss|7
2876578|NCT02005562|9897811|P2|Overall Study|Death|2
2876579|NCT02005562|9897812|P1|Overall Study|Death|2
2876580|NCT02005484|9897854|P1|Overall Study|Sponsor decision|1
2876581|NCT02005484|9897854|P1|Overall Study|Changed to a Different Study|1
2876582|NCT02005484|9897854|P1|Overall Study|Disease progression|1
2876583|NCT02005484|9897854|P1|Overall Study|Death|1
2876584|NCT02005471|9897866|P2|Overall Study|Withdrawal by Subject|7
2876585|NCT02005471|9897867|P1|Overall Study|Withdrawal by Subject|18
2876586|NCT02005471|9897866|P2|Overall Study|Progressive Disease|0
2876587|NCT02005471|9897867|P1|Overall Study|Progressive Disease|3
2876588|NCT02005471|9897866|P2|Overall Study|Physician Decision|1
2876589|NCT02005471|9897867|P1|Overall Study|Physician Decision|2
2876590|NCT02005471|9897866|P2|Overall Study|Lost to Follow-up|0
2876591|NCT02005471|9897867|P1|Overall Study|Lost to Follow-up|1
2876592|NCT02005471|9897866|P2|Overall Study|Death|15
2876593|NCT02005471|9897867|P1|Overall Study|Death|26
2876594|NCT02005471|9897866|P2|Overall Study|Adverse Event|0
2876595|NCT02005471|9897867|P1|Overall Study|Adverse Event|1
2876596|NCT02005471|9897866|P2|Overall Study|Ongoing in Study|171
2876597|NCT02005471|9897867|P1|Overall Study|Ongoing in Study|144
2876598|NCT02005445|9897922|P2|Overall Study|Dual study enrollment|1
2876599|NCT02005445|9897923|P1|Overall Study|Dual study enrollment|0
2876600|NCT02005276|9897946|P4|Overall Study|No longer interested|3
2876601|NCT02005276|9897947|P3|Overall Study|No longer interested|3
2876602|NCT02005276|9897948|P2|Overall Study|No longer interested|2
2876603|NCT02005276|9897949|P1|Overall Study|No longer interested|5
2876604|NCT02005250|9897965|P2|Overall Study|Lost to Follow-up|5
2876605|NCT02005250|9897966|P1|Overall Study|Lost to Follow-up|15
2876606|NCT02005211|9897979|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876607|NCT02005211|9897980|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876608|NCT02005211|9897981|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
2876609|NCT02005211|9897982|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876610|NCT02005211|9897983|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876611|NCT02005211|9897984|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876612|NCT02005211|9897985|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2876613|NCT02005029|9898020|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
2876614|NCT02005029|9898021|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
2876615|NCT02004886|9898078|P4|Overall Study|Unable to attend future visits|0
2876616|NCT02004886|9898079|P3|Overall Study|Unable to attend future visits|0
2876617|NCT02004886|9898080|P2|Overall Study|Unable to attend future visits|0
2876618|NCT02004886|9898081|P1|Overall Study|Unable to attend future visits|1
2876619|NCT02004886|9898078|P4|Overall Study|Adverse Event|0
2876620|NCT02004886|9898079|P3|Overall Study|Adverse Event|0
2876621|NCT02004886|9898080|P2|Overall Study|Adverse Event|1
2876622|NCT02004886|9898081|P1|Overall Study|Adverse Event|0
2876623|NCT02004873|9898131|P1|Overall Study|Withdrawal by Subject|1
2876624|NCT02004873|9898131|P1|Overall Study|Death|23
2876625|NCT02004873|9898131|P1|Overall Study|Missed 6-month visit|4
2876626|NCT02004873|9898131|P1|Overall Study|Awaiting 6-month visit|390
2876627|NCT02004873|9898131|P1|Overall Study|Implant unsuccessful|6
2876628|NCT02004847|9898140|P2|Overall Study|Protocol Violation|1
2876629|NCT02004847|9898141|P1|Overall Study|Protocol Violation|1
2876630|NCT02004522|9898187|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
2876631|NCT02004522|9898188|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
2876632|NCT02004522|9898187|P2|Overall Study|Disease Progression|31
2876633|NCT02004522|9898188|P1|Overall Study|Disease Progression|35
2876634|NCT02004522|9898187|P2|Overall Study|Never Dosed|4
2876635|NCT02004522|9898188|P1|Overall Study|Never Dosed|2
2876636|NCT02004522|9898187|P2|Overall Study|Other is reason listed by PI.|1
2876637|NCT02004522|9898188|P1|Overall Study|Other is reason listed by PI.|4
2876638|NCT02004522|9898187|P2|Overall Study|Protocol Violation|0
2876639|NCT02004522|9898188|P1|Overall Study|Protocol Violation|1
2876640|NCT02004522|9898187|P2|Overall Study|Physician Decision|4
2876641|NCT02004522|9898188|P1|Overall Study|Physician Decision|3
2876642|NCT02004522|9898187|P2|Overall Study|Death|3
2876643|NCT02004522|9898188|P1|Overall Study|Death|12
2876644|NCT02004522|9898187|P2|Overall Study|Withdrawal by Subject|7
2876645|NCT02004522|9898188|P1|Overall Study|Withdrawal by Subject|13
2876646|NCT02004522|9898187|P2|Overall Study|Adverse Event|6
2876647|NCT02004522|9898188|P1|Overall Study|Adverse Event|55
2876648|NCT02004262|9898309|P6|Overall Study|Study Terminated by Sponsor|5
2876649|NCT02004262|9898310|P5|Overall Study|Study Terminated by Sponsor|1
2876650|NCT02004262|9898311|P4|Overall Study|Study Terminated by Sponsor|1
2876651|NCT02004262|9898312|P3|Overall Study|Study Terminated by Sponsor|2
2876652|NCT02004262|9898313|P2|Overall Study|Study Terminated by Sponsor|3
2876653|NCT02004262|9898314|P1|Overall Study|Study Terminated by Sponsor|4
2876654|NCT02004262|9898309|P6|Overall Study|Lost to Follow-up|0
2876655|NCT02004262|9898310|P5|Overall Study|Lost to Follow-up|0
2876656|NCT02004262|9898311|P4|Overall Study|Lost to Follow-up|0
2876657|NCT02004262|9898312|P3|Overall Study|Lost to Follow-up|0
2876658|NCT02004262|9898313|P2|Overall Study|Lost to Follow-up|1
2876659|NCT02004262|9898314|P1|Overall Study|Lost to Follow-up|1
2876660|NCT02004262|9898309|P6|Overall Study|Withdrawal by Subject|3
2876661|NCT02004262|9898310|P5|Overall Study|Withdrawal by Subject|1
2876662|NCT02004262|9898311|P4|Overall Study|Withdrawal by Subject|0
2876663|NCT02004262|9898312|P3|Overall Study|Withdrawal by Subject|4
2876664|NCT02004262|9898313|P2|Overall Study|Withdrawal by Subject|0
2876665|NCT02004262|9898314|P1|Overall Study|Withdrawal by Subject|1
2876666|NCT02004262|9898309|P6|Overall Study|Death|22
2876667|NCT02004262|9898310|P5|Overall Study|Death|29
2876668|NCT02004262|9898311|P4|Overall Study|Death|28
2876669|NCT02004262|9898312|P3|Overall Study|Death|66
2876670|NCT02004262|9898313|P2|Overall Study|Death|64
2876671|NCT02004262|9898314|P1|Overall Study|Death|67
2876672|NCT02004236|9898334|P3|Overall Study|Lack of Efficacy|16
2876673|NCT02004236|9898335|P2|Overall Study|Lack of Efficacy|0
2876674|NCT02004236|9898336|P1|Overall Study|Lack of Efficacy|0
2876675|NCT02004093|9898396|P2|Overall Study|Other|1
2876676|NCT02004093|9898397|P1|Overall Study|Other|3
2876677|NCT02004093|9898396|P2|Overall Study|Withdrawal by Subject|7
2876678|NCT02004093|9898397|P1|Overall Study|Withdrawal by Subject|3
2876679|NCT02004093|9898396|P2|Overall Study|Lost to Follow-up|1
2876680|NCT02004093|9898397|P1|Overall Study|Lost to Follow-up|0
2876681|NCT02004093|9898396|P2|Overall Study|Protocol Violation|1
2876682|NCT02004093|9898397|P1|Overall Study|Protocol Violation|0
2876683|NCT02004093|9898396|P2|Overall Study|Lack of Efficacy|62
2876684|NCT02004093|9898397|P1|Overall Study|Lack of Efficacy|66
2876685|NCT02004093|9898396|P2|Overall Study|Death|1
2876686|NCT02004093|9898397|P1|Overall Study|Death|2
2876687|NCT02003963|9898429|P2|Overall Study|Lost to Follow-up|1
2876688|NCT02003963|9898430|P1|Overall Study|Lost to Follow-up|2
2876689|NCT02003924|9898452|P2|Overall Study|Adverse Event|29
2876690|NCT02003924|9898453|P1|Overall Study|Adverse Event|91
2876691|NCT02003924|9898452|P2|Overall Study|Withdrawal by Subject|34
2876692|NCT02003924|9898453|P1|Overall Study|Withdrawal by Subject|49
2876693|NCT02003924|9898452|P2|Overall Study|Other than specified|19
2876694|NCT02003924|9898453|P1|Overall Study|Other than specified|18
2876695|NCT02003924|9898452|P2|Overall Study|Lost to Follow-up|1
2876696|NCT02003924|9898453|P1|Overall Study|Lost to Follow-up|2
2876697|NCT02003924|9898452|P2|Overall Study|Protocol Violation|2
2876698|NCT02003924|9898453|P1|Overall Study|Protocol Violation|1
2876699|NCT02003924|9898452|P2|Overall Study|Disease progression|207
2876700|NCT02003924|9898453|P1|Overall Study|Disease progression|138
2876701|NCT02003924|9898452|P2|Overall Study|Ongoing in study|176
2876702|NCT02003924|9898453|P1|Overall Study|Ongoing in study|634
2876703|NCT02003898|9898551|P1|Overall Study|Withdrawal by Subject|52
2876704|NCT02003898|9898551|P1|Overall Study|Lost to Follow-up|12
2876705|NCT02003898|9898551|P1|Overall Study|Death|3
2876706|NCT02003638|9898560|P2|Overall Study|Withdrawal by Subject|0
2876707|NCT02003638|9898561|P1|Overall Study|Withdrawal by Subject|1
2876708|NCT02003573|9898591|P3|Overall Study|Other than specified|3
2876709|NCT02003573|9898592|P2|Overall Study|Other than specified|2
2876710|NCT02003573|9898593|P1|Overall Study|Other than specified|1
2876711|NCT02003573|9898591|P3|Overall Study|Refuse to take trial medication|1
2876712|NCT02003573|9898592|P2|Overall Study|Refuse to take trial medication|1
2876713|NCT02003573|9898593|P1|Overall Study|Refuse to take trial medication|0
2876714|NCT02003573|9898591|P3|Overall Study|Other Adverse event|1
2876715|NCT02003573|9898592|P2|Overall Study|Other Adverse event|1
2876716|NCT02003573|9898593|P1|Overall Study|Other Adverse event|0
2876717|NCT02003573|9898591|P3|Overall Study|Progressive disease|1
2876718|NCT02003573|9898592|P2|Overall Study|Progressive disease|0
2876719|NCT02003573|9898593|P1|Overall Study|Progressive disease|2
2876720|NCT02003534|9898603|P1|Overall Study|Lost to Follow-up|47
2876721|NCT02003391|9898624|P2|Overall Study|Adverse Event|0
2876722|NCT02003391|9898625|P1|Overall Study|Adverse Event|1
2876723|NCT02003391|9898624|P2|Overall Study|Protocol Violation|1
2876724|NCT02003391|9898625|P1|Overall Study|Protocol Violation|0
2876725|NCT02003391|9898624|P2|Overall Study|Withdrawal by Subject|1
2876726|NCT02003391|9898625|P1|Overall Study|Withdrawal by Subject|2
2876727|NCT02003365|9898638|P3|Overall Study|Lost to Follow-up|1
2876728|NCT02003365|9898639|P2|Overall Study|Lost to Follow-up|0
2876729|NCT02003365|9898640|P1|Overall Study|Lost to Follow-up|0
2876730|NCT02003183|9898657|P2|Overall Study|Lost to Follow-up|2
2876731|NCT02003183|9898658|P1|Overall Study|Lost to Follow-up|0
2876732|NCT02003014|9898673|P1|Overall Study|Investigator's transfer|4
2876733|NCT02003014|9898673|P1|Overall Study|Patient did not visit the study site|5
2876734|NCT02003014|9898673|P1|Overall Study|Treatment started after contract period|1
2876735|NCT02003014|9898673|P1|Overall Study|Case report forms uncollected|9
2876736|NCT02002975|9898683|P1|Overall Study|Protocol Deviation|437
2876737|NCT02002975|9898683|P1|Overall Study|Case Report Forms Uncollected|135
2876738|NCT02002689|9898782|P1|Overall Study|Adverse Event|3
2876739|NCT02002689|9898782|P1|Overall Study|Disease Progression|7
2876740|NCT02002533|9898801|P2|Overall Study|Lost to Follow-up|1
2876741|NCT02002533|9898802|P1|Overall Study|Lost to Follow-up|0
2876742|NCT02002533|9898801|P2|Overall Study|Adverse Event|3
2876743|NCT02002533|9898802|P1|Overall Study|Adverse Event|0
2876744|NCT02002533|9898801|P2|Overall Study|Protocol Violation|1
2876745|NCT02002533|9898802|P1|Overall Study|Protocol Violation|0
2876746|NCT02002533|9898801|P2|Overall Study|Withdrawal by Subject|13
2876747|NCT02002533|9898802|P1|Overall Study|Withdrawal by Subject|6
2876748|NCT02002221|9898827|P2|Overall Study|Patient withdrew consent|1
2876749|NCT02002221|9898828|P1|Overall Study|Patient withdrew consent|0
2876750|NCT02002221|9898827|P2|Overall Study|Unsatisfactory therapeutic effect|1
2876751|NCT02002221|9898828|P1|Overall Study|Unsatisfactory therapeutic effect|0
2876752|NCT02002221|9898827|P2|Overall Study|Adverse Event|1
2876753|NCT02002221|9898828|P1|Overall Study|Adverse Event|2
2876754|NCT02002091|9898855|P2|Screening|Death|2
2876755|NCT02002091|9898856|P1|Screening|Death|3
2876756|NCT02002091|9898855|P2|Screening|Lost to Follow-up|12
2876757|NCT02002091|9898856|P1|Screening|Lost to Follow-up|10
2876758|NCT02001987|9898891|P1|LTE Period (52 Weeks)|Other|3
2876759|NCT02001987|9898891|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
2876760|NCT02001987|9898891|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
2876761|NCT02001987|9898891|P1|LTE Period (52 Weeks)|Physician Decision|2
2876762|NCT02001987|9898891|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
2876763|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
2876764|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Protocol Violation|3
2876765|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
2876766|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Physician Decision|1
2876767|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
2876768|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Death|1
2876769|NCT02001987|9898891|P1|Core Study Period (24 Weeks)|Adverse Event|9
2876770|NCT02001688|9898977|P3|Overall Study|Adverse Event|0
2876771|NCT02001688|9898978|P2|Overall Study|Adverse Event|1
2876772|NCT02001688|9898979|P1|Overall Study|Adverse Event|0
2876773|NCT02001688|9898977|P3|Overall Study|Withdrawal by Subject|1
2876774|NCT02001688|9898978|P2|Overall Study|Withdrawal by Subject|0
2876775|NCT02001688|9898979|P1|Overall Study|Withdrawal by Subject|0
2876776|NCT02001558|9898998|P2|Overall Study|Lost to Follow-up|14
2876777|NCT02001558|9898999|P1|Overall Study|Lost to Follow-up|8
2876778|NCT02001194|9899035|P4|Follow-Up Period (13 Weeks)|No longer interested|0
2876779|NCT02001194|9899036|P3|Follow-Up Period (13 Weeks)|No longer interested|1
2876780|NCT02001194|9899037|P2|Follow-Up Period (13 Weeks)|No longer interested|2
2876781|NCT02001194|9899038|P1|Follow-Up Period (13 Weeks)|No longer interested|3
2876782|NCT02001194|9899035|P4|Intervention Period (13 Weeks)|No longer interested|2
2876783|NCT02001194|9899036|P3|Intervention Period (13 Weeks)|No longer interested|2
2876784|NCT02001194|9899037|P2|Intervention Period (13 Weeks)|No longer interested|0
2876785|NCT02001194|9899038|P1|Intervention Period (13 Weeks)|No longer interested|1
2876786|NCT02001181|9899054|P2|Overall Study|Withdrawal by Subject|1
2876787|NCT02001181|9899055|P1|Overall Study|Withdrawal by Subject|0
2876788|NCT02001181|9899054|P2|Overall Study|Lost to Follow-up|0
2876789|NCT02001181|9899055|P1|Overall Study|Lost to Follow-up|1
2876790|NCT02001181|9899054|P2|Overall Study|Adverse Event|2
2876791|NCT02001181|9899055|P1|Overall Study|Adverse Event|0
2876792|NCT02001051|9899071|P2|Overall Study|Deemed not eligible following enrollment|1
2876793|NCT02001051|9899072|P1|Overall Study|Deemed not eligible following enrollment|0
2876794|NCT02000921|9899124|P3|Overall Study|Physician Decision|0
2876795|NCT02000921|9899125|P2|Overall Study|Physician Decision|2
2876796|NCT02000921|9899126|P1|Overall Study|Physician Decision|0
2876797|NCT02000921|9899124|P3|Overall Study|Lost to Follow-up|5
2876798|NCT02000921|9899125|P2|Overall Study|Lost to Follow-up|4
2876799|NCT02000921|9899126|P1|Overall Study|Lost to Follow-up|2
2876800|NCT02000921|9899124|P3|Overall Study|Withdrawal by Subject|5
2876801|NCT02000921|9899125|P2|Overall Study|Withdrawal by Subject|10
2876802|NCT02000921|9899126|P1|Overall Study|Withdrawal by Subject|3
2876803|NCT02000817|9899156|P4|Overall Study|Lost to Follow-up|0
2876804|NCT02000817|9899157|P3|Overall Study|Lost to Follow-up|1
2876805|NCT02000817|9899158|P2|Overall Study|Lost to Follow-up|0
2876806|NCT02000817|9899159|P1|Overall Study|Lost to Follow-up|0
2876807|NCT02000817|9899156|P4|Overall Study|Adverse Event|0
2876808|NCT02000817|9899157|P3|Overall Study|Adverse Event|0
2876809|NCT02000817|9899158|P2|Overall Study|Adverse Event|1
2876810|NCT02000817|9899159|P1|Overall Study|Adverse Event|0
2876811|NCT02000817|9899156|P4|Overall Study|Withdrawal by Subject|0
2876812|NCT02000817|9899157|P3|Overall Study|Withdrawal by Subject|0
2876813|NCT02000817|9899158|P2|Overall Study|Withdrawal by Subject|0
2876814|NCT02000817|9899159|P1|Overall Study|Withdrawal by Subject|2
2876815|NCT02000752|9899254|P2|Overall Study|Shift Changes|5
2876816|NCT02000752|9899255|P1|Overall Study|Shift Changes|12
2876817|NCT02000752|9899254|P2|Overall Study|Dystocic delivery|8
2876818|NCT02000752|9899255|P1|Overall Study|Dystocic delivery|19
2876819|NCT02000622|9899269|P2|Overall Study|Withdrawal by Subject|7
2876820|NCT02000622|9899270|P1|Overall Study|Withdrawal by Subject|5
2876821|NCT02000622|9899269|P2|Overall Study|Death|46
2876822|NCT02000622|9899270|P1|Overall Study|Death|94
2876823|NCT02000622|9899269|P2|Overall Study|Lost to Follow-up|0
2876824|NCT02000622|9899270|P1|Overall Study|Lost to Follow-up|1
2876825|NCT02000622|9899269|P2|Overall Study|Withdrawn due to site closure|0
2876826|NCT02000622|9899270|P1|Overall Study|Withdrawn due to site closure|1
2876827|NCT02000531|9899292|P2|Overall Study|Discontinued due to data cut-off|8
2876828|NCT02000531|9899293|P1|Overall Study|Discontinued due to data cut-off|3
2876829|NCT02000531|9899292|P2|Overall Study|Lost to Follow-up|0
2876830|NCT02000531|9899293|P1|Overall Study|Lost to Follow-up|1
2876831|NCT02000440|9899301|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
2876832|NCT02000440|9899301|P1|Overall Study|Adverse Event|3
2876833|NCT02000427|9899321|P1|Overall Study|Death|22
2876834|NCT01999972|9899375|P6|Dose Expansion Part|Death|1
2876835|NCT01999972|9899376|P5|Dose Expansion Part|Death|2
2876836|NCT01999972|9899377|P4|Dose Expansion Part|Death|0
2876837|NCT01999972|9899378|P3|Dose Expansion Part|Death|0
2876838|NCT01999972|9899379|P2|Dose Expansion Part|Death|0
2876839|NCT01999972|9899380|P1|Dose Expansion Part|Death|0
2876840|NCT01999972|9899375|P6|Dose Expansion Part|Ongoing at data cut-off date|2
2876841|NCT01999972|9899376|P5|Dose Expansion Part|Ongoing at data cut-off date|8
2876842|NCT01999972|9899377|P4|Dose Expansion Part|Ongoing at data cut-off date|0
2876843|NCT01999972|9899378|P3|Dose Expansion Part|Ongoing at data cut-off date|0
2876844|NCT01999972|9899379|P2|Dose Expansion Part|Ongoing at data cut-off date|0
2876845|NCT01999972|9899380|P1|Dose Expansion Part|Ongoing at data cut-off date|0
2876846|NCT01999972|9899375|P6|Dose Expansion Part|Disease progression|4
2876847|NCT01999972|9899376|P5|Dose Expansion Part|Disease progression|11
2876848|NCT01999972|9899377|P4|Dose Expansion Part|Disease progression|0
2876849|NCT01999972|9899378|P3|Dose Expansion Part|Disease progression|0
2876850|NCT01999972|9899379|P2|Dose Expansion Part|Disease progression|0
2876851|NCT01999972|9899380|P1|Dose Expansion Part|Disease progression|0
2876852|NCT01999972|9899375|P6|Dose Escalation Part|Enrolled but not treated|0
2876853|NCT01999972|9899376|P5|Dose Escalation Part|Enrolled but not treated|0
2876854|NCT01999972|9899377|P4|Dose Escalation Part|Enrolled but not treated|1
2876855|NCT01999972|9899378|P3|Dose Escalation Part|Enrolled but not treated|1
2876856|NCT01999972|9899379|P2|Dose Escalation Part|Enrolled but not treated|0
2876857|NCT01999972|9899380|P1|Dose Escalation Part|Enrolled but not treated|0
2876858|NCT01999972|9899375|P6|Dose Escalation Part|Death|0
2876859|NCT01999972|9899376|P5|Dose Escalation Part|Death|0
2876860|NCT01999972|9899377|P4|Dose Escalation Part|Death|0
2876861|NCT01999972|9899378|P3|Dose Escalation Part|Death|0
2876862|NCT01999972|9899379|P2|Dose Escalation Part|Death|1
2876863|NCT01999972|9899380|P1|Dose Escalation Part|Death|0
2876864|NCT01999972|9899375|P6|Dose Escalation Part|Ongoing at data cut-off date|0
2876865|NCT01999972|9899376|P5|Dose Escalation Part|Ongoing at data cut-off date|0
2876866|NCT01999972|9899377|P4|Dose Escalation Part|Ongoing at data cut-off date|1
2876867|NCT01999972|9899378|P3|Dose Escalation Part|Ongoing at data cut-off date|1
2876868|NCT01999972|9899379|P2|Dose Escalation Part|Ongoing at data cut-off date|0
2876869|NCT01999972|9899380|P1|Dose Escalation Part|Ongoing at data cut-off date|0
2876870|NCT01999972|9899375|P6|Dose Escalation Part|Disease progression|0
2876871|NCT01999972|9899376|P5|Dose Escalation Part|Disease progression|0
2876872|NCT01999972|9899377|P4|Dose Escalation Part|Disease progression|8
2876873|NCT01999972|9899378|P3|Dose Escalation Part|Disease progression|3
2876874|NCT01999972|9899379|P2|Dose Escalation Part|Disease progression|2
2876875|NCT01999972|9899380|P1|Dose Escalation Part|Disease progression|4
2876876|NCT01999972|9899375|P6|Dose Escalation Part|Participant refused further follow-up|0
2876877|NCT01999972|9899376|P5|Dose Escalation Part|Participant refused further follow-up|0
2876878|NCT01999972|9899377|P4|Dose Escalation Part|Participant refused further follow-up|1
2876879|NCT01999972|9899378|P3|Dose Escalation Part|Participant refused further follow-up|0
2876880|NCT01999972|9899379|P2|Dose Escalation Part|Participant refused further follow-up|0
2876881|NCT01999972|9899380|P1|Dose Escalation Part|Participant refused further follow-up|1
2876882|NCT01999946|9899495|P3|Overall Study|Not included in primary outcome analysis|79
2876883|NCT01999946|9899496|P2|Overall Study|Not included in primary outcome analysis|0
2876884|NCT01999946|9899497|P1|Overall Study|Not included in primary outcome analysis|0
2876885|NCT01999946|9899495|P3|Overall Study|Participant not released from jail|0
2876886|NCT01999946|9899496|P2|Overall Study|Participant not released from jail|2
2876887|NCT01999946|9899497|P1|Overall Study|Participant not released from jail|2
2876888|NCT01999894|9899523|P1|Overall Study|Inclusion/exclusion criteria not met|1
2876889|NCT01999894|9899523|P1|Overall Study|Other Reason|3
2876890|NCT01999894|9899523|P1|Overall Study|Lost to Follow-up|10
2876891|NCT01999894|9899523|P1|Overall Study|Withdrawal by Subject|7
2876892|NCT01999894|9899523|P1|Overall Study|Protocol Violation|1
2876893|NCT01999894|9899523|P1|Overall Study|Lack of Efficacy|5
2876894|NCT01999894|9899523|P1|Overall Study|Adverse Event|9
2876895|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|0
2876896|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|4
2876897|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|12
2876898|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
2876899|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|2
2876900|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
2876901|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|0
2876902|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|19
2876903|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|10
2876904|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|0
2876905|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|2
2876906|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|1
2876907|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
2876908|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|1
2876909|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
2876910|NCT01999868|9899531|P3|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
2876911|NCT01999868|9899532|P2|Blinded Observation Phase (Week 40 – 88)|Adverse Event|1
2876912|NCT01999868|9899533|P1|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
2876913|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
2876914|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
2876915|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|4
2876916|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
2876917|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
2876918|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|1
2876919|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|0
2876920|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|1
2876921|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|8
2876922|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|0
2876923|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|2
2876924|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|1
2876925|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
2876926|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|2
2876927|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
2876928|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
2876929|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|1
2876930|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
2876931|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|0
2876932|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|4
2876933|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|3
2876934|NCT01999868|9899531|P3|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|0
2876935|NCT01999868|9899532|P2|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
2876936|NCT01999868|9899533|P1|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
2876937|NCT01999868|9899531|P3|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|5
2876938|NCT01999868|9899532|P2|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
2876939|NCT01999868|9899533|P1|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
2876940|NCT01999465|9899584|P2|Overall Study|Protocol Violation|1
2876941|NCT01999465|9899585|P1|Overall Study|Protocol Violation|0
2876942|NCT01999465|9899584|P2|Overall Study|Lost to Follow-up|2
2876943|NCT01999465|9899585|P1|Overall Study|Lost to Follow-up|0
2876944|NCT01999322|9899630|P2|Overall Study|Adverse Event|0
2876945|NCT01999322|9899631|P1|Overall Study|Adverse Event|1
2876946|NCT01999218|9899683|P3|Overall Study|Treated but excluded at 1 trial site|2
2876947|NCT01999218|9899684|P2|Overall Study|Treated but excluded at 1 trial site|5
2876948|NCT01999218|9899685|P1|Overall Study|Treated but excluded at 1 trial site|3
2876949|NCT01999218|9899683|P3|Overall Study|Adverse Event|7
2876950|NCT01999218|9899684|P2|Overall Study|Adverse Event|7
2876951|NCT01999218|9899685|P1|Overall Study|Adverse Event|9
2876952|NCT01999218|9899683|P3|Overall Study|Excluded Medication|2
2876953|NCT01999218|9899684|P2|Overall Study|Excluded Medication|1
2876954|NCT01999218|9899685|P1|Overall Study|Excluded Medication|1
2876955|NCT01999218|9899683|P3|Overall Study|Death|2
2876956|NCT01999218|9899684|P2|Overall Study|Death|1
2876957|NCT01999218|9899685|P1|Overall Study|Death|7
2876958|NCT01999218|9899683|P3|Overall Study|Creatinine/eGFR|1
2876959|NCT01999218|9899684|P2|Overall Study|Creatinine/eGFR|0
2876960|NCT01999218|9899685|P1|Overall Study|Creatinine/eGFR|0
2876961|NCT01999218|9899683|P3|Overall Study|Withdrawal by Subject|34
2876962|NCT01999218|9899684|P2|Overall Study|Withdrawal by Subject|29
2876963|NCT01999218|9899685|P1|Overall Study|Withdrawal by Subject|28
2876964|NCT01999218|9899683|P3|Overall Study|Participant moves|3
2876965|NCT01999218|9899684|P2|Overall Study|Participant moves|5
2876966|NCT01999218|9899685|P1|Overall Study|Participant moves|2
2876967|NCT01999218|9899683|P3|Overall Study|Study Terminated By Sponsor|12
2876968|NCT01999218|9899684|P2|Overall Study|Study Terminated By Sponsor|5
2876969|NCT01999218|9899685|P1|Overall Study|Study Terminated By Sponsor|7
2876970|NCT01999218|9899683|P3|Overall Study|Screen failure|0
2876971|NCT01999218|9899684|P2|Overall Study|Screen failure|1
2876972|NCT01999218|9899685|P1|Overall Study|Screen failure|0
2876973|NCT01999218|9899683|P3|Overall Study|Protocol Violation|4
2876974|NCT01999218|9899684|P2|Overall Study|Protocol Violation|5
2876975|NCT01999218|9899685|P1|Overall Study|Protocol Violation|4
2876976|NCT01999218|9899683|P3|Overall Study|Physician Decision|6
2876977|NCT01999218|9899684|P2|Overall Study|Physician Decision|4
2876978|NCT01999218|9899685|P1|Overall Study|Physician Decision|1
2876979|NCT01999218|9899683|P3|Overall Study|Non-Compliance With Study Drug|1
2876980|NCT01999218|9899684|P2|Overall Study|Non-Compliance With Study Drug|4
2876981|NCT01999218|9899685|P1|Overall Study|Non-Compliance With Study Drug|6
2876982|NCT01999218|9899683|P3|Overall Study|Lost to Follow-up|18
2876983|NCT01999218|9899684|P2|Overall Study|Lost to Follow-up|17
2876984|NCT01999218|9899685|P1|Overall Study|Lost to Follow-up|22
2876985|NCT01999218|9899683|P3|Overall Study|Lack of Efficacy|1
2876986|NCT01999218|9899684|P2|Overall Study|Lack of Efficacy|0
2876987|NCT01999218|9899685|P1|Overall Study|Lack of Efficacy|1
2876988|NCT01999218|9899683|P3|Overall Study|Hyperglycemia|17
2876989|NCT01999218|9899684|P2|Overall Study|Hyperglycemia|17
2876990|NCT01999218|9899685|P1|Overall Study|Hyperglycemia|18
2876991|NCT01999114|9899730|P5|Overall Study|Administrative|2
2876992|NCT01999114|9899731|P4|Overall Study|Administrative|1
2876993|NCT01999114|9899732|P3|Overall Study|Administrative|1
2876994|NCT01999114|9899733|P2|Overall Study|Administrative|0
2876995|NCT01999114|9899734|P1|Overall Study|Administrative|0
2876996|NCT01999114|9899730|P5|Overall Study|Lost to Follow-up|0
2876997|NCT01999114|9899731|P4|Overall Study|Lost to Follow-up|0
2876998|NCT01999114|9899732|P3|Overall Study|Lost to Follow-up|1
2876999|NCT01999114|9899733|P2|Overall Study|Lost to Follow-up|0
2877000|NCT01999114|9899734|P1|Overall Study|Lost to Follow-up|0
2877001|NCT01999114|9899730|P5|Overall Study|Withdrawal by Subject|1
2877002|NCT01999114|9899731|P4|Overall Study|Withdrawal by Subject|0
2877003|NCT01999114|9899732|P3|Overall Study|Withdrawal by Subject|1
2877004|NCT01999114|9899733|P2|Overall Study|Withdrawal by Subject|0
2877005|NCT01999114|9899734|P1|Overall Study|Withdrawal by Subject|0
2877006|NCT01999114|9899730|P5|Overall Study|Adverse Event|1
2877007|NCT01999114|9899731|P4|Overall Study|Adverse Event|2
2877008|NCT01999114|9899732|P3|Overall Study|Adverse Event|2
2877009|NCT01999114|9899733|P2|Overall Study|Adverse Event|7
2877010|NCT01999114|9899734|P1|Overall Study|Adverse Event|8
2877011|NCT01998984|9899802|P4|Overall Study|Other|1
2877012|NCT01998984|9899803|P3|Overall Study|Other|0
2877013|NCT01998984|9899804|P2|Overall Study|Other|0
2877014|NCT01998984|9899805|P1|Overall Study|Other|0
2877015|NCT01998984|9899802|P4|Overall Study|Withdrawal by Subject|0
2877016|NCT01998984|9899803|P3|Overall Study|Withdrawal by Subject|1
2877017|NCT01998984|9899804|P2|Overall Study|Withdrawal by Subject|0
2877018|NCT01998984|9899805|P1|Overall Study|Withdrawal by Subject|0
2877019|NCT01998984|9899802|P4|Overall Study|Lost to Follow-up|1
2877020|NCT01998984|9899803|P3|Overall Study|Lost to Follow-up|0
2877021|NCT01998984|9899804|P2|Overall Study|Lost to Follow-up|1
2877022|NCT01998984|9899805|P1|Overall Study|Lost to Follow-up|0
2877023|NCT01998984|9899802|P4|Overall Study|Adverse Event|1
2877024|NCT01998984|9899803|P3|Overall Study|Adverse Event|0
2877025|NCT01998984|9899804|P2|Overall Study|Adverse Event|0
2877026|NCT01998984|9899805|P1|Overall Study|Adverse Event|0
2877027|NCT01998958|9899830|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
2877028|NCT01998958|9899831|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
2877029|NCT01998958|9899832|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
2877030|NCT01998958|9899833|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
2877031|NCT01998958|9899834|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
2877032|NCT01998958|9899835|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
2877033|NCT01998958|9899836|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
2877034|NCT01998958|9899837|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
2877035|NCT01998958|9899838|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
2877036|NCT01998958|9899839|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
2877037|NCT01998958|9899840|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
2877038|NCT01998958|9899841|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
2877039|NCT01998958|9899842|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
2877040|NCT01998958|9899843|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
2877041|NCT01998958|9899844|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
2877042|NCT01998958|9899845|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
2877043|NCT01998958|9899846|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
2877044|NCT01998958|9899847|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
2877045|NCT01998958|9899848|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
2877046|NCT01998958|9899849|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
2877047|NCT01998958|9899850|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
2877048|NCT01998958|9899851|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
2877049|NCT01998958|9899852|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
2877050|NCT01998958|9899853|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
2877051|NCT01998958|9899854|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
2877052|NCT01998958|9899855|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
2877053|NCT01998958|9899856|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
2877054|NCT01998958|9899857|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
2877055|NCT01998958|9899858|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
2877056|NCT01998958|9899859|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
2877057|NCT01998958|9899860|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
2877058|NCT01998958|9899861|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
2877059|NCT01998958|9899830|P32|Open Label Phase (Optional)|Lack of Efficacy|0
2877060|NCT01998958|9899831|P31|Open Label Phase (Optional)|Lack of Efficacy|0
2877061|NCT01998958|9899832|P30|Open Label Phase (Optional)|Lack of Efficacy|0
2877062|NCT01998958|9899833|P29|Open Label Phase (Optional)|Lack of Efficacy|0
2877063|NCT01998958|9899834|P28|Open Label Phase (Optional)|Lack of Efficacy|0
2877064|NCT01998958|9899835|P27|Open Label Phase (Optional)|Lack of Efficacy|0
2877065|NCT01998958|9899836|P26|Open Label Phase (Optional)|Lack of Efficacy|0
2877066|NCT01998958|9899837|P25|Open Label Phase (Optional)|Lack of Efficacy|0
2877067|NCT01998958|9899838|P24|Open Label Phase (Optional)|Lack of Efficacy|0
2877068|NCT01998958|9899839|P23|Open Label Phase (Optional)|Lack of Efficacy|2
2877069|NCT01998958|9899840|P22|Open Label Phase (Optional)|Lack of Efficacy|1
2877070|NCT01998958|9899841|P21|Open Label Phase (Optional)|Lack of Efficacy|0
2877071|NCT01998958|9899842|P20|Open Label Phase (Optional)|Lack of Efficacy|0
2877072|NCT01998958|9899843|P19|Open Label Phase (Optional)|Lack of Efficacy|0
2877073|NCT01998958|9899844|P18|Open Label Phase (Optional)|Lack of Efficacy|0
2877074|NCT01998958|9899845|P17|Open Label Phase (Optional)|Lack of Efficacy|0
2877075|NCT01998958|9899846|P16|Open Label Phase (Optional)|Lack of Efficacy|0
2877076|NCT01998958|9899847|P15|Open Label Phase (Optional)|Lack of Efficacy|0
2877077|NCT01998958|9899848|P14|Open Label Phase (Optional)|Lack of Efficacy|0
2877078|NCT01998958|9899849|P13|Open Label Phase (Optional)|Lack of Efficacy|0
2877079|NCT01998958|9899850|P12|Open Label Phase (Optional)|Lack of Efficacy|0
2877080|NCT01998958|9899851|P11|Open Label Phase (Optional)|Lack of Efficacy|0
2877081|NCT01998958|9899852|P10|Open Label Phase (Optional)|Lack of Efficacy|0
2877082|NCT01998958|9899853|P9|Open Label Phase (Optional)|Lack of Efficacy|0
2877083|NCT01998958|9899854|P8|Open Label Phase (Optional)|Lack of Efficacy|0
2877084|NCT01998958|9899855|P7|Open Label Phase (Optional)|Lack of Efficacy|0
2877085|NCT01998958|9899856|P6|Open Label Phase (Optional)|Lack of Efficacy|0
2877086|NCT01998958|9899857|P5|Open Label Phase (Optional)|Lack of Efficacy|0
2877087|NCT01998958|9899858|P4|Open Label Phase (Optional)|Lack of Efficacy|0
2877088|NCT01998958|9899859|P3|Open Label Phase (Optional)|Lack of Efficacy|0
2877089|NCT01998958|9899860|P2|Open Label Phase (Optional)|Lack of Efficacy|0
2877090|NCT01998958|9899861|P1|Open Label Phase (Optional)|Lack of Efficacy|0
2877091|NCT01998958|9899830|P32|Open Label Phase (Optional)|Lost to Follow-up|0
2877092|NCT01998958|9899831|P31|Open Label Phase (Optional)|Lost to Follow-up|0
2877093|NCT01998958|9899832|P30|Open Label Phase (Optional)|Lost to Follow-up|0
2877094|NCT01998958|9899833|P29|Open Label Phase (Optional)|Lost to Follow-up|0
2877095|NCT01998958|9899834|P28|Open Label Phase (Optional)|Lost to Follow-up|0
2877096|NCT01998958|9899835|P27|Open Label Phase (Optional)|Lost to Follow-up|0
2877097|NCT01998958|9899836|P26|Open Label Phase (Optional)|Lost to Follow-up|0
2877098|NCT01998958|9899837|P25|Open Label Phase (Optional)|Lost to Follow-up|0
2877099|NCT01998958|9899838|P24|Open Label Phase (Optional)|Lost to Follow-up|0
2877100|NCT01998958|9899839|P23|Open Label Phase (Optional)|Lost to Follow-up|1
2877101|NCT01998958|9899840|P22|Open Label Phase (Optional)|Lost to Follow-up|0
2877102|NCT01998958|9899841|P21|Open Label Phase (Optional)|Lost to Follow-up|0
2877103|NCT01998958|9899842|P20|Open Label Phase (Optional)|Lost to Follow-up|0
2877104|NCT01998958|9899843|P19|Open Label Phase (Optional)|Lost to Follow-up|0
2877105|NCT01998958|9899844|P18|Open Label Phase (Optional)|Lost to Follow-up|0
2877106|NCT01998958|9899845|P17|Open Label Phase (Optional)|Lost to Follow-up|0
2877107|NCT01998958|9899846|P16|Open Label Phase (Optional)|Lost to Follow-up|0
2877108|NCT01998958|9899847|P15|Open Label Phase (Optional)|Lost to Follow-up|0
2877109|NCT01998958|9899848|P14|Open Label Phase (Optional)|Lost to Follow-up|0
2877110|NCT01998958|9899849|P13|Open Label Phase (Optional)|Lost to Follow-up|0
2877111|NCT01998958|9899850|P12|Open Label Phase (Optional)|Lost to Follow-up|0
2877112|NCT01998958|9899851|P11|Open Label Phase (Optional)|Lost to Follow-up|0
2877113|NCT01998958|9899852|P10|Open Label Phase (Optional)|Lost to Follow-up|0
2877114|NCT01998958|9899853|P9|Open Label Phase (Optional)|Lost to Follow-up|0
2877115|NCT01998958|9899854|P8|Open Label Phase (Optional)|Lost to Follow-up|0
2877116|NCT01998958|9899855|P7|Open Label Phase (Optional)|Lost to Follow-up|0
2877117|NCT01998958|9899856|P6|Open Label Phase (Optional)|Lost to Follow-up|0
2877118|NCT01998958|9899857|P5|Open Label Phase (Optional)|Lost to Follow-up|0
2877119|NCT01998958|9899858|P4|Open Label Phase (Optional)|Lost to Follow-up|0
2877120|NCT01998958|9899859|P3|Open Label Phase (Optional)|Lost to Follow-up|0
2877121|NCT01998958|9899860|P2|Open Label Phase (Optional)|Lost to Follow-up|0
2877122|NCT01998958|9899861|P1|Open Label Phase (Optional)|Lost to Follow-up|0
2877123|NCT01998958|9899830|P32|Open Label Phase (Optional)|Other|0
2877124|NCT01998958|9899831|P31|Open Label Phase (Optional)|Other|0
2877125|NCT01998958|9899832|P30|Open Label Phase (Optional)|Other|0
2877126|NCT01998958|9899833|P29|Open Label Phase (Optional)|Other|0
2877127|NCT01998958|9899834|P28|Open Label Phase (Optional)|Other|0
2877128|NCT01998958|9899835|P27|Open Label Phase (Optional)|Other|0
2877129|NCT01998958|9899836|P26|Open Label Phase (Optional)|Other|0
2877130|NCT01998958|9899837|P25|Open Label Phase (Optional)|Other|0
2877131|NCT01998958|9899838|P24|Open Label Phase (Optional)|Other|1
2877132|NCT01998958|9899839|P23|Open Label Phase (Optional)|Other|5
2877133|NCT01998958|9899840|P22|Open Label Phase (Optional)|Other|0
2877134|NCT01998958|9899841|P21|Open Label Phase (Optional)|Other|0
2877135|NCT01998958|9899842|P20|Open Label Phase (Optional)|Other|0
2877136|NCT01998958|9899843|P19|Open Label Phase (Optional)|Other|0
2877137|NCT01998958|9899844|P18|Open Label Phase (Optional)|Other|0
2877138|NCT01998958|9899845|P17|Open Label Phase (Optional)|Other|0
2877139|NCT01998958|9899846|P16|Open Label Phase (Optional)|Other|0
2877140|NCT01998958|9899847|P15|Open Label Phase (Optional)|Other|0
2877141|NCT01998958|9899848|P14|Open Label Phase (Optional)|Other|0
2877142|NCT01998958|9899849|P13|Open Label Phase (Optional)|Other|0
2877143|NCT01998958|9899850|P12|Open Label Phase (Optional)|Other|0
2877144|NCT01998958|9899851|P11|Open Label Phase (Optional)|Other|0
2877145|NCT01998958|9899852|P10|Open Label Phase (Optional)|Other|0
2877146|NCT01998958|9899853|P9|Open Label Phase (Optional)|Other|0
2877147|NCT01998958|9899854|P8|Open Label Phase (Optional)|Other|0
2877148|NCT01998958|9899855|P7|Open Label Phase (Optional)|Other|0
2877149|NCT01998958|9899856|P6|Open Label Phase (Optional)|Other|0
2877150|NCT01998958|9899857|P5|Open Label Phase (Optional)|Other|0
2877151|NCT01998958|9899858|P4|Open Label Phase (Optional)|Other|0
2877152|NCT01998958|9899859|P3|Open Label Phase (Optional)|Other|0
2877153|NCT01998958|9899860|P2|Open Label Phase (Optional)|Other|0
2877154|NCT01998958|9899861|P1|Open Label Phase (Optional)|Other|0
2877155|NCT01998958|9899830|P32|Open Label Phase (Optional)|Adverse Event|0
2877156|NCT01998958|9899831|P31|Open Label Phase (Optional)|Adverse Event|0
2877157|NCT01998958|9899832|P30|Open Label Phase (Optional)|Adverse Event|0
2877158|NCT01998958|9899833|P29|Open Label Phase (Optional)|Adverse Event|0
2877159|NCT01998958|9899834|P28|Open Label Phase (Optional)|Adverse Event|0
2877160|NCT01998958|9899835|P27|Open Label Phase (Optional)|Adverse Event|0
2877161|NCT01998958|9899836|P26|Open Label Phase (Optional)|Adverse Event|0
2877162|NCT01998958|9899837|P25|Open Label Phase (Optional)|Adverse Event|0
2877163|NCT01998958|9899838|P24|Open Label Phase (Optional)|Adverse Event|1
2877164|NCT01998958|9899839|P23|Open Label Phase (Optional)|Adverse Event|0
2877165|NCT01998958|9899840|P22|Open Label Phase (Optional)|Adverse Event|0
2877166|NCT01998958|9899841|P21|Open Label Phase (Optional)|Adverse Event|0
2877167|NCT01998958|9899842|P20|Open Label Phase (Optional)|Adverse Event|0
2877168|NCT01998958|9899843|P19|Open Label Phase (Optional)|Adverse Event|0
2877169|NCT01998958|9899844|P18|Open Label Phase (Optional)|Adverse Event|0
2877170|NCT01998958|9899845|P17|Open Label Phase (Optional)|Adverse Event|0
2877171|NCT01998958|9899846|P16|Open Label Phase (Optional)|Adverse Event|0
2877172|NCT01998958|9899847|P15|Open Label Phase (Optional)|Adverse Event|0
2877173|NCT01998958|9899848|P14|Open Label Phase (Optional)|Adverse Event|0
2877174|NCT01998958|9899849|P13|Open Label Phase (Optional)|Adverse Event|0
2877175|NCT01998958|9899850|P12|Open Label Phase (Optional)|Adverse Event|0
2877176|NCT01998958|9899851|P11|Open Label Phase (Optional)|Adverse Event|0
2877177|NCT01998958|9899852|P10|Open Label Phase (Optional)|Adverse Event|0
2877178|NCT01998958|9899853|P9|Open Label Phase (Optional)|Adverse Event|0
2877179|NCT01998958|9899854|P8|Open Label Phase (Optional)|Adverse Event|0
2877180|NCT01998958|9899855|P7|Open Label Phase (Optional)|Adverse Event|0
2877181|NCT01998958|9899856|P6|Open Label Phase (Optional)|Adverse Event|0
2877182|NCT01998958|9899857|P5|Open Label Phase (Optional)|Adverse Event|0
2877183|NCT01998958|9899858|P4|Open Label Phase (Optional)|Adverse Event|0
2877184|NCT01998958|9899859|P3|Open Label Phase (Optional)|Adverse Event|0
2877185|NCT01998958|9899860|P2|Open Label Phase (Optional)|Adverse Event|0
2877186|NCT01998958|9899861|P1|Open Label Phase (Optional)|Adverse Event|0
2877187|NCT01998958|9899830|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877188|NCT01998958|9899831|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877189|NCT01998958|9899832|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877190|NCT01998958|9899833|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877191|NCT01998958|9899834|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877192|NCT01998958|9899835|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877193|NCT01998958|9899836|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877194|NCT01998958|9899837|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877195|NCT01998958|9899838|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877196|NCT01998958|9899839|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877197|NCT01998958|9899840|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877198|NCT01998958|9899841|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877199|NCT01998958|9899842|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877200|NCT01998958|9899843|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
2877201|NCT01998958|9899844|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877202|NCT01998958|9899845|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877203|NCT01998958|9899846|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877204|NCT01998958|9899847|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
2877205|NCT01998958|9899848|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877206|NCT01998958|9899849|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877207|NCT01998958|9899850|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877208|NCT01998958|9899851|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877209|NCT01998958|9899852|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877210|NCT01998958|9899853|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877211|NCT01998958|9899854|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877212|NCT01998958|9899855|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877213|NCT01998958|9899856|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877214|NCT01998958|9899857|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877215|NCT01998958|9899858|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877216|NCT01998958|9899859|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877217|NCT01998958|9899860|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877218|NCT01998958|9899861|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
2877219|NCT01998958|9899830|P32|Period 2 (Panel A and B)|Adverse Event|0
2877220|NCT01998958|9899831|P31|Period 2 (Panel A and B)|Adverse Event|0
2877221|NCT01998958|9899832|P30|Period 2 (Panel A and B)|Adverse Event|0
2877222|NCT01998958|9899833|P29|Period 2 (Panel A and B)|Adverse Event|0
2877223|NCT01998958|9899834|P28|Period 2 (Panel A and B)|Adverse Event|0
2877224|NCT01998958|9899835|P27|Period 2 (Panel A and B)|Adverse Event|0
2877225|NCT01998958|9899836|P26|Period 2 (Panel A and B)|Adverse Event|0
2877226|NCT01998958|9899837|P25|Period 2 (Panel A and B)|Adverse Event|0
2877227|NCT01998958|9899838|P24|Period 2 (Panel A and B)|Adverse Event|0
2877228|NCT01998958|9899839|P23|Period 2 (Panel A and B)|Adverse Event|0
2877229|NCT01998958|9899840|P22|Period 2 (Panel A and B)|Adverse Event|0
2877230|NCT01998958|9899841|P21|Period 2 (Panel A and B)|Adverse Event|0
2877231|NCT01998958|9899842|P20|Period 2 (Panel A and B)|Adverse Event|0
2877232|NCT01998958|9899843|P19|Period 2 (Panel A and B)|Adverse Event|0
2877233|NCT01998958|9899844|P18|Period 2 (Panel A and B)|Adverse Event|0
2877234|NCT01998958|9899845|P17|Period 2 (Panel A and B)|Adverse Event|0
2877235|NCT01998958|9899846|P16|Period 2 (Panel A and B)|Adverse Event|0
2877236|NCT01998958|9899847|P15|Period 2 (Panel A and B)|Adverse Event|1
2877237|NCT01998958|9899848|P14|Period 2 (Panel A and B)|Adverse Event|0
2877238|NCT01998958|9899849|P13|Period 2 (Panel A and B)|Adverse Event|0
2877239|NCT01998958|9899850|P12|Period 2 (Panel A and B)|Adverse Event|0
2877240|NCT01998958|9899851|P11|Period 2 (Panel A and B)|Adverse Event|1
2877241|NCT01998958|9899852|P10|Period 2 (Panel A and B)|Adverse Event|0
2877242|NCT01998958|9899853|P9|Period 2 (Panel A and B)|Adverse Event|0
2877243|NCT01998958|9899854|P8|Period 2 (Panel A and B)|Adverse Event|0
2877244|NCT01998958|9899855|P7|Period 2 (Panel A and B)|Adverse Event|0
2877245|NCT01998958|9899856|P6|Period 2 (Panel A and B)|Adverse Event|0
2877246|NCT01998958|9899857|P5|Period 2 (Panel A and B)|Adverse Event|0
2877247|NCT01998958|9899858|P4|Period 2 (Panel A and B)|Adverse Event|0
2877248|NCT01998958|9899859|P3|Period 2 (Panel A and B)|Adverse Event|0
2877249|NCT01998958|9899860|P2|Period 2 (Panel A and B)|Adverse Event|0
2877250|NCT01998958|9899861|P1|Period 2 (Panel A and B)|Adverse Event|0
2877251|NCT01998958|9899830|P32|Period 1 (Panel A and B)|Other|0
2877252|NCT01998958|9899831|P31|Period 1 (Panel A and B)|Other|0
2877253|NCT01998958|9899832|P30|Period 1 (Panel A and B)|Other|0
2877254|NCT01998958|9899833|P29|Period 1 (Panel A and B)|Other|0
2877255|NCT01998958|9899834|P28|Period 1 (Panel A and B)|Other|0
2877256|NCT01998958|9899835|P27|Period 1 (Panel A and B)|Other|0
2877257|NCT01998958|9899836|P26|Period 1 (Panel A and B)|Other|0
2877258|NCT01998958|9899837|P25|Period 1 (Panel A and B)|Other|0
2877259|NCT01998958|9899838|P24|Period 1 (Panel A and B)|Other|0
2877260|NCT01998958|9899839|P23|Period 1 (Panel A and B)|Other|0
2877261|NCT01998958|9899840|P22|Period 1 (Panel A and B)|Other|0
2877262|NCT01998958|9899841|P21|Period 1 (Panel A and B)|Other|0
2877263|NCT01998958|9899842|P20|Period 1 (Panel A and B)|Other|0
2877264|NCT01998958|9899843|P19|Period 1 (Panel A and B)|Other|0
2877265|NCT01998958|9899844|P18|Period 1 (Panel A and B)|Other|0
2877266|NCT01998958|9899845|P17|Period 1 (Panel A and B)|Other|0
2877267|NCT01998958|9899846|P16|Period 1 (Panel A and B)|Other|0
2877268|NCT01998958|9899847|P15|Period 1 (Panel A and B)|Other|0
2877269|NCT01998958|9899848|P14|Period 1 (Panel A and B)|Other|0
2877270|NCT01998958|9899849|P13|Period 1 (Panel A and B)|Other|0
2877271|NCT01998958|9899850|P12|Period 1 (Panel A and B)|Other|0
2877272|NCT01998958|9899851|P11|Period 1 (Panel A and B)|Other|0
2877273|NCT01998958|9899852|P10|Period 1 (Panel A and B)|Other|0
2877274|NCT01998958|9899853|P9|Period 1 (Panel A and B)|Other|0
2877275|NCT01998958|9899854|P8|Period 1 (Panel A and B)|Other|0
2877276|NCT01998958|9899855|P7|Period 1 (Panel A and B)|Other|0
2877277|NCT01998958|9899856|P6|Period 1 (Panel A and B)|Other|0
2877278|NCT01998958|9899857|P5|Period 1 (Panel A and B)|Other|0
2877279|NCT01998958|9899858|P4|Period 1 (Panel A and B)|Other|0
2877280|NCT01998958|9899859|P3|Period 1 (Panel A and B)|Other|0
2877281|NCT01998958|9899860|P2|Period 1 (Panel A and B)|Other|0
2877282|NCT01998958|9899861|P1|Period 1 (Panel A and B)|Other|1
2877283|NCT01998958|9899830|P32|Period 1 (Panel A and B)|Adverse Event|0
2877284|NCT01998958|9899831|P31|Period 1 (Panel A and B)|Adverse Event|0
2877285|NCT01998958|9899832|P30|Period 1 (Panel A and B)|Adverse Event|0
2877286|NCT01998958|9899833|P29|Period 1 (Panel A and B)|Adverse Event|0
2877287|NCT01998958|9899834|P28|Period 1 (Panel A and B)|Adverse Event|0
2877288|NCT01998958|9899835|P27|Period 1 (Panel A and B)|Adverse Event|0
2877289|NCT01998958|9899836|P26|Period 1 (Panel A and B)|Adverse Event|0
2877290|NCT01998958|9899837|P25|Period 1 (Panel A and B)|Adverse Event|0
2877291|NCT01998958|9899838|P24|Period 1 (Panel A and B)|Adverse Event|0
2877292|NCT01998958|9899839|P23|Period 1 (Panel A and B)|Adverse Event|0
2877293|NCT01998958|9899840|P22|Period 1 (Panel A and B)|Adverse Event|0
2877294|NCT01998958|9899841|P21|Period 1 (Panel A and B)|Adverse Event|0
2877295|NCT01998958|9899842|P20|Period 1 (Panel A and B)|Adverse Event|0
2877296|NCT01998958|9899843|P19|Period 1 (Panel A and B)|Adverse Event|0
2877297|NCT01998958|9899844|P18|Period 1 (Panel A and B)|Adverse Event|0
2877298|NCT01998958|9899845|P17|Period 1 (Panel A and B)|Adverse Event|0
2877299|NCT01998958|9899846|P16|Period 1 (Panel A and B)|Adverse Event|0
2877300|NCT01998958|9899847|P15|Period 1 (Panel A and B)|Adverse Event|0
2877301|NCT01998958|9899848|P14|Period 1 (Panel A and B)|Adverse Event|0
2877302|NCT01998958|9899849|P13|Period 1 (Panel A and B)|Adverse Event|0
2877303|NCT01998958|9899850|P12|Period 1 (Panel A and B)|Adverse Event|0
2877304|NCT01998958|9899851|P11|Period 1 (Panel A and B)|Adverse Event|0
2877305|NCT01998958|9899852|P10|Period 1 (Panel A and B)|Adverse Event|0
2877306|NCT01998958|9899853|P9|Period 1 (Panel A and B)|Adverse Event|0
2877307|NCT01998958|9899854|P8|Period 1 (Panel A and B)|Adverse Event|0
2877308|NCT01998958|9899855|P7|Period 1 (Panel A and B)|Adverse Event|0
2877309|NCT01998958|9899856|P6|Period 1 (Panel A and B)|Adverse Event|0
2877310|NCT01998958|9899857|P5|Period 1 (Panel A and B)|Adverse Event|0
2877311|NCT01998958|9899858|P4|Period 1 (Panel A and B)|Adverse Event|0
2877312|NCT01998958|9899859|P3|Period 1 (Panel A and B)|Adverse Event|0
2877313|NCT01998958|9899860|P2|Period 1 (Panel A and B)|Adverse Event|1
2877314|NCT01998958|9899861|P1|Period 1 (Panel A and B)|Adverse Event|0
2877315|NCT01998958|9899830|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
2877316|NCT01998958|9899831|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
2877317|NCT01998958|9899832|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
2877318|NCT01998958|9899833|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
2877319|NCT01998958|9899834|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
2877320|NCT01998958|9899835|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
2877321|NCT01998958|9899836|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
2877322|NCT01998958|9899837|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
2877323|NCT01998958|9899838|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
2877324|NCT01998958|9899839|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
2877325|NCT01998958|9899840|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
2877326|NCT01998958|9899841|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
2877327|NCT01998958|9899842|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
2877328|NCT01998958|9899843|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
2877329|NCT01998958|9899844|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
2877330|NCT01998958|9899845|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
2877331|NCT01998958|9899846|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
2877332|NCT01998958|9899847|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
2877333|NCT01998958|9899848|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
2877334|NCT01998958|9899849|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
2877335|NCT01998958|9899850|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
2877336|NCT01998958|9899851|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
2877337|NCT01998958|9899852|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
2877338|NCT01998958|9899853|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
2877339|NCT01998958|9899854|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
2877340|NCT01998958|9899855|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
2877341|NCT01998958|9899856|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
2877342|NCT01998958|9899857|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
2877343|NCT01998958|9899858|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
2877344|NCT01998958|9899859|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
2877345|NCT01998958|9899860|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
2877346|NCT01998958|9899861|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
2877347|NCT01998958|9899830|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877348|NCT01998958|9899831|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877349|NCT01998958|9899832|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877350|NCT01998958|9899833|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877351|NCT01998958|9899834|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877352|NCT01998958|9899835|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877353|NCT01998958|9899836|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877354|NCT01998958|9899837|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877355|NCT01998958|9899838|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877356|NCT01998958|9899839|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877357|NCT01998958|9899840|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877358|NCT01998958|9899841|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877359|NCT01998958|9899842|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877360|NCT01998958|9899843|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877361|NCT01998958|9899844|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877362|NCT01998958|9899845|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877363|NCT01998958|9899846|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877364|NCT01998958|9899847|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877365|NCT01998958|9899848|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877366|NCT01998958|9899849|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877367|NCT01998958|9899850|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877368|NCT01998958|9899851|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877369|NCT01998958|9899852|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877370|NCT01998958|9899853|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877371|NCT01998958|9899854|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877372|NCT01998958|9899855|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877373|NCT01998958|9899856|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877374|NCT01998958|9899857|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877375|NCT01998958|9899858|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877376|NCT01998958|9899859|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877377|NCT01998958|9899860|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
2877378|NCT01998958|9899861|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
2877379|NCT01998919|9900000|P2|Overall Study|Other|2
2877380|NCT01998919|9900001|P1|Overall Study|Other|5
2877381|NCT01998919|9900000|P2|Overall Study|Lost to Follow-up|0
2877382|NCT01998919|9900001|P1|Overall Study|Lost to Follow-up|2
2877383|NCT01998919|9900000|P2|Overall Study|Withdrawal by Subject|4
2877384|NCT01998919|9900001|P1|Overall Study|Withdrawal by Subject|2
2877385|NCT01998919|9900000|P2|Overall Study|Disease progression|22
2877386|NCT01998919|9900001|P1|Overall Study|Disease progression|31
2877387|NCT01998919|9900000|P2|Overall Study|Adverse Event|5
2877388|NCT01998919|9900001|P1|Overall Study|Adverse Event|0
2877389|NCT01998919|9900000|P2|Overall Study|Death|2
2877390|NCT01998919|9900001|P1|Overall Study|Death|2
2877391|NCT01998906|9900022|P3|Overall Study|Other|4
2877392|NCT01998906|9900023|P2|Overall Study|Other|8
2877393|NCT01998906|9900024|P1|Overall Study|Other|3
2877394|NCT01998906|9900022|P3|Overall Study|Administrative/Other|3
2877395|NCT01998906|9900023|P2|Overall Study|Administrative/Other|1
2877396|NCT01998906|9900024|P1|Overall Study|Administrative/Other|2
2877397|NCT01998906|9900022|P3|Overall Study|Withdrawal by Subject|3
2877398|NCT01998906|9900023|P2|Overall Study|Withdrawal by Subject|4
2877399|NCT01998906|9900024|P1|Overall Study|Withdrawal by Subject|1
2877400|NCT01998906|9900022|P3|Overall Study|Violation of Selection Criteria|1
2877401|NCT01998906|9900023|P2|Overall Study|Violation of Selection Criteria|0
2877402|NCT01998906|9900024|P1|Overall Study|Violation of Selection Criteria|0
2877403|NCT01998906|9900022|P3|Overall Study|Failure to return|4
2877404|NCT01998906|9900023|P2|Overall Study|Failure to return|2
2877405|NCT01998906|9900024|P1|Overall Study|Failure to return|0
2877406|NCT01998906|9900022|P3|Overall Study|Lack of Efficacy|8
2877407|NCT01998906|9900023|P2|Overall Study|Lack of Efficacy|9
2877408|NCT01998906|9900024|P1|Overall Study|Lack of Efficacy|10
2877409|NCT01998906|9900022|P3|Overall Study|Death|17
2877410|NCT01998906|9900023|P2|Overall Study|Death|30
2877411|NCT01998906|9900024|P1|Overall Study|Death|21
2877412|NCT01998906|9900022|P3|Overall Study|Participants ongoing in follow−up|58
2877413|NCT01998906|9900023|P2|Overall Study|Participants ongoing in follow−up|60
2877414|NCT01998906|9900024|P1|Overall Study|Participants ongoing in follow−up|77
2877415|NCT01998893|9900068|P1|Overall Study|Transformation to high-grade lymphoma|1
2877416|NCT01998893|9900068|P1|Overall Study|Withdrawal by Subject|1
2877417|NCT01998893|9900068|P1|Overall Study|Protocol Violation|2
2877418|NCT01998893|9900068|P1|Overall Study|Physician Decision|2
2877419|NCT01998893|9900068|P1|Overall Study|Lost to Follow-up|8
2877420|NCT01998893|9900068|P1|Overall Study|Death|1
2877421|NCT01998893|9900068|P1|Overall Study|Adverse Event|2
2877422|NCT01998880|9900080|P2|Overall Study|Did Not Receive Treatment|2
2877423|NCT01998880|9900081|P1|Overall Study|Did Not Receive Treatment|3
2877424|NCT01998880|9900080|P2|Overall Study|Violation of Selection Criteria at Entry|1
2877425|NCT01998880|9900081|P1|Overall Study|Violation of Selection Criteria at Entry|0
2877426|NCT01998880|9900080|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
2877427|NCT01998880|9900081|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
2877428|NCT01998880|9900080|P2|Overall Study|Administrative/Other|1
2877429|NCT01998880|9900081|P1|Overall Study|Administrative/Other|1
2877430|NCT01998880|9900080|P2|Overall Study|Insufficient Therapeutic Response|5
2877431|NCT01998880|9900081|P1|Overall Study|Insufficient Therapeutic Response|1
2877432|NCT01998880|9900080|P2|Overall Study|Death|6
2877433|NCT01998880|9900081|P1|Overall Study|Death|3
2877434|NCT01998880|9900080|P2|Overall Study|Withdrew Consent|1
2877435|NCT01998880|9900081|P1|Overall Study|Withdrew Consent|2
2877436|NCT01998880|9900080|P2|Overall Study|Disease Progression|8
2877437|NCT01998880|9900081|P1|Overall Study|Disease Progression|1
2877438|NCT01998880|9900080|P2|Overall Study|Adverse Events or Intercurrent Illness|16
2877439|NCT01998880|9900081|P1|Overall Study|Adverse Events or Intercurrent Illness|16
2877440|NCT01998737|9900113|P2|Overall Study|Corrupted database|0
2877441|NCT01998737|9900114|P1|Overall Study|Corrupted database|23
2877442|NCT01998633|9900126|P1|Overall Study|Death|1
2877443|NCT01998581|9900144|P2|Overall Study|Randomized but withdrew before treatment|0
2877444|NCT01998581|9900145|P1|Overall Study|Randomized but withdrew before treatment|1
2877445|NCT01998581|9900144|P2|Overall Study|Other reasons|2
2877446|NCT01998581|9900145|P1|Overall Study|Other reasons|3
2877447|NCT01998581|9900144|P2|Overall Study|Adverse Event|1
2877448|NCT01998581|9900145|P1|Overall Study|Adverse Event|1
2877449|NCT01998581|9900144|P2|Overall Study|Lost to Follow-up|4
2877450|NCT01998581|9900145|P1|Overall Study|Lost to Follow-up|12
2877451|NCT01998581|9900144|P2|Overall Study|Withdrawal by Subject|1
2877452|NCT01998581|9900145|P1|Overall Study|Withdrawal by Subject|8
2877453|NCT01998581|9900144|P2|Overall Study|Protocol Violation|0
2877454|NCT01998581|9900145|P1|Overall Study|Protocol Violation|1
2877455|NCT01998581|9900144|P2|Overall Study|Refused repeat treatment|4
2877456|NCT01998581|9900145|P1|Overall Study|Refused repeat treatment|20
2877457|NCT01998477|9900158|P2|Overall Study|Withdrawal by Subject|0
2877458|NCT01998477|9900159|P1|Overall Study|Withdrawal by Subject|6
2877459|NCT01998477|9900158|P2|Overall Study|Lost to Follow-up|5
2877460|NCT01998477|9900159|P1|Overall Study|Lost to Follow-up|4
2877461|NCT01998399|9900205|P2|Overall Study|Withdrawal by Subject|1
2877462|NCT01998399|9900206|P1|Overall Study|Withdrawal by Subject|0
2877463|NCT01998399|9900205|P2|Overall Study|Study stopped before dosing completed|3
2877464|NCT01998399|9900206|P1|Overall Study|Study stopped before dosing completed|3
2877465|NCT01998399|9900205|P2|Overall Study|Death|2
2877466|NCT01998399|9900206|P1|Overall Study|Death|4
2877467|NCT01998399|9900205|P2|Overall Study|Lost to Follow-up|3
2877468|NCT01998399|9900206|P1|Overall Study|Lost to Follow-up|1
2877469|NCT01998243|9900261|P2|Overall Study|Withdrawal by Subject|4
2877470|NCT01998243|9900262|P1|Overall Study|Withdrawal by Subject|3
2877471|NCT01998243|9900261|P2|Overall Study|Protocol Violation|2
2877472|NCT01998243|9900262|P1|Overall Study|Protocol Violation|5
2877473|NCT01998243|9900261|P2|Overall Study|Pregnancy|1
2877474|NCT01998243|9900262|P1|Overall Study|Pregnancy|0
2877475|NCT01997892|9900285|P1|Overall Study|Study completion data not recorded|35
2877476|NCT01997892|9900285|P1|Overall Study|Other|3
2877477|NCT01997892|9900285|P1|Overall Study|Renal transplant|8
2877478|NCT01997892|9900285|P1|Overall Study|Death|14
2877479|NCT01997892|9900285|P1|Overall Study|Lost to Follow-up|6
2877480|NCT01997892|9900285|P1|Overall Study|Physician Decision|2
2877481|NCT01997333|9900459|P2|Survival Follow up|Various|2
2877482|NCT01997333|9900460|P1|Survival Follow up|Various|1
2877483|NCT01997333|9900459|P2|Survival Follow up|Lost to Follow-up|6
2877484|NCT01997333|9900460|P1|Survival Follow up|Lost to Follow-up|0
2877485|NCT01997333|9900459|P2|Survival Follow up|Withdrawal by Subject|6
2877486|NCT01997333|9900460|P1|Survival Follow up|Withdrawal by Subject|15
2877487|NCT01997333|9900459|P2|Randomization and Treatment|Did not receive treatment|5
2877488|NCT01997333|9900460|P1|Randomization and Treatment|Did not receive treatment|17
2877489|NCT01997333|9900459|P2|Randomization and Treatment|Withdrawal by Subject|3
2877490|NCT01997333|9900460|P1|Randomization and Treatment|Withdrawal by Subject|6
2877491|NCT01997333|9900459|P2|Randomization and Treatment|Physician Decision|4
2877492|NCT01997333|9900460|P1|Randomization and Treatment|Physician Decision|0
2877493|NCT01997333|9900459|P2|Randomization and Treatment|Adverse Event|32
2877494|NCT01997333|9900460|P1|Randomization and Treatment|Adverse Event|10
2877495|NCT01997333|9900459|P2|Randomization and Treatment|Disease Progression|159
2877496|NCT01997333|9900460|P1|Randomization and Treatment|Disease Progression|70
2877497|NCT01996982|9900495|P1|Overall Study|PI/team left institution|7
2877498|NCT01996904|9900511|P2|Overall Study|Lost to Follow-up|27
2877499|NCT01996904|9900512|P1|Overall Study|Lost to Follow-up|38
2877500|NCT01996748|9900580|P2|Overall Study|Lost to Follow-up|1
2877501|NCT01996748|9900581|P1|Overall Study|Lost to Follow-up|4
2877502|NCT01996748|9900580|P2|Overall Study|Withdrawal by Subject|1
2877503|NCT01996748|9900581|P1|Overall Study|Withdrawal by Subject|0
2877504|NCT01996748|9900580|P2|Overall Study|Adverse Event|4
2877505|NCT01996748|9900581|P1|Overall Study|Adverse Event|1
2877506|NCT01996748|9900580|P2|Overall Study|Physician Decision|0
2877507|NCT01996748|9900581|P1|Overall Study|Physician Decision|2
2877508|NCT01996748|9900580|P2|Overall Study|Personal reason|0
2877509|NCT01996748|9900581|P1|Overall Study|Personal reason|1
2877510|NCT01996709|9900595|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
2877511|NCT01996709|9900596|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
2877512|NCT01996709|9900595|P2|Overall Study|Subject Non-Compliant|0
2877513|NCT01996709|9900596|P1|Overall Study|Subject Non-Compliant|1
2877514|NCT01996709|9900595|P2|Overall Study|Lost to Follow-up|0
2877515|NCT01996709|9900596|P1|Overall Study|Lost to Follow-up|3
2877516|NCT01996709|9900595|P2|Overall Study|Withdrawal by Subject|0
2877517|NCT01996709|9900596|P1|Overall Study|Withdrawal by Subject|1
2877518|NCT01996592|9900643|P1|Overall Study|change in mode of delivery|4
2877519|NCT01996592|9900643|P1|Overall Study|Withdrawal by Subject|5
2877520|NCT01996592|9900643|P1|Overall Study|change in surgical date|4
2877521|NCT01996592|9900643|P1|Overall Study|no response to text/no diary entry|32
2877522|NCT01996332|9900679|P1|Overall Study|Lost to Follow-up|34
2877523|NCT01996332|9900679|P1|Overall Study|Physician Decision|17
2877524|NCT01996332|9900679|P1|Overall Study|Clinical Deterioration|28
2877525|NCT01996332|9900679|P1|Overall Study|Other|20
2877526|NCT01996332|9900679|P1|Overall Study|Withdrawal by Subject|71
2877527|NCT01996332|9900679|P1|Overall Study|Protocol Violation|9
2877528|NCT01996332|9900679|P1|Overall Study|Death|264
2877529|NCT01996332|9900679|P1|Overall Study|Lack of Efficacy|1245
2877530|NCT01996332|9900679|P1|Overall Study|Adverse Event|117
2877531|NCT01996319|9900687|P2|Overall Study|Adverse Event|2
2877532|NCT01996319|9900688|P1|Overall Study|Adverse Event|2
2877533|NCT01996319|9900687|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
2877534|NCT01996319|9900688|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
2877535|NCT01996319|9900687|P2|Overall Study|Protocol Violation|0
2877536|NCT01996319|9900688|P1|Overall Study|Protocol Violation|1
2877537|NCT01996254|9900710|P3|Overall Study|Lost to Follow-up|4
2877538|NCT01996254|9900711|P2|Overall Study|Lost to Follow-up|0
2877539|NCT01996254|9900712|P1|Overall Study|Lost to Follow-up|1
2877540|NCT01996254|9900710|P3|Overall Study|Withdrawal by Subject|4
2877541|NCT01996254|9900711|P2|Overall Study|Withdrawal by Subject|3
2877542|NCT01996254|9900712|P1|Overall Study|Withdrawal by Subject|0
2877543|NCT01996254|9900710|P3|Overall Study|Change in Eligibility|0
2877544|NCT01996254|9900711|P2|Overall Study|Change in Eligibility|2
2877545|NCT01996254|9900712|P1|Overall Study|Change in Eligibility|0
2877546|NCT01996241|9900740|P2|Overall Study|Lost to Follow-up|235
2877547|NCT01996241|9900741|P1|Overall Study|Lost to Follow-up|252
2877548|NCT01996033|9900757|P1|Overall Study|Lost to Follow-up|3
2877549|NCT01996033|9900757|P1|Overall Study|Withdrawal by Subject|4
2877550|NCT01996033|9900757|P1|Overall Study|Physician Decision|1
2877551|NCT01996033|9900757|P1|Overall Study|Death|1
2877552|NCT01995838|9900777|P7|Overall Study|Other|2
2877553|NCT01995838|9900778|P6|Overall Study|Other|1
2877554|NCT01995838|9900779|P5|Overall Study|Other|1
2877555|NCT01995838|9900780|P4|Overall Study|Other|2
2877556|NCT01995838|9900781|P3|Overall Study|Other|0
2877557|NCT01995838|9900782|P2|Overall Study|Other|1
2877558|NCT01995838|9900783|P1|Overall Study|Other|3
2877559|NCT01995838|9900777|P7|Overall Study|Withdrawal by Subject|0
2877560|NCT01995838|9900778|P6|Overall Study|Withdrawal by Subject|0
2877561|NCT01995838|9900779|P5|Overall Study|Withdrawal by Subject|1
2877562|NCT01995838|9900780|P4|Overall Study|Withdrawal by Subject|0
2877563|NCT01995838|9900781|P3|Overall Study|Withdrawal by Subject|0
2877564|NCT01995838|9900782|P2|Overall Study|Withdrawal by Subject|0
2877565|NCT01995838|9900783|P1|Overall Study|Withdrawal by Subject|0
2877566|NCT01995838|9900777|P7|Overall Study|Adverse Event|1
2877567|NCT01995838|9900778|P6|Overall Study|Adverse Event|0
2877568|NCT01995838|9900779|P5|Overall Study|Adverse Event|0
2877569|NCT01995838|9900780|P4|Overall Study|Adverse Event|0
2877570|NCT01995838|9900781|P3|Overall Study|Adverse Event|0
2877571|NCT01995838|9900782|P2|Overall Study|Adverse Event|0
2877572|NCT01995838|9900783|P1|Overall Study|Adverse Event|0
2877573|NCT01995838|9900777|P7|Overall Study|Participant choice|1
2877574|NCT01995838|9900778|P6|Overall Study|Participant choice|1
2877575|NCT01995838|9900779|P5|Overall Study|Participant choice|0
2877576|NCT01995838|9900780|P4|Overall Study|Participant choice|0
2877577|NCT01995838|9900781|P3|Overall Study|Participant choice|0
2877578|NCT01995838|9900782|P2|Overall Study|Participant choice|0
2877579|NCT01995838|9900783|P1|Overall Study|Participant choice|2
2877580|NCT01995838|9900777|P7|Overall Study|Lost to Follow-up|1
2877581|NCT01995838|9900778|P6|Overall Study|Lost to Follow-up|0
2877582|NCT01995838|9900779|P5|Overall Study|Lost to Follow-up|0
2877583|NCT01995838|9900780|P4|Overall Study|Lost to Follow-up|0
2877584|NCT01995838|9900781|P3|Overall Study|Lost to Follow-up|0
2877585|NCT01995838|9900782|P2|Overall Study|Lost to Follow-up|1
2877586|NCT01995838|9900783|P1|Overall Study|Lost to Follow-up|0
2877587|NCT01995552|9900882|P1|Overall Study|Death|1
2877588|NCT01995552|9900882|P1|Overall Study|Lack of Efficacy|15
2877589|NCT01995552|9900882|P1|Overall Study|Protocol Violation|1
2877590|NCT01995539|9900888|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
2877591|NCT01995539|9900888|P1|Overall Study|Lost to Follow-up|5
2877592|NCT01995539|9900888|P1|Overall Study|Withdrawal by Subject|11
2877593|NCT01995539|9900888|P1|Overall Study|Withdrawal by Investigator|15
2877594|NCT01995539|9900888|P1|Overall Study|Screening Failure|1
2877595|NCT01995526|9900893|P1|Overall Study|Physician Decision|1
2877596|NCT01995513|9900901|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
2877597|NCT01995513|9900902|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
2877598|NCT01995513|9900903|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2877599|NCT01995513|9900901|P3|Double Blind Treatment Period|Disease Progression|93
2877600|NCT01995513|9900902|P2|Double Blind Treatment Period|Disease Progression|82
2877601|NCT01995513|9900903|P1|Double Blind Treatment Period|Disease Progression|0
2877602|NCT01995513|9900901|P3|Double Blind Treatment Period|Death|1
2877603|NCT01995513|9900902|P2|Double Blind Treatment Period|Death|0
2877604|NCT01995513|9900903|P1|Double Blind Treatment Period|Death|0
2877605|NCT01995513|9900901|P3|Double Blind Treatment Period|Withdrawal by Subject|6
2877606|NCT01995513|9900902|P2|Double Blind Treatment Period|Withdrawal by Subject|4
2877607|NCT01995513|9900903|P1|Double Blind Treatment Period|Withdrawal by Subject|0
2877608|NCT01995513|9900901|P3|Double Blind Treatment Period|Other|2
2877609|NCT01995513|9900902|P2|Double Blind Treatment Period|Other|1
2877610|NCT01995513|9900903|P1|Double Blind Treatment Period|Other|0
2877611|NCT01995513|9900901|P3|Double Blind Treatment Period|Adverse Event|5
2877612|NCT01995513|9900902|P2|Double Blind Treatment Period|Adverse Event|12
2877613|NCT01995513|9900903|P1|Double Blind Treatment Period|Adverse Event|0
2877614|NCT01995513|9900901|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2877615|NCT01995513|9900902|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2877616|NCT01995513|9900903|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
2877617|NCT01995513|9900901|P3|Open Label Treatment Period|Death|0
2877618|NCT01995513|9900902|P2|Open Label Treatment Period|Death|0
2877619|NCT01995513|9900903|P1|Open Label Treatment Period|Death|8
2877620|NCT01995513|9900901|P3|Open Label Treatment Period|Adverse Event|0
2877621|NCT01995513|9900902|P2|Open Label Treatment Period|Adverse Event|0
2877622|NCT01995513|9900903|P1|Open Label Treatment Period|Adverse Event|35
2877623|NCT01995513|9900901|P3|Open Label Treatment Period|No PSA response at week 13|0
2877624|NCT01995513|9900902|P2|Open Label Treatment Period|No PSA response at week 13|0
2877625|NCT01995513|9900903|P1|Open Label Treatment Period|No PSA response at week 13|43
2877626|NCT01995513|9900901|P3|Open Label Treatment Period|Disease Progression|0
2877627|NCT01995513|9900902|P2|Open Label Treatment Period|Disease Progression|0
2877628|NCT01995513|9900903|P1|Open Label Treatment Period|Disease Progression|64
2877629|NCT01995513|9900901|P3|Open Label Treatment Period|Protocol Violation|0
2877630|NCT01995513|9900902|P2|Open Label Treatment Period|Protocol Violation|0
2877631|NCT01995513|9900903|P1|Open Label Treatment Period|Protocol Violation|1
2877632|NCT01995513|9900901|P3|Open Label Treatment Period|Withdrawal by Subject|0
2877633|NCT01995513|9900902|P2|Open Label Treatment Period|Withdrawal by Subject|0
2877634|NCT01995513|9900903|P1|Open Label Treatment Period|Withdrawal by Subject|14
2877635|NCT01995513|9900901|P3|Open Label Treatment Period|Other|0
2877636|NCT01995513|9900902|P2|Open Label Treatment Period|Other|0
2877637|NCT01995513|9900903|P1|Open Label Treatment Period|Other|9
2877638|NCT01995461|9900946|P1|Overall Study|Withdrawal by Subject|2
2877639|NCT01995461|9900946|P1|Overall Study|Lost to Follow-up|2
2877640|NCT01995461|9900946|P1|Overall Study|Death|1
2877641|NCT01995357|9900952|P6|Period 5|Adverse Event|0
2877642|NCT01995357|9900953|P5|Period 5|Adverse Event|0
2877643|NCT01995357|9900954|P4|Period 5|Adverse Event|0
2877644|NCT01995357|9900955|P3|Period 5|Adverse Event|1
2877645|NCT01995357|9900956|P2|Period 5|Adverse Event|0
2877646|NCT01995357|9900957|P1|Period 5|Adverse Event|1
2877647|NCT01995357|9900952|P6|Period 5|Lack of Efficacy|0
2877648|NCT01995357|9900953|P5|Period 5|Lack of Efficacy|0
2877649|NCT01995357|9900954|P4|Period 5|Lack of Efficacy|0
2877650|NCT01995357|9900955|P3|Period 5|Lack of Efficacy|0
2877651|NCT01995357|9900956|P2|Period 5|Lack of Efficacy|0
2877652|NCT01995357|9900957|P1|Period 5|Lack of Efficacy|1
2877653|NCT01995266|9900973|P1|Overall Study|Adverse Event|2
2877654|NCT01995266|9900973|P1|Overall Study|Lack of Efficacy|6
2877655|NCT01995266|9900973|P1|Overall Study|Death|1
2877656|NCT01995201|9900988|P7|From Week 24 Until Week 48|Protocol Violation|0
2877657|NCT01995201|9900989|P6|From Week 24 Until Week 48|Protocol Violation|0
2877658|NCT01995201|9900990|P5|From Week 24 Until Week 48|Protocol Violation|2
2877659|NCT01995201|9900991|P4|From Week 24 Until Week 48|Protocol Violation|0
2877660|NCT01995201|9900992|P3|From Week 24 Until Week 48|Protocol Violation|1
2877661|NCT01995201|9900993|P2|From Week 24 Until Week 48|Protocol Violation|0
2877662|NCT01995201|9900994|P1|From Week 24 Until Week 48|Protocol Violation|0
2877663|NCT01995201|9900988|P7|From Week 24 Until Week 48|Physician Decision|0
2877664|NCT01995201|9900989|P6|From Week 24 Until Week 48|Physician Decision|0
2877665|NCT01995201|9900990|P5|From Week 24 Until Week 48|Physician Decision|1
2877666|NCT01995201|9900991|P4|From Week 24 Until Week 48|Physician Decision|0
2877667|NCT01995201|9900992|P3|From Week 24 Until Week 48|Physician Decision|0
2877668|NCT01995201|9900993|P2|From Week 24 Until Week 48|Physician Decision|0
2877669|NCT01995201|9900994|P1|From Week 24 Until Week 48|Physician Decision|0
2877670|NCT01995201|9900988|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
2877671|NCT01995201|9900989|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
2877672|NCT01995201|9900990|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
2877673|NCT01995201|9900991|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
2877674|NCT01995201|9900992|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
2877675|NCT01995201|9900993|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
2877676|NCT01995201|9900994|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
2877677|NCT01995201|9900988|P7|From Week 24 Until Week 48|Lost to Follow-up|0
2877678|NCT01995201|9900989|P6|From Week 24 Until Week 48|Lost to Follow-up|1
2877679|NCT01995201|9900990|P5|From Week 24 Until Week 48|Lost to Follow-up|1
2877680|NCT01995201|9900991|P4|From Week 24 Until Week 48|Lost to Follow-up|0
2877681|NCT01995201|9900992|P3|From Week 24 Until Week 48|Lost to Follow-up|0
2877682|NCT01995201|9900993|P2|From Week 24 Until Week 48|Lost to Follow-up|0
2877683|NCT01995201|9900994|P1|From Week 24 Until Week 48|Lost to Follow-up|0
2877684|NCT01995201|9900988|P7|From Week 24 Until Week 48|Lack of Efficacy|1
2877685|NCT01995201|9900989|P6|From Week 24 Until Week 48|Lack of Efficacy|2
2877686|NCT01995201|9900990|P5|From Week 24 Until Week 48|Lack of Efficacy|0
2877687|NCT01995201|9900991|P4|From Week 24 Until Week 48|Lack of Efficacy|0
2877688|NCT01995201|9900992|P3|From Week 24 Until Week 48|Lack of Efficacy|1
2877689|NCT01995201|9900993|P2|From Week 24 Until Week 48|Lack of Efficacy|0
2877690|NCT01995201|9900994|P1|From Week 24 Until Week 48|Lack of Efficacy|0
2877691|NCT01995201|9900988|P7|From Week 24 Until Week 48|Death|0
2877692|NCT01995201|9900989|P6|From Week 24 Until Week 48|Death|2
2877693|NCT01995201|9900990|P5|From Week 24 Until Week 48|Death|0
2877694|NCT01995201|9900991|P4|From Week 24 Until Week 48|Death|0
2877695|NCT01995201|9900992|P3|From Week 24 Until Week 48|Death|0
2877696|NCT01995201|9900993|P2|From Week 24 Until Week 48|Death|0
2877697|NCT01995201|9900994|P1|From Week 24 Until Week 48|Death|0
2877698|NCT01995201|9900988|P7|From Week 24 Until Week 48|Adverse Event|1
2877699|NCT01995201|9900989|P6|From Week 24 Until Week 48|Adverse Event|3
2877700|NCT01995201|9900990|P5|From Week 24 Until Week 48|Adverse Event|1
2877701|NCT01995201|9900991|P4|From Week 24 Until Week 48|Adverse Event|1
2877702|NCT01995201|9900992|P3|From Week 24 Until Week 48|Adverse Event|2
2877703|NCT01995201|9900993|P2|From Week 24 Until Week 48|Adverse Event|0
2877704|NCT01995201|9900994|P1|From Week 24 Until Week 48|Adverse Event|0
2877705|NCT01995201|9900988|P7|From Baseline Until Week 24|Protocol Violation|0
2877706|NCT01995201|9900989|P6|From Baseline Until Week 24|Protocol Violation|0
2877707|NCT01995201|9900990|P5|From Baseline Until Week 24|Protocol Violation|0
2877708|NCT01995201|9900991|P4|From Baseline Until Week 24|Protocol Violation|0
2877709|NCT01995201|9900992|P3|From Baseline Until Week 24|Protocol Violation|0
2877710|NCT01995201|9900993|P2|From Baseline Until Week 24|Protocol Violation|9
2877711|NCT01995201|9900994|P1|From Baseline Until Week 24|Protocol Violation|0
2877712|NCT01995201|9900988|P7|From Baseline Until Week 24|Physician Decision|0
2877713|NCT01995201|9900989|P6|From Baseline Until Week 24|Physician Decision|0
2877714|NCT01995201|9900990|P5|From Baseline Until Week 24|Physician Decision|0
2877715|NCT01995201|9900991|P4|From Baseline Until Week 24|Physician Decision|0
2877716|NCT01995201|9900992|P3|From Baseline Until Week 24|Physician Decision|0
2877717|NCT01995201|9900993|P2|From Baseline Until Week 24|Physician Decision|2
2877718|NCT01995201|9900994|P1|From Baseline Until Week 24|Physician Decision|0
2877719|NCT01995201|9900988|P7|From Baseline Until Week 24|Withdrawal by Subject|0
2877720|NCT01995201|9900989|P6|From Baseline Until Week 24|Withdrawal by Subject|0
2877721|NCT01995201|9900990|P5|From Baseline Until Week 24|Withdrawal by Subject|0
2877722|NCT01995201|9900991|P4|From Baseline Until Week 24|Withdrawal by Subject|0
2877723|NCT01995201|9900992|P3|From Baseline Until Week 24|Withdrawal by Subject|0
2877724|NCT01995201|9900993|P2|From Baseline Until Week 24|Withdrawal by Subject|8
2877725|NCT01995201|9900994|P1|From Baseline Until Week 24|Withdrawal by Subject|2
2877726|NCT01995201|9900988|P7|From Baseline Until Week 24|Lost to Follow-up|0
2877727|NCT01995201|9900989|P6|From Baseline Until Week 24|Lost to Follow-up|0
2877728|NCT01995201|9900990|P5|From Baseline Until Week 24|Lost to Follow-up|0
2877729|NCT01995201|9900991|P4|From Baseline Until Week 24|Lost to Follow-up|0
2877730|NCT01995201|9900992|P3|From Baseline Until Week 24|Lost to Follow-up|0
2877731|NCT01995201|9900993|P2|From Baseline Until Week 24|Lost to Follow-up|3
2877732|NCT01995201|9900994|P1|From Baseline Until Week 24|Lost to Follow-up|2
2877733|NCT01995201|9900988|P7|From Baseline Until Week 24|Lack of Efficacy|0
2877734|NCT01995201|9900989|P6|From Baseline Until Week 24|Lack of Efficacy|0
2877735|NCT01995201|9900990|P5|From Baseline Until Week 24|Lack of Efficacy|0
2877736|NCT01995201|9900991|P4|From Baseline Until Week 24|Lack of Efficacy|0
2877737|NCT01995201|9900992|P3|From Baseline Until Week 24|Lack of Efficacy|0
2877738|NCT01995201|9900993|P2|From Baseline Until Week 24|Lack of Efficacy|5
2877739|NCT01995201|9900994|P1|From Baseline Until Week 24|Lack of Efficacy|2
2877740|NCT01995201|9900988|P7|From Baseline Until Week 24|Death|0
2877741|NCT01995201|9900989|P6|From Baseline Until Week 24|Death|0
2877742|NCT01995201|9900990|P5|From Baseline Until Week 24|Death|0
2877743|NCT01995201|9900991|P4|From Baseline Until Week 24|Death|0
2877744|NCT01995201|9900992|P3|From Baseline Until Week 24|Death|0
2877745|NCT01995201|9900993|P2|From Baseline Until Week 24|Death|1
2877746|NCT01995201|9900994|P1|From Baseline Until Week 24|Death|0
2877747|NCT01995201|9900988|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877748|NCT01995201|9900989|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877749|NCT01995201|9900990|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877750|NCT01995201|9900991|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877751|NCT01995201|9900992|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877752|NCT01995201|9900993|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
2877753|NCT01995201|9900994|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2877754|NCT01995201|9900988|P7|From Baseline Until Week 24|Adverse Event|0
2877755|NCT01995201|9900989|P6|From Baseline Until Week 24|Adverse Event|0
2877756|NCT01995201|9900990|P5|From Baseline Until Week 24|Adverse Event|0
2877757|NCT01995201|9900991|P4|From Baseline Until Week 24|Adverse Event|0
2877758|NCT01995201|9900992|P3|From Baseline Until Week 24|Adverse Event|0
2877759|NCT01995201|9900993|P2|From Baseline Until Week 24|Adverse Event|15
2877760|NCT01995201|9900994|P1|From Baseline Until Week 24|Adverse Event|4
2877761|NCT01995175|9901103|P1|Overall Study|Migrated / moved from the study area|49
2877762|NCT01995175|9901103|P1|Overall Study|Other|67
2877763|NCT01995175|9901103|P1|Overall Study|Lost to Follow-up|102
2877764|NCT01995175|9901103|P1|Overall Study|Withdrawal by Subject|35
2877765|NCT01995136|9901113|P1|Overall Study|Change in residence|1
2877766|NCT01995071|9901142|P12|Overall Study|Incarcerated|0
2877767|NCT01995071|9901143|P11|Overall Study|Incarcerated|0
2877768|NCT01995071|9901144|P10|Overall Study|Incarcerated|0
2877769|NCT01995071|9901145|P9|Overall Study|Incarcerated|0
2877770|NCT01995071|9901146|P8|Overall Study|Incarcerated|1
2877771|NCT01995071|9901147|P7|Overall Study|Incarcerated|0
2877772|NCT01995071|9901148|P6|Overall Study|Incarcerated|0
2877773|NCT01995071|9901149|P5|Overall Study|Incarcerated|0
2877774|NCT01995071|9901150|P4|Overall Study|Incarcerated|0
2877775|NCT01995071|9901151|P3|Overall Study|Incarcerated|0
2877776|NCT01995071|9901152|P2|Overall Study|Incarcerated|0
2877777|NCT01995071|9901153|P1|Overall Study|Incarcerated|0
2877778|NCT01995071|9901142|P12|Overall Study|Lost to Follow-up|0
2877779|NCT01995071|9901143|P11|Overall Study|Lost to Follow-up|0
2877780|NCT01995071|9901144|P10|Overall Study|Lost to Follow-up|0
2877781|NCT01995071|9901145|P9|Overall Study|Lost to Follow-up|1
2877782|NCT01995071|9901146|P8|Overall Study|Lost to Follow-up|1
2877783|NCT01995071|9901147|P7|Overall Study|Lost to Follow-up|0
2877784|NCT01995071|9901148|P6|Overall Study|Lost to Follow-up|0
2877785|NCT01995071|9901149|P5|Overall Study|Lost to Follow-up|0
2877786|NCT01995071|9901150|P4|Overall Study|Lost to Follow-up|0
2877787|NCT01995071|9901151|P3|Overall Study|Lost to Follow-up|0
2877788|NCT01995071|9901152|P2|Overall Study|Lost to Follow-up|0
2877789|NCT01995071|9901153|P1|Overall Study|Lost to Follow-up|1
2877790|NCT01995071|9901142|P12|Overall Study|Moved|0
2877791|NCT01995071|9901143|P11|Overall Study|Moved|1
2877792|NCT01995071|9901144|P10|Overall Study|Moved|0
2877793|NCT01995071|9901145|P9|Overall Study|Moved|0
2877794|NCT01995071|9901146|P8|Overall Study|Moved|0
2877795|NCT01995071|9901147|P7|Overall Study|Moved|0
2877796|NCT01995071|9901148|P6|Overall Study|Moved|0
2877797|NCT01995071|9901149|P5|Overall Study|Moved|1
2877798|NCT01995071|9901150|P4|Overall Study|Moved|0
2877799|NCT01995071|9901151|P3|Overall Study|Moved|1
2877800|NCT01995071|9901152|P2|Overall Study|Moved|0
2877801|NCT01995071|9901153|P1|Overall Study|Moved|0
2877802|NCT01995071|9901142|P12|Overall Study|Adverse Event|0
2877803|NCT01995071|9901143|P11|Overall Study|Adverse Event|0
2877804|NCT01995071|9901144|P10|Overall Study|Adverse Event|0
2877805|NCT01995071|9901145|P9|Overall Study|Adverse Event|0
2877806|NCT01995071|9901146|P8|Overall Study|Adverse Event|0
2877807|NCT01995071|9901147|P7|Overall Study|Adverse Event|1
2877808|NCT01995071|9901148|P6|Overall Study|Adverse Event|0
2877809|NCT01995071|9901149|P5|Overall Study|Adverse Event|0
2877810|NCT01995071|9901150|P4|Overall Study|Adverse Event|0
2877811|NCT01995071|9901151|P3|Overall Study|Adverse Event|0
2877812|NCT01995071|9901152|P2|Overall Study|Adverse Event|0
2877813|NCT01995071|9901153|P1|Overall Study|Adverse Event|0
2877814|NCT01994954|9901290|P2|Overall Study|6 Month Follow-up Not Complete|4
2877815|NCT01994954|9901291|P1|Overall Study|6 Month Follow-up Not Complete|5
2877816|NCT01994954|9901290|P2|Overall Study|Lost to Follow-up|10
2877817|NCT01994954|9901291|P1|Overall Study|Lost to Follow-up|8
2877818|NCT01994954|9901290|P2|Overall Study|Physician Decision|2
2877819|NCT01994954|9901291|P1|Overall Study|Physician Decision|2
2877820|NCT01994954|9901290|P2|Overall Study|Withdrawal by Subject|14
2877821|NCT01994954|9901291|P1|Overall Study|Withdrawal by Subject|9
2877822|NCT01994954|9901290|P2|Overall Study|Death|0
2877823|NCT01994954|9901291|P1|Overall Study|Death|1
2877824|NCT01994902|9901309|P2|Test Period 2|Other|3
2877825|NCT01994902|9901310|P1|Test Period 2|Other|0
2877826|NCT01994902|9901309|P2|Test Period 2|Lack of Efficacy|1
2877827|NCT01994902|9901310|P1|Test Period 2|Lack of Efficacy|0
2877828|NCT01994902|9901309|P2|Test Period 2|Withdrawal by Subject|2
2877829|NCT01994902|9901310|P1|Test Period 2|Withdrawal by Subject|0
2877830|NCT01994902|9901309|P2|Test Period 1|bag too small|0
2877831|NCT01994902|9901310|P1|Test Period 1|bag too small|1
2877832|NCT01994902|9901309|P2|Test Period 1|Lack of Efficacy|1
2877833|NCT01994902|9901310|P1|Test Period 1|Lack of Efficacy|0
2877834|NCT01994902|9901309|P2|Test Period 1|Adverse Event|1
2877835|NCT01994902|9901310|P1|Test Period 1|Adverse Event|2
2877836|NCT01994902|9901309|P2|Test Period 1|device deficiency with adverse event|1
2877837|NCT01994902|9901310|P1|Test Period 1|device deficiency with adverse event|0
2877838|NCT01994902|9901309|P2|Test Period 1|Withdrawal by Subject|0
2877839|NCT01994902|9901310|P1|Test Period 1|Withdrawal by Subject|3
2877840|NCT01994889|9901319|P3|Overall Study|Death|38
2877841|NCT01994889|9901320|P2|Overall Study|Death|25
2877842|NCT01994889|9901321|P1|Overall Study|Death|14
2877843|NCT01994889|9901319|P3|Overall Study|Protocol Violation|1
2877844|NCT01994889|9901320|P2|Overall Study|Protocol Violation|1
2877845|NCT01994889|9901321|P1|Overall Study|Protocol Violation|0
2877846|NCT01994889|9901319|P3|Overall Study|Lost to Follow-up|0
2877847|NCT01994889|9901320|P2|Overall Study|Lost to Follow-up|1
2877848|NCT01994889|9901321|P1|Overall Study|Lost to Follow-up|0
2877849|NCT01994889|9901319|P3|Overall Study|No longer willing to participate|37
2877850|NCT01994889|9901320|P2|Overall Study|No longer willing to participate|17
2877851|NCT01994889|9901321|P1|Overall Study|No longer willing to participate|8
2877852|NCT01994889|9901319|P3|Overall Study|Organ Transplantation|5
2877853|NCT01994889|9901320|P2|Overall Study|Organ Transplantation|5
2877854|NCT01994889|9901321|P1|Overall Study|Organ Transplantation|1
2877855|NCT01994889|9901319|P3|Overall Study|Cardiac Device Implantation|0
2877856|NCT01994889|9901320|P2|Overall Study|Cardiac Device Implantation|2
2877857|NCT01994889|9901321|P1|Overall Study|Cardiac Device Implantation|0
2877858|NCT01994889|9901319|P3|Overall Study|Adverse Event|11
2877859|NCT01994889|9901320|P2|Overall Study|Adverse Event|12
2877860|NCT01994889|9901321|P1|Overall Study|Adverse Event|5
2877861|NCT01994876|9901340|P2|Test Period 2|Protocol Violation|1
2877862|NCT01994876|9901341|P1|Test Period 2|Protocol Violation|0
2877863|NCT01994876|9901340|P2|Test Period 2|Adverse Event|0
2877864|NCT01994876|9901341|P1|Test Period 2|Adverse Event|1
2877865|NCT01994876|9901340|P2|Test Period 1|Adverse Event|1
2877866|NCT01994876|9901341|P1|Test Period 1|Adverse Event|0
2877867|NCT01994876|9901340|P2|Test Period 1|Withdrawal by Subject|1
2877868|NCT01994876|9901341|P1|Test Period 1|Withdrawal by Subject|0
2877869|NCT01994863|9901349|P2|Period 2|Withdrawal by Subject|1
2877870|NCT01994863|9901350|P1|Period 2|Withdrawal by Subject|1
2877871|NCT01994863|9901349|P2|Period 2|Lack of Efficacy|2
2877872|NCT01994863|9901350|P1|Period 2|Lack of Efficacy|0
2877873|NCT01994863|9901349|P2|Period 2|Adverse Event|1
2877874|NCT01994863|9901350|P1|Period 2|Adverse Event|0
2877875|NCT01994863|9901349|P2|Period 1|Lack of Efficacy|0
2877876|NCT01994863|9901350|P1|Period 1|Lack of Efficacy|1
2877877|NCT01994863|9901349|P2|Period 1|Trial stopped by sponsor|3
2877878|NCT01994863|9901350|P1|Period 1|Trial stopped by sponsor|1
2877879|NCT01994863|9901349|P2|Period 1|Withdrawal by Subject|0
2877880|NCT01994863|9901350|P1|Period 1|Withdrawal by Subject|1
2877881|NCT01994863|9901349|P2|Period 1|Adverse Event|0
2877882|NCT01994863|9901350|P1|Period 1|Adverse Event|4
2877883|NCT01994850|9901356|P1|Overall Study|Withdrawal by Subject|1
2877884|NCT01994850|9901356|P1|Overall Study|Physician Decision|1
2877885|NCT01994837|9901361|P1|Overall Study|Removed from study due to no response|1
2877886|NCT01994837|9901361|P1|Overall Study|Proceeded to transplant|1
2877887|NCT01994837|9901361|P1|Overall Study|Chose palliative care|1
2877888|NCT01994837|9901361|P1|Overall Study|Adverse event not related to progression|1
2877889|NCT01994837|9901361|P1|Overall Study|Fatal progressive disease|2
2877890|NCT01994837|9901361|P1|Overall Study|Adv event related to progressive disease|3
2877891|NCT01994837|9901361|P1|Overall Study|Progressive disease per protocol|23
2877892|NCT01994720|9901418|P2|Overall Study|Withdrawal by Subject|56
2877893|NCT01994720|9901419|P1|Overall Study|Withdrawal by Subject|46
2877894|NCT01994629|9901461|P2|Overall Study|Lost to Follow-up|3
2877895|NCT01994629|9901462|P1|Overall Study|Lost to Follow-up|0
2877896|NCT01994629|9901461|P2|Overall Study|Withdrawal by Subject|0
2877897|NCT01994629|9901462|P1|Overall Study|Withdrawal by Subject|1
2877898|NCT01994590|9901486|P1|Overall Study|Trial Terminated|1
2877899|NCT01994590|9901486|P1|Overall Study|Adverse Event|1
2877900|NCT01994395|9901501|P2|Overall Study|Withdrawal by Subject|2
2877901|NCT01994395|9901502|P1|Overall Study|Withdrawal by Subject|1
2877902|NCT01994291|9901527|P3|Overall Study|Other|0
2877903|NCT01994291|9901528|P2|Overall Study|Other|2
2877904|NCT01994291|9901529|P1|Overall Study|Other|1
2877905|NCT01994291|9901527|P3|Overall Study|Withdrawal by Subject|5
2877906|NCT01994291|9901528|P2|Overall Study|Withdrawal by Subject|3
2877907|NCT01994291|9901529|P1|Overall Study|Withdrawal by Subject|6
2877908|NCT01994291|9901527|P3|Overall Study|Protocol Violation|0
2877909|NCT01994291|9901528|P2|Overall Study|Protocol Violation|0
2877910|NCT01994291|9901529|P1|Overall Study|Protocol Violation|1
2877911|NCT01994291|9901527|P3|Overall Study|Medication error without associated AE|1
2877912|NCT01994291|9901528|P2|Overall Study|Medication error without associated AE|0
2877913|NCT01994291|9901529|P1|Overall Study|Medication error without associated AE|1
2877914|NCT01994291|9901527|P3|Overall Study|Does not meet entrance criteria|0
2877915|NCT01994291|9901528|P2|Overall Study|Does not meet entrance criteria|0
2877916|NCT01994291|9901529|P1|Overall Study|Does not meet entrance criteria|1
2877917|NCT01994291|9901527|P3|Overall Study|Lost to Follow-up|0
2877918|NCT01994291|9901528|P2|Overall Study|Lost to Follow-up|1
2877919|NCT01994291|9901529|P1|Overall Study|Lost to Follow-up|1
2877920|NCT01994291|9901527|P3|Overall Study|Adverse Event|3
2877921|NCT01994291|9901528|P2|Overall Study|Adverse Event|1
2877922|NCT01994291|9901529|P1|Overall Study|Adverse Event|4
2877923|NCT01994226|9901585|P2|Overall Study|Early Cessation of treatment|11
2877924|NCT01994226|9901586|P1|Overall Study|Early Cessation of treatment|6
2877925|NCT01994226|9901585|P2|Overall Study|Protocol Violation|10
2877926|NCT01994226|9901586|P1|Overall Study|Protocol Violation|13
2877927|NCT01993940|9901612|P2|Overall Study|Other - Miscellaneous|1
2877928|NCT01993940|9901613|P1|Overall Study|Other - Miscellaneous|1
2877929|NCT01993940|9901612|P2|Overall Study|Death|0
2877930|NCT01993940|9901613|P1|Overall Study|Death|1
2877931|NCT01993940|9901612|P2|Overall Study|Protocol Violation|8
2877932|NCT01993940|9901613|P1|Overall Study|Protocol Violation|5
2877933|NCT01993940|9901612|P2|Overall Study|Lost to Follow-up|5
2877934|NCT01993940|9901613|P1|Overall Study|Lost to Follow-up|2
2877935|NCT01993940|9901612|P2|Overall Study|Withdrawal by Subject|19
2877936|NCT01993940|9901613|P1|Overall Study|Withdrawal by Subject|15
2877937|NCT01993940|9901612|P2|Overall Study|Adverse Event|11
2877938|NCT01993940|9901613|P1|Overall Study|Adverse Event|16
2877939|NCT01993927|9901627|P1|Overall Study|Protocol Violation|11
2877940|NCT01993927|9901627|P1|Overall Study|Case Report Forms Uncollected|18
2877941|NCT01993888|9901635|P2|Overall Study|Withdrawal by Subject|1
2877942|NCT01993888|9901636|P1|Overall Study|Withdrawal by Subject|0
2877943|NCT01993888|9901635|P2|Overall Study|Lost to Follow-up|1
2877944|NCT01993888|9901636|P1|Overall Study|Lost to Follow-up|1
2877945|NCT01993888|9901635|P2|Overall Study|Death|1
2877946|NCT01993888|9901636|P1|Overall Study|Death|1
2877947|NCT01993836|9901685|P3|Overall Study|Withdrawal by Subject|5
2877948|NCT01993836|9901686|P2|Overall Study|Withdrawal by Subject|10
2877949|NCT01993836|9901687|P1|Overall Study|Withdrawal by Subject|12
2877950|NCT01993836|9901685|P3|Overall Study|Death|0
2877951|NCT01993836|9901686|P2|Overall Study|Death|2
2877952|NCT01993836|9901687|P1|Overall Study|Death|0
2877953|NCT01993836|9901685|P3|Overall Study|Physician Decision|0
2877954|NCT01993836|9901686|P2|Overall Study|Physician Decision|1
2877955|NCT01993836|9901687|P1|Overall Study|Physician Decision|2
2877956|NCT01993836|9901685|P3|Overall Study|Surgery Cancelled|0
2877957|NCT01993836|9901686|P2|Overall Study|Surgery Cancelled|0
2877958|NCT01993836|9901687|P1|Overall Study|Surgery Cancelled|3
2877959|NCT01993823|9901703|P2|Overall Study|Lost to Follow-up|4
2877960|NCT01993823|9901704|P1|Overall Study|Lost to Follow-up|1
2877961|NCT01993823|9901703|P2|Overall Study|Protocol Violation|1
2877962|NCT01993823|9901704|P1|Overall Study|Protocol Violation|0
2877963|NCT01993823|9901703|P2|Overall Study|Requested by the patient|11
2877964|NCT01993823|9901704|P1|Overall Study|Requested by the patient|6
2877965|NCT01993667|9901714|P2|Overall Study|Lost to Follow-up|2
2877966|NCT01993667|9901715|P1|Overall Study|Lost to Follow-up|2
2877967|NCT01993667|9901714|P2|Overall Study|Insufficient altitude reached|1
2877968|NCT01993667|9901715|P1|Overall Study|Insufficient altitude reached|3
2877969|NCT01993667|9901714|P2|Overall Study|Insufficient data to analyze|16
2877970|NCT01993667|9901715|P1|Overall Study|Insufficient data to analyze|16
2877971|NCT01993186|9901730|P2|Open-Label Extension Period|Subject Non-Compliance|0
2877972|NCT01993186|9901731|P1|Open-Label Extension Period|Subject Non-Compliance|1
2877973|NCT01993186|9901730|P2|Open-Label Extension Period|Withdrawal by Subject|5
2877974|NCT01993186|9901731|P1|Open-Label Extension Period|Withdrawal by Subject|4
2877975|NCT01993186|9901730|P2|Open-Label Extension Period|Principal Investigator Decision|0
2877976|NCT01993186|9901731|P1|Open-Label Extension Period|Principal Investigator Decision|1
2877977|NCT01993186|9901730|P2|Open-Label Extension Period|Adverse Event|0
2877978|NCT01993186|9901731|P1|Open-Label Extension Period|Adverse Event|1
2877979|NCT01993186|9901730|P2|Open-Label Extension Period|Other, Not Specified|1
2877980|NCT01993186|9901731|P1|Open-Label Extension Period|Other, Not Specified|0
2877981|NCT01993186|9901730|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
2877982|NCT01993186|9901731|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
2877983|NCT01993186|9901730|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
2877984|NCT01993186|9901731|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
2877985|NCT01993030|9901808|P2|Overall Study|Adverse Event|4
2877986|NCT01993030|9901809|P1|Overall Study|Adverse Event|0
2877987|NCT01993017|9901826|P3|Overall Study|Ineligible after randomization|5
2877988|NCT01993017|9901827|P2|Overall Study|Ineligible after randomization|5
2877989|NCT01993017|9901828|P1|Overall Study|Ineligible after randomization|4
2877990|NCT01993017|9901826|P3|Overall Study|Other reasons|7
2877991|NCT01993017|9901827|P2|Overall Study|Other reasons|11
2877992|NCT01993017|9901828|P1|Overall Study|Other reasons|17
2877993|NCT01993017|9901826|P3|Overall Study|Dropped out|11
2877994|NCT01993017|9901827|P2|Overall Study|Dropped out|6
2877995|NCT01993017|9901828|P1|Overall Study|Dropped out|19
2877996|NCT01993017|9901826|P3|Overall Study|Could not be contacted|38
2877997|NCT01993017|9901827|P2|Overall Study|Could not be contacted|42
2877998|NCT01993017|9901828|P1|Overall Study|Could not be contacted|43
2877999|NCT01993017|9901826|P3|Overall Study|Death|18
2878000|NCT01993017|9901827|P2|Overall Study|Death|26
2878001|NCT01993017|9901828|P1|Overall Study|Death|23
2878002|NCT01992757|9901869|P1|Overall Study|2 patients excluded due to FFP given.|2
2878003|NCT01992653|9901882|P8|Overall Study|Disease Progression|0
2878004|NCT01992653|9901883|P7|Overall Study|Disease Progression|4
2878005|NCT01992653|9901884|P6|Overall Study|Disease Progression|0
2878006|NCT01992653|9901885|P5|Overall Study|Disease Progression|0
2878007|NCT01992653|9901886|P4|Overall Study|Disease Progression|0
2878008|NCT01992653|9901887|P3|Overall Study|Disease Progression|0
2878009|NCT01992653|9901888|P2|Overall Study|Disease Progression|0
2878010|NCT01992653|9901889|P1|Overall Study|Disease Progression|0
2878011|NCT01992653|9901882|P8|Overall Study|Study Completed|1
2878012|NCT01992653|9901883|P7|Overall Study|Study Completed|0
2878013|NCT01992653|9901884|P6|Overall Study|Study Completed|0
2878014|NCT01992653|9901885|P5|Overall Study|Study Completed|0
2878015|NCT01992653|9901886|P4|Overall Study|Study Completed|0
2878016|NCT01992653|9901887|P3|Overall Study|Study Completed|0
2878017|NCT01992653|9901888|P2|Overall Study|Study Completed|0
2878018|NCT01992653|9901889|P1|Overall Study|Study Completed|0
2878019|NCT01992653|9901882|P8|Overall Study|Lost to Follow-up|1
2878020|NCT01992653|9901883|P7|Overall Study|Lost to Follow-up|0
2878021|NCT01992653|9901884|P6|Overall Study|Lost to Follow-up|0
2878022|NCT01992653|9901885|P5|Overall Study|Lost to Follow-up|0
2878023|NCT01992653|9901886|P4|Overall Study|Lost to Follow-up|0
2878024|NCT01992653|9901887|P3|Overall Study|Lost to Follow-up|0
2878025|NCT01992653|9901888|P2|Overall Study|Lost to Follow-up|0
2878026|NCT01992653|9901889|P1|Overall Study|Lost to Follow-up|0
2878027|NCT01992653|9901882|P8|Overall Study|Death|2
2878028|NCT01992653|9901883|P7|Overall Study|Death|4
2878029|NCT01992653|9901884|P6|Overall Study|Death|0
2878030|NCT01992653|9901885|P5|Overall Study|Death|1
2878031|NCT01992653|9901886|P4|Overall Study|Death|0
2878032|NCT01992653|9901887|P3|Overall Study|Death|1
2878033|NCT01992653|9901888|P2|Overall Study|Death|0
2878034|NCT01992653|9901889|P1|Overall Study|Death|0
2878035|NCT01992549|9902115|P1|Overall Study|Product Switch to Extend Half Life|1
2878036|NCT01992549|9902115|P1|Overall Study|Serious Adverse Event|1
2878037|NCT01992549|9902115|P1|Overall Study|Lost to Follow-up|2
2878038|NCT01992536|9902135|P10|Overall Study|Withdrawal by Subject|0
2878039|NCT01992536|9902136|P9|Overall Study|Withdrawal by Subject|0
2878040|NCT01992536|9902137|P8|Overall Study|Withdrawal by Subject|0
2878041|NCT01992536|9902138|P7|Overall Study|Withdrawal by Subject|0
2878042|NCT01992536|9902139|P6|Overall Study|Withdrawal by Subject|0
2878043|NCT01992536|9902140|P5|Overall Study|Withdrawal by Subject|0
2878044|NCT01992536|9902141|P4|Overall Study|Withdrawal by Subject|2
2878045|NCT01992536|9902142|P3|Overall Study|Withdrawal by Subject|0
2878046|NCT01992536|9902143|P2|Overall Study|Withdrawal by Subject|1
2878047|NCT01992536|9902144|P1|Overall Study|Withdrawal by Subject|0
2878048|NCT01992536|9902135|P10|Overall Study|Lost to Follow-up|1
2878049|NCT01992536|9902136|P9|Overall Study|Lost to Follow-up|1
2878050|NCT01992536|9902137|P8|Overall Study|Lost to Follow-up|0
2878051|NCT01992536|9902138|P7|Overall Study|Lost to Follow-up|0
2878052|NCT01992536|9902139|P6|Overall Study|Lost to Follow-up|1
2878053|NCT01992536|9902140|P5|Overall Study|Lost to Follow-up|0
2878054|NCT01992536|9902141|P4|Overall Study|Lost to Follow-up|0
2878055|NCT01992536|9902142|P3|Overall Study|Lost to Follow-up|1
2878056|NCT01992536|9902143|P2|Overall Study|Lost to Follow-up|2
2878057|NCT01992536|9902144|P1|Overall Study|Lost to Follow-up|4
2878058|NCT01992536|9902135|P10|Overall Study|Administrative Reason|0
2878059|NCT01992536|9902136|P9|Overall Study|Administrative Reason|0
2878060|NCT01992536|9902137|P8|Overall Study|Administrative Reason|0
2878061|NCT01992536|9902138|P7|Overall Study|Administrative Reason|7
2878062|NCT01992536|9902139|P6|Overall Study|Administrative Reason|0
2878063|NCT01992536|9902140|P5|Overall Study|Administrative Reason|0
2878064|NCT01992536|9902141|P4|Overall Study|Administrative Reason|0
2878065|NCT01992536|9902142|P3|Overall Study|Administrative Reason|0
2878066|NCT01992536|9902143|P2|Overall Study|Administrative Reason|0
2878067|NCT01992536|9902144|P1|Overall Study|Administrative Reason|0
2878068|NCT01992159|9902401|P4|Overall Study|Death|0
2878069|NCT01992159|9902402|P3|Overall Study|Death|1
2878070|NCT01992159|9902403|P2|Overall Study|Death|0
2878071|NCT01992159|9902404|P1|Overall Study|Death|0
2878072|NCT01992159|9902401|P4|Overall Study|Adverse Event|1
2878073|NCT01992159|9902402|P3|Overall Study|Adverse Event|0
2878074|NCT01992159|9902403|P2|Overall Study|Adverse Event|1
2878075|NCT01992159|9902404|P1|Overall Study|Adverse Event|0
2878076|NCT01992159|9902401|P4|Overall Study|Withdrawal by Subject|3
2878077|NCT01992159|9902402|P3|Overall Study|Withdrawal by Subject|0
2878078|NCT01992159|9902403|P2|Overall Study|Withdrawal by Subject|7
2878079|NCT01992159|9902404|P1|Overall Study|Withdrawal by Subject|4
2878080|NCT01992107|9902457|P3|Overall Study|Withdrawal by Subject|8
2878081|NCT01992107|9902458|P2|Overall Study|Withdrawal by Subject|7
2878082|NCT01992107|9902459|P1|Overall Study|Withdrawal by Subject|13
2878083|NCT01992107|9902457|P3|Overall Study|noncompliance and were unavailable|2
2878084|NCT01992107|9902458|P2|Overall Study|noncompliance and were unavailable|3
2878085|NCT01992107|9902459|P1|Overall Study|noncompliance and were unavailable|7
2878086|NCT01992107|9902457|P3|Overall Study|Lost to Follow-up|26
2878087|NCT01992107|9902458|P2|Overall Study|Lost to Follow-up|22
2878088|NCT01992107|9902459|P1|Overall Study|Lost to Follow-up|46
2878089|NCT01992107|9902457|P3|Overall Study|Adverse Event|0
2878090|NCT01992107|9902458|P2|Overall Study|Adverse Event|1
2878091|NCT01992107|9902459|P1|Overall Study|Adverse Event|0
2878092|NCT01992107|9902457|P3|Overall Study|Administrative reasons|0
2878093|NCT01992107|9902458|P2|Overall Study|Administrative reasons|0
2878094|NCT01992107|9902459|P1|Overall Study|Administrative reasons|2
2878095|NCT01992094|9902515|P3|Overall Study|Withdrawal by Subject|4
2878096|NCT01992094|9902516|P2|Overall Study|Withdrawal by Subject|3
2878097|NCT01992094|9902517|P1|Overall Study|Withdrawal by Subject|7
2878098|NCT01992094|9902515|P3|Overall Study|Protocol Violation|1
2878099|NCT01992094|9902516|P2|Overall Study|Protocol Violation|0
2878100|NCT01992094|9902517|P1|Overall Study|Protocol Violation|1
2878101|NCT01992094|9902515|P3|Overall Study|OTHER|0
2878102|NCT01992094|9902516|P2|Overall Study|OTHER|0
2878103|NCT01992094|9902517|P1|Overall Study|OTHER|4
2878104|NCT01992094|9902515|P3|Overall Study|Lost to Follow-up|13
2878105|NCT01992094|9902516|P2|Overall Study|Lost to Follow-up|9
2878106|NCT01992094|9902517|P1|Overall Study|Lost to Follow-up|26
2878107|NCT01992094|9902515|P3|Overall Study|Death|2
2878108|NCT01992094|9902516|P2|Overall Study|Death|5
2878109|NCT01992094|9902517|P1|Overall Study|Death|5
2878110|NCT01992094|9902515|P3|Overall Study|Adverse Event|0
2878111|NCT01992094|9902516|P2|Overall Study|Adverse Event|0
2878112|NCT01992094|9902517|P1|Overall Study|Adverse Event|1
2878113|NCT01992094|9902515|P3|Overall Study|ADMINISTRATIVE REASON|1
2878114|NCT01992094|9902516|P2|Overall Study|ADMINISTRATIVE REASON|7
2878115|NCT01992094|9902517|P1|Overall Study|ADMINISTRATIVE REASON|6
2878116|NCT01991977|9902625|P1|Overall Study|Withdrew after start of treatment|5
2878117|NCT01991977|9902625|P1|Overall Study|Withdrew prior to receiving treatment|7
2878118|NCT01991795|9902677|P2|Overall Study|Site prematurely closed by sponsor|25
2878119|NCT01991795|9902678|P1|Overall Study|Site prematurely closed by sponsor|26
2878120|NCT01991795|9902677|P2|Overall Study|Withdrawal by Subject|94
2878121|NCT01991795|9902678|P1|Overall Study|Withdrawal by Subject|117
2878122|NCT01991795|9902677|P2|Overall Study|Lost to Follow-up|4
2878123|NCT01991795|9902678|P1|Overall Study|Lost to Follow-up|6
2878124|NCT01991743|9902704|P4|Overall Study|external cephalic version not performed|0
2878125|NCT01991743|9902705|P3|Overall Study|external cephalic version not performed|1
2878126|NCT01991743|9902706|P2|Overall Study|external cephalic version not performed|0
2878127|NCT01991743|9902707|P1|Overall Study|external cephalic version not performed|0
2878128|NCT01991483|9902752|P4|Dose Level 1000 mg|Protocol Violation|1
2878129|NCT01991483|9902753|P3|Dose Level 1000 mg|Protocol Violation|0
2878130|NCT01991483|9902754|P2|Dose Level 1000 mg|Protocol Violation|0
2878131|NCT01991483|9902755|P1|Dose Level 1000 mg|Protocol Violation|0
2878132|NCT01991483|9902752|P4|Dose Level 600 mg|Physician Decision|0
2878133|NCT01991483|9902753|P3|Dose Level 600 mg|Physician Decision|1
2878134|NCT01991483|9902754|P2|Dose Level 600 mg|Physician Decision|0
2878135|NCT01991483|9902755|P1|Dose Level 600 mg|Physician Decision|0
2878136|NCT01991483|9902752|P4|Dose Level 600 mg|Withdrawal by Subject|0
2878137|NCT01991483|9902753|P3|Dose Level 600 mg|Withdrawal by Subject|1
2878138|NCT01991483|9902754|P2|Dose Level 600 mg|Withdrawal by Subject|0
2878139|NCT01991483|9902755|P1|Dose Level 600 mg|Withdrawal by Subject|0
2878140|NCT01991470|9902821|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
2878141|NCT01991470|9902821|P1|Enlite 3 Period|Physician Decision|8
2878142|NCT01991470|9902821|P1|Enlite 3 Period|Physician Decision|2
2878143|NCT01991470|9902821|P1|Enlite 3 Period|Lost to Follow-up|1
2878144|NCT01991470|9902821|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
2878145|NCT01991470|9902821|P1|Enlite 1 Period|Adverse Event|1
2878146|NCT01991470|9902821|P1|Enlite 1 Period|Withdrawal by Subject|18
2878147|NCT01991314|9902835|P2|Overall Study|Lost to Follow-up|10
2878148|NCT01991314|9902836|P1|Overall Study|Lost to Follow-up|6
2878149|NCT01991314|9902835|P2|Overall Study|Adverse Event|1
2878150|NCT01991314|9902836|P1|Overall Study|Adverse Event|5
2878151|NCT01991197|9902856|P2|Overall Study|Withdrawal by Subject|0
2878152|NCT01991197|9902857|P1|Overall Study|Withdrawal by Subject|2
2878153|NCT01991197|9902856|P2|Overall Study|Physician Decision|2
2878154|NCT01991197|9902857|P1|Overall Study|Physician Decision|0
2878155|NCT01991197|9902856|P2|Overall Study|Lost to Follow-up|1
2878156|NCT01991197|9902857|P1|Overall Study|Lost to Follow-up|1
2878157|NCT01990859|9902897|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
2878158|NCT01990859|9902897|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
2878159|NCT01990768|9903032|P3|6-Month Follow-up|Patient at psychiatric hospital|0
2878160|NCT01990768|9903033|P2|6-Month Follow-up|Patient at psychiatric hospital|0
2878161|NCT01990768|9903034|P1|6-Month Follow-up|Patient at psychiatric hospital|1
2878162|NCT01990768|9903032|P3|6-Month Follow-up|Prisoner at time of follow-up|0
2878163|NCT01990768|9903033|P2|6-Month Follow-up|Prisoner at time of follow-up|2
2878164|NCT01990768|9903034|P1|6-Month Follow-up|Prisoner at time of follow-up|0
2878165|NCT01990768|9903032|P3|6-Month Follow-up|Prisoner at time of enrollment|1
2878166|NCT01990768|9903033|P2|6-Month Follow-up|Prisoner at time of enrollment|0
2878167|NCT01990768|9903034|P1|6-Month Follow-up|Prisoner at time of enrollment|0
2878168|NCT01990768|9903032|P3|6-Month Follow-up|Homeless|6
2878169|NCT01990768|9903033|P2|6-Month Follow-up|Homeless|3
2878170|NCT01990768|9903034|P1|6-Month Follow-up|Homeless|4
2878171|NCT01990768|9903032|P3|6-Month Follow-up|No contact information|5
2878172|NCT01990768|9903033|P2|6-Month Follow-up|No contact information|6
2878173|NCT01990768|9903034|P1|6-Month Follow-up|No contact information|5
2878174|NCT01990768|9903032|P3|6-Month Follow-up|Calls unreturned or refused contact|20
2878175|NCT01990768|9903033|P2|6-Month Follow-up|Calls unreturned or refused contact|15
2878176|NCT01990768|9903034|P1|6-Month Follow-up|Calls unreturned or refused contact|4
2878177|NCT01990768|9903032|P3|6-Month Follow-up|Withdrawal by Subject|26
2878178|NCT01990768|9903033|P2|6-Month Follow-up|Withdrawal by Subject|25
2878179|NCT01990768|9903034|P1|6-Month Follow-up|Withdrawal by Subject|25
2878180|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
2878181|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
2878182|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
2878183|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
2878184|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
2878185|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
2878186|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
2878187|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2878188|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2878189|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
2878190|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
2878191|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
2878192|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
2878193|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
2878194|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
2878195|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Other safety concern|3
2878196|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Other safety concern|2
2878197|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Other safety concern|4
2878198|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Required CPR|1
2878199|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Required CPR|7
2878200|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Required CPR|3
2878201|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
2878202|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2878203|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2878204|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
2878205|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
2878206|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
2878207|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
2878208|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
2878209|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
2878210|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
2878211|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
2878212|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
2878213|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
2878214|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
2878215|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
2878216|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
2878217|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
2878218|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
2878219|NCT01990768|9903032|P3|In-Hospital Study Drug Infusion|Discharged|13
2878220|NCT01990768|9903033|P2|In-Hospital Study Drug Infusion|Discharged|18
2878221|NCT01990768|9903034|P1|In-Hospital Study Drug Infusion|Discharged|19
2878222|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Unknown if completed|2
2878223|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Unknown if completed|4
2878224|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Unknown if completed|1
2878225|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
2878226|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
2878227|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
2878228|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2878229|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2878230|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
2878231|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Discharged|0
2878232|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Discharged|1
2878233|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Discharged|2
2878234|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Death|1
2878235|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Death|1
2878236|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Death|3
2878237|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Other safety concern|1
2878238|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Other safety concern|1
2878239|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Other safety concern|2
2878240|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Required CPR|0
2878241|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Required CPR|6
2878242|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Required CPR|2
2878243|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2878244|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
2878245|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2878246|NCT01990768|9903032|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
2878247|NCT01990768|9903033|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
2878248|NCT01990768|9903034|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
2878249|NCT01990768|9903032|P3|Intervention Started|Discovered to be pregnant|0
2878250|NCT01990768|9903033|P2|Intervention Started|Discovered to be pregnant|1
2878251|NCT01990768|9903034|P1|Intervention Started|Discovered to be pregnant|0
2878252|NCT01990768|9903032|P3|Intervention Started|Seizure or hx of seizure|2
2878253|NCT01990768|9903033|P2|Intervention Started|Seizure or hx of seizure|0
2878254|NCT01990768|9903034|P1|Intervention Started|Seizure or hx of seizure|0
2878255|NCT01990768|9903032|P3|Intervention Started|Required CPR|0
2878256|NCT01990768|9903033|P2|Intervention Started|Required CPR|1
2878257|NCT01990768|9903034|P1|Intervention Started|Required CPR|1
2878258|NCT01990768|9903032|P3|Intervention Started|IV lost|2
2878259|NCT01990768|9903033|P2|Intervention Started|IV lost|2
2878260|NCT01990768|9903034|P1|Intervention Started|IV lost|2
2878261|NCT01990768|9903032|P3|Intervention Started|Patient care priority|3
2878262|NCT01990768|9903033|P2|Intervention Started|Patient care priority|2
2878263|NCT01990768|9903034|P1|Intervention Started|Patient care priority|1
2878264|NCT01990768|9903032|P3|Intervention Started|Not enough time for EMS to enroll|0
2878265|NCT01990768|9903033|P2|Intervention Started|Not enough time for EMS to enroll|3
2878266|NCT01990768|9903034|P1|Intervention Started|Not enough time for EMS to enroll|4
2878267|NCT01990768|9903032|P3|Intervention Started|Patient became ineligible due to vitals|2
2878268|NCT01990768|9903033|P2|Intervention Started|Patient became ineligible due to vitals|5
2878269|NCT01990768|9903034|P1|Intervention Started|Patient became ineligible due to vitals|5
2878270|NCT01990768|9903032|P3|Intervention Started|Study drug issue or kit malfunction|7
2878271|NCT01990768|9903033|P2|Intervention Started|Study drug issue or kit malfunction|6
2878272|NCT01990768|9903034|P1|Intervention Started|Study drug issue or kit malfunction|9
2878273|NCT01990768|9903032|P3|Intervention Started|Found to be ineligible|11
2878274|NCT01990768|9903033|P2|Intervention Started|Found to be ineligible|13
2878275|NCT01990768|9903034|P1|Intervention Started|Found to be ineligible|14
2878276|NCT01990742|9903099|P2|Overall Study|Facility closed|270
2878277|NCT01990742|9903100|P1|Overall Study|Facility closed|0
2878278|NCT01990742|9903099|P2|Overall Study|Withdrawal by facility|1083
2878279|NCT01990742|9903100|P1|Overall Study|Withdrawal by facility|407
2878280|NCT01990664|9903136|P2|Overall Study|Unsatisfactory Visual Response|1
2878281|NCT01990664|9903137|P1|Overall Study|Unsatisfactory Visual Response|0
2878282|NCT01990664|9903136|P2|Overall Study|Lens Handling Difficulties|0
2878283|NCT01990664|9903137|P1|Overall Study|Lens Handling Difficulties|1
2878284|NCT01990664|9903136|P2|Overall Study|Lens Discomfort|1
2878285|NCT01990664|9903137|P1|Overall Study|Lens Discomfort|1
2878286|NCT01990664|9903136|P2|Overall Study|Protocol Violation|0
2878287|NCT01990664|9903137|P1|Overall Study|Protocol Violation|1
2878288|NCT01990664|9903136|P2|Overall Study|Withdrawal by Subject|3
2878289|NCT01990664|9903137|P1|Overall Study|Withdrawal by Subject|2
2878290|NCT01990664|9903136|P2|Overall Study|Lost to Follow-up|6
2878291|NCT01990664|9903137|P1|Overall Study|Lost to Follow-up|2
2878292|NCT01990612|9903145|P2|Overall Study|Withdrawal by Subject|2
2878293|NCT01990612|9903146|P1|Overall Study|Withdrawal by Subject|5
2878294|NCT01990612|9903145|P2|Overall Study|Lost to Follow-up|1
2878295|NCT01990612|9903146|P1|Overall Study|Lost to Follow-up|2
2878296|NCT01990573|9903227|P3|Overall Study|Physician Decision|1
2878297|NCT01990573|9903228|P2|Overall Study|Physician Decision|0
2878298|NCT01990573|9903229|P1|Overall Study|Physician Decision|0
2878299|NCT01990560|9903242|P1|Overall Study|Withdrawal by Subject|1
2878300|NCT01990534|9903256|P1|Overall Study|Overall Survival Follow-up|25
2878301|NCT01990534|9903256|P1|Overall Study|Progression Free Survival Follow-up|11
2878302|NCT01990534|9903256|P1|Overall Study|Reason Not Specified|2
2878303|NCT01990534|9903256|P1|Overall Study|Withdrawal by Subject|3
2878304|NCT01990534|9903256|P1|Overall Study|Symptomatic Deterioration|1
2878305|NCT01990534|9903256|P1|Overall Study|Withdrawal of Informed Consent|2
2878306|NCT01990534|9903256|P1|Overall Study|Protocol Violation|1
2878307|NCT01990534|9903256|P1|Overall Study|Progressive disease|3
2878308|NCT01990534|9903256|P1|Overall Study|Death|12
2878309|NCT01990339|9903272|P1|Overall Study|Lost to Follow-up|861
2878310|NCT01990339|9903272|P1|Overall Study|Voluntary Withdrawal|1402
2878311|NCT01990339|9903272|P1|Overall Study|Data Not Available|49
2878312|NCT01990313|9903277|P1|Overall Study|Lost to Follow-up|1
2878313|NCT01990300|9903282|P1|Overall Study|Protocol Deviation|53
2878314|NCT01990300|9903282|P1|Overall Study|Case Report Forms Uncollected|89
2878315|NCT01990261|9903288|P1|Overall Study|Lost to Follow-up|2
2878316|NCT01990261|9903288|P1|Overall Study|Dossier not Approved|1
2878317|NCT01990261|9903288|P1|Overall Study|PD Before Treatment Start|1
2878318|NCT01990261|9903288|P1|Overall Study|Disease Progression (PD)|8
2878319|NCT01990261|9903288|P1|Overall Study|Death From other Causes|1
2878320|NCT01990261|9903288|P1|Overall Study|Death due to Disease Progression (PD)|10
2878321|NCT01990261|9903288|P1|Overall Study|Death Before Treatment Start|2
2878322|NCT01989754|9903345|P2|Overall Study|Closed Site|1
2878323|NCT01989754|9903346|P1|Overall Study|Closed Site|1
2878324|NCT01989754|9903345|P2|Overall Study|Lost to Follow-up|20
2878325|NCT01989754|9903346|P1|Overall Study|Lost to Follow-up|28
2878326|NCT01989754|9903345|P2|Overall Study|Withdrawal by Subject|14
2878327|NCT01989754|9903346|P1|Overall Study|Withdrawal by Subject|10
2878328|NCT01989689|9903358|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
2878329|NCT01989689|9903359|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
2878330|NCT01989689|9903358|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
2878331|NCT01989689|9903359|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
2878332|NCT01989676|9903371|P2|Overall Study|Discontinued|68
2878333|NCT01989676|9903372|P1|Overall Study|Discontinued|59
2878334|NCT01989676|9903371|P2|Overall Study|Ongoing at data cutoff|279
2878335|NCT01989676|9903372|P1|Overall Study|Ongoing at data cutoff|279
2878336|NCT01989572|9903398|P6|Overall Study|alternative therapy|3
2878337|NCT01989572|9903399|P5|Overall Study|alternative therapy|1
2878338|NCT01989572|9903400|P4|Overall Study|alternative therapy|0
2878339|NCT01989572|9903401|P3|Overall Study|alternative therapy|0
2878340|NCT01989572|9903402|P2|Overall Study|alternative therapy|0
2878341|NCT01989572|9903403|P1|Overall Study|alternative therapy|3
2878342|NCT01989572|9903398|P6|Overall Study|not start protocol therapy|18
2878343|NCT01989572|9903399|P5|Overall Study|not start protocol therapy|4
2878344|NCT01989572|9903400|P4|Overall Study|not start protocol therapy|3
2878345|NCT01989572|9903401|P3|Overall Study|not start protocol therapy|2
2878346|NCT01989572|9903402|P2|Overall Study|not start protocol therapy|1
2878347|NCT01989572|9903403|P1|Overall Study|not start protocol therapy|5
2878348|NCT01989572|9903398|P6|Overall Study|unknown/not specify|5
2878349|NCT01989572|9903399|P5|Overall Study|unknown/not specify|3
2878350|NCT01989572|9903400|P4|Overall Study|unknown/not specify|3
2878351|NCT01989572|9903401|P3|Overall Study|unknown/not specify|1
2878352|NCT01989572|9903402|P2|Overall Study|unknown/not specify|4
2878353|NCT01989572|9903403|P1|Overall Study|unknown/not specify|3
2878354|NCT01989572|9903398|P6|Overall Study|maximum dose reached|0
2878355|NCT01989572|9903399|P5|Overall Study|maximum dose reached|1
2878356|NCT01989572|9903400|P4|Overall Study|maximum dose reached|0
2878357|NCT01989572|9903401|P3|Overall Study|maximum dose reached|0
2878358|NCT01989572|9903402|P2|Overall Study|maximum dose reached|1
2878359|NCT01989572|9903403|P1|Overall Study|maximum dose reached|0
2878360|NCT01989572|9903398|P6|Overall Study|error|1
2878361|NCT01989572|9903399|P5|Overall Study|error|1
2878362|NCT01989572|9903400|P4|Overall Study|error|1
2878363|NCT01989572|9903401|P3|Overall Study|error|1
2878364|NCT01989572|9903402|P2|Overall Study|error|1
2878365|NCT01989572|9903403|P1|Overall Study|error|2
2878366|NCT01989572|9903398|P6|Overall Study|complicating disease|0
2878367|NCT01989572|9903399|P5|Overall Study|complicating disease|1
2878368|NCT01989572|9903400|P4|Overall Study|complicating disease|0
2878369|NCT01989572|9903401|P3|Overall Study|complicating disease|2
2878370|NCT01989572|9903402|P2|Overall Study|complicating disease|1
2878371|NCT01989572|9903403|P1|Overall Study|complicating disease|1
2878372|NCT01989572|9903398|P6|Overall Study|Withdrawal by Subject|4
2878373|NCT01989572|9903399|P5|Overall Study|Withdrawal by Subject|12
2878374|NCT01989572|9903400|P4|Overall Study|Withdrawal by Subject|1
2878375|NCT01989572|9903401|P3|Overall Study|Withdrawal by Subject|5
2878376|NCT01989572|9903402|P2|Overall Study|Withdrawal by Subject|1
2878377|NCT01989572|9903403|P1|Overall Study|Withdrawal by Subject|4
2878378|NCT01989572|9903398|P6|Overall Study|Death|0
2878379|NCT01989572|9903399|P5|Overall Study|Death|1
2878380|NCT01989572|9903400|P4|Overall Study|Death|0
2878381|NCT01989572|9903401|P3|Overall Study|Death|0
2878382|NCT01989572|9903402|P2|Overall Study|Death|0
2878383|NCT01989572|9903403|P1|Overall Study|Death|0
2878384|NCT01989572|9903398|P6|Overall Study|Adverse Event|0
2878385|NCT01989572|9903399|P5|Overall Study|Adverse Event|3
2878386|NCT01989572|9903400|P4|Overall Study|Adverse Event|0
2878387|NCT01989572|9903401|P3|Overall Study|Adverse Event|3
2878388|NCT01989572|9903402|P2|Overall Study|Adverse Event|1
2878389|NCT01989572|9903403|P1|Overall Study|Adverse Event|2
2878390|NCT01989572|9903398|P6|Overall Study|Lack of Efficacy|79
2878391|NCT01989572|9903399|P5|Overall Study|Lack of Efficacy|71
2878392|NCT01989572|9903400|P4|Overall Study|Lack of Efficacy|43
2878393|NCT01989572|9903401|P3|Overall Study|Lack of Efficacy|48
2878394|NCT01989572|9903402|P2|Overall Study|Lack of Efficacy|48
2878395|NCT01989572|9903403|P1|Overall Study|Lack of Efficacy|35
2878396|NCT01989468|9903434|P5|Overall Study|Death|0
2878397|NCT01989468|9903435|P4|Overall Study|Death|0
2878398|NCT01989468|9903436|P3|Overall Study|Death|1
2878399|NCT01989468|9903437|P2|Overall Study|Death|0
2878400|NCT01989468|9903438|P1|Overall Study|Death|3
2878401|NCT01989468|9903434|P5|Overall Study|Subject Guardian Decision|1
2878402|NCT01989468|9903435|P4|Overall Study|Subject Guardian Decision|4
2878403|NCT01989468|9903436|P3|Overall Study|Subject Guardian Decision|4
2878404|NCT01989468|9903437|P2|Overall Study|Subject Guardian Decision|6
2878405|NCT01989468|9903438|P1|Overall Study|Subject Guardian Decision|11
2878406|NCT01989468|9903434|P5|Overall Study|Technical Problems|0
2878407|NCT01989468|9903435|P4|Overall Study|Technical Problems|1
2878408|NCT01989468|9903436|P3|Overall Study|Technical Problems|3
2878409|NCT01989468|9903437|P2|Overall Study|Technical Problems|1
2878410|NCT01989468|9903438|P1|Overall Study|Technical Problems|3
2878411|NCT01989468|9903434|P5|Overall Study|Pregnancy|0
2878412|NCT01989468|9903435|P4|Overall Study|Pregnancy|0
2878413|NCT01989468|9903436|P3|Overall Study|Pregnancy|0
2878414|NCT01989468|9903437|P2|Overall Study|Pregnancy|1
2878415|NCT01989468|9903438|P1|Overall Study|Pregnancy|0
2878416|NCT01989468|9903434|P5|Overall Study|Physician Decision|0
2878417|NCT01989468|9903435|P4|Overall Study|Physician Decision|1
2878418|NCT01989468|9903436|P3|Overall Study|Physician Decision|0
2878419|NCT01989468|9903437|P2|Overall Study|Physician Decision|1
2878420|NCT01989468|9903438|P1|Overall Study|Physician Decision|4
2878421|NCT01989468|9903434|P5|Overall Study|Lost to Follow-up|1
2878422|NCT01989468|9903435|P4|Overall Study|Lost to Follow-up|1
2878423|NCT01989468|9903436|P3|Overall Study|Lost to Follow-up|0
2878424|NCT01989468|9903437|P2|Overall Study|Lost to Follow-up|2
2878425|NCT01989468|9903438|P1|Overall Study|Lost to Follow-up|5
2878426|NCT01989468|9903434|P5|Overall Study|Lack of Efficacy|2
2878427|NCT01989468|9903435|P4|Overall Study|Lack of Efficacy|4
2878428|NCT01989468|9903436|P3|Overall Study|Lack of Efficacy|7
2878429|NCT01989468|9903437|P2|Overall Study|Lack of Efficacy|11
2878430|NCT01989468|9903438|P1|Overall Study|Lack of Efficacy|11
2878431|NCT01989468|9903434|P5|Overall Study|Adverse Event|4
2878432|NCT01989468|9903435|P4|Overall Study|Adverse Event|5
2878433|NCT01989468|9903436|P3|Overall Study|Adverse Event|4
2878434|NCT01989468|9903437|P2|Overall Study|Adverse Event|15
2878435|NCT01989468|9903438|P1|Overall Study|Adverse Event|10
2878436|NCT01989455|9903480|P5|Overall Study|Technical problems with infusion|1
2878437|NCT01989455|9903481|P4|Overall Study|Technical problems with infusion|0
2878438|NCT01989455|9903482|P3|Overall Study|Technical problems with infusion|1
2878439|NCT01989455|9903483|P2|Overall Study|Technical problems with infusion|0
2878440|NCT01989455|9903484|P1|Overall Study|Technical problems with infusion|0
2878441|NCT01989455|9903480|P5|Overall Study|Withdrawal by Subject|0
2878442|NCT01989455|9903481|P4|Overall Study|Withdrawal by Subject|0
2878443|NCT01989455|9903482|P3|Overall Study|Withdrawal by Subject|0
2878444|NCT01989455|9903483|P2|Overall Study|Withdrawal by Subject|1
2878445|NCT01989455|9903484|P1|Overall Study|Withdrawal by Subject|0
2878446|NCT01989455|9903480|P5|Overall Study|Adverse Event|0
2878447|NCT01989455|9903481|P4|Overall Study|Adverse Event|0
2878448|NCT01989455|9903482|P3|Overall Study|Adverse Event|0
2878449|NCT01989455|9903483|P2|Overall Study|Adverse Event|1
2878450|NCT01989455|9903484|P1|Overall Study|Adverse Event|0
2878451|NCT01989208|9903520|P2|200 mg (7 Days)|Protocol Violation|1
2878452|NCT01989208|9903521|P1|200 mg (7 Days)|Protocol Violation|0
2878453|NCT01989169|9903549|P2|Period 2|Adverse Event|1
2878454|NCT01989169|9903550|P1|Period 2|Adverse Event|0
2878455|NCT01989156|9903563|P3|End of Study (Population at Day 90)|Employment Conflict|0
2878456|NCT01989156|9903564|P2|End of Study (Population at Day 90)|Employment Conflict|1
2878457|NCT01989156|9903565|P1|End of Study (Population at Day 90)|Employment Conflict|0
2878458|NCT01989156|9903563|P3|End of Study (Population at Day 90)|Moved out of state|0
2878459|NCT01989156|9903564|P2|End of Study (Population at Day 90)|Moved out of state|0
2878460|NCT01989156|9903565|P1|End of Study (Population at Day 90)|Moved out of state|1
2878461|NCT01989156|9903563|P3|End of Study (Population at Day 90)|Physician Decision|1
2878462|NCT01989156|9903564|P2|End of Study (Population at Day 90)|Physician Decision|0
2878463|NCT01989156|9903565|P1|End of Study (Population at Day 90)|Physician Decision|1
2878464|NCT01989156|9903563|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
2878465|NCT01989156|9903564|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
2878466|NCT01989156|9903565|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
2878467|NCT01989156|9903563|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
2878468|NCT01989156|9903564|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
2878469|NCT01989156|9903565|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
2878470|NCT01989156|9903563|P3|Confinement Period (Population at Day 5)|Adverse Event|1
2878471|NCT01989156|9903564|P2|Confinement Period (Population at Day 5)|Adverse Event|0
2878472|NCT01989156|9903565|P1|Confinement Period (Population at Day 5)|Adverse Event|0
2878473|NCT01989156|9903563|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
2878474|NCT01989156|9903564|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
2878475|NCT01989156|9903565|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
2878476|NCT01989156|9903563|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
2878477|NCT01989156|9903564|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2878478|NCT01989156|9903565|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
2878479|NCT01988779|9903625|P2|Overall Study|Protocol Violation|0
2878480|NCT01988779|9903626|P1|Overall Study|Protocol Violation|1
2878481|NCT01988779|9903625|P2|Overall Study|Withdrawal by Subject|2
2878482|NCT01988779|9903626|P1|Overall Study|Withdrawal by Subject|2
2878483|NCT01988662|9903642|P2|Overall Study|Adverse Event|1
2878484|NCT01988662|9903643|P1|Overall Study|Adverse Event|3
2878485|NCT01988662|9903642|P2|Overall Study|Subject/guardian decision|1
2878486|NCT01988662|9903643|P1|Overall Study|Subject/guardian decision|1
2878487|NCT01988493|9903665|P5|Overall Study|Ongoing|0
2878488|NCT01988493|9903666|P4|Overall Study|Ongoing|2
2878489|NCT01988493|9903667|P3|Overall Study|Ongoing|0
2878490|NCT01988493|9903668|P2|Overall Study|Ongoing|0
2878491|NCT01988493|9903669|P1|Overall Study|Ongoing|0
2878492|NCT01988493|9903665|P5|Overall Study|Randomized but not treated|1
2878493|NCT01988493|9903666|P4|Overall Study|Randomized but not treated|0
2878494|NCT01988493|9903667|P3|Overall Study|Randomized but not treated|0
2878495|NCT01988493|9903668|P2|Overall Study|Randomized but not treated|0
2878496|NCT01988493|9903669|P1|Overall Study|Randomized but not treated|0
2878497|NCT01988402|9903748|P2|Overall Study|Withdrawal by Subject|0
2878498|NCT01988402|9903749|P1|Overall Study|Withdrawal by Subject|1
2878499|NCT01988402|9903748|P2|Overall Study|Adverse Event|2
2878500|NCT01988402|9903749|P1|Overall Study|Adverse Event|1
2878501|NCT01988103|9903816|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2878502|NCT01988103|9903817|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2878503|NCT01988103|9903818|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2878504|NCT01988103|9903819|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
2878505|NCT01988103|9903820|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2878506|NCT01988103|9903816|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
2878507|NCT01988103|9903817|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2878508|NCT01988103|9903818|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
2878509|NCT01988103|9903819|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
2878510|NCT01988103|9903820|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2878511|NCT01988103|9903816|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2878512|NCT01988103|9903817|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2878513|NCT01988103|9903818|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
2878514|NCT01988103|9903819|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
2878515|NCT01988103|9903820|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2878516|NCT01988103|9903816|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
2878517|NCT01988103|9903817|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2878518|NCT01988103|9903818|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2878519|NCT01988103|9903819|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
2878520|NCT01988103|9903820|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
2878521|NCT01988103|9903816|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2878522|NCT01988103|9903817|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2878523|NCT01988103|9903818|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
2878524|NCT01988103|9903819|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
2878525|NCT01988103|9903820|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
2878526|NCT01988103|9903816|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2878527|NCT01988103|9903817|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2878528|NCT01988103|9903818|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2878529|NCT01988103|9903819|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2878530|NCT01988103|9903820|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
2878531|NCT01988103|9903816|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2878532|NCT01988103|9903817|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2878533|NCT01988103|9903818|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
2878534|NCT01988103|9903819|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
2878535|NCT01988103|9903820|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
2878536|NCT01988090|9903867|P2|Complete Study After Start|Protocol Violation|1
2878537|NCT01988090|9903868|P1|Complete Study After Start|Protocol Violation|1
2878538|NCT01988090|9903867|P2|Complete Study After Start|Withdrawal by Subject|0
2878539|NCT01988090|9903868|P1|Complete Study After Start|Withdrawal by Subject|2
2878540|NCT01988090|9903867|P2|Start Treament After Randomization|Protocol Violation|1
2878541|NCT01988090|9903868|P1|Start Treament After Randomization|Protocol Violation|0
2878542|NCT01988090|9903867|P2|Start Treament After Randomization|Withdrawal by Subject|3
2878543|NCT01988090|9903868|P1|Start Treament After Randomization|Withdrawal by Subject|2
2878544|NCT01988012|9903878|P1|Overall Study|Protocol Violation|1
2878545|NCT01988012|9903878|P1|Overall Study|Physician Decision|1
2878546|NCT01988012|9903878|P1|Overall Study|Lost to Follow-up|1
2878547|NCT01988012|9903878|P1|Overall Study|Patient Withdrawal of Consent|4
2878548|NCT01988012|9903878|P1|Overall Study|Insufficient Therapeutic Response|3
2878549|NCT01988012|9903878|P1|Overall Study|Adverse Event|5
2878550|NCT01987986|9903904|P4|Overall Study|Adverse Event|0
2878551|NCT01987986|9903905|P3|Overall Study|Adverse Event|2
2878552|NCT01987986|9903906|P2|Overall Study|Adverse Event|0
2878553|NCT01987986|9903907|P1|Overall Study|Adverse Event|1
2878554|NCT01987986|9903904|P4|Overall Study|Lost to Follow-up|0
2878555|NCT01987986|9903905|P3|Overall Study|Lost to Follow-up|0
2878556|NCT01987986|9903906|P2|Overall Study|Lost to Follow-up|0
2878557|NCT01987986|9903907|P1|Overall Study|Lost to Follow-up|1
2878558|NCT01987960|9903947|P4|Period 3|Administrative or other reason|43
2878559|NCT01987960|9903948|P3|Period 3|Administrative or other reason|0
2878560|NCT01987960|9903949|P2|Period 3|Administrative or other reason|0
2878561|NCT01987960|9903950|P1|Period 3|Administrative or other reason|0
2878562|NCT01987960|9903947|P4|Period 3|Lost to Follow-up|5
2878563|NCT01987960|9903948|P3|Period 3|Lost to Follow-up|0
2878564|NCT01987960|9903949|P2|Period 3|Lost to Follow-up|0
2878565|NCT01987960|9903950|P1|Period 3|Lost to Follow-up|0
2878566|NCT01987960|9903947|P4|Period 3|Withdrawal by Subject|9
2878567|NCT01987960|9903948|P3|Period 3|Withdrawal by Subject|0
2878568|NCT01987960|9903949|P2|Period 3|Withdrawal by Subject|0
2878569|NCT01987960|9903950|P1|Period 3|Withdrawal by Subject|0
2878570|NCT01987960|9903947|P4|Period 3|Protocol Violation|6
2878571|NCT01987960|9903948|P3|Period 3|Protocol Violation|0
2878572|NCT01987960|9903949|P2|Period 3|Protocol Violation|0
2878573|NCT01987960|9903950|P1|Period 3|Protocol Violation|0
2878574|NCT01987960|9903947|P4|Period 3|Non-compliance with IMP|1
2878575|NCT01987960|9903948|P3|Period 3|Non-compliance with IMP|0
2878576|NCT01987960|9903949|P2|Period 3|Non-compliance with IMP|0
2878577|NCT01987960|9903950|P1|Period 3|Non-compliance with IMP|0
2878578|NCT01987960|9903947|P4|Period 3|Adverse Event|7
2878579|NCT01987960|9903948|P3|Period 3|Adverse Event|0
2878580|NCT01987960|9903949|P2|Period 3|Adverse Event|0
2878581|NCT01987960|9903950|P1|Period 3|Adverse Event|0
2878582|NCT01987960|9903947|P4|Period 2|Administrative or other reason|0
2878583|NCT01987960|9903948|P3|Period 2|Administrative or other reason|7
2878584|NCT01987960|9903949|P2|Period 2|Administrative or other reason|5
2878585|NCT01987960|9903950|P1|Period 2|Administrative or other reason|0
2878586|NCT01987960|9903947|P4|Period 2|Withdrawal by Subject|0
2878587|NCT01987960|9903948|P3|Period 2|Withdrawal by Subject|1
2878588|NCT01987960|9903949|P2|Period 2|Withdrawal by Subject|0
2878589|NCT01987960|9903950|P1|Period 2|Withdrawal by Subject|0
2878590|NCT01987960|9903947|P4|Period 2|Adverse Event|0
2878591|NCT01987960|9903948|P3|Period 2|Adverse Event|1
2878592|NCT01987960|9903949|P2|Period 2|Adverse Event|0
2878593|NCT01987960|9903950|P1|Period 2|Adverse Event|0
2878594|NCT01987960|9903947|P4|Period 1|Withdrawal of consent before treatment|0
2878595|NCT01987960|9903948|P3|Period 1|Withdrawal of consent before treatment|0
2878596|NCT01987960|9903949|P2|Period 1|Withdrawal of consent before treatment|0
2878597|NCT01987960|9903950|P1|Period 1|Withdrawal of consent before treatment|4
2878598|NCT01987960|9903947|P4|Period 1|administrative or other reason|0
2878599|NCT01987960|9903948|P3|Period 1|administrative or other reason|0
2878600|NCT01987960|9903949|P2|Period 1|administrative or other reason|0
2878601|NCT01987960|9903950|P1|Period 1|administrative or other reason|75
2878602|NCT01987960|9903947|P4|Period 1|Lost to Follow-up|0
2878603|NCT01987960|9903948|P3|Period 1|Lost to Follow-up|0
2878604|NCT01987960|9903949|P2|Period 1|Lost to Follow-up|0
2878605|NCT01987960|9903950|P1|Period 1|Lost to Follow-up|40
2878606|NCT01987960|9903947|P4|Period 1|Withdrawal by Subject|0
2878607|NCT01987960|9903948|P3|Period 1|Withdrawal by Subject|0
2878608|NCT01987960|9903949|P2|Period 1|Withdrawal by Subject|0
2878609|NCT01987960|9903950|P1|Period 1|Withdrawal by Subject|21
2878610|NCT01987960|9903947|P4|Period 1|Protocol Violation|0
2878611|NCT01987960|9903948|P3|Period 1|Protocol Violation|0
2878612|NCT01987960|9903949|P2|Period 1|Protocol Violation|0
2878613|NCT01987960|9903950|P1|Period 1|Protocol Violation|12
2878614|NCT01987960|9903947|P4|Period 1|Non-compliance with IMP|0
2878615|NCT01987960|9903948|P3|Period 1|Non-compliance with IMP|0
2878616|NCT01987960|9903949|P2|Period 1|Non-compliance with IMP|0
2878617|NCT01987960|9903950|P1|Period 1|Non-compliance with IMP|6
2878618|NCT01987960|9903947|P4|Period 1|Lack of Efficacy|0
2878619|NCT01987960|9903948|P3|Period 1|Lack of Efficacy|0
2878620|NCT01987960|9903949|P2|Period 1|Lack of Efficacy|0
2878621|NCT01987960|9903950|P1|Period 1|Lack of Efficacy|4
2878622|NCT01987960|9903947|P4|Period 1|Adverse Event|0
2878623|NCT01987960|9903948|P3|Period 1|Adverse Event|0
2878624|NCT01987960|9903949|P2|Period 1|Adverse Event|0
2878625|NCT01987960|9903950|P1|Period 1|Adverse Event|24
2878626|NCT01987908|9903962|P3|Post-Treatment Observation Period|Other: Bad Veins|0
2878627|NCT01987908|9903963|P2|Post-Treatment Observation Period|Other: Bad Veins|1
2878628|NCT01987908|9903964|P1|Post-Treatment Observation Period|Other: Bad Veins|0
2878629|NCT01987908|9903962|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2878630|NCT01987908|9903963|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
2878631|NCT01987908|9903964|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2878632|NCT01987908|9903962|P3|Treatment Period|Adverse Event|1
2878633|NCT01987908|9903963|P2|Treatment Period|Adverse Event|1
2878634|NCT01987908|9903964|P1|Treatment Period|Adverse Event|0
2878635|NCT01987908|9903962|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2878636|NCT01987908|9903963|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2878637|NCT01987908|9903964|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
2878638|NCT01987908|9903962|P3|Placebo Lead-in Period|Withdrawal by Subject|0
2878639|NCT01987908|9903963|P2|Placebo Lead-in Period|Withdrawal by Subject|0
2878640|NCT01987908|9903964|P1|Placebo Lead-in Period|Withdrawal by Subject|1
2878641|NCT01987908|9903962|P3|Placebo Lead-in Period|Physician Decision|0
2878642|NCT01987908|9903963|P2|Placebo Lead-in Period|Physician Decision|0
2878643|NCT01987908|9903964|P1|Placebo Lead-in Period|Physician Decision|2
2878644|NCT01987908|9903962|P3|Placebo Lead-in Period|Adverse Event|0
2878645|NCT01987908|9903963|P2|Placebo Lead-in Period|Adverse Event|0
2878646|NCT01987908|9903964|P1|Placebo Lead-in Period|Adverse Event|2
2878647|NCT01987895|9904047|P2|Overall Study|randomized before giving IC|1
2878648|NCT01987895|9904048|P1|Overall Study|randomized before giving IC|0
2878649|NCT01987895|9904047|P2|Overall Study|Lost to Follow-up|5
2878650|NCT01987895|9904048|P1|Overall Study|Lost to Follow-up|3
2878651|NCT01987895|9904047|P2|Overall Study|Death|7
2878652|NCT01987895|9904048|P1|Overall Study|Death|7
2878653|NCT01987895|9904047|P2|Overall Study|Physician Decision|10
2878654|NCT01987895|9904048|P1|Overall Study|Physician Decision|8
2878655|NCT01987895|9904047|P2|Overall Study|Withdrawal by Subject|7
2878656|NCT01987895|9904048|P1|Overall Study|Withdrawal by Subject|12
2878657|NCT01987765|9904072|P1|Overall Study|Lost to Follow-up|37
2878658|NCT01987765|9904072|P1|Overall Study|Protocol Violation|65
2878659|NCT01987609|9904082|P1|Overall Study|Adverse Event|1
2878660|NCT01987557|9904127|P3|Overall Study|Adverse Event|0
2878661|NCT01987557|9904128|P2|Overall Study|Adverse Event|2
2878662|NCT01987557|9904129|P1|Overall Study|Adverse Event|0
2878663|NCT01987557|9904127|P3|Overall Study|Withdrawal by Subject|2
2878664|NCT01987557|9904128|P2|Overall Study|Withdrawal by Subject|1
2878665|NCT01987557|9904129|P1|Overall Study|Withdrawal by Subject|2
2878666|NCT01987557|9904127|P3|Overall Study|Protocol Violation|1
2878667|NCT01987557|9904128|P2|Overall Study|Protocol Violation|0
2878668|NCT01987557|9904129|P1|Overall Study|Protocol Violation|1
2878669|NCT01987505|9904139|P1|Overall Study|Death|4
2878670|NCT01987505|9904139|P1|Overall Study|Investigator Decision|2
2878671|NCT01987505|9904139|P1|Overall Study|Lost to Follow-up|15
2878672|NCT01987505|9904139|P1|Overall Study|Other Reason|2
2878673|NCT01987505|9904139|P1|Overall Study|Withdrawal by Subject|2
2878674|NCT01987505|9904139|P1|Overall Study|Other|9
2878675|NCT01987479|9904169|P1|Overall Study|Adverse Event|7
2878676|NCT01987479|9904169|P1|Overall Study|Lost to Follow-up|1
2878677|NCT01987479|9904169|P1|Overall Study|Other|5
2878678|NCT01987479|9904169|P1|Overall Study|Participant/legal guardian decision|1
2878679|NCT01987479|9904169|P1|Overall Study|Physician Decision|2
2878680|NCT01987479|9904169|P1|Overall Study|Protocol Violation|1
2878681|NCT01987453|9904197|P3|Overall Study|Lack of Efficacy|0
2878682|NCT01987453|9904198|P2|Overall Study|Lack of Efficacy|12
2878683|NCT01987453|9904199|P1|Overall Study|Lack of Efficacy|1
2878684|NCT01987453|9904197|P3|Overall Study|Death|1
2878685|NCT01987453|9904198|P2|Overall Study|Death|0
2878686|NCT01987453|9904199|P1|Overall Study|Death|0
2878687|NCT01987427|9904225|P3|Overall Study|Other|0
2878688|NCT01987427|9904226|P2|Overall Study|Other|1
2878689|NCT01987427|9904227|P1|Overall Study|Other|1
2878690|NCT01987427|9904225|P3|Overall Study|Lack of Efficacy|0
2878691|NCT01987427|9904226|P2|Overall Study|Lack of Efficacy|0
2878692|NCT01987427|9904227|P1|Overall Study|Lack of Efficacy|1
2878693|NCT01987427|9904225|P3|Overall Study|Withdrawal by Subject|3
2878694|NCT01987427|9904226|P2|Overall Study|Withdrawal by Subject|1
2878695|NCT01987427|9904227|P1|Overall Study|Withdrawal by Subject|2
2878696|NCT01987427|9904225|P3|Overall Study|Lost to Follow-up|9
2878697|NCT01987427|9904226|P2|Overall Study|Lost to Follow-up|6
2878698|NCT01987427|9904227|P1|Overall Study|Lost to Follow-up|6
2878699|NCT01987427|9904225|P3|Overall Study|Adverse Event|8
2878700|NCT01987427|9904226|P2|Overall Study|Adverse Event|2
2878701|NCT01987427|9904227|P1|Overall Study|Adverse Event|4
2878702|NCT01987232|9904364|P5|Overall Study|Ongoing in Study|0
2878703|NCT01987232|9904365|P4|Overall Study|Ongoing in Study|1
2878704|NCT01987232|9904366|P3|Overall Study|Ongoing in Study|0
2878705|NCT01987232|9904367|P2|Overall Study|Ongoing in Study|0
2878706|NCT01987232|9904368|P1|Overall Study|Ongoing in Study|0
2878707|NCT01987102|9904457|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
2878708|NCT01987102|9904458|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
2878709|NCT01987102|9904457|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
2878710|NCT01987102|9904458|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
2878711|NCT01987102|9904457|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
2878712|NCT01987102|9904458|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
2878713|NCT01987102|9904457|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
2878714|NCT01987102|9904458|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
2878715|NCT01987102|9904457|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
2878716|NCT01987102|9904458|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
2878717|NCT01987102|9904457|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2878718|NCT01987102|9904458|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2878719|NCT01986985|9904490|P1|Overall Study|Scan not completed due to malfunction|3
2878720|NCT01986985|9904490|P1|Overall Study|Withdrawal by Subject|4
2878721|NCT01986920|9904527|P4|Placebo|Withdrawal by Subject|1
2878722|NCT01986920|9904528|P3|Placebo|Withdrawal by Subject|0
2878723|NCT01986920|9904529|P2|Placebo|Withdrawal by Subject|0
2878724|NCT01986920|9904530|P1|Placebo|Withdrawal by Subject|0
2878725|NCT01986920|9904527|P4|A-101 40%|Withdrawal by Subject|0
2878726|NCT01986920|9904528|P3|A-101 40%|Withdrawal by Subject|1
2878727|NCT01986920|9904529|P2|A-101 40%|Withdrawal by Subject|0
2878728|NCT01986920|9904530|P1|A-101 40%|Withdrawal by Subject|0
2878729|NCT01986920|9904527|P4|A-101 32.5%|Withdrawal by Subject|0
2878730|NCT01986920|9904528|P3|A-101 32.5%|Withdrawal by Subject|0
2878731|NCT01986920|9904529|P2|A-101 32.5%|Withdrawal by Subject|1
2878732|NCT01986920|9904530|P1|A-101 32.5%|Withdrawal by Subject|0
2878733|NCT01986920|9904527|P4|A- 101 25%|Withdrawal by Subject|0
2878734|NCT01986920|9904528|P3|A- 101 25%|Withdrawal by Subject|0
2878735|NCT01986920|9904529|P2|A- 101 25%|Withdrawal by Subject|0
2878736|NCT01986920|9904530|P1|A- 101 25%|Withdrawal by Subject|1
2878737|NCT01986907|9904544|P1|Overall Study|Death|9
2878738|NCT01986907|9904544|P1|Overall Study|Lost to Follow-up|38
2878739|NCT01986907|9904544|P1|Overall Study|Withdrawal by Subject|76
2878740|NCT01986907|9904544|P1|Overall Study|Protocol Violation|4
2878741|NCT01986907|9904544|P1|Overall Study|Unsatisfactory therapeutic effect|24
2878742|NCT01986907|9904544|P1|Overall Study|Adverse Event|11
2878743|NCT01986855|9904557|P3|Overall Study|Withdrawal by Subject|5
2878744|NCT01986855|9904558|P2|Overall Study|Withdrawal by Subject|8
2878745|NCT01986855|9904559|P1|Overall Study|Withdrawal by Subject|7
2878746|NCT01986855|9904557|P3|Overall Study|Participant Moved|2
2878747|NCT01986855|9904558|P2|Overall Study|Participant Moved|0
2878748|NCT01986855|9904559|P1|Overall Study|Participant Moved|0
2878749|NCT01986855|9904557|P3|Overall Study|Screen Failure|0
2878750|NCT01986855|9904558|P2|Overall Study|Screen Failure|1
2878751|NCT01986855|9904559|P1|Overall Study|Screen Failure|0
2878752|NCT01986855|9904557|P3|Overall Study|Lost to Follow-up|0
2878753|NCT01986855|9904558|P2|Overall Study|Lost to Follow-up|1
2878754|NCT01986855|9904559|P1|Overall Study|Lost to Follow-up|2
2878755|NCT01986855|9904557|P3|Overall Study|Death|4
2878756|NCT01986855|9904558|P2|Overall Study|Death|4
2878757|NCT01986855|9904559|P1|Overall Study|Death|3
2878758|NCT01986855|9904557|P3|Overall Study|Adverse Event|0
2878759|NCT01986855|9904558|P2|Overall Study|Adverse Event|0
2878760|NCT01986855|9904559|P1|Overall Study|Adverse Event|1
2878761|NCT01986829|9904588|P1|Overall Study|Death|1
2878762|NCT01986751|9904636|P2|Overall Study|improperly consented|2
2878763|NCT01986751|9904637|P1|Overall Study|improperly consented|10
2878764|NCT01986647|9904670|P4|Overall Study|Health|4
2878765|NCT01986647|9904671|P3|Overall Study|Health|6
2878766|NCT01986647|9904672|P2|Overall Study|Health|3
2878767|NCT01986647|9904673|P1|Overall Study|Health|5
2878768|NCT01986647|9904670|P4|Overall Study|Withdrawal by Subject|3
2878769|NCT01986647|9904671|P3|Overall Study|Withdrawal by Subject|2
2878770|NCT01986647|9904672|P2|Overall Study|Withdrawal by Subject|3
2878771|NCT01986647|9904673|P1|Overall Study|Withdrawal by Subject|1
2878772|NCT01986647|9904670|P4|Overall Study|Lost to Follow-up|4
2878773|NCT01986647|9904671|P3|Overall Study|Lost to Follow-up|4
2878774|NCT01986647|9904672|P2|Overall Study|Lost to Follow-up|1
2878775|NCT01986647|9904673|P1|Overall Study|Lost to Follow-up|4
2878776|NCT01986231|9904768|P1|Overall Study|Adverse Event|1
2878777|NCT01986140|9904775|P2|Overall Study|progression disease|1
2878778|NCT01986140|9904776|P1|Overall Study|progression disease|0
2878779|NCT01986140|9904775|P2|Overall Study|Adverse Event|1
2878780|NCT01986140|9904776|P1|Overall Study|Adverse Event|0
2878781|NCT01986140|9904775|P2|Overall Study|found not eligible|0
2878782|NCT01986140|9904776|P1|Overall Study|found not eligible|3
2878783|NCT01986140|9904775|P2|Overall Study|alternative treatment|1
2878784|NCT01986140|9904776|P1|Overall Study|alternative treatment|1
2878785|NCT01986140|9904775|P2|Overall Study|Withdrawal by Subject|25
2878786|NCT01986140|9904776|P1|Overall Study|Withdrawal by Subject|31
2878787|NCT01986114|9904782|P1|Overall Study|Other reason|7
2878788|NCT01986114|9904782|P1|Overall Study|Lost to Follow-up|5
2878789|NCT01986114|9904782|P1|Overall Study|Protocol Violation|1
2878790|NCT01986114|9904782|P1|Overall Study|Noncompliance|3
2878791|NCT01986114|9904782|P1|Overall Study|Withdrawal by Subject|58
2878792|NCT01986114|9904782|P1|Overall Study|Lack of Efficacy|23
2878793|NCT01986114|9904782|P1|Overall Study|Adverse Event|59
2878794|NCT01986062|9904821|P2|Overall Study|Lost to Follow-up|1
2878795|NCT01986062|9904822|P1|Overall Study|Lost to Follow-up|1
2878796|NCT01985334|9904926|P8|Overall Study|Lost to Follow-up|3
2878797|NCT01985334|9904927|P7|Overall Study|Lost to Follow-up|0
2878798|NCT01985334|9904928|P6|Overall Study|Lost to Follow-up|4
2878799|NCT01985334|9904929|P5|Overall Study|Lost to Follow-up|1
2878800|NCT01985334|9904930|P4|Overall Study|Lost to Follow-up|3
2878801|NCT01985334|9904931|P3|Overall Study|Lost to Follow-up|0
2878802|NCT01985334|9904932|P2|Overall Study|Lost to Follow-up|2
2878803|NCT01985334|9904933|P1|Overall Study|Lost to Follow-up|0
2878804|NCT01985334|9904926|P8|Overall Study|Investigator decision|4
2878805|NCT01985334|9904927|P7|Overall Study|Investigator decision|0
2878806|NCT01985334|9904928|P6|Overall Study|Investigator decision|1
2878807|NCT01985334|9904929|P5|Overall Study|Investigator decision|1
2878808|NCT01985334|9904930|P4|Overall Study|Investigator decision|7
2878809|NCT01985334|9904931|P3|Overall Study|Investigator decision|0
2878810|NCT01985334|9904932|P2|Overall Study|Investigator decision|3
2878811|NCT01985334|9904933|P1|Overall Study|Investigator decision|0
2878812|NCT01985334|9904926|P8|Overall Study|Use of prohibited treatment|0
2878813|NCT01985334|9904927|P7|Overall Study|Use of prohibited treatment|2
2878814|NCT01985334|9904928|P6|Overall Study|Use of prohibited treatment|6
2878815|NCT01985334|9904929|P5|Overall Study|Use of prohibited treatment|1
2878816|NCT01985334|9904930|P4|Overall Study|Use of prohibited treatment|2
2878817|NCT01985334|9904931|P3|Overall Study|Use of prohibited treatment|1
2878818|NCT01985334|9904932|P2|Overall Study|Use of prohibited treatment|4
2878819|NCT01985334|9904933|P1|Overall Study|Use of prohibited treatment|1
2878820|NCT01985334|9904926|P8|Overall Study|Medication non-compliance|3
2878821|NCT01985334|9904927|P7|Overall Study|Medication non-compliance|1
2878822|NCT01985334|9904928|P6|Overall Study|Medication non-compliance|3
2878823|NCT01985334|9904929|P5|Overall Study|Medication non-compliance|2
2878824|NCT01985334|9904930|P4|Overall Study|Medication non-compliance|6
2878825|NCT01985334|9904931|P3|Overall Study|Medication non-compliance|1
2878826|NCT01985334|9904932|P2|Overall Study|Medication non-compliance|4
2878827|NCT01985334|9904933|P1|Overall Study|Medication non-compliance|0
2878828|NCT01985334|9904926|P8|Overall Study|Other|2
2878829|NCT01985334|9904927|P7|Overall Study|Other|2
2878830|NCT01985334|9904928|P6|Overall Study|Other|6
2878831|NCT01985334|9904929|P5|Overall Study|Other|1
2878832|NCT01985334|9904930|P4|Overall Study|Other|10
2878833|NCT01985334|9904931|P3|Overall Study|Other|3
2878834|NCT01985334|9904932|P2|Overall Study|Other|2
2878835|NCT01985334|9904933|P1|Overall Study|Other|4
2878836|NCT01985334|9904926|P8|Overall Study|Adverse Event|15
2878837|NCT01985334|9904927|P7|Overall Study|Adverse Event|3
2878838|NCT01985334|9904928|P6|Overall Study|Adverse Event|18
2878839|NCT01985334|9904929|P5|Overall Study|Adverse Event|3
2878840|NCT01985334|9904930|P4|Overall Study|Adverse Event|26
2878841|NCT01985334|9904931|P3|Overall Study|Adverse Event|2
2878842|NCT01985334|9904932|P2|Overall Study|Adverse Event|8
2878843|NCT01985334|9904933|P1|Overall Study|Adverse Event|0
2878844|NCT01985334|9904926|P8|Overall Study|Subject withdrawal of consent|20
2878845|NCT01985334|9904927|P7|Overall Study|Subject withdrawal of consent|0
2878846|NCT01985334|9904928|P6|Overall Study|Subject withdrawal of consent|19
2878847|NCT01985334|9904929|P5|Overall Study|Subject withdrawal of consent|4
2878848|NCT01985334|9904930|P4|Overall Study|Subject withdrawal of consent|28
2878849|NCT01985334|9904931|P3|Overall Study|Subject withdrawal of consent|2
2878850|NCT01985334|9904932|P2|Overall Study|Subject withdrawal of consent|6
2878851|NCT01985334|9904933|P1|Overall Study|Subject withdrawal of consent|3
2878852|NCT01985334|9904926|P8|Overall Study|Moderate / severe COPD exacerbation|19
2878853|NCT01985334|9904927|P7|Overall Study|Moderate / severe COPD exacerbation|8
2878854|NCT01985334|9904928|P6|Overall Study|Moderate / severe COPD exacerbation|40
2878855|NCT01985334|9904929|P5|Overall Study|Moderate / severe COPD exacerbation|6
2878856|NCT01985334|9904930|P4|Overall Study|Moderate / severe COPD exacerbation|40
2878857|NCT01985334|9904931|P3|Overall Study|Moderate / severe COPD exacerbation|12
2878858|NCT01985334|9904932|P2|Overall Study|Moderate / severe COPD exacerbation|14
2878859|NCT01985334|9904933|P1|Overall Study|Moderate / severe COPD exacerbation|5
2878860|NCT01985334|9904926|P8|Overall Study|Protocol deviation|42
2878861|NCT01985334|9904927|P7|Overall Study|Protocol deviation|15
2878862|NCT01985334|9904928|P6|Overall Study|Protocol deviation|47
2878863|NCT01985334|9904929|P5|Overall Study|Protocol deviation|17
2878864|NCT01985334|9904930|P4|Overall Study|Protocol deviation|84
2878865|NCT01985334|9904931|P3|Overall Study|Protocol deviation|25
2878866|NCT01985334|9904932|P2|Overall Study|Protocol deviation|31
2878867|NCT01985334|9904933|P1|Overall Study|Protocol deviation|6
2878868|NCT01985334|9904926|P8|Overall Study|Other|7
2878869|NCT01985334|9904927|P7|Overall Study|Other|4
2878870|NCT01985334|9904928|P6|Overall Study|Other|8
2878871|NCT01985334|9904929|P5|Overall Study|Other|4
2878872|NCT01985334|9904930|P4|Overall Study|Other|17
2878873|NCT01985334|9904931|P3|Overall Study|Other|7
2878874|NCT01985334|9904932|P2|Overall Study|Other|9
2878875|NCT01985334|9904933|P1|Overall Study|Other|2
2878876|NCT01985334|9904926|P8|Overall Study|Worsening of disease|1
2878877|NCT01985334|9904927|P7|Overall Study|Worsening of disease|0
2878878|NCT01985334|9904928|P6|Overall Study|Worsening of disease|3
2878879|NCT01985334|9904929|P5|Overall Study|Worsening of disease|0
2878880|NCT01985334|9904930|P4|Overall Study|Worsening of disease|1
2878881|NCT01985334|9904931|P3|Overall Study|Worsening of disease|0
2878882|NCT01985334|9904932|P2|Overall Study|Worsening of disease|0
2878883|NCT01985334|9904933|P1|Overall Study|Worsening of disease|0
2878884|NCT01985334|9904926|P8|Overall Study|Death|2
2878885|NCT01985334|9904927|P7|Overall Study|Death|1
2878886|NCT01985334|9904928|P6|Overall Study|Death|0
2878887|NCT01985334|9904929|P5|Overall Study|Death|0
2878888|NCT01985334|9904930|P4|Overall Study|Death|3
2878889|NCT01985334|9904931|P3|Overall Study|Death|0
2878890|NCT01985334|9904932|P2|Overall Study|Death|0
2878891|NCT01985334|9904933|P1|Overall Study|Death|1
2878892|NCT01985334|9904926|P8|Overall Study|Administrative problems|3
2878893|NCT01985334|9904927|P7|Overall Study|Administrative problems|1
2878894|NCT01985334|9904928|P6|Overall Study|Administrative problems|1
2878895|NCT01985334|9904929|P5|Overall Study|Administrative problems|0
2878896|NCT01985334|9904930|P4|Overall Study|Administrative problems|2
2878897|NCT01985334|9904931|P3|Overall Study|Administrative problems|0
2878898|NCT01985334|9904932|P2|Overall Study|Administrative problems|1
2878899|NCT01985334|9904933|P1|Overall Study|Administrative problems|1
2878900|NCT01985321|9905001|P2|Overall Study|Subject treated wrong type of sore|0
2878901|NCT01985321|9905002|P1|Overall Study|Subject treated wrong type of sore|1
2878902|NCT01985321|9905001|P2|Overall Study|Lost to Follow-up|2
2878903|NCT01985321|9905002|P1|Overall Study|Lost to Follow-up|5
2878904|NCT01985321|9905001|P2|Overall Study|Withdrawal by Subject|0
2878905|NCT01985321|9905002|P1|Overall Study|Withdrawal by Subject|1
2878906|NCT01985321|9905001|P2|Overall Study|Protocol Violation|3
2878907|NCT01985321|9905002|P1|Overall Study|Protocol Violation|4
2878908|NCT01985126|9905012|P2|Overall Study|Withdrawal by Subject|7
2878909|NCT01985126|9905013|P1|Overall Study|Withdrawal by Subject|2
2878910|NCT01985126|9905012|P2|Overall Study|Study Terminated By Sponsor|22
2878911|NCT01985126|9905013|P1|Overall Study|Study Terminated By Sponsor|1
2878912|NCT01985126|9905012|P2|Overall Study|Lost to Follow-up|8
2878913|NCT01985126|9905013|P1|Overall Study|Lost to Follow-up|0
2878914|NCT01985126|9905012|P2|Overall Study|Death|69
2878915|NCT01985126|9905013|P1|Overall Study|Death|15
2878916|NCT01984892|9905031|P1|Overall Study|Progressive disease|7
2878917|NCT01984697|9905042|P5|Overall Study|Pregnancy|1
2878918|NCT01984697|9905043|P4|Overall Study|Pregnancy|0
2878919|NCT01984697|9905044|P3|Overall Study|Pregnancy|1
2878920|NCT01984697|9905045|P2|Overall Study|Pregnancy|0
2878921|NCT01984697|9905046|P1|Overall Study|Pregnancy|2
2878922|NCT01984697|9905042|P5|Overall Study|Death|0
2878923|NCT01984697|9905043|P4|Overall Study|Death|1
2878924|NCT01984697|9905044|P3|Overall Study|Death|0
2878925|NCT01984697|9905045|P2|Overall Study|Death|0
2878926|NCT01984697|9905046|P1|Overall Study|Death|0
2878927|NCT01984697|9905042|P5|Overall Study|Missed last follow-up visit|0
2878928|NCT01984697|9905043|P4|Overall Study|Missed last follow-up visit|0
2878929|NCT01984697|9905044|P3|Overall Study|Missed last follow-up visit|0
2878930|NCT01984697|9905045|P2|Overall Study|Missed last follow-up visit|0
2878931|NCT01984697|9905046|P1|Overall Study|Missed last follow-up visit|1
2878932|NCT01984697|9905042|P5|Overall Study|Withdrawal by Subject|13
2878933|NCT01984697|9905043|P4|Overall Study|Withdrawal by Subject|11
2878934|NCT01984697|9905044|P3|Overall Study|Withdrawal by Subject|13
2878935|NCT01984697|9905045|P2|Overall Study|Withdrawal by Subject|21
2878936|NCT01984697|9905046|P1|Overall Study|Withdrawal by Subject|15
2878937|NCT01984697|9905042|P5|Overall Study|Protocol Violation|0
2878938|NCT01984697|9905043|P4|Overall Study|Protocol Violation|2
2878939|NCT01984697|9905044|P3|Overall Study|Protocol Violation|3
2878940|NCT01984697|9905045|P2|Overall Study|Protocol Violation|5
2878941|NCT01984697|9905046|P1|Overall Study|Protocol Violation|8
2878942|NCT01984697|9905042|P5|Overall Study|Physician Decision|0
2878943|NCT01984697|9905043|P4|Overall Study|Physician Decision|1
2878944|NCT01984697|9905044|P3|Overall Study|Physician Decision|0
2878945|NCT01984697|9905045|P2|Overall Study|Physician Decision|0
2878946|NCT01984697|9905046|P1|Overall Study|Physician Decision|3
2878947|NCT01984697|9905042|P5|Overall Study|Lost to Follow-up|21
2878948|NCT01984697|9905043|P4|Overall Study|Lost to Follow-up|6
2878949|NCT01984697|9905044|P3|Overall Study|Lost to Follow-up|10
2878950|NCT01984697|9905045|P2|Overall Study|Lost to Follow-up|5
2878951|NCT01984697|9905046|P1|Overall Study|Lost to Follow-up|14
2878952|NCT01984697|9905042|P5|Overall Study|Adverse Event|0
2878953|NCT01984697|9905043|P4|Overall Study|Adverse Event|0
2878954|NCT01984697|9905044|P3|Overall Study|Adverse Event|2
2878955|NCT01984697|9905045|P2|Overall Study|Adverse Event|0
2878956|NCT01984697|9905046|P1|Overall Study|Adverse Event|0
2878957|NCT01984684|9905165|P2|Overall Study|Subject had inadequate IV access|1
2878958|NCT01984684|9905166|P1|Overall Study|Subject had inadequate IV access|0
2878959|NCT01984684|9905165|P2|Overall Study|Study drug not available at site|1
2878960|NCT01984684|9905166|P1|Overall Study|Study drug not available at site|1
2878961|NCT01984684|9905165|P2|Overall Study|Subject incarcerated|0
2878962|NCT01984684|9905166|P1|Overall Study|Subject incarcerated|1
2878963|NCT01984684|9905165|P2|Overall Study|Noncompliance with study drug|1
2878964|NCT01984684|9905166|P1|Overall Study|Noncompliance with study drug|2
2878965|NCT01984684|9905165|P2|Overall Study|Death|1
2878966|NCT01984684|9905166|P1|Overall Study|Death|0
2878967|NCT01984684|9905165|P2|Overall Study|Protocol Violation|2
2878968|NCT01984684|9905166|P1|Overall Study|Protocol Violation|4
2878969|NCT01984684|9905165|P2|Overall Study|Physician Decision|2
2878970|NCT01984684|9905166|P1|Overall Study|Physician Decision|4
2878971|NCT01984684|9905165|P2|Overall Study|Lack of Efficacy|6
2878972|NCT01984684|9905166|P1|Overall Study|Lack of Efficacy|3
2878973|NCT01984684|9905165|P2|Overall Study|Withdrawal by Subject|9
2878974|NCT01984684|9905166|P1|Overall Study|Withdrawal by Subject|9
2878975|NCT01984684|9905165|P2|Overall Study|Adverse Event|12
2878976|NCT01984684|9905166|P1|Overall Study|Adverse Event|8
2878977|NCT01984684|9905165|P2|Overall Study|Lost to Follow-up|24
2878978|NCT01984684|9905166|P1|Overall Study|Lost to Follow-up|25
2878979|NCT01984424|9905184|P2|Overall Study|Lost to Follow-up|1
2878980|NCT01984424|9905185|P1|Overall Study|Lost to Follow-up|0
2878981|NCT01984424|9905184|P2|Overall Study|Sponsor Decision|1
2878982|NCT01984424|9905185|P1|Overall Study|Sponsor Decision|0
2878983|NCT01984424|9905184|P2|Overall Study|Withdrawal by Subject|5
2878984|NCT01984424|9905185|P1|Overall Study|Withdrawal by Subject|3
2878985|NCT01984294|9905255|P3|Overall Study|Adverse Event|0
2878986|NCT01984294|9905256|P2|Overall Study|Adverse Event|1
2878987|NCT01984294|9905257|P1|Overall Study|Adverse Event|0
2878988|NCT01984294|9905255|P3|Overall Study|Lack of Efficacy|6
2878989|NCT01984294|9905256|P2|Overall Study|Lack of Efficacy|2
2878990|NCT01984294|9905257|P1|Overall Study|Lack of Efficacy|4
2878991|NCT01984294|9905255|P3|Overall Study|Randomized but Never Treated|1
2878992|NCT01984294|9905256|P2|Overall Study|Randomized but Never Treated|0
2878993|NCT01984294|9905257|P1|Overall Study|Randomized but Never Treated|0
2878994|NCT01984242|9905280|P3|Overall Study|Disease Progression|1
2878995|NCT01984242|9905281|P2|Overall Study|Disease Progression|0
2878996|NCT01984242|9905282|P1|Overall Study|Disease Progression|0
2878997|NCT01984242|9905280|P3|Overall Study|Study terminated by Sponsor|34
2878998|NCT01984242|9905281|P2|Overall Study|Study terminated by Sponsor|50
2878999|NCT01984242|9905282|P1|Overall Study|Study terminated by Sponsor|38
2879000|NCT01984242|9905280|P3|Overall Study|Non-Compliance|0
2879001|NCT01984242|9905281|P2|Overall Study|Non-Compliance|0
2879002|NCT01984242|9905282|P1|Overall Study|Non-Compliance|1
2879003|NCT01984242|9905280|P3|Overall Study|Sponsor Decision|0
2879004|NCT01984242|9905281|P2|Overall Study|Sponsor Decision|0
2879005|NCT01984242|9905282|P1|Overall Study|Sponsor Decision|1
2879006|NCT01984242|9905280|P3|Overall Study|Lost to Follow-up|3
2879007|NCT01984242|9905281|P2|Overall Study|Lost to Follow-up|0
2879008|NCT01984242|9905282|P1|Overall Study|Lost to Follow-up|4
2879009|NCT01984242|9905280|P3|Overall Study|Physician Decision|1
2879010|NCT01984242|9905281|P2|Overall Study|Physician Decision|0
2879011|NCT01984242|9905282|P1|Overall Study|Physician Decision|0
2879012|NCT01984242|9905280|P3|Overall Study|Withdrawal by Subject|10
2879013|NCT01984242|9905281|P2|Overall Study|Withdrawal by Subject|3
2879014|NCT01984242|9905282|P1|Overall Study|Withdrawal by Subject|5
2879015|NCT01984242|9905280|P3|Overall Study|Death|52
2879016|NCT01984242|9905281|P2|Overall Study|Death|50
2879017|NCT01984242|9905282|P1|Overall Study|Death|52
2879018|NCT01984229|9905432|P2|Safety Follow-up Period|Lost to Follow-up|0
2879019|NCT01984229|9905433|P1|Safety Follow-up Period|Lost to Follow-up|1
2879020|NCT01984229|9905432|P2|Safety Follow-up Period|Adverse Event|1
2879021|NCT01984229|9905433|P1|Safety Follow-up Period|Adverse Event|1
2879022|NCT01983969|9905486|P3|Overall Study|Disease Progression|0
2879023|NCT01983969|9905487|P2|Overall Study|Disease Progression|1
2879024|NCT01983969|9905488|P1|Overall Study|Disease Progression|0
2879025|NCT01983930|9905502|P2|Overall Study|Adverse Event|1
2879026|NCT01983930|9905503|P1|Overall Study|Adverse Event|0
2879027|NCT01983930|9905502|P2|Overall Study|Withdrawal by Subject|8
2879028|NCT01983930|9905503|P1|Overall Study|Withdrawal by Subject|9
2879029|NCT01983683|9905577|P2|Overall Study|Sponsor Decision|1
2879030|NCT01983683|9905578|P1|Overall Study|Sponsor Decision|1
2879031|NCT01983683|9905577|P2|Overall Study|Lost to Follow-up|8
2879032|NCT01983683|9905578|P1|Overall Study|Lost to Follow-up|4
2879033|NCT01983683|9905577|P2|Overall Study|Physician Decision|9
2879034|NCT01983683|9905578|P1|Overall Study|Physician Decision|8
2879035|NCT01983683|9905577|P2|Overall Study|Death|15
2879036|NCT01983683|9905578|P1|Overall Study|Death|11
2879037|NCT01983683|9905577|P2|Overall Study|Withdrawal by Subject|18
2879038|NCT01983683|9905578|P1|Overall Study|Withdrawal by Subject|14
2879039|NCT01983293|9905665|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
2879040|NCT01983293|9905666|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
2879041|NCT01983293|9905665|P2|Overall Study|Missing 12-month visit|3
2879042|NCT01983293|9905666|P1|Overall Study|Missing 12-month visit|3
2879043|NCT01983293|9905665|P2|Overall Study|Withdrawal by Subject|15
2879044|NCT01983293|9905666|P1|Overall Study|Withdrawal by Subject|29
2879045|NCT01983254|9905674|P2|Overall Study|too ill|8
2879046|NCT01983254|9905675|P1|Overall Study|too ill|11
2879047|NCT01983254|9905674|P2|Overall Study|Lost to Follow-up|16
2879048|NCT01983254|9905675|P1|Overall Study|Lost to Follow-up|17
2879049|NCT01983254|9905674|P2|Overall Study|Death|6
2879050|NCT01983254|9905675|P1|Overall Study|Death|6
2879051|NCT01983111|9905687|P2|Overall Study|Protocol Violation|1
2879052|NCT01983111|9905688|P1|Overall Study|Protocol Violation|0
2879053|NCT01983111|9905687|P2|Overall Study|Adverse Event|0
2879054|NCT01983111|9905688|P1|Overall Study|Adverse Event|4
2879055|NCT01983111|9905687|P2|Overall Study|Withdrawal by Subject|6
2879056|NCT01983111|9905688|P1|Overall Study|Withdrawal by Subject|8
2879057|NCT01982812|9905723|P2|Overall Study|Adverse Event|5
2879058|NCT01982812|9905724|P1|Overall Study|Adverse Event|0
2879059|NCT01982812|9905723|P2|Overall Study|Death|5
2879060|NCT01982812|9905724|P1|Overall Study|Death|1
2879061|NCT01982773|9905738|P2|Overall Study|Lost to Follow-up|1
2879062|NCT01982773|9905739|P1|Overall Study|Lost to Follow-up|7
2879063|NCT01982773|9905738|P2|Overall Study|Withdrawal by Subject|3
2879064|NCT01982773|9905739|P1|Overall Study|Withdrawal by Subject|1
2879065|NCT01982682|9905760|P1|Overall Study|Physician Decision|1
2879066|NCT01982435|9905780|P2|Overall Study|Adverse Event|0
2879067|NCT01982435|9905781|P1|Overall Study|Adverse Event|1
2879068|NCT01982331|9905820|P2|Completed Study (Day 112)|Withdrawal by Subject|0
2879069|NCT01982331|9905821|P1|Completed Study (Day 112)|Withdrawal by Subject|2
2879070|NCT01982331|9905820|P2|Received Vaccination 2|Withdrawal by Subject|1
2879071|NCT01982331|9905821|P1|Received Vaccination 2|Withdrawal by Subject|0
2879072|NCT01982331|9905820|P2|Received Vaccination 2|Adverse Event|2
2879073|NCT01982331|9905821|P1|Received Vaccination 2|Adverse Event|1
2879074|NCT01982292|9905857|P2|Overall Study|Technical Problems|0
2879075|NCT01982292|9905858|P1|Overall Study|Technical Problems|2
2879076|NCT01982292|9905857|P2|Overall Study|Patient/Guardian Decision|1
2879077|NCT01982292|9905858|P1|Overall Study|Patient/Guardian Decision|3
2879078|NCT01982292|9905857|P2|Overall Study|Protocol Deviation|0
2879079|NCT01982292|9905858|P1|Overall Study|Protocol Deviation|1
2879080|NCT01982292|9905857|P2|Overall Study|Non-Compliance With Study Treatment|0
2879081|NCT01982292|9905858|P1|Overall Study|Non-Compliance With Study Treatment|1
2879082|NCT01982292|9905857|P2|Overall Study|Lost to Follow-up|0
2879083|NCT01982292|9905858|P1|Overall Study|Lost to Follow-up|2
2879084|NCT01982292|9905857|P2|Overall Study|Death|0
2879085|NCT01982292|9905858|P1|Overall Study|Death|1
2879086|NCT01982292|9905857|P2|Overall Study|Adverse Event|0
2879087|NCT01982292|9905858|P1|Overall Study|Adverse Event|2
2879088|NCT01982253|9905879|P3|Overall Study|Study terminated by sponsor|4
2879089|NCT01982253|9905880|P2|Overall Study|Study terminated by sponsor|4
2879090|NCT01982253|9905881|P1|Overall Study|Study terminated by sponsor|1
2879091|NCT01982253|9905879|P3|Overall Study|Withdrawal by Subject|0
2879092|NCT01982253|9905880|P2|Overall Study|Withdrawal by Subject|0
2879093|NCT01982253|9905881|P1|Overall Study|Withdrawal by Subject|1
2879094|NCT01981954|9905935|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
2879095|NCT01981954|9905935|P1|Titration Period|Protocol Deviation|1
2879096|NCT01981616|9906008|P2|Overall Study|Protocol Violation|0
2879097|NCT01981616|9906009|P1|Overall Study|Protocol Violation|1
2879098|NCT01981616|9906008|P2|Overall Study|Adverse Event|1
2879099|NCT01981616|9906009|P1|Overall Study|Adverse Event|0
2879100|NCT01981551|9906039|P1|Overall Study|Adverse Event|1
2879101|NCT01981551|9906039|P1|Overall Study|Refused further treatment|8
2879102|NCT01981473|9906049|P3|Overall Study|Received treatment for >24 months|6
2879103|NCT01981473|9906050|P2|Overall Study|Received treatment for >24 months|0
2879104|NCT01981473|9906051|P1|Overall Study|Received treatment for >24 months|2
2879105|NCT01981473|9906049|P3|Overall Study|Received treatment for < 6 months|1
2879106|NCT01981473|9906050|P2|Overall Study|Received treatment for < 6 months|0
2879107|NCT01981473|9906051|P1|Overall Study|Received treatment for < 6 months|0
2879108|NCT01981473|9906049|P3|Overall Study|Incorrect diagnosis of RA|1
2879109|NCT01981473|9906050|P2|Overall Study|Incorrect diagnosis of RA|0
2879110|NCT01981473|9906051|P1|Overall Study|Incorrect diagnosis of RA|0
2879111|NCT01981356|9906092|P2|Overall Study|Protocol Violation|0
2879112|NCT01981356|9906093|P1|Overall Study|Protocol Violation|2
2879113|NCT01981356|9906092|P2|Overall Study|Withdrawal by Subject|1
2879114|NCT01981356|9906093|P1|Overall Study|Withdrawal by Subject|1
2879115|NCT01981356|9906092|P2|Overall Study|Lost to Follow-up|1
2879116|NCT01981356|9906093|P1|Overall Study|Lost to Follow-up|4
2879117|NCT01981122|9906120|P2|Overall Study|Death|15
2879118|NCT01981122|9906121|P1|Overall Study|Death|14
2879119|NCT01981122|9906120|P2|Overall Study|Investigator Or Dendreon Discretion|1
2879120|NCT01981122|9906121|P1|Overall Study|Investigator Or Dendreon Discretion|0
2879121|NCT01981122|9906120|P2|Overall Study|Lost to Follow-up|1
2879122|NCT01981122|9906121|P1|Overall Study|Lost to Follow-up|0
2879123|NCT01981122|9906120|P2|Overall Study|Protocol Violation|1
2879124|NCT01981122|9906121|P1|Overall Study|Protocol Violation|0
2879125|NCT01981122|9906120|P2|Overall Study|Withdrawal by Subject|2
2879126|NCT01981122|9906121|P1|Overall Study|Withdrawal by Subject|0
2879127|NCT01981109|9906127|P1|Overall Study|No data available|2
2879128|NCT01981109|9906127|P1|Overall Study|Study Termination|100
2879129|NCT01981109|9906127|P1|Overall Study|No Discontinuation Documentation|37
2879130|NCT01981109|9906127|P1|Overall Study|Lost to Follow-up|9
2879131|NCT01981109|9906127|P1|Overall Study|Withdrawal by Subject|40
2879132|NCT01981109|9906127|P1|Overall Study|Death|36
2879133|NCT01981096|9906134|P2|Overall Study|Lost to Follow-up|0
2879134|NCT01981096|9906135|P1|Overall Study|Lost to Follow-up|2
2879135|NCT01981096|9906134|P2|Overall Study|Withdrawal by Subject|1
2879136|NCT01981096|9906135|P1|Overall Study|Withdrawal by Subject|0
2879137|NCT01981096|9906134|P2|Overall Study|Parent illness|0
2879138|NCT01981096|9906135|P1|Overall Study|Parent illness|1
2879139|NCT01980992|9906156|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
2879140|NCT01980992|9906157|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
2879141|NCT01980992|9906156|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
2879142|NCT01980992|9906157|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
2879143|NCT01980992|9906156|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
2879144|NCT01980992|9906157|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
2879145|NCT01980992|9906156|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
2879146|NCT01980992|9906157|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
2879147|NCT01980992|9906156|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2879148|NCT01980992|9906157|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2879149|NCT01980992|9906156|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
2879150|NCT01980992|9906157|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
2879151|NCT01980940|9906182|P8|Overall Study|Protocol Violation|0
2879152|NCT01980940|9906183|P7|Overall Study|Protocol Violation|0
2879153|NCT01980940|9906184|P6|Overall Study|Protocol Violation|2
2879154|NCT01980940|9906185|P5|Overall Study|Protocol Violation|0
2879155|NCT01980940|9906186|P4|Overall Study|Protocol Violation|0
2879156|NCT01980940|9906187|P3|Overall Study|Protocol Violation|0
2879157|NCT01980940|9906188|P2|Overall Study|Protocol Violation|0
2879158|NCT01980940|9906189|P1|Overall Study|Protocol Violation|0
2879159|NCT01980888|9906248|P2|Overall Study|Non-Compliance with Study Drug|2
2879160|NCT01980888|9906249|P1|Overall Study|Non-Compliance with Study Drug|3
2879161|NCT01980888|9906248|P2|Overall Study|Investigator's Discretion|3
2879162|NCT01980888|9906249|P1|Overall Study|Investigator's Discretion|8
2879163|NCT01980888|9906248|P2|Overall Study|Withdrew Consent|6
2879164|NCT01980888|9906249|P1|Overall Study|Withdrew Consent|17
2879165|NCT01980888|9906248|P2|Overall Study|Study Terminated by Sponsor|122
2879166|NCT01980888|9906249|P1|Overall Study|Study Terminated by Sponsor|116
2879167|NCT01980875|9906268|P3|Overall Study|Lost to Follow-up|1
2879168|NCT01980875|9906269|P2|Overall Study|Lost to Follow-up|0
2879169|NCT01980875|9906270|P1|Overall Study|Lost to Follow-up|0
2879170|NCT01980875|9906268|P3|Overall Study|Study Terminated by Sponsor|22
2879171|NCT01980875|9906269|P2|Overall Study|Study Terminated by Sponsor|24
2879172|NCT01980875|9906270|P1|Overall Study|Study Terminated by Sponsor|7
2879173|NCT01980875|9906268|P3|Overall Study|Withdrew Consent|1
2879174|NCT01980875|9906269|P2|Overall Study|Withdrew Consent|1
2879175|NCT01980875|9906270|P1|Overall Study|Withdrew Consent|1
2879176|NCT01980706|9906305|P3|Overall Study|miscellaneous|3
2879177|NCT01980706|9906306|P2|Overall Study|miscellaneous|5
2879178|NCT01980706|9906307|P1|Overall Study|miscellaneous|4
2879179|NCT01980706|9906305|P3|Overall Study|Lost to Follow-up|3
2879180|NCT01980706|9906306|P2|Overall Study|Lost to Follow-up|4
2879181|NCT01980706|9906307|P1|Overall Study|Lost to Follow-up|3
2879182|NCT01980706|9906305|P3|Overall Study|Adverse Event|5
2879183|NCT01980706|9906306|P2|Overall Study|Adverse Event|2
2879184|NCT01980706|9906307|P1|Overall Study|Adverse Event|1
2879185|NCT01980706|9906305|P3|Overall Study|Withdrawal by Subject|2
2879186|NCT01980706|9906306|P2|Overall Study|Withdrawal by Subject|6
2879187|NCT01980706|9906307|P1|Overall Study|Withdrawal by Subject|9
2879188|NCT01980628|9906347|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
2879189|NCT01980628|9906347|P1|Overall Study|Withdrawal by Subject|4
2879190|NCT01980628|9906347|P1|Overall Study|Physician Decision|5
2879191|NCT01980628|9906347|P1|Overall Study|Adverse Event|12
2879192|NCT01980095|9906406|P2|Overall Study|Randomized by mistake|0
2879193|NCT01980095|9906407|P1|Overall Study|Randomized by mistake|1
2879194|NCT01980095|9906406|P2|Overall Study|Study drug discontinued|0
2879195|NCT01980095|9906407|P1|Overall Study|Study drug discontinued|1
2879196|NCT01980095|9906406|P2|Overall Study|Safety issue|1
2879197|NCT01980095|9906407|P1|Overall Study|Safety issue|0
2879198|NCT01980095|9906406|P2|Overall Study|Poor compliance|0
2879199|NCT01980095|9906407|P1|Overall Study|Poor compliance|5
2879200|NCT01980095|9906406|P2|Overall Study|Withdrawal by Subject|3
2879201|NCT01980095|9906407|P1|Overall Study|Withdrawal by Subject|2
2879202|NCT01980095|9906406|P2|Overall Study|Lost to Follow-up|7
2879203|NCT01980095|9906407|P1|Overall Study|Lost to Follow-up|6
2879204|NCT01980056|9906418|P3|Overall Study|Death|0
2879205|NCT01980056|9906419|P2|Overall Study|Death|1
2879206|NCT01980056|9906420|P1|Overall Study|Death|1
2879207|NCT01979952|9906434|P2|Overall Study|Other than specified above|0
2879208|NCT01979952|9906435|P1|Overall Study|Other than specified above|1
2879209|NCT01979952|9906434|P2|Overall Study|Withdrawal by Subject|1
2879210|NCT01979952|9906435|P1|Overall Study|Withdrawal by Subject|2
2879211|NCT01979952|9906434|P2|Overall Study|Protocol Violation|0
2879212|NCT01979952|9906435|P1|Overall Study|Protocol Violation|1
2879213|NCT01979952|9906434|P2|Overall Study|Adverse Event|5
2879214|NCT01979952|9906435|P1|Overall Study|Adverse Event|4
2879215|NCT01979835|9906463|P1|Follow-up|Lost to Follow-up|32
2879216|NCT01979835|9906463|P1|Primary Outcome SA Measurment|failed insertion|18
2879217|NCT01979614|9906470|P2|Overall Study|Adverse Event|1
2879218|NCT01979614|9906471|P1|Overall Study|Adverse Event|1
2879219|NCT01979523|9906493|P2|Overall Study|Withdrawal by Subject|0
2879220|NCT01979523|9906494|P1|Overall Study|Withdrawal by Subject|1
2879221|NCT01979185|9906554|P2|Period 2|Other|1
2879222|NCT01979185|9906555|P1|Period 2|Other|0
2879223|NCT01979016|9906603|P2|Overall Study|Adverse Event|1
2879224|NCT01979016|9906604|P1|Overall Study|Adverse Event|0
2879225|NCT01979016|9906603|P2|Overall Study|Withdrawal by Subject|0
2879226|NCT01979016|9906604|P1|Overall Study|Withdrawal by Subject|2
2879227|NCT01978938|9906638|P2|Overall Study|Previously scheduled procedure|1
2879228|NCT01978938|9906639|P1|Overall Study|Previously scheduled procedure|0
2879229|NCT01978938|9906638|P2|Overall Study|Did not meet inclusion criteria|1
2879230|NCT01978938|9906639|P1|Overall Study|Did not meet inclusion criteria|0
2879231|NCT01978938|9906638|P2|Overall Study|Participant noncompliance|1
2879232|NCT01978938|9906639|P1|Overall Study|Participant noncompliance|1
2879233|NCT01978938|9906638|P2|Overall Study|Adverse Event, non-fatal|1
2879234|NCT01978938|9906639|P1|Overall Study|Adverse Event, non-fatal|2
2879235|NCT01978938|9906638|P2|Overall Study|Withdrawal by Subject|4
2879236|NCT01978938|9906639|P1|Overall Study|Withdrawal by Subject|8
2879237|NCT01978938|9906638|P2|Overall Study|Lost to Follow-up|6
2879238|NCT01978938|9906639|P1|Overall Study|Lost to Follow-up|12
2879239|NCT01978912|9906653|P4|Overall Study|Intradiscal Steroid Injection|0
2879240|NCT01978912|9906654|P3|Overall Study|Intradiscal Steroid Injection|0
2879241|NCT01978912|9906655|P2|Overall Study|Intradiscal Steroid Injection|1
2879242|NCT01978912|9906656|P1|Overall Study|Intradiscal Steroid Injection|0
2879243|NCT01978912|9906653|P4|Overall Study|Lumbar Surgery|0
2879244|NCT01978912|9906654|P3|Overall Study|Lumbar Surgery|1
2879245|NCT01978912|9906655|P2|Overall Study|Lumbar Surgery|0
2879246|NCT01978912|9906656|P1|Overall Study|Lumbar Surgery|1
2879247|NCT01978912|9906653|P4|Overall Study|Withdrawal by Subject|2
2879248|NCT01978912|9906654|P3|Overall Study|Withdrawal by Subject|2
2879249|NCT01978912|9906655|P2|Overall Study|Withdrawal by Subject|0
2879250|NCT01978912|9906656|P1|Overall Study|Withdrawal by Subject|1
2879251|NCT01978912|9906653|P4|Overall Study|Lost to Follow-up|1
2879252|NCT01978912|9906654|P3|Overall Study|Lost to Follow-up|0
2879253|NCT01978912|9906655|P2|Overall Study|Lost to Follow-up|1
2879254|NCT01978912|9906656|P1|Overall Study|Lost to Follow-up|1
2879255|NCT01978912|9906653|P4|Overall Study|Adverse Event|0
2879256|NCT01978912|9906654|P3|Overall Study|Adverse Event|0
2879257|NCT01978912|9906655|P2|Overall Study|Adverse Event|1
2879258|NCT01978912|9906656|P1|Overall Study|Adverse Event|0
2879259|NCT01978262|9906827|P1|Overall Study|Lost to Follow-up|2
2879260|NCT01978262|9906827|P1|Overall Study|Withdrawal by Subject|9
2879261|NCT01978236|9906832|P1|Overall Study|Discontinued due to study close|2
2879262|NCT01978184|9906853|P2|Overall Study|Withdrew- toxicities or physical decline|8
2879263|NCT01978184|9906854|P1|Overall Study|Withdrew- toxicities or physical decline|4
2879264|NCT01978184|9906853|P2|Overall Study|Death|0
2879265|NCT01978184|9906854|P1|Overall Study|Death|1
2879266|NCT01978184|9906853|P2|Overall Study|Noncompliance|2
2879267|NCT01978184|9906854|P1|Overall Study|Noncompliance|1
2879268|NCT01978184|9906853|P2|Overall Study|Physician Decision|3
2879269|NCT01978184|9906854|P1|Overall Study|Physician Decision|0
2879270|NCT01978184|9906853|P2|Overall Study|Other than PDA|2
2879271|NCT01978184|9906854|P1|Overall Study|Other than PDA|2
2879272|NCT01978184|9906853|P2|Overall Study|Progressive disease|5
2879273|NCT01978184|9906854|P1|Overall Study|Progressive disease|5
2879274|NCT01978145|9906880|P2|Treatment Period 2|Par. reached defined stopping criteria|5
2879275|NCT01978145|9906881|P1|Treatment Period 2|Par. reached defined stopping criteria|8
2879276|NCT01978145|9906880|P2|Treatment Period 2|Withdrawal by Subject|4
2879277|NCT01978145|9906881|P1|Treatment Period 2|Withdrawal by Subject|7
2879278|NCT01978145|9906880|P2|Treatment Period 2|Lost to Follow-up|1
2879279|NCT01978145|9906881|P1|Treatment Period 2|Lost to Follow-up|1
2879280|NCT01978145|9906880|P2|Treatment Period 2|Protocol Violation|1
2879281|NCT01978145|9906881|P1|Treatment Period 2|Protocol Violation|0
2879282|NCT01978145|9906880|P2|Treatment Period 2|Adverse Event|3
2879283|NCT01978145|9906881|P1|Treatment Period 2|Adverse Event|3
2879284|NCT01978145|9906880|P2|Washout Period 1|Par. reached defined stopping criteria|1
2879285|NCT01978145|9906881|P1|Washout Period 1|Par. reached defined stopping criteria|0
2879286|NCT01978145|9906880|P2|Washout Period 1|Withdrawal by Subject|1
2879287|NCT01978145|9906881|P1|Washout Period 1|Withdrawal by Subject|1
2879288|NCT01978145|9906880|P2|Washout Period 1|Adverse Event|1
2879289|NCT01978145|9906881|P1|Washout Period 1|Adverse Event|0
2879290|NCT01978145|9906880|P2|Treatment Period 1|Par. reached defined stopping criteria|3
2879291|NCT01978145|9906881|P1|Treatment Period 1|Par. reached defined stopping criteria|2
2879292|NCT01978145|9906880|P2|Treatment Period 1|Withdrawal by Subject|4
2879293|NCT01978145|9906881|P1|Treatment Period 1|Withdrawal by Subject|5
2879294|NCT01978145|9906880|P2|Treatment Period 1|Physician Decision|0
2879295|NCT01978145|9906881|P1|Treatment Period 1|Physician Decision|1
2879296|NCT01978145|9906880|P2|Treatment Period 1|Adverse Event|9
2879297|NCT01978145|9906881|P1|Treatment Period 1|Adverse Event|1
2879298|NCT01978119|9906897|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2879299|NCT01978119|9906898|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2879300|NCT01978119|9906897|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2879301|NCT01978119|9906898|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2879302|NCT01978119|9906897|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
2879303|NCT01978119|9906898|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
2879304|NCT01978093|9906924|P2|Overall Study|N/A for vaccine administration|1
2879305|NCT01978093|9906925|P1|Overall Study|N/A for vaccine administration|0
2879306|NCT01978093|9906924|P2|Overall Study|Child was in care of grandmother|1
2879307|NCT01978093|9906925|P1|Overall Study|Child was in care of grandmother|0
2879308|NCT01978093|9906924|P2|Overall Study|Mother lost custody of child|1
2879309|NCT01978093|9906925|P1|Overall Study|Mother lost custody of child|0
2879310|NCT01978093|9906924|P2|Overall Study|Lost kaiser health plan unable to contac|0
2879311|NCT01978093|9906925|P1|Overall Study|Lost kaiser health plan unable to contac|1
2879312|NCT01978093|9906924|P2|Overall Study|Loss of kaiser coverage|10
2879313|NCT01978093|9906925|P1|Overall Study|Loss of kaiser coverage|4
2879314|NCT01978093|9906924|P2|Overall Study|Migrated/moved from study area|13
2879315|NCT01978093|9906925|P1|Overall Study|Migrated/moved from study area|11
2879316|NCT01978093|9906924|P2|Overall Study|Lost to Follow-up|15
2879317|NCT01978093|9906925|P1|Overall Study|Lost to Follow-up|11
2879318|NCT01978093|9906924|P2|Overall Study|Withdrawal by Subject|25
2879319|NCT01978093|9906925|P1|Overall Study|Withdrawal by Subject|29
2879320|NCT01978093|9906924|P2|Overall Study|Protocol Violation|2
2879321|NCT01978093|9906925|P1|Overall Study|Protocol Violation|8
2879322|NCT01978093|9906924|P2|Overall Study|Adverse Event|5
2879323|NCT01978093|9906925|P1|Overall Study|Adverse Event|0
2879324|NCT01978093|9906924|P2|Overall Study|Death|0
2879325|NCT01978093|9906925|P1|Overall Study|Death|1
2879326|NCT01977937|9906969|P2|Overall Study|Physician Decision|1
2879327|NCT01977937|9906970|P1|Overall Study|Physician Decision|0
2879328|NCT01977937|9906969|P2|Overall Study|Adverse Event|0
2879329|NCT01977937|9906970|P1|Overall Study|Adverse Event|1
2879330|NCT01977937|9906969|P2|Overall Study|Withdrawal by Subject|1
2879331|NCT01977937|9906970|P1|Overall Study|Withdrawal by Subject|2
2879332|NCT01977846|9906980|P2|Total Study - Prospective|Protocol Violation|1
2879333|NCT01977846|9906981|P1|Total Study - Prospective|Protocol Violation|0
2879334|NCT01977846|9906980|P2|Total Study - Prospective|No show|1
2879335|NCT01977846|9906981|P1|Total Study - Prospective|No show|0
2879336|NCT01977846|9906980|P2|Total Study - Prospective|Not available at time of visit|5
2879337|NCT01977846|9906981|P1|Total Study - Prospective|Not available at time of visit|0
2879338|NCT01977846|9906980|P2|Total Study - Prospective|Withdrawal by Subject|13
2879339|NCT01977846|9906981|P1|Total Study - Prospective|Withdrawal by Subject|0
2879340|NCT01977846|9906980|P2|Total Study - Prospective|Lost to Follow-up|8
2879341|NCT01977846|9906981|P1|Total Study - Prospective|Lost to Follow-up|0
2879342|NCT01977846|9906980|P2|Total Study - Prospective|Death|1
2879343|NCT01977846|9906981|P1|Total Study - Prospective|Death|0
2879344|NCT01977820|9906999|P2|Overall Study|Sponsor terminated the study|1
2879345|NCT01977820|9907000|P1|Overall Study|Sponsor terminated the study|1
2879346|NCT01977794|9907008|P2|Overall Study|Other|1
2879347|NCT01977794|9907009|P1|Overall Study|Other|0
2879348|NCT01977794|9907008|P2|Overall Study|Withdrew consent|1
2879349|NCT01977794|9907009|P1|Overall Study|Withdrew consent|2
2879350|NCT01977794|9907008|P2|Overall Study|Death|1
2879351|NCT01977794|9907009|P1|Overall Study|Death|1
2879352|NCT01977794|9907008|P2|Overall Study|Protocol Violation|0
2879353|NCT01977794|9907009|P1|Overall Study|Protocol Violation|1
2879354|NCT01977794|9907008|P2|Overall Study|Lost to Follow-up|1
2879355|NCT01977794|9907009|P1|Overall Study|Lost to Follow-up|2
2879356|NCT01977794|9907008|P2|Overall Study|Adverse Event|2
2879357|NCT01977794|9907009|P1|Overall Study|Adverse Event|2
2879358|NCT01977729|9907044|P1|Overall Study|Study terminated|1
2879359|NCT01977690|9907056|P2|Overall Study|Withdrawal by Subject|4
2879360|NCT01977690|9907057|P1|Overall Study|Withdrawal by Subject|0
2879361|NCT01977677|9907066|P3|Overall Study|Unrelated Adverse Event|1
2879362|NCT01977677|9907067|P2|Overall Study|Unrelated Adverse Event|0
2879363|NCT01977677|9907068|P1|Overall Study|Unrelated Adverse Event|0
2879364|NCT01977625|9907079|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2879365|NCT01977625|9907080|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2879366|NCT01977625|9907079|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
2879367|NCT01977625|9907080|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
2879368|NCT01977612|9907090|P2|Overall Study|Lost to Follow-up|1
2879369|NCT01977612|9907091|P1|Overall Study|Lost to Follow-up|1
2879370|NCT01977573|9907113|P4|Overall Study|Withdrawal by Subject|1
2879371|NCT01977573|9907114|P3|Overall Study|Withdrawal by Subject|1
2879372|NCT01977573|9907115|P2|Overall Study|Withdrawal by Subject|1
2879373|NCT01977573|9907116|P1|Overall Study|Withdrawal by Subject|6
2879374|NCT01977573|9907113|P4|Overall Study|Reached Defined Stopping Criteria|0
2879375|NCT01977573|9907114|P3|Overall Study|Reached Defined Stopping Criteria|1
2879376|NCT01977573|9907115|P2|Overall Study|Reached Defined Stopping Criteria|1
2879377|NCT01977573|9907116|P1|Overall Study|Reached Defined Stopping Criteria|2
2879378|NCT01977573|9907113|P4|Overall Study|Protocol Violation|0
2879379|NCT01977573|9907114|P3|Overall Study|Protocol Violation|0
2879380|NCT01977573|9907115|P2|Overall Study|Protocol Violation|1
2879381|NCT01977573|9907116|P1|Overall Study|Protocol Violation|3
2879382|NCT01977573|9907113|P4|Overall Study|Physician Decision|0
2879383|NCT01977573|9907114|P3|Overall Study|Physician Decision|0
2879384|NCT01977573|9907115|P2|Overall Study|Physician Decision|0
2879385|NCT01977573|9907116|P1|Overall Study|Physician Decision|1
2879386|NCT01977573|9907113|P4|Overall Study|Lost to Follow-up|1
2879387|NCT01977573|9907114|P3|Overall Study|Lost to Follow-up|0
2879388|NCT01977573|9907115|P2|Overall Study|Lost to Follow-up|0
2879389|NCT01977573|9907116|P1|Overall Study|Lost to Follow-up|1
2879390|NCT01977573|9907113|P4|Overall Study|Adverse Event|1
2879391|NCT01977573|9907114|P3|Overall Study|Adverse Event|2
2879392|NCT01977573|9907115|P2|Overall Study|Adverse Event|0
2879393|NCT01977573|9907116|P1|Overall Study|Adverse Event|7
2879394|NCT01977482|9907230|P6|Overall Study|Withdrawal by Subject|5
2879395|NCT01977482|9907231|P5|Overall Study|Withdrawal by Subject|1
2879396|NCT01977482|9907232|P4|Overall Study|Withdrawal by Subject|3
2879397|NCT01977482|9907233|P3|Overall Study|Withdrawal by Subject|1
2879398|NCT01977482|9907234|P2|Overall Study|Withdrawal by Subject|4
2879399|NCT01977482|9907235|P1|Overall Study|Withdrawal by Subject|2
2879400|NCT01977482|9907230|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
2879401|NCT01977482|9907231|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
2879402|NCT01977482|9907232|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
2879403|NCT01977482|9907233|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
2879404|NCT01977482|9907234|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
2879405|NCT01977482|9907235|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
2879406|NCT01977482|9907230|P6|Overall Study|Protocol Violation|0
2879407|NCT01977482|9907231|P5|Overall Study|Protocol Violation|0
2879408|NCT01977482|9907232|P4|Overall Study|Protocol Violation|0
2879409|NCT01977482|9907233|P3|Overall Study|Protocol Violation|1
2879410|NCT01977482|9907234|P2|Overall Study|Protocol Violation|0
2879411|NCT01977482|9907235|P1|Overall Study|Protocol Violation|0
2879412|NCT01977482|9907230|P6|Overall Study|Physician Decision|0
2879413|NCT01977482|9907231|P5|Overall Study|Physician Decision|0
2879414|NCT01977482|9907232|P4|Overall Study|Physician Decision|0
2879415|NCT01977482|9907233|P3|Overall Study|Physician Decision|0
2879416|NCT01977482|9907234|P2|Overall Study|Physician Decision|1
2879417|NCT01977482|9907235|P1|Overall Study|Physician Decision|0
2879418|NCT01977482|9907230|P6|Overall Study|Lost to Follow-up|0
2879419|NCT01977482|9907231|P5|Overall Study|Lost to Follow-up|0
2879420|NCT01977482|9907232|P4|Overall Study|Lost to Follow-up|0
2879421|NCT01977482|9907233|P3|Overall Study|Lost to Follow-up|0
2879422|NCT01977482|9907234|P2|Overall Study|Lost to Follow-up|0
2879423|NCT01977482|9907235|P1|Overall Study|Lost to Follow-up|1
2879424|NCT01977482|9907230|P6|Overall Study|Adverse Event|0
2879425|NCT01977482|9907231|P5|Overall Study|Adverse Event|2
2879426|NCT01977482|9907232|P4|Overall Study|Adverse Event|0
2879427|NCT01977482|9907233|P3|Overall Study|Adverse Event|1
2879428|NCT01977482|9907234|P2|Overall Study|Adverse Event|1
2879429|NCT01977482|9907235|P1|Overall Study|Adverse Event|0
2879430|NCT01977456|9907350|P1|Overall Study|Death|5
2879431|NCT01977352|9907359|P2|Overall Study|Lost to Follow-up|2
2879432|NCT01977352|9907360|P1|Overall Study|Lost to Follow-up|1
2879433|NCT01977222|9907378|P1|Overall Study|Withdrawal by Subject|1
2879434|NCT01977092|9907391|P2|Overall Study|In prison|11
2879435|NCT01977092|9907392|P1|Overall Study|In prison|3
2879436|NCT01977092|9907391|P2|Overall Study|Withdrawal by Subject|1
2879437|NCT01977092|9907392|P1|Overall Study|Withdrawal by Subject|2
2879438|NCT01977092|9907391|P2|Overall Study|Lost to Follow-up|14
2879439|NCT01977092|9907392|P1|Overall Study|Lost to Follow-up|23
2879440|NCT01977092|9907391|P2|Overall Study|Death|4
2879441|NCT01977092|9907392|P1|Overall Study|Death|3
2879442|NCT01977040|9907402|P1|Overall Study|Vasa previa not confirmed|2
2879443|NCT01976845|9907456|P3|Overall Study|Physician Decision|3
2879444|NCT01976845|9907457|P2|Overall Study|Physician Decision|8
2879445|NCT01976845|9907458|P1|Overall Study|Physician Decision|8
2879446|NCT01976806|9907483|P2|Overall Study|Withdrawal by Subject|1
2879447|NCT01976806|9907484|P1|Overall Study|Withdrawal by Subject|1
2879448|NCT01976806|9907483|P2|Overall Study|Adverse Event|1
2879449|NCT01976806|9907484|P1|Overall Study|Adverse Event|1
2879450|NCT01976806|9907483|P2|Overall Study|Lost to Follow-up|4
2879451|NCT01976806|9907484|P1|Overall Study|Lost to Follow-up|1
2879452|NCT01976741|9907522|P10|Overall Study|Adverse Event|4
2879453|NCT01976741|9907523|P9|Overall Study|Adverse Event|1
2879454|NCT01976741|9907524|P8|Overall Study|Adverse Event|8
2879455|NCT01976741|9907525|P7|Overall Study|Adverse Event|3
2879456|NCT01976741|9907526|P6|Overall Study|Adverse Event|0
2879457|NCT01976741|9907527|P5|Overall Study|Adverse Event|0
2879458|NCT01976741|9907528|P4|Overall Study|Adverse Event|0
2879459|NCT01976741|9907529|P3|Overall Study|Adverse Event|2
2879460|NCT01976741|9907530|P2|Overall Study|Adverse Event|0
2879461|NCT01976741|9907531|P1|Overall Study|Adverse Event|0
2879462|NCT01976741|9907522|P10|Overall Study|Withdrawal by Subject|0
2879463|NCT01976741|9907523|P9|Overall Study|Withdrawal by Subject|0
2879464|NCT01976741|9907524|P8|Overall Study|Withdrawal by Subject|4
2879465|NCT01976741|9907525|P7|Overall Study|Withdrawal by Subject|1
2879466|NCT01976741|9907526|P6|Overall Study|Withdrawal by Subject|0
2879467|NCT01976741|9907527|P5|Overall Study|Withdrawal by Subject|0
2879468|NCT01976741|9907528|P4|Overall Study|Withdrawal by Subject|1
2879469|NCT01976741|9907529|P3|Overall Study|Withdrawal by Subject|1
2879470|NCT01976741|9907530|P2|Overall Study|Withdrawal by Subject|0
2879471|NCT01976741|9907531|P1|Overall Study|Withdrawal by Subject|1
2879472|NCT01976663|9907769|P1|Overall Study|Lost to Follow-up|3
2879473|NCT01976663|9907769|P1|Overall Study|Adverse Event|2
2879474|NCT01976663|9907769|P1|Overall Study|Screen Failure|3
2879475|NCT01976663|9907769|P1|Overall Study|Withdrawal by Subject|4
2879476|NCT01976663|9907769|P1|Overall Study|Personal Reasons|6
2879477|NCT01976663|9907769|P1|Overall Study|Completed 18 mos but no repeat treatment|24
2879478|NCT01976624|9907788|P1|Overall Study|Participants age less than 19 years|12
2879479|NCT01976624|9907788|P1|Overall Study|Participants contraindicated|2
2879480|NCT01976507|9907816|P1|Overall Study|ablation not done, drug not given|1
2879481|NCT01976507|9907816|P1|Overall Study|Adverse Event|6
2879482|NCT01976364|9907847|P3|Sub-study (12 Months)|Adverse Event|3
2879483|NCT01976364|9907848|P2|Sub-study (12 Months)|Adverse Event|4
2879484|NCT01976364|9907849|P1|Sub-study (12 Months)|Adverse Event|0
2879485|NCT01976364|9907847|P3|Sub-study (12 Months)|Protocol Violation|1
2879486|NCT01976364|9907848|P2|Sub-study (12 Months)|Protocol Violation|1
2879487|NCT01976364|9907849|P1|Sub-study (12 Months)|Protocol Violation|0
2879488|NCT01976364|9907847|P3|Sub-study (12 Months)|Withdrawal by Subject|1
2879489|NCT01976364|9907848|P2|Sub-study (12 Months)|Withdrawal by Subject|0
2879490|NCT01976364|9907849|P1|Sub-study (12 Months)|Withdrawal by Subject|0
2879491|NCT01976364|9907847|P3|Sub-study (12 Months)|Lost to Follow-up|0
2879492|NCT01976364|9907848|P2|Sub-study (12 Months)|Lost to Follow-up|1
2879493|NCT01976364|9907849|P1|Sub-study (12 Months)|Lost to Follow-up|0
2879494|NCT01976364|9907847|P3|Main Study (36 Months)|Death|0
2879495|NCT01976364|9907848|P2|Main Study (36 Months)|Death|0
2879496|NCT01976364|9907849|P1|Main Study (36 Months)|Death|5
2879497|NCT01976364|9907847|P3|Main Study (36 Months)|Withdrawal by Subject|0
2879498|NCT01976364|9907848|P2|Main Study (36 Months)|Withdrawal by Subject|0
2879499|NCT01976364|9907849|P1|Main Study (36 Months)|Withdrawal by Subject|69
2879500|NCT01976364|9907847|P3|Main Study (36 Months)|Protocol Violation|0
2879501|NCT01976364|9907848|P2|Main Study (36 Months)|Protocol Violation|0
2879502|NCT01976364|9907849|P1|Main Study (36 Months)|Protocol Violation|13
2879503|NCT01976364|9907847|P3|Main Study (36 Months)|Lack of Efficacy|0
2879504|NCT01976364|9907848|P2|Main Study (36 Months)|Lack of Efficacy|0
2879505|NCT01976364|9907849|P1|Main Study (36 Months)|Lack of Efficacy|40
2879506|NCT01976364|9907847|P3|Main Study (36 Months)|Lost to Follow-up|0
2879507|NCT01976364|9907848|P2|Main Study (36 Months)|Lost to Follow-up|0
2879508|NCT01976364|9907849|P1|Main Study (36 Months)|Lost to Follow-up|10
2879509|NCT01976364|9907847|P3|Main Study (36 Months)|Medication error|0
2879510|NCT01976364|9907848|P2|Main Study (36 Months)|Medication error|0
2879511|NCT01976364|9907849|P1|Main Study (36 Months)|Medication error|1
2879512|NCT01976364|9907847|P3|Main Study (36 Months)|No longer met eligibility criteria|0
2879513|NCT01976364|9907848|P2|Main Study (36 Months)|No longer met eligibility criteria|0
2879514|NCT01976364|9907849|P1|Main Study (36 Months)|No longer met eligibility criteria|2
2879515|NCT01976364|9907847|P3|Main Study (36 Months)|Other|0
2879516|NCT01976364|9907848|P2|Main Study (36 Months)|Other|0
2879517|NCT01976364|9907849|P1|Main Study (36 Months)|Other|13
2879518|NCT01976364|9907847|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
2879519|NCT01976364|9907848|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
2879520|NCT01976364|9907849|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
2879521|NCT01976364|9907847|P3|Main Study (36 Months)|Adverse Event|0
2879522|NCT01976364|9907848|P2|Main Study (36 Months)|Adverse Event|0
2879523|NCT01976364|9907849|P1|Main Study (36 Months)|Adverse Event|63
2879524|NCT01976338|9907969|P2|Overall Study|Adverse Event|1
2879525|NCT01976338|9907970|P1|Overall Study|Adverse Event|5
2879526|NCT01976338|9907969|P2|Overall Study|Withdrawal by Subject|2
2879527|NCT01976338|9907970|P1|Overall Study|Withdrawal by Subject|5
2879528|NCT01976338|9907969|P2|Overall Study|Lost to Follow-up|0
2879529|NCT01976338|9907970|P1|Overall Study|Lost to Follow-up|3
2879530|NCT01976338|9907969|P2|Overall Study|Physician Decision|1
2879531|NCT01976338|9907970|P1|Overall Study|Physician Decision|0
2879532|NCT01976312|9907997|P2|Overall Study|Protocol Violation|0
2879533|NCT01976312|9907998|P1|Overall Study|Protocol Violation|2
2879534|NCT01976312|9907997|P2|Overall Study|Adverse Event|6
2879535|NCT01976312|9907998|P1|Overall Study|Adverse Event|6
2879536|NCT01976312|9907997|P2|Overall Study|Withdrawal by Subject|2
2879537|NCT01976312|9907998|P1|Overall Study|Withdrawal by Subject|7
2879538|NCT01976312|9907997|P2|Overall Study|Lost to Follow-up|0
2879539|NCT01976312|9907998|P1|Overall Study|Lost to Follow-up|2
2879540|NCT01976312|9907997|P2|Overall Study|Pregnancy|1
2879541|NCT01976312|9907998|P1|Overall Study|Pregnancy|0
2879542|NCT01976299|9908019|P2|Overall Study|See clarification above in comments|2
2879543|NCT01976299|9908020|P1|Overall Study|See clarification above in comments|9
2879544|NCT01976299|9908019|P2|Overall Study|Lost to Follow-up|1
2879545|NCT01976299|9908020|P1|Overall Study|Lost to Follow-up|7
2879546|NCT01976299|9908019|P2|Overall Study|Death|2
2879547|NCT01976299|9908020|P1|Overall Study|Death|4
2879548|NCT01976299|9908019|P2|Overall Study|Withdrawal by Subject|1
2879549|NCT01976299|9908020|P1|Overall Study|Withdrawal by Subject|3
2879550|NCT01976104|9908047|P4|Overall Study|Other|0
2879551|NCT01976104|9908048|P3|Overall Study|Other|0
2879552|NCT01976104|9908049|P2|Overall Study|Other|1
2879553|NCT01976104|9908050|P1|Overall Study|Other|0
2879554|NCT01976104|9908047|P4|Overall Study|Withdrawal by Subject|1
2879555|NCT01976104|9908048|P3|Overall Study|Withdrawal by Subject|0
2879556|NCT01976104|9908049|P2|Overall Study|Withdrawal by Subject|0
2879557|NCT01976104|9908050|P1|Overall Study|Withdrawal by Subject|3
2879558|NCT01976104|9908047|P4|Overall Study|Subject Choice|1
2879559|NCT01976104|9908048|P3|Overall Study|Subject Choice|0
2879560|NCT01976104|9908049|P2|Overall Study|Subject Choice|1
2879561|NCT01976104|9908050|P1|Overall Study|Subject Choice|0
2879562|NCT01976104|9908047|P4|Overall Study|Lost to Follow-up|1
2879563|NCT01976104|9908048|P3|Overall Study|Lost to Follow-up|1
2879564|NCT01976104|9908049|P2|Overall Study|Lost to Follow-up|0
2879565|NCT01976104|9908050|P1|Overall Study|Lost to Follow-up|3
2879566|NCT01976104|9908047|P4|Overall Study|Adverse Event|0
2879567|NCT01976104|9908048|P3|Overall Study|Adverse Event|1
2879568|NCT01976104|9908049|P2|Overall Study|Adverse Event|0
2879569|NCT01976104|9908050|P1|Overall Study|Adverse Event|0
2879570|NCT01975948|9908084|P4|Overall Study|Withdrawal by Subject|6
2879571|NCT01975948|9908085|P3|Overall Study|Withdrawal by Subject|7
2879572|NCT01975948|9908086|P2|Overall Study|Withdrawal by Subject|21
2879573|NCT01975948|9908087|P1|Overall Study|Withdrawal by Subject|17
2879574|NCT01975701|9908154|P1|Overall Study|Physician Decision|1
2879575|NCT01975701|9908154|P1|Overall Study|Death|23
2879576|NCT01975701|9908154|P1|Overall Study|Lost to Follow-up|1
2879577|NCT01975675|9908165|P4|Overall Study|Death|0
2879578|NCT01975675|9908166|P3|Overall Study|Death|0
2879579|NCT01975675|9908167|P2|Overall Study|Death|1
2879580|NCT01975675|9908168|P1|Overall Study|Death|0
2879581|NCT01975389|9908219|P2|Overall Study|Randomized, not treated|5
2879582|NCT01975389|9908220|P1|Overall Study|Randomized, not treated|4
2879583|NCT01975389|9908219|P2|Overall Study|Other|9
2879584|NCT01975389|9908220|P1|Overall Study|Other|6
2879585|NCT01975389|9908219|P2|Overall Study|Withdrawal by Subject|76
2879586|NCT01975389|9908220|P1|Overall Study|Withdrawal by Subject|90
2879587|NCT01975389|9908219|P2|Overall Study|Lost to Follow-up|86
2879588|NCT01975389|9908220|P1|Overall Study|Lost to Follow-up|81
2879589|NCT01975389|9908219|P2|Overall Study|Death|54
2879590|NCT01975389|9908220|P1|Overall Study|Death|61
2879591|NCT01975389|9908219|P2|Overall Study|Adverse Event|6
2879592|NCT01975389|9908220|P1|Overall Study|Adverse Event|10
2879593|NCT01975376|9908280|P2|Overall Study|Randomized, Not Treated|8
2879594|NCT01975376|9908281|P1|Overall Study|Randomized, Not Treated|16
2879595|NCT01975376|9908280|P2|Overall Study|Other|4
2879596|NCT01975376|9908281|P1|Overall Study|Other|2
2879597|NCT01975376|9908280|P2|Overall Study|Withdrew consent|62
2879598|NCT01975376|9908281|P1|Overall Study|Withdrew consent|68
2879599|NCT01975376|9908280|P2|Overall Study|Lost to Follow-up|66
2879600|NCT01975376|9908281|P1|Overall Study|Lost to Follow-up|70
2879601|NCT01975376|9908280|P2|Overall Study|Death|72
2879602|NCT01975376|9908281|P1|Overall Study|Death|65
2879603|NCT01975376|9908280|P2|Overall Study|Adverse Event|5
2879604|NCT01975376|9908281|P1|Overall Study|Adverse Event|5
2879605|NCT01975285|9908341|P2|Overall Study|Failed Block and follow up|2
2879606|NCT01975285|9908342|P1|Overall Study|Failed Block and follow up|2
2879607|NCT01975246|9908358|P2|Overall Study|Other than stated|1
2879608|NCT01975246|9908359|P1|Overall Study|Other than stated|0
2879609|NCT01975246|9908358|P2|Overall Study|Protocol Violation|0
2879610|NCT01975246|9908359|P1|Overall Study|Protocol Violation|1
2879611|NCT01975246|9908358|P2|Overall Study|Lack of Efficacy|0
2879612|NCT01975246|9908359|P1|Overall Study|Lack of Efficacy|1
2879613|NCT01975246|9908358|P2|Overall Study|Adverse Event|1
2879614|NCT01975246|9908359|P1|Overall Study|Adverse Event|2
2879615|NCT01975220|9908372|P6|Test Period 1|Not treated|0
2879616|NCT01975220|9908373|P5|Test Period 1|Not treated|0
2879617|NCT01975220|9908374|P4|Test Period 1|Not treated|0
2879618|NCT01975220|9908375|P3|Test Period 1|Not treated|0
2879619|NCT01975220|9908376|P2|Test Period 1|Not treated|1
2879620|NCT01975220|9908377|P1|Test Period 1|Not treated|0
2879621|NCT01974895|9908433|P2|Overall Study|Other (Reason unknown)|8
2879622|NCT01974895|9908434|P1|Overall Study|Other (Reason unknown)|9
2879623|NCT01974895|9908433|P2|Overall Study|Other (Missed Visit)|0
2879624|NCT01974895|9908434|P1|Overall Study|Other (Missed Visit)|1
2879625|NCT01974895|9908433|P2|Overall Study|Withdrawal by Subject|1
2879626|NCT01974895|9908434|P1|Overall Study|Withdrawal by Subject|0
2879627|NCT01974895|9908433|P2|Overall Study|Lost to Follow-up|6
2879628|NCT01974895|9908434|P1|Overall Study|Lost to Follow-up|4
2879629|NCT01974895|9908433|P2|Overall Study|Protocol Violation|0
2879630|NCT01974895|9908434|P1|Overall Study|Protocol Violation|1
2879631|NCT01974817|9908464|P1|Overall Study|Protocol Violation|2
2879632|NCT01974817|9908464|P1|Overall Study|Lost to Follow-up|2
2879633|NCT01974817|9908464|P1|Overall Study|Death|4
2879634|NCT01974752|9908470|P2|Overall Study|Other Eligibility Criteria|1
2879635|NCT01974752|9908471|P1|Overall Study|Other Eligibility Criteria|0
2879636|NCT01974752|9908470|P2|Overall Study|Withdrawal by Subject|3
2879637|NCT01974752|9908471|P1|Overall Study|Withdrawal by Subject|2
2879638|NCT01974752|9908470|P2|Overall Study|Lost to Follow-up|0
2879639|NCT01974752|9908471|P1|Overall Study|Lost to Follow-up|2
2879640|NCT01974752|9908470|P2|Overall Study|Death|11
2879641|NCT01974752|9908471|P1|Overall Study|Death|33
2879642|NCT01974323|9908899|P2|Overall Study|Adverse Event|2
2879643|NCT01974323|9908900|P1|Overall Study|Adverse Event|2
2879644|NCT01974323|9908899|P2|Overall Study|Lack of Efficacy|1
2879645|NCT01974323|9908900|P1|Overall Study|Lack of Efficacy|1
2879646|NCT01974323|9908899|P2|Overall Study|Pregnancy|1
2879647|NCT01974323|9908900|P1|Overall Study|Pregnancy|2
2879648|NCT01974323|9908899|P2|Overall Study|Lost to Follow-up|40
2879649|NCT01974323|9908900|P1|Overall Study|Lost to Follow-up|45
2879650|NCT01974323|9908899|P2|Overall Study|Personal Reasons|19
2879651|NCT01974323|9908900|P1|Overall Study|Personal Reasons|15
2879652|NCT01974323|9908899|P2|Overall Study|Protocol Violation|2
2879653|NCT01974323|9908900|P1|Overall Study|Protocol Violation|2
2879654|NCT01974323|9908899|P2|Overall Study|Other Reasons|28
2879655|NCT01974323|9908900|P1|Overall Study|Other Reasons|25
2879656|NCT01974141|9908940|P2|Overall Study|Adverse Event|5
2879657|NCT01974141|9908941|P1|Overall Study|Adverse Event|4
2879658|NCT01974141|9908940|P2|Overall Study|Lack of Efficacy|1
2879659|NCT01974141|9908941|P1|Overall Study|Lack of Efficacy|0
2879660|NCT01974141|9908940|P2|Overall Study|Pregnancy|3
2879661|NCT01974141|9908941|P1|Overall Study|Pregnancy|3
2879662|NCT01974141|9908940|P2|Overall Study|Lost to Follow-up|29
2879663|NCT01974141|9908941|P1|Overall Study|Lost to Follow-up|38
2879664|NCT01974141|9908940|P2|Overall Study|Personal Reasons|20
2879665|NCT01974141|9908941|P1|Overall Study|Personal Reasons|21
2879666|NCT01974141|9908940|P2|Overall Study|Protocol Violation|6
2879667|NCT01974141|9908941|P1|Overall Study|Protocol Violation|2
2879668|NCT01974141|9908940|P2|Overall Study|Other Reasons|18
2879669|NCT01974141|9908941|P1|Overall Study|Other Reasons|28
2879670|NCT01973998|9908985|P2|Overall Study|Death|2
2879671|NCT01973998|9908986|P1|Overall Study|Death|2
2879672|NCT01973595|9909048|P4|Washout|Withdrawal by Subject|0
2879673|NCT01973595|9909049|P3|Washout|Withdrawal by Subject|1
2879674|NCT01973595|9909050|P2|Washout|Withdrawal by Subject|0
2879675|NCT01973595|9909051|P1|Washout|Withdrawal by Subject|1
2879676|NCT01973569|9909068|P3|Overall Study|Did not receive study drug|3
2879677|NCT01973569|9909069|P2|Overall Study|Did not receive study drug|3
2879678|NCT01973569|9909070|P1|Overall Study|Did not receive study drug|6
2879679|NCT01973569|9909068|P3|Overall Study|Other|0
2879680|NCT01973569|9909069|P2|Overall Study|Other|1
2879681|NCT01973569|9909070|P1|Overall Study|Other|1
2879682|NCT01973569|9909068|P3|Overall Study|Disease progression|0
2879683|NCT01973569|9909069|P2|Overall Study|Disease progression|3
2879684|NCT01973569|9909070|P1|Overall Study|Disease progression|0
2879685|NCT01973569|9909068|P3|Overall Study|Prohibited concomitant d|0
2879686|NCT01973569|9909069|P2|Overall Study|Prohibited concomitant d|5
2879687|NCT01973569|9909070|P1|Overall Study|Prohibited concomitant d|1
2879688|NCT01973569|9909068|P3|Overall Study|Invasive dental treatment|6
2879689|NCT01973569|9909069|P2|Overall Study|Invasive dental treatment|5
2879690|NCT01973569|9909070|P1|Overall Study|Invasive dental treatment|3
2879691|NCT01973569|9909068|P3|Overall Study|Withdrawal by Subject|2
2879692|NCT01973569|9909069|P2|Overall Study|Withdrawal by Subject|5
2879693|NCT01973569|9909070|P1|Overall Study|Withdrawal by Subject|7
2879694|NCT01973569|9909068|P3|Overall Study|Protocol Violation|3
2879695|NCT01973569|9909069|P2|Overall Study|Protocol Violation|1
2879696|NCT01973569|9909070|P1|Overall Study|Protocol Violation|2
2879697|NCT01973569|9909068|P3|Overall Study|Adverse Event|4
2879698|NCT01973569|9909069|P2|Overall Study|Adverse Event|2
2879699|NCT01973569|9909070|P1|Overall Study|Adverse Event|9
2879700|NCT01973491|9909096|P1|Treatment Period (16 Weeks)|Adverse Event|1
2879701|NCT01973491|9909096|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
2879702|NCT01973491|9909096|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
2879703|NCT01973439|9909112|P1|Overall Study|PK curve incomplete|2
2879704|NCT01973439|9909112|P1|Overall Study|Vomiting after commencing once daily|1
2879705|NCT01973439|9909112|P1|Overall Study|Lost samples from one PK Day|2
2879706|NCT01973387|9909134|P2|Overall Study|Randomized, not treated|2
2879707|NCT01973387|9909135|P1|Overall Study|Randomized, not treated|2
2879708|NCT01973387|9909134|P2|Overall Study|Death|3
2879709|NCT01973387|9909135|P1|Overall Study|Death|4
2879710|NCT01973387|9909134|P2|Overall Study|Progressive disease or relapse|5
2879711|NCT01973387|9909135|P1|Overall Study|Progressive disease or relapse|16
2879712|NCT01973387|9909134|P2|Overall Study|Study terminated by sponsor|0
2879713|NCT01973387|9909135|P1|Overall Study|Study terminated by sponsor|63
2879714|NCT01973387|9909134|P2|Overall Study|Withdrawal by Subject|4
2879715|NCT01973387|9909135|P1|Overall Study|Withdrawal by Subject|7
2879716|NCT01973387|9909134|P2|Overall Study|Adverse Event|4
2879717|NCT01973387|9909135|P1|Overall Study|Adverse Event|14
2879718|NCT01973231|9909217|P2|Overall Study|Withdrawal by Subject|9
2879719|NCT01973231|9909218|P1|Overall Study|Withdrawal by Subject|7
2879720|NCT01973231|9909217|P2|Overall Study|unclassified|1
2879721|NCT01973231|9909218|P1|Overall Study|unclassified|2
2879722|NCT01973231|9909217|P2|Overall Study|Lost to Follow-up|1
2879723|NCT01973231|9909218|P1|Overall Study|Lost to Follow-up|1
2879724|NCT01973231|9909217|P2|Overall Study|Protocol Violation|1
2879725|NCT01973231|9909218|P1|Overall Study|Protocol Violation|1
2879726|NCT01973218|9909238|P2|Overall Study|Withdrawal by Subject|0
2879727|NCT01973218|9909239|P1|Overall Study|Withdrawal by Subject|1
2879728|NCT01973218|9909238|P2|Overall Study|Adverse Event|0
2879729|NCT01973218|9909239|P1|Overall Study|Adverse Event|1
2879730|NCT01972841|9909332|P6|Overall Study|Did not have end of treatment page|0
2879731|NCT01972841|9909333|P5|Overall Study|Did not have end of treatment page|1
2879732|NCT01972841|9909334|P4|Overall Study|Did not have end of treatment page|0
2879733|NCT01972841|9909335|P3|Overall Study|Did not have end of treatment page|0
2879734|NCT01972841|9909336|P2|Overall Study|Did not have end of treatment page|0
2879735|NCT01972841|9909337|P1|Overall Study|Did not have end of treatment page|0
2879736|NCT01972841|9909332|P6|Overall Study|Miscellaneous|4
2879737|NCT01972841|9909333|P5|Overall Study|Miscellaneous|0
2879738|NCT01972841|9909334|P4|Overall Study|Miscellaneous|1
2879739|NCT01972841|9909335|P3|Overall Study|Miscellaneous|4
2879740|NCT01972841|9909336|P2|Overall Study|Miscellaneous|0
2879741|NCT01972841|9909337|P1|Overall Study|Miscellaneous|0
2879742|NCT01972841|9909332|P6|Overall Study|Withdrawal by participants|34
2879743|NCT01972841|9909333|P5|Overall Study|Withdrawal by participants|33
2879744|NCT01972841|9909334|P4|Overall Study|Withdrawal by participants|16
2879745|NCT01972841|9909335|P3|Overall Study|Withdrawal by participants|23
2879746|NCT01972841|9909336|P2|Overall Study|Withdrawal by participants|27
2879747|NCT01972841|9909337|P1|Overall Study|Withdrawal by participants|21
2879748|NCT01972841|9909332|P6|Overall Study|Protocol Violation|4
2879749|NCT01972841|9909333|P5|Overall Study|Protocol Violation|9
2879750|NCT01972841|9909334|P4|Overall Study|Protocol Violation|5
2879751|NCT01972841|9909335|P3|Overall Study|Protocol Violation|3
2879752|NCT01972841|9909336|P2|Overall Study|Protocol Violation|2
2879753|NCT01972841|9909337|P1|Overall Study|Protocol Violation|2
2879754|NCT01972841|9909332|P6|Overall Study|Lost to Follow-up|3
2879755|NCT01972841|9909333|P5|Overall Study|Lost to Follow-up|9
2879756|NCT01972841|9909334|P4|Overall Study|Lost to Follow-up|2
2879757|NCT01972841|9909335|P3|Overall Study|Lost to Follow-up|4
2879758|NCT01972841|9909336|P2|Overall Study|Lost to Follow-up|2
2879759|NCT01972841|9909337|P1|Overall Study|Lost to Follow-up|4
2879760|NCT01972841|9909332|P6|Overall Study|Lack of Efficacy|1
2879761|NCT01972841|9909333|P5|Overall Study|Lack of Efficacy|4
2879762|NCT01972841|9909334|P4|Overall Study|Lack of Efficacy|2
2879763|NCT01972841|9909335|P3|Overall Study|Lack of Efficacy|0
2879764|NCT01972841|9909336|P2|Overall Study|Lack of Efficacy|0
2879765|NCT01972841|9909337|P1|Overall Study|Lack of Efficacy|1
2879766|NCT01972841|9909332|P6|Overall Study|Adverse Event|26
2879767|NCT01972841|9909333|P5|Overall Study|Adverse Event|21
2879768|NCT01972841|9909334|P4|Overall Study|Adverse Event|9
2879769|NCT01972841|9909335|P3|Overall Study|Adverse Event|12
2879770|NCT01972841|9909336|P2|Overall Study|Adverse Event|8
2879771|NCT01972841|9909337|P1|Overall Study|Adverse Event|13
2879772|NCT01972841|9909332|P6|Overall Study|Randomized but Never Received Treatment|13
2879773|NCT01972841|9909333|P5|Overall Study|Randomized but Never Received Treatment|6
2879774|NCT01972841|9909334|P4|Overall Study|Randomized but Never Received Treatment|2
2879775|NCT01972841|9909335|P3|Overall Study|Randomized but Never Received Treatment|4
2879776|NCT01972841|9909336|P2|Overall Study|Randomized but Never Received Treatment|5
2879777|NCT01972841|9909337|P1|Overall Study|Randomized but Never Received Treatment|2
2879778|NCT01972789|9909767|P2|Overall Study|Physician Decision|2
2879779|NCT01972789|9909768|P1|Overall Study|Physician Decision|3
2879780|NCT01972789|9909767|P2|Overall Study|Protocol deviation|0
2879781|NCT01972789|9909768|P1|Overall Study|Protocol deviation|1
2879782|NCT01972789|9909767|P2|Overall Study|Death|5
2879783|NCT01972789|9909768|P1|Overall Study|Death|7
2879784|NCT01972789|9909767|P2|Overall Study|Lost to Follow-up|7
2879785|NCT01972789|9909768|P1|Overall Study|Lost to Follow-up|4
2879786|NCT01972789|9909767|P2|Overall Study|Subject withdrew consent|12
2879787|NCT01972789|9909768|P1|Overall Study|Subject withdrew consent|14
2879788|NCT01972789|9909767|P2|Overall Study|Adverse Event|4
2879789|NCT01972789|9909768|P1|Overall Study|Adverse Event|11
2879790|NCT01972776|9909802|P6|Part 2|Administrative problems|7
2879791|NCT01972776|9909803|P5|Part 2|Administrative problems|10
2879792|NCT01972776|9909804|P4|Part 2|Administrative problems|0
2879793|NCT01972776|9909805|P3|Part 2|Administrative problems|0
2879794|NCT01972776|9909806|P2|Part 2|Administrative problems|0
2879795|NCT01972776|9909807|P1|Part 2|Administrative problems|0
2879796|NCT01972776|9909802|P6|Part 2|Adverse Event|0
2879797|NCT01972776|9909803|P5|Part 2|Adverse Event|3
2879798|NCT01972776|9909804|P4|Part 2|Adverse Event|0
2879799|NCT01972776|9909805|P3|Part 2|Adverse Event|0
2879800|NCT01972776|9909806|P2|Part 2|Adverse Event|0
2879801|NCT01972776|9909807|P1|Part 2|Adverse Event|0
2879802|NCT01972776|9909802|P6|Part 1|Adverse Event|0
2879803|NCT01972776|9909803|P5|Part 1|Adverse Event|0
2879804|NCT01972776|9909804|P4|Part 1|Adverse Event|1
2879805|NCT01972776|9909805|P3|Part 1|Adverse Event|1
2879806|NCT01972776|9909806|P2|Part 1|Adverse Event|0
2879807|NCT01972776|9909807|P1|Part 1|Adverse Event|0
2879808|NCT01972776|9909802|P6|Part 1|Withdrawal by Subject|0
2879809|NCT01972776|9909803|P5|Part 1|Withdrawal by Subject|0
2879810|NCT01972776|9909804|P4|Part 1|Withdrawal by Subject|0
2879811|NCT01972776|9909805|P3|Part 1|Withdrawal by Subject|1
2879812|NCT01972776|9909806|P2|Part 1|Withdrawal by Subject|0
2879813|NCT01972776|9909807|P1|Part 1|Withdrawal by Subject|0
2879814|NCT01972724|9909878|P3|Open-Label|Significant Protocol Deviation|2
2879815|NCT01972724|9909879|P2|Open-Label|Significant Protocol Deviation|0
2879816|NCT01972724|9909880|P1|Open-Label|Significant Protocol Deviation|0
2879817|NCT01972724|9909878|P3|Open-Label|Withdrew Consent|3
2879818|NCT01972724|9909879|P2|Open-Label|Withdrew Consent|0
2879819|NCT01972724|9909880|P1|Open-Label|Withdrew Consent|0
2879820|NCT01972724|9909878|P3|Double-Blind|Significant Protocol Deviation|0
2879821|NCT01972724|9909879|P2|Double-Blind|Significant Protocol Deviation|8
2879822|NCT01972724|9909880|P1|Double-Blind|Significant Protocol Deviation|5
2879823|NCT01972724|9909878|P3|Double-Blind|Withdrawal of Consent|0
2879824|NCT01972724|9909879|P2|Double-Blind|Withdrawal of Consent|1
2879825|NCT01972724|9909880|P1|Double-Blind|Withdrawal of Consent|2
2879826|NCT01972724|9909878|P3|Double-Blind|Adverse Event|0
2879827|NCT01972724|9909879|P2|Double-Blind|Adverse Event|0
2879828|NCT01972724|9909880|P1|Double-Blind|Adverse Event|1
2879829|NCT01972724|9909878|P3|Double-Blind|Rescue Criteria Met|0
2879830|NCT01972724|9909879|P2|Double-Blind|Rescue Criteria Met|0
2879831|NCT01972724|9909880|P1|Double-Blind|Rescue Criteria Met|1
2879832|NCT01972659|9909893|P2|Overall Study|problems realted to acceleromyograph|1
2879833|NCT01972659|9909894|P1|Overall Study|problems realted to acceleromyograph|2
2879834|NCT01972659|9909893|P2|Overall Study|Protocol Violation|2
2879835|NCT01972659|9909894|P1|Overall Study|Protocol Violation|2
2879836|NCT01972568|9909903|P3|Overall Study|Adverse Event|5
2879837|NCT01972568|9909904|P2|Overall Study|Adverse Event|6
2879838|NCT01972568|9909905|P1|Overall Study|Adverse Event|5
2879839|NCT01972568|9909903|P3|Overall Study|Lost to Follow-up|0
2879840|NCT01972568|9909904|P2|Overall Study|Lost to Follow-up|0
2879841|NCT01972568|9909905|P1|Overall Study|Lost to Follow-up|1
2879842|NCT01972568|9909903|P3|Overall Study|Withdrawal by Subject|7
2879843|NCT01972568|9909904|P2|Overall Study|Withdrawal by Subject|3
2879844|NCT01972568|9909905|P1|Overall Study|Withdrawal by Subject|6
2879845|NCT01972568|9909903|P3|Overall Study|Protocol Violation|2
2879846|NCT01972568|9909904|P2|Overall Study|Protocol Violation|2
2879847|NCT01972568|9909905|P1|Overall Study|Protocol Violation|1
2879848|NCT01972568|9909903|P3|Overall Study|Lack of Efficacy|2
2879849|NCT01972568|9909904|P2|Overall Study|Lack of Efficacy|1
2879850|NCT01972568|9909905|P1|Overall Study|Lack of Efficacy|0
2879851|NCT01972568|9909903|P3|Overall Study|Other events|0
2879852|NCT01972568|9909904|P2|Overall Study|Other events|0
2879853|NCT01972568|9909905|P1|Overall Study|Other events|3
2879854|NCT01972529|9909944|P4|Overall Study|Not treated|1
2879855|NCT01972529|9909945|P3|Overall Study|Not treated|2
2879856|NCT01972529|9909946|P2|Overall Study|Not treated|1
2879857|NCT01972529|9909947|P1|Overall Study|Not treated|0
2879858|NCT01972529|9909944|P4|Overall Study|Other|2
2879859|NCT01972529|9909945|P3|Overall Study|Other|0
2879860|NCT01972529|9909946|P2|Overall Study|Other|0
2879861|NCT01972529|9909947|P1|Overall Study|Other|0
2879862|NCT01972529|9909944|P4|Overall Study|Withdrawl of Consent|1
2879863|NCT01972529|9909945|P3|Overall Study|Withdrawl of Consent|0
2879864|NCT01972529|9909946|P2|Overall Study|Withdrawl of Consent|2
2879865|NCT01972529|9909947|P1|Overall Study|Withdrawl of Consent|1
2879866|NCT01972529|9909944|P4|Overall Study|Participant Choice|0
2879867|NCT01972529|9909945|P3|Overall Study|Participant Choice|0
2879868|NCT01972529|9909946|P2|Overall Study|Participant Choice|1
2879869|NCT01972529|9909947|P1|Overall Study|Participant Choice|0
2879870|NCT01972529|9909944|P4|Overall Study|Lost to Follow-up|0
2879871|NCT01972529|9909945|P3|Overall Study|Lost to Follow-up|0
2879872|NCT01972529|9909946|P2|Overall Study|Lost to Follow-up|0
2879873|NCT01972529|9909947|P1|Overall Study|Lost to Follow-up|1
2879874|NCT01972529|9909944|P4|Overall Study|Adverse Event|0
2879875|NCT01972529|9909945|P3|Overall Study|Adverse Event|0
2879876|NCT01972529|9909946|P2|Overall Study|Adverse Event|1
2879877|NCT01972529|9909947|P1|Overall Study|Adverse Event|0
2879878|NCT01972464|9909992|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2879879|NCT01972464|9909993|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2879880|NCT01972464|9909992|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
2879881|NCT01972464|9909993|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
2879882|NCT01972464|9909992|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
2879883|NCT01972464|9909993|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
2879884|NCT01972464|9909992|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
2879885|NCT01972464|9909993|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
2879886|NCT01972438|9910009|P2|Post Month 12 Study Period|Early Study Closure|4
2879887|NCT01972438|9910010|P1|Post Month 12 Study Period|Early Study Closure|3
2879888|NCT01972438|9910009|P2|Months 6-12 Study Period|Early Study Closure|2
2879889|NCT01972438|9910010|P1|Months 6-12 Study Period|Early Study Closure|2
2879890|NCT01972438|9910009|P2|Months 6-12 Study Period|Death|0
2879891|NCT01972438|9910010|P1|Months 6-12 Study Period|Death|1
2879892|NCT01972438|9910009|P2|Months 3-6 Crossover Period|Early Study Closure|1
2879893|NCT01972438|9910010|P1|Months 3-6 Crossover Period|Early Study Closure|0
2879894|NCT01972438|9910009|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
2879895|NCT01972438|9910010|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
2879896|NCT01972438|9910009|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
2879897|NCT01972438|9910010|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
2879898|NCT01972438|9910009|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
2879899|NCT01972438|9910010|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
2879900|NCT01972438|9910009|P2|Baseline-Month 3 Crossover Period|Death|0
2879901|NCT01972438|9910010|P1|Baseline-Month 3 Crossover Period|Death|1
2879902|NCT01972308|9910064|P2|Overall Study|Death|1
2879903|NCT01972308|9910065|P1|Overall Study|Death|4
2879904|NCT01972308|9910064|P2|Overall Study|Lost to Follow-up|6
2879905|NCT01972308|9910065|P1|Overall Study|Lost to Follow-up|4
2879906|NCT01972308|9910064|P2|Overall Study|Withdrawal by Subject|1
2879907|NCT01972308|9910065|P1|Overall Study|Withdrawal by Subject|0
2879908|NCT01972217|9910091|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
2879909|NCT01972217|9910092|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2879910|NCT01972217|9910093|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2879911|NCT01972217|9910094|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2879912|NCT01972217|9910091|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
2879913|NCT01972217|9910092|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
2879914|NCT01972217|9910093|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
2879915|NCT01972217|9910094|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
2879916|NCT01972217|9910091|P4|Part B Double-blind, Randomised Period|Screen failure|1
2879917|NCT01972217|9910092|P3|Part B Double-blind, Randomised Period|Screen failure|0
2879918|NCT01972217|9910093|P2|Part B Double-blind, Randomised Period|Screen failure|0
2879919|NCT01972217|9910094|P1|Part B Double-blind, Randomised Period|Screen failure|0
2879920|NCT01972217|9910091|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
2879921|NCT01972217|9910092|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
2879922|NCT01972217|9910093|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
2879923|NCT01972217|9910094|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
2879924|NCT01972217|9910091|P4|Part B Double-blind, Randomised Period|Death|44
2879925|NCT01972217|9910092|P3|Part B Double-blind, Randomised Period|Death|43
2879926|NCT01972217|9910093|P2|Part B Double-blind, Randomised Period|Death|0
2879927|NCT01972217|9910094|P1|Part B Double-blind, Randomised Period|Death|0
2879928|NCT01972217|9910091|P4|Part A: Open-label Safety Run-in Period|Death|0
2879929|NCT01972217|9910092|P3|Part A: Open-label Safety Run-in Period|Death|0
2879930|NCT01972217|9910093|P2|Part A: Open-label Safety Run-in Period|Death|1
2879931|NCT01972217|9910094|P1|Part A: Open-label Safety Run-in Period|Death|0
2879932|NCT01972217|9910091|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
2879933|NCT01972217|9910092|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
2879934|NCT01972217|9910093|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
2879935|NCT01972217|9910094|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
2879936|NCT01972217|9910091|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
2879937|NCT01972217|9910092|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
2879938|NCT01972217|9910093|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
2879939|NCT01972217|9910094|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
2879940|NCT01972217|9910091|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2879941|NCT01972217|9910092|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2879942|NCT01972217|9910093|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
2879943|NCT01972217|9910094|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2879944|NCT01972152|9910155|P6|Second Treatment Visit|Protocol Violation|0
2879945|NCT01972152|9910156|P5|Second Treatment Visit|Protocol Violation|0
2879946|NCT01972152|9910157|P4|Second Treatment Visit|Protocol Violation|0
2879947|NCT01972152|9910158|P3|Second Treatment Visit|Protocol Violation|0
2879948|NCT01972152|9910159|P2|Second Treatment Visit|Protocol Violation|1
2879949|NCT01972152|9910160|P1|Second Treatment Visit|Protocol Violation|0
2879950|NCT01972152|9910155|P6|First Treatment Visit|Lost to Follow-up|0
2879951|NCT01972152|9910156|P5|First Treatment Visit|Lost to Follow-up|0
2879952|NCT01972152|9910157|P4|First Treatment Visit|Lost to Follow-up|0
2879953|NCT01972152|9910158|P3|First Treatment Visit|Lost to Follow-up|0
2879954|NCT01972152|9910159|P2|First Treatment Visit|Lost to Follow-up|1
2879955|NCT01972152|9910160|P1|First Treatment Visit|Lost to Follow-up|0
2879956|NCT01972074|9910198|P3|Overall Study|Scanner Unavailable|1
2879957|NCT01972074|9910199|P2|Overall Study|Scanner Unavailable|0
2879958|NCT01972074|9910200|P1|Overall Study|Scanner Unavailable|0
2879959|NCT01972074|9910198|P3|Overall Study|Withdrawal by Subject|1
2879960|NCT01972074|9910199|P2|Overall Study|Withdrawal by Subject|1
2879961|NCT01972074|9910200|P1|Overall Study|Withdrawal by Subject|1
2879962|NCT01972074|9910198|P3|Overall Study|Lost to Follow-up|1
2879963|NCT01972074|9910199|P2|Overall Study|Lost to Follow-up|1
2879964|NCT01972074|9910200|P1|Overall Study|Lost to Follow-up|0
2879965|NCT01972074|9910198|P3|Overall Study|Lack of Efficacy|0
2879966|NCT01972074|9910199|P2|Overall Study|Lack of Efficacy|1
2879967|NCT01972074|9910200|P1|Overall Study|Lack of Efficacy|1
2879968|NCT01972074|9910198|P3|Overall Study|Adverse Event|0
2879969|NCT01972074|9910199|P2|Overall Study|Adverse Event|1
2879970|NCT01972074|9910200|P1|Overall Study|Adverse Event|4
2879971|NCT01971723|9910226|P2|Overall Study|Protocol Violation|2
2879972|NCT01971723|9910227|P1|Overall Study|Protocol Violation|1
2879973|NCT01971723|9910226|P2|Overall Study|Withdrawal by Subject|1
2879974|NCT01971723|9910227|P1|Overall Study|Withdrawal by Subject|1
2879975|NCT01971645|9910260|P3|Overall Study|Protocol Violation|1
2879976|NCT01971645|9910261|P2|Overall Study|Protocol Violation|0
2879977|NCT01971645|9910262|P1|Overall Study|Protocol Violation|0
2879978|NCT01971645|9910260|P3|Overall Study|Lost to Follow-up|1
2879979|NCT01971645|9910261|P2|Overall Study|Lost to Follow-up|0
2879980|NCT01971645|9910262|P1|Overall Study|Lost to Follow-up|1
2879981|NCT01971645|9910260|P3|Overall Study|Adverse Event|0
2879982|NCT01971645|9910261|P2|Overall Study|Adverse Event|0
2879983|NCT01971645|9910262|P1|Overall Study|Adverse Event|1
2879984|NCT01971567|9910296|P2|Overall Study|Lost to Follow-up|0
2879985|NCT01971567|9910297|P1|Overall Study|Lost to Follow-up|1
2879986|NCT01971567|9910296|P2|Overall Study|Withdrawal by Subject|2
2879987|NCT01971567|9910297|P1|Overall Study|Withdrawal by Subject|3
2879988|NCT01971554|9910323|P4|Overall Study|Lost to Follow-up|0
2879989|NCT01971554|9910324|P3|Overall Study|Lost to Follow-up|0
2879990|NCT01971554|9910325|P2|Overall Study|Lost to Follow-up|0
2879991|NCT01971554|9910326|P1|Overall Study|Lost to Follow-up|1
2879992|NCT01971476|9910363|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
2879993|NCT01971476|9910364|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
2879994|NCT01971476|9910365|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
2879995|NCT01971476|9910363|P3|Cohort 2: 12 to <18 Years|Other not defined|0
2879996|NCT01971476|9910364|P2|Cohort 2: 12 to <18 Years|Other not defined|3
2879997|NCT01971476|9910365|P1|Cohort 2: 12 to <18 Years|Other not defined|6
2879998|NCT01971476|9910363|P3|Cohort 1: 2 to <12 Years|Other not defined|6
2879999|NCT01971476|9910364|P2|Cohort 1: 2 to <12 Years|Other not defined|3
2880000|NCT01971476|9910365|P1|Cohort 1: 2 to <12 Years|Other not defined|3
2880001|NCT01971346|9910459|P1|Overall Study|Physician Decision|1
2880002|NCT01971346|9910459|P1|Overall Study|Withdrawal by Subject|2
2880003|NCT01971346|9910459|P1|Overall Study|Lost to Follow-up|2
2880004|NCT01971346|9910459|P1|Overall Study|Protocol Violation|3
2880005|NCT01971203|9910492|P2|Overall Study|Adverse Event|0
2880006|NCT01971203|9910493|P1|Overall Study|Adverse Event|1
2880007|NCT01971203|9910492|P2|Overall Study|Withdrawal by Subject|6
2880008|NCT01971203|9910493|P1|Overall Study|Withdrawal by Subject|5
2880009|NCT01971203|9910492|P2|Overall Study|Protocol Violation|2
2880010|NCT01971203|9910493|P1|Overall Study|Protocol Violation|3
2880011|NCT01970995|9910520|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
2880012|NCT01970995|9910521|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
2880013|NCT01970995|9910522|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
2880014|NCT01970995|9910520|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2880015|NCT01970995|9910521|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2880016|NCT01970995|9910522|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2880017|NCT01970982|9910545|P3|Overall Study|Withdrawal by Subject|2
2880018|NCT01970982|9910546|P2|Overall Study|Withdrawal by Subject|0
2880019|NCT01970982|9910547|P1|Overall Study|Withdrawal by Subject|0
2880020|NCT01970878|9910582|P4|Overall Study|No Completion Status|0
2880021|NCT01970878|9910583|P3|Overall Study|No Completion Status|0
2880022|NCT01970878|9910584|P2|Overall Study|No Completion Status|1
2880023|NCT01970878|9910585|P1|Overall Study|No Completion Status|0
2880024|NCT01970878|9910582|P4|Overall Study|Physician Decision|0
2880025|NCT01970878|9910583|P3|Overall Study|Physician Decision|1
2880026|NCT01970878|9910584|P2|Overall Study|Physician Decision|1
2880027|NCT01970878|9910585|P1|Overall Study|Physician Decision|0
2880028|NCT01970878|9910582|P4|Overall Study|Protocol Specified Criteria|6
2880029|NCT01970878|9910583|P3|Overall Study|Protocol Specified Criteria|3
2880030|NCT01970878|9910584|P2|Overall Study|Protocol Specified Criteria|4
2880031|NCT01970878|9910585|P1|Overall Study|Protocol Specified Criteria|10
2880032|NCT01970878|9910582|P4|Overall Study|Adverse Event|3
2880033|NCT01970878|9910583|P3|Overall Study|Adverse Event|4
2880034|NCT01970878|9910584|P2|Overall Study|Adverse Event|7
2880035|NCT01970878|9910585|P1|Overall Study|Adverse Event|12
2880036|NCT01970878|9910582|P4|Overall Study|Lack of Efficacy|0
2880037|NCT01970878|9910583|P3|Overall Study|Lack of Efficacy|2
2880038|NCT01970878|9910584|P2|Overall Study|Lack of Efficacy|1
2880039|NCT01970878|9910585|P1|Overall Study|Lack of Efficacy|2
2880040|NCT01970878|9910582|P4|Overall Study|Administrative Reasons|4
2880041|NCT01970878|9910583|P3|Overall Study|Administrative Reasons|0
2880042|NCT01970878|9910584|P2|Overall Study|Administrative Reasons|0
2880043|NCT01970878|9910585|P1|Overall Study|Administrative Reasons|1
2880044|NCT01970878|9910582|P4|Overall Study|Lost to Follow-up|4
2880045|NCT01970878|9910583|P3|Overall Study|Lost to Follow-up|2
2880046|NCT01970878|9910584|P2|Overall Study|Lost to Follow-up|3
2880047|NCT01970878|9910585|P1|Overall Study|Lost to Follow-up|1
2880048|NCT01970878|9910582|P4|Overall Study|Withdrawal by Subject|7
2880049|NCT01970878|9910583|P3|Overall Study|Withdrawal by Subject|14
2880050|NCT01970878|9910584|P2|Overall Study|Withdrawal by Subject|10
2880051|NCT01970878|9910585|P1|Overall Study|Withdrawal by Subject|11
2880052|NCT01970865|9910628|P17|Overall Study|Study ongoing|2
2880053|NCT01970865|9910629|P16|Overall Study|Study ongoing|29
2880054|NCT01970865|9910630|P15|Overall Study|Study ongoing|29
2880055|NCT01970865|9910631|P14|Overall Study|Study ongoing|41
2880056|NCT01970865|9910632|P13|Overall Study|Study ongoing|43
2880057|NCT01970865|9910633|P12|Overall Study|Study ongoing|22
2880058|NCT01970865|9910634|P11|Overall Study|Study ongoing|29
2880059|NCT01970865|9910635|P10|Overall Study|Study ongoing|3
2880060|NCT01970865|9910636|P9|Overall Study|Study ongoing|1
2880061|NCT01970865|9910637|P8|Overall Study|Study ongoing|0
2880062|NCT01970865|9910638|P7|Overall Study|Study ongoing|2
2880063|NCT01970865|9910639|P6|Overall Study|Study ongoing|0
2880064|NCT01970865|9910640|P5|Overall Study|Study ongoing|8
2880065|NCT01970865|9910641|P4|Overall Study|Study ongoing|6
2880066|NCT01970865|9910642|P3|Overall Study|Study ongoing|0
2880067|NCT01970865|9910643|P2|Overall Study|Study ongoing|2
2880068|NCT01970865|9910644|P1|Overall Study|Study ongoing|0
2880069|NCT01970865|9910628|P17|Overall Study|Other|0
2880070|NCT01970865|9910629|P16|Overall Study|Other|1
2880071|NCT01970865|9910630|P15|Overall Study|Other|0
2880072|NCT01970865|9910631|P14|Overall Study|Other|1
2880073|NCT01970865|9910632|P13|Overall Study|Other|0
2880074|NCT01970865|9910633|P12|Overall Study|Other|0
2880075|NCT01970865|9910634|P11|Overall Study|Other|0
2880076|NCT01970865|9910635|P10|Overall Study|Other|0
2880077|NCT01970865|9910636|P9|Overall Study|Other|0
2880078|NCT01970865|9910637|P8|Overall Study|Other|0
2880079|NCT01970865|9910638|P7|Overall Study|Other|0
2880080|NCT01970865|9910639|P6|Overall Study|Other|0
2880081|NCT01970865|9910640|P5|Overall Study|Other|0
2880082|NCT01970865|9910641|P4|Overall Study|Other|1
2880083|NCT01970865|9910642|P3|Overall Study|Other|0
2880084|NCT01970865|9910643|P2|Overall Study|Other|0
2880085|NCT01970865|9910644|P1|Overall Study|Other|0
2880086|NCT01970865|9910628|P17|Overall Study|Withdrawal by Subject|0
2880087|NCT01970865|9910629|P16|Overall Study|Withdrawal by Subject|7
2880088|NCT01970865|9910630|P15|Overall Study|Withdrawal by Subject|2
2880089|NCT01970865|9910631|P14|Overall Study|Withdrawal by Subject|5
2880090|NCT01970865|9910632|P13|Overall Study|Withdrawal by Subject|2
2880091|NCT01970865|9910633|P12|Overall Study|Withdrawal by Subject|1
2880092|NCT01970865|9910634|P11|Overall Study|Withdrawal by Subject|0
2880093|NCT01970865|9910635|P10|Overall Study|Withdrawal by Subject|0
2880094|NCT01970865|9910636|P9|Overall Study|Withdrawal by Subject|0
2880095|NCT01970865|9910637|P8|Overall Study|Withdrawal by Subject|0
2880096|NCT01970865|9910638|P7|Overall Study|Withdrawal by Subject|0
2880097|NCT01970865|9910639|P6|Overall Study|Withdrawal by Subject|0
2880098|NCT01970865|9910640|P5|Overall Study|Withdrawal by Subject|2
2880099|NCT01970865|9910641|P4|Overall Study|Withdrawal by Subject|1
2880100|NCT01970865|9910642|P3|Overall Study|Withdrawal by Subject|0
2880101|NCT01970865|9910643|P2|Overall Study|Withdrawal by Subject|0
2880102|NCT01970865|9910644|P1|Overall Study|Withdrawal by Subject|0
2880103|NCT01970865|9910628|P17|Overall Study|Lost to Follow-up|0
2880104|NCT01970865|9910629|P16|Overall Study|Lost to Follow-up|0
2880105|NCT01970865|9910630|P15|Overall Study|Lost to Follow-up|0
2880106|NCT01970865|9910631|P14|Overall Study|Lost to Follow-up|0
2880107|NCT01970865|9910632|P13|Overall Study|Lost to Follow-up|1
2880108|NCT01970865|9910633|P12|Overall Study|Lost to Follow-up|0
2880109|NCT01970865|9910634|P11|Overall Study|Lost to Follow-up|0
2880110|NCT01970865|9910635|P10|Overall Study|Lost to Follow-up|0
2880111|NCT01970865|9910636|P9|Overall Study|Lost to Follow-up|0
2880112|NCT01970865|9910637|P8|Overall Study|Lost to Follow-up|0
2880113|NCT01970865|9910638|P7|Overall Study|Lost to Follow-up|0
2880114|NCT01970865|9910639|P6|Overall Study|Lost to Follow-up|0
2880115|NCT01970865|9910640|P5|Overall Study|Lost to Follow-up|1
2880116|NCT01970865|9910641|P4|Overall Study|Lost to Follow-up|1
2880117|NCT01970865|9910642|P3|Overall Study|Lost to Follow-up|0
2880118|NCT01970865|9910643|P2|Overall Study|Lost to Follow-up|0
2880119|NCT01970865|9910644|P1|Overall Study|Lost to Follow-up|0
2880120|NCT01970865|9910628|P17|Overall Study|Death|1
2880121|NCT01970865|9910629|P16|Overall Study|Death|10
2880122|NCT01970865|9910630|P15|Overall Study|Death|15
2880123|NCT01970865|9910631|P14|Overall Study|Death|19
2880124|NCT01970865|9910632|P13|Overall Study|Death|14
2880125|NCT01970865|9910633|P12|Overall Study|Death|4
2880126|NCT01970865|9910634|P11|Overall Study|Death|1
2880127|NCT01970865|9910635|P10|Overall Study|Death|1
2880128|NCT01970865|9910636|P9|Overall Study|Death|2
2880129|NCT01970865|9910637|P8|Overall Study|Death|3
2880130|NCT01970865|9910638|P7|Overall Study|Death|1
2880131|NCT01970865|9910639|P6|Overall Study|Death|3
2880132|NCT01970865|9910640|P5|Overall Study|Death|6
2880133|NCT01970865|9910641|P4|Overall Study|Death|4
2880134|NCT01970865|9910642|P3|Overall Study|Death|3
2880135|NCT01970865|9910643|P2|Overall Study|Death|1
2880136|NCT01970865|9910644|P1|Overall Study|Death|3
2880137|NCT01970592|9911076|P1|Overall Study|Adverse Event|1
2880138|NCT01970592|9911076|P1|Overall Study|Physician Decision|1
2880139|NCT01970592|9911076|P1|Overall Study|Withdrawal by Subject|4
2880140|NCT01970540|9911084|P3|Overall Study|Clinical deterioration|0
2880141|NCT01970540|9911085|P2|Overall Study|Clinical deterioration|0
2880142|NCT01970540|9911086|P1|Overall Study|Clinical deterioration|1
2880143|NCT01970540|9911084|P3|Overall Study|Withdrawal by Subject|1
2880144|NCT01970540|9911085|P2|Overall Study|Withdrawal by Subject|0
2880145|NCT01970540|9911086|P1|Overall Study|Withdrawal by Subject|4
2880146|NCT01970540|9911084|P3|Overall Study|Treatment-related AE|2
2880147|NCT01970540|9911085|P2|Overall Study|Treatment-related AE|0
2880148|NCT01970540|9911086|P1|Overall Study|Treatment-related AE|4
2880149|NCT01970540|9911084|P3|Overall Study|Adverse Event|1
2880150|NCT01970540|9911085|P2|Overall Study|Adverse Event|2
2880151|NCT01970540|9911086|P1|Overall Study|Adverse Event|0
2880152|NCT01970540|9911084|P3|Overall Study|End of study|2
2880153|NCT01970540|9911085|P2|Overall Study|End of study|0
2880154|NCT01970540|9911086|P1|Overall Study|End of study|2
2880155|NCT01970540|9911084|P3|Overall Study|Clinical progression|1
2880156|NCT01970540|9911085|P2|Overall Study|Clinical progression|1
2880157|NCT01970540|9911086|P1|Overall Study|Clinical progression|0
2880158|NCT01970540|9911084|P3|Overall Study|Physician Decision|0
2880159|NCT01970540|9911085|P2|Overall Study|Physician Decision|2
2880160|NCT01970540|9911086|P1|Overall Study|Physician Decision|7
2880161|NCT01970540|9911084|P3|Overall Study|Treatment delay over protocol|1
2880162|NCT01970540|9911085|P2|Overall Study|Treatment delay over protocol|0
2880163|NCT01970540|9911086|P1|Overall Study|Treatment delay over protocol|0
2880164|NCT01970540|9911084|P3|Overall Study|Progressive disease|10
2880165|NCT01970540|9911085|P2|Overall Study|Progressive disease|23
2880166|NCT01970540|9911086|P1|Overall Study|Progressive disease|55
2880167|NCT01970540|9911084|P3|Overall Study|Non-treatment-related AE|1
2880168|NCT01970540|9911085|P2|Overall Study|Non-treatment-related AE|0
2880169|NCT01970540|9911086|P1|Overall Study|Non-treatment-related AE|0
2880170|NCT01970527|9911117|P2|Follow-up Clinic Visit|Lost to Follow-up|1
2880171|NCT01970527|9911118|P1|Follow-up Clinic Visit|Lost to Follow-up|0
2880172|NCT01970527|9911117|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
2880173|NCT01970527|9911118|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
2880174|NCT01970527|9911117|P2|Follow-up Clinic Visit|Disease progression|1
2880175|NCT01970527|9911118|P1|Follow-up Clinic Visit|Disease progression|1
2880176|NCT01970527|9911117|P2|Treatment|Death|1
2880177|NCT01970527|9911118|P1|Treatment|Death|0
2880178|NCT01970527|9911117|P2|Treatment|Participant did not tolerate Ipilimumab|1
2880179|NCT01970527|9911118|P1|Treatment|Participant did not tolerate Ipilimumab|0
2880180|NCT01970527|9911117|P2|Treatment|Disease progression|1
2880181|NCT01970527|9911118|P1|Treatment|Disease progression|0
2880182|NCT01970527|9911117|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
2880183|NCT01970527|9911118|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
2880184|NCT01970488|9911131|P5|Part 2: Post Week 16|Lost to Follow-up|2
2880185|NCT01970488|9911132|P4|Part 2: Post Week 16|Lost to Follow-up|1
2880186|NCT01970488|9911133|P3|Part 2: Post Week 16|Lost to Follow-up|1
2880187|NCT01970488|9911134|P2|Part 2: Post Week 16|Lost to Follow-up|0
2880188|NCT01970488|9911135|P1|Part 2: Post Week 16|Lost to Follow-up|0
2880189|NCT01970488|9911131|P5|Part 2: Post Week 16|Withdrawal by Subject|3
2880190|NCT01970488|9911132|P4|Part 2: Post Week 16|Withdrawal by Subject|3
2880191|NCT01970488|9911133|P3|Part 2: Post Week 16|Withdrawal by Subject|8
2880192|NCT01970488|9911134|P2|Part 2: Post Week 16|Withdrawal by Subject|0
2880193|NCT01970488|9911135|P1|Part 2: Post Week 16|Withdrawal by Subject|0
2880194|NCT01970488|9911131|P5|Part 2: Post Week 16|Adverse Event|1
2880195|NCT01970488|9911132|P4|Part 2: Post Week 16|Adverse Event|1
2880196|NCT01970488|9911133|P3|Part 2: Post Week 16|Adverse Event|5
2880197|NCT01970488|9911134|P2|Part 2: Post Week 16|Adverse Event|0
2880198|NCT01970488|9911135|P1|Part 2: Post Week 16|Adverse Event|0
2880199|NCT01970488|9911131|P5|Part 2: Post Week 16|Lack of Efficacy|1
2880200|NCT01970488|9911132|P4|Part 2: Post Week 16|Lack of Efficacy|3
2880201|NCT01970488|9911133|P3|Part 2: Post Week 16|Lack of Efficacy|2
2880202|NCT01970488|9911134|P2|Part 2: Post Week 16|Lack of Efficacy|0
2880203|NCT01970488|9911135|P1|Part 2: Post Week 16|Lack of Efficacy|0
2880204|NCT01970488|9911131|P5|Part 2: Post Week 16|Non-compliance|0
2880205|NCT01970488|9911132|P4|Part 2: Post Week 16|Non-compliance|0
2880206|NCT01970488|9911133|P3|Part 2: Post Week 16|Non-compliance|1
2880207|NCT01970488|9911134|P2|Part 2: Post Week 16|Non-compliance|0
2880208|NCT01970488|9911135|P1|Part 2: Post Week 16|Non-compliance|0
2880209|NCT01970488|9911131|P5|Part 2: Post Week 16|Physician Decision|1
2880210|NCT01970488|9911132|P4|Part 2: Post Week 16|Physician Decision|0
2880211|NCT01970488|9911133|P3|Part 2: Post Week 16|Physician Decision|0
2880212|NCT01970488|9911134|P2|Part 2: Post Week 16|Physician Decision|0
2880213|NCT01970488|9911135|P1|Part 2: Post Week 16|Physician Decision|0
2880214|NCT01970488|9911131|P5|Part 1: Through Week 16|Lost to Follow-up|0
2880215|NCT01970488|9911132|P4|Part 1: Through Week 16|Lost to Follow-up|0
2880216|NCT01970488|9911133|P3|Part 1: Through Week 16|Lost to Follow-up|0
2880217|NCT01970488|9911134|P2|Part 1: Through Week 16|Lost to Follow-up|2
2880218|NCT01970488|9911135|P1|Part 1: Through Week 16|Lost to Follow-up|0
2880219|NCT01970488|9911131|P5|Part 1: Through Week 16|Withdrawal by Subject|0
2880220|NCT01970488|9911132|P4|Part 1: Through Week 16|Withdrawal by Subject|0
2880221|NCT01970488|9911133|P3|Part 1: Through Week 16|Withdrawal by Subject|0
2880222|NCT01970488|9911134|P2|Part 1: Through Week 16|Withdrawal by Subject|2
2880223|NCT01970488|9911135|P1|Part 1: Through Week 16|Withdrawal by Subject|3
2880224|NCT01970488|9911131|P5|Part 1: Through Week 16|Adverse Event|0
2880225|NCT01970488|9911132|P4|Part 1: Through Week 16|Adverse Event|0
2880226|NCT01970488|9911133|P3|Part 1: Through Week 16|Adverse Event|0
2880227|NCT01970488|9911134|P2|Part 1: Through Week 16|Adverse Event|5
2880228|NCT01970488|9911135|P1|Part 1: Through Week 16|Adverse Event|6
2880229|NCT01970488|9911131|P5|Part 1: Through Week 16|Protocol Violation|0
2880230|NCT01970488|9911132|P4|Part 1: Through Week 16|Protocol Violation|0
2880231|NCT01970488|9911133|P3|Part 1: Through Week 16|Protocol Violation|0
2880232|NCT01970488|9911134|P2|Part 1: Through Week 16|Protocol Violation|2
2880233|NCT01970488|9911135|P1|Part 1: Through Week 16|Protocol Violation|1
2880234|NCT01970488|9911131|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
2880235|NCT01970488|9911132|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
2880236|NCT01970488|9911133|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
2880237|NCT01970488|9911134|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
2880238|NCT01970488|9911135|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
2880239|NCT01970475|9911202|P2|Overall Study|Protocol Violation|0
2880240|NCT01970475|9911203|P1|Overall Study|Protocol Violation|1
2880241|NCT01970475|9911202|P2|Overall Study|Lost to Follow-up|2
2880242|NCT01970475|9911203|P1|Overall Study|Lost to Follow-up|2
2880243|NCT01970475|9911202|P2|Overall Study|Adverse Event|3
2880244|NCT01970475|9911203|P1|Overall Study|Adverse Event|7
2880245|NCT01970475|9911202|P2|Overall Study|Withdrawal by Subject|6
2880246|NCT01970475|9911203|P1|Overall Study|Withdrawal by Subject|11
2880247|NCT01970462|9911223|P2|Overall Study|Lost to Follow-up|2
2880248|NCT01970462|9911224|P1|Overall Study|Lost to Follow-up|0
2880249|NCT01970397|9911238|P2|Overall Study|Protocol Violation|1
2880250|NCT01970397|9911239|P1|Overall Study|Protocol Violation|1
2880251|NCT01970397|9911238|P2|Overall Study|Personal Reasons|2
2880252|NCT01970397|9911239|P1|Overall Study|Personal Reasons|1
2880253|NCT01970397|9911238|P2|Overall Study|Lost to Follow-up|1
2880254|NCT01970397|9911239|P1|Overall Study|Lost to Follow-up|0
2880255|NCT01970397|9911238|P2|Overall Study|Adverse Event|1
2880256|NCT01970397|9911239|P1|Overall Study|Adverse Event|0
2880257|NCT01970371|9911252|P3|Overall Study|Lost to Follow-up|1
2880258|NCT01970371|9911253|P2|Overall Study|Lost to Follow-up|0
2880259|NCT01970371|9911254|P1|Overall Study|Lost to Follow-up|0
2880260|NCT01970371|9911252|P3|Overall Study|Death|12
2880261|NCT01970371|9911253|P2|Overall Study|Death|13
2880262|NCT01970371|9911254|P1|Overall Study|Death|8
2880263|NCT01970241|9911279|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
2880264|NCT01970241|9911280|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
2880265|NCT01970241|9911279|P2|Overall Study|Withdrawal by Subject|0
2880266|NCT01970241|9911280|P1|Overall Study|Withdrawal by Subject|2
2880267|NCT01969851|9911327|P3|Overall Study|Sponsor decision|1
2880268|NCT01969851|9911328|P2|Overall Study|Sponsor decision|0
2880269|NCT01969851|9911329|P1|Overall Study|Sponsor decision|0
2880270|NCT01969851|9911327|P3|Overall Study|No effective dose in Titration period|1
2880271|NCT01969851|9911328|P2|Overall Study|No effective dose in Titration period|0
2880272|NCT01969851|9911329|P1|Overall Study|No effective dose in Titration period|0
2880273|NCT01969851|9911327|P3|Overall Study|Withdrawal by Subject|1
2880274|NCT01969851|9911328|P2|Overall Study|Withdrawal by Subject|0
2880275|NCT01969851|9911329|P1|Overall Study|Withdrawal by Subject|1
2880276|NCT01969851|9911327|P3|Overall Study|Lack of Efficacy|1
2880277|NCT01969851|9911328|P2|Overall Study|Lack of Efficacy|3
2880278|NCT01969851|9911329|P1|Overall Study|Lack of Efficacy|0
2880279|NCT01969851|9911327|P3|Overall Study|Adverse Event|3
2880280|NCT01969851|9911328|P2|Overall Study|Adverse Event|0
2880281|NCT01969851|9911329|P1|Overall Study|Adverse Event|0
2880282|NCT01969799|9911351|P2|Overall Study|Physician Decision|0
2880283|NCT01969799|9911352|P1|Overall Study|Physician Decision|1
2880284|NCT01969799|9911351|P2|Overall Study|Lost to Follow-up|2
2880285|NCT01969799|9911352|P1|Overall Study|Lost to Follow-up|0
2880286|NCT01969799|9911351|P2|Overall Study|Death|11
2880287|NCT01969799|9911352|P1|Overall Study|Death|16
2880288|NCT01969799|9911351|P2|Overall Study|Adverse Event|1
2880289|NCT01969799|9911352|P1|Overall Study|Adverse Event|0
2880290|NCT01969721|9911389|P4|Overall Study|Discontinued during washout periods.|2
2880291|NCT01969721|9911390|P3|Overall Study|Discontinued during washout periods.|1
2880292|NCT01969721|9911391|P2|Overall Study|Discontinued during washout periods.|1
2880293|NCT01969721|9911392|P1|Overall Study|Discontinued during washout periods.|0
2880294|NCT01969721|9911389|P4|Overall Study|Other not defined above|0
2880295|NCT01969721|9911390|P3|Overall Study|Other not defined above|0
2880296|NCT01969721|9911391|P2|Overall Study|Other not defined above|2
2880297|NCT01969721|9911392|P1|Overall Study|Other not defined above|0
2880298|NCT01969721|9911389|P4|Overall Study|Non compliant with protocol|2
2880299|NCT01969721|9911390|P3|Overall Study|Non compliant with protocol|0
2880300|NCT01969721|9911391|P2|Overall Study|Non compliant with protocol|1
2880301|NCT01969721|9911392|P1|Overall Study|Non compliant with protocol|1
2880302|NCT01969721|9911389|P4|Overall Study|Lack of Efficacy|0
2880303|NCT01969721|9911390|P3|Overall Study|Lack of Efficacy|1
2880304|NCT01969721|9911391|P2|Overall Study|Lack of Efficacy|0
2880305|NCT01969721|9911392|P1|Overall Study|Lack of Efficacy|0
2880306|NCT01969721|9911389|P4|Overall Study|Adverse Event|2
2880307|NCT01969721|9911390|P3|Overall Study|Adverse Event|3
2880308|NCT01969721|9911391|P2|Overall Study|Adverse Event|8
2880309|NCT01969721|9911392|P1|Overall Study|Adverse Event|3
2880310|NCT01969565|9911437|P1|Overall Study|Withdrawal by Subject|1
2880311|NCT01969500|9911451|P2|Overall Study|extended hospitalization|1
2880312|NCT01969500|9911452|P1|Overall Study|extended hospitalization|1
2880313|NCT01969500|9911451|P2|Overall Study|Death|1
2880314|NCT01969500|9911452|P1|Overall Study|Death|0
2880315|NCT01969084|9911573|P2|Overall Study|Adverse Event|1
2880316|NCT01969084|9911574|P1|Overall Study|Adverse Event|0
2880317|NCT01969058|9911590|P2|Overall Study|Adverse Event|0
2880318|NCT01969058|9911591|P1|Overall Study|Adverse Event|1
2880319|NCT01969058|9911590|P2|Overall Study|Withdrawal by Subject|0
2880320|NCT01969058|9911591|P1|Overall Study|Withdrawal by Subject|2
2880321|NCT01968980|9911635|P2|Overall Study|Other unspecified|2
2880322|NCT01968980|9911636|P1|Overall Study|Other unspecified|1
2880323|NCT01968980|9911635|P2|Overall Study|Withdrawal by Subject|5
2880324|NCT01968980|9911636|P1|Overall Study|Withdrawal by Subject|13
2880325|NCT01968980|9911635|P2|Overall Study|Does not meet entry criteria|3
2880326|NCT01968980|9911636|P1|Overall Study|Does not meet entry criteria|1
2880327|NCT01968980|9911635|P2|Overall Study|Adverse Event|3
2880328|NCT01968980|9911636|P1|Overall Study|Adverse Event|1
2880329|NCT01968980|9911635|P2|Overall Study|Death|1
2880330|NCT01968980|9911636|P1|Overall Study|Death|0
2880331|NCT01968967|9911698|P5|Extension Period|Withdrew Consent|5
2880332|NCT01968967|9911699|P4|Extension Period|Withdrew Consent|0
2880333|NCT01968967|9911700|P3|Extension Period|Withdrew Consent|2
2880334|NCT01968967|9911701|P2|Extension Period|Withdrew Consent|0
2880335|NCT01968967|9911702|P1|Extension Period|Withdrew Consent|0
2880336|NCT01968967|9911698|P5|Treatment Period|Randomized Not Treated|0
2880337|NCT01968967|9911699|P4|Treatment Period|Randomized Not Treated|0
2880338|NCT01968967|9911700|P3|Treatment Period|Randomized Not Treated|0
2880339|NCT01968967|9911701|P2|Treatment Period|Randomized Not Treated|5
2880340|NCT01968967|9911702|P1|Treatment Period|Randomized Not Treated|6
2880341|NCT01968967|9911698|P5|Treatment Period|Death|0
2880342|NCT01968967|9911699|P4|Treatment Period|Death|0
2880343|NCT01968967|9911700|P3|Treatment Period|Death|0
2880344|NCT01968967|9911701|P2|Treatment Period|Death|2
2880345|NCT01968967|9911702|P1|Treatment Period|Death|9
2880346|NCT01968967|9911698|P5|Treatment Period|Adverse Event|0
2880347|NCT01968967|9911699|P4|Treatment Period|Adverse Event|0
2880348|NCT01968967|9911700|P3|Treatment Period|Adverse Event|0
2880349|NCT01968967|9911701|P2|Treatment Period|Adverse Event|8
2880350|NCT01968967|9911702|P1|Treatment Period|Adverse Event|9
2880351|NCT01968967|9911698|P5|Treatment Period|Protocol Violation|0
2880352|NCT01968967|9911699|P4|Treatment Period|Protocol Violation|0
2880353|NCT01968967|9911700|P3|Treatment Period|Protocol Violation|0
2880354|NCT01968967|9911701|P2|Treatment Period|Protocol Violation|2
2880355|NCT01968967|9911702|P1|Treatment Period|Protocol Violation|1
2880356|NCT01968967|9911698|P5|Treatment Period|Lost to Follow-up|0
2880357|NCT01968967|9911699|P4|Treatment Period|Lost to Follow-up|0
2880358|NCT01968967|9911700|P3|Treatment Period|Lost to Follow-up|0
2880359|NCT01968967|9911701|P2|Treatment Period|Lost to Follow-up|31
2880360|NCT01968967|9911702|P1|Treatment Period|Lost to Follow-up|26
2880361|NCT01968967|9911698|P5|Treatment Period|Did Not Meet Entrance Criteria|0
2880362|NCT01968967|9911699|P4|Treatment Period|Did Not Meet Entrance Criteria|0
2880363|NCT01968967|9911700|P3|Treatment Period|Did Not Meet Entrance Criteria|0
2880364|NCT01968967|9911701|P2|Treatment Period|Did Not Meet Entrance Criteria|3
2880365|NCT01968967|9911702|P1|Treatment Period|Did Not Meet Entrance Criteria|2
2880366|NCT01968967|9911698|P5|Treatment Period|Withdrawal by Subject|0
2880367|NCT01968967|9911699|P4|Treatment Period|Withdrawal by Subject|0
2880368|NCT01968967|9911700|P3|Treatment Period|Withdrawal by Subject|0
2880369|NCT01968967|9911701|P2|Treatment Period|Withdrawal by Subject|61
2880370|NCT01968967|9911702|P1|Treatment Period|Withdrawal by Subject|71
2880371|NCT01968967|9911698|P5|Treatment Period|Other|0
2880372|NCT01968967|9911699|P4|Treatment Period|Other|0
2880373|NCT01968967|9911700|P3|Treatment Period|Other|0
2880374|NCT01968967|9911701|P2|Treatment Period|Other|22
2880375|NCT01968967|9911702|P1|Treatment Period|Other|22
2880376|NCT01968954|9911771|P2|Overall Study|Did not met inclusion criteria|2
2880377|NCT01968954|9911772|P1|Overall Study|Did not met inclusion criteria|0
2880378|NCT01968954|9911771|P2|Overall Study|Protocol Violation|1
2880379|NCT01968954|9911772|P1|Overall Study|Protocol Violation|0
2880380|NCT01968954|9911771|P2|Overall Study|Other|8
2880381|NCT01968954|9911772|P1|Overall Study|Other|7
2880382|NCT01968954|9911771|P2|Overall Study|Withdrawal by Subject|23
2880383|NCT01968954|9911772|P1|Overall Study|Withdrawal by Subject|20
2880384|NCT01968954|9911771|P2|Overall Study|Lost to Follow-up|4
2880385|NCT01968954|9911772|P1|Overall Study|Lost to Follow-up|6
2880386|NCT01968954|9911771|P2|Overall Study|Death|2
2880387|NCT01968954|9911772|P1|Overall Study|Death|1
2880388|NCT01968954|9911771|P2|Overall Study|Adverse Event|3
2880389|NCT01968954|9911772|P1|Overall Study|Adverse Event|6
2880390|NCT01968811|9911836|P1|Overall Study|post op.ref. of subject to other hospita|1
2880391|NCT01968811|9911836|P1|Overall Study|Protocol Violation|4
2880392|NCT01968694|9911843|P2|Washout (1 Month)|Lost to Follow-up|1
2880393|NCT01968694|9911844|P1|Washout (1 Month)|Lost to Follow-up|0
2880394|NCT01968551|9911861|P3|Extension Phase|Lost to Follow-up|1
2880395|NCT01968551|9911862|P2|Extension Phase|Lost to Follow-up|0
2880396|NCT01968551|9911863|P1|Extension Phase|Lost to Follow-up|1
2880397|NCT01968551|9911861|P3|Extension Phase|Withdrew Consent|1
2880398|NCT01968551|9911862|P2|Extension Phase|Withdrew Consent|0
2880399|NCT01968551|9911863|P1|Extension Phase|Withdrew Consent|0
2880400|NCT01968551|9911861|P3|Extension Phase|Death|0
2880401|NCT01968551|9911862|P2|Extension Phase|Death|1
2880402|NCT01968551|9911863|P1|Extension Phase|Death|0
2880403|NCT01968551|9911861|P3|Extension Phase|Adverse Event|2
2880404|NCT01968551|9911862|P2|Extension Phase|Adverse Event|0
2880405|NCT01968551|9911863|P1|Extension Phase|Adverse Event|0
2880406|NCT01968551|9911861|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
2880407|NCT01968551|9911862|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2880408|NCT01968551|9911863|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2880409|NCT01968551|9911861|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
2880410|NCT01968551|9911862|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
2880411|NCT01968551|9911863|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
2880412|NCT01968551|9911861|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
2880413|NCT01968551|9911862|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
2880414|NCT01968551|9911863|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
2880415|NCT01968551|9911861|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
2880416|NCT01968551|9911862|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2880417|NCT01968551|9911863|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2880418|NCT01968434|9911900|P2|Overall Study|Lost to Follow-up|6
2880419|NCT01968434|9911901|P1|Overall Study|Lost to Follow-up|3
2880420|NCT01968226|9911969|P1|Overall Study|[F-18] RDG-K5 was not available|2
2880421|NCT01968213|9911975|P2|Overall Study|Ongoing|9
2880422|NCT01968213|9911976|P1|Overall Study|Ongoing|90
2880423|NCT01968070|9912018|P18|Period 2|Withdrawal by Subject|0
2880424|NCT01968070|9912019|P17|Period 2|Withdrawal by Subject|0
2880425|NCT01968070|9912020|P16|Period 2|Withdrawal by Subject|0
2880426|NCT01968070|9912021|P15|Period 2|Withdrawal by Subject|0
2880427|NCT01968070|9912022|P14|Period 2|Withdrawal by Subject|0
2880428|NCT01968070|9912023|P13|Period 2|Withdrawal by Subject|0
2880429|NCT01968070|9912024|P12|Period 2|Withdrawal by Subject|0
2880430|NCT01968070|9912025|P11|Period 2|Withdrawal by Subject|0
2880431|NCT01968070|9912026|P10|Period 2|Withdrawal by Subject|0
2880432|NCT01968070|9912027|P9|Period 2|Withdrawal by Subject|0
2880433|NCT01968070|9912028|P8|Period 2|Withdrawal by Subject|0
2880434|NCT01968070|9912029|P7|Period 2|Withdrawal by Subject|0
2880435|NCT01968070|9912030|P6|Period 2|Withdrawal by Subject|0
2880436|NCT01968070|9912031|P5|Period 2|Withdrawal by Subject|1
2880437|NCT01968070|9912032|P4|Period 2|Withdrawal by Subject|0
2880438|NCT01968070|9912033|P3|Period 2|Withdrawal by Subject|0
2880439|NCT01968070|9912034|P2|Period 2|Withdrawal by Subject|0
2880440|NCT01968070|9912035|P1|Period 2|Withdrawal by Subject|0
2880441|NCT01968070|9912018|P18|Period 1|Physician Decision|0
2880442|NCT01968070|9912019|P17|Period 1|Physician Decision|0
2880443|NCT01968070|9912020|P16|Period 1|Physician Decision|0
2880444|NCT01968070|9912021|P15|Period 1|Physician Decision|0
2880445|NCT01968070|9912022|P14|Period 1|Physician Decision|0
2880446|NCT01968070|9912023|P13|Period 1|Physician Decision|0
2880447|NCT01968070|9912024|P12|Period 1|Physician Decision|1
2880448|NCT01968070|9912025|P11|Period 1|Physician Decision|0
2880449|NCT01968070|9912026|P10|Period 1|Physician Decision|0
2880450|NCT01968070|9912027|P9|Period 1|Physician Decision|0
2880451|NCT01968070|9912028|P8|Period 1|Physician Decision|0
2880452|NCT01968070|9912029|P7|Period 1|Physician Decision|0
2880453|NCT01968070|9912030|P6|Period 1|Physician Decision|0
2880454|NCT01968070|9912031|P5|Period 1|Physician Decision|0
2880455|NCT01968070|9912032|P4|Period 1|Physician Decision|0
2880456|NCT01968070|9912033|P3|Period 1|Physician Decision|0
2880457|NCT01968070|9912034|P2|Period 1|Physician Decision|0
2880458|NCT01968070|9912035|P1|Period 1|Physician Decision|0
2880459|NCT01968070|9912018|P18|Period 1|Adverse Event|0
2880460|NCT01968070|9912019|P17|Period 1|Adverse Event|0
2880461|NCT01968070|9912020|P16|Period 1|Adverse Event|0
2880462|NCT01968070|9912021|P15|Period 1|Adverse Event|0
2880463|NCT01968070|9912022|P14|Period 1|Adverse Event|0
2880464|NCT01968070|9912023|P13|Period 1|Adverse Event|0
2880465|NCT01968070|9912024|P12|Period 1|Adverse Event|0
2880466|NCT01968070|9912025|P11|Period 1|Adverse Event|0
2880467|NCT01968070|9912026|P10|Period 1|Adverse Event|0
2880468|NCT01968070|9912027|P9|Period 1|Adverse Event|0
2880469|NCT01968070|9912028|P8|Period 1|Adverse Event|0
2880470|NCT01968070|9912029|P7|Period 1|Adverse Event|1
2880471|NCT01968070|9912030|P6|Period 1|Adverse Event|0
2880472|NCT01968070|9912031|P5|Period 1|Adverse Event|0
2880473|NCT01968070|9912032|P4|Period 1|Adverse Event|0
2880474|NCT01968070|9912033|P3|Period 1|Adverse Event|0
2880475|NCT01968070|9912034|P2|Period 1|Adverse Event|0
2880476|NCT01968070|9912035|P1|Period 1|Adverse Event|0
2880477|NCT01968070|9912018|P18|Period 1|Lost to Follow-up|0
2880478|NCT01968070|9912019|P17|Period 1|Lost to Follow-up|0
2880479|NCT01968070|9912020|P16|Period 1|Lost to Follow-up|0
2880480|NCT01968070|9912021|P15|Period 1|Lost to Follow-up|0
2880481|NCT01968070|9912022|P14|Period 1|Lost to Follow-up|0
2880482|NCT01968070|9912023|P13|Period 1|Lost to Follow-up|0
2880483|NCT01968070|9912024|P12|Period 1|Lost to Follow-up|0
2880484|NCT01968070|9912025|P11|Period 1|Lost to Follow-up|0
2880485|NCT01968070|9912026|P10|Period 1|Lost to Follow-up|0
2880486|NCT01968070|9912027|P9|Period 1|Lost to Follow-up|0
2880487|NCT01968070|9912028|P8|Period 1|Lost to Follow-up|0
2880488|NCT01968070|9912029|P7|Period 1|Lost to Follow-up|0
2880489|NCT01968070|9912030|P6|Period 1|Lost to Follow-up|0
2880490|NCT01968070|9912031|P5|Period 1|Lost to Follow-up|0
2880491|NCT01968070|9912032|P4|Period 1|Lost to Follow-up|1
2880492|NCT01968070|9912033|P3|Period 1|Lost to Follow-up|0
2880493|NCT01968070|9912034|P2|Period 1|Lost to Follow-up|0
2880494|NCT01968070|9912035|P1|Period 1|Lost to Follow-up|0
2880495|NCT01968070|9912018|P18|Period 1|Protocol Violation|0
2880496|NCT01968070|9912019|P17|Period 1|Protocol Violation|0
2880497|NCT01968070|9912020|P16|Period 1|Protocol Violation|0
2880498|NCT01968070|9912021|P15|Period 1|Protocol Violation|0
2880499|NCT01968070|9912022|P14|Period 1|Protocol Violation|0
2880500|NCT01968070|9912023|P13|Period 1|Protocol Violation|0
2880501|NCT01968070|9912024|P12|Period 1|Protocol Violation|0
2880502|NCT01968070|9912025|P11|Period 1|Protocol Violation|0
2880503|NCT01968070|9912026|P10|Period 1|Protocol Violation|0
2880504|NCT01968070|9912027|P9|Period 1|Protocol Violation|0
2880505|NCT01968070|9912028|P8|Period 1|Protocol Violation|0
2880506|NCT01968070|9912029|P7|Period 1|Protocol Violation|0
2880507|NCT01968070|9912030|P6|Period 1|Protocol Violation|0
2880508|NCT01968070|9912031|P5|Period 1|Protocol Violation|1
2880509|NCT01968070|9912032|P4|Period 1|Protocol Violation|1
2880510|NCT01968070|9912033|P3|Period 1|Protocol Violation|0
2880511|NCT01968070|9912034|P2|Period 1|Protocol Violation|0
2880512|NCT01968070|9912035|P1|Period 1|Protocol Violation|0
2880513|NCT01968070|9912018|P18|Period 1|Withdrawal by Subject|0
2880514|NCT01968070|9912019|P17|Period 1|Withdrawal by Subject|0
2880515|NCT01968070|9912020|P16|Period 1|Withdrawal by Subject|1
2880516|NCT01968070|9912021|P15|Period 1|Withdrawal by Subject|0
2880517|NCT01968070|9912022|P14|Period 1|Withdrawal by Subject|0
2880518|NCT01968070|9912023|P13|Period 1|Withdrawal by Subject|0
2880519|NCT01968070|9912024|P12|Period 1|Withdrawal by Subject|0
2880520|NCT01968070|9912025|P11|Period 1|Withdrawal by Subject|0
2880521|NCT01968070|9912026|P10|Period 1|Withdrawal by Subject|0
2880522|NCT01968070|9912027|P9|Period 1|Withdrawal by Subject|0
2880523|NCT01968070|9912028|P8|Period 1|Withdrawal by Subject|0
2880524|NCT01968070|9912029|P7|Period 1|Withdrawal by Subject|1
2880525|NCT01968070|9912030|P6|Period 1|Withdrawal by Subject|0
2880526|NCT01968070|9912031|P5|Period 1|Withdrawal by Subject|0
2880527|NCT01968070|9912032|P4|Period 1|Withdrawal by Subject|0
2880528|NCT01968070|9912033|P3|Period 1|Withdrawal by Subject|0
2880529|NCT01968070|9912034|P2|Period 1|Withdrawal by Subject|1
2880530|NCT01968070|9912035|P1|Period 1|Withdrawal by Subject|0
2880531|NCT01967940|9912106|P4|Part 2|Unknown Reason|1
2880532|NCT01967940|9912107|P3|Part 2|Unknown Reason|0
2880533|NCT01967940|9912108|P2|Part 2|Unknown Reason|0
2880534|NCT01967940|9912109|P1|Part 2|Unknown Reason|0
2880535|NCT01967940|9912106|P4|Part 2|Adverse Event|1
2880536|NCT01967940|9912107|P3|Part 2|Adverse Event|0
2880537|NCT01967940|9912108|P2|Part 2|Adverse Event|0
2880538|NCT01967940|9912109|P1|Part 2|Adverse Event|0
2880539|NCT01967940|9912106|P4|Part 2|Enrolled in Part 2 and Never Treated|1
2880540|NCT01967940|9912107|P3|Part 2|Enrolled in Part 2 and Never Treated|0
2880541|NCT01967940|9912108|P2|Part 2|Enrolled in Part 2 and Never Treated|0
2880542|NCT01967940|9912109|P1|Part 2|Enrolled in Part 2 and Never Treated|0
2880543|NCT01967888|9912137|P2|Overall Study|Subject Unable To Comply With Final Day|1
2880544|NCT01967888|9912138|P1|Overall Study|Subject Unable To Comply With Final Day|0
2880545|NCT01967888|9912137|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
2880546|NCT01967888|9912138|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
2880547|NCT01967888|9912137|P2|Overall Study|Subject excluded after randomization|0
2880548|NCT01967888|9912138|P1|Overall Study|Subject excluded after randomization|1
2880549|NCT01967888|9912137|P2|Overall Study|Research visit not done, data recorded|0
2880550|NCT01967888|9912138|P1|Overall Study|Research visit not done, data recorded|1
2880551|NCT01967888|9912137|P2|Overall Study|Did Not Have Transplant|0
2880552|NCT01967888|9912138|P1|Overall Study|Did Not Have Transplant|1
2880553|NCT01967888|9912137|P2|Overall Study|Withdrawal by Subject|1
2880554|NCT01967888|9912138|P1|Overall Study|Withdrawal by Subject|1
2880555|NCT01967888|9912137|P2|Overall Study|Lost to Follow-up|4
2880556|NCT01967888|9912138|P1|Overall Study|Lost to Follow-up|6
2880557|NCT01967732|9912222|P4|First Intervention (Day 1)|Poor venous access|0
2880558|NCT01967732|9912223|P3|First Intervention (Day 1)|Poor venous access|0
2880559|NCT01967732|9912224|P2|First Intervention (Day 1)|Poor venous access|1
2880560|NCT01967732|9912225|P1|First Intervention (Day 1)|Poor venous access|0
2880561|NCT01967732|9912222|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2880562|NCT01967732|9912223|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2880563|NCT01967732|9912224|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
2880564|NCT01967732|9912225|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2880565|NCT01967719|9912239|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
2880566|NCT01967719|9912240|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
2880567|NCT01967719|9912241|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
2880568|NCT01967719|9912242|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
2880569|NCT01967719|9912239|P4|First Intervention (Day 1)|Withdrawal by Subject|1
2880570|NCT01967719|9912240|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2880571|NCT01967719|9912241|P2|First Intervention (Day 1)|Withdrawal by Subject|1
2880572|NCT01967719|9912242|P1|First Intervention (Day 1)|Withdrawal by Subject|0
2880573|NCT01967706|9912257|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2880574|NCT01967706|9912258|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2880575|NCT01967706|9912259|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2880576|NCT01967706|9912260|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2880577|NCT01967628|9912281|P2|Overall Study|Low protein concentration in sample|25
2880578|NCT01967628|9912282|P1|Overall Study|Low protein concentration in sample|20
2880579|NCT01967628|9912281|P2|Overall Study|Lost to Follow-up|0
2880580|NCT01967628|9912282|P1|Overall Study|Lost to Follow-up|1
2880581|NCT01967628|9912281|P2|Overall Study|Unable to complete bronchoscopy|6
2880582|NCT01967628|9912282|P1|Overall Study|Unable to complete bronchoscopy|4
2880583|NCT01967628|9912281|P2|Overall Study|Withdrawal by Subject|0
2880584|NCT01967628|9912282|P1|Overall Study|Withdrawal by Subject|2
2880585|NCT01967550|9912290|P2|Overall Study|Non Compliance|1
2880586|NCT01967550|9912291|P1|Overall Study|Non Compliance|0
2880587|NCT01967550|9912290|P2|Overall Study|Protocol Violation|1
2880588|NCT01967550|9912291|P1|Overall Study|Protocol Violation|2
2880589|NCT01967550|9912290|P2|Overall Study|Adverse Event|0
2880590|NCT01967550|9912291|P1|Overall Study|Adverse Event|2
2880591|NCT01967550|9912290|P2|Overall Study|Withdrawal by Subject|0
2880592|NCT01967550|9912291|P1|Overall Study|Withdrawal by Subject|1
2880593|NCT01967537|9912297|P1|Overall Study|Lost to Follow-up|6
2880594|NCT01967537|9912297|P1|Overall Study|Refuse treatment|2
2880595|NCT01967537|9912297|P1|Overall Study|Withdrawal by Subject|52
2880596|NCT01967277|9912351|P2|Overall Study|Unrelated illness|1
2880597|NCT01967277|9912352|P1|Overall Study|Unrelated illness|0
2880598|NCT01967277|9912351|P2|Overall Study|Lost to Follow-up|2
2880599|NCT01967277|9912352|P1|Overall Study|Lost to Follow-up|1
2880600|NCT01967225|9912364|P2|Overall Study|Protocol Violation|0
2880601|NCT01967225|9912365|P1|Overall Study|Protocol Violation|2
2880602|NCT01967225|9912364|P2|Overall Study|Logistical difficulties|0
2880603|NCT01967225|9912365|P1|Overall Study|Logistical difficulties|1
2880604|NCT01967225|9912364|P2|Overall Study|Protocol driven decision point|0
2880605|NCT01967225|9912365|P1|Overall Study|Protocol driven decision point|1
2880606|NCT01967225|9912364|P2|Overall Study|Switching to other therapy|0
2880607|NCT01967225|9912365|P1|Overall Study|Switching to other therapy|2
2880608|NCT01967225|9912364|P2|Overall Study|Lack of Efficacy|1
2880609|NCT01967225|9912365|P1|Overall Study|Lack of Efficacy|1
2880610|NCT01967225|9912364|P2|Overall Study|Withdrawal by Subject|1
2880611|NCT01967225|9912365|P1|Overall Study|Withdrawal by Subject|2
2880612|NCT01967225|9912364|P2|Overall Study|Adverse Event|1
2880613|NCT01967225|9912365|P1|Overall Study|Adverse Event|3
2880614|NCT01967173|9912397|P8|Overall Study|Withdrawal by Subject|12
2880615|NCT01967173|9912398|P7|Overall Study|Withdrawal by Subject|10
2880616|NCT01967173|9912399|P6|Overall Study|Withdrawal by Subject|9
2880617|NCT01967173|9912400|P5|Overall Study|Withdrawal by Subject|8
2880618|NCT01967173|9912401|P4|Overall Study|Withdrawal by Subject|7
2880619|NCT01967173|9912402|P3|Overall Study|Withdrawal by Subject|10
2880620|NCT01967173|9912403|P2|Overall Study|Withdrawal by Subject|14
2880621|NCT01967173|9912404|P1|Overall Study|Withdrawal by Subject|15
2880622|NCT01967173|9912397|P8|Overall Study|Adverse Event|1
2880623|NCT01967173|9912398|P7|Overall Study|Adverse Event|0
2880624|NCT01967173|9912399|P6|Overall Study|Adverse Event|0
2880625|NCT01967173|9912400|P5|Overall Study|Adverse Event|0
2880626|NCT01967173|9912401|P4|Overall Study|Adverse Event|0
2880627|NCT01967173|9912402|P3|Overall Study|Adverse Event|0
2880628|NCT01967173|9912403|P2|Overall Study|Adverse Event|0
2880629|NCT01967173|9912404|P1|Overall Study|Adverse Event|0
2880630|NCT01967173|9912397|P8|Overall Study|Pregnancy|1
2880631|NCT01967173|9912398|P7|Overall Study|Pregnancy|1
2880632|NCT01967173|9912399|P6|Overall Study|Pregnancy|0
2880633|NCT01967173|9912400|P5|Overall Study|Pregnancy|0
2880634|NCT01967173|9912401|P4|Overall Study|Pregnancy|0
2880635|NCT01967173|9912402|P3|Overall Study|Pregnancy|0
2880636|NCT01967173|9912403|P2|Overall Study|Pregnancy|0
2880637|NCT01967173|9912404|P1|Overall Study|Pregnancy|0
2880638|NCT01967173|9912397|P8|Overall Study|Lack of Efficacy|2
2880639|NCT01967173|9912398|P7|Overall Study|Lack of Efficacy|0
2880640|NCT01967173|9912399|P6|Overall Study|Lack of Efficacy|1
2880641|NCT01967173|9912400|P5|Overall Study|Lack of Efficacy|0
2880642|NCT01967173|9912401|P4|Overall Study|Lack of Efficacy|2
2880643|NCT01967173|9912402|P3|Overall Study|Lack of Efficacy|2
2880644|NCT01967173|9912403|P2|Overall Study|Lack of Efficacy|0
2880645|NCT01967173|9912404|P1|Overall Study|Lack of Efficacy|2
2880646|NCT01967173|9912397|P8|Overall Study|Physician Decision|0
2880647|NCT01967173|9912398|P7|Overall Study|Physician Decision|1
2880648|NCT01967173|9912399|P6|Overall Study|Physician Decision|1
2880649|NCT01967173|9912400|P5|Overall Study|Physician Decision|1
2880650|NCT01967173|9912401|P4|Overall Study|Physician Decision|1
2880651|NCT01967173|9912402|P3|Overall Study|Physician Decision|2
2880652|NCT01967173|9912403|P2|Overall Study|Physician Decision|0
2880653|NCT01967173|9912404|P1|Overall Study|Physician Decision|2
2880654|NCT01967173|9912397|P8|Overall Study|Lost to Follow-up|8
2880655|NCT01967173|9912398|P7|Overall Study|Lost to Follow-up|6
2880656|NCT01967173|9912399|P6|Overall Study|Lost to Follow-up|12
2880657|NCT01967173|9912400|P5|Overall Study|Lost to Follow-up|8
2880658|NCT01967173|9912401|P4|Overall Study|Lost to Follow-up|4
2880659|NCT01967173|9912402|P3|Overall Study|Lost to Follow-up|2
2880660|NCT01967173|9912403|P2|Overall Study|Lost to Follow-up|3
2880661|NCT01967173|9912404|P1|Overall Study|Lost to Follow-up|5
2880662|NCT01967147|9912418|P2|Overall Study|Other|5
2880663|NCT01967147|9912419|P1|Overall Study|Other|4
2880664|NCT01967147|9912418|P2|Overall Study|Non-compliance with Study Drug|3
2880665|NCT01967147|9912419|P1|Overall Study|Non-compliance with Study Drug|0
2880666|NCT01967147|9912418|P2|Overall Study|Withdrawal by Subject|4
2880667|NCT01967147|9912419|P1|Overall Study|Withdrawal by Subject|2
2880668|NCT01967147|9912418|P2|Overall Study|Lost to Follow-up|2
2880669|NCT01967147|9912419|P1|Overall Study|Lost to Follow-up|1
2880670|NCT01967147|9912418|P2|Overall Study|Lack of Efficacy|4
2880671|NCT01967147|9912419|P1|Overall Study|Lack of Efficacy|1
2880672|NCT01967147|9912418|P2|Overall Study|Adverse Event|2
2880673|NCT01967147|9912419|P1|Overall Study|Adverse Event|5
2880674|NCT01967134|9912437|P3|Overall Study|Lost to Follow-up|0
2880675|NCT01967134|9912438|P2|Overall Study|Lost to Follow-up|1
2880676|NCT01967134|9912439|P1|Overall Study|Lost to Follow-up|0
2880677|NCT01967069|9912474|P2|Overall Study|Lack of Efficacy|1
2880678|NCT01967069|9912475|P1|Overall Study|Lack of Efficacy|0
2880679|NCT01967069|9912474|P2|Overall Study|Withdrawal by Subject|3
2880680|NCT01967069|9912475|P1|Overall Study|Withdrawal by Subject|1
2880681|NCT01967069|9912474|P2|Overall Study|Lost to Follow-up|2
2880682|NCT01967069|9912475|P1|Overall Study|Lost to Follow-up|5
2880683|NCT01967069|9912474|P2|Overall Study|Adverse Event|2
2880684|NCT01967069|9912475|P1|Overall Study|Adverse Event|2
2880685|NCT01966445|9912678|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
2880686|NCT01966445|9912679|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880687|NCT01966445|9912680|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880688|NCT01966445|9912681|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880689|NCT01966445|9912682|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880690|NCT01966445|9912683|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880691|NCT01966445|9912684|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2880692|NCT01966445|9912678|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
2880693|NCT01966445|9912679|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880694|NCT01966445|9912680|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880695|NCT01966445|9912681|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880696|NCT01966445|9912682|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880697|NCT01966445|9912683|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880698|NCT01966445|9912684|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2880699|NCT01966445|9912678|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2880700|NCT01966445|9912679|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2880701|NCT01966445|9912680|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
2880702|NCT01966445|9912681|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2880703|NCT01966445|9912682|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2880704|NCT01966445|9912683|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2880705|NCT01966445|9912684|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2880706|NCT01966445|9912678|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2880707|NCT01966445|9912679|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2880708|NCT01966445|9912680|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2880709|NCT01966445|9912681|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2880710|NCT01966445|9912682|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2880711|NCT01966445|9912683|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2880712|NCT01966445|9912684|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2880713|NCT01966445|9912678|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2880714|NCT01966445|9912679|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
2880715|NCT01966445|9912680|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2880716|NCT01966445|9912681|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
2880717|NCT01966445|9912682|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2880718|NCT01966445|9912683|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2880719|NCT01966445|9912684|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2880720|NCT01966432|9912794|P3|Overall Study|SBIRT program ended|20
2880721|NCT01966432|9912795|P2|Overall Study|SBIRT program ended|8
2880722|NCT01966432|9912796|P1|Overall Study|SBIRT program ended|1
2880723|NCT01966432|9912794|P3|Overall Study|Subject Incarcerated|1
2880724|NCT01966432|9912795|P2|Overall Study|Subject Incarcerated|0
2880725|NCT01966432|9912796|P1|Overall Study|Subject Incarcerated|0
2880726|NCT01966432|9912794|P3|Overall Study|Withdrawal by Subject|0
2880727|NCT01966432|9912795|P2|Overall Study|Withdrawal by Subject|3
2880728|NCT01966432|9912796|P1|Overall Study|Withdrawal by Subject|1
2880729|NCT01966432|9912794|P3|Overall Study|Lost to Follow-up|5
2880730|NCT01966432|9912795|P2|Overall Study|Lost to Follow-up|2
2880731|NCT01966432|9912796|P1|Overall Study|Lost to Follow-up|3
2880732|NCT01966120|9912866|P2|Overall Study|Lost to Follow-up|1
2880733|NCT01966120|9912867|P1|Overall Study|Lost to Follow-up|1
2880734|NCT01966120|9912866|P2|Overall Study|Withdrawal by Subject|5
2880735|NCT01966120|9912867|P1|Overall Study|Withdrawal by Subject|0
2880736|NCT01966107|9912891|P2|Overall Study|withdrew from the study|303
2880737|NCT01966107|9912892|P1|Overall Study|withdrew from the study|272
2880738|NCT01966107|9912891|P2|Overall Study|due to study closure|186
2880739|NCT01966107|9912892|P1|Overall Study|due to study closure|164
2880740|NCT01966107|9912891|P2|Overall Study|discontinued treatment|372
2880741|NCT01966107|9912892|P1|Overall Study|discontinued treatment|345
2880742|NCT01966107|9912891|P2|Overall Study|excluded from FAS|20
2880743|NCT01966107|9912892|P1|Overall Study|excluded from FAS|21
2880744|NCT01966068|9912906|P1|Overall Study|Lost to Follow-up|81
2880745|NCT01966068|9912906|P1|Overall Study|Withdrawal by Subject|57
2880746|NCT01966042|9912911|P1|Overall Study|Death|2
2880747|NCT01966003|9912920|P2|Overall Study|Other|1
2880748|NCT01966003|9912921|P1|Overall Study|Other|1
2880749|NCT01966003|9912920|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
2880750|NCT01966003|9912921|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
2880751|NCT01966003|9912920|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
2880752|NCT01966003|9912921|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
2880753|NCT01966003|9912920|P2|Overall Study|Withdrawal by Subject|19
2880754|NCT01966003|9912921|P1|Overall Study|Withdrawal by Subject|29
2880755|NCT01966003|9912920|P2|Overall Study|Physician Decision|13
2880756|NCT01966003|9912921|P1|Overall Study|Physician Decision|12
2880757|NCT01966003|9912920|P2|Overall Study|Lost to Follow-up|3
2880758|NCT01966003|9912921|P1|Overall Study|Lost to Follow-up|4
2880759|NCT01966003|9912920|P2|Overall Study|Protocol Violation|4
2880760|NCT01966003|9912921|P1|Overall Study|Protocol Violation|6
2880761|NCT01966003|9912920|P2|Overall Study|Death|36
2880762|NCT01966003|9912921|P1|Overall Study|Death|43
2880763|NCT01965938|9912939|P2|Overall Study|Withdrawal by Subject|0
2880764|NCT01965938|9912940|P1|Overall Study|Withdrawal by Subject|1
2880765|NCT01965834|9912971|P1|Overall Study|Lack of Efficacy|4
2880766|NCT01965652|9913012|P2|Overall Study|Pregnancy|1
2880767|NCT01965652|9913013|P1|Overall Study|Pregnancy|0
2880768|NCT01965652|9913012|P2|Overall Study|Other - Miscellaneous|21
2880769|NCT01965652|9913013|P1|Overall Study|Other - Miscellaneous|18
2880770|NCT01965652|9913012|P2|Overall Study|Death|4
2880771|NCT01965652|9913013|P1|Overall Study|Death|3
2880772|NCT01965652|9913012|P2|Overall Study|Protocol Violation|38
2880773|NCT01965652|9913013|P1|Overall Study|Protocol Violation|34
2880774|NCT01965652|9913012|P2|Overall Study|Lost to Follow-up|40
2880775|NCT01965652|9913013|P1|Overall Study|Lost to Follow-up|53
2880776|NCT01965652|9913012|P2|Overall Study|Withdrawal by Subject|69
2880777|NCT01965652|9913013|P1|Overall Study|Withdrawal by Subject|62
2880778|NCT01965652|9913012|P2|Overall Study|Adverse Event|37
2880779|NCT01965652|9913013|P1|Overall Study|Adverse Event|40
2880780|NCT01965600|9913043|P4|Second Intervention|Study terminated by Sponsor|2
2880781|NCT01965600|9913044|P3|Second Intervention|Study terminated by Sponsor|2
2880782|NCT01965600|9913045|P2|Second Intervention|Study terminated by Sponsor|0
2880783|NCT01965600|9913046|P1|Second Intervention|Study terminated by Sponsor|0
2880784|NCT01965600|9913043|P4|Washout Period of Approximately 15 Days|Adverse Event|1
2880785|NCT01965600|9913044|P3|Washout Period of Approximately 15 Days|Adverse Event|0
2880786|NCT01965600|9913045|P2|Washout Period of Approximately 15 Days|Adverse Event|0
2880787|NCT01965600|9913046|P1|Washout Period of Approximately 15 Days|Adverse Event|0
2880788|NCT01965600|9913043|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2880789|NCT01965600|9913044|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2880790|NCT01965600|9913045|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2880791|NCT01965600|9913046|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
2880792|NCT01965600|9913043|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2880793|NCT01965600|9913044|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2880794|NCT01965600|9913045|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
2880795|NCT01965600|9913046|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2880796|NCT01965600|9913043|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2880797|NCT01965600|9913044|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
2880798|NCT01965600|9913045|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
2880799|NCT01965600|9913046|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2880800|NCT01965535|9913103|P2|Overall Study|Lack of Efficacy|1
2880801|NCT01965535|9913104|P1|Overall Study|Lack of Efficacy|2
2880802|NCT01965431|9913118|P6|Overall Study|Other than stated above|6
2880803|NCT01965431|9913119|P5|Overall Study|Other than stated above|6
2880804|NCT01965431|9913120|P4|Overall Study|Other than stated above|6
2880805|NCT01965431|9913121|P3|Overall Study|Other than stated above|6
2880806|NCT01965431|9913122|P2|Overall Study|Other than stated above|5
2880807|NCT01965431|9913123|P1|Overall Study|Other than stated above|6
2880808|NCT01965431|9913118|P6|Overall Study|Adverse Event|0
2880809|NCT01965431|9913119|P5|Overall Study|Adverse Event|0
2880810|NCT01965431|9913120|P4|Overall Study|Adverse Event|0
2880811|NCT01965431|9913121|P3|Overall Study|Adverse Event|0
2880812|NCT01965431|9913122|P2|Overall Study|Adverse Event|1
2880813|NCT01965431|9913123|P1|Overall Study|Adverse Event|0
2880814|NCT01965327|9913147|P1|Overall Study|Physician Decision|2
2880815|NCT01965262|9913361|P2|Second Intervention (7 Days)|Poor visual acuity|0
2880816|NCT01965262|9913362|P1|Second Intervention (7 Days)|Poor visual acuity|1
2880817|NCT01965262|9913361|P2|Second Intervention (7 Days)|Poor lens fit|9
2880818|NCT01965262|9913362|P1|Second Intervention (7 Days)|Poor lens fit|0
2880819|NCT01965262|9913361|P2|Second Intervention (7 Days)|Discontinued|1
2880820|NCT01965262|9913362|P1|Second Intervention (7 Days)|Discontinued|0
2880821|NCT01965158|9913426|P2|Overall Study|Other - Miscellaneous|0
2880822|NCT01965158|9913427|P1|Overall Study|Other - Miscellaneous|3
2880823|NCT01965158|9913426|P2|Overall Study|Protocol Violation|1
2880824|NCT01965158|9913427|P1|Overall Study|Protocol Violation|1
2880825|NCT01965158|9913426|P2|Overall Study|Lost to Follow-up|5
2880826|NCT01965158|9913427|P1|Overall Study|Lost to Follow-up|7
2880827|NCT01965158|9913426|P2|Overall Study|Withdrawal by Subject|24
2880828|NCT01965158|9913427|P1|Overall Study|Withdrawal by Subject|16
2880829|NCT01965158|9913426|P2|Overall Study|Adverse Event|5
2880830|NCT01965158|9913427|P1|Overall Study|Adverse Event|14
2880831|NCT01964976|9913468|P1|Overall Study|Protocol Violation|31
2880832|NCT01964963|9913480|P1|Overall Study|Data Reliability was not Assured|5
2880833|NCT01964963|9913480|P1|Overall Study|Protocol Deviation|50
2880834|NCT01964963|9913480|P1|Overall Study|Case Report Forms Uncollected|888
2880835|NCT01964950|9913488|P1|Overall Study|Protocol Violation|25
2880836|NCT01964924|9913500|P2|Trametinib Monotherapy|Progression|0
2880837|NCT01964924|9913501|P1|Trametinib Monotherapy|Progression|19
2880838|NCT01964898|9913525|P2|Overall Study|Withdrawal by Subject|0
2880839|NCT01964898|9913526|P1|Overall Study|Withdrawal by Subject|1
2880840|NCT01964898|9913525|P2|Overall Study|Lost to Follow-up|5
2880841|NCT01964898|9913526|P1|Overall Study|Lost to Follow-up|3
2880842|NCT01964898|9913525|P2|Overall Study|did not receive the allocated interventi|1
2880843|NCT01964898|9913526|P1|Overall Study|did not receive the allocated interventi|2
2880844|NCT01964898|9913525|P2|Overall Study|ineligible post-randomization|1
2880845|NCT01964898|9913526|P1|Overall Study|ineligible post-randomization|1
2880846|NCT01964755|9913546|P1|Overall Study|Death|2
2880847|NCT01964716|9913561|P2|Overall Study|Death|0
2880848|NCT01964716|9913562|P1|Overall Study|Death|1
2880849|NCT01964716|9913561|P2|Overall Study|No longer met eligibility criteria|1
2880850|NCT01964716|9913562|P1|Overall Study|No longer met eligibility criteria|1
2880851|NCT01964716|9913561|P2|Overall Study|Lost to Follow-up|2
2880852|NCT01964716|9913562|P1|Overall Study|Lost to Follow-up|1
2880853|NCT01964716|9913561|P2|Overall Study|Withdrawal by Subject|3
2880854|NCT01964716|9913562|P1|Overall Study|Withdrawal by Subject|2
2880855|NCT01964547|9913600|P2|Overall Study|Withdrawal by Investigator|1
2880856|NCT01964547|9913601|P1|Overall Study|Withdrawal by Investigator|0
2880857|NCT01964547|9913600|P2|Overall Study|Lost to Follow-up|1
2880858|NCT01964547|9913601|P1|Overall Study|Lost to Follow-up|0
2880859|NCT01964547|9913600|P2|Overall Study|Withdrawal by Subject|7
2880860|NCT01964547|9913601|P1|Overall Study|Withdrawal by Subject|4
2880861|NCT01964547|9913600|P2|Overall Study|Adverse Event|2
2880862|NCT01964547|9913601|P1|Overall Study|Adverse Event|8
2880863|NCT01964521|9913625|P1|Overall Study|Lost to Follow-up|4
2880864|NCT01964430|9913632|P2|Overall Study|Randomized but not Treated|11
2880865|NCT01964430|9913633|P1|Overall Study|Randomized but not Treated|3
2880866|NCT01964430|9913632|P2|Overall Study|Miscellaneous|3
2880867|NCT01964430|9913633|P1|Overall Study|Miscellaneous|1
2880868|NCT01964430|9913632|P2|Overall Study|Disease Relapse|38
2880869|NCT01964430|9913633|P1|Overall Study|Disease Relapse|28
2880870|NCT01964430|9913632|P2|Overall Study|Physician Decision|4
2880871|NCT01964430|9913633|P1|Overall Study|Physician Decision|5
2880872|NCT01964430|9913632|P2|Overall Study|Protocol Deviation|1
2880873|NCT01964430|9913633|P1|Overall Study|Protocol Deviation|0
2880874|NCT01964430|9913632|P2|Overall Study|Death|3
2880875|NCT01964430|9913633|P1|Overall Study|Death|1
2880876|NCT01964430|9913632|P2|Overall Study|Withdrawal by Subject|27
2880877|NCT01964430|9913633|P1|Overall Study|Withdrawal by Subject|36
2880878|NCT01964430|9913632|P2|Overall Study|Adverse Event|37
2880879|NCT01964430|9913633|P1|Overall Study|Adverse Event|71
2880880|NCT01964378|9913645|P2|Overall Study|Other|2
2880881|NCT01964378|9913646|P1|Overall Study|Other|1
2880882|NCT01964378|9913645|P2|Overall Study|Inclusion/exclusion criteria not met|3
2880883|NCT01964378|9913646|P1|Overall Study|Inclusion/exclusion criteria not met|1
2880884|NCT01964378|9913645|P2|Overall Study|Withdrawal by Subject|5
2880885|NCT01964378|9913646|P1|Overall Study|Withdrawal by Subject|7
2880886|NCT01964378|9913645|P2|Overall Study|Lost to Follow-up|1
2880887|NCT01964378|9913646|P1|Overall Study|Lost to Follow-up|0
2880888|NCT01964378|9913645|P2|Overall Study|Protocol Violation|1
2880889|NCT01964378|9913646|P1|Overall Study|Protocol Violation|0
2880890|NCT01964378|9913645|P2|Overall Study|Lack of Efficacy|1
2880891|NCT01964378|9913646|P1|Overall Study|Lack of Efficacy|0
2880892|NCT01964378|9913645|P2|Overall Study|Adverse Event|5
2880893|NCT01964378|9913646|P1|Overall Study|Adverse Event|12
2880894|NCT01964378|9913645|P2|Overall Study|Death|2
2880895|NCT01964378|9913646|P1|Overall Study|Death|3
2880896|NCT01964378|9913645|P2|Overall Study|Disc. due to AE before first dosing|0
2880897|NCT01964378|9913646|P1|Overall Study|Disc. due to AE before first dosing|1
2880898|NCT01964378|9913645|P2|Overall Study|Disc. due to death before first dosing|1
2880899|NCT01964378|9913646|P1|Overall Study|Disc. due to death before first dosing|0
2880900|NCT01964352|9913682|P4|Overall Study|Other than stated above|2
2880901|NCT01964352|9913683|P3|Overall Study|Other than stated above|1
2880902|NCT01964352|9913684|P2|Overall Study|Other than stated above|2
2880903|NCT01964352|9913685|P1|Overall Study|Other than stated above|0
2880904|NCT01964352|9913682|P4|Overall Study|Withdrawal by Subject|0
2880905|NCT01964352|9913683|P3|Overall Study|Withdrawal by Subject|1
2880906|NCT01964352|9913684|P2|Overall Study|Withdrawal by Subject|2
2880907|NCT01964352|9913685|P1|Overall Study|Withdrawal by Subject|4
2880908|NCT01964352|9913682|P4|Overall Study|Lost to Follow-up|1
2880909|NCT01964352|9913683|P3|Overall Study|Lost to Follow-up|0
2880910|NCT01964352|9913684|P2|Overall Study|Lost to Follow-up|0
2880911|NCT01964352|9913685|P1|Overall Study|Lost to Follow-up|1
2880912|NCT01964352|9913682|P4|Overall Study|Protocol Violation|2
2880913|NCT01964352|9913683|P3|Overall Study|Protocol Violation|0
2880914|NCT01964352|9913684|P2|Overall Study|Protocol Violation|4
2880915|NCT01964352|9913685|P1|Overall Study|Protocol Violation|2
2880916|NCT01964352|9913682|P4|Overall Study|Lack of Efficacy|0
2880917|NCT01964352|9913683|P3|Overall Study|Lack of Efficacy|0
2880918|NCT01964352|9913684|P2|Overall Study|Lack of Efficacy|0
2880919|NCT01964352|9913685|P1|Overall Study|Lack of Efficacy|6
2880920|NCT01964352|9913682|P4|Overall Study|Adverse Event|3
2880921|NCT01964352|9913683|P3|Overall Study|Adverse Event|4
2880922|NCT01964352|9913684|P2|Overall Study|Adverse Event|3
2880923|NCT01964352|9913685|P1|Overall Study|Adverse Event|13
2880924|NCT01964326|9913715|P1|Overall Study|Did not meet eligibility criteria|1
2880925|NCT01964326|9913715|P1|Overall Study|Other|9
2880926|NCT01964326|9913715|P1|Overall Study|Investigator Discretion|1
2880927|NCT01964326|9913715|P1|Overall Study|Physician Decision|55
2880928|NCT01964326|9913715|P1|Overall Study|No Longer Meets Eligibility Criteria|1
2880929|NCT01964326|9913715|P1|Overall Study|Pregnancy|1
2880930|NCT01964326|9913715|P1|Overall Study|Withdrawal by Subject|87
2880931|NCT01964326|9913715|P1|Overall Study|Lost to Follow-up|88
2880932|NCT01964326|9913715|P1|Overall Study|Protocol Violation|4
2880933|NCT01964326|9913715|P1|Overall Study|Death|2
2880934|NCT01964326|9913715|P1|Overall Study|Adverse Event|48
2880935|NCT01964300|9913724|P2|Overall Study|Weight criteria not met|1
2880936|NCT01964300|9913725|P1|Overall Study|Weight criteria not met|0
2880937|NCT01964300|9913724|P2|Overall Study|Enlargement of cyst requiring drainage|0
2880938|NCT01964300|9913725|P1|Overall Study|Enlargement of cyst requiring drainage|1
2880939|NCT01964300|9913724|P2|Overall Study|To receive alternative therapy|2
2880940|NCT01964300|9913725|P1|Overall Study|To receive alternative therapy|1
2880941|NCT01964300|9913724|P2|Overall Study|Withdrawal by Subject|1
2880942|NCT01964300|9913725|P1|Overall Study|Withdrawal by Subject|0
2880943|NCT01964300|9913724|P2|Overall Study|Lack of Efficacy|5
2880944|NCT01964300|9913725|P1|Overall Study|Lack of Efficacy|3
2880945|NCT01964300|9913724|P2|Overall Study|Adverse Event|1
2880946|NCT01964300|9913725|P1|Overall Study|Adverse Event|1
2880947|NCT01964300|9913724|P2|Overall Study|Ineligible after enrollment|1
2880948|NCT01964300|9913725|P1|Overall Study|Ineligible after enrollment|0
2880949|NCT01964222|9913739|P2|Overall Study|Screening Failure|0
2880950|NCT01964222|9913740|P1|Overall Study|Screening Failure|2
2880951|NCT01964222|9913739|P2|Overall Study|Withdrawal by Subject|6
2880952|NCT01964222|9913740|P1|Overall Study|Withdrawal by Subject|6
2880953|NCT01964222|9913739|P2|Overall Study|Lost to Follow-up|5
2880954|NCT01964222|9913740|P1|Overall Study|Lost to Follow-up|7
2880955|NCT01964105|9913757|P3|Overall Study|Lost to Follow-up|0
2880956|NCT01964105|9913758|P2|Overall Study|Lost to Follow-up|13
2880957|NCT01964105|9913759|P1|Overall Study|Lost to Follow-up|2
2880958|NCT01963767|9913818|P2|Overall Study|Adverse Event|0
2880959|NCT01963767|9913819|P1|Overall Study|Adverse Event|2
2880960|NCT01963767|9913818|P2|Overall Study|Withdrawal by Subject|2
2880961|NCT01963767|9913819|P1|Overall Study|Withdrawal by Subject|4
2880962|NCT01963676|9913829|P2|Overall Study|Withdrawal by Subject|0
2880963|NCT01963676|9913830|P1|Overall Study|Withdrawal by Subject|1
2880964|NCT01963611|9913843|P5|Overall Study|Other|45
2880965|NCT01963611|9913844|P4|Overall Study|Other|45
2880966|NCT01963611|9913845|P3|Overall Study|Other|48
2880967|NCT01963611|9913846|P2|Overall Study|Other|46
2880968|NCT01963611|9913847|P1|Overall Study|Other|47
2880969|NCT01963611|9913843|P5|Overall Study|Withdrawal by Subject|3
2880970|NCT01963611|9913844|P4|Overall Study|Withdrawal by Subject|1
2880971|NCT01963611|9913845|P3|Overall Study|Withdrawal by Subject|1
2880972|NCT01963611|9913846|P2|Overall Study|Withdrawal by Subject|2
2880973|NCT01963611|9913847|P1|Overall Study|Withdrawal by Subject|3
2880974|NCT01963611|9913843|P5|Overall Study|Lack of Efficacy|0
2880975|NCT01963611|9913844|P4|Overall Study|Lack of Efficacy|1
2880976|NCT01963611|9913845|P3|Overall Study|Lack of Efficacy|0
2880977|NCT01963611|9913846|P2|Overall Study|Lack of Efficacy|0
2880978|NCT01963611|9913847|P1|Overall Study|Lack of Efficacy|0
2880979|NCT01963611|9913843|P5|Overall Study|Protocol Violation|0
2880980|NCT01963611|9913844|P4|Overall Study|Protocol Violation|1
2880981|NCT01963611|9913845|P3|Overall Study|Protocol Violation|0
2880982|NCT01963611|9913846|P2|Overall Study|Protocol Violation|0
2880983|NCT01963611|9913847|P1|Overall Study|Protocol Violation|0
2880984|NCT01963611|9913843|P5|Overall Study|Adverse Event|3
2880985|NCT01963611|9913844|P4|Overall Study|Adverse Event|4
2880986|NCT01963611|9913845|P3|Overall Study|Adverse Event|3
2880987|NCT01963611|9913846|P2|Overall Study|Adverse Event|1
2880988|NCT01963611|9913847|P1|Overall Study|Adverse Event|1
2880989|NCT01963403|9913912|P2|Overall Study|Implant removal|1
2880990|NCT01963403|9913913|P1|Overall Study|Implant removal|0
2880991|NCT01963403|9913912|P2|Overall Study|Lost to Follow-up|3
2880992|NCT01963403|9913913|P1|Overall Study|Lost to Follow-up|2
2880993|NCT01963260|9913935|P10|Overall Study|Withdrawal by Subject|0
2880994|NCT01963260|9913936|P9|Overall Study|Withdrawal by Subject|0
2880995|NCT01963260|9913937|P8|Overall Study|Withdrawal by Subject|0
2880996|NCT01963260|9913938|P7|Overall Study|Withdrawal by Subject|0
2880997|NCT01963260|9913939|P6|Overall Study|Withdrawal by Subject|0
2880998|NCT01963260|9913940|P5|Overall Study|Withdrawal by Subject|2
2880999|NCT01963260|9913941|P4|Overall Study|Withdrawal by Subject|1
2881000|NCT01963260|9913942|P3|Overall Study|Withdrawal by Subject|0
2881001|NCT01963260|9913943|P2|Overall Study|Withdrawal by Subject|0
2881002|NCT01963260|9913944|P1|Overall Study|Withdrawal by Subject|2
2881003|NCT01963117|9914058|P1|Overall Study|Death|1
2881004|NCT01962974|9914097|P1|Overall Study|Study termination|7
2881005|NCT01962922|9914124|P2|Extendion Portion (up to Month 6)|Physician Decision|0
2881006|NCT01962922|9914125|P1|Extendion Portion (up to Month 6)|Physician Decision|1
2881007|NCT01962922|9914124|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
2881008|NCT01962922|9914125|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
2881009|NCT01962922|9914124|P2|PK Portion Day 7|non-compliance|0
2881010|NCT01962922|9914125|P1|PK Portion Day 7|non-compliance|1
2881011|NCT01962922|9914124|P2|PK Portion Day 7|Withdrawal by Subject|0
2881012|NCT01962922|9914125|P1|PK Portion Day 7|Withdrawal by Subject|3
2881013|NCT01962896|9914147|P1|Overall Study|Lack of Efficacy|4
2881014|NCT01962493|9914269|P2|Overall Study|Withdrawal by Subject|2
2881015|NCT01962493|9914270|P1|Overall Study|Withdrawal by Subject|4
2881016|NCT01962493|9914269|P2|Overall Study|Protocol Violation|1
2881017|NCT01962493|9914270|P1|Overall Study|Protocol Violation|0
2881018|NCT01962493|9914269|P2|Overall Study|Adverse Event|2
2881019|NCT01962493|9914270|P1|Overall Study|Adverse Event|1
2881020|NCT01962441|9914293|P3|Retreatment Substudy|Lost to Follow-up|0
2881021|NCT01962441|9914294|P2|Retreatment Substudy|Lost to Follow-up|0
2881022|NCT01962441|9914295|P1|Retreatment Substudy|Lost to Follow-up|1
2881023|NCT01962441|9914293|P3|Retreatment Substudy|Lack of Efficacy|0
2881024|NCT01962441|9914294|P2|Retreatment Substudy|Lack of Efficacy|0
2881025|NCT01962441|9914295|P1|Retreatment Substudy|Lack of Efficacy|1
2881026|NCT01962441|9914293|P3|Randomized Period|Protocol Violation|0
2881027|NCT01962441|9914294|P2|Randomized Period|Protocol Violation|1
2881028|NCT01962441|9914295|P1|Randomized Period|Protocol Violation|0
2881029|NCT01962441|9914293|P3|Randomized Period|Death|2
2881030|NCT01962441|9914294|P2|Randomized Period|Death|0
2881031|NCT01962441|9914295|P1|Randomized Period|Death|0
2881032|NCT01962441|9914293|P3|Randomized Period|Adverse Event|0
2881033|NCT01962441|9914294|P2|Randomized Period|Adverse Event|1
2881034|NCT01962441|9914295|P1|Randomized Period|Adverse Event|1
2881035|NCT01962441|9914293|P3|Randomized Period|Withdrew Consent|2
2881036|NCT01962441|9914294|P2|Randomized Period|Withdrew Consent|3
2881037|NCT01962441|9914295|P1|Randomized Period|Withdrew Consent|3
2881038|NCT01962441|9914293|P3|Randomized Period|Lost to Follow-up|4
2881039|NCT01962441|9914294|P2|Randomized Period|Lost to Follow-up|4
2881040|NCT01962441|9914295|P1|Randomized Period|Lost to Follow-up|2
2881041|NCT01962441|9914293|P3|Randomized Period|Randomized but Never Treated|3
2881042|NCT01962441|9914294|P2|Randomized Period|Randomized but Never Treated|2
2881043|NCT01962441|9914295|P1|Randomized Period|Randomized but Never Treated|4
2881044|NCT01962298|9914339|P5|Overall Study|Physician Decision|1
2881045|NCT01962298|9914340|P4|Overall Study|Physician Decision|0
2881046|NCT01962298|9914341|P3|Overall Study|Physician Decision|0
2881047|NCT01962298|9914342|P2|Overall Study|Physician Decision|1
2881048|NCT01962298|9914343|P1|Overall Study|Physician Decision|0
2881049|NCT01962298|9914339|P5|Overall Study|Incorrect data recorded|0
2881050|NCT01962298|9914340|P4|Overall Study|Incorrect data recorded|0
2881051|NCT01962298|9914341|P3|Overall Study|Incorrect data recorded|0
2881052|NCT01962298|9914342|P2|Overall Study|Incorrect data recorded|1
2881053|NCT01962298|9914343|P1|Overall Study|Incorrect data recorded|0
2881054|NCT01962298|9914339|P5|Overall Study|Insufficient data|1
2881055|NCT01962298|9914340|P4|Overall Study|Insufficient data|0
2881056|NCT01962298|9914341|P3|Overall Study|Insufficient data|1
2881057|NCT01962298|9914342|P2|Overall Study|Insufficient data|2
2881058|NCT01962298|9914343|P1|Overall Study|Insufficient data|0
2881059|NCT01962298|9914339|P5|Overall Study|Data quality insufficient|4
2881060|NCT01962298|9914340|P4|Overall Study|Data quality insufficient|1
2881061|NCT01962298|9914341|P3|Overall Study|Data quality insufficient|3
2881062|NCT01962298|9914342|P2|Overall Study|Data quality insufficient|0
2881063|NCT01962298|9914343|P1|Overall Study|Data quality insufficient|2
2881064|NCT01962298|9914339|P5|Overall Study|Protocol Violation|0
2881065|NCT01962298|9914340|P4|Overall Study|Protocol Violation|1
2881066|NCT01962298|9914341|P3|Overall Study|Protocol Violation|1
2881067|NCT01962298|9914342|P2|Overall Study|Protocol Violation|0
2881068|NCT01962298|9914343|P1|Overall Study|Protocol Violation|1
2881069|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
2881070|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
2881071|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
2881072|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
2881073|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Adverse Event|0
2881074|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Adverse Event|1
2881075|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Adverse Event|0
2881076|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Adverse Event|0
2881077|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
2881078|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
2881079|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2881080|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2881081|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
2881082|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
2881083|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
2881084|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
2881085|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
2881086|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
2881087|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
2881088|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
2881089|NCT01962207|9914364|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
2881090|NCT01962207|9914365|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
2881091|NCT01962207|9914366|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
2881092|NCT01962207|9914367|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
2881093|NCT01962103|9914478|P9|Phase 2|Symptomatic Deterioration|0
2881094|NCT01962103|9914479|P8|Phase 2|Symptomatic Deterioration|2
2881095|NCT01962103|9914480|P7|Phase 2|Symptomatic Deterioration|2
2881096|NCT01962103|9914481|P6|Phase 2|Symptomatic Deterioration|0
2881097|NCT01962103|9914482|P5|Phase 2|Symptomatic Deterioration|0
2881098|NCT01962103|9914483|P4|Phase 2|Symptomatic Deterioration|0
2881099|NCT01962103|9914484|P3|Phase 2|Symptomatic Deterioration|0
2881100|NCT01962103|9914485|P2|Phase 2|Symptomatic Deterioration|0
2881101|NCT01962103|9914486|P1|Phase 2|Symptomatic Deterioration|0
2881102|NCT01962103|9914478|P9|Phase 2|Progressive Disease|11
2881103|NCT01962103|9914479|P8|Phase 2|Progressive Disease|12
2881104|NCT01962103|9914480|P7|Phase 2|Progressive Disease|11
2881105|NCT01962103|9914481|P6|Phase 2|Progressive Disease|0
2881106|NCT01962103|9914482|P5|Phase 2|Progressive Disease|0
2881107|NCT01962103|9914483|P4|Phase 2|Progressive Disease|0
2881108|NCT01962103|9914484|P3|Phase 2|Progressive Disease|0
2881109|NCT01962103|9914485|P2|Phase 2|Progressive Disease|0
2881110|NCT01962103|9914486|P1|Phase 2|Progressive Disease|0
2881111|NCT01962103|9914478|P9|Phase 2|Adverse Event|3
2881112|NCT01962103|9914479|P8|Phase 2|Adverse Event|0
2881113|NCT01962103|9914480|P7|Phase 2|Adverse Event|1
2881114|NCT01962103|9914481|P6|Phase 2|Adverse Event|0
2881115|NCT01962103|9914482|P5|Phase 2|Adverse Event|0
2881116|NCT01962103|9914483|P4|Phase 2|Adverse Event|0
2881117|NCT01962103|9914484|P3|Phase 2|Adverse Event|0
2881118|NCT01962103|9914485|P2|Phase 2|Adverse Event|0
2881119|NCT01962103|9914486|P1|Phase 2|Adverse Event|0
2881120|NCT01962103|9914478|P9|Phase 1|Miscellaneous|0
2881121|NCT01962103|9914479|P8|Phase 1|Miscellaneous|0
2881122|NCT01962103|9914480|P7|Phase 1|Miscellaneous|0
2881123|NCT01962103|9914481|P6|Phase 1|Miscellaneous|0
2881124|NCT01962103|9914482|P5|Phase 1|Miscellaneous|0
2881125|NCT01962103|9914483|P4|Phase 1|Miscellaneous|0
2881126|NCT01962103|9914484|P3|Phase 1|Miscellaneous|0
2881127|NCT01962103|9914485|P2|Phase 1|Miscellaneous|0
2881128|NCT01962103|9914486|P1|Phase 1|Miscellaneous|1
2881129|NCT01962103|9914478|P9|Phase 1|Symptomatic Deterioration|0
2881130|NCT01962103|9914479|P8|Phase 1|Symptomatic Deterioration|0
2881131|NCT01962103|9914480|P7|Phase 1|Symptomatic Deterioration|0
2881132|NCT01962103|9914481|P6|Phase 1|Symptomatic Deterioration|1
2881133|NCT01962103|9914482|P5|Phase 1|Symptomatic Deterioration|1
2881134|NCT01962103|9914483|P4|Phase 1|Symptomatic Deterioration|2
2881135|NCT01962103|9914484|P3|Phase 1|Symptomatic Deterioration|2
2881136|NCT01962103|9914485|P2|Phase 1|Symptomatic Deterioration|2
2881137|NCT01962103|9914486|P1|Phase 1|Symptomatic Deterioration|3
2881138|NCT01962103|9914478|P9|Phase 1|Physician Decision|0
2881139|NCT01962103|9914479|P8|Phase 1|Physician Decision|0
2881140|NCT01962103|9914480|P7|Phase 1|Physician Decision|0
2881141|NCT01962103|9914481|P6|Phase 1|Physician Decision|0
2881142|NCT01962103|9914482|P5|Phase 1|Physician Decision|0
2881143|NCT01962103|9914483|P4|Phase 1|Physician Decision|1
2881144|NCT01962103|9914484|P3|Phase 1|Physician Decision|0
2881145|NCT01962103|9914485|P2|Phase 1|Physician Decision|0
2881146|NCT01962103|9914486|P1|Phase 1|Physician Decision|0
2881147|NCT01962103|9914478|P9|Phase 1|Withdrawal by Parent/Guardian|0
2881148|NCT01962103|9914479|P8|Phase 1|Withdrawal by Parent/Guardian|0
2881149|NCT01962103|9914480|P7|Phase 1|Withdrawal by Parent/Guardian|0
2881150|NCT01962103|9914481|P6|Phase 1|Withdrawal by Parent/Guardian|0
2881151|NCT01962103|9914482|P5|Phase 1|Withdrawal by Parent/Guardian|0
2881152|NCT01962103|9914483|P4|Phase 1|Withdrawal by Parent/Guardian|1
2881153|NCT01962103|9914484|P3|Phase 1|Withdrawal by Parent/Guardian|2
2881154|NCT01962103|9914485|P2|Phase 1|Withdrawal by Parent/Guardian|0
2881155|NCT01962103|9914486|P1|Phase 1|Withdrawal by Parent/Guardian|0
2881156|NCT01962103|9914478|P9|Phase 1|Withdrawal by Subject|0
2881157|NCT01962103|9914479|P8|Phase 1|Withdrawal by Subject|0
2881158|NCT01962103|9914480|P7|Phase 1|Withdrawal by Subject|0
2881159|NCT01962103|9914481|P6|Phase 1|Withdrawal by Subject|0
2881160|NCT01962103|9914482|P5|Phase 1|Withdrawal by Subject|0
2881161|NCT01962103|9914483|P4|Phase 1|Withdrawal by Subject|2
2881162|NCT01962103|9914484|P3|Phase 1|Withdrawal by Subject|0
2881163|NCT01962103|9914485|P2|Phase 1|Withdrawal by Subject|0
2881164|NCT01962103|9914486|P1|Phase 1|Withdrawal by Subject|0
2881165|NCT01962103|9914478|P9|Phase 1|Progressive Disease|0
2881166|NCT01962103|9914479|P8|Phase 1|Progressive Disease|0
2881167|NCT01962103|9914480|P7|Phase 1|Progressive Disease|0
2881168|NCT01962103|9914481|P6|Phase 1|Progressive Disease|4
2881169|NCT01962103|9914482|P5|Phase 1|Progressive Disease|5
2881170|NCT01962103|9914483|P4|Phase 1|Progressive Disease|4
2881171|NCT01962103|9914484|P3|Phase 1|Progressive Disease|8
2881172|NCT01962103|9914485|P2|Phase 1|Progressive Disease|6
2881173|NCT01962103|9914486|P1|Phase 1|Progressive Disease|8
2881174|NCT01962103|9914478|P9|Phase 1|Adverse Event|0
2881175|NCT01962103|9914479|P8|Phase 1|Adverse Event|0
2881176|NCT01962103|9914480|P7|Phase 1|Adverse Event|0
2881177|NCT01962103|9914481|P6|Phase 1|Adverse Event|2
2881178|NCT01962103|9914482|P5|Phase 1|Adverse Event|2
2881179|NCT01962103|9914483|P4|Phase 1|Adverse Event|1
2881180|NCT01962103|9914484|P3|Phase 1|Adverse Event|2
2881181|NCT01962103|9914485|P2|Phase 1|Adverse Event|0
2881182|NCT01962103|9914486|P1|Phase 1|Adverse Event|4
2881183|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
2881184|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2881185|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2881186|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
2881187|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
2881188|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2881189|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
2881190|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2881191|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2881192|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2881193|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
2881194|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2881195|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2881196|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2881197|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2881198|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
2881199|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2881200|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
2881201|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2881202|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2881203|NCT01961609|9914598|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
2881204|NCT01961609|9914599|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
2881205|NCT01961609|9914600|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
2881206|NCT01961609|9914601|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
2881207|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2881208|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
2881209|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2881210|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2881211|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
2881212|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
2881213|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2881214|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2881215|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
2881216|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
2881217|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
2881218|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
2881219|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2881220|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2881221|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2881222|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2881223|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2881224|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
2881225|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2881226|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
2881227|NCT01961609|9914598|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2881228|NCT01961609|9914599|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
2881229|NCT01961609|9914600|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2881230|NCT01961609|9914601|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
2881231|NCT01961609|9914598|P4|Initiation|Randomized but not treated|0
2881232|NCT01961609|9914599|P3|Initiation|Randomized but not treated|0
2881233|NCT01961609|9914600|P2|Initiation|Randomized but not treated|1
2881234|NCT01961609|9914601|P1|Initiation|Randomized but not treated|1
2881235|NCT01961609|9914598|P4|Initiation|Adverse Event|0
2881236|NCT01961609|9914599|P3|Initiation|Adverse Event|0
2881237|NCT01961609|9914600|P2|Initiation|Adverse Event|5
2881238|NCT01961609|9914601|P1|Initiation|Adverse Event|3
2881239|NCT01961609|9914598|P4|Initiation|Abnormal lab values|0
2881240|NCT01961609|9914599|P3|Initiation|Abnormal lab values|0
2881241|NCT01961609|9914600|P2|Initiation|Abnormal lab values|1
2881242|NCT01961609|9914601|P1|Initiation|Abnormal lab values|0
2881243|NCT01961609|9914598|P4|Initiation|Lack of Efficacy|0
2881244|NCT01961609|9914599|P3|Initiation|Lack of Efficacy|0
2881245|NCT01961609|9914600|P2|Initiation|Lack of Efficacy|1
2881246|NCT01961609|9914601|P1|Initiation|Lack of Efficacy|2
2881247|NCT01961609|9914598|P4|Initiation|Withdrawal by Subject|0
2881248|NCT01961609|9914599|P3|Initiation|Withdrawal by Subject|0
2881249|NCT01961609|9914600|P2|Initiation|Withdrawal by Subject|2
2881250|NCT01961609|9914601|P1|Initiation|Withdrawal by Subject|1
2881251|NCT01961609|9914598|P4|Initiation|Administrative problems|0
2881252|NCT01961609|9914599|P3|Initiation|Administrative problems|0
2881253|NCT01961609|9914600|P2|Initiation|Administrative problems|0
2881254|NCT01961609|9914601|P1|Initiation|Administrative problems|1
2881255|NCT01961609|9914598|P4|Initiation|Death|0
2881256|NCT01961609|9914599|P3|Initiation|Death|0
2881257|NCT01961609|9914600|P2|Initiation|Death|1
2881258|NCT01961609|9914601|P1|Initiation|Death|0
2881259|NCT01961609|9914598|P4|Initiation|Protocol deviation|0
2881260|NCT01961609|9914599|P3|Initiation|Protocol deviation|0
2881261|NCT01961609|9914600|P2|Initiation|Protocol deviation|0
2881262|NCT01961609|9914601|P1|Initiation|Protocol deviation|1
2881263|NCT01961609|9914598|P4|Initiation|Missing|0
2881264|NCT01961609|9914599|P3|Initiation|Missing|0
2881265|NCT01961609|9914600|P2|Initiation|Missing|2
2881266|NCT01961609|9914601|P1|Initiation|Missing|3
2881267|NCT01961544|9914653|P1|Overall Study|Aggravation of Steral Pain|1
2881268|NCT01961544|9914653|P1|Overall Study|Poor Tolerance|1
2881269|NCT01961544|9914653|P1|Overall Study|Physician Decision|2
2881270|NCT01961544|9914653|P1|Overall Study|Adverse Event|1
2881271|NCT01961544|9914653|P1|Overall Study|Withdrawal by Subject|7
2881272|NCT01961544|9914653|P1|Overall Study|Protocol Violation|1
2881273|NCT01961349|9914667|P3|Overall Study|registration error, personal reason etc|1
2881274|NCT01961349|9914668|P2|Overall Study|registration error, personal reason etc|2
2881275|NCT01961349|9914669|P1|Overall Study|registration error, personal reason etc|2
2881276|NCT01961349|9914667|P3|Overall Study|Adverse Event|1
2881277|NCT01961349|9914668|P2|Overall Study|Adverse Event|0
2881278|NCT01961349|9914669|P1|Overall Study|Adverse Event|0
2881279|NCT01961349|9914667|P3|Overall Study|Withdrawal by Subject|0
2881280|NCT01961349|9914668|P2|Overall Study|Withdrawal by Subject|4
2881281|NCT01961349|9914669|P1|Overall Study|Withdrawal by Subject|1
2881282|NCT01961323|9914680|P1|Overall Study|screen failure|34
2881283|NCT01961323|9914680|P1|Overall Study|Lost to Follow-up|8
2881284|NCT01961323|9914680|P1|Overall Study|Withdrawal by Subject|7
2881285|NCT01961297|9914688|P2|Overall Study|unconfirmed diagnosis of SD|1
2881286|NCT01961297|9914689|P1|Overall Study|unconfirmed diagnosis of SD|2
2881287|NCT01961115|9914753|P3|Overall Study|Adverse Event|1
2881288|NCT01961115|9914754|P2|Overall Study|Adverse Event|0
2881289|NCT01961115|9914755|P1|Overall Study|Adverse Event|1
2881290|NCT01961115|9914753|P3|Overall Study|Disease Progression|3
2881291|NCT01961115|9914754|P2|Overall Study|Disease Progression|0
2881292|NCT01961115|9914755|P1|Overall Study|Disease Progression|1
2881293|NCT01960907|9914798|P2|Overall Study|Withdrawal by Subject|42
2881294|NCT01960907|9914799|P1|Overall Study|Withdrawal by Subject|32
2881295|NCT01960907|9914798|P2|Overall Study|Death|3
2881296|NCT01960907|9914799|P1|Overall Study|Death|4
2881297|NCT01960855|9914814|P5|Overall Study|Lost to Follow-up|2
2881298|NCT01960855|9914815|P4|Overall Study|Lost to Follow-up|0
2881299|NCT01960855|9914816|P3|Overall Study|Lost to Follow-up|0
2881300|NCT01960855|9914817|P2|Overall Study|Lost to Follow-up|1
2881301|NCT01960855|9914818|P1|Overall Study|Lost to Follow-up|2
2881302|NCT01960855|9914814|P5|Overall Study|Consent withdrawn by subject|1
2881303|NCT01960855|9914815|P4|Overall Study|Consent withdrawn by subject|1
2881304|NCT01960855|9914816|P3|Overall Study|Consent withdrawn by subject|2
2881305|NCT01960855|9914817|P2|Overall Study|Consent withdrawn by subject|1
2881306|NCT01960855|9914818|P1|Overall Study|Consent withdrawn by subject|3
2881307|NCT01960855|9914814|P5|Overall Study|Other|0
2881308|NCT01960855|9914815|P4|Overall Study|Other|1
2881309|NCT01960855|9914816|P3|Overall Study|Other|1
2881310|NCT01960855|9914817|P2|Overall Study|Other|1
2881311|NCT01960855|9914818|P1|Overall Study|Other|2
2881312|NCT01960855|9914814|P5|Overall Study|Lack of Efficacy|0
2881313|NCT01960855|9914815|P4|Overall Study|Lack of Efficacy|0
2881314|NCT01960855|9914816|P3|Overall Study|Lack of Efficacy|0
2881315|NCT01960855|9914817|P2|Overall Study|Lack of Efficacy|1
2881316|NCT01960855|9914818|P1|Overall Study|Lack of Efficacy|1
2881317|NCT01960855|9914814|P5|Overall Study|Adverse Event|2
2881318|NCT01960855|9914815|P4|Overall Study|Adverse Event|2
2881319|NCT01960855|9914816|P3|Overall Study|Adverse Event|6
2881320|NCT01960855|9914817|P2|Overall Study|Adverse Event|0
2881321|NCT01960855|9914818|P1|Overall Study|Adverse Event|2
2881322|NCT01960855|9914814|P5|Overall Study|Subject noncompliant|0
2881323|NCT01960855|9914815|P4|Overall Study|Subject noncompliant|0
2881324|NCT01960855|9914816|P3|Overall Study|Subject noncompliant|0
2881325|NCT01960855|9914817|P2|Overall Study|Subject noncompliant|0
2881326|NCT01960855|9914818|P1|Overall Study|Subject noncompliant|1
2881327|NCT01960842|9914850|P1|Overall Study|Withdrawal by Subject|2
2881328|NCT01960842|9914850|P1|Overall Study|Adverse Event|1
2881329|NCT01960816|9914873|P1|Overall Study|Lost to Follow-up|1
2881330|NCT01960790|9914879|P1|Overall Study|Unevaluable for safety|1
2881331|NCT01960790|9914879|P1|Overall Study|Transferred to another hospital|4
2881332|NCT01960790|9914879|P1|Overall Study|Treat with Humira outside survey period|3
2881333|NCT01960790|9914879|P1|Overall Study|Survey forms could not be recovered|3
2881334|NCT01960725|9914891|P2|Overall Study|unable to obtain blood sample|2
2881335|NCT01960725|9914892|P1|Overall Study|unable to obtain blood sample|1
2881336|NCT01960725|9914891|P2|Overall Study|Withdrawal by Subject|0
2881337|NCT01960725|9914892|P1|Overall Study|Withdrawal by Subject|1
2881338|NCT01960725|9914891|P2|Overall Study|Lost to Follow-up|3
2881339|NCT01960725|9914892|P1|Overall Study|Lost to Follow-up|4
2881340|NCT01960413|9914949|P2|Overall Study|Lost to Follow-up|0
2881341|NCT01960413|9914950|P1|Overall Study|Lost to Follow-up|2
2881342|NCT01960413|9914949|P2|Overall Study|Physician Decision|0
2881343|NCT01960413|9914950|P1|Overall Study|Physician Decision|1
2881344|NCT01960413|9914949|P2|Overall Study|Withdrawal by Subject|1
2881345|NCT01960413|9914950|P1|Overall Study|Withdrawal by Subject|1
2881346|NCT01960348|9914980|P2|Overall Study|Protocol Violation|0
2881347|NCT01960348|9914981|P1|Overall Study|Protocol Violation|1
2881348|NCT01960348|9914980|P2|Overall Study|Physician Decision|1
2881349|NCT01960348|9914981|P1|Overall Study|Physician Decision|0
2881350|NCT01960348|9914980|P2|Overall Study|Withdrawal by Subject|11
2881351|NCT01960348|9914981|P1|Overall Study|Withdrawal by Subject|1
2881352|NCT01960348|9914980|P2|Overall Study|Adverse event, serious non-fatal|3
2881353|NCT01960348|9914981|P1|Overall Study|Adverse event, serious non-fatal|0
2881354|NCT01960348|9914980|P2|Overall Study|Adverse event, serious fatal|5
2881355|NCT01960348|9914981|P1|Overall Study|Adverse event, serious fatal|6
2881356|NCT01960348|9914980|P2|Overall Study|Adverse event, not serious|2
2881357|NCT01960348|9914981|P1|Overall Study|Adverse event, not serious|2
2881358|NCT01960296|9915001|P2|Overall Study|Received different procedure|3
2881359|NCT01960296|9915002|P1|Overall Study|Received different procedure|1
2881360|NCT01960296|9915001|P2|Overall Study|Postponed surgery|0
2881361|NCT01960296|9915002|P1|Overall Study|Postponed surgery|1
2881362|NCT01960140|9915022|P1|Period 2 (Days 3-18)|Adverse Event|2
2881363|NCT01960114|9915033|P2|Overall Study|Could not swallow study medication|1
2881364|NCT01960114|9915034|P1|Overall Study|Could not swallow study medication|0
2881365|NCT01960114|9915033|P2|Overall Study|Adverse Event|0
2881366|NCT01960114|9915034|P1|Overall Study|Adverse Event|1
2881367|NCT01959932|9915141|P3|Overall Study|Withdrawal by Subject|0
2881368|NCT01959932|9915142|P2|Overall Study|Withdrawal by Subject|0
2881369|NCT01959932|9915143|P1|Overall Study|Withdrawal by Subject|1
2881370|NCT01959919|9915161|P1|Overall Study|Did not meet the eligibility criteria|2
2881371|NCT01959880|9915175|P4|Overall Study|Study completed early-FDA approved|152
2881372|NCT01959880|9915176|P3|Overall Study|Study completed early-FDA approved|179
2881373|NCT01959880|9915177|P2|Overall Study|Study completed early-FDA approved|311
2881374|NCT01959880|9915178|P1|Overall Study|Study completed early-FDA approved|1003
2881375|NCT01959880|9915175|P4|Overall Study|Explantation w/o study device reimplant.|12
2881376|NCT01959880|9915176|P3|Overall Study|Explantation w/o study device reimplant.|5
2881377|NCT01959880|9915177|P2|Overall Study|Explantation w/o study device reimplant.|17
2881378|NCT01959880|9915178|P1|Overall Study|Explantation w/o study device reimplant.|22
2881379|NCT01959880|9915175|P4|Overall Study|Lost to Follow-up|8
2881380|NCT01959880|9915176|P3|Overall Study|Lost to Follow-up|15
2881381|NCT01959880|9915177|P2|Overall Study|Lost to Follow-up|18
2881382|NCT01959880|9915178|P1|Overall Study|Lost to Follow-up|95
2881383|NCT01959880|9915175|P4|Overall Study|Death|2
2881384|NCT01959880|9915176|P3|Overall Study|Death|1
2881385|NCT01959880|9915177|P2|Overall Study|Death|10
2881386|NCT01959880|9915178|P1|Overall Study|Death|1
2881387|NCT01959880|9915175|P4|Overall Study|Withdrawal by Subject|7
2881388|NCT01959880|9915176|P3|Overall Study|Withdrawal by Subject|8
2881389|NCT01959880|9915177|P2|Overall Study|Withdrawal by Subject|13
2881390|NCT01959880|9915178|P1|Overall Study|Withdrawal by Subject|11
2881391|NCT01959841|9915203|P3|Overall Study|Platelet count below on day1 or 4|11
2881392|NCT01959841|9915204|P2|Overall Study|Platelet count below on day1 or 4|15
2881393|NCT01959841|9915205|P1|Overall Study|Platelet count below on day1 or 4|11
2881394|NCT01959841|9915203|P3|Overall Study|Clinical laboratory value|6
2881395|NCT01959841|9915204|P2|Overall Study|Clinical laboratory value|6
2881396|NCT01959841|9915205|P1|Overall Study|Clinical laboratory value|2
2881397|NCT01959841|9915203|P3|Overall Study|Withdrawal by Subject|5
2881398|NCT01959841|9915204|P2|Overall Study|Withdrawal by Subject|7
2881399|NCT01959841|9915205|P1|Overall Study|Withdrawal by Subject|7
2881400|NCT01959841|9915203|P3|Overall Study|Protocol Violation|16
2881401|NCT01959841|9915204|P2|Overall Study|Protocol Violation|23
2881402|NCT01959841|9915205|P1|Overall Study|Protocol Violation|16
2881403|NCT01959841|9915203|P3|Overall Study|Physician Decision|3
2881404|NCT01959841|9915204|P2|Overall Study|Physician Decision|2
2881405|NCT01959841|9915205|P1|Overall Study|Physician Decision|0
2881406|NCT01959841|9915203|P3|Overall Study|Lost to Follow-up|0
2881407|NCT01959841|9915204|P2|Overall Study|Lost to Follow-up|1
2881408|NCT01959841|9915205|P1|Overall Study|Lost to Follow-up|1
2881409|NCT01959841|9915203|P3|Overall Study|Lack of Efficacy|0
2881410|NCT01959841|9915204|P2|Overall Study|Lack of Efficacy|0
2881411|NCT01959841|9915205|P1|Overall Study|Lack of Efficacy|5
2881412|NCT01959841|9915203|P3|Overall Study|Adverse Event|2
2881413|NCT01959841|9915204|P2|Overall Study|Adverse Event|3
2881414|NCT01959841|9915205|P1|Overall Study|Adverse Event|1
2881415|NCT01959672|9915233|P1|Overall Study|Death|1
2881416|NCT01959607|9915244|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2881417|NCT01959607|9915245|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2881418|NCT01959607|9915246|P2|First Intervention (Day 1)|Withdrawal by Subject|1
2881419|NCT01959607|9915247|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2881420|NCT01959581|9915260|P1|Overall Study|Lost to Follow-up|5
2881421|NCT01959529|9915271|P2|Overall Study|Lack of glycaemic control|1
2881422|NCT01959529|9915272|P1|Overall Study|Lack of glycaemic control|1
2881423|NCT01959529|9915271|P2|Overall Study|Hypoglycaemia|1
2881424|NCT01959529|9915272|P1|Overall Study|Hypoglycaemia|1
2881425|NCT01959529|9915271|P2|Overall Study|Other|68
2881426|NCT01959529|9915272|P1|Overall Study|Other|70
2881427|NCT01959529|9915271|P2|Overall Study|Lost to Follow-up|1
2881428|NCT01959529|9915272|P1|Overall Study|Lost to Follow-up|4
2881429|NCT01959529|9915271|P2|Overall Study|Adverse event (not hypoglycaemia)|1
2881430|NCT01959529|9915272|P1|Overall Study|Adverse event (not hypoglycaemia)|0
2881431|NCT01959516|9915284|P2|Epoch 2|Moderate or severe COPD exacerbation|1
2881432|NCT01959516|9915285|P1|Epoch 2|Moderate or severe COPD exacerbation|0
2881433|NCT01959516|9915284|P2|Epoch 2|Subject withdrew consent|0
2881434|NCT01959516|9915285|P1|Epoch 2|Subject withdrew consent|1
2881435|NCT01959516|9915284|P2|Epoch 2|unsatisfactory therapeutic effect|0
2881436|NCT01959516|9915285|P1|Epoch 2|unsatisfactory therapeutic effect|1
2881437|NCT01959516|9915284|P2|Epoch 1|Protocol deviation|1
2881438|NCT01959516|9915285|P1|Epoch 1|Protocol deviation|0
2881439|NCT01959516|9915284|P2|Epoch 1|Moderate or severe COPD exacerbation|1
2881440|NCT01959516|9915285|P1|Epoch 1|Moderate or severe COPD exacerbation|0
2881441|NCT01959516|9915284|P2|Epoch 1|Use of prohibited treatment|0
2881442|NCT01959516|9915285|P1|Epoch 1|Use of prohibited treatment|1
2881443|NCT01959516|9915284|P2|Epoch 1|Administrative problems|0
2881444|NCT01959516|9915285|P1|Epoch 1|Administrative problems|1
2881445|NCT01959516|9915284|P2|Epoch 1|Subject withdrew consent|2
2881446|NCT01959516|9915285|P1|Epoch 1|Subject withdrew consent|3
2881447|NCT01959516|9915284|P2|Epoch 1|unsatisfactory therapeutic effect|0
2881448|NCT01959516|9915285|P1|Epoch 1|unsatisfactory therapeutic effect|1
2881449|NCT01959516|9915284|P2|Epoch 1|Adverse Event|1
2881450|NCT01959516|9915285|P1|Epoch 1|Adverse Event|4
2881451|NCT01959503|9915295|P2|Overall Study|Randomized but not treated|1
2881452|NCT01959503|9915296|P1|Overall Study|Randomized but not treated|1
2881453|NCT01959503|9915295|P2|Overall Study|Death|1
2881454|NCT01959503|9915296|P1|Overall Study|Death|2
2881455|NCT01959412|9915347|P6|Overall Study|Adverse Event|0
2881456|NCT01959412|9915348|P5|Overall Study|Adverse Event|0
2881457|NCT01959412|9915349|P4|Overall Study|Adverse Event|1
2881458|NCT01959412|9915350|P3|Overall Study|Adverse Event|0
2881459|NCT01959412|9915351|P2|Overall Study|Adverse Event|0
2881460|NCT01959412|9915352|P1|Overall Study|Adverse Event|0
2881461|NCT01959412|9915347|P6|Overall Study|Protocol deviation|0
2881462|NCT01959412|9915348|P5|Overall Study|Protocol deviation|3
2881463|NCT01959412|9915349|P4|Overall Study|Protocol deviation|1
2881464|NCT01959412|9915350|P3|Overall Study|Protocol deviation|0
2881465|NCT01959412|9915351|P2|Overall Study|Protocol deviation|1
2881466|NCT01959412|9915352|P1|Overall Study|Protocol deviation|1
2881467|NCT01959347|9915392|P2|Overall Study|Protocol Violation|7
2881468|NCT01959347|9915393|P1|Overall Study|Protocol Violation|9
2881469|NCT01959334|9915499|P2|Third Dose|Adverse Event|1
2881470|NCT01959334|9915500|P1|Third Dose|Adverse Event|0
2881471|NCT01959334|9915499|P2|Second Dose|Adverse Event|0
2881472|NCT01959334|9915500|P1|Second Dose|Adverse Event|1
2881473|NCT01959243|9915512|P2|Overall Study|Lost to Follow-up|1
2881474|NCT01959243|9915513|P1|Overall Study|Lost to Follow-up|3
2881475|NCT01959243|9915512|P2|Overall Study|Administrative reasons|1
2881476|NCT01959243|9915513|P1|Overall Study|Administrative reasons|2
2881477|NCT01959243|9915512|P2|Overall Study|Adverse Event|2
2881478|NCT01959243|9915513|P1|Overall Study|Adverse Event|5
2881479|NCT01959243|9915512|P2|Overall Study|Investigator Decision|0
2881480|NCT01959243|9915513|P1|Overall Study|Investigator Decision|3
2881481|NCT01959230|9915525|P2|Overall Study|Withdrawal by Subject|0
2881482|NCT01959230|9915526|P1|Overall Study|Withdrawal by Subject|2
2881483|NCT01959230|9915525|P2|Overall Study|Administrative reasons|0
2881484|NCT01959230|9915526|P1|Overall Study|Administrative reasons|2
2881485|NCT01959230|9915525|P2|Overall Study|Failure to follow study procedures|1
2881486|NCT01959230|9915526|P1|Overall Study|Failure to follow study procedures|0
2881487|NCT01959165|9915540|P4|Overall Study|Welfare recipient|0
2881488|NCT01959165|9915541|P3|Overall Study|Welfare recipient|0
2881489|NCT01959165|9915542|P2|Overall Study|Welfare recipient|1
2881490|NCT01959165|9915543|P1|Overall Study|Welfare recipient|0
2881491|NCT01959165|9915540|P4|Overall Study|overdose|1
2881492|NCT01959165|9915541|P3|Overall Study|overdose|0
2881493|NCT01959165|9915542|P2|Overall Study|overdose|0
2881494|NCT01959165|9915543|P1|Overall Study|overdose|0
2881495|NCT01959165|9915540|P4|Overall Study|Lack of Efficacy|0
2881496|NCT01959165|9915541|P3|Overall Study|Lack of Efficacy|0
2881497|NCT01959165|9915542|P2|Overall Study|Lack of Efficacy|0
2881498|NCT01959165|9915543|P1|Overall Study|Lack of Efficacy|1
2881499|NCT01959165|9915540|P4|Overall Study|Adverse Event|1
2881500|NCT01959165|9915541|P3|Overall Study|Adverse Event|0
2881501|NCT01959165|9915542|P2|Overall Study|Adverse Event|0
2881502|NCT01959165|9915543|P1|Overall Study|Adverse Event|0
2881503|NCT01959139|9915569|P4|Phase II|On treatment|0
2881504|NCT01959139|9915570|P3|Phase II|On treatment|4
2881505|NCT01959139|9915571|P2|Phase II|On treatment|0
2881506|NCT01959139|9915572|P1|Phase II|On treatment|0
2881507|NCT01959139|9915569|P4|Phase II|Other/Unknown|5
2881508|NCT01959139|9915570|P3|Phase II|Other/Unknown|8
2881509|NCT01959139|9915571|P2|Phase II|Other/Unknown|0
2881510|NCT01959139|9915572|P1|Phase II|Other/Unknown|0
2881511|NCT01959139|9915569|P4|Phase II|Death|1
2881512|NCT01959139|9915570|P3|Phase II|Death|3
2881513|NCT01959139|9915571|P2|Phase II|Death|0
2881514|NCT01959139|9915572|P1|Phase II|Death|0
2881515|NCT01959139|9915569|P4|Phase II|Patient Refusal|4
2881516|NCT01959139|9915570|P3|Phase II|Patient Refusal|5
2881517|NCT01959139|9915571|P2|Phase II|Patient Refusal|0
2881518|NCT01959139|9915572|P1|Phase II|Patient Refusal|0
2881519|NCT01959139|9915569|P4|Phase II|Adverse Event|11
2881520|NCT01959139|9915570|P3|Phase II|Adverse Event|10
2881521|NCT01959139|9915571|P2|Phase II|Adverse Event|0
2881522|NCT01959139|9915572|P1|Phase II|Adverse Event|0
2881523|NCT01959139|9915569|P4|Phase II|Disease progression|34
2881524|NCT01959139|9915570|P3|Phase II|Disease progression|26
2881525|NCT01959139|9915571|P2|Phase II|Disease progression|0
2881526|NCT01959139|9915572|P1|Phase II|Disease progression|0
2881527|NCT01959035|9915599|P1|Overall Study|Other (no primary reason given)|1
2881528|NCT01959035|9915599|P1|Overall Study|Lost to Follow-up|1
2881529|NCT01959035|9915599|P1|Overall Study|Withdrawal by Subject|4
2881530|NCT01959035|9915599|P1|Overall Study|Adverse Event|5
2881531|NCT01958918|9915627|P2|Overall Study|administrative problems|2
2881532|NCT01958918|9915628|P1|Overall Study|administrative problems|0
2881533|NCT01958918|9915627|P2|Overall Study|Adverse Event|12
2881534|NCT01958918|9915628|P1|Overall Study|Adverse Event|12
2881535|NCT01958918|9915627|P2|Overall Study|Lack of Efficacy|10
2881536|NCT01958918|9915628|P1|Overall Study|Lack of Efficacy|13
2881537|NCT01958918|9915627|P2|Overall Study|Withdrawal by Subject|8
2881538|NCT01958918|9915628|P1|Overall Study|Withdrawal by Subject|13
2881539|NCT01958918|9915627|P2|Overall Study|Lost to Follow-up|7
2881540|NCT01958918|9915628|P1|Overall Study|Lost to Follow-up|4
2881541|NCT01958918|9915627|P2|Overall Study|Death|3
2881542|NCT01958918|9915628|P1|Overall Study|Death|1
2881543|NCT01958827|9915642|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
2881544|NCT01958827|9915642|P1|Overall Study|Lack of Efficacy|6
2881545|NCT01958827|9915642|P1|Overall Study|Adverse Event|3
2881546|NCT01958671|9915673|P3|Overall Study|Withdrawal by Subject|13
2881547|NCT01958671|9915674|P2|Overall Study|Withdrawal by Subject|10
2881548|NCT01958671|9915675|P1|Overall Study|Withdrawal by Subject|8
2881549|NCT01958671|9915673|P3|Overall Study|Participant moved|1
2881550|NCT01958671|9915674|P2|Overall Study|Participant moved|0
2881551|NCT01958671|9915675|P1|Overall Study|Participant moved|0
2881552|NCT01958671|9915673|P3|Overall Study|Study site terminated by sponsor|1
2881553|NCT01958671|9915674|P2|Overall Study|Study site terminated by sponsor|0
2881554|NCT01958671|9915675|P1|Overall Study|Study site terminated by sponsor|1
2881555|NCT01958671|9915673|P3|Overall Study|Protocol Violation|0
2881556|NCT01958671|9915674|P2|Overall Study|Protocol Violation|1
2881557|NCT01958671|9915675|P1|Overall Study|Protocol Violation|0
2881558|NCT01958671|9915673|P3|Overall Study|Pregnancy|1
2881559|NCT01958671|9915674|P2|Overall Study|Pregnancy|0
2881560|NCT01958671|9915675|P1|Overall Study|Pregnancy|0
2881561|NCT01958671|9915673|P3|Overall Study|Non-compliance with study drug|1
2881562|NCT01958671|9915674|P2|Overall Study|Non-compliance with study drug|1
2881563|NCT01958671|9915675|P1|Overall Study|Non-compliance with study drug|1
2881564|NCT01958671|9915673|P3|Overall Study|Lost to Follow-up|7
2881565|NCT01958671|9915674|P2|Overall Study|Lost to Follow-up|11
2881566|NCT01958671|9915675|P1|Overall Study|Lost to Follow-up|7
2881567|NCT01958671|9915673|P3|Overall Study|Hyperglycemia|2
2881568|NCT01958671|9915674|P2|Overall Study|Hyperglycemia|0
2881569|NCT01958671|9915675|P1|Overall Study|Hyperglycemia|0
2881570|NCT01958671|9915673|P3|Overall Study|Excluded medication|1
2881571|NCT01958671|9915674|P2|Overall Study|Excluded medication|0
2881572|NCT01958671|9915675|P1|Overall Study|Excluded medication|0
2881573|NCT01958671|9915673|P3|Overall Study|Death|0
2881574|NCT01958671|9915674|P2|Overall Study|Death|0
2881575|NCT01958671|9915675|P1|Overall Study|Death|1
2881576|NCT01958671|9915673|P3|Overall Study|Adverse Event|5
2881577|NCT01958671|9915674|P2|Overall Study|Adverse Event|1
2881578|NCT01958671|9915675|P1|Overall Study|Adverse Event|1
2881579|NCT01958619|9915749|P4|Overall Study|Protocol Violation|0
2881580|NCT01958619|9915750|P3|Overall Study|Protocol Violation|1
2881581|NCT01958619|9915751|P2|Overall Study|Protocol Violation|0
2881582|NCT01958619|9915752|P1|Overall Study|Protocol Violation|2
2881583|NCT01958489|9915813|P2|Period 2|Adverse Event|1
2881584|NCT01958489|9915814|P1|Period 2|Adverse Event|0
2881585|NCT01958476|9915830|P2|Overall Study|Parent requested exclusion from analysis|0
2881586|NCT01958476|9915831|P1|Overall Study|Parent requested exclusion from analysis|1
2881587|NCT01958437|9915861|P4|Overall Study|Incidental MRI findings|1
2881588|NCT01958437|9915862|P3|Overall Study|Incidental MRI findings|1
2881589|NCT01958437|9915863|P2|Overall Study|Incidental MRI findings|0
2881590|NCT01958437|9915864|P1|Overall Study|Incidental MRI findings|0
2881591|NCT01958294|9915928|P1|Overall Study|Clinical Circumstances|2
2881592|NCT01958281|9915937|P3|Overall Study|Withdrew Consent|0
2881593|NCT01958281|9915938|P2|Overall Study|Withdrew Consent|0
2881594|NCT01958281|9915939|P1|Overall Study|Withdrew Consent|1
2881595|NCT01958281|9915937|P3|Overall Study|Adverse Event|0
2881596|NCT01958281|9915938|P2|Overall Study|Adverse Event|2
2881597|NCT01958281|9915939|P1|Overall Study|Adverse Event|0
2881598|NCT01958281|9915937|P3|Overall Study|Lack of Efficacy|0
2881599|NCT01958281|9915938|P2|Overall Study|Lack of Efficacy|2
2881600|NCT01958281|9915939|P1|Overall Study|Lack of Efficacy|5
2881601|NCT01958164|9916015|P2|Overall Study|Lost to Follow-up|3
2881602|NCT01958164|9916016|P1|Overall Study|Lost to Follow-up|2
2881603|NCT01958164|9916015|P2|Overall Study|Adverse Event|2
2881604|NCT01958164|9916016|P1|Overall Study|Adverse Event|0
2881605|NCT01958125|9916031|P2|Overall Study|No headache attacks|2
2881606|NCT01958125|9916032|P1|Overall Study|No headache attacks|0
2881607|NCT01958125|9916031|P2|Overall Study|Missing diary data|6
2881608|NCT01958125|9916032|P1|Overall Study|Missing diary data|2
2881609|NCT01958060|9916060|P6|Overall Study|Not treated|0
2881610|NCT01958060|9916061|P5|Overall Study|Not treated|1
2881611|NCT01958060|9916062|P4|Overall Study|Not treated|0
2881612|NCT01958060|9916063|P3|Overall Study|Not treated|0
2881613|NCT01958060|9916064|P2|Overall Study|Not treated|0
2881614|NCT01958060|9916065|P1|Overall Study|Not treated|2
2881615|NCT01958021|9916090|P2|Overall Study|Death|0
2881616|NCT01958021|9916091|P1|Overall Study|Death|2
2881617|NCT01958021|9916090|P2|Overall Study|Protocol Violation|1
2881618|NCT01958021|9916091|P1|Overall Study|Protocol Violation|3
2881619|NCT01958021|9916090|P2|Overall Study|Physician Decision|13
2881620|NCT01958021|9916091|P1|Overall Study|Physician Decision|10
2881621|NCT01958021|9916090|P2|Overall Study|Subject/guardian decision|13
2881622|NCT01958021|9916091|P1|Overall Study|Subject/guardian decision|12
2881623|NCT01958021|9916090|P2|Overall Study|Adverse Event|7
2881624|NCT01958021|9916091|P1|Overall Study|Adverse Event|25
2881625|NCT01958021|9916090|P2|Overall Study|Progressive disease|146
2881626|NCT01958021|9916091|P1|Overall Study|Progressive disease|87
2881627|NCT01958008|9916103|P4|Overall Study|Other adverse event|0
2881628|NCT01958008|9916104|P3|Overall Study|Other adverse event|0
2881629|NCT01958008|9916105|P2|Overall Study|Other adverse event|0
2881630|NCT01958008|9916106|P1|Overall Study|Other adverse event|1
2881631|NCT01958008|9916103|P4|Overall Study|Worsening of disease under study|0
2881632|NCT01958008|9916104|P3|Overall Study|Worsening of disease under study|1
2881633|NCT01958008|9916105|P2|Overall Study|Worsening of disease under study|0
2881634|NCT01958008|9916106|P1|Overall Study|Worsening of disease under study|0
2881635|NCT01957865|9916149|P3|Overall Study|Lost to Follow-up|2
2881636|NCT01957865|9916150|P2|Overall Study|Lost to Follow-up|2
2881637|NCT01957865|9916151|P1|Overall Study|Lost to Follow-up|0
2881638|NCT01957865|9916149|P3|Overall Study|Found HIV negative|1
2881639|NCT01957865|9916150|P2|Overall Study|Found HIV negative|0
2881640|NCT01957865|9916151|P1|Overall Study|Found HIV negative|0
2881641|NCT01957787|9916162|P1|Overall Study|Local therapy, not cryoablation|6
2881642|NCT01957787|9916162|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
2881643|NCT01957787|9916162|P1|Overall Study|Index Tumor(s) Resected|2
2881644|NCT01957787|9916162|P1|Overall Study|Entered Hospice or Similar Program|2
2881645|NCT01957787|9916162|P1|Overall Study|Withdrawal by Subject|3
2881646|NCT01957787|9916162|P1|Overall Study|Lost to Follow-up|3
2881647|NCT01957787|9916162|P1|Overall Study|Death|18
2881648|NCT01957709|9916181|P1|Overall Study|Patient refused to complete post-tx bx|1
2881649|NCT01957644|9916206|P5|Overall Study|Protocol Violation|0
2881650|NCT01957644|9916207|P4|Overall Study|Protocol Violation|0
2881651|NCT01957644|9916208|P3|Overall Study|Protocol Violation|0
2881652|NCT01957644|9916209|P2|Overall Study|Protocol Violation|1
2881653|NCT01957644|9916210|P1|Overall Study|Protocol Violation|0
2881654|NCT01957644|9916206|P5|Overall Study|Withdrawal by Subject|0
2881655|NCT01957644|9916207|P4|Overall Study|Withdrawal by Subject|0
2881656|NCT01957644|9916208|P3|Overall Study|Withdrawal by Subject|0
2881657|NCT01957644|9916209|P2|Overall Study|Withdrawal by Subject|0
2881658|NCT01957644|9916210|P1|Overall Study|Withdrawal by Subject|1
2881659|NCT01957644|9916206|P5|Overall Study|Other reason|0
2881660|NCT01957644|9916207|P4|Overall Study|Other reason|1
2881661|NCT01957644|9916208|P3|Overall Study|Other reason|1
2881662|NCT01957644|9916209|P2|Overall Study|Other reason|2
2881663|NCT01957644|9916210|P1|Overall Study|Other reason|1
2881664|NCT01957644|9916206|P5|Overall Study|Progressive disease / relapse|0
2881665|NCT01957644|9916207|P4|Overall Study|Progressive disease / relapse|1
2881666|NCT01957644|9916208|P3|Overall Study|Progressive disease / relapse|0
2881667|NCT01957644|9916209|P2|Overall Study|Progressive disease / relapse|1
2881668|NCT01957644|9916210|P1|Overall Study|Progressive disease / relapse|0
2881669|NCT01957644|9916206|P5|Overall Study|Adverse Event|1
2881670|NCT01957644|9916207|P4|Overall Study|Adverse Event|0
2881671|NCT01957644|9916208|P3|Overall Study|Adverse Event|0
2881672|NCT01957644|9916209|P2|Overall Study|Adverse Event|2
2881673|NCT01957644|9916210|P1|Overall Study|Adverse Event|4
2881674|NCT01957579|9916234|P4|Overall Study|Death|0
2881675|NCT01957579|9916235|P3|Overall Study|Death|2
2881676|NCT01957579|9916236|P2|Overall Study|Death|0
2881677|NCT01957579|9916237|P1|Overall Study|Death|0
2881678|NCT01957579|9916234|P4|Overall Study|Withdrawal of concent|0
2881679|NCT01957579|9916235|P3|Overall Study|Withdrawal of concent|0
2881680|NCT01957579|9916236|P2|Overall Study|Withdrawal of concent|1
2881681|NCT01957579|9916237|P1|Overall Study|Withdrawal of concent|0
2881682|NCT01957553|9916304|P2|Test Period 2 (21 +- 1 Days)|Other|0
2881683|NCT01957553|9916305|P1|Test Period 2 (21 +- 1 Days)|Other|1
2881684|NCT01957553|9916304|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
2881685|NCT01957553|9916305|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
2881686|NCT01957553|9916304|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
2881687|NCT01957553|9916305|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
2881688|NCT01957553|9916304|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
2881689|NCT01957553|9916305|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
2881690|NCT01957553|9916304|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
2881691|NCT01957553|9916305|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
2881692|NCT01957553|9916304|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
2881693|NCT01957553|9916305|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
2881694|NCT01957553|9916304|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
2881695|NCT01957553|9916305|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
2881696|NCT01957553|9916304|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
2881697|NCT01957553|9916305|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
2881698|NCT01957553|9916304|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
2881699|NCT01957553|9916305|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
2881700|NCT01957488|9916311|P6|Test Period 3|Lack of Efficacy|0
2881701|NCT01957488|9916312|P5|Test Period 3|Lack of Efficacy|0
2881702|NCT01957488|9916313|P4|Test Period 3|Lack of Efficacy|0
2881703|NCT01957488|9916314|P3|Test Period 3|Lack of Efficacy|0
2881704|NCT01957488|9916315|P2|Test Period 3|Lack of Efficacy|1
2881705|NCT01957488|9916316|P1|Test Period 3|Lack of Efficacy|0
2881706|NCT01957488|9916311|P6|Test Period 3|Withdrawal by Subject|0
2881707|NCT01957488|9916312|P5|Test Period 3|Withdrawal by Subject|0
2881708|NCT01957488|9916313|P4|Test Period 3|Withdrawal by Subject|0
2881709|NCT01957488|9916314|P3|Test Period 3|Withdrawal by Subject|0
2881710|NCT01957488|9916315|P2|Test Period 3|Withdrawal by Subject|0
2881711|NCT01957488|9916316|P1|Test Period 3|Withdrawal by Subject|1
2881712|NCT01957488|9916311|P6|Test Period 2|Discontinue due to personal problems|1
2881713|NCT01957488|9916312|P5|Test Period 2|Discontinue due to personal problems|0
2881714|NCT01957488|9916313|P4|Test Period 2|Discontinue due to personal problems|0
2881715|NCT01957488|9916314|P3|Test Period 2|Discontinue due to personal problems|0
2881716|NCT01957488|9916315|P2|Test Period 2|Discontinue due to personal problems|0
2881717|NCT01957488|9916316|P1|Test Period 2|Discontinue due to personal problems|0
2881718|NCT01957488|9916311|P6|Test Period 2|Adverse Event|0
2881719|NCT01957488|9916312|P5|Test Period 2|Adverse Event|2
2881720|NCT01957488|9916313|P4|Test Period 2|Adverse Event|0
2881721|NCT01957488|9916314|P3|Test Period 2|Adverse Event|0
2881722|NCT01957488|9916315|P2|Test Period 2|Adverse Event|0
2881723|NCT01957488|9916316|P1|Test Period 2|Adverse Event|0
2881724|NCT01957488|9916311|P6|Test Period 2|Withdrawal by Subject|0
2881725|NCT01957488|9916312|P5|Test Period 2|Withdrawal by Subject|0
2881726|NCT01957488|9916313|P4|Test Period 2|Withdrawal by Subject|0
2881727|NCT01957488|9916314|P3|Test Period 2|Withdrawal by Subject|0
2881728|NCT01957488|9916315|P2|Test Period 2|Withdrawal by Subject|1
2881729|NCT01957488|9916316|P1|Test Period 2|Withdrawal by Subject|0
2881730|NCT01957488|9916311|P6|Test Period 2|Other|0
2881731|NCT01957488|9916312|P5|Test Period 2|Other|0
2881732|NCT01957488|9916313|P4|Test Period 2|Other|0
2881733|NCT01957488|9916314|P3|Test Period 2|Other|0
2881734|NCT01957488|9916315|P2|Test Period 2|Other|0
2881735|NCT01957488|9916316|P1|Test Period 2|Other|1
2881736|NCT01957488|9916311|P6|Test Period 2|Protocol Violation|0
2881737|NCT01957488|9916312|P5|Test Period 2|Protocol Violation|0
2881738|NCT01957488|9916313|P4|Test Period 2|Protocol Violation|1
2881739|NCT01957488|9916314|P3|Test Period 2|Protocol Violation|1
2881740|NCT01957488|9916315|P2|Test Period 2|Protocol Violation|0
2881741|NCT01957488|9916316|P1|Test Period 2|Protocol Violation|2
2881742|NCT01957488|9916311|P6|Test Period 1|screen failure|1
2881743|NCT01957488|9916312|P5|Test Period 1|screen failure|0
2881744|NCT01957488|9916313|P4|Test Period 1|screen failure|0
2881745|NCT01957488|9916314|P3|Test Period 1|screen failure|0
2881746|NCT01957488|9916315|P2|Test Period 1|screen failure|0
2881747|NCT01957488|9916316|P1|Test Period 1|screen failure|0
2881748|NCT01957488|9916311|P6|Test Period 1|subject did not want to wait for cut bag|0
2881749|NCT01957488|9916312|P5|Test Period 1|subject did not want to wait for cut bag|1
2881750|NCT01957488|9916313|P4|Test Period 1|subject did not want to wait for cut bag|0
2881751|NCT01957488|9916314|P3|Test Period 1|subject did not want to wait for cut bag|0
2881752|NCT01957488|9916315|P2|Test Period 1|subject did not want to wait for cut bag|0
2881753|NCT01957488|9916316|P1|Test Period 1|subject did not want to wait for cut bag|0
2881754|NCT01957488|9916311|P6|Test Period 1|Withdrawal by Subject|2
2881755|NCT01957488|9916312|P5|Test Period 1|Withdrawal by Subject|1
2881756|NCT01957488|9916313|P4|Test Period 1|Withdrawal by Subject|1
2881757|NCT01957488|9916314|P3|Test Period 1|Withdrawal by Subject|0
2881758|NCT01957488|9916315|P2|Test Period 1|Withdrawal by Subject|0
2881759|NCT01957488|9916316|P1|Test Period 1|Withdrawal by Subject|0
2881760|NCT01957488|9916311|P6|Test Period 1|Adverse Event|0
2881761|NCT01957488|9916312|P5|Test Period 1|Adverse Event|1
2881762|NCT01957488|9916313|P4|Test Period 1|Adverse Event|0
2881763|NCT01957488|9916314|P3|Test Period 1|Adverse Event|1
2881764|NCT01957488|9916315|P2|Test Period 1|Adverse Event|1
2881765|NCT01957488|9916316|P1|Test Period 1|Adverse Event|0
2881766|NCT01957488|9916311|P6|Test Period 1|Protocol Violation|3
2881767|NCT01957488|9916312|P5|Test Period 1|Protocol Violation|0
2881768|NCT01957488|9916313|P4|Test Period 1|Protocol Violation|1
2881769|NCT01957488|9916314|P3|Test Period 1|Protocol Violation|2
2881770|NCT01957488|9916315|P2|Test Period 1|Protocol Violation|2
2881771|NCT01957488|9916316|P1|Test Period 1|Protocol Violation|1
2881772|NCT01957488|9916311|P6|Test Period 1|Lost to Follow-up|0
2881773|NCT01957488|9916312|P5|Test Period 1|Lost to Follow-up|0
2881774|NCT01957488|9916313|P4|Test Period 1|Lost to Follow-up|1
2881775|NCT01957488|9916314|P3|Test Period 1|Lost to Follow-up|1
2881776|NCT01957488|9916315|P2|Test Period 1|Lost to Follow-up|0
2881777|NCT01957488|9916316|P1|Test Period 1|Lost to Follow-up|2
2881778|NCT01957475|9916324|P2|Test Period 2|Adverse Event|0
2881779|NCT01957475|9916325|P1|Test Period 2|Adverse Event|1
2881780|NCT01957475|9916324|P2|Test Period 1|Lack of Efficacy|1
2881781|NCT01957475|9916325|P1|Test Period 1|Lack of Efficacy|0
2881782|NCT01957475|9916324|P2|Test Period 1|Other|0
2881783|NCT01957475|9916325|P1|Test Period 1|Other|1
2881784|NCT01957475|9916324|P2|Test Period 1|Withdrawal by Subject|0
2881785|NCT01957475|9916325|P1|Test Period 1|Withdrawal by Subject|1
2881786|NCT01957462|9916331|P2|Test Period 1|Adverse Event|0
2881787|NCT01957462|9916332|P1|Test Period 1|Adverse Event|1
2881788|NCT01957462|9916331|P2|Test Period 1|Withdrawal by Subject|0
2881789|NCT01957462|9916332|P1|Test Period 1|Withdrawal by Subject|1
2881790|NCT01957397|9916343|P2|Test Period 3|the adhesive did not work|0
2881791|NCT01957397|9916344|P1|Test Period 3|the adhesive did not work|1
2881792|NCT01957397|9916343|P2|Test Period 3|Adverse Event|2
2881793|NCT01957397|9916344|P1|Test Period 3|Adverse Event|1
2881794|NCT01957397|9916343|P2|Test Period 2|Adverse Event|1
2881795|NCT01957397|9916344|P1|Test Period 2|Adverse Event|0
2881796|NCT01957397|9916343|P2|Test Period 1|Withdrawal by Subject|0
2881797|NCT01957397|9916344|P1|Test Period 1|Withdrawal by Subject|1
2881798|NCT01957397|9916343|P2|Test Period 1|sudden leakage/small bag|1
2881799|NCT01957397|9916344|P1|Test Period 1|sudden leakage/small bag|1
2881800|NCT01957215|9916369|P2|Overall Study|Withdrawal by Subject|5
2881801|NCT01957215|9916370|P1|Overall Study|Withdrawal by Subject|7
2881802|NCT01957215|9916369|P2|Overall Study|Protocol Violation|2
2881803|NCT01957215|9916370|P1|Overall Study|Protocol Violation|1
2881804|NCT01957215|9916369|P2|Overall Study|Lost to Follow-up|3
2881805|NCT01957215|9916370|P1|Overall Study|Lost to Follow-up|3
2881806|NCT01957215|9916369|P2|Overall Study|Adverse Event|2
2881807|NCT01957215|9916370|P1|Overall Study|Adverse Event|2
2881808|NCT01957202|9916398|P18|Treatment Period 3 (8 Days)|Adverse Event|0
2881809|NCT01957202|9916399|P17|Treatment Period 3 (8 Days)|Adverse Event|1
2881810|NCT01957202|9916400|P16|Treatment Period 3 (8 Days)|Adverse Event|0
2881811|NCT01957202|9916401|P15|Treatment Period 3 (8 Days)|Adverse Event|0
2881812|NCT01957202|9916402|P14|Treatment Period 3 (8 Days)|Adverse Event|0
2881813|NCT01957202|9916403|P13|Treatment Period 3 (8 Days)|Adverse Event|0
2881814|NCT01957202|9916404|P12|Treatment Period 3 (8 Days)|Adverse Event|0
2881815|NCT01957202|9916405|P11|Treatment Period 3 (8 Days)|Adverse Event|0
2881816|NCT01957202|9916406|P10|Treatment Period 3 (8 Days)|Adverse Event|0
2881817|NCT01957202|9916407|P9|Treatment Period 3 (8 Days)|Adverse Event|0
2881818|NCT01957202|9916408|P8|Treatment Period 3 (8 Days)|Adverse Event|0
2881819|NCT01957202|9916409|P7|Treatment Period 3 (8 Days)|Adverse Event|0
2881820|NCT01957202|9916410|P6|Treatment Period 3 (8 Days)|Adverse Event|0
2881821|NCT01957202|9916411|P5|Treatment Period 3 (8 Days)|Adverse Event|0
2881822|NCT01957202|9916412|P4|Treatment Period 3 (8 Days)|Adverse Event|0
2881823|NCT01957202|9916413|P3|Treatment Period 3 (8 Days)|Adverse Event|0
2881824|NCT01957202|9916414|P2|Treatment Period 3 (8 Days)|Adverse Event|0
2881825|NCT01957202|9916415|P1|Treatment Period 3 (8 Days)|Adverse Event|0
2881826|NCT01957202|9916398|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881827|NCT01957202|9916399|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2881828|NCT01957202|9916400|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881829|NCT01957202|9916401|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881830|NCT01957202|9916402|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881831|NCT01957202|9916403|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881832|NCT01957202|9916404|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881833|NCT01957202|9916405|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881834|NCT01957202|9916406|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881835|NCT01957202|9916407|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881836|NCT01957202|9916408|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881837|NCT01957202|9916409|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881838|NCT01957202|9916410|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881839|NCT01957202|9916411|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881840|NCT01957202|9916412|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881841|NCT01957202|9916413|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881842|NCT01957202|9916414|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2881843|NCT01957202|9916415|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2881844|NCT01957163|9916440|P3|Overall Study|Withdrawal by Subject|4
2881845|NCT01957163|9916441|P2|Overall Study|Withdrawal by Subject|2
2881846|NCT01957163|9916442|P1|Overall Study|Withdrawal by Subject|4
2881847|NCT01957163|9916440|P3|Overall Study|Lost to Follow-up|0
2881848|NCT01957163|9916441|P2|Overall Study|Lost to Follow-up|1
2881849|NCT01957163|9916442|P1|Overall Study|Lost to Follow-up|0
2881850|NCT01957163|9916440|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
2881851|NCT01957163|9916441|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
2881852|NCT01957163|9916442|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
2881853|NCT01957163|9916440|P3|Overall Study|Protocol Violation|0
2881854|NCT01957163|9916441|P2|Overall Study|Protocol Violation|2
2881855|NCT01957163|9916442|P1|Overall Study|Protocol Violation|1
2881856|NCT01957163|9916440|P3|Overall Study|Lack of Efficacy|9
2881857|NCT01957163|9916441|P2|Overall Study|Lack of Efficacy|4
2881858|NCT01957163|9916442|P1|Overall Study|Lack of Efficacy|5
2881859|NCT01957163|9916440|P3|Overall Study|Adverse Event|4
2881860|NCT01957163|9916441|P2|Overall Study|Adverse Event|2
2881861|NCT01957163|9916442|P1|Overall Study|Adverse Event|5
2881862|NCT01957150|9916455|P2|Overall Study|Lack of Efficacy|11
2881863|NCT01957150|9916456|P1|Overall Study|Lack of Efficacy|11
2881864|NCT01957150|9916455|P2|Overall Study|Protocol Violation|0
2881865|NCT01957150|9916456|P1|Overall Study|Protocol Violation|1
2881866|NCT01957150|9916455|P2|Overall Study|Lost to Follow-up|4
2881867|NCT01957150|9916456|P1|Overall Study|Lost to Follow-up|4
2881868|NCT01957150|9916455|P2|Overall Study|Physician Decision|6
2881869|NCT01957150|9916456|P1|Overall Study|Physician Decision|3
2881870|NCT01957150|9916455|P2|Overall Study|Withdrawal by Subject|17
2881871|NCT01957150|9916456|P1|Overall Study|Withdrawal by Subject|13
2881872|NCT01957150|9916455|P2|Overall Study|Adverse Event|20
2881873|NCT01957150|9916456|P1|Overall Study|Adverse Event|23
2881874|NCT01957137|9916472|P1|Randomized Portion|Withdrawal by Subject|1
2881875|NCT01957137|9916472|P1|Randomized Portion|Adverse Event|1
2881876|NCT01957111|9916502|P2|Overall Study|Withdrawal by Subject|1
2881877|NCT01957111|9916503|P1|Overall Study|Withdrawal by Subject|1
2881878|NCT01956773|9916522|P2|Overall Study|Lost to Follow-up|1
2881879|NCT01956773|9916523|P1|Overall Study|Lost to Follow-up|628
2881880|NCT01956240|9916561|P2|Overall Study|Adverse Event|4
2881881|NCT01956240|9916562|P1|Overall Study|Adverse Event|17
2881882|NCT01956240|9916561|P2|Overall Study|Lost to Follow-up|20
2881883|NCT01956240|9916562|P1|Overall Study|Lost to Follow-up|6
2881884|NCT01956123|9916572|P4|COS Cycle 3|Withdrawal by Subject|1
2881885|NCT01956123|9916573|P3|COS Cycle 3|Withdrawal by Subject|0
2881886|NCT01956123|9916574|P2|COS Cycle 3|Withdrawal by Subject|0
2881887|NCT01956123|9916575|P1|COS Cycle 3|Withdrawal by Subject|0
2881888|NCT01956123|9916572|P4|COS Cycle 3|Personal Reasons|0
2881889|NCT01956123|9916573|P3|COS Cycle 3|Personal Reasons|1
2881890|NCT01956123|9916574|P2|COS Cycle 3|Personal Reasons|0
2881891|NCT01956123|9916575|P1|COS Cycle 3|Personal Reasons|0
2881892|NCT01956123|9916572|P4|COS Cycle 3|Adverse Event|0
2881893|NCT01956123|9916573|P3|COS Cycle 3|Adverse Event|3
2881894|NCT01956123|9916574|P2|COS Cycle 3|Adverse Event|0
2881895|NCT01956123|9916575|P1|COS Cycle 3|Adverse Event|0
2881896|NCT01956123|9916572|P4|COS Cycle 3|Protocol Violation|1
2881897|NCT01956123|9916573|P3|COS Cycle 3|Protocol Violation|2
2881898|NCT01956123|9916574|P2|COS Cycle 3|Protocol Violation|0
2881899|NCT01956123|9916575|P1|COS Cycle 3|Protocol Violation|0
2881900|NCT01956123|9916572|P4|COS Cycle 2|Withdrawal by Subject|0
2881901|NCT01956123|9916573|P3|COS Cycle 2|Withdrawal by Subject|0
2881902|NCT01956123|9916574|P2|COS Cycle 2|Withdrawal by Subject|0
2881903|NCT01956123|9916575|P1|COS Cycle 2|Withdrawal by Subject|1
2881904|NCT01956123|9916572|P4|COS Cycle 2|Personal Reasons|0
2881905|NCT01956123|9916573|P3|COS Cycle 2|Personal Reasons|0
2881906|NCT01956123|9916574|P2|COS Cycle 2|Personal Reasons|0
2881907|NCT01956123|9916575|P1|COS Cycle 2|Personal Reasons|2
2881908|NCT01956123|9916572|P4|COS Cycle 2|Adverse Event|0
2881909|NCT01956123|9916573|P3|COS Cycle 2|Adverse Event|0
2881910|NCT01956123|9916574|P2|COS Cycle 2|Adverse Event|4
2881911|NCT01956123|9916575|P1|COS Cycle 2|Adverse Event|3
2881912|NCT01956123|9916572|P4|COS Cycle 2|Protocol Violation|0
2881913|NCT01956123|9916573|P3|COS Cycle 2|Protocol Violation|0
2881914|NCT01956123|9916574|P2|COS Cycle 2|Protocol Violation|3
2881915|NCT01956123|9916575|P1|COS Cycle 2|Protocol Violation|8
2881916|NCT01956110|9916627|P2|Overall Study|Personal reasons|1
2881917|NCT01956110|9916628|P1|Overall Study|Personal reasons|1
2881918|NCT01956110|9916627|P2|Overall Study|Adverse Event|10
2881919|NCT01956110|9916628|P1|Overall Study|Adverse Event|9
2881920|NCT01956110|9916627|P2|Overall Study|Protocol Violation|11
2881921|NCT01956110|9916628|P1|Overall Study|Protocol Violation|25
2881922|NCT01955733|9916763|P3|Period 2|Other not defined above|2
2881923|NCT01955733|9916764|P2|Period 2|Other not defined above|2
2881924|NCT01955733|9916765|P1|Period 2|Other not defined above|0
2881925|NCT01955733|9916763|P3|Period 2|Lost to Follow-up|0
2881926|NCT01955733|9916764|P2|Period 2|Lost to Follow-up|0
2881927|NCT01955733|9916765|P1|Period 2|Lost to Follow-up|2
2881928|NCT01955733|9916763|P3|Period 2|Study terminated by sponsor|16
2881929|NCT01955733|9916764|P2|Period 2|Study terminated by sponsor|14
2881930|NCT01955733|9916765|P1|Period 2|Study terminated by sponsor|8
2881931|NCT01955733|9916763|P3|Period 2|Withdrawal by Subject|2
2881932|NCT01955733|9916764|P2|Period 2|Withdrawal by Subject|3
2881933|NCT01955733|9916765|P1|Period 2|Withdrawal by Subject|1
2881934|NCT01955733|9916763|P3|Period 2|Physician Decision|1
2881935|NCT01955733|9916764|P2|Period 2|Physician Decision|0
2881936|NCT01955733|9916765|P1|Period 2|Physician Decision|0
2881937|NCT01955733|9916763|P3|Period 2|Adverse Event|0
2881938|NCT01955733|9916764|P2|Period 2|Adverse Event|0
2881939|NCT01955733|9916765|P1|Period 2|Adverse Event|1
2881940|NCT01955733|9916763|P3|Period 1|Lost to Follow-up|0
2881941|NCT01955733|9916764|P2|Period 1|Lost to Follow-up|0
2881942|NCT01955733|9916765|P1|Period 1|Lost to Follow-up|1
2881943|NCT01955707|9916858|P2|Overall Study|Other|2
2881944|NCT01955707|9916859|P1|Overall Study|Other|4
2881945|NCT01955707|9916858|P2|Overall Study|Death|14
2881946|NCT01955707|9916859|P1|Overall Study|Death|13
2881947|NCT01955707|9916858|P2|Overall Study|Withdrawal by Subject|3
2881948|NCT01955707|9916859|P1|Overall Study|Withdrawal by Subject|0
2881949|NCT01955707|9916858|P2|Overall Study|Lost to Follow-up|1
2881950|NCT01955707|9916859|P1|Overall Study|Lost to Follow-up|2
2881951|NCT01955707|9916858|P2|Overall Study|Adverse Event|2
2881952|NCT01955707|9916859|P1|Overall Study|Adverse Event|1
2881953|NCT01955161|9917127|P3|Overall Study|Other reason: patient's will|1
2881954|NCT01955161|9917128|P2|Overall Study|Other reason: patient's will|0
2881955|NCT01955161|9917129|P1|Overall Study|Other reason: patient's will|0
2881956|NCT01955161|9917127|P3|Overall Study|Other reason: primary biliary cirrhosis|0
2881957|NCT01955161|9917128|P2|Overall Study|Other reason: primary biliary cirrhosis|0
2881958|NCT01955161|9917129|P1|Overall Study|Other reason: primary biliary cirrhosis|1
2881959|NCT01955161|9917127|P3|Overall Study|Other reason: insufficient compliance|1
2881960|NCT01955161|9917128|P2|Overall Study|Other reason: insufficient compliance|0
2881961|NCT01955161|9917129|P1|Overall Study|Other reason: insufficient compliance|0
2881962|NCT01955161|9917127|P3|Overall Study|Other reason: moved to nursing home|0
2881963|NCT01955161|9917128|P2|Overall Study|Other reason: moved to nursing home|1
2881964|NCT01955161|9917129|P1|Overall Study|Other reason: moved to nursing home|0
2881965|NCT01955161|9917127|P3|Overall Study|Other reason: caregiver unavailable|0
2881966|NCT01955161|9917128|P2|Overall Study|Other reason: caregiver unavailable|0
2881967|NCT01955161|9917129|P1|Overall Study|Other reason: caregiver unavailable|1
2881968|NCT01955161|9917127|P3|Overall Study|Other reason: disallowed medication|1
2881969|NCT01955161|9917128|P2|Overall Study|Other reason: disallowed medication|0
2881970|NCT01955161|9917129|P1|Overall Study|Other reason: disallowed medication|1
2881971|NCT01955161|9917127|P3|Overall Study|Other reason: physician decision|1
2881972|NCT01955161|9917128|P2|Overall Study|Other reason: physician decision|1
2881973|NCT01955161|9917129|P1|Overall Study|Other reason: physician decision|0
2881974|NCT01955161|9917127|P3|Overall Study|Protocol Violation|0
2881975|NCT01955161|9917128|P2|Overall Study|Protocol Violation|0
2881976|NCT01955161|9917129|P1|Overall Study|Protocol Violation|2
2881977|NCT01955161|9917127|P3|Overall Study|Withdrawal by Subject|12
2881978|NCT01955161|9917128|P2|Overall Study|Withdrawal by Subject|8
2881979|NCT01955161|9917129|P1|Overall Study|Withdrawal by Subject|9
2881980|NCT01955161|9917127|P3|Overall Study|Death|3
2881981|NCT01955161|9917128|P2|Overall Study|Death|1
2881982|NCT01955161|9917129|P1|Overall Study|Death|1
2881983|NCT01955161|9917127|P3|Overall Study|Adverse Event|15
2881984|NCT01955161|9917128|P2|Overall Study|Adverse Event|14
2881985|NCT01955161|9917129|P1|Overall Study|Adverse Event|10
2881986|NCT01955161|9917127|P3|Overall Study|Withdrawal before treatment|1
2881987|NCT01955161|9917128|P2|Overall Study|Withdrawal before treatment|0
2881988|NCT01955161|9917129|P1|Overall Study|Withdrawal before treatment|2
2881989|NCT01955122|9917169|P2|Overall Study|Physician Decision|5
2881990|NCT01955122|9917170|P1|Overall Study|Physician Decision|5
2881991|NCT01955083|9917190|P2|Overall Study|Lost to Follow-up|1
2881992|NCT01955083|9917191|P1|Overall Study|Lost to Follow-up|1
2881993|NCT01955044|9917224|P3|Overall Study|Death|0
2881994|NCT01955044|9917225|P2|Overall Study|Death|1
2881995|NCT01955044|9917226|P1|Overall Study|Death|1
2881996|NCT01955005|9917239|P2|Overall Study|Withdrawal by Subject|5
2881997|NCT01955005|9917240|P1|Overall Study|Withdrawal by Subject|3
2881998|NCT01954927|9917252|P2|Overall Study|Withdrawal by Subject|1
2881999|NCT01954927|9917253|P1|Overall Study|Withdrawal by Subject|3
2882000|NCT01954771|9917274|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
2882001|NCT01954771|9917275|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
2882002|NCT01954771|9917276|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
2882003|NCT01954771|9917274|P3|Overall Study|Missing CGMS of end-point|0
2882004|NCT01954771|9917275|P2|Overall Study|Missing CGMS of end-point|1
2882005|NCT01954771|9917276|P1|Overall Study|Missing CGMS of end-point|1
2882006|NCT01954771|9917274|P3|Overall Study|Missing HbA1c of end-point|0
2882007|NCT01954771|9917275|P2|Overall Study|Missing HbA1c of end-point|1
2882008|NCT01954771|9917276|P1|Overall Study|Missing HbA1c of end-point|1
2882009|NCT01954745|9917293|P1|Overall Study|Death|1
2882010|NCT01954745|9917293|P1|Overall Study|Adverse Event|2
2882011|NCT01954745|9917293|P1|Overall Study|Clinical Progression|5
2882012|NCT01954745|9917293|P1|Overall Study|Radiological Progression|11
2882013|NCT01954394|9917324|P2|Overall Study|Other than specified above|21
2882014|NCT01954394|9917325|P1|Overall Study|Other than specified above|10
2882015|NCT01954394|9917324|P2|Overall Study|Related to Study Drug administration|2
2882016|NCT01954394|9917325|P1|Overall Study|Related to Study Drug administration|2
2882017|NCT01954394|9917324|P2|Overall Study|Participant Moved|4
2882018|NCT01954394|9917325|P1|Overall Study|Participant Moved|0
2882019|NCT01954394|9917324|P2|Overall Study|Poor compliance to protocol|7
2882020|NCT01954394|9917325|P1|Overall Study|Poor compliance to protocol|7
2882021|NCT01954394|9917324|P2|Overall Study|Adverse Event|23
2882022|NCT01954394|9917325|P1|Overall Study|Adverse Event|10
2882023|NCT01954394|9917324|P2|Overall Study|Enrolled but not treated|0
2882024|NCT01954394|9917325|P1|Overall Study|Enrolled but not treated|1
2882025|NCT01954251|9917427|P2|Overall Study|Withdrawal by Subject|6
2882026|NCT01954251|9917428|P1|Overall Study|Withdrawal by Subject|2
2882027|NCT01954251|9917427|P2|Overall Study|Lost to Follow-up|6
2882028|NCT01954251|9917428|P1|Overall Study|Lost to Follow-up|6
2882029|NCT01954251|9917427|P2|Overall Study|Adverse Event|7
2882030|NCT01954251|9917428|P1|Overall Study|Adverse Event|5
2882031|NCT01954121|9917525|P2|Overall Study|Subject did not follow instructions|2
2882032|NCT01954121|9917526|P1|Overall Study|Subject did not follow instructions|0
2882033|NCT01954121|9917525|P2|Overall Study|Non-compliant patient|1
2882034|NCT01954121|9917526|P1|Overall Study|Non-compliant patient|1
2882035|NCT01954121|9917525|P2|Overall Study|Non-compliant with study procedures|0
2882036|NCT01954121|9917526|P1|Overall Study|Non-compliant with study procedures|1
2882037|NCT01954121|9917525|P2|Overall Study|SAE, non-fatal|4
2882038|NCT01954121|9917526|P1|Overall Study|SAE, non-fatal|1
2882039|NCT01954121|9917525|P2|Overall Study|AE, non-serious non-fatal|22
2882040|NCT01954121|9917526|P1|Overall Study|AE, non-serious non-fatal|5
2882041|NCT01954121|9917525|P2|Overall Study|AE, serious fatal|0
2882042|NCT01954121|9917526|P1|Overall Study|AE, serious fatal|1
2882043|NCT01954121|9917525|P2|Overall Study|Pregnancy|1
2882044|NCT01954121|9917526|P1|Overall Study|Pregnancy|1
2882045|NCT01954121|9917525|P2|Overall Study|Withdrawal by Subject|12
2882046|NCT01954121|9917526|P1|Overall Study|Withdrawal by Subject|18
2882047|NCT01954121|9917525|P2|Overall Study|Lost to Follow-up|6
2882048|NCT01954121|9917526|P1|Overall Study|Lost to Follow-up|5
2882049|NCT01954121|9917525|P2|Overall Study|Protocol Violation|2
2882050|NCT01954121|9917526|P1|Overall Study|Protocol Violation|0
2882051|NCT01954121|9917525|P2|Overall Study|Lack of Efficacy|41
2882052|NCT01954121|9917526|P1|Overall Study|Lack of Efficacy|94
2882053|NCT01954082|9917542|P2|Overall Study|Randomized not Treated|2
2882054|NCT01954082|9917543|P1|Overall Study|Randomized not Treated|4
2882055|NCT01954082|9917542|P2|Overall Study|Infant Moved|1
2882056|NCT01954082|9917543|P1|Overall Study|Infant Moved|0
2882057|NCT01954082|9917542|P2|Overall Study|Comfort Care|1
2882058|NCT01954082|9917543|P1|Overall Study|Comfort Care|0
2882059|NCT01954082|9917542|P2|Overall Study|Miscalculation of Final Dose Day|3
2882060|NCT01954082|9917543|P1|Overall Study|Miscalculation of Final Dose Day|0
2882061|NCT01954082|9917542|P2|Overall Study|Redirection of Care|2
2882062|NCT01954082|9917543|P1|Overall Study|Redirection of Care|0
2882063|NCT01954082|9917542|P2|Overall Study|Discontinued Early Prior to Transfer|2
2882064|NCT01954082|9917543|P1|Overall Study|Discontinued Early Prior to Transfer|3
2882065|NCT01954082|9917542|P2|Overall Study|Withdrawal by Subject|1
2882066|NCT01954082|9917543|P1|Overall Study|Withdrawal by Subject|0
2882067|NCT01954082|9917542|P2|Overall Study|Parent Decision|0
2882068|NCT01954082|9917543|P1|Overall Study|Parent Decision|1
2882069|NCT01954082|9917542|P2|Overall Study|Physician Decision|0
2882070|NCT01954082|9917543|P1|Overall Study|Physician Decision|2
2882071|NCT01954082|9917542|P2|Overall Study|Non-compliance|4
2882072|NCT01954082|9917543|P1|Overall Study|Non-compliance|6
2882073|NCT01954082|9917542|P2|Overall Study|Intolerance|1
2882074|NCT01954082|9917543|P1|Overall Study|Intolerance|0
2882075|NCT01954082|9917542|P2|Overall Study|Adverse Event|4
2882076|NCT01954082|9917543|P1|Overall Study|Adverse Event|10
2882077|NCT01954082|9917542|P2|Overall Study|Study Suspension|36
2882078|NCT01954082|9917543|P1|Overall Study|Study Suspension|42
2882079|NCT01954056|9917563|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
2882080|NCT01954056|9917564|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
2882081|NCT01954017|9917609|P3|Overall Study|All other reasons|7
2882082|NCT01954017|9917610|P2|Overall Study|All other reasons|2
2882083|NCT01954017|9917611|P1|Overall Study|All other reasons|2
2882084|NCT01954017|9917609|P3|Overall Study|Enteral intake stopped >7 days|1
2882085|NCT01954017|9917610|P2|Overall Study|Enteral intake stopped >7 days|1
2882086|NCT01954017|9917611|P1|Overall Study|Enteral intake stopped >7 days|0
2882087|NCT01954017|9917609|P3|Overall Study|Necrotizing enterocolitis|1
2882088|NCT01954017|9917610|P2|Overall Study|Necrotizing enterocolitis|0
2882089|NCT01954017|9917611|P1|Overall Study|Necrotizing enterocolitis|1
2882090|NCT01954017|9917609|P3|Overall Study|Protocol Violation|2
2882091|NCT01954017|9917610|P2|Overall Study|Protocol Violation|3
2882092|NCT01954017|9917611|P1|Overall Study|Protocol Violation|0
2882093|NCT01954017|9917609|P3|Overall Study|Withdrawal by Subject|0
2882094|NCT01954017|9917610|P2|Overall Study|Withdrawal by Subject|1
2882095|NCT01954017|9917611|P1|Overall Study|Withdrawal by Subject|0
2882096|NCT01954017|9917609|P3|Overall Study|Death|1
2882097|NCT01954017|9917610|P2|Overall Study|Death|1
2882098|NCT01954017|9917611|P1|Overall Study|Death|2
2882099|NCT01954017|9917609|P3|Overall Study|Adverse Event|1
2882100|NCT01954017|9917610|P2|Overall Study|Adverse Event|0
2882101|NCT01954017|9917611|P1|Overall Study|Adverse Event|0
2882102|NCT01953913|9917837|P1|Overall Study|Not Treated|1
2882103|NCT01953913|9917837|P1|Overall Study|Other than listed|108
2882104|NCT01953913|9917837|P1|Overall Study|Withdrawal by Subject|32
2882105|NCT01953913|9917837|P1|Overall Study|Lost to Follow-up|4
2882106|NCT01953913|9917837|P1|Overall Study|Protocol Violation|6
2882107|NCT01953913|9917837|P1|Overall Study|Adverse Event|20
2882108|NCT01953913|9917837|P1|Overall Study|Worsening of underlying cancer|22
2882109|NCT01953913|9917837|P1|Overall Study|Disease Progression|349
2882110|NCT01953601|9917892|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
2882111|NCT01953601|9917893|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
2882112|NCT01953601|9917894|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
2882113|NCT01953601|9917892|P3|Part 2 (Extension Study)|Subject moved|1
2882114|NCT01953601|9917893|P2|Part 2 (Extension Study)|Subject moved|0
2882115|NCT01953601|9917894|P1|Part 2 (Extension Study)|Subject moved|0
2882116|NCT01953601|9917892|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
2882117|NCT01953601|9917893|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
2882118|NCT01953601|9917894|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
2882119|NCT01953601|9917892|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
2882120|NCT01953601|9917893|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
2882121|NCT01953601|9917894|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
2882122|NCT01953601|9917892|P3|Part 2 (Extension Study)|Site discontinued study participation|1
2882123|NCT01953601|9917893|P2|Part 2 (Extension Study)|Site discontinued study participation|1
2882124|NCT01953601|9917894|P1|Part 2 (Extension Study)|Site discontinued study participation|0
2882125|NCT01953601|9917892|P3|Part 2 (Extension Study)|Physician Decision|2
2882126|NCT01953601|9917893|P2|Part 2 (Extension Study)|Physician Decision|0
2882127|NCT01953601|9917894|P1|Part 2 (Extension Study)|Physician Decision|2
2882128|NCT01953601|9917892|P3|Part 2 (Extension Study)|Lost to Follow-up|1
2882129|NCT01953601|9917893|P2|Part 2 (Extension Study)|Lost to Follow-up|1
2882130|NCT01953601|9917894|P1|Part 2 (Extension Study)|Lost to Follow-up|2
2882131|NCT01953601|9917892|P3|Part 2 (Extension Study)|Lack of Efficacy|0
2882132|NCT01953601|9917893|P2|Part 2 (Extension Study)|Lack of Efficacy|0
2882133|NCT01953601|9917894|P1|Part 2 (Extension Study)|Lack of Efficacy|2
2882134|NCT01953601|9917892|P3|Part 2 (Extension Study)|Death|0
2882135|NCT01953601|9917893|P2|Part 2 (Extension Study)|Death|3
2882136|NCT01953601|9917894|P1|Part 2 (Extension Study)|Death|0
2882137|NCT01953601|9917892|P3|Part 2 (Extension Study)|Adverse Event|10
2882138|NCT01953601|9917893|P2|Part 2 (Extension Study)|Adverse Event|1
2882139|NCT01953601|9917894|P1|Part 2 (Extension Study)|Adverse Event|1
2882140|NCT01953601|9917892|P3|Part 1 (Base Study)|Withdrawal by Subject|22
2882141|NCT01953601|9917893|P2|Part 1 (Base Study)|Withdrawal by Subject|23
2882142|NCT01953601|9917894|P1|Part 1 (Base Study)|Withdrawal by Subject|32
2882143|NCT01953601|9917892|P3|Part 1 (Base Study)|Subject moved|1
2882144|NCT01953601|9917893|P2|Part 1 (Base Study)|Subject moved|2
2882145|NCT01953601|9917894|P1|Part 1 (Base Study)|Subject moved|2
2882146|NCT01953601|9917892|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
2882147|NCT01953601|9917893|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
2882148|NCT01953601|9917894|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
2882149|NCT01953601|9917892|P3|Part 1 (Base Study)|Study terminated by sponsor|179
2882150|NCT01953601|9917893|P2|Part 1 (Base Study)|Study terminated by sponsor|169
2882151|NCT01953601|9917894|P1|Part 1 (Base Study)|Study terminated by sponsor|174
2882152|NCT01953601|9917892|P3|Part 1 (Base Study)|Site discontinued study participation|0
2882153|NCT01953601|9917893|P2|Part 1 (Base Study)|Site discontinued study participation|0
2882154|NCT01953601|9917894|P1|Part 1 (Base Study)|Site discontinued study participation|2
2882155|NCT01953601|9917892|P3|Part 1 (Base Study)|Screen failure|1
2882156|NCT01953601|9917893|P2|Part 1 (Base Study)|Screen failure|0
2882157|NCT01953601|9917894|P1|Part 1 (Base Study)|Screen failure|1
2882158|NCT01953601|9917892|P3|Part 1 (Base Study)|Physician Decision|4
2882159|NCT01953601|9917893|P2|Part 1 (Base Study)|Physician Decision|7
2882160|NCT01953601|9917894|P1|Part 1 (Base Study)|Physician Decision|3
2882161|NCT01953601|9917892|P3|Part 1 (Base Study)|Non-compliance with study drug|1
2882162|NCT01953601|9917893|P2|Part 1 (Base Study)|Non-compliance with study drug|3
2882163|NCT01953601|9917894|P1|Part 1 (Base Study)|Non-compliance with study drug|0
2882164|NCT01953601|9917892|P3|Part 1 (Base Study)|Lost to Follow-up|6
2882165|NCT01953601|9917893|P2|Part 1 (Base Study)|Lost to Follow-up|3
2882166|NCT01953601|9917894|P1|Part 1 (Base Study)|Lost to Follow-up|1
2882167|NCT01953601|9917892|P3|Part 1 (Base Study)|Lack of Efficacy|4
2882168|NCT01953601|9917893|P2|Part 1 (Base Study)|Lack of Efficacy|1
2882169|NCT01953601|9917894|P1|Part 1 (Base Study)|Lack of Efficacy|3
2882170|NCT01953601|9917892|P3|Part 1 (Base Study)|Death|3
2882171|NCT01953601|9917893|P2|Part 1 (Base Study)|Death|0
2882172|NCT01953601|9917894|P1|Part 1 (Base Study)|Death|2
2882173|NCT01953601|9917892|P3|Part 1 (Base Study)|Adverse Event|15
2882174|NCT01953601|9917893|P2|Part 1 (Base Study)|Adverse Event|37
2882175|NCT01953601|9917894|P1|Part 1 (Base Study)|Adverse Event|24
2882176|NCT01953354|9917965|P2|Overall Study|Disease Exacerbation|0
2882177|NCT01953354|9917966|P1|Overall Study|Disease Exacerbation|1
2882178|NCT01953354|9917965|P2|Overall Study|Decision of Sponsor|1
2882179|NCT01953354|9917966|P1|Overall Study|Decision of Sponsor|0
2882180|NCT01953354|9917965|P2|Overall Study|Withdrawal by Subject|1
2882181|NCT01953354|9917966|P1|Overall Study|Withdrawal by Subject|0
2882182|NCT01953328|9917994|P8|Overall Study|Lost to Follow-up|0
2882183|NCT01953328|9917995|P7|Overall Study|Lost to Follow-up|0
2882184|NCT01953328|9917996|P6|Overall Study|Lost to Follow-up|0
2882185|NCT01953328|9917997|P5|Overall Study|Lost to Follow-up|1
2882186|NCT01953328|9917998|P4|Overall Study|Lost to Follow-up|0
2882187|NCT01953328|9917999|P3|Overall Study|Lost to Follow-up|0
2882188|NCT01953328|9918000|P2|Overall Study|Lost to Follow-up|0
2882189|NCT01953328|9918001|P1|Overall Study|Lost to Follow-up|0
2882190|NCT01953328|9917994|P8|Overall Study|Withdrawal by Subject|0
2882191|NCT01953328|9917995|P7|Overall Study|Withdrawal by Subject|0
2882192|NCT01953328|9917996|P6|Overall Study|Withdrawal by Subject|0
2882193|NCT01953328|9917997|P5|Overall Study|Withdrawal by Subject|1
2882194|NCT01953328|9917998|P4|Overall Study|Withdrawal by Subject|0
2882195|NCT01953328|9917999|P3|Overall Study|Withdrawal by Subject|0
2882196|NCT01953328|9918000|P2|Overall Study|Withdrawal by Subject|0
2882197|NCT01953328|9918001|P1|Overall Study|Withdrawal by Subject|0
2882198|NCT01953224|9918214|P2|Overall Study|Withdrawal by Subject|2
2882199|NCT01953224|9918215|P1|Overall Study|Withdrawal by Subject|1
2882200|NCT01953224|9918214|P2|Overall Study|Lost to Follow-up|1
2882201|NCT01953224|9918215|P1|Overall Study|Lost to Follow-up|1
2882202|NCT01953003|9918264|P2|Overall Study|Withdrawal by Subject|4
2882203|NCT01953003|9918265|P1|Overall Study|Withdrawal by Subject|14
2882204|NCT01953003|9918264|P2|Overall Study|Protocol Violation|1
2882205|NCT01953003|9918265|P1|Overall Study|Protocol Violation|0
2882206|NCT01953003|9918264|P2|Overall Study|Non-related adverse events|2
2882207|NCT01953003|9918265|P1|Overall Study|Non-related adverse events|0
2882208|NCT01953003|9918264|P2|Overall Study|Related Adverse events|2
2882209|NCT01953003|9918265|P1|Overall Study|Related Adverse events|7
2882210|NCT01953003|9918264|P2|Overall Study|Progressive disease|45
2882211|NCT01953003|9918265|P1|Overall Study|Progressive disease|35
2882212|NCT01953003|9918264|P2|Overall Study|Not treated|1
2882213|NCT01953003|9918265|P1|Overall Study|Not treated|0
2882214|NCT01952834|9918271|P1|Overall Study|Adverse Event|1
2882215|NCT01952691|9918278|P1|Overall Study|Lost to Follow-up|2
2882216|NCT01952665|9918305|P2|Overall Study|Protocol Violation|1
2882217|NCT01952665|9918306|P1|Overall Study|Protocol Violation|0
2882218|NCT01952665|9918305|P2|Overall Study|Adverse Event|1
2882219|NCT01952665|9918306|P1|Overall Study|Adverse Event|2
2882220|NCT01952665|9918305|P2|Overall Study|Lost to Follow-up|2
2882221|NCT01952665|9918306|P1|Overall Study|Lost to Follow-up|1
2882222|NCT01952665|9918305|P2|Overall Study|Physician Decision|2
2882223|NCT01952665|9918306|P1|Overall Study|Physician Decision|3
2882224|NCT01952574|9918461|P4|Overall Study|Lost to Follow-up|0
2882225|NCT01952574|9918462|P3|Overall Study|Lost to Follow-up|1
2882226|NCT01952574|9918463|P2|Overall Study|Lost to Follow-up|0
2882227|NCT01952574|9918464|P1|Overall Study|Lost to Follow-up|2
2882228|NCT01952574|9918461|P4|Overall Study|Sponsor Decision|2
2882229|NCT01952574|9918462|P3|Overall Study|Sponsor Decision|5
2882230|NCT01952574|9918463|P2|Overall Study|Sponsor Decision|0
2882231|NCT01952574|9918464|P1|Overall Study|Sponsor Decision|6
2882232|NCT01952574|9918461|P4|Overall Study|Withdrawal by Subject|4
2882233|NCT01952574|9918462|P3|Overall Study|Withdrawal by Subject|3
2882234|NCT01952574|9918463|P2|Overall Study|Withdrawal by Subject|3
2882235|NCT01952574|9918464|P1|Overall Study|Withdrawal by Subject|9
2882236|NCT01952366|9918563|P1|Overall Study|Withdrawal by Subject|9
2882237|NCT01952366|9918563|P1|Overall Study|Death|22
2882238|NCT01952145|9918578|P2|Overall Study|Unclassified|1
2882239|NCT01952145|9918579|P1|Overall Study|Unclassified|1
2882240|NCT01952145|9918578|P2|Overall Study|Withdrawal Criteria|11
2882241|NCT01952145|9918579|P1|Overall Study|Withdrawal Criteria|16
2882242|NCT01952145|9918578|P2|Overall Study|Adverse Event|0
2882243|NCT01952145|9918579|P1|Overall Study|Adverse Event|9
2882244|NCT01952145|9918578|P2|Overall Study|Death|1
2882245|NCT01952145|9918579|P1|Overall Study|Death|0
2882246|NCT01952145|9918578|P2|Overall Study|Protocol Violation|1
2882247|NCT01952145|9918579|P1|Overall Study|Protocol Violation|2
2882248|NCT01952080|9918593|P4|Overall Study|Protocol Non-compliance|0
2882249|NCT01952080|9918594|P3|Overall Study|Protocol Non-compliance|0
2882250|NCT01952080|9918595|P2|Overall Study|Protocol Non-compliance|1
2882251|NCT01952080|9918596|P1|Overall Study|Protocol Non-compliance|0
2882252|NCT01952080|9918593|P4|Overall Study|Withdrawal by Subject|1
2882253|NCT01952080|9918594|P3|Overall Study|Withdrawal by Subject|0
2882254|NCT01952080|9918595|P2|Overall Study|Withdrawal by Subject|0
2882255|NCT01952080|9918596|P1|Overall Study|Withdrawal by Subject|0
2882256|NCT01952054|9918642|P1|Overall Study|Physician Decision|1
2882257|NCT01952041|9918650|P2|Overall Study|Death|0
2882258|NCT01952041|9918651|P1|Overall Study|Death|1
2882259|NCT01952041|9918650|P2|Overall Study|Withdrawal by Subject|5
2882260|NCT01952041|9918651|P1|Overall Study|Withdrawal by Subject|7
2882261|NCT01952041|9918650|P2|Overall Study|Lost to Follow-up|16
2882262|NCT01952041|9918651|P1|Overall Study|Lost to Follow-up|9
2882263|NCT01952015|9918665|P1|Treatment Period 3|Physician Decision|9
2882264|NCT01952015|9918665|P1|Maintenance|Adverse Event|2
2882265|NCT01952015|9918665|P1|Induction|Protocol Violation|1
2882266|NCT01951703|9918732|P2|Second Intervention|Unsatisfactory Lens fitting|1
2882267|NCT01951703|9918733|P1|Second Intervention|Unsatisfactory Lens fitting|0
2882268|NCT01951703|9918732|P2|Second Intervention|Protocol Violation|1
2882269|NCT01951703|9918733|P1|Second Intervention|Protocol Violation|0
2882270|NCT01951703|9918732|P2|First Intervention|Physician Decision|0
2882271|NCT01951703|9918733|P1|First Intervention|Physician Decision|1
2882272|NCT01951703|9918732|P2|First Intervention|Subject was not compliant|1
2882273|NCT01951703|9918733|P1|First Intervention|Subject was not compliant|1
2882274|NCT01951703|9918732|P2|First Intervention|Withdrawal by Subject|0
2882275|NCT01951703|9918733|P1|First Intervention|Withdrawal by Subject|1
2882276|NCT01951586|9918758|P2|Overall Study|Sponsor Decision|10
2882277|NCT01951586|9918759|P1|Overall Study|Sponsor Decision|9
2882278|NCT01951586|9918758|P2|Overall Study|Lost to Follow-up|1
2882279|NCT01951586|9918759|P1|Overall Study|Lost to Follow-up|0
2882280|NCT01951586|9918758|P2|Overall Study|Withdrawal by Subject|17
2882281|NCT01951586|9918759|P1|Overall Study|Withdrawal by Subject|8
2882282|NCT01951586|9918758|P2|Overall Study|Death|120
2882283|NCT01951586|9918759|P1|Overall Study|Death|61
2882284|NCT01951573|9918783|P2|Washout Period|Adverse Event|1
2882285|NCT01951573|9918784|P1|Washout Period|Adverse Event|0
2882286|NCT01951417|9918794|P1|Overall Study|Lost to Follow-up|6
2882287|NCT01951417|9918794|P1|Overall Study|Protocol Violation|2
2882288|NCT01951417|9918794|P1|Overall Study|Withdrawal by Subject|1
2882289|NCT01951170|9918895|P1|Overall Study|Investigator decision|1
2882290|NCT01951157|9918921|P3|Overall Study|Treatment-related death|0
2882291|NCT01951157|9918922|P2|Overall Study|Treatment-related death|2
2882292|NCT01951157|9918923|P1|Overall Study|Treatment-related death|0
2882293|NCT01951157|9918921|P3|Overall Study|Consent withdrawn by subject|3
2882294|NCT01951157|9918922|P2|Overall Study|Consent withdrawn by subject|1
2882295|NCT01951157|9918923|P1|Overall Study|Consent withdrawn by subject|0
2882296|NCT01951157|9918921|P3|Overall Study|Treatment-related AE|4
2882297|NCT01951157|9918922|P2|Overall Study|Treatment-related AE|0
2882298|NCT01951157|9918923|P1|Overall Study|Treatment-related AE|2
2882299|NCT01951157|9918921|P3|Overall Study|No treated|0
2882300|NCT01951157|9918922|P2|Overall Study|No treated|1
2882301|NCT01951157|9918923|P1|Overall Study|No treated|0
2882302|NCT01951157|9918921|P3|Overall Study|Non-treatmentrelated death|2
2882303|NCT01951157|9918922|P2|Overall Study|Non-treatmentrelated death|2
2882304|NCT01951157|9918923|P1|Overall Study|Non-treatmentrelated death|2
2882305|NCT01951157|9918921|P3|Overall Study|Physician Decision|2
2882306|NCT01951157|9918922|P2|Overall Study|Physician Decision|3
2882307|NCT01951157|9918923|P1|Overall Study|Physician Decision|5
2882308|NCT01951157|9918921|P3|Overall Study|Study Termination|1
2882309|NCT01951157|9918922|P2|Overall Study|Study Termination|0
2882310|NCT01951157|9918923|P1|Overall Study|Study Termination|0
2882311|NCT01951157|9918921|P3|Overall Study|Treatment-unrelated AE|3
2882312|NCT01951157|9918922|P2|Overall Study|Treatment-unrelated AE|0
2882313|NCT01951157|9918923|P1|Overall Study|Treatment-unrelated AE|1
2882314|NCT01951157|9918921|P3|Overall Study|Progressive Disease|10
2882315|NCT01951157|9918922|P2|Overall Study|Progressive Disease|13
2882316|NCT01951157|9918923|P1|Overall Study|Progressive Disease|12
2882317|NCT01951105|9918955|P3|Overall Study|Withdrawal by Subject|1
2882318|NCT01951105|9918956|P2|Overall Study|Withdrawal by Subject|3
2882319|NCT01951105|9918957|P1|Overall Study|Withdrawal by Subject|0
2882320|NCT01951105|9918955|P3|Overall Study|Protocol Violation|1
2882321|NCT01951105|9918956|P2|Overall Study|Protocol Violation|1
2882322|NCT01951105|9918957|P1|Overall Study|Protocol Violation|1
2882323|NCT01951105|9918955|P3|Overall Study|Lost to Follow-up|0
2882324|NCT01951105|9918956|P2|Overall Study|Lost to Follow-up|1
2882325|NCT01951105|9918957|P1|Overall Study|Lost to Follow-up|0
2882326|NCT01951105|9918955|P3|Overall Study|Adverse Event|0
2882327|NCT01951105|9918956|P2|Overall Study|Adverse Event|5
2882328|NCT01951105|9918957|P1|Overall Study|Adverse Event|0
2882329|NCT01951092|9918971|P1|Overall Study|Transfer of Care|1
2882330|NCT01951092|9918971|P1|Overall Study|Incarceration|1
2882331|NCT01951092|9918971|P1|Overall Study|Lost to Follow-up|10
2882332|NCT01950819|9918984|P2|Overall Study|Lost to Follow-up|17
2882333|NCT01950819|9918985|P1|Overall Study|Lost to Follow-up|9
2882334|NCT01950819|9918984|P2|Overall Study|Pregnancy|2
2882335|NCT01950819|9918985|P1|Overall Study|Pregnancy|0
2882336|NCT01950819|9918984|P2|Overall Study|technical problems|0
2882337|NCT01950819|9918985|P1|Overall Study|technical problems|2
2882338|NCT01950819|9918984|P2|Overall Study|Subject / Gardian decision|51
2882339|NCT01950819|9918985|P1|Overall Study|Subject / Gardian decision|54
2882340|NCT01950819|9918984|P2|Overall Study|Death|34
2882341|NCT01950819|9918985|P1|Overall Study|Death|29
2882342|NCT01950819|9918984|P2|Overall Study|Graft Loss|30
2882343|NCT01950819|9918985|P1|Overall Study|Graft Loss|35
2882344|NCT01950741|9919038|P1|Overall Study|Withdrawal by Subject|1
2882345|NCT01950741|9919038|P1|Overall Study|Death|1
2882346|NCT01950741|9919038|P1|Overall Study|Lost to Follow-up|1
2882347|NCT01950364|9919053|P2|Overall Study|Protocol Violation|1
2882348|NCT01950364|9919054|P1|Overall Study|Protocol Violation|0
2882349|NCT01950364|9919053|P2|Overall Study|Withdrawal by Subject|1
2882350|NCT01950364|9919054|P1|Overall Study|Withdrawal by Subject|0
2882351|NCT01950364|9919053|P2|Overall Study|Disease Progression|2
2882352|NCT01950364|9919054|P1|Overall Study|Disease Progression|5
2882353|NCT01950364|9919053|P2|Overall Study|Stem Cell Transplant|6
2882354|NCT01950364|9919054|P1|Overall Study|Stem Cell Transplant|2
2882355|NCT01950364|9919053|P2|Overall Study|Adverse Event|0
2882356|NCT01950364|9919054|P1|Overall Study|Adverse Event|3
2882357|NCT01950273|9919176|P2|Overall Study|Other not defined above|0
2882358|NCT01950273|9919177|P1|Overall Study|Other not defined above|1
2882359|NCT01950273|9919176|P2|Overall Study|Withdrawal by Subject|0
2882360|NCT01950273|9919177|P1|Overall Study|Withdrawal by Subject|2
2882361|NCT01950273|9919176|P2|Overall Study|Protocol Violation|0
2882362|NCT01950273|9919177|P1|Overall Study|Protocol Violation|1
2882363|NCT01950013|9919224|P3|Overall Study|Withdrawal by Subject|0
2882364|NCT01950013|9919225|P2|Overall Study|Withdrawal by Subject|2
2882365|NCT01950013|9919226|P1|Overall Study|Withdrawal by Subject|0
2882366|NCT01949870|9919237|P1|Overall Study|Eligibility requirements not fulfilled|2
2882367|NCT01949870|9919237|P1|Overall Study|Study termination|1
2882368|NCT01949870|9919237|P1|Overall Study|Adverse Event|1
2882369|NCT01949870|9919237|P1|Overall Study|Lack of Efficacy|2
2882370|NCT01949532|9919406|P2|Overall Study|On-study at the Data Cut-off Date|3
2882371|NCT01949532|9919407|P1|Overall Study|On-study at the Data Cut-off Date|3
2882372|NCT01949480|9919477|P2|Overall Study|Physician Decision|8
2882373|NCT01949480|9919478|P1|Overall Study|Physician Decision|5
2882374|NCT01949155|9919513|P2|Overall Study|Protocol Violation|0
2882375|NCT01949155|9919514|P1|Overall Study|Protocol Violation|1
2882376|NCT01949155|9919513|P2|Overall Study|Lost to Follow-up|0
2882377|NCT01949155|9919514|P1|Overall Study|Lost to Follow-up|1
2882378|NCT01949142|9919526|P2|Overall Study|Parent changed their mind|0
2882379|NCT01949142|9919527|P1|Overall Study|Parent changed their mind|1
2882380|NCT01949142|9919526|P2|Overall Study|Lost to Follow-up|1
2882381|NCT01949142|9919527|P1|Overall Study|Lost to Follow-up|1
2882382|NCT01949142|9919526|P2|Overall Study|Withdrawal of consent|0
2882383|NCT01949142|9919527|P1|Overall Study|Withdrawal of consent|1
2882384|NCT01949116|9919539|P2|Overall Study|Withdrawal by Subject|3
2882385|NCT01949116|9919540|P1|Overall Study|Withdrawal by Subject|5
2882386|NCT01949116|9919539|P2|Overall Study|Lost to Follow-up|3
2882387|NCT01949116|9919540|P1|Overall Study|Lost to Follow-up|1
2882388|NCT01949116|9919539|P2|Overall Study|Death|0
2882389|NCT01949116|9919540|P1|Overall Study|Death|2
2882390|NCT01949090|9919577|P5|Overall Study|Lost to Follow-up|1
2882391|NCT01949090|9919578|P4|Overall Study|Lost to Follow-up|1
2882392|NCT01949090|9919579|P3|Overall Study|Lost to Follow-up|0
2882393|NCT01949090|9919580|P2|Overall Study|Lost to Follow-up|1
2882394|NCT01949090|9919581|P1|Overall Study|Lost to Follow-up|2
2882395|NCT01949090|9919577|P5|Overall Study|Protocol non-compliance|1
2882396|NCT01949090|9919578|P4|Overall Study|Protocol non-compliance|0
2882397|NCT01949090|9919579|P3|Overall Study|Protocol non-compliance|0
2882398|NCT01949090|9919580|P2|Overall Study|Protocol non-compliance|0
2882399|NCT01949090|9919581|P1|Overall Study|Protocol non-compliance|0
2882400|NCT01949090|9919577|P5|Overall Study|Withdrawal by Subject|1
2882401|NCT01949090|9919578|P4|Overall Study|Withdrawal by Subject|0
2882402|NCT01949090|9919579|P3|Overall Study|Withdrawal by Subject|0
2882403|NCT01949090|9919580|P2|Overall Study|Withdrawal by Subject|0
2882404|NCT01949090|9919581|P1|Overall Study|Withdrawal by Subject|2
2882405|NCT01949090|9919577|P5|Overall Study|Serious Adverse Event|1
2882406|NCT01949090|9919578|P4|Overall Study|Serious Adverse Event|0
2882407|NCT01949090|9919579|P3|Overall Study|Serious Adverse Event|2
2882408|NCT01949090|9919580|P2|Overall Study|Serious Adverse Event|1
2882409|NCT01949090|9919581|P1|Overall Study|Serious Adverse Event|0
2882410|NCT01949051|9919758|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2882411|NCT01949051|9919759|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2882412|NCT01949051|9919760|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2882413|NCT01949051|9919761|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
2882414|NCT01949051|9919762|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2882415|NCT01949051|9919763|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2882416|NCT01949051|9919758|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2882417|NCT01949051|9919759|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2882418|NCT01949051|9919760|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2882419|NCT01949051|9919761|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2882420|NCT01949051|9919762|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
2882421|NCT01949051|9919763|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2882422|NCT01949051|9919758|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
2882423|NCT01949051|9919759|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
2882424|NCT01949051|9919760|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
2882425|NCT01949051|9919761|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
2882426|NCT01949051|9919762|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
2882427|NCT01949051|9919763|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
2882428|NCT01949051|9919758|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2882429|NCT01949051|9919759|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2882430|NCT01949051|9919760|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2882431|NCT01949051|9919761|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2882432|NCT01949051|9919762|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2882433|NCT01949051|9919763|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2882434|NCT01949051|9919758|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
2882435|NCT01949051|9919759|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
2882436|NCT01949051|9919760|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
2882437|NCT01949051|9919761|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
2882438|NCT01949051|9919762|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
2882439|NCT01949051|9919763|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
2882440|NCT01948908|9919958|P3|Overall Study|Protocol Violation|2
2882441|NCT01948908|9919959|P2|Overall Study|Protocol Violation|0
2882442|NCT01948908|9919960|P1|Overall Study|Protocol Violation|1
2882443|NCT01948830|9919976|P2|Overall Study|Death|4
2882444|NCT01948830|9919977|P1|Overall Study|Death|3
2882445|NCT01948830|9919976|P2|Overall Study|Adverse Event|2
2882446|NCT01948830|9919977|P1|Overall Study|Adverse Event|9
2882447|NCT01948830|9919976|P2|Overall Study|Withdrawal by Subject|17
2882448|NCT01948830|9919977|P1|Overall Study|Withdrawal by Subject|14
2882449|NCT01948830|9919976|P2|Overall Study|Lost to Follow-up|4
2882450|NCT01948830|9919977|P1|Overall Study|Lost to Follow-up|5
2882451|NCT01948830|9919976|P2|Overall Study|Protocol deviation|2
2882452|NCT01948830|9919977|P1|Overall Study|Protocol deviation|1
2882453|NCT01948830|9919976|P2|Overall Study|Physician Decision|3
2882454|NCT01948830|9919977|P1|Overall Study|Physician Decision|1
2882455|NCT01948791|9920009|P1|Overall Study|Screening failure|35
2882456|NCT01948791|9920009|P1|Overall Study|Others|7
2882457|NCT01948791|9920009|P1|Overall Study|Management issues|1
2882458|NCT01948791|9920009|P1|Overall Study|Lost to Follow-up|6
2882459|NCT01948791|9920009|P1|Overall Study|Withdrawal by Subject|5
2882460|NCT01948791|9920009|P1|Overall Study|Protocol Violation|2
2882461|NCT01948791|9920009|P1|Overall Study|Lack of Efficacy|3
2882462|NCT01948791|9920009|P1|Overall Study|Adverse Event|12
2882463|NCT01948258|9920069|P1|Overall Study|Removed from statistical analysis|2
2882464|NCT01948258|9920069|P1|Overall Study|Health Care Professional|43
2882465|NCT01948258|9920069|P1|Overall Study|Withdrawal by Subject|6
2882466|NCT01948258|9920069|P1|Overall Study|Withdrawal by SPD|8
2882467|NCT01948258|9920069|P1|Overall Study|Lost to Follow-up|27
2882468|NCT01948258|9920069|P1|Overall Study|Did not complete by cut-off date|35
2882469|NCT01948258|9920069|P1|Overall Study|Pregnancy|41
2882470|NCT01948193|9920075|P1|Overall Study|Lost to Follow-up|7
2882471|NCT01948193|9920075|P1|Overall Study|Serious event|2
2882472|NCT01948076|9920097|P2|Overall Study|Withdrawal by Subject|1
2882473|NCT01948076|9920098|P1|Overall Study|Withdrawal by Subject|0
2882474|NCT01948063|9920108|P2|Overall Study|Blood samples were accidentally thawed|0
2882475|NCT01948063|9920109|P1|Overall Study|Blood samples were accidentally thawed|1
2882476|NCT01948063|9920108|P2|Overall Study|Discovered an enrollment in other study|1
2882477|NCT01948063|9920109|P1|Overall Study|Discovered an enrollment in other study|0
2882478|NCT01948063|9920108|P2|Overall Study|Boston MCI halted research protocol|1
2882479|NCT01948063|9920109|P1|Overall Study|Boston MCI halted research protocol|0
2882480|NCT01948050|9920117|P2|Overall Study|Withdrawal by Subject|1
2882481|NCT01948050|9920118|P1|Overall Study|Withdrawal by Subject|0
2882482|NCT01947894|9920186|P3|Overall Study|Switched to other growth hormone brand|23
2882483|NCT01947894|9920187|P2|Overall Study|Switched to other growth hormone brand|8
2882484|NCT01947894|9920188|P1|Overall Study|Switched to other growth hormone brand|53
2882485|NCT01947894|9920186|P3|Overall Study|Adverse Event|0
2882486|NCT01947894|9920187|P2|Overall Study|Adverse Event|1
2882487|NCT01947894|9920188|P1|Overall Study|Adverse Event|5
2882488|NCT01947894|9920186|P3|Overall Study|Physician Decision|0
2882489|NCT01947894|9920187|P2|Overall Study|Physician Decision|0
2882490|NCT01947894|9920188|P1|Overall Study|Physician Decision|2
2882491|NCT01947894|9920186|P3|Overall Study|Death|0
2882492|NCT01947894|9920187|P2|Overall Study|Death|1
2882493|NCT01947894|9920188|P1|Overall Study|Death|12
2882494|NCT01947894|9920186|P3|Overall Study|Withdrawal by Subject|1
2882495|NCT01947894|9920187|P2|Overall Study|Withdrawal by Subject|4
2882496|NCT01947894|9920188|P1|Overall Study|Withdrawal by Subject|12
2882497|NCT01947894|9920186|P3|Overall Study|Other|3
2882498|NCT01947894|9920187|P2|Overall Study|Other|4
2882499|NCT01947894|9920188|P1|Overall Study|Other|3
2882500|NCT01947855|9920253|P3|Overall Study|Withdrawal by Subject|0
2882501|NCT01947855|9920254|P2|Overall Study|Withdrawal by Subject|0
2882502|NCT01947855|9920255|P1|Overall Study|Withdrawal by Subject|1
2882503|NCT01947582|9920290|P1|Overall Study|Withdrawal by Subject|1
2882504|NCT01947517|9920299|P2|Overall Study|Withdrawal by Subject|1
2882505|NCT01947517|9920300|P1|Overall Study|Withdrawal by Subject|1
2882506|NCT01947491|9920318|P4|Overall Study|Adverse Event|2
2882507|NCT01947491|9920319|P3|Overall Study|Adverse Event|0
2882508|NCT01947491|9920320|P2|Overall Study|Adverse Event|1
2882509|NCT01947491|9920321|P1|Overall Study|Adverse Event|0
2882510|NCT01947491|9920318|P4|Overall Study|Worsening of condition|0
2882511|NCT01947491|9920319|P3|Overall Study|Worsening of condition|0
2882512|NCT01947491|9920320|P2|Overall Study|Worsening of condition|1
2882513|NCT01947491|9920321|P1|Overall Study|Worsening of condition|0
2882514|NCT01947491|9920318|P4|Overall Study|Withdrawal by Subject|0
2882515|NCT01947491|9920319|P3|Overall Study|Withdrawal by Subject|1
2882516|NCT01947491|9920320|P2|Overall Study|Withdrawal by Subject|1
2882517|NCT01947491|9920321|P1|Overall Study|Withdrawal by Subject|1
2882518|NCT01947491|9920318|P4|Overall Study|Protocol Violation|0
2882519|NCT01947491|9920319|P3|Overall Study|Protocol Violation|0
2882520|NCT01947491|9920320|P2|Overall Study|Protocol Violation|0
2882521|NCT01947491|9920321|P1|Overall Study|Protocol Violation|1
2882522|NCT01947491|9920318|P4|Overall Study|Lack of Efficacy|1
2882523|NCT01947491|9920319|P3|Overall Study|Lack of Efficacy|0
2882524|NCT01947491|9920320|P2|Overall Study|Lack of Efficacy|0
2882525|NCT01947491|9920321|P1|Overall Study|Lack of Efficacy|1
2882526|NCT01947491|9920318|P4|Overall Study|Lost to Follow-up|2
2882527|NCT01947491|9920319|P3|Overall Study|Lost to Follow-up|1
2882528|NCT01947491|9920320|P2|Overall Study|Lost to Follow-up|3
2882529|NCT01947491|9920321|P1|Overall Study|Lost to Follow-up|5
2882530|NCT01947283|9920351|P7|Overall Study|No patients were enrolled in study|1
2882531|NCT01947283|9920352|P6|Overall Study|No patients were enrolled in study|3
2882532|NCT01947283|9920353|P5|Overall Study|No patients were enrolled in study|0
2882533|NCT01947283|9920354|P4|Overall Study|No patients were enrolled in study|0
2882534|NCT01947283|9920355|P3|Overall Study|No patients were enrolled in study|0
2882535|NCT01947283|9920356|P2|Overall Study|No patients were enrolled in study|0
2882536|NCT01947283|9920357|P1|Overall Study|No patients were enrolled in study|0
2882537|NCT01947283|9920351|P7|Overall Study|Missing Follow-up Assessment|0
2882538|NCT01947283|9920352|P6|Overall Study|Missing Follow-up Assessment|2
2882539|NCT01947283|9920353|P5|Overall Study|Missing Follow-up Assessment|0
2882540|NCT01947283|9920354|P4|Overall Study|Missing Follow-up Assessment|0
2882541|NCT01947283|9920355|P3|Overall Study|Missing Follow-up Assessment|3
2882542|NCT01947283|9920356|P2|Overall Study|Missing Follow-up Assessment|2
2882543|NCT01947283|9920357|P1|Overall Study|Missing Follow-up Assessment|2
2882544|NCT01947283|9920351|P7|Overall Study|Non-coding Clinical Recording language|0
2882545|NCT01947283|9920352|P6|Overall Study|Non-coding Clinical Recording language|0
2882546|NCT01947283|9920353|P5|Overall Study|Non-coding Clinical Recording language|0
2882547|NCT01947283|9920354|P4|Overall Study|Non-coding Clinical Recording language|1
2882548|NCT01947283|9920355|P3|Overall Study|Non-coding Clinical Recording language|0
2882549|NCT01947283|9920356|P2|Overall Study|Non-coding Clinical Recording language|0
2882550|NCT01947283|9920357|P1|Overall Study|Non-coding Clinical Recording language|0
2882551|NCT01947283|9920351|P7|Overall Study|No Clinical Recording|0
2882552|NCT01947283|9920352|P6|Overall Study|No Clinical Recording|0
2882553|NCT01947283|9920353|P5|Overall Study|No Clinical Recording|0
2882554|NCT01947283|9920354|P4|Overall Study|No Clinical Recording|10
2882555|NCT01947283|9920355|P3|Overall Study|No Clinical Recording|8
2882556|NCT01947283|9920356|P2|Overall Study|No Clinical Recording|6
2882557|NCT01947283|9920357|P1|Overall Study|No Clinical Recording|12
2882558|NCT01947283|9920351|P7|Overall Study|Withdrawal by Subject|2
2882559|NCT01947283|9920352|P6|Overall Study|Withdrawal by Subject|0
2882560|NCT01947283|9920353|P5|Overall Study|Withdrawal by Subject|0
2882561|NCT01947283|9920354|P4|Overall Study|Withdrawal by Subject|1
2882562|NCT01947283|9920355|P3|Overall Study|Withdrawal by Subject|4
2882563|NCT01947283|9920356|P2|Overall Study|Withdrawal by Subject|8
2882564|NCT01947283|9920357|P1|Overall Study|Withdrawal by Subject|10
2882565|NCT01947283|9920351|P7|Overall Study|Lost to Follow-up|5
2882566|NCT01947283|9920352|P6|Overall Study|Lost to Follow-up|2
2882567|NCT01947283|9920353|P5|Overall Study|Lost to Follow-up|0
2882568|NCT01947283|9920354|P4|Overall Study|Lost to Follow-up|5
2882569|NCT01947283|9920355|P3|Overall Study|Lost to Follow-up|5
2882570|NCT01947283|9920356|P2|Overall Study|Lost to Follow-up|6
2882571|NCT01947283|9920357|P1|Overall Study|Lost to Follow-up|4
2882572|NCT01947283|9920351|P7|Overall Study|Death|0
2882573|NCT01947283|9920352|P6|Overall Study|Death|0
2882574|NCT01947283|9920353|P5|Overall Study|Death|0
2882575|NCT01947283|9920354|P4|Overall Study|Death|0
2882576|NCT01947283|9920355|P3|Overall Study|Death|1
2882577|NCT01947283|9920356|P2|Overall Study|Death|1
2882578|NCT01947283|9920357|P1|Overall Study|Death|1
2882579|NCT01947127|9920429|P2|Overall Study|Data loss|4
2882580|NCT01947127|9920430|P1|Overall Study|Data loss|4
2882581|NCT01947127|9920429|P2|Overall Study|Withdrawal by Subject|1
2882582|NCT01947127|9920430|P1|Overall Study|Withdrawal by Subject|1
2882583|NCT01947127|9920429|P2|Overall Study|Protocol Violation|38
2882584|NCT01947127|9920430|P1|Overall Study|Protocol Violation|18
2882585|NCT01946529|9920454|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
2882586|NCT01946529|9920455|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
2882587|NCT01946529|9920456|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
2882588|NCT01946529|9920454|P3|End of Window Therapy (2 Courses)|Physician Decision|0
2882589|NCT01946529|9920455|P2|End of Window Therapy (2 Courses)|Physician Decision|1
2882590|NCT01946529|9920456|P1|End of Window Therapy (2 Courses)|Physician Decision|0
2882591|NCT01946438|9920467|P4|Overall Study|Withdrawal by Subject|0
2882592|NCT01946438|9920468|P3|Overall Study|Withdrawal by Subject|0
2882593|NCT01946438|9920469|P2|Overall Study|Withdrawal by Subject|0
2882594|NCT01946438|9920470|P1|Overall Study|Withdrawal by Subject|1
2882595|NCT01946438|9920467|P4|Overall Study|Protocol Violation|0
2882596|NCT01946438|9920468|P3|Overall Study|Protocol Violation|1
2882597|NCT01946438|9920469|P2|Overall Study|Protocol Violation|0
2882598|NCT01946438|9920470|P1|Overall Study|Protocol Violation|0
2882599|NCT01946438|9920467|P4|Overall Study|Serious Adverse event|0
2882600|NCT01946438|9920468|P3|Overall Study|Serious Adverse event|0
2882601|NCT01946438|9920469|P2|Overall Study|Serious Adverse event|0
2882602|NCT01946438|9920470|P1|Overall Study|Serious Adverse event|1
2882603|NCT01946438|9920467|P4|Overall Study|Adverse Event|1
2882604|NCT01946438|9920468|P3|Overall Study|Adverse Event|0
2882605|NCT01946438|9920469|P2|Overall Study|Adverse Event|0
2882606|NCT01946438|9920470|P1|Overall Study|Adverse Event|0
2882607|NCT01946425|9920498|P2|Overall Study|Withdrawal by Subject|0
2882608|NCT01946425|9920499|P1|Overall Study|Withdrawal by Subject|1
2882609|NCT01946425|9920498|P2|Overall Study|Protocol Violation|0
2882610|NCT01946425|9920499|P1|Overall Study|Protocol Violation|1
2882611|NCT01946412|9920513|P1|Overall Study|Difficulty in swallowing|1
2882612|NCT01946412|9920513|P1|Overall Study|Continued with commercial Kalydeco|2
2882613|NCT01946412|9920513|P1|Overall Study|Non-Compliance|1
2882614|NCT01946412|9920513|P1|Overall Study|Adverse Event|1
2882615|NCT01946282|9920538|P3|Year 3|Did not return FIT kit|30
2882616|NCT01946282|9920539|P2|Year 3|Did not return FIT kit|43
2882617|NCT01946282|9920540|P1|Year 3|Did not return FIT kit|288
2882618|NCT01946282|9920538|P3|Year 2|Did not return FIT kit|115
2882619|NCT01946282|9920539|P2|Year 2|Did not return FIT kit|131
2882620|NCT01946282|9920540|P1|Year 2|Did not return FIT kit|803
2882621|NCT01946282|9920538|P3|Year 1|Did not return FIT kit|654
2882622|NCT01946282|9920539|P2|Year 1|Did not return FIT kit|608
2882623|NCT01946282|9920540|P1|Year 1|Did not return FIT kit|4186
2882624|NCT01946204|9920573|P2|Overall Study|Other|3
2882625|NCT01946204|9920574|P1|Overall Study|Other|7
2882626|NCT01946204|9920573|P2|Overall Study|Ongoing|687
2882627|NCT01946204|9920574|P1|Overall Study|Ongoing|316
2882628|NCT01946204|9920573|P2|Overall Study|Lost to Follow-up|7
2882629|NCT01946204|9920574|P1|Overall Study|Lost to Follow-up|3
2882630|NCT01946204|9920573|P2|Overall Study|Withdrawal by Subject|50
2882631|NCT01946204|9920574|P1|Overall Study|Withdrawal by Subject|37
2882632|NCT01946204|9920573|P2|Overall Study|Death|59
2882633|NCT01946204|9920574|P1|Overall Study|Death|38
2882634|NCT01946178|9920590|P1|Overall Study|Lost to Follow-up|1
2882635|NCT01946178|9920590|P1|Overall Study|Pregnancy|1
2882636|NCT01946165|9920600|P2|Overall Study|Withdrawal by Subject|2
2882637|NCT01946165|9920601|P1|Overall Study|Withdrawal by Subject|0
2882638|NCT01946165|9920600|P2|Overall Study|Physician Decision|0
2882639|NCT01946165|9920601|P1|Overall Study|Physician Decision|2
2882640|NCT01945996|9920628|P2|Overall Study|Lost to Follow-up|5
2882641|NCT01945996|9920629|P1|Overall Study|Lost to Follow-up|3
2882642|NCT01945944|9920705|P2|Overall Study|Withdrawal by Subject|1
2882643|NCT01945944|9920706|P1|Overall Study|Withdrawal by Subject|0
2882644|NCT01945944|9920705|P2|Overall Study|Physician Decision|0
2882645|NCT01945944|9920706|P1|Overall Study|Physician Decision|1
2882646|NCT01945944|9920705|P2|Overall Study|Adverse Event|2
2882647|NCT01945944|9920706|P1|Overall Study|Adverse Event|0
2882648|NCT01945866|9920730|P2|Overall Study|Eyes did not complete or were dropped|0
2882649|NCT01945866|9920731|P1|Overall Study|Eyes did not complete or were dropped|2
2882650|NCT01945775|9920752|P2|Overall Study|Lost to Follow-up|6
2882651|NCT01945775|9920753|P1|Overall Study|Lost to Follow-up|7
2882652|NCT01945775|9920752|P2|Overall Study|Withdrawal by Subject|20
2882653|NCT01945775|9920753|P1|Overall Study|Withdrawal by Subject|7
2882654|NCT01945775|9920752|P2|Overall Study|Death|53
2882655|NCT01945775|9920753|P1|Overall Study|Death|107
2882656|NCT01945775|9920752|P2|Overall Study|On going|65
2882657|NCT01945775|9920753|P1|Overall Study|On going|166
2882658|NCT01945710|9920789|P7|Overall Study|Withdrawal by Subject|0
2882659|NCT01945710|9920790|P6|Overall Study|Withdrawal by Subject|0
2882660|NCT01945710|9920791|P5|Overall Study|Withdrawal by Subject|1
2882661|NCT01945710|9920792|P4|Overall Study|Withdrawal by Subject|0
2882662|NCT01945710|9920793|P3|Overall Study|Withdrawal by Subject|1
2882663|NCT01945710|9920794|P2|Overall Study|Withdrawal by Subject|1
2882664|NCT01945710|9920795|P1|Overall Study|Withdrawal by Subject|0
2882665|NCT01945710|9920789|P7|Overall Study|Other|4
2882666|NCT01945710|9920790|P6|Overall Study|Other|0
2882667|NCT01945710|9920791|P5|Overall Study|Other|1
2882668|NCT01945710|9920792|P4|Overall Study|Other|1
2882669|NCT01945710|9920793|P3|Overall Study|Other|3
2882670|NCT01945710|9920794|P2|Overall Study|Other|0
2882671|NCT01945710|9920795|P1|Overall Study|Other|2
2882672|NCT01945710|9920789|P7|Overall Study|Adverse Event|0
2882673|NCT01945710|9920790|P6|Overall Study|Adverse Event|0
2882674|NCT01945710|9920791|P5|Overall Study|Adverse Event|0
2882675|NCT01945710|9920792|P4|Overall Study|Adverse Event|0
2882676|NCT01945710|9920793|P3|Overall Study|Adverse Event|0
2882677|NCT01945710|9920794|P2|Overall Study|Adverse Event|1
2882678|NCT01945710|9920795|P1|Overall Study|Adverse Event|0
2882679|NCT01945710|9920789|P7|Overall Study|Progressive Disease|19
2882680|NCT01945710|9920790|P6|Overall Study|Progressive Disease|3
2882681|NCT01945710|9920791|P5|Overall Study|Progressive Disease|7
2882682|NCT01945710|9920792|P4|Overall Study|Progressive Disease|2
2882683|NCT01945710|9920793|P3|Overall Study|Progressive Disease|3
2882684|NCT01945710|9920794|P2|Overall Study|Progressive Disease|4
2882685|NCT01945710|9920795|P1|Overall Study|Progressive Disease|5
2882686|NCT01945593|9920914|P4|Overall Study|Other: Screen Failure|0
2882687|NCT01945593|9920915|P3|Overall Study|Other: Screen Failure|0
2882688|NCT01945593|9920916|P2|Overall Study|Other: Screen Failure|2
2882689|NCT01945593|9920917|P1|Overall Study|Other: Screen Failure|0
2882690|NCT01945593|9920914|P4|Overall Study|Other: Surgical Procedure|6
2882691|NCT01945593|9920915|P3|Overall Study|Other: Surgical Procedure|0
2882692|NCT01945593|9920916|P2|Overall Study|Other: Surgical Procedure|2
2882693|NCT01945593|9920917|P1|Overall Study|Other: Surgical Procedure|0
2882694|NCT01945593|9920914|P4|Overall Study|Other: Terminated|1
2882695|NCT01945593|9920915|P3|Overall Study|Other: Terminated|0
2882696|NCT01945593|9920916|P2|Overall Study|Other: Terminated|0
2882697|NCT01945593|9920917|P1|Overall Study|Other: Terminated|0
2882698|NCT01945593|9920914|P4|Overall Study|Death|0
2882699|NCT01945593|9920915|P3|Overall Study|Death|1
2882700|NCT01945593|9920916|P2|Overall Study|Death|0
2882701|NCT01945593|9920917|P1|Overall Study|Death|0
2882702|NCT01945593|9920914|P4|Overall Study|Protocol Violation|3
2882703|NCT01945593|9920915|P3|Overall Study|Protocol Violation|1
2882704|NCT01945593|9920916|P2|Overall Study|Protocol Violation|2
2882705|NCT01945593|9920917|P1|Overall Study|Protocol Violation|0
2882706|NCT01945593|9920914|P4|Overall Study|Withdrawal by Subject|4
2882707|NCT01945593|9920915|P3|Overall Study|Withdrawal by Subject|0
2882708|NCT01945593|9920916|P2|Overall Study|Withdrawal by Subject|2
2882709|NCT01945593|9920917|P1|Overall Study|Withdrawal by Subject|0
2882710|NCT01945593|9920914|P4|Overall Study|Physician Decision|1
2882711|NCT01945593|9920915|P3|Overall Study|Physician Decision|1
2882712|NCT01945593|9920916|P2|Overall Study|Physician Decision|0
2882713|NCT01945593|9920917|P1|Overall Study|Physician Decision|0
2882714|NCT01945593|9920914|P4|Overall Study|Adverse Event|5
2882715|NCT01945593|9920915|P3|Overall Study|Adverse Event|0
2882716|NCT01945593|9920916|P2|Overall Study|Adverse Event|0
2882717|NCT01945593|9920917|P1|Overall Study|Adverse Event|0
2882718|NCT01945489|9920999|P2|Cycle 2|Lost to Follow-up|1
2882719|NCT01945489|9921000|P1|Cycle 2|Lost to Follow-up|0
2882720|NCT01945489|9920999|P2|Cycle 2|Adverse Event|0
2882721|NCT01945489|9921000|P1|Cycle 2|Adverse Event|1
2882722|NCT01945489|9920999|P2|Cycle 1|Other Miscellaneous Reasons|1
2882723|NCT01945489|9921000|P1|Cycle 1|Other Miscellaneous Reasons|3
2882724|NCT01945489|9920999|P2|Cycle 1|Protocol Violation|1
2882725|NCT01945489|9921000|P1|Cycle 1|Protocol Violation|0
2882726|NCT01945489|9920999|P2|Cycle 1|Personal Reasons|2
2882727|NCT01945489|9921000|P1|Cycle 1|Personal Reasons|4
2882728|NCT01945489|9920999|P2|Cycle 1|Lost to Follow-up|0
2882729|NCT01945489|9921000|P1|Cycle 1|Lost to Follow-up|4
2882730|NCT01945489|9920999|P2|Cycle 1|Adverse Event|0
2882731|NCT01945489|9921000|P1|Cycle 1|Adverse Event|2
2882732|NCT01945281|9921054|P2|Overall Study|Technical Problems|0
2882733|NCT01945281|9921055|P1|Overall Study|Technical Problems|1
2882734|NCT01945281|9921054|P2|Overall Study|Physician Decision|1
2882735|NCT01945281|9921055|P1|Overall Study|Physician Decision|1
2882736|NCT01945281|9921054|P2|Overall Study|Death|3
2882737|NCT01945281|9921055|P1|Overall Study|Death|3
2882738|NCT01945281|9921054|P2|Overall Study|Adverse Event|0
2882739|NCT01945281|9921055|P1|Overall Study|Adverse Event|1
2882740|NCT01945242|9921067|P2|Overall Study|Physician Decision|3
2882741|NCT01945242|9921068|P1|Overall Study|Physician Decision|3
2882742|NCT01945216|9921083|P1|Overall Study|CRF not assured by investigators|5
2882743|NCT01945216|9921083|P1|Overall Study|Protocol Violation|42
2882744|NCT01945216|9921083|P1|Overall Study|Case report forms (CRF) uncollected|52
2882745|NCT01945086|9921141|P3|Overall Study|Adverse Event|1
2882746|NCT01945086|9921142|P2|Overall Study|Adverse Event|0
2882747|NCT01945086|9921143|P1|Overall Study|Adverse Event|0
2882748|NCT01945086|9921141|P3|Overall Study|Withdrawal by Subject|1
2882749|NCT01945086|9921142|P2|Overall Study|Withdrawal by Subject|0
2882750|NCT01945086|9921143|P1|Overall Study|Withdrawal by Subject|1
2882751|NCT01945034|9921187|P3|Overall Study|Protocol Violation|1
2882752|NCT01945034|9921188|P2|Overall Study|Protocol Violation|0
2882753|NCT01945034|9921189|P1|Overall Study|Protocol Violation|1
2882754|NCT01945034|9921187|P3|Overall Study|Lost to Follow-up|2
2882755|NCT01945034|9921188|P2|Overall Study|Lost to Follow-up|0
2882756|NCT01945034|9921189|P1|Overall Study|Lost to Follow-up|0
2882757|NCT01945034|9921187|P3|Overall Study|Other|3
2882758|NCT01945034|9921188|P2|Overall Study|Other|1
2882759|NCT01945034|9921189|P1|Overall Study|Other|0
2882760|NCT01945034|9921187|P3|Overall Study|Withdrawal by Subject|1
2882761|NCT01945034|9921188|P2|Overall Study|Withdrawal by Subject|3
2882762|NCT01945034|9921189|P1|Overall Study|Withdrawal by Subject|0
2882763|NCT01945034|9921187|P3|Overall Study|Medication Error|0
2882764|NCT01945034|9921188|P2|Overall Study|Medication Error|1
2882765|NCT01945034|9921189|P1|Overall Study|Medication Error|0
2882766|NCT01945021|9921239|P1|Overall Study|Non-RECIST disease progression|1
2882767|NCT01945021|9921239|P1|Overall Study|Withdrawal of consent|3
2882768|NCT01945021|9921239|P1|Overall Study|Withdrawal by Subject|2
2882769|NCT01945021|9921239|P1|Overall Study|Global deterioration of health-related s|1
2882770|NCT01945021|9921239|P1|Overall Study|Disease progression by RECIST v1.1|30
2882771|NCT01945021|9921239|P1|Overall Study|Pregnancy|1
2882772|NCT01945021|9921239|P1|Overall Study|Death|1
2882773|NCT01945021|9921239|P1|Overall Study|Adverse Event|8
2882774|NCT01944969|9921253|P1|Overall Study|Administrative or other reasons|23
2882775|NCT01944969|9921253|P1|Overall Study|Non-compliance with IMP|1
2882776|NCT01944969|9921253|P1|Overall Study|Lack of Efficacy|1
2882777|NCT01944969|9921253|P1|Overall Study|Adverse Event|1
2882778|NCT01944839|9921277|P2|Overall Study|Subject non-compliance|3
2882779|NCT01944839|9921278|P1|Overall Study|Subject non-compliance|0
2882780|NCT01944839|9921277|P2|Overall Study|Lost to Follow-up|0
2882781|NCT01944839|9921278|P1|Overall Study|Lost to Follow-up|1
2882782|NCT01944839|9921277|P2|Overall Study|Withdrawal by Subject|17
2882783|NCT01944839|9921278|P1|Overall Study|Withdrawal by Subject|9
2882784|NCT01944839|9921277|P2|Overall Study|Adverse Event|5
2882785|NCT01944839|9921278|P1|Overall Study|Adverse Event|10
2882786|NCT01944839|9921277|P2|Overall Study|Protocol Violation|1
2882787|NCT01944839|9921278|P1|Overall Study|Protocol Violation|0
2882788|NCT01944839|9921277|P2|Overall Study|Physician Decision|2
2882789|NCT01944839|9921278|P1|Overall Study|Physician Decision|2
2882790|NCT01944774|9921287|P3|Overall Study|Lost to Follow-up|0
2882791|NCT01944774|9921288|P2|Overall Study|Lost to Follow-up|1
2882792|NCT01944774|9921289|P1|Overall Study|Lost to Follow-up|0
2882793|NCT01944774|9921287|P3|Overall Study|Lack of Efficacy|2
2882794|NCT01944774|9921288|P2|Overall Study|Lack of Efficacy|2
2882795|NCT01944774|9921289|P1|Overall Study|Lack of Efficacy|1
2882796|NCT01944774|9921287|P3|Overall Study|Adverse Event|3
2882797|NCT01944774|9921288|P2|Overall Study|Adverse Event|2
2882798|NCT01944774|9921289|P1|Overall Study|Adverse Event|3
2882799|NCT01944774|9921287|P3|Overall Study|Withdrawal by Subject|3
2882800|NCT01944774|9921288|P2|Overall Study|Withdrawal by Subject|3
2882801|NCT01944774|9921289|P1|Overall Study|Withdrawal by Subject|2
2882802|NCT01944722|9921332|P1|Overall Study|>ASCUS Cytology|1122
2882803|NCT01944722|9921332|P1|Overall Study|Unsatisfactory Cytology Result|63
2882804|NCT01944722|9921332|P1|Overall Study|NILM Subjects <30 years old|8106
2882805|NCT01944722|9921332|P1|Overall Study|Withdrawal by Subject|8
2882806|NCT01944722|9921332|P1|Overall Study|Specimens Mislabeled|2
2882807|NCT01944722|9921332|P1|Overall Study|Missing Specimens|3
2882808|NCT01944722|9921332|P1|Overall Study|Insufficient Volume for Test|1
2882809|NCT01944722|9921332|P1|Overall Study|Improper Storage/Transport|5
2882810|NCT01944722|9921332|P1|Overall Study|Specimen Shipping Issues|34
2882811|NCT01944722|9921332|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
2882812|NCT01944670|9921366|P1|Overall Study|Lost to Follow-up|2
2882813|NCT01944631|9921388|P2|Overall Study|Withdrawal by Subject|1
2882814|NCT01944631|9921389|P1|Overall Study|Withdrawal by Subject|0
2882815|NCT01944631|9921388|P2|Overall Study|Lost to Follow-up|1
2882816|NCT01944631|9921389|P1|Overall Study|Lost to Follow-up|3
2882817|NCT01944631|9921388|P2|Overall Study|Adverse Event|0
2882818|NCT01944631|9921389|P1|Overall Study|Adverse Event|1
2882819|NCT01944462|9921405|P1|PPPP Educational Program|Lost to Follow-up|60
2882820|NCT01944098|9921468|P2|Overall Study|Physician Decision|0
2882821|NCT01944098|9921469|P1|Overall Study|Physician Decision|1
2882822|NCT01944059|9921481|P1|Overall Study|Adverse Event|2
2882823|NCT01944059|9921481|P1|Overall Study|Withdrawal by Subject|1
2882824|NCT01944059|9921481|P1|Overall Study|Physician Decision|3
2882825|NCT01944059|9921481|P1|Overall Study|Lost to Follow-up|1
2882826|NCT01943825|9921522|P4|Overall Study|Other than specified above|1
2882827|NCT01943825|9921523|P3|Overall Study|Other than specified above|0
2882828|NCT01943825|9921524|P2|Overall Study|Other than specified above|1
2882829|NCT01943825|9921525|P1|Overall Study|Other than specified above|0
2882830|NCT01943825|9921522|P4|Overall Study|Withdrawal by Subject|2
2882831|NCT01943825|9921523|P3|Overall Study|Withdrawal by Subject|3
2882832|NCT01943825|9921524|P2|Overall Study|Withdrawal by Subject|0
2882833|NCT01943825|9921525|P1|Overall Study|Withdrawal by Subject|1
2882834|NCT01943825|9921522|P4|Overall Study|Lost to Follow-up|8
2882835|NCT01943825|9921523|P3|Overall Study|Lost to Follow-up|12
2882836|NCT01943825|9921524|P2|Overall Study|Lost to Follow-up|3
2882837|NCT01943825|9921525|P1|Overall Study|Lost to Follow-up|9
2882838|NCT01943799|9921567|P4|Overall Study|Withdrawal by Subject|0
2882839|NCT01943799|9921568|P3|Overall Study|Withdrawal by Subject|1
2882840|NCT01943799|9921569|P2|Overall Study|Withdrawal by Subject|2
2882841|NCT01943799|9921570|P1|Overall Study|Withdrawal by Subject|4
2882842|NCT01943799|9921567|P4|Overall Study|Protocol Violation|0
2882843|NCT01943799|9921568|P3|Overall Study|Protocol Violation|0
2882844|NCT01943799|9921569|P2|Overall Study|Protocol Violation|0
2882845|NCT01943799|9921570|P1|Overall Study|Protocol Violation|1
2882846|NCT01943799|9921567|P4|Overall Study|Lost to Follow-up|0
2882847|NCT01943799|9921568|P3|Overall Study|Lost to Follow-up|1
2882848|NCT01943799|9921569|P2|Overall Study|Lost to Follow-up|1
2882849|NCT01943799|9921570|P1|Overall Study|Lost to Follow-up|0
2882850|NCT01943591|9921610|P2|Overall Study|Death|7
2882851|NCT01943591|9921611|P1|Overall Study|Death|2
2882852|NCT01943591|9921610|P2|Overall Study|Lost to Follow-up|4
2882853|NCT01943591|9921611|P1|Overall Study|Lost to Follow-up|3
2882854|NCT01943552|9921669|P2|Overall Study|Other Reasons|17
2882855|NCT01943552|9921670|P1|Overall Study|Other Reasons|16
2882856|NCT01943552|9921669|P2|Overall Study|Withdrawal by Subject|6
2882857|NCT01943552|9921670|P1|Overall Study|Withdrawal by Subject|6
2882858|NCT01943552|9921669|P2|Overall Study|Adverse Event|2
2882859|NCT01943552|9921670|P1|Overall Study|Adverse Event|3
2882860|NCT01943539|9921686|P2|Overall Study|Non-compliance with at-home intervention|0
2882861|NCT01943539|9921687|P1|Overall Study|Non-compliance with at-home intervention|4
2882862|NCT01943435|9921723|P3|6 Month Follow up|Lost to Follow-up|15
2882863|NCT01943435|9921724|P2|6 Month Follow up|Lost to Follow-up|7
2882864|NCT01943435|9921725|P1|6 Month Follow up|Lost to Follow-up|12
2882865|NCT01943435|9921723|P3|2 Month Follow up|Lost to Follow-up|0
2882866|NCT01943435|9921724|P2|2 Month Follow up|Lost to Follow-up|3
2882867|NCT01943435|9921725|P1|2 Month Follow up|Lost to Follow-up|2
2882868|NCT01943435|9921723|P3|Intervention Period|Withdrawal by Subject|4
2882869|NCT01943435|9921724|P2|Intervention Period|Withdrawal by Subject|3
2882870|NCT01943435|9921725|P1|Intervention Period|Withdrawal by Subject|3
2882871|NCT01943435|9921723|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
2882872|NCT01943435|9921724|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
2882873|NCT01943435|9921725|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
2882874|NCT01943292|9921748|P3|Overall Study|Withdrawal by Subject|0
2882875|NCT01943292|9921749|P2|Overall Study|Withdrawal by Subject|0
2882876|NCT01943292|9921750|P1|Overall Study|Withdrawal by Subject|1
2882877|NCT01942785|9921786|P1|Overall Study|Protocol Violation|1
2882878|NCT01942785|9921786|P1|Overall Study|Withdrawal by Subject|1
2882879|NCT01942785|9921786|P1|Overall Study|Adverse Event|2
2882880|NCT01942733|9921815|P1|Overall Study|Administrative|1
2882881|NCT01942733|9921815|P1|Overall Study|Non-compliance with IMP|1
2882882|NCT01942733|9921815|P1|Overall Study|Lost to Follow-up|1
2882883|NCT01942590|9922933|P2|Overall Study|Adverse Event|0
2882884|NCT01942590|9922934|P1|Overall Study|Adverse Event|1
2882885|NCT01942590|9922933|P2|Overall Study|Withdrawal by Subject|1
2882886|NCT01942590|9922934|P1|Overall Study|Withdrawal by Subject|0
2882887|NCT01942486|9922964|P1|Overall Study|Lost to Follow-up|27
2882888|NCT01942161|9922971|P3|Overall Study|Withdrawal by Subject|1
2882889|NCT01942161|9922972|P2|Overall Study|Withdrawal by Subject|3
2882890|NCT01942161|9922973|P1|Overall Study|Withdrawal by Subject|3
2882891|NCT01942161|9922971|P3|Overall Study|Protocol Violation|0
2882892|NCT01942161|9922972|P2|Overall Study|Protocol Violation|0
2882893|NCT01942161|9922973|P1|Overall Study|Protocol Violation|1
2882894|NCT01942161|9922971|P3|Overall Study|Physician Decision|0
2882895|NCT01942161|9922972|P2|Overall Study|Physician Decision|1
2882896|NCT01942161|9922973|P1|Overall Study|Physician Decision|3
2882897|NCT01942161|9922971|P3|Overall Study|Adverse Event|5
2882898|NCT01942161|9922972|P2|Overall Study|Adverse Event|2
2882899|NCT01942161|9922973|P1|Overall Study|Adverse Event|1
2882900|NCT01942148|9922993|P1|Overall Study|Use of the prohibition medicine|1
2882901|NCT01942148|9922993|P1|Overall Study|Withdrawal by Subject|8
2882902|NCT01942148|9922993|P1|Overall Study|Protocol Violation|1
2882903|NCT01942148|9922993|P1|Overall Study|Physician Decision|11
2882904|NCT01942148|9922993|P1|Overall Study|Lack of Efficacy|2
2882905|NCT01942148|9922993|P1|Overall Study|Adverse Event|4
2882906|NCT01942135|9923001|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
2882907|NCT01942135|9923002|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
2882908|NCT01942135|9923001|P2|Overall Study|Withdrawal by Subject|2
2882909|NCT01942135|9923002|P1|Overall Study|Withdrawal by Subject|4
2882910|NCT01942135|9923001|P2|Overall Study|Participant Refused toContinue Treatment|1
2882911|NCT01942135|9923002|P1|Overall Study|Participant Refused toContinue Treatment|1
2882912|NCT01942135|9923001|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
2882913|NCT01942135|9923002|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
2882914|NCT01942135|9923001|P2|Overall Study|Death|1
2882915|NCT01942135|9923002|P1|Overall Study|Death|0
2882916|NCT01942135|9923001|P2|Overall Study|Randomized Not Treated|2
2882917|NCT01942135|9923002|P1|Overall Study|Randomized Not Treated|2
2882918|NCT01942135|9923001|P2|Overall Study|Global deterioration of health status|3
2882919|NCT01942135|9923002|P1|Overall Study|Global deterioration of health status|8
2882920|NCT01942135|9923001|P2|Overall Study|Adverse Event|3
2882921|NCT01942135|9923002|P1|Overall Study|Adverse Event|9
2882922|NCT01941940|9923039|P1|Overall Study|Other|1
2882923|NCT01941940|9923039|P1|Overall Study|Other|1
2882924|NCT01941940|9923039|P1|Overall Study|Death|1
2882925|NCT01941940|9923039|P1|Overall Study|Withdrawal by Subject|15
2882926|NCT01941940|9923039|P1|Overall Study|Physician Decision|2
2882927|NCT01941940|9923039|P1|Overall Study|Lost to Follow-up|2
2882928|NCT01941940|9923039|P1|Overall Study|Adverse Event|11
2882929|NCT01941537|9923147|P2|Overall Study|Withdrawal by Subject|1
2882930|NCT01941537|9923148|P1|Overall Study|Withdrawal by Subject|0
2882931|NCT01941537|9923147|P2|Overall Study|Adverse Event|0
2882932|NCT01941537|9923148|P1|Overall Study|Adverse Event|1
2882933|NCT01941537|9923147|P2|Overall Study|Pregnancy|0
2882934|NCT01941537|9923148|P1|Overall Study|Pregnancy|1
2882935|NCT01941537|9923147|P2|Overall Study|Lost to Follow-up|0
2882936|NCT01941537|9923148|P1|Overall Study|Lost to Follow-up|1
2882937|NCT01941537|9923147|P2|Overall Study|Lack of Efficacy|2
2882938|NCT01941537|9923148|P1|Overall Study|Lack of Efficacy|1
2882939|NCT01941498|9923160|P1|Overall Study|Relocated out of state|1
2882940|NCT01941186|9923278|P2|Follow-up|Lost to Follow-up|0
2882941|NCT01941186|9923279|P1|Follow-up|Lost to Follow-up|1
2882942|NCT01941095|9923305|P1|Overall Study|Lost to Follow-up|10
2882943|NCT01941095|9923305|P1|Overall Study|Withdrawal by Subject|17
2882944|NCT01941095|9923305|P1|Overall Study|Physician Decision|3
2882945|NCT01941095|9923305|P1|Overall Study|Adverse Event|11
2882946|NCT01941095|9923305|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
2882947|NCT01941095|9923305|P1|Overall Study|Insufficient therapeutic response|13
2882948|NCT01941030|9923330|P2|Overall Study|Withdrawal by Subject|6
2882949|NCT01941030|9923331|P1|Overall Study|Withdrawal by Subject|4
2882950|NCT01941030|9923330|P2|Overall Study|Lost to Follow-up|5
2882951|NCT01941030|9923331|P1|Overall Study|Lost to Follow-up|6
2882952|NCT01941030|9923330|P2|Overall Study|Death|2
2882953|NCT01941030|9923331|P1|Overall Study|Death|3
2882954|NCT01940939|9923353|P2|Overall Study|Withdrawal by Subject|8
2882955|NCT01940939|9923354|P1|Overall Study|Withdrawal by Subject|2
2882956|NCT01940900|9923366|P2|Overall Study|other|0
2882957|NCT01940900|9923367|P1|Overall Study|other|1
2882958|NCT01940900|9923366|P2|Overall Study|subject non-compliance|1
2882959|NCT01940900|9923367|P1|Overall Study|subject non-compliance|1
2882960|NCT01940900|9923366|P2|Overall Study|Sponsor Decision|0
2882961|NCT01940900|9923367|P1|Overall Study|Sponsor Decision|1
2882962|NCT01940900|9923366|P2|Overall Study|Lost to Follow-up|0
2882963|NCT01940900|9923367|P1|Overall Study|Lost to Follow-up|1
2882964|NCT01940900|9923366|P2|Overall Study|Withdrawal by Subject|15
2882965|NCT01940900|9923367|P1|Overall Study|Withdrawal by Subject|11
2882966|NCT01940900|9923366|P2|Overall Study|Adverse Event|15
2882967|NCT01940900|9923367|P1|Overall Study|Adverse Event|10
2882968|NCT01940900|9923366|P2|Overall Study|Physician Decision|0
2882969|NCT01940900|9923367|P1|Overall Study|Physician Decision|4
2882970|NCT01940705|9923377|P4|Overall Study|Withdrawal by team - hearing aid change|0
2882971|NCT01940705|9923378|P3|Overall Study|Withdrawal by team - hearing aid change|0
2882972|NCT01940705|9923379|P2|Overall Study|Withdrawal by team - hearing aid change|0
2882973|NCT01940705|9923380|P1|Overall Study|Withdrawal by team - hearing aid change|1
2882974|NCT01940705|9923377|P4|Overall Study|Intervention not given|0
2882975|NCT01940705|9923378|P3|Overall Study|Intervention not given|3
2882976|NCT01940705|9923379|P2|Overall Study|Intervention not given|3
2882977|NCT01940705|9923380|P1|Overall Study|Intervention not given|0
2882978|NCT01940705|9923377|P4|Overall Study|Withdrawal by Subject|2
2882979|NCT01940705|9923378|P3|Overall Study|Withdrawal by Subject|3
2882980|NCT01940705|9923379|P2|Overall Study|Withdrawal by Subject|2
2882981|NCT01940705|9923380|P1|Overall Study|Withdrawal by Subject|2
2882982|NCT01940705|9923377|P4|Overall Study|Lost to Follow-up|2
2882983|NCT01940705|9923378|P3|Overall Study|Lost to Follow-up|2
2882984|NCT01940705|9923379|P2|Overall Study|Lost to Follow-up|3
2882985|NCT01940705|9923380|P1|Overall Study|Lost to Follow-up|1
2882986|NCT01940497|9923444|P2|Overall Study|Administrative/Other|1
2882987|NCT01940497|9923445|P1|Overall Study|Administrative/Other|1
2882988|NCT01940497|9923444|P2|Overall Study|Withdrew Consent|2
2882989|NCT01940497|9923445|P1|Overall Study|Withdrew Consent|6
2882990|NCT01940497|9923444|P2|Overall Study|Refused Treatment|3
2882991|NCT01940497|9923445|P1|Overall Study|Refused Treatment|1
2882992|NCT01940497|9923444|P2|Overall Study|Violation of Entry Criteria|1
2882993|NCT01940497|9923445|P1|Overall Study|Violation of Entry Criteria|1
2882994|NCT01940497|9923444|P2|Overall Study|Recurrence of Disease Postsurgery|3
2882995|NCT01940497|9923445|P1|Overall Study|Recurrence of Disease Postsurgery|1
2882996|NCT01940497|9923444|P2|Overall Study|Adverse Event/Intercurrent Illness|8
2882997|NCT01940497|9923445|P1|Overall Study|Adverse Event/Intercurrent Illness|11
2882998|NCT01940484|9923486|P1|Overall Study|Adverse Event|1
2882999|NCT01940484|9923486|P1|Overall Study|Death|2
2883000|NCT01940484|9923486|P1|Overall Study|Underwent transplantation|4
2883001|NCT01940484|9923486|P1|Overall Study|Withdrawal by Subject|3
2883002|NCT01940471|9923506|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
2883003|NCT01940471|9923507|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
2883004|NCT01940471|9923506|P2|Double-Blind Phase|Still in Double-Blind Phase|270
2883005|NCT01940471|9923507|P1|Double-Blind Phase|Still in Double-Blind Phase|539
2883006|NCT01940471|9923506|P2|Double-Blind Phase|Protocol Violation|1
2883007|NCT01940471|9923507|P1|Double-Blind Phase|Protocol Violation|0
2883008|NCT01940471|9923506|P2|Double-Blind Phase|Lack of Efficacy|0
2883009|NCT01940471|9923507|P1|Double-Blind Phase|Lack of Efficacy|1
2883010|NCT01940471|9923506|P2|Double-Blind Phase|Death|0
2883011|NCT01940471|9923507|P1|Double-Blind Phase|Death|1
2883012|NCT01940471|9923506|P2|Double-Blind Phase|Protocol-Specified Criteria|0
2883013|NCT01940471|9923507|P1|Double-Blind Phase|Protocol-Specified Criteria|1
2883014|NCT01940471|9923506|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2883015|NCT01940471|9923507|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2883016|NCT01940471|9923506|P2|Double-Blind Phase|Investigator's Discretion|0
2883017|NCT01940471|9923507|P1|Double-Blind Phase|Investigator's Discretion|5
2883018|NCT01940471|9923506|P2|Double-Blind Phase|Pregnancy|1
2883019|NCT01940471|9923507|P1|Double-Blind Phase|Pregnancy|2
2883020|NCT01940471|9923506|P2|Double-Blind Phase|Lost to Follow-up|2
2883021|NCT01940471|9923507|P1|Double-Blind Phase|Lost to Follow-up|3
2883022|NCT01940471|9923506|P2|Double-Blind Phase|Adverse Event|2
2883023|NCT01940471|9923507|P1|Double-Blind Phase|Adverse Event|1
2883024|NCT01940471|9923506|P2|Double-Blind Phase|Withdrew Consent|7
2883025|NCT01940471|9923507|P1|Double-Blind Phase|Withdrew Consent|13
2883026|NCT01940471|9923506|P2|Double-Blind Phase|Randomized but Never Treated|1
2883027|NCT01940471|9923507|P1|Double-Blind Phase|Randomized but Never Treated|1
2883028|NCT01940354|9923525|P2|Overall Study|Withdrawal by Subject|2
2883029|NCT01940354|9923526|P1|Overall Study|Withdrawal by Subject|4
2883030|NCT01940341|9923538|P2|Open-label Extension Phase|Still on Study|1
2883031|NCT01940341|9923539|P1|Open-label Extension Phase|Still on Study|4
2883032|NCT01940341|9923538|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
2883033|NCT01940341|9923539|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
2883034|NCT01940341|9923538|P2|Double-Blind Phase|Protocol Specified Criteria|0
2883035|NCT01940341|9923539|P1|Double-Blind Phase|Protocol Specified Criteria|1
2883036|NCT01940341|9923538|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2883037|NCT01940341|9923539|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
2883038|NCT01940341|9923538|P2|Double-Blind Phase|Investigator's Discretion|0
2883039|NCT01940341|9923539|P1|Double-Blind Phase|Investigator's Discretion|1
2883040|NCT01940341|9923538|P2|Double-Blind Phase|Pregnancy|1
2883041|NCT01940341|9923539|P1|Double-Blind Phase|Pregnancy|0
2883042|NCT01940341|9923538|P2|Double-Blind Phase|Lost to Follow-up|1
2883043|NCT01940341|9923539|P1|Double-Blind Phase|Lost to Follow-up|4
2883044|NCT01940341|9923538|P2|Double-Blind Phase|Withdrew Consent|2
2883045|NCT01940341|9923539|P1|Double-Blind Phase|Withdrew Consent|3
2883046|NCT01940341|9923538|P2|Double-Blind Phase|Adverse Event|2
2883047|NCT01940341|9923539|P1|Double-Blind Phase|Adverse Event|3
2883048|NCT01940341|9923538|P2|Double-Blind Phase|Randomized but Never Treated|1
2883049|NCT01940341|9923539|P1|Double-Blind Phase|Randomized but Never Treated|0
2883050|NCT01940120|9923570|P1|Overall Study|Withdrawal by Subject|8
2883051|NCT01940120|9923570|P1|Overall Study|Death|40
2883052|NCT01939977|9923726|P2|Overall Study|Did not receive study medication|1
2883053|NCT01939977|9923727|P1|Overall Study|Did not receive study medication|0
2883054|NCT01939977|9923726|P2|Overall Study|Did not meet inclusion criteria|0
2883055|NCT01939977|9923727|P1|Overall Study|Did not meet inclusion criteria|1
2883056|NCT01939977|9923726|P2|Overall Study|Withdrawal by Subject|2
2883057|NCT01939977|9923727|P1|Overall Study|Withdrawal by Subject|0
2883058|NCT01939977|9923726|P2|Overall Study|Physician Decision|1
2883059|NCT01939977|9923727|P1|Overall Study|Physician Decision|1
2883060|NCT01939977|9923726|P2|Overall Study|Lack of Efficacy|0
2883061|NCT01939977|9923727|P1|Overall Study|Lack of Efficacy|3
2883062|NCT01939977|9923726|P2|Overall Study|Adverse Event|3
2883063|NCT01939977|9923727|P1|Overall Study|Adverse Event|4
2883064|NCT01939899|9923774|P5|Phase 2|Disease Progression|1
2883065|NCT01939899|9923775|P4|Phase 2|Disease Progression|9
2883066|NCT01939899|9923776|P3|Phase 2|Disease Progression|0
2883067|NCT01939899|9923777|P2|Phase 2|Disease Progression|0
2883068|NCT01939899|9923778|P1|Phase 2|Disease Progression|0
2883069|NCT01939899|9923774|P5|Phase 2|Withdrawal by Subject|0
2883070|NCT01939899|9923775|P4|Phase 2|Withdrawal by Subject|2
2883071|NCT01939899|9923776|P3|Phase 2|Withdrawal by Subject|0
2883072|NCT01939899|9923777|P2|Phase 2|Withdrawal by Subject|0
2883073|NCT01939899|9923778|P1|Phase 2|Withdrawal by Subject|0
2883074|NCT01939899|9923774|P5|Lead-in Dose Finding Phase|Other|0
2883075|NCT01939899|9923775|P4|Lead-in Dose Finding Phase|Other|0
2883076|NCT01939899|9923776|P3|Lead-in Dose Finding Phase|Other|1
2883077|NCT01939899|9923777|P2|Lead-in Dose Finding Phase|Other|0
2883078|NCT01939899|9923778|P1|Lead-in Dose Finding Phase|Other|0
2883079|NCT01939899|9923774|P5|Lead-in Dose Finding Phase|Disease Progression|0
2883080|NCT01939899|9923775|P4|Lead-in Dose Finding Phase|Disease Progression|0
2883081|NCT01939899|9923776|P3|Lead-in Dose Finding Phase|Disease Progression|3
2883082|NCT01939899|9923777|P2|Lead-in Dose Finding Phase|Disease Progression|4
2883083|NCT01939899|9923778|P1|Lead-in Dose Finding Phase|Disease Progression|2
2883084|NCT01939899|9923774|P5|Lead-in Dose Finding Phase|Death|0
2883085|NCT01939899|9923775|P4|Lead-in Dose Finding Phase|Death|0
2883086|NCT01939899|9923776|P3|Lead-in Dose Finding Phase|Death|1
2883087|NCT01939899|9923777|P2|Lead-in Dose Finding Phase|Death|3
2883088|NCT01939899|9923778|P1|Lead-in Dose Finding Phase|Death|0
2883089|NCT01939548|9923825|P3|Overall Study|Did not complete follow-up|0
2883090|NCT01939548|9923826|P2|Overall Study|Did not complete follow-up|1
2883091|NCT01939548|9923827|P1|Overall Study|Did not complete follow-up|0
2883092|NCT01939548|9923825|P3|Overall Study|Participant withdrew consent|0
2883093|NCT01939548|9923826|P2|Overall Study|Participant withdrew consent|2
2883094|NCT01939548|9923827|P1|Overall Study|Participant withdrew consent|0
2883095|NCT01939548|9923825|P3|Overall Study|Participant unwilling to continue|0
2883096|NCT01939548|9923826|P2|Overall Study|Participant unwilling to continue|1
2883097|NCT01939548|9923827|P1|Overall Study|Participant unwilling to continue|0
2883098|NCT01939548|9923825|P3|Overall Study|Participant dropped|1
2883099|NCT01939548|9923826|P2|Overall Study|Participant dropped|0
2883100|NCT01939548|9923827|P1|Overall Study|Participant dropped|0
2883101|NCT01939548|9923825|P3|Overall Study|Death|1
2883102|NCT01939548|9923826|P2|Overall Study|Death|0
2883103|NCT01939548|9923827|P1|Overall Study|Death|0
2883104|NCT01939548|9923825|P3|Overall Study|Adverse Event|7
2883105|NCT01939548|9923826|P2|Overall Study|Adverse Event|9
2883106|NCT01939548|9923827|P1|Overall Study|Adverse Event|2
2883107|NCT01939548|9923825|P3|Overall Study|Lost to Follow-up|3
2883108|NCT01939548|9923826|P2|Overall Study|Lost to Follow-up|5
2883109|NCT01939548|9923827|P1|Overall Study|Lost to Follow-up|5
2883110|NCT01939548|9923825|P3|Overall Study|Protocol Violation|5
2883111|NCT01939548|9923826|P2|Overall Study|Protocol Violation|6
2883112|NCT01939548|9923827|P1|Overall Study|Protocol Violation|7
2883113|NCT01939548|9923825|P3|Overall Study|Withdrawal by Subject|1
2883114|NCT01939548|9923826|P2|Overall Study|Withdrawal by Subject|4
2883115|NCT01939548|9923827|P1|Overall Study|Withdrawal by Subject|4
2883116|NCT01939548|9923825|P3|Overall Study|Did Not Meet Entrance Criteria|0
2883117|NCT01939548|9923826|P2|Overall Study|Did Not Meet Entrance Criteria|0
2883118|NCT01939548|9923827|P1|Overall Study|Did Not Meet Entrance Criteria|1
2883119|NCT01939548|9923825|P3|Overall Study|Insufficient Clinical Response|0
2883120|NCT01939548|9923826|P2|Overall Study|Insufficient Clinical Response|0
2883121|NCT01939548|9923827|P1|Overall Study|Insufficient Clinical Response|1
2883122|NCT01939548|9923825|P3|Overall Study|Study Terminated by Sponsor|12
2883123|NCT01939548|9923826|P2|Overall Study|Study Terminated by Sponsor|19
2883124|NCT01939548|9923827|P1|Overall Study|Study Terminated by Sponsor|17
2883125|NCT01939548|9923825|P3|Overall Study|Non compliance|0
2883126|NCT01939548|9923826|P2|Overall Study|Non compliance|2
2883127|NCT01939548|9923827|P1|Overall Study|Non compliance|0
2883128|NCT01939496|9923901|P3|Overall Study|Other|1
2883129|NCT01939496|9923902|P2|Overall Study|Other|0
2883130|NCT01939496|9923903|P1|Overall Study|Other|2
2883131|NCT01939496|9923901|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
2883132|NCT01939496|9923902|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
2883133|NCT01939496|9923903|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
2883134|NCT01939496|9923901|P3|Overall Study|Withdrawal by Subject|1
2883135|NCT01939496|9923902|P2|Overall Study|Withdrawal by Subject|1
2883136|NCT01939496|9923903|P1|Overall Study|Withdrawal by Subject|0
2883137|NCT01939496|9923901|P3|Overall Study|Protocol Violation|0
2883138|NCT01939496|9923902|P2|Overall Study|Protocol Violation|0
2883139|NCT01939496|9923903|P1|Overall Study|Protocol Violation|3
2883140|NCT01939496|9923901|P3|Overall Study|Physician Decision|0
2883141|NCT01939496|9923902|P2|Overall Study|Physician Decision|0
2883142|NCT01939496|9923903|P1|Overall Study|Physician Decision|1
2883143|NCT01939496|9923901|P3|Overall Study|Lost to Follow-up|0
2883144|NCT01939496|9923902|P2|Overall Study|Lost to Follow-up|1
2883145|NCT01939496|9923903|P1|Overall Study|Lost to Follow-up|1
2883146|NCT01939496|9923901|P3|Overall Study|Adverse Event|0
2883147|NCT01939496|9923902|P2|Overall Study|Adverse Event|0
2883148|NCT01939496|9923903|P1|Overall Study|Adverse Event|2
2883149|NCT01939366|9923973|P5|Overall Study|GCP non-compliance at site|3
2883150|NCT01939366|9923974|P4|Overall Study|GCP non-compliance at site|3
2883151|NCT01939366|9923975|P3|Overall Study|GCP non-compliance at site|2
2883152|NCT01939366|9923976|P2|Overall Study|GCP non-compliance at site|3
2883153|NCT01939366|9923977|P1|Overall Study|GCP non-compliance at site|2
2883154|NCT01939366|9923973|P5|Overall Study|Sponsor decision|2
2883155|NCT01939366|9923974|P4|Overall Study|Sponsor decision|0
2883156|NCT01939366|9923975|P3|Overall Study|Sponsor decision|0
2883157|NCT01939366|9923976|P2|Overall Study|Sponsor decision|0
2883158|NCT01939366|9923977|P1|Overall Study|Sponsor decision|0
2883159|NCT01939366|9923973|P5|Overall Study|Protocol Violation|0
2883160|NCT01939366|9923974|P4|Overall Study|Protocol Violation|1
2883161|NCT01939366|9923975|P3|Overall Study|Protocol Violation|0
2883162|NCT01939366|9923976|P2|Overall Study|Protocol Violation|0
2883163|NCT01939366|9923977|P1|Overall Study|Protocol Violation|0
2883164|NCT01939366|9923973|P5|Overall Study|Other|1
2883165|NCT01939366|9923974|P4|Overall Study|Other|2
2883166|NCT01939366|9923975|P3|Overall Study|Other|2
2883167|NCT01939366|9923976|P2|Overall Study|Other|0
2883168|NCT01939366|9923977|P1|Overall Study|Other|0
2883169|NCT01939366|9923973|P5|Overall Study|Inclusion criteria not met|1
2883170|NCT01939366|9923974|P4|Overall Study|Inclusion criteria not met|0
2883171|NCT01939366|9923975|P3|Overall Study|Inclusion criteria not met|1
2883172|NCT01939366|9923976|P2|Overall Study|Inclusion criteria not met|1
2883173|NCT01939366|9923977|P1|Overall Study|Inclusion criteria not met|0
2883174|NCT01939366|9923973|P5|Overall Study|Withdrawal by Subject|3
2883175|NCT01939366|9923974|P4|Overall Study|Withdrawal by Subject|2
2883176|NCT01939366|9923975|P3|Overall Study|Withdrawal by Subject|2
2883177|NCT01939366|9923976|P2|Overall Study|Withdrawal by Subject|0
2883178|NCT01939366|9923977|P1|Overall Study|Withdrawal by Subject|1
2883179|NCT01939366|9923973|P5|Overall Study|Lost to Follow-up|0
2883180|NCT01939366|9923974|P4|Overall Study|Lost to Follow-up|0
2883181|NCT01939366|9923975|P3|Overall Study|Lost to Follow-up|0
2883182|NCT01939366|9923976|P2|Overall Study|Lost to Follow-up|1
2883183|NCT01939366|9923977|P1|Overall Study|Lost to Follow-up|1
2883184|NCT01939366|9923973|P5|Overall Study|Lack of Efficacy|3
2883185|NCT01939366|9923974|P4|Overall Study|Lack of Efficacy|1
2883186|NCT01939366|9923975|P3|Overall Study|Lack of Efficacy|1
2883187|NCT01939366|9923976|P2|Overall Study|Lack of Efficacy|1
2883188|NCT01939366|9923977|P1|Overall Study|Lack of Efficacy|2
2883189|NCT01939366|9923973|P5|Overall Study|Adverse Event|5
2883190|NCT01939366|9923974|P4|Overall Study|Adverse Event|8
2883191|NCT01939366|9923975|P3|Overall Study|Adverse Event|30
2883192|NCT01939366|9923976|P2|Overall Study|Adverse Event|17
2883193|NCT01939366|9923977|P1|Overall Study|Adverse Event|8
2883194|NCT01939314|9923991|P2|Overall Study|Lost to Follow-up|6
2883195|NCT01939314|9923992|P1|Overall Study|Lost to Follow-up|5
2883196|NCT01939314|9923991|P2|Overall Study|Pregnancy|1
2883197|NCT01939314|9923992|P1|Overall Study|Pregnancy|0
2883198|NCT01939314|9923991|P2|Overall Study|Protocol Violation|0
2883199|NCT01939314|9923992|P1|Overall Study|Protocol Violation|1
2883200|NCT01939314|9923991|P2|Overall Study|Withdrawal by Subject|1
2883201|NCT01939314|9923992|P1|Overall Study|Withdrawal by Subject|3
2883202|NCT01939223|9924026|P2|Overall Study|Withdrawal by Subject|0
2883203|NCT01939223|9924027|P1|Overall Study|Withdrawal by Subject|6
2883204|NCT01939223|9924026|P2|Overall Study|Study stopped by Sponsor|7
2883205|NCT01939223|9924027|P1|Overall Study|Study stopped by Sponsor|5
2883206|NCT01939223|9924026|P2|Overall Study|Disease recurrence (radiological)|3
2883207|NCT01939223|9924027|P1|Overall Study|Disease recurrence (radiological)|1
2883208|NCT01939223|9924026|P2|Overall Study|AE not assoc. with disease recurrence|1
2883209|NCT01939223|9924027|P1|Overall Study|AE not assoc. with disease recurrence|1
2883210|NCT01939197|9924042|P7|Overall Study|Lost to Follow-up|2
2883211|NCT01939197|9924043|P6|Overall Study|Lost to Follow-up|1
2883212|NCT01939197|9924044|P5|Overall Study|Lost to Follow-up|3
2883213|NCT01939197|9924045|P4|Overall Study|Lost to Follow-up|1
2883214|NCT01939197|9924046|P3|Overall Study|Lost to Follow-up|0
2883215|NCT01939197|9924047|P2|Overall Study|Lost to Follow-up|1
2883216|NCT01939197|9924048|P1|Overall Study|Lost to Follow-up|0
2883217|NCT01939197|9924042|P7|Overall Study|Withdrawal by Subject|0
2883218|NCT01939197|9924043|P6|Overall Study|Withdrawal by Subject|0
2883219|NCT01939197|9924044|P5|Overall Study|Withdrawal by Subject|1
2883220|NCT01939197|9924045|P4|Overall Study|Withdrawal by Subject|0
2883221|NCT01939197|9924046|P3|Overall Study|Withdrawal by Subject|0
2883222|NCT01939197|9924047|P2|Overall Study|Withdrawal by Subject|0
2883223|NCT01939197|9924048|P1|Overall Study|Withdrawal by Subject|1
2883224|NCT01939002|9924119|P2|Overall Study|Other|2
2883225|NCT01939002|9924120|P1|Overall Study|Other|1
2883226|NCT01939002|9924119|P2|Overall Study|Withdrawal by Subject|3
2883227|NCT01939002|9924120|P1|Overall Study|Withdrawal by Subject|5
2883228|NCT01939002|9924119|P2|Overall Study|Adverse Event|13
2883229|NCT01939002|9924120|P1|Overall Study|Adverse Event|13
2883230|NCT01938846|9924196|P3|Overall Study|Other than listed|4
2883231|NCT01938846|9924197|P2|Overall Study|Other than listed|1
2883232|NCT01938846|9924198|P1|Overall Study|Other than listed|5
2883233|NCT01938846|9924196|P3|Overall Study|Withdrawal by Subject|1
2883234|NCT01938846|9924197|P2|Overall Study|Withdrawal by Subject|2
2883235|NCT01938846|9924198|P1|Overall Study|Withdrawal by Subject|2
2883236|NCT01938846|9924196|P3|Overall Study|Adverse Event|3
2883237|NCT01938846|9924197|P2|Overall Study|Adverse Event|4
2883238|NCT01938846|9924198|P1|Overall Study|Adverse Event|8
2883239|NCT01938846|9924196|P3|Overall Study|Progressive disease|16
2883240|NCT01938846|9924197|P2|Overall Study|Progressive disease|18
2883241|NCT01938846|9924198|P1|Overall Study|Progressive disease|26
2883242|NCT01938625|9924413|P2|Overall Study|Adverse Event|1
2883243|NCT01938625|9924414|P1|Overall Study|Adverse Event|0
2883244|NCT01938625|9924413|P2|Overall Study|Withdrawal by Subject|1
2883245|NCT01938625|9924414|P1|Overall Study|Withdrawal by Subject|0
2883246|NCT01938573|9924434|P2|Overall Study|Operation at other hospital|0
2883247|NCT01938573|9924435|P1|Overall Study|Operation at other hospital|1
2883248|NCT01938573|9924434|P2|Overall Study|Lack of Efficacy|0
2883249|NCT01938573|9924435|P1|Overall Study|Lack of Efficacy|1
2883250|NCT01938430|9924455|P14|Overall Study|Withdrew Consent|0
2883251|NCT01938430|9924456|P13|Overall Study|Withdrew Consent|0
2883252|NCT01938430|9924457|P12|Overall Study|Withdrew Consent|0
2883253|NCT01938430|9924458|P11|Overall Study|Withdrew Consent|0
2883254|NCT01938430|9924459|P10|Overall Study|Withdrew Consent|0
2883255|NCT01938430|9924460|P9|Overall Study|Withdrew Consent|1
2883256|NCT01938430|9924461|P8|Overall Study|Withdrew Consent|0
2883257|NCT01938430|9924462|P7|Overall Study|Withdrew Consent|0
2883258|NCT01938430|9924463|P6|Overall Study|Withdrew Consent|0
2883259|NCT01938430|9924464|P5|Overall Study|Withdrew Consent|0
2883260|NCT01938430|9924465|P4|Overall Study|Withdrew Consent|0
2883261|NCT01938430|9924466|P3|Overall Study|Withdrew Consent|0
2883262|NCT01938430|9924467|P2|Overall Study|Withdrew Consent|0
2883263|NCT01938430|9924468|P1|Overall Study|Withdrew Consent|0
2883264|NCT01938430|9924455|P14|Overall Study|Lost to Follow-up|0
2883265|NCT01938430|9924456|P13|Overall Study|Lost to Follow-up|0
2883266|NCT01938430|9924457|P12|Overall Study|Lost to Follow-up|0
2883267|NCT01938430|9924458|P11|Overall Study|Lost to Follow-up|0
2883268|NCT01938430|9924459|P10|Overall Study|Lost to Follow-up|0
2883269|NCT01938430|9924460|P9|Overall Study|Lost to Follow-up|0
2883270|NCT01938430|9924461|P8|Overall Study|Lost to Follow-up|0
2883271|NCT01938430|9924462|P7|Overall Study|Lost to Follow-up|0
2883272|NCT01938430|9924463|P6|Overall Study|Lost to Follow-up|1
2883273|NCT01938430|9924464|P5|Overall Study|Lost to Follow-up|0
2883274|NCT01938430|9924465|P4|Overall Study|Lost to Follow-up|0
2883275|NCT01938430|9924466|P3|Overall Study|Lost to Follow-up|1
2883276|NCT01938430|9924467|P2|Overall Study|Lost to Follow-up|0
2883277|NCT01938430|9924468|P1|Overall Study|Lost to Follow-up|0
2883278|NCT01938430|9924455|P14|Overall Study|Lack of Efficacy|0
2883279|NCT01938430|9924456|P13|Overall Study|Lack of Efficacy|0
2883280|NCT01938430|9924457|P12|Overall Study|Lack of Efficacy|1
2883281|NCT01938430|9924458|P11|Overall Study|Lack of Efficacy|2
2883282|NCT01938430|9924459|P10|Overall Study|Lack of Efficacy|0
2883283|NCT01938430|9924460|P9|Overall Study|Lack of Efficacy|1
2883284|NCT01938430|9924461|P8|Overall Study|Lack of Efficacy|0
2883285|NCT01938430|9924462|P7|Overall Study|Lack of Efficacy|0
2883286|NCT01938430|9924463|P6|Overall Study|Lack of Efficacy|0
2883287|NCT01938430|9924464|P5|Overall Study|Lack of Efficacy|0
2883288|NCT01938430|9924465|P4|Overall Study|Lack of Efficacy|1
2883289|NCT01938430|9924466|P3|Overall Study|Lack of Efficacy|1
2883290|NCT01938430|9924467|P2|Overall Study|Lack of Efficacy|1
2883291|NCT01938430|9924468|P1|Overall Study|Lack of Efficacy|3
2883292|NCT01938430|9924455|P14|Overall Study|Investigator's Discretion|0
2883293|NCT01938430|9924456|P13|Overall Study|Investigator's Discretion|0
2883294|NCT01938430|9924457|P12|Overall Study|Investigator's Discretion|0
2883295|NCT01938430|9924458|P11|Overall Study|Investigator's Discretion|0
2883296|NCT01938430|9924459|P10|Overall Study|Investigator's Discretion|0
2883297|NCT01938430|9924460|P9|Overall Study|Investigator's Discretion|0
2883298|NCT01938430|9924461|P8|Overall Study|Investigator's Discretion|0
2883299|NCT01938430|9924462|P7|Overall Study|Investigator's Discretion|0
2883300|NCT01938430|9924463|P6|Overall Study|Investigator's Discretion|0
2883301|NCT01938430|9924464|P5|Overall Study|Investigator's Discretion|0
2883302|NCT01938430|9924465|P4|Overall Study|Investigator's Discretion|0
2883303|NCT01938430|9924466|P3|Overall Study|Investigator's Discretion|1
2883304|NCT01938430|9924467|P2|Overall Study|Investigator's Discretion|0
2883305|NCT01938430|9924468|P1|Overall Study|Investigator's Discretion|0
2883306|NCT01938430|9924455|P14|Overall Study|Death|0
2883307|NCT01938430|9924456|P13|Overall Study|Death|0
2883308|NCT01938430|9924457|P12|Overall Study|Death|0
2883309|NCT01938430|9924458|P11|Overall Study|Death|0
2883310|NCT01938430|9924459|P10|Overall Study|Death|3
2883311|NCT01938430|9924460|P9|Overall Study|Death|2
2883312|NCT01938430|9924461|P8|Overall Study|Death|1
2883313|NCT01938430|9924462|P7|Overall Study|Death|1
2883314|NCT01938430|9924463|P6|Overall Study|Death|0
2883315|NCT01938430|9924464|P5|Overall Study|Death|0
2883316|NCT01938430|9924465|P4|Overall Study|Death|1
2883317|NCT01938430|9924466|P3|Overall Study|Death|2
2883318|NCT01938430|9924467|P2|Overall Study|Death|2
2883319|NCT01938430|9924468|P1|Overall Study|Death|1
2883320|NCT01938430|9924455|P14|Overall Study|Adverse Event|0
2883321|NCT01938430|9924456|P13|Overall Study|Adverse Event|0
2883322|NCT01938430|9924457|P12|Overall Study|Adverse Event|0
2883323|NCT01938430|9924458|P11|Overall Study|Adverse Event|0
2883324|NCT01938430|9924459|P10|Overall Study|Adverse Event|0
2883325|NCT01938430|9924460|P9|Overall Study|Adverse Event|0
2883326|NCT01938430|9924461|P8|Overall Study|Adverse Event|0
2883327|NCT01938430|9924462|P7|Overall Study|Adverse Event|1
2883328|NCT01938430|9924463|P6|Overall Study|Adverse Event|0
2883329|NCT01938430|9924464|P5|Overall Study|Adverse Event|0
2883330|NCT01938430|9924465|P4|Overall Study|Adverse Event|0
2883331|NCT01938430|9924466|P3|Overall Study|Adverse Event|0
2883332|NCT01938430|9924467|P2|Overall Study|Adverse Event|0
2883333|NCT01938430|9924468|P1|Overall Study|Adverse Event|0
2883334|NCT01938430|9924455|P14|Overall Study|Randomized but Not Treated|1
2883335|NCT01938430|9924456|P13|Overall Study|Randomized but Not Treated|0
2883336|NCT01938430|9924457|P12|Overall Study|Randomized but Not Treated|0
2883337|NCT01938430|9924458|P11|Overall Study|Randomized but Not Treated|1
2883338|NCT01938430|9924459|P10|Overall Study|Randomized but Not Treated|0
2883339|NCT01938430|9924460|P9|Overall Study|Randomized but Not Treated|0
2883340|NCT01938430|9924461|P8|Overall Study|Randomized but Not Treated|0
2883341|NCT01938430|9924462|P7|Overall Study|Randomized but Not Treated|0
2883342|NCT01938430|9924463|P6|Overall Study|Randomized but Not Treated|0
2883343|NCT01938430|9924464|P5|Overall Study|Randomized but Not Treated|0
2883344|NCT01938430|9924465|P4|Overall Study|Randomized but Not Treated|0
2883345|NCT01938430|9924466|P3|Overall Study|Randomized but Not Treated|0
2883346|NCT01938430|9924467|P2|Overall Study|Randomized but Not Treated|0
2883347|NCT01938430|9924468|P1|Overall Study|Randomized but Not Treated|0
2883348|NCT01938391|9924793|P1|12 Month Follow up|Withdrawal by Subject|1
2883349|NCT01938391|9924793|P1|12 Month Follow up|Physician Decision|1
2883350|NCT01938391|9924793|P1|6 Month Follow up|Withdrawal by Subject|1
2883351|NCT01938001|9924927|P2|Overall Study|Death|26
2883352|NCT01938001|9924928|P1|Overall Study|Death|16
2883353|NCT01938001|9924927|P2|Overall Study|Lost to Follow-up|3
2883354|NCT01938001|9924928|P1|Overall Study|Lost to Follow-up|1
2883355|NCT01938001|9924927|P2|Overall Study|Participant Moved|1
2883356|NCT01938001|9924928|P1|Overall Study|Participant Moved|0
2883357|NCT01938001|9924927|P2|Overall Study|Non-compliant|0
2883358|NCT01938001|9924928|P1|Overall Study|Non-compliant|1
2883359|NCT01938001|9924927|P2|Overall Study|Withdrawal by Subject|17
2883360|NCT01938001|9924928|P1|Overall Study|Withdrawal by Subject|25
2883361|NCT01937871|9925007|P3|Overall Study|Entry Criteria Not Met|1
2883362|NCT01937871|9925008|P2|Overall Study|Entry Criteria Not Met|2
2883363|NCT01937871|9925009|P1|Overall Study|Entry Criteria Not Met|1
2883364|NCT01937871|9925007|P3|Overall Study|Physician Decision|0
2883365|NCT01937871|9925008|P2|Overall Study|Physician Decision|1
2883366|NCT01937871|9925009|P1|Overall Study|Physician Decision|0
2883367|NCT01937871|9925007|P3|Overall Study|Withdrawal by Subject|4
2883368|NCT01937871|9925008|P2|Overall Study|Withdrawal by Subject|6
2883369|NCT01937871|9925009|P1|Overall Study|Withdrawal by Subject|9
2883370|NCT01937871|9925007|P3|Overall Study|Lost to Follow-up|4
2883371|NCT01937871|9925008|P2|Overall Study|Lost to Follow-up|2
2883372|NCT01937871|9925009|P1|Overall Study|Lost to Follow-up|8
2883373|NCT01937871|9925007|P3|Overall Study|Adverse Event|2
2883374|NCT01937871|9925008|P2|Overall Study|Adverse Event|6
2883375|NCT01937871|9925009|P1|Overall Study|Adverse Event|6
2883376|NCT01937715|9925085|P5|Overall Study|Other|0
2883377|NCT01937715|9925086|P4|Overall Study|Other|3
2883378|NCT01937715|9925087|P3|Overall Study|Other|0
2883379|NCT01937715|9925088|P2|Overall Study|Other|0
2883380|NCT01937715|9925089|P1|Overall Study|Other|0
2883381|NCT01937715|9925085|P5|Overall Study|Withdrawal by Subject|2
2883382|NCT01937715|9925086|P4|Overall Study|Withdrawal by Subject|0
2883383|NCT01937715|9925087|P3|Overall Study|Withdrawal by Subject|0
2883384|NCT01937715|9925088|P2|Overall Study|Withdrawal by Subject|1
2883385|NCT01937715|9925089|P1|Overall Study|Withdrawal by Subject|0
2883386|NCT01937715|9925085|P5|Overall Study|Death|0
2883387|NCT01937715|9925086|P4|Overall Study|Death|1
2883388|NCT01937715|9925087|P3|Overall Study|Death|0
2883389|NCT01937715|9925088|P2|Overall Study|Death|0
2883390|NCT01937715|9925089|P1|Overall Study|Death|0
2883391|NCT01937559|9925241|P3|Overall Study|screen fail|0
2883392|NCT01937559|9925242|P2|Overall Study|screen fail|4
2883393|NCT01937559|9925243|P1|Overall Study|screen fail|2
2883394|NCT01937559|9925241|P3|Overall Study|Withdrawal by Subject|0
2883395|NCT01937559|9925242|P2|Overall Study|Withdrawal by Subject|4
2883396|NCT01937559|9925243|P1|Overall Study|Withdrawal by Subject|6
2883397|NCT01937559|9925241|P3|Overall Study|Physician Decision|0
2883398|NCT01937559|9925242|P2|Overall Study|Physician Decision|3
2883399|NCT01937559|9925243|P1|Overall Study|Physician Decision|3
2883400|NCT01937390|9925313|P1|Overall Study|Fail to return|21
2883401|NCT01937390|9925313|P1|Overall Study|Withdrawal by Subject|5
2883402|NCT01937390|9925313|P1|Overall Study|Lost to Follow-up|7
2883403|NCT01937390|9925313|P1|Overall Study|Death|2
2883404|NCT01937364|9925323|P2|Overall Study|Adverse Event|1
2883405|NCT01937364|9925324|P1|Overall Study|Adverse Event|2
2883406|NCT01937351|9925336|P2|Overall Study|Not treated w device, per protocol fail|0
2883407|NCT01937351|9925337|P1|Overall Study|Not treated w device, per protocol fail|4
2883408|NCT01937351|9925336|P2|Overall Study|Death|0
2883409|NCT01937351|9925337|P1|Overall Study|Death|1
2883410|NCT01937351|9925336|P2|Overall Study|Withdrawal by Subject|2
2883411|NCT01937351|9925337|P1|Overall Study|Withdrawal by Subject|4
2883412|NCT01937312|9925345|P2|Overall Study|Withdrawal of subject prior to treatment|1
2883413|NCT01937312|9925346|P1|Overall Study|Withdrawal of subject prior to treatment|1
2883414|NCT01937312|9925345|P2|Overall Study|Lack of Efficacy|1
2883415|NCT01937312|9925346|P1|Overall Study|Lack of Efficacy|0
2883416|NCT01937312|9925345|P2|Overall Study|Adverse Event|1
2883417|NCT01937312|9925346|P1|Overall Study|Adverse Event|10
2883418|NCT01937299|9925361|P2|Overall Study|Withdrawal by Subject|0
2883419|NCT01937299|9925362|P1|Overall Study|Withdrawal by Subject|1
2883420|NCT01937299|9925361|P2|Overall Study|Lack of Efficacy|4
2883421|NCT01937299|9925362|P1|Overall Study|Lack of Efficacy|0
2883422|NCT01937299|9925361|P2|Overall Study|Adverse Event|0
2883423|NCT01937299|9925362|P1|Overall Study|Adverse Event|13
2883424|NCT01937130|9925397|P4|Overall Study|Patient lost to FU due to death|0
2883425|NCT01937130|9925398|P3|Overall Study|Patient lost to FU due to death|0
2883426|NCT01937130|9925399|P2|Overall Study|Patient lost to FU due to death|0
2883427|NCT01937130|9925400|P1|Overall Study|Patient lost to FU due to death|2
2883428|NCT01937130|9925397|P4|Overall Study|Patients unable to swallow|0
2883429|NCT01937130|9925398|P3|Overall Study|Patients unable to swallow|0
2883430|NCT01937130|9925399|P2|Overall Study|Patients unable to swallow|1
2883431|NCT01937130|9925400|P1|Overall Study|Patients unable to swallow|0
2883432|NCT01937130|9925397|P4|Overall Study|Physician Decision|0
2883433|NCT01937130|9925398|P3|Overall Study|Physician Decision|0
2883434|NCT01937130|9925399|P2|Overall Study|Physician Decision|1
2883435|NCT01937130|9925400|P1|Overall Study|Physician Decision|0
2883436|NCT01937130|9925397|P4|Overall Study|Lost to Follow-up|0
2883437|NCT01937130|9925398|P3|Overall Study|Lost to Follow-up|2
2883438|NCT01937130|9925399|P2|Overall Study|Lost to Follow-up|0
2883439|NCT01937130|9925400|P1|Overall Study|Lost to Follow-up|2
2883440|NCT01937130|9925397|P4|Overall Study|Death|0
2883441|NCT01937130|9925398|P3|Overall Study|Death|1
2883442|NCT01937130|9925399|P2|Overall Study|Death|1
2883443|NCT01937130|9925400|P1|Overall Study|Death|1
2883444|NCT01937130|9925397|P4|Overall Study|Adverse Event|1
2883445|NCT01937130|9925398|P3|Overall Study|Adverse Event|0
2883446|NCT01937130|9925399|P2|Overall Study|Adverse Event|1
2883447|NCT01937130|9925400|P1|Overall Study|Adverse Event|0
2883448|NCT01937130|9925397|P4|Overall Study|Withdrawal by Subject|1
2883449|NCT01937130|9925398|P3|Overall Study|Withdrawal by Subject|0
2883450|NCT01937130|9925399|P2|Overall Study|Withdrawal by Subject|0
2883451|NCT01937130|9925400|P1|Overall Study|Withdrawal by Subject|0
2883452|NCT01937117|9925427|P1|Overall Study|Adverse Event|2
2883453|NCT01937117|9925427|P1|Overall Study|Physician Decision|4
2883454|NCT01937117|9925427|P1|Overall Study|Disease Progression|7
2883455|NCT01936974|9925442|P2|Overall Study|Physician Decision|5
2883456|NCT01936974|9925443|P1|Overall Study|Physician Decision|2
2883457|NCT01936870|9925473|P1|Overall Study|No Drug Administration|1
2883458|NCT01936870|9925473|P1|Overall Study|Protocol Violation|12
2883459|NCT01936870|9925473|P1|Overall Study|No Visit After Treatment|176
2883460|NCT01936649|9925510|P1|Overall Study|Other than specified above|5
2883461|NCT01936649|9925510|P1|Overall Study|Protocol Violation|2
2883462|NCT01936649|9925510|P1|Overall Study|Physician Decision|2
2883463|NCT01936649|9925510|P1|Overall Study|Withdrawal by Subject|4
2883464|NCT01936623|9925517|P2|Overall Study|Lost to Follow-up|5
2883465|NCT01936623|9925518|P1|Overall Study|Lost to Follow-up|0
2883466|NCT01936181|9925626|P4|Transition-extension|Withdrawal by Subject|1
2883467|NCT01936181|9925627|P3|Transition-extension|Withdrawal by Subject|2
2883468|NCT01936181|9925628|P2|Transition-extension|Withdrawal by Subject|0
2883469|NCT01936181|9925629|P1|Transition-extension|Withdrawal by Subject|7
2883470|NCT01936181|9925626|P4|Transition-extension|Physician Decision|1
2883471|NCT01936181|9925627|P3|Transition-extension|Physician Decision|0
2883472|NCT01936181|9925628|P2|Transition-extension|Physician Decision|0
2883473|NCT01936181|9925629|P1|Transition-extension|Physician Decision|2
2883474|NCT01936181|9925626|P4|Transition-extension|Lost to Follow-up|2
2883475|NCT01936181|9925627|P3|Transition-extension|Lost to Follow-up|1
2883476|NCT01936181|9925628|P2|Transition-extension|Lost to Follow-up|0
2883477|NCT01936181|9925629|P1|Transition-extension|Lost to Follow-up|3
2883478|NCT01936181|9925626|P4|Transition-extension|Adverse Event|1
2883479|NCT01936181|9925627|P3|Transition-extension|Adverse Event|3
2883480|NCT01936181|9925628|P2|Transition-extension|Adverse Event|0
2883481|NCT01936181|9925629|P1|Transition-extension|Adverse Event|3
2883482|NCT01936181|9925626|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2883483|NCT01936181|9925627|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2883484|NCT01936181|9925628|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2883485|NCT01936181|9925629|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2883486|NCT01936181|9925626|P4|Randomised, Double-blind|Withdrawal by Subject|0
2883487|NCT01936181|9925627|P3|Randomised, Double-blind|Withdrawal by Subject|0
2883488|NCT01936181|9925628|P2|Randomised, Double-blind|Withdrawal by Subject|26
2883489|NCT01936181|9925629|P1|Randomised, Double-blind|Withdrawal by Subject|23
2883490|NCT01936181|9925626|P4|Randomised, Double-blind|Physician Decision|0
2883491|NCT01936181|9925627|P3|Randomised, Double-blind|Physician Decision|0
2883492|NCT01936181|9925628|P2|Randomised, Double-blind|Physician Decision|4
2883493|NCT01936181|9925629|P1|Randomised, Double-blind|Physician Decision|4
2883494|NCT01936181|9925626|P4|Randomised, Double-blind|Pregnancy|0
2883495|NCT01936181|9925627|P3|Randomised, Double-blind|Pregnancy|0
2883496|NCT01936181|9925628|P2|Randomised, Double-blind|Pregnancy|1
2883497|NCT01936181|9925629|P1|Randomised, Double-blind|Pregnancy|0
2883498|NCT01936181|9925626|P4|Randomised, Double-blind|Lost to Follow-up|0
2883499|NCT01936181|9925627|P3|Randomised, Double-blind|Lost to Follow-up|0
2883500|NCT01936181|9925628|P2|Randomised, Double-blind|Lost to Follow-up|1
2883501|NCT01936181|9925629|P1|Randomised, Double-blind|Lost to Follow-up|0
2883502|NCT01936181|9925626|P4|Randomised, Double-blind|Lack of Efficacy|0
2883503|NCT01936181|9925627|P3|Randomised, Double-blind|Lack of Efficacy|0
2883504|NCT01936181|9925628|P2|Randomised, Double-blind|Lack of Efficacy|6
2883505|NCT01936181|9925629|P1|Randomised, Double-blind|Lack of Efficacy|5
2883506|NCT01936181|9925626|P4|Randomised, Double-blind|Protocol Violation|0
2883507|NCT01936181|9925627|P3|Randomised, Double-blind|Protocol Violation|0
2883508|NCT01936181|9925628|P2|Randomised, Double-blind|Protocol Violation|5
2883509|NCT01936181|9925629|P1|Randomised, Double-blind|Protocol Violation|1
2883510|NCT01936181|9925626|P4|Randomised, Double-blind|Adverse Event|0
2883511|NCT01936181|9925627|P3|Randomised, Double-blind|Adverse Event|0
2883512|NCT01936181|9925628|P2|Randomised, Double-blind|Adverse Event|21
2883513|NCT01936181|9925629|P1|Randomised, Double-blind|Adverse Event|27
2883514|NCT01935947|9925643|P3|Overall Study|Death|0
2883515|NCT01935947|9925644|P2|Overall Study|Death|0
2883516|NCT01935947|9925645|P1|Overall Study|Death|1
2883517|NCT01935947|9925643|P3|Overall Study|Diease Progression|2
2883518|NCT01935947|9925644|P2|Overall Study|Diease Progression|2
2883519|NCT01935947|9925645|P1|Overall Study|Diease Progression|2
2883520|NCT01935947|9925643|P3|Overall Study|Adverse Event|0
2883521|NCT01935947|9925644|P2|Overall Study|Adverse Event|2
2883522|NCT01935947|9925645|P1|Overall Study|Adverse Event|0
2883523|NCT01934894|9925704|P2|Overall Study|Progressive Disease|2
2883524|NCT01934894|9925705|P1|Overall Study|Progressive Disease|3
2883525|NCT01934894|9925704|P2|Overall Study|Withdrawal by Subject|1
2883526|NCT01934894|9925705|P1|Overall Study|Withdrawal by Subject|0
2883527|NCT01934894|9925704|P2|Overall Study|Death|0
2883528|NCT01934894|9925705|P1|Overall Study|Death|2
2883529|NCT01934894|9925704|P2|Overall Study|Adverse Event|2
2883530|NCT01934894|9925705|P1|Overall Study|Adverse Event|1
2883531|NCT01934790|9925720|P1|Active Follow up|Other reason|1
2883532|NCT01934790|9925720|P1|Active Follow up|Progressive disease|1
2883533|NCT01934790|9925720|P1|Active Follow up|Physician Decision|2
2883534|NCT01934790|9925720|P1|Active Follow up|Death|20
2883535|NCT01934790|9925720|P1|Treatment|Study drug never administered|1
2883536|NCT01934790|9925720|P1|Treatment|Withdrawal by Subject|2
2883537|NCT01934790|9925720|P1|Treatment|Radiological progression|4
2883538|NCT01934790|9925720|P1|Treatment|Clinical progression|6
2883539|NCT01934790|9925720|P1|Treatment|Adverse Event|3
2883540|NCT01934504|9925787|P4|Overall Study|Study Terminated by Sponsor|5
2883541|NCT01934504|9925788|P3|Overall Study|Study Terminated by Sponsor|5
2883542|NCT01934504|9925789|P2|Overall Study|Study Terminated by Sponsor|0
2883543|NCT01934504|9925790|P1|Overall Study|Study Terminated by Sponsor|1
2883544|NCT01934504|9925787|P4|Overall Study|Protocol Deviation|2
2883545|NCT01934504|9925788|P3|Overall Study|Protocol Deviation|0
2883546|NCT01934504|9925789|P2|Overall Study|Protocol Deviation|0
2883547|NCT01934504|9925790|P1|Overall Study|Protocol Deviation|0
2883548|NCT01934218|9925823|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
2883549|NCT01934218|9925824|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
2883550|NCT01934218|9925823|P2|Open-Label Phase|Noncompliance with Study Protocol|2
2883551|NCT01934218|9925824|P1|Open-Label Phase|Noncompliance with Study Protocol|4
2883552|NCT01934218|9925823|P2|Open-Label Phase|Withdrawal by Subject|11
2883553|NCT01934218|9925824|P1|Open-Label Phase|Withdrawal by Subject|13
2883554|NCT01934218|9925823|P2|Open-Label Phase|Protocol Violation|0
2883555|NCT01934218|9925824|P1|Open-Label Phase|Protocol Violation|1
2883556|NCT01934218|9925823|P2|Open-Label Phase|Physician Decision|0
2883557|NCT01934218|9925824|P1|Open-Label Phase|Physician Decision|1
2883558|NCT01934218|9925823|P2|Open-Label Phase|Lost to Follow-up|2
2883559|NCT01934218|9925824|P1|Open-Label Phase|Lost to Follow-up|4
2883560|NCT01934218|9925823|P2|Open-Label Phase|Lack of Efficacy|4
2883561|NCT01934218|9925824|P1|Open-Label Phase|Lack of Efficacy|1
2883562|NCT01934218|9925823|P2|Open-Label Phase|Adverse Event|4
2883563|NCT01934218|9925824|P1|Open-Label Phase|Adverse Event|2
2883564|NCT01934218|9925823|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
2883565|NCT01934218|9925824|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
2883566|NCT01934218|9925823|P2|Double-blind Phase|Noncompliance with Study Protocol|8
2883567|NCT01934218|9925824|P1|Double-blind Phase|Noncompliance with Study Protocol|5
2883568|NCT01934218|9925823|P2|Double-blind Phase|Withdrawal by Subject|13
2883569|NCT01934218|9925824|P1|Double-blind Phase|Withdrawal by Subject|16
2883570|NCT01934218|9925823|P2|Double-blind Phase|Protocol Violation|0
2883571|NCT01934218|9925824|P1|Double-blind Phase|Protocol Violation|4
2883572|NCT01934218|9925823|P2|Double-blind Phase|Physician Decision|2
2883573|NCT01934218|9925824|P1|Double-blind Phase|Physician Decision|1
2883574|NCT01934218|9925823|P2|Double-blind Phase|Lost to Follow-up|14
2883575|NCT01934218|9925824|P1|Double-blind Phase|Lost to Follow-up|7
2883576|NCT01934218|9925823|P2|Double-blind Phase|Lack of Efficacy|7
2883577|NCT01934218|9925824|P1|Double-blind Phase|Lack of Efficacy|6
2883578|NCT01934218|9925823|P2|Double-blind Phase|Adverse Event|8
2883579|NCT01934218|9925824|P1|Double-blind Phase|Adverse Event|8
2883580|NCT01934192|9925835|P4|Overall Study|Physician Decision|0
2883581|NCT01934192|9925836|P3|Overall Study|Physician Decision|0
2883582|NCT01934192|9925837|P2|Overall Study|Physician Decision|2
2883583|NCT01934192|9925838|P1|Overall Study|Physician Decision|3
2883584|NCT01934192|9925835|P4|Overall Study|Other: reached stopping criteria|0
2883585|NCT01934192|9925836|P3|Overall Study|Other: reached stopping criteria|1
2883586|NCT01934192|9925837|P2|Overall Study|Other: reached stopping criteria|5
2883587|NCT01934192|9925838|P1|Overall Study|Other: reached stopping criteria|6
2883588|NCT01934192|9925835|P4|Overall Study|Protocol Violation|1
2883589|NCT01934192|9925836|P3|Overall Study|Protocol Violation|0
2883590|NCT01934192|9925837|P2|Overall Study|Protocol Violation|0
2883591|NCT01934192|9925838|P1|Overall Study|Protocol Violation|0
2883592|NCT01934140|9925974|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
2883593|NCT01934140|9925975|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
2883594|NCT01934140|9925974|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
2883595|NCT01934140|9925975|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
2883596|NCT01934140|9925974|P2|Booster Phase (6 Months)|Lost to Follow-up|0
2883597|NCT01934140|9925975|P1|Booster Phase (6 Months)|Lost to Follow-up|1
2883598|NCT01934140|9925974|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
2883599|NCT01934140|9925975|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
2883600|NCT01934140|9925974|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
2883601|NCT01934140|9925975|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
2883602|NCT01934140|9925974|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
2883603|NCT01934140|9925975|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
2883604|NCT01934140|9925974|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
2883605|NCT01934140|9925975|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
2883606|NCT01934140|9925974|P2|Persistence Phase (Year 6-10)|Other|6
2883607|NCT01934140|9925975|P1|Persistence Phase (Year 6-10)|Other|24
2883608|NCT01934010|9926026|P3|Overall Study|Lost to Follow-up|0
2883609|NCT01934010|9926027|P2|Overall Study|Lost to Follow-up|4
2883610|NCT01934010|9926028|P1|Overall Study|Lost to Follow-up|7
2883611|NCT01934010|9926026|P3|Overall Study|Withdrawal by Subject|2
2883612|NCT01934010|9926027|P2|Overall Study|Withdrawal by Subject|6
2883613|NCT01934010|9926028|P1|Overall Study|Withdrawal by Subject|15
2883614|NCT01934010|9926026|P3|Overall Study|Adverse Event|0
2883615|NCT01934010|9926027|P2|Overall Study|Adverse Event|1
2883616|NCT01934010|9926028|P1|Overall Study|Adverse Event|1
2883617|NCT01933932|9926070|P2|Overall Study|Eligibility criteria not fulfilled|1
2883618|NCT01933932|9926071|P1|Overall Study|Eligibility criteria not fulfilled|0
2883619|NCT01933932|9926070|P2|Overall Study|Withdrawal by Subject|14
2883620|NCT01933932|9926071|P1|Overall Study|Withdrawal by Subject|11
2883621|NCT01933932|9926070|P2|Overall Study|Death|163
2883622|NCT01933932|9926071|P1|Overall Study|Death|173
2883623|NCT01933919|9926089|P2|Open-label Long-term Phase|Other|2
2883624|NCT01933919|9926090|P1|Open-label Long-term Phase|Other|1
2883625|NCT01933919|9926089|P2|Open-label Long-term Phase|Lost to Follow-up|0
2883626|NCT01933919|9926090|P1|Open-label Long-term Phase|Lost to Follow-up|1
2883627|NCT01933919|9926089|P2|Open-label Long-term Phase|Withdrawal by Subject|4
2883628|NCT01933919|9926090|P1|Open-label Long-term Phase|Withdrawal by Subject|3
2883629|NCT01933919|9926089|P2|Open-label Long-term Phase|Adverse Event|0
2883630|NCT01933919|9926090|P1|Open-label Long-term Phase|Adverse Event|2
2883631|NCT01933919|9926089|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
2883632|NCT01933919|9926090|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
2883633|NCT01933919|9926089|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
2883634|NCT01933919|9926090|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
2883635|NCT01933919|9926089|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
2883636|NCT01933919|9926090|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
2883637|NCT01933880|9926126|P2|Overall Study|Protocol Violation|0
2883638|NCT01933880|9926127|P1|Overall Study|Protocol Violation|1
2883639|NCT01933880|9926126|P2|Overall Study|Other|0
2883640|NCT01933880|9926127|P1|Overall Study|Other|4
2883641|NCT01933880|9926126|P2|Overall Study|Followup exceeded 4 days to visit window|0
2883642|NCT01933880|9926127|P1|Overall Study|Followup exceeded 4 days to visit window|19
2883643|NCT01933880|9926126|P2|Overall Study|Concomitant medication Interference|1
2883644|NCT01933880|9926127|P1|Overall Study|Concomitant medication Interference|0
2883645|NCT01933880|9926126|P2|Overall Study|Lack of Efficacy|0
2883646|NCT01933880|9926127|P1|Overall Study|Lack of Efficacy|1
2883647|NCT01933880|9926126|P2|Overall Study|Withdrawal by Subject|0
2883648|NCT01933880|9926127|P1|Overall Study|Withdrawal by Subject|5
2883649|NCT01933789|9926201|P9|Overall Study|Became Ineligible|0
2883650|NCT01933789|9926202|P8|Overall Study|Became Ineligible|6
2883651|NCT01933789|9926203|P7|Overall Study|Became Ineligible|13
2883652|NCT01933789|9926204|P6|Overall Study|Became Ineligible|10
2883653|NCT01933789|9926205|P5|Overall Study|Became Ineligible|13
2883654|NCT01933789|9926206|P4|Overall Study|Became Ineligible|0
2883655|NCT01933789|9926207|P3|Overall Study|Became Ineligible|0
2883656|NCT01933789|9926208|P2|Overall Study|Became Ineligible|0
2883657|NCT01933789|9926209|P1|Overall Study|Became Ineligible|4
2883658|NCT01933789|9926201|P9|Overall Study|Withdrawal by Subject|0
2883659|NCT01933789|9926202|P8|Overall Study|Withdrawal by Subject|4
2883660|NCT01933789|9926203|P7|Overall Study|Withdrawal by Subject|1
2883661|NCT01933789|9926204|P6|Overall Study|Withdrawal by Subject|16
2883662|NCT01933789|9926205|P5|Overall Study|Withdrawal by Subject|17
2883663|NCT01933789|9926206|P4|Overall Study|Withdrawal by Subject|0
2883664|NCT01933789|9926207|P3|Overall Study|Withdrawal by Subject|0
2883665|NCT01933789|9926208|P2|Overall Study|Withdrawal by Subject|1
2883666|NCT01933789|9926209|P1|Overall Study|Withdrawal by Subject|2
2883667|NCT01933789|9926201|P9|Overall Study|Lost to Follow-up|0
2883668|NCT01933789|9926202|P8|Overall Study|Lost to Follow-up|4
2883669|NCT01933789|9926203|P7|Overall Study|Lost to Follow-up|1
2883670|NCT01933789|9926204|P6|Overall Study|Lost to Follow-up|9
2883671|NCT01933789|9926205|P5|Overall Study|Lost to Follow-up|8
2883672|NCT01933789|9926206|P4|Overall Study|Lost to Follow-up|1
2883673|NCT01933789|9926207|P3|Overall Study|Lost to Follow-up|0
2883674|NCT01933789|9926208|P2|Overall Study|Lost to Follow-up|0
2883675|NCT01933789|9926209|P1|Overall Study|Lost to Follow-up|0
2883676|NCT01933789|9926201|P9|Overall Study|Death|0
2883677|NCT01933789|9926202|P8|Overall Study|Death|0
2883678|NCT01933789|9926203|P7|Overall Study|Death|0
2883679|NCT01933789|9926204|P6|Overall Study|Death|32
2883680|NCT01933789|9926205|P5|Overall Study|Death|21
2883681|NCT01933789|9926206|P4|Overall Study|Death|0
2883682|NCT01933789|9926207|P3|Overall Study|Death|0
2883683|NCT01933789|9926208|P2|Overall Study|Death|0
2883684|NCT01933789|9926209|P1|Overall Study|Death|0
2883685|NCT01933672|9926519|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883686|NCT01933672|9926520|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883687|NCT01933672|9926521|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883688|NCT01933672|9926522|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883689|NCT01933672|9926523|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883690|NCT01933672|9926524|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
2883691|NCT01933672|9926525|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2883692|NCT01933672|9926519|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883693|NCT01933672|9926520|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883694|NCT01933672|9926521|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883695|NCT01933672|9926522|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
2883696|NCT01933672|9926523|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883697|NCT01933672|9926524|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883698|NCT01933672|9926525|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2883699|NCT01933672|9926519|P7|Second Intervention Period (12-16 Days)|Other|0
2883700|NCT01933672|9926520|P6|Second Intervention Period (12-16 Days)|Other|0
2883701|NCT01933672|9926521|P5|Second Intervention Period (12-16 Days)|Other|0
2883702|NCT01933672|9926522|P4|Second Intervention Period (12-16 Days)|Other|0
2883703|NCT01933672|9926523|P3|Second Intervention Period (12-16 Days)|Other|1
2883704|NCT01933672|9926524|P2|Second Intervention Period (12-16 Days)|Other|1
2883705|NCT01933672|9926525|P1|Second Intervention Period (12-16 Days)|Other|0
2883706|NCT01933672|9926519|P7|First Intervention Period (12-16 Days)|Other|0
2883707|NCT01933672|9926520|P6|First Intervention Period (12-16 Days)|Other|1
2883708|NCT01933672|9926521|P5|First Intervention Period (12-16 Days)|Other|0
2883709|NCT01933672|9926522|P4|First Intervention Period (12-16 Days)|Other|0
2883710|NCT01933672|9926523|P3|First Intervention Period (12-16 Days)|Other|1
2883711|NCT01933672|9926524|P2|First Intervention Period (12-16 Days)|Other|0
2883712|NCT01933672|9926525|P1|First Intervention Period (12-16 Days)|Other|0
2883713|NCT01933672|9926519|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883714|NCT01933672|9926520|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883715|NCT01933672|9926521|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
2883716|NCT01933672|9926522|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883717|NCT01933672|9926523|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883718|NCT01933672|9926524|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883719|NCT01933672|9926525|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2883720|NCT01933672|9926519|P7|Metformin Run-in Period|Other|0
2883721|NCT01933672|9926520|P6|Metformin Run-in Period|Other|0
2883722|NCT01933672|9926521|P5|Metformin Run-in Period|Other|0
2883723|NCT01933672|9926522|P4|Metformin Run-in Period|Other|0
2883724|NCT01933672|9926523|P3|Metformin Run-in Period|Other|0
2883725|NCT01933672|9926524|P2|Metformin Run-in Period|Other|0
2883726|NCT01933672|9926525|P1|Metformin Run-in Period|Other|5
2883727|NCT01933672|9926519|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
2883728|NCT01933672|9926520|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
2883729|NCT01933672|9926521|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
2883730|NCT01933672|9926522|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
2883731|NCT01933672|9926523|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
2883732|NCT01933672|9926524|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
2883733|NCT01933672|9926525|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
2883734|NCT01933672|9926519|P7|Metformin Run-in Period|Adverse Event|0
2883735|NCT01933672|9926520|P6|Metformin Run-in Period|Adverse Event|0
2883736|NCT01933672|9926521|P5|Metformin Run-in Period|Adverse Event|0
2883737|NCT01933672|9926522|P4|Metformin Run-in Period|Adverse Event|0
2883738|NCT01933672|9926523|P3|Metformin Run-in Period|Adverse Event|0
2883739|NCT01933672|9926524|P2|Metformin Run-in Period|Adverse Event|0
2883740|NCT01933672|9926525|P1|Metformin Run-in Period|Adverse Event|1
2883741|NCT01933594|9926577|P6|Overall Study|Ineligible for subsequent study step|0
2883742|NCT01933594|9926578|P5|Overall Study|Ineligible for subsequent study step|1
2883743|NCT01933594|9926579|P4|Overall Study|Ineligible for subsequent study step|0
2883744|NCT01933594|9926580|P3|Overall Study|Ineligible for subsequent study step|0
2883745|NCT01933594|9926581|P2|Overall Study|Ineligible for subsequent study step|0
2883746|NCT01933594|9926582|P1|Overall Study|Ineligible for subsequent study step|0
2883747|NCT01933594|9926577|P6|Overall Study|Lost to Follow-up|0
2883748|NCT01933594|9926578|P5|Overall Study|Lost to Follow-up|1
2883749|NCT01933594|9926579|P4|Overall Study|Lost to Follow-up|0
2883750|NCT01933594|9926580|P3|Overall Study|Lost to Follow-up|0
2883751|NCT01933594|9926581|P2|Overall Study|Lost to Follow-up|0
2883752|NCT01933594|9926582|P1|Overall Study|Lost to Follow-up|1
2883753|NCT01933334|9926716|P2|Overall Study|Withdrawal by Subject|1
2883754|NCT01933334|9926717|P1|Overall Study|Withdrawal by Subject|0
2883755|NCT01933334|9926716|P2|Overall Study|Adverse Event|1
2883756|NCT01933334|9926717|P1|Overall Study|Adverse Event|5
2883757|NCT01933113|9926744|P1|Overall Study|Fractured nonfunctioning lead.|1
2883758|NCT01933048|9926750|P2|Overall Study|unknown reasons|1
2883759|NCT01933048|9926751|P1|Overall Study|unknown reasons|1
2883760|NCT01933048|9926750|P2|Overall Study|Physician Decision|0
2883761|NCT01933048|9926751|P1|Overall Study|Physician Decision|1
2883762|NCT01933048|9926750|P2|Overall Study|Protocol Violation|8
2883763|NCT01933048|9926751|P1|Overall Study|Protocol Violation|7
2883764|NCT01933048|9926750|P2|Overall Study|personal reasons|1
2883765|NCT01933048|9926751|P1|Overall Study|personal reasons|1
2883766|NCT01933048|9926750|P2|Overall Study|Lost to Follow-up|18
2883767|NCT01933048|9926751|P1|Overall Study|Lost to Follow-up|15
2883768|NCT01932970|9926764|P1|Overall Study|Protocol Specified Criteria|10
2883769|NCT01932970|9926764|P1|Overall Study|Lost to Follow-up|2
2883770|NCT01932970|9926764|P1|Overall Study|Death|1
2883771|NCT01932970|9926764|P1|Overall Study|Withdrawal by Subject|5
2883772|NCT01932788|9926774|P2|Overall Study|Withdrawal by Subject|5
2883773|NCT01932788|9926775|P1|Overall Study|Withdrawal by Subject|0
2883774|NCT01932788|9926774|P2|Overall Study|Lack of Efficacy|0
2883775|NCT01932788|9926775|P1|Overall Study|Lack of Efficacy|2
2883776|NCT01932788|9926774|P2|Overall Study|Lost to Follow-up|46
2883777|NCT01932788|9926775|P1|Overall Study|Lost to Follow-up|18
2883778|NCT01932788|9926774|P2|Overall Study|Protocol Violation|0
2883779|NCT01932788|9926775|P1|Overall Study|Protocol Violation|18
2883780|NCT01932762|9926785|P4|Overall Study|Physician Decision|0
2883781|NCT01932762|9926786|P3|Overall Study|Physician Decision|0
2883782|NCT01932762|9926787|P2|Overall Study|Physician Decision|0
2883783|NCT01932762|9926788|P1|Overall Study|Physician Decision|1
2883784|NCT01932762|9926785|P4|Overall Study|Lost to Follow-up|1
2883785|NCT01932762|9926786|P3|Overall Study|Lost to Follow-up|0
2883786|NCT01932762|9926787|P2|Overall Study|Lost to Follow-up|0
2883787|NCT01932762|9926788|P1|Overall Study|Lost to Follow-up|4
2883788|NCT01932762|9926785|P4|Overall Study|Withdrawal by Subject|0
2883789|NCT01932762|9926786|P3|Overall Study|Withdrawal by Subject|0
2883790|NCT01932762|9926787|P2|Overall Study|Withdrawal by Subject|2
2883791|NCT01932762|9926788|P1|Overall Study|Withdrawal by Subject|1
2883792|NCT01932697|9926824|P2|Overall Study|Ineligible|0
2883793|NCT01932697|9926825|P1|Overall Study|Ineligible|1
2883794|NCT01932697|9926824|P2|Overall Study|Received a different amount of tx|0
2883795|NCT01932697|9926825|P1|Overall Study|Received a different amount of tx|1
2883796|NCT01932437|9926892|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
2883797|NCT01932437|9926893|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2883798|NCT01932437|9926894|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2883799|NCT01932437|9926895|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2883800|NCT01932437|9926896|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2883801|NCT01932437|9926897|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2883802|NCT01932294|9926947|P1|Overall Study|Transferred to other hospitals|12
2883803|NCT01932294|9926947|P1|Overall Study|Heart Transplantation|16
2883804|NCT01932294|9926947|P1|Overall Study|VAD Implantation|20
2883805|NCT01932294|9926947|P1|Overall Study|Lost to Follow-up|8
2883806|NCT01932294|9926947|P1|Overall Study|Death|43
2883807|NCT01931956|9927024|P4|Overall Study|Not due|0
2883808|NCT01931956|9927025|P3|Overall Study|Not due|21
2883809|NCT01931956|9927026|P2|Overall Study|Not due|0
2883810|NCT01931956|9927027|P1|Overall Study|Not due|0
2883811|NCT01931956|9927024|P4|Overall Study|Expected|0
2883812|NCT01931956|9927025|P3|Overall Study|Expected|6
2883813|NCT01931956|9927026|P2|Overall Study|Expected|0
2883814|NCT01931956|9927027|P1|Overall Study|Expected|2
2883815|NCT01931956|9927024|P4|Overall Study|Lost to Follow-up|7
2883816|NCT01931956|9927025|P3|Overall Study|Lost to Follow-up|11
2883817|NCT01931956|9927026|P2|Overall Study|Lost to Follow-up|0
2883818|NCT01931956|9927027|P1|Overall Study|Lost to Follow-up|2
2883819|NCT01931956|9927024|P4|Overall Study|Withdrawal by Subject|30
2883820|NCT01931956|9927025|P3|Overall Study|Withdrawal by Subject|70
2883821|NCT01931956|9927026|P2|Overall Study|Withdrawal by Subject|0
2883822|NCT01931956|9927027|P1|Overall Study|Withdrawal by Subject|5
2883823|NCT01931956|9927024|P4|Overall Study|Death|96
2883824|NCT01931956|9927025|P3|Overall Study|Death|379
2883825|NCT01931956|9927026|P2|Overall Study|Death|7
2883826|NCT01931956|9927027|P1|Overall Study|Death|42
2883827|NCT01931865|9927394|P1|Overall Study|Withdrawal by Subject|2
2883828|NCT01931865|9927394|P1|Overall Study|Lost to Follow-up|2
2883829|NCT01931839|9927407|P7|Overall Study|Other|0
2883830|NCT01931839|9927408|P6|Overall Study|Other|0
2883831|NCT01931839|9927409|P5|Overall Study|Other|0
2883832|NCT01931839|9927410|P4|Overall Study|Other|0
2883833|NCT01931839|9927411|P3|Overall Study|Other|6
2883834|NCT01931839|9927412|P2|Overall Study|Other|2
2883835|NCT01931839|9927413|P1|Overall Study|Other|4
2883836|NCT01931839|9927407|P7|Overall Study|Lost to Follow-up|0
2883837|NCT01931839|9927408|P6|Overall Study|Lost to Follow-up|0
2883838|NCT01931839|9927409|P5|Overall Study|Lost to Follow-up|0
2883839|NCT01931839|9927410|P4|Overall Study|Lost to Follow-up|5
2883840|NCT01931839|9927411|P3|Overall Study|Lost to Follow-up|4
2883841|NCT01931839|9927412|P2|Overall Study|Lost to Follow-up|2
2883842|NCT01931839|9927413|P1|Overall Study|Lost to Follow-up|1
2883843|NCT01931839|9927407|P7|Overall Study|Other non-compliance|0
2883844|NCT01931839|9927408|P6|Overall Study|Other non-compliance|3
2883845|NCT01931839|9927409|P5|Overall Study|Other non-compliance|0
2883846|NCT01931839|9927410|P4|Overall Study|Other non-compliance|3
2883847|NCT01931839|9927411|P3|Overall Study|Other non-compliance|12
2883848|NCT01931839|9927412|P2|Overall Study|Other non-compliance|9
2883849|NCT01931839|9927413|P1|Overall Study|Other non-compliance|15
2883850|NCT01931839|9927407|P7|Overall Study|Withdrawal of consent (not due to AE)|2
2883851|NCT01931839|9927408|P6|Overall Study|Withdrawal of consent (not due to AE)|2
2883852|NCT01931839|9927409|P5|Overall Study|Withdrawal of consent (not due to AE)|0
2883853|NCT01931839|9927410|P4|Overall Study|Withdrawal of consent (not due to AE)|3
2883854|NCT01931839|9927411|P3|Overall Study|Withdrawal of consent (not due to AE)|13
2883855|NCT01931839|9927412|P2|Overall Study|Withdrawal of consent (not due to AE)|8
2883856|NCT01931839|9927413|P1|Overall Study|Withdrawal of consent (not due to AE)|11
2883857|NCT01931839|9927407|P7|Overall Study|Adverse Event|1
2883858|NCT01931839|9927408|P6|Overall Study|Adverse Event|0
2883859|NCT01931839|9927409|P5|Overall Study|Adverse Event|0
2883860|NCT01931839|9927410|P4|Overall Study|Adverse Event|3
2883861|NCT01931839|9927411|P3|Overall Study|Adverse Event|1
2883862|NCT01931839|9927412|P2|Overall Study|Adverse Event|4
2883863|NCT01931839|9927413|P1|Overall Study|Adverse Event|9
2883864|NCT01931839|9927407|P7|Overall Study|Withdrawal of consent|0
2883865|NCT01931839|9927408|P6|Overall Study|Withdrawal of consent|0
2883866|NCT01931839|9927409|P5|Overall Study|Withdrawal of consent|1
2883867|NCT01931839|9927410|P4|Overall Study|Withdrawal of consent|0
2883868|NCT01931839|9927411|P3|Overall Study|Withdrawal of consent|0
2883869|NCT01931839|9927412|P2|Overall Study|Withdrawal of consent|0
2883870|NCT01931839|9927413|P1|Overall Study|Withdrawal of consent|0
2883871|NCT01931839|9927407|P7|Overall Study|Physician Decision|1
2883872|NCT01931839|9927408|P6|Overall Study|Physician Decision|0
2883873|NCT01931839|9927409|P5|Overall Study|Physician Decision|0
2883874|NCT01931839|9927410|P4|Overall Study|Physician Decision|0
2883875|NCT01931839|9927411|P3|Overall Study|Physician Decision|1
2883876|NCT01931839|9927412|P2|Overall Study|Physician Decision|0
2883877|NCT01931839|9927413|P1|Overall Study|Physician Decision|1
2883878|NCT01931839|9927407|P7|Overall Study|Death|0
2883879|NCT01931839|9927408|P6|Overall Study|Death|0
2883880|NCT01931839|9927409|P5|Overall Study|Death|0
2883881|NCT01931839|9927410|P4|Overall Study|Death|0
2883882|NCT01931839|9927411|P3|Overall Study|Death|2
2883883|NCT01931839|9927412|P2|Overall Study|Death|1
2883884|NCT01931839|9927413|P1|Overall Study|Death|0
2883885|NCT01931735|9927485|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
2883886|NCT01931735|9927486|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
2883887|NCT01931735|9927487|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
2883888|NCT01931735|9927488|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
2883889|NCT01931735|9927485|P4|Observational Non-Randomized Phase|Adverse Event|1
2883890|NCT01931735|9927486|P3|Observational Non-Randomized Phase|Adverse Event|0
2883891|NCT01931735|9927487|P2|Observational Non-Randomized Phase|Adverse Event|0
2883892|NCT01931735|9927488|P1|Observational Non-Randomized Phase|Adverse Event|0
2883893|NCT01931735|9927485|P4|Randomized Phase|Lost to Follow-up|0
2883894|NCT01931735|9927486|P3|Randomized Phase|Lost to Follow-up|5
2883895|NCT01931735|9927487|P2|Randomized Phase|Lost to Follow-up|2
2883896|NCT01931735|9927488|P1|Randomized Phase|Lost to Follow-up|2
2883897|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
2883898|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2883899|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2883900|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
2883901|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
2883902|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
2883903|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
2883904|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
2883905|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
2883906|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
2883907|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2883908|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2883909|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
2883910|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
2883911|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
2883912|NCT01931670|9927535|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2883913|NCT01931670|9927536|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2883914|NCT01931670|9927537|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
2883915|NCT01931670|9927535|P3|Treatment Period|Lost to Follow-up|7
2883916|NCT01931670|9927536|P2|Treatment Period|Lost to Follow-up|5
2883917|NCT01931670|9927537|P1|Treatment Period|Lost to Follow-up|19
2883918|NCT01931670|9927535|P3|Treatment Period|Consent Withdrawn by Subject|7
2883919|NCT01931670|9927536|P2|Treatment Period|Consent Withdrawn by Subject|12
2883920|NCT01931670|9927537|P1|Treatment Period|Consent Withdrawn by Subject|17
2883921|NCT01931670|9927535|P3|Treatment Period|Other|2
2883922|NCT01931670|9927536|P2|Treatment Period|Other|7
2883923|NCT01931670|9927537|P1|Treatment Period|Other|8
2883924|NCT01931670|9927535|P3|Treatment Period|Pregnancy|0
2883925|NCT01931670|9927536|P2|Treatment Period|Pregnancy|2
2883926|NCT01931670|9927537|P1|Treatment Period|Pregnancy|7
2883927|NCT01931670|9927535|P3|Treatment Period|Lack of Efficacy|2
2883928|NCT01931670|9927536|P2|Treatment Period|Lack of Efficacy|2
2883929|NCT01931670|9927537|P1|Treatment Period|Lack of Efficacy|11
2883930|NCT01931670|9927535|P3|Treatment Period|Adverse Event|21
2883931|NCT01931670|9927536|P2|Treatment Period|Adverse Event|8
2883932|NCT01931670|9927537|P1|Treatment Period|Adverse Event|19
2883933|NCT01931670|9927535|P3|Treatment Period|Subject Noncompliant|5
2883934|NCT01931670|9927536|P2|Treatment Period|Subject Noncompliant|9
2883935|NCT01931670|9927537|P1|Treatment Period|Subject Noncompliant|4
2883936|NCT01931670|9927535|P3|Treatment Period|Surgery/Invasive Intervention|0
2883937|NCT01931670|9927536|P2|Treatment Period|Surgery/Invasive Intervention|2
2883938|NCT01931670|9927537|P1|Treatment Period|Surgery/Invasive Intervention|4
2883939|NCT01931670|9927535|P3|Treatment Period|Exclusionary Medication Received|1
2883940|NCT01931670|9927536|P2|Treatment Period|Exclusionary Medication Received|1
2883941|NCT01931670|9927537|P1|Treatment Period|Exclusionary Medication Received|1
2883942|NCT01931566|9927638|P3|Overall Study|Missing|1
2883943|NCT01931566|9927639|P2|Overall Study|Missing|0
2883944|NCT01931566|9927640|P1|Overall Study|Missing|0
2883945|NCT01931566|9927638|P3|Overall Study|Reason Not Specified|53
2883946|NCT01931566|9927639|P2|Overall Study|Reason Not Specified|47
2883947|NCT01931566|9927640|P1|Overall Study|Reason Not Specified|11
2883948|NCT01931566|9927638|P3|Overall Study|Study Termination|1037
2883949|NCT01931566|9927639|P2|Overall Study|Study Termination|968
2883950|NCT01931566|9927640|P1|Overall Study|Study Termination|289
2883951|NCT01931566|9927638|P3|Overall Study|Voluntary Withdrawal|225
2883952|NCT01931566|9927639|P2|Overall Study|Voluntary Withdrawal|245
2883953|NCT01931566|9927640|P1|Overall Study|Voluntary Withdrawal|78
2883954|NCT01931566|9927638|P3|Overall Study|Lost to Follow-up|23
2883955|NCT01931566|9927639|P2|Overall Study|Lost to Follow-up|26
2883956|NCT01931566|9927640|P1|Overall Study|Lost to Follow-up|3
2883957|NCT01931566|9927638|P3|Overall Study|Major Protocol Deviation|21
2883958|NCT01931566|9927639|P2|Overall Study|Major Protocol Deviation|14
2883959|NCT01931566|9927640|P1|Overall Study|Major Protocol Deviation|5
2883960|NCT01931566|9927638|P3|Overall Study|Adverse Event|132
2883961|NCT01931566|9927639|P2|Overall Study|Adverse Event|167
2883962|NCT01931566|9927640|P1|Overall Study|Adverse Event|37
2883963|NCT01931566|9927638|P3|Overall Study|Randomized But Not Treated|14
2883964|NCT01931566|9927639|P2|Overall Study|Randomized But Not Treated|9
2883965|NCT01931566|9927640|P1|Overall Study|Randomized But Not Treated|6
2883966|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2883967|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2883968|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
2883969|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
2883970|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Physician Decision|1
2883971|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Physician Decision|1
2883972|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
2883973|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
2883974|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
2883975|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
2883976|NCT01931475|9927678|P2|Period 2: Extension Treatment Phase|Adverse Event|8
2883977|NCT01931475|9927679|P1|Period 2: Extension Treatment Phase|Adverse Event|0
2883978|NCT01931475|9927678|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
2883979|NCT01931475|9927679|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
2883980|NCT01931475|9927678|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
2883981|NCT01931475|9927679|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
2883982|NCT01931475|9927678|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
2883983|NCT01931475|9927679|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
2883984|NCT01931475|9927678|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
2883985|NCT01931475|9927679|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
2883986|NCT01931475|9927678|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
2883987|NCT01931475|9927679|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
2883988|NCT01931462|9927706|P1|Overall Study|Withdrawal by Subject|1
2883989|NCT01931397|9927717|P1|Overall Study|moved out of state|1
2883990|NCT01931397|9927717|P1|Overall Study|Withdrawal by Subject|8
2883991|NCT01931397|9927717|P1|Overall Study|Physician Decision|2
2883992|NCT01931202|9927729|P3|Overall Study|Lost to Follow-up|2
2883993|NCT01931202|9927730|P2|Overall Study|Lost to Follow-up|5
2883994|NCT01931202|9927731|P1|Overall Study|Lost to Follow-up|0
2883995|NCT01931202|9927729|P3|Overall Study|Withdrawal by Subject|2
2883996|NCT01931202|9927730|P2|Overall Study|Withdrawal by Subject|0
2883997|NCT01931202|9927731|P1|Overall Study|Withdrawal by Subject|0
2883998|NCT01931150|9927777|P2|Overall Study|Withdrawal by Subject|2
2883999|NCT01931150|9927778|P1|Overall Study|Withdrawal by Subject|1
2884000|NCT01931059|9927786|P2|Day3|Lost to Follow-up|0
2884001|NCT01931059|9927787|P1|Day3|Lost to Follow-up|1
2884002|NCT01931059|9927786|P2|Day 1|Pregnancy|1
2884003|NCT01931059|9927787|P1|Day 1|Pregnancy|0
2884004|NCT01930890|9927803|P4|Overall Study|Adverse Event|0
2884005|NCT01930890|9927804|P3|Overall Study|Adverse Event|0
2884006|NCT01930890|9927805|P2|Overall Study|Adverse Event|1
2884007|NCT01930890|9927806|P1|Overall Study|Adverse Event|0
2884008|NCT01930890|9927803|P4|Overall Study|Consent Withdrawn|1
2884009|NCT01930890|9927804|P3|Overall Study|Consent Withdrawn|0
2884010|NCT01930890|9927805|P2|Overall Study|Consent Withdrawn|3
2884011|NCT01930890|9927806|P1|Overall Study|Consent Withdrawn|0
2884012|NCT01930890|9927803|P4|Overall Study|Investigator Decision|0
2884013|NCT01930890|9927804|P3|Overall Study|Investigator Decision|0
2884014|NCT01930890|9927805|P2|Overall Study|Investigator Decision|1
2884015|NCT01930890|9927806|P1|Overall Study|Investigator Decision|0
2884016|NCT01930890|9927803|P4|Overall Study|Death|1
2884017|NCT01930890|9927804|P3|Overall Study|Death|0
2884018|NCT01930890|9927805|P2|Overall Study|Death|0
2884019|NCT01930890|9927806|P1|Overall Study|Death|0
2884020|NCT01930890|9927803|P4|Overall Study|Study Termination|25
2884021|NCT01930890|9927804|P3|Overall Study|Study Termination|13
2884022|NCT01930890|9927805|P2|Overall Study|Study Termination|28
2884023|NCT01930890|9927806|P1|Overall Study|Study Termination|14
2884024|NCT01930799|9927820|P1|Overall Study|Lost to Follow-up|5
2884025|NCT01930799|9927820|P1|Overall Study|Withdrawal by Subject|3
2884026|NCT01930214|9927959|P3|Overall Study|Physician Decision|0
2884027|NCT01930214|9927960|P2|Overall Study|Physician Decision|0
2884028|NCT01930214|9927961|P1|Overall Study|Physician Decision|2
2884029|NCT01930214|9927959|P3|Overall Study|Voluntary withdrawal of infomed consent|2
2884030|NCT01930214|9927960|P2|Overall Study|Voluntary withdrawal of infomed consent|4
2884031|NCT01930214|9927961|P1|Overall Study|Voluntary withdrawal of infomed consent|2
2884032|NCT01930214|9927959|P3|Overall Study|Lost to Follow-up|12
2884033|NCT01930214|9927960|P2|Overall Study|Lost to Follow-up|13
2884034|NCT01930214|9927961|P1|Overall Study|Lost to Follow-up|12
2884035|NCT01930214|9927959|P3|Overall Study|Death|11
2884036|NCT01930214|9927960|P2|Overall Study|Death|4
2884037|NCT01930214|9927961|P1|Overall Study|Death|4
2884038|NCT01930188|9927981|P3|Overall Study|Withdrawal by Subject|8
2884039|NCT01930188|9927982|P2|Overall Study|Withdrawal by Subject|11
2884040|NCT01930188|9927983|P1|Overall Study|Withdrawal by Subject|9
2884041|NCT01930188|9927981|P3|Overall Study|Death|3
2884042|NCT01930188|9927982|P2|Overall Study|Death|1
2884043|NCT01930188|9927983|P1|Overall Study|Death|2
2884044|NCT01930188|9927981|P3|Overall Study|Lost to Follow-up|2
2884045|NCT01930188|9927982|P2|Overall Study|Lost to Follow-up|2
2884046|NCT01930188|9927983|P1|Overall Study|Lost to Follow-up|5
2884047|NCT01930188|9927981|P3|Overall Study|Missing follow-up information|3
2884048|NCT01930188|9927982|P2|Overall Study|Missing follow-up information|2
2884049|NCT01930188|9927983|P1|Overall Study|Missing follow-up information|2
2884050|NCT01930188|9927981|P3|Overall Study|unclassified|3
2884051|NCT01930188|9927982|P2|Overall Study|unclassified|5
2884052|NCT01930188|9927983|P1|Overall Study|unclassified|4
2884053|NCT01930162|9928007|P1|Overall Study|Death|1
2884054|NCT01930162|9928007|P1|Overall Study|Abnormal test procedure result(s)|4
2884055|NCT01930045|9928043|P6|Pause (up to 37 Days)|Protocol Violation|1
2884056|NCT01930045|9928044|P5|Pause (up to 37 Days)|Protocol Violation|0
2884057|NCT01930045|9928045|P4|Pause (up to 37 Days)|Protocol Violation|0
2884058|NCT01930045|9928046|P3|Pause (up to 37 Days)|Protocol Violation|0
2884059|NCT01930045|9928047|P2|Pause (up to 37 Days)|Protocol Violation|0
2884060|NCT01930045|9928048|P1|Pause (up to 37 Days)|Protocol Violation|0
2884061|NCT01930045|9928043|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
2884062|NCT01930045|9928044|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
2884063|NCT01930045|9928045|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
2884064|NCT01930045|9928046|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
2884065|NCT01930045|9928047|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
2884066|NCT01930045|9928048|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
2884067|NCT01929993|9928075|P2|Overall Study|Absent CIN, invasion present or artifact|22
2884068|NCT01929993|9928076|P1|Overall Study|Absent CIN, invasion present or artifact|26
2884069|NCT01929993|9928075|P2|Overall Study|Protocol Violation|6
2884070|NCT01929993|9928076|P1|Overall Study|Protocol Violation|4
2884071|NCT01929980|9928082|P1|Overall Study|Physician Decision|1
2884072|NCT01929876|9928090|P1|Period 2|Non-Compliance|1
2884073|NCT01929863|9928103|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
2884074|NCT01929863|9928104|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
2884075|NCT01929863|9928103|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
2884076|NCT01929863|9928104|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
2884077|NCT01929863|9928103|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
2884078|NCT01929863|9928104|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
2884079|NCT01929707|9928159|P8|Intervention Period 2|Withdrawal by Subject|0
2884080|NCT01929707|9928160|P7|Intervention Period 2|Withdrawal by Subject|0
2884081|NCT01929707|9928161|P6|Intervention Period 2|Withdrawal by Subject|2
2884082|NCT01929707|9928162|P5|Intervention Period 2|Withdrawal by Subject|0
2884083|NCT01929707|9928163|P4|Intervention Period 2|Withdrawal by Subject|0
2884084|NCT01929707|9928164|P3|Intervention Period 2|Withdrawal by Subject|0
2884085|NCT01929707|9928165|P2|Intervention Period 2|Withdrawal by Subject|0
2884086|NCT01929707|9928166|P1|Intervention Period 2|Withdrawal by Subject|0
2884087|NCT01929707|9928159|P8|Intervention Period 1|Withdrawal by Subject|0
2884088|NCT01929707|9928160|P7|Intervention Period 1|Withdrawal by Subject|0
2884089|NCT01929707|9928161|P6|Intervention Period 1|Withdrawal by Subject|0
2884090|NCT01929707|9928162|P5|Intervention Period 1|Withdrawal by Subject|0
2884091|NCT01929707|9928163|P4|Intervention Period 1|Withdrawal by Subject|2
2884092|NCT01929707|9928164|P3|Intervention Period 1|Withdrawal by Subject|0
2884093|NCT01929707|9928165|P2|Intervention Period 1|Withdrawal by Subject|0
2884094|NCT01929707|9928166|P1|Intervention Period 1|Withdrawal by Subject|0
2884095|NCT01929707|9928159|P8|Intervention Period 1|Lost to Follow-up|0
2884096|NCT01929707|9928160|P7|Intervention Period 1|Lost to Follow-up|0
2884097|NCT01929707|9928161|P6|Intervention Period 1|Lost to Follow-up|0
2884098|NCT01929707|9928162|P5|Intervention Period 1|Lost to Follow-up|0
2884099|NCT01929707|9928163|P4|Intervention Period 1|Lost to Follow-up|1
2884100|NCT01929707|9928164|P3|Intervention Period 1|Lost to Follow-up|0
2884101|NCT01929707|9928165|P2|Intervention Period 1|Lost to Follow-up|0
2884102|NCT01929707|9928166|P1|Intervention Period 1|Lost to Follow-up|0
2884103|NCT01929681|9928198|P2|Overall Study|Physician Decision|1
2884104|NCT01929681|9928199|P1|Overall Study|Physician Decision|1
2884105|NCT01929681|9928198|P2|Overall Study|Withdrawal by Subject|0
2884106|NCT01929681|9928199|P1|Overall Study|Withdrawal by Subject|1
2884107|NCT01929408|9928242|P1|Overall Study|received HCT as initial treatment|8
2884108|NCT01929395|9928250|P3|Overall Study|Screen Fail|1
2884109|NCT01929395|9928251|P2|Overall Study|Screen Fail|0
2884110|NCT01929395|9928252|P1|Overall Study|Screen Fail|0
2884111|NCT01929395|9928250|P3|Overall Study|Withdrawal by Subject|0
2884112|NCT01929395|9928251|P2|Overall Study|Withdrawal by Subject|1
2884113|NCT01929395|9928252|P1|Overall Study|Withdrawal by Subject|0
2884114|NCT01929395|9928250|P3|Overall Study|Did not complete - non-related toxicity|0
2884115|NCT01929395|9928251|P2|Overall Study|Did not complete - non-related toxicity|0
2884116|NCT01929395|9928252|P1|Overall Study|Did not complete - non-related toxicity|1
2884117|NCT01929317|9928264|P2|Long-term Phase|Study Closed/Terminated|3
2884118|NCT01929317|9928265|P1|Long-term Phase|Study Closed/Terminated|5
2884119|NCT01929317|9928264|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
2884120|NCT01929317|9928265|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
2884121|NCT01929317|9928264|P2|Long-term Phase|Protocol Violation|0
2884122|NCT01929317|9928265|P1|Long-term Phase|Protocol Violation|1
2884123|NCT01929317|9928264|P2|Long-term Phase|Withdrawal by Subject|0
2884124|NCT01929317|9928265|P1|Long-term Phase|Withdrawal by Subject|4
2884125|NCT01929317|9928264|P2|Long-term Phase|Physician Decision|0
2884126|NCT01929317|9928265|P1|Long-term Phase|Physician Decision|3
2884127|NCT01929317|9928264|P2|Long-term Phase|Adverse Event|1
2884128|NCT01929317|9928265|P1|Long-term Phase|Adverse Event|5
2884129|NCT01929317|9928264|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
2884130|NCT01929317|9928265|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
2884131|NCT01929317|9928264|P2|Dose Increase Effect Verification Phase|Physician Decision|0
2884132|NCT01929317|9928265|P1|Dose Increase Effect Verification Phase|Physician Decision|1
2884133|NCT01929317|9928264|P2|Dose Increase Effect Verification Phase|Adverse Event|1
2884134|NCT01929317|9928265|P1|Dose Increase Effect Verification Phase|Adverse Event|5
2884135|NCT01929226|9928340|P2|Overall Study|Withdrawal by Subject|1
2884136|NCT01929226|9928341|P1|Overall Study|Withdrawal by Subject|1
2884137|NCT01929226|9928340|P2|Overall Study|Lost to Follow-up|0
2884138|NCT01929226|9928341|P1|Overall Study|Lost to Follow-up|4
2884139|NCT01929135|9928367|P2|Overall Study|Lost to Follow-up|1
2884140|NCT01929135|9928368|P1|Overall Study|Lost to Follow-up|1
2884141|NCT01929109|9928387|P5|Period 1 (All Groups)|Deviation from protocol|0
2884142|NCT01929109|9928388|P4|Period 1 (All Groups)|Deviation from protocol|0
2884143|NCT01929109|9928389|P3|Period 1 (All Groups)|Deviation from protocol|1
2884144|NCT01929109|9928390|P2|Period 1 (All Groups)|Deviation from protocol|0
2884145|NCT01929109|9928391|P1|Period 1 (All Groups)|Deviation from protocol|0
2884146|NCT01929083|9928410|P2|Intervention 2|Adverse Event|1
2884147|NCT01929083|9928411|P1|Intervention 2|Adverse Event|0
2884148|NCT01929083|9928410|P2|Intervention 1|Nonadherent to study medications|0
2884149|NCT01929083|9928411|P1|Intervention 1|Nonadherent to study medications|1
2884150|NCT01929083|9928410|P2|Intervention 1|Lost to Follow-up|0
2884151|NCT01929083|9928411|P1|Intervention 1|Lost to Follow-up|2
2884152|NCT01929044|9928448|P2|Overall Study|Not Treated|3
2884153|NCT01929044|9928449|P1|Overall Study|Not Treated|1
2884154|NCT01929044|9928448|P2|Overall Study|Protocol Violation|14
2884155|NCT01929044|9928449|P1|Overall Study|Protocol Violation|9
2884156|NCT01929044|9928448|P2|Overall Study|Adverse Event|0
2884157|NCT01929044|9928449|P1|Overall Study|Adverse Event|1
2884158|NCT01929031|9928471|P6|Overall Study|Reason other than specified above|0
2884159|NCT01929031|9928472|P5|Overall Study|Reason other than specified above|1
2884160|NCT01929031|9928473|P4|Overall Study|Reason other than specified above|0
2884161|NCT01929031|9928474|P3|Overall Study|Reason other than specified above|0
2884162|NCT01929031|9928475|P2|Overall Study|Reason other than specified above|1
2884163|NCT01929031|9928476|P1|Overall Study|Reason other than specified above|0
2884164|NCT01929031|9928471|P6|Overall Study|Protocol Violation|1
2884165|NCT01929031|9928472|P5|Overall Study|Protocol Violation|0
2884166|NCT01929031|9928473|P4|Overall Study|Protocol Violation|0
2884167|NCT01929031|9928474|P3|Overall Study|Protocol Violation|0
2884168|NCT01929031|9928475|P2|Overall Study|Protocol Violation|0
2884169|NCT01929031|9928476|P1|Overall Study|Protocol Violation|1
2884170|NCT01929031|9928471|P6|Overall Study|Adverse Event|0
2884171|NCT01929031|9928472|P5|Overall Study|Adverse Event|0
2884172|NCT01929031|9928473|P4|Overall Study|Adverse Event|0
2884173|NCT01929031|9928474|P3|Overall Study|Adverse Event|1
2884174|NCT01929031|9928475|P2|Overall Study|Adverse Event|1
2884175|NCT01929031|9928476|P1|Overall Study|Adverse Event|3
2884176|NCT01929018|9928500|P2|Overall Study|Hospitalization|1
2884177|NCT01929018|9928501|P1|Overall Study|Hospitalization|0
2884178|NCT01929018|9928500|P2|Overall Study|Lost to Follow-up|0
2884179|NCT01929018|9928501|P1|Overall Study|Lost to Follow-up|1
2884180|NCT01928940|9928525|P2|Overall Study|Adverse Event|1
2884181|NCT01928940|9928526|P1|Overall Study|Adverse Event|0
2884182|NCT01928927|9928569|P2|Overall Study|Withdrawal by Subject|1
2884183|NCT01928927|9928570|P1|Overall Study|Withdrawal by Subject|1
2884184|NCT01928927|9928569|P2|Overall Study|Lost to Follow-up|0
2884185|NCT01928927|9928570|P1|Overall Study|Lost to Follow-up|1
2884186|NCT01928862|9928697|P5|Overall Study|Lost to Follow-up|1
2884187|NCT01928862|9928698|P4|Overall Study|Lost to Follow-up|0
2884188|NCT01928862|9928699|P3|Overall Study|Lost to Follow-up|0
2884189|NCT01928862|9928700|P2|Overall Study|Lost to Follow-up|0
2884190|NCT01928862|9928701|P1|Overall Study|Lost to Follow-up|1
2884191|NCT01928771|9928775|P3|Overall Study|Severe Non-Compliance to Protocol|2
2884192|NCT01928771|9928776|P2|Overall Study|Severe Non-Compliance to Protocol|2
2884193|NCT01928771|9928777|P1|Overall Study|Severe Non-Compliance to Protocol|4
2884194|NCT01928771|9928775|P3|Overall Study|Other Reasons|14
2884195|NCT01928771|9928776|P2|Overall Study|Other Reasons|9
2884196|NCT01928771|9928777|P1|Overall Study|Other Reasons|9
2884197|NCT01928771|9928775|P3|Overall Study|Study-Specific Withdrawal Criteria|1
2884198|NCT01928771|9928776|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2884199|NCT01928771|9928777|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2884200|NCT01928771|9928775|P3|Overall Study|Withdrawal by Subject|17
2884201|NCT01928771|9928776|P2|Overall Study|Withdrawal by Subject|15
2884202|NCT01928771|9928777|P1|Overall Study|Withdrawal by Subject|20
2884203|NCT01928771|9928775|P3|Overall Study|Lost to Follow-up|3
2884204|NCT01928771|9928776|P2|Overall Study|Lost to Follow-up|6
2884205|NCT01928771|9928777|P1|Overall Study|Lost to Follow-up|5
2884206|NCT01928771|9928775|P3|Overall Study|Death|2
2884207|NCT01928771|9928776|P2|Overall Study|Death|2
2884208|NCT01928771|9928777|P1|Overall Study|Death|2
2884209|NCT01928771|9928775|P3|Overall Study|Adverse Event|1
2884210|NCT01928771|9928776|P2|Overall Study|Adverse Event|5
2884211|NCT01928771|9928777|P1|Overall Study|Adverse Event|6
2884212|NCT01928758|9928856|P2|Overall Study|Protocol Violation|4
2884213|NCT01928758|9928857|P1|Overall Study|Protocol Violation|3
2884214|NCT01928758|9928856|P2|Overall Study|Adverse Event|5
2884215|NCT01928758|9928857|P1|Overall Study|Adverse Event|3
2884216|NCT01928758|9928856|P2|Overall Study|Withdrawal by Subject|2
2884217|NCT01928758|9928857|P1|Overall Study|Withdrawal by Subject|5
2884218|NCT01928758|9928856|P2|Overall Study|Lost to Follow-up|9
2884219|NCT01928758|9928857|P1|Overall Study|Lost to Follow-up|14
2884220|NCT01928719|9928875|P2|Overall Study|Adverse Event|0
2884221|NCT01928719|9928876|P1|Overall Study|Adverse Event|1
2884222|NCT01928719|9928875|P2|Overall Study|Protocol Violation|1
2884223|NCT01928719|9928876|P1|Overall Study|Protocol Violation|3
2884224|NCT01928719|9928875|P2|Overall Study|Withdrawal by Subject|7
2884225|NCT01928719|9928876|P1|Overall Study|Withdrawal by Subject|22
2884226|NCT01928719|9928875|P2|Overall Study|Lost to Follow-up|11
2884227|NCT01928719|9928876|P1|Overall Study|Lost to Follow-up|26
2884228|NCT01928615|9928928|P1|Overall Study|Study Terminated by Sponsor|2
2884229|NCT01928485|9928945|P2|Overall Study|Physician Decision|1
2884230|NCT01928485|9928946|P1|Overall Study|Physician Decision|0
2884231|NCT01928472|9928976|P4|Overall Study|Unclassified|0
2884232|NCT01928472|9928977|P3|Overall Study|Unclassified|1
2884233|NCT01928472|9928978|P2|Overall Study|Unclassified|0
2884234|NCT01928472|9928979|P1|Overall Study|Unclassified|0
2884235|NCT01928472|9928976|P4|Overall Study|Administrative Reason|0
2884236|NCT01928472|9928977|P3|Overall Study|Administrative Reason|0
2884237|NCT01928472|9928978|P2|Overall Study|Administrative Reason|1
2884238|NCT01928472|9928979|P1|Overall Study|Administrative Reason|2
2884239|NCT01928472|9928976|P4|Overall Study|Lost to Follow-up|0
2884240|NCT01928472|9928977|P3|Overall Study|Lost to Follow-up|4
2884241|NCT01928472|9928978|P2|Overall Study|Lost to Follow-up|3
2884242|NCT01928472|9928979|P1|Overall Study|Lost to Follow-up|2
2884243|NCT01928472|9928976|P4|Overall Study|Withdrawal by Subject|2
2884244|NCT01928472|9928977|P3|Overall Study|Withdrawal by Subject|1
2884245|NCT01928472|9928978|P2|Overall Study|Withdrawal by Subject|4
2884246|NCT01928472|9928979|P1|Overall Study|Withdrawal by Subject|4
2884247|NCT01928472|9928976|P4|Overall Study|Death|0
2884248|NCT01928472|9928977|P3|Overall Study|Death|1
2884249|NCT01928472|9928978|P2|Overall Study|Death|0
2884250|NCT01928472|9928979|P1|Overall Study|Death|0
2884251|NCT01928433|9929049|P3|Overall Study|Other reasons|4
2884252|NCT01928433|9929050|P2|Overall Study|Other reasons|3
2884253|NCT01928433|9929051|P1|Overall Study|Other reasons|3
2884254|NCT01928433|9929049|P3|Overall Study|Lost to Follow-up|3
2884255|NCT01928433|9929050|P2|Overall Study|Lost to Follow-up|2
2884256|NCT01928433|9929051|P1|Overall Study|Lost to Follow-up|0
2884257|NCT01928433|9929049|P3|Overall Study|Negative screening urine culture|10
2884258|NCT01928433|9929050|P2|Overall Study|Negative screening urine culture|6
2884259|NCT01928433|9929051|P1|Overall Study|Negative screening urine culture|7
2884260|NCT01928433|9929049|P3|Overall Study|Withdrawal by Subject|0
2884261|NCT01928433|9929050|P2|Overall Study|Withdrawal by Subject|4
2884262|NCT01928433|9929051|P1|Overall Study|Withdrawal by Subject|0
2884263|NCT01928433|9929049|P3|Overall Study|Lack of Efficacy|4
2884264|NCT01928433|9929050|P2|Overall Study|Lack of Efficacy|4
2884265|NCT01928433|9929051|P1|Overall Study|Lack of Efficacy|5
2884266|NCT01928433|9929049|P3|Overall Study|Protocol Violation|2
2884267|NCT01928433|9929050|P2|Overall Study|Protocol Violation|0
2884268|NCT01928433|9929051|P1|Overall Study|Protocol Violation|0
2884269|NCT01928433|9929049|P3|Overall Study|Adverse Event|5
2884270|NCT01928433|9929050|P2|Overall Study|Adverse Event|2
2884271|NCT01928433|9929051|P1|Overall Study|Adverse Event|5
2884272|NCT01928394|9929097|P23|Follow-up Period|Lost to Follow-up|1
2884273|NCT01928394|9929098|P22|Follow-up Period|Lost to Follow-up|0
2884274|NCT01928394|9929099|P21|Follow-up Period|Lost to Follow-up|0
2884275|NCT01928394|9929100|P20|Follow-up Period|Lost to Follow-up|0
2884276|NCT01928394|9929101|P19|Follow-up Period|Lost to Follow-up|0
2884277|NCT01928394|9929102|P18|Follow-up Period|Lost to Follow-up|0
2884278|NCT01928394|9929103|P17|Follow-up Period|Lost to Follow-up|1
2884279|NCT01928394|9929104|P16|Follow-up Period|Lost to Follow-up|0
2884280|NCT01928394|9929105|P15|Follow-up Period|Lost to Follow-up|1
2884281|NCT01928394|9929106|P14|Follow-up Period|Lost to Follow-up|0
2884282|NCT01928394|9929107|P13|Follow-up Period|Lost to Follow-up|1
2884283|NCT01928394|9929108|P12|Follow-up Period|Lost to Follow-up|1
2884284|NCT01928394|9929109|P11|Follow-up Period|Lost to Follow-up|0
2884285|NCT01928394|9929110|P10|Follow-up Period|Lost to Follow-up|0
2884286|NCT01928394|9929111|P9|Follow-up Period|Lost to Follow-up|0
2884287|NCT01928394|9929112|P8|Follow-up Period|Lost to Follow-up|0
2884288|NCT01928394|9929113|P7|Follow-up Period|Lost to Follow-up|0
2884289|NCT01928394|9929114|P6|Follow-up Period|Lost to Follow-up|0
2884290|NCT01928394|9929115|P5|Follow-up Period|Lost to Follow-up|0
2884291|NCT01928394|9929116|P4|Follow-up Period|Lost to Follow-up|0
2884292|NCT01928394|9929117|P3|Follow-up Period|Lost to Follow-up|0
2884293|NCT01928394|9929118|P2|Follow-up Period|Lost to Follow-up|0
2884294|NCT01928394|9929119|P1|Follow-up Period|Lost to Follow-up|0
2884295|NCT01928394|9929097|P23|Follow-up Period|other reason|1
2884296|NCT01928394|9929098|P22|Follow-up Period|other reason|0
2884297|NCT01928394|9929099|P21|Follow-up Period|other reason|0
2884298|NCT01928394|9929100|P20|Follow-up Period|other reason|1
2884299|NCT01928394|9929101|P19|Follow-up Period|other reason|1
2884300|NCT01928394|9929102|P18|Follow-up Period|other reason|0
2884301|NCT01928394|9929103|P17|Follow-up Period|other reason|2
2884302|NCT01928394|9929104|P16|Follow-up Period|other reason|0
2884303|NCT01928394|9929105|P15|Follow-up Period|other reason|4
2884304|NCT01928394|9929106|P14|Follow-up Period|other reason|1
2884305|NCT01928394|9929107|P13|Follow-up Period|other reason|0
2884306|NCT01928394|9929108|P12|Follow-up Period|other reason|1
2884307|NCT01928394|9929109|P11|Follow-up Period|other reason|2
2884308|NCT01928394|9929110|P10|Follow-up Period|other reason|0
2884309|NCT01928394|9929111|P9|Follow-up Period|other reason|0
2884310|NCT01928394|9929112|P8|Follow-up Period|other reason|3
2884311|NCT01928394|9929113|P7|Follow-up Period|other reason|1
2884312|NCT01928394|9929114|P6|Follow-up Period|other reason|0
2884313|NCT01928394|9929115|P5|Follow-up Period|other reason|0
2884314|NCT01928394|9929116|P4|Follow-up Period|other reason|0
2884315|NCT01928394|9929117|P3|Follow-up Period|other reason|0
2884316|NCT01928394|9929118|P2|Follow-up Period|other reason|0
2884317|NCT01928394|9929119|P1|Follow-up Period|other reason|0
2884318|NCT01928394|9929097|P23|Follow-up Period|Death|2
2884319|NCT01928394|9929098|P22|Follow-up Period|Death|3
2884320|NCT01928394|9929099|P21|Follow-up Period|Death|5
2884321|NCT01928394|9929100|P20|Follow-up Period|Death|13
2884322|NCT01928394|9929101|P19|Follow-up Period|Death|13
2884323|NCT01928394|9929102|P18|Follow-up Period|Death|5
2884324|NCT01928394|9929103|P17|Follow-up Period|Death|6
2884325|NCT01928394|9929104|P16|Follow-up Period|Death|0
2884326|NCT01928394|9929105|P15|Follow-up Period|Death|18
2884327|NCT01928394|9929106|P14|Follow-up Period|Death|25
2884328|NCT01928394|9929107|P13|Follow-up Period|Death|11
2884329|NCT01928394|9929108|P12|Follow-up Period|Death|12
2884330|NCT01928394|9929109|P11|Follow-up Period|Death|4
2884331|NCT01928394|9929110|P10|Follow-up Period|Death|2
2884332|NCT01928394|9929111|P9|Follow-up Period|Death|1
2884333|NCT01928394|9929112|P8|Follow-up Period|Death|2
2884334|NCT01928394|9929113|P7|Follow-up Period|Death|6
2884335|NCT01928394|9929114|P6|Follow-up Period|Death|6
2884336|NCT01928394|9929115|P5|Follow-up Period|Death|0
2884337|NCT01928394|9929116|P4|Follow-up Period|Death|6
2884338|NCT01928394|9929117|P3|Follow-up Period|Death|2
2884339|NCT01928394|9929118|P2|Follow-up Period|Death|0
2884340|NCT01928394|9929119|P1|Follow-up Period|Death|0
2884341|NCT01928394|9929097|P23|Follow-up Period|Participant withdrew consent|2
2884342|NCT01928394|9929098|P22|Follow-up Period|Participant withdrew consent|6
2884343|NCT01928394|9929099|P21|Follow-up Period|Participant withdrew consent|4
2884344|NCT01928394|9929100|P20|Follow-up Period|Participant withdrew consent|7
2884345|NCT01928394|9929101|P19|Follow-up Period|Participant withdrew consent|2
2884346|NCT01928394|9929102|P18|Follow-up Period|Participant withdrew consent|3
2884347|NCT01928394|9929103|P17|Follow-up Period|Participant withdrew consent|5
2884348|NCT01928394|9929104|P16|Follow-up Period|Participant withdrew consent|0
2884349|NCT01928394|9929105|P15|Follow-up Period|Participant withdrew consent|7
2884350|NCT01928394|9929106|P14|Follow-up Period|Participant withdrew consent|12
2884351|NCT01928394|9929107|P13|Follow-up Period|Participant withdrew consent|2
2884352|NCT01928394|9929108|P12|Follow-up Period|Participant withdrew consent|8
2884353|NCT01928394|9929109|P11|Follow-up Period|Participant withdrew consent|5
2884354|NCT01928394|9929110|P10|Follow-up Period|Participant withdrew consent|0
2884355|NCT01928394|9929111|P9|Follow-up Period|Participant withdrew consent|0
2884356|NCT01928394|9929112|P8|Follow-up Period|Participant withdrew consent|1
2884357|NCT01928394|9929113|P7|Follow-up Period|Participant withdrew consent|5
2884358|NCT01928394|9929114|P6|Follow-up Period|Participant withdrew consent|2
2884359|NCT01928394|9929115|P5|Follow-up Period|Participant withdrew consent|0
2884360|NCT01928394|9929116|P4|Follow-up Period|Participant withdrew consent|4
2884361|NCT01928394|9929117|P3|Follow-up Period|Participant withdrew consent|1
2884450|NCT01928394|9929114|P6|Treatment Period|other reason|0
2884362|NCT01928394|9929118|P2|Follow-up Period|Participant withdrew consent|0
2884363|NCT01928394|9929119|P1|Follow-up Period|Participant withdrew consent|3
2884364|NCT01928394|9929097|P23|Treatment Period|Death|0
2884365|NCT01928394|9929098|P22|Treatment Period|Death|0
2884366|NCT01928394|9929099|P21|Treatment Period|Death|0
2884367|NCT01928394|9929100|P20|Treatment Period|Death|0
2884368|NCT01928394|9929101|P19|Treatment Period|Death|0
2884369|NCT01928394|9929102|P18|Treatment Period|Death|0
2884370|NCT01928394|9929103|P17|Treatment Period|Death|0
2884371|NCT01928394|9929104|P16|Treatment Period|Death|0
2884372|NCT01928394|9929105|P15|Treatment Period|Death|2
2884373|NCT01928394|9929106|P14|Treatment Period|Death|1
2884374|NCT01928394|9929107|P13|Treatment Period|Death|0
2884375|NCT01928394|9929108|P12|Treatment Period|Death|0
2884376|NCT01928394|9929109|P11|Treatment Period|Death|0
2884377|NCT01928394|9929110|P10|Treatment Period|Death|0
2884378|NCT01928394|9929111|P9|Treatment Period|Death|0
2884379|NCT01928394|9929112|P8|Treatment Period|Death|0
2884380|NCT01928394|9929113|P7|Treatment Period|Death|0
2884381|NCT01928394|9929114|P6|Treatment Period|Death|0
2884382|NCT01928394|9929115|P5|Treatment Period|Death|0
2884383|NCT01928394|9929116|P4|Treatment Period|Death|0
2884384|NCT01928394|9929117|P3|Treatment Period|Death|0
2884385|NCT01928394|9929118|P2|Treatment Period|Death|0
2884386|NCT01928394|9929119|P1|Treatment Period|Death|0
2884387|NCT01928394|9929097|P23|Treatment Period|Lost to Follow-up|1
2884388|NCT01928394|9929098|P22|Treatment Period|Lost to Follow-up|0
2884389|NCT01928394|9929099|P21|Treatment Period|Lost to Follow-up|0
2884390|NCT01928394|9929100|P20|Treatment Period|Lost to Follow-up|0
2884391|NCT01928394|9929101|P19|Treatment Period|Lost to Follow-up|0
2884392|NCT01928394|9929102|P18|Treatment Period|Lost to Follow-up|0
2884393|NCT01928394|9929103|P17|Treatment Period|Lost to Follow-up|0
2884394|NCT01928394|9929104|P16|Treatment Period|Lost to Follow-up|0
2884395|NCT01928394|9929105|P15|Treatment Period|Lost to Follow-up|0
2884396|NCT01928394|9929106|P14|Treatment Period|Lost to Follow-up|0
2884397|NCT01928394|9929107|P13|Treatment Period|Lost to Follow-up|0
2884398|NCT01928394|9929108|P12|Treatment Period|Lost to Follow-up|0
2884399|NCT01928394|9929109|P11|Treatment Period|Lost to Follow-up|0
2884400|NCT01928394|9929110|P10|Treatment Period|Lost to Follow-up|0
2884401|NCT01928394|9929111|P9|Treatment Period|Lost to Follow-up|0
2884402|NCT01928394|9929112|P8|Treatment Period|Lost to Follow-up|0
2884403|NCT01928394|9929113|P7|Treatment Period|Lost to Follow-up|0
2884404|NCT01928394|9929114|P6|Treatment Period|Lost to Follow-up|0
2884405|NCT01928394|9929115|P5|Treatment Period|Lost to Follow-up|0
2884406|NCT01928394|9929116|P4|Treatment Period|Lost to Follow-up|0
2884407|NCT01928394|9929117|P3|Treatment Period|Lost to Follow-up|0
2884408|NCT01928394|9929118|P2|Treatment Period|Lost to Follow-up|0
2884409|NCT01928394|9929119|P1|Treatment Period|Lost to Follow-up|0
2884410|NCT01928394|9929097|P23|Treatment Period|Maximum clinical benefit|0
2884411|NCT01928394|9929098|P22|Treatment Period|Maximum clinical benefit|0
2884412|NCT01928394|9929099|P21|Treatment Period|Maximum clinical benefit|2
2884413|NCT01928394|9929100|P20|Treatment Period|Maximum clinical benefit|0
2884414|NCT01928394|9929101|P19|Treatment Period|Maximum clinical benefit|1
2884415|NCT01928394|9929102|P18|Treatment Period|Maximum clinical benefit|1
2884416|NCT01928394|9929103|P17|Treatment Period|Maximum clinical benefit|0
2884417|NCT01928394|9929104|P16|Treatment Period|Maximum clinical benefit|0
2884418|NCT01928394|9929105|P15|Treatment Period|Maximum clinical benefit|1
2884419|NCT01928394|9929106|P14|Treatment Period|Maximum clinical benefit|0
2884420|NCT01928394|9929107|P13|Treatment Period|Maximum clinical benefit|0
2884421|NCT01928394|9929108|P12|Treatment Period|Maximum clinical benefit|1
2884422|NCT01928394|9929109|P11|Treatment Period|Maximum clinical benefit|1
2884423|NCT01928394|9929110|P10|Treatment Period|Maximum clinical benefit|0
2884424|NCT01928394|9929111|P9|Treatment Period|Maximum clinical benefit|0
2884425|NCT01928394|9929112|P8|Treatment Period|Maximum clinical benefit|0
2884426|NCT01928394|9929113|P7|Treatment Period|Maximum clinical benefit|0
2884427|NCT01928394|9929114|P6|Treatment Period|Maximum clinical benefit|0
2884428|NCT01928394|9929115|P5|Treatment Period|Maximum clinical benefit|0
2884429|NCT01928394|9929116|P4|Treatment Period|Maximum clinical benefit|0
2884430|NCT01928394|9929117|P3|Treatment Period|Maximum clinical benefit|0
2884431|NCT01928394|9929118|P2|Treatment Period|Maximum clinical benefit|0
2884432|NCT01928394|9929119|P1|Treatment Period|Maximum clinical benefit|0
2884433|NCT01928394|9929097|P23|Treatment Period|other reason|0
2884434|NCT01928394|9929098|P22|Treatment Period|other reason|0
2884435|NCT01928394|9929099|P21|Treatment Period|other reason|0
2884436|NCT01928394|9929100|P20|Treatment Period|other reason|2
2884437|NCT01928394|9929101|P19|Treatment Period|other reason|2
2884438|NCT01928394|9929102|P18|Treatment Period|other reason|0
2884439|NCT01928394|9929103|P17|Treatment Period|other reason|0
2884440|NCT01928394|9929104|P16|Treatment Period|other reason|0
2884441|NCT01928394|9929105|P15|Treatment Period|other reason|1
2884442|NCT01928394|9929106|P14|Treatment Period|other reason|0
2884443|NCT01928394|9929107|P13|Treatment Period|other reason|1
2884444|NCT01928394|9929108|P12|Treatment Period|other reason|1
2884445|NCT01928394|9929109|P11|Treatment Period|other reason|1
2884446|NCT01928394|9929110|P10|Treatment Period|other reason|0
2884447|NCT01928394|9929111|P9|Treatment Period|other reason|0
2884448|NCT01928394|9929112|P8|Treatment Period|other reason|0
2884449|NCT01928394|9929113|P7|Treatment Period|other reason|0
2884451|NCT01928394|9929115|P5|Treatment Period|other reason|0
2884452|NCT01928394|9929116|P4|Treatment Period|other reason|0
2884453|NCT01928394|9929117|P3|Treatment Period|other reason|0
2884454|NCT01928394|9929118|P2|Treatment Period|other reason|0
2884455|NCT01928394|9929119|P1|Treatment Period|other reason|0
2884456|NCT01928394|9929097|P23|Treatment Period|Poor/non-compliance|0
2884457|NCT01928394|9929098|P22|Treatment Period|Poor/non-compliance|0
2884458|NCT01928394|9929099|P21|Treatment Period|Poor/non-compliance|0
2884459|NCT01928394|9929100|P20|Treatment Period|Poor/non-compliance|1
2884460|NCT01928394|9929101|P19|Treatment Period|Poor/non-compliance|0
2884461|NCT01928394|9929102|P18|Treatment Period|Poor/non-compliance|1
2884462|NCT01928394|9929103|P17|Treatment Period|Poor/non-compliance|0
2884463|NCT01928394|9929104|P16|Treatment Period|Poor/non-compliance|0
2884464|NCT01928394|9929105|P15|Treatment Period|Poor/non-compliance|1
2884465|NCT01928394|9929106|P14|Treatment Period|Poor/non-compliance|0
2884466|NCT01928394|9929107|P13|Treatment Period|Poor/non-compliance|1
2884467|NCT01928394|9929108|P12|Treatment Period|Poor/non-compliance|0
2884468|NCT01928394|9929109|P11|Treatment Period|Poor/non-compliance|0
2884469|NCT01928394|9929110|P10|Treatment Period|Poor/non-compliance|0
2884470|NCT01928394|9929111|P9|Treatment Period|Poor/non-compliance|0
2884471|NCT01928394|9929112|P8|Treatment Period|Poor/non-compliance|0
2884472|NCT01928394|9929113|P7|Treatment Period|Poor/non-compliance|0
2884473|NCT01928394|9929114|P6|Treatment Period|Poor/non-compliance|0
2884474|NCT01928394|9929115|P5|Treatment Period|Poor/non-compliance|0
2884475|NCT01928394|9929116|P4|Treatment Period|Poor/non-compliance|1
2884476|NCT01928394|9929117|P3|Treatment Period|Poor/non-compliance|0
2884477|NCT01928394|9929118|P2|Treatment Period|Poor/non-compliance|0
2884478|NCT01928394|9929119|P1|Treatment Period|Poor/non-compliance|0
2884479|NCT01928394|9929097|P23|Treatment Period|Participant withdrew consent|0
2884480|NCT01928394|9929098|P22|Treatment Period|Participant withdrew consent|2
2884481|NCT01928394|9929099|P21|Treatment Period|Participant withdrew consent|0
2884482|NCT01928394|9929100|P20|Treatment Period|Participant withdrew consent|1
2884483|NCT01928394|9929101|P19|Treatment Period|Participant withdrew consent|1
2884484|NCT01928394|9929102|P18|Treatment Period|Participant withdrew consent|1
2884485|NCT01928394|9929103|P17|Treatment Period|Participant withdrew consent|2
2884486|NCT01928394|9929104|P16|Treatment Period|Participant withdrew consent|0
2884487|NCT01928394|9929105|P15|Treatment Period|Participant withdrew consent|2
2884488|NCT01928394|9929106|P14|Treatment Period|Participant withdrew consent|0
2884489|NCT01928394|9929107|P13|Treatment Period|Participant withdrew consent|1
2884490|NCT01928394|9929108|P12|Treatment Period|Participant withdrew consent|1
2884491|NCT01928394|9929109|P11|Treatment Period|Participant withdrew consent|1
2884492|NCT01928394|9929110|P10|Treatment Period|Participant withdrew consent|0
2884493|NCT01928394|9929111|P9|Treatment Period|Participant withdrew consent|0
2884494|NCT01928394|9929112|P8|Treatment Period|Participant withdrew consent|1
2884495|NCT01928394|9929113|P7|Treatment Period|Participant withdrew consent|0
2884496|NCT01928394|9929114|P6|Treatment Period|Participant withdrew consent|1
2884497|NCT01928394|9929115|P5|Treatment Period|Participant withdrew consent|0
2884498|NCT01928394|9929116|P4|Treatment Period|Participant withdrew consent|1
2884499|NCT01928394|9929117|P3|Treatment Period|Participant withdrew consent|1
2884500|NCT01928394|9929118|P2|Treatment Period|Participant withdrew consent|0
2884501|NCT01928394|9929119|P1|Treatment Period|Participant withdrew consent|0
2884502|NCT01928394|9929097|P23|Treatment Period|Participant request to stop therapy|3
2884503|NCT01928394|9929098|P22|Treatment Period|Participant request to stop therapy|1
2884504|NCT01928394|9929099|P21|Treatment Period|Participant request to stop therapy|3
2884505|NCT01928394|9929100|P20|Treatment Period|Participant request to stop therapy|1
2884506|NCT01928394|9929101|P19|Treatment Period|Participant request to stop therapy|1
2884507|NCT01928394|9929102|P18|Treatment Period|Participant request to stop therapy|3
2884508|NCT01928394|9929103|P17|Treatment Period|Participant request to stop therapy|1
2884509|NCT01928394|9929104|P16|Treatment Period|Participant request to stop therapy|0
2884510|NCT01928394|9929105|P15|Treatment Period|Participant request to stop therapy|4
2884511|NCT01928394|9929106|P14|Treatment Period|Participant request to stop therapy|2
2884512|NCT01928394|9929107|P13|Treatment Period|Participant request to stop therapy|1
2884513|NCT01928394|9929108|P12|Treatment Period|Participant request to stop therapy|2
2884514|NCT01928394|9929109|P11|Treatment Period|Participant request to stop therapy|3
2884515|NCT01928394|9929110|P10|Treatment Period|Participant request to stop therapy|0
2884516|NCT01928394|9929111|P9|Treatment Period|Participant request to stop therapy|0
2884517|NCT01928394|9929112|P8|Treatment Period|Participant request to stop therapy|0
2884518|NCT01928394|9929113|P7|Treatment Period|Participant request to stop therapy|3
2884519|NCT01928394|9929114|P6|Treatment Period|Participant request to stop therapy|3
2884520|NCT01928394|9929115|P5|Treatment Period|Participant request to stop therapy|0
2884521|NCT01928394|9929116|P4|Treatment Period|Participant request to stop therapy|0
2884522|NCT01928394|9929117|P3|Treatment Period|Participant request to stop therapy|0
2884523|NCT01928394|9929118|P2|Treatment Period|Participant request to stop therapy|0
2884524|NCT01928394|9929119|P1|Treatment Period|Participant request to stop therapy|0
2884525|NCT01928394|9929097|P23|Treatment Period|AE unrelated to study drug|0
2884526|NCT01928394|9929098|P22|Treatment Period|AE unrelated to study drug|1
2884527|NCT01928394|9929099|P21|Treatment Period|AE unrelated to study drug|1
2884528|NCT01928394|9929100|P20|Treatment Period|AE unrelated to study drug|5
2884529|NCT01928394|9929101|P19|Treatment Period|AE unrelated to study drug|3
2884530|NCT01928394|9929102|P18|Treatment Period|AE unrelated to study drug|6
2884531|NCT01928394|9929103|P17|Treatment Period|AE unrelated to study drug|1
2884532|NCT01928394|9929104|P16|Treatment Period|AE unrelated to study drug|1
2884533|NCT01928394|9929105|P15|Treatment Period|AE unrelated to study drug|6
2884534|NCT01928394|9929106|P14|Treatment Period|AE unrelated to study drug|13
2884535|NCT01928394|9929107|P13|Treatment Period|AE unrelated to study drug|6
2884536|NCT01928394|9929108|P12|Treatment Period|AE unrelated to study drug|12
2884537|NCT01928394|9929109|P11|Treatment Period|AE unrelated to study drug|0
2884538|NCT01928394|9929110|P10|Treatment Period|AE unrelated to study drug|2
2884539|NCT01928394|9929111|P9|Treatment Period|AE unrelated to study drug|0
2884540|NCT01928394|9929112|P8|Treatment Period|AE unrelated to study drug|0
2884541|NCT01928394|9929113|P7|Treatment Period|AE unrelated to study drug|1
2884542|NCT01928394|9929114|P6|Treatment Period|AE unrelated to study drug|5
2884543|NCT01928394|9929115|P5|Treatment Period|AE unrelated to study drug|0
2884544|NCT01928394|9929116|P4|Treatment Period|AE unrelated to study drug|3
2884545|NCT01928394|9929117|P3|Treatment Period|AE unrelated to study drug|2
2884546|NCT01928394|9929118|P2|Treatment Period|AE unrelated to study drug|0
2884547|NCT01928394|9929119|P1|Treatment Period|AE unrelated to study drug|0
2884548|NCT01928394|9929097|P23|Treatment Period|Study drug toxicity|4
2884549|NCT01928394|9929098|P22|Treatment Period|Study drug toxicity|7
2884550|NCT01928394|9929099|P21|Treatment Period|Study drug toxicity|4
2884551|NCT01928394|9929100|P20|Treatment Period|Study drug toxicity|15
2884552|NCT01928394|9929101|P19|Treatment Period|Study drug toxicity|12
2884553|NCT01928394|9929102|P18|Treatment Period|Study drug toxicity|3
2884554|NCT01928394|9929103|P17|Treatment Period|Study drug toxicity|3
2884555|NCT01928394|9929104|P16|Treatment Period|Study drug toxicity|0
2884556|NCT01928394|9929105|P15|Treatment Period|Study drug toxicity|12
2884557|NCT01928394|9929106|P14|Treatment Period|Study drug toxicity|5
2884558|NCT01928394|9929107|P13|Treatment Period|Study drug toxicity|7
2884559|NCT01928394|9929108|P12|Treatment Period|Study drug toxicity|3
2884560|NCT01928394|9929109|P11|Treatment Period|Study drug toxicity|2
2884561|NCT01928394|9929110|P10|Treatment Period|Study drug toxicity|5
2884562|NCT01928394|9929111|P9|Treatment Period|Study drug toxicity|0
2884563|NCT01928394|9929112|P8|Treatment Period|Study drug toxicity|1
2884564|NCT01928394|9929113|P7|Treatment Period|Study drug toxicity|7
2884565|NCT01928394|9929114|P6|Treatment Period|Study drug toxicity|9
2884566|NCT01928394|9929115|P5|Treatment Period|Study drug toxicity|0
2884567|NCT01928394|9929116|P4|Treatment Period|Study drug toxicity|3
2884568|NCT01928394|9929117|P3|Treatment Period|Study drug toxicity|3
2884569|NCT01928394|9929118|P2|Treatment Period|Study drug toxicity|1
2884570|NCT01928394|9929119|P1|Treatment Period|Study drug toxicity|1
2884571|NCT01928394|9929097|P23|Treatment Period|Disease progression|31
2884572|NCT01928394|9929098|P22|Treatment Period|Disease progression|31
2884573|NCT01928394|9929099|P21|Treatment Period|Disease progression|30
2884574|NCT01928394|9929100|P20|Treatment Period|Disease progression|71
2884575|NCT01928394|9929101|P19|Treatment Period|Disease progression|50
2884576|NCT01928394|9929102|P18|Treatment Period|Disease progression|56
2884577|NCT01928394|9929103|P17|Treatment Period|Disease progression|43
2884578|NCT01928394|9929104|P16|Treatment Period|Disease progression|1
2884579|NCT01928394|9929105|P15|Treatment Period|Disease progression|59
2884580|NCT01928394|9929106|P14|Treatment Period|Disease progression|118
2884581|NCT01928394|9929107|P13|Treatment Period|Disease progression|38
2884582|NCT01928394|9929108|P12|Treatment Period|Disease progression|73
2884583|NCT01928394|9929109|P11|Treatment Period|Disease progression|22
2884584|NCT01928394|9929110|P10|Treatment Period|Disease progression|11
2884585|NCT01928394|9929111|P9|Treatment Period|Disease progression|3
2884586|NCT01928394|9929112|P8|Treatment Period|Disease progression|16
2884587|NCT01928394|9929113|P7|Treatment Period|Disease progression|38
2884588|NCT01928394|9929114|P6|Treatment Period|Disease progression|25
2884589|NCT01928394|9929115|P5|Treatment Period|Disease progression|3
2884590|NCT01928394|9929116|P4|Treatment Period|Disease progression|48
2884591|NCT01928394|9929117|P3|Treatment Period|Disease progression|12
2884592|NCT01928394|9929118|P2|Treatment Period|Disease progression|2
2884593|NCT01928394|9929119|P1|Treatment Period|Disease progression|17
2884594|NCT01928381|9929167|P7|Part 2 - Post Third Intervention|Protocol Violation|0
2884595|NCT01928381|9929168|P6|Part 2 - Post Third Intervention|Protocol Violation|0
2884596|NCT01928381|9929169|P5|Part 2 - Post Third Intervention|Protocol Violation|0
2884597|NCT01928381|9929170|P4|Part 2 - Post Third Intervention|Protocol Violation|0
2884598|NCT01928381|9929171|P3|Part 2 - Post Third Intervention|Protocol Violation|1
2884599|NCT01928381|9929172|P2|Part 2 - Post Third Intervention|Protocol Violation|0
2884600|NCT01928381|9929173|P1|Part 2 - Post Third Intervention|Protocol Violation|0
2884601|NCT01928381|9929167|P7|Part 2 - Second Intervention|Lost to Follow-up|0
2884602|NCT01928381|9929168|P6|Part 2 - Second Intervention|Lost to Follow-up|0
2884603|NCT01928381|9929169|P5|Part 2 - Second Intervention|Lost to Follow-up|0
2884604|NCT01928381|9929170|P4|Part 2 - Second Intervention|Lost to Follow-up|1
2884605|NCT01928381|9929171|P3|Part 2 - Second Intervention|Lost to Follow-up|0
2884606|NCT01928381|9929172|P2|Part 2 - Second Intervention|Lost to Follow-up|1
2884607|NCT01928381|9929173|P1|Part 2 - Second Intervention|Lost to Follow-up|0
2884608|NCT01928381|9929167|P7|Washout First Intervention|Protocol Violation|0
2884609|NCT01928381|9929168|P6|Washout First Intervention|Protocol Violation|0
2884610|NCT01928381|9929169|P5|Washout First Intervention|Protocol Violation|1
2884611|NCT01928381|9929170|P4|Washout First Intervention|Protocol Violation|0
2884612|NCT01928381|9929171|P3|Washout First Intervention|Protocol Violation|0
2884613|NCT01928381|9929172|P2|Washout First Intervention|Protocol Violation|0
2884614|NCT01928381|9929173|P1|Washout First Intervention|Protocol Violation|0
2884615|NCT01928381|9929167|P7|Part 2 - First Intervention|Lost to Follow-up|0
2884616|NCT01928381|9929168|P6|Part 2 - First Intervention|Lost to Follow-up|0
2884617|NCT01928381|9929169|P5|Part 2 - First Intervention|Lost to Follow-up|0
2884618|NCT01928381|9929170|P4|Part 2 - First Intervention|Lost to Follow-up|1
2884619|NCT01928381|9929171|P3|Part 2 - First Intervention|Lost to Follow-up|0
2884620|NCT01928381|9929172|P2|Part 2 - First Intervention|Lost to Follow-up|0
2884621|NCT01928381|9929173|P1|Part 2 - First Intervention|Lost to Follow-up|0
2884622|NCT01928381|9929167|P7|Part 2 - First Intervention|Eligibility criterion not met|1
2884623|NCT01928381|9929168|P6|Part 2 - First Intervention|Eligibility criterion not met|1
2884624|NCT01928381|9929169|P5|Part 2 - First Intervention|Eligibility criterion not met|0
2884625|NCT01928381|9929170|P4|Part 2 - First Intervention|Eligibility criterion not met|0
2884626|NCT01928381|9929171|P3|Part 2 - First Intervention|Eligibility criterion not met|0
2884627|NCT01928381|9929172|P2|Part 2 - First Intervention|Eligibility criterion not met|0
2884628|NCT01928381|9929173|P1|Part 2 - First Intervention|Eligibility criterion not met|0
2884629|NCT01928381|9929167|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884630|NCT01928381|9929168|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884631|NCT01928381|9929169|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884632|NCT01928381|9929170|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884633|NCT01928381|9929171|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
2884634|NCT01928381|9929172|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884635|NCT01928381|9929173|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
2884636|NCT01928381|9929167|P7|Part 2 - First Intervention|Withdrawal by Subject|0
2884637|NCT01928381|9929168|P6|Part 2 - First Intervention|Withdrawal by Subject|0
2884638|NCT01928381|9929169|P5|Part 2 - First Intervention|Withdrawal by Subject|0
2884639|NCT01928381|9929170|P4|Part 2 - First Intervention|Withdrawal by Subject|0
2884640|NCT01928381|9929171|P3|Part 2 - First Intervention|Withdrawal by Subject|1
2884641|NCT01928381|9929172|P2|Part 2 - First Intervention|Withdrawal by Subject|0
2884642|NCT01928381|9929173|P1|Part 2 - First Intervention|Withdrawal by Subject|0
2884643|NCT01928381|9929167|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884644|NCT01928381|9929168|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884645|NCT01928381|9929169|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884646|NCT01928381|9929170|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884647|NCT01928381|9929171|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884648|NCT01928381|9929172|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2884649|NCT01928381|9929173|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
2884650|NCT01928381|9929167|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884651|NCT01928381|9929168|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884652|NCT01928381|9929169|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884653|NCT01928381|9929170|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884654|NCT01928381|9929171|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884655|NCT01928381|9929172|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2884656|NCT01928381|9929173|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
2884657|NCT01928381|9929167|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884658|NCT01928381|9929168|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884659|NCT01928381|9929169|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884660|NCT01928381|9929170|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884661|NCT01928381|9929171|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884662|NCT01928381|9929172|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2884663|NCT01928381|9929173|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
2884664|NCT01928381|9929167|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884665|NCT01928381|9929168|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884666|NCT01928381|9929169|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884667|NCT01928381|9929170|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884668|NCT01928381|9929171|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884669|NCT01928381|9929172|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2884670|NCT01928381|9929173|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
2884671|NCT01928381|9929167|P7|Part 1 - Pain Training|Protocol Violation|0
2884672|NCT01928381|9929168|P6|Part 1 - Pain Training|Protocol Violation|0
2884673|NCT01928381|9929169|P5|Part 1 - Pain Training|Protocol Violation|0
2884674|NCT01928381|9929170|P4|Part 1 - Pain Training|Protocol Violation|0
2884675|NCT01928381|9929171|P3|Part 1 - Pain Training|Protocol Violation|0
2884676|NCT01928381|9929172|P2|Part 1 - Pain Training|Protocol Violation|0
2884677|NCT01928381|9929173|P1|Part 1 - Pain Training|Protocol Violation|1
2884678|NCT01928381|9929167|P7|Part 1 - Pain Training|Lost to Follow-up|0
2884679|NCT01928381|9929168|P6|Part 1 - Pain Training|Lost to Follow-up|0
2884680|NCT01928381|9929169|P5|Part 1 - Pain Training|Lost to Follow-up|0
2884681|NCT01928381|9929170|P4|Part 1 - Pain Training|Lost to Follow-up|0
2884682|NCT01928381|9929171|P3|Part 1 - Pain Training|Lost to Follow-up|0
2884683|NCT01928381|9929172|P2|Part 1 - Pain Training|Lost to Follow-up|0
2884684|NCT01928381|9929173|P1|Part 1 - Pain Training|Lost to Follow-up|4
2884685|NCT01928381|9929167|P7|Part 1 - Pain Training|Withdrawal by Subject|0
2884686|NCT01928381|9929168|P6|Part 1 - Pain Training|Withdrawal by Subject|0
2884687|NCT01928381|9929169|P5|Part 1 - Pain Training|Withdrawal by Subject|0
2884688|NCT01928381|9929170|P4|Part 1 - Pain Training|Withdrawal by Subject|0
2884689|NCT01928381|9929171|P3|Part 1 - Pain Training|Withdrawal by Subject|0
2884690|NCT01928381|9929172|P2|Part 1 - Pain Training|Withdrawal by Subject|0
2884691|NCT01928381|9929173|P1|Part 1 - Pain Training|Withdrawal by Subject|1
2884692|NCT01928381|9929167|P7|Part 1 - Pain Training|Pain training criteria not met|0
2884693|NCT01928381|9929168|P6|Part 1 - Pain Training|Pain training criteria not met|0
2884694|NCT01928381|9929169|P5|Part 1 - Pain Training|Pain training criteria not met|0
2884695|NCT01928381|9929170|P4|Part 1 - Pain Training|Pain training criteria not met|0
2884696|NCT01928381|9929171|P3|Part 1 - Pain Training|Pain training criteria not met|0
2884697|NCT01928381|9929172|P2|Part 1 - Pain Training|Pain training criteria not met|0
2884698|NCT01928381|9929173|P1|Part 1 - Pain Training|Pain training criteria not met|29
2884699|NCT01928381|9929167|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884700|NCT01928381|9929168|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884701|NCT01928381|9929169|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884702|NCT01928381|9929170|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884703|NCT01928381|9929171|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884704|NCT01928381|9929172|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2884705|NCT01928381|9929173|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
2884706|NCT01928329|9929188|P2|Overall Study|Physician Decision|1
2884707|NCT01928329|9929189|P1|Overall Study|Physician Decision|1
2884708|NCT01928329|9929188|P2|Overall Study|Withdrawal by Subject|5
2884709|NCT01928329|9929189|P1|Overall Study|Withdrawal by Subject|1
2884710|NCT01928329|9929188|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
2884711|NCT01928329|9929189|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
2884712|NCT01928329|9929188|P2|Overall Study|Adverse Event|3
2884713|NCT01928329|9929189|P1|Overall Study|Adverse Event|5
2884714|NCT01928329|9929188|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
2884715|NCT01928329|9929189|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
2884716|NCT01928329|9929188|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
2884717|NCT01928329|9929189|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
2884718|NCT01928082|9929228|P1|Overall Study|Study terminated.|1
2884719|NCT01927861|9929262|P2|Extension Phase (104 Weeks)|Unclassified|1
2884720|NCT01927861|9929263|P1|Extension Phase (104 Weeks)|Unclassified|0
2884721|NCT01927861|9929262|P2|Extension Phase (104 Weeks)|Adverse Event|2
2884722|NCT01927861|9929263|P1|Extension Phase (104 Weeks)|Adverse Event|0
2884723|NCT01927757|9929401|P1|Overall Study|Ethical Reasons|4
2884724|NCT01927757|9929401|P1|Overall Study|Other|1
2884725|NCT01927757|9929401|P1|Overall Study|Decision by Sponsor|2
2884726|NCT01927757|9929401|P1|Overall Study|Lost to Follow-up|2
2884727|NCT01927757|9929401|P1|Overall Study|Withdrawal by Subject|14
2884728|NCT01927627|9929423|P1|Overall Study|Financial Concerns|1
2884729|NCT01927627|9929423|P1|Overall Study|Lack of Efficacy|1
2884730|NCT01927627|9929423|P1|Overall Study|Adverse Event|3
2884731|NCT01927562|9929436|P1|Overall Study|Physician Decision|5
2884732|NCT01927562|9929436|P1|Overall Study|Withdrawal by Subject|3
2884733|NCT01927562|9929436|P1|Overall Study|Lost to Follow-up|30
2884734|NCT01927419|9929442|P2|Overall Study|Not reported|0
2884735|NCT01927419|9929443|P1|Overall Study|Not reported|1
2884736|NCT01927419|9929442|P2|Overall Study|Other|1
2884737|NCT01927419|9929443|P1|Overall Study|Other|2
2884738|NCT01927419|9929442|P2|Overall Study|Withdrawal by Subject|1
2884739|NCT01927419|9929443|P1|Overall Study|Withdrawal by Subject|3
2884740|NCT01927419|9929442|P2|Overall Study|Adverse event unrelated to study drug|1
2884741|NCT01927419|9929443|P1|Overall Study|Adverse event unrelated to study drug|6
2884742|NCT01927419|9929442|P2|Overall Study|Death|1
2884743|NCT01927419|9929443|P1|Overall Study|Death|0
2884744|NCT01927419|9929442|P2|Overall Study|Study drug toxicity|7
2884745|NCT01927419|9929443|P1|Overall Study|Study drug toxicity|43
2884746|NCT01927419|9929442|P2|Overall Study|Disease progression|17
2884747|NCT01927419|9929443|P1|Overall Study|Disease progression|15
2884748|NCT01927055|9929477|P3|Double-Blind|Extended Vacation|0
2884749|NCT01927055|9929478|P2|Double-Blind|Extended Vacation|1
2884750|NCT01927055|9929479|P1|Double-Blind|Extended Vacation|0
2884751|NCT01927055|9929477|P3|Double-Blind|Supine Hypertension|1
2884752|NCT01927055|9929478|P2|Double-Blind|Supine Hypertension|0
2884753|NCT01927055|9929479|P1|Double-Blind|Supine Hypertension|0
2884754|NCT01927055|9929477|P3|Double-Blind|Study Stopped|7
2884755|NCT01927055|9929478|P2|Double-Blind|Study Stopped|7
2884756|NCT01927055|9929479|P1|Double-Blind|Study Stopped|0
2884757|NCT01927055|9929477|P3|Double-Blind|Withdrawal by Subject|3
2884758|NCT01927055|9929478|P2|Double-Blind|Withdrawal by Subject|2
2884759|NCT01927055|9929479|P1|Double-Blind|Withdrawal by Subject|0
2884760|NCT01927055|9929477|P3|Double-Blind|Protocol Violation|1
2884761|NCT01927055|9929478|P2|Double-Blind|Protocol Violation|0
2884762|NCT01927055|9929479|P1|Double-Blind|Protocol Violation|0
2884763|NCT01927055|9929477|P3|Double-Blind|Adverse Event|1
2884764|NCT01927055|9929478|P2|Double-Blind|Adverse Event|1
2884765|NCT01927055|9929479|P1|Double-Blind|Adverse Event|0
2884766|NCT01927055|9929477|P3|Open-label|Difficulty attending study visits|0
2884767|NCT01927055|9929478|P2|Open-label|Difficulty attending study visits|0
2884768|NCT01927055|9929479|P1|Open-label|Difficulty attending study visits|1
2884769|NCT01927055|9929477|P3|Open-label|Supine Hypertension|0
2884770|NCT01927055|9929478|P2|Open-label|Supine Hypertension|0
2884771|NCT01927055|9929479|P1|Open-label|Supine Hypertension|4
2884772|NCT01927055|9929477|P3|Open-label|Study Stopped|0
2884773|NCT01927055|9929478|P2|Open-label|Study Stopped|0
2884774|NCT01927055|9929479|P1|Open-label|Study Stopped|4
2884775|NCT01927055|9929477|P3|Open-label|Withdrawal by Subject|0
2884776|NCT01927055|9929478|P2|Open-label|Withdrawal by Subject|0
2884777|NCT01927055|9929479|P1|Open-label|Withdrawal by Subject|1
2884778|NCT01927055|9929477|P3|Open-label|Adverse Event|0
2884779|NCT01927055|9929478|P2|Open-label|Adverse Event|0
2884780|NCT01927055|9929479|P1|Open-label|Adverse Event|6
2884781|NCT01926886|9929497|P2|Overall Study|Did not cooperate|0
2884782|NCT01926886|9929498|P1|Overall Study|Did not cooperate|1
2884783|NCT01926886|9929497|P2|Overall Study|Death|0
2884784|NCT01926886|9929498|P1|Overall Study|Death|1
2884785|NCT01926886|9929497|P2|Overall Study|Progression of disease|0
2884786|NCT01926886|9929498|P1|Overall Study|Progression of disease|2
2884787|NCT01926886|9929497|P2|Overall Study|Recurrence of disease|0
2884788|NCT01926886|9929498|P1|Overall Study|Recurrence of disease|1
2884789|NCT01926886|9929497|P2|Overall Study|Failure to return|0
2884790|NCT01926886|9929498|P1|Overall Study|Failure to return|3
2884791|NCT01926886|9929497|P2|Overall Study|Withdrawal by Subject|0
2884792|NCT01926886|9929498|P1|Overall Study|Withdrawal by Subject|15
2884793|NCT01926886|9929497|P2|Overall Study|Disease progression/recurrence|0
2884794|NCT01926886|9929498|P1|Overall Study|Disease progression/recurrence|4
2884795|NCT01926886|9929497|P2|Overall Study|Adverse event/intercurrent illness|0
2884796|NCT01926886|9929498|P1|Overall Study|Adverse event/intercurrent illness|4
2884797|NCT01926886|9929497|P2|Overall Study|Administrative/other|0
2884798|NCT01926886|9929498|P1|Overall Study|Administrative/other|1
2884799|NCT01926782|9929517|P6|Overall Study|Related to study drug administration|2
2884800|NCT01926782|9929518|P5|Overall Study|Related to study drug administration|0
2884801|NCT01926782|9929519|P4|Overall Study|Related to study drug administration|0
2884802|NCT01926782|9929520|P3|Overall Study|Related to study drug administration|0
2884803|NCT01926782|9929521|P2|Overall Study|Related to study drug administration|0
2884804|NCT01926782|9929522|P1|Overall Study|Related to study drug administration|0
2884805|NCT01926782|9929517|P6|Overall Study|Withdrawal by Subject|5
2884806|NCT01926782|9929518|P5|Overall Study|Withdrawal by Subject|0
2884807|NCT01926782|9929519|P4|Overall Study|Withdrawal by Subject|1
2884808|NCT01926782|9929520|P3|Overall Study|Withdrawal by Subject|8
2884809|NCT01926782|9929521|P2|Overall Study|Withdrawal by Subject|1
2884810|NCT01926782|9929522|P1|Overall Study|Withdrawal by Subject|6
2884811|NCT01926782|9929517|P6|Overall Study|Randomized and not treated|0
2884812|NCT01926782|9929518|P5|Overall Study|Randomized and not treated|0
2884813|NCT01926782|9929519|P4|Overall Study|Randomized and not treated|1
2884814|NCT01926782|9929520|P3|Overall Study|Randomized and not treated|0
2884815|NCT01926782|9929521|P2|Overall Study|Randomized and not treated|0
2884816|NCT01926782|9929522|P1|Overall Study|Randomized and not treated|0
2884817|NCT01926782|9929517|P6|Overall Study|Poor compliance to protocol|6
2884818|NCT01926782|9929518|P5|Overall Study|Poor compliance to protocol|1
2884819|NCT01926782|9929519|P4|Overall Study|Poor compliance to protocol|0
2884820|NCT01926782|9929520|P3|Overall Study|Poor compliance to protocol|8
2884821|NCT01926782|9929521|P2|Overall Study|Poor compliance to protocol|3
2884822|NCT01926782|9929522|P1|Overall Study|Poor compliance to protocol|5
2884823|NCT01926782|9929517|P6|Overall Study|Adverse Event|14
2884824|NCT01926782|9929518|P5|Overall Study|Adverse Event|3
2884825|NCT01926782|9929519|P4|Overall Study|Adverse Event|4
2884826|NCT01926782|9929520|P3|Overall Study|Adverse Event|17
2884827|NCT01926782|9929521|P2|Overall Study|Adverse Event|4
2884828|NCT01926782|9929522|P1|Overall Study|Adverse Event|13
2884829|NCT01926782|9929517|P6|Overall Study|Other than specified|11
2884830|NCT01926782|9929518|P5|Overall Study|Other than specified|4
2884831|NCT01926782|9929519|P4|Overall Study|Other than specified|12
2884832|NCT01926782|9929520|P3|Overall Study|Other than specified|5
2884833|NCT01926782|9929521|P2|Overall Study|Other than specified|3
2884834|NCT01926782|9929522|P1|Overall Study|Other than specified|2
2884835|NCT01926782|9929517|P6|Overall Study|Physician Decision|0
2884836|NCT01926782|9929518|P5|Overall Study|Physician Decision|0
2884837|NCT01926782|9929519|P4|Overall Study|Physician Decision|1
2884838|NCT01926782|9929520|P3|Overall Study|Physician Decision|1
2884839|NCT01926782|9929521|P2|Overall Study|Physician Decision|2
2884840|NCT01926782|9929522|P1|Overall Study|Physician Decision|0
2884841|NCT01926782|9929517|P6|Overall Study|Participant moved|3
2884842|NCT01926782|9929518|P5|Overall Study|Participant moved|0
2884843|NCT01926782|9929519|P4|Overall Study|Participant moved|1
2884844|NCT01926782|9929520|P3|Overall Study|Participant moved|1
2884845|NCT01926782|9929521|P2|Overall Study|Participant moved|0
2884846|NCT01926782|9929522|P1|Overall Study|Participant moved|2
2884847|NCT01926626|9929671|P1|Overall Study|Lost to Follow-up|7
2884848|NCT01926626|9929671|P1|Overall Study|Withdrawal by Subject|15
2884849|NCT01926509|9929685|P4|Overall Study|vital sign met discontinuation criteria|0
2884850|NCT01926509|9929686|P3|Overall Study|vital sign met discontinuation criteria|0
2884851|NCT01926509|9929687|P2|Overall Study|vital sign met discontinuation criteria|0
2884852|NCT01926509|9929688|P1|Overall Study|vital sign met discontinuation criteria|1
2884853|NCT01926444|9929709|P4|Overall Study|Colonoscopy not performed|2
2884854|NCT01926444|9929710|P3|Overall Study|Colonoscopy not performed|4
2884855|NCT01926444|9929711|P2|Overall Study|Colonoscopy not performed|0
2884856|NCT01926444|9929712|P1|Overall Study|Colonoscopy not performed|0
2884857|NCT01926119|9929754|P1|Overall Study|Withdrawal by Subject|1
2884858|NCT01926028|9929767|P3|Overall Study|Non compliance or other reasons|0
2884859|NCT01926028|9929768|P2|Overall Study|Non compliance or other reasons|2
2884860|NCT01926028|9929769|P1|Overall Study|Non compliance or other reasons|4
2884861|NCT01926028|9929767|P3|Overall Study|Withdrawal by Subject|2
2884862|NCT01926028|9929768|P2|Overall Study|Withdrawal by Subject|9
2884863|NCT01926028|9929769|P1|Overall Study|Withdrawal by Subject|9
2884864|NCT01926028|9929767|P3|Overall Study|Physician Decision|0
2884865|NCT01926028|9929768|P2|Overall Study|Physician Decision|5
2884866|NCT01926028|9929769|P1|Overall Study|Physician Decision|1
2884867|NCT01926028|9929767|P3|Overall Study|Lost to Follow-up|0
2884868|NCT01926028|9929768|P2|Overall Study|Lost to Follow-up|6
2884869|NCT01926028|9929769|P1|Overall Study|Lost to Follow-up|7
2884870|NCT01926015|9929805|P2|Overall Study|Randomized not treated|0
2884871|NCT01926015|9929806|P1|Overall Study|Randomized not treated|2
2884872|NCT01926015|9929805|P2|Overall Study|Withdrawal by parent/guardian|1
2884873|NCT01926015|9929806|P1|Overall Study|Withdrawal by parent/guardian|0
2884874|NCT01925989|9929838|P3|Period 1|Withdrawal by Subject|0
2884875|NCT01925989|9929839|P2|Period 1|Withdrawal by Subject|1
2884876|NCT01925989|9929840|P1|Period 1|Withdrawal by Subject|0
2884877|NCT01925989|9929838|P3|Period 1|Sponsor Decision|0
2884878|NCT01925989|9929839|P2|Period 1|Sponsor Decision|1
2884879|NCT01925989|9929840|P1|Period 1|Sponsor Decision|1
2884880|NCT01925950|9929860|P2|Part 2|Withdrawal by Subject|0
2884881|NCT01925950|9929861|P1|Part 2|Withdrawal by Subject|1
2884882|NCT01925768|9929880|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
2884883|NCT01925768|9929881|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
2884884|NCT01925768|9929880|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
2884885|NCT01925768|9929881|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
2884886|NCT01925768|9929880|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
2884887|NCT01925768|9929881|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
2884888|NCT01925768|9929880|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
2884889|NCT01925768|9929881|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
2884890|NCT01925768|9929880|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2884891|NCT01925768|9929881|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2884892|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
2884893|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
2884894|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2884895|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2884896|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2884897|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2884898|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2884899|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2884900|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
2884901|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2884902|NCT01925768|9929880|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2884903|NCT01925768|9929881|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2884904|NCT01925703|9929929|P1|Overall Study|Discharge prior to full iron repletion|1
2884905|NCT01925703|9929929|P1|Overall Study|Lost to Follow-up|2
2884906|NCT01925703|9929929|P1|Overall Study|Physician Decision|1
2884907|NCT01925612|9929947|P5|Overall Study|Adverse Event|2
2884908|NCT01925612|9929948|P4|Overall Study|Adverse Event|1
2884909|NCT01925612|9929949|P3|Overall Study|Adverse Event|0
2884910|NCT01925612|9929950|P2|Overall Study|Adverse Event|3
2884911|NCT01925612|9929951|P1|Overall Study|Adverse Event|3
2884912|NCT01925612|9929947|P5|Overall Study|Progressive Disease|0
2884913|NCT01925612|9929948|P4|Overall Study|Progressive Disease|0
2884914|NCT01925612|9929949|P3|Overall Study|Progressive Disease|1
2884915|NCT01925612|9929950|P2|Overall Study|Progressive Disease|1
2884916|NCT01925612|9929951|P1|Overall Study|Progressive Disease|1
2884917|NCT01925417|9930001|P1|Overall Study|Death|1
2884918|NCT01925417|9930001|P1|Overall Study|Withdrawal by Subject|2
2884919|NCT01925339|9930032|P2|Overall Study|Adverse Event|0
2884920|NCT01925339|9930033|P1|Overall Study|Adverse Event|2
2884921|NCT01925274|9930044|P3|Overall Study|Protocol amendment|6
2884922|NCT01925274|9930045|P2|Overall Study|Protocol amendment|3
2884923|NCT01925274|9930046|P1|Overall Study|Protocol amendment|1
2884924|NCT01925274|9930044|P3|Overall Study|Study terminated by sponsor|0
2884925|NCT01925274|9930045|P2|Overall Study|Study terminated by sponsor|0
2884926|NCT01925274|9930046|P1|Overall Study|Study terminated by sponsor|4
2884927|NCT01925274|9930044|P3|Overall Study|Withdrawal by Subject|0
2884928|NCT01925274|9930045|P2|Overall Study|Withdrawal by Subject|2
2884929|NCT01925274|9930046|P1|Overall Study|Withdrawal by Subject|1
2884930|NCT01925274|9930044|P3|Overall Study|Lost to Follow-up|0
2884931|NCT01925274|9930045|P2|Overall Study|Lost to Follow-up|1
2884932|NCT01925274|9930046|P1|Overall Study|Lost to Follow-up|0
2884933|NCT01925274|9930044|P3|Overall Study|Death|0
2884934|NCT01925274|9930045|P2|Overall Study|Death|0
2884935|NCT01925274|9930046|P1|Overall Study|Death|1
2884936|NCT01925209|9930127|P4|Follow-up|Withdrawal by Subject|2
2884937|NCT01925209|9930128|P3|Follow-up|Withdrawal by Subject|0
2884938|NCT01925209|9930129|P2|Follow-up|Withdrawal by Subject|2
2884939|NCT01925209|9930130|P1|Follow-up|Withdrawal by Subject|0
2884940|NCT01925209|9930127|P4|Follow-up|Non-compliance with study treatment|1
2884941|NCT01925209|9930128|P3|Follow-up|Non-compliance with study treatment|0
2884942|NCT01925209|9930129|P2|Follow-up|Non-compliance with study treatment|0
2884943|NCT01925209|9930130|P1|Follow-up|Non-compliance with study treatment|0
2884944|NCT01925209|9930127|P4|Follow-up|Physician Decision|0
2884945|NCT01925209|9930128|P3|Follow-up|Physician Decision|1
2884946|NCT01925209|9930129|P2|Follow-up|Physician Decision|0
2884947|NCT01925209|9930130|P1|Follow-up|Physician Decision|0
2884948|NCT01925209|9930127|P4|Follow-up|Adverse Event|1
2884949|NCT01925209|9930128|P3|Follow-up|Adverse Event|0
2884950|NCT01925209|9930129|P2|Follow-up|Adverse Event|4
2884951|NCT01925209|9930130|P1|Follow-up|Adverse Event|1
2884952|NCT01925209|9930127|P4|Maintenance Treatment Epoch|Adverse Event|0
2884953|NCT01925209|9930128|P3|Maintenance Treatment Epoch|Adverse Event|1
2884954|NCT01925209|9930129|P2|Maintenance Treatment Epoch|Adverse Event|0
2884955|NCT01925209|9930130|P1|Maintenance Treatment Epoch|Adverse Event|0
2884956|NCT01925209|9930127|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
2884957|NCT01925209|9930128|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
2884958|NCT01925209|9930129|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
2884959|NCT01925209|9930130|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
2884960|NCT01925209|9930127|P4|Treatment Epoch|Adverse Event|1
2884961|NCT01925209|9930128|P3|Treatment Epoch|Adverse Event|3
2884962|NCT01925209|9930129|P2|Treatment Epoch|Adverse Event|5
2884963|NCT01925209|9930130|P1|Treatment Epoch|Adverse Event|3
2884964|NCT01925209|9930127|P4|Treatment Epoch|Withdrawal by Subject|2
2884965|NCT01925209|9930128|P3|Treatment Epoch|Withdrawal by Subject|3
2884966|NCT01925209|9930129|P2|Treatment Epoch|Withdrawal by Subject|3
2884967|NCT01925209|9930130|P1|Treatment Epoch|Withdrawal by Subject|4
2884968|NCT01925209|9930127|P4|Treatment Epoch|Protocol deviation|1
2884969|NCT01925209|9930128|P3|Treatment Epoch|Protocol deviation|1
2884970|NCT01925209|9930129|P2|Treatment Epoch|Protocol deviation|0
2884971|NCT01925209|9930130|P1|Treatment Epoch|Protocol deviation|0
2884972|NCT01925209|9930127|P4|Treatment Epoch|Death|0
2884973|NCT01925209|9930128|P3|Treatment Epoch|Death|0
2884974|NCT01925209|9930129|P2|Treatment Epoch|Death|0
2884975|NCT01925209|9930130|P1|Treatment Epoch|Death|1
2884976|NCT01925209|9930127|P4|Treatment Epoch|Non-compliance with study treatment|1
2884977|NCT01925209|9930128|P3|Treatment Epoch|Non-compliance with study treatment|0
2884978|NCT01925209|9930129|P2|Treatment Epoch|Non-compliance with study treatment|0
2884979|NCT01925209|9930130|P1|Treatment Epoch|Non-compliance with study treatment|0
2884980|NCT01925209|9930127|P4|Treatment Epoch|Physician Decision|0
2884981|NCT01925209|9930128|P3|Treatment Epoch|Physician Decision|0
2884982|NCT01925209|9930129|P2|Treatment Epoch|Physician Decision|0
2884983|NCT01925209|9930130|P1|Treatment Epoch|Physician Decision|1
2884984|NCT01925183|9930162|P2|Overall Study|Adverse Event|0
2884985|NCT01925183|9930163|P1|Overall Study|Adverse Event|1
2884986|NCT01925170|9930171|P1|Overall Study|Unverified cancer status|53
2884987|NCT01925014|9930202|P2|Overall Study|Withdrawal by Subject|13
2884988|NCT01925014|9930203|P1|Overall Study|Withdrawal by Subject|5
2884989|NCT01925014|9930202|P2|Overall Study|Inappropriate enrollment|6
2884990|NCT01925014|9930203|P1|Overall Study|Inappropriate enrollment|4
2884991|NCT01924845|9930278|P1|Overall Study|Protocol Violation|1
2884992|NCT01924845|9930278|P1|Overall Study|Withdrawal by Subject|2
2884993|NCT01924845|9930278|P1|Overall Study|Adverse Event|3
2884994|NCT01924806|9930288|P2|Overall Study|Physician Decision|1
2884995|NCT01924806|9930289|P1|Overall Study|Physician Decision|2
2884996|NCT01924767|9930306|P5|Overall Study|Adverse Event|0
2884997|NCT01924767|9930307|P4|Overall Study|Adverse Event|0
2884998|NCT01924767|9930308|P3|Overall Study|Adverse Event|1
2884999|NCT01924767|9930309|P2|Overall Study|Adverse Event|0
2885000|NCT01924767|9930310|P1|Overall Study|Adverse Event|1
2885001|NCT01924689|9930416|P6|Overall Study|Other|0
2885002|NCT01924689|9930417|P5|Overall Study|Other|1
2885003|NCT01924689|9930418|P4|Overall Study|Other|0
2885004|NCT01924689|9930419|P3|Overall Study|Other|0
2885005|NCT01924689|9930420|P2|Overall Study|Other|0
2885006|NCT01924689|9930421|P1|Overall Study|Other|0
2885007|NCT01924689|9930416|P6|Overall Study|Withdrawal of consent|0
2885008|NCT01924689|9930417|P5|Overall Study|Withdrawal of consent|0
2885009|NCT01924689|9930418|P4|Overall Study|Withdrawal of consent|1
2885010|NCT01924689|9930419|P3|Overall Study|Withdrawal of consent|1
2885011|NCT01924689|9930420|P2|Overall Study|Withdrawal of consent|0
2885012|NCT01924689|9930421|P1|Overall Study|Withdrawal of consent|0
2885013|NCT01924689|9930416|P6|Overall Study|New therapy or study|0
2885014|NCT01924689|9930417|P5|Overall Study|New therapy or study|2
2885015|NCT01924689|9930418|P4|Overall Study|New therapy or study|4
2885016|NCT01924689|9930419|P3|Overall Study|New therapy or study|1
2885017|NCT01924689|9930420|P2|Overall Study|New therapy or study|2
2885018|NCT01924689|9930421|P1|Overall Study|New therapy or study|3
2885019|NCT01924689|9930416|P6|Overall Study|Disease progression|2
2885020|NCT01924689|9930417|P5|Overall Study|Disease progression|3
2885021|NCT01924689|9930418|P4|Overall Study|Disease progression|0
2885022|NCT01924689|9930419|P3|Overall Study|Disease progression|2
2885023|NCT01924689|9930420|P2|Overall Study|Disease progression|0
2885024|NCT01924689|9930421|P1|Overall Study|Disease progression|0
2885025|NCT01924689|9930416|P6|Overall Study|Death|0
2885026|NCT01924689|9930417|P5|Overall Study|Death|0
2885027|NCT01924689|9930418|P4|Overall Study|Death|1
2885028|NCT01924689|9930419|P3|Overall Study|Death|0
2885029|NCT01924689|9930420|P2|Overall Study|Death|1
2885030|NCT01924689|9930421|P1|Overall Study|Death|0
2885031|NCT01924533|9930495|P2|Overall Study|Other Eligibility criteria|1
2885032|NCT01924533|9930496|P1|Overall Study|Other Eligibility criteria|1
2885033|NCT01924533|9930495|P2|Overall Study|Withdrawal by Subject|3
2885034|NCT01924533|9930496|P1|Overall Study|Withdrawal by Subject|7
2885035|NCT01924533|9930495|P2|Overall Study|Lost to Follow-up|1
2885036|NCT01924533|9930496|P1|Overall Study|Lost to Follow-up|0
2885037|NCT01924533|9930495|P2|Overall Study|Death|200
2885038|NCT01924533|9930496|P1|Overall Study|Death|181
2885039|NCT01924429|9930537|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
2885040|NCT01924429|9930538|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
2885041|NCT01924364|9930581|P1|Overall Study|Physician Decision|3
2885042|NCT01924299|9930598|P2|Period 2|Adverse Event|1
2885043|NCT01924299|9930599|P1|Period 2|Adverse Event|0
2885044|NCT01924299|9930598|P2|Period 2|Withdrawal by Subject|0
2885045|NCT01924299|9930599|P1|Period 2|Withdrawal by Subject|1
2885046|NCT01924182|9930621|P2|Overall Study|Withdrawal by Subject|0
2885047|NCT01924182|9930622|P1|Overall Study|Withdrawal by Subject|1
2885048|NCT01923896|9930663|P2|Overall Study|Adverse Event|0
2885049|NCT01923896|9930664|P1|Overall Study|Adverse Event|1
2885050|NCT01923740|9930687|P2|Overall Study|Withdrawal by Subject|0
2885051|NCT01923740|9930688|P1|Overall Study|Withdrawal by Subject|2
2885052|NCT01923740|9930687|P2|Overall Study|Lost to Follow-up|9
2885053|NCT01923740|9930688|P1|Overall Study|Lost to Follow-up|4
2885054|NCT01923467|9931113|P1|Overall Study|Subject non-interest|479
2885055|NCT01923467|9931113|P1|Overall Study|Lost to Follow-up|62
2885056|NCT01923428|9931121|P4|Overall Study|Lack of Efficacy|1
2885057|NCT01923428|9931122|P3|Overall Study|Lack of Efficacy|1
2885058|NCT01923428|9931123|P2|Overall Study|Lack of Efficacy|0
2885059|NCT01923428|9931124|P1|Overall Study|Lack of Efficacy|0
2885060|NCT01923428|9931121|P4|Overall Study|Non Compliance to treatment|1
2885061|NCT01923428|9931122|P3|Overall Study|Non Compliance to treatment|0
2885062|NCT01923428|9931123|P2|Overall Study|Non Compliance to treatment|2
2885063|NCT01923428|9931124|P1|Overall Study|Non Compliance to treatment|1
2885064|NCT01923428|9931121|P4|Overall Study|Protocol Violation|1
2885065|NCT01923428|9931122|P3|Overall Study|Protocol Violation|2
2885066|NCT01923428|9931123|P2|Overall Study|Protocol Violation|0
2885067|NCT01923428|9931124|P1|Overall Study|Protocol Violation|3
2885068|NCT01923428|9931121|P4|Overall Study|Lost to Follow-up|0
2885069|NCT01923428|9931122|P3|Overall Study|Lost to Follow-up|5
2885070|NCT01923428|9931123|P2|Overall Study|Lost to Follow-up|1
2885071|NCT01923428|9931124|P1|Overall Study|Lost to Follow-up|2
2885072|NCT01923428|9931121|P4|Overall Study|Withdrawal by Subject|4
2885073|NCT01923428|9931122|P3|Overall Study|Withdrawal by Subject|0
2885074|NCT01923428|9931123|P2|Overall Study|Withdrawal by Subject|3
2885075|NCT01923428|9931124|P1|Overall Study|Withdrawal by Subject|5
2885076|NCT01923428|9931121|P4|Overall Study|Adverse Event|3
2885077|NCT01923428|9931122|P3|Overall Study|Adverse Event|3
2885078|NCT01923428|9931123|P2|Overall Study|Adverse Event|6
2885079|NCT01923428|9931124|P1|Overall Study|Adverse Event|8
2885080|NCT01923389|9931136|P2|Overall Study|Protocol Violation|0
2885081|NCT01923389|9931137|P1|Overall Study|Protocol Violation|1
2885082|NCT01923363|9931159|P1|Overall Study|Protocol Violation|1
2885083|NCT01923311|9931168|P2|Overall Study|Study Terminated by Sponsor|0
2885084|NCT01923311|9931169|P1|Overall Study|Study Terminated by Sponsor|12
2885085|NCT01923311|9931168|P2|Overall Study|Withdrew Consent|0
2885086|NCT01923311|9931169|P1|Overall Study|Withdrew Consent|1
2885087|NCT01923311|9931168|P2|Overall Study|Non-Compliance with Study Drug|1
2885088|NCT01923311|9931169|P1|Overall Study|Non-Compliance with Study Drug|2
2885089|NCT01923311|9931168|P2|Overall Study|Investigator's Discretion|0
2885090|NCT01923311|9931169|P1|Overall Study|Investigator's Discretion|1
2885091|NCT01923311|9931168|P2|Overall Study|Pregnancy|0
2885092|NCT01923311|9931169|P1|Overall Study|Pregnancy|1
2885093|NCT01923181|9931221|P9|Overall Study|Lost to Follow-up|1
2885094|NCT01923181|9931222|P8|Overall Study|Lost to Follow-up|3
2885095|NCT01923181|9931223|P7|Overall Study|Lost to Follow-up|3
2885096|NCT01923181|9931224|P6|Overall Study|Lost to Follow-up|1
2885097|NCT01923181|9931225|P5|Overall Study|Lost to Follow-up|2
2885098|NCT01923181|9931226|P4|Overall Study|Lost to Follow-up|1
2885099|NCT01923181|9931227|P3|Overall Study|Lost to Follow-up|2
2885100|NCT01923181|9931228|P2|Overall Study|Lost to Follow-up|3
2885101|NCT01923181|9931229|P1|Overall Study|Lost to Follow-up|0
2885102|NCT01923181|9931221|P9|Overall Study|Other|0
2885103|NCT01923181|9931222|P8|Overall Study|Other|0
2885104|NCT01923181|9931223|P7|Overall Study|Other|0
2885105|NCT01923181|9931224|P6|Overall Study|Other|0
2885106|NCT01923181|9931225|P5|Overall Study|Other|0
2885107|NCT01923181|9931226|P4|Overall Study|Other|1
2885108|NCT01923181|9931227|P3|Overall Study|Other|0
2885109|NCT01923181|9931228|P2|Overall Study|Other|0
2885110|NCT01923181|9931229|P1|Overall Study|Other|1
2885111|NCT01923181|9931221|P9|Overall Study|Withdrawal by Subject|1
2885112|NCT01923181|9931222|P8|Overall Study|Withdrawal by Subject|3
2885113|NCT01923181|9931223|P7|Overall Study|Withdrawal by Subject|4
2885114|NCT01923181|9931224|P6|Overall Study|Withdrawal by Subject|2
2885115|NCT01923181|9931225|P5|Overall Study|Withdrawal by Subject|4
2885116|NCT01923181|9931226|P4|Overall Study|Withdrawal by Subject|1
2885117|NCT01923181|9931227|P3|Overall Study|Withdrawal by Subject|0
2885118|NCT01923181|9931228|P2|Overall Study|Withdrawal by Subject|1
2885119|NCT01923181|9931229|P1|Overall Study|Withdrawal by Subject|0
2885120|NCT01923181|9931221|P9|Overall Study|Protocol Violation|1
2885121|NCT01923181|9931222|P8|Overall Study|Protocol Violation|2
2885122|NCT01923181|9931223|P7|Overall Study|Protocol Violation|1
2885123|NCT01923181|9931224|P6|Overall Study|Protocol Violation|1
2885124|NCT01923181|9931225|P5|Overall Study|Protocol Violation|2
2885125|NCT01923181|9931226|P4|Overall Study|Protocol Violation|2
2885126|NCT01923181|9931227|P3|Overall Study|Protocol Violation|0
2885127|NCT01923181|9931228|P2|Overall Study|Protocol Violation|2
2885128|NCT01923181|9931229|P1|Overall Study|Protocol Violation|2
2885129|NCT01923168|9931307|P3|Overall Study|Death|1
2885130|NCT01923168|9931308|P2|Overall Study|Death|0
2885131|NCT01923168|9931309|P1|Overall Study|Death|0
2885132|NCT01923168|9931307|P3|Overall Study|Progressive disease|7
2885133|NCT01923168|9931308|P2|Overall Study|Progressive disease|3
2885134|NCT01923168|9931309|P1|Overall Study|Progressive disease|4
2885135|NCT01923168|9931307|P3|Overall Study|Physician Decision|5
2885136|NCT01923168|9931308|P2|Overall Study|Physician Decision|9
2885137|NCT01923168|9931309|P1|Overall Study|Physician Decision|6
2885138|NCT01923168|9931307|P3|Overall Study|Adverse Event|0
2885139|NCT01923168|9931308|P2|Overall Study|Adverse Event|12
2885140|NCT01923168|9931309|P1|Overall Study|Adverse Event|12
2885141|NCT01923168|9931307|P3|Overall Study|Subject/guardian decision|4
2885142|NCT01923168|9931308|P2|Overall Study|Subject/guardian decision|14
2885143|NCT01923168|9931309|P1|Overall Study|Subject/guardian decision|14
2885144|NCT01923168|9931307|P3|Overall Study|Protocol Violation|0
2885145|NCT01923168|9931308|P2|Overall Study|Protocol Violation|1
2885146|NCT01923168|9931309|P1|Overall Study|Protocol Violation|1
2885147|NCT01922934|9931392|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
2885148|NCT01922934|9931393|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
2885149|NCT01922934|9931392|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
2885150|NCT01922934|9931393|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
2885151|NCT01922934|9931392|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
2885152|NCT01922934|9931393|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
2885153|NCT01922934|9931392|P2|Eligible Patients|Did not meet inclusion criteria|81
2885154|NCT01922934|9931393|P1|Eligible Patients|Did not meet inclusion criteria|36
2885155|NCT01922934|9931392|P2|Eligible Patients|Physician Decision|0
2885156|NCT01922934|9931393|P1|Eligible Patients|Physician Decision|17
2885157|NCT01922934|9931392|P2|Eligible Patients|Death|7
2885158|NCT01922934|9931393|P1|Eligible Patients|Death|0
2885159|NCT01922739|9931405|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
2885160|NCT01922739|9931405|P1|Open-label Treatment Period|Physician Decision|1
2885161|NCT01922739|9931405|P1|Open-label Treatment Period|Lost to Follow-up|2
2885162|NCT01922739|9931405|P1|Open-label Treatment Period|Noncompliance to study procedures|1
2885163|NCT01922739|9931405|P1|Open-label Treatment Period|Pregnancy|1
2885164|NCT01922739|9931405|P1|Open-label Treatment Period|Protocol Violation|5
2885165|NCT01922739|9931405|P1|Open-label Treatment Period|Noncompliance to study medication|3
2885166|NCT01922739|9931405|P1|Open-label Treatment Period|Withdrawal by Subject|14
2885167|NCT01922739|9931405|P1|Open-label Treatment Period|Adverse Event|6
2885168|NCT01922739|9931405|P1|Titration/Adjustment Period|Lack of Efficacy|3
2885169|NCT01922739|9931405|P1|Titration/Adjustment Period|Lost to Follow-up|1
2885170|NCT01922739|9931405|P1|Titration/Adjustment Period|Withdrawal by Subject|5
2885171|NCT01922739|9931405|P1|Titration/Adjustment Period|Adverse Event|3
2885172|NCT01922349|9931434|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
2885173|NCT01922349|9931435|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
2885174|NCT01922349|9931436|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
2885175|NCT01922349|9931437|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
2885176|NCT01922271|9931566|P2|WASHOUT Period|Withdrawal by Subject|0
2885177|NCT01922271|9931567|P1|WASHOUT Period|Withdrawal by Subject|1
2885178|NCT01922102|9931609|P3|Overall Study|Administrative problems|0
2885179|NCT01922102|9931610|P2|Overall Study|Administrative problems|2
2885180|NCT01922102|9931611|P1|Overall Study|Administrative problems|0
2885181|NCT01922102|9931609|P3|Overall Study|Lost to Follow-up|0
2885182|NCT01922102|9931610|P2|Overall Study|Lost to Follow-up|0
2885183|NCT01922102|9931611|P1|Overall Study|Lost to Follow-up|1
2885184|NCT01922102|9931609|P3|Overall Study|Adverse Event|0
2885185|NCT01922102|9931610|P2|Overall Study|Adverse Event|2
2885186|NCT01922102|9931611|P1|Overall Study|Adverse Event|1
2885187|NCT01922102|9931609|P3|Overall Study|Physician Decision|1
2885188|NCT01922102|9931610|P2|Overall Study|Physician Decision|2
2885189|NCT01922102|9931611|P1|Overall Study|Physician Decision|0
2885190|NCT01922102|9931609|P3|Overall Study|Withdrawal by Subject|7
2885191|NCT01922102|9931610|P2|Overall Study|Withdrawal by Subject|3
2885192|NCT01922102|9931611|P1|Overall Study|Withdrawal by Subject|7
2885193|NCT01922089|9931647|P2|Overall Study|Lost to Follow-up|1
2885194|NCT01922089|9931648|P1|Overall Study|Lost to Follow-up|0
2885195|NCT01922089|9931647|P2|Overall Study|Death|1
2885196|NCT01922089|9931648|P1|Overall Study|Death|2
2885197|NCT01922089|9931647|P2|Overall Study|Physician Decision|3
2885198|NCT01922089|9931648|P1|Overall Study|Physician Decision|2
2885199|NCT01922089|9931647|P2|Overall Study|administrative problems|1
2885200|NCT01922089|9931648|P1|Overall Study|administrative problems|4
2885201|NCT01922089|9931647|P2|Overall Study|Withdrawal by Subject|4
2885202|NCT01922089|9931648|P1|Overall Study|Withdrawal by Subject|3
2885203|NCT01922089|9931647|P2|Overall Study|Protocol Deviation|7
2885204|NCT01922089|9931648|P1|Overall Study|Protocol Deviation|10
2885205|NCT01922089|9931647|P2|Overall Study|Adverse Event|13
2885206|NCT01922089|9931648|P1|Overall Study|Adverse Event|18
2885207|NCT01922037|9931725|P2|Overall Study|Other unspecified|66
2885208|NCT01922037|9931726|P1|Overall Study|Other unspecified|2
2885209|NCT01922037|9931725|P2|Overall Study|Investigator/Sponsor decision|4
2885210|NCT01922037|9931726|P1|Overall Study|Investigator/Sponsor decision|1
2885211|NCT01922037|9931725|P2|Overall Study|Participant non-compliance|46
2885212|NCT01922037|9931726|P1|Overall Study|Participant non-compliance|4
2885213|NCT01922037|9931725|P2|Overall Study|Pregnancy|2
2885214|NCT01922037|9931726|P1|Overall Study|Pregnancy|0
2885215|NCT01922037|9931725|P2|Overall Study|Death|5
2885216|NCT01922037|9931726|P1|Overall Study|Death|0
2885217|NCT01922037|9931725|P2|Overall Study|Adverse Event|7
2885218|NCT01922037|9931726|P1|Overall Study|Adverse Event|1
2885219|NCT01922037|9931725|P2|Overall Study|Withdrawal by Subject|44
2885220|NCT01922037|9931726|P1|Overall Study|Withdrawal by Subject|2
2885221|NCT01922011|9931829|P2|Overall Study|Randomized in error|0
2885222|NCT01922011|9931830|P1|Overall Study|Randomized in error|1
2885223|NCT01922011|9931829|P2|Overall Study|Lack of willing home health agency|0
2885224|NCT01922011|9931830|P1|Overall Study|Lack of willing home health agency|1
2885225|NCT01922011|9931829|P2|Overall Study|Not Treated|0
2885226|NCT01922011|9931830|P1|Overall Study|Not Treated|1
2885227|NCT01922011|9931829|P2|Overall Study|Missed Test-of-Cure Visit|2
2885228|NCT01922011|9931830|P1|Overall Study|Missed Test-of-Cure Visit|0
2885229|NCT01922011|9931829|P2|Overall Study|Lost to Follow-up|1
2885230|NCT01922011|9931830|P1|Overall Study|Lost to Follow-up|0
2885231|NCT01922011|9931829|P2|Overall Study|Parent/Guardian Decision|0
2885232|NCT01922011|9931830|P1|Overall Study|Parent/Guardian Decision|3
2885233|NCT01922011|9931829|P2|Overall Study|Physician Decision|1
2885234|NCT01922011|9931830|P1|Overall Study|Physician Decision|0
2885235|NCT01922011|9931829|P2|Overall Study|Protocol Violation|1
2885236|NCT01922011|9931830|P1|Overall Study|Protocol Violation|0
2885237|NCT01921829|9931897|P2|Overall Study|Withdrawal by Subject|1
2885238|NCT01921829|9931898|P1|Overall Study|Withdrawal by Subject|0
2885239|NCT01921517|9931969|P2|Overall Study|Subject missed final imaging|4
2885240|NCT01921517|9931970|P1|Overall Study|Subject missed final imaging|1
2885241|NCT01921517|9931969|P2|Overall Study|Withdrawal by Subject|3
2885242|NCT01921517|9931970|P1|Overall Study|Withdrawal by Subject|7
2885243|NCT01921517|9931969|P2|Overall Study|Physician Decision|2
2885244|NCT01921517|9931970|P1|Overall Study|Physician Decision|0
2885245|NCT01921517|9931969|P2|Overall Study|Newly diagnosed health concern|0
2885246|NCT01921517|9931970|P1|Overall Study|Newly diagnosed health concern|2
2885247|NCT01921517|9931969|P2|Overall Study|Lost to Follow-up|0
2885248|NCT01921517|9931970|P1|Overall Study|Lost to Follow-up|5
2885249|NCT01921387|9931981|P1|Overall Study|Adverse Event|1
2885250|NCT01921348|9931990|P2|Overall Study|Lost to Follow-up|2
2885251|NCT01921348|9931991|P1|Overall Study|Lost to Follow-up|0
2885252|NCT01921348|9931990|P2|Overall Study|Withdrawal by Subject|0
2885253|NCT01921348|9931991|P1|Overall Study|Withdrawal by Subject|1
2885254|NCT01921270|9932020|P1|Overall Study|Withdrawal by Subject|1
2885255|NCT01921257|9932036|P1|Overall Study|Withdrawal by Subject|1
2885256|NCT01921257|9932036|P1|Overall Study|Protocol Violation|1
2885257|NCT01921257|9932036|P1|Overall Study|Adverse Event|1
2885258|NCT01921205|9932043|P2|Overall Study|Non Compliance Of Child|1
2885259|NCT01921205|9932044|P1|Overall Study|Non Compliance Of Child|0
2885260|NCT01921205|9932043|P2|Overall Study|Non Compliance Of The Parent|1
2885261|NCT01921205|9932044|P1|Overall Study|Non Compliance Of The Parent|0
2885262|NCT01921205|9932043|P2|Overall Study|The Excessive Use Of Rescue Medication|1
2885263|NCT01921205|9932044|P1|Overall Study|The Excessive Use Of Rescue Medication|0
2885264|NCT01921205|9932043|P2|Overall Study|Use Of Prohibited Medication|1
2885265|NCT01921205|9932044|P1|Overall Study|Use Of Prohibited Medication|0
2885266|NCT01921205|9932043|P2|Overall Study|Withdrawal by Subject|5
2885267|NCT01921205|9932044|P1|Overall Study|Withdrawal by Subject|6
2885268|NCT01921205|9932043|P2|Overall Study|Lost to Follow-up|1
2885269|NCT01921205|9932044|P1|Overall Study|Lost to Follow-up|1
2885270|NCT01921205|9932043|P2|Overall Study|Protocol Violation|3
2885271|NCT01921205|9932044|P1|Overall Study|Protocol Violation|1
2885272|NCT01921205|9932043|P2|Overall Study|Lack of Efficacy|0
2885273|NCT01921205|9932044|P1|Overall Study|Lack of Efficacy|1
2885274|NCT01921205|9932043|P2|Overall Study|Adverse Event|7
2885275|NCT01921205|9932044|P1|Overall Study|Adverse Event|12
2885276|NCT01921179|9932074|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
2885277|NCT01921179|9932075|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
2885278|NCT01921179|9932074|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2885279|NCT01921179|9932075|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2885280|NCT01921101|9932112|P2|Overall Study|Death|6
2885281|NCT01921101|9932113|P1|Overall Study|Death|16
2885282|NCT01920958|9932121|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
2885283|NCT01920893|9932139|P2|Overall Study|Lack of Efficacy|0
2885284|NCT01920893|9932140|P1|Overall Study|Lack of Efficacy|2
2885285|NCT01920893|9932139|P2|Overall Study|Adverse Event|2
2885286|NCT01920893|9932140|P1|Overall Study|Adverse Event|5
2885287|NCT01920854|9932173|P7|Overall Study|Withdrawal by Subject|1
2885288|NCT01920854|9932174|P6|Overall Study|Withdrawal by Subject|0
2885289|NCT01920854|9932175|P5|Overall Study|Withdrawal by Subject|1
2885290|NCT01920854|9932176|P4|Overall Study|Withdrawal by Subject|0
2885291|NCT01920854|9932177|P3|Overall Study|Withdrawal by Subject|0
2885292|NCT01920854|9932178|P2|Overall Study|Withdrawal by Subject|0
2885293|NCT01920854|9932179|P1|Overall Study|Withdrawal by Subject|1
2885294|NCT01920594|9932339|P2|Overall Study|Investigator discretion|1
2885295|NCT01920594|9932340|P1|Overall Study|Investigator discretion|0
2885296|NCT01920594|9932339|P2|Overall Study|Recovery|0
2885297|NCT01920594|9932340|P1|Overall Study|Recovery|2
2885298|NCT01920594|9932339|P2|Overall Study|Lost to Follow-up|0
2885299|NCT01920594|9932340|P1|Overall Study|Lost to Follow-up|1
2885300|NCT01920594|9932339|P2|Overall Study|Adverse Event|2
2885301|NCT01920594|9932340|P1|Overall Study|Adverse Event|4
2885302|NCT01920568|9932390|P2|Overall Study|Death due to disease progression|12
2885303|NCT01920568|9932391|P1|Overall Study|Death due to disease progression|25
2885304|NCT01920568|9932390|P2|Overall Study|Withdrawal by Subject|55
2885305|NCT01920568|9932391|P1|Overall Study|Withdrawal by Subject|79
2885306|NCT01920568|9932390|P2|Overall Study|Physician Decision|4
2885307|NCT01920568|9932391|P1|Overall Study|Physician Decision|13
2885308|NCT01920568|9932390|P2|Overall Study|Lost to Follow-up|2
2885309|NCT01920568|9932391|P1|Overall Study|Lost to Follow-up|2
2885310|NCT01920568|9932390|P2|Overall Study|Protocol Violation|3
2885311|NCT01920568|9932391|P1|Overall Study|Protocol Violation|5
2885312|NCT01920568|9932390|P2|Overall Study|Adverse Event|8
2885313|NCT01920568|9932391|P1|Overall Study|Adverse Event|27
2885314|NCT01920555|9932417|P5|Overall Study|Lost to Follow-up|0
2885315|NCT01920555|9932418|P4|Overall Study|Lost to Follow-up|1
2885316|NCT01920555|9932419|P3|Overall Study|Lost to Follow-up|0
2885317|NCT01920555|9932420|P2|Overall Study|Lost to Follow-up|1
2885318|NCT01920555|9932421|P1|Overall Study|Lost to Follow-up|0
2885319|NCT01920555|9932417|P5|Overall Study|Travel Difficulties|1
2885320|NCT01920555|9932418|P4|Overall Study|Travel Difficulties|0
2885321|NCT01920555|9932419|P3|Overall Study|Travel Difficulties|0
2885322|NCT01920555|9932420|P2|Overall Study|Travel Difficulties|1
2885323|NCT01920555|9932421|P1|Overall Study|Travel Difficulties|1
2885324|NCT01920555|9932417|P5|Overall Study|Lack of Efficacy|0
2885325|NCT01920555|9932418|P4|Overall Study|Lack of Efficacy|0
2885326|NCT01920555|9932419|P3|Overall Study|Lack of Efficacy|0
2885327|NCT01920555|9932420|P2|Overall Study|Lack of Efficacy|0
2885328|NCT01920555|9932421|P1|Overall Study|Lack of Efficacy|2
2885329|NCT01920555|9932417|P5|Overall Study|Physician Decision|0
2885330|NCT01920555|9932418|P4|Overall Study|Physician Decision|2
2885331|NCT01920555|9932419|P3|Overall Study|Physician Decision|1
2885332|NCT01920555|9932420|P2|Overall Study|Physician Decision|2
2885333|NCT01920555|9932421|P1|Overall Study|Physician Decision|1
2885334|NCT01920477|9932480|P2|Overall Study|Withdrawal by Subject|1
2885335|NCT01920477|9932481|P1|Overall Study|Withdrawal by Subject|0
2885336|NCT01920477|9932480|P2|Overall Study|Study closed/terminated|15
2885337|NCT01920477|9932481|P1|Overall Study|Study closed/terminated|14
2885338|NCT01920477|9932480|P2|Overall Study|Lack of Efficacy|0
2885339|NCT01920477|9932481|P1|Overall Study|Lack of Efficacy|1
2885340|NCT01920477|9932480|P2|Overall Study|Adverse Event|1
2885341|NCT01920477|9932481|P1|Overall Study|Adverse Event|0
2885342|NCT01920178|9932530|P2|Overall Study|Lost to Follow-up|1
2885343|NCT01920178|9932531|P1|Overall Study|Lost to Follow-up|2
2885344|NCT01919970|9932549|P2|Overall Study|Withdrawal by Subject|0
2885345|NCT01919970|9932550|P1|Overall Study|Withdrawal by Subject|3
2885346|NCT01919814|9932558|P2|Overall Study|Withdrawal by Subject|0
2885347|NCT01919814|9932559|P1|Overall Study|Withdrawal by Subject|1
2885348|NCT01919814|9932558|P2|Overall Study|Protocol Violation|0
2885349|NCT01919814|9932559|P1|Overall Study|Protocol Violation|1
2885350|NCT01919814|9932558|P2|Overall Study|Adverse Event|0
2885351|NCT01919814|9932559|P1|Overall Study|Adverse Event|1
2885352|NCT01919801|9932571|P2|Overall Study|Other|1
2885353|NCT01919801|9932572|P1|Overall Study|Other|0
2885354|NCT01919801|9932571|P2|Overall Study|Lost to Follow-up|1
2885355|NCT01919801|9932572|P1|Overall Study|Lost to Follow-up|0
2885356|NCT01919801|9932571|P2|Overall Study|Physician Decision|1
2885357|NCT01919801|9932572|P1|Overall Study|Physician Decision|0
2885358|NCT01919801|9932571|P2|Overall Study|Withdrawal by Subject|0
2885359|NCT01919801|9932572|P1|Overall Study|Withdrawal by Subject|1
2885360|NCT01919723|9932597|P2|Overall Study|Blood Samples Hemolyzed|2
2885361|NCT01919723|9932598|P1|Overall Study|Blood Samples Hemolyzed|2
2885362|NCT01919411|9932671|P2|Overall Study|Protocol Violation|1
2885363|NCT01919411|9932672|P1|Overall Study|Protocol Violation|2
2885364|NCT01919411|9932671|P2|Overall Study|Physician Decision|0
2885365|NCT01919411|9932672|P1|Overall Study|Physician Decision|1
2885366|NCT01919411|9932671|P2|Overall Study|Lost to Follow-up|4
2885367|NCT01919411|9932672|P1|Overall Study|Lost to Follow-up|2
2885368|NCT01919398|9932691|P3|Overall Study|Progressive Disease|4
2885369|NCT01919398|9932692|P2|Overall Study|Progressive Disease|0
2885370|NCT01919398|9932693|P1|Overall Study|Progressive Disease|0
2885371|NCT01919307|9932713|P1|Overall Study|Withdrawal by Subject|9
2885372|NCT01919229|9932723|P3|Overall Study|Subject/guardian decision|1
2885373|NCT01919229|9932724|P2|Overall Study|Subject/guardian decision|0
2885374|NCT01919229|9932725|P1|Overall Study|Subject/guardian decision|0
2885375|NCT01918774|9932788|P1|Overall Study|Lost to Follow-up|1
2885376|NCT01918774|9932788|P1|Overall Study|Lost prior to first CBTw session|4
2885377|NCT01918371|9932812|P2|Overall Study|Missing Data|1
2885378|NCT01918371|9932813|P1|Overall Study|Missing Data|1
2885379|NCT01918332|9932891|P4|Overall Study|lipid result by central lab did not meet|0
2885380|NCT01918332|9932892|P3|Overall Study|lipid result by central lab did not meet|1
2885381|NCT01918332|9932893|P2|Overall Study|lipid result by central lab did not meet|0
2885382|NCT01918332|9932894|P1|Overall Study|lipid result by central lab did not meet|0
2885383|NCT01918332|9932891|P4|Overall Study|Protocol Violation|3
2885384|NCT01918332|9932892|P3|Overall Study|Protocol Violation|6
2885385|NCT01918332|9932893|P2|Overall Study|Protocol Violation|2
2885386|NCT01918332|9932894|P1|Overall Study|Protocol Violation|6
2885387|NCT01918332|9932891|P4|Overall Study|Withdrawal by Subject|3
2885388|NCT01918332|9932892|P3|Overall Study|Withdrawal by Subject|2
2885389|NCT01918332|9932893|P2|Overall Study|Withdrawal by Subject|3
2885390|NCT01918332|9932894|P1|Overall Study|Withdrawal by Subject|2
2885391|NCT01918332|9932891|P4|Overall Study|Adverse Event|1
2885392|NCT01918332|9932892|P3|Overall Study|Adverse Event|0
2885393|NCT01918332|9932893|P2|Overall Study|Adverse Event|0
2885394|NCT01918332|9932894|P1|Overall Study|Adverse Event|0
2885395|NCT01918306|9932906|P4|Overall Study|progress disease, crossover|0
2885396|NCT01918306|9932907|P3|Overall Study|progress disease, crossover|1
2885397|NCT01918306|9932908|P2|Overall Study|progress disease, crossover|0
2885398|NCT01918306|9932909|P1|Overall Study|progress disease, crossover|0
2885399|NCT01918306|9932906|P4|Overall Study|Lack of Efficacy|0
2885400|NCT01918306|9932907|P3|Overall Study|Lack of Efficacy|0
2885401|NCT01918306|9932908|P2|Overall Study|Lack of Efficacy|0
2885402|NCT01918306|9932909|P1|Overall Study|Lack of Efficacy|1
2885403|NCT01918306|9932906|P4|Overall Study|neutropenia|0
2885404|NCT01918306|9932907|P3|Overall Study|neutropenia|0
2885405|NCT01918306|9932908|P2|Overall Study|neutropenia|0
2885406|NCT01918306|9932909|P1|Overall Study|neutropenia|1
2885407|NCT01918306|9932906|P4|Overall Study|Withdrawal by Subject|2
2885408|NCT01918306|9932907|P3|Overall Study|Withdrawal by Subject|0
2885409|NCT01918306|9932908|P2|Overall Study|Withdrawal by Subject|0
2885410|NCT01918306|9932909|P1|Overall Study|Withdrawal by Subject|0
2885411|NCT01918306|9932906|P4|Overall Study|progresive disease|1
2885412|NCT01918306|9932907|P3|Overall Study|progresive disease|1
2885413|NCT01918306|9932908|P2|Overall Study|progresive disease|0
2885414|NCT01918306|9932909|P1|Overall Study|progresive disease|4
2885415|NCT01918085|9932940|P2|Test Period 1: Strata Strip|Adverse Event|1
2885416|NCT01918085|9932941|P1|Test Period 1: Strata Strip|Adverse Event|0
2885417|NCT01918033|9932965|P3|Overall Study|Withdrawal by Subject|0
2885418|NCT01918033|9932966|P2|Overall Study|Withdrawal by Subject|1
2885419|NCT01918033|9932967|P1|Overall Study|Withdrawal by Subject|2
2885420|NCT01918033|9932965|P3|Overall Study|Protocol Violation|1
2885421|NCT01918033|9932966|P2|Overall Study|Protocol Violation|0
2885422|NCT01918033|9932967|P1|Overall Study|Protocol Violation|2
2885423|NCT01918033|9932965|P3|Overall Study|Lost to Follow-up|0
2885424|NCT01918033|9932966|P2|Overall Study|Lost to Follow-up|1
2885425|NCT01918033|9932967|P1|Overall Study|Lost to Follow-up|0
2885426|NCT01918033|9932965|P3|Overall Study|Adverse Event|2
2885427|NCT01918033|9932966|P2|Overall Study|Adverse Event|0
2885428|NCT01918033|9932967|P1|Overall Study|Adverse Event|1
2885429|NCT01917747|9933038|P2|Overall Study|Lost to Follow-up|9
2885430|NCT01917747|9933039|P1|Overall Study|Lost to Follow-up|18
2885431|NCT01917747|9933038|P2|Overall Study|Withdrawal by Subject|2
2885432|NCT01917747|9933039|P1|Overall Study|Withdrawal by Subject|1
2885433|NCT01917656|9933053|P2|Overall Study|Lost to Follow-up|4
2885434|NCT01917656|9933054|P1|Overall Study|Lost to Follow-up|3
2885435|NCT01917656|9933053|P2|Overall Study|Withdrawal by Subject|3
2885436|NCT01917656|9933054|P1|Overall Study|Withdrawal by Subject|4
2885437|NCT01917656|9933053|P2|Overall Study|Unclassified|3
2885438|NCT01917656|9933054|P1|Overall Study|Unclassified|0
2885439|NCT01917656|9933053|P2|Overall Study|Withdrawal criteria|14
2885440|NCT01917656|9933054|P1|Overall Study|Withdrawal criteria|8
2885441|NCT01917656|9933053|P2|Overall Study|Adverse Event|0
2885442|NCT01917656|9933054|P1|Overall Study|Adverse Event|11
2885443|NCT01917526|9933080|P2|Overall Study|Protocol Violation|1
2885444|NCT01917526|9933081|P1|Overall Study|Protocol Violation|1
2885445|NCT01917344|9933098|P1|Overall Study|Withdrawal by Subject|1
2885446|NCT01917318|9933104|P2|First Treatment|Withdrawal by Subject|1
2885447|NCT01917318|9933105|P1|First Treatment|Withdrawal by Subject|0
2885448|NCT01917006|9933158|P8|Open-label Period|Lost to Follow-up|1
2885449|NCT01917006|9933159|P7|Open-label Period|Lost to Follow-up|0
2885450|NCT01917006|9933160|P6|Open-label Period|Lost to Follow-up|0
2885451|NCT01917006|9933161|P5|Open-label Period|Lost to Follow-up|0
2885452|NCT01917006|9933162|P4|Open-label Period|Lost to Follow-up|0
2885453|NCT01917006|9933163|P3|Open-label Period|Lost to Follow-up|0
2885454|NCT01917006|9933164|P2|Open-label Period|Lost to Follow-up|0
2885455|NCT01917006|9933165|P1|Open-label Period|Lost to Follow-up|0
2885456|NCT01917006|9933158|P8|Open-label Period|Adverse Event|1
2885457|NCT01917006|9933159|P7|Open-label Period|Adverse Event|0
2885458|NCT01917006|9933160|P6|Open-label Period|Adverse Event|0
2885459|NCT01917006|9933161|P5|Open-label Period|Adverse Event|0
2885460|NCT01917006|9933162|P4|Open-label Period|Adverse Event|0
2885461|NCT01917006|9933163|P3|Open-label Period|Adverse Event|0
2885462|NCT01917006|9933164|P2|Open-label Period|Adverse Event|0
2885463|NCT01917006|9933165|P1|Open-label Period|Adverse Event|0
2885464|NCT01917006|9933158|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885465|NCT01917006|9933159|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
2885466|NCT01917006|9933160|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885467|NCT01917006|9933161|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885468|NCT01917006|9933162|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885469|NCT01917006|9933163|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885470|NCT01917006|9933164|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885471|NCT01917006|9933165|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
2885472|NCT01917006|9933158|P8|Randomized-treatment Period|Protocol Violation|0
2885473|NCT01917006|9933159|P7|Randomized-treatment Period|Protocol Violation|0
2885474|NCT01917006|9933160|P6|Randomized-treatment Period|Protocol Violation|0
2885475|NCT01917006|9933161|P5|Randomized-treatment Period|Protocol Violation|0
2885476|NCT01917006|9933162|P4|Randomized-treatment Period|Protocol Violation|0
2885477|NCT01917006|9933163|P3|Randomized-treatment Period|Protocol Violation|0
2885478|NCT01917006|9933164|P2|Randomized-treatment Period|Protocol Violation|0
2885479|NCT01917006|9933165|P1|Randomized-treatment Period|Protocol Violation|1
2885480|NCT01917006|9933158|P8|Randomized-treatment Period|Personal Reasons|0
2885481|NCT01917006|9933159|P7|Randomized-treatment Period|Personal Reasons|0
2885482|NCT01917006|9933160|P6|Randomized-treatment Period|Personal Reasons|1
2885483|NCT01917006|9933161|P5|Randomized-treatment Period|Personal Reasons|0
2885484|NCT01917006|9933162|P4|Randomized-treatment Period|Personal Reasons|0
2885485|NCT01917006|9933163|P3|Randomized-treatment Period|Personal Reasons|0
2885486|NCT01917006|9933164|P2|Randomized-treatment Period|Personal Reasons|0
2885487|NCT01917006|9933165|P1|Randomized-treatment Period|Personal Reasons|0
2885488|NCT01917006|9933158|P8|Randomized-treatment Period|Lost to Follow-up|0
2885489|NCT01917006|9933159|P7|Randomized-treatment Period|Lost to Follow-up|0
2885490|NCT01917006|9933160|P6|Randomized-treatment Period|Lost to Follow-up|0
2885491|NCT01917006|9933161|P5|Randomized-treatment Period|Lost to Follow-up|0
2885492|NCT01917006|9933162|P4|Randomized-treatment Period|Lost to Follow-up|1
2885493|NCT01917006|9933163|P3|Randomized-treatment Period|Lost to Follow-up|0
2885494|NCT01917006|9933164|P2|Randomized-treatment Period|Lost to Follow-up|0
2885495|NCT01917006|9933165|P1|Randomized-treatment Period|Lost to Follow-up|1
2885496|NCT01916980|9933198|P2|Overall Study|Withdrawal by Subject|0
2885497|NCT01916980|9933199|P1|Overall Study|Withdrawal by Subject|1
2885498|NCT01916980|9933198|P2|Overall Study|Lack of Efficacy|2
2885499|NCT01916980|9933199|P1|Overall Study|Lack of Efficacy|2
2885500|NCT01916980|9933198|P2|Overall Study|Adverse Event|2
2885501|NCT01916980|9933199|P1|Overall Study|Adverse Event|4
2885502|NCT01916967|9933218|P3|Overall Study|Protocol Violation|0
2885503|NCT01916967|9933219|P2|Overall Study|Protocol Violation|1
2885504|NCT01916967|9933220|P1|Overall Study|Protocol Violation|0
2885505|NCT01916967|9933218|P3|Overall Study|Physician Decision|1
2885506|NCT01916967|9933219|P2|Overall Study|Physician Decision|0
2885507|NCT01916967|9933220|P1|Overall Study|Physician Decision|0
2885508|NCT01916967|9933218|P3|Overall Study|Lack of Efficacy|6
2885509|NCT01916967|9933219|P2|Overall Study|Lack of Efficacy|0
2885510|NCT01916967|9933220|P1|Overall Study|Lack of Efficacy|0
2885511|NCT01916967|9933218|P3|Overall Study|Adverse Event|2
2885512|NCT01916967|9933219|P2|Overall Study|Adverse Event|0
2885513|NCT01916967|9933220|P1|Overall Study|Adverse Event|0
2885514|NCT01916824|9933276|P2|Overall Study|Withdrawal by Subject|3
2885515|NCT01916824|9933277|P1|Overall Study|Withdrawal by Subject|2
2885516|NCT01916824|9933276|P2|Overall Study|Physician Decision|0
2885517|NCT01916824|9933277|P1|Overall Study|Physician Decision|2
2885518|NCT01916824|9933276|P2|Overall Study|Lost to Follow-up|6
2885519|NCT01916824|9933277|P1|Overall Study|Lost to Follow-up|3
2885520|NCT01916304|9933359|P1|Overall Study|Screening failure|17
2885521|NCT01916226|9933371|P4|Overall Study|Physician Decision|1
2885522|NCT01916226|9933372|P3|Overall Study|Physician Decision|0
2885523|NCT01916226|9933373|P2|Overall Study|Physician Decision|0
2885524|NCT01916226|9933374|P1|Overall Study|Physician Decision|0
2885525|NCT01916226|9933371|P4|Overall Study|Protocol Violation|1
2885526|NCT01916226|9933372|P3|Overall Study|Protocol Violation|0
2885527|NCT01916226|9933373|P2|Overall Study|Protocol Violation|1
2885528|NCT01916226|9933374|P1|Overall Study|Protocol Violation|0
2885529|NCT01916226|9933371|P4|Overall Study|Lack of Efficacy|1
2885530|NCT01916226|9933372|P3|Overall Study|Lack of Efficacy|2
2885531|NCT01916226|9933373|P2|Overall Study|Lack of Efficacy|0
2885532|NCT01916226|9933374|P1|Overall Study|Lack of Efficacy|0
2885533|NCT01916226|9933371|P4|Overall Study|Adverse Event|1
2885534|NCT01916226|9933372|P3|Overall Study|Adverse Event|1
2885535|NCT01916226|9933373|P2|Overall Study|Adverse Event|0
2885536|NCT01916226|9933374|P1|Overall Study|Adverse Event|1
2885537|NCT01916109|9933408|P1|Overall Study|Withdrawal by Subject|1
2885538|NCT01915940|9933414|P3|Treatment Period|Other Miscellaneous Reasons|0
2885539|NCT01915940|9933415|P2|Treatment Period|Other Miscellaneous Reasons|1
2885540|NCT01915940|9933416|P1|Treatment Period|Other Miscellaneous Reasons|0
2885541|NCT01915940|9933414|P3|Treatment Period|Adverse Event|1
2885542|NCT01915940|9933415|P2|Treatment Period|Adverse Event|9
2885543|NCT01915940|9933416|P1|Treatment Period|Adverse Event|0
2885544|NCT01915940|9933414|P3|Treatment Period|Decision of Participant|3
2885545|NCT01915940|9933415|P2|Treatment Period|Decision of Participant|1
2885546|NCT01915940|9933416|P1|Treatment Period|Decision of Participant|0
2885547|NCT01915940|9933414|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
2885548|NCT01915940|9933415|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
2885549|NCT01915940|9933416|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
2885550|NCT01915914|9933432|P4|Follow-up Phase|Physician Decision|1
2885551|NCT01915914|9933433|P3|Follow-up Phase|Physician Decision|0
2885552|NCT01915914|9933434|P2|Follow-up Phase|Physician Decision|0
2885553|NCT01915914|9933435|P1|Follow-up Phase|Physician Decision|0
2885554|NCT01915914|9933432|P4|Follow-up Phase|Withdrawal by Subject|1
2885555|NCT01915914|9933433|P3|Follow-up Phase|Withdrawal by Subject|0
2885556|NCT01915914|9933434|P2|Follow-up Phase|Withdrawal by Subject|0
2885557|NCT01915914|9933435|P1|Follow-up Phase|Withdrawal by Subject|0
2885558|NCT01915914|9933432|P4|Maintenance Phase|Missing|0
2885559|NCT01915914|9933433|P3|Maintenance Phase|Missing|0
2885560|NCT01915914|9933434|P2|Maintenance Phase|Missing|1
2885561|NCT01915914|9933435|P1|Maintenance Phase|Missing|0
2885562|NCT01915914|9933432|P4|Maintenance Phase|Lost to Follow-up|0
2885563|NCT01915914|9933433|P3|Maintenance Phase|Lost to Follow-up|1
2885564|NCT01915914|9933434|P2|Maintenance Phase|Lost to Follow-up|4
2885565|NCT01915914|9933435|P1|Maintenance Phase|Lost to Follow-up|0
2885566|NCT01915914|9933432|P4|Maintenance Phase|Withdrawal by Subject|0
2885567|NCT01915914|9933433|P3|Maintenance Phase|Withdrawal by Subject|1
2885568|NCT01915914|9933434|P2|Maintenance Phase|Withdrawal by Subject|1
2885569|NCT01915914|9933435|P1|Maintenance Phase|Withdrawal by Subject|0
2885570|NCT01915914|9933432|P4|Acute Phase|Missing|0
2885571|NCT01915914|9933433|P3|Acute Phase|Missing|0
2885572|NCT01915914|9933434|P2|Acute Phase|Missing|0
2885573|NCT01915914|9933435|P1|Acute Phase|Missing|1
2885574|NCT01915914|9933432|P4|Acute Phase|"Not Achieved treatment success"|0
2885575|NCT01915914|9933433|P3|Acute Phase|"Not Achieved treatment success"|0
2885576|NCT01915914|9933434|P2|Acute Phase|"Not Achieved treatment success"|0
2885577|NCT01915914|9933435|P1|Acute Phase|"Not Achieved treatment success"|1
2885578|NCT01915914|9933432|P4|Acute Phase|Accepted Other Topic Therapies|0
2885579|NCT01915914|9933433|P3|Acute Phase|Accepted Other Topic Therapies|0
2885580|NCT01915914|9933434|P2|Acute Phase|Accepted Other Topic Therapies|0
2885581|NCT01915914|9933435|P1|Acute Phase|Accepted Other Topic Therapies|1
2885582|NCT01915914|9933432|P4|Acute Phase|Physician Decision|0
2885583|NCT01915914|9933433|P3|Acute Phase|Physician Decision|0
2885584|NCT01915914|9933434|P2|Acute Phase|Physician Decision|0
2885585|NCT01915914|9933435|P1|Acute Phase|Physician Decision|1
2885586|NCT01915914|9933432|P4|Acute Phase|Lost to Follow-up|0
2885587|NCT01915914|9933433|P3|Acute Phase|Lost to Follow-up|0
2885588|NCT01915914|9933434|P2|Acute Phase|Lost to Follow-up|0
2885589|NCT01915914|9933435|P1|Acute Phase|Lost to Follow-up|4
2885590|NCT01915914|9933432|P4|Acute Phase|Withdrawal by Subject|0
2885591|NCT01915914|9933433|P3|Acute Phase|Withdrawal by Subject|0
2885592|NCT01915914|9933434|P2|Acute Phase|Withdrawal by Subject|0
2885593|NCT01915914|9933435|P1|Acute Phase|Withdrawal by Subject|4
2885594|NCT01915849|9933467|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2885595|NCT01915849|9933468|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2885596|NCT01915849|9933469|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2885597|NCT01915849|9933470|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2885598|NCT01915849|9933467|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
2885599|NCT01915849|9933468|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
2885600|NCT01915849|9933469|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
2885601|NCT01915849|9933470|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
2885602|NCT01915771|9933493|P1|Day 15|Withdrawal by Subject|1
2885603|NCT01915771|9933493|P1|Day 1|Withdrawal by Subject|1
2885604|NCT01915732|9933517|P2|Overall Study|Poor Conscious Effect|1
2885605|NCT01915732|9933518|P1|Overall Study|Poor Conscious Effect|0
2885606|NCT01915732|9933517|P2|Overall Study|Improper Facial Procedure|1
2885607|NCT01915732|9933518|P1|Overall Study|Improper Facial Procedure|0
2885608|NCT01915732|9933517|P2|Overall Study|Job Transfer|1
2885609|NCT01915732|9933518|P1|Overall Study|Job Transfer|0
2885610|NCT01915732|9933517|P2|Overall Study|Par. Refused to Hospital Visits|1
2885611|NCT01915732|9933518|P1|Overall Study|Par. Refused to Hospital Visits|0
2885612|NCT01915732|9933517|P2|Overall Study|Par. not Willing to Continue Treatment|1
2885613|NCT01915732|9933518|P1|Overall Study|Par. not Willing to Continue Treatment|0
2885614|NCT01915732|9933517|P2|Overall Study|Got Well|1
2885615|NCT01915732|9933518|P1|Overall Study|Got Well|0
2885616|NCT01915732|9933517|P2|Overall Study|Par. Unable to Come to the Hospital|1
2885617|NCT01915732|9933518|P1|Overall Study|Par. Unable to Come to the Hospital|0
2885618|NCT01915732|9933517|P2|Overall Study|Poor Perceived Efficacy|0
2885619|NCT01915732|9933518|P1|Overall Study|Poor Perceived Efficacy|1
2885620|NCT01915732|9933517|P2|Overall Study|Pregnancy|0
2885621|NCT01915732|9933518|P1|Overall Study|Pregnancy|1
2885622|NCT01915732|9933517|P2|Overall Study|Recovered|0
2885623|NCT01915732|9933518|P1|Overall Study|Recovered|1
2885624|NCT01915732|9933517|P2|Overall Study|Drug Release Error|0
2885625|NCT01915732|9933518|P1|Overall Study|Drug Release Error|1
2885626|NCT01915732|9933517|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
2885627|NCT01915732|9933518|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
2885628|NCT01915732|9933517|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
2885629|NCT01915732|9933518|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
2885630|NCT01915732|9933517|P2|Overall Study|Lost to Follow-up|26
2885631|NCT01915732|9933518|P1|Overall Study|Lost to Follow-up|22
2885632|NCT01915732|9933517|P2|Overall Study|Lack of Efficacy|11
2885633|NCT01915732|9933518|P1|Overall Study|Lack of Efficacy|6
2885634|NCT01915732|9933517|P2|Overall Study|Protocol Violation|5
2885635|NCT01915732|9933518|P1|Overall Study|Protocol Violation|5
2885636|NCT01915732|9933517|P2|Overall Study|Adverse Event|4
2885637|NCT01915732|9933518|P1|Overall Study|Adverse Event|12
2885638|NCT01915732|9933517|P2|Overall Study|Failure to Meet Randomization Criteria|0
2885639|NCT01915732|9933518|P1|Overall Study|Failure to Meet Randomization Criteria|1
2885640|NCT01915732|9933517|P2|Overall Study|Withdrawal by Subject|18
2885641|NCT01915732|9933518|P1|Overall Study|Withdrawal by Subject|18
2885642|NCT01914926|9933597|P2|Overall Study|uncooperative, agitated and removed|1
2885643|NCT01914926|9933598|P1|Overall Study|uncooperative, agitated and removed|0
2885644|NCT01914926|9933597|P2|Overall Study|Adverse Event|0
2885645|NCT01914926|9933598|P1|Overall Study|Adverse Event|1
2885646|NCT01914757|9933607|P3|Overall Study|Other reasons|4
2885647|NCT01914757|9933608|P2|Overall Study|Other reasons|9
2885648|NCT01914757|9933609|P1|Overall Study|Other reasons|5
2885649|NCT01914757|9933607|P3|Overall Study|Eligibility criteria not fulfilled|2
2885650|NCT01914757|9933608|P2|Overall Study|Eligibility criteria not fulfilled|0
2885651|NCT01914757|9933609|P1|Overall Study|Eligibility criteria not fulfilled|2
2885652|NCT01914757|9933607|P3|Overall Study|Study specific withdrawal criteria|0
2885653|NCT01914757|9933608|P2|Overall Study|Study specific withdrawal criteria|1
2885654|NCT01914757|9933609|P1|Overall Study|Study specific withdrawal criteria|0
2885655|NCT01914757|9933607|P3|Overall Study|Adverse Event|4
2885656|NCT01914757|9933608|P2|Overall Study|Adverse Event|3
2885657|NCT01914757|9933609|P1|Overall Study|Adverse Event|4
2885658|NCT01914757|9933607|P3|Overall Study|Death|1
2885659|NCT01914757|9933608|P2|Overall Study|Death|2
2885660|NCT01914757|9933609|P1|Overall Study|Death|2
2885661|NCT01914757|9933607|P3|Overall Study|Withdrawal by Subject|19
2885662|NCT01914757|9933608|P2|Overall Study|Withdrawal by Subject|27
2885663|NCT01914757|9933609|P1|Overall Study|Withdrawal by Subject|15
2885664|NCT01914757|9933607|P3|Overall Study|Lost to Follow-up|6
2885665|NCT01914757|9933608|P2|Overall Study|Lost to Follow-up|8
2885666|NCT01914757|9933609|P1|Overall Study|Lost to Follow-up|5
2885667|NCT01914757|9933607|P3|Overall Study|Severe non-compliance to protocol|2
2885668|NCT01914757|9933608|P2|Overall Study|Severe non-compliance to protocol|1
2885669|NCT01914757|9933609|P1|Overall Study|Severe non-compliance to protocol|3
2885670|NCT01914679|9933683|P1|Overall Study|Sponsor terminated study|4
2885671|NCT01914679|9933683|P1|Overall Study|Lack of Efficacy|1
2885672|NCT01914666|9933690|P3|Treatment Period|Physician Decision|2
2885673|NCT01914666|9933691|P2|Treatment Period|Physician Decision|0
2885674|NCT01914666|9933692|P1|Treatment Period|Physician Decision|0
2885675|NCT01914666|9933690|P3|Treatment Period|Withdrawal by Subject|2
2885676|NCT01914666|9933691|P2|Treatment Period|Withdrawal by Subject|2
2885677|NCT01914666|9933692|P1|Treatment Period|Withdrawal by Subject|3
2885678|NCT01914666|9933690|P3|Treatment Period|Adverse Event|2
2885679|NCT01914666|9933691|P2|Treatment Period|Adverse Event|4
2885680|NCT01914666|9933692|P1|Treatment Period|Adverse Event|10
2885681|NCT01914666|9933690|P3|Treatment Period|Lack of Efficacy|2
2885682|NCT01914666|9933691|P2|Treatment Period|Lack of Efficacy|0
2885683|NCT01914666|9933692|P1|Treatment Period|Lack of Efficacy|0
2885684|NCT01914393|9933735|P3|Overall Study|subject never dosed|1
2885685|NCT01914393|9933736|P2|Overall Study|subject never dosed|0
2885686|NCT01914393|9933737|P1|Overall Study|subject never dosed|0
2885687|NCT01914393|9933735|P3|Overall Study|Lost to Follow-up|19
2885688|NCT01914393|9933736|P2|Overall Study|Lost to Follow-up|6
2885689|NCT01914393|9933737|P1|Overall Study|Lost to Follow-up|12
2885690|NCT01914393|9933735|P3|Overall Study|Withdrawal by Subject|47
2885691|NCT01914393|9933736|P2|Overall Study|Withdrawal by Subject|20
2885692|NCT01914393|9933737|P1|Overall Study|Withdrawal by Subject|38
2885693|NCT01914393|9933735|P3|Overall Study|Adverse Event|31
2885694|NCT01914393|9933736|P2|Overall Study|Adverse Event|18
2885695|NCT01914393|9933737|P1|Overall Study|Adverse Event|29
2885696|NCT01914393|9933735|P3|Overall Study|no reason given|16
2885697|NCT01914393|9933736|P2|Overall Study|no reason given|8
2885698|NCT01914393|9933737|P1|Overall Study|no reason given|14
2885699|NCT01914393|9933735|P3|Overall Study|Lack of Efficacy|5
2885700|NCT01914393|9933736|P2|Overall Study|Lack of Efficacy|16
2885701|NCT01914393|9933737|P1|Overall Study|Lack of Efficacy|11
2885702|NCT01914393|9933735|P3|Overall Study|Protocol Violation|19
2885703|NCT01914393|9933736|P2|Overall Study|Protocol Violation|3
2885704|NCT01914393|9933737|P1|Overall Study|Protocol Violation|11
2885705|NCT01913639|9933805|P1|Overall Study|Not Eligible|3
2885706|NCT01913483|9933871|P2|Overall Study|Death|17
2885707|NCT01913483|9933872|P1|Overall Study|Death|14
2885708|NCT01913483|9933871|P2|Overall Study|Lost to Follow-up|3
2885709|NCT01913483|9933872|P1|Overall Study|Lost to Follow-up|6
2885710|NCT01913483|9933871|P2|Overall Study|Withdrawal by Subject|2
2885711|NCT01913483|9933872|P1|Overall Study|Withdrawal by Subject|1
2885712|NCT01913470|9933884|P2|Overall Study|Withdrawal by Subject|1
2885713|NCT01913470|9933885|P1|Overall Study|Withdrawal by Subject|0
2885714|NCT01913470|9933884|P2|Overall Study|Physician Decision|1
2885715|NCT01913470|9933885|P1|Overall Study|Physician Decision|0
2885716|NCT01913470|9933884|P2|Overall Study|Lost to Follow-up|1
2885717|NCT01913470|9933885|P1|Overall Study|Lost to Follow-up|0
2885718|NCT01913405|9933903|P1|Overall Study|Adverse Event|1
2885719|NCT01913405|9933903|P1|Overall Study|Withdrawal by Subject|1
2885720|NCT01913353|9933959|P2|Overall Study|multiple reasons|7
2885721|NCT01913353|9933960|P1|Overall Study|multiple reasons|10
2885722|NCT01913353|9933959|P2|Overall Study|Withdrawal by Subject|6
2885723|NCT01913353|9933960|P1|Overall Study|Withdrawal by Subject|20
2885724|NCT01913353|9933959|P2|Overall Study|Physician Decision|2
2885725|NCT01913353|9933960|P1|Overall Study|Physician Decision|0
2885726|NCT01913353|9933959|P2|Overall Study|Adverse Event|0
2885727|NCT01913353|9933960|P1|Overall Study|Adverse Event|2
2885728|NCT01913327|9934030|P2|Overall Study|Withdrawal by Subject|1
2885729|NCT01913327|9934031|P1|Overall Study|Withdrawal by Subject|0
2885730|NCT01913041|9934056|P1|Overall Study|Physician Decision|1
2885731|NCT01913041|9934056|P1|Overall Study|Withdrawal by Subject|3
2885732|NCT01913041|9934056|P1|Overall Study|Protocol Violation|35
2885733|NCT01912963|9934063|P3|Overall Study|Sought treatment locally|0
2885734|NCT01912963|9934064|P2|Overall Study|Sought treatment locally|1
2885735|NCT01912963|9934065|P1|Overall Study|Sought treatment locally|0
2885736|NCT01912963|9934063|P3|Overall Study|Withdrawal by Subject|0
2885737|NCT01912963|9934064|P2|Overall Study|Withdrawal by Subject|1
2885738|NCT01912963|9934065|P1|Overall Study|Withdrawal by Subject|0
2885739|NCT01912963|9934063|P3|Overall Study|Adverse Event|1
2885740|NCT01912963|9934064|P2|Overall Study|Adverse Event|1
2885741|NCT01912963|9934065|P1|Overall Study|Adverse Event|0
2885742|NCT01912963|9934063|P3|Overall Study|Disease Progression (not RECIST1.1)|1
2885743|NCT01912963|9934064|P2|Overall Study|Disease Progression (not RECIST1.1)|7
2885744|NCT01912963|9934065|P1|Overall Study|Disease Progression (not RECIST1.1)|0
2885745|NCT01912963|9934063|P3|Overall Study|Disease Progression (RECIST1.1)|5
2885746|NCT01912963|9934064|P2|Overall Study|Disease Progression (RECIST1.1)|9
2885747|NCT01912963|9934065|P1|Overall Study|Disease Progression (RECIST1.1)|6
2885748|NCT01912872|9934088|P4|Overall Study|Missing|1
2885749|NCT01912872|9934089|P3|Overall Study|Missing|0
2885750|NCT01912872|9934090|P2|Overall Study|Missing|0
2885751|NCT01912872|9934091|P1|Overall Study|Missing|0
2885752|NCT01912872|9934088|P4|Overall Study|Withdrawal of study medication|2
2885753|NCT01912872|9934089|P3|Overall Study|Withdrawal of study medication|0
2885754|NCT01912872|9934090|P2|Overall Study|Withdrawal of study medication|0
2885755|NCT01912872|9934091|P1|Overall Study|Withdrawal of study medication|0
2885756|NCT01912872|9934088|P4|Overall Study|Unsatisfactory therapeutic effect|2
2885757|NCT01912872|9934089|P3|Overall Study|Unsatisfactory therapeutic effect|0
2885758|NCT01912872|9934090|P2|Overall Study|Unsatisfactory therapeutic effect|0
2885759|NCT01912872|9934091|P1|Overall Study|Unsatisfactory therapeutic effect|0
2885760|NCT01912872|9934088|P4|Overall Study|Protocol Violation|0
2885761|NCT01912872|9934089|P3|Overall Study|Protocol Violation|1
2885762|NCT01912872|9934090|P2|Overall Study|Protocol Violation|0
2885763|NCT01912872|9934091|P1|Overall Study|Protocol Violation|0
2885764|NCT01912872|9934088|P4|Overall Study|Non-compliance with lab inc/exclusion|1
2885765|NCT01912872|9934089|P3|Overall Study|Non-compliance with lab inc/exclusion|0
2885766|NCT01912872|9934090|P2|Overall Study|Non-compliance with lab inc/exclusion|0
2885767|NCT01912872|9934091|P1|Overall Study|Non-compliance with lab inc/exclusion|0
2885768|NCT01912872|9934088|P4|Overall Study|Informed consent withdrawn|1
2885769|NCT01912872|9934089|P3|Overall Study|Informed consent withdrawn|1
2885770|NCT01912872|9934090|P2|Overall Study|Informed consent withdrawn|0
2885771|NCT01912872|9934091|P1|Overall Study|Informed consent withdrawn|0
2885772|NCT01912872|9934088|P4|Overall Study|Other unspecified|0
2885773|NCT01912872|9934089|P3|Overall Study|Other unspecified|3
2885774|NCT01912872|9934090|P2|Overall Study|Other unspecified|1
2885775|NCT01912872|9934091|P1|Overall Study|Other unspecified|3
2885776|NCT01912872|9934088|P4|Overall Study|Lost to Follow-up|5
2885777|NCT01912872|9934089|P3|Overall Study|Lost to Follow-up|5
2885778|NCT01912872|9934090|P2|Overall Study|Lost to Follow-up|3
2885779|NCT01912872|9934091|P1|Overall Study|Lost to Follow-up|2
2885780|NCT01912781|9934135|P2|Overall Study|Withdrawal by Subject|0
2885781|NCT01912781|9934136|P1|Overall Study|Withdrawal by Subject|2
2885782|NCT01912768|9934167|P2|Overall Study|Randomized in error|0
2885783|NCT01912768|9934168|P1|Overall Study|Randomized in error|1
2885784|NCT01912768|9934167|P2|Overall Study|Withdrawal by Subject|3
2885785|NCT01912768|9934168|P1|Overall Study|Withdrawal by Subject|5
2885786|NCT01912768|9934167|P2|Overall Study|Lost to Follow-up|1
2885787|NCT01912768|9934168|P1|Overall Study|Lost to Follow-up|2
2885788|NCT01912768|9934167|P2|Overall Study|Adverse Event|0
2885789|NCT01912768|9934168|P1|Overall Study|Adverse Event|2
2885790|NCT01912729|9934199|P2|Overall Study|Withdrawal by Subject|1
2885791|NCT01912729|9934200|P1|Overall Study|Withdrawal by Subject|0
2885792|NCT01912599|9934223|P2|Overall Study|Withdrawal by Subject|1
2885793|NCT01912599|9934224|P1|Overall Study|Withdrawal by Subject|0
2885794|NCT01912404|9934249|P2|Overall Study|Due to personal reasons|0
2885795|NCT01912404|9934250|P1|Overall Study|Due to personal reasons|1
2885796|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
2885797|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
2885798|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
2885799|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
2885800|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2885801|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2885802|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
2885803|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2885804|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2885805|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
2885806|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2885807|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2885808|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
2885809|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2885810|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2885811|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2885812|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2885813|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
2885814|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2885815|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2885816|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
2885817|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
2885818|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
2885819|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
2885820|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2885821|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2885822|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
2885823|NCT01912339|9934263|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2885824|NCT01912339|9934264|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2885825|NCT01912339|9934265|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
2885826|NCT01912339|9934263|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2885827|NCT01912339|9934264|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2885828|NCT01912339|9934265|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
2885829|NCT01912339|9934263|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
2885830|NCT01912339|9934264|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
2885831|NCT01912339|9934265|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
2885832|NCT01912339|9934263|P3|Blinded (0 to 3 Months)|Declined to participate|0
2885833|NCT01912339|9934264|P2|Blinded (0 to 3 Months)|Declined to participate|0
2885834|NCT01912339|9934265|P1|Blinded (0 to 3 Months)|Declined to participate|1
2885835|NCT01912222|9934282|P3|Part B: Treatment Period|Withdrawal by Subject|2
2885836|NCT01912222|9934283|P2|Part B: Treatment Period|Withdrawal by Subject|1
2885837|NCT01912222|9934284|P1|Part B: Treatment Period|Withdrawal by Subject|2
2885838|NCT01912222|9934282|P3|Part B: Treatment Period|Adverse Event|3
2885839|NCT01912222|9934283|P2|Part B: Treatment Period|Adverse Event|2
2885840|NCT01912222|9934284|P1|Part B: Treatment Period|Adverse Event|1
2885841|NCT01912222|9934282|P3|Part B: Treatment Period|Progressive disease|15
2885842|NCT01912222|9934283|P2|Part B: Treatment Period|Progressive disease|12
2885843|NCT01912222|9934284|P1|Part B: Treatment Period|Progressive disease|10
2885844|NCT01912222|9934282|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2885845|NCT01912222|9934283|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2885846|NCT01912222|9934284|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
2885847|NCT01911845|9934307|P1|Overall Study|Other (not specified)|3
2885848|NCT01911845|9934307|P1|Overall Study|Lost to Follow-up|1
2885849|NCT01911845|9934307|P1|Overall Study|Adverse Event|2
2885850|NCT01911819|9934324|P3|Overall Study|Withdrawal by Subject|0
2885851|NCT01911819|9934325|P2|Overall Study|Withdrawal by Subject|1
2885852|NCT01911819|9934326|P1|Overall Study|Withdrawal by Subject|1
2885853|NCT01911819|9934324|P3|Overall Study|Adverse Event|0
2885854|NCT01911819|9934325|P2|Overall Study|Adverse Event|1
2885855|NCT01911819|9934326|P1|Overall Study|Adverse Event|0
2885856|NCT01911793|9934339|P2|Overall Study|Physician Decision|5
2885857|NCT01911793|9934340|P1|Overall Study|Physician Decision|1
2885858|NCT01911780|9934364|P2|Extension Period (52 Weeks)|Personal reason|1
2885859|NCT01911780|9934365|P1|Extension Period (52 Weeks)|Personal reason|1
2885860|NCT01911780|9934364|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
2885861|NCT01911780|9934365|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
2885862|NCT01911780|9934364|P2|Extension Period (52 Weeks)|Adverse Event|0
2885863|NCT01911780|9934365|P1|Extension Period (52 Weeks)|Adverse Event|3
2885864|NCT01911780|9934364|P2|Double-blind Period (8 Weeks)|Personal reason|0
2885865|NCT01911780|9934365|P1|Double-blind Period (8 Weeks)|Personal reason|1
2885866|NCT01911780|9934364|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2885867|NCT01911780|9934365|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2885868|NCT01911780|9934364|P2|Double-blind Period (8 Weeks)|Adverse Event|2
2885869|NCT01911780|9934365|P1|Double-blind Period (8 Weeks)|Adverse Event|1
2885870|NCT01911546|9934399|P1|Overall Study|Everolimus was discontinued|5
2885871|NCT01911546|9934399|P1|Overall Study|Lost to Follow-up|1
2885872|NCT01911442|9934409|P3|Overall Study|Mother's Work Schedule|0
2885873|NCT01911442|9934410|P2|Overall Study|Mother's Work Schedule|1
2885874|NCT01911442|9934411|P1|Overall Study|Mother's Work Schedule|0
2885875|NCT01911442|9934409|P3|Overall Study|Withdrawal by Subject|6
2885876|NCT01911442|9934410|P2|Overall Study|Withdrawal by Subject|0
2885877|NCT01911442|9934411|P1|Overall Study|Withdrawal by Subject|1
2885878|NCT01911442|9934409|P3|Overall Study|Lost to Follow-up|1
2885879|NCT01911442|9934410|P2|Overall Study|Lost to Follow-up|0
2885880|NCT01911442|9934411|P1|Overall Study|Lost to Follow-up|2
2885881|NCT01911442|9934409|P3|Overall Study|Lack of Efficacy|1
2885882|NCT01911442|9934410|P2|Overall Study|Lack of Efficacy|1
2885883|NCT01911442|9934411|P1|Overall Study|Lack of Efficacy|1
2885884|NCT01911442|9934409|P3|Overall Study|Adverse Event|4
2885885|NCT01911442|9934410|P2|Overall Study|Adverse Event|2
2885886|NCT01911442|9934411|P1|Overall Study|Adverse Event|2
2885887|NCT01911429|9934440|P3|Overall Study|subject left study|0
2885888|NCT01911429|9934441|P2|Overall Study|subject left study|0
2885889|NCT01911429|9934442|P1|Overall Study|subject left study|1
2885890|NCT01911429|9934440|P3|Overall Study|Accidental randomization|1
2885891|NCT01911429|9934441|P2|Overall Study|Accidental randomization|0
2885892|NCT01911429|9934442|P1|Overall Study|Accidental randomization|0
2885893|NCT01911429|9934440|P3|Overall Study|Withdrawal by Subject|4
2885894|NCT01911429|9934441|P2|Overall Study|Withdrawal by Subject|5
2885895|NCT01911429|9934442|P1|Overall Study|Withdrawal by Subject|5
2885896|NCT01911429|9934440|P3|Overall Study|Protocol Violation|1
2885897|NCT01911429|9934441|P2|Overall Study|Protocol Violation|0
2885898|NCT01911429|9934442|P1|Overall Study|Protocol Violation|0
2885899|NCT01911429|9934440|P3|Overall Study|Lost to Follow-up|1
2885900|NCT01911429|9934441|P2|Overall Study|Lost to Follow-up|0
2885901|NCT01911429|9934442|P1|Overall Study|Lost to Follow-up|0
2885902|NCT01911429|9934440|P3|Overall Study|Lack of Efficacy|4
2885903|NCT01911429|9934441|P2|Overall Study|Lack of Efficacy|2
2885904|NCT01911429|9934442|P1|Overall Study|Lack of Efficacy|1
2885905|NCT01911429|9934440|P3|Overall Study|Adverse Event|9
2885906|NCT01911429|9934441|P2|Overall Study|Adverse Event|3
2885907|NCT01911429|9934442|P1|Overall Study|Adverse Event|5
2885908|NCT01911273|9934534|P2|Overall Study|Withdrawal by Subject|2
2885909|NCT01911273|9934535|P1|Overall Study|Withdrawal by Subject|0
2885910|NCT01911273|9934534|P2|Overall Study|Progression of Disease|0
2885911|NCT01911273|9934535|P1|Overall Study|Progression of Disease|1
2885912|NCT01911260|9934569|P4|Follow-up Period|transference or evasion of school|12
2885913|NCT01911260|9934570|P3|Follow-up Period|transference or evasion of school|15
2885914|NCT01911260|9934571|P2|Follow-up Period|transference or evasion of school|20
2885915|NCT01911260|9934572|P1|Follow-up Period|transference or evasion of school|13
2885916|NCT01911260|9934569|P4|Supplementation Period|less than 12 weeks supplementation|2
2885917|NCT01911260|9934570|P3|Supplementation Period|less than 12 weeks supplementation|1
2885918|NCT01911260|9934571|P2|Supplementation Period|less than 12 weeks supplementation|3
2885919|NCT01911260|9934572|P1|Supplementation Period|less than 12 weeks supplementation|0
2885920|NCT01911260|9934569|P4|Supplementation Period|refused to receive supplement|0
2885921|NCT01911260|9934570|P3|Supplementation Period|refused to receive supplement|1
2885922|NCT01911260|9934571|P2|Supplementation Period|refused to receive supplement|0
2885923|NCT01911260|9934572|P1|Supplementation Period|refused to receive supplement|1
2885924|NCT01911260|9934569|P4|Supplementation Period|Adverse Event|0
2885925|NCT01911260|9934570|P3|Supplementation Period|Adverse Event|1
2885926|NCT01911260|9934571|P2|Supplementation Period|Adverse Event|0
2885927|NCT01911260|9934572|P1|Supplementation Period|Adverse Event|2
2885928|NCT01911260|9934569|P4|Supplementation Period|transference or evasion of school|6
2885929|NCT01911260|9934570|P3|Supplementation Period|transference or evasion of school|7
2885930|NCT01911260|9934571|P2|Supplementation Period|transference or evasion of school|9
2885931|NCT01911260|9934572|P1|Supplementation Period|transference or evasion of school|7
2885932|NCT01910519|9934658|P2|Overall Study|Adverse Event|0
2885933|NCT01910519|9934659|P1|Overall Study|Adverse Event|2
2885934|NCT01910519|9934658|P2|Overall Study|Withdrawal by Subject|0
2885935|NCT01910519|9934659|P1|Overall Study|Withdrawal by Subject|2
2885936|NCT01910441|9934685|P2|Overall Study|Physician Decision|1
2885937|NCT01910441|9934686|P1|Overall Study|Physician Decision|0
2885938|NCT01910441|9934685|P2|Overall Study|Adverse Event|0
2885939|NCT01910441|9934686|P1|Overall Study|Adverse Event|1
2885940|NCT01910441|9934685|P2|Overall Study|Non-compliance|1
2885941|NCT01910441|9934686|P1|Overall Study|Non-compliance|0
2885942|NCT01910441|9934685|P2|Overall Study|Withdrawal by Subject|1
2885943|NCT01910441|9934686|P1|Overall Study|Withdrawal by Subject|0
2885944|NCT01910441|9934685|P2|Overall Study|Lost to Follow-up|5
2885945|NCT01910441|9934686|P1|Overall Study|Lost to Follow-up|6
2885946|NCT01910441|9934685|P2|Overall Study|Sponsor decision|2
2885947|NCT01910441|9934686|P1|Overall Study|Sponsor decision|0
2885948|NCT01910402|9934694|P2|Continuation Phase|Withdrawal by Subject|0
2885949|NCT01910402|9934695|P1|Continuation Phase|Withdrawal by Subject|2
2885950|NCT01910402|9934694|P2|Continuation Phase|Protocol Violation|0
2885951|NCT01910402|9934695|P1|Continuation Phase|Protocol Violation|3
2885952|NCT01910402|9934694|P2|Continuation Phase|Adverse Event|0
2885953|NCT01910402|9934695|P1|Continuation Phase|Adverse Event|1
2885954|NCT01910402|9934694|P2|Continuation Phase|Ongoing|0
2885955|NCT01910402|9934695|P1|Continuation Phase|Ongoing|84
2885956|NCT01910402|9934694|P2|Randomized Phase|Withdrawal by Subject|7
2885957|NCT01910402|9934695|P1|Randomized Phase|Withdrawal by Subject|5
2885958|NCT01910402|9934694|P2|Randomized Phase|Protocol Violation|13
2885959|NCT01910402|9934695|P1|Randomized Phase|Protocol Violation|10
2885960|NCT01910402|9934694|P2|Randomized Phase|Lost to Follow-up|13
2885961|NCT01910402|9934695|P1|Randomized Phase|Lost to Follow-up|11
2885962|NCT01910402|9934694|P2|Randomized Phase|Lack of Efficacy|4
2885963|NCT01910402|9934695|P1|Randomized Phase|Lack of Efficacy|5
2885964|NCT01910402|9934694|P2|Randomized Phase|Physician Decision|0
2885965|NCT01910402|9934695|P1|Randomized Phase|Physician Decision|1
2885966|NCT01910402|9934694|P2|Randomized Phase|Adverse Event|18
2885967|NCT01910402|9934695|P1|Randomized Phase|Adverse Event|10
2885968|NCT01910389|9934765|P2|Overall Study|Study Closed|8
2885969|NCT01910389|9934766|P1|Overall Study|Study Closed|13
2885970|NCT01910389|9934765|P2|Overall Study|Withdrawal by Subject|0
2885971|NCT01910389|9934766|P1|Overall Study|Withdrawal by Subject|2
2885972|NCT01910298|9934809|P2|Overall Study|Other Miscellaneous Reasons|2
2885973|NCT01910298|9934810|P1|Overall Study|Other Miscellaneous Reasons|0
2885974|NCT01910298|9934809|P2|Overall Study|Study Terminated by Sponsor|17
2885975|NCT01910298|9934810|P1|Overall Study|Study Terminated by Sponsor|1
2885976|NCT01910298|9934809|P2|Overall Study|Lost to Follow-up|1
2885977|NCT01910298|9934810|P1|Overall Study|Lost to Follow-up|1
2885978|NCT01910298|9934809|P2|Overall Study|Protocol Deviation|5
2885979|NCT01910298|9934810|P1|Overall Study|Protocol Deviation|0
2885980|NCT01910298|9934809|P2|Overall Study|Withdrawal by Subject|7
2885981|NCT01910298|9934810|P1|Overall Study|Withdrawal by Subject|2
2885982|NCT01910298|9934809|P2|Overall Study|Adverse Event|0
2885983|NCT01910298|9934810|P1|Overall Study|Adverse Event|1
2885984|NCT01910181|9934828|P1|Overall Study|Study Terminated by Sponsor|6
2885985|NCT01910181|9934828|P1|Overall Study|Lost to Follow-up|3
2885986|NCT01910181|9934828|P1|Overall Study|Death|37
2885987|NCT01910129|9934855|P3|Randomized Phase 3|Withdrawal by Subject|0
2885988|NCT01910129|9934856|P2|Randomized Phase 3|Withdrawal by Subject|1
2885989|NCT01910129|9934857|P1|Randomized Phase 3|Withdrawal by Subject|0
2885990|NCT01910129|9934855|P3|Randomized Phase 2|Withdrawal by Subject|0
2885991|NCT01910129|9934856|P2|Randomized Phase 2|Withdrawal by Subject|1
2885992|NCT01910129|9934857|P1|Randomized Phase 2|Withdrawal by Subject|2
2885993|NCT01910116|9934881|P2|Overall Study|incomplete data|1
2885994|NCT01910116|9934882|P1|Overall Study|incomplete data|0
2885995|NCT01910116|9934881|P2|Overall Study|uncertain allocation|3
2885996|NCT01910116|9934882|P1|Overall Study|uncertain allocation|1
2885997|NCT01910116|9934881|P2|Overall Study|Withdrawal by Subject|3
2885998|NCT01910116|9934882|P1|Overall Study|Withdrawal by Subject|8
2885999|NCT01910116|9934881|P2|Overall Study|Protocol Violation|2
2886000|NCT01910116|9934882|P1|Overall Study|Protocol Violation|1
2886001|NCT01910116|9934881|P2|Overall Study|Lost to Follow-up|0
2886002|NCT01910116|9934882|P1|Overall Study|Lost to Follow-up|1
2886003|NCT01910116|9934881|P2|Overall Study|Lack of Efficacy|4
2886004|NCT01910116|9934882|P1|Overall Study|Lack of Efficacy|3
2886005|NCT01910116|9934881|P2|Overall Study|Adverse Event|3
2886006|NCT01910116|9934882|P1|Overall Study|Adverse Event|0
2886007|NCT01909973|9934969|P2|Overall Study|Lost to Follow-up|0
2886008|NCT01909973|9934970|P1|Overall Study|Lost to Follow-up|1
2886009|NCT01909804|9934990|P12|Overall Study|Protocol Violation|1
2886010|NCT01909804|9934991|P11|Overall Study|Protocol Violation|0
2886011|NCT01909804|9934992|P10|Overall Study|Protocol Violation|0
2886012|NCT01909804|9934993|P9|Overall Study|Protocol Violation|0
2886013|NCT01909804|9934994|P8|Overall Study|Protocol Violation|0
2886014|NCT01909804|9934995|P7|Overall Study|Protocol Violation|0
2886015|NCT01909804|9934996|P6|Overall Study|Protocol Violation|0
2886016|NCT01909804|9934997|P5|Overall Study|Protocol Violation|0
2886017|NCT01909804|9934998|P4|Overall Study|Protocol Violation|0
2886018|NCT01909804|9934999|P3|Overall Study|Protocol Violation|0
2886019|NCT01909804|9935000|P2|Overall Study|Protocol Violation|0
2886020|NCT01909804|9935001|P1|Overall Study|Protocol Violation|0
2886021|NCT01909804|9934990|P12|Overall Study|Withdrew Consent|0
2886022|NCT01909804|9934991|P11|Overall Study|Withdrew Consent|0
2886023|NCT01909804|9934992|P10|Overall Study|Withdrew Consent|0
2886024|NCT01909804|9934993|P9|Overall Study|Withdrew Consent|0
2886025|NCT01909804|9934994|P8|Overall Study|Withdrew Consent|0
2886026|NCT01909804|9934995|P7|Overall Study|Withdrew Consent|0
2886027|NCT01909804|9934996|P6|Overall Study|Withdrew Consent|1
2886028|NCT01909804|9934997|P5|Overall Study|Withdrew Consent|1
2886029|NCT01909804|9934998|P4|Overall Study|Withdrew Consent|0
2886030|NCT01909804|9934999|P3|Overall Study|Withdrew Consent|0
2886031|NCT01909804|9935000|P2|Overall Study|Withdrew Consent|0
2886032|NCT01909804|9935001|P1|Overall Study|Withdrew Consent|0
2886033|NCT01909804|9934990|P12|Overall Study|Lack of Efficacy|1
2886034|NCT01909804|9934991|P11|Overall Study|Lack of Efficacy|0
2886035|NCT01909804|9934992|P10|Overall Study|Lack of Efficacy|1
2886036|NCT01909804|9934993|P9|Overall Study|Lack of Efficacy|0
2886037|NCT01909804|9934994|P8|Overall Study|Lack of Efficacy|1
2886038|NCT01909804|9934995|P7|Overall Study|Lack of Efficacy|1
2886039|NCT01909804|9934996|P6|Overall Study|Lack of Efficacy|3
2886040|NCT01909804|9934997|P5|Overall Study|Lack of Efficacy|7
2886041|NCT01909804|9934998|P4|Overall Study|Lack of Efficacy|0
2886042|NCT01909804|9934999|P3|Overall Study|Lack of Efficacy|0
2886043|NCT01909804|9935000|P2|Overall Study|Lack of Efficacy|1
2886044|NCT01909804|9935001|P1|Overall Study|Lack of Efficacy|4
2886045|NCT01909804|9934990|P12|Overall Study|Death|0
2886046|NCT01909804|9934991|P11|Overall Study|Death|1
2886047|NCT01909804|9934992|P10|Overall Study|Death|0
2886048|NCT01909804|9934993|P9|Overall Study|Death|0
2886049|NCT01909804|9934994|P8|Overall Study|Death|0
2886050|NCT01909804|9934995|P7|Overall Study|Death|0
2886051|NCT01909804|9934996|P6|Overall Study|Death|0
2886052|NCT01909804|9934997|P5|Overall Study|Death|0
2886053|NCT01909804|9934998|P4|Overall Study|Death|0
2886054|NCT01909804|9934999|P3|Overall Study|Death|0
2886055|NCT01909804|9935000|P2|Overall Study|Death|0
2886056|NCT01909804|9935001|P1|Overall Study|Death|0
2886057|NCT01909804|9934990|P12|Overall Study|Randomized but Never Treated|1
2886058|NCT01909804|9934991|P11|Overall Study|Randomized but Never Treated|0
2886059|NCT01909804|9934992|P10|Overall Study|Randomized but Never Treated|0
2886060|NCT01909804|9934993|P9|Overall Study|Randomized but Never Treated|0
2886061|NCT01909804|9934994|P8|Overall Study|Randomized but Never Treated|0
2886062|NCT01909804|9934995|P7|Overall Study|Randomized but Never Treated|1
2886063|NCT01909804|9934996|P6|Overall Study|Randomized but Never Treated|0
2886064|NCT01909804|9934997|P5|Overall Study|Randomized but Never Treated|0
2886065|NCT01909804|9934998|P4|Overall Study|Randomized but Never Treated|0
2886066|NCT01909804|9934999|P3|Overall Study|Randomized but Never Treated|0
2886067|NCT01909804|9935000|P2|Overall Study|Randomized but Never Treated|0
2886068|NCT01909804|9935001|P1|Overall Study|Randomized but Never Treated|0
2886069|NCT01909791|9935050|P3|Overall Study|Missed Visit|1
2886070|NCT01909791|9935051|P2|Overall Study|Missed Visit|0
2886071|NCT01909791|9935052|P1|Overall Study|Missed Visit|2
2886072|NCT01909791|9935050|P3|Overall Study|Lost to Follow-up|10
2886073|NCT01909791|9935051|P2|Overall Study|Lost to Follow-up|11
2886074|NCT01909791|9935052|P1|Overall Study|Lost to Follow-up|5
2886075|NCT01909791|9935050|P3|Overall Study|Withdrawal by Subject|13
2886076|NCT01909791|9935051|P2|Overall Study|Withdrawal by Subject|9
2886077|NCT01909791|9935052|P1|Overall Study|Withdrawal by Subject|5
2886078|NCT01909791|9935050|P3|Overall Study|Death|4
2886079|NCT01909791|9935051|P2|Overall Study|Death|8
2886080|NCT01909791|9935052|P1|Overall Study|Death|9
2886081|NCT01909778|9935110|P1|Overall Study|failed screening|1
2886082|NCT01909674|9935189|P2|Overall Study|Withdrawal by Subject|2
2886083|NCT01909674|9935190|P1|Overall Study|Withdrawal by Subject|5
2886084|NCT01909466|9935209|P2|Overall Study|Lack of Efficacy|0
2886085|NCT01909466|9935210|P1|Overall Study|Lack of Efficacy|1
2886086|NCT01909466|9935209|P2|Overall Study|Withdrawal by Subject|9
2886087|NCT01909466|9935210|P1|Overall Study|Withdrawal by Subject|11
2886088|NCT01909466|9935209|P2|Overall Study|Physician Decision|0
2886089|NCT01909466|9935210|P1|Overall Study|Physician Decision|2
2886090|NCT01909466|9935209|P2|Overall Study|Met Withdrawal Criteria|3
2886091|NCT01909466|9935210|P1|Overall Study|Met Withdrawal Criteria|0
2886092|NCT01909466|9935209|P2|Overall Study|Adverse Event|4
2886093|NCT01909466|9935210|P1|Overall Study|Adverse Event|3
2886094|NCT01909466|9935209|P2|Overall Study|Lost to Follow-up|7
2886095|NCT01909466|9935210|P1|Overall Study|Lost to Follow-up|5
2886096|NCT01909336|9935233|P3|Overall Study|Physician Decision|1
2886097|NCT01909336|9935234|P2|Overall Study|Physician Decision|1
2886098|NCT01909336|9935235|P1|Overall Study|Physician Decision|0
2886099|NCT01909336|9935233|P3|Overall Study|Lost to Follow-up|2
2886100|NCT01909336|9935234|P2|Overall Study|Lost to Follow-up|2
2886101|NCT01909336|9935235|P1|Overall Study|Lost to Follow-up|4
2886102|NCT01908907|9935333|P2|Overall Study|Protocol Violation|0
2886103|NCT01908907|9935334|P1|Overall Study|Protocol Violation|1
2886104|NCT01908907|9935333|P2|Overall Study|Physician Decision|0
2886105|NCT01908907|9935334|P1|Overall Study|Physician Decision|1
2886106|NCT01908829|9935378|P3|Overall Study|Withdrawal by Subject|22
2886107|NCT01908829|9935379|P2|Overall Study|Withdrawal by Subject|29
2886108|NCT01908829|9935380|P1|Overall Study|Withdrawal by Subject|26
2886109|NCT01908829|9935378|P3|Overall Study|Lack of Efficacy|2
2886110|NCT01908829|9935379|P2|Overall Study|Lack of Efficacy|3
2886111|NCT01908829|9935380|P1|Overall Study|Lack of Efficacy|1
2886112|NCT01908829|9935378|P3|Overall Study|Protocol Violation|0
2886113|NCT01908829|9935379|P2|Overall Study|Protocol Violation|2
2886114|NCT01908829|9935380|P1|Overall Study|Protocol Violation|2
2886115|NCT01908829|9935378|P3|Overall Study|Miscellaneous|0
2886116|NCT01908829|9935379|P2|Overall Study|Miscellaneous|2
2886117|NCT01908829|9935380|P1|Overall Study|Miscellaneous|0
2886118|NCT01908829|9935378|P3|Overall Study|Discontinued (no EoT page)|0
2886119|NCT01908829|9935379|P2|Overall Study|Discontinued (no EoT page)|0
2886120|NCT01908829|9935380|P1|Overall Study|Discontinued (no EoT page)|2
2886121|NCT01908829|9935378|P3|Overall Study|Randomized no double-blind drug received|1
2886122|NCT01908829|9935379|P2|Overall Study|Randomized no double-blind drug received|0
2886123|NCT01908829|9935380|P1|Overall Study|Randomized no double-blind drug received|1
2886124|NCT01908829|9935378|P3|Overall Study|Lost to Follow-up|1
2886125|NCT01908829|9935379|P2|Overall Study|Lost to Follow-up|2
2886126|NCT01908829|9935380|P1|Overall Study|Lost to Follow-up|4
2886127|NCT01908829|9935378|P3|Overall Study|Adverse Event|13
2886128|NCT01908829|9935379|P2|Overall Study|Adverse Event|11
2886129|NCT01908829|9935380|P1|Overall Study|Adverse Event|13
2886130|NCT01908816|9935497|P4|Overall Study|Early termination|28
2886131|NCT01908816|9935498|P3|Overall Study|Early termination|43
2886132|NCT01908816|9935499|P2|Overall Study|Early termination|60
2886133|NCT01908816|9935500|P1|Overall Study|Early termination|87
2886134|NCT01908816|9935497|P4|Overall Study|Unsatisfactory therapeutic effect|0
2886135|NCT01908816|9935498|P3|Overall Study|Unsatisfactory therapeutic effect|1
2886136|NCT01908816|9935499|P2|Overall Study|Unsatisfactory therapeutic effect|13
2886137|NCT01908816|9935500|P1|Overall Study|Unsatisfactory therapeutic effect|1
2886138|NCT01908816|9935497|P4|Overall Study|Death|1
2886139|NCT01908816|9935498|P3|Overall Study|Death|7
2886140|NCT01908816|9935499|P2|Overall Study|Death|0
2886141|NCT01908816|9935500|P1|Overall Study|Death|1
2886142|NCT01908816|9935497|P4|Overall Study|Lost to Follow-up|2
2886143|NCT01908816|9935498|P3|Overall Study|Lost to Follow-up|4
2886144|NCT01908816|9935499|P2|Overall Study|Lost to Follow-up|5
2886145|NCT01908816|9935500|P1|Overall Study|Lost to Follow-up|3
2886146|NCT01908816|9935497|P4|Overall Study|Withdrawal by Subject|2
2886147|NCT01908816|9935498|P3|Overall Study|Withdrawal by Subject|2
2886148|NCT01908816|9935499|P2|Overall Study|Withdrawal by Subject|4
2886149|NCT01908816|9935500|P1|Overall Study|Withdrawal by Subject|0
2886150|NCT01908816|9935497|P4|Overall Study|Protocol deviation|1
2886151|NCT01908816|9935498|P3|Overall Study|Protocol deviation|1
2886152|NCT01908816|9935499|P2|Overall Study|Protocol deviation|2
2886153|NCT01908816|9935500|P1|Overall Study|Protocol deviation|1
2886154|NCT01908816|9935497|P4|Overall Study|Subject's no longer requires study drug|1
2886155|NCT01908816|9935498|P3|Overall Study|Subject's no longer requires study drug|0
2886156|NCT01908816|9935499|P2|Overall Study|Subject's no longer requires study drug|0
2886157|NCT01908816|9935500|P1|Overall Study|Subject's no longer requires study drug|0
2886158|NCT01908803|9935525|P2|Overall Study|Adverse Event (pre-treatment)|0
2886159|NCT01908803|9935526|P1|Overall Study|Adverse Event (pre-treatment)|1
2886160|NCT01908803|9935525|P2|Overall Study|Randomization Error|0
2886161|NCT01908803|9935526|P1|Overall Study|Randomization Error|1
2886162|NCT01908803|9935525|P2|Overall Study|Withdrawal by Subject|0
2886163|NCT01908803|9935526|P1|Overall Study|Withdrawal by Subject|1
2886164|NCT01908803|9935525|P2|Overall Study|Physician Decision|1
2886165|NCT01908803|9935526|P1|Overall Study|Physician Decision|0
2886166|NCT01908803|9935525|P2|Overall Study|Adverse Event|0
2886167|NCT01908803|9935526|P1|Overall Study|Adverse Event|1
2886168|NCT01908699|9935539|P2|Overall Study|Progressive Disease|29
2886169|NCT01908699|9935540|P1|Overall Study|Progressive Disease|30
2886170|NCT01908699|9935539|P2|Overall Study|Death|12
2886171|NCT01908699|9935540|P1|Overall Study|Death|9
2886172|NCT01908699|9935539|P2|Overall Study|Randomized in Error|0
2886173|NCT01908699|9935540|P1|Overall Study|Randomized in Error|1
2886174|NCT01908699|9935539|P2|Overall Study|Pregnancy|1
2886175|NCT01908699|9935540|P1|Overall Study|Pregnancy|0
2886176|NCT01908699|9935539|P2|Overall Study|Withdrawal by Subject|10
2886177|NCT01908699|9935540|P1|Overall Study|Withdrawal by Subject|15
2886178|NCT01908699|9935539|P2|Overall Study|Physician Decision|8
2886179|NCT01908699|9935540|P1|Overall Study|Physician Decision|8
2886180|NCT01908699|9935539|P2|Overall Study|Lost to Follow-up|4
2886181|NCT01908699|9935540|P1|Overall Study|Lost to Follow-up|2
2886182|NCT01908699|9935539|P2|Overall Study|Lack of Efficacy|2
2886183|NCT01908699|9935540|P1|Overall Study|Lack of Efficacy|2
2886184|NCT01908699|9935539|P2|Overall Study|Adverse Event|12
2886185|NCT01908699|9935540|P1|Overall Study|Adverse Event|8
2886186|NCT01908582|9935556|P1|Period 2|Withdrawal by Subject|1
2886187|NCT01908582|9935556|P1|Period 2|Physician Decision|1
2886188|NCT01908426|9935600|P2|Overall Study|No Study Treatment Given|0
2886189|NCT01908426|9935601|P1|Overall Study|No Study Treatment Given|3
2886190|NCT01908426|9935600|P2|Overall Study|Protocol Violation|0
2886191|NCT01908426|9935601|P1|Overall Study|Protocol Violation|1
2886192|NCT01908426|9935600|P2|Overall Study|Progressive Disease|152
2886193|NCT01908426|9935601|P1|Overall Study|Progressive Disease|206
2886194|NCT01908426|9935600|P2|Overall Study|Withdrawal by Subject|6
2886195|NCT01908426|9935601|P1|Overall Study|Withdrawal by Subject|11
2886196|NCT01908426|9935600|P2|Overall Study|Physician Decision|3
2886197|NCT01908426|9935601|P1|Overall Study|Physician Decision|3
2886198|NCT01908426|9935600|P2|Overall Study|Lost to Follow-up|1
2886199|NCT01908426|9935601|P1|Overall Study|Lost to Follow-up|0
2886200|NCT01908426|9935600|P2|Overall Study|Lack of Efficacy|0
2886201|NCT01908426|9935601|P1|Overall Study|Lack of Efficacy|3
2886202|NCT01908426|9935600|P2|Overall Study|Clinical Deterioration|38
2886203|NCT01908426|9935601|P1|Overall Study|Clinical Deterioration|72
2886204|NCT01908426|9935600|P2|Overall Study|Adverse Event|11
2886205|NCT01908426|9935601|P1|Overall Study|Adverse Event|98
2886206|NCT01908140|9935613|P2|Overall Study|Adverse Event|23
2886207|NCT01908140|9935614|P1|Overall Study|Adverse Event|22
2886208|NCT01908140|9935613|P2|Overall Study|Protocol Violation|9
2886209|NCT01908140|9935614|P1|Overall Study|Protocol Violation|8
2886210|NCT01908140|9935613|P2|Overall Study|Lost to Follow-up|6
2886211|NCT01908140|9935614|P1|Overall Study|Lost to Follow-up|1
2886212|NCT01908140|9935613|P2|Overall Study|Withdrawal by Subject|24
2886213|NCT01908140|9935614|P1|Overall Study|Withdrawal by Subject|23
2886214|NCT01908140|9935613|P2|Overall Study|Lack of Efficacy|5
2886215|NCT01908140|9935614|P1|Overall Study|Lack of Efficacy|7
2886216|NCT01908140|9935613|P2|Overall Study|Other or Progressive Disease|12
2886217|NCT01908140|9935614|P1|Overall Study|Other or Progressive Disease|5
2886218|NCT01907906|9935663|P2|Overall Study|Physician Decision|1
2886219|NCT01907906|9935664|P1|Overall Study|Physician Decision|3
2886220|NCT01907906|9935663|P2|Overall Study|Withdrawal by Subject|0
2886221|NCT01907906|9935664|P1|Overall Study|Withdrawal by Subject|1
2886222|NCT01907854|9935744|P2|Overall Study|Unclassified|3
2886223|NCT01907854|9935745|P1|Overall Study|Unclassified|4
2886224|NCT01907854|9935744|P2|Overall Study|Lost to Follow-up|2
2886225|NCT01907854|9935745|P1|Overall Study|Lost to Follow-up|2
2886226|NCT01907854|9935744|P2|Overall Study|Withdrawal by Subject|7
2886227|NCT01907854|9935745|P1|Overall Study|Withdrawal by Subject|9
2886228|NCT01907854|9935744|P2|Overall Study|Protocol Violation|1
2886229|NCT01907854|9935745|P1|Overall Study|Protocol Violation|1
2886230|NCT01907828|9935765|P2|Overall Study|Participant met exclusion criteria|1
2886231|NCT01907828|9935766|P1|Overall Study|Participant met exclusion criteria|0
2886232|NCT01907828|9935765|P2|Overall Study|Participant refused 24-month follow-up|0
2886233|NCT01907828|9935766|P1|Overall Study|Participant refused 24-month follow-up|1
2886234|NCT01907828|9935765|P2|Overall Study|Lost to Follow-up|0
2886235|NCT01907828|9935766|P1|Overall Study|Lost to Follow-up|3
2886236|NCT01907828|9935765|P2|Overall Study|Withdrawal by Subject|4
2886237|NCT01907828|9935766|P1|Overall Study|Withdrawal by Subject|3
2886238|NCT01907828|9935765|P2|Overall Study|Exclusion criteria not met|1
2886239|NCT01907828|9935766|P1|Overall Study|Exclusion criteria not met|0
2886240|NCT01907815|9935794|P2|Overall Study|Withdrawal by Subject|0
2886241|NCT01907815|9935795|P1|Overall Study|Withdrawal by Subject|1
2886242|NCT01907737|9935809|P1|Overall Study|Withdrawal by Subject|1
2886243|NCT01907516|9935821|P2|First Intervention (3 Weeks)|Developed DKA during study|0
2886244|NCT01907516|9935822|P1|First Intervention (3 Weeks)|Developed DKA during study|1
2886245|NCT01907516|9935821|P2|First Intervention (3 Weeks)|Delivered before second arm|4
2886246|NCT01907516|9935822|P1|First Intervention (3 Weeks)|Delivered before second arm|3
2886247|NCT01907516|9935821|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
2886248|NCT01907516|9935822|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
2886249|NCT01907516|9935821|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
2886250|NCT01907516|9935822|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
2886251|NCT01907217|9935866|P2|Overall Study|Withdrawal by Subject|2
2886252|NCT01907217|9935867|P1|Overall Study|Withdrawal by Subject|0
2886253|NCT01907100|9935979|P4|Overall Study|Worsening/AE underlying cancer disease|8
2886254|NCT01907100|9935980|P3|Overall Study|Worsening/AE underlying cancer disease|8
2886255|NCT01907100|9935981|P2|Overall Study|Worsening/AE underlying cancer disease|0
2886256|NCT01907100|9935982|P1|Overall Study|Worsening/AE underlying cancer disease|0
2886257|NCT01907100|9935979|P4|Overall Study|Adverse event (AE)|23
2886258|NCT01907100|9935980|P3|Overall Study|Adverse event (AE)|22
2886259|NCT01907100|9935981|P2|Overall Study|Adverse event (AE)|3
2886260|NCT01907100|9935982|P1|Overall Study|Adverse event (AE)|6
2886261|NCT01907100|9935979|P4|Overall Study|Other than reasons specified|6
2886262|NCT01907100|9935980|P3|Overall Study|Other than reasons specified|10
2886263|NCT01907100|9935981|P2|Overall Study|Other than reasons specified|0
2886264|NCT01907100|9935982|P1|Overall Study|Other than reasons specified|1
2886265|NCT01907100|9935979|P4|Overall Study|Not treated|2
2886266|NCT01907100|9935980|P3|Overall Study|Not treated|1
2886267|NCT01907100|9935981|P2|Overall Study|Not treated|0
2886268|NCT01907100|9935982|P1|Overall Study|Not treated|2
2886269|NCT01907100|9935979|P4|Overall Study|Lost to Follow-up|1
2886270|NCT01907100|9935980|P3|Overall Study|Lost to Follow-up|0
2886271|NCT01907100|9935981|P2|Overall Study|Lost to Follow-up|0
2886272|NCT01907100|9935982|P1|Overall Study|Lost to Follow-up|0
2886273|NCT01907100|9935979|P4|Overall Study|Protocol Violation|1
2886274|NCT01907100|9935980|P3|Overall Study|Protocol Violation|1
2886275|NCT01907100|9935981|P2|Overall Study|Protocol Violation|0
2886276|NCT01907100|9935982|P1|Overall Study|Protocol Violation|0
2886277|NCT01907100|9935979|P4|Overall Study|Withdrawal by Subject|13
2886278|NCT01907100|9935980|P3|Overall Study|Withdrawal by Subject|10
2886279|NCT01907100|9935981|P2|Overall Study|Withdrawal by Subject|5
2886280|NCT01907100|9935982|P1|Overall Study|Withdrawal by Subject|2
2886281|NCT01907100|9935979|P4|Overall Study|PD based on modified RECIST criteria|92
2886282|NCT01907100|9935980|P3|Overall Study|PD based on modified RECIST criteria|95
2886283|NCT01907100|9935981|P2|Overall Study|PD based on modified RECIST criteria|32
2886284|NCT01907100|9935982|P1|Overall Study|PD based on modified RECIST criteria|31
2886285|NCT01907087|9935996|P1|Overall Study|Withdrawal by Subject|1
2886286|NCT01906476|9936059|P2|Overall Study|Lost to Follow-up|16
2886287|NCT01906476|9936060|P1|Overall Study|Lost to Follow-up|17
2886288|NCT01906372|9936068|P1|Overall Study|Withdrawal by Subject|2
2886289|NCT01906346|9936073|P1|Overall Study|AEs|1
2886290|NCT01906008|9936081|P2|Overall Study|Adverse Event|3
2886291|NCT01906008|9936082|P1|Overall Study|Adverse Event|0
2886292|NCT01906008|9936081|P2|Overall Study|Lack of compliance of study med|3
2886293|NCT01906008|9936082|P1|Overall Study|Lack of compliance of study med|5
2886294|NCT01906008|9936081|P2|Overall Study|Physician Decision|3
2886295|NCT01906008|9936082|P1|Overall Study|Physician Decision|3
2886296|NCT01906008|9936081|P2|Overall Study|Hospice|0
2886297|NCT01906008|9936082|P1|Overall Study|Hospice|1
2886298|NCT01906008|9936081|P2|Overall Study|Oxaliplatin stops|8
2886299|NCT01906008|9936082|P1|Overall Study|Oxaliplatin stops|10
2886300|NCT01906008|9936081|P2|Overall Study|Did not start study med|4
2886301|NCT01906008|9936082|P1|Overall Study|Did not start study med|3
2886302|NCT01906008|9936081|P2|Overall Study|Withdrawal by Subject|5
2886303|NCT01906008|9936082|P1|Overall Study|Withdrawal by Subject|1
2886304|NCT01906008|9936081|P2|Overall Study|Protocol Violation|1
2886305|NCT01906008|9936082|P1|Overall Study|Protocol Violation|0
2886306|NCT01906008|9936081|P2|Overall Study|Oxaliplatin toxicity|0
2886307|NCT01906008|9936082|P1|Overall Study|Oxaliplatin toxicity|2
2886308|NCT01906008|9936081|P2|Overall Study|Lost to Follow-up|0
2886309|NCT01906008|9936082|P1|Overall Study|Lost to Follow-up|2
2886310|NCT01905943|9936115|P1|Overall Study|Other|12
2886311|NCT01905943|9936115|P1|Overall Study|Adverse Event|3
2886312|NCT01905943|9936115|P1|Overall Study|Death|186
2886313|NCT01905943|9936115|P1|Overall Study|Investigator discretion|7
2886314|NCT01905943|9936115|P1|Overall Study|Lost to Follow-up|16
2886315|NCT01905943|9936115|P1|Overall Study|Withdrawal of consent|90
2886316|NCT01905683|9936232|P1|Overall Study|Lost to Follow-up|4
2886317|NCT01905683|9936232|P1|Overall Study|Adverse Event|4
2886318|NCT01905683|9936232|P1|Overall Study|Withdrawal by Subject|20
2886319|NCT01905683|9936232|P1|Overall Study|Lack of Efficacy|8
2886320|NCT01905683|9936232|P1|Overall Study|Physician Decision|1
2886321|NCT01905683|9936232|P1|Overall Study|Re-injection criteria not met; others|13
2886322|NCT01905683|9936232|P1|Overall Study|Protocol Violation|1
2886323|NCT01905657|9936248|P3|Overall Study|Excluded from Efficacy Analysis|0
2886324|NCT01905657|9936249|P2|Overall Study|Excluded from Efficacy Analysis|0
2886325|NCT01905657|9936250|P1|Overall Study|Excluded from Efficacy Analysis|1
2886326|NCT01905657|9936248|P3|Overall Study|Continuing in Study|11
2886327|NCT01905657|9936249|P2|Overall Study|Continuing in Study|74
2886328|NCT01905657|9936250|P1|Overall Study|Continuing in Study|74
2886329|NCT01905657|9936248|P3|Overall Study|Withdrawal by Subject|45
2886330|NCT01905657|9936249|P2|Overall Study|Withdrawal by Subject|10
2886331|NCT01905657|9936250|P1|Overall Study|Withdrawal by Subject|5
2886332|NCT01905657|9936248|P3|Overall Study|Protocol Violation|1
2886333|NCT01905657|9936249|P2|Overall Study|Protocol Violation|1
2886334|NCT01905657|9936250|P1|Overall Study|Protocol Violation|2
2886335|NCT01905657|9936248|P3|Overall Study|Progressive Disease|89
2886336|NCT01905657|9936249|P2|Overall Study|Progressive Disease|126
2886337|NCT01905657|9936250|P1|Overall Study|Progressive Disease|124
2886338|NCT01905657|9936248|P3|Overall Study|Physician Decision|113
2886339|NCT01905657|9936249|P2|Overall Study|Physician Decision|74
2886340|NCT01905657|9936250|P1|Overall Study|Physician Decision|82
2886341|NCT01905657|9936248|P3|Overall Study|Other|1
2886342|NCT01905657|9936249|P2|Overall Study|Other|7
2886343|NCT01905657|9936250|P1|Overall Study|Other|3
2886344|NCT01905657|9936248|P3|Overall Study|Death|21
2886345|NCT01905657|9936249|P2|Overall Study|Death|21
2886346|NCT01905657|9936250|P1|Overall Study|Death|21
2886347|NCT01905657|9936248|P3|Overall Study|Adverse Event|47
2886348|NCT01905657|9936249|P2|Overall Study|Adverse Event|32
2886349|NCT01905657|9936250|P1|Overall Study|Adverse Event|33
2886350|NCT01905657|9936248|P3|Overall Study|Not Treated|0
2886351|NCT01905657|9936249|P2|Overall Study|Not Treated|1
2886352|NCT01905657|9936250|P1|Overall Study|Not Treated|0
2886353|NCT01905553|9936275|P2|Period 2|Adverse Event|0
2886354|NCT01905553|9936276|P1|Period 2|Adverse Event|1
2886355|NCT01905540|9936290|P4|Period 3|Other|1
2886356|NCT01905540|9936291|P3|Period 3|Other|1
2886357|NCT01905540|9936292|P2|Period 3|Other|0
2886358|NCT01905540|9936293|P1|Period 3|Other|1
2886359|NCT01905267|9936328|P2|Overall Study|Physician Decision|2
2886360|NCT01905267|9936329|P1|Overall Study|Physician Decision|2
2886361|NCT01904773|9936350|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886362|NCT01904773|9936351|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886363|NCT01904773|9936352|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886364|NCT01904773|9936353|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886365|NCT01904773|9936354|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886366|NCT01904773|9936355|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886367|NCT01904773|9936356|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886368|NCT01904773|9936357|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
2886369|NCT01904773|9936358|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2886370|NCT01904773|9936350|P9|Fifth Intervention|Adverse Event|0
2886371|NCT01904773|9936351|P8|Fifth Intervention|Adverse Event|1
2886372|NCT01904773|9936352|P7|Fifth Intervention|Adverse Event|0
2886373|NCT01904773|9936353|P6|Fifth Intervention|Adverse Event|0
2886374|NCT01904773|9936354|P5|Fifth Intervention|Adverse Event|0
2886375|NCT01904773|9936355|P4|Fifth Intervention|Adverse Event|0
2886376|NCT01904773|9936356|P3|Fifth Intervention|Adverse Event|0
2886377|NCT01904773|9936357|P2|Fifth Intervention|Adverse Event|0
2886378|NCT01904773|9936358|P1|Fifth Intervention|Adverse Event|0
2886379|NCT01904773|9936350|P9|Placebo Washout First Intervention|Condition worsened|0
2886380|NCT01904773|9936351|P8|Placebo Washout First Intervention|Condition worsened|0
2886381|NCT01904773|9936352|P7|Placebo Washout First Intervention|Condition worsened|0
2886382|NCT01904773|9936353|P6|Placebo Washout First Intervention|Condition worsened|0
2886383|NCT01904773|9936354|P5|Placebo Washout First Intervention|Condition worsened|0
2886384|NCT01904773|9936355|P4|Placebo Washout First Intervention|Condition worsened|0
2886385|NCT01904773|9936356|P3|Placebo Washout First Intervention|Condition worsened|0
2886386|NCT01904773|9936357|P2|Placebo Washout First Intervention|Condition worsened|1
2886387|NCT01904773|9936358|P1|Placebo Washout First Intervention|Condition worsened|0
2886388|NCT01904773|9936350|P9|First Intervention|Adverse Event|0
2886389|NCT01904773|9936351|P8|First Intervention|Adverse Event|0
2886390|NCT01904773|9936352|P7|First Intervention|Adverse Event|1
2886391|NCT01904773|9936353|P6|First Intervention|Adverse Event|0
2886392|NCT01904773|9936354|P5|First Intervention|Adverse Event|0
2886393|NCT01904773|9936355|P4|First Intervention|Adverse Event|0
2886394|NCT01904773|9936356|P3|First Intervention|Adverse Event|0
2886395|NCT01904773|9936357|P2|First Intervention|Adverse Event|0
2886396|NCT01904773|9936358|P1|First Intervention|Adverse Event|0
2886397|NCT01904773|9936350|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886398|NCT01904773|9936351|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886399|NCT01904773|9936352|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886400|NCT01904773|9936353|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886401|NCT01904773|9936354|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886402|NCT01904773|9936355|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886403|NCT01904773|9936356|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886404|NCT01904773|9936357|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2886405|NCT01904773|9936358|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
2886406|NCT01904773|9936350|P9|Screen|Withdrawal by Subject|0
2886407|NCT01904773|9936351|P8|Screen|Withdrawal by Subject|0
2886408|NCT01904773|9936352|P7|Screen|Withdrawal by Subject|0
2886409|NCT01904773|9936353|P6|Screen|Withdrawal by Subject|0
2886410|NCT01904773|9936354|P5|Screen|Withdrawal by Subject|0
2886411|NCT01904773|9936355|P4|Screen|Withdrawal by Subject|0
2886412|NCT01904773|9936356|P3|Screen|Withdrawal by Subject|0
2886413|NCT01904773|9936357|P2|Screen|Withdrawal by Subject|0
2886414|NCT01904773|9936358|P1|Screen|Withdrawal by Subject|1
2886415|NCT01904773|9936350|P9|Screen|Screen failure|0
2886416|NCT01904773|9936351|P8|Screen|Screen failure|0
2886417|NCT01904773|9936352|P7|Screen|Screen failure|0
2886418|NCT01904773|9936353|P6|Screen|Screen failure|0
2886419|NCT01904773|9936354|P5|Screen|Screen failure|0
2886420|NCT01904773|9936355|P4|Screen|Screen failure|0
2886421|NCT01904773|9936356|P3|Screen|Screen failure|0
2886422|NCT01904773|9936357|P2|Screen|Screen failure|0
2886423|NCT01904773|9936358|P1|Screen|Screen failure|3
2886424|NCT01904760|9936375|P2|Overall Study|Protocol Violation|0
2886425|NCT01904760|9936376|P1|Overall Study|Protocol Violation|1
2886426|NCT01904721|9936391|P7|Overall Study|Adverse Event|0
2886427|NCT01904721|9936392|P6|Overall Study|Adverse Event|1
2886428|NCT01904721|9936393|P5|Overall Study|Adverse Event|3
2886429|NCT01904721|9936394|P4|Overall Study|Adverse Event|0
2886430|NCT01904721|9936395|P3|Overall Study|Adverse Event|0
2886431|NCT01904721|9936396|P2|Overall Study|Adverse Event|0
2886432|NCT01904721|9936397|P1|Overall Study|Adverse Event|0
2886433|NCT01904721|9936391|P7|Overall Study|Lack of Efficacy|1
2886434|NCT01904721|9936392|P6|Overall Study|Lack of Efficacy|0
2886435|NCT01904721|9936393|P5|Overall Study|Lack of Efficacy|0
2886436|NCT01904721|9936394|P4|Overall Study|Lack of Efficacy|0
2886437|NCT01904721|9936395|P3|Overall Study|Lack of Efficacy|0
2886438|NCT01904721|9936396|P2|Overall Study|Lack of Efficacy|0
2886439|NCT01904721|9936397|P1|Overall Study|Lack of Efficacy|0
2886440|NCT01904721|9936391|P7|Overall Study|Lost to Follow-up|1
2886441|NCT01904721|9936392|P6|Overall Study|Lost to Follow-up|3
2886442|NCT01904721|9936393|P5|Overall Study|Lost to Follow-up|1
2886443|NCT01904721|9936394|P4|Overall Study|Lost to Follow-up|0
2886444|NCT01904721|9936395|P3|Overall Study|Lost to Follow-up|0
2886445|NCT01904721|9936396|P2|Overall Study|Lost to Follow-up|0
2886446|NCT01904721|9936397|P1|Overall Study|Lost to Follow-up|0
2886447|NCT01904721|9936391|P7|Overall Study|Personal Reasons|3
2886448|NCT01904721|9936392|P6|Overall Study|Personal Reasons|3
2886449|NCT01904721|9936393|P5|Overall Study|Personal Reasons|2
2886450|NCT01904721|9936394|P4|Overall Study|Personal Reasons|0
2886451|NCT01904721|9936395|P3|Overall Study|Personal Reasons|0
2886452|NCT01904721|9936396|P2|Overall Study|Personal Reasons|0
2886453|NCT01904721|9936397|P1|Overall Study|Personal Reasons|0
2886454|NCT01904721|9936391|P7|Overall Study|Other Reasons|2
2886455|NCT01904721|9936392|P6|Overall Study|Other Reasons|2
2886456|NCT01904721|9936393|P5|Overall Study|Other Reasons|2
2886457|NCT01904721|9936394|P4|Overall Study|Other Reasons|1
2886458|NCT01904721|9936395|P3|Overall Study|Other Reasons|1
2886459|NCT01904721|9936396|P2|Overall Study|Other Reasons|0
2886460|NCT01904721|9936397|P1|Overall Study|Other Reasons|0
2886461|NCT01904604|9936427|P3|Overall Study|Lost to Follow-up|1
2886462|NCT01904604|9936428|P2|Overall Study|Lost to Follow-up|0
2886463|NCT01904604|9936429|P1|Overall Study|Lost to Follow-up|0
2886464|NCT01904604|9936427|P3|Overall Study|Participant Relocated|1
2886465|NCT01904604|9936428|P2|Overall Study|Participant Relocated|1
2886466|NCT01904604|9936429|P1|Overall Study|Participant Relocated|1
2886467|NCT01904604|9936427|P3|Overall Study|Withdrawal by Subject|0
2886468|NCT01904604|9936428|P2|Overall Study|Withdrawal by Subject|2
2886469|NCT01904604|9936429|P1|Overall Study|Withdrawal by Subject|1
2886470|NCT01904604|9936427|P3|Overall Study|Passed Week 52 OFC|0
2886471|NCT01904604|9936428|P2|Overall Study|Passed Week 52 OFC|0
2886472|NCT01904604|9936429|P1|Overall Study|Passed Week 52 OFC|1
2886473|NCT01904604|9936427|P3|Overall Study|Unrelated illness|0
2886474|NCT01904604|9936428|P2|Overall Study|Unrelated illness|1
2886475|NCT01904604|9936429|P1|Overall Study|Unrelated illness|0
2886476|NCT01904604|9936427|P3|Overall Study|Increased syncope|0
2886477|NCT01904604|9936428|P2|Overall Study|Increased syncope|1
2886478|NCT01904604|9936429|P1|Overall Study|Increased syncope|0
2886479|NCT01904604|9936427|P3|Overall Study|Patch site reactions|0
2886480|NCT01904604|9936428|P2|Overall Study|Patch site reactions|1
2886481|NCT01904604|9936429|P1|Overall Study|Patch site reactions|1
2886482|NCT01904604|9936427|P3|Overall Study|Anxiety about OFC/Refused OFC|0
2886483|NCT01904604|9936428|P2|Overall Study|Anxiety about OFC/Refused OFC|0
2886484|NCT01904604|9936429|P1|Overall Study|Anxiety about OFC/Refused OFC|2
2886485|NCT01904604|9936427|P3|Overall Study|Non-compliance|0
2886486|NCT01904604|9936428|P2|Overall Study|Non-compliance|0
2886487|NCT01904604|9936429|P1|Overall Study|Non-compliance|1
2886488|NCT01904604|9936427|P3|Overall Study|Withdrew before receiving dosing|0
2886489|NCT01904604|9936428|P2|Overall Study|Withdrew before receiving dosing|1
2886490|NCT01904604|9936429|P1|Overall Study|Withdrew before receiving dosing|0
2886491|NCT01904383|9936494|P1|Overall Study|No patient visit after entry|54
2886492|NCT01904383|9936494|P1|Overall Study|Adverse Event|271
2886493|NCT01904383|9936494|P1|Overall Study|Improvement|141
2886494|NCT01904383|9936494|P1|Overall Study|Lack of Efficacy|370
2886495|NCT01904383|9936494|P1|Overall Study|Lost to Follow-up|674
2886496|NCT01904383|9936494|P1|Overall Study|Reason not listed|147
2886497|NCT01904383|9936494|P1|Overall Study|CRF not collected|117
2886498|NCT01904279|9936501|P2|Overall Study|Withdrawal by Subject|0
2886499|NCT01904279|9936502|P1|Overall Study|Withdrawal by Subject|1
2886500|NCT01904279|9936501|P2|Overall Study|Lack of Efficacy|3
2886501|NCT01904279|9936502|P1|Overall Study|Lack of Efficacy|2
2886502|NCT01904149|9936528|P6|Overall Study|non compliance with study drug|0
2886503|NCT01904149|9936529|P5|Overall Study|non compliance with study drug|0
2886504|NCT01904149|9936530|P4|Overall Study|non compliance with study drug|0
2886505|NCT01904149|9936531|P3|Overall Study|non compliance with study drug|0
2886506|NCT01904149|9936532|P2|Overall Study|non compliance with study drug|0
2886507|NCT01904149|9936533|P1|Overall Study|non compliance with study drug|1
2886508|NCT01904149|9936528|P6|Overall Study|Protocol Violation|0
2886509|NCT01904149|9936529|P5|Overall Study|Protocol Violation|0
2886510|NCT01904149|9936530|P4|Overall Study|Protocol Violation|0
2886511|NCT01904149|9936531|P3|Overall Study|Protocol Violation|0
2886512|NCT01904149|9936532|P2|Overall Study|Protocol Violation|1
2886513|NCT01904149|9936533|P1|Overall Study|Protocol Violation|0
2886514|NCT01904149|9936528|P6|Overall Study|Withdrawal by Subject|0
2886515|NCT01904149|9936529|P5|Overall Study|Withdrawal by Subject|1
2886516|NCT01904149|9936530|P4|Overall Study|Withdrawal by Subject|0
2886517|NCT01904149|9936531|P3|Overall Study|Withdrawal by Subject|1
2886518|NCT01904149|9936532|P2|Overall Study|Withdrawal by Subject|3
2886519|NCT01904149|9936533|P1|Overall Study|Withdrawal by Subject|1
2886520|NCT01904149|9936528|P6|Overall Study|Lack of Efficacy|1
2886521|NCT01904149|9936529|P5|Overall Study|Lack of Efficacy|3
2886522|NCT01904149|9936530|P4|Overall Study|Lack of Efficacy|3
2886523|NCT01904149|9936531|P3|Overall Study|Lack of Efficacy|1
2886524|NCT01904149|9936532|P2|Overall Study|Lack of Efficacy|3
2886525|NCT01904149|9936533|P1|Overall Study|Lack of Efficacy|0
2886526|NCT01904149|9936528|P6|Overall Study|Adverse Event|2
2886527|NCT01904149|9936529|P5|Overall Study|Adverse Event|1
2886528|NCT01904149|9936530|P4|Overall Study|Adverse Event|1
2886529|NCT01904149|9936531|P3|Overall Study|Adverse Event|0
2886530|NCT01904149|9936532|P2|Overall Study|Adverse Event|4
2886531|NCT01904149|9936533|P1|Overall Study|Adverse Event|3
2886532|NCT01904058|9936584|P4|Overall Study|Pregnancy|1
2886533|NCT01904058|9936585|P3|Overall Study|Pregnancy|0
2886534|NCT01904058|9936586|P2|Overall Study|Pregnancy|0
2886535|NCT01904058|9936587|P1|Overall Study|Pregnancy|0
2886536|NCT01904058|9936584|P4|Overall Study|Withdrawal by Subject|0
2886537|NCT01904058|9936585|P3|Overall Study|Withdrawal by Subject|1
2886538|NCT01904058|9936586|P2|Overall Study|Withdrawal by Subject|0
2886539|NCT01904058|9936587|P1|Overall Study|Withdrawal by Subject|1
2886540|NCT01904058|9936584|P4|Overall Study|Adverse Event|0
2886541|NCT01904058|9936585|P3|Overall Study|Adverse Event|0
2886542|NCT01904058|9936586|P2|Overall Study|Adverse Event|0
2886543|NCT01904058|9936587|P1|Overall Study|Adverse Event|2
2886544|NCT01903993|9936627|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
2886545|NCT01903993|9936628|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
2886546|NCT01903993|9936627|P2|Overall Study|Study Terminated by Sponsor|14
2886547|NCT01903993|9936628|P1|Overall Study|Study Terminated by Sponsor|8
2886548|NCT01903993|9936627|P2|Overall Study|Lost to Follow-up|3
2886549|NCT01903993|9936628|P1|Overall Study|Lost to Follow-up|2
2886550|NCT01903993|9936627|P2|Overall Study|Withdrawal by Subject|4
2886551|NCT01903993|9936628|P1|Overall Study|Withdrawal by Subject|15
2886552|NCT01903993|9936627|P2|Overall Study|Death|121
2886553|NCT01903993|9936628|P1|Overall Study|Death|118
2886554|NCT01903876|9936645|P2|Six-Month Follow-up Period|Lost to Follow-up|145
2886555|NCT01903876|9936646|P1|Six-Month Follow-up Period|Lost to Follow-up|91
2886556|NCT01903876|9936645|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
2886557|NCT01903876|9936646|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
2886558|NCT01903863|9936656|P2|Overall Study|Physician Decision|0
2886559|NCT01903863|9936657|P1|Overall Study|Physician Decision|2
2886560|NCT01903811|9936679|P2|Overall Study|Withdrawal by Subject|1
2886561|NCT01903811|9936680|P1|Overall Study|Withdrawal by Subject|0
2886562|NCT01903811|9936679|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
2886563|NCT01903811|9936680|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
2886564|NCT01903811|9936679|P2|Overall Study|Incomplete/discontinued prior therapy|1
2886565|NCT01903811|9936680|P1|Overall Study|Incomplete/discontinued prior therapy|1
2886566|NCT01903811|9936679|P2|Overall Study|No measurable disease|1
2886567|NCT01903811|9936680|P1|Overall Study|No measurable disease|1
2886568|NCT01903720|9936714|P1|Overall Study|Treatment with alternative drug|1
2886569|NCT01903720|9936714|P1|Overall Study|Lost to Follow-up|2
2886570|NCT01903720|9936714|P1|Overall Study|Rescinding of informed consent|2
2886571|NCT01903720|9936714|P1|Overall Study|Adverse Event|1
2886572|NCT01903720|9936714|P1|Overall Study|Inclusion / exclusion criteria not met|6
2886573|NCT01903460|9936752|P4|Overall Study|Adverse Event|1
2886574|NCT01903460|9936753|P3|Overall Study|Adverse Event|0
2886575|NCT01903460|9936754|P2|Overall Study|Adverse Event|0
2886576|NCT01903460|9936755|P1|Overall Study|Adverse Event|0
2886577|NCT01903434|9936772|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
2886578|NCT01903434|9936773|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
2886579|NCT01903434|9936772|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
2886580|NCT01903434|9936773|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
2886581|NCT01903356|9936781|P1|Overall Study|Violated the dosage and administration|3
2886582|NCT01903356|9936781|P1|Overall Study|Violated inclusion/exclusion criteria|5
2886583|NCT01903356|9936781|P1|Overall Study|Lost to Follow-up|7
2886584|NCT01903252|9936808|P6|Maintenance, Open-Label|Other|2
2886585|NCT01903252|9936809|P5|Maintenance, Open-Label|Other|6
2886586|NCT01903252|9936810|P4|Maintenance, Open-Label|Other|2
2886587|NCT01903252|9936811|P3|Maintenance, Open-Label|Other|0
2886588|NCT01903252|9936812|P2|Maintenance, Open-Label|Other|0
2886589|NCT01903252|9936813|P1|Maintenance, Open-Label|Other|0
2886590|NCT01903252|9936808|P6|Maintenance, Open-Label|Withdrawal by Subject|2
2886591|NCT01903252|9936809|P5|Maintenance, Open-Label|Withdrawal by Subject|6
2886592|NCT01903252|9936810|P4|Maintenance, Open-Label|Withdrawal by Subject|1
2886593|NCT01903252|9936811|P3|Maintenance, Open-Label|Withdrawal by Subject|0
2886594|NCT01903252|9936812|P2|Maintenance, Open-Label|Withdrawal by Subject|0
2886595|NCT01903252|9936813|P1|Maintenance, Open-Label|Withdrawal by Subject|0
2886596|NCT01903252|9936808|P6|Maintenance, Open-Label|Adverse Event|14
2886597|NCT01903252|9936809|P5|Maintenance, Open-Label|Adverse Event|9
2886598|NCT01903252|9936810|P4|Maintenance, Open-Label|Adverse Event|3
2886599|NCT01903252|9936811|P3|Maintenance, Open-Label|Adverse Event|0
2886600|NCT01903252|9936812|P2|Maintenance, Open-Label|Adverse Event|0
2886601|NCT01903252|9936813|P1|Maintenance, Open-Label|Adverse Event|0
2886602|NCT01903252|9936808|P6|Extended Induction, Open-Label|Physician Decision|0
2886603|NCT01903252|9936809|P5|Extended Induction, Open-Label|Physician Decision|0
2886604|NCT01903252|9936810|P4|Extended Induction, Open-Label|Physician Decision|0
2886605|NCT01903252|9936811|P3|Extended Induction, Open-Label|Physician Decision|1
2886606|NCT01903252|9936812|P2|Extended Induction, Open-Label|Physician Decision|0
2886607|NCT01903252|9936813|P1|Extended Induction, Open-Label|Physician Decision|0
2886608|NCT01903252|9936808|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
2886609|NCT01903252|9936809|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
2886610|NCT01903252|9936810|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
2886611|NCT01903252|9936811|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
2886612|NCT01903252|9936812|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
2886613|NCT01903252|9936813|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
2886614|NCT01903252|9936808|P6|Extended Induction, Open-Label|Adverse Event|0
2886615|NCT01903252|9936809|P5|Extended Induction, Open-Label|Adverse Event|0
2886616|NCT01903252|9936810|P4|Extended Induction, Open-Label|Adverse Event|0
2886617|NCT01903252|9936811|P3|Extended Induction, Open-Label|Adverse Event|17
2886618|NCT01903252|9936812|P2|Extended Induction, Open-Label|Adverse Event|0
2886619|NCT01903252|9936813|P1|Extended Induction, Open-Label|Adverse Event|0
2886620|NCT01903252|9936808|P6|Double-Blind Induction|non-compliance,|0
2886621|NCT01903252|9936809|P5|Double-Blind Induction|non-compliance,|0
2886622|NCT01903252|9936810|P4|Double-Blind Induction|non-compliance,|0
2886623|NCT01903252|9936811|P3|Double-Blind Induction|non-compliance,|0
2886624|NCT01903252|9936812|P2|Double-Blind Induction|non-compliance,|7
2886625|NCT01903252|9936813|P1|Double-Blind Induction|non-compliance,|7
2886626|NCT01903252|9936808|P6|Double-Blind Induction|Physician Decision|0
2886627|NCT01903252|9936809|P5|Double-Blind Induction|Physician Decision|0
2886628|NCT01903252|9936810|P4|Double-Blind Induction|Physician Decision|0
2886629|NCT01903252|9936811|P3|Double-Blind Induction|Physician Decision|0
2886630|NCT01903252|9936812|P2|Double-Blind Induction|Physician Decision|3
2886631|NCT01903252|9936813|P1|Double-Blind Induction|Physician Decision|2
2886632|NCT01903252|9936808|P6|Double-Blind Induction|Withdrawal by Subject|0
2886633|NCT01903252|9936809|P5|Double-Blind Induction|Withdrawal by Subject|0
2886634|NCT01903252|9936810|P4|Double-Blind Induction|Withdrawal by Subject|0
2886635|NCT01903252|9936811|P3|Double-Blind Induction|Withdrawal by Subject|0
2886636|NCT01903252|9936812|P2|Double-Blind Induction|Withdrawal by Subject|13
2886637|NCT01903252|9936813|P1|Double-Blind Induction|Withdrawal by Subject|10
2886638|NCT01903252|9936808|P6|Double-Blind Induction|Adverse Event|0
2886639|NCT01903252|9936809|P5|Double-Blind Induction|Adverse Event|0
2886640|NCT01903252|9936810|P4|Double-Blind Induction|Adverse Event|0
2886641|NCT01903252|9936811|P3|Double-Blind Induction|Adverse Event|0
2886642|NCT01903252|9936812|P2|Double-Blind Induction|Adverse Event|18
2886643|NCT01903252|9936813|P1|Double-Blind Induction|Adverse Event|20
2886644|NCT01903031|9936926|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
2886645|NCT01903031|9936927|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
2886646|NCT01903031|9936928|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
2886647|NCT01903031|9936926|P3|Overall Study|Lost to Follow-up|1
2886648|NCT01903031|9936927|P2|Overall Study|Lost to Follow-up|0
2886649|NCT01903031|9936928|P1|Overall Study|Lost to Follow-up|0
2886650|NCT01903031|9936926|P3|Overall Study|Protocol Violation|2
2886651|NCT01903031|9936927|P2|Overall Study|Protocol Violation|0
2886652|NCT01903031|9936928|P1|Overall Study|Protocol Violation|0
2886653|NCT01903031|9936926|P3|Overall Study|Withdrawal by Subject|1
2886654|NCT01903031|9936927|P2|Overall Study|Withdrawal by Subject|1
2886655|NCT01903031|9936928|P1|Overall Study|Withdrawal by Subject|0
2886656|NCT01903031|9936926|P3|Overall Study|Adverse Event|0
2886657|NCT01903031|9936927|P2|Overall Study|Adverse Event|1
2886658|NCT01903031|9936928|P1|Overall Study|Adverse Event|0
2886659|NCT01903031|9936926|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2886660|NCT01903031|9936927|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2886661|NCT01903031|9936928|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
2886662|NCT01903031|9936926|P3|Overall Study|Not Able to Attend Clinic|0
2886663|NCT01903031|9936927|P2|Overall Study|Not Able to Attend Clinic|1
2886664|NCT01903031|9936928|P1|Overall Study|Not Able to Attend Clinic|1
2886665|NCT01902888|9937002|P1|Overall Study|Study Terminated|3
2886666|NCT01902628|9937016|P1|Overall Study|Lost to Follow-up|35
2886667|NCT01902628|9937016|P1|Overall Study|Adverse Event|41
2886668|NCT01902628|9937016|P1|Overall Study|Withdrawal of participant's consent|7
2886669|NCT01902303|9937044|P2|Overall Study|Did not develop a cold sore|19
2886670|NCT01902303|9937045|P1|Overall Study|Did not develop a cold sore|21
2886671|NCT01902303|9937044|P2|Overall Study|subject lost investigational product|1
2886672|NCT01902303|9937045|P1|Overall Study|subject lost investigational product|0
2886673|NCT01902303|9937044|P2|Overall Study|Protocol Violation|2
2886674|NCT01902303|9937045|P1|Overall Study|Protocol Violation|2
2886675|NCT01902303|9937044|P2|Overall Study|Lost to Follow-up|1
2886676|NCT01902303|9937045|P1|Overall Study|Lost to Follow-up|0
2886677|NCT01902303|9937044|P2|Overall Study|Adverse Event|1
2886678|NCT01902303|9937045|P1|Overall Study|Adverse Event|0
2886679|NCT01902134|9937059|P6|Overall Study|Other|0
2886680|NCT01902134|9937060|P5|Overall Study|Other|1
2886681|NCT01902134|9937061|P4|Overall Study|Other|0
2886682|NCT01902134|9937062|P3|Overall Study|Other|2
2886683|NCT01902134|9937063|P2|Overall Study|Other|1
2886684|NCT01902134|9937064|P1|Overall Study|Other|0
2886685|NCT01902134|9937059|P6|Overall Study|no compliance|0
2886686|NCT01902134|9937060|P5|Overall Study|no compliance|0
2886687|NCT01902134|9937061|P4|Overall Study|no compliance|0
2886688|NCT01902134|9937062|P3|Overall Study|no compliance|0
2886689|NCT01902134|9937063|P2|Overall Study|no compliance|0
2886690|NCT01902134|9937064|P1|Overall Study|no compliance|1
2886691|NCT01902134|9937059|P6|Overall Study|Withdrawal by Subject|4
2886692|NCT01902134|9937060|P5|Overall Study|Withdrawal by Subject|5
2886693|NCT01902134|9937061|P4|Overall Study|Withdrawal by Subject|1
2886694|NCT01902134|9937062|P3|Overall Study|Withdrawal by Subject|9
2886695|NCT01902134|9937063|P2|Overall Study|Withdrawal by Subject|8
2886696|NCT01902134|9937064|P1|Overall Study|Withdrawal by Subject|4
2886697|NCT01902134|9937059|P6|Overall Study|Protocol Violation|1
2886698|NCT01902134|9937060|P5|Overall Study|Protocol Violation|0
2886699|NCT01902134|9937061|P4|Overall Study|Protocol Violation|0
2886700|NCT01902134|9937062|P3|Overall Study|Protocol Violation|0
2886701|NCT01902134|9937063|P2|Overall Study|Protocol Violation|0
2886702|NCT01902134|9937064|P1|Overall Study|Protocol Violation|0
2886703|NCT01902134|9937059|P6|Overall Study|Physician Decision|0
2886704|NCT01902134|9937060|P5|Overall Study|Physician Decision|0
2886705|NCT01902134|9937061|P4|Overall Study|Physician Decision|0
2886706|NCT01902134|9937062|P3|Overall Study|Physician Decision|0
2886707|NCT01902134|9937063|P2|Overall Study|Physician Decision|1
2886708|NCT01902134|9937064|P1|Overall Study|Physician Decision|0
2886709|NCT01902134|9937059|P6|Overall Study|Lack of Efficacy|1
2886710|NCT01902134|9937060|P5|Overall Study|Lack of Efficacy|0
2886711|NCT01902134|9937061|P4|Overall Study|Lack of Efficacy|0
2886712|NCT01902134|9937062|P3|Overall Study|Lack of Efficacy|2
2886713|NCT01902134|9937063|P2|Overall Study|Lack of Efficacy|0
2886714|NCT01902134|9937064|P1|Overall Study|Lack of Efficacy|0
2886715|NCT01902134|9937059|P6|Overall Study|Adverse Event|3
2886716|NCT01902134|9937060|P5|Overall Study|Adverse Event|1
2886717|NCT01902134|9937061|P4|Overall Study|Adverse Event|1
2886718|NCT01902134|9937062|P3|Overall Study|Adverse Event|2
2886719|NCT01902134|9937063|P2|Overall Study|Adverse Event|1
2886720|NCT01902134|9937064|P1|Overall Study|Adverse Event|3
2886721|NCT01901874|9937101|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
2886722|NCT01901874|9937101|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
2886723|NCT01901874|9937101|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
2886724|NCT01901874|9937101|P1|1-Year (365-Day) MAE Evaluation|Death|7
2886725|NCT01901874|9937101|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
2886726|NCT01901874|9937101|P1|Screening Committee Retrospective Review|Protocol Violation|47
2886727|NCT01901848|9937116|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
2886728|NCT01901848|9937117|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
2886729|NCT01901848|9937116|P2|Randomized and Treated|Lost to Follow-up|6
2886730|NCT01901848|9937117|P1|Randomized and Treated|Lost to Follow-up|3
2886731|NCT01901653|9937159|P13|Overall Study|Alive at Study Termination by Sponsor|1
2886732|NCT01901653|9937160|P12|Overall Study|Alive at Study Termination by Sponsor|1
2886733|NCT01901653|9937161|P11|Overall Study|Alive at Study Termination by Sponsor|0
2886734|NCT01901653|9937162|P10|Overall Study|Alive at Study Termination by Sponsor|2
2886735|NCT01901653|9937163|P9|Overall Study|Alive at Study Termination by Sponsor|0
2886736|NCT01901653|9937164|P8|Overall Study|Alive at Study Termination by Sponsor|0
2886737|NCT01901653|9937165|P7|Overall Study|Alive at Study Termination by Sponsor|0
2886738|NCT01901653|9937166|P6|Overall Study|Alive at Study Termination by Sponsor|0
2886739|NCT01901653|9937167|P5|Overall Study|Alive at Study Termination by Sponsor|0
2886740|NCT01901653|9937168|P4|Overall Study|Alive at Study Termination by Sponsor|0
2886741|NCT01901653|9937169|P3|Overall Study|Alive at Study Termination by Sponsor|1
2886742|NCT01901653|9937170|P2|Overall Study|Alive at Study Termination by Sponsor|0
2886743|NCT01901653|9937171|P1|Overall Study|Alive at Study Termination by Sponsor|0
2886744|NCT01901653|9937159|P13|Overall Study|Withdrawal by Subject|0
2886745|NCT01901653|9937160|P12|Overall Study|Withdrawal by Subject|0
2886746|NCT01901653|9937161|P11|Overall Study|Withdrawal by Subject|0
2886747|NCT01901653|9937162|P10|Overall Study|Withdrawal by Subject|0
2886748|NCT01901653|9937163|P9|Overall Study|Withdrawal by Subject|0
2886749|NCT01901653|9937164|P8|Overall Study|Withdrawal by Subject|0
2886750|NCT01901653|9937165|P7|Overall Study|Withdrawal by Subject|1
2886751|NCT01901653|9937166|P6|Overall Study|Withdrawal by Subject|0
2886752|NCT01901653|9937167|P5|Overall Study|Withdrawal by Subject|0
2886753|NCT01901653|9937168|P4|Overall Study|Withdrawal by Subject|0
2886754|NCT01901653|9937169|P3|Overall Study|Withdrawal by Subject|0
2886755|NCT01901653|9937170|P2|Overall Study|Withdrawal by Subject|0
2886756|NCT01901653|9937171|P1|Overall Study|Withdrawal by Subject|0
2886757|NCT01901653|9937159|P13|Overall Study|Lost to Follow-up|0
2886758|NCT01901653|9937160|P12|Overall Study|Lost to Follow-up|0
2886759|NCT01901653|9937161|P11|Overall Study|Lost to Follow-up|0
2886760|NCT01901653|9937162|P10|Overall Study|Lost to Follow-up|0
2886761|NCT01901653|9937163|P9|Overall Study|Lost to Follow-up|0
2886762|NCT01901653|9937164|P8|Overall Study|Lost to Follow-up|1
2886763|NCT01901653|9937165|P7|Overall Study|Lost to Follow-up|0
2886764|NCT01901653|9937166|P6|Overall Study|Lost to Follow-up|1
2886765|NCT01901653|9937167|P5|Overall Study|Lost to Follow-up|0
2886766|NCT01901653|9937168|P4|Overall Study|Lost to Follow-up|0
2886767|NCT01901653|9937169|P3|Overall Study|Lost to Follow-up|2
2886768|NCT01901653|9937170|P2|Overall Study|Lost to Follow-up|0
2886769|NCT01901653|9937171|P1|Overall Study|Lost to Follow-up|1
2886770|NCT01901653|9937159|P13|Overall Study|Death|4
2886771|NCT01901653|9937160|P12|Overall Study|Death|15
2886772|NCT01901653|9937161|P11|Overall Study|Death|2
2886773|NCT01901653|9937162|P10|Overall Study|Death|16
2886774|NCT01901653|9937163|P9|Overall Study|Death|1
2886775|NCT01901653|9937164|P8|Overall Study|Death|9
2886776|NCT01901653|9937165|P7|Overall Study|Death|6
2886777|NCT01901653|9937166|P6|Overall Study|Death|2
2886778|NCT01901653|9937167|P5|Overall Study|Death|2
2886779|NCT01901653|9937168|P4|Overall Study|Death|3
2886780|NCT01901653|9937169|P3|Overall Study|Death|8
2886781|NCT01901653|9937170|P2|Overall Study|Death|1
2886782|NCT01901653|9937171|P1|Overall Study|Death|2
2886783|NCT01901614|9937215|P2|Overall Study|Screen Fail|0
2886784|NCT01901614|9937216|P1|Overall Study|Screen Fail|1
2886785|NCT01901614|9937215|P2|Overall Study|Lost to Follow-up|0
2886786|NCT01901614|9937216|P1|Overall Study|Lost to Follow-up|1
2886787|NCT01901614|9937215|P2|Overall Study|Adverse Event|1
2886788|NCT01901614|9937216|P1|Overall Study|Adverse Event|0
2886789|NCT01901432|9937251|P5|Overall Study|Patient decision to stop study drug|1
2886790|NCT01901432|9937252|P4|Overall Study|Patient decision to stop study drug|0
2886791|NCT01901432|9937253|P3|Overall Study|Patient decision to stop study drug|0
2886792|NCT01901432|9937254|P2|Overall Study|Patient decision to stop study drug|0
2886793|NCT01901432|9937255|P1|Overall Study|Patient decision to stop study drug|0
2886794|NCT01901432|9937251|P5|Overall Study|Physician Decision|2
2886795|NCT01901432|9937252|P4|Overall Study|Physician Decision|0
2886796|NCT01901432|9937253|P3|Overall Study|Physician Decision|0
2886797|NCT01901432|9937254|P2|Overall Study|Physician Decision|0
2886798|NCT01901432|9937255|P1|Overall Study|Physician Decision|0
2886799|NCT01901432|9937251|P5|Overall Study|Withdrawal by Subject|5
2886800|NCT01901432|9937252|P4|Overall Study|Withdrawal by Subject|0
2886801|NCT01901432|9937253|P3|Overall Study|Withdrawal by Subject|1
2886802|NCT01901432|9937254|P2|Overall Study|Withdrawal by Subject|0
2886803|NCT01901432|9937255|P1|Overall Study|Withdrawal by Subject|0
2886804|NCT01901432|9937251|P5|Overall Study|Adverse Event|1
2886805|NCT01901432|9937252|P4|Overall Study|Adverse Event|0
2886806|NCT01901432|9937253|P3|Overall Study|Adverse Event|1
2886807|NCT01901432|9937254|P2|Overall Study|Adverse Event|1
2886808|NCT01901432|9937255|P1|Overall Study|Adverse Event|0
2886809|NCT01901393|9937307|P2|Overall Study|Adverse Event|0
2886810|NCT01901393|9937308|P1|Overall Study|Adverse Event|1
2886811|NCT01901341|9937326|P2|Overall Study|Withdrawal by Subject|1
2886812|NCT01901341|9937327|P1|Overall Study|Withdrawal by Subject|1
2886813|NCT01901341|9937326|P2|Overall Study|Study Terminated by Sponsor|15
2886814|NCT01901341|9937327|P1|Overall Study|Study Terminated by Sponsor|13
2886815|NCT01901341|9937326|P2|Overall Study|Protocol Violation|0
2886816|NCT01901341|9937327|P1|Overall Study|Protocol Violation|2
2886817|NCT01901341|9937326|P2|Overall Study|Lost to Follow-up|1
2886818|NCT01901341|9937327|P1|Overall Study|Lost to Follow-up|0
2886819|NCT01901341|9937326|P2|Overall Study|Lack of Efficacy|2
2886820|NCT01901341|9937327|P1|Overall Study|Lack of Efficacy|0
2886821|NCT01901341|9937326|P2|Overall Study|Adverse Event|2
2886822|NCT01901341|9937327|P1|Overall Study|Adverse Event|4
2886823|NCT01901328|9937341|P2|Overall Study|Lack of Efficacy|1
2886824|NCT01901328|9937342|P1|Overall Study|Lack of Efficacy|0
2886825|NCT01901328|9937341|P2|Overall Study|Withdrawal by Subject|2
2886826|NCT01901328|9937342|P1|Overall Study|Withdrawal by Subject|1
2886827|NCT01901328|9937341|P2|Overall Study|Study Terminated by Sponsor|16
2886828|NCT01901328|9937342|P1|Overall Study|Study Terminated by Sponsor|19
2886829|NCT01901328|9937341|P2|Overall Study|Protocol Violation|1
2886830|NCT01901328|9937342|P1|Overall Study|Protocol Violation|1
2886831|NCT01901328|9937341|P2|Overall Study|Physician Decision|1
2886832|NCT01901328|9937342|P1|Overall Study|Physician Decision|0
2886833|NCT01901328|9937341|P2|Overall Study|Lost to Follow-up|0
2886834|NCT01901328|9937342|P1|Overall Study|Lost to Follow-up|1
2886835|NCT01901302|9937356|P2|Overall Study|Withdrawal by Subject|0
2886836|NCT01901302|9937357|P1|Overall Study|Withdrawal by Subject|2
2886837|NCT01901302|9937356|P2|Overall Study|Study Terminated by Sponsor|20
2886838|NCT01901302|9937357|P1|Overall Study|Study Terminated by Sponsor|23
2886839|NCT01901302|9937356|P2|Overall Study|Lack of Efficacy|2
2886840|NCT01901302|9937357|P1|Overall Study|Lack of Efficacy|0
2886841|NCT01901302|9937356|P2|Overall Study|Adverse Event|1
2886842|NCT01901302|9937357|P1|Overall Study|Adverse Event|2
2886843|NCT01901224|9937382|P1|Overall Study|study was not funded and terminated|2
2886844|NCT01901185|9937417|P1|Overall Study|Withdrawal by Subject|2
2886845|NCT01901146|9937426|P5|Adjuvant Phase|Withdrawal by Subject|4
2886846|NCT01901146|9937427|P4|Adjuvant Phase|Withdrawal by Subject|1
2886847|NCT01901146|9937428|P3|Adjuvant Phase|Withdrawal by Subject|4
2886848|NCT01901146|9937429|P2|Adjuvant Phase|Withdrawal by Subject|0
2886849|NCT01901146|9937430|P1|Adjuvant Phase|Withdrawal by Subject|0
2886850|NCT01901146|9937426|P5|Adjuvant Phase|Physician Decision|4
2886851|NCT01901146|9937427|P4|Adjuvant Phase|Physician Decision|2
2886852|NCT01901146|9937428|P3|Adjuvant Phase|Physician Decision|9
2886853|NCT01901146|9937429|P2|Adjuvant Phase|Physician Decision|0
2886854|NCT01901146|9937430|P1|Adjuvant Phase|Physician Decision|0
2886855|NCT01901146|9937426|P5|Adjuvant Phase|Disease Progression or Recurrence|3
2886856|NCT01901146|9937427|P4|Adjuvant Phase|Disease Progression or Recurrence|4
2886857|NCT01901146|9937428|P3|Adjuvant Phase|Disease Progression or Recurrence|12
2886858|NCT01901146|9937429|P2|Adjuvant Phase|Disease Progression or Recurrence|0
2886859|NCT01901146|9937430|P1|Adjuvant Phase|Disease Progression or Recurrence|0
2886860|NCT01901146|9937426|P5|Adjuvant Phase|Death|3
2886861|NCT01901146|9937427|P4|Adjuvant Phase|Death|0
2886862|NCT01901146|9937428|P3|Adjuvant Phase|Death|0
2886863|NCT01901146|9937429|P2|Adjuvant Phase|Death|0
2886864|NCT01901146|9937430|P1|Adjuvant Phase|Death|0
2886865|NCT01901146|9937426|P5|Adjuvant Phase|Other|0
2886866|NCT01901146|9937427|P4|Adjuvant Phase|Other|0
2886867|NCT01901146|9937428|P3|Adjuvant Phase|Other|1
2886868|NCT01901146|9937429|P2|Adjuvant Phase|Other|0
2886869|NCT01901146|9937430|P1|Adjuvant Phase|Other|0
2886870|NCT01901146|9937426|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2886871|NCT01901146|9937427|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2886872|NCT01901146|9937428|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2886873|NCT01901146|9937429|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
2886874|NCT01901146|9937430|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2886875|NCT01901146|9937426|P5|Neoadjuvant Phase|Withdrawal by Subject|0
2886876|NCT01901146|9937427|P4|Neoadjuvant Phase|Withdrawal by Subject|0
2886877|NCT01901146|9937428|P3|Neoadjuvant Phase|Withdrawal by Subject|0
2886878|NCT01901146|9937429|P2|Neoadjuvant Phase|Withdrawal by Subject|5
2886879|NCT01901146|9937430|P1|Neoadjuvant Phase|Withdrawal by Subject|2
2886880|NCT01901146|9937426|P5|Neoadjuvant Phase|Physician Decision|0
2886881|NCT01901146|9937427|P4|Neoadjuvant Phase|Physician Decision|0
2886882|NCT01901146|9937428|P3|Neoadjuvant Phase|Physician Decision|0
2886883|NCT01901146|9937429|P2|Neoadjuvant Phase|Physician Decision|2
2886884|NCT01901146|9937430|P1|Neoadjuvant Phase|Physician Decision|1
2886885|NCT01901146|9937426|P5|Neoadjuvant Phase|Lost to Follow-up|0
2886886|NCT01901146|9937427|P4|Neoadjuvant Phase|Lost to Follow-up|0
2886887|NCT01901146|9937428|P3|Neoadjuvant Phase|Lost to Follow-up|0
2886888|NCT01901146|9937429|P2|Neoadjuvant Phase|Lost to Follow-up|1
2886889|NCT01901146|9937430|P1|Neoadjuvant Phase|Lost to Follow-up|0
2886890|NCT01901146|9937426|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
2886891|NCT01901146|9937427|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
2886892|NCT01901146|9937428|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
2886893|NCT01901146|9937429|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
2886894|NCT01901146|9937430|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
2886895|NCT01901146|9937426|P5|Neoadjuvant Phase|Death|0
2886896|NCT01901146|9937427|P4|Neoadjuvant Phase|Death|0
2886897|NCT01901146|9937428|P3|Neoadjuvant Phase|Death|0
2886898|NCT01901146|9937429|P2|Neoadjuvant Phase|Death|2
2886899|NCT01901146|9937430|P1|Neoadjuvant Phase|Death|1
2886900|NCT01900899|9937445|P2|Overall Study|Migrated from study area|0
2886901|NCT01900899|9937446|P1|Overall Study|Migrated from study area|2
2886902|NCT01900899|9937445|P2|Overall Study|Withdrawal by Subject|1
2886903|NCT01900899|9937446|P1|Overall Study|Withdrawal by Subject|7
2886904|NCT01900730|9937472|P2|Overall Study|Screen Failure|0
2886905|NCT01900730|9937473|P1|Overall Study|Screen Failure|1
2886906|NCT01900730|9937472|P2|Overall Study|Withdrawal by Subject|0
2886907|NCT01900730|9937473|P1|Overall Study|Withdrawal by Subject|1
2886908|NCT01900665|9937481|P2|Open Label Period|Withdrawal by Subject|28
2886909|NCT01900665|9937482|P1|Open Label Period|Withdrawal by Subject|20
2886910|NCT01900665|9937481|P2|Open Label Period|Sponsor Decision|765
2886911|NCT01900665|9937482|P1|Open Label Period|Sponsor Decision|802
2886912|NCT01900665|9937481|P2|Open Label Period|Protocol Violation|1
2886913|NCT01900665|9937482|P1|Open Label Period|Protocol Violation|0
2886914|NCT01900665|9937481|P2|Open Label Period|Physician Decision|4
2886915|NCT01900665|9937482|P1|Open Label Period|Physician Decision|4
2886916|NCT01900665|9937481|P2|Open Label Period|Parent/Caregiver Decision|34
2886917|NCT01900665|9937482|P1|Open Label Period|Parent/Caregiver Decision|33
2886918|NCT01900665|9937481|P2|Open Label Period|Lost to Follow-up|1
2886919|NCT01900665|9937482|P1|Open Label Period|Lost to Follow-up|1
2886920|NCT01900665|9937481|P2|Open Label Period|Death|6
2886921|NCT01900665|9937482|P1|Open Label Period|Death|5
2886922|NCT01900665|9937481|P2|Open Label Period|Adverse Event|20
2886923|NCT01900665|9937482|P1|Open Label Period|Adverse Event|16
2886924|NCT01900665|9937481|P2|Placebo Controlled Period|Entry Criteria Not Met|9
2886925|NCT01900665|9937482|P1|Placebo Controlled Period|Entry Criteria Not Met|5
2886926|NCT01900665|9937481|P2|Placebo Controlled Period|Caregiver Decision|41
2886927|NCT01900665|9937482|P1|Placebo Controlled Period|Caregiver Decision|33
2886928|NCT01900665|9937481|P2|Placebo Controlled Period|Lost to Follow-up|0
2886929|NCT01900665|9937482|P1|Placebo Controlled Period|Lost to Follow-up|3
2886930|NCT01900665|9937481|P2|Placebo Controlled Period|Physician Decision|7
2886931|NCT01900665|9937482|P1|Placebo Controlled Period|Physician Decision|11
2886932|NCT01900665|9937481|P2|Placebo Controlled Period|Withdrawal by Subject|45
2886933|NCT01900665|9937482|P1|Placebo Controlled Period|Withdrawal by Subject|33
2886934|NCT01900665|9937481|P2|Placebo Controlled Period|Protocol Violation|7
2886935|NCT01900665|9937482|P1|Placebo Controlled Period|Protocol Violation|1
2886936|NCT01900665|9937481|P2|Placebo Controlled Period|Adverse Event|39
2886937|NCT01900665|9937482|P1|Placebo Controlled Period|Adverse Event|48
2886938|NCT01900665|9937481|P2|Placebo Controlled Period|Death|16
2886939|NCT01900665|9937482|P1|Placebo Controlled Period|Death|9
2886940|NCT01900652|9937525|P2|Overall Study|Physician Decision|1
2886941|NCT01900652|9937526|P1|Overall Study|Physician Decision|1
2886942|NCT01900652|9937525|P2|Overall Study|Adverse Event|1
2886943|NCT01900652|9937526|P1|Overall Study|Adverse Event|2
2886944|NCT01900652|9937525|P2|Overall Study|Death|0
2886945|NCT01900652|9937526|P1|Overall Study|Death|3
2886946|NCT01900652|9937525|P2|Overall Study|Consent withdrawn by subject|1
2886947|NCT01900652|9937526|P1|Overall Study|Consent withdrawn by subject|1
2886948|NCT01900652|9937525|P2|Overall Study|Progressive Disease|0
2886949|NCT01900652|9937526|P1|Overall Study|Progressive Disease|1
2886950|NCT01900626|9937562|P2|Overall Study|study was closed due to low enrollment|1
2886951|NCT01900626|9937563|P1|Overall Study|study was closed due to low enrollment|1
2886952|NCT01900444|9937642|P1|Overall Study|Lost to Follow-up|1
2886953|NCT01900444|9937642|P1|Overall Study|Protocol Violation|2
2886954|NCT01900431|9937655|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
2886955|NCT01900431|9937656|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2886956|NCT01900431|9937657|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2886957|NCT01900431|9937655|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
2886958|NCT01900431|9937656|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2886959|NCT01900431|9937657|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2886960|NCT01900431|9937655|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
2886961|NCT01900431|9937656|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
2886962|NCT01900431|9937657|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
2886963|NCT01900431|9937655|P3|Extended Treatment Period (Part B)|Other than specified above|0
2886964|NCT01900431|9937656|P2|Extended Treatment Period (Part B)|Other than specified above|1
2886965|NCT01900431|9937657|P1|Extended Treatment Period (Part B)|Other than specified above|0
2886966|NCT01900431|9937655|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
2886967|NCT01900431|9937656|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
2886968|NCT01900431|9937657|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
2886969|NCT01900431|9937655|P3|Extended Treatment Period (Part B)|Adverse Event|0
2886970|NCT01900431|9937656|P2|Extended Treatment Period (Part B)|Adverse Event|2
2886971|NCT01900431|9937657|P1|Extended Treatment Period (Part B)|Adverse Event|0
2886972|NCT01900431|9937655|P3|Principal Treatment Period (Part A)|Other than specified above|0
2886973|NCT01900431|9937656|P2|Principal Treatment Period (Part A)|Other than specified above|1
2886974|NCT01900431|9937657|P1|Principal Treatment Period (Part A)|Other than specified above|0
2886975|NCT01900431|9937655|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
2886976|NCT01900431|9937656|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
2886977|NCT01900431|9937657|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
2886978|NCT01900431|9937655|P3|Principal Treatment Period (Part A)|Adverse Event|0
2886979|NCT01900431|9937656|P2|Principal Treatment Period (Part A)|Adverse Event|3
2886980|NCT01900431|9937657|P1|Principal Treatment Period (Part A)|Adverse Event|1
2886981|NCT01900314|9937699|P2|Overall Study|Withdrawal by Subject|3
2886982|NCT01900314|9937700|P1|Overall Study|Withdrawal by Subject|3
2886983|NCT01900314|9937699|P2|Overall Study|Protocol Violation|1
2886984|NCT01900314|9937700|P1|Overall Study|Protocol Violation|0
2886985|NCT01900314|9937699|P2|Overall Study|Lost to Follow-up|0
2886986|NCT01900314|9937700|P1|Overall Study|Lost to Follow-up|1
2886987|NCT01900054|9937730|P1|Overall Study|Withdrawal by Subject|1
2886988|NCT01900054|9937730|P1|Overall Study|Physician Decision|1
2886989|NCT01899768|9937739|P1|Part B|Withdrawal by Subject|1
2886990|NCT01899768|9937739|P1|Part B|Adverse Event|1
2886991|NCT01899768|9937739|P1|Part A|Withdrawal by Subject|1
2886992|NCT01899768|9937739|P1|Part A|Adverse Event|2
2886993|NCT01899742|9937813|P2|Overall Study|Withdrawal by Subject|5
2886994|NCT01899742|9937814|P1|Overall Study|Withdrawal by Subject|9
2886995|NCT01899742|9937813|P2|Overall Study|Protocol Violation|2
2886996|NCT01899742|9937814|P1|Overall Study|Protocol Violation|2
2886997|NCT01899742|9937813|P2|Overall Study|Lack of Efficacy|5
2886998|NCT01899742|9937814|P1|Overall Study|Lack of Efficacy|1
2886999|NCT01899742|9937813|P2|Overall Study|Adverse Event|4
2887000|NCT01899742|9937814|P1|Overall Study|Adverse Event|5
2887001|NCT01899729|9937827|P5|Overall Study|Lack of Efficacy|1
2887002|NCT01899729|9937828|P4|Overall Study|Lack of Efficacy|0
2887003|NCT01899729|9937829|P3|Overall Study|Lack of Efficacy|2
2887004|NCT01899729|9937830|P2|Overall Study|Lack of Efficacy|0
2887005|NCT01899729|9937831|P1|Overall Study|Lack of Efficacy|0
2887006|NCT01899729|9937827|P5|Overall Study|Withdrawal by Subject|0
2887007|NCT01899729|9937828|P4|Overall Study|Withdrawal by Subject|0
2887008|NCT01899729|9937829|P3|Overall Study|Withdrawal by Subject|0
2887009|NCT01899729|9937830|P2|Overall Study|Withdrawal by Subject|2
2887010|NCT01899729|9937831|P1|Overall Study|Withdrawal by Subject|1
2887011|NCT01899729|9937827|P5|Overall Study|Adverse Event|1
2887012|NCT01899729|9937828|P4|Overall Study|Adverse Event|0
2887013|NCT01899729|9937829|P3|Overall Study|Adverse Event|0
2887014|NCT01899729|9937830|P2|Overall Study|Adverse Event|0
2887015|NCT01899729|9937831|P1|Overall Study|Adverse Event|1
2887016|NCT01899144|9937878|P1|Treatment Period 5|Other|1
2887017|NCT01899144|9937878|P1|Treatment Period 3|Other|2
2887018|NCT01899144|9937878|P1|Treatment Period 2|Other|1
2887019|NCT01899053|9937914|P14|Overall Study|Symptomatic Deterioration|0
2887020|NCT01899053|9937915|P13|Overall Study|Symptomatic Deterioration|2
2887021|NCT01899053|9937916|P12|Overall Study|Symptomatic Deterioration|1
2887022|NCT01899053|9937917|P11|Overall Study|Symptomatic Deterioration|0
2887023|NCT01899053|9937918|P10|Overall Study|Symptomatic Deterioration|0
2887024|NCT01899053|9937919|P9|Overall Study|Symptomatic Deterioration|0
2887025|NCT01899053|9937920|P8|Overall Study|Symptomatic Deterioration|1
2887026|NCT01899053|9937921|P7|Overall Study|Symptomatic Deterioration|0
2887027|NCT01899053|9937922|P6|Overall Study|Symptomatic Deterioration|1
2887028|NCT01899053|9937923|P5|Overall Study|Symptomatic Deterioration|0
2887029|NCT01899053|9937924|P4|Overall Study|Symptomatic Deterioration|0
2887030|NCT01899053|9937925|P3|Overall Study|Symptomatic Deterioration|0
2887031|NCT01899053|9937926|P2|Overall Study|Symptomatic Deterioration|0
2887032|NCT01899053|9937927|P1|Overall Study|Symptomatic Deterioration|0
2887033|NCT01899053|9937914|P14|Overall Study|Unsatisfactory Therapeutic Response|0
2887034|NCT01899053|9937915|P13|Overall Study|Unsatisfactory Therapeutic Response|0
2887035|NCT01899053|9937916|P12|Overall Study|Unsatisfactory Therapeutic Response|0
2887036|NCT01899053|9937917|P11|Overall Study|Unsatisfactory Therapeutic Response|1
2887037|NCT01899053|9937918|P10|Overall Study|Unsatisfactory Therapeutic Response|0
2887038|NCT01899053|9937919|P9|Overall Study|Unsatisfactory Therapeutic Response|0
2887039|NCT01899053|9937920|P8|Overall Study|Unsatisfactory Therapeutic Response|0
2887040|NCT01899053|9937921|P7|Overall Study|Unsatisfactory Therapeutic Response|0
2887041|NCT01899053|9937922|P6|Overall Study|Unsatisfactory Therapeutic Response|0
2887042|NCT01899053|9937923|P5|Overall Study|Unsatisfactory Therapeutic Response|0
2887043|NCT01899053|9937924|P4|Overall Study|Unsatisfactory Therapeutic Response|0
2887044|NCT01899053|9937925|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2887045|NCT01899053|9937926|P2|Overall Study|Unsatisfactory Therapeutic Response|1
2887046|NCT01899053|9937927|P1|Overall Study|Unsatisfactory Therapeutic Response|1
2887047|NCT01899053|9937914|P14|Overall Study|Protocol Violation|0
2887048|NCT01899053|9937915|P13|Overall Study|Protocol Violation|0
2887049|NCT01899053|9937916|P12|Overall Study|Protocol Violation|0
2887050|NCT01899053|9937917|P11|Overall Study|Protocol Violation|0
2887051|NCT01899053|9937918|P10|Overall Study|Protocol Violation|0
2887052|NCT01899053|9937919|P9|Overall Study|Protocol Violation|0
2887053|NCT01899053|9937920|P8|Overall Study|Protocol Violation|0
2887054|NCT01899053|9937921|P7|Overall Study|Protocol Violation|0
2887055|NCT01899053|9937922|P6|Overall Study|Protocol Violation|0
2887056|NCT01899053|9937923|P5|Overall Study|Protocol Violation|0
2887057|NCT01899053|9937924|P4|Overall Study|Protocol Violation|0
2887058|NCT01899053|9937925|P3|Overall Study|Protocol Violation|1
2887059|NCT01899053|9937926|P2|Overall Study|Protocol Violation|0
2887060|NCT01899053|9937927|P1|Overall Study|Protocol Violation|0
2887061|NCT01899053|9937914|P14|Overall Study|Withdrawal by Subject|1
2887062|NCT01899053|9937915|P13|Overall Study|Withdrawal by Subject|1
2887063|NCT01899053|9937916|P12|Overall Study|Withdrawal by Subject|0
2887064|NCT01899053|9937917|P11|Overall Study|Withdrawal by Subject|0
2887065|NCT01899053|9937918|P10|Overall Study|Withdrawal by Subject|0
2887066|NCT01899053|9937919|P9|Overall Study|Withdrawal by Subject|0
2887067|NCT01899053|9937920|P8|Overall Study|Withdrawal by Subject|1
2887068|NCT01899053|9937921|P7|Overall Study|Withdrawal by Subject|0
2887069|NCT01899053|9937922|P6|Overall Study|Withdrawal by Subject|0
2887070|NCT01899053|9937923|P5|Overall Study|Withdrawal by Subject|2
2887071|NCT01899053|9937924|P4|Overall Study|Withdrawal by Subject|0
2887072|NCT01899053|9937925|P3|Overall Study|Withdrawal by Subject|2
2887073|NCT01899053|9937926|P2|Overall Study|Withdrawal by Subject|1
2887074|NCT01899053|9937927|P1|Overall Study|Withdrawal by Subject|1
2887075|NCT01899053|9937914|P14|Overall Study|Reason Not Specified|0
2887076|NCT01899053|9937915|P13|Overall Study|Reason Not Specified|1
2887077|NCT01899053|9937916|P12|Overall Study|Reason Not Specified|0
2887078|NCT01899053|9937917|P11|Overall Study|Reason Not Specified|0
2887079|NCT01899053|9937918|P10|Overall Study|Reason Not Specified|0
2887080|NCT01899053|9937919|P9|Overall Study|Reason Not Specified|0
2887081|NCT01899053|9937920|P8|Overall Study|Reason Not Specified|0
2887082|NCT01899053|9937921|P7|Overall Study|Reason Not Specified|1
2887083|NCT01899053|9937922|P6|Overall Study|Reason Not Specified|0
2887084|NCT01899053|9937923|P5|Overall Study|Reason Not Specified|0
2887085|NCT01899053|9937924|P4|Overall Study|Reason Not Specified|0
2887086|NCT01899053|9937925|P3|Overall Study|Reason Not Specified|0
2887087|NCT01899053|9937926|P2|Overall Study|Reason Not Specified|0
2887088|NCT01899053|9937927|P1|Overall Study|Reason Not Specified|0
2887089|NCT01899053|9937914|P14|Overall Study|Adverse Event|2
2887090|NCT01899053|9937915|P13|Overall Study|Adverse Event|2
2887091|NCT01899053|9937916|P12|Overall Study|Adverse Event|1
2887092|NCT01899053|9937917|P11|Overall Study|Adverse Event|3
2887093|NCT01899053|9937918|P10|Overall Study|Adverse Event|0
2887094|NCT01899053|9937919|P9|Overall Study|Adverse Event|2
2887095|NCT01899053|9937920|P8|Overall Study|Adverse Event|0
2887096|NCT01899053|9937921|P7|Overall Study|Adverse Event|1
2887097|NCT01899053|9937922|P6|Overall Study|Adverse Event|1
2887098|NCT01899053|9937923|P5|Overall Study|Adverse Event|1
2887099|NCT01899053|9937924|P4|Overall Study|Adverse Event|3
2887100|NCT01899053|9937925|P3|Overall Study|Adverse Event|1
2887101|NCT01899053|9937926|P2|Overall Study|Adverse Event|1
2887102|NCT01899053|9937927|P1|Overall Study|Adverse Event|1
2887103|NCT01899053|9937914|P14|Overall Study|Progressive Disease|17
2887104|NCT01899053|9937915|P13|Overall Study|Progressive Disease|8
2887105|NCT01899053|9937916|P12|Overall Study|Progressive Disease|5
2887106|NCT01899053|9937917|P11|Overall Study|Progressive Disease|12
2887107|NCT01899053|9937918|P10|Overall Study|Progressive Disease|3
2887108|NCT01899053|9937919|P9|Overall Study|Progressive Disease|4
2887109|NCT01899053|9937920|P8|Overall Study|Progressive Disease|1
2887110|NCT01899053|9937921|P7|Overall Study|Progressive Disease|1
2887111|NCT01899053|9937922|P6|Overall Study|Progressive Disease|1
2887112|NCT01899053|9937923|P5|Overall Study|Progressive Disease|3
2887113|NCT01899053|9937924|P4|Overall Study|Progressive Disease|0
2887114|NCT01899053|9937925|P3|Overall Study|Progressive Disease|3
2887115|NCT01899053|9937926|P2|Overall Study|Progressive Disease|0
2887116|NCT01899053|9937927|P1|Overall Study|Progressive Disease|4
2887117|NCT01898884|9938184|P9|Multiple Dose Period|Randomized Not Treated|1
2887118|NCT01898884|9938185|P8|Multiple Dose Period|Randomized Not Treated|0
2887119|NCT01898884|9938186|P7|Multiple Dose Period|Randomized Not Treated|0
2887120|NCT01898884|9938187|P6|Multiple Dose Period|Randomized Not Treated|0
2887121|NCT01898884|9938188|P5|Multiple Dose Period|Randomized Not Treated|0
2887122|NCT01898884|9938189|P4|Multiple Dose Period|Randomized Not Treated|0
2887123|NCT01898884|9938190|P3|Multiple Dose Period|Randomized Not Treated|0
2887124|NCT01898884|9938191|P2|Multiple Dose Period|Randomized Not Treated|0
2887125|NCT01898884|9938192|P1|Multiple Dose Period|Randomized Not Treated|0
2887126|NCT01898884|9938184|P9|Multiple Dose Period|Adverse Event|0
2887127|NCT01898884|9938185|P8|Multiple Dose Period|Adverse Event|0
2887128|NCT01898884|9938186|P7|Multiple Dose Period|Adverse Event|1
2887129|NCT01898884|9938187|P6|Multiple Dose Period|Adverse Event|0
2887130|NCT01898884|9938188|P5|Multiple Dose Period|Adverse Event|0
2887131|NCT01898884|9938189|P4|Multiple Dose Period|Adverse Event|0
2887132|NCT01898884|9938190|P3|Multiple Dose Period|Adverse Event|0
2887133|NCT01898884|9938191|P2|Multiple Dose Period|Adverse Event|0
2887134|NCT01898884|9938192|P1|Multiple Dose Period|Adverse Event|0
2887135|NCT01898806|9938342|P1|Overall Study|Physician Decision|1
2887136|NCT01898806|9938342|P1|Overall Study|Withdrawal by Subject|2
2887137|NCT01898598|9938372|P2|Overall Study|Other|1
2887138|NCT01898598|9938373|P1|Overall Study|Other|0
2887139|NCT01898598|9938372|P2|Overall Study|Lost to Follow-up|1
2887140|NCT01898598|9938373|P1|Overall Study|Lost to Follow-up|0
2887141|NCT01898598|9938372|P2|Overall Study|Withdrawal by Subject|0
2887142|NCT01898598|9938373|P1|Overall Study|Withdrawal by Subject|3
2887143|NCT01898598|9938372|P2|Overall Study|Adverse Event|0
2887144|NCT01898598|9938373|P1|Overall Study|Adverse Event|1
2887145|NCT01898442|9938392|P3|Overall Study|Patient vomited pills|1
2887146|NCT01898442|9938393|P2|Overall Study|Patient vomited pills|0
2887147|NCT01898442|9938394|P1|Overall Study|Patient vomited pills|0
2887148|NCT01898442|9938392|P3|Overall Study|Hemolysis/technical problems|2
2887149|NCT01898442|9938393|P2|Overall Study|Hemolysis/technical problems|2
2887150|NCT01898442|9938394|P1|Overall Study|Hemolysis/technical problems|1
2887151|NCT01898299|9938431|P2|Post Treatment (One Month)|Lost to Follow-up|4
2887152|NCT01898299|9938432|P1|Post Treatment (One Month)|Lost to Follow-up|3
2887153|NCT01898286|9938438|P1|Overall Study|Lost to Follow-up|1
2887154|NCT01898286|9938438|P1|Overall Study|Protocol Violation|1
2887155|NCT01898286|9938438|P1|Overall Study|Withdrawal by Subject|1
2887156|NCT01898208|9938448|P3|Overall Study|Lost to Follow-up|1
2887157|NCT01898208|9938449|P2|Overall Study|Lost to Follow-up|1
2887158|NCT01898208|9938450|P1|Overall Study|Lost to Follow-up|3
2887159|NCT01898208|9938448|P3|Overall Study|System/Technical Error|3
2887160|NCT01898208|9938449|P2|Overall Study|System/Technical Error|2
2887161|NCT01898208|9938450|P1|Overall Study|System/Technical Error|1
2887162|NCT01898208|9938448|P3|Overall Study|Non-Blood Specimens in Bottles|4
2887163|NCT01898208|9938449|P2|Overall Study|Non-Blood Specimens in Bottles|5
2887164|NCT01898208|9938450|P1|Overall Study|Non-Blood Specimens in Bottles|3
2887165|NCT01898208|9938448|P3|Overall Study|Negative Gram Stain|6
2887166|NCT01898208|9938449|P2|Overall Study|Negative Gram Stain|9
2887167|NCT01898208|9938450|P1|Overall Study|Negative Gram Stain|6
2887168|NCT01898208|9938448|P3|Overall Study|Death/comfort care within 24 hours|8
2887169|NCT01898208|9938449|P2|Overall Study|Death/comfort care within 24 hours|9
2887170|NCT01898208|9938450|P1|Overall Study|Death/comfort care within 24 hours|10
2887171|NCT01898208|9938448|P3|Overall Study|Positive blood culture|15
2887172|NCT01898208|9938449|P2|Overall Study|Positive blood culture|23
2887173|NCT01898208|9938450|P1|Overall Study|Positive blood culture|17
2887174|NCT01898195|9938497|P3|Smoking Abstinence|Did not have good measurements|36
2887175|NCT01898195|9938498|P2|Smoking Abstinence|Did not have good measurements|38
2887176|NCT01898195|9938499|P1|Smoking Abstinence|Did not have good measurements|35
2887177|NCT01898130|9938510|P1|Follow up Until PD or Death|Lost to Follow-up|1
2887178|NCT01898130|9938510|P1|Treatment|Progressive Disease|4
2887179|NCT01898130|9938510|P1|Treatment|Withdrawal by Subject|2
2887180|NCT01898091|9938525|P2|Overall Study|Withdrawal by Subject|5
2887181|NCT01898091|9938526|P1|Overall Study|Withdrawal by Subject|1
2887182|NCT01898091|9938525|P2|Overall Study|Lost to Follow-up|1
2887183|NCT01898091|9938526|P1|Overall Study|Lost to Follow-up|1
2887184|NCT01898078|9938534|P2|Overall Study|Reason not Specified|1
2887185|NCT01898078|9938535|P1|Overall Study|Reason not Specified|0
2887186|NCT01898078|9938534|P2|Overall Study|Symptomatic Deterioration|0
2887187|NCT01898078|9938535|P1|Overall Study|Symptomatic Deterioration|2
2887188|NCT01898078|9938534|P2|Overall Study|Withdrawal by Subject|1
2887189|NCT01898078|9938535|P1|Overall Study|Withdrawal by Subject|1
2887190|NCT01898078|9938534|P2|Overall Study|Adverse Event|1
2887191|NCT01898078|9938535|P1|Overall Study|Adverse Event|2
2887192|NCT01898078|9938534|P2|Overall Study|Progressive Disease|5
2887193|NCT01898078|9938535|P1|Overall Study|Progressive Disease|1
2887194|NCT01897896|9938572|P2|Overall Study|Other than specified|1
2887195|NCT01897896|9938573|P1|Overall Study|Other than specified|2
2887196|NCT01897896|9938572|P2|Overall Study|Caregiver can no longer participate|2
2887197|NCT01897896|9938573|P1|Overall Study|Caregiver can no longer participate|0
2887198|NCT01897896|9938572|P2|Overall Study|Withdrawal per Investigator’s judgement|1
2887199|NCT01897896|9938573|P1|Overall Study|Withdrawal per Investigator’s judgement|1
2887200|NCT01897896|9938572|P2|Overall Study|Protocol Violation|1
2887201|NCT01897896|9938573|P1|Overall Study|Protocol Violation|1
2887202|NCT01897896|9938572|P2|Overall Study|Require drug that interfere with study|4
2887203|NCT01897896|9938573|P1|Overall Study|Require drug that interfere with study|1
2887204|NCT01897896|9938572|P2|Overall Study|Withdrawal by Subject|1
2887205|NCT01897896|9938573|P1|Overall Study|Withdrawal by Subject|7
2887206|NCT01897896|9938572|P2|Overall Study|Non-compliance with study drug dosing|1
2887207|NCT01897896|9938573|P1|Overall Study|Non-compliance with study drug dosing|1
2887208|NCT01897896|9938572|P2|Overall Study|Lost to Follow-up|0
2887209|NCT01897896|9938573|P1|Overall Study|Lost to Follow-up|1
2887210|NCT01897896|9938572|P2|Overall Study|Adverse Event|1
2887211|NCT01897896|9938573|P1|Overall Study|Adverse Event|11
2887212|NCT01897896|9938572|P2|Overall Study|Death|0
2887213|NCT01897896|9938573|P1|Overall Study|Death|1
2887214|NCT01897727|9938705|P2|Overall Study|Exclusion: central sleep apnea|1
2887215|NCT01897727|9938706|P1|Overall Study|Exclusion: central sleep apnea|0
2887216|NCT01897532|9938714|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
2887217|NCT01897532|9938715|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
2887218|NCT01897532|9938714|P2|Discontinuation From Trial|Not Treated|5
2887219|NCT01897532|9938715|P1|Discontinuation From Trial|Not Treated|7
2887220|NCT01897532|9938714|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
2887221|NCT01897532|9938715|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
2887222|NCT01897532|9938714|P2|Discontinuation From Treatment|Non compliance|15
2887223|NCT01897532|9938715|P1|Discontinuation From Treatment|Non compliance|24
2887224|NCT01897532|9938714|P2|Discontinuation From Treatment|Withdrawal by Subject|281
2887225|NCT01897532|9938715|P1|Discontinuation From Treatment|Withdrawal by Subject|333
2887226|NCT01897532|9938714|P2|Discontinuation From Treatment|Other reason than specified|176
2887227|NCT01897532|9938715|P1|Discontinuation From Treatment|Other reason than specified|196
2887228|NCT01897532|9938714|P2|Discontinuation From Treatment|Not Treated|5
2887229|NCT01897532|9938715|P1|Discontinuation From Treatment|Not Treated|7
2887230|NCT01897493|9938723|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
2887231|NCT01897233|9938759|P1|Part B (24 Weeks)|Physician Decision|1
2887232|NCT01897233|9938759|P1|Part B (24 Weeks)|Withdrawal by Subject|2
2887233|NCT01897233|9938759|P1|Part B (24 Weeks)|Adverse Event|1
2887234|NCT01896986|9938811|P2|Overall Study|samples lost|23
2887235|NCT01896986|9938812|P1|Overall Study|samples lost|14
2887236|NCT01896934|9938818|P1|Overall Study|Withdrawal by Subject|1
2887237|NCT01896934|9938818|P1|Overall Study|Adverse Event|1
2887238|NCT01896895|9938831|P4|Double-blind MP|Lost to Follow-up|0
2887239|NCT01896895|9938832|P3|Double-blind MP|Lost to Follow-up|1
2887240|NCT01896895|9938833|P2|Double-blind MP|Lost to Follow-up|0
2887241|NCT01896895|9938834|P1|Double-blind MP|Lost to Follow-up|1
2887242|NCT01896895|9938831|P4|Double-blind MP|Withdrawal by Subject|0
2887243|NCT01896895|9938832|P3|Double-blind MP|Withdrawal by Subject|1
2887244|NCT01896895|9938833|P2|Double-blind MP|Withdrawal by Subject|2
2887245|NCT01896895|9938834|P1|Double-blind MP|Withdrawal by Subject|0
2887246|NCT01896895|9938831|P4|Double-blind MP|Physician Decision|0
2887247|NCT01896895|9938832|P3|Double-blind MP|Physician Decision|1
2887248|NCT01896895|9938833|P2|Double-blind MP|Physician Decision|0
2887249|NCT01896895|9938834|P1|Double-blind MP|Physician Decision|0
2887250|NCT01896869|9938851|P2|Overall Study|Lost to Follow-up|0
2887251|NCT01896869|9938852|P1|Overall Study|Lost to Follow-up|1
2887252|NCT01896869|9938851|P2|Overall Study|Withdrawal by Subject|6
2887253|NCT01896869|9938852|P1|Overall Study|Withdrawal by Subject|0
2887254|NCT01896726|9938871|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
2887255|NCT01896726|9938871|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
2887256|NCT01896700|9938886|P2|Overall Study|Withdrawal by Subject|1
2887257|NCT01896700|9938887|P1|Overall Study|Withdrawal by Subject|0
2887258|NCT01896700|9938886|P2|Overall Study|Adverse Event|5
2887259|NCT01896700|9938887|P1|Overall Study|Adverse Event|4
2887260|NCT01896557|9938918|P2|Clopidogrel + GI Protector|Reading error|3
2887261|NCT01896557|9938919|P1|Clopidogrel + GI Protector|Reading error|1
2887262|NCT01896557|9938918|P2|Clopidogrel + GI Protector|low adherence|1
2887263|NCT01896557|9938919|P1|Clopidogrel + GI Protector|low adherence|1
2887264|NCT01896557|9938918|P2|Clopidogrel Alone|Adverse Event|0
2887265|NCT01896557|9938919|P1|Clopidogrel Alone|Adverse Event|1
2887266|NCT01896297|9938956|P1|Overall Study|Died in post treatment phase|1
2887267|NCT01896232|9938963|P2|Overall Study|Lost to Follow-up|12
2887268|NCT01896232|9938964|P1|Overall Study|Lost to Follow-up|9
2887269|NCT01896232|9938963|P2|Overall Study|Sponsor Decision|0
2887270|NCT01896232|9938964|P1|Overall Study|Sponsor Decision|2
2887271|NCT01896232|9938963|P2|Overall Study|Withdrawal by Subject|31
2887272|NCT01896232|9938964|P1|Overall Study|Withdrawal by Subject|32
2887273|NCT01896232|9938963|P2|Overall Study|Death|10
2887274|NCT01896232|9938964|P1|Overall Study|Death|6
2887275|NCT01896193|9938992|P2|Overall Study|Withdrew Consent|0
2887276|NCT01896193|9938993|P1|Overall Study|Withdrew Consent|1
2887277|NCT01896193|9938992|P2|Overall Study|Protocol Violation|1
2887278|NCT01896193|9938993|P1|Overall Study|Protocol Violation|0
2887279|NCT01896193|9938992|P2|Overall Study|Lack of Efficacy|11
2887280|NCT01896193|9938993|P1|Overall Study|Lack of Efficacy|20
2887281|NCT01896128|9939019|P2|Overall Study|Withdrawal by Subject|3
2887282|NCT01896128|9939020|P1|Overall Study|Withdrawal by Subject|3
2887283|NCT01896050|9939062|P2|Overall Study|Death|0
2887284|NCT01896050|9939063|P1|Overall Study|Death|1
2887285|NCT01896050|9939062|P2|Overall Study|Adverse Event|2
2887286|NCT01896050|9939063|P1|Overall Study|Adverse Event|37
2887287|NCT01895608|9939130|P4|Overall Study|Withdrawal by Subject|0
2887288|NCT01895608|9939131|P3|Overall Study|Withdrawal by Subject|2
2887289|NCT01895608|9939132|P2|Overall Study|Withdrawal by Subject|0
2887290|NCT01895608|9939133|P1|Overall Study|Withdrawal by Subject|0
2887291|NCT01895608|9939130|P4|Overall Study|change in health status|0
2887292|NCT01895608|9939131|P3|Overall Study|change in health status|1
2887293|NCT01895608|9939132|P2|Overall Study|change in health status|1
2887294|NCT01895608|9939133|P1|Overall Study|change in health status|0
2887295|NCT01895543|9939163|P1|Overall Study|Other (Not fulfilling above criteria)|24
2887296|NCT01895543|9939163|P1|Overall Study|Physician Decision|2
2887297|NCT01895543|9939163|P1|Overall Study|Protocol Violation|1
2887298|NCT01895543|9939163|P1|Overall Study|Subject's substantial non-compliance|6
2887299|NCT01895543|9939163|P1|Overall Study|Adverse Event|28
2887300|NCT01895543|9939163|P1|Overall Study|Lost to Follow-up|25
2887301|NCT01895543|9939163|P1|Overall Study|Withdrawal by Subject|43
2887302|NCT01895452|9939179|P2|Overall Study|Noncompliance with study drug|1
2887303|NCT01895452|9939180|P1|Overall Study|Noncompliance with study drug|0
2887304|NCT01895452|9939179|P2|Overall Study|Underlying disease|3
2887305|NCT01895452|9939180|P1|Overall Study|Underlying disease|0
2887306|NCT01895452|9939179|P2|Overall Study|Withdrawal by Subject|14
2887307|NCT01895452|9939180|P1|Overall Study|Withdrawal by Subject|2
2887308|NCT01895452|9939179|P2|Overall Study|Pregnancy|1
2887309|NCT01895452|9939180|P1|Overall Study|Pregnancy|0
2887310|NCT01895452|9939179|P2|Overall Study|Lost to Follow-up|5
2887311|NCT01895452|9939180|P1|Overall Study|Lost to Follow-up|1
2887312|NCT01895452|9939179|P2|Overall Study|Adverse Event|4
2887313|NCT01895452|9939180|P1|Overall Study|Adverse Event|1
2887314|NCT01895361|9939193|P3|Overall Study|Reasons different from categories above|4
2887315|NCT01895361|9939194|P2|Overall Study|Reasons different from categories above|3
2887316|NCT01895361|9939195|P1|Overall Study|Reasons different from categories above|7
2887317|NCT01895361|9939193|P3|Overall Study|Lack of Efficacy|0
2887318|NCT01895361|9939194|P2|Overall Study|Lack of Efficacy|1
2887319|NCT01895361|9939195|P1|Overall Study|Lack of Efficacy|0
2887320|NCT01895361|9939193|P3|Overall Study|Withdrawal by Subject|6
2887321|NCT01895361|9939194|P2|Overall Study|Withdrawal by Subject|6
2887322|NCT01895361|9939195|P1|Overall Study|Withdrawal by Subject|7
2887323|NCT01895361|9939193|P3|Overall Study|Physician Decision|2
2887324|NCT01895361|9939194|P2|Overall Study|Physician Decision|2
2887325|NCT01895361|9939195|P1|Overall Study|Physician Decision|2
2887326|NCT01895361|9939193|P3|Overall Study|Non-compliance with study|1
2887327|NCT01895361|9939194|P2|Overall Study|Non-compliance with study|3
2887328|NCT01895361|9939195|P1|Overall Study|Non-compliance with study|1
2887329|NCT01895361|9939193|P3|Overall Study|Lost to Follow-up|6
2887330|NCT01895361|9939194|P2|Overall Study|Lost to Follow-up|4
2887331|NCT01895361|9939195|P1|Overall Study|Lost to Follow-up|4
2887332|NCT01895361|9939193|P3|Overall Study|Death|2
2887333|NCT01895361|9939194|P2|Overall Study|Death|1
2887334|NCT01895361|9939195|P1|Overall Study|Death|2
2887335|NCT01895361|9939193|P3|Overall Study|Adverse Event|3
2887336|NCT01895361|9939194|P2|Overall Study|Adverse Event|1
2887337|NCT01895361|9939195|P1|Overall Study|Adverse Event|1
2887338|NCT01895335|9939224|P1|Overall Study|Other than Specified Above|44
2887339|NCT01895335|9939224|P1|Overall Study|Included But Not treated|1
2887340|NCT01895335|9939224|P1|Overall Study|Poor Compliance to Protocol|11
2887341|NCT01895335|9939224|P1|Overall Study|Lack of Efficacy|53
2887342|NCT01895335|9939224|P1|Overall Study|Adverse Event|106
2887343|NCT01895322|9939241|P1|Overall Study|Protocol Violation|10
2887344|NCT01895322|9939241|P1|Overall Study|Withdrawal by Subject|2
2887345|NCT01895322|9939241|P1|Overall Study|Adverse Event|1
2887346|NCT01895309|9939250|P2|Overall Study|Withdrawal by Subject|18
2887347|NCT01895309|9939251|P1|Overall Study|Withdrawal by Subject|9
2887348|NCT01895309|9939250|P2|Overall Study|Physician Decision|10
2887349|NCT01895309|9939251|P1|Overall Study|Physician Decision|15
2887350|NCT01895309|9939250|P2|Overall Study|Lost to Follow-up|3
2887351|NCT01895309|9939251|P1|Overall Study|Lost to Follow-up|1
2887352|NCT01895309|9939250|P2|Overall Study|Lack of Efficacy|3
2887353|NCT01895309|9939251|P1|Overall Study|Lack of Efficacy|1
2887354|NCT01895309|9939250|P2|Overall Study|Protocol Violation|0
2887355|NCT01895309|9939251|P1|Overall Study|Protocol Violation|1
2887356|NCT01895309|9939250|P2|Overall Study|Adverse Event|17
2887357|NCT01895309|9939251|P1|Overall Study|Adverse Event|13
2887358|NCT01895270|9939265|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
2887359|NCT01895270|9939266|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
2887360|NCT01895270|9939265|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
2887361|NCT01895270|9939266|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
2887362|NCT01895270|9939265|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
2887363|NCT01895270|9939266|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
2887364|NCT01895270|9939265|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
2887365|NCT01895270|9939266|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
2887366|NCT01895270|9939265|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
2887367|NCT01895270|9939266|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
2887368|NCT01895270|9939265|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
2887369|NCT01895270|9939266|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
2887370|NCT01895270|9939265|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
2887371|NCT01895270|9939266|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
2887372|NCT01895101|9939285|P3|Overall Study|coagulation disorder|0
2887373|NCT01895101|9939286|P2|Overall Study|coagulation disorder|1
2887374|NCT01895101|9939287|P1|Overall Study|coagulation disorder|0
2887375|NCT01895101|9939285|P3|Overall Study|Death|0
2887376|NCT01895101|9939286|P2|Overall Study|Death|1
2887377|NCT01895101|9939287|P1|Overall Study|Death|0
2887378|NCT01895101|9939285|P3|Overall Study|another study, enrolled in other study|0
2887379|NCT01895101|9939286|P2|Overall Study|another study, enrolled in other study|1
2887380|NCT01895101|9939287|P1|Overall Study|another study, enrolled in other study|0
2887381|NCT01895101|9939285|P3|Overall Study|Withdrawal by Subject|2
2887382|NCT01895101|9939286|P2|Overall Study|Withdrawal by Subject|1
2887383|NCT01895101|9939287|P1|Overall Study|Withdrawal by Subject|0
2887384|NCT01895101|9939285|P3|Overall Study|OPCAB procedure|3
2887385|NCT01895101|9939286|P2|Overall Study|OPCAB procedure|1
2887386|NCT01895101|9939287|P1|Overall Study|OPCAB procedure|1
2887387|NCT01894984|9939322|P2|Overall Study|Other|175
2887388|NCT01894984|9939323|P1|Overall Study|Other|314
2887389|NCT01894919|9939352|P13|Overall Study|Lost to Follow-up|0
2887390|NCT01894919|9939353|P12|Overall Study|Lost to Follow-up|0
2887391|NCT01894919|9939354|P11|Overall Study|Lost to Follow-up|0
2887392|NCT01894919|9939355|P10|Overall Study|Lost to Follow-up|0
2887393|NCT01894919|9939356|P9|Overall Study|Lost to Follow-up|0
2887394|NCT01894919|9939357|P8|Overall Study|Lost to Follow-up|0
2887395|NCT01894919|9939358|P7|Overall Study|Lost to Follow-up|0
2887396|NCT01894919|9939359|P6|Overall Study|Lost to Follow-up|0
2887397|NCT01894919|9939360|P5|Overall Study|Lost to Follow-up|2
2887398|NCT01894919|9939361|P4|Overall Study|Lost to Follow-up|0
2887399|NCT01894919|9939362|P3|Overall Study|Lost to Follow-up|0
2887400|NCT01894919|9939363|P2|Overall Study|Lost to Follow-up|0
2887401|NCT01894919|9939364|P1|Overall Study|Lost to Follow-up|0
2887402|NCT01894919|9939352|P13|Overall Study|Other-Unspecified|0
2887403|NCT01894919|9939353|P12|Overall Study|Other-Unspecified|0
2887404|NCT01894919|9939354|P11|Overall Study|Other-Unspecified|0
2887405|NCT01894919|9939355|P10|Overall Study|Other-Unspecified|0
2887406|NCT01894919|9939356|P9|Overall Study|Other-Unspecified|0
2887407|NCT01894919|9939357|P8|Overall Study|Other-Unspecified|0
2887408|NCT01894919|9939358|P7|Overall Study|Other-Unspecified|0
2887409|NCT01894919|9939359|P6|Overall Study|Other-Unspecified|0
2887410|NCT01894919|9939360|P5|Overall Study|Other-Unspecified|0
2887411|NCT01894919|9939361|P4|Overall Study|Other-Unspecified|0
2887412|NCT01894919|9939362|P3|Overall Study|Other-Unspecified|0
2887413|NCT01894919|9939363|P2|Overall Study|Other-Unspecified|0
2887414|NCT01894919|9939364|P1|Overall Study|Other-Unspecified|1
2887415|NCT01894919|9939352|P13|Overall Study|Adverse Event|0
2887416|NCT01894919|9939353|P12|Overall Study|Adverse Event|0
2887417|NCT01894919|9939354|P11|Overall Study|Adverse Event|1
2887418|NCT01894919|9939355|P10|Overall Study|Adverse Event|0
2887419|NCT01894919|9939356|P9|Overall Study|Adverse Event|0
2887420|NCT01894919|9939357|P8|Overall Study|Adverse Event|0
2887421|NCT01894919|9939358|P7|Overall Study|Adverse Event|0
2887422|NCT01894919|9939359|P6|Overall Study|Adverse Event|0
2887423|NCT01894919|9939360|P5|Overall Study|Adverse Event|0
2887424|NCT01894919|9939361|P4|Overall Study|Adverse Event|0
2887425|NCT01894919|9939362|P3|Overall Study|Adverse Event|0
2887426|NCT01894919|9939363|P2|Overall Study|Adverse Event|0
2887427|NCT01894919|9939364|P1|Overall Study|Adverse Event|0
2887428|NCT01894919|9939352|P13|Overall Study|Withdrawal by Subject|0
2887429|NCT01894919|9939353|P12|Overall Study|Withdrawal by Subject|0
2887430|NCT01894919|9939354|P11|Overall Study|Withdrawal by Subject|1
2887431|NCT01894919|9939355|P10|Overall Study|Withdrawal by Subject|1
2887432|NCT01894919|9939356|P9|Overall Study|Withdrawal by Subject|0
2887433|NCT01894919|9939357|P8|Overall Study|Withdrawal by Subject|0
2887434|NCT01894919|9939358|P7|Overall Study|Withdrawal by Subject|0
2887435|NCT01894919|9939359|P6|Overall Study|Withdrawal by Subject|0
2887436|NCT01894919|9939360|P5|Overall Study|Withdrawal by Subject|1
2887437|NCT01894919|9939361|P4|Overall Study|Withdrawal by Subject|0
2887438|NCT01894919|9939362|P3|Overall Study|Withdrawal by Subject|0
2887439|NCT01894919|9939363|P2|Overall Study|Withdrawal by Subject|0
2887440|NCT01894919|9939364|P1|Overall Study|Withdrawal by Subject|1
2887441|NCT01894841|9939519|P2|Overall Study|Lost to Follow-up|3
2887442|NCT01894841|9939520|P1|Overall Study|Lost to Follow-up|7
2887443|NCT01894841|9939519|P2|Overall Study|Withdrawn by investigator|2
2887444|NCT01894841|9939520|P1|Overall Study|Withdrawn by investigator|2
2887445|NCT01894841|9939519|P2|Overall Study|Withdrawal by Subject|4
2887446|NCT01894841|9939520|P1|Overall Study|Withdrawal by Subject|9
2887447|NCT01894776|9939536|P1|Overall Study|Withdrawal by Subject|1
2887448|NCT01894620|9939550|P2|Overall Study|Withdrawal by Subject|1
2887449|NCT01894620|9939551|P1|Overall Study|Withdrawal by Subject|0
2887450|NCT01894607|9939559|P1|Overall Study|Ineligible|1
2887451|NCT01894581|9939566|P2|Overall Study|Screen Failure|4
2887452|NCT01894581|9939567|P1|Overall Study|Screen Failure|3
2887453|NCT01894581|9939566|P2|Overall Study|Withdrawal by Subject|3
2887454|NCT01894581|9939567|P1|Overall Study|Withdrawal by Subject|2
2887455|NCT01894568|9939575|P2|Overall Study|Lost to Follow-up|1
2887456|NCT01894568|9939576|P1|Overall Study|Lost to Follow-up|0
2887457|NCT01894568|9939575|P2|Overall Study|Physician Decision|0
2887458|NCT01894568|9939576|P1|Overall Study|Physician Decision|1
2887459|NCT01894568|9939575|P2|Overall Study|Withdrawal by Subject|5
2887460|NCT01894568|9939576|P1|Overall Study|Withdrawal by Subject|5
2887461|NCT01894568|9939575|P2|Overall Study|Protocol required discontinuation|1
2887462|NCT01894568|9939576|P1|Overall Study|Protocol required discontinuation|2
2887463|NCT01894568|9939575|P2|Overall Study|Adverse Event|3
2887464|NCT01894568|9939576|P1|Overall Study|Adverse Event|2
2887465|NCT01894477|9939627|P2|Overall Study|protocol changed due SC changed to cord|1
2887466|NCT01894477|9939628|P1|Overall Study|protocol changed due SC changed to cord|0
2887467|NCT01894477|9939627|P2|Overall Study|Protocol Violation|1
2887468|NCT01894477|9939628|P1|Overall Study|Protocol Violation|0
2887469|NCT01894256|9939639|P3|Part B|Lack of Efficacy|13
2887470|NCT01894256|9939640|P2|Part B|Lack of Efficacy|12
2887471|NCT01894256|9939641|P1|Part B|Lack of Efficacy|15
2887472|NCT01894256|9939639|P3|Part B|Withdrawal by Subject|0
2887473|NCT01894256|9939640|P2|Part B|Withdrawal by Subject|1
2887474|NCT01894256|9939641|P1|Part B|Withdrawal by Subject|0
2887475|NCT01894256|9939639|P3|Part B|Death|1
2887476|NCT01894256|9939640|P2|Part B|Death|1
2887477|NCT01894256|9939641|P1|Part B|Death|0
2887478|NCT01894256|9939639|P3|Part A|Adverse Event|0
2887479|NCT01894256|9939640|P2|Part A|Adverse Event|1
2887480|NCT01894256|9939641|P1|Part A|Adverse Event|0
2887481|NCT01894243|9939688|P3|Overall Study|Other|0
2887482|NCT01894243|9939689|P2|Overall Study|Other|0
2887483|NCT01894243|9939690|P1|Overall Study|Other|1
2887484|NCT01894243|9939688|P3|Overall Study|Subject decision|0
2887485|NCT01894243|9939689|P2|Overall Study|Subject decision|0
2887486|NCT01894243|9939690|P1|Overall Study|Subject decision|1
2887487|NCT01894243|9939688|P3|Overall Study|Condition under investigation worsened|2
2887488|NCT01894243|9939689|P2|Overall Study|Condition under investigation worsened|6
2887489|NCT01894243|9939690|P1|Overall Study|Condition under investigation worsened|8
2887490|NCT01894243|9939688|P3|Overall Study|Lack of Efficacy|1
2887491|NCT01894243|9939689|P2|Overall Study|Lack of Efficacy|3
2887492|NCT01894243|9939690|P1|Overall Study|Lack of Efficacy|3
2887493|NCT01894243|9939688|P3|Overall Study|Death|3
2887494|NCT01894243|9939689|P2|Overall Study|Death|0
2887495|NCT01894243|9939690|P1|Overall Study|Death|0
2887496|NCT01894243|9939688|P3|Overall Study|Adverse Event|2
2887497|NCT01894243|9939689|P2|Overall Study|Adverse Event|1
2887498|NCT01894243|9939690|P1|Overall Study|Adverse Event|0
2887499|NCT01894230|9939729|P2|Overall Study|Death|0
2887500|NCT01894230|9939730|P1|Overall Study|Death|1
2887501|NCT01894230|9939729|P2|Overall Study|Non-adherent|1
2887502|NCT01894230|9939730|P1|Overall Study|Non-adherent|0
2887503|NCT01894230|9939729|P2|Overall Study|Withdrawal by Subject|4
2887504|NCT01894230|9939730|P1|Overall Study|Withdrawal by Subject|4
2887505|NCT01894230|9939729|P2|Overall Study|Lost to Follow-up|2
2887506|NCT01894230|9939730|P1|Overall Study|Lost to Follow-up|2
2887507|NCT01894152|9939765|P1|Overall Study|No DMR and no Stent thrombosis|151
2887508|NCT01894100|9939808|P2|Overall Study|Withdrawal by Subject|0
2887509|NCT01894100|9939809|P1|Overall Study|Withdrawal by Subject|3
2887510|NCT01894100|9939808|P2|Overall Study|Lost to Follow-up|1
2887511|NCT01894100|9939809|P1|Overall Study|Lost to Follow-up|0
2887512|NCT01894022|9939834|P2|Overall Study|Study Closed/terminated|10
2887513|NCT01894022|9939835|P1|Overall Study|Study Closed/terminated|7
2887514|NCT01894022|9939834|P2|Overall Study|Adverse Event, non-fatal|0
2887515|NCT01894022|9939835|P1|Overall Study|Adverse Event, non-fatal|1
2887516|NCT01894022|9939834|P2|Overall Study|Death|0
2887517|NCT01894022|9939835|P1|Overall Study|Death|1
2887518|NCT01893905|9939904|P2|Overall Study|Other reason|3
2887519|NCT01893905|9939905|P1|Overall Study|Other reason|1
2887520|NCT01893905|9939904|P2|Overall Study|Lack of adherence to treatment|0
2887521|NCT01893905|9939905|P1|Overall Study|Lack of adherence to treatment|2
2887522|NCT01893905|9939904|P2|Overall Study|Protocol Violation|1
2887523|NCT01893905|9939905|P1|Overall Study|Protocol Violation|6
2887524|NCT01893905|9939904|P2|Overall Study|Lost to Follow-up|0
2887525|NCT01893905|9939905|P1|Overall Study|Lost to Follow-up|1
2887526|NCT01893905|9939904|P2|Overall Study|Lack of Efficacy|7
2887527|NCT01893905|9939905|P1|Overall Study|Lack of Efficacy|5
2887528|NCT01893905|9939904|P2|Overall Study|Adverse Event|3
2887529|NCT01893905|9939905|P1|Overall Study|Adverse Event|9
2887530|NCT01893905|9939904|P2|Overall Study|Withdrawal by Subject|0
2887531|NCT01893905|9939905|P1|Overall Study|Withdrawal by Subject|1
2887532|NCT01893411|9939944|P3|Overall Study|Lost to Follow-up|1
2887533|NCT01893411|9939945|P2|Overall Study|Lost to Follow-up|0
2887534|NCT01893411|9939946|P1|Overall Study|Lost to Follow-up|2
2887535|NCT01893411|9939944|P3|Overall Study|Withdrawal by Subject|3
2887536|NCT01893411|9939945|P2|Overall Study|Withdrawal by Subject|4
2887537|NCT01893411|9939946|P1|Overall Study|Withdrawal by Subject|7
2887538|NCT01893411|9939944|P3|Overall Study|Adverse Event|0
2887539|NCT01893411|9939945|P2|Overall Study|Adverse Event|0
2887540|NCT01893411|9939946|P1|Overall Study|Adverse Event|1
2887541|NCT01893411|9939944|P3|Overall Study|Other|3
2887542|NCT01893411|9939945|P2|Overall Study|Other|1
2887543|NCT01893411|9939946|P1|Overall Study|Other|3
2887544|NCT01893411|9939944|P3|Overall Study|Lack of Efficacy|0
2887545|NCT01893411|9939945|P2|Overall Study|Lack of Efficacy|1
2887546|NCT01893411|9939946|P1|Overall Study|Lack of Efficacy|2
2887547|NCT01893411|9939944|P3|Overall Study|Physician Decision|2
2887548|NCT01893411|9939945|P2|Overall Study|Physician Decision|1
2887549|NCT01893411|9939946|P1|Overall Study|Physician Decision|1
2887550|NCT01893411|9939944|P3|Overall Study|Protocol Violation|0
2887551|NCT01893411|9939945|P2|Overall Study|Protocol Violation|0
2887552|NCT01893411|9939946|P1|Overall Study|Protocol Violation|1
2887553|NCT01893346|9940043|P4|Overall Study|Withdrawal by Subject|0
2887554|NCT01893346|9940044|P3|Overall Study|Withdrawal by Subject|0
2887555|NCT01893346|9940045|P2|Overall Study|Withdrawal by Subject|0
2887556|NCT01893346|9940046|P1|Overall Study|Withdrawal by Subject|2
2887557|NCT01893346|9940043|P4|Overall Study|Protocol Violation|0
2887558|NCT01893346|9940044|P3|Overall Study|Protocol Violation|0
2887559|NCT01893346|9940045|P2|Overall Study|Protocol Violation|0
2887560|NCT01893346|9940046|P1|Overall Study|Protocol Violation|1
2887561|NCT01893346|9940043|P4|Overall Study|Lost to Follow-up|0
2887562|NCT01893346|9940044|P3|Overall Study|Lost to Follow-up|0
2887563|NCT01893346|9940045|P2|Overall Study|Lost to Follow-up|1
2887564|NCT01893346|9940046|P1|Overall Study|Lost to Follow-up|0
2887565|NCT01893281|9940060|P1|Overall Study|Withdrawal by Subject|1
2887566|NCT01893281|9940060|P1|Overall Study|Protocol Violation|1
2887567|NCT01893281|9940060|P1|Overall Study|Adverse Event|1
2887568|NCT01893203|9940067|P1|Overall Study|Withdrawal by Subject|1
2887569|NCT01892722|9940091|P2|Overall Study|Withdrawal by Subject|5
2887570|NCT01892722|9940092|P1|Overall Study|Withdrawal by Subject|3
2887571|NCT01892722|9940091|P2|Overall Study|Lack of Efficacy|7
2887572|NCT01892722|9940092|P1|Overall Study|Lack of Efficacy|0
2887573|NCT01892722|9940091|P2|Overall Study|Adverse Event|2
2887574|NCT01892722|9940092|P1|Overall Study|Adverse Event|3
2887575|NCT01892722|9940091|P2|Overall Study|Physician Decision|2
2887576|NCT01892722|9940092|P1|Overall Study|Physician Decision|1
2887577|NCT01892722|9940091|P2|Overall Study|Patient/guardian decision|2
2887578|NCT01892722|9940092|P1|Overall Study|Patient/guardian decision|0
2887579|NCT01892722|9940091|P2|Overall Study|Administrative problems|1
2887580|NCT01892722|9940092|P1|Overall Study|Administrative problems|0
2887581|NCT01892722|9940091|P2|Overall Study|Protocol deviation|1
2887582|NCT01892722|9940092|P1|Overall Study|Protocol deviation|0
2887583|NCT01892657|9940108|P1|Overall Study|Protocol Violation|12
2887584|NCT01892657|9940108|P1|Overall Study|Withdrawal by Subject|6
2887585|NCT01892540|9940127|P3|Overall Study|Did not fit in scanner|1
2887586|NCT01892540|9940128|P2|Overall Study|Did not fit in scanner|0
2887587|NCT01892540|9940129|P1|Overall Study|Did not fit in scanner|0
2887588|NCT01892540|9940127|P3|Overall Study|Did not complete PET/MRI|2
2887589|NCT01892540|9940128|P2|Overall Study|Did not complete PET/MRI|0
2887590|NCT01892540|9940129|P1|Overall Study|Did not complete PET/MRI|0
2887591|NCT01892436|9940150|P4|Overall Study|Adverse Event|3
2887592|NCT01892436|9940151|P3|Overall Study|Adverse Event|2
2887593|NCT01892436|9940152|P2|Overall Study|Adverse Event|6
2887594|NCT01892436|9940153|P1|Overall Study|Adverse Event|7
2887595|NCT01892436|9940150|P4|Overall Study|non-compliance with treatment|0
2887596|NCT01892436|9940151|P3|Overall Study|non-compliance with treatment|0
2887597|NCT01892436|9940152|P2|Overall Study|non-compliance with treatment|0
2887598|NCT01892436|9940153|P1|Overall Study|non-compliance with treatment|1
2887599|NCT01892436|9940150|P4|Overall Study|Lost to Follow-up|3
2887600|NCT01892436|9940151|P3|Overall Study|Lost to Follow-up|1
2887601|NCT01892436|9940152|P2|Overall Study|Lost to Follow-up|1
2887602|NCT01892436|9940153|P1|Overall Study|Lost to Follow-up|1
2887603|NCT01892436|9940150|P4|Overall Study|Lack of Efficacy|2
2887604|NCT01892436|9940151|P3|Overall Study|Lack of Efficacy|2
2887605|NCT01892436|9940152|P2|Overall Study|Lack of Efficacy|2
2887606|NCT01892436|9940153|P1|Overall Study|Lack of Efficacy|1
2887607|NCT01892436|9940150|P4|Overall Study|Technical problems|1
2887608|NCT01892436|9940151|P3|Overall Study|Technical problems|1
2887609|NCT01892436|9940152|P2|Overall Study|Technical problems|1
2887610|NCT01892436|9940153|P1|Overall Study|Technical problems|2
2887611|NCT01892436|9940150|P4|Overall Study|Pregnancy|0
2887612|NCT01892436|9940151|P3|Overall Study|Pregnancy|1
2887613|NCT01892436|9940152|P2|Overall Study|Pregnancy|2
2887614|NCT01892436|9940153|P1|Overall Study|Pregnancy|0
2887615|NCT01892436|9940150|P4|Overall Study|Physician Decision|1
2887616|NCT01892436|9940151|P3|Overall Study|Physician Decision|0
2887617|NCT01892436|9940152|P2|Overall Study|Physician Decision|1
2887618|NCT01892436|9940153|P1|Overall Study|Physician Decision|2
2887619|NCT01892436|9940150|P4|Overall Study|Death|0
2887620|NCT01892436|9940151|P3|Overall Study|Death|0
2887621|NCT01892436|9940152|P2|Overall Study|Death|1
2887622|NCT01892436|9940153|P1|Overall Study|Death|1
2887623|NCT01892436|9940150|P4|Overall Study|Withdrawal by Subject|4
2887624|NCT01892436|9940151|P3|Overall Study|Withdrawal by Subject|4
2887625|NCT01892436|9940152|P2|Overall Study|Withdrawal by Subject|15
2887626|NCT01892436|9940153|P1|Overall Study|Withdrawal by Subject|8
2887627|NCT01892345|9940193|P2|Overall Study|Withdrawal by Subject|1
2887628|NCT01892345|9940194|P1|Overall Study|Withdrawal by Subject|12
2887629|NCT01892345|9940193|P2|Overall Study|Lost to Follow-up|0
2887630|NCT01892345|9940194|P1|Overall Study|Lost to Follow-up|3
2887631|NCT01892345|9940193|P2|Overall Study|Death|0
2887632|NCT01892345|9940194|P1|Overall Study|Death|1
2887633|NCT01892345|9940193|P2|Overall Study|Adverse Event|2
2887634|NCT01892345|9940194|P1|Overall Study|Adverse Event|0
2887635|NCT01892293|9940235|P1|Overall Study|Apheresed but not treated|4
2887636|NCT01892189|9940279|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887637|NCT01892189|9940280|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887638|NCT01892189|9940281|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887639|NCT01892189|9940282|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
2887640|NCT01892189|9940283|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887641|NCT01892189|9940284|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887642|NCT01892189|9940285|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887643|NCT01892189|9940286|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887644|NCT01892189|9940287|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2887645|NCT01892189|9940279|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2887646|NCT01892189|9940280|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2887647|NCT01892189|9940281|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2887648|NCT01892189|9940282|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2887649|NCT01892189|9940283|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2887650|NCT01892189|9940284|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2887651|NCT01892189|9940285|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
2887652|NCT01892189|9940286|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2887653|NCT01892189|9940287|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2887654|NCT01892189|9940279|P9|Washout Period 1 (7 Days)|Adverse Event|1
2887655|NCT01892189|9940280|P8|Washout Period 1 (7 Days)|Adverse Event|0
2887656|NCT01892189|9940281|P7|Washout Period 1 (7 Days)|Adverse Event|0
2887657|NCT01892189|9940282|P6|Washout Period 1 (7 Days)|Adverse Event|0
2887658|NCT01892189|9940283|P5|Washout Period 1 (7 Days)|Adverse Event|0
2887659|NCT01892189|9940284|P4|Washout Period 1 (7 Days)|Adverse Event|0
2887660|NCT01892189|9940285|P3|Washout Period 1 (7 Days)|Adverse Event|0
2887661|NCT01892189|9940286|P2|Washout Period 1 (7 Days)|Adverse Event|0
2887662|NCT01892189|9940287|P1|Washout Period 1 (7 Days)|Adverse Event|0
2887663|NCT01892163|9940329|P2|Overall Study|Lost to Follow-up|0
2887664|NCT01892163|9940330|P1|Overall Study|Lost to Follow-up|1
2887665|NCT01892163|9940329|P2|Overall Study|Death|1
2887666|NCT01892163|9940330|P1|Overall Study|Death|1
2887667|NCT01892020|9940342|P2|Period 2|Protocol Violation|0
2887668|NCT01892020|9940343|P1|Period 2|Protocol Violation|1
2887669|NCT01892020|9940342|P2|Period 1|Unclassified|1
2887670|NCT01892020|9940343|P1|Period 1|Unclassified|0
2887671|NCT01892020|9940342|P2|Period 1|Protocol Violation|4
2887672|NCT01892020|9940343|P1|Period 1|Protocol Violation|2
2887673|NCT01892020|9940342|P2|Period 1|Adverse Event|1
2887674|NCT01892020|9940343|P1|Period 1|Adverse Event|1
2887675|NCT01891890|9940372|P3|Overall Study|Study ended before endpoint reached|6
2887676|NCT01891890|9940373|P2|Overall Study|Study ended before endpoint reached|3
2887677|NCT01891890|9940374|P1|Overall Study|Study ended before endpoint reached|7
2887678|NCT01891890|9940372|P3|Overall Study|Lost to Follow-up|1
2887679|NCT01891890|9940373|P2|Overall Study|Lost to Follow-up|0
2887680|NCT01891890|9940374|P1|Overall Study|Lost to Follow-up|0
2887681|NCT01891864|9940417|P6|Extension Period|Lost to Follow-up|0
2887682|NCT01891864|9940418|P5|Extension Period|Lost to Follow-up|0
2887683|NCT01891864|9940419|P4|Extension Period|Lost to Follow-up|0
2887684|NCT01891864|9940420|P3|Extension Period|Lost to Follow-up|2
2887685|NCT01891864|9940421|P2|Extension Period|Lost to Follow-up|0
2887686|NCT01891864|9940422|P1|Extension Period|Lost to Follow-up|0
2887687|NCT01891864|9940417|P6|Extension Period|Withdrawal by Subject|0
2887688|NCT01891864|9940418|P5|Extension Period|Withdrawal by Subject|4
2887689|NCT01891864|9940419|P4|Extension Period|Withdrawal by Subject|2
2887690|NCT01891864|9940420|P3|Extension Period|Withdrawal by Subject|1
2887691|NCT01891864|9940421|P2|Extension Period|Withdrawal by Subject|0
2887692|NCT01891864|9940422|P1|Extension Period|Withdrawal by Subject|0
2887693|NCT01891864|9940417|P6|Extension Period|Adverse Event|0
2887694|NCT01891864|9940418|P5|Extension Period|Adverse Event|2
2887695|NCT01891864|9940419|P4|Extension Period|Adverse Event|2
2887696|NCT01891864|9940420|P3|Extension Period|Adverse Event|4
2887697|NCT01891864|9940421|P2|Extension Period|Adverse Event|0
2887698|NCT01891864|9940422|P1|Extension Period|Adverse Event|0
2887699|NCT01891864|9940417|P6|Extension Period|Pregnancy|0
2887700|NCT01891864|9940418|P5|Extension Period|Pregnancy|0
2887701|NCT01891864|9940419|P4|Extension Period|Pregnancy|0
2887702|NCT01891864|9940420|P3|Extension Period|Pregnancy|1
2887703|NCT01891864|9940421|P2|Extension Period|Pregnancy|0
2887704|NCT01891864|9940422|P1|Extension Period|Pregnancy|0
2887705|NCT01891864|9940417|P6|Extension Period|Lack of Efficacy|0
2887706|NCT01891864|9940418|P5|Extension Period|Lack of Efficacy|1
2887707|NCT01891864|9940419|P4|Extension Period|Lack of Efficacy|1
2887708|NCT01891864|9940420|P3|Extension Period|Lack of Efficacy|0
2887709|NCT01891864|9940421|P2|Extension Period|Lack of Efficacy|0
2887710|NCT01891864|9940422|P1|Extension Period|Lack of Efficacy|0
2887711|NCT01891864|9940417|P6|Treatment Period 2|Withdrawal by Subject|1
2887712|NCT01891864|9940418|P5|Treatment Period 2|Withdrawal by Subject|1
2887713|NCT01891864|9940419|P4|Treatment Period 2|Withdrawal by Subject|4
2887714|NCT01891864|9940420|P3|Treatment Period 2|Withdrawal by Subject|3
2887715|NCT01891864|9940421|P2|Treatment Period 2|Withdrawal by Subject|0
2887716|NCT01891864|9940422|P1|Treatment Period 2|Withdrawal by Subject|0
2887717|NCT01891864|9940417|P6|Treatment Period 2|Termination of Site|0
2887718|NCT01891864|9940418|P5|Treatment Period 2|Termination of Site|2
2887719|NCT01891864|9940419|P4|Treatment Period 2|Termination of Site|0
2887720|NCT01891864|9940420|P3|Treatment Period 2|Termination of Site|0
2887721|NCT01891864|9940421|P2|Treatment Period 2|Termination of Site|0
2887722|NCT01891864|9940422|P1|Treatment Period 2|Termination of Site|0
2887723|NCT01891864|9940417|P6|Treatment Period 2|Adverse Event|4
2887724|NCT01891864|9940418|P5|Treatment Period 2|Adverse Event|0
2887725|NCT01891864|9940419|P4|Treatment Period 2|Adverse Event|2
2887726|NCT01891864|9940420|P3|Treatment Period 2|Adverse Event|1
2887727|NCT01891864|9940421|P2|Treatment Period 2|Adverse Event|0
2887728|NCT01891864|9940422|P1|Treatment Period 2|Adverse Event|0
2887729|NCT01891864|9940417|P6|Treatment Period 2|Lack of Efficacy|0
2887730|NCT01891864|9940418|P5|Treatment Period 2|Lack of Efficacy|1
2887731|NCT01891864|9940419|P4|Treatment Period 2|Lack of Efficacy|0
2887732|NCT01891864|9940420|P3|Treatment Period 2|Lack of Efficacy|1
2887733|NCT01891864|9940421|P2|Treatment Period 2|Lack of Efficacy|0
2887734|NCT01891864|9940422|P1|Treatment Period 2|Lack of Efficacy|0
2887735|NCT01891864|9940417|P6|Treatment Period 2|Site Termination|0
2887736|NCT01891864|9940418|P5|Treatment Period 2|Site Termination|0
2887737|NCT01891864|9940419|P4|Treatment Period 2|Site Termination|2
2887738|NCT01891864|9940420|P3|Treatment Period 2|Site Termination|1
2887739|NCT01891864|9940421|P2|Treatment Period 2|Site Termination|0
2887740|NCT01891864|9940422|P1|Treatment Period 2|Site Termination|0
2887741|NCT01891864|9940417|P6|Treatment Period 2|Physician Decision|0
2887742|NCT01891864|9940418|P5|Treatment Period 2|Physician Decision|0
2887743|NCT01891864|9940419|P4|Treatment Period 2|Physician Decision|0
2887744|NCT01891864|9940420|P3|Treatment Period 2|Physician Decision|1
2887745|NCT01891864|9940421|P2|Treatment Period 2|Physician Decision|0
2887746|NCT01891864|9940422|P1|Treatment Period 2|Physician Decision|0
2887747|NCT01891864|9940417|P6|Treatment Period 2|Protocol Violation|0
2887748|NCT01891864|9940418|P5|Treatment Period 2|Protocol Violation|0
2887749|NCT01891864|9940419|P4|Treatment Period 2|Protocol Violation|1
2887750|NCT01891864|9940420|P3|Treatment Period 2|Protocol Violation|0
2887751|NCT01891864|9940421|P2|Treatment Period 2|Protocol Violation|0
2887752|NCT01891864|9940422|P1|Treatment Period 2|Protocol Violation|0
2887753|NCT01891864|9940417|P6|Treatment Period 1|Lost to Follow-up|0
2887754|NCT01891864|9940418|P5|Treatment Period 1|Lost to Follow-up|0
2887755|NCT01891864|9940419|P4|Treatment Period 1|Lost to Follow-up|0
2887756|NCT01891864|9940420|P3|Treatment Period 1|Lost to Follow-up|0
2887757|NCT01891864|9940421|P2|Treatment Period 1|Lost to Follow-up|0
2887758|NCT01891864|9940422|P1|Treatment Period 1|Lost to Follow-up|1
2887759|NCT01891864|9940417|P6|Treatment Period 1|Withdrawal by Subject|0
2887760|NCT01891864|9940418|P5|Treatment Period 1|Withdrawal by Subject|0
2887761|NCT01891864|9940419|P4|Treatment Period 1|Withdrawal by Subject|0
2887762|NCT01891864|9940420|P3|Treatment Period 1|Withdrawal by Subject|0
2887763|NCT01891864|9940421|P2|Treatment Period 1|Withdrawal by Subject|5
2887764|NCT01891864|9940422|P1|Treatment Period 1|Withdrawal by Subject|2
2887765|NCT01891864|9940417|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2887766|NCT01891864|9940418|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2887767|NCT01891864|9940419|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2887768|NCT01891864|9940420|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2887769|NCT01891864|9940421|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2887770|NCT01891864|9940422|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2887771|NCT01891864|9940417|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
2887772|NCT01891864|9940418|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
2887773|NCT01891864|9940419|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
2887774|NCT01891864|9940420|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
2887775|NCT01891864|9940421|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
2887776|NCT01891864|9940422|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
2887777|NCT01891864|9940417|P6|Treatment Period 1|Physician Decision|0
2887778|NCT01891864|9940418|P5|Treatment Period 1|Physician Decision|0
2887779|NCT01891864|9940419|P4|Treatment Period 1|Physician Decision|0
2887780|NCT01891864|9940420|P3|Treatment Period 1|Physician Decision|0
2887781|NCT01891864|9940421|P2|Treatment Period 1|Physician Decision|1
2887782|NCT01891864|9940422|P1|Treatment Period 1|Physician Decision|0
2887783|NCT01891864|9940417|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2887784|NCT01891864|9940418|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2887785|NCT01891864|9940419|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2887786|NCT01891864|9940420|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2887787|NCT01891864|9940421|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2887788|NCT01891864|9940422|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2887789|NCT01891721|9940458|P3|Overall Study|Lost to Follow-up|1
2887790|NCT01891721|9940459|P2|Overall Study|Lost to Follow-up|5
2887791|NCT01891721|9940460|P1|Overall Study|Lost to Follow-up|10
2887792|NCT01891669|9940484|P10|Overall Study|Other|0
2887793|NCT01891669|9940485|P9|Overall Study|Other|0
2887794|NCT01891669|9940486|P8|Overall Study|Other|1
2887795|NCT01891669|9940487|P7|Overall Study|Other|0
2887796|NCT01891669|9940488|P6|Overall Study|Other|0
2887797|NCT01891669|9940489|P5|Overall Study|Other|0
2887798|NCT01891669|9940490|P4|Overall Study|Other|0
2887799|NCT01891669|9940491|P3|Overall Study|Other|0
2887800|NCT01891669|9940492|P2|Overall Study|Other|0
2887801|NCT01891669|9940493|P1|Overall Study|Other|1
2887802|NCT01891669|9940484|P10|Overall Study|Withdrawal by Subject|1
2887803|NCT01891669|9940485|P9|Overall Study|Withdrawal by Subject|1
2887804|NCT01891669|9940486|P8|Overall Study|Withdrawal by Subject|2
2887805|NCT01891669|9940487|P7|Overall Study|Withdrawal by Subject|1
2887806|NCT01891669|9940488|P6|Overall Study|Withdrawal by Subject|0
2887807|NCT01891669|9940489|P5|Overall Study|Withdrawal by Subject|0
2887808|NCT01891669|9940490|P4|Overall Study|Withdrawal by Subject|0
2887809|NCT01891669|9940491|P3|Overall Study|Withdrawal by Subject|0
2887810|NCT01891669|9940492|P2|Overall Study|Withdrawal by Subject|1
2887811|NCT01891669|9940493|P1|Overall Study|Withdrawal by Subject|1
2887812|NCT01891669|9940484|P10|Overall Study|Death|1
2887813|NCT01891669|9940485|P9|Overall Study|Death|0
2887814|NCT01891669|9940486|P8|Overall Study|Death|1
2887815|NCT01891669|9940487|P7|Overall Study|Death|0
2887816|NCT01891669|9940488|P6|Overall Study|Death|0
2887817|NCT01891669|9940489|P5|Overall Study|Death|0
2887818|NCT01891669|9940490|P4|Overall Study|Death|0
2887819|NCT01891669|9940491|P3|Overall Study|Death|0
2887820|NCT01891669|9940492|P2|Overall Study|Death|0
2887821|NCT01891669|9940493|P1|Overall Study|Death|0
2887822|NCT01891357|9940644|P1|Overall Study|Protocol Violation|3
2887823|NCT01890967|9940691|P6|Overall Study|Withdrawal by Subject|1
2887824|NCT01890967|9940692|P5|Overall Study|Withdrawal by Subject|3
2887825|NCT01890967|9940693|P4|Overall Study|Withdrawal by Subject|3
2887826|NCT01890967|9940694|P3|Overall Study|Withdrawal by Subject|2
2887827|NCT01890967|9940695|P2|Overall Study|Withdrawal by Subject|4
2887828|NCT01890967|9940696|P1|Overall Study|Withdrawal by Subject|3
2887829|NCT01890967|9940691|P6|Overall Study|Sponsor Decision|3
2887830|NCT01890967|9940692|P5|Overall Study|Sponsor Decision|2
2887831|NCT01890967|9940693|P4|Overall Study|Sponsor Decision|3
2887832|NCT01890967|9940694|P3|Overall Study|Sponsor Decision|1
2887833|NCT01890967|9940695|P2|Overall Study|Sponsor Decision|0
2887834|NCT01890967|9940696|P1|Overall Study|Sponsor Decision|2
2887835|NCT01890967|9940691|P6|Overall Study|Protocol Violation|1
2887836|NCT01890967|9940692|P5|Overall Study|Protocol Violation|4
2887837|NCT01890967|9940693|P4|Overall Study|Protocol Violation|2
2887838|NCT01890967|9940694|P3|Overall Study|Protocol Violation|3
2887839|NCT01890967|9940695|P2|Overall Study|Protocol Violation|3
2887840|NCT01890967|9940696|P1|Overall Study|Protocol Violation|0
2887841|NCT01890967|9940691|P6|Overall Study|Lost to Follow-up|1
2887842|NCT01890967|9940692|P5|Overall Study|Lost to Follow-up|0
2887843|NCT01890967|9940693|P4|Overall Study|Lost to Follow-up|1
2887844|NCT01890967|9940694|P3|Overall Study|Lost to Follow-up|1
2887845|NCT01890967|9940695|P2|Overall Study|Lost to Follow-up|1
2887846|NCT01890967|9940696|P1|Overall Study|Lost to Follow-up|1
2887847|NCT01890967|9940691|P6|Overall Study|Death|0
2887848|NCT01890967|9940692|P5|Overall Study|Death|0
2887849|NCT01890967|9940693|P4|Overall Study|Death|0
2887850|NCT01890967|9940694|P3|Overall Study|Death|0
2887851|NCT01890967|9940695|P2|Overall Study|Death|0
2887852|NCT01890967|9940696|P1|Overall Study|Death|1
2887853|NCT01890967|9940691|P6|Overall Study|Adverse Event|7
2887854|NCT01890967|9940692|P5|Overall Study|Adverse Event|1
2887855|NCT01890967|9940693|P4|Overall Study|Adverse Event|2
2887856|NCT01890967|9940694|P3|Overall Study|Adverse Event|3
2887857|NCT01890967|9940695|P2|Overall Study|Adverse Event|3
2887858|NCT01890967|9940696|P1|Overall Study|Adverse Event|3
2887859|NCT01890915|9940774|P2|Overall Study|Equipment Malfunction|1
2887860|NCT01890915|9940775|P1|Overall Study|Equipment Malfunction|0
2887861|NCT01890915|9940774|P2|Overall Study|Protocol Violation|0
2887862|NCT01890915|9940775|P1|Overall Study|Protocol Violation|2
2887863|NCT01890915|9940774|P2|Overall Study|Adverse Event|0
2887864|NCT01890915|9940775|P1|Overall Study|Adverse Event|1
2887865|NCT01890785|9940791|P6|Third Intervention|Withdrawal by Subject|0
2887866|NCT01890785|9940792|P5|Third Intervention|Withdrawal by Subject|0
2887867|NCT01890785|9940793|P4|Third Intervention|Withdrawal by Subject|0
2887868|NCT01890785|9940794|P3|Third Intervention|Withdrawal by Subject|0
2887869|NCT01890785|9940795|P2|Third Intervention|Withdrawal by Subject|1
2887870|NCT01890785|9940796|P1|Third Intervention|Withdrawal by Subject|0
2887871|NCT01890759|9940815|P2|Overall Study|Withdrawal by Subject|8
2887872|NCT01890759|9940816|P1|Overall Study|Withdrawal by Subject|2
2887873|NCT01890759|9940815|P2|Overall Study|Lost to Follow-up|2
2887874|NCT01890759|9940816|P1|Overall Study|Lost to Follow-up|0
2887875|NCT01890759|9940815|P2|Overall Study|Protocol Violation|2
2887876|NCT01890759|9940816|P1|Overall Study|Protocol Violation|0
2887877|NCT01890746|9940850|P2|Overall Study|Withdrawal by Subject|8
2887878|NCT01890746|9940851|P1|Overall Study|Withdrawal by Subject|5
2887879|NCT01890746|9940850|P2|Overall Study|Physician Decision|2
2887880|NCT01890746|9940851|P1|Overall Study|Physician Decision|3
2887881|NCT01890746|9940850|P2|Overall Study|Lost to Follow-up|1
2887882|NCT01890746|9940851|P1|Overall Study|Lost to Follow-up|4
2887883|NCT01890746|9940850|P2|Overall Study|Adverse Event|0
2887884|NCT01890746|9940851|P1|Overall Study|Adverse Event|1
2887885|NCT01890746|9940850|P2|Overall Study|Death|30
2887886|NCT01890746|9940851|P1|Overall Study|Death|39
2887887|NCT01890707|9940937|P2|Overall Study|Lost to Follow-up|1
2887888|NCT01890707|9940938|P1|Overall Study|Lost to Follow-up|1
2887889|NCT01890512|9941017|P1|Overall Study|Protocol Violation|1
2887890|NCT01890512|9941017|P1|Overall Study|Withdrawal by Subject|1
2887891|NCT01890512|9941017|P1|Overall Study|Physician Decision|1
2887892|NCT01890473|9941023|P2|Overall Study|Poor/non-compliance|0
2887893|NCT01890473|9941024|P1|Overall Study|Poor/non-compliance|1
2887894|NCT01890473|9941023|P2|Overall Study|Lost to Follow-up|0
2887895|NCT01890473|9941024|P1|Overall Study|Lost to Follow-up|1
2887896|NCT01890434|9941050|P1|Overall Study|Withdrawal by PI for ICA not performed|2
2887897|NCT01890434|9941050|P1|Overall Study|Unable to contact|1
2887898|NCT01890434|9941050|P1|Overall Study|Moved out of position|1
2887899|NCT01890434|9941050|P1|Overall Study|Uncontactable by phone|1
2887900|NCT01890434|9941050|P1|Overall Study|Participant didn't complete MRI|1
2887901|NCT01890434|9941050|P1|Overall Study|GSPECT at rest was not done|1
2887902|NCT01890434|9941050|P1|Overall Study|Decline to return for GSPECT|1
2887903|NCT01890434|9941050|P1|Overall Study|Could not get whole set of images|1
2887904|NCT01890434|9941050|P1|Overall Study|CRC didn't contact participant for FU|1
2887905|NCT01890434|9941050|P1|Overall Study|Assessment discrepancy|1
2887906|NCT01890434|9941050|P1|Overall Study|PCI at external hospital|1
2887907|NCT01890434|9941050|P1|Overall Study|Adverse Event|8
2887908|NCT01890421|9941080|P1|Overall Study|Other reason|10
2887909|NCT01890421|9941080|P1|Overall Study|Adverse Event|1
2887910|NCT01890148|9941134|P1|Overall Study|Adverse Event|1
2887911|NCT01890122|9941154|P4|Overall Study|Randomized but not Treated|0
2887912|NCT01890122|9941155|P3|Overall Study|Randomized but not Treated|0
2887913|NCT01890122|9941156|P2|Overall Study|Randomized but not Treated|1
2887914|NCT01890122|9941157|P1|Overall Study|Randomized but not Treated|1
2887915|NCT01890122|9941154|P4|Overall Study|Reason not Specified|2
2887916|NCT01890122|9941155|P3|Overall Study|Reason not Specified|1
2887917|NCT01890122|9941156|P2|Overall Study|Reason not Specified|1
2887918|NCT01890122|9941157|P1|Overall Study|Reason not Specified|0
2887919|NCT01890122|9941154|P4|Overall Study|Lack of Efficacy|41
2887920|NCT01890122|9941155|P3|Overall Study|Lack of Efficacy|7
2887921|NCT01890122|9941156|P2|Overall Study|Lack of Efficacy|24
2887922|NCT01890122|9941157|P1|Overall Study|Lack of Efficacy|14
2887923|NCT01890122|9941154|P4|Overall Study|Voluntary Withdrawal|11
2887924|NCT01890122|9941155|P3|Overall Study|Voluntary Withdrawal|2
2887925|NCT01890122|9941156|P2|Overall Study|Voluntary Withdrawal|8
2887926|NCT01890122|9941157|P1|Overall Study|Voluntary Withdrawal|8
2887927|NCT01890122|9941154|P4|Overall Study|Lost to Follow-up|2
2887928|NCT01890122|9941155|P3|Overall Study|Lost to Follow-up|2
2887929|NCT01890122|9941156|P2|Overall Study|Lost to Follow-up|1
2887930|NCT01890122|9941157|P1|Overall Study|Lost to Follow-up|0
2887931|NCT01890122|9941154|P4|Overall Study|Major Protocol Deviation|1
2887932|NCT01890122|9941155|P3|Overall Study|Major Protocol Deviation|0
2887933|NCT01890122|9941156|P2|Overall Study|Major Protocol Deviation|1
2887934|NCT01890122|9941157|P1|Overall Study|Major Protocol Deviation|3
2887935|NCT01890122|9941154|P4|Overall Study|Adverse Event|2
2887936|NCT01890122|9941155|P3|Overall Study|Adverse Event|1
2887937|NCT01890122|9941156|P2|Overall Study|Adverse Event|1
2887938|NCT01890122|9941157|P1|Overall Study|Adverse Event|1
2887939|NCT01890109|9941221|P2|Overall Study|Lost to Follow-up|2
2887940|NCT01890109|9941222|P1|Overall Study|Lost to Follow-up|1
2887941|NCT01890109|9941221|P2|Overall Study|Withdrawal by Subject|3
2887942|NCT01890109|9941222|P1|Overall Study|Withdrawal by Subject|0
2887943|NCT01889602|9941327|P3|Third Intervention|Withdrawal by Subject|0
2887944|NCT01889602|9941328|P2|Third Intervention|Withdrawal by Subject|2
2887945|NCT01889602|9941329|P1|Third Intervention|Withdrawal by Subject|2
2887946|NCT01889602|9941327|P3|Third Intervention|Protocol Violation|0
2887947|NCT01889602|9941328|P2|Third Intervention|Protocol Violation|0
2887948|NCT01889602|9941329|P1|Third Intervention|Protocol Violation|1
2887949|NCT01889602|9941327|P3|Second Intervention|Withdrawal by Subject|1
2887950|NCT01889602|9941328|P2|Second Intervention|Withdrawal by Subject|0
2887951|NCT01889602|9941329|P1|Second Intervention|Withdrawal by Subject|0
2887952|NCT01889602|9941327|P3|Second Intervention|Study ending|0
2887953|NCT01889602|9941328|P2|Second Intervention|Study ending|0
2887954|NCT01889602|9941329|P1|Second Intervention|Study ending|1
2887955|NCT01889602|9941327|P3|Second Intervention|Adverse Event|1
2887956|NCT01889602|9941328|P2|Second Intervention|Adverse Event|0
2887957|NCT01889602|9941329|P1|Second Intervention|Adverse Event|0
2887958|NCT01889602|9941327|P3|First Intervention|Study ending|0
2887959|NCT01889602|9941328|P2|First Intervention|Study ending|1
2887960|NCT01889602|9941329|P1|First Intervention|Study ending|0
2887961|NCT01889602|9941327|P3|First Intervention|Protocol Violation|1
2887962|NCT01889602|9941328|P2|First Intervention|Protocol Violation|1
2887963|NCT01889602|9941329|P1|First Intervention|Protocol Violation|0
2887964|NCT01889602|9941327|P3|First Intervention|Adverse Event|1
2887965|NCT01889602|9941328|P2|First Intervention|Adverse Event|1
2887966|NCT01889602|9941329|P1|First Intervention|Adverse Event|1
2887967|NCT01889251|9941377|P2|Overall Study|Adverse Event|0
2887968|NCT01889251|9941378|P1|Overall Study|Adverse Event|1
2887969|NCT01889238|9941384|P1|Overall Study|Treatment ongoing|9
2887970|NCT01888965|9941401|P1|Overall Study|Lack of Efficacy|4
2887971|NCT01888965|9941401|P1|Overall Study|Adverse Event|5
2887972|NCT01888900|9941413|P2|Overall Study|failed treatment|2
2887973|NCT01888900|9941414|P1|Overall Study|failed treatment|0
2887974|NCT01888640|9941437|P3|Overall Study|Researcher Termination of Participant|1
2887975|NCT01888640|9941438|P2|Overall Study|Researcher Termination of Participant|1
2887976|NCT01888640|9941439|P1|Overall Study|Researcher Termination of Participant|0
2887977|NCT01888640|9941437|P3|Overall Study|Excluded for prior TENS|0
2887978|NCT01888640|9941438|P2|Overall Study|Excluded for prior TENS|1
2887979|NCT01888640|9941439|P1|Overall Study|Excluded for prior TENS|0
2887980|NCT01888640|9941437|P3|Overall Study|Given wrong unit (placebo)|0
2887981|NCT01888640|9941438|P2|Overall Study|Given wrong unit (placebo)|0
2887982|NCT01888640|9941439|P1|Overall Study|Given wrong unit (placebo)|1
2887983|NCT01888640|9941437|P3|Overall Study|Minimum dose not met|0
2887984|NCT01888640|9941438|P2|Overall Study|Minimum dose not met|16
2887985|NCT01888640|9941439|P1|Overall Study|Minimum dose not met|10
2887986|NCT01888640|9941437|P3|Overall Study|Withdrawal by Subject|4
2887987|NCT01888640|9941438|P2|Overall Study|Withdrawal by Subject|11
2887988|NCT01888640|9941439|P1|Overall Study|Withdrawal by Subject|15
2887989|NCT01888640|9941437|P3|Overall Study|Lost to Follow-up|0
2887990|NCT01888640|9941438|P2|Overall Study|Lost to Follow-up|2
2887991|NCT01888640|9941439|P1|Overall Study|Lost to Follow-up|1
2887992|NCT01888432|9941495|P2|36-month Analysis (Extension)|Death|0
2887993|NCT01888432|9941496|P1|36-month Analysis (Extension)|Death|1
2887994|NCT01888432|9941495|P2|24-month Analysis (FAS)|Death|4
2887995|NCT01888432|9941496|P1|24-month Analysis (FAS)|Death|8
2887996|NCT01888432|9941495|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
2887997|NCT01888432|9941496|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
2887998|NCT01888432|9941495|P2|24-month Analysis (FAS)|Physician Decision|4
2887999|NCT01888432|9941496|P1|24-month Analysis (FAS)|Physician Decision|2
2888000|NCT01888432|9941495|P2|24-month Analysis (FAS)|Lost to Follow-up|2
2888001|NCT01888432|9941496|P1|24-month Analysis (FAS)|Lost to Follow-up|0
2888002|NCT01888432|9941495|P2|24-month Analysis (FAS)|Graft loss|1
2888003|NCT01888432|9941496|P1|24-month Analysis (FAS)|Graft loss|0
2888004|NCT01888432|9941495|P2|12-month Analysis (FAS)|Death|3
2888005|NCT01888432|9941496|P1|12-month Analysis (FAS)|Death|4
2888006|NCT01888432|9941495|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
2888007|NCT01888432|9941496|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
2888008|NCT01888432|9941495|P2|12-month Analysis (FAS)|Physician Decision|1
2888009|NCT01888432|9941496|P1|12-month Analysis (FAS)|Physician Decision|1
2888010|NCT01888432|9941495|P2|12-month Analysis (FAS)|Lost to Follow-up|2
2888011|NCT01888432|9941496|P1|12-month Analysis (FAS)|Lost to Follow-up|0
2888012|NCT01888367|9941537|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2888013|NCT01888367|9941538|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2888014|NCT01888367|9941539|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
2888015|NCT01888367|9941537|P3|Overall Study|Protocol Violation|1
2888016|NCT01888367|9941538|P2|Overall Study|Protocol Violation|0
2888017|NCT01888367|9941539|P1|Overall Study|Protocol Violation|0
2888018|NCT01888367|9941537|P3|Overall Study|Lost to Follow-up|0
2888019|NCT01888367|9941538|P2|Overall Study|Lost to Follow-up|1
2888020|NCT01888367|9941539|P1|Overall Study|Lost to Follow-up|1
2888021|NCT01888367|9941537|P3|Overall Study|Withdrawal by Subject|1
2888022|NCT01888367|9941538|P2|Overall Study|Withdrawal by Subject|0
2888023|NCT01888367|9941539|P1|Overall Study|Withdrawal by Subject|1
2888024|NCT01888367|9941537|P3|Overall Study|Death|1
2888025|NCT01888367|9941538|P2|Overall Study|Death|0
2888026|NCT01888367|9941539|P1|Overall Study|Death|2
2888027|NCT01888367|9941537|P3|Overall Study|Physician Decision|2
2888028|NCT01888367|9941538|P2|Overall Study|Physician Decision|4
2888029|NCT01888367|9941539|P1|Overall Study|Physician Decision|3
2888030|NCT01888003|9941559|P3|Overall Study|Study Terminated|40
2888031|NCT01888003|9941560|P2|Overall Study|Study Terminated|6
2888032|NCT01888003|9941561|P1|Overall Study|Study Terminated|5
2888033|NCT01887912|9941601|P2|Overall Study|Other|58
2888034|NCT01887912|9941602|P1|Overall Study|Other|122
2888035|NCT01887912|9941601|P2|Overall Study|Withdrawal by Subject|349
2888036|NCT01887912|9941602|P1|Overall Study|Withdrawal by Subject|606
2888037|NCT01887912|9941601|P2|Overall Study|Lost to Follow-up|74
2888038|NCT01887912|9941602|P1|Overall Study|Lost to Follow-up|163
2888039|NCT01887912|9941601|P2|Overall Study|Protocol Violation|37
2888040|NCT01887912|9941602|P1|Overall Study|Protocol Violation|67
2888041|NCT01887912|9941601|P2|Overall Study|Other Adverse Event|15
2888042|NCT01887912|9941602|P1|Overall Study|Other Adverse Event|34
2888043|NCT01887912|9941601|P2|Overall Study|Serious adverse event|198
2888044|NCT01887912|9941602|P1|Overall Study|Serious adverse event|400
2888045|NCT01887717|9941630|P2|Overall Study|Administrative reasons|2
2888046|NCT01887717|9941631|P1|Overall Study|Administrative reasons|5
2888047|NCT01887717|9941630|P2|Overall Study|Physician Decision|2
2888048|NCT01887717|9941631|P1|Overall Study|Physician Decision|0
2888049|NCT01887717|9941630|P2|Overall Study|Withdrawal by Subject|7
2888050|NCT01887717|9941631|P1|Overall Study|Withdrawal by Subject|1
2888051|NCT01887678|9941653|P2|Overall Study|Specified|2
2888052|NCT01887678|9941654|P1|Overall Study|Specified|1
2888053|NCT01887678|9941653|P2|Overall Study|Non-compliance|3
2888054|NCT01887678|9941654|P1|Overall Study|Non-compliance|0
2888055|NCT01887678|9941653|P2|Overall Study|Lack of Efficacy|2
2888056|NCT01887678|9941654|P1|Overall Study|Lack of Efficacy|1
2888057|NCT01887678|9941653|P2|Overall Study|Deterioration of clinical condition|4
2888058|NCT01887678|9941654|P1|Overall Study|Deterioration of clinical condition|0
2888059|NCT01887678|9941653|P2|Overall Study|Lost to Follow-up|2
2888060|NCT01887678|9941654|P1|Overall Study|Lost to Follow-up|4
2888061|NCT01887678|9941653|P2|Overall Study|Withdrawal of consent|4
2888062|NCT01887678|9941654|P1|Overall Study|Withdrawal of consent|3
2888063|NCT01887678|9941653|P2|Overall Study|Exceeded rescue medication dosage|5
2888064|NCT01887678|9941654|P1|Overall Study|Exceeded rescue medication dosage|4
2888065|NCT01887678|9941653|P2|Overall Study|Adverse Event|6
2888066|NCT01887678|9941654|P1|Overall Study|Adverse Event|4
2888067|NCT01887418|9941727|P3|Overall Study|Travelling difficulties|1
2888068|NCT01887418|9941728|P2|Overall Study|Travelling difficulties|0
2888069|NCT01887418|9941729|P1|Overall Study|Travelling difficulties|0
2888070|NCT01887353|9941748|P2|Overall Study|Study stopped early|3
2888071|NCT01887353|9941749|P1|Overall Study|Study stopped early|4
2888072|NCT01887288|9941777|P1|Overall Study|The study was terminated and the PI has|16
2888073|NCT01887210|9941784|P2|Overall Study|Lost to Follow-up|1
2888074|NCT01887210|9941785|P1|Overall Study|Lost to Follow-up|0
2888075|NCT01887210|9941784|P2|Overall Study|Withdrawal by Subject|3
2888076|NCT01887210|9941785|P1|Overall Study|Withdrawal by Subject|1
2888077|NCT01886872|9941832|P3|Overall Study|Ineligible|12
2888078|NCT01886872|9941833|P2|Overall Study|Ineligible|4
2888079|NCT01886872|9941834|P1|Overall Study|Ineligible|7
2888080|NCT01886833|9941867|P1|Overall Study|IgA not available from both periods|204
2888081|NCT01886781|9941899|P2|Overall Study|Worsening of symptoms|1
2888082|NCT01886781|9941900|P1|Overall Study|Worsening of symptoms|1
2888083|NCT01886781|9941899|P2|Overall Study|Withdrawal by Subject|1
2888084|NCT01886781|9941900|P1|Overall Study|Withdrawal by Subject|2
2888085|NCT01886781|9941899|P2|Overall Study|Lost to Follow-up|0
2888086|NCT01886781|9941900|P1|Overall Study|Lost to Follow-up|5
2888087|NCT01886781|9941899|P2|Overall Study|Adverse Event|0
2888088|NCT01886781|9941900|P1|Overall Study|Adverse Event|1
2888089|NCT01886781|9941899|P2|Overall Study|Protocol Violation|0
2888090|NCT01886781|9941900|P1|Overall Study|Protocol Violation|5
2888091|NCT01886716|9941910|P4|Week 3|Lost to Follow-up|1
2888092|NCT01886716|9941911|P3|Week 3|Lost to Follow-up|0
2888093|NCT01886716|9941912|P2|Week 3|Lost to Follow-up|1
2888094|NCT01886716|9941913|P1|Week 3|Lost to Follow-up|1
2888095|NCT01886716|9941910|P4|Week 2|Lost to Follow-up|3
2888096|NCT01886716|9941911|P3|Week 2|Lost to Follow-up|1
2888097|NCT01886716|9941912|P2|Week 2|Lost to Follow-up|2
2888098|NCT01886716|9941913|P1|Week 2|Lost to Follow-up|3
2888099|NCT01886716|9941910|P4|Week 1|Lost to Follow-up|2
2888100|NCT01886716|9941911|P3|Week 1|Lost to Follow-up|2
2888101|NCT01886716|9941912|P2|Week 1|Lost to Follow-up|0
2888102|NCT01886716|9941913|P1|Week 1|Lost to Follow-up|0
2888103|NCT01886690|9941929|P2|Overall Study|Personal Reasons|1
2888104|NCT01886690|9941930|P1|Overall Study|Personal Reasons|0
2888105|NCT01886690|9941929|P2|Overall Study|Protocol Violation|1
2888106|NCT01886690|9941930|P1|Overall Study|Protocol Violation|0
2888107|NCT01886313|9941946|P2|Overall Study|Adverse Event|1
2888108|NCT01886313|9941947|P1|Overall Study|Adverse Event|1
2888109|NCT01886300|9941953|P1|Overall Study|Trial terminated by sponsor|16
2888110|NCT01886287|9941964|P1|Overall Study|Clinical progression due to disease|1
2888111|NCT01886287|9941964|P1|Overall Study|Radiographic disease progression|1
2888112|NCT01886105|9941980|P1|Overall Study|Lack of Efficacy|3
2888113|NCT01885936|9941987|P2|Overall Study|Withdrawal by Subject|0
2888114|NCT01885936|9941988|P1|Overall Study|Withdrawal by Subject|1
2888115|NCT01885559|9942022|P2|Overall Study|Protocol Violation|1
2888116|NCT01885559|9942023|P1|Overall Study|Protocol Violation|0
2888117|NCT01885559|9942022|P2|Overall Study|Less than full participation|19
2888118|NCT01885559|9942023|P1|Overall Study|Less than full participation|9
2888119|NCT01885559|9942022|P2|Overall Study|Lost to Follow-up|16
2888120|NCT01885559|9942023|P1|Overall Study|Lost to Follow-up|15
2888121|NCT01885208|9942045|P2|Overall Study|Unclassified|38
2888122|NCT01885208|9942046|P1|Overall Study|Unclassified|32
2888123|NCT01885182|9942064|P2|Overall Study|Lack of Efficacy|1
2888124|NCT01885182|9942065|P1|Overall Study|Lack of Efficacy|8
2888125|NCT01885182|9942064|P2|Overall Study|Lost to Follow-up|2
2888126|NCT01885182|9942065|P1|Overall Study|Lost to Follow-up|2
2888127|NCT01885182|9942064|P2|Overall Study|Withdrawal by Subject|6
2888128|NCT01885182|9942065|P1|Overall Study|Withdrawal by Subject|13
2888129|NCT01885182|9942064|P2|Overall Study|Adverse Event|13
2888130|NCT01885182|9942065|P1|Overall Study|Adverse Event|11
2888131|NCT01885104|9942112|P2|Overall Study|Physician Decision|0
2888132|NCT01885104|9942113|P1|Overall Study|Physician Decision|1
2888133|NCT01885104|9942112|P2|Overall Study|Lost to Follow-up|1
2888134|NCT01885104|9942113|P1|Overall Study|Lost to Follow-up|0
2888135|NCT01885104|9942112|P2|Overall Study|Withdrawal of Consent|0
2888136|NCT01885104|9942113|P1|Overall Study|Withdrawal of Consent|1
2888137|NCT01885000|9942123|P2|Overall Study|Protocol Violation|1
2888138|NCT01885000|9942124|P1|Overall Study|Protocol Violation|0
2888139|NCT01885000|9942123|P2|Overall Study|Withdrawal by Subject|1
2888140|NCT01885000|9942124|P1|Overall Study|Withdrawal by Subject|1
2888141|NCT01885000|9942123|P2|Overall Study|Adverse Event|0
2888142|NCT01885000|9942124|P1|Overall Study|Adverse Event|1
2888143|NCT01884688|9942145|P1|Overall Study|Screen Failure|2
2888144|NCT01884675|9942151|P2|Overall Study|Study closed/terminated|2
2888145|NCT01884675|9942152|P1|Overall Study|Study closed/terminated|3
2888146|NCT01884597|9942195|P3|Overall Study|Death|0
2888147|NCT01884597|9942196|P2|Overall Study|Death|1
2888148|NCT01884597|9942197|P1|Overall Study|Death|0
2888149|NCT01884597|9942195|P3|Overall Study|Lack of Efficacy|0
2888150|NCT01884597|9942196|P2|Overall Study|Lack of Efficacy|0
2888151|NCT01884597|9942197|P1|Overall Study|Lack of Efficacy|1
2888152|NCT01884597|9942195|P3|Overall Study|Adverse Event|1
2888153|NCT01884597|9942196|P2|Overall Study|Adverse Event|0
2888154|NCT01884597|9942197|P1|Overall Study|Adverse Event|0
2888155|NCT01884571|9942226|P1|Overall Study|Disease progression|3
2888156|NCT01884571|9942226|P1|Overall Study|Withdrawal by Subject|2
2888157|NCT01884571|9942226|P1|Overall Study|Death|2
2888158|NCT01884571|9942226|P1|Overall Study|Adverse Event|1
2888159|NCT01884545|9942241|P4|Overall Study|Non-adherence|0
2888160|NCT01884545|9942242|P3|Overall Study|Non-adherence|0
2888161|NCT01884545|9942243|P2|Overall Study|Non-adherence|2
2888162|NCT01884545|9942244|P1|Overall Study|Non-adherence|0
2888163|NCT01884545|9942241|P4|Overall Study|Patient withdrawn|5
2888164|NCT01884545|9942242|P3|Overall Study|Patient withdrawn|5
2888165|NCT01884545|9942243|P2|Overall Study|Patient withdrawn|12
2888166|NCT01884545|9942244|P1|Overall Study|Patient withdrawn|7
2888167|NCT01884545|9942241|P4|Overall Study|Lost to Follow-up|4
2888168|NCT01884545|9942242|P3|Overall Study|Lost to Follow-up|9
2888169|NCT01884545|9942243|P2|Overall Study|Lost to Follow-up|4
2888170|NCT01884545|9942244|P1|Overall Study|Lost to Follow-up|6
2888171|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2888172|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2888173|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
2888174|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2888175|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2888176|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
2888177|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
2888178|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
2888179|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
2888180|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2888181|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2888182|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
2888183|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2888184|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2888185|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
2888186|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
2888187|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
2888188|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
2888189|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
2888190|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
2888191|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
2888192|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
2888193|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
2888194|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
2888195|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2888196|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
2888197|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2888198|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2888199|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2888200|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
2888201|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
2888202|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
2888203|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
2888280|NCT01882907|9942632|P1|Overall Study|Lost to Follow-up|1
2888204|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
2888205|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2888206|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2888207|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
2888208|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2888209|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2888210|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
2888211|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2888212|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2888213|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2888214|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2888215|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
2888216|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
2888217|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
2888218|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
2888219|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2888220|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
2888221|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2888222|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
2888223|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
2888224|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
2888225|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
2888226|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
2888227|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
2888228|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2888229|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
2888230|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2888231|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
2888232|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
2888233|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
2888234|NCT01884350|9942397|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
2888235|NCT01884350|9942398|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
2888236|NCT01884350|9942399|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
2888237|NCT01884337|9942422|P2|Follow-up Period|Lost to Follow-up|1
2888238|NCT01884337|9942423|P1|Follow-up Period|Lost to Follow-up|1
2888239|NCT01884337|9942422|P2|Treatment|Subj. request to discont. treatment|0
2888240|NCT01884337|9942423|P1|Treatment|Subj. request to discont. treatment|2
2888241|NCT01884337|9942422|P2|Treatment|Adverse Event|2
2888242|NCT01884337|9942423|P1|Treatment|Adverse Event|2
2888243|NCT01884311|9942431|P1|Overall Study|Precautionary measure|1
2888244|NCT01884311|9942431|P1|Overall Study|withdrew consent due to AEs|1
2888245|NCT01884311|9942431|P1|Overall Study|Withdrawal by Subject|3
2888246|NCT01884077|9942441|P2|Overall Study|study closed|4
2888247|NCT01884077|9942442|P1|Overall Study|study closed|6
2888248|NCT01884077|9942441|P2|Overall Study|Lost to Follow-up|4
2888249|NCT01884077|9942442|P1|Overall Study|Lost to Follow-up|0
2888250|NCT01884077|9942441|P2|Overall Study|canceled surgery|0
2888251|NCT01884077|9942442|P1|Overall Study|canceled surgery|2
2888252|NCT01884077|9942441|P2|Overall Study|screen fail|2
2888253|NCT01884077|9942442|P1|Overall Study|screen fail|0
2888254|NCT01884025|9942463|P2|Overall Study|Lost to Follow-up|4
2888255|NCT01884025|9942464|P1|Overall Study|Lost to Follow-up|3
2888256|NCT01883895|9942524|P1|Overall Study|Lost to Follow-up|2
2888257|NCT01883635|9942538|P2|Overall Study|Withdrawal by Subject|0
2888258|NCT01883635|9942539|P1|Overall Study|Withdrawal by Subject|4
2888259|NCT01883492|9942553|P2|Overall Study|bone anatomy did not meet study criteria|1
2888260|NCT01883492|9942554|P1|Overall Study|bone anatomy did not meet study criteria|1
2888261|NCT01883492|9942553|P2|Overall Study|inappropriate implant used|1
2888262|NCT01883492|9942554|P1|Overall Study|inappropriate implant used|1
2888263|NCT01883492|9942553|P2|Overall Study|Withdrawal by Subject|0
2888264|NCT01883492|9942554|P1|Overall Study|Withdrawal by Subject|1
2888265|NCT01883492|9942553|P2|Overall Study|Poor X-ray quality|4
2888266|NCT01883492|9942554|P1|Overall Study|Poor X-ray quality|7
2888267|NCT01883492|9942553|P2|Overall Study|Surgery on contra-lateral hip|1
2888268|NCT01883492|9942554|P1|Overall Study|Surgery on contra-lateral hip|0
2888269|NCT01883492|9942553|P2|Overall Study|Lost to Follow-up|4
2888270|NCT01883492|9942554|P1|Overall Study|Lost to Follow-up|3
2888271|NCT01883453|9942586|P2|Overall Study|No episode of common cold|23
2888272|NCT01883453|9942587|P1|Overall Study|No episode of common cold|25
2888273|NCT01882985|9942622|P1|Overall Study|Withdrawal by Subject|1
2888274|NCT01882985|9942622|P1|Overall Study|Lost to Follow-up|1
2888275|NCT01882907|9942631|P2|Overall Study|Withdrawal by Subject|6
2888276|NCT01882907|9942632|P1|Overall Study|Withdrawal by Subject|0
2888277|NCT01882907|9942631|P2|Overall Study|Protocol Violation|14
2888278|NCT01882907|9942632|P1|Overall Study|Protocol Violation|10
2888279|NCT01882907|9942631|P2|Overall Study|Lost to Follow-up|4
2888281|NCT01882907|9942631|P2|Overall Study|Lack of Efficacy|3
2888282|NCT01882907|9942632|P1|Overall Study|Lack of Efficacy|0
2888283|NCT01882907|9942631|P2|Overall Study|Adverse Event|1
2888284|NCT01882907|9942632|P1|Overall Study|Adverse Event|3
2888285|NCT01882829|9942678|P1|Overall Study|Withdrawal by Subject|1
2888286|NCT01882829|9942678|P1|Overall Study|Protocol Violation|1
2888287|NCT01882829|9942678|P1|Overall Study|Adverse Event|4
2888288|NCT01882803|9942692|P1|Overall Study|Withdrawal by Subject|4
2888289|NCT01882803|9942692|P1|Overall Study|Protocol Violation|1
2888290|NCT01882803|9942692|P1|Overall Study|Physician Decision|7
2888291|NCT01882803|9942692|P1|Overall Study|Death|7
2888292|NCT01882803|9942692|P1|Overall Study|Adverse Event|22
2888293|NCT01882803|9942692|P1|Overall Study|Disease Progression|53
2888294|NCT01882647|9942719|P2|Overall Study|Withdrawal by Subject|4
2888295|NCT01882647|9942720|P1|Overall Study|Withdrawal by Subject|0
2888296|NCT01882647|9942719|P2|Overall Study|Lost to Follow-up|2
2888297|NCT01882647|9942720|P1|Overall Study|Lost to Follow-up|2
2888298|NCT01882465|9942760|P7|Period 2|Protocol Violation|0
2888299|NCT01882465|9942761|P6|Period 2|Protocol Violation|0
2888300|NCT01882465|9942762|P5|Period 2|Protocol Violation|1
2888301|NCT01882465|9942763|P4|Period 2|Protocol Violation|0
2888302|NCT01882465|9942764|P3|Period 2|Protocol Violation|0
2888303|NCT01882465|9942765|P2|Period 2|Protocol Violation|0
2888304|NCT01882465|9942766|P1|Period 2|Protocol Violation|0
2888305|NCT01882465|9942760|P7|Period 1|Withdrawal by Subject|1
2888306|NCT01882465|9942761|P6|Period 1|Withdrawal by Subject|0
2888307|NCT01882465|9942762|P5|Period 1|Withdrawal by Subject|0
2888308|NCT01882465|9942763|P4|Period 1|Withdrawal by Subject|0
2888309|NCT01882465|9942764|P3|Period 1|Withdrawal by Subject|0
2888310|NCT01882465|9942765|P2|Period 1|Withdrawal by Subject|0
2888311|NCT01882465|9942766|P1|Period 1|Withdrawal by Subject|0
2888312|NCT01882465|9942760|P7|Period 1|Lens Discomfort|0
2888313|NCT01882465|9942761|P6|Period 1|Lens Discomfort|0
2888314|NCT01882465|9942762|P5|Period 1|Lens Discomfort|0
2888315|NCT01882465|9942763|P4|Period 1|Lens Discomfort|1
2888316|NCT01882465|9942764|P3|Period 1|Lens Discomfort|0
2888317|NCT01882465|9942765|P2|Period 1|Lens Discomfort|0
2888318|NCT01882465|9942766|P1|Period 1|Lens Discomfort|0
2888319|NCT01882439|9942778|P4|Overall Study|Adverse event unrelated to study drug|1
2888320|NCT01882439|9942779|P3|Overall Study|Adverse event unrelated to study drug|1
2888321|NCT01882439|9942780|P2|Overall Study|Adverse event unrelated to study drug|2
2888322|NCT01882439|9942781|P1|Overall Study|Adverse event unrelated to study drug|2
2888323|NCT01882439|9942778|P4|Overall Study|Insufficient clinical response|2
2888324|NCT01882439|9942779|P3|Overall Study|Insufficient clinical response|4
2888325|NCT01882439|9942780|P2|Overall Study|Insufficient clinical response|4
2888326|NCT01882439|9942781|P1|Overall Study|Insufficient clinical response|1
2888327|NCT01882439|9942778|P4|Overall Study|Medication error with no associated AE|0
2888328|NCT01882439|9942779|P3|Overall Study|Medication error with no associated AE|2
2888329|NCT01882439|9942780|P2|Overall Study|Medication error with no associated AE|0
2888330|NCT01882439|9942781|P1|Overall Study|Medication error with no associated AE|0
2888331|NCT01882439|9942778|P4|Overall Study|No longer willing to participate|3
2888332|NCT01882439|9942779|P3|Overall Study|No longer willing to participate|2
2888333|NCT01882439|9942780|P2|Overall Study|No longer willing to participate|4
2888334|NCT01882439|9942781|P1|Overall Study|No longer willing to participate|1
2888335|NCT01882439|9942778|P4|Overall Study|Protocol Violation|1
2888336|NCT01882439|9942779|P3|Overall Study|Protocol Violation|0
2888337|NCT01882439|9942780|P2|Overall Study|Protocol Violation|2
2888338|NCT01882439|9942781|P1|Overall Study|Protocol Violation|2
2888339|NCT01882439|9942778|P4|Overall Study|Pregnancy|0
2888340|NCT01882439|9942779|P3|Overall Study|Pregnancy|0
2888341|NCT01882439|9942780|P2|Overall Study|Pregnancy|1
2888342|NCT01882439|9942781|P1|Overall Study|Pregnancy|0
2888343|NCT01882439|9942778|P4|Overall Study|Adverse event related to study drug|2
2888344|NCT01882439|9942779|P3|Overall Study|Adverse event related to study drug|1
2888345|NCT01882439|9942780|P2|Overall Study|Adverse event related to study drug|8
2888346|NCT01882439|9942781|P1|Overall Study|Adverse event related to study drug|3
2888347|NCT01882257|9942978|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
2888348|NCT01882257|9942979|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
2888349|NCT01882257|9942980|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
2888350|NCT01882257|9942978|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
2888351|NCT01882257|9942979|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
2888352|NCT01882257|9942980|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
2888353|NCT01882088|9942987|P1|Overall Study|inadequate pH-impedance tracings|2
2888354|NCT01882088|9942987|P1|Overall Study|Protocol Violation|1
2888355|NCT01882088|9942987|P1|Overall Study|no possibility to place the catheter|1
2888356|NCT01882088|9942987|P1|Overall Study|Intolerance of esophageal manometry|1
2888357|NCT01881776|9943069|P3|Overall Study|Protocol Violation|1
2888358|NCT01881776|9943070|P2|Overall Study|Protocol Violation|2
2888359|NCT01881776|9943071|P1|Overall Study|Protocol Violation|0
2888360|NCT01881776|9943069|P3|Overall Study|Lost to Follow-up|1
2888361|NCT01881776|9943070|P2|Overall Study|Lost to Follow-up|2
2888362|NCT01881776|9943071|P1|Overall Study|Lost to Follow-up|1
2888363|NCT01881750|9943099|P2|Overall Study|Lost to Follow-up|1
2888364|NCT01881750|9943100|P1|Overall Study|Lost to Follow-up|0
2888365|NCT01881750|9943099|P2|Overall Study|Changes in concomitant therapies|3
2888366|NCT01881750|9943100|P1|Overall Study|Changes in concomitant therapies|2
2888367|NCT01881737|9943118|P1|Overall Study|Worsening of baseline behavior|1
2888368|NCT01881737|9943118|P1|Overall Study|Withdrawal by Subject|1
2888369|NCT01881737|9943118|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2888370|NCT01881620|9943127|P1|Overall Study|Protocol Violation|4
2888371|NCT01881230|9943207|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
2888372|NCT01881230|9943208|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
2888373|NCT01881230|9943209|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
2888374|NCT01881230|9943207|P3|Overall Study|Untreated: Death|1
2888375|NCT01881230|9943208|P2|Overall Study|Untreated: Death|0
2888376|NCT01881230|9943209|P1|Overall Study|Untreated: Death|0
2888377|NCT01881230|9943207|P3|Overall Study|Untreated: Other|1
2888378|NCT01881230|9943208|P2|Overall Study|Untreated: Other|0
2888379|NCT01881230|9943209|P1|Overall Study|Untreated: Other|0
2888380|NCT01881230|9943207|P3|Overall Study|Miscellaneous|0
2888381|NCT01881230|9943208|P2|Overall Study|Miscellaneous|3
2888382|NCT01881230|9943209|P1|Overall Study|Miscellaneous|3
2888383|NCT01881230|9943207|P3|Overall Study|Protocol Violation|0
2888384|NCT01881230|9943208|P2|Overall Study|Protocol Violation|1
2888385|NCT01881230|9943209|P1|Overall Study|Protocol Violation|1
2888386|NCT01881230|9943207|P3|Overall Study|Given Commercially Available Drug|2
2888387|NCT01881230|9943208|P2|Overall Study|Given Commercially Available Drug|0
2888388|NCT01881230|9943209|P1|Overall Study|Given Commercially Available Drug|0
2888389|NCT01881230|9943207|P3|Overall Study|Non-Compliance with Study Drug|0
2888390|NCT01881230|9943208|P2|Overall Study|Non-Compliance with Study Drug|2
2888391|NCT01881230|9943209|P1|Overall Study|Non-Compliance with Study Drug|1
2888392|NCT01881230|9943207|P3|Overall Study|Physician Decision|6
2888393|NCT01881230|9943208|P2|Overall Study|Physician Decision|3
2888394|NCT01881230|9943209|P1|Overall Study|Physician Decision|4
2888395|NCT01881230|9943207|P3|Overall Study|Withdrawal by Subject|6
2888396|NCT01881230|9943208|P2|Overall Study|Withdrawal by Subject|4
2888397|NCT01881230|9943209|P1|Overall Study|Withdrawal by Subject|6
2888398|NCT01881230|9943207|P3|Overall Study|Symptomatic Deterioration|1
2888399|NCT01881230|9943208|P2|Overall Study|Symptomatic Deterioration|3
2888400|NCT01881230|9943209|P1|Overall Study|Symptomatic Deterioration|3
2888401|NCT01881230|9943207|P3|Overall Study|Progressive Disease|36
2888402|NCT01881230|9943208|P2|Overall Study|Progressive Disease|35
2888403|NCT01881230|9943209|P1|Overall Study|Progressive Disease|31
2888404|NCT01881230|9943207|P3|Overall Study|Adverse Event|12
2888405|NCT01881230|9943208|P2|Overall Study|Adverse Event|13
2888406|NCT01881230|9943209|P1|Overall Study|Adverse Event|9
2888407|NCT01881230|9943207|P3|Overall Study|Death|1
2888408|NCT01881230|9943208|P2|Overall Study|Death|0
2888409|NCT01881230|9943209|P1|Overall Study|Death|2
2888410|NCT01881126|9943237|P2|Overall Study|Adverse Event|1
2888411|NCT01881126|9943238|P1|Overall Study|Adverse Event|0
2888412|NCT01881126|9943237|P2|Overall Study|Non-compliance|1
2888413|NCT01881126|9943238|P1|Overall Study|Non-compliance|1
2888414|NCT01881009|9943319|P2|Summer Camp Session (6 Days)|Unable to wear device|1
2888415|NCT01881009|9943320|P1|Summer Camp Session (6 Days)|Unable to wear device|0
2888416|NCT01880736|9943342|P4|Overall Study|Withdrawal Criteria|5
2888417|NCT01880736|9943343|P3|Overall Study|Withdrawal Criteria|1
2888418|NCT01880736|9943344|P2|Overall Study|Withdrawal Criteria|2
2888419|NCT01880736|9943345|P1|Overall Study|Withdrawal Criteria|1
2888420|NCT01880736|9943342|P4|Overall Study|Adverse Event|1
2888421|NCT01880736|9943343|P3|Overall Study|Adverse Event|0
2888422|NCT01880736|9943344|P2|Overall Study|Adverse Event|0
2888423|NCT01880736|9943345|P1|Overall Study|Adverse Event|0
2888424|NCT01880593|9943429|P2|Overall Study|Withdrawal by Subject|1
2888425|NCT01880593|9943430|P1|Overall Study|Withdrawal by Subject|6
2888426|NCT01880593|9943429|P2|Overall Study|Lack of Efficacy|5
2888427|NCT01880593|9943430|P1|Overall Study|Lack of Efficacy|1
2888428|NCT01880593|9943429|P2|Overall Study|Adverse Event|0
2888429|NCT01880593|9943430|P1|Overall Study|Adverse Event|1
2888430|NCT01880528|9943450|P2|Overall Study|Other|1
2888431|NCT01880528|9943451|P1|Overall Study|Other|1
2888432|NCT01880515|9943467|P2|Overall Study|Disease Progression|7
2888433|NCT01880515|9943468|P1|Overall Study|Disease Progression|5
2888434|NCT01880515|9943467|P2|Overall Study|Lost to Follow-up|2
2888435|NCT01880515|9943468|P1|Overall Study|Lost to Follow-up|3
2888436|NCT01880437|9943479|P3|Overall Study|Study terminated by Sponsor|2
2888437|NCT01880437|9943480|P2|Overall Study|Study terminated by Sponsor|0
2888438|NCT01880437|9943481|P1|Overall Study|Study terminated by Sponsor|3
2888439|NCT01880437|9943479|P3|Overall Study|Death|17
2888440|NCT01880437|9943480|P2|Overall Study|Death|4
2888441|NCT01880437|9943481|P1|Overall Study|Death|12
2888442|NCT01880424|9943507|P2|Overall Study|Other|0
2888443|NCT01880424|9943508|P1|Overall Study|Other|1
2888444|NCT01880424|9943507|P2|Overall Study|Withdrawal by Subject|30
2888445|NCT01880424|9943508|P1|Overall Study|Withdrawal by Subject|10
2888446|NCT01880424|9943507|P2|Overall Study|Protocol Violation|13
2888447|NCT01880424|9943508|P1|Overall Study|Protocol Violation|11
2888448|NCT01880424|9943507|P2|Overall Study|Lost to Follow-up|2
2888449|NCT01880424|9943508|P1|Overall Study|Lost to Follow-up|3
2888450|NCT01880424|9943507|P2|Overall Study|Lack of Efficacy|4
2888451|NCT01880424|9943508|P1|Overall Study|Lack of Efficacy|1
2888452|NCT01880424|9943507|P2|Overall Study|Adverse Event|6
2888453|NCT01880424|9943508|P1|Overall Study|Adverse Event|7
2888454|NCT01880086|9943564|P2|Overall Study|Lost to Follow-up|1
2888455|NCT01880086|9943565|P1|Overall Study|Lost to Follow-up|1
2888456|NCT01879852|9943620|P2|Overall Study|Withdrawal by Subject|0
2888457|NCT01879852|9943621|P1|Overall Study|Withdrawal by Subject|2
2888458|NCT01879722|9943676|P10|Overall Study|Voluntary Withdrawal|0
2888459|NCT01879722|9943677|P9|Overall Study|Voluntary Withdrawal|1
2888460|NCT01879722|9943678|P8|Overall Study|Voluntary Withdrawal|0
2888461|NCT01879722|9943679|P7|Overall Study|Voluntary Withdrawal|0
2888462|NCT01879722|9943680|P6|Overall Study|Voluntary Withdrawal|0
2888463|NCT01879722|9943681|P5|Overall Study|Voluntary Withdrawal|0
2888464|NCT01879722|9943682|P4|Overall Study|Voluntary Withdrawal|0
2888465|NCT01879722|9943683|P3|Overall Study|Voluntary Withdrawal|0
2888466|NCT01879722|9943684|P2|Overall Study|Voluntary Withdrawal|0
2888467|NCT01879722|9943685|P1|Overall Study|Voluntary Withdrawal|0
2888468|NCT01879722|9943676|P10|Overall Study|Pretreatment Event/Adverse Event|0
2888469|NCT01879722|9943677|P9|Overall Study|Pretreatment Event/Adverse Event|1
2888470|NCT01879722|9943678|P8|Overall Study|Pretreatment Event/Adverse Event|1
2888471|NCT01879722|9943679|P7|Overall Study|Pretreatment Event/Adverse Event|0
2888472|NCT01879722|9943680|P6|Overall Study|Pretreatment Event/Adverse Event|0
2888473|NCT01879722|9943681|P5|Overall Study|Pretreatment Event/Adverse Event|1
2888474|NCT01879722|9943682|P4|Overall Study|Pretreatment Event/Adverse Event|1
2888475|NCT01879722|9943683|P3|Overall Study|Pretreatment Event/Adverse Event|0
2888476|NCT01879722|9943684|P2|Overall Study|Pretreatment Event/Adverse Event|1
2888477|NCT01879722|9943685|P1|Overall Study|Pretreatment Event/Adverse Event|0
2888478|NCT01879683|9943833|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
2888479|NCT01879618|9943840|P1|Overall Study|Adverse Event|5
2888480|NCT01879618|9943840|P1|Overall Study|Protocol Violation|6
2888481|NCT01879618|9943840|P1|Overall Study|Surgery;changed schedule; not available|8
2888482|NCT01879618|9943840|P1|Overall Study|Withdrawal by Subject|1
2888483|NCT01879618|9943840|P1|Overall Study|Does not meet entrance criteria|1
2888484|NCT01879579|9943847|P2|Overall Study|Discontinued insulin - possible allergy|1
2888485|NCT01879579|9943848|P1|Overall Study|Discontinued insulin - possible allergy|0
2888486|NCT01879579|9943847|P2|Overall Study|Phenotypic type 1 diabetes|1
2888487|NCT01879579|9943848|P1|Overall Study|Phenotypic type 1 diabetes|0
2888488|NCT01879579|9943847|P2|Overall Study|Did not initiate insulin treatment|0
2888489|NCT01879579|9943848|P1|Overall Study|Did not initiate insulin treatment|1
2888490|NCT01879579|9943847|P2|Overall Study|Did not enroll in texting platform|0
2888491|NCT01879579|9943848|P1|Overall Study|Did not enroll in texting platform|1
2888492|NCT01879579|9943847|P2|Overall Study|Phone incompatible with texting platform|0
2888493|NCT01879579|9943848|P1|Overall Study|Phone incompatible with texting platform|3
2888494|NCT01879553|9943878|P2|Overall Study|Withdrawal by Subject|0
2888495|NCT01879553|9943879|P1|Overall Study|Withdrawal by Subject|1
2888496|NCT01879410|9943913|P2|Overall Study|Randomised in Error|2
2888497|NCT01879410|9943914|P1|Overall Study|Randomised in Error|1
2888498|NCT01879410|9943913|P2|Overall Study|Withdrawal by Subject|8
2888499|NCT01879410|9943914|P1|Overall Study|Withdrawal by Subject|7
2888500|NCT01879410|9943913|P2|Overall Study|Lost to Follow-up|1
2888501|NCT01879410|9943914|P1|Overall Study|Lost to Follow-up|2
2888502|NCT01879410|9943913|P2|Overall Study|Protocol Violation|7
2888503|NCT01879410|9943914|P1|Overall Study|Protocol Violation|1
2888504|NCT01879410|9943913|P2|Overall Study|Lack of Efficacy|6
2888505|NCT01879410|9943914|P1|Overall Study|Lack of Efficacy|4
2888506|NCT01879410|9943913|P2|Overall Study|Adverse Event|14
2888507|NCT01879410|9943914|P1|Overall Study|Adverse Event|9
2888508|NCT01879319|9943981|P2|Overall Study|Lost to Follow-up|5
2888509|NCT01879319|9943982|P1|Overall Study|Lost to Follow-up|1
2888510|NCT01879319|9943981|P2|Overall Study|Withdrawal by Subject|0
2888511|NCT01879319|9943982|P1|Overall Study|Withdrawal by Subject|1
2888512|NCT01879072|9943999|P1|Overall Study|Not Transplanted|30
2888513|NCT01879072|9943999|P1|Overall Study|Withdrawal by Subject|121
2888514|NCT01878292|9944144|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
2888515|NCT01878292|9944145|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
2888516|NCT01878292|9944146|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
2888517|NCT01878292|9944144|P3|Double-blind Treatment Period|Adverse Event|8
2888518|NCT01878292|9944145|P2|Double-blind Treatment Period|Adverse Event|9
2888519|NCT01878292|9944146|P1|Double-blind Treatment Period|Adverse Event|4
2888520|NCT01878292|9944144|P3|Double-blind Treatment Period|Lack of Efficacy|0
2888521|NCT01878292|9944145|P2|Double-blind Treatment Period|Lack of Efficacy|3
2888522|NCT01878292|9944146|P1|Double-blind Treatment Period|Lack of Efficacy|5
2888523|NCT01878292|9944144|P3|Double-blind Treatment Period|Protocol Violation|2
2888524|NCT01878292|9944145|P2|Double-blind Treatment Period|Protocol Violation|4
2888525|NCT01878292|9944146|P1|Double-blind Treatment Period|Protocol Violation|3
2888526|NCT01878292|9944144|P3|Double-blind Treatment Period|Withdrawal by Subject|8
2888527|NCT01878292|9944145|P2|Double-blind Treatment Period|Withdrawal by Subject|7
2888528|NCT01878292|9944146|P1|Double-blind Treatment Period|Withdrawal by Subject|9
2888529|NCT01878292|9944144|P3|Double-blind Treatment Period|Lost to Follow-up|1
2888530|NCT01878292|9944145|P2|Double-blind Treatment Period|Lost to Follow-up|3
2888531|NCT01878292|9944146|P1|Double-blind Treatment Period|Lost to Follow-up|6
2888532|NCT01878292|9944144|P3|Double-blind Treatment Period|Other Reasons|0
2888533|NCT01878292|9944145|P2|Double-blind Treatment Period|Other Reasons|0
2888534|NCT01878292|9944146|P1|Double-blind Treatment Period|Other Reasons|2
2888535|NCT01878292|9944144|P3|Randomized|Adverse Event|0
2888536|NCT01878292|9944145|P2|Randomized|Adverse Event|0
2888537|NCT01878292|9944146|P1|Randomized|Adverse Event|1
2888538|NCT01878292|9944144|P3|Randomized|Lost to Follow-up|0
2888539|NCT01878292|9944145|P2|Randomized|Lost to Follow-up|0
2888540|NCT01878292|9944146|P1|Randomized|Lost to Follow-up|1
2888541|NCT01878292|9944144|P3|Randomized|Protocol Violation|0
2888542|NCT01878292|9944145|P2|Randomized|Protocol Violation|0
2888543|NCT01878292|9944146|P1|Randomized|Protocol Violation|1
2888544|NCT01878253|9944157|P1|Overall Study|Completed Study w/o Follow-up Data|2
2888545|NCT01878253|9944157|P1|Overall Study|Lost to Follow-up|2
2888546|NCT01878253|9944157|P1|Overall Study|Withdrawal by Subject|1
2888547|NCT01878253|9944157|P1|Overall Study|SIdus System Removal|3
2888548|NCT01878253|9944157|P1|Overall Study|Death|1
2888549|NCT01878214|9944168|P2|Overall Study|Lost to Follow-up|36
2888550|NCT01878214|9944169|P1|Overall Study|Lost to Follow-up|35
2888551|NCT01878214|9944168|P2|Overall Study|Death|1
2888552|NCT01878214|9944169|P1|Overall Study|Death|0
2888553|NCT01878214|9944168|P2|Overall Study|Withdrawal by Subject|7
2888554|NCT01878214|9944169|P1|Overall Study|Withdrawal by Subject|18
2888555|NCT01878175|9944183|P1|Overall Study|Developed contraindicated health problem|2
2888556|NCT01878149|9944202|P2|Overall Study|Did Not Meet Eligibility Criteria|2
2888557|NCT01878149|9944203|P1|Overall Study|Did Not Meet Eligibility Criteria|2
2888558|NCT01878097|9944211|P2|Implementation Year 4|Surveys not fully completed|3007
2888559|NCT01878097|9944212|P1|Implementation Year 4|Surveys not fully completed|3604
2888560|NCT01878097|9944211|P2|Implementation Year 3|Surveys not fully completed|2980
2888561|NCT01878097|9944212|P1|Implementation Year 3|Surveys not fully completed|3494
2888562|NCT01878097|9944211|P2|Implementation Year 2|Surveys not fully completed|2841
2888563|NCT01878097|9944212|P1|Implementation Year 2|Surveys not fully completed|3281
2888564|NCT01878097|9944211|P2|Implementation Year 1|Surveys not fully completed|2549
2888565|NCT01878097|9944212|P1|Implementation Year 1|Surveys not fully completed|3202
2888566|NCT01878097|9944211|P2|Baseline|Surveys not fully completed|1800
2888567|NCT01878097|9944212|P1|Baseline|Surveys not fully completed|2497
2888568|NCT01878084|9944220|P1|Overall Study|Physician Decision|2
2888569|NCT01877915|9944254|P2|Overall Study|Other|4
2888570|NCT01877915|9944255|P1|Overall Study|Other|2
2888571|NCT01877915|9944254|P2|Overall Study|Withdrawal by Subject|55
2888572|NCT01877915|9944255|P1|Overall Study|Withdrawal by Subject|42
2888573|NCT01877915|9944254|P2|Overall Study|Lost to Follow-up|9
2888574|NCT01877915|9944255|P1|Overall Study|Lost to Follow-up|10
2888575|NCT01877720|9944277|P2|Overall Study|Adverse Event|0
2888576|NCT01877720|9944278|P1|Overall Study|Adverse Event|1
2888577|NCT01877668|9944307|P5|Overall Study|Adverse event unrelated to study drug|1
2888578|NCT01877668|9944308|P4|Overall Study|Adverse event unrelated to study drug|0
2888579|NCT01877668|9944309|P3|Overall Study|Adverse event unrelated to study drug|2
2888580|NCT01877668|9944310|P2|Overall Study|Adverse event unrelated to study drug|1
2888581|NCT01877668|9944311|P1|Overall Study|Adverse event unrelated to study drug|4
2888582|NCT01877668|9944307|P5|Overall Study|Adverse event related to study drug|1
2888583|NCT01877668|9944308|P4|Overall Study|Adverse event related to study drug|2
2888584|NCT01877668|9944309|P3|Overall Study|Adverse event related to study drug|2
2888585|NCT01877668|9944310|P2|Overall Study|Adverse event related to study drug|2
2888586|NCT01877668|9944311|P1|Overall Study|Adverse event related to study drug|2
2888587|NCT01877668|9944307|P5|Overall Study|Protocol Violation|3
2888588|NCT01877668|9944308|P4|Overall Study|Protocol Violation|0
2888589|NCT01877668|9944309|P3|Overall Study|Protocol Violation|0
2888590|NCT01877668|9944310|P2|Overall Study|Protocol Violation|1
2888591|NCT01877668|9944311|P1|Overall Study|Protocol Violation|1
2888592|NCT01877668|9944307|P5|Overall Study|Other|3
2888593|NCT01877668|9944308|P4|Overall Study|Other|1
2888594|NCT01877668|9944309|P3|Overall Study|Other|1
2888595|NCT01877668|9944310|P2|Overall Study|Other|1
2888596|NCT01877668|9944311|P1|Overall Study|Other|1
2888597|NCT01877668|9944307|P5|Overall Study|Withdrawal by Subject|2
2888598|NCT01877668|9944308|P4|Overall Study|Withdrawal by Subject|2
2888599|NCT01877668|9944309|P3|Overall Study|Withdrawal by Subject|3
2888600|NCT01877668|9944310|P2|Overall Study|Withdrawal by Subject|0
2888601|NCT01877668|9944311|P1|Overall Study|Withdrawal by Subject|2
2888602|NCT01877668|9944307|P5|Overall Study|Lost to Follow-up|0
2888603|NCT01877668|9944308|P4|Overall Study|Lost to Follow-up|0
2888604|NCT01877668|9944309|P3|Overall Study|Lost to Follow-up|1
2888605|NCT01877668|9944310|P2|Overall Study|Lost to Follow-up|2
2888606|NCT01877668|9944311|P1|Overall Study|Lost to Follow-up|0
2888607|NCT01877668|9944307|P5|Overall Study|Insufficient clinical response|0
2888608|NCT01877668|9944308|P4|Overall Study|Insufficient clinical response|2
2888609|NCT01877668|9944309|P3|Overall Study|Insufficient clinical response|2
2888610|NCT01877668|9944310|P2|Overall Study|Insufficient clinical response|1
2888611|NCT01877668|9944311|P1|Overall Study|Insufficient clinical response|0
2888612|NCT01877668|9944307|P5|Overall Study|No longer met study criteria|0
2888613|NCT01877668|9944308|P4|Overall Study|No longer met study criteria|0
2888614|NCT01877668|9944309|P3|Overall Study|No longer met study criteria|1
2888615|NCT01877668|9944310|P2|Overall Study|No longer met study criteria|0
2888616|NCT01877668|9944311|P1|Overall Study|No longer met study criteria|1
2888617|NCT01877668|9944307|P5|Overall Study|Death|0
2888618|NCT01877668|9944308|P4|Overall Study|Death|1
2888619|NCT01877668|9944309|P3|Overall Study|Death|0
2888620|NCT01877668|9944310|P2|Overall Study|Death|0
2888621|NCT01877668|9944311|P1|Overall Study|Death|0
2888622|NCT01877655|9944542|P2|Overall Study|Randomized but Never Received Drug|5
2888623|NCT01877655|9944543|P1|Overall Study|Randomized but Never Received Drug|8
2888624|NCT01877655|9944542|P2|Overall Study|Miscellaneous|4
2888625|NCT01877655|9944543|P1|Overall Study|Miscellaneous|4
2888626|NCT01877655|9944542|P2|Overall Study|Physician Decision|10
2888627|NCT01877655|9944543|P1|Overall Study|Physician Decision|11
2888628|NCT01877655|9944542|P2|Overall Study|Withdrawal by Subject|26
2888629|NCT01877655|9944543|P1|Overall Study|Withdrawal by Subject|18
2888630|NCT01877655|9944542|P2|Overall Study|Death|52
2888631|NCT01877655|9944543|P1|Overall Study|Death|57
2888632|NCT01877551|9944599|P2|Overall Study|Physician Decision|1
2888633|NCT01877551|9944600|P1|Overall Study|Physician Decision|0
2888634|NCT01877421|9944649|P18|Phase 2|Protocol Violation|0
2888635|NCT01877421|9944650|P17|Phase 2|Protocol Violation|0
2888636|NCT01877421|9944651|P16|Phase 2|Protocol Violation|0
2888637|NCT01877421|9944652|P15|Phase 2|Protocol Violation|0
2888638|NCT01877421|9944653|P14|Phase 2|Protocol Violation|0
2888639|NCT01877421|9944654|P13|Phase 2|Protocol Violation|0
2888640|NCT01877421|9944655|P12|Phase 2|Protocol Violation|0
2888641|NCT01877421|9944656|P11|Phase 2|Protocol Violation|1
2888642|NCT01877421|9944657|P10|Phase 2|Protocol Violation|0
2888643|NCT01877421|9944658|P9|Phase 2|Protocol Violation|0
2888644|NCT01877421|9944659|P8|Phase 2|Protocol Violation|0
2888645|NCT01877421|9944660|P7|Phase 2|Protocol Violation|0
2888646|NCT01877421|9944661|P6|Phase 2|Protocol Violation|0
2888647|NCT01877421|9944662|P5|Phase 2|Protocol Violation|0
2888648|NCT01877421|9944663|P4|Phase 2|Protocol Violation|0
2888649|NCT01877421|9944664|P3|Phase 2|Protocol Violation|0
2888650|NCT01877421|9944665|P2|Phase 2|Protocol Violation|0
2888651|NCT01877421|9944666|P1|Phase 2|Protocol Violation|0
2888652|NCT01877421|9944649|P18|Phase 2|Withdrawal by Subject|0
2888653|NCT01877421|9944650|P17|Phase 2|Withdrawal by Subject|0
2888654|NCT01877421|9944651|P16|Phase 2|Withdrawal by Subject|1
2888655|NCT01877421|9944652|P15|Phase 2|Withdrawal by Subject|0
2888656|NCT01877421|9944653|P14|Phase 2|Withdrawal by Subject|0
2888657|NCT01877421|9944654|P13|Phase 2|Withdrawal by Subject|1
2888658|NCT01877421|9944655|P12|Phase 2|Withdrawal by Subject|0
2888659|NCT01877421|9944656|P11|Phase 2|Withdrawal by Subject|1
2888660|NCT01877421|9944657|P10|Phase 2|Withdrawal by Subject|0
2888661|NCT01877421|9944658|P9|Phase 2|Withdrawal by Subject|1
2888662|NCT01877421|9944659|P8|Phase 2|Withdrawal by Subject|0
2888663|NCT01877421|9944660|P7|Phase 2|Withdrawal by Subject|0
2888664|NCT01877421|9944661|P6|Phase 2|Withdrawal by Subject|0
2888665|NCT01877421|9944662|P5|Phase 2|Withdrawal by Subject|0
2888666|NCT01877421|9944663|P4|Phase 2|Withdrawal by Subject|0
2888667|NCT01877421|9944664|P3|Phase 2|Withdrawal by Subject|0
2888668|NCT01877421|9944665|P2|Phase 2|Withdrawal by Subject|0
2888669|NCT01877421|9944666|P1|Phase 2|Withdrawal by Subject|0
2888670|NCT01877421|9944649|P18|Phase 2|Lost to Follow-up|0
2888671|NCT01877421|9944650|P17|Phase 2|Lost to Follow-up|0
2888672|NCT01877421|9944651|P16|Phase 2|Lost to Follow-up|0
2888673|NCT01877421|9944652|P15|Phase 2|Lost to Follow-up|0
2888674|NCT01877421|9944653|P14|Phase 2|Lost to Follow-up|0
2888675|NCT01877421|9944654|P13|Phase 2|Lost to Follow-up|0
2888676|NCT01877421|9944655|P12|Phase 2|Lost to Follow-up|0
2888677|NCT01877421|9944656|P11|Phase 2|Lost to Follow-up|0
2888678|NCT01877421|9944657|P10|Phase 2|Lost to Follow-up|0
2888679|NCT01877421|9944658|P9|Phase 2|Lost to Follow-up|0
2888680|NCT01877421|9944659|P8|Phase 2|Lost to Follow-up|0
2888681|NCT01877421|9944660|P7|Phase 2|Lost to Follow-up|1
2888682|NCT01877421|9944661|P6|Phase 2|Lost to Follow-up|0
2888683|NCT01877421|9944662|P5|Phase 2|Lost to Follow-up|0
2888684|NCT01877421|9944663|P4|Phase 2|Lost to Follow-up|0
2888685|NCT01877421|9944664|P3|Phase 2|Lost to Follow-up|0
2888686|NCT01877421|9944665|P2|Phase 2|Lost to Follow-up|0
2888687|NCT01877421|9944666|P1|Phase 2|Lost to Follow-up|0
2888688|NCT01877408|9944776|P2|Overall Study|Lost to Follow-up|2
2888689|NCT01877408|9944777|P1|Overall Study|Lost to Follow-up|0
2888690|NCT01877278|9944810|P2|Overall Study|Lost to Follow-up|3
2888691|NCT01877278|9944811|P1|Overall Study|Lost to Follow-up|3
2888692|NCT01877265|9944819|P6|Treatment Period 3|Lost to Follow-up|0
2888693|NCT01877265|9944820|P5|Treatment Period 3|Lost to Follow-up|0
2888694|NCT01877265|9944821|P4|Treatment Period 3|Lost to Follow-up|0
2888695|NCT01877265|9944822|P3|Treatment Period 3|Lost to Follow-up|0
2888696|NCT01877265|9944823|P2|Treatment Period 3|Lost to Follow-up|0
2888697|NCT01877265|9944824|P1|Treatment Period 3|Lost to Follow-up|1
2888698|NCT01877265|9944819|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
2888699|NCT01877265|9944820|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2888700|NCT01877265|9944821|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2888701|NCT01877265|9944822|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2888702|NCT01877265|9944823|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2888703|NCT01877265|9944824|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2888704|NCT01877265|9944819|P6|Treatment Period 1|Sponsor Decision|0
2888705|NCT01877265|9944820|P5|Treatment Period 1|Sponsor Decision|0
2888706|NCT01877265|9944821|P4|Treatment Period 1|Sponsor Decision|0
2888707|NCT01877265|9944822|P3|Treatment Period 1|Sponsor Decision|1
2888708|NCT01877265|9944823|P2|Treatment Period 1|Sponsor Decision|0
2888709|NCT01877265|9944824|P1|Treatment Period 1|Sponsor Decision|0
2888710|NCT01877239|9944841|P1|Overall Study|Data not available|35
2888711|NCT01877239|9944841|P1|Overall Study|Lack of Efficacy|4
2888712|NCT01877239|9944841|P1|Overall Study|Other|2
2888713|NCT01877239|9944841|P1|Overall Study|Withdrawal by Subject|4
2888714|NCT01877239|9944841|P1|Overall Study|Disease Remission|1
2888715|NCT01877239|9944841|P1|Overall Study|Adverse Event|4
2888716|NCT01877187|9944847|P1|Overall Study|Liver transplant|2
2888717|NCT01877187|9944847|P1|Overall Study|Declining clinical status|11
2888718|NCT01877187|9944847|P1|Overall Study|Lost to Follow-up|3
2888719|NCT01877187|9944847|P1|Overall Study|Withdrawal by Subject|4
2888720|NCT01877187|9944847|P1|Overall Study|Death|2
2888721|NCT01877083|9944899|P1|Extension Phase|Adverse Event|2
2888722|NCT01877083|9944899|P1|Extension Phase|Disease Progression|3
2888723|NCT01877083|9944899|P1|Treatment Phase|Lost to Follow-up|1
2888724|NCT01877083|9944899|P1|Treatment Phase|Withdrawal by Subject|2
2888725|NCT01877083|9944899|P1|Treatment Phase|Adverse Event|6
2888726|NCT01877083|9944899|P1|Treatment Phase|Clinical Progression|1
2888727|NCT01877083|9944899|P1|Treatment Phase|Disease Progression|10
2888728|NCT01876979|9944923|P2|Overall Study|Physician Decision|3
2888729|NCT01876979|9944924|P1|Overall Study|Physician Decision|2
2888730|NCT01876823|9944930|P1|Overall Study|Patients moved|2
2888731|NCT01876823|9944930|P1|Overall Study|Physician Decision|2
2888732|NCT01876823|9944930|P1|Overall Study|Withdrawal by Subject|5
2888733|NCT01876810|9944943|P2|Overall Study|Physician Decision|1
2888734|NCT01876810|9944944|P1|Overall Study|Physician Decision|0
2888735|NCT01876784|9944956|P2|Overall Study|Ongoing|40
2888736|NCT01876784|9944957|P1|Overall Study|Ongoing|41
2888737|NCT01876784|9944956|P2|Overall Study|Other than specified above|6
2888738|NCT01876784|9944957|P1|Overall Study|Other than specified above|5
2888739|NCT01876784|9944956|P2|Overall Study|Randomized but not treated|1
2888740|NCT01876784|9944957|P1|Overall Study|Randomized but not treated|2
2888741|NCT01876784|9944956|P2|Overall Study|Death|0
2888742|NCT01876784|9944957|P1|Overall Study|Death|1
2888743|NCT01876784|9944956|P2|Overall Study|Lost to Follow-up|1
2888744|NCT01876784|9944957|P1|Overall Study|Lost to Follow-up|0
2888745|NCT01876784|9944956|P2|Overall Study|Disease progression|67
2888746|NCT01876784|9944957|P1|Overall Study|Disease progression|37
2888747|NCT01876784|9944956|P2|Overall Study|Protocol Violation|0
2888748|NCT01876784|9944957|P1|Overall Study|Protocol Violation|1
2888749|NCT01876784|9944956|P2|Overall Study|Adverse Event|2
2888750|NCT01876784|9944957|P1|Overall Study|Adverse Event|15
2888751|NCT01876784|9944956|P2|Overall Study|Withdrawal by Subject|2
2888752|NCT01876784|9944957|P1|Overall Study|Withdrawal by Subject|17
2888753|NCT01876732|9944963|P1|Overall Study|MMA was not over 800mg/dL|75
2888754|NCT01876706|9944968|P1|Overall Study|Death|3
2888755|NCT01876706|9944968|P1|Overall Study|Withdrawals|6
2888756|NCT01876706|9944968|P1|Overall Study|Lost to Follow-up|7
2888757|NCT01876706|9944968|P1|Overall Study|BPH Intervention|9
2888758|NCT01876511|9944988|P3|Overall Study|Physician Decision|1
2888759|NCT01876511|9944989|P2|Overall Study|Physician Decision|0
2888760|NCT01876511|9944990|P1|Overall Study|Physician Decision|1
2888761|NCT01876511|9944988|P3|Overall Study|Patient Decision|6
2888762|NCT01876511|9944989|P2|Overall Study|Patient Decision|0
2888763|NCT01876511|9944990|P1|Overall Study|Patient Decision|3
2888764|NCT01876511|9944988|P3|Overall Study|Drug-related Toxicity|6
2888765|NCT01876511|9944989|P2|Overall Study|Drug-related Toxicity|1
2888766|NCT01876511|9944990|P1|Overall Study|Drug-related Toxicity|5
2888767|NCT01876511|9944988|P3|Overall Study|Death (unrelated)|2
2888768|NCT01876511|9944989|P2|Overall Study|Death (unrelated)|0
2888769|NCT01876511|9944990|P1|Overall Study|Death (unrelated)|3
2888770|NCT01876511|9944988|P3|Overall Study|Disease Progression-clinical/radiologic|16
2888771|NCT01876511|9944989|P2|Overall Study|Disease Progression-clinical/radiologic|24
2888772|NCT01876511|9944990|P1|Overall Study|Disease Progression-clinical/radiologic|11
2888773|NCT01876446|9945038|P2|Overall Study|Physician Decision|3
2888774|NCT01876446|9945039|P1|Overall Study|Physician Decision|1
2888775|NCT01876446|9945038|P2|Overall Study|Withdrawal by Subject|2
2888776|NCT01876446|9945039|P1|Overall Study|Withdrawal by Subject|1
2888777|NCT01876446|9945038|P2|Overall Study|Death|1
2888778|NCT01876446|9945039|P1|Overall Study|Death|0
2888779|NCT01876420|9945055|P1|Overall Study|Missed 30 day visit|1
2888780|NCT01876381|9945067|P1|Overall Study|Withdrawal by Subject|1
2888781|NCT01876381|9945067|P1|Overall Study|Physician Decision|1
2888782|NCT01876381|9945067|P1|Overall Study|Lack of Efficacy|5
2888783|NCT01876368|9945074|P2|Overall Study|Subject/guardian decision|1
2888784|NCT01876368|9945075|P1|Overall Study|Subject/guardian decision|3
2888785|NCT01876368|9945074|P2|Overall Study|Protocol deviation|3
2888786|NCT01876368|9945075|P1|Overall Study|Protocol deviation|3
2888787|NCT01876368|9945074|P2|Overall Study|Physician Decision|2
2888788|NCT01876368|9945075|P1|Overall Study|Physician Decision|0
2888789|NCT01876368|9945074|P2|Overall Study|Non-compliance with study treatment|1
2888790|NCT01876368|9945075|P1|Overall Study|Non-compliance with study treatment|0
2888791|NCT01876368|9945074|P2|Overall Study|Lost to Follow-up|1
2888792|NCT01876368|9945075|P1|Overall Study|Lost to Follow-up|0
2888793|NCT01876368|9945074|P2|Overall Study|Lack of Efficacy|0
2888794|NCT01876368|9945075|P1|Overall Study|Lack of Efficacy|1
2888795|NCT01876368|9945074|P2|Overall Study|Adverse Event|5
2888796|NCT01876368|9945075|P1|Overall Study|Adverse Event|2
2888797|NCT01876251|9945120|P3|Overall Study|Objective progression or relapse|8
2888798|NCT01876251|9945121|P2|Overall Study|Objective progression or relapse|3
2888799|NCT01876251|9945122|P1|Overall Study|Objective progression or relapse|10
2888800|NCT01876251|9945120|P3|Overall Study|Study terminated|0
2888801|NCT01876251|9945121|P2|Overall Study|Study terminated|0
2888802|NCT01876251|9945122|P1|Overall Study|Study terminated|1
2888803|NCT01876251|9945120|P3|Overall Study|Participant refused further follow-up|1
2888804|NCT01876251|9945121|P2|Overall Study|Participant refused further follow-up|0
2888805|NCT01876251|9945122|P1|Overall Study|Participant refused further follow-up|0
2888806|NCT01876251|9945120|P3|Overall Study|Participant started new treatment|1
2888807|NCT01876251|9945121|P2|Overall Study|Participant started new treatment|0
2888808|NCT01876251|9945122|P1|Overall Study|Participant started new treatment|1
2888809|NCT01876251|9945120|P3|Overall Study|Death|1
2888810|NCT01876251|9945121|P2|Overall Study|Death|0
2888811|NCT01876251|9945122|P1|Overall Study|Death|2
2888812|NCT01876251|9945120|P3|Overall Study|Clinical progression|0
2888813|NCT01876251|9945121|P2|Overall Study|Clinical progression|0
2888814|NCT01876251|9945122|P1|Overall Study|Clinical progression|1
2888815|NCT01876043|9945226|P1|Overall Study|Withdrawal by Subject|1
2888816|NCT01876043|9945226|P1|Overall Study|Death|1
2888817|NCT01875991|9945238|P2|Overall Study|Sponsor Decision|0
2888818|NCT01875991|9945239|P1|Overall Study|Sponsor Decision|1
2888819|NCT01875991|9945238|P2|Overall Study|Withdrawal by Subject|6
2888820|NCT01875991|9945239|P1|Overall Study|Withdrawal by Subject|6
2888821|NCT01875874|9945275|P1|Overall Study|Death|3
2888822|NCT01875848|9945295|P2|Overall Study|Withdrawal by Subject|0
2888823|NCT01875848|9945296|P1|Overall Study|Withdrawal by Subject|2
2888824|NCT01875731|9945313|P2|Overall Study|Fail to obtain lab sample|0
2888825|NCT01875731|9945314|P1|Overall Study|Fail to obtain lab sample|1
2888826|NCT01875471|9945333|P2|Overall Study|Unsatisfactory Lens Fitting|0
2888827|NCT01875471|9945334|P1|Overall Study|Unsatisfactory Lens Fitting|1
2888828|NCT01875471|9945333|P2|Overall Study|Adverse Event|1
2888829|NCT01875471|9945334|P1|Overall Study|Adverse Event|0
2888830|NCT01875445|9945342|P2|Overall Study|Withdrawal by Subject|0
2888831|NCT01875445|9945343|P1|Overall Study|Withdrawal by Subject|2
2888832|NCT01875445|9945342|P2|Overall Study|Lost to Follow-up|0
2888833|NCT01875445|9945343|P1|Overall Study|Lost to Follow-up|5
2888834|NCT01875237|9945353|P2|Overall Study|DLI cells could not be produced|0
2888835|NCT01875237|9945354|P1|Overall Study|DLI cells could not be produced|1
2888836|NCT01875237|9945353|P2|Overall Study|GVDH before DLI|0
2888837|NCT01875237|9945354|P1|Overall Study|GVDH before DLI|1
2888838|NCT01875185|9945380|P2|Overall Study|study was terminated|48
2888839|NCT01875185|9945381|P1|Overall Study|study was terminated|52
2888840|NCT01874665|9945466|P2|Overall Study|Other|0
2888841|NCT01874665|9945467|P1|Overall Study|Other|2
2888842|NCT01874665|9945466|P2|Overall Study|Documented Progressive Disease|7
2888843|NCT01874665|9945467|P1|Overall Study|Documented Progressive Disease|11
2888844|NCT01874665|9945466|P2|Overall Study|Study Terminated by Sponsor|2
2888845|NCT01874665|9945467|P1|Overall Study|Study Terminated by Sponsor|0
2888846|NCT01874665|9945466|P2|Overall Study|Clinical Progressive Disease|3
2888847|NCT01874665|9945467|P1|Overall Study|Clinical Progressive Disease|4
2888848|NCT01874665|9945466|P2|Overall Study|Physician Decision|0
2888849|NCT01874665|9945467|P1|Overall Study|Physician Decision|3
2888850|NCT01874665|9945466|P2|Overall Study|Withdrawal by Subject|1
2888851|NCT01874665|9945467|P1|Overall Study|Withdrawal by Subject|4
2888852|NCT01874665|9945466|P2|Overall Study|Adverse Event|2
2888853|NCT01874665|9945467|P1|Overall Study|Adverse Event|6
2888854|NCT01874535|9945495|P2|Overall Study|incomplete symptom resolution|35
2888855|NCT01874535|9945496|P1|Overall Study|incomplete symptom resolution|45
2888856|NCT01874535|9945495|P2|Overall Study|Lost to Follow-up|9
2888857|NCT01874535|9945496|P1|Overall Study|Lost to Follow-up|10
2888858|NCT01874353|9945504|P2|Overall Study|Withdrawal by Subject|9
2888859|NCT01874353|9945505|P1|Overall Study|Withdrawal by Subject|7
2888860|NCT01874353|9945504|P2|Overall Study|Death|27
2888861|NCT01874353|9945505|P1|Overall Study|Death|45
2888862|NCT01874353|9945504|P2|Overall Study|Lost to Follow-up|1
2888863|NCT01874353|9945505|P1|Overall Study|Lost to Follow-up|1
2888864|NCT01874353|9945504|P2|Overall Study|Other|0
2888865|NCT01874353|9945505|P1|Overall Study|Other|2
2888866|NCT01874340|9945532|P4|Overall Study|Withdrawal by Subject|1
2888867|NCT01874340|9945533|P3|Overall Study|Withdrawal by Subject|0
2888868|NCT01874340|9945534|P2|Overall Study|Withdrawal by Subject|0
2888869|NCT01874340|9945535|P1|Overall Study|Withdrawal by Subject|0
2888870|NCT01874340|9945532|P4|Overall Study|Study terminated by Sponsor|4
2888871|NCT01874340|9945533|P3|Overall Study|Study terminated by Sponsor|8
2888872|NCT01874340|9945534|P2|Overall Study|Study terminated by Sponsor|8
2888873|NCT01874340|9945535|P1|Overall Study|Study terminated by Sponsor|6
2888874|NCT01874275|9945563|P2|Overall Study|Lost to Follow-up|0
2888875|NCT01874275|9945564|P1|Overall Study|Lost to Follow-up|1
2888876|NCT01874145|9945587|P2|Extension Period|Lost to Follow-up|1
2888877|NCT01874145|9945588|P1|Extension Period|Lost to Follow-up|1
2888878|NCT01874145|9945587|P2|Extension Period|Withdrawal by Subject|1
2888879|NCT01874145|9945588|P1|Extension Period|Withdrawal by Subject|2
2888880|NCT01874145|9945587|P2|Extension Period|Adverse Event|2
2888881|NCT01874145|9945588|P1|Extension Period|Adverse Event|3
2888882|NCT01874145|9945587|P2|Core Period|Withdrawal by Subject|4
2888883|NCT01874145|9945588|P1|Core Period|Withdrawal by Subject|0
2888884|NCT01874145|9945587|P2|Core Period|Adverse Event|1
2888885|NCT01874145|9945588|P1|Core Period|Adverse Event|0
2888886|NCT01874145|9945587|P2|Core Period|Physician Decision|1
2888887|NCT01874145|9945588|P1|Core Period|Physician Decision|1
2888888|NCT01874145|9945587|P2|Core Period|Protocol Violation|1
2888889|NCT01874145|9945588|P1|Core Period|Protocol Violation|1
2888890|NCT01874145|9945587|P2|Core Period|Non-compliance|0
2888891|NCT01874145|9945588|P1|Core Period|Non-compliance|1
2888892|NCT01874054|9945647|P1|Overall Study|Death|5
2888893|NCT01874054|9945647|P1|Overall Study|Lost to Follow-up|5
2888894|NCT01874054|9945647|P1|Overall Study|Study Termination by Sponsor|42
2888895|NCT01874054|9945647|P1|Overall Study|Withdrawal by Subject|3
2888896|NCT01873950|9945669|P5|Period 5|Withdrawal by Subject|0
2888897|NCT01873950|9945670|P4|Period 5|Withdrawal by Subject|1
2888898|NCT01873950|9945671|P3|Period 5|Withdrawal by Subject|0
2888899|NCT01873950|9945672|P2|Period 5|Withdrawal by Subject|0
2888900|NCT01873950|9945673|P1|Period 5|Withdrawal by Subject|0
2888901|NCT01873859|9945710|P2|Overall Study|Withdrawal by Subject|4
2888902|NCT01873859|9945711|P1|Overall Study|Withdrawal by Subject|0
2888903|NCT01873742|9945729|P2|Overall Study|Lost to Follow-up|76
2888904|NCT01873742|9945730|P1|Overall Study|Lost to Follow-up|68
2888905|NCT01873729|9945736|P1|Overall Study|Withdrawal by Subject|1
2888906|NCT01873586|9945741|P1|Overall Study|Lost to Follow-up|3
2888907|NCT01873495|9945754|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
2888908|NCT01873495|9945754|P1|Overall Study|Removed for Transplantation|1
2888909|NCT01873495|9945754|P1|Overall Study|Adverse Event|1
2888910|NCT01873495|9945754|P1|Overall Study|Physician Decision|3
2888911|NCT01873495|9945754|P1|Overall Study|Withdrawal by Subject|1
2888912|NCT01873417|9945762|P1|Overall Study|Physician Decision|3
2888913|NCT01873417|9945762|P1|Overall Study|Withdrawal by Subject|2
2888914|NCT01873417|9945762|P1|Overall Study|Lost to Follow-up|2
2888915|NCT01873417|9945762|P1|Overall Study|Adverse Event|24
2888916|NCT01873417|9945762|P1|Overall Study|Did Not Receive Any Study Drug|4
2888917|NCT01872910|9945790|P6|Overall Study|Lost to Follow-up|0
2888918|NCT01872910|9945791|P5|Overall Study|Lost to Follow-up|0
2888919|NCT01872910|9945792|P4|Overall Study|Lost to Follow-up|0
2888920|NCT01872910|9945793|P3|Overall Study|Lost to Follow-up|2
2888921|NCT01872910|9945794|P2|Overall Study|Lost to Follow-up|0
2888922|NCT01872910|9945795|P1|Overall Study|Lost to Follow-up|2
2888923|NCT01872715|9945840|P1|Overall Study|Withdrawal by Subject|2
2888924|NCT01872715|9945840|P1|Overall Study|Protocol Violation|1
2888925|NCT01872715|9945840|P1|Overall Study|Adverse Event|1
2888926|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2888927|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2888928|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
2888929|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
2888930|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Death|0
2888931|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Death|0
2888932|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Death|3
2888933|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Death|5
2888934|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2888935|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2888936|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
2888937|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
2888938|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2888939|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2888940|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
2888941|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2888942|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2888943|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2888944|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
2888945|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
2888946|NCT01872689|9945859|P4|Open-Label Period (Only For Monotherapy)|Other|0
2888947|NCT01872689|9945860|P3|Open-Label Period (Only For Monotherapy)|Other|0
2888948|NCT01872689|9945861|P2|Open-Label Period (Only For Monotherapy)|Other|3
2888949|NCT01872689|9945862|P1|Open-Label Period (Only For Monotherapy)|Other|2
2888950|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
2888951|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
2888952|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
2888953|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
2888954|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Death|9
2888955|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Death|14
2888956|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Death|4
2888957|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Death|3
2888958|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2888959|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2888960|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2888961|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2888962|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
2888963|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2888964|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2888965|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
2888966|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2888967|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2888968|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2888969|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2888970|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
2888971|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
2888972|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
2888973|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
2888974|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Other|3
2888975|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Other|6
2888976|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Other|1
2888977|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Other|1
2888978|NCT01872689|9945859|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2888979|NCT01872689|9945860|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2888980|NCT01872689|9945861|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
2888981|NCT01872689|9945862|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2888982|NCT01872611|9945938|P2|Overall Study|Reason not provided|6
2888983|NCT01872611|9945939|P1|Overall Study|Reason not provided|6
2888984|NCT01872611|9945938|P2|Overall Study|Withdrawal by Subject|1
2888985|NCT01872611|9945939|P1|Overall Study|Withdrawal by Subject|6
2888986|NCT01872611|9945938|P2|Overall Study|Physician Decision|0
2888987|NCT01872611|9945939|P1|Overall Study|Physician Decision|1
2888988|NCT01872611|9945938|P2|Overall Study|Lost to Follow-up|1
2888989|NCT01872611|9945939|P1|Overall Study|Lost to Follow-up|8
2888990|NCT01872611|9945938|P2|Overall Study|Death, prior to treatment|1
2888991|NCT01872611|9945939|P1|Overall Study|Death, prior to treatment|0
2888992|NCT01872611|9945938|P2|Overall Study|Death|1
2888993|NCT01872611|9945939|P1|Overall Study|Death|0
2888994|NCT01872611|9945938|P2|Overall Study|Adverse Event, prior to treatment|1
2888995|NCT01872611|9945939|P1|Overall Study|Adverse Event, prior to treatment|0
2888996|NCT01872611|9945938|P2|Overall Study|Adverse Event|1
2888997|NCT01872611|9945939|P1|Overall Study|Adverse Event|3
2888998|NCT01872078|9945976|P4|Overall Study|Patient met exclusion criterion 16.|1
2888999|NCT01872078|9945977|P3|Overall Study|Patient met exclusion criterion 16.|0
2889000|NCT01872078|9945978|P2|Overall Study|Patient met exclusion criterion 16.|0
2889001|NCT01872078|9945979|P1|Overall Study|Patient met exclusion criterion 16.|0
2889002|NCT01872078|9945976|P4|Overall Study|Withdrawal by Subject|0
2889003|NCT01872078|9945977|P3|Overall Study|Withdrawal by Subject|1
2889004|NCT01872078|9945978|P2|Overall Study|Withdrawal by Subject|0
2889005|NCT01872078|9945979|P1|Overall Study|Withdrawal by Subject|0
2889006|NCT01872078|9945976|P4|Overall Study|Protocol Violation|0
2889007|NCT01872078|9945977|P3|Overall Study|Protocol Violation|1
2889008|NCT01872078|9945978|P2|Overall Study|Protocol Violation|0
2889009|NCT01872078|9945979|P1|Overall Study|Protocol Violation|0
2889010|NCT01872078|9945976|P4|Overall Study|Dose administration non-compliance|1
2889011|NCT01872078|9945977|P3|Overall Study|Dose administration non-compliance|0
2889012|NCT01872078|9945978|P2|Overall Study|Dose administration non-compliance|0
2889013|NCT01872078|9945979|P1|Overall Study|Dose administration non-compliance|0
2889014|NCT01872078|9945976|P4|Overall Study|Adverse Event|0
2889015|NCT01872078|9945977|P3|Overall Study|Adverse Event|1
2889016|NCT01872078|9945978|P2|Overall Study|Adverse Event|0
2889017|NCT01872078|9945979|P1|Overall Study|Adverse Event|0
2889018|NCT01871870|9945989|P1|Overall Study|hyperglycemia|2
2889019|NCT01871870|9945989|P1|Overall Study|Hardware issues|7
2889020|NCT01871805|9946000|P6|Phase II|Lost to Follow-up|13
2889021|NCT01871805|9946001|P5|Phase II|Lost to Follow-up|0
2889022|NCT01871805|9946002|P4|Phase II|Lost to Follow-up|0
2889023|NCT01871805|9946003|P3|Phase II|Lost to Follow-up|0
2889024|NCT01871805|9946004|P2|Phase II|Lost to Follow-up|0
2889025|NCT01871805|9946005|P1|Phase II|Lost to Follow-up|0
2889026|NCT01871805|9946000|P6|Phase II|Alive in Survival Follow-up|29
2889027|NCT01871805|9946001|P5|Phase II|Alive in Survival Follow-up|0
2889028|NCT01871805|9946002|P4|Phase II|Alive in Survival Follow-up|0
2889029|NCT01871805|9946003|P3|Phase II|Alive in Survival Follow-up|0
2889030|NCT01871805|9946004|P2|Phase II|Alive in Survival Follow-up|0
2889031|NCT01871805|9946005|P1|Phase II|Alive in Survival Follow-up|0
2889032|NCT01871805|9946000|P6|Phase II|Death|45
2889033|NCT01871805|9946001|P5|Phase II|Death|0
2889034|NCT01871805|9946002|P4|Phase II|Death|0
2889035|NCT01871805|9946003|P3|Phase II|Death|0
2889036|NCT01871805|9946004|P2|Phase II|Death|0
2889037|NCT01871805|9946005|P1|Phase II|Death|0
2889038|NCT01871805|9946000|P6|Phase I|Lost to Follow-up|0
2889039|NCT01871805|9946001|P5|Phase I|Lost to Follow-up|0
2889040|NCT01871805|9946002|P4|Phase I|Lost to Follow-up|0
2889041|NCT01871805|9946003|P3|Phase I|Lost to Follow-up|3
2889042|NCT01871805|9946004|P2|Phase I|Lost to Follow-up|1
2889043|NCT01871805|9946005|P1|Phase I|Lost to Follow-up|0
2889044|NCT01871805|9946000|P6|Phase I|Alive in Survival Follow-up|0
2889045|NCT01871805|9946001|P5|Phase I|Alive in Survival Follow-up|4
2889046|NCT01871805|9946002|P4|Phase I|Alive in Survival Follow-up|5
2889047|NCT01871805|9946003|P3|Phase I|Alive in Survival Follow-up|4
2889048|NCT01871805|9946004|P2|Phase I|Alive in Survival Follow-up|2
2889049|NCT01871805|9946005|P1|Phase I|Alive in Survival Follow-up|0
2889050|NCT01871805|9946000|P6|Phase I|Death|0
2889051|NCT01871805|9946001|P5|Phase I|Death|9
2889052|NCT01871805|9946002|P4|Phase I|Death|2
2889053|NCT01871805|9946003|P3|Phase I|Death|6
2889054|NCT01871805|9946004|P2|Phase I|Death|4
2889055|NCT01871805|9946005|P1|Phase I|Death|7
2889056|NCT01871558|9946077|P2|Overall Study|Withdrawal by Subject|0
2889057|NCT01871558|9946078|P1|Overall Study|Withdrawal by Subject|2
2889058|NCT01871558|9946077|P2|Overall Study|antidiabetic drug prematurely stopped|1
2889059|NCT01871558|9946078|P1|Overall Study|antidiabetic drug prematurely stopped|1
2889060|NCT01871558|9946077|P2|Overall Study|Other reason|1
2889061|NCT01871558|9946078|P1|Overall Study|Other reason|0
2889062|NCT01871532|9946098|P2|Overall Study|Withdrawal by Subject|2
2889063|NCT01871532|9946099|P1|Overall Study|Withdrawal by Subject|1
2889064|NCT01871519|9946133|P1|Overall Study|Withdrawal by Subject|49
2889065|NCT01871519|9946133|P1|Overall Study|Lost to Follow-up|15
2889066|NCT01871519|9946133|P1|Overall Study|Death|26
2889067|NCT01871402|9946190|P2|Overall Study|Non-compliance|1
2889068|NCT01871402|9946191|P1|Overall Study|Non-compliance|0
2889069|NCT01871402|9946190|P2|Overall Study|Withdrawal by Subject|2
2889070|NCT01871402|9946191|P1|Overall Study|Withdrawal by Subject|0
2889071|NCT01871402|9946190|P2|Overall Study|Lost to Follow-up|0
2889072|NCT01871402|9946191|P1|Overall Study|Lost to Follow-up|1
2889073|NCT01871285|9946209|P4|First Intervention (1 Day)|Lost to Follow-up|0
2889074|NCT01871285|9946210|P3|First Intervention (1 Day)|Lost to Follow-up|1
2889075|NCT01871285|9946211|P2|First Intervention (1 Day)|Lost to Follow-up|1
2889076|NCT01871285|9946212|P1|First Intervention (1 Day)|Lost to Follow-up|0
2889077|NCT01871285|9946209|P4|First Intervention (1 Day)|Adverse Event|0
2889078|NCT01871285|9946210|P3|First Intervention (1 Day)|Adverse Event|0
2889079|NCT01871285|9946211|P2|First Intervention (1 Day)|Adverse Event|0
2889080|NCT01871285|9946212|P1|First Intervention (1 Day)|Adverse Event|1
2889081|NCT01871142|9946238|P1|Overall Study|Adverse Event|1
2889082|NCT01871090|9946254|P2|Overall Study|Subject Non-Compliance|1
2889083|NCT01871090|9946255|P1|Overall Study|Subject Non-Compliance|0
2889084|NCT01871090|9946254|P2|Overall Study|Interrogation not completed correctly|0
2889085|NCT01871090|9946255|P1|Overall Study|Interrogation not completed correctly|1
2889086|NCT01871090|9946254|P2|Overall Study|Interrogation not done in Emergency Room|22
2889087|NCT01871090|9946255|P1|Overall Study|Interrogation not done in Emergency Room|1
2889088|NCT01870999|9946275|P3|Overall Study|Protocol Violation|1
2889089|NCT01870999|9946276|P2|Overall Study|Protocol Violation|0
2889090|NCT01870999|9946277|P1|Overall Study|Protocol Violation|0
2889091|NCT01870999|9946275|P3|Overall Study|Withdrawal by Subject|5
2889092|NCT01870999|9946276|P2|Overall Study|Withdrawal by Subject|2
2889093|NCT01870999|9946277|P1|Overall Study|Withdrawal by Subject|0
2889094|NCT01870999|9946275|P3|Overall Study|Subject withdrawn by Investigator|0
2889095|NCT01870999|9946276|P2|Overall Study|Subject withdrawn by Investigator|0
2889096|NCT01870999|9946277|P1|Overall Study|Subject withdrawn by Investigator|1
2889097|NCT01870999|9946275|P3|Overall Study|Subject met withdrawal criteria|0
2889098|NCT01870999|9946276|P2|Overall Study|Subject met withdrawal criteria|2
2889099|NCT01870999|9946277|P1|Overall Study|Subject met withdrawal criteria|3
2889100|NCT01870999|9946275|P3|Overall Study|Adverse Event|1
2889101|NCT01870999|9946276|P2|Overall Study|Adverse Event|4
2889102|NCT01870999|9946277|P1|Overall Study|Adverse Event|0
2889103|NCT01870973|9946335|P2|Overall Study|Lost to Follow-up|3
2889104|NCT01870973|9946336|P1|Overall Study|Lost to Follow-up|10
2889105|NCT01870921|9946342|P1|Overall Study|Other|1
2889106|NCT01870921|9946342|P1|Overall Study|Subject Lost to Follow up|2
2889107|NCT01870921|9946342|P1|Overall Study|Severe non-compliance to protocol|7
2889108|NCT01870921|9946342|P1|Overall Study|Subject decision|80
2889109|NCT01870843|9946361|P1|Overall Study|Withdrawal by Subject|18
2889110|NCT01870843|9946361|P1|Overall Study|Death|1
2889111|NCT01870843|9946361|P1|Overall Study|Lost to Follow-up|24
2889112|NCT01870843|9946361|P1|Overall Study|Adverse Event|10
2889113|NCT01870778|9946376|P2|Overall Study|Lost to Follow-up|2
2889114|NCT01870778|9946377|P1|Overall Study|Lost to Follow-up|0
2889115|NCT01870778|9946376|P2|Overall Study|Withdrawal by Subject|7
2889116|NCT01870778|9946377|P1|Overall Study|Withdrawal by Subject|8
2889117|NCT01870739|9946403|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
2889118|NCT01870739|9946404|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
2889119|NCT01870739|9946403|P2|Add-on Period (40 Weeks)|Protocol deviation|1
2889120|NCT01870739|9946404|P1|Add-on Period (40 Weeks)|Protocol deviation|1
2889121|NCT01870739|9946403|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
2889122|NCT01870739|9946404|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
2889123|NCT01870739|9946403|P2|Add-on Period (40 Weeks)|Adverse Event|1
2889124|NCT01870739|9946404|P1|Add-on Period (40 Weeks)|Adverse Event|0
2889125|NCT01870739|9946403|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
2889126|NCT01870739|9946404|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
2889127|NCT01870739|9946403|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
2889128|NCT01870739|9946404|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
2889129|NCT01870739|9946403|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
2889130|NCT01870739|9946404|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
2889131|NCT01870726|9946443|P7|Overall Study|Progressive disease|10
2889132|NCT01870726|9946444|P6|Overall Study|Progressive disease|4
2889133|NCT01870726|9946445|P5|Overall Study|Progressive disease|6
2889134|NCT01870726|9946446|P4|Overall Study|Progressive disease|5
2889135|NCT01870726|9946447|P3|Overall Study|Progressive disease|4
2889136|NCT01870726|9946448|P2|Overall Study|Progressive disease|5
2889137|NCT01870726|9946449|P1|Overall Study|Progressive disease|5
2889138|NCT01870726|9946443|P7|Overall Study|Adverse Event|0
2889139|NCT01870726|9946444|P6|Overall Study|Adverse Event|1
2889140|NCT01870726|9946445|P5|Overall Study|Adverse Event|1
2889141|NCT01870726|9946446|P4|Overall Study|Adverse Event|0
2889142|NCT01870726|9946447|P3|Overall Study|Adverse Event|0
2889143|NCT01870726|9946448|P2|Overall Study|Adverse Event|0
2889144|NCT01870726|9946449|P1|Overall Study|Adverse Event|0
2889145|NCT01870726|9946443|P7|Overall Study|Withdrawal by Subject|0
2889146|NCT01870726|9946444|P6|Overall Study|Withdrawal by Subject|0
2889147|NCT01870726|9946445|P5|Overall Study|Withdrawal by Subject|0
2889148|NCT01870726|9946446|P4|Overall Study|Withdrawal by Subject|0
2889149|NCT01870726|9946447|P3|Overall Study|Withdrawal by Subject|0
2889150|NCT01870726|9946448|P2|Overall Study|Withdrawal by Subject|1
2889151|NCT01870726|9946449|P1|Overall Study|Withdrawal by Subject|0
2889152|NCT01870726|9946443|P7|Overall Study|Withdrawal of informed consent|0
2889153|NCT01870726|9946444|P6|Overall Study|Withdrawal of informed consent|0
2889154|NCT01870726|9946445|P5|Overall Study|Withdrawal of informed consent|0
2889155|NCT01870726|9946446|P4|Overall Study|Withdrawal of informed consent|1
2889156|NCT01870726|9946447|P3|Overall Study|Withdrawal of informed consent|0
2889157|NCT01870726|9946448|P2|Overall Study|Withdrawal of informed consent|0
2889158|NCT01870726|9946449|P1|Overall Study|Withdrawal of informed consent|0
2889159|NCT01870583|9946544|P3|Overall Study|Lost to Follow-up|5
2889160|NCT01870583|9946545|P2|Overall Study|Lost to Follow-up|13
2889161|NCT01870583|9946546|P1|Overall Study|Lost to Follow-up|11
2889162|NCT01870583|9946544|P3|Overall Study|Protocol Violation|3
2889163|NCT01870583|9946545|P2|Overall Study|Protocol Violation|5
2889164|NCT01870583|9946546|P1|Overall Study|Protocol Violation|0
2889165|NCT01870297|9946572|P7|Overall Study|Sponsor Decision|1
2889166|NCT01870297|9946573|P6|Overall Study|Sponsor Decision|0
2889167|NCT01870297|9946574|P5|Overall Study|Sponsor Decision|0
2889168|NCT01870297|9946575|P4|Overall Study|Sponsor Decision|0
2889169|NCT01870297|9946576|P3|Overall Study|Sponsor Decision|0
2889170|NCT01870297|9946577|P2|Overall Study|Sponsor Decision|6
2889171|NCT01870297|9946578|P1|Overall Study|Sponsor Decision|0
2889172|NCT01870297|9946572|P7|Overall Study|Withdrawal by Subject|1
2889173|NCT01870297|9946573|P6|Overall Study|Withdrawal by Subject|1
2889174|NCT01870297|9946574|P5|Overall Study|Withdrawal by Subject|1
2889175|NCT01870297|9946575|P4|Overall Study|Withdrawal by Subject|0
2889176|NCT01870297|9946576|P3|Overall Study|Withdrawal by Subject|0
2889177|NCT01870297|9946577|P2|Overall Study|Withdrawal by Subject|0
2889178|NCT01870297|9946578|P1|Overall Study|Withdrawal by Subject|0
2889179|NCT01870297|9946572|P7|Overall Study|Lost to Follow-up|0
2889180|NCT01870297|9946573|P6|Overall Study|Lost to Follow-up|0
2889181|NCT01870297|9946574|P5|Overall Study|Lost to Follow-up|0
2889182|NCT01870297|9946575|P4|Overall Study|Lost to Follow-up|0
2889183|NCT01870297|9946576|P3|Overall Study|Lost to Follow-up|1
2889184|NCT01870297|9946577|P2|Overall Study|Lost to Follow-up|1
2889185|NCT01870297|9946578|P1|Overall Study|Lost to Follow-up|0
2889186|NCT01870297|9946572|P7|Overall Study|Adverse Event|0
2889187|NCT01870297|9946573|P6|Overall Study|Adverse Event|0
2889188|NCT01870297|9946574|P5|Overall Study|Adverse Event|2
2889189|NCT01870297|9946575|P4|Overall Study|Adverse Event|0
2889190|NCT01870297|9946576|P3|Overall Study|Adverse Event|0
2889191|NCT01870297|9946577|P2|Overall Study|Adverse Event|0
2889192|NCT01870297|9946578|P1|Overall Study|Adverse Event|0
2889193|NCT01870076|9946622|P4|Overall Study|Withdrawal by Subject|0
2889194|NCT01870076|9946623|P3|Overall Study|Withdrawal by Subject|1
2889195|NCT01870076|9946624|P2|Overall Study|Withdrawal by Subject|0
2889196|NCT01870076|9946625|P1|Overall Study|Withdrawal by Subject|1
2889197|NCT01869959|9946643|P5|Treatment Period|Withdrawal by Subject|0
2889198|NCT01869959|9946644|P4|Treatment Period|Withdrawal by Subject|0
2889199|NCT01869959|9946645|P3|Treatment Period|Withdrawal by Subject|0
2889200|NCT01869959|9946646|P2|Treatment Period|Withdrawal by Subject|1
2889201|NCT01869959|9946647|P1|Treatment Period|Withdrawal by Subject|0
2889202|NCT01869959|9946643|P5|Treatment Period|Sponsor decision|0
2889203|NCT01869959|9946644|P4|Treatment Period|Sponsor decision|1
2889204|NCT01869959|9946645|P3|Treatment Period|Sponsor decision|0
2889205|NCT01869959|9946646|P2|Treatment Period|Sponsor decision|1
2889206|NCT01869959|9946647|P1|Treatment Period|Sponsor decision|0
2889207|NCT01869959|9946643|P5|Treatment Period|Adverse Event|0
2889208|NCT01869959|9946644|P4|Treatment Period|Adverse Event|1
2889209|NCT01869959|9946645|P3|Treatment Period|Adverse Event|3
2889210|NCT01869959|9946646|P2|Treatment Period|Adverse Event|0
2889211|NCT01869959|9946647|P1|Treatment Period|Adverse Event|1
2889212|NCT01869959|9946643|P5|Randomization Period|Physician Decision|1
2889213|NCT01869959|9946644|P4|Randomization Period|Physician Decision|0
2889214|NCT01869959|9946645|P3|Randomization Period|Physician Decision|0
2889215|NCT01869959|9946646|P2|Randomization Period|Physician Decision|0
2889216|NCT01869959|9946647|P1|Randomization Period|Physician Decision|0
2889217|NCT01869777|9946715|P1|Overall Study|Excluded from the analysis, ineligible|1
2889218|NCT01869764|9946728|P2|Overall Study|Withdrawal by Subject|2
2889219|NCT01869764|9946729|P1|Overall Study|Withdrawal by Subject|0
2889220|NCT01869699|9946747|P2|Overall Study|Withdrawal by Subject|0
2889221|NCT01869699|9946748|P1|Overall Study|Withdrawal by Subject|1
2889222|NCT01869348|9946824|P2|Overall Study|Withdrawal by Subject|1
2889223|NCT01869348|9946825|P1|Overall Study|Withdrawal by Subject|1
2889224|NCT01869192|9946833|P2|Postoperative Chemotherapy|Physician Decision|2
2889225|NCT01869192|9946834|P1|Postoperative Chemotherapy|Physician Decision|0
2889226|NCT01869192|9946833|P2|Preoperative Chemotherapy to Surgery|patient choice|1
2889227|NCT01869192|9946834|P1|Preoperative Chemotherapy to Surgery|patient choice|2
2889228|NCT01868997|9946869|P2|Overall Study|Other|1
2889229|NCT01868997|9946870|P1|Overall Study|Other|3
2889230|NCT01868997|9946869|P2|Overall Study|Lack of Efficacy|0
2889231|NCT01868997|9946870|P1|Overall Study|Lack of Efficacy|2
2889232|NCT01868997|9946869|P2|Overall Study|Adverse Event|5
2889233|NCT01868997|9946870|P1|Overall Study|Adverse Event|2
2889234|NCT01868893|9946886|P1|Overall Study|Neutropenia|1
2889235|NCT01868893|9946886|P1|Overall Study|Commercial availability of study drug|17
2889236|NCT01868893|9946886|P1|Overall Study|Adverse Event|2
2889237|NCT01868646|9946915|P2|Overall Study|Do not meet inclusion criteria|5
2889238|NCT01868646|9946916|P1|Overall Study|Do not meet inclusion criteria|3
2889239|NCT01868594|9946961|P2|Overall Study|Do not meet inclusion criteria|3
2889240|NCT01868594|9946962|P1|Overall Study|Do not meet inclusion criteria|4
2889241|NCT01868542|9946982|P2|Overall Study|Unclassified|1
2889242|NCT01868542|9946983|P1|Overall Study|Unclassified|0
2889243|NCT01868542|9946982|P2|Overall Study|Protocol Violation|1
2889244|NCT01868542|9946983|P1|Overall Study|Protocol Violation|0
2889245|NCT01868503|9947001|P1|Overall Study|Protocol Violation|1
2889246|NCT01868503|9947001|P1|Overall Study|Withdrawal by Subject|1
2889247|NCT01868477|9947011|P2|Overall Study|Withdrawal by Subject|0
2889248|NCT01868477|9947012|P1|Overall Study|Withdrawal by Subject|1
2889249|NCT01868477|9947011|P2|Overall Study|Disease progression|1
2889250|NCT01868477|9947012|P1|Overall Study|Disease progression|1
2889251|NCT01868477|9947011|P2|Overall Study|Adverse Event|4
2889252|NCT01868477|9947012|P1|Overall Study|Adverse Event|2
2889253|NCT01868243|9947116|P2|Overall Study|Death|1
2889254|NCT01868243|9947117|P1|Overall Study|Death|0
2889255|NCT01868165|9947125|P1|Overall Study|Death|4
2889256|NCT01868165|9947125|P1|Overall Study|Lost to Follow-up|3
2889257|NCT01868165|9947125|P1|Overall Study|Physician Decision|2
2889258|NCT01868165|9947125|P1|Overall Study|Withdrawal by Subject|36
2889259|NCT01868074|9947141|P2|Overall Study|Withdrawal by Subject|2
2889260|NCT01868074|9947142|P1|Overall Study|Withdrawal by Subject|4
2889261|NCT01868074|9947141|P2|Overall Study|Lost to Follow-up|2
2889262|NCT01868074|9947142|P1|Overall Study|Lost to Follow-up|3
2889263|NCT01868035|9947152|P1|Overall Study|Non-compliance|1
2889264|NCT01868035|9947152|P1|Overall Study|Progressive Disease|2
2889265|NCT01868035|9947152|P1|Overall Study|Withdrawal by Subject|1
2889266|NCT01868035|9947152|P1|Overall Study|Lost to Follow-up|3
2889267|NCT01868022|9947177|P9|Overall Study|Ongoing|0
2889268|NCT01868022|9947178|P8|Overall Study|Ongoing|3
2889269|NCT01868022|9947179|P7|Overall Study|Ongoing|0
2889270|NCT01868022|9947180|P6|Overall Study|Ongoing|0
2889271|NCT01868022|9947181|P5|Overall Study|Ongoing|0
2889272|NCT01868022|9947182|P4|Overall Study|Ongoing|0
2889273|NCT01868022|9947183|P3|Overall Study|Ongoing|0
2889274|NCT01868022|9947184|P2|Overall Study|Ongoing|0
2889275|NCT01868022|9947185|P1|Overall Study|Ongoing|0
2889276|NCT01868022|9947177|P9|Overall Study|Study closed/terminated|0
2889277|NCT01868022|9947178|P8|Overall Study|Study closed/terminated|1
2889278|NCT01868022|9947179|P7|Overall Study|Study closed/terminated|0
2889279|NCT01868022|9947180|P6|Overall Study|Study closed/terminated|0
2889280|NCT01868022|9947181|P5|Overall Study|Study closed/terminated|0
2889281|NCT01868022|9947182|P4|Overall Study|Study closed/terminated|0
2889282|NCT01868022|9947183|P3|Overall Study|Study closed/terminated|0
2889283|NCT01868022|9947184|P2|Overall Study|Study closed/terminated|0
2889284|NCT01868022|9947185|P1|Overall Study|Study closed/terminated|0
2889285|NCT01868022|9947177|P9|Overall Study|Physician Decision|0
2889286|NCT01868022|9947178|P8|Overall Study|Physician Decision|2
2889287|NCT01868022|9947179|P7|Overall Study|Physician Decision|0
2889288|NCT01868022|9947180|P6|Overall Study|Physician Decision|1
2889289|NCT01868022|9947181|P5|Overall Study|Physician Decision|0
2889290|NCT01868022|9947182|P4|Overall Study|Physician Decision|0
2889291|NCT01868022|9947183|P3|Overall Study|Physician Decision|0
2889292|NCT01868022|9947184|P2|Overall Study|Physician Decision|0
2889293|NCT01868022|9947185|P1|Overall Study|Physician Decision|0
2889294|NCT01868022|9947177|P9|Overall Study|Adverse Event|2
2889295|NCT01868022|9947178|P8|Overall Study|Adverse Event|2
2889296|NCT01868022|9947179|P7|Overall Study|Adverse Event|0
2889297|NCT01868022|9947180|P6|Overall Study|Adverse Event|0
2889298|NCT01868022|9947181|P5|Overall Study|Adverse Event|2
2889299|NCT01868022|9947182|P4|Overall Study|Adverse Event|0
2889300|NCT01868022|9947183|P3|Overall Study|Adverse Event|0
2889301|NCT01868022|9947184|P2|Overall Study|Adverse Event|0
2889302|NCT01868022|9947185|P1|Overall Study|Adverse Event|0
2889303|NCT01868022|9947177|P9|Overall Study|Withdrawal by Subject|0
2889304|NCT01868022|9947178|P8|Overall Study|Withdrawal by Subject|1
2889305|NCT01868022|9947179|P7|Overall Study|Withdrawal by Subject|0
2889306|NCT01868022|9947180|P6|Overall Study|Withdrawal by Subject|0
2889307|NCT01868022|9947181|P5|Overall Study|Withdrawal by Subject|0
2889308|NCT01868022|9947182|P4|Overall Study|Withdrawal by Subject|1
2889309|NCT01868022|9947183|P3|Overall Study|Withdrawal by Subject|1
2889310|NCT01868022|9947184|P2|Overall Study|Withdrawal by Subject|0
2889311|NCT01868022|9947185|P1|Overall Study|Withdrawal by Subject|0
2889312|NCT01868009|9947391|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
2889313|NCT01868009|9947392|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
2889314|NCT01868009|9947391|P2|Period 2 (5-9 Days)|Adverse Event|0
2889315|NCT01868009|9947392|P1|Period 2 (5-9 Days)|Adverse Event|1
2889316|NCT01868009|9947391|P2|Period 1 (5-9 Days)|Adverse Event|2
2889317|NCT01868009|9947392|P1|Period 1 (5-9 Days)|Adverse Event|0
2889318|NCT01867710|9947406|P4|Overall Study|Study medication no longer effective|0
2889319|NCT01867710|9947407|P3|Overall Study|Study medication no longer effective|0
2889320|NCT01867710|9947408|P2|Overall Study|Study medication no longer effective|1
2889321|NCT01867710|9947409|P1|Overall Study|Study medication no longer effective|0
2889322|NCT01867710|9947406|P4|Overall Study|PSA-progression|0
2889323|NCT01867710|9947407|P3|Overall Study|PSA-progression|0
2889324|NCT01867710|9947408|P2|Overall Study|PSA-progression|1
2889325|NCT01867710|9947409|P1|Overall Study|PSA-progression|0
2889326|NCT01867710|9947406|P4|Overall Study|Protocol Violation|1
2889327|NCT01867710|9947407|P3|Overall Study|Protocol Violation|0
2889328|NCT01867710|9947408|P2|Overall Study|Protocol Violation|0
2889329|NCT01867710|9947409|P1|Overall Study|Protocol Violation|0
2889330|NCT01867710|9947406|P4|Overall Study|Progressive disease|0
2889331|NCT01867710|9947407|P3|Overall Study|Progressive disease|0
2889332|NCT01867710|9947408|P2|Overall Study|Progressive disease|0
2889333|NCT01867710|9947409|P1|Overall Study|Progressive disease|1
2889334|NCT01867710|9947406|P4|Overall Study|Patient to follow subsequent treatment|0
2889335|NCT01867710|9947407|P3|Overall Study|Patient to follow subsequent treatment|0
2889336|NCT01867710|9947408|P2|Overall Study|Patient to follow subsequent treatment|1
2889337|NCT01867710|9947409|P1|Overall Study|Patient to follow subsequent treatment|0
2889338|NCT01867710|9947406|P4|Overall Study|Patient decision|1
2889339|NCT01867710|9947407|P3|Overall Study|Patient decision|0
2889340|NCT01867710|9947408|P2|Overall Study|Patient decision|0
2889341|NCT01867710|9947409|P1|Overall Study|Patient decision|0
2889342|NCT01867710|9947406|P4|Overall Study|Disease progression|0
2889343|NCT01867710|9947407|P3|Overall Study|Disease progression|0
2889344|NCT01867710|9947408|P2|Overall Study|Disease progression|0
2889345|NCT01867710|9947409|P1|Overall Study|Disease progression|1
2889346|NCT01867710|9947406|P4|Overall Study|Clinical progression|0
2889347|NCT01867710|9947407|P3|Overall Study|Clinical progression|1
2889348|NCT01867710|9947408|P2|Overall Study|Clinical progression|0
2889349|NCT01867710|9947409|P1|Overall Study|Clinical progression|0
2889350|NCT01867710|9947406|P4|Overall Study|Biochemical progression|0
2889351|NCT01867710|9947407|P3|Overall Study|Biochemical progression|0
2889352|NCT01867710|9947408|P2|Overall Study|Biochemical progression|1
2889353|NCT01867710|9947409|P1|Overall Study|Biochemical progression|0
2889354|NCT01867710|9947406|P4|Overall Study|Study Terminated by Sponsor|16
2889355|NCT01867710|9947407|P3|Overall Study|Study Terminated by Sponsor|8
2889356|NCT01867710|9947408|P2|Overall Study|Study Terminated by Sponsor|13
2889357|NCT01867710|9947409|P1|Overall Study|Study Terminated by Sponsor|9
2889358|NCT01867710|9947406|P4|Overall Study|Withdrawal of consent|2
2889359|NCT01867710|9947407|P3|Overall Study|Withdrawal of consent|1
2889360|NCT01867710|9947408|P2|Overall Study|Withdrawal of consent|5
2889361|NCT01867710|9947409|P1|Overall Study|Withdrawal of consent|2
2889362|NCT01867710|9947406|P4|Overall Study|Lost to Follow-up|2
2889363|NCT01867710|9947407|P3|Overall Study|Lost to Follow-up|3
2889364|NCT01867710|9947408|P2|Overall Study|Lost to Follow-up|4
2889365|NCT01867710|9947409|P1|Overall Study|Lost to Follow-up|3
2889366|NCT01867710|9947406|P4|Overall Study|Death|20
2889367|NCT01867710|9947407|P3|Overall Study|Death|27
2889368|NCT01867710|9947408|P2|Overall Study|Death|15
2889369|NCT01867710|9947409|P1|Overall Study|Death|25
2889370|NCT01867671|9947477|P2|Overall Study|Withdrawal by Subject|21
2889371|NCT01867671|9947478|P1|Overall Study|Withdrawal by Subject|21
2889372|NCT01867671|9947477|P2|Overall Study|Non-compliance with Study Drug|2
2889373|NCT01867671|9947478|P1|Overall Study|Non-compliance with Study Drug|1
2889374|NCT01867671|9947477|P2|Overall Study|Lost to Follow-up|1
2889375|NCT01867671|9947478|P1|Overall Study|Lost to Follow-up|0
2889376|NCT01867671|9947477|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
2889377|NCT01867671|9947478|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
2889378|NCT01867671|9947477|P2|Overall Study|Anaphylaxis|1
2889379|NCT01867671|9947478|P1|Overall Study|Anaphylaxis|0
2889380|NCT01867671|9947477|P2|Overall Study|Adverse Event|3
2889381|NCT01867671|9947478|P1|Overall Study|Adverse Event|5
2889382|NCT01867658|9947491|P1|Overall Study|Subject could not be contacted|1
2889383|NCT01867658|9947491|P1|Overall Study|Death|2
2889384|NCT01867658|9947491|P1|Overall Study|Withdrawal by Subject|6
2889385|NCT01867606|9947515|P2|Overall Study|Protocol Violation|1
2889386|NCT01867606|9947516|P1|Overall Study|Protocol Violation|0
2889387|NCT01867606|9947515|P2|Overall Study|Withdrawal by Subject|14
2889388|NCT01867606|9947516|P1|Overall Study|Withdrawal by Subject|10
2889389|NCT01867580|9947534|P2|Overall Study|Wound recurrence|1
2889390|NCT01867580|9947535|P1|Overall Study|Wound recurrence|0
2889391|NCT01867580|9947534|P2|Overall Study|Continuation of therapy|1
2889392|NCT01867580|9947535|P1|Overall Study|Continuation of therapy|0
2889393|NCT01867580|9947534|P2|Overall Study|Osteomyelitis|1
2889394|NCT01867580|9947535|P1|Overall Study|Osteomyelitis|0
2889395|NCT01867580|9947534|P2|Overall Study|Interruption to therapy|0
2889396|NCT01867580|9947535|P1|Overall Study|Interruption to therapy|3
2889397|NCT01867580|9947534|P2|Overall Study|Missed follow-up assessment|1
2889398|NCT01867580|9947535|P1|Overall Study|Missed follow-up assessment|2
2889399|NCT01867580|9947534|P2|Overall Study|Sponsor terminated study|0
2889400|NCT01867580|9947535|P1|Overall Study|Sponsor terminated study|1
2889401|NCT01867580|9947534|P2|Overall Study|Lost to Follow-up|5
2889402|NCT01867580|9947535|P1|Overall Study|Lost to Follow-up|3
2889403|NCT01867580|9947534|P2|Overall Study|Physician Decision|12
2889404|NCT01867580|9947535|P1|Overall Study|Physician Decision|17
2889405|NCT01867580|9947534|P2|Overall Study|Withdrawal by Subject|3
2889406|NCT01867580|9947535|P1|Overall Study|Withdrawal by Subject|2
2889407|NCT01867424|9947560|P2|Overall Study|Patient noncompliance|1
2889408|NCT01867424|9947561|P1|Overall Study|Patient noncompliance|2
2889409|NCT01867307|9947575|P2|Overall Study|Other Adverse Event|3
2889410|NCT01867307|9947576|P1|Overall Study|Other Adverse Event|1
2889411|NCT01867307|9947575|P2|Overall Study|Protocol Violation|0
2889412|NCT01867307|9947576|P1|Overall Study|Protocol Violation|2
2889413|NCT01867294|9947586|P4|Overall Study|Withdrawal by Subject|0
2889414|NCT01867294|9947587|P3|Overall Study|Withdrawal by Subject|0
2889415|NCT01867294|9947588|P2|Overall Study|Withdrawal by Subject|1
2889416|NCT01867294|9947589|P1|Overall Study|Withdrawal by Subject|1
2889417|NCT01867216|9947636|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
2889418|NCT01867216|9947637|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
2889419|NCT01867216|9947638|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
2889420|NCT01867216|9947639|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
2889421|NCT01867216|9947640|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
2889422|NCT01867216|9947641|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
2889423|NCT01867216|9947642|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
2889424|NCT01867216|9947636|P7|Overall Study|Physician Decision|0
2889425|NCT01867216|9947637|P6|Overall Study|Physician Decision|0
2889426|NCT01867216|9947638|P5|Overall Study|Physician Decision|0
2889427|NCT01867216|9947639|P4|Overall Study|Physician Decision|0
2889428|NCT01867216|9947640|P3|Overall Study|Physician Decision|0
2889429|NCT01867216|9947641|P2|Overall Study|Physician Decision|0
2889430|NCT01867216|9947642|P1|Overall Study|Physician Decision|1
2889431|NCT01867216|9947636|P7|Overall Study|Withdrawal by Subject|1
2889432|NCT01867216|9947637|P6|Overall Study|Withdrawal by Subject|0
2889433|NCT01867216|9947638|P5|Overall Study|Withdrawal by Subject|1
2889434|NCT01867216|9947639|P4|Overall Study|Withdrawal by Subject|0
2889435|NCT01867216|9947640|P3|Overall Study|Withdrawal by Subject|0
2889436|NCT01867216|9947641|P2|Overall Study|Withdrawal by Subject|0
2889437|NCT01867216|9947642|P1|Overall Study|Withdrawal by Subject|2
2889438|NCT01867086|9947714|P1|Overall Study|Disease Progression|1
2889439|NCT01867047|9947723|P2|Overall Study|surgery not indicated in protocol|2
2889440|NCT01867047|9947724|P1|Overall Study|surgery not indicated in protocol|1
2889441|NCT01867047|9947723|P2|Overall Study|Physician Decision|0
2889442|NCT01867047|9947724|P1|Overall Study|Physician Decision|2
2889443|NCT01867047|9947723|P2|Overall Study|Withdrawal by Subject|0
2889444|NCT01867047|9947724|P1|Overall Study|Withdrawal by Subject|2
2889445|NCT01867047|9947723|P2|Overall Study|Lost to Follow-up|3
2889446|NCT01867047|9947724|P1|Overall Study|Lost to Follow-up|3
2889447|NCT01867021|9947744|P2|Overall Study|Withdrawal by Subject|6
2889448|NCT01867021|9947745|P1|Overall Study|Withdrawal by Subject|1
2889449|NCT01867021|9947744|P2|Overall Study|Lost to Follow-up|2
2889450|NCT01867021|9947745|P1|Overall Study|Lost to Follow-up|0
2889451|NCT01867021|9947744|P2|Overall Study|Death|0
2889452|NCT01867021|9947745|P1|Overall Study|Death|1
2889453|NCT01867021|9947744|P2|Overall Study|Not Eligible|1
2889454|NCT01867021|9947745|P1|Overall Study|Not Eligible|0
2889455|NCT01867021|9947744|P2|Overall Study|Adverse Event|1
2889456|NCT01867021|9947745|P1|Overall Study|Adverse Event|0
2889457|NCT01866826|9947790|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
2889458|NCT01866826|9947791|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
2889459|NCT01866826|9947790|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
2889460|NCT01866826|9947791|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
2889461|NCT01866826|9947790|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
2889462|NCT01866826|9947791|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
2889463|NCT01866709|9947807|P2|Overall Study|Adverse Event|0
2889464|NCT01866709|9947808|P1|Overall Study|Adverse Event|1
2889465|NCT01866423|9947849|P1|Overall Study|Sponsor Decision|1
2889466|NCT01866423|9947849|P1|Overall Study|Lack of Efficacy|3
2889467|NCT01866319|9947877|P3|Overall Study|Withdrawal by Subject|12
2889468|NCT01866319|9947878|P2|Overall Study|Withdrawal by Subject|14
2889469|NCT01866319|9947879|P1|Overall Study|Withdrawal by Subject|32
2889470|NCT01866319|9947877|P3|Overall Study|Protocol Violation|1
2889471|NCT01866319|9947878|P2|Overall Study|Protocol Violation|0
2889472|NCT01866319|9947879|P1|Overall Study|Protocol Violation|0
2889473|NCT01866319|9947877|P3|Overall Study|Physician Decision|1
2889474|NCT01866319|9947878|P2|Overall Study|Physician Decision|0
2889475|NCT01866319|9947879|P1|Overall Study|Physician Decision|1
2889476|NCT01866319|9947877|P3|Overall Study|Lost to Follow-up|8
2889477|NCT01866319|9947878|P2|Overall Study|Lost to Follow-up|3
2889478|NCT01866319|9947879|P1|Overall Study|Lost to Follow-up|6
2889479|NCT01866319|9947877|P3|Overall Study|Death|147
2889480|NCT01866319|9947878|P2|Overall Study|Death|154
2889481|NCT01866319|9947879|P1|Overall Study|Death|153
2889482|NCT01866319|9947877|P3|Overall Study|Clinical progression|2
2889483|NCT01866319|9947878|P2|Overall Study|Clinical progression|2
2889484|NCT01866319|9947879|P1|Overall Study|Clinical progression|3
2889485|NCT01866319|9947877|P3|Overall Study|Adverse Event|9
2889486|NCT01866319|9947878|P2|Overall Study|Adverse Event|5
2889487|NCT01866319|9947879|P1|Overall Study|Adverse Event|12
2889488|NCT01866293|9947978|P1|Overall Study|Adverse Event|2
2889489|NCT01866098|9948023|P3|Overall Study|Death|0
2889490|NCT01866098|9948024|P2|Overall Study|Death|1
2889491|NCT01866098|9948025|P1|Overall Study|Death|0
2889492|NCT01866098|9948023|P3|Overall Study|Pregnancy|0
2889493|NCT01866098|9948024|P2|Overall Study|Pregnancy|0
2889494|NCT01866098|9948025|P1|Overall Study|Pregnancy|2
2889495|NCT01866098|9948023|P3|Overall Study|Non-compliance|1
2889496|NCT01866098|9948024|P2|Overall Study|Non-compliance|0
2889497|NCT01866098|9948025|P1|Overall Study|Non-compliance|1
2889498|NCT01866098|9948023|P3|Overall Study|Unrelated Hospitalization|1
2889499|NCT01866098|9948024|P2|Overall Study|Unrelated Hospitalization|0
2889500|NCT01866098|9948025|P1|Overall Study|Unrelated Hospitalization|2
2889501|NCT01866098|9948023|P3|Overall Study|Withdrawal by Subject|0
2889502|NCT01866098|9948024|P2|Overall Study|Withdrawal by Subject|2
2889503|NCT01866098|9948025|P1|Overall Study|Withdrawal by Subject|1
2889504|NCT01866098|9948023|P3|Overall Study|Protocol Violation|0
2889505|NCT01866098|9948024|P2|Overall Study|Protocol Violation|0
2889506|NCT01866098|9948025|P1|Overall Study|Protocol Violation|1
2889507|NCT01866098|9948023|P3|Overall Study|Adverse Event|4
2889508|NCT01866098|9948024|P2|Overall Study|Adverse Event|5
2889509|NCT01866098|9948025|P1|Overall Study|Adverse Event|1
2889510|NCT01866098|9948023|P3|Overall Study|Physician Decision|2
2889511|NCT01866098|9948024|P2|Overall Study|Physician Decision|1
2889512|NCT01866098|9948025|P1|Overall Study|Physician Decision|0
2889513|NCT01866098|9948023|P3|Overall Study|Lost to Follow-up|13
2889514|NCT01866098|9948024|P2|Overall Study|Lost to Follow-up|18
2889515|NCT01866098|9948025|P1|Overall Study|Lost to Follow-up|11
2889516|NCT01865812|9948054|P1|Overall Study|Adverse Event|2
2889517|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Other|1
2889518|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Other|0
2889519|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
2889520|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
2889521|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
2889522|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
2889523|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Physician Decision|2
2889524|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Physician Decision|4
2889525|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
2889526|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
2889527|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
2889528|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
2889529|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
2889530|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
2889531|NCT01865747|9948062|P2|Primary Intent to Treat (PITT)|Adverse Event|20
2889532|NCT01865747|9948063|P1|Primary Intent to Treat (PITT)|Adverse Event|21
2889533|NCT01865747|9948062|P2|Overall Study (ITT)|Reason Not Provided|1
2889534|NCT01865747|9948063|P1|Overall Study (ITT)|Reason Not Provided|0
2889535|NCT01865747|9948062|P2|Overall Study (ITT)|Progressive Disease|158
2889536|NCT01865747|9948063|P1|Overall Study (ITT)|Progressive Disease|122
2889537|NCT01865747|9948062|P2|Overall Study (ITT)|Sponsor Decision|1
2889538|NCT01865747|9948063|P1|Overall Study (ITT)|Sponsor Decision|0
2889539|NCT01865747|9948062|P2|Overall Study (ITT)|Withdrawal by Subject|11
2889540|NCT01865747|9948063|P1|Overall Study (ITT)|Withdrawal by Subject|6
2889541|NCT01865747|9948062|P2|Overall Study (ITT)|Physician Decision|2
2889542|NCT01865747|9948063|P1|Overall Study (ITT)|Physician Decision|5
2889543|NCT01865747|9948062|P2|Overall Study (ITT)|Protocol Violation|1
2889544|NCT01865747|9948063|P1|Overall Study (ITT)|Protocol Violation|1
2889545|NCT01865747|9948062|P2|Overall Study (ITT)|Lack of Efficacy|0
2889546|NCT01865747|9948063|P1|Overall Study (ITT)|Lack of Efficacy|3
2889547|NCT01865747|9948062|P2|Overall Study (ITT)|Clinical Deterioration|50
2889548|NCT01865747|9948063|P1|Overall Study (ITT)|Clinical Deterioration|29
2889549|NCT01865747|9948062|P2|Overall Study (ITT)|Adverse Event|31
2889550|NCT01865747|9948063|P1|Overall Study (ITT)|Adverse Event|32
2889551|NCT01865552|9948084|P6|Period 1|Other|0
2889552|NCT01865552|9948085|P5|Period 1|Other|1
2889553|NCT01865552|9948086|P4|Period 1|Other|0
2889554|NCT01865552|9948087|P3|Period 1|Other|0
2889555|NCT01865552|9948088|P2|Period 1|Other|0
2889556|NCT01865552|9948089|P1|Period 1|Other|0
2889557|NCT01865552|9948084|P6|Period 1|Pathological lab|0
2889558|NCT01865552|9948085|P5|Period 1|Pathological lab|1
2889559|NCT01865552|9948086|P4|Period 1|Pathological lab|0
2889560|NCT01865552|9948087|P3|Period 1|Pathological lab|0
2889561|NCT01865552|9948088|P2|Period 1|Pathological lab|0
2889562|NCT01865552|9948089|P1|Period 1|Pathological lab|0
2889563|NCT01865552|9948084|P6|Period 1|Adverse Event|1
2889564|NCT01865552|9948085|P5|Period 1|Adverse Event|1
2889565|NCT01865552|9948086|P4|Period 1|Adverse Event|1
2889566|NCT01865552|9948087|P3|Period 1|Adverse Event|0
2889567|NCT01865552|9948088|P2|Period 1|Adverse Event|0
2889568|NCT01865552|9948089|P1|Period 1|Adverse Event|1
2889569|NCT01865487|9948127|P10|Overall Study|Withdrawal by Subject|0
2889570|NCT01865487|9948128|P9|Overall Study|Withdrawal by Subject|0
2889571|NCT01865487|9948129|P8|Overall Study|Withdrawal by Subject|0
2889572|NCT01865487|9948130|P7|Overall Study|Withdrawal by Subject|0
2889573|NCT01865487|9948131|P6|Overall Study|Withdrawal by Subject|0
2889574|NCT01865487|9948132|P5|Overall Study|Withdrawal by Subject|1
2889575|NCT01865487|9948133|P4|Overall Study|Withdrawal by Subject|0
2889576|NCT01865487|9948134|P3|Overall Study|Withdrawal by Subject|0
2889577|NCT01865487|9948135|P2|Overall Study|Withdrawal by Subject|0
2889578|NCT01865487|9948136|P1|Overall Study|Withdrawal by Subject|0
2889579|NCT01865487|9948127|P10|Overall Study|Lost to Follow-up|0
2889580|NCT01865487|9948128|P9|Overall Study|Lost to Follow-up|0
2889581|NCT01865487|9948129|P8|Overall Study|Lost to Follow-up|0
2889582|NCT01865487|9948130|P7|Overall Study|Lost to Follow-up|1
2889583|NCT01865487|9948131|P6|Overall Study|Lost to Follow-up|0
2889584|NCT01865487|9948132|P5|Overall Study|Lost to Follow-up|0
2889585|NCT01865487|9948133|P4|Overall Study|Lost to Follow-up|1
2889586|NCT01865487|9948134|P3|Overall Study|Lost to Follow-up|0
2889587|NCT01865487|9948135|P2|Overall Study|Lost to Follow-up|0
2889588|NCT01865487|9948136|P1|Overall Study|Lost to Follow-up|0
2889589|NCT01865448|9948175|P2|Overall Study|dropout unrelated to study|1
2889590|NCT01865448|9948176|P1|Overall Study|dropout unrelated to study|1
2889591|NCT01865448|9948175|P2|Overall Study|Pregnancy|1
2889592|NCT01865448|9948176|P1|Overall Study|Pregnancy|0
2889593|NCT01865448|9948175|P2|Overall Study|Adverse Event|1
2889594|NCT01865448|9948176|P1|Overall Study|Adverse Event|1
2889595|NCT01865084|9948287|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2889596|NCT01865084|9948288|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2889597|NCT01865084|9948289|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2889598|NCT01865084|9948287|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
2889599|NCT01865084|9948288|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
2889600|NCT01865084|9948289|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
2889601|NCT01865084|9948287|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
2889602|NCT01865084|9948288|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
2889603|NCT01865084|9948289|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
2889604|NCT01865084|9948287|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
2889605|NCT01865084|9948288|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
2889606|NCT01865084|9948289|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
2889607|NCT01865084|9948287|P3|Open Label Extension (OLE) Period|Adverse Event|1
2889608|NCT01865084|9948288|P2|Open Label Extension (OLE) Period|Adverse Event|0
2889609|NCT01865084|9948289|P1|Open Label Extension (OLE) Period|Adverse Event|0
2889610|NCT01865084|9948287|P3|Double Blind Period (DB)|Withdrawal by Subject|0
2889611|NCT01865084|9948288|P2|Double Blind Period (DB)|Withdrawal by Subject|0
2889612|NCT01865084|9948289|P1|Double Blind Period (DB)|Withdrawal by Subject|1
2889613|NCT01865084|9948287|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
2889614|NCT01865084|9948288|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2889615|NCT01865084|9948289|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2889616|NCT01865084|9948287|P3|Double Blind Period (DB)|Protocol Violation|1
2889617|NCT01865084|9948288|P2|Double Blind Period (DB)|Protocol Violation|0
2889618|NCT01865084|9948289|P1|Double Blind Period (DB)|Protocol Violation|0
2889619|NCT01865084|9948287|P3|Double Blind Period (DB)|Adverse Event|1
2889620|NCT01865084|9948288|P2|Double Blind Period (DB)|Adverse Event|2
2889621|NCT01865084|9948289|P1|Double Blind Period (DB)|Adverse Event|2
2889622|NCT01864525|9948321|P2|Overall Study|Adverse Event|0
2889623|NCT01864525|9948322|P1|Overall Study|Adverse Event|1
2889624|NCT01864291|9948343|P1|Overall Study|need for revision surgery|2
2889625|NCT01864200|9948351|P2|Overall Study|Protocol Violation|0
2889626|NCT01864200|9948352|P1|Overall Study|Protocol Violation|1
2889627|NCT01864200|9948351|P2|Overall Study|Lost to Follow-up|3
2889628|NCT01864200|9948352|P1|Overall Study|Lost to Follow-up|1
2889629|NCT01864174|9948360|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
2889630|NCT01864174|9948361|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
2889631|NCT01864174|9948360|P2|Off Treatment Follow-Up|Other|0
2889632|NCT01864174|9948361|P1|Off Treatment Follow-Up|Other|2
2889633|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Other|10
2889634|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Other|6
2889635|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
2889636|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
2889637|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
2889638|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
2889639|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Death|0
2889640|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Death|1
2889641|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
2889642|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
2889643|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
2889644|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
2889645|NCT01864174|9948360|P2|Double Blind - Compliant Randomized|Adverse Event|1
2889646|NCT01864174|9948361|P1|Double Blind - Compliant Randomized|Adverse Event|6
2889647|NCT01864174|9948360|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
2889648|NCT01864174|9948361|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
2889649|NCT01864148|9948380|P5|Overall Study|Not Dosed|0
2889650|NCT01864148|9948381|P4|Overall Study|Not Dosed|1
2889651|NCT01864148|9948382|P3|Overall Study|Not Dosed|0
2889652|NCT01864148|9948383|P2|Overall Study|Not Dosed|0
2889653|NCT01864148|9948384|P1|Overall Study|Not Dosed|0
2889654|NCT01864148|9948380|P5|Overall Study|Adverse Event|7
2889655|NCT01864148|9948381|P4|Overall Study|Adverse Event|7
2889656|NCT01864148|9948382|P3|Overall Study|Adverse Event|4
2889657|NCT01864148|9948383|P2|Overall Study|Adverse Event|2
2889658|NCT01864148|9948384|P1|Overall Study|Adverse Event|4
2889659|NCT01864148|9948380|P5|Overall Study|Lost to Follow-up|1
2889660|NCT01864148|9948381|P4|Overall Study|Lost to Follow-up|2
2889661|NCT01864148|9948382|P3|Overall Study|Lost to Follow-up|0
2889662|NCT01864148|9948383|P2|Overall Study|Lost to Follow-up|0
2889663|NCT01864148|9948384|P1|Overall Study|Lost to Follow-up|0
2889664|NCT01864148|9948380|P5|Overall Study|Withdrawal by Subject|8
2889665|NCT01864148|9948381|P4|Overall Study|Withdrawal by Subject|8
2889666|NCT01864148|9948382|P3|Overall Study|Withdrawal by Subject|6
2889667|NCT01864148|9948383|P2|Overall Study|Withdrawal by Subject|2
2889668|NCT01864148|9948384|P1|Overall Study|Withdrawal by Subject|9
2889669|NCT01864148|9948380|P5|Overall Study|Investigator Decision|6
2889670|NCT01864148|9948381|P4|Overall Study|Investigator Decision|4
2889671|NCT01864148|9948382|P3|Overall Study|Investigator Decision|0
2889672|NCT01864148|9948383|P2|Overall Study|Investigator Decision|0
2889673|NCT01864148|9948384|P1|Overall Study|Investigator Decision|5
2889674|NCT01864148|9948380|P5|Overall Study|Death|0
2889675|NCT01864148|9948381|P4|Overall Study|Death|1
2889676|NCT01864148|9948382|P3|Overall Study|Death|0
2889677|NCT01864148|9948383|P2|Overall Study|Death|0
2889678|NCT01864148|9948384|P1|Overall Study|Death|0
2889679|NCT01864148|9948380|P5|Overall Study|Other|1
2889680|NCT01864148|9948381|P4|Overall Study|Other|3
2889681|NCT01864148|9948382|P3|Overall Study|Other|1
2889682|NCT01864148|9948383|P2|Overall Study|Other|1
2889683|NCT01864148|9948384|P1|Overall Study|Other|2
2889684|NCT01864005|9948413|P2|Overall Study|Need GP IIb/IIIa|3
2889685|NCT01864005|9948414|P1|Overall Study|Need GP IIb/IIIa|1
2889686|NCT01864005|9948413|P2|Overall Study|Disease need|1
2889687|NCT01864005|9948414|P1|Overall Study|Disease need|1
2889688|NCT01864005|9948413|P2|Overall Study|Incorrect enrolment|0
2889689|NCT01864005|9948414|P1|Overall Study|Incorrect enrolment|1
2889690|NCT01864005|9948413|P2|Overall Study|Withdrawal by Subject|1
2889691|NCT01864005|9948414|P1|Overall Study|Withdrawal by Subject|0
2889692|NCT01864005|9948413|P2|Overall Study|Protocol Violation|1
2889693|NCT01864005|9948414|P1|Overall Study|Protocol Violation|0
2889694|NCT01863953|9948431|P3|Overall Study|Adverse Event|1
2889695|NCT01863953|9948432|P2|Overall Study|Adverse Event|0
2889696|NCT01863953|9948433|P1|Overall Study|Adverse Event|0
2889697|NCT01863771|9948447|P4|Maintenance Phase|Withdrawal by Subject|3
2889698|NCT01863771|9948448|P3|Maintenance Phase|Withdrawal by Subject|2
2889699|NCT01863771|9948449|P2|Maintenance Phase|Withdrawal by Subject|1
2889700|NCT01863771|9948450|P1|Maintenance Phase|Withdrawal by Subject|0
2889701|NCT01863771|9948447|P4|Maintenance Phase|Pregnancy|0
2889702|NCT01863771|9948448|P3|Maintenance Phase|Pregnancy|0
2889703|NCT01863771|9948449|P2|Maintenance Phase|Pregnancy|1
2889704|NCT01863771|9948450|P1|Maintenance Phase|Pregnancy|0
2889705|NCT01863771|9948447|P4|Maintenance Phase|Physician Decision|1
2889706|NCT01863771|9948448|P3|Maintenance Phase|Physician Decision|2
2889707|NCT01863771|9948449|P2|Maintenance Phase|Physician Decision|0
2889708|NCT01863771|9948450|P1|Maintenance Phase|Physician Decision|0
2889709|NCT01863771|9948447|P4|Maintenance Phase|Lack of Efficacy|38
2889710|NCT01863771|9948448|P3|Maintenance Phase|Lack of Efficacy|7
2889711|NCT01863771|9948449|P2|Maintenance Phase|Lack of Efficacy|3
2889712|NCT01863771|9948450|P1|Maintenance Phase|Lack of Efficacy|0
2889713|NCT01863771|9948447|P4|Maintenance Phase|Adverse Event|1
2889714|NCT01863771|9948448|P3|Maintenance Phase|Adverse Event|1
2889715|NCT01863771|9948449|P2|Maintenance Phase|Adverse Event|0
2889716|NCT01863771|9948450|P1|Maintenance Phase|Adverse Event|0
2889717|NCT01863771|9948447|P4|Induction Phase|Withdrawal by Subject|0
2889718|NCT01863771|9948448|P3|Induction Phase|Withdrawal by Subject|0
2889719|NCT01863771|9948449|P2|Induction Phase|Withdrawal by Subject|0
2889720|NCT01863771|9948450|P1|Induction Phase|Withdrawal by Subject|2
2889721|NCT01863771|9948447|P4|Induction Phase|Lack of Efficacy|0
2889722|NCT01863771|9948448|P3|Induction Phase|Lack of Efficacy|0
2889723|NCT01863771|9948449|P2|Induction Phase|Lack of Efficacy|0
2889724|NCT01863771|9948450|P1|Induction Phase|Lack of Efficacy|10
2889725|NCT01863771|9948447|P4|Induction Phase|Adverse Event|0
2889726|NCT01863771|9948448|P3|Induction Phase|Adverse Event|0
2889727|NCT01863771|9948449|P2|Induction Phase|Adverse Event|0
2889728|NCT01863771|9948450|P1|Induction Phase|Adverse Event|9
2889729|NCT01863758|9948462|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
2889730|NCT01863758|9948462|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
2889731|NCT01863732|9948474|P4|Overall Study|Death|1
2889732|NCT01863732|9948475|P3|Overall Study|Death|0
2889733|NCT01863732|9948476|P2|Overall Study|Death|0
2889734|NCT01863732|9948477|P1|Overall Study|Death|1
2889735|NCT01863732|9948474|P4|Overall Study|Subject/guardian decision|1
2889736|NCT01863732|9948475|P3|Overall Study|Subject/guardian decision|3
2889737|NCT01863732|9948476|P2|Overall Study|Subject/guardian decision|9
2889738|NCT01863732|9948477|P1|Overall Study|Subject/guardian decision|6
2889739|NCT01863732|9948474|P4|Overall Study|Technical problems|0
2889740|NCT01863732|9948475|P3|Overall Study|Technical problems|1
2889741|NCT01863732|9948476|P2|Overall Study|Technical problems|1
2889742|NCT01863732|9948477|P1|Overall Study|Technical problems|0
2889743|NCT01863732|9948474|P4|Overall Study|Pregnancy|1
2889744|NCT01863732|9948475|P3|Overall Study|Pregnancy|0
2889745|NCT01863732|9948476|P2|Overall Study|Pregnancy|0
2889746|NCT01863732|9948477|P1|Overall Study|Pregnancy|0
2889747|NCT01863732|9948474|P4|Overall Study|Physician Decision|0
2889748|NCT01863732|9948475|P3|Overall Study|Physician Decision|1
2889749|NCT01863732|9948476|P2|Overall Study|Physician Decision|0
2889750|NCT01863732|9948477|P1|Overall Study|Physician Decision|1
2889751|NCT01863732|9948474|P4|Overall Study|Lost to Follow-up|1
2889752|NCT01863732|9948475|P3|Overall Study|Lost to Follow-up|1
2889753|NCT01863732|9948476|P2|Overall Study|Lost to Follow-up|2
2889754|NCT01863732|9948477|P1|Overall Study|Lost to Follow-up|2
2889755|NCT01863732|9948474|P4|Overall Study|Lack of Efficacy|1
2889756|NCT01863732|9948475|P3|Overall Study|Lack of Efficacy|2
2889757|NCT01863732|9948476|P2|Overall Study|Lack of Efficacy|0
2889758|NCT01863732|9948477|P1|Overall Study|Lack of Efficacy|1
2889759|NCT01863732|9948474|P4|Overall Study|Adverse Event|3
2889760|NCT01863732|9948475|P3|Overall Study|Adverse Event|3
2889761|NCT01863732|9948476|P2|Overall Study|Adverse Event|0
2889762|NCT01863732|9948477|P1|Overall Study|Adverse Event|2
2889763|NCT01863680|9948490|P1|Overall Study|Other|6
2889764|NCT01863680|9948490|P1|Overall Study|Did not undergo IVF/ET|14
2889765|NCT01863680|9948490|P1|Overall Study|Withdrawal by Subject|1
2889766|NCT01863680|9948490|P1|Overall Study|Spontaneous pregnancy|2
2889767|NCT01863680|9948490|P1|Overall Study|Risk of OHSS|17
2889768|NCT01863680|9948490|P1|Overall Study|Adverse Event|17
2889769|NCT01863667|9948498|P2|Overall Study|Withdrawal by Subject|2
2889770|NCT01863667|9948499|P1|Overall Study|Withdrawal by Subject|2
2889771|NCT01863667|9948498|P2|Overall Study|Study terminated by Sponsor|30
2889772|NCT01863667|9948499|P1|Overall Study|Study terminated by Sponsor|30
2889773|NCT01863667|9948498|P2|Overall Study|Adverse Event|0
2889774|NCT01863667|9948499|P1|Overall Study|Adverse Event|1
2889775|NCT01863433|9948523|P1|Overall Study|Protocol Violation|1
2889776|NCT01863368|9948533|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
2889777|NCT01863368|9948534|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
2889778|NCT01863368|9948533|P2|Phase II, Day 35 to Day 90|Adverse Event|0
2889779|NCT01863368|9948534|P1|Phase II, Day 35 to Day 90|Adverse Event|1
2889780|NCT01863368|9948533|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
2889781|NCT01863368|9948534|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
2889782|NCT01863368|9948533|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
2889783|NCT01863368|9948534|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
2889784|NCT01863368|9948533|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
2889785|NCT01863368|9948534|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
2889786|NCT01863368|9948533|P2|Phase I, Day 0 to Day 35|Adverse Event|4
2889787|NCT01863368|9948534|P1|Phase I, Day 0 to Day 35|Adverse Event|2
2889788|NCT01862991|9948588|P3|Overall Study|Protocol Violation|0
2889789|NCT01862991|9948589|P2|Overall Study|Protocol Violation|0
2889790|NCT01862991|9948590|P1|Overall Study|Protocol Violation|1
2889791|NCT01862991|9948588|P3|Overall Study|Lost to Follow-up|1
2889792|NCT01862991|9948589|P2|Overall Study|Lost to Follow-up|1
2889793|NCT01862991|9948590|P1|Overall Study|Lost to Follow-up|2
2889794|NCT01862874|9948603|P2|Overall Study|Death|1
2889795|NCT01862874|9948604|P1|Overall Study|Death|0
2889796|NCT01862874|9948603|P2|Overall Study|Withdrawal by Subject|40
2889797|NCT01862874|9948604|P1|Overall Study|Withdrawal by Subject|46
2889798|NCT01862874|9948603|P2|Overall Study|Withdrawn by parent/guardian|1
2889799|NCT01862874|9948604|P1|Overall Study|Withdrawn by parent/guardian|1
2889800|NCT01862874|9948603|P2|Overall Study|Physician Decision|3
2889801|NCT01862874|9948604|P1|Overall Study|Physician Decision|5
2889802|NCT01862874|9948603|P2|Overall Study|Lost to Follow-up|29
2889803|NCT01862874|9948604|P1|Overall Study|Lost to Follow-up|26
2889804|NCT01862874|9948603|P2|Overall Study|Adverse Event|3
2889805|NCT01862874|9948604|P1|Overall Study|Adverse Event|0
2889806|NCT01862874|9948603|P2|Overall Study|Randomized not treated|0
2889807|NCT01862874|9948604|P1|Overall Study|Randomized not treated|1
2889808|NCT01862796|9948623|P3|Overall Study|Prohibited medications|1
2889809|NCT01862796|9948624|P2|Overall Study|Prohibited medications|0
2889810|NCT01862796|9948625|P1|Overall Study|Prohibited medications|0
2889811|NCT01862484|9948638|P2|Overall Study|Withdrawal by Subject|3
2889812|NCT01862484|9948639|P1|Overall Study|Withdrawal by Subject|0
2889813|NCT01862484|9948638|P2|Overall Study|Protocol Violation|2
2889814|NCT01862484|9948639|P1|Overall Study|Protocol Violation|0
2889815|NCT01862484|9948638|P2|Overall Study|Lost to Follow-up|2
2889816|NCT01862484|9948639|P1|Overall Study|Lost to Follow-up|1
2889817|NCT01862484|9948638|P2|Overall Study|Lack of Efficacy|1
2889818|NCT01862484|9948639|P1|Overall Study|Lack of Efficacy|1
2889819|NCT01862250|9948658|P1|Overall Study|Adverse Event|4
2889820|NCT01862029|9948679|P1|Overall Study|Physician Decision|1
2889821|NCT01861522|9948782|P2|Overall Study|Withdrawal by Subject|0
2889822|NCT01861522|9948783|P1|Overall Study|Withdrawal by Subject|2
2889823|NCT01861522|9948782|P2|Overall Study|Adverse Event|0
2889824|NCT01861522|9948783|P1|Overall Study|Adverse Event|1
2889825|NCT01860989|9948807|P1|Overall Study|Unsatisfactory therapeutic|5
2889826|NCT01860976|9948813|P2|Long Term Extension|Ongoing treatment at time of analysis|100
2889827|NCT01860976|9948814|P1|Long Term Extension|Ongoing treatment at time of analysis|106
2889828|NCT01860976|9948813|P2|Long Term Extension|Withdrawal by Subject|0
2889829|NCT01860976|9948814|P1|Long Term Extension|Withdrawal by Subject|1
2889830|NCT01860976|9948813|P2|Long Term Extension|Subject request to discontinue treatment|0
2889831|NCT01860976|9948814|P1|Long Term Extension|Subject request to discontinue treatment|2
2889832|NCT01860976|9948813|P2|Long Term Extension|Lack of Efficacy|7
2889833|NCT01860976|9948814|P1|Long Term Extension|Lack of Efficacy|3
2889834|NCT01860976|9948813|P2|Long Term Extension|Adverse Event|0
2889835|NCT01860976|9948814|P1|Long Term Extension|Adverse Event|1
2889836|NCT01860976|9948813|P2|Open-Label|Ongoing OL treatment at time of analysis|45
2889837|NCT01860976|9948814|P1|Open-Label|Ongoing OL treatment at time of analysis|46
2889838|NCT01860976|9948813|P2|Open-Label|Other Reasons|1
2889839|NCT01860976|9948814|P1|Open-Label|Other Reasons|1
2889840|NCT01860976|9948813|P2|Open-Label|Withdrawal by Subject|1
2889841|NCT01860976|9948814|P1|Open-Label|Withdrawal by Subject|4
2889842|NCT01860976|9948813|P2|Open-Label|Subject request discontinue treatment|3
2889843|NCT01860976|9948814|P1|Open-Label|Subject request discontinue treatment|4
2889844|NCT01860976|9948813|P2|Open-Label|Lost to Follow-up|2
2889845|NCT01860976|9948814|P1|Open-Label|Lost to Follow-up|1
2889846|NCT01860976|9948813|P2|Open-Label|Lack of Efficacy|8
2889847|NCT01860976|9948814|P1|Open-Label|Lack of Efficacy|16
2889848|NCT01860976|9948813|P2|Open-Label|Adverse Event|4
2889849|NCT01860976|9948814|P1|Open-Label|Adverse Event|2
2889850|NCT01860976|9948813|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
2889851|NCT01860976|9948814|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
2889852|NCT01860976|9948813|P2|Blinded Treatment|Entered Open-Label in error|1
2889853|NCT01860976|9948814|P1|Blinded Treatment|Entered Open-Label in error|0
2889854|NCT01860976|9948813|P2|Blinded Treatment|Subject no longer met criteria|0
2889855|NCT01860976|9948814|P1|Blinded Treatment|Subject no longer met criteria|1
2889856|NCT01860976|9948813|P2|Blinded Treatment|Withdrawal by Subject|5
2889857|NCT01860976|9948814|P1|Blinded Treatment|Withdrawal by Subject|3
2889858|NCT01860976|9948813|P2|Blinded Treatment|Subject request to discontinue treatment|3
2889859|NCT01860976|9948814|P1|Blinded Treatment|Subject request to discontinue treatment|2
2889860|NCT01860976|9948813|P2|Blinded Treatment|Lack of Efficacy|12
2889861|NCT01860976|9948814|P1|Blinded Treatment|Lack of Efficacy|5
2889862|NCT01860976|9948813|P2|Blinded Treatment|Adverse Event|3
2889863|NCT01860976|9948814|P1|Blinded Treatment|Adverse Event|1
2889864|NCT01860846|9948868|P1|Overall Study|Lost to Follow-up|33
2889865|NCT01860703|9948888|P4|Overall Study|Personal reason|0
2889866|NCT01860703|9948889|P3|Overall Study|Personal reason|1
2889867|NCT01860703|9948890|P2|Overall Study|Personal reason|0
2889868|NCT01860703|9948891|P1|Overall Study|Personal reason|1
2889869|NCT01860703|9948888|P4|Overall Study|Withdrawal by Subject|0
2889870|NCT01860703|9948889|P3|Overall Study|Withdrawal by Subject|0
2889871|NCT01860703|9948890|P2|Overall Study|Withdrawal by Subject|1
2889872|NCT01860703|9948891|P1|Overall Study|Withdrawal by Subject|0
2889873|NCT01860703|9948888|P4|Overall Study|Adverse Event|2
2889874|NCT01860703|9948889|P3|Overall Study|Adverse Event|0
2889875|NCT01860703|9948890|P2|Overall Study|Adverse Event|4
2889876|NCT01860703|9948891|P1|Overall Study|Adverse Event|1
2889877|NCT01860677|9948923|P2|Second Intervention (1 Day)|Lost to Follow-up|0
2889878|NCT01860677|9948924|P1|Second Intervention (1 Day)|Lost to Follow-up|7
2889879|NCT01860534|9948981|P2|ROP #2|discharged prior to ROP #2|0
2889880|NCT01860534|9948982|P1|ROP #2|discharged prior to ROP #2|1
2889881|NCT01860534|9948981|P2|ROP #1|Needed treatment for ROP|1
2889882|NCT01860534|9948982|P1|ROP #1|Needed treatment for ROP|0
2889883|NCT01860079|9949043|P2|Overall Study|Physician Decision|22
2889884|NCT01860079|9949044|P1|Overall Study|Physician Decision|14
2889885|NCT01860040|9949052|P2|Overall Study|Withdrawal by Subject|0
2889886|NCT01860040|9949053|P1|Overall Study|Withdrawal by Subject|1
2889887|NCT01859988|9949064|P6|Overall Study|Other than specified above|3
2889888|NCT01859988|9949065|P5|Overall Study|Other than specified above|5
2889889|NCT01859988|9949066|P4|Overall Study|Other than specified above|3
2889890|NCT01859988|9949067|P3|Overall Study|Other than specified above|11
2889891|NCT01859988|9949068|P2|Overall Study|Other than specified above|2
2889892|NCT01859988|9949069|P1|Overall Study|Other than specified above|0
2889893|NCT01859988|9949064|P6|Overall Study|Protocol Violation|0
2889894|NCT01859988|9949065|P5|Overall Study|Protocol Violation|0
2889895|NCT01859988|9949066|P4|Overall Study|Protocol Violation|0
2889896|NCT01859988|9949067|P3|Overall Study|Protocol Violation|1
2889897|NCT01859988|9949068|P2|Overall Study|Protocol Violation|0
2889898|NCT01859988|9949069|P1|Overall Study|Protocol Violation|0
2889899|NCT01859988|9949064|P6|Overall Study|Lost to Follow-up|2
2889900|NCT01859988|9949065|P5|Overall Study|Lost to Follow-up|3
2889901|NCT01859988|9949066|P4|Overall Study|Lost to Follow-up|0
2889902|NCT01859988|9949067|P3|Overall Study|Lost to Follow-up|3
2889903|NCT01859988|9949068|P2|Overall Study|Lost to Follow-up|2
2889904|NCT01859988|9949069|P1|Overall Study|Lost to Follow-up|1
2889905|NCT01859988|9949064|P6|Overall Study|Adverse Event|2
2889906|NCT01859988|9949065|P5|Overall Study|Adverse Event|2
2889907|NCT01859988|9949066|P4|Overall Study|Adverse Event|1
2889908|NCT01859988|9949067|P3|Overall Study|Adverse Event|3
2889909|NCT01859988|9949068|P2|Overall Study|Adverse Event|1
2889910|NCT01859988|9949069|P1|Overall Study|Adverse Event|2
2889911|NCT01859988|9949064|P6|Overall Study|Physician Decision|1
2889912|NCT01859988|9949065|P5|Overall Study|Physician Decision|4
2889913|NCT01859988|9949066|P4|Overall Study|Physician Decision|3
2889914|NCT01859988|9949067|P3|Overall Study|Physician Decision|1
2889915|NCT01859988|9949068|P2|Overall Study|Physician Decision|3
2889916|NCT01859988|9949069|P1|Overall Study|Physician Decision|1
2889917|NCT01859988|9949064|P6|Overall Study|Lack of Efficacy|9
2889918|NCT01859988|9949065|P5|Overall Study|Lack of Efficacy|7
2889919|NCT01859988|9949066|P4|Overall Study|Lack of Efficacy|0
2889920|NCT01859988|9949067|P3|Overall Study|Lack of Efficacy|5
2889921|NCT01859988|9949068|P2|Overall Study|Lack of Efficacy|1
2889922|NCT01859988|9949069|P1|Overall Study|Lack of Efficacy|1
2889923|NCT01859988|9949064|P6|Overall Study|Withdrawal by Subject|2
2889924|NCT01859988|9949065|P5|Overall Study|Withdrawal by Subject|2
2889925|NCT01859988|9949066|P4|Overall Study|Withdrawal by Subject|3
2889926|NCT01859988|9949067|P3|Overall Study|Withdrawal by Subject|4
2889927|NCT01859988|9949068|P2|Overall Study|Withdrawal by Subject|3
2889928|NCT01859988|9949069|P1|Overall Study|Withdrawal by Subject|6
2889929|NCT01859949|9949163|P2|Overall Study|Adverse Event|1
2889930|NCT01859949|9949164|P1|Overall Study|Adverse Event|0
2889931|NCT01859949|9949163|P2|Overall Study|Protocol Violation|1
2889932|NCT01859949|9949164|P1|Overall Study|Protocol Violation|1
2889933|NCT01859949|9949163|P2|Overall Study|Withdrawal by Subject|10
2889934|NCT01859949|9949164|P1|Overall Study|Withdrawal by Subject|11
2889935|NCT01859949|9949163|P2|Overall Study|Physician Decision|4
2889936|NCT01859949|9949164|P1|Overall Study|Physician Decision|2
2889937|NCT01859949|9949163|P2|Overall Study|Family Matters|1
2889938|NCT01859949|9949164|P1|Overall Study|Family Matters|0
2889939|NCT01859793|9949182|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
2889940|NCT01859793|9949183|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
2889941|NCT01859793|9949182|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
2889942|NCT01859793|9949183|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2889943|NCT01859793|9949182|P2|First Intervention (8 Weeks)|Adverse Event|0
2889944|NCT01859793|9949183|P1|First Intervention (8 Weeks)|Adverse Event|1
2889945|NCT01859793|9949182|P2|First Intervention (8 Weeks)|Protocol Violation|0
2889946|NCT01859793|9949183|P1|First Intervention (8 Weeks)|Protocol Violation|2
2889947|NCT01859741|9949201|P8|Overall Study|Other|0
2889948|NCT01859741|9949202|P7|Overall Study|Other|2
2889949|NCT01859741|9949203|P6|Overall Study|Other|0
2889950|NCT01859741|9949204|P5|Overall Study|Other|0
2889951|NCT01859741|9949205|P4|Overall Study|Other|0
2889952|NCT01859741|9949206|P3|Overall Study|Other|0
2889953|NCT01859741|9949207|P2|Overall Study|Other|0
2889954|NCT01859741|9949208|P1|Overall Study|Other|0
2889955|NCT01859741|9949201|P8|Overall Study|Study Terminated by Sponsor|14
2889956|NCT01859741|9949202|P7|Overall Study|Study Terminated by Sponsor|16
2889957|NCT01859741|9949203|P6|Overall Study|Study Terminated by Sponsor|0
2889958|NCT01859741|9949204|P5|Overall Study|Study Terminated by Sponsor|1
2889959|NCT01859741|9949205|P4|Overall Study|Study Terminated by Sponsor|0
2889960|NCT01859741|9949206|P3|Overall Study|Study Terminated by Sponsor|0
2889961|NCT01859741|9949207|P2|Overall Study|Study Terminated by Sponsor|0
2889962|NCT01859741|9949208|P1|Overall Study|Study Terminated by Sponsor|0
2889963|NCT01859741|9949201|P8|Overall Study|Withdrawal by Subject|1
2889964|NCT01859741|9949202|P7|Overall Study|Withdrawal by Subject|1
2889965|NCT01859741|9949203|P6|Overall Study|Withdrawal by Subject|1
2889966|NCT01859741|9949204|P5|Overall Study|Withdrawal by Subject|0
2889967|NCT01859741|9949205|P4|Overall Study|Withdrawal by Subject|0
2889968|NCT01859741|9949206|P3|Overall Study|Withdrawal by Subject|2
2889969|NCT01859741|9949207|P2|Overall Study|Withdrawal by Subject|1
2889970|NCT01859741|9949208|P1|Overall Study|Withdrawal by Subject|0
2889971|NCT01859741|9949201|P8|Overall Study|Lost to Follow-up|4
2889972|NCT01859741|9949202|P7|Overall Study|Lost to Follow-up|0
2889973|NCT01859741|9949203|P6|Overall Study|Lost to Follow-up|1
2889974|NCT01859741|9949204|P5|Overall Study|Lost to Follow-up|0
2889975|NCT01859741|9949205|P4|Overall Study|Lost to Follow-up|0
2889976|NCT01859741|9949206|P3|Overall Study|Lost to Follow-up|0
2889977|NCT01859741|9949207|P2|Overall Study|Lost to Follow-up|0
2889978|NCT01859741|9949208|P1|Overall Study|Lost to Follow-up|0
2889979|NCT01859741|9949201|P8|Overall Study|Death|51
2889980|NCT01859741|9949202|P7|Overall Study|Death|51
2889981|NCT01859741|9949203|P6|Overall Study|Death|4
2889982|NCT01859741|9949204|P5|Overall Study|Death|5
2889983|NCT01859741|9949205|P4|Overall Study|Death|3
2889984|NCT01859741|9949206|P3|Overall Study|Death|4
2889985|NCT01859741|9949207|P2|Overall Study|Death|2
2889986|NCT01859741|9949208|P1|Overall Study|Death|3
2889987|NCT01859715|9949237|P3|Overall Study|No 2nd VAS|23
2889988|NCT01859715|9949238|P2|Overall Study|No 2nd VAS|8
2889989|NCT01859715|9949239|P1|Overall Study|No 2nd VAS|16
2889990|NCT01859702|9949250|P1|Overall Study|Adverse Event|2
2889991|NCT01859702|9949250|P1|Overall Study|Protocol deviation|3
2889992|NCT01859598|9949264|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
2889993|NCT01859507|9949272|P1|Overall Study|left the country|4
2889994|NCT01859494|9949277|P1|Overall Study|Adverse Event|1
2889995|NCT01859390|9949288|P2|Overall Study|Shipment Error|1
2889996|NCT01859390|9949289|P1|Overall Study|Shipment Error|0
2889997|NCT01859390|9949288|P2|Overall Study|Tube Cracked|2
2889998|NCT01859390|9949289|P1|Overall Study|Tube Cracked|0
2889999|NCT01859390|9949288|P2|Overall Study|Sample Missing Collection Date|1
2890000|NCT01859390|9949289|P1|Overall Study|Sample Missing Collection Date|0
2890001|NCT01859390|9949288|P2|Overall Study|Insufficient Sputum Collected|3
2890002|NCT01859390|9949289|P1|Overall Study|Insufficient Sputum Collected|1
2890003|NCT01859143|9949423|P2|Overall Study|Lost to Follow-up|0
2890004|NCT01859143|9949424|P1|Overall Study|Lost to Follow-up|2
2890005|NCT01858766|9949480|P19|Overall Study|Withdrew Consent|0
2890006|NCT01858766|9949481|P18|Overall Study|Withdrew Consent|0
2890007|NCT01858766|9949482|P17|Overall Study|Withdrew Consent|0
2890008|NCT01858766|9949483|P16|Overall Study|Withdrew Consent|0
2890009|NCT01858766|9949484|P15|Overall Study|Withdrew Consent|0
2890010|NCT01858766|9949485|P14|Overall Study|Withdrew Consent|0
2890011|NCT01858766|9949486|P13|Overall Study|Withdrew Consent|0
2890012|NCT01858766|9949487|P12|Overall Study|Withdrew Consent|1
2890013|NCT01858766|9949488|P11|Overall Study|Withdrew Consent|0
2890014|NCT01858766|9949489|P10|Overall Study|Withdrew Consent|0
2890015|NCT01858766|9949490|P9|Overall Study|Withdrew Consent|0
2890016|NCT01858766|9949491|P8|Overall Study|Withdrew Consent|0
2890017|NCT01858766|9949492|P7|Overall Study|Withdrew Consent|0
2890018|NCT01858766|9949493|P6|Overall Study|Withdrew Consent|0
2890019|NCT01858766|9949494|P5|Overall Study|Withdrew Consent|0
2890020|NCT01858766|9949495|P4|Overall Study|Withdrew Consent|0
2890021|NCT01858766|9949496|P3|Overall Study|Withdrew Consent|0
2890022|NCT01858766|9949497|P2|Overall Study|Withdrew Consent|0
2890023|NCT01858766|9949498|P1|Overall Study|Withdrew Consent|0
2890024|NCT01858766|9949480|P19|Overall Study|Lost to Follow-up|1
2890025|NCT01858766|9949481|P18|Overall Study|Lost to Follow-up|0
2890026|NCT01858766|9949482|P17|Overall Study|Lost to Follow-up|1
2890027|NCT01858766|9949483|P16|Overall Study|Lost to Follow-up|1
2890028|NCT01858766|9949484|P15|Overall Study|Lost to Follow-up|3
2890029|NCT01858766|9949485|P14|Overall Study|Lost to Follow-up|0
2890030|NCT01858766|9949486|P13|Overall Study|Lost to Follow-up|0
2890031|NCT01858766|9949487|P12|Overall Study|Lost to Follow-up|1
2890032|NCT01858766|9949488|P11|Overall Study|Lost to Follow-up|0
2890033|NCT01858766|9949489|P10|Overall Study|Lost to Follow-up|0
2890034|NCT01858766|9949490|P9|Overall Study|Lost to Follow-up|0
2890035|NCT01858766|9949491|P8|Overall Study|Lost to Follow-up|2
2890036|NCT01858766|9949492|P7|Overall Study|Lost to Follow-up|0
2890037|NCT01858766|9949493|P6|Overall Study|Lost to Follow-up|1
2890038|NCT01858766|9949494|P5|Overall Study|Lost to Follow-up|0
2890039|NCT01858766|9949495|P4|Overall Study|Lost to Follow-up|0
2890040|NCT01858766|9949496|P3|Overall Study|Lost to Follow-up|0
2890041|NCT01858766|9949497|P2|Overall Study|Lost to Follow-up|0
2890042|NCT01858766|9949498|P1|Overall Study|Lost to Follow-up|0
2890043|NCT01858766|9949480|P19|Overall Study|Lack of Efficacy|3
2890044|NCT01858766|9949481|P18|Overall Study|Lack of Efficacy|3
2890045|NCT01858766|9949482|P17|Overall Study|Lack of Efficacy|2
2890046|NCT01858766|9949483|P16|Overall Study|Lack of Efficacy|5
2890047|NCT01858766|9949484|P15|Overall Study|Lack of Efficacy|5
2890048|NCT01858766|9949485|P14|Overall Study|Lack of Efficacy|3
2890049|NCT01858766|9949486|P13|Overall Study|Lack of Efficacy|5
2890050|NCT01858766|9949487|P12|Overall Study|Lack of Efficacy|3
2890051|NCT01858766|9949488|P11|Overall Study|Lack of Efficacy|0
2890052|NCT01858766|9949489|P10|Overall Study|Lack of Efficacy|0
2890053|NCT01858766|9949490|P9|Overall Study|Lack of Efficacy|0
2890054|NCT01858766|9949491|P8|Overall Study|Lack of Efficacy|0
2890055|NCT01858766|9949492|P7|Overall Study|Lack of Efficacy|0
2890056|NCT01858766|9949493|P6|Overall Study|Lack of Efficacy|2
2890057|NCT01858766|9949494|P5|Overall Study|Lack of Efficacy|1
2890058|NCT01858766|9949495|P4|Overall Study|Lack of Efficacy|0
2890059|NCT01858766|9949496|P3|Overall Study|Lack of Efficacy|0
2890060|NCT01858766|9949497|P2|Overall Study|Lack of Efficacy|0
2890061|NCT01858766|9949498|P1|Overall Study|Lack of Efficacy|1
2890062|NCT01858766|9949480|P19|Overall Study|Death|0
2890063|NCT01858766|9949481|P18|Overall Study|Death|0
2890064|NCT01858766|9949482|P17|Overall Study|Death|0
2890065|NCT01858766|9949483|P16|Overall Study|Death|0
2890066|NCT01858766|9949484|P15|Overall Study|Death|0
2890067|NCT01858766|9949485|P14|Overall Study|Death|0
2890068|NCT01858766|9949486|P13|Overall Study|Death|0
2890069|NCT01858766|9949487|P12|Overall Study|Death|0
2890070|NCT01858766|9949488|P11|Overall Study|Death|0
2890071|NCT01858766|9949489|P10|Overall Study|Death|0
2890072|NCT01858766|9949490|P9|Overall Study|Death|0
2890073|NCT01858766|9949491|P8|Overall Study|Death|0
2890074|NCT01858766|9949492|P7|Overall Study|Death|0
2890075|NCT01858766|9949493|P6|Overall Study|Death|0
2890076|NCT01858766|9949494|P5|Overall Study|Death|0
2890077|NCT01858766|9949495|P4|Overall Study|Death|0
2890078|NCT01858766|9949496|P3|Overall Study|Death|1
2890079|NCT01858766|9949497|P2|Overall Study|Death|0
2890080|NCT01858766|9949498|P1|Overall Study|Death|0
2890081|NCT01858766|9949480|P19|Overall Study|Randomized but Never Treated|0
2890082|NCT01858766|9949481|P18|Overall Study|Randomized but Never Treated|1
2890083|NCT01858766|9949482|P17|Overall Study|Randomized but Never Treated|0
2890084|NCT01858766|9949483|P16|Overall Study|Randomized but Never Treated|0
2890085|NCT01858766|9949484|P15|Overall Study|Randomized but Never Treated|0
2890086|NCT01858766|9949485|P14|Overall Study|Randomized but Never Treated|0
2890087|NCT01858766|9949486|P13|Overall Study|Randomized but Never Treated|0
2890088|NCT01858766|9949487|P12|Overall Study|Randomized but Never Treated|0
2890089|NCT01858766|9949488|P11|Overall Study|Randomized but Never Treated|0
2890090|NCT01858766|9949489|P10|Overall Study|Randomized but Never Treated|0
2890091|NCT01858766|9949490|P9|Overall Study|Randomized but Never Treated|0
2890092|NCT01858766|9949491|P8|Overall Study|Randomized but Never Treated|0
2890093|NCT01858766|9949492|P7|Overall Study|Randomized but Never Treated|0
2890094|NCT01858766|9949493|P6|Overall Study|Randomized but Never Treated|1
2890095|NCT01858766|9949494|P5|Overall Study|Randomized but Never Treated|0
2890096|NCT01858766|9949495|P4|Overall Study|Randomized but Never Treated|0
2890097|NCT01858766|9949496|P3|Overall Study|Randomized but Never Treated|0
2890098|NCT01858766|9949497|P2|Overall Study|Randomized but Never Treated|0
2890099|NCT01858766|9949498|P1|Overall Study|Randomized but Never Treated|0
2890100|NCT01858701|9949569|P2|Period 2, Second 30 Days of Wear|Comfort|1
2890101|NCT01858701|9949570|P1|Period 2, Second 30 Days of Wear|Comfort|0
2890102|NCT01858701|9949569|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
2890103|NCT01858701|9949570|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
2890104|NCT01858701|9949569|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
2890105|NCT01858701|9949570|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
2890106|NCT01858701|9949569|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2890107|NCT01858701|9949570|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2890108|NCT01858636|9949576|P1|Overall Study|Withdrawal by Subject|1
2890109|NCT01858636|9949576|P1|Overall Study|Lost to Follow-up|1
2890110|NCT01858636|9949576|P1|Overall Study|Death|1
2890111|NCT01858636|9949576|P1|Overall Study|Physician Decision|1
2890112|NCT01858636|9949576|P1|Overall Study|No Device Deployment Attempted|24
2890113|NCT01858532|9949594|P4|Overall Study|Other, not specified|11
2890114|NCT01858532|9949595|P3|Overall Study|Other, not specified|13
2890115|NCT01858532|9949596|P2|Overall Study|Other, not specified|15
2890116|NCT01858532|9949597|P1|Overall Study|Other, not specified|29
2890117|NCT01858532|9949594|P4|Overall Study|Investigator request|6
2890118|NCT01858532|9949595|P3|Overall Study|Investigator request|2
2890119|NCT01858532|9949596|P2|Overall Study|Investigator request|4
2890120|NCT01858532|9949597|P1|Overall Study|Investigator request|3
2890121|NCT01858532|9949594|P4|Overall Study|Deterioration of medical status|7
2890122|NCT01858532|9949595|P3|Overall Study|Deterioration of medical status|3
2890123|NCT01858532|9949596|P2|Overall Study|Deterioration of medical status|4
2890124|NCT01858532|9949597|P1|Overall Study|Deterioration of medical status|3
2890125|NCT01858532|9949594|P4|Overall Study|Lost to Follow-up|14
2890126|NCT01858532|9949595|P3|Overall Study|Lost to Follow-up|11
2890127|NCT01858532|9949596|P2|Overall Study|Lost to Follow-up|26
2890128|NCT01858532|9949597|P1|Overall Study|Lost to Follow-up|17
2890129|NCT01858532|9949594|P4|Overall Study|Withdrew consent|27
2890130|NCT01858532|9949595|P3|Overall Study|Withdrew consent|46
2890131|NCT01858532|9949596|P2|Overall Study|Withdrew consent|93
2890132|NCT01858532|9949597|P1|Overall Study|Withdrew consent|71
2890133|NCT01858532|9949594|P4|Overall Study|Adverse Event|28
2890134|NCT01858532|9949595|P3|Overall Study|Adverse Event|23
2890135|NCT01858532|9949596|P2|Overall Study|Adverse Event|50
2890136|NCT01858532|9949597|P1|Overall Study|Adverse Event|58
2890137|NCT01858389|9949651|P2|Overall Study|Did not receive treatment|3
2890138|NCT01858389|9949652|P1|Overall Study|Did not receive treatment|0
2890139|NCT01858389|9949651|P2|Overall Study|Adverse Event|1
2890140|NCT01858389|9949652|P1|Overall Study|Adverse Event|3
2890141|NCT01858389|9949651|P2|Overall Study|Other|4
2890142|NCT01858389|9949652|P1|Overall Study|Other|2
2890143|NCT01858389|9949651|P2|Overall Study|Progressive disease|11
2890144|NCT01858389|9949652|P1|Overall Study|Progressive disease|10
2890145|NCT01858389|9949651|P2|Overall Study|Withdrawal by Subject|1
2890146|NCT01858389|9949652|P1|Overall Study|Withdrawal by Subject|0
2890147|NCT01858389|9949651|P2|Overall Study|Study terminated by sponsor|2
2890148|NCT01858389|9949652|P1|Overall Study|Study terminated by sponsor|0
2890149|NCT01858389|9949651|P2|Overall Study|Death|3
2890150|NCT01858389|9949652|P1|Overall Study|Death|1
2890151|NCT01858376|9949667|P1|Overall Study|Dropped d/t lab work not fitting criter|4
2890152|NCT01858194|9949676|P2|Overall Study|Lost to Follow-up|1
2890153|NCT01858194|9949677|P1|Overall Study|Lost to Follow-up|0
2890154|NCT01858194|9949676|P2|Overall Study|Total Artificial Heart Implant|1
2890155|NCT01858194|9949677|P1|Overall Study|Total Artificial Heart Implant|0
2890156|NCT01857973|9949730|P1|Overall Study|Physician Decision|1
2890157|NCT01857973|9949730|P1|Overall Study|drop out after 3 failed attempts|1
2890158|NCT01857973|9949730|P1|Overall Study|Subject did not meet required BG range|3
2890159|NCT01857869|9949760|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890160|NCT01857869|9949761|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890161|NCT01857869|9949762|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890162|NCT01857869|9949763|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890163|NCT01857869|9949764|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890164|NCT01857869|9949765|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890165|NCT01857869|9949766|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
2890166|NCT01857869|9949767|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890167|NCT01857869|9949768|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890168|NCT01857869|9949769|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2890169|NCT01857869|9949760|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890170|NCT01857869|9949761|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890171|NCT01857869|9949762|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890172|NCT01857869|9949763|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890173|NCT01857869|9949764|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890174|NCT01857869|9949765|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890175|NCT01857869|9949766|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
2890176|NCT01857869|9949767|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890177|NCT01857869|9949768|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890178|NCT01857869|9949769|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
2890179|NCT01857869|9949760|P10|Primary/Challenge Phase|Other|0
2890180|NCT01857869|9949761|P9|Primary/Challenge Phase|Other|0
2890181|NCT01857869|9949762|P8|Primary/Challenge Phase|Other|0
2890182|NCT01857869|9949763|P7|Primary/Challenge Phase|Other|0
2890183|NCT01857869|9949764|P6|Primary/Challenge Phase|Other|0
2890184|NCT01857869|9949765|P5|Primary/Challenge Phase|Other|0
2890185|NCT01857869|9949766|P4|Primary/Challenge Phase|Other|0
2890186|NCT01857869|9949767|P3|Primary/Challenge Phase|Other|0
2890187|NCT01857869|9949768|P2|Primary/Challenge Phase|Other|1
2890188|NCT01857869|9949769|P1|Primary/Challenge Phase|Other|1
2890189|NCT01857869|9949760|P10|Primary/Challenge Phase|Protocol Violation|0
2890190|NCT01857869|9949761|P9|Primary/Challenge Phase|Protocol Violation|0
2890191|NCT01857869|9949762|P8|Primary/Challenge Phase|Protocol Violation|0
2890192|NCT01857869|9949763|P7|Primary/Challenge Phase|Protocol Violation|0
2890193|NCT01857869|9949764|P6|Primary/Challenge Phase|Protocol Violation|0
2890194|NCT01857869|9949765|P5|Primary/Challenge Phase|Protocol Violation|0
2890195|NCT01857869|9949766|P4|Primary/Challenge Phase|Protocol Violation|0
2890196|NCT01857869|9949767|P3|Primary/Challenge Phase|Protocol Violation|0
2890197|NCT01857869|9949768|P2|Primary/Challenge Phase|Protocol Violation|0
2890198|NCT01857869|9949769|P1|Primary/Challenge Phase|Protocol Violation|1
2890199|NCT01857869|9949760|P10|Primary/Challenge Phase|Pregnancy|0
2890200|NCT01857869|9949761|P9|Primary/Challenge Phase|Pregnancy|0
2890201|NCT01857869|9949762|P8|Primary/Challenge Phase|Pregnancy|0
2890202|NCT01857869|9949763|P7|Primary/Challenge Phase|Pregnancy|0
2890203|NCT01857869|9949764|P6|Primary/Challenge Phase|Pregnancy|0
2890204|NCT01857869|9949765|P5|Primary/Challenge Phase|Pregnancy|0
2890205|NCT01857869|9949766|P4|Primary/Challenge Phase|Pregnancy|0
2890206|NCT01857869|9949767|P3|Primary/Challenge Phase|Pregnancy|0
2890207|NCT01857869|9949768|P2|Primary/Challenge Phase|Pregnancy|0
2890208|NCT01857869|9949769|P1|Primary/Challenge Phase|Pregnancy|1
2890209|NCT01857869|9949760|P10|Primary/Challenge Phase|Lost to Follow-up|0
2890210|NCT01857869|9949761|P9|Primary/Challenge Phase|Lost to Follow-up|0
2890211|NCT01857869|9949762|P8|Primary/Challenge Phase|Lost to Follow-up|0
2890212|NCT01857869|9949763|P7|Primary/Challenge Phase|Lost to Follow-up|0
2890213|NCT01857869|9949764|P6|Primary/Challenge Phase|Lost to Follow-up|0
2890214|NCT01857869|9949765|P5|Primary/Challenge Phase|Lost to Follow-up|0
2890215|NCT01857869|9949766|P4|Primary/Challenge Phase|Lost to Follow-up|0
2890216|NCT01857869|9949767|P3|Primary/Challenge Phase|Lost to Follow-up|0
2890217|NCT01857869|9949768|P2|Primary/Challenge Phase|Lost to Follow-up|0
2890218|NCT01857869|9949769|P1|Primary/Challenge Phase|Lost to Follow-up|2
2890219|NCT01857622|9949859|P3|Overall Study|Withdrawal by Subject|0
2890220|NCT01857622|9949860|P2|Overall Study|Withdrawal by Subject|0
2890221|NCT01857622|9949861|P1|Overall Study|Withdrawal by Subject|1
2890222|NCT01857622|9949859|P3|Overall Study|Protocol Violation|0
2890223|NCT01857622|9949860|P2|Overall Study|Protocol Violation|1
2890224|NCT01857622|9949861|P1|Overall Study|Protocol Violation|4
2890225|NCT01857622|9949859|P3|Overall Study|Physician Decision|0
2890226|NCT01857622|9949860|P2|Overall Study|Physician Decision|0
2890227|NCT01857622|9949861|P1|Overall Study|Physician Decision|1
2890228|NCT01857622|9949859|P3|Overall Study|Adverse Event|2
2890229|NCT01857622|9949860|P2|Overall Study|Adverse Event|0
2890230|NCT01857622|9949861|P1|Overall Study|Adverse Event|5
2890231|NCT01857583|9949873|P4|Overall Study|Withdrawal by Subject|2
2890232|NCT01857583|9949874|P3|Overall Study|Withdrawal by Subject|1
2890233|NCT01857583|9949875|P2|Overall Study|Withdrawal by Subject|0
2890234|NCT01857583|9949876|P1|Overall Study|Withdrawal by Subject|1
2890235|NCT01857583|9949873|P4|Overall Study|Physician Decision|1
2890236|NCT01857583|9949874|P3|Overall Study|Physician Decision|0
2890237|NCT01857583|9949875|P2|Overall Study|Physician Decision|0
2890238|NCT01857583|9949876|P1|Overall Study|Physician Decision|0
2890239|NCT01857583|9949873|P4|Overall Study|Death|0
2890240|NCT01857583|9949874|P3|Overall Study|Death|1
2890241|NCT01857583|9949875|P2|Overall Study|Death|1
2890242|NCT01857583|9949876|P1|Overall Study|Death|0
2890243|NCT01857583|9949873|P4|Overall Study|Adverse Event|1
2890244|NCT01857583|9949874|P3|Overall Study|Adverse Event|1
2890245|NCT01857583|9949875|P2|Overall Study|Adverse Event|0
2890246|NCT01857583|9949876|P1|Overall Study|Adverse Event|0
2890247|NCT01857531|9949886|P1|Overall Study|Withdrawal by Subject|4
2890248|NCT01857323|9949904|P1|Overall Study|Did not complete 180 doses|48
2890249|NCT01857323|9949904|P1|Overall Study|Other|4
2890250|NCT01857323|9949904|P1|Overall Study|Lost to Follow-up|1
2890251|NCT01857323|9949904|P1|Overall Study|Protocol Violation|6
2890252|NCT01857323|9949904|P1|Overall Study|Non-compliance|1
2890253|NCT01857323|9949904|P1|Overall Study|Withdrawal by Subject|3
2890254|NCT01857323|9949904|P1|Overall Study|Adverse Event|1
2890255|NCT01857206|9949979|P2|Overall Study|Withdrawal by Subject|0
2890256|NCT01857206|9949980|P1|Overall Study|Withdrawal by Subject|1
2890257|NCT01857206|9949979|P2|Overall Study|Unclassified|3
2890258|NCT01857206|9949980|P1|Overall Study|Unclassified|3
2890259|NCT01857206|9949979|P2|Overall Study|Lost to Follow-up|6
2890260|NCT01857206|9949980|P1|Overall Study|Lost to Follow-up|9
2890261|NCT01857206|9949979|P2|Overall Study|ADMINISTRATIVE REASON|1
2890262|NCT01857206|9949980|P1|Overall Study|ADMINISTRATIVE REASON|0
2890263|NCT01857102|9949998|P2|Period 2|Unsatisfactory Lens Fit|0
2890264|NCT01857102|9949999|P1|Period 2|Unsatisfactory Lens Fit|1
2890265|NCT01857102|9949998|P2|Period 2|Lens Discomfort|0
2890266|NCT01857102|9949999|P1|Period 2|Lens Discomfort|1
2890267|NCT01857102|9949998|P2|Period 1|Physician Decision|0
2890268|NCT01857102|9949999|P1|Period 1|Physician Decision|1
2890269|NCT01857102|9949998|P2|Period 1|Unsatisfactory Visual Response|0
2890270|NCT01857102|9949999|P1|Period 1|Unsatisfactory Visual Response|1
2890271|NCT01857102|9949998|P2|Period 1|Unsatisfactory Lens Fit|0
2890272|NCT01857102|9949999|P1|Period 1|Unsatisfactory Lens Fit|1
2890273|NCT01857102|9949998|P2|Period 1|Lost to Follow-up|3
2890274|NCT01857102|9949999|P1|Period 1|Lost to Follow-up|0
2890275|NCT01857102|9949998|P2|Period 1|No longer meets Eligibility Criteria|2
2890276|NCT01857102|9949999|P1|Period 1|No longer meets Eligibility Criteria|0
2890277|NCT01857063|9950009|P2|Period 2 (7 Days)|Withdrawal by Subject|0
2890278|NCT01857063|9950010|P1|Period 2 (7 Days)|Withdrawal by Subject|1
2890279|NCT01857063|9950009|P2|Period 2 (7 Days)|Physician Decision|1
2890280|NCT01857063|9950010|P1|Period 2 (7 Days)|Physician Decision|1
2890281|NCT01857063|9950009|P2|Period 2 (7 Days)|Adverse Event|1
2890282|NCT01857063|9950010|P1|Period 2 (7 Days)|Adverse Event|2
2890283|NCT01857063|9950009|P2|Period 1 (7 Days)|Withdrawal by Subject|3
2890284|NCT01857063|9950010|P1|Period 1 (7 Days)|Withdrawal by Subject|1
2890285|NCT01857063|9950009|P2|Period 1 (7 Days)|Physician Decision|0
2890286|NCT01857063|9950010|P1|Period 1 (7 Days)|Physician Decision|1
2890287|NCT01857063|9950009|P2|Period 1 (7 Days)|Adverse Event|1
2890288|NCT01857063|9950010|P1|Period 1 (7 Days)|Adverse Event|0
2890289|NCT01856907|9950044|P3|Overall Study|Withdrawal by Subject|0
2890290|NCT01856907|9950045|P2|Overall Study|Withdrawal by Subject|1
2890291|NCT01856907|9950046|P1|Overall Study|Withdrawal by Subject|0
2890292|NCT01856907|9950044|P3|Overall Study|Pregnancy|0
2890293|NCT01856907|9950045|P2|Overall Study|Pregnancy|1
2890294|NCT01856907|9950046|P1|Overall Study|Pregnancy|0
2890295|NCT01856907|9950044|P3|Overall Study|Pregnancy|0
2890296|NCT01856907|9950045|P2|Overall Study|Pregnancy|1
2890297|NCT01856907|9950046|P1|Overall Study|Pregnancy|0
2890298|NCT01856790|9950084|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
2890299|NCT01856790|9950084|P1|Closed Loop Control|Withdrawal by Subject|2
2890300|NCT01856686|9950138|P2|Overall Study|Lost to Follow-up|11
2890301|NCT01856686|9950139|P1|Overall Study|Lost to Follow-up|5
2890302|NCT01856673|9950182|P3|Overall Study|Protocol Violation|1
2890303|NCT01856673|9950183|P2|Overall Study|Protocol Violation|0
2890304|NCT01856673|9950184|P1|Overall Study|Protocol Violation|1
2890305|NCT01856673|9950182|P3|Overall Study|Death|0
2890306|NCT01856673|9950183|P2|Overall Study|Death|1
2890307|NCT01856673|9950184|P1|Overall Study|Death|2
2890308|NCT01856673|9950182|P3|Overall Study|Paperwork errors|0
2890309|NCT01856673|9950183|P2|Overall Study|Paperwork errors|0
2890310|NCT01856673|9950184|P1|Overall Study|Paperwork errors|4
2890311|NCT01856673|9950182|P3|Overall Study|Psychologist decision|0
2890312|NCT01856673|9950183|P2|Overall Study|Psychologist decision|0
2890313|NCT01856673|9950184|P1|Overall Study|Psychologist decision|3
2890314|NCT01856673|9950182|P3|Overall Study|Unknown reasons|0
2890315|NCT01856673|9950183|P2|Overall Study|Unknown reasons|0
2890316|NCT01856673|9950184|P1|Overall Study|Unknown reasons|20
2890317|NCT01856673|9950182|P3|Overall Study|Lost to Follow-up|0
2890318|NCT01856673|9950183|P2|Overall Study|Lost to Follow-up|34
2890319|NCT01856673|9950184|P1|Overall Study|Lost to Follow-up|22
2890320|NCT01856673|9950182|P3|Overall Study|Withdrawal by Subject|33
2890321|NCT01856673|9950183|P2|Overall Study|Withdrawal by Subject|50
2890322|NCT01856673|9950184|P1|Overall Study|Withdrawal by Subject|46
2890323|NCT01856595|9950204|P9|Overall Study|Withdrawal by Subject|0
2890324|NCT01856595|9950205|P8|Overall Study|Withdrawal by Subject|0
2890325|NCT01856595|9950206|P7|Overall Study|Withdrawal by Subject|1
2890326|NCT01856595|9950207|P6|Overall Study|Withdrawal by Subject|0
2890327|NCT01856595|9950208|P5|Overall Study|Withdrawal by Subject|0
2890328|NCT01856595|9950209|P4|Overall Study|Withdrawal by Subject|0
2890329|NCT01856595|9950210|P3|Overall Study|Withdrawal by Subject|0
2890330|NCT01856595|9950211|P2|Overall Study|Withdrawal by Subject|1
2890331|NCT01856595|9950212|P1|Overall Study|Withdrawal by Subject|0
2890332|NCT01856582|9950445|P1|Overall Study|Died prior to Boost infusion|1
2890333|NCT01856569|9950449|P1|Overall Study|Did not met inclusion criteria|8
2890334|NCT01856569|9950449|P1|Overall Study|Lost to Follow-up|3
2890335|NCT01856569|9950449|P1|Overall Study|Changed Site/Structure|1
2890336|NCT01856569|9950449|P1|Overall Study|Other|1
2890337|NCT01856543|9950460|P2|Overall Study|Withdrawn before start|3
2890338|NCT01856543|9950461|P1|Overall Study|Withdrawn before start|7
2890339|NCT01856543|9950460|P2|Overall Study|Treatment discontinued|3
2890340|NCT01856543|9950461|P1|Overall Study|Treatment discontinued|6
2890341|NCT01856322|9950519|P3|Overall Study|off study due to lack of accrual|3
2890342|NCT01856322|9950520|P2|Overall Study|off study due to lack of accrual|0
2890343|NCT01856322|9950521|P1|Overall Study|off study due to lack of accrual|0
2890344|NCT01856309|9950532|P4|Overall Study|Noncompliance With Study Drug|1
2890345|NCT01856309|9950533|P3|Overall Study|Noncompliance With Study Drug|4
2890346|NCT01856309|9950534|P2|Overall Study|Noncompliance With Study Drug|1
2890347|NCT01856309|9950535|P1|Overall Study|Noncompliance With Study Drug|0
2890348|NCT01856309|9950532|P4|Overall Study|Physician Decision|8
2890349|NCT01856309|9950533|P3|Overall Study|Physician Decision|6
2890350|NCT01856309|9950534|P2|Overall Study|Physician Decision|1
2890351|NCT01856309|9950535|P1|Overall Study|Physician Decision|6
2890352|NCT01856309|9950532|P4|Overall Study|Pregnancy|1
2890353|NCT01856309|9950533|P3|Overall Study|Pregnancy|0
2890354|NCT01856309|9950534|P2|Overall Study|Pregnancy|0
2890355|NCT01856309|9950535|P1|Overall Study|Pregnancy|0
2890356|NCT01856309|9950532|P4|Overall Study|Adverse Event|65
2890357|NCT01856309|9950533|P3|Overall Study|Adverse Event|55
2890358|NCT01856309|9950534|P2|Overall Study|Adverse Event|31
2890359|NCT01856309|9950535|P1|Overall Study|Adverse Event|31
2890360|NCT01856309|9950532|P4|Overall Study|Lack of Efficacy|25
2890361|NCT01856309|9950533|P3|Overall Study|Lack of Efficacy|40
2890362|NCT01856309|9950534|P2|Overall Study|Lack of Efficacy|9
2890363|NCT01856309|9950535|P1|Overall Study|Lack of Efficacy|14
2890364|NCT01856309|9950532|P4|Overall Study|Other|469
2890365|NCT01856309|9950533|P3|Overall Study|Other|447
2890366|NCT01856309|9950534|P2|Overall Study|Other|225
2890367|NCT01856309|9950535|P1|Overall Study|Other|227
2890368|NCT01856309|9950532|P4|Overall Study|Withdrawal by Subject|26
2890369|NCT01856309|9950533|P3|Overall Study|Withdrawal by Subject|28
2890370|NCT01856309|9950534|P2|Overall Study|Withdrawal by Subject|13
2890371|NCT01856309|9950535|P1|Overall Study|Withdrawal by Subject|11
2890372|NCT01856309|9950532|P4|Overall Study|Lost to Follow-up|8
2890373|NCT01856309|9950533|P3|Overall Study|Lost to Follow-up|4
2890374|NCT01856309|9950534|P2|Overall Study|Lost to Follow-up|2
2890375|NCT01856309|9950535|P1|Overall Study|Lost to Follow-up|6
2890376|NCT01856309|9950532|P4|Overall Study|Death|6
2890377|NCT01856309|9950533|P3|Overall Study|Death|11
2890378|NCT01856309|9950534|P2|Overall Study|Death|6
2890379|NCT01856309|9950535|P1|Overall Study|Death|4
2890380|NCT01856257|9950659|P4|Overall Study|Donor complication|1
2890381|NCT01856257|9950660|P3|Overall Study|Donor complication|0
2890382|NCT01856257|9950661|P2|Overall Study|Donor complication|0
2890383|NCT01856257|9950662|P1|Overall Study|Donor complication|0
2890384|NCT01856257|9950659|P4|Overall Study|Withdrawal by Subject|0
2890385|NCT01856257|9950660|P3|Overall Study|Withdrawal by Subject|0
2890386|NCT01856257|9950661|P2|Overall Study|Withdrawal by Subject|1
2890387|NCT01856257|9950662|P1|Overall Study|Withdrawal by Subject|1
2890388|NCT01856257|9950659|P4|Overall Study|Physician Decision|1
2890389|NCT01856257|9950660|P3|Overall Study|Physician Decision|0
2890390|NCT01856257|9950661|P2|Overall Study|Physician Decision|0
2890391|NCT01856257|9950662|P1|Overall Study|Physician Decision|0
2890392|NCT01856257|9950659|P4|Overall Study|Death|0
2890393|NCT01856257|9950660|P3|Overall Study|Death|0
2890394|NCT01856257|9950661|P2|Overall Study|Death|0
2890395|NCT01856257|9950662|P1|Overall Study|Death|2
2890396|NCT01855958|9950830|P2|Overall Study|Withdrawal by Subject|0
2890397|NCT01855958|9950831|P1|Overall Study|Withdrawal by Subject|1
2890398|NCT01855945|9950861|P12|Overall Study|Withdrawal by Subject|1
2890399|NCT01855945|9950862|P11|Overall Study|Withdrawal by Subject|4
2890400|NCT01855945|9950863|P10|Overall Study|Withdrawal by Subject|2
2890401|NCT01855945|9950864|P9|Overall Study|Withdrawal by Subject|0
2890402|NCT01855945|9950865|P8|Overall Study|Withdrawal by Subject|0
2890403|NCT01855945|9950866|P7|Overall Study|Withdrawal by Subject|1
2890404|NCT01855945|9950867|P6|Overall Study|Withdrawal by Subject|0
2890405|NCT01855945|9950868|P5|Overall Study|Withdrawal by Subject|1
2890406|NCT01855945|9950869|P4|Overall Study|Withdrawal by Subject|1
2890407|NCT01855945|9950870|P3|Overall Study|Withdrawal by Subject|4
2890408|NCT01855945|9950871|P2|Overall Study|Withdrawal by Subject|0
2890409|NCT01855945|9950872|P1|Overall Study|Withdrawal by Subject|4
2890410|NCT01855945|9950861|P12|Overall Study|Other - Unclassified|0
2890411|NCT01855945|9950862|P11|Overall Study|Other - Unclassified|1
2890412|NCT01855945|9950863|P10|Overall Study|Other - Unclassified|0
2890413|NCT01855945|9950864|P9|Overall Study|Other - Unclassified|0
2890414|NCT01855945|9950865|P8|Overall Study|Other - Unclassified|1
2890415|NCT01855945|9950866|P7|Overall Study|Other - Unclassified|2
2890416|NCT01855945|9950867|P6|Overall Study|Other - Unclassified|0
2890417|NCT01855945|9950868|P5|Overall Study|Other - Unclassified|0
2890418|NCT01855945|9950869|P4|Overall Study|Other - Unclassified|0
2890419|NCT01855945|9950870|P3|Overall Study|Other - Unclassified|1
2890420|NCT01855945|9950871|P2|Overall Study|Other - Unclassified|1
2890421|NCT01855945|9950872|P1|Overall Study|Other - Unclassified|1
2890422|NCT01855945|9950861|P12|Overall Study|Lost to Follow-up|2
2890423|NCT01855945|9950862|P11|Overall Study|Lost to Follow-up|0
2890424|NCT01855945|9950863|P10|Overall Study|Lost to Follow-up|0
2890425|NCT01855945|9950864|P9|Overall Study|Lost to Follow-up|2
2890426|NCT01855945|9950865|P8|Overall Study|Lost to Follow-up|7
2890427|NCT01855945|9950866|P7|Overall Study|Lost to Follow-up|4
2890428|NCT01855945|9950867|P6|Overall Study|Lost to Follow-up|3
2890429|NCT01855945|9950868|P5|Overall Study|Lost to Follow-up|0
2890430|NCT01855945|9950869|P4|Overall Study|Lost to Follow-up|3
2890431|NCT01855945|9950870|P3|Overall Study|Lost to Follow-up|7
2890432|NCT01855945|9950871|P2|Overall Study|Lost to Follow-up|10
2890433|NCT01855945|9950872|P1|Overall Study|Lost to Follow-up|11
2890434|NCT01855945|9950861|P12|Overall Study|Death|0
2890435|NCT01855945|9950862|P11|Overall Study|Death|0
2890436|NCT01855945|9950863|P10|Overall Study|Death|0
2890437|NCT01855945|9950864|P9|Overall Study|Death|0
2890438|NCT01855945|9950865|P8|Overall Study|Death|0
2890439|NCT01855945|9950866|P7|Overall Study|Death|2
2890440|NCT01855945|9950867|P6|Overall Study|Death|0
2890441|NCT01855945|9950868|P5|Overall Study|Death|0
2890442|NCT01855945|9950869|P4|Overall Study|Death|0
2890443|NCT01855945|9950870|P3|Overall Study|Death|0
2890444|NCT01855945|9950871|P2|Overall Study|Death|0
2890445|NCT01855945|9950872|P1|Overall Study|Death|0
2890446|NCT01855945|9950861|P12|Overall Study|Adverse Event|0
2890447|NCT01855945|9950862|P11|Overall Study|Adverse Event|0
2890448|NCT01855945|9950863|P10|Overall Study|Adverse Event|0
2890449|NCT01855945|9950864|P9|Overall Study|Adverse Event|0
2890450|NCT01855945|9950865|P8|Overall Study|Adverse Event|0
2890451|NCT01855945|9950866|P7|Overall Study|Adverse Event|1
2890452|NCT01855945|9950867|P6|Overall Study|Adverse Event|0
2890453|NCT01855945|9950868|P5|Overall Study|Adverse Event|0
2890454|NCT01855945|9950869|P4|Overall Study|Adverse Event|0
2890455|NCT01855945|9950870|P3|Overall Study|Adverse Event|0
2890456|NCT01855945|9950871|P2|Overall Study|Adverse Event|0
2890457|NCT01855945|9950872|P1|Overall Study|Adverse Event|0
2890458|NCT01855919|9951008|P2|Overall Study|Protocol Violation|4
2890459|NCT01855919|9951009|P1|Overall Study|Protocol Violation|1
2890460|NCT01855919|9951008|P2|Overall Study|Entry Criteria Not Met|1
2890461|NCT01855919|9951009|P1|Overall Study|Entry Criteria Not Met|1
2890462|NCT01855919|9951008|P2|Overall Study|Withdrawal by Subject|10
2890463|NCT01855919|9951009|P1|Overall Study|Withdrawal by Subject|4
2890464|NCT01855919|9951008|P2|Overall Study|Lack of Efficacy|3
2890465|NCT01855919|9951009|P1|Overall Study|Lack of Efficacy|1
2890466|NCT01855919|9951008|P2|Overall Study|Adverse Event|8
2890467|NCT01855919|9951009|P1|Overall Study|Adverse Event|16
2890468|NCT01855828|9951041|P1|Overall Study|Withdrawal by Subject|1
2890469|NCT01855828|9951041|P1|Overall Study|Adverse Event|1
2890470|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Other|1
2890471|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Other|0
2890472|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Other|0
2890473|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Other|0
2890474|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Sponsor Decision|1
2890475|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Sponsor Decision|0
2890476|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Sponsor Decision|0
2890477|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Sponsor Decision|0
2890478|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
2890479|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
2890480|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
2890481|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
2890482|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Physician Decision|4
2890483|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Physician Decision|2
2890484|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Physician Decision|0
2890485|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Physician Decision|0
2890486|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
2890487|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
2890488|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
2890489|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
2890490|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Protocol Violation|1
2890491|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Protocol Violation|0
2890492|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Protocol Violation|0
2890493|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Protocol Violation|0
2890494|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
2890495|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
2890496|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
2890497|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
2890498|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
2890499|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
2890500|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
2890501|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
2890502|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
2890503|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2890504|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2890505|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2890506|NCT01855789|9951051|P4|2) Week 24 up to End of Study|Adverse Event|21
2890507|NCT01855789|9951052|P3|2) Week 24 up to End of Study|Adverse Event|5
2890508|NCT01855789|9951053|P2|2) Week 24 up to End of Study|Adverse Event|4
2890509|NCT01855789|9951054|P1|2) Week 24 up to End of Study|Adverse Event|0
2890510|NCT01855789|9951051|P4|1) Baseline up to Week 24|Other|0
2890511|NCT01855789|9951052|P3|1) Baseline up to Week 24|Other|0
2890512|NCT01855789|9951053|P2|1) Baseline up to Week 24|Other|0
2890513|NCT01855789|9951054|P1|1) Baseline up to Week 24|Other|4
2890514|NCT01855789|9951051|P4|1) Baseline up to Week 24|Sponsor Decision|0
2890515|NCT01855789|9951052|P3|1) Baseline up to Week 24|Sponsor Decision|0
2890516|NCT01855789|9951053|P2|1) Baseline up to Week 24|Sponsor Decision|0
2890517|NCT01855789|9951054|P1|1) Baseline up to Week 24|Sponsor Decision|3
2890518|NCT01855789|9951051|P4|1) Baseline up to Week 24|Participant Non-compliance|0
2890519|NCT01855789|9951052|P3|1) Baseline up to Week 24|Participant Non-compliance|0
2890520|NCT01855789|9951053|P2|1) Baseline up to Week 24|Participant Non-compliance|0
2890521|NCT01855789|9951054|P1|1) Baseline up to Week 24|Participant Non-compliance|3
2890522|NCT01855789|9951051|P4|1) Baseline up to Week 24|Pregnancy|0
2890523|NCT01855789|9951052|P3|1) Baseline up to Week 24|Pregnancy|0
2890524|NCT01855789|9951053|P2|1) Baseline up to Week 24|Pregnancy|0
2890525|NCT01855789|9951054|P1|1) Baseline up to Week 24|Pregnancy|1
2890526|NCT01855789|9951051|P4|1) Baseline up to Week 24|Physician Decision|0
2890527|NCT01855789|9951052|P3|1) Baseline up to Week 24|Physician Decision|0
2890528|NCT01855789|9951053|P2|1) Baseline up to Week 24|Physician Decision|0
2890529|NCT01855789|9951054|P1|1) Baseline up to Week 24|Physician Decision|4
2890530|NCT01855789|9951051|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
2890616|NCT01854697|9951276|P1|Overall Study|Other|0
2890531|NCT01855789|9951052|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
2890532|NCT01855789|9951053|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
2890533|NCT01855789|9951054|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
2890534|NCT01855789|9951051|P4|1) Baseline up to Week 24|Protocol Violation|0
2890535|NCT01855789|9951052|P3|1) Baseline up to Week 24|Protocol Violation|0
2890536|NCT01855789|9951053|P2|1) Baseline up to Week 24|Protocol Violation|0
2890537|NCT01855789|9951054|P1|1) Baseline up to Week 24|Protocol Violation|4
2890538|NCT01855789|9951051|P4|1) Baseline up to Week 24|Lost to Follow-up|0
2890539|NCT01855789|9951052|P3|1) Baseline up to Week 24|Lost to Follow-up|0
2890540|NCT01855789|9951053|P2|1) Baseline up to Week 24|Lost to Follow-up|0
2890541|NCT01855789|9951054|P1|1) Baseline up to Week 24|Lost to Follow-up|11
2890542|NCT01855789|9951051|P4|1) Baseline up to Week 24|Lack of Efficacy|0
2890543|NCT01855789|9951052|P3|1) Baseline up to Week 24|Lack of Efficacy|0
2890544|NCT01855789|9951053|P2|1) Baseline up to Week 24|Lack of Efficacy|0
2890545|NCT01855789|9951054|P1|1) Baseline up to Week 24|Lack of Efficacy|16
2890546|NCT01855789|9951051|P4|1) Baseline up to Week 24|Death|0
2890547|NCT01855789|9951052|P3|1) Baseline up to Week 24|Death|0
2890548|NCT01855789|9951053|P2|1) Baseline up to Week 24|Death|0
2890549|NCT01855789|9951054|P1|1) Baseline up to Week 24|Death|2
2890550|NCT01855789|9951051|P4|1) Baseline up to Week 24|Adverse Event|0
2890551|NCT01855789|9951052|P3|1) Baseline up to Week 24|Adverse Event|0
2890552|NCT01855789|9951053|P2|1) Baseline up to Week 24|Adverse Event|0
2890553|NCT01855789|9951054|P1|1) Baseline up to Week 24|Adverse Event|37
2890554|NCT01855750|9951078|P2|Overall Study|Sponsor ends the study|290
2890555|NCT01855750|9951079|P1|Overall Study|Sponsor ends the study|297
2890556|NCT01855750|9951078|P2|Overall Study|Withdrawal by Subject|28
2890557|NCT01855750|9951079|P1|Overall Study|Withdrawal by Subject|35
2890558|NCT01855750|9951078|P2|Overall Study|Lost to Follow-up|23
2890559|NCT01855750|9951079|P1|Overall Study|Lost to Follow-up|9
2890560|NCT01855750|9951078|P2|Overall Study|Death|78
2890561|NCT01855750|9951079|P1|Overall Study|Death|78
2890562|NCT01855425|9951095|P1|Overall Study|Physician Decision|20
2890563|NCT01855399|9951101|P2|12 Month|Lost to Follow-up|11
2890564|NCT01855399|9951102|P1|12 Month|Lost to Follow-up|7
2890565|NCT01855399|9951101|P2|6 Month|Withdrawal by Subject|6
2890566|NCT01855399|9951102|P1|6 Month|Withdrawal by Subject|8
2890567|NCT01855399|9951101|P2|6 Month|Lost to Follow-up|9
2890568|NCT01855399|9951102|P1|6 Month|Lost to Follow-up|12
2890569|NCT01855243|9951111|P3|Overall Study|develpoed diabetic ketoacidosis|0
2890570|NCT01855243|9951112|P2|Overall Study|develpoed diabetic ketoacidosis|0
2890571|NCT01855243|9951113|P1|Overall Study|develpoed diabetic ketoacidosis|1
2890572|NCT01855126|9951135|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2890573|NCT01855126|9951136|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2890574|NCT01855126|9951135|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
2890575|NCT01855126|9951136|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
2890576|NCT01855074|9951148|P1|Overall Study|Started but not treated|1
2890577|NCT01855074|9951148|P1|Overall Study|Withdrawal by Subject|8
2890578|NCT01855074|9951148|P1|Overall Study|Lost to Follow-up|4
2890579|NCT01855074|9951148|P1|Overall Study|Adverse Event|1
2890580|NCT01854944|9951160|P3|Overall Study|Withdrawal by Subject|1
2890581|NCT01854944|9951161|P2|Overall Study|Withdrawal by Subject|0
2890582|NCT01854944|9951162|P1|Overall Study|Withdrawal by Subject|0
2890583|NCT01854918|9951214|P2|All-IP Period (Years 2 and 3)|Death|16
2890584|NCT01854918|9951215|P1|All-IP Period (Years 2 and 3)|Death|5
2890585|NCT01854918|9951214|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
2890586|NCT01854918|9951215|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
2890587|NCT01854918|9951214|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
2890588|NCT01854918|9951215|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
2890589|NCT01854918|9951214|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
2890590|NCT01854918|9951215|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
2890591|NCT01854918|9951214|P2|SOC-controlled Period (Year 1)|Death|5
2890592|NCT01854918|9951215|P1|SOC-controlled Period (Year 1)|Death|5
2890593|NCT01854918|9951214|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
2890594|NCT01854918|9951215|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
2890595|NCT01854918|9951214|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
2890596|NCT01854918|9951215|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
2890597|NCT01854918|9951214|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
2890598|NCT01854918|9951215|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
2890599|NCT01854827|9951234|P1|Overall Study|Death|1
2890600|NCT01854710|9951246|P6|Overall Study|CRI procedural error|2
2890601|NCT01854710|9951247|P5|Overall Study|CRI procedural error|2
2890602|NCT01854710|9951248|P4|Overall Study|CRI procedural error|2
2890603|NCT01854710|9951249|P3|Overall Study|CRI procedural error|2
2890604|NCT01854710|9951250|P2|Overall Study|CRI procedural error|2
2890605|NCT01854710|9951251|P1|Overall Study|CRI procedural error|2
2890606|NCT01854710|9951246|P6|Overall Study|Withdrawal by Subject|0
2890607|NCT01854710|9951247|P5|Overall Study|Withdrawal by Subject|0
2890608|NCT01854710|9951248|P4|Overall Study|Withdrawal by Subject|0
2890609|NCT01854710|9951249|P3|Overall Study|Withdrawal by Subject|0
2890610|NCT01854710|9951250|P2|Overall Study|Withdrawal by Subject|1
2890611|NCT01854710|9951251|P1|Overall Study|Withdrawal by Subject|2
2890612|NCT01854697|9951272|P5|Overall Study|Other|0
2890613|NCT01854697|9951273|P4|Overall Study|Other|0
2890614|NCT01854697|9951274|P3|Overall Study|Other|1
2890615|NCT01854697|9951275|P2|Overall Study|Other|1
2890617|NCT01854697|9951272|P5|Overall Study|Withdrew Consent|0
2890618|NCT01854697|9951273|P4|Overall Study|Withdrew Consent|1
2890619|NCT01854697|9951274|P3|Overall Study|Withdrew Consent|0
2890620|NCT01854697|9951275|P2|Overall Study|Withdrew Consent|1
2890621|NCT01854697|9951276|P1|Overall Study|Withdrew Consent|0
2890622|NCT01854697|9951272|P5|Overall Study|To enter another AbbVie study|1
2890623|NCT01854697|9951273|P4|Overall Study|To enter another AbbVie study|0
2890624|NCT01854697|9951274|P3|Overall Study|To enter another AbbVie study|0
2890625|NCT01854697|9951275|P2|Overall Study|To enter another AbbVie study|0
2890626|NCT01854697|9951276|P1|Overall Study|To enter another AbbVie study|1
2890627|NCT01854697|9951272|P5|Overall Study|Lost to Follow-up|0
2890628|NCT01854697|9951273|P4|Overall Study|Lost to Follow-up|2
2890629|NCT01854697|9951274|P3|Overall Study|Lost to Follow-up|1
2890630|NCT01854697|9951275|P2|Overall Study|Lost to Follow-up|1
2890631|NCT01854697|9951276|P1|Overall Study|Lost to Follow-up|4
2890632|NCT01854697|9951272|P5|Overall Study|Adverse Event|1
2890633|NCT01854697|9951273|P4|Overall Study|Adverse Event|0
2890634|NCT01854697|9951274|P3|Overall Study|Adverse Event|0
2890635|NCT01854697|9951275|P2|Overall Study|Adverse Event|0
2890636|NCT01854697|9951276|P1|Overall Study|Adverse Event|1
2890637|NCT01854658|9951320|P4|Overall Study|Administrative reasons|2
2890638|NCT01854658|9951321|P3|Overall Study|Administrative reasons|2
2890639|NCT01854658|9951322|P2|Overall Study|Administrative reasons|1
2890640|NCT01854658|9951323|P1|Overall Study|Administrative reasons|5
2890641|NCT01854658|9951320|P4|Overall Study|Adverse Event|19
2890642|NCT01854658|9951321|P3|Overall Study|Adverse Event|23
2890643|NCT01854658|9951322|P2|Overall Study|Adverse Event|14
2890644|NCT01854658|9951323|P1|Overall Study|Adverse Event|21
2890645|NCT01854658|9951320|P4|Overall Study|Lack of Efficacy|7
2890646|NCT01854658|9951321|P3|Overall Study|Lack of Efficacy|4
2890647|NCT01854658|9951322|P2|Overall Study|Lack of Efficacy|8
2890648|NCT01854658|9951323|P1|Overall Study|Lack of Efficacy|3
2890649|NCT01854658|9951320|P4|Overall Study|Protocol-specified criteria|7
2890650|NCT01854658|9951321|P3|Overall Study|Protocol-specified criteria|10
2890651|NCT01854658|9951322|P2|Overall Study|Protocol-specified criteria|15
2890652|NCT01854658|9951323|P1|Overall Study|Protocol-specified criteria|15
2890653|NCT01854658|9951320|P4|Overall Study|Withdrawal by Subject|15
2890654|NCT01854658|9951321|P3|Overall Study|Withdrawal by Subject|29
2890655|NCT01854658|9951322|P2|Overall Study|Withdrawal by Subject|21
2890656|NCT01854658|9951323|P1|Overall Study|Withdrawal by Subject|28
2890657|NCT01854658|9951320|P4|Overall Study|Lost to Follow-up|4
2890658|NCT01854658|9951321|P3|Overall Study|Lost to Follow-up|8
2890659|NCT01854658|9951322|P2|Overall Study|Lost to Follow-up|9
2890660|NCT01854658|9951323|P1|Overall Study|Lost to Follow-up|8
2890661|NCT01854658|9951320|P4|Overall Study|Physician Decision|4
2890662|NCT01854658|9951321|P3|Overall Study|Physician Decision|2
2890663|NCT01854658|9951322|P2|Overall Study|Physician Decision|5
2890664|NCT01854658|9951323|P1|Overall Study|Physician Decision|7
2890665|NCT01854658|9951320|P4|Overall Study|Protocol Violation|1
2890666|NCT01854658|9951321|P3|Overall Study|Protocol Violation|2
2890667|NCT01854658|9951322|P2|Overall Study|Protocol Violation|2
2890668|NCT01854658|9951323|P1|Overall Study|Protocol Violation|6
2890669|NCT01854645|9951358|P5|Overall Study|Adverse Event|11
2890670|NCT01854645|9951359|P4|Overall Study|Adverse Event|20
2890671|NCT01854645|9951360|P3|Overall Study|Adverse Event|19
2890672|NCT01854645|9951361|P2|Overall Study|Adverse Event|31
2890673|NCT01854645|9951362|P1|Overall Study|Adverse Event|33
2890674|NCT01854645|9951358|P5|Overall Study|Lack of Efficacy|9
2890675|NCT01854645|9951359|P4|Overall Study|Lack of Efficacy|3
2890676|NCT01854645|9951360|P3|Overall Study|Lack of Efficacy|9
2890677|NCT01854645|9951361|P2|Overall Study|Lack of Efficacy|12
2890678|NCT01854645|9951362|P1|Overall Study|Lack of Efficacy|7
2890679|NCT01854645|9951358|P5|Overall Study|Withdrawal by Subject|24
2890680|NCT01854645|9951359|P4|Overall Study|Withdrawal by Subject|21
2890681|NCT01854645|9951360|P3|Overall Study|Withdrawal by Subject|30
2890682|NCT01854645|9951361|P2|Overall Study|Withdrawal by Subject|41
2890683|NCT01854645|9951362|P1|Overall Study|Withdrawal by Subject|31
2890684|NCT01854645|9951358|P5|Overall Study|Physician Decision|7
2890685|NCT01854645|9951359|P4|Overall Study|Physician Decision|3
2890686|NCT01854645|9951360|P3|Overall Study|Physician Decision|3
2890687|NCT01854645|9951361|P2|Overall Study|Physician Decision|5
2890688|NCT01854645|9951362|P1|Overall Study|Physician Decision|1
2890689|NCT01854645|9951358|P5|Overall Study|Lost to Follow-up|0
2890690|NCT01854645|9951359|P4|Overall Study|Lost to Follow-up|5
2890691|NCT01854645|9951360|P3|Overall Study|Lost to Follow-up|8
2890692|NCT01854645|9951361|P2|Overall Study|Lost to Follow-up|7
2890693|NCT01854645|9951362|P1|Overall Study|Lost to Follow-up|10
2890694|NCT01854645|9951358|P5|Overall Study|Protocol Violation|1
2890695|NCT01854645|9951359|P4|Overall Study|Protocol Violation|4
2890696|NCT01854645|9951360|P3|Overall Study|Protocol Violation|5
2890697|NCT01854645|9951361|P2|Overall Study|Protocol Violation|0
2890698|NCT01854645|9951362|P1|Overall Study|Protocol Violation|3
2890699|NCT01854645|9951358|P5|Overall Study|Administrative Reasons / Missing|1
2890700|NCT01854645|9951359|P4|Overall Study|Administrative Reasons / Missing|1
2890701|NCT01854645|9951360|P3|Overall Study|Administrative Reasons / Missing|0
2890702|NCT01854645|9951361|P2|Overall Study|Administrative Reasons / Missing|0
2890703|NCT01854645|9951362|P1|Overall Study|Administrative Reasons / Missing|0
2890704|NCT01854645|9951358|P5|Overall Study|Protocol-Specified Criteria|7
2890705|NCT01854645|9951359|P4|Overall Study|Protocol-Specified Criteria|5
2890706|NCT01854645|9951360|P3|Overall Study|Protocol-Specified Criteria|8
2890707|NCT01854645|9951361|P2|Overall Study|Protocol-Specified Criteria|10
2890708|NCT01854645|9951362|P1|Overall Study|Protocol-Specified Criteria|13
2890709|NCT01854528|9951443|P2|Overall Study|Virologic Failure|9
2890710|NCT01854528|9951444|P1|Overall Study|Virologic Failure|0
2890711|NCT01854528|9951443|P2|Overall Study|Withdrawal by Subject|2
2890712|NCT01854528|9951444|P1|Overall Study|Withdrawal by Subject|0
2890713|NCT01854528|9951443|P2|Overall Study|Adverse Event|4
2890714|NCT01854528|9951444|P1|Overall Study|Adverse Event|0
2890715|NCT01854047|9951515|P5|Overall Study|Other than specified above|8
2890716|NCT01854047|9951516|P4|Overall Study|Other than specified above|5
2890717|NCT01854047|9951517|P3|Overall Study|Other than specified above|3
2890718|NCT01854047|9951518|P2|Overall Study|Other than specified above|3
2890719|NCT01854047|9951519|P1|Overall Study|Other than specified above|3
2890720|NCT01854047|9951515|P5|Overall Study|Randomized but not treated|4
2890721|NCT01854047|9951516|P4|Overall Study|Randomized but not treated|0
2890722|NCT01854047|9951517|P3|Overall Study|Randomized but not treated|2
2890723|NCT01854047|9951518|P2|Overall Study|Randomized but not treated|1
2890724|NCT01854047|9951519|P1|Overall Study|Randomized but not treated|0
2890725|NCT01854047|9951515|P5|Overall Study|Adverse Event|7
2890726|NCT01854047|9951516|P4|Overall Study|Adverse Event|10
2890727|NCT01854047|9951517|P3|Overall Study|Adverse Event|6
2890728|NCT01854047|9951518|P2|Overall Study|Adverse Event|4
2890729|NCT01854047|9951519|P1|Overall Study|Adverse Event|5
2890730|NCT01854047|9951515|P5|Overall Study|Poor compliance to protocol|0
2890731|NCT01854047|9951516|P4|Overall Study|Poor compliance to protocol|0
2890732|NCT01854047|9951517|P3|Overall Study|Poor compliance to protocol|2
2890733|NCT01854047|9951518|P2|Overall Study|Poor compliance to protocol|0
2890734|NCT01854047|9951519|P1|Overall Study|Poor compliance to protocol|3
2890735|NCT01854047|9951515|P5|Overall Study|Lack of Efficacy|0
2890736|NCT01854047|9951516|P4|Overall Study|Lack of Efficacy|0
2890737|NCT01854047|9951517|P3|Overall Study|Lack of Efficacy|0
2890738|NCT01854047|9951518|P2|Overall Study|Lack of Efficacy|0
2890739|NCT01854047|9951519|P1|Overall Study|Lack of Efficacy|1
2890740|NCT01853982|9951650|P2|Overall Study|Lost to Follow-up|1
2890741|NCT01853982|9951651|P1|Overall Study|Lost to Follow-up|0
2890742|NCT01853982|9951650|P2|Overall Study|Death|0
2890743|NCT01853982|9951651|P1|Overall Study|Death|1
2890744|NCT01853982|9951650|P2|Overall Study|Withdrawal by Subject|0
2890745|NCT01853982|9951651|P1|Overall Study|Withdrawal by Subject|1
2890746|NCT01853878|9951668|P2|Overall Study|Other|43
2890747|NCT01853878|9951669|P1|Overall Study|Other|55
2890748|NCT01853878|9951668|P2|Overall Study|Migrated/moved from the study area|0
2890749|NCT01853878|9951669|P1|Overall Study|Migrated/moved from the study area|1
2890750|NCT01853878|9951668|P2|Overall Study|Withdrawal by Subject|1
2890751|NCT01853878|9951669|P1|Overall Study|Withdrawal by Subject|3
2890752|NCT01853878|9951668|P2|Overall Study|Adverse Event|0
2890753|NCT01853878|9951669|P1|Overall Study|Adverse Event|2
2890754|NCT01853878|9951668|P2|Overall Study|Recurrence|0
2890755|NCT01853878|9951669|P1|Overall Study|Recurrence|2
2890756|NCT01853839|9951693|P1|Overall Study|Lost to follow-up or no valid BP measure|336
2890757|NCT01853839|9951693|P1|Overall Study|End of treatment visit too early|33
2890758|NCT01853839|9951693|P1|Overall Study|Not meet ITT population definition|58
2890759|NCT01853839|9951693|P1|Overall Study|Violated inclusion criteria|2
2890760|NCT01853696|9951726|P2|Overall Study|Lost to Follow-up|4
2890761|NCT01853696|9951727|P1|Overall Study|Lost to Follow-up|5
2890762|NCT01853696|9951726|P2|Overall Study|Withdrawal by Subject|1
2890763|NCT01853696|9951727|P1|Overall Study|Withdrawal by Subject|1
2890764|NCT01853644|9951735|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
2890765|NCT01853644|9951735|P1|Continued Treatment After First Response|Progressive Diseaes|10
2890766|NCT01853644|9951735|P1|Continued Treatment After First Response|Adverse Event|2
2890767|NCT01853644|9951735|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
2890768|NCT01853644|9951735|P1|Reached First Response/Complete 2 Cycles|Other|1
2890769|NCT01853644|9951735|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
2890770|NCT01853644|9951735|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
2890771|NCT01853644|9951735|P1|Registration and Treatment Start|Did not start treatment|1
2890772|NCT01853618|9951749|P5|Overall Study|Refused further treatment|1
2890773|NCT01853618|9951750|P4|Overall Study|Refused further treatment|0
2890774|NCT01853618|9951751|P3|Overall Study|Refused further treatment|0
2890775|NCT01853618|9951752|P2|Overall Study|Refused further treatment|0
2890776|NCT01853618|9951753|P1|Overall Study|Refused further treatment|0
2890777|NCT01853618|9951749|P5|Overall Study|Physician Decision|0
2890778|NCT01853618|9951750|P4|Overall Study|Physician Decision|0
2890779|NCT01853618|9951751|P3|Overall Study|Physician Decision|1
2890780|NCT01853618|9951752|P2|Overall Study|Physician Decision|1
2890781|NCT01853618|9951753|P1|Overall Study|Physician Decision|0
2890782|NCT01853618|9951749|P5|Overall Study|Progressive disease|2
2890783|NCT01853618|9951750|P4|Overall Study|Progressive disease|1
2890784|NCT01853618|9951751|P3|Overall Study|Progressive disease|1
2890785|NCT01853618|9951752|P2|Overall Study|Progressive disease|1
2890786|NCT01853618|9951753|P1|Overall Study|Progressive disease|1
2890787|NCT01853618|9951749|P5|Overall Study|Bile duct stent blockage/progressive dis|0
2890788|NCT01853618|9951750|P4|Overall Study|Bile duct stent blockage/progressive dis|0
2890789|NCT01853618|9951751|P3|Overall Study|Bile duct stent blockage/progressive dis|0
2890790|NCT01853618|9951752|P2|Overall Study|Bile duct stent blockage/progressive dis|0
2890791|NCT01853618|9951753|P1|Overall Study|Bile duct stent blockage/progressive dis|1
2890792|NCT01853475|9951819|P3|Overall Study|Withdrawal by Subject|0
2890793|NCT01853475|9951820|P2|Overall Study|Withdrawal by Subject|1
2890794|NCT01853475|9951821|P1|Overall Study|Withdrawal by Subject|0
2890795|NCT01853462|9951840|P2|Overall Study|Withdrawal by Subject|1
2890796|NCT01853462|9951841|P1|Overall Study|Withdrawal by Subject|1
2890797|NCT01853397|9951911|P4|Overall Study|Subject Noncompliance|1
2890798|NCT01853397|9951912|P3|Overall Study|Subject Noncompliance|0
2890799|NCT01853397|9951913|P2|Overall Study|Subject Noncompliance|0
2890800|NCT01853397|9951914|P1|Overall Study|Subject Noncompliance|0
2890801|NCT01853397|9951911|P4|Overall Study|Withdrawal by Subject|1
2890802|NCT01853397|9951912|P3|Overall Study|Withdrawal by Subject|0
2890803|NCT01853397|9951913|P2|Overall Study|Withdrawal by Subject|0
2890804|NCT01853397|9951914|P1|Overall Study|Withdrawal by Subject|0
2890805|NCT01853384|9951942|P2|Completed Follow up Visit 2|Lost to Follow-up|1
2890806|NCT01853384|9951943|P1|Completed Follow up Visit 2|Lost to Follow-up|0
2890807|NCT01853384|9951942|P2|Completed Follow up Visit 2|Death|0
2890808|NCT01853384|9951943|P1|Completed Follow up Visit 2|Death|1
2890809|NCT01853384|9951942|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
2890810|NCT01853384|9951943|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
2890811|NCT01853384|9951942|P2|Completed Follow up Visit 2|Adverse Event|0
2890812|NCT01853384|9951943|P1|Completed Follow up Visit 2|Adverse Event|1
2890813|NCT01853384|9951942|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
2890814|NCT01853384|9951943|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
2890815|NCT01853384|9951942|P2|Completed Follow up Visit 1|Early Termination|9
2890816|NCT01853384|9951943|P1|Completed Follow up Visit 1|Early Termination|13
2890817|NCT01853384|9951942|P2|Randomized|Other|3
2890818|NCT01853384|9951943|P1|Randomized|Other|3
2890819|NCT01853384|9951942|P2|Randomized|Sponsor Decision|34
2890820|NCT01853384|9951943|P1|Randomized|Sponsor Decision|47
2890821|NCT01853384|9951942|P2|Randomized|Withdrawal by Subject|3
2890822|NCT01853384|9951943|P1|Randomized|Withdrawal by Subject|5
2890823|NCT01853384|9951942|P2|Randomized|Lost to Follow-up|1
2890824|NCT01853384|9951943|P1|Randomized|Lost to Follow-up|1
2890825|NCT01853384|9951942|P2|Randomized|Death|2
2890826|NCT01853384|9951943|P1|Randomized|Death|1
2890827|NCT01853384|9951942|P2|Randomized|Adverse Event|3
2890828|NCT01853384|9951943|P1|Randomized|Adverse Event|5
2890829|NCT01853280|9951983|P2|Overall Study|Ineligible|1
2890830|NCT01853280|9951984|P1|Overall Study|Ineligible|0
2890831|NCT01853280|9951983|P2|Overall Study|Withdrawal by Subject|1
2890832|NCT01853280|9951984|P1|Overall Study|Withdrawal by Subject|0
2890833|NCT01853280|9951983|P2|Overall Study|Physician Decision|1
2890834|NCT01853280|9951984|P1|Overall Study|Physician Decision|0
2890835|NCT01853280|9951983|P2|Overall Study|Lost to Follow-up|1
2890836|NCT01853280|9951984|P1|Overall Study|Lost to Follow-up|0
2890837|NCT01853280|9951983|P2|Overall Study|Lack of Efficacy|2
2890838|NCT01853280|9951984|P1|Overall Study|Lack of Efficacy|2
2890839|NCT01853254|9951990|P1|Overall Study|Administrative/Other|16
2890840|NCT01853254|9951990|P1|Overall Study|Withdrawal of Consent|16
2890841|NCT01853254|9951990|P1|Overall Study|Other Protocol Violation|1
2890842|NCT01853254|9951990|P1|Overall Study|Refusal of Treatment|1
2890843|NCT01853254|9951990|P1|Overall Study|Insufficient Therapeutic Response|22
2890844|NCT01853254|9951990|P1|Overall Study|Failure to Return|43
2890845|NCT01853254|9951990|P1|Overall Study|Death|1
2890846|NCT01853254|9951990|P1|Overall Study|Adverse Event/Intercurrent Illness|3
2890847|NCT01853254|9951990|P1|Overall Study|Abnormal Laboratory Test|1
2890848|NCT01853228|9951994|P2|Phase 2|Lack of Efficacy|4
2890849|NCT01853228|9951995|P1|Phase 2|Lack of Efficacy|0
2890850|NCT01853228|9951994|P2|Phase 2|Proceed To Transplant|3
2890851|NCT01853228|9951995|P1|Phase 2|Proceed To Transplant|0
2890852|NCT01853228|9951994|P2|Phase 2|Physician Decision|1
2890853|NCT01853228|9951995|P1|Phase 2|Physician Decision|0
2890854|NCT01853228|9951994|P2|Phase 1|Other|0
2890855|NCT01853228|9951995|P1|Phase 1|Other|1
2890856|NCT01853228|9951994|P2|Phase 1|Lack of Efficacy|0
2890857|NCT01853228|9951995|P1|Phase 1|Lack of Efficacy|8
2890858|NCT01853176|9952025|P2|Overall Study|Study terminated|0
2890859|NCT01853176|9952026|P1|Overall Study|Study terminated|4
2890860|NCT01853072|9952045|P2|Overall Study|Reason not specified|6
2890861|NCT01853072|9952046|P1|Overall Study|Reason not specified|9
2890862|NCT01853072|9952045|P2|Overall Study|Withdrawal by Subject|2
2890863|NCT01853072|9952046|P1|Overall Study|Withdrawal by Subject|1
2890864|NCT01853072|9952045|P2|Overall Study|Physician Decision|1
2890865|NCT01853072|9952046|P1|Overall Study|Physician Decision|1
2890866|NCT01853072|9952045|P2|Overall Study|Non-compliance with study drug|1
2890867|NCT01853072|9952046|P1|Overall Study|Non-compliance with study drug|0
2890868|NCT01853072|9952045|P2|Overall Study|Lost to Follow-up|3
2890869|NCT01853072|9952046|P1|Overall Study|Lost to Follow-up|0
2890870|NCT01853072|9952045|P2|Overall Study|Death|4
2890871|NCT01853072|9952046|P1|Overall Study|Death|1
2890872|NCT01853072|9952045|P2|Overall Study|Adverse Event|3
2890873|NCT01853072|9952046|P1|Overall Study|Adverse Event|0
2890874|NCT01853072|9952045|P2|Overall Study|Adverse event prior to treatment|1
2890875|NCT01853072|9952046|P1|Overall Study|Adverse event prior to treatment|0
2890876|NCT01853046|9952066|P2|Overall Study|Disease progression|3
2890877|NCT01853046|9952067|P1|Overall Study|Disease progression|13
2890878|NCT01853046|9952066|P2|Overall Study|Adverse Event|2
2890879|NCT01853046|9952067|P1|Overall Study|Adverse Event|4
2890880|NCT01853046|9952066|P2|Overall Study|Withdrawal by Subject|1
2890881|NCT01853046|9952067|P1|Overall Study|Withdrawal by Subject|1
2890882|NCT01852825|9952135|P3|Overall Study|Withdrawal by Subject|0
2890883|NCT01852825|9952136|P2|Overall Study|Withdrawal by Subject|0
2890884|NCT01852825|9952137|P1|Overall Study|Withdrawal by Subject|2
2890885|NCT01852812|9952163|P3|Overall Study|Non-compliance With Study Drug|0
2890886|NCT01852812|9952164|P2|Overall Study|Non-compliance With Study Drug|1
2890887|NCT01852812|9952165|P1|Overall Study|Non-compliance With Study Drug|0
2890888|NCT01852812|9952163|P3|Overall Study|Adverse Event|1
2890889|NCT01852812|9952164|P2|Overall Study|Adverse Event|0
2890890|NCT01852812|9952165|P1|Overall Study|Adverse Event|0
2890891|NCT01852591|9952203|P1|Overall Study|Not Evaluable at Time of Analysis|1
2890892|NCT01852591|9952203|P1|Overall Study|Withdrawal by Subject|2
2890893|NCT01852292|9952244|P2|Overall Study|Progressive disease|52
2890894|NCT01852292|9952245|P1|Overall Study|Progressive disease|42
2890895|NCT01852292|9952244|P2|Overall Study|Study terminated by Sponsor|1
2890896|NCT01852292|9952245|P1|Overall Study|Study terminated by Sponsor|0
2890897|NCT01852292|9952244|P2|Overall Study|Non-compliance with study treatment|0
2890898|NCT01852292|9952245|P1|Overall Study|Non-compliance with study treatment|1
2890899|NCT01852292|9952244|P2|Overall Study|Protocol Violation|0
2890900|NCT01852292|9952245|P1|Overall Study|Protocol Violation|2
2890901|NCT01852292|9952244|P2|Overall Study|Physician Decision|2
2890902|NCT01852292|9952245|P1|Overall Study|Physician Decision|6
2890903|NCT01852292|9952244|P2|Overall Study|Adverse Event|11
2890904|NCT01852292|9952245|P1|Overall Study|Adverse Event|8
2890905|NCT01852292|9952244|P2|Overall Study|Patient/guardian decision|4
2890906|NCT01852292|9952245|P1|Overall Study|Patient/guardian decision|8
2890907|NCT01852292|9952244|P2|Overall Study|Death|8
2890908|NCT01852292|9952245|P1|Overall Study|Death|9
2890909|NCT01852292|9952244|P2|Overall Study|Untreated - did not receive study drug|1
2890910|NCT01852292|9952245|P1|Overall Study|Untreated - did not receive study drug|3
2890911|NCT01852214|9952269|P2|Washout Period|Withdrawal by Subject|1
2890912|NCT01852214|9952270|P1|Washout Period|Withdrawal by Subject|0
2890913|NCT01852214|9952269|P2|Period 1|Withdrawal by Subject|1
2890914|NCT01852214|9952270|P1|Period 1|Withdrawal by Subject|0
2890915|NCT01852214|9952269|P2|Period 1|Adverse Event|2
2890916|NCT01852214|9952270|P1|Period 1|Adverse Event|1
2890917|NCT01852162|9952322|P2|Overall Study|Withdrawal by Subject|1
2890918|NCT01852162|9952323|P1|Overall Study|Withdrawal by Subject|3
2890919|NCT01852162|9952322|P2|Overall Study|Adverse Event|0
2890920|NCT01852162|9952323|P1|Overall Study|Adverse Event|1
2890921|NCT01852110|9952339|P6|Overall Study|Withdrawal by Subject|0
2890922|NCT01852110|9952340|P5|Overall Study|Withdrawal by Subject|0
2890923|NCT01852110|9952341|P4|Overall Study|Withdrawal by Subject|0
2890924|NCT01852110|9952342|P3|Overall Study|Withdrawal by Subject|0
2890925|NCT01852110|9952343|P2|Overall Study|Withdrawal by Subject|4
2890926|NCT01852110|9952344|P1|Overall Study|Withdrawal by Subject|4
2890927|NCT01852110|9952339|P6|Overall Study|Study Terminated by Sponsor|0
2890928|NCT01852110|9952340|P5|Overall Study|Study Terminated by Sponsor|0
2890929|NCT01852110|9952341|P4|Overall Study|Study Terminated by Sponsor|0
2890930|NCT01852110|9952342|P3|Overall Study|Study Terminated by Sponsor|0
2890931|NCT01852110|9952343|P2|Overall Study|Study Terminated by Sponsor|32
2890932|NCT01852110|9952344|P1|Overall Study|Study Terminated by Sponsor|30
2890933|NCT01852110|9952339|P6|Overall Study|Protocol Violation|0
2890934|NCT01852110|9952340|P5|Overall Study|Protocol Violation|0
2890935|NCT01852110|9952341|P4|Overall Study|Protocol Violation|0
2890936|NCT01852110|9952342|P3|Overall Study|Protocol Violation|0
2890937|NCT01852110|9952343|P2|Overall Study|Protocol Violation|1
2890938|NCT01852110|9952344|P1|Overall Study|Protocol Violation|0
2890939|NCT01852110|9952339|P6|Overall Study|Physician Decision|0
2890940|NCT01852110|9952340|P5|Overall Study|Physician Decision|0
2890941|NCT01852110|9952341|P4|Overall Study|Physician Decision|0
2890942|NCT01852110|9952342|P3|Overall Study|Physician Decision|0
2890943|NCT01852110|9952343|P2|Overall Study|Physician Decision|0
2890944|NCT01852110|9952344|P1|Overall Study|Physician Decision|1
2890945|NCT01852110|9952339|P6|Overall Study|Non-compliance with Study Drug|0
2890946|NCT01852110|9952340|P5|Overall Study|Non-compliance with Study Drug|0
2890947|NCT01852110|9952341|P4|Overall Study|Non-compliance with Study Drug|0
2890948|NCT01852110|9952342|P3|Overall Study|Non-compliance with Study Drug|0
2890949|NCT01852110|9952343|P2|Overall Study|Non-compliance with Study Drug|1
2890950|NCT01852110|9952344|P1|Overall Study|Non-compliance with Study Drug|2
2890951|NCT01852110|9952339|P6|Overall Study|Lost to Follow-up|0
2890952|NCT01852110|9952340|P5|Overall Study|Lost to Follow-up|0
2890953|NCT01852110|9952341|P4|Overall Study|Lost to Follow-up|0
2890954|NCT01852110|9952342|P3|Overall Study|Lost to Follow-up|0
2890955|NCT01852110|9952343|P2|Overall Study|Lost to Follow-up|3
2890956|NCT01852110|9952344|P1|Overall Study|Lost to Follow-up|1
2890957|NCT01852110|9952339|P6|Overall Study|Adverse Event|0
2890958|NCT01852110|9952340|P5|Overall Study|Adverse Event|0
2890959|NCT01852110|9952341|P4|Overall Study|Adverse Event|0
2890960|NCT01852110|9952342|P3|Overall Study|Adverse Event|0
2890961|NCT01852110|9952343|P2|Overall Study|Adverse Event|5
2890962|NCT01852110|9952344|P1|Overall Study|Adverse Event|12
2890963|NCT01852058|9952375|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890964|NCT01852058|9952376|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890965|NCT01852058|9952377|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890966|NCT01852058|9952378|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
2890967|NCT01852058|9952379|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890968|NCT01852058|9952380|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890969|NCT01852058|9952381|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890970|NCT01852058|9952382|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890971|NCT01852058|9952383|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890972|NCT01852058|9952384|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890973|NCT01852058|9952385|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890974|NCT01852058|9952386|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
2890975|NCT01852058|9952375|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890976|NCT01852058|9952376|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890977|NCT01852058|9952377|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890978|NCT01852058|9952378|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890979|NCT01852058|9952379|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
2890980|NCT01852058|9952380|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890981|NCT01852058|9952381|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890982|NCT01852058|9952382|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890983|NCT01852058|9952383|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890984|NCT01852058|9952384|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890985|NCT01852058|9952385|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890986|NCT01852058|9952386|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
2890987|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890988|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890989|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890990|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890991|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890992|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890993|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
2890994|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
2890995|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890996|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890997|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890998|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
2890999|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891000|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891001|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891002|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891003|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891004|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891005|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891006|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891007|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
2891008|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891009|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891010|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
2891011|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891012|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891013|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891014|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891015|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891016|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891017|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
2891018|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
2891019|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891020|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891021|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891022|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
2891023|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891024|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891025|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891026|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891027|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891028|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891029|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891030|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
2891031|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891032|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891033|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891034|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
2891035|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891036|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891037|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891038|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891039|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891040|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891041|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
2891042|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
2891043|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891044|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891045|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891046|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
2891047|NCT01852058|9952375|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891048|NCT01852058|9952376|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891049|NCT01852058|9952377|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891050|NCT01852058|9952378|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891051|NCT01852058|9952379|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891052|NCT01852058|9952380|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891053|NCT01852058|9952381|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891054|NCT01852058|9952382|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
2891055|NCT01852058|9952383|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891056|NCT01852058|9952384|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891057|NCT01852058|9952385|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891058|NCT01852058|9952386|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
2891059|NCT01852058|9952375|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891060|NCT01852058|9952376|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891061|NCT01852058|9952377|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891062|NCT01852058|9952378|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891063|NCT01852058|9952379|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891064|NCT01852058|9952380|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891065|NCT01852058|9952381|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891066|NCT01852058|9952382|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891067|NCT01852058|9952383|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891068|NCT01852058|9952384|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891069|NCT01852058|9952385|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
2891070|NCT01852058|9952386|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
2891071|NCT01852045|9952466|P3|Overall Study|Other Miscellaneous Reasons|2
2891072|NCT01852045|9952467|P2|Overall Study|Other Miscellaneous Reasons|3
2891073|NCT01852045|9952468|P1|Overall Study|Other Miscellaneous Reasons|1
2891074|NCT01852045|9952466|P3|Overall Study|Withdrawal by Subject|1
2891075|NCT01852045|9952467|P2|Overall Study|Withdrawal by Subject|0
2891076|NCT01852045|9952468|P1|Overall Study|Withdrawal by Subject|1
2891077|NCT01852045|9952466|P3|Overall Study|Lost to Follow-up|1
2891078|NCT01852045|9952467|P2|Overall Study|Lost to Follow-up|1
2891079|NCT01852045|9952468|P1|Overall Study|Lost to Follow-up|0
2891080|NCT01852045|9952466|P3|Overall Study|Lack of Efficacy|0
2891081|NCT01852045|9952467|P2|Overall Study|Lack of Efficacy|0
2891082|NCT01852045|9952468|P1|Overall Study|Lack of Efficacy|3
2891083|NCT01852045|9952466|P3|Overall Study|Adverse Event|0
2891084|NCT01852045|9952467|P2|Overall Study|Adverse Event|0
2891085|NCT01852045|9952468|P1|Overall Study|Adverse Event|1
2891086|NCT01851863|9952552|P4|Overall Study|Lost to Follow-up|3
2891087|NCT01851863|9952553|P3|Overall Study|Lost to Follow-up|2
2891088|NCT01851863|9952554|P2|Overall Study|Lost to Follow-up|4
2891089|NCT01851863|9952555|P1|Overall Study|Lost to Follow-up|3
2891090|NCT01851863|9952552|P4|Overall Study|Did not receive study medication|0
2891091|NCT01851863|9952553|P3|Overall Study|Did not receive study medication|3
2891092|NCT01851863|9952554|P2|Overall Study|Did not receive study medication|5
2891093|NCT01851863|9952555|P1|Overall Study|Did not receive study medication|2
2891094|NCT01851720|9952584|P2|Overall Study|Lost to Follow-up|1
2891095|NCT01851720|9952585|P1|Overall Study|Lost to Follow-up|0
2891096|NCT01851590|9952615|P3|Overall Study|Lack of Efficacy|0
2891097|NCT01851590|9952616|P2|Overall Study|Lack of Efficacy|1
2891098|NCT01851590|9952617|P1|Overall Study|Lack of Efficacy|0
2891099|NCT01851590|9952615|P3|Overall Study|Adverse Event|2
2891100|NCT01851590|9952616|P2|Overall Study|Adverse Event|0
2891101|NCT01851590|9952617|P1|Overall Study|Adverse Event|0
2891102|NCT01851590|9952615|P3|Overall Study|Withdrawal by Subject|1
2891103|NCT01851590|9952616|P2|Overall Study|Withdrawal by Subject|0
2891104|NCT01851590|9952617|P1|Overall Study|Withdrawal by Subject|0
2891105|NCT01851330|9952640|P3|Overall Study|Investigator’s Discretion|1
2891106|NCT01851330|9952641|P2|Overall Study|Investigator’s Discretion|0
2891107|NCT01851330|9952642|P1|Overall Study|Investigator’s Discretion|0
2891108|NCT01851330|9952640|P3|Overall Study|Withdrew Consent|0
2891109|NCT01851330|9952641|P2|Overall Study|Withdrew Consent|1
2891110|NCT01851330|9952642|P1|Overall Study|Withdrew Consent|2
2891111|NCT01851330|9952640|P3|Overall Study|Lost to Follow-up|9
2891112|NCT01851330|9952641|P2|Overall Study|Lost to Follow-up|6
2891113|NCT01851330|9952642|P1|Overall Study|Lost to Follow-up|1
2891114|NCT01851330|9952640|P3|Overall Study|Lack of Efficacy|2
2891115|NCT01851330|9952641|P2|Overall Study|Lack of Efficacy|9
2891116|NCT01851330|9952642|P1|Overall Study|Lack of Efficacy|10
2891117|NCT01850641|9952695|P1|Overall Study|Increase in serum ferritin|1
2891118|NCT01850641|9952695|P1|Overall Study|Decrease in serum calcium|2
2891119|NCT01850641|9952695|P1|Overall Study|Decrease in serum phosphorus|1
2891120|NCT01850641|9952695|P1|Overall Study|Physician Decision|1
2891121|NCT01850615|9952709|P2|Overall Study|Unclassified|1
2891122|NCT01850615|9952710|P1|Overall Study|Unclassified|0
2891123|NCT01850615|9952709|P2|Overall Study|Lost to Follow-up|1
2891124|NCT01850615|9952710|P1|Overall Study|Lost to Follow-up|0
2891125|NCT01850615|9952709|P2|Overall Study|Withdrawal by Subject|1
2891126|NCT01850615|9952710|P1|Overall Study|Withdrawal by Subject|3
2891127|NCT01850615|9952709|P2|Overall Study|Adverse Event|1
2891128|NCT01850615|9952710|P1|Overall Study|Adverse Event|2
2891129|NCT01850615|9952709|P2|Overall Study|Protocol Violation|1
2891130|NCT01850615|9952710|P1|Overall Study|Protocol Violation|4
2891131|NCT01850602|9952728|P2|Overall Study|Increase in serum ferritin|0
2891132|NCT01850602|9952729|P1|Overall Study|Increase in serum ferritin|1
2891133|NCT01850602|9952728|P2|Overall Study|Decrease in serum calcium|3
2891134|NCT01850602|9952729|P1|Overall Study|Decrease in serum calcium|2
2891135|NCT01850602|9952728|P2|Overall Study|Withdrawal by Subject|4
2891136|NCT01850602|9952729|P1|Overall Study|Withdrawal by Subject|2
2891137|NCT01850602|9952728|P2|Overall Study|Physician Decision|1
2891138|NCT01850602|9952729|P1|Overall Study|Physician Decision|2
2891139|NCT01850602|9952728|P2|Overall Study|Adverse Event|10
2891140|NCT01850602|9952729|P1|Overall Study|Adverse Event|7
2891141|NCT01850589|9952743|P2|Overall Study|Withdrawal by Subject|0
2891142|NCT01850589|9952744|P1|Overall Study|Withdrawal by Subject|8
2891143|NCT01850446|9952784|P2|Overall Study|Protocol Violation|2
2891144|NCT01850446|9952785|P1|Overall Study|Protocol Violation|0
2891145|NCT01850446|9952784|P2|Overall Study|Withdrawal by Subject|0
2891146|NCT01850446|9952785|P1|Overall Study|Withdrawal by Subject|4
2891147|NCT01850446|9952784|P2|Overall Study|Lack of Efficacy|0
2891148|NCT01850446|9952785|P1|Overall Study|Lack of Efficacy|1
2891149|NCT01850030|9952844|P2|Overall Study|pregnancy not confirmed at visit 4|249
2891150|NCT01850030|9952845|P1|Overall Study|pregnancy not confirmed at visit 4|248
2891151|NCT01850030|9952844|P2|Overall Study|Protocol Violation|28
2891152|NCT01850030|9952845|P1|Overall Study|Protocol Violation|24
2891153|NCT01850030|9952844|P2|Overall Study|Withdrawal by Subject|4
2891154|NCT01850030|9952845|P1|Overall Study|Withdrawal by Subject|3
2891155|NCT01850030|9952844|P2|Overall Study|Lost to Follow-up|5
2891156|NCT01850030|9952845|P1|Overall Study|Lost to Follow-up|5
2891157|NCT01850030|9952844|P2|Overall Study|Lack of Efficacy|1
2891158|NCT01850030|9952845|P1|Overall Study|Lack of Efficacy|3
2891159|NCT01850030|9952844|P2|Overall Study|Adverse Event|82
2891160|NCT01850030|9952845|P1|Overall Study|Adverse Event|64
2891161|NCT01850004|9952857|P1|Overall Study|AE Unrelated to Study Drug|1
2891162|NCT01850004|9952857|P1|Overall Study|Subject Request to Discontinue Treatment|1
2891163|NCT01850004|9952857|P1|Overall Study|Subject Withdrew Consent|4
2891164|NCT01850004|9952857|P1|Overall Study|Poor/Non-compliance|1
2891165|NCT01850004|9952857|P1|Overall Study|Subject Moved|1
2891166|NCT01849848|9952864|P1|Overall Study|Progression of the primary disease|3
2891167|NCT01849848|9952864|P1|Overall Study|Physician Decision|1
2891168|NCT01849588|9952962|P1|Overall Study|Lack of Efficacy|3
2891169|NCT01849562|9952981|P3|Overall Study|Non-compliance with Study Drug|0
2891170|NCT01849562|9952982|P2|Overall Study|Non-compliance with Study Drug|0
2891171|NCT01849562|9952983|P1|Overall Study|Non-compliance with Study Drug|1
2891172|NCT01849562|9952981|P3|Overall Study|Lost to Follow-up|0
2891173|NCT01849562|9952982|P2|Overall Study|Lost to Follow-up|0
2891174|NCT01849562|9952983|P1|Overall Study|Lost to Follow-up|1
2891175|NCT01849497|9952996|P2|Overall Study|Lost to Follow-up|1
2891176|NCT01849497|9952997|P1|Overall Study|Lost to Follow-up|0
2891177|NCT01849497|9952996|P2|Overall Study|Sponsor Decision|1
2891178|NCT01849497|9952997|P1|Overall Study|Sponsor Decision|0
2891179|NCT01849497|9952996|P2|Overall Study|Withdrawal by Subject|2
2891180|NCT01849497|9952997|P1|Overall Study|Withdrawal by Subject|1
2891181|NCT01849458|9953005|P1|Overall Study|Lost to Follow-up|4
2891182|NCT01849289|9953044|P2|Overall Study|Unclassified|18
2891183|NCT01849289|9953045|P1|Overall Study|Unclassified|25
2891184|NCT01849289|9953044|P2|Overall Study|Withdrawal criteria|0
2891185|NCT01849289|9953045|P1|Overall Study|Withdrawal criteria|1
2891186|NCT01849289|9953044|P2|Overall Study|Protocol Violation|3
2891187|NCT01849289|9953045|P1|Overall Study|Protocol Violation|3
2891188|NCT01849289|9953044|P2|Overall Study|Adverse Event|3
2891189|NCT01849289|9953045|P1|Overall Study|Adverse Event|3
2891190|NCT01849276|9953061|P1|Followed for Survival for 5 Years|Early termination of the study|1
2891191|NCT01849276|9953061|P1|Followed for Survival for 5 Years|Death|1
2891192|NCT01849055|9953143|P6|Overall Study|Withdrawal by Subject|0
2891193|NCT01849055|9953144|P5|Overall Study|Withdrawal by Subject|0
2891194|NCT01849055|9953145|P4|Overall Study|Withdrawal by Subject|0
2891195|NCT01849055|9953146|P3|Overall Study|Withdrawal by Subject|1
2891196|NCT01849055|9953147|P2|Overall Study|Withdrawal by Subject|0
2891197|NCT01849055|9953148|P1|Overall Study|Withdrawal by Subject|0
2891198|NCT01848990|9953183|P3|Overall Study|Other|2
2891199|NCT01848990|9953184|P2|Overall Study|Other|4
2891200|NCT01848990|9953185|P1|Overall Study|Other|1
2891201|NCT01848990|9953183|P3|Overall Study|Death|1
2891202|NCT01848990|9953184|P2|Overall Study|Death|0
2891203|NCT01848990|9953185|P1|Overall Study|Death|1
2891204|NCT01848990|9953183|P3|Overall Study|Non Compliance|0
2891205|NCT01848990|9953184|P2|Overall Study|Non Compliance|0
2891206|NCT01848990|9953185|P1|Overall Study|Non Compliance|1
2891207|NCT01848990|9953183|P3|Overall Study|Physician Decision|0
2891208|NCT01848990|9953184|P2|Overall Study|Physician Decision|1
2891209|NCT01848990|9953185|P1|Overall Study|Physician Decision|1
2891210|NCT01848990|9953183|P3|Overall Study|Withdrawal by Subject|11
2891211|NCT01848990|9953184|P2|Overall Study|Withdrawal by Subject|10
2891212|NCT01848990|9953185|P1|Overall Study|Withdrawal by Subject|29
2891213|NCT01848990|9953183|P3|Overall Study|Protocol Violation|0
2891214|NCT01848990|9953184|P2|Overall Study|Protocol Violation|1
2891215|NCT01848990|9953185|P1|Overall Study|Protocol Violation|1
2891216|NCT01848990|9953183|P3|Overall Study|Lost to Follow-up|2
2891217|NCT01848990|9953184|P2|Overall Study|Lost to Follow-up|2
2891218|NCT01848990|9953185|P1|Overall Study|Lost to Follow-up|6
2891219|NCT01848990|9953183|P3|Overall Study|Adverse Event|0
2891220|NCT01848990|9953184|P2|Overall Study|Adverse Event|2
2891221|NCT01848990|9953185|P1|Overall Study|Adverse Event|6
2891222|NCT01848938|9953255|P2|Overall Study|Lost to Follow-up|1
2891223|NCT01848938|9953256|P1|Overall Study|Lost to Follow-up|1
2891224|NCT01848834|9953305|P5|Overall Study|Not Treated|0
2891225|NCT01848834|9953306|P4|Overall Study|Not Treated|0
2891226|NCT01848834|9953307|P3|Overall Study|Not Treated|0
2891227|NCT01848834|9953308|P2|Overall Study|Not Treated|1
2891228|NCT01848834|9953309|P1|Overall Study|Not Treated|0
2891229|NCT01848834|9953305|P5|Overall Study|Withdrawal by Subject|7
2891230|NCT01848834|9953306|P4|Overall Study|Withdrawal by Subject|0
2891231|NCT01848834|9953307|P3|Overall Study|Withdrawal by Subject|3
2891232|NCT01848834|9953308|P2|Overall Study|Withdrawal by Subject|2
2891233|NCT01848834|9953309|P1|Overall Study|Withdrawal by Subject|0
2891234|NCT01848834|9953305|P5|Overall Study|Protocol Violation|2
2891235|NCT01848834|9953306|P4|Overall Study|Protocol Violation|0
2891236|NCT01848834|9953307|P3|Overall Study|Protocol Violation|1
2891237|NCT01848834|9953308|P2|Overall Study|Protocol Violation|0
2891238|NCT01848834|9953309|P1|Overall Study|Protocol Violation|0
2891239|NCT01848834|9953305|P5|Overall Study|Progressive Disease|78
2891240|NCT01848834|9953306|P4|Overall Study|Progressive Disease|36
2891241|NCT01848834|9953307|P3|Overall Study|Progressive Disease|21
2891242|NCT01848834|9953308|P2|Overall Study|Progressive Disease|41
2891243|NCT01848834|9953309|P1|Overall Study|Progressive Disease|27
2891244|NCT01848834|9953305|P5|Overall Study|Death|3
2891245|NCT01848834|9953306|P4|Overall Study|Death|0
2891246|NCT01848834|9953307|P3|Overall Study|Death|0
2891247|NCT01848834|9953308|P2|Overall Study|Death|1
2891248|NCT01848834|9953309|P1|Overall Study|Death|0
2891249|NCT01848834|9953305|P5|Overall Study|Complete Response|0
2891250|NCT01848834|9953306|P4|Overall Study|Complete Response|0
2891251|NCT01848834|9953307|P3|Overall Study|Complete Response|0
2891252|NCT01848834|9953308|P2|Overall Study|Complete Response|1
2891253|NCT01848834|9953309|P1|Overall Study|Complete Response|0
2891254|NCT01848834|9953305|P5|Overall Study|Adverse Event|15
2891255|NCT01848834|9953306|P4|Overall Study|Adverse Event|1
2891256|NCT01848834|9953307|P3|Overall Study|Adverse Event|6
2891257|NCT01848834|9953308|P2|Overall Study|Adverse Event|8
2891258|NCT01848834|9953309|P1|Overall Study|Adverse Event|3
2891259|NCT01848834|9953305|P5|Overall Study|Physician Decision|1
2891260|NCT01848834|9953306|P4|Overall Study|Physician Decision|0
2891261|NCT01848834|9953307|P3|Overall Study|Physician Decision|0
2891262|NCT01848834|9953308|P2|Overall Study|Physician Decision|0
2891263|NCT01848834|9953309|P1|Overall Study|Physician Decision|0
2891264|NCT01848834|9953305|P5|Overall Study|Ongoing in Study|26
2891265|NCT01848834|9953306|P4|Overall Study|Ongoing in Study|0
2891266|NCT01848834|9953307|P3|Overall Study|Ongoing in Study|1
2891267|NCT01848834|9953308|P2|Overall Study|Ongoing in Study|6
2891268|NCT01848834|9953309|P1|Overall Study|Ongoing in Study|0
2891269|NCT01848756|9953357|P1|Overall Study|Enrolled in Error|1
2891270|NCT01848756|9953357|P1|Overall Study|Withdrawal by Subject|1
2891271|NCT01848756|9953357|P1|Overall Study|Adverse Event|1
2891272|NCT01848483|9953369|P2|Overall Study|Incarceration|2
2891273|NCT01848483|9953370|P1|Overall Study|Incarceration|2
2891274|NCT01848483|9953369|P2|Overall Study|Withdrawal by Subject|0
2891275|NCT01848483|9953370|P1|Overall Study|Withdrawal by Subject|1
2891276|NCT01848483|9953369|P2|Overall Study|Lost to Follow-up|8
2891277|NCT01848483|9953370|P1|Overall Study|Lost to Follow-up|6
2891278|NCT01848483|9953369|P2|Overall Study|Death|1
2891279|NCT01848483|9953370|P1|Overall Study|Death|2
2891280|NCT01848457|9953388|P4|Overall Study|Death|0
2891281|NCT01848457|9953389|P3|Overall Study|Death|0
2891282|NCT01848457|9953390|P2|Overall Study|Death|0
2891283|NCT01848457|9953391|P1|Overall Study|Death|1
2891284|NCT01848353|9953423|P4|Phase 3|Withdrawal by Subject|0
2891285|NCT01848353|9953424|P3|Phase 3|Withdrawal by Subject|0
2891286|NCT01848353|9953425|P2|Phase 3|Withdrawal by Subject|1
2891287|NCT01848353|9953426|P1|Phase 3|Withdrawal by Subject|1
2891288|NCT01848353|9953423|P4|Phase 2|Withdrawal by Subject|0
2891289|NCT01848353|9953424|P3|Phase 2|Withdrawal by Subject|0
2891290|NCT01848353|9953425|P2|Phase 2|Withdrawal by Subject|2
2891291|NCT01848353|9953426|P1|Phase 2|Withdrawal by Subject|3
2891292|NCT01848353|9953423|P4|Phase 1|Withdrawal by Subject|0
2891293|NCT01848353|9953424|P3|Phase 1|Withdrawal by Subject|0
2891294|NCT01848353|9953425|P2|Phase 1|Withdrawal by Subject|1
2891295|NCT01848353|9953426|P1|Phase 1|Withdrawal by Subject|3
2891296|NCT01848288|9953482|P1|Overall Study|Withdrawal by Subject|1
2891297|NCT01848288|9953482|P1|Overall Study|Protocol Violation|1
2891298|NCT01848288|9953482|P1|Overall Study|Death|1
2891299|NCT01848210|9953493|P2|Overall Study|Administrative|0
2891300|NCT01848210|9953494|P1|Overall Study|Administrative|1
2891301|NCT01848210|9953493|P2|Overall Study|Chronic Venous Insufficiency Course|2
2891302|NCT01848210|9953494|P1|Overall Study|Chronic Venous Insufficiency Course|1
2891303|NCT01848210|9953493|P2|Overall Study|Hepatic Function Alteration|0
2891304|NCT01848210|9953494|P1|Overall Study|Hepatic Function Alteration|4
2891305|NCT01848210|9953493|P2|Overall Study|Hypesensitivity|0
2891306|NCT01848210|9953494|P1|Overall Study|Hypesensitivity|1
2891307|NCT01848210|9953493|P2|Overall Study|Discontinuation Criterion|7
2891308|NCT01848210|9953494|P1|Overall Study|Discontinuation Criterion|5
2891309|NCT01848210|9953493|P2|Overall Study|Adverse Event|9
2891310|NCT01848210|9953494|P1|Overall Study|Adverse Event|7
2891311|NCT01848210|9953493|P2|Overall Study|Impedition Condition|9
2891312|NCT01848210|9953494|P1|Overall Study|Impedition Condition|5
2891313|NCT01848210|9953493|P2|Overall Study|Use of Forbidden Drugs|10
2891314|NCT01848210|9953494|P1|Overall Study|Use of Forbidden Drugs|9
2891315|NCT01848210|9953493|P2|Overall Study|Protocol Violation|5
2891316|NCT01848210|9953494|P1|Overall Study|Protocol Violation|3
2891317|NCT01848210|9953493|P2|Overall Study|Lost to Follow-up|12
2891318|NCT01848210|9953494|P1|Overall Study|Lost to Follow-up|24
2891319|NCT01848210|9953493|P2|Overall Study|Informed Consent Form Withdrawal|24
2891320|NCT01848210|9953494|P1|Overall Study|Informed Consent Form Withdrawal|28
2891321|NCT01848145|9953516|P1|Subsequent Infusions: Weeks 3-8|Death|1
2891322|NCT01848145|9953516|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
2891323|NCT01848145|9953516|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
2891324|NCT01848145|9953516|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
2891325|NCT01848145|9953516|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
2891326|NCT01848145|9953516|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
2891327|NCT01848145|9953516|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
2891328|NCT01847885|9953556|P3|Randomization|Screen Failure|0
2891329|NCT01847885|9953557|P2|Randomization|Screen Failure|3
2891330|NCT01847885|9953558|P1|Randomization|Screen Failure|0
2891331|NCT01847885|9953556|P3|Randomization|Withdrawal by Subject|2
2891332|NCT01847885|9953557|P2|Randomization|Withdrawal by Subject|0
2891333|NCT01847885|9953558|P1|Randomization|Withdrawal by Subject|0
2891334|NCT01847885|9953556|P3|Randomization|Protocol Violation|0
2891335|NCT01847885|9953557|P2|Randomization|Protocol Violation|1
2891336|NCT01847885|9953558|P1|Randomization|Protocol Violation|0
2891337|NCT01847885|9953556|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2891338|NCT01847885|9953557|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2891339|NCT01847885|9953558|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
2891340|NCT01847885|9953556|P3|Initial Enrollment (Consented)|Screen failure|0
2891341|NCT01847885|9953557|P2|Initial Enrollment (Consented)|Screen failure|0
2891342|NCT01847885|9953558|P1|Initial Enrollment (Consented)|Screen failure|39
2891343|NCT01847885|9953556|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
2891344|NCT01847885|9953557|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
2891345|NCT01847885|9953558|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
2891346|NCT01847885|9953556|P3|Initial Enrollment (Consented)|Protocol Violation|0
2891347|NCT01847885|9953557|P2|Initial Enrollment (Consented)|Protocol Violation|0
2891348|NCT01847885|9953558|P1|Initial Enrollment (Consented)|Protocol Violation|1
2891349|NCT01847443|9953722|P4|Washout Period Before Study Period 4|Positive alcohol test|0
2891350|NCT01847443|9953723|P3|Washout Period Before Study Period 4|Positive alcohol test|0
2891351|NCT01847443|9953724|P2|Washout Period Before Study Period 4|Positive alcohol test|0
2891352|NCT01847443|9953725|P1|Washout Period Before Study Period 4|Positive alcohol test|1
2891353|NCT01847443|9953722|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
2891354|NCT01847443|9953723|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
2891355|NCT01847443|9953724|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
2891356|NCT01847443|9953725|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
2891357|NCT01847443|9953722|P4|Washout Period Before Study Period 3|Other reason|0
2891358|NCT01847443|9953723|P3|Washout Period Before Study Period 3|Other reason|0
2891359|NCT01847443|9953724|P2|Washout Period Before Study Period 3|Other reason|0
2891360|NCT01847443|9953725|P1|Washout Period Before Study Period 3|Other reason|1
2891361|NCT01847443|9953722|P4|Washout Period Before Study Period 2|Other reason|0
2891362|NCT01847443|9953723|P3|Washout Period Before Study Period 2|Other reason|0
2891363|NCT01847443|9953724|P2|Washout Period Before Study Period 2|Other reason|0
2891364|NCT01847443|9953725|P1|Washout Period Before Study Period 2|Other reason|1
2891365|NCT01847443|9953722|P4|Washout Period Before Study Period 2|Adverse Event|0
2891366|NCT01847443|9953723|P3|Washout Period Before Study Period 2|Adverse Event|0
2891367|NCT01847443|9953724|P2|Washout Period Before Study Period 2|Adverse Event|1
2891368|NCT01847443|9953725|P1|Washout Period Before Study Period 2|Adverse Event|1
2891369|NCT01847443|9953722|P4|Study Period 1|Withdrawal by Subject|0
2891370|NCT01847443|9953723|P3|Study Period 1|Withdrawal by Subject|0
2891371|NCT01847443|9953724|P2|Study Period 1|Withdrawal by Subject|1
2891372|NCT01847443|9953725|P1|Study Period 1|Withdrawal by Subject|0
2891373|NCT01847313|9953768|P2|Overall Study|Withdrawal by Subject|1
2891374|NCT01847313|9953769|P1|Overall Study|Withdrawal by Subject|0
2891375|NCT01847313|9953768|P2|Overall Study|Death|1
2891376|NCT01847313|9953769|P1|Overall Study|Death|0
2891377|NCT01847274|9953785|P4|Overall Study|Non Compliance|0
2891378|NCT01847274|9953786|P3|Overall Study|Non Compliance|2
2891379|NCT01847274|9953787|P2|Overall Study|Non Compliance|0
2891380|NCT01847274|9953788|P1|Overall Study|Non Compliance|0
2891381|NCT01847274|9953785|P4|Overall Study|Other Reasons|3
2891382|NCT01847274|9953786|P3|Overall Study|Other Reasons|11
2891383|NCT01847274|9953787|P2|Overall Study|Other Reasons|1
2891384|NCT01847274|9953788|P1|Overall Study|Other Reasons|3
2891385|NCT01847274|9953785|P4|Overall Study|Treatment Associated Risk|0
2891386|NCT01847274|9953786|P3|Overall Study|Treatment Associated Risk|2
2891387|NCT01847274|9953787|P2|Overall Study|Treatment Associated Risk|2
2891388|NCT01847274|9953788|P1|Overall Study|Treatment Associated Risk|0
2891389|NCT01847274|9953785|P4|Overall Study|Disease Progression|98
2891390|NCT01847274|9953786|P3|Overall Study|Disease Progression|129
2891391|NCT01847274|9953787|P2|Overall Study|Disease Progression|49
2891392|NCT01847274|9953788|P1|Overall Study|Disease Progression|63
2891393|NCT01847274|9953785|P4|Overall Study|Withdrawal by Subject|1
2891394|NCT01847274|9953786|P3|Overall Study|Withdrawal by Subject|11
2891395|NCT01847274|9953787|P2|Overall Study|Withdrawal by Subject|8
2891396|NCT01847274|9953788|P1|Overall Study|Withdrawal by Subject|8
2891397|NCT01847274|9953785|P4|Overall Study|Adverse Event|2
2891398|NCT01847274|9953786|P3|Overall Study|Adverse Event|33
2891399|NCT01847274|9953787|P2|Overall Study|Adverse Event|1
2891400|NCT01847274|9953788|P1|Overall Study|Adverse Event|17
2891401|NCT01847209|9953842|P1|Overall Study|No lung nodule found on intraop CT scan|1
2891402|NCT01847209|9953842|P1|Overall Study|Withdrawal by Subject|1
2891403|NCT01847092|9953865|P2|Overall Study|Protocol Violation|2
2891404|NCT01847092|9953866|P1|Overall Study|Protocol Violation|0
2891405|NCT01847092|9953865|P2|Overall Study|Physician Decision|1
2891406|NCT01847092|9953866|P1|Overall Study|Physician Decision|1
2891407|NCT01847092|9953865|P2|Overall Study|Protocol Specified|0
2891408|NCT01847092|9953866|P1|Overall Study|Protocol Specified|8
2891409|NCT01847092|9953865|P2|Overall Study|Withdrawal by Subject|5
2891410|NCT01847092|9953866|P1|Overall Study|Withdrawal by Subject|5
2891411|NCT01847092|9953865|P2|Overall Study|Adverse Event|3
2891412|NCT01847092|9953866|P1|Overall Study|Adverse Event|12
2891413|NCT01846741|9953920|P1|Baseline Visit|Subject did not meet entry criteria|2
2891414|NCT01846624|9954076|P1|Overall Study|Died during induction, no midostaurin|1
2891415|NCT01846611|9954086|P2|Overall Study|Other|18
2891416|NCT01846611|9954087|P1|Overall Study|Other|19
2891417|NCT01846611|9954086|P2|Overall Study|Withdrawal by Subject|19
2891418|NCT01846611|9954087|P1|Overall Study|Withdrawal by Subject|15
2891419|NCT01846611|9954086|P2|Overall Study|Lost to Follow-up|6
2891420|NCT01846611|9954087|P1|Overall Study|Lost to Follow-up|4
2891421|NCT01846507|9954097|P1|Overall Study|Missing data|2
2891422|NCT01846507|9954097|P1|Overall Study|Protocol Violation|1
2891423|NCT01846507|9954097|P1|Overall Study|Lost to Follow-up|4
2891424|NCT01846442|9954195|P4|Overall Study|Left the city/Lost medication|1
2891425|NCT01846442|9954196|P3|Overall Study|Left the city/Lost medication|1
2891426|NCT01846442|9954197|P2|Overall Study|Left the city/Lost medication|0
2891427|NCT01846442|9954198|P1|Overall Study|Left the city/Lost medication|1
2891428|NCT01846442|9954195|P4|Overall Study|Withdrawal by Subject|1
2891429|NCT01846442|9954196|P3|Overall Study|Withdrawal by Subject|0
2891430|NCT01846442|9954197|P2|Overall Study|Withdrawal by Subject|2
2891431|NCT01846442|9954198|P1|Overall Study|Withdrawal by Subject|3
2891432|NCT01846442|9954195|P4|Overall Study|Lost to Follow-up|0
2891433|NCT01846442|9954196|P3|Overall Study|Lost to Follow-up|1
2891434|NCT01846442|9954197|P2|Overall Study|Lost to Follow-up|0
2891435|NCT01846442|9954198|P1|Overall Study|Lost to Follow-up|0
2891436|NCT01846442|9954195|P4|Overall Study|Adverse Event|1
2891437|NCT01846442|9954196|P3|Overall Study|Adverse Event|2
2891438|NCT01846442|9954197|P2|Overall Study|Adverse Event|4
2891439|NCT01846442|9954198|P1|Overall Study|Adverse Event|2
2891440|NCT01846416|9954239|P3|Survival Follow-up|Other|1
2891441|NCT01846416|9954240|P2|Survival Follow-up|Other|1
2891442|NCT01846416|9954241|P1|Survival Follow-up|Other|3
2891443|NCT01846416|9954239|P3|Survival Follow-up|Study Terminated by Sponsor|0
2891444|NCT01846416|9954240|P2|Survival Follow-up|Study Terminated by Sponsor|8
2891445|NCT01846416|9954241|P1|Survival Follow-up|Study Terminated by Sponsor|2
2891446|NCT01846416|9954239|P3|Survival Follow-up|Withdrawal by Subject|0
2891447|NCT01846416|9954240|P2|Survival Follow-up|Withdrawal by Subject|7
2891448|NCT01846416|9954241|P1|Survival Follow-up|Withdrawal by Subject|2
2891449|NCT01846416|9954239|P3|Survival Follow-up|Lost to Follow-up|2
2891450|NCT01846416|9954240|P2|Survival Follow-up|Lost to Follow-up|2
2891451|NCT01846416|9954241|P1|Survival Follow-up|Lost to Follow-up|0
2891452|NCT01846416|9954239|P3|Survival Follow-up|Death|9
2891453|NCT01846416|9954240|P2|Survival Follow-up|Death|62
2891454|NCT01846416|9954241|P1|Survival Follow-up|Death|21
2891455|NCT01846416|9954239|P3|Treatment Phase|Progressive Disease|9
2891456|NCT01846416|9954240|P2|Treatment Phase|Progressive Disease|63
2891457|NCT01846416|9954241|P1|Treatment Phase|Progressive Disease|21
2891458|NCT01846416|9954239|P3|Treatment Phase|Study Terminated by Sponsor|0
2891459|NCT01846416|9954240|P2|Treatment Phase|Study Terminated by Sponsor|4
2891460|NCT01846416|9954241|P1|Treatment Phase|Study Terminated by Sponsor|1
2891461|NCT01846416|9954239|P3|Treatment Phase|Non-compliance|0
2891462|NCT01846416|9954240|P2|Treatment Phase|Non-compliance|2
2891463|NCT01846416|9954241|P1|Treatment Phase|Non-compliance|0
2891464|NCT01846416|9954239|P3|Treatment Phase|Adverse Event|0
2891465|NCT01846416|9954240|P2|Treatment Phase|Adverse Event|4
2891466|NCT01846416|9954241|P1|Treatment Phase|Adverse Event|3
2891467|NCT01846416|9954239|P3|Treatment Phase|Physician Decision|0
2891468|NCT01846416|9954240|P2|Treatment Phase|Physician Decision|2
2891469|NCT01846416|9954241|P1|Treatment Phase|Physician Decision|1
2891470|NCT01846416|9954239|P3|Treatment Phase|Other|1
2891471|NCT01846416|9954240|P2|Treatment Phase|Other|5
2891472|NCT01846416|9954241|P1|Treatment Phase|Other|1
2891473|NCT01846416|9954239|P3|Treatment Phase|Withdrawal by Subject|2
2891474|NCT01846416|9954240|P2|Treatment Phase|Withdrawal by Subject|4
2891475|NCT01846416|9954241|P1|Treatment Phase|Withdrawal by Subject|2
2891476|NCT01846416|9954239|P3|Treatment Phase|Death|1
2891477|NCT01846416|9954240|P2|Treatment Phase|Death|9
2891478|NCT01846416|9954241|P1|Treatment Phase|Death|2
2891479|NCT01846299|9954286|P2|Overall Study|Adverse Event|0
2891480|NCT01846299|9954287|P1|Overall Study|Adverse Event|2
2891481|NCT01846299|9954286|P2|Overall Study|Withdrawal by Subject|6
2891482|NCT01846299|9954287|P1|Overall Study|Withdrawal by Subject|1
2891483|NCT01846299|9954286|P2|Overall Study|Lost to Follow-up|0
2891484|NCT01846299|9954287|P1|Overall Study|Lost to Follow-up|3
2891485|NCT01846299|9954286|P2|Overall Study|Death|2
2891486|NCT01846299|9954287|P1|Overall Study|Death|1
2891487|NCT01846299|9954286|P2|Overall Study|Protocol deviation|0
2891488|NCT01846299|9954287|P1|Overall Study|Protocol deviation|1
2891489|NCT01846299|9954286|P2|Overall Study|Physician Decision|2
2891490|NCT01846299|9954287|P1|Overall Study|Physician Decision|4
2891491|NCT01846273|9954326|P3|Overall Study|Physician Decision|0
2891492|NCT01846273|9954327|P2|Overall Study|Physician Decision|2
2891493|NCT01846273|9954328|P1|Overall Study|Physician Decision|1
2891494|NCT01846273|9954326|P3|Overall Study|Protocol Deviation|0
2891495|NCT01846273|9954327|P2|Overall Study|Protocol Deviation|3
2891496|NCT01846273|9954328|P1|Overall Study|Protocol Deviation|2
2891497|NCT01846273|9954326|P3|Overall Study|Disease Progression|0
2891498|NCT01846273|9954327|P2|Overall Study|Disease Progression|4
2891499|NCT01846273|9954328|P1|Overall Study|Disease Progression|0
2891500|NCT01846273|9954326|P3|Overall Study|Death|0
2891501|NCT01846273|9954327|P2|Overall Study|Death|1
2891502|NCT01846273|9954328|P1|Overall Study|Death|2
2891503|NCT01846273|9954326|P3|Overall Study|Administrative problems|0
2891504|NCT01846273|9954327|P2|Overall Study|Administrative problems|0
2891505|NCT01846273|9954328|P1|Overall Study|Administrative problems|1
2891506|NCT01846273|9954326|P3|Overall Study|Lost to Follow-up|0
2891507|NCT01846273|9954327|P2|Overall Study|Lost to Follow-up|1
2891508|NCT01846273|9954328|P1|Overall Study|Lost to Follow-up|2
2891509|NCT01846273|9954326|P3|Overall Study|Subject withdrew consent|0
2891510|NCT01846273|9954327|P2|Overall Study|Subject withdrew consent|8
2891511|NCT01846273|9954328|P1|Overall Study|Subject withdrew consent|5
2891512|NCT01846273|9954326|P3|Overall Study|Adverse Event|0
2891513|NCT01846273|9954327|P2|Overall Study|Adverse Event|7
2891514|NCT01846273|9954328|P1|Overall Study|Adverse Event|9
2891515|NCT01846221|9954384|P2|Overall Study|Age Exclusion|0
2891516|NCT01846221|9954385|P1|Overall Study|Age Exclusion|1
2891517|NCT01846221|9954384|P2|Overall Study|Catheter Failure|0
2891518|NCT01846221|9954385|P1|Overall Study|Catheter Failure|2
2891519|NCT01846208|9954402|P3|Overall Study|Refused SU OFC|1
2891520|NCT01846208|9954403|P2|Overall Study|Refused SU OFC|0
2891521|NCT01846208|9954404|P1|Overall Study|Refused SU OFC|0
2891522|NCT01846208|9954402|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2891523|NCT01846208|9954403|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2891524|NCT01846208|9954404|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
2891525|NCT01846208|9954402|P3|Overall Study|Non-compliance|0
2891526|NCT01846208|9954403|P2|Overall Study|Non-compliance|1
2891527|NCT01846208|9954404|P1|Overall Study|Non-compliance|1
2891528|NCT01846208|9954402|P3|Overall Study|Withdrawal by Subject|0
2891529|NCT01846208|9954403|P2|Overall Study|Withdrawal by Subject|0
2891530|NCT01846208|9954404|P1|Overall Study|Withdrawal by Subject|5
2891531|NCT01846208|9954402|P3|Overall Study|Dosing Symptoms|6
2891532|NCT01846208|9954403|P2|Overall Study|Dosing Symptoms|2
2891533|NCT01846208|9954404|P1|Overall Study|Dosing Symptoms|1
2891534|NCT01846208|9954402|P3|Overall Study|Withdrew prior to treatment|1
2891535|NCT01846208|9954403|P2|Overall Study|Withdrew prior to treatment|1
2891536|NCT01846208|9954404|P1|Overall Study|Withdrew prior to treatment|1
2891537|NCT01846104|9954424|P1|Overall Study|Withdrawal by Subject|1
2891538|NCT01846039|9954430|P1|Overall Study|Subject Withdrew Consent|1
2891539|NCT01846039|9954430|P1|Overall Study|Protocol Violation|1
2891540|NCT01845974|9954442|P2|Overall Study|screen failure|0
2891541|NCT01845974|9954443|P1|Overall Study|screen failure|1
2891542|NCT01845831|9954451|P5|Inpatient Phase|Withdrawal by Subject|0
2891543|NCT01845831|9954452|P4|Inpatient Phase|Withdrawal by Subject|0
2891544|NCT01845831|9954453|P3|Inpatient Phase|Withdrawal by Subject|0
2891545|NCT01845831|9954454|P2|Inpatient Phase|Withdrawal by Subject|1
2891546|NCT01845831|9954455|P1|Inpatient Phase|Withdrawal by Subject|1
2891547|NCT01845818|9954484|P2|Overall Study|No Follow-Up Data Available|1
2891548|NCT01845818|9954485|P1|Overall Study|No Follow-Up Data Available|4
2891549|NCT01845818|9954484|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
2891550|NCT01845818|9954485|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
2891551|NCT01845818|9954484|P2|Overall Study|Other|8
2891552|NCT01845818|9954485|P1|Overall Study|Other|25
2891553|NCT01845818|9954484|P2|Overall Study|Serious Adverse Event|1
2891554|NCT01845818|9954485|P1|Overall Study|Serious Adverse Event|1
2891555|NCT01845818|9954484|P2|Overall Study|Administrative Reasons|1
2891556|NCT01845818|9954485|P1|Overall Study|Administrative Reasons|3
2891557|NCT01845818|9954484|P2|Overall Study|Lost to Follow-up|5
2891558|NCT01845818|9954485|P1|Overall Study|Lost to Follow-up|7
2891559|NCT01845818|9954484|P2|Overall Study|Withdrawal by Subject|1
2891560|NCT01845818|9954485|P1|Overall Study|Withdrawal by Subject|0
2891561|NCT01845077|9954569|P6|Washout Period|Protocol Violation|0
2891562|NCT01845077|9954570|P5|Washout Period|Protocol Violation|1
2891563|NCT01845077|9954571|P4|Washout Period|Protocol Violation|1
2891564|NCT01845077|9954572|P3|Washout Period|Protocol Violation|0
2891565|NCT01845077|9954573|P2|Washout Period|Protocol Violation|0
2891566|NCT01845077|9954574|P1|Washout Period|Protocol Violation|0
2891567|NCT01845077|9954569|P6|Washout Period|elevated lab values (not clinic. sign.)|0
2891568|NCT01845077|9954570|P5|Washout Period|elevated lab values (not clinic. sign.)|0
2891569|NCT01845077|9954571|P4|Washout Period|elevated lab values (not clinic. sign.)|0
2891570|NCT01845077|9954572|P3|Washout Period|elevated lab values (not clinic. sign.)|1
2891571|NCT01845077|9954573|P2|Washout Period|elevated lab values (not clinic. sign.)|0
2891572|NCT01845077|9954574|P1|Washout Period|elevated lab values (not clinic. sign.)|0
2891573|NCT01845077|9954569|P6|Washout Period|Adverse Event|0
2891574|NCT01845077|9954570|P5|Washout Period|Adverse Event|0
2891575|NCT01845077|9954571|P4|Washout Period|Adverse Event|0
2891576|NCT01845077|9954572|P3|Washout Period|Adverse Event|0
2891577|NCT01845077|9954573|P2|Washout Period|Adverse Event|0
2891578|NCT01845077|9954574|P1|Washout Period|Adverse Event|1
2891579|NCT01845077|9954569|P6|Washout Period|Lost to Follow-up|1
2891580|NCT01845077|9954570|P5|Washout Period|Lost to Follow-up|0
2891581|NCT01845077|9954571|P4|Washout Period|Lost to Follow-up|1
2891582|NCT01845077|9954572|P3|Washout Period|Lost to Follow-up|0
2891583|NCT01845077|9954573|P2|Washout Period|Lost to Follow-up|1
2891584|NCT01845077|9954574|P1|Washout Period|Lost to Follow-up|0
2891585|NCT01845025|9954620|P2|Overall Study|Missing|1
2891586|NCT01845025|9954621|P1|Overall Study|Missing|1
2891587|NCT01845025|9954620|P2|Overall Study|Protocol deviation|6
2891588|NCT01845025|9954621|P1|Overall Study|Protocol deviation|3
2891589|NCT01845025|9954620|P2|Overall Study|Death|0
2891590|NCT01845025|9954621|P1|Overall Study|Death|2
2891591|NCT01845025|9954620|P2|Overall Study|Administrative problems|8
2891592|NCT01845025|9954621|P1|Overall Study|Administrative problems|8
2891593|NCT01845025|9954620|P2|Overall Study|Lost to Follow-up|13
2891594|NCT01845025|9954621|P1|Overall Study|Lost to Follow-up|13
2891595|NCT01845025|9954620|P2|Overall Study|Withdrawal by Subject|44
2891596|NCT01845025|9954621|P1|Overall Study|Withdrawal by Subject|48
2891597|NCT01845025|9954620|P2|Overall Study|Unsatisfactory therapeutic effect|2
2891598|NCT01845025|9954621|P1|Overall Study|Unsatisfactory therapeutic effect|4
2891599|NCT01845025|9954620|P2|Overall Study|Adverse Event|3
2891600|NCT01845025|9954621|P1|Overall Study|Adverse Event|6
2891601|NCT01844986|9954645|P2|Overall Study|Death|26
2891602|NCT01844986|9954646|P1|Overall Study|Death|55
2891603|NCT01844986|9954645|P2|Overall Study|Withdrawal by Subject|14
2891604|NCT01844986|9954646|P1|Overall Study|Withdrawal by Subject|21
2891605|NCT01844986|9954645|P2|Overall Study|Severe non-compliance to protocol|0
2891606|NCT01844986|9954646|P1|Overall Study|Severe non-compliance to protocol|1
2891607|NCT01844895|9954668|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
2891608|NCT01844895|9954668|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
2891609|NCT01844895|9954668|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
2891610|NCT01844895|9954668|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
2891611|NCT01844895|9954668|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
2891612|NCT01844895|9954668|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
2891613|NCT01844895|9954668|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
2891614|NCT01844856|9954686|P2|Overall Study|Randomized but was a Screen Failure|1
2891615|NCT01844856|9954687|P1|Overall Study|Randomized but was a Screen Failure|0
2891616|NCT01844856|9954686|P2|Overall Study|Inadvertently Not Scheduled|0
2891617|NCT01844856|9954687|P1|Overall Study|Inadvertently Not Scheduled|1
2891618|NCT01844856|9954686|P2|Overall Study|Enterococcus Resistant|1
2891619|NCT01844856|9954687|P1|Overall Study|Enterococcus Resistant|0
2891620|NCT01844856|9954686|P2|Overall Study|Noncompliance|3
2891621|NCT01844856|9954687|P1|Overall Study|Noncompliance|2
2891622|NCT01844856|9954686|P2|Overall Study|Withdrawal by Subject|2
2891623|NCT01844856|9954687|P1|Overall Study|Withdrawal by Subject|3
2891624|NCT01844856|9954686|P2|Overall Study|Adverse Event|6
2891625|NCT01844856|9954687|P1|Overall Study|Adverse Event|3
2891626|NCT01844856|9954686|P2|Overall Study|Lost to Follow-up|3
2891627|NCT01844856|9954687|P1|Overall Study|Lost to Follow-up|15
2891628|NCT01844830|9954699|P2|Overall Study|Withdrawal by Subject|0
2891629|NCT01844830|9954700|P1|Overall Study|Withdrawal by Subject|1
2891630|NCT01844817|9954730|P2|Treatment|Other|3
2891631|NCT01844817|9954731|P1|Treatment|Other|0
2891632|NCT01844817|9954730|P2|Treatment|Lost to Follow-up|1
2891633|NCT01844817|9954731|P1|Treatment|Lost to Follow-up|0
2891634|NCT01844817|9954730|P2|Treatment|Death|8
2891635|NCT01844817|9954731|P1|Treatment|Death|10
2891636|NCT01844817|9954730|P2|Treatment|Withdrawal by Subject|6
2891637|NCT01844817|9954731|P1|Treatment|Withdrawal by Subject|10
2891638|NCT01844817|9954730|P2|Treatment|Adverse Event|9
2891639|NCT01844817|9954731|P1|Treatment|Adverse Event|17
2891640|NCT01844817|9954730|P2|Treatment|Progressive Disease|36
2891641|NCT01844817|9954731|P1|Treatment|Progressive Disease|27
2891642|NCT01844817|9954730|P2|Enrolled and Randomized|Withdrawal by Subject|3
2891643|NCT01844817|9954731|P1|Enrolled and Randomized|Withdrawal by Subject|2
2891644|NCT01844778|9954744|P3|Overall Study|Adverse Event|2
2891645|NCT01844778|9954745|P2|Overall Study|Adverse Event|2
2891646|NCT01844778|9954746|P1|Overall Study|Adverse Event|0
2891647|NCT01844778|9954744|P3|Overall Study|Withdrawal by Subject|0
2891648|NCT01844778|9954745|P2|Overall Study|Withdrawal by Subject|0
2891649|NCT01844778|9954746|P1|Overall Study|Withdrawal by Subject|2
2891650|NCT01844778|9954744|P3|Overall Study|Protocol deviation|2
2891651|NCT01844778|9954745|P2|Overall Study|Protocol deviation|1
2891652|NCT01844778|9954746|P1|Overall Study|Protocol deviation|0
2891653|NCT01844765|9954772|P2|Overall Study|Untreated|0
2891654|NCT01844765|9954773|P1|Overall Study|Untreated|1
2891655|NCT01844765|9954772|P2|Overall Study|Protocol Violation|0
2891656|NCT01844765|9954773|P1|Overall Study|Protocol Violation|1
2891657|NCT01844765|9954772|P2|Overall Study|Disease progression|0
2891658|NCT01844765|9954773|P1|Overall Study|Disease progression|1
2891659|NCT01844765|9954772|P2|Overall Study|Administrative problems|1
2891660|NCT01844765|9954773|P1|Overall Study|Administrative problems|1
2891661|NCT01844765|9954772|P2|Overall Study|Withdrawal by Subject|1
2891662|NCT01844765|9954773|P1|Overall Study|Withdrawal by Subject|0
2891663|NCT01844765|9954772|P2|Overall Study|Adverse Event|4
2891664|NCT01844765|9954773|P1|Overall Study|Adverse Event|5
2891665|NCT01844700|9954793|P2|Overall Study|stopped taking meds|1
2891666|NCT01844700|9954794|P1|Overall Study|stopped taking meds|0
2891667|NCT01844700|9954793|P2|Overall Study|Withdrawal by Subject|0
2891668|NCT01844700|9954794|P1|Overall Study|Withdrawal by Subject|1
2891669|NCT01844700|9954793|P2|Overall Study|refused medication switch|0
2891670|NCT01844700|9954794|P1|Overall Study|refused medication switch|1
2891671|NCT01844700|9954793|P2|Overall Study|Lack of Efficacy|0
2891672|NCT01844700|9954794|P1|Overall Study|Lack of Efficacy|1
2891673|NCT01844687|9954806|P1|Visit 4|Withdrawal by Subject|2
2891674|NCT01844687|9954806|P1|Visit 4|Lost to Follow-up|1
2891675|NCT01844687|9954806|P1|Visit 4|Pregnancy|1
2891676|NCT01844687|9954806|P1|Visit 3|child care problems|1
2891677|NCT01844687|9954806|P1|Visit 3|Withdrawal by Subject|3
2891678|NCT01844687|9954806|P1|Visit 3|Lost to Follow-up|1
2891679|NCT01844687|9954806|P1|Visit 2|Protocol Violation|1
2891680|NCT01844687|9954806|P1|Visit 2|Withdrawal by Subject|1
2891681|NCT01844687|9954806|P1|Visit 1|Lost to Follow-up|5
2891682|NCT01844687|9954806|P1|Visit 1|Protocol Violation|3
2891683|NCT01844583|9954867|P2|Overall Study|Didn’t complete dosing;PK/ECG assessment|10
2891684|NCT01844583|9954868|P1|Overall Study|Didn’t complete dosing;PK/ECG assessment|8
2891685|NCT01844531|9954900|P4|Overall Study|Withdrawal by Subject|0
2891686|NCT01844531|9954901|P3|Overall Study|Withdrawal by Subject|0
2891687|NCT01844531|9954902|P2|Overall Study|Withdrawal by Subject|1
2891688|NCT01844531|9954903|P1|Overall Study|Withdrawal by Subject|0
2891689|NCT01844518|9954933|P1|Long-Term Extension|Still in On-Going Study|149
2891690|NCT01844518|9954933|P1|Long-Term Extension|No Longer Met Study Criteria|1
2891691|NCT01844518|9954933|P1|Long-Term Extension|Adverse Event|1
2891692|NCT01844518|9954933|P1|Long-Term Extension|Lack of Efficacy|6
2891693|NCT01844518|9954933|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
2891694|NCT01844518|9954933|P1|Short-Term (ST) Period|Withdrawal of Consent|2
2891695|NCT01844518|9954933|P1|Short-Term (ST) Period|Lack of Efficacy|3
2891696|NCT01844518|9954933|P1|Short-Term (ST) Period|Adverse Event|3
2891697|NCT01844505|9954950|P3|Overall Study|Not Reported|1
2891698|NCT01844505|9954951|P2|Overall Study|Not Reported|0
2891699|NCT01844505|9954952|P1|Overall Study|Not Reported|0
2891700|NCT01844505|9954950|P3|Overall Study|Other Reasons|2
2891701|NCT01844505|9954951|P2|Overall Study|Other Reasons|2
2891702|NCT01844505|9954952|P1|Overall Study|Other Reasons|4
2891703|NCT01844505|9954950|P3|Overall Study|Subject no longer meets criteria|0
2891704|NCT01844505|9954951|P2|Overall Study|Subject no longer meets criteria|1
2891705|NCT01844505|9954952|P1|Overall Study|Subject no longer meets criteria|0
2891706|NCT01844505|9954950|P3|Overall Study|Poor/non-compliance|1
2891707|NCT01844505|9954951|P2|Overall Study|Poor/non-compliance|1
2891708|NCT01844505|9954952|P1|Overall Study|Poor/non-compliance|1
2891709|NCT01844505|9954950|P3|Overall Study|Maximum clinical benefit|2
2891710|NCT01844505|9954951|P2|Overall Study|Maximum clinical benefit|11
2891711|NCT01844505|9954952|P1|Overall Study|Maximum clinical benefit|8
2891712|NCT01844505|9954950|P3|Overall Study|Lost to Follow-up|0
2891713|NCT01844505|9954951|P2|Overall Study|Lost to Follow-up|0
2891714|NCT01844505|9954952|P1|Overall Study|Lost to Follow-up|1
2891715|NCT01844505|9954950|P3|Overall Study|Withdrawal by Subject|0
2891716|NCT01844505|9954951|P2|Overall Study|Withdrawal by Subject|3
2891717|NCT01844505|9954952|P1|Overall Study|Withdrawal by Subject|0
2891718|NCT01844505|9954950|P3|Overall Study|Subject request discontinue treatment|8
2891719|NCT01844505|9954951|P2|Overall Study|Subject request discontinue treatment|14
2891720|NCT01844505|9954952|P1|Overall Study|Subject request discontinue treatment|17
2891721|NCT01844505|9954950|P3|Overall Study|Adverse event unrelated to study drug|6
2891722|NCT01844505|9954951|P2|Overall Study|Adverse event unrelated to study drug|15
2891723|NCT01844505|9954952|P1|Overall Study|Adverse event unrelated to study drug|7
2891724|NCT01844505|9954950|P3|Overall Study|Death|1
2891725|NCT01844505|9954951|P2|Overall Study|Death|3
2891726|NCT01844505|9954952|P1|Overall Study|Death|1
2891727|NCT01844505|9954950|P3|Overall Study|Study drug toxicity|50
2891728|NCT01844505|9954951|P2|Overall Study|Study drug toxicity|131
2891729|NCT01844505|9954952|P1|Overall Study|Study drug toxicity|40
2891730|NCT01844505|9954950|P3|Overall Study|Disease progression|224
2891731|NCT01844505|9954951|P2|Overall Study|Disease progression|88
2891732|NCT01844505|9954952|P1|Overall Study|Disease progression|170
2891733|NCT01844375|9955046|P2|Overall Study|Protocol Violation|1
2891734|NCT01844375|9955047|P1|Overall Study|Protocol Violation|1
2891735|NCT01844284|9955059|P2|Overall Study|Lost to Follow-up|7
2891736|NCT01844284|9955060|P1|Overall Study|Lost to Follow-up|12
2891737|NCT01844115|9955279|P2|Overall Study|Pregnancy|1
2891738|NCT01844115|9955280|P1|Overall Study|Pregnancy|0
2891739|NCT01844115|9955279|P2|Overall Study|Lost to Follow-up|10
2891740|NCT01844115|9955280|P1|Overall Study|Lost to Follow-up|11
2891741|NCT01844115|9955279|P2|Overall Study|Withdrawal by Subject|11
2891742|NCT01844115|9955280|P1|Overall Study|Withdrawal by Subject|11
2891743|NCT01844115|9955279|P2|Overall Study|Protocol Violation|10
2891744|NCT01844115|9955280|P1|Overall Study|Protocol Violation|12
2891745|NCT01844115|9955279|P2|Overall Study|Lack of Efficacy|4
2891746|NCT01844115|9955280|P1|Overall Study|Lack of Efficacy|1
2891747|NCT01844115|9955279|P2|Overall Study|Adverse Event|22
2891748|NCT01844115|9955280|P1|Overall Study|Adverse Event|4
2891749|NCT01843972|9955298|P10|Overall Study|Withdrawal by Subject|0
2891750|NCT01843972|9955299|P9|Overall Study|Withdrawal by Subject|0
2891751|NCT01843972|9955300|P8|Overall Study|Withdrawal by Subject|0
2891752|NCT01843972|9955301|P7|Overall Study|Withdrawal by Subject|0
2891753|NCT01843972|9955302|P6|Overall Study|Withdrawal by Subject|0
2891754|NCT01843972|9955303|P5|Overall Study|Withdrawal by Subject|1
2891755|NCT01843972|9955304|P4|Overall Study|Withdrawal by Subject|0
2891756|NCT01843972|9955305|P3|Overall Study|Withdrawal by Subject|0
2891757|NCT01843972|9955306|P2|Overall Study|Withdrawal by Subject|0
2891758|NCT01843972|9955307|P1|Overall Study|Withdrawal by Subject|0
2891759|NCT01843933|9955377|P2|Overall Study|Data lost|4
2891760|NCT01843933|9955378|P1|Overall Study|Data lost|6
2891761|NCT01843842|9955397|P2|Overall Study|Do not meet inclusion criteria|1
2891762|NCT01843842|9955398|P1|Overall Study|Do not meet inclusion criteria|1
2891763|NCT01843803|9955420|P2|Overall Study|not a Veteran, did not see provider|3
2891764|NCT01843803|9955421|P1|Overall Study|not a Veteran, did not see provider|1
2891765|NCT01843777|9955435|P2|Overall Study|Withdrawal by Subject|0
2891766|NCT01843777|9955436|P1|Overall Study|Withdrawal by Subject|1
2891767|NCT01843673|9955461|P1|Overall Study|Withdrawal by Subject|4
2891768|NCT01843673|9955461|P1|Overall Study|Lack of Efficacy|2
2891769|NCT01843660|9955473|P1|Overall Study|Other|30
2891770|NCT01843374|9955514|P2|Overall Study|Withdrawing due to Other reason|46
2891771|NCT01843374|9955515|P1|Overall Study|Withdrawing due to Other reason|20
2891772|NCT01843374|9955514|P2|Overall Study|Withdrawal by Subject|20
2891773|NCT01843374|9955515|P1|Overall Study|Withdrawal by Subject|14
2891774|NCT01843374|9955514|P2|Overall Study|Death|313
2891775|NCT01843374|9955515|P1|Overall Study|Death|155
2891776|NCT01843348|9955542|P3|Overall Study|Various reasons|6
2891777|NCT01843348|9955543|P2|Overall Study|Various reasons|9
2891778|NCT01843348|9955544|P1|Overall Study|Various reasons|4
2891779|NCT01843348|9955542|P3|Overall Study|Graft loss/retransplantation|11
2891780|NCT01843348|9955543|P2|Overall Study|Graft loss/retransplantation|8
2891781|NCT01843348|9955544|P1|Overall Study|Graft loss/retransplantation|5
2891782|NCT01843348|9955542|P3|Overall Study|Death|4
2891783|NCT01843348|9955543|P2|Overall Study|Death|3
2891784|NCT01843348|9955544|P1|Overall Study|Death|5
2891785|NCT01843348|9955542|P3|Overall Study|Lost to Follow-up|2
2891786|NCT01843348|9955543|P2|Overall Study|Lost to Follow-up|4
2891787|NCT01843348|9955544|P1|Overall Study|Lost to Follow-up|5
2891788|NCT01843348|9955542|P3|Overall Study|Withdrawal by Subject|18
2891789|NCT01843348|9955543|P2|Overall Study|Withdrawal by Subject|16
2891790|NCT01843348|9955544|P1|Overall Study|Withdrawal by Subject|4
2891791|NCT01843205|9955584|P2|First Treatment (11 Days)|Withdrawal by Subject|0
2891792|NCT01843205|9955585|P1|First Treatment (11 Days)|Withdrawal by Subject|1
2891793|NCT01843192|9955646|P3|Overall Study|Intra-operative exclusions per protocol|2
2891794|NCT01843192|9955647|P2|Overall Study|Intra-operative exclusions per protocol|6
2891795|NCT01843192|9955648|P1|Overall Study|Intra-operative exclusions per protocol|2
2891796|NCT01843062|9955679|P2|Overall Study|Lost to Follow-up|4
2891797|NCT01843062|9955680|P1|Overall Study|Lost to Follow-up|2
2891798|NCT01843062|9955679|P2|Overall Study|Death|2
2891799|NCT01843062|9955680|P1|Overall Study|Death|1
2891800|NCT01843062|9955679|P2|Overall Study|Withdrawal by Subject|3
2891801|NCT01843062|9955680|P1|Overall Study|Withdrawal by Subject|12
2891802|NCT01843062|9955679|P2|Overall Study|Incorrect randomisation|0
2891803|NCT01843062|9955680|P1|Overall Study|Incorrect randomisation|1
2891804|NCT01843062|9955679|P2|Overall Study|Adverse Event|0
2891805|NCT01843062|9955680|P1|Overall Study|Adverse Event|2
2891806|NCT01843062|9955679|P2|Overall Study|Pregnancy|0
2891807|NCT01843062|9955680|P1|Overall Study|Pregnancy|1
2891808|NCT01843062|9955679|P2|Overall Study|New treatment following progression|0
2891809|NCT01843062|9955680|P1|Overall Study|New treatment following progression|2
2891810|NCT01843062|9955679|P2|Overall Study|Protocol Violation|0
2891811|NCT01843062|9955680|P1|Overall Study|Protocol Violation|1
2891812|NCT01842958|9955694|P2|Overall Study|Lost to Follow-up|1
2891813|NCT01842958|9955695|P1|Overall Study|Lost to Follow-up|1
2891814|NCT01842633|9955770|P3|Overall Study|Technical issues|0
2891815|NCT01842633|9955771|P2|Overall Study|Technical issues|0
2891816|NCT01842633|9955772|P1|Overall Study|Technical issues|1
2891817|NCT01842633|9955770|P3|Overall Study|Withdrawal by Subject|0
2891818|NCT01842633|9955771|P2|Overall Study|Withdrawal by Subject|1
2891819|NCT01842633|9955772|P1|Overall Study|Withdrawal by Subject|0
2891820|NCT01842633|9955770|P3|Overall Study|Adverse Event|0
2891821|NCT01842633|9955771|P2|Overall Study|Adverse Event|1
2891822|NCT01842633|9955772|P1|Overall Study|Adverse Event|1
2891823|NCT01842633|9955770|P3|Overall Study|Screen Failure|0
2891824|NCT01842633|9955771|P2|Overall Study|Screen Failure|0
2891825|NCT01842633|9955772|P1|Overall Study|Screen Failure|1
2891826|NCT01842620|9955819|P2|Period 1|Withdrawal by Subject|0
2891827|NCT01842620|9955820|P1|Period 1|Withdrawal by Subject|1
2891828|NCT01842607|9955836|P1|Overall Study|Withdrawal by Subject|14
2891829|NCT01842607|9955836|P1|Overall Study|Physician Decision|9
2891830|NCT01842607|9955836|P1|Overall Study|Lost to Follow-up|3
2891831|NCT01842607|9955836|P1|Overall Study|Protocol defined stopping criteria|2
2891832|NCT01842607|9955836|P1|Overall Study|Protocol Violation|8
2891833|NCT01842607|9955836|P1|Overall Study|Lack of Efficacy|19
2891834|NCT01842607|9955836|P1|Overall Study|Adverse Event|11
2891835|NCT01842581|9955862|P2|Overall Study|Other than specified|1
2891836|NCT01842581|9955863|P1|Overall Study|Other than specified|3
2891837|NCT01842581|9955862|P2|Overall Study|Withdrawal by Subject|7
2891838|NCT01842581|9955863|P1|Overall Study|Withdrawal by Subject|5
2891839|NCT01842581|9955862|P2|Overall Study|Lost to Follow-up|5
2891840|NCT01842581|9955863|P1|Overall Study|Lost to Follow-up|2
2891841|NCT01842581|9955862|P2|Overall Study|Liver transplant|0
2891842|NCT01842581|9955863|P1|Overall Study|Liver transplant|2
2891843|NCT01842581|9955862|P2|Overall Study|HE breakthrough|13
2891844|NCT01842581|9955863|P1|Overall Study|HE breakthrough|26
2891845|NCT01842581|9955862|P2|Overall Study|Adverse Event|4
2891846|NCT01842581|9955863|P1|Overall Study|Adverse Event|6
2891847|NCT01842438|9955887|P2|T2: 6month Follow-up|Death|1
2891848|NCT01842438|9955888|P1|T2: 6month Follow-up|Death|0
2891849|NCT01842438|9955887|P2|T2: 6month Follow-up|Withdrawal by Subject|3
2891850|NCT01842438|9955888|P1|T2: 6month Follow-up|Withdrawal by Subject|4
2891851|NCT01842438|9955887|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
2891852|NCT01842438|9955888|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
2891853|NCT01842334|9955902|P2|Overall Study|Moved away mid-study|1
2891854|NCT01842334|9955903|P1|Overall Study|Moved away mid-study|0
2891855|NCT01842334|9955902|P2|Overall Study|Withdrawal by Subject|3
2891856|NCT01842334|9955903|P1|Overall Study|Withdrawal by Subject|3
2891857|NCT01841970|9955909|P1|Overall Study|Lost to Follow-up|8
2891858|NCT01841970|9955909|P1|Overall Study|Physician Decision|2
2891859|NCT01841970|9955909|P1|Overall Study|Withdrawal by Subject|1
2891860|NCT01841762|9955933|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
2891861|NCT01841762|9955933|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
2891862|NCT01841762|9955933|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
2891863|NCT01841762|9955933|P1|Post-Treatment Safety Follow-Up Period|Death|1
2891864|NCT01841762|9955933|P1|Treatment Period|Other, including non-compliance|5
2891865|NCT01841762|9955933|P1|Treatment Period|Physician Decision|2
2891866|NCT01841762|9955933|P1|Treatment Period|Lost to Follow-up|1
2891867|NCT01841762|9955933|P1|Treatment Period|Withdrawal by Subject|7
2891868|NCT01841762|9955933|P1|Treatment Period|Death|1
2891869|NCT01841762|9955933|P1|Treatment Period|Adverse Event|16
2891870|NCT01841762|9955933|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
2891871|NCT01841697|9955943|P2|Overall Study|Withdrawal by Subject|16
2891872|NCT01841697|9955944|P1|Overall Study|Withdrawal by Subject|16
2891873|NCT01841697|9955943|P2|Overall Study|Lost to Follow-up|1
2891874|NCT01841697|9955944|P1|Overall Study|Lost to Follow-up|4
2891875|NCT01841697|9955943|P2|Overall Study|Death|1
2891876|NCT01841697|9955944|P1|Overall Study|Death|0
2891877|NCT01841593|9955984|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
2891878|NCT01841593|9955985|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
2891879|NCT01841593|9955984|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
2891880|NCT01841593|9955985|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
2891881|NCT01841567|9956001|P1|Overall Study|Adverse Event|3
2891882|NCT01841554|9956006|P1|Overall Study|Study exit due to secondary intervention|6
2891883|NCT01841554|9956006|P1|Overall Study|Discontinued Follow Up|5
2891884|NCT01841554|9956006|P1|Overall Study|No Implantation|1
2891885|NCT01841554|9956006|P1|Overall Study|Death|7
2891886|NCT01841073|9956055|P2|Overall Study|Lost to Follow-up|2
2891887|NCT01841073|9956056|P1|Overall Study|Lost to Follow-up|0
2891888|NCT01841073|9956055|P2|Overall Study|Physician Decision|0
2891889|NCT01841073|9956056|P1|Overall Study|Physician Decision|1
2891890|NCT01841073|9956055|P2|Overall Study|Adverse Event|1
2891891|NCT01841073|9956056|P1|Overall Study|Adverse Event|1
2891892|NCT01840943|9956078|P2|Overall Study|Lost to Follow-up|4
2891893|NCT01840943|9956079|P1|Overall Study|Lost to Follow-up|4
2891894|NCT01840943|9956078|P2|Overall Study|Physician Decision|2
2891895|NCT01840943|9956079|P1|Overall Study|Physician Decision|4
2891896|NCT01840943|9956078|P2|Overall Study|Withdrawal by Subject|6
2891897|NCT01840943|9956079|P1|Overall Study|Withdrawal by Subject|5
2891898|NCT01840605|9956128|P2|Overall Study|Physician Decision|1
2891899|NCT01840605|9956129|P1|Overall Study|Physician Decision|2
2891900|NCT01840605|9956128|P2|Overall Study|Adverse Event|1
2891901|NCT01840605|9956129|P1|Overall Study|Adverse Event|0
2891902|NCT01840410|9956143|P2|Overall Study|Adverse Event|1
2891903|NCT01840410|9956144|P1|Overall Study|Adverse Event|1
2891904|NCT01840410|9956143|P2|Overall Study|Withdrawal by Subject|1
2891905|NCT01840410|9956144|P1|Overall Study|Withdrawal by Subject|2
2891906|NCT01840410|9956143|P2|Overall Study|Lost to Follow-up|0
2891907|NCT01840410|9956144|P1|Overall Study|Lost to Follow-up|1
2891908|NCT01840410|9956143|P2|Overall Study|Protocol deviation|0
2891909|NCT01840410|9956144|P1|Overall Study|Protocol deviation|1
2891910|NCT01840410|9956143|P2|Overall Study|Pregnancy|0
2891911|NCT01840410|9956144|P1|Overall Study|Pregnancy|1
2891912|NCT01840410|9956143|P2|Overall Study|Physician Decision|2
2891913|NCT01840410|9956144|P1|Overall Study|Physician Decision|1
2891914|NCT01840228|9956193|P2|Overall Study|Lost to Follow-up|1
2891915|NCT01840228|9956194|P1|Overall Study|Lost to Follow-up|1
2891916|NCT01840163|9956222|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
2891917|NCT01840163|9956223|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
2891918|NCT01840163|9956222|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
2891919|NCT01840163|9956223|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
2891920|NCT01840163|9956222|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
2891921|NCT01840163|9956223|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
2891922|NCT01839916|9956268|P1|Overall Study|Graft Failure|1
2891923|NCT01839916|9956268|P1|Overall Study|GVHD|2
2891924|NCT01839916|9956268|P1|Overall Study|Relapse|12
2891925|NCT01839916|9956268|P1|Overall Study|Physician Decision|17
2891926|NCT01839916|9956268|P1|Overall Study|Death|9
2891927|NCT01839656|9956319|P2|Overall Study|Adverse Event|0
2891928|NCT01839656|9956320|P1|Overall Study|Adverse Event|1
2891929|NCT01839656|9956319|P2|Overall Study|Early study closure|11
2891930|NCT01839656|9956320|P1|Overall Study|Early study closure|0
2891931|NCT01839656|9956319|P2|Overall Study|Adverse event, serious fatal|4
2891932|NCT01839656|9956320|P1|Overall Study|Adverse event, serious fatal|1
2891933|NCT01839656|9956319|P2|Overall Study|Withdrawal by Subject|1
2891934|NCT01839656|9956320|P1|Overall Study|Withdrawal by Subject|1
2891935|NCT01839279|9956408|P3|Overall Study|Classified as 'Other'|0
2891936|NCT01839279|9956409|P2|Overall Study|Classified as 'Other'|0
2891937|NCT01839279|9956410|P1|Overall Study|Classified as 'Other'|5
2891938|NCT01839279|9956408|P3|Overall Study|Withdrawal by Subject|1
2891939|NCT01839279|9956409|P2|Overall Study|Withdrawal by Subject|1
2891940|NCT01839279|9956410|P1|Overall Study|Withdrawal by Subject|4
2891941|NCT01839279|9956408|P3|Overall Study|Adverse Event|1
2891942|NCT01839279|9956409|P2|Overall Study|Adverse Event|1
2891943|NCT01839279|9956410|P1|Overall Study|Adverse Event|4
2891944|NCT01839188|9956429|P1|Overall Study|Withdrawal by Subject|1
2891945|NCT01838941|9956501|P1|Overall Study|Withdrawal by Subject|1
2891946|NCT01838941|9956501|P1|Overall Study|Adverse Event|1
2891947|NCT01838876|9956506|P1|Overall Study|Did not meet eligibility criteria|78
2891948|NCT01838876|9956506|P1|Overall Study|Reason not Specified|7
2891949|NCT01838876|9956506|P1|Overall Study|Study or Site Terminated by Sponsor|1
2891950|NCT01838876|9956506|P1|Overall Study|Lost to Follow-up|21
2891951|NCT01838876|9956506|P1|Overall Study|Withdrawal of Consent|33
2891952|NCT01838876|9956506|P1|Overall Study|Protocol Violation|34
2891953|NCT01838876|9956506|P1|Overall Study|Insufficient Therapeutic Response|10
2891954|NCT01838876|9956506|P1|Overall Study|Adverse Event|49
2891955|NCT01838694|9956615|P2|Overall Study|Adverse Event|1
2891956|NCT01838694|9956616|P1|Overall Study|Adverse Event|0
2891957|NCT01838681|9956625|P4|Period B/A+|Administrative or other reasons|28
2891958|NCT01838681|9956626|P3|Period B/A+|Administrative or other reasons|10
2891959|NCT01838681|9956627|P2|Period B/A+|Administrative or other reasons|6
2891960|NCT01838681|9956628|P1|Period B/A+|Administrative or other reasons|0
2891961|NCT01838681|9956625|P4|Period B/A+|Withdrawal before treatment|0
2891962|NCT01838681|9956626|P3|Period B/A+|Withdrawal before treatment|0
2891963|NCT01838681|9956627|P2|Period B/A+|Withdrawal before treatment|1
2891964|NCT01838681|9956628|P1|Period B/A+|Withdrawal before treatment|0
2891965|NCT01838681|9956625|P4|Period B/A+|Lost to Follow-up|11
2891966|NCT01838681|9956626|P3|Period B/A+|Lost to Follow-up|5
2891967|NCT01838681|9956627|P2|Period B/A+|Lost to Follow-up|2
2891968|NCT01838681|9956628|P1|Period B/A+|Lost to Follow-up|0
2891969|NCT01838681|9956625|P4|Period B/A+|Non-compliance with IMP|3
2891970|NCT01838681|9956626|P3|Period B/A+|Non-compliance with IMP|3
2891971|NCT01838681|9956627|P2|Period B/A+|Non-compliance with IMP|2
2891972|NCT01838681|9956628|P1|Period B/A+|Non-compliance with IMP|0
2891973|NCT01838681|9956625|P4|Period B/A+|Protocol Violation|6
2891974|NCT01838681|9956626|P3|Period B/A+|Protocol Violation|4
2891975|NCT01838681|9956627|P2|Period B/A+|Protocol Violation|1
2891976|NCT01838681|9956628|P1|Period B/A+|Protocol Violation|0
2891977|NCT01838681|9956625|P4|Period B/A+|Withdrawal by Subject|47
2891978|NCT01838681|9956626|P3|Period B/A+|Withdrawal by Subject|35
2891979|NCT01838681|9956627|P2|Period B/A+|Withdrawal by Subject|28
2891980|NCT01838681|9956628|P1|Period B/A+|Withdrawal by Subject|0
2891981|NCT01838681|9956625|P4|Period B/A+|Lack of Efficacy|6
2891982|NCT01838681|9956626|P3|Period B/A+|Lack of Efficacy|11
2891983|NCT01838681|9956627|P2|Period B/A+|Lack of Efficacy|9
2891984|NCT01838681|9956628|P1|Period B/A+|Lack of Efficacy|0
2891985|NCT01838681|9956625|P4|Period B/A+|Adverse Event|16
2891986|NCT01838681|9956626|P3|Period B/A+|Adverse Event|27
2891987|NCT01838681|9956627|P2|Period B/A+|Adverse Event|13
2891988|NCT01838681|9956628|P1|Period B/A+|Adverse Event|0
2891989|NCT01838681|9956625|P4|Period A|Administrative or other reasons|0
2891990|NCT01838681|9956626|P3|Period A|Administrative or other reasons|0
2891991|NCT01838681|9956627|P2|Period A|Administrative or other reasons|0
2891992|NCT01838681|9956628|P1|Period A|Administrative or other reasons|17
2891993|NCT01838681|9956625|P4|Period A|Withdrawal before treatment|0
2891994|NCT01838681|9956626|P3|Period A|Withdrawal before treatment|0
2891995|NCT01838681|9956627|P2|Period A|Withdrawal before treatment|0
2891996|NCT01838681|9956628|P1|Period A|Withdrawal before treatment|4
2891997|NCT01838681|9956625|P4|Period A|Lost to Follow-up|0
2891998|NCT01838681|9956626|P3|Period A|Lost to Follow-up|0
2891999|NCT01838681|9956627|P2|Period A|Lost to Follow-up|0
2892000|NCT01838681|9956628|P1|Period A|Lost to Follow-up|4
2892001|NCT01838681|9956625|P4|Period A|Non-compliance with IMP|0
2892002|NCT01838681|9956626|P3|Period A|Non-compliance with IMP|0
2892003|NCT01838681|9956627|P2|Period A|Non-compliance with IMP|0
2892004|NCT01838681|9956628|P1|Period A|Non-compliance with IMP|6
2892005|NCT01838681|9956625|P4|Period A|Protocol Violation|0
2892006|NCT01838681|9956626|P3|Period A|Protocol Violation|0
2892007|NCT01838681|9956627|P2|Period A|Protocol Violation|0
2892008|NCT01838681|9956628|P1|Period A|Protocol Violation|16
2892009|NCT01838681|9956625|P4|Period A|Withdrawal by Subject|0
2892010|NCT01838681|9956626|P3|Period A|Withdrawal by Subject|0
2892011|NCT01838681|9956627|P2|Period A|Withdrawal by Subject|0
2892012|NCT01838681|9956628|P1|Period A|Withdrawal by Subject|70
2892013|NCT01838681|9956625|P4|Period A|Early response|0
2892014|NCT01838681|9956626|P3|Period A|Early response|0
2892015|NCT01838681|9956627|P2|Period A|Early response|0
2892016|NCT01838681|9956628|P1|Period A|Early response|148
2892017|NCT01838681|9956625|P4|Period A|Lack of Efficacy|0
2892018|NCT01838681|9956626|P3|Period A|Lack of Efficacy|0
2892019|NCT01838681|9956627|P2|Period A|Lack of Efficacy|0
2892020|NCT01838681|9956628|P1|Period A|Lack of Efficacy|21
2892021|NCT01838681|9956625|P4|Period A|Adverse Event|0
2892022|NCT01838681|9956626|P3|Period A|Adverse Event|0
2892023|NCT01838681|9956627|P2|Period A|Adverse Event|0
2892024|NCT01838681|9956628|P1|Period A|Adverse Event|39
2892025|NCT01838642|9956736|P1|Overall Study|Died on study|1
2892026|NCT01838616|9956749|P2|Pick-up Arm|Technical problems|0
2892027|NCT01838616|9956750|P1|Pick-up Arm|Technical problems|1
2892028|NCT01838616|9956749|P2|Pick-up Arm|Withdrawal by Subject|0
2892029|NCT01838616|9956750|P1|Pick-up Arm|Withdrawal by Subject|1
2892030|NCT01838616|9956749|P2|Pick-up Arm|Adverse Event|0
2892031|NCT01838616|9956750|P1|Pick-up Arm|Adverse Event|9
2892032|NCT01838616|9956749|P2|Pick-up Arm|Lack of Efficacy|0
2892033|NCT01838616|9956750|P1|Pick-up Arm|Lack of Efficacy|4
2892034|NCT01838616|9956749|P2|Continuation Period|Technical problems|1
2892035|NCT01838616|9956750|P1|Continuation Period|Technical problems|0
2892036|NCT01838616|9956749|P2|Continuation Period|Withdrawal by Subject|4
2892037|NCT01838616|9956750|P1|Continuation Period|Withdrawal by Subject|0
2892038|NCT01838616|9956749|P2|Continuation Period|Lost to Follow-up|0
2892039|NCT01838616|9956750|P1|Continuation Period|Lost to Follow-up|1
2892040|NCT01838616|9956749|P2|Continuation Period|Protocol Violation|0
2892041|NCT01838616|9956750|P1|Continuation Period|Protocol Violation|2
2892042|NCT01838616|9956749|P2|Continuation Period|Adverse Event|4
2892043|NCT01838616|9956750|P1|Continuation Period|Adverse Event|8
2892044|NCT01838616|9956749|P2|Continuation Period|Lack of Efficacy|5
2892045|NCT01838616|9956750|P1|Continuation Period|Lack of Efficacy|3
2892046|NCT01838616|9956749|P2|Titration Period|Protocol Violation|1
2892047|NCT01838616|9956750|P1|Titration Period|Protocol Violation|0
2892048|NCT01838616|9956749|P2|Titration Period|Other|0
2892049|NCT01838616|9956750|P1|Titration Period|Other|1
2892050|NCT01838616|9956749|P2|Titration Period|Technical problems|0
2892051|NCT01838616|9956750|P1|Titration Period|Technical problems|1
2892052|NCT01838616|9956749|P2|Titration Period|Withdrawal by Subject|5
2892053|NCT01838616|9956750|P1|Titration Period|Withdrawal by Subject|5
2892054|NCT01838616|9956749|P2|Titration Period|Lack of Efficacy|12
2892055|NCT01838616|9956750|P1|Titration Period|Lack of Efficacy|5
2892056|NCT01838616|9956749|P2|Titration Period|Adverse Event|48
2892057|NCT01838616|9956750|P1|Titration Period|Adverse Event|18
2892058|NCT01838590|9956821|P2|Overall Study|Lost to Follow-up|1
2892059|NCT01838590|9956822|P1|Overall Study|Lost to Follow-up|0
2892060|NCT01838590|9956821|P2|Overall Study|Lack of Efficacy|4
2892061|NCT01838590|9956822|P1|Overall Study|Lack of Efficacy|12
2892062|NCT01838499|9956846|P2|Overall Study|Withdrawal by Subject|9
2892063|NCT01838499|9956847|P1|Overall Study|Withdrawal by Subject|19
2892064|NCT01838499|9956846|P2|Overall Study|Adverse Event|1
2892065|NCT01838499|9956847|P1|Overall Study|Adverse Event|2
2892066|NCT01838499|9956846|P2|Overall Study|Lack of Efficacy|2
2892067|NCT01838499|9956847|P1|Overall Study|Lack of Efficacy|1
2892068|NCT01838499|9956846|P2|Overall Study|Lost to Follow-up|4
2892069|NCT01838499|9956847|P1|Overall Study|Lost to Follow-up|2
2892070|NCT01838499|9956846|P2|Overall Study|Protocol Violation|1
2892071|NCT01838499|9956847|P1|Overall Study|Protocol Violation|0
2892072|NCT01838447|9956859|P2|Overall Study|Withdrawal by Subject|1
2892073|NCT01838447|9956860|P1|Overall Study|Withdrawal by Subject|1
2892074|NCT01838447|9956859|P2|Overall Study|Change in surgical plan|2
2892075|NCT01838447|9956860|P1|Overall Study|Change in surgical plan|1
2892076|NCT01838213|9956908|P2|Overall Study|Ineligible|191
2892077|NCT01838213|9956909|P1|Overall Study|Ineligible|166
2892078|NCT01838200|9956917|P2|Overall Study|Progressive disease|0
2892079|NCT01838200|9956918|P1|Overall Study|Progressive disease|3
2892080|NCT01838200|9956917|P2|Overall Study|Adverse Event|2
2892081|NCT01838200|9956918|P1|Overall Study|Adverse Event|0
2892082|NCT01838044|9956930|P2|Overall Study|Lost to Follow-up|2
2892083|NCT01838044|9956931|P1|Overall Study|Lost to Follow-up|0
2892084|NCT01838044|9956930|P2|Overall Study|Medication error without associated AE|1
2892085|NCT01838044|9956931|P1|Overall Study|Medication error without associated AE|0
2892086|NCT01838044|9956930|P2|Overall Study|Insufficient clinical response|2
2892087|NCT01838044|9956931|P1|Overall Study|Insufficient clinical response|1
2892088|NCT01838044|9956930|P2|Overall Study|Withdrawal by Subject|2
2892089|NCT01838044|9956931|P1|Overall Study|Withdrawal by Subject|0
2892090|NCT01838044|9956930|P2|Overall Study|Protocol Violation|3
2892091|NCT01838044|9956931|P1|Overall Study|Protocol Violation|3
2892092|NCT01838044|9956930|P2|Overall Study|Adverse Event|6
2892093|NCT01838044|9956931|P1|Overall Study|Adverse Event|4
2892094|NCT01837966|9956964|P2|Overall Study|Withdrawal by Subject|1
2892095|NCT01837966|9956965|P1|Overall Study|Withdrawal by Subject|2
2892096|NCT01837823|9956971|P1|Overall Study|Lost to Follow-up|6
2892097|NCT01837797|9957002|P5|Period 3|Other|2
2892098|NCT01837797|9957003|P4|Period 3|Other|0
2892099|NCT01837797|9957004|P3|Period 3|Other|0
2892100|NCT01837797|9957005|P2|Period 3|Other|0
2892101|NCT01837797|9957006|P1|Period 3|Other|0
2892102|NCT01837797|9957002|P5|Period 3|Administrative reasons|20
2892103|NCT01837797|9957003|P4|Period 3|Administrative reasons|0
2892104|NCT01837797|9957004|P3|Period 3|Administrative reasons|0
2892105|NCT01837797|9957005|P2|Period 3|Administrative reasons|0
2892106|NCT01837797|9957006|P1|Period 3|Administrative reasons|0
2892107|NCT01837797|9957002|P5|Period 3|Adverse Event|1
2892108|NCT01837797|9957003|P4|Period 3|Adverse Event|0
2892109|NCT01837797|9957004|P3|Period 3|Adverse Event|0
2892110|NCT01837797|9957005|P2|Period 3|Adverse Event|0
2892111|NCT01837797|9957006|P1|Period 3|Adverse Event|0
2892112|NCT01837797|9957002|P5|Period 2|Adverse Event|0
2892113|NCT01837797|9957003|P4|Period 2|Adverse Event|1
2892114|NCT01837797|9957004|P3|Period 2|Adverse Event|0
2892115|NCT01837797|9957005|P2|Period 2|Adverse Event|0
2892116|NCT01837797|9957006|P1|Period 2|Adverse Event|0
2892117|NCT01837797|9957002|P5|Period 2|Administrative or other reasons|0
2892118|NCT01837797|9957003|P4|Period 2|Administrative or other reasons|4
2892119|NCT01837797|9957004|P3|Period 2|Administrative or other reasons|2
2892120|NCT01837797|9957005|P2|Period 2|Administrative or other reasons|5
2892121|NCT01837797|9957006|P1|Period 2|Administrative or other reasons|0
2892122|NCT01837797|9957002|P5|Period 1|Other|0
2892123|NCT01837797|9957003|P4|Period 1|Other|0
2892124|NCT01837797|9957004|P3|Period 1|Other|0
2892125|NCT01837797|9957005|P2|Period 1|Other|0
2892126|NCT01837797|9957006|P1|Period 1|Other|10
2892127|NCT01837797|9957002|P5|Period 1|Withdrawal of consent before treatment|0
2892128|NCT01837797|9957003|P4|Period 1|Withdrawal of consent before treatment|0
2892129|NCT01837797|9957004|P3|Period 1|Withdrawal of consent before treatment|0
2892130|NCT01837797|9957005|P2|Period 1|Withdrawal of consent before treatment|0
2892131|NCT01837797|9957006|P1|Period 1|Withdrawal of consent before treatment|1
2892132|NCT01837797|9957002|P5|Period 1|Administrative reasons|0
2892133|NCT01837797|9957003|P4|Period 1|Administrative reasons|0
2892134|NCT01837797|9957004|P3|Period 1|Administrative reasons|0
2892135|NCT01837797|9957005|P2|Period 1|Administrative reasons|0
2892136|NCT01837797|9957006|P1|Period 1|Administrative reasons|76
2892137|NCT01837797|9957002|P5|Period 1|Withdrawal by Subject|0
2892138|NCT01837797|9957003|P4|Period 1|Withdrawal by Subject|0
2892139|NCT01837797|9957004|P3|Period 1|Withdrawal by Subject|0
2892140|NCT01837797|9957005|P2|Period 1|Withdrawal by Subject|0
2892141|NCT01837797|9957006|P1|Period 1|Withdrawal by Subject|6
2892142|NCT01837797|9957002|P5|Period 1|Adverse Event|0
2892143|NCT01837797|9957003|P4|Period 1|Adverse Event|0
2892144|NCT01837797|9957004|P3|Period 1|Adverse Event|0
2892145|NCT01837797|9957005|P2|Period 1|Adverse Event|0
2892146|NCT01837797|9957006|P1|Period 1|Adverse Event|9
2892147|NCT01837719|9957041|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
2892148|NCT01837719|9957041|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
2892149|NCT01837680|9957110|P2|Overall Study|switched to oral hypoglycemic or diet|4
2892150|NCT01837680|9957111|P1|Overall Study|switched to oral hypoglycemic or diet|2
2892151|NCT01837680|9957110|P2|Overall Study|allergic reaction|0
2892152|NCT01837680|9957111|P1|Overall Study|allergic reaction|6
2892153|NCT01837680|9957110|P2|Overall Study|lack of insurance|2
2892154|NCT01837680|9957111|P1|Overall Study|lack of insurance|0
2892155|NCT01837680|9957110|P2|Overall Study|Lost to Follow-up|2
2892156|NCT01837680|9957111|P1|Overall Study|Lost to Follow-up|2
2892157|NCT01836549|9957230|P7|Overall Study|Patient inevaluable to start therapy|1
2892158|NCT01836549|9957231|P6|Overall Study|Patient inevaluable to start therapy|0
2892159|NCT01836549|9957232|P5|Overall Study|Patient inevaluable to start therapy|0
2892160|NCT01836549|9957233|P4|Overall Study|Patient inevaluable to start therapy|0
2892161|NCT01836549|9957234|P3|Overall Study|Patient inevaluable to start therapy|0
2892162|NCT01836549|9957235|P2|Overall Study|Patient inevaluable to start therapy|0
2892163|NCT01836549|9957236|P1|Overall Study|Patient inevaluable to start therapy|0
2892164|NCT01836549|9957230|P7|Overall Study|Patient declared ineligible|0
2892165|NCT01836549|9957231|P6|Overall Study|Patient declared ineligible|0
2892166|NCT01836549|9957232|P5|Overall Study|Patient declared ineligible|0
2892167|NCT01836549|9957233|P4|Overall Study|Patient declared ineligible|1
2892168|NCT01836549|9957234|P3|Overall Study|Patient declared ineligible|0
2892169|NCT01836549|9957235|P2|Overall Study|Patient declared ineligible|0
2892170|NCT01836549|9957236|P1|Overall Study|Patient declared ineligible|0
2892171|NCT01836549|9957230|P7|Overall Study|Did not receive study drug|0
2892172|NCT01836549|9957231|P6|Overall Study|Did not receive study drug|0
2892173|NCT01836549|9957232|P5|Overall Study|Did not receive study drug|0
2892174|NCT01836549|9957233|P4|Overall Study|Did not receive study drug|0
2892175|NCT01836549|9957234|P3|Overall Study|Did not receive study drug|1
2892176|NCT01836549|9957235|P2|Overall Study|Did not receive study drug|0
2892177|NCT01836549|9957236|P1|Overall Study|Did not receive study drug|0
2892178|NCT01836523|9957260|P4|Overall Study|Unclassified|29
2892179|NCT01836523|9957261|P3|Overall Study|Unclassified|19
2892180|NCT01836523|9957262|P2|Overall Study|Unclassified|28
2892181|NCT01836523|9957263|P1|Overall Study|Unclassified|17
2892182|NCT01836523|9957260|P4|Overall Study|Met Withdrawal Criteria|27
2892183|NCT01836523|9957261|P3|Overall Study|Met Withdrawal Criteria|21
2892184|NCT01836523|9957262|P2|Overall Study|Met Withdrawal Criteria|13
2892185|NCT01836523|9957263|P1|Overall Study|Met Withdrawal Criteria|13
2892186|NCT01836523|9957260|P4|Overall Study|Protocol Violation|4
2892187|NCT01836523|9957261|P3|Overall Study|Protocol Violation|2
2892188|NCT01836523|9957262|P2|Overall Study|Protocol Violation|3
2892189|NCT01836523|9957263|P1|Overall Study|Protocol Violation|6
2892190|NCT01836523|9957260|P4|Overall Study|Adverse Event|14
2892191|NCT01836523|9957261|P3|Overall Study|Adverse Event|49
2892192|NCT01836523|9957262|P2|Overall Study|Adverse Event|41
2892193|NCT01836523|9957263|P1|Overall Study|Adverse Event|15
2892194|NCT01836471|9957290|P5|Overall Study|Non compliance with tx|0
2892195|NCT01836471|9957291|P4|Overall Study|Non compliance with tx|0
2892196|NCT01836471|9957292|P3|Overall Study|Non compliance with tx|0
2892197|NCT01836471|9957293|P2|Overall Study|Non compliance with tx|1
2892198|NCT01836471|9957294|P1|Overall Study|Non compliance with tx|1
2892199|NCT01836471|9957290|P5|Overall Study|Adverse Event|2
2892200|NCT01836471|9957291|P4|Overall Study|Adverse Event|1
2892201|NCT01836471|9957292|P3|Overall Study|Adverse Event|1
2892202|NCT01836471|9957293|P2|Overall Study|Adverse Event|3
2892203|NCT01836471|9957294|P1|Overall Study|Adverse Event|6
2892204|NCT01836471|9957290|P5|Overall Study|Lost to Follow-up|1
2892205|NCT01836471|9957291|P4|Overall Study|Lost to Follow-up|1
2892206|NCT01836471|9957292|P3|Overall Study|Lost to Follow-up|0
2892207|NCT01836471|9957293|P2|Overall Study|Lost to Follow-up|0
2892208|NCT01836471|9957294|P1|Overall Study|Lost to Follow-up|0
2892209|NCT01836471|9957290|P5|Overall Study|Physician Decision|0
2892210|NCT01836471|9957291|P4|Overall Study|Physician Decision|0
2892211|NCT01836471|9957292|P3|Overall Study|Physician Decision|0
2892212|NCT01836471|9957293|P2|Overall Study|Physician Decision|1
2892213|NCT01836471|9957294|P1|Overall Study|Physician Decision|0
2892214|NCT01836471|9957290|P5|Overall Study|Withdrawal by Subject|2
2892215|NCT01836471|9957291|P4|Overall Study|Withdrawal by Subject|0
2892216|NCT01836471|9957292|P3|Overall Study|Withdrawal by Subject|1
2892217|NCT01836471|9957293|P2|Overall Study|Withdrawal by Subject|4
2892218|NCT01836471|9957294|P1|Overall Study|Withdrawal by Subject|3
2892219|NCT01836471|9957290|P5|Overall Study|Pregnancy|0
2892220|NCT01836471|9957291|P4|Overall Study|Pregnancy|0
2892221|NCT01836471|9957292|P3|Overall Study|Pregnancy|0
2892222|NCT01836471|9957293|P2|Overall Study|Pregnancy|0
2892223|NCT01836471|9957294|P1|Overall Study|Pregnancy|1
2892224|NCT01836458|9957323|P4|Overall Study|Unsatisfactory therapeutic effect|6
2892225|NCT01836458|9957324|P3|Overall Study|Unsatisfactory therapeutic effect|5
2892226|NCT01836458|9957325|P2|Overall Study|Unsatisfactory therapeutic effect|2
2892227|NCT01836458|9957326|P1|Overall Study|Unsatisfactory therapeutic effect|3
2892228|NCT01836276|9957411|P2|Overall Study|Lost to Follow-up|51
2892229|NCT01836276|9957412|P1|Overall Study|Lost to Follow-up|28
2892230|NCT01836198|9957420|P3|Part A, Period 2|Protocol Violation|0
2892231|NCT01836198|9957421|P2|Part A, Period 2|Protocol Violation|1
2892232|NCT01836198|9957422|P1|Part A, Period 2|Protocol Violation|0
2892233|NCT01835899|9957524|P3|Overall Study|Other than stated above|0
2892234|NCT01835899|9957525|P2|Overall Study|Other than stated above|1
2892235|NCT01835899|9957526|P1|Overall Study|Other than stated above|0
2892236|NCT01835899|9957524|P3|Overall Study|Adverse Event|1
2892237|NCT01835899|9957525|P2|Overall Study|Adverse Event|0
2892238|NCT01835899|9957526|P1|Overall Study|Adverse Event|0
2892239|NCT01835587|9957572|P4|Overall Study|Miscellaneous|0
2892240|NCT01835587|9957573|P3|Overall Study|Miscellaneous|0
2892241|NCT01835587|9957574|P2|Overall Study|Miscellaneous|1
2892242|NCT01835587|9957575|P1|Overall Study|Miscellaneous|0
2892243|NCT01835587|9957572|P4|Overall Study|Death|1
2892244|NCT01835587|9957573|P3|Overall Study|Death|0
2892245|NCT01835587|9957574|P2|Overall Study|Death|0
2892246|NCT01835587|9957575|P1|Overall Study|Death|0
2892247|NCT01835587|9957572|P4|Overall Study|Adverse Event|2
2892248|NCT01835587|9957573|P3|Overall Study|Adverse Event|2
2892249|NCT01835587|9957574|P2|Overall Study|Adverse Event|0
2892250|NCT01835587|9957575|P1|Overall Study|Adverse Event|0
2892251|NCT01835587|9957572|P4|Overall Study|Withdrawal by Subject|3
2892252|NCT01835587|9957573|P3|Overall Study|Withdrawal by Subject|0
2892253|NCT01835587|9957574|P2|Overall Study|Withdrawal by Subject|0
2892254|NCT01835587|9957575|P1|Overall Study|Withdrawal by Subject|2
2892255|NCT01835587|9957572|P4|Overall Study|Disease Recurrence or Relapse|3
2892256|NCT01835587|9957573|P3|Overall Study|Disease Recurrence or Relapse|0
2892257|NCT01835587|9957574|P2|Overall Study|Disease Recurrence or Relapse|3
2892258|NCT01835587|9957575|P1|Overall Study|Disease Recurrence or Relapse|0
2892259|NCT01835548|9957636|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
2892260|NCT01835548|9957637|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2892261|NCT01835548|9957638|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2892262|NCT01835548|9957636|P3|Double-Blind Treatment Period|Adverse Event|0
2892263|NCT01835548|9957637|P2|Double-Blind Treatment Period|Adverse Event|1
2892264|NCT01835548|9957638|P1|Double-Blind Treatment Period|Adverse Event|0
2892265|NCT01835548|9957636|P3|Dose Optimization Period|Withdrawal by Subject|1
2892266|NCT01835548|9957637|P2|Dose Optimization Period|Withdrawal by Subject|0
2892267|NCT01835548|9957638|P1|Dose Optimization Period|Withdrawal by Subject|0
2892268|NCT01835548|9957636|P3|Dose Optimization Period|Adverse Event|1
2892269|NCT01835548|9957637|P2|Dose Optimization Period|Adverse Event|0
2892270|NCT01835548|9957638|P1|Dose Optimization Period|Adverse Event|0
2892271|NCT01835470|9957667|P1|Long Term Treatment Period|Lack of Efficacy|3
2892272|NCT01835470|9957667|P1|Long Term Treatment Period|Subject Request to Discontinue|1
2892273|NCT01835431|9957679|P2|Overall Study|Protocol Violation|0
2892274|NCT01835431|9957680|P1|Overall Study|Protocol Violation|1
2892275|NCT01835431|9957679|P2|Overall Study|Withdrawal by Subject|10
2892276|NCT01835431|9957680|P1|Overall Study|Withdrawal by Subject|6
2892277|NCT01835431|9957679|P2|Overall Study|other|2
2892278|NCT01835431|9957680|P1|Overall Study|other|0
2892279|NCT01835431|9957679|P2|Overall Study|Adverse Event|0
2892280|NCT01835431|9957680|P1|Overall Study|Adverse Event|1
2892281|NCT01835158|9957720|P2|Overall Study|Withdrawal by Subject|6
2892282|NCT01835158|9957721|P1|Overall Study|Withdrawal by Subject|1
2892283|NCT01835145|9957733|P2|Overall Study|Ineligible prior to treatment|0
2892284|NCT01835145|9957734|P1|Overall Study|Ineligible prior to treatment|1
2892285|NCT01835132|9957749|P1|Initial Phase|Insufficient Therapeutic Response|2
2892286|NCT01835015|9957794|P5|Overall Study|Adverse Event|0
2892287|NCT01835015|9957795|P4|Overall Study|Adverse Event|0
2892288|NCT01835015|9957796|P3|Overall Study|Adverse Event|1
2892289|NCT01835015|9957797|P2|Overall Study|Adverse Event|0
2892290|NCT01835015|9957798|P1|Overall Study|Adverse Event|0
2892291|NCT01834729|9957875|P4|Overall Study|Adverse Event|2
2892292|NCT01834729|9957876|P3|Overall Study|Adverse Event|0
2892293|NCT01834729|9957877|P2|Overall Study|Adverse Event|0
2892294|NCT01834729|9957878|P1|Overall Study|Adverse Event|0
2892295|NCT01834729|9957875|P4|Overall Study|Withdrawal by Subject|0
2892296|NCT01834729|9957876|P3|Overall Study|Withdrawal by Subject|0
2892297|NCT01834729|9957877|P2|Overall Study|Withdrawal by Subject|1
2892298|NCT01834729|9957878|P1|Overall Study|Withdrawal by Subject|1
2892299|NCT01834729|9957875|P4|Overall Study|Did not return bowel diaries|0
2892300|NCT01834729|9957876|P3|Overall Study|Did not return bowel diaries|3
2892301|NCT01834729|9957877|P2|Overall Study|Did not return bowel diaries|0
2892302|NCT01834729|9957878|P1|Overall Study|Did not return bowel diaries|0
2892303|NCT01834586|9957911|P1|Overall Study|Adverse Event|1
2892304|NCT01834274|9957951|P2|Overall Study|Other|1
2892305|NCT01834274|9957952|P1|Overall Study|Other|2
2892306|NCT01834274|9957951|P2|Overall Study|Lost to Follow-up|1
2892307|NCT01834274|9957952|P1|Overall Study|Lost to Follow-up|3
2892308|NCT01834274|9957951|P2|Overall Study|Withdrawal by Subject|1
2892309|NCT01834274|9957952|P1|Overall Study|Withdrawal by Subject|1
2892310|NCT01834274|9957951|P2|Overall Study|Study Termination|38
2892311|NCT01834274|9957952|P1|Overall Study|Study Termination|41
2892312|NCT01834222|9957975|P1|Overall Study|Not meet inclusion/exclusion criteria|1
2892313|NCT01833897|9958070|P1|Overall Study|Lack of Efficacy|1
2892314|NCT01833832|9958082|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
2892315|NCT01833533|9958237|P2|Overall Study|Other|7
2892316|NCT01833533|9958238|P1|Overall Study|Other|2
2892317|NCT01833533|9958237|P2|Overall Study|To Enter an Extension Study|4
2892318|NCT01833533|9958238|P1|Overall Study|To Enter an Extension Study|0
2892319|NCT01833533|9958237|P2|Overall Study|Lost to Follow-up|9
2892320|NCT01833533|9958238|P1|Overall Study|Lost to Follow-up|4
2892321|NCT01833533|9958237|P2|Overall Study|Adverse Event|1
2892322|NCT01833533|9958238|P1|Overall Study|Adverse Event|0
2892323|NCT01833494|9958252|P1|Overall Study|Increase in serum ferritin|1
2892324|NCT01833494|9958252|P1|Overall Study|Decrease in serum calcium|4
2892325|NCT01833494|9958252|P1|Overall Study|Decrease in serum phosphorus|4
2892326|NCT01833494|9958252|P1|Overall Study|Withdrawal by Subject|6
2892327|NCT01833494|9958252|P1|Overall Study|Physician Decision|6
2892328|NCT01833494|9958252|P1|Overall Study|Adverse Event|24
2892329|NCT01833455|9958280|P2|Overall Study|Withdrawal by Subject|0
2892330|NCT01833455|9958281|P1|Overall Study|Withdrawal by Subject|1
2892331|NCT01833169|9958310|P1|Overall Study|Physician Decision|2
2892332|NCT01833169|9958310|P1|Overall Study|Death|3
2892333|NCT01833169|9958310|P1|Overall Study|Withdrawal by Subject|9
2892334|NCT01833169|9958310|P1|Overall Study|Adverse Event|33
2892335|NCT01833169|9958310|P1|Overall Study|Disease Progression|99
2892336|NCT01833065|9958379|P5|Overall Study|Others|4
2892337|NCT01833065|9958380|P4|Overall Study|Others|1
2892338|NCT01833065|9958381|P3|Overall Study|Others|1
2892339|NCT01833065|9958382|P2|Overall Study|Others|1
2892340|NCT01833065|9958383|P1|Overall Study|Others|2
2892341|NCT01833065|9958379|P5|Overall Study|Trial terminated by sponsor|13
2892342|NCT01833065|9958380|P4|Overall Study|Trial terminated by sponsor|3
2892343|NCT01833065|9958381|P3|Overall Study|Trial terminated by sponsor|7
2892344|NCT01833065|9958382|P2|Overall Study|Trial terminated by sponsor|8
2892345|NCT01833065|9958383|P1|Overall Study|Trial terminated by sponsor|8
2892346|NCT01833065|9958379|P5|Overall Study|Subject's substantial non-compliance|0
2892347|NCT01833065|9958380|P4|Overall Study|Subject's substantial non-compliance|0
2892348|NCT01833065|9958381|P3|Overall Study|Subject's substantial non-compliance|0
2892349|NCT01833065|9958382|P2|Overall Study|Subject's substantial non-compliance|1
2892350|NCT01833065|9958383|P1|Overall Study|Subject's substantial non-compliance|0
2892351|NCT01833065|9958379|P5|Overall Study|Withdrawal by Subject|11
2892352|NCT01833065|9958380|P4|Overall Study|Withdrawal by Subject|3
2892353|NCT01833065|9958381|P3|Overall Study|Withdrawal by Subject|4
2892354|NCT01833065|9958382|P2|Overall Study|Withdrawal by Subject|2
2892355|NCT01833065|9958383|P1|Overall Study|Withdrawal by Subject|6
2892356|NCT01833065|9958379|P5|Overall Study|Lost to Follow-up|3
2892357|NCT01833065|9958380|P4|Overall Study|Lost to Follow-up|0
2892358|NCT01833065|9958381|P3|Overall Study|Lost to Follow-up|0
2892359|NCT01833065|9958382|P2|Overall Study|Lost to Follow-up|0
2892360|NCT01833065|9958383|P1|Overall Study|Lost to Follow-up|1
2892361|NCT01833065|9958379|P5|Overall Study|Protocol Violation|2
2892362|NCT01833065|9958380|P4|Overall Study|Protocol Violation|0
2892363|NCT01833065|9958381|P3|Overall Study|Protocol Violation|0
2892364|NCT01833065|9958382|P2|Overall Study|Protocol Violation|0
2892365|NCT01833065|9958383|P1|Overall Study|Protocol Violation|1
2892366|NCT01833065|9958379|P5|Overall Study|Adverse Event|3
2892367|NCT01833065|9958380|P4|Overall Study|Adverse Event|2
2892368|NCT01833065|9958381|P3|Overall Study|Adverse Event|0
2892369|NCT01833065|9958382|P2|Overall Study|Adverse Event|1
2892370|NCT01833065|9958383|P1|Overall Study|Adverse Event|6
2892371|NCT01832818|9958452|P1|Overall Study|Lost to Follow-up|6
2892372|NCT01832766|9958461|P2|Washout|Lost to Follow-up|1
2892373|NCT01832766|9958462|P1|Washout|Lost to Follow-up|0
2892374|NCT01832493|9958556|P1|Overall Study|Unable to place LV lead|2
2892375|NCT01832493|9958556|P1|Overall Study|Protocol Violation|4
2892376|NCT01832493|9958556|P1|Overall Study|Physician Decision|2
2892377|NCT01832480|9958565|P2|Overall Study|post randomization ineligible|10
2892378|NCT01832480|9958566|P1|Overall Study|post randomization ineligible|8
2892379|NCT01832480|9958565|P2|Overall Study|Withdrawal by Subject|2
2892380|NCT01832480|9958566|P1|Overall Study|Withdrawal by Subject|0
2892381|NCT01832480|9958565|P2|Overall Study|Lost to Follow-up|30
2892382|NCT01832480|9958566|P1|Overall Study|Lost to Follow-up|33
2892383|NCT01832155|9958587|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
2892384|NCT01832155|9958588|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
2892385|NCT01832155|9958587|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
2892386|NCT01832155|9958588|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
2892387|NCT01831856|9958691|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
2892388|NCT01831856|9958692|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
2892389|NCT01831856|9958691|P2|Overall Study|Lack of Efficacy|11
2892390|NCT01831856|9958692|P1|Overall Study|Lack of Efficacy|13
2892391|NCT01831856|9958691|P2|Overall Study|Adverse Event|8
2892392|NCT01831856|9958692|P1|Overall Study|Adverse Event|5
2892393|NCT01831817|9958702|P4|Overall Study|Withdrawl of Consent|0
2892394|NCT01831817|9958703|P3|Overall Study|Withdrawl of Consent|0
2892395|NCT01831817|9958704|P2|Overall Study|Withdrawl of Consent|0
2892396|NCT01831817|9958705|P1|Overall Study|Withdrawl of Consent|3
2892397|NCT01831817|9958702|P4|Overall Study|Lost to Follow-up|0
2892398|NCT01831817|9958703|P3|Overall Study|Lost to Follow-up|0
2892399|NCT01831817|9958704|P2|Overall Study|Lost to Follow-up|0
2892400|NCT01831817|9958705|P1|Overall Study|Lost to Follow-up|1
2892401|NCT01831804|9958752|P9|Overall Study|Withdrew Consent|0
2892402|NCT01831804|9958753|P8|Overall Study|Withdrew Consent|2
2892403|NCT01831804|9958754|P7|Overall Study|Withdrew Consent|0
2892404|NCT01831804|9958755|P6|Overall Study|Withdrew Consent|0
2892405|NCT01831804|9958756|P5|Overall Study|Withdrew Consent|0
2892406|NCT01831804|9958757|P4|Overall Study|Withdrew Consent|0
2892407|NCT01831804|9958758|P3|Overall Study|Withdrew Consent|0
2892408|NCT01831804|9958759|P2|Overall Study|Withdrew Consent|1
2892409|NCT01831804|9958760|P1|Overall Study|Withdrew Consent|0
2892410|NCT01831804|9958752|P9|Overall Study|Investigator discretion|0
2892411|NCT01831804|9958753|P8|Overall Study|Investigator discretion|1
2892412|NCT01831804|9958754|P7|Overall Study|Investigator discretion|0
2892413|NCT01831804|9958755|P6|Overall Study|Investigator discretion|0
2892414|NCT01831804|9958756|P5|Overall Study|Investigator discretion|1
2892415|NCT01831804|9958757|P4|Overall Study|Investigator discretion|0
2892416|NCT01831804|9958758|P3|Overall Study|Investigator discretion|0
2892417|NCT01831804|9958759|P2|Overall Study|Investigator discretion|0
2892418|NCT01831804|9958760|P1|Overall Study|Investigator discretion|0
2892419|NCT01831804|9958752|P9|Overall Study|Lost to Follow-up|1
2892420|NCT01831804|9958753|P8|Overall Study|Lost to Follow-up|0
2892421|NCT01831804|9958754|P7|Overall Study|Lost to Follow-up|0
2892422|NCT01831804|9958755|P6|Overall Study|Lost to Follow-up|0
2892423|NCT01831804|9958756|P5|Overall Study|Lost to Follow-up|0
2892424|NCT01831804|9958757|P4|Overall Study|Lost to Follow-up|0
2892425|NCT01831804|9958758|P3|Overall Study|Lost to Follow-up|1
2892426|NCT01831804|9958759|P2|Overall Study|Lost to Follow-up|0
2892427|NCT01831804|9958760|P1|Overall Study|Lost to Follow-up|0
2892428|NCT01831804|9958752|P9|Overall Study|Protocol defined stopping criteria|0
2892429|NCT01831804|9958753|P8|Overall Study|Protocol defined stopping criteria|0
2892430|NCT01831804|9958754|P7|Overall Study|Protocol defined stopping criteria|0
2892431|NCT01831804|9958755|P6|Overall Study|Protocol defined stopping criteria|0
2892432|NCT01831804|9958756|P5|Overall Study|Protocol defined stopping criteria|1
2892433|NCT01831804|9958757|P4|Overall Study|Protocol defined stopping criteria|0
2892434|NCT01831804|9958758|P3|Overall Study|Protocol defined stopping criteria|3
2892435|NCT01831804|9958759|P2|Overall Study|Protocol defined stopping criteria|1
2892436|NCT01831804|9958760|P1|Overall Study|Protocol defined stopping criteria|1
2892437|NCT01831804|9958752|P9|Overall Study|Protocol Violation|0
2892438|NCT01831804|9958753|P8|Overall Study|Protocol Violation|0
2892439|NCT01831804|9958754|P7|Overall Study|Protocol Violation|0
2892440|NCT01831804|9958755|P6|Overall Study|Protocol Violation|0
2892441|NCT01831804|9958756|P5|Overall Study|Protocol Violation|0
2892442|NCT01831804|9958757|P4|Overall Study|Protocol Violation|0
2892443|NCT01831804|9958758|P3|Overall Study|Protocol Violation|2
2892444|NCT01831804|9958759|P2|Overall Study|Protocol Violation|0
2892445|NCT01831804|9958760|P1|Overall Study|Protocol Violation|0
2892446|NCT01831804|9958752|P9|Overall Study|Adverse Event|1
2892447|NCT01831804|9958753|P8|Overall Study|Adverse Event|0
2892448|NCT01831804|9958754|P7|Overall Study|Adverse Event|1
2892449|NCT01831804|9958755|P6|Overall Study|Adverse Event|0
2892450|NCT01831804|9958756|P5|Overall Study|Adverse Event|0
2892451|NCT01831804|9958757|P4|Overall Study|Adverse Event|0
2892452|NCT01831804|9958758|P3|Overall Study|Adverse Event|0
2892453|NCT01831804|9958759|P2|Overall Study|Adverse Event|0
2892454|NCT01831804|9958760|P1|Overall Study|Adverse Event|0
2892455|NCT01831791|9958855|P1|Overall Study|Withdrawal by Subject|10
2892456|NCT01831765|9958884|P3|Overall Study|Lost to Follow-up|3
2892457|NCT01831765|9958885|P2|Overall Study|Lost to Follow-up|3
2892458|NCT01831765|9958886|P1|Overall Study|Lost to Follow-up|2
2892459|NCT01831765|9958884|P3|Overall Study|Withdrawal criteria|16
2892460|NCT01831765|9958885|P2|Overall Study|Withdrawal criteria|10
2892461|NCT01831765|9958886|P1|Overall Study|Withdrawal criteria|12
2892462|NCT01831765|9958884|P3|Overall Study|Withdrawal by Subject|17
2892463|NCT01831765|9958885|P2|Overall Study|Withdrawal by Subject|7
2892464|NCT01831765|9958886|P1|Overall Study|Withdrawal by Subject|22
2892465|NCT01831765|9958884|P3|Overall Study|Adverse Event|3
2892466|NCT01831765|9958885|P2|Overall Study|Adverse Event|3
2892467|NCT01831765|9958886|P1|Overall Study|Adverse Event|5
2892468|NCT01831765|9958884|P3|Overall Study|Other, site closed|0
2892469|NCT01831765|9958885|P2|Overall Study|Other, site closed|1
2892470|NCT01831765|9958886|P1|Overall Study|Other, site closed|1
2892471|NCT01831765|9958884|P3|Overall Study|Death|1
2892472|NCT01831765|9958885|P2|Overall Study|Death|1
2892473|NCT01831765|9958886|P1|Overall Study|Death|0
2892474|NCT01831765|9958884|P3|Overall Study|Pregnancy|2
2892475|NCT01831765|9958885|P2|Overall Study|Pregnancy|1
2892476|NCT01831765|9958886|P1|Overall Study|Pregnancy|1
2892477|NCT01831765|9958884|P3|Overall Study|Other, sponsor withdrew subject|0
2892478|NCT01831765|9958885|P2|Overall Study|Other, sponsor withdrew subject|1
2892479|NCT01831765|9958886|P1|Overall Study|Other, sponsor withdrew subject|0
2892480|NCT01831765|9958884|P3|Overall Study|Lack of Efficacy|0
2892481|NCT01831765|9958885|P2|Overall Study|Lack of Efficacy|0
2892482|NCT01831765|9958886|P1|Overall Study|Lack of Efficacy|1
2892483|NCT01831726|9958912|P1|Overall Study|Subject/guardian decision|7
2892484|NCT01831726|9958912|P1|Overall Study|Physician Decision|1
2892485|NCT01831726|9958912|P1|Overall Study|Disease Progression|49
2892486|NCT01831726|9958912|P1|Overall Study|Death|7
2892487|NCT01831726|9958912|P1|Overall Study|Adverse Event|16
2892488|NCT01831544|9958919|P1|Overall Study|Still on original MVAD device|2
2892489|NCT01831544|9958919|P1|Overall Study|Death|1
2892490|NCT01831466|9958948|P12|Overall Study|Adverse Event|2
2892491|NCT01831466|9958949|P11|Overall Study|Adverse Event|0
2892492|NCT01831466|9958950|P10|Overall Study|Adverse Event|1
2892493|NCT01831466|9958951|P9|Overall Study|Adverse Event|1
2892494|NCT01831466|9958952|P8|Overall Study|Adverse Event|1
2892495|NCT01831466|9958953|P7|Overall Study|Adverse Event|0
2892496|NCT01831466|9958954|P6|Overall Study|Adverse Event|7
2892497|NCT01831466|9958955|P5|Overall Study|Adverse Event|3
2892498|NCT01831466|9958956|P4|Overall Study|Adverse Event|6
2892499|NCT01831466|9958957|P3|Overall Study|Adverse Event|4
2892500|NCT01831466|9958958|P2|Overall Study|Adverse Event|0
2892501|NCT01831466|9958959|P1|Overall Study|Adverse Event|0
2892502|NCT01831466|9958948|P12|Overall Study|Lack of Efficacy|0
2892503|NCT01831466|9958949|P11|Overall Study|Lack of Efficacy|2
2892504|NCT01831466|9958950|P10|Overall Study|Lack of Efficacy|2
2892505|NCT01831466|9958951|P9|Overall Study|Lack of Efficacy|2
2892506|NCT01831466|9958952|P8|Overall Study|Lack of Efficacy|1
2892507|NCT01831466|9958953|P7|Overall Study|Lack of Efficacy|1
2892508|NCT01831466|9958954|P6|Overall Study|Lack of Efficacy|8
2892509|NCT01831466|9958955|P5|Overall Study|Lack of Efficacy|9
2892510|NCT01831466|9958956|P4|Overall Study|Lack of Efficacy|6
2892511|NCT01831466|9958957|P3|Overall Study|Lack of Efficacy|7
2892512|NCT01831466|9958958|P2|Overall Study|Lack of Efficacy|8
2892513|NCT01831466|9958959|P1|Overall Study|Lack of Efficacy|5
2892514|NCT01831466|9958948|P12|Overall Study|Lost to Follow-up|1
2892515|NCT01831466|9958949|P11|Overall Study|Lost to Follow-up|0
2892516|NCT01831466|9958950|P10|Overall Study|Lost to Follow-up|1
2892517|NCT01831466|9958951|P9|Overall Study|Lost to Follow-up|0
2892518|NCT01831466|9958952|P8|Overall Study|Lost to Follow-up|0
2892519|NCT01831466|9958953|P7|Overall Study|Lost to Follow-up|0
2892520|NCT01831466|9958954|P6|Overall Study|Lost to Follow-up|3
2892521|NCT01831466|9958955|P5|Overall Study|Lost to Follow-up|0
2892522|NCT01831466|9958956|P4|Overall Study|Lost to Follow-up|2
2892523|NCT01831466|9958957|P3|Overall Study|Lost to Follow-up|4
2892524|NCT01831466|9958958|P2|Overall Study|Lost to Follow-up|1
2892525|NCT01831466|9958959|P1|Overall Study|Lost to Follow-up|0
2892526|NCT01831466|9958948|P12|Overall Study|Withdrawal by Subject|1
2892527|NCT01831466|9958949|P11|Overall Study|Withdrawal by Subject|0
2892528|NCT01831466|9958950|P10|Overall Study|Withdrawal by Subject|1
2892529|NCT01831466|9958951|P9|Overall Study|Withdrawal by Subject|0
2892530|NCT01831466|9958952|P8|Overall Study|Withdrawal by Subject|0
2892531|NCT01831466|9958953|P7|Overall Study|Withdrawal by Subject|0
2892532|NCT01831466|9958954|P6|Overall Study|Withdrawal by Subject|5
2892533|NCT01831466|9958955|P5|Overall Study|Withdrawal by Subject|3
2892534|NCT01831466|9958956|P4|Overall Study|Withdrawal by Subject|3
2892535|NCT01831466|9958957|P3|Overall Study|Withdrawal by Subject|3
2892536|NCT01831466|9958958|P2|Overall Study|Withdrawal by Subject|3
2892537|NCT01831466|9958959|P1|Overall Study|Withdrawal by Subject|6
2892538|NCT01831466|9958948|P12|Overall Study|Death|0
2892539|NCT01831466|9958949|P11|Overall Study|Death|0
2892540|NCT01831466|9958950|P10|Overall Study|Death|0
2892541|NCT01831466|9958951|P9|Overall Study|Death|0
2892542|NCT01831466|9958952|P8|Overall Study|Death|0
2892543|NCT01831466|9958953|P7|Overall Study|Death|0
2892544|NCT01831466|9958954|P6|Overall Study|Death|0
2892545|NCT01831466|9958955|P5|Overall Study|Death|0
2892546|NCT01831466|9958956|P4|Overall Study|Death|0
2892547|NCT01831466|9958957|P3|Overall Study|Death|0
2892548|NCT01831466|9958958|P2|Overall Study|Death|1
2892549|NCT01831466|9958959|P1|Overall Study|Death|0
2892550|NCT01831466|9958948|P12|Overall Study|Non-compliance with study treatment|0
2892551|NCT01831466|9958949|P11|Overall Study|Non-compliance with study treatment|0
2892552|NCT01831466|9958950|P10|Overall Study|Non-compliance with study treatment|0
2892553|NCT01831466|9958951|P9|Overall Study|Non-compliance with study treatment|0
2892554|NCT01831466|9958952|P8|Overall Study|Non-compliance with study treatment|0
2892555|NCT01831466|9958953|P7|Overall Study|Non-compliance with study treatment|0
2892556|NCT01831466|9958954|P6|Overall Study|Non-compliance with study treatment|1
2892557|NCT01831466|9958955|P5|Overall Study|Non-compliance with study treatment|0
2892558|NCT01831466|9958956|P4|Overall Study|Non-compliance with study treatment|0
2892559|NCT01831466|9958957|P3|Overall Study|Non-compliance with study treatment|1
2892560|NCT01831466|9958958|P2|Overall Study|Non-compliance with study treatment|1
2892561|NCT01831466|9958959|P1|Overall Study|Non-compliance with study treatment|2
2892562|NCT01831466|9958948|P12|Overall Study|Other|0
2892563|NCT01831466|9958949|P11|Overall Study|Other|0
2892564|NCT01831466|9958950|P10|Overall Study|Other|0
2892565|NCT01831466|9958951|P9|Overall Study|Other|0
2892566|NCT01831466|9958952|P8|Overall Study|Other|0
2892567|NCT01831466|9958953|P7|Overall Study|Other|0
2892568|NCT01831466|9958954|P6|Overall Study|Other|1
2892569|NCT01831466|9958955|P5|Overall Study|Other|2
2892570|NCT01831466|9958956|P4|Overall Study|Other|2
2892571|NCT01831466|9958957|P3|Overall Study|Other|2
2892572|NCT01831466|9958958|P2|Overall Study|Other|3
2892573|NCT01831466|9958959|P1|Overall Study|Other|2
2892574|NCT01831466|9958948|P12|Overall Study|Protocol Violation|0
2892575|NCT01831466|9958949|P11|Overall Study|Protocol Violation|0
2892576|NCT01831466|9958950|P10|Overall Study|Protocol Violation|0
2892577|NCT01831466|9958951|P9|Overall Study|Protocol Violation|0
2892578|NCT01831466|9958952|P8|Overall Study|Protocol Violation|0
2892579|NCT01831466|9958953|P7|Overall Study|Protocol Violation|0
2892580|NCT01831466|9958954|P6|Overall Study|Protocol Violation|1
2892581|NCT01831466|9958955|P5|Overall Study|Protocol Violation|0
2892582|NCT01831466|9958956|P4|Overall Study|Protocol Violation|0
2892583|NCT01831466|9958957|P3|Overall Study|Protocol Violation|2
2892584|NCT01831466|9958958|P2|Overall Study|Protocol Violation|1
2892585|NCT01831466|9958959|P1|Overall Study|Protocol Violation|1
2892586|NCT01831258|9959081|P2|Overall Study|Lost to Follow-up|2
2892587|NCT01831258|9959082|P1|Overall Study|Lost to Follow-up|3
2892588|NCT01831258|9959081|P2|Overall Study|Withdrawal by Subject|1
2892589|NCT01831258|9959082|P1|Overall Study|Withdrawal by Subject|2
2892590|NCT01831089|9959172|P6|Cohort B: Arm B|Global end of study|1
2892591|NCT01831089|9959173|P5|Cohort B: Arm B|Global end of study|0
2892592|NCT01831089|9959174|P4|Cohort B: Arm B|Global end of study|0
2892593|NCT01831089|9959175|P3|Cohort B: Arm B|Global end of study|0
2892594|NCT01831089|9959176|P2|Cohort B: Arm B|Global end of study|0
2892595|NCT01831089|9959177|P1|Cohort B: Arm B|Global end of study|0
2892596|NCT01831089|9959172|P6|Cohort B: Arm B|Adverse Event|1
2892597|NCT01831089|9959173|P5|Cohort B: Arm B|Adverse Event|0
2892598|NCT01831089|9959174|P4|Cohort B: Arm B|Adverse Event|0
2892599|NCT01831089|9959175|P3|Cohort B: Arm B|Adverse Event|0
2892600|NCT01831089|9959176|P2|Cohort B: Arm B|Adverse Event|0
2892601|NCT01831089|9959177|P1|Cohort B: Arm B|Adverse Event|0
2892602|NCT01831089|9959172|P6|Cohort B: Arm B|Never treated|2
2892603|NCT01831089|9959173|P5|Cohort B: Arm B|Never treated|0
2892604|NCT01831089|9959174|P4|Cohort B: Arm B|Never treated|0
2892605|NCT01831089|9959175|P3|Cohort B: Arm B|Never treated|0
2892606|NCT01831089|9959176|P2|Cohort B: Arm B|Never treated|0
2892607|NCT01831089|9959177|P1|Cohort B: Arm B|Never treated|0
2892608|NCT01831089|9959172|P6|Cohort B: Arm B|Physician Decision|2
2892609|NCT01831089|9959173|P5|Cohort B: Arm B|Physician Decision|0
2892610|NCT01831089|9959174|P4|Cohort B: Arm B|Physician Decision|0
2892611|NCT01831089|9959175|P3|Cohort B: Arm B|Physician Decision|0
2892612|NCT01831089|9959176|P2|Cohort B: Arm B|Physician Decision|0
2892613|NCT01831089|9959177|P1|Cohort B: Arm B|Physician Decision|0
2892614|NCT01831089|9959172|P6|Cohort B: Arm B|Progressive disease|8
2892615|NCT01831089|9959173|P5|Cohort B: Arm B|Progressive disease|0
2892616|NCT01831089|9959174|P4|Cohort B: Arm B|Progressive disease|0
2892617|NCT01831089|9959175|P3|Cohort B: Arm B|Progressive disease|0
2892618|NCT01831089|9959176|P2|Cohort B: Arm B|Progressive disease|0
2892619|NCT01831089|9959177|P1|Cohort B: Arm B|Progressive disease|0
2892620|NCT01831089|9959172|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
2892621|NCT01831089|9959173|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
2892622|NCT01831089|9959174|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
2892623|NCT01831089|9959175|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
2892624|NCT01831089|9959176|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
2892625|NCT01831089|9959177|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
2892626|NCT01831089|9959172|P6|Cohort V: Dose Level 5|Global end of study|0
2892627|NCT01831089|9959173|P5|Cohort V: Dose Level 5|Global end of study|2
2892628|NCT01831089|9959174|P4|Cohort V: Dose Level 5|Global end of study|0
2892629|NCT01831089|9959175|P3|Cohort V: Dose Level 5|Global end of study|0
2892630|NCT01831089|9959176|P2|Cohort V: Dose Level 5|Global end of study|0
2892631|NCT01831089|9959177|P1|Cohort V: Dose Level 5|Global end of study|0
2892632|NCT01831089|9959172|P6|Cohort V: Dose Level 5|Death|0
2892633|NCT01831089|9959173|P5|Cohort V: Dose Level 5|Death|1
2892634|NCT01831089|9959174|P4|Cohort V: Dose Level 5|Death|0
2892635|NCT01831089|9959175|P3|Cohort V: Dose Level 5|Death|0
2892636|NCT01831089|9959176|P2|Cohort V: Dose Level 5|Death|0
2892637|NCT01831089|9959177|P1|Cohort V: Dose Level 5|Death|0
2892638|NCT01831089|9959172|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
2892639|NCT01831089|9959173|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
2892640|NCT01831089|9959174|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
2892641|NCT01831089|9959175|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
2892642|NCT01831089|9959176|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
2892643|NCT01831089|9959177|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
2892644|NCT01831089|9959172|P6|Cohort V: Dose Level 5|Progressive disease|0
2892645|NCT01831089|9959173|P5|Cohort V: Dose Level 5|Progressive disease|30
2892646|NCT01831089|9959174|P4|Cohort V: Dose Level 5|Progressive disease|0
2892647|NCT01831089|9959175|P3|Cohort V: Dose Level 5|Progressive disease|0
2892648|NCT01831089|9959176|P2|Cohort V: Dose Level 5|Progressive disease|0
2892649|NCT01831089|9959177|P1|Cohort V: Dose Level 5|Progressive disease|0
2892650|NCT01831089|9959172|P6|Cohort IV: Dose Level 4|Progressive disease|0
2892651|NCT01831089|9959173|P5|Cohort IV: Dose Level 4|Progressive disease|0
2892652|NCT01831089|9959174|P4|Cohort IV: Dose Level 4|Progressive disease|6
2892653|NCT01831089|9959175|P3|Cohort IV: Dose Level 4|Progressive disease|0
2892654|NCT01831089|9959176|P2|Cohort IV: Dose Level 4|Progressive disease|0
2892655|NCT01831089|9959177|P1|Cohort IV: Dose Level 4|Progressive disease|0
2892656|NCT01831089|9959172|P6|Cohort III: Dose Level 3|Global end of study|0
2892657|NCT01831089|9959173|P5|Cohort III: Dose Level 3|Global end of study|0
2892658|NCT01831089|9959174|P4|Cohort III: Dose Level 3|Global end of study|0
2892659|NCT01831089|9959175|P3|Cohort III: Dose Level 3|Global end of study|1
2892660|NCT01831089|9959176|P2|Cohort III: Dose Level 3|Global end of study|0
2892661|NCT01831089|9959177|P1|Cohort III: Dose Level 3|Global end of study|0
2892662|NCT01831089|9959172|P6|Cohort III: Dose Level 3|Adverse Event|0
2892663|NCT01831089|9959173|P5|Cohort III: Dose Level 3|Adverse Event|0
2892664|NCT01831089|9959174|P4|Cohort III: Dose Level 3|Adverse Event|0
2892665|NCT01831089|9959175|P3|Cohort III: Dose Level 3|Adverse Event|1
2892666|NCT01831089|9959176|P2|Cohort III: Dose Level 3|Adverse Event|0
2892667|NCT01831089|9959177|P1|Cohort III: Dose Level 3|Adverse Event|0
2892668|NCT01831089|9959172|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
2892669|NCT01831089|9959173|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
2892670|NCT01831089|9959174|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
2892671|NCT01831089|9959175|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
2892672|NCT01831089|9959176|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
2892673|NCT01831089|9959177|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
2892674|NCT01831089|9959172|P6|Cohort III: Dose Level 3|Progressive disease|0
2892675|NCT01831089|9959173|P5|Cohort III: Dose Level 3|Progressive disease|0
2892676|NCT01831089|9959174|P4|Cohort III: Dose Level 3|Progressive disease|0
2892677|NCT01831089|9959175|P3|Cohort III: Dose Level 3|Progressive disease|3
2892678|NCT01831089|9959176|P2|Cohort III: Dose Level 3|Progressive disease|0
2892679|NCT01831089|9959177|P1|Cohort III: Dose Level 3|Progressive disease|0
2892680|NCT01831089|9959172|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
2892681|NCT01831089|9959173|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
2892682|NCT01831089|9959174|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
2892683|NCT01831089|9959175|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
2892684|NCT01831089|9959176|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
2892685|NCT01831089|9959177|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
2892686|NCT01831089|9959172|P6|Cohort II: Dose Level 2|Progressive disease|0
2892687|NCT01831089|9959173|P5|Cohort II: Dose Level 2|Progressive disease|0
2892688|NCT01831089|9959174|P4|Cohort II: Dose Level 2|Progressive disease|0
2892689|NCT01831089|9959175|P3|Cohort II: Dose Level 2|Progressive disease|0
2892690|NCT01831089|9959176|P2|Cohort II: Dose Level 2|Progressive disease|2
2892691|NCT01831089|9959177|P1|Cohort II: Dose Level 2|Progressive disease|0
2892692|NCT01831089|9959172|P6|Cohort I: Dose Level 1|Progressive disease|0
2892693|NCT01831089|9959173|P5|Cohort I: Dose Level 1|Progressive disease|0
2892694|NCT01831089|9959174|P4|Cohort I: Dose Level 1|Progressive disease|0
2892695|NCT01831089|9959175|P3|Cohort I: Dose Level 1|Progressive disease|0
2892696|NCT01831089|9959176|P2|Cohort I: Dose Level 1|Progressive disease|0
2892697|NCT01831089|9959177|P1|Cohort I: Dose Level 1|Progressive disease|3
2892698|NCT01830972|9959228|P2|Part IV|Non-Compliance|0
2892699|NCT01830972|9959229|P1|Part IV|Non-Compliance|1
2892700|NCT01830972|9959228|P2|Part IV|Withdrawal by Subject|1
2892701|NCT01830972|9959229|P1|Part IV|Withdrawal by Subject|2
2892702|NCT01830972|9959228|P2|Part III|Noncompliance|0
2892703|NCT01830972|9959229|P1|Part III|Noncompliance|1
2892704|NCT01830972|9959228|P2|Part III|Withdrawal by Subject|0
2892705|NCT01830972|9959229|P1|Part III|Withdrawal by Subject|1
2892706|NCT01830972|9959228|P2|Part II|Withdrawal by Subject|2
2892707|NCT01830972|9959229|P1|Part II|Withdrawal by Subject|2
2892708|NCT01830920|9959273|P5|Overall Study|Other|3
2892709|NCT01830920|9959274|P4|Overall Study|Other|5
2892710|NCT01830920|9959275|P3|Overall Study|Other|1
2892711|NCT01830920|9959276|P2|Overall Study|Other|1
2892712|NCT01830920|9959277|P1|Overall Study|Other|15
2892713|NCT01830920|9959273|P5|Overall Study|Death|4
2892714|NCT01830920|9959274|P4|Overall Study|Death|4
2892715|NCT01830920|9959275|P3|Overall Study|Death|5
2892716|NCT01830920|9959276|P2|Overall Study|Death|3
2892717|NCT01830920|9959277|P1|Overall Study|Death|3
2892718|NCT01830920|9959273|P5|Overall Study|Withdrawal by Subject|1
2892719|NCT01830920|9959274|P4|Overall Study|Withdrawal by Subject|7
2892720|NCT01830920|9959275|P3|Overall Study|Withdrawal by Subject|1
2892721|NCT01830920|9959276|P2|Overall Study|Withdrawal by Subject|2
2892722|NCT01830920|9959277|P1|Overall Study|Withdrawal by Subject|2
2892723|NCT01830920|9959273|P5|Overall Study|Adverse Event|0
2892724|NCT01830920|9959274|P4|Overall Study|Adverse Event|0
2892725|NCT01830920|9959275|P3|Overall Study|Adverse Event|1
2892726|NCT01830920|9959276|P2|Overall Study|Adverse Event|0
2892727|NCT01830920|9959277|P1|Overall Study|Adverse Event|1
2892728|NCT01830881|9959316|P2|Overall Study|Changed decision to have an abortion|1
2892729|NCT01830881|9959317|P1|Overall Study|Changed decision to have an abortion|0
2892730|NCT01830855|9959365|P4|Overall Study|Lost to Follow-up|33
2892731|NCT01830855|9959366|P3|Overall Study|Lost to Follow-up|23
2892732|NCT01830855|9959367|P2|Overall Study|Lost to Follow-up|20
2892733|NCT01830855|9959368|P1|Overall Study|Lost to Follow-up|47
2892734|NCT01830855|9959365|P4|Overall Study|No longer willing to participate|17
2892735|NCT01830855|9959366|P3|Overall Study|No longer willing to participate|12
2892736|NCT01830855|9959367|P2|Overall Study|No longer willing to participate|13
2892737|NCT01830855|9959368|P1|Overall Study|No longer willing to participate|32
2892738|NCT01830855|9959365|P4|Overall Study|Withdrawal by Subject|12
2892739|NCT01830855|9959366|P3|Overall Study|Withdrawal by Subject|10
2892740|NCT01830855|9959367|P2|Overall Study|Withdrawal by Subject|14
2892741|NCT01830855|9959368|P1|Overall Study|Withdrawal by Subject|33
2892742|NCT01830855|9959365|P4|Overall Study|Protocol deviation|6
2892743|NCT01830855|9959366|P3|Overall Study|Protocol deviation|6
2892744|NCT01830855|9959367|P2|Overall Study|Protocol deviation|5
2892745|NCT01830855|9959368|P1|Overall Study|Protocol deviation|10
2892746|NCT01830855|9959365|P4|Overall Study|Adverse Event|3
2892747|NCT01830855|9959366|P3|Overall Study|Adverse Event|6
2892748|NCT01830855|9959367|P2|Overall Study|Adverse Event|5
2892749|NCT01830855|9959368|P1|Overall Study|Adverse Event|11
2892750|NCT01830855|9959365|P4|Overall Study|No longer meets eligibility criteria|5
2892751|NCT01830855|9959366|P3|Overall Study|No longer meets eligibility criteria|3
2892752|NCT01830855|9959367|P2|Overall Study|No longer meets eligibility criteria|2
2892753|NCT01830855|9959368|P1|Overall Study|No longer meets eligibility criteria|11
2892754|NCT01830855|9959365|P4|Overall Study|Pregnancy|1
2892755|NCT01830855|9959366|P3|Overall Study|Pregnancy|2
2892756|NCT01830855|9959367|P2|Overall Study|Pregnancy|1
2892757|NCT01830855|9959368|P1|Overall Study|Pregnancy|3
2892758|NCT01830855|9959365|P4|Overall Study|Medication error without associated AE|1
2892759|NCT01830855|9959366|P3|Overall Study|Medication error without associated AE|0
2892760|NCT01830855|9959367|P2|Overall Study|Medication error without associated AE|0
2892761|NCT01830855|9959368|P1|Overall Study|Medication error without associated AE|1
2892762|NCT01830855|9959365|P4|Overall Study|Other|4
2892763|NCT01830855|9959366|P3|Overall Study|Other|4
2892764|NCT01830855|9959367|P2|Overall Study|Other|1
2892765|NCT01830855|9959368|P1|Overall Study|Other|7
2892766|NCT01830816|9959484|P3|Overall Study|Reason not Specified|0
2892767|NCT01830816|9959485|P2|Overall Study|Reason not Specified|0
2892768|NCT01830816|9959486|P1|Overall Study|Reason not Specified|2
2892769|NCT01830816|9959484|P3|Overall Study|Symptomatic Deterioration|0
2892770|NCT01830816|9959485|P2|Overall Study|Symptomatic Deterioration|0
2892771|NCT01830816|9959486|P1|Overall Study|Symptomatic Deterioration|1
2892772|NCT01830816|9959484|P3|Overall Study|Lost to Follow-up|0
2892773|NCT01830816|9959485|P2|Overall Study|Lost to Follow-up|1
2892774|NCT01830816|9959486|P1|Overall Study|Lost to Follow-up|0
2892775|NCT01830816|9959484|P3|Overall Study|Withdrawal by Subject|0
2892776|NCT01830816|9959485|P2|Overall Study|Withdrawal by Subject|1
2892777|NCT01830816|9959486|P1|Overall Study|Withdrawal by Subject|1
2892778|NCT01830816|9959484|P3|Overall Study|Study Terminated by Sponsor|0
2892779|NCT01830816|9959485|P2|Overall Study|Study Terminated by Sponsor|1
2892780|NCT01830816|9959486|P1|Overall Study|Study Terminated by Sponsor|1
2892781|NCT01830816|9959484|P3|Overall Study|Adverse Event|0
2892782|NCT01830816|9959485|P2|Overall Study|Adverse Event|4
2892783|NCT01830816|9959486|P1|Overall Study|Adverse Event|3
2892784|NCT01830816|9959484|P3|Overall Study|Progressive Disease|7
2892785|NCT01830816|9959485|P2|Overall Study|Progressive Disease|7
2892786|NCT01830816|9959486|P1|Overall Study|Progressive Disease|12
2892787|NCT01830595|9959550|P2|Washout|Withdrawal by Subject|2
2892788|NCT01830595|9959551|P1|Washout|Withdrawal by Subject|2
2892789|NCT01830595|9959550|P2|First Period|Withdrawal by Subject|3
2892790|NCT01830595|9959551|P1|First Period|Withdrawal by Subject|1
2892791|NCT01830543|9959568|P3|Overall Study|Other|37
2892792|NCT01830543|9959569|P2|Overall Study|Other|17
2892793|NCT01830543|9959570|P1|Overall Study|Other|12
2892794|NCT01830543|9959568|P3|Overall Study|Withdrawal by consent|3
2892795|NCT01830543|9959569|P2|Overall Study|Withdrawal by consent|3
2892796|NCT01830543|9959570|P1|Overall Study|Withdrawal by consent|3
2892797|NCT01830543|9959568|P3|Overall Study|Physician Decision|12
2892798|NCT01830543|9959569|P2|Overall Study|Physician Decision|5
2892799|NCT01830543|9959570|P1|Overall Study|Physician Decision|11
2892800|NCT01830543|9959568|P3|Overall Study|Protocol Violation|7
2892801|NCT01830543|9959569|P2|Overall Study|Protocol Violation|7
2892802|NCT01830543|9959570|P1|Overall Study|Protocol Violation|3
2892803|NCT01830543|9959568|P3|Overall Study|Death|22
2892804|NCT01830543|9959569|P2|Overall Study|Death|22
2892805|NCT01830543|9959570|P1|Overall Study|Death|20
2892806|NCT01830543|9959568|P3|Overall Study|Adverse Event|76
2892807|NCT01830543|9959569|P2|Overall Study|Adverse Event|77
2892808|NCT01830543|9959570|P1|Overall Study|Adverse Event|91
2892809|NCT01830543|9959568|P3|Overall Study|Subject Decision|57
2892810|NCT01830543|9959569|P2|Overall Study|Subject Decision|21
2892811|NCT01830543|9959570|P1|Overall Study|Subject Decision|19
2892812|NCT01830127|9959702|P2|Overall Study|Other reason not defined above|2
2892813|NCT01830127|9959703|P1|Overall Study|Other reason not defined above|0
2892814|NCT01830127|9959702|P2|Overall Study|Withdrawal by Subject|1
2892815|NCT01830127|9959703|P1|Overall Study|Withdrawal by Subject|1
2892816|NCT01830127|9959702|P2|Overall Study|Lack of Efficacy|0
2892817|NCT01830127|9959703|P1|Overall Study|Lack of Efficacy|3
2892818|NCT01830127|9959702|P2|Overall Study|Adverse Event|6
2892819|NCT01830127|9959703|P1|Overall Study|Adverse Event|1
2892820|NCT01829711|9959736|P1|Overall Study|Due to lack of response|1
2892821|NCT01829711|9959736|P1|Overall Study|Due to progression of disease|13
2892822|NCT01829711|9959736|P1|Overall Study|Adverse Event|3
2892823|NCT01829711|9959736|P1|Overall Study|Started new therapies|17
2892824|NCT01829711|9959736|P1|Overall Study|Death|4
2892825|NCT01829711|9959736|P1|Overall Study|Withdrawal by Subject|3
2892826|NCT01829711|9959736|P1|Overall Study|Lost to Follow-up|2
2892827|NCT01829477|9959793|P2|Overall Study|Withdrawal by Subject|0
2892828|NCT01829477|9959794|P1|Overall Study|Withdrawal by Subject|1
2892829|NCT01829477|9959793|P2|Overall Study|Study Terminated by Sponsor|15
2892830|NCT01829477|9959794|P1|Overall Study|Study Terminated by Sponsor|15
2892831|NCT01829464|9959807|P3|Overall Study|Lack of Efficacy|0
2892832|NCT01829464|9959808|P2|Overall Study|Lack of Efficacy|1
2892833|NCT01829464|9959809|P1|Overall Study|Lack of Efficacy|0
2892834|NCT01829464|9959807|P3|Overall Study|Study terminated by sponsor|25
2892835|NCT01829464|9959808|P2|Overall Study|Study terminated by sponsor|28
2892836|NCT01829464|9959809|P1|Overall Study|Study terminated by sponsor|25
2892837|NCT01829464|9959807|P3|Overall Study|Withdrawal by Subject|0
2892838|NCT01829464|9959808|P2|Overall Study|Withdrawal by Subject|0
2892839|NCT01829464|9959809|P1|Overall Study|Withdrawal by Subject|2
2892840|NCT01829464|9959807|P3|Overall Study|Lost to Follow-up|1
2892841|NCT01829464|9959808|P2|Overall Study|Lost to Follow-up|0
2892842|NCT01829464|9959809|P1|Overall Study|Lost to Follow-up|0
2892843|NCT01829464|9959807|P3|Overall Study|Adverse Event|0
2892844|NCT01829464|9959808|P2|Overall Study|Adverse Event|0
2892845|NCT01829464|9959809|P1|Overall Study|Adverse Event|1
2892846|NCT01829425|9959825|P2|Overall Study|Lost to Follow-up|1
2892847|NCT01829425|9959826|P1|Overall Study|Lost to Follow-up|2
2892848|NCT01829425|9959825|P2|Overall Study|Withdrawal by Subject|3
2892849|NCT01829425|9959826|P1|Overall Study|Withdrawal by Subject|4
2892850|NCT01829360|9959869|P4|Overall Study|Protocol Violation|0
2892851|NCT01829360|9959870|P3|Overall Study|Protocol Violation|1
2892852|NCT01829360|9959871|P2|Overall Study|Protocol Violation|0
2892853|NCT01829360|9959872|P1|Overall Study|Protocol Violation|0
2892854|NCT01829347|9959892|P2|VTI-210E|Study terminated prematurely|5
2892855|NCT01829347|9959893|P1|VTI-210E|Study terminated prematurely|1
2892856|NCT01829347|9959892|P2|VTI-210E|Death|1
2892857|NCT01829347|9959893|P1|VTI-210E|Death|2
2892858|NCT01829347|9959892|P2|VTI-210|Withdrawal by Subject|0
2892859|NCT01829347|9959893|P1|VTI-210|Withdrawal by Subject|1
2892860|NCT01829347|9959892|P2|VTI-210|Death|3
2892861|NCT01829347|9959893|P1|VTI-210|Death|5
2892862|NCT01829295|9959903|P4|6-12 Months|Withdrawal by Subject|0
2892863|NCT01829295|9959904|P3|6-12 Months|Withdrawal by Subject|0
2892864|NCT01829295|9959905|P2|6-12 Months|Withdrawal by Subject|2
2892865|NCT01829295|9959906|P1|6-12 Months|Withdrawal by Subject|2
2892866|NCT01829295|9959903|P4|6-12 Months|Lost to Follow-up|0
2892867|NCT01829295|9959904|P3|6-12 Months|Lost to Follow-up|0
2892868|NCT01829295|9959905|P2|6-12 Months|Lost to Follow-up|0
2892869|NCT01829295|9959906|P1|6-12 Months|Lost to Follow-up|2
2892870|NCT01829295|9959903|P4|6-12 Months|Adverse Event|2
2892871|NCT01829295|9959904|P3|6-12 Months|Adverse Event|3
2892872|NCT01829295|9959905|P2|6-12 Months|Adverse Event|0
2892873|NCT01829295|9959906|P1|6-12 Months|Adverse Event|0
2892874|NCT01829295|9959903|P4|6-12 Months|Did not want to switch antimetabolites|11
2892875|NCT01829295|9959904|P3|6-12 Months|Did not want to switch antimetabolites|9
2892876|NCT01829295|9959905|P2|6-12 Months|Did not want to switch antimetabolites|0
2892877|NCT01829295|9959906|P1|6-12 Months|Did not want to switch antimetabolites|0
2892878|NCT01829243|9959916|P2|First Intervention|Screen Failure|2
2892879|NCT01829243|9959917|P1|First Intervention|Screen Failure|4
2892880|NCT01829230|9959931|P2|Overall Study|Lost to Follow-up|1
2892881|NCT01829230|9959932|P1|Overall Study|Lost to Follow-up|1
2892882|NCT01829230|9959931|P2|Overall Study|Withdrawal by Subject|1
2892883|NCT01829230|9959932|P1|Overall Study|Withdrawal by Subject|0
2892884|NCT01829230|9959931|P2|Overall Study|Protocol Violation|2
2892885|NCT01829230|9959932|P1|Overall Study|Protocol Violation|0
2892886|NCT01829191|9959946|P2|Overall Study|Subject was fit for ortho - k|1
2892887|NCT01829191|9959947|P1|Overall Study|Subject was fit for ortho - k|0
2892888|NCT01829191|9959946|P2|Overall Study|Lost to Follow-up|1
2892889|NCT01829191|9959947|P1|Overall Study|Lost to Follow-up|0
2892890|NCT01829191|9959946|P2|Overall Study|Withdrawal by Subject|3
2892891|NCT01829191|9959947|P1|Overall Study|Withdrawal by Subject|2
2892892|NCT01829191|9959946|P2|Overall Study|Protocol Violation|1
2892893|NCT01829191|9959947|P1|Overall Study|Protocol Violation|4
2892894|NCT01829191|9959946|P2|Overall Study|Lens handling difficulty|4
2892895|NCT01829191|9959947|P1|Overall Study|Lens handling difficulty|1
2892896|NCT01829191|9959946|P2|Overall Study|Lens discomfort|3
2892897|NCT01829191|9959947|P1|Overall Study|Lens discomfort|0
2892898|NCT01829191|9959946|P2|Overall Study|Relocation|1
2892899|NCT01829191|9959947|P1|Overall Study|Relocation|0
2892900|NCT01829165|9959956|P2|Overall Study|Did not complete intervention|0
2892901|NCT01829165|9959957|P1|Overall Study|Did not complete intervention|2
2892902|NCT01829113|9959965|P2|Overall Study|Physician Decision|1
2892903|NCT01829113|9959966|P1|Overall Study|Physician Decision|1
2892904|NCT01829113|9959965|P2|Overall Study|No Study Treatment Received|2
2892905|NCT01829113|9959966|P1|Overall Study|No Study Treatment Received|3
2892906|NCT01829113|9959965|P2|Overall Study|Sponsor Decision|1
2892907|NCT01829113|9959966|P1|Overall Study|Sponsor Decision|1
2892908|NCT01829113|9959965|P2|Overall Study|Death|6
2892909|NCT01829113|9959966|P1|Overall Study|Death|4
2892910|NCT01829113|9959965|P2|Overall Study|Withdrawal by Subject|10
2892911|NCT01829113|9959966|P1|Overall Study|Withdrawal by Subject|17
2892912|NCT01829113|9959965|P2|Overall Study|Adverse Event|10
2892913|NCT01829113|9959966|P1|Overall Study|Adverse Event|14
2892914|NCT01829113|9959965|P2|Overall Study|Disease Progression|48
2892915|NCT01829113|9959966|P1|Overall Study|Disease Progression|37
2892916|NCT01829048|9959983|P5|Overall Study|Withdrawal by Subject|0
2892917|NCT01829048|9959984|P4|Overall Study|Withdrawal by Subject|2
2892918|NCT01829048|9959985|P3|Overall Study|Withdrawal by Subject|0
2892919|NCT01829048|9959986|P2|Overall Study|Withdrawal by Subject|0
2892920|NCT01829048|9959987|P1|Overall Study|Withdrawal by Subject|0
2892921|NCT01828567|9960100|P2|Overall Study|Excluded - did not meet criteria|1
2892922|NCT01828567|9960101|P1|Overall Study|Excluded - did not meet criteria|4
2892923|NCT01828567|9960100|P2|Overall Study|Lost to Follow-up|9
2892924|NCT01828567|9960101|P1|Overall Study|Lost to Follow-up|27
2892925|NCT01828281|9960156|P2|Overall Study|Withdrawal by Subject|0
2892926|NCT01828281|9960157|P1|Overall Study|Withdrawal by Subject|1
2892927|NCT01828112|9960190|P2|Overall Study|Subject/guardian decision|8
2892928|NCT01828112|9960191|P1|Overall Study|Subject/guardian decision|6
2892929|NCT01828112|9960190|P2|Overall Study|Progressive disease|82
2892930|NCT01828112|9960191|P1|Overall Study|Progressive disease|56
2892931|NCT01828112|9960190|P2|Overall Study|Physician Decision|5
2892932|NCT01828112|9960191|P1|Overall Study|Physician Decision|5
2892933|NCT01828112|9960190|P2|Overall Study|Death|5
2892934|NCT01828112|9960191|P1|Overall Study|Death|9
2892935|NCT01828112|9960190|P2|Overall Study|Adverse Event|8
2892936|NCT01828112|9960191|P1|Overall Study|Adverse Event|6
2892937|NCT01828099|9960199|P2|Overall Study|Subject/guardian decision|23
2892938|NCT01828099|9960200|P1|Overall Study|Subject/guardian decision|7
2892939|NCT01828099|9960199|P2|Overall Study|Protocol Violation|0
2892940|NCT01828099|9960200|P1|Overall Study|Protocol Violation|1
2892941|NCT01828099|9960199|P2|Overall Study|Progressive disease|94
2892942|NCT01828099|9960200|P1|Overall Study|Progressive disease|51
2892943|NCT01828099|9960199|P2|Overall Study|Physician Decision|11
2892944|NCT01828099|9960200|P1|Overall Study|Physician Decision|7
2892945|NCT01828099|9960199|P2|Overall Study|Non-compliance with study treatment|0
2892946|NCT01828099|9960200|P1|Overall Study|Non-compliance with study treatment|2
2892947|NCT01828099|9960199|P2|Overall Study|Lost to Follow-up|0
2892948|NCT01828099|9960200|P1|Overall Study|Lost to Follow-up|2
2892949|NCT01828099|9960199|P2|Overall Study|Death|11
2892950|NCT01828099|9960200|P1|Overall Study|Death|9
2892951|NCT01828099|9960199|P2|Overall Study|Adverse Event|18
2892952|NCT01828099|9960200|P1|Overall Study|Adverse Event|15
2892953|NCT01828073|9960208|P2|Overall Study|Lost to Follow-up|2
2892954|NCT01828073|9960209|P1|Overall Study|Lost to Follow-up|1
2892955|NCT01827839|9960229|P1|Overall Study|Consent Withdrawal|2
2892956|NCT01827839|9960229|P1|Overall Study|Adverse Event|1
2892957|NCT01827670|9960274|P2|Overall Study|Lost to Follow-up|1
2892958|NCT01827670|9960275|P1|Overall Study|Lost to Follow-up|0
2892959|NCT01827670|9960274|P2|Overall Study|Withdrawal of Consent|2
2892960|NCT01827670|9960275|P1|Overall Study|Withdrawal of Consent|3
2892961|NCT01827592|9960294|P3|Overall Study|Others|3
2892962|NCT01827592|9960295|P2|Overall Study|Others|1
2892963|NCT01827592|9960296|P1|Overall Study|Others|0
2892964|NCT01827592|9960294|P3|Overall Study|Trial terminated by Sponsor|51
2892965|NCT01827592|9960295|P2|Overall Study|Trial terminated by Sponsor|53
2892966|NCT01827592|9960296|P1|Overall Study|Trial terminated by Sponsor|47
2892967|NCT01827592|9960294|P3|Overall Study|Patient's substantial non-compliance|6
2892968|NCT01827592|9960295|P2|Overall Study|Patient's substantial non-compliance|1
2892969|NCT01827592|9960296|P1|Overall Study|Patient's substantial non-compliance|1
2892970|NCT01827592|9960294|P3|Overall Study|Withdrawal by Subject|11
2892971|NCT01827592|9960295|P2|Overall Study|Withdrawal by Subject|11
2892972|NCT01827592|9960296|P1|Overall Study|Withdrawal by Subject|12
2892973|NCT01827592|9960294|P3|Overall Study|Lost to Follow-up|2
2892974|NCT01827592|9960295|P2|Overall Study|Lost to Follow-up|2
2892975|NCT01827592|9960296|P1|Overall Study|Lost to Follow-up|1
2892976|NCT01827592|9960294|P3|Overall Study|Protocol Violation|0
2892977|NCT01827592|9960295|P2|Overall Study|Protocol Violation|1
2892978|NCT01827592|9960296|P1|Overall Study|Protocol Violation|2
2892979|NCT01827592|9960294|P3|Overall Study|Physician Decision|1
2892980|NCT01827592|9960295|P2|Overall Study|Physician Decision|2
2892981|NCT01827592|9960296|P1|Overall Study|Physician Decision|0
2892982|NCT01827592|9960294|P3|Overall Study|Adverse Event|2
2892983|NCT01827592|9960295|P2|Overall Study|Adverse Event|9
2892984|NCT01827592|9960296|P1|Overall Study|Adverse Event|11
2892985|NCT01827371|9960361|P4|Overall Study|Temporary study halt to vaccinations|13
2892986|NCT01827371|9960362|P3|Overall Study|Temporary study halt to vaccinations|5
2892987|NCT01827371|9960363|P2|Overall Study|Temporary study halt to vaccinations|2
2892988|NCT01827371|9960364|P1|Overall Study|Temporary study halt to vaccinations|11
2892989|NCT01827371|9960361|P4|Overall Study|Physician Decision|1
2892990|NCT01827371|9960362|P3|Overall Study|Physician Decision|0
2892991|NCT01827371|9960363|P2|Overall Study|Physician Decision|1
2892992|NCT01827371|9960364|P1|Overall Study|Physician Decision|0
2892993|NCT01827371|9960361|P4|Overall Study|Withdrawal by Subject|3
2892994|NCT01827371|9960362|P3|Overall Study|Withdrawal by Subject|2
2892995|NCT01827371|9960363|P2|Overall Study|Withdrawal by Subject|2
2892996|NCT01827371|9960364|P1|Overall Study|Withdrawal by Subject|1
2892997|NCT01827371|9960361|P4|Overall Study|Protocol Violation|0
2892998|NCT01827371|9960362|P3|Overall Study|Protocol Violation|0
2892999|NCT01827371|9960363|P2|Overall Study|Protocol Violation|0
2893000|NCT01827371|9960364|P1|Overall Study|Protocol Violation|1
2893001|NCT01827371|9960361|P4|Overall Study|Lost to Follow-up|4
2893002|NCT01827371|9960362|P3|Overall Study|Lost to Follow-up|0
2893003|NCT01827371|9960363|P2|Overall Study|Lost to Follow-up|2
2893004|NCT01827371|9960364|P1|Overall Study|Lost to Follow-up|0
2893005|NCT01827371|9960361|P4|Overall Study|Adverse Event|2
2893006|NCT01827371|9960362|P3|Overall Study|Adverse Event|4
2893007|NCT01827371|9960363|P2|Overall Study|Adverse Event|0
2893008|NCT01827371|9960364|P1|Overall Study|Adverse Event|0
2893009|NCT01827332|9960423|P2|Overall Study|Lost to Follow-up|1
2893010|NCT01827332|9960424|P1|Overall Study|Lost to Follow-up|2
2893011|NCT01827319|9960432|P1|Overall Study|Lost to Follow-up|3
2893012|NCT01827267|9960455|P2|Overall Study|Still on study|2
2893013|NCT01827267|9960456|P1|Overall Study|Still on study|0
2893014|NCT01827267|9960455|P2|Overall Study|Sponsor Discontinued Study|8
2893015|NCT01827267|9960456|P1|Overall Study|Sponsor Discontinued Study|2
2893016|NCT01827267|9960455|P2|Overall Study|Disease Progression|1
2893017|NCT01827267|9960456|P1|Overall Study|Disease Progression|1
2893018|NCT01827267|9960455|P2|Overall Study|Physician Decision|0
2893019|NCT01827267|9960456|P1|Overall Study|Physician Decision|1
2893020|NCT01827267|9960455|P2|Overall Study|Did not receive study drug|1
2893021|NCT01827267|9960456|P1|Overall Study|Did not receive study drug|1
2893022|NCT01827254|9960471|P1|Overall Study|Intolerance to treatment|4
2893023|NCT01827254|9960471|P1|Overall Study|Disease progression|36
2893024|NCT01827254|9960471|P1|Overall Study|Did not complete re-challenge|1
2893025|NCT01827254|9960471|P1|Overall Study|Discontinued prior initiation: sunitinib|1
2893026|NCT01827254|9960471|P1|Overall Study|Invalidated centre|3
2893027|NCT01827254|9960471|P1|Overall Study|Case report form not completed|4
2893028|NCT01827254|9960471|P1|Overall Study|Death|10
2893029|NCT01827163|9960481|P1|Overall Study|Adverse Event|9
2893030|NCT01827163|9960481|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
2893031|NCT01827046|9960488|P2|Overall Study|Withdrawal by Subject|4
2893032|NCT01827046|9960489|P1|Overall Study|Withdrawal by Subject|0
2893033|NCT01827046|9960488|P2|Overall Study|Lost to Follow-up|5
2893034|NCT01827046|9960489|P1|Overall Study|Lost to Follow-up|1
2893035|NCT01826981|9960544|P15|Overall Study|Enrolled/Randomized but Not Treated|0
2893036|NCT01826981|9960545|P14|Overall Study|Enrolled/Randomized but Not Treated|0
2893037|NCT01826981|9960546|P13|Overall Study|Enrolled/Randomized but Not Treated|0
2893038|NCT01826981|9960547|P12|Overall Study|Enrolled/Randomized but Not Treated|0
2893039|NCT01826981|9960548|P11|Overall Study|Enrolled/Randomized but Not Treated|0
2893040|NCT01826981|9960549|P10|Overall Study|Enrolled/Randomized but Not Treated|0
2893041|NCT01826981|9960550|P9|Overall Study|Enrolled/Randomized but Not Treated|0
2893042|NCT01826981|9960551|P8|Overall Study|Enrolled/Randomized but Not Treated|1
2893043|NCT01826981|9960552|P7|Overall Study|Enrolled/Randomized but Not Treated|0
2893044|NCT01826981|9960553|P6|Overall Study|Enrolled/Randomized but Not Treated|0
2893045|NCT01826981|9960554|P5|Overall Study|Enrolled/Randomized but Not Treated|0
2893046|NCT01826981|9960555|P4|Overall Study|Enrolled/Randomized but Not Treated|0
2893047|NCT01826981|9960556|P3|Overall Study|Enrolled/Randomized but Not Treated|0
2893048|NCT01826981|9960557|P2|Overall Study|Enrolled/Randomized but Not Treated|0
2893049|NCT01826981|9960558|P1|Overall Study|Enrolled/Randomized but Not Treated|0
2893050|NCT01826981|9960544|P15|Overall Study|Upper G-I Haemorrhage|0
2893051|NCT01826981|9960545|P14|Overall Study|Upper G-I Haemorrhage|1
2893052|NCT01826981|9960546|P13|Overall Study|Upper G-I Haemorrhage|0
2893053|NCT01826981|9960547|P12|Overall Study|Upper G-I Haemorrhage|0
2893054|NCT01826981|9960548|P11|Overall Study|Upper G-I Haemorrhage|0
2893055|NCT01826981|9960549|P10|Overall Study|Upper G-I Haemorrhage|0
2893056|NCT01826981|9960550|P9|Overall Study|Upper G-I Haemorrhage|0
2893057|NCT01826981|9960551|P8|Overall Study|Upper G-I Haemorrhage|0
2893058|NCT01826981|9960552|P7|Overall Study|Upper G-I Haemorrhage|0
2893059|NCT01826981|9960553|P6|Overall Study|Upper G-I Haemorrhage|0
2893060|NCT01826981|9960554|P5|Overall Study|Upper G-I Haemorrhage|0
2893061|NCT01826981|9960555|P4|Overall Study|Upper G-I Haemorrhage|0
2893062|NCT01826981|9960556|P3|Overall Study|Upper G-I Haemorrhage|0
2893063|NCT01826981|9960557|P2|Overall Study|Upper G-I Haemorrhage|0
2893064|NCT01826981|9960558|P1|Overall Study|Upper G-I Haemorrhage|0
2893065|NCT01826981|9960544|P15|Overall Study|Adverse Event|0
2893066|NCT01826981|9960545|P14|Overall Study|Adverse Event|0
2893067|NCT01826981|9960546|P13|Overall Study|Adverse Event|0
2893068|NCT01826981|9960547|P12|Overall Study|Adverse Event|0
2893069|NCT01826981|9960548|P11|Overall Study|Adverse Event|0
2893070|NCT01826981|9960549|P10|Overall Study|Adverse Event|0
2893071|NCT01826981|9960550|P9|Overall Study|Adverse Event|0
2893072|NCT01826981|9960551|P8|Overall Study|Adverse Event|0
2893073|NCT01826981|9960552|P7|Overall Study|Adverse Event|0
2893074|NCT01826981|9960553|P6|Overall Study|Adverse Event|0
2893075|NCT01826981|9960554|P5|Overall Study|Adverse Event|1
2893076|NCT01826981|9960555|P4|Overall Study|Adverse Event|0
2893077|NCT01826981|9960556|P3|Overall Study|Adverse Event|0
2893078|NCT01826981|9960557|P2|Overall Study|Adverse Event|0
2893079|NCT01826981|9960558|P1|Overall Study|Adverse Event|0
2893080|NCT01826981|9960544|P15|Overall Study|Withdrew Consent|0
2893081|NCT01826981|9960545|P14|Overall Study|Withdrew Consent|1
2893082|NCT01826981|9960546|P13|Overall Study|Withdrew Consent|0
2893083|NCT01826981|9960547|P12|Overall Study|Withdrew Consent|1
2893084|NCT01826981|9960548|P11|Overall Study|Withdrew Consent|0
2893085|NCT01826981|9960549|P10|Overall Study|Withdrew Consent|0
2893086|NCT01826981|9960550|P9|Overall Study|Withdrew Consent|0
2893087|NCT01826981|9960551|P8|Overall Study|Withdrew Consent|1
2893088|NCT01826981|9960552|P7|Overall Study|Withdrew Consent|1
2893089|NCT01826981|9960553|P6|Overall Study|Withdrew Consent|0
2893090|NCT01826981|9960554|P5|Overall Study|Withdrew Consent|0
2893091|NCT01826981|9960555|P4|Overall Study|Withdrew Consent|0
2893092|NCT01826981|9960556|P3|Overall Study|Withdrew Consent|0
2893093|NCT01826981|9960557|P2|Overall Study|Withdrew Consent|0
2893094|NCT01826981|9960558|P1|Overall Study|Withdrew Consent|0
2893095|NCT01826981|9960544|P15|Overall Study|Lost to Follow-up|0
2893096|NCT01826981|9960545|P14|Overall Study|Lost to Follow-up|0
2893097|NCT01826981|9960546|P13|Overall Study|Lost to Follow-up|1
2893098|NCT01826981|9960547|P12|Overall Study|Lost to Follow-up|1
2893099|NCT01826981|9960548|P11|Overall Study|Lost to Follow-up|1
2893100|NCT01826981|9960549|P10|Overall Study|Lost to Follow-up|1
2893101|NCT01826981|9960550|P9|Overall Study|Lost to Follow-up|0
2893102|NCT01826981|9960551|P8|Overall Study|Lost to Follow-up|1
2893103|NCT01826981|9960552|P7|Overall Study|Lost to Follow-up|0
2893104|NCT01826981|9960553|P6|Overall Study|Lost to Follow-up|1
2893105|NCT01826981|9960554|P5|Overall Study|Lost to Follow-up|1
2893106|NCT01826981|9960555|P4|Overall Study|Lost to Follow-up|0
2893107|NCT01826981|9960556|P3|Overall Study|Lost to Follow-up|0
2893108|NCT01826981|9960557|P2|Overall Study|Lost to Follow-up|0
2893109|NCT01826981|9960558|P1|Overall Study|Lost to Follow-up|0
2893110|NCT01826981|9960544|P15|Overall Study|Lack of Efficacy|0
2893111|NCT01826981|9960545|P14|Overall Study|Lack of Efficacy|3
2893112|NCT01826981|9960546|P13|Overall Study|Lack of Efficacy|0
2893113|NCT01826981|9960547|P12|Overall Study|Lack of Efficacy|0
2893114|NCT01826981|9960548|P11|Overall Study|Lack of Efficacy|1
2893115|NCT01826981|9960549|P10|Overall Study|Lack of Efficacy|0
2893116|NCT01826981|9960550|P9|Overall Study|Lack of Efficacy|7
2893117|NCT01826981|9960551|P8|Overall Study|Lack of Efficacy|8
2893118|NCT01826981|9960552|P7|Overall Study|Lack of Efficacy|0
2893119|NCT01826981|9960553|P6|Overall Study|Lack of Efficacy|0
2893120|NCT01826981|9960554|P5|Overall Study|Lack of Efficacy|5
2893121|NCT01826981|9960555|P4|Overall Study|Lack of Efficacy|0
2893122|NCT01826981|9960556|P3|Overall Study|Lack of Efficacy|0
2893123|NCT01826981|9960557|P2|Overall Study|Lack of Efficacy|1
2893124|NCT01826981|9960558|P1|Overall Study|Lack of Efficacy|0
2893125|NCT01826604|9960744|P2|Overall Study|Lost to Follow-up|9
2893126|NCT01826604|9960745|P1|Overall Study|Lost to Follow-up|8
2893127|NCT01826448|9960789|P2|Overall Study|2 active cancers|1
2893128|NCT01826448|9960790|P1|Overall Study|2 active cancers|0
2893129|NCT01826448|9960789|P2|Overall Study|Physician Decision|1
2893130|NCT01826448|9960790|P1|Overall Study|Physician Decision|0
2893131|NCT01826448|9960789|P2|Overall Study|Withdrawal by Subject|0
2893132|NCT01826448|9960790|P1|Overall Study|Withdrawal by Subject|1
2893133|NCT01826448|9960789|P2|Overall Study|Disease progression|4
2893134|NCT01826448|9960790|P1|Overall Study|Disease progression|2
2893135|NCT01826448|9960789|P2|Overall Study|Adverse Event|3
2893136|NCT01826448|9960790|P1|Overall Study|Adverse Event|1
2893137|NCT01826422|9960798|P2|Overall Study|Withdrawal by Subject|3
2893138|NCT01826422|9960799|P1|Overall Study|Withdrawal by Subject|1
2893139|NCT01826370|9960843|P1|Overall Study|Other reason not defined above|2
2893140|NCT01826370|9960843|P1|Overall Study|Lost to Follow-up|12
2893141|NCT01826370|9960843|P1|Overall Study|Protocol Violation|6
2893142|NCT01826214|9960855|P2|Overall Study|Subject/guardian decision|3
2893143|NCT01826214|9960856|P1|Overall Study|Subject/guardian decision|2
2893144|NCT01826214|9960855|P2|Overall Study|Study terminated by Sponsor|1
2893145|NCT01826214|9960856|P1|Overall Study|Study terminated by Sponsor|0
2893146|NCT01826214|9960855|P2|Overall Study|Progressive disease|21
2893147|NCT01826214|9960856|P1|Overall Study|Progressive disease|22
2893148|NCT01826214|9960855|P2|Overall Study|Physician Decision|2
2893149|NCT01826214|9960856|P1|Overall Study|Physician Decision|0
2893150|NCT01826214|9960855|P2|Overall Study|Lost to Follow-up|0
2893151|NCT01826214|9960856|P1|Overall Study|Lost to Follow-up|1
2893152|NCT01826214|9960855|P2|Overall Study|Death|1
2893153|NCT01826214|9960856|P1|Overall Study|Death|3
2893154|NCT01826214|9960855|P2|Overall Study|Adverse Event|6
2893155|NCT01826214|9960856|P1|Overall Study|Adverse Event|7
2893156|NCT01826201|9960874|P1|Overall Study|Non compliance with protocol|4
2893157|NCT01825941|9960882|P2|Overall Study|Lost to Follow-up|1
2893158|NCT01825941|9960883|P1|Overall Study|Lost to Follow-up|4
2893159|NCT01825876|9960902|P2|Period 2|Withdrawal by Subject|1
2893160|NCT01825876|9960903|P1|Period 2|Withdrawal by Subject|0
2893161|NCT01825837|9960924|P4|PART II|reason unspecified|0
2893162|NCT01825837|9960925|P3|PART II|reason unspecified|2
2893163|NCT01825837|9960926|P2|PART II|reason unspecified|2
2893164|NCT01825837|9960927|P1|PART II|reason unspecified|2
2893165|NCT01825837|9960924|P4|PART II|Treatment failure|0
2893166|NCT01825837|9960925|P3|PART II|Treatment failure|5
2893167|NCT01825837|9960926|P2|PART II|Treatment failure|4
2893168|NCT01825837|9960927|P1|PART II|Treatment failure|6
2893169|NCT01825837|9960924|P4|PART II|Adverse Event|0
2893170|NCT01825837|9960925|P3|PART II|Adverse Event|1
2893171|NCT01825837|9960926|P2|PART II|Adverse Event|3
2893172|NCT01825837|9960927|P1|PART II|Adverse Event|3
2893173|NCT01825837|9960924|P4|PART II|Patient non-compliance|0
2893174|NCT01825837|9960925|P3|PART II|Patient non-compliance|4
2893175|NCT01825837|9960926|P2|PART II|Patient non-compliance|2
2893176|NCT01825837|9960927|P1|PART II|Patient non-compliance|5
2893177|NCT01825837|9960924|P4|PART II|Withdrawal by Subject|0
2893178|NCT01825837|9960925|P3|PART II|Withdrawal by Subject|7
2893179|NCT01825837|9960926|P2|PART II|Withdrawal by Subject|3
2893180|NCT01825837|9960927|P1|PART II|Withdrawal by Subject|3
2893181|NCT01825837|9960924|P4|PART I|reason unspecified|3
2893182|NCT01825837|9960925|P3|PART I|reason unspecified|0
2893183|NCT01825837|9960926|P2|PART I|reason unspecified|0
2893184|NCT01825837|9960927|P1|PART I|reason unspecified|0
2893185|NCT01825837|9960924|P4|PART I|Treatment failure|7
2893186|NCT01825837|9960925|P3|PART I|Treatment failure|0
2893187|NCT01825837|9960926|P2|PART I|Treatment failure|0
2893188|NCT01825837|9960927|P1|PART I|Treatment failure|0
2893189|NCT01825837|9960924|P4|PART I|Patient non-compliance|1
2893190|NCT01825837|9960925|P3|PART I|Patient non-compliance|0
2893191|NCT01825837|9960926|P2|PART I|Patient non-compliance|0
2893192|NCT01825837|9960927|P1|PART I|Patient non-compliance|0
2893193|NCT01825837|9960924|P4|PART I|Withdrawal by Subject|6
2893194|NCT01825837|9960925|P3|PART I|Withdrawal by Subject|0
2893195|NCT01825837|9960926|P2|PART I|Withdrawal by Subject|0
2893196|NCT01825837|9960927|P1|PART I|Withdrawal by Subject|0
2893197|NCT01825798|9960937|P2|Overall Study|Lost to Follow-up|0
2893198|NCT01825798|9960938|P1|Overall Study|Lost to Follow-up|1
2893199|NCT01825798|9960937|P2|Overall Study|Adverse Event|5
2893200|NCT01825798|9960938|P1|Overall Study|Adverse Event|1
2893201|NCT01825785|9960973|P7|Overall Study|Withdrawal by Subject|0
2893202|NCT01825785|9960974|P6|Overall Study|Withdrawal by Subject|1
2893203|NCT01825785|9960975|P5|Overall Study|Withdrawal by Subject|1
2893204|NCT01825785|9960976|P4|Overall Study|Withdrawal by Subject|0
2893205|NCT01825785|9960977|P3|Overall Study|Withdrawal by Subject|0
2893206|NCT01825785|9960978|P2|Overall Study|Withdrawal by Subject|0
2893207|NCT01825785|9960979|P1|Overall Study|Withdrawal by Subject|0
2893208|NCT01825785|9960973|P7|Overall Study|Adverse Event|0
2893209|NCT01825785|9960974|P6|Overall Study|Adverse Event|0
2893210|NCT01825785|9960975|P5|Overall Study|Adverse Event|1
2893211|NCT01825785|9960976|P4|Overall Study|Adverse Event|0
2893212|NCT01825785|9960977|P3|Overall Study|Adverse Event|0
2893213|NCT01825785|9960978|P2|Overall Study|Adverse Event|0
2893214|NCT01825785|9960979|P1|Overall Study|Adverse Event|0
2893215|NCT01825577|9961132|P1|Overall Study|Lack of Efficacy|3
2893216|NCT01825577|9961132|P1|Overall Study|Withdrawn by family members|2
2893217|NCT01825577|9961132|P1|Overall Study|Withdrawal by Subject|1
2893218|NCT01825577|9961132|P1|Overall Study|Physician Decision|2
2893219|NCT01825200|9961156|P2|Overall Study|Withdrawal by Subject|1
2893220|NCT01825200|9961157|P1|Overall Study|Withdrawal by Subject|0
2893221|NCT01825200|9961156|P2|Overall Study|Lost to Follow-up|6
2893222|NCT01825200|9961157|P1|Overall Study|Lost to Follow-up|5
2893223|NCT01824979|9961180|P2|Overall Study|Protocol Violation|13
2893224|NCT01824979|9961181|P1|Overall Study|Protocol Violation|6
2893225|NCT01824979|9961180|P2|Overall Study|Physician Decision|0
2893226|NCT01824979|9961181|P1|Overall Study|Physician Decision|2
2893227|NCT01824979|9961180|P2|Overall Study|Withdrawal by Subject|0
2893228|NCT01824979|9961181|P1|Overall Study|Withdrawal by Subject|5
2893229|NCT01824823|9961198|P2|Overall Study|Off-treatment reason not submitted|0
2893230|NCT01824823|9961199|P1|Overall Study|Off-treatment reason not submitted|1
2893231|NCT01824823|9961198|P2|Overall Study|Lack of Efficacy|1
2893232|NCT01824823|9961199|P1|Overall Study|Lack of Efficacy|1
2893233|NCT01824693|9961208|P3|Overall Study|No Transplant Planned|10
2893234|NCT01824693|9961209|P2|Overall Study|No Transplant Planned|0
2893235|NCT01824693|9961210|P1|Overall Study|No Transplant Planned|0
2893236|NCT01824693|9961208|P3|Overall Study|Ineligible|3
2893237|NCT01824693|9961209|P2|Overall Study|Ineligible|0
2893238|NCT01824693|9961210|P1|Overall Study|Ineligible|0
2893239|NCT01824693|9961208|P3|Overall Study|Progressive Disease|0
2893240|NCT01824693|9961209|P2|Overall Study|Progressive Disease|5
2893241|NCT01824693|9961210|P1|Overall Study|Progressive Disease|0
2893242|NCT01824693|9961208|P3|Overall Study|Withdrawal by Subject|1
2893243|NCT01824693|9961209|P2|Overall Study|Withdrawal by Subject|0
2893244|NCT01824693|9961210|P1|Overall Study|Withdrawal by Subject|0
2893245|NCT01824693|9961208|P3|Overall Study|Physician Decision|1
2893246|NCT01824693|9961209|P2|Overall Study|Physician Decision|1
2893247|NCT01824693|9961210|P1|Overall Study|Physician Decision|1
2893248|NCT01824693|9961208|P3|Overall Study|Death|0
2893249|NCT01824693|9961209|P2|Overall Study|Death|1
2893250|NCT01824693|9961210|P1|Overall Study|Death|0
2893251|NCT01824602|9961227|P4|Overall Study|Treatment failure|1
2893252|NCT01824602|9961228|P3|Overall Study|Treatment failure|0
2893253|NCT01824602|9961229|P2|Overall Study|Treatment failure|0
2893254|NCT01824602|9961230|P1|Overall Study|Treatment failure|0
2893255|NCT01824602|9961227|P4|Overall Study|Adverse Event|2
2893256|NCT01824602|9961228|P3|Overall Study|Adverse Event|2
2893257|NCT01824602|9961229|P2|Overall Study|Adverse Event|0
2893258|NCT01824602|9961230|P1|Overall Study|Adverse Event|1
2893259|NCT01824602|9961227|P4|Overall Study|Patient non-compliance|0
2893260|NCT01824602|9961228|P3|Overall Study|Patient non-compliance|1
2893261|NCT01824602|9961229|P2|Overall Study|Patient non-compliance|0
2893262|NCT01824602|9961230|P1|Overall Study|Patient non-compliance|0
2893263|NCT01824602|9961227|P4|Overall Study|Withdrawal by Subject|2
2893264|NCT01824602|9961228|P3|Overall Study|Withdrawal by Subject|1
2893265|NCT01824602|9961229|P2|Overall Study|Withdrawal by Subject|0
2893266|NCT01824602|9961230|P1|Overall Study|Withdrawal by Subject|0
2893267|NCT01824576|9961269|P1|Overall Study|Device deficiency|2
2893268|NCT01824498|9961287|P6|Washout (8 Weeks)|Withdrawal by Subject|0
2893269|NCT01824498|9961288|P5|Washout (8 Weeks)|Withdrawal by Subject|1
2893270|NCT01824498|9961289|P4|Washout (8 Weeks)|Withdrawal by Subject|1
2893271|NCT01824498|9961290|P3|Washout (8 Weeks)|Withdrawal by Subject|2
2893272|NCT01824498|9961291|P2|Washout (8 Weeks)|Withdrawal by Subject|0
2893273|NCT01824498|9961292|P1|Washout (8 Weeks)|Withdrawal by Subject|2
2893274|NCT01824394|9961326|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
2893275|NCT01824394|9961327|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
2893276|NCT01824394|9961328|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
2893277|NCT01824394|9961326|P3|Overall Study|Discontinued Subjects|2
2893278|NCT01824394|9961327|P2|Overall Study|Discontinued Subjects|1
2893279|NCT01824394|9961328|P1|Overall Study|Discontinued Subjects|1
2893280|NCT01824394|9961326|P3|Overall Study|Death|4
2893281|NCT01824394|9961327|P2|Overall Study|Death|2
2893282|NCT01824394|9961328|P1|Overall Study|Death|3
2893283|NCT01824394|9961326|P3|Overall Study|Lost to Follow-up|3
2893284|NCT01824394|9961327|P2|Overall Study|Lost to Follow-up|9
2893285|NCT01824394|9961328|P1|Overall Study|Lost to Follow-up|0
2893286|NCT01824394|9961326|P3|Overall Study|Withdrawn due to Study Termination|41
2893287|NCT01824394|9961327|P2|Overall Study|Withdrawn due to Study Termination|83
2893288|NCT01824394|9961328|P1|Overall Study|Withdrawn due to Study Termination|91
2893289|NCT01824394|9961326|P3|Overall Study|Early Termination|3
2893290|NCT01824394|9961327|P2|Overall Study|Early Termination|1
2893291|NCT01824394|9961328|P1|Overall Study|Early Termination|1
2893292|NCT01824355|9961338|P1|Overall Study|unevaluable reference method results per|1
2893293|NCT01824355|9961338|P1|Overall Study|Adverse Event|2
2893294|NCT01824342|9961349|P2|Overall Study|Death|0
2893295|NCT01824342|9961350|P1|Overall Study|Death|2
2893296|NCT01824342|9961349|P2|Overall Study|Physician Decision|0
2893297|NCT01824342|9961350|P1|Overall Study|Physician Decision|5
2893298|NCT01824342|9961349|P2|Overall Study|Disease Progression|1
2893299|NCT01824342|9961350|P1|Overall Study|Disease Progression|1
2893300|NCT01824342|9961349|P2|Overall Study|Adverse Event|1
2893301|NCT01824342|9961350|P1|Overall Study|Adverse Event|1
2893302|NCT01824342|9961349|P2|Overall Study|Withdrawal by Subject|3
2893303|NCT01824342|9961350|P1|Overall Study|Withdrawal by Subject|0
2893304|NCT01824303|9961364|P2|Randomized Study|Other Miscellaneous Reasons|0
2893305|NCT01824303|9961365|P1|Randomized Study|Other Miscellaneous Reasons|1
2893306|NCT01824303|9961364|P2|Randomized Study|Withdrawal by Subject|1
2893307|NCT01824303|9961365|P1|Randomized Study|Withdrawal by Subject|1
2893308|NCT01824290|9961391|P2|Overall Study|Investigator Reported Clinical Worsening|1
2893309|NCT01824290|9961392|P1|Overall Study|Investigator Reported Clinical Worsening|1
2893310|NCT01824290|9961391|P2|Overall Study|Parent/Caregiver Decision|1
2893311|NCT01824290|9961392|P1|Overall Study|Parent/Caregiver Decision|1
2893312|NCT01824290|9961391|P2|Overall Study|Entry Criteria Not Met|0
2893313|NCT01824290|9961392|P1|Overall Study|Entry Criteria Not Met|1
2893314|NCT01823991|9961410|P2|Overall Study|Withdrawal by Subject|5
2893315|NCT01823991|9961411|P1|Overall Study|Withdrawal by Subject|8
2893316|NCT01823679|9961452|P1|Overall Study|Death|1
2893317|NCT01823536|9961505|P6|Overall Study|Subject moved out of the state|0
2893318|NCT01823536|9961506|P5|Overall Study|Subject moved out of the state|1
2893319|NCT01823536|9961507|P4|Overall Study|Subject moved out of the state|0
2893320|NCT01823536|9961508|P3|Overall Study|Subject moved out of the state|0
2893321|NCT01823536|9961509|P2|Overall Study|Subject moved out of the state|0
2893322|NCT01823536|9961510|P1|Overall Study|Subject moved out of the state|0
2893323|NCT01823536|9961505|P6|Overall Study|Met exclusion criterion No 6|0
2893324|NCT01823536|9961506|P5|Overall Study|Met exclusion criterion No 6|0
2893325|NCT01823536|9961507|P4|Overall Study|Met exclusion criterion No 6|1
2893326|NCT01823536|9961508|P3|Overall Study|Met exclusion criterion No 6|0
2893327|NCT01823536|9961509|P2|Overall Study|Met exclusion criterion No 6|0
2893328|NCT01823536|9961510|P1|Overall Study|Met exclusion criterion No 6|0
2893329|NCT01823536|9961505|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
2893330|NCT01823536|9961506|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
2893331|NCT01823536|9961507|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
2893332|NCT01823536|9961508|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
2893333|NCT01823536|9961509|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
2893334|NCT01823536|9961510|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
2893335|NCT01823536|9961505|P6|Overall Study|Withdrawal by Subject|0
2893336|NCT01823536|9961506|P5|Overall Study|Withdrawal by Subject|0
2893337|NCT01823536|9961507|P4|Overall Study|Withdrawal by Subject|0
2893338|NCT01823536|9961508|P3|Overall Study|Withdrawal by Subject|0
2893339|NCT01823536|9961509|P2|Overall Study|Withdrawal by Subject|1
2893340|NCT01823536|9961510|P1|Overall Study|Withdrawal by Subject|1
2893341|NCT01823536|9961505|P6|Overall Study|Protocol Violation|0
2893342|NCT01823536|9961506|P5|Overall Study|Protocol Violation|0
2893343|NCT01823536|9961507|P4|Overall Study|Protocol Violation|0
2893344|NCT01823536|9961508|P3|Overall Study|Protocol Violation|0
2893345|NCT01823536|9961509|P2|Overall Study|Protocol Violation|1
2893346|NCT01823536|9961510|P1|Overall Study|Protocol Violation|0
2893347|NCT01823536|9961505|P6|Overall Study|Lost to Follow-up|0
2893348|NCT01823536|9961506|P5|Overall Study|Lost to Follow-up|1
2893349|NCT01823536|9961507|P4|Overall Study|Lost to Follow-up|1
2893350|NCT01823536|9961508|P3|Overall Study|Lost to Follow-up|0
2893351|NCT01823536|9961509|P2|Overall Study|Lost to Follow-up|0
2893352|NCT01823536|9961510|P1|Overall Study|Lost to Follow-up|1
2893353|NCT01823341|9961561|P1|Overall Study|Adverse Event|1
2893354|NCT01823341|9961561|P1|Overall Study|Withdrawal by Subject|7
2893355|NCT01823341|9961561|P1|Overall Study|Failed run-in|7
2893356|NCT01823328|9961606|P2|Overall Study|Withdrawal by Subject|6
2893357|NCT01823328|9961607|P1|Overall Study|Withdrawal by Subject|8
2893358|NCT01823289|9961627|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
2893359|NCT01823289|9961627|P1|Overall Study|Drug affected efficacy and safety|1
2893360|NCT01823289|9961627|P1|Overall Study|Transaminase increased more than 3 times|1
2893361|NCT01823289|9961627|P1|Overall Study|Administered contraindicated medicine|1
2893362|NCT01823289|9961627|P1|Overall Study|Physician Decision|9
2893363|NCT01823289|9961627|P1|Overall Study|Lack of Efficacy|1
2893364|NCT01823289|9961627|P1|Overall Study|Adverse Event|5
2893365|NCT01823289|9961627|P1|Overall Study|Lost to Follow-up|5
2893366|NCT01823224|9961635|P2|Overall Study|Withdrawal by Subject|1
2893367|NCT01823224|9961636|P1|Overall Study|Withdrawal by Subject|0
2893368|NCT01823224|9961635|P2|Overall Study|missed med dose|1
2893369|NCT01823224|9961636|P1|Overall Study|missed med dose|0
2893370|NCT01823224|9961635|P2|Overall Study|pharmacy error|1
2893371|NCT01823224|9961636|P1|Overall Study|pharmacy error|0
2893372|NCT01823224|9961635|P2|Overall Study|didn't qualify|2
2893373|NCT01823224|9961636|P1|Overall Study|didn't qualify|1
2893374|NCT01823224|9961635|P2|Overall Study|Lost to Follow-up|6
2893375|NCT01823224|9961636|P1|Overall Study|Lost to Follow-up|5
2893376|NCT01823146|9961646|P2|Overall Study|Lost to Follow-up|1
2893377|NCT01823146|9961647|P1|Overall Study|Lost to Follow-up|2
2893378|NCT01823146|9961646|P2|Overall Study|Withdrawal by Subject|1
2893379|NCT01823146|9961647|P1|Overall Study|Withdrawal by Subject|0
2893380|NCT01823107|9961657|P1|Overall Study|Withdrawal by Subject|1
2893381|NCT01822925|9961667|P4|Overall Study|Taking prohibited medication|1
2893382|NCT01822925|9961668|P3|Overall Study|Taking prohibited medication|0
2893383|NCT01822925|9961669|P2|Overall Study|Taking prohibited medication|0
2893384|NCT01822925|9961670|P1|Overall Study|Taking prohibited medication|2
2893385|NCT01822925|9961667|P4|Overall Study|Withdrawal by Subject|2
2893386|NCT01822925|9961668|P3|Overall Study|Withdrawal by Subject|2
2893387|NCT01822925|9961669|P2|Overall Study|Withdrawal by Subject|0
2893388|NCT01822925|9961670|P1|Overall Study|Withdrawal by Subject|2
2893389|NCT01822925|9961667|P4|Overall Study|Protocol Violation|1
2893390|NCT01822925|9961668|P3|Overall Study|Protocol Violation|0
2893391|NCT01822925|9961669|P2|Overall Study|Protocol Violation|0
2893392|NCT01822925|9961670|P1|Overall Study|Protocol Violation|1
2893393|NCT01822925|9961667|P4|Overall Study|Lost to Follow-up|0
2893394|NCT01822925|9961668|P3|Overall Study|Lost to Follow-up|0
2893395|NCT01822925|9961669|P2|Overall Study|Lost to Follow-up|1
2893396|NCT01822925|9961670|P1|Overall Study|Lost to Follow-up|0
2893397|NCT01822925|9961667|P4|Overall Study|Adverse Event|1
2893398|NCT01822925|9961668|P3|Overall Study|Adverse Event|1
2893399|NCT01822925|9961669|P2|Overall Study|Adverse Event|1
2893400|NCT01822925|9961670|P1|Overall Study|Adverse Event|1
2893401|NCT01822899|9961722|P2|Overall Study|Withdrawal by Subject|7
2893402|NCT01822899|9961723|P1|Overall Study|Withdrawal by Subject|5
2893403|NCT01822899|9961722|P2|Overall Study|Lost to Follow-up|0
2893404|NCT01822899|9961723|P1|Overall Study|Lost to Follow-up|1
2893405|NCT01822899|9961722|P2|Overall Study|Protocol Violation|3
2893406|NCT01822899|9961723|P1|Overall Study|Protocol Violation|6
2893407|NCT01822899|9961722|P2|Overall Study|Lack of Efficacy|3
2893408|NCT01822899|9961723|P1|Overall Study|Lack of Efficacy|6
2893409|NCT01822899|9961722|P2|Overall Study|Adverse Event|5
2893410|NCT01822899|9961723|P1|Overall Study|Adverse Event|6
2893411|NCT01822821|9961741|P2|Overall Study|Other reasons|0
2893412|NCT01822821|9961742|P1|Overall Study|Other reasons|1
2893413|NCT01822821|9961741|P2|Overall Study|Eligible surgery cancelled|1
2893414|NCT01822821|9961742|P1|Overall Study|Eligible surgery cancelled|1
2893415|NCT01822756|9961771|P5|Overall Study|disease progression & patient preference|0
2893416|NCT01822756|9961772|P4|Overall Study|disease progression & patient preference|0
2893417|NCT01822756|9961773|P3|Overall Study|disease progression & patient preference|1
2893418|NCT01822756|9961774|P2|Overall Study|disease progression & patient preference|0
2893419|NCT01822756|9961775|P1|Overall Study|disease progression & patient preference|2
2893420|NCT01822756|9961771|P5|Overall Study|Physician Decision|0
2893421|NCT01822756|9961772|P4|Overall Study|Physician Decision|0
2893422|NCT01822756|9961773|P3|Overall Study|Physician Decision|0
2893423|NCT01822756|9961774|P2|Overall Study|Physician Decision|1
2893424|NCT01822756|9961775|P1|Overall Study|Physician Decision|0
2893425|NCT01822756|9961771|P5|Overall Study|Lost to Follow-up|1
2893426|NCT01822756|9961772|P4|Overall Study|Lost to Follow-up|0
2893427|NCT01822756|9961773|P3|Overall Study|Lost to Follow-up|1
2893428|NCT01822756|9961774|P2|Overall Study|Lost to Follow-up|0
2893429|NCT01822756|9961775|P1|Overall Study|Lost to Follow-up|1
2893430|NCT01822756|9961771|P5|Overall Study|Death|0
2893431|NCT01822756|9961772|P4|Overall Study|Death|0
2893432|NCT01822756|9961773|P3|Overall Study|Death|1
2893433|NCT01822756|9961774|P2|Overall Study|Death|2
2893434|NCT01822756|9961775|P1|Overall Study|Death|2
2893435|NCT01822756|9961771|P5|Overall Study|Disease progression|6
2893436|NCT01822756|9961772|P4|Overall Study|Disease progression|2
2893437|NCT01822756|9961773|P3|Overall Study|Disease progression|7
2893438|NCT01822756|9961774|P2|Overall Study|Disease progression|1
2893439|NCT01822756|9961775|P1|Overall Study|Disease progression|11
2893440|NCT01822756|9961771|P5|Overall Study|Adverse Event|0
2893441|NCT01822756|9961772|P4|Overall Study|Adverse Event|2
2893442|NCT01822756|9961773|P3|Overall Study|Adverse Event|0
2893443|NCT01822756|9961774|P2|Overall Study|Adverse Event|0
2893444|NCT01822756|9961775|P1|Overall Study|Adverse Event|0
2893445|NCT01822691|9961817|P1|Overall Study|Withdrawal by Subject|2
2893446|NCT01822678|9961828|P3|Overall Study|Lost to Follow-up|1
2893447|NCT01822678|9961829|P2|Overall Study|Lost to Follow-up|2
2893448|NCT01822678|9961830|P1|Overall Study|Lost to Follow-up|0
2893449|NCT01822678|9961828|P3|Overall Study|Lack of Efficacy|5
2893450|NCT01822678|9961829|P2|Overall Study|Lack of Efficacy|6
2893451|NCT01822678|9961830|P1|Overall Study|Lack of Efficacy|3
2893452|NCT01822678|9961828|P3|Overall Study|Adverse Event|1
2893453|NCT01822678|9961829|P2|Overall Study|Adverse Event|3
2893454|NCT01822678|9961830|P1|Overall Study|Adverse Event|4
2893455|NCT01822678|9961828|P3|Overall Study|Withdrawal by Subject|4
2893456|NCT01822678|9961829|P2|Overall Study|Withdrawal by Subject|4
2893457|NCT01822678|9961830|P1|Overall Study|Withdrawal by Subject|5
2893458|NCT01822665|9961838|P1|Overall Study|Other Reason|5
2893459|NCT01822665|9961838|P1|Overall Study|Adverse Event|3
2893460|NCT01822587|9961865|P3|Overall Study|Physician Decision|6
2893461|NCT01822587|9961866|P2|Overall Study|Physician Decision|6
2893462|NCT01822587|9961867|P1|Overall Study|Physician Decision|9
2893463|NCT01822587|9961865|P3|Overall Study|Lost to Follow-up|12
2893464|NCT01822587|9961866|P2|Overall Study|Lost to Follow-up|9
2893465|NCT01822587|9961867|P1|Overall Study|Lost to Follow-up|7
2893466|NCT01822561|9961906|P1|Overall Study|Withdrawal by Subject|2
2893467|NCT01822535|9961927|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
2893468|NCT01822535|9961928|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
2893469|NCT01822535|9961927|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
2893470|NCT01822535|9961928|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
2893471|NCT01822535|9961927|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
2893472|NCT01822535|9961928|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
2893473|NCT01822496|9961944|P4|Overall Study|Withdrawal by Subject|3
2893474|NCT01822496|9961945|P3|Overall Study|Withdrawal by Subject|0
2893475|NCT01822496|9961946|P2|Overall Study|Withdrawal by Subject|0
2893476|NCT01822496|9961947|P1|Overall Study|Withdrawal by Subject|0
2893477|NCT01822496|9961944|P4|Overall Study|Protocol Violation|1
2893478|NCT01822496|9961945|P3|Overall Study|Protocol Violation|0
2893479|NCT01822496|9961946|P2|Overall Study|Protocol Violation|2
2893480|NCT01822496|9961947|P1|Overall Study|Protocol Violation|2
2893481|NCT01822366|9962000|P4|Overall Study|Partial Intervention Completion|15
2893482|NCT01822366|9962001|P3|Overall Study|Partial Intervention Completion|0
2893483|NCT01822366|9962002|P2|Overall Study|Partial Intervention Completion|15
2893484|NCT01822366|9962003|P1|Overall Study|Partial Intervention Completion|0
2893485|NCT01822366|9962000|P4|Overall Study|Withdrawal by Subject|6
2893486|NCT01822366|9962001|P3|Overall Study|Withdrawal by Subject|0
2893487|NCT01822366|9962002|P2|Overall Study|Withdrawal by Subject|6
2893488|NCT01822366|9962003|P1|Overall Study|Withdrawal by Subject|0
2893489|NCT01822366|9962000|P4|Overall Study|Lost to Follow-up|1
2893490|NCT01822366|9962001|P3|Overall Study|Lost to Follow-up|5
2893491|NCT01822366|9962002|P2|Overall Study|Lost to Follow-up|1
2893492|NCT01822366|9962003|P1|Overall Study|Lost to Follow-up|5
2893493|NCT01822353|9962034|P3|Overall Study|Withdrawal by Subject|0
2893494|NCT01822353|9962035|P2|Overall Study|Withdrawal by Subject|1
2893495|NCT01822353|9962036|P1|Overall Study|Withdrawal by Subject|3
2893496|NCT01822353|9962034|P3|Overall Study|Pregnancy|0
2893497|NCT01822353|9962035|P2|Overall Study|Pregnancy|1
2893498|NCT01822353|9962036|P1|Overall Study|Pregnancy|0
2893499|NCT01822353|9962034|P3|Overall Study|Adverse Event|1
2893500|NCT01822353|9962035|P2|Overall Study|Adverse Event|3
2893501|NCT01822353|9962036|P1|Overall Study|Adverse Event|1
2893502|NCT01822223|9962056|P2|Overall Study|Death|1
2893503|NCT01822223|9962057|P1|Overall Study|Death|0
2893504|NCT01822132|9962081|P2|Overall Study|Lost to Follow-up|2
2893505|NCT01822132|9962082|P1|Overall Study|Lost to Follow-up|4
2893506|NCT01821963|9962119|P1|Overall Study|Adverse Event|1
2893507|NCT01821937|9962125|P2|Overall Study|Adverse Event|3
2893508|NCT01821937|9962126|P1|Overall Study|Adverse Event|0
2893509|NCT01821807|9962150|P2|Overall Study|Lost to Follow-up|1
2893510|NCT01821807|9962151|P1|Overall Study|Lost to Follow-up|3
2893511|NCT01821729|9962159|P1|Overall Study|Withdrawal by Subject|1
2893512|NCT01821625|9962164|P1|Overall Study|Medical contraindication|1
2893513|NCT01821625|9962164|P1|Overall Study|Adverse Event|1
2893514|NCT01821625|9962164|P1|Overall Study|Lack of Efficacy|2
2893515|NCT01821625|9962164|P1|Overall Study|Withdrawal by Subject|2
2893516|NCT01821560|9962170|P2|Overall Study|Protocol Violation|1
2893517|NCT01821560|9962171|P1|Overall Study|Protocol Violation|0
2893518|NCT01821560|9962170|P2|Overall Study|Withdrawal by Subject|1
2893519|NCT01821560|9962171|P1|Overall Study|Withdrawal by Subject|1
2893520|NCT01821560|9962170|P2|Overall Study|Lost to Follow-up|5
2893521|NCT01821560|9962171|P1|Overall Study|Lost to Follow-up|5
2893522|NCT01821118|9962292|P2|Overall Study|Death|1
2893523|NCT01821118|9962293|P1|Overall Study|Death|0
2893524|NCT01820637|9962340|P1|Overall Study|Withdrawal by Subject|1
2893525|NCT01820637|9962340|P1|Overall Study|Death|2
2893526|NCT01820585|9962349|P4|Overall Study|Pregnancy|0
2893527|NCT01820585|9962350|P3|Overall Study|Pregnancy|0
2893528|NCT01820585|9962351|P2|Overall Study|Pregnancy|1
2893529|NCT01820585|9962352|P1|Overall Study|Pregnancy|0
2893530|NCT01820585|9962349|P4|Overall Study|at sponsor request|0
2893531|NCT01820585|9962350|P3|Overall Study|at sponsor request|1
2893532|NCT01820585|9962351|P2|Overall Study|at sponsor request|0
2893533|NCT01820585|9962352|P1|Overall Study|at sponsor request|0
2893534|NCT01820585|9962349|P4|Overall Study|Subject non-compliance|2
2893535|NCT01820585|9962350|P3|Overall Study|Subject non-compliance|1
2893536|NCT01820585|9962351|P2|Overall Study|Subject non-compliance|0
2893537|NCT01820585|9962352|P1|Overall Study|Subject non-compliance|0
2893538|NCT01820585|9962349|P4|Overall Study|Protocol Violation|1
2893539|NCT01820585|9962350|P3|Overall Study|Protocol Violation|1
2893540|NCT01820585|9962351|P2|Overall Study|Protocol Violation|1
2893541|NCT01820585|9962352|P1|Overall Study|Protocol Violation|3
2893542|NCT01820585|9962349|P4|Overall Study|Lost to Follow-up|3
2893543|NCT01820585|9962350|P3|Overall Study|Lost to Follow-up|0
2893544|NCT01820585|9962351|P2|Overall Study|Lost to Follow-up|3
2893545|NCT01820585|9962352|P1|Overall Study|Lost to Follow-up|3
2893546|NCT01820585|9962349|P4|Overall Study|Withdrawal by Subject|8
2893547|NCT01820585|9962350|P3|Overall Study|Withdrawal by Subject|3
2893548|NCT01820585|9962351|P2|Overall Study|Withdrawal by Subject|7
2893549|NCT01820585|9962352|P1|Overall Study|Withdrawal by Subject|3
2893550|NCT01820585|9962349|P4|Overall Study|Lack of Efficacy|1
2893551|NCT01820585|9962350|P3|Overall Study|Lack of Efficacy|5
2893552|NCT01820585|9962351|P2|Overall Study|Lack of Efficacy|7
2893553|NCT01820585|9962352|P1|Overall Study|Lack of Efficacy|9
2893554|NCT01820585|9962349|P4|Overall Study|Adverse Event|34
2893555|NCT01820585|9962350|P3|Overall Study|Adverse Event|23
2893556|NCT01820585|9962351|P2|Overall Study|Adverse Event|13
2893557|NCT01820585|9962352|P1|Overall Study|Adverse Event|9
2893558|NCT01820559|9962365|P3|Overall Study|Lack of Efficacy|3
2893559|NCT01820559|9962366|P2|Overall Study|Lack of Efficacy|2
2893560|NCT01820559|9962367|P1|Overall Study|Lack of Efficacy|3
2893561|NCT01820559|9962365|P3|Overall Study|At sponsor request|1
2893562|NCT01820559|9962366|P2|Overall Study|At sponsor request|0
2893563|NCT01820559|9962367|P1|Overall Study|At sponsor request|0
2893564|NCT01820559|9962365|P3|Overall Study|Lost to Follow-up|2
2893565|NCT01820559|9962366|P2|Overall Study|Lost to Follow-up|2
2893566|NCT01820559|9962367|P1|Overall Study|Lost to Follow-up|3
2893567|NCT01820559|9962365|P3|Overall Study|Subject's non-compliance|2
2893568|NCT01820559|9962366|P2|Overall Study|Subject's non-compliance|0
2893569|NCT01820559|9962367|P1|Overall Study|Subject's non-compliance|1
2893570|NCT01820559|9962365|P3|Overall Study|Protocol Violation|3
2893571|NCT01820559|9962366|P2|Overall Study|Protocol Violation|1
2893572|NCT01820559|9962367|P1|Overall Study|Protocol Violation|2
2893573|NCT01820559|9962365|P3|Overall Study|Withdrawal by Subject|5
2893574|NCT01820559|9962366|P2|Overall Study|Withdrawal by Subject|2
2893575|NCT01820559|9962367|P1|Overall Study|Withdrawal by Subject|1
2893576|NCT01820559|9962365|P3|Overall Study|Adverse Event|13
2893577|NCT01820559|9962366|P2|Overall Study|Adverse Event|6
2893578|NCT01820559|9962367|P1|Overall Study|Adverse Event|4
2893579|NCT01820364|9962388|P2|Part II: LGX818 + MEK162|Study Termination|1
2893580|NCT01820364|9962389|P1|Part II: LGX818 + MEK162|Study Termination|0
2893581|NCT01820364|9962388|P2|Part I: LGX818|Disease Progression|0
2893582|NCT01820364|9962389|P1|Part I: LGX818|Disease Progression|4
2893583|NCT01820364|9962388|P2|Part I: LGX818|Adverse Event|0
2893584|NCT01820364|9962389|P1|Part I: LGX818|Adverse Event|6
2893585|NCT01820364|9962388|P2|Part I: LGX818|Administrative Problems|0
2893586|NCT01820364|9962389|P1|Part I: LGX818|Administrative Problems|3
2893587|NCT01820364|9962388|P2|Part I: LGX818|Death|0
2893588|NCT01820364|9962389|P1|Part I: LGX818|Death|1
2893589|NCT01819727|9962533|P2|Overall Study|Quit due to lack of health benifits|1
2893590|NCT01819727|9962534|P1|Overall Study|Quit due to lack of health benifits|0
2893591|NCT01819727|9962533|P2|Overall Study|Unable to demostrate ability self-inject|1
2893592|NCT01819727|9962534|P1|Overall Study|Unable to demostrate ability self-inject|0
2893593|NCT01819727|9962533|P2|Overall Study|Withdrawal by Subject|11
2893594|NCT01819727|9962534|P1|Overall Study|Withdrawal by Subject|6
2893595|NCT01819727|9962533|P2|Overall Study|Study Terminated by Sponsor|1
2893596|NCT01819727|9962534|P1|Overall Study|Study Terminated by Sponsor|0
2893597|NCT01819727|9962533|P2|Overall Study|Protocol Violation|2
2893598|NCT01819727|9962534|P1|Overall Study|Protocol Violation|0
2893599|NCT01819727|9962533|P2|Overall Study|Pregnancy|0
2893600|NCT01819727|9962534|P1|Overall Study|Pregnancy|1
2893601|NCT01819727|9962533|P2|Overall Study|Physician Decision|2
2893602|NCT01819727|9962534|P1|Overall Study|Physician Decision|3
2893603|NCT01819727|9962533|P2|Overall Study|Lost to Follow-up|1
2893604|NCT01819727|9962534|P1|Overall Study|Lost to Follow-up|1
2893605|NCT01819727|9962533|P2|Overall Study|Death|0
2893606|NCT01819727|9962534|P1|Overall Study|Death|1
2893607|NCT01819727|9962533|P2|Overall Study|Adverse Event|9
2893608|NCT01819727|9962534|P1|Overall Study|Adverse Event|8
2893609|NCT01819506|9962556|P2|Overall Study|Withdrawal by Subject|3
2893610|NCT01819506|9962557|P1|Overall Study|Withdrawal by Subject|3
2893611|NCT01819506|9962556|P2|Overall Study|Physician Decision|2
2893612|NCT01819506|9962557|P1|Overall Study|Physician Decision|5
2893613|NCT01819272|9962609|P6|Overall Study|Loss of Glucose Control|0
2893614|NCT01819272|9962610|P5|Overall Study|Loss of Glucose Control|2
2893615|NCT01819272|9962611|P4|Overall Study|Loss of Glucose Control|1
2893616|NCT01819272|9962612|P3|Overall Study|Loss of Glucose Control|0
2893617|NCT01819272|9962613|P2|Overall Study|Loss of Glucose Control|1
2893618|NCT01819272|9962614|P1|Overall Study|Loss of Glucose Control|2
2893619|NCT01819272|9962609|P6|Overall Study|Withdrawal of Consent|1
2893620|NCT01819272|9962610|P5|Overall Study|Withdrawal of Consent|0
2893621|NCT01819272|9962611|P4|Overall Study|Withdrawal of Consent|1
2893622|NCT01819272|9962612|P3|Overall Study|Withdrawal of Consent|2
2893623|NCT01819272|9962613|P2|Overall Study|Withdrawal of Consent|1
2893624|NCT01819272|9962614|P1|Overall Study|Withdrawal of Consent|0
2893625|NCT01819272|9962609|P6|Overall Study|Physician Decision|0
2893626|NCT01819272|9962610|P5|Overall Study|Physician Decision|0
2893627|NCT01819272|9962611|P4|Overall Study|Physician Decision|0
2893628|NCT01819272|9962612|P3|Overall Study|Physician Decision|0
2893629|NCT01819272|9962613|P2|Overall Study|Physician Decision|1
2893630|NCT01819272|9962614|P1|Overall Study|Physician Decision|0
2893631|NCT01819272|9962609|P6|Overall Study|Protocol Violation|3
2893632|NCT01819272|9962610|P5|Overall Study|Protocol Violation|2
2893633|NCT01819272|9962611|P4|Overall Study|Protocol Violation|1
2893634|NCT01819272|9962612|P3|Overall Study|Protocol Violation|0
2893635|NCT01819272|9962613|P2|Overall Study|Protocol Violation|0
2893636|NCT01819272|9962614|P1|Overall Study|Protocol Violation|0
2893637|NCT01819272|9962609|P6|Overall Study|Lost to Follow-up|3
2893638|NCT01819272|9962610|P5|Overall Study|Lost to Follow-up|0
2893639|NCT01819272|9962611|P4|Overall Study|Lost to Follow-up|0
2893640|NCT01819272|9962612|P3|Overall Study|Lost to Follow-up|1
2893641|NCT01819272|9962613|P2|Overall Study|Lost to Follow-up|0
2893642|NCT01819272|9962614|P1|Overall Study|Lost to Follow-up|3
2893643|NCT01819272|9962609|P6|Overall Study|Adverse Event|0
2893644|NCT01819272|9962610|P5|Overall Study|Adverse Event|0
2893645|NCT01819272|9962611|P4|Overall Study|Adverse Event|2
2893646|NCT01819272|9962612|P3|Overall Study|Adverse Event|0
2893647|NCT01819272|9962613|P2|Overall Study|Adverse Event|0
2893648|NCT01819272|9962614|P1|Overall Study|Adverse Event|1
2893649|NCT01819194|9962652|P1|Overall Study|Loss of study articles|2
2893650|NCT01819129|9962659|P2|Overall Study|Withdrawal Criteria|15
2893651|NCT01819129|9962660|P1|Overall Study|Withdrawal Criteria|20
2893652|NCT01819129|9962659|P2|Overall Study|Death|1
2893653|NCT01819129|9962660|P1|Overall Study|Death|1
2893654|NCT01819129|9962659|P2|Overall Study|Adverse Event|4
2893655|NCT01819129|9962660|P1|Overall Study|Adverse Event|1
2893656|NCT01819129|9962659|P2|Overall Study|Lack of Efficacy|1
2893657|NCT01819129|9962660|P1|Overall Study|Lack of Efficacy|0
2893658|NCT01819129|9962659|P2|Overall Study|Lost to Follow-up|2
2893659|NCT01819129|9962660|P1|Overall Study|Lost to Follow-up|5
2893660|NCT01819129|9962659|P2|Overall Study|Withdrawal by Subject|15
2893661|NCT01819129|9962660|P1|Overall Study|Withdrawal by Subject|15
2893662|NCT01819129|9962659|P2|Overall Study|Other, Subject moved out of the country|1
2893663|NCT01819129|9962660|P1|Overall Study|Other, Subject moved out of the country|0
2893664|NCT01819129|9962659|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
2893665|NCT01819129|9962660|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
2893666|NCT01819129|9962659|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
2893667|NCT01819129|9962660|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
2893668|NCT01818765|9962672|P1|Overall Study|Death|2
2893669|NCT01818752|9962685|P2|Overall Study|Randomized but not Dosed|4
2893670|NCT01818752|9962686|P1|Overall Study|Randomized but not Dosed|7
2893671|NCT01818752|9962685|P2|Overall Study|Continuing Treatment|4
2893672|NCT01818752|9962686|P1|Overall Study|Continuing Treatment|1
2893673|NCT01818752|9962685|P2|Overall Study|Other|8
2893674|NCT01818752|9962686|P1|Overall Study|Other|7
2893675|NCT01818752|9962685|P2|Overall Study|Disease Progression|48
2893676|NCT01818752|9962686|P1|Overall Study|Disease Progression|54
2893677|NCT01818752|9962685|P2|Overall Study|Physician Decision|8
2893678|NCT01818752|9962686|P1|Overall Study|Physician Decision|9
2893679|NCT01818752|9962685|P2|Overall Study|Withdrawal by Subject|14
2893680|NCT01818752|9962686|P1|Overall Study|Withdrawal by Subject|15
2893681|NCT01818752|9962685|P2|Overall Study|Non-compliance|20
2893682|NCT01818752|9962686|P1|Overall Study|Non-compliance|16
2893683|NCT01818752|9962685|P2|Overall Study|Death|18
2893684|NCT01818752|9962686|P1|Overall Study|Death|14
2893685|NCT01818752|9962685|P2|Overall Study|Adverse Event|74
2893686|NCT01818752|9962686|P1|Overall Study|Adverse Event|64
2893687|NCT01818726|9962706|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
2893688|NCT01818726|9962707|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
2893689|NCT01818726|9962706|P2|Overall Study|Withdrawal by Subject|1
2893690|NCT01818726|9962707|P1|Overall Study|Withdrawal by Subject|0
2893691|NCT01818726|9962706|P2|Overall Study|Administrative reasons|1
2893692|NCT01818726|9962707|P1|Overall Study|Administrative reasons|5
2893693|NCT01818700|9962717|P1|Overall Study|Other|1
2893694|NCT01818700|9962717|P1|Overall Study|Protocol Violation|2
2893695|NCT01818700|9962717|P1|Overall Study|Withdrawal by Subject|27
2893696|NCT01818700|9962717|P1|Overall Study|Lost to Follow-up|5
2893697|NCT01818700|9962717|P1|Overall Study|Lack of Efficacy|2
2893698|NCT01818700|9962717|P1|Overall Study|Adverse Event|67
2893699|NCT01818596|9962728|P2|Overall Study|Lost to Follow-up|0
2893700|NCT01818596|9962729|P1|Overall Study|Lost to Follow-up|7
2893701|NCT01818596|9962728|P2|Overall Study|Withdrew Consent|0
2893702|NCT01818596|9962729|P1|Overall Study|Withdrew Consent|5
2893703|NCT01818596|9962728|P2|Overall Study|Protocol Violation|0
2893704|NCT01818596|9962729|P1|Overall Study|Protocol Violation|1
2893705|NCT01818596|9962728|P2|Overall Study|Investigator's Discretion|0
2893706|NCT01818596|9962729|P1|Overall Study|Investigator's Discretion|4
2893707|NCT01818596|9962728|P2|Overall Study|Death|0
2893708|NCT01818596|9962729|P1|Overall Study|Death|3
2893709|NCT01818596|9962728|P2|Overall Study|Adverse Event|0
2893710|NCT01818596|9962729|P1|Overall Study|Adverse Event|7
2893711|NCT01818596|9962728|P2|Overall Study|Enrolled but Not Treated|0
2893712|NCT01818596|9962729|P1|Overall Study|Enrolled but Not Treated|4
2893713|NCT01818531|9962768|P2|Overall Study|Withdrawn for failure to place block|1
2893714|NCT01818531|9962769|P1|Overall Study|Withdrawn for failure to place block|0
2893715|NCT01818531|9962768|P2|Overall Study|Withdrawn for long-acting opioid patch|1
2893716|NCT01818531|9962769|P1|Overall Study|Withdrawn for long-acting opioid patch|0
2893717|NCT01818531|9962768|P2|Overall Study|Withdrawn for case delay after block|0
2893718|NCT01818531|9962769|P1|Overall Study|Withdrawn for case delay after block|1
2893719|NCT01818336|9962842|P2|Overall Study|Lost to Follow-up|1
2893720|NCT01818336|9962843|P1|Overall Study|Lost to Follow-up|0
2893721|NCT01818336|9962842|P2|Overall Study|Declined retest visit|11
2893722|NCT01818336|9962843|P1|Overall Study|Declined retest visit|0
2893723|NCT01818297|9962851|P2|Open Label Phase (3-12 Months)|Early study closure|10
2893724|NCT01818297|9962852|P1|Open Label Phase (3-12 Months)|Early study closure|17
2893725|NCT01818297|9962851|P2|Open Label Phase (3-12 Months)|Physician Decision|0
2893726|NCT01818297|9962852|P1|Open Label Phase (3-12 Months)|Physician Decision|1
2893727|NCT01818297|9962851|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
2893728|NCT01818297|9962852|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
2893729|NCT01818284|9962870|P2|Overall Study|Death|2
2893730|NCT01818284|9962871|P1|Overall Study|Death|0
2893731|NCT01818284|9962870|P2|Overall Study|Not eligible due to White Blood Counts|4
2893732|NCT01818284|9962871|P1|Overall Study|Not eligible due to White Blood Counts|4
2893733|NCT01818141|9962904|P2|Overall Study|Lost to Follow-up|2
2893734|NCT01818141|9962905|P1|Overall Study|Lost to Follow-up|0
2893735|NCT01818141|9962904|P2|Overall Study|No baseline C.diff colonies|1
2893736|NCT01818141|9962905|P1|Overall Study|No baseline C.diff colonies|1
2893737|NCT01818141|9962904|P2|Overall Study|Withdrawal by Subject|0
2893738|NCT01818141|9962905|P1|Overall Study|Withdrawal by Subject|2
2893739|NCT01817959|9962928|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2893740|NCT01817959|9962929|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2893741|NCT01817959|9962928|P2|Overall Study|Adverse Event|0
2893742|NCT01817959|9962929|P1|Overall Study|Adverse Event|1
2893743|NCT01817959|9962928|P2|Overall Study|forbidden medication|1
2893744|NCT01817959|9962929|P1|Overall Study|forbidden medication|1
2893745|NCT01817959|9962928|P2|Overall Study|Graft loss|1
2893746|NCT01817959|9962929|P1|Overall Study|Graft loss|1
2893747|NCT01817790|9963021|P2|Overall Study|Other: Could not attend appointment|1
2893748|NCT01817790|9963022|P1|Overall Study|Other: Could not attend appointment|1
2893749|NCT01817790|9963021|P2|Overall Study|Withdrawal by Subject|3
2893750|NCT01817790|9963022|P1|Overall Study|Withdrawal by Subject|1
2893751|NCT01817790|9963021|P2|Overall Study|Protocol Violation|1
2893752|NCT01817790|9963022|P1|Overall Study|Protocol Violation|2
2893753|NCT01817790|9963021|P2|Overall Study|Lost to Follow-up|1
2893754|NCT01817790|9963022|P1|Overall Study|Lost to Follow-up|0
2893755|NCT01817790|9963021|P2|Overall Study|Adverse Event|2
2893756|NCT01817790|9963022|P1|Overall Study|Adverse Event|0
2893757|NCT01817777|9963066|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
2893758|NCT01817777|9963067|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
2893759|NCT01817777|9963068|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
2893760|NCT01817777|9963066|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
2893761|NCT01817777|9963067|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
2893762|NCT01817777|9963068|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
2893763|NCT01817777|9963066|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2893764|NCT01817777|9963067|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
2893765|NCT01817777|9963068|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2893766|NCT01817777|9963066|P3|Observational Phase (8 Weeks)|Early Study Termination|0
2893767|NCT01817777|9963067|P2|Observational Phase (8 Weeks)|Early Study Termination|0
2893768|NCT01817777|9963068|P1|Observational Phase (8 Weeks)|Early Study Termination|2
2893769|NCT01817777|9963066|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
2893770|NCT01817777|9963067|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
2893771|NCT01817777|9963068|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
2893772|NCT01817764|9963092|P2|Overall Study|Withdrawal by Subject|12
2893773|NCT01817764|9963093|P1|Overall Study|Withdrawal by Subject|10
2893774|NCT01817764|9963092|P2|Overall Study|Lost to Follow-up|4
2893775|NCT01817764|9963093|P1|Overall Study|Lost to Follow-up|1
2893776|NCT01817764|9963092|P2|Overall Study|Protocol Violation|5
2893777|NCT01817764|9963093|P1|Overall Study|Protocol Violation|7
2893778|NCT01817764|9963092|P2|Overall Study|Lack of Efficacy|7
2893779|NCT01817764|9963093|P1|Overall Study|Lack of Efficacy|9
2893780|NCT01817764|9963092|P2|Overall Study|Adverse Event|10
2893781|NCT01817764|9963093|P1|Overall Study|Adverse Event|7
2893782|NCT01817725|9963101|P1|Overall Study|Withdrawal by Subject|1
2893783|NCT01817582|9963122|P3|Overall Study|Randomized but exclusion criteria met|0
2893784|NCT01817582|9963123|P2|Overall Study|Randomized but exclusion criteria met|0
2893785|NCT01817582|9963124|P1|Overall Study|Randomized but exclusion criteria met|1
2893786|NCT01817582|9963122|P3|Overall Study|Participant revealed masked treatment|0
2893787|NCT01817582|9963123|P2|Overall Study|Participant revealed masked treatment|0
2893788|NCT01817582|9963124|P1|Overall Study|Participant revealed masked treatment|1
2893789|NCT01817582|9963122|P3|Overall Study|Withdrawal by Subject|0
2893790|NCT01817582|9963123|P2|Overall Study|Withdrawal by Subject|1
2893791|NCT01817582|9963124|P1|Overall Study|Withdrawal by Subject|0
2893792|NCT01817075|9963249|P2|Overall Study|Ineligible|2
2893793|NCT01817075|9963250|P1|Overall Study|Ineligible|0
2893794|NCT01817075|9963249|P2|Overall Study|Received Sorafenib after enrollment|1
2893795|NCT01817075|9963250|P1|Overall Study|Received Sorafenib after enrollment|0
2893796|NCT01817075|9963249|P2|Overall Study|Withdrawal by Subject|15
2893797|NCT01817075|9963250|P1|Overall Study|Withdrawal by Subject|31
2893798|NCT01817075|9963249|P2|Overall Study|Physician Decision|12
2893799|NCT01817075|9963250|P1|Overall Study|Physician Decision|9
2893800|NCT01817075|9963249|P2|Overall Study|Adverse Event|5
2893801|NCT01817075|9963250|P1|Overall Study|Adverse Event|7
2893802|NCT01816906|9963264|P2|12 Months|Lost to Follow-up|1
2893803|NCT01816906|9963265|P1|12 Months|Lost to Follow-up|2
2893804|NCT01816906|9963264|P2|12 Months|Death|2
2893805|NCT01816906|9963265|P1|12 Months|Death|0
2893806|NCT01816906|9963264|P2|12 Months|Adverse Event|2
2893807|NCT01816906|9963265|P1|12 Months|Adverse Event|2
2893808|NCT01816906|9963264|P2|Six Months|Lost to Follow-up|16
2893809|NCT01816906|9963265|P1|Six Months|Lost to Follow-up|14
2893810|NCT01816906|9963264|P2|Six Months|Did Not Show Up for Baseline Measurement|6
2893811|NCT01816906|9963265|P1|Six Months|Did Not Show Up for Baseline Measurement|7
2893812|NCT01816893|9963283|P2|Washout Period|Withdrawal by Subject|0
2893813|NCT01816893|9963284|P1|Washout Period|Withdrawal by Subject|2
2893814|NCT01816763|9963320|P3|Overall Study|The main reason for an incomplete survey|11
2893815|NCT01816763|9963321|P2|Overall Study|The main reason for an incomplete survey|15
2893816|NCT01816763|9963322|P1|Overall Study|The main reason for an incomplete survey|4
2893817|NCT01816685|9963338|P2|Overall Study|Surgery Cancelled|2
2893818|NCT01816685|9963339|P1|Overall Study|Surgery Cancelled|3
2893819|NCT01816685|9963338|P2|Overall Study|Lost to Follow-up|9
2893820|NCT01816685|9963339|P1|Overall Study|Lost to Follow-up|7
2893821|NCT01816594|9963349|P2|Overall Study|Physician Decision|0
2893822|NCT01816594|9963350|P1|Overall Study|Physician Decision|1
2893823|NCT01816594|9963349|P2|Overall Study|Withdrawal by Subject|0
2893824|NCT01816594|9963350|P1|Overall Study|Withdrawal by Subject|1
2893825|NCT01816594|9963349|P2|Overall Study|Adverse Event|0
2893826|NCT01816594|9963350|P1|Overall Study|Adverse Event|9
2893827|NCT01816594|9963349|P2|Overall Study|Local Progress|2
2893828|NCT01816594|9963350|P1|Overall Study|Local Progress|0
2893829|NCT01816477|9963388|P2|Overall Study|Unable to tolerate catheter placement|0
2893830|NCT01816477|9963389|P1|Overall Study|Unable to tolerate catheter placement|3
2893831|NCT01816477|9963388|P2|Overall Study|Withdrawal by Subject|1
2893832|NCT01816477|9963389|P1|Overall Study|Withdrawal by Subject|13
2893833|NCT01816295|9963443|P2|OLE Phase|Lack of Efficacy|7
2893834|NCT01816295|9963444|P1|OLE Phase|Lack of Efficacy|3
2893835|NCT01816295|9963443|P2|OLE Phase|Withdrawal by Subject|10
2893836|NCT01816295|9963444|P1|OLE Phase|Withdrawal by Subject|10
2893837|NCT01816295|9963443|P2|OLE Phase|Sponsor Decision|9
2893838|NCT01816295|9963444|P1|OLE Phase|Sponsor Decision|7
2893839|NCT01816295|9963443|P2|OLE Phase|Protocol Violation|4
2893840|NCT01816295|9963444|P1|OLE Phase|Protocol Violation|4
2893841|NCT01816295|9963443|P2|OLE Phase|Physician Decision|1
2893842|NCT01816295|9963444|P1|OLE Phase|Physician Decision|3
2893843|NCT01816295|9963443|P2|OLE Phase|Lost to Follow-up|5
2893844|NCT01816295|9963444|P1|OLE Phase|Lost to Follow-up|5
2893845|NCT01816295|9963443|P2|OLE Phase|Entry Criteria Not Met|5
2893846|NCT01816295|9963444|P1|OLE Phase|Entry Criteria Not Met|3
2893847|NCT01816295|9963443|P2|OLE Phase|Death|0
2893848|NCT01816295|9963444|P1|OLE Phase|Death|1
2893849|NCT01816295|9963443|P2|OLE Phase|Adverse Event|15
2893850|NCT01816295|9963444|P1|OLE Phase|Adverse Event|17
2893851|NCT01816295|9963443|P2|Double Blind Phase|Withdrawal by Subject|20
2893852|NCT01816295|9963444|P1|Double Blind Phase|Withdrawal by Subject|22
2893853|NCT01816295|9963443|P2|Double Blind Phase|Sponsor Decision|8
2893854|NCT01816295|9963444|P1|Double Blind Phase|Sponsor Decision|8
2893855|NCT01816295|9963443|P2|Double Blind Phase|Protocol Violation|11
2893856|NCT01816295|9963444|P1|Double Blind Phase|Protocol Violation|17
2893857|NCT01816295|9963443|P2|Double Blind Phase|Physician Decision|2
2893858|NCT01816295|9963444|P1|Double Blind Phase|Physician Decision|2
2893859|NCT01816295|9963443|P2|Double Blind Phase|Lost to Follow-up|5
2893860|NCT01816295|9963444|P1|Double Blind Phase|Lost to Follow-up|3
2893861|NCT01816295|9963443|P2|Double Blind Phase|Entry Criteria Not Met|2
2893862|NCT01816295|9963444|P1|Double Blind Phase|Entry Criteria Not Met|0
2893863|NCT01816295|9963443|P2|Double Blind Phase|Adverse Event|8
2893864|NCT01816295|9963444|P1|Double Blind Phase|Adverse Event|11
2893865|NCT01816243|9963459|P1|Overall Study|Amputation|3
2893866|NCT01816243|9963459|P1|Overall Study|Not eligible for the study|1
2893867|NCT01816243|9963459|P1|Overall Study|Lack of Efficacy|1
2893868|NCT01816243|9963459|P1|Overall Study|Lost to Follow-up|1
2893869|NCT01816243|9963459|P1|Overall Study|Adverse Event|6
2893870|NCT01816074|9963470|P4|Phase 2|Withdrawal by Subject|0
2893871|NCT01816074|9963471|P3|Phase 2|Withdrawal by Subject|0
2893872|NCT01816074|9963472|P2|Phase 2|Withdrawal by Subject|0
2893873|NCT01816074|9963473|P1|Phase 2|Withdrawal by Subject|1
2893874|NCT01816074|9963470|P4|Phase 2|Physician Decision|1
2893875|NCT01816074|9963471|P3|Phase 2|Physician Decision|0
2893876|NCT01816074|9963472|P2|Phase 2|Physician Decision|0
2893877|NCT01816074|9963473|P1|Phase 2|Physician Decision|0
2893878|NCT01816074|9963470|P4|Phase 2|Unsatisfied with Randomization assignmen|0
2893879|NCT01816074|9963471|P3|Phase 2|Unsatisfied with Randomization assignmen|0
2893880|NCT01816074|9963472|P2|Phase 2|Unsatisfied with Randomization assignmen|0
2893881|NCT01816074|9963473|P1|Phase 2|Unsatisfied with Randomization assignmen|1
2893882|NCT01816074|9963470|P4|Phase 2|Time commitment Issues|0
2893883|NCT01816074|9963471|P3|Phase 2|Time commitment Issues|0
2893884|NCT01816074|9963472|P2|Phase 2|Time commitment Issues|2
2893885|NCT01816074|9963473|P1|Phase 2|Time commitment Issues|0
2893886|NCT01816074|9963470|P4|Phase 1|Time commitment issues|0
2893887|NCT01816074|9963471|P3|Phase 1|Time commitment issues|1
2893888|NCT01816074|9963472|P2|Phase 1|Time commitment issues|0
2893889|NCT01816074|9963473|P1|Phase 1|Time commitment issues|0
2893890|NCT01816061|9963503|P2|Overall Study|Lost to Follow-up|24
2893891|NCT01816061|9963504|P1|Overall Study|Lost to Follow-up|13
2893892|NCT01816048|9963512|P1|Overall Study|Disease Progression|3
2893893|NCT01816048|9963512|P1|Overall Study|Withdrawal by Subject|1
2893894|NCT01816048|9963512|P1|Overall Study|Death|1
2893895|NCT01816048|9963512|P1|Overall Study|Adverse Event|1
2893896|NCT01815918|9963527|P2|Overall Study|Lack of Efficacy|15
2893897|NCT01815918|9963528|P1|Overall Study|Lack of Efficacy|15
2893898|NCT01815918|9963527|P2|Overall Study|Patient samples not analyzable|4
2893899|NCT01815918|9963528|P1|Overall Study|Patient samples not analyzable|3
2893900|NCT01815840|9963544|P2|Overall Study|Sponsor Termination Treatment|0
2893901|NCT01815840|9963545|P1|Overall Study|Sponsor Termination Treatment|1
2893902|NCT01815840|9963544|P2|Overall Study|Refused Treatment|1
2893903|NCT01815840|9963545|P1|Overall Study|Refused Treatment|5
2893904|NCT01815840|9963544|P2|Overall Study|Lost to Follow-up|6
2893905|NCT01815840|9963545|P1|Overall Study|Lost to Follow-up|3
2893906|NCT01815840|9963544|P2|Overall Study|Investigators Decision|3
2893907|NCT01815840|9963545|P1|Overall Study|Investigators Decision|2
2893908|NCT01815840|9963544|P2|Overall Study|Disease progression|2
2893909|NCT01815840|9963545|P1|Overall Study|Disease progression|3
2893910|NCT01815840|9963544|P2|Overall Study|Death|2
2893911|NCT01815840|9963545|P1|Overall Study|Death|2
2893912|NCT01815840|9963544|P2|Overall Study|Adverse Event|16
2893913|NCT01815840|9963545|P1|Overall Study|Adverse Event|10
2893914|NCT01815840|9963544|P2|Overall Study|Administrative/Other|3
2893915|NCT01815840|9963545|P1|Overall Study|Administrative/Other|1
2893916|NCT01815840|9963544|P2|Overall Study|Withdrew Consent|30
2893917|NCT01815840|9963545|P1|Overall Study|Withdrew Consent|31
2893918|NCT01815840|9963544|P2|Overall Study|Missing|0
2893919|NCT01815840|9963545|P1|Overall Study|Missing|1
2893920|NCT01815736|9963575|P2|Overall Study|Still on Study|449
2893921|NCT01815736|9963576|P1|Overall Study|Still on Study|929
2893922|NCT01815736|9963575|P2|Overall Study|Lost to Follow-up|7
2893923|NCT01815736|9963576|P1|Overall Study|Lost to Follow-up|6
2893924|NCT01815736|9963575|P2|Overall Study|Withdrew Consent|15
2893925|NCT01815736|9963576|P1|Overall Study|Withdrew Consent|7
2893926|NCT01815736|9963575|P2|Overall Study|Investigator's Discretion|0
2893927|NCT01815736|9963576|P1|Overall Study|Investigator's Discretion|4
2893928|NCT01815736|9963575|P2|Overall Study|Death|0
2893929|NCT01815736|9963576|P1|Overall Study|Death|4
2893930|NCT01815736|9963575|P2|Overall Study|Adverse Event|4
2893931|NCT01815736|9963576|P1|Overall Study|Adverse Event|7
2893932|NCT01815736|9963575|P2|Overall Study|Randomized but Not Treated|3
2893933|NCT01815736|9963576|P1|Overall Study|Randomized but Not Treated|4
2893934|NCT01815424|9963645|P5|Week 16 to 52|Withdrawal by Subject|0
2893935|NCT01815424|9963646|P4|Week 16 to 52|Withdrawal by Subject|0
2893936|NCT01815424|9963647|P3|Week 16 to 52|Withdrawal by Subject|0
2893937|NCT01815424|9963648|P2|Week 16 to 52|Withdrawal by Subject|2
2893938|NCT01815424|9963649|P1|Week 16 to 52|Withdrawal by Subject|1
2893939|NCT01815424|9963645|P5|Week 16 to 52|Lost to Follow-up|1
2893940|NCT01815424|9963646|P4|Week 16 to 52|Lost to Follow-up|2
2893941|NCT01815424|9963647|P3|Week 16 to 52|Lost to Follow-up|0
2893942|NCT01815424|9963648|P2|Week 16 to 52|Lost to Follow-up|2
2893943|NCT01815424|9963649|P1|Week 16 to 52|Lost to Follow-up|0
2893944|NCT01815424|9963645|P5|Week 16 to 52|Insufficient Clinical Response|1
2893945|NCT01815424|9963646|P4|Week 16 to 52|Insufficient Clinical Response|1
2893946|NCT01815424|9963647|P3|Week 16 to 52|Insufficient Clinical Response|0
2893947|NCT01815424|9963648|P2|Week 16 to 52|Insufficient Clinical Response|0
2893948|NCT01815424|9963649|P1|Week 16 to 52|Insufficient Clinical Response|1
2893949|NCT01815424|9963645|P5|Week 16 to 52|Adverse Event|1
2893950|NCT01815424|9963646|P4|Week 16 to 52|Adverse Event|0
2893951|NCT01815424|9963647|P3|Week 16 to 52|Adverse Event|0
2893952|NCT01815424|9963648|P2|Week 16 to 52|Adverse Event|0
2893953|NCT01815424|9963649|P1|Week 16 to 52|Adverse Event|0
2893954|NCT01815424|9963645|P5|Week 16 to 52|Other|0
2893955|NCT01815424|9963646|P4|Week 16 to 52|Other|0
2893956|NCT01815424|9963647|P3|Week 16 to 52|Other|0
2893957|NCT01815424|9963648|P2|Week 16 to 52|Other|1
2893958|NCT01815424|9963649|P1|Week 16 to 52|Other|0
2893959|NCT01815424|9963645|P5|Week 0 to 16|Insufficient Clinical Response|0
2893960|NCT01815424|9963646|P4|Week 0 to 16|Insufficient Clinical Response|0
2893961|NCT01815424|9963647|P3|Week 0 to 16|Insufficient Clinical Response|4
2893962|NCT01815424|9963648|P2|Week 0 to 16|Insufficient Clinical Response|0
2893963|NCT01815424|9963649|P1|Week 0 to 16|Insufficient Clinical Response|2
2893964|NCT01815424|9963645|P5|Week 0 to 16|Protocol Violation|0
2893965|NCT01815424|9963646|P4|Week 0 to 16|Protocol Violation|0
2893966|NCT01815424|9963647|P3|Week 0 to 16|Protocol Violation|0
2893967|NCT01815424|9963648|P2|Week 0 to 16|Protocol Violation|0
2893968|NCT01815424|9963649|P1|Week 0 to 16|Protocol Violation|1
2893969|NCT01815424|9963645|P5|Week 0 to 16|Other|0
2893970|NCT01815424|9963646|P4|Week 0 to 16|Other|0
2893971|NCT01815424|9963647|P3|Week 0 to 16|Other|3
2893972|NCT01815424|9963648|P2|Week 0 to 16|Other|0
2893973|NCT01815424|9963649|P1|Week 0 to 16|Other|1
2893974|NCT01815424|9963645|P5|Week 0 to 16|Withdrawal by Subject|0
2893975|NCT01815424|9963646|P4|Week 0 to 16|Withdrawal by Subject|0
2893976|NCT01815424|9963647|P3|Week 0 to 16|Withdrawal by Subject|1
2893977|NCT01815424|9963648|P2|Week 0 to 16|Withdrawal by Subject|0
2893978|NCT01815424|9963649|P1|Week 0 to 16|Withdrawal by Subject|0
2893979|NCT01815424|9963645|P5|Week 0 to 16|Lost to Follow-up|0
2893980|NCT01815424|9963646|P4|Week 0 to 16|Lost to Follow-up|0
2893981|NCT01815424|9963647|P3|Week 0 to 16|Lost to Follow-up|0
2893982|NCT01815424|9963648|P2|Week 0 to 16|Lost to Follow-up|1
2893983|NCT01815424|9963649|P1|Week 0 to 16|Lost to Follow-up|0
2893984|NCT01815424|9963645|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
2893985|NCT01815424|9963646|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
2893986|NCT01815424|9963647|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
2893987|NCT01815424|9963648|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
2893988|NCT01815424|9963649|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
2893989|NCT01815424|9963645|P5|Week 0 to 16|Adverse Event|0
2893990|NCT01815424|9963646|P4|Week 0 to 16|Adverse Event|0
2893991|NCT01815424|9963647|P3|Week 0 to 16|Adverse Event|3
2893992|NCT01815424|9963648|P2|Week 0 to 16|Adverse Event|3
2893993|NCT01815424|9963649|P1|Week 0 to 16|Adverse Event|1
2893994|NCT01815138|9963861|P2|Overall Study|Physician Decision|5
2893995|NCT01815138|9963862|P1|Overall Study|Physician Decision|8
2893996|NCT01815138|9963861|P2|Overall Study|Withdrawal by Subject|1
2893997|NCT01815138|9963862|P1|Overall Study|Withdrawal by Subject|0
2893998|NCT01815099|9963874|P1|Overall Study|unable to attend study visits|1
2893999|NCT01815099|9963874|P1|Overall Study|Lack of Efficacy|1
2894000|NCT01814878|9963888|P2|Overall Study|Other|0
2894001|NCT01814878|9963889|P1|Overall Study|Other|2
2894002|NCT01814878|9963888|P2|Overall Study|Screening failure (drop-out)|3
2894003|NCT01814878|9963889|P1|Overall Study|Screening failure (drop-out)|0
2894004|NCT01814878|9963888|P2|Overall Study|Physician Decision|1
2894005|NCT01814878|9963889|P1|Overall Study|Physician Decision|3
2894006|NCT01814878|9963888|P2|Overall Study|Protocol Violation|5
2894007|NCT01814878|9963889|P1|Overall Study|Protocol Violation|5
2894008|NCT01814878|9963888|P2|Overall Study|Withdrawal by Subject|16
2894009|NCT01814878|9963889|P1|Overall Study|Withdrawal by Subject|20
2894010|NCT01814878|9963888|P2|Overall Study|Adverse Event|5
2894011|NCT01814878|9963889|P1|Overall Study|Adverse Event|16
2894012|NCT01814826|9963912|P3|Overall Study|Death|3
2894013|NCT01814826|9963913|P2|Overall Study|Death|24
2894014|NCT01814826|9963914|P1|Overall Study|Death|29
2894015|NCT01814826|9963912|P3|Overall Study|Other|0
2894016|NCT01814826|9963913|P2|Overall Study|Other|5
2894017|NCT01814826|9963914|P1|Overall Study|Other|3
2894018|NCT01814800|9964006|P1|Overall Study|Subject relocation|1
2894019|NCT01814800|9964006|P1|Overall Study|Sponsor decision|1
2894020|NCT01814800|9964006|P1|Overall Study|Pregnancy|1
2894021|NCT01814800|9964006|P1|Overall Study|Adverse Event|2
2894022|NCT01814761|9964066|P2|Overall Study|Lost to Follow-up|5
2894023|NCT01814761|9964067|P1|Overall Study|Lost to Follow-up|1
2894024|NCT01814761|9964066|P2|Overall Study|Ocular Adverse Event|15
2894025|NCT01814761|9964067|P1|Overall Study|Ocular Adverse Event|6
2894026|NCT01814761|9964066|P2|Overall Study|Other Reasons|10
2894027|NCT01814761|9964067|P1|Overall Study|Other Reasons|1
2894028|NCT01814748|9964081|P2|Overall Study|Withdrawal by Subject|4
2894029|NCT01814748|9964082|P1|Overall Study|Withdrawal by Subject|6
2894030|NCT01814748|9964081|P2|Overall Study|Study site terminated by sponsor|1
2894031|NCT01814748|9964082|P1|Overall Study|Study site terminated by sponsor|1
2894032|NCT01814748|9964081|P2|Overall Study|Lost to Follow-up|2
2894033|NCT01814748|9964082|P1|Overall Study|Lost to Follow-up|1
2894034|NCT01814696|9964126|P2|Overall Study|Randomized to wrong group|0
2894035|NCT01814696|9964127|P1|Overall Study|Randomized to wrong group|1
2894036|NCT01814696|9964126|P2|Overall Study|Withdrawal by Subject|0
2894037|NCT01814696|9964127|P1|Overall Study|Withdrawal by Subject|1
2894038|NCT01814670|9964145|P1|Overall Study|Protocol Violation|12
2894039|NCT01814553|9964155|P2|Overall Study|Other than stated|8
2894040|NCT01814553|9964156|P1|Overall Study|Other than stated|7
2894041|NCT01814553|9964155|P2|Overall Study|Withdrawal by Subject|1
2894042|NCT01814553|9964156|P1|Overall Study|Withdrawal by Subject|1
2894043|NCT01814553|9964155|P2|Overall Study|Other Adverse Event|5
2894044|NCT01814553|9964156|P1|Overall Study|Other Adverse Event|4
2894045|NCT01814553|9964155|P2|Overall Study|PD per clinical progression|8
2894046|NCT01814553|9964156|P1|Overall Study|PD per clinical progression|6
2894047|NCT01814397|9964170|P1|Overall Study|Withdrawal by Subject|7
2894048|NCT01814397|9964170|P1|Overall Study|Adverse Event|7
2894049|NCT01814371|9964179|P2|Overall Study|Lost to Follow-up|27
2894050|NCT01814371|9964180|P1|Overall Study|Lost to Follow-up|30
2894051|NCT01814332|9964215|P2|Overall Study|Lost to Follow-up|1
2894052|NCT01814332|9964216|P1|Overall Study|Lost to Follow-up|5
2894053|NCT01814332|9964215|P2|Overall Study|Protocol Violation|4
2894054|NCT01814332|9964216|P1|Overall Study|Protocol Violation|0
2894055|NCT01814332|9964215|P2|Overall Study|Withdrawal by Subject|8
2894056|NCT01814332|9964216|P1|Overall Study|Withdrawal by Subject|3
2894057|NCT01814332|9964215|P2|Overall Study|Adverse Event|3
2894058|NCT01814332|9964216|P1|Overall Study|Adverse Event|8
2894059|NCT01814137|9964238|P2|Overall Study|Unclassified|1
2894060|NCT01814137|9964239|P1|Overall Study|Unclassified|2
2894061|NCT01814137|9964238|P2|Overall Study|Physician Decision|1
2894062|NCT01814137|9964239|P1|Overall Study|Physician Decision|1
2894063|NCT01814137|9964238|P2|Overall Study|Withdrawal by Subject|2
2894064|NCT01814137|9964239|P1|Overall Study|Withdrawal by Subject|2
2894065|NCT01814137|9964238|P2|Overall Study|Adverse Event|1
2894066|NCT01814137|9964239|P1|Overall Study|Adverse Event|0
2894067|NCT01814046|9964255|P3|Drug Administration|Death due to complications of RSV|0
2894068|NCT01814046|9964256|P2|Drug Administration|Death due to complications of RSV|0
2894069|NCT01814046|9964257|P1|Drug Administration|Death due to complications of RSV|1
2894070|NCT01813890|9964271|P3|Overall Study|Lack of Efficacy|2
2894071|NCT01813890|9964272|P2|Overall Study|Lack of Efficacy|1
2894072|NCT01813890|9964273|P1|Overall Study|Lack of Efficacy|9
2894073|NCT01813890|9964271|P3|Overall Study|Adverse Event|4
2894074|NCT01813890|9964272|P2|Overall Study|Adverse Event|3
2894075|NCT01813890|9964273|P1|Overall Study|Adverse Event|0
2894076|NCT01813721|9964310|P1|Overall Study|Withdrawal by Subject|1
2894077|NCT01813721|9964310|P1|Overall Study|Ineligibility determined|63
2894078|NCT01813474|9964365|P3|Overall Study|Death|1
2894079|NCT01813474|9964366|P2|Overall Study|Death|0
2894080|NCT01813474|9964367|P1|Overall Study|Death|0
2894081|NCT01813474|9964365|P3|Overall Study|Lack of Efficacy|9
2894082|NCT01813474|9964366|P2|Overall Study|Lack of Efficacy|6
2894083|NCT01813474|9964367|P1|Overall Study|Lack of Efficacy|2
2894084|NCT01813474|9964365|P3|Overall Study|Adverse Event|0
2894085|NCT01813474|9964366|P2|Overall Study|Adverse Event|1
2894086|NCT01813474|9964367|P1|Overall Study|Adverse Event|1
2894087|NCT01813474|9964365|P3|Overall Study|Withdrawal by Subject|1
2894088|NCT01813474|9964366|P2|Overall Study|Withdrawal by Subject|0
2894089|NCT01813474|9964367|P1|Overall Study|Withdrawal by Subject|0
2894090|NCT01813435|9964391|P2|Overall Study|Lost to Follow-up|237
2894091|NCT01813435|9964392|P1|Overall Study|Lost to Follow-up|268
2894092|NCT01813435|9964391|P2|Overall Study|did not finish experimental regimen|770
2894093|NCT01813435|9964392|P1|Overall Study|did not finish experimental regimen|1902
2894094|NCT01813422|9964416|P2|Overall Study|Lost to Follow-up|4
2894095|NCT01813422|9964417|P1|Overall Study|Lost to Follow-up|2
2894096|NCT01813422|9964416|P2|Overall Study|Sponsor Decision|1
2894097|NCT01813422|9964417|P1|Overall Study|Sponsor Decision|2
2894098|NCT01813422|9964416|P2|Overall Study|Death|3
2894099|NCT01813422|9964417|P1|Overall Study|Death|2
2894100|NCT01813422|9964416|P2|Overall Study|Withdrawal by Subject|8
2894101|NCT01813422|9964417|P1|Overall Study|Withdrawal by Subject|14
2894102|NCT01813071|9964462|P9|Overall Study|Met inc/exc criteria|1
2894103|NCT01813071|9964463|P8|Overall Study|Met inc/exc criteria|1
2894104|NCT01813071|9964464|P7|Overall Study|Met inc/exc criteria|0
2894105|NCT01813071|9964465|P6|Overall Study|Met inc/exc criteria|1
2894106|NCT01813071|9964466|P5|Overall Study|Met inc/exc criteria|0
2894107|NCT01813071|9964467|P4|Overall Study|Met inc/exc criteria|0
2894108|NCT01813071|9964468|P3|Overall Study|Met inc/exc criteria|0
2894109|NCT01813071|9964469|P2|Overall Study|Met inc/exc criteria|0
2894110|NCT01813071|9964470|P1|Overall Study|Met inc/exc criteria|0
2894111|NCT01813071|9964462|P9|Overall Study|Physician Decision|0
2894112|NCT01813071|9964463|P8|Overall Study|Physician Decision|0
2894113|NCT01813071|9964464|P7|Overall Study|Physician Decision|1
2894114|NCT01813071|9964465|P6|Overall Study|Physician Decision|0
2894115|NCT01813071|9964466|P5|Overall Study|Physician Decision|0
2894116|NCT01813071|9964467|P4|Overall Study|Physician Decision|0
2894117|NCT01813071|9964468|P3|Overall Study|Physician Decision|0
2894118|NCT01813071|9964469|P2|Overall Study|Physician Decision|0
2894119|NCT01813071|9964470|P1|Overall Study|Physician Decision|0
2894120|NCT01813071|9964462|P9|Overall Study|Adverse Event|0
2894121|NCT01813071|9964463|P8|Overall Study|Adverse Event|0
2894122|NCT01813071|9964464|P7|Overall Study|Adverse Event|0
2894123|NCT01813071|9964465|P6|Overall Study|Adverse Event|1
2894124|NCT01813071|9964466|P5|Overall Study|Adverse Event|0
2894125|NCT01813071|9964467|P4|Overall Study|Adverse Event|0
2894126|NCT01813071|9964468|P3|Overall Study|Adverse Event|0
2894127|NCT01813071|9964469|P2|Overall Study|Adverse Event|0
2894128|NCT01813071|9964470|P1|Overall Study|Adverse Event|0
2894129|NCT01813071|9964462|P9|Overall Study|Withdrawal by Subject|0
2894130|NCT01813071|9964463|P8|Overall Study|Withdrawal by Subject|0
2894131|NCT01813071|9964464|P7|Overall Study|Withdrawal by Subject|0
2894132|NCT01813071|9964465|P6|Overall Study|Withdrawal by Subject|1
2894133|NCT01813071|9964466|P5|Overall Study|Withdrawal by Subject|0
2894134|NCT01813071|9964467|P4|Overall Study|Withdrawal by Subject|0
2894135|NCT01813071|9964468|P3|Overall Study|Withdrawal by Subject|0
2894136|NCT01813071|9964469|P2|Overall Study|Withdrawal by Subject|0
2894137|NCT01813071|9964470|P1|Overall Study|Withdrawal by Subject|0
2894138|NCT01813071|9964462|P9|Overall Study|Protocol Violation|2
2894139|NCT01813071|9964463|P8|Overall Study|Protocol Violation|4
2894140|NCT01813071|9964464|P7|Overall Study|Protocol Violation|2
2894141|NCT01813071|9964465|P6|Overall Study|Protocol Violation|4
2894142|NCT01813071|9964466|P5|Overall Study|Protocol Violation|1
2894143|NCT01813071|9964467|P4|Overall Study|Protocol Violation|0
2894144|NCT01813071|9964468|P3|Overall Study|Protocol Violation|0
2894145|NCT01813071|9964469|P2|Overall Study|Protocol Violation|0
2894146|NCT01813071|9964470|P1|Overall Study|Protocol Violation|0
2894147|NCT01813058|9964937|P2|Overall Study|Withdrawal by Subject|4
2894148|NCT01813058|9964938|P1|Overall Study|Withdrawal by Subject|5
2894149|NCT01813019|9964946|P2|Overall Study|Protocol Deviation|1
2894150|NCT01813019|9964947|P1|Overall Study|Protocol Deviation|2
2894151|NCT01813019|9964946|P2|Overall Study|administrative problems|0
2894152|NCT01813019|9964947|P1|Overall Study|administrative problems|2
2894153|NCT01813019|9964946|P2|Overall Study|Withdrawal by Subject|2
2894154|NCT01813019|9964947|P1|Overall Study|Withdrawal by Subject|3
2894155|NCT01813019|9964946|P2|Overall Study|Adverse Event|3
2894156|NCT01813019|9964947|P1|Overall Study|Adverse Event|0
2894157|NCT01812837|9964958|P3|Overall Study|Protocol Violation|0
2894158|NCT01812837|9964959|P2|Overall Study|Protocol Violation|0
2894159|NCT01812837|9964960|P1|Overall Study|Protocol Violation|1
2894160|NCT01812837|9964958|P3|Overall Study|Lost to Follow-up|0
2894161|NCT01812837|9964959|P2|Overall Study|Lost to Follow-up|1
2894162|NCT01812837|9964960|P1|Overall Study|Lost to Follow-up|1
2894163|NCT01812707|9964972|P4|Overall Study|Consent withdrawn by participant|0
2894164|NCT01812707|9964973|P3|Overall Study|Consent withdrawn by participant|0
2894165|NCT01812707|9964974|P2|Overall Study|Consent withdrawn by participant|0
2894166|NCT01812707|9964975|P1|Overall Study|Consent withdrawn by participant|1
2894167|NCT01812707|9964972|P4|Overall Study|Poor compliance to protocol|0
2894168|NCT01812707|9964973|P3|Overall Study|Poor compliance to protocol|0
2894169|NCT01812707|9964974|P2|Overall Study|Poor compliance to protocol|0
2894170|NCT01812707|9964975|P1|Overall Study|Poor compliance to protocol|1
2894171|NCT01812707|9964972|P4|Overall Study|Adverse Event|2
2894172|NCT01812707|9964973|P3|Overall Study|Adverse Event|0
2894173|NCT01812707|9964974|P2|Overall Study|Adverse Event|0
2894174|NCT01812707|9964975|P1|Overall Study|Adverse Event|0
2894175|NCT01812655|9965023|P3|Overall Study|Protocol Violation|0
2894176|NCT01812655|9965024|P2|Overall Study|Protocol Violation|1
2894177|NCT01812655|9965025|P1|Overall Study|Protocol Violation|1
2894178|NCT01812057|9965050|P2|Overall Study|Physician Decision|0
2894179|NCT01812057|9965051|P1|Overall Study|Physician Decision|1
2894180|NCT01812057|9965050|P2|Overall Study|Protocol Violation|0
2894181|NCT01812057|9965051|P1|Overall Study|Protocol Violation|1
2894182|NCT01811953|9965154|P6|Overall Study|Protocol Violation|0
2894183|NCT01811953|9965155|P5|Overall Study|Protocol Violation|1
2894184|NCT01811953|9965156|P4|Overall Study|Protocol Violation|0
2894185|NCT01811953|9965157|P3|Overall Study|Protocol Violation|0
2894186|NCT01811953|9965158|P2|Overall Study|Protocol Violation|0
2894187|NCT01811953|9965159|P1|Overall Study|Protocol Violation|0
2894188|NCT01811953|9965154|P6|Overall Study|Adverse Event|1
2894189|NCT01811953|9965155|P5|Overall Study|Adverse Event|0
2894190|NCT01811953|9965156|P4|Overall Study|Adverse Event|1
2894191|NCT01811953|9965157|P3|Overall Study|Adverse Event|0
2894192|NCT01811953|9965158|P2|Overall Study|Adverse Event|0
2894193|NCT01811953|9965159|P1|Overall Study|Adverse Event|0
2894194|NCT01811732|9965216|P2|Overall Study|Correct study drug not available on site|0
2894195|NCT01811732|9965217|P1|Overall Study|Correct study drug not available on site|1
2894196|NCT01811732|9965216|P2|Overall Study|Admitted to another facility|0
2894197|NCT01811732|9965217|P1|Overall Study|Admitted to another facility|1
2894198|NCT01811732|9965216|P2|Overall Study|Subject incarcerated|2
2894199|NCT01811732|9965217|P1|Overall Study|Subject incarcerated|1
2894200|NCT01811732|9965216|P2|Overall Study|Protocol Violation|1
2894201|NCT01811732|9965217|P1|Overall Study|Protocol Violation|0
2894202|NCT01811732|9965216|P2|Overall Study|Insufficient venous access|1
2894203|NCT01811732|9965217|P1|Overall Study|Insufficient venous access|0
2894204|NCT01811732|9965216|P2|Overall Study|Death|1
2894205|NCT01811732|9965217|P1|Overall Study|Death|1
2894206|NCT01811732|9965216|P2|Overall Study|Physician Decision|0
2894207|NCT01811732|9965217|P1|Overall Study|Physician Decision|2
2894208|NCT01811732|9965216|P2|Overall Study|Non-compliance with study drug/procedure|3
2894209|NCT01811732|9965217|P1|Overall Study|Non-compliance with study drug/procedure|3
2894210|NCT01811732|9965216|P2|Overall Study|Lack of Efficacy|1
2894211|NCT01811732|9965217|P1|Overall Study|Lack of Efficacy|3
2894212|NCT01811732|9965216|P2|Overall Study|Adverse Event|9
2894213|NCT01811732|9965217|P1|Overall Study|Adverse Event|3
2894214|NCT01811732|9965216|P2|Overall Study|Withdrawal by Subject|10
2894215|NCT01811732|9965217|P1|Overall Study|Withdrawal by Subject|16
2894216|NCT01811732|9965216|P2|Overall Study|Lost to Follow-up|30
2894217|NCT01811732|9965217|P1|Overall Study|Lost to Follow-up|24
2894218|NCT01811706|9965227|P2|First Intervention ( 4 Weeks)|Adverse Event|0
2894219|NCT01811706|9965228|P1|First Intervention ( 4 Weeks)|Adverse Event|1
2894220|NCT01811563|9965256|P2|Overall Study|Incorrect Randomization procedure|1
2894221|NCT01811563|9965257|P1|Overall Study|Incorrect Randomization procedure|0
2894222|NCT01811563|9965256|P2|Overall Study|Lost to Follow-up|2
2894223|NCT01811563|9965257|P1|Overall Study|Lost to Follow-up|5
2894224|NCT01811485|9965286|P3|Overall Study|Protocol Deviation|0
2894225|NCT01811485|9965287|P2|Overall Study|Protocol Deviation|1
2894226|NCT01811485|9965288|P1|Overall Study|Protocol Deviation|0
2894227|NCT01811485|9965286|P3|Overall Study|Administrative problems|0
2894228|NCT01811485|9965287|P2|Overall Study|Administrative problems|0
2894229|NCT01811485|9965288|P1|Overall Study|Administrative problems|1
2894230|NCT01811485|9965286|P3|Overall Study|Unsatisfactory therapeutic effect|3
2894231|NCT01811485|9965287|P2|Overall Study|Unsatisfactory therapeutic effect|0
2894232|NCT01811485|9965288|P1|Overall Study|Unsatisfactory therapeutic effect|0
2894233|NCT01811485|9965286|P3|Overall Study|Adverse Event|2
2894234|NCT01811485|9965287|P2|Overall Study|Adverse Event|3
2894235|NCT01811485|9965288|P1|Overall Study|Adverse Event|1
2894236|NCT01811472|9965308|P3|Overall Study|Subject/guardian decision|0
2894237|NCT01811472|9965309|P2|Overall Study|Subject/guardian decision|0
2894238|NCT01811472|9965310|P1|Overall Study|Subject/guardian decision|1
2894239|NCT01811472|9965308|P3|Overall Study|Lost to Follow-up|1
2894240|NCT01811472|9965309|P2|Overall Study|Lost to Follow-up|0
2894241|NCT01811472|9965310|P1|Overall Study|Lost to Follow-up|0
2894242|NCT01811472|9965308|P3|Overall Study|Adverse Event|4
2894243|NCT01811472|9965309|P2|Overall Study|Adverse Event|0
2894244|NCT01811472|9965310|P1|Overall Study|Adverse Event|1
2894245|NCT01811238|9965397|P1|Overall Study|subject refused study medication|6
2894246|NCT01811238|9965397|P1|Overall Study|Lack of Efficacy|4
2894247|NCT01811238|9965397|P1|Overall Study|Protocol Violation|4
2894248|NCT01811238|9965397|P1|Overall Study|Adverse Event|25
2894249|NCT01811238|9965397|P1|Overall Study|Withdrawal by Subject|42
2894250|NCT01811186|9965421|P2|Overall Study|Lost to Follow-up|2
2894251|NCT01811186|9965422|P1|Overall Study|Lost to Follow-up|4
2894252|NCT01811186|9965421|P2|Overall Study|Lack of Efficacy|6
2894253|NCT01811186|9965422|P1|Overall Study|Lack of Efficacy|3
2894254|NCT01811186|9965421|P2|Overall Study|Withdrawal by Subject|10
2894255|NCT01811186|9965422|P1|Overall Study|Withdrawal by Subject|5
2894256|NCT01811186|9965421|P2|Overall Study|Protocol Violation|6
2894257|NCT01811186|9965422|P1|Overall Study|Protocol Violation|5
2894258|NCT01811186|9965421|P2|Overall Study|Adverse Event|38
2894259|NCT01811186|9965422|P1|Overall Study|Adverse Event|54
2894260|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2894261|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
2894262|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2894263|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
2894264|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
2894265|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
2894266|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
2894267|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
2894268|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
2894269|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
2894270|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
2894271|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
2894272|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2894273|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2894274|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
2894275|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
2894276|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2894277|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2894278|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Death|1
2894279|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Death|0
2894280|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Death|0
2894281|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2894282|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2894283|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
2894284|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2894285|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
2894286|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2894287|NCT01810939|9965476|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2894288|NCT01810939|9965477|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2894289|NCT01810939|9965478|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
2894290|NCT01810939|9965476|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
2894291|NCT01810939|9965477|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
2894292|NCT01810939|9965478|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
2894293|NCT01810939|9965476|P3|Part A Treatment Period|Protocol-specified (High K+)|0
2894294|NCT01810939|9965477|P2|Part A Treatment Period|Protocol-specified (High K+)|0
2894295|NCT01810939|9965478|P1|Part A Treatment Period|Protocol-specified (High K+)|3
2894296|NCT01810939|9965476|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
2894297|NCT01810939|9965477|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
2894298|NCT01810939|9965478|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
2894299|NCT01810939|9965476|P3|Part A Treatment Period|Withdrawal by Subject|0
2894300|NCT01810939|9965477|P2|Part A Treatment Period|Withdrawal by Subject|0
2894301|NCT01810939|9965478|P1|Part A Treatment Period|Withdrawal by Subject|5
2894302|NCT01810939|9965476|P3|Part A Treatment Period|Adverse Event|0
2894303|NCT01810939|9965477|P2|Part A Treatment Period|Adverse Event|0
2894304|NCT01810939|9965478|P1|Part A Treatment Period|Adverse Event|10
2894305|NCT01810939|9965476|P3|Part A Treatment Period|Protocol Violation|0
2894306|NCT01810939|9965477|P2|Part A Treatment Period|Protocol Violation|0
2894307|NCT01810939|9965478|P1|Part A Treatment Period|Protocol Violation|2
2894308|NCT01810939|9965476|P3|Part A Treatment Period|Non-compliance with Study Drug|0
2894309|NCT01810939|9965477|P2|Part A Treatment Period|Non-compliance with Study Drug|0
2894310|NCT01810939|9965478|P1|Part A Treatment Period|Non-compliance with Study Drug|1
2894311|NCT01810783|9965491|P1|Overall Study|Enrolled, not treated|1
2894312|NCT01810783|9965491|P1|Overall Study|Adminstrative or other reason(s)|23
2894313|NCT01810783|9965491|P1|Overall Study|Non-compliance with IMP|4
2894314|NCT01810783|9965491|P1|Overall Study|Protocol Violation|5
2894315|NCT01810783|9965491|P1|Overall Study|Lost to Follow-up|10
2894316|NCT01810783|9965491|P1|Overall Study|Lack of Efficacy|12
2894317|NCT01810783|9965491|P1|Overall Study|Withdrawal by Subject|22
2894318|NCT01810783|9965491|P1|Overall Study|Adverse Event|32
2894319|NCT01810432|9965516|P2|Period 2|Lost to Follow-up|1
2894320|NCT01810432|9965517|P1|Period 2|Lost to Follow-up|1
2894321|NCT01810432|9965516|P2|Period 2|Physician Decision|0
2894322|NCT01810432|9965517|P1|Period 2|Physician Decision|1
2894323|NCT01810432|9965516|P2|Period 2|Withdrawal by Subject|1
2894324|NCT01810432|9965517|P1|Period 2|Withdrawal by Subject|2
2894325|NCT01810432|9965516|P2|Washout|Adverse Event|0
2894326|NCT01810432|9965517|P1|Washout|Adverse Event|1
2894327|NCT01810432|9965516|P2|Washout|Protocol Violation|1
2894328|NCT01810432|9965517|P1|Washout|Protocol Violation|0
2894329|NCT01810380|9965530|P3|Overall Study|Administrative or other reasons|9
2894330|NCT01810380|9965531|P2|Overall Study|Administrative or other reasons|13
2894331|NCT01810380|9965532|P1|Overall Study|Administrative or other reasons|11
2894332|NCT01810380|9965530|P3|Overall Study|Withdrawal by Subject|6
2894333|NCT01810380|9965531|P2|Overall Study|Withdrawal by Subject|0
2894334|NCT01810380|9965532|P1|Overall Study|Withdrawal by Subject|6
2894335|NCT01810380|9965530|P3|Overall Study|Protocol Violation|1
2894336|NCT01810380|9965531|P2|Overall Study|Protocol Violation|0
2894337|NCT01810380|9965532|P1|Overall Study|Protocol Violation|1
2894338|NCT01810380|9965530|P3|Overall Study|Lack of Efficacy|11
2894339|NCT01810380|9965531|P2|Overall Study|Lack of Efficacy|10
2894340|NCT01810380|9965532|P1|Overall Study|Lack of Efficacy|24
2894341|NCT01810380|9965530|P3|Overall Study|Adverse Event|4
2894342|NCT01810380|9965531|P2|Overall Study|Adverse Event|14
2894343|NCT01810380|9965532|P1|Overall Study|Adverse Event|11
2894344|NCT01810380|9965530|P3|Overall Study|Randomised not treated|1
2894345|NCT01810380|9965531|P2|Overall Study|Randomised not treated|1
2894346|NCT01810380|9965532|P1|Overall Study|Randomised not treated|2
2894347|NCT01810302|9965593|P2|Overall Study|Physician Decision|1
2894348|NCT01810302|9965594|P1|Overall Study|Physician Decision|0
2894349|NCT01810302|9965593|P2|Overall Study|Death|0
2894350|NCT01810302|9965594|P1|Overall Study|Death|1
2894351|NCT01810263|9965621|P2|Overall Study|Lost to Follow-up|7
2894352|NCT01810263|9965622|P1|Overall Study|Lost to Follow-up|8
2894353|NCT01810042|9965628|P1|Overall Study|Lost to Follow-up|10
2894354|NCT01810016|9965638|P3|Overall Study|Death|1
2894355|NCT01810016|9965639|P2|Overall Study|Death|0
2894356|NCT01810016|9965640|P1|Overall Study|Death|0
2894357|NCT01810016|9965638|P3|Overall Study|Progressive disease|0
2894358|NCT01810016|9965639|P2|Overall Study|Progressive disease|1
2894359|NCT01810016|9965640|P1|Overall Study|Progressive disease|1
2894360|NCT01809327|9965710|P5|Overall Study|Other|9
2894361|NCT01809327|9965711|P4|Overall Study|Other|4
2894362|NCT01809327|9965712|P3|Overall Study|Other|7
2894363|NCT01809327|9965713|P2|Overall Study|Other|15
2894364|NCT01809327|9965714|P1|Overall Study|Other|14
2894365|NCT01809327|9965710|P5|Overall Study|Pregnancy|0
2894366|NCT01809327|9965711|P4|Overall Study|Pregnancy|0
2894367|NCT01809327|9965712|P3|Overall Study|Pregnancy|0
2894368|NCT01809327|9965713|P2|Overall Study|Pregnancy|0
2894369|NCT01809327|9965714|P1|Overall Study|Pregnancy|1
2894370|NCT01809327|9965710|P5|Overall Study|Physician Decision|0
2894371|NCT01809327|9965711|P4|Overall Study|Physician Decision|0
2894372|NCT01809327|9965712|P3|Overall Study|Physician Decision|0
2894373|NCT01809327|9965713|P2|Overall Study|Physician Decision|1
2894374|NCT01809327|9965714|P1|Overall Study|Physician Decision|1
2894375|NCT01809327|9965710|P5|Overall Study|Protocol Violation|0
2894376|NCT01809327|9965711|P4|Overall Study|Protocol Violation|0
2894377|NCT01809327|9965712|P3|Overall Study|Protocol Violation|0
2894378|NCT01809327|9965713|P2|Overall Study|Protocol Violation|1
2894379|NCT01809327|9965714|P1|Overall Study|Protocol Violation|0
2894380|NCT01809327|9965710|P5|Overall Study|Death|0
2894381|NCT01809327|9965711|P4|Overall Study|Death|0
2894382|NCT01809327|9965712|P3|Overall Study|Death|0
2894383|NCT01809327|9965713|P2|Overall Study|Death|0
2894384|NCT01809327|9965714|P1|Overall Study|Death|1
2894385|NCT01809327|9965710|P5|Overall Study|Adverse Event|8
2894386|NCT01809327|9965711|P4|Overall Study|Adverse Event|4
2894387|NCT01809327|9965712|P3|Overall Study|Adverse Event|7
2894388|NCT01809327|9965713|P2|Overall Study|Adverse Event|3
2894389|NCT01809327|9965714|P1|Overall Study|Adverse Event|4
2894390|NCT01809327|9965710|P5|Overall Study|Withdrawal by Subject|5
2894391|NCT01809327|9965711|P4|Overall Study|Withdrawal by Subject|2
2894392|NCT01809327|9965712|P3|Overall Study|Withdrawal by Subject|4
2894393|NCT01809327|9965713|P2|Overall Study|Withdrawal by Subject|4
2894394|NCT01809327|9965714|P1|Overall Study|Withdrawal by Subject|6
2894395|NCT01809327|9965710|P5|Overall Study|Lost to Follow-up|3
2894396|NCT01809327|9965711|P4|Overall Study|Lost to Follow-up|2
2894397|NCT01809327|9965712|P3|Overall Study|Lost to Follow-up|4
2894398|NCT01809327|9965713|P2|Overall Study|Lost to Follow-up|2
2894399|NCT01809327|9965714|P1|Overall Study|Lost to Follow-up|5
2894400|NCT01809314|9965756|P1|Overall Study|Lost to Follow-up|724
2894401|NCT01809314|9965756|P1|Overall Study|Insufficient Therapeutic Response|14
2894402|NCT01809314|9965756|P1|Overall Study|Adverse Event|6
2894403|NCT01809314|9965756|P1|Overall Study|Withdrawal Prior to Treatment|1
2894404|NCT01809262|9965762|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
2894405|NCT01809262|9965763|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
2894406|NCT01809262|9965764|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
2894407|NCT01809262|9965765|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
2894408|NCT01809262|9965766|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
2894409|NCT01809262|9965767|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
2894410|NCT01809262|9965768|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
2894411|NCT01809262|9965769|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
2894412|NCT01809262|9965770|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
2894413|NCT01809262|9965771|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
2894414|NCT01809262|9965762|P10|Period 1 (First Dose + Washout)|Adverse Event|0
2894415|NCT01809262|9965763|P9|Period 1 (First Dose + Washout)|Adverse Event|0
2894416|NCT01809262|9965764|P8|Period 1 (First Dose + Washout)|Adverse Event|0
2894417|NCT01809262|9965765|P7|Period 1 (First Dose + Washout)|Adverse Event|0
2894418|NCT01809262|9965766|P6|Period 1 (First Dose + Washout)|Adverse Event|0
2894419|NCT01809262|9965767|P5|Period 1 (First Dose + Washout)|Adverse Event|1
2894420|NCT01809262|9965768|P4|Period 1 (First Dose + Washout)|Adverse Event|0
2894421|NCT01809262|9965769|P3|Period 1 (First Dose + Washout)|Adverse Event|0
2894422|NCT01809262|9965770|P2|Period 1 (First Dose + Washout)|Adverse Event|0
2894423|NCT01809262|9965771|P1|Period 1 (First Dose + Washout)|Adverse Event|0
2894424|NCT01809210|9965845|P7|Overall Study|Death|1
2894425|NCT01809210|9965846|P6|Overall Study|Death|3
2894426|NCT01809210|9965847|P5|Overall Study|Death|1
2894427|NCT01809210|9965848|P4|Overall Study|Death|0
2894428|NCT01809210|9965849|P3|Overall Study|Death|2
2894429|NCT01809210|9965850|P2|Overall Study|Death|1
2894430|NCT01809210|9965851|P1|Overall Study|Death|1
2894431|NCT01809210|9965845|P7|Overall Study|Withdrawal by Subject|4
2894432|NCT01809210|9965846|P6|Overall Study|Withdrawal by Subject|0
2894433|NCT01809210|9965847|P5|Overall Study|Withdrawal by Subject|1
2894434|NCT01809210|9965848|P4|Overall Study|Withdrawal by Subject|1
2894435|NCT01809210|9965849|P3|Overall Study|Withdrawal by Subject|1
2894436|NCT01809210|9965850|P2|Overall Study|Withdrawal by Subject|0
2894437|NCT01809210|9965851|P1|Overall Study|Withdrawal by Subject|0
2894438|NCT01809197|9965925|P2|Overall Study|Product not available|1
2894439|NCT01809197|9965926|P1|Overall Study|Product not available|0
2894440|NCT01809197|9965925|P2|Overall Study|Withdrawal by Subject|1
2894441|NCT01809197|9965926|P1|Overall Study|Withdrawal by Subject|1
2894442|NCT01809197|9965925|P2|Overall Study|Decision Unrelated to an Adverse Event|0
2894443|NCT01809197|9965926|P1|Overall Study|Decision Unrelated to an Adverse Event|1
2894444|NCT01809197|9965925|P2|Overall Study|Non-Compliance|1
2894445|NCT01809197|9965926|P1|Overall Study|Non-Compliance|1
2894446|NCT01809197|9965925|P2|Overall Study|Failed slit lamp exam|0
2894447|NCT01809197|9965926|P1|Overall Study|Failed slit lamp exam|1
2894448|NCT01809197|9965925|P2|Overall Study|Adverse Event|3
2894449|NCT01809197|9965926|P1|Overall Study|Adverse Event|2
2894450|NCT01809197|9965925|P2|Overall Study|Lost to Follow-up|2
2894451|NCT01809197|9965926|P1|Overall Study|Lost to Follow-up|4
2894452|NCT01808690|9966007|P2|Overall Study|Withdrawal by Subject|2
2894453|NCT01808690|9966008|P1|Overall Study|Withdrawal by Subject|1
2894454|NCT01808651|9966027|P3|Study Period 1|Participant Decision|3
2894455|NCT01808651|9966028|P2|Study Period 1|Participant Decision|7
2894456|NCT01808651|9966029|P1|Study Period 1|Participant Decision|9
2894457|NCT01808651|9966027|P3|Study Period 1|Adverse Event|1
2894458|NCT01808651|9966028|P2|Study Period 1|Adverse Event|4
2894459|NCT01808651|9966029|P1|Study Period 1|Adverse Event|10
2894460|NCT01808651|9966027|P3|Study Period 1|Lack of Efficacy|0
2894461|NCT01808651|9966028|P2|Study Period 1|Lack of Efficacy|1
2894462|NCT01808651|9966029|P1|Study Period 1|Lack of Efficacy|2
2894463|NCT01808651|9966027|P3|Study Period 1|Physician Decision|0
2894464|NCT01808651|9966028|P2|Study Period 1|Physician Decision|2
2894465|NCT01808651|9966029|P1|Study Period 1|Physician Decision|3
2894466|NCT01808651|9966027|P3|Study Period 1|Protocol Violation|1
2894467|NCT01808651|9966028|P2|Study Period 1|Protocol Violation|0
2894468|NCT01808651|9966029|P1|Study Period 1|Protocol Violation|1
2894469|NCT01808651|9966027|P3|Study Period 1|Lost to Follow-up|0
2894470|NCT01808651|9966028|P2|Study Period 1|Lost to Follow-up|3
2894471|NCT01808651|9966029|P1|Study Period 1|Lost to Follow-up|1
2894472|NCT01808612|9966064|P3|Discontinuation Period|Lost to Follow-up|0
2894473|NCT01808612|9966065|P2|Discontinuation Period|Lost to Follow-up|1
2894474|NCT01808612|9966066|P1|Discontinuation Period|Lost to Follow-up|0
2894475|NCT01808612|9966064|P3|Discontinuation Period|Physician Decision|0
2894476|NCT01808612|9966065|P2|Discontinuation Period|Physician Decision|0
2894477|NCT01808612|9966066|P1|Discontinuation Period|Physician Decision|1
2894478|NCT01808612|9966064|P3|Discontinuation Period|Adverse Event|0
2894479|NCT01808612|9966065|P2|Discontinuation Period|Adverse Event|0
2894480|NCT01808612|9966066|P1|Discontinuation Period|Adverse Event|1
2894481|NCT01808612|9966064|P3|Treatment Period|Lack of Efficacy|2
2894482|NCT01808612|9966065|P2|Treatment Period|Lack of Efficacy|1
2894483|NCT01808612|9966066|P1|Treatment Period|Lack of Efficacy|1
2894484|NCT01808612|9966064|P3|Treatment Period|Sponsor Decision|0
2894485|NCT01808612|9966065|P2|Treatment Period|Sponsor Decision|0
2894486|NCT01808612|9966066|P1|Treatment Period|Sponsor Decision|1
2894487|NCT01808612|9966064|P3|Treatment Period|Physician Decision|4
2894488|NCT01808612|9966065|P2|Treatment Period|Physician Decision|0
2894489|NCT01808612|9966066|P1|Treatment Period|Physician Decision|1
2894490|NCT01808612|9966064|P3|Treatment Period|Withdrawal by Subject|4
2894491|NCT01808612|9966065|P2|Treatment Period|Withdrawal by Subject|0
2894492|NCT01808612|9966066|P1|Treatment Period|Withdrawal by Subject|1
2894493|NCT01808612|9966064|P3|Treatment Period|Protocol Violation|0
2894494|NCT01808612|9966065|P2|Treatment Period|Protocol Violation|0
2894495|NCT01808612|9966066|P1|Treatment Period|Protocol Violation|1
2894496|NCT01808612|9966064|P3|Treatment Period|Lost to Follow-up|1
2894497|NCT01808612|9966065|P2|Treatment Period|Lost to Follow-up|2
2894498|NCT01808612|9966066|P1|Treatment Period|Lost to Follow-up|2
2894499|NCT01808612|9966064|P3|Treatment Period|Adverse Event|3
2894500|NCT01808612|9966065|P2|Treatment Period|Adverse Event|4
2894501|NCT01808612|9966066|P1|Treatment Period|Adverse Event|8
2894502|NCT01808573|9966097|P2|Overall Study|Randomized in Error|0
2894503|NCT01808573|9966098|P1|Overall Study|Randomized in Error|1
2894504|NCT01808573|9966097|P2|Overall Study|Discontinuation of study by sponsor|64
2894505|NCT01808573|9966098|P1|Overall Study|Discontinuation of study by sponsor|79
2894506|NCT01808573|9966097|P2|Overall Study|Lost to Follow-up|0
2894507|NCT01808573|9966098|P1|Overall Study|Lost to Follow-up|3
2894508|NCT01808573|9966097|P2|Overall Study|Withdrawal by Subject|10
2894509|NCT01808573|9966098|P1|Overall Study|Withdrawal by Subject|12
2894510|NCT01808573|9966097|P2|Overall Study|Death|240
2894511|NCT01808573|9966098|P1|Overall Study|Death|212
2894512|NCT01808534|9966153|P1|Overall Study|Physician Decision|1
2894513|NCT01808534|9966153|P1|Overall Study|Disease progression|3
2894514|NCT01808508|9966164|P3|Overall Study|Lost to Follow-up|0
2894515|NCT01808508|9966165|P2|Overall Study|Lost to Follow-up|0
2894516|NCT01808508|9966166|P1|Overall Study|Lost to Follow-up|1
2894517|NCT01808339|9966183|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894518|NCT01808339|9966184|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894519|NCT01808339|9966185|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894520|NCT01808339|9966186|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
2894521|NCT01808339|9966187|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894522|NCT01808339|9966188|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894523|NCT01808339|9966183|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2894524|NCT01808339|9966184|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2894525|NCT01808339|9966185|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2894526|NCT01808339|9966186|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2894527|NCT01808339|9966187|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2894528|NCT01808339|9966188|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2894529|NCT01808339|9966183|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2894530|NCT01808339|9966184|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
2894531|NCT01808339|9966185|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2894532|NCT01808339|9966186|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894533|NCT01808339|9966187|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894534|NCT01808339|9966188|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2894535|NCT01808313|9966232|P1|Overall Study|Physician Decision|1
2894536|NCT01808313|9966232|P1|Overall Study|Lost to Follow-up|1
2894537|NCT01808313|9966232|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2894538|NCT01808313|9966232|P1|Overall Study|Protocol Violation|2
2894539|NCT01808313|9966232|P1|Overall Study|Adverse Event|5
2894540|NCT01808261|9966262|P2|Overall Study|Lost to Follow-up|1
2894541|NCT01808261|9966263|P1|Overall Study|Lost to Follow-up|3
2894542|NCT01808261|9966262|P2|Overall Study|Consent withdrawn by subject|7
2894543|NCT01808261|9966263|P1|Overall Study|Consent withdrawn by subject|6
2894544|NCT01808261|9966262|P2|Overall Study|Adverse event, non-fatal|0
2894545|NCT01808261|9966263|P1|Overall Study|Adverse event, non-fatal|2
2894546|NCT01808261|9966262|P2|Overall Study|Study Closed/Terminated|23
2894547|NCT01808261|9966263|P1|Overall Study|Study Closed/Terminated|25
2894548|NCT01808261|9966262|P2|Overall Study|Physician Decision|2
2894549|NCT01808261|9966263|P1|Overall Study|Physician Decision|0
2894550|NCT01808248|9966319|P1|Overall Study|Lost to Follow-up|1
2894551|NCT01808248|9966319|P1|Overall Study|Withdrawal by Subject|1
2894552|NCT01808248|9966319|P1|Overall Study|Lack of Efficacy|3
2894553|NCT01808222|9966331|P1|Overall Study|mpMR scan was not performed|1
2894554|NCT01808209|9966338|P2|Overall Study|Lost to Follow-up|1
2894555|NCT01808209|9966339|P1|Overall Study|Lost to Follow-up|0
2894556|NCT01808144|9966383|P2|Overall Study|Adverse Event|15
2894557|NCT01808144|9966384|P1|Overall Study|Adverse Event|11
2894558|NCT01808144|9966383|P2|Overall Study|Gout flare|1
2894559|NCT01808144|9966384|P1|Overall Study|Gout flare|0
2894560|NCT01808144|9966383|P2|Overall Study|Protocol Violation|6
2894561|NCT01808144|9966384|P1|Overall Study|Protocol Violation|6
2894562|NCT01808144|9966383|P2|Overall Study|Lost to Follow-up|3
2894563|NCT01808144|9966384|P1|Overall Study|Lost to Follow-up|6
2894564|NCT01808144|9966383|P2|Overall Study|Withdrawal by Subject|23
2894565|NCT01808144|9966384|P1|Overall Study|Withdrawal by Subject|16
2894566|NCT01808144|9966383|P2|Overall Study|Death|0
2894567|NCT01808144|9966384|P1|Overall Study|Death|1
2894568|NCT01808118|9966392|P3|Period 2|Switched to other therapy|0
2894569|NCT01808118|9966393|P2|Period 2|Switched to other therapy|1
2894570|NCT01808118|9966394|P1|Period 2|Switched to other therapy|0
2894571|NCT01808118|9966392|P3|Period 2|Investigator no longer conducting trials|0
2894572|NCT01808118|9966393|P2|Period 2|Investigator no longer conducting trials|1
2894573|NCT01808118|9966394|P1|Period 2|Investigator no longer conducting trials|0
2894574|NCT01808118|9966392|P3|Period 2|Lost to Follow-up|2
2894575|NCT01808118|9966393|P2|Period 2|Lost to Follow-up|0
2894576|NCT01808118|9966394|P1|Period 2|Lost to Follow-up|0
2894577|NCT01808118|9966392|P3|Period 2|Withdrew consent|6
2894578|NCT01808118|9966393|P2|Period 2|Withdrew consent|7
2894579|NCT01808118|9966394|P1|Period 2|Withdrew consent|0
2894580|NCT01808118|9966392|P3|Period 2|Adverse Event|0
2894581|NCT01808118|9966393|P2|Period 2|Adverse Event|4
2894582|NCT01808118|9966394|P1|Period 2|Adverse Event|0
2894583|NCT01808118|9966392|P3|Period 1|Lack of Efficacy|0
2894584|NCT01808118|9966393|P2|Period 1|Lack of Efficacy|0
2894585|NCT01808118|9966394|P1|Period 1|Lack of Efficacy|1
2894586|NCT01808118|9966392|P3|Period 1|Non-compliance per sponsor|0
2894587|NCT01808118|9966393|P2|Period 1|Non-compliance per sponsor|0
2894588|NCT01808118|9966394|P1|Period 1|Non-compliance per sponsor|1
2894589|NCT01808118|9966392|P3|Period 1|Investigator decision: site closure|0
2894590|NCT01808118|9966393|P2|Period 1|Investigator decision: site closure|0
2894591|NCT01808118|9966394|P1|Period 1|Investigator decision: site closure|2
2894592|NCT01808118|9966392|P3|Period 1|Non-conformance with inclusion criteria|0
2894593|NCT01808118|9966393|P2|Period 1|Non-conformance with inclusion criteria|0
2894594|NCT01808118|9966394|P1|Period 1|Non-conformance with inclusion criteria|3
2894595|NCT01808118|9966392|P3|Period 1|Did not meet inclusion criteria|0
2894596|NCT01808118|9966393|P2|Period 1|Did not meet inclusion criteria|0
2894597|NCT01808118|9966394|P1|Period 1|Did not meet inclusion criteria|3
2894598|NCT01808118|9966392|P3|Period 1|Enrolled in error|0
2894599|NCT01808118|9966393|P2|Period 1|Enrolled in error|0
2894600|NCT01808118|9966394|P1|Period 1|Enrolled in error|7
2894601|NCT01808118|9966392|P3|Period 1|Did not meet criteria for remission|0
2894602|NCT01808118|9966393|P2|Period 1|Did not meet criteria for remission|0
2894603|NCT01808118|9966394|P1|Period 1|Did not meet criteria for remission|303
2894604|NCT01808118|9966392|P3|Period 1|Lost to Follow-up|0
2894605|NCT01808118|9966393|P2|Period 1|Lost to Follow-up|0
2894606|NCT01808118|9966394|P1|Period 1|Lost to Follow-up|9
2894607|NCT01808118|9966392|P3|Period 1|Withdrew consent|0
2894608|NCT01808118|9966393|P2|Period 1|Withdrew consent|0
2894609|NCT01808118|9966394|P1|Period 1|Withdrew consent|24
2894610|NCT01808118|9966392|P3|Period 1|Adverse Event|0
2894611|NCT01808118|9966393|P2|Period 1|Adverse Event|0
2894612|NCT01808118|9966394|P1|Period 1|Adverse Event|15
2894613|NCT01808092|9966457|P2|Overall Study|Other Eligibility criteria|5
2894614|NCT01808092|9966458|P1|Overall Study|Other Eligibility criteria|3
2894615|NCT01808092|9966457|P2|Overall Study|Withdrawal by Subject|4
2894616|NCT01808092|9966458|P1|Overall Study|Withdrawal by Subject|9
2894617|NCT01808092|9966457|P2|Overall Study|Lost to Follow-up|7
2894618|NCT01808092|9966458|P1|Overall Study|Lost to Follow-up|3
2894619|NCT01808092|9966457|P2|Overall Study|Death|29
2894620|NCT01808092|9966458|P1|Overall Study|Death|39
2894621|NCT01808066|9966560|P1|Overall Study|Withdrawal by Subject|15
2894622|NCT01807949|9966571|P3|Overall Study|Randomized But Not Treated|2
2894623|NCT01807949|9966572|P2|Overall Study|Randomized But Not Treated|2
2894624|NCT01807949|9966573|P1|Overall Study|Randomized But Not Treated|0
2894625|NCT01807949|9966571|P3|Overall Study|Undefined|2
2894626|NCT01807949|9966572|P2|Overall Study|Undefined|1
2894627|NCT01807949|9966573|P1|Overall Study|Undefined|0
2894628|NCT01807949|9966571|P3|Overall Study|Non-Compliance|1
2894629|NCT01807949|9966572|P2|Overall Study|Non-Compliance|0
2894630|NCT01807949|9966573|P1|Overall Study|Non-Compliance|0
2894631|NCT01807949|9966571|P3|Overall Study|Withdrawal by Subject|2
2894632|NCT01807949|9966572|P2|Overall Study|Withdrawal by Subject|2
2894633|NCT01807949|9966573|P1|Overall Study|Withdrawal by Subject|1
2894634|NCT01807949|9966571|P3|Overall Study|Adverse Event|2
2894635|NCT01807949|9966572|P2|Overall Study|Adverse Event|2
2894636|NCT01807949|9966573|P1|Overall Study|Adverse Event|1
2894637|NCT01807923|9966625|P3|Overall Study|Randomized But Not Treated|5
2894638|NCT01807923|9966626|P2|Overall Study|Randomized But Not Treated|2
2894639|NCT01807923|9966627|P1|Overall Study|Randomized But Not Treated|3
2894640|NCT01807923|9966625|P3|Overall Study|Not Eligible (Genotype)|1
2894641|NCT01807923|9966626|P2|Overall Study|Not Eligible (Genotype)|0
2894642|NCT01807923|9966627|P1|Overall Study|Not Eligible (Genotype)|0
2894643|NCT01807923|9966625|P3|Overall Study|Physician Decision|1
2894644|NCT01807923|9966626|P2|Overall Study|Physician Decision|0
2894645|NCT01807923|9966627|P1|Overall Study|Physician Decision|0
2894646|NCT01807923|9966625|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
2894647|NCT01807923|9966626|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
2894648|NCT01807923|9966627|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
2894649|NCT01807923|9966625|P3|Overall Study|Adverse Event|2
2894650|NCT01807923|9966626|P2|Overall Study|Adverse Event|1
2894651|NCT01807923|9966627|P1|Overall Study|Adverse Event|2
2894652|NCT01807650|9966689|P1|Overall Study|Other|2
2894653|NCT01807650|9966689|P1|Overall Study|Adverse Event|5
2894654|NCT01807650|9966689|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
2894655|NCT01807598|9966775|P1|Overall Study|Other Physician Decision|1
2894656|NCT01807598|9966775|P1|Overall Study|Adverse Event|1
2894657|NCT01807598|9966775|P1|Overall Study|Withdrawal by Subject|4
2894658|NCT01807520|9966807|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
2894659|NCT01807520|9966808|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
2894660|NCT01807520|9966809|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2894661|NCT01807520|9966810|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2894662|NCT01807520|9966811|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2894663|NCT01807520|9966812|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2894664|NCT01807520|9966813|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2894665|NCT01807520|9966807|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
2894666|NCT01807520|9966808|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
2894667|NCT01807520|9966809|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
2894668|NCT01807520|9966810|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
2894669|NCT01807520|9966811|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
2894670|NCT01807520|9966812|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
2894671|NCT01807520|9966813|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
2894672|NCT01807520|9966807|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894673|NCT01807520|9966808|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
2894674|NCT01807520|9966809|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894675|NCT01807520|9966810|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894676|NCT01807520|9966811|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894677|NCT01807520|9966812|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894678|NCT01807520|9966813|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2894679|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2894680|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2894681|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2894682|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2894683|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2894684|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
2894685|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
2894686|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2894687|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2894688|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2894689|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2894690|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2894691|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2894692|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2894693|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2894694|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2894695|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
2894696|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2894697|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2894698|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
2894699|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
2894700|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2894701|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2894702|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2894703|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
2894704|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2894705|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2894706|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
2894707|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894708|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894709|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894710|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894711|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894712|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
2894713|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2894714|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894715|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894716|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894717|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894718|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894719|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2894720|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
2894721|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894722|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894723|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894724|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
2894725|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894726|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894727|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2894728|NCT01807520|9966807|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2894729|NCT01807520|9966808|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2894730|NCT01807520|9966809|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
2894731|NCT01807520|9966810|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2894732|NCT01807520|9966811|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2894733|NCT01807520|9966812|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
2894734|NCT01807520|9966813|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
2894735|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894736|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894737|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894738|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894739|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894740|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2894741|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
2894742|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894743|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894744|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894745|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894746|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
2894747|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894748|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2894749|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894750|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894751|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894752|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894753|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894754|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2894755|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
2894756|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894757|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894758|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894759|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894760|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
2894761|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894762|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2894763|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2894764|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2894765|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2894766|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2894767|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2894768|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2894769|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2894770|NCT01807520|9966807|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2894771|NCT01807520|9966808|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2894772|NCT01807520|9966809|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2894773|NCT01807520|9966810|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2894774|NCT01807520|9966811|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
2894775|NCT01807520|9966812|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
2894776|NCT01807520|9966813|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2894777|NCT01807299|9966844|P4|Overall Study|Protocol Violation|2
2894778|NCT01807299|9966845|P3|Overall Study|Protocol Violation|0
2894779|NCT01807299|9966846|P2|Overall Study|Protocol Violation|1
2894780|NCT01807299|9966847|P1|Overall Study|Protocol Violation|3
2894781|NCT01807234|9966863|P6|Overall Study|Lack of Efficacy|1
2894782|NCT01807234|9966864|P5|Overall Study|Lack of Efficacy|1
2894783|NCT01807234|9966865|P4|Overall Study|Lack of Efficacy|0
2894784|NCT01807234|9966866|P3|Overall Study|Lack of Efficacy|0
2894785|NCT01807234|9966867|P2|Overall Study|Lack of Efficacy|0
2894786|NCT01807234|9966868|P1|Overall Study|Lack of Efficacy|0
2894787|NCT01807234|9966863|P6|Overall Study|Withdrawal by Subject|1
2894788|NCT01807234|9966864|P5|Overall Study|Withdrawal by Subject|2
2894789|NCT01807234|9966865|P4|Overall Study|Withdrawal by Subject|1
2894790|NCT01807234|9966866|P3|Overall Study|Withdrawal by Subject|1
2894791|NCT01807234|9966867|P2|Overall Study|Withdrawal by Subject|1
2894792|NCT01807234|9966868|P1|Overall Study|Withdrawal by Subject|3
2894793|NCT01807234|9966863|P6|Overall Study|Lost to Follow-up|2
2894794|NCT01807234|9966864|P5|Overall Study|Lost to Follow-up|1
2894795|NCT01807234|9966865|P4|Overall Study|Lost to Follow-up|1
2894796|NCT01807234|9966866|P3|Overall Study|Lost to Follow-up|1
2894797|NCT01807234|9966867|P2|Overall Study|Lost to Follow-up|5
2894798|NCT01807234|9966868|P1|Overall Study|Lost to Follow-up|2
2894799|NCT01807156|9966903|P1|Overall Study|Physician Decision|1
2894800|NCT01806961|9966975|P1|Overall Study|sponsor decision|16
2894801|NCT01806896|9966981|P2|Overall Study|Other|0
2894802|NCT01806896|9966982|P1|Overall Study|Other|1
2894803|NCT01806896|9966981|P2|Overall Study|Adverse Event|0
2894804|NCT01806896|9966982|P1|Overall Study|Adverse Event|2
2894805|NCT01806779|9967049|P3|Overall Study|Withdrawal by Subject|22
2894806|NCT01806779|9967050|P2|Overall Study|Withdrawal by Subject|23
2894807|NCT01806779|9967051|P1|Overall Study|Withdrawal by Subject|20
2894808|NCT01806779|9967049|P3|Overall Study|Lost to Follow-up|0
2894809|NCT01806779|9967050|P2|Overall Study|Lost to Follow-up|20
2894810|NCT01806779|9967051|P1|Overall Study|Lost to Follow-up|19
2894811|NCT01806779|9967049|P3|Overall Study|Lack of Efficacy|0
2894812|NCT01806779|9967050|P2|Overall Study|Lack of Efficacy|1
2894813|NCT01806779|9967051|P1|Overall Study|Lack of Efficacy|1
2894814|NCT01806779|9967049|P3|Overall Study|Physician Decision|1
2894815|NCT01806779|9967050|P2|Overall Study|Physician Decision|0
2894816|NCT01806779|9967051|P1|Overall Study|Physician Decision|2
2894817|NCT01806740|9967064|P1|Overall Study|Patient’s refusal of treatment|1
2894818|NCT01806740|9967064|P1|Overall Study|Physician Decision|1
2894819|NCT01806740|9967064|P1|Overall Study|Withdrawal by Subject|4
2894820|NCT01806714|9967075|P2|Overall Study|No functioning phone number|170
2894821|NCT01806714|9967076|P1|Overall Study|No functioning phone number|200
2894822|NCT01806662|9967111|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
2894823|NCT01806662|9967112|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
2894824|NCT01806662|9967111|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
2894825|NCT01806662|9967112|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
2894826|NCT01806662|9967111|P2|First Intervention (Weeks 0-16)|Adverse Event|1
2894827|NCT01806662|9967112|P1|First Intervention (Weeks 0-16)|Adverse Event|0
2894828|NCT01806662|9967111|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
2894829|NCT01806662|9967112|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
2894830|NCT01806623|9967118|P1|Overall Study|Did not meet the inclusion criteria|56
2894831|NCT01806623|9967118|P1|Overall Study|Adverse Event|1
2894832|NCT01806623|9967118|P1|Overall Study|Withdrawal by Subject|1
2894833|NCT01806597|9967138|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
2894834|NCT01806597|9967139|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2894835|NCT01806597|9967140|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2894836|NCT01806597|9967141|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2894837|NCT01806597|9967142|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2894838|NCT01806597|9967143|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2894839|NCT01806597|9967138|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
2894840|NCT01806597|9967139|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2894841|NCT01806597|9967140|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2894842|NCT01806597|9967141|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2894843|NCT01806597|9967142|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2894844|NCT01806597|9967143|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2894845|NCT01806597|9967138|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
2894846|NCT01806597|9967139|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2894847|NCT01806597|9967140|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2894848|NCT01806597|9967141|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2894849|NCT01806597|9967142|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2894850|NCT01806597|9967143|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2894851|NCT01806597|9967138|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
2894852|NCT01806597|9967139|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2894853|NCT01806597|9967140|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2894854|NCT01806597|9967141|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2894855|NCT01806597|9967142|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2894856|NCT01806597|9967143|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2894857|NCT01806597|9967138|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
2894858|NCT01806597|9967139|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2894859|NCT01806597|9967140|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2894860|NCT01806597|9967141|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2894861|NCT01806597|9967142|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2894862|NCT01806597|9967143|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2894863|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
2894864|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
2894865|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
2894866|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
2894867|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
2894868|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
2894869|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2894870|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2894871|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2894872|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2894873|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2894874|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2894875|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2894876|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2894877|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2894878|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
2894879|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2894880|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
2894881|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2894882|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2894883|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2894884|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2894885|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2894886|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2894887|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2894888|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2894889|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2894890|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2894891|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2894892|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
2894893|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2894894|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2894895|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2894896|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2894897|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2894898|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2894899|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2894900|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2894901|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2894902|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2894903|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2894904|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
2894905|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2894906|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2894907|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
2894908|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
2894909|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
2894910|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
2894911|NCT01806597|9967138|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
2894912|NCT01806597|9967139|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
2894913|NCT01806597|9967140|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
2894914|NCT01806597|9967141|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
2894915|NCT01806597|9967142|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
2894916|NCT01806597|9967143|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
2894917|NCT01806597|9967138|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
2894918|NCT01806597|9967139|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
2894919|NCT01806597|9967140|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
2894920|NCT01806597|9967141|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
2894921|NCT01806597|9967142|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
2894922|NCT01806597|9967143|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
2894923|NCT01806597|9967138|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2894924|NCT01806597|9967139|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2894925|NCT01806597|9967140|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2894926|NCT01806597|9967141|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2894927|NCT01806597|9967142|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2894928|NCT01806597|9967143|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
2894929|NCT01806597|9967138|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
2894930|NCT01806597|9967139|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
2894931|NCT01806597|9967140|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
2894932|NCT01806597|9967141|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
2894933|NCT01806597|9967142|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
2894934|NCT01806597|9967143|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
2894935|NCT01806597|9967138|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2894936|NCT01806597|9967139|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2894937|NCT01806597|9967140|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2894938|NCT01806597|9967141|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2894939|NCT01806597|9967142|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2894940|NCT01806597|9967143|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2894941|NCT01806597|9967138|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
2894942|NCT01806597|9967139|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
2894943|NCT01806597|9967140|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
2894944|NCT01806597|9967141|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
2894945|NCT01806597|9967142|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
2894946|NCT01806597|9967143|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
2894947|NCT01806584|9967179|P2|Overall Study|Other unspecified|0
2894948|NCT01806584|9967180|P1|Overall Study|Other unspecified|1
2894949|NCT01806584|9967179|P2|Overall Study|Withdrawal by Subject|1
2894950|NCT01806584|9967180|P1|Overall Study|Withdrawal by Subject|1
2894951|NCT01806584|9967179|P2|Overall Study|Study terminated by sponsor|14
2894952|NCT01806584|9967180|P1|Overall Study|Study terminated by sponsor|9
2894953|NCT01806584|9967179|P2|Overall Study|Lost to Follow-up|2
2894954|NCT01806584|9967180|P1|Overall Study|Lost to Follow-up|0
2894955|NCT01806584|9967179|P2|Overall Study|Death|0
2894956|NCT01806584|9967180|P1|Overall Study|Death|1
2894957|NCT01806584|9967179|P2|Overall Study|Adverse Event|1
2894958|NCT01806584|9967180|P1|Overall Study|Adverse Event|2
2894959|NCT01806545|9967202|P2|Overall Study|Withdrawal by Subject|2
2894960|NCT01806545|9967203|P1|Overall Study|Withdrawal by Subject|3
2894961|NCT01806545|9967202|P2|Overall Study|Lost to Follow-up|0
2894962|NCT01806545|9967203|P1|Overall Study|Lost to Follow-up|1
2894963|NCT01806545|9967202|P2|Overall Study|Adverse Event|3
2894964|NCT01806545|9967203|P1|Overall Study|Adverse Event|2
2894965|NCT01806506|9967227|P2|Overall Study|Lost to Follow-up|1
2894966|NCT01806506|9967228|P1|Overall Study|Lost to Follow-up|2
2894967|NCT01806389|9967234|P1|Overall Study|Withdrawal by Subject|4
2894968|NCT01806298|9967248|P1|Overall Study|Other|5
2894969|NCT01806298|9967248|P1|Overall Study|Withdrawal by Subject|1
2894970|NCT01806298|9967248|P1|Overall Study|Protocol Non-compliance|1
2894971|NCT01806298|9967248|P1|Overall Study|Adverse Event|3
2894972|NCT01806051|9967269|P1|Overall Study|Withdrawal by Subject|6
2894973|NCT01805180|9967386|P3|Lead-in Donor Phase|screen failure|0
2894974|NCT01805180|9967387|P2|Lead-in Donor Phase|screen failure|0
2894975|NCT01805180|9967388|P1|Lead-in Donor Phase|screen failure|1
2894976|NCT01804946|9967463|P2|Overall Study|Do not meet inclusion criteria|2
2894977|NCT01804946|9967464|P1|Overall Study|Do not meet inclusion criteria|1
2894978|NCT01804946|9967463|P2|Overall Study|Insufficient data available|1
2894979|NCT01804946|9967464|P1|Overall Study|Insufficient data available|0
2894980|NCT01804946|9967463|P2|Overall Study|Adverse Event|1
2894981|NCT01804946|9967464|P1|Overall Study|Adverse Event|0
2894982|NCT01804946|9967463|P2|Overall Study|Protocol Violation|0
2894983|NCT01804946|9967464|P1|Overall Study|Protocol Violation|1
2894984|NCT01804842|9967502|P3|Overall Study|Personal Reason|1
2894985|NCT01804842|9967503|P2|Overall Study|Personal Reason|0
2894986|NCT01804842|9967504|P1|Overall Study|Personal Reason|0
2894987|NCT01804842|9967502|P3|Overall Study|Non-Compliance|0
2894988|NCT01804842|9967503|P2|Overall Study|Non-Compliance|1
2894989|NCT01804842|9967504|P1|Overall Study|Non-Compliance|1
2894990|NCT01804842|9967502|P3|Overall Study|Lost to Follow-up|0
2894991|NCT01804842|9967503|P2|Overall Study|Lost to Follow-up|0
2894992|NCT01804842|9967504|P1|Overall Study|Lost to Follow-up|1
2894993|NCT01804842|9967502|P3|Overall Study|Adverse Event|0
2894994|NCT01804842|9967503|P2|Overall Study|Adverse Event|1
2894995|NCT01804842|9967504|P1|Overall Study|Adverse Event|1
2894996|NCT01804816|9967521|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
2894997|NCT01804816|9967521|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
2894998|NCT01804673|9967533|P1|Overall Study|Other|4
2894999|NCT01804673|9967533|P1|Overall Study|Use of Prohibited Medication|1
2895000|NCT01804673|9967533|P1|Overall Study|No Further Therapy Required|84
2895001|NCT01804673|9967533|P1|Overall Study|Change to Oral Therapy|37
2895002|NCT01804673|9967533|P1|Overall Study|Lack of Efficacy|9
2895003|NCT01804673|9967533|P1|Overall Study|Withdrawal by Subject|1
2895004|NCT01804673|9967533|P1|Overall Study|Adverse Event|4
2895005|NCT01804582|9967551|P2|Overall Study|Physician Decision|0
2895006|NCT01804582|9967552|P1|Overall Study|Physician Decision|2
2895007|NCT01804582|9967551|P2|Overall Study|Lost to Follow-up|56
2895008|NCT01804582|9967552|P1|Overall Study|Lost to Follow-up|47
2895009|NCT01804140|9967572|P1|Overall Study|No sampling or biopsy procedures done|114
2895010|NCT01804049|9967606|P2|Overall Study|Enrollment in dual studies|1
2895011|NCT01804049|9967607|P1|Overall Study|Enrollment in dual studies|0
2895012|NCT01804049|9967606|P2|Overall Study|other MD recommended|1
2895013|NCT01804049|9967607|P1|Overall Study|other MD recommended|1
2895014|NCT01804049|9967606|P2|Overall Study|Moved out of area|7
2895015|NCT01804049|9967607|P1|Overall Study|Moved out of area|0
2895016|NCT01804049|9967606|P2|Overall Study|Other health concerns|7
2895017|NCT01804049|9967607|P1|Overall Study|Other health concerns|2
2895018|NCT01804049|9967606|P2|Overall Study|Decreased interest/personal|5
2895019|NCT01804049|9967607|P1|Overall Study|Decreased interest/personal|4
2895020|NCT01804049|9967606|P2|Overall Study|Lost to Follow-up|1
2895021|NCT01804049|9967607|P1|Overall Study|Lost to Follow-up|2
2895022|NCT01804049|9967606|P2|Overall Study|Adverse Event|10
2895023|NCT01804049|9967607|P1|Overall Study|Adverse Event|2
2895024|NCT01803880|9967655|P3|Overall Study|Incomplete data entry by sites|0
2895025|NCT01803880|9967656|P2|Overall Study|Incomplete data entry by sites|0
2895026|NCT01803880|9967657|P1|Overall Study|Incomplete data entry by sites|2
2895027|NCT01803880|9967655|P3|Overall Study|Early study termination|5
2895028|NCT01803880|9967656|P2|Overall Study|Early study termination|6
2895029|NCT01803880|9967657|P1|Overall Study|Early study termination|0
2895030|NCT01803880|9967655|P3|Overall Study|Protocol Violation|0
2895031|NCT01803880|9967656|P2|Overall Study|Protocol Violation|0
2895032|NCT01803880|9967657|P1|Overall Study|Protocol Violation|1
2895033|NCT01803880|9967655|P3|Overall Study|Lost to Follow-up|3
2895034|NCT01803880|9967656|P2|Overall Study|Lost to Follow-up|2
2895035|NCT01803880|9967657|P1|Overall Study|Lost to Follow-up|1
2895036|NCT01803880|9967655|P3|Overall Study|Unable to return for follow-up visits|2
2895037|NCT01803880|9967656|P2|Overall Study|Unable to return for follow-up visits|1
2895038|NCT01803880|9967657|P1|Overall Study|Unable to return for follow-up visits|0
2895039|NCT01803880|9967655|P3|Overall Study|Physician Decision|1
2895040|NCT01803880|9967656|P2|Overall Study|Physician Decision|0
2895041|NCT01803880|9967657|P1|Overall Study|Physician Decision|0
2895042|NCT01803880|9967655|P3|Overall Study|Withdrawal by Subject|4
2895043|NCT01803880|9967656|P2|Overall Study|Withdrawal by Subject|1
2895044|NCT01803880|9967657|P1|Overall Study|Withdrawal by Subject|1
2895045|NCT01803880|9967655|P3|Overall Study|Adverse Event|0
2895046|NCT01803880|9967656|P2|Overall Study|Adverse Event|0
2895047|NCT01803880|9967657|P1|Overall Study|Adverse Event|1
2895048|NCT01803737|9967693|P2|Overall Study|Lost to Follow-up|2
2895049|NCT01803737|9967694|P1|Overall Study|Lost to Follow-up|0
2895050|NCT01803737|9967693|P2|Overall Study|Medical Reason|1
2895051|NCT01803737|9967694|P1|Overall Study|Medical Reason|0
2895052|NCT01803737|9967693|P2|Overall Study|Lack of Time|0
2895053|NCT01803737|9967694|P1|Overall Study|Lack of Time|1
2895054|NCT01803711|9967718|P2|Overall Study|Adverse Event|1
2895055|NCT01803711|9967719|P1|Overall Study|Adverse Event|1
2895056|NCT01803646|9967737|P2|Overall Study|Lost to Follow-up|1
2895057|NCT01803646|9967738|P1|Overall Study|Lost to Follow-up|5
2895058|NCT01803646|9967737|P2|Overall Study|Randomization error|2
2895059|NCT01803646|9967738|P1|Overall Study|Randomization error|1
2895060|NCT01803646|9967737|P2|Overall Study|Withdrawal by Subject|6
2895061|NCT01803646|9967738|P1|Overall Study|Withdrawal by Subject|9
2895062|NCT01803646|9967737|P2|Overall Study|Adverse Event|1
2895063|NCT01803646|9967738|P1|Overall Study|Adverse Event|1
2895064|NCT01803646|9967737|P2|Overall Study|Protocol Violation|0
2895065|NCT01803646|9967738|P1|Overall Study|Protocol Violation|1
2895066|NCT01803607|9967750|P2|Overall Study|Withdrawal by Subject|5
2895067|NCT01803607|9967751|P1|Overall Study|Withdrawal by Subject|6
2895068|NCT01803607|9967750|P2|Overall Study|Study terminated by sponsor|56
2895069|NCT01803607|9967751|P1|Overall Study|Study terminated by sponsor|54
2895070|NCT01803607|9967750|P2|Overall Study|Protocol Violation|2
2895071|NCT01803607|9967751|P1|Overall Study|Protocol Violation|3
2895072|NCT01803607|9967750|P2|Overall Study|Lack of Efficacy|1
2895073|NCT01803607|9967751|P1|Overall Study|Lack of Efficacy|0
2895074|NCT01803607|9967750|P2|Overall Study|Adverse Event|3
2895075|NCT01803607|9967751|P1|Overall Study|Adverse Event|5
2895076|NCT01803464|9967775|P4|Overall Study|Withdrawal by Subject|0
2895077|NCT01803464|9967776|P3|Overall Study|Withdrawal by Subject|0
2895078|NCT01803464|9967777|P2|Overall Study|Withdrawal by Subject|0
2895079|NCT01803464|9967778|P1|Overall Study|Withdrawal by Subject|1
2895080|NCT01803464|9967775|P4|Overall Study|Incomplete data|0
2895081|NCT01803464|9967776|P3|Overall Study|Incomplete data|4
2895082|NCT01803464|9967777|P2|Overall Study|Incomplete data|0
2895083|NCT01803464|9967778|P1|Overall Study|Incomplete data|0
2895084|NCT01803282|9967808|P12|Overall Study|Enrolled but Never Treated|0
2895085|NCT01803282|9967809|P11|Overall Study|Enrolled but Never Treated|0
2895086|NCT01803282|9967810|P10|Overall Study|Enrolled but Never Treated|1
2895087|NCT01803282|9967811|P9|Overall Study|Enrolled but Never Treated|0
2895088|NCT01803282|9967812|P8|Overall Study|Enrolled but Never Treated|1
2895089|NCT01803282|9967813|P7|Overall Study|Enrolled but Never Treated|1
2895090|NCT01803282|9967814|P6|Overall Study|Enrolled but Never Treated|0
2895091|NCT01803282|9967815|P5|Overall Study|Enrolled but Never Treated|1
2895092|NCT01803282|9967816|P4|Overall Study|Enrolled but Never Treated|0
2895093|NCT01803282|9967817|P3|Overall Study|Enrolled but Never Treated|0
2895094|NCT01803282|9967818|P2|Overall Study|Enrolled but Never Treated|0
2895095|NCT01803282|9967819|P1|Overall Study|Enrolled but Never Treated|0
2895096|NCT01803282|9967808|P12|Overall Study|Specified Criteria for Withdrawal|0
2895097|NCT01803282|9967809|P11|Overall Study|Specified Criteria for Withdrawal|1
2895098|NCT01803282|9967810|P10|Overall Study|Specified Criteria for Withdrawal|1
2895099|NCT01803282|9967811|P9|Overall Study|Specified Criteria for Withdrawal|0
2895100|NCT01803282|9967812|P8|Overall Study|Specified Criteria for Withdrawal|0
2895101|NCT01803282|9967813|P7|Overall Study|Specified Criteria for Withdrawal|0
2895102|NCT01803282|9967814|P6|Overall Study|Specified Criteria for Withdrawal|0
2895103|NCT01803282|9967815|P5|Overall Study|Specified Criteria for Withdrawal|0
2895104|NCT01803282|9967816|P4|Overall Study|Specified Criteria for Withdrawal|0
2895105|NCT01803282|9967817|P3|Overall Study|Specified Criteria for Withdrawal|0
2895106|NCT01803282|9967818|P2|Overall Study|Specified Criteria for Withdrawal|0
2895107|NCT01803282|9967819|P1|Overall Study|Specified Criteria for Withdrawal|0
2895108|NCT01803282|9967808|P12|Overall Study|Unknown Reason|0
2895109|NCT01803282|9967809|P11|Overall Study|Unknown Reason|0
2895110|NCT01803282|9967810|P10|Overall Study|Unknown Reason|0
2895111|NCT01803282|9967811|P9|Overall Study|Unknown Reason|0
2895112|NCT01803282|9967812|P8|Overall Study|Unknown Reason|1
2895113|NCT01803282|9967813|P7|Overall Study|Unknown Reason|0
2895114|NCT01803282|9967814|P6|Overall Study|Unknown Reason|0
2895115|NCT01803282|9967815|P5|Overall Study|Unknown Reason|0
2895116|NCT01803282|9967816|P4|Overall Study|Unknown Reason|0
2895117|NCT01803282|9967817|P3|Overall Study|Unknown Reason|0
2895118|NCT01803282|9967818|P2|Overall Study|Unknown Reason|0
2895119|NCT01803282|9967819|P1|Overall Study|Unknown Reason|0
2895120|NCT01803282|9967808|P12|Overall Study|Non-Compliance with Study Drug|0
2895121|NCT01803282|9967809|P11|Overall Study|Non-Compliance with Study Drug|0
2895122|NCT01803282|9967810|P10|Overall Study|Non-Compliance with Study Drug|0
2895123|NCT01803282|9967811|P9|Overall Study|Non-Compliance with Study Drug|0
2895124|NCT01803282|9967812|P8|Overall Study|Non-Compliance with Study Drug|0
2895125|NCT01803282|9967813|P7|Overall Study|Non-Compliance with Study Drug|0
2895126|NCT01803282|9967814|P6|Overall Study|Non-Compliance with Study Drug|0
2895127|NCT01803282|9967815|P5|Overall Study|Non-Compliance with Study Drug|0
2895128|NCT01803282|9967816|P4|Overall Study|Non-Compliance with Study Drug|1
2895129|NCT01803282|9967817|P3|Overall Study|Non-Compliance with Study Drug|0
2895130|NCT01803282|9967818|P2|Overall Study|Non-Compliance with Study Drug|0
2895131|NCT01803282|9967819|P1|Overall Study|Non-Compliance with Study Drug|0
2895132|NCT01803282|9967808|P12|Overall Study|Adverse Event|3
2895133|NCT01803282|9967809|P11|Overall Study|Adverse Event|0
2895134|NCT01803282|9967810|P10|Overall Study|Adverse Event|1
2895135|NCT01803282|9967811|P9|Overall Study|Adverse Event|0
2895136|NCT01803282|9967812|P8|Overall Study|Adverse Event|2
2895137|NCT01803282|9967813|P7|Overall Study|Adverse Event|1
2895138|NCT01803282|9967814|P6|Overall Study|Adverse Event|0
2895139|NCT01803282|9967815|P5|Overall Study|Adverse Event|0
2895140|NCT01803282|9967816|P4|Overall Study|Adverse Event|0
2895141|NCT01803282|9967817|P3|Overall Study|Adverse Event|0
2895142|NCT01803282|9967818|P2|Overall Study|Adverse Event|0
2895143|NCT01803282|9967819|P1|Overall Study|Adverse Event|0
2895144|NCT01803282|9967808|P12|Overall Study|Investigator's Discretion|0
2895145|NCT01803282|9967809|P11|Overall Study|Investigator's Discretion|1
2895146|NCT01803282|9967810|P10|Overall Study|Investigator's Discretion|7
2895147|NCT01803282|9967811|P9|Overall Study|Investigator's Discretion|6
2895148|NCT01803282|9967812|P8|Overall Study|Investigator's Discretion|10
2895149|NCT01803282|9967813|P7|Overall Study|Investigator's Discretion|7
2895150|NCT01803282|9967814|P6|Overall Study|Investigator's Discretion|1
2895151|NCT01803282|9967815|P5|Overall Study|Investigator's Discretion|2
2895152|NCT01803282|9967816|P4|Overall Study|Investigator's Discretion|7
2895153|NCT01803282|9967817|P3|Overall Study|Investigator's Discretion|0
2895154|NCT01803282|9967818|P2|Overall Study|Investigator's Discretion|0
2895155|NCT01803282|9967819|P1|Overall Study|Investigator's Discretion|0
2895156|NCT01803282|9967808|P12|Overall Study|Withdrew Consent|1
2895157|NCT01803282|9967809|P11|Overall Study|Withdrew Consent|0
2895158|NCT01803282|9967810|P10|Overall Study|Withdrew Consent|5
2895159|NCT01803282|9967811|P9|Overall Study|Withdrew Consent|1
2895160|NCT01803282|9967812|P8|Overall Study|Withdrew Consent|3
2895161|NCT01803282|9967813|P7|Overall Study|Withdrew Consent|8
2895162|NCT01803282|9967814|P6|Overall Study|Withdrew Consent|0
2895163|NCT01803282|9967815|P5|Overall Study|Withdrew Consent|1
2895164|NCT01803282|9967816|P4|Overall Study|Withdrew Consent|6
2895165|NCT01803282|9967817|P3|Overall Study|Withdrew Consent|0
2895166|NCT01803282|9967818|P2|Overall Study|Withdrew Consent|0
2895167|NCT01803282|9967819|P1|Overall Study|Withdrew Consent|0
2895168|NCT01803282|9967808|P12|Overall Study|Death|0
2895169|NCT01803282|9967809|P11|Overall Study|Death|0
2895170|NCT01803282|9967810|P10|Overall Study|Death|1
2895171|NCT01803282|9967811|P9|Overall Study|Death|1
2895172|NCT01803282|9967812|P8|Overall Study|Death|5
2895173|NCT01803282|9967813|P7|Overall Study|Death|1
2895174|NCT01803282|9967814|P6|Overall Study|Death|1
2895175|NCT01803282|9967815|P5|Overall Study|Death|2
2895176|NCT01803282|9967816|P4|Overall Study|Death|0
2895177|NCT01803282|9967817|P3|Overall Study|Death|0
2895178|NCT01803282|9967818|P2|Overall Study|Death|0
2895179|NCT01803282|9967819|P1|Overall Study|Death|0
2895180|NCT01803282|9967808|P12|Overall Study|Progressive Disease|11
2895181|NCT01803282|9967809|P11|Overall Study|Progressive Disease|6
2895182|NCT01803282|9967810|P10|Overall Study|Progressive Disease|29
2895183|NCT01803282|9967811|P9|Overall Study|Progressive Disease|3
2895184|NCT01803282|9967812|P8|Overall Study|Progressive Disease|24
2895185|NCT01803282|9967813|P7|Overall Study|Progressive Disease|23
2895186|NCT01803282|9967814|P6|Overall Study|Progressive Disease|8
2895187|NCT01803282|9967815|P5|Overall Study|Progressive Disease|5
2895188|NCT01803282|9967816|P4|Overall Study|Progressive Disease|22
2895189|NCT01803282|9967817|P3|Overall Study|Progressive Disease|6
2895190|NCT01803282|9967818|P2|Overall Study|Progressive Disease|3
2895191|NCT01803282|9967819|P1|Overall Study|Progressive Disease|4
2895192|NCT01803269|9967860|P3|Overall Study|Withdrawal by Subject|0
2895193|NCT01803269|9967861|P2|Overall Study|Withdrawal by Subject|0
2895194|NCT01803269|9967862|P1|Overall Study|Withdrawal by Subject|3
2895195|NCT01802879|9968176|P1|Overall Study|Disease progression|6
2895196|NCT01802879|9968176|P1|Overall Study|Administrative problems|2
2895197|NCT01802775|9968183|P2|Overall Study|Lost to Follow-up|2
2895198|NCT01802775|9968184|P1|Overall Study|Lost to Follow-up|1
2895199|NCT01802775|9968183|P2|Overall Study|Withdrawal by Subject|5
2895200|NCT01802775|9968184|P1|Overall Study|Withdrawal by Subject|3
2895201|NCT01802775|9968183|P2|Overall Study|Adverse Event|1
2895202|NCT01802775|9968184|P1|Overall Study|Adverse Event|1
2895203|NCT01802775|9968183|P2|Overall Study|Physician Decision|0
2895204|NCT01802775|9968184|P1|Overall Study|Physician Decision|1
2895205|NCT01802775|9968183|P2|Overall Study|Reason not provided|1
2895206|NCT01802775|9968184|P1|Overall Study|Reason not provided|0
2895207|NCT01802775|9968183|P2|Overall Study|Death|3
2895208|NCT01802775|9968184|P1|Overall Study|Death|0
2895209|NCT01802632|9968219|P6|Overall Study|Other (not specified)|1
2895210|NCT01802632|9968220|P5|Overall Study|Other (not specified)|0
2895211|NCT01802632|9968221|P4|Overall Study|Other (not specified)|1
2895212|NCT01802632|9968222|P3|Overall Study|Other (not specified)|7
2895213|NCT01802632|9968223|P2|Overall Study|Other (not specified)|0
2895214|NCT01802632|9968224|P1|Overall Study|Other (not specified)|0
2895215|NCT01802632|9968219|P6|Overall Study|Ongoing Study at Data Cut-off|22
2895216|NCT01802632|9968220|P5|Overall Study|Ongoing Study at Data Cut-off|6
2895217|NCT01802632|9968221|P4|Overall Study|Ongoing Study at Data Cut-off|50
2895218|NCT01802632|9968222|P3|Overall Study|Ongoing Study at Data Cut-off|115
2895219|NCT01802632|9968223|P2|Overall Study|Ongoing Study at Data Cut-off|16
2895220|NCT01802632|9968224|P1|Overall Study|Ongoing Study at Data Cut-off|168
2895221|NCT01802632|9968219|P6|Overall Study|Objective Disease Progression|4
2895222|NCT01802632|9968220|P5|Overall Study|Objective Disease Progression|4
2895223|NCT01802632|9968221|P4|Overall Study|Objective Disease Progression|6
2895224|NCT01802632|9968222|P3|Overall Study|Objective Disease Progression|104
2895225|NCT01802632|9968223|P2|Overall Study|Objective Disease Progression|12
2895226|NCT01802632|9968224|P1|Overall Study|Objective Disease Progression|1
2895227|NCT01802632|9968219|P6|Overall Study|Withdrawal by Subject|1
2895228|NCT01802632|9968220|P5|Overall Study|Withdrawal by Subject|0
2895229|NCT01802632|9968221|P4|Overall Study|Withdrawal by Subject|3
2895230|NCT01802632|9968222|P3|Overall Study|Withdrawal by Subject|7
2895231|NCT01802632|9968223|P2|Overall Study|Withdrawal by Subject|2
2895232|NCT01802632|9968224|P1|Overall Study|Withdrawal by Subject|4
2895233|NCT01802632|9968219|P6|Overall Study|Death|0
2895234|NCT01802632|9968220|P5|Overall Study|Death|2
2895235|NCT01802632|9968221|P4|Overall Study|Death|0
2895236|NCT01802632|9968222|P3|Overall Study|Death|38
2895237|NCT01802632|9968223|P2|Overall Study|Death|1
2895238|NCT01802632|9968224|P1|Overall Study|Death|28
2895239|NCT01802580|9968240|P2|Overall Study|Lack of Efficacy|2
2895240|NCT01802580|9968241|P1|Overall Study|Lack of Efficacy|0
2895241|NCT01802580|9968240|P2|Overall Study|Other|3
2895242|NCT01802580|9968241|P1|Overall Study|Other|1
2895243|NCT01802580|9968240|P2|Overall Study|Withdrawal by Subject|6
2895244|NCT01802580|9968241|P1|Overall Study|Withdrawal by Subject|5
2895245|NCT01802580|9968240|P2|Overall Study|Protocol Violation|0
2895246|NCT01802580|9968241|P1|Overall Study|Protocol Violation|2
2895247|NCT01802580|9968240|P2|Overall Study|Physician Decision|0
2895248|NCT01802580|9968241|P1|Overall Study|Physician Decision|1
2895249|NCT01802515|9968272|P3|Overall Study|Withdrawal by Subject|0
2895250|NCT01802515|9968273|P2|Overall Study|Withdrawal by Subject|0
2895251|NCT01802515|9968274|P1|Overall Study|Withdrawal by Subject|3
2895252|NCT01802437|9968287|P2|Overall Study|Withdrawal by Subject|4
2895253|NCT01802437|9968288|P1|Overall Study|Withdrawal by Subject|3
2895254|NCT01802437|9968287|P2|Overall Study|Lost to Follow-up|0
2895255|NCT01802437|9968288|P1|Overall Study|Lost to Follow-up|1
2895256|NCT01802385|9968300|P2|Overall Study|Death|120
2895257|NCT01802385|9968301|P1|Overall Study|Death|106
2895258|NCT01802333|9968324|P3|Overall Study|Did not start treatment|5
2895259|NCT01802333|9968325|P2|Overall Study|Did not start treatment|2
2895260|NCT01802333|9968326|P1|Overall Study|Did not start treatment|0
2895261|NCT01802333|9968324|P3|Overall Study|Other - not protocol specified|24
2895262|NCT01802333|9968325|P2|Overall Study|Other - not protocol specified|22
2895263|NCT01802333|9968326|P1|Overall Study|Other - not protocol specified|32
2895264|NCT01802333|9968324|P3|Overall Study|Death|13
2895265|NCT01802333|9968325|P2|Overall Study|Death|14
2895266|NCT01802333|9968326|P1|Overall Study|Death|7
2895267|NCT01802333|9968324|P3|Overall Study|Progression/relapse|0
2895268|NCT01802333|9968325|P2|Overall Study|Progression/relapse|3
2895269|NCT01802333|9968326|P1|Overall Study|Progression/relapse|1
2895270|NCT01802333|9968324|P3|Overall Study|Withdrawal by Subject|5
2895271|NCT01802333|9968325|P2|Overall Study|Withdrawal by Subject|6
2895272|NCT01802333|9968326|P1|Overall Study|Withdrawal by Subject|6
2895273|NCT01802333|9968324|P3|Overall Study|Adverse Event|8
2895274|NCT01802333|9968325|P2|Overall Study|Adverse Event|8
2895275|NCT01802333|9968326|P1|Overall Study|Adverse Event|1
2895276|NCT01802333|9968324|P3|Overall Study|Ineligible|8
2895277|NCT01802333|9968325|P2|Overall Study|Ineligible|6
2895278|NCT01802333|9968326|P1|Overall Study|Ineligible|2
2895279|NCT01802320|9968353|P1|Overall Study|Withdrawal by Subject|1
2895280|NCT01802320|9968353|P1|Overall Study|Death|1
2895281|NCT01802216|9968363|P2|12 Month Visit|Participant did not show to visit|4
2895282|NCT01802216|9968364|P1|12 Month Visit|Participant did not show to visit|3
2895283|NCT01802216|9968363|P2|8 Month Visit|Participant did not show to visit|5
2895284|NCT01802216|9968364|P1|8 Month Visit|Participant did not show to visit|3
2895285|NCT01802216|9968363|P2|4 Month Visit|Participant did not show to visit|4
2895286|NCT01802216|9968364|P1|4 Month Visit|Participant did not show to visit|3
2895287|NCT01802073|9968443|P2|Overall Study|Physician Decision|7
2895288|NCT01802073|9968444|P1|Overall Study|Physician Decision|0
2895289|NCT01802073|9968443|P2|Overall Study|Withdrawal by Subject|1
2895290|NCT01802073|9968444|P1|Overall Study|Withdrawal by Subject|1
2895291|NCT01802073|9968443|P2|Overall Study|Non-compliant|2
2895292|NCT01802073|9968444|P1|Overall Study|Non-compliant|4
2895293|NCT01802073|9968443|P2|Overall Study|Lost to Follow-up|1
2895294|NCT01802073|9968444|P1|Overall Study|Lost to Follow-up|0
2895295|NCT01801982|9968460|P1|Overall Study|Lost to Follow-up|1
2895296|NCT01801917|9968474|P4|Period 1 - Randomized|Adverse Event|0
2895297|NCT01801917|9968475|P3|Period 1 - Randomized|Adverse Event|1
2895298|NCT01801917|9968476|P2|Period 1 - Randomized|Adverse Event|0
2895299|NCT01801917|9968477|P1|Period 1 - Randomized|Adverse Event|1
2895300|NCT01801735|9968497|P1|Overall Study|Other, including site closure|19
2895301|NCT01801735|9968497|P1|Overall Study|Death|1
2895302|NCT01801735|9968497|P1|Overall Study|Physician Decision|3
2895303|NCT01801735|9968497|P1|Overall Study|Non-compliance with Trial Drug|13
2895304|NCT01801735|9968497|P1|Overall Study|Lost to Follow-up|15
2895305|NCT01801735|9968497|P1|Overall Study|Protocol Violation|25
2895306|NCT01801735|9968497|P1|Overall Study|Withdrawal by Subject|27
2895307|NCT01801735|9968497|P1|Overall Study|Lack of Efficacy|28
2895308|NCT01801735|9968497|P1|Overall Study|Adverse Event|79
2895309|NCT01801475|9968504|P5|Overall Study|Withdrawal by Subject|1
2895310|NCT01801475|9968505|P4|Overall Study|Withdrawal by Subject|0
2895311|NCT01801475|9968506|P3|Overall Study|Withdrawal by Subject|0
2895312|NCT01801475|9968507|P2|Overall Study|Withdrawal by Subject|0
2895313|NCT01801475|9968508|P1|Overall Study|Withdrawal by Subject|0
2895314|NCT01801436|9968533|P1|Overall Study|Progressive disease|4
2895315|NCT01801436|9968533|P1|Overall Study|Adverse Event|2
2895316|NCT01801436|9968533|P1|Overall Study|Withdrawal by Subject|3
2895317|NCT01801358|9968571|P6|Overall Study|Withdrawal by Subject|2
2895318|NCT01801358|9968572|P5|Overall Study|Withdrawal by Subject|0
2895319|NCT01801358|9968573|P4|Overall Study|Withdrawal by Subject|1
2895320|NCT01801358|9968574|P3|Overall Study|Withdrawal by Subject|0
2895321|NCT01801358|9968575|P2|Overall Study|Withdrawal by Subject|0
2895322|NCT01801358|9968576|P1|Overall Study|Withdrawal by Subject|0
2895323|NCT01801358|9968571|P6|Overall Study|Progressive Disease|5
2895324|NCT01801358|9968572|P5|Overall Study|Progressive Disease|6
2895325|NCT01801358|9968573|P4|Overall Study|Progressive Disease|5
2895326|NCT01801358|9968574|P3|Overall Study|Progressive Disease|4
2895327|NCT01801358|9968575|P2|Overall Study|Progressive Disease|4
2895328|NCT01801358|9968576|P1|Overall Study|Progressive Disease|6
2895329|NCT01801358|9968571|P6|Overall Study|Physician Decision|0
2895330|NCT01801358|9968572|P5|Overall Study|Physician Decision|0
2895331|NCT01801358|9968573|P4|Overall Study|Physician Decision|0
2895332|NCT01801358|9968574|P3|Overall Study|Physician Decision|1
2895333|NCT01801358|9968575|P2|Overall Study|Physician Decision|0
2895334|NCT01801358|9968576|P1|Overall Study|Physician Decision|0
2895335|NCT01801358|9968571|P6|Overall Study|Adverse Event|1
2895336|NCT01801358|9968572|P5|Overall Study|Adverse Event|0
2895337|NCT01801358|9968573|P4|Overall Study|Adverse Event|0
2895338|NCT01801358|9968574|P3|Overall Study|Adverse Event|1
2895339|NCT01801358|9968575|P2|Overall Study|Adverse Event|2
2895340|NCT01801358|9968576|P1|Overall Study|Adverse Event|0
2895341|NCT01801280|9968698|P4|Period 4|Protocol Violation|0
2895342|NCT01801280|9968699|P3|Period 4|Protocol Violation|1
2895343|NCT01801280|9968700|P2|Period 4|Protocol Violation|0
2895344|NCT01801280|9968701|P1|Period 4|Protocol Violation|0
2895345|NCT01801280|9968698|P4|Period 2|Withdrawal by Subject|0
2895346|NCT01801280|9968699|P3|Period 2|Withdrawal by Subject|0
2895347|NCT01801280|9968700|P2|Period 2|Withdrawal by Subject|0
2895348|NCT01801280|9968701|P1|Period 2|Withdrawal by Subject|1
2895349|NCT01801280|9968698|P4|Period 1|Withdrawal by Subject|0
2895350|NCT01801280|9968699|P3|Period 1|Withdrawal by Subject|0
2895351|NCT01801280|9968700|P2|Period 1|Withdrawal by Subject|1
2895352|NCT01801280|9968701|P1|Period 1|Withdrawal by Subject|0
2895353|NCT01801111|9968716|P1|Overall Study|Progressive Disease|81
2895354|NCT01801111|9968716|P1|Overall Study|Study Terminated by Sponsor|27
2895355|NCT01801111|9968716|P1|Overall Study|Withdrawal by Subject|4
2895356|NCT01801111|9968716|P1|Overall Study|Other|1
2895357|NCT01801111|9968716|P1|Overall Study|Physician Decision|5
2895358|NCT01801111|9968716|P1|Overall Study|Death|8
2895359|NCT01801111|9968716|P1|Overall Study|Adverse Event|12
2895360|NCT01800968|9968757|P2|Overall Study|Physician Decision|0
2895361|NCT01800968|9968758|P1|Overall Study|Physician Decision|1
2895362|NCT01800968|9968757|P2|Overall Study|Withdrawal by Subject|9
2895363|NCT01800968|9968758|P1|Overall Study|Withdrawal by Subject|7
2895364|NCT01800968|9968757|P2|Overall Study|Lost to Follow-up|7
2895365|NCT01800968|9968758|P1|Overall Study|Lost to Follow-up|5
2895366|NCT01800968|9968757|P2|Overall Study|Death|16
2895367|NCT01800968|9968758|P1|Overall Study|Death|23
2895368|NCT01800916|9968800|P9|Test Period 1 (1 Week)|Adverse Event|0
2895369|NCT01800916|9968801|P8|Test Period 1 (1 Week)|Adverse Event|0
2895370|NCT01800916|9968802|P7|Test Period 1 (1 Week)|Adverse Event|0
2895371|NCT01800916|9968803|P6|Test Period 1 (1 Week)|Adverse Event|0
2895372|NCT01800916|9968804|P5|Test Period 1 (1 Week)|Adverse Event|1
2895373|NCT01800916|9968805|P4|Test Period 1 (1 Week)|Adverse Event|0
2895374|NCT01800916|9968806|P3|Test Period 1 (1 Week)|Adverse Event|0
2895375|NCT01800916|9968807|P2|Test Period 1 (1 Week)|Adverse Event|0
2895376|NCT01800916|9968808|P1|Test Period 1 (1 Week)|Adverse Event|0
2895377|NCT01800916|9968800|P9|Test Period 1 (1 Week)|Convex product user|0
2895378|NCT01800916|9968801|P8|Test Period 1 (1 Week)|Convex product user|0
2895379|NCT01800916|9968802|P7|Test Period 1 (1 Week)|Convex product user|0
2895380|NCT01800916|9968803|P6|Test Period 1 (1 Week)|Convex product user|0
2895381|NCT01800916|9968804|P5|Test Period 1 (1 Week)|Convex product user|0
2895382|NCT01800916|9968805|P4|Test Period 1 (1 Week)|Convex product user|1
2895383|NCT01800916|9968806|P3|Test Period 1 (1 Week)|Convex product user|0
2895384|NCT01800916|9968807|P2|Test Period 1 (1 Week)|Convex product user|0
2895385|NCT01800916|9968808|P1|Test Period 1 (1 Week)|Convex product user|0
2895386|NCT01800903|9968818|P6|Second Test Period|unable to catheterise|0
2895387|NCT01800903|9968819|P5|Second Test Period|unable to catheterise|0
2895388|NCT01800903|9968820|P4|Second Test Period|unable to catheterise|0
2895389|NCT01800903|9968821|P3|Second Test Period|unable to catheterise|0
2895390|NCT01800903|9968822|P2|Second Test Period|unable to catheterise|0
2895391|NCT01800903|9968823|P1|Second Test Period|unable to catheterise|1
2895392|NCT01800201|9968912|P2|Overall Study|PI withdrawal, cognitive concerns|1
2895393|NCT01800201|9968913|P1|Overall Study|PI withdrawal, cognitive concerns|0
2895394|NCT01800201|9968912|P2|Overall Study|did not want to use device|1
2895395|NCT01800201|9968913|P1|Overall Study|did not want to use device|0
2895396|NCT01800201|9968912|P2|Overall Study|patient privacy concerns|1
2895397|NCT01800201|9968913|P1|Overall Study|patient privacy concerns|1
2895398|NCT01800201|9968912|P2|Overall Study|Withdrawal by Subject|0
2895399|NCT01800201|9968913|P1|Overall Study|Withdrawal by Subject|2
2895400|NCT01799993|9968956|P2|Overall Study|Subject didn't return for follow-up|1
2895401|NCT01799993|9968957|P1|Overall Study|Subject didn't return for follow-up|0
2895402|NCT01799993|9968956|P2|Overall Study|Other|0
2895403|NCT01799993|9968957|P1|Overall Study|Other|1
2895404|NCT01799993|9968956|P2|Overall Study|Withdrawal by parent/guardian|1
2895405|NCT01799993|9968957|P1|Overall Study|Withdrawal by parent/guardian|0
2895406|NCT01799993|9968956|P2|Overall Study|Non-compliance with medical device|0
2895407|NCT01799993|9968957|P1|Overall Study|Non-compliance with medical device|1
2895408|NCT01799993|9968956|P2|Overall Study|Protocol deviation|0
2895409|NCT01799993|9968957|P1|Overall Study|Protocol deviation|1
2895410|NCT01799993|9968956|P2|Overall Study|Logistical difficulties|0
2895411|NCT01799993|9968957|P1|Overall Study|Logistical difficulties|1
2895412|NCT01799993|9968956|P2|Overall Study|Recovery|1
2895413|NCT01799993|9968957|P1|Overall Study|Recovery|0
2895414|NCT01799993|9968956|P2|Overall Study|Lack of Efficacy|0
2895415|NCT01799993|9968957|P1|Overall Study|Lack of Efficacy|1
2895416|NCT01799993|9968956|P2|Overall Study|Adverse Event|0
2895417|NCT01799993|9968957|P1|Overall Study|Adverse Event|1
2895418|NCT01799993|9968956|P2|Overall Study|Screen failure|1
2895419|NCT01799993|9968957|P1|Overall Study|Screen failure|0
2895420|NCT01799993|9968956|P2|Overall Study|Deterioration of general conditions|0
2895421|NCT01799993|9968957|P1|Overall Study|Deterioration of general conditions|2
2895422|NCT01799993|9968956|P2|Overall Study|Protocol Violation|1
2895423|NCT01799993|9968957|P1|Overall Study|Protocol Violation|1
2895424|NCT01799993|9968956|P2|Overall Study|Protocol driven decision point|3
2895425|NCT01799993|9968957|P1|Overall Study|Protocol driven decision point|0
2895426|NCT01799993|9968956|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
2895427|NCT01799993|9968957|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
2895428|NCT01799993|9968956|P2|Overall Study|Lost to Follow-up|8
2895429|NCT01799993|9968957|P1|Overall Study|Lost to Follow-up|5
2895430|NCT01799993|9968956|P2|Overall Study|Withdrawal by Subject|24
2895431|NCT01799993|9968957|P1|Overall Study|Withdrawal by Subject|23
2895432|NCT01799993|9968956|P2|Overall Study|Death|45
2895433|NCT01799993|9968957|P1|Overall Study|Death|61
2895434|NCT01799993|9968956|P2|Overall Study|"Didn't complete CRF page End of FU"|40
2895435|NCT01799993|9968957|P1|Overall Study|"Didn't complete CRF page End of FU"|30
2895436|NCT01799941|9968989|P1|Overall Study|Other|15
2895437|NCT01799941|9968989|P1|Overall Study|Lost to Follow-up|17
2895438|NCT01799941|9968989|P1|Overall Study|Lack of Efficacy|3
2895439|NCT01799941|9968989|P1|Overall Study|Investigator Decision|4
2895440|NCT01799941|9968989|P1|Overall Study|Death|2
2895441|NCT01799941|9968989|P1|Overall Study|Withdrawal by Subject|21
2895442|NCT01799941|9968989|P1|Overall Study|Adverse Event|34
2895443|NCT01799720|9969046|P3|Overall Study|Pregnancy|1
2895444|NCT01799720|9969047|P2|Overall Study|Pregnancy|0
2895445|NCT01799720|9969048|P1|Overall Study|Pregnancy|0
2895446|NCT01799720|9969046|P3|Overall Study|Protocol Violation|0
2895447|NCT01799720|9969047|P2|Overall Study|Protocol Violation|1
2895448|NCT01799720|9969048|P1|Overall Study|Protocol Violation|0
2895449|NCT01799720|9969046|P3|Overall Study|Withdrawal by Subject|0
2895450|NCT01799720|9969047|P2|Overall Study|Withdrawal by Subject|0
2895451|NCT01799720|9969048|P1|Overall Study|Withdrawal by Subject|3
2895452|NCT01799590|9969086|P3|Overall Study|Other|1
2895453|NCT01799590|9969087|P2|Overall Study|Other|0
2895454|NCT01799590|9969088|P1|Overall Study|Other|3
2895455|NCT01799590|9969086|P3|Overall Study|Use of prohibited concomitant drugs|0
2895456|NCT01799590|9969087|P2|Overall Study|Use of prohibited concomitant drugs|0
2895457|NCT01799590|9969088|P1|Overall Study|Use of prohibited concomitant drugs|1
2895458|NCT01799590|9969086|P3|Overall Study|Using drugs with restricted days of use|2
2895459|NCT01799590|9969087|P2|Overall Study|Using drugs with restricted days of use|3
2895460|NCT01799590|9969088|P1|Overall Study|Using drugs with restricted days of use|0
2895461|NCT01799590|9969086|P3|Overall Study|Aggravation of complications|1
2895462|NCT01799590|9969087|P2|Overall Study|Aggravation of complications|1
2895463|NCT01799590|9969088|P1|Overall Study|Aggravation of complications|0
2895464|NCT01799590|9969086|P3|Overall Study|Participants convenience|2
2895465|NCT01799590|9969087|P2|Overall Study|Participants convenience|4
2895466|NCT01799590|9969088|P1|Overall Study|Participants convenience|4
2895467|NCT01799590|9969086|P3|Overall Study|Lack of Efficacy|3
2895468|NCT01799590|9969087|P2|Overall Study|Lack of Efficacy|1
2895469|NCT01799590|9969088|P1|Overall Study|Lack of Efficacy|3
2895470|NCT01799590|9969086|P3|Overall Study|Pregnancy|0
2895471|NCT01799590|9969087|P2|Overall Study|Pregnancy|0
2895472|NCT01799590|9969088|P1|Overall Study|Pregnancy|2
2895473|NCT01799590|9969086|P3|Overall Study|Adverse Event|5
2895474|NCT01799590|9969087|P2|Overall Study|Adverse Event|7
2895475|NCT01799590|9969088|P1|Overall Study|Adverse Event|13
2895476|NCT01799239|9969131|P2|Period 2 (7 Days)|Protocol Violation|0
2895477|NCT01799239|9969132|P1|Period 2 (7 Days)|Protocol Violation|1
2895478|NCT01799239|9969131|P2|Period 2 (7 Days)|Withdrawal by Subject|1
2895479|NCT01799239|9969132|P1|Period 2 (7 Days)|Withdrawal by Subject|1
2895480|NCT01799239|9969131|P2|Period 1 (7 Days)|Protocol Violation|1
2895481|NCT01799239|9969132|P1|Period 1 (7 Days)|Protocol Violation|0
2895482|NCT01799239|9969131|P2|Period 1 (7 Days)|Withdrawal by Subject|0
2895483|NCT01799239|9969132|P1|Period 1 (7 Days)|Withdrawal by Subject|2
2895484|NCT01799239|9969131|P2|Period 1 (7 Days)|Lack of Efficacy|0
2895485|NCT01799239|9969132|P1|Period 1 (7 Days)|Lack of Efficacy|1
2895486|NCT01799226|9969140|P2|Overall Study|Disqualified at Day 14|0
2895487|NCT01799226|9969141|P1|Overall Study|Disqualified at Day 14|1
2895488|NCT01799226|9969140|P2|Overall Study|Withdrawal by Subject|0
2895489|NCT01799226|9969141|P1|Overall Study|Withdrawal by Subject|1
2895490|NCT01798992|9969172|P4|Overall Study|Insufficient biopsy tissue|0
2895491|NCT01798992|9969173|P3|Overall Study|Insufficient biopsy tissue|1
2895492|NCT01798992|9969174|P2|Overall Study|Insufficient biopsy tissue|0
2895493|NCT01798992|9969175|P1|Overall Study|Insufficient biopsy tissue|0
2895494|NCT01798992|9969172|P4|Overall Study|Lost to Follow-up|0
2895495|NCT01798992|9969173|P3|Overall Study|Lost to Follow-up|1
2895496|NCT01798992|9969174|P2|Overall Study|Lost to Follow-up|1
2895497|NCT01798992|9969175|P1|Overall Study|Lost to Follow-up|0
2895498|NCT01798992|9969172|P4|Overall Study|Administrative withdrawal|1
2895499|NCT01798992|9969173|P3|Overall Study|Administrative withdrawal|0
2895500|NCT01798992|9969174|P2|Overall Study|Administrative withdrawal|1
2895501|NCT01798992|9969175|P1|Overall Study|Administrative withdrawal|0
2895502|NCT01798927|9969195|P1|Overall Study|Withdrawal by Subject|1
2895503|NCT01798849|9969204|P3|Overall Study|Physician Decision|1
2895504|NCT01798849|9969205|P2|Overall Study|Physician Decision|0
2895505|NCT01798849|9969206|P1|Overall Study|Physician Decision|0
2895506|NCT01798706|9969396|P2|Overall Study|Other than specified above|9
2895507|NCT01798706|9969397|P1|Overall Study|Other than specified above|5
2895508|NCT01798706|9969396|P2|Overall Study|Poor compliance to protocol|0
2895509|NCT01798706|9969397|P1|Overall Study|Poor compliance to protocol|1
2895510|NCT01798706|9969396|P2|Overall Study|Lack of Efficacy|2
2895511|NCT01798706|9969397|P1|Overall Study|Lack of Efficacy|0
2895512|NCT01798706|9969396|P2|Overall Study|Adverse Event|10
2895513|NCT01798706|9969397|P1|Overall Study|Adverse Event|15
2895514|NCT01798485|9969468|P2|Overall Study|Clinical Progression|24
2895515|NCT01798485|9969469|P1|Overall Study|Clinical Progression|35
2895516|NCT01798485|9969468|P2|Overall Study|Sponsor Decision|54
2895517|NCT01798485|9969469|P1|Overall Study|Sponsor Decision|61
2895518|NCT01798485|9969468|P2|Overall Study|Death|22
2895519|NCT01798485|9969469|P1|Overall Study|Death|25
2895520|NCT01798485|9969468|P2|Overall Study|Objective Disease Progression|106
2895521|NCT01798485|9969469|P1|Overall Study|Objective Disease Progression|152
2895522|NCT01798485|9969468|P2|Overall Study|Physician Decision|10
2895523|NCT01798485|9969469|P1|Overall Study|Physician Decision|14
2895524|NCT01798485|9969468|P2|Overall Study|Lost to Follow-up|3
2895525|NCT01798485|9969469|P1|Overall Study|Lost to Follow-up|0
2895526|NCT01798485|9969468|P2|Overall Study|Withdrawal by Subject|31
2895527|NCT01798485|9969469|P1|Overall Study|Withdrawal by Subject|27
2895528|NCT01798485|9969468|P2|Overall Study|Adverse Event|40
2895529|NCT01798485|9969469|P1|Overall Study|Adverse Event|32
2895530|NCT01798134|9969606|P1|Overall Study|Liver transplant/surgery|4
2895531|NCT01798134|9969606|P1|Overall Study|Physician Decision|3
2895532|NCT01798134|9969606|P1|Overall Study|Adverse Event|3
2895533|NCT01798134|9969606|P1|Overall Study|Death|2
2895534|NCT01798134|9969606|P1|Overall Study|Withdrawal by Subject|3
2895535|NCT01798134|9969606|P1|Overall Study|Lost to Follow-up|1
2895536|NCT01798056|9969615|P2|Overall Study|Other|2
2895537|NCT01798056|9969616|P1|Overall Study|Other|0
2895538|NCT01798056|9969615|P2|Overall Study|Lost to Follow-up|1
2895539|NCT01798056|9969616|P1|Overall Study|Lost to Follow-up|1
2895540|NCT01798056|9969615|P2|Overall Study|Migrated/moved from study area|1
2895541|NCT01798056|9969616|P1|Overall Study|Migrated/moved from study area|1
2895542|NCT01798056|9969615|P2|Overall Study|Withdrawal by Subject|9
2895543|NCT01798056|9969616|P1|Overall Study|Withdrawal by Subject|12
2895544|NCT01798056|9969615|P2|Overall Study|Serious Adverse Event|12
2895545|NCT01798056|9969616|P1|Overall Study|Serious Adverse Event|13
2895546|NCT01798004|9969650|P1|Overall Study|Enrollment another COG therapeutic trial|32
2895547|NCT01798004|9969650|P1|Overall Study|Initiation of other non-protocol therapy|5
2895548|NCT01798004|9969650|P1|Overall Study|Patient/parent refusal|7
2895549|NCT01798004|9969650|P1|Overall Study|Ineligible|4
2895550|NCT01798004|9969650|P1|Overall Study|Withdrawal by Subject|4
2895551|NCT01798004|9969650|P1|Overall Study|Physician Decision|25
2895552|NCT01798004|9969650|P1|Overall Study|Lack of Efficacy|8
2895553|NCT01798004|9969650|P1|Overall Study|Death|2
2895554|NCT01797965|9969658|P4|Overall Study|Reason Not Specified|15
2895555|NCT01797965|9969659|P3|Overall Study|Reason Not Specified|0
2895556|NCT01797965|9969660|P2|Overall Study|Reason Not Specified|295
2895557|NCT01797965|9969661|P1|Overall Study|Reason Not Specified|280
2895558|NCT01797965|9969658|P4|Overall Study|Disease progression, defined by protocol|0
2895559|NCT01797965|9969659|P3|Overall Study|Disease progression, defined by protocol|0
2895560|NCT01797965|9969660|P2|Overall Study|Disease progression, defined by protocol|1
2895561|NCT01797965|9969661|P1|Overall Study|Disease progression, defined by protocol|3
2895562|NCT01797965|9969658|P4|Overall Study|Death|0
2895563|NCT01797965|9969659|P3|Overall Study|Death|0
2895564|NCT01797965|9969660|P2|Overall Study|Death|4
2895565|NCT01797965|9969661|P1|Overall Study|Death|2
2895566|NCT01797965|9969658|P4|Overall Study|Investigator decision|0
2895567|NCT01797965|9969659|P3|Overall Study|Investigator decision|0
2895568|NCT01797965|9969660|P2|Overall Study|Investigator decision|15
2895569|NCT01797965|9969661|P1|Overall Study|Investigator decision|21
2895570|NCT01797965|9969658|P4|Overall Study|Consent withdrawn|35
2895571|NCT01797965|9969659|P3|Overall Study|Consent withdrawn|3
2895572|NCT01797965|9969660|P2|Overall Study|Consent withdrawn|117
2895573|NCT01797965|9969661|P1|Overall Study|Consent withdrawn|130
2895574|NCT01797965|9969658|P4|Overall Study|Lost to Follow-up|2
2895575|NCT01797965|9969659|P3|Overall Study|Lost to Follow-up|1
2895576|NCT01797965|9969660|P2|Overall Study|Lost to Follow-up|8
2895577|NCT01797965|9969661|P1|Overall Study|Lost to Follow-up|9
2895578|NCT01797965|9969658|P4|Overall Study|Adverse Event|21
2895579|NCT01797965|9969659|P3|Overall Study|Adverse Event|4
2895580|NCT01797965|9969660|P2|Overall Study|Adverse Event|129
2895581|NCT01797965|9969661|P1|Overall Study|Adverse Event|104
2895582|NCT01797835|9969795|P2|Overall Study|Lost to Follow-up|27
2895583|NCT01797835|9969796|P1|Overall Study|Lost to Follow-up|31
2895584|NCT01797783|9969812|P2|Overall Study|Withdrawal by Subject|0
2895585|NCT01797783|9969813|P1|Overall Study|Withdrawal by Subject|1
2895586|NCT01797783|9969812|P2|Overall Study|Adverse Event|1
2895587|NCT01797783|9969813|P1|Overall Study|Adverse Event|1
2895588|NCT01797731|9969837|P2|Overall Study|Didn't have proper radiographs required|3
2895589|NCT01797731|9969838|P1|Overall Study|Didn't have proper radiographs required|3
2895590|NCT01797705|9969846|P1|Overall Study|Withdrawal by Subject|1
2895591|NCT01797705|9969846|P1|Overall Study|Equipment anomalies during sleep studies|4
2895592|NCT01797536|9969911|P4|Overall Study|Adverse Event|0
2895593|NCT01797536|9969912|P3|Overall Study|Adverse Event|0
2895594|NCT01797536|9969913|P2|Overall Study|Adverse Event|1
2895595|NCT01797536|9969914|P1|Overall Study|Adverse Event|0
2895596|NCT01797445|9969986|P2|Open-Label Extension Phase|Investigator's Discretion|0
2895597|NCT01797445|9969987|P1|Open-Label Extension Phase|Investigator's Discretion|1
2895598|NCT01797445|9969986|P2|Double-Blind Phase|Lost to Follow-up|26
2895599|NCT01797445|9969987|P1|Double-Blind Phase|Lost to Follow-up|34
2895600|NCT01797445|9969986|P2|Double-Blind Phase|Withdrew Consent|35
2895601|NCT01797445|9969987|P1|Double-Blind Phase|Withdrew Consent|20
2895602|NCT01797445|9969986|P2|Double-Blind Phase|Protocol Violation|1
2895603|NCT01797445|9969987|P1|Double-Blind Phase|Protocol Violation|0
2895604|NCT01797445|9969986|P2|Double-Blind Phase|Noncompliance with Study Drug|1
2895605|NCT01797445|9969987|P1|Double-Blind Phase|Noncompliance with Study Drug|5
2895606|NCT01797445|9969986|P2|Double-Blind Phase|Investigator's Discretion|17
2895607|NCT01797445|9969987|P1|Double-Blind Phase|Investigator's Discretion|15
2895608|NCT01797445|9969986|P2|Double-Blind Phase|Lack of Efficacy|2
2895609|NCT01797445|9969987|P1|Double-Blind Phase|Lack of Efficacy|1
2895610|NCT01797445|9969986|P2|Double-Blind Phase|Pregnancy|1
2895611|NCT01797445|9969987|P1|Double-Blind Phase|Pregnancy|0
2895612|NCT01797445|9969986|P2|Double-Blind Phase|Death|4
2895613|NCT01797445|9969987|P1|Double-Blind Phase|Death|5
2895614|NCT01797445|9969986|P2|Double-Blind Phase|Adverse Event|0
2895615|NCT01797445|9969987|P1|Double-Blind Phase|Adverse Event|3
2895616|NCT01797445|9969986|P2|Double-Blind Phase|Randomized but Not Treated|2
2895617|NCT01797445|9969987|P1|Double-Blind Phase|Randomized but Not Treated|4
2895618|NCT01797263|9970047|P2|Overall Study|Lost to Follow-up|15
2895619|NCT01797263|9970048|P1|Overall Study|Lost to Follow-up|15
2895620|NCT01797263|9970047|P2|Overall Study|Death|0
2895621|NCT01797263|9970048|P1|Overall Study|Death|1
2895622|NCT01797263|9970047|P2|Overall Study|Withdrawal by Subject|25
2895623|NCT01797263|9970048|P1|Overall Study|Withdrawal by Subject|21
2895624|NCT01797185|9970083|P3|Overall Study|Protocol Violation|0
2895625|NCT01797185|9970084|P2|Overall Study|Protocol Violation|1
2895626|NCT01797185|9970085|P1|Overall Study|Protocol Violation|1
2895627|NCT01797185|9970083|P3|Overall Study|Physician Decision|0
2895628|NCT01797185|9970084|P2|Overall Study|Physician Decision|3
2895629|NCT01797185|9970085|P1|Overall Study|Physician Decision|1
2895630|NCT01797185|9970083|P3|Overall Study|Withdrawn per sponsor|0
2895631|NCT01797185|9970084|P2|Overall Study|Withdrawn per sponsor|0
2895632|NCT01797185|9970085|P1|Overall Study|Withdrawn per sponsor|5
2895633|NCT01797185|9970083|P3|Overall Study|Lost to Follow-up|1
2895634|NCT01797185|9970084|P2|Overall Study|Lost to Follow-up|6
2895635|NCT01797185|9970085|P1|Overall Study|Lost to Follow-up|2
2895636|NCT01797185|9970083|P3|Overall Study|Site terminated|0
2895637|NCT01797185|9970084|P2|Overall Study|Site terminated|4
2895638|NCT01797185|9970085|P1|Overall Study|Site terminated|8
2895639|NCT01797185|9970083|P3|Overall Study|Withdrawal by Subject|5
2895640|NCT01797185|9970084|P2|Overall Study|Withdrawal by Subject|9
2895641|NCT01797185|9970085|P1|Overall Study|Withdrawal by Subject|6
2895642|NCT01797185|9970083|P3|Overall Study|Adverse Event|6
2895643|NCT01797185|9970084|P2|Overall Study|Adverse Event|15
2895644|NCT01797185|9970085|P1|Overall Study|Adverse Event|5
2895645|NCT01797120|9970095|P2|Overall Study|never start protocol therapy|0
2895646|NCT01797120|9970096|P1|Overall Study|never start protocol therapy|2
2895647|NCT01797120|9970095|P2|Overall Study|still on treatment|4
2895648|NCT01797120|9970096|P1|Overall Study|still on treatment|2
2895649|NCT01797120|9970095|P2|Overall Study|Physician Decision|0
2895650|NCT01797120|9970096|P1|Overall Study|Physician Decision|3
2895651|NCT01797120|9970095|P2|Overall Study|Non-compliance|0
2895652|NCT01797120|9970096|P1|Overall Study|Non-compliance|1
2895653|NCT01797120|9970095|P2|Overall Study|Symptomatic progression|1
2895654|NCT01797120|9970096|P1|Overall Study|Symptomatic progression|2
2895655|NCT01797120|9970095|P2|Overall Study|Withdrawal by Subject|6
2895656|NCT01797120|9970096|P1|Overall Study|Withdrawal by Subject|6
2895657|NCT01797120|9970095|P2|Overall Study|Adverse Event|5
2895658|NCT01797120|9970096|P1|Overall Study|Adverse Event|13
2895659|NCT01797120|9970095|P2|Overall Study|Disesae progression|49
2895660|NCT01797120|9970096|P1|Overall Study|Disesae progression|37
2895661|NCT01797094|9970110|P2|Overall Study|Other Miscellaneous Reasons|0
2895662|NCT01797094|9970111|P1|Overall Study|Other Miscellaneous Reasons|1
2895663|NCT01797094|9970110|P2|Overall Study|Protocol Violation|1
2895664|NCT01797094|9970111|P1|Overall Study|Protocol Violation|0
2895665|NCT01797094|9970110|P2|Overall Study|Personal Reasons|0
2895666|NCT01797094|9970111|P1|Overall Study|Personal Reasons|4
2895667|NCT01797094|9970110|P2|Overall Study|Adverse Event|1
2895668|NCT01797094|9970111|P1|Overall Study|Adverse Event|1
2895669|NCT01797081|9970133|P4|Overall Study|Protocol Violation|1
2895670|NCT01797081|9970134|P3|Overall Study|Protocol Violation|0
2895671|NCT01797081|9970135|P2|Overall Study|Protocol Violation|0
2895672|NCT01797081|9970136|P1|Overall Study|Protocol Violation|0
2895673|NCT01797081|9970133|P4|Overall Study|Personal Reasons|8
2895674|NCT01797081|9970134|P3|Overall Study|Personal Reasons|4
2895675|NCT01797081|9970135|P2|Overall Study|Personal Reasons|4
2895676|NCT01797081|9970136|P1|Overall Study|Personal Reasons|12
2895677|NCT01797081|9970133|P4|Overall Study|Pregnancy|0
2895678|NCT01797081|9970134|P3|Overall Study|Pregnancy|0
2895679|NCT01797081|9970135|P2|Overall Study|Pregnancy|0
2895680|NCT01797081|9970136|P1|Overall Study|Pregnancy|1
2895681|NCT01797081|9970133|P4|Overall Study|Adverse Event|0
2895682|NCT01797081|9970134|P3|Overall Study|Adverse Event|1
2895683|NCT01797081|9970135|P2|Overall Study|Adverse Event|0
2895684|NCT01797081|9970136|P1|Overall Study|Adverse Event|1
2895685|NCT01796964|9970177|P2|Overall Study|Withdrawal by Subject|1
2895686|NCT01796964|9970178|P1|Overall Study|Withdrawal by Subject|1
2895687|NCT01796964|9970177|P2|Overall Study|Protocol Violation|1
2895688|NCT01796964|9970178|P1|Overall Study|Protocol Violation|0
2895689|NCT01796964|9970177|P2|Overall Study|Death|0
2895690|NCT01796964|9970178|P1|Overall Study|Death|1
2895691|NCT01796964|9970177|P2|Overall Study|Adverse Event|1
2895692|NCT01796964|9970178|P1|Overall Study|Adverse Event|1
2895693|NCT01796860|9970219|P1|Overall Study|Withdrawal by Subject|3
2895694|NCT01796548|9970225|P1|Overall Study|Other|2
2895695|NCT01796548|9970225|P1|Overall Study|Lost to Follow-up|1
2895696|NCT01796392|9970239|P2|Overall Study|Lost to Follow-up|0
2895697|NCT01796392|9970240|P1|Overall Study|Lost to Follow-up|1
2895698|NCT01796392|9970239|P2|Overall Study|Excluded for medical reasons|2
2895699|NCT01796392|9970240|P1|Overall Study|Excluded for medical reasons|1
2895700|NCT01796392|9970239|P2|Overall Study|Death|1
2895701|NCT01796392|9970240|P1|Overall Study|Death|5
2895702|NCT01796392|9970239|P2|Overall Study|Withdrawal by Subject|0
2895703|NCT01796392|9970240|P1|Overall Study|Withdrawal by Subject|2
2895704|NCT01796301|9970254|P2|Overall Study|Decision by Sponsor|1
2895705|NCT01796301|9970255|P1|Overall Study|Decision by Sponsor|0
2895706|NCT01796301|9970254|P2|Overall Study|Death|1
2895707|NCT01796301|9970255|P1|Overall Study|Death|0
2895708|NCT01796301|9970254|P2|Overall Study|Lost to Follow-up|3
2895709|NCT01796301|9970255|P1|Overall Study|Lost to Follow-up|3
2895710|NCT01796301|9970254|P2|Overall Study|Withdrawal by Subject|15
2895711|NCT01796301|9970255|P1|Overall Study|Withdrawal by Subject|15
2895712|NCT01795937|9970341|P3|Overall Study|Physician Decision|0
2895713|NCT01795937|9970342|P2|Overall Study|Physician Decision|1
2895714|NCT01795937|9970343|P1|Overall Study|Physician Decision|0
2895715|NCT01795937|9970341|P3|Overall Study|Withdrawal by Subject|0
2895716|NCT01795937|9970342|P2|Overall Study|Withdrawal by Subject|0
2895717|NCT01795937|9970343|P1|Overall Study|Withdrawal by Subject|1
2895718|NCT01795898|9970372|P1|Overall Study|Physician Decision|1
2895719|NCT01795898|9970372|P1|Overall Study|Withdrew consent & had adverse events|3
2895720|NCT01795898|9970372|P1|Overall Study|Death|1
2895721|NCT01795898|9970372|P1|Overall Study|No pain|1
2895722|NCT01795898|9970372|P1|Overall Study|Diagnosed with metastasis|1
2895723|NCT01795898|9970372|P1|Overall Study|Withdrawal of consent|6
2895724|NCT01795898|9970372|P1|Overall Study|Lost to Follow-up|20
2895725|NCT01795898|9970372|P1|Overall Study|Adverse Event|27
2895726|NCT01795547|9970431|P2|Overall Study|Not stated|1
2895727|NCT01795547|9970432|P1|Overall Study|Not stated|0
2895728|NCT01795547|9970431|P2|Overall Study|Others|1
2895729|NCT01795547|9970432|P1|Overall Study|Others|4
2895730|NCT01795547|9970431|P2|Overall Study|Non-compliance with IMP|1
2895731|NCT01795547|9970432|P1|Overall Study|Non-compliance with IMP|1
2895732|NCT01795547|9970431|P2|Overall Study|Not Treated|10
2895733|NCT01795547|9970432|P1|Overall Study|Not Treated|4
2895734|NCT01795547|9970431|P2|Overall Study|Withdrawal of consent|12
2895735|NCT01795547|9970432|P1|Overall Study|Withdrawal of consent|7
2895736|NCT01795547|9970431|P2|Overall Study|Lost to Follow-up|5
2895737|NCT01795547|9970432|P1|Overall Study|Lost to Follow-up|2
2895738|NCT01795547|9970431|P2|Overall Study|Protocol Violation|4
2895739|NCT01795547|9970432|P1|Overall Study|Protocol Violation|6
2895740|NCT01795547|9970431|P2|Overall Study|Lack of Efficacy|3
2895741|NCT01795547|9970432|P1|Overall Study|Lack of Efficacy|8
2895742|NCT01795547|9970431|P2|Overall Study|Adverse Event|27
2895743|NCT01795547|9970432|P1|Overall Study|Adverse Event|16
2895744|NCT01795495|9970464|P3|Overall Study|Physician Decision|1
2895745|NCT01795495|9970465|P2|Overall Study|Physician Decision|0
2895746|NCT01795495|9970466|P1|Overall Study|Physician Decision|0
2895747|NCT01795495|9970464|P3|Overall Study|Protocol Violation|1
2895748|NCT01795495|9970465|P2|Overall Study|Protocol Violation|0
2895749|NCT01795495|9970466|P1|Overall Study|Protocol Violation|1
2895750|NCT01794949|9970486|P2|Overall Study|Lost to Follow-up|0
2895751|NCT01794949|9970487|P1|Overall Study|Lost to Follow-up|1
2895752|NCT01794845|9970498|P1|Overall Study|Withdrawal by Subject|1
2895753|NCT01794780|9970526|P8|Overall Study|Other|1
2895754|NCT01794780|9970527|P7|Overall Study|Other|4
2895755|NCT01794780|9970528|P6|Overall Study|Other|24
2895756|NCT01794780|9970529|P5|Overall Study|Other|1
2895757|NCT01794780|9970530|P4|Overall Study|Other|20
2895758|NCT01794780|9970531|P3|Overall Study|Other|25
2895759|NCT01794780|9970532|P2|Overall Study|Other|12
2895760|NCT01794780|9970533|P1|Overall Study|Other|0
2895761|NCT01794780|9970526|P8|Overall Study|Withdrew informed consent|3
2895762|NCT01794780|9970527|P7|Overall Study|Withdrew informed consent|4
2895763|NCT01794780|9970528|P6|Overall Study|Withdrew informed consent|48
2895764|NCT01794780|9970529|P5|Overall Study|Withdrew informed consent|0
2895765|NCT01794780|9970530|P4|Overall Study|Withdrew informed consent|9
2895766|NCT01794780|9970531|P3|Overall Study|Withdrew informed consent|36
2895767|NCT01794780|9970532|P2|Overall Study|Withdrew informed consent|17
2895768|NCT01794780|9970533|P1|Overall Study|Withdrew informed consent|7
2895769|NCT01794780|9970526|P8|Overall Study|Lost to Follow-up|5
2895770|NCT01794780|9970527|P7|Overall Study|Lost to Follow-up|30
2895771|NCT01794780|9970528|P6|Overall Study|Lost to Follow-up|99
2895772|NCT01794780|9970529|P5|Overall Study|Lost to Follow-up|2
2895773|NCT01794780|9970530|P4|Overall Study|Lost to Follow-up|53
2895774|NCT01794780|9970531|P3|Overall Study|Lost to Follow-up|165
2895775|NCT01794780|9970532|P2|Overall Study|Lost to Follow-up|64
2895776|NCT01794780|9970533|P1|Overall Study|Lost to Follow-up|10
2895777|NCT01794780|9970526|P8|Overall Study|Death|0
2895778|NCT01794780|9970527|P7|Overall Study|Death|4
2895779|NCT01794780|9970528|P6|Overall Study|Death|9
2895780|NCT01794780|9970529|P5|Overall Study|Death|0
2895781|NCT01794780|9970530|P4|Overall Study|Death|1
2895782|NCT01794780|9970531|P3|Overall Study|Death|14
2895783|NCT01794780|9970532|P2|Overall Study|Death|2
2895784|NCT01794780|9970533|P1|Overall Study|Death|0
2895785|NCT01794780|9970526|P8|Overall Study|Adverse Event|0
2895786|NCT01794780|9970527|P7|Overall Study|Adverse Event|0
2895787|NCT01794780|9970528|P6|Overall Study|Adverse Event|0
2895788|NCT01794780|9970529|P5|Overall Study|Adverse Event|0
2895789|NCT01794780|9970530|P4|Overall Study|Adverse Event|0
2895790|NCT01794780|9970531|P3|Overall Study|Adverse Event|2
2895791|NCT01794780|9970532|P2|Overall Study|Adverse Event|1
2895792|NCT01794780|9970533|P1|Overall Study|Adverse Event|0
2895793|NCT01794689|9970609|P4|Intervention 1 (2 Nights)|Adverse Event|0
2895794|NCT01794689|9970610|P3|Intervention 1 (2 Nights)|Adverse Event|0
2895795|NCT01794689|9970611|P2|Intervention 1 (2 Nights)|Adverse Event|1
2895796|NCT01794689|9970612|P1|Intervention 1 (2 Nights)|Adverse Event|0
2895797|NCT01794689|9970609|P4|Intervention 1 (2 Nights)|Physician Decision|0
2895798|NCT01794689|9970610|P3|Intervention 1 (2 Nights)|Physician Decision|0
2895799|NCT01794689|9970611|P2|Intervention 1 (2 Nights)|Physician Decision|1
2895800|NCT01794689|9970612|P1|Intervention 1 (2 Nights)|Physician Decision|1
2895801|NCT01794689|9970609|P4|Intervention 1 (2 Nights)|Protocol Violation|0
2895802|NCT01794689|9970610|P3|Intervention 1 (2 Nights)|Protocol Violation|1
2895803|NCT01794689|9970611|P2|Intervention 1 (2 Nights)|Protocol Violation|0
2895804|NCT01794689|9970612|P1|Intervention 1 (2 Nights)|Protocol Violation|1
2895805|NCT01794689|9970609|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
2895806|NCT01794689|9970610|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
2895807|NCT01794689|9970611|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
2895808|NCT01794689|9970612|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
2895809|NCT01794000|9970681|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2895810|NCT01794000|9970682|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
2895811|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
2895812|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
2895813|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
2895814|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
2895815|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Physician Decision|0
2895816|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Physician Decision|2
2895817|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
2895818|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
2895819|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
2895820|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
2895821|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Death|2
2895822|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Death|1
2895823|NCT01794000|9970681|P2|Double-Blind Phase (DBP)|Adverse Event|2
2895824|NCT01794000|9970682|P1|Double-Blind Phase (DBP)|Adverse Event|5
2895825|NCT01793935|9970715|P2|Overall Study|Lost to Follow-up|1
2895826|NCT01793935|9970716|P1|Overall Study|Lost to Follow-up|0
2895827|NCT01793935|9970715|P2|Overall Study|Patient did not take study medication|1
2895828|NCT01793935|9970716|P1|Overall Study|Patient did not take study medication|1
2895829|NCT01793935|9970715|P2|Overall Study|Adverse Event|0
2895830|NCT01793935|9970716|P1|Overall Study|Adverse Event|2
2895831|NCT01793935|9970715|P2|Overall Study|Protocol Violation|1
2895832|NCT01793935|9970716|P1|Overall Study|Protocol Violation|2
2895833|NCT01793935|9970715|P2|Overall Study|Pregnancy|0
2895834|NCT01793935|9970716|P1|Overall Study|Pregnancy|1
2895835|NCT01793883|9970762|P3|Overall Study|Respiratory distress during spirometry|1
2895836|NCT01793883|9970763|P2|Overall Study|Respiratory distress during spirometry|0
2895837|NCT01793883|9970764|P1|Overall Study|Respiratory distress during spirometry|0
2895838|NCT01793883|9970762|P3|Overall Study|Dosing error|0
2895839|NCT01793883|9970763|P2|Overall Study|Dosing error|1
2895840|NCT01793883|9970764|P1|Overall Study|Dosing error|0
2895841|NCT01793883|9970762|P3|Overall Study|Met exclusion criteria|0
2895842|NCT01793883|9970763|P2|Overall Study|Met exclusion criteria|0
2895843|NCT01793883|9970764|P1|Overall Study|Met exclusion criteria|1
2895844|NCT01793883|9970762|P3|Overall Study|Unable to complete measurements|0
2895845|NCT01793883|9970763|P2|Overall Study|Unable to complete measurements|0
2895846|NCT01793883|9970764|P1|Overall Study|Unable to complete measurements|1
2895847|NCT01793883|9970762|P3|Overall Study|Unable to complete spriometry|0
2895848|NCT01793883|9970763|P2|Overall Study|Unable to complete spriometry|0
2895849|NCT01793883|9970764|P1|Overall Study|Unable to complete spriometry|1
2895850|NCT01793883|9970762|P3|Overall Study|Randomized in error|0
2895851|NCT01793883|9970763|P2|Overall Study|Randomized in error|0
2895852|NCT01793883|9970764|P1|Overall Study|Randomized in error|1
2895853|NCT01793883|9970762|P3|Overall Study|Lost to Follow-up|3
2895854|NCT01793883|9970763|P2|Overall Study|Lost to Follow-up|1
2895855|NCT01793883|9970764|P1|Overall Study|Lost to Follow-up|5
2895856|NCT01793883|9970762|P3|Overall Study|Subject noncompliance|1
2895857|NCT01793883|9970763|P2|Overall Study|Subject noncompliance|1
2895858|NCT01793883|9970764|P1|Overall Study|Subject noncompliance|0
2895859|NCT01793883|9970762|P3|Overall Study|Withdrawal by Subject|3
2895860|NCT01793883|9970763|P2|Overall Study|Withdrawal by Subject|7
2895861|NCT01793883|9970764|P1|Overall Study|Withdrawal by Subject|3
2895862|NCT01793792|9970772|P1|Overall Study|Device Not Implanted|1
2895863|NCT01793792|9970772|P1|Overall Study|Withdrawal by Subject|1
2895864|NCT01793792|9970772|P1|Overall Study|Lost to Follow-up|5
2895865|NCT01793792|9970772|P1|Overall Study|Death|5
2895866|NCT01793688|9970777|P1|Overall Study|Protocol Violation|2
2895867|NCT01793142|9970804|P1|Overall Study|Randomized not treated|7
2895868|NCT01792830|9970834|P11|Overall Study|Adverse Event|0
2895869|NCT01792830|9970835|P10|Overall Study|Adverse Event|0
2895870|NCT01792830|9970836|P9|Overall Study|Adverse Event|1
2895871|NCT01792830|9970837|P8|Overall Study|Adverse Event|0
2895872|NCT01792830|9970838|P7|Overall Study|Adverse Event|0
2895873|NCT01792830|9970839|P6|Overall Study|Adverse Event|0
2895874|NCT01792830|9970840|P5|Overall Study|Adverse Event|0
2895875|NCT01792830|9970841|P4|Overall Study|Adverse Event|0
2895876|NCT01792830|9970842|P3|Overall Study|Adverse Event|0
2895877|NCT01792830|9970843|P2|Overall Study|Adverse Event|0
2895878|NCT01792830|9970844|P1|Overall Study|Adverse Event|0
2895879|NCT01792830|9970834|P11|Overall Study|Death|1
2895880|NCT01792830|9970835|P10|Overall Study|Death|0
2895881|NCT01792830|9970836|P9|Overall Study|Death|1
2895882|NCT01792830|9970837|P8|Overall Study|Death|0
2895883|NCT01792830|9970838|P7|Overall Study|Death|1
2895884|NCT01792830|9970839|P6|Overall Study|Death|0
2895885|NCT01792830|9970840|P5|Overall Study|Death|0
2895886|NCT01792830|9970841|P4|Overall Study|Death|1
2895887|NCT01792830|9970842|P3|Overall Study|Death|0
2895888|NCT01792830|9970843|P2|Overall Study|Death|0
2895889|NCT01792830|9970844|P1|Overall Study|Death|3
2895890|NCT01792830|9970834|P11|Overall Study|Withdrawal by Subject|2
2895891|NCT01792830|9970835|P10|Overall Study|Withdrawal by Subject|0
2895892|NCT01792830|9970836|P9|Overall Study|Withdrawal by Subject|7
2895893|NCT01792830|9970837|P8|Overall Study|Withdrawal by Subject|1
2895894|NCT01792830|9970838|P7|Overall Study|Withdrawal by Subject|1
2895895|NCT01792830|9970839|P6|Overall Study|Withdrawal by Subject|1
2895896|NCT01792830|9970840|P5|Overall Study|Withdrawal by Subject|1
2895897|NCT01792830|9970841|P4|Overall Study|Withdrawal by Subject|2
2895898|NCT01792830|9970842|P3|Overall Study|Withdrawal by Subject|0
2895899|NCT01792830|9970843|P2|Overall Study|Withdrawal by Subject|0
2895900|NCT01792830|9970844|P1|Overall Study|Withdrawal by Subject|22
2895901|NCT01792635|9970931|P3|Part B|Study terminated|3
2895902|NCT01792635|9970932|P2|Part B|Study terminated|4
2895903|NCT01792635|9970933|P1|Part B|Study terminated|0
2895904|NCT01792635|9970931|P3|Part B|Adverse Event|1
2895905|NCT01792635|9970932|P2|Part B|Adverse Event|0
2895906|NCT01792635|9970933|P1|Part B|Adverse Event|0
2895907|NCT01792518|9970961|P2|Overall Study|Other Reason|1
2895908|NCT01792518|9970962|P1|Overall Study|Other Reason|0
2895909|NCT01792518|9970961|P2|Overall Study|Withdrawal by Subject|0
2895910|NCT01792518|9970962|P1|Overall Study|Withdrawal by Subject|2
2895911|NCT01792518|9970961|P2|Overall Study|Lost to Follow-up|1
2895912|NCT01792518|9970962|P1|Overall Study|Lost to Follow-up|3
2895913|NCT01792518|9970961|P2|Overall Study|Protocol Violation|1
2895914|NCT01792518|9970962|P1|Overall Study|Protocol Violation|0
2895915|NCT01792518|9970961|P2|Overall Study|Adverse Event|4
2895916|NCT01792518|9970962|P1|Overall Study|Adverse Event|3
2895917|NCT01792284|9970972|P3|Randomization Period 2|Withdrawal by Subject|0
2895918|NCT01792284|9970973|P2|Randomization Period 2|Withdrawal by Subject|2
2895919|NCT01792284|9970974|P1|Randomization Period 2|Withdrawal by Subject|0
2895920|NCT01792284|9970972|P3|Randomization Period 2|Protocol Violation|0
2895921|NCT01792284|9970973|P2|Randomization Period 2|Protocol Violation|1
2895922|NCT01792284|9970974|P1|Randomization Period 2|Protocol Violation|0
2895923|NCT01792284|9970972|P3|Randomization Period 1|Lost to Follow-up|1
2895924|NCT01792284|9970973|P2|Randomization Period 1|Lost to Follow-up|0
2895925|NCT01792284|9970974|P1|Randomization Period 1|Lost to Follow-up|0
2895926|NCT01792284|9970972|P3|Randomization Period 1|Adverse Event|2
2895927|NCT01792284|9970973|P2|Randomization Period 1|Adverse Event|0
2895928|NCT01792284|9970974|P1|Randomization Period 1|Adverse Event|0
2895929|NCT01792284|9970972|P3|Randomization Period 1|Physician Decision|1
2895930|NCT01792284|9970973|P2|Randomization Period 1|Physician Decision|1
2895931|NCT01792284|9970974|P1|Randomization Period 1|Physician Decision|0
2895932|NCT01792284|9970972|P3|Randomization Period 1|Withdrawal by Subject|1
2895933|NCT01792284|9970973|P2|Randomization Period 1|Withdrawal by Subject|1
2895934|NCT01792284|9970974|P1|Randomization Period 1|Withdrawal by Subject|0
2895935|NCT01792284|9970972|P3|Lead-in Period|Protocol Required Discontinuation|0
2895936|NCT01792284|9970973|P2|Lead-in Period|Protocol Required Discontinuation|0
2895937|NCT01792284|9970974|P1|Lead-in Period|Protocol Required Discontinuation|1
2895938|NCT01792284|9970972|P3|Lead-in Period|Physician Decision|0
2895939|NCT01792284|9970973|P2|Lead-in Period|Physician Decision|0
2895940|NCT01792284|9970974|P1|Lead-in Period|Physician Decision|1
2895941|NCT01792284|9970972|P3|Lead-in Period|Withdrawal by Subject|0
2895942|NCT01792284|9970973|P2|Lead-in Period|Withdrawal by Subject|0
2895943|NCT01792284|9970974|P1|Lead-in Period|Withdrawal by Subject|10
2895944|NCT01792284|9970972|P3|Lead-in Period|Protocol Violation|0
2895945|NCT01792284|9970973|P2|Lead-in Period|Protocol Violation|0
2895946|NCT01792284|9970974|P1|Lead-in Period|Protocol Violation|1
2895947|NCT01792284|9970972|P3|Lead-in Period|Lost to Follow-up|0
2895948|NCT01792284|9970973|P2|Lead-in Period|Lost to Follow-up|0
2895949|NCT01792284|9970974|P1|Lead-in Period|Lost to Follow-up|2
2895950|NCT01792284|9970972|P3|Lead-in Period|Adverse Event|0
2895951|NCT01792284|9970973|P2|Lead-in Period|Adverse Event|0
2895952|NCT01792284|9970974|P1|Lead-in Period|Adverse Event|15
2895953|NCT01791894|9971033|P1|Overall Study|Adverse Event|1
2895954|NCT01791803|9971044|P4|Overall Study|Death|2
2895955|NCT01791803|9971045|P3|Overall Study|Death|2
2895956|NCT01791803|9971046|P2|Overall Study|Death|0
2895957|NCT01791803|9971047|P1|Overall Study|Death|0
2895958|NCT01791803|9971044|P4|Overall Study|Physician Decision|1
2895959|NCT01791803|9971045|P3|Overall Study|Physician Decision|0
2895960|NCT01791803|9971046|P2|Overall Study|Physician Decision|2
2895961|NCT01791803|9971047|P1|Overall Study|Physician Decision|0
2895962|NCT01791803|9971044|P4|Overall Study|Withdrawal by Subject|2
2895963|NCT01791803|9971045|P3|Overall Study|Withdrawal by Subject|0
2895964|NCT01791803|9971046|P2|Overall Study|Withdrawal by Subject|0
2895965|NCT01791803|9971047|P1|Overall Study|Withdrawal by Subject|0
2895966|NCT01791725|9971065|P3|Overall Study|Withdrawal by Subject|0
2895967|NCT01791725|9971066|P2|Overall Study|Withdrawal by Subject|1
2895968|NCT01791725|9971067|P1|Overall Study|Withdrawal by Subject|0
2895969|NCT01791517|9971090|P12|Phase II|Pre-Existing Ocular Issue|1
2895970|NCT01791517|9971091|P11|Phase II|Pre-Existing Ocular Issue|0
2895971|NCT01791517|9971092|P10|Phase II|Pre-Existing Ocular Issue|0
2895972|NCT01791517|9971093|P9|Phase II|Pre-Existing Ocular Issue|0
2895973|NCT01791517|9971094|P8|Phase II|Pre-Existing Ocular Issue|0
2895974|NCT01791517|9971095|P7|Phase II|Pre-Existing Ocular Issue|0
2895975|NCT01791517|9971096|P6|Phase II|Pre-Existing Ocular Issue|0
2895976|NCT01791517|9971097|P5|Phase II|Pre-Existing Ocular Issue|0
2895977|NCT01791517|9971098|P4|Phase II|Pre-Existing Ocular Issue|0
2895978|NCT01791517|9971099|P3|Phase II|Pre-Existing Ocular Issue|0
2895979|NCT01791517|9971100|P2|Phase II|Pre-Existing Ocular Issue|0
2895980|NCT01791517|9971101|P1|Phase II|Pre-Existing Ocular Issue|0
2895981|NCT01791517|9971090|P12|Phase II|Unsatisfactory Lens Fitting|0
2895982|NCT01791517|9971091|P11|Phase II|Unsatisfactory Lens Fitting|0
2895983|NCT01791517|9971092|P10|Phase II|Unsatisfactory Lens Fitting|1
2895984|NCT01791517|9971093|P9|Phase II|Unsatisfactory Lens Fitting|0
2895985|NCT01791517|9971094|P8|Phase II|Unsatisfactory Lens Fitting|0
2895986|NCT01791517|9971095|P7|Phase II|Unsatisfactory Lens Fitting|0
2895987|NCT01791517|9971096|P6|Phase II|Unsatisfactory Lens Fitting|0
2895988|NCT01791517|9971097|P5|Phase II|Unsatisfactory Lens Fitting|0
2895989|NCT01791517|9971098|P4|Phase II|Unsatisfactory Lens Fitting|0
2895990|NCT01791517|9971099|P3|Phase II|Unsatisfactory Lens Fitting|0
2895991|NCT01791517|9971100|P2|Phase II|Unsatisfactory Lens Fitting|0
2895992|NCT01791517|9971101|P1|Phase II|Unsatisfactory Lens Fitting|0
2895993|NCT01791517|9971090|P12|Phase II|Lens Handling Difficulties|0
2895994|NCT01791517|9971091|P11|Phase II|Lens Handling Difficulties|0
2895995|NCT01791517|9971092|P10|Phase II|Lens Handling Difficulties|0
2895996|NCT01791517|9971093|P9|Phase II|Lens Handling Difficulties|1
2895997|NCT01791517|9971094|P8|Phase II|Lens Handling Difficulties|0
2895998|NCT01791517|9971095|P7|Phase II|Lens Handling Difficulties|0
2895999|NCT01791517|9971096|P6|Phase II|Lens Handling Difficulties|0
2896000|NCT01791517|9971097|P5|Phase II|Lens Handling Difficulties|0
2896001|NCT01791517|9971098|P4|Phase II|Lens Handling Difficulties|0
2896002|NCT01791517|9971099|P3|Phase II|Lens Handling Difficulties|0
2896003|NCT01791517|9971100|P2|Phase II|Lens Handling Difficulties|0
2896004|NCT01791517|9971101|P1|Phase II|Lens Handling Difficulties|0
2896005|NCT01791517|9971090|P12|Phase II|Adverse Event|0
2896006|NCT01791517|9971091|P11|Phase II|Adverse Event|0
2896007|NCT01791517|9971092|P10|Phase II|Adverse Event|1
2896008|NCT01791517|9971093|P9|Phase II|Adverse Event|0
2896009|NCT01791517|9971094|P8|Phase II|Adverse Event|1
2896010|NCT01791517|9971095|P7|Phase II|Adverse Event|2
2896011|NCT01791517|9971096|P6|Phase II|Adverse Event|0
2896012|NCT01791517|9971097|P5|Phase II|Adverse Event|0
2896013|NCT01791517|9971098|P4|Phase II|Adverse Event|0
2896014|NCT01791517|9971099|P3|Phase II|Adverse Event|0
2896015|NCT01791517|9971100|P2|Phase II|Adverse Event|0
2896016|NCT01791517|9971101|P1|Phase II|Adverse Event|0
2896017|NCT01791517|9971090|P12|Phase II|Lack of Efficacy|0
2896018|NCT01791517|9971091|P11|Phase II|Lack of Efficacy|0
2896019|NCT01791517|9971092|P10|Phase II|Lack of Efficacy|0
2896020|NCT01791517|9971093|P9|Phase II|Lack of Efficacy|0
2896021|NCT01791517|9971094|P8|Phase II|Lack of Efficacy|0
2896022|NCT01791517|9971095|P7|Phase II|Lack of Efficacy|0
2896023|NCT01791517|9971096|P6|Phase II|Lack of Efficacy|0
2896024|NCT01791517|9971097|P5|Phase II|Lack of Efficacy|1
2896025|NCT01791517|9971098|P4|Phase II|Lack of Efficacy|0
2896026|NCT01791517|9971099|P3|Phase II|Lack of Efficacy|0
2896027|NCT01791517|9971100|P2|Phase II|Lack of Efficacy|0
2896028|NCT01791517|9971101|P1|Phase II|Lack of Efficacy|0
2896029|NCT01791517|9971090|P12|Phase II|Withdrawal by Subject|0
2896030|NCT01791517|9971091|P11|Phase II|Withdrawal by Subject|1
2896031|NCT01791517|9971092|P10|Phase II|Withdrawal by Subject|0
2896032|NCT01791517|9971093|P9|Phase II|Withdrawal by Subject|0
2896033|NCT01791517|9971094|P8|Phase II|Withdrawal by Subject|1
2896034|NCT01791517|9971095|P7|Phase II|Withdrawal by Subject|0
2896035|NCT01791517|9971096|P6|Phase II|Withdrawal by Subject|2
2896036|NCT01791517|9971097|P5|Phase II|Withdrawal by Subject|0
2896037|NCT01791517|9971098|P4|Phase II|Withdrawal by Subject|0
2896038|NCT01791517|9971099|P3|Phase II|Withdrawal by Subject|0
2896039|NCT01791517|9971100|P2|Phase II|Withdrawal by Subject|0
2896040|NCT01791517|9971101|P1|Phase II|Withdrawal by Subject|1
2896041|NCT01791517|9971090|P12|Phase II|Lost to Follow-up|0
2896042|NCT01791517|9971091|P11|Phase II|Lost to Follow-up|0
2896043|NCT01791517|9971092|P10|Phase II|Lost to Follow-up|1
2896044|NCT01791517|9971093|P9|Phase II|Lost to Follow-up|1
2896045|NCT01791517|9971094|P8|Phase II|Lost to Follow-up|1
2896046|NCT01791517|9971095|P7|Phase II|Lost to Follow-up|0
2896047|NCT01791517|9971096|P6|Phase II|Lost to Follow-up|2
2896048|NCT01791517|9971097|P5|Phase II|Lost to Follow-up|1
2896049|NCT01791517|9971098|P4|Phase II|Lost to Follow-up|0
2896050|NCT01791517|9971099|P3|Phase II|Lost to Follow-up|1
2896051|NCT01791517|9971100|P2|Phase II|Lost to Follow-up|0
2896052|NCT01791517|9971101|P1|Phase II|Lost to Follow-up|1
2896053|NCT01791517|9971090|P12|Phase I: Period 3|Adverse Event|0
2896054|NCT01791517|9971091|P11|Phase I: Period 3|Adverse Event|0
2896055|NCT01791517|9971092|P10|Phase I: Period 3|Adverse Event|0
2896056|NCT01791517|9971093|P9|Phase I: Period 3|Adverse Event|0
2896057|NCT01791517|9971094|P8|Phase I: Period 3|Adverse Event|0
2896058|NCT01791517|9971095|P7|Phase I: Period 3|Adverse Event|0
2896059|NCT01791517|9971096|P6|Phase I: Period 3|Adverse Event|0
2896060|NCT01791517|9971097|P5|Phase I: Period 3|Adverse Event|0
2896061|NCT01791517|9971098|P4|Phase I: Period 3|Adverse Event|1
2896062|NCT01791517|9971099|P3|Phase I: Period 3|Adverse Event|0
2896063|NCT01791517|9971100|P2|Phase I: Period 3|Adverse Event|0
2896064|NCT01791517|9971101|P1|Phase I: Period 3|Adverse Event|0
2896065|NCT01791517|9971090|P12|Phase I: Period 3|Lost to Follow-up|0
2896066|NCT01791517|9971091|P11|Phase I: Period 3|Lost to Follow-up|0
2896067|NCT01791517|9971092|P10|Phase I: Period 3|Lost to Follow-up|0
2896068|NCT01791517|9971093|P9|Phase I: Period 3|Lost to Follow-up|0
2896069|NCT01791517|9971094|P8|Phase I: Period 3|Lost to Follow-up|0
2896070|NCT01791517|9971095|P7|Phase I: Period 3|Lost to Follow-up|0
2896071|NCT01791517|9971096|P6|Phase I: Period 3|Lost to Follow-up|0
2896072|NCT01791517|9971097|P5|Phase I: Period 3|Lost to Follow-up|1
2896073|NCT01791517|9971098|P4|Phase I: Period 3|Lost to Follow-up|0
2896074|NCT01791517|9971099|P3|Phase I: Period 3|Lost to Follow-up|0
2896075|NCT01791517|9971100|P2|Phase I: Period 3|Lost to Follow-up|1
2896076|NCT01791517|9971101|P1|Phase I: Period 3|Lost to Follow-up|0
2896077|NCT01791517|9971090|P12|Phase I: Period 3|Lens Discomfort|1
2896078|NCT01791517|9971091|P11|Phase I: Period 3|Lens Discomfort|0
2896079|NCT01791517|9971092|P10|Phase I: Period 3|Lens Discomfort|0
2896080|NCT01791517|9971093|P9|Phase I: Period 3|Lens Discomfort|0
2896081|NCT01791517|9971094|P8|Phase I: Period 3|Lens Discomfort|0
2896082|NCT01791517|9971095|P7|Phase I: Period 3|Lens Discomfort|0
2896083|NCT01791517|9971096|P6|Phase I: Period 3|Lens Discomfort|0
2896084|NCT01791517|9971097|P5|Phase I: Period 3|Lens Discomfort|0
2896085|NCT01791517|9971098|P4|Phase I: Period 3|Lens Discomfort|0
2896086|NCT01791517|9971099|P3|Phase I: Period 3|Lens Discomfort|0
2896087|NCT01791517|9971100|P2|Phase I: Period 3|Lens Discomfort|0
2896088|NCT01791517|9971101|P1|Phase I: Period 3|Lens Discomfort|0
2896089|NCT01791517|9971090|P12|Phase I: Period 2|Lost to Follow-up|0
2896090|NCT01791517|9971091|P11|Phase I: Period 2|Lost to Follow-up|0
2896091|NCT01791517|9971092|P10|Phase I: Period 2|Lost to Follow-up|0
2896092|NCT01791517|9971093|P9|Phase I: Period 2|Lost to Follow-up|0
2896093|NCT01791517|9971094|P8|Phase I: Period 2|Lost to Follow-up|0
2896094|NCT01791517|9971095|P7|Phase I: Period 2|Lost to Follow-up|0
2896095|NCT01791517|9971096|P6|Phase I: Period 2|Lost to Follow-up|0
2896096|NCT01791517|9971097|P5|Phase I: Period 2|Lost to Follow-up|0
2896097|NCT01791517|9971098|P4|Phase I: Period 2|Lost to Follow-up|0
2896098|NCT01791517|9971099|P3|Phase I: Period 2|Lost to Follow-up|2
2896099|NCT01791517|9971100|P2|Phase I: Period 2|Lost to Follow-up|3
2896100|NCT01791517|9971101|P1|Phase I: Period 2|Lost to Follow-up|0
2896101|NCT01791517|9971090|P12|Phase I: Period 2|Lens Discomfort|0
2896102|NCT01791517|9971091|P11|Phase I: Period 2|Lens Discomfort|0
2896103|NCT01791517|9971092|P10|Phase I: Period 2|Lens Discomfort|0
2896104|NCT01791517|9971093|P9|Phase I: Period 2|Lens Discomfort|0
2896105|NCT01791517|9971094|P8|Phase I: Period 2|Lens Discomfort|0
2896106|NCT01791517|9971095|P7|Phase I: Period 2|Lens Discomfort|0
2896107|NCT01791517|9971096|P6|Phase I: Period 2|Lens Discomfort|1
2896108|NCT01791517|9971097|P5|Phase I: Period 2|Lens Discomfort|0
2896109|NCT01791517|9971098|P4|Phase I: Period 2|Lens Discomfort|0
2896110|NCT01791517|9971099|P3|Phase I: Period 2|Lens Discomfort|0
2896111|NCT01791517|9971100|P2|Phase I: Period 2|Lens Discomfort|0
2896112|NCT01791517|9971101|P1|Phase I: Period 2|Lens Discomfort|0
2896113|NCT01791517|9971090|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
2896114|NCT01791517|9971091|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
2896115|NCT01791517|9971092|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
2896116|NCT01791517|9971093|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
2896117|NCT01791517|9971094|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
2896118|NCT01791517|9971095|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
2896119|NCT01791517|9971096|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
2896120|NCT01791517|9971097|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
2896121|NCT01791517|9971098|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
2896122|NCT01791517|9971099|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
2896123|NCT01791517|9971100|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
2896124|NCT01791517|9971101|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
2896125|NCT01791517|9971090|P12|Phase I: Period 2|Withdrawal by Subject|0
2896126|NCT01791517|9971091|P11|Phase I: Period 2|Withdrawal by Subject|1
2896127|NCT01791517|9971092|P10|Phase I: Period 2|Withdrawal by Subject|1
2896128|NCT01791517|9971093|P9|Phase I: Period 2|Withdrawal by Subject|0
2896129|NCT01791517|9971094|P8|Phase I: Period 2|Withdrawal by Subject|0
2896130|NCT01791517|9971095|P7|Phase I: Period 2|Withdrawal by Subject|0
2896131|NCT01791517|9971096|P6|Phase I: Period 2|Withdrawal by Subject|0
2896132|NCT01791517|9971097|P5|Phase I: Period 2|Withdrawal by Subject|0
2896133|NCT01791517|9971098|P4|Phase I: Period 2|Withdrawal by Subject|0
2896134|NCT01791517|9971099|P3|Phase I: Period 2|Withdrawal by Subject|0
2896135|NCT01791517|9971100|P2|Phase I: Period 2|Withdrawal by Subject|0
2896136|NCT01791517|9971101|P1|Phase I: Period 2|Withdrawal by Subject|0
2896137|NCT01791517|9971090|P12|Phase I: Period 2|Protocol Violation|0
2896138|NCT01791517|9971091|P11|Phase I: Period 2|Protocol Violation|0
2896139|NCT01791517|9971092|P10|Phase I: Period 2|Protocol Violation|0
2896140|NCT01791517|9971093|P9|Phase I: Period 2|Protocol Violation|0
2896141|NCT01791517|9971094|P8|Phase I: Period 2|Protocol Violation|0
2896142|NCT01791517|9971095|P7|Phase I: Period 2|Protocol Violation|0
2896143|NCT01791517|9971096|P6|Phase I: Period 2|Protocol Violation|0
2896144|NCT01791517|9971097|P5|Phase I: Period 2|Protocol Violation|0
2896145|NCT01791517|9971098|P4|Phase I: Period 2|Protocol Violation|1
2896146|NCT01791517|9971099|P3|Phase I: Period 2|Protocol Violation|0
2896147|NCT01791517|9971100|P2|Phase I: Period 2|Protocol Violation|0
2896148|NCT01791517|9971101|P1|Phase I: Period 2|Protocol Violation|0
2896149|NCT01791517|9971090|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896150|NCT01791517|9971091|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896151|NCT01791517|9971092|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896152|NCT01791517|9971093|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896153|NCT01791517|9971094|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896154|NCT01791517|9971095|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896155|NCT01791517|9971096|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896156|NCT01791517|9971097|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896157|NCT01791517|9971098|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896158|NCT01791517|9971099|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896159|NCT01791517|9971100|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
2896160|NCT01791517|9971101|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
2896161|NCT01791517|9971090|P12|Phase I: Period 1|Lens Handling DIfficulties|1
2896162|NCT01791517|9971091|P11|Phase I: Period 1|Lens Handling DIfficulties|0
2896163|NCT01791517|9971092|P10|Phase I: Period 1|Lens Handling DIfficulties|0
2896164|NCT01791517|9971093|P9|Phase I: Period 1|Lens Handling DIfficulties|0
2896165|NCT01791517|9971094|P8|Phase I: Period 1|Lens Handling DIfficulties|0
2896166|NCT01791517|9971095|P7|Phase I: Period 1|Lens Handling DIfficulties|0
2896167|NCT01791517|9971096|P6|Phase I: Period 1|Lens Handling DIfficulties|0
2896168|NCT01791517|9971097|P5|Phase I: Period 1|Lens Handling DIfficulties|0
2896169|NCT01791517|9971098|P4|Phase I: Period 1|Lens Handling DIfficulties|0
2896170|NCT01791517|9971099|P3|Phase I: Period 1|Lens Handling DIfficulties|0
2896171|NCT01791517|9971100|P2|Phase I: Period 1|Lens Handling DIfficulties|0
2896172|NCT01791517|9971101|P1|Phase I: Period 1|Lens Handling DIfficulties|0
2896173|NCT01791517|9971090|P12|Phase I: Period 1|Lost to Follow-up|0
2896174|NCT01791517|9971091|P11|Phase I: Period 1|Lost to Follow-up|0
2896175|NCT01791517|9971092|P10|Phase I: Period 1|Lost to Follow-up|1
2896176|NCT01791517|9971093|P9|Phase I: Period 1|Lost to Follow-up|1
2896177|NCT01791517|9971094|P8|Phase I: Period 1|Lost to Follow-up|0
2896178|NCT01791517|9971095|P7|Phase I: Period 1|Lost to Follow-up|1
2896179|NCT01791517|9971096|P6|Phase I: Period 1|Lost to Follow-up|0
2896180|NCT01791517|9971097|P5|Phase I: Period 1|Lost to Follow-up|0
2896181|NCT01791517|9971098|P4|Phase I: Period 1|Lost to Follow-up|1
2896182|NCT01791517|9971099|P3|Phase I: Period 1|Lost to Follow-up|0
2896183|NCT01791517|9971100|P2|Phase I: Period 1|Lost to Follow-up|0
2896184|NCT01791517|9971101|P1|Phase I: Period 1|Lost to Follow-up|0
2896185|NCT01791517|9971090|P12|Phase I: Period 1|Protocol Violation|0
2896186|NCT01791517|9971091|P11|Phase I: Period 1|Protocol Violation|0
2896187|NCT01791517|9971092|P10|Phase I: Period 1|Protocol Violation|0
2896188|NCT01791517|9971093|P9|Phase I: Period 1|Protocol Violation|0
2896189|NCT01791517|9971094|P8|Phase I: Period 1|Protocol Violation|0
2896190|NCT01791517|9971095|P7|Phase I: Period 1|Protocol Violation|0
2896191|NCT01791517|9971096|P6|Phase I: Period 1|Protocol Violation|0
2896192|NCT01791517|9971097|P5|Phase I: Period 1|Protocol Violation|0
2896193|NCT01791517|9971098|P4|Phase I: Period 1|Protocol Violation|0
2896194|NCT01791517|9971099|P3|Phase I: Period 1|Protocol Violation|0
2896195|NCT01791517|9971100|P2|Phase I: Period 1|Protocol Violation|1
2896196|NCT01791517|9971101|P1|Phase I: Period 1|Protocol Violation|0
2896197|NCT01791517|9971090|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896198|NCT01791517|9971091|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896199|NCT01791517|9971092|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896200|NCT01791517|9971093|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896201|NCT01791517|9971094|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896202|NCT01791517|9971095|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896203|NCT01791517|9971096|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896204|NCT01791517|9971097|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896205|NCT01791517|9971098|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896206|NCT01791517|9971099|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896207|NCT01791517|9971100|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2896208|NCT01791517|9971101|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
2896209|NCT01791517|9971090|P12|Phase I: Period 1|Adverse Event|0
2896210|NCT01791517|9971091|P11|Phase I: Period 1|Adverse Event|0
2896211|NCT01791517|9971092|P10|Phase I: Period 1|Adverse Event|0
2896212|NCT01791517|9971093|P9|Phase I: Period 1|Adverse Event|0
2896213|NCT01791517|9971094|P8|Phase I: Period 1|Adverse Event|0
2896214|NCT01791517|9971095|P7|Phase I: Period 1|Adverse Event|0
2896215|NCT01791517|9971096|P6|Phase I: Period 1|Adverse Event|0
2896216|NCT01791517|9971097|P5|Phase I: Period 1|Adverse Event|0
2896217|NCT01791517|9971098|P4|Phase I: Period 1|Adverse Event|1
2896218|NCT01791517|9971099|P3|Phase I: Period 1|Adverse Event|1
2896219|NCT01791517|9971100|P2|Phase I: Period 1|Adverse Event|0
2896220|NCT01791517|9971101|P1|Phase I: Period 1|Adverse Event|0
2896221|NCT01791517|9971090|P12|Phase I: Period 1|Withdrawal by Subject|0
2896222|NCT01791517|9971091|P11|Phase I: Period 1|Withdrawal by Subject|0
2896223|NCT01791517|9971092|P10|Phase I: Period 1|Withdrawal by Subject|0
2896224|NCT01791517|9971093|P9|Phase I: Period 1|Withdrawal by Subject|0
2896225|NCT01791517|9971094|P8|Phase I: Period 1|Withdrawal by Subject|0
2896226|NCT01791517|9971095|P7|Phase I: Period 1|Withdrawal by Subject|0
2896227|NCT01791517|9971096|P6|Phase I: Period 1|Withdrawal by Subject|1
2896228|NCT01791517|9971097|P5|Phase I: Period 1|Withdrawal by Subject|1
2896229|NCT01791517|9971098|P4|Phase I: Period 1|Withdrawal by Subject|0
2896230|NCT01791517|9971099|P3|Phase I: Period 1|Withdrawal by Subject|1
2896231|NCT01791517|9971100|P2|Phase I: Period 1|Withdrawal by Subject|1
2896232|NCT01791517|9971101|P1|Phase I: Period 1|Withdrawal by Subject|0
2896233|NCT01791413|9971165|P2|Overall Study|Lost to Follow-up|1
2896234|NCT01791413|9971166|P1|Overall Study|Lost to Follow-up|5
2896235|NCT01791244|9971175|P2|Overall Study|Laboratory Abnormality|1
2896236|NCT01791244|9971176|P1|Overall Study|Laboratory Abnormality|0
2896237|NCT01791244|9971175|P2|Overall Study|Insufficient clinical response|10
2896238|NCT01791244|9971176|P1|Overall Study|Insufficient clinical response|10
2896239|NCT01791244|9971175|P2|Overall Study|Adverse Event|7
2896240|NCT01791244|9971176|P1|Overall Study|Adverse Event|5
2896241|NCT01791205|9971212|P2|Phase II|Physician’s decision|0
2896242|NCT01791205|9971213|P1|Phase II|Physician’s decision|1
2896243|NCT01791205|9971212|P2|Phase II|Remission of disease|0
2896244|NCT01791205|9971213|P1|Phase II|Remission of disease|1
2896245|NCT01791205|9971212|P2|Phase II|Lost to Follow-up|0
2896246|NCT01791205|9971213|P1|Phase II|Lost to Follow-up|1
2896247|NCT01791205|9971212|P2|Phase II|Safety|0
2896248|NCT01791205|9971213|P1|Phase II|Safety|1
2896249|NCT01791205|9971212|P2|Phase II|Adverse Event|0
2896250|NCT01791205|9971213|P1|Phase II|Adverse Event|2
2896251|NCT01791205|9971212|P2|Phase II|Lack of Efficacy|0
2896252|NCT01791205|9971213|P1|Phase II|Lack of Efficacy|6
2896253|NCT01791153|9971297|P8|Part 2: Open-label Period|Physician Decision|0
2896254|NCT01791153|9971298|P7|Part 2: Open-label Period|Physician Decision|0
2896255|NCT01791153|9971299|P6|Part 2: Open-label Period|Physician Decision|1
2896256|NCT01791153|9971300|P5|Part 2: Open-label Period|Physician Decision|1
2896257|NCT01791153|9971301|P4|Part 2: Open-label Period|Physician Decision|0
2896258|NCT01791153|9971302|P3|Part 2: Open-label Period|Physician Decision|0
2896259|NCT01791153|9971303|P2|Part 2: Open-label Period|Physician Decision|0
2896260|NCT01791153|9971304|P1|Part 2: Open-label Period|Physician Decision|0
2896261|NCT01791153|9971297|P8|Part 2: Open-label Period|Withdrawal by Subject|2
2896262|NCT01791153|9971298|P7|Part 2: Open-label Period|Withdrawal by Subject|3
2896263|NCT01791153|9971299|P6|Part 2: Open-label Period|Withdrawal by Subject|1
2896264|NCT01791153|9971300|P5|Part 2: Open-label Period|Withdrawal by Subject|1
2896265|NCT01791153|9971301|P4|Part 2: Open-label Period|Withdrawal by Subject|0
2896266|NCT01791153|9971302|P3|Part 2: Open-label Period|Withdrawal by Subject|0
2896267|NCT01791153|9971303|P2|Part 2: Open-label Period|Withdrawal by Subject|0
2896268|NCT01791153|9971304|P1|Part 2: Open-label Period|Withdrawal by Subject|0
2896269|NCT01791153|9971297|P8|Part 2: Open-label Period|Lack of Efficacy|1
2896270|NCT01791153|9971298|P7|Part 2: Open-label Period|Lack of Efficacy|0
2896271|NCT01791153|9971299|P6|Part 2: Open-label Period|Lack of Efficacy|0
2896272|NCT01791153|9971300|P5|Part 2: Open-label Period|Lack of Efficacy|0
2896273|NCT01791153|9971301|P4|Part 2: Open-label Period|Lack of Efficacy|0
2896274|NCT01791153|9971302|P3|Part 2: Open-label Period|Lack of Efficacy|0
2896275|NCT01791153|9971303|P2|Part 2: Open-label Period|Lack of Efficacy|0
2896276|NCT01791153|9971304|P1|Part 2: Open-label Period|Lack of Efficacy|0
2896277|NCT01791153|9971297|P8|Part 2: Open-label Period|Lost to Follow-up|0
2896278|NCT01791153|9971298|P7|Part 2: Open-label Period|Lost to Follow-up|1
2896279|NCT01791153|9971299|P6|Part 2: Open-label Period|Lost to Follow-up|0
2896280|NCT01791153|9971300|P5|Part 2: Open-label Period|Lost to Follow-up|0
2896281|NCT01791153|9971301|P4|Part 2: Open-label Period|Lost to Follow-up|0
2896282|NCT01791153|9971302|P3|Part 2: Open-label Period|Lost to Follow-up|0
2896283|NCT01791153|9971303|P2|Part 2: Open-label Period|Lost to Follow-up|0
2896284|NCT01791153|9971304|P1|Part 2: Open-label Period|Lost to Follow-up|0
2896285|NCT01791153|9971297|P8|Part 2: Open-label Period|Death|1
2896286|NCT01791153|9971298|P7|Part 2: Open-label Period|Death|1
2896287|NCT01791153|9971299|P6|Part 2: Open-label Period|Death|1
2896288|NCT01791153|9971300|P5|Part 2: Open-label Period|Death|0
2896289|NCT01791153|9971301|P4|Part 2: Open-label Period|Death|0
2896290|NCT01791153|9971302|P3|Part 2: Open-label Period|Death|0
2896291|NCT01791153|9971303|P2|Part 2: Open-label Period|Death|0
2896292|NCT01791153|9971304|P1|Part 2: Open-label Period|Death|0
2896293|NCT01791153|9971297|P8|Part 2: Open-label Period|Adverse Event|2
2896294|NCT01791153|9971298|P7|Part 2: Open-label Period|Adverse Event|1
2896295|NCT01791153|9971299|P6|Part 2: Open-label Period|Adverse Event|1
2896296|NCT01791153|9971300|P5|Part 2: Open-label Period|Adverse Event|0
2896297|NCT01791153|9971301|P4|Part 2: Open-label Period|Adverse Event|0
2896298|NCT01791153|9971302|P3|Part 2: Open-label Period|Adverse Event|0
2896299|NCT01791153|9971303|P2|Part 2: Open-label Period|Adverse Event|0
2896300|NCT01791153|9971304|P1|Part 2: Open-label Period|Adverse Event|0
2896301|NCT01791153|9971297|P8|Part 1: Blinded Period|Withdrawal by Subject|0
2896302|NCT01791153|9971298|P7|Part 1: Blinded Period|Withdrawal by Subject|0
2896303|NCT01791153|9971299|P6|Part 1: Blinded Period|Withdrawal by Subject|0
2896304|NCT01791153|9971300|P5|Part 1: Blinded Period|Withdrawal by Subject|0
2896305|NCT01791153|9971301|P4|Part 1: Blinded Period|Withdrawal by Subject|1
2896306|NCT01791153|9971302|P3|Part 1: Blinded Period|Withdrawal by Subject|2
2896307|NCT01791153|9971303|P2|Part 1: Blinded Period|Withdrawal by Subject|2
2896308|NCT01791153|9971304|P1|Part 1: Blinded Period|Withdrawal by Subject|6
2896309|NCT01791153|9971297|P8|Part 1: Blinded Period|Protocol Violation|0
2896310|NCT01791153|9971298|P7|Part 1: Blinded Period|Protocol Violation|0
2896311|NCT01791153|9971299|P6|Part 1: Blinded Period|Protocol Violation|0
2896312|NCT01791153|9971300|P5|Part 1: Blinded Period|Protocol Violation|0
2896313|NCT01791153|9971301|P4|Part 1: Blinded Period|Protocol Violation|1
2896314|NCT01791153|9971302|P3|Part 1: Blinded Period|Protocol Violation|0
2896315|NCT01791153|9971303|P2|Part 1: Blinded Period|Protocol Violation|0
2896316|NCT01791153|9971304|P1|Part 1: Blinded Period|Protocol Violation|0
2896317|NCT01791153|9971297|P8|Part 1: Blinded Period|Physician Decision|0
2896318|NCT01791153|9971298|P7|Part 1: Blinded Period|Physician Decision|0
2896319|NCT01791153|9971299|P6|Part 1: Blinded Period|Physician Decision|0
2896320|NCT01791153|9971300|P5|Part 1: Blinded Period|Physician Decision|0
2896321|NCT01791153|9971301|P4|Part 1: Blinded Period|Physician Decision|1
2896322|NCT01791153|9971302|P3|Part 1: Blinded Period|Physician Decision|0
2896323|NCT01791153|9971303|P2|Part 1: Blinded Period|Physician Decision|0
2896324|NCT01791153|9971304|P1|Part 1: Blinded Period|Physician Decision|0
2896325|NCT01791153|9971297|P8|Part 1: Blinded Period|Non-Compliance|0
2896326|NCT01791153|9971298|P7|Part 1: Blinded Period|Non-Compliance|0
2896327|NCT01791153|9971299|P6|Part 1: Blinded Period|Non-Compliance|0
2896328|NCT01791153|9971300|P5|Part 1: Blinded Period|Non-Compliance|0
2896329|NCT01791153|9971301|P4|Part 1: Blinded Period|Non-Compliance|0
2896330|NCT01791153|9971302|P3|Part 1: Blinded Period|Non-Compliance|0
2896331|NCT01791153|9971303|P2|Part 1: Blinded Period|Non-Compliance|0
2896332|NCT01791153|9971304|P1|Part 1: Blinded Period|Non-Compliance|1
2896333|NCT01791153|9971297|P8|Part 1: Blinded Period|Lack of Efficacy|0
2896334|NCT01791153|9971298|P7|Part 1: Blinded Period|Lack of Efficacy|0
2896335|NCT01791153|9971299|P6|Part 1: Blinded Period|Lack of Efficacy|0
2896336|NCT01791153|9971300|P5|Part 1: Blinded Period|Lack of Efficacy|0
2896337|NCT01791153|9971301|P4|Part 1: Blinded Period|Lack of Efficacy|2
2896338|NCT01791153|9971302|P3|Part 1: Blinded Period|Lack of Efficacy|2
2896339|NCT01791153|9971303|P2|Part 1: Blinded Period|Lack of Efficacy|3
2896340|NCT01791153|9971304|P1|Part 1: Blinded Period|Lack of Efficacy|1
2896341|NCT01791153|9971297|P8|Part 1: Blinded Period|Adverse Event|0
2896342|NCT01791153|9971298|P7|Part 1: Blinded Period|Adverse Event|0
2896343|NCT01791153|9971299|P6|Part 1: Blinded Period|Adverse Event|0
2896344|NCT01791153|9971300|P5|Part 1: Blinded Period|Adverse Event|0
2896345|NCT01791153|9971301|P4|Part 1: Blinded Period|Adverse Event|0
2896346|NCT01791153|9971302|P3|Part 1: Blinded Period|Adverse Event|2
2896347|NCT01791153|9971303|P2|Part 1: Blinded Period|Adverse Event|3
2896348|NCT01791153|9971304|P1|Part 1: Blinded Period|Adverse Event|7
2896349|NCT01791127|9971364|P1|Overall Study|Study terminated for EP Passion|749
2896350|NCT01791127|9971364|P1|Overall Study|Completion of 30 day safety registry|1
2896351|NCT01791127|9971364|P1|Overall Study|All Siello leads are explanted|31
2896352|NCT01791127|9971364|P1|Overall Study|Lost to Follow-up|42
2896353|NCT01791127|9971364|P1|Overall Study|Patient has withdrawn from study|293
2896354|NCT01791127|9971364|P1|Overall Study|Death|356
2896355|NCT01790932|9971388|P1|Overall Study|Withdrawal by Subject|1
2896356|NCT01790932|9971388|P1|Overall Study|Physician Decision|1
2896357|NCT01790932|9971388|P1|Overall Study|Adverse Event|7
2896358|NCT01790932|9971388|P1|Overall Study|Disease Progression|41
2896359|NCT01790828|9971394|P1|Overall Study|Other|34
2896360|NCT01790633|9971452|P2|Overall Study|RT failure and no follow-up ELISA|3
2896361|NCT01790633|9971453|P1|Overall Study|RT failure and no follow-up ELISA|0
2896362|NCT01790633|9971452|P2|Overall Study|Did not have serology performed|0
2896363|NCT01790633|9971453|P1|Overall Study|Did not have serology performed|47
2896364|NCT01790633|9971452|P2|Overall Study|Protocol Violation|2
2896365|NCT01790633|9971453|P1|Overall Study|Protocol Violation|1
2896366|NCT01790594|9971466|P3|Overall Study|Terminated prior to week 76|0
2896367|NCT01790594|9971467|P2|Overall Study|Terminated prior to week 76|2
2896368|NCT01790594|9971468|P1|Overall Study|Terminated prior to week 76|0
2896369|NCT01790594|9971466|P3|Overall Study|Transplant was not done|3
2896370|NCT01790594|9971467|P2|Overall Study|Transplant was not done|0
2896371|NCT01790594|9971468|P1|Overall Study|Transplant was not done|0
2896372|NCT01790594|9971466|P3|Overall Study|Withdrawal by Subject|0
2896373|NCT01790594|9971467|P2|Overall Study|Withdrawal by Subject|0
2896374|NCT01790594|9971468|P1|Overall Study|Withdrawal by Subject|2
2896375|NCT01790594|9971466|P3|Overall Study|Physician Decision|0
2896376|NCT01790594|9971467|P2|Overall Study|Physician Decision|1
2896377|NCT01790594|9971468|P1|Overall Study|Physician Decision|2
2896378|NCT01790594|9971466|P3|Overall Study|Death|0
2896379|NCT01790594|9971467|P2|Overall Study|Death|0
2896380|NCT01790594|9971468|P1|Overall Study|Death|1
2896381|NCT01790568|9971545|P2|Overall Study|Progression prior to transplant|1
2896382|NCT01790568|9971546|P1|Overall Study|Progression prior to transplant|0
2896383|NCT01790516|9971554|P2|Overall Study|Physician Decision|0
2896384|NCT01790516|9971555|P1|Overall Study|Physician Decision|1
2896385|NCT01790503|9971572|P11|Overall Study|Other|0
2896386|NCT01790503|9971573|P10|Overall Study|Other|2
2896387|NCT01790503|9971574|P9|Overall Study|Other|1
2896388|NCT01790503|9971575|P8|Overall Study|Other|0
2896389|NCT01790503|9971576|P7|Overall Study|Other|0
2896390|NCT01790503|9971577|P6|Overall Study|Other|0
2896391|NCT01790503|9971578|P5|Overall Study|Other|1
2896392|NCT01790503|9971579|P4|Overall Study|Other|0
2896393|NCT01790503|9971580|P3|Overall Study|Other|0
2896394|NCT01790503|9971581|P2|Overall Study|Other|0
2896395|NCT01790503|9971582|P1|Overall Study|Other|0
2896396|NCT01790503|9971572|P11|Overall Study|Non Compliance|0
2896397|NCT01790503|9971573|P10|Overall Study|Non Compliance|0
2896398|NCT01790503|9971574|P9|Overall Study|Non Compliance|0
2896399|NCT01790503|9971575|P8|Overall Study|Non Compliance|0
2896400|NCT01790503|9971576|P7|Overall Study|Non Compliance|0
2896401|NCT01790503|9971577|P6|Overall Study|Non Compliance|0
2896402|NCT01790503|9971578|P5|Overall Study|Non Compliance|1
2896403|NCT01790503|9971579|P4|Overall Study|Non Compliance|0
2896404|NCT01790503|9971580|P3|Overall Study|Non Compliance|0
2896405|NCT01790503|9971581|P2|Overall Study|Non Compliance|0
2896406|NCT01790503|9971582|P1|Overall Study|Non Compliance|0
2896407|NCT01790503|9971572|P11|Overall Study|Death|0
2896408|NCT01790503|9971573|P10|Overall Study|Death|1
2896409|NCT01790503|9971574|P9|Overall Study|Death|0
2896410|NCT01790503|9971575|P8|Overall Study|Death|0
2896411|NCT01790503|9971576|P7|Overall Study|Death|0
2896412|NCT01790503|9971577|P6|Overall Study|Death|0
2896413|NCT01790503|9971578|P5|Overall Study|Death|0
2896414|NCT01790503|9971579|P4|Overall Study|Death|0
2896415|NCT01790503|9971580|P3|Overall Study|Death|0
2896416|NCT01790503|9971581|P2|Overall Study|Death|0
2896417|NCT01790503|9971582|P1|Overall Study|Death|0
2896418|NCT01790503|9971572|P11|Overall Study|Physician Decision|1
2896419|NCT01790503|9971573|P10|Overall Study|Physician Decision|1
2896420|NCT01790503|9971574|P9|Overall Study|Physician Decision|0
2896421|NCT01790503|9971575|P8|Overall Study|Physician Decision|0
2896422|NCT01790503|9971576|P7|Overall Study|Physician Decision|0
2896423|NCT01790503|9971577|P6|Overall Study|Physician Decision|0
2896424|NCT01790503|9971578|P5|Overall Study|Physician Decision|0
2896425|NCT01790503|9971579|P4|Overall Study|Physician Decision|0
2896426|NCT01790503|9971580|P3|Overall Study|Physician Decision|0
2896427|NCT01790503|9971581|P2|Overall Study|Physician Decision|0
2896428|NCT01790503|9971582|P1|Overall Study|Physician Decision|0
2896429|NCT01790503|9971572|P11|Overall Study|Protocol Violation|0
2896430|NCT01790503|9971573|P10|Overall Study|Protocol Violation|1
2896431|NCT01790503|9971574|P9|Overall Study|Protocol Violation|0
2896432|NCT01790503|9971575|P8|Overall Study|Protocol Violation|0
2896433|NCT01790503|9971576|P7|Overall Study|Protocol Violation|0
2896434|NCT01790503|9971577|P6|Overall Study|Protocol Violation|0
2896435|NCT01790503|9971578|P5|Overall Study|Protocol Violation|0
2896436|NCT01790503|9971579|P4|Overall Study|Protocol Violation|0
2896437|NCT01790503|9971580|P3|Overall Study|Protocol Violation|0
2896438|NCT01790503|9971581|P2|Overall Study|Protocol Violation|0
2896439|NCT01790503|9971582|P1|Overall Study|Protocol Violation|0
2896440|NCT01790503|9971572|P11|Overall Study|Disease progression|7
2896441|NCT01790503|9971573|P10|Overall Study|Disease progression|17
2896442|NCT01790503|9971574|P9|Overall Study|Disease progression|0
2896443|NCT01790503|9971575|P8|Overall Study|Disease progression|1
2896444|NCT01790503|9971576|P7|Overall Study|Disease progression|0
2896445|NCT01790503|9971577|P6|Overall Study|Disease progression|1
2896446|NCT01790503|9971578|P5|Overall Study|Disease progression|2
2896447|NCT01790503|9971579|P4|Overall Study|Disease progression|1
2896448|NCT01790503|9971580|P3|Overall Study|Disease progression|0
2896449|NCT01790503|9971581|P2|Overall Study|Disease progression|1
2896450|NCT01790503|9971582|P1|Overall Study|Disease progression|2
2896451|NCT01790503|9971572|P11|Overall Study|Withdrawal by Subject|1
2896452|NCT01790503|9971573|P10|Overall Study|Withdrawal by Subject|0
2896453|NCT01790503|9971574|P9|Overall Study|Withdrawal by Subject|0
2896454|NCT01790503|9971575|P8|Overall Study|Withdrawal by Subject|0
2896455|NCT01790503|9971576|P7|Overall Study|Withdrawal by Subject|1
2896456|NCT01790503|9971577|P6|Overall Study|Withdrawal by Subject|2
2896457|NCT01790503|9971578|P5|Overall Study|Withdrawal by Subject|1
2896458|NCT01790503|9971579|P4|Overall Study|Withdrawal by Subject|1
2896459|NCT01790503|9971580|P3|Overall Study|Withdrawal by Subject|1
2896460|NCT01790503|9971581|P2|Overall Study|Withdrawal by Subject|0
2896461|NCT01790503|9971582|P1|Overall Study|Withdrawal by Subject|0
2896462|NCT01790503|9971572|P11|Overall Study|Adverse Event|7
2896463|NCT01790503|9971573|P10|Overall Study|Adverse Event|4
2896464|NCT01790503|9971574|P9|Overall Study|Adverse Event|2
2896465|NCT01790503|9971575|P8|Overall Study|Adverse Event|0
2896466|NCT01790503|9971576|P7|Overall Study|Adverse Event|0
2896467|NCT01790503|9971577|P6|Overall Study|Adverse Event|2
2896468|NCT01790503|9971578|P5|Overall Study|Adverse Event|0
2896469|NCT01790503|9971579|P4|Overall Study|Adverse Event|0
2896470|NCT01790503|9971580|P3|Overall Study|Adverse Event|0
2896471|NCT01790503|9971581|P2|Overall Study|Adverse Event|0
2896472|NCT01790503|9971582|P1|Overall Study|Adverse Event|1
2896473|NCT01790438|9971652|P2|Overall Study|Protocol Required Discontinuation|1
2896474|NCT01790438|9971653|P1|Overall Study|Protocol Required Discontinuation|7
2896475|NCT01790438|9971652|P2|Overall Study|Sponsor Decision|3
2896476|NCT01790438|9971653|P1|Overall Study|Sponsor Decision|0
2896477|NCT01790438|9971652|P2|Overall Study|Physician Decision|1
2896478|NCT01790438|9971653|P1|Overall Study|Physician Decision|3
2896479|NCT01790438|9971652|P2|Overall Study|Withdrawal by Subject|2
2896480|NCT01790438|9971653|P1|Overall Study|Withdrawal by Subject|13
2896481|NCT01790438|9971652|P2|Overall Study|Lost to Follow-up|2
2896482|NCT01790438|9971653|P1|Overall Study|Lost to Follow-up|5
2896483|NCT01790438|9971652|P2|Overall Study|Death|0
2896484|NCT01790438|9971653|P1|Overall Study|Death|4
2896485|NCT01790438|9971652|P2|Overall Study|Adverse Event|2
2896486|NCT01790438|9971653|P1|Overall Study|Adverse Event|3
2896487|NCT01790295|9971703|P1|Overall Study|Study closure|4
2896488|NCT01790295|9971703|P1|Overall Study|Lack of Efficacy|2
2896489|NCT01790295|9971703|P1|Overall Study|Death|4
2896490|NCT01790295|9971703|P1|Overall Study|Adverse Event|1
2896491|NCT01790126|9971746|P3|Overall Study|Radiographic Progression|0
2896492|NCT01790126|9971747|P2|Overall Study|Radiographic Progression|1
2896493|NCT01790126|9971748|P1|Overall Study|Radiographic Progression|3
2896494|NCT01790126|9971746|P3|Overall Study|Death|0
2896495|NCT01790126|9971747|P2|Overall Study|Death|0
2896496|NCT01790126|9971748|P1|Overall Study|Death|2
2896497|NCT01790126|9971746|P3|Overall Study|Adverse Event|0
2896498|NCT01790126|9971747|P2|Overall Study|Adverse Event|2
2896499|NCT01790126|9971748|P1|Overall Study|Adverse Event|0
2896500|NCT01790126|9971746|P3|Overall Study|Lost to Follow-up|1
2896501|NCT01790126|9971747|P2|Overall Study|Lost to Follow-up|0
2896502|NCT01790126|9971748|P1|Overall Study|Lost to Follow-up|1
2896503|NCT01790126|9971746|P3|Overall Study|Withdrawal by Subject|2
2896504|NCT01790126|9971747|P2|Overall Study|Withdrawal by Subject|1
2896505|NCT01790126|9971748|P1|Overall Study|Withdrawal by Subject|3
2896506|NCT01790126|9971746|P3|Overall Study|Withdrawal by Physician|2
2896507|NCT01790126|9971747|P2|Overall Study|Withdrawal by Physician|1
2896508|NCT01790126|9971748|P1|Overall Study|Withdrawal by Physician|1
2896509|NCT01790126|9971746|P3|Overall Study|Initiation of Non-Protocol Therapy|2
2896510|NCT01790126|9971747|P2|Overall Study|Initiation of Non-Protocol Therapy|4
2896511|NCT01790126|9971748|P1|Overall Study|Initiation of Non-Protocol Therapy|3
2896512|NCT01790126|9971746|P3|Overall Study|Other|8
2896513|NCT01790126|9971747|P2|Overall Study|Other|4
2896514|NCT01790126|9971748|P1|Overall Study|Other|5
2896515|NCT01790126|9971746|P3|Overall Study|PSA Progression|16
2896516|NCT01790126|9971747|P2|Overall Study|PSA Progression|16
2896517|NCT01790126|9971748|P1|Overall Study|PSA Progression|12
2896518|NCT01790048|9971805|P2|Overall Study|Measurement error|0
2896519|NCT01790048|9971806|P1|Overall Study|Measurement error|1
2896520|NCT01790048|9971805|P2|Overall Study|SAM at Enrollment|0
2896521|NCT01790048|9971806|P1|Overall Study|SAM at Enrollment|2
2896522|NCT01790048|9971805|P2|Overall Study|Other|2
2896523|NCT01790048|9971806|P1|Overall Study|Other|0
2896524|NCT01790048|9971805|P2|Overall Study|data entry error|1
2896525|NCT01790048|9971806|P1|Overall Study|data entry error|0
2896526|NCT01790048|9971805|P2|Overall Study|Incorrect Age|14
2896527|NCT01790048|9971806|P1|Overall Study|Incorrect Age|9
2896528|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2896529|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
2896530|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2896531|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Other|3
2896532|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Other|1
2896533|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Other|0
2896534|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2896535|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
2896536|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2896537|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
2896538|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
2896539|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
2896540|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
2896541|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
2896542|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
2896543|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2896544|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2896545|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2896546|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
2896547|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2896548|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2896549|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
2896550|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
2896551|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2896552|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2896553|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2896554|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2896555|NCT01789970|9971824|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
2896556|NCT01789970|9971825|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
2896557|NCT01789970|9971826|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2896558|NCT01789970|9971824|P3|Open-label Titration Period|Dropped out prior to dosing|0
2896559|NCT01789970|9971825|P2|Open-label Titration Period|Dropped out prior to dosing|0
2896560|NCT01789970|9971826|P1|Open-label Titration Period|Dropped out prior to dosing|2
2896561|NCT01789970|9971824|P3|Open-label Titration Period|Other|0
2896562|NCT01789970|9971825|P2|Open-label Titration Period|Other|0
2896563|NCT01789970|9971826|P1|Open-label Titration Period|Other|76
2896564|NCT01789970|9971824|P3|Open-label Titration Period|Pregnancy|0
2896565|NCT01789970|9971825|P2|Open-label Titration Period|Pregnancy|0
2896566|NCT01789970|9971826|P1|Open-label Titration Period|Pregnancy|2
2896567|NCT01789970|9971824|P3|Open-label Titration Period|Noncompliance with study procedures|0
2896568|NCT01789970|9971825|P2|Open-label Titration Period|Noncompliance with study procedures|0
2896569|NCT01789970|9971826|P1|Open-label Titration Period|Noncompliance with study procedures|8
2896570|NCT01789970|9971824|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
2896571|NCT01789970|9971825|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
2896572|NCT01789970|9971826|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
2896573|NCT01789970|9971824|P3|Open-label Titration Period|Noncompliance to study drug admin|0
2896574|NCT01789970|9971825|P2|Open-label Titration Period|Noncompliance to study drug admin|0
2896575|NCT01789970|9971826|P1|Open-label Titration Period|Noncompliance to study drug admin|11
2896576|NCT01789970|9971824|P3|Open-label Titration Period|Lost to Follow-up|0
2896577|NCT01789970|9971825|P2|Open-label Titration Period|Lost to Follow-up|0
2896578|NCT01789970|9971826|P1|Open-label Titration Period|Lost to Follow-up|5
2896579|NCT01789970|9971824|P3|Open-label Titration Period|Protocol Violation|0
2896580|NCT01789970|9971825|P2|Open-label Titration Period|Protocol Violation|0
2896581|NCT01789970|9971826|P1|Open-label Titration Period|Protocol Violation|18
2896582|NCT01789970|9971824|P3|Open-label Titration Period|Withdrawal by Subject|0
2896583|NCT01789970|9971825|P2|Open-label Titration Period|Withdrawal by Subject|0
2896584|NCT01789970|9971826|P1|Open-label Titration Period|Withdrawal by Subject|31
2896585|NCT01789970|9971824|P3|Open-label Titration Period|Lack of Efficacy|0
2896586|NCT01789970|9971825|P2|Open-label Titration Period|Lack of Efficacy|0
2896587|NCT01789970|9971826|P1|Open-label Titration Period|Lack of Efficacy|31
2896588|NCT01789970|9971824|P3|Open-label Titration Period|Adverse Event|0
2896589|NCT01789970|9971825|P2|Open-label Titration Period|Adverse Event|0
2896590|NCT01789970|9971826|P1|Open-label Titration Period|Adverse Event|68
2896591|NCT01789606|9971884|P2|Overall Study|Ineligible or not Willing to Continue|348
2896592|NCT01789606|9971885|P1|Overall Study|Ineligible or not Willing to Continue|0
2896593|NCT01789606|9971884|P2|Overall Study|Lost to Follow-up|14
2896594|NCT01789606|9971885|P1|Overall Study|Lost to Follow-up|0
2896595|NCT01789606|9971884|P2|Overall Study|Adverse Event|3
2896596|NCT01789606|9971885|P1|Overall Study|Adverse Event|0
2896597|NCT01789606|9971884|P2|Overall Study|Protocol Violation|55
2896598|NCT01789606|9971885|P1|Overall Study|Protocol Violation|0
2896599|NCT01789606|9971884|P2|Overall Study|No Study Medication Taken|1
2896600|NCT01789606|9971885|P1|Overall Study|No Study Medication Taken|0
2896601|NCT01789606|9971884|P2|Overall Study|Administrative Reasons|6
2896602|NCT01789606|9971885|P1|Overall Study|Administrative Reasons|17
2896603|NCT01789606|9971884|P2|Overall Study|Ineligible|2
2896604|NCT01789606|9971885|P1|Overall Study|Ineligible|6
2896605|NCT01789606|9971884|P2|Overall Study|Withdrawal by Subject|1
2896606|NCT01789606|9971885|P1|Overall Study|Withdrawal by Subject|0
2896607|NCT01789606|9971884|P2|Overall Study|Participant not Purchased the Product|20
2896608|NCT01789606|9971885|P1|Overall Study|Participant not Purchased the Product|0
2896609|NCT01789567|9971903|P1|Overall Study|Death|6
2896610|NCT01789476|9971912|P2|Overall Study|Unable to get IV access|0
2896611|NCT01789476|9971913|P1|Overall Study|Unable to get IV access|1
2896612|NCT01789476|9971912|P2|Overall Study|Adverse Event|0
2896613|NCT01789476|9971913|P1|Overall Study|Adverse Event|1
2896614|NCT01789476|9971912|P2|Overall Study|Lack of Efficacy|2
2896615|NCT01789476|9971913|P1|Overall Study|Lack of Efficacy|6
2896616|NCT01789203|9971935|P2|Overall Study|patient non-adherent|0
2896617|NCT01789203|9971936|P1|Overall Study|patient non-adherent|2
2896618|NCT01789203|9971935|P2|Overall Study|Other|1
2896619|NCT01789203|9971936|P1|Overall Study|Other|1
2896620|NCT01789203|9971935|P2|Overall Study|Protocol Violation|1
2896621|NCT01789203|9971936|P1|Overall Study|Protocol Violation|2
2896622|NCT01789203|9971935|P2|Overall Study|Death|0
2896623|NCT01789203|9971936|P1|Overall Study|Death|1
2896624|NCT01789203|9971935|P2|Overall Study|Withdrawal by Subject|0
2896625|NCT01789203|9971936|P1|Overall Study|Withdrawal by Subject|1
2896626|NCT01789203|9971935|P2|Overall Study|Adverse Event|2
2896627|NCT01789203|9971936|P1|Overall Study|Adverse Event|2
2896628|NCT01789047|9971977|P2|Overall Study|Withdrawal by Subject|2
2896629|NCT01789047|9971978|P1|Overall Study|Withdrawal by Subject|1
2896630|NCT01789047|9971977|P2|Overall Study|Adverse Event|2
2896631|NCT01789047|9971978|P1|Overall Study|Adverse Event|3
2896632|NCT01788943|9971986|P2|Overall Study|Withdrawal by Subject|0
2896633|NCT01788943|9971987|P1|Overall Study|Withdrawal by Subject|1
2896634|NCT01788566|9972016|P1|Overall Study|Clinical Progressive Disease|3
2896635|NCT01788566|9972016|P1|Overall Study|Adverse Event|1
2896636|NCT01788566|9972016|P1|Overall Study|Death|4
2896637|NCT01788423|9972054|P3|Overall Study|See Comments in Completed (above)|5
2896638|NCT01788423|9972055|P2|Overall Study|See Comments in Completed (above)|4
2896639|NCT01788423|9972056|P1|Overall Study|See Comments in Completed (above)|0
2896640|NCT01788358|9972067|P1|Overall Study|Adverse Event|51
2896641|NCT01788358|9972067|P1|Overall Study|Lack of Efficacy|1
2896642|NCT01788358|9972067|P1|Overall Study|Withdrawal by Subject|26
2896643|NCT01788358|9972067|P1|Overall Study|Protocol Violation|3
2896644|NCT01788358|9972067|P1|Overall Study|Lost to Follow-up|5
2896645|NCT01788358|9972067|P1|Overall Study|Logistical difficulties|1
2896646|NCT01788358|9972067|P1|Overall Study|Other|11
2896647|NCT01788228|9972081|P2|Overall Study|Migrated/moved from study area|0
2896648|NCT01788228|9972082|P1|Overall Study|Migrated/moved from study area|1
2896649|NCT01788215|9972101|P2|Overall Study|Lost to Follow-up|0
2896650|NCT01788215|9972102|P1|Overall Study|Lost to Follow-up|2
2896651|NCT01788215|9972101|P2|Overall Study|Withdrawal by Subject|1
2896652|NCT01788215|9972102|P1|Overall Study|Withdrawal by Subject|0
2896653|NCT01788163|9972131|P9|Overall Study|Withdrawal by Subject|1
2896654|NCT01788163|9972132|P8|Overall Study|Withdrawal by Subject|0
2896655|NCT01788163|9972133|P7|Overall Study|Withdrawal by Subject|0
2896656|NCT01788163|9972134|P6|Overall Study|Withdrawal by Subject|0
2896657|NCT01788163|9972135|P5|Overall Study|Withdrawal by Subject|0
2896658|NCT01788163|9972136|P4|Overall Study|Withdrawal by Subject|0
2896659|NCT01788163|9972137|P3|Overall Study|Withdrawal by Subject|0
2896660|NCT01788163|9972138|P2|Overall Study|Withdrawal by Subject|0
2896661|NCT01788163|9972139|P1|Overall Study|Withdrawal by Subject|2
2896662|NCT01788163|9972131|P9|Overall Study|Other|15
2896663|NCT01788163|9972132|P8|Overall Study|Other|48
2896664|NCT01788163|9972133|P7|Overall Study|Other|1
2896665|NCT01788163|9972134|P6|Overall Study|Other|7
2896666|NCT01788163|9972135|P5|Overall Study|Other|0
2896667|NCT01788163|9972136|P4|Overall Study|Other|0
2896668|NCT01788163|9972137|P3|Overall Study|Other|0
2896669|NCT01788163|9972138|P2|Overall Study|Other|0
2896670|NCT01788163|9972139|P1|Overall Study|Other|53
2896671|NCT01788046|9972302|P2|Overall Study|Protocol Specified Criteria|1
2896672|NCT01788046|9972303|P1|Overall Study|Protocol Specified Criteria|25
2896673|NCT01788046|9972302|P2|Overall Study|Death|5
2896674|NCT01788046|9972303|P1|Overall Study|Death|7
2896675|NCT01788046|9972302|P2|Overall Study|Lost to Follow-up|19
2896676|NCT01788046|9972303|P1|Overall Study|Lost to Follow-up|12
2896677|NCT01788046|9972302|P2|Overall Study|Withdrawal by Subject|12
2896678|NCT01788046|9972303|P1|Overall Study|Withdrawal by Subject|12
2896679|NCT01787838|9972326|P1|Overall Study|refused|1413
2896680|NCT01787825|9972330|P2|Overall Study|Data Not Analyzable|1
2896681|NCT01787825|9972331|P1|Overall Study|Data Not Analyzable|5
2896682|NCT01787825|9972330|P2|Overall Study|Subject Did Not Ingest Capsules|0
2896683|NCT01787825|9972331|P1|Overall Study|Subject Did Not Ingest Capsules|1
2896684|NCT01787760|9972349|P3|Overall Study|Near vision blur|0
2896685|NCT01787760|9972350|P2|Overall Study|Near vision blur|0
2896686|NCT01787760|9972351|P1|Overall Study|Near vision blur|1
2896687|NCT01787760|9972349|P3|Overall Study|Unsatisfactory visual response|0
2896688|NCT01787760|9972350|P2|Overall Study|Unsatisfactory visual response|1
2896689|NCT01787760|9972351|P1|Overall Study|Unsatisfactory visual response|1
2896690|NCT01787760|9972349|P3|Overall Study|Unsatisfactory physiological response|0
2896691|NCT01787760|9972350|P2|Overall Study|Unsatisfactory physiological response|4
2896692|NCT01787760|9972351|P1|Overall Study|Unsatisfactory physiological response|2
2896693|NCT01787760|9972349|P3|Overall Study|Unsatisfactory lens fitting performance|0
2896694|NCT01787760|9972350|P2|Overall Study|Unsatisfactory lens fitting performance|6
2896695|NCT01787760|9972351|P1|Overall Study|Unsatisfactory lens fitting performance|3
2896696|NCT01787760|9972349|P3|Overall Study|Stroke|0
2896697|NCT01787760|9972350|P2|Overall Study|Stroke|0
2896698|NCT01787760|9972351|P1|Overall Study|Stroke|1
2896699|NCT01787760|9972349|P3|Overall Study|Lost to Follow-up|1
2896700|NCT01787760|9972350|P2|Overall Study|Lost to Follow-up|0
2896701|NCT01787760|9972351|P1|Overall Study|Lost to Follow-up|1
2896702|NCT01787760|9972349|P3|Overall Study|Withdrawal by Subject|2
2896703|NCT01787760|9972350|P2|Overall Study|Withdrawal by Subject|1
2896704|NCT01787760|9972351|P1|Overall Study|Withdrawal by Subject|5
2896705|NCT01787760|9972349|P3|Overall Study|Protocol Violation|1
2896706|NCT01787760|9972350|P2|Overall Study|Protocol Violation|0
2896707|NCT01787760|9972351|P1|Overall Study|Protocol Violation|6
2896708|NCT01787760|9972349|P3|Overall Study|Lens handling difficulty|0
2896709|NCT01787760|9972350|P2|Overall Study|Lens handling difficulty|2
2896710|NCT01787760|9972351|P1|Overall Study|Lens handling difficulty|1
2896711|NCT01787760|9972349|P3|Overall Study|Lens discomfort|0
2896712|NCT01787760|9972350|P2|Overall Study|Lens discomfort|0
2896713|NCT01787760|9972351|P1|Overall Study|Lens discomfort|3
2896714|NCT01787760|9972349|P3|Overall Study|Relocation|0
2896715|NCT01787760|9972350|P2|Overall Study|Relocation|1
2896716|NCT01787760|9972351|P1|Overall Study|Relocation|1
2896717|NCT01787760|9972349|P3|Overall Study|Dryness|0
2896718|NCT01787760|9972350|P2|Overall Study|Dryness|1
2896719|NCT01787760|9972351|P1|Overall Study|Dryness|0
2896720|NCT01787760|9972349|P3|Overall Study|Decompensated on left exotropia|1
2896721|NCT01787760|9972350|P2|Overall Study|Decompensated on left exotropia|0
2896722|NCT01787760|9972351|P1|Overall Study|Decompensated on left exotropia|0
2896723|NCT01787760|9972349|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
2896724|NCT01787760|9972350|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
2896725|NCT01787760|9972351|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
2896726|NCT01787591|9972376|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
2896727|NCT01787591|9972377|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2896728|NCT01787591|9972378|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2896729|NCT01787591|9972379|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2896730|NCT01787552|9972409|P4|Overall Study|Progressive Disease|1
2896731|NCT01787552|9972410|P3|Overall Study|Progressive Disease|1
2896732|NCT01787552|9972411|P2|Overall Study|Progressive Disease|2
2896733|NCT01787552|9972412|P1|Overall Study|Progressive Disease|2
2896734|NCT01787552|9972409|P4|Overall Study|Study terminated by Sponsor|3
2896735|NCT01787552|9972410|P3|Overall Study|Study terminated by Sponsor|1
2896736|NCT01787552|9972411|P2|Overall Study|Study terminated by Sponsor|0
2896737|NCT01787552|9972412|P1|Overall Study|Study terminated by Sponsor|0
2896738|NCT01787552|9972409|P4|Overall Study|Adverse Event|16
2896739|NCT01787552|9972410|P3|Overall Study|Adverse Event|2
2896740|NCT01787552|9972411|P2|Overall Study|Adverse Event|5
2896741|NCT01787552|9972412|P1|Overall Study|Adverse Event|2
2896742|NCT01787552|9972409|P4|Overall Study|Death|1
2896743|NCT01787552|9972410|P3|Overall Study|Death|0
2896744|NCT01787552|9972411|P2|Overall Study|Death|0
2896745|NCT01787552|9972412|P1|Overall Study|Death|0
2896746|NCT01787552|9972409|P4|Overall Study|Physician Decision|2
2896747|NCT01787552|9972410|P3|Overall Study|Physician Decision|1
2896748|NCT01787552|9972411|P2|Overall Study|Physician Decision|2
2896749|NCT01787552|9972412|P1|Overall Study|Physician Decision|2
2896750|NCT01787552|9972409|P4|Overall Study|Withdrawal by Subject|4
2896751|NCT01787552|9972410|P3|Overall Study|Withdrawal by Subject|0
2896752|NCT01787552|9972411|P2|Overall Study|Withdrawal by Subject|0
2896753|NCT01787552|9972412|P1|Overall Study|Withdrawal by Subject|2
2896754|NCT01787461|9972482|P2|Overall Study|Protocol Violation|0
2896755|NCT01787461|9972483|P1|Overall Study|Protocol Violation|3
2896756|NCT01787461|9972482|P2|Overall Study|Withdrawal by Subject|4
2896757|NCT01787461|9972483|P1|Overall Study|Withdrawal by Subject|3
2896758|NCT01787461|9972482|P2|Overall Study|No longer met eligibility criteria|0
2896759|NCT01787461|9972483|P1|Overall Study|No longer met eligibility criteria|1
2896760|NCT01787461|9972482|P2|Overall Study|Lost to Follow-up|2
2896761|NCT01787461|9972483|P1|Overall Study|Lost to Follow-up|3
2896762|NCT01787461|9972482|P2|Overall Study|Adverse Event|3
2896763|NCT01787461|9972483|P1|Overall Study|Adverse Event|4
2896764|NCT01787331|9972532|P1|Overall Study|Withdrawal by Subject|1
2896765|NCT01787331|9972532|P1|Overall Study|Physician Decision|1
2896766|NCT01787292|9972544|P2|Home Based Exercise Program|Withdrawal by Subject|1
2896767|NCT01787292|9972545|P1|Home Based Exercise Program|Withdrawal by Subject|3
2896768|NCT01787292|9972544|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
2896769|NCT01787292|9972545|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
2896770|NCT01787279|9972562|P1|Overall Study|Lack of Efficacy|1
2896771|NCT01787279|9972562|P1|Overall Study|Lost to Follow-up|2
2896772|NCT01787188|9972588|P3|Overall Study|Other, including patient moved|0
2896773|NCT01787188|9972589|P2|Overall Study|Other, including patient moved|3
2896774|NCT01787188|9972590|P1|Overall Study|Other, including patient moved|0
2896775|NCT01787188|9972588|P3|Overall Study|Lost to Follow-up|2
2896776|NCT01787188|9972589|P2|Overall Study|Lost to Follow-up|2
2896777|NCT01787188|9972590|P1|Overall Study|Lost to Follow-up|1
2896778|NCT01787188|9972588|P3|Overall Study|Protocol Violation|3
2896779|NCT01787188|9972589|P2|Overall Study|Protocol Violation|2
2896780|NCT01787188|9972590|P1|Overall Study|Protocol Violation|3
2896781|NCT01787188|9972588|P3|Overall Study|Withdrawal by Subject|2
2896782|NCT01787188|9972589|P2|Overall Study|Withdrawal by Subject|3
2896783|NCT01787188|9972590|P1|Overall Study|Withdrawal by Subject|4
2896784|NCT01787188|9972588|P3|Overall Study|Non-compliance with Study Drug|0
2896785|NCT01787188|9972589|P2|Overall Study|Non-compliance with Study Drug|1
2896786|NCT01787188|9972590|P1|Overall Study|Non-compliance with Study Drug|0
2896787|NCT01787188|9972588|P3|Overall Study|Lack of Efficacy|5
2896788|NCT01787188|9972589|P2|Overall Study|Lack of Efficacy|3
2896789|NCT01787188|9972590|P1|Overall Study|Lack of Efficacy|7
2896790|NCT01787188|9972588|P3|Overall Study|Adverse Event|6
2896791|NCT01787188|9972589|P2|Overall Study|Adverse Event|4
2896792|NCT01787188|9972590|P1|Overall Study|Adverse Event|2
2896793|NCT01787032|9972662|P6|Overall Study|Protocol Violation|1
2896794|NCT01787032|9972663|P5|Overall Study|Protocol Violation|1
2896795|NCT01787032|9972664|P4|Overall Study|Protocol Violation|0
2896796|NCT01787032|9972665|P3|Overall Study|Protocol Violation|0
2896797|NCT01787032|9972666|P2|Overall Study|Protocol Violation|0
2896798|NCT01787032|9972667|P1|Overall Study|Protocol Violation|0
2896799|NCT01786993|9972720|P2|Overall Study|Hospice Admission|0
2896800|NCT01786993|9972721|P1|Overall Study|Hospice Admission|1
2896801|NCT01786993|9972720|P2|Overall Study|System Explant|0
2896802|NCT01786993|9972721|P1|Overall Study|System Explant|1
2896803|NCT01786993|9972720|P2|Overall Study|Subject Non-Compliance|0
2896804|NCT01786993|9972721|P1|Overall Study|Subject Non-Compliance|1
2896805|NCT01786993|9972720|P2|Overall Study|Lost to Follow-up|1
2896806|NCT01786993|9972721|P1|Overall Study|Lost to Follow-up|0
2896807|NCT01786993|9972720|P2|Overall Study|Withdrawal by Subject|2
2896808|NCT01786993|9972721|P1|Overall Study|Withdrawal by Subject|3
2896809|NCT01786993|9972720|P2|Overall Study|Death|7
2896810|NCT01786993|9972721|P1|Overall Study|Death|6
2896811|NCT01786707|9972780|P2|Overall Study|Lost to Follow-up|1
2896812|NCT01786707|9972781|P1|Overall Study|Lost to Follow-up|1
2896813|NCT01786668|9972793|P4|Overall Study|Lost to Follow-up|0
2896814|NCT01786668|9972794|P3|Overall Study|Lost to Follow-up|1
2896815|NCT01786668|9972795|P2|Overall Study|Lost to Follow-up|0
2896816|NCT01786668|9972796|P1|Overall Study|Lost to Follow-up|1
2896817|NCT01786668|9972793|P4|Overall Study|Pregnancy|1
2896818|NCT01786668|9972794|P3|Overall Study|Pregnancy|0
2896819|NCT01786668|9972795|P2|Overall Study|Pregnancy|0
2896820|NCT01786668|9972796|P1|Overall Study|Pregnancy|0
2896821|NCT01786668|9972793|P4|Overall Study|Withdrawal by Subject|1
2896822|NCT01786668|9972794|P3|Overall Study|Withdrawal by Subject|3
2896823|NCT01786668|9972795|P2|Overall Study|Withdrawal by Subject|0
2896824|NCT01786668|9972796|P1|Overall Study|Withdrawal by Subject|0
2896825|NCT01786668|9972793|P4|Overall Study|Adverse Event|2
2896826|NCT01786668|9972794|P3|Overall Study|Adverse Event|1
2896827|NCT01786668|9972795|P2|Overall Study|Adverse Event|1
2896828|NCT01786668|9972796|P1|Overall Study|Adverse Event|0
2896829|NCT01786629|9972896|P2|Overall Study|Adverse Event|1
2896830|NCT01786629|9972897|P1|Overall Study|Adverse Event|0
2896831|NCT01786629|9972896|P2|Overall Study|Lack of Efficacy|4
2896832|NCT01786629|9972897|P1|Overall Study|Lack of Efficacy|0
2896833|NCT01786603|9972905|P2|Overall Study|Lost to Follow-up|2
2896834|NCT01786603|9972906|P1|Overall Study|Lost to Follow-up|1
2896835|NCT01786603|9972905|P2|Overall Study|Physician decision to withdraw|7
2896836|NCT01786603|9972906|P1|Overall Study|Physician decision to withdraw|6
2896837|NCT01786603|9972905|P2|Overall Study|Adverse Event|2
2896838|NCT01786603|9972906|P1|Overall Study|Adverse Event|6
2896839|NCT01786603|9972905|P2|Overall Study|Death|1
2896840|NCT01786603|9972906|P1|Overall Study|Death|5
2896841|NCT01786551|9972924|P1|Overall Study|Participant withdrew consent|2
2896842|NCT01786330|9972945|P2|Overall Study|Protocol Violation|0
2896843|NCT01786330|9972946|P1|Overall Study|Protocol Violation|1
2896844|NCT01786330|9972945|P2|Overall Study|Excluded intraoperatively|1
2896845|NCT01786330|9972946|P1|Overall Study|Excluded intraoperatively|0
2896846|NCT01786330|9972945|P2|Overall Study|Lost to Follow-up|1
2896847|NCT01786330|9972946|P1|Overall Study|Lost to Follow-up|0
2896848|NCT01786330|9972945|P2|Overall Study|Withdrawal by Subject|1
2896849|NCT01786330|9972946|P1|Overall Study|Withdrawal by Subject|0
2896850|NCT01786174|9972998|P2|Overall Study|Discontinued Study Drug|0
2896851|NCT01786174|9972999|P1|Overall Study|Discontinued Study Drug|2
2896852|NCT01786148|9973028|P2|Overall Study|Incarceration|1
2896853|NCT01786148|9973029|P1|Overall Study|Incarceration|1
2896854|NCT01786148|9973028|P2|Overall Study|Withdrawal by Subject|7
2896855|NCT01786148|9973029|P1|Overall Study|Withdrawal by Subject|0
2896856|NCT01786148|9973028|P2|Overall Study|Death|1
2896857|NCT01786148|9973029|P1|Overall Study|Death|0
2896858|NCT01786148|9973028|P2|Overall Study|Lost to Follow-up|13
2896859|NCT01786148|9973029|P1|Overall Study|Lost to Follow-up|21
2896860|NCT01786109|9973044|P3|Overall Study|adverse effects colon preparation|1
2896861|NCT01786109|9973045|P2|Overall Study|adverse effects colon preparation|0
2896862|NCT01786109|9973046|P1|Overall Study|adverse effects colon preparation|0
2896863|NCT01786109|9973044|P3|Overall Study|unrelated illness|1
2896864|NCT01786109|9973045|P2|Overall Study|unrelated illness|0
2896865|NCT01786109|9973046|P1|Overall Study|unrelated illness|0
2896866|NCT01786109|9973044|P3|Overall Study|fail manometry barostat tube placement|0
2896867|NCT01786109|9973045|P2|Overall Study|fail manometry barostat tube placement|0
2896868|NCT01786109|9973046|P1|Overall Study|fail manometry barostat tube placement|1
2896869|NCT01785875|9973075|P3|Overall Study|Missing|3
2896870|NCT01785875|9973076|P2|Overall Study|Missing|1
2896871|NCT01785875|9973077|P1|Overall Study|Missing|0
2896872|NCT01785875|9973075|P3|Overall Study|Protocol Specified Criteria|55
2896873|NCT01785875|9973076|P2|Overall Study|Protocol Specified Criteria|214
2896874|NCT01785875|9973077|P1|Overall Study|Protocol Specified Criteria|207
2896875|NCT01785875|9973075|P3|Overall Study|Sponsor Decision|0
2896876|NCT01785875|9973076|P2|Overall Study|Sponsor Decision|2
2896877|NCT01785875|9973077|P1|Overall Study|Sponsor Decision|0
2896878|NCT01785875|9973075|P3|Overall Study|Death|7
2896879|NCT01785875|9973076|P2|Overall Study|Death|16
2896880|NCT01785875|9973077|P1|Overall Study|Death|27
2896881|NCT01785875|9973075|P3|Overall Study|Lost to Follow-up|6
2896882|NCT01785875|9973076|P2|Overall Study|Lost to Follow-up|22
2896883|NCT01785875|9973077|P1|Overall Study|Lost to Follow-up|19
2896884|NCT01785875|9973075|P3|Overall Study|Withdrawal by Subject|36
2896885|NCT01785875|9973076|P2|Overall Study|Withdrawal by Subject|34
2896886|NCT01785875|9973077|P1|Overall Study|Withdrawal by Subject|41
2896887|NCT01785849|9973146|P2|Overall Study|Lost to Follow-up|11
2896888|NCT01785849|9973147|P1|Overall Study|Lost to Follow-up|10
2896889|NCT01785849|9973146|P2|Overall Study|Sponsor Decision|1
2896890|NCT01785849|9973147|P1|Overall Study|Sponsor Decision|0
2896891|NCT01785849|9973146|P2|Overall Study|Withdrawal by Subject|12
2896892|NCT01785849|9973147|P1|Overall Study|Withdrawal by Subject|15
2896893|NCT01785849|9973146|P2|Overall Study|Protocol Specified Criteria|1
2896894|NCT01785849|9973147|P1|Overall Study|Protocol Specified Criteria|29
2896895|NCT01785849|9973146|P2|Overall Study|Death|9
2896896|NCT01785849|9973147|P1|Overall Study|Death|7
2896897|NCT01785628|9973180|P2|Overall Study|Lost to Follow-up|3
2896898|NCT01785628|9973181|P1|Overall Study|Lost to Follow-up|2
2896899|NCT01785615|9973204|P4|Dietary Phase|Lost to Follow-up|24
2896900|NCT01785615|9973205|P3|Dietary Phase|Lost to Follow-up|0
2896901|NCT01785615|9973206|P2|Dietary Phase|Lost to Follow-up|0
2896902|NCT01785615|9973207|P1|Dietary Phase|Lost to Follow-up|0
2896903|NCT01785602|9973279|P2|Overall Study|Administrative problems|3
2896904|NCT01785602|9973280|P1|Overall Study|Administrative problems|7
2896905|NCT01785602|9973279|P2|Overall Study|Adverse Event|5
2896906|NCT01785602|9973280|P1|Overall Study|Adverse Event|3
2896907|NCT01785602|9973279|P2|Overall Study|Lost to Follow-up|1
2896908|NCT01785602|9973280|P1|Overall Study|Lost to Follow-up|1
2896909|NCT01785602|9973279|P2|Overall Study|Withdrawal by Subject|0
2896910|NCT01785602|9973280|P1|Overall Study|Withdrawal by Subject|2
2896911|NCT01785524|9973290|P2|Overall Study|Withdrawal by Subject|2
2896912|NCT01785524|9973291|P1|Overall Study|Withdrawal by Subject|2
2896913|NCT01785472|9973310|P3|Overall Study|Technical problems|1
2896914|NCT01785472|9973311|P2|Overall Study|Technical problems|0
2896915|NCT01785472|9973312|P1|Overall Study|Technical problems|0
2896916|NCT01785472|9973310|P3|Overall Study|Subject/guardian decision|11
2896917|NCT01785472|9973311|P2|Overall Study|Subject/guardian decision|10
2896918|NCT01785472|9973312|P1|Overall Study|Subject/guardian decision|15
2896919|NCT01785472|9973310|P3|Overall Study|Protocol deviation|2
2896920|NCT01785472|9973311|P2|Overall Study|Protocol deviation|2
2896921|NCT01785472|9973312|P1|Overall Study|Protocol deviation|0
2896922|NCT01785472|9973310|P3|Overall Study|Physician Decision|1
2896923|NCT01785472|9973311|P2|Overall Study|Physician Decision|1
2896924|NCT01785472|9973312|P1|Overall Study|Physician Decision|1
2896925|NCT01785472|9973310|P3|Overall Study|Lost to Follow-up|0
2896926|NCT01785472|9973311|P2|Overall Study|Lost to Follow-up|2
2896927|NCT01785472|9973312|P1|Overall Study|Lost to Follow-up|1
2896928|NCT01785472|9973310|P3|Overall Study|Lack of Efficacy|1
2896929|NCT01785472|9973311|P2|Overall Study|Lack of Efficacy|0
2896930|NCT01785472|9973312|P1|Overall Study|Lack of Efficacy|2
2896931|NCT01785472|9973310|P3|Overall Study|Adverse Event|6
2896932|NCT01785472|9973311|P2|Overall Study|Adverse Event|4
2896933|NCT01785472|9973312|P1|Overall Study|Adverse Event|5
2896934|NCT01785160|9973398|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
2896935|NCT01785160|9973398|P1|Treatment Period 1: Raltegravir|Not treated|1
2896936|NCT01784965|9973454|P2|Overall Study|Adverse Event|8
2896937|NCT01784965|9973455|P1|Overall Study|Adverse Event|0
2896938|NCT01784965|9973454|P2|Overall Study|Withdrawal by Subject|3
2896939|NCT01784965|9973455|P1|Overall Study|Withdrawal by Subject|6
2896940|NCT01784211|9973578|P6|Part A (Days 1-15)|Withdrawal by Subject|0
2896941|NCT01784211|9973579|P5|Part A (Days 1-15)|Withdrawal by Subject|0
2896942|NCT01784211|9973580|P4|Part A (Days 1-15)|Withdrawal by Subject|0
2896943|NCT01784211|9973581|P3|Part A (Days 1-15)|Withdrawal by Subject|0
2896944|NCT01784211|9973582|P2|Part A (Days 1-15)|Withdrawal by Subject|1
2896945|NCT01784211|9973583|P1|Part A (Days 1-15)|Withdrawal by Subject|2
2896946|NCT01784211|9973578|P6|Part A (Days 1-15)|Adverse Event|0
2896947|NCT01784211|9973579|P5|Part A (Days 1-15)|Adverse Event|0
2896948|NCT01784211|9973580|P4|Part A (Days 1-15)|Adverse Event|0
2896949|NCT01784211|9973581|P3|Part A (Days 1-15)|Adverse Event|0
2896950|NCT01784211|9973582|P2|Part A (Days 1-15)|Adverse Event|1
2896951|NCT01784211|9973583|P1|Part A (Days 1-15)|Adverse Event|1
2896952|NCT01784029|9973608|P3|Overall Study|Lost to Follow-up|22
2896953|NCT01784029|9973609|P2|Overall Study|Lost to Follow-up|20
2896954|NCT01784029|9973610|P1|Overall Study|Lost to Follow-up|19
2896955|NCT01783938|9973620|P2|Overall Study|Other|0
2896956|NCT01783938|9973621|P1|Overall Study|Other|1
2896957|NCT01783938|9973620|P2|Overall Study|Withdrew Consent|0
2896958|NCT01783938|9973621|P1|Overall Study|Withdrew Consent|3
2896959|NCT01783938|9973620|P2|Overall Study|Request to Discontinue Study Treatment|2
2896960|NCT01783938|9973621|P1|Overall Study|Request to Discontinue Study Treatment|1
2896961|NCT01783938|9973620|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
2896962|NCT01783938|9973621|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
2896963|NCT01783938|9973620|P2|Overall Study|Study Drug Toxicity|10
2896964|NCT01783938|9973621|P1|Overall Study|Study Drug Toxicity|22
2896965|NCT01783938|9973620|P2|Overall Study|Disease Progression|39
2896966|NCT01783938|9973621|P1|Overall Study|Disease Progression|18
2896967|NCT01783886|9973649|P3|Overall Study|Adverse Event|4
2896968|NCT01783886|9973650|P2|Overall Study|Adverse Event|5
2896969|NCT01783886|9973651|P1|Overall Study|Adverse Event|4
2896970|NCT01783886|9973649|P3|Overall Study|Withdrawal of consent by participant|4
2896971|NCT01783886|9973650|P2|Overall Study|Withdrawal of consent by participant|3
2896972|NCT01783886|9973651|P1|Overall Study|Withdrawal of consent by participant|1
2896973|NCT01783886|9973649|P3|Overall Study|Protocol deviation|2
2896974|NCT01783886|9973650|P2|Overall Study|Protocol deviation|0
2896975|NCT01783886|9973651|P1|Overall Study|Protocol deviation|0
2896976|NCT01783886|9973649|P3|Overall Study|Lost to Follow-up|0
2896977|NCT01783886|9973650|P2|Overall Study|Lost to Follow-up|3
2896978|NCT01783886|9973651|P1|Overall Study|Lost to Follow-up|0
2896979|NCT01783821|9973714|P2|Overall Study|Screen Failure|1
2896980|NCT01783821|9973715|P1|Overall Study|Screen Failure|1
2896981|NCT01783743|9973733|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
2896982|NCT01783743|9973734|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
2896983|NCT01783743|9973733|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
2896984|NCT01783743|9973734|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
2896985|NCT01783743|9973733|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
2896986|NCT01783743|9973734|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
2896987|NCT01783730|9973748|P1|Overall Study|Failed to meet inclusion criteria|6
2896988|NCT01783678|9973773|P6|Overall Study|Withdrew Consent|0
2896989|NCT01783678|9973774|P5|Overall Study|Withdrew Consent|0
2896990|NCT01783678|9973775|P4|Overall Study|Withdrew Consent|2
2896991|NCT01783678|9973776|P3|Overall Study|Withdrew Consent|0
2896992|NCT01783678|9973777|P2|Overall Study|Withdrew Consent|1
2896993|NCT01783678|9973778|P1|Overall Study|Withdrew Consent|1
2896994|NCT01783678|9973773|P6|Overall Study|Lost to Follow-up|0
2896995|NCT01783678|9973774|P5|Overall Study|Lost to Follow-up|1
2896996|NCT01783678|9973775|P4|Overall Study|Lost to Follow-up|2
2896997|NCT01783678|9973776|P3|Overall Study|Lost to Follow-up|0
2896998|NCT01783678|9973777|P2|Overall Study|Lost to Follow-up|4
2896999|NCT01783678|9973778|P1|Overall Study|Lost to Follow-up|0
2897000|NCT01783678|9973773|P6|Overall Study|Lack of Efficacy|5
2897001|NCT01783678|9973774|P5|Overall Study|Lack of Efficacy|6
2897002|NCT01783678|9973775|P4|Overall Study|Lack of Efficacy|3
2897003|NCT01783678|9973776|P3|Overall Study|Lack of Efficacy|1
2897004|NCT01783678|9973777|P2|Overall Study|Lack of Efficacy|13
2897005|NCT01783678|9973778|P1|Overall Study|Lack of Efficacy|1
2897006|NCT01783678|9973773|P6|Overall Study|Randomized but Not Treated|0
2897007|NCT01783678|9973774|P5|Overall Study|Randomized but Not Treated|0
2897008|NCT01783678|9973775|P4|Overall Study|Randomized but Not Treated|1
2897009|NCT01783678|9973776|P3|Overall Study|Randomized but Not Treated|0
2897010|NCT01783678|9973777|P2|Overall Study|Randomized but Not Treated|0
2897011|NCT01783678|9973778|P1|Overall Study|Randomized but Not Treated|0
2897012|NCT01783548|9973882|P2|Overall Study|Lack of Efficacy|1
2897013|NCT01783548|9973883|P1|Overall Study|Lack of Efficacy|1
2897014|NCT01783548|9973882|P2|Overall Study|Lost to Follow-up|3
2897015|NCT01783548|9973883|P1|Overall Study|Lost to Follow-up|8
2897016|NCT01783548|9973882|P2|Overall Study|Protocol Violation|2
2897017|NCT01783548|9973883|P1|Overall Study|Protocol Violation|2
2897018|NCT01783548|9973882|P2|Overall Study|Non-compliance|0
2897019|NCT01783548|9973883|P1|Overall Study|Non-compliance|4
2897020|NCT01783548|9973882|P2|Overall Study|Withdrawal by Subject|8
2897021|NCT01783548|9973883|P1|Overall Study|Withdrawal by Subject|11
2897022|NCT01783548|9973882|P2|Overall Study|Adverse Event|4
2897023|NCT01783548|9973883|P1|Overall Study|Adverse Event|8
2897024|NCT01783496|9973916|P6|Overall Study|Withdrawal by Subject|0
2897025|NCT01783496|9973917|P5|Overall Study|Withdrawal by Subject|0
2897026|NCT01783496|9973918|P4|Overall Study|Withdrawal by Subject|0
2897027|NCT01783496|9973919|P3|Overall Study|Withdrawal by Subject|0
2897028|NCT01783496|9973920|P2|Overall Study|Withdrawal by Subject|0
2897029|NCT01783496|9973921|P1|Overall Study|Withdrawal by Subject|1
2897030|NCT01783496|9973916|P6|Overall Study|Lost to Follow-up|1
2897031|NCT01783496|9973917|P5|Overall Study|Lost to Follow-up|0
2897032|NCT01783496|9973918|P4|Overall Study|Lost to Follow-up|2
2897033|NCT01783496|9973919|P3|Overall Study|Lost to Follow-up|0
2897034|NCT01783496|9973920|P2|Overall Study|Lost to Follow-up|0
2897035|NCT01783496|9973921|P1|Overall Study|Lost to Follow-up|0
2897036|NCT01783483|9973949|P2|Overall Study|Physician Decision|1
2897037|NCT01783483|9973950|P1|Overall Study|Physician Decision|1
2897038|NCT01783483|9973949|P2|Overall Study|Withdrawal by Subject|1
2897039|NCT01783483|9973950|P1|Overall Study|Withdrawal by Subject|2
2897040|NCT01783483|9973949|P2|Overall Study|Lost to Follow-up|10
2897041|NCT01783483|9973950|P1|Overall Study|Lost to Follow-up|14
2897042|NCT01783483|9973949|P2|Overall Study|Death|3
2897043|NCT01783483|9973950|P1|Overall Study|Death|3
2897044|NCT01783418|9973988|P2|Overall Study|Withdrawal by Subject|0
2897045|NCT01783418|9973989|P1|Overall Study|Withdrawal by Subject|1
2897046|NCT01783015|9974042|P3|Open Label Treatment|Study Terminated by Sponsor|6
2897047|NCT01783015|9974043|P2|Open Label Treatment|Study Terminated by Sponsor|0
2897048|NCT01783015|9974044|P1|Open Label Treatment|Study Terminated by Sponsor|0
2897049|NCT01783015|9974042|P3|Blinded Treatment|Study Terminated by Sponsor|0
2897050|NCT01783015|9974043|P2|Blinded Treatment|Study Terminated by Sponsor|0
2897051|NCT01783015|9974044|P1|Blinded Treatment|Study Terminated by Sponsor|2
2897052|NCT01783015|9974042|P3|Blinded Treatment|Withdrawal by Subject|0
2897053|NCT01783015|9974043|P2|Blinded Treatment|Withdrawal by Subject|1
2897054|NCT01783015|9974044|P1|Blinded Treatment|Withdrawal by Subject|0
2897055|NCT01783015|9974042|P3|Blinded Treatment|Protocol Violation|0
2897056|NCT01783015|9974043|P2|Blinded Treatment|Protocol Violation|1
2897057|NCT01783015|9974044|P1|Blinded Treatment|Protocol Violation|0
2897058|NCT01783015|9974042|P3|Blinded Treatment|Adverse Event|0
2897059|NCT01783015|9974043|P2|Blinded Treatment|Adverse Event|1
2897060|NCT01783015|9974044|P1|Blinded Treatment|Adverse Event|0
2897061|NCT01782885|9974157|P2|Overall Study|Lost to Follow-up|6
2897062|NCT01782885|9974158|P1|Overall Study|Lost to Follow-up|4
2897063|NCT01782872|9974184|P4|Overall Study|Withdrawal by Subject|0
2897064|NCT01782872|9974185|P3|Overall Study|Withdrawal by Subject|0
2897065|NCT01782872|9974186|P2|Overall Study|Withdrawal by Subject|1
2897066|NCT01782872|9974187|P1|Overall Study|Withdrawal by Subject|0
2897067|NCT01782872|9974184|P4|Overall Study|Protocol Violation|1
2897068|NCT01782872|9974185|P3|Overall Study|Protocol Violation|0
2897069|NCT01782872|9974186|P2|Overall Study|Protocol Violation|0
2897070|NCT01782872|9974187|P1|Overall Study|Protocol Violation|0
2897071|NCT01782859|9974211|P2|Overall Study|Withdrawal by Subject|1
2897072|NCT01782859|9974212|P1|Overall Study|Withdrawal by Subject|0
2897073|NCT01782859|9974211|P2|Overall Study|Protocol Violation|6
2897074|NCT01782859|9974212|P1|Overall Study|Protocol Violation|6
2897075|NCT01782742|9974234|P2|Double-blind Treatment Phase|Adverse Event|0
2897076|NCT01782742|9974235|P1|Double-blind Treatment Phase|Adverse Event|1
2897077|NCT01782690|9974268|P1|Overall Study|Study completion unknown|7
2897078|NCT01782690|9974268|P1|Overall Study|Death|133
2897079|NCT01782690|9974268|P1|Overall Study|Tumor progression|74
2897080|NCT01782690|9974268|P1|Overall Study|Patient's wish|21
2897081|NCT01782690|9974268|P1|Overall Study|Physician Decision|13
2897082|NCT01782690|9974268|P1|Overall Study|Absent rash|9
2897083|NCT01782690|9974268|P1|Overall Study|Withdrawal of informed consent|2
2897084|NCT01782690|9974268|P1|Overall Study|Lost to Follow-up|31
2897085|NCT01782690|9974268|P1|Overall Study|Toxicity of erlotinib|1
2897086|NCT01782690|9974268|P1|Overall Study|Toxicity of gemcitabine|1
2897087|NCT01782690|9974268|P1|Overall Study|Not reported|7
2897088|NCT01782664|9974290|P6|Overall Study|Withdrawal by Subject|0
2897089|NCT01782664|9974291|P5|Overall Study|Withdrawal by Subject|0
2897090|NCT01782664|9974292|P4|Overall Study|Withdrawal by Subject|0
2897091|NCT01782664|9974293|P3|Overall Study|Withdrawal by Subject|0
2897092|NCT01782664|9974294|P2|Overall Study|Withdrawal by Subject|2
2897093|NCT01782664|9974295|P1|Overall Study|Withdrawal by Subject|2
2897094|NCT01782664|9974290|P6|Overall Study|Protocol Violation|0
2897095|NCT01782664|9974291|P5|Overall Study|Protocol Violation|0
2897096|NCT01782664|9974292|P4|Overall Study|Protocol Violation|1
2897097|NCT01782664|9974293|P3|Overall Study|Protocol Violation|0
2897098|NCT01782664|9974294|P2|Overall Study|Protocol Violation|1
2897099|NCT01782664|9974295|P1|Overall Study|Protocol Violation|0
2897100|NCT01782664|9974290|P6|Overall Study|Lack of Efficacy|0
2897101|NCT01782664|9974291|P5|Overall Study|Lack of Efficacy|0
2897102|NCT01782664|9974292|P4|Overall Study|Lack of Efficacy|2
2897103|NCT01782664|9974293|P3|Overall Study|Lack of Efficacy|2
2897104|NCT01782664|9974294|P2|Overall Study|Lack of Efficacy|0
2897105|NCT01782664|9974295|P1|Overall Study|Lack of Efficacy|2
2897106|NCT01782664|9974290|P6|Overall Study|Adverse Event|0
2897107|NCT01782664|9974291|P5|Overall Study|Adverse Event|0
2897108|NCT01782664|9974292|P4|Overall Study|Adverse Event|2
2897109|NCT01782664|9974293|P3|Overall Study|Adverse Event|2
2897110|NCT01782664|9974294|P2|Overall Study|Adverse Event|2
2897111|NCT01782664|9974295|P1|Overall Study|Adverse Event|2
2897112|NCT01782495|9974452|P11|Overall Study|Withdrew Consent|0
2897113|NCT01782495|9974453|P10|Overall Study|Withdrew Consent|0
2897114|NCT01782495|9974454|P9|Overall Study|Withdrew Consent|0
2897115|NCT01782495|9974455|P8|Overall Study|Withdrew Consent|1
2897116|NCT01782495|9974456|P7|Overall Study|Withdrew Consent|0
2897117|NCT01782495|9974457|P6|Overall Study|Withdrew Consent|0
2897118|NCT01782495|9974458|P5|Overall Study|Withdrew Consent|0
2897119|NCT01782495|9974459|P4|Overall Study|Withdrew Consent|0
2897120|NCT01782495|9974460|P3|Overall Study|Withdrew Consent|0
2897121|NCT01782495|9974461|P2|Overall Study|Withdrew Consent|1
2897122|NCT01782495|9974462|P1|Overall Study|Withdrew Consent|0
2897123|NCT01782495|9974452|P11|Overall Study|Adverse Event|0
2897124|NCT01782495|9974453|P10|Overall Study|Adverse Event|0
2897125|NCT01782495|9974454|P9|Overall Study|Adverse Event|0
2897126|NCT01782495|9974455|P8|Overall Study|Adverse Event|2
2897127|NCT01782495|9974456|P7|Overall Study|Adverse Event|0
2897128|NCT01782495|9974457|P6|Overall Study|Adverse Event|0
2897129|NCT01782495|9974458|P5|Overall Study|Adverse Event|0
2897130|NCT01782495|9974459|P4|Overall Study|Adverse Event|0
2897131|NCT01782495|9974460|P3|Overall Study|Adverse Event|0
2897132|NCT01782495|9974461|P2|Overall Study|Adverse Event|0
2897133|NCT01782495|9974462|P1|Overall Study|Adverse Event|0
2897134|NCT01782482|9974521|P2|Overall Study|Habitually wearing toric lens OS|1
2897135|NCT01782482|9974522|P1|Overall Study|Habitually wearing toric lens OS|0
2897136|NCT01782482|9974521|P2|Overall Study|Randomized in Error|2
2897137|NCT01782482|9974522|P1|Overall Study|Randomized in Error|2
2897138|NCT01782482|9974521|P2|Overall Study|Withdrawal by Subject|3
2897139|NCT01782482|9974522|P1|Overall Study|Withdrawal by Subject|2
2897140|NCT01782482|9974521|P2|Overall Study|Protocol Violation|0
2897141|NCT01782482|9974522|P1|Overall Study|Protocol Violation|1
2897142|NCT01782482|9974521|P2|Overall Study|Physician Decision|0
2897143|NCT01782482|9974522|P1|Overall Study|Physician Decision|1
2897144|NCT01782482|9974521|P2|Overall Study|Lost to Follow-up|3
2897145|NCT01782482|9974522|P1|Overall Study|Lost to Follow-up|2
2897146|NCT01782482|9974521|P2|Overall Study|Adverse Event|1
2897147|NCT01782482|9974522|P1|Overall Study|Adverse Event|2
2897148|NCT01782469|9974530|P1|Overall Study|Lost to Follow-up|1
2897149|NCT01782378|9974540|P2|Second Series|Did not choose to complete S2 Optional|0
2897150|NCT01782378|9974541|P1|Second Series|Did not choose to complete S2 Optional|18
2897151|NCT01782378|9974540|P2|Second Series|Lost to Follow-up|7
2897152|NCT01782378|9974541|P1|Second Series|Lost to Follow-up|8
2897153|NCT01782378|9974540|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
2897154|NCT01782378|9974541|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
2897155|NCT01782378|9974540|P2|First Series|Lost to Follow-up|8
2897156|NCT01782378|9974541|P1|First Series|Lost to Follow-up|7
2897157|NCT01782326|9974607|P2|Double-blind Treatment|Technical problems|5
2897158|NCT01782326|9974608|P1|Double-blind Treatment|Technical problems|0
2897159|NCT01782326|9974607|P2|Double-blind Treatment|Protocol deviation|7
2897160|NCT01782326|9974608|P1|Double-blind Treatment|Protocol deviation|8
2897161|NCT01782326|9974607|P2|Double-blind Treatment|Physician Decision|16
2897162|NCT01782326|9974608|P1|Double-blind Treatment|Physician Decision|13
2897163|NCT01782326|9974607|P2|Double-blind Treatment|Lack of Efficacy|22
2897164|NCT01782326|9974608|P1|Double-blind Treatment|Lack of Efficacy|17
2897165|NCT01782326|9974607|P2|Double-blind Treatment|Subject/guardian decision|125
2897166|NCT01782326|9974608|P1|Double-blind Treatment|Subject/guardian decision|111
2897167|NCT01782326|9974607|P2|Double-blind Treatment|Adverse Event|145
2897168|NCT01782326|9974608|P1|Double-blind Treatment|Adverse Event|129
2897169|NCT01782326|9974607|P2|Planned Treatment Epoch|Technical problems|4
2897170|NCT01782326|9974608|P1|Planned Treatment Epoch|Technical problems|0
2897171|NCT01782326|9974607|P2|Planned Treatment Epoch|Lost to Follow-up|4
2897172|NCT01782326|9974608|P1|Planned Treatment Epoch|Lost to Follow-up|4
2897173|NCT01782326|9974607|P2|Planned Treatment Epoch|Protocol deviation|3
2897174|NCT01782326|9974608|P1|Planned Treatment Epoch|Protocol deviation|2
2897175|NCT01782326|9974607|P2|Planned Treatment Epoch|Physician Decision|16
2897176|NCT01782326|9974608|P1|Planned Treatment Epoch|Physician Decision|18
2897177|NCT01782326|9974607|P2|Planned Treatment Epoch|Death|30
2897178|NCT01782326|9974608|P1|Planned Treatment Epoch|Death|29
2897179|NCT01782326|9974607|P2|Planned Treatment Epoch|Subject/guardian decision|151
2897180|NCT01782326|9974608|P1|Planned Treatment Epoch|Subject/guardian decision|149
2897181|NCT01782313|9974668|P1|Survival Follow up|Lost to Follow-up|1
2897182|NCT01782313|9974668|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
2897183|NCT01782313|9974668|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
2897184|NCT01782313|9974668|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
2897185|NCT01782313|9974668|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
2897186|NCT01782313|9974668|P1|Treated Cycle 3|Progressive Disease|21
2897187|NCT01782313|9974668|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
2897188|NCT01782313|9974668|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
2897189|NCT01782222|9974682|P3|Overall Study|Moved to other state|0
2897190|NCT01782222|9974683|P2|Overall Study|Moved to other state|1
2897191|NCT01782222|9974684|P1|Overall Study|Moved to other state|0
2897192|NCT01782222|9974682|P3|Overall Study|Withdrawal by Subject|1
2897193|NCT01782222|9974683|P2|Overall Study|Withdrawal by Subject|4
2897194|NCT01782222|9974684|P1|Overall Study|Withdrawal by Subject|1
2897195|NCT01782222|9974682|P3|Overall Study|Protocol Violation|0
2897196|NCT01782222|9974683|P2|Overall Study|Protocol Violation|0
2897197|NCT01782222|9974684|P1|Overall Study|Protocol Violation|1
2897198|NCT01782222|9974682|P3|Overall Study|Lack of Efficacy|0
2897199|NCT01782222|9974683|P2|Overall Study|Lack of Efficacy|1
2897200|NCT01782222|9974684|P1|Overall Study|Lack of Efficacy|2
2897201|NCT01782222|9974682|P3|Overall Study|Adverse Event|3
2897202|NCT01782222|9974683|P2|Overall Study|Adverse Event|5
2897203|NCT01782222|9974684|P1|Overall Study|Adverse Event|4
2897204|NCT01781975|9974718|P2|Overall Study|Withdrawal by Subject|1
2897205|NCT01781975|9974719|P1|Overall Study|Withdrawal by Subject|1
2897206|NCT01781975|9974718|P2|Overall Study|Death|0
2897207|NCT01781975|9974719|P1|Overall Study|Death|1
2897208|NCT01781962|9974735|P1|Overall Study|Other Miscellaneous Reasons|5
2897209|NCT01781832|9974741|P1|Overall Study|Withdrawal by Subject|1
2897210|NCT01781637|9974761|P2|Overall Study|Withdrawal by Subject|0
2897211|NCT01781637|9974762|P1|Overall Study|Withdrawal by Subject|1
2897212|NCT01781637|9974761|P2|Overall Study|Lack of Efficacy|6
2897213|NCT01781637|9974762|P1|Overall Study|Lack of Efficacy|2
2897214|NCT01781637|9974761|P2|Overall Study|Adverse Event|0
2897215|NCT01781637|9974762|P1|Overall Study|Adverse Event|1
2897216|NCT01781429|9974869|P16|Overall Study|Enrolled, but not treated|0
2897217|NCT01781429|9974870|P15|Overall Study|Enrolled, but not treated|0
2897218|NCT01781429|9974871|P14|Overall Study|Enrolled, but not treated|0
2897219|NCT01781429|9974872|P13|Overall Study|Enrolled, but not treated|0
2897220|NCT01781429|9974873|P12|Overall Study|Enrolled, but not treated|0
2897221|NCT01781429|9974874|P11|Overall Study|Enrolled, but not treated|1
2897222|NCT01781429|9974875|P10|Overall Study|Enrolled, but not treated|0
2897223|NCT01781429|9974876|P9|Overall Study|Enrolled, but not treated|0
2897224|NCT01781429|9974877|P8|Overall Study|Enrolled, but not treated|0
2897225|NCT01781429|9974878|P7|Overall Study|Enrolled, but not treated|0
2897226|NCT01781429|9974879|P6|Overall Study|Enrolled, but not treated|0
2897227|NCT01781429|9974880|P5|Overall Study|Enrolled, but not treated|0
2897228|NCT01781429|9974881|P4|Overall Study|Enrolled, but not treated|0
2897229|NCT01781429|9974882|P3|Overall Study|Enrolled, but not treated|0
2897230|NCT01781429|9974883|P2|Overall Study|Enrolled, but not treated|0
2897231|NCT01781429|9974884|P1|Overall Study|Enrolled, but not treated|0
2897232|NCT01781429|9974869|P16|Overall Study|Other - as entered by PI in eCRF|0
2897233|NCT01781429|9974870|P15|Overall Study|Other - as entered by PI in eCRF|1
2897234|NCT01781429|9974871|P14|Overall Study|Other - as entered by PI in eCRF|1
2897235|NCT01781429|9974872|P13|Overall Study|Other - as entered by PI in eCRF|1
2897236|NCT01781429|9974873|P12|Overall Study|Other - as entered by PI in eCRF|2
2897237|NCT01781429|9974874|P11|Overall Study|Other - as entered by PI in eCRF|1
2897238|NCT01781429|9974875|P10|Overall Study|Other - as entered by PI in eCRF|1
2897239|NCT01781429|9974876|P9|Overall Study|Other - as entered by PI in eCRF|0
2897240|NCT01781429|9974877|P8|Overall Study|Other - as entered by PI in eCRF|0
2897241|NCT01781429|9974878|P7|Overall Study|Other - as entered by PI in eCRF|0
2897242|NCT01781429|9974879|P6|Overall Study|Other - as entered by PI in eCRF|0
2897243|NCT01781429|9974880|P5|Overall Study|Other - as entered by PI in eCRF|0
2897244|NCT01781429|9974881|P4|Overall Study|Other - as entered by PI in eCRF|0
2897245|NCT01781429|9974882|P3|Overall Study|Other - as entered by PI in eCRF|0
2897246|NCT01781429|9974883|P2|Overall Study|Other - as entered by PI in eCRF|1
2897247|NCT01781429|9974884|P1|Overall Study|Other - as entered by PI in eCRF|0
2897248|NCT01781429|9974869|P16|Overall Study|Patient Condition Changed|0
2897249|NCT01781429|9974870|P15|Overall Study|Patient Condition Changed|0
2897250|NCT01781429|9974871|P14|Overall Study|Patient Condition Changed|1
2897251|NCT01781429|9974872|P13|Overall Study|Patient Condition Changed|0
2897252|NCT01781429|9974873|P12|Overall Study|Patient Condition Changed|1
2897253|NCT01781429|9974874|P11|Overall Study|Patient Condition Changed|0
2897254|NCT01781429|9974875|P10|Overall Study|Patient Condition Changed|4
2897255|NCT01781429|9974876|P9|Overall Study|Patient Condition Changed|0
2897256|NCT01781429|9974877|P8|Overall Study|Patient Condition Changed|0
2897257|NCT01781429|9974878|P7|Overall Study|Patient Condition Changed|0
2897258|NCT01781429|9974879|P6|Overall Study|Patient Condition Changed|0
2897259|NCT01781429|9974880|P5|Overall Study|Patient Condition Changed|0
2897260|NCT01781429|9974881|P4|Overall Study|Patient Condition Changed|0
2897261|NCT01781429|9974882|P3|Overall Study|Patient Condition Changed|0
2897262|NCT01781429|9974883|P2|Overall Study|Patient Condition Changed|0
2897263|NCT01781429|9974884|P1|Overall Study|Patient Condition Changed|0
2897264|NCT01781429|9974869|P16|Overall Study|Unacceptable Toxicity|0
2897265|NCT01781429|9974870|P15|Overall Study|Unacceptable Toxicity|0
2897266|NCT01781429|9974871|P14|Overall Study|Unacceptable Toxicity|0
2897267|NCT01781429|9974872|P13|Overall Study|Unacceptable Toxicity|0
2897268|NCT01781429|9974873|P12|Overall Study|Unacceptable Toxicity|2
2897269|NCT01781429|9974874|P11|Overall Study|Unacceptable Toxicity|0
2897270|NCT01781429|9974875|P10|Overall Study|Unacceptable Toxicity|0
2897271|NCT01781429|9974876|P9|Overall Study|Unacceptable Toxicity|0
2897272|NCT01781429|9974877|P8|Overall Study|Unacceptable Toxicity|0
2897273|NCT01781429|9974878|P7|Overall Study|Unacceptable Toxicity|0
2897274|NCT01781429|9974879|P6|Overall Study|Unacceptable Toxicity|0
2897275|NCT01781429|9974880|P5|Overall Study|Unacceptable Toxicity|0
2897276|NCT01781429|9974881|P4|Overall Study|Unacceptable Toxicity|0
2897277|NCT01781429|9974882|P3|Overall Study|Unacceptable Toxicity|0
2897278|NCT01781429|9974883|P2|Overall Study|Unacceptable Toxicity|0
2897279|NCT01781429|9974884|P1|Overall Study|Unacceptable Toxicity|0
2897280|NCT01781429|9974869|P16|Overall Study|Disease Progression|0
2897281|NCT01781429|9974870|P15|Overall Study|Disease Progression|11
2897282|NCT01781429|9974871|P14|Overall Study|Disease Progression|4
2897283|NCT01781429|9974872|P13|Overall Study|Disease Progression|15
2897284|NCT01781429|9974873|P12|Overall Study|Disease Progression|15
2897285|NCT01781429|9974874|P11|Overall Study|Disease Progression|15
2897286|NCT01781429|9974875|P10|Overall Study|Disease Progression|15
2897287|NCT01781429|9974876|P9|Overall Study|Disease Progression|6
2897288|NCT01781429|9974877|P8|Overall Study|Disease Progression|4
2897289|NCT01781429|9974878|P7|Overall Study|Disease Progression|7
2897290|NCT01781429|9974879|P6|Overall Study|Disease Progression|4
2897291|NCT01781429|9974880|P5|Overall Study|Disease Progression|1
2897292|NCT01781429|9974881|P4|Overall Study|Disease Progression|1
2897293|NCT01781429|9974882|P3|Overall Study|Disease Progression|1
2897294|NCT01781429|9974883|P2|Overall Study|Disease Progression|0
2897295|NCT01781429|9974884|P1|Overall Study|Disease Progression|1
2897296|NCT01781429|9974869|P16|Overall Study|Withdrawal by Subject|0
2897297|NCT01781429|9974870|P15|Overall Study|Withdrawal by Subject|3
2897298|NCT01781429|9974871|P14|Overall Study|Withdrawal by Subject|2
2897299|NCT01781429|9974872|P13|Overall Study|Withdrawal by Subject|5
2897300|NCT01781429|9974873|P12|Overall Study|Withdrawal by Subject|1
2897301|NCT01781429|9974874|P11|Overall Study|Withdrawal by Subject|1
2897302|NCT01781429|9974875|P10|Overall Study|Withdrawal by Subject|3
2897303|NCT01781429|9974876|P9|Overall Study|Withdrawal by Subject|1
2897304|NCT01781429|9974877|P8|Overall Study|Withdrawal by Subject|0
2897305|NCT01781429|9974878|P7|Overall Study|Withdrawal by Subject|0
2897306|NCT01781429|9974879|P6|Overall Study|Withdrawal by Subject|0
2897307|NCT01781429|9974880|P5|Overall Study|Withdrawal by Subject|0
2897308|NCT01781429|9974881|P4|Overall Study|Withdrawal by Subject|0
2897309|NCT01781429|9974882|P3|Overall Study|Withdrawal by Subject|0
2897310|NCT01781429|9974883|P2|Overall Study|Withdrawal by Subject|0
2897311|NCT01781429|9974884|P1|Overall Study|Withdrawal by Subject|0
2897312|NCT01781429|9974869|P16|Overall Study|Death|0
2897313|NCT01781429|9974870|P15|Overall Study|Death|1
2897314|NCT01781429|9974871|P14|Overall Study|Death|0
2897315|NCT01781429|9974872|P13|Overall Study|Death|1
2897316|NCT01781429|9974873|P12|Overall Study|Death|0
2897317|NCT01781429|9974874|P11|Overall Study|Death|0
2897318|NCT01781429|9974875|P10|Overall Study|Death|1
2897319|NCT01781429|9974876|P9|Overall Study|Death|0
2897320|NCT01781429|9974877|P8|Overall Study|Death|0
2897321|NCT01781429|9974878|P7|Overall Study|Death|0
2897322|NCT01781429|9974879|P6|Overall Study|Death|0
2897323|NCT01781429|9974880|P5|Overall Study|Death|0
2897324|NCT01781429|9974881|P4|Overall Study|Death|0
2897325|NCT01781429|9974882|P3|Overall Study|Death|0
2897326|NCT01781429|9974883|P2|Overall Study|Death|0
2897327|NCT01781429|9974884|P1|Overall Study|Death|0
2897328|NCT01781299|9974961|P2|Overall Study|Withdrawal by Subject|1
2897329|NCT01781299|9974962|P1|Overall Study|Withdrawal by Subject|0
2897330|NCT01781286|9974970|P6|Overall Study|Noncompliance|0
2897331|NCT01781286|9974971|P5|Overall Study|Noncompliance|0
2897332|NCT01781286|9974972|P4|Overall Study|Noncompliance|1
2897333|NCT01781286|9974973|P3|Overall Study|Noncompliance|0
2897334|NCT01781286|9974974|P2|Overall Study|Noncompliance|0
2897335|NCT01781286|9974975|P1|Overall Study|Noncompliance|0
2897336|NCT01781286|9974970|P6|Overall Study|Time Constraints|0
2897337|NCT01781286|9974971|P5|Overall Study|Time Constraints|0
2897338|NCT01781286|9974972|P4|Overall Study|Time Constraints|0
2897339|NCT01781286|9974973|P3|Overall Study|Time Constraints|2
2897340|NCT01781286|9974974|P2|Overall Study|Time Constraints|0
2897341|NCT01781286|9974975|P1|Overall Study|Time Constraints|2
2897342|NCT01781286|9974970|P6|Overall Study|Lost to Follow-up|1
2897343|NCT01781286|9974971|P5|Overall Study|Lost to Follow-up|0
2897344|NCT01781286|9974972|P4|Overall Study|Lost to Follow-up|0
2897345|NCT01781286|9974973|P3|Overall Study|Lost to Follow-up|0
2897346|NCT01781286|9974974|P2|Overall Study|Lost to Follow-up|0
2897347|NCT01781286|9974975|P1|Overall Study|Lost to Follow-up|0
2897348|NCT01781234|9975000|P2|Overall Study|Withdrawal by Subject|3
2897349|NCT01781234|9975001|P1|Overall Study|Withdrawal by Subject|4
2897350|NCT01781234|9975000|P2|Overall Study|Protocol Violation|0
2897351|NCT01781234|9975001|P1|Overall Study|Protocol Violation|3
2897352|NCT01781234|9975000|P2|Overall Study|Adverse Event|0
2897353|NCT01781234|9975001|P1|Overall Study|Adverse Event|2
2897354|NCT01781026|9975039|P1|Overall Study|Lack of Efficacy|2
2897355|NCT01780987|9975045|P2|Overall Study|Not Receiving any Study Medication|1
2897356|NCT01780987|9975046|P1|Overall Study|Not Receiving any Study Medication|0
2897357|NCT01780987|9975045|P2|Overall Study|Changing Residence|0
2897358|NCT01780987|9975046|P1|Overall Study|Changing Residence|1
2897359|NCT01780987|9975045|P2|Overall Study|Request of Changing Hospital|1
2897360|NCT01780987|9975046|P1|Overall Study|Request of Changing Hospital|0
2897361|NCT01780987|9975045|P2|Overall Study|Withdrawal by Subject|0
2897362|NCT01780987|9975046|P1|Overall Study|Withdrawal by Subject|2
2897363|NCT01780987|9975045|P2|Overall Study|Adverse Event|4
2897364|NCT01780987|9975046|P1|Overall Study|Adverse Event|0
2897365|NCT01780974|9975064|P2|Overall Study|Adverse Event|3
2897366|NCT01780974|9975065|P1|Overall Study|Adverse Event|1
2897367|NCT01780974|9975064|P2|Overall Study|Death|0
2897368|NCT01780974|9975065|P1|Overall Study|Death|1
2897369|NCT01780935|9975075|P2|Overall Study|Patient withdrew consent|9
2897370|NCT01780935|9975076|P1|Overall Study|Patient withdrew consent|8
2897371|NCT01780935|9975075|P2|Overall Study|Protocol deviation|1
2897372|NCT01780935|9975076|P1|Overall Study|Protocol deviation|0
2897373|NCT01780935|9975075|P2|Overall Study|Physician Decision|1
2897374|NCT01780935|9975076|P1|Overall Study|Physician Decision|1
2897375|NCT01780935|9975075|P2|Overall Study|Lost to Follow-up|6
2897376|NCT01780935|9975076|P1|Overall Study|Lost to Follow-up|2
2897377|NCT01780935|9975075|P2|Overall Study|Death|6
2897378|NCT01780935|9975076|P1|Overall Study|Death|1
2897379|NCT01780935|9975075|P2|Overall Study|Adverse Event|4
2897380|NCT01780935|9975076|P1|Overall Study|Adverse Event|2
2897381|NCT01780935|9975075|P2|Overall Study|Admin problems due to early termination|309
2897382|NCT01780935|9975076|P1|Overall Study|Admin problems due to early termination|321
2897383|NCT01780662|9975180|P3|Overall Study|Ineligible|1
2897384|NCT01780662|9975181|P2|Overall Study|Ineligible|0
2897385|NCT01780662|9975182|P1|Overall Study|Ineligible|0
2897386|NCT01780662|9975180|P3|Overall Study|Protocol Violation|0
2897387|NCT01780662|9975181|P2|Overall Study|Protocol Violation|1
2897388|NCT01780662|9975182|P1|Overall Study|Protocol Violation|0
2897389|NCT01780662|9975180|P3|Overall Study|Physician Decision|7
2897390|NCT01780662|9975181|P2|Overall Study|Physician Decision|5
2897391|NCT01780662|9975182|P1|Overall Study|Physician Decision|0
2897392|NCT01780662|9975180|P3|Overall Study|Adverse Event|2
2897393|NCT01780662|9975181|P2|Overall Study|Adverse Event|0
2897394|NCT01780662|9975182|P1|Overall Study|Adverse Event|1
2897395|NCT01780584|9975199|P3|Overall Study|Protocol Violation|1
2897396|NCT01780584|9975200|P2|Overall Study|Protocol Violation|0
2897397|NCT01780584|9975201|P1|Overall Study|Protocol Violation|0
2897398|NCT01780584|9975199|P3|Overall Study|Adverse Event|0
2897399|NCT01780584|9975200|P2|Overall Study|Adverse Event|1
2897400|NCT01780584|9975201|P1|Overall Study|Adverse Event|0
2897401|NCT01780584|9975199|P3|Overall Study|Death|1
2897402|NCT01780584|9975200|P2|Overall Study|Death|0
2897403|NCT01780584|9975201|P1|Overall Study|Death|1
2897404|NCT01780545|9975223|P2|Overall Study|Lost to Follow-up|1
2897405|NCT01780545|9975224|P1|Overall Study|Lost to Follow-up|1
2897406|NCT01780545|9975223|P2|Overall Study|Withdrawal by Subject|1
2897407|NCT01780545|9975224|P1|Overall Study|Withdrawal by Subject|3
2897408|NCT01780506|9975242|P2|Open-Label Extension Phase|Enrolled but not Treated|1
2897409|NCT01780506|9975243|P1|Open-Label Extension Phase|Enrolled but not Treated|0
2897410|NCT01780506|9975242|P2|Double-Blind Phase|Lost to Follow-up|26
2897411|NCT01780506|9975243|P1|Double-Blind Phase|Lost to Follow-up|23
2897412|NCT01780506|9975242|P2|Double-Blind Phase|Withdrew Consent|24
2897413|NCT01780506|9975243|P1|Double-Blind Phase|Withdrew Consent|23
2897414|NCT01780506|9975242|P2|Double-Blind Phase|Protocol Violation|3
2897415|NCT01780506|9975243|P1|Double-Blind Phase|Protocol Violation|4
2897416|NCT01780506|9975242|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
2897417|NCT01780506|9975243|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
2897418|NCT01780506|9975242|P2|Double-Blind Phase|Investigator's Discretion|2
2897419|NCT01780506|9975243|P1|Double-Blind Phase|Investigator's Discretion|5
2897420|NCT01780506|9975242|P2|Double-Blind Phase|Lack of Efficacy|1
2897421|NCT01780506|9975243|P1|Double-Blind Phase|Lack of Efficacy|1
2897422|NCT01780506|9975242|P2|Double-Blind Phase|Pregnancy|1
2897423|NCT01780506|9975243|P1|Double-Blind Phase|Pregnancy|2
2897424|NCT01780506|9975242|P2|Double-Blind Phase|Death|2
2897425|NCT01780506|9975243|P1|Double-Blind Phase|Death|1
2897426|NCT01780506|9975242|P2|Double-Blind Phase|Adverse Event|14
2897427|NCT01780506|9975243|P1|Double-Blind Phase|Adverse Event|4
2897428|NCT01780506|9975242|P2|Double-Blind Phase|Randomized but not Treated|2
2897429|NCT01780506|9975243|P1|Double-Blind Phase|Randomized but not Treated|3
2897430|NCT01780389|9975297|P1|Overall Study|Adverse Event|1
2897431|NCT01779869|9975335|P1|Overall Study|Physician Decision|2
2897432|NCT01779700|9975341|P2|Overall Study|Withdrawal by Subject|2
2897433|NCT01779700|9975342|P1|Overall Study|Withdrawal by Subject|0
2897434|NCT01779700|9975341|P2|Overall Study|Adverse Event|3
2897435|NCT01779700|9975342|P1|Overall Study|Adverse Event|4
2897436|NCT01779648|9975382|P2|Overall Study|Protocol Violation|0
2897437|NCT01779648|9975383|P1|Overall Study|Protocol Violation|1
2897438|NCT01779440|9975413|P2|Overall Study|Withdrawal by Subject|5
2897439|NCT01779440|9975414|P1|Overall Study|Withdrawal by Subject|3
2897440|NCT01778985|9975479|P2|Overall Study|Protocol Violation|1
2897441|NCT01778985|9975480|P1|Overall Study|Protocol Violation|4
2897442|NCT01778985|9975479|P2|Overall Study|Physician Decision|2
2897443|NCT01778985|9975480|P1|Overall Study|Physician Decision|2
2897444|NCT01778985|9975479|P2|Overall Study|Lost to Follow-up|0
2897445|NCT01778985|9975480|P1|Overall Study|Lost to Follow-up|1
2897446|NCT01778855|9975526|P2|Overall Study|Death|1
2897447|NCT01778855|9975527|P1|Overall Study|Death|0
2897448|NCT01778751|9975535|P2|Overall Study|Transfered care|0
2897449|NCT01778751|9975536|P1|Overall Study|Transfered care|1
2897450|NCT01778751|9975535|P2|Overall Study|Withdrawal by Subject|2
2897451|NCT01778751|9975536|P1|Overall Study|Withdrawal by Subject|0
2897452|NCT01778751|9975535|P2|Overall Study|Lost to Follow-up|0
2897453|NCT01778751|9975536|P1|Overall Study|Lost to Follow-up|1
2897454|NCT01778556|9975589|P2|Long-term Follow-up|noncompliance with metreleptin|0
2897455|NCT01778556|9975590|P1|Long-term Follow-up|noncompliance with metreleptin|1
2897456|NCT01778556|9975589|P2|Intervention 2 (14 Days)|Protocol Violation|0
2897457|NCT01778556|9975590|P1|Intervention 2 (14 Days)|Protocol Violation|1
2897458|NCT01778556|9975589|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
2897459|NCT01778556|9975590|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
2897460|NCT01778556|9975589|P2|Intervention 1 (5 Days)|Protocol Violation|1
2897461|NCT01778556|9975590|P1|Intervention 1 (5 Days)|Protocol Violation|0
2897462|NCT01778530|9975603|P1|Overall Study|Adverse event/side effect|1
2897463|NCT01778530|9975603|P1|Overall Study|Progression on study|1
2897464|NCT01778127|9975634|P3|Overall Study|Withdrawal by Subject|4
2897465|NCT01778127|9975635|P2|Overall Study|Withdrawal by Subject|1
2897466|NCT01778127|9975636|P1|Overall Study|Withdrawal by Subject|3
2897467|NCT01778127|9975634|P3|Overall Study|Lost to Follow-up|2
2897468|NCT01778127|9975635|P2|Overall Study|Lost to Follow-up|1
2897469|NCT01778127|9975636|P1|Overall Study|Lost to Follow-up|5
2897470|NCT01778062|9975679|P2|Overall Study|major protocol deviation|3
2897471|NCT01778062|9975680|P1|Overall Study|major protocol deviation|4
2897472|NCT01778062|9975679|P2|Overall Study|Consent Withdrawal|5
2897473|NCT01778062|9975680|P1|Overall Study|Consent Withdrawal|1
2897474|NCT01778062|9975679|P2|Overall Study|Adverse Event|3
2897475|NCT01778062|9975680|P1|Overall Study|Adverse Event|1
2897476|NCT01778049|9975694|P6|Double Blind Treatment Period|Other reason not defined above|1
2897477|NCT01778049|9975695|P5|Double Blind Treatment Period|Other reason not defined above|2
2897478|NCT01778049|9975696|P4|Double Blind Treatment Period|Other reason not defined above|2
2897479|NCT01778049|9975697|P3|Double Blind Treatment Period|Other reason not defined above|4
2897480|NCT01778049|9975698|P2|Double Blind Treatment Period|Other reason not defined above|0
2897481|NCT01778049|9975699|P1|Double Blind Treatment Period|Other reason not defined above|0
2897482|NCT01778049|9975694|P6|Double Blind Treatment Period|Not treated|0
2897483|NCT01778049|9975695|P5|Double Blind Treatment Period|Not treated|2
2897484|NCT01778049|9975696|P4|Double Blind Treatment Period|Not treated|2
2897485|NCT01778049|9975697|P3|Double Blind Treatment Period|Not treated|0
2897486|NCT01778049|9975698|P2|Double Blind Treatment Period|Not treated|0
2897487|NCT01778049|9975699|P1|Double Blind Treatment Period|Not treated|0
2897488|NCT01778049|9975694|P6|Double Blind Treatment Period|Withdrawal by Subject|1
2897489|NCT01778049|9975695|P5|Double Blind Treatment Period|Withdrawal by Subject|0
2897490|NCT01778049|9975696|P4|Double Blind Treatment Period|Withdrawal by Subject|2
2897491|NCT01778049|9975697|P3|Double Blind Treatment Period|Withdrawal by Subject|1
2897492|NCT01778049|9975698|P2|Double Blind Treatment Period|Withdrawal by Subject|0
2897493|NCT01778049|9975699|P1|Double Blind Treatment Period|Withdrawal by Subject|0
2897494|NCT01778049|9975694|P6|Double Blind Treatment Period|Lost to Follow-up|2
2897495|NCT01778049|9975695|P5|Double Blind Treatment Period|Lost to Follow-up|5
2897496|NCT01778049|9975696|P4|Double Blind Treatment Period|Lost to Follow-up|1
2897497|NCT01778049|9975697|P3|Double Blind Treatment Period|Lost to Follow-up|4
2897498|NCT01778049|9975698|P2|Double Blind Treatment Period|Lost to Follow-up|0
2897499|NCT01778049|9975699|P1|Double Blind Treatment Period|Lost to Follow-up|0
2897500|NCT01778049|9975694|P6|Double Blind Treatment Period|Protocol Violation|0
2897501|NCT01778049|9975695|P5|Double Blind Treatment Period|Protocol Violation|0
2897502|NCT01778049|9975696|P4|Double Blind Treatment Period|Protocol Violation|0
2897503|NCT01778049|9975697|P3|Double Blind Treatment Period|Protocol Violation|2
2897504|NCT01778049|9975698|P2|Double Blind Treatment Period|Protocol Violation|0
2897505|NCT01778049|9975699|P1|Double Blind Treatment Period|Protocol Violation|0
2897506|NCT01778049|9975694|P6|Double Blind Treatment Period|Lack of Efficacy|1
2897507|NCT01778049|9975695|P5|Double Blind Treatment Period|Lack of Efficacy|0
2897508|NCT01778049|9975696|P4|Double Blind Treatment Period|Lack of Efficacy|0
2897509|NCT01778049|9975697|P3|Double Blind Treatment Period|Lack of Efficacy|0
2897510|NCT01778049|9975698|P2|Double Blind Treatment Period|Lack of Efficacy|0
2897511|NCT01778049|9975699|P1|Double Blind Treatment Period|Lack of Efficacy|0
2897512|NCT01778049|9975694|P6|Double Blind Treatment Period|Adverse Event|2
2897513|NCT01778049|9975695|P5|Double Blind Treatment Period|Adverse Event|3
2897514|NCT01778049|9975696|P4|Double Blind Treatment Period|Adverse Event|5
2897515|NCT01778049|9975697|P3|Double Blind Treatment Period|Adverse Event|4
2897516|NCT01778049|9975698|P2|Double Blind Treatment Period|Adverse Event|0
2897517|NCT01778049|9975699|P1|Double Blind Treatment Period|Adverse Event|0
2897518|NCT01778049|9975694|P6|Open Label Treatment Period|Other reason not defined above|0
2897519|NCT01778049|9975695|P5|Open Label Treatment Period|Other reason not defined above|0
2897520|NCT01778049|9975696|P4|Open Label Treatment Period|Other reason not defined above|0
2897521|NCT01778049|9975697|P3|Open Label Treatment Period|Other reason not defined above|0
2897522|NCT01778049|9975698|P2|Open Label Treatment Period|Other reason not defined above|94
2897523|NCT01778049|9975699|P1|Open Label Treatment Period|Other reason not defined above|77
2897524|NCT01778049|9975694|P6|Open Label Treatment Period|Not treated|0
2897525|NCT01778049|9975695|P5|Open Label Treatment Period|Not treated|0
2897526|NCT01778049|9975696|P4|Open Label Treatment Period|Not treated|0
2897527|NCT01778049|9975697|P3|Open Label Treatment Period|Not treated|0
2897528|NCT01778049|9975698|P2|Open Label Treatment Period|Not treated|1
2897529|NCT01778049|9975699|P1|Open Label Treatment Period|Not treated|2
2897530|NCT01778049|9975694|P6|Open Label Treatment Period|Withdrawal by Subject|0
2897531|NCT01778049|9975695|P5|Open Label Treatment Period|Withdrawal by Subject|0
2897532|NCT01778049|9975696|P4|Open Label Treatment Period|Withdrawal by Subject|0
2897533|NCT01778049|9975697|P3|Open Label Treatment Period|Withdrawal by Subject|0
2897534|NCT01778049|9975698|P2|Open Label Treatment Period|Withdrawal by Subject|10
2897535|NCT01778049|9975699|P1|Open Label Treatment Period|Withdrawal by Subject|4
2897536|NCT01778049|9975694|P6|Open Label Treatment Period|Lost to Follow-up|0
2897537|NCT01778049|9975695|P5|Open Label Treatment Period|Lost to Follow-up|0
2897538|NCT01778049|9975696|P4|Open Label Treatment Period|Lost to Follow-up|0
2897539|NCT01778049|9975697|P3|Open Label Treatment Period|Lost to Follow-up|0
2897540|NCT01778049|9975698|P2|Open Label Treatment Period|Lost to Follow-up|3
2897541|NCT01778049|9975699|P1|Open Label Treatment Period|Lost to Follow-up|4
2897542|NCT01778049|9975694|P6|Open Label Treatment Period|Protocol Violation|0
2897543|NCT01778049|9975695|P5|Open Label Treatment Period|Protocol Violation|0
2897544|NCT01778049|9975696|P4|Open Label Treatment Period|Protocol Violation|0
2897545|NCT01778049|9975697|P3|Open Label Treatment Period|Protocol Violation|0
2897546|NCT01778049|9975698|P2|Open Label Treatment Period|Protocol Violation|5
2897547|NCT01778049|9975699|P1|Open Label Treatment Period|Protocol Violation|5
2897548|NCT01778049|9975694|P6|Open Label Treatment Period|Lack of Efficacy|0
2897549|NCT01778049|9975695|P5|Open Label Treatment Period|Lack of Efficacy|0
2897550|NCT01778049|9975696|P4|Open Label Treatment Period|Lack of Efficacy|0
2897551|NCT01778049|9975697|P3|Open Label Treatment Period|Lack of Efficacy|0
2897552|NCT01778049|9975698|P2|Open Label Treatment Period|Lack of Efficacy|1
2897553|NCT01778049|9975699|P1|Open Label Treatment Period|Lack of Efficacy|1
2897554|NCT01778049|9975694|P6|Open Label Treatment Period|Adverse Event|0
2897555|NCT01778049|9975695|P5|Open Label Treatment Period|Adverse Event|0
2897556|NCT01778049|9975696|P4|Open Label Treatment Period|Adverse Event|0
2897557|NCT01778049|9975697|P3|Open Label Treatment Period|Adverse Event|0
2897558|NCT01778049|9975698|P2|Open Label Treatment Period|Adverse Event|15
2897559|NCT01778049|9975699|P1|Open Label Treatment Period|Adverse Event|5
2897560|NCT01778023|9975717|P2|Overall Study|Withdrawal by Subject|3
2897561|NCT01778023|9975718|P1|Overall Study|Withdrawal by Subject|0
2897562|NCT01778010|9975735|P1|Overall Study|rash while on placebo|1
2897563|NCT01778010|9975735|P1|Overall Study|Arrested|1
2897564|NCT01778010|9975735|P1|Overall Study|abnormal ECG before meds|1
2897565|NCT01778010|9975735|P1|Overall Study|Withdrawal by Subject|2
2897566|NCT01777997|9975776|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
2897567|NCT01777997|9975776|P1|Weeks 48 to 72/96 on ART|Death|1
2897568|NCT01777997|9975776|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
2897569|NCT01777997|9975776|P1|12 Week lead-in of no ART|Severe debilitation|2
2897570|NCT01777932|9975798|P1|Overall Study|Patient refused further treatment|10
2897571|NCT01777932|9975798|P1|Overall Study|Reimbursement limit|9
2897572|NCT01777932|9975798|P1|Overall Study|Investigator decision|10
2897573|NCT01777932|9975798|P1|Overall Study|Lost to Follow-up|3
2897574|NCT01777932|9975798|P1|Overall Study|Adverse Event|34
2897575|NCT01777932|9975798|P1|Overall Study|Death|3
2897576|NCT01777932|9975798|P1|Overall Study|Disease progression|136
2897577|NCT01777854|9975812|P2|Overall Study|Physician Decision|3
2897578|NCT01777854|9975813|P1|Overall Study|Physician Decision|3
2897579|NCT01777776|9975821|P4|Overall Study|Withdrawal by Subject|1
2897580|NCT01777776|9975822|P3|Overall Study|Withdrawal by Subject|0
2897581|NCT01777776|9975823|P2|Overall Study|Withdrawal by Subject|0
2897582|NCT01777776|9975824|P1|Overall Study|Withdrawal by Subject|0
2897583|NCT01777776|9975821|P4|Overall Study|Disease Progression|3
2897584|NCT01777776|9975822|P3|Overall Study|Disease Progression|6
2897585|NCT01777776|9975823|P2|Overall Study|Disease Progression|8
2897586|NCT01777776|9975824|P1|Overall Study|Disease Progression|4
2897587|NCT01777776|9975821|P4|Overall Study|Adverse Event|0
2897588|NCT01777776|9975822|P3|Overall Study|Adverse Event|0
2897589|NCT01777776|9975823|P2|Overall Study|Adverse Event|4
2897590|NCT01777776|9975824|P1|Overall Study|Adverse Event|2
2897591|NCT01777763|9975883|P2|Overall Study|Treatment Failure|6
2897592|NCT01777763|9975884|P1|Overall Study|Treatment Failure|1
2897593|NCT01777763|9975883|P2|Overall Study|Withdrawal by Subject|2
2897594|NCT01777763|9975884|P1|Overall Study|Withdrawal by Subject|0
2897595|NCT01777763|9975883|P2|Overall Study|Protocol Violation|7
2897596|NCT01777763|9975884|P1|Overall Study|Protocol Violation|1
2897597|NCT01777763|9975883|P2|Overall Study|Adverse Event|32
2897598|NCT01777763|9975884|P1|Overall Study|Adverse Event|2
2897599|NCT01777620|9975908|P2|Overall Study|Subject Withdrawal|0
2897600|NCT01777620|9975909|P1|Overall Study|Subject Withdrawal|1
2897601|NCT01777581|9975935|P2|Overall Study|Lack of Efficacy|1
2897602|NCT01777581|9975936|P1|Overall Study|Lack of Efficacy|0
2897603|NCT01777581|9975935|P2|Overall Study|Adverse Event|0
2897604|NCT01777581|9975936|P1|Overall Study|Adverse Event|2
2897605|NCT01777581|9975935|P2|Overall Study|Lost to Follow-up|1
2897606|NCT01777581|9975936|P1|Overall Study|Lost to Follow-up|1
2897607|NCT01777542|9975965|P2|Second Intervention (20 Weeks)|Adverse Event|1
2897608|NCT01777542|9975966|P1|Second Intervention (20 Weeks)|Adverse Event|0
2897609|NCT01777490|9976009|P4|Overall Study|Dyad withdrew with data use prohibition|1
2897610|NCT01777490|9976010|P3|Overall Study|Dyad withdrew with data use prohibition|1
2897611|NCT01777490|9976011|P2|Overall Study|Dyad withdrew with data use prohibition|0
2897612|NCT01777490|9976012|P1|Overall Study|Dyad withdrew with data use prohibition|0
2897613|NCT01777334|9976057|P2|Overall Study|Withdrawal by Subject|11
2897614|NCT01777334|9976058|P1|Overall Study|Withdrawal by Subject|14
2897615|NCT01777334|9976057|P2|Overall Study|Lost to Follow-up|2
2897616|NCT01777334|9976058|P1|Overall Study|Lost to Follow-up|3
2897617|NCT01777334|9976057|P2|Overall Study|Protocol Violation|7
2897618|NCT01777334|9976058|P1|Overall Study|Protocol Violation|3
2897619|NCT01777334|9976057|P2|Overall Study|Lack of Efficacy|29
2897620|NCT01777334|9976058|P1|Overall Study|Lack of Efficacy|15
2897621|NCT01777334|9976057|P2|Overall Study|Adverse Event|14
2897622|NCT01777334|9976058|P1|Overall Study|Adverse Event|18
2897623|NCT01777321|9976068|P2|Overall Study|Withdrawal by Subject|1
2897624|NCT01777321|9976069|P1|Overall Study|Withdrawal by Subject|0
2897625|NCT01777308|9976107|P2|Overall Study|Blood draw refusal at Visit 3|0
2897626|NCT01777308|9976108|P1|Overall Study|Blood draw refusal at Visit 3|1
2897627|NCT01777308|9976107|P2|Overall Study|Lost to Follow-up|2
2897628|NCT01777308|9976108|P1|Overall Study|Lost to Follow-up|7
2897629|NCT01777308|9976107|P2|Overall Study|Migrated/moved from study area|0
2897630|NCT01777308|9976108|P1|Overall Study|Migrated/moved from study area|1
2897631|NCT01777308|9976107|P2|Overall Study|Withdrawal by Subject|1
2897632|NCT01777308|9976108|P1|Overall Study|Withdrawal by Subject|5
2897633|NCT01777295|9976140|P2|Overall Study|Investigator call for AEs check|0
2897634|NCT01777295|9976141|P1|Overall Study|Investigator call for AEs check|1
2897635|NCT01777295|9976140|P2|Overall Study|Personal problem|0
2897636|NCT01777295|9976141|P1|Overall Study|Personal problem|1
2897637|NCT01777295|9976140|P2|Overall Study|Pregnancy|1
2897638|NCT01777295|9976141|P1|Overall Study|Pregnancy|0
2897639|NCT01777295|9976140|P2|Overall Study|Withdrawal by Subject|2
2897640|NCT01777295|9976141|P1|Overall Study|Withdrawal by Subject|2
2897641|NCT01777282|9976348|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
2897642|NCT01777282|9976349|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
2897643|NCT01777282|9976350|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
2897644|NCT01777282|9976351|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
2897645|NCT01777282|9976352|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
2897646|NCT01777282|9976348|P5|Overall Study|Protocol Violation|2
2897647|NCT01777282|9976349|P4|Overall Study|Protocol Violation|0
2897648|NCT01777282|9976350|P3|Overall Study|Protocol Violation|1
2897649|NCT01777282|9976351|P2|Overall Study|Protocol Violation|0
2897650|NCT01777282|9976352|P1|Overall Study|Protocol Violation|2
2897651|NCT01777282|9976348|P5|Overall Study|Withdrawal by Subject|2
2897652|NCT01777282|9976349|P4|Overall Study|Withdrawal by Subject|1
2897653|NCT01777282|9976350|P3|Overall Study|Withdrawal by Subject|0
2897654|NCT01777282|9976351|P2|Overall Study|Withdrawal by Subject|0
2897655|NCT01777282|9976352|P1|Overall Study|Withdrawal by Subject|4
2897656|NCT01777282|9976348|P5|Overall Study|Adverse Event|3
2897657|NCT01777282|9976349|P4|Overall Study|Adverse Event|1
2897658|NCT01777282|9976350|P3|Overall Study|Adverse Event|2
2897659|NCT01777282|9976351|P2|Overall Study|Adverse Event|4
2897660|NCT01777282|9976352|P1|Overall Study|Adverse Event|4
2897661|NCT01777282|9976348|P5|Overall Study|New Antidiabetic Medication|0
2897662|NCT01777282|9976349|P4|Overall Study|New Antidiabetic Medication|0
2897663|NCT01777282|9976350|P3|Overall Study|New Antidiabetic Medication|1
2897664|NCT01777282|9976351|P2|Overall Study|New Antidiabetic Medication|0
2897665|NCT01777282|9976352|P1|Overall Study|New Antidiabetic Medication|0
2897666|NCT01777282|9976348|P5|Overall Study|Persistent Hyperglycemia|0
2897667|NCT01777282|9976349|P4|Overall Study|Persistent Hyperglycemia|0
2897668|NCT01777282|9976350|P3|Overall Study|Persistent Hyperglycemia|1
2897669|NCT01777282|9976351|P2|Overall Study|Persistent Hyperglycemia|0
2897670|NCT01777282|9976352|P1|Overall Study|Persistent Hyperglycemia|0
2897671|NCT01777269|9976396|P2|Overall Study|Withdrawal by Subject|9
2897672|NCT01777269|9976397|P1|Overall Study|Withdrawal by Subject|9
2897673|NCT01777269|9976396|P2|Overall Study|Physician Decision|2
2897674|NCT01777269|9976397|P1|Overall Study|Physician Decision|5
2897675|NCT01777269|9976396|P2|Overall Study|Lost to Follow-up|0
2897676|NCT01777269|9976397|P1|Overall Study|Lost to Follow-up|4
2897677|NCT01777269|9976396|P2|Overall Study|Participants reached stopping criteria|1
2897678|NCT01777269|9976397|P1|Overall Study|Participants reached stopping criteria|1
2897679|NCT01777269|9976396|P2|Overall Study|Protocol Violation|4
2897680|NCT01777269|9976397|P1|Overall Study|Protocol Violation|4
2897681|NCT01777269|9976396|P2|Overall Study|Lack of Efficacy|10
2897682|NCT01777269|9976397|P1|Overall Study|Lack of Efficacy|8
2897683|NCT01777269|9976396|P2|Overall Study|Adverse Event|33
2897684|NCT01777269|9976397|P1|Overall Study|Adverse Event|24
2897685|NCT01777191|9976434|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
2897686|NCT01777191|9976435|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
2897687|NCT01777191|9976434|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
2897688|NCT01777191|9976435|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
2897689|NCT01777191|9976434|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2897690|NCT01777191|9976435|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2897691|NCT01777191|9976434|P2|Safety Extension Per (Week 12-Week 48)|Death|1
2897692|NCT01777191|9976435|P1|Safety Extension Per (Week 12-Week 48)|Death|0
2897693|NCT01777191|9976434|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2897694|NCT01777191|9976435|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2897695|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
2897696|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
2897697|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2897698|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2897699|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
2897700|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
2897701|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
2897702|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
2897703|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2897704|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2897705|NCT01777191|9976434|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
2897706|NCT01777191|9976435|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
2897707|NCT01777152|9976465|P2|Overall Study|Change of diagnosis|0
2897708|NCT01777152|9976466|P1|Overall Study|Change of diagnosis|1
2897709|NCT01777152|9976465|P2|Overall Study|Not eligible, no study drug received|0
2897710|NCT01777152|9976466|P1|Overall Study|Not eligible, no study drug received|1
2897711|NCT01777152|9976465|P2|Overall Study|Death|73
2897712|NCT01777152|9976466|P1|Overall Study|Death|51
2897713|NCT01777152|9976465|P2|Overall Study|Lost to Follow-up|4
2897714|NCT01777152|9976466|P1|Overall Study|Lost to Follow-up|0
2897715|NCT01777152|9976465|P2|Overall Study|Withdrawal by Subject|10
2897716|NCT01777152|9976466|P1|Overall Study|Withdrawal by Subject|16
2897717|NCT01777152|9976465|P2|Overall Study|In Follow Up|139
2897718|NCT01777152|9976466|P1|Overall Study|In Follow Up|157
2897719|NCT01777139|9976482|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
2897720|NCT01777139|9976483|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
2897721|NCT01777139|9976482|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
2897722|NCT01777139|9976483|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
2897723|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
2897724|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
2897725|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
2897726|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
2897727|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
2897728|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
2897729|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
2897730|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
2897731|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
2897732|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
2897733|NCT01777139|9976482|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
2897734|NCT01777139|9976483|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
2897735|NCT01776554|9976597|P2|Overall Study|Unclassified|1
2897736|NCT01776554|9976598|P1|Overall Study|Unclassified|4
2897737|NCT01776554|9976597|P2|Overall Study|Protocol Violation|0
2897738|NCT01776554|9976598|P1|Overall Study|Protocol Violation|1
2897739|NCT01776554|9976597|P2|Overall Study|Administrative Reason|5
2897740|NCT01776554|9976598|P1|Overall Study|Administrative Reason|2
2897741|NCT01776554|9976597|P2|Overall Study|Lost to Follow-up|9
2897742|NCT01776554|9976598|P1|Overall Study|Lost to Follow-up|6
2897743|NCT01776554|9976597|P2|Overall Study|Withdrawal by Subject|8
2897744|NCT01776554|9976598|P1|Overall Study|Withdrawal by Subject|3
2897745|NCT01776554|9976597|P2|Overall Study|Adverse Event|0
2897746|NCT01776554|9976598|P1|Overall Study|Adverse Event|1
2897747|NCT01776541|9976641|P2|Overall Study|Withdrawal by Subject|20
2897748|NCT01776541|9976642|P1|Overall Study|Withdrawal by Subject|12
2897749|NCT01776541|9976641|P2|Overall Study|Protocol Violation|1
2897750|NCT01776541|9976642|P1|Overall Study|Protocol Violation|2
2897751|NCT01776541|9976641|P2|Overall Study|Unclassified|4
2897752|NCT01776541|9976642|P1|Overall Study|Unclassified|5
2897753|NCT01776541|9976641|P2|Overall Study|Lost to Follow-up|48
2897754|NCT01776541|9976642|P1|Overall Study|Lost to Follow-up|27
2897755|NCT01776541|9976641|P2|Overall Study|Death|0
2897756|NCT01776541|9976642|P1|Overall Study|Death|4
2897757|NCT01776541|9976641|P2|Overall Study|Administrative Reason|2
2897758|NCT01776541|9976642|P1|Overall Study|Administrative Reason|6
2897759|NCT01776424|9976664|P3|Overall Study|Withdrawal by Subject|15
2897760|NCT01776424|9976665|P2|Overall Study|Withdrawal by Subject|11
2897761|NCT01776424|9976666|P1|Overall Study|Withdrawal by Subject|10
2897762|NCT01776424|9976664|P3|Overall Study|Lost to Follow-up|9
2897763|NCT01776424|9976665|P2|Overall Study|Lost to Follow-up|8
2897764|NCT01776424|9976666|P1|Overall Study|Lost to Follow-up|10
2897765|NCT01776008|9976697|P1|Overall Study|ineligible|2
2897766|NCT01775995|9976711|P2|Overall Study|Lost to Follow-up|1
2897767|NCT01775995|9976712|P1|Overall Study|Lost to Follow-up|1
2897768|NCT01775930|9976772|P1|Overall Study|Futility stopping boundary met|1
2897769|NCT01775904|9976780|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
2897770|NCT01775904|9976780|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
2897771|NCT01775787|9976846|P2|Second 7-10 Days|concerns with using IV|1
2897772|NCT01775787|9976847|P1|Second 7-10 Days|concerns with using IV|0
2897773|NCT01775787|9976846|P2|Second 7-10 Days|time commitment|1
2897774|NCT01775787|9976847|P1|Second 7-10 Days|time commitment|0
2897775|NCT01775787|9976846|P2|First 7-10 Days|concerns with using IV|2
2897776|NCT01775787|9976847|P1|First 7-10 Days|concerns with using IV|1
2897777|NCT01775787|9976846|P2|First 7-10 Days|time commitment|2
2897778|NCT01775787|9976847|P1|First 7-10 Days|time commitment|0
2897779|NCT01775787|9976846|P2|First 7-10 Days|family emergency|1
2897780|NCT01775787|9976847|P1|First 7-10 Days|family emergency|0
2897781|NCT01775787|9976846|P2|First 7-10 Days|Adverse Event|1
2897782|NCT01775787|9976847|P1|First 7-10 Days|Adverse Event|0
2897783|NCT01775670|9976903|P2|Overall Study|Lost to Follow-up|1
2897784|NCT01775670|9976904|P1|Overall Study|Lost to Follow-up|1
2897785|NCT01775553|9976930|P1|Overall Study|Disease Progression|12
2897786|NCT01775553|9976930|P1|Overall Study|Adverse Event|1
2897787|NCT01775501|9976938|P1|Overall Study|Discontinued prior to treatment|1
2897788|NCT01775189|9976947|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
2897789|NCT01775189|9976948|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
2897790|NCT01775189|9976949|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
2897791|NCT01775189|9976950|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
2897792|NCT01775189|9976951|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
2897793|NCT01775189|9976952|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
2897794|NCT01775189|9976953|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
2897795|NCT01775189|9976947|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
2897796|NCT01775189|9976948|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
2897797|NCT01775189|9976949|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
2897798|NCT01775189|9976950|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
2897799|NCT01775189|9976951|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
2897800|NCT01775189|9976952|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
2897801|NCT01775189|9976953|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
2897802|NCT01775189|9976947|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
2897803|NCT01775189|9976948|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
2897804|NCT01775189|9976949|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
2897805|NCT01775189|9976950|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
2897806|NCT01775189|9976951|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
2897807|NCT01775189|9976952|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
2897808|NCT01775189|9976953|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
2897809|NCT01775189|9976947|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2897810|NCT01775189|9976948|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2897811|NCT01775189|9976949|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2897812|NCT01775189|9976950|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2897813|NCT01775189|9976951|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
2897814|NCT01775189|9976952|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
2897815|NCT01775189|9976953|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2897816|NCT01775189|9976947|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897817|NCT01775189|9976948|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897818|NCT01775189|9976949|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897819|NCT01775189|9976950|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897820|NCT01775189|9976951|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897821|NCT01775189|9976952|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
2897822|NCT01775189|9976953|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
2897823|NCT01775189|9976947|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
2897824|NCT01775189|9976948|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
2897825|NCT01775189|9976949|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
2897826|NCT01775189|9976950|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
2897827|NCT01775189|9976951|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
2897828|NCT01775189|9976952|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
2897829|NCT01775189|9976953|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
2897830|NCT01775137|9977172|P1|Overall Study|Withdrawal by participants|5
2897831|NCT01775137|9977172|P1|Overall Study|Adverse Event|1
2897832|NCT01775137|9977172|P1|Overall Study|Unsatisfactory therapeutic effect|2
2897833|NCT01775137|9977172|P1|Overall Study|Protocol deviation|2
2897834|NCT01775137|9977172|P1|Overall Study|Death|1
2897835|NCT01775124|9977199|P2|Extension Period|Withdrawal by Subject|12
2897836|NCT01775124|9977200|P1|Extension Period|Withdrawal by Subject|9
2897837|NCT01775124|9977199|P2|Extension Period|Lost to Follow-up|1
2897838|NCT01775124|9977200|P1|Extension Period|Lost to Follow-up|0
2897839|NCT01775124|9977199|P2|Extension Period|Administrative problems|1
2897840|NCT01775124|9977200|P1|Extension Period|Administrative problems|0
2897841|NCT01775124|9977199|P2|Extension Period|Physician Decision|2
2897842|NCT01775124|9977200|P1|Extension Period|Physician Decision|0
2897843|NCT01775124|9977199|P2|Extension Period|Adverse Event|2
2897844|NCT01775124|9977200|P1|Extension Period|Adverse Event|3
2897845|NCT01775124|9977199|P2|Core Period|Adverse Event|5
2897846|NCT01775124|9977200|P1|Core Period|Adverse Event|5
2897847|NCT01775124|9977199|P2|Core Period|Withdrawal by Subject|2
2897848|NCT01775124|9977200|P1|Core Period|Withdrawal by Subject|4
2897849|NCT01775124|9977199|P2|Core Period|Administrative problems|0
2897850|NCT01775124|9977200|P1|Core Period|Administrative problems|1
2897851|NCT01775124|9977199|P2|Core Period|Death|1
2897852|NCT01775124|9977200|P1|Core Period|Death|0
2897853|NCT01775124|9977199|P2|Core Period|Physician Decision|1
2897854|NCT01775124|9977200|P1|Core Period|Physician Decision|1
2897855|NCT01775124|9977199|P2|Core Period|Disease Progression|1
2897856|NCT01775124|9977200|P1|Core Period|Disease Progression|0
2897857|NCT01774981|9977235|P8|Overall Study|Death|0
2897858|NCT01774981|9977236|P7|Overall Study|Death|0
2897859|NCT01774981|9977237|P6|Overall Study|Death|0
2897860|NCT01774981|9977238|P5|Overall Study|Death|1
2897861|NCT01774981|9977239|P4|Overall Study|Death|0
2897862|NCT01774981|9977240|P3|Overall Study|Death|0
2897863|NCT01774981|9977241|P2|Overall Study|Death|0
2897864|NCT01774981|9977242|P1|Overall Study|Death|0
2897865|NCT01774981|9977235|P8|Overall Study|Withdrawal by Subject|1
2897866|NCT01774981|9977236|P7|Overall Study|Withdrawal by Subject|0
2897867|NCT01774981|9977237|P6|Overall Study|Withdrawal by Subject|0
2897868|NCT01774981|9977238|P5|Overall Study|Withdrawal by Subject|0
2897869|NCT01774981|9977239|P4|Overall Study|Withdrawal by Subject|0
2897870|NCT01774981|9977240|P3|Overall Study|Withdrawal by Subject|0
2897871|NCT01774981|9977241|P2|Overall Study|Withdrawal by Subject|0
2897872|NCT01774981|9977242|P1|Overall Study|Withdrawal by Subject|0
2897873|NCT01774981|9977235|P8|Overall Study|Adverse Event|0
2897874|NCT01774981|9977236|P7|Overall Study|Adverse Event|0
2897875|NCT01774981|9977237|P6|Overall Study|Adverse Event|1
2897876|NCT01774981|9977238|P5|Overall Study|Adverse Event|0
2897877|NCT01774981|9977239|P4|Overall Study|Adverse Event|0
2897878|NCT01774981|9977240|P3|Overall Study|Adverse Event|0
2897879|NCT01774981|9977241|P2|Overall Study|Adverse Event|0
2897880|NCT01774981|9977242|P1|Overall Study|Adverse Event|0
2897881|NCT01774968|9977274|P2|Overall Study|Withdrawal by Subject|11
2897882|NCT01774968|9977275|P1|Overall Study|Withdrawal by Subject|6
2897883|NCT01774968|9977274|P2|Overall Study|Sponsor Decision|2
2897884|NCT01774968|9977275|P1|Overall Study|Sponsor Decision|0
2897885|NCT01774968|9977274|P2|Overall Study|Protocol Violation|13
2897886|NCT01774968|9977275|P1|Overall Study|Protocol Violation|14
2897887|NCT01774968|9977274|P2|Overall Study|Physician Decision|1
2897888|NCT01774968|9977275|P1|Overall Study|Physician Decision|5
2897889|NCT01774968|9977274|P2|Overall Study|Lost to Follow-up|3
2897890|NCT01774968|9977275|P1|Overall Study|Lost to Follow-up|1
2897891|NCT01774968|9977274|P2|Overall Study|Death|1
2897892|NCT01774968|9977275|P1|Overall Study|Death|0
2897893|NCT01774968|9977274|P2|Overall Study|Adverse Event|4
2897894|NCT01774968|9977275|P1|Overall Study|Adverse Event|4
2897895|NCT01774929|9977309|P1|Overall Study|Adverse Event|3
2897896|NCT01774903|9977315|P1|Overall Study|Ineligible to continue the trial|1
2897897|NCT01774903|9977315|P1|Overall Study|Lack of Efficacy|1
2897898|NCT01774903|9977315|P1|Overall Study|Withdrawal by Subject|2
2897899|NCT01774903|9977315|P1|Overall Study|Adverse Event|7
2897900|NCT01774799|9977335|P4|Overall Study|Lost to Follow-up|0
2897901|NCT01774799|9977336|P3|Overall Study|Lost to Follow-up|0
2897902|NCT01774799|9977337|P2|Overall Study|Lost to Follow-up|1
2897903|NCT01774799|9977338|P1|Overall Study|Lost to Follow-up|1
2897904|NCT01774786|9977354|P2|Overall Study|Ineligible for Study|3
2897905|NCT01774786|9977355|P1|Overall Study|Ineligible for Study|1
2897906|NCT01774786|9977354|P2|Overall Study|Physician Decision|0
2897907|NCT01774786|9977355|P1|Overall Study|Physician Decision|1
2897908|NCT01774786|9977354|P2|Overall Study|Withdrawal by Subject|12
2897909|NCT01774786|9977355|P1|Overall Study|Withdrawal by Subject|15
2897910|NCT01774786|9977354|P2|Overall Study|Lost to Follow-up|4
2897911|NCT01774786|9977355|P1|Overall Study|Lost to Follow-up|3
2897912|NCT01774786|9977354|P2|Overall Study|Death|262
2897913|NCT01774786|9977355|P1|Overall Study|Death|242
2897914|NCT01774786|9977354|P2|Overall Study|In Follow-up|62
2897915|NCT01774786|9977355|P1|Overall Study|In Follow-up|65
2897916|NCT01774786|9977354|P2|Overall Study|Between Treatment and Follow-up|2
2897917|NCT01774786|9977355|P1|Overall Study|Between Treatment and Follow-up|6
2897918|NCT01774786|9977354|P2|Overall Study|On Treatment|47
2897919|NCT01774786|9977355|P1|Overall Study|On Treatment|55
2897920|NCT01774721|9977389|P2|Overall Study|Ongoing in study|120
2897921|NCT01774721|9977390|P1|Overall Study|Ongoing in study|136
2897922|NCT01774721|9977389|P2|Overall Study|Did not meet eligibility criteria|3
2897923|NCT01774721|9977390|P1|Overall Study|Did not meet eligibility criteria|0
2897924|NCT01774721|9977389|P2|Overall Study|Lost to Follow-up|1
2897925|NCT01774721|9977390|P1|Overall Study|Lost to Follow-up|1
2897926|NCT01774721|9977389|P2|Overall Study|Withdrawal by Subject|10
2897927|NCT01774721|9977390|P1|Overall Study|Withdrawal by Subject|14
2897928|NCT01774721|9977389|P2|Overall Study|Death|91
2897929|NCT01774721|9977390|P1|Overall Study|Death|76
2897930|NCT01774591|9977455|P2|Overall Study|Adverse Event|2
2897931|NCT01774591|9977456|P1|Overall Study|Adverse Event|0
2897932|NCT01774591|9977455|P2|Overall Study|Withdrawal by Subject|1
2897933|NCT01774591|9977456|P1|Overall Study|Withdrawal by Subject|0
2897934|NCT01774591|9977455|P2|Overall Study|Physician Decision|1
2897935|NCT01774591|9977456|P1|Overall Study|Physician Decision|1
2897936|NCT01774370|9977466|P1|Overall Study|Follow-up failure|34
2897937|NCT01774370|9977466|P1|Overall Study|Violated inclusion/exclusion criteria|53
2897938|NCT01774370|9977466|P1|Overall Study|Subjects of contraindications|34
2897939|NCT01774370|9977466|P1|Overall Study|Administered prior to the contract date|4
2897940|NCT01774370|9977466|P1|Overall Study|Never taken the PRADAXA during the study|4
2897941|NCT01774344|9977474|P2|Overall Study|Non-compliance with study drug|2
2897942|NCT01774344|9977475|P1|Overall Study|Non-compliance with study drug|0
2897943|NCT01774344|9977474|P2|Overall Study|Physician Decision|1
2897944|NCT01774344|9977475|P1|Overall Study|Physician Decision|0
2897945|NCT01774344|9977474|P2|Overall Study|Adverse event (AE)|1
2897946|NCT01774344|9977475|P1|Overall Study|Adverse event (AE)|0
2897947|NCT01774344|9977474|P2|Overall Study|AE not related to disease progression|47
2897948|NCT01774344|9977475|P1|Overall Study|AE not related to disease progression|12
2897949|NCT01774344|9977474|P2|Overall Study|Ongoing with treatment|65
2897950|NCT01774344|9977475|P1|Overall Study|Ongoing with treatment|10
2897951|NCT01774344|9977474|P2|Overall Study|Other|0
2897952|NCT01774344|9977475|P1|Overall Study|Other|1
2897953|NCT01774344|9977474|P2|Overall Study|Study drug never administered|5
2897954|NCT01774344|9977475|P1|Overall Study|Study drug never administered|1
2897955|NCT01774344|9977474|P2|Overall Study|Withdrawal by Subject|26
2897956|NCT01774344|9977475|P1|Overall Study|Withdrawal by Subject|5
2897957|NCT01774344|9977474|P2|Overall Study|Protocol Violation|1
2897958|NCT01774344|9977475|P1|Overall Study|Protocol Violation|3
2897959|NCT01774305|9977491|P2|Overall Study|Physician Decision|0
2897960|NCT01774305|9977492|P1|Overall Study|Physician Decision|1
2897961|NCT01774253|9977500|P1|Overall Study|Death|1
2897962|NCT01774253|9977500|P1|Overall Study|Withdrawal by Subject|2
2897963|NCT01774253|9977500|P1|Overall Study|Physician Decision|2
2897964|NCT01774253|9977500|P1|Overall Study|Lack of Efficacy|4
2897965|NCT01774110|9977519|P1|Overall Study|Lost to Follow-up|7
2897966|NCT01774097|9977527|P2|Overall Study|Adverse Event|1
2897967|NCT01774097|9977528|P1|Overall Study|Adverse Event|1
2897968|NCT01774097|9977527|P2|Overall Study|Withdrawal by Subject|1
2897969|NCT01774097|9977528|P1|Overall Study|Withdrawal by Subject|1
2897970|NCT01774084|9977558|P2|Overall Study|Personal reasons|0
2897971|NCT01774084|9977559|P1|Overall Study|Personal reasons|1
2897972|NCT01773993|9977584|P1|Overall Study|No Visit After Treatment|35
2897973|NCT01773967|9977603|P2|Overall Study|Lost to Follow-up|13
2897974|NCT01773967|9977604|P1|Overall Study|Lost to Follow-up|15
2897975|NCT01773889|9977619|P1|Overall Study|lack of funding|2
2897976|NCT01773473|9977625|P2|Overall Study|Lost to Follow-up|0
2897977|NCT01773473|9977626|P1|Overall Study|Lost to Follow-up|2
2897978|NCT01773473|9977625|P2|Overall Study|Withdrawal by Subject|3
2897979|NCT01773473|9977626|P1|Overall Study|Withdrawal by Subject|5
2897980|NCT01773473|9977625|P2|Overall Study|Non-Compliance with study drug|4
2897981|NCT01773473|9977626|P1|Overall Study|Non-Compliance with study drug|1
2897982|NCT01773473|9977625|P2|Overall Study|Lack of Efficacy|1
2897983|NCT01773473|9977626|P1|Overall Study|Lack of Efficacy|0
2897984|NCT01773473|9977625|P2|Overall Study|Sponsor Decision|0
2897985|NCT01773473|9977626|P1|Overall Study|Sponsor Decision|2
2897986|NCT01773473|9977625|P2|Overall Study|Physician Decision|5
2897987|NCT01773473|9977626|P1|Overall Study|Physician Decision|3
2897988|NCT01773473|9977625|P2|Overall Study|Protocol Violation|4
2897989|NCT01773473|9977626|P1|Overall Study|Protocol Violation|0
2897990|NCT01773473|9977625|P2|Overall Study|Adverse Event|2
2897991|NCT01773473|9977626|P1|Overall Study|Adverse Event|3
2897992|NCT01773421|9977648|P7|Extension Phase|Adverse Event|0
2897993|NCT01773421|9977649|P6|Extension Phase|Adverse Event|0
2897994|NCT01773421|9977650|P5|Extension Phase|Adverse Event|2
2897995|NCT01773421|9977651|P4|Extension Phase|Adverse Event|0
2897996|NCT01773421|9977652|P3|Extension Phase|Adverse Event|0
2897997|NCT01773421|9977653|P2|Extension Phase|Adverse Event|0
2897998|NCT01773421|9977654|P1|Extension Phase|Adverse Event|0
2897999|NCT01773421|9977648|P7|Extension Phase|Other|0
2898000|NCT01773421|9977649|P6|Extension Phase|Other|2
2898001|NCT01773421|9977650|P5|Extension Phase|Other|1
2898002|NCT01773421|9977651|P4|Extension Phase|Other|0
2898003|NCT01773421|9977652|P3|Extension Phase|Other|0
2898004|NCT01773421|9977653|P2|Extension Phase|Other|0
2898005|NCT01773421|9977654|P1|Extension Phase|Other|0
2898006|NCT01773421|9977648|P7|Treatment Phase|Withdrawal by Subject|0
2898007|NCT01773421|9977649|P6|Treatment Phase|Withdrawal by Subject|0
2898008|NCT01773421|9977650|P5|Treatment Phase|Withdrawal by Subject|0
2898009|NCT01773421|9977651|P4|Treatment Phase|Withdrawal by Subject|1
2898010|NCT01773421|9977652|P3|Treatment Phase|Withdrawal by Subject|1
2898011|NCT01773421|9977653|P2|Treatment Phase|Withdrawal by Subject|0
2898012|NCT01773421|9977654|P1|Treatment Phase|Withdrawal by Subject|0
2898013|NCT01773421|9977648|P7|Treatment Phase|Adverse Event|0
2898014|NCT01773421|9977649|P6|Treatment Phase|Adverse Event|0
2898015|NCT01773421|9977650|P5|Treatment Phase|Adverse Event|0
2898016|NCT01773421|9977651|P4|Treatment Phase|Adverse Event|1
2898017|NCT01773421|9977652|P3|Treatment Phase|Adverse Event|3
2898018|NCT01773421|9977653|P2|Treatment Phase|Adverse Event|0
2898019|NCT01773421|9977654|P1|Treatment Phase|Adverse Event|0
2898020|NCT01773421|9977648|P7|Treatment Phase|Other|0
2898021|NCT01773421|9977649|P6|Treatment Phase|Other|0
2898022|NCT01773421|9977650|P5|Treatment Phase|Other|0
2898023|NCT01773421|9977651|P4|Treatment Phase|Other|0
2898024|NCT01773421|9977652|P3|Treatment Phase|Other|2
2898025|NCT01773421|9977653|P2|Treatment Phase|Other|0
2898026|NCT01773421|9977654|P1|Treatment Phase|Other|0
2898027|NCT01773291|9977685|P3|Overall Study|Withdrawal by Subject|1
2898028|NCT01773291|9977686|P2|Overall Study|Withdrawal by Subject|0
2898029|NCT01773291|9977687|P1|Overall Study|Withdrawal by Subject|0
2898030|NCT01773291|9977685|P3|Overall Study|Protocol Violation|0
2898031|NCT01773291|9977686|P2|Overall Study|Protocol Violation|0
2898032|NCT01773291|9977687|P1|Overall Study|Protocol Violation|1
2898033|NCT01773226|9977698|P1|Overall Study|Withdrawal by Subject|1
2898034|NCT01773122|9977717|P4|Overall Study|Due to amended age eligibility criteria|1
2898035|NCT01773122|9977718|P3|Overall Study|Due to amended age eligibility criteria|0
2898036|NCT01773122|9977719|P2|Overall Study|Due to amended age eligibility criteria|1
2898037|NCT01773122|9977720|P1|Overall Study|Due to amended age eligibility criteria|3
2898038|NCT01773109|9977734|P1|Overall Study|Death|1
2898039|NCT01773109|9977734|P1|Overall Study|Symptomatic Progression|2
2898040|NCT01773070|9977738|P1|Overall Study|Death (unrelated to study procedures)|3
2898041|NCT01773070|9977738|P1|Overall Study|Other|15
2898042|NCT01773070|9977738|P1|Overall Study|Lost to Follow-up|39
2898043|NCT01773070|9977738|P1|Overall Study|Withdrawal by Subject|24
2898044|NCT01772823|9977748|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
2898045|NCT01772823|9977749|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
2898046|NCT01772823|9977748|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2898047|NCT01772823|9977749|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2898048|NCT01772823|9977748|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
2898049|NCT01772823|9977749|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
2898050|NCT01772823|9977748|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
2898051|NCT01772823|9977749|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
2898052|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2898053|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2898054|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
2898055|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
2898056|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
2898057|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
2898058|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
2898059|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
2898060|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
2898061|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
2898062|NCT01772823|9977748|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
2898063|NCT01772823|9977749|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
2898064|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
2898065|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
2898066|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
2898067|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
2898068|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
2898069|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
2898070|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
2898071|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
2898072|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2898073|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2898074|NCT01772823|9977748|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
2898075|NCT01772823|9977749|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
2898076|NCT01772719|9977862|P1|Overall Study|Lost to Follow-up|1
2898077|NCT01772719|9977862|P1|Overall Study|Protocol Violation|1
2898078|NCT01772719|9977862|P1|Overall Study|Adverse Event|2
2898079|NCT01772719|9977862|P1|Overall Study|Withdrawal by Subject|3
2898080|NCT01772576|9977882|P1|Overall Study|Withdrawal by Subject|6
2898081|NCT01772576|9977882|P1|Overall Study|Adverse Event|6
2898082|NCT01772576|9977882|P1|Overall Study|Study device not used|3
2898083|NCT01772576|9977882|P1|Overall Study|Lost to Follow-up|3
2898084|NCT01772576|9977882|P1|Overall Study|Protocol Violation|1
2898085|NCT01772576|9977882|P1|Overall Study|Death|15
2898086|NCT01772550|9977894|P3|Overall Study|Adverse Event|1
2898087|NCT01772550|9977895|P2|Overall Study|Adverse Event|0
2898088|NCT01772550|9977896|P1|Overall Study|Adverse Event|0
2898089|NCT01772550|9977894|P3|Overall Study|Unable to insert IV in antecubital vein|5
2898090|NCT01772550|9977895|P2|Overall Study|Unable to insert IV in antecubital vein|1
2898091|NCT01772550|9977896|P1|Overall Study|Unable to insert IV in antecubital vein|1
2898092|NCT01772537|9977937|P3|Overall Study|unsuccessful lumbar drain placement|0
2898093|NCT01772537|9977938|P2|Overall Study|unsuccessful lumbar drain placement|0
2898094|NCT01772537|9977939|P1|Overall Study|unsuccessful lumbar drain placement|1
2898095|NCT01772472|9977955|P2|Overall Study|Ongoing|635
2898096|NCT01772472|9977956|P1|Overall Study|Ongoing|597
2898097|NCT01772472|9977955|P2|Overall Study|Withdrawal by Subject|50
2898098|NCT01772472|9977956|P1|Overall Study|Withdrawal by Subject|72
2898099|NCT01772472|9977955|P2|Overall Study|Lost to Follow-up|8
2898100|NCT01772472|9977956|P1|Overall Study|Lost to Follow-up|12
2898101|NCT01772472|9977955|P2|Overall Study|Other|5
2898102|NCT01772472|9977956|P1|Overall Study|Other|5
2898103|NCT01772472|9977955|P2|Overall Study|Physician Decision|3
2898104|NCT01772472|9977956|P1|Overall Study|Physician Decision|1
2898105|NCT01772472|9977955|P2|Overall Study|Death|42
2898106|NCT01772472|9977956|P1|Overall Study|Death|56
2898107|NCT01772368|9977968|P1|Overall Study|Other|1
2898108|NCT01772368|9977968|P1|Overall Study|Protocol Violation|2
2898109|NCT01772368|9977968|P1|Overall Study|Withdrawal by Subject|3
2898110|NCT01772368|9977968|P1|Overall Study|Adverse Event|1
2898111|NCT01772316|9978014|P1|Overall Study|Withdrawn by sponsor decision|5
2898112|NCT01772316|9978014|P1|Overall Study|Inform consent withdrawn|1
2898113|NCT01772316|9978014|P1|Overall Study|Serious adverse event|1
2898114|NCT01772160|9978032|P1|Overall Study|Other|5
2898115|NCT01772160|9978032|P1|Overall Study|Lost to Follow-up|30
2898116|NCT01772160|9978032|P1|Overall Study|Migrated / moved from the study area|4
2898117|NCT01772160|9978032|P1|Overall Study|Consent withdrawal|3
2898118|NCT01772160|9978032|P1|Overall Study|Eligibility criteria not fulfilled|3
2898119|NCT01772160|9978032|P1|Overall Study|Death|3
2898120|NCT01772147|9978055|P3|Overall Study|Lack of Efficacy|6
2898121|NCT01772147|9978056|P2|Overall Study|Lack of Efficacy|6
2898122|NCT01772147|9978057|P1|Overall Study|Lack of Efficacy|8
2898123|NCT01772147|9978055|P3|Overall Study|Protocol Deviation|1
2898124|NCT01772147|9978056|P2|Overall Study|Protocol Deviation|1
2898125|NCT01772147|9978057|P1|Overall Study|Protocol Deviation|2
2898126|NCT01772147|9978055|P3|Overall Study|Lost to Follow-up|1
2898127|NCT01772147|9978056|P2|Overall Study|Lost to Follow-up|0
2898128|NCT01772147|9978057|P1|Overall Study|Lost to Follow-up|1
2898129|NCT01772147|9978055|P3|Overall Study|Withdrew Consent|4
2898130|NCT01772147|9978056|P2|Overall Study|Withdrew Consent|8
2898131|NCT01772147|9978057|P1|Overall Study|Withdrew Consent|7
2898132|NCT01772147|9978055|P3|Overall Study|Adverse Event|6
2898133|NCT01772147|9978056|P2|Overall Study|Adverse Event|10
2898134|NCT01772147|9978057|P1|Overall Study|Adverse Event|13
2898135|NCT01772134|9978077|P3|Overall Study|Randomized Study Medication Not Received|1
2898136|NCT01772134|9978078|P2|Overall Study|Randomized Study Medication Not Received|0
2898137|NCT01772134|9978079|P1|Overall Study|Randomized Study Medication Not Received|2
2898138|NCT01772134|9978077|P3|Overall Study|Protocol-defined Stopping Criteria|0
2898139|NCT01772134|9978078|P2|Overall Study|Protocol-defined Stopping Criteria|0
2898140|NCT01772134|9978079|P1|Overall Study|Protocol-defined Stopping Criteria|1
2898141|NCT01772134|9978077|P3|Overall Study|Lack of Efficacy|3
2898142|NCT01772134|9978078|P2|Overall Study|Lack of Efficacy|5
2898143|NCT01772134|9978079|P1|Overall Study|Lack of Efficacy|11
2898144|NCT01772134|9978077|P3|Overall Study|Protocol Deviation|3
2898145|NCT01772134|9978078|P2|Overall Study|Protocol Deviation|3
2898146|NCT01772134|9978079|P1|Overall Study|Protocol Deviation|4
2898147|NCT01772134|9978077|P3|Overall Study|Lost to Follow-up|0
2898148|NCT01772134|9978078|P2|Overall Study|Lost to Follow-up|0
2898149|NCT01772134|9978079|P1|Overall Study|Lost to Follow-up|2
2898150|NCT01772134|9978077|P3|Overall Study|Withdrew Consent|5
2898151|NCT01772134|9978078|P2|Overall Study|Withdrew Consent|1
2898152|NCT01772134|9978079|P1|Overall Study|Withdrew Consent|3
2898153|NCT01772134|9978077|P3|Overall Study|Adverse Event|10
2898154|NCT01772134|9978078|P2|Overall Study|Adverse Event|5
2898155|NCT01772134|9978079|P1|Overall Study|Adverse Event|6
2898156|NCT01771913|9978122|P2|Overall Study|Withdrawal by Subject|0
2898157|NCT01771913|9978123|P1|Overall Study|Withdrawal by Subject|1
2898158|NCT01771809|9978135|P2|Overall Study|Other (other)|5
2898159|NCT01771809|9978136|P1|Overall Study|Other (other)|9
2898160|NCT01771809|9978135|P2|Overall Study|Death|0
2898161|NCT01771809|9978136|P1|Overall Study|Death|1
2898162|NCT01771809|9978135|P2|Overall Study|Other (Insufficient clinical response)|20
2898163|NCT01771809|9978136|P1|Overall Study|Other (Insufficient clinical response)|22
2898164|NCT01771809|9978135|P2|Overall Study|Lost to Follow-up|3
2898165|NCT01771809|9978136|P1|Overall Study|Lost to Follow-up|1
2898166|NCT01771809|9978135|P2|Overall Study|Withdrawal by Subject|42
2898167|NCT01771809|9978136|P1|Overall Study|Withdrawal by Subject|34
2898168|NCT01771809|9978135|P2|Overall Study|Protocol Violation|1
2898169|NCT01771809|9978136|P1|Overall Study|Protocol Violation|0
2898170|NCT01771809|9978135|P2|Overall Study|Adverse Event|12
2898171|NCT01771809|9978136|P1|Overall Study|Adverse Event|4
2898172|NCT01771250|9978155|P2|Period 1|Met exclusion criteria|0
2898173|NCT01771250|9978156|P1|Period 1|Met exclusion criteria|1
2898174|NCT01770860|9978172|P1|Overall Study|Administrative decision made by the PI|1
2898175|NCT01770860|9978172|P1|Overall Study|Lost to Follow-up|1
2898176|NCT01770860|9978172|P1|Overall Study|Withdrawal by Subject|4
2898177|NCT01770743|9978220|P5|Overall Study|Moving Out of State|0
2898178|NCT01770743|9978221|P4|Overall Study|Moving Out of State|0
2898179|NCT01770743|9978222|P3|Overall Study|Moving Out of State|0
2898180|NCT01770743|9978223|P2|Overall Study|Moving Out of State|1
2898181|NCT01770743|9978224|P1|Overall Study|Moving Out of State|0
2898182|NCT01770743|9978220|P5|Overall Study|Sponsor Terminated Subject|0
2898183|NCT01770743|9978221|P4|Overall Study|Sponsor Terminated Subject|1
2898184|NCT01770743|9978222|P3|Overall Study|Sponsor Terminated Subject|0
2898185|NCT01770743|9978223|P2|Overall Study|Sponsor Terminated Subject|0
2898186|NCT01770743|9978224|P1|Overall Study|Sponsor Terminated Subject|1
2898187|NCT01770743|9978220|P5|Overall Study|Lost to Follow-up|1
2898188|NCT01770743|9978221|P4|Overall Study|Lost to Follow-up|0
2898189|NCT01770743|9978222|P3|Overall Study|Lost to Follow-up|0
2898190|NCT01770743|9978223|P2|Overall Study|Lost to Follow-up|2
2898191|NCT01770743|9978224|P1|Overall Study|Lost to Follow-up|0
2898192|NCT01770743|9978220|P5|Overall Study|Withdrawal by Subject|1
2898193|NCT01770743|9978221|P4|Overall Study|Withdrawal by Subject|1
2898194|NCT01770743|9978222|P3|Overall Study|Withdrawal by Subject|1
2898195|NCT01770743|9978223|P2|Overall Study|Withdrawal by Subject|0
2898196|NCT01770743|9978224|P1|Overall Study|Withdrawal by Subject|0
2898197|NCT01770743|9978220|P5|Overall Study|Adverse Event|0
2898198|NCT01770743|9978221|P4|Overall Study|Adverse Event|0
2898199|NCT01770743|9978222|P3|Overall Study|Adverse Event|0
2898200|NCT01770743|9978223|P2|Overall Study|Adverse Event|0
2898201|NCT01770743|9978224|P1|Overall Study|Adverse Event|1
2898202|NCT01770509|9978326|P2|Overall Study|Lost to Follow-up|2
2898203|NCT01770509|9978327|P1|Overall Study|Lost to Follow-up|1
2898204|NCT01770509|9978326|P2|Overall Study|Injury|1
2898205|NCT01770509|9978327|P1|Overall Study|Injury|0
2898206|NCT01770392|9978363|P1|Washout Period of at Least 14 Days|Adverse Event|1
2898207|NCT01770379|9978378|P3|Overall Study|Adverse Event|2
2898208|NCT01770379|9978379|P2|Overall Study|Adverse Event|3
2898209|NCT01770379|9978380|P1|Overall Study|Adverse Event|1
2898210|NCT01770379|9978378|P3|Overall Study|Lack of Efficacy|6
2898211|NCT01770379|9978379|P2|Overall Study|Lack of Efficacy|6
2898212|NCT01770379|9978380|P1|Overall Study|Lack of Efficacy|8
2898213|NCT01770379|9978378|P3|Overall Study|Lost to Follow-up|2
2898214|NCT01770379|9978379|P2|Overall Study|Lost to Follow-up|0
2898215|NCT01770379|9978380|P1|Overall Study|Lost to Follow-up|0
2898216|NCT01770379|9978378|P3|Overall Study|Physician Decision|2
2898217|NCT01770379|9978379|P2|Overall Study|Physician Decision|1
2898218|NCT01770379|9978380|P1|Overall Study|Physician Decision|0
2898219|NCT01770379|9978378|P3|Overall Study|Protocol Violation|1
2898220|NCT01770379|9978379|P2|Overall Study|Protocol Violation|1
2898221|NCT01770379|9978380|P1|Overall Study|Protocol Violation|0
2898222|NCT01770379|9978378|P3|Overall Study|study terminated by sponsor|22
2898223|NCT01770379|9978379|P2|Overall Study|study terminated by sponsor|23
2898224|NCT01770379|9978380|P1|Overall Study|study terminated by sponsor|22
2898225|NCT01770379|9978378|P3|Overall Study|Withdrawal by Subject|7
2898226|NCT01770379|9978379|P2|Overall Study|Withdrawal by Subject|10
2898227|NCT01770379|9978380|P1|Overall Study|Withdrawal by Subject|7
2898228|NCT01770379|9978378|P3|Overall Study|Technical issues|0
2898229|NCT01770379|9978379|P2|Overall Study|Technical issues|0
2898230|NCT01770379|9978380|P1|Overall Study|Technical issues|1
2898231|NCT01770353|9978408|P2|Overall Study|Toxicity related diarrhoea + progression|1
2898232|NCT01770353|9978409|P1|Overall Study|Toxicity related diarrhoea + progression|0
2898233|NCT01770353|9978408|P2|Overall Study|Clinical deterioration|6
2898234|NCT01770353|9978409|P1|Overall Study|Clinical deterioration|3
2898235|NCT01770353|9978408|P2|Overall Study|Physician Decision|3
2898236|NCT01770353|9978409|P1|Overall Study|Physician Decision|0
2898237|NCT01770353|9978408|P2|Overall Study|Protocol Violation|0
2898238|NCT01770353|9978409|P1|Overall Study|Protocol Violation|1
2898239|NCT01770353|9978408|P2|Overall Study|Adverse Event|1
2898240|NCT01770353|9978409|P1|Overall Study|Adverse Event|0
2898241|NCT01770353|9978408|P2|Overall Study|Progressive disease|1
2898242|NCT01770353|9978409|P1|Overall Study|Progressive disease|2
2898243|NCT01770145|9978468|P1|Treatment|Withdrawal by Subject|1
2898244|NCT01770145|9978468|P1|Treatment|Adverse Event|3
2898245|NCT01770145|9978468|P1|Baseline|Unable to define optimal dose|4
2898246|NCT01770145|9978468|P1|Baseline|Lost to Follow-up|1
2898247|NCT01770145|9978468|P1|Baseline|Withdrawal by Subject|1
2898248|NCT01770145|9978468|P1|Baseline|Adverse Event|20
2898249|NCT01769508|9978524|P1|Overall Study|Lost to Follow-up|1
2898250|NCT01769508|9978524|P1|Overall Study|Adverse Event|1
2898251|NCT01769508|9978524|P1|Overall Study|Withdrawal by Subject|1
2898252|NCT01769508|9978524|P1|Overall Study|Death|3
2898253|NCT01769469|9978533|P1|Overall Study|Subject Confirmed HIV Positive|3
2898254|NCT01769469|9978533|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
2898255|NCT01769469|9978533|P1|Overall Study|Lost to Follow-up|17
2898256|NCT01769469|9978533|P1|Overall Study|Moved Out Of Area|3
2898257|NCT01769469|9978533|P1|Overall Study|Consent Withdrawn|5
2898258|NCT01769456|9978693|P1|Overall Study|Parental request to youth to withdraw|1
2898259|NCT01769456|9978693|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
2898260|NCT01769456|9978693|P1|Overall Study|Moved out of the area|3
2898261|NCT01769456|9978693|P1|Overall Study|Did not receive PCC intervention|6
2898262|NCT01769456|9978693|P1|Overall Study|Withdrawal by Subject|3
2898263|NCT01769456|9978693|P1|Overall Study|Lost to Follow-up|19
2898264|NCT01769443|9978714|P2|Overall Study|Study closure|0
2898265|NCT01769443|9978715|P1|Overall Study|Study closure|1
2898266|NCT01769404|9978757|P2|Treatment Period 2|Sponsor decision|0
2898267|NCT01769404|9978758|P1|Treatment Period 2|Sponsor decision|7
2898268|NCT01769404|9978757|P2|Treatment Period 1|Sponsor decision|0
2898269|NCT01769404|9978758|P1|Treatment Period 1|Sponsor decision|1
2898270|NCT01769404|9978757|P2|Treatment Period 1|Withdrawal by Subject|0
2898271|NCT01769404|9978758|P1|Treatment Period 1|Withdrawal by Subject|3
2898272|NCT01769404|9978757|P2|Treatment Period 1|Did not meet eligibility criteria|0
2898273|NCT01769404|9978758|P1|Treatment Period 1|Did not meet eligibility criteria|1
2898274|NCT01769391|9978780|P2|Overall Study|Investigator Decision|0
2898275|NCT01769391|9978781|P1|Overall Study|Investigator Decision|2
2898276|NCT01769391|9978780|P2|Overall Study|Withdrawal by Subject|3
2898277|NCT01769391|9978781|P1|Overall Study|Withdrawal by Subject|4
2898278|NCT01769391|9978780|P2|Overall Study|Progressive Disease|2
2898279|NCT01769391|9978781|P1|Overall Study|Progressive Disease|1
2898280|NCT01769391|9978780|P2|Overall Study|Adverse Event|3
2898281|NCT01769391|9978781|P1|Overall Study|Adverse Event|0
2898282|NCT01769391|9978780|P2|Overall Study|Death|1
2898283|NCT01769391|9978781|P1|Overall Study|Death|10
2898284|NCT01769378|9978800|P2|Overall Study|Lost to Follow-up|0
2898285|NCT01769378|9978801|P1|Overall Study|Lost to Follow-up|2
2898286|NCT01769378|9978800|P2|Overall Study|Sponsor Decision|0
2898287|NCT01769378|9978801|P1|Overall Study|Sponsor Decision|1
2898288|NCT01769378|9978800|P2|Overall Study|Withdrawal by Subject|3
2898289|NCT01769378|9978801|P1|Overall Study|Withdrawal by Subject|10
2898290|NCT01769378|9978800|P2|Overall Study|Protocol Violation|1
2898291|NCT01769378|9978801|P1|Overall Study|Protocol Violation|1
2898292|NCT01769378|9978800|P2|Overall Study|Entry criteria not met|0
2898293|NCT01769378|9978801|P1|Overall Study|Entry criteria not met|1
2898294|NCT01769378|9978800|P2|Overall Study|Adverse Event|0
2898295|NCT01769378|9978801|P1|Overall Study|Adverse Event|10
2898296|NCT01769339|9978881|P1|Overall Study|Adverse Event|1
2898297|NCT01769339|9978881|P1|Overall Study|Lost to Follow-up|42
2898298|NCT01769326|9978892|P4|Overall Study|Got sick and could not complete study|0
2898299|NCT01769326|9978893|P3|Overall Study|Got sick and could not complete study|1
2898300|NCT01769326|9978894|P2|Overall Study|Got sick and could not complete study|0
2898301|NCT01769326|9978895|P1|Overall Study|Got sick and could not complete study|0
2898302|NCT01769326|9978892|P4|Overall Study|got a job|0
2898303|NCT01769326|9978893|P3|Overall Study|got a job|0
2898304|NCT01769326|9978894|P2|Overall Study|got a job|1
2898305|NCT01769326|9978895|P1|Overall Study|got a job|0
2898306|NCT01769326|9978892|P4|Overall Study|unrelated injry|0
2898307|NCT01769326|9978893|P3|Overall Study|unrelated injry|0
2898308|NCT01769326|9978894|P2|Overall Study|unrelated injry|1
2898309|NCT01769326|9978895|P1|Overall Study|unrelated injry|1
2898310|NCT01769326|9978892|P4|Overall Study|Lost to Follow-up|0
2898311|NCT01769326|9978893|P3|Overall Study|Lost to Follow-up|0
2898312|NCT01769326|9978894|P2|Overall Study|Lost to Follow-up|2
2898313|NCT01769326|9978895|P1|Overall Study|Lost to Follow-up|1
2898314|NCT01769196|9979040|P2|Overall Study|Withdrew consent|40
2898315|NCT01769196|9979041|P1|Overall Study|Withdrew consent|36
2898316|NCT01769196|9979040|P2|Overall Study|Participant never dosed with study drug|0
2898317|NCT01769196|9979041|P1|Overall Study|Participant never dosed with study drug|1
2898318|NCT01769196|9979040|P2|Overall Study|Study terminated by sponsor|161
2898319|NCT01769196|9979041|P1|Overall Study|Study terminated by sponsor|160
2898320|NCT01769196|9979040|P2|Overall Study|Protocol Violation|3
2898321|NCT01769196|9979041|P1|Overall Study|Protocol Violation|0
2898322|NCT01769196|9979040|P2|Overall Study|Protocol defined criteria for withdrawal|11
2898323|NCT01769196|9979041|P1|Overall Study|Protocol defined criteria for withdrawal|9
2898324|NCT01769196|9979040|P2|Overall Study|Progressive disease|6
2898325|NCT01769196|9979041|P1|Overall Study|Progressive disease|11
2898326|NCT01769196|9979040|P2|Overall Study|Lack of Efficacy|2
2898327|NCT01769196|9979041|P1|Overall Study|Lack of Efficacy|3
2898328|NCT01769196|9979040|P2|Overall Study|Investigator Discretion|3
2898329|NCT01769196|9979041|P1|Overall Study|Investigator Discretion|7
2898330|NCT01769196|9979040|P2|Overall Study|Death|26
2898331|NCT01769196|9979041|P1|Overall Study|Death|21
2898332|NCT01769196|9979040|P2|Overall Study|Adverse Event|20
2898333|NCT01769196|9979041|P1|Overall Study|Adverse Event|24
2898334|NCT01769105|9979071|P2|Cross-over|Lost to Follow-up|0
2898335|NCT01769105|9979072|P1|Cross-over|Lost to Follow-up|5
2898336|NCT01769105|9979071|P2|First Intervention|Protocol Violation|2
2898337|NCT01769105|9979072|P1|First Intervention|Protocol Violation|2
2898338|NCT01768858|9979091|P1|Overall Study|Withdrawal by Subject|1
2898339|NCT01768858|9979091|P1|Overall Study|Exanthema|1
2898340|NCT01768858|9979091|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
2898341|NCT01768858|9979091|P1|Overall Study|Participant moved to Germany|1
2898342|NCT01768858|9979091|P1|Overall Study|Serious Adverse Event|1
2898343|NCT01768858|9979091|P1|Overall Study|Lack of Efficacy|8
2898344|NCT01768858|9979091|P1|Overall Study|Lost to Follow-up|9
2898345|NCT01768676|9979142|P2|Overall Study|Withdrawal by Subject|10
2898346|NCT01768676|9979143|P1|Overall Study|Withdrawal by Subject|3
2898347|NCT01768676|9979142|P2|Overall Study|Physician Decision|1
2898348|NCT01768676|9979143|P1|Overall Study|Physician Decision|4
2898349|NCT01768676|9979142|P2|Overall Study|Protocol Violation|1
2898350|NCT01768676|9979143|P1|Overall Study|Protocol Violation|1
2898351|NCT01768676|9979142|P2|Overall Study|Lost to Follow-up|16
2898352|NCT01768676|9979143|P1|Overall Study|Lost to Follow-up|13
2898353|NCT01768676|9979142|P2|Overall Study|Adverse Event|3
2898354|NCT01768676|9979143|P1|Overall Study|Adverse Event|3
2898355|NCT01768637|9979159|P2|Overall Study|Difficult blood draw|0
2898356|NCT01768637|9979160|P1|Overall Study|Difficult blood draw|1
2898357|NCT01768637|9979159|P2|Overall Study|Lost to Follow-up|7
2898358|NCT01768637|9979160|P1|Overall Study|Lost to Follow-up|2
2898359|NCT01768572|9979173|P3|Overall Study|Other, Not due to an adverse event|1
2898360|NCT01768572|9979174|P2|Overall Study|Other, Not due to an adverse event|1
2898361|NCT01768572|9979175|P1|Overall Study|Other, Not due to an adverse event|1
2898362|NCT01768572|9979173|P3|Overall Study|Lack of Efficacy|1
2898363|NCT01768572|9979174|P2|Overall Study|Lack of Efficacy|3
2898364|NCT01768572|9979175|P1|Overall Study|Lack of Efficacy|1
2898365|NCT01768572|9979173|P3|Overall Study|Adverse Event|4
2898366|NCT01768572|9979174|P2|Overall Study|Adverse Event|8
2898367|NCT01768572|9979175|P1|Overall Study|Adverse Event|7
2898368|NCT01768559|9979186|P3|Overall Study|Other than specified|5
2898369|NCT01768559|9979187|P2|Overall Study|Other than specified|8
2898370|NCT01768559|9979188|P1|Overall Study|Other than specified|9
2898371|NCT01768559|9979186|P3|Overall Study|Poor compliance to protocol|2
2898372|NCT01768559|9979187|P2|Overall Study|Poor compliance to protocol|3
2898373|NCT01768559|9979188|P1|Overall Study|Poor compliance to protocol|0
2898374|NCT01768559|9979186|P3|Overall Study|Lack of Efficacy|0
2898375|NCT01768559|9979187|P2|Overall Study|Lack of Efficacy|4
2898376|NCT01768559|9979188|P1|Overall Study|Lack of Efficacy|6
2898377|NCT01768559|9979186|P3|Overall Study|Adverse Event|5
2898378|NCT01768559|9979187|P2|Overall Study|Adverse Event|2
2898379|NCT01768559|9979188|P1|Overall Study|Adverse Event|15
2898380|NCT01768559|9979186|P3|Overall Study|Randomized but not treated|1
2898381|NCT01768559|9979187|P2|Overall Study|Randomized but not treated|0
2898382|NCT01768559|9979188|P1|Overall Study|Randomized but not treated|0
2898383|NCT01768286|9979269|P4|Overall Study|Withdrew Consent|0
2898384|NCT01768286|9979270|P3|Overall Study|Withdrew Consent|1
2898385|NCT01768286|9979271|P2|Overall Study|Withdrew Consent|0
2898386|NCT01768286|9979272|P1|Overall Study|Withdrew Consent|0
2898387|NCT01768286|9979269|P4|Overall Study|Lack of Efficacy|1
2898388|NCT01768286|9979270|P3|Overall Study|Lack of Efficacy|0
2898389|NCT01768286|9979271|P2|Overall Study|Lack of Efficacy|4
2898390|NCT01768286|9979272|P1|Overall Study|Lack of Efficacy|7
2898391|NCT01768286|9979269|P4|Overall Study|Randomized But Not Treated|0
2898392|NCT01768286|9979270|P3|Overall Study|Randomized But Not Treated|1
2898393|NCT01768286|9979271|P2|Overall Study|Randomized But Not Treated|0
2898394|NCT01768286|9979272|P1|Overall Study|Randomized But Not Treated|0
2898395|NCT01768117|9979334|P1|Overall Study|Protocol Violation|3
2898396|NCT01768117|9979334|P1|Overall Study|Withdrawal by Subject|2
2898397|NCT01768117|9979334|P1|Overall Study|Lost to Follow-up|1
2898398|NCT01767987|9979398|P2|Overall Study|Physician Decision|1
2898399|NCT01767987|9979399|P1|Overall Study|Physician Decision|4
2898400|NCT01767909|9979431|P2|Overall Study|LP uncessessful|1
2898401|NCT01767909|9979432|P1|Overall Study|LP uncessessful|0
2898402|NCT01767909|9979431|P2|Overall Study|Lost to Follow-up|1
2898403|NCT01767909|9979432|P1|Overall Study|Lost to Follow-up|0
2898404|NCT01767909|9979431|P2|Overall Study|Investigator Recommendation|1
2898405|NCT01767909|9979432|P1|Overall Study|Investigator Recommendation|0
2898406|NCT01767909|9979431|P2|Overall Study|Perceived Lack of Efficacy|0
2898407|NCT01767909|9979432|P1|Overall Study|Perceived Lack of Efficacy|1
2898408|NCT01767909|9979431|P2|Overall Study|Non-Compliance|0
2898409|NCT01767909|9979432|P1|Overall Study|Non-Compliance|2
2898410|NCT01767909|9979431|P2|Overall Study|Withdrawal by Study Partner|1
2898411|NCT01767909|9979432|P1|Overall Study|Withdrawal by Study Partner|3
2898412|NCT01767909|9979431|P2|Overall Study|Adverse Event|1
2898413|NCT01767909|9979432|P1|Overall Study|Adverse Event|3
2898414|NCT01767909|9979431|P2|Overall Study|Withdrawal by Subject|7
2898415|NCT01767909|9979432|P1|Overall Study|Withdrawal by Subject|4
2898416|NCT01767597|9979502|P2|Overall Study|Withdrawal by Subject|0
2898417|NCT01767597|9979503|P1|Overall Study|Withdrawal by Subject|1
2898418|NCT01767597|9979502|P2|Overall Study|Incomplete intervention|1
2898419|NCT01767597|9979503|P1|Overall Study|Incomplete intervention|3
2898420|NCT01767519|9979512|P3|Overall Study|Adverse Event|1
2898421|NCT01767519|9979513|P2|Overall Study|Adverse Event|5
2898422|NCT01767519|9979514|P1|Overall Study|Adverse Event|5
2898423|NCT01767519|9979512|P3|Overall Study|Lack of Efficacy|0
2898424|NCT01767519|9979513|P2|Overall Study|Lack of Efficacy|0
2898425|NCT01767519|9979514|P1|Overall Study|Lack of Efficacy|1
2898426|NCT01767519|9979512|P3|Overall Study|Lost to Follow-up|2
2898427|NCT01767519|9979513|P2|Overall Study|Lost to Follow-up|1
2898428|NCT01767519|9979514|P1|Overall Study|Lost to Follow-up|3
2898429|NCT01767519|9979512|P3|Overall Study|Personal Reasons|0
2898430|NCT01767519|9979513|P2|Overall Study|Personal Reasons|0
2898431|NCT01767519|9979514|P1|Overall Study|Personal Reasons|1
2898432|NCT01767519|9979512|P3|Overall Study|Protocol Violation|0
2898433|NCT01767519|9979513|P2|Overall Study|Protocol Violation|3
2898434|NCT01767519|9979514|P1|Overall Study|Protocol Violation|0
2898435|NCT01767519|9979512|P3|Overall Study|Other Reasons|2
2898436|NCT01767519|9979513|P2|Overall Study|Other Reasons|4
2898437|NCT01767519|9979514|P1|Overall Study|Other Reasons|4
2898438|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
2898439|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
2898440|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Physician Decision|0
2898441|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Physician Decision|1
2898442|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
2898443|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
2898444|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
2898445|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
2898446|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
2898447|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
2898448|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
2898449|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
2898450|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
2898451|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
2898452|NCT01767467|9979555|P2|End of Study Phase (up to Month 13)|Adverse Event|39
2898453|NCT01767467|9979556|P1|End of Study Phase (up to Month 13)|Adverse Event|29
2898454|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
2898455|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
2898456|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
2898457|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
2898458|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
2898459|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
2898460|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
2898461|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
2898462|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
2898463|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
2898464|NCT01767467|9979555|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
2898465|NCT01767467|9979556|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
2898466|NCT01767376|9979612|P3|Overall Study|Withdrawal by Subject|0
2898467|NCT01767376|9979613|P2|Overall Study|Withdrawal by Subject|1
2898468|NCT01767376|9979614|P1|Overall Study|Withdrawal by Subject|1
2898469|NCT01767376|9979612|P3|Overall Study|Lost to Follow-up|0
2898470|NCT01767376|9979613|P2|Overall Study|Lost to Follow-up|2
2898471|NCT01767376|9979614|P1|Overall Study|Lost to Follow-up|3
2898472|NCT01767194|9979680|P2|Overall Study|Criteria not met on time for next cycle|1
2898473|NCT01767194|9979681|P1|Overall Study|Criteria not met on time for next cycle|0
2898474|NCT01767194|9979680|P2|Overall Study|Refusal by patient/parent|4
2898475|NCT01767194|9979681|P1|Overall Study|Refusal by patient/parent|2
2898476|NCT01767194|9979680|P2|Overall Study|Ineligible|1
2898477|NCT01767194|9979681|P1|Overall Study|Ineligible|1
2898478|NCT01767194|9979680|P2|Overall Study|Withdrawal by Subject|1
2898479|NCT01767194|9979681|P1|Overall Study|Withdrawal by Subject|0
2898480|NCT01767194|9979680|P2|Overall Study|Physician Decision|23
2898481|NCT01767194|9979681|P1|Overall Study|Physician Decision|2
2898482|NCT01767194|9979680|P2|Overall Study|Lack of Efficacy|11
2898483|NCT01767194|9979681|P1|Overall Study|Lack of Efficacy|12
2898484|NCT01767194|9979680|P2|Overall Study|Death|1
2898485|NCT01767194|9979681|P1|Overall Study|Death|0
2898486|NCT01767194|9979680|P2|Overall Study|Adverse Event|1
2898487|NCT01767194|9979681|P1|Overall Study|Adverse Event|1
2898488|NCT01767116|9979705|P2|Overall Study|Lost to Follow-up|2
2898489|NCT01767116|9979706|P1|Overall Study|Lost to Follow-up|2
2898490|NCT01766921|9979764|P2|Overall Study|Withdrawal by Subject|5
2898491|NCT01766921|9979765|P1|Overall Study|Withdrawal by Subject|14
2898492|NCT01766921|9979764|P2|Overall Study|Protocol Violation|1
2898493|NCT01766921|9979765|P1|Overall Study|Protocol Violation|1
2898494|NCT01766921|9979764|P2|Overall Study|Unclassified|2
2898495|NCT01766921|9979765|P1|Overall Study|Unclassified|2
2898496|NCT01766921|9979764|P2|Overall Study|Lost to Follow-up|3
2898497|NCT01766921|9979765|P1|Overall Study|Lost to Follow-up|1
2898498|NCT01766921|9979764|P2|Overall Study|Death|1
2898499|NCT01766921|9979765|P1|Overall Study|Death|1
2898500|NCT01766921|9979764|P2|Overall Study|Administrative Reason|5
2898501|NCT01766921|9979765|P1|Overall Study|Administrative Reason|5
2898502|NCT01766817|9979787|P3|Overall Study|Other|0
2898503|NCT01766817|9979788|P2|Overall Study|Other|0
2898504|NCT01766817|9979789|P1|Overall Study|Other|1
2898505|NCT01766817|9979787|P3|Overall Study|Physician Decision|4
2898506|NCT01766817|9979788|P2|Overall Study|Physician Decision|3
2898507|NCT01766817|9979789|P1|Overall Study|Physician Decision|3
2898508|NCT01766817|9979787|P3|Overall Study|Subject non-compliance|2
2898509|NCT01766817|9979788|P2|Overall Study|Subject non-compliance|1
2898510|NCT01766817|9979789|P1|Overall Study|Subject non-compliance|0
2898511|NCT01766817|9979787|P3|Overall Study|Withdrawal by Subject|3
2898512|NCT01766817|9979788|P2|Overall Study|Withdrawal by Subject|0
2898513|NCT01766817|9979789|P1|Overall Study|Withdrawal by Subject|2
2898514|NCT01766817|9979787|P3|Overall Study|Unable to take study drug|0
2898515|NCT01766817|9979788|P2|Overall Study|Unable to take study drug|1
2898516|NCT01766817|9979789|P1|Overall Study|Unable to take study drug|0
2898517|NCT01766817|9979787|P3|Overall Study|Death|0
2898518|NCT01766817|9979788|P2|Overall Study|Death|1
2898519|NCT01766817|9979789|P1|Overall Study|Death|1
2898520|NCT01766817|9979787|P3|Overall Study|Drug-unrelated adverse event|3
2898521|NCT01766817|9979788|P2|Overall Study|Drug-unrelated adverse event|3
2898522|NCT01766817|9979789|P1|Overall Study|Drug-unrelated adverse event|3
2898523|NCT01766817|9979787|P3|Overall Study|Drug-related adverse event|1
2898524|NCT01766817|9979788|P2|Overall Study|Drug-related adverse event|2
2898525|NCT01766817|9979789|P1|Overall Study|Drug-related adverse event|1
2898526|NCT01766778|9979840|P2|Overall Study|Withdrawal by Subject|0
2898527|NCT01766778|9979841|P1|Overall Study|Withdrawal by Subject|1
2898528|NCT01766778|9979840|P2|Overall Study|Adverse Event|4
2898529|NCT01766778|9979841|P1|Overall Study|Adverse Event|4
2898530|NCT01766401|9979895|P2|Overall Study|Pregnancy|1
2898531|NCT01766401|9979896|P1|Overall Study|Pregnancy|1
2898532|NCT01766401|9979895|P2|Overall Study|Lost to Follow-up|11
2898533|NCT01766401|9979896|P1|Overall Study|Lost to Follow-up|10
2898534|NCT01766401|9979895|P2|Overall Study|Withdrawal by Subject|12
2898535|NCT01766401|9979896|P1|Overall Study|Withdrawal by Subject|15
2898536|NCT01766401|9979895|P2|Overall Study|Protocol Violation|8
2898537|NCT01766401|9979896|P1|Overall Study|Protocol Violation|3
2898538|NCT01766401|9979895|P2|Overall Study|Lack of Efficacy|2
2898539|NCT01766401|9979896|P1|Overall Study|Lack of Efficacy|1
2898540|NCT01766401|9979895|P2|Overall Study|Adverse Event|22
2898541|NCT01766401|9979896|P1|Overall Study|Adverse Event|7
2898542|NCT01766336|9979906|P2|Overall Study|Withdrawal by Subject|15
2898543|NCT01766336|9979907|P1|Overall Study|Withdrawal by Subject|18
2898544|NCT01766336|9979906|P2|Overall Study|Sponsor Decision|43
2898545|NCT01766336|9979907|P1|Overall Study|Sponsor Decision|52
2898546|NCT01766336|9979906|P2|Overall Study|Protocol Violation|1
2898547|NCT01766336|9979907|P1|Overall Study|Protocol Violation|0
2898548|NCT01766336|9979906|P2|Overall Study|Physician Decision|2
2898549|NCT01766336|9979907|P1|Overall Study|Physician Decision|4
2898550|NCT01766336|9979906|P2|Overall Study|Lost to Follow-up|3
2898551|NCT01766336|9979907|P1|Overall Study|Lost to Follow-up|1
2898552|NCT01766336|9979906|P2|Overall Study|Death|3
2898553|NCT01766336|9979907|P1|Overall Study|Death|4
2898554|NCT01766336|9979906|P2|Overall Study|Adverse Event|8
2898555|NCT01766336|9979907|P1|Overall Study|Adverse Event|11
2898556|NCT01766310|9979915|P2|Overall Study|Lost to Follow-up|3
2898557|NCT01766310|9979916|P1|Overall Study|Lost to Follow-up|1
2898558|NCT01766206|9979946|P1|Overall Study|Withdrawal and inappropriate enrollment|1
2898559|NCT01766206|9979946|P1|Overall Study|Inappropriate enrollment|18
2898560|NCT01766206|9979946|P1|Overall Study|Lost to Follow-up|10
2898561|NCT01766206|9979946|P1|Overall Study|Withdrawal by Subject|22
2898562|NCT01766050|9979973|P1|Overall Study|Withdrawal by Subject|2
2898563|NCT01766050|9979973|P1|Overall Study|Lost to Follow-up|1
2898564|NCT01766050|9979973|P1|Overall Study|Adverse Event|1
2898565|NCT01766037|9980108|P2|Overall Study|nausea / discomfort|0
2898566|NCT01766037|9980109|P1|Overall Study|nausea / discomfort|3
2898567|NCT01766037|9980108|P2|Overall Study|medical - unrelated|2
2898568|NCT01766037|9980109|P1|Overall Study|medical - unrelated|1
2898569|NCT01766037|9980108|P2|Overall Study|Moved from area|0
2898570|NCT01766037|9980109|P1|Overall Study|Moved from area|5
2898571|NCT01766037|9980108|P2|Overall Study|Withdrawal by Subject|16
2898572|NCT01766037|9980109|P1|Overall Study|Withdrawal by Subject|18
2898573|NCT01766037|9980108|P2|Overall Study|Physician Decision|1
2898574|NCT01766037|9980109|P1|Overall Study|Physician Decision|0
2898575|NCT01766037|9980108|P2|Overall Study|Lost to Follow-up|10
2898576|NCT01766037|9980109|P1|Overall Study|Lost to Follow-up|0
2898577|NCT01766037|9980108|P2|Overall Study|Lack of Efficacy|0
2898578|NCT01766037|9980109|P1|Overall Study|Lack of Efficacy|1
2898579|NCT01766037|9980108|P2|Overall Study|Adverse Event|0
2898580|NCT01766037|9980109|P1|Overall Study|Adverse Event|1
2898581|NCT01765764|9980178|P3|Treatment Period|Other Miscellaneous Reasons|2
2898582|NCT01765764|9980179|P2|Treatment Period|Other Miscellaneous Reasons|2
2898583|NCT01765764|9980180|P1|Treatment Period|Other Miscellaneous Reasons|1
2898584|NCT01765764|9980178|P3|Treatment Period|Personal Reasons|1
2898585|NCT01765764|9980179|P2|Treatment Period|Personal Reasons|2
2898586|NCT01765764|9980180|P1|Treatment Period|Personal Reasons|1
2898587|NCT01765764|9980178|P3|Treatment Period|Lost to Follow-up|2
2898588|NCT01765764|9980179|P2|Treatment Period|Lost to Follow-up|3
2898589|NCT01765764|9980180|P1|Treatment Period|Lost to Follow-up|0
2898590|NCT01765764|9980178|P3|Treatment Period|Adverse Event|1
2898591|NCT01765764|9980179|P2|Treatment Period|Adverse Event|2
2898592|NCT01765764|9980180|P1|Treatment Period|Adverse Event|1
2898593|NCT01765751|9980200|P3|Overall Study|Lost to Follow-up|1
2898594|NCT01765751|9980201|P2|Overall Study|Lost to Follow-up|2
2898595|NCT01765751|9980202|P1|Overall Study|Lost to Follow-up|0
2898596|NCT01765673|9980234|P1|Overall Study|No transportation for 2nd/3rd visits|1
2898597|NCT01765582|9980267|P3|Overall Study|Withdrawal of Consent|10
2898598|NCT01765582|9980268|P2|Overall Study|Withdrawal of Consent|6
2898599|NCT01765582|9980269|P1|Overall Study|Withdrawal of Consent|11
2898600|NCT01765582|9980267|P3|Overall Study|Sponsor Decision|42
2898601|NCT01765582|9980268|P2|Overall Study|Sponsor Decision|42
2898602|NCT01765582|9980269|P1|Overall Study|Sponsor Decision|46
2898603|NCT01765582|9980267|P3|Overall Study|Death|33
2898604|NCT01765582|9980268|P2|Overall Study|Death|36
2898605|NCT01765582|9980269|P1|Overall Study|Death|31
2898606|NCT01765582|9980267|P3|Overall Study|Lost to Follow-up|1
2898607|NCT01765582|9980268|P2|Overall Study|Lost to Follow-up|2
2898608|NCT01765582|9980269|P1|Overall Study|Lost to Follow-up|2
2898609|NCT01765582|9980267|P3|Overall Study|Other|9
2898610|NCT01765582|9980268|P2|Overall Study|Other|6
2898611|NCT01765582|9980269|P1|Overall Study|Other|3
2898612|NCT01765569|9980302|P1|Period C|Death|1
2898613|NCT01765569|9980302|P1|Period B|Withdrawal by Subject|1
2898614|NCT01765543|9980323|P1|Overall Study|Withdrawal by Subject|2
2898615|NCT01765543|9980323|P1|Overall Study|Death|1
2898616|NCT01765426|9980375|P4|Overall Study|Lost to Follow-up|0
2898617|NCT01765426|9980376|P3|Overall Study|Lost to Follow-up|0
2898618|NCT01765426|9980377|P2|Overall Study|Lost to Follow-up|1
2898619|NCT01765426|9980378|P1|Overall Study|Lost to Follow-up|0
2898620|NCT01765270|9980434|P2|Overall Study|Withdrawal by Subject|1
2898621|NCT01765270|9980435|P1|Overall Study|Withdrawal by Subject|0
2898622|NCT01765270|9980434|P2|Overall Study|Physician Decision|0
2898623|NCT01765270|9980435|P1|Overall Study|Physician Decision|1
2898624|NCT01765192|9980457|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
2898625|NCT01765192|9980458|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
2898626|NCT01765192|9980457|P2|Treatment Period 2|Reason not specified|2
2898627|NCT01765192|9980458|P1|Treatment Period 2|Reason not specified|0
2898628|NCT01765192|9980457|P2|Washout Period|Reason not specified|0
2898629|NCT01765192|9980458|P1|Washout Period|Reason not specified|1
2898630|NCT01765192|9980457|P2|Washout Period|Voluntary Withdrawal|1
2898631|NCT01765192|9980458|P1|Washout Period|Voluntary Withdrawal|1
2898632|NCT01765192|9980457|P2|Treatment Period 1|Adverse Event|1
2898633|NCT01765192|9980458|P1|Treatment Period 1|Adverse Event|0
2898634|NCT01765179|9980476|P1|Overall Study|Ca elevated 10.6|1
2898635|NCT01765179|9980476|P1|Overall Study|work conflict|1
2898636|NCT01765179|9980476|P1|Overall Study|lack of venous access|1
2898637|NCT01765179|9980476|P1|Overall Study|Out of country unable to finish study|1
2898638|NCT01765179|9980476|P1|Overall Study|prohibited med|1
2898639|NCT01765179|9980476|P1|Overall Study|Hematocrit >54%|3
2898640|NCT01765179|9980476|P1|Overall Study|Withdrawal by Subject|8
2898641|NCT01765179|9980476|P1|Overall Study|Protocol Violation|1
2898642|NCT01765179|9980476|P1|Overall Study|Non-compliance with study drug|2
2898643|NCT01765179|9980476|P1|Overall Study|Lost to Follow-up|5
2898644|NCT01765179|9980476|P1|Overall Study|Adverse Event|3
2898645|NCT01765153|9980483|P2|Rest Phase 2|Lost to Follow-up|1
2898646|NCT01765153|9980484|P1|Rest Phase 2|Lost to Follow-up|2
2898647|NCT01765153|9980483|P2|Training Phase 2|Withdrawal by Subject|1
2898648|NCT01765153|9980484|P1|Training Phase 2|Withdrawal by Subject|0
2898649|NCT01765153|9980483|P2|Rest Phase 1|Withdrawal by Subject|1
2898650|NCT01765153|9980484|P1|Rest Phase 1|Withdrawal by Subject|0
2898651|NCT01765153|9980483|P2|Training Phase 1|Poor participation in intervention|1
2898652|NCT01765153|9980484|P1|Training Phase 1|Poor participation in intervention|0
2898653|NCT01765153|9980483|P2|Training Phase 1|Format of intervention differed|0
2898654|NCT01765153|9980484|P1|Training Phase 1|Format of intervention differed|1
2898655|NCT01764997|9980591|P5|Study Drug Treatment Period|Other than specified above|10
2898656|NCT01764997|9980592|P4|Study Drug Treatment Period|Other than specified above|0
2898657|NCT01764997|9980593|P3|Study Drug Treatment Period|Other than specified above|0
2898658|NCT01764997|9980594|P2|Study Drug Treatment Period|Other than specified above|0
2898659|NCT01764997|9980595|P1|Study Drug Treatment Period|Other than specified above|0
2898660|NCT01764997|9980591|P5|Study Drug Treatment Period|Lack of Efficacy|2
2898661|NCT01764997|9980592|P4|Study Drug Treatment Period|Lack of Efficacy|0
2898662|NCT01764997|9980593|P3|Study Drug Treatment Period|Lack of Efficacy|0
2898663|NCT01764997|9980594|P2|Study Drug Treatment Period|Lack of Efficacy|0
2898664|NCT01764997|9980595|P1|Study Drug Treatment Period|Lack of Efficacy|0
2898665|NCT01764997|9980591|P5|Study Drug Treatment Period|Adverse Event|24
2898666|NCT01764997|9980592|P4|Study Drug Treatment Period|Adverse Event|0
2898667|NCT01764997|9980593|P3|Study Drug Treatment Period|Adverse Event|0
2898668|NCT01764997|9980594|P2|Study Drug Treatment Period|Adverse Event|1
2898669|NCT01764997|9980595|P1|Study Drug Treatment Period|Adverse Event|0
2898670|NCT01764997|9980591|P5|Run-in Period|Other than specified above|0
2898671|NCT01764997|9980592|P4|Run-in Period|Other than specified above|0
2898672|NCT01764997|9980593|P3|Run-in Period|Other than specified above|0
2898673|NCT01764997|9980594|P2|Run-in Period|Other than specified above|0
2898674|NCT01764997|9980595|P1|Run-in Period|Other than specified above|17
2898675|NCT01764997|9980591|P5|Run-in Period|Poor compliance to protocol|0
2898676|NCT01764997|9980592|P4|Run-in Period|Poor compliance to protocol|0
2898677|NCT01764997|9980593|P3|Run-in Period|Poor compliance to protocol|0
2898678|NCT01764997|9980594|P2|Run-in Period|Poor compliance to protocol|0
2898679|NCT01764997|9980595|P1|Run-in Period|Poor compliance to protocol|1
2898680|NCT01764997|9980591|P5|Run-in Period|Lack of Efficacy|0
2898681|NCT01764997|9980592|P4|Run-in Period|Lack of Efficacy|0
2898682|NCT01764997|9980593|P3|Run-in Period|Lack of Efficacy|0
2898683|NCT01764997|9980594|P2|Run-in Period|Lack of Efficacy|0
2898684|NCT01764997|9980595|P1|Run-in Period|Lack of Efficacy|5
2898685|NCT01764997|9980591|P5|Run-in Period|Adverse Event|0
2898686|NCT01764997|9980592|P4|Run-in Period|Adverse Event|0
2898687|NCT01764997|9980593|P3|Run-in Period|Adverse Event|0
2898688|NCT01764997|9980594|P2|Run-in Period|Adverse Event|0
2898689|NCT01764997|9980595|P1|Run-in Period|Adverse Event|15
2898690|NCT01764945|9980622|P8|Overall Study|Adverse Event|0
2898691|NCT01764945|9980623|P7|Overall Study|Adverse Event|1
2898692|NCT01764945|9980624|P6|Overall Study|Adverse Event|0
2898693|NCT01764945|9980625|P5|Overall Study|Adverse Event|0
2898694|NCT01764945|9980626|P4|Overall Study|Adverse Event|0
2898695|NCT01764945|9980627|P3|Overall Study|Adverse Event|0
2898696|NCT01764945|9980628|P2|Overall Study|Adverse Event|1
2898697|NCT01764945|9980629|P1|Overall Study|Adverse Event|0
2898698|NCT01764841|9980675|P4|Overall Study|Lost to Follow-up|0
2898699|NCT01764841|9980676|P3|Overall Study|Lost to Follow-up|1
2898700|NCT01764841|9980677|P2|Overall Study|Lost to Follow-up|0
2898701|NCT01764841|9980678|P1|Overall Study|Lost to Follow-up|3
2898702|NCT01764841|9980675|P4|Overall Study|Withdrawal by Subject|15
2898703|NCT01764841|9980676|P3|Overall Study|Withdrawal by Subject|11
2898704|NCT01764841|9980677|P2|Overall Study|Withdrawal by Subject|24
2898705|NCT01764841|9980678|P1|Overall Study|Withdrawal by Subject|16
2898706|NCT01764841|9980675|P4|Overall Study|Protocol Violation|0
2898707|NCT01764841|9980676|P3|Overall Study|Protocol Violation|0
2898708|NCT01764841|9980677|P2|Overall Study|Protocol Violation|1
2898709|NCT01764841|9980678|P1|Overall Study|Protocol Violation|0
2898710|NCT01764841|9980675|P4|Overall Study|No Follow Up|0
2898711|NCT01764841|9980676|P3|Overall Study|No Follow Up|1
2898712|NCT01764841|9980677|P2|Overall Study|No Follow Up|0
2898713|NCT01764841|9980678|P1|Overall Study|No Follow Up|1
2898714|NCT01764841|9980675|P4|Overall Study|Death|4
2898715|NCT01764841|9980676|P3|Overall Study|Death|1
2898716|NCT01764841|9980677|P2|Overall Study|Death|0
2898717|NCT01764841|9980678|P1|Overall Study|Death|3
2898718|NCT01764841|9980675|P4|Overall Study|Logistical Difficulties|0
2898719|NCT01764841|9980676|P3|Overall Study|Logistical Difficulties|0
2898720|NCT01764841|9980677|P2|Overall Study|Logistical Difficulties|1
2898721|NCT01764841|9980678|P1|Overall Study|Logistical Difficulties|0
2898722|NCT01764659|9980719|P1|Overall Study|Physician Decision|1
2898723|NCT01764659|9980719|P1|Overall Study|Death|1
2898724|NCT01764633|9980733|P2|Overall Study|Lost to Follow-up|5
2898725|NCT01764633|9980734|P1|Overall Study|Lost to Follow-up|13
2898726|NCT01764633|9980733|P2|Overall Study|Withdrawal by Subject|88
2898727|NCT01764633|9980734|P1|Overall Study|Withdrawal by Subject|105
2898728|NCT01764464|9980763|P2|Second Intervention (Cross-over)|Adverse Event|0
2898729|NCT01764464|9980764|P1|Second Intervention (Cross-over)|Adverse Event|2
2898730|NCT01764464|9980763|P2|First Intervention|did not receive study drug|1
2898731|NCT01764464|9980764|P1|First Intervention|did not receive study drug|0
2898732|NCT01764464|9980763|P2|First Intervention|Adverse Event|2
2898733|NCT01764464|9980764|P1|First Intervention|Adverse Event|0
2898734|NCT01764464|9980763|P2|First Intervention|Lost to Follow-up|0
2898735|NCT01764464|9980764|P1|First Intervention|Lost to Follow-up|1
2898736|NCT01764464|9980763|P2|First Intervention|Withdrawal by Subject|0
2898737|NCT01764464|9980764|P1|First Intervention|Withdrawal by Subject|1
2898738|NCT01764386|9980782|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2898739|NCT01764386|9980783|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2898740|NCT01764386|9980782|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2898741|NCT01764386|9980783|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2898742|NCT01764386|9980782|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
2898743|NCT01764386|9980783|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
2898744|NCT01764386|9980782|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
2898745|NCT01764386|9980783|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
2898746|NCT01764386|9980782|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
2898747|NCT01764386|9980783|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
2898748|NCT01764386|9980782|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
2898749|NCT01764386|9980783|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
2898750|NCT01764386|9980782|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
2898751|NCT01764386|9980783|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
2898752|NCT01764386|9980782|P2|Controlled Treatment Period (CTP)|Adverse Event|0
2898753|NCT01764386|9980783|P1|Controlled Treatment Period (CTP)|Adverse Event|35
2898754|NCT01764256|9980828|P4|Completed Study|Lost to Follow-up|1
2898755|NCT01764256|9980829|P3|Completed Study|Lost to Follow-up|0
2898756|NCT01764256|9980830|P2|Completed Study|Lost to Follow-up|0
2898757|NCT01764256|9980831|P1|Completed Study|Lost to Follow-up|0
2898758|NCT01764256|9980828|P4|Received All Vaccinations|Lost to Follow-up|0
2898759|NCT01764256|9980829|P3|Received All Vaccinations|Lost to Follow-up|0
2898760|NCT01764256|9980830|P2|Received All Vaccinations|Lost to Follow-up|0
2898761|NCT01764256|9980831|P1|Received All Vaccinations|Lost to Follow-up|1
2898762|NCT01764256|9980828|P4|Received All Vaccinations|Did not meet inclusion criteria|0
2898763|NCT01764256|9980829|P3|Received All Vaccinations|Did not meet inclusion criteria|1
2898764|NCT01764256|9980830|P2|Received All Vaccinations|Did not meet inclusion criteria|0
2898765|NCT01764256|9980831|P1|Received All Vaccinations|Did not meet inclusion criteria|0
2898766|NCT01764256|9980828|P4|Received All Vaccinations|Adverse Event|0
2898767|NCT01764256|9980829|P3|Received All Vaccinations|Adverse Event|0
2898768|NCT01764256|9980830|P2|Received All Vaccinations|Adverse Event|1
2898769|NCT01764256|9980831|P1|Received All Vaccinations|Adverse Event|1
2898770|NCT01764022|9980874|P2|Overall Study|Protocol Violation|0
2898771|NCT01764022|9980875|P1|Overall Study|Protocol Violation|1
2898772|NCT01764022|9980874|P2|Overall Study|Lost to Follow-up|0
2898773|NCT01764022|9980875|P1|Overall Study|Lost to Follow-up|2
2898774|NCT01764022|9980874|P2|Overall Study|Physician Decision|2
2898775|NCT01764022|9980875|P1|Overall Study|Physician Decision|0
2898776|NCT01764022|9980874|P2|Overall Study|Lack of Efficacy|1
2898777|NCT01764022|9980875|P1|Overall Study|Lack of Efficacy|0
2898778|NCT01764022|9980874|P2|Overall Study|Withdrawal by Subject|6
2898779|NCT01764022|9980875|P1|Overall Study|Withdrawal by Subject|2
2898780|NCT01764022|9980874|P2|Overall Study|Death|5
2898781|NCT01764022|9980875|P1|Overall Study|Death|3
2898782|NCT01763996|9980907|P2|Treatment Period 2|Adverse Event|1
2898783|NCT01763996|9980908|P1|Treatment Period 2|Adverse Event|0
2898784|NCT01763918|9980949|P4|Overall Study|Sponsor Decision|0
2898785|NCT01763918|9980950|P3|Overall Study|Sponsor Decision|9
2898786|NCT01763918|9980951|P2|Overall Study|Sponsor Decision|0
2898787|NCT01763918|9980952|P1|Overall Study|Sponsor Decision|4
2898788|NCT01763918|9980949|P4|Overall Study|Withdrawal by Subject|2
2898789|NCT01763918|9980950|P3|Overall Study|Withdrawal by Subject|1
2898790|NCT01763918|9980951|P2|Overall Study|Withdrawal by Subject|1
2898791|NCT01763918|9980952|P1|Overall Study|Withdrawal by Subject|2
2898792|NCT01763905|9981050|P4|Overall Study|Lost to Follow-up|0
2898793|NCT01763905|9981051|P3|Overall Study|Lost to Follow-up|1
2898794|NCT01763905|9981052|P2|Overall Study|Lost to Follow-up|0
2898795|NCT01763905|9981053|P1|Overall Study|Lost to Follow-up|0
2898796|NCT01763905|9981050|P4|Overall Study|Decision by sponsor|0
2898797|NCT01763905|9981051|P3|Overall Study|Decision by sponsor|8
2898798|NCT01763905|9981052|P2|Overall Study|Decision by sponsor|0
2898799|NCT01763905|9981053|P1|Overall Study|Decision by sponsor|5
2898800|NCT01763905|9981050|P4|Overall Study|Withdrawal by Subject|1
2898801|NCT01763905|9981051|P3|Overall Study|Withdrawal by Subject|0
2898802|NCT01763905|9981052|P2|Overall Study|Withdrawal by Subject|1
2898803|NCT01763905|9981053|P1|Overall Study|Withdrawal by Subject|1
2898804|NCT01763866|9981171|P24|Overall Study|Death|0
2898805|NCT01763866|9981172|P23|Overall Study|Death|0
2898806|NCT01763866|9981173|P22|Overall Study|Death|0
2898807|NCT01763866|9981174|P21|Overall Study|Death|0
2898808|NCT01763866|9981175|P20|Overall Study|Death|0
2898809|NCT01763866|9981176|P19|Overall Study|Death|0
2898810|NCT01763866|9981177|P18|Overall Study|Death|0
2898811|NCT01763866|9981178|P17|Overall Study|Death|1
2898812|NCT01763866|9981179|P16|Overall Study|Death|0
2898813|NCT01763866|9981180|P15|Overall Study|Death|0
2898814|NCT01763866|9981181|P14|Overall Study|Death|0
2898815|NCT01763866|9981182|P13|Overall Study|Death|0
2898816|NCT01763866|9981183|P12|Overall Study|Death|0
2898817|NCT01763866|9981184|P11|Overall Study|Death|0
2898818|NCT01763866|9981185|P10|Overall Study|Death|0
2898819|NCT01763866|9981186|P9|Overall Study|Death|0
2898820|NCT01763866|9981187|P8|Overall Study|Death|0
2898821|NCT01763866|9981188|P7|Overall Study|Death|0
2898822|NCT01763866|9981189|P6|Overall Study|Death|0
2898823|NCT01763866|9981190|P5|Overall Study|Death|0
2898824|NCT01763866|9981191|P4|Overall Study|Death|0
2898825|NCT01763866|9981192|P3|Overall Study|Death|0
2898826|NCT01763866|9981193|P2|Overall Study|Death|0
2898827|NCT01763866|9981194|P1|Overall Study|Death|0
2898828|NCT01763866|9981171|P24|Overall Study|Lost to Follow-up|1
2898829|NCT01763866|9981172|P23|Overall Study|Lost to Follow-up|0
2898830|NCT01763866|9981173|P22|Overall Study|Lost to Follow-up|0
2898831|NCT01763866|9981174|P21|Overall Study|Lost to Follow-up|0
2898832|NCT01763866|9981175|P20|Overall Study|Lost to Follow-up|1
2898833|NCT01763866|9981176|P19|Overall Study|Lost to Follow-up|1
2898834|NCT01763866|9981177|P18|Overall Study|Lost to Follow-up|0
2898835|NCT01763866|9981178|P17|Overall Study|Lost to Follow-up|0
2898836|NCT01763866|9981179|P16|Overall Study|Lost to Follow-up|0
2898837|NCT01763866|9981180|P15|Overall Study|Lost to Follow-up|1
2898838|NCT01763866|9981181|P14|Overall Study|Lost to Follow-up|0
2898839|NCT01763866|9981182|P13|Overall Study|Lost to Follow-up|1
2898840|NCT01763866|9981183|P12|Overall Study|Lost to Follow-up|0
2898841|NCT01763866|9981184|P11|Overall Study|Lost to Follow-up|0
2898842|NCT01763866|9981185|P10|Overall Study|Lost to Follow-up|0
2898843|NCT01763866|9981186|P9|Overall Study|Lost to Follow-up|0
2898844|NCT01763866|9981187|P8|Overall Study|Lost to Follow-up|0
2898845|NCT01763866|9981188|P7|Overall Study|Lost to Follow-up|1
2898846|NCT01763866|9981189|P6|Overall Study|Lost to Follow-up|0
2898847|NCT01763866|9981190|P5|Overall Study|Lost to Follow-up|0
2898848|NCT01763866|9981191|P4|Overall Study|Lost to Follow-up|0
2898849|NCT01763866|9981192|P3|Overall Study|Lost to Follow-up|0
2898850|NCT01763866|9981193|P2|Overall Study|Lost to Follow-up|0
2898851|NCT01763866|9981194|P1|Overall Study|Lost to Follow-up|0
2898852|NCT01763866|9981171|P24|Overall Study|Decision by sponsor|0
2898853|NCT01763866|9981172|P23|Overall Study|Decision by sponsor|1
2898854|NCT01763866|9981173|P22|Overall Study|Decision by sponsor|0
2898855|NCT01763866|9981174|P21|Overall Study|Decision by sponsor|2
2898856|NCT01763866|9981175|P20|Overall Study|Decision by sponsor|0
2898857|NCT01763866|9981176|P19|Overall Study|Decision by sponsor|4
2898858|NCT01763866|9981177|P18|Overall Study|Decision by sponsor|0
2898859|NCT01763866|9981178|P17|Overall Study|Decision by sponsor|0
2898860|NCT01763866|9981179|P16|Overall Study|Decision by sponsor|0
2898861|NCT01763866|9981180|P15|Overall Study|Decision by sponsor|5
2898862|NCT01763866|9981181|P14|Overall Study|Decision by sponsor|0
2898863|NCT01763866|9981182|P13|Overall Study|Decision by sponsor|1
2898864|NCT01763866|9981183|P12|Overall Study|Decision by sponsor|0
2898865|NCT01763866|9981184|P11|Overall Study|Decision by sponsor|6
2898866|NCT01763866|9981185|P10|Overall Study|Decision by sponsor|0
2898867|NCT01763866|9981186|P9|Overall Study|Decision by sponsor|2
2898868|NCT01763866|9981187|P8|Overall Study|Decision by sponsor|0
2898869|NCT01763866|9981188|P7|Overall Study|Decision by sponsor|2
2898870|NCT01763866|9981189|P6|Overall Study|Decision by sponsor|0
2898871|NCT01763866|9981190|P5|Overall Study|Decision by sponsor|2
2898872|NCT01763866|9981191|P4|Overall Study|Decision by sponsor|0
2898873|NCT01763866|9981192|P3|Overall Study|Decision by sponsor|1
2898874|NCT01763866|9981193|P2|Overall Study|Decision by sponsor|0
2898875|NCT01763866|9981194|P1|Overall Study|Decision by sponsor|0
2898876|NCT01763866|9981171|P24|Overall Study|Withdrawal by Subject|1
2898877|NCT01763866|9981172|P23|Overall Study|Withdrawal by Subject|2
2898878|NCT01763866|9981173|P22|Overall Study|Withdrawal by Subject|1
2898879|NCT01763866|9981174|P21|Overall Study|Withdrawal by Subject|2
2898880|NCT01763866|9981175|P20|Overall Study|Withdrawal by Subject|1
2898881|NCT01763866|9981176|P19|Overall Study|Withdrawal by Subject|1
2898882|NCT01763866|9981177|P18|Overall Study|Withdrawal by Subject|1
2898883|NCT01763866|9981178|P17|Overall Study|Withdrawal by Subject|0
2898884|NCT01763866|9981179|P16|Overall Study|Withdrawal by Subject|3
2898885|NCT01763866|9981180|P15|Overall Study|Withdrawal by Subject|6
2898886|NCT01763866|9981181|P14|Overall Study|Withdrawal by Subject|0
2898887|NCT01763866|9981182|P13|Overall Study|Withdrawal by Subject|2
2898888|NCT01763866|9981183|P12|Overall Study|Withdrawal by Subject|2
2898889|NCT01763866|9981184|P11|Overall Study|Withdrawal by Subject|2
2898890|NCT01763866|9981185|P10|Overall Study|Withdrawal by Subject|1
2898891|NCT01763866|9981186|P9|Overall Study|Withdrawal by Subject|1
2898892|NCT01763866|9981187|P8|Overall Study|Withdrawal by Subject|0
2898893|NCT01763866|9981188|P7|Overall Study|Withdrawal by Subject|4
2898894|NCT01763866|9981189|P6|Overall Study|Withdrawal by Subject|3
2898895|NCT01763866|9981190|P5|Overall Study|Withdrawal by Subject|0
2898896|NCT01763866|9981191|P4|Overall Study|Withdrawal by Subject|0
2898897|NCT01763866|9981192|P3|Overall Study|Withdrawal by Subject|4
2898898|NCT01763866|9981193|P2|Overall Study|Withdrawal by Subject|1
2898899|NCT01763866|9981194|P1|Overall Study|Withdrawal by Subject|2
2898900|NCT01763827|9981754|P6|Overall Study|Lost to Follow-up|1
2898901|NCT01763827|9981755|P5|Overall Study|Lost to Follow-up|2
2898902|NCT01763827|9981756|P4|Overall Study|Lost to Follow-up|1
2898903|NCT01763827|9981757|P3|Overall Study|Lost to Follow-up|1
2898904|NCT01763827|9981758|P2|Overall Study|Lost to Follow-up|1
2898905|NCT01763827|9981759|P1|Overall Study|Lost to Follow-up|0
2898906|NCT01763827|9981754|P6|Overall Study|Decision by sponsor|1
2898907|NCT01763827|9981755|P5|Overall Study|Decision by sponsor|2
2898908|NCT01763827|9981756|P4|Overall Study|Decision by sponsor|0
2898909|NCT01763827|9981757|P3|Overall Study|Decision by sponsor|3
2898910|NCT01763827|9981758|P2|Overall Study|Decision by sponsor|0
2898911|NCT01763827|9981759|P1|Overall Study|Decision by sponsor|2
2898912|NCT01763827|9981754|P6|Overall Study|Withdrawal by Subject|0
2898913|NCT01763827|9981755|P5|Overall Study|Withdrawal by Subject|2
2898914|NCT01763827|9981756|P4|Overall Study|Withdrawal by Subject|0
2898915|NCT01763827|9981757|P3|Overall Study|Withdrawal by Subject|0
2898916|NCT01763827|9981758|P2|Overall Study|Withdrawal by Subject|0
2898917|NCT01763827|9981759|P1|Overall Study|Withdrawal by Subject|1
2898918|NCT01763788|9981903|P4|Overall Study|Lost to Follow-up|0
2898919|NCT01763788|9981904|P3|Overall Study|Lost to Follow-up|1
2898920|NCT01763788|9981905|P2|Overall Study|Lost to Follow-up|0
2898921|NCT01763788|9981906|P1|Overall Study|Lost to Follow-up|0
2898922|NCT01763203|9982127|P2|Overall Study|Physician Decision|1
2898923|NCT01763203|9982128|P1|Overall Study|Physician Decision|2
2898924|NCT01763203|9982127|P2|Overall Study|Moved out of study region|10
2898925|NCT01763203|9982128|P1|Overall Study|Moved out of study region|7
2898926|NCT01763203|9982127|P2|Overall Study|Withdrawal by Subject|12
2898927|NCT01763203|9982128|P1|Overall Study|Withdrawal by Subject|8
2898928|NCT01763203|9982127|P2|Overall Study|Lost to Follow-up|12
2898929|NCT01763203|9982128|P1|Overall Study|Lost to Follow-up|12
2898930|NCT01763203|9982127|P2|Overall Study|Death|7
2898931|NCT01763203|9982128|P1|Overall Study|Death|4
2898932|NCT01763047|9982174|P2|Period 2|Unsatisfactory lens Fitting|1
2898933|NCT01763047|9982175|P1|Period 2|Unsatisfactory lens Fitting|0
2898934|NCT01763047|9982174|P2|Period 2|Protocol Violation|2
2898935|NCT01763047|9982175|P1|Period 2|Protocol Violation|0
2898936|NCT01763047|9982174|P2|Period 2|Unsatisfactory Visual Response|1
2898937|NCT01763047|9982175|P1|Period 2|Unsatisfactory Visual Response|1
2898938|NCT01763047|9982174|P2|Period 2|Study Site office Closed|1
2898939|NCT01763047|9982175|P1|Period 2|Study Site office Closed|1
2898940|NCT01763047|9982174|P2|Period 2|No longer meets Eligibility Criteria|0
2898941|NCT01763047|9982175|P1|Period 2|No longer meets Eligibility Criteria|1
2898942|NCT01763047|9982174|P2|Period 2|Lens Discomfort|0
2898943|NCT01763047|9982175|P1|Period 2|Lens Discomfort|1
2898944|NCT01763047|9982174|P2|Period 1|Study Site office Closed|1
2898945|NCT01763047|9982175|P1|Period 1|Study Site office Closed|0
2898946|NCT01763047|9982174|P2|Period 1|Lens Power Not Available|1
2898947|NCT01763047|9982175|P1|Period 1|Lens Power Not Available|0
2898948|NCT01763047|9982174|P2|Period 1|Unsatisfactory Visual Response|3
2898949|NCT01763047|9982175|P1|Period 1|Unsatisfactory Visual Response|0
2898950|NCT01763047|9982174|P2|Period 1|Adverse Event|1
2898951|NCT01763047|9982175|P1|Period 1|Adverse Event|0
2898952|NCT01763047|9982174|P2|Period 1|No Longer Meets Eligibility criteria|0
2898953|NCT01763047|9982175|P1|Period 1|No Longer Meets Eligibility criteria|1
2898954|NCT01763047|9982174|P2|Period 1|Protocol Violation|4
2898955|NCT01763047|9982175|P1|Period 1|Protocol Violation|4
2898956|NCT01763047|9982174|P2|Period 1|Test Article Not Available|1
2898957|NCT01763047|9982175|P1|Period 1|Test Article Not Available|4
2898958|NCT01762943|9982214|P2|Overall Study|Withdrawal by Subject|1
2898959|NCT01762943|9982215|P1|Overall Study|Withdrawal by Subject|2
2898960|NCT01762943|9982214|P2|Overall Study|Protocol Violation|0
2898961|NCT01762943|9982215|P1|Overall Study|Protocol Violation|1
2898962|NCT01762943|9982214|P2|Overall Study|Physician Decision|1
2898963|NCT01762943|9982215|P1|Overall Study|Physician Decision|1
2898964|NCT01762800|9982232|P2|Overall Study|Withdrawal by Subject|4
2898965|NCT01762800|9982233|P1|Overall Study|Withdrawal by Subject|7
2898966|NCT01762800|9982232|P2|Overall Study|Physician Decision|1
2898967|NCT01762800|9982233|P1|Overall Study|Physician Decision|1
2898968|NCT01762800|9982232|P2|Overall Study|Study Closed/Terminated|1
2898969|NCT01762800|9982233|P1|Overall Study|Study Closed/Terminated|0
2898970|NCT01762800|9982232|P2|Overall Study|Lack of Efficacy|2
2898971|NCT01762800|9982233|P1|Overall Study|Lack of Efficacy|3
2898972|NCT01762800|9982232|P2|Overall Study|Adverse Event|13
2898973|NCT01762800|9982233|P1|Overall Study|Adverse Event|8
2898974|NCT01762761|9982307|P2|Overall Study|Withdrawal by Subject|8
2898975|NCT01762761|9982308|P1|Overall Study|Withdrawal by Subject|7
2898976|NCT01762761|9982307|P2|Overall Study|Physician Decision|6
2898977|NCT01762761|9982308|P1|Overall Study|Physician Decision|4
2898978|NCT01762761|9982307|P2|Overall Study|Lost to Follow-up|6
2898979|NCT01762761|9982308|P1|Overall Study|Lost to Follow-up|3
2898980|NCT01762761|9982307|P2|Overall Study|Study closed/terminated|2
2898981|NCT01762761|9982308|P1|Overall Study|Study closed/terminated|0
2898982|NCT01762761|9982307|P2|Overall Study|Protocol Violation|1
2898983|NCT01762761|9982308|P1|Overall Study|Protocol Violation|1
2898984|NCT01762761|9982307|P2|Overall Study|Lack of Efficacy|25
2898985|NCT01762761|9982308|P1|Overall Study|Lack of Efficacy|9
2898986|NCT01762761|9982307|P2|Overall Study|Adverse Event|17
2898987|NCT01762761|9982308|P1|Overall Study|Adverse Event|15
2898988|NCT01762345|9982407|P1|Overall Study|Protocol Violation|2
2898989|NCT01762345|9982407|P1|Overall Study|Adverse Event|5
2898990|NCT01761565|9982455|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
2898991|NCT01761266|9982479|P2|Overall Study|Ongoing as of data-cut off|107
2898992|NCT01761266|9982480|P1|Overall Study|Ongoing as of data-cut off|109
2898993|NCT01761266|9982479|P2|Overall Study|Withdrawal by Subject|8
2898994|NCT01761266|9982480|P1|Overall Study|Withdrawal by Subject|13
2898995|NCT01761266|9982479|P2|Overall Study|Lost to Follow-up|11
2898996|NCT01761266|9982480|P1|Overall Study|Lost to Follow-up|5
2898997|NCT01761266|9982479|P2|Overall Study|Death|350
2898998|NCT01761266|9982480|P1|Overall Study|Death|351
2898999|NCT01761162|9982537|P1|Overall Study|Withdrawal by Subject|3
2899000|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Other|6
2899001|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Other|9
2899002|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Other|8
2899003|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Other|13
2899004|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2899005|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
2899006|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2899007|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2899008|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2899009|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2899010|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
2899011|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
2899012|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2899013|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2899014|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
2899015|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
2899016|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
2899017|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
2899018|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
2899019|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
2899020|NCT01760954|9982626|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
2899021|NCT01760954|9982627|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2899022|NCT01760954|9982628|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2899023|NCT01760954|9982629|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2899024|NCT01760954|9982626|P4|Treatment Period (6 Months)|Exclusionary Medication|0
2899025|NCT01760954|9982627|P3|Treatment Period (6 Months)|Exclusionary Medication|0
2899026|NCT01760954|9982628|P2|Treatment Period (6 Months)|Exclusionary Medication|0
2899027|NCT01760954|9982629|P1|Treatment Period (6 Months)|Exclusionary Medication|1
2899028|NCT01760954|9982626|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2899029|NCT01760954|9982627|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2899030|NCT01760954|9982628|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
2899031|NCT01760954|9982629|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
2899032|NCT01760954|9982626|P4|Treatment Period (6 Months)|Other|1
2899033|NCT01760954|9982627|P3|Treatment Period (6 Months)|Other|3
2899034|NCT01760954|9982628|P2|Treatment Period (6 Months)|Other|3
2899035|NCT01760954|9982629|P1|Treatment Period (6 Months)|Other|0
2899036|NCT01760954|9982626|P4|Treatment Period (6 Months)|Non-compliance|3
2899037|NCT01760954|9982627|P3|Treatment Period (6 Months)|Non-compliance|0
2899038|NCT01760954|9982628|P2|Treatment Period (6 Months)|Non-compliance|4
2899039|NCT01760954|9982629|P1|Treatment Period (6 Months)|Non-compliance|1
2899040|NCT01760954|9982626|P4|Treatment Period (6 Months)|Pregnancy|2
2899041|NCT01760954|9982627|P3|Treatment Period (6 Months)|Pregnancy|3
2899042|NCT01760954|9982628|P2|Treatment Period (6 Months)|Pregnancy|0
2899043|NCT01760954|9982629|P1|Treatment Period (6 Months)|Pregnancy|5
2899044|NCT01760954|9982626|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
2899045|NCT01760954|9982627|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2899046|NCT01760954|9982628|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2899047|NCT01760954|9982629|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2899048|NCT01760954|9982626|P4|Treatment Period (6 Months)|Lost to Follow-up|3
2899049|NCT01760954|9982627|P3|Treatment Period (6 Months)|Lost to Follow-up|4
2899050|NCT01760954|9982628|P2|Treatment Period (6 Months)|Lost to Follow-up|1
2899051|NCT01760954|9982629|P1|Treatment Period (6 Months)|Lost to Follow-up|9
2899052|NCT01760954|9982626|P4|Treatment Period (6 Months)|Adverse Event|10
2899053|NCT01760954|9982627|P3|Treatment Period (6 Months)|Adverse Event|4
2899054|NCT01760954|9982628|P2|Treatment Period (6 Months)|Adverse Event|3
2899055|NCT01760954|9982629|P1|Treatment Period (6 Months)|Adverse Event|5
2899056|NCT01760954|9982626|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
2899057|NCT01760954|9982627|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
2899058|NCT01760954|9982628|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
2899059|NCT01760954|9982629|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
2899060|NCT01760876|9982766|P1|Overall Study|Very poor baseline OCT quality|2
2899061|NCT01760876|9982766|P1|Overall Study|Major depression|1
2899062|NCT01760876|9982766|P1|Overall Study|Impaired renal function|1
2899063|NCT01760876|9982766|P1|Overall Study|Carcinoma of prostate|1
2899064|NCT01760876|9982766|P1|Overall Study|Non-cardiac death (head injury)|1
2899065|NCT01760733|9982781|P1|Transplanted|Graft loss|7
2899066|NCT01760733|9982781|P1|Transplanted|Death|26
2899067|NCT01760733|9982781|P1|Transplanted|Not reached 10 years post transplant|184
2899068|NCT01760733|9982781|P1|Waiting List|Not received a transplant yet|13
2899069|NCT01760733|9982781|P1|Waiting List|Removed from waiting list|41
2899070|NCT01760733|9982781|P1|Waiting List|Death|18
2899071|NCT01759862|9983077|P2|Overall Study|Adverse Event|1
2899072|NCT01759862|9983078|P1|Overall Study|Adverse Event|0
2899073|NCT01759862|9983077|P2|Overall Study|Physician Decision|1
2899074|NCT01759862|9983078|P1|Overall Study|Physician Decision|3
2899075|NCT01759511|9983096|P1|Overall Study|Withdrawal by Subject|3
2899076|NCT01759511|9983096|P1|Overall Study|Study Terminated by Sponsor|13
2899077|NCT01759511|9983096|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
2899078|NCT01759511|9983096|P1|Overall Study|Progressive Disease|5
2899079|NCT01759511|9983096|P1|Overall Study|Physician Decision|1
2899080|NCT01759511|9983096|P1|Overall Study|Lack of Efficacy|2
2899081|NCT01759511|9983096|P1|Overall Study|Death|2
2899082|NCT01759511|9983096|P1|Overall Study|Adverse Event|4
2899083|NCT01759446|9983109|P5|Overall Study|Withdrawal by Subject|0
2899084|NCT01759446|9983110|P4|Overall Study|Withdrawal by Subject|1
2899085|NCT01759446|9983111|P3|Overall Study|Withdrawal by Subject|0
2899086|NCT01759446|9983112|P2|Overall Study|Withdrawal by Subject|1
2899087|NCT01759446|9983113|P1|Overall Study|Withdrawal by Subject|0
2899088|NCT01759446|9983109|P5|Overall Study|Protocol Violation|0
2899089|NCT01759446|9983110|P4|Overall Study|Protocol Violation|0
2899090|NCT01759446|9983111|P3|Overall Study|Protocol Violation|1
2899091|NCT01759446|9983112|P2|Overall Study|Protocol Violation|0
2899092|NCT01759446|9983113|P1|Overall Study|Protocol Violation|1
2899093|NCT01759420|9983125|P1|Overall Study|Inaccurate EKG machine readings|1
2899094|NCT01759420|9983125|P1|Overall Study|Screen failure|5
2899095|NCT01759407|9983132|P2|Overall Study|Protocol Violation|2
2899096|NCT01759407|9983133|P1|Overall Study|Protocol Violation|0
2899097|NCT01759381|9983145|P2|Overall Study|Death|0
2899098|NCT01759381|9983146|P1|Overall Study|Death|1
2899099|NCT01759368|9983154|P2|Overall Study|Lost to Follow-up|0
2899100|NCT01759368|9983155|P1|Overall Study|Lost to Follow-up|1
2899101|NCT01759290|9983173|P1|Overall Study|Unknown reason|4
2899102|NCT01759290|9983173|P1|Overall Study|Lost to Follow-up|53
2899103|NCT01759290|9983173|P1|Overall Study|Death|17
2899104|NCT01759290|9983173|P1|Overall Study|Physician Decision|2
2899105|NCT01759290|9983173|P1|Overall Study|Subjects withdrawn consent|5
2899106|NCT01759264|9983242|P1|Overall Study|Discontinued Humira Due to Business Trip|1
2899107|NCT01759264|9983242|P1|Overall Study|Withdrawal by Subject|3
2899108|NCT01759264|9983242|P1|Overall Study|Lost to Follow-up|2
2899109|NCT01759264|9983242|P1|Overall Study|Other|2
2899110|NCT01759264|9983242|P1|Overall Study|Adverse Event|1
2899111|NCT01759264|9983242|P1|Overall Study|Serious Adverse Events (SAEs)|1
2899112|NCT01758900|9983270|P2|Overall Study|difficulty for further intubation|8
2899113|NCT01758900|9983271|P1|Overall Study|difficulty for further intubation|7
2899114|NCT01758731|9983289|P1|Overall Study|Physician Decision|1
2899115|NCT01758523|9983308|P2|Overall Study|Withdrawal by Subject|7
2899116|NCT01758523|9983309|P1|Overall Study|Withdrawal by Subject|12
2899117|NCT01758523|9983308|P2|Overall Study|Lost to Follow-up|4
2899118|NCT01758523|9983309|P1|Overall Study|Lost to Follow-up|3
2899119|NCT01758523|9983308|P2|Overall Study|Lack of Efficacy|2
2899120|NCT01758523|9983309|P1|Overall Study|Lack of Efficacy|4
2899121|NCT01758523|9983308|P2|Overall Study|Adverse Event|1
2899122|NCT01758523|9983309|P1|Overall Study|Adverse Event|2
2899123|NCT01758289|9983412|P1|Overall Study|Adverse Event|9
2899124|NCT01758289|9983412|P1|Overall Study|Premature Study Termination|44
2899125|NCT01757847|9983438|P2|Overall Study|Withdrawal by Subject|4
2899126|NCT01757847|9983439|P1|Overall Study|Withdrawal by Subject|3
2899127|NCT01757821|9983447|P1|Overall Study|Adverse Event|1
2899128|NCT01757704|9983462|P2|Overall Study|Protocol Violation|3
2899129|NCT01757704|9983463|P1|Overall Study|Protocol Violation|1
2899130|NCT01757691|9983481|P2|Overall Study|Administrative problems|0
2899131|NCT01757691|9983482|P1|Overall Study|Administrative problems|2
2899132|NCT01757665|9983509|P2|Overall Study|Not Implanted with Device|1
2899133|NCT01757665|9983510|P1|Overall Study|Not Implanted with Device|5
2899134|NCT01757665|9983509|P2|Overall Study|Lost to Follow-up|1
2899135|NCT01757665|9983510|P1|Overall Study|Lost to Follow-up|1
2899136|NCT01757665|9983509|P2|Overall Study|Withdrawal by Subject|0
2899137|NCT01757665|9983510|P1|Overall Study|Withdrawal by Subject|10
2899138|NCT01757665|9983509|P2|Overall Study|Explant|2
2899139|NCT01757665|9983510|P1|Overall Study|Explant|1
2899140|NCT01757665|9983509|P2|Overall Study|Death|8
2899141|NCT01757665|9983510|P1|Overall Study|Death|25
2899142|NCT01757665|9983509|P2|Overall Study|Still on Study - Missed Visit|1
2899143|NCT01757665|9983510|P1|Overall Study|Still on Study - Missed Visit|14
2899144|NCT01757665|9983509|P2|Overall Study|Still on Study - Visit Pending|40
2899145|NCT01757665|9983510|P1|Overall Study|Still on Study - Visit Pending|398
2899146|NCT01757665|9983509|P2|Overall Study|Still on Study - Visit Completed|30
2899147|NCT01757665|9983510|P1|Overall Study|Still on Study - Visit Completed|240
2899148|NCT01757405|9983682|P2|Overall Study|Withdrawal by Subject|1
2899149|NCT01757405|9983683|P1|Overall Study|Withdrawal by Subject|0
2899150|NCT01757405|9983682|P2|Overall Study|Lost to Follow-up|1
2899151|NCT01757405|9983683|P1|Overall Study|Lost to Follow-up|1
2899152|NCT01757275|9983718|P2|Overall Study|Not treated|4
2899153|NCT01757275|9983719|P1|Overall Study|Not treated|3
2899154|NCT01757275|9983718|P2|Overall Study|Withdrawal by Subject|4
2899155|NCT01757275|9983719|P1|Overall Study|Withdrawal by Subject|2
2899156|NCT01757275|9983718|P2|Overall Study|Adverse Event|3
2899157|NCT01757275|9983719|P1|Overall Study|Adverse Event|3
2899158|NCT01757275|9983718|P2|Overall Study|Lost to Follow-up|2
2899159|NCT01757275|9983719|P1|Overall Study|Lost to Follow-up|1
2899160|NCT01757197|9983741|P1|Overall Study|Death|2
2899161|NCT01757184|9983750|P4|Open-label Period|Discontinued by Sponsor|2
2899162|NCT01757184|9983751|P3|Open-label Period|Discontinued by Sponsor|1
2899163|NCT01757184|9983752|P2|Open-label Period|Discontinued by Sponsor|0
2899164|NCT01757184|9983753|P1|Open-label Period|Discontinued by Sponsor|0
2899165|NCT01757184|9983750|P4|Open-label Period|Withdrawal by Subject|1
2899166|NCT01757184|9983751|P3|Open-label Period|Withdrawal by Subject|1
2899167|NCT01757184|9983752|P2|Open-label Period|Withdrawal by Subject|0
2899168|NCT01757184|9983753|P1|Open-label Period|Withdrawal by Subject|0
2899169|NCT01757184|9983750|P4|Open-label Period|Lost to Follow-up|0
2899170|NCT01757184|9983751|P3|Open-label Period|Lost to Follow-up|2
2899171|NCT01757184|9983752|P2|Open-label Period|Lost to Follow-up|0
2899172|NCT01757184|9983753|P1|Open-label Period|Lost to Follow-up|0
2899173|NCT01757184|9983750|P4|Double-blind Period|Adverse Event|0
2899174|NCT01757184|9983751|P3|Double-blind Period|Adverse Event|0
2899175|NCT01757184|9983752|P2|Double-blind Period|Adverse Event|0
2899176|NCT01757184|9983753|P1|Double-blind Period|Adverse Event|1
2899177|NCT01757171|9983797|P2|Overall Study|ECOG decline|0
2899178|NCT01757171|9983798|P1|Overall Study|ECOG decline|1
2899179|NCT01757171|9983797|P2|Overall Study|Hospitalization|0
2899180|NCT01757171|9983798|P1|Overall Study|Hospitalization|1
2899181|NCT01757171|9983797|P2|Overall Study|Disease Progression|0
2899182|NCT01757171|9983798|P1|Overall Study|Disease Progression|1
2899183|NCT01757171|9983797|P2|Overall Study|Adverse Event|1
2899184|NCT01757171|9983798|P1|Overall Study|Adverse Event|5
2899185|NCT01756846|9983834|P2|Overall Study|Withdrawal by Subject|2
2899186|NCT01756846|9983835|P1|Overall Study|Withdrawal by Subject|1
2899187|NCT01756846|9983834|P2|Overall Study|Lost to Follow-up|10
2899188|NCT01756846|9983835|P1|Overall Study|Lost to Follow-up|5
2899189|NCT01756456|9983880|P6|Follow Up Period Phase I/II|Other causes|5
2899190|NCT01756456|9983881|P5|Follow Up Period Phase I/II|Other causes|3
2899191|NCT01756456|9983882|P4|Follow Up Period Phase I/II|Other causes|1
2899192|NCT01756456|9983883|P3|Follow Up Period Phase I/II|Other causes|0
2899193|NCT01756456|9983884|P2|Follow Up Period Phase I/II|Other causes|0
2899194|NCT01756456|9983885|P1|Follow Up Period Phase I/II|Other causes|0
2899195|NCT01756456|9983880|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
2899196|NCT01756456|9983881|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
2899197|NCT01756456|9983882|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
2899198|NCT01756456|9983883|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
2899199|NCT01756456|9983884|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
2899200|NCT01756456|9983885|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
2899201|NCT01756456|9983880|P6|Follow Up Period Phase I/II|Adverse Event|1
2899202|NCT01756456|9983881|P5|Follow Up Period Phase I/II|Adverse Event|0
2899203|NCT01756456|9983882|P4|Follow Up Period Phase I/II|Adverse Event|5
2899204|NCT01756456|9983883|P3|Follow Up Period Phase I/II|Adverse Event|0
2899205|NCT01756456|9983884|P2|Follow Up Period Phase I/II|Adverse Event|0
2899206|NCT01756456|9983885|P1|Follow Up Period Phase I/II|Adverse Event|1
2899207|NCT01756456|9983880|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
2899208|NCT01756456|9983881|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
2899209|NCT01756456|9983882|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
2899210|NCT01756456|9983883|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
2899211|NCT01756456|9983884|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
2899212|NCT01756456|9983885|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
2899213|NCT01756456|9983880|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2899214|NCT01756456|9983881|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2899215|NCT01756456|9983882|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2899216|NCT01756456|9983883|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2899217|NCT01756456|9983884|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
2899218|NCT01756456|9983885|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2899219|NCT01756456|9983880|P6|Follow Up Period Phase I/II|still in study after week 20|25
2899220|NCT01756456|9983881|P5|Follow Up Period Phase I/II|still in study after week 20|23
2899221|NCT01756456|9983882|P4|Follow Up Period Phase I/II|still in study after week 20|25
2899222|NCT01756456|9983883|P3|Follow Up Period Phase I/II|still in study after week 20|0
2899223|NCT01756456|9983884|P2|Follow Up Period Phase I/II|still in study after week 20|0
2899224|NCT01756456|9983885|P1|Follow Up Period Phase I/II|still in study after week 20|0
2899225|NCT01756456|9983880|P6|Treatment Period: Phase I/II|Other causes|2
2899226|NCT01756456|9983881|P5|Treatment Period: Phase I/II|Other causes|2
2899227|NCT01756456|9983882|P4|Treatment Period: Phase I/II|Other causes|1
2899228|NCT01756456|9983883|P3|Treatment Period: Phase I/II|Other causes|0
2899229|NCT01756456|9983884|P2|Treatment Period: Phase I/II|Other causes|0
2899230|NCT01756456|9983885|P1|Treatment Period: Phase I/II|Other causes|0
2899231|NCT01756456|9983880|P6|Treatment Period: Phase I/II|Adverse Event|1
2899232|NCT01756456|9983881|P5|Treatment Period: Phase I/II|Adverse Event|9
2899233|NCT01756456|9983882|P4|Treatment Period: Phase I/II|Adverse Event|3
2899234|NCT01756456|9983883|P3|Treatment Period: Phase I/II|Adverse Event|2
2899235|NCT01756456|9983884|P2|Treatment Period: Phase I/II|Adverse Event|0
2899236|NCT01756456|9983885|P1|Treatment Period: Phase I/II|Adverse Event|1
2899237|NCT01756456|9983880|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
2899238|NCT01756456|9983881|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
2899239|NCT01756456|9983882|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
2899240|NCT01756456|9983883|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
2899241|NCT01756456|9983884|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
2899242|NCT01756456|9983885|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
2899243|NCT01756456|9983880|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
2899244|NCT01756456|9983881|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
2899245|NCT01756456|9983882|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
2899246|NCT01756456|9983883|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
2899247|NCT01756456|9983884|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
2899248|NCT01756456|9983885|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
2899249|NCT01756456|9983880|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2899250|NCT01756456|9983881|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2899251|NCT01756456|9983882|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2899252|NCT01756456|9983883|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2899253|NCT01756456|9983884|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2899254|NCT01756456|9983885|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2899255|NCT01756352|9983987|P1|Overall Study|moved away and lost to followup|1
2899256|NCT01756300|9983992|P1|Overall Study|Withdrawal by Subject|1
2899257|NCT01756300|9983992|P1|Overall Study|Death|1
2899258|NCT01756274|9984014|P1|Overall Study|Laboratory error|1
2899259|NCT01756274|9984014|P1|Overall Study|Protocol Violation|2
2899260|NCT01756235|9984021|P1|Overall Study|Adalimumab Treatment was not Documented|2
2899261|NCT01756157|9984059|P2|First Intervention Period|Lost to Follow-up|2
2899262|NCT01756157|9984060|P1|First Intervention Period|Lost to Follow-up|0
2899263|NCT01756157|9984059|P2|First Intervention Period|Withdrawal by Subject|0
2899264|NCT01756157|9984060|P1|First Intervention Period|Withdrawal by Subject|1
2899265|NCT01756079|9984074|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
2899266|NCT01756079|9984074|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
2899267|NCT01756079|9984074|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
2899268|NCT01756079|9984074|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
2899269|NCT01756079|9984074|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
2899270|NCT01756053|9984080|P2|Period 2 (10 Days)|Protocol Violation|2
2899271|NCT01756053|9984081|P1|Period 2 (10 Days)|Protocol Violation|0
2899272|NCT01756053|9984080|P2|Period 1 (10 Days)|Protocol Violation|1
2899273|NCT01756053|9984081|P1|Period 1 (10 Days)|Protocol Violation|1
2899274|NCT01755702|9984138|P1|Washout Period II|Other Reason|5
2899275|NCT01755702|9984138|P1|Wash Out Period I|Other Reason|3
2899276|NCT01755689|9984185|P5|Overall Study|Pregnancy|2
2899277|NCT01755689|9984186|P4|Overall Study|Pregnancy|4
2899278|NCT01755689|9984187|P3|Overall Study|Pregnancy|2
2899279|NCT01755689|9984188|P2|Overall Study|Pregnancy|1
2899280|NCT01755689|9984189|P1|Overall Study|Pregnancy|1
2899281|NCT01755689|9984185|P5|Overall Study|Lost to Follow-up|2
2899282|NCT01755689|9984186|P4|Overall Study|Lost to Follow-up|0
2899283|NCT01755689|9984187|P3|Overall Study|Lost to Follow-up|1
2899284|NCT01755689|9984188|P2|Overall Study|Lost to Follow-up|0
2899285|NCT01755689|9984189|P1|Overall Study|Lost to Follow-up|1
2899286|NCT01755689|9984185|P5|Overall Study|Migrated/moved from study area|1
2899287|NCT01755689|9984186|P4|Overall Study|Migrated/moved from study area|1
2899288|NCT01755689|9984187|P3|Overall Study|Migrated/moved from study area|1
2899289|NCT01755689|9984188|P2|Overall Study|Migrated/moved from study area|1
2899290|NCT01755689|9984189|P1|Overall Study|Migrated/moved from study area|0
2899291|NCT01755689|9984185|P5|Overall Study|Withdrawal by Subject|1
2899292|NCT01755689|9984186|P4|Overall Study|Withdrawal by Subject|1
2899293|NCT01755689|9984187|P3|Overall Study|Withdrawal by Subject|2
2899294|NCT01755689|9984188|P2|Overall Study|Withdrawal by Subject|3
2899295|NCT01755689|9984189|P1|Overall Study|Withdrawal by Subject|1
2899296|NCT01755637|9984264|P2|Period 1|Adverse Event|1
2899297|NCT01755637|9984265|P1|Period 1|Adverse Event|0
2899298|NCT01755598|9984285|P2|Overall Study|Adverse Event|28
2899299|NCT01755598|9984286|P1|Overall Study|Adverse Event|19
2899300|NCT01755598|9984285|P2|Overall Study|Protocol Violation|7
2899301|NCT01755598|9984286|P1|Overall Study|Protocol Violation|7
2899302|NCT01755598|9984285|P2|Overall Study|Withdrawal by Subject|31
2899303|NCT01755598|9984286|P1|Overall Study|Withdrawal by Subject|22
2899304|NCT01755598|9984285|P2|Overall Study|Migrated/moved from study area|65
2899305|NCT01755598|9984286|P1|Overall Study|Migrated/moved from study area|76
2899306|NCT01755598|9984285|P2|Overall Study|Lost to Follow-up|43
2899307|NCT01755598|9984286|P1|Overall Study|Lost to Follow-up|32
2899308|NCT01755598|9984285|P2|Overall Study|Other|109
2899309|NCT01755598|9984286|P1|Overall Study|Other|109
2899310|NCT01755546|9984320|P1|Long Term Treatment|other and ongoing|41
2899311|NCT01755546|9984320|P1|Long Term Treatment|Lost to Follow-up|17
2899312|NCT01755546|9984320|P1|Long Term Treatment|Withdrawal by Subject|35
2899313|NCT01755546|9984320|P1|Long Term Treatment|Protocol Violation|10
2899314|NCT01755546|9984320|P1|Long Term Treatment|Lack of Efficacy|6
2899315|NCT01755546|9984320|P1|Long Term Treatment|Adverse Event|12
2899316|NCT01755546|9984320|P1|Titration Phase|Withdrawal by Subject|8
2899317|NCT01755546|9984320|P1|Titration Phase|Other and Continuing|22
2899318|NCT01755546|9984320|P1|Titration Phase|Lost to Follow-up|2
2899319|NCT01755546|9984320|P1|Titration Phase|Protocol Violation|9
2899320|NCT01755546|9984320|P1|Titration Phase|Lack of Efficacy|18
2899321|NCT01755546|9984320|P1|Titration Phase|Adverse Event|11
2899322|NCT01755546|9984320|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
2899323|NCT01755546|9984320|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
2899324|NCT01755546|9984320|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
2899325|NCT01755546|9984320|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
2899326|NCT01755416|9984337|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
2899327|NCT01755416|9984338|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
2899328|NCT01755234|9984346|P2|Overall Study|unblinded|0
2899329|NCT01755234|9984347|P1|Overall Study|unblinded|1
2899330|NCT01755234|9984346|P2|Overall Study|Withdrawal by Subject|1
2899331|NCT01755234|9984347|P1|Overall Study|Withdrawal by Subject|0
2899332|NCT01755234|9984346|P2|Overall Study|case cancelled|0
2899333|NCT01755234|9984347|P1|Overall Study|case cancelled|1
2899334|NCT01755234|9984346|P2|Overall Study|Change in surgical case|1
2899335|NCT01755234|9984347|P1|Overall Study|Change in surgical case|2
2899336|NCT01755234|9984346|P2|Overall Study|Lost to Follow-up|6
2899337|NCT01755234|9984347|P1|Overall Study|Lost to Follow-up|11
2899338|NCT01755156|9984378|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
2899339|NCT01755156|9984379|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
2899340|NCT01755156|9984378|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
2899341|NCT01755156|9984379|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
2899342|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2899343|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2899344|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
2899345|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
2899346|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
2899347|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
2899348|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Protocol Violation|1
2899349|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Protocol Violation|1
2899350|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Physician Decision|1
2899351|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Physician Decision|0
2899352|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
2899353|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
2899354|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
2899355|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
2899356|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
2899357|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
2899358|NCT01755156|9984378|P2|Phase A (Weeks 0-24)|Adverse Event|3
2899359|NCT01755156|9984379|P1|Phase A (Weeks 0-24)|Adverse Event|2
2899360|NCT01755091|9984443|P3|Overall Study|Physician Decision|2
2899361|NCT01755091|9984444|P2|Overall Study|Physician Decision|1
2899362|NCT01755091|9984445|P1|Overall Study|Physician Decision|1
2899363|NCT01755091|9984443|P3|Overall Study|Lost to Follow-up|1
2899364|NCT01755091|9984444|P2|Overall Study|Lost to Follow-up|0
2899365|NCT01755091|9984445|P1|Overall Study|Lost to Follow-up|1
2899366|NCT01755091|9984443|P3|Overall Study|Adverse Event|1
2899367|NCT01755091|9984444|P2|Overall Study|Adverse Event|1
2899368|NCT01755091|9984445|P1|Overall Study|Adverse Event|1
2899369|NCT01755091|9984443|P3|Overall Study|Withdrawal by Subject|3
2899370|NCT01755091|9984444|P2|Overall Study|Withdrawal by Subject|1
2899371|NCT01755091|9984445|P1|Overall Study|Withdrawal by Subject|6
2899372|NCT01755026|9984470|P2|Overall Study|Withdrawal by Subject|1
2899373|NCT01755026|9984471|P1|Overall Study|Withdrawal by Subject|1
2899374|NCT01755026|9984470|P2|Overall Study|Adverse Event|0
2899375|NCT01755026|9984471|P1|Overall Study|Adverse Event|1
2899376|NCT01754922|9984494|P2|Overall Study|Adverse Event|1
2899377|NCT01754922|9984495|P1|Overall Study|Adverse Event|0
2899378|NCT01754766|9984521|P3|Overall Study|Personal reasons|0
2899379|NCT01754766|9984522|P2|Overall Study|Personal reasons|1
2899380|NCT01754766|9984523|P1|Overall Study|Personal reasons|1
2899381|NCT01754727|9984537|P1|Overall Study|Adalimumab Treatment was not Documented|2
2899382|NCT01754493|9984669|P1|Overall Study|Scheduling conflict|1
2899383|NCT01754493|9984669|P1|Overall Study|Moved out of town|1
2899384|NCT01754493|9984669|P1|Overall Study|Withdrawal by Subject|1
2899385|NCT01754493|9984669|P1|Overall Study|Lost to Follow-up|3
2899386|NCT01754493|9984669|P1|Overall Study|Adverse Event|1
2899387|NCT01754467|9984694|P1|Overall Study|Lost to Follow-up|1
2899388|NCT01754402|9984704|P3|Overall Study|Lack of Efficacy|1
2899389|NCT01754402|9984705|P2|Overall Study|Lack of Efficacy|0
2899390|NCT01754402|9984706|P1|Overall Study|Lack of Efficacy|0
2899391|NCT01754402|9984704|P3|Overall Study|Withdrawal by Subject|1
2899392|NCT01754402|9984705|P2|Overall Study|Withdrawal by Subject|0
2899393|NCT01754402|9984706|P1|Overall Study|Withdrawal by Subject|0
2899394|NCT01754402|9984704|P3|Overall Study|Adverse Event|1
2899395|NCT01754402|9984705|P2|Overall Study|Adverse Event|2
2899396|NCT01754402|9984706|P1|Overall Study|Adverse Event|2
2899397|NCT01754402|9984704|P3|Overall Study|Death|1
2899398|NCT01754402|9984705|P2|Overall Study|Death|0
2899399|NCT01754402|9984706|P1|Overall Study|Death|0
2899400|NCT01754376|9984740|P1|Overall Study|Lack of Efficacy|2
2899401|NCT01754376|9984740|P1|Overall Study|Adverse Event|1
2899402|NCT01754259|9984751|P2|Overall Study|Lost to Follow-up|1
2899403|NCT01754259|9984752|P1|Overall Study|Lost to Follow-up|0
2899404|NCT01754259|9984751|P2|Overall Study|Adverse Event|1
2899405|NCT01754259|9984752|P1|Overall Study|Adverse Event|3
2899406|NCT01754259|9984751|P2|Overall Study|Withdrawal by Subject|4
2899407|NCT01754259|9984752|P1|Overall Study|Withdrawal by Subject|2
2899408|NCT01754194|9984762|P2|Overall Study|Other|8
2899409|NCT01754194|9984763|P1|Overall Study|Other|9
2899410|NCT01754194|9984762|P2|Overall Study|Withdrawal by Subject|5
2899411|NCT01754194|9984763|P1|Overall Study|Withdrawal by Subject|4
2899412|NCT01754194|9984762|P2|Overall Study|Lost to Follow-up|14
2899413|NCT01754194|9984763|P1|Overall Study|Lost to Follow-up|39
2899414|NCT01754129|9984783|P1|Overall Study|Inclusion/exclusion criteria violation|3
2899415|NCT01754129|9984783|P1|Overall Study|Withdrew consent|1
2899416|NCT01754129|9984783|P1|Overall Study|Lost to Follow-up|7
2899417|NCT01754129|9984783|P1|Overall Study|Duodopa discontinuation|9
2899418|NCT01754129|9984783|P1|Overall Study|Death|13
2899419|NCT01753999|9984806|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
2899420|NCT01753999|9984807|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
2899421|NCT01753999|9984806|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
2899422|NCT01753999|9984807|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
2899423|NCT01753999|9984806|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
2899424|NCT01753999|9984807|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
2899425|NCT01753999|9984806|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
2899426|NCT01753999|9984807|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
2899427|NCT01753999|9984806|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
2899428|NCT01753999|9984807|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
2899429|NCT01753999|9984806|P2|Period 1 - Initial Assignment|Physician Decision|3
2899430|NCT01753999|9984807|P1|Period 1 - Initial Assignment|Physician Decision|2
2899431|NCT01753856|9984821|P2|Overall Study|Sponsor Decision|0
2899432|NCT01753856|9984822|P1|Overall Study|Sponsor Decision|2
2899433|NCT01753856|9984821|P2|Overall Study|Withdrawal by Subject|2
2899434|NCT01753856|9984822|P1|Overall Study|Withdrawal by Subject|0
2899435|NCT01753856|9984821|P2|Overall Study|Adverse Event|0
2899436|NCT01753856|9984822|P1|Overall Study|Adverse Event|1
2899437|NCT01753570|9984894|P3|Overall Study|Withdrawal by Subject|0
2899438|NCT01753570|9984895|P2|Overall Study|Withdrawal by Subject|4
2899439|NCT01753570|9984896|P1|Overall Study|Withdrawal by Subject|1
2899440|NCT01753570|9984894|P3|Overall Study|Physician Decision|0
2899441|NCT01753570|9984895|P2|Overall Study|Physician Decision|1
2899442|NCT01753570|9984896|P1|Overall Study|Physician Decision|0
2899443|NCT01753570|9984894|P3|Overall Study|Adverse Event|1
2899444|NCT01753570|9984895|P2|Overall Study|Adverse Event|0
2899445|NCT01753570|9984896|P1|Overall Study|Adverse Event|1
2899446|NCT01753518|9984939|P2|Postpartum Follow-up|Lost to Follow-up|15
2899447|NCT01753518|9984940|P1|Postpartum Follow-up|Lost to Follow-up|22
2899448|NCT01753518|9984939|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
2899449|NCT01753518|9984940|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
2899450|NCT01753518|9984939|P2|Intention-to-Treat Analysis|Multifetal gestation|3
2899451|NCT01753518|9984940|P1|Intention-to-Treat Analysis|Multifetal gestation|2
2899452|NCT01753518|9984939|P2|Intention-to-Treat Analysis|Missing consent form|3
2899453|NCT01753518|9984940|P1|Intention-to-Treat Analysis|Missing consent form|5
2899454|NCT01753401|9984964|P4|Open Label Period (44 Weeks)|Reason not provided|2
2899455|NCT01753401|9984965|P3|Open Label Period (44 Weeks)|Reason not provided|0
2899456|NCT01753401|9984966|P2|Open Label Period (44 Weeks)|Reason not provided|0
2899457|NCT01753401|9984967|P1|Open Label Period (44 Weeks)|Reason not provided|0
2899458|NCT01753401|9984964|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
2899459|NCT01753401|9984965|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
2899460|NCT01753401|9984966|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
2899461|NCT01753401|9984967|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
2899462|NCT01753401|9984964|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
2899463|NCT01753401|9984965|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2899464|NCT01753401|9984966|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2899465|NCT01753401|9984967|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2899466|NCT01753401|9984964|P4|Open Label Period (44 Weeks)|Adverse Event|4
2899467|NCT01753401|9984965|P3|Open Label Period (44 Weeks)|Adverse Event|3
2899468|NCT01753401|9984966|P2|Open Label Period (44 Weeks)|Adverse Event|0
2899469|NCT01753401|9984967|P1|Open Label Period (44 Weeks)|Adverse Event|0
2899470|NCT01753401|9984964|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
2899471|NCT01753401|9984965|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
2899472|NCT01753401|9984966|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
2899473|NCT01753401|9984967|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
2899474|NCT01753401|9984964|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2899475|NCT01753401|9984965|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2899476|NCT01753401|9984966|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2899477|NCT01753401|9984967|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2899478|NCT01753401|9984964|P4|Double-blind Period (8 Weeks)|Adverse Event|0
2899479|NCT01753401|9984965|P3|Double-blind Period (8 Weeks)|Adverse Event|0
2899480|NCT01753401|9984966|P2|Double-blind Period (8 Weeks)|Adverse Event|2
2899481|NCT01753401|9984967|P1|Double-blind Period (8 Weeks)|Adverse Event|0
2899482|NCT01753336|9985026|P1|Overall Study|Withdrawal by Subject|1
2899483|NCT01753336|9985026|P1|Overall Study|Sponsor's decision|2
2899484|NCT01753336|9985026|P1|Overall Study|Physician Decision|2
2899485|NCT01753336|9985026|P1|Overall Study|Lost to Follow-up|3
2899486|NCT01753336|9985026|P1|Overall Study|Patient decision|12
2899487|NCT01753323|9985038|P3|Overall Study|Adverse Event|1
2899488|NCT01753323|9985039|P2|Overall Study|Adverse Event|0
2899489|NCT01753323|9985040|P1|Overall Study|Adverse Event|0
2899490|NCT01753323|9985038|P3|Overall Study|Protocol deviation|0
2899491|NCT01753323|9985039|P2|Overall Study|Protocol deviation|0
2899492|NCT01753323|9985040|P1|Overall Study|Protocol deviation|1
2899493|NCT01753323|9985038|P3|Overall Study|Lack of Efficacy|8
2899494|NCT01753323|9985039|P2|Overall Study|Lack of Efficacy|0
2899495|NCT01753323|9985040|P1|Overall Study|Lack of Efficacy|0
2899496|NCT01753310|9985078|P2|Overall Study|Withdrawal by Subject|0
2899497|NCT01753310|9985079|P1|Overall Study|Withdrawal by Subject|1
2899498|NCT01753310|9985078|P2|Overall Study|Sponsor decision|0
2899499|NCT01753310|9985079|P1|Overall Study|Sponsor decision|1
2899500|NCT01753310|9985078|P2|Overall Study|Subject decision|2
2899501|NCT01753310|9985079|P1|Overall Study|Subject decision|2
2899502|NCT01753310|9985078|P2|Overall Study|Lost to Follow-up|0
2899503|NCT01753310|9985079|P1|Overall Study|Lost to Follow-up|2
2899504|NCT01753310|9985078|P2|Overall Study|Adverse Event|0
2899505|NCT01753310|9985079|P1|Overall Study|Adverse Event|1
2899506|NCT01753310|9985078|P2|Overall Study|Entered into open label extension study|22
2899507|NCT01753310|9985079|P1|Overall Study|Entered into open label extension study|25
2899508|NCT01753193|9985099|P1|Overall Study|Other|16
2899509|NCT01753193|9985099|P1|Overall Study|Death|1
2899510|NCT01753193|9985099|P1|Overall Study|Lost to Follow-up|6
2899511|NCT01753193|9985099|P1|Overall Study|Withdrawal by Subject|23
2899512|NCT01753115|9985114|P3|Overall Study|Used excluded drug|0
2899513|NCT01753115|9985115|P2|Overall Study|Used excluded drug|1
2899514|NCT01753115|9985116|P1|Overall Study|Used excluded drug|0
2899515|NCT01753115|9985114|P3|Overall Study|Subject non-compliant|0
2899516|NCT01753115|9985115|P2|Overall Study|Subject non-compliant|3
2899517|NCT01753115|9985116|P1|Overall Study|Subject non-compliant|3
2899518|NCT01753115|9985114|P3|Overall Study|Withdrawal by Subject|6
2899519|NCT01753115|9985115|P2|Overall Study|Withdrawal by Subject|5
2899520|NCT01753115|9985116|P1|Overall Study|Withdrawal by Subject|6
2899521|NCT01753115|9985114|P3|Overall Study|Lost to Follow-up|8
2899522|NCT01753115|9985115|P2|Overall Study|Lost to Follow-up|6
2899523|NCT01753115|9985116|P1|Overall Study|Lost to Follow-up|3
2899524|NCT01753076|9985126|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
2899525|NCT01753076|9985127|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
2899526|NCT01753076|9985126|P2|Overall Study|Withdrawal by Subject|24
2899527|NCT01753076|9985127|P1|Overall Study|Withdrawal by Subject|14
2899528|NCT01753076|9985126|P2|Overall Study|Physician Decision|2
2899529|NCT01753076|9985127|P1|Overall Study|Physician Decision|4
2899530|NCT01753076|9985126|P2|Overall Study|Lost to Follow-up|1
2899531|NCT01753076|9985127|P1|Overall Study|Lost to Follow-up|2
2899532|NCT01753076|9985126|P2|Overall Study|Lack of Efficacy|1
2899533|NCT01753076|9985127|P1|Overall Study|Lack of Efficacy|3
2899534|NCT01753076|9985126|P2|Overall Study|Adverse Event|18
2899535|NCT01753076|9985127|P1|Overall Study|Adverse Event|17
2899536|NCT01752985|9985154|P3|Treatment Period|Lost to Follow-up|1
2899537|NCT01752985|9985155|P2|Treatment Period|Lost to Follow-up|0
2899538|NCT01752985|9985156|P1|Treatment Period|Lost to Follow-up|0
2899539|NCT01752985|9985154|P3|Treatment Period|Withdrawal by Subject|0
2899540|NCT01752985|9985155|P2|Treatment Period|Withdrawal by Subject|1
2899541|NCT01752985|9985156|P1|Treatment Period|Withdrawal by Subject|1
2899542|NCT01752985|9985154|P3|Treatment Period|Adverse Event|2
2899543|NCT01752985|9985155|P2|Treatment Period|Adverse Event|1
2899544|NCT01752985|9985156|P1|Treatment Period|Adverse Event|2
2899545|NCT01752985|9985154|P3|Treatment Period|Subject no longer meets study criteria|1
2899546|NCT01752985|9985155|P2|Treatment Period|Subject no longer meets study criteria|1
2899547|NCT01752985|9985156|P1|Treatment Period|Subject no longer meets study criteria|0
2899967|NCT01747499|9987230|P1|Overall Study|Developed AML and death|0
2899548|NCT01752985|9985154|P3|Treatment Period|Subject request to discontinue treatment|1
2899549|NCT01752985|9985155|P2|Treatment Period|Subject request to discontinue treatment|0
2899550|NCT01752985|9985156|P1|Treatment Period|Subject request to discontinue treatment|1
2899551|NCT01752933|9985184|P2|Overall Study and Follow-up|Lost to Follow-up|2
2899552|NCT01752933|9985185|P1|Overall Study and Follow-up|Lost to Follow-up|0
2899553|NCT01752933|9985184|P2|Overall Study and Follow-up|Withdrawal by Subject|3
2899554|NCT01752933|9985185|P1|Overall Study and Follow-up|Withdrawal by Subject|0
2899555|NCT01752933|9985184|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
2899556|NCT01752933|9985185|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
2899557|NCT01752933|9985184|P2|Overall Study and Follow-up|Death|34
2899558|NCT01752933|9985185|P1|Overall Study and Follow-up|Death|4
2899559|NCT01752933|9985184|P2|Treatment|Patient unable to travel to appointments|1
2899560|NCT01752933|9985185|P1|Treatment|Patient unable to travel to appointments|0
2899561|NCT01752933|9985184|P2|Treatment|Patient noncompliant|1
2899562|NCT01752933|9985185|P1|Treatment|Patient noncompliant|0
2899563|NCT01752933|9985184|P2|Treatment|Hepatocellular carcinoma not confirmed|1
2899564|NCT01752933|9985185|P1|Treatment|Hepatocellular carcinoma not confirmed|0
2899565|NCT01752933|9985184|P2|Treatment|Death|2
2899566|NCT01752933|9985185|P1|Treatment|Death|0
2899567|NCT01752933|9985184|P2|Treatment|Physician Decision|3
2899568|NCT01752933|9985185|P1|Treatment|Physician Decision|0
2899569|NCT01752933|9985184|P2|Treatment|Adverse Event|4
2899570|NCT01752933|9985185|P1|Treatment|Adverse Event|1
2899571|NCT01752933|9985184|P2|Treatment|Withdrawal by Subject|5
2899572|NCT01752933|9985185|P1|Treatment|Withdrawal by Subject|0
2899573|NCT01752933|9985184|P2|Treatment|Disease Progression|29
2899574|NCT01752933|9985185|P1|Treatment|Disease Progression|3
2899575|NCT01752907|9985203|P2|Overall Study|Decision by Sponsor|9
2899576|NCT01752907|9985204|P1|Overall Study|Decision by Sponsor|6
2899577|NCT01752907|9985203|P2|Overall Study|Lost to Follow-up|1
2899578|NCT01752907|9985204|P1|Overall Study|Lost to Follow-up|2
2899579|NCT01752907|9985203|P2|Overall Study|Withdrawal by Subject|10
2899580|NCT01752907|9985204|P1|Overall Study|Withdrawal by Subject|4
2899581|NCT01752855|9985224|P2|Overall Study|Lack of Efficacy|2
2899582|NCT01752855|9985225|P1|Overall Study|Lack of Efficacy|0
2899583|NCT01752855|9985224|P2|Overall Study|Withdrew Consent|2
2899584|NCT01752855|9985225|P1|Overall Study|Withdrew Consent|0
2899585|NCT01752855|9985224|P2|Overall Study|Adverse Event|0
2899586|NCT01752855|9985225|P1|Overall Study|Adverse Event|1
2899587|NCT01752842|9985241|P2|Overall Study|Withdrawal by Subject|2
2899588|NCT01752842|9985242|P1|Overall Study|Withdrawal by Subject|0
2899589|NCT01752842|9985241|P2|Overall Study|Adverse Event|0
2899590|NCT01752842|9985242|P1|Overall Study|Adverse Event|3
2899591|NCT01752634|9985277|P6|Week 24 to Week 260|Adverse Event|0
2899592|NCT01752634|9985278|P5|Week 24 to Week 260|Adverse Event|2
2899593|NCT01752634|9985279|P4|Week 24 to Week 260|Adverse Event|4
2899594|NCT01752634|9985280|P3|Week 24 to Week 260|Adverse Event|8
2899595|NCT01752634|9985281|P2|Week 24 to Week 260|Adverse Event|8
2899596|NCT01752634|9985282|P1|Week 24 to Week 260|Adverse Event|4
2899597|NCT01752634|9985277|P6|Week 24 to Week 260|Lost to Follow-up|0
2899598|NCT01752634|9985278|P5|Week 24 to Week 260|Lost to Follow-up|2
2899599|NCT01752634|9985279|P4|Week 24 to Week 260|Lost to Follow-up|0
2899600|NCT01752634|9985280|P3|Week 24 to Week 260|Lost to Follow-up|3
2899601|NCT01752634|9985281|P2|Week 24 to Week 260|Lost to Follow-up|2
2899602|NCT01752634|9985282|P1|Week 24 to Week 260|Lost to Follow-up|2
2899603|NCT01752634|9985277|P6|Week 24 to Week 260|Noncompliance with study treatment|0
2899604|NCT01752634|9985278|P5|Week 24 to Week 260|Noncompliance with study treatment|0
2899605|NCT01752634|9985279|P4|Week 24 to Week 260|Noncompliance with study treatment|0
2899606|NCT01752634|9985280|P3|Week 24 to Week 260|Noncompliance with study treatment|1
2899607|NCT01752634|9985281|P2|Week 24 to Week 260|Noncompliance with study treatment|0
2899608|NCT01752634|9985282|P1|Week 24 to Week 260|Noncompliance with study treatment|0
2899609|NCT01752634|9985277|P6|Week 24 to Week 260|Pregnancy|0
2899610|NCT01752634|9985278|P5|Week 24 to Week 260|Pregnancy|0
2899611|NCT01752634|9985279|P4|Week 24 to Week 260|Pregnancy|0
2899612|NCT01752634|9985280|P3|Week 24 to Week 260|Pregnancy|1
2899613|NCT01752634|9985281|P2|Week 24 to Week 260|Pregnancy|0
2899614|NCT01752634|9985282|P1|Week 24 to Week 260|Pregnancy|0
2899615|NCT01752634|9985277|P6|Week 24 to Week 260|Death|0
2899616|NCT01752634|9985278|P5|Week 24 to Week 260|Death|0
2899617|NCT01752634|9985279|P4|Week 24 to Week 260|Death|0
2899618|NCT01752634|9985280|P3|Week 24 to Week 260|Death|0
2899619|NCT01752634|9985281|P2|Week 24 to Week 260|Death|1
2899620|NCT01752634|9985282|P1|Week 24 to Week 260|Death|0
2899621|NCT01752634|9985277|P6|Week 24 to Week 260|Physician Decision|0
2899622|NCT01752634|9985278|P5|Week 24 to Week 260|Physician Decision|1
2899623|NCT01752634|9985279|P4|Week 24 to Week 260|Physician Decision|2
2899624|NCT01752634|9985280|P3|Week 24 to Week 260|Physician Decision|4
2899625|NCT01752634|9985281|P2|Week 24 to Week 260|Physician Decision|2
2899626|NCT01752634|9985282|P1|Week 24 to Week 260|Physician Decision|1
2899627|NCT01752634|9985277|P6|Week 24 to Week 260|Subject/guardian decision|0
2899628|NCT01752634|9985278|P5|Week 24 to Week 260|Subject/guardian decision|5
2899629|NCT01752634|9985279|P4|Week 24 to Week 260|Subject/guardian decision|5
2899630|NCT01752634|9985280|P3|Week 24 to Week 260|Subject/guardian decision|9
2899631|NCT01752634|9985281|P2|Week 24 to Week 260|Subject/guardian decision|10
2899632|NCT01752634|9985282|P1|Week 24 to Week 260|Subject/guardian decision|12
2899633|NCT01752634|9985277|P6|Week 24 to Week 260|Lack of Efficacy|0
2899634|NCT01752634|9985278|P5|Week 24 to Week 260|Lack of Efficacy|4
2899635|NCT01752634|9985279|P4|Week 24 to Week 260|Lack of Efficacy|3
2899636|NCT01752634|9985280|P3|Week 24 to Week 260|Lack of Efficacy|7
2899637|NCT01752634|9985281|P2|Week 24 to Week 260|Lack of Efficacy|7
2899638|NCT01752634|9985282|P1|Week 24 to Week 260|Lack of Efficacy|15
2899639|NCT01752634|9985277|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
2899640|NCT01752634|9985278|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
2899641|NCT01752634|9985279|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
2899642|NCT01752634|9985280|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
2899643|NCT01752634|9985281|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
2899644|NCT01752634|9985282|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
2899645|NCT01752634|9985277|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
2899646|NCT01752634|9985278|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2899647|NCT01752634|9985279|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2899648|NCT01752634|9985280|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
2899649|NCT01752634|9985281|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
2899650|NCT01752634|9985282|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
2899651|NCT01752634|9985277|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
2899652|NCT01752634|9985278|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
2899653|NCT01752634|9985279|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
2899654|NCT01752634|9985280|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
2899655|NCT01752634|9985281|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
2899656|NCT01752634|9985282|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
2899657|NCT01752634|9985277|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
2899658|NCT01752634|9985278|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
2899659|NCT01752634|9985279|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
2899660|NCT01752634|9985280|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2899661|NCT01752634|9985281|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2899662|NCT01752634|9985282|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
2899663|NCT01752023|9985342|P2|Overall Study|Physician Decision|1
2899664|NCT01752023|9985343|P1|Overall Study|Physician Decision|2
2899665|NCT01751906|9985379|P2|Overall Study|Other|0
2899666|NCT01751906|9985380|P1|Overall Study|Other|1
2899667|NCT01751906|9985379|P2|Overall Study|Death|22
2899668|NCT01751906|9985380|P1|Overall Study|Death|38
2899669|NCT01751906|9985379|P2|Overall Study|Physician Decision|1
2899670|NCT01751906|9985380|P1|Overall Study|Physician Decision|3
2899671|NCT01751906|9985379|P2|Overall Study|Withdrawal by Subject|6
2899672|NCT01751906|9985380|P1|Overall Study|Withdrawal by Subject|14
2899673|NCT01751906|9985379|P2|Overall Study|Lost to Follow-up|18
2899674|NCT01751906|9985380|P1|Overall Study|Lost to Follow-up|28
2899675|NCT01751867|9985584|P2|Overall Study|Randomized but not treated.|1
2899676|NCT01751867|9985585|P1|Overall Study|Randomized but not treated.|2
2899677|NCT01751867|9985584|P2|Overall Study|Other|37
2899678|NCT01751867|9985585|P1|Overall Study|Other|11
2899679|NCT01751867|9985584|P2|Overall Study|Death|5
2899680|NCT01751867|9985585|P1|Overall Study|Death|0
2899681|NCT01751867|9985584|P2|Overall Study|Protocol Violation|2
2899682|NCT01751867|9985585|P1|Overall Study|Protocol Violation|0
2899683|NCT01751867|9985584|P2|Overall Study|Physician Decision|7
2899684|NCT01751867|9985585|P1|Overall Study|Physician Decision|4
2899685|NCT01751867|9985584|P2|Overall Study|Withdrawal by Subject|1
2899686|NCT01751867|9985585|P1|Overall Study|Withdrawal by Subject|3
2899687|NCT01751867|9985584|P2|Overall Study|Poor Compliance|5
2899688|NCT01751867|9985585|P1|Overall Study|Poor Compliance|0
2899689|NCT01751867|9985584|P2|Overall Study|Adverse Event|15
2899690|NCT01751867|9985585|P1|Overall Study|Adverse Event|8
2899691|NCT01751867|9985584|P2|Overall Study|Diease Progression|18
2899692|NCT01751867|9985585|P1|Overall Study|Diease Progression|4
2899693|NCT01751867|9985584|P2|Overall Study|Completed treatment,dropped in follow-up|8
2899694|NCT01751867|9985585|P1|Overall Study|Completed treatment,dropped in follow-up|4
2899695|NCT01751802|9985605|P2|Overall Study|Adverse Event|2
2899696|NCT01751802|9985606|P1|Overall Study|Adverse Event|4
2899697|NCT01751724|9985620|P2|Overall Study|withdrawn by parent|2
2899698|NCT01751724|9985621|P1|Overall Study|withdrawn by parent|0
2899699|NCT01751724|9985620|P2|Overall Study|extubated bef.start assigned treatment|0
2899700|NCT01751724|9985621|P1|Overall Study|extubated bef.start assigned treatment|1
2899701|NCT01751646|9985649|P2|Overall Study|Childcare issues|1
2899702|NCT01751646|9985650|P1|Overall Study|Childcare issues|1
2899703|NCT01751646|9985649|P2|Overall Study|Fails to comply with study requirements|1
2899704|NCT01751646|9985650|P1|Overall Study|Fails to comply with study requirements|0
2899705|NCT01751646|9985649|P2|Overall Study|Off study due to multiple obligations|1
2899706|NCT01751646|9985650|P1|Overall Study|Off study due to multiple obligations|0
2899707|NCT01751646|9985649|P2|Overall Study|Inability to attend required visits|1
2899708|NCT01751646|9985650|P1|Overall Study|Inability to attend required visits|0
2899709|NCT01751646|9985649|P2|Overall Study|Moved out of the area|5
2899710|NCT01751646|9985650|P1|Overall Study|Moved out of the area|1
2899711|NCT01751646|9985649|P2|Overall Study|Inadvertent enrollment|1
2899712|NCT01751646|9985650|P1|Overall Study|Inadvertent enrollment|1
2899713|NCT01751646|9985649|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
2899968|NCT01747499|9987226|P5|Overall Study|Withdrawal by Subject|6
2899714|NCT01751646|9985650|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
2899715|NCT01751646|9985649|P2|Overall Study|Starting hormone therapy|0
2899716|NCT01751646|9985650|P1|Overall Study|Starting hormone therapy|1
2899717|NCT01751646|9985649|P2|Overall Study|Withdrawal by Subject|4
2899718|NCT01751646|9985650|P1|Overall Study|Withdrawal by Subject|0
2899719|NCT01751646|9985649|P2|Overall Study|Lost to Follow-up|1
2899720|NCT01751646|9985650|P1|Overall Study|Lost to Follow-up|5
2899721|NCT01751412|9985798|P1|Overall Study|Disease Progression Before Treatment|1
2899722|NCT01751178|9985908|P3|Overall Study|Other Reason (unknown)|2
2899723|NCT01751178|9985909|P2|Overall Study|Other Reason (unknown)|0
2899724|NCT01751178|9985910|P1|Overall Study|Other Reason (unknown)|1
2899725|NCT01751178|9985908|P3|Overall Study|Adverse Event|0
2899726|NCT01751178|9985909|P2|Overall Study|Adverse Event|0
2899727|NCT01751178|9985910|P1|Overall Study|Adverse Event|2
2899728|NCT01751165|9985930|P3|Overall Study|Lost to Follow-up|1
2899729|NCT01751165|9985931|P2|Overall Study|Lost to Follow-up|1
2899730|NCT01751165|9985932|P1|Overall Study|Lost to Follow-up|1
2899731|NCT01751165|9985930|P3|Overall Study|Serious adverse event|0
2899732|NCT01751165|9985931|P2|Overall Study|Serious adverse event|2
2899733|NCT01751165|9985932|P1|Overall Study|Serious adverse event|0
2899734|NCT01751165|9985930|P3|Overall Study|Withdrawal by Subject|1
2899735|NCT01751165|9985931|P2|Overall Study|Withdrawal by Subject|0
2899736|NCT01751165|9985932|P1|Overall Study|Withdrawal by Subject|0
2899737|NCT01751165|9985930|P3|Overall Study|Adverse event, serious fatal|1
2899738|NCT01751165|9985931|P2|Overall Study|Adverse event, serious fatal|0
2899739|NCT01751165|9985932|P1|Overall Study|Adverse event, serious fatal|1
2899740|NCT01751139|9985972|P1|Overall Study|Death|31
2899741|NCT01751139|9985972|P1|Overall Study|Adverse Event|1
2899742|NCT01751139|9985972|P1|Overall Study|Withdrawal by Subject|251
2899743|NCT01751139|9985972|P1|Overall Study|Lost to Follow-up|240
2899744|NCT01751139|9985972|P1|Overall Study|Sponsor study termination|1609
2899745|NCT01751139|9985972|P1|Overall Study|Other|135
2899746|NCT01751113|9985990|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
2899747|NCT01751113|9985991|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
2899748|NCT01751113|9985992|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
2899749|NCT01751113|9985993|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
2899750|NCT01751113|9985994|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
2899751|NCT01751113|9985995|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
2899752|NCT01751113|9985990|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
2899753|NCT01751113|9985991|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
2899754|NCT01751113|9985992|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
2899755|NCT01751113|9985993|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
2899756|NCT01751113|9985994|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
2899757|NCT01751113|9985995|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
2899758|NCT01751087|9986036|P3|Overall Study|Physician Decision|1
2899759|NCT01751087|9986037|P2|Overall Study|Physician Decision|0
2899760|NCT01751087|9986038|P1|Overall Study|Physician Decision|0
2899761|NCT01751087|9986036|P3|Overall Study|Withdrawal by Subject|0
2899762|NCT01751087|9986037|P2|Overall Study|Withdrawal by Subject|0
2899763|NCT01751087|9986038|P1|Overall Study|Withdrawal by Subject|1
2899764|NCT01751061|9986072|P2|Overall Study|Physician Decision|0
2899765|NCT01751061|9986073|P1|Overall Study|Physician Decision|2
2899766|NCT01751061|9986072|P2|Overall Study|Withdrawal by Subject|1
2899767|NCT01751061|9986073|P1|Overall Study|Withdrawal by Subject|4
2899768|NCT01751061|9986072|P2|Overall Study|patient regained decisional capacity|8
2899769|NCT01751061|9986073|P1|Overall Study|patient regained decisional capacity|4
2899770|NCT01751061|9986072|P2|Overall Study|Lost to Follow-up|25
2899771|NCT01751061|9986073|P1|Overall Study|Lost to Follow-up|40
2899772|NCT01751061|9986072|P2|Overall Study|patient death|0
2899773|NCT01751061|9986073|P1|Overall Study|patient death|5
2899774|NCT01751061|9986072|P2|Overall Study|Death|0
2899775|NCT01751061|9986073|P1|Overall Study|Death|1
2899776|NCT01750840|9986147|P1|Overall Study|Lost to Follow-up|4
2899777|NCT01750697|9986152|P1|Overall Study|Withdrawal by Subject|1
2899778|NCT01750697|9986152|P1|Overall Study|Physician Decision|1
2899779|NCT01750697|9986152|P1|Overall Study|Transferred to Adult Services|5
2899780|NCT01750697|9986152|P1|Overall Study|Physician and Family Decision|1
2899781|NCT01750697|9986152|P1|Overall Study|Transferred Back to Local Hospital|1
2899782|NCT01750684|9986164|P2|Overall Study|Protocol Violation|0
2899783|NCT01750684|9986165|P1|Overall Study|Protocol Violation|1
2899784|NCT01750684|9986164|P2|Overall Study|Withdrawn by Sponsor|1
2899785|NCT01750684|9986165|P1|Overall Study|Withdrawn by Sponsor|0
2899786|NCT01750684|9986164|P2|Overall Study|Non-compliance with Study Drug|1
2899787|NCT01750684|9986165|P1|Overall Study|Non-compliance with Study Drug|0
2899788|NCT01750684|9986164|P2|Overall Study|Death|0
2899789|NCT01750684|9986165|P1|Overall Study|Death|1
2899790|NCT01750346|9986202|P3|Overall Study|Adverse Event|0
2899791|NCT01750346|9986203|P2|Overall Study|Adverse Event|0
2899792|NCT01750346|9986204|P1|Overall Study|Adverse Event|1
2899793|NCT01750294|9986230|P1|Overall Study|Safety Endpoint|1
2899794|NCT01750294|9986230|P1|Overall Study|Withdrawal by Subject|1
2899795|NCT01750281|9986237|P3|Overall Study|Did not receive treatment|0
2899796|NCT01750281|9986238|P2|Overall Study|Did not receive treatment|1
2899797|NCT01750281|9986239|P1|Overall Study|Did not receive treatment|0
2899798|NCT01750281|9986237|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
2899799|NCT01750281|9986238|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
2899800|NCT01750281|9986239|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
2899801|NCT01750281|9986237|P3|Overall Study|Discontinued Selumetinib/Placebo|75
2899802|NCT01750281|9986238|P2|Overall Study|Discontinued Selumetinib/Placebo|77
2899803|NCT01750281|9986239|P1|Overall Study|Discontinued Selumetinib/Placebo|37
2899804|NCT01750242|9986269|P1|Overall Study|Unreadable Images|3
2899805|NCT01750229|9986274|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
2899806|NCT01750229|9986274|P1|Long-term Follow-up Phase|Adverse Event|2
2899807|NCT01750229|9986274|P1|Randomized Crossover Phase|Withdrawal by Subject|1
2899808|NCT01750229|9986274|P1|Randomized Crossover Phase|Adverse Event|1
2899809|NCT01749982|9986301|P4|Overall Study|Withdrawal by Subject|1
2899810|NCT01749982|9986302|P3|Overall Study|Withdrawal by Subject|0
2899811|NCT01749982|9986303|P2|Overall Study|Withdrawal by Subject|0
2899812|NCT01749982|9986304|P1|Overall Study|Withdrawal by Subject|0
2899813|NCT01749982|9986301|P4|Overall Study|Lost to Follow-up|1
2899814|NCT01749982|9986302|P3|Overall Study|Lost to Follow-up|0
2899815|NCT01749982|9986303|P2|Overall Study|Lost to Follow-up|0
2899816|NCT01749982|9986304|P1|Overall Study|Lost to Follow-up|0
2899817|NCT01749982|9986301|P4|Overall Study|Physician Decision|1
2899818|NCT01749982|9986302|P3|Overall Study|Physician Decision|0
2899819|NCT01749982|9986303|P2|Overall Study|Physician Decision|0
2899820|NCT01749982|9986304|P1|Overall Study|Physician Decision|0
2899821|NCT01749826|9986368|P2|Overall Study|Study Terminated|0
2899822|NCT01749826|9986369|P1|Overall Study|Study Terminated|20
2899823|NCT01749800|9986384|P3|Overall Study|Withdrawal by Subject|0
2899824|NCT01749800|9986385|P2|Overall Study|Withdrawal by Subject|1
2899825|NCT01749800|9986386|P1|Overall Study|Withdrawal by Subject|0
2899826|NCT01749800|9986384|P3|Overall Study|not meeting inclusion criteria|0
2899827|NCT01749800|9986385|P2|Overall Study|not meeting inclusion criteria|0
2899828|NCT01749800|9986386|P1|Overall Study|not meeting inclusion criteria|3
2899829|NCT01749735|9986396|P2|Overall Study|Withdrawal by Subject|0
2899830|NCT01749735|9986397|P1|Overall Study|Withdrawal by Subject|1
2899831|NCT01749033|9986448|P3|Overall Study|Lost to Follow-up|1
2899832|NCT01749033|9986449|P2|Overall Study|Lost to Follow-up|2
2899833|NCT01749033|9986450|P1|Overall Study|Lost to Follow-up|0
2899834|NCT01749033|9986448|P3|Overall Study|Did not receive allocated intervention|0
2899835|NCT01749033|9986449|P2|Overall Study|Did not receive allocated intervention|3
2899836|NCT01749033|9986450|P1|Overall Study|Did not receive allocated intervention|3
2899837|NCT01748890|9986520|P1|Overall Study|Insufficient recruitment for analysis|4
2899838|NCT01748760|9986575|P2|Overall Study|Lost to Follow-up|1
2899839|NCT01748760|9986576|P1|Overall Study|Lost to Follow-up|5
2899840|NCT01748760|9986575|P2|Overall Study|Withdrawal by Subject|1
2899841|NCT01748760|9986576|P1|Overall Study|Withdrawal by Subject|1
2899842|NCT01748552|9986622|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
2899843|NCT01748552|9986623|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
2899844|NCT01748552|9986624|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
2899845|NCT01748552|9986625|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
2899846|NCT01748552|9986626|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
2899847|NCT01748552|9986627|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
2899848|NCT01748552|9986628|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
2899849|NCT01748552|9986629|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
2899850|NCT01748552|9986630|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
2899851|NCT01748552|9986631|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
2899852|NCT01748552|9986632|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
2899853|NCT01748552|9986633|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
2899854|NCT01748552|9986622|P12|Intervention Period 2 and Washout|Physician Decision|0
2899855|NCT01748552|9986623|P11|Intervention Period 2 and Washout|Physician Decision|0
2899856|NCT01748552|9986624|P10|Intervention Period 2 and Washout|Physician Decision|0
2899857|NCT01748552|9986625|P9|Intervention Period 2 and Washout|Physician Decision|0
2899858|NCT01748552|9986626|P8|Intervention Period 2 and Washout|Physician Decision|0
2899859|NCT01748552|9986627|P7|Intervention Period 2 and Washout|Physician Decision|0
2899860|NCT01748552|9986628|P6|Intervention Period 2 and Washout|Physician Decision|0
2899861|NCT01748552|9986629|P5|Intervention Period 2 and Washout|Physician Decision|0
2899862|NCT01748552|9986630|P4|Intervention Period 2 and Washout|Physician Decision|0
2899863|NCT01748552|9986631|P3|Intervention Period 2 and Washout|Physician Decision|1
2899864|NCT01748552|9986632|P2|Intervention Period 2 and Washout|Physician Decision|0
2899865|NCT01748552|9986633|P1|Intervention Period 2 and Washout|Physician Decision|0
2899866|NCT01748292|9986703|P2|Overall Study|Withdrawal by Subject|2
2899867|NCT01748292|9986704|P1|Overall Study|Withdrawal by Subject|0
2899868|NCT01748292|9986703|P2|Overall Study|Death|3
2899869|NCT01748292|9986704|P1|Overall Study|Death|0
2899870|NCT01748292|9986703|P2|Overall Study|Lost to Follow-up|3
2899871|NCT01748292|9986704|P1|Overall Study|Lost to Follow-up|0
2899872|NCT01748292|9986703|P2|Overall Study|Adverse Event|4
2899873|NCT01748292|9986704|P1|Overall Study|Adverse Event|2
2899874|NCT01748162|9986738|P2|Overall Study|reasons not available|2
2899875|NCT01748162|9986739|P1|Overall Study|reasons not available|3
2899876|NCT01748162|9986738|P2|Overall Study|participant consented but did not begin|1
2899877|NCT01748162|9986739|P1|Overall Study|participant consented but did not begin|0
2899878|NCT01748162|9986738|P2|Overall Study|no additional croup episodes to evaluate|2
2899879|NCT01748162|9986739|P1|Overall Study|no additional croup episodes to evaluate|2
2899880|NCT01748071|9986750|P3|Overall Study|Adverse Event|0
2899881|NCT01748071|9986751|P2|Overall Study|Adverse Event|2
2899882|NCT01748071|9986752|P1|Overall Study|Adverse Event|2
2899883|NCT01747915|9987015|P3|Overall Study|Pregnancy|1
2899884|NCT01747915|9987016|P2|Overall Study|Pregnancy|0
2899885|NCT01747915|9987017|P1|Overall Study|Pregnancy|0
2899886|NCT01747915|9987015|P3|Overall Study|Protocol Violation|0
2899887|NCT01747915|9987016|P2|Overall Study|Protocol Violation|0
2899888|NCT01747915|9987017|P1|Overall Study|Protocol Violation|1
2899889|NCT01747915|9987015|P3|Overall Study|Withdrawal by Subject|1
2899890|NCT01747915|9987016|P2|Overall Study|Withdrawal by Subject|4
2899891|NCT01747915|9987017|P1|Overall Study|Withdrawal by Subject|4
2899892|NCT01747915|9987015|P3|Overall Study|Lost to Follow-up|0
2899893|NCT01747915|9987016|P2|Overall Study|Lost to Follow-up|0
2899894|NCT01747915|9987017|P1|Overall Study|Lost to Follow-up|1
2899895|NCT01747915|9987015|P3|Overall Study|Lack of Efficacy|0
2899896|NCT01747915|9987016|P2|Overall Study|Lack of Efficacy|1
2899897|NCT01747915|9987017|P1|Overall Study|Lack of Efficacy|0
2899898|NCT01747915|9987015|P3|Overall Study|Death|1
2899899|NCT01747915|9987016|P2|Overall Study|Death|0
2899900|NCT01747915|9987017|P1|Overall Study|Death|0
2899901|NCT01747915|9987015|P3|Overall Study|Adverse Event|2
2899902|NCT01747915|9987016|P2|Overall Study|Adverse Event|5
2899903|NCT01747915|9987017|P1|Overall Study|Adverse Event|8
2899904|NCT01747915|9987015|P3|Overall Study|Other|1
2899905|NCT01747915|9987016|P2|Overall Study|Other|1
2899906|NCT01747915|9987017|P1|Overall Study|Other|1
2899907|NCT01747876|9987031|P3|Overall Study|Trtment duration compl. as per protocol|1
2899908|NCT01747876|9987032|P2|Overall Study|Trtment duration compl. as per protocol|1
2899909|NCT01747876|9987033|P1|Overall Study|Trtment duration compl. as per protocol|0
2899910|NCT01747876|9987031|P3|Overall Study|Disease progression|8
2899911|NCT01747876|9987032|P2|Overall Study|Disease progression|13
2899912|NCT01747876|9987033|P1|Overall Study|Disease progression|4
2899913|NCT01747876|9987031|P3|Overall Study|Withdrawal by Subject|1
2899914|NCT01747876|9987032|P2|Overall Study|Withdrawal by Subject|1
2899915|NCT01747876|9987033|P1|Overall Study|Withdrawal by Subject|0
2899916|NCT01747876|9987031|P3|Overall Study|Adverse Event|2
2899917|NCT01747876|9987032|P2|Overall Study|Adverse Event|0
2899918|NCT01747876|9987033|P1|Overall Study|Adverse Event|1
2899919|NCT01747837|9987086|P2|Overall Study|Death|4
2899920|NCT01747837|9987087|P1|Overall Study|Death|4
2899921|NCT01747837|9987086|P2|Overall Study|Lost to Follow-up|2
2899922|NCT01747837|9987087|P1|Overall Study|Lost to Follow-up|5
2899923|NCT01747811|9987117|P2|Overall Study|Lack of Efficacy|4
2899924|NCT01747811|9987118|P1|Overall Study|Lack of Efficacy|2
2899925|NCT01747772|9987134|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
2899926|NCT01747655|9987142|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
2899927|NCT01747655|9987143|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
2899928|NCT01747655|9987142|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
2899929|NCT01747655|9987143|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
2899930|NCT01747655|9987142|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
2899931|NCT01747655|9987143|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
2899932|NCT01747629|9987173|P2|Overall Study|Other|1
2899933|NCT01747629|9987174|P1|Overall Study|Other|2
2899934|NCT01747629|9987173|P2|Overall Study|Not treated|0
2899935|NCT01747629|9987174|P1|Overall Study|Not treated|1
2899936|NCT01747629|9987173|P2|Overall Study|Inclusion criteria not met|0
2899937|NCT01747629|9987174|P1|Overall Study|Inclusion criteria not met|1
2899938|NCT01747629|9987173|P2|Overall Study|Noncompliance|1
2899939|NCT01747629|9987174|P1|Overall Study|Noncompliance|1
2899940|NCT01747629|9987173|P2|Overall Study|Withdrawal by Subject|2
2899941|NCT01747629|9987174|P1|Overall Study|Withdrawal by Subject|2
2899942|NCT01747629|9987173|P2|Overall Study|Adverse Event|2
2899943|NCT01747629|9987174|P1|Overall Study|Adverse Event|1
2899944|NCT01747551|9987208|P2|Overall Study|Other|0
2899945|NCT01747551|9987209|P1|Overall Study|Other|2
2899946|NCT01747551|9987208|P2|Overall Study|Physician Decision|1
2899947|NCT01747551|9987209|P1|Overall Study|Physician Decision|2
2899948|NCT01747551|9987208|P2|Overall Study|Withdrawal by Subject|1
2899949|NCT01747551|9987209|P1|Overall Study|Withdrawal by Subject|3
2899950|NCT01747551|9987208|P2|Overall Study|Prolonged Treatment Delay|0
2899951|NCT01747551|9987209|P1|Overall Study|Prolonged Treatment Delay|2
2899952|NCT01747551|9987208|P2|Overall Study|Adverse Event|1
2899953|NCT01747551|9987209|P1|Overall Study|Adverse Event|7
2899954|NCT01747551|9987208|P2|Overall Study|Death|1
2899955|NCT01747551|9987209|P1|Overall Study|Death|3
2899956|NCT01747551|9987208|P2|Overall Study|Progressive Disease|17
2899957|NCT01747551|9987209|P1|Overall Study|Progressive Disease|24
2899958|NCT01747499|9987226|P5|Overall Study|Determined not to be eligible|1
2899959|NCT01747499|9987227|P4|Overall Study|Determined not to be eligible|0
2899960|NCT01747499|9987228|P3|Overall Study|Determined not to be eligible|0
2899961|NCT01747499|9987229|P2|Overall Study|Determined not to be eligible|0
2899962|NCT01747499|9987230|P1|Overall Study|Determined not to be eligible|0
2899963|NCT01747499|9987226|P5|Overall Study|Developed AML and death|1
2899964|NCT01747499|9987227|P4|Overall Study|Developed AML and death|0
2899965|NCT01747499|9987228|P3|Overall Study|Developed AML and death|0
2899966|NCT01747499|9987229|P2|Overall Study|Developed AML and death|0
2899969|NCT01747499|9987227|P4|Overall Study|Withdrawal by Subject|0
2899970|NCT01747499|9987228|P3|Overall Study|Withdrawal by Subject|0
2899971|NCT01747499|9987229|P2|Overall Study|Withdrawal by Subject|0
2899972|NCT01747499|9987230|P1|Overall Study|Withdrawal by Subject|0
2899973|NCT01747499|9987226|P5|Overall Study|Death|1
2899974|NCT01747499|9987227|P4|Overall Study|Death|1
2899975|NCT01747499|9987228|P3|Overall Study|Death|0
2899976|NCT01747499|9987229|P2|Overall Study|Death|0
2899977|NCT01747499|9987230|P1|Overall Study|Death|0
2899978|NCT01747499|9987226|P5|Overall Study|Physician Decision|2
2899979|NCT01747499|9987227|P4|Overall Study|Physician Decision|0
2899980|NCT01747499|9987228|P3|Overall Study|Physician Decision|0
2899981|NCT01747499|9987229|P2|Overall Study|Physician Decision|1
2899982|NCT01747499|9987230|P1|Overall Study|Physician Decision|0
2899983|NCT01747499|9987226|P5|Overall Study|Steroid refractory aGvHD|4
2899984|NCT01747499|9987227|P4|Overall Study|Steroid refractory aGvHD|1
2899985|NCT01747499|9987228|P3|Overall Study|Steroid refractory aGvHD|0
2899986|NCT01747499|9987229|P2|Overall Study|Steroid refractory aGvHD|0
2899987|NCT01747499|9987230|P1|Overall Study|Steroid refractory aGvHD|1
2899988|NCT01747486|9987266|P2|Stage 2|Disease Progression|0
2899989|NCT01747486|9987267|P1|Stage 2|Disease Progression|3
2899990|NCT01747486|9987266|P2|Stage 2|New Cancer Therapy|0
2899991|NCT01747486|9987267|P1|Stage 2|New Cancer Therapy|3
2899992|NCT01747486|9987266|P2|Stage 2|Withdrawal by Subject|0
2899993|NCT01747486|9987267|P1|Stage 2|Withdrawal by Subject|1
2899994|NCT01747486|9987266|P2|Stage 2|Physician Decision|0
2899995|NCT01747486|9987267|P1|Stage 2|Physician Decision|2
2899996|NCT01747486|9987266|P2|Stage 1|Death|1
2899997|NCT01747486|9987267|P1|Stage 1|Death|1
2899998|NCT01747486|9987266|P2|Stage 1|Disease progression|9
2899999|NCT01747486|9987267|P1|Stage 1|Disease progression|4
2900000|NCT01747486|9987266|P2|Stage 1|Withdrawal by Subject|3
2900001|NCT01747486|9987267|P1|Stage 1|Withdrawal by Subject|4
2900002|NCT01747486|9987266|P2|Stage 1|Physician Decision|0
2900003|NCT01747486|9987267|P1|Stage 1|Physician Decision|3
2900004|NCT01746901|9987317|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
2900005|NCT01746901|9987318|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900006|NCT01746901|9987319|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
2900007|NCT01746901|9987320|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900008|NCT01746901|9987321|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900009|NCT01746901|9987322|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900010|NCT01746901|9987323|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900011|NCT01746901|9987324|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900012|NCT01746901|9987325|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
2900013|NCT01746901|9987317|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
2900014|NCT01746901|9987318|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
2900015|NCT01746901|9987319|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
2900016|NCT01746901|9987320|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
2900017|NCT01746901|9987321|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
2900018|NCT01746901|9987322|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
2900019|NCT01746901|9987323|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
2900020|NCT01746901|9987324|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
2900021|NCT01746901|9987325|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
2900022|NCT01746901|9987317|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900023|NCT01746901|9987318|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900024|NCT01746901|9987319|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900025|NCT01746901|9987320|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900026|NCT01746901|9987321|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900027|NCT01746901|9987322|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
2900028|NCT01746901|9987323|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900029|NCT01746901|9987324|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900030|NCT01746901|9987325|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2900031|NCT01746901|9987317|P9|Treatment Phase: Third Intervention|Protocol Violation|0
2900032|NCT01746901|9987318|P8|Treatment Phase: Third Intervention|Protocol Violation|0
2900033|NCT01746901|9987319|P7|Treatment Phase: Third Intervention|Protocol Violation|1
2900034|NCT01746901|9987320|P6|Treatment Phase: Third Intervention|Protocol Violation|1
2900035|NCT01746901|9987321|P5|Treatment Phase: Third Intervention|Protocol Violation|0
2900036|NCT01746901|9987322|P4|Treatment Phase: Third Intervention|Protocol Violation|0
2900037|NCT01746901|9987323|P3|Treatment Phase: Third Intervention|Protocol Violation|0
2900038|NCT01746901|9987324|P2|Treatment Phase: Third Intervention|Protocol Violation|0
2900039|NCT01746901|9987325|P1|Treatment Phase: Third Intervention|Protocol Violation|0
2900040|NCT01746901|9987317|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900041|NCT01746901|9987318|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
2900042|NCT01746901|9987319|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900043|NCT01746901|9987320|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900044|NCT01746901|9987321|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900045|NCT01746901|9987322|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900046|NCT01746901|9987323|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900047|NCT01746901|9987324|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900048|NCT01746901|9987325|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2900049|NCT01746901|9987317|P9|Treatment Phase: First Intervention|Protocol Violation|0
2900050|NCT01746901|9987318|P8|Treatment Phase: First Intervention|Protocol Violation|0
2900051|NCT01746901|9987319|P7|Treatment Phase: First Intervention|Protocol Violation|1
2900052|NCT01746901|9987320|P6|Treatment Phase: First Intervention|Protocol Violation|0
2900053|NCT01746901|9987321|P5|Treatment Phase: First Intervention|Protocol Violation|0
2900054|NCT01746901|9987322|P4|Treatment Phase: First Intervention|Protocol Violation|0
2900055|NCT01746901|9987323|P3|Treatment Phase: First Intervention|Protocol Violation|0
2900056|NCT01746901|9987324|P2|Treatment Phase: First Intervention|Protocol Violation|0
2900057|NCT01746901|9987325|P1|Treatment Phase: First Intervention|Protocol Violation|0
2900058|NCT01746901|9987317|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900059|NCT01746901|9987318|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900060|NCT01746901|9987319|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900061|NCT01746901|9987320|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900062|NCT01746901|9987321|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900063|NCT01746901|9987322|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900064|NCT01746901|9987323|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
2900065|NCT01746901|9987324|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
2900066|NCT01746901|9987325|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
2900067|NCT01746901|9987317|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900068|NCT01746901|9987318|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900069|NCT01746901|9987319|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900070|NCT01746901|9987320|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900071|NCT01746901|9987321|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900072|NCT01746901|9987322|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900073|NCT01746901|9987323|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
2900074|NCT01746901|9987324|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
2900075|NCT01746901|9987325|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2900076|NCT01746901|9987317|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
2900077|NCT01746901|9987318|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
2900078|NCT01746901|9987319|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
2900079|NCT01746901|9987320|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
2900080|NCT01746901|9987321|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
2900081|NCT01746901|9987322|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
2900082|NCT01746901|9987323|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
2900083|NCT01746901|9987324|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
2900084|NCT01746901|9987325|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
2900085|NCT01746901|9987317|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
2900086|NCT01746901|9987318|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
2900087|NCT01746901|9987319|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
2900088|NCT01746901|9987320|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
2900089|NCT01746901|9987321|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
2900090|NCT01746901|9987322|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
2900091|NCT01746901|9987323|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
2900092|NCT01746901|9987324|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
2900093|NCT01746901|9987325|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
2900094|NCT01746901|9987317|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900095|NCT01746901|9987318|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900096|NCT01746901|9987319|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900097|NCT01746901|9987320|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900098|NCT01746901|9987321|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900099|NCT01746901|9987322|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900100|NCT01746901|9987323|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900101|NCT01746901|9987324|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
2900102|NCT01746901|9987325|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
2900103|NCT01746901|9987317|P9|Naloxone Challenge Phase|Adverse Event|0
2900104|NCT01746901|9987318|P8|Naloxone Challenge Phase|Adverse Event|0
2900105|NCT01746901|9987319|P7|Naloxone Challenge Phase|Adverse Event|0
2900106|NCT01746901|9987320|P6|Naloxone Challenge Phase|Adverse Event|0
2900107|NCT01746901|9987321|P5|Naloxone Challenge Phase|Adverse Event|0
2900108|NCT01746901|9987322|P4|Naloxone Challenge Phase|Adverse Event|0
2900109|NCT01746901|9987323|P3|Naloxone Challenge Phase|Adverse Event|0
2900110|NCT01746901|9987324|P2|Naloxone Challenge Phase|Adverse Event|0
2900111|NCT01746901|9987325|P1|Naloxone Challenge Phase|Adverse Event|2
2900112|NCT01746862|9987648|P2|Overall Study|Entered puberty during the study|0
2900113|NCT01746862|9987649|P1|Overall Study|Entered puberty during the study|1
2900114|NCT01746862|9987648|P2|Overall Study|Consent withdrawal by parent’s guardian|2
2900115|NCT01746862|9987649|P1|Overall Study|Consent withdrawal by parent’s guardian|5
2900116|NCT01746862|9987648|P2|Overall Study|Protocol Violation|0
2900117|NCT01746862|9987649|P1|Overall Study|Protocol Violation|1
2900118|NCT01746862|9987648|P2|Overall Study|Withdrawal by Subject|1
2900119|NCT01746862|9987649|P1|Overall Study|Withdrawal by Subject|1
2900120|NCT01746732|9987713|P3|Period 2|Lost to Follow-up|1
2900121|NCT01746732|9987714|P2|Period 2|Lost to Follow-up|0
2900122|NCT01746732|9987715|P1|Period 2|Lost to Follow-up|0
2900123|NCT01746732|9987713|P3|Period 2|Adverse Event|1
2900124|NCT01746732|9987714|P2|Period 2|Adverse Event|0
2900125|NCT01746732|9987715|P1|Period 2|Adverse Event|0
2900126|NCT01746732|9987713|P3|Period 2|Withdrawal by Subject|2
2900127|NCT01746732|9987714|P2|Period 2|Withdrawal by Subject|0
2900128|NCT01746732|9987715|P1|Period 2|Withdrawal by Subject|0
2900129|NCT01746732|9987713|P3|Period 1|Physician Decision|0
2900130|NCT01746732|9987714|P2|Period 1|Physician Decision|1
2900131|NCT01746732|9987715|P1|Period 1|Physician Decision|0
2900132|NCT01746732|9987713|P3|Lead-In Period|Withdrawal by Subject|0
2900133|NCT01746732|9987714|P2|Lead-In Period|Withdrawal by Subject|0
2900134|NCT01746732|9987715|P1|Lead-In Period|Withdrawal by Subject|1
2900135|NCT01746368|9987796|P2|Overall Study|Withdrawal by Subject|1
2900136|NCT01746368|9987797|P1|Overall Study|Withdrawal by Subject|0
2900137|NCT01746368|9987796|P2|Overall Study|Lost to Follow-up|0
2900138|NCT01746368|9987797|P1|Overall Study|Lost to Follow-up|2
2900139|NCT01746225|9987827|P3|Overall Study|Continuing Treatment|3
2900140|NCT01746225|9987828|P2|Overall Study|Continuing Treatment|8
2900141|NCT01746225|9987829|P1|Overall Study|Continuing Treatment|5
2900142|NCT01746225|9987827|P3|Overall Study|Adverse Event|17
2900143|NCT01746225|9987828|P2|Overall Study|Adverse Event|12
2900144|NCT01746225|9987829|P1|Overall Study|Adverse Event|15
2900145|NCT01746225|9987827|P3|Overall Study|Physician Decision|3
2900146|NCT01746225|9987828|P2|Overall Study|Physician Decision|11
2900147|NCT01746225|9987829|P1|Overall Study|Physician Decision|14
2900148|NCT01746225|9987827|P3|Overall Study|Withdrawal by Subject|19
2900149|NCT01746225|9987828|P2|Overall Study|Withdrawal by Subject|15
2900150|NCT01746225|9987829|P1|Overall Study|Withdrawal by Subject|5
2900151|NCT01746225|9987827|P3|Overall Study|Death|1
2900152|NCT01746225|9987828|P2|Overall Study|Death|0
2900153|NCT01746225|9987829|P1|Overall Study|Death|1
2900154|NCT01746173|9987852|P1|Overall Study|Disease Progression|2
2900155|NCT01746108|9987860|P3|Overall Study|Lost to Follow-up|0
2900156|NCT01746108|9987861|P2|Overall Study|Lost to Follow-up|1
2900157|NCT01746108|9987862|P1|Overall Study|Lost to Follow-up|0
2900158|NCT01746108|9987860|P3|Overall Study|Withdrawal by Subject|0
2900159|NCT01746108|9987861|P2|Overall Study|Withdrawal by Subject|1
2900160|NCT01746108|9987862|P1|Overall Study|Withdrawal by Subject|0
2900161|NCT01746108|9987860|P3|Overall Study|Adverse event, non-fatal|0
2900162|NCT01746108|9987861|P2|Overall Study|Adverse event, non-fatal|1
2900163|NCT01746108|9987862|P1|Overall Study|Adverse event, non-fatal|0
2900164|NCT01746108|9987860|P3|Overall Study|Migrated /moved from study area|0
2900165|NCT01746108|9987861|P2|Overall Study|Migrated /moved from study area|1
2900166|NCT01746108|9987862|P1|Overall Study|Migrated /moved from study area|0
2900167|NCT01746017|9987979|P11|Period 3|Withdrawal by Subject|0
2900168|NCT01746017|9987980|P10|Period 3|Withdrawal by Subject|0
2900169|NCT01746017|9987981|P9|Period 3|Withdrawal by Subject|0
2900170|NCT01746017|9987982|P8|Period 3|Withdrawal by Subject|0
2900171|NCT01746017|9987983|P7|Period 3|Withdrawal by Subject|0
2900172|NCT01746017|9987984|P6|Period 3|Withdrawal by Subject|1
2900173|NCT01746017|9987985|P5|Period 3|Withdrawal by Subject|0
2900174|NCT01746017|9987986|P4|Period 3|Withdrawal by Subject|0
2900175|NCT01746017|9987987|P3|Period 3|Withdrawal by Subject|0
2900176|NCT01746017|9987988|P2|Period 3|Withdrawal by Subject|0
2900177|NCT01746017|9987989|P1|Period 3|Withdrawal by Subject|0
2900178|NCT01746017|9987979|P11|Period 1|Withdrawal by Subject|0
2900179|NCT01746017|9987980|P10|Period 1|Withdrawal by Subject|0
2900180|NCT01746017|9987981|P9|Period 1|Withdrawal by Subject|0
2900181|NCT01746017|9987982|P8|Period 1|Withdrawal by Subject|0
2900182|NCT01746017|9987983|P7|Period 1|Withdrawal by Subject|1
2900183|NCT01746017|9987984|P6|Period 1|Withdrawal by Subject|0
2900184|NCT01746017|9987985|P5|Period 1|Withdrawal by Subject|0
2900185|NCT01746017|9987986|P4|Period 1|Withdrawal by Subject|0
2900186|NCT01746017|9987987|P3|Period 1|Withdrawal by Subject|0
2900187|NCT01746017|9987988|P2|Period 1|Withdrawal by Subject|0
2900188|NCT01746017|9987989|P1|Period 1|Withdrawal by Subject|0
2900189|NCT01745848|9988110|P1|Overall Study|Adverse Event|6
2900190|NCT01745393|9988117|P2|12-month Follow-up|Lost to Follow-up|5
2900191|NCT01745393|9988118|P1|12-month Follow-up|Lost to Follow-up|6
2900192|NCT01745393|9988117|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
2900193|NCT01745393|9988118|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
2900194|NCT01745393|9988117|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
2900195|NCT01745393|9988118|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
2900196|NCT01745380|9988130|P2|Overall Study|Lack of Efficacy|1
2900197|NCT01745380|9988131|P1|Overall Study|Lack of Efficacy|0
2900198|NCT01745380|9988130|P2|Overall Study|Lost to Follow-up|0
2900199|NCT01745380|9988131|P1|Overall Study|Lost to Follow-up|1
2900200|NCT01745146|9988169|P2|Overall Study|Lost to Follow-up|0
2900201|NCT01745146|9988170|P1|Overall Study|Lost to Follow-up|2
2900202|NCT01745146|9988169|P2|Overall Study|Withdrawal by Subject|3
2900203|NCT01745146|9988170|P1|Overall Study|Withdrawal by Subject|1
2900204|NCT01745120|9988192|P2|Overall Study|Investigator decision|0
2900205|NCT01745120|9988193|P1|Overall Study|Investigator decision|1
2900206|NCT01745094|9988251|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
2900207|NCT01745094|9988252|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
2900208|NCT01745094|9988253|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
2900209|NCT01745094|9988254|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
2900210|NCT01745094|9988251|P4|Overall Study|Show no Stable Solifenacin Intake|0
2900211|NCT01745094|9988252|P3|Overall Study|Show no Stable Solifenacin Intake|1
2900212|NCT01745094|9988253|P2|Overall Study|Show no Stable Solifenacin Intake|0
2900213|NCT01745094|9988254|P1|Overall Study|Show no Stable Solifenacin Intake|0
2900214|NCT01745094|9988251|P4|Overall Study|Need Further Examinations Due to Biopsy|0
2900215|NCT01745094|9988252|P3|Overall Study|Need Further Examinations Due to Biopsy|1
2900216|NCT01745094|9988253|P2|Overall Study|Need Further Examinations Due to Biopsy|0
2900217|NCT01745094|9988254|P1|Overall Study|Need Further Examinations Due to Biopsy|0
2900218|NCT01745094|9988251|P4|Overall Study|Protocol Violation|1
2900219|NCT01745094|9988252|P3|Overall Study|Protocol Violation|3
2900220|NCT01745094|9988253|P2|Overall Study|Protocol Violation|0
2900221|NCT01745094|9988254|P1|Overall Study|Protocol Violation|1
2900222|NCT01745094|9988251|P4|Overall Study|Withdrawal by Subject|2
2900223|NCT01745094|9988252|P3|Overall Study|Withdrawal by Subject|1
2900224|NCT01745094|9988253|P2|Overall Study|Withdrawal by Subject|0
2900225|NCT01745094|9988254|P1|Overall Study|Withdrawal by Subject|2
2900226|NCT01745094|9988251|P4|Overall Study|Adverse Event|0
2900227|NCT01745094|9988252|P3|Overall Study|Adverse Event|3
2900228|NCT01745094|9988253|P2|Overall Study|Adverse Event|0
2900229|NCT01745094|9988254|P1|Overall Study|Adverse Event|0
2900230|NCT01745094|9988251|P4|Overall Study|Not Meeting the Eligibility Criteria|0
2900231|NCT01745094|9988252|P3|Overall Study|Not Meeting the Eligibility Criteria|3
2900232|NCT01745094|9988253|P2|Overall Study|Not Meeting the Eligibility Criteria|0
2900233|NCT01745094|9988254|P1|Overall Study|Not Meeting the Eligibility Criteria|1
2900234|NCT01744977|9988355|P2|Overall Study|No longer meets inclusion|0
2900235|NCT01744977|9988356|P1|Overall Study|No longer meets inclusion|6
2900236|NCT01744977|9988355|P2|Overall Study|Lost to Follow-up|0
2900237|NCT01744977|9988356|P1|Overall Study|Lost to Follow-up|2
2900238|NCT01744977|9988355|P2|Overall Study|Death|3
2900239|NCT01744977|9988356|P1|Overall Study|Death|2
2900240|NCT01744977|9988355|P2|Overall Study|Withdrawal by Subject|2
2900241|NCT01744977|9988356|P1|Overall Study|Withdrawal by Subject|1
2900242|NCT01744782|9988427|P1|Overall Study|Death|1
2900243|NCT01744691|9988588|P1|Overall Study|Physician Decision|4
2900244|NCT01744691|9988588|P1|Overall Study|Withdrawal of consent for treatment|3
2900245|NCT01744691|9988588|P1|Overall Study|Unacceptable toxicity, AE or death|18
2900246|NCT01744691|9988588|P1|Overall Study|Progressive Disease|18
2900247|NCT01744665|9988593|P1|Re-initiation Phase|Withdrawal by Subject|1
2900248|NCT01744665|9988593|P1|Re-initiation Phase|No longer required treatment|1
2900249|NCT01744665|9988593|P1|Re-initiation Phase|Adverse Event|1
2900250|NCT01744665|9988593|P1|Re-initiation Phase|Administrative problems|10
2900251|NCT01744665|9988593|P1|Consolidation Phase|Administrative problems|9
2900252|NCT01744665|9988593|P1|Consolidation Phase|Withdrawal by Subject|4
2900253|NCT01744665|9988593|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
2900254|NCT01744665|9988593|P1|Consolidation Phase|Adverse Event|2
2900255|NCT01744665|9988593|P1|Monitoring Phase|Did not achieve MR4.5|1
2900256|NCT01744665|9988593|P1|Monitoring Phase|Withdrawal by Subject|5
2900257|NCT01744665|9988593|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
2900258|NCT01744665|9988593|P1|Monitoring Phase|Abnormal laboratory value(s)|1
2900259|NCT01744665|9988593|P1|Monitoring Phase|Adverse Event|4
2900260|NCT01744496|9988663|P2|Maintenance Period|Subject left town|0
2900261|NCT01744496|9988664|P1|Maintenance Period|Subject left town|1
2900262|NCT01744496|9988663|P2|Maintenance Period|Withdrawal by Subject|1
2900263|NCT01744496|9988664|P1|Maintenance Period|Withdrawal by Subject|1
2900264|NCT01744496|9988663|P2|Maintenance Period|Protocol Violation|0
2900265|NCT01744496|9988664|P1|Maintenance Period|Protocol Violation|1
2900266|NCT01744496|9988663|P2|Maintenance Period|Adverse Event|3
2900267|NCT01744496|9988664|P1|Maintenance Period|Adverse Event|1
2900268|NCT01744496|9988663|P2|Titration Period|Personal reasons|1
2900269|NCT01744496|9988664|P1|Titration Period|Personal reasons|0
2900270|NCT01744496|9988663|P2|Titration Period|Adverse Event|1
2900271|NCT01744496|9988664|P1|Titration Period|Adverse Event|2
2900272|NCT01744483|9988685|P3|Overall Study|Routed to OSH|1
2900273|NCT01744483|9988686|P2|Overall Study|Routed to OSH|0
2900274|NCT01744483|9988687|P1|Overall Study|Routed to OSH|2
2900275|NCT01744483|9988685|P3|Overall Study|No ICU Admit|2
2900276|NCT01744483|9988686|P2|Overall Study|No ICU Admit|1
2900277|NCT01744483|9988687|P1|Overall Study|No ICU Admit|5
2900278|NCT01744483|9988685|P3|Overall Study|Withdrawal by Subject|2
2900279|NCT01744483|9988686|P2|Overall Study|Withdrawal by Subject|6
2900280|NCT01744483|9988687|P1|Overall Study|Withdrawal by Subject|4
2900281|NCT01744483|9988685|P3|Overall Study|Protocol Violation|1
2900282|NCT01744483|9988686|P2|Overall Study|Protocol Violation|2
2900283|NCT01744483|9988687|P1|Overall Study|Protocol Violation|1
2900284|NCT01744483|9988685|P3|Overall Study|Lost to Follow-up|11
2900285|NCT01744483|9988686|P2|Overall Study|Lost to Follow-up|9
2900286|NCT01744483|9988687|P1|Overall Study|Lost to Follow-up|8
2900287|NCT01744483|9988685|P3|Overall Study|Death|11
2900288|NCT01744483|9988686|P2|Overall Study|Death|4
2900289|NCT01744483|9988687|P1|Overall Study|Death|9
2900290|NCT01744392|9988695|P1|Overall Study|Physician Decision|1
2900291|NCT01744197|9988735|P2|Overall Study|No patch received|2
2900292|NCT01744197|9988736|P1|Overall Study|No patch received|2
2900293|NCT01744197|9988735|P2|Overall Study|Received 1 patch|1
2900294|NCT01744197|9988736|P1|Overall Study|Received 1 patch|2
2900295|NCT01743560|9988787|P1|Overall Study|>1 dose of study drug|3
2900296|NCT01743560|9988787|P1|Overall Study|Protocol Violation|1
2900297|NCT01743560|9988787|P1|Overall Study|Withdrawal by Subject|2
2900298|NCT01743560|9988787|P1|Overall Study|Death|3
2900299|NCT01743560|9988787|P1|Overall Study|Adverse Event|8
2900300|NCT01743560|9988787|P1|Overall Study|Disease progression|26
2900301|NCT01743469|9988871|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2900302|NCT01743469|9988872|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2900303|NCT01743469|9988873|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2900304|NCT01743469|9988874|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2900305|NCT01743469|9988871|P4|Follow-up Period - Post-Treatment|Death|16
2900306|NCT01743469|9988872|P3|Follow-up Period - Post-Treatment|Death|22
2900307|NCT01743469|9988873|P2|Follow-up Period - Post-Treatment|Death|47
2900308|NCT01743469|9988874|P1|Follow-up Period - Post-Treatment|Death|43
2900309|NCT01743469|9988871|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2900310|NCT01743469|9988872|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2900311|NCT01743469|9988873|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2900312|NCT01743469|9988874|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2900313|NCT01743469|9988871|P4|Active Treatment Phase|Missing|0
2900314|NCT01743469|9988872|P3|Active Treatment Phase|Missing|0
2900315|NCT01743469|9988873|P2|Active Treatment Phase|Missing|0
2900316|NCT01743469|9988874|P1|Active Treatment Phase|Missing|1
2900317|NCT01743469|9988871|P4|Active Treatment Phase|Withdrawal by Subject|0
2900318|NCT01743469|9988872|P3|Active Treatment Phase|Withdrawal by Subject|0
2900319|NCT01743469|9988873|P2|Active Treatment Phase|Withdrawal by Subject|3
2900320|NCT01743469|9988874|P1|Active Treatment Phase|Withdrawal by Subject|2
2900321|NCT01743469|9988871|P4|Active Treatment Phase|Disease Progression|20
2900322|NCT01743469|9988872|P3|Active Treatment Phase|Disease Progression|30
2900323|NCT01743469|9988873|P2|Active Treatment Phase|Disease Progression|47
2900324|NCT01743469|9988874|P1|Active Treatment Phase|Disease Progression|40
2900325|NCT01743469|9988871|P4|Active Treatment Phase|Adverse Event|1
2900326|NCT01743469|9988872|P3|Active Treatment Phase|Adverse Event|8
2900327|NCT01743469|9988873|P2|Active Treatment Phase|Adverse Event|5
2900328|NCT01743469|9988874|P1|Active Treatment Phase|Adverse Event|10
2900329|NCT01743092|9988914|P2|Overall Study|Lost to Follow-up|15
2900330|NCT01743092|9988915|P1|Overall Study|Lost to Follow-up|14
2900331|NCT01743027|9988927|P4|Overall Study|Withdrawal by Subject|1
2900332|NCT01743027|9988928|P3|Overall Study|Withdrawal by Subject|3
2900333|NCT01743027|9988929|P2|Overall Study|Withdrawal by Subject|0
2900334|NCT01743027|9988930|P1|Overall Study|Withdrawal by Subject|1
2900335|NCT01743027|9988927|P4|Overall Study|Protocol Violation|0
2900336|NCT01743027|9988928|P3|Overall Study|Protocol Violation|1
2900337|NCT01743027|9988929|P2|Overall Study|Protocol Violation|1
2900338|NCT01743027|9988930|P1|Overall Study|Protocol Violation|1
2900339|NCT01743027|9988927|P4|Overall Study|Progressive Disease|0
2900340|NCT01743027|9988928|P3|Overall Study|Progressive Disease|3
2900341|NCT01743027|9988929|P2|Overall Study|Progressive Disease|4
2900342|NCT01743027|9988930|P1|Overall Study|Progressive Disease|1
2900343|NCT01743027|9988927|P4|Overall Study|Lost to Follow-up|0
2900344|NCT01743027|9988928|P3|Overall Study|Lost to Follow-up|2
2900345|NCT01743027|9988929|P2|Overall Study|Lost to Follow-up|0
2900346|NCT01743027|9988930|P1|Overall Study|Lost to Follow-up|0
2900347|NCT01743027|9988927|P4|Overall Study|Adverse Event|0
2900348|NCT01743027|9988928|P3|Overall Study|Adverse Event|0
2900349|NCT01743027|9988929|P2|Overall Study|Adverse Event|0
2900350|NCT01743027|9988930|P1|Overall Study|Adverse Event|2
2900351|NCT01743001|9988970|P2|Overall Study|Death|0
2900352|NCT01743001|9988971|P1|Overall Study|Death|1
2900353|NCT01743001|9988970|P2|Overall Study|Pregnancy|0
2900354|NCT01743001|9988971|P1|Overall Study|Pregnancy|1
2900355|NCT01743001|9988970|P2|Overall Study|Physician Decision|0
2900356|NCT01743001|9988971|P1|Overall Study|Physician Decision|1
2900357|NCT01742897|9989014|P1|Overall Study|Other|1
2900358|NCT01742897|9989014|P1|Overall Study|Withdrawal by Subject|1
2900359|NCT01742897|9989014|P1|Overall Study|Adverse Event|3
2900360|NCT01742091|9989095|P6|Overall Study|Lost to Follow-up|1
2900361|NCT01742091|9989096|P5|Overall Study|Lost to Follow-up|0
2900362|NCT01742091|9989097|P4|Overall Study|Lost to Follow-up|0
2900363|NCT01742091|9989098|P3|Overall Study|Lost to Follow-up|0
2900364|NCT01742091|9989099|P2|Overall Study|Lost to Follow-up|0
2900365|NCT01742091|9989100|P1|Overall Study|Lost to Follow-up|0
2900366|NCT01742091|9989095|P6|Overall Study|Withdrawal by Subject|0
2900367|NCT01742091|9989096|P5|Overall Study|Withdrawal by Subject|0
2900368|NCT01742091|9989097|P4|Overall Study|Withdrawal by Subject|1
2900369|NCT01742091|9989098|P3|Overall Study|Withdrawal by Subject|0
2900370|NCT01742091|9989099|P2|Overall Study|Withdrawal by Subject|0
2900371|NCT01742091|9989100|P1|Overall Study|Withdrawal by Subject|0
2900372|NCT01742091|9989095|P6|Overall Study|Physician Decision|1
2900373|NCT01742091|9989096|P5|Overall Study|Physician Decision|0
2900374|NCT01742091|9989097|P4|Overall Study|Physician Decision|0
2900375|NCT01742091|9989098|P3|Overall Study|Physician Decision|0
2900376|NCT01742091|9989099|P2|Overall Study|Physician Decision|0
2900377|NCT01742091|9989100|P1|Overall Study|Physician Decision|0
2900378|NCT01742091|9989095|P6|Overall Study|Adverse Event|0
2900379|NCT01742091|9989096|P5|Overall Study|Adverse Event|1
2900380|NCT01742091|9989097|P4|Overall Study|Adverse Event|0
2900381|NCT01742091|9989098|P3|Overall Study|Adverse Event|0
2900382|NCT01742091|9989099|P2|Overall Study|Adverse Event|0
2900383|NCT01742091|9989100|P1|Overall Study|Adverse Event|0
2900384|NCT01742078|9989146|P9|Overall Study|Withdrawal by Subject|0
2900385|NCT01742078|9989147|P8|Overall Study|Withdrawal by Subject|0
2900386|NCT01742078|9989148|P7|Overall Study|Withdrawal by Subject|0
2900387|NCT01742078|9989149|P6|Overall Study|Withdrawal by Subject|0
2900388|NCT01742078|9989150|P5|Overall Study|Withdrawal by Subject|0
2900389|NCT01742078|9989151|P4|Overall Study|Withdrawal by Subject|1
2900390|NCT01742078|9989152|P3|Overall Study|Withdrawal by Subject|0
2900391|NCT01742078|9989153|P2|Overall Study|Withdrawal by Subject|0
2900392|NCT01742078|9989154|P1|Overall Study|Withdrawal by Subject|0
2900393|NCT01741792|9989223|P3|Overall Study|Death|12
2900394|NCT01741792|9989224|P2|Overall Study|Death|1
2900395|NCT01741792|9989225|P1|Overall Study|Death|6
2900396|NCT01741701|9989292|P2|Overall Study|Withdrawal by Subject|1
2900397|NCT01741701|9989293|P1|Overall Study|Withdrawal by Subject|0
2900398|NCT01741701|9989292|P2|Overall Study|Adverse Event|1
2900399|NCT01741701|9989293|P1|Overall Study|Adverse Event|5
2900400|NCT01741688|9989309|P1|Overall Study|Withdrawal by Subject|1
2900401|NCT01741688|9989309|P1|Overall Study|Lack of insurance coverage|2
2900402|NCT01741545|9989328|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2900403|NCT01741545|9989329|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2900404|NCT01741545|9989328|P2|Follow-up Period (24 Weeks)|Other than specified|1
2900405|NCT01741545|9989329|P1|Follow-up Period (24 Weeks)|Other than specified|0
2900406|NCT01741545|9989328|P2|Treatment Period|Adverse event, non-fatal|3
2900407|NCT01741545|9989329|P1|Treatment Period|Adverse event, non-fatal|1
2900408|NCT01741545|9989328|P2|Treatment Period|Lack of Efficacy|1
2900409|NCT01741545|9989329|P1|Treatment Period|Lack of Efficacy|0
2900410|NCT01741532|9989353|P2|Overall Study|Medical event|0
2900411|NCT01741532|9989354|P1|Overall Study|Medical event|1
2900412|NCT01741532|9989353|P2|Overall Study|Sponsor decision|0
2900413|NCT01741532|9989354|P1|Overall Study|Sponsor decision|1
2900414|NCT01741532|9989353|P2|Overall Study|Worsening of the disease|1
2900415|NCT01741532|9989354|P1|Overall Study|Worsening of the disease|3
2900416|NCT01741532|9989353|P2|Overall Study|Protocol Violation|1
2900417|NCT01741532|9989354|P1|Overall Study|Protocol Violation|0
2900418|NCT01741532|9989353|P2|Overall Study|Withdrawal by Subject|1
2900419|NCT01741532|9989354|P1|Overall Study|Withdrawal by Subject|1
2900420|NCT01741532|9989353|P2|Overall Study|Adverse Event|0
2900421|NCT01741532|9989354|P1|Overall Study|Adverse Event|4
2900422|NCT01741259|9989568|P2|Overall Study|Withdrawal by Subject|2
2900423|NCT01741259|9989569|P1|Overall Study|Withdrawal by Subject|0
2900424|NCT01741259|9989568|P2|Overall Study|Protocol Violation|4
2900425|NCT01741259|9989569|P1|Overall Study|Protocol Violation|6
2900426|NCT01741012|9989623|P1|Overall Study|Withdrawal by Subject|2
2900427|NCT01741012|9989623|P1|Overall Study|Lost to Follow-up|1
2900428|NCT01740440|9989695|P1|Overall Study|Lost to Follow-up|3
2900429|NCT01740427|9989703|P2|Overall Study|Study terminated by Sponsor|0
2900430|NCT01740427|9989704|P1|Overall Study|Study terminated by Sponsor|1
2900431|NCT01740427|9989703|P2|Overall Study|Lost to Follow-up|0
2900432|NCT01740427|9989704|P1|Overall Study|Lost to Follow-up|1
2900433|NCT01740427|9989703|P2|Overall Study|Protocol Violation|3
2900434|NCT01740427|9989704|P1|Overall Study|Protocol Violation|5
2900435|NCT01740427|9989703|P2|Overall Study|Death|2
2900436|NCT01740427|9989704|P1|Overall Study|Death|6
2900437|NCT01740427|9989703|P2|Overall Study|Unspecified reasons|4
2900438|NCT01740427|9989704|P1|Overall Study|Unspecified reasons|6
2900439|NCT01740427|9989703|P2|Overall Study|Subject refused continued treatment|9
2900440|NCT01740427|9989704|P1|Overall Study|Subject refused continued treatment|12
2900441|NCT01740427|9989703|P2|Overall Study|Global deterioration of health status|9
2900442|NCT01740427|9989704|P1|Overall Study|Global deterioration of health status|16
2900443|NCT01740427|9989703|P2|Overall Study|Adverse Event|9
2900444|NCT01740427|9989704|P1|Overall Study|Adverse Event|20
2900445|NCT01740427|9989703|P2|Overall Study|Objective progression or relapse|125
2900446|NCT01740427|9989704|P1|Overall Study|Objective progression or relapse|172
2900447|NCT01740427|9989703|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
2900448|NCT01740427|9989704|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
2900449|NCT01740401|9989756|P1|Overall Study|Did not reach primary endpoint|2
2900450|NCT01740401|9989756|P1|Overall Study|Adverse Event|2
2900451|NCT01740401|9989756|P1|Overall Study|Progression of disease|6
2900452|NCT01740388|9989765|P2|Overall Study|Subjects missing data, completed|36
2900453|NCT01740388|9989766|P1|Overall Study|Subjects missing data, completed|41
2900454|NCT01740388|9989765|P2|Overall Study|Physician Decision|6
2900455|NCT01740388|9989766|P1|Overall Study|Physician Decision|2
2900456|NCT01740388|9989765|P2|Overall Study|Lost to Follow-up|0
2900457|NCT01740388|9989766|P1|Overall Study|Lost to Follow-up|2
2900458|NCT01740388|9989765|P2|Overall Study|Withdrawal by Subject|2
2900459|NCT01740388|9989766|P1|Overall Study|Withdrawal by Subject|1
2900460|NCT01740323|9989817|P2|Overall Study|Randomized but did not take study drug|0
2900461|NCT01740323|9989818|P1|Overall Study|Randomized but did not take study drug|1
2900462|NCT01740323|9989817|P2|Overall Study|Adverse Event|0
2900463|NCT01740323|9989818|P1|Overall Study|Adverse Event|1
2900464|NCT01740297|9989839|P3|Overall Study|Sponsor Decision|0
2900465|NCT01740297|9989840|P2|Overall Study|Sponsor Decision|1
2900466|NCT01740297|9989841|P1|Overall Study|Sponsor Decision|0
2900467|NCT01740297|9989839|P3|Overall Study|Death|19
2900468|NCT01740297|9989840|P2|Overall Study|Death|23
2900469|NCT01740297|9989841|P1|Overall Study|Death|8
2900470|NCT01740297|9989839|P3|Overall Study|Withdrawal by Subject|11
2900471|NCT01740297|9989840|P2|Overall Study|Withdrawal by Subject|9
2900472|NCT01740297|9989841|P1|Overall Study|Withdrawal by Subject|1
2900473|NCT01740297|9989839|P3|Overall Study|Continuing Study|68
2900474|NCT01740297|9989840|P2|Overall Study|Continuing Study|67
2900475|NCT01740297|9989841|P1|Overall Study|Continuing Study|10
2900476|NCT01740154|9989890|P1|Overall Study|Adverse Event|1
2900477|NCT01740128|9989898|P2|Overall Study|Insufficient protocol compliance|2
2900478|NCT01740128|9989899|P1|Overall Study|Insufficient protocol compliance|2
2900479|NCT01740128|9989898|P2|Overall Study|Withdrawal by Subject|0
2900480|NCT01740128|9989899|P1|Overall Study|Withdrawal by Subject|1
2900481|NCT01740128|9989898|P2|Overall Study|Lost to Follow-up|2
2900482|NCT01740128|9989899|P1|Overall Study|Lost to Follow-up|2
2900483|NCT01740128|9989898|P2|Overall Study|Protocol Violation|2
2900484|NCT01740128|9989899|P1|Overall Study|Protocol Violation|1
2900485|NCT01740128|9989898|P2|Overall Study|Pregnancy|1
2900486|NCT01740128|9989899|P1|Overall Study|Pregnancy|0
2900487|NCT01740089|9989928|P3|After 12 Weeks|Withdrawal by Subject|1
2900488|NCT01740089|9989929|P2|After 12 Weeks|Withdrawal by Subject|1
2900489|NCT01740089|9989930|P1|After 12 Weeks|Withdrawal by Subject|1
2900490|NCT01740089|9989928|P3|After 12 Weeks|Protocol Violation|1
2900491|NCT01740089|9989929|P2|After 12 Weeks|Protocol Violation|1
2900492|NCT01740089|9989930|P1|After 12 Weeks|Protocol Violation|1
2900493|NCT01740089|9989928|P3|After 12 Weeks|Adverse Event|5
2900494|NCT01740089|9989929|P2|After 12 Weeks|Adverse Event|0
2900495|NCT01740089|9989930|P1|After 12 Weeks|Adverse Event|2
2900496|NCT01740089|9989928|P3|After 12 Weeks|Lack of Efficacy|4
2900497|NCT01740089|9989929|P2|After 12 Weeks|Lack of Efficacy|1
2900498|NCT01740089|9989930|P1|After 12 Weeks|Lack of Efficacy|3
2900499|NCT01740089|9989928|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
2900500|NCT01740089|9989929|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
2900501|NCT01740089|9989930|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
2900502|NCT01740089|9989928|P3|First 12 Weeks of Treatment|Adverse Event|2
2900503|NCT01740089|9989929|P2|First 12 Weeks of Treatment|Adverse Event|1
2900504|NCT01740089|9989930|P1|First 12 Weeks of Treatment|Adverse Event|0
2900505|NCT01739803|9989948|P2|Overall Study|Lost to Follow-up|6
2900506|NCT01739803|9989949|P1|Overall Study|Lost to Follow-up|9
2900507|NCT01739790|9989961|P2|Overall Study|Early Trial Termination|4
2900508|NCT01739790|9989962|P1|Overall Study|Early Trial Termination|2
2900509|NCT01739595|9989971|P3|Overall Study|Drug discrepancy|0
2900510|NCT01739595|9989972|P2|Overall Study|Drug discrepancy|0
2900511|NCT01739595|9989973|P1|Overall Study|Drug discrepancy|1
2900512|NCT01739595|9989971|P3|Overall Study|Lab assessment|0
2900513|NCT01739595|9989972|P2|Overall Study|Lab assessment|0
2900514|NCT01739595|9989973|P1|Overall Study|Lab assessment|1
2900515|NCT01739595|9989971|P3|Overall Study|Protocol Violation|0
2900516|NCT01739595|9989972|P2|Overall Study|Protocol Violation|0
2900517|NCT01739595|9989973|P1|Overall Study|Protocol Violation|1
2900518|NCT01739595|9989971|P3|Overall Study|Eligibility issue|0
2900519|NCT01739595|9989972|P2|Overall Study|Eligibility issue|0
2900520|NCT01739595|9989973|P1|Overall Study|Eligibility issue|3
2900521|NCT01739595|9989971|P3|Overall Study|Withdrawal by Subject|2
2900522|NCT01739595|9989972|P2|Overall Study|Withdrawal by Subject|1
2900523|NCT01739595|9989973|P1|Overall Study|Withdrawal by Subject|2
2900524|NCT01739595|9989971|P3|Overall Study|Lost to Follow-up|0
2900525|NCT01739595|9989972|P2|Overall Study|Lost to Follow-up|0
2900526|NCT01739595|9989973|P1|Overall Study|Lost to Follow-up|2
2900527|NCT01739595|9989971|P3|Overall Study|Adverse Event|0
2900528|NCT01739595|9989972|P2|Overall Study|Adverse Event|0
2900529|NCT01739595|9989973|P1|Overall Study|Adverse Event|3
2900530|NCT01739400|9989983|P2|Overall Study|Withdrawal by Subject|7
2900531|NCT01739400|9989984|P1|Overall Study|Withdrawal by Subject|7
2900532|NCT01739400|9989983|P2|Overall Study|Death|2
2900533|NCT01739400|9989984|P1|Overall Study|Death|5
2900534|NCT01739400|9989983|P2|Overall Study|Lost to Follow-up|0
2900535|NCT01739400|9989984|P1|Overall Study|Lost to Follow-up|2
2900536|NCT01739400|9989983|P2|Overall Study|Physician Decision|0
2900537|NCT01739400|9989984|P1|Overall Study|Physician Decision|3
2900538|NCT01739348|9990012|P4|Part II (Extension Study)|Withdrawal by Subject|7
2900539|NCT01739348|9990013|P3|Part II (Extension Study)|Withdrawal by Subject|4
2900540|NCT01739348|9990014|P2|Part II (Extension Study)|Withdrawal by Subject|2
2900541|NCT01739348|9990015|P1|Part II (Extension Study)|Withdrawal by Subject|5
2900542|NCT01739348|9990012|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
2900543|NCT01739348|9990013|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
2900544|NCT01739348|9990014|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
2900545|NCT01739348|9990015|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
2900546|NCT01739348|9990012|P4|Part II (Extension Study)|Participant Moved|3
2900547|NCT01739348|9990013|P3|Part II (Extension Study)|Participant Moved|0
2900548|NCT01739348|9990014|P2|Part II (Extension Study)|Participant Moved|3
2900549|NCT01739348|9990015|P1|Part II (Extension Study)|Participant Moved|3
2900550|NCT01739348|9990012|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
2900551|NCT01739348|9990013|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
2900552|NCT01739348|9990014|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
2900553|NCT01739348|9990015|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
2900554|NCT01739348|9990012|P4|Part II (Extension Study)|Physician Decision|12
2900555|NCT01739348|9990013|P3|Part II (Extension Study)|Physician Decision|6
2900556|NCT01739348|9990014|P2|Part II (Extension Study)|Physician Decision|11
2900557|NCT01739348|9990015|P1|Part II (Extension Study)|Physician Decision|7
2900558|NCT01739348|9990012|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
2900559|NCT01739348|9990013|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
2900560|NCT01739348|9990014|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
2900561|NCT01739348|9990015|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
2900562|NCT01739348|9990012|P4|Part II (Extension Study)|Lost to Follow-up|1
2900563|NCT01739348|9990013|P3|Part II (Extension Study)|Lost to Follow-up|0
2900564|NCT01739348|9990014|P2|Part II (Extension Study)|Lost to Follow-up|4
2900565|NCT01739348|9990015|P1|Part II (Extension Study)|Lost to Follow-up|3
2900566|NCT01739348|9990012|P4|Part II (Extension Study)|Lack of Efficacy|1
2900567|NCT01739348|9990013|P3|Part II (Extension Study)|Lack of Efficacy|0
2900568|NCT01739348|9990014|P2|Part II (Extension Study)|Lack of Efficacy|5
2900569|NCT01739348|9990015|P1|Part II (Extension Study)|Lack of Efficacy|1
2900570|NCT01739348|9990012|P4|Part II (Extension Study)|Death|6
2900571|NCT01739348|9990013|P3|Part II (Extension Study)|Death|2
2900572|NCT01739348|9990014|P2|Part II (Extension Study)|Death|3
2900573|NCT01739348|9990015|P1|Part II (Extension Study)|Death|3
2900574|NCT01739348|9990012|P4|Part II (Extension Study)|Adverse Event|26
2900575|NCT01739348|9990013|P3|Part II (Extension Study)|Adverse Event|7
2900576|NCT01739348|9990014|P2|Part II (Extension Study)|Adverse Event|11
2900577|NCT01739348|9990015|P1|Part II (Extension Study)|Adverse Event|10
2900578|NCT01739348|9990012|P4|Part I (Base Study)|Withdrawal by Subject|20
2900579|NCT01739348|9990013|P3|Part I (Base Study)|Withdrawal by Subject|7
2900580|NCT01739348|9990014|P2|Part I (Base Study)|Withdrawal by Subject|21
2900581|NCT01739348|9990015|P1|Part I (Base Study)|Withdrawal by Subject|23
2900582|NCT01739348|9990012|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
2900583|NCT01739348|9990013|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
2900584|NCT01739348|9990014|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
2900585|NCT01739348|9990015|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
2900586|NCT01739348|9990012|P4|Part I (Base Study)|Participant Moved|7
2900587|NCT01739348|9990013|P3|Part I (Base Study)|Participant Moved|1
2900588|NCT01739348|9990014|P2|Part I (Base Study)|Participant Moved|3
2900589|NCT01739348|9990015|P1|Part I (Base Study)|Participant Moved|4
2900590|NCT01739348|9990012|P4|Part I (Base Study)|Study Terminated by Sponsor|86
2900591|NCT01739348|9990013|P3|Part I (Base Study)|Study Terminated by Sponsor|0
2900592|NCT01739348|9990014|P2|Part I (Base Study)|Study Terminated by Sponsor|73
2900593|NCT01739348|9990015|P1|Part I (Base Study)|Study Terminated by Sponsor|72
2900594|NCT01739348|9990012|P4|Part I (Base Study)|Site Discontinued Study Participation|0
2900595|NCT01739348|9990013|P3|Part I (Base Study)|Site Discontinued Study Participation|0
2900596|NCT01739348|9990014|P2|Part I (Base Study)|Site Discontinued Study Participation|3
2900597|NCT01739348|9990015|P1|Part I (Base Study)|Site Discontinued Study Participation|1
2900598|NCT01739348|9990012|P4|Part I (Base Study)|Screen Failure|0
2900599|NCT01739348|9990013|P3|Part I (Base Study)|Screen Failure|0
2900600|NCT01739348|9990014|P2|Part I (Base Study)|Screen Failure|0
2900601|NCT01739348|9990015|P1|Part I (Base Study)|Screen Failure|2
2900602|NCT01739348|9990012|P4|Part I (Base Study)|Protocol Violation|2
2900603|NCT01739348|9990013|P3|Part I (Base Study)|Protocol Violation|1
2900604|NCT01739348|9990014|P2|Part I (Base Study)|Protocol Violation|0
2900605|NCT01739348|9990015|P1|Part I (Base Study)|Protocol Violation|2
2900606|NCT01739348|9990012|P4|Part I (Base Study)|Physician Decision|4
2900607|NCT01739348|9990013|P3|Part I (Base Study)|Physician Decision|1
2900608|NCT01739348|9990014|P2|Part I (Base Study)|Physician Decision|7
2900609|NCT01739348|9990015|P1|Part I (Base Study)|Physician Decision|10
2900610|NCT01739348|9990012|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
2900611|NCT01739348|9990013|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
2900612|NCT01739348|9990014|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
2900613|NCT01739348|9990015|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
2900614|NCT01739348|9990012|P4|Part I (Base Study)|Lost to Follow-up|4
2900615|NCT01739348|9990013|P3|Part I (Base Study)|Lost to Follow-up|4
2900616|NCT01739348|9990014|P2|Part I (Base Study)|Lost to Follow-up|2
2900617|NCT01739348|9990015|P1|Part I (Base Study)|Lost to Follow-up|4
2900618|NCT01739348|9990012|P4|Part I (Base Study)|Lack of Efficacy|7
2900619|NCT01739348|9990013|P3|Part I (Base Study)|Lack of Efficacy|0
2900620|NCT01739348|9990014|P2|Part I (Base Study)|Lack of Efficacy|8
2900621|NCT01739348|9990015|P1|Part I (Base Study)|Lack of Efficacy|3
2900622|NCT01739348|9990012|P4|Part I (Base Study)|Death|8
2900623|NCT01739348|9990013|P3|Part I (Base Study)|Death|2
2900624|NCT01739348|9990014|P2|Part I (Base Study)|Death|7
2900625|NCT01739348|9990015|P1|Part I (Base Study)|Death|10
2900626|NCT01739348|9990012|P4|Part I (Base Study)|Adverse Event|33
2900627|NCT01739348|9990013|P3|Part I (Base Study)|Adverse Event|8
2900628|NCT01739348|9990014|P2|Part I (Base Study)|Adverse Event|52
2900629|NCT01739348|9990015|P1|Part I (Base Study)|Adverse Event|41
2900630|NCT01739335|9990087|P2|Overall Study|Ineligible patient randomized|1
2900631|NCT01739335|9990088|P1|Overall Study|Ineligible patient randomized|0
2900632|NCT01739335|9990087|P2|Overall Study|Lost to Follow-up|4
2900633|NCT01739335|9990088|P1|Overall Study|Lost to Follow-up|7
2900634|NCT01739309|9990120|P1|Overall Study|On study treatment|3
2900635|NCT01738984|9990315|P2|Overall Study|Lost to Follow-up|39
2900636|NCT01738984|9990316|P1|Overall Study|Lost to Follow-up|59
2900637|NCT01738984|9990315|P2|Overall Study|Withdrawal by Subject|0
2900638|NCT01738984|9990316|P1|Overall Study|Withdrawal by Subject|1
2900639|NCT01738984|9990315|P2|Overall Study|Pregnancy|0
2900640|NCT01738984|9990316|P1|Overall Study|Pregnancy|4
2900641|NCT01738971|9990329|P3|Overall Study|Lost to Follow-up|17
2900642|NCT01738971|9990330|P2|Overall Study|Lost to Follow-up|30
2900643|NCT01738971|9990331|P1|Overall Study|Lost to Follow-up|19
2900644|NCT01738919|9990347|P2|Overall Study|Not treated in accordance to guidelines|1
2900645|NCT01738919|9990348|P1|Overall Study|Not treated in accordance to guidelines|0
2900646|NCT01738919|9990347|P2|Overall Study|Withdrawal by Subject|1
2900647|NCT01738919|9990348|P1|Overall Study|Withdrawal by Subject|0
2900648|NCT01738919|9990347|P2|Overall Study|Immigrated|1
2900649|NCT01738919|9990348|P1|Overall Study|Immigrated|0
2900650|NCT01738919|9990347|P2|Overall Study|Lost to Follow-up|0
2900651|NCT01738919|9990348|P1|Overall Study|Lost to Follow-up|1
2900652|NCT01738646|9990498|P1|Overall Study|Still Receiving Treatment|2
2900653|NCT01738594|9990509|P8|Follow up for 1 Year|Other|0
2900654|NCT01738594|9990510|P7|Follow up for 1 Year|Other|0
2900655|NCT01738594|9990511|P6|Follow up for 1 Year|Other|2
2900656|NCT01738594|9990512|P5|Follow up for 1 Year|Other|0
2900657|NCT01738594|9990513|P4|Follow up for 1 Year|Other|0
2900658|NCT01738594|9990514|P3|Follow up for 1 Year|Other|0
2900659|NCT01738594|9990515|P2|Follow up for 1 Year|Other|0
2900660|NCT01738594|9990516|P1|Follow up for 1 Year|Other|0
2900661|NCT01738594|9990509|P8|Follow up for 1 Year|Death|0
2900662|NCT01738594|9990510|P7|Follow up for 1 Year|Death|0
2900663|NCT01738594|9990511|P6|Follow up for 1 Year|Death|1
2900664|NCT01738594|9990512|P5|Follow up for 1 Year|Death|0
2900665|NCT01738594|9990513|P4|Follow up for 1 Year|Death|0
2900666|NCT01738594|9990514|P3|Follow up for 1 Year|Death|0
2900667|NCT01738594|9990515|P2|Follow up for 1 Year|Death|0
2900668|NCT01738594|9990516|P1|Follow up for 1 Year|Death|0
2900669|NCT01738594|9990509|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900670|NCT01738594|9990510|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900671|NCT01738594|9990511|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900672|NCT01738594|9990512|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
2900673|NCT01738594|9990513|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900674|NCT01738594|9990514|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900675|NCT01738594|9990515|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900676|NCT01738594|9990516|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2900677|NCT01738594|9990509|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900678|NCT01738594|9990510|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900679|NCT01738594|9990511|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
2900680|NCT01738594|9990512|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900681|NCT01738594|9990513|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900682|NCT01738594|9990514|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900683|NCT01738594|9990515|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900684|NCT01738594|9990516|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2900685|NCT01738594|9990509|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900686|NCT01738594|9990510|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900687|NCT01738594|9990511|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
2900688|NCT01738594|9990512|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900689|NCT01738594|9990513|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900690|NCT01738594|9990514|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900691|NCT01738594|9990515|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900692|NCT01738594|9990516|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
2900693|NCT01738594|9990509|P8|Completed 4 Cycles of Treatment|Progressive disease|0
2900694|NCT01738594|9990510|P7|Completed 4 Cycles of Treatment|Progressive disease|0
2900695|NCT01738594|9990511|P6|Completed 4 Cycles of Treatment|Progressive disease|0
2900696|NCT01738594|9990512|P5|Completed 4 Cycles of Treatment|Progressive disease|0
2900697|NCT01738594|9990513|P4|Completed 4 Cycles of Treatment|Progressive disease|0
2900698|NCT01738594|9990514|P3|Completed 4 Cycles of Treatment|Progressive disease|0
2900699|NCT01738594|9990515|P2|Completed 4 Cycles of Treatment|Progressive disease|2
2900700|NCT01738594|9990516|P1|Completed 4 Cycles of Treatment|Progressive disease|0
2900701|NCT01738594|9990509|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900702|NCT01738594|9990510|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900703|NCT01738594|9990511|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
2900704|NCT01738594|9990512|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900705|NCT01738594|9990513|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900706|NCT01738594|9990514|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900707|NCT01738594|9990515|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900708|NCT01738594|9990516|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2900709|NCT01738594|9990509|P8|Registration and Treatment Start|Adverse Event|0
2900710|NCT01738594|9990510|P7|Registration and Treatment Start|Adverse Event|0
2900711|NCT01738594|9990511|P6|Registration and Treatment Start|Adverse Event|0
2900712|NCT01738594|9990512|P5|Registration and Treatment Start|Adverse Event|0
2900713|NCT01738594|9990513|P4|Registration and Treatment Start|Adverse Event|0
2900714|NCT01738594|9990514|P3|Registration and Treatment Start|Adverse Event|0
2900715|NCT01738594|9990515|P2|Registration and Treatment Start|Adverse Event|1
2900716|NCT01738594|9990516|P1|Registration and Treatment Start|Adverse Event|0
2900717|NCT01738581|9990534|P2|Overall Study|Lost to Follow-up|0
2900718|NCT01738581|9990535|P1|Overall Study|Lost to Follow-up|1
2900719|NCT01738503|9990559|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2900720|NCT01738503|9990560|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2900721|NCT01738503|9990561|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2900722|NCT01738503|9990562|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2900723|NCT01738503|9990563|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2900724|NCT01738503|9990564|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2900725|NCT01738503|9990565|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2900726|NCT01738503|9990559|P7|PET Imaging Sub-study|Adverse Event|0
2900727|NCT01738503|9990560|P6|PET Imaging Sub-study|Adverse Event|1
2900728|NCT01738503|9990561|P5|PET Imaging Sub-study|Adverse Event|0
2900729|NCT01738503|9990562|P4|PET Imaging Sub-study|Adverse Event|0
2900730|NCT01738503|9990563|P3|PET Imaging Sub-study|Adverse Event|0
2900731|NCT01738503|9990564|P2|PET Imaging Sub-study|Adverse Event|0
2900732|NCT01738503|9990565|P1|PET Imaging Sub-study|Adverse Event|0
2900733|NCT01738503|9990559|P7|Treatment Period|Other|0
2900734|NCT01738503|9990560|P6|Treatment Period|Other|0
2900735|NCT01738503|9990561|P5|Treatment Period|Other|0
2900736|NCT01738503|9990562|P4|Treatment Period|Other|0
2900737|NCT01738503|9990563|P3|Treatment Period|Other|1
2900738|NCT01738503|9990564|P2|Treatment Period|Other|0
2900739|NCT01738503|9990565|P1|Treatment Period|Other|0
2900740|NCT01738503|9990559|P7|Treatment Period|Protocol Violation|0
2900741|NCT01738503|9990560|P6|Treatment Period|Protocol Violation|2
2900742|NCT01738503|9990561|P5|Treatment Period|Protocol Violation|4
2900743|NCT01738503|9990562|P4|Treatment Period|Protocol Violation|0
2900744|NCT01738503|9990563|P3|Treatment Period|Protocol Violation|1
2900745|NCT01738503|9990564|P2|Treatment Period|Protocol Violation|3
2900746|NCT01738503|9990565|P1|Treatment Period|Protocol Violation|0
2900747|NCT01738503|9990559|P7|Treatment Period|Withdrawal by Subject|1
2900748|NCT01738503|9990560|P6|Treatment Period|Withdrawal by Subject|1
2900749|NCT01738503|9990561|P5|Treatment Period|Withdrawal by Subject|1
2900750|NCT01738503|9990562|P4|Treatment Period|Withdrawal by Subject|1
2900751|NCT01738503|9990563|P3|Treatment Period|Withdrawal by Subject|0
2900752|NCT01738503|9990564|P2|Treatment Period|Withdrawal by Subject|1
2900753|NCT01738503|9990565|P1|Treatment Period|Withdrawal by Subject|0
2900754|NCT01738503|9990559|P7|Treatment Period|Lost to Follow-up|5
2900755|NCT01738503|9990560|P6|Treatment Period|Lost to Follow-up|1
2900756|NCT01738503|9990561|P5|Treatment Period|Lost to Follow-up|1
2900757|NCT01738503|9990562|P4|Treatment Period|Lost to Follow-up|4
2900758|NCT01738503|9990563|P3|Treatment Period|Lost to Follow-up|3
2900759|NCT01738503|9990564|P2|Treatment Period|Lost to Follow-up|0
2900760|NCT01738503|9990565|P1|Treatment Period|Lost to Follow-up|0
2900761|NCT01738503|9990559|P7|Treatment Period|Adverse Event|2
2900762|NCT01738503|9990560|P6|Treatment Period|Adverse Event|2
2900763|NCT01738503|9990561|P5|Treatment Period|Adverse Event|2
2900764|NCT01738503|9990562|P4|Treatment Period|Adverse Event|1
2900765|NCT01738503|9990563|P3|Treatment Period|Adverse Event|0
2900766|NCT01738503|9990564|P2|Treatment Period|Adverse Event|1
2900767|NCT01738503|9990565|P1|Treatment Period|Adverse Event|0
2900768|NCT01738503|9990559|P7|Induction/Stabilization (Days -14 to -1)|Other|0
2900769|NCT01738503|9990560|P6|Induction/Stabilization (Days -14 to -1)|Other|0
2900770|NCT01738503|9990561|P5|Induction/Stabilization (Days -14 to -1)|Other|0
2900771|NCT01738503|9990562|P4|Induction/Stabilization (Days -14 to -1)|Other|0
2900772|NCT01738503|9990563|P3|Induction/Stabilization (Days -14 to -1)|Other|0
2900773|NCT01738503|9990564|P2|Induction/Stabilization (Days -14 to -1)|Other|0
2900774|NCT01738503|9990565|P1|Induction/Stabilization (Days -14 to -1)|Other|35
2900775|NCT01738477|9990763|P2|Overall Study|Lost to Follow-up|4
2900776|NCT01738477|9990764|P1|Overall Study|Lost to Follow-up|1
2900777|NCT01738438|9990792|P1|Overall Study|Adverse Event|3
2900778|NCT01738438|9990792|P1|Overall Study|Disease Progression|32
2900779|NCT01738191|9990809|P2|Overall Study|Withdrawal by Subject|1
2900780|NCT01738191|9990810|P1|Overall Study|Withdrawal by Subject|4
2900781|NCT01737996|9990833|P3|Overall Study|Withdrawal by Subject|1
2900782|NCT01737996|9990834|P2|Overall Study|Withdrawal by Subject|0
2900783|NCT01737996|9990835|P1|Overall Study|Withdrawal by Subject|0
2900784|NCT01737996|9990833|P3|Overall Study|Adverse Event|1
2900785|NCT01737996|9990834|P2|Overall Study|Adverse Event|1
2900786|NCT01737996|9990835|P1|Overall Study|Adverse Event|0
2900787|NCT01737931|9990897|P3|Overall Study|Physician Decision|0
2900788|NCT01737931|9990898|P2|Overall Study|Physician Decision|1
2900789|NCT01737931|9990899|P1|Overall Study|Physician Decision|0
2900790|NCT01737931|9990897|P3|Overall Study|Withdrawal by Subject|1
2900791|NCT01737931|9990898|P2|Overall Study|Withdrawal by Subject|1
2900792|NCT01737931|9990899|P1|Overall Study|Withdrawal by Subject|0
2900793|NCT01737879|9990914|P1|Overall Study|Sponsor decision|40
2900794|NCT01737879|9990914|P1|Overall Study|Death|1
2900795|NCT01737840|9990923|P2|Overall Study|Diagnosed with an other pathology|2
2900796|NCT01737840|9990924|P1|Overall Study|Diagnosed with an other pathology|2
2900797|NCT01737762|9990934|P2|Overall Study|Trial termination|9
2900798|NCT01737762|9990935|P1|Overall Study|Trial termination|11
2900799|NCT01737762|9990934|P2|Overall Study|Moved from area|1
2900800|NCT01737762|9990935|P1|Overall Study|Moved from area|2
2900801|NCT01737762|9990934|P2|Overall Study|Physician Decision|1
2900802|NCT01737762|9990935|P1|Overall Study|Physician Decision|1
2900803|NCT01737762|9990934|P2|Overall Study|Progressive disease|2
2900804|NCT01737762|9990935|P1|Overall Study|Progressive disease|1
2900805|NCT01737762|9990934|P2|Overall Study|Withdrawal by Subject|2
2900806|NCT01737762|9990935|P1|Overall Study|Withdrawal by Subject|2
2900807|NCT01737762|9990934|P2|Overall Study|Lost to Follow-up|0
2900808|NCT01737762|9990935|P1|Overall Study|Lost to Follow-up|1
2900809|NCT01737762|9990934|P2|Overall Study|Adverse Event|2
2900810|NCT01737762|9990935|P1|Overall Study|Adverse Event|2
2900811|NCT01737710|9990948|P5|Overall Study|Vaccinated in Error/Ineligible|0
2900812|NCT01737710|9990949|P4|Overall Study|Vaccinated in Error/Ineligible|0
2900813|NCT01737710|9990950|P3|Overall Study|Vaccinated in Error/Ineligible|0
2900814|NCT01737710|9990951|P2|Overall Study|Vaccinated in Error/Ineligible|1
2900815|NCT01737710|9990952|P1|Overall Study|Vaccinated in Error/Ineligible|1
2900816|NCT01737710|9990948|P5|Overall Study|Withdrawal by Subject|0
2900817|NCT01737710|9990949|P4|Overall Study|Withdrawal by Subject|0
2900818|NCT01737710|9990950|P3|Overall Study|Withdrawal by Subject|1
2900819|NCT01737710|9990951|P2|Overall Study|Withdrawal by Subject|1
2900820|NCT01737710|9990952|P1|Overall Study|Withdrawal by Subject|1
2900821|NCT01737710|9990948|P5|Overall Study|Lost to Follow-up|0
2900822|NCT01737710|9990949|P4|Overall Study|Lost to Follow-up|0
2900823|NCT01737710|9990950|P3|Overall Study|Lost to Follow-up|2
2900824|NCT01737710|9990951|P2|Overall Study|Lost to Follow-up|2
2900825|NCT01737710|9990952|P1|Overall Study|Lost to Follow-up|0
2900826|NCT01737697|9990994|P15|Subacute Phase|Death|0
2900827|NCT01737697|9990995|P14|Subacute Phase|Death|0
2900828|NCT01737697|9990996|P13|Subacute Phase|Death|0
2900829|NCT01737697|9990997|P12|Subacute Phase|Death|0
2900830|NCT01737697|9990998|P11|Subacute Phase|Death|1
2900831|NCT01737697|9990999|P10|Subacute Phase|Death|0
2900832|NCT01737697|9991000|P9|Subacute Phase|Death|0
2900833|NCT01737697|9991001|P8|Subacute Phase|Death|0
2900834|NCT01737697|9991002|P7|Subacute Phase|Death|0
2900835|NCT01737697|9991003|P6|Subacute Phase|Death|0
2900836|NCT01737697|9991004|P5|Subacute Phase|Death|0
2900837|NCT01737697|9991005|P4|Subacute Phase|Death|0
2900838|NCT01737697|9991006|P3|Subacute Phase|Death|0
2900839|NCT01737697|9991007|P2|Subacute Phase|Death|0
2900840|NCT01737697|9991008|P1|Subacute Phase|Death|0
2900841|NCT01737697|9990994|P15|Subacute Phase|Physician Decision|0
2900842|NCT01737697|9990995|P14|Subacute Phase|Physician Decision|0
2900843|NCT01737697|9990996|P13|Subacute Phase|Physician Decision|0
2900844|NCT01737697|9990997|P12|Subacute Phase|Physician Decision|0
2900845|NCT01737697|9990998|P11|Subacute Phase|Physician Decision|0
2900846|NCT01737697|9990999|P10|Subacute Phase|Physician Decision|0
2900847|NCT01737697|9991000|P9|Subacute Phase|Physician Decision|1
2900848|NCT01737697|9991001|P8|Subacute Phase|Physician Decision|0
2900849|NCT01737697|9991002|P7|Subacute Phase|Physician Decision|0
2900850|NCT01737697|9991003|P6|Subacute Phase|Physician Decision|0
2900851|NCT01737697|9991004|P5|Subacute Phase|Physician Decision|0
2900852|NCT01737697|9991005|P4|Subacute Phase|Physician Decision|0
2900853|NCT01737697|9991006|P3|Subacute Phase|Physician Decision|0
2900854|NCT01737697|9991007|P2|Subacute Phase|Physician Decision|0
2900855|NCT01737697|9991008|P1|Subacute Phase|Physician Decision|0
2900856|NCT01737697|9990994|P15|Subacute Phase|Protocol Violation|0
2900857|NCT01737697|9990995|P14|Subacute Phase|Protocol Violation|0
2900858|NCT01737697|9990996|P13|Subacute Phase|Protocol Violation|0
2900859|NCT01737697|9990997|P12|Subacute Phase|Protocol Violation|0
2900860|NCT01737697|9990998|P11|Subacute Phase|Protocol Violation|1
2900861|NCT01737697|9990999|P10|Subacute Phase|Protocol Violation|0
2900862|NCT01737697|9991000|P9|Subacute Phase|Protocol Violation|0
2900863|NCT01737697|9991001|P8|Subacute Phase|Protocol Violation|0
2900864|NCT01737697|9991002|P7|Subacute Phase|Protocol Violation|0
2900865|NCT01737697|9991003|P6|Subacute Phase|Protocol Violation|1
2900866|NCT01737697|9991004|P5|Subacute Phase|Protocol Violation|0
2900867|NCT01737697|9991005|P4|Subacute Phase|Protocol Violation|0
2900868|NCT01737697|9991006|P3|Subacute Phase|Protocol Violation|0
2900869|NCT01737697|9991007|P2|Subacute Phase|Protocol Violation|0
2900870|NCT01737697|9991008|P1|Subacute Phase|Protocol Violation|0
2900871|NCT01737697|9990994|P15|Subacute Phase|Hypo-or hyperkalemia|0
2900872|NCT01737697|9990995|P14|Subacute Phase|Hypo-or hyperkalemia|1
2900873|NCT01737697|9990996|P13|Subacute Phase|Hypo-or hyperkalemia|0
2900874|NCT01737697|9990997|P12|Subacute Phase|Hypo-or hyperkalemia|1
2900875|NCT01737697|9990998|P11|Subacute Phase|Hypo-or hyperkalemia|0
2900876|NCT01737697|9990999|P10|Subacute Phase|Hypo-or hyperkalemia|0
2900877|NCT01737697|9991000|P9|Subacute Phase|Hypo-or hyperkalemia|0
2900878|NCT01737697|9991001|P8|Subacute Phase|Hypo-or hyperkalemia|0
2900879|NCT01737697|9991002|P7|Subacute Phase|Hypo-or hyperkalemia|0
2900880|NCT01737697|9991003|P6|Subacute Phase|Hypo-or hyperkalemia|0
2900881|NCT01737697|9991004|P5|Subacute Phase|Hypo-or hyperkalemia|0
2900882|NCT01737697|9991005|P4|Subacute Phase|Hypo-or hyperkalemia|0
2900883|NCT01737697|9991006|P3|Subacute Phase|Hypo-or hyperkalemia|0
2900884|NCT01737697|9991007|P2|Subacute Phase|Hypo-or hyperkalemia|0
2900885|NCT01737697|9991008|P1|Subacute Phase|Hypo-or hyperkalemia|0
2900886|NCT01737697|9990994|P15|Subacute Phase|Lost to Follow-up|1
2900887|NCT01737697|9990995|P14|Subacute Phase|Lost to Follow-up|0
2900888|NCT01737697|9990996|P13|Subacute Phase|Lost to Follow-up|0
2900889|NCT01737697|9990997|P12|Subacute Phase|Lost to Follow-up|0
2900890|NCT01737697|9990998|P11|Subacute Phase|Lost to Follow-up|0
2900891|NCT01737697|9990999|P10|Subacute Phase|Lost to Follow-up|0
2900892|NCT01737697|9991000|P9|Subacute Phase|Lost to Follow-up|0
2900893|NCT01737697|9991001|P8|Subacute Phase|Lost to Follow-up|0
2900894|NCT01737697|9991002|P7|Subacute Phase|Lost to Follow-up|0
2900895|NCT01737697|9991003|P6|Subacute Phase|Lost to Follow-up|0
2900896|NCT01737697|9991004|P5|Subacute Phase|Lost to Follow-up|0
2900897|NCT01737697|9991005|P4|Subacute Phase|Lost to Follow-up|0
2900898|NCT01737697|9991006|P3|Subacute Phase|Lost to Follow-up|0
2900899|NCT01737697|9991007|P2|Subacute Phase|Lost to Follow-up|0
2900900|NCT01737697|9991008|P1|Subacute Phase|Lost to Follow-up|0
2900901|NCT01737697|9990994|P15|Subacute Phase|Withdrawal by Subject|0
2900902|NCT01737697|9990995|P14|Subacute Phase|Withdrawal by Subject|1
2900903|NCT01737697|9990996|P13|Subacute Phase|Withdrawal by Subject|1
2900904|NCT01737697|9990997|P12|Subacute Phase|Withdrawal by Subject|1
2900905|NCT01737697|9990998|P11|Subacute Phase|Withdrawal by Subject|0
2900906|NCT01737697|9990999|P10|Subacute Phase|Withdrawal by Subject|1
2900907|NCT01737697|9991000|P9|Subacute Phase|Withdrawal by Subject|0
2900908|NCT01737697|9991001|P8|Subacute Phase|Withdrawal by Subject|2
2900909|NCT01737697|9991002|P7|Subacute Phase|Withdrawal by Subject|0
2900910|NCT01737697|9991003|P6|Subacute Phase|Withdrawal by Subject|1
2900911|NCT01737697|9991004|P5|Subacute Phase|Withdrawal by Subject|0
2900912|NCT01737697|9991005|P4|Subacute Phase|Withdrawal by Subject|0
2900913|NCT01737697|9991006|P3|Subacute Phase|Withdrawal by Subject|0
2900914|NCT01737697|9991007|P2|Subacute Phase|Withdrawal by Subject|0
2900915|NCT01737697|9991008|P1|Subacute Phase|Withdrawal by Subject|0
2900916|NCT01737697|9990994|P15|Subacute Phase|Adverse Event|0
2900917|NCT01737697|9990995|P14|Subacute Phase|Adverse Event|0
2900918|NCT01737697|9990996|P13|Subacute Phase|Adverse Event|1
2900919|NCT01737697|9990997|P12|Subacute Phase|Adverse Event|1
2900920|NCT01737697|9990998|P11|Subacute Phase|Adverse Event|4
2900921|NCT01737697|9990999|P10|Subacute Phase|Adverse Event|1
2900922|NCT01737697|9991000|P9|Subacute Phase|Adverse Event|1
2900923|NCT01737697|9991001|P8|Subacute Phase|Adverse Event|1
2900924|NCT01737697|9991002|P7|Subacute Phase|Adverse Event|1
2900925|NCT01737697|9991003|P6|Subacute Phase|Adverse Event|1
2900926|NCT01737697|9991004|P5|Subacute Phase|Adverse Event|0
2900927|NCT01737697|9991005|P4|Subacute Phase|Adverse Event|0
2900928|NCT01737697|9991006|P3|Subacute Phase|Adverse Event|0
2900929|NCT01737697|9991007|P2|Subacute Phase|Adverse Event|0
2900930|NCT01737697|9991008|P1|Subacute Phase|Adverse Event|0
2900931|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900932|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900933|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900934|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900935|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900936|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900937|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900938|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900939|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900940|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900941|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2900942|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
2900943|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2900944|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2900945|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2900946|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900947|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900948|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900949|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900950|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900951|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900952|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900953|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900954|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900955|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900956|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
2900957|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900958|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900959|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900960|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2900961|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900962|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900963|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900964|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900965|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900966|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900967|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900968|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900969|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900970|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900971|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900972|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900973|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900974|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
2900975|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2900976|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|Family emergency|0
2900977|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|Family emergency|0
2900978|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|Family emergency|0
2900979|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|Family emergency|0
2900980|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|Family emergency|0
2900981|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|Family emergency|0
2900982|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|Family emergency|0
2900983|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|Family emergency|0
2900984|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|Family emergency|0
2900985|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|Family emergency|0
2900986|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|Family emergency|0
2900987|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|Family emergency|1
2900988|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|Family emergency|0
2900989|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|Family emergency|0
2900990|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|Family emergency|0
2900991|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900992|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900993|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900994|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900995|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900996|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900997|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900998|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2900999|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2901000|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2901001|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2901002|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2901003|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
2901004|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2901005|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2901006|NCT01737697|9990994|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
2901007|NCT01737697|9990995|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
2901008|NCT01737697|9990996|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
2901009|NCT01737697|9990997|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
2901010|NCT01737697|9990998|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
2901011|NCT01737697|9990999|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
2901012|NCT01737697|9991000|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
2901013|NCT01737697|9991001|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
2901014|NCT01737697|9991002|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
2901015|NCT01737697|9991003|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
2901016|NCT01737697|9991004|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
2901017|NCT01737697|9991005|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
2901018|NCT01737697|9991006|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
2901019|NCT01737697|9991007|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
2901020|NCT01737697|9991008|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
2901021|NCT01737398|9991151|P2|Overall Study|Sponsor's decision|0
2901022|NCT01737398|9991152|P1|Overall Study|Sponsor's decision|2
2901023|NCT01737398|9991151|P2|Overall Study|Disease progression|3
2901024|NCT01737398|9991152|P1|Overall Study|Disease progression|2
2901025|NCT01737398|9991151|P2|Overall Study|Liver transplant|0
2901026|NCT01737398|9991152|P1|Overall Study|Liver transplant|1
2901027|NCT01737398|9991151|P2|Overall Study|Ineligibility|0
2901028|NCT01737398|9991152|P1|Overall Study|Ineligibility|1
2901029|NCT01737398|9991151|P2|Overall Study|Voluntary withdrawal|3
2901030|NCT01737398|9991152|P1|Overall Study|Voluntary withdrawal|2
2901031|NCT01737398|9991151|P2|Overall Study|Stopping rule met|1
2901032|NCT01737398|9991152|P1|Overall Study|Stopping rule met|2
2901033|NCT01737398|9991151|P2|Overall Study|Adverse event or SAE|1
2901034|NCT01737398|9991152|P1|Overall Study|Adverse event or SAE|16
2901035|NCT01737268|9991205|P1|Overall Study|In consideration of the patient’s safety|1
2901036|NCT01737268|9991205|P1|Overall Study|Worsening of Target Disease|2
2901037|NCT01737268|9991205|P1|Overall Study|Adverse Event|6
2901038|NCT01737021|9991219|P2|Overall Study|Lost to Follow-up|3
2901039|NCT01737021|9991220|P1|Overall Study|Lost to Follow-up|5
2901040|NCT01736917|9991266|P1|Overall Study|Protocol Violation|10
2901041|NCT01736917|9991266|P1|Overall Study|Adverse Event|1
2901042|NCT01736696|9991295|P7|Overall Study|Withdrawal by Subject|0
2901043|NCT01736696|9991296|P6|Overall Study|Withdrawal by Subject|0
2901044|NCT01736696|9991297|P5|Overall Study|Withdrawal by Subject|0
2901045|NCT01736696|9991298|P4|Overall Study|Withdrawal by Subject|0
2901046|NCT01736696|9991299|P3|Overall Study|Withdrawal by Subject|1
2901047|NCT01736696|9991300|P2|Overall Study|Withdrawal by Subject|0
2901048|NCT01736696|9991301|P1|Overall Study|Withdrawal by Subject|0
2901049|NCT01736683|9991623|P5|Overall Study|Other|1
2901050|NCT01736683|9991624|P4|Overall Study|Other|9
2901051|NCT01736683|9991625|P3|Overall Study|Other|1
2901052|NCT01736683|9991626|P2|Overall Study|Other|0
2901053|NCT01736683|9991627|P1|Overall Study|Other|0
2901054|NCT01736683|9991623|P5|Overall Study|Progressive Disease|0
2901055|NCT01736683|9991624|P4|Overall Study|Progressive Disease|1
2901056|NCT01736683|9991625|P3|Overall Study|Progressive Disease|0
2901057|NCT01736683|9991626|P2|Overall Study|Progressive Disease|0
2901058|NCT01736683|9991627|P1|Overall Study|Progressive Disease|0
2901059|NCT01736683|9991623|P5|Overall Study|Lack of Therapeutic Effect|1
2901060|NCT01736683|9991624|P4|Overall Study|Lack of Therapeutic Effect|20
2901061|NCT01736683|9991625|P3|Overall Study|Lack of Therapeutic Effect|13
2901062|NCT01736683|9991626|P2|Overall Study|Lack of Therapeutic Effect|4
2901063|NCT01736683|9991627|P1|Overall Study|Lack of Therapeutic Effect|7
2901064|NCT01736683|9991623|P5|Overall Study|Withdrawal by Subject|1
2901065|NCT01736683|9991624|P4|Overall Study|Withdrawal by Subject|1
2901066|NCT01736683|9991625|P3|Overall Study|Withdrawal by Subject|3
2901067|NCT01736683|9991626|P2|Overall Study|Withdrawal by Subject|0
2901068|NCT01736683|9991627|P1|Overall Study|Withdrawal by Subject|0
2901069|NCT01736683|9991623|P5|Overall Study|Adverse Event|2
2901070|NCT01736683|9991624|P4|Overall Study|Adverse Event|3
2901071|NCT01736683|9991625|P3|Overall Study|Adverse Event|2
2901072|NCT01736683|9991626|P2|Overall Study|Adverse Event|2
2901073|NCT01736683|9991627|P1|Overall Study|Adverse Event|0
2901074|NCT01736683|9991623|P5|Overall Study|Disease Relapse|0
2901075|NCT01736683|9991624|P4|Overall Study|Disease Relapse|1
2901076|NCT01736683|9991625|P3|Overall Study|Disease Relapse|2
2901077|NCT01736683|9991626|P2|Overall Study|Disease Relapse|0
2901078|NCT01736683|9991627|P1|Overall Study|Disease Relapse|0
2901079|NCT01736657|9991689|P1|Overall Study|insufficient vascular access|1
2901080|NCT01736579|9991698|P2|Overall Study|Termination of Study by Sponsor|2
2901081|NCT01736579|9991699|P1|Overall Study|Termination of Study by Sponsor|2
2901082|NCT01736566|9991738|P5|Long Term Follow-up|Still collecting data|1
2901083|NCT01736566|9991739|P4|Long Term Follow-up|Still collecting data|0
2901084|NCT01736566|9991740|P3|Long Term Follow-up|Still collecting data|49
2901085|NCT01736566|9991741|P2|Long Term Follow-up|Still collecting data|0
2901086|NCT01736566|9991742|P1|Long Term Follow-up|Still collecting data|42
2901087|NCT01736553|9991827|P2|Overall Study|Lost to Follow-up|2
2901088|NCT01736553|9991828|P1|Overall Study|Lost to Follow-up|2
2901089|NCT01736553|9991827|P2|Overall Study|Withdrawal by Subject|2
2901090|NCT01736553|9991828|P1|Overall Study|Withdrawal by Subject|5
2901091|NCT01736553|9991827|P2|Overall Study|Death|0
2901092|NCT01736553|9991828|P1|Overall Study|Death|12
2901093|NCT01736540|9991879|P1|Overall Study|Unable to make MRI appointment|3
2901094|NCT01736540|9991879|P1|Overall Study|No show for MRI appointment|1
2901095|NCT01736540|9991879|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
2901096|NCT01736540|9991879|P1|Overall Study|Protocol Violation|1
2901097|NCT01736540|9991879|P1|Overall Study|Withdrawal by Subject|5
2901098|NCT01736540|9991879|P1|Overall Study|Abnormal test procedure|1
2901099|NCT01736540|9991879|P1|Overall Study|Death|1
2901100|NCT01736540|9991879|P1|Overall Study|Did not complete scan within 45 days|2
2901101|NCT01736475|9991945|P2|Overall Study|Other - Surgical procedure|0
2901102|NCT01736475|9991946|P1|Overall Study|Other - Surgical procedure|1
2901103|NCT01736475|9991945|P2|Overall Study|Other - Screen failure|0
2901104|NCT01736475|9991946|P1|Overall Study|Other - Screen failure|1
2901105|NCT01736475|9991945|P2|Overall Study|Protocol Violation|0
2901106|NCT01736475|9991946|P1|Overall Study|Protocol Violation|4
2901107|NCT01736475|9991945|P2|Overall Study|Withdrawal by Subject|0
2901108|NCT01736475|9991946|P1|Overall Study|Withdrawal by Subject|2
2901109|NCT01736475|9991945|P2|Overall Study|Adverse Event|0
2901110|NCT01736475|9991946|P1|Overall Study|Adverse Event|4
2901111|NCT01736397|9992001|P2|Overall Study|Not stated|4
2901112|NCT01736397|9992002|P1|Overall Study|Not stated|1
2901113|NCT01736397|9992001|P2|Overall Study|Adverse Event|3
2901114|NCT01736397|9992002|P1|Overall Study|Adverse Event|6
2901115|NCT01736397|9992001|P2|Overall Study|Lost to Follow-up|1
2901116|NCT01736397|9992002|P1|Overall Study|Lost to Follow-up|0
2901117|NCT01736397|9992001|P2|Overall Study|Withdrawal by Subject|5
2901118|NCT01736397|9992002|P1|Overall Study|Withdrawal by Subject|6
2901119|NCT01736397|9992001|P2|Overall Study|Lack of Efficacy|11
2901120|NCT01736397|9992002|P1|Overall Study|Lack of Efficacy|1
2901121|NCT01736254|9992035|P1|Period 3 (Days 13 to 23)|Adverse Event|1
2901122|NCT01736254|9992035|P1|Period 2 (Days 2 to 12)|Adverse Event|3
2901123|NCT01736215|9992100|P1|Overall Study|Insufficient data to perform analysis|8
2901124|NCT01736215|9992100|P1|Overall Study|Progressive disease stop chemotherapy|1
2901125|NCT01736215|9992100|P1|Overall Study|Adverse Event|4
2901126|NCT01736215|9992100|P1|Overall Study|Early termination of erythropoietin use|1
2901127|NCT01736189|9992112|P1|Overall Study|Criteria and protocol violations|1
2901128|NCT01736189|9992112|P1|Overall Study|Protocol Violation|4
2901129|NCT01736189|9992112|P1|Overall Study|Violation of registration criteria|41
2901130|NCT01736176|9992121|P1|Overall Study|Unable to Complete PEG Placement|1
2901131|NCT01736176|9992121|P1|Overall Study|Lack of Efficacy|3
2901132|NCT01736176|9992121|P1|Overall Study|Withdrawal by Subject|4
2901133|NCT01736176|9992121|P1|Overall Study|Adverse Event|3
2901134|NCT01735994|9992192|P2|Overall Study|Lost to Follow-up|62
2901135|NCT01735994|9992193|P1|Overall Study|Lost to Follow-up|50
2901136|NCT01735994|9992192|P2|Overall Study|Kicked off team|0
2901137|NCT01735994|9992193|P1|Overall Study|Kicked off team|5
2901138|NCT01735994|9992192|P2|Overall Study|Injury|0
2901139|NCT01735994|9992193|P1|Overall Study|Injury|2
2901140|NCT01735994|9992192|P2|Overall Study|Withdrawal by Subject|4
2901141|NCT01735994|9992193|P1|Overall Study|Withdrawal by Subject|6
2901142|NCT01735916|9992208|P3|Overall Study|Withdrawal by Subject|0
2901143|NCT01735916|9992209|P2|Overall Study|Withdrawal by Subject|0
2901144|NCT01735916|9992210|P1|Overall Study|Withdrawal by Subject|3
2901145|NCT01735916|9992208|P3|Overall Study|Early termination of study by sponsor|7
2901146|NCT01735916|9992209|P2|Overall Study|Early termination of study by sponsor|19
2901147|NCT01735916|9992210|P1|Overall Study|Early termination of study by sponsor|4
2901148|NCT01735916|9992208|P3|Overall Study|Subject not eligible to be randomized|0
2901149|NCT01735916|9992209|P2|Overall Study|Subject not eligible to be randomized|0
2901150|NCT01735916|9992210|P1|Overall Study|Subject not eligible to be randomized|11
2901151|NCT01735630|9992248|P2|Overall Study|Withdrawal by Subject|9
2901152|NCT01735630|9992249|P1|Overall Study|Withdrawal by Subject|7
2901153|NCT01735630|9992248|P2|Overall Study|Sponsor Decision|1
2901154|NCT01735630|9992249|P1|Overall Study|Sponsor Decision|2
2901155|NCT01735630|9992248|P2|Overall Study|Physician Decision|1
2901156|NCT01735630|9992249|P1|Overall Study|Physician Decision|0
2901157|NCT01735630|9992248|P2|Overall Study|Lost to Follow-up|0
2901158|NCT01735630|9992249|P1|Overall Study|Lost to Follow-up|1
2901159|NCT01735630|9992248|P2|Overall Study|Adverse Event|7
2901160|NCT01735630|9992249|P1|Overall Study|Adverse Event|8
2901161|NCT01735396|9992276|P1|Overall Study|not evaluable|1
2901162|NCT01735201|9992305|P8|Overall Study|Other Miscellaneous Reasons|1
2901163|NCT01735201|9992306|P7|Overall Study|Other Miscellaneous Reasons|1
2901164|NCT01735201|9992307|P6|Overall Study|Other Miscellaneous Reasons|2
2901165|NCT01735201|9992308|P5|Overall Study|Other Miscellaneous Reasons|0
2901166|NCT01735201|9992309|P4|Overall Study|Other Miscellaneous Reasons|1
2901167|NCT01735201|9992310|P3|Overall Study|Other Miscellaneous Reasons|0
2901168|NCT01735201|9992311|P2|Overall Study|Other Miscellaneous Reasons|0
2901169|NCT01735201|9992312|P1|Overall Study|Other Miscellaneous Reasons|0
2901170|NCT01735201|9992305|P8|Overall Study|Protocol Violation|0
2901171|NCT01735201|9992306|P7|Overall Study|Protocol Violation|0
2901172|NCT01735201|9992307|P6|Overall Study|Protocol Violation|0
2901173|NCT01735201|9992308|P5|Overall Study|Protocol Violation|0
2901174|NCT01735201|9992309|P4|Overall Study|Protocol Violation|0
2901175|NCT01735201|9992310|P3|Overall Study|Protocol Violation|0
2901176|NCT01735201|9992311|P2|Overall Study|Protocol Violation|0
2901177|NCT01735201|9992312|P1|Overall Study|Protocol Violation|1
2901178|NCT01735201|9992305|P8|Overall Study|Personal Reasons|0
2901179|NCT01735201|9992306|P7|Overall Study|Personal Reasons|0
2901180|NCT01735201|9992307|P6|Overall Study|Personal Reasons|0
2901181|NCT01735201|9992308|P5|Overall Study|Personal Reasons|0
2901182|NCT01735201|9992309|P4|Overall Study|Personal Reasons|0
2901183|NCT01735201|9992310|P3|Overall Study|Personal Reasons|0
2901184|NCT01735201|9992311|P2|Overall Study|Personal Reasons|0
2901185|NCT01735201|9992312|P1|Overall Study|Personal Reasons|1
2901186|NCT01735201|9992305|P8|Overall Study|Adverse Event|1
2901187|NCT01735201|9992306|P7|Overall Study|Adverse Event|2
2901188|NCT01735201|9992307|P6|Overall Study|Adverse Event|3
2901189|NCT01735201|9992308|P5|Overall Study|Adverse Event|1
2901190|NCT01735201|9992309|P4|Overall Study|Adverse Event|1
2901191|NCT01735201|9992310|P3|Overall Study|Adverse Event|0
2901192|NCT01735201|9992311|P2|Overall Study|Adverse Event|1
2901193|NCT01735201|9992312|P1|Overall Study|Adverse Event|1
2901194|NCT01735175|9992348|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
2901195|NCT01735175|9992349|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
2901196|NCT01735175|9992348|P2|Overall Study|Death|2
2901197|NCT01735175|9992349|P1|Overall Study|Death|3
2901198|NCT01735175|9992348|P2|Overall Study|Lost to Follow-up|2
2901199|NCT01735175|9992349|P1|Overall Study|Lost to Follow-up|4
2901200|NCT01735175|9992348|P2|Overall Study|Withdrawal by Subject|2
2901201|NCT01735175|9992349|P1|Overall Study|Withdrawal by Subject|9
2901202|NCT01734993|9992369|P1|Overall Study|Lack of Efficacy|1
2901203|NCT01734993|9992369|P1|Overall Study|Adverse Event|1
2901204|NCT01734902|9992397|P2|Overall Study|Other than listed|2
2901205|NCT01734902|9992398|P1|Overall Study|Other than listed|0
2901206|NCT01734785|9992419|P4|Double−Blind Period|Not treated|0
2901207|NCT01734785|9992420|P3|Double−Blind Period|Not treated|0
2901208|NCT01734785|9992421|P2|Double−Blind Period|Not treated|0
2901209|NCT01734785|9992422|P1|Double−Blind Period|Not treated|1
2901210|NCT01734785|9992419|P4|Double−Blind Period|Withdrawal by Subject|0
2901211|NCT01734785|9992420|P3|Double−Blind Period|Withdrawal by Subject|0
2901212|NCT01734785|9992421|P2|Double−Blind Period|Withdrawal by Subject|0
2901213|NCT01734785|9992422|P1|Double−Blind Period|Withdrawal by Subject|2
2901214|NCT01734785|9992419|P4|Double−Blind Period|Lost to Follow-up|0
2901215|NCT01734785|9992420|P3|Double−Blind Period|Lost to Follow-up|2
2901216|NCT01734785|9992421|P2|Double−Blind Period|Lost to Follow-up|4
2901217|NCT01734785|9992422|P1|Double−Blind Period|Lost to Follow-up|2
2901218|NCT01734785|9992419|P4|Double−Blind Period|Protocol Violation|0
2901219|NCT01734785|9992420|P3|Double−Blind Period|Protocol Violation|1
2901220|NCT01734785|9992421|P2|Double−Blind Period|Protocol Violation|1
2901221|NCT01734785|9992422|P1|Double−Blind Period|Protocol Violation|0
2901222|NCT01734785|9992419|P4|Double−Blind Period|Lack of Efficacy|0
2901223|NCT01734785|9992420|P3|Double−Blind Period|Lack of Efficacy|0
2901224|NCT01734785|9992421|P2|Double−Blind Period|Lack of Efficacy|1
2901225|NCT01734785|9992422|P1|Double−Blind Period|Lack of Efficacy|0
2901226|NCT01734785|9992419|P4|Double−Blind Period|Adverse Event|0
2901227|NCT01734785|9992420|P3|Double−Blind Period|Adverse Event|2
2901228|NCT01734785|9992421|P2|Double−Blind Period|Adverse Event|3
2901229|NCT01734785|9992422|P1|Double−Blind Period|Adverse Event|0
2901230|NCT01734785|9992419|P4|Open−Label Period|Other Reasons|224
2901231|NCT01734785|9992420|P3|Open−Label Period|Other Reasons|0
2901232|NCT01734785|9992421|P2|Open−Label Period|Other Reasons|0
2901233|NCT01734785|9992422|P1|Open−Label Period|Other Reasons|0
2901234|NCT01734785|9992419|P4|Open−Label Period|Withdrawal by Subject|12
2901235|NCT01734785|9992420|P3|Open−Label Period|Withdrawal by Subject|0
2901236|NCT01734785|9992421|P2|Open−Label Period|Withdrawal by Subject|0
2901237|NCT01734785|9992422|P1|Open−Label Period|Withdrawal by Subject|0
2901238|NCT01734785|9992419|P4|Open−Label Period|Lost to Follow-up|14
2901239|NCT01734785|9992420|P3|Open−Label Period|Lost to Follow-up|0
2901240|NCT01734785|9992421|P2|Open−Label Period|Lost to Follow-up|0
2901241|NCT01734785|9992422|P1|Open−Label Period|Lost to Follow-up|0
2901242|NCT01734785|9992419|P4|Open−Label Period|Protocol Violation|13
2901243|NCT01734785|9992420|P3|Open−Label Period|Protocol Violation|0
2901244|NCT01734785|9992421|P2|Open−Label Period|Protocol Violation|0
2901245|NCT01734785|9992422|P1|Open−Label Period|Protocol Violation|0
2901246|NCT01734785|9992419|P4|Open−Label Period|Lack of Efficacy|1
2901247|NCT01734785|9992420|P3|Open−Label Period|Lack of Efficacy|0
2901248|NCT01734785|9992421|P2|Open−Label Period|Lack of Efficacy|0
2901249|NCT01734785|9992422|P1|Open−Label Period|Lack of Efficacy|0
2901250|NCT01734785|9992419|P4|Open−Label Period|Adverse Event|9
2901251|NCT01734785|9992420|P3|Open−Label Period|Adverse Event|0
2901252|NCT01734785|9992421|P2|Open−Label Period|Adverse Event|0
2901253|NCT01734785|9992422|P1|Open−Label Period|Adverse Event|0
2901254|NCT01734772|9992439|P2|Overall Study|Withdrawal by Subject|1
2901255|NCT01734772|9992440|P1|Overall Study|Withdrawal by Subject|0
2901256|NCT01734772|9992439|P2|Overall Study|Adverse Event|2
2901257|NCT01734772|9992440|P1|Overall Study|Adverse Event|1
2901258|NCT01734434|9992495|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
2901259|NCT01734434|9992496|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
2901260|NCT01734434|9992497|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
2901261|NCT01734434|9992498|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
2901262|NCT01734434|9992495|P4|Overall Study|Wrong Version of Consent Form Signed|0
2901263|NCT01734434|9992496|P3|Overall Study|Wrong Version of Consent Form Signed|1
2901264|NCT01734434|9992497|P2|Overall Study|Wrong Version of Consent Form Signed|0
2901265|NCT01734434|9992498|P1|Overall Study|Wrong Version of Consent Form Signed|0
2901266|NCT01734434|9992495|P4|Overall Study|Treatment Defaulter|0
2901267|NCT01734434|9992496|P3|Overall Study|Treatment Defaulter|1
2901268|NCT01734434|9992497|P2|Overall Study|Treatment Defaulter|0
2901269|NCT01734434|9992498|P1|Overall Study|Treatment Defaulter|0
2901270|NCT01734434|9992495|P4|Overall Study|Subject Not Reachable|0
2901271|NCT01734434|9992496|P3|Overall Study|Subject Not Reachable|1
2901272|NCT01734434|9992497|P2|Overall Study|Subject Not Reachable|0
2901273|NCT01734434|9992498|P1|Overall Study|Subject Not Reachable|0
2901274|NCT01734434|9992495|P4|Overall Study|Signed Adult Version of Consent Form|0
2901275|NCT01734434|9992496|P3|Overall Study|Signed Adult Version of Consent Form|1
2901276|NCT01734434|9992497|P2|Overall Study|Signed Adult Version of Consent Form|0
2901277|NCT01734434|9992498|P1|Overall Study|Signed Adult Version of Consent Form|0
2901278|NCT01734434|9992495|P4|Overall Study|Withdrawal by Subject|1
2901279|NCT01734434|9992496|P3|Overall Study|Withdrawal by Subject|8
2901280|NCT01734434|9992497|P2|Overall Study|Withdrawal by Subject|0
2901281|NCT01734434|9992498|P1|Overall Study|Withdrawal by Subject|4
2901282|NCT01734434|9992495|P4|Overall Study|No Live Birth|6
2901283|NCT01734434|9992496|P3|Overall Study|No Live Birth|32
2901284|NCT01734434|9992497|P2|Overall Study|No Live Birth|2
2901285|NCT01734434|9992498|P1|Overall Study|No Live Birth|1
2901286|NCT01734434|9992495|P4|Overall Study|Lost to Follow-up|11
2901287|NCT01734434|9992496|P3|Overall Study|Lost to Follow-up|67
2901288|NCT01734434|9992497|P2|Overall Study|Lost to Follow-up|9
2901289|NCT01734434|9992498|P1|Overall Study|Lost to Follow-up|2
2901290|NCT01734434|9992495|P4|Overall Study|Death Infant|5
2901291|NCT01734434|9992496|P3|Overall Study|Death Infant|17
2901292|NCT01734434|9992497|P2|Overall Study|Death Infant|1
2901293|NCT01734434|9992498|P1|Overall Study|Death Infant|3
2901294|NCT01734395|9992520|P1|Overall Study|Missing the reasons for not completed|3
2901295|NCT01734395|9992520|P1|Overall Study|Withdrawal by Subject|10
2901296|NCT01734395|9992520|P1|Overall Study|Adverse Event|40
2901297|NCT01734395|9992520|P1|Overall Study|Lack of Efficacy|5
2901298|NCT01734395|9992520|P1|Overall Study|Lost to Follow-up|287
2901299|NCT01734395|9992520|P1|Overall Study|Other|65
2901300|NCT01734382|9992529|P3|Part 2|Withdrawal by Subject|1
2901301|NCT01734382|9992530|P2|Part 2|Withdrawal by Subject|0
2901302|NCT01734382|9992531|P1|Part 2|Withdrawal by Subject|0
2901303|NCT01734382|9992529|P3|Part 2|Protocol Violation|0
2901304|NCT01734382|9992530|P2|Part 2|Protocol Violation|1
2901305|NCT01734382|9992531|P1|Part 2|Protocol Violation|0
2901306|NCT01734382|9992529|P3|Part 2|Physician Decision|3
2901307|NCT01734382|9992530|P2|Part 2|Physician Decision|0
2901308|NCT01734382|9992531|P1|Part 2|Physician Decision|0
2901309|NCT01734382|9992529|P3|Part 2|Other|1
2901310|NCT01734382|9992530|P2|Part 2|Other|0
2901311|NCT01734382|9992531|P1|Part 2|Other|0
2901312|NCT01734382|9992529|P3|Part 2|Lack of Efficacy|1
2901313|NCT01734382|9992530|P2|Part 2|Lack of Efficacy|1
2901314|NCT01734382|9992531|P1|Part 2|Lack of Efficacy|0
2901315|NCT01734382|9992529|P3|Part 2|Adverse Event|1
2901316|NCT01734382|9992530|P2|Part 2|Adverse Event|0
2901317|NCT01734382|9992531|P1|Part 2|Adverse Event|0
2901318|NCT01734382|9992529|P3|Part 1|Adverse Event|0
2901319|NCT01734382|9992530|P2|Part 1|Adverse Event|0
2901320|NCT01734382|9992531|P1|Part 1|Adverse Event|2
2901321|NCT01733758|9992644|P4|Overall Study|Inv Decision, HbA1c not controlled|1
2901322|NCT01733758|9992645|P3|Overall Study|Inv Decision, HbA1c not controlled|0
2901323|NCT01733758|9992646|P2|Overall Study|Inv Decision, HbA1c not controlled|1
2901324|NCT01733758|9992647|P1|Overall Study|Inv Decision, HbA1c not controlled|1
2901325|NCT01733758|9992644|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
2901326|NCT01733758|9992645|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
2901327|NCT01733758|9992646|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
2901328|NCT01733758|9992647|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
2901329|NCT01733758|9992644|P4|Overall Study|Non-compliance|0
2901330|NCT01733758|9992645|P3|Overall Study|Non-compliance|0
2901331|NCT01733758|9992646|P2|Overall Study|Non-compliance|0
2901332|NCT01733758|9992647|P1|Overall Study|Non-compliance|1
2901333|NCT01733758|9992644|P4|Overall Study|Protocol Violation|2
2901334|NCT01733758|9992645|P3|Overall Study|Protocol Violation|2
2901335|NCT01733758|9992646|P2|Overall Study|Protocol Violation|1
2901336|NCT01733758|9992647|P1|Overall Study|Protocol Violation|0
2901337|NCT01733758|9992644|P4|Overall Study|Persistent Hyperglycemia|0
2901338|NCT01733758|9992645|P3|Overall Study|Persistent Hyperglycemia|0
2901339|NCT01733758|9992646|P2|Overall Study|Persistent Hyperglycemia|2
2901340|NCT01733758|9992647|P1|Overall Study|Persistent Hyperglycemia|3
2901341|NCT01733758|9992644|P4|Overall Study|Withdrawal by Subject|3
2901342|NCT01733758|9992645|P3|Overall Study|Withdrawal by Subject|5
2901343|NCT01733758|9992646|P2|Overall Study|Withdrawal by Subject|1
2901344|NCT01733758|9992647|P1|Overall Study|Withdrawal by Subject|1
2901345|NCT01733758|9992644|P4|Overall Study|Adverse Event|1
2901346|NCT01733758|9992645|P3|Overall Study|Adverse Event|8
2901347|NCT01733758|9992646|P2|Overall Study|Adverse Event|7
2901348|NCT01733758|9992647|P1|Overall Study|Adverse Event|5
2901349|NCT01733732|9992713|P2|Overall Study|Did not attend all study visits|0
2901350|NCT01733732|9992714|P1|Overall Study|Did not attend all study visits|1
2901351|NCT01733732|9992713|P2|Overall Study|Adverse Event|0
2901352|NCT01733732|9992714|P1|Overall Study|Adverse Event|1
2901353|NCT01733680|9992750|P2|Overall Study|Withdrawal by Subject|1
2901354|NCT01733680|9992751|P1|Overall Study|Withdrawal by Subject|0
2901355|NCT01733329|9992810|P2|Overall Study|Uterine artery injury|0
2901356|NCT01733329|9992811|P1|Overall Study|Uterine artery injury|1
2901357|NCT01733329|9992810|P2|Overall Study|Protocol Violation|1
2901358|NCT01733329|9992811|P1|Overall Study|Protocol Violation|1
2901359|NCT01733316|9992823|P1|Long Term Extension Phase|Sponsor Decision|2
2901360|NCT01733316|9992823|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
2901361|NCT01733316|9992823|P1|Long Term Extension Phase|Adverse Event|1
2901362|NCT01733316|9992823|P1|RP103 Phase|Non-compliance|1
2901363|NCT01733121|9992866|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2901364|NCT01733121|9992867|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2901365|NCT01733121|9992866|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
2901366|NCT01733121|9992867|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2901367|NCT01733121|9992866|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2901368|NCT01733121|9992867|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2901369|NCT01733121|9992866|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2901370|NCT01733121|9992867|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
2901371|NCT01732926|9992909|P2|Overall Study|Blind Broken by Subject or Study Site|1
2901372|NCT01732926|9992910|P1|Overall Study|Blind Broken by Subject or Study Site|1
2901373|NCT01732926|9992909|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
2901374|NCT01732926|9992910|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
2901375|NCT01732926|9992909|P2|Overall Study|Other Reason|4
2901376|NCT01732926|9992910|P1|Overall Study|Other Reason|21
2901377|NCT01732926|9992909|P2|Overall Study|Physician Decision|11
2901378|NCT01732926|9992910|P1|Overall Study|Physician Decision|24
2901379|NCT01732926|9992909|P2|Overall Study|Withdrawal by Subject|8
2901380|NCT01732926|9992910|P1|Overall Study|Withdrawal by Subject|46
2901381|NCT01732926|9992909|P2|Overall Study|Study Terminated by Sponsor|80
2901382|NCT01732926|9992910|P1|Overall Study|Study Terminated by Sponsor|168
2901383|NCT01732913|9992926|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
2901384|NCT01732913|9992927|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
2901385|NCT01732913|9992926|P2|Overall Study|Other|1
2901386|NCT01732913|9992927|P1|Overall Study|Other|7
2901387|NCT01732913|9992926|P2|Overall Study|Physician Decision|7
2901388|NCT01732913|9992927|P1|Overall Study|Physician Decision|14
2901389|NCT01732913|9992926|P2|Overall Study|Withdrawal by Subject|4
2901390|NCT01732913|9992927|P1|Overall Study|Withdrawal by Subject|27
2901391|NCT01732913|9992926|P2|Overall Study|Study Terminated by Sponsor|55
2901392|NCT01732913|9992927|P1|Overall Study|Study Terminated by Sponsor|105
2901393|NCT01732835|9992941|P1|2-year Extended Follow-up|Death|1
2901394|NCT01732835|9992941|P1|2-year Extended Follow-up|Adverse Event|3
2901395|NCT01732835|9992941|P1|2-year Extended Follow-up|Withdrawal by Subject|1
2901396|NCT01732835|9992941|P1|6-month Primary Endpoint|Adverse Event|3
2901397|NCT01732835|9992941|P1|6-month Primary Endpoint|Withdrawal by Subject|2
2901398|NCT01732835|9992941|P1|6-month Primary Endpoint|Did not receive device|19
2901399|NCT01732822|9992974|P2|Overall Study|Withdrawal by Subject|113
2901400|NCT01732822|9992975|P1|Overall Study|Withdrawal by Subject|123
2901401|NCT01732796|9993048|P3|Overall Study|Other reason not defined above|2
2901402|NCT01732796|9993049|P2|Overall Study|Other reason not defined above|0
2901403|NCT01732796|9993050|P1|Overall Study|Other reason not defined above|1
2901404|NCT01732796|9993048|P3|Overall Study|Withdrawal by Subject|2
2901405|NCT01732796|9993049|P2|Overall Study|Withdrawal by Subject|8
2901406|NCT01732796|9993050|P1|Overall Study|Withdrawal by Subject|6
2901407|NCT01732796|9993048|P3|Overall Study|Lost to Follow-up|0
2901408|NCT01732796|9993049|P2|Overall Study|Lost to Follow-up|0
2901409|NCT01732796|9993050|P1|Overall Study|Lost to Follow-up|2
2901410|NCT01732796|9993048|P3|Overall Study|Lack of Efficacy|5
2901411|NCT01732796|9993049|P2|Overall Study|Lack of Efficacy|18
2901412|NCT01732796|9993050|P1|Overall Study|Lack of Efficacy|21
2901413|NCT01732796|9993048|P3|Overall Study|Adverse Event|4
2901414|NCT01732796|9993049|P2|Overall Study|Adverse Event|16
2901415|NCT01732796|9993050|P1|Overall Study|Adverse Event|16
2901416|NCT01732783|9993069|P3|Overall Study|Withdrawal by Subject|0
2901417|NCT01732783|9993070|P2|Overall Study|Withdrawal by Subject|0
2901418|NCT01732783|9993071|P1|Overall Study|Withdrawal by Subject|1
2901419|NCT01732783|9993069|P3|Overall Study|Administrative Decision|1
2901420|NCT01732783|9993070|P2|Overall Study|Administrative Decision|2
2901421|NCT01732783|9993071|P1|Overall Study|Administrative Decision|8
2901422|NCT01732783|9993069|P3|Overall Study|Lost to Follow-up|1
2901423|NCT01732783|9993070|P2|Overall Study|Lost to Follow-up|1
2901424|NCT01732783|9993071|P1|Overall Study|Lost to Follow-up|7
2901425|NCT01732783|9993069|P3|Overall Study|Death|1
2901426|NCT01732783|9993070|P2|Overall Study|Death|4
2901427|NCT01732783|9993071|P1|Overall Study|Death|13
2901428|NCT01732783|9993069|P3|Overall Study|Discontinued Panitumumab Treatment|7
2901429|NCT01732783|9993070|P2|Overall Study|Discontinued Panitumumab Treatment|25
2901430|NCT01732783|9993071|P1|Overall Study|Discontinued Panitumumab Treatment|106
2901431|NCT01732770|9993135|P2|Overall Study|Death|0
2901432|NCT01732770|9993136|P1|Overall Study|Death|1
2901433|NCT01732770|9993135|P2|Overall Study|Decision by Sponsor|2
2901434|NCT01732770|9993136|P1|Overall Study|Decision by Sponsor|2
2901435|NCT01732770|9993135|P2|Overall Study|Withdrawal by Subject|3
2901436|NCT01732770|9993136|P1|Overall Study|Withdrawal by Subject|5
2901437|NCT01732770|9993135|P2|Overall Study|Lost to Follow-up|3
2901438|NCT01732770|9993136|P1|Overall Study|Lost to Follow-up|2
2901439|NCT01732757|9993151|P3|Overall Study|Lost to Follow-up|0
2901440|NCT01732757|9993152|P2|Overall Study|Lost to Follow-up|0
2901441|NCT01732757|9993153|P1|Overall Study|Lost to Follow-up|1
2901442|NCT01732692|9993230|P2|Overall Study|Adverse Event|1
2901443|NCT01732692|9993231|P1|Overall Study|Adverse Event|0
2901444|NCT01732640|9993245|P2|Overall Study|Death|1
2901445|NCT01732640|9993246|P1|Overall Study|Death|0
2901446|NCT01732640|9993245|P2|Overall Study|Adverse Event|1
2901447|NCT01732640|9993246|P1|Overall Study|Adverse Event|0
2901448|NCT01732588|9993264|P3|First Intervention (7 Days)|Adverse Event|0
2901449|NCT01732588|9993265|P2|First Intervention (7 Days)|Adverse Event|1
2901450|NCT01732588|9993266|P1|First Intervention (7 Days)|Adverse Event|0
2901451|NCT01732549|9993282|P2|Overall Study|Other|14
2901452|NCT01732549|9993283|P1|Overall Study|Other|8
2901453|NCT01732549|9993282|P2|Overall Study|Disease progression|50
2901454|NCT01732549|9993283|P1|Overall Study|Disease progression|37
2901455|NCT01732549|9993282|P2|Overall Study|Consent withdrawn|6
2901456|NCT01732549|9993283|P1|Overall Study|Consent withdrawn|13
2901457|NCT01732549|9993282|P2|Overall Study|Adverse Event|3
2901458|NCT01732549|9993283|P1|Overall Study|Adverse Event|13
2901459|NCT01732536|9993305|P2|Overall Study|Withdrawal by Subject|1
2901460|NCT01732536|9993306|P1|Overall Study|Withdrawal by Subject|1
2901461|NCT01732510|9993329|P7|Overall Study|Study Terminated By Sponsor|6
2901462|NCT01732510|9993330|P6|Overall Study|Study Terminated By Sponsor|12
2901463|NCT01732510|9993331|P5|Overall Study|Study Terminated By Sponsor|0
2901464|NCT01732510|9993332|P4|Overall Study|Study Terminated By Sponsor|1
2901465|NCT01732510|9993333|P3|Overall Study|Study Terminated By Sponsor|0
2901466|NCT01732510|9993334|P2|Overall Study|Study Terminated By Sponsor|0
2901467|NCT01732510|9993335|P1|Overall Study|Study Terminated By Sponsor|0
2901468|NCT01732510|9993329|P7|Overall Study|Pregnancy|0
2901469|NCT01732510|9993330|P6|Overall Study|Pregnancy|0
2901470|NCT01732510|9993331|P5|Overall Study|Pregnancy|0
2901471|NCT01732510|9993332|P4|Overall Study|Pregnancy|1
2901472|NCT01732510|9993333|P3|Overall Study|Pregnancy|0
2901473|NCT01732510|9993334|P2|Overall Study|Pregnancy|0
2901474|NCT01732510|9993335|P1|Overall Study|Pregnancy|0
2901475|NCT01732510|9993329|P7|Overall Study|Physician Decision|0
2901476|NCT01732510|9993330|P6|Overall Study|Physician Decision|0
2901477|NCT01732510|9993331|P5|Overall Study|Physician Decision|0
2901478|NCT01732510|9993332|P4|Overall Study|Physician Decision|0
2901479|NCT01732510|9993333|P3|Overall Study|Physician Decision|0
2901480|NCT01732510|9993334|P2|Overall Study|Physician Decision|1
2901481|NCT01732510|9993335|P1|Overall Study|Physician Decision|0
2901482|NCT01732510|9993329|P7|Overall Study|Lost to Follow-up|0
2901483|NCT01732510|9993330|P6|Overall Study|Lost to Follow-up|1
2901484|NCT01732510|9993331|P5|Overall Study|Lost to Follow-up|0
2901485|NCT01732510|9993332|P4|Overall Study|Lost to Follow-up|1
2901486|NCT01732510|9993333|P3|Overall Study|Lost to Follow-up|1
2901487|NCT01732510|9993334|P2|Overall Study|Lost to Follow-up|0
2901488|NCT01732510|9993335|P1|Overall Study|Lost to Follow-up|0
2901489|NCT01732510|9993329|P7|Overall Study|Withdrawal by Subject|1
2901490|NCT01732510|9993330|P6|Overall Study|Withdrawal by Subject|0
2901491|NCT01732510|9993331|P5|Overall Study|Withdrawal by Subject|5
2901492|NCT01732510|9993332|P4|Overall Study|Withdrawal by Subject|1
2901493|NCT01732510|9993333|P3|Overall Study|Withdrawal by Subject|2
2901494|NCT01732510|9993334|P2|Overall Study|Withdrawal by Subject|3
2901495|NCT01732510|9993335|P1|Overall Study|Withdrawal by Subject|1
2901496|NCT01732510|9993329|P7|Overall Study|Protocol Violation|0
2901497|NCT01732510|9993330|P6|Overall Study|Protocol Violation|0
2901498|NCT01732510|9993331|P5|Overall Study|Protocol Violation|0
2901499|NCT01732510|9993332|P4|Overall Study|Protocol Violation|1
2901500|NCT01732510|9993333|P3|Overall Study|Protocol Violation|0
2901501|NCT01732510|9993334|P2|Overall Study|Protocol Violation|0
2901502|NCT01732510|9993335|P1|Overall Study|Protocol Violation|0
2901503|NCT01732510|9993329|P7|Overall Study|Adverse Event|1
2901504|NCT01732510|9993330|P6|Overall Study|Adverse Event|0
2901505|NCT01732510|9993331|P5|Overall Study|Adverse Event|0
2901506|NCT01732510|9993332|P4|Overall Study|Adverse Event|0
2901507|NCT01732510|9993333|P3|Overall Study|Adverse Event|1
2901508|NCT01732510|9993334|P2|Overall Study|Adverse Event|1
2901509|NCT01732510|9993335|P1|Overall Study|Adverse Event|0
2901510|NCT01732484|9993414|P1|Overall Study|chronical illness|5
2901511|NCT01732484|9993414|P1|Overall Study|Lost to Follow-up|14
2901512|NCT01732484|9993414|P1|Overall Study|Death|7
2901513|NCT01732471|9993422|P1|Overall Study|Withdrawal by Subject|1
2901514|NCT01732458|9993433|P4|Overall Study|Screen Failure|0
2901515|NCT01732458|9993434|P3|Overall Study|Screen Failure|0
2901516|NCT01732458|9993435|P2|Overall Study|Screen Failure|1
2901517|NCT01732458|9993436|P1|Overall Study|Screen Failure|0
2901518|NCT01732458|9993433|P4|Overall Study|Protocol Violation|2
2901519|NCT01732458|9993434|P3|Overall Study|Protocol Violation|0
2901520|NCT01732458|9993435|P2|Overall Study|Protocol Violation|0
2901521|NCT01732458|9993436|P1|Overall Study|Protocol Violation|2
2901522|NCT01732458|9993433|P4|Overall Study|Physician Decision|0
2901523|NCT01732458|9993434|P3|Overall Study|Physician Decision|2
2901524|NCT01732458|9993435|P2|Overall Study|Physician Decision|2
2901525|NCT01732458|9993436|P1|Overall Study|Physician Decision|1
2901526|NCT01732458|9993433|P4|Overall Study|Non-Compliance With Study Drug|0
2901527|NCT01732458|9993434|P3|Overall Study|Non-Compliance With Study Drug|1
2901528|NCT01732458|9993435|P2|Overall Study|Non-Compliance With Study Drug|0
2901529|NCT01732458|9993436|P1|Overall Study|Non-Compliance With Study Drug|0
2901530|NCT01732458|9993433|P4|Overall Study|Lost to Follow-up|0
2901531|NCT01732458|9993434|P3|Overall Study|Lost to Follow-up|0
2901532|NCT01732458|9993435|P2|Overall Study|Lost to Follow-up|2
2901533|NCT01732458|9993436|P1|Overall Study|Lost to Follow-up|0
2901534|NCT01732107|9993598|P1|Overall Study|Withdrawal by Subject|2
2901535|NCT01732107|9993598|P1|Overall Study|Physician Decision|1
2901536|NCT01732107|9993598|P1|Overall Study|Disease Progression|8
2901537|NCT01732107|9993598|P1|Overall Study|Adverse Event|2
2901538|NCT01731990|9993615|P2|Overall Study|Death|0
2901539|NCT01731990|9993616|P1|Overall Study|Death|1
2901540|NCT01731990|9993615|P2|Overall Study|Protocol deviation|2
2901541|NCT01731990|9993616|P1|Overall Study|Protocol deviation|1
2901542|NCT01731990|9993615|P2|Overall Study|Withdrawal by Subject|1
2901543|NCT01731990|9993616|P1|Overall Study|Withdrawal by Subject|1
2901544|NCT01731990|9993615|P2|Overall Study|Adverse Event|5
2901545|NCT01731990|9993616|P1|Overall Study|Adverse Event|1
2901546|NCT01731938|9993632|P2|Primary Part II|Missed Week 6 visit|3
2901547|NCT01731938|9993633|P1|Primary Part II|Missed Week 6 visit|2
2901548|NCT01731938|9993632|P2|Primary Part II|Death|1
2901549|NCT01731938|9993633|P1|Primary Part II|Death|2
2901550|NCT01731938|9993632|P2|Primary Part II|Lost to Follow-up|5
2901551|NCT01731938|9993633|P1|Primary Part II|Lost to Follow-up|4
2901552|NCT01731938|9993632|P2|Primary Part II|Withdrawal by Subject|4
2901553|NCT01731938|9993633|P1|Primary Part II|Withdrawal by Subject|5
2901554|NCT01731938|9993632|P2|Preliminary Part I|Missed Week 6 visit|3
2901555|NCT01731938|9993633|P1|Preliminary Part I|Missed Week 6 visit|0
2901556|NCT01731938|9993632|P2|Preliminary Part I|Lost to Follow-up|3
2901557|NCT01731938|9993633|P1|Preliminary Part I|Lost to Follow-up|0
2901558|NCT01731938|9993632|P2|Preliminary Part I|Physician Decision|0
2901559|NCT01731938|9993633|P1|Preliminary Part I|Physician Decision|1
2901560|NCT01731938|9993632|P2|Preliminary Part I|Withdrawal by Subject|2
2901561|NCT01731938|9993633|P1|Preliminary Part I|Withdrawal by Subject|2
2901562|NCT01731912|9993645|P1|Overall Study|noncompliance|2
2901563|NCT01731886|9993652|P2|Overall Study|Non-compliant|0
2901564|NCT01731886|9993653|P1|Overall Study|Non-compliant|1
2901565|NCT01731886|9993652|P2|Overall Study|Never started treatment|1
2901566|NCT01731886|9993653|P1|Overall Study|Never started treatment|0
2901567|NCT01731886|9993652|P2|Overall Study|Death|0
2901568|NCT01731886|9993653|P1|Overall Study|Death|1
2901569|NCT01731678|9993667|P1|Overall Study|RMT too high, making TMS difficult|3
2901570|NCT01731678|9993667|P1|Overall Study|Did not meet inclusion criteria|1
2901571|NCT01731678|9993667|P1|Overall Study|Withdrawal by Subject|3
2901572|NCT01731600|9993673|P2|Overall Study|Other reasons|0
2901573|NCT01731600|9993674|P1|Overall Study|Other reasons|3
2901574|NCT01731600|9993673|P2|Overall Study|Withdrawal criteria|0
2901575|NCT01731600|9993674|P1|Overall Study|Withdrawal criteria|1
2901576|NCT01731600|9993673|P2|Overall Study|Adverse Event|0
2901577|NCT01731600|9993674|P1|Overall Study|Adverse Event|2
2901578|NCT01731470|9993728|P1|Overall Study|Did not meet study criteria|1
2901579|NCT01731470|9993728|P1|Overall Study|Withdrawal by Subject|1
2901580|NCT01731171|9993735|P2|Overall Study|Terminated for Safety Reasons|1
2901581|NCT01731171|9993736|P1|Overall Study|Terminated for Safety Reasons|0
2901582|NCT01731171|9993735|P2|Overall Study|Terminated for Lack of Adherence|1
2901583|NCT01731171|9993736|P1|Overall Study|Terminated for Lack of Adherence|0
2901584|NCT01731171|9993735|P2|Overall Study|Moved out of Area|2
2901585|NCT01731171|9993736|P1|Overall Study|Moved out of Area|0
2901586|NCT01731171|9993735|P2|Overall Study|Lost to Follow-up|2
2901587|NCT01731171|9993736|P1|Overall Study|Lost to Follow-up|3
2901588|NCT01731171|9993735|P2|Overall Study|Withdrawal by Subject|1
2901589|NCT01731171|9993736|P1|Overall Study|Withdrawal by Subject|4
2901590|NCT01731002|9993770|P3|Overall Study|Inappropriate use of study medications|1
2901591|NCT01731002|9993771|P2|Overall Study|Inappropriate use of study medications|0
2901592|NCT01731002|9993772|P1|Overall Study|Inappropriate use of study medications|0
2901593|NCT01731002|9993770|P3|Overall Study|Elevated IOP|0
2901594|NCT01731002|9993771|P2|Overall Study|Elevated IOP|0
2901595|NCT01731002|9993772|P1|Overall Study|Elevated IOP|1
2901596|NCT01731002|9993770|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2901597|NCT01731002|9993771|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2901598|NCT01731002|9993772|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
2901599|NCT01731002|9993770|P3|Overall Study|Test Agent Discontinuation|0
2901600|NCT01731002|9993771|P2|Overall Study|Test Agent Discontinuation|1
2901601|NCT01731002|9993772|P1|Overall Study|Test Agent Discontinuation|0
2901602|NCT01731002|9993770|P3|Overall Study|Lost to Follow-up|0
2901603|NCT01731002|9993771|P2|Overall Study|Lost to Follow-up|0
2901604|NCT01731002|9993772|P1|Overall Study|Lost to Follow-up|1
2901605|NCT01731002|9993770|P3|Overall Study|Non-Compliant|0
2901606|NCT01731002|9993771|P2|Overall Study|Non-Compliant|1
2901607|NCT01731002|9993772|P1|Overall Study|Non-Compliant|0
2901608|NCT01731002|9993770|P3|Overall Study|Adverse Event|2
2901609|NCT01731002|9993771|P2|Overall Study|Adverse Event|2
2901610|NCT01731002|9993772|P1|Overall Study|Adverse Event|0
2901611|NCT01730950|9993785|P2|Overall Study|Protocol Violation|6
2901612|NCT01730950|9993786|P1|Overall Study|Protocol Violation|6
2901613|NCT01730729|9993832|P1|Overall Study|Progressive Disease|12
2901614|NCT01730729|9993832|P1|Overall Study|Death|1
2901615|NCT01730729|9993832|P1|Overall Study|Adverse Event|1
2901616|NCT01730586|9993846|P1|Overall Study|Hospice|1
2901617|NCT01730586|9993846|P1|Overall Study|Adverse Event|2
2901618|NCT01730586|9993846|P1|Overall Study|Inadequate Trial|8
2901619|NCT01730586|9993846|P1|Overall Study|Progressive Disease|2
2901620|NCT01730534|9993855|P2|Overall Study|Lost to Follow-up|18
2901621|NCT01730534|9993856|P1|Overall Study|Lost to Follow-up|12
2901622|NCT01730534|9993855|P2|Overall Study|Withdrawal by Subject|127
2901623|NCT01730534|9993856|P1|Overall Study|Withdrawal by Subject|97
2901624|NCT01730378|9993870|P2|Overall Study|Lost to Follow-up|0
2901625|NCT01730378|9993871|P1|Overall Study|Lost to Follow-up|1
2901626|NCT01730339|9993902|P2|Overall Study|Un-specified|0
2901627|NCT01730339|9993903|P1|Overall Study|Un-specified|1
2901628|NCT01730339|9993902|P2|Overall Study|Lost to Follow-up|1
2901629|NCT01730339|9993903|P1|Overall Study|Lost to Follow-up|1
2901630|NCT01730339|9993902|P2|Overall Study|Withdrawal by Subject|2
2901631|NCT01730339|9993903|P1|Overall Study|Withdrawal by Subject|3
2901632|NCT01730053|9993943|P6|Overall Study|Other than specified|9
2901633|NCT01730053|9993944|P5|Overall Study|Other than specified|7
2901634|NCT01730053|9993945|P4|Overall Study|Other than specified|4
2901635|NCT01730053|9993946|P3|Overall Study|Other than specified|5
2901636|NCT01730053|9993947|P2|Overall Study|Other than specified|6
2901637|NCT01730053|9993948|P1|Overall Study|Other than specified|2
2901638|NCT01730053|9993943|P6|Overall Study|Poor compliance to protocol|2
2901639|NCT01730053|9993944|P5|Overall Study|Poor compliance to protocol|0
2901640|NCT01730053|9993945|P4|Overall Study|Poor compliance to protocol|0
2901641|NCT01730053|9993946|P3|Overall Study|Poor compliance to protocol|2
2901642|NCT01730053|9993947|P2|Overall Study|Poor compliance to protocol|2
2901643|NCT01730053|9993948|P1|Overall Study|Poor compliance to protocol|1
2901644|NCT01730053|9993943|P6|Overall Study|Adverse Event|2
2901645|NCT01730053|9993944|P5|Overall Study|Adverse Event|2
2901646|NCT01730053|9993945|P4|Overall Study|Adverse Event|3
2901647|NCT01730053|9993946|P3|Overall Study|Adverse Event|3
2901648|NCT01730053|9993947|P2|Overall Study|Adverse Event|6
2901649|NCT01730053|9993948|P1|Overall Study|Adverse Event|2
2901650|NCT01730053|9993943|P6|Overall Study|Physician Decision|0
2901651|NCT01730053|9993944|P5|Overall Study|Physician Decision|0
2901652|NCT01730053|9993945|P4|Overall Study|Physician Decision|1
2901653|NCT01730053|9993946|P3|Overall Study|Physician Decision|0
2901654|NCT01730053|9993947|P2|Overall Study|Physician Decision|0
2901655|NCT01730053|9993948|P1|Overall Study|Physician Decision|0
2901656|NCT01730053|9993943|P6|Overall Study|Participant moved|0
2901657|NCT01730053|9993944|P5|Overall Study|Participant moved|0
2901658|NCT01730053|9993945|P4|Overall Study|Participant moved|0
2901659|NCT01730053|9993946|P3|Overall Study|Participant moved|1
2901660|NCT01730053|9993947|P2|Overall Study|Participant moved|0
2901661|NCT01730053|9993948|P1|Overall Study|Participant moved|0
2901662|NCT01730040|9994107|P7|Overall Study|Poor compliance to protocol|1
2901663|NCT01730040|9994108|P6|Overall Study|Poor compliance to protocol|0
2901664|NCT01730040|9994109|P5|Overall Study|Poor compliance to protocol|0
2901665|NCT01730040|9994110|P4|Overall Study|Poor compliance to protocol|0
2901666|NCT01730040|9994111|P3|Overall Study|Poor compliance to protocol|0
2901667|NCT01730040|9994112|P2|Overall Study|Poor compliance to protocol|4
2901668|NCT01730040|9994113|P1|Overall Study|Poor compliance to protocol|2
2901669|NCT01730040|9994107|P7|Overall Study|Adverse Event|2
2901670|NCT01730040|9994108|P6|Overall Study|Adverse Event|1
2901671|NCT01730040|9994109|P5|Overall Study|Adverse Event|1
2901672|NCT01730040|9994110|P4|Overall Study|Adverse Event|3
2901673|NCT01730040|9994111|P3|Overall Study|Adverse Event|5
2901674|NCT01730040|9994112|P2|Overall Study|Adverse Event|3
2901675|NCT01730040|9994113|P1|Overall Study|Adverse Event|4
2901676|NCT01730040|9994107|P7|Overall Study|Other than specified|4
2901677|NCT01730040|9994108|P6|Overall Study|Other than specified|4
2901678|NCT01730040|9994109|P5|Overall Study|Other than specified|5
2901679|NCT01730040|9994110|P4|Overall Study|Other than specified|5
2901680|NCT01730040|9994111|P3|Overall Study|Other than specified|5
2901681|NCT01730040|9994112|P2|Overall Study|Other than specified|8
2901682|NCT01730040|9994113|P1|Overall Study|Other than specified|7
2901683|NCT01730040|9994107|P7|Overall Study|Physician Decision|1
2901684|NCT01730040|9994108|P6|Overall Study|Physician Decision|1
2901685|NCT01730040|9994109|P5|Overall Study|Physician Decision|0
2901686|NCT01730040|9994110|P4|Overall Study|Physician Decision|0
2901687|NCT01730040|9994111|P3|Overall Study|Physician Decision|0
2901688|NCT01730040|9994112|P2|Overall Study|Physician Decision|0
2901689|NCT01730040|9994113|P1|Overall Study|Physician Decision|0
2901690|NCT01730040|9994107|P7|Overall Study|Subject moved|1
2901691|NCT01730040|9994108|P6|Overall Study|Subject moved|0
2901692|NCT01730040|9994109|P5|Overall Study|Subject moved|0
2901693|NCT01730040|9994110|P4|Overall Study|Subject moved|0
2901694|NCT01730040|9994111|P3|Overall Study|Subject moved|1
2901695|NCT01730040|9994112|P2|Overall Study|Subject moved|0
2901696|NCT01730040|9994113|P1|Overall Study|Subject moved|0
2901697|NCT01730040|9994107|P7|Overall Study|Randomized but not treated|0
2901698|NCT01730040|9994108|P6|Overall Study|Randomized but not treated|1
2901699|NCT01730040|9994109|P5|Overall Study|Randomized but not treated|0
2901700|NCT01730040|9994110|P4|Overall Study|Randomized but not treated|0
2901701|NCT01730040|9994111|P3|Overall Study|Randomized but not treated|0
2901702|NCT01730040|9994112|P2|Overall Study|Randomized but not treated|0
2901703|NCT01730040|9994113|P1|Overall Study|Randomized but not treated|0
2901704|NCT01729871|9994302|P2|Overall Study|Other|9
2901705|NCT01729871|9994303|P1|Overall Study|Other|4
2901706|NCT01729871|9994302|P2|Overall Study|Withdrawal by Subject|3
2901707|NCT01729871|9994303|P1|Overall Study|Withdrawal by Subject|0
2901708|NCT01729871|9994302|P2|Overall Study|Protocol Violation|0
2901709|NCT01729871|9994303|P1|Overall Study|Protocol Violation|1
2901710|NCT01729871|9994302|P2|Overall Study|Physician Decision|2
2901711|NCT01729871|9994303|P1|Overall Study|Physician Decision|0
2901712|NCT01729871|9994302|P2|Overall Study|Lack of Efficacy|1
2901713|NCT01729871|9994303|P1|Overall Study|Lack of Efficacy|0
2901714|NCT01729871|9994302|P2|Overall Study|Death|1
2901715|NCT01729871|9994303|P1|Overall Study|Death|0
2901716|NCT01729871|9994302|P2|Overall Study|Adverse Event|7
2901717|NCT01729871|9994303|P1|Overall Study|Adverse Event|7
2901718|NCT01729819|9994337|P2|Overall Study|Withdrawal by Subject|2
2901719|NCT01729819|9994338|P1|Overall Study|Withdrawal by Subject|0
2901720|NCT01729819|9994337|P2|Overall Study|Protocol Violation|1
2901721|NCT01729819|9994338|P1|Overall Study|Protocol Violation|0
2901722|NCT01729819|9994337|P2|Overall Study|Other reason|0
2901723|NCT01729819|9994338|P1|Overall Study|Other reason|1
2901724|NCT01729819|9994337|P2|Overall Study|Lost to Follow-up|0
2901725|NCT01729819|9994338|P1|Overall Study|Lost to Follow-up|2
2901726|NCT01729819|9994337|P2|Overall Study|Lack of Efficacy|0
2901727|NCT01729819|9994338|P1|Overall Study|Lack of Efficacy|1
2901728|NCT01729819|9994337|P2|Overall Study|Adverse Event|4
2901729|NCT01729819|9994338|P1|Overall Study|Adverse Event|2
2901730|NCT01729754|9994357|P10|Part 3|Other Protocol Specified Criteria|0
2901731|NCT01729754|9994358|P9|Part 3|Other Protocol Specified Criteria|0
2901732|NCT01729754|9994359|P8|Part 3|Other Protocol Specified Criteria|1
2901733|NCT01729754|9994360|P7|Part 3|Other Protocol Specified Criteria|0
2901734|NCT01729754|9994361|P6|Part 3|Other Protocol Specified Criteria|2
2901735|NCT01729754|9994362|P5|Part 3|Other Protocol Specified Criteria|0
2901736|NCT01729754|9994363|P4|Part 3|Other Protocol Specified Criteria|0
2901737|NCT01729754|9994364|P3|Part 3|Other Protocol Specified Criteria|0
2901738|NCT01729754|9994365|P2|Part 3|Other Protocol Specified Criteria|0
2901739|NCT01729754|9994366|P1|Part 3|Other Protocol Specified Criteria|0
2901740|NCT01729754|9994357|P10|Part 3|Withdrawal by Subject|0
2901741|NCT01729754|9994358|P9|Part 3|Withdrawal by Subject|0
2901742|NCT01729754|9994359|P8|Part 3|Withdrawal by Subject|2
2901743|NCT01729754|9994360|P7|Part 3|Withdrawal by Subject|0
2901744|NCT01729754|9994361|P6|Part 3|Withdrawal by Subject|1
2901745|NCT01729754|9994362|P5|Part 3|Withdrawal by Subject|2
2901746|NCT01729754|9994363|P4|Part 3|Withdrawal by Subject|0
2901747|NCT01729754|9994364|P3|Part 3|Withdrawal by Subject|1
2901748|NCT01729754|9994365|P2|Part 3|Withdrawal by Subject|4
2901749|NCT01729754|9994366|P1|Part 3|Withdrawal by Subject|0
2901750|NCT01729754|9994357|P10|Part 3|Physician Decision|0
2901751|NCT01729754|9994358|P9|Part 3|Physician Decision|0
2901752|NCT01729754|9994359|P8|Part 3|Physician Decision|0
2901753|NCT01729754|9994360|P7|Part 3|Physician Decision|0
2901754|NCT01729754|9994361|P6|Part 3|Physician Decision|0
2901755|NCT01729754|9994362|P5|Part 3|Physician Decision|0
2901756|NCT01729754|9994363|P4|Part 3|Physician Decision|0
2901757|NCT01729754|9994364|P3|Part 3|Physician Decision|1
2901758|NCT01729754|9994365|P2|Part 3|Physician Decision|0
2901759|NCT01729754|9994366|P1|Part 3|Physician Decision|0
2901760|NCT01729754|9994357|P10|Part 3|Lost to Follow-up|0
2901761|NCT01729754|9994358|P9|Part 3|Lost to Follow-up|1
2901762|NCT01729754|9994359|P8|Part 3|Lost to Follow-up|0
2901763|NCT01729754|9994360|P7|Part 3|Lost to Follow-up|0
2901764|NCT01729754|9994361|P6|Part 3|Lost to Follow-up|3
2901765|NCT01729754|9994362|P5|Part 3|Lost to Follow-up|0
2901766|NCT01729754|9994363|P4|Part 3|Lost to Follow-up|0
2901767|NCT01729754|9994364|P3|Part 3|Lost to Follow-up|2
2901768|NCT01729754|9994365|P2|Part 3|Lost to Follow-up|1
2901769|NCT01729754|9994366|P1|Part 3|Lost to Follow-up|0
2901770|NCT01729754|9994357|P10|Part 3|Lack of Efficacy|4
2901771|NCT01729754|9994358|P9|Part 3|Lack of Efficacy|0
2901772|NCT01729754|9994359|P8|Part 3|Lack of Efficacy|0
2901773|NCT01729754|9994360|P7|Part 3|Lack of Efficacy|0
2901774|NCT01729754|9994361|P6|Part 3|Lack of Efficacy|0
2901775|NCT01729754|9994362|P5|Part 3|Lack of Efficacy|2
2901776|NCT01729754|9994363|P4|Part 3|Lack of Efficacy|0
2901777|NCT01729754|9994364|P3|Part 3|Lack of Efficacy|0
2901778|NCT01729754|9994365|P2|Part 3|Lack of Efficacy|0
2901779|NCT01729754|9994366|P1|Part 3|Lack of Efficacy|0
2901780|NCT01729754|9994357|P10|Part 3|Death|0
2901781|NCT01729754|9994358|P9|Part 3|Death|0
2901782|NCT01729754|9994359|P8|Part 3|Death|0
2901783|NCT01729754|9994360|P7|Part 3|Death|0
2901784|NCT01729754|9994361|P6|Part 3|Death|2
2901785|NCT01729754|9994362|P5|Part 3|Death|0
2901786|NCT01729754|9994363|P4|Part 3|Death|0
2901787|NCT01729754|9994364|P3|Part 3|Death|0
2901788|NCT01729754|9994365|P2|Part 3|Death|0
2901789|NCT01729754|9994366|P1|Part 3|Death|0
2901790|NCT01729754|9994357|P10|Part 3|Adverse Event|3
2901791|NCT01729754|9994358|P9|Part 3|Adverse Event|0
2901792|NCT01729754|9994359|P8|Part 3|Adverse Event|0
2901793|NCT01729754|9994360|P7|Part 3|Adverse Event|0
2901794|NCT01729754|9994361|P6|Part 3|Adverse Event|5
2901795|NCT01729754|9994362|P5|Part 3|Adverse Event|0
2901796|NCT01729754|9994363|P4|Part 3|Adverse Event|0
2901797|NCT01729754|9994364|P3|Part 3|Adverse Event|1
2901798|NCT01729754|9994365|P2|Part 3|Adverse Event|0
2901799|NCT01729754|9994366|P1|Part 3|Adverse Event|0
2901800|NCT01729754|9994357|P10|Part 2|Other Protocol Specified Criteria|0
2901801|NCT01729754|9994358|P9|Part 2|Other Protocol Specified Criteria|0
2901802|NCT01729754|9994359|P8|Part 2|Other Protocol Specified Criteria|1
2901803|NCT01729754|9994360|P7|Part 2|Other Protocol Specified Criteria|0
2901804|NCT01729754|9994361|P6|Part 2|Other Protocol Specified Criteria|0
2901805|NCT01729754|9994362|P5|Part 2|Other Protocol Specified Criteria|0
2901806|NCT01729754|9994363|P4|Part 2|Other Protocol Specified Criteria|0
2901807|NCT01729754|9994364|P3|Part 2|Other Protocol Specified Criteria|0
2901808|NCT01729754|9994365|P2|Part 2|Other Protocol Specified Criteria|0
2901809|NCT01729754|9994366|P1|Part 2|Other Protocol Specified Criteria|1
2901810|NCT01729754|9994357|P10|Part 2|Withdrawal by Subject|4
2901811|NCT01729754|9994358|P9|Part 2|Withdrawal by Subject|1
2901812|NCT01729754|9994359|P8|Part 2|Withdrawal by Subject|1
2901813|NCT01729754|9994360|P7|Part 2|Withdrawal by Subject|0
2901814|NCT01729754|9994361|P6|Part 2|Withdrawal by Subject|0
2901815|NCT01729754|9994362|P5|Part 2|Withdrawal by Subject|0
2901816|NCT01729754|9994363|P4|Part 2|Withdrawal by Subject|2
2901817|NCT01729754|9994364|P3|Part 2|Withdrawal by Subject|0
2901818|NCT01729754|9994365|P2|Part 2|Withdrawal by Subject|0
2901819|NCT01729754|9994366|P1|Part 2|Withdrawal by Subject|3
2901820|NCT01729754|9994357|P10|Part 2|Pregnancy|1
2901821|NCT01729754|9994358|P9|Part 2|Pregnancy|0
2901822|NCT01729754|9994359|P8|Part 2|Pregnancy|0
2901823|NCT01729754|9994360|P7|Part 2|Pregnancy|0
2901824|NCT01729754|9994361|P6|Part 2|Pregnancy|0
2901825|NCT01729754|9994362|P5|Part 2|Pregnancy|0
2901826|NCT01729754|9994363|P4|Part 2|Pregnancy|1
2901827|NCT01729754|9994364|P3|Part 2|Pregnancy|0
2901828|NCT01729754|9994365|P2|Part 2|Pregnancy|0
2901829|NCT01729754|9994366|P1|Part 2|Pregnancy|0
2901830|NCT01729754|9994357|P10|Part 2|Non-Compliance with Study Drug|1
2901831|NCT01729754|9994358|P9|Part 2|Non-Compliance with Study Drug|0
2901832|NCT01729754|9994359|P8|Part 2|Non-Compliance with Study Drug|0
2901833|NCT01729754|9994360|P7|Part 2|Non-Compliance with Study Drug|0
2901834|NCT01729754|9994361|P6|Part 2|Non-Compliance with Study Drug|0
2901835|NCT01729754|9994362|P5|Part 2|Non-Compliance with Study Drug|0
2901836|NCT01729754|9994363|P4|Part 2|Non-Compliance with Study Drug|0
2901837|NCT01729754|9994364|P3|Part 2|Non-Compliance with Study Drug|0
2901838|NCT01729754|9994365|P2|Part 2|Non-Compliance with Study Drug|0
2901839|NCT01729754|9994366|P1|Part 2|Non-Compliance with Study Drug|0
2901840|NCT01729754|9994357|P10|Part 2|Lost to Follow-up|2
2901841|NCT01729754|9994358|P9|Part 2|Lost to Follow-up|0
2901842|NCT01729754|9994359|P8|Part 2|Lost to Follow-up|1
2901843|NCT01729754|9994360|P7|Part 2|Lost to Follow-up|0
2901844|NCT01729754|9994361|P6|Part 2|Lost to Follow-up|0
2901845|NCT01729754|9994362|P5|Part 2|Lost to Follow-up|0
2901846|NCT01729754|9994363|P4|Part 2|Lost to Follow-up|2
2901847|NCT01729754|9994364|P3|Part 2|Lost to Follow-up|0
2901848|NCT01729754|9994365|P2|Part 2|Lost to Follow-up|0
2901849|NCT01729754|9994366|P1|Part 2|Lost to Follow-up|0
2901850|NCT01729754|9994357|P10|Part 2|Lack of Efficacy|2
2901851|NCT01729754|9994358|P9|Part 2|Lack of Efficacy|2
2901852|NCT01729754|9994359|P8|Part 2|Lack of Efficacy|0
2901853|NCT01729754|9994360|P7|Part 2|Lack of Efficacy|0
2901854|NCT01729754|9994361|P6|Part 2|Lack of Efficacy|0
2901855|NCT01729754|9994362|P5|Part 2|Lack of Efficacy|0
2901856|NCT01729754|9994363|P4|Part 2|Lack of Efficacy|0
2901857|NCT01729754|9994364|P3|Part 2|Lack of Efficacy|0
2901858|NCT01729754|9994365|P2|Part 2|Lack of Efficacy|0
2901859|NCT01729754|9994366|P1|Part 2|Lack of Efficacy|0
2901860|NCT01729754|9994357|P10|Part 2|Adverse Event|2
2901861|NCT01729754|9994358|P9|Part 2|Adverse Event|1
2901862|NCT01729754|9994359|P8|Part 2|Adverse Event|0
2901863|NCT01729754|9994360|P7|Part 2|Adverse Event|0
2901864|NCT01729754|9994361|P6|Part 2|Adverse Event|0
2901865|NCT01729754|9994362|P5|Part 2|Adverse Event|0
2901866|NCT01729754|9994363|P4|Part 2|Adverse Event|0
2901867|NCT01729754|9994364|P3|Part 2|Adverse Event|0
2901868|NCT01729754|9994365|P2|Part 2|Adverse Event|0
2901869|NCT01729754|9994366|P1|Part 2|Adverse Event|2
2901870|NCT01729754|9994357|P10|Part 1|Other Protocol Specified Criteria|4
2901871|NCT01729754|9994358|P9|Part 1|Other Protocol Specified Criteria|0
2901872|NCT01729754|9994359|P8|Part 1|Other Protocol Specified Criteria|0
2901873|NCT01729754|9994360|P7|Part 1|Other Protocol Specified Criteria|1
2901874|NCT01729754|9994361|P6|Part 1|Other Protocol Specified Criteria|0
2901875|NCT01729754|9994362|P5|Part 1|Other Protocol Specified Criteria|0
2901876|NCT01729754|9994363|P4|Part 1|Other Protocol Specified Criteria|0
2901877|NCT01729754|9994364|P3|Part 1|Other Protocol Specified Criteria|0
2901878|NCT01729754|9994365|P2|Part 1|Other Protocol Specified Criteria|0
2901879|NCT01729754|9994366|P1|Part 1|Other Protocol Specified Criteria|2
2901880|NCT01729754|9994357|P10|Part 1|Withdrawal by Subject|6
2901881|NCT01729754|9994358|P9|Part 1|Withdrawal by Subject|0
2901882|NCT01729754|9994359|P8|Part 1|Withdrawal by Subject|0
2901883|NCT01729754|9994360|P7|Part 1|Withdrawal by Subject|5
2901884|NCT01729754|9994361|P6|Part 1|Withdrawal by Subject|0
2901885|NCT01729754|9994362|P5|Part 1|Withdrawal by Subject|0
2901886|NCT01729754|9994363|P4|Part 1|Withdrawal by Subject|7
2901887|NCT01729754|9994364|P3|Part 1|Withdrawal by Subject|0
2901888|NCT01729754|9994365|P2|Part 1|Withdrawal by Subject|0
2901889|NCT01729754|9994366|P1|Part 1|Withdrawal by Subject|5
2901890|NCT01729754|9994357|P10|Part 1|Protocol Violation|0
2901891|NCT01729754|9994358|P9|Part 1|Protocol Violation|0
2901892|NCT01729754|9994359|P8|Part 1|Protocol Violation|0
2901893|NCT01729754|9994360|P7|Part 1|Protocol Violation|1
2901894|NCT01729754|9994361|P6|Part 1|Protocol Violation|0
2901895|NCT01729754|9994362|P5|Part 1|Protocol Violation|0
2901896|NCT01729754|9994363|P4|Part 1|Protocol Violation|1
2901897|NCT01729754|9994364|P3|Part 1|Protocol Violation|0
2901898|NCT01729754|9994365|P2|Part 1|Protocol Violation|0
2901899|NCT01729754|9994366|P1|Part 1|Protocol Violation|2
2901900|NCT01729754|9994357|P10|Part 1|Progressive Disease|1
2901901|NCT01729754|9994358|P9|Part 1|Progressive Disease|0
2901902|NCT01729754|9994359|P8|Part 1|Progressive Disease|0
2901903|NCT01729754|9994360|P7|Part 1|Progressive Disease|0
2901904|NCT01729754|9994361|P6|Part 1|Progressive Disease|0
2901905|NCT01729754|9994362|P5|Part 1|Progressive Disease|0
2901906|NCT01729754|9994363|P4|Part 1|Progressive Disease|0
2901907|NCT01729754|9994364|P3|Part 1|Progressive Disease|0
2901908|NCT01729754|9994365|P2|Part 1|Progressive Disease|0
2901909|NCT01729754|9994366|P1|Part 1|Progressive Disease|0
2901910|NCT01729754|9994357|P10|Part 1|Pregnancy|1
2901911|NCT01729754|9994358|P9|Part 1|Pregnancy|0
2901912|NCT01729754|9994359|P8|Part 1|Pregnancy|0
2901913|NCT01729754|9994360|P7|Part 1|Pregnancy|0
2901914|NCT01729754|9994361|P6|Part 1|Pregnancy|0
2901915|NCT01729754|9994362|P5|Part 1|Pregnancy|0
2901916|NCT01729754|9994363|P4|Part 1|Pregnancy|1
2901917|NCT01729754|9994364|P3|Part 1|Pregnancy|0
2901918|NCT01729754|9994365|P2|Part 1|Pregnancy|0
2901919|NCT01729754|9994366|P1|Part 1|Pregnancy|0
2901920|NCT01729754|9994357|P10|Part 1|Physician Decision|4
2901921|NCT01729754|9994358|P9|Part 1|Physician Decision|0
2901922|NCT01729754|9994359|P8|Part 1|Physician Decision|0
2901923|NCT01729754|9994360|P7|Part 1|Physician Decision|0
2901924|NCT01729754|9994361|P6|Part 1|Physician Decision|0
2901925|NCT01729754|9994362|P5|Part 1|Physician Decision|0
2901926|NCT01729754|9994363|P4|Part 1|Physician Decision|0
2901927|NCT01729754|9994364|P3|Part 1|Physician Decision|0
2901928|NCT01729754|9994365|P2|Part 1|Physician Decision|0
2901929|NCT01729754|9994366|P1|Part 1|Physician Decision|0
2901930|NCT01729754|9994357|P10|Part 1|Non-compliance with Study Drug|0
2901931|NCT01729754|9994358|P9|Part 1|Non-compliance with Study Drug|0
2901932|NCT01729754|9994359|P8|Part 1|Non-compliance with Study Drug|0
2901933|NCT01729754|9994360|P7|Part 1|Non-compliance with Study Drug|0
2901934|NCT01729754|9994361|P6|Part 1|Non-compliance with Study Drug|0
2901935|NCT01729754|9994362|P5|Part 1|Non-compliance with Study Drug|0
2901936|NCT01729754|9994363|P4|Part 1|Non-compliance with Study Drug|0
2901937|NCT01729754|9994364|P3|Part 1|Non-compliance with Study Drug|0
2901938|NCT01729754|9994365|P2|Part 1|Non-compliance with Study Drug|0
2901939|NCT01729754|9994366|P1|Part 1|Non-compliance with Study Drug|1
2901940|NCT01729754|9994357|P10|Part 1|Lost to Follow-up|3
2901941|NCT01729754|9994358|P9|Part 1|Lost to Follow-up|0
2901942|NCT01729754|9994359|P8|Part 1|Lost to Follow-up|0
2901943|NCT01729754|9994360|P7|Part 1|Lost to Follow-up|3
2901944|NCT01729754|9994361|P6|Part 1|Lost to Follow-up|0
2901945|NCT01729754|9994362|P5|Part 1|Lost to Follow-up|0
2901946|NCT01729754|9994363|P4|Part 1|Lost to Follow-up|2
2901947|NCT01729754|9994364|P3|Part 1|Lost to Follow-up|0
2901948|NCT01729754|9994365|P2|Part 1|Lost to Follow-up|0
2901949|NCT01729754|9994366|P1|Part 1|Lost to Follow-up|1
2901950|NCT01729754|9994357|P10|Part 1|Lack of Efficacy|0
2901951|NCT01729754|9994358|P9|Part 1|Lack of Efficacy|0
2901952|NCT01729754|9994359|P8|Part 1|Lack of Efficacy|0
2901953|NCT01729754|9994360|P7|Part 1|Lack of Efficacy|2
2901954|NCT01729754|9994361|P6|Part 1|Lack of Efficacy|0
2901955|NCT01729754|9994362|P5|Part 1|Lack of Efficacy|0
2901956|NCT01729754|9994363|P4|Part 1|Lack of Efficacy|0
2901957|NCT01729754|9994364|P3|Part 1|Lack of Efficacy|0
2901958|NCT01729754|9994365|P2|Part 1|Lack of Efficacy|0
2901959|NCT01729754|9994366|P1|Part 1|Lack of Efficacy|1
2901960|NCT01729754|9994357|P10|Part 1|Adverse Event|5
2901961|NCT01729754|9994358|P9|Part 1|Adverse Event|0
2901962|NCT01729754|9994359|P8|Part 1|Adverse Event|0
2901963|NCT01729754|9994360|P7|Part 1|Adverse Event|2
2901964|NCT01729754|9994361|P6|Part 1|Adverse Event|0
2901965|NCT01729754|9994362|P5|Part 1|Adverse Event|0
2901966|NCT01729754|9994363|P4|Part 1|Adverse Event|1
2901967|NCT01729754|9994364|P3|Part 1|Adverse Event|0
2901968|NCT01729754|9994365|P2|Part 1|Adverse Event|0
2901969|NCT01729754|9994366|P1|Part 1|Adverse Event|2
2901970|NCT01729728|9994573|P3|Overall Study|Protocol Violation|1
2901971|NCT01729728|9994574|P2|Overall Study|Protocol Violation|0
2901972|NCT01729728|9994575|P1|Overall Study|Protocol Violation|1
2901973|NCT01729728|9994573|P3|Overall Study|Adverse Event|0
2901974|NCT01729728|9994574|P2|Overall Study|Adverse Event|6
2901975|NCT01729728|9994575|P1|Overall Study|Adverse Event|0
2901976|NCT01729559|9994725|P2|Overall Study|Protocol Violation|28
2901977|NCT01729559|9994726|P1|Overall Study|Protocol Violation|31
2901978|NCT01729208|9994769|P2|36 Months Follow-up|Withdrawal by Subject|4
2901979|NCT01729208|9994770|P1|36 Months Follow-up|Withdrawal by Subject|2
2901980|NCT01729208|9994769|P2|36 Months Follow-up|Physician Decision|0
2901981|NCT01729208|9994770|P1|36 Months Follow-up|Physician Decision|1
2901982|NCT01729208|9994769|P2|24 Months Follow-up|Lost to Follow-up|0
2901983|NCT01729208|9994770|P1|24 Months Follow-up|Lost to Follow-up|3
2901984|NCT01729208|9994769|P2|12 Months Follow-up|Lost to Follow-up|3
2901985|NCT01729208|9994770|P1|12 Months Follow-up|Lost to Follow-up|3
2901986|NCT01729208|9994769|P2|12 Months Follow-up|Withdrawal by Subject|7
2901987|NCT01729208|9994770|P1|12 Months Follow-up|Withdrawal by Subject|4
2901988|NCT01729208|9994769|P2|Baseline|Physician Decision|4
2901989|NCT01729208|9994770|P1|Baseline|Physician Decision|5
2901990|NCT01729156|9994803|P3|Overall Study|Withdrawal by Subject|0
2901991|NCT01729156|9994804|P2|Overall Study|Withdrawal by Subject|0
2901992|NCT01729156|9994805|P1|Overall Study|Withdrawal by Subject|1
2901993|NCT01729039|9994833|P2|Overall Study|Withdrawal by Subject|7
2901994|NCT01729039|9994834|P1|Overall Study|Withdrawal by Subject|8
2901995|NCT01729039|9994833|P2|Overall Study|disqualified|5
2901996|NCT01729039|9994834|P1|Overall Study|disqualified|2
2901997|NCT01729026|9994850|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
2901998|NCT01729026|9994851|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
2901999|NCT01729026|9994850|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
2902000|NCT01729026|9994851|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
2902001|NCT01728792|9994879|P5|Overall Study|Lost to Follow-up|0
2902002|NCT01728792|9994880|P4|Overall Study|Lost to Follow-up|2
2902003|NCT01728792|9994881|P3|Overall Study|Lost to Follow-up|4
2902004|NCT01728792|9994882|P2|Overall Study|Lost to Follow-up|1
2902005|NCT01728792|9994883|P1|Overall Study|Lost to Follow-up|2
2902006|NCT01728792|9994879|P5|Overall Study|Withdrawal of Consent|0
2902007|NCT01728792|9994880|P4|Overall Study|Withdrawal of Consent|1
2902008|NCT01728792|9994881|P3|Overall Study|Withdrawal of Consent|0
2902009|NCT01728792|9994882|P2|Overall Study|Withdrawal of Consent|1
2902010|NCT01728792|9994883|P1|Overall Study|Withdrawal of Consent|1
2902011|NCT01728584|9994934|P4|Overall Study|Other reason (not specified)|1
2902012|NCT01728584|9994935|P3|Overall Study|Other reason (not specified)|0
2902013|NCT01728584|9994936|P2|Overall Study|Other reason (not specified)|0
2902014|NCT01728584|9994937|P1|Overall Study|Other reason (not specified)|1
2902015|NCT01728584|9994934|P4|Overall Study|Screen failure|0
2902016|NCT01728584|9994935|P3|Overall Study|Screen failure|0
2902017|NCT01728584|9994936|P2|Overall Study|Screen failure|0
2902018|NCT01728584|9994937|P1|Overall Study|Screen failure|1
2902019|NCT01728584|9994934|P4|Overall Study|Withdrawal by Subject|0
2902020|NCT01728584|9994935|P3|Overall Study|Withdrawal by Subject|0
2902021|NCT01728584|9994936|P2|Overall Study|Withdrawal by Subject|0
2902022|NCT01728584|9994937|P1|Overall Study|Withdrawal by Subject|1
2902023|NCT01728584|9994934|P4|Overall Study|Physician Decision|0
2902024|NCT01728584|9994935|P3|Overall Study|Physician Decision|1
2902025|NCT01728584|9994936|P2|Overall Study|Physician Decision|0
2902026|NCT01728584|9994937|P1|Overall Study|Physician Decision|4
2902027|NCT01728584|9994934|P4|Overall Study|Adverse Event|0
2902028|NCT01728584|9994935|P3|Overall Study|Adverse Event|0
2902029|NCT01728584|9994936|P2|Overall Study|Adverse Event|0
2902030|NCT01728584|9994937|P1|Overall Study|Adverse Event|1
2902031|NCT01728454|9994992|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2902032|NCT01728454|9994993|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2902033|NCT01728454|9994994|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
2902034|NCT01728454|9994992|P3|Stage 3|Lost to Follow-up|1
2902035|NCT01728454|9994993|P2|Stage 3|Lost to Follow-up|3
2902036|NCT01728454|9994994|P1|Stage 3|Lost to Follow-up|0
2902037|NCT01728454|9994992|P3|Stage 3|Non-compliance with Protocol|1
2902038|NCT01728454|9994993|P2|Stage 3|Non-compliance with Protocol|0
2902039|NCT01728454|9994994|P1|Stage 3|Non-compliance with Protocol|0
2902040|NCT01728454|9994992|P3|Stage 3|Withdrew Consent|1
2902041|NCT01728454|9994993|P2|Stage 3|Withdrew Consent|0
2902042|NCT01728454|9994994|P1|Stage 3|Withdrew Consent|1
2902043|NCT01728454|9994992|P3|Stage 3|Pregnancy|0
2902044|NCT01728454|9994993|P2|Stage 3|Pregnancy|0
2902045|NCT01728454|9994994|P1|Stage 3|Pregnancy|1
2902046|NCT01728454|9994992|P3|Stage 3|Subject Required Other Treatment|0
2902047|NCT01728454|9994993|P2|Stage 3|Subject Required Other Treatment|1
2902048|NCT01728454|9994994|P1|Stage 3|Subject Required Other Treatment|0
2902049|NCT01728454|9994992|P3|Stage 3|Reason Missing|1
2902050|NCT01728454|9994993|P2|Stage 3|Reason Missing|0
2902051|NCT01728454|9994994|P1|Stage 3|Reason Missing|0
2902052|NCT01728454|9994992|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2902053|NCT01728454|9994993|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2902054|NCT01728454|9994994|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
2902055|NCT01728454|9994992|P3|Stage 1 and 2|Lost to Follow-up|0
2902056|NCT01728454|9994993|P2|Stage 1 and 2|Lost to Follow-up|1
2902057|NCT01728454|9994994|P1|Stage 1 and 2|Lost to Follow-up|1
2902058|NCT01728454|9994992|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2902059|NCT01728454|9994993|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2902060|NCT01728454|9994994|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
2902061|NCT01728454|9994992|P3|Stage 1 and 2|Non-compliance with Protocol|1
2902062|NCT01728454|9994993|P2|Stage 1 and 2|Non-compliance with Protocol|0
2902063|NCT01728454|9994994|P1|Stage 1 and 2|Non-compliance with Protocol|0
2902064|NCT01728454|9994992|P3|Stage 1 and 2|Pregnancy|0
2902065|NCT01728454|9994993|P2|Stage 1 and 2|Pregnancy|0
2902066|NCT01728454|9994994|P1|Stage 1 and 2|Pregnancy|1
2902067|NCT01728376|9995044|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
2902068|NCT01728376|9995045|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
2902069|NCT01728376|9995046|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
2902070|NCT01728376|9995047|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
2902071|NCT01728376|9995048|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
2902072|NCT01728376|9995049|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
2902073|NCT01728376|9995044|P6|Overall Study|Did not receive treatment|0
2902074|NCT01728376|9995045|P5|Overall Study|Did not receive treatment|0
2902075|NCT01728376|9995046|P4|Overall Study|Did not receive treatment|0
2902076|NCT01728376|9995047|P3|Overall Study|Did not receive treatment|0
2902077|NCT01728376|9995048|P2|Overall Study|Did not receive treatment|1
2902078|NCT01728376|9995049|P1|Overall Study|Did not receive treatment|0
2902079|NCT01728376|9995044|P6|Overall Study|No relevant bacteria|1
2902080|NCT01728376|9995045|P5|Overall Study|No relevant bacteria|1
2902081|NCT01728376|9995046|P4|Overall Study|No relevant bacteria|0
2902082|NCT01728376|9995047|P3|Overall Study|No relevant bacteria|0
2902083|NCT01728376|9995048|P2|Overall Study|No relevant bacteria|0
2902084|NCT01728376|9995049|P1|Overall Study|No relevant bacteria|2
2902085|NCT01728376|9995044|P6|Overall Study|Persistent Positive Blood Cultures|0
2902086|NCT01728376|9995045|P5|Overall Study|Persistent Positive Blood Cultures|0
2902087|NCT01728376|9995046|P4|Overall Study|Persistent Positive Blood Cultures|0
2902088|NCT01728376|9995047|P3|Overall Study|Persistent Positive Blood Cultures|1
2902089|NCT01728376|9995048|P2|Overall Study|Persistent Positive Blood Cultures|0
2902090|NCT01728376|9995049|P1|Overall Study|Persistent Positive Blood Cultures|1
2902091|NCT01728376|9995044|P6|Overall Study|Adverse Event|0
2902092|NCT01728376|9995045|P5|Overall Study|Adverse Event|1
2902093|NCT01728376|9995046|P4|Overall Study|Adverse Event|1
2902094|NCT01728376|9995047|P3|Overall Study|Adverse Event|1
2902095|NCT01728376|9995048|P2|Overall Study|Adverse Event|1
2902096|NCT01728376|9995049|P1|Overall Study|Adverse Event|1
2902097|NCT01728324|9995122|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
2902098|NCT01728324|9995123|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
2902099|NCT01728324|9995124|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
2902100|NCT01728324|9995122|P3|Termination of RBV|Adverse Event (Placebo Period)|0
2902101|NCT01728324|9995123|P2|Termination of RBV|Adverse Event (Placebo Period)|1
2902102|NCT01728324|9995124|P1|Termination of RBV|Adverse Event (Placebo Period)|0
2902103|NCT01728324|9995122|P3|Termination of RBV|Other than stated|1
2902104|NCT01728324|9995123|P2|Termination of RBV|Other than stated|3
2902105|NCT01728324|9995124|P1|Termination of RBV|Other than stated|1
2902106|NCT01728324|9995122|P3|Termination of RBV|Withdrawal by Subject|2
2902107|NCT01728324|9995123|P2|Termination of RBV|Withdrawal by Subject|5
2902108|NCT01728324|9995124|P1|Termination of RBV|Withdrawal by Subject|9
2902109|NCT01728324|9995122|P3|Termination of RBV|Lack of Efficacy|7
2902110|NCT01728324|9995123|P2|Termination of RBV|Lack of Efficacy|11
2902111|NCT01728324|9995124|P1|Termination of RBV|Lack of Efficacy|14
2902112|NCT01728324|9995122|P3|Termination of RBV|Adverse Event|5
2902113|NCT01728324|9995123|P2|Termination of RBV|Adverse Event|16
2902114|NCT01728324|9995124|P1|Termination of RBV|Adverse Event|15
2902115|NCT01728324|9995122|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
2902116|NCT01728324|9995123|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
2902117|NCT01728324|9995124|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
2902118|NCT01728324|9995122|P3|Termination of FDV|Adverse Event (Placebo Period)|0
2902119|NCT01728324|9995123|P2|Termination of FDV|Adverse Event (Placebo Period)|1
2902120|NCT01728324|9995124|P1|Termination of FDV|Adverse Event (Placebo Period)|0
2902121|NCT01728324|9995122|P3|Termination of FDV|Other than stated|0
2902122|NCT01728324|9995123|P2|Termination of FDV|Other than stated|3
2902123|NCT01728324|9995124|P1|Termination of FDV|Other than stated|1
2902124|NCT01728324|9995122|P3|Termination of FDV|Withdrawal by Subject|2
2902125|NCT01728324|9995123|P2|Termination of FDV|Withdrawal by Subject|6
2902126|NCT01728324|9995124|P1|Termination of FDV|Withdrawal by Subject|9
2902127|NCT01728324|9995122|P3|Termination of FDV|Lack of Efficacy|8
2902128|NCT01728324|9995123|P2|Termination of FDV|Lack of Efficacy|12
2902129|NCT01728324|9995124|P1|Termination of FDV|Lack of Efficacy|14
2902130|NCT01728324|9995122|P3|Termination of FDV|Adverse Event|4
2902131|NCT01728324|9995123|P2|Termination of FDV|Adverse Event|13
2902132|NCT01728324|9995124|P1|Termination of FDV|Adverse Event|14
2902133|NCT01728324|9995122|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
2902134|NCT01728324|9995123|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
2902135|NCT01728324|9995124|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
2902136|NCT01728324|9995122|P3|Termination of DBV|Adverse Event (Placebo Period)|0
2902137|NCT01728324|9995123|P2|Termination of DBV|Adverse Event (Placebo Period)|1
2902138|NCT01728324|9995124|P1|Termination of DBV|Adverse Event (Placebo Period)|0
2902139|NCT01728324|9995122|P3|Termination of DBV|Other than stated|0
2902140|NCT01728324|9995123|P2|Termination of DBV|Other than stated|3
2902141|NCT01728324|9995124|P1|Termination of DBV|Other than stated|1
2902142|NCT01728324|9995122|P3|Termination of DBV|Withdrawal by Subject|2
2902143|NCT01728324|9995123|P2|Termination of DBV|Withdrawal by Subject|6
2902144|NCT01728324|9995124|P1|Termination of DBV|Withdrawal by Subject|9
2902145|NCT01728324|9995122|P3|Termination of DBV|Lack of Efficacy|8
2902146|NCT01728324|9995123|P2|Termination of DBV|Lack of Efficacy|12
2902147|NCT01728324|9995124|P1|Termination of DBV|Lack of Efficacy|14
2902148|NCT01728324|9995122|P3|Termination of DBV|Adverse Event|4
2902149|NCT01728324|9995123|P2|Termination of DBV|Adverse Event|13
2902150|NCT01728324|9995124|P1|Termination of DBV|Adverse Event|14
2902151|NCT01728246|9995145|P2|Overall Study|Adverse Event|5
2902152|NCT01728246|9995146|P1|Overall Study|Adverse Event|8
2902153|NCT01728246|9995145|P2|Overall Study|Lack of Efficacy|1
2902154|NCT01728246|9995146|P1|Overall Study|Lack of Efficacy|1
2902155|NCT01728246|9995145|P2|Overall Study|Lost to Follow-up|22
2902156|NCT01728246|9995146|P1|Overall Study|Lost to Follow-up|23
2902157|NCT01728246|9995145|P2|Overall Study|Withdrawal by Subject|3
2902158|NCT01728246|9995146|P1|Overall Study|Withdrawal by Subject|2
2902159|NCT01728246|9995145|P2|Overall Study|Protocol Violation|0
2902160|NCT01728246|9995146|P1|Overall Study|Protocol Violation|1
2902161|NCT01728246|9995145|P2|Overall Study|Participant needed rescue medication|5
2902162|NCT01728246|9995146|P1|Overall Study|Participant needed rescue medication|1
2902163|NCT01728116|9995164|P2|Overall Study|various not noted previously|0
2902164|NCT01728116|9995165|P1|Overall Study|various not noted previously|5
2902165|NCT01728116|9995164|P2|Overall Study|Incorrectly enrolled in Study|1
2902166|NCT01728116|9995165|P1|Overall Study|Incorrectly enrolled in Study|0
2902167|NCT01728116|9995164|P2|Overall Study|Inter-current finding at procedure|0
2902168|NCT01728116|9995165|P1|Overall Study|Inter-current finding at procedure|1
2902169|NCT01728116|9995164|P2|Overall Study|Subject Non-Compliance|0
2902170|NCT01728116|9995165|P1|Overall Study|Subject Non-Compliance|2
2902171|NCT01728116|9995164|P2|Overall Study|Physician Decision|0
2902172|NCT01728116|9995165|P1|Overall Study|Physician Decision|2
2902173|NCT01728116|9995164|P2|Overall Study|Lost to Follow-up|2
2902174|NCT01728116|9995165|P1|Overall Study|Lost to Follow-up|9
2902175|NCT01728116|9995164|P2|Overall Study|Procedure/device failure|0
2902176|NCT01728116|9995165|P1|Overall Study|Procedure/device failure|7
2902177|NCT01728116|9995164|P2|Overall Study|Adverse Event|0
2902178|NCT01728116|9995165|P1|Overall Study|Adverse Event|13
2902179|NCT01728116|9995164|P2|Overall Study|Withdrawal by Subject|9
2902180|NCT01728116|9995165|P1|Overall Study|Withdrawal by Subject|16
2902181|NCT01728116|9995164|P2|Overall Study|Sponsor Terminated Study|35
2902182|NCT01728116|9995165|P1|Overall Study|Sponsor Terminated Study|106
2902183|NCT01728077|9995190|P2|Overall Study|Non compliance|0
2902184|NCT01728077|9995191|P1|Overall Study|Non compliance|1
2902185|NCT01728077|9995190|P2|Overall Study|Patient moving|0
2902186|NCT01728077|9995191|P1|Overall Study|Patient moving|1
2902187|NCT01728077|9995190|P2|Overall Study|Death|1
2902188|NCT01728077|9995191|P1|Overall Study|Death|0
2902189|NCT01728077|9995190|P2|Overall Study|Subject choice|3
2902190|NCT01728077|9995191|P1|Overall Study|Subject choice|2
2902191|NCT01728077|9995190|P2|Overall Study|Lost to Follow-up|0
2902192|NCT01728077|9995191|P1|Overall Study|Lost to Follow-up|1
2902193|NCT01728077|9995190|P2|Overall Study|Lack of Efficacy|1
2902194|NCT01728077|9995191|P1|Overall Study|Lack of Efficacy|3
2902195|NCT01727713|9995289|P1|Overall Study|Protocol Deviation|2
2902196|NCT01727713|9995289|P1|Overall Study|Withdrawal by Subject|13
2902197|NCT01727713|9995289|P1|Overall Study|Participant Met Withdrawal Criteria|5
2902198|NCT01727713|9995289|P1|Overall Study|Adverse Event|10
2902199|NCT01727713|9995289|P1|Overall Study|Lost to Follow-up|5
2902200|NCT01727700|9995316|P3|Overall Study|Protocol Violation|0
2902201|NCT01727700|9995317|P2|Overall Study|Protocol Violation|0
2902202|NCT01727700|9995318|P1|Overall Study|Protocol Violation|2
2902203|NCT01727700|9995316|P3|Overall Study|Particpant withdrew consent|1
2902204|NCT01727700|9995317|P2|Overall Study|Particpant withdrew consent|3
2902205|NCT01727700|9995318|P1|Overall Study|Particpant withdrew consent|0
2902206|NCT01727700|9995316|P3|Overall Study|Adverse Event|1
2902207|NCT01727700|9995317|P2|Overall Study|Adverse Event|7
2902208|NCT01727700|9995318|P1|Overall Study|Adverse Event|0
2902209|NCT01727505|9995341|P2|Second 24 Hours|Missing data|1
2902210|NCT01727505|9995342|P1|Second 24 Hours|Missing data|0
2902211|NCT01727505|9995341|P2|First 24 Hours|Adverse Event|1
2902212|NCT01727505|9995342|P1|First 24 Hours|Adverse Event|0
2902213|NCT01727297|9995367|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
2902214|NCT01727297|9995368|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
2902215|NCT01727297|9995367|P2|Overall Study|Physician Decision|5
2902216|NCT01727297|9995368|P1|Overall Study|Physician Decision|19
2902217|NCT01727297|9995367|P2|Overall Study|Withdrawal by Subject|27
2902218|NCT01727297|9995368|P1|Overall Study|Withdrawal by Subject|26
2902219|NCT01727297|9995367|P2|Overall Study|Lost to Follow-up|0
2902220|NCT01727297|9995368|P1|Overall Study|Lost to Follow-up|11
2902221|NCT01727297|9995367|P2|Overall Study|Adverse Event|1
2902222|NCT01727297|9995368|P1|Overall Study|Adverse Event|3
2902223|NCT01727297|9995367|P2|Overall Study|Protocol Violation|10
2902224|NCT01727297|9995368|P1|Overall Study|Protocol Violation|1
2902225|NCT01727297|9995367|P2|Overall Study|Death|0
2902226|NCT01727297|9995368|P1|Overall Study|Death|13
2902227|NCT01727258|9995384|P3|Overall Study|Lost to Follow-up|0
2902228|NCT01727258|9995385|P2|Overall Study|Lost to Follow-up|0
2902229|NCT01727258|9995386|P1|Overall Study|Lost to Follow-up|1
2902230|NCT01727258|9995384|P3|Overall Study|Withdrawal by Subject|0
2902231|NCT01727258|9995385|P2|Overall Study|Withdrawal by Subject|1
2902232|NCT01727258|9995386|P1|Overall Study|Withdrawal by Subject|1
2902233|NCT01727258|9995384|P3|Overall Study|Noncompliance with Study Drug|1
2902234|NCT01727258|9995385|P2|Overall Study|Noncompliance with Study Drug|0
2902235|NCT01727258|9995386|P1|Overall Study|Noncompliance with Study Drug|0
2902236|NCT01727258|9995384|P3|Overall Study|Adverse Event|0
2902237|NCT01727258|9995385|P2|Overall Study|Adverse Event|2
2902238|NCT01727258|9995386|P1|Overall Study|Adverse Event|0
2902239|NCT01727154|9995424|P1|Overall Study|No Discontinuation Documentation|4
2902240|NCT01727154|9995424|P1|Overall Study|Study Terminated|6
2902241|NCT01727154|9995424|P1|Overall Study|Subject Withdrew Consent|18
2902242|NCT01727154|9995424|P1|Overall Study|Withdrawal by Subject|14
2902243|NCT01727154|9995424|P1|Overall Study|Death|17
2902244|NCT01727141|9995432|P4|Overall Study|Withdrawal by Subject|11
2902245|NCT01727141|9995433|P3|Overall Study|Withdrawal by Subject|2
2902246|NCT01727141|9995434|P2|Overall Study|Withdrawal by Subject|4
2902247|NCT01727141|9995435|P1|Overall Study|Withdrawal by Subject|4
2902248|NCT01727141|9995432|P4|Overall Study|Protocol deviation|1
2902249|NCT01727141|9995433|P3|Overall Study|Protocol deviation|0
2902250|NCT01727141|9995434|P2|Overall Study|Protocol deviation|1
2902251|NCT01727141|9995435|P1|Overall Study|Protocol deviation|1
2902252|NCT01727141|9995432|P4|Overall Study|Death|1
2902253|NCT01727141|9995433|P3|Overall Study|Death|1
2902254|NCT01727141|9995434|P2|Overall Study|Death|1
2902255|NCT01727141|9995435|P1|Overall Study|Death|0
2902256|NCT01727141|9995432|P4|Overall Study|Lost to Follow-up|0
2902257|NCT01727141|9995433|P3|Overall Study|Lost to Follow-up|0
2902258|NCT01727141|9995434|P2|Overall Study|Lost to Follow-up|2
2902259|NCT01727141|9995435|P1|Overall Study|Lost to Follow-up|0
2902260|NCT01727141|9995432|P4|Overall Study|Physician Decision|2
2902261|NCT01727141|9995433|P3|Overall Study|Physician Decision|0
2902262|NCT01727141|9995434|P2|Overall Study|Physician Decision|1
2902263|NCT01727141|9995435|P1|Overall Study|Physician Decision|0
2902264|NCT01727024|9995500|P2|Period 1|Withdrawal by Subject|3
2902265|NCT01727024|9995501|P1|Period 1|Withdrawal by Subject|2
2902266|NCT01727024|9995500|P2|Period 1|Lost to Follow-up|1
2902267|NCT01727024|9995501|P1|Period 1|Lost to Follow-up|1
2902268|NCT01726803|9995516|P2|Overall Study|Withdrawal by Subject|0
2902269|NCT01726803|9995517|P1|Overall Study|Withdrawal by Subject|1
2902270|NCT01726803|9995516|P2|Overall Study|Lost to Follow-up|1
2902271|NCT01726803|9995517|P1|Overall Study|Lost to Follow-up|6
2902272|NCT01726517|9995559|P5|Overall Study|Withdrawal by Subject|0
2902273|NCT01726517|9995560|P4|Overall Study|Withdrawal by Subject|0
2902274|NCT01726517|9995561|P3|Overall Study|Withdrawal by Subject|1
2902275|NCT01726517|9995562|P2|Overall Study|Withdrawal by Subject|0
2902276|NCT01726517|9995563|P1|Overall Study|Withdrawal by Subject|0
2902277|NCT01726335|9995619|P1|Overall Study|Exacerbation of psychotic symptoms|1
2902278|NCT01726335|9995619|P1|Overall Study|Lost to Follow-up|2
2902279|NCT01726335|9995619|P1|Overall Study|Adverse Event|4
2902280|NCT01726335|9995619|P1|Overall Study|Withdrawal by Subject|15
2902281|NCT01726335|9995619|P1|Overall Study|Lost to Follow-up|2
2902282|NCT01726270|9995635|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
2902283|NCT01726270|9995635|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
2902284|NCT01726270|9995635|P1|Part 2, Actual-Use Phase|Adverse Event|6
2902285|NCT01726270|9995635|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
2902286|NCT01726270|9995635|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
2902287|NCT01726270|9995635|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
2902288|NCT01726049|9995648|P2|Overall Study|refused second HC|2
2902289|NCT01726049|9995649|P1|Overall Study|refused second HC|0
2902290|NCT01726049|9995648|P2|Overall Study|Adverse Event|1
2902291|NCT01726049|9995649|P1|Overall Study|Adverse Event|4
2902292|NCT01726049|9995648|P2|Overall Study|Death|1
2902293|NCT01726049|9995649|P1|Overall Study|Death|1
2902294|NCT01726023|9995674|P2|Overall Study|Withdrawal by Subject|8
2902295|NCT01726023|9995675|P1|Overall Study|Withdrawal by Subject|16
2902296|NCT01726023|9995674|P2|Overall Study|Other Eligibility criteria|7
2902297|NCT01726023|9995675|P1|Overall Study|Other Eligibility criteria|7
2902298|NCT01726023|9995674|P2|Overall Study|Lost to Follow-up|10
2902299|NCT01726023|9995675|P1|Overall Study|Lost to Follow-up|5
2902300|NCT01726023|9995674|P2|Overall Study|Death|1
2902301|NCT01726023|9995675|P1|Overall Study|Death|1
2902302|NCT01725750|9995809|P2|Overall Study|Withdrawal by Subject|9
2902303|NCT01725750|9995810|P1|Overall Study|Withdrawal by Subject|0
2902304|NCT01725750|9995809|P2|Overall Study|Lost to Follow-up|1
2902305|NCT01725750|9995810|P1|Overall Study|Lost to Follow-up|1
2902306|NCT01725750|9995809|P2|Overall Study|Adverse Event|0
2902307|NCT01725750|9995810|P1|Overall Study|Adverse Event|1
2902308|NCT01725529|9995843|P3|Overall Study|Withdrawal by Subject|8
2902309|NCT01725529|9995844|P2|Overall Study|Withdrawal by Subject|14
2902310|NCT01725529|9995845|P1|Overall Study|Withdrawal by Subject|12
2902311|NCT01725529|9995843|P3|Overall Study|Protocol Violation|1
2902312|NCT01725529|9995844|P2|Overall Study|Protocol Violation|1
2902313|NCT01725529|9995845|P1|Overall Study|Protocol Violation|0
2902314|NCT01725529|9995843|P3|Overall Study|Lost to Follow-up|1
2902315|NCT01725529|9995844|P2|Overall Study|Lost to Follow-up|1
2902316|NCT01725529|9995845|P1|Overall Study|Lost to Follow-up|2
2902317|NCT01725529|9995843|P3|Overall Study|Adverse Event|0
2902318|NCT01725529|9995844|P2|Overall Study|Adverse Event|0
2902319|NCT01725529|9995845|P1|Overall Study|Adverse Event|1
2902320|NCT01725451|9995871|P4|Period 4|Adverse Event|0
2902321|NCT01725451|9995872|P3|Period 4|Adverse Event|1
2902322|NCT01725451|9995873|P2|Period 4|Adverse Event|0
2902323|NCT01725451|9995874|P1|Period 4|Adverse Event|0
2902324|NCT01725451|9995871|P4|Washout From Period 3|Adverse Event|0
2902325|NCT01725451|9995872|P3|Washout From Period 3|Adverse Event|0
2902326|NCT01725451|9995873|P2|Washout From Period 3|Adverse Event|1
2902327|NCT01725451|9995874|P1|Washout From Period 3|Adverse Event|0
2902328|NCT01725451|9995871|P4|Washout From Period 3|Protocol Violation|0
2902329|NCT01725451|9995872|P3|Washout From Period 3|Protocol Violation|1
2902330|NCT01725451|9995873|P2|Washout From Period 3|Protocol Violation|0
2902331|NCT01725451|9995874|P1|Washout From Period 3|Protocol Violation|0
2902332|NCT01725451|9995871|P4|Period 1|Withdrawal by Subject|0
2902333|NCT01725451|9995872|P3|Period 1|Withdrawal by Subject|0
2902334|NCT01725451|9995873|P2|Period 1|Withdrawal by Subject|0
2902335|NCT01725451|9995874|P1|Period 1|Withdrawal by Subject|1
2902336|NCT01725386|9995896|P2|Overall Study|Withdrawal by Subject|0
2902337|NCT01725386|9995897|P1|Overall Study|Withdrawal by Subject|10
2902338|NCT01725386|9995896|P2|Overall Study|Lost to Follow-up|6
2902339|NCT01725386|9995897|P1|Overall Study|Lost to Follow-up|81
2902340|NCT01725386|9995896|P2|Overall Study|Death|40
2902341|NCT01725386|9995897|P1|Overall Study|Death|84
2902342|NCT01725308|9995916|P3|Treatment Period II|Miscellaneous|7
2902343|NCT01725308|9995917|P2|Treatment Period II|Miscellaneous|3
2902344|NCT01725308|9995918|P1|Treatment Period II|Miscellaneous|5
2902345|NCT01725308|9995916|P3|Treatment Period II|Protocol Deviations|1
2902346|NCT01725308|9995917|P2|Treatment Period II|Protocol Deviations|0
2902347|NCT01725308|9995918|P1|Treatment Period II|Protocol Deviations|0
2902348|NCT01725308|9995916|P3|Treatment Period II|Lost to Follow-up|3
2902349|NCT01725308|9995917|P2|Treatment Period II|Lost to Follow-up|5
2902350|NCT01725308|9995918|P1|Treatment Period II|Lost to Follow-up|1
2902351|NCT01725308|9995916|P3|Treatment Period II|Withdrawal of Consent|16
2902352|NCT01725308|9995917|P2|Treatment Period II|Withdrawal of Consent|2
2902353|NCT01725308|9995918|P1|Treatment Period II|Withdrawal of Consent|28
2902354|NCT01725308|9995916|P3|Treatment Period II|Changes in the Episodes|5
2902355|NCT01725308|9995917|P2|Treatment Period II|Changes in the Episodes|0
2902356|NCT01725308|9995918|P1|Treatment Period II|Changes in the Episodes|1
2902357|NCT01725308|9995916|P3|Treatment Period II|Worsening of the Target Disease|2
2902358|NCT01725308|9995917|P2|Treatment Period II|Worsening of the Target Disease|4
2902359|NCT01725308|9995918|P1|Treatment Period II|Worsening of the Target Disease|1
2902360|NCT01725308|9995916|P3|Treatment Period II|Insufficient Response|6
2902361|NCT01725308|9995917|P2|Treatment Period II|Insufficient Response|4
2902362|NCT01725308|9995918|P1|Treatment Period II|Insufficient Response|2
2902363|NCT01725308|9995916|P3|Treatment Period II|Adverse Event|20
2902364|NCT01725308|9995917|P2|Treatment Period II|Adverse Event|8
2902365|NCT01725308|9995918|P1|Treatment Period II|Adverse Event|13
2902366|NCT01725308|9995916|P3|Treatment Period II|Did Not Receive Drug|0
2902367|NCT01725308|9995917|P2|Treatment Period II|Did Not Receive Drug|0
2902368|NCT01725308|9995918|P1|Treatment Period II|Did Not Receive Drug|4
2902369|NCT01725308|9995916|P3|Treatment Period II|Did Not Meet Transition Criteria|4
2902370|NCT01725308|9995917|P2|Treatment Period II|Did Not Meet Transition Criteria|3
2902371|NCT01725308|9995918|P1|Treatment Period II|Did Not Meet Transition Criteria|0
2902372|NCT01725308|9995916|P3|Treatment Period I|Miscellaneous|3
2902373|NCT01725308|9995917|P2|Treatment Period I|Miscellaneous|0
2902374|NCT01725308|9995918|P1|Treatment Period I|Miscellaneous|2
2902375|NCT01725308|9995916|P3|Treatment Period I|Protocol Deviations|1
2902376|NCT01725308|9995917|P2|Treatment Period I|Protocol Deviations|1
2902377|NCT01725308|9995918|P1|Treatment Period I|Protocol Deviations|3
2902378|NCT01725308|9995916|P3|Treatment Period I|Lost to Follow-up|2
2902379|NCT01725308|9995917|P2|Treatment Period I|Lost to Follow-up|2
2902380|NCT01725308|9995918|P1|Treatment Period I|Lost to Follow-up|3
2902381|NCT01725308|9995916|P3|Treatment Period I|Withdrawal of Consent|5
2902382|NCT01725308|9995917|P2|Treatment Period I|Withdrawal of Consent|7
2902383|NCT01725308|9995918|P1|Treatment Period I|Withdrawal of Consent|12
2902384|NCT01725308|9995916|P3|Treatment Period I|Changes in the Episodes|2
2902385|NCT01725308|9995917|P2|Treatment Period I|Changes in the Episodes|0
2902386|NCT01725308|9995918|P1|Treatment Period I|Changes in the Episodes|3
2902387|NCT01725308|9995916|P3|Treatment Period I|Worsening of the Target Disease|2
2902388|NCT01725308|9995917|P2|Treatment Period I|Worsening of the Target Disease|0
2902389|NCT01725308|9995918|P1|Treatment Period I|Worsening of the Target Disease|8
2902390|NCT01725308|9995916|P3|Treatment Period I|Insufficient Response|5
2902391|NCT01725308|9995917|P2|Treatment Period I|Insufficient Response|0
2902392|NCT01725308|9995918|P1|Treatment Period I|Insufficient Response|7
2902393|NCT01725308|9995916|P3|Treatment Period I|Adverse Event|21
2902394|NCT01725308|9995917|P2|Treatment Period I|Adverse Event|4
2902395|NCT01725308|9995918|P1|Treatment Period I|Adverse Event|5
2902396|NCT01725308|9995916|P3|Treatment Period I|Did Not Receive Drug|0
2902397|NCT01725308|9995917|P2|Treatment Period I|Did Not Receive Drug|0
2902398|NCT01725308|9995918|P1|Treatment Period I|Did Not Receive Drug|1
2902399|NCT01725282|9996065|P4|Overall Study|Lack of Efficacy|1
2902400|NCT01725282|9996066|P3|Overall Study|Lack of Efficacy|0
2902401|NCT01725282|9996067|P2|Overall Study|Lack of Efficacy|1
2902402|NCT01725282|9996068|P1|Overall Study|Lack of Efficacy|0
2902403|NCT01725282|9996065|P4|Overall Study|Withdrawal by Subject|1
2902404|NCT01725282|9996066|P3|Overall Study|Withdrawal by Subject|1
2902405|NCT01725282|9996067|P2|Overall Study|Withdrawal by Subject|0
2902406|NCT01725282|9996068|P1|Overall Study|Withdrawal by Subject|0
2902407|NCT01725282|9996065|P4|Overall Study|Study Site Withdrawal|0
2902408|NCT01725282|9996066|P3|Overall Study|Study Site Withdrawal|0
2902409|NCT01725282|9996067|P2|Overall Study|Study Site Withdrawal|1
2902410|NCT01725282|9996068|P1|Overall Study|Study Site Withdrawal|0
2902411|NCT01725282|9996065|P4|Overall Study|Met Exclusion Criteria|0
2902412|NCT01725282|9996066|P3|Overall Study|Met Exclusion Criteria|1
2902413|NCT01725282|9996067|P2|Overall Study|Met Exclusion Criteria|0
2902414|NCT01725282|9996068|P1|Overall Study|Met Exclusion Criteria|0
2902415|NCT01725282|9996065|P4|Overall Study|Exacerbation of Target Disease|1
2902416|NCT01725282|9996066|P3|Overall Study|Exacerbation of Target Disease|0
2902417|NCT01725282|9996067|P2|Overall Study|Exacerbation of Target Disease|0
2902418|NCT01725282|9996068|P1|Overall Study|Exacerbation of Target Disease|1
2902419|NCT01725282|9996065|P4|Overall Study|Adverse Event|4
2902420|NCT01725282|9996066|P3|Overall Study|Adverse Event|6
2902421|NCT01725282|9996067|P2|Overall Study|Adverse Event|3
2902422|NCT01725282|9996068|P1|Overall Study|Adverse Event|1
2902423|NCT01725217|9996101|P3|Overall Study|Withdrawal by Subject|0
2902424|NCT01725217|9996102|P2|Overall Study|Withdrawal by Subject|0
2902425|NCT01725217|9996103|P1|Overall Study|Withdrawal by Subject|1
2902426|NCT01725126|9996137|P6|Overall Study|Withdrawal by Subject|0
2902427|NCT01725126|9996138|P5|Overall Study|Withdrawal by Subject|0
2902428|NCT01725126|9996139|P4|Overall Study|Withdrawal by Subject|1
2902429|NCT01725126|9996140|P3|Overall Study|Withdrawal by Subject|0
2902430|NCT01725126|9996141|P2|Overall Study|Withdrawal by Subject|0
2902431|NCT01725126|9996142|P1|Overall Study|Withdrawal by Subject|0
2902432|NCT01725126|9996137|P6|Overall Study|Protocol Violation|0
2902433|NCT01725126|9996138|P5|Overall Study|Protocol Violation|0
2902434|NCT01725126|9996139|P4|Overall Study|Protocol Violation|0
2902435|NCT01725126|9996140|P3|Overall Study|Protocol Violation|0
2902436|NCT01725126|9996141|P2|Overall Study|Protocol Violation|1
2902437|NCT01725126|9996142|P1|Overall Study|Protocol Violation|0
2902438|NCT01724528|9996340|P2|Overall Study|Patient refused to attend last visit|0
2902439|NCT01724528|9996341|P1|Overall Study|Patient refused to attend last visit|1
2902440|NCT01724528|9996340|P2|Overall Study|Protocol Violation|1
2902441|NCT01724528|9996341|P1|Overall Study|Protocol Violation|0
2902442|NCT01724528|9996340|P2|Overall Study|Withdrawal by Subject|2
2902443|NCT01724528|9996341|P1|Overall Study|Withdrawal by Subject|0
2902444|NCT01724528|9996340|P2|Overall Study|Death|0
2902445|NCT01724528|9996341|P1|Overall Study|Death|3
2902446|NCT01724489|9996357|P2|Overall Study|Withdrawal by Subject|6
2902447|NCT01724489|9996358|P1|Overall Study|Withdrawal by Subject|6
2902448|NCT01724489|9996357|P2|Overall Study|Lost to Follow-up|2
2902449|NCT01724489|9996358|P1|Overall Study|Lost to Follow-up|1
2902450|NCT01724489|9996357|P2|Overall Study|Surgery, medication|1
2902451|NCT01724489|9996358|P1|Overall Study|Surgery, medication|1
2902452|NCT01724489|9996357|P2|Overall Study|Adverse Event|3
2902453|NCT01724489|9996358|P1|Overall Study|Adverse Event|8
2902454|NCT01724359|9996364|P1|Overall Study|Other|20
2902455|NCT01724359|9996364|P1|Overall Study|Death|1
2902456|NCT01724359|9996364|P1|Overall Study|Adverse Event|10
2902457|NCT01724216|9996377|P1|Overall Study|Scan was not completed|1
2902458|NCT01724177|9996381|P1|Overall Study|Serious Adverse Event Related|1
2902459|NCT01724177|9996381|P1|Overall Study|Nervous participant|1
2902460|NCT01724177|9996381|P1|Overall Study|Progressive disease or Relapsed Disease|16
2902461|NCT01724177|9996381|P1|Overall Study|Adverse Event|8
2902462|NCT01724021|9996427|P2|Overall Study|Missing|1
2902463|NCT01724021|9996428|P1|Overall Study|Missing|1
2902464|NCT01724021|9996427|P2|Overall Study|Reason Not Specified|39
2902465|NCT01724021|9996428|P1|Overall Study|Reason Not Specified|36
2902466|NCT01724021|9996427|P2|Overall Study|Lost to Follow-up|15
2902467|NCT01724021|9996428|P1|Overall Study|Lost to Follow-up|15
2902468|NCT01724021|9996427|P2|Overall Study|Participant request/ Withdrew consent|14
2902469|NCT01724021|9996428|P1|Overall Study|Participant request/ Withdrew consent|18
2902470|NCT01724021|9996427|P2|Overall Study|Death|58
2902471|NCT01724021|9996428|P1|Overall Study|Death|46
2902472|NCT01724021|9996427|P2|Overall Study|Adverse Event|6
2902473|NCT01724021|9996428|P1|Overall Study|Adverse Event|11
2902474|NCT01723904|9996460|P1|Overall Study|Unable to follow protocol/ judged by inv|3
2902475|NCT01723904|9996460|P1|Overall Study|Adverse Event|5
2902476|NCT01723904|9996460|P1|Overall Study|Noncompliant|3
2902477|NCT01723826|9996474|P4|Overall Study|Withdrawal by Subject|48
2902478|NCT01723826|9996475|P3|Overall Study|Withdrawal by Subject|27
2902479|NCT01723826|9996476|P2|Overall Study|Withdrawal by Subject|17
2902480|NCT01723826|9996477|P1|Overall Study|Withdrawal by Subject|10
2902481|NCT01723826|9996474|P4|Overall Study|Protocol Violation|1
2902482|NCT01723826|9996475|P3|Overall Study|Protocol Violation|3
2902483|NCT01723826|9996476|P2|Overall Study|Protocol Violation|1
2902484|NCT01723826|9996477|P1|Overall Study|Protocol Violation|1
2902485|NCT01723826|9996474|P4|Overall Study|Physician Decision|11
2902486|NCT01723826|9996475|P3|Overall Study|Physician Decision|4
2902487|NCT01723826|9996476|P2|Overall Study|Physician Decision|3
2902488|NCT01723826|9996477|P1|Overall Study|Physician Decision|1
2902489|NCT01723826|9996474|P4|Overall Study|Other Reason|14
2902490|NCT01723826|9996475|P3|Overall Study|Other Reason|12
2902491|NCT01723826|9996476|P2|Overall Study|Other Reason|6
2902492|NCT01723826|9996477|P1|Overall Study|Other Reason|8
2902493|NCT01723826|9996474|P4|Overall Study|Non-compliance With Study Drug|0
2902494|NCT01723826|9996475|P3|Overall Study|Non-compliance With Study Drug|0
2902495|NCT01723826|9996476|P2|Overall Study|Non-compliance With Study Drug|1
2902496|NCT01723826|9996477|P1|Overall Study|Non-compliance With Study Drug|0
2902497|NCT01723826|9996474|P4|Overall Study|Non-compliance|3
2902498|NCT01723826|9996475|P3|Overall Study|Non-compliance|3
2902499|NCT01723826|9996476|P2|Overall Study|Non-compliance|1
2902500|NCT01723826|9996477|P1|Overall Study|Non-compliance|0
2902501|NCT01723826|9996474|P4|Overall Study|Lost to Follow-up|1
2902502|NCT01723826|9996475|P3|Overall Study|Lost to Follow-up|1
2902503|NCT01723826|9996476|P2|Overall Study|Lost to Follow-up|3
2902504|NCT01723826|9996477|P1|Overall Study|Lost to Follow-up|1
2902505|NCT01723826|9996474|P4|Overall Study|Death according to AE eCRF|7
2902506|NCT01723826|9996475|P3|Overall Study|Death according to AE eCRF|3
2902507|NCT01723826|9996476|P2|Overall Study|Death according to AE eCRF|3
2902508|NCT01723826|9996477|P1|Overall Study|Death according to AE eCRF|2
2902509|NCT01723826|9996474|P4|Overall Study|Adverse Event|5
2902510|NCT01723826|9996475|P3|Overall Study|Adverse Event|4
2902511|NCT01723826|9996476|P2|Overall Study|Adverse Event|1
2902512|NCT01723826|9996477|P1|Overall Study|Adverse Event|4
2902513|NCT01723397|9996622|P2|Study Period 2|Protocol Violation|1
2902514|NCT01723397|9996623|P1|Study Period 2|Protocol Violation|0
2902515|NCT01723397|9996622|P2|Study Period 1|Protocol Violation|1
2902516|NCT01723397|9996623|P1|Study Period 1|Protocol Violation|0
2902517|NCT01723254|9996650|P8|Overall Study|Withdrawal by Subject|2
2902518|NCT01723254|9996651|P7|Overall Study|Withdrawal by Subject|1
2902519|NCT01723254|9996652|P6|Overall Study|Withdrawal by Subject|1
2902520|NCT01723254|9996653|P5|Overall Study|Withdrawal by Subject|1
2902521|NCT01723254|9996654|P4|Overall Study|Withdrawal by Subject|0
2902522|NCT01723254|9996655|P3|Overall Study|Withdrawal by Subject|1
2902523|NCT01723254|9996656|P2|Overall Study|Withdrawal by Subject|2
2902524|NCT01723254|9996657|P1|Overall Study|Withdrawal by Subject|1
2902525|NCT01723254|9996650|P8|Overall Study|Protocol Violation|0
2902526|NCT01723254|9996651|P7|Overall Study|Protocol Violation|0
2902527|NCT01723254|9996652|P6|Overall Study|Protocol Violation|0
2902528|NCT01723254|9996653|P5|Overall Study|Protocol Violation|0
2902529|NCT01723254|9996654|P4|Overall Study|Protocol Violation|0
2902530|NCT01723254|9996655|P3|Overall Study|Protocol Violation|0
2902531|NCT01723254|9996656|P2|Overall Study|Protocol Violation|1
2902532|NCT01723254|9996657|P1|Overall Study|Protocol Violation|0
2902533|NCT01723254|9996650|P8|Overall Study|Move/Left to another country/city|0
2902534|NCT01723254|9996651|P7|Overall Study|Move/Left to another country/city|0
2902535|NCT01723254|9996652|P6|Overall Study|Move/Left to another country/city|0
2902536|NCT01723254|9996653|P5|Overall Study|Move/Left to another country/city|1
2902537|NCT01723254|9996654|P4|Overall Study|Move/Left to another country/city|1
2902538|NCT01723254|9996655|P3|Overall Study|Move/Left to another country/city|2
2902539|NCT01723254|9996656|P2|Overall Study|Move/Left to another country/city|0
2902540|NCT01723254|9996657|P1|Overall Study|Move/Left to another country/city|0
2902541|NCT01723254|9996650|P8|Overall Study|No longer have time to participate|0
2902542|NCT01723254|9996651|P7|Overall Study|No longer have time to participate|0
2902543|NCT01723254|9996652|P6|Overall Study|No longer have time to participate|0
2902544|NCT01723254|9996653|P5|Overall Study|No longer have time to participate|0
2902545|NCT01723254|9996654|P4|Overall Study|No longer have time to participate|1
2902546|NCT01723254|9996655|P3|Overall Study|No longer have time to participate|0
2902547|NCT01723254|9996656|P2|Overall Study|No longer have time to participate|0
2902548|NCT01723254|9996657|P1|Overall Study|No longer have time to participate|0
2902549|NCT01723254|9996650|P8|Overall Study|Personal issues|0
2902550|NCT01723254|9996651|P7|Overall Study|Personal issues|0
2902551|NCT01723254|9996652|P6|Overall Study|Personal issues|1
2902552|NCT01723254|9996653|P5|Overall Study|Personal issues|0
2902553|NCT01723254|9996654|P4|Overall Study|Personal issues|0
2902554|NCT01723254|9996655|P3|Overall Study|Personal issues|0
2902555|NCT01723254|9996656|P2|Overall Study|Personal issues|0
2902556|NCT01723254|9996657|P1|Overall Study|Personal issues|0
2902557|NCT01723254|9996650|P8|Overall Study|Conflict with work schedule|1
2902558|NCT01723254|9996651|P7|Overall Study|Conflict with work schedule|0
2902559|NCT01723254|9996652|P6|Overall Study|Conflict with work schedule|0
2902560|NCT01723254|9996653|P5|Overall Study|Conflict with work schedule|0
2902561|NCT01723254|9996654|P4|Overall Study|Conflict with work schedule|0
2902562|NCT01723254|9996655|P3|Overall Study|Conflict with work schedule|0
2902563|NCT01723254|9996656|P2|Overall Study|Conflict with work schedule|0
2902564|NCT01723254|9996657|P1|Overall Study|Conflict with work schedule|0
2902565|NCT01723228|9996709|P2|Overall Study|Other|1
2902566|NCT01723228|9996710|P1|Overall Study|Other|2
2902567|NCT01723228|9996709|P2|Overall Study|Lost to Follow-up|1
2902568|NCT01723228|9996710|P1|Overall Study|Lost to Follow-up|2
2902569|NCT01723228|9996709|P2|Overall Study|Protocol Violation|2
2902570|NCT01723228|9996710|P1|Overall Study|Protocol Violation|0
2902571|NCT01723228|9996709|P2|Overall Study|Withdrawal by Subject|1
2902572|NCT01723228|9996710|P1|Overall Study|Withdrawal by Subject|2
2902573|NCT01723228|9996709|P2|Overall Study|Adverse Event|6
2902574|NCT01723228|9996710|P1|Overall Study|Adverse Event|2
2902575|NCT01723163|9996728|P2|12-Month Follow-up|Unable to Contact|28
2902576|NCT01723163|9996729|P1|12-Month Follow-up|Unable to Contact|23
2902577|NCT01723163|9996728|P2|12-Month Follow-up|Death|0
2902578|NCT01723163|9996729|P1|12-Month Follow-up|Death|1
2902579|NCT01723163|9996728|P2|6-Month Follow-up|Unable to Contact|15
2902580|NCT01723163|9996729|P1|6-Month Follow-up|Unable to Contact|17
2902581|NCT01723163|9996728|P2|6-Month Follow-up|Death|0
2902582|NCT01723163|9996729|P1|6-Month Follow-up|Death|1
2902583|NCT01723163|9996728|P2|3-Month Follow-up|Unable to Contact|19
2902584|NCT01723163|9996729|P1|3-Month Follow-up|Unable to Contact|12
2902585|NCT01723163|9996728|P2|3-Month Follow-up|Withdrawal by Subject|0
2902586|NCT01723163|9996729|P1|3-Month Follow-up|Withdrawal by Subject|1
2902587|NCT01723163|9996728|P2|Treatment Phase|Withdrawal by PI|1
2902588|NCT01723163|9996729|P1|Treatment Phase|Withdrawal by PI|5
2902589|NCT01723163|9996728|P2|Treatment Phase|Withdrawal by Subject|6
2902590|NCT01723163|9996729|P1|Treatment Phase|Withdrawal by Subject|14
2902591|NCT01722994|9996737|P2|Overall Study|Missing data|17
2902592|NCT01722994|9996738|P1|Overall Study|Missing data|25
2902593|NCT01722877|9996757|P1|Overall Study|Lost to Follow-up|1
2902594|NCT01722877|9996757|P1|Overall Study|Death|1
2902595|NCT01722331|9996828|P7|Part 3|Other Protocol Specified Criteria|0
2902596|NCT01722331|9996829|P6|Part 3|Other Protocol Specified Criteria|0
2902597|NCT01722331|9996830|P5|Part 3|Other Protocol Specified Criteria|0
2902598|NCT01722331|9996831|P4|Part 3|Other Protocol Specified Criteria|0
2902599|NCT01722331|9996832|P3|Part 3|Other Protocol Specified Criteria|0
2902600|NCT01722331|9996833|P2|Part 3|Other Protocol Specified Criteria|1
2902601|NCT01722331|9996834|P1|Part 3|Other Protocol Specified Criteria|1
2902602|NCT01722331|9996828|P7|Part 3|Withdrawal by Subject|1
2902603|NCT01722331|9996829|P6|Part 3|Withdrawal by Subject|2
2902604|NCT01722331|9996830|P5|Part 3|Withdrawal by Subject|0
2902605|NCT01722331|9996831|P4|Part 3|Withdrawal by Subject|0
2902606|NCT01722331|9996832|P3|Part 3|Withdrawal by Subject|0
2902607|NCT01722331|9996833|P2|Part 3|Withdrawal by Subject|7
2902608|NCT01722331|9996834|P1|Part 3|Withdrawal by Subject|4
2902609|NCT01722331|9996828|P7|Part 3|Protocol Violation|0
2902610|NCT01722331|9996829|P6|Part 3|Protocol Violation|0
2902611|NCT01722331|9996830|P5|Part 3|Protocol Violation|0
2902612|NCT01722331|9996831|P4|Part 3|Protocol Violation|0
2902613|NCT01722331|9996832|P3|Part 3|Protocol Violation|0
2902614|NCT01722331|9996833|P2|Part 3|Protocol Violation|1
2902615|NCT01722331|9996834|P1|Part 3|Protocol Violation|2
2902616|NCT01722331|9996828|P7|Part 3|Physician Decision|1
2902617|NCT01722331|9996829|P6|Part 3|Physician Decision|0
2902618|NCT01722331|9996830|P5|Part 3|Physician Decision|0
2902619|NCT01722331|9996831|P4|Part 3|Physician Decision|0
2902620|NCT01722331|9996832|P3|Part 3|Physician Decision|0
2902621|NCT01722331|9996833|P2|Part 3|Physician Decision|1
2902622|NCT01722331|9996834|P1|Part 3|Physician Decision|1
2902623|NCT01722331|9996828|P7|Part 3|Non-Compliance with Study Drug|0
2902624|NCT01722331|9996829|P6|Part 3|Non-Compliance with Study Drug|0
2902625|NCT01722331|9996830|P5|Part 3|Non-Compliance with Study Drug|0
2902626|NCT01722331|9996831|P4|Part 3|Non-Compliance with Study Drug|0
2902627|NCT01722331|9996832|P3|Part 3|Non-Compliance with Study Drug|0
2902628|NCT01722331|9996833|P2|Part 3|Non-Compliance with Study Drug|1
2902629|NCT01722331|9996834|P1|Part 3|Non-Compliance with Study Drug|0
2902630|NCT01722331|9996828|P7|Part 3|Lost to Follow-up|0
2902631|NCT01722331|9996829|P6|Part 3|Lost to Follow-up|1
2902632|NCT01722331|9996830|P5|Part 3|Lost to Follow-up|0
2902633|NCT01722331|9996831|P4|Part 3|Lost to Follow-up|0
2902634|NCT01722331|9996832|P3|Part 3|Lost to Follow-up|0
2902635|NCT01722331|9996833|P2|Part 3|Lost to Follow-up|4
2902636|NCT01722331|9996834|P1|Part 3|Lost to Follow-up|3
2902637|NCT01722331|9996828|P7|Part 3|Lack of Efficacy|0
2902638|NCT01722331|9996829|P6|Part 3|Lack of Efficacy|0
2902639|NCT01722331|9996830|P5|Part 3|Lack of Efficacy|0
2902640|NCT01722331|9996831|P4|Part 3|Lack of Efficacy|0
2902641|NCT01722331|9996832|P3|Part 3|Lack of Efficacy|0
2902642|NCT01722331|9996833|P2|Part 3|Lack of Efficacy|0
2902643|NCT01722331|9996834|P1|Part 3|Lack of Efficacy|1
2902644|NCT01722331|9996828|P7|Part 3|Death|0
2902645|NCT01722331|9996829|P6|Part 3|Death|0
2902646|NCT01722331|9996830|P5|Part 3|Death|0
2902647|NCT01722331|9996831|P4|Part 3|Death|0
2902648|NCT01722331|9996832|P3|Part 3|Death|0
2902649|NCT01722331|9996833|P2|Part 3|Death|0
2902650|NCT01722331|9996834|P1|Part 3|Death|1
2902651|NCT01722331|9996828|P7|Part 3|Adverse Event|0
2902652|NCT01722331|9996829|P6|Part 3|Adverse Event|0
2902653|NCT01722331|9996830|P5|Part 3|Adverse Event|0
2902654|NCT01722331|9996831|P4|Part 3|Adverse Event|1
2902655|NCT01722331|9996832|P3|Part 3|Adverse Event|0
2902656|NCT01722331|9996833|P2|Part 3|Adverse Event|2
2902657|NCT01722331|9996834|P1|Part 3|Adverse Event|2
2902658|NCT01722331|9996828|P7|Part 2|Other Protocol Specified Criteria|1
2902659|NCT01722331|9996829|P6|Part 2|Other Protocol Specified Criteria|2
2902660|NCT01722331|9996830|P5|Part 2|Other Protocol Specified Criteria|0
2902661|NCT01722331|9996831|P4|Part 2|Other Protocol Specified Criteria|0
2902662|NCT01722331|9996832|P3|Part 2|Other Protocol Specified Criteria|10
2902663|NCT01722331|9996833|P2|Part 2|Other Protocol Specified Criteria|0
2902664|NCT01722331|9996834|P1|Part 2|Other Protocol Specified Criteria|6
2902665|NCT01722331|9996828|P7|Part 2|Withdrawal by Subject|2
2902666|NCT01722331|9996829|P6|Part 2|Withdrawal by Subject|2
2902667|NCT01722331|9996830|P5|Part 2|Withdrawal by Subject|0
2902668|NCT01722331|9996831|P4|Part 2|Withdrawal by Subject|0
2902669|NCT01722331|9996832|P3|Part 2|Withdrawal by Subject|3
2902670|NCT01722331|9996833|P2|Part 2|Withdrawal by Subject|0
2902671|NCT01722331|9996834|P1|Part 2|Withdrawal by Subject|5
2902672|NCT01722331|9996828|P7|Part 2|Protocol Violation|0
2902673|NCT01722331|9996829|P6|Part 2|Protocol Violation|0
2902674|NCT01722331|9996830|P5|Part 2|Protocol Violation|0
2902675|NCT01722331|9996831|P4|Part 2|Protocol Violation|0
2902676|NCT01722331|9996832|P3|Part 2|Protocol Violation|0
2902677|NCT01722331|9996833|P2|Part 2|Protocol Violation|0
2902678|NCT01722331|9996834|P1|Part 2|Protocol Violation|1
2902679|NCT01722331|9996828|P7|Part 2|Progressive Disease|0
2902680|NCT01722331|9996829|P6|Part 2|Progressive Disease|0
2902681|NCT01722331|9996830|P5|Part 2|Progressive Disease|0
2902682|NCT01722331|9996831|P4|Part 2|Progressive Disease|0
2902683|NCT01722331|9996832|P3|Part 2|Progressive Disease|1
2902684|NCT01722331|9996833|P2|Part 2|Progressive Disease|0
2902685|NCT01722331|9996834|P1|Part 2|Progressive Disease|0
2902686|NCT01722331|9996828|P7|Part 2|Pregnancy|0
2902687|NCT01722331|9996829|P6|Part 2|Pregnancy|1
2902688|NCT01722331|9996830|P5|Part 2|Pregnancy|0
2902689|NCT01722331|9996831|P4|Part 2|Pregnancy|0
2902690|NCT01722331|9996832|P3|Part 2|Pregnancy|0
2902691|NCT01722331|9996833|P2|Part 2|Pregnancy|0
2902692|NCT01722331|9996834|P1|Part 2|Pregnancy|0
2902693|NCT01722331|9996828|P7|Part 2|Physician Decision|0
2902694|NCT01722331|9996829|P6|Part 2|Physician Decision|0
2902695|NCT01722331|9996830|P5|Part 2|Physician Decision|0
2902696|NCT01722331|9996831|P4|Part 2|Physician Decision|0
2902697|NCT01722331|9996832|P3|Part 2|Physician Decision|2
2902698|NCT01722331|9996833|P2|Part 2|Physician Decision|0
2902699|NCT01722331|9996834|P1|Part 2|Physician Decision|0
2902700|NCT01722331|9996828|P7|Part 2|Non-Compliance with Study Drug|0
2902701|NCT01722331|9996829|P6|Part 2|Non-Compliance with Study Drug|0
2902702|NCT01722331|9996830|P5|Part 2|Non-Compliance with Study Drug|0
2902703|NCT01722331|9996831|P4|Part 2|Non-Compliance with Study Drug|0
2902704|NCT01722331|9996832|P3|Part 2|Non-Compliance with Study Drug|1
2902705|NCT01722331|9996833|P2|Part 2|Non-Compliance with Study Drug|0
2902706|NCT01722331|9996834|P1|Part 2|Non-Compliance with Study Drug|1
2902707|NCT01722331|9996828|P7|Part 2|Lost to Follow-up|1
2902708|NCT01722331|9996829|P6|Part 2|Lost to Follow-up|1
2902709|NCT01722331|9996830|P5|Part 2|Lost to Follow-up|0
2902710|NCT01722331|9996831|P4|Part 2|Lost to Follow-up|0
2902711|NCT01722331|9996832|P3|Part 2|Lost to Follow-up|3
2902712|NCT01722331|9996833|P2|Part 2|Lost to Follow-up|0
2902713|NCT01722331|9996834|P1|Part 2|Lost to Follow-up|0
2902714|NCT01722331|9996828|P7|Part 2|Lack of Efficacy|3
2902715|NCT01722331|9996829|P6|Part 2|Lack of Efficacy|3
2902716|NCT01722331|9996830|P5|Part 2|Lack of Efficacy|0
2902717|NCT01722331|9996831|P4|Part 2|Lack of Efficacy|0
2902718|NCT01722331|9996832|P3|Part 2|Lack of Efficacy|11
2902719|NCT01722331|9996833|P2|Part 2|Lack of Efficacy|0
2902720|NCT01722331|9996834|P1|Part 2|Lack of Efficacy|3
2902721|NCT01722331|9996828|P7|Part 2|Adverse Event|0
2902722|NCT01722331|9996829|P6|Part 2|Adverse Event|1
2902723|NCT01722331|9996830|P5|Part 2|Adverse Event|0
2902724|NCT01722331|9996831|P4|Part 2|Adverse Event|0
2902725|NCT01722331|9996832|P3|Part 2|Adverse Event|0
2902726|NCT01722331|9996833|P2|Part 2|Adverse Event|0
2902727|NCT01722331|9996834|P1|Part 2|Adverse Event|3
2902728|NCT01722331|9996828|P7|Part 1|Withdrawal by Subject|0
2902729|NCT01722331|9996829|P6|Part 1|Withdrawal by Subject|0
2902730|NCT01722331|9996830|P5|Part 1|Withdrawal by Subject|3
2902731|NCT01722331|9996831|P4|Part 1|Withdrawal by Subject|0
2902732|NCT01722331|9996832|P3|Part 1|Withdrawal by Subject|3
2902733|NCT01722331|9996833|P2|Part 1|Withdrawal by Subject|0
2902734|NCT01722331|9996834|P1|Part 1|Withdrawal by Subject|2
2902735|NCT01722331|9996828|P7|Part 1|Protocol Violation|0
2902736|NCT01722331|9996829|P6|Part 1|Protocol Violation|0
2902737|NCT01722331|9996830|P5|Part 1|Protocol Violation|1
2902738|NCT01722331|9996831|P4|Part 1|Protocol Violation|0
2902739|NCT01722331|9996832|P3|Part 1|Protocol Violation|0
2902740|NCT01722331|9996833|P2|Part 1|Protocol Violation|0
2902741|NCT01722331|9996834|P1|Part 1|Protocol Violation|1
2902742|NCT01722331|9996828|P7|Part 1|Progressive Disease|0
2902743|NCT01722331|9996829|P6|Part 1|Progressive Disease|0
2902744|NCT01722331|9996830|P5|Part 1|Progressive Disease|1
2902745|NCT01722331|9996831|P4|Part 1|Progressive Disease|0
2902746|NCT01722331|9996832|P3|Part 1|Progressive Disease|0
2902747|NCT01722331|9996833|P2|Part 1|Progressive Disease|0
2902748|NCT01722331|9996834|P1|Part 1|Progressive Disease|0
2902749|NCT01722331|9996828|P7|Part 1|Pregnancy|0
2902750|NCT01722331|9996829|P6|Part 1|Pregnancy|0
2902751|NCT01722331|9996830|P5|Part 1|Pregnancy|0
2902752|NCT01722331|9996831|P4|Part 1|Pregnancy|0
2902753|NCT01722331|9996832|P3|Part 1|Pregnancy|0
2902754|NCT01722331|9996833|P2|Part 1|Pregnancy|0
2902755|NCT01722331|9996834|P1|Part 1|Pregnancy|1
2902756|NCT01722331|9996828|P7|Part 1|Physician Decision|0
2902757|NCT01722331|9996829|P6|Part 1|Physician Decision|0
2902758|NCT01722331|9996830|P5|Part 1|Physician Decision|1
2902759|NCT01722331|9996831|P4|Part 1|Physician Decision|0
2902760|NCT01722331|9996832|P3|Part 1|Physician Decision|3
2902761|NCT01722331|9996833|P2|Part 1|Physician Decision|0
2902762|NCT01722331|9996834|P1|Part 1|Physician Decision|0
2902763|NCT01722331|9996828|P7|Part 1|Lost to Follow-up|0
2902764|NCT01722331|9996829|P6|Part 1|Lost to Follow-up|0
2902765|NCT01722331|9996830|P5|Part 1|Lost to Follow-up|1
2902766|NCT01722331|9996831|P4|Part 1|Lost to Follow-up|0
2902767|NCT01722331|9996832|P3|Part 1|Lost to Follow-up|2
2902768|NCT01722331|9996833|P2|Part 1|Lost to Follow-up|0
2902769|NCT01722331|9996834|P1|Part 1|Lost to Follow-up|1
2902770|NCT01722331|9996828|P7|Part 1|Lack of Efficacy|0
2902771|NCT01722331|9996829|P6|Part 1|Lack of Efficacy|0
2902772|NCT01722331|9996830|P5|Part 1|Lack of Efficacy|2
2902773|NCT01722331|9996831|P4|Part 1|Lack of Efficacy|0
2902774|NCT01722331|9996832|P3|Part 1|Lack of Efficacy|1
2902775|NCT01722331|9996833|P2|Part 1|Lack of Efficacy|0
2902776|NCT01722331|9996834|P1|Part 1|Lack of Efficacy|0
2902777|NCT01722331|9996828|P7|Part 1|Adverse Event|0
2902778|NCT01722331|9996829|P6|Part 1|Adverse Event|0
2902779|NCT01722331|9996830|P5|Part 1|Adverse Event|0
2902780|NCT01722331|9996831|P4|Part 1|Adverse Event|0
2902781|NCT01722331|9996832|P3|Part 1|Adverse Event|0
2902782|NCT01722331|9996833|P2|Part 1|Adverse Event|0
2902783|NCT01722331|9996834|P1|Part 1|Adverse Event|5
2902784|NCT01722266|9996950|P4|Overall Study|Dropped out due to Nausea|0
2902785|NCT01722266|9996951|P3|Overall Study|Dropped out due to Nausea|2
2902786|NCT01722266|9996952|P2|Overall Study|Dropped out due to Nausea|0
2902787|NCT01722266|9996953|P1|Overall Study|Dropped out due to Nausea|0
2902788|NCT01722266|9996950|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
2902789|NCT01722266|9996951|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
2902790|NCT01722266|9996952|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
2902791|NCT01722266|9996953|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
2902792|NCT01722266|9996950|P4|Overall Study|Withdrawal by Subject|0
2902793|NCT01722266|9996951|P3|Overall Study|Withdrawal by Subject|0
2902794|NCT01722266|9996952|P2|Overall Study|Withdrawal by Subject|2
2902795|NCT01722266|9996953|P1|Overall Study|Withdrawal by Subject|1
2902796|NCT01722162|9996981|P2|Overall Study|Noncompliance|1
2902797|NCT01722162|9996982|P1|Overall Study|Noncompliance|0
2902798|NCT01722162|9996981|P2|Overall Study|Insurance denial post enrollment|1
2902799|NCT01722162|9996982|P1|Overall Study|Insurance denial post enrollment|0
2902800|NCT01722162|9996981|P2|Overall Study|Adverse Event|1
2902801|NCT01722162|9996982|P1|Overall Study|Adverse Event|1
2902802|NCT01722162|9996981|P2|Overall Study|Unrelated to study adverse event|2
2902803|NCT01722162|9996982|P1|Overall Study|Unrelated to study adverse event|2
2902804|NCT01722162|9996981|P2|Overall Study|Found ineligible|0
2902805|NCT01722162|9996982|P1|Overall Study|Found ineligible|1
2902806|NCT01722162|9996981|P2|Overall Study|Withdrawal by Subject|1
2902807|NCT01722162|9996982|P1|Overall Study|Withdrawal by Subject|1
2902808|NCT01722097|9996992|P2|Overall Study|Patient sheets not returned|5
2902809|NCT01722097|9996993|P1|Overall Study|Patient sheets not returned|6
2902810|NCT01722071|9997001|P2|Overall Study|Protocol Violation|0
2902811|NCT01722071|9997002|P1|Overall Study|Protocol Violation|1
2902812|NCT01722045|9997008|P1|Overall Study|Relocation (did not wish to transfer)|1
2902813|NCT01722045|9997008|P1|Overall Study|Physician Decision|3
2902814|NCT01722045|9997008|P1|Overall Study|Protocol Deviation|1
2902815|NCT01722045|9997008|P1|Overall Study|Lost to Follow-up|4
2902816|NCT01722045|9997008|P1|Overall Study|Withdrawal by Subject|8
2902817|NCT01722045|9997008|P1|Overall Study|Death|3
2902818|NCT01722045|9997008|P1|Overall Study|Adverse Event|8
2902819|NCT01721954|9997029|P2|Overall Study|Lost to Follow-up|1
2902820|NCT01721954|9997030|P1|Overall Study|Lost to Follow-up|2
2902821|NCT01721954|9997029|P2|Overall Study|Adverse Event|0
2902822|NCT01721954|9997030|P1|Overall Study|Adverse Event|2
2902823|NCT01721954|9997029|P2|Overall Study|Withdrawal by Subject|4
2902824|NCT01721954|9997030|P1|Overall Study|Withdrawal by Subject|8
2902825|NCT01721954|9997029|P2|Overall Study|Death|64
2902826|NCT01721954|9997030|P1|Overall Study|Death|58
2902827|NCT01721772|9997044|P2|Overall Study|Other|1
2902828|NCT01721772|9997045|P1|Overall Study|Other|0
2902829|NCT01721772|9997044|P2|Overall Study|Maximum clinical benefit|1
2902830|NCT01721772|9997045|P1|Overall Study|Maximum clinical benefit|1
2902831|NCT01721772|9997044|P2|Overall Study|Withdrawal by Subject|5
2902832|NCT01721772|9997045|P1|Overall Study|Withdrawal by Subject|7
2902833|NCT01721772|9997044|P2|Overall Study|Unrelated adverse event|3
2902834|NCT01721772|9997045|P1|Overall Study|Unrelated adverse event|2
2902835|NCT01721772|9997044|P2|Overall Study|Study drug toxicity|7
2902836|NCT01721772|9997045|P1|Overall Study|Study drug toxicity|5
2902837|NCT01721772|9997044|P2|Overall Study|Disease progression|175
2902838|NCT01721772|9997045|P1|Overall Study|Disease progression|96
2902839|NCT01721759|9997065|P1|Overall Study|Withdrawal by Subject|1
2902840|NCT01721759|9997065|P1|Overall Study|Adverse event unrelated to study drug|9
2902841|NCT01721759|9997065|P1|Overall Study|Study drug toxicity|14
2902842|NCT01721759|9997065|P1|Overall Study|Disease progression|78
2902843|NCT01721746|9997073|P3|Treatment Period|Other|1
2902844|NCT01721746|9997074|P2|Treatment Period|Other|1
2902845|NCT01721746|9997075|P1|Treatment Period|Other|2
2902846|NCT01721746|9997073|P3|Treatment Period|Subject No Longer Met Study Criteria|0
2902847|NCT01721746|9997074|P2|Treatment Period|Subject No Longer Met Study Criteria|0
2902848|NCT01721746|9997075|P1|Treatment Period|Subject No Longer Met Study Criteria|4
2902849|NCT01721746|9997073|P3|Treatment Period|Poor/Non-compliance|0
2902850|NCT01721746|9997074|P2|Treatment Period|Poor/Non-compliance|0
2902851|NCT01721746|9997075|P1|Treatment Period|Poor/Non-compliance|1
2902852|NCT01721746|9997073|P3|Treatment Period|Maximum Clinical Benefit|3
2902853|NCT01721746|9997074|P2|Treatment Period|Maximum Clinical Benefit|0
2902854|NCT01721746|9997075|P1|Treatment Period|Maximum Clinical Benefit|1
2902855|NCT01721746|9997073|P3|Treatment Period|Subject Withdrew Consent|2
2902856|NCT01721746|9997074|P2|Treatment Period|Subject Withdrew Consent|0
2902857|NCT01721746|9997075|P1|Treatment Period|Subject Withdrew Consent|3
2902858|NCT01721746|9997073|P3|Treatment Period|Subject Request to Discontinue Treatment|6
2902859|NCT01721746|9997074|P2|Treatment Period|Subject Request to Discontinue Treatment|1
2902860|NCT01721746|9997075|P1|Treatment Period|Subject Request to Discontinue Treatment|19
2902861|NCT01721746|9997073|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
2902862|NCT01721746|9997074|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
2902863|NCT01721746|9997075|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
2902864|NCT01721746|9997073|P3|Treatment Period|Study Drug Toxicity|9
2902865|NCT01721746|9997074|P2|Treatment Period|Study Drug Toxicity|2
2902866|NCT01721746|9997075|P1|Treatment Period|Study Drug Toxicity|15
2902867|NCT01721746|9997073|P3|Treatment Period|Disease Progression|34
2902868|NCT01721746|9997074|P2|Treatment Period|Disease Progression|40
2902869|NCT01721746|9997075|P1|Treatment Period|Disease Progression|182
2902870|NCT01721486|9997115|P2|Overall Study|Physician Decision|1
2902871|NCT01721486|9997116|P1|Overall Study|Physician Decision|0
2902872|NCT01721486|9997115|P2|Overall Study|Protocol Violation|0
2902873|NCT01721486|9997116|P1|Overall Study|Protocol Violation|1
2902874|NCT01721408|9997164|P2|Overall Study|Does not meet entrance criteria|0
2902875|NCT01721408|9997165|P1|Overall Study|Does not meet entrance criteria|1
2902876|NCT01721408|9997164|P2|Overall Study|Lost to Follow-up|2
2902877|NCT01721408|9997165|P1|Overall Study|Lost to Follow-up|1
2902878|NCT01721408|9997164|P2|Overall Study|Other|3
2902879|NCT01721408|9997165|P1|Overall Study|Other|3
2902880|NCT01721408|9997164|P2|Overall Study|Protocol Violation|2
2902881|NCT01721408|9997165|P1|Overall Study|Protocol Violation|0
2902882|NCT01721408|9997164|P2|Overall Study|No longer willing to participate study|10
2902883|NCT01721408|9997165|P1|Overall Study|No longer willing to participate study|9
2902884|NCT01721408|9997164|P2|Overall Study|Insufficient clinical response|6
2902885|NCT01721408|9997165|P1|Overall Study|Insufficient clinical response|15
2902886|NCT01721408|9997164|P2|Overall Study|Death|0
2902887|NCT01721408|9997165|P1|Overall Study|Death|1
2902888|NCT01721408|9997164|P2|Overall Study|Adverse Event|1
2902889|NCT01721408|9997165|P1|Overall Study|Adverse Event|6
2902890|NCT01721330|9997181|P2|Overall Study|Withdrawal by Subject|1
2902891|NCT01721330|9997182|P1|Overall Study|Withdrawal by Subject|0
2902892|NCT01721317|9997190|P2|Overall Study|Withdrawal by Subject|1
2902893|NCT01721317|9997191|P1|Overall Study|Withdrawal by Subject|0
2902894|NCT01721317|9997190|P2|Overall Study|Physician Decision|1
2902895|NCT01721317|9997191|P1|Overall Study|Physician Decision|0
2902896|NCT01721317|9997190|P2|Overall Study|Study Closed / Terminated|2
2902897|NCT01721317|9997191|P1|Overall Study|Study Closed / Terminated|2
2902898|NCT01721200|9997270|P2|Overall Study|Lost to Follow-up|5
2902899|NCT01721200|9997271|P1|Overall Study|Lost to Follow-up|3
2902900|NCT01721161|9997296|P2|Overall Study|Other|1
2902901|NCT01721161|9997297|P1|Overall Study|Other|0
2902902|NCT01721161|9997296|P2|Overall Study|Withdrawal by Subject|1
2902903|NCT01721161|9997297|P1|Overall Study|Withdrawal by Subject|1
2902904|NCT01721161|9997296|P2|Overall Study|Lost to Follow-up|2
2902905|NCT01721161|9997297|P1|Overall Study|Lost to Follow-up|1
2902906|NCT01721161|9997296|P2|Overall Study|Adverse Event|3
2902907|NCT01721161|9997297|P1|Overall Study|Adverse Event|2
2902908|NCT01721109|9997320|P1|Overall Study|Lost to Follow-up|2
2902909|NCT01721109|9997320|P1|Overall Study|Withdrew Consent|1
2902910|NCT01721109|9997320|P1|Overall Study|Non- Compliance with Study Drug|3
2902911|NCT01721109|9997320|P1|Overall Study|Lack of Efficacy|1
2902912|NCT01721070|9997515|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
2902913|NCT01721057|9997526|P7|Rescue Period|Lack of Efficacy|0
2902914|NCT01721057|9997527|P6|Rescue Period|Lack of Efficacy|0
2902915|NCT01721057|9997528|P5|Rescue Period|Lack of Efficacy|0
2902916|NCT01721057|9997529|P4|Rescue Period|Lack of Efficacy|2
2902917|NCT01721057|9997530|P3|Rescue Period|Lack of Efficacy|0
2902918|NCT01721057|9997531|P2|Rescue Period|Lack of Efficacy|0
2902919|NCT01721057|9997532|P1|Rescue Period|Lack of Efficacy|0
2902920|NCT01721057|9997526|P7|Rescue Period|Adverse Event|0
2902921|NCT01721057|9997527|P6|Rescue Period|Adverse Event|0
2902922|NCT01721057|9997528|P5|Rescue Period|Adverse Event|0
2902923|NCT01721057|9997529|P4|Rescue Period|Adverse Event|1
2902924|NCT01721057|9997530|P3|Rescue Period|Adverse Event|0
2902925|NCT01721057|9997531|P2|Rescue Period|Adverse Event|0
2902926|NCT01721057|9997532|P1|Rescue Period|Adverse Event|0
2902927|NCT01721057|9997526|P7|Treatment Period|Death|0
2902928|NCT01721057|9997527|P6|Treatment Period|Death|0
2902929|NCT01721057|9997528|P5|Treatment Period|Death|0
2902930|NCT01721057|9997529|P4|Treatment Period|Death|0
2902931|NCT01721057|9997530|P3|Treatment Period|Death|0
2902932|NCT01721057|9997531|P2|Treatment Period|Death|0
2902933|NCT01721057|9997532|P1|Treatment Period|Death|2
2902934|NCT01721057|9997526|P7|Treatment Period|Physician Decision|0
2902935|NCT01721057|9997527|P6|Treatment Period|Physician Decision|0
2902936|NCT01721057|9997528|P5|Treatment Period|Physician Decision|0
2902937|NCT01721057|9997529|P4|Treatment Period|Physician Decision|0
2902938|NCT01721057|9997530|P3|Treatment Period|Physician Decision|3
2902939|NCT01721057|9997531|P2|Treatment Period|Physician Decision|1
2902940|NCT01721057|9997532|P1|Treatment Period|Physician Decision|0
2902941|NCT01721057|9997526|P7|Treatment Period|Lost to Follow-up|0
2902942|NCT01721057|9997527|P6|Treatment Period|Lost to Follow-up|0
2902943|NCT01721057|9997528|P5|Treatment Period|Lost to Follow-up|0
2902944|NCT01721057|9997529|P4|Treatment Period|Lost to Follow-up|0
2902945|NCT01721057|9997530|P3|Treatment Period|Lost to Follow-up|0
2902946|NCT01721057|9997531|P2|Treatment Period|Lost to Follow-up|0
2902947|NCT01721057|9997532|P1|Treatment Period|Lost to Follow-up|1
2902948|NCT01721057|9997526|P7|Treatment Period|Lack of Efficacy|0
2902949|NCT01721057|9997527|P6|Treatment Period|Lack of Efficacy|0
2902950|NCT01721057|9997528|P5|Treatment Period|Lack of Efficacy|0
2902951|NCT01721057|9997529|P4|Treatment Period|Lack of Efficacy|0
2902952|NCT01721057|9997530|P3|Treatment Period|Lack of Efficacy|0
2902953|NCT01721057|9997531|P2|Treatment Period|Lack of Efficacy|3
2902954|NCT01721057|9997532|P1|Treatment Period|Lack of Efficacy|7
2902955|NCT01721057|9997526|P7|Treatment Period|Adverse Event|0
2902956|NCT01721057|9997527|P6|Treatment Period|Adverse Event|0
2902957|NCT01721057|9997528|P5|Treatment Period|Adverse Event|0
2902958|NCT01721057|9997529|P4|Treatment Period|Adverse Event|0
2902959|NCT01721057|9997530|P3|Treatment Period|Adverse Event|12
2902960|NCT01721057|9997531|P2|Treatment Period|Adverse Event|10
2902961|NCT01721057|9997532|P1|Treatment Period|Adverse Event|7
2902962|NCT01721057|9997526|P7|Treatment Period|Withdrawal by Subject|0
2902963|NCT01721057|9997527|P6|Treatment Period|Withdrawal by Subject|0
2902964|NCT01721057|9997528|P5|Treatment Period|Withdrawal by Subject|0
2902965|NCT01721057|9997529|P4|Treatment Period|Withdrawal by Subject|0
2902966|NCT01721057|9997530|P3|Treatment Period|Withdrawal by Subject|8
2902967|NCT01721057|9997531|P2|Treatment Period|Withdrawal by Subject|5
2902968|NCT01721057|9997532|P1|Treatment Period|Withdrawal by Subject|11
2902969|NCT01721044|9997605|P3|Treatment Period|Withdrawal by Subject|1
2902970|NCT01721044|9997606|P2|Treatment Period|Withdrawal by Subject|6
2902971|NCT01721044|9997607|P1|Treatment Period|Withdrawal by Subject|7
2902972|NCT01721044|9997605|P3|Treatment Period|Protocol Violation|0
2902973|NCT01721044|9997606|P2|Treatment Period|Protocol Violation|0
2902974|NCT01721044|9997607|P1|Treatment Period|Protocol Violation|1
2902975|NCT01721044|9997605|P3|Treatment Period|Physician Decision|2
2902976|NCT01721044|9997606|P2|Treatment Period|Physician Decision|0
2902977|NCT01721044|9997607|P1|Treatment Period|Physician Decision|1
2902978|NCT01721044|9997605|P3|Treatment Period|Lost to Follow-up|1
2902979|NCT01721044|9997606|P2|Treatment Period|Lost to Follow-up|0
2902980|NCT01721044|9997607|P1|Treatment Period|Lost to Follow-up|0
2902981|NCT01721044|9997605|P3|Treatment Period|Lack of Efficacy|4
2902982|NCT01721044|9997606|P2|Treatment Period|Lack of Efficacy|4
2902983|NCT01721044|9997607|P1|Treatment Period|Lack of Efficacy|16
2902984|NCT01721044|9997605|P3|Treatment Period|Death|1
2902985|NCT01721044|9997606|P2|Treatment Period|Death|0
2902986|NCT01721044|9997607|P1|Treatment Period|Death|0
2902987|NCT01721044|9997605|P3|Treatment Period|Adverse Event|10
2902988|NCT01721044|9997606|P2|Treatment Period|Adverse Event|7
2902989|NCT01721044|9997607|P1|Treatment Period|Adverse Event|7
2902990|NCT01720797|9997680|P2|Overall Study|Withdrawal by Subject|0
2902991|NCT01720797|9997681|P1|Overall Study|Withdrawal by Subject|3
2902992|NCT01720667|9997689|P2|Overall Study|Withdrawal by Subject|0
2902993|NCT01720667|9997690|P1|Overall Study|Withdrawal by Subject|3
2902994|NCT01720667|9997689|P2|Overall Study|Adverse Event|1
2902995|NCT01720667|9997690|P1|Overall Study|Adverse Event|1
2902996|NCT01720602|9997704|P1|Overall Study|Progressive disease on therapy|2
2902997|NCT01720602|9997704|P1|Overall Study|Adverse Event|3
2902998|NCT01720524|9997714|P2|Part B|Death|2
2902999|NCT01720524|9997715|P1|Part B|Death|0
2903000|NCT01720524|9997714|P2|Part B|Lost to Follow-up|3
2903001|NCT01720524|9997715|P1|Part B|Lost to Follow-up|1
2903002|NCT01720524|9997714|P2|Part B|Other|0
2903003|NCT01720524|9997715|P1|Part B|Other|2
2903004|NCT01720524|9997714|P2|Part B|Withdrawal by Subject|4
2903005|NCT01720524|9997715|P1|Part B|Withdrawal by Subject|1
2903006|NCT01720524|9997714|P2|Part B|Ongoing|5
2903007|NCT01720524|9997715|P1|Part B|Ongoing|3
2903008|NCT01720524|9997714|P2|Part A|Lost to Follow-up|1
2903009|NCT01720524|9997715|P1|Part A|Lost to Follow-up|0
2903010|NCT01720524|9997714|P2|Part A|Other|1
2903011|NCT01720524|9997715|P1|Part A|Other|0
2903012|NCT01720524|9997714|P2|Part A|Withdrawal by Subject|1
2903013|NCT01720524|9997715|P1|Part A|Withdrawal by Subject|0
2903014|NCT01720524|9997714|P2|Part A|Missed 28 day follow-up visit|1
2903015|NCT01720524|9997715|P1|Part A|Missed 28 day follow-up visit|1
2903016|NCT01720524|9997714|P2|Part A|Lost to Follow-up|1
2903017|NCT01720524|9997715|P1|Part A|Lost to Follow-up|0
2903018|NCT01720524|9997714|P2|Part A|Death|1
2903019|NCT01720524|9997715|P1|Part A|Death|2
2903020|NCT01720524|9997714|P2|Part A|Adverse Event|2
2903021|NCT01720524|9997715|P1|Part A|Adverse Event|2
2903022|NCT01720524|9997714|P2|Part A|Insufficient Clinical Response|4
2903023|NCT01720524|9997715|P1|Part A|Insufficient Clinical Response|2
2903024|NCT01720446|9997748|P4|Overall Study|Withdrawal by Subject|4
2903025|NCT01720446|9997749|P3|Overall Study|Withdrawal by Subject|4
2903026|NCT01720446|9997750|P2|Overall Study|Withdrawal by Subject|5
2903027|NCT01720446|9997751|P1|Overall Study|Withdrawal by Subject|2
2903028|NCT01720446|9997748|P4|Overall Study|Lost to Follow-up|16
2903029|NCT01720446|9997749|P3|Overall Study|Lost to Follow-up|16
2903030|NCT01720446|9997750|P2|Overall Study|Lost to Follow-up|6
2903031|NCT01720446|9997751|P1|Overall Study|Lost to Follow-up|12
2903032|NCT01720264|9997872|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
2903033|NCT01720264|9997872|P1|Post-transplant (Day 16) to 1 Year|Death|8
2903034|NCT01720264|9997872|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
2903035|NCT01720069|9997903|P3|Overall Study|Lost to Follow-up|1
2903036|NCT01720069|9997904|P2|Overall Study|Lost to Follow-up|0
2903037|NCT01720069|9997905|P1|Overall Study|Lost to Follow-up|0
2903038|NCT01720069|9997903|P3|Overall Study|Non-compliance on using e-diary|1
2903039|NCT01720069|9997904|P2|Overall Study|Non-compliance on using e-diary|0
2903040|NCT01720069|9997905|P1|Overall Study|Non-compliance on using e-diary|0
2903041|NCT01720069|9997903|P3|Overall Study|OCS bursts occured, discontinued in line|0
2903042|NCT01720069|9997904|P2|Overall Study|OCS bursts occured, discontinued in line|0
2903043|NCT01720069|9997905|P1|Overall Study|OCS bursts occured, discontinued in line|1
2903044|NCT01720069|9997903|P3|Overall Study|Withdrawal by Subject|1
2903045|NCT01720069|9997904|P2|Overall Study|Withdrawal by Subject|2
2903046|NCT01720069|9997905|P1|Overall Study|Withdrawal by Subject|0
2903047|NCT01720069|9997903|P3|Overall Study|Treatment period withdrawal criteria met|9
2903048|NCT01720069|9997904|P2|Overall Study|Treatment period withdrawal criteria met|8
2903049|NCT01720069|9997905|P1|Overall Study|Treatment period withdrawal criteria met|4
2903050|NCT01720069|9997903|P3|Overall Study|Lack of Efficacy|0
2903051|NCT01720069|9997904|P2|Overall Study|Lack of Efficacy|4
2903052|NCT01720069|9997905|P1|Overall Study|Lack of Efficacy|0
2903053|NCT01720069|9997903|P3|Overall Study|Adverse Event|1
2903054|NCT01720069|9997904|P2|Overall Study|Adverse Event|0
2903055|NCT01720069|9997905|P1|Overall Study|Adverse Event|0
2903056|NCT01720069|9997903|P3|Overall Study|Randomised without baseline values|1
2903057|NCT01720069|9997904|P2|Overall Study|Randomised without baseline values|0
2903058|NCT01720069|9997905|P1|Overall Study|Randomised without baseline values|0
2903059|NCT01720069|9997903|P3|Overall Study|Could not use e-diary correctly|1
2903060|NCT01720069|9997904|P2|Overall Study|Could not use e-diary correctly|1
2903061|NCT01720069|9997905|P1|Overall Study|Could not use e-diary correctly|0
2903062|NCT01720043|9997931|P1|Overall Study|Withdrawal by Subject|1
2903063|NCT01719861|9997960|P1|Cycle 2|Death|1
2903064|NCT01719861|9997960|P1|Cycle 1|Death|4
2903065|NCT01719783|9997970|P2|Dose 2|Physician Decision|0
2903066|NCT01719783|9997971|P1|Dose 2|Physician Decision|1
2903067|NCT01719757|9998057|P1|Overall Study|well controlled pain|27
2903068|NCT01719757|9998057|P1|Overall Study|Protocol Violation|1
2903069|NCT01719757|9998057|P1|Overall Study|Lost to Follow-up|20
2903070|NCT01719757|9998057|P1|Overall Study|Withdrawal by Subject|15
2903071|NCT01719757|9998057|P1|Overall Study|Adverse Event|38
2903072|NCT01719224|9998111|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
2903073|NCT01719224|9998112|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
2903074|NCT01719172|9998121|P1|Overall Study|Death|1
2903075|NCT01719172|9998121|P1|Overall Study|Lost to Follow-up|1
2903076|NCT01719003|9998135|P9|Overall Study|Lack of Efficacy|0
2903077|NCT01719003|9998136|P8|Overall Study|Lack of Efficacy|0
2903078|NCT01719003|9998137|P7|Overall Study|Lack of Efficacy|1
2903079|NCT01719003|9998138|P6|Overall Study|Lack of Efficacy|0
2903080|NCT01719003|9998139|P5|Overall Study|Lack of Efficacy|0
2903081|NCT01719003|9998140|P4|Overall Study|Lack of Efficacy|0
2903082|NCT01719003|9998141|P3|Overall Study|Lack of Efficacy|0
2903083|NCT01719003|9998142|P2|Overall Study|Lack of Efficacy|0
2903084|NCT01719003|9998143|P1|Overall Study|Lack of Efficacy|0
2903085|NCT01719003|9998135|P9|Overall Study|Reason other than those specified|1
2903086|NCT01719003|9998136|P8|Overall Study|Reason other than those specified|3
2903087|NCT01719003|9998137|P7|Overall Study|Reason other than those specified|0
2903088|NCT01719003|9998138|P6|Overall Study|Reason other than those specified|1
2903089|NCT01719003|9998139|P5|Overall Study|Reason other than those specified|4
2903090|NCT01719003|9998140|P4|Overall Study|Reason other than those specified|3
2903091|NCT01719003|9998141|P3|Overall Study|Reason other than those specified|2
2903092|NCT01719003|9998142|P2|Overall Study|Reason other than those specified|0
2903093|NCT01719003|9998143|P1|Overall Study|Reason other than those specified|0
2903094|NCT01719003|9998135|P9|Overall Study|Refusal to continue, not due to AE|1
2903095|NCT01719003|9998136|P8|Overall Study|Refusal to continue, not due to AE|7
2903096|NCT01719003|9998137|P7|Overall Study|Refusal to continue, not due to AE|8
2903097|NCT01719003|9998138|P6|Overall Study|Refusal to continue, not due to AE|3
2903098|NCT01719003|9998139|P5|Overall Study|Refusal to continue, not due to AE|4
2903099|NCT01719003|9998140|P4|Overall Study|Refusal to continue, not due to AE|4
2903100|NCT01719003|9998141|P3|Overall Study|Refusal to continue, not due to AE|4
2903101|NCT01719003|9998142|P2|Overall Study|Refusal to continue, not due to AE|5
2903102|NCT01719003|9998143|P1|Overall Study|Refusal to continue, not due to AE|2
2903103|NCT01719003|9998135|P9|Overall Study|Lost to Follow-up|2
2903104|NCT01719003|9998136|P8|Overall Study|Lost to Follow-up|2
2903105|NCT01719003|9998137|P7|Overall Study|Lost to Follow-up|3
2903106|NCT01719003|9998138|P6|Overall Study|Lost to Follow-up|4
2903107|NCT01719003|9998139|P5|Overall Study|Lost to Follow-up|3
2903108|NCT01719003|9998140|P4|Overall Study|Lost to Follow-up|2
2903109|NCT01719003|9998141|P3|Overall Study|Lost to Follow-up|7
2903110|NCT01719003|9998142|P2|Overall Study|Lost to Follow-up|6
2903111|NCT01719003|9998143|P1|Overall Study|Lost to Follow-up|0
2903112|NCT01719003|9998135|P9|Overall Study|Adverse Event|0
2903113|NCT01719003|9998136|P8|Overall Study|Adverse Event|5
2903114|NCT01719003|9998137|P7|Overall Study|Adverse Event|6
2903115|NCT01719003|9998138|P6|Overall Study|Adverse Event|3
2903116|NCT01719003|9998139|P5|Overall Study|Adverse Event|4
2903117|NCT01719003|9998140|P4|Overall Study|Adverse Event|3
2903118|NCT01719003|9998141|P3|Overall Study|Adverse Event|4
2903119|NCT01719003|9998142|P2|Overall Study|Adverse Event|5
2903120|NCT01719003|9998143|P1|Overall Study|Adverse Event|6
2903121|NCT01719003|9998135|P9|Overall Study|Non compliant with protocol|0
2903122|NCT01719003|9998136|P8|Overall Study|Non compliant with protocol|3
2903123|NCT01719003|9998137|P7|Overall Study|Non compliant with protocol|2
2903124|NCT01719003|9998138|P6|Overall Study|Non compliant with protocol|1
2903125|NCT01719003|9998139|P5|Overall Study|Non compliant with protocol|2
2903126|NCT01719003|9998140|P4|Overall Study|Non compliant with protocol|1
2903127|NCT01719003|9998141|P3|Overall Study|Non compliant with protocol|0
2903128|NCT01719003|9998142|P2|Overall Study|Non compliant with protocol|1
2903129|NCT01719003|9998143|P1|Overall Study|Non compliant with protocol|1
2903130|NCT01718535|9998224|P10|Overall Study|Bidirectional Sequencing not possible|0
2903131|NCT01718535|9998225|P9|Overall Study|Bidirectional Sequencing not possible|0
2903132|NCT01718535|9998226|P8|Overall Study|Bidirectional Sequencing not possible|0
2903133|NCT01718535|9998227|P7|Overall Study|Bidirectional Sequencing not possible|0
2903134|NCT01718535|9998228|P6|Overall Study|Bidirectional Sequencing not possible|0
2903135|NCT01718535|9998229|P5|Overall Study|Bidirectional Sequencing not possible|0
2903136|NCT01718535|9998230|P4|Overall Study|Bidirectional Sequencing not possible|1
2903137|NCT01718535|9998231|P3|Overall Study|Bidirectional Sequencing not possible|0
2903138|NCT01718535|9998232|P2|Overall Study|Bidirectional Sequencing not possible|0
2903139|NCT01718535|9998233|P1|Overall Study|Bidirectional Sequencing not possible|1
2903140|NCT01718509|9998271|P2|Overall Study|Lack of Efficacy|0
2903141|NCT01718509|9998272|P1|Overall Study|Lack of Efficacy|1
2903142|NCT01718509|9998271|P2|Overall Study|Protocol Violation|2
2903143|NCT01718509|9998272|P1|Overall Study|Protocol Violation|4
2903144|NCT01718509|9998271|P2|Overall Study|Other|11
2903145|NCT01718509|9998272|P1|Overall Study|Other|13
2903146|NCT01718509|9998271|P2|Overall Study|Adverse Event|7
2903147|NCT01718509|9998272|P1|Overall Study|Adverse Event|5
2903148|NCT01718509|9998271|P2|Overall Study|Withdrawal by Subject|13
2903149|NCT01718509|9998272|P1|Overall Study|Withdrawal by Subject|7
2903150|NCT01718509|9998271|P2|Overall Study|Lost to Follow-up|15
2903151|NCT01718509|9998272|P1|Overall Study|Lost to Follow-up|18
2903152|NCT01718483|9998318|P2|Overall Study|Lack of Efficacy|0
2903153|NCT01718483|9998319|P1|Overall Study|Lack of Efficacy|1
2903154|NCT01718483|9998318|P2|Overall Study|Pregnancy|1
2903155|NCT01718483|9998319|P1|Overall Study|Pregnancy|1
2903156|NCT01718483|9998318|P2|Overall Study|Other|4
2903157|NCT01718483|9998319|P1|Overall Study|Other|1
2903158|NCT01718483|9998318|P2|Overall Study|Protocol Violation|2
2903159|NCT01718483|9998319|P1|Overall Study|Protocol Violation|4
2903160|NCT01718483|9998318|P2|Overall Study|Lost to Follow-up|3
2903161|NCT01718483|9998319|P1|Overall Study|Lost to Follow-up|8
2903162|NCT01718483|9998318|P2|Overall Study|Adverse Event|12
2903163|NCT01718483|9998319|P1|Overall Study|Adverse Event|5
2903164|NCT01718483|9998318|P2|Overall Study|Withdrawal by Subject|12
2903165|NCT01718483|9998319|P1|Overall Study|Withdrawal by Subject|14
2903166|NCT01718353|9998365|P2|Overall Study|Randomized but not treated|0
2903167|NCT01718353|9998366|P1|Overall Study|Randomized but not treated|2
2903168|NCT01718353|9998365|P2|Overall Study|Principal Investigator's Decision|4
2903169|NCT01718353|9998366|P1|Overall Study|Principal Investigator's Decision|10
2903170|NCT01718353|9998365|P2|Overall Study|Lost to Follow-up|1
2903171|NCT01718353|9998366|P1|Overall Study|Lost to Follow-up|0
2903172|NCT01717989|9998397|P1|Overall Study|Other|40
2903173|NCT01717989|9998397|P1|Overall Study|Protocol-specified criteria|551
2903174|NCT01717989|9998397|P1|Overall Study|Death|439
2903175|NCT01717989|9998397|P1|Overall Study|Lost to Follow-up|11
2903176|NCT01717989|9998397|P1|Overall Study|Physician Decision|2
2903177|NCT01717989|9998397|P1|Overall Study|Withdrawal by Subject|11
2903178|NCT01717989|9998397|P1|Overall Study|Protocol deviation|6
2903179|NCT01717989|9998397|P1|Overall Study|Ineligibility determined|6
2903180|NCT01717976|9998465|P2|Overall Study|Protocol Violation|1
2903181|NCT01717976|9998466|P1|Overall Study|Protocol Violation|0
2903182|NCT01717859|9998521|P1|Overall Study|Withdrawal by Subject|2
2903183|NCT01717859|9998521|P1|Overall Study|Lost to Follow-up|1
2903184|NCT01717859|9998521|P1|Overall Study|Patient concerned about mental health|1
2903185|NCT01717859|9998521|P1|Overall Study|Moved out of state|1
2903186|NCT01717859|9998521|P1|Overall Study|Adverse Event|5
2903187|NCT01717768|9998542|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903188|NCT01717768|9998543|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903189|NCT01717768|9998544|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
2903190|NCT01717768|9998545|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903191|NCT01717768|9998546|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903192|NCT01717768|9998547|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903193|NCT01717768|9998548|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903194|NCT01717768|9998549|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903195|NCT01717768|9998550|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903196|NCT01717768|9998551|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903197|NCT01717768|9998552|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903198|NCT01717768|9998553|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2903199|NCT01717768|9998542|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903200|NCT01717768|9998543|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903201|NCT01717768|9998544|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903202|NCT01717768|9998545|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903203|NCT01717768|9998546|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
2903204|NCT01717768|9998547|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903205|NCT01717768|9998548|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903206|NCT01717768|9998549|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903207|NCT01717768|9998550|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903208|NCT01717768|9998551|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903209|NCT01717768|9998552|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903210|NCT01717768|9998553|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2903211|NCT01717768|9998542|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
2903212|NCT01717768|9998543|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903213|NCT01717768|9998544|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903214|NCT01717768|9998545|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903215|NCT01717768|9998546|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903216|NCT01717768|9998547|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903217|NCT01717768|9998548|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903218|NCT01717768|9998549|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903219|NCT01717768|9998550|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903220|NCT01717768|9998551|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903221|NCT01717768|9998552|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903222|NCT01717768|9998553|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2903223|NCT01717768|9998542|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903224|NCT01717768|9998543|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903225|NCT01717768|9998544|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903226|NCT01717768|9998545|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903227|NCT01717768|9998546|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903228|NCT01717768|9998547|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903229|NCT01717768|9998548|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903230|NCT01717768|9998549|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903231|NCT01717768|9998550|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903232|NCT01717768|9998551|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903233|NCT01717768|9998552|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
2903234|NCT01717768|9998553|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2903235|NCT01717638|9998633|P13|Overall Study|Withdrawal by Subject|18
2903236|NCT01717638|9998634|P12|Overall Study|Withdrawal by Subject|0
2903237|NCT01717638|9998635|P11|Overall Study|Withdrawal by Subject|0
2903238|NCT01717638|9998636|P10|Overall Study|Withdrawal by Subject|1
2903239|NCT01717638|9998637|P9|Overall Study|Withdrawal by Subject|2
2903240|NCT01717638|9998638|P8|Overall Study|Withdrawal by Subject|1
2903241|NCT01717638|9998639|P7|Overall Study|Withdrawal by Subject|2
2903242|NCT01717638|9998640|P6|Overall Study|Withdrawal by Subject|0
2903243|NCT01717638|9998641|P5|Overall Study|Withdrawal by Subject|1
2903244|NCT01717638|9998642|P4|Overall Study|Withdrawal by Subject|0
2903245|NCT01717638|9998643|P3|Overall Study|Withdrawal by Subject|1
2903246|NCT01717638|9998644|P2|Overall Study|Withdrawal by Subject|1
2903247|NCT01717638|9998645|P1|Overall Study|Withdrawal by Subject|0
2903248|NCT01717638|9998633|P13|Overall Study|Father in hospital|1
2903249|NCT01717638|9998634|P12|Overall Study|Father in hospital|0
2903250|NCT01717638|9998635|P11|Overall Study|Father in hospital|0
2903251|NCT01717638|9998636|P10|Overall Study|Father in hospital|0
2903252|NCT01717638|9998637|P9|Overall Study|Father in hospital|0
2903253|NCT01717638|9998638|P8|Overall Study|Father in hospital|0
2903254|NCT01717638|9998639|P7|Overall Study|Father in hospital|0
2903255|NCT01717638|9998640|P6|Overall Study|Father in hospital|0
2903256|NCT01717638|9998641|P5|Overall Study|Father in hospital|0
2903257|NCT01717638|9998642|P4|Overall Study|Father in hospital|0
2903258|NCT01717638|9998643|P3|Overall Study|Father in hospital|0
2903259|NCT01717638|9998644|P2|Overall Study|Father in hospital|0
2903260|NCT01717638|9998645|P1|Overall Study|Father in hospital|0
2903261|NCT01717638|9998633|P13|Overall Study|Lost to Follow-up|0
2903262|NCT01717638|9998634|P12|Overall Study|Lost to Follow-up|0
2903263|NCT01717638|9998635|P11|Overall Study|Lost to Follow-up|0
2903264|NCT01717638|9998636|P10|Overall Study|Lost to Follow-up|0
2903265|NCT01717638|9998637|P9|Overall Study|Lost to Follow-up|0
2903266|NCT01717638|9998638|P8|Overall Study|Lost to Follow-up|0
2903267|NCT01717638|9998639|P7|Overall Study|Lost to Follow-up|0
2903268|NCT01717638|9998640|P6|Overall Study|Lost to Follow-up|1
2903269|NCT01717638|9998641|P5|Overall Study|Lost to Follow-up|0
2903270|NCT01717638|9998642|P4|Overall Study|Lost to Follow-up|0
2903271|NCT01717638|9998643|P3|Overall Study|Lost to Follow-up|0
2903272|NCT01717638|9998644|P2|Overall Study|Lost to Follow-up|0
2903273|NCT01717638|9998645|P1|Overall Study|Lost to Follow-up|0
2903274|NCT01717456|9998821|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2903275|NCT01717456|9998822|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2903276|NCT01717456|9998821|P2|End of Treatment|Lost to Follow-up|1
2903277|NCT01717456|9998822|P1|End of Treatment|Lost to Follow-up|0
2903278|NCT01717456|9998821|P2|End of Treatment|Physician Decision|1
2903279|NCT01717456|9998822|P1|End of Treatment|Physician Decision|0
2903280|NCT01717391|9998890|P1|Overall Study|FLT technical failure|3
2903281|NCT01717391|9998890|P1|Overall Study|Physician Decision|1
2903282|NCT01717391|9998890|P1|Overall Study|Withdrawal by Subject|5
2903283|NCT01717326|9998919|P20|Overall Study|Withdrawal by Subject|3
2903284|NCT01717326|9998920|P19|Overall Study|Withdrawal by Subject|2
2903285|NCT01717326|9998921|P18|Overall Study|Withdrawal by Subject|0
2903286|NCT01717326|9998922|P17|Overall Study|Withdrawal by Subject|0
2903287|NCT01717326|9998923|P16|Overall Study|Withdrawal by Subject|1
2903288|NCT01717326|9998924|P15|Overall Study|Withdrawal by Subject|0
2903289|NCT01717326|9998925|P14|Overall Study|Withdrawal by Subject|0
2903290|NCT01717326|9998926|P13|Overall Study|Withdrawal by Subject|1
2903291|NCT01717326|9998927|P12|Overall Study|Withdrawal by Subject|0
2903292|NCT01717326|9998928|P11|Overall Study|Withdrawal by Subject|0
2903293|NCT01717326|9998929|P10|Overall Study|Withdrawal by Subject|1
2903294|NCT01717326|9998930|P9|Overall Study|Withdrawal by Subject|0
2903295|NCT01717326|9998931|P8|Overall Study|Withdrawal by Subject|0
2903296|NCT01717326|9998932|P7|Overall Study|Withdrawal by Subject|0
2903297|NCT01717326|9998933|P6|Overall Study|Withdrawal by Subject|0
2903298|NCT01717326|9998934|P5|Overall Study|Withdrawal by Subject|0
2903299|NCT01717326|9998935|P4|Overall Study|Withdrawal by Subject|0
2903300|NCT01717326|9998936|P3|Overall Study|Withdrawal by Subject|0
2903301|NCT01717326|9998937|P2|Overall Study|Withdrawal by Subject|1
2903302|NCT01717326|9998938|P1|Overall Study|Withdrawal by Subject|0
2903303|NCT01717326|9998919|P20|Overall Study|Protocol Violation|0
2903304|NCT01717326|9998920|P19|Overall Study|Protocol Violation|0
2903305|NCT01717326|9998921|P18|Overall Study|Protocol Violation|0
2903306|NCT01717326|9998922|P17|Overall Study|Protocol Violation|0
2903307|NCT01717326|9998923|P16|Overall Study|Protocol Violation|0
2903308|NCT01717326|9998924|P15|Overall Study|Protocol Violation|0
2903309|NCT01717326|9998925|P14|Overall Study|Protocol Violation|0
2903310|NCT01717326|9998926|P13|Overall Study|Protocol Violation|0
2903311|NCT01717326|9998927|P12|Overall Study|Protocol Violation|0
2903312|NCT01717326|9998928|P11|Overall Study|Protocol Violation|0
2903313|NCT01717326|9998929|P10|Overall Study|Protocol Violation|0
2903314|NCT01717326|9998930|P9|Overall Study|Protocol Violation|0
2903315|NCT01717326|9998931|P8|Overall Study|Protocol Violation|0
2903316|NCT01717326|9998932|P7|Overall Study|Protocol Violation|0
2903317|NCT01717326|9998933|P6|Overall Study|Protocol Violation|0
2903318|NCT01717326|9998934|P5|Overall Study|Protocol Violation|1
2903319|NCT01717326|9998935|P4|Overall Study|Protocol Violation|0
2903320|NCT01717326|9998936|P3|Overall Study|Protocol Violation|0
2903321|NCT01717326|9998937|P2|Overall Study|Protocol Violation|0
2903322|NCT01717326|9998938|P1|Overall Study|Protocol Violation|0
2903323|NCT01717326|9998919|P20|Overall Study|Physician Decision|0
2903324|NCT01717326|9998920|P19|Overall Study|Physician Decision|0
2903325|NCT01717326|9998921|P18|Overall Study|Physician Decision|0
2903326|NCT01717326|9998922|P17|Overall Study|Physician Decision|0
2903327|NCT01717326|9998923|P16|Overall Study|Physician Decision|0
2903328|NCT01717326|9998924|P15|Overall Study|Physician Decision|0
2903329|NCT01717326|9998925|P14|Overall Study|Physician Decision|0
2903330|NCT01717326|9998926|P13|Overall Study|Physician Decision|0
2903331|NCT01717326|9998927|P12|Overall Study|Physician Decision|0
2903332|NCT01717326|9998928|P11|Overall Study|Physician Decision|0
2903333|NCT01717326|9998929|P10|Overall Study|Physician Decision|1
2903334|NCT01717326|9998930|P9|Overall Study|Physician Decision|0
2903335|NCT01717326|9998931|P8|Overall Study|Physician Decision|0
2903336|NCT01717326|9998932|P7|Overall Study|Physician Decision|0
2903337|NCT01717326|9998933|P6|Overall Study|Physician Decision|0
2903338|NCT01717326|9998934|P5|Overall Study|Physician Decision|0
2903339|NCT01717326|9998935|P4|Overall Study|Physician Decision|0
2903340|NCT01717326|9998936|P3|Overall Study|Physician Decision|0
2903341|NCT01717326|9998937|P2|Overall Study|Physician Decision|0
2903342|NCT01717326|9998938|P1|Overall Study|Physician Decision|0
2903343|NCT01717326|9998919|P20|Overall Study|Lost to Follow-up|3
2903344|NCT01717326|9998920|P19|Overall Study|Lost to Follow-up|2
2903345|NCT01717326|9998921|P18|Overall Study|Lost to Follow-up|0
2903346|NCT01717326|9998922|P17|Overall Study|Lost to Follow-up|1
2903347|NCT01717326|9998923|P16|Overall Study|Lost to Follow-up|2
2903348|NCT01717326|9998924|P15|Overall Study|Lost to Follow-up|0
2903349|NCT01717326|9998925|P14|Overall Study|Lost to Follow-up|0
2903350|NCT01717326|9998926|P13|Overall Study|Lost to Follow-up|0
2903351|NCT01717326|9998927|P12|Overall Study|Lost to Follow-up|0
2903352|NCT01717326|9998928|P11|Overall Study|Lost to Follow-up|1
2903353|NCT01717326|9998929|P10|Overall Study|Lost to Follow-up|0
2903354|NCT01717326|9998930|P9|Overall Study|Lost to Follow-up|0
2903355|NCT01717326|9998931|P8|Overall Study|Lost to Follow-up|0
2903356|NCT01717326|9998932|P7|Overall Study|Lost to Follow-up|1
2903357|NCT01717326|9998933|P6|Overall Study|Lost to Follow-up|0
2903358|NCT01717326|9998934|P5|Overall Study|Lost to Follow-up|1
2903359|NCT01717326|9998935|P4|Overall Study|Lost to Follow-up|2
2903360|NCT01717326|9998936|P3|Overall Study|Lost to Follow-up|0
2903361|NCT01717326|9998937|P2|Overall Study|Lost to Follow-up|0
2903362|NCT01717326|9998938|P1|Overall Study|Lost to Follow-up|3
2903363|NCT01717326|9998919|P20|Overall Study|Death|0
2903364|NCT01717326|9998920|P19|Overall Study|Death|0
2903365|NCT01717326|9998921|P18|Overall Study|Death|0
2903366|NCT01717326|9998922|P17|Overall Study|Death|0
2903367|NCT01717326|9998923|P16|Overall Study|Death|0
2903368|NCT01717326|9998924|P15|Overall Study|Death|0
2903369|NCT01717326|9998925|P14|Overall Study|Death|0
2903370|NCT01717326|9998926|P13|Overall Study|Death|0
2903371|NCT01717326|9998927|P12|Overall Study|Death|0
2903372|NCT01717326|9998928|P11|Overall Study|Death|1
2903373|NCT01717326|9998929|P10|Overall Study|Death|0
2903374|NCT01717326|9998930|P9|Overall Study|Death|0
2903375|NCT01717326|9998931|P8|Overall Study|Death|0
2903376|NCT01717326|9998932|P7|Overall Study|Death|0
2903377|NCT01717326|9998933|P6|Overall Study|Death|0
2903378|NCT01717326|9998934|P5|Overall Study|Death|0
2903379|NCT01717326|9998935|P4|Overall Study|Death|0
2903380|NCT01717326|9998936|P3|Overall Study|Death|0
2903381|NCT01717326|9998937|P2|Overall Study|Death|0
2903382|NCT01717326|9998938|P1|Overall Study|Death|0
2903383|NCT01717313|9999202|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
2903384|NCT01717313|9999203|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
2903385|NCT01717313|9999202|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
2903386|NCT01717313|9999203|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
2903387|NCT01717313|9999202|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2903388|NCT01717313|9999203|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2903389|NCT01717313|9999202|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
2903390|NCT01717313|9999203|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
2903391|NCT01717313|9999202|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2903392|NCT01717313|9999203|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2903393|NCT01717313|9999202|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
2903394|NCT01717313|9999203|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
2903395|NCT01717313|9999202|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
2903396|NCT01717313|9999203|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
2903397|NCT01717313|9999202|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
2903398|NCT01717313|9999203|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
2903399|NCT01717313|9999202|P2|Phase A (Weeks 0 to 24)|Death|1
2903400|NCT01717313|9999203|P1|Phase A (Weeks 0 to 24)|Death|0
2903401|NCT01717287|9999241|P2|Overall Study|Protocol Violation|1
2903402|NCT01717287|9999242|P1|Overall Study|Protocol Violation|0
2903403|NCT01717287|9999241|P2|Overall Study|Lost to Follow-up|2
2903404|NCT01717287|9999242|P1|Overall Study|Lost to Follow-up|0
2903405|NCT01717040|9999282|P2|Overall Study|New Substance Use Disorder|0
2903406|NCT01717040|9999283|P1|Overall Study|New Substance Use Disorder|1
2903407|NCT01717040|9999282|P2|Overall Study|Required Medication Change|1
2903408|NCT01717040|9999283|P1|Overall Study|Required Medication Change|0
2903409|NCT01717040|9999282|P2|Overall Study|Adverse Event|0
2903410|NCT01717040|9999283|P1|Overall Study|Adverse Event|1
2903411|NCT01717040|9999282|P2|Overall Study|Lack of Efficacy|1
2903412|NCT01717040|9999283|P1|Overall Study|Lack of Efficacy|1
2903413|NCT01717040|9999282|P2|Overall Study|Lost to Follow-up|3
2903414|NCT01717040|9999283|P1|Overall Study|Lost to Follow-up|2
2903415|NCT01716754|9999301|P4|Overall Study|Withdrawal by Subject|3
2903416|NCT01716754|9999302|P3|Overall Study|Withdrawal by Subject|4
2903417|NCT01716754|9999303|P2|Overall Study|Withdrawal by Subject|0
2903418|NCT01716754|9999304|P1|Overall Study|Withdrawal by Subject|5
2903419|NCT01716754|9999301|P4|Overall Study|Adverse Event|1
2903420|NCT01716754|9999302|P3|Overall Study|Adverse Event|2
2903421|NCT01716754|9999303|P2|Overall Study|Adverse Event|2
2903422|NCT01716754|9999304|P1|Overall Study|Adverse Event|4
2903423|NCT01716754|9999301|P4|Overall Study|Lost to Follow-up|1
2903424|NCT01716754|9999302|P3|Overall Study|Lost to Follow-up|0
2903425|NCT01716754|9999303|P2|Overall Study|Lost to Follow-up|0
2903426|NCT01716754|9999304|P1|Overall Study|Lost to Follow-up|1
2903427|NCT01716754|9999301|P4|Overall Study|Physician Decision|0
2903428|NCT01716754|9999302|P3|Overall Study|Physician Decision|0
2903429|NCT01716754|9999303|P2|Overall Study|Physician Decision|0
2903430|NCT01716754|9999304|P1|Overall Study|Physician Decision|1
2903431|NCT01716754|9999301|P4|Overall Study|Non-compliance with study treatment|0
2903432|NCT01716754|9999302|P3|Overall Study|Non-compliance with study treatment|1
2903433|NCT01716754|9999303|P2|Overall Study|Non-compliance with study treatment|0
2903434|NCT01716754|9999304|P1|Overall Study|Non-compliance with study treatment|0
2903435|NCT01716754|9999301|P4|Overall Study|Protocol deviation|2
2903436|NCT01716754|9999302|P3|Overall Study|Protocol deviation|7
2903437|NCT01716754|9999303|P2|Overall Study|Protocol deviation|2
2903438|NCT01716754|9999304|P1|Overall Study|Protocol deviation|0
2903439|NCT01716754|9999301|P4|Overall Study|Death|1
2903440|NCT01716754|9999302|P3|Overall Study|Death|0
2903441|NCT01716754|9999303|P2|Overall Study|Death|0
2903442|NCT01716754|9999304|P1|Overall Study|Death|0
2903443|NCT01716715|9999327|P2|Overall Study|Never Treated|4
2903444|NCT01716715|9999328|P1|Overall Study|Never Treated|2
2903445|NCT01716663|9999344|P1|Overall Study|Treated with non-study catheter|2
2903446|NCT01716663|9999344|P1|Overall Study|Withdrawn prior to procedure|4
2903447|NCT01716585|9999354|P2|Open-label Treatment|Withdrawal by Subject|3
2903448|NCT01716585|9999355|P1|Open-label Treatment|Withdrawal by Subject|0
2903449|NCT01716585|9999354|P2|Open-label Treatment|Virologic Failure|2
2903450|NCT01716585|9999355|P1|Open-label Treatment|Virologic Failure|0
2903451|NCT01716585|9999354|P2|Open-label Treatment|Adverse Event|2
2903452|NCT01716585|9999355|P1|Open-label Treatment|Adverse Event|0
2903453|NCT01716585|9999354|P2|Double-blind Treatment|Other|0
2903454|NCT01716585|9999355|P1|Double-blind Treatment|Other|1
2903455|NCT01716585|9999354|P2|Double-blind Treatment|Subject Noncompliant|0
2903456|NCT01716585|9999355|P1|Double-blind Treatment|Subject Noncompliant|1
2903457|NCT01716585|9999354|P2|Double-blind Treatment|Lost to Follow-up|0
2903458|NCT01716585|9999355|P1|Double-blind Treatment|Lost to Follow-up|2
2903459|NCT01716585|9999354|P2|Double-blind Treatment|Withdrawal by Subject|0
2903460|NCT01716585|9999355|P1|Double-blind Treatment|Withdrawal by Subject|3
2903461|NCT01716585|9999354|P2|Double-blind Treatment|Adverse Event|1
2903462|NCT01716585|9999355|P1|Double-blind Treatment|Adverse Event|2
2903463|NCT01716585|9999354|P2|Double-blind Treatment|Did Not Receive Study Drug|1
2903464|NCT01716585|9999355|P1|Double-blind Treatment|Did Not Receive Study Drug|4
2903465|NCT01716559|9999367|P1|Overall Study|Other withdrawal reason|75
2903466|NCT01716559|9999367|P1|Overall Study|Withdrawal by Subject|4
2903467|NCT01716559|9999367|P1|Overall Study|Death|21
2903468|NCT01716559|9999367|P1|Overall Study|Adverse Event|11
2903469|NCT01716533|9999379|P4|Overall Study|Immunosuppressants>14days past 6months|1
2903470|NCT01716533|9999380|P3|Overall Study|Immunosuppressants>14days past 6months|0
2903471|NCT01716533|9999381|P2|Overall Study|Immunosuppressants>14days past 6months|0
2903472|NCT01716533|9999382|P1|Overall Study|Immunosuppressants>14days past 6months|0
2903473|NCT01716533|9999379|P4|Overall Study|Death|2
2903474|NCT01716533|9999380|P3|Overall Study|Death|0
2903475|NCT01716533|9999381|P2|Overall Study|Death|0
2903476|NCT01716533|9999382|P1|Overall Study|Death|0
2903477|NCT01716533|9999379|P4|Overall Study|Withdrawal by Subject|5
2903478|NCT01716533|9999380|P3|Overall Study|Withdrawal by Subject|0
2903479|NCT01716533|9999381|P2|Overall Study|Withdrawal by Subject|0
2903480|NCT01716533|9999382|P1|Overall Study|Withdrawal by Subject|0
2903481|NCT01716533|9999379|P4|Overall Study|Failure of antibiotic treatment to treat|0
2903482|NCT01716533|9999380|P3|Overall Study|Failure of antibiotic treatment to treat|5
2903483|NCT01716533|9999381|P2|Overall Study|Failure of antibiotic treatment to treat|0
2903484|NCT01716533|9999382|P1|Overall Study|Failure of antibiotic treatment to treat|0
2903485|NCT01716520|9999436|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2903486|NCT01716520|9999437|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2903487|NCT01716520|9999438|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2903488|NCT01716520|9999439|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2903489|NCT01716520|9999440|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2903490|NCT01716520|9999441|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2903491|NCT01716520|9999436|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
2903492|NCT01716520|9999437|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2903493|NCT01716520|9999438|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2903494|NCT01716520|9999439|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2903495|NCT01716520|9999440|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2903496|NCT01716520|9999441|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2903497|NCT01716520|9999436|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2903498|NCT01716520|9999437|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2903499|NCT01716520|9999438|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2903500|NCT01716520|9999439|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2903501|NCT01716520|9999440|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
2903502|NCT01716520|9999441|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2903503|NCT01716520|9999436|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
2903504|NCT01716520|9999437|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2903505|NCT01716520|9999438|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2903506|NCT01716520|9999439|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2903507|NCT01716520|9999440|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2903508|NCT01716520|9999441|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2903509|NCT01716520|9999436|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2903510|NCT01716520|9999437|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2903511|NCT01716520|9999438|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2903512|NCT01716520|9999439|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2903513|NCT01716520|9999440|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2903514|NCT01716520|9999441|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
2903515|NCT01716520|9999436|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2903516|NCT01716520|9999437|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2903517|NCT01716520|9999438|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2903518|NCT01716520|9999439|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2903519|NCT01716520|9999440|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2903520|NCT01716520|9999441|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2903521|NCT01716520|9999436|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2903522|NCT01716520|9999437|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2903523|NCT01716520|9999438|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
2903524|NCT01716520|9999439|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2903525|NCT01716520|9999440|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2903526|NCT01716520|9999441|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2903527|NCT01716520|9999436|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
2903528|NCT01716520|9999437|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
2903529|NCT01716520|9999438|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
2903530|NCT01716520|9999439|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
2903531|NCT01716520|9999440|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
2903532|NCT01716520|9999441|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
2903533|NCT01716520|9999436|P6|Treatment Period 2 (14 Days)|Adverse Event|0
2903534|NCT01716520|9999437|P5|Treatment Period 2 (14 Days)|Adverse Event|1
2903535|NCT01716520|9999438|P4|Treatment Period 2 (14 Days)|Adverse Event|0
2903536|NCT01716520|9999439|P3|Treatment Period 2 (14 Days)|Adverse Event|0
2903537|NCT01716520|9999440|P2|Treatment Period 2 (14 Days)|Adverse Event|0
2903538|NCT01716520|9999441|P1|Treatment Period 2 (14 Days)|Adverse Event|0
2903539|NCT01716520|9999436|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2903540|NCT01716520|9999437|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2903541|NCT01716520|9999438|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2903542|NCT01716520|9999439|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2903543|NCT01716520|9999440|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2903544|NCT01716520|9999441|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2903545|NCT01716520|9999436|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2903546|NCT01716520|9999437|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2903547|NCT01716520|9999438|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2903548|NCT01716520|9999439|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2903549|NCT01716520|9999440|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2903550|NCT01716520|9999441|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2903551|NCT01716520|9999436|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2903552|NCT01716520|9999437|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2903553|NCT01716520|9999438|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2903554|NCT01716520|9999439|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2903555|NCT01716520|9999440|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
2903556|NCT01716520|9999441|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2903557|NCT01716520|9999436|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2903558|NCT01716520|9999437|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2903559|NCT01716520|9999438|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2903560|NCT01716520|9999439|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2903561|NCT01716520|9999440|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2903562|NCT01716520|9999441|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2903563|NCT01716520|9999436|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2903564|NCT01716520|9999437|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2903565|NCT01716520|9999438|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2903566|NCT01716520|9999439|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
2903567|NCT01716520|9999440|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2903568|NCT01716520|9999441|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2903569|NCT01716520|9999436|P6|Treatment Period 1 (14 Days)|Adverse Event|0
2903570|NCT01716520|9999437|P5|Treatment Period 1 (14 Days)|Adverse Event|0
2903571|NCT01716520|9999438|P4|Treatment Period 1 (14 Days)|Adverse Event|0
2903572|NCT01716520|9999439|P3|Treatment Period 1 (14 Days)|Adverse Event|0
2903573|NCT01716520|9999440|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2903574|NCT01716520|9999441|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2903575|NCT01716234|9999496|P7|Overall Study|Withdrawal by Subject|0
2903576|NCT01716234|9999497|P6|Overall Study|Withdrawal by Subject|3
2903577|NCT01716234|9999498|P5|Overall Study|Withdrawal by Subject|1
2903578|NCT01716234|9999499|P4|Overall Study|Withdrawal by Subject|2
2903579|NCT01716234|9999500|P3|Overall Study|Withdrawal by Subject|2
2903580|NCT01716234|9999501|P2|Overall Study|Withdrawal by Subject|0
2903581|NCT01716234|9999502|P1|Overall Study|Withdrawal by Subject|3
2903582|NCT01716234|9999496|P7|Overall Study|Adverse Event|0
2903583|NCT01716234|9999497|P6|Overall Study|Adverse Event|6
2903584|NCT01716234|9999498|P5|Overall Study|Adverse Event|3
2903585|NCT01716234|9999499|P4|Overall Study|Adverse Event|8
2903586|NCT01716234|9999500|P3|Overall Study|Adverse Event|2
2903587|NCT01716234|9999501|P2|Overall Study|Adverse Event|10
2903588|NCT01716234|9999502|P1|Overall Study|Adverse Event|7
2903589|NCT01716234|9999496|P7|Overall Study|Did not meet protocol eligibility|0
2903590|NCT01716234|9999497|P6|Overall Study|Did not meet protocol eligibility|4
2903591|NCT01716234|9999498|P5|Overall Study|Did not meet protocol eligibility|0
2903592|NCT01716234|9999499|P4|Overall Study|Did not meet protocol eligibility|0
2903593|NCT01716234|9999500|P3|Overall Study|Did not meet protocol eligibility|1
2903594|NCT01716234|9999501|P2|Overall Study|Did not meet protocol eligibility|0
2903595|NCT01716234|9999502|P1|Overall Study|Did not meet protocol eligibility|0
2903596|NCT01716234|9999496|P7|Overall Study|Lack of Efficacy|0
2903597|NCT01716234|9999497|P6|Overall Study|Lack of Efficacy|0
2903598|NCT01716234|9999498|P5|Overall Study|Lack of Efficacy|0
2903599|NCT01716234|9999499|P4|Overall Study|Lack of Efficacy|1
2903600|NCT01716234|9999500|P3|Overall Study|Lack of Efficacy|0
2903601|NCT01716234|9999501|P2|Overall Study|Lack of Efficacy|0
2903602|NCT01716234|9999502|P1|Overall Study|Lack of Efficacy|0
2903603|NCT01716234|9999496|P7|Overall Study|Protocol Violation|0
2903604|NCT01716234|9999497|P6|Overall Study|Protocol Violation|1
2903605|NCT01716234|9999498|P5|Overall Study|Protocol Violation|1
2903606|NCT01716234|9999499|P4|Overall Study|Protocol Violation|1
2903607|NCT01716234|9999500|P3|Overall Study|Protocol Violation|0
2903608|NCT01716234|9999501|P2|Overall Study|Protocol Violation|0
2903609|NCT01716234|9999502|P1|Overall Study|Protocol Violation|0
2903610|NCT01716169|9999565|P1|Overall Study|inconsistent dressing application|1
2903611|NCT01716169|9999565|P1|Overall Study|Withdrawal by Subject|1
2903612|NCT01716169|9999565|P1|Overall Study|Lost to Follow-up|1
2903613|NCT01716169|9999565|P1|Overall Study|Adverse Event|1
2903614|NCT01716156|9999574|P3|Overall Study|Lost to Follow-up|0
2903615|NCT01716156|9999575|P2|Overall Study|Lost to Follow-up|0
2903616|NCT01716156|9999576|P1|Overall Study|Lost to Follow-up|1
2903617|NCT01716156|9999574|P3|Overall Study|Withdrawal by Subject|2
2903618|NCT01716156|9999575|P2|Overall Study|Withdrawal by Subject|1
2903619|NCT01716156|9999576|P1|Overall Study|Withdrawal by Subject|0
2903620|NCT01716156|9999574|P3|Overall Study|Protocol Violation|0
2903621|NCT01716156|9999575|P2|Overall Study|Protocol Violation|0
2903622|NCT01716156|9999576|P1|Overall Study|Protocol Violation|1
2903623|NCT01716117|9999602|P2|Overall Study|Withdrawal by Subject|0
2903624|NCT01716117|9999603|P1|Overall Study|Withdrawal by Subject|2
2903625|NCT01716117|9999602|P2|Overall Study|Death|2
2903626|NCT01716117|9999603|P1|Overall Study|Death|5
2903627|NCT01716104|9999622|P2|Overall Study|Do not meet inclusion criteria|7
2903628|NCT01716104|9999623|P1|Overall Study|Do not meet inclusion criteria|6
2903629|NCT01716052|9999649|P2|Overall Study|Withdrawal of funding|1
2903630|NCT01716052|9999650|P1|Overall Study|Withdrawal of funding|1
2903631|NCT01715896|9999692|P2|Overall Study|Other|5
2903632|NCT01715896|9999693|P1|Overall Study|Other|2
2903633|NCT01715896|9999692|P2|Overall Study|Withdrawal by Subject|4
2903634|NCT01715896|9999693|P1|Overall Study|Withdrawal by Subject|1
2903635|NCT01715896|9999692|P2|Overall Study|Lost to Follow-up|2
2903636|NCT01715896|9999693|P1|Overall Study|Lost to Follow-up|0
2903637|NCT01715857|9999766|P1|Overall Study|Did Not Meet Eligibility Criteria|96
2903638|NCT01715831|9999776|P1|Overall Study|Adverse Event|1
2903639|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2903640|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2903641|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
2903642|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2903643|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
2903644|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2903645|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
2903646|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2903647|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
2903648|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
2903649|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
2903650|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
2903651|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
2903652|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
2903653|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
2903654|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
2903655|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Protocol Violation|19
2903656|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Protocol Violation|12
2903657|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Protocol Violation|14
2903658|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Protocol Violation|0
2903659|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Adverse Event|2
2903660|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Adverse Event|23
2903661|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Adverse Event|3
2903662|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Adverse Event|0
2903663|NCT01715805|9999792|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
2903664|NCT01715805|9999793|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2903665|NCT01715805|9999794|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2903666|NCT01715805|9999795|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2903749|NCT01715129|9999901|P1|Overall Study|Adverse Event, fatal|1
2903667|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2903668|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2903669|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2903670|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
2903671|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2903672|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2903673|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2903674|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
2903675|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2903676|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2903677|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2903678|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
2903679|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2903680|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2903681|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2903682|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
2903683|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
2903684|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
2903685|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
2903686|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
2903687|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2903688|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2903689|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2903690|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
2903691|NCT01715805|9999792|P4|Placebo + ADT Lead-in Period|Adverse Event|0
2903692|NCT01715805|9999793|P3|Placebo + ADT Lead-in Period|Adverse Event|0
2903693|NCT01715805|9999794|P2|Placebo + ADT Lead-in Period|Adverse Event|0
2903694|NCT01715805|9999795|P1|Placebo + ADT Lead-in Period|Adverse Event|41
2903695|NCT01715415|9999809|P2|Open-label Treatment|Subject Noncompliant|1
2903696|NCT01715415|9999810|P1|Open-label Treatment|Subject Noncompliant|0
2903697|NCT01715415|9999809|P2|Open-label Treatment|Adverse Event|1
2903698|NCT01715415|9999810|P1|Open-label Treatment|Adverse Event|0
2903699|NCT01715415|9999809|P2|Double-blind Treatment|Other|0
2903700|NCT01715415|9999810|P1|Double-blind Treatment|Other|1
2903701|NCT01715415|9999809|P2|Double-blind Treatment|Withdrawal by Subject|1
2903702|NCT01715415|9999810|P1|Double-blind Treatment|Withdrawal by Subject|1
2903703|NCT01715415|9999809|P2|Double-blind Treatment|Adverse Event|0
2903704|NCT01715415|9999810|P1|Double-blind Treatment|Adverse Event|3
2903705|NCT01715415|9999809|P2|Double-blind Treatment|Did Not Receive Study Drug|1
2903706|NCT01715415|9999810|P1|Double-blind Treatment|Did Not Receive Study Drug|0
2903707|NCT01715298|9999824|P2|Overall Study|Patient/guardian decision|9
2903708|NCT01715298|9999825|P1|Overall Study|Patient/guardian decision|7
2903709|NCT01715298|9999824|P2|Overall Study|Lost to Follow-up|2
2903710|NCT01715298|9999825|P1|Overall Study|Lost to Follow-up|0
2903711|NCT01715285|9999863|P3|Open-label (OL) Extension Phase|Ongoing|72
2903712|NCT01715285|9999864|P2|Open-label (OL) Extension Phase|Ongoing|0
2903713|NCT01715285|9999865|P1|Open-label (OL) Extension Phase|Ongoing|157
2903714|NCT01715285|9999863|P3|Treatment Period|Placebo Cross-over|0
2903715|NCT01715285|9999864|P2|Treatment Period|Placebo Cross-over|72
2903716|NCT01715285|9999865|P1|Treatment Period|Placebo Cross-over|0
2903717|NCT01715285|9999863|P3|Treatment Period|Other|0
2903718|NCT01715285|9999864|P2|Treatment Period|Other|12
2903719|NCT01715285|9999865|P1|Treatment Period|Other|10
2903720|NCT01715285|9999863|P3|Treatment Period|Ongoing|0
2903721|NCT01715285|9999864|P2|Treatment Period|Ongoing|0
2903722|NCT01715285|9999865|P1|Treatment Period|Ongoing|157
2903723|NCT01715285|9999863|P3|Treatment Period|Physician Decision|0
2903724|NCT01715285|9999864|P2|Treatment Period|Physician Decision|23
2903725|NCT01715285|9999865|P1|Treatment Period|Physician Decision|21
2903726|NCT01715285|9999863|P3|Treatment Period|Withdrawal Of Consent|0
2903727|NCT01715285|9999864|P2|Treatment Period|Withdrawal Of Consent|47
2903728|NCT01715285|9999865|P1|Treatment Period|Withdrawal Of Consent|52
2903729|NCT01715285|9999863|P3|Treatment Period|Progressive Disease|0
2903730|NCT01715285|9999864|P2|Treatment Period|Progressive Disease|388
2903731|NCT01715285|9999865|P1|Treatment Period|Progressive Disease|254
2903732|NCT01715285|9999863|P3|Treatment Period|Noncompliance With Study Drug|0
2903733|NCT01715285|9999864|P2|Treatment Period|Noncompliance With Study Drug|2
2903734|NCT01715285|9999865|P1|Treatment Period|Noncompliance With Study Drug|4
2903735|NCT01715285|9999863|P3|Treatment Period|Death|0
2903736|NCT01715285|9999864|P2|Treatment Period|Death|23
2903737|NCT01715285|9999865|P1|Treatment Period|Death|36
2903738|NCT01715285|9999863|P3|Treatment Period|Lost to Follow-up|0
2903739|NCT01715285|9999864|P2|Treatment Period|Lost to Follow-up|2
2903740|NCT01715285|9999865|P1|Treatment Period|Lost to Follow-up|3
2903741|NCT01715285|9999863|P3|Treatment Period|Adverse Event|0
2903742|NCT01715285|9999864|P2|Treatment Period|Adverse Event|33
2903743|NCT01715285|9999865|P1|Treatment Period|Adverse Event|60
2903744|NCT01715129|9999901|P1|Overall Study|Other|1
2903745|NCT01715129|9999901|P1|Overall Study|Lost to Follow-up|1
2903746|NCT01715129|9999901|P1|Overall Study|Consent Withdrawn|2
2903747|NCT01715129|9999901|P1|Overall Study|Protocol Violation|1
2903748|NCT01715129|9999901|P1|Overall Study|Lack of Efficacy|3
2903750|NCT01714947|9999927|P1|Part B|Progressive Disease|3
2903751|NCT01714817|9999968|P2|Overall Study|Hypersensitivity to the medication|1
2903752|NCT01714817|9999969|P1|Overall Study|Hypersensitivity to the medication|0
2903753|NCT01714817|9999968|P2|Overall Study|Antiproteinuric changed/dose increased|1
2903754|NCT01714817|9999969|P1|Overall Study|Antiproteinuric changed/dose increased|0
2903755|NCT01714817|9999968|P2|Overall Study|Need of use of Prohibited Medications|0
2903756|NCT01714817|9999969|P1|Overall Study|Need of use of Prohibited Medications|1
2903757|NCT01714817|9999968|P2|Overall Study|Change in Concomitant Medication|1
2903758|NCT01714817|9999969|P1|Overall Study|Change in Concomitant Medication|0
2903759|NCT01714817|9999968|P2|Overall Study|Not treated- received ACE inhibition|0
2903760|NCT01714817|9999969|P1|Overall Study|Not treated- received ACE inhibition|1
2903761|NCT01714817|9999968|P2|Overall Study|Participant no longer meets criteria|2
2903762|NCT01714817|9999969|P1|Overall Study|Participant no longer meets criteria|6
2903763|NCT01714817|9999968|P2|Overall Study|Pregnancy|0
2903764|NCT01714817|9999969|P1|Overall Study|Pregnancy|2
2903765|NCT01714817|9999968|P2|Overall Study|Poor / non-compliance|1
2903766|NCT01714817|9999969|P1|Overall Study|Poor / non-compliance|0
2903767|NCT01714817|9999968|P2|Overall Study|Lost to Follow-up|2
2903768|NCT01714817|9999969|P1|Overall Study|Lost to Follow-up|0
2903769|NCT01714817|9999968|P2|Overall Study|Death|1
2903770|NCT01714817|9999969|P1|Overall Study|Death|1
2903771|NCT01714817|9999968|P2|Overall Study|Withdrawal by Subject|7
2903772|NCT01714817|9999969|P1|Overall Study|Withdrawal by Subject|6
2903773|NCT01714817|9999968|P2|Overall Study|Adverse Event|17
2903774|NCT01714817|9999969|P1|Overall Study|Adverse Event|20
2903775|NCT01714817|9999968|P2|Overall Study|Lack of Efficacy|9
2903776|NCT01714817|9999969|P1|Overall Study|Lack of Efficacy|11
2903777|NCT01714726|10000001|P4|Open-Label Period|Lost to Follow-up|4
2903778|NCT01714726|10000002|P3|Open-Label Period|Lost to Follow-up|3
2903779|NCT01714726|10000003|P2|Open-Label Period|Lost to Follow-up|0
2903780|NCT01714726|10000004|P1|Open-Label Period|Lost to Follow-up|0
2903781|NCT01714726|10000001|P4|Open-Label Period|Developed specific withdrawal criteria|2
2903782|NCT01714726|10000002|P3|Open-Label Period|Developed specific withdrawal criteria|5
2903783|NCT01714726|10000003|P2|Open-Label Period|Developed specific withdrawal criteria|0
2903784|NCT01714726|10000004|P1|Open-Label Period|Developed specific withdrawal criteria|0
2903785|NCT01714726|10000001|P4|Open-Label Period|Withdrawal by Subject|19
2903786|NCT01714726|10000002|P3|Open-Label Period|Withdrawal by Subject|9
2903787|NCT01714726|10000003|P2|Open-Label Period|Withdrawal by Subject|0
2903788|NCT01714726|10000004|P1|Open-Label Period|Withdrawal by Subject|0
2903789|NCT01714726|10000001|P4|Open-Label Period|Adverse Event|0
2903790|NCT01714726|10000002|P3|Open-Label Period|Adverse Event|1
2903791|NCT01714726|10000003|P2|Open-Label Period|Adverse Event|0
2903792|NCT01714726|10000004|P1|Open-Label Period|Adverse Event|0
2903793|NCT01714726|10000001|P4|Open-Label Period|Other|3
2903794|NCT01714726|10000002|P3|Open-Label Period|Other|1
2903795|NCT01714726|10000003|P2|Open-Label Period|Other|0
2903796|NCT01714726|10000004|P1|Open-Label Period|Other|0
2903797|NCT01714726|10000001|P4|Double-Blinded Induction Period|Lost to Follow-up|0
2903798|NCT01714726|10000002|P3|Double-Blinded Induction Period|Lost to Follow-up|0
2903799|NCT01714726|10000003|P2|Double-Blinded Induction Period|Lost to Follow-up|2
2903800|NCT01714726|10000004|P1|Double-Blinded Induction Period|Lost to Follow-up|0
2903801|NCT01714726|10000001|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
2903802|NCT01714726|10000002|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
2903803|NCT01714726|10000003|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
2903804|NCT01714726|10000004|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
2903805|NCT01714726|10000001|P4|Double-Blinded Induction Period|Adverse Event|0
2903806|NCT01714726|10000002|P3|Double-Blinded Induction Period|Adverse Event|0
2903807|NCT01714726|10000003|P2|Double-Blinded Induction Period|Adverse Event|1
2903808|NCT01714726|10000004|P1|Double-Blinded Induction Period|Adverse Event|0
2903809|NCT01714726|10000001|P4|Double-Blinded Induction Period|Subject not in open label period|0
2903810|NCT01714726|10000002|P3|Double-Blinded Induction Period|Subject not in open label period|0
2903811|NCT01714726|10000003|P2|Double-Blinded Induction Period|Subject not in open label period|1
2903812|NCT01714726|10000004|P1|Double-Blinded Induction Period|Subject not in open label period|3
2903813|NCT01714687|10000084|P2|Overall Study|Lost to Follow-up|4
2903814|NCT01714687|10000085|P1|Overall Study|Lost to Follow-up|2
2903815|NCT01714687|10000084|P2|Overall Study|Withdrawal by Subject|0
2903816|NCT01714687|10000085|P1|Overall Study|Withdrawal by Subject|1
2903817|NCT01714635|10000109|P3|Overall Study|Missed 6-month exam|0
2903818|NCT01714635|10000110|P2|Overall Study|Missed 6-month exam|0
2903819|NCT01714635|10000111|P1|Overall Study|Missed 6-month exam|1
2903820|NCT01714635|10000109|P3|Overall Study|Discontinued|2
2903821|NCT01714635|10000110|P2|Overall Study|Discontinued|0
2903822|NCT01714635|10000111|P1|Overall Study|Discontinued|1
2903823|NCT01714609|10000127|P2|Overall Study|Protocol Violation|0
2903824|NCT01714609|10000128|P1|Overall Study|Protocol Violation|1
2903825|NCT01714544|10000134|P1|Overall Study|Withdrawal by Subject|1
2903826|NCT01714544|10000134|P1|Overall Study|Physician Decision|1
2903827|NCT01714544|10000134|P1|Overall Study|Lost to Follow-up|1
2903828|NCT01714310|10000205|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
2903829|NCT01714310|10000206|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
2903830|NCT01714310|10000207|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
2903831|NCT01714310|10000205|P3|Double Blind Adjunctive Treatment|Adverse Event|0
2903832|NCT01714310|10000206|P2|Double Blind Adjunctive Treatment|Adverse Event|1
2903833|NCT01714310|10000207|P1|Double Blind Adjunctive Treatment|Adverse Event|1
2903834|NCT01714310|10000205|P3|Open Lisdexamfetamine Titration|Adverse Event|3
2903835|NCT01714310|10000206|P2|Open Lisdexamfetamine Titration|Adverse Event|0
2903836|NCT01714310|10000207|P1|Open Lisdexamfetamine Titration|Adverse Event|0
2903837|NCT01714310|10000205|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
2903838|NCT01714310|10000206|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
2903839|NCT01714310|10000207|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
2903840|NCT01714063|10000260|P1|Overall Study|Equipment malfunction|2
2903841|NCT01713998|10000297|P3|Overall Study|Withdrawal by Subject|0
2903842|NCT01713998|10000298|P2|Overall Study|Withdrawal by Subject|0
2903843|NCT01713998|10000299|P1|Overall Study|Withdrawal by Subject|1
2903844|NCT01713998|10000297|P3|Overall Study|Lost to Follow-up|2
2903845|NCT01713998|10000298|P2|Overall Study|Lost to Follow-up|0
2903846|NCT01713998|10000299|P1|Overall Study|Lost to Follow-up|2
2903847|NCT01713946|10000320|P3|Overall Study|Patients never switched to everolimus|5
2903848|NCT01713946|10000321|P2|Overall Study|Patients never switched to everolimus|0
2903849|NCT01713946|10000322|P1|Overall Study|Patients never switched to everolimus|0
2903850|NCT01713946|10000320|P3|Overall Study|Did not continue in Post-Ext. Phase|0
2903851|NCT01713946|10000321|P2|Overall Study|Did not continue in Post-Ext. Phase|2
2903852|NCT01713946|10000322|P1|Overall Study|Did not continue in Post-Ext. Phase|1
2903853|NCT01713946|10000320|P3|Overall Study|Did not continue in Ext|0
2903854|NCT01713946|10000321|P2|Overall Study|Did not continue in Ext|3
2903855|NCT01713946|10000322|P1|Overall Study|Did not continue in Ext|0
2903856|NCT01713946|10000320|P3|Overall Study|Administrative problems|0
2903857|NCT01713946|10000321|P2|Overall Study|Administrative problems|0
2903858|NCT01713946|10000322|P1|Overall Study|Administrative problems|1
2903859|NCT01713946|10000320|P3|Overall Study|Lost to Follow-up|1
2903860|NCT01713946|10000321|P2|Overall Study|Lost to Follow-up|0
2903861|NCT01713946|10000322|P1|Overall Study|Lost to Follow-up|0
2903862|NCT01713946|10000320|P3|Overall Study|Protocol Violation|1
2903863|NCT01713946|10000321|P2|Overall Study|Protocol Violation|4
2903864|NCT01713946|10000322|P1|Overall Study|Protocol Violation|2
2903865|NCT01713946|10000320|P3|Overall Study|Lack of Efficacy|14
2903866|NCT01713946|10000321|P2|Overall Study|Lack of Efficacy|8
2903867|NCT01713946|10000322|P1|Overall Study|Lack of Efficacy|8
2903868|NCT01713946|10000320|P3|Overall Study|Withdrawal by Subject|8
2903869|NCT01713946|10000321|P2|Overall Study|Withdrawal by Subject|12
2903870|NCT01713946|10000322|P1|Overall Study|Withdrawal by Subject|12
2903871|NCT01713946|10000320|P3|Overall Study|Adverse Event|13
2903872|NCT01713946|10000321|P2|Overall Study|Adverse Event|14
2903873|NCT01713946|10000322|P1|Overall Study|Adverse Event|19
2903874|NCT01713946|10000320|P3|Overall Study|Death|2
2903875|NCT01713946|10000321|P2|Overall Study|Death|2
2903876|NCT01713946|10000322|P1|Overall Study|Death|0
2903877|NCT01713933|10000413|P1|Overall Study|Excluded from analysis as a BMI outlier|1
2903878|NCT01713933|10000413|P1|Overall Study|Withdrawal by Subject|3
2903879|NCT01713933|10000413|P1|Overall Study|Lost to Follow-up|2
2903880|NCT01713686|10000462|P1|Overall Study|Withdrawal by Subject|6
2903881|NCT01713686|10000462|P1|Overall Study|Lost to Follow-up|9
2903882|NCT01713582|10000532|P21|Overall Study|Disease progression and adverse event|0
2903883|NCT01713582|10000533|P20|Overall Study|Disease progression and adverse event|0
2903884|NCT01713582|10000534|P19|Overall Study|Disease progression and adverse event|0
2903885|NCT01713582|10000535|P18|Overall Study|Disease progression and adverse event|0
2903886|NCT01713582|10000536|P17|Overall Study|Disease progression and adverse event|1
2903887|NCT01713582|10000537|P16|Overall Study|Disease progression and adverse event|0
2903888|NCT01713582|10000538|P15|Overall Study|Disease progression and adverse event|0
2903889|NCT01713582|10000539|P14|Overall Study|Disease progression and adverse event|0
2903890|NCT01713582|10000540|P13|Overall Study|Disease progression and adverse event|0
2903891|NCT01713582|10000541|P12|Overall Study|Disease progression and adverse event|0
2903892|NCT01713582|10000542|P11|Overall Study|Disease progression and adverse event|0
2903893|NCT01713582|10000543|P10|Overall Study|Disease progression and adverse event|0
2903894|NCT01713582|10000544|P9|Overall Study|Disease progression and adverse event|0
2903895|NCT01713582|10000545|P8|Overall Study|Disease progression and adverse event|0
2903896|NCT01713582|10000546|P7|Overall Study|Disease progression and adverse event|0
2903897|NCT01713582|10000547|P6|Overall Study|Disease progression and adverse event|0
2903898|NCT01713582|10000548|P5|Overall Study|Disease progression and adverse event|0
2903899|NCT01713582|10000549|P4|Overall Study|Disease progression and adverse event|0
2903900|NCT01713582|10000550|P3|Overall Study|Disease progression and adverse event|0
2903901|NCT01713582|10000551|P2|Overall Study|Disease progression and adverse event|0
2903902|NCT01713582|10000552|P1|Overall Study|Disease progression and adverse event|0
2903903|NCT01713582|10000532|P21|Overall Study|Stopped to receive bone marrow graft|0
2903904|NCT01713582|10000533|P20|Overall Study|Stopped to receive bone marrow graft|0
2903905|NCT01713582|10000534|P19|Overall Study|Stopped to receive bone marrow graft|0
2903906|NCT01713582|10000535|P18|Overall Study|Stopped to receive bone marrow graft|0
2903907|NCT01713582|10000536|P17|Overall Study|Stopped to receive bone marrow graft|1
2903908|NCT01713582|10000537|P16|Overall Study|Stopped to receive bone marrow graft|0
2903909|NCT01713582|10000538|P15|Overall Study|Stopped to receive bone marrow graft|0
2903910|NCT01713582|10000539|P14|Overall Study|Stopped to receive bone marrow graft|0
2903911|NCT01713582|10000540|P13|Overall Study|Stopped to receive bone marrow graft|0
2903997|NCT01713582|10000542|P11|Overall Study|Adverse event-unrelated|0
2903912|NCT01713582|10000541|P12|Overall Study|Stopped to receive bone marrow graft|0
2903913|NCT01713582|10000542|P11|Overall Study|Stopped to receive bone marrow graft|0
2903914|NCT01713582|10000543|P10|Overall Study|Stopped to receive bone marrow graft|0
2903915|NCT01713582|10000544|P9|Overall Study|Stopped to receive bone marrow graft|0
2903916|NCT01713582|10000545|P8|Overall Study|Stopped to receive bone marrow graft|0
2903917|NCT01713582|10000546|P7|Overall Study|Stopped to receive bone marrow graft|0
2903918|NCT01713582|10000547|P6|Overall Study|Stopped to receive bone marrow graft|0
2903919|NCT01713582|10000548|P5|Overall Study|Stopped to receive bone marrow graft|0
2903920|NCT01713582|10000549|P4|Overall Study|Stopped to receive bone marrow graft|0
2903921|NCT01713582|10000550|P3|Overall Study|Stopped to receive bone marrow graft|0
2903922|NCT01713582|10000551|P2|Overall Study|Stopped to receive bone marrow graft|0
2903923|NCT01713582|10000552|P1|Overall Study|Stopped to receive bone marrow graft|0
2903924|NCT01713582|10000532|P21|Overall Study|Withdrawal by Subject|0
2903925|NCT01713582|10000533|P20|Overall Study|Withdrawal by Subject|0
2903926|NCT01713582|10000534|P19|Overall Study|Withdrawal by Subject|0
2903927|NCT01713582|10000535|P18|Overall Study|Withdrawal by Subject|1
2903928|NCT01713582|10000536|P17|Overall Study|Withdrawal by Subject|0
2903929|NCT01713582|10000537|P16|Overall Study|Withdrawal by Subject|0
2903930|NCT01713582|10000538|P15|Overall Study|Withdrawal by Subject|0
2903931|NCT01713582|10000539|P14|Overall Study|Withdrawal by Subject|0
2903932|NCT01713582|10000540|P13|Overall Study|Withdrawal by Subject|0
2903933|NCT01713582|10000541|P12|Overall Study|Withdrawal by Subject|0
2903934|NCT01713582|10000542|P11|Overall Study|Withdrawal by Subject|0
2903935|NCT01713582|10000543|P10|Overall Study|Withdrawal by Subject|0
2903936|NCT01713582|10000544|P9|Overall Study|Withdrawal by Subject|0
2903937|NCT01713582|10000545|P8|Overall Study|Withdrawal by Subject|0
2903938|NCT01713582|10000546|P7|Overall Study|Withdrawal by Subject|0
2903939|NCT01713582|10000547|P6|Overall Study|Withdrawal by Subject|0
2903940|NCT01713582|10000548|P5|Overall Study|Withdrawal by Subject|0
2903941|NCT01713582|10000549|P4|Overall Study|Withdrawal by Subject|0
2903942|NCT01713582|10000550|P3|Overall Study|Withdrawal by Subject|0
2903943|NCT01713582|10000551|P2|Overall Study|Withdrawal by Subject|0
2903944|NCT01713582|10000552|P1|Overall Study|Withdrawal by Subject|0
2903945|NCT01713582|10000532|P21|Overall Study|Lack of Efficacy|0
2903946|NCT01713582|10000533|P20|Overall Study|Lack of Efficacy|0
2903947|NCT01713582|10000534|P19|Overall Study|Lack of Efficacy|0
2903948|NCT01713582|10000535|P18|Overall Study|Lack of Efficacy|0
2903949|NCT01713582|10000536|P17|Overall Study|Lack of Efficacy|0
2903950|NCT01713582|10000537|P16|Overall Study|Lack of Efficacy|0
2903951|NCT01713582|10000538|P15|Overall Study|Lack of Efficacy|0
2903952|NCT01713582|10000539|P14|Overall Study|Lack of Efficacy|0
2903953|NCT01713582|10000540|P13|Overall Study|Lack of Efficacy|0
2903954|NCT01713582|10000541|P12|Overall Study|Lack of Efficacy|0
2903955|NCT01713582|10000542|P11|Overall Study|Lack of Efficacy|2
2903956|NCT01713582|10000543|P10|Overall Study|Lack of Efficacy|1
2903957|NCT01713582|10000544|P9|Overall Study|Lack of Efficacy|0
2903958|NCT01713582|10000545|P8|Overall Study|Lack of Efficacy|0
2903959|NCT01713582|10000546|P7|Overall Study|Lack of Efficacy|0
2903960|NCT01713582|10000547|P6|Overall Study|Lack of Efficacy|0
2903961|NCT01713582|10000548|P5|Overall Study|Lack of Efficacy|0
2903962|NCT01713582|10000549|P4|Overall Study|Lack of Efficacy|0
2903963|NCT01713582|10000550|P3|Overall Study|Lack of Efficacy|0
2903964|NCT01713582|10000551|P2|Overall Study|Lack of Efficacy|0
2903965|NCT01713582|10000552|P1|Overall Study|Lack of Efficacy|0
2903966|NCT01713582|10000532|P21|Overall Study|Withdrawal of consent|0
2903967|NCT01713582|10000533|P20|Overall Study|Withdrawal of consent|0
2903968|NCT01713582|10000534|P19|Overall Study|Withdrawal of consent|1
2903969|NCT01713582|10000535|P18|Overall Study|Withdrawal of consent|0
2903970|NCT01713582|10000536|P17|Overall Study|Withdrawal of consent|0
2903971|NCT01713582|10000537|P16|Overall Study|Withdrawal of consent|0
2903972|NCT01713582|10000538|P15|Overall Study|Withdrawal of consent|0
2903973|NCT01713582|10000539|P14|Overall Study|Withdrawal of consent|0
2903974|NCT01713582|10000540|P13|Overall Study|Withdrawal of consent|0
2903975|NCT01713582|10000541|P12|Overall Study|Withdrawal of consent|0
2903976|NCT01713582|10000542|P11|Overall Study|Withdrawal of consent|0
2903977|NCT01713582|10000543|P10|Overall Study|Withdrawal of consent|1
2903978|NCT01713582|10000544|P9|Overall Study|Withdrawal of consent|0
2903979|NCT01713582|10000545|P8|Overall Study|Withdrawal of consent|0
2903980|NCT01713582|10000546|P7|Overall Study|Withdrawal of consent|0
2903981|NCT01713582|10000547|P6|Overall Study|Withdrawal of consent|1
2903982|NCT01713582|10000548|P5|Overall Study|Withdrawal of consent|0
2903983|NCT01713582|10000549|P4|Overall Study|Withdrawal of consent|0
2903984|NCT01713582|10000550|P3|Overall Study|Withdrawal of consent|1
2903985|NCT01713582|10000551|P2|Overall Study|Withdrawal of consent|0
2903986|NCT01713582|10000552|P1|Overall Study|Withdrawal of consent|0
2903987|NCT01713582|10000532|P21|Overall Study|Adverse event-unrelated|0
2903988|NCT01713582|10000533|P20|Overall Study|Adverse event-unrelated|0
2903989|NCT01713582|10000534|P19|Overall Study|Adverse event-unrelated|0
2903990|NCT01713582|10000535|P18|Overall Study|Adverse event-unrelated|0
2903991|NCT01713582|10000536|P17|Overall Study|Adverse event-unrelated|0
2903992|NCT01713582|10000537|P16|Overall Study|Adverse event-unrelated|0
2903993|NCT01713582|10000538|P15|Overall Study|Adverse event-unrelated|1
2903994|NCT01713582|10000539|P14|Overall Study|Adverse event-unrelated|1
2903995|NCT01713582|10000540|P13|Overall Study|Adverse event-unrelated|0
2903996|NCT01713582|10000541|P12|Overall Study|Adverse event-unrelated|0
2903998|NCT01713582|10000543|P10|Overall Study|Adverse event-unrelated|0
2903999|NCT01713582|10000544|P9|Overall Study|Adverse event-unrelated|0
2904000|NCT01713582|10000545|P8|Overall Study|Adverse event-unrelated|1
2904001|NCT01713582|10000546|P7|Overall Study|Adverse event-unrelated|1
2904002|NCT01713582|10000547|P6|Overall Study|Adverse event-unrelated|1
2904003|NCT01713582|10000548|P5|Overall Study|Adverse event-unrelated|0
2904004|NCT01713582|10000549|P4|Overall Study|Adverse event-unrelated|0
2904005|NCT01713582|10000550|P3|Overall Study|Adverse event-unrelated|0
2904006|NCT01713582|10000551|P2|Overall Study|Adverse event-unrelated|0
2904007|NCT01713582|10000552|P1|Overall Study|Adverse event-unrelated|0
2904008|NCT01713582|10000532|P21|Overall Study|Adverse event-related|0
2904009|NCT01713582|10000533|P20|Overall Study|Adverse event-related|0
2904010|NCT01713582|10000534|P19|Overall Study|Adverse event-related|1
2904011|NCT01713582|10000535|P18|Overall Study|Adverse event-related|0
2904012|NCT01713582|10000536|P17|Overall Study|Adverse event-related|0
2904013|NCT01713582|10000537|P16|Overall Study|Adverse event-related|0
2904014|NCT01713582|10000538|P15|Overall Study|Adverse event-related|0
2904015|NCT01713582|10000539|P14|Overall Study|Adverse event-related|0
2904016|NCT01713582|10000540|P13|Overall Study|Adverse event-related|0
2904017|NCT01713582|10000541|P12|Overall Study|Adverse event-related|0
2904018|NCT01713582|10000542|P11|Overall Study|Adverse event-related|1
2904019|NCT01713582|10000543|P10|Overall Study|Adverse event-related|1
2904020|NCT01713582|10000544|P9|Overall Study|Adverse event-related|0
2904021|NCT01713582|10000545|P8|Overall Study|Adverse event-related|0
2904022|NCT01713582|10000546|P7|Overall Study|Adverse event-related|0
2904023|NCT01713582|10000547|P6|Overall Study|Adverse event-related|0
2904024|NCT01713582|10000548|P5|Overall Study|Adverse event-related|0
2904025|NCT01713582|10000549|P4|Overall Study|Adverse event-related|0
2904026|NCT01713582|10000550|P3|Overall Study|Adverse event-related|0
2904027|NCT01713582|10000551|P2|Overall Study|Adverse event-related|0
2904028|NCT01713582|10000552|P1|Overall Study|Adverse event-related|0
2904029|NCT01713582|10000532|P21|Overall Study|Death|0
2904030|NCT01713582|10000533|P20|Overall Study|Death|0
2904031|NCT01713582|10000534|P19|Overall Study|Death|0
2904032|NCT01713582|10000535|P18|Overall Study|Death|0
2904033|NCT01713582|10000536|P17|Overall Study|Death|0
2904034|NCT01713582|10000537|P16|Overall Study|Death|0
2904035|NCT01713582|10000538|P15|Overall Study|Death|0
2904036|NCT01713582|10000539|P14|Overall Study|Death|0
2904037|NCT01713582|10000540|P13|Overall Study|Death|0
2904038|NCT01713582|10000541|P12|Overall Study|Death|0
2904039|NCT01713582|10000542|P11|Overall Study|Death|3
2904040|NCT01713582|10000543|P10|Overall Study|Death|4
2904041|NCT01713582|10000544|P9|Overall Study|Death|3
2904042|NCT01713582|10000545|P8|Overall Study|Death|2
2904043|NCT01713582|10000546|P7|Overall Study|Death|3
2904044|NCT01713582|10000547|P6|Overall Study|Death|3
2904045|NCT01713582|10000548|P5|Overall Study|Death|1
2904046|NCT01713582|10000549|P4|Overall Study|Death|1
2904047|NCT01713582|10000550|P3|Overall Study|Death|0
2904048|NCT01713582|10000551|P2|Overall Study|Death|0
2904049|NCT01713582|10000552|P1|Overall Study|Death|0
2904050|NCT01713582|10000532|P21|Overall Study|Disease progression|15
2904051|NCT01713582|10000533|P20|Overall Study|Disease progression|5
2904052|NCT01713582|10000534|P19|Overall Study|Disease progression|3
2904053|NCT01713582|10000535|P18|Overall Study|Disease progression|2
2904054|NCT01713582|10000536|P17|Overall Study|Disease progression|5
2904055|NCT01713582|10000537|P16|Overall Study|Disease progression|6
2904056|NCT01713582|10000538|P15|Overall Study|Disease progression|6
2904057|NCT01713582|10000539|P14|Overall Study|Disease progression|3
2904058|NCT01713582|10000540|P13|Overall Study|Disease progression|3
2904059|NCT01713582|10000541|P12|Overall Study|Disease progression|5
2904060|NCT01713582|10000542|P11|Overall Study|Disease progression|10
2904061|NCT01713582|10000543|P10|Overall Study|Disease progression|11
2904062|NCT01713582|10000544|P9|Overall Study|Disease progression|3
2904063|NCT01713582|10000545|P8|Overall Study|Disease progression|3
2904064|NCT01713582|10000546|P7|Overall Study|Disease progression|3
2904065|NCT01713582|10000547|P6|Overall Study|Disease progression|3
2904066|NCT01713582|10000548|P5|Overall Study|Disease progression|3
2904067|NCT01713582|10000549|P4|Overall Study|Disease progression|2
2904068|NCT01713582|10000550|P3|Overall Study|Disease progression|3
2904069|NCT01713582|10000551|P2|Overall Study|Disease progression|3
2904070|NCT01713582|10000552|P1|Overall Study|Disease progression|3
2904071|NCT01713530|10000715|P2|Overall Study|Unclassified|2
2904072|NCT01713530|10000716|P1|Overall Study|Unclassified|4
2904073|NCT01713530|10000715|P2|Overall Study|Withdrawal criteria|12
2904074|NCT01713530|10000716|P1|Overall Study|Withdrawal criteria|21
2904075|NCT01713530|10000715|P2|Overall Study|Adverse Event|5
2904076|NCT01713530|10000716|P1|Overall Study|Adverse Event|0
2904077|NCT01713348|10000747|P4|Overall Study|Lost to Follow-up|0
2904078|NCT01713348|10000748|P3|Overall Study|Lost to Follow-up|0
2904079|NCT01713348|10000749|P2|Overall Study|Lost to Follow-up|0
2904080|NCT01713348|10000750|P1|Overall Study|Lost to Follow-up|1
2904081|NCT01713348|10000747|P4|Overall Study|Withdrawal by Subject|0
2904082|NCT01713348|10000748|P3|Overall Study|Withdrawal by Subject|2
2904083|NCT01713348|10000749|P2|Overall Study|Withdrawal by Subject|2
2904084|NCT01713348|10000750|P1|Overall Study|Withdrawal by Subject|3
2904085|NCT01713283|10000780|P2|Overall Study|Lost to Follow-up|1
2904086|NCT01713283|10000781|P1|Overall Study|Lost to Follow-up|1
2904087|NCT01713283|10000780|P2|Overall Study|Lack of Efficacy|2
2904088|NCT01713283|10000781|P1|Overall Study|Lack of Efficacy|10
2904089|NCT01713036|10000803|P1|Overall Study|Death|1
2904090|NCT01712984|10000843|P3|Overall Study|Withdrawal by Subject|7
2904091|NCT01712984|10000844|P2|Overall Study|Withdrawal by Subject|6
2904092|NCT01712984|10000845|P1|Overall Study|Withdrawal by Subject|6
2904093|NCT01712984|10000843|P3|Overall Study|Lost to Follow-up|1
2904094|NCT01712984|10000844|P2|Overall Study|Lost to Follow-up|10
2904095|NCT01712984|10000845|P1|Overall Study|Lost to Follow-up|8
2904096|NCT01712984|10000843|P3|Overall Study|Protocol Violation|1
2904097|NCT01712984|10000844|P2|Overall Study|Protocol Violation|0
2904098|NCT01712984|10000845|P1|Overall Study|Protocol Violation|2
2904099|NCT01712984|10000843|P3|Overall Study|Adverse Event|1
2904100|NCT01712984|10000844|P2|Overall Study|Adverse Event|0
2904101|NCT01712984|10000845|P1|Overall Study|Adverse Event|0
2904102|NCT01712854|10000865|P1|Overall Study|Physician Decision|1
2904103|NCT01712685|10000888|P1|Overall Study|pt declined to participate before trmt|1
2904104|NCT01712516|10000904|P4|Overall Study|Withdrawal by Subject|9
2904105|NCT01712516|10000905|P3|Overall Study|Withdrawal by Subject|3
2904106|NCT01712516|10000906|P2|Overall Study|Withdrawal by Subject|9
2904107|NCT01712516|10000907|P1|Overall Study|Withdrawal by Subject|3
2904108|NCT01712516|10000904|P4|Overall Study|Physician Decision|1
2904109|NCT01712516|10000905|P3|Overall Study|Physician Decision|0
2904110|NCT01712516|10000906|P2|Overall Study|Physician Decision|0
2904111|NCT01712516|10000907|P1|Overall Study|Physician Decision|2
2904112|NCT01712516|10000904|P4|Overall Study|Protocol deviation|0
2904113|NCT01712516|10000905|P3|Overall Study|Protocol deviation|1
2904114|NCT01712516|10000906|P2|Overall Study|Protocol deviation|0
2904115|NCT01712516|10000907|P1|Overall Study|Protocol deviation|1
2904116|NCT01712516|10000904|P4|Overall Study|Death|0
2904117|NCT01712516|10000905|P3|Overall Study|Death|0
2904118|NCT01712516|10000906|P2|Overall Study|Death|1
2904119|NCT01712516|10000907|P1|Overall Study|Death|0
2904120|NCT01712516|10000904|P4|Overall Study|Lost to Follow-up|1
2904121|NCT01712516|10000905|P3|Overall Study|Lost to Follow-up|2
2904122|NCT01712516|10000906|P2|Overall Study|Lost to Follow-up|0
2904123|NCT01712516|10000907|P1|Overall Study|Lost to Follow-up|0
2904124|NCT01712516|10000904|P4|Overall Study|Technical problems|2
2904125|NCT01712516|10000905|P3|Overall Study|Technical problems|0
2904126|NCT01712516|10000906|P2|Overall Study|Technical problems|0
2904127|NCT01712516|10000907|P1|Overall Study|Technical problems|0
2904128|NCT01712490|10000959|P2|Overall Study|Lost to Follow-up|29
2904129|NCT01712490|10000960|P1|Overall Study|Lost to Follow-up|16
2904130|NCT01712490|10000959|P2|Overall Study|Withdrawal by Subject|44
2904131|NCT01712490|10000960|P1|Overall Study|Withdrawal by Subject|36
2904132|NCT01712490|10000959|P2|Overall Study|Other|11
2904133|NCT01712490|10000960|P1|Overall Study|Other|11
2904134|NCT01712490|10000959|P2|Overall Study|Ongoing|586
2904135|NCT01712490|10000960|P1|Overall Study|Ongoing|601
2904136|NCT01712438|10000997|P1|Overall Study|Prematurely Discontinued|25
2904137|NCT01712438|10000997|P1|Overall Study|Violated inclusion & exclusion criteria|4
2904138|NCT01712438|10000997|P1|Overall Study|Ongoing ITI treatment|6
2904139|NCT01712438|10000997|P1|Overall Study|Not treated with Human-cl rhFVIII|2
2904140|NCT01712399|10001007|P1|Overall Study|Study closure|345
2904141|NCT01712399|10001007|P1|Overall Study|Adverse Event|11
2904142|NCT01712399|10001007|P1|Overall Study|Death|1
2904143|NCT01712399|10001007|P1|Overall Study|Withdrawal by Subject|39
2904144|NCT01712399|10001007|P1|Overall Study|Lost to Follow-up|1
2904145|NCT01712334|10001053|P2|Treatment Period 1|Randomized in Error|2
2904146|NCT01712334|10001054|P1|Treatment Period 1|Randomized in Error|0
2904147|NCT01712256|10001062|P1|Overall Study|Lost to Follow-up|1
2904148|NCT01712204|10001092|P2|Overall Study|Protocol Violation|1
2904149|NCT01712204|10001093|P1|Overall Study|Protocol Violation|1
2904150|NCT01712204|10001092|P2|Overall Study|Lost to Follow-up|0
2904151|NCT01712204|10001093|P1|Overall Study|Lost to Follow-up|1
2904152|NCT01712204|10001092|P2|Overall Study|Withdrawal by Subject|3
2904153|NCT01712204|10001093|P1|Overall Study|Withdrawal by Subject|3
2904154|NCT01712204|10001092|P2|Overall Study|Adverse Event|1
2904155|NCT01712204|10001093|P1|Overall Study|Adverse Event|3
2904156|NCT01712178|10001101|P2|Overall Study|Lost to Follow-up|1
2904157|NCT01712178|10001102|P1|Overall Study|Lost to Follow-up|0
2904158|NCT01712178|10001101|P2|Overall Study|Serious adverse event/withdrew consent|1
2904159|NCT01712178|10001102|P1|Overall Study|Serious adverse event/withdrew consent|0
2904160|NCT01712178|10001101|P2|Overall Study|Withdrew consent due to an adverse event|1
2904161|NCT01712178|10001102|P1|Overall Study|Withdrew consent due to an adverse event|1
2904162|NCT01712074|10001127|P3|Double Blind Period|No longer met eligibility criteria|0
2904163|NCT01712074|10001128|P2|Double Blind Period|No longer met eligibility criteria|3
2904164|NCT01712074|10001129|P1|Double Blind Period|No longer met eligibility criteria|0
2904165|NCT01712074|10001127|P3|Double Blind Period|Protocol Violation|1
2904166|NCT01712074|10001128|P2|Double Blind Period|Protocol Violation|0
2904167|NCT01712074|10001129|P1|Double Blind Period|Protocol Violation|0
2904168|NCT01712074|10001127|P3|Double Blind Period|Other|1
2904169|NCT01712074|10001128|P2|Double Blind Period|Other|4
2904170|NCT01712074|10001129|P1|Double Blind Period|Other|0
2904171|NCT01712074|10001127|P3|Double Blind Period|Lost to Follow-up|1
2904172|NCT01712074|10001128|P2|Double Blind Period|Lost to Follow-up|2
2904173|NCT01712074|10001129|P1|Double Blind Period|Lost to Follow-up|0
2904174|NCT01712074|10001127|P3|Double Blind Period|Death|0
2904175|NCT01712074|10001128|P2|Double Blind Period|Death|1
2904176|NCT01712074|10001129|P1|Double Blind Period|Death|0
2904177|NCT01712074|10001127|P3|Double Blind Period|No longer willing to participate|4
2904178|NCT01712074|10001128|P2|Double Blind Period|No longer willing to participate|2
2904179|NCT01712074|10001129|P1|Double Blind Period|No longer willing to participate|0
2904180|NCT01712074|10001127|P3|Double Blind Period|Adverse Event|1
2904181|NCT01712074|10001128|P2|Double Blind Period|Adverse Event|2
2904182|NCT01712074|10001129|P1|Double Blind Period|Adverse Event|0
2904183|NCT01712074|10001127|P3|Placebo Run-in Period|No longer willing to participate|0
2904184|NCT01712074|10001128|P2|Placebo Run-in Period|No longer willing to participate|0
2904185|NCT01712074|10001129|P1|Placebo Run-in Period|No longer willing to participate|1
2904186|NCT01712074|10001127|P3|Placebo Run-in Period|Other|0
2904187|NCT01712074|10001128|P2|Placebo Run-in Period|Other|0
2904188|NCT01712074|10001129|P1|Placebo Run-in Period|Other|1
2904189|NCT01712074|10001127|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
2904190|NCT01712074|10001128|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
2904191|NCT01712074|10001129|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
2904192|NCT01712074|10001127|P3|Placebo Run-in Period|Lost to Follow-up|0
2904193|NCT01712074|10001128|P2|Placebo Run-in Period|Lost to Follow-up|0
2904194|NCT01712074|10001129|P1|Placebo Run-in Period|Lost to Follow-up|1
2904195|NCT01712074|10001127|P3|Placebo Run-in Period|Adverse Event|0
2904196|NCT01712074|10001128|P2|Placebo Run-in Period|Adverse Event|0
2904197|NCT01712074|10001129|P1|Placebo Run-in Period|Adverse Event|2
2904198|NCT01712061|10001185|P3|Overall Study|Other|0
2904199|NCT01712061|10001186|P2|Overall Study|Other|3
2904200|NCT01712061|10001187|P1|Overall Study|Other|0
2904201|NCT01712061|10001185|P3|Overall Study|Withdrawal by Subject|1
2904202|NCT01712061|10001186|P2|Overall Study|Withdrawal by Subject|7
2904203|NCT01712061|10001187|P1|Overall Study|Withdrawal by Subject|1
2904204|NCT01712061|10001185|P3|Overall Study|Medication Error Without Associated AE|0
2904205|NCT01712061|10001186|P2|Overall Study|Medication Error Without Associated AE|1
2904206|NCT01712061|10001187|P1|Overall Study|Medication Error Without Associated AE|0
2904207|NCT01712061|10001185|P3|Overall Study|Did Not Meet Entrance Criteria|3
2904208|NCT01712061|10001186|P2|Overall Study|Did Not Meet Entrance Criteria|6
2904209|NCT01712061|10001187|P1|Overall Study|Did Not Meet Entrance Criteria|4
2904210|NCT01712061|10001185|P3|Overall Study|Lost to Follow-up|1
2904211|NCT01712061|10001186|P2|Overall Study|Lost to Follow-up|0
2904212|NCT01712061|10001187|P1|Overall Study|Lost to Follow-up|1
2904213|NCT01712061|10001185|P3|Overall Study|Death|1
2904214|NCT01712061|10001186|P2|Overall Study|Death|0
2904215|NCT01712061|10001187|P1|Overall Study|Death|0
2904216|NCT01712061|10001185|P3|Overall Study|Adverse Event|5
2904217|NCT01712061|10001186|P2|Overall Study|Adverse Event|9
2904218|NCT01712061|10001187|P1|Overall Study|Adverse Event|4
2904219|NCT01712009|10001227|P3|Overall Study|Decision by Sponsor|12
2904220|NCT01712009|10001228|P2|Overall Study|Decision by Sponsor|14
2904221|NCT01712009|10001229|P1|Overall Study|Decision by Sponsor|12
2904222|NCT01712009|10001227|P3|Overall Study|Lost to Follow-up|1
2904223|NCT01712009|10001228|P2|Overall Study|Lost to Follow-up|0
2904224|NCT01712009|10001229|P1|Overall Study|Lost to Follow-up|2
2904225|NCT01712009|10001227|P3|Overall Study|Withdrawal by Subject|8
2904226|NCT01712009|10001228|P2|Overall Study|Withdrawal by Subject|15
2904227|NCT01712009|10001229|P1|Overall Study|Withdrawal by Subject|24
2904228|NCT01711866|10001263|P1|Overall Study|Adverse Event|2
2904229|NCT01711866|10001263|P1|Overall Study|Withdrawal by Subject|3
2904230|NCT01711866|10001263|P1|Overall Study|Noncompliant|3
2904231|NCT01711853|10001268|P1|Overall Study|Not treated|3
2904232|NCT01711736|10001275|P2|Overall Study|Migrated/moved from study area|1
2904233|NCT01711736|10001276|P1|Overall Study|Migrated/moved from study area|2
2904234|NCT01711736|10001275|P2|Overall Study|Withdrawal by Subject|6
2904235|NCT01711736|10001276|P1|Overall Study|Withdrawal by Subject|6
2904236|NCT01711736|10001275|P2|Overall Study|Lost to Follow-up|1
2904237|NCT01711736|10001276|P1|Overall Study|Lost to Follow-up|4
2904238|NCT01711645|10001304|P1|Overall Study|Physician Decision|5
2904239|NCT01711645|10001304|P1|Overall Study|Lost to Follow-up|6
2904240|NCT01711645|10001304|P1|Overall Study|Withdrawal by Subject|8
2904241|NCT01711619|10001341|P2|Overall Study|Lost to Follow-up|0
2904242|NCT01711619|10001342|P1|Overall Study|Lost to Follow-up|1
2904243|NCT01711619|10001341|P2|Overall Study|Adverse Event|0
2904244|NCT01711619|10001342|P1|Overall Study|Adverse Event|2
2904245|NCT01711619|10001341|P2|Overall Study|Protocol Violation|3
2904246|NCT01711619|10001342|P1|Overall Study|Protocol Violation|2
2904247|NCT01711619|10001341|P2|Overall Study|Withdrawal by Subject|7
2904248|NCT01711619|10001342|P1|Overall Study|Withdrawal by Subject|3
2904249|NCT01711619|10001341|P2|Overall Study|Early study termination|14
2904250|NCT01711619|10001342|P1|Overall Study|Early study termination|10
2904251|NCT01711541|10001359|P5|Overall Study|Ineligible|0
2904252|NCT01711541|10001360|P4|Overall Study|Ineligible|0
2904253|NCT01711541|10001361|P3|Overall Study|Ineligible|0
2904254|NCT01711541|10001362|P2|Overall Study|Ineligible|1
2904255|NCT01711541|10001363|P1|Overall Study|Ineligible|0
2904256|NCT01711541|10001359|P5|Overall Study|Cancel prior to treatment|0
2904257|NCT01711541|10001360|P4|Overall Study|Cancel prior to treatment|1
2904258|NCT01711541|10001361|P3|Overall Study|Cancel prior to treatment|0
2904259|NCT01711541|10001362|P2|Overall Study|Cancel prior to treatment|0
2904260|NCT01711541|10001363|P1|Overall Study|Cancel prior to treatment|0
2904261|NCT01711359|10001412|P3|Treatment Period|Randomized, Not Treated|0
2904262|NCT01711359|10001413|P2|Treatment Period|Randomized, Not Treated|1
2904263|NCT01711359|10001414|P1|Treatment Period|Randomized, Not Treated|3
2904264|NCT01711359|10001412|P3|Treatment Period|Lost to Follow-up|1
2904265|NCT01711359|10001413|P2|Treatment Period|Lost to Follow-up|1
2904266|NCT01711359|10001414|P1|Treatment Period|Lost to Follow-up|1
2904267|NCT01711359|10001412|P3|Treatment Period|Sponsor Decision|0
2904268|NCT01711359|10001413|P2|Treatment Period|Sponsor Decision|0
2904269|NCT01711359|10001414|P1|Treatment Period|Sponsor Decision|1
2904270|NCT01711359|10001412|P3|Treatment Period|Entry Criteria Not Met|0
2904271|NCT01711359|10001413|P2|Treatment Period|Entry Criteria Not Met|0
2904272|NCT01711359|10001414|P1|Treatment Period|Entry Criteria Not Met|1
2904273|NCT01711359|10001412|P3|Treatment Period|Death|0
2904274|NCT01711359|10001413|P2|Treatment Period|Death|0
2904275|NCT01711359|10001414|P1|Treatment Period|Death|3
2904276|NCT01711359|10001412|P3|Treatment Period|Physician Decision|2
2904277|NCT01711359|10001413|P2|Treatment Period|Physician Decision|3
2904278|NCT01711359|10001414|P1|Treatment Period|Physician Decision|4
2904279|NCT01711359|10001412|P3|Treatment Period|Adverse Event|24
2904280|NCT01711359|10001413|P2|Treatment Period|Adverse Event|10
2904281|NCT01711359|10001414|P1|Treatment Period|Adverse Event|8
2904282|NCT01711359|10001412|P3|Treatment Period|Lack of Efficacy|2
2904283|NCT01711359|10001413|P2|Treatment Period|Lack of Efficacy|2
2904284|NCT01711359|10001414|P1|Treatment Period|Lack of Efficacy|13
2904285|NCT01711359|10001412|P3|Treatment Period|Withdrawal by Subject|13
2904286|NCT01711359|10001413|P2|Treatment Period|Withdrawal by Subject|7
2904287|NCT01711359|10001414|P1|Treatment Period|Withdrawal by Subject|18
2904288|NCT01711216|10001485|P1|Overall Study|no reason specified|22
2904289|NCT01711216|10001485|P1|Overall Study|variety of other minor reasons|83
2904290|NCT01711216|10001485|P1|Overall Study|Lost to Follow-up|46
2904291|NCT01711216|10001485|P1|Overall Study|Withdrawal by Subject|6
2904292|NCT01711216|10001485|P1|Overall Study|Pregnancy|56
2904293|NCT01711216|10001485|P1|Overall Study|Adverse Event|4
2904294|NCT01710800|10001563|P1|Overall Study|Protocol Violation|1
2904295|NCT01710800|10001563|P1|Overall Study|Withdrawal by Subject|21
2904296|NCT01710709|10001627|P1|Overall Study|Lack of Efficacy|3
2904297|NCT01710709|10001627|P1|Overall Study|Protocol Violation|5
2904298|NCT01710709|10001627|P1|Overall Study|Withdrawal by Subject|53
2904299|NCT01710709|10001627|P1|Overall Study|Participant withdrawn by investigator|2
2904300|NCT01710709|10001627|P1|Overall Study|Participant met withdrawal criteria|33
2904301|NCT01710709|10001627|P1|Overall Study|Adverse Event|48
2904302|NCT01710709|10001627|P1|Overall Study|Lost to Follow-up|29
2904303|NCT01710657|10001642|P3|Overall Study|Lack of Efficacy|1
2904304|NCT01710657|10001643|P2|Overall Study|Lack of Efficacy|1
2904305|NCT01710657|10001644|P1|Overall Study|Lack of Efficacy|0
2904306|NCT01710657|10001642|P3|Overall Study|Withdrawal by Subject|2
2904307|NCT01710657|10001643|P2|Overall Study|Withdrawal by Subject|1
2904308|NCT01710657|10001644|P1|Overall Study|Withdrawal by Subject|0
2904309|NCT01710657|10001642|P3|Overall Study|Adverse Event|28
2904310|NCT01710657|10001643|P2|Overall Study|Adverse Event|8
2904311|NCT01710657|10001644|P1|Overall Study|Adverse Event|14
2904312|NCT01710657|10001642|P3|Overall Study|Protocol Violation|0
2904313|NCT01710657|10001643|P2|Overall Study|Protocol Violation|2
2904314|NCT01710657|10001644|P1|Overall Study|Protocol Violation|2
2904315|NCT01710657|10001642|P3|Overall Study|Lost to Follow-up|1
2904316|NCT01710657|10001643|P2|Overall Study|Lost to Follow-up|0
2904317|NCT01710657|10001644|P1|Overall Study|Lost to Follow-up|2
2904318|NCT01710527|10001661|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
2904319|NCT01710527|10001662|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
2904320|NCT01710514|10001688|P2|Overall Study|Withdrawal by Subject|0
2904321|NCT01710514|10001689|P1|Overall Study|Withdrawal by Subject|1
2904322|NCT01710514|10001688|P2|Overall Study|Adverse Event|7
2904323|NCT01710514|10001689|P1|Overall Study|Adverse Event|6
2904324|NCT01710501|10001710|P3|Overall Study|Lost to Follow-up|0
2904325|NCT01710501|10001711|P2|Overall Study|Lost to Follow-up|0
2904326|NCT01710501|10001712|P1|Overall Study|Lost to Follow-up|2
2904327|NCT01710358|10001744|P3|Rescue Period|Withdrawal by Subject|0
2904328|NCT01710358|10001745|P2|Rescue Period|Withdrawal by Subject|8
2904329|NCT01710358|10001746|P1|Rescue Period|Withdrawal by Subject|0
2904330|NCT01710358|10001744|P3|Rescue Period|Lack of Efficacy|0
2904331|NCT01710358|10001745|P2|Rescue Period|Lack of Efficacy|7
2904332|NCT01710358|10001746|P1|Rescue Period|Lack of Efficacy|0
2904333|NCT01710358|10001744|P3|Rescue Period|Death|0
2904334|NCT01710358|10001745|P2|Rescue Period|Death|1
2904335|NCT01710358|10001746|P1|Rescue Period|Death|0
2904336|NCT01710358|10001744|P3|Rescue Period|Adverse Event|0
2904337|NCT01710358|10001745|P2|Rescue Period|Adverse Event|15
2904338|NCT01710358|10001746|P1|Rescue Period|Adverse Event|0
2904339|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
2904340|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
2904341|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
2904342|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
2904343|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
2904344|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
2904345|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2904346|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
2904347|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2904348|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
2904349|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2904515|NCT01709318|10002509|P5|Overall Study|Protocol Violation|2
2904350|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2904351|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
2904352|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2904353|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2904354|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
2904355|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
2904356|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
2904357|NCT01710358|10001744|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
2904358|NCT01710358|10001745|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
2904359|NCT01710358|10001746|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
2904360|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
2904361|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2904362|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2904363|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
2904364|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
2904365|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
2904366|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2904367|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2904368|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
2904369|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2904370|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2904371|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
2904372|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2904373|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
2904374|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2904375|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
2904376|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
2904377|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
2904378|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2904379|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2904380|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
2904381|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
2904382|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
2904383|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
2904384|NCT01710358|10001744|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
2904385|NCT01710358|10001745|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
2904386|NCT01710358|10001746|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
2904387|NCT01710345|10001817|P3|Overall Study|Drug Dosing Error|0
2904388|NCT01710345|10001818|P2|Overall Study|Drug Dosing Error|0
2904389|NCT01710345|10001819|P1|Overall Study|Drug Dosing Error|1
2904390|NCT01710345|10001817|P3|Overall Study|Lack of Efficacy|1
2904391|NCT01710345|10001818|P2|Overall Study|Lack of Efficacy|3
2904392|NCT01710345|10001819|P1|Overall Study|Lack of Efficacy|2
2904393|NCT01710345|10001817|P3|Overall Study|Adverse Event|0
2904394|NCT01710345|10001818|P2|Overall Study|Adverse Event|2
2904395|NCT01710345|10001819|P1|Overall Study|Adverse Event|0
2904396|NCT01710046|10001878|P2|Overall Study|Lost to Follow-up|0
2904397|NCT01710046|10001879|P1|Overall Study|Lost to Follow-up|1
2904398|NCT01710033|10001919|P5|Stage 2|Adverse Event|1
2904399|NCT01710033|10001920|P4|Stage 2|Adverse Event|0
2904400|NCT01710033|10001921|P3|Stage 2|Adverse Event|0
2904401|NCT01710033|10001922|P2|Stage 2|Adverse Event|0
2904402|NCT01710033|10001923|P1|Stage 2|Adverse Event|0
2904403|NCT01710020|10002004|P1|Period 1|Protocol Violation|1
2904404|NCT01709903|10002023|P2|Overall Study|Adverse Event|18
2904405|NCT01709903|10002024|P1|Overall Study|Adverse Event|11
2904406|NCT01709903|10002023|P2|Overall Study|Withdrawal by Subject|6
2904407|NCT01709903|10002024|P1|Overall Study|Withdrawal by Subject|6
2904408|NCT01709903|10002023|P2|Overall Study|Lack of Efficacy|3
2904409|NCT01709903|10002024|P1|Overall Study|Lack of Efficacy|3
2904410|NCT01709903|10002023|P2|Overall Study|Protocol Violation|2
2904411|NCT01709903|10002024|P1|Overall Study|Protocol Violation|3
2904412|NCT01709903|10002023|P2|Overall Study|Death|0
2904413|NCT01709903|10002024|P1|Overall Study|Death|2
2904414|NCT01709903|10002023|P2|Overall Study|Lost to Follow-up|2
2904415|NCT01709903|10002024|P1|Overall Study|Lost to Follow-up|0
2904416|NCT01709903|10002023|P2|Overall Study|no longer needed study drug|1
2904417|NCT01709903|10002024|P1|Overall Study|no longer needed study drug|0
2904418|NCT01709903|10002023|P2|Overall Study|In ability to use device|1
2904419|NCT01709903|10002024|P1|Overall Study|In ability to use device|1
2904420|NCT01709903|10002023|P2|Overall Study|Abnormal test procedure results|0
2904421|NCT01709903|10002024|P1|Overall Study|Abnormal test procedure results|1
2904422|NCT01709903|10002023|P2|Overall Study|administrative problems|6
2904423|NCT01709903|10002024|P1|Overall Study|administrative problems|2
2904424|NCT01709864|10002048|P2|Overall Study|Death|1
2904425|NCT01709864|10002049|P1|Overall Study|Death|0
2904426|NCT01709864|10002048|P2|Overall Study|Adverse Event|2
2904427|NCT01709864|10002049|P1|Overall Study|Adverse Event|0
2904428|NCT01709864|10002048|P2|Overall Study|non-compliance with study treatment|1
2904429|NCT01709864|10002049|P1|Overall Study|non-compliance with study treatment|1
2904430|NCT01709864|10002048|P2|Overall Study|Lost to Follow-up|0
2904431|NCT01709864|10002049|P1|Overall Study|Lost to Follow-up|1
2904432|NCT01709864|10002048|P2|Overall Study|subject/guardian decision|6
2904433|NCT01709864|10002049|P1|Overall Study|subject/guardian decision|5
2904434|NCT01709864|10002048|P2|Overall Study|Physician Decision|1
2904435|NCT01709864|10002049|P1|Overall Study|Physician Decision|0
2904436|NCT01709838|10002083|P1|Overall Study|Protocol Violation|1
2904437|NCT01709838|10002083|P1|Overall Study|Death|3
2904438|NCT01709838|10002083|P1|Overall Study|Physician Decision|4
2904439|NCT01709838|10002083|P1|Overall Study|Adverse Event|4
2904440|NCT01709838|10002083|P1|Overall Study|Subject/guardian decision|8
2904441|NCT01709838|10002083|P1|Overall Study|Pregnancy|10
2904442|NCT01709838|10002083|P1|Overall Study|Lost to Follow-up|16
2904443|NCT01709838|10002083|P1|Overall Study|Withdrawal by Subject|21
2904444|NCT01709708|10002140|P2|Overall Study|Protocol Violation|2
2904445|NCT01709708|10002141|P1|Overall Study|Protocol Violation|1
2904446|NCT01709695|10002165|P2|Overall Study|Withdrawal by Subject|1
2904447|NCT01709695|10002166|P1|Overall Study|Withdrawal by Subject|1
2904448|NCT01709578|10002191|P3|Overall Study|Other, not related to safety or efficacy|5
2904449|NCT01709578|10002192|P2|Overall Study|Other, not related to safety or efficacy|7
2904450|NCT01709578|10002193|P1|Overall Study|Other, not related to safety or efficacy|2
2904451|NCT01709578|10002191|P3|Overall Study|Poor compliance to protocol|1
2904452|NCT01709578|10002192|P2|Overall Study|Poor compliance to protocol|2
2904453|NCT01709578|10002193|P1|Overall Study|Poor compliance to protocol|1
2904454|NCT01709578|10002191|P3|Overall Study|Lack of Efficacy|2
2904455|NCT01709578|10002192|P2|Overall Study|Lack of Efficacy|4
2904456|NCT01709578|10002193|P1|Overall Study|Lack of Efficacy|5
2904457|NCT01709578|10002191|P3|Overall Study|Adverse Event|17
2904458|NCT01709578|10002192|P2|Overall Study|Adverse Event|18
2904459|NCT01709578|10002193|P1|Overall Study|Adverse Event|9
2904460|NCT01709578|10002191|P3|Overall Study|Rescued and entered in long term safety|26
2904461|NCT01709578|10002192|P2|Overall Study|Rescued and entered in long term safety|25
2904462|NCT01709578|10002193|P1|Overall Study|Rescued and entered in long term safety|63
2904463|NCT01709513|10002324|P3|Overall Study|Other|7
2904464|NCT01709513|10002325|P2|Overall Study|Other|11
2904465|NCT01709513|10002326|P1|Overall Study|Other|3
2904466|NCT01709513|10002324|P3|Overall Study|Poor compliance to protocol|0
2904467|NCT01709513|10002325|P2|Overall Study|Poor compliance to protocol|0
2904468|NCT01709513|10002326|P1|Overall Study|Poor compliance to protocol|2
2904469|NCT01709513|10002324|P3|Overall Study|Adverse Event|23
2904470|NCT01709513|10002325|P2|Overall Study|Adverse Event|31
2904471|NCT01709513|10002326|P1|Overall Study|Adverse Event|16
2904472|NCT01709513|10002324|P3|Overall Study|Randomized but not treated|0
2904473|NCT01709513|10002325|P2|Overall Study|Randomized but not treated|1
2904474|NCT01709513|10002326|P1|Overall Study|Randomized but not treated|0
2904475|NCT01709500|10002387|P2|Overall Study|Treatment ongoing|78
2904476|NCT01709500|10002388|P1|Overall Study|Treatment ongoing|156
2904477|NCT01709500|10002387|P2|Overall Study|Related to IMP administration|0
2904478|NCT01709500|10002388|P1|Overall Study|Related to IMP administration|1
2904479|NCT01709500|10002387|P2|Overall Study|Other|1
2904480|NCT01709500|10002388|P1|Overall Study|Other|3
2904481|NCT01709500|10002387|P2|Overall Study|Poor compliance to protocol|1
2904482|NCT01709500|10002388|P1|Overall Study|Poor compliance to protocol|2
2904483|NCT01709500|10002387|P2|Overall Study|Adverse Event|1
2904484|NCT01709500|10002388|P1|Overall Study|Adverse Event|5
2904485|NCT01709500|10002387|P2|Overall Study|Randomized but not treated|1
2904486|NCT01709500|10002388|P1|Overall Study|Randomized but not treated|0
2904487|NCT01709409|10002466|P2|Overall Study|Protocol Violation|0
2904488|NCT01709409|10002467|P1|Overall Study|Protocol Violation|1
2904489|NCT01709383|10002475|P2|Overall Study|Lost to Follow-up|0
2904490|NCT01709383|10002476|P1|Overall Study|Lost to Follow-up|1
2904491|NCT01709331|10002494|P1|Overall Study|Adverse Event|1
2904492|NCT01709318|10002507|P7|Overall Study|Other Protocol Specified Criteria|0
2904493|NCT01709318|10002508|P6|Overall Study|Other Protocol Specified Criteria|0
2904494|NCT01709318|10002509|P5|Overall Study|Other Protocol Specified Criteria|0
2904495|NCT01709318|10002510|P4|Overall Study|Other Protocol Specified Criteria|0
2904496|NCT01709318|10002511|P3|Overall Study|Other Protocol Specified Criteria|0
2904497|NCT01709318|10002512|P2|Overall Study|Other Protocol Specified Criteria|1
2904498|NCT01709318|10002513|P1|Overall Study|Other Protocol Specified Criteria|0
2904499|NCT01709318|10002507|P7|Overall Study|Withdrawal by Subject|4
2904500|NCT01709318|10002508|P6|Overall Study|Withdrawal by Subject|2
2904501|NCT01709318|10002509|P5|Overall Study|Withdrawal by Subject|0
2904502|NCT01709318|10002510|P4|Overall Study|Withdrawal by Subject|3
2904503|NCT01709318|10002511|P3|Overall Study|Withdrawal by Subject|3
2904504|NCT01709318|10002512|P2|Overall Study|Withdrawal by Subject|0
2904505|NCT01709318|10002513|P1|Overall Study|Withdrawal by Subject|3
2904506|NCT01709318|10002507|P7|Overall Study|Technical Problems|0
2904507|NCT01709318|10002508|P6|Overall Study|Technical Problems|0
2904508|NCT01709318|10002509|P5|Overall Study|Technical Problems|0
2904509|NCT01709318|10002510|P4|Overall Study|Technical Problems|0
2904510|NCT01709318|10002511|P3|Overall Study|Technical Problems|0
2904511|NCT01709318|10002512|P2|Overall Study|Technical Problems|0
2904512|NCT01709318|10002513|P1|Overall Study|Technical Problems|1
2904513|NCT01709318|10002507|P7|Overall Study|Protocol Violation|1
2904514|NCT01709318|10002508|P6|Overall Study|Protocol Violation|0
2904516|NCT01709318|10002510|P4|Overall Study|Protocol Violation|0
2904517|NCT01709318|10002511|P3|Overall Study|Protocol Violation|0
2904518|NCT01709318|10002512|P2|Overall Study|Protocol Violation|0
2904519|NCT01709318|10002513|P1|Overall Study|Protocol Violation|0
2904520|NCT01709318|10002507|P7|Overall Study|Pregnancy|0
2904521|NCT01709318|10002508|P6|Overall Study|Pregnancy|0
2904522|NCT01709318|10002509|P5|Overall Study|Pregnancy|1
2904523|NCT01709318|10002510|P4|Overall Study|Pregnancy|0
2904524|NCT01709318|10002511|P3|Overall Study|Pregnancy|0
2904525|NCT01709318|10002512|P2|Overall Study|Pregnancy|0
2904526|NCT01709318|10002513|P1|Overall Study|Pregnancy|0
2904527|NCT01709318|10002507|P7|Overall Study|Physician Decision|1
2904528|NCT01709318|10002508|P6|Overall Study|Physician Decision|0
2904529|NCT01709318|10002509|P5|Overall Study|Physician Decision|0
2904530|NCT01709318|10002510|P4|Overall Study|Physician Decision|0
2904531|NCT01709318|10002511|P3|Overall Study|Physician Decision|0
2904532|NCT01709318|10002512|P2|Overall Study|Physician Decision|0
2904533|NCT01709318|10002513|P1|Overall Study|Physician Decision|0
2904534|NCT01709318|10002507|P7|Overall Study|Non-compliance with Study Drug|2
2904535|NCT01709318|10002508|P6|Overall Study|Non-compliance with Study Drug|0
2904536|NCT01709318|10002509|P5|Overall Study|Non-compliance with Study Drug|0
2904537|NCT01709318|10002510|P4|Overall Study|Non-compliance with Study Drug|1
2904538|NCT01709318|10002511|P3|Overall Study|Non-compliance with Study Drug|1
2904539|NCT01709318|10002512|P2|Overall Study|Non-compliance with Study Drug|2
2904540|NCT01709318|10002513|P1|Overall Study|Non-compliance with Study Drug|0
2904541|NCT01709318|10002507|P7|Overall Study|Lost to Follow-up|1
2904542|NCT01709318|10002508|P6|Overall Study|Lost to Follow-up|1
2904543|NCT01709318|10002509|P5|Overall Study|Lost to Follow-up|1
2904544|NCT01709318|10002510|P4|Overall Study|Lost to Follow-up|0
2904545|NCT01709318|10002511|P3|Overall Study|Lost to Follow-up|0
2904546|NCT01709318|10002512|P2|Overall Study|Lost to Follow-up|0
2904547|NCT01709318|10002513|P1|Overall Study|Lost to Follow-up|2
2904548|NCT01709318|10002507|P7|Overall Study|Adverse Event|2
2904549|NCT01709318|10002508|P6|Overall Study|Adverse Event|1
2904550|NCT01709318|10002509|P5|Overall Study|Adverse Event|0
2904551|NCT01709318|10002510|P4|Overall Study|Adverse Event|2
2904552|NCT01709318|10002511|P3|Overall Study|Adverse Event|2
2904553|NCT01709318|10002512|P2|Overall Study|Adverse Event|4
2904554|NCT01709318|10002513|P1|Overall Study|Adverse Event|3
2904555|NCT01709305|10002606|P5|Phase 2|Withdrawal by Subject|12
2904556|NCT01709305|10002607|P4|Phase 2|Withdrawal by Subject|15
2904557|NCT01709305|10002608|P3|Phase 2|Withdrawal by Subject|6
2904558|NCT01709305|10002609|P2|Phase 2|Withdrawal by Subject|8
2904559|NCT01709305|10002610|P1|Phase 2|Withdrawal by Subject|0
2904560|NCT01709305|10002606|P5|Phase 2|Protocol Violation|9
2904561|NCT01709305|10002607|P4|Phase 2|Protocol Violation|13
2904562|NCT01709305|10002608|P3|Phase 2|Protocol Violation|19
2904563|NCT01709305|10002609|P2|Phase 2|Protocol Violation|19
2904564|NCT01709305|10002610|P1|Phase 2|Protocol Violation|0
2904565|NCT01709305|10002606|P5|Phase 2|Physician Decision|2
2904566|NCT01709305|10002607|P4|Phase 2|Physician Decision|1
2904567|NCT01709305|10002608|P3|Phase 2|Physician Decision|0
2904568|NCT01709305|10002609|P2|Phase 2|Physician Decision|2
2904569|NCT01709305|10002610|P1|Phase 2|Physician Decision|0
2904570|NCT01709305|10002606|P5|Phase 2|Travel, moving, etc.|5
2904571|NCT01709305|10002607|P4|Phase 2|Travel, moving, etc.|3
2904572|NCT01709305|10002608|P3|Phase 2|Travel, moving, etc.|3
2904573|NCT01709305|10002609|P2|Phase 2|Travel, moving, etc.|2
2904574|NCT01709305|10002610|P1|Phase 2|Travel, moving, etc.|0
2904575|NCT01709305|10002606|P5|Phase 2|Lost to Follow-up|5
2904576|NCT01709305|10002607|P4|Phase 2|Lost to Follow-up|9
2904577|NCT01709305|10002608|P3|Phase 2|Lost to Follow-up|6
2904578|NCT01709305|10002609|P2|Phase 2|Lost to Follow-up|10
2904579|NCT01709305|10002610|P1|Phase 2|Lost to Follow-up|0
2904580|NCT01709305|10002606|P5|Phase 2|Laboratory Adverse Event|1
2904581|NCT01709305|10002607|P4|Phase 2|Laboratory Adverse Event|1
2904582|NCT01709305|10002608|P3|Phase 2|Laboratory Adverse Event|0
2904583|NCT01709305|10002609|P2|Phase 2|Laboratory Adverse Event|1
2904584|NCT01709305|10002610|P1|Phase 2|Laboratory Adverse Event|0
2904585|NCT01709305|10002606|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
2904586|NCT01709305|10002607|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
2904587|NCT01709305|10002608|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
2904588|NCT01709305|10002609|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
2904589|NCT01709305|10002610|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
2904590|NCT01709305|10002606|P5|Phase 2|Death|0
2904591|NCT01709305|10002607|P4|Phase 2|Death|0
2904592|NCT01709305|10002608|P3|Phase 2|Death|1
2904593|NCT01709305|10002609|P2|Phase 2|Death|0
2904594|NCT01709305|10002610|P1|Phase 2|Death|0
2904595|NCT01709305|10002606|P5|Phase 2|Clinical Adverse Event|11
2904596|NCT01709305|10002607|P4|Phase 2|Clinical Adverse Event|6
2904597|NCT01709305|10002608|P3|Phase 2|Clinical Adverse Event|10
2904598|NCT01709305|10002609|P2|Phase 2|Clinical Adverse Event|10
2904599|NCT01709305|10002610|P1|Phase 2|Clinical Adverse Event|0
2904600|NCT01709305|10002606|P5|Phase 1|Withdrawal by Subject|0
2904601|NCT01709305|10002607|P4|Phase 1|Withdrawal by Subject|0
2904602|NCT01709305|10002608|P3|Phase 1|Withdrawal by Subject|0
2904603|NCT01709305|10002609|P2|Phase 1|Withdrawal by Subject|0
2904604|NCT01709305|10002610|P1|Phase 1|Withdrawal by Subject|218
2904605|NCT01709305|10002606|P5|Phase 1|Protocol Violation|0
2904606|NCT01709305|10002607|P4|Phase 1|Protocol Violation|0
2904607|NCT01709305|10002608|P3|Phase 1|Protocol Violation|0
2904608|NCT01709305|10002609|P2|Phase 1|Protocol Violation|0
2904609|NCT01709305|10002610|P1|Phase 1|Protocol Violation|118
2904610|NCT01709305|10002606|P5|Phase 1|Physician Decision|0
2904611|NCT01709305|10002607|P4|Phase 1|Physician Decision|0
2904612|NCT01709305|10002608|P3|Phase 1|Physician Decision|0
2904613|NCT01709305|10002609|P2|Phase 1|Physician Decision|0
2904614|NCT01709305|10002610|P1|Phase 1|Physician Decision|13
2904615|NCT01709305|10002606|P5|Phase 1|Travel, moving, etc.|0
2904616|NCT01709305|10002607|P4|Phase 1|Travel, moving, etc.|0
2904617|NCT01709305|10002608|P3|Phase 1|Travel, moving, etc.|0
2904618|NCT01709305|10002609|P2|Phase 1|Travel, moving, etc.|0
2904619|NCT01709305|10002610|P1|Phase 1|Travel, moving, etc.|30
2904620|NCT01709305|10002606|P5|Phase 1|Lost to Follow-up|0
2904621|NCT01709305|10002607|P4|Phase 1|Lost to Follow-up|0
2904622|NCT01709305|10002608|P3|Phase 1|Lost to Follow-up|0
2904623|NCT01709305|10002609|P2|Phase 1|Lost to Follow-up|0
2904624|NCT01709305|10002610|P1|Phase 1|Lost to Follow-up|147
2904625|NCT01709305|10002606|P5|Phase 1|Laboratory Adverse Event|0
2904626|NCT01709305|10002607|P4|Phase 1|Laboratory Adverse Event|0
2904627|NCT01709305|10002608|P3|Phase 1|Laboratory Adverse Event|0
2904628|NCT01709305|10002609|P2|Phase 1|Laboratory Adverse Event|0
2904629|NCT01709305|10002610|P1|Phase 1|Laboratory Adverse Event|16
2904630|NCT01709305|10002606|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
2904631|NCT01709305|10002607|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
2904632|NCT01709305|10002608|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
2904633|NCT01709305|10002609|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
2904634|NCT01709305|10002610|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
2904635|NCT01709305|10002606|P5|Phase 1|Death|0
2904636|NCT01709305|10002607|P4|Phase 1|Death|0
2904637|NCT01709305|10002608|P3|Phase 1|Death|0
2904638|NCT01709305|10002609|P2|Phase 1|Death|0
2904639|NCT01709305|10002610|P1|Phase 1|Death|2
2904640|NCT01709305|10002606|P5|Phase 1|Clinical Adverse Event|0
2904641|NCT01709305|10002607|P4|Phase 1|Clinical Adverse Event|0
2904642|NCT01709305|10002608|P3|Phase 1|Clinical Adverse Event|0
2904643|NCT01709305|10002609|P2|Phase 1|Clinical Adverse Event|0
2904644|NCT01709305|10002610|P1|Phase 1|Clinical Adverse Event|80
2904645|NCT01709227|10002647|P2|Overall Study|Pleural Peritoneal communication|9
2904646|NCT01709227|10002648|P1|Overall Study|Pleural Peritoneal communication|0
2904647|NCT01709227|10002647|P2|Overall Study|Physician Decision|0
2904648|NCT01709227|10002648|P1|Overall Study|Physician Decision|1
2904649|NCT01709162|10002674|P2|Overall Study|Withdrawal by Subject|1
2904650|NCT01709162|10002675|P1|Overall Study|Withdrawal by Subject|0
2904651|NCT01709162|10002674|P2|Overall Study|Other|0
2904652|NCT01709162|10002675|P1|Overall Study|Other|1
2904653|NCT01709162|10002674|P2|Overall Study|Administrative reason by sponsor|1
2904654|NCT01709162|10002675|P1|Overall Study|Administrative reason by sponsor|0
2904655|NCT01709162|10002674|P2|Overall Study|Study drug toxicity|0
2904656|NCT01709162|10002675|P1|Overall Study|Study drug toxicity|2
2904657|NCT01709162|10002674|P2|Overall Study|Disease progression|3
2904658|NCT01709162|10002675|P1|Overall Study|Disease progression|3
2904659|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2904660|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
2904661|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2904662|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|not defined|2
2904663|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|not defined|1
2904664|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|not defined|0
2904665|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|Death|0
2904666|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|Death|2
2904667|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|Death|0
2904668|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
2904669|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
2904670|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
2904671|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
2904672|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
2904673|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2904674|NCT01709149|10002690|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
2904675|NCT01709149|10002691|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
2904676|NCT01709149|10002692|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
2904677|NCT01709149|10002690|P3|Open-label Lead-in Phase|Protocol Violation|0
2904678|NCT01709149|10002691|P2|Open-label Lead-in Phase|Protocol Violation|0
2904679|NCT01709149|10002692|P1|Open-label Lead-in Phase|Protocol Violation|3
2904680|NCT01709149|10002690|P3|Open-label Lead-in Phase|Death|0
2904681|NCT01709149|10002691|P2|Open-label Lead-in Phase|Death|0
2904682|NCT01709149|10002692|P1|Open-label Lead-in Phase|Death|1
2904683|NCT01709149|10002690|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
2904684|NCT01709149|10002691|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
2904685|NCT01709149|10002692|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
2904686|NCT01709149|10002690|P3|Open-label Lead-in Phase|Adverse Event|0
2904687|NCT01709149|10002691|P2|Open-label Lead-in Phase|Adverse Event|0
2904688|NCT01709149|10002692|P1|Open-label Lead-in Phase|Adverse Event|109
2904689|NCT01709110|10002720|P2|Overall Study|Caregiver Decision|1
2904690|NCT01709110|10002721|P1|Overall Study|Caregiver Decision|1
2904691|NCT01709110|10002720|P2|Overall Study|Lack of Efficacy|1
2904692|NCT01709110|10002721|P1|Overall Study|Lack of Efficacy|1
2904693|NCT01709110|10002720|P2|Overall Study|Sponsor Decision|2
2904694|NCT01709110|10002721|P1|Overall Study|Sponsor Decision|2
2904695|NCT01709110|10002720|P2|Overall Study|Physician Decision|10
2904696|NCT01709110|10002721|P1|Overall Study|Physician Decision|4
2904697|NCT01709110|10002720|P2|Overall Study|Withdrawal by Subject|89
2904698|NCT01709110|10002721|P1|Overall Study|Withdrawal by Subject|96
2904699|NCT01709110|10002720|P2|Overall Study|Protocol Violation|6
2904700|NCT01709110|10002721|P1|Overall Study|Protocol Violation|4
2904701|NCT01709110|10002720|P2|Overall Study|Lost to Follow-up|5
2904702|NCT01709110|10002721|P1|Overall Study|Lost to Follow-up|7
2904703|NCT01709110|10002720|P2|Overall Study|Death|6
2904704|NCT01709110|10002721|P1|Overall Study|Death|14
2904705|NCT01709110|10002720|P2|Overall Study|Adverse Event|48
2904706|NCT01709110|10002721|P1|Overall Study|Adverse Event|56
2904707|NCT01709084|10002751|P2|Overall Study|Not Treated|2
2904708|NCT01709084|10002752|P1|Overall Study|Not Treated|0
2904709|NCT01709084|10002751|P2|Overall Study|Participant Reached a Virologic Endpoint|1
2904710|NCT01709084|10002752|P1|Overall Study|Participant Reached a Virologic Endpoint|0
2904711|NCT01709084|10002751|P2|Overall Study|Other|3
2904712|NCT01709084|10002752|P1|Overall Study|Other|5
2904713|NCT01709084|10002751|P2|Overall Study|Adverse Event|0
2904714|NCT01709084|10002752|P1|Overall Study|Adverse Event|5
2904715|NCT01709084|10002751|P2|Overall Study|Withdrawal by Subject|2
2904716|NCT01709084|10002752|P1|Overall Study|Withdrawal by Subject|2
2904717|NCT01709084|10002751|P2|Overall Study|Lost to Follow-up|7
2904718|NCT01709084|10002752|P1|Overall Study|Lost to Follow-up|4
2904719|NCT01708954|10002785|P3|Step 2|Withdrawal by Subject|0
2904720|NCT01708954|10002786|P2|Step 2|Withdrawal by Subject|1
2904721|NCT01708954|10002787|P1|Step 2|Withdrawal by Subject|1
2904722|NCT01708954|10002785|P3|Step 2|Adverse Event|0
2904723|NCT01708954|10002786|P2|Step 2|Adverse Event|2
2904724|NCT01708954|10002787|P1|Step 2|Adverse Event|3
2904725|NCT01708954|10002785|P3|Step 2|Disease progression|0
2904726|NCT01708954|10002786|P2|Step 2|Disease progression|4
2904727|NCT01708954|10002787|P1|Step 2|Disease progression|9
2904728|NCT01708954|10002785|P3|Step 1|Ineligible or never received treatment|8
2904729|NCT01708954|10002786|P2|Step 1|Ineligible or never received treatment|2
2904730|NCT01708954|10002787|P1|Step 1|Ineligible or never received treatment|4
2904731|NCT01708954|10002785|P3|Step 1|Off-treatment reason not submitted|1
2904732|NCT01708954|10002786|P2|Step 1|Off-treatment reason not submitted|1
2904733|NCT01708954|10002787|P1|Step 1|Off-treatment reason not submitted|1
2904734|NCT01708954|10002785|P3|Step 1|Symptomatic deterioration|1
2904735|NCT01708954|10002786|P2|Step 1|Symptomatic deterioration|0
2904736|NCT01708954|10002787|P1|Step 1|Symptomatic deterioration|1
2904737|NCT01708954|10002785|P3|Step 1|Crossed over to Step 2|0
2904738|NCT01708954|10002786|P2|Step 1|Crossed over to Step 2|0
2904739|NCT01708954|10002787|P1|Step 1|Crossed over to Step 2|2
2904740|NCT01708954|10002785|P3|Step 1|Other complicating disease|0
2904741|NCT01708954|10002786|P2|Step 1|Other complicating disease|2
2904742|NCT01708954|10002787|P1|Step 1|Other complicating disease|0
2904743|NCT01708954|10002785|P3|Step 1|Withdrawal by Subject|3
2904744|NCT01708954|10002786|P2|Step 1|Withdrawal by Subject|5
2904745|NCT01708954|10002787|P1|Step 1|Withdrawal by Subject|2
2904746|NCT01708954|10002785|P3|Step 1|Death|3
2904747|NCT01708954|10002786|P2|Step 1|Death|2
2904748|NCT01708954|10002787|P1|Step 1|Death|3
2904749|NCT01708954|10002785|P3|Step 1|Adverse Event|13
2904750|NCT01708954|10002786|P2|Step 1|Adverse Event|11
2904751|NCT01708954|10002787|P1|Step 1|Adverse Event|3
2904752|NCT01708954|10002785|P3|Step 1|Disease progression|14
2904753|NCT01708954|10002786|P2|Step 1|Disease progression|17
2904754|NCT01708954|10002787|P1|Step 1|Disease progression|26
2904755|NCT01708941|10002812|P4|Overall Study|Ineligible|0
2904756|NCT01708941|10002813|P3|Overall Study|Ineligible|2
2904757|NCT01708941|10002814|P2|Overall Study|Ineligible|0
2904758|NCT01708941|10002815|P1|Overall Study|Ineligible|0
2904759|NCT01708941|10002812|P4|Overall Study|Never started treatment|0
2904760|NCT01708941|10002813|P3|Overall Study|Never started treatment|0
2904761|NCT01708941|10002814|P2|Overall Study|Never started treatment|1
2904762|NCT01708941|10002815|P1|Overall Study|Never started treatment|2
2904763|NCT01708941|10002812|P4|Overall Study|Ineligible and never started treatment|0
2904764|NCT01708941|10002813|P3|Overall Study|Ineligible and never started treatment|1
2904765|NCT01708941|10002814|P2|Overall Study|Ineligible and never started treatment|0
2904766|NCT01708941|10002815|P1|Overall Study|Ineligible and never started treatment|1
2904767|NCT01708941|10002812|P4|Overall Study|Alternative therapy|0
2904768|NCT01708941|10002813|P3|Overall Study|Alternative therapy|2
2904769|NCT01708941|10002814|P2|Overall Study|Alternative therapy|0
2904770|NCT01708941|10002815|P1|Overall Study|Alternative therapy|0
2904771|NCT01708941|10002812|P4|Overall Study|Disease progression|0
2904772|NCT01708941|10002813|P3|Overall Study|Disease progression|8
2904773|NCT01708941|10002814|P2|Overall Study|Disease progression|10
2904774|NCT01708941|10002815|P1|Overall Study|Disease progression|9
2904775|NCT01708941|10002812|P4|Overall Study|Withdrawal by Subject|4
2904776|NCT01708941|10002813|P3|Overall Study|Withdrawal by Subject|3
2904777|NCT01708941|10002814|P2|Overall Study|Withdrawal by Subject|0
2904778|NCT01708941|10002815|P1|Overall Study|Withdrawal by Subject|1
2904779|NCT01708941|10002812|P4|Overall Study|Death|14
2904780|NCT01708941|10002813|P3|Overall Study|Death|2
2904781|NCT01708941|10002814|P2|Overall Study|Death|1
2904782|NCT01708941|10002815|P1|Overall Study|Death|1
2904783|NCT01708941|10002812|P4|Overall Study|Adverse Event|0
2904784|NCT01708941|10002813|P3|Overall Study|Adverse Event|1
2904785|NCT01708941|10002814|P2|Overall Study|Adverse Event|6
2904786|NCT01708941|10002815|P1|Overall Study|Adverse Event|4
2904787|NCT01708915|10002833|P4|Overall Study|Other reasons than stated above|2
2904788|NCT01708915|10002834|P3|Overall Study|Other reasons than stated above|0
2904789|NCT01708915|10002835|P2|Overall Study|Other reasons than stated above|1
2904790|NCT01708915|10002836|P1|Overall Study|Other reasons than stated above|1
2904791|NCT01708915|10002833|P4|Overall Study|Withdrawal by Subject|2
2904792|NCT01708915|10002834|P3|Overall Study|Withdrawal by Subject|2
2904793|NCT01708915|10002835|P2|Overall Study|Withdrawal by Subject|1
2904794|NCT01708915|10002836|P1|Overall Study|Withdrawal by Subject|0
2904795|NCT01708915|10002833|P4|Overall Study|Protocol Violation|1
2904796|NCT01708915|10002834|P3|Overall Study|Protocol Violation|0
2904797|NCT01708915|10002835|P2|Overall Study|Protocol Violation|0
2904798|NCT01708915|10002836|P1|Overall Study|Protocol Violation|0
2904799|NCT01708915|10002833|P4|Overall Study|Lack of Efficacy|15
2904800|NCT01708915|10002834|P3|Overall Study|Lack of Efficacy|35
2904801|NCT01708915|10002835|P2|Overall Study|Lack of Efficacy|60
2904802|NCT01708915|10002836|P1|Overall Study|Lack of Efficacy|84
2904803|NCT01708915|10002833|P4|Overall Study|Adverse Event|13
2904804|NCT01708915|10002834|P3|Overall Study|Adverse Event|9
2904805|NCT01708915|10002835|P2|Overall Study|Adverse Event|0
2904806|NCT01708915|10002836|P1|Overall Study|Adverse Event|1
2904807|NCT01708902|10002865|P7|Overall Study|Other Reason|0
2904808|NCT01708902|10002866|P6|Overall Study|Other Reason|2
2904809|NCT01708902|10002867|P5|Overall Study|Other Reason|1
2904810|NCT01708902|10002868|P4|Overall Study|Other Reason|1
2904811|NCT01708902|10002869|P3|Overall Study|Other Reason|1
2904812|NCT01708902|10002870|P2|Overall Study|Other Reason|0
2904813|NCT01708902|10002871|P1|Overall Study|Other Reason|1
2904814|NCT01708902|10002865|P7|Overall Study|Refused to continue trial medication|1
2904815|NCT01708902|10002866|P6|Overall Study|Refused to continue trial medication|1
2904816|NCT01708902|10002867|P5|Overall Study|Refused to continue trial medication|8
2904817|NCT01708902|10002868|P4|Overall Study|Refused to continue trial medication|2
2904818|NCT01708902|10002869|P3|Overall Study|Refused to continue trial medication|4
2904819|NCT01708902|10002870|P2|Overall Study|Refused to continue trial medication|0
2904820|NCT01708902|10002871|P1|Overall Study|Refused to continue trial medication|8
2904821|NCT01708902|10002865|P7|Overall Study|Lost to Follow-up|1
2904822|NCT01708902|10002866|P6|Overall Study|Lost to Follow-up|0
2904823|NCT01708902|10002867|P5|Overall Study|Lost to Follow-up|0
2904824|NCT01708902|10002868|P4|Overall Study|Lost to Follow-up|2
2904825|NCT01708902|10002869|P3|Overall Study|Lost to Follow-up|2
2904826|NCT01708902|10002870|P2|Overall Study|Lost to Follow-up|1
2904827|NCT01708902|10002871|P1|Overall Study|Lost to Follow-up|2
2904828|NCT01708902|10002865|P7|Overall Study|Non compliance with protocol|0
2904829|NCT01708902|10002866|P6|Overall Study|Non compliance with protocol|0
2904830|NCT01708902|10002867|P5|Overall Study|Non compliance with protocol|0
2904831|NCT01708902|10002868|P4|Overall Study|Non compliance with protocol|3
2904832|NCT01708902|10002869|P3|Overall Study|Non compliance with protocol|1
2904833|NCT01708902|10002870|P2|Overall Study|Non compliance with protocol|2
2904834|NCT01708902|10002871|P1|Overall Study|Non compliance with protocol|0
2904835|NCT01708902|10002865|P7|Overall Study|Lack of Efficacy|0
2904836|NCT01708902|10002866|P6|Overall Study|Lack of Efficacy|1
2904837|NCT01708902|10002867|P5|Overall Study|Lack of Efficacy|0
2904838|NCT01708902|10002868|P4|Overall Study|Lack of Efficacy|0
2904839|NCT01708902|10002869|P3|Overall Study|Lack of Efficacy|0
2904840|NCT01708902|10002870|P2|Overall Study|Lack of Efficacy|1
2904841|NCT01708902|10002871|P1|Overall Study|Lack of Efficacy|3
2904842|NCT01708902|10002865|P7|Overall Study|Adverse Event|5
2904843|NCT01708902|10002866|P6|Overall Study|Adverse Event|3
2904844|NCT01708902|10002867|P5|Overall Study|Adverse Event|7
2904845|NCT01708902|10002868|P4|Overall Study|Adverse Event|2
2904846|NCT01708902|10002869|P3|Overall Study|Adverse Event|9
2904847|NCT01708902|10002870|P2|Overall Study|Adverse Event|4
2904848|NCT01708902|10002871|P1|Overall Study|Adverse Event|3
2904849|NCT01708291|10003013|P2|Overall Study|fighting|1
2904850|NCT01708291|10003014|P1|Overall Study|fighting|2
2904851|NCT01708187|10003053|P2|Overall Study|Lost to Follow-up|1
2904852|NCT01708187|10003054|P1|Overall Study|Lost to Follow-up|0
2904853|NCT01708174|10003063|P3|Treatment Period|Adverse Event|0
2904854|NCT01708174|10003064|P2|Treatment Period|Adverse Event|1
2904855|NCT01708174|10003065|P1|Treatment Period|Adverse Event|0
2904856|NCT01708174|10003063|P3|Treatment Period|Death|1
2904857|NCT01708174|10003064|P2|Treatment Period|Death|0
2904858|NCT01708174|10003065|P1|Treatment Period|Death|0
2904859|NCT01708174|10003063|P3|Treatment Period|Progressive disease|0
2904860|NCT01708174|10003064|P2|Treatment Period|Progressive disease|1
2904861|NCT01708174|10003065|P1|Treatment Period|Progressive disease|0
2904862|NCT01708174|10003063|P3|Treatment Period|Withdrawal by Subject|0
2904863|NCT01708174|10003064|P2|Treatment Period|Withdrawal by Subject|0
2904864|NCT01708174|10003065|P1|Treatment Period|Withdrawal by Subject|1
2904865|NCT01708161|10003097|P6|Overall Study|Disease progression|0
2904866|NCT01708161|10003098|P5|Overall Study|Disease progression|3
2904867|NCT01708161|10003099|P4|Overall Study|Disease progression|13
2904868|NCT01708161|10003100|P3|Overall Study|Disease progression|5
2904869|NCT01708161|10003101|P2|Overall Study|Disease progression|5
2904870|NCT01708161|10003102|P1|Overall Study|Disease progression|3
2904871|NCT01708161|10003097|P6|Overall Study|Administrative problems|0
2904872|NCT01708161|10003098|P5|Overall Study|Administrative problems|0
2904873|NCT01708161|10003099|P4|Overall Study|Administrative problems|0
2904874|NCT01708161|10003100|P3|Overall Study|Administrative problems|0
2904875|NCT01708161|10003101|P2|Overall Study|Administrative problems|1
2904876|NCT01708161|10003102|P1|Overall Study|Administrative problems|0
2904877|NCT01708161|10003097|P6|Overall Study|Withdrawal by Subject|0
2904878|NCT01708161|10003098|P5|Overall Study|Withdrawal by Subject|0
2904879|NCT01708161|10003099|P4|Overall Study|Withdrawal by Subject|0
2904880|NCT01708161|10003100|P3|Overall Study|Withdrawal by Subject|1
2904881|NCT01708161|10003101|P2|Overall Study|Withdrawal by Subject|1
2904882|NCT01708161|10003102|P1|Overall Study|Withdrawal by Subject|0
2904883|NCT01708161|10003097|P6|Overall Study|Death|1
2904884|NCT01708161|10003098|P5|Overall Study|Death|0
2904885|NCT01708161|10003099|P4|Overall Study|Death|1
2904886|NCT01708161|10003100|P3|Overall Study|Death|0
2904887|NCT01708161|10003101|P2|Overall Study|Death|0
2904888|NCT01708161|10003102|P1|Overall Study|Death|0
2904889|NCT01708161|10003097|P6|Overall Study|Adverse Event|0
2904890|NCT01708161|10003098|P5|Overall Study|Adverse Event|3
2904891|NCT01708161|10003099|P4|Overall Study|Adverse Event|2
2904892|NCT01708161|10003100|P3|Overall Study|Adverse Event|4
2904893|NCT01708161|10003101|P2|Overall Study|Adverse Event|3
2904894|NCT01708161|10003102|P1|Overall Study|Adverse Event|1
2904895|NCT01708057|10003153|P3|Overall Study|Withdrawal due to study termination.|1
2904896|NCT01708057|10003154|P2|Overall Study|Withdrawal due to study termination.|1
2904897|NCT01708057|10003155|P1|Overall Study|Withdrawal due to study termination.|1
2904898|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2904899|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
2904900|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2904901|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2904902|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2904903|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2904904|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
2904905|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
2904906|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
2904907|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2904908|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2904909|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2904910|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Noncompliance|2
2904911|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Noncompliance|4
2904912|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Noncompliance|0
2904913|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Noncompliance|0
2904914|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Noncompliance|0
2904915|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Noncompliance|0
2904916|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Other than specified|2
2904917|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Other than specified|5
2904918|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Other than specified|1
2904919|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Other than specified|0
2904920|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Other than specified|0
2904921|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Other than specified|0
2904922|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Death|0
2904923|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Death|0
2904924|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Death|2
2904925|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Death|0
2904926|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Death|0
2904927|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Death|0
2904928|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
2904929|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
2904930|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
2904931|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2904932|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2904933|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2904934|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Pregnancy|2
2904935|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Pregnancy|5
2904936|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Pregnancy|2
2904937|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Pregnancy|0
2904938|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Pregnancy|0
2904939|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Pregnancy|0
2904940|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
2904941|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
2904942|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
2904943|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2904944|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2904945|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2904946|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
2904947|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
2904948|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
2904949|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2904950|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2904951|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2904952|NCT01707992|10003214|P6|Active Treatment Phase (24 Months)|Adverse Event|0
2904953|NCT01707992|10003215|P5|Active Treatment Phase (24 Months)|Adverse Event|1
2904954|NCT01707992|10003216|P4|Active Treatment Phase (24 Months)|Adverse Event|4
2904955|NCT01707992|10003217|P3|Active Treatment Phase (24 Months)|Adverse Event|0
2904956|NCT01707992|10003218|P2|Active Treatment Phase (24 Months)|Adverse Event|0
2904957|NCT01707992|10003219|P1|Active Treatment Phase (24 Months)|Adverse Event|0
2904958|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
2904959|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
2904960|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
2904961|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
2904962|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
2904963|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
2904964|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2904965|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2904966|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2904967|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
2904968|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
2904969|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
2904970|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Death|0
2904971|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Death|0
2904972|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Death|0
2904973|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Death|1
2904974|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Death|1
2904975|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Death|2
2904976|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2904977|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2904978|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2904979|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
2904980|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
2904981|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
2904982|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2904983|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2904984|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2904985|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
2904986|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
2904987|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
2904988|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2904989|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2904990|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2904991|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2904992|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2904993|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
2904994|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2904995|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2904996|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2904997|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
2904998|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
2904999|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
2905000|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2905001|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2905002|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2905003|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
2905004|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
2905005|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
2905006|NCT01707992|10003214|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2905007|NCT01707992|10003215|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2905008|NCT01707992|10003216|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2905009|NCT01707992|10003217|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
2905010|NCT01707992|10003218|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
2905011|NCT01707992|10003219|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
2905012|NCT01707693|10003271|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
2905013|NCT01707693|10003272|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
2905014|NCT01707693|10003271|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
2905015|NCT01707693|10003272|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
2905016|NCT01707693|10003271|P2|Overall Study Allocation|Protocol Violation|3
2905017|NCT01707693|10003272|P1|Overall Study Allocation|Protocol Violation|4
2905018|NCT01707693|10003271|P2|Overall Study Allocation|Withdrawal by Subject|5
2905019|NCT01707693|10003272|P1|Overall Study Allocation|Withdrawal by Subject|9
2905020|NCT01707667|10003286|P2|Period 1|expulsion of colonic sensor catheter|0
2905021|NCT01707667|10003287|P1|Period 1|expulsion of colonic sensor catheter|1
2905022|NCT01707290|10003357|P2|Overall Study|Other unspecified|0
2905023|NCT01707290|10003358|P1|Overall Study|Other unspecified|17
2905024|NCT01707290|10003357|P2|Overall Study|Commercial drug available|1
2905025|NCT01707290|10003358|P1|Overall Study|Commercial drug available|60
2905026|NCT01707290|10003357|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
2905027|NCT01707290|10003358|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
2905028|NCT01707290|10003357|P2|Overall Study|Lost to Follow-up|0
2905029|NCT01707290|10003358|P1|Overall Study|Lost to Follow-up|3
2905030|NCT01707290|10003357|P2|Overall Study|Physician Decision|0
2905031|NCT01707290|10003358|P1|Overall Study|Physician Decision|1
2905032|NCT01707290|10003357|P2|Overall Study|Adverse event (AE)|0
2905033|NCT01707290|10003358|P1|Overall Study|Adverse event (AE)|1
2905034|NCT01707147|10003403|P1|Overall Study|Violated inclusion/exclusion criteria|77
2905035|NCT01707147|10003403|P1|Overall Study|Follow-up failure|17
2905036|NCT01707147|10003403|P1|Overall Study|Patients who have not taken Trajenta|1
2905037|NCT01707147|10003403|P1|Overall Study|Administered Trajenta prior to contract|5
2905038|NCT01707030|10003435|P2|Overall Study|Lost to Follow-up|13
2905039|NCT01707030|10003436|P1|Overall Study|Lost to Follow-up|8
2905040|NCT01707030|10003435|P2|Overall Study|Withdrawal by Subject|3
2905041|NCT01707030|10003436|P1|Overall Study|Withdrawal by Subject|2
2905042|NCT01707030|10003435|P2|Overall Study|Death|1
2905043|NCT01707030|10003436|P1|Overall Study|Death|1
2905044|NCT01707004|10003452|P1|Overall Study|Physician Decision|3
2905045|NCT01706926|10003506|P4|Overall Study|Other|3
2905046|NCT01706926|10003507|P3|Overall Study|Other|4
2905047|NCT01706926|10003508|P2|Overall Study|Other|4
2905048|NCT01706926|10003509|P1|Overall Study|Other|4
2905049|NCT01706926|10003506|P4|Overall Study|Withdrawal by Subject|2
2905050|NCT01706926|10003507|P3|Overall Study|Withdrawal by Subject|1
2905051|NCT01706926|10003508|P2|Overall Study|Withdrawal by Subject|0
2905052|NCT01706926|10003509|P1|Overall Study|Withdrawal by Subject|2
2905053|NCT01706926|10003506|P4|Overall Study|Lost to Follow-up|0
2905054|NCT01706926|10003507|P3|Overall Study|Lost to Follow-up|1
2905055|NCT01706926|10003508|P2|Overall Study|Lost to Follow-up|0
2905056|NCT01706926|10003509|P1|Overall Study|Lost to Follow-up|0
2905057|NCT01706770|10003628|P2|Overall Study|Physician Decision|0
2905058|NCT01706770|10003629|P1|Overall Study|Physician Decision|1
2905059|NCT01706770|10003628|P2|Overall Study|Lost to Follow-up|0
2905060|NCT01706770|10003629|P1|Overall Study|Lost to Follow-up|1
2905061|NCT01706575|10003677|P1|Overall Study|Started but not Treated|6
2905062|NCT01706575|10003677|P1|Overall Study|Lost to Follow-up|2
2905063|NCT01706575|10003677|P1|Overall Study|Participant Withdrew Consent|4
2905064|NCT01706536|10003698|P5|Overall Study|non compliance|0
2905065|NCT01706536|10003699|P4|Overall Study|non compliance|0
2905066|NCT01706536|10003700|P3|Overall Study|non compliance|0
2905067|NCT01706536|10003701|P2|Overall Study|non compliance|1
2905068|NCT01706536|10003702|P1|Overall Study|non compliance|0
2905069|NCT01706536|10003698|P5|Overall Study|Lack of Efficacy|0
2905070|NCT01706536|10003699|P4|Overall Study|Lack of Efficacy|1
2905071|NCT01706536|10003700|P3|Overall Study|Lack of Efficacy|0
2905072|NCT01706536|10003701|P2|Overall Study|Lack of Efficacy|0
2905073|NCT01706536|10003702|P1|Overall Study|Lack of Efficacy|1
2905074|NCT01706536|10003698|P5|Overall Study|Adverse Event|2
2905075|NCT01706536|10003699|P4|Overall Study|Adverse Event|3
2905076|NCT01706536|10003700|P3|Overall Study|Adverse Event|4
2905077|NCT01706536|10003701|P2|Overall Study|Adverse Event|3
2905078|NCT01706536|10003702|P1|Overall Study|Adverse Event|2
2905079|NCT01706536|10003698|P5|Overall Study|Withdrawal by Subject|0
2905080|NCT01706536|10003699|P4|Overall Study|Withdrawal by Subject|0
2905081|NCT01706536|10003700|P3|Overall Study|Withdrawal by Subject|1
2905082|NCT01706536|10003701|P2|Overall Study|Withdrawal by Subject|0
2905083|NCT01706536|10003702|P1|Overall Study|Withdrawal by Subject|1
2905084|NCT01706458|10003769|P2|Overall Study|Physician Decision|4
2905085|NCT01706458|10003770|P1|Overall Study|Physician Decision|3
2905086|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
2905087|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
2905088|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
2905089|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Physician Decision|2
2905090|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Physician Decision|2
2905091|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Physician Decision|0
2905092|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
2905093|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
2905094|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
2905095|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
2905096|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
2905097|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
2905098|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Protocol Violation|2
2905099|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Protocol Violation|4
2905100|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Protocol Violation|0
2905101|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
2905102|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
2905191|NCT01705574|10004072|P1|Open-Label Extension Phase|Pregnancy|0
2905103|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
2905104|NCT01706328|10003794|P3|12-week Double-blind Treatment Period|Adverse Event|16
2905105|NCT01706328|10003795|P2|12-week Double-blind Treatment Period|Adverse Event|14
2905106|NCT01706328|10003796|P1|12-week Double-blind Treatment Period|Adverse Event|0
2905107|NCT01706328|10003794|P3|2-week Run-in Period|Lost to Follow-up|0
2905108|NCT01706328|10003795|P2|2-week Run-in Period|Lost to Follow-up|0
2905109|NCT01706328|10003796|P1|2-week Run-in Period|Lost to Follow-up|2
2905110|NCT01706328|10003794|P3|2-week Run-in Period|Adverse Event|0
2905111|NCT01706328|10003795|P2|2-week Run-in Period|Adverse Event|0
2905112|NCT01706328|10003796|P1|2-week Run-in Period|Adverse Event|4
2905113|NCT01706328|10003794|P3|2-week Run-in Period|Physician Decision|0
2905114|NCT01706328|10003795|P2|2-week Run-in Period|Physician Decision|0
2905115|NCT01706328|10003796|P1|2-week Run-in Period|Physician Decision|4
2905116|NCT01706328|10003794|P3|2-week Run-in Period|Withdrawal by Subject|0
2905117|NCT01706328|10003795|P2|2-week Run-in Period|Withdrawal by Subject|0
2905118|NCT01706328|10003796|P1|2-week Run-in Period|Withdrawal by Subject|15
2905119|NCT01706328|10003794|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2905120|NCT01706328|10003795|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2905121|NCT01706328|10003796|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
2905122|NCT01706250|10003815|P1|Overall Study|Lost to Follow-up|2
2905123|NCT01706198|10003846|P2|Overall Study|Withdrawal by Subject|31
2905124|NCT01706198|10003847|P1|Overall Study|Withdrawal by Subject|23
2905125|NCT01706198|10003846|P2|Overall Study|Physician Decision|37
2905126|NCT01706198|10003847|P1|Overall Study|Physician Decision|23
2905127|NCT01706198|10003846|P2|Overall Study|Lost to Follow-up|93
2905128|NCT01706198|10003847|P1|Overall Study|Lost to Follow-up|97
2905129|NCT01706198|10003846|P2|Overall Study|Other: Subject reached stopping criteria|13
2905130|NCT01706198|10003847|P1|Overall Study|Other: Subject reached stopping criteria|11
2905131|NCT01706198|10003846|P2|Overall Study|Protocol Violation|5
2905132|NCT01706198|10003847|P1|Overall Study|Protocol Violation|7
2905133|NCT01706198|10003846|P2|Overall Study|Adverse Event|15
2905134|NCT01706198|10003847|P1|Overall Study|Adverse Event|12
2905135|NCT01706159|10003899|P2|Overall Study|Unclassified|1
2905136|NCT01706159|10003900|P1|Overall Study|Unclassified|6
2905137|NCT01706159|10003899|P2|Overall Study|Withdrawal Criteria|1
2905138|NCT01706159|10003900|P1|Overall Study|Withdrawal Criteria|2
2905139|NCT01706146|10003914|P1|Overall Study|Developed AF and need for antiplatelets|2
2905140|NCT01706146|10003914|P1|Overall Study|Adverse Event|3
2905141|NCT01706146|10003914|P1|Overall Study|Withdrawal by Subject|1
2905142|NCT01706003|10003934|P2|Overall Study|Lost to Follow-up|4
2905143|NCT01706003|10003935|P1|Overall Study|Lost to Follow-up|6
2905144|NCT01706003|10003934|P2|Overall Study|Not scheduled|0
2905145|NCT01706003|10003935|P1|Overall Study|Not scheduled|3
2905146|NCT01706003|10003934|P2|Overall Study|Withdrawal by Subject|0
2905147|NCT01706003|10003935|P1|Overall Study|Withdrawal by Subject|2
2905148|NCT01705977|10003943|P2|Overall Study|Missing study conclusion form|2
2905149|NCT01705977|10003944|P1|Overall Study|Missing study conclusion form|2
2905150|NCT01705977|10003943|P2|Overall Study|Physician Decision|38
2905151|NCT01705977|10003944|P1|Overall Study|Physician Decision|48
2905152|NCT01705977|10003943|P2|Overall Study|Lost to Follow-up|37
2905153|NCT01705977|10003944|P1|Overall Study|Lost to Follow-up|33
2905154|NCT01705977|10003943|P2|Overall Study|Site closure|2
2905155|NCT01705977|10003944|P1|Overall Study|Site closure|3
2905156|NCT01705977|10003943|P2|Overall Study|Protocol Violation|4
2905157|NCT01705977|10003944|P1|Overall Study|Protocol Violation|2
2905158|NCT01705977|10003943|P2|Overall Study|Adverse Event|49
2905159|NCT01705977|10003944|P1|Overall Study|Adverse Event|57
2905160|NCT01705977|10003943|P2|Overall Study|Withdrawal by Subject|128
2905161|NCT01705977|10003944|P1|Overall Study|Withdrawal by Subject|128
2905162|NCT01705730|10003962|P1|Overall Study|Reason not Specified|4
2905163|NCT01705730|10003962|P1|Overall Study|Lost to Follow-up|1
2905164|NCT01705730|10003962|P1|Overall Study|Adverse Event|3
2905165|NCT01705730|10003962|P1|Overall Study|Lack of Efficacy|1
2905166|NCT01705717|10004002|P2|Overall Study|Other|2
2905167|NCT01705717|10004003|P1|Overall Study|Other|0
2905168|NCT01705717|10004002|P2|Overall Study|Lack of Efficacy|1
2905169|NCT01705717|10004003|P1|Overall Study|Lack of Efficacy|0
2905170|NCT01705717|10004002|P2|Overall Study|Adverse Event|2
2905171|NCT01705717|10004003|P1|Overall Study|Adverse Event|2
2905172|NCT01705691|10004020|P2|Overall Study|Other|1
2905173|NCT01705691|10004021|P1|Overall Study|Other|0
2905174|NCT01705691|10004020|P2|Overall Study|Lost to Follow-up|1
2905175|NCT01705691|10004021|P1|Overall Study|Lost to Follow-up|1
2905176|NCT01705691|10004020|P2|Overall Study|Withdrawal by Subject|2
2905177|NCT01705691|10004021|P1|Overall Study|Withdrawal by Subject|1
2905178|NCT01705691|10004020|P2|Overall Study|Death|2
2905179|NCT01705691|10004021|P1|Overall Study|Death|1
2905180|NCT01705652|10004041|P2|Overall Study|non-compliance|1
2905181|NCT01705652|10004042|P1|Overall Study|non-compliance|1
2905182|NCT01705652|10004041|P2|Overall Study|Withdrawal by Subject|2
2905183|NCT01705652|10004042|P1|Overall Study|Withdrawal by Subject|1
2905184|NCT01705652|10004041|P2|Overall Study|Adverse Event|0
2905185|NCT01705652|10004042|P1|Overall Study|Adverse Event|1
2905186|NCT01705587|10004050|P2|Overall Study|Withdrawal by Subject|1
2905187|NCT01705587|10004051|P1|Overall Study|Withdrawal by Subject|0
2905188|NCT01705574|10004069|P4|Open-Label Extension Phase|Pregnancy|1
2905189|NCT01705574|10004070|P3|Open-Label Extension Phase|Pregnancy|1
2905190|NCT01705574|10004071|P2|Open-Label Extension Phase|Pregnancy|0
2905192|NCT01705574|10004069|P4|Open-Label Extension Phase|Physician Decision|0
2905193|NCT01705574|10004070|P3|Open-Label Extension Phase|Physician Decision|2
2905194|NCT01705574|10004071|P2|Open-Label Extension Phase|Physician Decision|0
2905195|NCT01705574|10004072|P1|Open-Label Extension Phase|Physician Decision|0
2905196|NCT01705574|10004069|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2905197|NCT01705574|10004070|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
2905198|NCT01705574|10004071|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2905199|NCT01705574|10004072|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2905200|NCT01705574|10004069|P4|Open-Label Extension Phase|Death|0
2905201|NCT01705574|10004070|P3|Open-Label Extension Phase|Death|1
2905202|NCT01705574|10004071|P2|Open-Label Extension Phase|Death|0
2905203|NCT01705574|10004072|P1|Open-Label Extension Phase|Death|2
2905204|NCT01705574|10004069|P4|Open-Label Extension Phase|Adverse Event|1
2905205|NCT01705574|10004070|P3|Open-Label Extension Phase|Adverse Event|0
2905206|NCT01705574|10004071|P2|Open-Label Extension Phase|Adverse Event|0
2905207|NCT01705574|10004072|P1|Open-Label Extension Phase|Adverse Event|3
2905208|NCT01705574|10004069|P4|Open-Label Extension Phase|Withdrew Consent|1
2905209|NCT01705574|10004070|P3|Open-Label Extension Phase|Withdrew Consent|4
2905210|NCT01705574|10004071|P2|Open-Label Extension Phase|Withdrew Consent|0
2905211|NCT01705574|10004072|P1|Open-Label Extension Phase|Withdrew Consent|4
2905212|NCT01705574|10004069|P4|Open-Label Extension Phase|Lost to Follow-up|2
2905213|NCT01705574|10004070|P3|Open-Label Extension Phase|Lost to Follow-up|2
2905214|NCT01705574|10004071|P2|Open-Label Extension Phase|Lost to Follow-up|0
2905215|NCT01705574|10004072|P1|Open-Label Extension Phase|Lost to Follow-up|6
2905216|NCT01705574|10004069|P4|Double-Blind Phase|Randomized but Not Treated|0
2905217|NCT01705574|10004070|P3|Double-Blind Phase|Randomized but Not Treated|0
2905218|NCT01705574|10004071|P2|Double-Blind Phase|Randomized but Not Treated|4
2905219|NCT01705574|10004072|P1|Double-Blind Phase|Randomized but Not Treated|4
2905220|NCT01705574|10004069|P4|Double-Blind Phase|Protocol Violation|0
2905221|NCT01705574|10004070|P3|Double-Blind Phase|Protocol Violation|0
2905222|NCT01705574|10004071|P2|Double-Blind Phase|Protocol Violation|0
2905223|NCT01705574|10004072|P1|Double-Blind Phase|Protocol Violation|1
2905224|NCT01705574|10004069|P4|Double-Blind Phase|Pregnancy|0
2905225|NCT01705574|10004070|P3|Double-Blind Phase|Pregnancy|0
2905226|NCT01705574|10004071|P2|Double-Blind Phase|Pregnancy|1
2905227|NCT01705574|10004072|P1|Double-Blind Phase|Pregnancy|1
2905228|NCT01705574|10004069|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
2905229|NCT01705574|10004070|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
2905230|NCT01705574|10004071|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
2905231|NCT01705574|10004072|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
2905232|NCT01705574|10004069|P4|Double-Blind Phase|Withdrew Consent|0
2905233|NCT01705574|10004070|P3|Double-Blind Phase|Withdrew Consent|0
2905234|NCT01705574|10004071|P2|Double-Blind Phase|Withdrew Consent|5
2905235|NCT01705574|10004072|P1|Double-Blind Phase|Withdrew Consent|8
2905236|NCT01705574|10004069|P4|Double-Blind Phase|Adverse Event|0
2905237|NCT01705574|10004070|P3|Double-Blind Phase|Adverse Event|0
2905238|NCT01705574|10004071|P2|Double-Blind Phase|Adverse Event|10
2905239|NCT01705574|10004072|P1|Double-Blind Phase|Adverse Event|3
2905240|NCT01705574|10004069|P4|Double-Blind Phase|Lost to Follow-up|0
2905241|NCT01705574|10004070|P3|Double-Blind Phase|Lost to Follow-up|0
2905242|NCT01705574|10004071|P2|Double-Blind Phase|Lost to Follow-up|16
2905243|NCT01705574|10004072|P1|Double-Blind Phase|Lost to Follow-up|12
2905244|NCT01705509|10004089|P1|CPET w/ Ranexa|Screen Failure|2
2905245|NCT01705509|10004089|P1|Inclusion CPET|Withdrawal by Subject|2
2905246|NCT01705509|10004089|P1|Inclusion CPET|Screen Failure|5
2905247|NCT01705236|10004116|P1|Overall Study|Adverse Event|5
2905248|NCT01705236|10004116|P1|Overall Study|Withdrawal by Subject|5
2905249|NCT01705236|10004116|P1|Overall Study|Abnormal laboratory value(s)|4
2905250|NCT01705236|10004116|P1|Overall Study|Abnormal test procedure result(s)|4
2905251|NCT01705236|10004116|P1|Overall Study|Protocol Violation|3
2905252|NCT01705236|10004116|P1|Overall Study|Unsatisfactory therapeutic effect|3
2905253|NCT01705236|10004116|P1|Overall Study|Administrative problems|2
2905254|NCT01705236|10004116|P1|Overall Study|Lost to Follow-up|1
2905255|NCT01705145|10004125|P1|Part B|Adverse Event|1
2905256|NCT01705080|10004165|P4|Overall Study|Missed 6 Month Visit|0
2905257|NCT01705080|10004166|P3|Overall Study|Missed 6 Month Visit|1
2905258|NCT01705080|10004167|P2|Overall Study|Missed 6 Month Visit|1
2905259|NCT01705080|10004168|P1|Overall Study|Missed 6 Month Visit|3
2905260|NCT01705080|10004165|P4|Overall Study|Protocol Violation|0
2905261|NCT01705080|10004166|P3|Overall Study|Protocol Violation|0
2905262|NCT01705080|10004167|P2|Overall Study|Protocol Violation|0
2905263|NCT01705080|10004168|P1|Overall Study|Protocol Violation|2
2905264|NCT01705080|10004165|P4|Overall Study|Lost to Follow-up|2
2905265|NCT01705080|10004166|P3|Overall Study|Lost to Follow-up|0
2905266|NCT01705080|10004167|P2|Overall Study|Lost to Follow-up|0
2905267|NCT01705080|10004168|P1|Overall Study|Lost to Follow-up|0
2905268|NCT01705080|10004165|P4|Overall Study|Physician Decision|8
2905269|NCT01705080|10004166|P3|Overall Study|Physician Decision|1
2905270|NCT01705080|10004167|P2|Overall Study|Physician Decision|2
2905271|NCT01705080|10004168|P1|Overall Study|Physician Decision|1
2905272|NCT01705080|10004165|P4|Overall Study|Withdrawal by Subject|12
2905273|NCT01705080|10004166|P3|Overall Study|Withdrawal by Subject|0
2905274|NCT01705080|10004167|P2|Overall Study|Withdrawal by Subject|1
2905275|NCT01705080|10004168|P1|Overall Study|Withdrawal by Subject|1
2905276|NCT01705080|10004165|P4|Overall Study|Death|0
2905277|NCT01705080|10004166|P3|Overall Study|Death|0
2905278|NCT01705080|10004167|P2|Overall Study|Death|1
2905279|NCT01705080|10004168|P1|Overall Study|Death|0
2905280|NCT01705080|10004165|P4|Overall Study|Failed Procedure|0
2905281|NCT01705080|10004166|P3|Overall Study|Failed Procedure|0
2905282|NCT01705080|10004167|P2|Overall Study|Failed Procedure|2
2905283|NCT01705080|10004168|P1|Overall Study|Failed Procedure|0
2905284|NCT01705080|10004165|P4|Overall Study|Screen Failure Post Consent|20
2905285|NCT01705080|10004166|P3|Overall Study|Screen Failure Post Consent|3
2905286|NCT01705080|10004167|P2|Overall Study|Screen Failure Post Consent|9
2905287|NCT01705080|10004168|P1|Overall Study|Screen Failure Post Consent|8
2905288|NCT01704846|10004297|P2|Treatment Period 2|Withdrawal by Subject|1
2905289|NCT01704846|10004298|P1|Treatment Period 2|Withdrawal by Subject|0
2905290|NCT01704755|10004353|P2|Overall Study|Withdrew consent and personal issues|0
2905291|NCT01704755|10004354|P1|Overall Study|Withdrew consent and personal issues|1
2905292|NCT01704755|10004353|P2|Overall Study|Other (not specified)|1
2905293|NCT01704755|10004354|P1|Overall Study|Other (not specified)|3
2905294|NCT01704755|10004353|P2|Overall Study|Withdrew consent|1
2905295|NCT01704755|10004354|P1|Overall Study|Withdrew consent|1
2905296|NCT01704755|10004353|P2|Overall Study|Lost to Follow-up|4
2905297|NCT01704755|10004354|P1|Overall Study|Lost to Follow-up|3
2905298|NCT01704755|10004353|P2|Overall Study|Adverse Event|1
2905299|NCT01704755|10004354|P1|Overall Study|Adverse Event|4
2905300|NCT01704651|10004368|P2|Overall Study|Post-op did not have laparotomy|1
2905301|NCT01704651|10004369|P1|Overall Study|Post-op did not have laparotomy|2
2905302|NCT01704651|10004368|P2|Overall Study|Nasogastric tube placement in surgery|1
2905303|NCT01704651|10004369|P1|Overall Study|Nasogastric tube placement in surgery|1
2905304|NCT01704651|10004368|P2|Overall Study|Pre-op change in treatment plan|4
2905305|NCT01704651|10004369|P1|Overall Study|Pre-op change in treatment plan|1
2905306|NCT01704651|10004368|P2|Overall Study|Pre-op withdrawal by subject|1
2905307|NCT01704651|10004369|P1|Overall Study|Pre-op withdrawal by subject|1
2905308|NCT01704599|10004377|P1|Overall Study|Adverse Event|1
2905309|NCT01704495|10004417|P4|Optional Safety Extension|Withdrawal by Subject|2
2905310|NCT01704495|10004418|P3|Optional Safety Extension|Withdrawal by Subject|1
2905311|NCT01704495|10004419|P2|Optional Safety Extension|Withdrawal by Subject|0
2905312|NCT01704495|10004420|P1|Optional Safety Extension|Withdrawal by Subject|2
2905313|NCT01704495|10004417|P4|Optional Safety Extension|Other reason|28
2905314|NCT01704495|10004418|P3|Optional Safety Extension|Other reason|30
2905315|NCT01704495|10004419|P2|Optional Safety Extension|Other reason|29
2905316|NCT01704495|10004420|P1|Optional Safety Extension|Other reason|27
2905317|NCT01704495|10004417|P4|Optional Safety Extension|Adverse Event|1
2905318|NCT01704495|10004418|P3|Optional Safety Extension|Adverse Event|0
2905319|NCT01704495|10004419|P2|Optional Safety Extension|Adverse Event|4
2905320|NCT01704495|10004420|P1|Optional Safety Extension|Adverse Event|0
2905321|NCT01704495|10004417|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
2905322|NCT01704495|10004418|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
2905323|NCT01704495|10004419|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
2905324|NCT01704495|10004420|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
2905325|NCT01704495|10004417|P4|Subjects Randomized|Protocol Violation|0
2905326|NCT01704495|10004418|P3|Subjects Randomized|Protocol Violation|2
2905327|NCT01704495|10004419|P2|Subjects Randomized|Protocol Violation|1
2905328|NCT01704495|10004420|P1|Subjects Randomized|Protocol Violation|1
2905329|NCT01704495|10004417|P4|Subjects Randomized|Withdrawal by Subject|5
2905330|NCT01704495|10004418|P3|Subjects Randomized|Withdrawal by Subject|5
2905331|NCT01704495|10004419|P2|Subjects Randomized|Withdrawal by Subject|5
2905332|NCT01704495|10004420|P1|Subjects Randomized|Withdrawal by Subject|5
2905333|NCT01704495|10004417|P4|Subjects Randomized|Adverse Event|7
2905334|NCT01704495|10004418|P3|Subjects Randomized|Adverse Event|0
2905335|NCT01704495|10004419|P2|Subjects Randomized|Adverse Event|2
2905336|NCT01704495|10004420|P1|Subjects Randomized|Adverse Event|8
2905337|NCT01704495|10004417|P4|Subjects Randomized|Discontinuation criteria met|0
2905338|NCT01704495|10004418|P3|Subjects Randomized|Discontinuation criteria met|2
2905339|NCT01704495|10004419|P2|Subjects Randomized|Discontinuation criteria met|2
2905340|NCT01704495|10004420|P1|Subjects Randomized|Discontinuation criteria met|4
2905341|NCT01704495|10004417|P4|Subjects Randomized|Other Reason|2
2905342|NCT01704495|10004418|P3|Subjects Randomized|Other Reason|3
2905343|NCT01704495|10004419|P2|Subjects Randomized|Other Reason|2
2905344|NCT01704495|10004420|P1|Subjects Randomized|Other Reason|3
2905345|NCT01704456|10004596|P2|Overall Study|Lost to Follow-up|14
2905346|NCT01704456|10004597|P1|Overall Study|Lost to Follow-up|8
2905347|NCT01704287|10004659|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2905348|NCT01704287|10004660|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
2905349|NCT01704287|10004661|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2905350|NCT01704287|10004662|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2905351|NCT01704287|10004663|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2905352|NCT01704287|10004659|P5|Switch to Pembrolizumab Treatment Period|Death|37
2905353|NCT01704287|10004660|P4|Switch to Pembrolizumab Treatment Period|Death|35
2905354|NCT01704287|10004661|P3|Switch to Pembrolizumab Treatment Period|Death|0
2905355|NCT01704287|10004662|P2|Switch to Pembrolizumab Treatment Period|Death|0
2905356|NCT01704287|10004663|P1|Switch to Pembrolizumab Treatment Period|Death|0
2905357|NCT01704287|10004659|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
2905358|NCT01704287|10004660|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
2905359|NCT01704287|10004661|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2905360|NCT01704287|10004662|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2905361|NCT01704287|10004663|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2905362|NCT01704287|10004659|P5|Initial Treatment Period|Switched to Pembrolizumab|0
2905363|NCT01704287|10004660|P4|Initial Treatment Period|Switched to Pembrolizumab|0
2905364|NCT01704287|10004661|P3|Initial Treatment Period|Switched to Pembrolizumab|98
2905365|NCT01704287|10004662|P2|Initial Treatment Period|Switched to Pembrolizumab|0
2905366|NCT01704287|10004663|P1|Initial Treatment Period|Switched to Pembrolizumab|0
2905367|NCT01704287|10004659|P5|Initial Treatment Period|Lost to Follow-up|0
2905368|NCT01704287|10004660|P4|Initial Treatment Period|Lost to Follow-up|0
2905369|NCT01704287|10004661|P3|Initial Treatment Period|Lost to Follow-up|0
2905370|NCT01704287|10004662|P2|Initial Treatment Period|Lost to Follow-up|3
2905371|NCT01704287|10004663|P1|Initial Treatment Period|Lost to Follow-up|5
2905372|NCT01704287|10004659|P5|Initial Treatment Period|Withdrawal by Subject|0
2905373|NCT01704287|10004660|P4|Initial Treatment Period|Withdrawal by Subject|0
2905374|NCT01704287|10004661|P3|Initial Treatment Period|Withdrawal by Subject|4
2905375|NCT01704287|10004662|P2|Initial Treatment Period|Withdrawal by Subject|2
2905376|NCT01704287|10004663|P1|Initial Treatment Period|Withdrawal by Subject|3
2905377|NCT01704287|10004659|P5|Initial Treatment Period|Death|0
2905378|NCT01704287|10004660|P4|Initial Treatment Period|Death|0
2905379|NCT01704287|10004661|P3|Initial Treatment Period|Death|71
2905380|NCT01704287|10004662|P2|Initial Treatment Period|Death|129
2905381|NCT01704287|10004663|P1|Initial Treatment Period|Death|139
2905382|NCT01704261|10004711|P2|Overall Study|Lost to Follow-up|0
2905383|NCT01704261|10004712|P1|Overall Study|Lost to Follow-up|1
2905384|NCT01704261|10004711|P2|Overall Study|Withdrawal by Subject|15
2905385|NCT01704261|10004712|P1|Overall Study|Withdrawal by Subject|12
2905386|NCT01704079|10004739|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
2905387|NCT01704079|10004740|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
2905388|NCT01704079|10004739|P2|Overall Study|Subject noncompliance|3
2905389|NCT01704079|10004740|P1|Overall Study|Subject noncompliance|2
2905390|NCT01704079|10004739|P2|Overall Study|Protocol Violation|0
2905391|NCT01704079|10004740|P1|Overall Study|Protocol Violation|1
2905392|NCT01704079|10004739|P2|Overall Study|Adverse Event|7
2905393|NCT01704079|10004740|P1|Overall Study|Adverse Event|4
2905394|NCT01704079|10004739|P2|Overall Study|Lost to Follow-up|5
2905395|NCT01704079|10004740|P1|Overall Study|Lost to Follow-up|2
2905396|NCT01704079|10004739|P2|Overall Study|Withdrawal by Subject|7
2905397|NCT01704079|10004740|P1|Overall Study|Withdrawal by Subject|5
2905398|NCT01703988|10004756|P4|Overall Study|Investigator Judgment|1
2905399|NCT01703988|10004757|P3|Overall Study|Investigator Judgment|0
2905400|NCT01703988|10004758|P2|Overall Study|Investigator Judgment|0
2905401|NCT01703988|10004759|P1|Overall Study|Investigator Judgment|0
2905402|NCT01703858|10004789|P3|Overall Study|Withdrawal by Subject|0
2905403|NCT01703858|10004790|P2|Overall Study|Withdrawal by Subject|1
2905404|NCT01703858|10004791|P1|Overall Study|Withdrawal by Subject|0
2905405|NCT01703845|10004816|P2|Overall Study|other than stated above|0
2905406|NCT01703845|10004817|P1|Overall Study|other than stated above|1
2905407|NCT01703845|10004816|P2|Overall Study|Protocol Violation|0
2905408|NCT01703845|10004817|P1|Overall Study|Protocol Violation|1
2905409|NCT01703845|10004816|P2|Overall Study|Adverse Event|0
2905410|NCT01703845|10004817|P1|Overall Study|Adverse Event|1
2905411|NCT01703832|10004854|P2|Overall Study|Withdrawal by Subject|0
2905412|NCT01703832|10004855|P1|Overall Study|Withdrawal by Subject|1
2905413|NCT01703819|10004887|P2|Overall Study|Withdrawal by Subject|1
2905414|NCT01703819|10004888|P1|Overall Study|Withdrawal by Subject|0
2905415|NCT01703819|10004887|P2|Overall Study|Adverse Event|1
2905416|NCT01703819|10004888|P1|Overall Study|Adverse Event|0
2905417|NCT01703741|10004918|P1|Overall Study|Subject started testosterone injections|1
2905418|NCT01703741|10004918|P1|Overall Study|Subject cannot comply with study visits|1
2905419|NCT01703741|10004918|P1|Overall Study|Subject did not want to continue|2
2905420|NCT01703741|10004918|P1|Overall Study|Lost to Follow-up|3
2905421|NCT01703741|10004918|P1|Overall Study|Protocol Violation|1
2905422|NCT01703741|10004918|P1|Overall Study|Physician Decision|2
2905423|NCT01703741|10004918|P1|Overall Study|Adverse Event|2
2905424|NCT01703741|10004918|P1|Overall Study|Withdrawal by Subject|6
2905425|NCT01703286|10004984|P6|Period 2 Including Washout|Adverse Event|0
2905426|NCT01703286|10004985|P5|Period 2 Including Washout|Adverse Event|0
2905427|NCT01703286|10004986|P4|Period 2 Including Washout|Adverse Event|1
2905428|NCT01703286|10004987|P3|Period 2 Including Washout|Adverse Event|0
2905429|NCT01703286|10004988|P2|Period 2 Including Washout|Adverse Event|0
2905430|NCT01703286|10004989|P1|Period 2 Including Washout|Adverse Event|0
2905431|NCT01703286|10004984|P6|Period 1 Including Washout|Withdrawal by Subject|1
2905432|NCT01703286|10004985|P5|Period 1 Including Washout|Withdrawal by Subject|0
2905433|NCT01703286|10004986|P4|Period 1 Including Washout|Withdrawal by Subject|1
2905434|NCT01703286|10004987|P3|Period 1 Including Washout|Withdrawal by Subject|0
2905435|NCT01703286|10004988|P2|Period 1 Including Washout|Withdrawal by Subject|0
2905436|NCT01703286|10004989|P1|Period 1 Including Washout|Withdrawal by Subject|0
2905437|NCT01703260|10005012|P3|Overall Study|Study Termination|0
2905438|NCT01703260|10005013|P2|Overall Study|Study Termination|2
2905439|NCT01703260|10005014|P1|Overall Study|Study Termination|1
2905440|NCT01703260|10005012|P3|Overall Study|Withdrawal by Subject|1
2905441|NCT01703260|10005013|P2|Overall Study|Withdrawal by Subject|0
2905442|NCT01703260|10005014|P1|Overall Study|Withdrawal by Subject|0
2905443|NCT01703260|10005012|P3|Overall Study|Lost to Follow-up|0
2905444|NCT01703260|10005013|P2|Overall Study|Lost to Follow-up|0
2905445|NCT01703260|10005014|P1|Overall Study|Lost to Follow-up|1
2905446|NCT01703260|10005012|P3|Overall Study|Adverse Event|2
2905447|NCT01703260|10005013|P2|Overall Study|Adverse Event|2
2905448|NCT01703260|10005014|P1|Overall Study|Adverse Event|1
2905449|NCT01703221|10005040|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
2905450|NCT01703221|10005041|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
2905451|NCT01703221|10005042|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
2905452|NCT01703221|10005040|P3|Phase B - (Week 25 to 52)|Adverse Event|2
2905453|NCT01703221|10005041|P2|Phase B - (Week 25 to 52)|Adverse Event|3
2905454|NCT01703221|10005042|P1|Phase B - (Week 25 to 52)|Adverse Event|2
2905455|NCT01703221|10005040|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
2905456|NCT01703221|10005041|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
2905457|NCT01703221|10005042|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
2905458|NCT01703221|10005040|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
2905459|NCT01703221|10005041|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
2905460|NCT01703221|10005042|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
2905461|NCT01703221|10005040|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2905462|NCT01703221|10005041|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2905463|NCT01703221|10005042|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
2905464|NCT01703221|10005040|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
2905465|NCT01703221|10005041|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
2905466|NCT01703221|10005042|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
2905467|NCT01703221|10005040|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
2905468|NCT01703221|10005041|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
2905469|NCT01703221|10005042|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
2905470|NCT01703221|10005040|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
2905471|NCT01703221|10005041|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
2905472|NCT01703221|10005042|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
2905473|NCT01703208|10005073|P2|Overall Study|Protocol Deviation|0
2905474|NCT01703208|10005074|P1|Overall Study|Protocol Deviation|2
2905475|NCT01703208|10005073|P2|Overall Study|Technical Problems|1
2905476|NCT01703208|10005074|P1|Overall Study|Technical Problems|0
2905477|NCT01703208|10005073|P2|Overall Study|Adverse Event|19
2905478|NCT01703208|10005074|P1|Overall Study|Adverse Event|14
2905479|NCT01703208|10005073|P2|Overall Study|Withdrawal by Subject|209
2905480|NCT01703208|10005074|P1|Overall Study|Withdrawal by Subject|205
2905481|NCT01703208|10005073|P2|Overall Study|Study Terminated by Sponsor|1716
2905482|NCT01703208|10005074|P1|Overall Study|Study Terminated by Sponsor|1710
2905483|NCT01703208|10005073|P2|Overall Study|Protocol Violation|1
2905484|NCT01703208|10005074|P1|Overall Study|Protocol Violation|1
2905485|NCT01703208|10005073|P2|Overall Study|Progressive disease|2
2905486|NCT01703208|10005074|P1|Overall Study|Progressive disease|2
2905487|NCT01703208|10005073|P2|Overall Study|Physician Decision|13
2905488|NCT01703208|10005074|P1|Overall Study|Physician Decision|11
2905489|NCT01703208|10005073|P2|Overall Study|Site Discontinued Study Participation|27
2905490|NCT01703208|10005074|P1|Overall Study|Site Discontinued Study Participation|23
2905491|NCT01703208|10005073|P2|Overall Study|Excluded Medication|2
2905492|NCT01703208|10005074|P1|Overall Study|Excluded Medication|1
2905493|NCT01703208|10005073|P2|Overall Study|Non-Compliance with Study Drug|0
2905494|NCT01703208|10005074|P1|Overall Study|Non-Compliance with Study Drug|1
2905495|NCT01703208|10005073|P2|Overall Study|Lost to Follow-up|62
2905496|NCT01703208|10005074|P1|Overall Study|Lost to Follow-up|68
2905497|NCT01703208|10005073|P2|Overall Study|Lack of Efficacy|2
2905498|NCT01703208|10005074|P1|Overall Study|Lack of Efficacy|1
2905499|NCT01703208|10005073|P2|Overall Study|Death|48
2905500|NCT01703208|10005074|P1|Overall Study|Death|61
2905501|NCT01703091|10005138|P2|Overall Study|Sponsor Decision|0
2905502|NCT01703091|10005139|P1|Overall Study|Sponsor Decision|1
2905503|NCT01703091|10005138|P2|Overall Study|Withdrawal by Subject|0
2905504|NCT01703091|10005139|P1|Overall Study|Withdrawal by Subject|1
2905505|NCT01703091|10005138|P2|Overall Study|Physician Decision|1
2905506|NCT01703091|10005139|P1|Overall Study|Physician Decision|2
2905507|NCT01703091|10005138|P2|Overall Study|Adverse Event|3
2905508|NCT01703091|10005139|P1|Overall Study|Adverse Event|5
2905509|NCT01703065|10005157|P2|Overall Study|Lack of Efficacy|0
2905510|NCT01703065|10005158|P1|Overall Study|Lack of Efficacy|1
2905511|NCT01703000|10005188|P1|Overall Study|Death|1
2905512|NCT01702987|10005221|P2|Overall Study|Withdrawal by Subject|0
2905513|NCT01702987|10005222|P1|Overall Study|Withdrawal by Subject|1
2905514|NCT01702961|10005228|P1|Overall Study|Ongoing|11
2905515|NCT01702961|10005228|P1|Overall Study|Lost to Follow-up|2
2905516|NCT01702961|10005228|P1|Overall Study|Death|6
2905517|NCT01702961|10005228|P1|Overall Study|Relapse|20
2905518|NCT01702961|10005228|P1|Overall Study|Progressive disease|5
2905519|NCT01702961|10005228|P1|Overall Study|Additional treatment|3
2905520|NCT01702558|10005251|P5|Overall Study|Other|17
2905521|NCT01702558|10005252|P4|Overall Study|Other|16
2905522|NCT01702558|10005253|P3|Overall Study|Other|0
2905523|NCT01702558|10005254|P2|Overall Study|Other|0
2905524|NCT01702558|10005255|P1|Overall Study|Other|0
2905525|NCT01702558|10005251|P5|Overall Study|Study Terminated by Sponsor|1
2905526|NCT01702558|10005252|P4|Overall Study|Study Terminated by Sponsor|0
2905527|NCT01702558|10005253|P3|Overall Study|Study Terminated by Sponsor|0
2905528|NCT01702558|10005254|P2|Overall Study|Study Terminated by Sponsor|1
2905529|NCT01702558|10005255|P1|Overall Study|Study Terminated by Sponsor|0
2905530|NCT01702558|10005251|P5|Overall Study|Safety Follow-Up less than 3 Months|0
2905531|NCT01702558|10005252|P4|Overall Study|Safety Follow-Up less than 3 Months|0
2905532|NCT01702558|10005253|P3|Overall Study|Safety Follow-Up less than 3 Months|2
2905533|NCT01702558|10005254|P2|Overall Study|Safety Follow-Up less than 3 Months|0
2905534|NCT01702558|10005255|P1|Overall Study|Safety Follow-Up less than 3 Months|0
2905535|NCT01702558|10005251|P5|Overall Study|Death|20
2905536|NCT01702558|10005252|P4|Overall Study|Death|16
2905537|NCT01702558|10005253|P3|Overall Study|Death|3
2905538|NCT01702558|10005254|P2|Overall Study|Death|3
2905539|NCT01702558|10005255|P1|Overall Study|Death|4
2905540|NCT01702558|10005251|P5|Overall Study|Lost to Follow-up|0
2905541|NCT01702558|10005252|P4|Overall Study|Lost to Follow-up|3
2905542|NCT01702558|10005253|P3|Overall Study|Lost to Follow-up|0
2905543|NCT01702558|10005254|P2|Overall Study|Lost to Follow-up|0
2905544|NCT01702558|10005255|P1|Overall Study|Lost to Follow-up|0
2905545|NCT01702558|10005251|P5|Overall Study|Withdrawal by Subject|4
2905546|NCT01702558|10005252|P4|Overall Study|Withdrawal by Subject|12
2905547|NCT01702558|10005253|P3|Overall Study|Withdrawal by Subject|0
2905548|NCT01702558|10005254|P2|Overall Study|Withdrawal by Subject|0
2905549|NCT01702558|10005255|P1|Overall Study|Withdrawal by Subject|0
2905550|NCT01702532|10005320|P2|Overall Study|Adverse Event|1
2905551|NCT01702532|10005321|P1|Overall Study|Adverse Event|0
2905552|NCT01702519|10005331|P2|Washout Period|Withdrawal by Subject|2
2905553|NCT01702519|10005332|P1|Washout Period|Withdrawal by Subject|0
2905554|NCT01702519|10005331|P2|Washout Period|Lost to Follow-up|0
2905555|NCT01702519|10005332|P1|Washout Period|Lost to Follow-up|1
2905556|NCT01702454|10005350|P2|Overall Study|Lost to Follow-up|6
2905557|NCT01702454|10005351|P1|Overall Study|Lost to Follow-up|3
2905558|NCT01702454|10005350|P2|Overall Study|Migrated/moved from study area|1
2905559|NCT01702454|10005351|P1|Overall Study|Migrated/moved from study area|0
2905560|NCT01702454|10005350|P2|Overall Study|Consent withdrawal|1
2905561|NCT01702454|10005351|P1|Overall Study|Consent withdrawal|0
2905562|NCT01702428|10005433|P4|Overall Study|Withdrawal by Subject|10
2905563|NCT01702428|10005434|P3|Overall Study|Withdrawal by Subject|14
2905564|NCT01702428|10005435|P2|Overall Study|Withdrawal by Subject|23
2905565|NCT01702428|10005436|P1|Overall Study|Withdrawal by Subject|21
2905566|NCT01702428|10005433|P4|Overall Study|Protocol Violation|0
2905567|NCT01702428|10005434|P3|Overall Study|Protocol Violation|1
2905568|NCT01702428|10005435|P2|Overall Study|Protocol Violation|0
2905569|NCT01702428|10005436|P1|Overall Study|Protocol Violation|3
2905570|NCT01702428|10005433|P4|Overall Study|Parents too busy|0
2905571|NCT01702428|10005434|P3|Overall Study|Parents too busy|0
2905572|NCT01702428|10005435|P2|Overall Study|Parents too busy|0
2905573|NCT01702428|10005436|P1|Overall Study|Parents too busy|1
2905574|NCT01702428|10005433|P4|Overall Study|Mother transferred care|0
2905575|NCT01702428|10005434|P3|Overall Study|Mother transferred care|0
2905576|NCT01702428|10005435|P2|Overall Study|Mother transferred care|1
2905577|NCT01702428|10005436|P1|Overall Study|Mother transferred care|0
2905578|NCT01702428|10005433|P4|Overall Study|Lost Health Plan|2
2905579|NCT01702428|10005434|P3|Overall Study|Lost Health Plan|0
2905580|NCT01702428|10005435|P2|Overall Study|Lost Health Plan|5
2905581|NCT01702428|10005436|P1|Overall Study|Lost Health Plan|3
2905582|NCT01702428|10005433|P4|Overall Study|Lost Coverage|1
2905583|NCT01702428|10005434|P3|Overall Study|Lost Coverage|0
2905584|NCT01702428|10005435|P2|Overall Study|Lost Coverage|0
2905585|NCT01702428|10005436|P1|Overall Study|Lost Coverage|0
2905586|NCT01702428|10005433|P4|Overall Study|Parents cannot assist to site|0
2905587|NCT01702428|10005434|P3|Overall Study|Parents cannot assist to site|1
2905588|NCT01702428|10005435|P2|Overall Study|Parents cannot assist to site|0
2905589|NCT01702428|10005436|P1|Overall Study|Parents cannot assist to site|1
2905590|NCT01702428|10005433|P4|Overall Study|Lost to Follow-up|44
2905591|NCT01702428|10005434|P3|Overall Study|Lost to Follow-up|37
2905592|NCT01702428|10005435|P2|Overall Study|Lost to Follow-up|41
2905593|NCT01702428|10005436|P1|Overall Study|Lost to Follow-up|33
2905594|NCT01702428|10005433|P4|Overall Study|Adverse Event|0
2905595|NCT01702428|10005434|P3|Overall Study|Adverse Event|0
2905596|NCT01702428|10005435|P2|Overall Study|Adverse Event|0
2905597|NCT01702428|10005436|P1|Overall Study|Adverse Event|2
2905598|NCT01702363|10005523|P1|Overall Study|Withdrawal by Subject|2
2905599|NCT01702363|10005523|P1|Overall Study|Lack of Efficacy|4
2905600|NCT01702363|10005523|P1|Overall Study|Adverse Event|14
2905601|NCT01702311|10005540|P2|Overall Study|Physician Decision|4
2905602|NCT01702311|10005541|P1|Overall Study|Physician Decision|3
2905603|NCT01702311|10005540|P2|Overall Study|Discharge less than 24 hours|7
2905604|NCT01702311|10005541|P1|Overall Study|Discharge less than 24 hours|10
2905605|NCT01702311|10005540|P2|Overall Study|Withdrawal by Subject|2
2905606|NCT01702311|10005541|P1|Overall Study|Withdrawal by Subject|3
2905607|NCT01702298|10005571|P1|Overall Study|Withdrawal by Subject|1
2905608|NCT01702246|10005599|P1|Overall Study|Physician Decision|1
2905609|NCT01702246|10005599|P1|Overall Study|Withdrawal by Subject|2
2905610|NCT01702246|10005599|P1|Overall Study|Lost to Follow-up|2
2905611|NCT01702025|10005653|P4|Overall Study|Adverse Event|0
2905612|NCT01702025|10005654|P3|Overall Study|Adverse Event|1
2905613|NCT01702025|10005655|P2|Overall Study|Adverse Event|1
2905614|NCT01702025|10005656|P1|Overall Study|Adverse Event|1
2905615|NCT01702025|10005653|P4|Overall Study|Equipment failure|0
2905616|NCT01702025|10005654|P3|Overall Study|Equipment failure|0
2905617|NCT01702025|10005655|P2|Overall Study|Equipment failure|0
2905618|NCT01702025|10005656|P1|Overall Study|Equipment failure|1
2905619|NCT01701973|10005685|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905620|NCT01701973|10005686|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905621|NCT01701973|10005687|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905622|NCT01701973|10005688|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905623|NCT01701973|10005689|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905624|NCT01701973|10005690|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905625|NCT01701973|10005691|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
2905626|NCT01701973|10005692|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
2905627|NCT01701674|10005739|P1|Overall Study|Unable to safely complete treatment|1
2905628|NCT01701401|10005825|P4|Overall Study|Protocol Violation|0
2905629|NCT01701401|10005826|P3|Overall Study|Protocol Violation|1
2905630|NCT01701401|10005827|P2|Overall Study|Protocol Violation|0
2905631|NCT01701401|10005828|P1|Overall Study|Protocol Violation|0
2905632|NCT01701401|10005825|P4|Overall Study|Adverse Event|0
2905633|NCT01701401|10005826|P3|Overall Study|Adverse Event|0
2905634|NCT01701401|10005827|P2|Overall Study|Adverse Event|0
2905635|NCT01701401|10005828|P1|Overall Study|Adverse Event|1
2905636|NCT01701401|10005825|P4|Overall Study|Lack of Efficacy|0
2905637|NCT01701401|10005826|P3|Overall Study|Lack of Efficacy|2
2905638|NCT01701401|10005827|P2|Overall Study|Lack of Efficacy|0
2905639|NCT01701401|10005828|P1|Overall Study|Lack of Efficacy|1
2905640|NCT01701401|10005825|P4|Overall Study|Withdrew Consent|2
2905641|NCT01701401|10005826|P3|Overall Study|Withdrew Consent|1
2905642|NCT01701401|10005827|P2|Overall Study|Withdrew Consent|3
2905643|NCT01701401|10005828|P1|Overall Study|Withdrew Consent|0
2905644|NCT01701401|10005825|P4|Overall Study|Lost to Follow-up|3
2905645|NCT01701401|10005826|P3|Overall Study|Lost to Follow-up|1
2905646|NCT01701401|10005827|P2|Overall Study|Lost to Follow-up|5
2905647|NCT01701401|10005828|P1|Overall Study|Lost to Follow-up|5
2905648|NCT01701401|10005825|P4|Overall Study|Randomized But Not Treated|1
2905649|NCT01701401|10005826|P3|Overall Study|Randomized But Not Treated|0
2905650|NCT01701401|10005827|P2|Overall Study|Randomized But Not Treated|1
2905651|NCT01701401|10005828|P1|Overall Study|Randomized But Not Treated|3
2905652|NCT01701362|10005880|P2|Overall Study|Reasons other than those mentioned above|5
2905653|NCT01701362|10005881|P1|Overall Study|Reasons other than those mentioned above|3
2905654|NCT01701362|10005880|P2|Overall Study|Randomized but not treated|2
2905655|NCT01701362|10005881|P1|Overall Study|Randomized but not treated|1
2905656|NCT01701362|10005880|P2|Overall Study|Death|1
2905657|NCT01701362|10005881|P1|Overall Study|Death|0
2905658|NCT01701362|10005880|P2|Overall Study|Insufficient clinical response|6
2905659|NCT01701362|10005881|P1|Overall Study|Insufficient clinical response|6
2905660|NCT01701362|10005880|P2|Overall Study|Lost to Follow-up|9
2905661|NCT01701362|10005881|P1|Overall Study|Lost to Follow-up|6
2905662|NCT01701362|10005880|P2|Overall Study|No longer willing to participate|14
2905663|NCT01701362|10005881|P1|Overall Study|No longer willing to participate|8
2905664|NCT01701362|10005880|P2|Overall Study|Protocol Violation|3
2905665|NCT01701362|10005881|P1|Overall Study|Protocol Violation|5
2905666|NCT01701362|10005880|P2|Overall Study|Adverse events related to study drug|10
2905667|NCT01701362|10005881|P1|Overall Study|Adverse events related to study drug|12
2905668|NCT01701362|10005880|P2|Overall Study|Adverse events not related to study drug|6
2905669|NCT01701362|10005881|P1|Overall Study|Adverse events not related to study drug|1
2905670|NCT01701258|10005919|P13|Assessment and Scheduling|Investigator Terminated|0
2905671|NCT01701258|10005920|P12|Assessment and Scheduling|Investigator Terminated|0
2905672|NCT01701258|10005921|P11|Assessment and Scheduling|Investigator Terminated|0
2905673|NCT01701258|10005922|P10|Assessment and Scheduling|Investigator Terminated|0
2905674|NCT01701258|10005923|P9|Assessment and Scheduling|Investigator Terminated|0
2905675|NCT01701258|10005924|P8|Assessment and Scheduling|Investigator Terminated|0
2905676|NCT01701258|10005925|P7|Assessment and Scheduling|Investigator Terminated|0
2905677|NCT01701258|10005926|P6|Assessment and Scheduling|Investigator Terminated|0
2905678|NCT01701258|10005927|P5|Assessment and Scheduling|Investigator Terminated|0
2905679|NCT01701258|10005928|P4|Assessment and Scheduling|Investigator Terminated|0
2905680|NCT01701258|10005929|P3|Assessment and Scheduling|Investigator Terminated|0
2905681|NCT01701258|10005930|P2|Assessment and Scheduling|Investigator Terminated|0
2905682|NCT01701258|10005931|P1|Assessment and Scheduling|Investigator Terminated|2
2905683|NCT01701258|10005919|P13|Assessment and Scheduling|Withdrawal by Subject|0
2905684|NCT01701258|10005920|P12|Assessment and Scheduling|Withdrawal by Subject|0
2905685|NCT01701258|10005921|P11|Assessment and Scheduling|Withdrawal by Subject|0
2905686|NCT01701258|10005922|P10|Assessment and Scheduling|Withdrawal by Subject|0
2905687|NCT01701258|10005923|P9|Assessment and Scheduling|Withdrawal by Subject|0
2905688|NCT01701258|10005924|P8|Assessment and Scheduling|Withdrawal by Subject|0
2905689|NCT01701258|10005925|P7|Assessment and Scheduling|Withdrawal by Subject|0
2905690|NCT01701258|10005926|P6|Assessment and Scheduling|Withdrawal by Subject|0
2905691|NCT01701258|10005927|P5|Assessment and Scheduling|Withdrawal by Subject|0
2905692|NCT01701258|10005928|P4|Assessment and Scheduling|Withdrawal by Subject|0
2905693|NCT01701258|10005929|P3|Assessment and Scheduling|Withdrawal by Subject|0
2905694|NCT01701258|10005930|P2|Assessment and Scheduling|Withdrawal by Subject|0
2905695|NCT01701258|10005931|P1|Assessment and Scheduling|Withdrawal by Subject|14
2905696|NCT01701258|10005919|P13|Assessment and Scheduling|Lost to Follow-up|0
2905697|NCT01701258|10005920|P12|Assessment and Scheduling|Lost to Follow-up|0
2905698|NCT01701258|10005921|P11|Assessment and Scheduling|Lost to Follow-up|0
2905699|NCT01701258|10005922|P10|Assessment and Scheduling|Lost to Follow-up|0
2905700|NCT01701258|10005923|P9|Assessment and Scheduling|Lost to Follow-up|0
2905701|NCT01701258|10005924|P8|Assessment and Scheduling|Lost to Follow-up|0
2905702|NCT01701258|10005925|P7|Assessment and Scheduling|Lost to Follow-up|0
2905703|NCT01701258|10005926|P6|Assessment and Scheduling|Lost to Follow-up|0
2905704|NCT01701258|10005927|P5|Assessment and Scheduling|Lost to Follow-up|0
2905705|NCT01701258|10005928|P4|Assessment and Scheduling|Lost to Follow-up|0
2905706|NCT01701258|10005929|P3|Assessment and Scheduling|Lost to Follow-up|0
2905707|NCT01701258|10005930|P2|Assessment and Scheduling|Lost to Follow-up|0
2905708|NCT01701258|10005931|P1|Assessment and Scheduling|Lost to Follow-up|10
2905709|NCT01701258|10005919|P13|Assessment and Scheduling|Found to be Ineligible|0
2905710|NCT01701258|10005920|P12|Assessment and Scheduling|Found to be Ineligible|0
2905711|NCT01701258|10005921|P11|Assessment and Scheduling|Found to be Ineligible|0
2905712|NCT01701258|10005922|P10|Assessment and Scheduling|Found to be Ineligible|0
2905713|NCT01701258|10005923|P9|Assessment and Scheduling|Found to be Ineligible|0
2905714|NCT01701258|10005924|P8|Assessment and Scheduling|Found to be Ineligible|0
2905715|NCT01701258|10005925|P7|Assessment and Scheduling|Found to be Ineligible|0
2905716|NCT01701258|10005926|P6|Assessment and Scheduling|Found to be Ineligible|0
2905717|NCT01701258|10005927|P5|Assessment and Scheduling|Found to be Ineligible|0
2905718|NCT01701258|10005928|P4|Assessment and Scheduling|Found to be Ineligible|0
2905719|NCT01701258|10005929|P3|Assessment and Scheduling|Found to be Ineligible|0
2905720|NCT01701258|10005930|P2|Assessment and Scheduling|Found to be Ineligible|0
2905721|NCT01701258|10005931|P1|Assessment and Scheduling|Found to be Ineligible|57
2905722|NCT01701245|10005985|P2|Overall Study|Did not complete the open label period|12
2905723|NCT01701245|10005986|P1|Overall Study|Did not complete the open label period|11
2905724|NCT01701245|10005985|P2|Overall Study|Protocol Violation|3
2905725|NCT01701245|10005986|P1|Overall Study|Protocol Violation|1
2905726|NCT01701063|10006033|P3|Overall Study|Other|1
2905727|NCT01701063|10006034|P2|Overall Study|Other|0
2905728|NCT01701063|10006035|P1|Overall Study|Other|0
2905729|NCT01701063|10006033|P3|Overall Study|Withdrawal by Subject|1
2905730|NCT01701063|10006034|P2|Overall Study|Withdrawal by Subject|0
2905731|NCT01701063|10006035|P1|Overall Study|Withdrawal by Subject|0
2905732|NCT01701063|10006033|P3|Overall Study|Lost to Follow-up|0
2905733|NCT01701063|10006034|P2|Overall Study|Lost to Follow-up|1
2905734|NCT01701063|10006035|P1|Overall Study|Lost to Follow-up|0
2905735|NCT01700985|10006119|P2|Overall Study|Incarcerated|1
2905736|NCT01700985|10006120|P1|Overall Study|Incarcerated|0
2905737|NCT01700959|10006142|P6|Overall Study|Side effects|1
2905738|NCT01700959|10006143|P5|Overall Study|Side effects|4
2905739|NCT01700959|10006144|P4|Overall Study|Side effects|4
2905740|NCT01700959|10006145|P3|Overall Study|Side effects|8
2905741|NCT01700959|10006146|P2|Overall Study|Side effects|4
2905742|NCT01700959|10006147|P1|Overall Study|Side effects|1
2905743|NCT01700959|10006142|P6|Overall Study|Noncompliant|9
2905744|NCT01700959|10006143|P5|Overall Study|Noncompliant|15
2905745|NCT01700959|10006144|P4|Overall Study|Noncompliant|18
2905746|NCT01700959|10006145|P3|Overall Study|Noncompliant|17
2905747|NCT01700959|10006146|P2|Overall Study|Noncompliant|9
2905748|NCT01700959|10006147|P1|Overall Study|Noncompliant|9
2905749|NCT01700959|10006142|P6|Overall Study|Ineligible|1
2905750|NCT01700959|10006143|P5|Overall Study|Ineligible|0
2905751|NCT01700959|10006144|P4|Overall Study|Ineligible|0
2905752|NCT01700959|10006145|P3|Overall Study|Ineligible|2
2905753|NCT01700959|10006146|P2|Overall Study|Ineligible|1
2905754|NCT01700959|10006147|P1|Overall Study|Ineligible|2
2905755|NCT01700959|10006142|P6|Overall Study|Withdrawal by Subject|12
2905756|NCT01700959|10006143|P5|Overall Study|Withdrawal by Subject|8
2905757|NCT01700959|10006144|P4|Overall Study|Withdrawal by Subject|11
2905758|NCT01700959|10006145|P3|Overall Study|Withdrawal by Subject|12
2905759|NCT01700959|10006146|P2|Overall Study|Withdrawal by Subject|9
2905760|NCT01700959|10006147|P1|Overall Study|Withdrawal by Subject|15
2905761|NCT01700959|10006142|P6|Overall Study|Adverse Event|2
2905762|NCT01700959|10006143|P5|Overall Study|Adverse Event|0
2905763|NCT01700959|10006144|P4|Overall Study|Adverse Event|2
2905764|NCT01700959|10006145|P3|Overall Study|Adverse Event|1
2905765|NCT01700959|10006146|P2|Overall Study|Adverse Event|1
2905766|NCT01700959|10006147|P1|Overall Study|Adverse Event|0
2905767|NCT01700829|10006188|P2|Overall Study|Withdrawal by Subject|1
2905768|NCT01700829|10006189|P1|Overall Study|Withdrawal by Subject|1
2905769|NCT01700621|10006249|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
2905770|NCT01700621|10006250|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
2905771|NCT01700621|10006249|P2|Analyzed for Immunogenicity|Protocol Violation|1
2905772|NCT01700621|10006250|P1|Analyzed for Immunogenicity|Protocol Violation|5
2905773|NCT01700621|10006249|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
2905774|NCT01700621|10006250|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
2905775|NCT01700530|10006288|P3|Overall Study|Withdrawal by Subject|1
2905776|NCT01700530|10006289|P2|Overall Study|Withdrawal by Subject|3
2905777|NCT01700530|10006290|P1|Overall Study|Withdrawal by Subject|0
2905778|NCT01700387|10006339|P2|Overall Study|Lost to Follow-up|1
2905779|NCT01700387|10006340|P1|Overall Study|Lost to Follow-up|2
2905780|NCT01700387|10006339|P2|Overall Study|Adverse Event|1
2905781|NCT01700387|10006340|P1|Overall Study|Adverse Event|1
2905782|NCT01700387|10006339|P2|Overall Study|Withdrawal by Subject|2
2905783|NCT01700387|10006340|P1|Overall Study|Withdrawal by Subject|1
2905784|NCT01700348|10006350|P1|Overall Study|Lost to Follow-up|1
2905785|NCT01700348|10006350|P1|Overall Study|Withdrawal by Subject|22
2905786|NCT01700205|10006373|P2|Overall Study|Protocol Violation|2
2905787|NCT01700205|10006374|P1|Overall Study|Protocol Violation|2
2905788|NCT01700205|10006373|P2|Overall Study|Withdrawal by Subject|13
2905789|NCT01700205|10006374|P1|Overall Study|Withdrawal by Subject|13
2905790|NCT01700192|10006396|P2|Overall Study|Never received study drug|0
2905791|NCT01700192|10006397|P1|Overall Study|Never received study drug|1
2905792|NCT01700192|10006396|P2|Overall Study|Withdrawal by Subject|64
2905793|NCT01700192|10006397|P1|Overall Study|Withdrawal by Subject|56
2905794|NCT01700192|10006396|P2|Overall Study|Technical problems|1
2905795|NCT01700192|10006397|P1|Overall Study|Technical problems|0
2905796|NCT01700192|10006396|P2|Overall Study|Protocol Violation|4
2905797|NCT01700192|10006397|P1|Overall Study|Protocol Violation|3
2905798|NCT01700192|10006396|P2|Overall Study|Progressive disease|0
2905799|NCT01700192|10006397|P1|Overall Study|Progressive disease|1
2905800|NCT01700192|10006396|P2|Overall Study|Pregnancy|4
2905801|NCT01700192|10006397|P1|Overall Study|Pregnancy|1
2905802|NCT01700192|10006396|P2|Overall Study|Physician Decision|3
2905803|NCT01700192|10006397|P1|Overall Study|Physician Decision|2
2905804|NCT01700192|10006396|P2|Overall Study|Noncompliance with study drug|5
2905805|NCT01700192|10006397|P1|Overall Study|Noncompliance with study drug|0
2905806|NCT01700192|10006396|P2|Overall Study|Lost to Follow-up|29
2905807|NCT01700192|10006397|P1|Overall Study|Lost to Follow-up|42
2905808|NCT01700192|10006396|P2|Overall Study|Lack of Efficacy|0
2905809|NCT01700192|10006397|P1|Overall Study|Lack of Efficacy|1
2905810|NCT01700192|10006396|P2|Overall Study|Adverse Event|18
2905811|NCT01700192|10006397|P1|Overall Study|Adverse Event|73
2905812|NCT01700179|10006415|P1|Overall Study|Physician Decision|2
2905813|NCT01700140|10006422|P3|Overall Study|Inclusion/exclusion criteria deviation|0
2905814|NCT01700140|10006423|P2|Overall Study|Inclusion/exclusion criteria deviation|4
2905815|NCT01700140|10006424|P1|Overall Study|Inclusion/exclusion criteria deviation|1
2905816|NCT01700140|10006422|P3|Overall Study|Adverse Event|0
2905817|NCT01700140|10006423|P2|Overall Study|Adverse Event|1
2905818|NCT01700140|10006424|P1|Overall Study|Adverse Event|0
2905819|NCT01700140|10006422|P3|Overall Study|Aggravation of symptoms|0
2905820|NCT01700140|10006423|P2|Overall Study|Aggravation of symptoms|0
2905821|NCT01700140|10006424|P1|Overall Study|Aggravation of symptoms|1
2905822|NCT01700140|10006422|P3|Overall Study|Use of chemotherapy or surgical therapy|0
2905823|NCT01700140|10006423|P2|Overall Study|Use of chemotherapy or surgical therapy|1
2905824|NCT01700140|10006424|P1|Overall Study|Use of chemotherapy or surgical therapy|0
2905825|NCT01700140|10006422|P3|Overall Study|Discontinuation of radiotherapy|0
2905826|NCT01700140|10006423|P2|Overall Study|Discontinuation of radiotherapy|0
2905827|NCT01700140|10006424|P1|Overall Study|Discontinuation of radiotherapy|1
2905828|NCT01700140|10006422|P3|Overall Study|Use of rescue drugs|1
2905829|NCT01700140|10006423|P2|Overall Study|Use of rescue drugs|3
2905830|NCT01700140|10006424|P1|Overall Study|Use of rescue drugs|3
2905831|NCT01700049|10006456|P1|Overall Study|Withdrawal by Subject|1
2905832|NCT01699867|10006471|P1|Overall Study|Screening Failure|3
2905833|NCT01699815|10006478|P2|Overall Study|Adverse Event|1
2905834|NCT01699815|10006479|P1|Overall Study|Adverse Event|0
2905835|NCT01699815|10006478|P2|Overall Study|record could not be located|0
2905836|NCT01699815|10006479|P1|Overall Study|record could not be located|1
2905837|NCT01699815|10006478|P2|Overall Study|Protocol Violation|7
2905838|NCT01699815|10006479|P1|Overall Study|Protocol Violation|4
2905839|NCT01699789|10006491|P2|Overall Study|Lost to Follow-up|101
2905840|NCT01699789|10006492|P1|Overall Study|Lost to Follow-up|83
2905841|NCT01699789|10006491|P2|Overall Study|Death|2
2905842|NCT01699789|10006492|P1|Overall Study|Death|1
2905843|NCT01699789|10006491|P2|Overall Study|Withdrawal by Subject|23
2905844|NCT01699789|10006492|P1|Overall Study|Withdrawal by Subject|18
2905845|NCT01699750|10006562|P2|Overall Study|Other|2
2905846|NCT01699750|10006563|P1|Overall Study|Other|0
2905847|NCT01699750|10006562|P2|Overall Study|Withdrew Consent|1
2905848|NCT01699750|10006563|P1|Overall Study|Withdrew Consent|0
2905849|NCT01699685|10006598|P2|Period 2|Lost to Follow-up|0
2905850|NCT01699685|10006599|P1|Period 2|Lost to Follow-up|1
2905851|NCT01699685|10006598|P2|Period 1|Patient request|1
2905852|NCT01699685|10006599|P1|Period 1|Patient request|0
2905853|NCT01699685|10006598|P2|Period 1|Other|1
2905854|NCT01699685|10006599|P1|Period 1|Other|0
2905855|NCT01699685|10006598|P2|Period 1|Medical or ethical, noncompliance|0
2905856|NCT01699685|10006599|P1|Period 1|Medical or ethical, noncompliance|2
2905857|NCT01699685|10006598|P2|Period 1|Adverse Event|1
2905858|NCT01699685|10006599|P1|Period 1|Adverse Event|1
2905859|NCT01699503|10006625|P2|Overall Study|Excluded due to quality|791
2905860|NCT01699503|10006626|P1|Overall Study|Excluded due to quality|783
2905861|NCT01699503|10006625|P2|Overall Study|Lost to Follow-up|117
2905862|NCT01699503|10006626|P1|Overall Study|Lost to Follow-up|121
2905863|NCT01699503|10006625|P2|Overall Study|Withdrawal by Subject|57
2905864|NCT01699503|10006626|P1|Overall Study|Withdrawal by Subject|65
2905865|NCT01699503|10006625|P2|Overall Study|Death|40
2905866|NCT01699503|10006626|P1|Overall Study|Death|31
2905867|NCT01699178|10006651|P2|Overall Study|ineligible/noncompliant/ subject reason|4
2905868|NCT01699178|10006652|P1|Overall Study|ineligible/noncompliant/ subject reason|4
2905869|NCT01699178|10006651|P2|Overall Study|PSA increase of >1.4 ng/mL|3
2905870|NCT01699178|10006652|P1|Overall Study|PSA increase of >1.4 ng/mL|4
2905871|NCT01699178|10006651|P2|Overall Study|Hematocrit >54%|1
2905872|NCT01699178|10006652|P1|Overall Study|Hematocrit >54%|1
2905873|NCT01699178|10006651|P2|Overall Study|Withdrawal by Subject|12
2905874|NCT01699178|10006652|P1|Overall Study|Withdrawal by Subject|4
2905875|NCT01699178|10006651|P2|Overall Study|Physician Decision|0
2905876|NCT01699178|10006652|P1|Overall Study|Physician Decision|1
2905877|NCT01699178|10006651|P2|Overall Study|Non-compliance with Study Drug|1
2905878|NCT01699178|10006652|P1|Overall Study|Non-compliance with Study Drug|3
2905879|NCT01699178|10006651|P2|Overall Study|Lost to Follow-up|6
2905880|NCT01699178|10006652|P1|Overall Study|Lost to Follow-up|1
2905881|NCT01699178|10006651|P2|Overall Study|Adverse Event|5
2905882|NCT01699178|10006652|P1|Overall Study|Adverse Event|1
2905883|NCT01699087|10006668|P1|Overall Study|Unable to make future visits|2
2905884|NCT01699087|10006668|P1|Overall Study|Screen failure (prior to treatment)|15
2905885|NCT01699087|10006668|P1|Overall Study|Lost to Follow-up|7
2905886|NCT01699022|10006682|P1|Overall Study|Early discontinuation from the study|3
2905887|NCT01698814|10006697|P2|Overall Study|Randomized in error|0
2905888|NCT01698814|10006698|P1|Overall Study|Randomized in error|1
2905889|NCT01698814|10006697|P2|Overall Study|Pregnancy|0
2905890|NCT01698814|10006698|P1|Overall Study|Pregnancy|1
2905891|NCT01698814|10006697|P2|Overall Study|Lost to Follow-up|1
2905892|NCT01698814|10006698|P1|Overall Study|Lost to Follow-up|0
2905893|NCT01698814|10006697|P2|Overall Study|Adverse Event|2
2905894|NCT01698814|10006698|P1|Overall Study|Adverse Event|0
2905895|NCT01698801|10006704|P1|Follow Up Phase|Death|4
2905896|NCT01698801|10006704|P1|Follow Up Phase|Withdrawal by Subject|1
2905897|NCT01698801|10006704|P1|Treatment Phase|Disease progression|1
2905898|NCT01698801|10006704|P1|Treatment Phase|Withdrawal by Subject|1
2905899|NCT01698801|10006704|P1|Treatment Phase|Other|4
2905900|NCT01698801|10006704|P1|Treatment Phase|Protocol Violation|1
2905901|NCT01698801|10006704|P1|Treatment Phase|Adverse Event|4
2905902|NCT01698775|10006715|P2|Phase B|Withdrawal by Subject|2
2905903|NCT01698775|10006716|P1|Phase B|Withdrawal by Subject|6
2905904|NCT01698775|10006715|P2|Phase B|Protocol Violation|1
2905905|NCT01698775|10006716|P1|Phase B|Protocol Violation|1
2905906|NCT01698775|10006715|P2|Phase B|Physician Decision|1
2905907|NCT01698775|10006716|P1|Phase B|Physician Decision|1
2905908|NCT01698775|10006715|P2|Phase B|Lost to Follow-up|1
2905909|NCT01698775|10006716|P1|Phase B|Lost to Follow-up|0
2905910|NCT01698775|10006715|P2|Phase B|Lack of Efficacy|1
2905911|NCT01698775|10006716|P1|Phase B|Lack of Efficacy|0
2905912|NCT01698775|10006715|P2|Phase B|Death|1
2905913|NCT01698775|10006716|P1|Phase B|Death|0
2905914|NCT01698775|10006715|P2|Phase B|Adverse Event|3
2905915|NCT01698775|10006716|P1|Phase B|Adverse Event|6
2905916|NCT01698775|10006715|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
2905917|NCT01698775|10006716|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
2905918|NCT01698775|10006715|P2|Phase A|Kidney [transplant]|1
2905919|NCT01698775|10006716|P1|Phase A|Kidney [transplant]|0
2905920|NCT01698775|10006715|P2|Phase A|Withdrawal by Subject|4
2905921|NCT01698775|10006716|P1|Phase A|Withdrawal by Subject|3
2905922|NCT01698775|10006715|P2|Phase A|Protocol Violation|0
2905923|NCT01698775|10006716|P1|Phase A|Protocol Violation|1
2905924|NCT01698775|10006715|P2|Phase A|Lost to Follow-up|2
2905925|NCT01698775|10006716|P1|Phase A|Lost to Follow-up|1
2905926|NCT01698775|10006715|P2|Phase A|Lack of Efficacy|0
2905927|NCT01698775|10006716|P1|Phase A|Lack of Efficacy|1
2905928|NCT01698775|10006715|P2|Phase A|Death|1
2905929|NCT01698775|10006716|P1|Phase A|Death|1
2905930|NCT01698775|10006715|P2|Phase A|Adverse Event|1
2905931|NCT01698775|10006716|P1|Phase A|Adverse Event|2
2905932|NCT01698554|10006765|P4|Overall Study|Other Miscellaneous Reasons|0
2905933|NCT01698554|10006766|P3|Overall Study|Other Miscellaneous Reasons|0
2905934|NCT01698554|10006767|P2|Overall Study|Other Miscellaneous Reasons|0
2905935|NCT01698554|10006768|P1|Overall Study|Other Miscellaneous Reasons|1
2905936|NCT01698554|10006765|P4|Overall Study|Protocol Violation|0
2905937|NCT01698554|10006766|P3|Overall Study|Protocol Violation|1
2905938|NCT01698554|10006767|P2|Overall Study|Protocol Violation|0
2905939|NCT01698554|10006768|P1|Overall Study|Protocol Violation|2
2905940|NCT01698554|10006765|P4|Overall Study|Personal Reasons|1
2905941|NCT01698554|10006766|P3|Overall Study|Personal Reasons|1
2905942|NCT01698554|10006767|P2|Overall Study|Personal Reasons|5
2905943|NCT01698554|10006768|P1|Overall Study|Personal Reasons|0
2905944|NCT01698554|10006765|P4|Overall Study|Lost to Follow-up|0
2905945|NCT01698554|10006766|P3|Overall Study|Lost to Follow-up|0
2905946|NCT01698554|10006767|P2|Overall Study|Lost to Follow-up|0
2905947|NCT01698554|10006768|P1|Overall Study|Lost to Follow-up|1
2905948|NCT01698554|10006765|P4|Overall Study|Adverse Event|1
2905949|NCT01698554|10006766|P3|Overall Study|Adverse Event|0
2905950|NCT01698554|10006767|P2|Overall Study|Adverse Event|5
2905951|NCT01698554|10006768|P1|Overall Study|Adverse Event|2
2905952|NCT01698320|10006838|P3|40-Week Open-Label Period|Lost to Follow-up|0
2905953|NCT01698320|10006839|P2|40-Week Open-Label Period|Lost to Follow-up|2
2905954|NCT01698320|10006840|P1|40-Week Open-Label Period|Lost to Follow-up|0
2905955|NCT01698320|10006838|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2905956|NCT01698320|10006839|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
2905957|NCT01698320|10006840|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2905958|NCT01698320|10006838|P3|40-Week Open-Label Period|Pregnancy|1
2905959|NCT01698320|10006839|P2|40-Week Open-Label Period|Pregnancy|2
2905960|NCT01698320|10006840|P1|40-Week Open-Label Period|Pregnancy|0
2905961|NCT01698320|10006838|P3|40-Week Open-Label Period|Withdrawal by Subject|7
2905962|NCT01698320|10006839|P2|40-Week Open-Label Period|Withdrawal by Subject|11
2905963|NCT01698320|10006840|P1|40-Week Open-Label Period|Withdrawal by Subject|0
2905964|NCT01698320|10006838|P3|40-Week Open-Label Period|Adverse Event|2
2905965|NCT01698320|10006839|P2|40-Week Open-Label Period|Adverse Event|3
2905966|NCT01698320|10006840|P1|40-Week Open-Label Period|Adverse Event|0
2905967|NCT01698320|10006838|P3|12-Week Double-Blind Period|Lost to Follow-up|4
2905968|NCT01698320|10006839|P2|12-Week Double-Blind Period|Lost to Follow-up|0
2905969|NCT01698320|10006840|P1|12-Week Double-Blind Period|Lost to Follow-up|0
2905970|NCT01698320|10006838|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
2905971|NCT01698320|10006839|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2905972|NCT01698320|10006840|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2905973|NCT01698320|10006838|P3|12-Week Double-Blind Period|Pregnancy|1
2905974|NCT01698320|10006839|P2|12-Week Double-Blind Period|Pregnancy|1
2905975|NCT01698320|10006840|P1|12-Week Double-Blind Period|Pregnancy|0
2905976|NCT01698320|10006838|P3|12-Week Double-Blind Period|Protocol Violation|2
2905977|NCT01698320|10006839|P2|12-Week Double-Blind Period|Protocol Violation|0
2905978|NCT01698320|10006840|P1|12-Week Double-Blind Period|Protocol Violation|0
2905979|NCT01698320|10006838|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
2905980|NCT01698320|10006839|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
2905981|NCT01698320|10006840|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
2905982|NCT01698320|10006838|P3|12-Week Double-Blind Period|Adverse Event|1
2905983|NCT01698320|10006839|P2|12-Week Double-Blind Period|Adverse Event|1
2905984|NCT01698320|10006840|P1|12-Week Double-Blind Period|Adverse Event|0
2905985|NCT01698320|10006838|P3|Run-In Period (Week -1 to Day 0)|Other|0
2905986|NCT01698320|10006839|P2|Run-In Period (Week -1 to Day 0)|Other|0
2905987|NCT01698320|10006840|P1|Run-In Period (Week -1 to Day 0)|Other|1
2905988|NCT01698320|10006838|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2905989|NCT01698320|10006839|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2905990|NCT01698320|10006840|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
2905991|NCT01698320|10006838|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2905992|NCT01698320|10006839|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2905993|NCT01698320|10006840|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
2905994|NCT01698320|10006838|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2905995|NCT01698320|10006839|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2905996|NCT01698320|10006840|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
2905997|NCT01698268|10006860|P2|Overall Study|Physician Decision|1
2905998|NCT01698268|10006861|P1|Overall Study|Physician Decision|2
2905999|NCT01698008|10006869|P2|Overall Study|Withdrawal by Subject|2
2906000|NCT01698008|10006870|P1|Overall Study|Withdrawal by Subject|1
2906001|NCT01697969|10006876|P1|Overall Study|Did not meet inc/exc criteria|3
2906002|NCT01697956|10006883|P2|Overall Study|Protocol Violation|1
2906003|NCT01697956|10006884|P1|Overall Study|Protocol Violation|1
2906004|NCT01697800|10006914|P2|Overall Study|Death|1
2906005|NCT01697800|10006915|P1|Overall Study|Death|0
2906006|NCT01697748|10006923|P2|Overall Study|Lost to Follow-up|65
2906007|NCT01697748|10006924|P1|Overall Study|Lost to Follow-up|53
2906008|NCT01697748|10006923|P2|Overall Study|ineligible uterine incision|1
2906009|NCT01697748|10006924|P1|Overall Study|ineligible uterine incision|4
2906010|NCT01697748|10006923|P2|Overall Study|ineligible skin incision|2
2906011|NCT01697748|10006924|P1|Overall Study|ineligible skin incision|1
2906012|NCT01697696|10006953|P2|Overall Study|Subject/guardian decision|35
2906013|NCT01697696|10006954|P1|Overall Study|Subject/guardian decision|31
2906014|NCT01697696|10006953|P2|Overall Study|Lost to Follow-up|7
2906015|NCT01697696|10006954|P1|Overall Study|Lost to Follow-up|10
2906016|NCT01697696|10006953|P2|Overall Study|Death|2
2906017|NCT01697696|10006954|P1|Overall Study|Death|4
2906018|NCT01697696|10006953|P2|Overall Study|Physician Decision|0
2906019|NCT01697696|10006954|P1|Overall Study|Physician Decision|1
2906020|NCT01697696|10006953|P2|Overall Study|Protocol deviation|0
2906021|NCT01697696|10006954|P1|Overall Study|Protocol deviation|1
2906022|NCT01697696|10006953|P2|Overall Study|Study terminated by sponsor|3
2906023|NCT01697696|10006954|P1|Overall Study|Study terminated by sponsor|0
2906024|NCT01697592|10006986|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
2906025|NCT01697592|10006987|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
2906026|NCT01697592|10006988|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
2906027|NCT01697592|10006989|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
2906028|NCT01697592|10006990|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
2906029|NCT01697592|10006991|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
2906030|NCT01697592|10006992|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
2906031|NCT01697592|10006993|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
2906032|NCT01697592|10006994|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
2906033|NCT01697592|10006995|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
2906034|NCT01697592|10006986|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906035|NCT01697592|10006987|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906036|NCT01697592|10006988|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2906037|NCT01697592|10006989|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906038|NCT01697592|10006990|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2906039|NCT01697592|10006991|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906040|NCT01697592|10006992|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906041|NCT01697592|10006993|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906042|NCT01697592|10006994|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2906043|NCT01697592|10006995|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
2906044|NCT01697592|10006986|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
2906045|NCT01697592|10006987|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
2906046|NCT01697592|10006988|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
2906047|NCT01697592|10006989|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
2906048|NCT01697592|10006990|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
2906049|NCT01697592|10006991|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
2906050|NCT01697592|10006992|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
2906051|NCT01697592|10006993|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
2906052|NCT01697592|10006994|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
2906053|NCT01697592|10006995|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
2906054|NCT01697592|10006986|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
2906055|NCT01697592|10006987|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
2906056|NCT01697592|10006988|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
2906057|NCT01697592|10006989|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
2906058|NCT01697592|10006990|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
2906059|NCT01697592|10006991|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
2906060|NCT01697592|10006992|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
2906061|NCT01697592|10006993|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
2906062|NCT01697592|10006994|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
2906063|NCT01697592|10006995|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
2906064|NCT01697592|10006986|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2906065|NCT01697592|10006987|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906066|NCT01697592|10006988|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906067|NCT01697592|10006989|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2906068|NCT01697592|10006990|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906069|NCT01697592|10006991|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906070|NCT01697592|10006992|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906071|NCT01697592|10006993|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2906072|NCT01697592|10006994|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2906073|NCT01697592|10006995|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2906074|NCT01697592|10006986|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906075|NCT01697592|10006987|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906076|NCT01697592|10006988|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906077|NCT01697592|10006989|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906078|NCT01697592|10006990|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906079|NCT01697592|10006991|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906080|NCT01697592|10006992|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906081|NCT01697592|10006993|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906082|NCT01697592|10006994|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
2906083|NCT01697592|10006995|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
2906084|NCT01697592|10006986|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
2906085|NCT01697592|10006987|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
2906086|NCT01697592|10006988|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
2906087|NCT01697592|10006989|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
2906088|NCT01697592|10006990|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
2906089|NCT01697592|10006991|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
2906090|NCT01697592|10006992|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
2906091|NCT01697592|10006993|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
2906092|NCT01697592|10006994|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
2906093|NCT01697592|10006995|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
2906094|NCT01697592|10006986|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906095|NCT01697592|10006987|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906096|NCT01697592|10006988|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906097|NCT01697592|10006989|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906098|NCT01697592|10006990|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906099|NCT01697592|10006991|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906100|NCT01697592|10006992|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906101|NCT01697592|10006993|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906102|NCT01697592|10006994|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2906103|NCT01697592|10006995|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
2906104|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
2906105|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906106|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906107|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906108|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906109|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906110|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2906111|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
2906112|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
2906113|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2906114|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2906115|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2906116|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2906117|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2906118|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Participant Moved|2
2906119|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Participant Moved|0
2906120|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Participant Moved|0
2906121|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Participant Moved|0
2906122|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Participant Moved|0
2906123|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Participant Moved|0
2906124|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Participant Moved|0
2906125|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Technical Problems|1
2906126|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Technical Problems|0
2906127|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Technical Problems|0
2906128|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Technical Problems|0
2906129|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Technical Problems|0
2906130|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Technical Problems|0
2906131|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Technical Problems|0
2906132|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
2906133|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906134|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906135|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906136|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906137|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906138|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2906139|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
2906140|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
2906141|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2906142|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2906143|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2906144|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2906145|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2906146|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
2906147|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
2906148|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2906149|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2906150|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2906151|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2906152|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2906153|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906154|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
2906155|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906156|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906157|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906158|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906159|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2906160|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
2906161|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
2906162|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
2906163|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
2906164|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
2906165|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
2906166|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
2906167|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
2906168|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
2906169|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
2906170|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
2906171|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
2906172|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
2906173|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
2906174|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Physician Decision|11
2906175|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Physician Decision|7
2906176|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Physician Decision|0
2906177|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Physician Decision|0
2906178|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Physician Decision|0
2906179|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Physician Decision|0
2906180|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Physician Decision|0
2906181|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
2906182|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
2906183|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2906184|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2906185|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2906186|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2906187|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2906188|NCT01697579|10007064|P7|Optional Extension-Cycles 2-6|Death|2
2906189|NCT01697579|10007065|P6|Optional Extension-Cycles 2-6|Death|0
2906190|NCT01697579|10007066|P5|Optional Extension-Cycles 2-6|Death|0
2906191|NCT01697579|10007067|P4|Optional Extension-Cycles 2-6|Death|0
2906192|NCT01697579|10007068|P3|Optional Extension-Cycles 2-6|Death|0
2906193|NCT01697579|10007069|P2|Optional Extension-Cycles 2-6|Death|0
2906194|NCT01697579|10007070|P1|Optional Extension-Cycles 2-6|Death|0
2906195|NCT01697579|10007064|P7|Base Study-Cycle 1|Technical Problems|0
2906196|NCT01697579|10007065|P6|Base Study-Cycle 1|Technical Problems|0
2906197|NCT01697579|10007066|P5|Base Study-Cycle 1|Technical Problems|0
2906198|NCT01697579|10007067|P4|Base Study-Cycle 1|Technical Problems|1
2906199|NCT01697579|10007068|P3|Base Study-Cycle 1|Technical Problems|1
2906200|NCT01697579|10007069|P2|Base Study-Cycle 1|Technical Problems|0
2906201|NCT01697579|10007070|P1|Base Study-Cycle 1|Technical Problems|0
2906202|NCT01697579|10007064|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906203|NCT01697579|10007065|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906204|NCT01697579|10007066|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906205|NCT01697579|10007067|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906206|NCT01697579|10007068|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906207|NCT01697579|10007069|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
2906208|NCT01697579|10007070|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2906209|NCT01697579|10007064|P7|Base Study-Cycle 1|Protocol Violation|0
2906210|NCT01697579|10007065|P6|Base Study-Cycle 1|Protocol Violation|0
2906211|NCT01697579|10007066|P5|Base Study-Cycle 1|Protocol Violation|3
2906212|NCT01697579|10007067|P4|Base Study-Cycle 1|Protocol Violation|0
2906213|NCT01697579|10007068|P3|Base Study-Cycle 1|Protocol Violation|0
2906214|NCT01697579|10007069|P2|Base Study-Cycle 1|Protocol Violation|0
2906215|NCT01697579|10007070|P1|Base Study-Cycle 1|Protocol Violation|0
2906216|NCT01697579|10007064|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906217|NCT01697579|10007065|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906218|NCT01697579|10007066|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906219|NCT01697579|10007067|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906220|NCT01697579|10007068|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906221|NCT01697579|10007069|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2906222|NCT01697579|10007070|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
2906223|NCT01697579|10007064|P7|Base Study-Cycle 1|Adverse Event|0
2906224|NCT01697579|10007065|P6|Base Study-Cycle 1|Adverse Event|0
2906225|NCT01697579|10007066|P5|Base Study-Cycle 1|Adverse Event|0
2906226|NCT01697579|10007067|P4|Base Study-Cycle 1|Adverse Event|0
2906227|NCT01697579|10007068|P3|Base Study-Cycle 1|Adverse Event|0
2906228|NCT01697579|10007069|P2|Base Study-Cycle 1|Adverse Event|0
2906229|NCT01697579|10007070|P1|Base Study-Cycle 1|Adverse Event|1
2906230|NCT01697501|10007182|P1|Overall Study|Protocol Violation|2
2906231|NCT01697462|10007225|P1|Overall Study|Missing|5
2906232|NCT01697462|10007225|P1|Overall Study|Other|10
2906233|NCT01697462|10007225|P1|Overall Study|Death|1
2906234|NCT01697462|10007225|P1|Overall Study|Investigator Decision|21
2906235|NCT01697462|10007225|P1|Overall Study|Withdrawal by Subject|12
2906236|NCT01697462|10007225|P1|Overall Study|Lost to Follow-up|21
2906237|NCT01697462|10007225|P1|Overall Study|Adverse Event|6
2906238|NCT01697462|10007225|P1|Overall Study|Disease Progression|1
2906239|NCT01697449|10007232|P1|Overall Study|Missing|25
2906240|NCT01697449|10007232|P1|Overall Study|Other|1
2906241|NCT01697449|10007232|P1|Overall Study|Death|2
2906242|NCT01697449|10007232|P1|Overall Study|Physician Decision|1
2906243|NCT01697449|10007232|P1|Overall Study|Withdrawal by Subject|2
2906244|NCT01697449|10007232|P1|Overall Study|Lost to Follow-up|5
2906245|NCT01697449|10007232|P1|Overall Study|Adverse Event|7
2906246|NCT01697449|10007232|P1|Overall Study|Disease progression|47
2906247|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
2906248|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
2906249|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
2906250|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
2906251|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Death|1
2906252|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Death|1
2906253|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2906254|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2906255|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
2906256|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
2906257|NCT01697358|10007243|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
2906258|NCT01697358|10007244|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
2906259|NCT01697358|10007243|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
2906260|NCT01697358|10007244|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
2906261|NCT01697358|10007243|P2|Period I: Randomization to 6 Months|Adverse Event|1
2906262|NCT01697358|10007244|P1|Period I: Randomization to 6 Months|Adverse Event|1
2906263|NCT01697358|10007243|P2|Period I: Randomization to 6 Months|Physician Decision|0
2906264|NCT01697358|10007244|P1|Period I: Randomization to 6 Months|Physician Decision|4
2906265|NCT01697358|10007243|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
2906266|NCT01697358|10007244|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
2906267|NCT01697345|10007260|P1|Overall Study|Withdrawal by Subject|1
2906268|NCT01697319|10007285|P1|Extension Phase|Terminated by Sponsor|15
2906269|NCT01697319|10007285|P1|Primary Phase|Withdrawal by Subject|1
2906270|NCT01696994|10007294|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
2906271|NCT01696994|10007295|P1|Overall Study|Refused Screen (Ovarian Screening)|0
2906272|NCT01696994|10007294|P2|Overall Study|Refused ASU (Control)|0
2906273|NCT01696994|10007295|P1|Overall Study|Refused ASU (Control)|311
2906274|NCT01696994|10007294|P2|Overall Study|No Ovaries at Baseline|4851
2906275|NCT01696994|10007295|P1|Overall Study|No Ovaries at Baseline|4807
2906276|NCT01696994|10007294|P2|Overall Study|Died Before ASU (Control)|0
2906277|NCT01696994|10007295|P1|Overall Study|Died Before ASU (Control)|73
2906278|NCT01696994|10007294|P2|Overall Study|Died Before Randomization|2
2906279|NCT01696994|10007295|P1|Overall Study|Died Before Randomization|1
2906280|NCT01696994|10007294|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
2906281|NCT01696994|10007295|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
2906282|NCT01696981|10007323|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
2906283|NCT01696981|10007324|P1|Overall Study|Refused Screen (Colorectal Screening)|0
2906284|NCT01696981|10007323|P2|Overall Study|Refused ASU (Control)|0
2906285|NCT01696981|10007324|P1|Overall Study|Refused ASU (Control)|920
2906286|NCT01696981|10007323|P2|Overall Study|Died Before ASU (Control)|0
2906287|NCT01696981|10007324|P1|Overall Study|Died Before ASU (Control)|278
2906288|NCT01696981|10007323|P2|Overall Study|Died Before Randomization|8
2906289|NCT01696981|10007324|P1|Overall Study|Died Before Randomization|3
2906290|NCT01696981|10007323|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
2906291|NCT01696981|10007324|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
2906292|NCT01696968|10007344|P2|Overall Study|Refused Screen (Lung Screening)|6796
2906293|NCT01696968|10007345|P1|Overall Study|Refused Screen (Lung Screening)|0
2906294|NCT01696968|10007344|P2|Overall Study|Refused ASU (Control)|0
2906295|NCT01696968|10007345|P1|Overall Study|Refused ASU (Control)|920
2906296|NCT01696968|10007344|P2|Overall Study|Died Before ASU (Control)|0
2906297|NCT01696968|10007345|P1|Overall Study|Died Before ASU (Control)|278
2906298|NCT01696968|10007344|P2|Overall Study|Died Before Randomization|8
2906299|NCT01696968|10007345|P1|Overall Study|Died Before Randomization|3
2906300|NCT01696968|10007344|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
2906301|NCT01696968|10007345|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
2906302|NCT01696955|10007367|P2|Main Study|Withdrawal by Subject|1
2906303|NCT01696955|10007368|P1|Main Study|Withdrawal by Subject|1
2906304|NCT01696955|10007367|P2|Main Study|Protocol Violation|0
2906305|NCT01696955|10007368|P1|Main Study|Protocol Violation|1
2906306|NCT01696942|10007393|P2|Overall Study|screen failure|1
2906307|NCT01696942|10007394|P1|Overall Study|screen failure|0
2906308|NCT01696942|10007393|P2|Overall Study|Protocol Violation|2
2906309|NCT01696942|10007394|P1|Overall Study|Protocol Violation|1
2906310|NCT01696942|10007393|P2|Overall Study|Withdrawal by Subject|0
2906311|NCT01696942|10007394|P1|Overall Study|Withdrawal by Subject|1
2906312|NCT01696929|10007402|P1|Overall Study|Physician Decision|1
2906313|NCT01696877|10007409|P2|Overall Study|Adverse Event|1
2906314|NCT01696877|10007410|P1|Overall Study|Adverse Event|0
2906315|NCT01696773|10007432|P2|Days 15-27, Washout|Adverse Event|0
2906316|NCT01696773|10007433|P1|Days 15-27, Washout|Adverse Event|1
2906317|NCT01696695|10007460|P1|Overall Study|Major Protocol Violation|192
2906318|NCT01696695|10007460|P1|Overall Study|Other|74
2906319|NCT01696695|10007460|P1|Overall Study|Lost to Follow-up|48
2906320|NCT01696695|10007460|P1|Overall Study|Withdrawal by Subject|92
2906321|NCT01696695|10007460|P1|Overall Study|Adverse Event|74
2906322|NCT01696695|10007460|P1|Overall Study|Death|29
2906323|NCT01696695|10007460|P1|Overall Study|Disease progression|373
2906324|NCT01696643|10007472|P2|Overall Study|Participant Did Not Receive Study Drug|2
2906325|NCT01696643|10007473|P1|Overall Study|Participant Did Not Receive Study Drug|2
2906326|NCT01696643|10007472|P2|Overall Study|Medical Monitor Decision|2
2906327|NCT01696643|10007473|P1|Overall Study|Medical Monitor Decision|0
2906328|NCT01696643|10007472|P2|Overall Study|Participant Incarcerated|1
2906329|NCT01696643|10007473|P1|Overall Study|Participant Incarcerated|0
2906330|NCT01696643|10007472|P2|Overall Study|Site Error|1
2906331|NCT01696643|10007473|P1|Overall Study|Site Error|2
2906332|NCT01696643|10007472|P2|Overall Study|Participant on Restricted Bed Rest|0
2906333|NCT01696643|10007473|P1|Overall Study|Participant on Restricted Bed Rest|1
2906334|NCT01696643|10007472|P2|Overall Study|Withdrawal by Subject|149
2906335|NCT01696643|10007473|P1|Overall Study|Withdrawal by Subject|142
2906336|NCT01696643|10007472|P2|Overall Study|Study Terminated by Sponsor|294
2906337|NCT01696643|10007473|P1|Overall Study|Study Terminated by Sponsor|286
2906338|NCT01696643|10007472|P2|Overall Study|Protocol Violation|7
2906339|NCT01696643|10007473|P1|Overall Study|Protocol Violation|7
2906340|NCT01696643|10007472|P2|Overall Study|Pregnancy|1
2906341|NCT01696643|10007473|P1|Overall Study|Pregnancy|0
2906342|NCT01696643|10007472|P2|Overall Study|Physician Decision|2
2906343|NCT01696643|10007473|P1|Overall Study|Physician Decision|3
2906344|NCT01696643|10007472|P2|Overall Study|Lost to Follow-up|67
2906345|NCT01696643|10007473|P1|Overall Study|Lost to Follow-up|67
2906346|NCT01696643|10007472|P2|Overall Study|Lack of Efficacy|0
2906347|NCT01696643|10007473|P1|Overall Study|Lack of Efficacy|3
2906348|NCT01696643|10007472|P2|Overall Study|Death|2
2906349|NCT01696643|10007473|P1|Overall Study|Death|1
2906350|NCT01696643|10007472|P2|Overall Study|Adverse Event|7
2906351|NCT01696643|10007473|P1|Overall Study|Adverse Event|15
2906352|NCT01696396|10007492|P4|Overall Study|Death|0
2906353|NCT01696396|10007493|P3|Overall Study|Death|1
2906354|NCT01696396|10007494|P2|Overall Study|Death|0
2906355|NCT01696396|10007495|P1|Overall Study|Death|0
2906356|NCT01696396|10007492|P4|Overall Study|Lost to Follow-up|1
2906357|NCT01696396|10007493|P3|Overall Study|Lost to Follow-up|4
2906358|NCT01696396|10007494|P2|Overall Study|Lost to Follow-up|1
2906359|NCT01696396|10007495|P1|Overall Study|Lost to Follow-up|9
2906360|NCT01696396|10007492|P4|Overall Study|Decision by Sponsor|2
2906361|NCT01696396|10007493|P3|Overall Study|Decision by Sponsor|2
2906362|NCT01696396|10007494|P2|Overall Study|Decision by Sponsor|1
2906363|NCT01696396|10007495|P1|Overall Study|Decision by Sponsor|3
2906364|NCT01696396|10007492|P4|Overall Study|Withdrawal by Subject|11
2906365|NCT01696396|10007493|P3|Overall Study|Withdrawal by Subject|19
2906366|NCT01696396|10007494|P2|Overall Study|Withdrawal by Subject|5
2906367|NCT01696396|10007495|P1|Overall Study|Withdrawal by Subject|19
2906368|NCT01696279|10007546|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
2906369|NCT01696279|10007547|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2906370|NCT01696279|10007548|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2906371|NCT01696279|10007549|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2906372|NCT01696279|10007546|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
2906373|NCT01696279|10007547|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2906374|NCT01696279|10007548|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2906375|NCT01696279|10007549|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2906376|NCT01696279|10007546|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
2906377|NCT01696279|10007547|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2906378|NCT01696279|10007548|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2906379|NCT01696279|10007549|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2906380|NCT01696279|10007546|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2906381|NCT01696279|10007547|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
2906382|NCT01696279|10007548|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2906383|NCT01696279|10007549|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2906384|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2906385|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2906386|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
2906387|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2906388|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2906389|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2906390|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
2906391|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2906392|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2906393|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2906394|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
2906395|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2906396|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2906397|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2906398|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
2906399|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2906400|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2906401|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2906402|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
2906403|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2906404|NCT01696279|10007546|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2906405|NCT01696279|10007547|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2906406|NCT01696279|10007548|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
2906407|NCT01696279|10007549|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2906408|NCT01696279|10007546|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2906409|NCT01696279|10007547|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2906410|NCT01696279|10007548|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2906411|NCT01696279|10007549|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
2906412|NCT01696214|10007587|P4|Overall Study|Lost to Follow-up|0
2906413|NCT01696214|10007588|P3|Overall Study|Lost to Follow-up|0
2906414|NCT01696214|10007589|P2|Overall Study|Lost to Follow-up|0
2906415|NCT01696214|10007590|P1|Overall Study|Lost to Follow-up|1
2906416|NCT01696188|10007610|P2|Overall Study|Protocol Violation|1
2906417|NCT01696188|10007611|P1|Overall Study|Protocol Violation|1
2906418|NCT01696071|10007642|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
2906419|NCT01696071|10007643|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
2906420|NCT01696058|10007671|P2|Overall Study|Other reason prematurely discontinued|3
2906421|NCT01696058|10007672|P1|Overall Study|Other reason prematurely discontinued|5
2906422|NCT01696058|10007671|P2|Overall Study|Withdrawal by Subject|6
2906423|NCT01696058|10007672|P1|Overall Study|Withdrawal by Subject|4
2906424|NCT01696058|10007671|P2|Overall Study|Lost to Follow-up|5
2906425|NCT01696058|10007672|P1|Overall Study|Lost to Follow-up|2
2906426|NCT01696058|10007671|P2|Overall Study|Protocol Violation|3
2906427|NCT01696058|10007672|P1|Overall Study|Protocol Violation|9
2906428|NCT01696058|10007671|P2|Overall Study|Lack of Efficacy|3
2906429|NCT01696058|10007672|P1|Overall Study|Lack of Efficacy|2
2906430|NCT01696058|10007671|P2|Overall Study|Adverse Event|11
2906431|NCT01696058|10007672|P1|Overall Study|Adverse Event|21
2906432|NCT01696045|10007700|P2|Overall Study|Disease progression|2
2906433|NCT01696045|10007701|P1|Overall Study|Disease progression|2
2906434|NCT01696045|10007700|P2|Overall Study|Study drug toxicity|5
2906435|NCT01696045|10007701|P1|Overall Study|Study drug toxicity|1
2906436|NCT01695993|10007720|P3|Overall Study|Changed Medical Facility|1
2906437|NCT01695993|10007721|P2|Overall Study|Changed Medical Facility|0
2906438|NCT01695993|10007722|P1|Overall Study|Changed Medical Facility|0
2906439|NCT01695993|10007720|P3|Overall Study|To ill to continue|0
2906440|NCT01695993|10007721|P2|Overall Study|To ill to continue|2
2906441|NCT01695993|10007722|P1|Overall Study|To ill to continue|1
2906442|NCT01695993|10007720|P3|Overall Study|Withdrawal by Subject|2
2906443|NCT01695993|10007721|P2|Overall Study|Withdrawal by Subject|2
2906444|NCT01695993|10007722|P1|Overall Study|Withdrawal by Subject|2
2906445|NCT01695993|10007720|P3|Overall Study|Lost to Follow-up|3
2906446|NCT01695993|10007721|P2|Overall Study|Lost to Follow-up|1
2906447|NCT01695993|10007722|P1|Overall Study|Lost to Follow-up|2
2906448|NCT01695772|10007730|P1|Overall Study|Unspecified Reason|1
2906449|NCT01695772|10007730|P1|Overall Study|Protocol Violation|2
2906450|NCT01695772|10007730|P1|Overall Study|Lost to Follow-up|4
2906451|NCT01695772|10007730|P1|Overall Study|Investigator Decision|5
2906452|NCT01695772|10007730|P1|Overall Study|Progressive Disease|8
2906453|NCT01695772|10007730|P1|Overall Study|Withdrawal by Subject|18
2906454|NCT01695746|10007742|P1|Overall Study|Participant not willing to participate|3
2906455|NCT01695746|10007742|P1|Overall Study|Protocol Violation|5
2906456|NCT01695746|10007742|P1|Overall Study|Non-compliance by the participant|3
2906457|NCT01695746|10007742|P1|Overall Study|Adverse Event|1
2906458|NCT01695239|10007802|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
2906459|NCT01695239|10007803|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
2906460|NCT01695239|10007804|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
2906461|NCT01695239|10007805|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
2906462|NCT01695239|10007806|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
2906463|NCT01695239|10007807|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
2906464|NCT01695239|10007808|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
2906465|NCT01695239|10007809|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
2906466|NCT01695239|10007810|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
2906467|NCT01695239|10007811|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
2906468|NCT01695239|10007812|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
2906469|NCT01695239|10007813|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
2906470|NCT01695239|10007814|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
2906471|NCT01695239|10007815|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
2906472|NCT01695239|10007802|P14|Post-Treatment Follow-Up Period|Physician Decision|0
2906473|NCT01695239|10007803|P13|Post-Treatment Follow-Up Period|Physician Decision|2
2906474|NCT01695239|10007804|P12|Post-Treatment Follow-Up Period|Physician Decision|0
2906475|NCT01695239|10007805|P11|Post-Treatment Follow-Up Period|Physician Decision|0
2906476|NCT01695239|10007806|P10|Post-Treatment Follow-Up Period|Physician Decision|0
2906477|NCT01695239|10007807|P9|Post-Treatment Follow-Up Period|Physician Decision|0
2906478|NCT01695239|10007808|P8|Post-Treatment Follow-Up Period|Physician Decision|0
2906479|NCT01695239|10007809|P7|Post-Treatment Follow-Up Period|Physician Decision|0
2906480|NCT01695239|10007810|P6|Post-Treatment Follow-Up Period|Physician Decision|0
2906481|NCT01695239|10007811|P5|Post-Treatment Follow-Up Period|Physician Decision|0
2906482|NCT01695239|10007812|P4|Post-Treatment Follow-Up Period|Physician Decision|0
2906483|NCT01695239|10007813|P3|Post-Treatment Follow-Up Period|Physician Decision|0
2906484|NCT01695239|10007814|P2|Post-Treatment Follow-Up Period|Physician Decision|0
2906485|NCT01695239|10007815|P1|Post-Treatment Follow-Up Period|Physician Decision|0
2906486|NCT01695239|10007802|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2906487|NCT01695239|10007803|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2906488|NCT01695239|10007804|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906489|NCT01695239|10007805|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906490|NCT01695239|10007806|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906491|NCT01695239|10007807|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906492|NCT01695239|10007808|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906493|NCT01695239|10007809|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906494|NCT01695239|10007810|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906495|NCT01695239|10007811|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906496|NCT01695239|10007812|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906497|NCT01695239|10007813|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906498|NCT01695239|10007814|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906499|NCT01695239|10007815|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2906500|NCT01695239|10007802|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2906501|NCT01695239|10007803|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
2906502|NCT01695239|10007804|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
2906503|NCT01695239|10007805|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906504|NCT01695239|10007806|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906505|NCT01695239|10007807|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906506|NCT01695239|10007808|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906507|NCT01695239|10007809|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906508|NCT01695239|10007810|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906509|NCT01695239|10007811|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906510|NCT01695239|10007812|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906511|NCT01695239|10007813|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906512|NCT01695239|10007814|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906513|NCT01695239|10007815|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2906514|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Death|0
2906515|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Death|0
2906516|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Death|0
2906517|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Death|0
2906518|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Death|0
2906519|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Death|1
2906520|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Death|0
2906521|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Death|0
2906522|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Death|0
2906523|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Death|0
2906524|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Death|0
2906525|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Death|0
2906526|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Death|0
2906527|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Death|0
2906528|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
2906529|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
2906530|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
2906531|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
2906532|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
2906533|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
2906534|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
2906535|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
2906536|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
2906537|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
2906538|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
2906539|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
2906540|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
2906541|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
2906542|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906543|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906544|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906545|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906546|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
2906547|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
2906548|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906549|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906550|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906551|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906552|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906553|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906554|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906555|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
2906556|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Physician Decision|0
2906557|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Physician Decision|0
2906558|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Physician Decision|0
2906559|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Physician Decision|0
2906560|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Physician Decision|0
2906561|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Physician Decision|3
2906562|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Physician Decision|0
2906563|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Physician Decision|0
2906564|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Physician Decision|0
2906565|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Physician Decision|0
2906566|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Physician Decision|0
2906567|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Physician Decision|0
2906568|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Physician Decision|0
2906569|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Physician Decision|0
2906570|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906571|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906572|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906573|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906574|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
2906575|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
2906576|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906577|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906578|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906579|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906580|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906581|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906582|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906583|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2906584|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Adverse Event|0
2906585|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Adverse Event|0
2906586|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Adverse Event|0
2906587|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Adverse Event|0
2906588|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Adverse Event|21
2906589|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Adverse Event|15
2906590|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Adverse Event|0
2906591|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Adverse Event|0
2906592|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Adverse Event|0
2906593|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Adverse Event|0
2906594|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Adverse Event|0
2906595|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Adverse Event|0
2906596|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Adverse Event|0
2906597|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Adverse Event|0
2906598|NCT01695239|10007802|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906599|NCT01695239|10007803|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906600|NCT01695239|10007804|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906601|NCT01695239|10007805|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906602|NCT01695239|10007806|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
2906603|NCT01695239|10007807|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
2906604|NCT01695239|10007808|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906605|NCT01695239|10007809|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906606|NCT01695239|10007810|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906607|NCT01695239|10007811|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906608|NCT01695239|10007812|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906609|NCT01695239|10007813|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906610|NCT01695239|10007814|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906611|NCT01695239|10007815|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
2906612|NCT01695239|10007802|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906613|NCT01695239|10007803|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906614|NCT01695239|10007804|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906615|NCT01695239|10007805|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906616|NCT01695239|10007806|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906617|NCT01695239|10007807|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906618|NCT01695239|10007808|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
2906619|NCT01695239|10007809|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906620|NCT01695239|10007810|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906621|NCT01695239|10007811|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906622|NCT01695239|10007812|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906623|NCT01695239|10007813|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906624|NCT01695239|10007814|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906625|NCT01695239|10007815|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2906626|NCT01695239|10007802|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906627|NCT01695239|10007803|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906628|NCT01695239|10007804|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906629|NCT01695239|10007805|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906630|NCT01695239|10007806|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906631|NCT01695239|10007807|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906632|NCT01695239|10007808|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
2906633|NCT01695239|10007809|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906634|NCT01695239|10007810|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906635|NCT01695239|10007811|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906636|NCT01695239|10007812|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906637|NCT01695239|10007813|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906638|NCT01695239|10007814|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906639|NCT01695239|10007815|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2906640|NCT01695239|10007802|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906641|NCT01695239|10007803|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906642|NCT01695239|10007804|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906643|NCT01695239|10007805|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906644|NCT01695239|10007806|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906645|NCT01695239|10007807|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906646|NCT01695239|10007808|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
2906647|NCT01695239|10007809|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906648|NCT01695239|10007810|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906649|NCT01695239|10007811|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906650|NCT01695239|10007812|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906651|NCT01695239|10007813|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906652|NCT01695239|10007814|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906653|NCT01695239|10007815|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2906654|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906655|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906656|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906657|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906658|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906659|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906660|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906661|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906662|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906663|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906664|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906665|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906666|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
2906667|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
2906668|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906669|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906670|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906671|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906672|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906673|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906674|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906675|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906676|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906677|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906678|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906679|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2906680|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2906681|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2906682|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906683|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906684|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906685|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906686|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906687|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906688|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906689|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906690|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906691|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906692|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906693|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
2906694|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2906695|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
2906696|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906697|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906698|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906699|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906700|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906701|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906702|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906703|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906704|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906705|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906706|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2906707|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2906708|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2906709|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
2906710|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906711|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906712|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906713|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906714|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906715|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906716|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906717|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906718|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906719|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906720|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906721|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2906722|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2906723|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
2906724|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
2906725|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
2906726|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
2906727|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
2906728|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
2906729|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
2906730|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
2906731|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
2906732|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
2906733|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
2906734|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
2906735|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
2906736|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
2906737|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
2906738|NCT01695239|10007802|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906739|NCT01695239|10007803|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906740|NCT01695239|10007804|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906741|NCT01695239|10007805|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906742|NCT01695239|10007806|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906743|NCT01695239|10007807|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906744|NCT01695239|10007808|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906745|NCT01695239|10007809|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906746|NCT01695239|10007810|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906747|NCT01695239|10007811|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2906748|NCT01695239|10007812|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
2906749|NCT01695239|10007813|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
2906750|NCT01695239|10007814|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2906751|NCT01695239|10007815|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2906752|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
2906753|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2906754|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2906755|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2906756|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Death|7
2906757|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Death|2
2906758|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Death|0
2906759|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Death|0
2906760|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Physician Decision|1
2906761|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Physician Decision|4
2906762|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Physician Decision|0
2906763|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Physician Decision|0
2906764|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Other|7
2906765|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Other|4
2906766|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Other|0
2906767|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Other|0
2906768|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Adverse Event|16
2906769|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Adverse Event|11
2906770|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Adverse Event|0
2906771|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Adverse Event|0
2906772|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
2906773|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
2906774|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2906775|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2906776|NCT01695135|10007956|P4|Open Label Extension Treatment Phase|Progressive disease|22
2906777|NCT01695135|10007957|P3|Open Label Extension Treatment Phase|Progressive disease|13
2906778|NCT01695135|10007958|P2|Open Label Extension Treatment Phase|Progressive disease|0
2906779|NCT01695135|10007959|P1|Open Label Extension Treatment Phase|Progressive disease|0
2906780|NCT01695135|10007956|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
2906781|NCT01695135|10007957|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
2906782|NCT01695135|10007958|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
2906783|NCT01695135|10007959|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
2906784|NCT01695135|10007956|P4|Double-blind Treatment Phase|Death|0
2906785|NCT01695135|10007957|P3|Double-blind Treatment Phase|Death|0
2906786|NCT01695135|10007958|P2|Double-blind Treatment Phase|Death|1
2906787|NCT01695135|10007959|P1|Double-blind Treatment Phase|Death|1
2906788|NCT01695135|10007956|P4|Double-blind Treatment Phase|Physician Decision|0
2906789|NCT01695135|10007957|P3|Double-blind Treatment Phase|Physician Decision|0
2906790|NCT01695135|10007958|P2|Double-blind Treatment Phase|Physician Decision|3
2906791|NCT01695135|10007959|P1|Double-blind Treatment Phase|Physician Decision|6
2906792|NCT01695135|10007956|P4|Double-blind Treatment Phase|Other|0
2906793|NCT01695135|10007957|P3|Double-blind Treatment Phase|Other|0
2906794|NCT01695135|10007958|P2|Double-blind Treatment Phase|Other|3
2906795|NCT01695135|10007959|P1|Double-blind Treatment Phase|Other|1
2906796|NCT01695135|10007956|P4|Double-blind Treatment Phase|Adverse Event|0
2906797|NCT01695135|10007957|P3|Double-blind Treatment Phase|Adverse Event|0
2906798|NCT01695135|10007958|P2|Double-blind Treatment Phase|Adverse Event|7
2906799|NCT01695135|10007959|P1|Double-blind Treatment Phase|Adverse Event|7
2906800|NCT01695135|10007956|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
2906801|NCT01695135|10007957|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
2906802|NCT01695135|10007958|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
2906803|NCT01695135|10007959|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
2906804|NCT01695135|10007956|P4|Double-blind Treatment Phase|Progressive disease|0
2906805|NCT01695135|10007957|P3|Double-blind Treatment Phase|Progressive disease|0
2906806|NCT01695135|10007958|P2|Double-blind Treatment Phase|Progressive disease|110
2906807|NCT01695135|10007959|P1|Double-blind Treatment Phase|Progressive disease|50
2906808|NCT01694771|10008008|P2|Overall Study|Other reasons|6
2906809|NCT01694771|10008009|P1|Overall Study|Other reasons|5
2906810|NCT01694771|10008008|P2|Overall Study|Consent withdrawn|9
2906811|NCT01694771|10008009|P1|Overall Study|Consent withdrawn|7
2906812|NCT01694771|10008008|P2|Overall Study|Lost to Follow-up|3
2906813|NCT01694771|10008009|P1|Overall Study|Lost to Follow-up|2
2906814|NCT01694771|10008008|P2|Overall Study|Non compliance protocol|6
2906815|NCT01694771|10008009|P1|Overall Study|Non compliance protocol|7
2906816|NCT01694771|10008008|P2|Overall Study|Lack of Efficacy|0
2906817|NCT01694771|10008009|P1|Overall Study|Lack of Efficacy|1
2906818|NCT01694771|10008008|P2|Overall Study|Adverse Event|16
2906819|NCT01694771|10008009|P1|Overall Study|Adverse Event|18
2906820|NCT01694706|10008033|P3|Overall Study|other reason not defined above|0
2906821|NCT01694706|10008034|P2|Overall Study|other reason not defined above|0
2906822|NCT01694706|10008035|P1|Overall Study|other reason not defined above|1
2906823|NCT01694706|10008033|P3|Overall Study|Adverse Event|0
2906824|NCT01694706|10008034|P2|Overall Study|Adverse Event|1
2906825|NCT01694706|10008035|P1|Overall Study|Adverse Event|0
2906826|NCT01694485|10008092|P5|Overall Study|Death|0
2906827|NCT01694485|10008093|P4|Overall Study|Death|1
2906828|NCT01694485|10008094|P3|Overall Study|Death|0
2906829|NCT01694485|10008095|P2|Overall Study|Death|0
2906830|NCT01694485|10008096|P1|Overall Study|Death|1
2906831|NCT01694485|10008092|P5|Overall Study|Lost to Follow-up|7
2906832|NCT01694485|10008093|P4|Overall Study|Lost to Follow-up|10
2906833|NCT01694485|10008094|P3|Overall Study|Lost to Follow-up|6
2906834|NCT01694485|10008095|P2|Overall Study|Lost to Follow-up|1
2906835|NCT01694485|10008096|P1|Overall Study|Lost to Follow-up|9
2906836|NCT01694485|10008092|P5|Overall Study|Sponsor Decision|0
2906837|NCT01694485|10008093|P4|Overall Study|Sponsor Decision|2
2906838|NCT01694485|10008094|P3|Overall Study|Sponsor Decision|0
2906839|NCT01694485|10008095|P2|Overall Study|Sponsor Decision|0
2906840|NCT01694485|10008096|P1|Overall Study|Sponsor Decision|3
2906841|NCT01694485|10008092|P5|Overall Study|Withdrawal by Subject|18
2906842|NCT01694485|10008093|P4|Overall Study|Withdrawal by Subject|25
2906843|NCT01694485|10008094|P3|Overall Study|Withdrawal by Subject|7
2906844|NCT01694485|10008095|P2|Overall Study|Withdrawal by Subject|6
2906845|NCT01694485|10008096|P1|Overall Study|Withdrawal by Subject|20
2906846|NCT01694433|10008130|P2|Overall Study|Withdrawal by Subject|4
2906847|NCT01694433|10008131|P1|Overall Study|Withdrawal by Subject|3
2906848|NCT01694433|10008130|P2|Overall Study|Physician Decision|0
2906849|NCT01694433|10008131|P1|Overall Study|Physician Decision|1
2906850|NCT01694433|10008130|P2|Overall Study|Adverse Event|0
2906851|NCT01694433|10008131|P1|Overall Study|Adverse Event|7
2906852|NCT01694420|10008139|P1|Overall Study|Lost to Follow-up|3
2906853|NCT01694121|10008176|P2|Overall Study|Participant used false ID, was withdrawn|0
2906854|NCT01694121|10008177|P1|Overall Study|Participant used false ID, was withdrawn|1
2906855|NCT01693614|10008291|P3|Overall Study|Withdrawal by Subject|5
2906856|NCT01693614|10008292|P2|Overall Study|Withdrawal by Subject|0
2906857|NCT01693614|10008293|P1|Overall Study|Withdrawal by Subject|1
2906858|NCT01693614|10008291|P3|Overall Study|Withdrawal by subject/guardian|2
2906859|NCT01693614|10008292|P2|Overall Study|Withdrawal by subject/guardian|0
2906860|NCT01693614|10008293|P1|Overall Study|Withdrawal by subject/guardian|0
2906861|NCT01693614|10008291|P3|Overall Study|Physician Decision|4
2906862|NCT01693614|10008292|P2|Overall Study|Physician Decision|1
2906863|NCT01693614|10008293|P1|Overall Study|Physician Decision|1
2906864|NCT01693614|10008291|P3|Overall Study|Death|0
2906865|NCT01693614|10008292|P2|Overall Study|Death|0
2906866|NCT01693614|10008293|P1|Overall Study|Death|1
2906867|NCT01693614|10008291|P3|Overall Study|Protocol Violation|1
2906868|NCT01693614|10008292|P2|Overall Study|Protocol Violation|2
2906869|NCT01693614|10008293|P1|Overall Study|Protocol Violation|5
2906870|NCT01693614|10008291|P3|Overall Study|Disease progression|7
2906871|NCT01693614|10008292|P2|Overall Study|Disease progression|8
2906872|NCT01693614|10008293|P1|Overall Study|Disease progression|11
2906873|NCT01693614|10008291|P3|Overall Study|Adverse Event|5
2906874|NCT01693614|10008292|P2|Overall Study|Adverse Event|11
2906875|NCT01693614|10008293|P1|Overall Study|Adverse Event|7
2906876|NCT01693523|10008318|P3|Overall Study|Chemotherapy was held|0
2906877|NCT01693523|10008319|P2|Overall Study|Chemotherapy was held|2
2906878|NCT01693523|10008320|P1|Overall Study|Chemotherapy was held|1
2906879|NCT01693523|10008318|P3|Overall Study|Lack of compliance study medication|0
2906880|NCT01693523|10008319|P2|Overall Study|Lack of compliance study medication|2
2906881|NCT01693523|10008320|P1|Overall Study|Lack of compliance study medication|1
2906882|NCT01693523|10008318|P3|Overall Study|Withdrawal by Subject|2
2906883|NCT01693523|10008319|P2|Overall Study|Withdrawal by Subject|2
2906884|NCT01693523|10008320|P1|Overall Study|Withdrawal by Subject|1
2906885|NCT01693523|10008318|P3|Overall Study|Physician Decision|1
2906886|NCT01693523|10008319|P2|Overall Study|Physician Decision|0
2906887|NCT01693523|10008320|P1|Overall Study|Physician Decision|0
2906888|NCT01693523|10008318|P3|Overall Study|Lost to Follow-up|4
2906889|NCT01693523|10008319|P2|Overall Study|Lost to Follow-up|0
2906890|NCT01693523|10008320|P1|Overall Study|Lost to Follow-up|0
2906891|NCT01693523|10008318|P3|Overall Study|Death|1
2906892|NCT01693523|10008319|P2|Overall Study|Death|1
2906893|NCT01693523|10008320|P1|Overall Study|Death|0
2906894|NCT01693523|10008318|P3|Overall Study|Adverse Event|0
2906895|NCT01693523|10008319|P2|Overall Study|Adverse Event|1
2906896|NCT01693523|10008320|P1|Overall Study|Adverse Event|2
2906897|NCT01693367|10008336|P2|Overall Study|Physician Decision|1
2906898|NCT01693367|10008337|P1|Overall Study|Physician Decision|0
2906899|NCT01693367|10008336|P2|Overall Study|Withdrawal by Subject|1
2906900|NCT01693367|10008337|P1|Overall Study|Withdrawal by Subject|1
2906901|NCT01693250|10008355|P2|Overall Study|Lost to Follow-up|2
2906902|NCT01693250|10008356|P1|Overall Study|Lost to Follow-up|2
2906903|NCT01693185|10008366|P2|Overall Study|diagnostic procedure after colonoscopy|6
2906904|NCT01693185|10008367|P1|Overall Study|diagnostic procedure after colonoscopy|0
2906905|NCT01693120|10008383|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
2906906|NCT01693120|10008383|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
2906907|NCT01693120|10008383|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
2906908|NCT01693120|10008383|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
2906909|NCT01693120|10008383|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
2906910|NCT01693120|10008383|P1|Enrollment|Other|1
2906911|NCT01693120|10008383|P1|Enrollment|Study closed|8
2906912|NCT01693120|10008383|P1|Enrollment|Adverse Event|1
2906913|NCT01693120|10008383|P1|Enrollment|Physician Decision|3
2906914|NCT01693120|10008383|P1|Enrollment|Protocol Violation|46
2906915|NCT01693120|10008383|P1|Enrollment|Withdrawal by Subject|10
2906916|NCT01693120|10008383|P1|Enrollment|Lost to Follow-up|1
2906917|NCT01693068|10008392|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
2906918|NCT01693068|10008393|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2906919|NCT01693068|10008394|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2906920|NCT01693068|10008392|P3|Randomization Period|On-study|0
2906921|NCT01693068|10008393|P2|Randomization Period|On-study|5
2906922|NCT01693068|10008394|P1|Randomization Period|On-study|2
2906923|NCT01693029|10008426|P2|Overall Study|Non-compliance|1
2906924|NCT01693029|10008427|P1|Overall Study|Non-compliance|2
2906925|NCT01693029|10008426|P2|Overall Study|Death|8
2906926|NCT01693029|10008427|P1|Overall Study|Death|5
2906927|NCT01693029|10008426|P2|Overall Study|Adverse Event|6
2906928|NCT01693029|10008427|P1|Overall Study|Adverse Event|1
2906929|NCT01693029|10008426|P2|Overall Study|Lost to Follow-up|1
2906930|NCT01693029|10008427|P1|Overall Study|Lost to Follow-up|0
2906931|NCT01693029|10008426|P2|Overall Study|Physician Decision|2
2906932|NCT01693029|10008427|P1|Overall Study|Physician Decision|0
2906933|NCT01693029|10008426|P2|Overall Study|Change in dialysis modality|1
2906934|NCT01693029|10008427|P1|Overall Study|Change in dialysis modality|2
2906935|NCT01693029|10008426|P2|Overall Study|Protocol Violation|7
2906936|NCT01693029|10008427|P1|Overall Study|Protocol Violation|6
2906937|NCT01693029|10008426|P2|Overall Study|Bindinging anti-EPO antibodies|2
2906938|NCT01693029|10008427|P1|Overall Study|Bindinging anti-EPO antibodies|6
2906939|NCT01693029|10008426|P2|Overall Study|Kidney transplantation|7
2906940|NCT01693029|10008427|P1|Overall Study|Kidney transplantation|7
2906941|NCT01693029|10008426|P2|Overall Study|Withdrawal by Subject|22
2906942|NCT01693029|10008427|P1|Overall Study|Withdrawal by Subject|15
2906943|NCT01692938|10008458|P2|Overall Study|Study completed prior to site completion|3
2906944|NCT01692938|10008459|P1|Overall Study|Study completed prior to site completion|3
2906945|NCT01692938|10008458|P2|Overall Study|Protocol Deviation|1
2906946|NCT01692938|10008459|P1|Overall Study|Protocol Deviation|1
2906947|NCT01692782|10008470|P3|Overall Study|Withdrawal by Subject|3
2906948|NCT01692782|10008471|P2|Overall Study|Withdrawal by Subject|10
2906949|NCT01692782|10008472|P1|Overall Study|Withdrawal by Subject|3
2906950|NCT01692782|10008470|P3|Overall Study|SAE not related to study drug|0
2906951|NCT01692782|10008471|P2|Overall Study|SAE not related to study drug|1
2906952|NCT01692782|10008472|P1|Overall Study|SAE not related to study drug|0
2906953|NCT01692782|10008470|P3|Overall Study|Non-compliant with study visits|1
2906954|NCT01692782|10008471|P2|Overall Study|Non-compliant with study visits|0
2906955|NCT01692782|10008472|P1|Overall Study|Non-compliant with study visits|0
2906956|NCT01692782|10008470|P3|Overall Study|Non-complance with study drug|1
2906957|NCT01692782|10008471|P2|Overall Study|Non-complance with study drug|4
2906958|NCT01692782|10008472|P1|Overall Study|Non-complance with study drug|0
2906959|NCT01692782|10008470|P3|Overall Study|Protocol Violation|2
2906960|NCT01692782|10008471|P2|Overall Study|Protocol Violation|0
2906961|NCT01692782|10008472|P1|Overall Study|Protocol Violation|1
2906962|NCT01692782|10008470|P3|Overall Study|Pregnancy|0
2906963|NCT01692782|10008471|P2|Overall Study|Pregnancy|0
2906964|NCT01692782|10008472|P1|Overall Study|Pregnancy|1
2906965|NCT01692782|10008470|P3|Overall Study|Lost to Follow-up|1
2906966|NCT01692782|10008471|P2|Overall Study|Lost to Follow-up|7
2906967|NCT01692782|10008472|P1|Overall Study|Lost to Follow-up|2
2906968|NCT01692782|10008470|P3|Overall Study|Lack of Efficacy|0
2906969|NCT01692782|10008471|P2|Overall Study|Lack of Efficacy|2
2906970|NCT01692782|10008472|P1|Overall Study|Lack of Efficacy|1
2906971|NCT01692782|10008470|P3|Overall Study|Adverse Event|2
2906972|NCT01692782|10008471|P2|Overall Study|Adverse Event|32
2906973|NCT01692782|10008472|P1|Overall Study|Adverse Event|12
2906974|NCT01692730|10008581|P2|Overall Study|Lost to Follow-up|227
2906975|NCT01692730|10008582|P1|Overall Study|Lost to Follow-up|225
2906976|NCT01692626|10008596|P2|Overall Study|Withdrawal by Subject|0
2906977|NCT01692626|10008597|P1|Overall Study|Withdrawal by Subject|1
2906978|NCT01692626|10008596|P2|Overall Study|Protocol Violation|2
2906979|NCT01692626|10008597|P1|Overall Study|Protocol Violation|1
2906980|NCT01692626|10008596|P2|Overall Study|Adverse Event|3
2906981|NCT01692626|10008597|P1|Overall Study|Adverse Event|2
2906982|NCT01692626|10008596|P2|Overall Study|Death|1
2906983|NCT01692626|10008597|P1|Overall Study|Death|0
2906984|NCT01692301|10008622|P2|Overall Study|Lost to Follow-up|1
2906985|NCT01692301|10008623|P1|Overall Study|Lost to Follow-up|1
2906986|NCT01692301|10008622|P2|Overall Study|Physician Decision|2
2906987|NCT01692301|10008623|P1|Overall Study|Physician Decision|2
2906988|NCT01692301|10008622|P2|Overall Study|Technical problems|1
2906989|NCT01692301|10008623|P1|Overall Study|Technical problems|0
2906990|NCT01692301|10008622|P2|Overall Study|Patient/guardian decision|15
2906991|NCT01692301|10008623|P1|Overall Study|Patient/guardian decision|16
2906992|NCT01692301|10008622|P2|Overall Study|Protocol deviation|2
2906993|NCT01692301|10008623|P1|Overall Study|Protocol deviation|9
2906994|NCT01692301|10008622|P2|Overall Study|Non-compliance with study treatment|2
2906995|NCT01692301|10008623|P1|Overall Study|Non-compliance with study treatment|1
2906996|NCT01692301|10008622|P2|Overall Study|Lack of Efficacy|5
2906997|NCT01692301|10008623|P1|Overall Study|Lack of Efficacy|0
2906998|NCT01692301|10008622|P2|Overall Study|Death|2
2906999|NCT01692301|10008623|P1|Overall Study|Death|1
2907000|NCT01692301|10008622|P2|Overall Study|Adverse Event|12
2907001|NCT01692301|10008623|P1|Overall Study|Adverse Event|15
2907002|NCT01692275|10008655|P2|Overall Study|Withdrawal by Subject|11
2907003|NCT01692275|10008656|P1|Overall Study|Withdrawal by Subject|9
2907004|NCT01692275|10008655|P2|Overall Study|Lost to Follow-up|48
2907005|NCT01692275|10008656|P1|Overall Study|Lost to Follow-up|57
2907006|NCT01692197|10008716|P1|Overall Study|Failed Screening|3
2907007|NCT01691898|10008738|P6|Overall Study|Non-Compliance|0
2907008|NCT01691898|10008739|P5|Overall Study|Non-Compliance|1
2907009|NCT01691898|10008740|P4|Overall Study|Non-Compliance|0
2907010|NCT01691898|10008741|P3|Overall Study|Non-Compliance|0
2907011|NCT01691898|10008742|P2|Overall Study|Non-Compliance|0
2907012|NCT01691898|10008743|P1|Overall Study|Non-Compliance|0
2907013|NCT01691898|10008738|P6|Overall Study|Withdrawal by Subject|3
2907014|NCT01691898|10008739|P5|Overall Study|Withdrawal by Subject|3
2907015|NCT01691898|10008740|P4|Overall Study|Withdrawal by Subject|1
2907016|NCT01691898|10008741|P3|Overall Study|Withdrawal by Subject|2
2907017|NCT01691898|10008742|P2|Overall Study|Withdrawal by Subject|8
2907018|NCT01691898|10008743|P1|Overall Study|Withdrawal by Subject|9
2907019|NCT01691898|10008738|P6|Overall Study|Lost to Follow-up|0
2907020|NCT01691898|10008739|P5|Overall Study|Lost to Follow-up|1
2907021|NCT01691898|10008740|P4|Overall Study|Lost to Follow-up|0
2907022|NCT01691898|10008741|P3|Overall Study|Lost to Follow-up|0
2907023|NCT01691898|10008742|P2|Overall Study|Lost to Follow-up|1
2907024|NCT01691898|10008743|P1|Overall Study|Lost to Follow-up|3
2907025|NCT01691898|10008738|P6|Overall Study|Progression of Disease|1
2907026|NCT01691898|10008739|P5|Overall Study|Progression of Disease|0
2907027|NCT01691898|10008740|P4|Overall Study|Progression of Disease|0
2907028|NCT01691898|10008741|P3|Overall Study|Progression of Disease|1
2907029|NCT01691898|10008742|P2|Overall Study|Progression of Disease|2
2907030|NCT01691898|10008743|P1|Overall Study|Progression of Disease|1
2907031|NCT01691898|10008738|P6|Overall Study|Adverse Event|0
2907032|NCT01691898|10008739|P5|Overall Study|Adverse Event|1
2907033|NCT01691898|10008740|P4|Overall Study|Adverse Event|1
2907034|NCT01691898|10008741|P3|Overall Study|Adverse Event|0
2907035|NCT01691898|10008742|P2|Overall Study|Adverse Event|1
2907036|NCT01691898|10008743|P1|Overall Study|Adverse Event|0
2907037|NCT01691898|10008738|P6|Overall Study|Death|31
2907038|NCT01691898|10008739|P5|Overall Study|Death|8
2907039|NCT01691898|10008740|P4|Overall Study|Death|3
2907040|NCT01691898|10008741|P3|Overall Study|Death|6
2907041|NCT01691898|10008742|P2|Overall Study|Death|32
2907042|NCT01691898|10008743|P1|Overall Study|Death|34
2907043|NCT01691885|10008897|P2|Washout Period (7-9 Days)|Adverse Event|1
2907044|NCT01691885|10008898|P1|Washout Period (7-9 Days)|Adverse Event|0
2907045|NCT01691885|10008897|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
2907046|NCT01691885|10008898|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
2907047|NCT01691859|10008904|P1|Overall Study|Withdrawal by Subject|31
2907048|NCT01691859|10008904|P1|Overall Study|Physician Decision|6
2907049|NCT01691859|10008904|P1|Overall Study|Lost to Follow-up|5
2907050|NCT01691859|10008904|P1|Overall Study|Study closed/terminated|50
2907051|NCT01691859|10008904|P1|Overall Study|Product commercially available|221
2907052|NCT01691859|10008904|P1|Overall Study|Protocol Violation|4
2907053|NCT01691859|10008904|P1|Overall Study|Lack of Efficacy|11
2907054|NCT01691859|10008904|P1|Overall Study|Adverse Event|19
2907055|NCT01691820|10008951|P3|Overall Study|Other (unspecified)|1
2907056|NCT01691820|10008952|P2|Overall Study|Other (unspecified)|0
2907057|NCT01691820|10008953|P1|Overall Study|Other (unspecified)|5
2907058|NCT01691820|10008951|P3|Overall Study|Lost to Follow-up|0
2907059|NCT01691820|10008952|P2|Overall Study|Lost to Follow-up|15
2907060|NCT01691820|10008953|P1|Overall Study|Lost to Follow-up|8
2907061|NCT01691820|10008951|P3|Overall Study|Migrated/moved from study area|0
2907062|NCT01691820|10008952|P2|Overall Study|Migrated/moved from study area|4
2907063|NCT01691820|10008953|P1|Overall Study|Migrated/moved from study area|7
2907064|NCT01691820|10008951|P3|Overall Study|Consent withdrawal (not due to an AE)|0
2907065|NCT01691820|10008952|P2|Overall Study|Consent withdrawal (not due to an AE)|15
2907066|NCT01691820|10008953|P1|Overall Study|Consent withdrawal (not due to an AE)|9
2907067|NCT01691794|10008991|P3|Overall Study|Did not complete first 24 weeks of study|3
2907068|NCT01691794|10008992|P2|Overall Study|Did not complete first 24 weeks of study|3
2907069|NCT01691794|10008993|P1|Overall Study|Did not complete first 24 weeks of study|0
2907070|NCT01691794|10008991|P3|Overall Study|Completed Only first 24 weeks of study|3
2907071|NCT01691794|10008992|P2|Overall Study|Completed Only first 24 weeks of study|2
2907072|NCT01691794|10008993|P1|Overall Study|Completed Only first 24 weeks of study|0
2907073|NCT01691794|10008991|P3|Overall Study|Adverse Event|1
2907074|NCT01691794|10008992|P2|Overall Study|Adverse Event|1
2907075|NCT01691794|10008993|P1|Overall Study|Adverse Event|0
2907076|NCT01691794|10008991|P3|Overall Study|Participant request to discontinue|0
2907077|NCT01691794|10008992|P2|Overall Study|Participant request to discontinue|1
2907078|NCT01691794|10008993|P1|Overall Study|Participant request to discontinue|0
2907079|NCT01691794|10008991|P3|Overall Study|Lack of Efficacy|1
2907080|NCT01691794|10008992|P2|Overall Study|Lack of Efficacy|7
2907081|NCT01691794|10008993|P1|Overall Study|Lack of Efficacy|0
2907082|NCT01691794|10008991|P3|Overall Study|Death|1
2907083|NCT01691794|10008992|P2|Overall Study|Death|0
2907084|NCT01691794|10008993|P1|Overall Study|Death|0
2907085|NCT01691794|10008991|P3|Overall Study|Poor/Non-Compliance|1
2907086|NCT01691794|10008992|P2|Overall Study|Poor/Non-Compliance|4
2907087|NCT01691794|10008993|P1|Overall Study|Poor/Non-Compliance|1
2907088|NCT01691781|10009009|P2|Overall Study|Adverse Event|1
2907089|NCT01691781|10009010|P1|Overall Study|Adverse Event|0
2907090|NCT01691781|10009009|P2|Overall Study|Protocol Violation|2
2907091|NCT01691781|10009010|P1|Overall Study|Protocol Violation|2
2907092|NCT01691781|10009009|P2|Overall Study|Physician Decision|1
2907093|NCT01691781|10009010|P1|Overall Study|Physician Decision|1
2907094|NCT01691781|10009009|P2|Overall Study|Withdrawal by Subject|3
2907095|NCT01691781|10009010|P1|Overall Study|Withdrawal by Subject|4
2907096|NCT01691768|10009022|P2|Overall Study|Investigator decision|1
2907097|NCT01691768|10009023|P1|Overall Study|Investigator decision|1
2907098|NCT01691768|10009022|P2|Overall Study|Relocated|1
2907099|NCT01691768|10009023|P1|Overall Study|Relocated|0
2907100|NCT01691768|10009022|P2|Overall Study|Withdrawal by Subject|9
2907101|NCT01691768|10009023|P1|Overall Study|Withdrawal by Subject|10
2907102|NCT01691768|10009022|P2|Overall Study|Lost to Follow-up|3
2907103|NCT01691768|10009023|P1|Overall Study|Lost to Follow-up|4
2907104|NCT01691768|10009022|P2|Overall Study|Death|2
2907105|NCT01691768|10009023|P1|Overall Study|Death|0
2907106|NCT01691612|10009058|P1|Overall Study|Adverse Event|1
2907107|NCT01691612|10009058|P1|Overall Study|deemed ineligible after 1st visit|6
2907108|NCT01691521|10009169|P3|Overall Study|Withdrawal by Subject|4
2907109|NCT01691521|10009170|P2|Overall Study|Withdrawal by Subject|9
2907110|NCT01691521|10009171|P1|Overall Study|Withdrawal by Subject|5
2907111|NCT01691521|10009169|P3|Overall Study|Physician Decision|0
2907112|NCT01691521|10009170|P2|Overall Study|Physician Decision|1
2907113|NCT01691521|10009171|P1|Overall Study|Physician Decision|2
2907114|NCT01691521|10009169|P3|Overall Study|Lost to Follow-up|2
2907115|NCT01691521|10009170|P2|Overall Study|Lost to Follow-up|2
2907116|NCT01691521|10009171|P1|Overall Study|Lost to Follow-up|0
2907117|NCT01691521|10009169|P3|Overall Study|Protocol Violation|0
2907118|NCT01691521|10009170|P2|Overall Study|Protocol Violation|3
2907119|NCT01691521|10009171|P1|Overall Study|Protocol Violation|0
2907120|NCT01691521|10009169|P3|Overall Study|Lack of Efficacy|2
2907121|NCT01691521|10009170|P2|Overall Study|Lack of Efficacy|1
2907122|NCT01691521|10009171|P1|Overall Study|Lack of Efficacy|1
2907123|NCT01691521|10009169|P3|Overall Study|Adverse Event|1
2907124|NCT01691521|10009170|P2|Overall Study|Adverse Event|0
2907125|NCT01691521|10009171|P1|Overall Study|Adverse Event|4
2907126|NCT01691508|10009193|P2|Overall Study|Withdrawal by Subject|0
2907127|NCT01691508|10009194|P1|Overall Study|Withdrawal by Subject|1
2907128|NCT01691508|10009193|P2|Overall Study|Adverse Event|3
2907129|NCT01691508|10009194|P1|Overall Study|Adverse Event|3
2907130|NCT01691482|10009208|P2|Treatment Period 2|Protocol Violation|1
2907131|NCT01691482|10009209|P1|Treatment Period 2|Protocol Violation|1
2907132|NCT01691482|10009208|P2|Treatment Period 2|Adverse Event|1
2907133|NCT01691482|10009209|P1|Treatment Period 2|Adverse Event|0
2907134|NCT01691430|10009227|P2|Overall Study|Lost to Follow-up|3
2907135|NCT01691430|10009228|P1|Overall Study|Lost to Follow-up|0
2907136|NCT01691430|10009227|P2|Overall Study|Withdrawal by Subject|1
2907137|NCT01691430|10009228|P1|Overall Study|Withdrawal by Subject|5
2907138|NCT01691430|10009227|P2|Overall Study|Death|16
2907139|NCT01691430|10009228|P1|Overall Study|Death|17
2907140|NCT01691378|10009254|P2|Overall Study|Lost to Follow-up|2
2907141|NCT01691378|10009255|P1|Overall Study|Lost to Follow-up|5
2907142|NCT01691378|10009254|P2|Overall Study|Withdrawal by Subject|0
2907143|NCT01691378|10009255|P1|Overall Study|Withdrawal by Subject|2
2907144|NCT01691248|10009338|P2|Overall Study|Not Treated|7
2907145|NCT01691248|10009339|P1|Overall Study|Not Treated|4
2907146|NCT01691248|10009338|P2|Overall Study|Reason not provided|4
2907147|NCT01691248|10009339|P1|Overall Study|Reason not provided|4
2907148|NCT01691248|10009338|P2|Overall Study|Lost to Follow-up|5
2907149|NCT01691248|10009339|P1|Overall Study|Lost to Follow-up|2
2907150|NCT01691248|10009338|P2|Overall Study|Confirmed CDAD|31
2907151|NCT01691248|10009339|P1|Overall Study|Confirmed CDAD|14
2907152|NCT01691248|10009338|P2|Overall Study|Withdrawal by Subject|18
2907153|NCT01691248|10009339|P1|Overall Study|Withdrawal by Subject|20
2907154|NCT01691248|10009338|P2|Overall Study|Adverse Event|22
2907155|NCT01691248|10009339|P1|Overall Study|Adverse Event|24
2907156|NCT01691248|10009338|P2|Overall Study|Protocol Violation|27
2907157|NCT01691248|10009339|P1|Overall Study|Protocol Violation|43
2907158|NCT01691105|10009351|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
2907159|NCT01691105|10009352|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
2907160|NCT01691105|10009351|P2|12 Month Biochemical Verification|Lost to Follow-up|71
2907161|NCT01691105|10009352|P1|12 Month Biochemical Verification|Lost to Follow-up|50
2907162|NCT01691105|10009351|P2|12 Month Biochemical Verification|Death|30
2907163|NCT01691105|10009352|P1|12 Month Biochemical Verification|Death|22
2907164|NCT01691105|10009351|P2|12 Month Follow-up|Death|30
2907165|NCT01691105|10009352|P1|12 Month Follow-up|Death|22
2907166|NCT01691105|10009351|P2|12 Month Follow-up|Lost to Follow-up|71
2907167|NCT01691105|10009352|P1|12 Month Follow-up|Lost to Follow-up|50
2907168|NCT01691105|10009351|P2|6 Month Follow-up|Death|13
2907169|NCT01691105|10009352|P1|6 Month Follow-up|Death|13
2907170|NCT01691105|10009351|P2|6 Month Follow-up|Lost to Follow-up|58
2907171|NCT01691105|10009352|P1|6 Month Follow-up|Lost to Follow-up|39
2907172|NCT01691105|10009351|P2|1 Month Follow-up|Death|3
2907173|NCT01691105|10009352|P1|1 Month Follow-up|Death|2
2907174|NCT01691105|10009351|P2|1 Month Follow-up|Lost to Follow-up|38
2907175|NCT01691105|10009352|P1|1 Month Follow-up|Lost to Follow-up|41
2907176|NCT01691092|10009372|P1|Overall Study|screen fail|19
2907177|NCT01691092|10009372|P1|Overall Study|used for different study|2
2907178|NCT01691092|10009372|P1|Overall Study|non-compliance|3
2907179|NCT01691092|10009372|P1|Overall Study|Withdrawal by Subject|3
2907180|NCT01691092|10009372|P1|Overall Study|Physician Decision|4
2907181|NCT01691092|10009372|P1|Overall Study|Lost to Follow-up|10
2907182|NCT01691014|10009385|P4|Overall Study|Lack of Efficacy|0
2907183|NCT01691014|10009386|P3|Overall Study|Lack of Efficacy|7
2907184|NCT01691014|10009387|P2|Overall Study|Lack of Efficacy|3
2907185|NCT01691014|10009388|P1|Overall Study|Lack of Efficacy|2
2907186|NCT01691014|10009385|P4|Overall Study|Adverse Event|1
2907187|NCT01691014|10009386|P3|Overall Study|Adverse Event|1
2907188|NCT01691014|10009387|P2|Overall Study|Adverse Event|5
2907189|NCT01691014|10009388|P1|Overall Study|Adverse Event|0
2907190|NCT01691014|10009385|P4|Overall Study|Withdrawal by Subject|1
2907191|NCT01691014|10009386|P3|Overall Study|Withdrawal by Subject|1
2907192|NCT01691014|10009387|P2|Overall Study|Withdrawal by Subject|1
2907193|NCT01691014|10009388|P1|Overall Study|Withdrawal by Subject|0
2907194|NCT01691014|10009385|P4|Overall Study|Other|0
2907195|NCT01691014|10009386|P3|Overall Study|Other|2
2907196|NCT01691014|10009387|P2|Overall Study|Other|0
2907197|NCT01691014|10009388|P1|Overall Study|Other|0
2907198|NCT01691014|10009385|P4|Overall Study|Premature Termination|3
2907199|NCT01691014|10009386|P3|Overall Study|Premature Termination|0
2907200|NCT01691014|10009387|P2|Overall Study|Premature Termination|6
2907201|NCT01691014|10009388|P1|Overall Study|Premature Termination|1
2907202|NCT01690988|10009433|P3|Overall Study|Sedated|2
2907203|NCT01690988|10009434|P2|Overall Study|Sedated|1
2907204|NCT01690988|10009435|P1|Overall Study|Sedated|1
2907205|NCT01690988|10009433|P3|Overall Study|Death|1
2907206|NCT01690988|10009434|P2|Overall Study|Death|1
2907207|NCT01690988|10009435|P1|Overall Study|Death|1
2907208|NCT01690988|10009433|P3|Overall Study|Determined ineligible|0
2907209|NCT01690988|10009434|P2|Overall Study|Determined ineligible|0
2907210|NCT01690988|10009435|P1|Overall Study|Determined ineligible|1
2907211|NCT01690988|10009433|P3|Overall Study|Operation Cancelled|0
2907212|NCT01690988|10009434|P2|Overall Study|Operation Cancelled|1
2907213|NCT01690988|10009435|P1|Overall Study|Operation Cancelled|1
2907214|NCT01690988|10009433|P3|Overall Study|Physician Decision|1
2907215|NCT01690988|10009434|P2|Overall Study|Physician Decision|0
2907216|NCT01690988|10009435|P1|Overall Study|Physician Decision|0
2907217|NCT01690988|10009433|P3|Overall Study|Withdrawal by Subject|3
2907218|NCT01690988|10009434|P2|Overall Study|Withdrawal by Subject|2
2907219|NCT01690988|10009435|P1|Overall Study|Withdrawal by Subject|2
2907220|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
2907221|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2907222|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2907223|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2907224|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2907225|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2907226|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2907227|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
2907228|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2907229|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2907230|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2907231|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2907232|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
2907233|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
2907234|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
2907235|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2907236|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2907237|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2907238|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2907239|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2907240|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2907241|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2907242|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2907243|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2907244|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
2907245|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
2907246|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
2907247|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2907248|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2907249|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2907250|NCT01690299|10009503|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2907251|NCT01690299|10009504|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
2907252|NCT01690299|10009505|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2907253|NCT01690299|10009506|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2907254|NCT01690299|10009507|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2907255|NCT01690299|10009508|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2907256|NCT01690299|10009503|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
2907257|NCT01690299|10009504|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
2907258|NCT01690299|10009505|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
2907259|NCT01690299|10009506|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
2907260|NCT01690299|10009507|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
2907261|NCT01690299|10009508|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
2907262|NCT01690299|10009503|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2907263|NCT01690299|10009504|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2907264|NCT01690299|10009505|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2907265|NCT01690299|10009506|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2907266|NCT01690299|10009507|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
2907267|NCT01690299|10009508|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
2907268|NCT01690299|10009503|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2907269|NCT01690299|10009504|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2907270|NCT01690299|10009505|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2907271|NCT01690299|10009506|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2907272|NCT01690299|10009507|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2907273|NCT01690299|10009508|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
2907274|NCT01690299|10009503|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2907275|NCT01690299|10009504|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2907276|NCT01690299|10009505|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2907277|NCT01690299|10009506|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
2907278|NCT01690299|10009507|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2907279|NCT01690299|10009508|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2907280|NCT01690143|10009605|P1|Overall Study|Withdrawal by Subject|1
2907281|NCT01690130|10009615|P2|Overall Study|Subject have cancelled visit.|0
2907282|NCT01690130|10009616|P1|Overall Study|Subject have cancelled visit.|1
2907283|NCT01690052|10009663|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
2907284|NCT01690052|10009664|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
2907285|NCT01689974|10009681|P2|Overall Study|Termination of Study|5
2907286|NCT01689974|10009682|P1|Overall Study|Termination of Study|5
2907287|NCT01689857|10009713|P2|Overall Study|Lost to Follow-up|2
2907288|NCT01689857|10009714|P1|Overall Study|Lost to Follow-up|5
2907289|NCT01689649|10009762|P1|Overall Study|Lost to Follow-up|5
2907290|NCT01689649|10009762|P1|Overall Study|Protocol Violation|3
2907291|NCT01689649|10009762|P1|Overall Study|Non-compliance|11
2907292|NCT01689649|10009762|P1|Overall Study|Lack of Efficacy|3
2907293|NCT01689532|10009774|P2|Overall Study|Physician Decision|0
2907294|NCT01689532|10009775|P1|Overall Study|Physician Decision|2
2907295|NCT01689532|10009774|P2|Overall Study|Withdrawal by Subject|2
2907296|NCT01689532|10009775|P1|Overall Study|Withdrawal by Subject|1
2907297|NCT01689532|10009774|P2|Overall Study|Lack of Efficacy|2
2907298|NCT01689532|10009775|P1|Overall Study|Lack of Efficacy|2
2907299|NCT01689532|10009774|P2|Overall Study|Adverse Event|5
2907300|NCT01689532|10009775|P1|Overall Study|Adverse Event|9
2907301|NCT01689519|10009839|P2|Overall Study|Physician Decision|3
2907302|NCT01689519|10009840|P1|Overall Study|Physician Decision|0
2907303|NCT01689519|10009839|P2|Overall Study|Withdrawal by Subject|17
2907304|NCT01689519|10009840|P1|Overall Study|Withdrawal by Subject|17
2907305|NCT01689519|10009839|P2|Overall Study|Lost to Follow-up|2
2907306|NCT01689519|10009840|P1|Overall Study|Lost to Follow-up|6
2907307|NCT01689519|10009839|P2|Overall Study|Death|116
2907308|NCT01689519|10009840|P1|Overall Study|Death|143
2907309|NCT01689363|10009867|P8|Overall Study|Protocol Violation|0
2907310|NCT01689363|10009868|P7|Overall Study|Protocol Violation|0
2907311|NCT01689363|10009869|P6|Overall Study|Protocol Violation|0
2907312|NCT01689363|10009870|P5|Overall Study|Protocol Violation|0
2907313|NCT01689363|10009871|P4|Overall Study|Protocol Violation|0
2907314|NCT01689363|10009872|P3|Overall Study|Protocol Violation|0
2907315|NCT01689363|10009873|P2|Overall Study|Protocol Violation|1
2907316|NCT01689363|10009874|P1|Overall Study|Protocol Violation|0
2907317|NCT01689337|10009929|P1|Overall Study|Study Discontinuation|1
2907318|NCT01689207|10009968|P11|Overall Study|Adverse Event|0
2907319|NCT01689207|10009969|P10|Overall Study|Adverse Event|0
2907320|NCT01689207|10009970|P9|Overall Study|Adverse Event|1
2907321|NCT01689207|10009971|P8|Overall Study|Adverse Event|0
2907322|NCT01689207|10009972|P7|Overall Study|Adverse Event|0
2907323|NCT01689207|10009973|P6|Overall Study|Adverse Event|1
2907324|NCT01689207|10009974|P5|Overall Study|Adverse Event|2
2907325|NCT01689207|10009975|P4|Overall Study|Adverse Event|0
2907326|NCT01689207|10009976|P3|Overall Study|Adverse Event|0
2907327|NCT01689207|10009977|P2|Overall Study|Adverse Event|1
2907328|NCT01689207|10009978|P1|Overall Study|Adverse Event|0
2907329|NCT01688973|10010085|P2|Overall Study|Ineligible|3
2907330|NCT01688973|10010086|P1|Overall Study|Ineligible|2
2907331|NCT01688921|10010100|P2|Overall Study|informed consent|0
2907332|NCT01688921|10010101|P1|Overall Study|informed consent|3
2907333|NCT01688921|10010100|P2|Overall Study|Protocol Violation|1
2907334|NCT01688921|10010101|P1|Overall Study|Protocol Violation|0
2907335|NCT01688921|10010100|P2|Overall Study|Physician Decision|1
2907336|NCT01688921|10010101|P1|Overall Study|Physician Decision|6
2907337|NCT01688921|10010100|P2|Overall Study|Lost to Follow-up|13
2907338|NCT01688921|10010101|P1|Overall Study|Lost to Follow-up|7
2907339|NCT01688882|10010133|P2|Overall Study|Administrative problems|0
2907340|NCT01688882|10010134|P1|Overall Study|Administrative problems|1
2907341|NCT01688882|10010133|P2|Overall Study|Unsatisfactory therapeutic effect|1
2907342|NCT01688882|10010134|P1|Overall Study|Unsatisfactory therapeutic effect|1
2907343|NCT01688882|10010133|P2|Overall Study|Adverse Event|0
2907344|NCT01688882|10010134|P1|Overall Study|Adverse Event|1
2907345|NCT01688830|10010205|P21|Overall Study|Lost to Follow-up|0
2907346|NCT01688830|10010206|P20|Overall Study|Lost to Follow-up|0
2907347|NCT01688830|10010207|P19|Overall Study|Lost to Follow-up|0
2907348|NCT01688830|10010208|P18|Overall Study|Lost to Follow-up|0
2907349|NCT01688830|10010209|P17|Overall Study|Lost to Follow-up|0
2907350|NCT01688830|10010210|P16|Overall Study|Lost to Follow-up|0
2907351|NCT01688830|10010211|P15|Overall Study|Lost to Follow-up|0
2907352|NCT01688830|10010212|P14|Overall Study|Lost to Follow-up|0
2907353|NCT01688830|10010213|P13|Overall Study|Lost to Follow-up|0
2907354|NCT01688830|10010214|P12|Overall Study|Lost to Follow-up|0
2907355|NCT01688830|10010215|P11|Overall Study|Lost to Follow-up|1
2907356|NCT01688830|10010216|P10|Overall Study|Lost to Follow-up|0
2907357|NCT01688830|10010217|P9|Overall Study|Lost to Follow-up|0
2907358|NCT01688830|10010218|P8|Overall Study|Lost to Follow-up|0
2907359|NCT01688830|10010219|P7|Overall Study|Lost to Follow-up|0
2907360|NCT01688830|10010220|P6|Overall Study|Lost to Follow-up|0
2907361|NCT01688830|10010221|P5|Overall Study|Lost to Follow-up|0
2907362|NCT01688830|10010222|P4|Overall Study|Lost to Follow-up|0
2907363|NCT01688830|10010223|P3|Overall Study|Lost to Follow-up|0
2907364|NCT01688830|10010224|P2|Overall Study|Lost to Follow-up|0
2907365|NCT01688830|10010225|P1|Overall Study|Lost to Follow-up|0
2907366|NCT01688739|10010379|P10|Overall Study|Administrative Decision|0
2907367|NCT01688739|10010380|P9|Overall Study|Administrative Decision|0
2907368|NCT01688739|10010381|P8|Overall Study|Administrative Decision|0
2907369|NCT01688739|10010382|P7|Overall Study|Administrative Decision|0
2907370|NCT01688739|10010383|P6|Overall Study|Administrative Decision|0
2907371|NCT01688739|10010384|P5|Overall Study|Administrative Decision|0
2907372|NCT01688739|10010385|P4|Overall Study|Administrative Decision|0
2907373|NCT01688739|10010386|P3|Overall Study|Administrative Decision|0
2907374|NCT01688739|10010387|P2|Overall Study|Administrative Decision|0
2907375|NCT01688739|10010388|P1|Overall Study|Administrative Decision|1
2907376|NCT01688726|10010464|P2|Overall Study|Relocated abroad|1
2907377|NCT01688726|10010465|P1|Overall Study|Relocated abroad|0
2907378|NCT01688726|10010464|P2|Overall Study|Adverse Event|0
2907379|NCT01688726|10010465|P1|Overall Study|Adverse Event|1
2907380|NCT01688635|10010477|P2|Washout 3|Withdrawal by Subject|0
2907381|NCT01688635|10010478|P1|Washout 3|Withdrawal by Subject|1
2907382|NCT01688635|10010477|P2|Washout 2|Sponsor Decision|2
2907383|NCT01688635|10010478|P1|Washout 2|Sponsor Decision|1
2907384|NCT01688635|10010477|P2|Washout 2|Withdrawal by Subject|0
2907385|NCT01688635|10010478|P1|Washout 2|Withdrawal by Subject|1
2907386|NCT01688635|10010477|P2|Washout 2|Physician Decision|0
2907387|NCT01688635|10010478|P1|Washout 2|Physician Decision|1
2907388|NCT01688635|10010477|P2|Washout 1|Physician Decision|1
2907389|NCT01688635|10010478|P1|Washout 1|Physician Decision|0
2907390|NCT01688635|10010477|P2|Washout 1|Adverse Event|1
2907391|NCT01688635|10010478|P1|Washout 1|Adverse Event|0
2907392|NCT01688635|10010477|P2|Washout 1|Withdrawal by Subject|0
2907393|NCT01688635|10010478|P1|Washout 1|Withdrawal by Subject|1
2907394|NCT01688466|10010525|P2|Overall Study|Not evaluable|1
2907395|NCT01688466|10010526|P1|Overall Study|Not evaluable|0
2907396|NCT01688466|10010525|P2|Overall Study|Adverse Event|4
2907397|NCT01688466|10010526|P1|Overall Study|Adverse Event|0
2907398|NCT01688466|10010525|P2|Overall Study|Death|1
2907399|NCT01688466|10010526|P1|Overall Study|Death|0
2907400|NCT01688466|10010525|P2|Overall Study|Withdrawal by Subject|1
2907401|NCT01688466|10010526|P1|Overall Study|Withdrawal by Subject|2
2907402|NCT01688050|10010617|P1|Overall Study|Still be eligible for follow-up|37
2907403|NCT01688050|10010617|P1|Overall Study|Withdrawal by Subject|2
2907404|NCT01688050|10010617|P1|Overall Study|Lost to Follow-up|5
2907405|NCT01688050|10010617|P1|Overall Study|Conversion to open repair|1
2907406|NCT01688050|10010617|P1|Overall Study|Death|5
2907407|NCT01688037|10010626|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2907408|NCT01688037|10010627|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
2907409|NCT01688037|10010628|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2907410|NCT01688037|10010626|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
2907411|NCT01688037|10010627|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2907412|NCT01688037|10010628|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2907413|NCT01688037|10010626|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
2907414|NCT01688037|10010627|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
2907415|NCT01688037|10010628|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
2907416|NCT01688037|10010626|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
2907417|NCT01688037|10010627|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
2907418|NCT01688037|10010628|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
2907419|NCT01688037|10010626|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
2907420|NCT01688037|10010627|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
2907421|NCT01688037|10010628|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
2907422|NCT01688037|10010626|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2907423|NCT01688037|10010627|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
2907424|NCT01688037|10010628|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2907425|NCT01688037|10010626|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2907426|NCT01688037|10010627|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2907427|NCT01688037|10010628|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2907428|NCT01688037|10010626|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2907429|NCT01688037|10010627|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
2907430|NCT01688037|10010628|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
2907431|NCT01688037|10010626|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2907432|NCT01688037|10010627|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2907433|NCT01688037|10010628|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
2907434|NCT01688037|10010626|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2907435|NCT01688037|10010627|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2907436|NCT01688037|10010628|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2907437|NCT01687998|10010644|P2|Overall Study|Lost to Follow-up|7
2907438|NCT01687998|10010645|P1|Overall Study|Lost to Follow-up|9
2907439|NCT01687998|10010644|P2|Overall Study|Known to be Alive at Study End|62
2907440|NCT01687998|10010645|P1|Overall Study|Known to be Alive at Study End|54
2907441|NCT01687998|10010644|P2|Overall Study|Withdrawal by Subject|51
2907442|NCT01687998|10010645|P1|Overall Study|Withdrawal by Subject|49
2907443|NCT01687712|10010681|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
2907444|NCT01687712|10010682|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
2907445|NCT01687712|10010681|P2|Cycle 3|Ectopic Pregnancy|0
2907446|NCT01687712|10010682|P1|Cycle 3|Ectopic Pregnancy|1
2907447|NCT01687712|10010681|P2|Cycle 3|Early Pregnancy Loss|2
2907448|NCT01687712|10010682|P1|Cycle 3|Early Pregnancy Loss|1
2907449|NCT01687712|10010681|P2|Cycle 3|Not Biochemically Pregnant|22
2907450|NCT01687712|10010682|P1|Cycle 3|Not Biochemically Pregnant|21
2907451|NCT01687712|10010681|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
2907452|NCT01687712|10010682|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
2907453|NCT01687712|10010681|P2|Cycle 2|Still Birth|0
2907454|NCT01687712|10010682|P1|Cycle 2|Still Birth|1
2907455|NCT01687712|10010681|P2|Cycle 2|Ectopic Pregnancy|1
2907456|NCT01687712|10010682|P1|Cycle 2|Ectopic Pregnancy|0
2907457|NCT01687712|10010681|P2|Cycle 2|Early Pregnancy Loss|16
2907458|NCT01687712|10010682|P1|Cycle 2|Early Pregnancy Loss|18
2907459|NCT01687712|10010681|P2|Cycle 2|Not Biochemically Pregnant|77
2907460|NCT01687712|10010682|P1|Cycle 2|Not Biochemically Pregnant|74
2907461|NCT01687712|10010681|P2|Cycle 1|Lost to Follow-up|1
2907462|NCT01687712|10010682|P1|Cycle 1|Lost to Follow-up|1
2907463|NCT01687712|10010681|P2|Cycle 1|Intrauterine Fetal Death|1
2907464|NCT01687712|10010682|P1|Cycle 1|Intrauterine Fetal Death|0
2907465|NCT01687712|10010681|P2|Cycle 1|Abortion|0
2907466|NCT01687712|10010682|P1|Cycle 1|Abortion|3
2907467|NCT01687712|10010681|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
2907468|NCT01687712|10010682|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
2907469|NCT01687712|10010681|P2|Cycle 1|Heterotropic Pregnancy|0
2907470|NCT01687712|10010682|P1|Cycle 1|Heterotropic Pregnancy|1
2907471|NCT01687712|10010681|P2|Cycle 1|Ectopic Pregnancy|5
2907472|NCT01687712|10010682|P1|Cycle 1|Ectopic Pregnancy|5
2907473|NCT01687712|10010681|P2|Cycle 1|Early Pregnancy Loss|60
2907474|NCT01687712|10010682|P1|Cycle 1|Early Pregnancy Loss|43
2907475|NCT01687712|10010681|P2|Cycle 1|Not Biochemically Pregnant|348
2907476|NCT01687712|10010682|P1|Cycle 1|Not Biochemically Pregnant|386
2907477|NCT01687478|10010722|P2|Overall Study|Entry Criteria Not Met|2
2907478|NCT01687478|10010723|P1|Overall Study|Entry Criteria Not Met|6
2907479|NCT01687478|10010722|P2|Overall Study|Physician Decision|3
2907480|NCT01687478|10010723|P1|Overall Study|Physician Decision|1
2907481|NCT01687478|10010722|P2|Overall Study|Withdrawal by Subject|19
2907482|NCT01687478|10010723|P1|Overall Study|Withdrawal by Subject|21
2907483|NCT01687478|10010722|P2|Overall Study|Protocol Violation|2
2907484|NCT01687478|10010723|P1|Overall Study|Protocol Violation|0
2907485|NCT01687478|10010722|P2|Overall Study|Lost to Follow-up|3
2907486|NCT01687478|10010723|P1|Overall Study|Lost to Follow-up|1
2907487|NCT01687478|10010722|P2|Overall Study|Adverse Event|10
2907488|NCT01687478|10010723|P1|Overall Study|Adverse Event|3
2907489|NCT01687296|10010774|P2|Overall Study|Withdrawal by Subject|3
2907490|NCT01687296|10010775|P1|Overall Study|Withdrawal by Subject|6
2907491|NCT01687296|10010774|P2|Overall Study|Protocol Violation|1
2907492|NCT01687296|10010775|P1|Overall Study|Protocol Violation|0
2907493|NCT01687296|10010774|P2|Overall Study|Lack of Efficacy|1
2907494|NCT01687296|10010775|P1|Overall Study|Lack of Efficacy|1
2907495|NCT01687283|10010797|P2|Overall Study|Withdrawal by Subject|8
2907496|NCT01687283|10010798|P1|Overall Study|Withdrawal by Subject|9
2907497|NCT01687283|10010797|P2|Overall Study|Investigator discretion|0
2907498|NCT01687283|10010798|P1|Overall Study|Investigator discretion|2
2907499|NCT01687283|10010797|P2|Overall Study|Lost to Follow-up|1
2907500|NCT01687283|10010798|P1|Overall Study|Lost to Follow-up|1
2907501|NCT01687283|10010797|P2|Overall Study|protocol defined stopping criteria|10
2907502|NCT01687283|10010798|P1|Overall Study|protocol defined stopping criteria|8
2907503|NCT01687283|10010797|P2|Overall Study|Protocol Violation|3
2907504|NCT01687283|10010798|P1|Overall Study|Protocol Violation|1
2907505|NCT01687283|10010797|P2|Overall Study|Lack of Efficacy|1
2907506|NCT01687283|10010798|P1|Overall Study|Lack of Efficacy|3
2907507|NCT01687283|10010797|P2|Overall Study|Adverse Event|4
2907508|NCT01687283|10010798|P1|Overall Study|Adverse Event|11
2907509|NCT01687270|10010821|P1|Overall Study|Lost to Follow-up|1
2907510|NCT01687270|10010821|P1|Overall Study|Lack of Efficacy|11
2907511|NCT01687257|10010832|P3|Overall Study|Investigator's Discretion|0
2907512|NCT01687257|10010833|P2|Overall Study|Investigator's Discretion|3
2907513|NCT01687257|10010834|P1|Overall Study|Investigator's Discretion|0
2907514|NCT01687257|10010832|P3|Overall Study|Adverse Event|0
2907515|NCT01687257|10010833|P2|Overall Study|Adverse Event|0
2907516|NCT01687257|10010834|P1|Overall Study|Adverse Event|1
2907517|NCT01687257|10010832|P3|Overall Study|Subject Withdrew Consent|1
2907518|NCT01687257|10010833|P2|Overall Study|Subject Withdrew Consent|1
2907519|NCT01687257|10010834|P1|Overall Study|Subject Withdrew Consent|1
2907520|NCT01687257|10010832|P3|Overall Study|Efficacy Failure|5
2907521|NCT01687257|10010833|P2|Overall Study|Efficacy Failure|0
2907522|NCT01687257|10010834|P1|Overall Study|Efficacy Failure|6
2907523|NCT01687218|10010899|P6|Overall Study|Relocated, no follow-up planned|0
2907524|NCT01687218|10010900|P5|Overall Study|Relocated, no follow-up planned|0
2907525|NCT01687218|10010901|P4|Overall Study|Relocated, no follow-up planned|1
2907526|NCT01687218|10010902|P3|Overall Study|Relocated, no follow-up planned|1
2907527|NCT01687218|10010903|P2|Overall Study|Relocated, no follow-up planned|0
2907528|NCT01687218|10010904|P1|Overall Study|Relocated, no follow-up planned|1
2907529|NCT01687218|10010899|P6|Overall Study|Withdrawal by Subject|0
2907530|NCT01687218|10010900|P5|Overall Study|Withdrawal by Subject|1
2907531|NCT01687218|10010901|P4|Overall Study|Withdrawal by Subject|1
2907532|NCT01687218|10010902|P3|Overall Study|Withdrawal by Subject|0
2907533|NCT01687218|10010903|P2|Overall Study|Withdrawal by Subject|3
2907534|NCT01687218|10010904|P1|Overall Study|Withdrawal by Subject|2
2907535|NCT01687166|10010956|P4|Overall Study|Insurance|1
2907536|NCT01687166|10010957|P3|Overall Study|Insurance|1
2907537|NCT01687166|10010958|P2|Overall Study|Insurance|0
2907538|NCT01687166|10010959|P1|Overall Study|Insurance|0
2907539|NCT01687166|10010956|P4|Overall Study|Physician choice to use different device|0
2907540|NCT01687166|10010957|P3|Overall Study|Physician choice to use different device|4
2907541|NCT01687166|10010958|P2|Overall Study|Physician choice to use different device|2
2907542|NCT01687166|10010959|P1|Overall Study|Physician choice to use different device|1
2907543|NCT01687166|10010956|P4|Overall Study|Patient unable to be compliant|0
2907544|NCT01687166|10010957|P3|Overall Study|Patient unable to be compliant|0
2907545|NCT01687166|10010958|P2|Overall Study|Patient unable to be compliant|0
2907546|NCT01687166|10010959|P1|Overall Study|Patient unable to be compliant|1
2907547|NCT01687166|10010956|P4|Overall Study|Subject moved out of state|0
2907548|NCT01687166|10010957|P3|Overall Study|Subject moved out of state|0
2907549|NCT01687166|10010958|P2|Overall Study|Subject moved out of state|1
2907550|NCT01687166|10010959|P1|Overall Study|Subject moved out of state|0
2907551|NCT01687166|10010956|P4|Overall Study|Protocol Violation|0
2907552|NCT01687166|10010957|P3|Overall Study|Protocol Violation|1
2907553|NCT01687166|10010958|P2|Overall Study|Protocol Violation|1
2907554|NCT01687166|10010959|P1|Overall Study|Protocol Violation|1
2907555|NCT01687166|10010956|P4|Overall Study|Death|0
2907556|NCT01687166|10010957|P3|Overall Study|Death|0
2907557|NCT01687166|10010958|P2|Overall Study|Death|1
2907558|NCT01687166|10010959|P1|Overall Study|Death|1
2907559|NCT01687166|10010956|P4|Overall Study|Equipment/Device Availability|0
2907560|NCT01687166|10010957|P3|Overall Study|Equipment/Device Availability|0
2907561|NCT01687166|10010958|P2|Overall Study|Equipment/Device Availability|1
2907562|NCT01687166|10010959|P1|Overall Study|Equipment/Device Availability|0
2907563|NCT01687166|10010956|P4|Overall Study|Lost to Follow-up|0
2907564|NCT01687166|10010957|P3|Overall Study|Lost to Follow-up|1
2907565|NCT01687166|10010958|P2|Overall Study|Lost to Follow-up|5
2907566|NCT01687166|10010959|P1|Overall Study|Lost to Follow-up|2
2907567|NCT01687166|10010956|P4|Overall Study|Withdrawal by Subject|0
2907568|NCT01687166|10010957|P3|Overall Study|Withdrawal by Subject|3
2907569|NCT01687166|10010958|P2|Overall Study|Withdrawal by Subject|4
2907570|NCT01687166|10010959|P1|Overall Study|Withdrawal by Subject|11
2907571|NCT01687166|10010956|P4|Overall Study|Physician Decision|0
2907572|NCT01687166|10010957|P3|Overall Study|Physician Decision|1
2907573|NCT01687166|10010958|P2|Overall Study|Physician Decision|2
2907574|NCT01687166|10010959|P1|Overall Study|Physician Decision|3
2907575|NCT01687166|10010956|P4|Overall Study|Adverse Event|0
2907576|NCT01687166|10010957|P3|Overall Study|Adverse Event|0
2907577|NCT01687166|10010958|P2|Overall Study|Adverse Event|1
2907578|NCT01687166|10010959|P1|Overall Study|Adverse Event|2
2907579|NCT01687166|10010956|P4|Overall Study|Did not meet eligibility criteria|1
2907580|NCT01687166|10010957|P3|Overall Study|Did not meet eligibility criteria|1
2907581|NCT01687166|10010958|P2|Overall Study|Did not meet eligibility criteria|6
2907582|NCT01687166|10010959|P1|Overall Study|Did not meet eligibility criteria|4
2907583|NCT01687166|10010956|P4|Overall Study|Attempt subject|0
2907584|NCT01687166|10010957|P3|Overall Study|Attempt subject|2
2907585|NCT01687166|10010958|P2|Overall Study|Attempt subject|3
2907586|NCT01687166|10010959|P1|Overall Study|Attempt subject|2
2907587|NCT01687101|10010975|P1|Overall Study|Lost to Follow-up|7
2907588|NCT01686958|10011000|P1|Overall Study|Withdrawal by Subject|1
2907589|NCT01686932|10011013|P2|Period 1|Adverse Event|1
2907590|NCT01686932|10011014|P1|Period 1|Adverse Event|1
2907591|NCT01686828|10011044|P4|Overall Study|Weight Loss|0
2907592|NCT01686828|10011045|P3|Overall Study|Weight Loss|1
2907593|NCT01686828|10011046|P2|Overall Study|Weight Loss|0
2907594|NCT01686828|10011047|P1|Overall Study|Weight Loss|0
2907595|NCT01686828|10011044|P4|Overall Study|New Job|0
2907596|NCT01686828|10011045|P3|Overall Study|New Job|0
2907597|NCT01686828|10011046|P2|Overall Study|New Job|1
2907598|NCT01686828|10011047|P1|Overall Study|New Job|0
2907599|NCT01686828|10011044|P4|Overall Study|Physician Decision|0
2907600|NCT01686828|10011045|P3|Overall Study|Physician Decision|0
2907601|NCT01686828|10011046|P2|Overall Study|Physician Decision|0
2907602|NCT01686828|10011047|P1|Overall Study|Physician Decision|1
2907603|NCT01686633|10011160|P3|Overall Study|Lost to Follow-up|1
2907604|NCT01686633|10011161|P2|Overall Study|Lost to Follow-up|1
2907605|NCT01686633|10011162|P1|Overall Study|Lost to Follow-up|0
2907606|NCT01686633|10011160|P3|Overall Study|Protocol-defined Stopping Criteria|1
2907607|NCT01686633|10011161|P2|Overall Study|Protocol-defined Stopping Criteria|0
2907608|NCT01686633|10011162|P1|Overall Study|Protocol-defined Stopping Criteria|1
2907609|NCT01686633|10011160|P3|Overall Study|Protocol Violation|0
2907610|NCT01686633|10011161|P2|Overall Study|Protocol Violation|3
2907611|NCT01686633|10011162|P1|Overall Study|Protocol Violation|2
2907612|NCT01686633|10011160|P3|Overall Study|Adverse Event|3
2907613|NCT01686633|10011161|P2|Overall Study|Adverse Event|3
2907614|NCT01686633|10011162|P1|Overall Study|Adverse Event|4
2907615|NCT01686633|10011160|P3|Overall Study|Physician Decision|4
2907616|NCT01686633|10011161|P2|Overall Study|Physician Decision|4
2907617|NCT01686633|10011162|P1|Overall Study|Physician Decision|3
2907618|NCT01686633|10011160|P3|Overall Study|Withdrawal by Subject|5
2907619|NCT01686633|10011161|P2|Overall Study|Withdrawal by Subject|8
2907620|NCT01686633|10011162|P1|Overall Study|Withdrawal by Subject|8
2907621|NCT01686633|10011160|P3|Overall Study|Lack of Efficacy|11
2907622|NCT01686633|10011161|P2|Overall Study|Lack of Efficacy|13
2907623|NCT01686633|10011162|P1|Overall Study|Lack of Efficacy|33
2907624|NCT01686581|10011185|P1|Overall Study|Reason Missing|1
2907625|NCT01686581|10011185|P1|Overall Study|Other Miscellaneous Reasons|36
2907626|NCT01686581|10011185|P1|Overall Study|Thinks it is Inconvenient|17
2907627|NCT01686581|10011185|P1|Overall Study|Trying to get Pregnant or Nursing|2
2907628|NCT01686581|10011185|P1|Overall Study|Thinks Injections Take Too Much Time|2
2907629|NCT01686581|10011185|P1|Overall Study|Thinks Injections Too Painful|8
2907630|NCT01686581|10011185|P1|Overall Study|Participant Concerned about Risks|6
2907631|NCT01686581|10011185|P1|Overall Study|Lack of Efficacy|90
2907632|NCT01686581|10011185|P1|Overall Study|Side-effects or Health Problems|15
2907633|NCT01686568|10011198|P2|Sub-Study|Not consented for sub-study|2
2907634|NCT01686568|10011199|P1|Sub-Study|Not consented for sub-study|2
2907635|NCT01686568|10011198|P2|Main Study|Liver enzymes above range of exclusion|0
2907636|NCT01686568|10011199|P1|Main Study|Liver enzymes above range of exclusion|1
2907637|NCT01686568|10011198|P2|Main Study|Noncompliance with protocol|1
2907638|NCT01686568|10011199|P1|Main Study|Noncompliance with protocol|0
2907639|NCT01686568|10011198|P2|Main Study|Withdrawal by Subject|3
2907640|NCT01686568|10011199|P1|Main Study|Withdrawal by Subject|1
2907641|NCT01686438|10011276|P3|Overall Study|Withdrawal by Subject|1
2907642|NCT01686438|10011277|P2|Overall Study|Withdrawal by Subject|0
2907643|NCT01686438|10011278|P1|Overall Study|Withdrawal by Subject|0
2907644|NCT01686438|10011276|P3|Overall Study|Protocol Violation|1
2907645|NCT01686438|10011277|P2|Overall Study|Protocol Violation|0
2907646|NCT01686438|10011278|P1|Overall Study|Protocol Violation|0
2907647|NCT01686438|10011276|P3|Overall Study|Adverse Event|1
2907648|NCT01686438|10011277|P2|Overall Study|Adverse Event|0
2907649|NCT01686438|10011278|P1|Overall Study|Adverse Event|0
2907650|NCT01686438|10011276|P3|Overall Study|Lost to Follow-up|10
2907651|NCT01686438|10011277|P2|Overall Study|Lost to Follow-up|9
2907652|NCT01686438|10011278|P1|Overall Study|Lost to Follow-up|8
2907653|NCT01686373|10011326|P2|Overall Study|Adverse Event|1
2907654|NCT01686373|10011327|P1|Overall Study|Adverse Event|0
2907655|NCT01686373|10011326|P2|Overall Study|Withdrawal by Subject|1
2907656|NCT01686373|10011327|P1|Overall Study|Withdrawal by Subject|0
2907657|NCT01686373|10011326|P2|Overall Study|Lost to Follow-up|0
2907658|NCT01686373|10011327|P1|Overall Study|Lost to Follow-up|3
2907659|NCT01685983|10011351|P1|Overall Study|Noncompliance with Study Drug|1
2907660|NCT01685983|10011351|P1|Overall Study|Progressive Disease|32
2907661|NCT01685983|10011351|P1|Overall Study|Other|7
2907662|NCT01685983|10011351|P1|Overall Study|Physician Decision|13
2907663|NCT01685983|10011351|P1|Overall Study|Protocol Violation|2
2907664|NCT01685983|10011351|P1|Overall Study|Withdrawal by Subject|19
2907665|NCT01685983|10011351|P1|Overall Study|Death|1
2907666|NCT01685983|10011351|P1|Overall Study|Adverse Event|7
2907667|NCT01685840|10011363|P2|Overall Study|Had VAD, Dialysis or Transplant|17
2907668|NCT01685840|10011364|P1|Overall Study|Had VAD, Dialysis or Transplant|11
2907669|NCT01685840|10011363|P2|Overall Study|Futility|200
2907670|NCT01685840|10011364|P1|Overall Study|Futility|197
2907671|NCT01685840|10011363|P2|Overall Study|Withdrawal by Subject|17
2907672|NCT01685840|10011364|P1|Overall Study|Withdrawal by Subject|14
2907673|NCT01685840|10011363|P2|Overall Study|Physician Decision|7
2907674|NCT01685840|10011364|P1|Overall Study|Physician Decision|3
2907675|NCT01685840|10011363|P2|Overall Study|Lost to Follow-up|25
2907676|NCT01685840|10011364|P1|Overall Study|Lost to Follow-up|27
2907677|NCT01685840|10011363|P2|Overall Study|Death|66
2907678|NCT01685840|10011364|P1|Overall Study|Death|77
2907679|NCT01685801|10011408|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2907680|NCT01685801|10011409|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2907681|NCT01685801|10011410|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2907682|NCT01685801|10011411|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2907683|NCT01685801|10011408|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
2907684|NCT01685801|10011409|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2907685|NCT01685801|10011410|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2907686|NCT01685801|10011411|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2907687|NCT01685697|10011433|P2|Overall Study|Protocol Violation|3
2907688|NCT01685697|10011434|P1|Overall Study|Protocol Violation|3
2907689|NCT01685606|10011468|P1|Overall Study|Withdrawal by Subject|1
2907690|NCT01685437|10011496|P1|Overall Study|Unable to make visits due to work|1
2907691|NCT01685437|10011496|P1|Overall Study|Protocol Violation|4
2907692|NCT01685437|10011496|P1|Overall Study|Adverse Event|1
2907693|NCT01685437|10011496|P1|Overall Study|Lost to Follow-up|3
2907694|NCT01685437|10011496|P1|Overall Study|Withdrawal by Subject|22
2907695|NCT01685372|10011510|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
2907696|NCT01685372|10011511|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
2907697|NCT01685229|10011601|P2|Overall Study|Death|0
2907698|NCT01685229|10011602|P1|Overall Study|Death|1
2907699|NCT01685229|10011601|P2|Overall Study|Withdrawal by Subject|5
2907700|NCT01685229|10011602|P1|Overall Study|Withdrawal by Subject|6
2907701|NCT01685229|10011601|P2|Overall Study|Lost to Follow-up|10
2907702|NCT01685229|10011602|P1|Overall Study|Lost to Follow-up|16
2907703|NCT01685229|10011601|P2|Overall Study|Subjects missing Study Exit form|1
2907704|NCT01685229|10011602|P1|Overall Study|Subjects missing Study Exit form|3
2907705|NCT01685216|10011628|P1|Overall Study|Did not receive study drug|1
2907706|NCT01685203|10011645|P7|Overall Study|Patient's decision|0
2907707|NCT01685203|10011646|P6|Overall Study|Patient's decision|1
2907708|NCT01685203|10011647|P5|Overall Study|Patient's decision|0
2907709|NCT01685203|10011648|P4|Overall Study|Patient's decision|0
2907710|NCT01685203|10011649|P3|Overall Study|Patient's decision|0
2907711|NCT01685203|10011650|P2|Overall Study|Patient's decision|0
2907712|NCT01685203|10011651|P1|Overall Study|Patient's decision|0
2907713|NCT01685203|10011645|P7|Overall Study|Adverse event and withdrew consent|0
2907714|NCT01685203|10011646|P6|Overall Study|Adverse event and withdrew consent|0
2907715|NCT01685203|10011647|P5|Overall Study|Adverse event and withdrew consent|0
2907716|NCT01685203|10011648|P4|Overall Study|Adverse event and withdrew consent|0
2907717|NCT01685203|10011649|P3|Overall Study|Adverse event and withdrew consent|0
2907718|NCT01685203|10011650|P2|Overall Study|Adverse event and withdrew consent|0
2907719|NCT01685203|10011651|P1|Overall Study|Adverse event and withdrew consent|1
2907720|NCT01685203|10011645|P7|Overall Study|Adverse Event|0
2907721|NCT01685203|10011646|P6|Overall Study|Adverse Event|2
2907722|NCT01685203|10011647|P5|Overall Study|Adverse Event|0
2907723|NCT01685203|10011648|P4|Overall Study|Adverse Event|0
2907724|NCT01685203|10011649|P3|Overall Study|Adverse Event|0
2907725|NCT01685203|10011650|P2|Overall Study|Adverse Event|0
2907726|NCT01685203|10011651|P1|Overall Study|Adverse Event|0
2907727|NCT01685203|10011645|P7|Overall Study|Lost to Follow-up|0
2907728|NCT01685203|10011646|P6|Overall Study|Lost to Follow-up|0
2907729|NCT01685203|10011647|P5|Overall Study|Lost to Follow-up|0
2907730|NCT01685203|10011648|P4|Overall Study|Lost to Follow-up|1
2907731|NCT01685203|10011649|P3|Overall Study|Lost to Follow-up|0
2907732|NCT01685203|10011650|P2|Overall Study|Lost to Follow-up|3
2907733|NCT01685203|10011651|P1|Overall Study|Lost to Follow-up|3
2907734|NCT01685138|10011695|P1|Overall Study|Progressive disease|53
2907735|NCT01685138|10011695|P1|Overall Study|Adverse Event|18
2907736|NCT01685138|10011695|P1|Overall Study|Death|10
2907737|NCT01685138|10011695|P1|Overall Study|Physician Decision|6
2907738|NCT01685138|10011695|P1|Overall Study|Subject/guardian decision|2
2907739|NCT01685138|10011695|P1|Overall Study|No longer requires treatment|1
2907740|NCT01685138|10011695|P1|Overall Study|Protocol Violation|1
2907741|NCT01685138|10011695|P1|Overall Study|Lost to Follow-up|1
2907742|NCT01685073|10011711|P2|Overall Study|Withdrawal by Subject|24
2907743|NCT01685073|10011712|P1|Overall Study|Withdrawal by Subject|24
2907744|NCT01685073|10011711|P2|Overall Study|Lost to Follow-up|8
2907745|NCT01685073|10011712|P1|Overall Study|Lost to Follow-up|6
2907746|NCT01685060|10011720|P1|Overall Study|Death|8
2907747|NCT01685060|10011720|P1|Overall Study|Lost to Follow-up|1
2907748|NCT01685060|10011720|P1|Overall Study|Subject/guardian decision|20
2907749|NCT01685060|10011720|P1|Overall Study|Physician Decision|14
2907750|NCT01685060|10011720|P1|Overall Study|Progressive disease|69
2907751|NCT01685060|10011720|P1|Overall Study|Adverse Event|12
2907752|NCT01685060|10011720|P1|Overall Study|Rollover patients|16
2907753|NCT01685047|10011735|P1|Overall Study|patient withdrawn by sponsor|1
2907754|NCT01685047|10011735|P1|Overall Study|Adverse Event|5
2907755|NCT01685047|10011735|P1|Overall Study|Physician Decision|25
2907756|NCT01685047|10011735|P1|Overall Study|Lost to Follow-up|8
2907757|NCT01685047|10011735|P1|Overall Study|Death|26
2907758|NCT01685047|10011735|P1|Overall Study|Withdrawal by Subject|20
2907759|NCT01684943|10011751|P3|Overall Study|Planning Pregnancy|0
2907760|NCT01684943|10011752|P2|Overall Study|Planning Pregnancy|0
2907761|NCT01684943|10011753|P1|Overall Study|Planning Pregnancy|1
2907762|NCT01684943|10011751|P3|Overall Study|Lost to Follow-up|0
2907763|NCT01684943|10011752|P2|Overall Study|Lost to Follow-up|0
2907764|NCT01684943|10011753|P1|Overall Study|Lost to Follow-up|3
2907765|NCT01684943|10011751|P3|Overall Study|Excluded from Analysis|1
2907766|NCT01684943|10011752|P2|Overall Study|Excluded from Analysis|1
2907767|NCT01684943|10011753|P1|Overall Study|Excluded from Analysis|1
2907768|NCT01684943|10011751|P3|Overall Study|Principal Investigator Determination|0
2907769|NCT01684943|10011752|P2|Overall Study|Principal Investigator Determination|0
2907770|NCT01684943|10011753|P1|Overall Study|Principal Investigator Determination|1
2907771|NCT01684943|10011751|P3|Overall Study|Inadequate Venous Access|0
2907772|NCT01684943|10011752|P2|Overall Study|Inadequate Venous Access|0
2907773|NCT01684943|10011753|P1|Overall Study|Inadequate Venous Access|3
2907774|NCT01684930|10011772|P2|Overall Study|Withdrawal by Subject|1
2907775|NCT01684930|10011773|P1|Overall Study|Withdrawal by Subject|3
2907776|NCT01684878|10011830|P4|Part 2: Randomized Phase|Participant noncompliance|1
2907777|NCT01684878|10011831|P3|Part 2: Randomized Phase|Participant noncompliance|0
2907778|NCT01684878|10011832|P2|Part 2: Randomized Phase|Participant noncompliance|0
2907779|NCT01684878|10011833|P1|Part 2: Randomized Phase|Participant noncompliance|0
2907780|NCT01684878|10011830|P4|Part 2: Randomized Phase|Alive at data-cut|7
2907781|NCT01684878|10011831|P3|Part 2: Randomized Phase|Alive at data-cut|13
2907782|NCT01684878|10011832|P2|Part 2: Randomized Phase|Alive at data-cut|0
2907783|NCT01684878|10011833|P1|Part 2: Randomized Phase|Alive at data-cut|0
2907784|NCT01684878|10011830|P4|Part 2: Randomized Phase|Death|68
2907785|NCT01684878|10011831|P3|Part 2: Randomized Phase|Death|62
2907786|NCT01684878|10011832|P2|Part 2: Randomized Phase|Death|0
2907787|NCT01684878|10011833|P1|Part 2: Randomized Phase|Death|0
2907788|NCT01684878|10011830|P4|Part 2: Randomized Phase|Lost to Follow-up|0
2907789|NCT01684878|10011831|P3|Part 2: Randomized Phase|Lost to Follow-up|2
2907790|NCT01684878|10011832|P2|Part 2: Randomized Phase|Lost to Follow-up|0
2907791|NCT01684878|10011833|P1|Part 2: Randomized Phase|Lost to Follow-up|0
2907792|NCT01684878|10011830|P4|Part 2: Randomized Phase|Participant withdrew consent|2
2907793|NCT01684878|10011831|P3|Part 2: Randomized Phase|Participant withdrew consent|1
2907794|NCT01684878|10011832|P2|Part 2: Randomized Phase|Participant withdrew consent|0
2907795|NCT01684878|10011833|P1|Part 2: Randomized Phase|Participant withdrew consent|0
2907796|NCT01684878|10011830|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
2907797|NCT01684878|10011831|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
2907798|NCT01684878|10011832|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
2907799|NCT01684878|10011833|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
2907800|NCT01684878|10011830|P4|Part 1: Safety Run in Phase|Death|0
2907801|NCT01684878|10011831|P3|Part 1: Safety Run in Phase|Death|0
2907802|NCT01684878|10011832|P2|Part 1: Safety Run in Phase|Death|20
2907803|NCT01684878|10011833|P1|Part 1: Safety Run in Phase|Death|15
2907804|NCT01684878|10011830|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2907805|NCT01684878|10011831|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2907806|NCT01684878|10011832|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2907807|NCT01684878|10011833|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2907808|NCT01684423|10011937|P5|Overall Study|Withdrawal by Subject|0
2907809|NCT01684423|10011938|P4|Overall Study|Withdrawal by Subject|0
2907810|NCT01684423|10011939|P3|Overall Study|Withdrawal by Subject|1
2907811|NCT01684423|10011940|P2|Overall Study|Withdrawal by Subject|0
2907812|NCT01684423|10011941|P1|Overall Study|Withdrawal by Subject|0
2907813|NCT01684215|10011998|P4|Phase 2|Lost to Follow-up|4
2907814|NCT01684215|10011999|P3|Phase 2|Lost to Follow-up|0
2907815|NCT01684215|10012000|P2|Phase 2|Lost to Follow-up|0
2907816|NCT01684215|10012001|P1|Phase 2|Lost to Follow-up|0
2907817|NCT01684215|10011998|P4|Phase 2|Enrolled but not treated|1
2907818|NCT01684215|10011999|P3|Phase 2|Enrolled but not treated|0
2907819|NCT01684215|10012000|P2|Phase 2|Enrolled but not treated|0
2907820|NCT01684215|10012001|P1|Phase 2|Enrolled but not treated|0
2907821|NCT01684215|10011998|P4|Phase 2|Study terminated by sponsor|30
2907822|NCT01684215|10011999|P3|Phase 2|Study terminated by sponsor|0
2907823|NCT01684215|10012000|P2|Phase 2|Study terminated by sponsor|0
2907824|NCT01684215|10012001|P1|Phase 2|Study terminated by sponsor|0
2907825|NCT01684215|10011998|P4|Phase 2|Death|8
2907826|NCT01684215|10011999|P3|Phase 2|Death|0
2907827|NCT01684215|10012000|P2|Phase 2|Death|0
2907828|NCT01684215|10012001|P1|Phase 2|Death|0
2907829|NCT01684215|10011998|P4|Phase 1, Part 2|Withdrawal by Subject|0
2907830|NCT01684215|10011999|P3|Phase 1, Part 2|Withdrawal by Subject|1
2907831|NCT01684215|10012000|P2|Phase 1, Part 2|Withdrawal by Subject|0
2907832|NCT01684215|10012001|P1|Phase 1, Part 2|Withdrawal by Subject|0
2907833|NCT01684215|10011998|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2907834|NCT01684215|10011999|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
2907835|NCT01684215|10012000|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2907836|NCT01684215|10012001|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2907837|NCT01684215|10011998|P4|Phase 1, Part 2|Adverse Event|0
2907838|NCT01684215|10011999|P3|Phase 1, Part 2|Adverse Event|1
2907839|NCT01684215|10012000|P2|Phase 1, Part 2|Adverse Event|0
2907840|NCT01684215|10012001|P1|Phase 1, Part 2|Adverse Event|0
2907841|NCT01684215|10011998|P4|Phase 1, Part 1|Objective progression or relapse|0
2907842|NCT01684215|10011999|P3|Phase 1, Part 1|Objective progression or relapse|0
2907843|NCT01684215|10012000|P2|Phase 1, Part 1|Objective progression or relapse|6
2907844|NCT01684215|10012001|P1|Phase 1, Part 1|Objective progression or relapse|5
2907845|NCT01684215|10011998|P4|Phase 1, Part 1|Adverse Event|0
2907846|NCT01684215|10011999|P3|Phase 1, Part 1|Adverse Event|0
2907847|NCT01684215|10012000|P2|Phase 1, Part 1|Adverse Event|0
2907848|NCT01684215|10012001|P1|Phase 1, Part 1|Adverse Event|1
2907849|NCT01684046|10012075|P2|Period 1, First 30 Days|Adverse Event|2
2907850|NCT01684046|10012076|P1|Period 1, First 30 Days|Adverse Event|0
2907851|NCT01684033|10012082|P2|Period 2, Second 30 Days|Adverse Event|0
2907852|NCT01684033|10012083|P1|Period 2, Second 30 Days|Adverse Event|1
2907853|NCT01684033|10012082|P2|Period 1, First 30 Days|Lost to Follow-up|0
2907854|NCT01684033|10012083|P1|Period 1, First 30 Days|Lost to Follow-up|1
2907855|NCT01684033|10012082|P2|Period 1, First 30 Days|Withdrawal by Subject|0
2907856|NCT01684033|10012083|P1|Period 1, First 30 Days|Withdrawal by Subject|1
2907857|NCT01684033|10012082|P2|Period 1, First 30 Days|Noncompliance|0
2907858|NCT01684033|10012083|P1|Period 1, First 30 Days|Noncompliance|1
2907859|NCT01684033|10012082|P2|Period 1, First 30 Days|Adverse Event|1
2907860|NCT01684033|10012083|P1|Period 1, First 30 Days|Adverse Event|1
2907861|NCT01683994|10012107|P5|Overall Study|Intercurrent illness|1
2907862|NCT01683994|10012108|P4|Overall Study|Intercurrent illness|2
2907863|NCT01683994|10012109|P3|Overall Study|Intercurrent illness|0
2907864|NCT01683994|10012110|P2|Overall Study|Intercurrent illness|0
2907865|NCT01683994|10012111|P1|Overall Study|Intercurrent illness|0
2907866|NCT01683994|10012107|P5|Overall Study|Withdrawal by Subject|0
2907867|NCT01683994|10012108|P4|Overall Study|Withdrawal by Subject|1
2907868|NCT01683994|10012109|P3|Overall Study|Withdrawal by Subject|0
2907869|NCT01683994|10012110|P2|Overall Study|Withdrawal by Subject|0
2907870|NCT01683994|10012111|P1|Overall Study|Withdrawal by Subject|1
2907871|NCT01683838|10012152|P2|Overall Study|Other|3
2907872|NCT01683838|10012153|P1|Overall Study|Other|4
2907873|NCT01683838|10012152|P2|Overall Study|Lost to Follow-up|1
2907874|NCT01683838|10012153|P1|Overall Study|Lost to Follow-up|1
2907875|NCT01683838|10012152|P2|Overall Study|Withdrawal by Subject|5
2907876|NCT01683838|10012153|P1|Overall Study|Withdrawal by Subject|6
2907877|NCT01683838|10012152|P2|Overall Study|Protocol Violation|1
2907878|NCT01683838|10012153|P1|Overall Study|Protocol Violation|3
2907879|NCT01683838|10012152|P2|Overall Study|Adverse Event|2
2907880|NCT01683838|10012153|P1|Overall Study|Adverse Event|12
2907881|NCT01683604|10012193|P1|Overall Study|Other|2
2907882|NCT01683604|10012193|P1|Overall Study|Lack of Efficacy|1
2907883|NCT01683604|10012193|P1|Overall Study|Adverse Event|2
2907884|NCT01683565|10012358|P2|Overall Study|Discontinued Intervention|1
2907885|NCT01683565|10012359|P1|Overall Study|Discontinued Intervention|1
2907886|NCT01683565|10012358|P2|Overall Study|Lost to Follow-up|0
2907887|NCT01683565|10012359|P1|Overall Study|Lost to Follow-up|2
2907888|NCT01683409|10012393|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2907889|NCT01683409|10012394|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2907890|NCT01683409|10012395|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
2907891|NCT01683409|10012396|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2907892|NCT01683409|10012397|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2907893|NCT01683409|10012393|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
2907894|NCT01683409|10012394|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2907895|NCT01683409|10012395|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2907896|NCT01683409|10012396|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2907897|NCT01683409|10012397|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2907898|NCT01683409|10012393|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
2907899|NCT01683409|10012394|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
2907900|NCT01683409|10012395|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2907901|NCT01683409|10012396|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
2907902|NCT01683409|10012397|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2907903|NCT01683409|10012393|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2907904|NCT01683409|10012394|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2907905|NCT01683409|10012395|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2907906|NCT01683409|10012396|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2907907|NCT01683409|10012397|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
2907908|NCT01683409|10012393|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2907909|NCT01683409|10012394|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2907910|NCT01683409|10012395|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2907911|NCT01683409|10012396|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2907912|NCT01683409|10012397|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2907913|NCT01683409|10012393|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2907914|NCT01683409|10012394|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2907915|NCT01683409|10012395|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2907916|NCT01683409|10012396|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2907917|NCT01683409|10012397|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2907918|NCT01683409|10012393|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2907919|NCT01683409|10012394|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2907920|NCT01683409|10012395|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
2907921|NCT01683409|10012396|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2907922|NCT01683409|10012397|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2907923|NCT01683409|10012393|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2907924|NCT01683409|10012394|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2907925|NCT01683409|10012395|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2907926|NCT01683409|10012396|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2907927|NCT01683409|10012397|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2907928|NCT01683409|10012393|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2907929|NCT01683409|10012394|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2907930|NCT01683409|10012395|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2907931|NCT01683409|10012396|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
2907932|NCT01683409|10012397|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2907933|NCT01683409|10012393|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
2907934|NCT01683409|10012394|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
2907935|NCT01683409|10012395|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
2907936|NCT01683409|10012396|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
2907937|NCT01683409|10012397|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
2907938|NCT01683409|10012393|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2907939|NCT01683409|10012394|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2907940|NCT01683409|10012395|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
2907941|NCT01683409|10012396|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2907942|NCT01683409|10012397|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2907943|NCT01683383|10012440|P2|Overall Study|Infant was not transported|0
2907944|NCT01683383|10012441|P1|Overall Study|Infant was not transported|1
2907945|NCT01683266|10012468|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
2907946|NCT01683266|10012469|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
2907947|NCT01683266|10012468|P2|Overall Study|Possibly Hypoglycemia|0
2907948|NCT01683266|10012469|P1|Overall Study|Possibly Hypoglycemia|1
2907949|NCT01683266|10012468|P2|Overall Study|Perceived Lack of Efficacy|1
2907950|NCT01683266|10012469|P1|Overall Study|Perceived Lack of Efficacy|1
2907951|NCT01683266|10012468|P2|Overall Study|Nonserious Hypoglycemia|3
2907952|NCT01683266|10012469|P1|Overall Study|Nonserious Hypoglycemia|0
2907953|NCT01683266|10012468|P2|Overall Study|Site Closure / Site Withdrawal|3
2907954|NCT01683266|10012469|P1|Overall Study|Site Closure / Site Withdrawal|1
2907955|NCT01683266|10012468|P2|Overall Study|Lost to Follow-up|0
2907956|NCT01683266|10012469|P1|Overall Study|Lost to Follow-up|5
2907957|NCT01683266|10012468|P2|Overall Study|Selection Criterion / Protocol Violation|5
2907958|NCT01683266|10012469|P1|Overall Study|Selection Criterion / Protocol Violation|7
2907959|NCT01683266|10012468|P2|Overall Study|Personal Reason|25
2907960|NCT01683266|10012469|P1|Overall Study|Personal Reason|17
2907961|NCT01683266|10012468|P2|Overall Study|Protocol Violation|6
2907962|NCT01683266|10012469|P1|Overall Study|Protocol Violation|13
2907963|NCT01683266|10012468|P2|Overall Study|Lack of Efficacy|2
2907964|NCT01683266|10012469|P1|Overall Study|Lack of Efficacy|5
2907965|NCT01683266|10012468|P2|Overall Study|Adverse Event|4
2907966|NCT01683266|10012469|P1|Overall Study|Adverse Event|5
2907967|NCT01683058|10012497|P1|Overall Study|Lack of Efficacy|2
2907968|NCT01683058|10012497|P1|Overall Study|Withdrawal by Subject|7
2907969|NCT01683058|10012497|P1|Overall Study|Subject Met Withdrawal Criteria|5
2907970|NCT01683058|10012497|P1|Overall Study|Adverse Event|6
2907971|NCT01683058|10012497|P1|Overall Study|Lost to Follow-up|9
2907972|NCT01683019|10012528|P3|Overall Study|Withdrawal by Subject|4
2907973|NCT01683019|10012529|P2|Overall Study|Withdrawal by Subject|1
2907974|NCT01683019|10012530|P1|Overall Study|Withdrawal by Subject|2
2907975|NCT01682876|10012564|P4|Overall Study|Other|1
2907976|NCT01682876|10012565|P3|Overall Study|Other|1
2907977|NCT01682876|10012566|P2|Overall Study|Other|0
2907978|NCT01682876|10012567|P1|Overall Study|Other|1
2907979|NCT01682876|10012564|P4|Overall Study|Withdrawal by Subject|2
2907980|NCT01682876|10012565|P3|Overall Study|Withdrawal by Subject|0
2907981|NCT01682876|10012566|P2|Overall Study|Withdrawal by Subject|0
2907982|NCT01682876|10012567|P1|Overall Study|Withdrawal by Subject|4
2907983|NCT01682876|10012564|P4|Overall Study|Protocol Violation|1
2907984|NCT01682876|10012565|P3|Overall Study|Protocol Violation|1
2907985|NCT01682876|10012566|P2|Overall Study|Protocol Violation|1
2907986|NCT01682876|10012567|P1|Overall Study|Protocol Violation|1
2907987|NCT01682876|10012564|P4|Overall Study|Lost to Follow-up|11
2907988|NCT01682876|10012565|P3|Overall Study|Lost to Follow-up|9
2907989|NCT01682876|10012566|P2|Overall Study|Lost to Follow-up|15
2907990|NCT01682876|10012567|P1|Overall Study|Lost to Follow-up|11
2907991|NCT01682876|10012564|P4|Overall Study|Adverse Event|1
2907992|NCT01682876|10012565|P3|Overall Study|Adverse Event|0
2907993|NCT01682876|10012566|P2|Overall Study|Adverse Event|0
2907994|NCT01682876|10012567|P1|Overall Study|Adverse Event|0
2907995|NCT01682876|10012564|P4|Overall Study|Administrative reason|3
2907996|NCT01682876|10012565|P3|Overall Study|Administrative reason|0
2907997|NCT01682876|10012566|P2|Overall Study|Administrative reason|4
2907998|NCT01682876|10012567|P1|Overall Study|Administrative reason|4
2907999|NCT01682863|10012613|P3|Overall Study|Physician Decision|1
2908000|NCT01682863|10012614|P2|Overall Study|Physician Decision|0
2908001|NCT01682863|10012615|P1|Overall Study|Physician Decision|0
2908002|NCT01682863|10012613|P3|Overall Study|Adverse Event|2
2908003|NCT01682863|10012614|P2|Overall Study|Adverse Event|1
2908004|NCT01682863|10012615|P1|Overall Study|Adverse Event|0
2908005|NCT01682863|10012613|P3|Overall Study|Technical problems|0
2908006|NCT01682863|10012614|P2|Overall Study|Technical problems|0
2908007|NCT01682863|10012615|P1|Overall Study|Technical problems|1
2908008|NCT01682863|10012613|P3|Overall Study|Protocol deviation|1
2908009|NCT01682863|10012614|P2|Overall Study|Protocol deviation|0
2908010|NCT01682863|10012615|P1|Overall Study|Protocol deviation|1
2908011|NCT01682863|10012613|P3|Overall Study|Death|4
2908012|NCT01682863|10012614|P2|Overall Study|Death|3
2908013|NCT01682863|10012615|P1|Overall Study|Death|1
2908014|NCT01682863|10012613|P3|Overall Study|Lost to Follow-up|6
2908015|NCT01682863|10012614|P2|Overall Study|Lost to Follow-up|1
2908016|NCT01682863|10012615|P1|Overall Study|Lost to Follow-up|5
2908017|NCT01682863|10012613|P3|Overall Study|Subject/guardian decision|10
2908018|NCT01682863|10012614|P2|Overall Study|Subject/guardian decision|12
2908019|NCT01682863|10012615|P1|Overall Study|Subject/guardian decision|19
2908020|NCT01682837|10012644|P1|Baseline|Withdrawal by Subject|5
2908021|NCT01682759|10012688|P2|Overall Study|Withdrawal by Subject|55
2908022|NCT01682759|10012689|P1|Overall Study|Withdrawal by Subject|56
2908023|NCT01682759|10012688|P2|Overall Study|Physician Decision|1
2908024|NCT01682759|10012689|P1|Overall Study|Physician Decision|1
2908025|NCT01682759|10012688|P2|Overall Study|Lost to Follow-up|13
2908026|NCT01682759|10012689|P1|Overall Study|Lost to Follow-up|10
2908027|NCT01682759|10012688|P2|Overall Study|Death|1
2908028|NCT01682759|10012689|P1|Overall Study|Death|2
2908029|NCT01682720|10012713|P4|Overall Study|Adverse Event|1
2908030|NCT01682720|10012714|P3|Overall Study|Adverse Event|1
2908031|NCT01682720|10012715|P2|Overall Study|Adverse Event|0
2908032|NCT01682720|10012716|P1|Overall Study|Adverse Event|1
2908033|NCT01682720|10012713|P4|Overall Study|Subject Withdrew Consent|2
2908034|NCT01682720|10012714|P3|Overall Study|Subject Withdrew Consent|2
2908035|NCT01682720|10012715|P2|Overall Study|Subject Withdrew Consent|0
2908036|NCT01682720|10012716|P1|Overall Study|Subject Withdrew Consent|0
2908037|NCT01682720|10012713|P4|Overall Study|Lost to Follow-up|6
2908038|NCT01682720|10012714|P3|Overall Study|Lost to Follow-up|0
2908039|NCT01682720|10012715|P2|Overall Study|Lost to Follow-up|1
2908040|NCT01682720|10012716|P1|Overall Study|Lost to Follow-up|1
2908041|NCT01682720|10012713|P4|Overall Study|Efficacy Failure|30
2908042|NCT01682720|10012714|P3|Overall Study|Efficacy Failure|3
2908043|NCT01682720|10012715|P2|Overall Study|Efficacy Failure|3
2908044|NCT01682720|10012716|P1|Overall Study|Efficacy Failure|0
2908045|NCT01682720|10012713|P4|Overall Study|Terminated by Sponsor|0
2908046|NCT01682720|10012714|P3|Overall Study|Terminated by Sponsor|0
2908047|NCT01682720|10012715|P2|Overall Study|Terminated by Sponsor|0
2908048|NCT01682720|10012716|P1|Overall Study|Terminated by Sponsor|83
2908049|NCT01682720|10012713|P4|Overall Study|Randomized but Not Treated|0
2908050|NCT01682720|10012714|P3|Overall Study|Randomized but Not Treated|1
2908051|NCT01682720|10012715|P2|Overall Study|Randomized but Not Treated|1
2908052|NCT01682720|10012716|P1|Overall Study|Randomized but Not Treated|0
2908053|NCT01682681|10012733|P1|Overall Study|Low compliance|13
2908054|NCT01682681|10012733|P1|Overall Study|Other|21
2908055|NCT01682681|10012733|P1|Overall Study|tapering of topiramate|5
2908056|NCT01682681|10012733|P1|Overall Study|Adverse Event|46
2908057|NCT01682681|10012733|P1|Overall Study|Lost to Follow-up|174
2908058|NCT01682681|10012733|P1|Overall Study|Moved to other hospital|10
2908059|NCT01682681|10012733|P1|Overall Study|Withdrawal by Subject|1
2908060|NCT01682681|10012733|P1|Overall Study|Lack of Efficacy|62
2908061|NCT01682603|10012762|P1|Overall Study|Lost to Follow-up|3
2908062|NCT01682512|10012807|P3|Overall Study|Other than stated above|2
2908063|NCT01682512|10012808|P2|Overall Study|Other than stated above|4
2908064|NCT01682512|10012809|P1|Overall Study|Other than stated above|2
2908065|NCT01682512|10012807|P3|Overall Study|Secondary lack of efficacy|0
2908066|NCT01682512|10012808|P2|Overall Study|Secondary lack of efficacy|1
2908067|NCT01682512|10012809|P1|Overall Study|Secondary lack of efficacy|1
2908068|NCT01682512|10012807|P3|Overall Study|Primary lack of efficacy|7
2908069|NCT01682512|10012808|P2|Overall Study|Primary lack of efficacy|7
2908070|NCT01682512|10012809|P1|Overall Study|Primary lack of efficacy|10
2908071|NCT01682512|10012807|P3|Overall Study|Protocol Violation|2
2908072|NCT01682512|10012808|P2|Overall Study|Protocol Violation|3
2908073|NCT01682512|10012809|P1|Overall Study|Protocol Violation|2
2908074|NCT01682512|10012807|P3|Overall Study|Lost to Follow-up|2
2908075|NCT01682512|10012808|P2|Overall Study|Lost to Follow-up|0
2908076|NCT01682512|10012809|P1|Overall Study|Lost to Follow-up|3
2908077|NCT01682512|10012807|P3|Overall Study|Study terminated by sponsor|0
2908078|NCT01682512|10012808|P2|Overall Study|Study terminated by sponsor|43
2908079|NCT01682512|10012809|P1|Overall Study|Study terminated by sponsor|46
2908080|NCT01682512|10012807|P3|Overall Study|Physician Decision|0
2908081|NCT01682512|10012808|P2|Overall Study|Physician Decision|2
2908082|NCT01682512|10012809|P1|Overall Study|Physician Decision|0
2908083|NCT01682512|10012807|P3|Overall Study|Withdrawal by Subject|3
2908084|NCT01682512|10012808|P2|Overall Study|Withdrawal by Subject|6
2908085|NCT01682512|10012809|P1|Overall Study|Withdrawal by Subject|2
2908086|NCT01682512|10012807|P3|Overall Study|Adverse Event|2
2908087|NCT01682512|10012808|P2|Overall Study|Adverse Event|5
2908088|NCT01682512|10012809|P1|Overall Study|Adverse Event|6
2908089|NCT01682460|10012834|P1|Overall Study|Did not meet inclusion criteria|2
2908090|NCT01682460|10012834|P1|Overall Study|Withdrawal by Subject|2
2908091|NCT01682213|10012849|P1|Overall Study|Withdrawal by Subject|2
2908092|NCT01682148|10012857|P2|Overall Study|Protocol Violation|1
2908093|NCT01682148|10012858|P1|Overall Study|Protocol Violation|1
2908094|NCT01682148|10012857|P2|Overall Study|Lost to Follow-up|2
2908095|NCT01682148|10012858|P1|Overall Study|Lost to Follow-up|1
2908096|NCT01682148|10012857|P2|Overall Study|Withdrawal by Subject|0
2908097|NCT01682148|10012858|P1|Overall Study|Withdrawal by Subject|2
2908098|NCT01682083|10012918|P2|Overall Study|Physician Decision|4
2908099|NCT01682083|10012919|P1|Overall Study|Physician Decision|5
2908100|NCT01682083|10012918|P2|Overall Study|Death|93
2908101|NCT01682083|10012919|P1|Overall Study|Death|60
2908102|NCT01682083|10012918|P2|Overall Study|Withdrawal by Subject|40
2908103|NCT01682083|10012919|P1|Overall Study|Withdrawal by Subject|31
2908104|NCT01682083|10012918|P2|Overall Study|Lost to Follow-up|18
2908105|NCT01682083|10012919|P1|Overall Study|Lost to Follow-up|11
2908106|NCT01682044|10012931|P1|Overall Study|Progression|3
2908107|NCT01682044|10012931|P1|Overall Study|Death|1
2908108|NCT01682031|10012943|P2|Overall Study|Patient stopped selenium on his own|1
2908109|NCT01682031|10012944|P1|Overall Study|Patient stopped selenium on his own|0
2908110|NCT01682031|10012943|P2|Overall Study|Patient could not swallow tablets|0
2908111|NCT01682031|10012944|P1|Overall Study|Patient could not swallow tablets|1
2908112|NCT01682031|10012943|P2|Overall Study|MRI results indicate increased nodul|1
2908113|NCT01682031|10012944|P1|Overall Study|MRI results indicate increased nodul|0
2908114|NCT01682031|10012943|P2|Overall Study|Adverse Event|2
2908115|NCT01682031|10012944|P1|Overall Study|Adverse Event|0
2908116|NCT01682031|10012943|P2|Overall Study|Withdrawal by Subject|1
2908117|NCT01682031|10012944|P1|Overall Study|Withdrawal by Subject|0
2908118|NCT01681992|10012967|P3|Overall Study|Withdrawal by Subject|25
2908119|NCT01681992|10012968|P2|Overall Study|Withdrawal by Subject|30
2908120|NCT01681992|10012969|P1|Overall Study|Withdrawal by Subject|27
2908121|NCT01681992|10012967|P3|Overall Study|Protocol Violation|1
2908122|NCT01681992|10012968|P2|Overall Study|Protocol Violation|0
2908123|NCT01681992|10012969|P1|Overall Study|Protocol Violation|0
2908124|NCT01681992|10012967|P3|Overall Study|As Per Sponsor Decision|1
2908125|NCT01681992|10012968|P2|Overall Study|As Per Sponsor Decision|0
2908126|NCT01681992|10012969|P1|Overall Study|As Per Sponsor Decision|0
2908127|NCT01681992|10012967|P3|Overall Study|Lost to Follow-up|53
2908128|NCT01681992|10012968|P2|Overall Study|Lost to Follow-up|38
2908129|NCT01681992|10012969|P1|Overall Study|Lost to Follow-up|36
2908130|NCT01681992|10012967|P3|Overall Study|Adverse Event|3
2908131|NCT01681992|10012968|P2|Overall Study|Adverse Event|2
2908132|NCT01681992|10012969|P1|Overall Study|Adverse Event|3
2908133|NCT01681849|10013058|P3|Overall Study|Lost to Follow-up|6
2908134|NCT01681849|10013059|P2|Overall Study|Lost to Follow-up|2
2908135|NCT01681849|10013060|P1|Overall Study|Lost to Follow-up|3
2908136|NCT01681849|10013058|P3|Overall Study|Withdrawal by Subject|33
2908137|NCT01681849|10013059|P2|Overall Study|Withdrawal by Subject|5
2908138|NCT01681849|10013060|P1|Overall Study|Withdrawal by Subject|3
2908139|NCT01681849|10013058|P3|Overall Study|Protocol Violation|0
2908140|NCT01681849|10013059|P2|Overall Study|Protocol Violation|0
2908141|NCT01681849|10013060|P1|Overall Study|Protocol Violation|2
2908142|NCT01681836|10013069|P2|Second Intervention|Withdrawal by Subject|1
2908143|NCT01681836|10013070|P1|Second Intervention|Withdrawal by Subject|0
2908144|NCT01681771|10013104|P2|Overall Study|Lost to Follow-up|2
2908145|NCT01681771|10013105|P1|Overall Study|Lost to Follow-up|4
2908146|NCT01681628|10013113|P2|19 Months Follow-up|Lost to Follow-up|43
2908147|NCT01681628|10013114|P1|19 Months Follow-up|Lost to Follow-up|61
2908148|NCT01681628|10013113|P2|19 Months Follow-up|Death|0
2908149|NCT01681628|10013114|P1|19 Months Follow-up|Death|1
2908150|NCT01681628|10013113|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
2908151|NCT01681628|10013114|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
2908152|NCT01681628|10013113|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
2908153|NCT01681628|10013114|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
2908154|NCT01681576|10013127|P2|Period 2|Non-compliance with study treatment|0
2908155|NCT01681576|10013128|P1|Period 2|Non-compliance with study treatment|1
2908156|NCT01681576|10013127|P2|Period 2|subject/guardian decision|1
2908157|NCT01681576|10013128|P1|Period 2|subject/guardian decision|3
2908158|NCT01681576|10013127|P2|Period 1|Protocol Deviation|0
2908159|NCT01681576|10013128|P1|Period 1|Protocol Deviation|1
2908160|NCT01681576|10013127|P2|Period 1|Adverse Event|0
2908161|NCT01681576|10013128|P1|Period 1|Adverse Event|1
2908162|NCT01681511|10013144|P2|Overall Study|No post-catheter sample collected|4
2908163|NCT01681511|10013145|P1|Overall Study|No post-catheter sample collected|11
2908164|NCT01681511|10013144|P2|Overall Study|No Daily Urine Sample Collected|1
2908165|NCT01681511|10013145|P1|Overall Study|No Daily Urine Sample Collected|0
2908166|NCT01681511|10013144|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
2908167|NCT01681511|10013145|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
2908168|NCT01681511|10013144|P2|Overall Study|Failed Inclusion/Exclusion|0
2908169|NCT01681511|10013145|P1|Overall Study|Failed Inclusion/Exclusion|3
2908170|NCT01681511|10013144|P2|Overall Study|No Treatment Received|3
2908171|NCT01681511|10013145|P1|Overall Study|No Treatment Received|1
2908172|NCT01681472|10013163|P4|Overall Study|Adverse Event|0
2908173|NCT01681472|10013164|P3|Overall Study|Adverse Event|0
2908174|NCT01681472|10013165|P2|Overall Study|Adverse Event|1
2908175|NCT01681472|10013166|P1|Overall Study|Adverse Event|0
2908176|NCT01681433|10013346|P2|Overall Study|Lost to Follow-up|1
2908177|NCT01681433|10013347|P1|Overall Study|Lost to Follow-up|0
2908178|NCT01681433|10013346|P2|Overall Study|Adverse Event|4
2908179|NCT01681433|10013347|P1|Overall Study|Adverse Event|2
2908180|NCT01681433|10013346|P2|Overall Study|Protocol Violation|0
2908181|NCT01681433|10013347|P1|Overall Study|Protocol Violation|2
2908182|NCT01681433|10013346|P2|Overall Study|Withdrawal by Subject|5
2908183|NCT01681433|10013347|P1|Overall Study|Withdrawal by Subject|5
2908184|NCT01681433|10013346|P2|Overall Study|Lack of Efficacy|23
2908185|NCT01681433|10013347|P1|Overall Study|Lack of Efficacy|23
2908186|NCT01681368|10013365|P1|Overall Study|Refused further follow up|1
2908187|NCT01681368|10013365|P1|Overall Study|Refused further treatment|1
2908188|NCT01681277|10013382|P5|Overall Study|Adverse Event|0
2908189|NCT01681277|10013383|P4|Overall Study|Adverse Event|0
2908190|NCT01681277|10013384|P3|Overall Study|Adverse Event|0
2908191|NCT01681277|10013385|P2|Overall Study|Adverse Event|0
2908192|NCT01681277|10013386|P1|Overall Study|Adverse Event|1
2908193|NCT01681212|10013427|P1|Overall Study|Administrative reason by sponsor|1
2908194|NCT01681212|10013427|P1|Overall Study|No longer met study criteria|5
2908195|NCT01681186|10013441|P8|Fourth Intervention|Protocol Violation|1
2908196|NCT01681186|10013442|P7|Fourth Intervention|Protocol Violation|0
2908197|NCT01681186|10013443|P6|Fourth Intervention|Protocol Violation|0
2908198|NCT01681186|10013444|P5|Fourth Intervention|Protocol Violation|0
2908199|NCT01681186|10013445|P4|Fourth Intervention|Protocol Violation|0
2908200|NCT01681186|10013446|P3|Fourth Intervention|Protocol Violation|0
2908201|NCT01681186|10013447|P2|Fourth Intervention|Protocol Violation|0
2908202|NCT01681186|10013448|P1|Fourth Intervention|Protocol Violation|0
2908203|NCT01681186|10013441|P8|Washout Period From Third Intervention|Lost to Follow-up|0
2908204|NCT01681186|10013442|P7|Washout Period From Third Intervention|Lost to Follow-up|1
2908205|NCT01681186|10013443|P6|Washout Period From Third Intervention|Lost to Follow-up|0
2908206|NCT01681186|10013444|P5|Washout Period From Third Intervention|Lost to Follow-up|0
2908207|NCT01681186|10013445|P4|Washout Period From Third Intervention|Lost to Follow-up|0
2908208|NCT01681186|10013446|P3|Washout Period From Third Intervention|Lost to Follow-up|0
2908209|NCT01681186|10013447|P2|Washout Period From Third Intervention|Lost to Follow-up|0
2908210|NCT01681186|10013448|P1|Washout Period From Third Intervention|Lost to Follow-up|0
2908211|NCT01681186|10013441|P8|Washout Period From Second Intervention|Protocol Violation|1
2908212|NCT01681186|10013442|P7|Washout Period From Second Intervention|Protocol Violation|0
2908213|NCT01681186|10013443|P6|Washout Period From Second Intervention|Protocol Violation|0
2908214|NCT01681186|10013444|P5|Washout Period From Second Intervention|Protocol Violation|0
2908215|NCT01681186|10013445|P4|Washout Period From Second Intervention|Protocol Violation|0
2908216|NCT01681186|10013446|P3|Washout Period From Second Intervention|Protocol Violation|0
2908217|NCT01681186|10013447|P2|Washout Period From Second Intervention|Protocol Violation|0
2908218|NCT01681186|10013448|P1|Washout Period From Second Intervention|Protocol Violation|0
2908219|NCT01681186|10013441|P8|Washout Period From Second Intervention|Adverse Event|0
2908220|NCT01681186|10013442|P7|Washout Period From Second Intervention|Adverse Event|1
2908221|NCT01681186|10013443|P6|Washout Period From Second Intervention|Adverse Event|0
2908222|NCT01681186|10013444|P5|Washout Period From Second Intervention|Adverse Event|0
2908223|NCT01681186|10013445|P4|Washout Period From Second Intervention|Adverse Event|0
2908224|NCT01681186|10013446|P3|Washout Period From Second Intervention|Adverse Event|0
2908225|NCT01681186|10013447|P2|Washout Period From Second Intervention|Adverse Event|0
2908226|NCT01681186|10013448|P1|Washout Period From Second Intervention|Adverse Event|0
2908227|NCT01681069|10013551|P2|Overall Study|Adverse Event|1
2908228|NCT01681069|10013552|P1|Overall Study|Adverse Event|0
2908229|NCT01681069|10013551|P2|Overall Study|Protocol Violation|1
2908230|NCT01681069|10013552|P1|Overall Study|Protocol Violation|1
2908231|NCT01681069|10013551|P2|Overall Study|Withdrawal by Subject|5
2908232|NCT01681069|10013552|P1|Overall Study|Withdrawal by Subject|4
2908233|NCT01681004|10013589|P2|Study Completion|Death|1
2908234|NCT01681004|10013590|P1|Study Completion|Death|1
2908235|NCT01681004|10013589|P2|Study Completion|Site Termination|1
2908236|NCT01681004|10013590|P1|Study Completion|Site Termination|2
2908237|NCT01681004|10013589|P2|Study Completion|Physician Decision|3
2908238|NCT01681004|10013590|P1|Study Completion|Physician Decision|1
2908239|NCT01681004|10013589|P2|Study Completion|Lost to Follow-up|3
2908240|NCT01681004|10013590|P1|Study Completion|Lost to Follow-up|8
2908241|NCT01681004|10013589|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
2908242|NCT01681004|10013590|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
2908243|NCT01680991|10013647|P3|Overall Study|PD confirmed in other hospital|0
2908244|NCT01680991|10013648|P2|Overall Study|PD confirmed in other hospital|0
2908245|NCT01680991|10013649|P1|Overall Study|PD confirmed in other hospital|1
2908246|NCT01680991|10013647|P3|Overall Study|Bad physical condition|1
2908247|NCT01680991|10013648|P2|Overall Study|Bad physical condition|0
2908248|NCT01680991|10013649|P1|Overall Study|Bad physical condition|0
2908249|NCT01680991|10013647|P3|Overall Study|Physician Decision|2
2908250|NCT01680991|10013648|P2|Overall Study|Physician Decision|7
2908251|NCT01680991|10013649|P1|Overall Study|Physician Decision|0
2908252|NCT01680991|10013647|P3|Overall Study|Progressive disease (PD)|0
2908253|NCT01680991|10013648|P2|Overall Study|Progressive disease (PD)|10
2908254|NCT01680991|10013649|P1|Overall Study|Progressive disease (PD)|0
2908255|NCT01680991|10013647|P3|Overall Study|Withdrawal by Subject|0
2908256|NCT01680991|10013648|P2|Overall Study|Withdrawal by Subject|1
2908257|NCT01680991|10013649|P1|Overall Study|Withdrawal by Subject|5
2908258|NCT01680991|10013647|P3|Overall Study|Protocol Violation|0
2908259|NCT01680991|10013648|P2|Overall Study|Protocol Violation|1
2908260|NCT01680991|10013649|P1|Overall Study|Protocol Violation|0
2908261|NCT01680991|10013647|P3|Overall Study|Death|1
2908262|NCT01680991|10013648|P2|Overall Study|Death|0
2908263|NCT01680991|10013649|P1|Overall Study|Death|1
2908264|NCT01680991|10013647|P3|Overall Study|Adverse Event|0
2908265|NCT01680991|10013648|P2|Overall Study|Adverse Event|0
2908266|NCT01680991|10013649|P1|Overall Study|Adverse Event|1
2908267|NCT01680861|10013740|P2|Early Post-transplant Period|Protocol Violation|1
2908268|NCT01680861|10013741|P1|Early Post-transplant Period|Protocol Violation|1
2908269|NCT01680497|10013838|P1|Overall Study|Lost to Follow-up|2
2908270|NCT01680458|10013848|P1|Overall Study|Protocol Violation|3
2908271|NCT01680341|10013859|P2|Overall Study|Unclassified|15
2908272|NCT01680341|10013860|P1|Overall Study|Unclassified|18
2908273|NCT01680341|10013859|P2|Overall Study|Adverse Event|2
2908274|NCT01680341|10013860|P1|Overall Study|Adverse Event|3
2908275|NCT01680159|10013931|P1|Increased Dose Period|Withdrawal by Subject|2
2908276|NCT01680159|10013931|P1|Increased Dose Period|Adverse Event|6
2908277|NCT01680159|10013931|P1|Screening Period|Not meet criteria for dose-up period|7
2908278|NCT01680016|10013958|P4|Overall Study|Withdrawal by Subject|1
2908279|NCT01680016|10013959|P3|Overall Study|Withdrawal by Subject|1
2908280|NCT01680016|10013960|P2|Overall Study|Withdrawal by Subject|7
2908281|NCT01680016|10013961|P1|Overall Study|Withdrawal by Subject|5
2908282|NCT01680016|10013958|P4|Overall Study|Protocol Violation|0
2908283|NCT01680016|10013959|P3|Overall Study|Protocol Violation|0
2908284|NCT01680016|10013960|P2|Overall Study|Protocol Violation|1
2908285|NCT01680016|10013961|P1|Overall Study|Protocol Violation|0
2908286|NCT01680016|10013958|P4|Overall Study|The Subject went out of The Trial|0
2908287|NCT01680016|10013959|P3|Overall Study|The Subject went out of The Trial|3
2908288|NCT01680016|10013960|P2|Overall Study|The Subject went out of The Trial|0
2908289|NCT01680016|10013961|P1|Overall Study|The Subject went out of The Trial|1
2908290|NCT01680016|10013958|P4|Overall Study|Adverse Event|4
2908291|NCT01680016|10013959|P3|Overall Study|Adverse Event|1
2908292|NCT01680016|10013960|P2|Overall Study|Adverse Event|0
2908293|NCT01680016|10013961|P1|Overall Study|Adverse Event|0
2908294|NCT01679613|10014023|P4|Overall Study|other than stated above|2
2908295|NCT01679613|10014024|P3|Overall Study|other than stated above|2
2908296|NCT01679613|10014025|P2|Overall Study|other than stated above|1
2908297|NCT01679613|10014026|P1|Overall Study|other than stated above|0
2908298|NCT01679405|10014048|P2|Overall Study|Death|5
2908299|NCT01679405|10014049|P1|Overall Study|Death|2
2908300|NCT01679301|10014084|P3|Screening Period|screen failure|0
2908301|NCT01679301|10014085|P2|Screening Period|screen failure|0
2908302|NCT01679301|10014086|P1|Screening Period|screen failure|3
2908303|NCT01679236|10014094|P2|Overall Study|Lost to Follow-up|15
2908304|NCT01679236|10014095|P1|Overall Study|Lost to Follow-up|15
2908305|NCT01679002|10014142|P3|Overall Study|Adverse Event|0
2908306|NCT01679002|10014143|P2|Overall Study|Adverse Event|1
2908307|NCT01679002|10014144|P1|Overall Study|Adverse Event|1
2908308|NCT01678924|10014175|P4|Overall Study|Unable to attend scheduled visits|1
2908309|NCT01678924|10014176|P3|Overall Study|Unable to attend scheduled visits|0
2908310|NCT01678924|10014177|P2|Overall Study|Unable to attend scheduled visits|0
2908311|NCT01678924|10014178|P1|Overall Study|Unable to attend scheduled visits|0
2908312|NCT01678924|10014175|P4|Overall Study|Withdrawal by Subject|2
2908313|NCT01678924|10014176|P3|Overall Study|Withdrawal by Subject|0
2908314|NCT01678924|10014177|P2|Overall Study|Withdrawal by Subject|3
2908315|NCT01678924|10014178|P1|Overall Study|Withdrawal by Subject|0
2908316|NCT01678924|10014175|P4|Overall Study|Personal Reasons|7
2908317|NCT01678924|10014176|P3|Overall Study|Personal Reasons|2
2908318|NCT01678924|10014177|P2|Overall Study|Personal Reasons|2
2908319|NCT01678924|10014178|P1|Overall Study|Personal Reasons|2
2908320|NCT01678924|10014175|P4|Overall Study|Lost to Follow-up|2
2908321|NCT01678924|10014176|P3|Overall Study|Lost to Follow-up|0
2908322|NCT01678924|10014177|P2|Overall Study|Lost to Follow-up|4
2908323|NCT01678924|10014178|P1|Overall Study|Lost to Follow-up|0
2908324|NCT01678924|10014175|P4|Overall Study|Lack of Efficacy|5
2908325|NCT01678924|10014176|P3|Overall Study|Lack of Efficacy|0
2908326|NCT01678924|10014177|P2|Overall Study|Lack of Efficacy|2
2908327|NCT01678924|10014178|P1|Overall Study|Lack of Efficacy|7
2908328|NCT01678924|10014175|P4|Overall Study|Adverse Event|1
2908329|NCT01678924|10014176|P3|Overall Study|Adverse Event|0
2908330|NCT01678924|10014177|P2|Overall Study|Adverse Event|1
2908331|NCT01678924|10014178|P1|Overall Study|Adverse Event|1
2908332|NCT01678911|10014309|P2|Second Intervention|Lost to Follow-up|0
2908333|NCT01678911|10014310|P1|Second Intervention|Lost to Follow-up|2
2908334|NCT01678898|10014327|P3|PB-102-F01|Physician Decision|0
2908335|NCT01678898|10014328|P2|PB-102-F01|Physician Decision|1
2908336|NCT01678898|10014329|P1|PB-102-F01|Physician Decision|0
2908337|NCT01678898|10014327|P3|PB-102-F01|Adverse Event|0
2908338|NCT01678898|10014328|P2|PB-102-F01|Adverse Event|1
2908339|NCT01678898|10014329|P1|PB-102-F01|Adverse Event|0
2908340|NCT01678820|10014439|P3|Overall Study|Not treated with double-blind study drug|2
2908341|NCT01678820|10014440|P2|Overall Study|Not treated with double-blind study drug|2
2908342|NCT01678820|10014441|P1|Overall Study|Not treated with double-blind study drug|0
2908343|NCT01678820|10014439|P3|Overall Study|Protocol Violation|4
2908344|NCT01678820|10014440|P2|Overall Study|Protocol Violation|5
2908345|NCT01678820|10014441|P1|Overall Study|Protocol Violation|4
2908346|NCT01678820|10014439|P3|Overall Study|Physician Decision|1
2908347|NCT01678820|10014440|P2|Overall Study|Physician Decision|0
2908348|NCT01678820|10014441|P1|Overall Study|Physician Decision|0
2908349|NCT01678820|10014439|P3|Overall Study|Non-compliance with study drug|0
2908350|NCT01678820|10014440|P2|Overall Study|Non-compliance with study drug|1
2908351|NCT01678820|10014441|P1|Overall Study|Non-compliance with study drug|0
2908352|NCT01678820|10014439|P3|Overall Study|Lost to Follow-up|2
2908353|NCT01678820|10014440|P2|Overall Study|Lost to Follow-up|2
2908354|NCT01678820|10014441|P1|Overall Study|Lost to Follow-up|7
2908355|NCT01678820|10014439|P3|Overall Study|Adverse Event|2
2908356|NCT01678820|10014440|P2|Overall Study|Adverse Event|2
2908357|NCT01678820|10014441|P1|Overall Study|Adverse Event|2
2908358|NCT01678820|10014439|P3|Overall Study|Protocol Specified Criteria|1
2908359|NCT01678820|10014440|P2|Overall Study|Protocol Specified Criteria|3
2908360|NCT01678820|10014441|P1|Overall Study|Protocol Specified Criteria|2
2908361|NCT01678820|10014439|P3|Overall Study|Withdrawal by Subject|2
2908362|NCT01678820|10014440|P2|Overall Study|Withdrawal by Subject|5
2908363|NCT01678820|10014441|P1|Overall Study|Withdrawal by Subject|2
2908364|NCT01678820|10014439|P3|Overall Study|Study Terminated by Sponsor|43
2908365|NCT01678820|10014440|P2|Overall Study|Study Terminated by Sponsor|43
2908366|NCT01678820|10014441|P1|Overall Study|Study Terminated by Sponsor|45
2908367|NCT01678807|10014486|P3|Overall Study|Withdrawn by Parent/Guardian|0
2908368|NCT01678807|10014487|P2|Overall Study|Withdrawn by Parent/Guardian|1
2908369|NCT01678807|10014488|P1|Overall Study|Withdrawn by Parent/Guardian|0
2908370|NCT01678807|10014486|P3|Overall Study|Adverse Event|0
2908371|NCT01678807|10014487|P2|Overall Study|Adverse Event|4
2908372|NCT01678807|10014488|P1|Overall Study|Adverse Event|4
2908373|NCT01678560|10014501|P2|Overall Study|Withdrawal by Subject|1
2908374|NCT01678560|10014502|P1|Overall Study|Withdrawal by Subject|0
2908375|NCT01678560|10014501|P2|Overall Study|Death|1
2908376|NCT01678560|10014502|P1|Overall Study|Death|0
2908377|NCT01678560|10014501|P2|Overall Study|Physician Decision|4
2908378|NCT01678560|10014502|P1|Overall Study|Physician Decision|4
2908379|NCT01678313|10014523|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
2908380|NCT01678313|10014524|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
2908381|NCT01678313|10014523|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
2908382|NCT01678313|10014524|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
2908383|NCT01678313|10014523|P2|Completed the 3-month Therapy|Physician Decision|4
2908384|NCT01678313|10014524|P1|Completed the 3-month Therapy|Physician Decision|3
2908385|NCT01678313|10014523|P2|Completed the 3-month Therapy|Lost to Follow-up|8
2908386|NCT01678313|10014524|P1|Completed the 3-month Therapy|Lost to Follow-up|3
2908387|NCT01678144|10014555|P1|Stage 1: MAR Classic|Adverse Event|1
2908388|NCT01678131|10014574|P3|Overall Study|Withdrawal by Subject|2
2908389|NCT01678131|10014575|P2|Overall Study|Withdrawal by Subject|0
2908390|NCT01678131|10014576|P1|Overall Study|Withdrawal by Subject|0
2908391|NCT01678131|10014574|P3|Overall Study|Adverse Event|0
2908392|NCT01678131|10014575|P2|Overall Study|Adverse Event|1
2908393|NCT01678131|10014576|P1|Overall Study|Adverse Event|0
2908394|NCT01677988|10014584|P1|Overall Study|Lack of Efficacy|2
2908395|NCT01677936|10014597|P2|Overall Study|Protocol Violation|4
2908396|NCT01677936|10014598|P1|Overall Study|Protocol Violation|0
2908397|NCT01677936|10014597|P2|Overall Study|Lost to Follow-up|0
2908398|NCT01677936|10014598|P1|Overall Study|Lost to Follow-up|1
2908399|NCT01677936|10014597|P2|Overall Study|Adverse Event|0
2908400|NCT01677936|10014598|P1|Overall Study|Adverse Event|1
2908401|NCT01677936|10014597|P2|Overall Study|Protocol Violation|0
2908402|NCT01677936|10014598|P1|Overall Study|Protocol Violation|3
2908403|NCT01677936|10014597|P2|Overall Study|Lost to Follow-up|1
2908404|NCT01677936|10014598|P1|Overall Study|Lost to Follow-up|4
2908405|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
2908406|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2908407|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2908408|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2908409|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Adverse Event|15
2908410|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Adverse Event|0
2908411|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Adverse Event|0
2908412|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Adverse Event|0
2908413|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
2908414|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2908415|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2908416|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2908417|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2908418|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2908419|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2908420|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2908421|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
2908422|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
2908423|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
2908424|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
2908425|NCT01677910|10014609|P4|Open-Label Extension Period (OLE)|Physician Decision|4
2908426|NCT01677910|10014610|P3|Open-Label Extension Period (OLE)|Physician Decision|0
2908427|NCT01677910|10014611|P2|Open-Label Extension Period (OLE)|Physician Decision|0
2908428|NCT01677910|10014612|P1|Open-Label Extension Period (OLE)|Physician Decision|0
2908429|NCT01677910|10014609|P4|Double-Blind Treatment Period|Reason Not Specified|0
2908430|NCT01677910|10014610|P3|Double-Blind Treatment Period|Reason Not Specified|0
2908431|NCT01677910|10014611|P2|Double-Blind Treatment Period|Reason Not Specified|1
2908432|NCT01677910|10014612|P1|Double-Blind Treatment Period|Reason Not Specified|0
2908433|NCT01677910|10014609|P4|Double-Blind Treatment Period|Withdrawal of consent|0
2908434|NCT01677910|10014610|P3|Double-Blind Treatment Period|Withdrawal of consent|3
2908435|NCT01677910|10014611|P2|Double-Blind Treatment Period|Withdrawal of consent|0
2908436|NCT01677910|10014612|P1|Double-Blind Treatment Period|Withdrawal of consent|1
2908437|NCT01677910|10014609|P4|Double-Blind Treatment Period|Physician Decision|0
2908438|NCT01677910|10014610|P3|Double-Blind Treatment Period|Physician Decision|1
2908439|NCT01677910|10014611|P2|Double-Blind Treatment Period|Physician Decision|0
2908440|NCT01677910|10014612|P1|Double-Blind Treatment Period|Physician Decision|0
2908441|NCT01677910|10014609|P4|Double-Blind Treatment Period|Adverse Event|0
2908442|NCT01677910|10014610|P3|Double-Blind Treatment Period|Adverse Event|3
2908443|NCT01677910|10014611|P2|Double-Blind Treatment Period|Adverse Event|2
2908444|NCT01677910|10014612|P1|Double-Blind Treatment Period|Adverse Event|6
2908445|NCT01677858|10014639|P5|Overall Study|Lost to Follow-up|1
2908446|NCT01677858|10014640|P4|Overall Study|Lost to Follow-up|0
2908447|NCT01677858|10014641|P3|Overall Study|Lost to Follow-up|0
2908448|NCT01677858|10014642|P2|Overall Study|Lost to Follow-up|0
2908449|NCT01677858|10014643|P1|Overall Study|Lost to Follow-up|0
2908450|NCT01677858|10014639|P5|Overall Study|Withdrawal by Subject|15
2908451|NCT01677858|10014640|P4|Overall Study|Withdrawal by Subject|0
2908452|NCT01677858|10014641|P3|Overall Study|Withdrawal by Subject|1
2908453|NCT01677858|10014642|P2|Overall Study|Withdrawal by Subject|1
2908454|NCT01677858|10014643|P1|Overall Study|Withdrawal by Subject|0
2908455|NCT01677858|10014639|P5|Overall Study|Progressive Disease|43
2908456|NCT01677858|10014640|P4|Overall Study|Progressive Disease|3
2908457|NCT01677858|10014641|P3|Overall Study|Progressive Disease|9
2908458|NCT01677858|10014642|P2|Overall Study|Progressive Disease|1
2908459|NCT01677858|10014643|P1|Overall Study|Progressive Disease|2
2908460|NCT01677858|10014639|P5|Overall Study|Physician Decision|12
2908461|NCT01677858|10014640|P4|Overall Study|Physician Decision|0
2908462|NCT01677858|10014641|P3|Overall Study|Physician Decision|2
2908463|NCT01677858|10014642|P2|Overall Study|Physician Decision|0
2908464|NCT01677858|10014643|P1|Overall Study|Physician Decision|1
2908465|NCT01677858|10014639|P5|Overall Study|Death|1
2908466|NCT01677858|10014640|P4|Overall Study|Death|0
2908467|NCT01677858|10014641|P3|Overall Study|Death|0
2908468|NCT01677858|10014642|P2|Overall Study|Death|0
2908469|NCT01677858|10014643|P1|Overall Study|Death|0
2908470|NCT01677858|10014639|P5|Overall Study|Adverse Event|13
2908471|NCT01677858|10014640|P4|Overall Study|Adverse Event|3
2908472|NCT01677858|10014641|P3|Overall Study|Adverse Event|2
2908473|NCT01677858|10014642|P2|Overall Study|Adverse Event|0
2908474|NCT01677858|10014643|P1|Overall Study|Adverse Event|0
2908475|NCT01677767|10014716|P1|Overall Study|Non-compliance by the participants|3
2908476|NCT01677767|10014716|P1|Overall Study|Withdrawal by Subject|10
2908477|NCT01677767|10014716|P1|Overall Study|Protocol Violation|4
2908478|NCT01677767|10014716|P1|Overall Study|Death|4
2908479|NCT01677767|10014716|P1|Overall Study|Adverse Event|1
2908480|NCT01677624|10014730|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
2908481|NCT01677507|10014735|P2|Second Assigment|Adverse Event|3
2908482|NCT01677507|10014736|P1|Second Assigment|Adverse Event|1
2908483|NCT01677507|10014735|P2|Second Assigment|Withdrawal by Subject|2
2908484|NCT01677507|10014736|P1|Second Assigment|Withdrawal by Subject|2
2908485|NCT01677507|10014735|P2|Initial Assignment|Protocol Violation|1
2908486|NCT01677507|10014736|P1|Initial Assignment|Protocol Violation|0
2908487|NCT01677507|10014735|P2|Initial Assignment|Adverse Event|1
2908488|NCT01677507|10014736|P1|Initial Assignment|Adverse Event|0
2908489|NCT01677377|10014749|P3|Overall Study|Pregnancy|1
2908490|NCT01677377|10014750|P2|Overall Study|Pregnancy|0
2908491|NCT01677377|10014751|P1|Overall Study|Pregnancy|0
2908492|NCT01677377|10014749|P3|Overall Study|Lack of Efficacy|1
2908493|NCT01677377|10014750|P2|Overall Study|Lack of Efficacy|0
2908494|NCT01677377|10014751|P1|Overall Study|Lack of Efficacy|0
2908495|NCT01677377|10014749|P3|Overall Study|Withdrawal by Subject|3
2908496|NCT01677377|10014750|P2|Overall Study|Withdrawal by Subject|0
2908497|NCT01677377|10014751|P1|Overall Study|Withdrawal by Subject|0
2908498|NCT01677377|10014749|P3|Overall Study|Lost to Follow-up|1
2908499|NCT01677377|10014750|P2|Overall Study|Lost to Follow-up|1
2908500|NCT01677377|10014751|P1|Overall Study|Lost to Follow-up|0
2908501|NCT01677377|10014749|P3|Overall Study|Protocol Violation|0
2908502|NCT01677377|10014750|P2|Overall Study|Protocol Violation|0
2908503|NCT01677377|10014751|P1|Overall Study|Protocol Violation|1
2908504|NCT01677299|10014967|P4|Overall Study|Withdrawal by Subject|1
2908505|NCT01677299|10014968|P3|Overall Study|Withdrawal by Subject|0
2908506|NCT01677299|10014969|P2|Overall Study|Withdrawal by Subject|1
2908507|NCT01677299|10014970|P1|Overall Study|Withdrawal by Subject|0
2908508|NCT01677299|10014967|P4|Overall Study|Adverse Event|0
2908509|NCT01677299|10014968|P3|Overall Study|Adverse Event|1
2908510|NCT01677299|10014969|P2|Overall Study|Adverse Event|2
2908511|NCT01677299|10014970|P1|Overall Study|Adverse Event|0
2908512|NCT01677195|10015002|P3|Overall Study|Protocol Violation|4
2908513|NCT01677195|10015003|P2|Overall Study|Protocol Violation|3
2908514|NCT01677195|10015004|P1|Overall Study|Protocol Violation|7
2908515|NCT01677195|10015002|P3|Overall Study|Pregnancy|0
2908516|NCT01677195|10015003|P2|Overall Study|Pregnancy|1
2908517|NCT01677195|10015004|P1|Overall Study|Pregnancy|0
2908518|NCT01677195|10015002|P3|Overall Study|Physician Decision|2
2908519|NCT01677195|10015003|P2|Overall Study|Physician Decision|2
2908520|NCT01677195|10015004|P1|Overall Study|Physician Decision|1
2908521|NCT01677195|10015002|P3|Overall Study|Adverse Event|1
2908522|NCT01677195|10015003|P2|Overall Study|Adverse Event|4
2908523|NCT01677195|10015004|P1|Overall Study|Adverse Event|6
2908524|NCT01677195|10015002|P3|Overall Study|Withdrawal by Subject|1
2908525|NCT01677195|10015003|P2|Overall Study|Withdrawal by Subject|0
2908526|NCT01677195|10015004|P1|Overall Study|Withdrawal by Subject|1
2908527|NCT01677195|10015002|P3|Overall Study|Lost to Follow-up|22
2908528|NCT01677195|10015003|P2|Overall Study|Lost to Follow-up|22
2908529|NCT01677195|10015004|P1|Overall Study|Lost to Follow-up|14
2908530|NCT01677182|10015015|P3|Overall Study|Other reasons|2
2908531|NCT01677182|10015016|P2|Overall Study|Other reasons|5
2908532|NCT01677182|10015017|P1|Overall Study|Other reasons|1
2908533|NCT01677182|10015015|P3|Overall Study|Lack of Efficacy|1
2908534|NCT01677182|10015016|P2|Overall Study|Lack of Efficacy|0
2908535|NCT01677182|10015017|P1|Overall Study|Lack of Efficacy|3
2908536|NCT01677182|10015015|P3|Overall Study|Study termination|11
2908537|NCT01677182|10015016|P2|Overall Study|Study termination|9
2908538|NCT01677182|10015017|P1|Overall Study|Study termination|12
2908539|NCT01677182|10015015|P3|Overall Study|Withdrawal by Subject|10
2908540|NCT01677182|10015016|P2|Overall Study|Withdrawal by Subject|12
2908541|NCT01677182|10015017|P1|Overall Study|Withdrawal by Subject|7
2908542|NCT01677182|10015015|P3|Overall Study|Lost to Follow-up|3
2908543|NCT01677182|10015016|P2|Overall Study|Lost to Follow-up|0
2908544|NCT01677182|10015017|P1|Overall Study|Lost to Follow-up|4
2908545|NCT01677182|10015015|P3|Overall Study|Protocol Violation|4
2908546|NCT01677182|10015016|P2|Overall Study|Protocol Violation|1
2908547|NCT01677182|10015017|P1|Overall Study|Protocol Violation|5
2908548|NCT01677182|10015015|P3|Overall Study|Adverse Event|8
2908549|NCT01677182|10015016|P2|Overall Study|Adverse Event|1
2908550|NCT01677182|10015017|P1|Overall Study|Adverse Event|2
2908551|NCT01676961|10015049|P1|Overall Study|Withdrawal by Subject|1
2908552|NCT01676961|10015049|P1|Overall Study|Lost to Follow-up|1
2908553|NCT01676961|10015049|P1|Overall Study|Death|3
2908554|NCT01676909|10015056|P2|Overall Study|Lost to Follow-up|9
2908555|NCT01676909|10015057|P1|Overall Study|Lost to Follow-up|15
2908556|NCT01676909|10015056|P2|Overall Study|Withdrawal by Subject|5
2908557|NCT01676909|10015057|P1|Overall Study|Withdrawal by Subject|3
2908558|NCT01676896|10015122|P3|Overall Study|Withdrawal by Subject|19
2908559|NCT01676896|10015123|P2|Overall Study|Withdrawal by Subject|7
2908560|NCT01676896|10015124|P1|Overall Study|Withdrawal by Subject|12
2908561|NCT01676727|10015232|P1|Overall Study|Valve explanted|1
2908562|NCT01676727|10015232|P1|Overall Study|Not willing to attend 1-year visit|2
2908563|NCT01676727|10015232|P1|Overall Study|Screening failure|5
2908564|NCT01676727|10015232|P1|Overall Study|Withdrawal by Subject|6
2908565|NCT01676727|10015232|P1|Overall Study|Death|18
2908566|NCT01676701|10015246|P2|Overall Study|Sponsor Decision|4
2908567|NCT01676701|10015247|P1|Overall Study|Sponsor Decision|3
2908568|NCT01676701|10015246|P2|Overall Study|Protocol Violation|0
2908569|NCT01676701|10015247|P1|Overall Study|Protocol Violation|1
2908570|NCT01676220|10015349|P2|Overall Study|No More Need of Insulin|0
2908571|NCT01676220|10015350|P1|Overall Study|No More Need of Insulin|1
2908572|NCT01676220|10015349|P2|Overall Study|Non Serious Hypoglycemia|0
2908573|NCT01676220|10015350|P1|Overall Study|Non Serious Hypoglycemia|2
2908574|NCT01676220|10015349|P2|Overall Study|Perceived Lack of Efficacy|1
2908575|NCT01676220|10015350|P1|Overall Study|Perceived Lack of Efficacy|3
2908576|NCT01676220|10015349|P2|Overall Study|Site Closure/Site Withdrawal|4
2908577|NCT01676220|10015350|P1|Overall Study|Site Closure/Site Withdrawal|1
2908578|NCT01676220|10015349|P2|Overall Study|Selection Criterion/Protocol Violation|9
2908579|NCT01676220|10015350|P1|Overall Study|Selection Criterion/Protocol Violation|9
2908580|NCT01676220|10015349|P2|Overall Study|Lost to Follow-up|18
2908581|NCT01676220|10015350|P1|Overall Study|Lost to Follow-up|11
2908582|NCT01676220|10015349|P2|Overall Study|Personal Reason|45
2908583|NCT01676220|10015350|P1|Overall Study|Personal Reason|34
2908584|NCT01676220|10015349|P2|Overall Study|Received Rescue Therapy|22
2908585|NCT01676220|10015350|P1|Overall Study|Received Rescue Therapy|14
2908586|NCT01676220|10015349|P2|Overall Study|Protocol Violation|12
2908587|NCT01676220|10015350|P1|Overall Study|Protocol Violation|11
2908588|NCT01676220|10015349|P2|Overall Study|Lack of Efficacy|5
2908589|NCT01676220|10015350|P1|Overall Study|Lack of Efficacy|2
2908590|NCT01676220|10015349|P2|Overall Study|Adverse Event|8
2908591|NCT01676220|10015350|P1|Overall Study|Adverse Event|10
2908592|NCT01676220|10015349|P2|Overall Study|Randomized But Not Treated|1
2908593|NCT01676220|10015350|P1|Overall Study|Randomized But Not Treated|4
2908594|NCT01676116|10015382|P2|Overall Study|Protocol Violation|3
2908595|NCT01676116|10015383|P1|Overall Study|Protocol Violation|9
2908596|NCT01676116|10015382|P2|Overall Study|Unclassified|10
2908597|NCT01676116|10015383|P1|Overall Study|Unclassified|4
2908598|NCT01676116|10015382|P2|Overall Study|Adverse Event|2
2908599|NCT01676116|10015383|P1|Overall Study|Adverse Event|1
2908600|NCT01676116|10015382|P2|Overall Study|Withdrawal criteria|14
2908601|NCT01676116|10015383|P1|Overall Study|Withdrawal criteria|2
2908602|NCT01676012|10015405|P1|Overall Study|incomplete set of videos|1
2908603|NCT01676012|10015405|P1|Overall Study|Adverse Event|2
2908604|NCT01675661|10015427|P2|Overall Study|Other reason|2
2908605|NCT01675661|10015428|P1|Overall Study|Other reason|1
2908606|NCT01675661|10015427|P2|Overall Study|Death|1
2908607|NCT01675661|10015428|P1|Overall Study|Death|0
2908608|NCT01675661|10015427|P2|Overall Study|Physician Decision|2
2908609|NCT01675661|10015428|P1|Overall Study|Physician Decision|0
2908610|NCT01675661|10015427|P2|Overall Study|Withdrawal by Subject|7
2908611|NCT01675661|10015428|P1|Overall Study|Withdrawal by Subject|3
2908612|NCT01675661|10015427|P2|Overall Study|Moved away|6
2908613|NCT01675661|10015428|P1|Overall Study|Moved away|5
2908614|NCT01675661|10015427|P2|Overall Study|Practical problems|5
2908615|NCT01675661|10015428|P1|Overall Study|Practical problems|9
2908616|NCT01675661|10015427|P2|Overall Study|Lost to Follow-up|23
2908617|NCT01675661|10015428|P1|Overall Study|Lost to Follow-up|22
2908618|NCT01675622|10015457|P2|Overall Study|Other|4
2908619|NCT01675622|10015458|P1|Overall Study|Other|5
2908620|NCT01675622|10015457|P2|Overall Study|Lost to Follow-up|3
2908621|NCT01675622|10015458|P1|Overall Study|Lost to Follow-up|1
2908622|NCT01675622|10015457|P2|Overall Study|Lack of Efficacy|4
2908623|NCT01675622|10015458|P1|Overall Study|Lack of Efficacy|2
2908624|NCT01675622|10015457|P2|Overall Study|Protocol Violation|1
2908625|NCT01675622|10015458|P1|Overall Study|Protocol Violation|4
2908626|NCT01675622|10015457|P2|Overall Study|Adverse Event|10
2908627|NCT01675622|10015458|P1|Overall Study|Adverse Event|12
2908628|NCT01675622|10015457|P2|Overall Study|Withdrawal by Subject|2
2908629|NCT01675622|10015458|P1|Overall Study|Withdrawal by Subject|2
2908630|NCT01675596|10015482|P1|Overall Study|Missed Visit|1
2908631|NCT01675596|10015482|P1|Overall Study|Exit with other reason|1
2908632|NCT01675596|10015482|P1|Overall Study|Death|6
2908633|NCT01675544|10015488|P1|Overall Study|Withdrawal by Subject|2
2908634|NCT01675531|10015493|P1|Overall Study|Protocol Violation|8
2908635|NCT01675531|10015493|P1|Overall Study|Lack of Efficacy|1
2908636|NCT01675531|10015493|P1|Overall Study|Withdrawal by Subject|7
2908637|NCT01675531|10015493|P1|Overall Study|Adverse Event|9
2908638|NCT01675492|10015500|P1|Overall Study|study completed early - product approval|42
2908639|NCT01675479|10015505|P1|Overall Study|Lost to Follow-up|11
2908640|NCT01675427|10015519|P1|Overall Study|Other|2
2908641|NCT01675427|10015519|P1|Overall Study|Lost to Follow-up|5
2908642|NCT01675427|10015519|P1|Overall Study|Sample not Collected by Mistake|2
2908643|NCT01675427|10015519|P1|Overall Study|Participant Refused Sample Collection|18
2908644|NCT01675427|10015519|P1|Overall Study|Withdrawal by Subject|7
2908645|NCT01675167|10015819|P3|Double-blind Treatment Phase|Other|5
2908646|NCT01675167|10015820|P2|Double-blind Treatment Phase|Other|7
2908647|NCT01675167|10015821|P1|Double-blind Treatment Phase|Other|0
2908648|NCT01675167|10015819|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
2908649|NCT01675167|10015820|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2908650|NCT01675167|10015821|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2908651|NCT01675167|10015819|P3|Double-blind Treatment Phase|Lost to Follow-up|5
2908652|NCT01675167|10015820|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2908653|NCT01675167|10015821|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2908654|NCT01675167|10015819|P3|Double-blind Treatment Phase|Protocol Violation|11
2908655|NCT01675167|10015820|P2|Double-blind Treatment Phase|Protocol Violation|4
2908656|NCT01675167|10015821|P1|Double-blind Treatment Phase|Protocol Violation|0
2908657|NCT01675167|10015819|P3|Double-blind Treatment Phase|Adverse Event|13
2908658|NCT01675167|10015820|P2|Double-blind Treatment Phase|Adverse Event|5
2908659|NCT01675167|10015821|P1|Double-blind Treatment Phase|Adverse Event|0
2908660|NCT01675167|10015819|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
2908661|NCT01675167|10015820|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
2908662|NCT01675167|10015821|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
2908663|NCT01675167|10015819|P3|Double-blind Treatment Phase|Lack of Efficacy|61
2908664|NCT01675167|10015820|P2|Double-blind Treatment Phase|Lack of Efficacy|19
2908665|NCT01675167|10015821|P1|Double-blind Treatment Phase|Lack of Efficacy|0
2908666|NCT01675167|10015819|P3|Open-label Titration Phase|Other|0
2908667|NCT01675167|10015820|P2|Open-label Titration Phase|Other|0
2908668|NCT01675167|10015821|P1|Open-label Titration Phase|Other|55
2908669|NCT01675167|10015819|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2908670|NCT01675167|10015820|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2908671|NCT01675167|10015821|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
2908672|NCT01675167|10015819|P3|Open-label Titration Phase|Lost to Follow-up|0
2908673|NCT01675167|10015820|P2|Open-label Titration Phase|Lost to Follow-up|0
2908674|NCT01675167|10015821|P1|Open-label Titration Phase|Lost to Follow-up|15
2908675|NCT01675167|10015819|P3|Open-label Titration Phase|Protocol Violation|0
2908676|NCT01675167|10015820|P2|Open-label Titration Phase|Protocol Violation|0
2908761|NCT01674647|10015955|P1|Treatment Period|Switching to other therapy|5
2908677|NCT01675167|10015821|P1|Open-label Titration Phase|Protocol Violation|43
2908678|NCT01675167|10015819|P3|Open-label Titration Phase|Withdrawal by Subject|0
2908679|NCT01675167|10015820|P2|Open-label Titration Phase|Withdrawal by Subject|0
2908680|NCT01675167|10015821|P1|Open-label Titration Phase|Withdrawal by Subject|46
2908681|NCT01675167|10015819|P3|Open-label Titration Phase|Lack of Efficacy|0
2908682|NCT01675167|10015820|P2|Open-label Titration Phase|Lack of Efficacy|0
2908683|NCT01675167|10015821|P1|Open-label Titration Phase|Lack of Efficacy|63
2908684|NCT01675167|10015819|P3|Open-label Titration Phase|Adverse Event|0
2908685|NCT01675167|10015820|P2|Open-label Titration Phase|Adverse Event|0
2908686|NCT01675167|10015821|P1|Open-label Titration Phase|Adverse Event|81
2908687|NCT01675141|10015843|P1|Overall Study|No treatment, per protocol|1
2908688|NCT01675141|10015843|P1|Overall Study|Physician Decision|4
2908689|NCT01675141|10015843|P1|Overall Study|Withdrawal by Subject|3
2908690|NCT01675141|10015843|P1|Overall Study|Lenalidomide outside NIH|3
2908691|NCT01675128|10015856|P3|Overall Study|Pulmonary complication; off study|0
2908692|NCT01675128|10015857|P2|Overall Study|Pulmonary complication; off study|1
2908693|NCT01675128|10015858|P1|Overall Study|Pulmonary complication; off study|0
2908694|NCT01675128|10015856|P3|Overall Study|Refused further treatment|0
2908695|NCT01675128|10015857|P2|Overall Study|Refused further treatment|0
2908696|NCT01675128|10015858|P1|Overall Study|Refused further treatment|1
2908697|NCT01675128|10015856|P3|Overall Study|Disease progression on study|1
2908698|NCT01675128|10015857|P2|Overall Study|Disease progression on study|1
2908699|NCT01675128|10015858|P1|Overall Study|Disease progression on study|1
2908700|NCT01675050|10015886|P2|Period One Treatment|Withdrawal by Subject|0
2908701|NCT01675050|10015887|P1|Period One Treatment|Withdrawal by Subject|1
2908702|NCT01675011|10015897|P2|Overall Study|Trial terminated by Sponsor|1
2908703|NCT01675011|10015898|P1|Overall Study|Trial terminated by Sponsor|3
2908704|NCT01674725|10015906|P2|Overall Study|Lost to Follow-up|1
2908705|NCT01674725|10015907|P1|Overall Study|Lost to Follow-up|0
2908706|NCT01674725|10015906|P2|Overall Study|Withdrawal by Subject|0
2908707|NCT01674725|10015907|P1|Overall Study|Withdrawal by Subject|1
2908708|NCT01674725|10015906|P2|Overall Study|Did not receive study drug|0
2908709|NCT01674725|10015907|P1|Overall Study|Did not receive study drug|1
2908710|NCT01674725|10015906|P2|Overall Study|Adverse Event|0
2908711|NCT01674725|10015907|P1|Overall Study|Adverse Event|1
2908712|NCT01674712|10015926|P5|Overall Study|Lack of Efficacy|1
2908713|NCT01674712|10015927|P4|Overall Study|Lack of Efficacy|0
2908714|NCT01674712|10015928|P3|Overall Study|Lack of Efficacy|1
2908715|NCT01674712|10015929|P2|Overall Study|Lack of Efficacy|0
2908716|NCT01674712|10015930|P1|Overall Study|Lack of Efficacy|0
2908717|NCT01674712|10015926|P5|Overall Study|Administrative|1
2908718|NCT01674712|10015927|P4|Overall Study|Administrative|0
2908719|NCT01674712|10015928|P3|Overall Study|Administrative|0
2908720|NCT01674712|10015929|P2|Overall Study|Administrative|1
2908721|NCT01674712|10015930|P1|Overall Study|Administrative|0
2908722|NCT01674712|10015926|P5|Overall Study|Withdrawal by Subject|3
2908723|NCT01674712|10015927|P4|Overall Study|Withdrawal by Subject|4
2908724|NCT01674712|10015928|P3|Overall Study|Withdrawal by Subject|5
2908725|NCT01674712|10015929|P2|Overall Study|Withdrawal by Subject|2
2908726|NCT01674712|10015930|P1|Overall Study|Withdrawal by Subject|2
2908727|NCT01674712|10015926|P5|Overall Study|Protocol Violation|0
2908728|NCT01674712|10015927|P4|Overall Study|Protocol Violation|0
2908729|NCT01674712|10015928|P3|Overall Study|Protocol Violation|0
2908730|NCT01674712|10015929|P2|Overall Study|Protocol Violation|0
2908731|NCT01674712|10015930|P1|Overall Study|Protocol Violation|2
2908732|NCT01674712|10015926|P5|Overall Study|Lost to Follow-up|0
2908733|NCT01674712|10015927|P4|Overall Study|Lost to Follow-up|0
2908734|NCT01674712|10015928|P3|Overall Study|Lost to Follow-up|0
2908735|NCT01674712|10015929|P2|Overall Study|Lost to Follow-up|0
2908736|NCT01674712|10015930|P1|Overall Study|Lost to Follow-up|1
2908737|NCT01674712|10015926|P5|Overall Study|Adverse Event|6
2908738|NCT01674712|10015927|P4|Overall Study|Adverse Event|4
2908739|NCT01674712|10015928|P3|Overall Study|Adverse Event|3
2908740|NCT01674712|10015929|P2|Overall Study|Adverse Event|6
2908741|NCT01674712|10015930|P1|Overall Study|Adverse Event|5
2908742|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
2908743|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
2908744|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
2908745|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
2908746|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Logistical difficulties|3
2908747|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Logistical difficulties|1
2908748|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Protocol Violation|22
2908749|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Protocol Violation|39
2908750|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
2908751|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
2908752|NCT01674647|10015954|P2|30-day Safety Follow-up Period|Death|2
2908753|NCT01674647|10015955|P1|30-day Safety Follow-up Period|Death|3
2908754|NCT01674647|10015954|P2|Treatment Period|Protocol Violation|36
2908755|NCT01674647|10015955|P1|Treatment Period|Protocol Violation|56
2908756|NCT01674647|10015954|P2|Treatment Period|Treatment failure|14
2908757|NCT01674647|10015955|P1|Treatment Period|Treatment failure|0
2908758|NCT01674647|10015954|P2|Treatment Period|Logistical difficulties|8
2908759|NCT01674647|10015955|P1|Treatment Period|Logistical difficulties|5
2908760|NCT01674647|10015954|P2|Treatment Period|Switching to other therapy|2
2908762|NCT01674647|10015954|P2|Treatment Period|Withdrawal by Subject|16
2908763|NCT01674647|10015955|P1|Treatment Period|Withdrawal by Subject|19
2908764|NCT01674647|10015954|P2|Treatment Period|Lost to Follow-up|1
2908765|NCT01674647|10015955|P1|Treatment Period|Lost to Follow-up|1
2908766|NCT01674647|10015954|P2|Treatment Period|Non-compliance with study drug|0
2908767|NCT01674647|10015955|P1|Treatment Period|Non-compliance with study drug|3
2908768|NCT01674647|10015954|P2|Treatment Period|Adverse Event|22
2908769|NCT01674647|10015955|P1|Treatment Period|Adverse Event|60
2908770|NCT01674647|10015954|P2|Treatment Period|Physician Decision|1
2908771|NCT01674647|10015955|P1|Treatment Period|Physician Decision|3
2908772|NCT01674647|10015954|P2|Treatment Period|Efficacy outcome reached|1
2908773|NCT01674647|10015955|P1|Treatment Period|Efficacy outcome reached|0
2908774|NCT01674647|10015954|P2|Treatment Period|Death|1
2908775|NCT01674647|10015955|P1|Treatment Period|Death|4
2908776|NCT01674634|10015981|P1|Overall Study|Lost to Follow-up|3
2908777|NCT01674634|10015981|P1|Overall Study|Withdrawal by Subject|3
2908778|NCT01674621|10016001|P5|Overall Study|Other than specified|2
2908779|NCT01674621|10016002|P4|Overall Study|Other than specified|0
2908780|NCT01674621|10016003|P3|Overall Study|Other than specified|0
2908781|NCT01674621|10016004|P2|Overall Study|Other than specified|1
2908782|NCT01674621|10016005|P1|Overall Study|Other than specified|0
2908783|NCT01674621|10016001|P5|Overall Study|Withdrawal by Subject|1
2908784|NCT01674621|10016002|P4|Overall Study|Withdrawal by Subject|0
2908785|NCT01674621|10016003|P3|Overall Study|Withdrawal by Subject|2
2908786|NCT01674621|10016004|P2|Overall Study|Withdrawal by Subject|5
2908787|NCT01674621|10016005|P1|Overall Study|Withdrawal by Subject|2
2908788|NCT01674621|10016001|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2908789|NCT01674621|10016002|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
2908790|NCT01674621|10016003|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2908791|NCT01674621|10016004|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2908792|NCT01674621|10016005|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
2908793|NCT01674621|10016001|P5|Overall Study|Inability to Complete Study Procedures|2
2908794|NCT01674621|10016002|P4|Overall Study|Inability to Complete Study Procedures|0
2908795|NCT01674621|10016003|P3|Overall Study|Inability to Complete Study Procedures|0
2908796|NCT01674621|10016004|P2|Overall Study|Inability to Complete Study Procedures|0
2908797|NCT01674621|10016005|P1|Overall Study|Inability to Complete Study Procedures|0
2908798|NCT01674621|10016001|P5|Overall Study|Adverse Event|1
2908799|NCT01674621|10016002|P4|Overall Study|Adverse Event|5
2908800|NCT01674621|10016003|P3|Overall Study|Adverse Event|5
2908801|NCT01674621|10016004|P2|Overall Study|Adverse Event|2
2908802|NCT01674621|10016005|P1|Overall Study|Adverse Event|3
2908803|NCT01674569|10016082|P6|Overall Study|Withdrawal by Subject|0
2908804|NCT01674569|10016083|P5|Overall Study|Withdrawal by Subject|0
2908805|NCT01674569|10016084|P4|Overall Study|Withdrawal by Subject|0
2908806|NCT01674569|10016085|P3|Overall Study|Withdrawal by Subject|1
2908807|NCT01674569|10016086|P2|Overall Study|Withdrawal by Subject|0
2908808|NCT01674569|10016087|P1|Overall Study|Withdrawal by Subject|0
2908809|NCT01674569|10016082|P6|Overall Study|Protocol Violation|0
2908810|NCT01674569|10016083|P5|Overall Study|Protocol Violation|0
2908811|NCT01674569|10016084|P4|Overall Study|Protocol Violation|0
2908812|NCT01674569|10016085|P3|Overall Study|Protocol Violation|1
2908813|NCT01674569|10016086|P2|Overall Study|Protocol Violation|1
2908814|NCT01674569|10016087|P1|Overall Study|Protocol Violation|0
2908815|NCT01674569|10016082|P6|Overall Study|Adverse Event|2
2908816|NCT01674569|10016083|P5|Overall Study|Adverse Event|2
2908817|NCT01674569|10016084|P4|Overall Study|Adverse Event|1
2908818|NCT01674569|10016085|P3|Overall Study|Adverse Event|0
2908819|NCT01674569|10016086|P2|Overall Study|Adverse Event|2
2908820|NCT01674569|10016087|P1|Overall Study|Adverse Event|0
2908821|NCT01674062|10016108|P2|Overall Study|Programming Error|0
2908822|NCT01674062|10016109|P1|Overall Study|Programming Error|1
2908823|NCT01674062|10016108|P2|Overall Study|Death|1
2908824|NCT01674062|10016109|P1|Overall Study|Death|0
2908825|NCT01674062|10016108|P2|Overall Study|Adverse Event|1
2908826|NCT01674062|10016109|P1|Overall Study|Adverse Event|1
2908827|NCT01674062|10016108|P2|Overall Study|Other|1
2908828|NCT01674062|10016109|P1|Overall Study|Other|8
2908829|NCT01674062|10016108|P2|Overall Study|Insufficient Therapeutic Response|26
2908830|NCT01674062|10016109|P1|Overall Study|Insufficient Therapeutic Response|56
2908831|NCT01674010|10016124|P3|Randomization Phase 2|Withdrawal by Subject|7
2908832|NCT01674010|10016125|P2|Randomization Phase 2|Withdrawal by Subject|8
2908833|NCT01674010|10016126|P1|Randomization Phase 2|Withdrawal by Subject|0
2908834|NCT01674010|10016124|P3|Randomization Phase 2|Sponsor Decision|45
2908835|NCT01674010|10016125|P2|Randomization Phase 2|Sponsor Decision|42
2908836|NCT01674010|10016126|P1|Randomization Phase 2|Sponsor Decision|0
2908837|NCT01674010|10016124|P3|Randomization Phase 2|Protocol Violation|1
2908838|NCT01674010|10016125|P2|Randomization Phase 2|Protocol Violation|1
2908839|NCT01674010|10016126|P1|Randomization Phase 2|Protocol Violation|0
2908840|NCT01674010|10016124|P3|Randomization Phase 2|Pregnancy|1
2908841|NCT01674010|10016125|P2|Randomization Phase 2|Pregnancy|1
2908842|NCT01674010|10016126|P1|Randomization Phase 2|Pregnancy|0
2908843|NCT01674010|10016124|P3|Randomization Phase 2|Physician Decision|2
2908844|NCT01674010|10016125|P2|Randomization Phase 2|Physician Decision|0
2908845|NCT01674010|10016126|P1|Randomization Phase 2|Physician Decision|0
2908846|NCT01674010|10016124|P3|Randomization Phase 2|Mood episode recurrence|2
2908847|NCT01674010|10016125|P2|Randomization Phase 2|Mood episode recurrence|8
2908848|NCT01674010|10016126|P1|Randomization Phase 2|Mood episode recurrence|0
2908849|NCT01674010|10016124|P3|Randomization Phase 2|Lost to Follow-up|2
2908850|NCT01674010|10016125|P2|Randomization Phase 2|Lost to Follow-up|1
2908851|NCT01674010|10016126|P1|Randomization Phase 2|Lost to Follow-up|0
2908852|NCT01674010|10016124|P3|Randomization Phase 2|Adverse Event|1
2908853|NCT01674010|10016125|P2|Randomization Phase 2|Adverse Event|1
2908854|NCT01674010|10016126|P1|Randomization Phase 2|Adverse Event|0
2908855|NCT01674010|10016124|P3|Open Treatment Phase 1|Withdrawal by Subject|0
2908856|NCT01674010|10016125|P2|Open Treatment Phase 1|Withdrawal by Subject|0
2908857|NCT01674010|10016126|P1|Open Treatment Phase 1|Withdrawal by Subject|25
2908858|NCT01674010|10016124|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
2908859|NCT01674010|10016125|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
2908860|NCT01674010|10016126|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
2908861|NCT01674010|10016124|P3|Open Treatment Phase 1|Sponsor Decision|0
2908862|NCT01674010|10016125|P2|Open Treatment Phase 1|Sponsor Decision|0
2908863|NCT01674010|10016126|P1|Open Treatment Phase 1|Sponsor Decision|79
2908864|NCT01674010|10016124|P3|Open Treatment Phase 1|Protocol Violation|0
2908865|NCT01674010|10016125|P2|Open Treatment Phase 1|Protocol Violation|0
2908866|NCT01674010|10016126|P1|Open Treatment Phase 1|Protocol Violation|7
2908867|NCT01674010|10016124|P3|Open Treatment Phase 1|Physician Decision|0
2908868|NCT01674010|10016125|P2|Open Treatment Phase 1|Physician Decision|0
2908869|NCT01674010|10016126|P1|Open Treatment Phase 1|Physician Decision|9
2908870|NCT01674010|10016124|P3|Open Treatment Phase 1|Lost to Follow-up|0
2908871|NCT01674010|10016125|P2|Open Treatment Phase 1|Lost to Follow-up|0
2908872|NCT01674010|10016126|P1|Open Treatment Phase 1|Lost to Follow-up|19
2908873|NCT01674010|10016124|P3|Open Treatment Phase 1|Death|0
2908874|NCT01674010|10016125|P2|Open Treatment Phase 1|Death|0
2908875|NCT01674010|10016126|P1|Open Treatment Phase 1|Death|1
2908876|NCT01674010|10016124|P3|Open Treatment Phase 1|Adverse Event|0
2908877|NCT01674010|10016125|P2|Open Treatment Phase 1|Adverse Event|0
2908878|NCT01674010|10016126|P1|Open Treatment Phase 1|Adverse Event|10
2908879|NCT01673984|10016145|P2|Overall Study|Study termination|6
2908880|NCT01673984|10016146|P1|Overall Study|Study termination|9
2908881|NCT01673984|10016145|P2|Overall Study|Adverse Event|0
2908882|NCT01673984|10016146|P1|Overall Study|Adverse Event|1
2908883|NCT01673867|10016196|P2|Treatment|Physician Decision|1
2908884|NCT01673867|10016197|P1|Treatment|Physician Decision|0
2908885|NCT01673867|10016196|P2|Treatment|Symptomatic deterioration|1
2908886|NCT01673867|10016197|P1|Treatment|Symptomatic deterioration|0
2908887|NCT01673867|10016196|P2|Treatment|Required prolonged hospitalization|1
2908888|NCT01673867|10016197|P1|Treatment|Required prolonged hospitalization|0
2908889|NCT01673867|10016196|P2|Treatment|Health status not improved|0
2908890|NCT01673867|10016197|P1|Treatment|Health status not improved|1
2908891|NCT01673867|10016196|P2|Treatment|Required steroid therapy|0
2908892|NCT01673867|10016197|P1|Treatment|Required steroid therapy|1
2908893|NCT01673867|10016196|P2|Treatment|No longer meets criteria|0
2908894|NCT01673867|10016197|P1|Treatment|No longer meets criteria|2
2908895|NCT01673867|10016196|P2|Treatment|Maximum clinical benefit|10
2908896|NCT01673867|10016197|P1|Treatment|Maximum clinical benefit|0
2908897|NCT01673867|10016196|P2|Treatment|Withdrawal by Subject|6
2908898|NCT01673867|10016197|P1|Treatment|Withdrawal by Subject|4
2908899|NCT01673867|10016196|P2|Treatment|Requested treatment discontinuation|16
2908900|NCT01673867|10016197|P1|Treatment|Requested treatment discontinuation|5
2908901|NCT01673867|10016196|P2|Treatment|AE unrelated to study drug|11
2908902|NCT01673867|10016197|P1|Treatment|AE unrelated to study drug|19
2908903|NCT01673867|10016196|P2|Treatment|Death|1
2908904|NCT01673867|10016197|P1|Treatment|Death|1
2908905|NCT01673867|10016196|P2|Treatment|Study Drug Toxicity|42
2908906|NCT01673867|10016197|P1|Treatment|Study Drug Toxicity|17
2908907|NCT01673867|10016196|P2|Treatment|Disease Progression|179
2908908|NCT01673867|10016197|P1|Treatment|Disease Progression|194
2908909|NCT01673867|10016196|P2|Randomization|No longer meets criteria|5
2908910|NCT01673867|10016197|P1|Randomization|No longer meets criteria|4
2908911|NCT01673867|10016196|P2|Randomization|Lost to Follow-up|1
2908912|NCT01673867|10016197|P1|Randomization|Lost to Follow-up|0
2908913|NCT01673867|10016196|P2|Randomization|Withdrawal by Subject|12
2908914|NCT01673867|10016197|P1|Randomization|Withdrawal by Subject|0
2908915|NCT01673867|10016196|P2|Randomization|Requested treatment discontinuation|4
2908916|NCT01673867|10016197|P1|Randomization|Requested treatment discontinuation|0
2908917|NCT01673867|10016196|P2|Randomization|AE unrelated to study drug|0
2908918|NCT01673867|10016197|P1|Randomization|AE unrelated to study drug|1
2908919|NCT01673854|10016223|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
2908920|NCT01673854|10016223|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
2908921|NCT01673854|10016223|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
2908922|NCT01673854|10016223|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
2908923|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
2908924|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
2908925|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
2908926|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
2908927|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
2908928|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
2908929|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
2908930|NCT01673854|10016223|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
2908931|NCT01673698|10016246|P2|Overall Study|Lost to Follow-up|13
2908932|NCT01673698|10016247|P1|Overall Study|Lost to Follow-up|51
2908933|NCT01673646|10016258|P3|Overall Study|Completed Core/did not enter Ext.|1
2908934|NCT01673646|10016259|P2|Overall Study|Completed Core/did not enter Ext.|1
2908935|NCT01673646|10016260|P1|Overall Study|Completed Core/did not enter Ext.|2
2908936|NCT01673646|10016258|P3|Overall Study|Withdrawal by Subject|2
2908937|NCT01673646|10016259|P2|Overall Study|Withdrawal by Subject|2
2908938|NCT01673646|10016260|P1|Overall Study|Withdrawal by Subject|0
2908939|NCT01673646|10016258|P3|Overall Study|Condition no longer requires study drug|0
2908940|NCT01673646|10016259|P2|Overall Study|Condition no longer requires study drug|1
2908941|NCT01673646|10016260|P1|Overall Study|Condition no longer requires study drug|0
2908942|NCT01673646|10016258|P3|Overall Study|Unsatisfactory therapeutic effect|0
2908943|NCT01673646|10016259|P2|Overall Study|Unsatisfactory therapeutic effect|2
2908944|NCT01673646|10016260|P1|Overall Study|Unsatisfactory therapeutic effect|0
2908945|NCT01673646|10016258|P3|Overall Study|Adverse Event|1
2908946|NCT01673646|10016259|P2|Overall Study|Adverse Event|1
2908947|NCT01673646|10016260|P1|Overall Study|Adverse Event|2
2908948|NCT01673620|10016299|P2|Overall Study|Adverse Event|0
2908949|NCT01673620|10016300|P1|Overall Study|Adverse Event|1
2908950|NCT01673594|10016310|P2|Overall Study|Withdrawal by Subject|1
2908951|NCT01673594|10016311|P1|Overall Study|Withdrawal by Subject|0
2908952|NCT01673594|10016310|P2|Overall Study|Physician Decision|4
2908953|NCT01673594|10016311|P1|Overall Study|Physician Decision|2
2908954|NCT01673594|10016310|P2|Overall Study|Lost to Follow-up|0
2908955|NCT01673594|10016311|P1|Overall Study|Lost to Follow-up|1
2908956|NCT01673594|10016310|P2|Overall Study|Adverse Event|1
2908957|NCT01673594|10016311|P1|Overall Study|Adverse Event|3
2908958|NCT01673490|10016330|P1|Overall Study|Withdrawal by Subject|3
2908959|NCT01673490|10016330|P1|Overall Study|Adverse Event|3
2908960|NCT01673490|10016330|P1|Overall Study|Lost to Follow-up|1
2908961|NCT01673373|10016347|P1|Overall Study|Death|2
2908962|NCT01673347|10016363|P1|Overall Study|failure of allograft|7
2908963|NCT01673282|10016372|P2|Overall Study|Other|6
2908964|NCT01673282|10016373|P1|Overall Study|Other|1
2908965|NCT01673282|10016372|P2|Overall Study|Withdrawal by Subject|3
2908966|NCT01673282|10016373|P1|Overall Study|Withdrawal by Subject|3
2908967|NCT01673282|10016372|P2|Overall Study|Lost to Follow-up|10
2908968|NCT01673282|10016373|P1|Overall Study|Lost to Follow-up|11
2908969|NCT01673282|10016372|P2|Overall Study|Lack of Efficacy|2
2908970|NCT01673282|10016373|P1|Overall Study|Lack of Efficacy|9
2908971|NCT01673282|10016372|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
2908972|NCT01673282|10016373|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
2908973|NCT01673178|10016409|P5|Overall Study|Other|0
2908974|NCT01673178|10016410|P4|Overall Study|Other|1
2908975|NCT01673178|10016411|P3|Overall Study|Other|2
2908976|NCT01673178|10016412|P2|Overall Study|Other|0
2908977|NCT01673178|10016413|P1|Overall Study|Other|1
2908978|NCT01673178|10016409|P5|Overall Study|Adverse Event|0
2908979|NCT01673178|10016410|P4|Overall Study|Adverse Event|2
2908980|NCT01673178|10016411|P3|Overall Study|Adverse Event|0
2908981|NCT01673178|10016412|P2|Overall Study|Adverse Event|0
2908982|NCT01673178|10016413|P1|Overall Study|Adverse Event|1
2908983|NCT01673178|10016409|P5|Overall Study|Protocol Violation|0
2908984|NCT01673178|10016410|P4|Overall Study|Protocol Violation|1
2908985|NCT01673178|10016411|P3|Overall Study|Protocol Violation|0
2908986|NCT01673178|10016412|P2|Overall Study|Protocol Violation|1
2908987|NCT01673178|10016413|P1|Overall Study|Protocol Violation|1
2908988|NCT01673178|10016409|P5|Overall Study|Withdrawal by Subject|2
2908989|NCT01673178|10016410|P4|Overall Study|Withdrawal by Subject|4
2908990|NCT01673178|10016411|P3|Overall Study|Withdrawal by Subject|1
2908991|NCT01673178|10016412|P2|Overall Study|Withdrawal by Subject|0
2908992|NCT01673178|10016413|P1|Overall Study|Withdrawal by Subject|0
2908993|NCT01673178|10016409|P5|Overall Study|Lost to Follow-up|0
2908994|NCT01673178|10016410|P4|Overall Study|Lost to Follow-up|0
2908995|NCT01673178|10016411|P3|Overall Study|Lost to Follow-up|0
2908996|NCT01673178|10016412|P2|Overall Study|Lost to Follow-up|1
2908997|NCT01673178|10016413|P1|Overall Study|Lost to Follow-up|0
2908998|NCT01673126|10016652|P2|Overall Study|change of diagnosis|3
2908999|NCT01673126|10016653|P1|Overall Study|change of diagnosis|4
2909000|NCT01673009|10016692|P1|Overall Study|Withdrawal by Subject|8
2909001|NCT01673009|10016692|P1|Overall Study|Physician Decision|5
2909002|NCT01672970|10016777|P1|Overall Study|Enrolled but not treated|1
2909003|NCT01672970|10016777|P1|Overall Study|Other|9
2909004|NCT01672970|10016777|P1|Overall Study|Lost to Follow-up|5
2909005|NCT01672970|10016777|P1|Overall Study|Withdrawal by Subject|2
2909006|NCT01672970|10016777|P1|Overall Study|Adverse Event|18
2909007|NCT01672970|10016777|P1|Overall Study|Lack of Efficacy|12
2909008|NCT01672957|10016813|P1|Overall Study|ICF Signed After Transplantation|5
2909009|NCT01672957|10016813|P1|Overall Study|Death|2
2909010|NCT01672957|10016813|P1|Overall Study|Protocol Violation|48
2909011|NCT01672892|10016828|P2|Overall Study|Protocol Violation|3
2909012|NCT01672892|10016829|P1|Overall Study|Protocol Violation|7
2909013|NCT01672879|10016858|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2909014|NCT01672879|10016859|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2909015|NCT01672879|10016860|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
2909016|NCT01672879|10016858|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2909176|NCT01670656|10017274|P2|Overall Study|Subject withdrew consent|1
2909017|NCT01672879|10016859|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
2909018|NCT01672879|10016860|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2909019|NCT01672879|10016858|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
2909020|NCT01672879|10016859|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
2909021|NCT01672879|10016860|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
2909022|NCT01672879|10016858|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
2909023|NCT01672879|10016859|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
2909024|NCT01672879|10016860|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
2909025|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
2909026|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
2909027|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
2909028|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
2909029|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2909030|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2909031|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
2909032|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
2909033|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
2909034|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Death|0
2909035|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Death|2
2909036|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Death|0
2909037|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
2909038|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
2909039|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
2909040|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
2909041|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
2909042|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
2909043|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
2909044|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
2909045|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
2909046|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
2909047|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
2909048|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
2909049|NCT01672879|10016858|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
2909050|NCT01672879|10016859|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
2909051|NCT01672879|10016860|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
2909052|NCT01672866|10016875|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2909053|NCT01672866|10016876|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2909054|NCT01672866|10016877|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
2909055|NCT01672866|10016875|P3|Open-Label Phase (up to 240 Weeks)|Death|0
2909056|NCT01672866|10016876|P2|Open-Label Phase (up to 240 Weeks)|Death|0
2909057|NCT01672866|10016877|P1|Open-Label Phase (up to 240 Weeks)|Death|1
2909058|NCT01672866|10016875|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2909059|NCT01672866|10016876|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
2909060|NCT01672866|10016877|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2909061|NCT01672866|10016875|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2909062|NCT01672866|10016876|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2909063|NCT01672866|10016877|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
2909064|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
2909065|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
2909066|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
2909067|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2909068|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2909069|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
2909070|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Death|1
2909071|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Death|0
2909072|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Death|0
2909073|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2909074|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2909075|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
2909076|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
2909077|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2909078|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2909079|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2909080|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2909081|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2909082|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
2909083|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2909084|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2909085|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
2909086|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
2909087|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
2909088|NCT01672866|10016875|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
2909089|NCT01672866|10016876|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
2909090|NCT01672866|10016877|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
2909091|NCT01672853|10016892|P3|Overall Study|Randomized but Never Treated|1
2909092|NCT01672853|10016893|P2|Overall Study|Randomized but Never Treated|0
2909093|NCT01672853|10016894|P1|Overall Study|Randomized but Never Treated|0
2909094|NCT01672853|10016892|P3|Overall Study|Lost to Follow-up|0
2909095|NCT01672853|10016893|P2|Overall Study|Lost to Follow-up|1
2909096|NCT01672853|10016894|P1|Overall Study|Lost to Follow-up|0
2909097|NCT01672853|10016892|P3|Overall Study|Adverse Event|8
2909098|NCT01672853|10016893|P2|Overall Study|Adverse Event|6
2909099|NCT01672853|10016894|P1|Overall Study|Adverse Event|4
2909100|NCT01672853|10016892|P3|Overall Study|Withdrew Consent|5
2909101|NCT01672853|10016893|P2|Overall Study|Withdrew Consent|5
2909102|NCT01672853|10016894|P1|Overall Study|Withdrew Consent|5
2909103|NCT01672853|10016892|P3|Overall Study|Investigator's Discretion|0
2909104|NCT01672853|10016893|P2|Overall Study|Investigator's Discretion|0
2909105|NCT01672853|10016894|P1|Overall Study|Investigator's Discretion|1
2909106|NCT01672853|10016892|P3|Overall Study|Pregnancy|0
2909107|NCT01672853|10016893|P2|Overall Study|Pregnancy|1
2909108|NCT01672853|10016894|P1|Overall Study|Pregnancy|0
2909109|NCT01672853|10016892|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
2909110|NCT01672853|10016893|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
2909111|NCT01672853|10016894|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
2909112|NCT01672788|10016917|P4|Washout Period 2 (7 Days)|Adverse Event|1
2909113|NCT01672788|10016918|P3|Washout Period 2 (7 Days)|Adverse Event|0
2909114|NCT01672788|10016919|P2|Washout Period 2 (7 Days)|Adverse Event|0
2909115|NCT01672788|10016920|P1|Washout Period 2 (7 Days)|Adverse Event|0
2909116|NCT01672736|10016950|P1|Overall Study|Available drug expired on 31 May 16|3
2909117|NCT01672723|10016954|P2|First Intervention|Adverse Event|0
2909118|NCT01672723|10016955|P1|First Intervention|Adverse Event|3
2909119|NCT01672710|10016967|P2|3 Month Follow up|follow up due after termination date|1
2909120|NCT01672710|10016968|P1|3 Month Follow up|follow up due after termination date|4
2909121|NCT01672710|10016967|P2|3 Month Follow up|Lost to Follow-up|3
2909122|NCT01672710|10016968|P1|3 Month Follow up|Lost to Follow-up|2
2909123|NCT01672710|10016967|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
2909124|NCT01672710|10016968|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
2909125|NCT01672294|10017003|P4|Overall Study|Lost to Follow-up|9
2909126|NCT01672294|10017004|P3|Overall Study|Lost to Follow-up|7
2909127|NCT01672294|10017005|P2|Overall Study|Lost to Follow-up|16
2909128|NCT01672294|10017006|P1|Overall Study|Lost to Follow-up|1
2909129|NCT01672294|10017003|P4|Overall Study|Excluded by study|0
2909130|NCT01672294|10017004|P3|Overall Study|Excluded by study|0
2909131|NCT01672294|10017005|P2|Overall Study|Excluded by study|1
2909132|NCT01672294|10017006|P1|Overall Study|Excluded by study|1
2909133|NCT01672294|10017003|P4|Overall Study|Withdrawal by Subject|4
2909134|NCT01672294|10017004|P3|Overall Study|Withdrawal by Subject|4
2909135|NCT01672294|10017005|P2|Overall Study|Withdrawal by Subject|4
2909136|NCT01672294|10017006|P1|Overall Study|Withdrawal by Subject|4
2909137|NCT01671748|10017051|P2|4 Week run-in Phase|Not eligible|0
2909138|NCT01671748|10017052|P1|4 Week run-in Phase|Not eligible|9
2909139|NCT01671748|10017051|P2|4 Week run-in Phase|Adverse Event|0
2909140|NCT01671748|10017052|P1|4 Week run-in Phase|Adverse Event|1
2909141|NCT01671748|10017051|P2|4 Week run-in Phase|Withdrawal by Subject|0
2909142|NCT01671748|10017052|P1|4 Week run-in Phase|Withdrawal by Subject|1
2909143|NCT01671488|10017079|P1|Overall Study|Withdrawal by Subject|1
2909144|NCT01671345|10017087|P2|Overall Study|visit with non-participating physician|3
2909145|NCT01671345|10017088|P1|Overall Study|visit with non-participating physician|3
2909146|NCT01671345|10017087|P2|Overall Study|Lost to Follow-up|6
2909147|NCT01671345|10017088|P1|Overall Study|Lost to Follow-up|10
2909148|NCT01671332|10017102|P2|Overall Study|Withdrawal by Subject|1
2909149|NCT01671332|10017103|P1|Overall Study|Withdrawal by Subject|1
2909150|NCT01671319|10017117|P1|Overall Study|Withdrawal by Subject|1
2909151|NCT01671280|10017132|P1|Overall Study|Withdrawal by Subject|2
2909152|NCT01671111|10017143|P1|Overall Study|Other|24
2909153|NCT01671111|10017143|P1|Overall Study|Physician Decision|1
2909154|NCT01671111|10017143|P1|Overall Study|Withdrawal by Subject|2
2909155|NCT01671111|10017143|P1|Overall Study|Lack of Efficacy|1
2909156|NCT01671111|10017143|P1|Overall Study|Adverse Event|2
2909157|NCT01671085|10017155|P2|Overall Study|Withdrawal by Subject|0
2909158|NCT01671085|10017156|P1|Overall Study|Withdrawal by Subject|1
2909159|NCT01671059|10017167|P1|Overall Study|Lack of Efficacy|1
2909160|NCT01671059|10017167|P1|Overall Study|Adverse Event|4
2909161|NCT01670721|10017259|P1|Overall Study|Other than specified above|38
2909162|NCT01670721|10017259|P1|Overall Study|Participant's decision|15
2909163|NCT01670656|10017271|P5|Overall Study|Subject moved|0
2909164|NCT01670656|10017272|P4|Overall Study|Subject moved|1
2909165|NCT01670656|10017273|P3|Overall Study|Subject moved|0
2909166|NCT01670656|10017274|P2|Overall Study|Subject moved|0
2909167|NCT01670656|10017275|P1|Overall Study|Subject moved|0
2909168|NCT01670656|10017271|P5|Overall Study|Lost to Follow-up|3
2909169|NCT01670656|10017272|P4|Overall Study|Lost to Follow-up|0
2909170|NCT01670656|10017273|P3|Overall Study|Lost to Follow-up|0
2909171|NCT01670656|10017274|P2|Overall Study|Lost to Follow-up|0
2909172|NCT01670656|10017275|P1|Overall Study|Lost to Follow-up|0
2909173|NCT01670656|10017271|P5|Overall Study|Subject withdrew consent|1
2909174|NCT01670656|10017272|P4|Overall Study|Subject withdrew consent|1
2909175|NCT01670656|10017273|P3|Overall Study|Subject withdrew consent|2
2909177|NCT01670656|10017275|P1|Overall Study|Subject withdrew consent|0
2909178|NCT01670656|10017271|P5|Overall Study|Adverse Event|3
2909179|NCT01670656|10017272|P4|Overall Study|Adverse Event|3
2909180|NCT01670656|10017273|P3|Overall Study|Adverse Event|2
2909181|NCT01670656|10017274|P2|Overall Study|Adverse Event|2
2909182|NCT01670656|10017275|P1|Overall Study|Adverse Event|2
2909183|NCT01670656|10017271|P5|Overall Study|Non-compliance with protocol|2
2909184|NCT01670656|10017272|P4|Overall Study|Non-compliance with protocol|1
2909185|NCT01670656|10017273|P3|Overall Study|Non-compliance with protocol|1
2909186|NCT01670656|10017274|P2|Overall Study|Non-compliance with protocol|3
2909187|NCT01670656|10017275|P1|Overall Study|Non-compliance with protocol|0
2909188|NCT01670656|10017271|P5|Overall Study|Withdrawal by Subject|0
2909189|NCT01670656|10017272|P4|Overall Study|Withdrawal by Subject|0
2909190|NCT01670656|10017273|P3|Overall Study|Withdrawal by Subject|0
2909191|NCT01670656|10017274|P2|Overall Study|Withdrawal by Subject|1
2909192|NCT01670656|10017275|P1|Overall Study|Withdrawal by Subject|1
2909193|NCT01670656|10017271|P5|Overall Study|Pregnancy|1
2909194|NCT01670656|10017272|P4|Overall Study|Pregnancy|0
2909195|NCT01670656|10017273|P3|Overall Study|Pregnancy|0
2909196|NCT01670656|10017274|P2|Overall Study|Pregnancy|0
2909197|NCT01670656|10017275|P1|Overall Study|Pregnancy|0
2909198|NCT01670656|10017271|P5|Overall Study|Non-compliance with study drug|1
2909199|NCT01670656|10017272|P4|Overall Study|Non-compliance with study drug|0
2909200|NCT01670656|10017273|P3|Overall Study|Non-compliance with study drug|3
2909201|NCT01670656|10017274|P2|Overall Study|Non-compliance with study drug|0
2909202|NCT01670656|10017275|P1|Overall Study|Non-compliance with study drug|0
2909203|NCT01670526|10017304|P2|Overall Study|Lost to Follow-up|5
2909204|NCT01670526|10017305|P1|Overall Study|Lost to Follow-up|9
2909205|NCT01670526|10017304|P2|Overall Study|Withdrawal by Subject|1
2909206|NCT01670526|10017305|P1|Overall Study|Withdrawal by Subject|3
2909207|NCT01670292|10017326|P1|Overall Study|Lost to Follow-up|14
2909208|NCT01670279|10017367|P4|Overall Study|Participant met withdrawal criteria|1
2909209|NCT01670279|10017368|P3|Overall Study|Participant met withdrawal criteria|0
2909210|NCT01670279|10017369|P2|Overall Study|Participant met withdrawal criteria|0
2909211|NCT01670279|10017370|P1|Overall Study|Participant met withdrawal criteria|0
2909212|NCT01670279|10017367|P4|Overall Study|Physician Decision|0
2909213|NCT01670279|10017368|P3|Overall Study|Physician Decision|0
2909214|NCT01670279|10017369|P2|Overall Study|Physician Decision|1
2909215|NCT01670279|10017370|P1|Overall Study|Physician Decision|0
2909216|NCT01670279|10017367|P4|Overall Study|Adverse Event|0
2909217|NCT01670279|10017368|P3|Overall Study|Adverse Event|0
2909218|NCT01670279|10017369|P2|Overall Study|Adverse Event|1
2909219|NCT01670279|10017370|P1|Overall Study|Adverse Event|0
2909220|NCT01670188|10017412|P2|Overall Study|Death|1
2909221|NCT01670188|10017413|P1|Overall Study|Death|0
2909222|NCT01670045|10017442|P1|Overall Study|Lost to Follow-up|11
2909223|NCT01670045|10017442|P1|Overall Study|Death|1
2909224|NCT01670045|10017442|P1|Overall Study|Adverse Event|1
2909225|NCT01670045|10017442|P1|Overall Study|Withdrawal by Subject|3
2909226|NCT01670019|10017460|P2|Overall Study|Withdrawal by Subject|0
2909227|NCT01670019|10017461|P1|Overall Study|Withdrawal by Subject|6
2909228|NCT01670019|10017460|P2|Overall Study|Adverse Event|0
2909229|NCT01670019|10017461|P1|Overall Study|Adverse Event|3
2909230|NCT01669902|10017475|P1|Overall Study|Other|8
2909231|NCT01669902|10017475|P1|Overall Study|Lack of Efficacy|10
2909232|NCT01669902|10017475|P1|Overall Study|Adverse Event|11
2909233|NCT01669811|10017510|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
2909234|NCT01669811|10017511|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2909235|NCT01669811|10017510|P2|Overall Study|Adverse Event|6
2909236|NCT01669811|10017511|P1|Overall Study|Adverse Event|2
2909237|NCT01669811|10017510|P2|Overall Study|Withdrawal by Subject|2
2909238|NCT01669811|10017511|P1|Overall Study|Withdrawal by Subject|1
2909239|NCT01669811|10017510|P2|Overall Study|Investigator decision|1
2909240|NCT01669811|10017511|P1|Overall Study|Investigator decision|0
2909241|NCT01669798|10017529|P1|Overall Study|Physician Decision|5
2909242|NCT01669629|10017635|P2|Period 1|protocol deviation|2
2909243|NCT01669629|10017636|P1|Period 1|protocol deviation|1
2909244|NCT01669577|10017659|P1|Overall Study|Physician Decision|34
2909245|NCT01669577|10017659|P1|Overall Study|Lost to Follow-up|78
2909246|NCT01669577|10017659|P1|Overall Study|Death|22
2909247|NCT01669421|10017697|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
2909248|NCT01669421|10017697|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
2909249|NCT01669174|10017716|P2|Overall Study|Administrative problems|2
2909250|NCT01669174|10017717|P1|Overall Study|Administrative problems|1
2909251|NCT01669174|10017716|P2|Overall Study|Adverse Event|2
2909252|NCT01669174|10017717|P1|Overall Study|Adverse Event|2
2909253|NCT01669174|10017716|P2|Overall Study|Lost to Follow-up|0
2909254|NCT01669174|10017717|P1|Overall Study|Lost to Follow-up|1
2909255|NCT01669174|10017716|P2|Overall Study|Subject withdrew consent|2
2909256|NCT01669174|10017717|P1|Overall Study|Subject withdrew consent|2
2909257|NCT01669122|10017733|P1|Washout Period II|Protocol Violation|2
2909258|NCT01669122|10017733|P1|Period I|Lost to Follow-up|1
2909259|NCT01668966|10017800|P1|Overall Study|Not treated|2
2909260|NCT01668966|10017800|P1|Overall Study|Death|1
2909261|NCT01668966|10017800|P1|Overall Study|Withdrawal by Subject|1
2909262|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
2909263|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
2909411|NCT01668667|10017994|P3|Overall Study|Adverse Event|4
2909264|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2909265|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2909266|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
2909267|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
2909268|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2909269|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2909270|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
2909271|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
2909272|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2909273|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2909274|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
2909275|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
2909276|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2909277|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2909278|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2909279|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
2909280|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2909281|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2909282|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
2909283|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
2909284|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2909285|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2909286|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
2909287|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
2909288|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2909289|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2909290|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2909291|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2909292|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2909293|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2909294|NCT01668797|10017896|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
2909295|NCT01668797|10017897|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
2909296|NCT01668797|10017898|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2909297|NCT01668797|10017899|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2909298|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2909299|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2909300|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
2909301|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2909302|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2909303|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2909304|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
2909305|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2909306|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
2909307|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
2909308|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
2909309|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
2909310|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Protocol Violation|0
2909311|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Protocol Violation|0
2909312|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Protocol Violation|3
2909313|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Protocol Violation|0
2909314|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2909315|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2909316|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
2909317|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2909318|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Physician Decision|0
2909319|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Physician Decision|0
2909320|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Physician Decision|11
2909321|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Physician Decision|0
2909322|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2909323|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2909324|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
2909325|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2909326|NCT01668797|10017896|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
2909327|NCT01668797|10017897|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
2909328|NCT01668797|10017898|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
2909329|NCT01668797|10017899|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
2909330|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2909331|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2909332|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2909333|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
2909334|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2909335|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2909336|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2909337|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
2909338|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
2909339|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
2909340|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
2909341|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
2909342|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Protocol Violation|0
2909343|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Protocol Violation|0
2909344|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Protocol Violation|0
2909345|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Protocol Violation|2
2909346|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
2909347|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
2909348|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
2909349|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
2909350|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Physician Decision|0
2909351|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Physician Decision|0
2909352|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Physician Decision|0
2909353|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Physician Decision|2
2909354|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2909355|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2909356|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2909357|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
2909358|NCT01668797|10017896|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
2909359|NCT01668797|10017897|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
2909360|NCT01668797|10017898|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
2909361|NCT01668797|10017899|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
2909362|NCT01668784|10017964|P2|Treated (Overall)|Other|4
2909363|NCT01668784|10017965|P1|Treated (Overall)|Other|0
2909364|NCT01668784|10017964|P2|Treated (Overall)|Maximal Clinical Benefit|3
2909365|NCT01668784|10017965|P1|Treated (Overall)|Maximal Clinical Benefit|2
2909366|NCT01668784|10017964|P2|Treated (Overall)|Withdrawal by Subject|3
2909367|NCT01668784|10017965|P1|Treated (Overall)|Withdrawal by Subject|2
2909368|NCT01668784|10017964|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
2909369|NCT01668784|10017965|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
2909370|NCT01668784|10017964|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
2909371|NCT01668784|10017965|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
2909372|NCT01668784|10017964|P2|Treated (Overall)|Death|1
2909373|NCT01668784|10017965|P1|Treated (Overall)|Death|1
2909374|NCT01668784|10017964|P2|Treated (Overall)|Study Drug Toxicity|53
2909375|NCT01668784|10017965|P1|Treated (Overall)|Study Drug Toxicity|35
2909376|NCT01668784|10017964|P2|Treated (Overall)|Disease Progression|273
2909377|NCT01668784|10017965|P1|Treated (Overall)|Disease Progression|285
2909378|NCT01668784|10017964|P2|Randomized (Pre-treatment)|Other|1
2909379|NCT01668784|10017965|P1|Randomized (Pre-treatment)|Other|0
2909380|NCT01668784|10017964|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
2909381|NCT01668784|10017965|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
2909382|NCT01668784|10017964|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
2909383|NCT01668784|10017965|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
2909384|NCT01668784|10017964|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
2909385|NCT01668784|10017965|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
2909386|NCT01668784|10017964|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
2909387|NCT01668784|10017965|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
2909388|NCT01668784|10017964|P2|Randomized (Pre-treatment)|Disease Progression|1
2909389|NCT01668784|10017965|P1|Randomized (Pre-treatment)|Disease Progression|0
2909390|NCT01668667|10017993|P4|Overall Study|Withdrawal by Subject|5
2909391|NCT01668667|10017994|P3|Overall Study|Withdrawal by Subject|5
2909392|NCT01668667|10017995|P2|Overall Study|Withdrawal by Subject|4
2909393|NCT01668667|10017996|P1|Overall Study|Withdrawal by Subject|7
2909394|NCT01668667|10017993|P4|Overall Study|Physician Decision|0
2909395|NCT01668667|10017994|P3|Overall Study|Physician Decision|1
2909396|NCT01668667|10017995|P2|Overall Study|Physician Decision|0
2909397|NCT01668667|10017996|P1|Overall Study|Physician Decision|3
2909398|NCT01668667|10017993|P4|Overall Study|Lost to Follow-up|6
2909399|NCT01668667|10017994|P3|Overall Study|Lost to Follow-up|7
2909400|NCT01668667|10017995|P2|Overall Study|Lost to Follow-up|4
2909401|NCT01668667|10017996|P1|Overall Study|Lost to Follow-up|9
2909402|NCT01668667|10017993|P4|Overall Study|Protocol Violation|5
2909403|NCT01668667|10017994|P3|Overall Study|Protocol Violation|12
2909404|NCT01668667|10017995|P2|Overall Study|Protocol Violation|10
2909405|NCT01668667|10017996|P1|Overall Study|Protocol Violation|6
2909406|NCT01668667|10017993|P4|Overall Study|Lack of Efficacy|3
2909407|NCT01668667|10017994|P3|Overall Study|Lack of Efficacy|2
2909408|NCT01668667|10017995|P2|Overall Study|Lack of Efficacy|2
2909409|NCT01668667|10017996|P1|Overall Study|Lack of Efficacy|3
2909410|NCT01668667|10017993|P4|Overall Study|Adverse Event|4
2909412|NCT01668667|10017995|P2|Overall Study|Adverse Event|6
2909413|NCT01668667|10017996|P1|Overall Study|Adverse Event|3
2909414|NCT01668654|10018018|P1|Overall Study|Withdrawal by Subject|1
2909415|NCT01668654|10018018|P1|Overall Study|Study Closed/Terminated|3
2909416|NCT01668589|10018079|P4|Overall Study|Other|15
2909417|NCT01668589|10018080|P3|Overall Study|Other|7
2909418|NCT01668589|10018081|P2|Overall Study|Other|10
2909419|NCT01668589|10018082|P1|Overall Study|Other|44
2909420|NCT01668589|10018079|P4|Overall Study|Death|11
2909421|NCT01668589|10018080|P3|Overall Study|Death|2
2909422|NCT01668589|10018081|P2|Overall Study|Death|3
2909423|NCT01668589|10018082|P1|Overall Study|Death|12
2909424|NCT01668589|10018079|P4|Overall Study|Full Consent/Agreement Withdrawn|4
2909425|NCT01668589|10018080|P3|Overall Study|Full Consent/Agreement Withdrawn|11
2909426|NCT01668589|10018081|P2|Overall Study|Full Consent/Agreement Withdrawn|8
2909427|NCT01668589|10018082|P1|Overall Study|Full Consent/Agreement Withdrawn|54
2909428|NCT01668589|10018079|P4|Overall Study|Lost to Follow-up|5
2909429|NCT01668589|10018080|P3|Overall Study|Lost to Follow-up|15
2909430|NCT01668589|10018081|P2|Overall Study|Lost to Follow-up|37
2909431|NCT01668589|10018082|P1|Overall Study|Lost to Follow-up|29
2909432|NCT01668355|10018122|P2|Overall Study|Withdrawal by Subject|1
2909433|NCT01668355|10018123|P1|Overall Study|Withdrawal by Subject|6
2909434|NCT01668355|10018122|P2|Overall Study|Death|1
2909435|NCT01668355|10018123|P1|Overall Study|Death|3
2909436|NCT01668173|10018143|P1|Overall Study|Trial suspension|4
2909437|NCT01668173|10018143|P1|Overall Study|Adverse Event|3
2909438|NCT01668147|10018147|P1|Overall Study|Withdrawal by Subject|6
2909439|NCT01668004|10018277|P1|Overall Study|Non-compliance with treatment|2
2909440|NCT01668004|10018277|P1|Overall Study|Lack of Efficacy|9
2909441|NCT01668004|10018277|P1|Overall Study|Lost to Follow-up|5
2909442|NCT01668004|10018277|P1|Overall Study|Withdrawal by Subject|2
2909443|NCT01668004|10018277|P1|Overall Study|Adverse Event|7
2909444|NCT01667926|10018299|P3|Overall Study|Side effects|0
2909445|NCT01667926|10018300|P2|Overall Study|Side effects|0
2909446|NCT01667926|10018301|P1|Overall Study|Side effects|3
2909447|NCT01667926|10018299|P3|Overall Study|Lost to Follow-up|1
2909448|NCT01667926|10018300|P2|Overall Study|Lost to Follow-up|2
2909449|NCT01667926|10018301|P1|Overall Study|Lost to Follow-up|1
2909450|NCT01667926|10018299|P3|Overall Study|Inclusion/Exclusion Criteria|5
2909451|NCT01667926|10018300|P2|Overall Study|Inclusion/Exclusion Criteria|0
2909452|NCT01667926|10018301|P1|Overall Study|Inclusion/Exclusion Criteria|0
2909453|NCT01667926|10018299|P3|Overall Study|Time committment|2
2909454|NCT01667926|10018300|P2|Overall Study|Time committment|0
2909455|NCT01667926|10018301|P1|Overall Study|Time committment|0
2909456|NCT01667926|10018299|P3|Overall Study|Physician Decision|1
2909457|NCT01667926|10018300|P2|Overall Study|Physician Decision|0
2909458|NCT01667926|10018301|P1|Overall Study|Physician Decision|0
2909459|NCT01667926|10018299|P3|Overall Study|Withdrawal by Subject|2
2909460|NCT01667926|10018300|P2|Overall Study|Withdrawal by Subject|2
2909461|NCT01667926|10018301|P1|Overall Study|Withdrawal by Subject|1
2909462|NCT01667900|10018314|P20|Part B|Death|0
2909463|NCT01667900|10018315|P19|Part B|Death|0
2909464|NCT01667900|10018316|P18|Part B|Death|0
2909465|NCT01667900|10018317|P17|Part B|Death|1
2909466|NCT01667900|10018318|P16|Part B|Death|0
2909467|NCT01667900|10018319|P15|Part B|Death|0
2909468|NCT01667900|10018320|P14|Part B|Death|0
2909469|NCT01667900|10018321|P13|Part B|Death|0
2909470|NCT01667900|10018322|P12|Part B|Death|0
2909471|NCT01667900|10018323|P11|Part B|Death|0
2909472|NCT01667900|10018324|P10|Part B|Death|0
2909473|NCT01667900|10018325|P9|Part B|Death|0
2909474|NCT01667900|10018326|P8|Part B|Death|0
2909475|NCT01667900|10018327|P7|Part B|Death|0
2909476|NCT01667900|10018328|P6|Part B|Death|0
2909477|NCT01667900|10018329|P5|Part B|Death|0
2909478|NCT01667900|10018330|P4|Part B|Death|0
2909479|NCT01667900|10018331|P3|Part B|Death|0
2909480|NCT01667900|10018332|P2|Part B|Death|0
2909481|NCT01667900|10018333|P1|Part B|Death|0
2909482|NCT01667731|10018403|P5|Overall Study|Death|0
2909483|NCT01667731|10018404|P4|Overall Study|Death|0
2909484|NCT01667731|10018405|P3|Overall Study|Death|0
2909485|NCT01667731|10018406|P2|Overall Study|Death|1
2909486|NCT01667731|10018407|P1|Overall Study|Death|0
2909487|NCT01667731|10018403|P5|Overall Study|Subject Withdrew Consent|1
2909488|NCT01667731|10018404|P4|Overall Study|Subject Withdrew Consent|0
2909489|NCT01667731|10018405|P3|Overall Study|Subject Withdrew Consent|1
2909490|NCT01667731|10018406|P2|Overall Study|Subject Withdrew Consent|0
2909491|NCT01667731|10018407|P1|Overall Study|Subject Withdrew Consent|2
2909492|NCT01667731|10018403|P5|Overall Study|Lost to Follow-up|2
2909493|NCT01667731|10018404|P4|Overall Study|Lost to Follow-up|1
2909494|NCT01667731|10018405|P3|Overall Study|Lost to Follow-up|1
2909495|NCT01667731|10018406|P2|Overall Study|Lost to Follow-up|3
2909496|NCT01667731|10018407|P1|Overall Study|Lost to Follow-up|2
2909497|NCT01667731|10018403|P5|Overall Study|Efficacy Failure|24
2909498|NCT01667731|10018404|P4|Overall Study|Efficacy Failure|1
2909499|NCT01667731|10018405|P3|Overall Study|Efficacy Failure|0
2909500|NCT01667731|10018406|P2|Overall Study|Efficacy Failure|12
2909501|NCT01667731|10018407|P1|Overall Study|Efficacy Failure|1
2909502|NCT01667731|10018403|P5|Overall Study|Enrolled but not treated|1
2909503|NCT01667731|10018404|P4|Overall Study|Enrolled but not treated|0
2909504|NCT01667731|10018405|P3|Overall Study|Enrolled but not treated|0
2909505|NCT01667731|10018406|P2|Overall Study|Enrolled but not treated|0
2909506|NCT01667731|10018407|P1|Overall Study|Enrolled but not treated|0
2909507|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
2909508|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
2909509|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
2909510|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
2909511|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
2909512|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
2909513|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
2909514|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
2909515|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
2909516|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
2909517|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
2909518|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
2909519|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
2909520|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
2909521|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
2909522|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
2909523|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
2909524|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
2909525|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
2909526|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
2909527|NCT01667679|10018462|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
2909528|NCT01667679|10018463|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
2909529|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
2909530|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
2909531|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
2909532|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
2909533|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
2909534|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
2909535|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
2909536|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
2909537|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2909538|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2909539|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
2909540|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
2909541|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
2909542|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
2909543|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
2909544|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
2909545|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
2909546|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
2909547|NCT01667679|10018462|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
2909548|NCT01667679|10018463|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
2909549|NCT01667562|10018521|P2|Erlotinib Phase|Switch to Commercial Drug|1
2909550|NCT01667562|10018522|P1|Erlotinib Phase|Switch to Commercial Drug|0
2909551|NCT01667562|10018521|P2|Erlotinib Phase|Adverse Event|1
2909552|NCT01667562|10018522|P1|Erlotinib Phase|Adverse Event|0
2909553|NCT01667562|10018521|P2|Erlotinib Phase|Lost to Follow-up|1
2909554|NCT01667562|10018522|P1|Erlotinib Phase|Lost to Follow-up|0
2909555|NCT01667562|10018521|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
2909556|NCT01667562|10018522|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
2909557|NCT01667549|10018536|P5|Overall Study|Withdrawal by Subject|1
2909558|NCT01667549|10018537|P4|Overall Study|Withdrawal by Subject|6
2909559|NCT01667549|10018538|P3|Overall Study|Withdrawal by Subject|7
2909560|NCT01667549|10018539|P2|Overall Study|Withdrawal by Subject|5
2909561|NCT01667549|10018540|P1|Overall Study|Withdrawal by Subject|3
2909562|NCT01667432|10018599|P1|Overall Study|Missing Information|4
2909563|NCT01667432|10018599|P1|Overall Study|Reason Not Specified|2
2909564|NCT01667432|10018599|P1|Overall Study|Principal Investigator Decision|1
2909565|NCT01667432|10018599|P1|Overall Study|Protocol Deviation|2
2909566|NCT01667432|10018599|P1|Overall Study|Adverse Event|1
2909567|NCT01667432|10018599|P1|Overall Study|Insufficient Therapeutic Response|4
2909568|NCT01667432|10018599|P1|Overall Study|Refused Treatment/Withdrew Consent|1
2909569|NCT01667432|10018599|P1|Overall Study|Lost to Follow-up|3
2909570|NCT01667432|10018599|P1|Overall Study|Moved to Another Center|3
2909571|NCT01667432|10018599|P1|Overall Study|Failure to Return|10
2909572|NCT01667432|10018599|P1|Overall Study|Premature Study Termination|26
2909573|NCT01667419|10018608|P4|Overall Study|Death|26
2909574|NCT01667419|10018609|P3|Overall Study|Death|25
2909575|NCT01667419|10018610|P2|Overall Study|Death|33
2909576|NCT01667419|10018611|P1|Overall Study|Death|18
2909577|NCT01667419|10018608|P4|Overall Study|Lost to Follow-up|4
2909578|NCT01667419|10018609|P3|Overall Study|Lost to Follow-up|2
2909579|NCT01667419|10018610|P2|Overall Study|Lost to Follow-up|6
2909580|NCT01667419|10018611|P1|Overall Study|Lost to Follow-up|7
2909581|NCT01667419|10018608|P4|Overall Study|Protocol Violation|0
2909582|NCT01667419|10018609|P3|Overall Study|Protocol Violation|0
2909583|NCT01667419|10018610|P2|Overall Study|Protocol Violation|0
2909584|NCT01667419|10018611|P1|Overall Study|Protocol Violation|1
2909585|NCT01667419|10018608|P4|Overall Study|Non-compliance|1
2909586|NCT01667419|10018609|P3|Overall Study|Non-compliance|0
2909587|NCT01667419|10018610|P2|Overall Study|Non-compliance|0
2909588|NCT01667419|10018611|P1|Overall Study|Non-compliance|0
2909589|NCT01667419|10018608|P4|Overall Study|Withdrawal by Subject|8
2909590|NCT01667419|10018609|P3|Overall Study|Withdrawal by Subject|9
2909591|NCT01667419|10018610|P2|Overall Study|Withdrawal by Subject|8
2909592|NCT01667419|10018611|P1|Overall Study|Withdrawal by Subject|16
2909593|NCT01667419|10018608|P4|Overall Study|Reason Not Specified|0
2909594|NCT01667419|10018609|P3|Overall Study|Reason Not Specified|0
2909595|NCT01667419|10018610|P2|Overall Study|Reason Not Specified|0
2909596|NCT01667419|10018611|P1|Overall Study|Reason Not Specified|1
2909597|NCT01667224|10018659|P2|Overall Study|Protocol Violation|1
2909598|NCT01667224|10018660|P1|Overall Study|Protocol Violation|1
2909599|NCT01667224|10018659|P2|Overall Study|Withdrawal by Subject|1
2909600|NCT01667224|10018660|P1|Overall Study|Withdrawal by Subject|3
2909601|NCT01667107|10018674|P2|Overall Study|Lack of Efficacy|1
2909602|NCT01667107|10018675|P1|Overall Study|Lack of Efficacy|0
2909603|NCT01667107|10018674|P2|Overall Study|Protocol Violation|1
2909604|NCT01667107|10018675|P1|Overall Study|Protocol Violation|0
2909605|NCT01667107|10018674|P2|Overall Study|Tolerability issues|2
2909606|NCT01667107|10018675|P1|Overall Study|Tolerability issues|0
2909607|NCT01667107|10018674|P2|Overall Study|Adverse Event|3
2909608|NCT01667107|10018675|P1|Overall Study|Adverse Event|4
2909609|NCT01666951|10018734|P2|Overall Study|Not dosed|1
2909610|NCT01666951|10018735|P1|Overall Study|Not dosed|1
2909611|NCT01666782|10018786|P2|Overall Study|Enrolled both years; year 1 data used|0
2909612|NCT01666782|10018787|P1|Overall Study|Enrolled both years; year 1 data used|4
2909613|NCT01666782|10018786|P2|Overall Study|Received 2 doses of vaccine|1
2909614|NCT01666782|10018787|P1|Overall Study|Received 2 doses of vaccine|0
2909615|NCT01666652|10018808|P5|Overall Study|Lost to Follow-up|0
2909616|NCT01666652|10018809|P4|Overall Study|Lost to Follow-up|1
2909617|NCT01666652|10018810|P3|Overall Study|Lost to Follow-up|1
2909618|NCT01666652|10018811|P2|Overall Study|Lost to Follow-up|1
2909619|NCT01666652|10018812|P1|Overall Study|Lost to Follow-up|1
2909620|NCT01666652|10018808|P5|Overall Study|Moved from study area|0
2909621|NCT01666652|10018809|P4|Overall Study|Moved from study area|2
2909622|NCT01666652|10018810|P3|Overall Study|Moved from study area|0
2909623|NCT01666652|10018811|P2|Overall Study|Moved from study area|0
2909624|NCT01666652|10018812|P1|Overall Study|Moved from study area|1
2909625|NCT01666652|10018808|P5|Overall Study|Withdrawal by Subject|1
2909626|NCT01666652|10018809|P4|Overall Study|Withdrawal by Subject|0
2909627|NCT01666652|10018810|P3|Overall Study|Withdrawal by Subject|0
2909628|NCT01666652|10018811|P2|Overall Study|Withdrawal by Subject|0
2909629|NCT01666652|10018812|P1|Overall Study|Withdrawal by Subject|0
2909630|NCT01666652|10018808|P5|Overall Study|Serious Adverse Event|0
2909631|NCT01666652|10018809|P4|Overall Study|Serious Adverse Event|1
2909632|NCT01666652|10018810|P3|Overall Study|Serious Adverse Event|0
2909633|NCT01666652|10018811|P2|Overall Study|Serious Adverse Event|0
2909634|NCT01666652|10018812|P1|Overall Study|Serious Adverse Event|0
2909635|NCT01666444|10018861|P2|Overall Study|Did not initiate treatment|1
2909636|NCT01666444|10018862|P1|Overall Study|Did not initiate treatment|2
2909637|NCT01666314|10018880|P4|Overall Study|Reason not Specified|5
2909638|NCT01666314|10018881|P3|Overall Study|Reason not Specified|5
2909639|NCT01666314|10018882|P2|Overall Study|Reason not Specified|7
2909640|NCT01666314|10018883|P1|Overall Study|Reason not Specified|10
2909641|NCT01666314|10018880|P4|Overall Study|Withdrawal by Subject|3
2909642|NCT01666314|10018881|P3|Overall Study|Withdrawal by Subject|2
2909643|NCT01666314|10018882|P2|Overall Study|Withdrawal by Subject|1
2909644|NCT01666314|10018883|P1|Overall Study|Withdrawal by Subject|1
2909645|NCT01666314|10018880|P4|Overall Study|Unsatisfactory Therapeutic Response|1
2909646|NCT01666314|10018881|P3|Overall Study|Unsatisfactory Therapeutic Response|1
2909647|NCT01666314|10018882|P2|Overall Study|Unsatisfactory Therapeutic Response|2
2909648|NCT01666314|10018883|P1|Overall Study|Unsatisfactory Therapeutic Response|7
2909649|NCT01666314|10018880|P4|Overall Study|Symptomatic Deterioration|0
2909650|NCT01666314|10018881|P3|Overall Study|Symptomatic Deterioration|2
2909651|NCT01666314|10018882|P2|Overall Study|Symptomatic Deterioration|0
2909652|NCT01666314|10018883|P1|Overall Study|Symptomatic Deterioration|1
2909653|NCT01666314|10018880|P4|Overall Study|Progressive Disease|20
2909654|NCT01666314|10018881|P3|Overall Study|Progressive Disease|19
2909655|NCT01666314|10018882|P2|Overall Study|Progressive Disease|9
2909656|NCT01666314|10018883|P1|Overall Study|Progressive Disease|11
2909657|NCT01666314|10018880|P4|Overall Study|Adverse Event|7
2909658|NCT01666314|10018881|P3|Overall Study|Adverse Event|7
2909659|NCT01666314|10018882|P2|Overall Study|Adverse Event|13
2909660|NCT01666314|10018883|P1|Overall Study|Adverse Event|3
2909661|NCT01666119|10019019|P1|Overall Study|Subject experiencing withdrawal symptoms|5
2909662|NCT01666119|10019019|P1|Overall Study|non compliance with study medication, pa|18
2909663|NCT01666119|10019019|P1|Overall Study|Lost to Follow-up|7
2909664|NCT01666119|10019019|P1|Overall Study|Withdrawal by Subject|16
2909665|NCT01666119|10019019|P1|Overall Study|Adverse Event|6
2909666|NCT01666002|10019026|P2|Overall Study|Lost to Follow-up|0
2909667|NCT01666002|10019027|P1|Overall Study|Lost to Follow-up|5
2909668|NCT01665911|10019048|P1|Overall Study|Adverse Event|1
2909669|NCT01665911|10019048|P1|Overall Study|Withdrawal by Subject|1
2909670|NCT01665911|10019048|P1|Overall Study|Protocol Violation|4
2909671|NCT01665807|10019074|P3|Overall Study|Withdrawal by Subject|1
2909672|NCT01665807|10019075|P2|Overall Study|Withdrawal by Subject|0
2909673|NCT01665807|10019076|P1|Overall Study|Withdrawal by Subject|2
2909674|NCT01665768|10019087|P1|Overall Study|Withdrawal by Subject|1
2909675|NCT01665768|10019087|P1|Overall Study|Lack of Efficacy|19
2909676|NCT01665768|10019087|P1|Overall Study|Adverse Event|3
2909677|NCT01665599|10019092|P1|Overall Study|Could Not Continue Due to Time Constrain|1
2909678|NCT01665599|10019092|P1|Overall Study|Participant Left for More Than 3 Months|1
2909679|NCT01665599|10019092|P1|Overall Study|Lost to Follow-up|2
2909680|NCT01665599|10019092|P1|Overall Study|Death|1
2909681|NCT01665599|10019092|P1|Overall Study|Investigator/Sponsor decision|1
2909682|NCT01665599|10019092|P1|Overall Study|Consent Withdrawn|1
2909683|NCT01665599|10019092|P1|Overall Study|Adverse Event|1
2909684|NCT01665430|10019128|P1|Overall Study|Other Unspecified|2
2909685|NCT01665430|10019128|P1|Overall Study|Withdrawal by Subject|6
2909686|NCT01665430|10019128|P1|Overall Study|Adverse Event|1
2909687|NCT01665144|10019226|P2|Overall Study|Withdrawal by Subject|77
2909688|NCT01665144|10019227|P1|Overall Study|Withdrawal by Subject|96
2909689|NCT01665144|10019226|P2|Overall Study|Adverse Event|18
2909690|NCT01665144|10019227|P1|Overall Study|Adverse Event|45
2909691|NCT01665144|10019226|P2|Overall Study|Lack of Efficacy|11
2909692|NCT01665144|10019227|P1|Overall Study|Lack of Efficacy|16
2909693|NCT01665144|10019226|P2|Overall Study|Physician Decision|1
2909694|NCT01665144|10019227|P1|Overall Study|Physician Decision|13
2909695|NCT01665144|10019226|P2|Overall Study|Lost to Follow-up|8
2909696|NCT01665144|10019227|P1|Overall Study|Lost to Follow-up|9
2909697|NCT01665144|10019226|P2|Overall Study|Progressive disease|4
2909698|NCT01665144|10019227|P1|Overall Study|Progressive disease|8
2909699|NCT01665144|10019226|P2|Overall Study|Non-compliance w/study treatment|0
2909700|NCT01665144|10019227|P1|Overall Study|Non-compliance w/study treatment|5
2909701|NCT01665144|10019226|P2|Overall Study|Protocol deviation|1
2909702|NCT01665144|10019227|P1|Overall Study|Protocol deviation|3
2909703|NCT01665144|10019226|P2|Overall Study|Death|1
2909704|NCT01665144|10019227|P1|Overall Study|Death|3
2909705|NCT01665144|10019226|P2|Overall Study|Technical problems|0
2909706|NCT01665144|10019227|P1|Overall Study|Technical problems|2
2909707|NCT01665144|10019226|P2|Overall Study|New therapy for study indication|1
2909708|NCT01665144|10019227|P1|Overall Study|New therapy for study indication|2
2909709|NCT01664949|10019307|P2|Overall Study|Other Miscellaneous Reasons|1
2909710|NCT01664949|10019308|P1|Overall Study|Other Miscellaneous Reasons|3
2909711|NCT01664949|10019307|P2|Overall Study|Protocol Violation|5
2909712|NCT01664949|10019308|P1|Overall Study|Protocol Violation|5
2909713|NCT01664949|10019307|P2|Overall Study|Personal Reasons|4
2909714|NCT01664949|10019308|P1|Overall Study|Personal Reasons|3
2909715|NCT01664949|10019307|P2|Overall Study|Lost to Follow-up|2
2909716|NCT01664949|10019308|P1|Overall Study|Lost to Follow-up|1
2909717|NCT01664949|10019307|P2|Overall Study|Lack of Efficacy|1
2909718|NCT01664949|10019308|P1|Overall Study|Lack of Efficacy|1
2909719|NCT01664949|10019307|P2|Overall Study|Adverse Event|12
2909720|NCT01664949|10019308|P1|Overall Study|Adverse Event|11
2909721|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
2909722|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
2909723|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
2909724|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
2909725|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|Other|1
2909726|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|Other|3
2909727|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
2909728|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
2909729|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
2909730|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
2909731|NCT01664923|10019324|P2|Period 2: Open-label Phase-36 Months|Death|1
2909732|NCT01664923|10019325|P1|Period 2: Open-label Phase-36 Months|Death|3
2909733|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
2909734|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
2909735|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Other|4
2909736|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Other|3
2909737|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
2909738|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
2909739|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
2909740|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
2909741|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
2909742|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
2909743|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
2909744|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
2909745|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
2909746|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
2909747|NCT01664923|10019324|P2|Period1:Double Blind Phase-29 Months|Death|6
2909748|NCT01664923|10019325|P1|Period1:Double Blind Phase-29 Months|Death|8
2909749|NCT01664624|10019416|P4|Overall Study|Adverse Event|0
2909750|NCT01664624|10019417|P3|Overall Study|Adverse Event|0
2909751|NCT01664624|10019418|P2|Overall Study|Adverse Event|1
2909752|NCT01664624|10019419|P1|Overall Study|Adverse Event|0
2909753|NCT01664533|10019466|P1|Overall Study|Protocol Violation|3
2909754|NCT01664533|10019466|P1|Overall Study|Study termination|9
2909755|NCT01664533|10019466|P1|Overall Study|Lost to Follow-up|3
2909756|NCT01664533|10019466|P1|Overall Study|Death|42
2909757|NCT01664494|10019474|P1|Overall Study|Lost to Follow-up|99
2909758|NCT01664494|10019474|P1|Overall Study|Other|49
2909759|NCT01664494|10019474|P1|Overall Study|Death|18
2909760|NCT01664494|10019474|P1|Overall Study|Withdrawal by Subject|27
2909761|NCT01664247|10019481|P2|Overall Study|Unclassified|29
2909762|NCT01664247|10019482|P1|Overall Study|Unclassified|5
2909763|NCT01664247|10019481|P2|Overall Study|Withdrawal Criteria|4
2909764|NCT01664247|10019482|P1|Overall Study|Withdrawal Criteria|1
2909765|NCT01664247|10019481|P2|Overall Study|Protocol Violation|5
2909766|NCT01664247|10019482|P1|Overall Study|Protocol Violation|3
2909767|NCT01664247|10019481|P2|Overall Study|Adverse Event|3
2909768|NCT01664247|10019482|P1|Overall Study|Adverse Event|5
2909769|NCT01664130|10019504|P1|Overall Study|competing secondary disease|2
2909770|NCT01664104|10019582|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
2909771|NCT01664104|10019582|P1|Overall Study|Other|1
2909772|NCT01664104|10019582|P1|Overall Study|Lost to Follow-up|4
2909773|NCT01664104|10019582|P1|Overall Study|Withdrawal by Subject|1
2909774|NCT01664104|10019582|P1|Overall Study|Lack of Efficacy|2
2909775|NCT01664104|10019582|P1|Overall Study|Adverse Event|6
2909776|NCT01664091|10019649|P1|Overall Study|Withdrawal by Subject|1
2909777|NCT01664091|10019649|P1|Overall Study|Lost to Follow-up|2
2909778|NCT01664091|10019649|P1|Overall Study|Disease Progression|2
2909779|NCT01664091|10019649|P1|Overall Study|Death|1
2909780|NCT01664052|10019659|P2|Phase 2|No device placement|4
2909781|NCT01664052|10019660|P1|Phase 2|No device placement|0
2909782|NCT01664052|10019659|P2|Phase 1|No HSG 1 hr post placement|0
2909783|NCT01664052|10019660|P1|Phase 1|No HSG 1 hr post placement|1
2909784|NCT01664052|10019659|P2|Phase 1|No device placement|0
2909785|NCT01664052|10019660|P1|Phase 1|No device placement|6
2909786|NCT01664039|10019678|P2|Overall Study|Noncompliance|1
2909787|NCT01664039|10019679|P1|Overall Study|Noncompliance|1
2909788|NCT01664039|10019678|P2|Overall Study|Withdrawal by Subject|3
2909789|NCT01664039|10019679|P1|Overall Study|Withdrawal by Subject|1
2909790|NCT01664039|10019678|P2|Overall Study|Lost to Follow-up|1
2909791|NCT01664039|10019679|P1|Overall Study|Lost to Follow-up|1
2909792|NCT01664039|10019678|P2|Overall Study|Adverse Event|4
2909793|NCT01664039|10019679|P1|Overall Study|Adverse Event|3
2909794|NCT01663987|10019701|P2|Overall Study|Other reason not defined above|0
2909795|NCT01663987|10019702|P1|Overall Study|Other reason not defined above|3
2909796|NCT01663987|10019701|P2|Overall Study|Withdrawal by Subject|3
2909797|NCT01663987|10019702|P1|Overall Study|Withdrawal by Subject|2
2909798|NCT01663987|10019701|P2|Overall Study|Lost to Follow-up|1
2909799|NCT01663987|10019702|P1|Overall Study|Lost to Follow-up|1
2909800|NCT01663987|10019701|P2|Overall Study|Adverse Event|2
2909801|NCT01663987|10019702|P1|Overall Study|Adverse Event|7
2909802|NCT01663857|10019745|P4|Overall Study|Lost to Follow-up|1
2909803|NCT01663857|10019746|P3|Overall Study|Lost to Follow-up|3
2909804|NCT01663857|10019747|P2|Overall Study|Lost to Follow-up|0
2909805|NCT01663857|10019748|P1|Overall Study|Lost to Follow-up|0
2909806|NCT01663857|10019745|P4|Overall Study|Withdrew Consent to Study Participation|3
2909807|NCT01663857|10019746|P3|Overall Study|Withdrew Consent to Study Participation|7
2909808|NCT01663857|10019747|P2|Overall Study|Withdrew Consent to Study Participation|1
2909809|NCT01663857|10019748|P1|Overall Study|Withdrew Consent to Study Participation|0
2909810|NCT01663740|10019776|P2|Overall Study|No end of study status|0
2909811|NCT01663740|10019777|P1|Overall Study|No end of study status|3
2909812|NCT01663740|10019776|P2|Overall Study|Withdrawal by Subject|1
2909813|NCT01663740|10019777|P1|Overall Study|Withdrawal by Subject|2
2909814|NCT01663740|10019776|P2|Overall Study|Death|1
2909815|NCT01663740|10019777|P1|Overall Study|Death|0
2909816|NCT01663740|10019776|P2|Overall Study|Inclusion/Exclusion not met|0
2909817|NCT01663740|10019777|P1|Overall Study|Inclusion/Exclusion not met|1
2909818|NCT01663740|10019776|P2|Overall Study|Other|2
2909819|NCT01663740|10019777|P1|Overall Study|Other|9
2909820|NCT01663740|10019776|P2|Overall Study|Lost to Follow-up|4
2909821|NCT01663740|10019777|P1|Overall Study|Lost to Follow-up|1
2909822|NCT01663727|10019837|P2|Overall Study|Withdrawal prior to dosing.|0
2909823|NCT01663727|10019838|P1|Overall Study|Withdrawal prior to dosing.|1
2909824|NCT01663727|10019837|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
2909825|NCT01663727|10019838|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
2909826|NCT01663727|10019837|P2|Overall Study|Study Terminated|50
2909827|NCT01663727|10019838|P1|Overall Study|Study Terminated|51
2909828|NCT01663727|10019837|P2|Overall Study|Withdrawal by Subject|25
2909829|NCT01663727|10019838|P1|Overall Study|Withdrawal by Subject|18
2909830|NCT01663727|10019837|P2|Overall Study|Lost to Follow-up|8
2909831|NCT01663727|10019838|P1|Overall Study|Lost to Follow-up|10
2909832|NCT01663727|10019837|P2|Overall Study|Death|155
2909833|NCT01663727|10019838|P1|Overall Study|Death|161
2909834|NCT01663714|10019870|P1|Long-Term Follow-Up|Non-compliance|1
2909835|NCT01663714|10019870|P1|Long-Term Follow-Up|Death|4
2909836|NCT01663714|10019870|P1|Long-Term Follow-Up|Lost to Follow-up|1
2909837|NCT01663714|10019870|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
2909838|NCT01663714|10019870|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
2909839|NCT01663714|10019870|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2909840|NCT01663636|10019899|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
2909841|NCT01663636|10019900|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
2909842|NCT01663623|10019908|P2|Overall Study|Withdrawal by Subject|1
2909843|NCT01663623|10019909|P1|Overall Study|Withdrawal by Subject|2
2909844|NCT01663623|10019908|P2|Overall Study|Physician Decision|4
2909845|NCT01663623|10019909|P1|Overall Study|Physician Decision|1
2909846|NCT01663623|10019908|P2|Overall Study|Other-Study closed/terminated|1
2909847|NCT01663623|10019909|P1|Overall Study|Other-Study closed/terminated|1
2909848|NCT01663623|10019908|P2|Overall Study|Protocol Violation|1
2909849|NCT01663623|10019909|P1|Overall Study|Protocol Violation|0
2909850|NCT01663623|10019908|P2|Overall Study|Lack of Efficacy|6
2909851|NCT01663623|10019909|P1|Overall Study|Lack of Efficacy|5
2909852|NCT01663623|10019908|P2|Overall Study|Adverse Event|7
2909853|NCT01663623|10019909|P1|Overall Study|Adverse Event|3
2909854|NCT01663532|10019919|P2|Overall Study|Lack of Efficacy|60
2909855|NCT01663532|10019920|P1|Overall Study|Lack of Efficacy|15
2909856|NCT01663532|10019919|P2|Overall Study|Withdrawal by Subject|17
2909857|NCT01663532|10019920|P1|Overall Study|Withdrawal by Subject|35
2909858|NCT01663532|10019919|P2|Overall Study|Physician Decision|1
2909859|NCT01663532|10019920|P1|Overall Study|Physician Decision|1
2909860|NCT01663532|10019919|P2|Overall Study|Met Withdrawal Criteria|6
2909861|NCT01663532|10019920|P1|Overall Study|Met Withdrawal Criteria|7
2909862|NCT01663532|10019919|P2|Overall Study|Adverse Event|13
2909863|NCT01663532|10019920|P1|Overall Study|Adverse Event|7
2909864|NCT01663532|10019919|P2|Overall Study|Lost to Follow-up|10
2909865|NCT01663532|10019920|P1|Overall Study|Lost to Follow-up|9
2909866|NCT01663506|10019938|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
2909867|NCT01663506|10019938|P1|Overall Study|Adverse Event|1
2909868|NCT01663506|10019938|P1|Overall Study|Lost to Follow-up|1
2909869|NCT01663506|10019938|P1|Overall Study|Consent Withdrawal by Subject|1
2909870|NCT01663506|10019938|P1|Overall Study|Lack of Efficacy|3
2909871|NCT01663402|10019969|P2|Overall Study|Other than specified above|147
2909872|NCT01663402|10019970|P1|Overall Study|Other than specified above|172
2909873|NCT01663402|10019969|P2|Overall Study|Lost to Follow-up|15
2909874|NCT01663402|10019970|P1|Overall Study|Lost to Follow-up|17
2909875|NCT01663402|10019969|P2|Overall Study|Related to study drug administration|105
2909876|NCT01663402|10019970|P1|Overall Study|Related to study drug administration|96
2909877|NCT01663402|10019969|P2|Overall Study|Withdrawal by Subject|91
2909878|NCT01663402|10019970|P1|Overall Study|Withdrawal by Subject|118
2909879|NCT01663402|10019969|P2|Overall Study|Participant moved|104
2909880|NCT01663402|10019970|P1|Overall Study|Participant moved|139
2909881|NCT01663402|10019969|P2|Overall Study|Site terminated by sponsor|3
2909882|NCT01663402|10019970|P1|Overall Study|Site terminated by sponsor|1
2909883|NCT01663402|10019969|P2|Overall Study|Physician Decision|62
2909884|NCT01663402|10019970|P1|Overall Study|Physician Decision|77
2909885|NCT01663402|10019969|P2|Overall Study|Poor compliance to protocol|454
2909886|NCT01663402|10019970|P1|Overall Study|Poor compliance to protocol|529
2909887|NCT01663402|10019969|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
2909888|NCT01663402|10019970|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
2909889|NCT01663402|10019969|P2|Overall Study|Adverse Event|362
2909890|NCT01663402|10019970|P1|Overall Study|Adverse Event|347
2909891|NCT01663402|10019969|P2|Overall Study|Randomized but not treated|11
2909892|NCT01663402|10019970|P1|Overall Study|Randomized but not treated|19
2909893|NCT01663233|10020024|P2|Overall Study|Lost to Follow-up|1
2909894|NCT01663233|10020025|P1|Overall Study|Lost to Follow-up|0
2909895|NCT01663233|10020024|P2|Overall Study|Protocol Deviation|4
2909896|NCT01663233|10020025|P1|Overall Study|Protocol Deviation|1
2909897|NCT01663233|10020024|P2|Overall Study|Withdrawal by Subject|2
2909898|NCT01663233|10020025|P1|Overall Study|Withdrawal by Subject|3
2909899|NCT01663103|10020049|P2|Overall Study|dog bite|0
2909900|NCT01663103|10020050|P1|Overall Study|dog bite|1
2909901|NCT01663103|10020049|P2|Overall Study|Adverse Event|0
2909902|NCT01663103|10020050|P1|Overall Study|Adverse Event|1
2909903|NCT01663103|10020049|P2|Overall Study|Withdrawal by Subject|2
2909904|NCT01663103|10020050|P1|Overall Study|Withdrawal by Subject|1
2909905|NCT01662999|10020078|P6|Period 3|Withdrawal by Subject|0
2909906|NCT01662999|10020079|P5|Period 3|Withdrawal by Subject|0
2909907|NCT01662999|10020080|P4|Period 3|Withdrawal by Subject|0
2909908|NCT01662999|10020081|P3|Period 3|Withdrawal by Subject|0
2909909|NCT01662999|10020082|P2|Period 3|Withdrawal by Subject|1
2909910|NCT01662999|10020083|P1|Period 3|Withdrawal by Subject|0
2909911|NCT01662986|10020154|P2|Overall Study|Other than stated above|0
2909912|NCT01662986|10020155|P1|Overall Study|Other than stated above|3
2909913|NCT01662986|10020154|P2|Overall Study|Not Treated|0
2909914|NCT01662986|10020155|P1|Overall Study|Not Treated|1
2909915|NCT01662986|10020154|P2|Overall Study|Withdrawal by Subject|2
2909916|NCT01662986|10020155|P1|Overall Study|Withdrawal by Subject|2
2909917|NCT01662986|10020154|P2|Overall Study|Lost to Follow-up|4
2909918|NCT01662986|10020155|P1|Overall Study|Lost to Follow-up|5
2909919|NCT01662986|10020154|P2|Overall Study|Protocol Violation|3
2909920|NCT01662986|10020155|P1|Overall Study|Protocol Violation|2
2909921|NCT01662986|10020154|P2|Overall Study|Adverse Event|4
2909922|NCT01662986|10020155|P1|Overall Study|Adverse Event|5
2909923|NCT01662895|10020243|P2|Overall Study|Lost to Follow-up|1
2909924|NCT01662895|10020244|P1|Overall Study|Lost to Follow-up|0
2909925|NCT01662648|10020368|P2|Overall Study|LOE and Participant non-compliant|1
2909926|NCT01662648|10020369|P1|Overall Study|LOE and Participant non-compliant|0
2909927|NCT01662648|10020368|P2|Overall Study|LOE and other reason unspecified|0
2909928|NCT01662648|10020369|P1|Overall Study|LOE and other reason unspecified|1
2909929|NCT01662648|10020368|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
2909930|NCT01662648|10020369|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
2909931|NCT01662648|10020368|P2|Overall Study|Other|11
2909932|NCT01662648|10020369|P1|Overall Study|Other|8
2909933|NCT01662648|10020368|P2|Overall Study|Participant non-compliant|20
2909934|NCT01662648|10020369|P1|Overall Study|Participant non-compliant|16
2909935|NCT01662648|10020368|P2|Overall Study|Withdrawal by Subject|53
2909936|NCT01662648|10020369|P1|Overall Study|Withdrawal by Subject|36
2909937|NCT01662648|10020368|P2|Overall Study|Lost to Follow-up|36
2909938|NCT01662648|10020369|P1|Overall Study|Lost to Follow-up|24
2909939|NCT01662648|10020368|P2|Overall Study|Participant ineligible to continue trial|1
2909940|NCT01662648|10020369|P1|Overall Study|Participant ineligible to continue trial|1
2909941|NCT01662648|10020368|P2|Overall Study|Lack of Efficacy|16
2909942|NCT01662648|10020369|P1|Overall Study|Lack of Efficacy|17
2909943|NCT01662648|10020368|P2|Overall Study|Adverse Event|37
2909944|NCT01662648|10020369|P1|Overall Study|Adverse Event|40
2909945|NCT01662648|10020368|P2|Overall Study|Death|3
2909946|NCT01662648|10020369|P1|Overall Study|Death|1
2909947|NCT01662635|10020391|P1|Overall Study|scarce samples for evaluation|30
2909948|NCT01662505|10020442|P3|Overall Study|Not specified above|2
2909949|NCT01662505|10020443|P2|Overall Study|Not specified above|3
2909950|NCT01662505|10020444|P1|Overall Study|Not specified above|1
2909951|NCT01662505|10020442|P3|Overall Study|Refused cont. medication|1
2909952|NCT01662505|10020443|P2|Overall Study|Refused cont. medication|0
2909953|NCT01662505|10020444|P1|Overall Study|Refused cont. medication|0
2909954|NCT01662505|10020442|P3|Overall Study|Progressive disease|5
2909955|NCT01662505|10020443|P2|Overall Study|Progressive disease|1
2909956|NCT01662505|10020444|P1|Overall Study|Progressive disease|6
2909957|NCT01662492|10020468|P3|Overall Study|Lack of Efficacy|2
2909958|NCT01662492|10020469|P2|Overall Study|Lack of Efficacy|1
2909959|NCT01662492|10020470|P1|Overall Study|Lack of Efficacy|1
2909960|NCT01662492|10020468|P3|Overall Study|Lost to Follow-up|2
2909961|NCT01662492|10020469|P2|Overall Study|Lost to Follow-up|0
2909962|NCT01662492|10020470|P1|Overall Study|Lost to Follow-up|0
2909963|NCT01662492|10020468|P3|Overall Study|Protocol Violation|0
2909964|NCT01662492|10020469|P2|Overall Study|Protocol Violation|0
2909965|NCT01662492|10020470|P1|Overall Study|Protocol Violation|1
2909966|NCT01662492|10020468|P3|Overall Study|Withdrawal by Subject|1
2909967|NCT01662492|10020469|P2|Overall Study|Withdrawal by Subject|0
2909968|NCT01662492|10020470|P1|Overall Study|Withdrawal by Subject|0
2909969|NCT01662492|10020468|P3|Overall Study|Other miscellaneous reasons.|1
2909970|NCT01662492|10020469|P2|Overall Study|Other miscellaneous reasons.|0
2909971|NCT01662492|10020470|P1|Overall Study|Other miscellaneous reasons.|1
2909972|NCT01662440|10020494|P4|Overall Study|Withdrawal by Subject|2
2909973|NCT01662440|10020495|P3|Overall Study|Withdrawal by Subject|2
2909974|NCT01662440|10020496|P2|Overall Study|Withdrawal by Subject|2
2909975|NCT01662440|10020497|P1|Overall Study|Withdrawal by Subject|5
2909976|NCT01662440|10020494|P4|Overall Study|Protocol Violation|0
2909977|NCT01662440|10020495|P3|Overall Study|Protocol Violation|0
2909978|NCT01662440|10020496|P2|Overall Study|Protocol Violation|0
2909979|NCT01662440|10020497|P1|Overall Study|Protocol Violation|1
2909980|NCT01662440|10020494|P4|Overall Study|Subject moved to another country.|0
2909981|NCT01662440|10020495|P3|Overall Study|Subject moved to another country.|0
2909982|NCT01662440|10020496|P2|Overall Study|Subject moved to another country.|1
2909983|NCT01662440|10020497|P1|Overall Study|Subject moved to another country.|0
2909984|NCT01662440|10020494|P4|Overall Study|Lost to Follow-up|1
2909985|NCT01662440|10020495|P3|Overall Study|Lost to Follow-up|4
2909986|NCT01662440|10020496|P2|Overall Study|Lost to Follow-up|2
2909987|NCT01662440|10020497|P1|Overall Study|Lost to Follow-up|2
2909988|NCT01662440|10020494|P4|Overall Study|Death|0
2909989|NCT01662440|10020495|P3|Overall Study|Death|0
2909990|NCT01662440|10020496|P2|Overall Study|Death|1
2909991|NCT01662440|10020497|P1|Overall Study|Death|0
2909992|NCT01662440|10020494|P4|Overall Study|Adverse Event|1
2909993|NCT01662440|10020495|P3|Overall Study|Adverse Event|0
2909994|NCT01662440|10020496|P2|Overall Study|Adverse Event|0
2909995|NCT01662440|10020497|P1|Overall Study|Adverse Event|1
2909996|NCT01662362|10020545|P1|Overall Study|Lost to Follow-up|38
2909997|NCT01662336|10020550|P1|Overall Study|Withdrawal by Subject|6
2909998|NCT01662336|10020550|P1|Overall Study|Other|29
2909999|NCT01662336|10020550|P1|Overall Study|No longer on LPV/r|30
2910000|NCT01662336|10020550|P1|Overall Study|Adverse Event|1
2910001|NCT01662310|10020576|P5|Open-Label Extension Phase|Withdrawal by Subject|7
2910002|NCT01662310|10020577|P4|Open-Label Extension Phase|Withdrawal by Subject|2
2910003|NCT01662310|10020578|P3|Open-Label Extension Phase|Withdrawal by Subject|0
2910004|NCT01662310|10020579|P2|Open-Label Extension Phase|Withdrawal by Subject|0
2910005|NCT01662310|10020580|P1|Open-Label Extension Phase|Withdrawal by Subject|0
2910006|NCT01662310|10020576|P5|Open-Label Extension Phase|Pregnancy|0
2910007|NCT01662310|10020577|P4|Open-Label Extension Phase|Pregnancy|1
2910008|NCT01662310|10020578|P3|Open-Label Extension Phase|Pregnancy|0
2910009|NCT01662310|10020579|P2|Open-Label Extension Phase|Pregnancy|0
2910010|NCT01662310|10020580|P1|Open-Label Extension Phase|Pregnancy|0
2910011|NCT01662310|10020576|P5|Open-Label Extension Phase|Lost to Follow-up|1
2910012|NCT01662310|10020577|P4|Open-Label Extension Phase|Lost to Follow-up|2
2910013|NCT01662310|10020578|P3|Open-Label Extension Phase|Lost to Follow-up|0
2910014|NCT01662310|10020579|P2|Open-Label Extension Phase|Lost to Follow-up|0
2910015|NCT01662310|10020580|P1|Open-Label Extension Phase|Lost to Follow-up|0
2910016|NCT01662310|10020576|P5|Open-Label Extension Phase|Lack of Efficacy|2
2910017|NCT01662310|10020577|P4|Open-Label Extension Phase|Lack of Efficacy|2
2910018|NCT01662310|10020578|P3|Open-Label Extension Phase|Lack of Efficacy|0
2910019|NCT01662310|10020579|P2|Open-Label Extension Phase|Lack of Efficacy|0
2910020|NCT01662310|10020580|P1|Open-Label Extension Phase|Lack of Efficacy|0
2910021|NCT01662310|10020576|P5|Open-Label Extension Phase|Death|0
2910022|NCT01662310|10020577|P4|Open-Label Extension Phase|Death|1
2910023|NCT01662310|10020578|P3|Open-Label Extension Phase|Death|0
2910024|NCT01662310|10020579|P2|Open-Label Extension Phase|Death|0
2910025|NCT01662310|10020580|P1|Open-Label Extension Phase|Death|0
2910026|NCT01662310|10020576|P5|Open-Label Extension Phase|Adverse Event|0
2910027|NCT01662310|10020577|P4|Open-Label Extension Phase|Adverse Event|3
2910028|NCT01662310|10020578|P3|Open-Label Extension Phase|Adverse Event|0
2910029|NCT01662310|10020579|P2|Open-Label Extension Phase|Adverse Event|0
2910030|NCT01662310|10020580|P1|Open-Label Extension Phase|Adverse Event|0
2910031|NCT01662310|10020576|P5|Double-Blind Phase|Randomized but not treated|0
2910032|NCT01662310|10020577|P4|Double-Blind Phase|Randomized but not treated|0
2910033|NCT01662310|10020578|P3|Double-Blind Phase|Randomized but not treated|0
2910034|NCT01662310|10020579|P2|Double-Blind Phase|Randomized but not treated|1
2910035|NCT01662310|10020580|P1|Double-Blind Phase|Randomized but not treated|0
2910036|NCT01662310|10020576|P5|Double-Blind Phase|Other|0
2910037|NCT01662310|10020577|P4|Double-Blind Phase|Other|0
2910038|NCT01662310|10020578|P3|Double-Blind Phase|Other|1
2910039|NCT01662310|10020579|P2|Double-Blind Phase|Other|0
2910040|NCT01662310|10020580|P1|Double-Blind Phase|Other|0
2910041|NCT01662310|10020576|P5|Double-Blind Phase|Withdrawal by Subject|0
2910042|NCT01662310|10020577|P4|Double-Blind Phase|Withdrawal by Subject|0
2910043|NCT01662310|10020578|P3|Double-Blind Phase|Withdrawal by Subject|3
2910044|NCT01662310|10020579|P2|Double-Blind Phase|Withdrawal by Subject|9
2910045|NCT01662310|10020580|P1|Double-Blind Phase|Withdrawal by Subject|0
2910046|NCT01662310|10020576|P5|Double-Blind Phase|Pregnancy|0
2910047|NCT01662310|10020577|P4|Double-Blind Phase|Pregnancy|0
2910048|NCT01662310|10020578|P3|Double-Blind Phase|Pregnancy|0
2910049|NCT01662310|10020579|P2|Double-Blind Phase|Pregnancy|2
2910050|NCT01662310|10020580|P1|Double-Blind Phase|Pregnancy|0
2910051|NCT01662310|10020576|P5|Double-Blind Phase|Lost to Follow-up|0
2910052|NCT01662310|10020577|P4|Double-Blind Phase|Lost to Follow-up|0
2910053|NCT01662310|10020578|P3|Double-Blind Phase|Lost to Follow-up|0
2910054|NCT01662310|10020579|P2|Double-Blind Phase|Lost to Follow-up|3
2910055|NCT01662310|10020580|P1|Double-Blind Phase|Lost to Follow-up|0
2910056|NCT01662310|10020576|P5|Double-Blind Phase|Adverse Event|0
2910057|NCT01662310|10020577|P4|Double-Blind Phase|Adverse Event|0
2910058|NCT01662310|10020578|P3|Double-Blind Phase|Adverse Event|1
2910059|NCT01662310|10020579|P2|Double-Blind Phase|Adverse Event|0
2910060|NCT01662310|10020580|P1|Double-Blind Phase|Adverse Event|0
2910061|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Other|0
2910062|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Other|0
2910063|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Other|0
2910064|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Other|0
2910065|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Other|1
2910066|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
2910067|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
2910068|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
2910069|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
2910070|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
2910071|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Protocol Violation|0
2910072|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Protocol Violation|0
2910073|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Protocol Violation|0
2910074|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Protocol Violation|0
2910075|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Protocol Violation|15
2910076|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
2910077|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
2910078|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
2910079|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
2910080|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
2910081|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
2910082|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
2910083|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
2910084|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
2910085|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
2910086|NCT01662310|10020576|P5|Run-In or Stabilization Phase|Adverse Event|0
2910087|NCT01662310|10020577|P4|Run-In or Stabilization Phase|Adverse Event|0
2910088|NCT01662310|10020578|P3|Run-In or Stabilization Phase|Adverse Event|0
2910089|NCT01662310|10020579|P2|Run-In or Stabilization Phase|Adverse Event|0
2910090|NCT01662310|10020580|P1|Run-In or Stabilization Phase|Adverse Event|11
2910091|NCT01662102|10020661|P2|Overall Study|Sponsor's decision|0
2910092|NCT01662102|10020662|P1|Overall Study|Sponsor's decision|1
2910093|NCT01662063|10020670|P3|Overall Study|Other|0
2910094|NCT01662063|10020671|P2|Overall Study|Other|1
2910095|NCT01662063|10020672|P1|Overall Study|Other|0
2910096|NCT01662063|10020670|P3|Overall Study|Physician Decision|0
2910097|NCT01662063|10020671|P2|Overall Study|Physician Decision|2
2910098|NCT01662063|10020672|P1|Overall Study|Physician Decision|0
2910099|NCT01662063|10020670|P3|Overall Study|Withdrawal by Subject|1
2910100|NCT01662063|10020671|P2|Overall Study|Withdrawal by Subject|4
2910101|NCT01662063|10020672|P1|Overall Study|Withdrawal by Subject|2
2910102|NCT01662063|10020670|P3|Overall Study|Protocol Violation|0
2910103|NCT01662063|10020671|P2|Overall Study|Protocol Violation|0
2910104|NCT01662063|10020672|P1|Overall Study|Protocol Violation|1
2910105|NCT01662063|10020670|P3|Overall Study|Lost to Follow-up|0
2910106|NCT01662063|10020671|P2|Overall Study|Lost to Follow-up|4
2910107|NCT01662063|10020672|P1|Overall Study|Lost to Follow-up|0
2910108|NCT01662063|10020670|P3|Overall Study|Lack of Efficacy|0
2910109|NCT01662063|10020671|P2|Overall Study|Lack of Efficacy|6
2910110|NCT01662063|10020672|P1|Overall Study|Lack of Efficacy|1
2910111|NCT01662063|10020670|P3|Overall Study|Adverse Event or Intercurrent Illness|0
2910112|NCT01662063|10020671|P2|Overall Study|Adverse Event or Intercurrent Illness|12
2910113|NCT01662063|10020672|P1|Overall Study|Adverse Event or Intercurrent Illness|1
2910114|NCT01662024|10020751|P1|Overall Study|Withdrawal by Subject|3
2910115|NCT01662024|10020751|P1|Overall Study|Pregnancy|2
2910116|NCT01661972|10020763|P2|Overall Study|Withdrawal by Subject|1
2910117|NCT01661972|10020764|P1|Overall Study|Withdrawal by Subject|0
2910118|NCT01661972|10020763|P2|Overall Study|Death during Treatment period|1
2910119|NCT01661972|10020764|P1|Overall Study|Death during Treatment period|1
2910120|NCT01661972|10020763|P2|Overall Study|Adverse Event|2
2910121|NCT01661972|10020764|P1|Overall Study|Adverse Event|1
2910122|NCT01661933|10020783|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
2910123|NCT01661933|10020783|P1|Low-dose Gluten Challenge|Physician Decision|2
2910124|NCT01661881|10020790|P1|Overall Study|Disease Progression|1
2910125|NCT01661790|10020798|P2|Overall Study|Lost to Follow-up|2
2910126|NCT01661790|10020799|P1|Overall Study|Lost to Follow-up|0
2910127|NCT01661686|10020899|P2|Overall Study|did not receive allocated intervention|1
2910128|NCT01661686|10020900|P1|Overall Study|did not receive allocated intervention|0
2910129|NCT01661686|10020899|P2|Overall Study|Lost to Follow-up|1
2910130|NCT01661686|10020900|P1|Overall Study|Lost to Follow-up|2
2910131|NCT01661595|10020941|P4|Phase 2: Week 5-8.|Protocol Violation|0
2910132|NCT01661595|10020942|P3|Phase 2: Week 5-8.|Protocol Violation|1
2910133|NCT01661595|10020943|P2|Phase 2: Week 5-8.|Protocol Violation|0
2910134|NCT01661595|10020944|P1|Phase 2: Week 5-8.|Protocol Violation|0
2910135|NCT01661595|10020941|P4|Phase 1: Week 0-4|Adverse Event|0
2910136|NCT01661595|10020942|P3|Phase 1: Week 0-4|Adverse Event|0
2910137|NCT01661595|10020943|P2|Phase 1: Week 0-4|Adverse Event|0
2910138|NCT01661595|10020944|P1|Phase 1: Week 0-4|Adverse Event|1
2910139|NCT01661205|10021072|P1|Overall Study|Physician Decision|2
2910140|NCT01661179|10021083|P1|Overall Study|Other Eligibility criteria|4
2910141|NCT01661179|10021083|P1|Overall Study|Withdrawal by Subject|1
2910142|NCT01661179|10021083|P1|Overall Study|Death|1
2910143|NCT01661140|10021087|P3|Double-Blind Period|Administrative/Other|6
2910144|NCT01661140|10021088|P2|Double-Blind Period|Administrative/Other|7
2910145|NCT01661140|10021089|P1|Double-Blind Period|Administrative/Other|0
2910146|NCT01661140|10021087|P3|Double-Blind Period|Sponsor Termination|17
2910147|NCT01661140|10021088|P2|Double-Blind Period|Sponsor Termination|14
2910148|NCT01661140|10021089|P1|Double-Blind Period|Sponsor Termination|0
2910149|NCT01661140|10021087|P3|Double-Blind Period|Investigator's Decision|2
2910150|NCT01661140|10021088|P2|Double-Blind Period|Investigator's Decision|1
2910151|NCT01661140|10021089|P1|Double-Blind Period|Investigator's Decision|0
2910152|NCT01661140|10021087|P3|Double-Blind Period|Withdrawal by Subject|3
2910153|NCT01661140|10021088|P2|Double-Blind Period|Withdrawal by Subject|1
2910154|NCT01661140|10021089|P1|Double-Blind Period|Withdrawal by Subject|0
2910155|NCT01661140|10021087|P3|Double-Blind Period|Protocol Violation|3
2910156|NCT01661140|10021088|P2|Double-Blind Period|Protocol Violation|2
2910157|NCT01661140|10021089|P1|Double-Blind Period|Protocol Violation|0
2910158|NCT01661140|10021087|P3|Double-Blind Period|Adverse Event|18
2910159|NCT01661140|10021088|P2|Double-Blind Period|Adverse Event|16
2910160|NCT01661140|10021089|P1|Double-Blind Period|Adverse Event|0
2910161|NCT01661140|10021087|P3|Double-Blind Period|Refused Treatment|1
2910162|NCT01661140|10021088|P2|Double-Blind Period|Refused Treatment|0
2910163|NCT01661140|10021089|P1|Double-Blind Period|Refused Treatment|0
2910164|NCT01661140|10021087|P3|Open-Label Period|Lost to Follow-up|0
2910165|NCT01661140|10021088|P2|Open-Label Period|Lost to Follow-up|0
2910166|NCT01661140|10021089|P1|Open-Label Period|Lost to Follow-up|2
2910167|NCT01661140|10021087|P3|Open-Label Period|Did not meet EULAR criteria|0
2910168|NCT01661140|10021088|P2|Open-Label Period|Did not meet EULAR criteria|0
2910169|NCT01661140|10021089|P1|Open-Label Period|Did not meet EULAR criteria|1
2910170|NCT01661140|10021087|P3|Open-Label Period|Sponsor termination|0
2910171|NCT01661140|10021088|P2|Open-Label Period|Sponsor termination|0
2910172|NCT01661140|10021089|P1|Open-Label Period|Sponsor termination|16
2910173|NCT01661140|10021087|P3|Open-Label Period|Administrative/Other|0
2910174|NCT01661140|10021088|P2|Open-Label Period|Administrative/Other|0
2910175|NCT01661140|10021089|P1|Open-Label Period|Administrative/Other|1
2910176|NCT01661140|10021087|P3|Open-Label Period|Death|0
2910177|NCT01661140|10021088|P2|Open-Label Period|Death|0
2910178|NCT01661140|10021089|P1|Open-Label Period|Death|1
2910179|NCT01661140|10021087|P3|Open-Label Period|Investigator Decision|0
2910180|NCT01661140|10021088|P2|Open-Label Period|Investigator Decision|0
2910181|NCT01661140|10021089|P1|Open-Label Period|Investigator Decision|3
2910182|NCT01661140|10021087|P3|Open-Label Period|Withdrawal by Subject|0
2910183|NCT01661140|10021088|P2|Open-Label Period|Withdrawal by Subject|0
2910184|NCT01661140|10021089|P1|Open-Label Period|Withdrawal by Subject|5
2910185|NCT01661140|10021087|P3|Open-Label Period|Protocol Violation|0
2910186|NCT01661140|10021088|P2|Open-Label Period|Protocol Violation|0
2910187|NCT01661140|10021089|P1|Open-Label Period|Protocol Violation|3
2910188|NCT01661140|10021087|P3|Open-Label Period|Adverse Event|0
2910189|NCT01661140|10021088|P2|Open-Label Period|Adverse Event|0
2910190|NCT01661140|10021089|P1|Open-Label Period|Adverse Event|44
2910191|NCT01661062|10021141|P1|Overall Study|Withdrawal by Subject|2
2910192|NCT01661062|10021141|P1|Overall Study|Completed Treatment Off Study|3
2910193|NCT01660906|10021146|P1|Overall Study|Discontinued due to study drug toxicity|3
2910194|NCT01660763|10021229|P2|Overall Study|Patient ready for early discharge|4
2910195|NCT01660763|10021230|P1|Overall Study|Patient ready for early discharge|28
2910196|NCT01660763|10021229|P2|Overall Study|Withdrawal by Subject|0
2910197|NCT01660763|10021230|P1|Overall Study|Withdrawal by Subject|4
2910198|NCT01660763|10021229|P2|Overall Study|Protocol Violation|0
2910199|NCT01660763|10021230|P1|Overall Study|Protocol Violation|1
2910200|NCT01660763|10021229|P2|Overall Study|Adverse Event|7
2910201|NCT01660763|10021230|P1|Overall Study|Adverse Event|22
2910202|NCT01660763|10021229|P2|Overall Study|Lack of Efficacy|50
2910203|NCT01660763|10021230|P1|Overall Study|Lack of Efficacy|45
2910204|NCT01660451|10021278|P3|Overall Study|Ongoing with treatment|46
2910205|NCT01660451|10021279|P2|Overall Study|Ongoing with treatment|3
2910206|NCT01660451|10021280|P1|Overall Study|Ongoing with treatment|3
2910207|NCT01660451|10021278|P3|Overall Study|Withdrawal by Subject|16
2910208|NCT01660451|10021279|P2|Overall Study|Withdrawal by Subject|0
2910209|NCT01660451|10021280|P1|Overall Study|Withdrawal by Subject|1
2910210|NCT01660451|10021278|P3|Overall Study|Physician Decision|5
2910211|NCT01660451|10021279|P2|Overall Study|Physician Decision|2
2910212|NCT01660451|10021280|P1|Overall Study|Physician Decision|1
2910213|NCT01660451|10021278|P3|Overall Study|Protocol Deviation|1
2910214|NCT01660451|10021279|P2|Overall Study|Protocol Deviation|0
2910215|NCT01660451|10021280|P1|Overall Study|Protocol Deviation|0
2910216|NCT01660451|10021278|P3|Overall Study|Sponsor Decision|1
2910217|NCT01660451|10021279|P2|Overall Study|Sponsor Decision|0
2910218|NCT01660451|10021280|P1|Overall Study|Sponsor Decision|0
2910219|NCT01660451|10021278|P3|Overall Study|AE with Clinical PD|9
2910220|NCT01660451|10021279|P2|Overall Study|AE with Clinical PD|3
2910221|NCT01660451|10021280|P1|Overall Study|AE with Clinical PD|1
2910222|NCT01660451|10021278|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
2910223|NCT01660451|10021279|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
2910224|NCT01660451|10021280|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
2910225|NCT01660451|10021278|P3|Overall Study|Protocol Violation|1
2910226|NCT01660451|10021279|P2|Overall Study|Protocol Violation|1
2910227|NCT01660451|10021280|P1|Overall Study|Protocol Violation|0
2910228|NCT01660412|10021308|P2|Overall Study|Protocol Violation|3
2910229|NCT01660412|10021309|P1|Overall Study|Protocol Violation|0
2910230|NCT01660334|10021315|P1|Overall Study|Lost to Follow-up|1
2910231|NCT01660022|10021558|P6|First Sequence (7 Days)|Protocol Violation|1
2910232|NCT01660022|10021559|P5|First Sequence (7 Days)|Protocol Violation|0
2910233|NCT01660022|10021560|P4|First Sequence (7 Days)|Protocol Violation|0
2910234|NCT01660022|10021561|P3|First Sequence (7 Days)|Protocol Violation|0
2910235|NCT01660022|10021562|P2|First Sequence (7 Days)|Protocol Violation|0
2910236|NCT01660022|10021563|P1|First Sequence (7 Days)|Protocol Violation|0
2910237|NCT01660022|10021558|P6|First Sequence (7 Days)|Adverse Event|3
2910238|NCT01660022|10021559|P5|First Sequence (7 Days)|Adverse Event|1
2910239|NCT01660022|10021560|P4|First Sequence (7 Days)|Adverse Event|0
2910240|NCT01660022|10021561|P3|First Sequence (7 Days)|Adverse Event|0
2910241|NCT01660022|10021562|P2|First Sequence (7 Days)|Adverse Event|0
2910242|NCT01660022|10021563|P1|First Sequence (7 Days)|Adverse Event|0
2910243|NCT01660022|10021558|P6|First Sequence (7 Days)|Withdrawal by Subject|0
2910244|NCT01660022|10021559|P5|First Sequence (7 Days)|Withdrawal by Subject|0
2910245|NCT01660022|10021560|P4|First Sequence (7 Days)|Withdrawal by Subject|1
2910246|NCT01660022|10021561|P3|First Sequence (7 Days)|Withdrawal by Subject|0
2910247|NCT01660022|10021562|P2|First Sequence (7 Days)|Withdrawal by Subject|1
2910248|NCT01660022|10021563|P1|First Sequence (7 Days)|Withdrawal by Subject|0
2910249|NCT01659996|10021622|P3|Overall Study|Withdrawal by Subject|5
2910250|NCT01659996|10021623|P2|Overall Study|Withdrawal by Subject|1
2910251|NCT01659996|10021624|P1|Overall Study|Withdrawal by Subject|4
2910252|NCT01659996|10021622|P3|Overall Study|Adverse Event|1
2910253|NCT01659996|10021623|P2|Overall Study|Adverse Event|0
2910254|NCT01659996|10021624|P1|Overall Study|Adverse Event|0
2910255|NCT01659996|10021622|P3|Overall Study|Lost to Follow-up|2
2910256|NCT01659996|10021623|P2|Overall Study|Lost to Follow-up|3
2910257|NCT01659996|10021624|P1|Overall Study|Lost to Follow-up|1
2910258|NCT01659996|10021622|P3|Overall Study|Protocol Violation|3
2910259|NCT01659996|10021623|P2|Overall Study|Protocol Violation|3
2910260|NCT01659996|10021624|P1|Overall Study|Protocol Violation|3
2910261|NCT01659853|10021665|P2|Washout , 3 to 7 Days|Protocol Violation|0
2910262|NCT01659853|10021666|P1|Washout , 3 to 7 Days|Protocol Violation|1
2910263|NCT01659853|10021665|P2|Washout , 3 to 7 Days|Adverse Event|0
2910264|NCT01659853|10021666|P1|Washout , 3 to 7 Days|Adverse Event|1
2910265|NCT01659736|10021676|P2|3-month Follow-up|Lost to Follow-up|1
2910266|NCT01659736|10021677|P1|3-month Follow-up|Lost to Follow-up|0
2910267|NCT01659736|10021676|P2|Treatment Period|Withdrawal by Subject|0
2910268|NCT01659736|10021677|P1|Treatment Period|Withdrawal by Subject|1
2910269|NCT01659736|10021676|P2|Treatment Period|Protocol Violation|1
2910270|NCT01659736|10021677|P1|Treatment Period|Protocol Violation|3
2910271|NCT01659736|10021676|P2|Treatment Period|Adverse Event|1
2910272|NCT01659736|10021677|P1|Treatment Period|Adverse Event|1
2910273|NCT01659567|10021691|P1|Overall Study|Other|13
2910274|NCT01659567|10021691|P1|Overall Study|Progression of the main disease|1
2910275|NCT01659567|10021691|P1|Overall Study|Withdrawal by Subject|64
2910276|NCT01659567|10021691|P1|Overall Study|Good result at early stage of treatment|5
2910277|NCT01659567|10021691|P1|Overall Study|Adverse Event|12
2910278|NCT01659567|10021691|P1|Overall Study|Switched to Pegferon|6
2910279|NCT01659567|10021691|P1|Overall Study|Lack of Efficacy|22
2910280|NCT01659554|10021708|P1|Overall Study|Study Termination|4
2910281|NCT01659320|10021715|P1|Overall Study|Physician Decision|1
2910282|NCT01659320|10021715|P1|Overall Study|Withdrawal by Subject|2
2910283|NCT01659125|10021734|P1|Overall Study|Failed to Start Treatment|2
2910284|NCT01659125|10021734|P1|Overall Study|Time Constraints|2
2910285|NCT01659125|10021734|P1|Overall Study|Technical Problem|1
2910286|NCT01659125|10021734|P1|Overall Study|Lost to Follow-up|7
2910287|NCT01659125|10021734|P1|Overall Study|Withdrawal by Subject|2
2910288|NCT01659021|10021741|P2|Long-Term Follow Up|Withdrawal by Subject|1
2910289|NCT01659021|10021742|P1|Long-Term Follow Up|Withdrawal by Subject|2
2910290|NCT01659021|10021741|P2|Long-Term Follow Up|Lost to Follow-up|3
2910291|NCT01659021|10021742|P1|Long-Term Follow Up|Lost to Follow-up|3
2910292|NCT01659021|10021741|P2|Main Study|Study Terminated by Sponsor|1
2910293|NCT01659021|10021742|P1|Main Study|Study Terminated by Sponsor|16
2910294|NCT01659021|10021741|P2|Main Study|Withdrawal by Subject|16
2910295|NCT01659021|10021742|P1|Main Study|Withdrawal by Subject|19
2910296|NCT01659021|10021741|P2|Main Study|Physician Decision|16
2910297|NCT01659021|10021742|P1|Main Study|Physician Decision|34
2910298|NCT01659021|10021741|P2|Main Study|Unknown Reasons|1
2910299|NCT01659021|10021742|P1|Main Study|Unknown Reasons|2
2910300|NCT01659021|10021741|P2|Main Study|Lost to Follow-up|0
2910301|NCT01659021|10021742|P1|Main Study|Lost to Follow-up|1
2910302|NCT01659021|10021741|P2|Main Study|Adverse Event|3
2910303|NCT01659021|10021742|P1|Main Study|Adverse Event|2
2910304|NCT01658943|10021760|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
2910305|NCT01658943|10021761|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
2910306|NCT01658943|10021760|P2|Overall Study|Not eligible|9
2910307|NCT01658943|10021761|P1|Overall Study|Not eligible|7
2910308|NCT01658943|10021760|P2|Overall Study|not protocol specified|1
2910309|NCT01658943|10021761|P1|Overall Study|not protocol specified|4
2910310|NCT01658943|10021760|P2|Overall Study|Death|2
2910311|NCT01658943|10021761|P1|Overall Study|Death|4
2910312|NCT01658943|10021760|P2|Overall Study|Progression/Relapse|40
2910313|NCT01658943|10021761|P1|Overall Study|Progression/Relapse|39
2910314|NCT01658943|10021760|P2|Overall Study|Withdrawal by Subject|2
2910315|NCT01658943|10021761|P1|Overall Study|Withdrawal by Subject|9
2910316|NCT01658943|10021760|P2|Overall Study|Adverse Event|13
2910317|NCT01658943|10021761|P1|Overall Study|Adverse Event|6
2910318|NCT01658904|10021776|P3|Overall Study|Principal Investigator discretion|0
2910319|NCT01658904|10021777|P2|Overall Study|Principal Investigator discretion|0
2910320|NCT01658904|10021778|P1|Overall Study|Principal Investigator discretion|2
2910321|NCT01658813|10021804|P1|Overall Study|Disease progression|3
2910322|NCT01658735|10021815|P3|Overall Study|Withdrawal by Subject|3
2910323|NCT01658735|10021816|P2|Overall Study|Withdrawal by Subject|5
2910324|NCT01658735|10021817|P1|Overall Study|Withdrawal by Subject|3
2910325|NCT01658735|10021815|P3|Overall Study|Protocol Violation|0
2910326|NCT01658735|10021816|P2|Overall Study|Protocol Violation|1
2910327|NCT01658735|10021817|P1|Overall Study|Protocol Violation|0
2910328|NCT01658735|10021815|P3|Overall Study|Lost to Follow-up|0
2910329|NCT01658735|10021816|P2|Overall Study|Lost to Follow-up|1
2910330|NCT01658735|10021817|P1|Overall Study|Lost to Follow-up|1
2910331|NCT01658735|10021815|P3|Overall Study|Lack of Efficacy|1
2910332|NCT01658735|10021816|P2|Overall Study|Lack of Efficacy|0
2910333|NCT01658735|10021817|P1|Overall Study|Lack of Efficacy|1
2910334|NCT01658579|10021859|P4|Treatment Period B|Other|1
2910335|NCT01658579|10021860|P3|Treatment Period B|Other|0
2910336|NCT01658579|10021861|P2|Treatment Period B|Other|0
2910337|NCT01658579|10021862|P1|Treatment Period B|Other|0
2910338|NCT01658579|10021859|P4|Treatment Period A|Adverse Event|0
2910339|NCT01658579|10021860|P3|Treatment Period A|Adverse Event|0
2910340|NCT01658579|10021861|P2|Treatment Period A|Adverse Event|0
2910341|NCT01658579|10021862|P1|Treatment Period A|Adverse Event|1
2910342|NCT01658579|10021859|P4|Treatment Period A|Other|1
2910343|NCT01658579|10021860|P3|Treatment Period A|Other|1
2910344|NCT01658579|10021861|P2|Treatment Period A|Other|0
2910345|NCT01658579|10021862|P1|Treatment Period A|Other|0
2910346|NCT01658514|10021890|P3|Overall Study|Protocol Violation|2
2910347|NCT01658514|10021891|P2|Overall Study|Protocol Violation|0
2910348|NCT01658514|10021892|P1|Overall Study|Protocol Violation|1
2910349|NCT01658436|10021903|P2|Overall Study|Death|0
2910350|NCT01658436|10021904|P1|Overall Study|Death|1
2910351|NCT01658436|10021903|P2|Overall Study|Subject/guardian decision|1
2910352|NCT01658436|10021904|P1|Overall Study|Subject/guardian decision|0
2910353|NCT01658436|10021903|P2|Overall Study|Study terminated by sponsor|1
2910354|NCT01658436|10021904|P1|Overall Study|Study terminated by sponsor|0
2910355|NCT01658436|10021903|P2|Overall Study|Progressive disease|4
2910356|NCT01658436|10021904|P1|Overall Study|Progressive disease|12
2910357|NCT01658436|10021903|P2|Overall Study|Physician Decision|0
2910358|NCT01658436|10021904|P1|Overall Study|Physician Decision|1
2910359|NCT01658436|10021903|P2|Overall Study|Adverse Event|5
2910360|NCT01658436|10021904|P1|Overall Study|Adverse Event|6
2910361|NCT01658150|10021924|P1|Overall Study|Withdrawal by Subject|1
2910362|NCT01658072|10021946|P2|Overall Study|Protocol Violation|2
2910363|NCT01658072|10021947|P1|Overall Study|Protocol Violation|4
2910364|NCT01658020|10021962|P2|Overall Study|Protocol Violation|1
2910365|NCT01658020|10021963|P1|Overall Study|Protocol Violation|0
2910366|NCT01658020|10021962|P2|Overall Study|Withdrawal by Subject|5
2910367|NCT01658020|10021963|P1|Overall Study|Withdrawal by Subject|4
2910368|NCT01658020|10021962|P2|Overall Study|Lost to Follow-up|0
2910369|NCT01658020|10021963|P1|Overall Study|Lost to Follow-up|1
2910370|NCT01658020|10021962|P2|Overall Study|Adverse Event|3
2910371|NCT01658020|10021963|P1|Overall Study|Adverse Event|3
2910372|NCT01657903|10021979|P1|Overall Study|Withdrawal by Subject|1
2910373|NCT01657903|10021979|P1|Overall Study|Lost to Follow-up|1
2910374|NCT01657877|10022001|P1|Overall Study|Other Reason|2
2910375|NCT01657877|10022001|P1|Overall Study|Adverse Event|2
2910376|NCT01657877|10022001|P1|Overall Study|Protocol Violation|6
2910377|NCT01657877|10022001|P1|Overall Study|Withdrawal by Subject|4
2910378|NCT01657799|10022021|P3|Overall Study|Other|49
2910379|NCT01657799|10022022|P2|Overall Study|Other|62
2910380|NCT01657799|10022023|P1|Overall Study|Other|52
2910381|NCT01657799|10022021|P3|Overall Study|Radiographic & Clinical Progression|15
2910382|NCT01657799|10022022|P2|Overall Study|Radiographic & Clinical Progression|11
2910383|NCT01657799|10022023|P1|Overall Study|Radiographic & Clinical Progression|16
2910384|NCT01657799|10022021|P3|Overall Study|Progressive Disease Clinical|7
2910385|NCT01657799|10022022|P2|Overall Study|Progressive Disease Clinical|4
2910386|NCT01657799|10022023|P1|Overall Study|Progressive Disease Clinical|7
2910387|NCT01657799|10022021|P3|Overall Study|Disease Progression|4
2910388|NCT01657799|10022022|P2|Overall Study|Disease Progression|4
2910389|NCT01657799|10022023|P1|Overall Study|Disease Progression|2
2910390|NCT01657799|10022021|P3|Overall Study|Lost to Follow-up|1
2910391|NCT01657799|10022022|P2|Overall Study|Lost to Follow-up|0
2910392|NCT01657799|10022023|P1|Overall Study|Lost to Follow-up|1
2910393|NCT01657799|10022021|P3|Overall Study|Withdrawal by Subject|10
2910394|NCT01657799|10022022|P2|Overall Study|Withdrawal by Subject|10
2910395|NCT01657799|10022023|P1|Overall Study|Withdrawal by Subject|13
2910396|NCT01657799|10022021|P3|Overall Study|Adverse Event Not Related to Progression|4
2910397|NCT01657799|10022022|P2|Overall Study|Adverse Event Not Related to Progression|4
2910398|NCT01657799|10022023|P1|Overall Study|Adverse Event Not Related to Progression|5
2910399|NCT01657799|10022021|P3|Overall Study|Adverse Event Related to progression|12
2910400|NCT01657799|10022022|P2|Overall Study|Adverse Event Related to progression|8
2910401|NCT01657799|10022023|P1|Overall Study|Adverse Event Related to progression|6
2910402|NCT01657760|10022042|P4|Overall Study|Physician Decision|2
2910403|NCT01657760|10022043|P3|Overall Study|Physician Decision|1
2910404|NCT01657760|10022044|P2|Overall Study|Physician Decision|1
2910405|NCT01657760|10022045|P1|Overall Study|Physician Decision|1
2910406|NCT01657760|10022042|P4|Overall Study|Withdrawal by Subject|1
2910407|NCT01657760|10022043|P3|Overall Study|Withdrawal by Subject|0
2910408|NCT01657760|10022044|P2|Overall Study|Withdrawal by Subject|0
2910409|NCT01657760|10022045|P1|Overall Study|Withdrawal by Subject|0
2910410|NCT01657461|10022064|P2|Overall Study|Withdrawal by Subject|3
2910411|NCT01657461|10022065|P1|Overall Study|Withdrawal by Subject|1
2910412|NCT01657461|10022064|P2|Overall Study|Physician Decision|2
2910413|NCT01657461|10022065|P1|Overall Study|Physician Decision|0
2910414|NCT01657461|10022064|P2|Overall Study|Lost to Follow-up|3
2910415|NCT01657461|10022065|P1|Overall Study|Lost to Follow-up|0
2910416|NCT01657461|10022064|P2|Overall Study|Death|12
2910417|NCT01657461|10022065|P1|Overall Study|Death|9
2910418|NCT01657370|10022095|P6|Overall Study|Lost to Follow-up|1
2910419|NCT01657370|10022096|P5|Overall Study|Lost to Follow-up|0
2910420|NCT01657370|10022097|P4|Overall Study|Lost to Follow-up|0
2910421|NCT01657370|10022098|P3|Overall Study|Lost to Follow-up|1
2910422|NCT01657370|10022099|P2|Overall Study|Lost to Follow-up|0
2910423|NCT01657370|10022100|P1|Overall Study|Lost to Follow-up|2
2910424|NCT01657370|10022095|P6|Overall Study|Protocol Violation|0
2910425|NCT01657370|10022096|P5|Overall Study|Protocol Violation|0
2910426|NCT01657370|10022097|P4|Overall Study|Protocol Violation|1
2910427|NCT01657370|10022098|P3|Overall Study|Protocol Violation|1
2910428|NCT01657370|10022099|P2|Overall Study|Protocol Violation|1
2910429|NCT01657370|10022100|P1|Overall Study|Protocol Violation|1
2910430|NCT01657370|10022095|P6|Overall Study|Adverse Event|0
2910431|NCT01657370|10022096|P5|Overall Study|Adverse Event|1
2910432|NCT01657370|10022097|P4|Overall Study|Adverse Event|0
2910433|NCT01657370|10022098|P3|Overall Study|Adverse Event|0
2910434|NCT01657370|10022099|P2|Overall Study|Adverse Event|0
2910435|NCT01657370|10022100|P1|Overall Study|Adverse Event|0
2910436|NCT01657370|10022095|P6|Overall Study|Lack of Qualifying Event|2
2910437|NCT01657370|10022096|P5|Overall Study|Lack of Qualifying Event|1
2910438|NCT01657370|10022097|P4|Overall Study|Lack of Qualifying Event|2
2910439|NCT01657370|10022098|P3|Overall Study|Lack of Qualifying Event|3
2910440|NCT01657370|10022099|P2|Overall Study|Lack of Qualifying Event|0
2910441|NCT01657370|10022100|P1|Overall Study|Lack of Qualifying Event|1
2910442|NCT01657370|10022095|P6|Overall Study|Physician Decision|0
2910443|NCT01657370|10022096|P5|Overall Study|Physician Decision|5
2910444|NCT01657370|10022097|P4|Overall Study|Physician Decision|2
2910445|NCT01657370|10022098|P3|Overall Study|Physician Decision|1
2910446|NCT01657370|10022099|P2|Overall Study|Physician Decision|3
2910447|NCT01657370|10022100|P1|Overall Study|Physician Decision|2
2910448|NCT01657370|10022095|P6|Overall Study|Withdrawal by Subject|1
2910449|NCT01657370|10022096|P5|Overall Study|Withdrawal by Subject|0
2910450|NCT01657370|10022097|P4|Overall Study|Withdrawal by Subject|0
2910451|NCT01657370|10022098|P3|Overall Study|Withdrawal by Subject|1
2910452|NCT01657370|10022099|P2|Overall Study|Withdrawal by Subject|0
2910453|NCT01657370|10022100|P1|Overall Study|Withdrawal by Subject|0
2910454|NCT01657305|10022198|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
2910455|NCT01657305|10022198|P1|Overall Study|Lost to Follow-up|1
2910456|NCT01657305|10022198|P1|Overall Study|Adverse Event|1
2910457|NCT01657305|10022198|P1|Overall Study|Withdrawal by Subject|4
2910458|NCT01657305|10022198|P1|Overall Study|Lack of Wound Closure at Day 28|15
2910459|NCT01657292|10022248|P1|Overall Study|Change of therapy|1
2910460|NCT01657292|10022248|P1|Overall Study|Violation of eligibility criteria|1
2910461|NCT01657292|10022248|P1|Overall Study|Withdrawal by Subject|2
2910462|NCT01657292|10022248|P1|Overall Study|Adverse Event|6
2910463|NCT01657266|10022257|P2|Overall Study|Adverse Event|3
2910464|NCT01657266|10022258|P1|Overall Study|Adverse Event|2
2910465|NCT01657266|10022257|P2|Overall Study|Lost to Follow-up|2
2910466|NCT01657266|10022258|P1|Overall Study|Lost to Follow-up|2
2910467|NCT01657253|10022280|P2|Overall Study|Adverse Event|1
2910468|NCT01657253|10022281|P1|Overall Study|Adverse Event|0
2910469|NCT01657253|10022280|P2|Overall Study|Withdrawal by Subject|12
2910470|NCT01657253|10022281|P1|Overall Study|Withdrawal by Subject|11
2910471|NCT01657253|10022280|P2|Overall Study|Lost to Follow-up|5
2910472|NCT01657253|10022281|P1|Overall Study|Lost to Follow-up|6
2910473|NCT01657032|10022293|P2|Overall Study|Lost to Follow-up|7
2910474|NCT01657032|10022294|P1|Overall Study|Lost to Follow-up|0
2910475|NCT01657019|10022320|P1|Overall Study|Other|58
2910476|NCT01657019|10022320|P1|Overall Study|Lack of Efficacy|3
2910477|NCT01657019|10022320|P1|Overall Study|Protocol Violation|6
2910478|NCT01657019|10022320|P1|Overall Study|Lost to Follow-up|48
2910479|NCT01657019|10022320|P1|Overall Study|Adverse Event|55
2910480|NCT01657019|10022320|P1|Overall Study|Withdrawal by Subject|65
2910481|NCT01656967|10022334|P2|Overall Study|unsuccessful ETT insertion|2
2910482|NCT01656967|10022335|P1|Overall Study|unsuccessful ETT insertion|3
2910483|NCT01656967|10022334|P2|Overall Study|faulty monitor|0
2910484|NCT01656967|10022335|P1|Overall Study|faulty monitor|1
2910485|NCT01656889|10022361|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
2910486|NCT01656889|10022362|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
2910487|NCT01656889|10022361|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
2910488|NCT01656889|10022362|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
2910489|NCT01656889|10022361|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
2910490|NCT01656889|10022362|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
2910491|NCT01656889|10022361|P2|Post Treatment Follow-Up, 3 Months|Death|5
2910492|NCT01656889|10022362|P1|Post Treatment Follow-Up, 3 Months|Death|1
2910493|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Moved out of the area|2
2910494|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Moved out of the area|0
2910495|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Protocol Violation|1
2910496|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Protocol Violation|0
2910497|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
2910498|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
2910499|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
2910500|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
2910501|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Death|1
2910502|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Death|0
2910503|NCT01656889|10022361|P2|Treatment Period, 12 Weeks|Adverse Event|4
2910504|NCT01656889|10022362|P1|Treatment Period, 12 Weeks|Adverse Event|10
2910505|NCT01656850|10022382|P2|First Intervention (3 Months)|Withdrawal by Subject|4
2910506|NCT01656850|10022383|P1|First Intervention (3 Months)|Withdrawal by Subject|3
2910507|NCT01656759|10022474|P2|Overall Study|Protocol Violation|3
2910508|NCT01656759|10022475|P1|Overall Study|Protocol Violation|2
2910509|NCT01656733|10022489|P2|Overall Study|Spontaneous abortion|1
2910510|NCT01656733|10022490|P1|Overall Study|Spontaneous abortion|0
2910511|NCT01656733|10022489|P2|Overall Study|Delivery at another hospital|2
2910512|NCT01656733|10022490|P1|Overall Study|Delivery at another hospital|0
2910513|NCT01656733|10022489|P2|Overall Study|No permission to collect birth outcomes|1
2910514|NCT01656733|10022490|P1|Overall Study|No permission to collect birth outcomes|0
2910515|NCT01656434|10022534|P2|Overall Study|Withdrawal by Subject|7
2910516|NCT01656434|10022535|P1|Overall Study|Withdrawal by Subject|64
2910517|NCT01656434|10022534|P2|Overall Study|Participant withdrew consent|9
2910518|NCT01656434|10022535|P1|Overall Study|Participant withdrew consent|28
2910519|NCT01656434|10022534|P2|Overall Study|Participant moved|12
2910520|NCT01656434|10022535|P1|Overall Study|Participant moved|40
2910521|NCT01656434|10022534|P2|Overall Study|Non-compliance with protocol|15
2910522|NCT01656434|10022535|P1|Overall Study|Non-compliance with protocol|39
2910523|NCT01656434|10022534|P2|Overall Study|Part. discontinued; unrelated to drug|10
2910524|NCT01656434|10022535|P1|Overall Study|Part. discontinued; unrelated to drug|55
2910525|NCT01656434|10022534|P2|Overall Study|Participant discontinued; drug related|4
2910526|NCT01656434|10022535|P1|Overall Study|Participant discontinued; drug related|13
2910527|NCT01656434|10022534|P2|Overall Study|Study terminated by sponsor|348
2910528|NCT01656434|10022535|P1|Overall Study|Study terminated by sponsor|1501
2910529|NCT01656434|10022534|P2|Overall Study|Non-compliance with study drug|9
2910530|NCT01656434|10022535|P1|Overall Study|Non-compliance with study drug|48
2910531|NCT01656434|10022534|P2|Overall Study|Physician Decision|2
2910532|NCT01656434|10022535|P1|Overall Study|Physician Decision|7
2910533|NCT01656434|10022534|P2|Overall Study|Pregnancy|10
2910534|NCT01656434|10022535|P1|Overall Study|Pregnancy|45
2910535|NCT01656434|10022534|P2|Overall Study|Pregnancy wish|6
2910536|NCT01656434|10022535|P1|Overall Study|Pregnancy wish|18
2910537|NCT01656434|10022534|P2|Overall Study|Protocol Violation|0
2910538|NCT01656434|10022535|P1|Overall Study|Protocol Violation|7
2910539|NCT01656434|10022534|P2|Overall Study|Screen failure|0
2910540|NCT01656434|10022535|P1|Overall Study|Screen failure|2
2910541|NCT01656434|10022534|P2|Overall Study|Site discontinued study participation|9
2910542|NCT01656434|10022535|P1|Overall Study|Site discontinued study participation|24
2910543|NCT01656434|10022534|P2|Overall Study|Lost to Follow-up|76
2910544|NCT01656434|10022535|P1|Overall Study|Lost to Follow-up|309
2910545|NCT01656434|10022534|P2|Overall Study|Enrollment terminated at trial site|0
2910546|NCT01656434|10022535|P1|Overall Study|Enrollment terminated at trial site|2
2910547|NCT01656434|10022534|P2|Overall Study|Adverse Event|63
2910548|NCT01656434|10022535|P1|Overall Study|Adverse Event|199
2910549|NCT01656408|10022561|P10|Overall Study|Physician Decision|3
2910550|NCT01656408|10022562|P9|Overall Study|Physician Decision|1
2910551|NCT01656408|10022563|P8|Overall Study|Physician Decision|1
2910552|NCT01656408|10022564|P7|Overall Study|Physician Decision|0
2910553|NCT01656408|10022565|P6|Overall Study|Physician Decision|1
2910554|NCT01656408|10022566|P5|Overall Study|Physician Decision|1
2910555|NCT01656408|10022567|P4|Overall Study|Physician Decision|0
2910556|NCT01656408|10022568|P3|Overall Study|Physician Decision|1
2910557|NCT01656408|10022569|P2|Overall Study|Physician Decision|0
2910558|NCT01656408|10022570|P1|Overall Study|Physician Decision|1
2910559|NCT01656408|10022561|P10|Overall Study|Adverse Event|0
2910560|NCT01656408|10022562|P9|Overall Study|Adverse Event|1
2910561|NCT01656408|10022563|P8|Overall Study|Adverse Event|0
2910562|NCT01656408|10022564|P7|Overall Study|Adverse Event|1
2910563|NCT01656408|10022565|P6|Overall Study|Adverse Event|1
2910564|NCT01656408|10022566|P5|Overall Study|Adverse Event|0
2910565|NCT01656408|10022567|P4|Overall Study|Adverse Event|0
2910566|NCT01656408|10022568|P3|Overall Study|Adverse Event|1
2910567|NCT01656408|10022569|P2|Overall Study|Adverse Event|0
2910568|NCT01656408|10022570|P1|Overall Study|Adverse Event|0
2910569|NCT01656395|10022765|P8|Overall Study|Withdrawal by Subject|0
2910570|NCT01656395|10022766|P7|Overall Study|Withdrawal by Subject|0
2910571|NCT01656395|10022767|P6|Overall Study|Withdrawal by Subject|3
2910572|NCT01656395|10022768|P5|Overall Study|Withdrawal by Subject|0
2910573|NCT01656395|10022769|P4|Overall Study|Withdrawal by Subject|2
2910574|NCT01656395|10022770|P3|Overall Study|Withdrawal by Subject|4
2910575|NCT01656395|10022771|P2|Overall Study|Withdrawal by Subject|1
2910576|NCT01656395|10022772|P1|Overall Study|Withdrawal by Subject|3
2910577|NCT01656395|10022765|P8|Overall Study|Screen Failure|0
2910578|NCT01656395|10022766|P7|Overall Study|Screen Failure|0
2910579|NCT01656395|10022767|P6|Overall Study|Screen Failure|8
2910580|NCT01656395|10022768|P5|Overall Study|Screen Failure|0
2910581|NCT01656395|10022769|P4|Overall Study|Screen Failure|1
2910582|NCT01656395|10022770|P3|Overall Study|Screen Failure|7
2910583|NCT01656395|10022771|P2|Overall Study|Screen Failure|1
2910584|NCT01656395|10022772|P1|Overall Study|Screen Failure|2
2910585|NCT01656395|10022765|P8|Overall Study|Protocol Violation|0
2910586|NCT01656395|10022766|P7|Overall Study|Protocol Violation|0
2910587|NCT01656395|10022767|P6|Overall Study|Protocol Violation|10
2910588|NCT01656395|10022768|P5|Overall Study|Protocol Violation|4
2910589|NCT01656395|10022769|P4|Overall Study|Protocol Violation|2
2910590|NCT01656395|10022770|P3|Overall Study|Protocol Violation|9
2910591|NCT01656395|10022771|P2|Overall Study|Protocol Violation|6
2910592|NCT01656395|10022772|P1|Overall Study|Protocol Violation|6
2910593|NCT01656395|10022765|P8|Overall Study|Progressive Disease|0
2910594|NCT01656395|10022766|P7|Overall Study|Progressive Disease|0
2910595|NCT01656395|10022767|P6|Overall Study|Progressive Disease|1
2910596|NCT01656395|10022768|P5|Overall Study|Progressive Disease|0
2910597|NCT01656395|10022769|P4|Overall Study|Progressive Disease|0
2910598|NCT01656395|10022770|P3|Overall Study|Progressive Disease|0
2910599|NCT01656395|10022771|P2|Overall Study|Progressive Disease|0
2910600|NCT01656395|10022772|P1|Overall Study|Progressive Disease|0
2910601|NCT01656395|10022765|P8|Overall Study|Pregnancy|0
2910602|NCT01656395|10022766|P7|Overall Study|Pregnancy|0
2910603|NCT01656395|10022767|P6|Overall Study|Pregnancy|0
2910604|NCT01656395|10022768|P5|Overall Study|Pregnancy|0
2910605|NCT01656395|10022769|P4|Overall Study|Pregnancy|0
2910606|NCT01656395|10022770|P3|Overall Study|Pregnancy|1
2910607|NCT01656395|10022771|P2|Overall Study|Pregnancy|0
2910608|NCT01656395|10022772|P1|Overall Study|Pregnancy|0
2910609|NCT01656395|10022765|P8|Overall Study|Physician Decision|0
2910610|NCT01656395|10022766|P7|Overall Study|Physician Decision|0
2910611|NCT01656395|10022767|P6|Overall Study|Physician Decision|3
2910612|NCT01656395|10022768|P5|Overall Study|Physician Decision|3
2910613|NCT01656395|10022769|P4|Overall Study|Physician Decision|2
2910614|NCT01656395|10022770|P3|Overall Study|Physician Decision|3
2910615|NCT01656395|10022771|P2|Overall Study|Physician Decision|3
2910616|NCT01656395|10022772|P1|Overall Study|Physician Decision|2
2910617|NCT01656395|10022765|P8|Overall Study|Other|0
2910618|NCT01656395|10022766|P7|Overall Study|Other|0
2910619|NCT01656395|10022767|P6|Overall Study|Other|1
2910620|NCT01656395|10022768|P5|Overall Study|Other|0
2910621|NCT01656395|10022769|P4|Overall Study|Other|0
2910622|NCT01656395|10022770|P3|Overall Study|Other|1
2910623|NCT01656395|10022771|P2|Overall Study|Other|0
2910624|NCT01656395|10022772|P1|Overall Study|Other|0
2910625|NCT01656395|10022765|P8|Overall Study|Non-Compliance with Study Drug|0
2910626|NCT01656395|10022766|P7|Overall Study|Non-Compliance with Study Drug|0
2910627|NCT01656395|10022767|P6|Overall Study|Non-Compliance with Study Drug|1
2910628|NCT01656395|10022768|P5|Overall Study|Non-Compliance with Study Drug|1
2910629|NCT01656395|10022769|P4|Overall Study|Non-Compliance with Study Drug|0
2910630|NCT01656395|10022770|P3|Overall Study|Non-Compliance with Study Drug|0
2910631|NCT01656395|10022771|P2|Overall Study|Non-Compliance with Study Drug|1
2910632|NCT01656395|10022772|P1|Overall Study|Non-Compliance with Study Drug|1
2910633|NCT01656395|10022765|P8|Overall Study|Lost to Follow-up|0
2910634|NCT01656395|10022766|P7|Overall Study|Lost to Follow-up|0
2910635|NCT01656395|10022767|P6|Overall Study|Lost to Follow-up|0
2910636|NCT01656395|10022768|P5|Overall Study|Lost to Follow-up|0
2910637|NCT01656395|10022769|P4|Overall Study|Lost to Follow-up|0
2910638|NCT01656395|10022770|P3|Overall Study|Lost to Follow-up|0
2910639|NCT01656395|10022771|P2|Overall Study|Lost to Follow-up|0
2910640|NCT01656395|10022772|P1|Overall Study|Lost to Follow-up|1
2910641|NCT01656395|10022765|P8|Overall Study|Lack of Efficacy|0
2910642|NCT01656395|10022766|P7|Overall Study|Lack of Efficacy|0
2910643|NCT01656395|10022767|P6|Overall Study|Lack of Efficacy|6
2910644|NCT01656395|10022768|P5|Overall Study|Lack of Efficacy|1
2910645|NCT01656395|10022769|P4|Overall Study|Lack of Efficacy|1
2910646|NCT01656395|10022770|P3|Overall Study|Lack of Efficacy|6
2910647|NCT01656395|10022771|P2|Overall Study|Lack of Efficacy|8
2910648|NCT01656395|10022772|P1|Overall Study|Lack of Efficacy|1
2910649|NCT01656395|10022765|P8|Overall Study|Adverse Event|0
2910650|NCT01656395|10022766|P7|Overall Study|Adverse Event|0
2910651|NCT01656395|10022767|P6|Overall Study|Adverse Event|7
2910652|NCT01656395|10022768|P5|Overall Study|Adverse Event|5
2910653|NCT01656395|10022769|P4|Overall Study|Adverse Event|4
2910654|NCT01656395|10022770|P3|Overall Study|Adverse Event|5
2910655|NCT01656395|10022771|P2|Overall Study|Adverse Event|14
2910656|NCT01656395|10022772|P1|Overall Study|Adverse Event|1
2910657|NCT01656304|10022858|P1|Overall Study|Ineligible, uncontrolled hypertension|1
2910658|NCT01656200|10022899|P1|Overall Study|Withdrawal by Subject|1
2910659|NCT01656161|10022914|P1|Overall Study|Withdrawal by Subject|1
2910660|NCT01656161|10022914|P1|Overall Study|Protocol Violation|1
2910661|NCT01656161|10022914|P1|Overall Study|Adverse Event|2
2910662|NCT01656161|10022914|P1|Overall Study|Death|3
2910663|NCT01655901|10022932|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
2910664|NCT01655901|10022933|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
2910665|NCT01655901|10022934|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
2910666|NCT01655901|10022935|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
2910667|NCT01655901|10022936|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
2910668|NCT01655901|10022937|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
2910669|NCT01655823|10022951|P5|Overall Study|Withdrawal by Subject|0
2910670|NCT01655823|10022952|P4|Overall Study|Withdrawal by Subject|1
2910671|NCT01655823|10022953|P3|Overall Study|Withdrawal by Subject|0
2910672|NCT01655823|10022954|P2|Overall Study|Withdrawal by Subject|1
2910673|NCT01655823|10022955|P1|Overall Study|Withdrawal by Subject|0
2910674|NCT01655823|10022951|P5|Overall Study|Lost to Follow-up|1
2910675|NCT01655823|10022952|P4|Overall Study|Lost to Follow-up|0
2910676|NCT01655823|10022953|P3|Overall Study|Lost to Follow-up|0
2910677|NCT01655823|10022954|P2|Overall Study|Lost to Follow-up|1
2910678|NCT01655823|10022955|P1|Overall Study|Lost to Follow-up|0
2910679|NCT01655498|10022986|P1|Overall Study|Withdrawal by Subject|1
2910680|NCT01655498|10022986|P1|Overall Study|Protocol Violation|2
2910681|NCT01655498|10022986|P1|Overall Study|Unrelated health issue|2
2910682|NCT01655381|10022993|P1|Overall Study|Insufficient Treatment Response|1
2910683|NCT01655381|10022993|P1|Overall Study|Moved to Another City|1
2910684|NCT01655381|10022993|P1|Overall Study|Investigator Decision|1
2910685|NCT01655069|10023033|P4|Overall Study|Withdrawal by Subject|0
2910686|NCT01655069|10023034|P3|Overall Study|Withdrawal by Subject|0
2910687|NCT01655069|10023035|P2|Overall Study|Withdrawal by Subject|3
2910688|NCT01655069|10023036|P1|Overall Study|Withdrawal by Subject|2
2910689|NCT01655069|10023033|P4|Overall Study|No Treatment Needed|0
2910690|NCT01655069|10023034|P3|Overall Study|No Treatment Needed|0
2910691|NCT01655069|10023035|P2|Overall Study|No Treatment Needed|1
2910692|NCT01655069|10023036|P1|Overall Study|No Treatment Needed|0
2910693|NCT01655069|10023033|P4|Overall Study|Lack of Efficacy|0
2910694|NCT01655069|10023034|P3|Overall Study|Lack of Efficacy|0
2910695|NCT01655069|10023035|P2|Overall Study|Lack of Efficacy|1
2910696|NCT01655069|10023036|P1|Overall Study|Lack of Efficacy|0
2910697|NCT01655069|10023033|P4|Overall Study|Adverse Event|3
2910698|NCT01655069|10023034|P3|Overall Study|Adverse Event|2
2910699|NCT01655069|10023035|P2|Overall Study|Adverse Event|7
2910700|NCT01655069|10023036|P1|Overall Study|Adverse Event|6
2910701|NCT01655069|10023033|P4|Overall Study|Physician Decision|1
2910702|NCT01655069|10023034|P3|Overall Study|Physician Decision|0
2910703|NCT01655069|10023035|P2|Overall Study|Physician Decision|0
2910704|NCT01655069|10023036|P1|Overall Study|Physician Decision|0
2910705|NCT01654666|10023096|P3|Overall Study|Withdrawal by Subject|1
2910706|NCT01654666|10023097|P2|Overall Study|Withdrawal by Subject|4
2910707|NCT01654666|10023098|P1|Overall Study|Withdrawal by Subject|4
2910708|NCT01654666|10023096|P3|Overall Study|Lost to Follow-up|5
2910709|NCT01654666|10023097|P2|Overall Study|Lost to Follow-up|5
2910710|NCT01654666|10023098|P1|Overall Study|Lost to Follow-up|4
2910711|NCT01654666|10023096|P3|Overall Study|Protocol Violation|8
2910712|NCT01654666|10023097|P2|Overall Study|Protocol Violation|4
2910713|NCT01654666|10023098|P1|Overall Study|Protocol Violation|7
2910714|NCT01654601|10023123|P2|2nd Administration|Protocol Violation|1
2910715|NCT01654601|10023124|P1|2nd Administration|Protocol Violation|0
2910716|NCT01654601|10023123|P2|2nd Administration|Adverse Event|0
2910717|NCT01654601|10023124|P1|2nd Administration|Adverse Event|1
2910718|NCT01654601|10023123|P2|1st Administration|Protocol Violation|2
2910719|NCT01654601|10023124|P1|1st Administration|Protocol Violation|0
2910720|NCT01654601|10023123|P2|1st Administration|Withdrawal by Subject|0
2910721|NCT01654601|10023124|P1|1st Administration|Withdrawal by Subject|2
2910722|NCT01654549|10023138|P2|Overall Study|H.pylori eradication not successful|1
2910723|NCT01654549|10023139|P1|Overall Study|H.pylori eradication not successful|0
2910724|NCT01654536|10023151|P2|Overall Study|Withdrawal by Subject|25
2910725|NCT01654536|10023152|P1|Overall Study|Withdrawal by Subject|27
2910726|NCT01654536|10023151|P2|Overall Study|Physician Decision|8
2910727|NCT01654536|10023152|P1|Overall Study|Physician Decision|12
2910728|NCT01654536|10023151|P2|Overall Study|Lost to Follow-up|5
2910729|NCT01654536|10023152|P1|Overall Study|Lost to Follow-up|5
2910730|NCT01654523|10023188|P1|Overall Study|Withdrawal by Subject|1
2910731|NCT01654380|10023194|P4|Part B, Period 1|Physician Decision|0
2910732|NCT01654380|10023195|P3|Part B, Period 1|Physician Decision|1
2910733|NCT01654380|10023196|P2|Part B, Period 1|Physician Decision|0
2910734|NCT01654380|10023197|P1|Part B, Period 1|Physician Decision|0
2910735|NCT01654302|10023240|P2|Second Intervention (Day 7)|Lost to Follow-up|1
2910736|NCT01654302|10023241|P1|Second Intervention (Day 7)|Lost to Follow-up|1
2910737|NCT01654289|10023250|P3|Overall Study|Withdrew from intervention only|0
2910738|NCT01654289|10023251|P2|Overall Study|Withdrew from intervention only|20
2910739|NCT01654289|10023252|P1|Overall Study|Withdrew from intervention only|17
2910740|NCT01654289|10023250|P3|Overall Study|Withdrawal by Subject|5
2910741|NCT01654289|10023251|P2|Overall Study|Withdrawal by Subject|8
2910742|NCT01654289|10023252|P1|Overall Study|Withdrawal by Subject|10
2910743|NCT01654276|10023290|P1|Overall Study|Withdrawal by Subject|1
2910744|NCT01654276|10023290|P1|Overall Study|Lost to Follow-up|4
2910745|NCT01654276|10023290|P1|Overall Study|Lack of Efficacy|1
2910746|NCT01654250|10023344|P2|Overall Study|Lost to Follow-up|0
2910747|NCT01654250|10023345|P1|Overall Study|Lost to Follow-up|1
2910748|NCT01654224|10023362|P2|Overall Study|Insufficient blood sample|2
2910749|NCT01654224|10023363|P1|Overall Study|Insufficient blood sample|3
2910750|NCT01654224|10023362|P2|Overall Study|Did not receive allocation|8
2910751|NCT01654224|10023363|P1|Overall Study|Did not receive allocation|1
2910752|NCT01654224|10023362|P2|Overall Study|Lost to Follow-up|2
2910753|NCT01654224|10023363|P1|Overall Study|Lost to Follow-up|2
2910754|NCT01653912|10023394|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
2910755|NCT01653912|10023395|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2910756|NCT01653912|10023396|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2910757|NCT01653912|10023397|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2910758|NCT01653912|10023398|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2910759|NCT01653912|10023399|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2910760|NCT01653912|10023394|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
2910761|NCT01653912|10023395|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2910762|NCT01653912|10023396|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2910763|NCT01653912|10023397|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2910764|NCT01653912|10023398|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2910765|NCT01653912|10023399|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2910766|NCT01653912|10023394|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
2910767|NCT01653912|10023395|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
2910768|NCT01653912|10023396|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
2910769|NCT01653912|10023397|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
2910770|NCT01653912|10023398|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
2910771|NCT01653912|10023399|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
2910772|NCT01653912|10023394|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2910773|NCT01653912|10023395|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2910774|NCT01653912|10023396|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
2910775|NCT01653912|10023397|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2910776|NCT01653912|10023398|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2910777|NCT01653912|10023399|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2910778|NCT01653912|10023394|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2910779|NCT01653912|10023395|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2910780|NCT01653912|10023396|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
2910781|NCT01653912|10023397|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2910782|NCT01653912|10023398|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2910783|NCT01653912|10023399|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2910784|NCT01653912|10023394|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2910785|NCT01653912|10023395|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2910786|NCT01653912|10023396|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2910787|NCT01653912|10023397|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
2910788|NCT01653912|10023398|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2910789|NCT01653912|10023399|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2910790|NCT01653912|10023394|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2910791|NCT01653912|10023395|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2910792|NCT01653912|10023396|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2910793|NCT01653912|10023397|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2910794|NCT01653912|10023398|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
2910795|NCT01653912|10023399|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2910796|NCT01653782|10023417|P3|Overall Study|Lost to Follow-up|2
2910797|NCT01653782|10023418|P2|Overall Study|Lost to Follow-up|3
2910798|NCT01653782|10023419|P1|Overall Study|Lost to Follow-up|7
2910799|NCT01653782|10023417|P3|Overall Study|Withdrawal by Subject|4
2910800|NCT01653782|10023418|P2|Overall Study|Withdrawal by Subject|15
2910801|NCT01653782|10023419|P1|Overall Study|Withdrawal by Subject|9
2910802|NCT01653743|10023429|P2|Overall Study|Investigator discretion|0
2910803|NCT01653743|10023430|P1|Overall Study|Investigator discretion|3
2910804|NCT01653743|10023429|P2|Overall Study|Withdrawal by Subject|0
2910805|NCT01653743|10023430|P1|Overall Study|Withdrawal by Subject|1
2910806|NCT01653704|10023446|P2|Overall Study|Performance not reflective of training|0
2910807|NCT01653704|10023447|P1|Overall Study|Performance not reflective of training|1
2910808|NCT01653704|10023446|P2|Overall Study|Technical failure during recording|1
2910809|NCT01653704|10023447|P1|Overall Study|Technical failure during recording|1
2910810|NCT01653327|10023516|P1|Overall Study|Withdrawal by Subject|1
2910811|NCT01653262|10023541|P1|Overall Study|AE, non-serious non-fatal|1
2910812|NCT01653262|10023541|P1|Overall Study|SAE, non-fatal|1
2910813|NCT01653262|10023541|P1|Overall Study|Lack of Efficacy|1
2910814|NCT01653158|10023559|P8|Overall Study|Withdrawal by Subject|0
2910815|NCT01653158|10023560|P7|Overall Study|Withdrawal by Subject|0
2910816|NCT01653158|10023561|P6|Overall Study|Withdrawal by Subject|0
2910817|NCT01653158|10023562|P5|Overall Study|Withdrawal by Subject|0
2910818|NCT01653158|10023563|P4|Overall Study|Withdrawal by Subject|0
2910819|NCT01653158|10023564|P3|Overall Study|Withdrawal by Subject|0
2910820|NCT01653158|10023565|P2|Overall Study|Withdrawal by Subject|0
2910821|NCT01653158|10023566|P1|Overall Study|Withdrawal by Subject|1
2910822|NCT01653158|10023559|P8|Overall Study|Progressive disease|9
2910823|NCT01653158|10023560|P7|Overall Study|Progressive disease|2
2910824|NCT01653158|10023561|P6|Overall Study|Progressive disease|1
2910825|NCT01653158|10023562|P5|Overall Study|Progressive disease|1
2910826|NCT01653158|10023563|P4|Overall Study|Progressive disease|0
2910827|NCT01653158|10023564|P3|Overall Study|Progressive disease|0
2910828|NCT01653158|10023565|P2|Overall Study|Progressive disease|0
2910829|NCT01653158|10023566|P1|Overall Study|Progressive disease|0
2910830|NCT01653158|10023559|P8|Overall Study|Other|1
2910831|NCT01653158|10023560|P7|Overall Study|Other|0
2910832|NCT01653158|10023561|P6|Overall Study|Other|0
2910833|NCT01653158|10023562|P5|Overall Study|Other|0
2910834|NCT01653158|10023563|P4|Overall Study|Other|0
2910835|NCT01653158|10023564|P3|Overall Study|Other|0
2910836|NCT01653158|10023565|P2|Overall Study|Other|0
2910837|NCT01653158|10023566|P1|Overall Study|Other|0
2910838|NCT01653158|10023559|P8|Overall Study|Adverse Event|3
2910839|NCT01653158|10023560|P7|Overall Study|Adverse Event|0
2910840|NCT01653158|10023561|P6|Overall Study|Adverse Event|0
2910841|NCT01653158|10023562|P5|Overall Study|Adverse Event|0
2910842|NCT01653158|10023563|P4|Overall Study|Adverse Event|1
2910843|NCT01653158|10023564|P3|Overall Study|Adverse Event|0
2910844|NCT01653158|10023565|P2|Overall Study|Adverse Event|0
2910845|NCT01653158|10023566|P1|Overall Study|Adverse Event|0
2910846|NCT01653158|10023559|P8|Overall Study|Death|2
2910847|NCT01653158|10023560|P7|Overall Study|Death|0
2910848|NCT01653158|10023561|P6|Overall Study|Death|0
2910849|NCT01653158|10023562|P5|Overall Study|Death|0
2910850|NCT01653158|10023563|P4|Overall Study|Death|1
2910851|NCT01653158|10023564|P3|Overall Study|Death|0
2910852|NCT01653158|10023565|P2|Overall Study|Death|0
2910853|NCT01653158|10023566|P1|Overall Study|Death|0
2910854|NCT01653132|10023838|P2|First Intervention|Protocol Violation|0
2910855|NCT01653132|10023839|P1|First Intervention|Protocol Violation|1
2910856|NCT01652885|10023903|P1|Overall Study|Adverse Event|1
2910857|NCT01652872|10023930|P2|Overall Study|Withdrawal by Subject|84
2910858|NCT01652872|10023931|P1|Overall Study|Withdrawal by Subject|76
2910859|NCT01652872|10023930|P2|Overall Study|Decision by sponsor|7
2910860|NCT01652872|10023931|P1|Overall Study|Decision by sponsor|5
2910861|NCT01652872|10023930|P2|Overall Study|Lost to Follow-up|23
2910862|NCT01652872|10023931|P1|Overall Study|Lost to Follow-up|28
2910863|NCT01652872|10023930|P2|Overall Study|Death|39
2910864|NCT01652872|10023931|P1|Overall Study|Death|36
2910865|NCT01652729|10023948|P3|Overall Study|Administrative|0
2910866|NCT01652729|10023949|P2|Overall Study|Administrative|0
2910867|NCT01652729|10023950|P1|Overall Study|Administrative|1
2910868|NCT01652729|10023948|P3|Overall Study|Lost to Follow-up|3
2910869|NCT01652729|10023949|P2|Overall Study|Lost to Follow-up|6
2910870|NCT01652729|10023950|P1|Overall Study|Lost to Follow-up|6
2910871|NCT01652729|10023948|P3|Overall Study|Protocol Violation|0
2910872|NCT01652729|10023949|P2|Overall Study|Protocol Violation|0
2910873|NCT01652729|10023950|P1|Overall Study|Protocol Violation|1
2910874|NCT01652729|10023948|P3|Overall Study|Physician Decision|1
2910875|NCT01652729|10023949|P2|Overall Study|Physician Decision|0
2910876|NCT01652729|10023950|P1|Overall Study|Physician Decision|1
2910877|NCT01652729|10023948|P3|Overall Study|Adverse Event|3
2910878|NCT01652729|10023949|P2|Overall Study|Adverse Event|0
2910879|NCT01652729|10023950|P1|Overall Study|Adverse Event|4
2910880|NCT01652729|10023948|P3|Overall Study|Withdrawal by Subject|7
2910881|NCT01652729|10023949|P2|Overall Study|Withdrawal by Subject|7
2910882|NCT01652729|10023950|P1|Overall Study|Withdrawal by Subject|14
2910883|NCT01652716|10023972|P2|Overall Study|Withdrawal by Subject|18
2910884|NCT01652716|10023973|P1|Overall Study|Withdrawal by Subject|33
2910885|NCT01652716|10023972|P2|Overall Study|Adverse Event|10
2910886|NCT01652716|10023973|P1|Overall Study|Adverse Event|7
2910887|NCT01652716|10023972|P2|Overall Study|Protocol Violation|1
2910888|NCT01652716|10023973|P1|Overall Study|Protocol Violation|2
2910889|NCT01652716|10023972|P2|Overall Study|Lost to Follow-up|11
2910890|NCT01652716|10023973|P1|Overall Study|Lost to Follow-up|12
2910891|NCT01652716|10023972|P2|Overall Study|Investigator decision|4
2910892|NCT01652716|10023973|P1|Overall Study|Investigator decision|1
2910893|NCT01652716|10023972|P2|Overall Study|Administrative|2
2910894|NCT01652716|10023973|P1|Overall Study|Administrative|0
2910895|NCT01652716|10023972|P2|Overall Study|Loss of glucose control|0
2910896|NCT01652716|10023973|P1|Overall Study|Loss of glucose control|1
2910897|NCT01652703|10023993|P6|Overall Study|Other|1
2910898|NCT01652703|10023994|P5|Overall Study|Other|1
2910899|NCT01652703|10023995|P4|Overall Study|Other|1
2910900|NCT01652703|10023996|P3|Overall Study|Other|0
2910901|NCT01652703|10023997|P2|Overall Study|Other|0
2910902|NCT01652703|10023998|P1|Overall Study|Other|0
2910903|NCT01652703|10023993|P6|Overall Study|Withdrawal by Subject|1
2910904|NCT01652703|10023994|P5|Overall Study|Withdrawal by Subject|0
2910905|NCT01652703|10023995|P4|Overall Study|Withdrawal by Subject|1
2910906|NCT01652703|10023996|P3|Overall Study|Withdrawal by Subject|3
2910907|NCT01652703|10023997|P2|Overall Study|Withdrawal by Subject|1
2910908|NCT01652703|10023998|P1|Overall Study|Withdrawal by Subject|0
2910909|NCT01652690|10024056|P2|Overall Study|Death|2
2910910|NCT01652690|10024057|P1|Overall Study|Death|5
2910911|NCT01652690|10024056|P2|Overall Study|Lost to Follow-up|6
2910912|NCT01652690|10024057|P1|Overall Study|Lost to Follow-up|6
2910913|NCT01652690|10024056|P2|Overall Study|Other|9
2910914|NCT01652690|10024057|P1|Overall Study|Other|8
2910915|NCT01652690|10024056|P2|Overall Study|Withdrawal by Subject|4
2910916|NCT01652690|10024057|P1|Overall Study|Withdrawal by Subject|16
2910917|NCT01652664|10024091|P2|Overall Study|Inadequate IOP control|0
2910918|NCT01652664|10024092|P1|Overall Study|Inadequate IOP control|1
2910919|NCT01652664|10024091|P2|Overall Study|Treatment Failure|1
2910920|NCT01652664|10024092|P1|Overall Study|Treatment Failure|5
2910921|NCT01652573|10024101|P2|Overall Study|Adverse Event|1
2910922|NCT01652573|10024102|P1|Overall Study|Adverse Event|0
2910923|NCT01652534|10024144|P2|Overall Study|Lack of Efficacy|0
2910924|NCT01652534|10024145|P1|Overall Study|Lack of Efficacy|1
2910925|NCT01652469|10024186|P2|Overall Study|Lost to Follow-up|2
2910926|NCT01652469|10024187|P1|Overall Study|Lost to Follow-up|0
2910927|NCT01652469|10024186|P2|Overall Study|Withdrawal by Subject|4
2910928|NCT01652469|10024187|P1|Overall Study|Withdrawal by Subject|1
2910929|NCT01652287|10024203|P2|Overall Study|Withdrawal by Subject|0
2910930|NCT01652287|10024204|P1|Overall Study|Withdrawal by Subject|2
2910931|NCT01651949|10024235|P3|Overall Study|Withdrawal by Subject|9
2910932|NCT01651949|10024236|P2|Overall Study|Withdrawal by Subject|18
2910933|NCT01651949|10024237|P1|Overall Study|Withdrawal by Subject|17
2910934|NCT01651949|10024235|P3|Overall Study|Screen failure|0
2910935|NCT01651949|10024236|P2|Overall Study|Screen failure|2
2910936|NCT01651949|10024237|P1|Overall Study|Screen failure|2
2910937|NCT01651949|10024235|P3|Overall Study|Adverse Event|1
2910938|NCT01651949|10024236|P2|Overall Study|Adverse Event|2
2910939|NCT01651949|10024237|P1|Overall Study|Adverse Event|0
2910940|NCT01651949|10024235|P3|Overall Study|Physician Decision|0
2910941|NCT01651949|10024236|P2|Overall Study|Physician Decision|2
2910942|NCT01651949|10024237|P1|Overall Study|Physician Decision|0
2910943|NCT01651949|10024235|P3|Overall Study|Protocol Violation|1
2910944|NCT01651949|10024236|P2|Overall Study|Protocol Violation|2
2910945|NCT01651949|10024237|P1|Overall Study|Protocol Violation|0
2910946|NCT01651949|10024235|P3|Overall Study|Lost to Follow-up|20
2910947|NCT01651949|10024236|P2|Overall Study|Lost to Follow-up|56
2910948|NCT01651949|10024237|P1|Overall Study|Lost to Follow-up|30
2910949|NCT01651949|10024235|P3|Overall Study|Unknown status|0
2910950|NCT01651949|10024236|P2|Overall Study|Unknown status|4
2910951|NCT01651949|10024237|P1|Overall Study|Unknown status|4
2910952|NCT01651936|10024257|P3|Extension Study|Study terminated by sponsor|13
2910953|NCT01651936|10024258|P2|Extension Study|Study terminated by sponsor|0
2910954|NCT01651936|10024259|P1|Extension Study|Study terminated by sponsor|0
2910955|NCT01651936|10024257|P3|Extension Study|Lack of Efficacy|1
2910956|NCT01651936|10024258|P2|Extension Study|Lack of Efficacy|0
2910957|NCT01651936|10024259|P1|Extension Study|Lack of Efficacy|0
2910958|NCT01651936|10024257|P3|Base Study|Study terminated by sponsor|0
2910959|NCT01651936|10024258|P2|Base Study|Study terminated by sponsor|16
2910960|NCT01651936|10024259|P1|Base Study|Study terminated by sponsor|21
2910961|NCT01651936|10024257|P3|Base Study|Early Escape|0
2910962|NCT01651936|10024258|P2|Base Study|Early Escape|8
2910963|NCT01651936|10024259|P1|Base Study|Early Escape|2
2910964|NCT01651936|10024257|P3|Base Study|Withdrawal by Subject|0
2910965|NCT01651936|10024258|P2|Base Study|Withdrawal by Subject|1
2910966|NCT01651936|10024259|P1|Base Study|Withdrawal by Subject|1
2910967|NCT01651936|10024257|P3|Base Study|Adverse Event|0
2910968|NCT01651936|10024258|P2|Base Study|Adverse Event|0
2910969|NCT01651936|10024259|P1|Base Study|Adverse Event|3
2910970|NCT01651780|10024329|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
2910971|NCT01651780|10024330|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
2910972|NCT01651780|10024329|P2|Overall Study|Lost to Follow-up|2
2910973|NCT01651780|10024330|P1|Overall Study|Lost to Follow-up|1
2910974|NCT01651780|10024329|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2910975|NCT01651780|10024330|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2910976|NCT01651780|10024329|P2|Overall Study|Withdrawal by Subject|0
2910977|NCT01651780|10024330|P1|Overall Study|Withdrawal by Subject|2
2910978|NCT01651780|10024329|P2|Overall Study|Reason Not Specified: No 30-day visit|2
2910979|NCT01651780|10024330|P1|Overall Study|Reason Not Specified: No 30-day visit|2
2910980|NCT01651780|10024329|P2|Overall Study|Physician decision: No 30-day visit|1
2910981|NCT01651780|10024330|P1|Overall Study|Physician decision: No 30-day visit|2
2910982|NCT01651403|10024381|P2|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|2
2910983|NCT01651403|10024382|P1|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|0
2910984|NCT01651403|10024381|P2|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|0
2910985|NCT01651403|10024382|P1|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|1
2910986|NCT01651403|10024381|P2|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|20
2910987|NCT01651403|10024382|P1|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|46
2910988|NCT01651403|10024381|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
2910989|NCT01651403|10024382|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
2910990|NCT01651403|10024381|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
2910991|NCT01651403|10024382|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
2910992|NCT01651403|10024381|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
2910993|NCT01651403|10024382|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
2910994|NCT01651260|10024430|P1|Overall Study|unable to apply product|3
2910995|NCT01651208|10024437|P2|Overall Study|Lost to Follow-up|16
2910996|NCT01651208|10024438|P1|Overall Study|Lost to Follow-up|14
2910997|NCT01651117|10024450|P4|Overall Study|Death|2
2910998|NCT01651117|10024451|P3|Overall Study|Death|2
2910999|NCT01651117|10024452|P2|Overall Study|Death|3
2911000|NCT01651117|10024453|P1|Overall Study|Death|2
2911001|NCT01651052|10024533|P1|Overall Study|Lost to Follow-up|3
2911002|NCT01651052|10024533|P1|Overall Study|Withdrawal by Subject|1
2911003|NCT01651052|10024533|P1|Overall Study|Explant|1
2911004|NCT01651052|10024533|P1|Overall Study|Death|21
2911005|NCT01651039|10024553|P1|Overall Study|Progressive Disease|22
2911006|NCT01651039|10024553|P1|Overall Study|Withdrawal by Subject|1
2911007|NCT01651039|10024553|P1|Overall Study|Physician Decision|2
2911008|NCT01651039|10024553|P1|Overall Study|Non-evaluables|5
2911009|NCT01651000|10024566|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
2911010|NCT01651000|10024567|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
2911011|NCT01651000|10024566|P2|Overall Study|Administrative reason|0
2911012|NCT01651000|10024567|P1|Overall Study|Administrative reason|1
2911013|NCT01651000|10024566|P2|Overall Study|Physician Decision|0
2911014|NCT01651000|10024567|P1|Overall Study|Physician Decision|1
2911015|NCT01651000|10024566|P2|Overall Study|Lack of Efficacy|1
2911016|NCT01651000|10024567|P1|Overall Study|Lack of Efficacy|1
2911017|NCT01651000|10024566|P2|Overall Study|Subject noncompliance|3
2911018|NCT01651000|10024567|P1|Overall Study|Subject noncompliance|0
2911019|NCT01651000|10024566|P2|Overall Study|Withdrawal by Subject|10
2911020|NCT01651000|10024567|P1|Overall Study|Withdrawal by Subject|2
2911021|NCT01651000|10024566|P2|Overall Study|Protocol Violation|3
2911022|NCT01651000|10024567|P1|Overall Study|Protocol Violation|0
2911023|NCT01651000|10024566|P2|Overall Study|Lost to Follow-up|2
2911024|NCT01651000|10024567|P1|Overall Study|Lost to Follow-up|3
2911025|NCT01651000|10024566|P2|Overall Study|Adverse Event|8
2911026|NCT01651000|10024567|P1|Overall Study|Adverse Event|2
2911027|NCT01650831|10024588|P1|Overall Study|Screen failure|1
2911028|NCT01650805|10024598|P2|Overall Study|Withdrawal by Subject|0
2911029|NCT01650805|10024599|P1|Overall Study|Withdrawal by Subject|1
2911030|NCT01650779|10024609|P1|Overall Study|Withdrawal by Subject|1
2911031|NCT01650636|10024618|P2|Washout up to 9 Months|Lost to Follow-up|1
2911032|NCT01650636|10024619|P1|Washout up to 9 Months|Lost to Follow-up|2
2911033|NCT01650636|10024618|P2|Washout up to 9 Months|Withdrawal by Subject|2
2911034|NCT01650636|10024619|P1|Washout up to 9 Months|Withdrawal by Subject|4
2911035|NCT01650636|10024618|P2|Washout up to 5 Months|Lost to Follow-up|8
2911036|NCT01650636|10024619|P1|Washout up to 5 Months|Lost to Follow-up|2
2911037|NCT01650636|10024618|P2|Washout up to 5 Months|Death|0
2911038|NCT01650636|10024619|P1|Washout up to 5 Months|Death|1
2911039|NCT01650636|10024618|P2|Washout up to 5 Months|Physician Decision|2
2911040|NCT01650636|10024619|P1|Washout up to 5 Months|Physician Decision|2
2911041|NCT01650636|10024618|P2|Washout up to 5 Months|Withdrawal by Subject|8
2911042|NCT01650636|10024619|P1|Washout up to 5 Months|Withdrawal by Subject|4
2911043|NCT01650519|10024652|P2|Overall Study|Withdrawal by Subject|0
2911044|NCT01650519|10024653|P1|Overall Study|Withdrawal by Subject|1
2911045|NCT01650285|10024715|P1|Overall Study|Adverse Event|1
2911046|NCT01650259|10024722|P2|Overall Study|Other than listed|146
2911047|NCT01650259|10024723|P1|Overall Study|Other than listed|64
2911048|NCT01650259|10024722|P2|Overall Study|Not treated|7
2911049|NCT01650259|10024723|P1|Overall Study|Not treated|1
2911050|NCT01650259|10024722|P2|Overall Study|CRF not collected|82
2911051|NCT01650259|10024723|P1|Overall Study|CRF not collected|98
2911052|NCT01650259|10024722|P2|Overall Study|Patients had no visit after entry|0
2911053|NCT01650259|10024723|P1|Overall Study|Patients had no visit after entry|70
2911054|NCT01650259|10024722|P2|Overall Study|Lost to Follow-up|0
2911055|NCT01650259|10024723|P1|Overall Study|Lost to Follow-up|435
2911056|NCT01650259|10024722|P2|Overall Study|Lack of Efficacy|0
2911057|NCT01650259|10024723|P1|Overall Study|Lack of Efficacy|143
2911058|NCT01650259|10024722|P2|Overall Study|Adverse Event|0
2911059|NCT01650259|10024723|P1|Overall Study|Adverse Event|127
2911060|NCT01650259|10024722|P2|Overall Study|Improvement|0
2911061|NCT01650259|10024723|P1|Overall Study|Improvement|105
2911062|NCT01650246|10024728|P1|Overall Study|Lack of Efficacy|30
2911063|NCT01650246|10024728|P1|Overall Study|Death|1
2911064|NCT01650246|10024728|P1|Overall Study|Withdrawal by Subject|26
2911065|NCT01650246|10024728|P1|Overall Study|Lost to Follow-up|5
2911066|NCT01650246|10024728|P1|Overall Study|Sponsor terminated study|53
2911067|NCT01650246|10024728|P1|Overall Study|Protocol Violation|5
2911068|NCT01650246|10024728|P1|Overall Study|Adverse Event|23
2911069|NCT01650194|10024733|P1|Overall Study|Miscellaneous|10
2911070|NCT01650194|10024733|P1|Overall Study|Withdrawal by Subject|2
2911071|NCT01650194|10024733|P1|Overall Study|Progressive Disease (PD)|35
2911072|NCT01649856|10024769|P2|Overall Study|Other|5
2911073|NCT01649856|10024770|P1|Overall Study|Other|20
2911074|NCT01649856|10024769|P2|Overall Study|Lack of Compliance|1
2911075|NCT01649856|10024770|P1|Overall Study|Lack of Compliance|6
2911076|NCT01649856|10024769|P2|Overall Study|Lost to Follow-up|16
2911077|NCT01649856|10024770|P1|Overall Study|Lost to Follow-up|20
2911078|NCT01649856|10024769|P2|Overall Study|Stable or Progressed Disease|3
2911079|NCT01649856|10024770|P1|Overall Study|Stable or Progressed Disease|5
2911080|NCT01649856|10024769|P2|Overall Study|Death|34
2911081|NCT01649856|10024770|P1|Overall Study|Death|69
2911082|NCT01649856|10024769|P2|Overall Study|Treatment Failure|1
2911083|NCT01649856|10024770|P1|Overall Study|Treatment Failure|1
2911084|NCT01649856|10024769|P2|Overall Study|Protocol Violation|4
2911085|NCT01649856|10024770|P1|Overall Study|Protocol Violation|4
2911086|NCT01649856|10024769|P2|Overall Study|Withdrawal by Subject|14
2911087|NCT01649856|10024770|P1|Overall Study|Withdrawal by Subject|14
2911088|NCT01649804|10024802|P1|Overall Study|Administrative/Other|8
2911089|NCT01649791|10024814|P1|Overall Study|Adverse Event|1
2911090|NCT01649791|10024814|P1|Overall Study|Disease Progression|2
2911091|NCT01649765|10024823|P2|Overall Study|Withdrawal by Subject|1
2911092|NCT01649765|10024824|P1|Overall Study|Withdrawal by Subject|2
2911093|NCT01649765|10024823|P2|Overall Study|Protocol Violation|0
2911094|NCT01649765|10024824|P1|Overall Study|Protocol Violation|1
2911095|NCT01649765|10024823|P2|Overall Study|Physician Decision|3
2911096|NCT01649765|10024824|P1|Overall Study|Physician Decision|0
2911097|NCT01649765|10024823|P2|Overall Study|Lack of Efficacy|1
2911098|NCT01649765|10024824|P1|Overall Study|Lack of Efficacy|1
2911099|NCT01649765|10024823|P2|Overall Study|Adverse Event|3
2911100|NCT01649765|10024824|P1|Overall Study|Adverse Event|5
2911101|NCT01649557|10024875|P3|Overall Study|Lack of Efficacy|0
2911102|NCT01649557|10024876|P2|Overall Study|Lack of Efficacy|0
2911103|NCT01649557|10024877|P1|Overall Study|Lack of Efficacy|5
2911104|NCT01649557|10024875|P3|Overall Study|Protocol deviation|0
2911105|NCT01649557|10024876|P2|Overall Study|Protocol deviation|2
2911106|NCT01649557|10024877|P1|Overall Study|Protocol deviation|0
2911107|NCT01649557|10024875|P3|Overall Study|Withdrawal by Subject|4
2911108|NCT01649557|10024876|P2|Overall Study|Withdrawal by Subject|5
2911109|NCT01649557|10024877|P1|Overall Study|Withdrawal by Subject|15
2911110|NCT01649557|10024875|P3|Overall Study|Physician Decision|1
2911111|NCT01649557|10024876|P2|Overall Study|Physician Decision|2
2911112|NCT01649557|10024877|P1|Overall Study|Physician Decision|8
2911113|NCT01649557|10024875|P3|Overall Study|Met withdrawal criteria|0
2911114|NCT01649557|10024876|P2|Overall Study|Met withdrawal criteria|0
2911115|NCT01649557|10024877|P1|Overall Study|Met withdrawal criteria|4
2911116|NCT01649557|10024875|P3|Overall Study|Adverse Event|1
2911117|NCT01649557|10024876|P2|Overall Study|Adverse Event|5
2911118|NCT01649557|10024877|P1|Overall Study|Adverse Event|7
2911119|NCT01649557|10024875|P3|Overall Study|Lost to Follow-up|3
2911120|NCT01649557|10024876|P2|Overall Study|Lost to Follow-up|0
2911121|NCT01649557|10024877|P1|Overall Study|Lost to Follow-up|5
2911122|NCT01649427|10024923|P2|Overall Study|Surgical problems during nephrectomy|2
2911123|NCT01649427|10024924|P1|Overall Study|Surgical problems during nephrectomy|2
2911124|NCT01649427|10024923|P2|Overall Study|Graft loss|1
2911125|NCT01649427|10024924|P1|Overall Study|Graft loss|0
2911126|NCT01649427|10024923|P2|Overall Study|Lost to Follow-up|1
2911127|NCT01649427|10024924|P1|Overall Study|Lost to Follow-up|0
2911128|NCT01649427|10024923|P2|Overall Study|Withdrawal by Subject|7
2911129|NCT01649427|10024924|P1|Overall Study|Withdrawal by Subject|8
2911130|NCT01649427|10024923|P2|Overall Study|Adverse Event|1
2911131|NCT01649427|10024924|P1|Overall Study|Adverse Event|1
2911132|NCT01649375|10024943|P5|Week 16 up to Week 260|Adverse Event|2
2911133|NCT01649375|10024944|P4|Week 16 up to Week 260|Adverse Event|3
2911134|NCT01649375|10024945|P3|Week 16 up to Week 260|Adverse Event|0
2911135|NCT01649375|10024946|P2|Week 16 up to Week 260|Adverse Event|2
2911136|NCT01649375|10024947|P1|Week 16 up to Week 260|Adverse Event|5
2911137|NCT01649375|10024943|P5|Week 16 up to Week 260|Death|0
2911138|NCT01649375|10024944|P4|Week 16 up to Week 260|Death|0
2911139|NCT01649375|10024945|P3|Week 16 up to Week 260|Death|0
2911140|NCT01649375|10024946|P2|Week 16 up to Week 260|Death|1
2911141|NCT01649375|10024947|P1|Week 16 up to Week 260|Death|1
2911142|NCT01649375|10024943|P5|Week 16 up to Week 260|Withdrawal by Subject|1
2911143|NCT01649375|10024944|P4|Week 16 up to Week 260|Withdrawal by Subject|3
2911144|NCT01649375|10024945|P3|Week 16 up to Week 260|Withdrawal by Subject|0
2911145|NCT01649375|10024946|P2|Week 16 up to Week 260|Withdrawal by Subject|2
2911146|NCT01649375|10024947|P1|Week 16 up to Week 260|Withdrawal by Subject|7
2911147|NCT01649375|10024943|P5|Week 16 up to Week 260|Technical issues|0
2911148|NCT01649375|10024944|P4|Week 16 up to Week 260|Technical issues|1
2911149|NCT01649375|10024945|P3|Week 16 up to Week 260|Technical issues|0
2911150|NCT01649375|10024946|P2|Week 16 up to Week 260|Technical issues|1
2911151|NCT01649375|10024947|P1|Week 16 up to Week 260|Technical issues|0
2911152|NCT01649375|10024943|P5|Week 16 up to Week 260|Physician Decision|0
2911153|NCT01649375|10024944|P4|Week 16 up to Week 260|Physician Decision|0
2911154|NCT01649375|10024945|P3|Week 16 up to Week 260|Physician Decision|0
2911155|NCT01649375|10024946|P2|Week 16 up to Week 260|Physician Decision|2
2911156|NCT01649375|10024947|P1|Week 16 up to Week 260|Physician Decision|0
2911157|NCT01649375|10024943|P5|Week 16 up to Week 260|Non-compliance|0
2911158|NCT01649375|10024944|P4|Week 16 up to Week 260|Non-compliance|1
2911159|NCT01649375|10024945|P3|Week 16 up to Week 260|Non-compliance|0
2911160|NCT01649375|10024946|P2|Week 16 up to Week 260|Non-compliance|1
2911161|NCT01649375|10024947|P1|Week 16 up to Week 260|Non-compliance|0
2911162|NCT01649375|10024943|P5|Week 16 up to Week 260|Lack of Efficacy|2
2911163|NCT01649375|10024944|P4|Week 16 up to Week 260|Lack of Efficacy|4
2911164|NCT01649375|10024945|P3|Week 16 up to Week 260|Lack of Efficacy|0
2911165|NCT01649375|10024946|P2|Week 16 up to Week 260|Lack of Efficacy|4
2911166|NCT01649375|10024947|P1|Week 16 up to Week 260|Lack of Efficacy|7
2911167|NCT01649375|10024943|P5|Up to Week 16|Death|0
2911168|NCT01649375|10024944|P4|Up to Week 16|Death|0
2911169|NCT01649375|10024945|P3|Up to Week 16|Death|0
2911170|NCT01649375|10024946|P2|Up to Week 16|Death|0
2911171|NCT01649375|10024947|P1|Up to Week 16|Death|1
2911172|NCT01649375|10024943|P5|Up to Week 16|Withdrawal by Subject|0
2911173|NCT01649375|10024944|P4|Up to Week 16|Withdrawal by Subject|0
2911174|NCT01649375|10024945|P3|Up to Week 16|Withdrawal by Subject|2
2911175|NCT01649375|10024946|P2|Up to Week 16|Withdrawal by Subject|1
2911176|NCT01649375|10024947|P1|Up to Week 16|Withdrawal by Subject|2
2911177|NCT01649375|10024943|P5|Up to Week 16|Physician Decision|0
2911178|NCT01649375|10024944|P4|Up to Week 16|Physician Decision|0
2911179|NCT01649375|10024945|P3|Up to Week 16|Physician Decision|1
2911180|NCT01649375|10024946|P2|Up to Week 16|Physician Decision|0
2911181|NCT01649375|10024947|P1|Up to Week 16|Physician Decision|0
2911182|NCT01649375|10024943|P5|Up to Week 16|Lack of Efficacy|0
2911183|NCT01649375|10024944|P4|Up to Week 16|Lack of Efficacy|0
2911184|NCT01649375|10024945|P3|Up to Week 16|Lack of Efficacy|1
2911185|NCT01649375|10024946|P2|Up to Week 16|Lack of Efficacy|0
2911186|NCT01649375|10024947|P1|Up to Week 16|Lack of Efficacy|0
2911187|NCT01649375|10024943|P5|Up to Week 16|Adverse Event|0
2911188|NCT01649375|10024944|P4|Up to Week 16|Adverse Event|0
2911189|NCT01649375|10024945|P3|Up to Week 16|Adverse Event|4
2911190|NCT01649375|10024946|P2|Up to Week 16|Adverse Event|5
2911191|NCT01649375|10024947|P1|Up to Week 16|Adverse Event|2
2911192|NCT01649297|10024994|P5|Overall Study|For other reason|0
2911193|NCT01649297|10024995|P4|Overall Study|For other reason|0
2911194|NCT01649297|10024996|P3|Overall Study|For other reason|2
2911195|NCT01649297|10024997|P2|Overall Study|For other reason|1
2911196|NCT01649297|10024998|P1|Overall Study|For other reason|4
2911197|NCT01649297|10024994|P5|Overall Study|Patient withdrawal (not due to AE)|1
2911198|NCT01649297|10024995|P4|Overall Study|Patient withdrawal (not due to AE)|1
2911199|NCT01649297|10024996|P3|Overall Study|Patient withdrawal (not due to AE)|4
2911200|NCT01649297|10024997|P2|Overall Study|Patient withdrawal (not due to AE)|6
2911201|NCT01649297|10024998|P1|Overall Study|Patient withdrawal (not due to AE)|3
2911202|NCT01649297|10024994|P5|Overall Study|Lost to Follow-up|0
2911203|NCT01649297|10024995|P4|Overall Study|Lost to Follow-up|3
2911204|NCT01649297|10024996|P3|Overall Study|Lost to Follow-up|4
2911205|NCT01649297|10024997|P2|Overall Study|Lost to Follow-up|1
2911206|NCT01649297|10024998|P1|Overall Study|Lost to Follow-up|1
2911207|NCT01649297|10024994|P5|Overall Study|Non compliant with Protocol|1
2911208|NCT01649297|10024995|P4|Overall Study|Non compliant with Protocol|2
2911209|NCT01649297|10024996|P3|Overall Study|Non compliant with Protocol|3
2911210|NCT01649297|10024997|P2|Overall Study|Non compliant with Protocol|0
2911211|NCT01649297|10024998|P1|Overall Study|Non compliant with Protocol|1
2911212|NCT01649297|10024994|P5|Overall Study|Lack of Efficacy|1
2911213|NCT01649297|10024995|P4|Overall Study|Lack of Efficacy|0
2911214|NCT01649297|10024996|P3|Overall Study|Lack of Efficacy|0
2911215|NCT01649297|10024997|P2|Overall Study|Lack of Efficacy|0
2911216|NCT01649297|10024998|P1|Overall Study|Lack of Efficacy|0
2911217|NCT01649297|10024994|P5|Overall Study|Adverse Event|1
2911218|NCT01649297|10024995|P4|Overall Study|Adverse Event|13
2911219|NCT01649297|10024996|P3|Overall Study|Adverse Event|4
2911220|NCT01649297|10024997|P2|Overall Study|Adverse Event|5
2911221|NCT01649297|10024998|P1|Overall Study|Adverse Event|5
2911222|NCT01649271|10025017|P2|Overall Study|Other than stated above|0
2911223|NCT01649271|10025018|P1|Overall Study|Other than stated above|1
2911224|NCT01649271|10025017|P2|Overall Study|Withdrawal by Subject|0
2911225|NCT01649271|10025018|P1|Overall Study|Withdrawal by Subject|1
2911226|NCT01649271|10025017|P2|Overall Study|Other Adverse Event|2
2911227|NCT01649271|10025018|P1|Overall Study|Other Adverse Event|0
2911228|NCT01649271|10025017|P2|Overall Study|Progressive disease|5
2911229|NCT01649271|10025018|P1|Overall Study|Progressive disease|4
2911230|NCT01649232|10025033|P2|Overall Study|Physician Decision|0
2911231|NCT01649232|10025034|P1|Overall Study|Physician Decision|2
2911232|NCT01648790|10025086|P5|Treatment 3|Withdrawal by Subject|0
2911233|NCT01648790|10025087|P4|Treatment 3|Withdrawal by Subject|1
2911234|NCT01648790|10025088|P3|Treatment 3|Withdrawal by Subject|0
2911235|NCT01648790|10025089|P2|Treatment 3|Withdrawal by Subject|0
2911236|NCT01648790|10025090|P1|Treatment 3|Withdrawal by Subject|0
2911237|NCT01648764|10025125|P14|Overall Study|Investigator Decision|0
2911238|NCT01648764|10025126|P13|Overall Study|Investigator Decision|0
2911239|NCT01648764|10025127|P12|Overall Study|Investigator Decision|1
2911240|NCT01648764|10025128|P11|Overall Study|Investigator Decision|0
2911241|NCT01648764|10025129|P10|Overall Study|Investigator Decision|0
2911242|NCT01648764|10025130|P9|Overall Study|Investigator Decision|0
2911243|NCT01648764|10025131|P8|Overall Study|Investigator Decision|0
2911244|NCT01648764|10025132|P7|Overall Study|Investigator Decision|1
2911245|NCT01648764|10025133|P6|Overall Study|Investigator Decision|0
2911246|NCT01648764|10025134|P5|Overall Study|Investigator Decision|0
2911247|NCT01648764|10025135|P4|Overall Study|Investigator Decision|0
2911248|NCT01648764|10025136|P3|Overall Study|Investigator Decision|0
2911249|NCT01648764|10025137|P2|Overall Study|Investigator Decision|0
2911250|NCT01648764|10025138|P1|Overall Study|Investigator Decision|0
2911251|NCT01648764|10025125|P14|Overall Study|Withdrawal by Subject|0
2911252|NCT01648764|10025126|P13|Overall Study|Withdrawal by Subject|1
2911253|NCT01648764|10025127|P12|Overall Study|Withdrawal by Subject|0
2911254|NCT01648764|10025128|P11|Overall Study|Withdrawal by Subject|0
2911255|NCT01648764|10025129|P10|Overall Study|Withdrawal by Subject|0
2911256|NCT01648764|10025130|P9|Overall Study|Withdrawal by Subject|0
2911257|NCT01648764|10025131|P8|Overall Study|Withdrawal by Subject|0
2911258|NCT01648764|10025132|P7|Overall Study|Withdrawal by Subject|2
2911259|NCT01648764|10025133|P6|Overall Study|Withdrawal by Subject|0
2911260|NCT01648764|10025134|P5|Overall Study|Withdrawal by Subject|0
2911261|NCT01648764|10025135|P4|Overall Study|Withdrawal by Subject|0
2911262|NCT01648764|10025136|P3|Overall Study|Withdrawal by Subject|0
2911263|NCT01648764|10025137|P2|Overall Study|Withdrawal by Subject|0
2911264|NCT01648764|10025138|P1|Overall Study|Withdrawal by Subject|0
2911265|NCT01648764|10025125|P14|Overall Study|Death|1
2911266|NCT01648764|10025126|P13|Overall Study|Death|0
2911267|NCT01648764|10025127|P12|Overall Study|Death|0
2911268|NCT01648764|10025128|P11|Overall Study|Death|0
2911269|NCT01648764|10025129|P10|Overall Study|Death|0
2911270|NCT01648764|10025130|P9|Overall Study|Death|0
2911271|NCT01648764|10025131|P8|Overall Study|Death|0
2911272|NCT01648764|10025132|P7|Overall Study|Death|1
2911273|NCT01648764|10025133|P6|Overall Study|Death|0
2911274|NCT01648764|10025134|P5|Overall Study|Death|0
2911275|NCT01648764|10025135|P4|Overall Study|Death|0
2911276|NCT01648764|10025136|P3|Overall Study|Death|0
2911277|NCT01648764|10025137|P2|Overall Study|Death|0
2911278|NCT01648764|10025138|P1|Overall Study|Death|0
2911279|NCT01648764|10025125|P14|Overall Study|Adverse Event|1
2911280|NCT01648764|10025126|P13|Overall Study|Adverse Event|1
2911281|NCT01648764|10025127|P12|Overall Study|Adverse Event|3
2911282|NCT01648764|10025128|P11|Overall Study|Adverse Event|0
2911283|NCT01648764|10025129|P10|Overall Study|Adverse Event|1
2911284|NCT01648764|10025130|P9|Overall Study|Adverse Event|0
2911285|NCT01648764|10025131|P8|Overall Study|Adverse Event|0
2911286|NCT01648764|10025132|P7|Overall Study|Adverse Event|0
2911287|NCT01648764|10025133|P6|Overall Study|Adverse Event|1
2911288|NCT01648764|10025134|P5|Overall Study|Adverse Event|0
2911289|NCT01648764|10025135|P4|Overall Study|Adverse Event|0
2911290|NCT01648764|10025136|P3|Overall Study|Adverse Event|0
2911291|NCT01648764|10025137|P2|Overall Study|Adverse Event|0
2911292|NCT01648764|10025138|P1|Overall Study|Adverse Event|0
2911293|NCT01648764|10025125|P14|Overall Study|Progressive Disease|1
2911294|NCT01648764|10025126|P13|Overall Study|Progressive Disease|2
2911295|NCT01648764|10025127|P12|Overall Study|Progressive Disease|1
2911296|NCT01648764|10025128|P11|Overall Study|Progressive Disease|0
2911297|NCT01648764|10025129|P10|Overall Study|Progressive Disease|2
2911298|NCT01648764|10025130|P9|Overall Study|Progressive Disease|0
2911299|NCT01648764|10025131|P8|Overall Study|Progressive Disease|0
2911300|NCT01648764|10025132|P7|Overall Study|Progressive Disease|1
2911301|NCT01648764|10025133|P6|Overall Study|Progressive Disease|1
2911302|NCT01648764|10025134|P5|Overall Study|Progressive Disease|0
2911303|NCT01648764|10025135|P4|Overall Study|Progressive Disease|0
2911304|NCT01648764|10025136|P3|Overall Study|Progressive Disease|0
2911305|NCT01648764|10025137|P2|Overall Study|Progressive Disease|1
2911306|NCT01648764|10025138|P1|Overall Study|Progressive Disease|0
2911307|NCT01648699|10025290|P1|Overall Study|Unspecified/unable to complete 4 visits|2
2911308|NCT01648699|10025290|P1|Overall Study|Lost to Follow-up|2
2911309|NCT01648699|10025290|P1|Overall Study|Death|1
2911310|NCT01648582|10025319|P3|Overall Study|Sponsor Decision|1
2911311|NCT01648582|10025320|P2|Overall Study|Sponsor Decision|1
2911312|NCT01648582|10025321|P1|Overall Study|Sponsor Decision|0
2911313|NCT01648582|10025319|P3|Overall Study|Death|0
2911314|NCT01648582|10025320|P2|Overall Study|Death|0
2911315|NCT01648582|10025321|P1|Overall Study|Death|1
2911316|NCT01648582|10025319|P3|Overall Study|Physician Decision|3
2911317|NCT01648582|10025320|P2|Overall Study|Physician Decision|1
2911318|NCT01648582|10025321|P1|Overall Study|Physician Decision|0
2911319|NCT01648582|10025319|P3|Overall Study|Withdrawal by Subject|17
2911320|NCT01648582|10025320|P2|Overall Study|Withdrawal by Subject|17
2911321|NCT01648582|10025321|P1|Overall Study|Withdrawal by Subject|15
2911322|NCT01648582|10025319|P3|Overall Study|Protocol Violation|1
2911323|NCT01648582|10025320|P2|Overall Study|Protocol Violation|2
2911324|NCT01648582|10025321|P1|Overall Study|Protocol Violation|1
2911325|NCT01648582|10025319|P3|Overall Study|Lost to Follow-up|8
2911326|NCT01648582|10025320|P2|Overall Study|Lost to Follow-up|6
2911327|NCT01648582|10025321|P1|Overall Study|Lost to Follow-up|9
2911328|NCT01648582|10025319|P3|Overall Study|Adverse Event|2
2911329|NCT01648582|10025320|P2|Overall Study|Adverse Event|11
2911330|NCT01648582|10025321|P1|Overall Study|Adverse Event|6
2911331|NCT01648348|10025424|P6|Overall Study|Replaced for MTD analysis|0
2911332|NCT01648348|10025425|P5|Overall Study|Replaced for MTD analysis|0
2911333|NCT01648348|10025426|P4|Overall Study|Replaced for MTD analysis|0
2911334|NCT01648348|10025427|P3|Overall Study|Replaced for MTD analysis|1
2911335|NCT01648348|10025428|P2|Overall Study|Replaced for MTD analysis|0
2911336|NCT01648348|10025429|P1|Overall Study|Replaced for MTD analysis|1
2911337|NCT01648348|10025424|P6|Overall Study|Cancel|6
2911338|NCT01648348|10025425|P5|Overall Study|Cancel|3
2911339|NCT01648348|10025426|P4|Overall Study|Cancel|0
2911340|NCT01648348|10025427|P3|Overall Study|Cancel|0
2911341|NCT01648348|10025428|P2|Overall Study|Cancel|0
2911342|NCT01648348|10025429|P1|Overall Study|Cancel|1
2911343|NCT01648283|10025516|P1|Overall Study|Withdrawal by Subject|14
2911344|NCT01648270|10025522|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
2911345|NCT01648166|10025534|P2|Overall Study|inadequate toenail samples|100
2911346|NCT01648166|10025535|P1|Overall Study|inadequate toenail samples|53
2911347|NCT01648140|10025545|P4|Overall Study|Lost to Follow-up|0
2911348|NCT01648140|10025546|P3|Overall Study|Lost to Follow-up|2
2911349|NCT01648140|10025547|P2|Overall Study|Lost to Follow-up|1
2911350|NCT01648140|10025548|P1|Overall Study|Lost to Follow-up|2
2911351|NCT01648140|10025545|P4|Overall Study|Withdrawal by Subject|2
2911352|NCT01648140|10025546|P3|Overall Study|Withdrawal by Subject|3
2911353|NCT01648140|10025547|P2|Overall Study|Withdrawal by Subject|3
2911354|NCT01648140|10025548|P1|Overall Study|Withdrawal by Subject|2
2911355|NCT01648140|10025545|P4|Overall Study|Adverse Event|0
2911356|NCT01648140|10025546|P3|Overall Study|Adverse Event|2
2911357|NCT01648140|10025547|P2|Overall Study|Adverse Event|1
2911358|NCT01648140|10025548|P1|Overall Study|Adverse Event|3
2911359|NCT01648140|10025545|P4|Overall Study|Lack of Efficacy|0
2911360|NCT01648140|10025546|P3|Overall Study|Lack of Efficacy|1
2911361|NCT01648140|10025547|P2|Overall Study|Lack of Efficacy|7
2911362|NCT01648140|10025548|P1|Overall Study|Lack of Efficacy|4
2911363|NCT01648140|10025545|P4|Overall Study|Physician Decision|0
2911364|NCT01648140|10025546|P3|Overall Study|Physician Decision|0
2911365|NCT01648140|10025547|P2|Overall Study|Physician Decision|0
2911366|NCT01648140|10025548|P1|Overall Study|Physician Decision|1
2911367|NCT01648101|10025713|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2911368|NCT01648101|10025714|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
2911369|NCT01648101|10025715|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2911370|NCT01648101|10025713|P3|Transition Phase (4 Weeks)|Study Terminated|0
2911371|NCT01648101|10025714|P2|Transition Phase (4 Weeks)|Study Terminated|0
2911372|NCT01648101|10025715|P1|Transition Phase (4 Weeks)|Study Terminated|1
2911373|NCT01648101|10025713|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
2911374|NCT01648101|10025714|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2911375|NCT01648101|10025715|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2911376|NCT01648101|10025713|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
2911377|NCT01648101|10025714|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
2911378|NCT01648101|10025715|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
2911379|NCT01648101|10025713|P3|Transition Phase (4 Weeks)|Adverse Event|2
2911380|NCT01648101|10025714|P2|Transition Phase (4 Weeks)|Adverse Event|3
2911381|NCT01648101|10025715|P1|Transition Phase (4 Weeks)|Adverse Event|4
2911382|NCT01648101|10025713|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
2911383|NCT01648101|10025714|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
2911384|NCT01648101|10025715|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
2911385|NCT01648101|10025713|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2911386|NCT01648101|10025714|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
2911387|NCT01648101|10025715|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2911388|NCT01648101|10025713|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2911389|NCT01648101|10025714|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
2911390|NCT01648101|10025715|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2911391|NCT01648101|10025713|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
2911392|NCT01648101|10025714|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2911393|NCT01648101|10025715|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2911394|NCT01648101|10025713|P3|Titration Phase (4 Weeks)|Adverse Event|3
2911395|NCT01648101|10025714|P2|Titration Phase (4 Weeks)|Adverse Event|2
2911396|NCT01648101|10025715|P1|Titration Phase (4 Weeks)|Adverse Event|0
2911397|NCT01648101|10025713|P3|Titration Phase (4 Weeks)|Protocol Violation|2
2911398|NCT01648101|10025714|P2|Titration Phase (4 Weeks)|Protocol Violation|1
2911399|NCT01648101|10025715|P1|Titration Phase (4 Weeks)|Protocol Violation|2
2911400|NCT01647711|10025802|P5|Overall Study|Other reason not defined|0
2911401|NCT01647711|10025803|P4|Overall Study|Other reason not defined|1
2911402|NCT01647711|10025804|P3|Overall Study|Other reason not defined|1
2911403|NCT01647711|10025805|P2|Overall Study|Other reason not defined|1
2911404|NCT01647711|10025806|P1|Overall Study|Other reason not defined|0
2911405|NCT01647711|10025802|P5|Overall Study|Refused to continue taking medication|1
2911406|NCT01647711|10025803|P4|Overall Study|Refused to continue taking medication|2
2911407|NCT01647711|10025804|P3|Overall Study|Refused to continue taking medication|0
2911408|NCT01647711|10025805|P2|Overall Study|Refused to continue taking medication|0
2911409|NCT01647711|10025806|P1|Overall Study|Refused to continue taking medication|0
2911410|NCT01647711|10025802|P5|Overall Study|Protocol Violation|1
2911411|NCT01647711|10025803|P4|Overall Study|Protocol Violation|0
2911412|NCT01647711|10025804|P3|Overall Study|Protocol Violation|0
2911413|NCT01647711|10025805|P2|Overall Study|Protocol Violation|0
2911414|NCT01647711|10025806|P1|Overall Study|Protocol Violation|0
2911415|NCT01647711|10025802|P5|Overall Study|Other adverse event|2
2911416|NCT01647711|10025803|P4|Overall Study|Other adverse event|0
2911417|NCT01647711|10025804|P3|Overall Study|Other adverse event|2
2911418|NCT01647711|10025805|P2|Overall Study|Other adverse event|0
2911419|NCT01647711|10025806|P1|Overall Study|Other adverse event|0
2911420|NCT01647711|10025802|P5|Overall Study|Progressive disease|2
2911421|NCT01647711|10025803|P4|Overall Study|Progressive disease|8
2911422|NCT01647711|10025804|P3|Overall Study|Progressive disease|6
2911423|NCT01647711|10025805|P2|Overall Study|Progressive disease|2
2911424|NCT01647711|10025806|P1|Overall Study|Progressive disease|6
2911425|NCT01647542|10025843|P3|Overall Study|Death|1
2911426|NCT01647542|10025844|P2|Overall Study|Death|0
2911427|NCT01647542|10025845|P1|Overall Study|Death|0
2911428|NCT01647542|10025843|P3|Overall Study|Lack of Efficacy|0
2911429|NCT01647542|10025844|P2|Overall Study|Lack of Efficacy|1
2911430|NCT01647542|10025845|P1|Overall Study|Lack of Efficacy|1
2911431|NCT01647542|10025843|P3|Overall Study|Study Termination|65
2911432|NCT01647542|10025844|P2|Overall Study|Study Termination|61
2911433|NCT01647542|10025845|P1|Overall Study|Study Termination|64
2911434|NCT01647542|10025843|P3|Overall Study|Withdrawal by Subject|0
2911435|NCT01647542|10025844|P2|Overall Study|Withdrawal by Subject|4
2911436|NCT01647542|10025845|P1|Overall Study|Withdrawal by Subject|6
2911437|NCT01647542|10025843|P3|Overall Study|Lost to Follow-up|2
2911438|NCT01647542|10025844|P2|Overall Study|Lost to Follow-up|2
2911439|NCT01647542|10025845|P1|Overall Study|Lost to Follow-up|0
2911440|NCT01647542|10025843|P3|Overall Study|Adverse Event|4
2911441|NCT01647542|10025844|P2|Overall Study|Adverse Event|5
2911442|NCT01647542|10025845|P1|Overall Study|Adverse Event|4
2911443|NCT01647542|10025843|P3|Overall Study|Major Protocol Deviation|0
2911444|NCT01647542|10025844|P2|Overall Study|Major Protocol Deviation|0
2911445|NCT01647542|10025845|P1|Overall Study|Major Protocol Deviation|1
2911446|NCT01647282|10025879|P2|Overall Study|Physician Decision|5
2911447|NCT01647282|10025880|P1|Overall Study|Physician Decision|7
2911448|NCT01646827|10025901|P2|Overall Study|Withdrawal by Subject|0
2911449|NCT01646827|10025902|P1|Overall Study|Withdrawal by Subject|1
2911450|NCT01646827|10025901|P2|Overall Study|Physician Decision|2
2911451|NCT01646827|10025902|P1|Overall Study|Physician Decision|1
2911452|NCT01646827|10025901|P2|Overall Study|Lost to Follow-up|3
2911453|NCT01646827|10025902|P1|Overall Study|Lost to Follow-up|0
2911454|NCT01646398|10025989|P2|Overall Study|Withdrawal by Subject|0
2911455|NCT01646398|10025990|P1|Overall Study|Withdrawal by Subject|1
2911456|NCT01646385|10026006|P2|Overall Study|Switched to alternate biologic|649
2911457|NCT01646385|10026007|P1|Overall Study|Switched to alternate biologic|636
2911458|NCT01646385|10026006|P2|Overall Study|Death|222
2911459|NCT01646385|10026007|P1|Overall Study|Death|202
2911460|NCT01646320|10026050|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
2911461|NCT01646320|10026051|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
2911462|NCT01646320|10026050|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
2911463|NCT01646320|10026051|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
2911464|NCT01646320|10026050|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
2911465|NCT01646320|10026051|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
2911466|NCT01646320|10026050|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
2911467|NCT01646320|10026051|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
2911468|NCT01646320|10026050|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
2911469|NCT01646320|10026051|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
2911470|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
2911471|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
2911472|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2911473|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2911474|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|Other|0
2911475|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|Other|1
2911476|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
2911477|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
2911478|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
2911479|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
2911480|NCT01646320|10026050|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
2911481|NCT01646320|10026051|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
2911482|NCT01646268|10026067|P2|Overall Study|Other|0
2911483|NCT01646268|10026068|P1|Overall Study|Other|2
2911484|NCT01646268|10026067|P2|Overall Study|Withdrawal by Subject|5
2911485|NCT01646268|10026068|P1|Overall Study|Withdrawal by Subject|2
2911486|NCT01646268|10026067|P2|Overall Study|Protocol Violation|1
2911487|NCT01646268|10026068|P1|Overall Study|Protocol Violation|0
2911488|NCT01646268|10026067|P2|Overall Study|Lack of Efficacy|3
2911489|NCT01646268|10026068|P1|Overall Study|Lack of Efficacy|1
2911490|NCT01646268|10026067|P2|Overall Study|Adverse Event|7
2911491|NCT01646268|10026068|P1|Overall Study|Adverse Event|6
2911492|NCT01646255|10026082|P2|Overall Study|Inclusion Criteria Deviation|0
2911493|NCT01646255|10026083|P1|Overall Study|Inclusion Criteria Deviation|1
2911494|NCT01646255|10026082|P2|Overall Study|Compliance is not well|0
2911495|NCT01646255|10026083|P1|Overall Study|Compliance is not well|1
2911496|NCT01646255|10026082|P2|Overall Study|Withdrawal by Subject|6
2911497|NCT01646255|10026083|P1|Overall Study|Withdrawal by Subject|10
2911498|NCT01646255|10026082|P2|Overall Study|Lack of Efficacy|0
2911499|NCT01646255|10026083|P1|Overall Study|Lack of Efficacy|2
2911500|NCT01646255|10026082|P2|Overall Study|Adverse Event|8
2911501|NCT01646255|10026083|P1|Overall Study|Adverse Event|7
2911502|NCT01646216|10026115|P2|Overall Study|Investigator decision|1
2911503|NCT01646216|10026116|P1|Overall Study|Investigator decision|1
2911504|NCT01646216|10026115|P2|Overall Study|Did not complete training|2
2911505|NCT01646216|10026116|P1|Overall Study|Did not complete training|0
2911506|NCT01646216|10026115|P2|Overall Study|Baseline step length difference (<5cm)|10
2911507|NCT01646216|10026116|P1|Overall Study|Baseline step length difference (<5cm)|10
2911508|NCT01646203|10026138|P3|Overall Study|Physician's Decision|0
2911509|NCT01646203|10026139|P2|Overall Study|Physician's Decision|1
2911510|NCT01646203|10026140|P1|Overall Study|Physician's Decision|0
2911511|NCT01646203|10026138|P3|Overall Study|Withdrawal by Subject|0
2911512|NCT01646203|10026139|P2|Overall Study|Withdrawal by Subject|1
2911513|NCT01646203|10026140|P1|Overall Study|Withdrawal by Subject|0
2911514|NCT01646203|10026138|P3|Overall Study|Adverse Event|1
2911515|NCT01646203|10026139|P2|Overall Study|Adverse Event|0
2911516|NCT01646203|10026140|P1|Overall Study|Adverse Event|2
2911517|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2911518|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2911519|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2911520|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
2911521|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
2911522|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
2911523|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2911524|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2911525|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2911526|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2911527|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2911528|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2911529|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2911530|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2911531|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
2911532|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
2911533|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
2911534|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
2911535|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
2911536|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
2911537|NCT01646177|10026169|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
2911538|NCT01646177|10026170|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
2911539|NCT01646177|10026171|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
2911540|NCT01646177|10026172|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
2911541|NCT01646138|10026266|P5|Overall Study|Lost to Follow-up|2
2911542|NCT01646138|10026267|P4|Overall Study|Lost to Follow-up|0
2911543|NCT01646138|10026268|P3|Overall Study|Lost to Follow-up|0
2911544|NCT01646138|10026269|P2|Overall Study|Lost to Follow-up|0
2911545|NCT01646138|10026270|P1|Overall Study|Lost to Follow-up|0
2911546|NCT01646125|10026284|P2|Overall Study|Subject/Guardian decision|1
2911547|NCT01646125|10026285|P1|Overall Study|Subject/Guardian decision|1
2911548|NCT01646125|10026284|P2|Overall Study|Study terminated by sponsor|1
2911549|NCT01646125|10026285|P1|Overall Study|Study terminated by sponsor|2
2911550|NCT01646125|10026284|P2|Overall Study|Progressive disease|16
2911551|NCT01646125|10026285|P1|Overall Study|Progressive disease|22
2911552|NCT01646125|10026284|P2|Overall Study|Physician Decision|3
2911553|NCT01646125|10026285|P1|Overall Study|Physician Decision|1
2911554|NCT01646125|10026284|P2|Overall Study|Death|1
2911555|NCT01646125|10026285|P1|Overall Study|Death|1
2911556|NCT01646125|10026284|P2|Overall Study|Adverse Event|1
2911557|NCT01646125|10026285|P1|Overall Study|Adverse Event|2
2911558|NCT01646125|10026284|P2|Overall Study|Untreated|5
2911559|NCT01646125|10026285|P1|Overall Study|Untreated|2
2911560|NCT01646073|10026310|P2|Period B (12 Weeks)|Lost to Follow-up|1
2911561|NCT01646073|10026311|P1|Period B (12 Weeks)|Lost to Follow-up|0
2911562|NCT01646073|10026310|P2|Period B (12 Weeks)|Withdrawal by Subject|5
2911563|NCT01646073|10026311|P1|Period B (12 Weeks)|Withdrawal by Subject|1
2911564|NCT01646073|10026310|P2|Period B (12 Weeks)|Adverse Event|7
2911565|NCT01646073|10026311|P1|Period B (12 Weeks)|Adverse Event|0
2911566|NCT01646073|10026310|P2|Period A (12 Weeks)|Other|1
2911567|NCT01646073|10026311|P1|Period A (12 Weeks)|Other|0
2911568|NCT01646073|10026310|P2|Period A (12 Weeks)|Protocol Violation|1
2911569|NCT01646073|10026311|P1|Period A (12 Weeks)|Protocol Violation|0
2911570|NCT01646073|10026310|P2|Period A (12 Weeks)|Lack of Efficacy|0
2911571|NCT01646073|10026311|P1|Period A (12 Weeks)|Lack of Efficacy|1
2911572|NCT01646073|10026310|P2|Period A (12 Weeks)|Withdrawal by Subject|1
2911573|NCT01646073|10026311|P1|Period A (12 Weeks)|Withdrawal by Subject|1
2911574|NCT01646073|10026310|P2|Period A (12 Weeks)|Adverse Event|2
2911575|NCT01646073|10026311|P1|Period A (12 Weeks)|Adverse Event|0
2911576|NCT01646021|10026352|P2|Overall Study|Withdrawal by Subject|15
2911577|NCT01646021|10026353|P1|Overall Study|Withdrawal by Subject|10
2911578|NCT01646021|10026352|P2|Overall Study|Lost to Follow-up|2
2911579|NCT01646021|10026353|P1|Overall Study|Lost to Follow-up|2
2911580|NCT01646021|10026352|P2|Overall Study|Study Terminated by Sponsor|41
2911581|NCT01646021|10026353|P1|Overall Study|Study Terminated by Sponsor|50
2911582|NCT01646021|10026352|P2|Overall Study|Death|83
2911583|NCT01646021|10026353|P1|Overall Study|Death|77
2911584|NCT01645930|10026390|P1|Overall Study|Reason not Defined|1
2911585|NCT01645930|10026390|P1|Overall Study|Withdrawal by Participant|2
2911586|NCT01645930|10026390|P1|Overall Study|Unsatisfactory Therapeutic Response|2
2911587|NCT01645930|10026390|P1|Overall Study|Adverse Event|4
2911588|NCT01645930|10026390|P1|Overall Study|Progressive Disease|12
2911589|NCT01645930|10026390|P1|Overall Study|Participants Ongoing on Study Treatment|22
2911590|NCT01645735|10026407|P2|Overall Study|Adverse Event|1
2911591|NCT01645735|10026408|P1|Overall Study|Adverse Event|0
2911592|NCT01645735|10026407|P2|Overall Study|Protocol Violation|0
2911593|NCT01645735|10026408|P1|Overall Study|Protocol Violation|1
2911594|NCT01645735|10026407|P2|Overall Study|Withdrawal by Subject|0
2911595|NCT01645735|10026408|P1|Overall Study|Withdrawal by Subject|1
2911596|NCT01645735|10026407|P2|Overall Study|Physician Decision|0
2911597|NCT01645735|10026408|P1|Overall Study|Physician Decision|2
2911598|NCT01645280|10026450|P5|Overall Study|Treatment not completed/Completed f/u|2
2911599|NCT01645280|10026451|P4|Overall Study|Treatment not completed/Completed f/u|0
2911600|NCT01645280|10026452|P3|Overall Study|Treatment not completed/Completed f/u|2
2911601|NCT01645280|10026453|P2|Overall Study|Treatment not completed/Completed f/u|1
2911602|NCT01645280|10026454|P1|Overall Study|Treatment not completed/Completed f/u|1
2911603|NCT01645280|10026450|P5|Overall Study|Other|0
2911604|NCT01645280|10026451|P4|Overall Study|Other|0
2911605|NCT01645280|10026452|P3|Overall Study|Other|2
2911606|NCT01645280|10026453|P2|Overall Study|Other|1
2911607|NCT01645280|10026454|P1|Overall Study|Other|1
2911608|NCT01645280|10026450|P5|Overall Study|Lost to Follow-up|1
2911609|NCT01645280|10026451|P4|Overall Study|Lost to Follow-up|2
2911610|NCT01645280|10026452|P3|Overall Study|Lost to Follow-up|0
2911611|NCT01645280|10026453|P2|Overall Study|Lost to Follow-up|0
2911612|NCT01645280|10026454|P1|Overall Study|Lost to Follow-up|0
2911613|NCT01645280|10026450|P5|Overall Study|Withdrawal by Subject|5
2911614|NCT01645280|10026451|P4|Overall Study|Withdrawal by Subject|4
2911615|NCT01645280|10026452|P3|Overall Study|Withdrawal by Subject|2
2911616|NCT01645280|10026453|P2|Overall Study|Withdrawal by Subject|0
2911617|NCT01645280|10026454|P1|Overall Study|Withdrawal by Subject|4
2911618|NCT01645280|10026450|P5|Overall Study|Death|0
2911619|NCT01645280|10026451|P4|Overall Study|Death|0
2911620|NCT01645280|10026452|P3|Overall Study|Death|0
2911621|NCT01645280|10026453|P2|Overall Study|Death|1
2911622|NCT01645280|10026454|P1|Overall Study|Death|0
2911623|NCT01645176|10026482|P1|Overall Study|did not complete final MRI|1
2911624|NCT01645176|10026482|P1|Overall Study|Lack of Efficacy|4
2911625|NCT01645111|10026486|P1|Overall Study|Did not require Clevidipine|15
2911626|NCT01644890|10026527|P2|Overall Study|Other|9
2911627|NCT01644890|10026528|P1|Overall Study|Other|8
2911628|NCT01644890|10026527|P2|Overall Study|> 28 days since last dose of study drug|3
2911629|NCT01644890|10026528|P1|Overall Study|> 28 days since last dose of study drug|6
2911630|NCT01644890|10026527|P2|Overall Study|Clinical Progression|6
2911631|NCT01644890|10026528|P1|Overall Study|Clinical Progression|6
2911632|NCT01644890|10026527|P2|Overall Study|Progression Disease|131
2911633|NCT01644890|10026528|P1|Overall Study|Progression Disease|160
2911634|NCT01644890|10026527|P2|Overall Study|Withdrawal by Subject|27
2911635|NCT01644890|10026528|P1|Overall Study|Withdrawal by Subject|19
2911636|NCT01644890|10026527|P2|Overall Study|Protocol Violation|7
2911637|NCT01644890|10026528|P1|Overall Study|Protocol Violation|6
2911638|NCT01644890|10026527|P2|Overall Study|Physician Decision|9
2911639|NCT01644890|10026528|P1|Overall Study|Physician Decision|3
2911640|NCT01644890|10026527|P2|Overall Study|Death|3
2911641|NCT01644890|10026528|P1|Overall Study|Death|1
2911642|NCT01644890|10026527|P2|Overall Study|Adverse Event|20
2911643|NCT01644890|10026528|P1|Overall Study|Adverse Event|7
2911644|NCT01644734|10026538|P1|Overall Study|Missing documentation|238
2911645|NCT01644734|10026538|P1|Overall Study|Reasons other than stated above|7
2911646|NCT01644734|10026538|P1|Overall Study|Lost to Follow-up|17
2911647|NCT01644734|10026538|P1|Overall Study|Adverse Event|4
2911648|NCT01644643|10026552|P4|Overall Study|Other Eligibility criteria|2
2911649|NCT01644643|10026553|P3|Overall Study|Other Eligibility criteria|0
2911650|NCT01644643|10026554|P2|Overall Study|Other Eligibility criteria|0
2911651|NCT01644643|10026555|P1|Overall Study|Other Eligibility criteria|0
2911652|NCT01644643|10026552|P4|Overall Study|Withdrawal by Subject|1
2911653|NCT01644643|10026553|P3|Overall Study|Withdrawal by Subject|2
2911654|NCT01644643|10026554|P2|Overall Study|Withdrawal by Subject|0
2911655|NCT01644643|10026555|P1|Overall Study|Withdrawal by Subject|1
2911656|NCT01644643|10026552|P4|Overall Study|Lost to Follow-up|4
2911657|NCT01644643|10026553|P3|Overall Study|Lost to Follow-up|0
2911658|NCT01644643|10026554|P2|Overall Study|Lost to Follow-up|0
2911659|NCT01644643|10026555|P1|Overall Study|Lost to Follow-up|0
2911660|NCT01644643|10026552|P4|Overall Study|Death|3
2911661|NCT01644643|10026553|P3|Overall Study|Death|3
2911662|NCT01644643|10026554|P2|Overall Study|Death|0
2911663|NCT01644643|10026555|P1|Overall Study|Death|1
2911664|NCT01644617|10026720|P3|Overall Study|Adverse Event|6
2911665|NCT01644617|10026721|P2|Overall Study|Adverse Event|0
2911666|NCT01644617|10026722|P1|Overall Study|Adverse Event|3
2911667|NCT01644617|10026720|P3|Overall Study|Lost to Follow-up|0
2911668|NCT01644617|10026721|P2|Overall Study|Lost to Follow-up|1
2911669|NCT01644617|10026722|P1|Overall Study|Lost to Follow-up|0
2911670|NCT01644617|10026720|P3|Overall Study|Withdrawal by Subject|1
2911671|NCT01644617|10026721|P2|Overall Study|Withdrawal by Subject|4
2911672|NCT01644617|10026722|P1|Overall Study|Withdrawal by Subject|3
2911673|NCT01644565|10026772|P9|Overall Study|Relocation|1
2911674|NCT01644565|10026773|P8|Overall Study|Relocation|0
2911675|NCT01644565|10026774|P7|Overall Study|Relocation|0
2911676|NCT01644565|10026775|P6|Overall Study|Relocation|0
2911677|NCT01644565|10026776|P5|Overall Study|Relocation|0
2911678|NCT01644565|10026777|P4|Overall Study|Relocation|0
2911679|NCT01644565|10026778|P3|Overall Study|Relocation|0
2911680|NCT01644565|10026779|P2|Overall Study|Relocation|0
2911681|NCT01644565|10026780|P1|Overall Study|Relocation|0
2911682|NCT01644565|10026772|P9|Overall Study|Family emergency|0
2911683|NCT01644565|10026773|P8|Overall Study|Family emergency|0
2911684|NCT01644565|10026774|P7|Overall Study|Family emergency|0
2911685|NCT01644565|10026775|P6|Overall Study|Family emergency|0
2911686|NCT01644565|10026776|P5|Overall Study|Family emergency|1
2911687|NCT01644565|10026777|P4|Overall Study|Family emergency|0
2911688|NCT01644565|10026778|P3|Overall Study|Family emergency|0
2911689|NCT01644565|10026779|P2|Overall Study|Family emergency|0
2911690|NCT01644565|10026780|P1|Overall Study|Family emergency|0
2911691|NCT01644565|10026772|P9|Overall Study|Lost to Follow-up|0
2911692|NCT01644565|10026773|P8|Overall Study|Lost to Follow-up|2
2911693|NCT01644565|10026774|P7|Overall Study|Lost to Follow-up|0
2911694|NCT01644565|10026775|P6|Overall Study|Lost to Follow-up|0
2911695|NCT01644565|10026776|P5|Overall Study|Lost to Follow-up|0
2911696|NCT01644565|10026777|P4|Overall Study|Lost to Follow-up|1
2911697|NCT01644565|10026778|P3|Overall Study|Lost to Follow-up|0
2911698|NCT01644565|10026779|P2|Overall Study|Lost to Follow-up|0
2911699|NCT01644565|10026780|P1|Overall Study|Lost to Follow-up|0
2911700|NCT01644565|10026772|P9|Overall Study|Undisclosed Medical History|0
2911701|NCT01644565|10026773|P8|Overall Study|Undisclosed Medical History|0
2911702|NCT01644565|10026774|P7|Overall Study|Undisclosed Medical History|0
2911703|NCT01644565|10026775|P6|Overall Study|Undisclosed Medical History|0
2911704|NCT01644565|10026776|P5|Overall Study|Undisclosed Medical History|0
2911705|NCT01644565|10026777|P4|Overall Study|Undisclosed Medical History|0
2911706|NCT01644565|10026778|P3|Overall Study|Undisclosed Medical History|0
2911707|NCT01644565|10026779|P2|Overall Study|Undisclosed Medical History|0
2911708|NCT01644565|10026780|P1|Overall Study|Undisclosed Medical History|1
2911709|NCT01644500|10026821|P3|Overall Study|Physician Decision|1
2911710|NCT01644500|10026822|P2|Overall Study|Physician Decision|1
2911711|NCT01644500|10026823|P1|Overall Study|Physician Decision|1
2911712|NCT01644500|10026821|P3|Overall Study|Withdrawal by Subject|12
2911713|NCT01644500|10026822|P2|Overall Study|Withdrawal by Subject|12
2911714|NCT01644500|10026823|P1|Overall Study|Withdrawal by Subject|11
2911715|NCT01644500|10026821|P3|Overall Study|Protocol Violation|0
2911716|NCT01644500|10026822|P2|Overall Study|Protocol Violation|1
2911717|NCT01644500|10026823|P1|Overall Study|Protocol Violation|1
2911718|NCT01644500|10026821|P3|Overall Study|Lost to Follow-up|0
2911719|NCT01644500|10026822|P2|Overall Study|Lost to Follow-up|8
2911720|NCT01644500|10026823|P1|Overall Study|Lost to Follow-up|3
2911721|NCT01644500|10026821|P3|Overall Study|Death|0
2911722|NCT01644500|10026822|P2|Overall Study|Death|1
2911723|NCT01644500|10026823|P1|Overall Study|Death|0
2911724|NCT01644500|10026821|P3|Overall Study|Adverse Event|2
2911725|NCT01644500|10026822|P2|Overall Study|Adverse Event|1
2911726|NCT01644500|10026823|P1|Overall Study|Adverse Event|6
2911727|NCT01644474|10026893|P2|Overall Study|Protocol Violation|0
2911728|NCT01644474|10026894|P1|Overall Study|Protocol Violation|1
2911729|NCT01644474|10026893|P2|Overall Study|Site scheduling error|1
2911730|NCT01644474|10026894|P1|Overall Study|Site scheduling error|1
2911731|NCT01644474|10026893|P2|Overall Study|Adverse Event|5
2911732|NCT01644474|10026894|P1|Overall Study|Adverse Event|4
2911733|NCT01644474|10026893|P2|Overall Study|Participant moved|1
2911734|NCT01644474|10026894|P1|Overall Study|Participant moved|0
2911735|NCT01644474|10026893|P2|Overall Study|Consent withdrawn by participant|1
2911736|NCT01644474|10026894|P1|Overall Study|Consent withdrawn by participant|0
2911737|NCT01644474|10026893|P2|Overall Study|Poor compliance to protocol|0
2911738|NCT01644474|10026894|P1|Overall Study|Poor compliance to protocol|1
2911739|NCT01644188|10027078|P2|Overall Study|Other than specified above|7
2911740|NCT01644188|10027079|P1|Overall Study|Other than specified above|6
2911741|NCT01644188|10027078|P2|Overall Study|Site closure|1
2911742|NCT01644188|10027079|P1|Overall Study|Site closure|1
2911743|NCT01644188|10027078|P2|Overall Study|Last visit outside protocol visit window|16
2911744|NCT01644188|10027079|P1|Overall Study|Last visit outside protocol visit window|14
2911745|NCT01644188|10027078|P2|Overall Study|Death|3
2911746|NCT01644188|10027079|P1|Overall Study|Death|4
2911747|NCT01644188|10027078|P2|Overall Study|Lost to Follow-up|0
2911748|NCT01644188|10027079|P1|Overall Study|Lost to Follow-up|1
2911749|NCT01644188|10027078|P2|Overall Study|Selection criteria finally not met|0
2911750|NCT01644188|10027079|P1|Overall Study|Selection criteria finally not met|2
2911751|NCT01644188|10027078|P2|Overall Study|Consent withdrawn by participant|7
2911752|NCT01644188|10027079|P1|Overall Study|Consent withdrawn by participant|14
2911753|NCT01644188|10027078|P2|Overall Study|Related to auto-injector administration|2
2911754|NCT01644188|10027079|P1|Overall Study|Related to auto-injector administration|2
2911755|NCT01644188|10027078|P2|Overall Study|Participant moved|2
2911756|NCT01644188|10027079|P1|Overall Study|Participant moved|7
2911757|NCT01644188|10027078|P2|Overall Study|Physician Decision|3
2911758|NCT01644188|10027079|P1|Overall Study|Physician Decision|1
2911759|NCT01644188|10027078|P2|Overall Study|Poor compliance to protocol|14
2911760|NCT01644188|10027079|P1|Overall Study|Poor compliance to protocol|26
2911761|NCT01644188|10027078|P2|Overall Study|Adverse Event|20
2911762|NCT01644188|10027079|P1|Overall Study|Adverse Event|44
2911763|NCT01644175|10027137|P2|Overall Study|Other than specified above|3
2911764|NCT01644175|10027138|P1|Overall Study|Other than specified above|0
2911765|NCT01644175|10027137|P2|Overall Study|Lost to Follow-up|0
2911766|NCT01644175|10027138|P1|Overall Study|Lost to Follow-up|1
2911767|NCT01644175|10027137|P2|Overall Study|Site closure|2
2911768|NCT01644175|10027138|P1|Overall Study|Site closure|2
2911769|NCT01644175|10027137|P2|Overall Study|Selection criteria finally not met|1
2911770|NCT01644175|10027138|P1|Overall Study|Selection criteria finally not met|0
2911771|NCT01644175|10027137|P2|Overall Study|Last visit outside protocol visit window|11
2911772|NCT01644175|10027138|P1|Overall Study|Last visit outside protocol visit window|4
2911773|NCT01644175|10027137|P2|Overall Study|Related to Autoinjector Administration|1
2911774|NCT01644175|10027138|P1|Overall Study|Related to Autoinjector Administration|2
2911775|NCT01644175|10027137|P2|Overall Study|Consent withdrawn by participant|4
2911776|NCT01644175|10027138|P1|Overall Study|Consent withdrawn by participant|3
2911777|NCT01644175|10027137|P2|Overall Study|Participant Moved|2
2911778|NCT01644175|10027138|P1|Overall Study|Participant Moved|1
2911779|NCT01644175|10027137|P2|Overall Study|Physician Decision|2
2911780|NCT01644175|10027138|P1|Overall Study|Physician Decision|1
2911781|NCT01644175|10027137|P2|Overall Study|Poor compliance to protocol|10
2911782|NCT01644175|10027138|P1|Overall Study|Poor compliance to protocol|9
2911783|NCT01644175|10027137|P2|Overall Study|Death|2
2911784|NCT01644175|10027138|P1|Overall Study|Death|1
2911785|NCT01644175|10027137|P2|Overall Study|Adverse Event|13
2911786|NCT01644175|10027138|P1|Overall Study|Adverse Event|8
2911787|NCT01644175|10027137|P2|Overall Study|Randomized But Not Treated|2
2911788|NCT01644175|10027138|P1|Overall Study|Randomized But Not Treated|0
2911789|NCT01644149|10027190|P2|Overall Study|Lost to Follow-up|1
2911790|NCT01644149|10027191|P1|Overall Study|Lost to Follow-up|3
2911791|NCT01644149|10027190|P2|Overall Study|Withdrawal by Subject|0
2911792|NCT01644149|10027191|P1|Overall Study|Withdrawal by Subject|1
2911793|NCT01643928|10027211|P5|Overall Study|Adverse Event|2
2911794|NCT01643928|10027212|P4|Overall Study|Adverse Event|1
2911795|NCT01643928|10027213|P3|Overall Study|Adverse Event|0
2911796|NCT01643928|10027214|P2|Overall Study|Adverse Event|1
2911797|NCT01643928|10027215|P1|Overall Study|Adverse Event|2
2911798|NCT01643928|10027211|P5|Overall Study|Other|0
2911799|NCT01643928|10027212|P4|Overall Study|Other|0
2911800|NCT01643928|10027213|P3|Overall Study|Other|1
2911801|NCT01643928|10027214|P2|Overall Study|Other|1
2911802|NCT01643928|10027215|P1|Overall Study|Other|5
2911803|NCT01643928|10027211|P5|Overall Study|Pregnancy|0
2911804|NCT01643928|10027212|P4|Overall Study|Pregnancy|1
2911805|NCT01643928|10027213|P3|Overall Study|Pregnancy|0
2911806|NCT01643928|10027214|P2|Overall Study|Pregnancy|0
2911807|NCT01643928|10027215|P1|Overall Study|Pregnancy|0
2911808|NCT01643928|10027211|P5|Overall Study|Withdrawal by Subject|0
2911809|NCT01643928|10027212|P4|Overall Study|Withdrawal by Subject|1
2911810|NCT01643928|10027213|P3|Overall Study|Withdrawal by Subject|0
2911811|NCT01643928|10027214|P2|Overall Study|Withdrawal by Subject|0
2911812|NCT01643928|10027215|P1|Overall Study|Withdrawal by Subject|2
2911813|NCT01643928|10027211|P5|Overall Study|Lost to Follow-up|0
2911814|NCT01643928|10027212|P4|Overall Study|Lost to Follow-up|0
2911815|NCT01643928|10027213|P3|Overall Study|Lost to Follow-up|2
2911816|NCT01643928|10027214|P2|Overall Study|Lost to Follow-up|0
2911817|NCT01643928|10027215|P1|Overall Study|Lost to Follow-up|1
2911818|NCT01643850|10027519|P9|Overall Study|Administrative Problems|0
2911819|NCT01643850|10027520|P8|Overall Study|Administrative Problems|0
2911820|NCT01643850|10027521|P7|Overall Study|Administrative Problems|0
2911821|NCT01643850|10027522|P6|Overall Study|Administrative Problems|0
2911822|NCT01643850|10027523|P5|Overall Study|Administrative Problems|1
2911823|NCT01643850|10027524|P4|Overall Study|Administrative Problems|0
2911824|NCT01643850|10027525|P3|Overall Study|Administrative Problems|1
2911825|NCT01643850|10027526|P2|Overall Study|Administrative Problems|0
2911826|NCT01643850|10027527|P1|Overall Study|Administrative Problems|0
2911827|NCT01643850|10027519|P9|Overall Study|Adverse Event|0
2911828|NCT01643850|10027520|P8|Overall Study|Adverse Event|0
2911829|NCT01643850|10027521|P7|Overall Study|Adverse Event|0
2911830|NCT01643850|10027522|P6|Overall Study|Adverse Event|0
2911831|NCT01643850|10027523|P5|Overall Study|Adverse Event|1
2911832|NCT01643850|10027524|P4|Overall Study|Adverse Event|0
2911833|NCT01643850|10027525|P3|Overall Study|Adverse Event|0
2911834|NCT01643850|10027526|P2|Overall Study|Adverse Event|0
2911835|NCT01643850|10027527|P1|Overall Study|Adverse Event|0
2911836|NCT01643850|10027519|P9|Overall Study|Lost to Follow-up|1
2911837|NCT01643850|10027520|P8|Overall Study|Lost to Follow-up|0
2911838|NCT01643850|10027521|P7|Overall Study|Lost to Follow-up|1
2911839|NCT01643850|10027522|P6|Overall Study|Lost to Follow-up|0
2911840|NCT01643850|10027523|P5|Overall Study|Lost to Follow-up|0
2911841|NCT01643850|10027524|P4|Overall Study|Lost to Follow-up|0
2911842|NCT01643850|10027525|P3|Overall Study|Lost to Follow-up|0
2911843|NCT01643850|10027526|P2|Overall Study|Lost to Follow-up|0
2911844|NCT01643850|10027527|P1|Overall Study|Lost to Follow-up|0
2911845|NCT01643850|10027519|P9|Overall Study|Withdrawal by Subject|0
2911846|NCT01643850|10027520|P8|Overall Study|Withdrawal by Subject|0
2911847|NCT01643850|10027521|P7|Overall Study|Withdrawal by Subject|0
2911848|NCT01643850|10027522|P6|Overall Study|Withdrawal by Subject|0
2911849|NCT01643850|10027523|P5|Overall Study|Withdrawal by Subject|1
2911850|NCT01643850|10027524|P4|Overall Study|Withdrawal by Subject|0
2911851|NCT01643850|10027525|P3|Overall Study|Withdrawal by Subject|0
2911852|NCT01643850|10027526|P2|Overall Study|Withdrawal by Subject|0
2911853|NCT01643850|10027527|P1|Overall Study|Withdrawal by Subject|0
2911854|NCT01643798|10027666|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
2911855|NCT01643798|10027667|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
2911856|NCT01643772|10027682|P4|Overall Study|Adverse Event|1
2911857|NCT01643772|10027683|P3|Overall Study|Adverse Event|0
2911858|NCT01643772|10027684|P2|Overall Study|Adverse Event|0
2911859|NCT01643772|10027685|P1|Overall Study|Adverse Event|0
2911860|NCT01643772|10027682|P4|Overall Study|Protocol Violation|1
2911861|NCT01643772|10027683|P3|Overall Study|Protocol Violation|0
2911862|NCT01643772|10027684|P2|Overall Study|Protocol Violation|0
2911863|NCT01643772|10027685|P1|Overall Study|Protocol Violation|0
2911864|NCT01643668|10027725|P1|Overall Study|Death|1
2911865|NCT01643473|10027756|P2|Overall Study|Lost to Follow-up|0
2911866|NCT01643473|10027757|P1|Overall Study|Lost to Follow-up|1
2911867|NCT01643044|10027780|P2|Overall Study|Delivered outside of hospital|2
2911868|NCT01643044|10027781|P1|Overall Study|Delivered outside of hospital|1
2911869|NCT01643044|10027780|P2|Overall Study|Miscarried baby|2
2911870|NCT01643044|10027781|P1|Overall Study|Miscarried baby|2
2911871|NCT01643044|10027780|P2|Overall Study|Lost to Follow-up|1
2911872|NCT01643044|10027781|P1|Overall Study|Lost to Follow-up|1
2911873|NCT01642914|10027790|P3|Overall Study|Other Reason|0
2911874|NCT01642914|10027791|P2|Overall Study|Other Reason|0
2911875|NCT01642914|10027792|P1|Overall Study|Other Reason|1
2911876|NCT01642914|10027790|P3|Overall Study|Lost to Follow-up|7
2911877|NCT01642914|10027791|P2|Overall Study|Lost to Follow-up|3
2911878|NCT01642914|10027792|P1|Overall Study|Lost to Follow-up|5
2911879|NCT01642914|10027790|P3|Overall Study|Withdrawal by Subject|10
2911880|NCT01642914|10027791|P2|Overall Study|Withdrawal by Subject|5
2911881|NCT01642914|10027792|P1|Overall Study|Withdrawal by Subject|5
2911882|NCT01642914|10027790|P3|Overall Study|Protocol Violation|6
2911883|NCT01642914|10027791|P2|Overall Study|Protocol Violation|13
2911884|NCT01642914|10027792|P1|Overall Study|Protocol Violation|15
2911885|NCT01642914|10027790|P3|Overall Study|Lack of Efficacy|2
2911886|NCT01642914|10027791|P2|Overall Study|Lack of Efficacy|4
2911887|NCT01642914|10027792|P1|Overall Study|Lack of Efficacy|9
2911888|NCT01642914|10027790|P3|Overall Study|Adverse Event|15
2911889|NCT01642914|10027791|P2|Overall Study|Adverse Event|7
2911890|NCT01642914|10027792|P1|Overall Study|Adverse Event|11
2911891|NCT01642732|10027867|P1|Overall Study|Withdrawal by Subject|1
2911892|NCT01642615|10027872|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
2911893|NCT01642615|10027873|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2911894|NCT01642615|10027874|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2911895|NCT01642615|10027872|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2911896|NCT01642615|10027873|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
2911897|NCT01642615|10027874|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2911898|NCT01642615|10027872|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
2911899|NCT01642615|10027873|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
2911900|NCT01642615|10027874|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
2911901|NCT01642615|10027872|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
2911902|NCT01642615|10027873|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
2911903|NCT01642615|10027874|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
2911904|NCT01642615|10027872|P3|Open Label Maintenance Phase|Did not receive treatment|0
2911905|NCT01642615|10027873|P2|Open Label Maintenance Phase|Did not receive treatment|0
2911906|NCT01642615|10027874|P1|Open Label Maintenance Phase|Did not receive treatment|1
2911907|NCT01642615|10027872|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
2911908|NCT01642615|10027873|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
2911909|NCT01642615|10027874|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
2911910|NCT01642615|10027872|P3|Open Label Maintenance Phase|Lost to Follow-up|0
2911911|NCT01642615|10027873|P2|Open Label Maintenance Phase|Lost to Follow-up|0
2911912|NCT01642615|10027874|P1|Open Label Maintenance Phase|Lost to Follow-up|1
2911913|NCT01642615|10027872|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
2911914|NCT01642615|10027873|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
2911915|NCT01642615|10027874|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
2911916|NCT01642615|10027872|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2912090|NCT01641926|10028318|P4|Overall Study|Lost to Follow-up|0
2911917|NCT01642615|10027873|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2911918|NCT01642615|10027874|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
2911919|NCT01642602|10027888|P1|Overall Study|Adverse Event|2
2911920|NCT01642589|10027895|P2|Overall Study|Withdrawal by Subject|1
2911921|NCT01642589|10027896|P1|Overall Study|Withdrawal by Subject|1
2911922|NCT01642407|10027935|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
2911923|NCT01642407|10027935|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
2911924|NCT01642407|10027935|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
2911925|NCT01642277|10027982|P2|Overall Study|Withdrawal by Subject|0
2911926|NCT01642277|10027983|P1|Overall Study|Withdrawal by Subject|11
2911927|NCT01642277|10027982|P2|Overall Study|Protocol Violation|0
2911928|NCT01642277|10027983|P1|Overall Study|Protocol Violation|1
2911929|NCT01642277|10027982|P2|Overall Study|Physician Decision|0
2911930|NCT01642277|10027983|P1|Overall Study|Physician Decision|2
2911931|NCT01642277|10027982|P2|Overall Study|Adverse Event|0
2911932|NCT01642277|10027983|P1|Overall Study|Adverse Event|10
2911933|NCT01642251|10027995|P4|Overall Study|Ineligible/never start protocol therapy|8
2911934|NCT01642251|10027996|P3|Overall Study|Ineligible/never start protocol therapy|11
2911935|NCT01642251|10027997|P2|Overall Study|Ineligible/never start protocol therapy|0
2911936|NCT01642251|10027998|P1|Overall Study|Ineligible/never start protocol therapy|0
2911937|NCT01642251|10027995|P4|Overall Study|Other complicating disease|0
2911938|NCT01642251|10027996|P3|Overall Study|Other complicating disease|1
2911939|NCT01642251|10027997|P2|Overall Study|Other complicating disease|0
2911940|NCT01642251|10027998|P1|Overall Study|Other complicating disease|0
2911941|NCT01642251|10027995|P4|Overall Study|Alternative therapy|2
2911942|NCT01642251|10027996|P3|Overall Study|Alternative therapy|0
2911943|NCT01642251|10027997|P2|Overall Study|Alternative therapy|0
2911944|NCT01642251|10027998|P1|Overall Study|Alternative therapy|0
2911945|NCT01642251|10027995|P4|Overall Study|Withdrawal by Subject|3
2911946|NCT01642251|10027996|P3|Overall Study|Withdrawal by Subject|1
2911947|NCT01642251|10027997|P2|Overall Study|Withdrawal by Subject|0
2911948|NCT01642251|10027998|P1|Overall Study|Withdrawal by Subject|0
2911949|NCT01642251|10027995|P4|Overall Study|Death|3
2911950|NCT01642251|10027996|P3|Overall Study|Death|1
2911951|NCT01642251|10027997|P2|Overall Study|Death|0
2911952|NCT01642251|10027998|P1|Overall Study|Death|0
2911953|NCT01642251|10027995|P4|Overall Study|Adverse Event|4
2911954|NCT01642251|10027996|P3|Overall Study|Adverse Event|5
2911955|NCT01642251|10027997|P2|Overall Study|Adverse Event|0
2911956|NCT01642251|10027998|P1|Overall Study|Adverse Event|0
2911957|NCT01642251|10027995|P4|Overall Study|Progressive disease|3
2911958|NCT01642251|10027996|P3|Overall Study|Progressive disease|3
2911959|NCT01642251|10027997|P2|Overall Study|Progressive disease|0
2911960|NCT01642251|10027998|P1|Overall Study|Progressive disease|0
2911961|NCT01642212|10028036|P5|Open-label Extension|Other|1
2911962|NCT01642212|10028037|P4|Open-label Extension|Other|0
2911963|NCT01642212|10028038|P3|Open-label Extension|Other|0
2911964|NCT01642212|10028039|P2|Open-label Extension|Other|0
2911965|NCT01642212|10028040|P1|Open-label Extension|Other|0
2911966|NCT01642212|10028036|P5|Open-label Extension|Lost to Follow-up|1
2911967|NCT01642212|10028037|P4|Open-label Extension|Lost to Follow-up|0
2911968|NCT01642212|10028038|P3|Open-label Extension|Lost to Follow-up|0
2911969|NCT01642212|10028039|P2|Open-label Extension|Lost to Follow-up|0
2911970|NCT01642212|10028040|P1|Open-label Extension|Lost to Follow-up|0
2911971|NCT01642212|10028036|P5|Open-label Extension|Consent Withdrawn|2
2911972|NCT01642212|10028037|P4|Open-label Extension|Consent Withdrawn|0
2911973|NCT01642212|10028038|P3|Open-label Extension|Consent Withdrawn|0
2911974|NCT01642212|10028039|P2|Open-label Extension|Consent Withdrawn|0
2911975|NCT01642212|10028040|P1|Open-label Extension|Consent Withdrawn|0
2911976|NCT01642212|10028036|P5|Open-label Extension|Sponsor Decision|4
2911977|NCT01642212|10028037|P4|Open-label Extension|Sponsor Decision|7
2911978|NCT01642212|10028038|P3|Open-label Extension|Sponsor Decision|0
2911979|NCT01642212|10028039|P2|Open-label Extension|Sponsor Decision|0
2911980|NCT01642212|10028040|P1|Open-label Extension|Sponsor Decision|0
2911981|NCT01642212|10028036|P5|Open-label Extension|Adverse Event|0
2911982|NCT01642212|10028037|P4|Open-label Extension|Adverse Event|3
2911983|NCT01642212|10028038|P3|Open-label Extension|Adverse Event|0
2911984|NCT01642212|10028039|P2|Open-label Extension|Adverse Event|0
2911985|NCT01642212|10028040|P1|Open-label Extension|Adverse Event|0
2911986|NCT01642212|10028036|P5|Double-blind Treatment|Adverse Event|0
2911987|NCT01642212|10028037|P4|Double-blind Treatment|Adverse Event|0
2911988|NCT01642212|10028038|P3|Double-blind Treatment|Adverse Event|1
2911989|NCT01642212|10028039|P2|Double-blind Treatment|Adverse Event|0
2911990|NCT01642212|10028040|P1|Double-blind Treatment|Adverse Event|0
2911991|NCT01642212|10028036|P5|Double-blind Treatment|Non-compliance|0
2911992|NCT01642212|10028037|P4|Double-blind Treatment|Non-compliance|0
2911993|NCT01642212|10028038|P3|Double-blind Treatment|Non-compliance|0
2911994|NCT01642212|10028039|P2|Double-blind Treatment|Non-compliance|1
2911995|NCT01642212|10028040|P1|Double-blind Treatment|Non-compliance|0
2911996|NCT01642212|10028036|P5|Double-blind Treatment|Other|0
2911997|NCT01642212|10028037|P4|Double-blind Treatment|Other|0
2911998|NCT01642212|10028038|P3|Double-blind Treatment|Other|1
2911999|NCT01642212|10028039|P2|Double-blind Treatment|Other|2
2912000|NCT01642212|10028040|P1|Double-blind Treatment|Other|0
2912001|NCT01642212|10028036|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2912002|NCT01642212|10028037|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2912003|NCT01642212|10028038|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2912004|NCT01642212|10028039|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2912005|NCT01642212|10028040|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
2912006|NCT01642004|10028135|P2|Treatment|Missing from data|1
2912007|NCT01642004|10028136|P1|Treatment|Missing from data|0
2912008|NCT01642004|10028135|P2|Treatment|Other|2
2912009|NCT01642004|10028136|P1|Treatment|Other|1
2912010|NCT01642004|10028135|P2|Treatment|No longer meets study criteria|2
2912011|NCT01642004|10028136|P1|Treatment|No longer meets study criteria|1
2912012|NCT01642004|10028135|P2|Treatment|Poor/non-compliance|0
2912013|NCT01642004|10028136|P1|Treatment|Poor/non-compliance|1
2912014|NCT01642004|10028135|P2|Treatment|Maximum clinical benefit|7
2912015|NCT01642004|10028136|P1|Treatment|Maximum clinical benefit|2
2912016|NCT01642004|10028135|P2|Treatment|Withdrawal by Subject|9
2912017|NCT01642004|10028136|P1|Treatment|Withdrawal by Subject|5
2912018|NCT01642004|10028135|P2|Treatment|Adverse event unrelated to study drug|13
2912019|NCT01642004|10028136|P1|Treatment|Adverse event unrelated to study drug|6
2912020|NCT01642004|10028135|P2|Treatment|Death|0
2912021|NCT01642004|10028136|P1|Treatment|Death|1
2912022|NCT01642004|10028135|P2|Treatment|Study drug toxicity|13
2912023|NCT01642004|10028136|P1|Treatment|Study drug toxicity|5
2912024|NCT01642004|10028135|P2|Treatment|Disease progression|80
2912025|NCT01642004|10028136|P1|Treatment|Disease progression|88
2912026|NCT01642004|10028135|P2|Randomization|No longer meets study criteria|2
2912027|NCT01642004|10028136|P1|Randomization|No longer meets study criteria|2
2912028|NCT01642004|10028135|P2|Randomization|Withdrawal by Subject|6
2912029|NCT01642004|10028136|P1|Randomization|Withdrawal by Subject|1
2912030|NCT01642004|10028135|P2|Randomization|Adverse Event unrelated to study drug|0
2912031|NCT01642004|10028136|P1|Randomization|Adverse Event unrelated to study drug|1
2912032|NCT01641991|10028170|P4|Overall Study|no longer eligible|4
2912033|NCT01641991|10028171|P3|Overall Study|no longer eligible|0
2912034|NCT01641991|10028172|P2|Overall Study|no longer eligible|1
2912035|NCT01641991|10028173|P1|Overall Study|no longer eligible|2
2912036|NCT01641991|10028170|P4|Overall Study|Pregnancy|0
2912037|NCT01641991|10028171|P3|Overall Study|Pregnancy|1
2912038|NCT01641991|10028172|P2|Overall Study|Pregnancy|0
2912039|NCT01641991|10028173|P1|Overall Study|Pregnancy|0
2912040|NCT01641991|10028170|P4|Overall Study|Protocol Violation|0
2912041|NCT01641991|10028171|P3|Overall Study|Protocol Violation|3
2912042|NCT01641991|10028172|P2|Overall Study|Protocol Violation|1
2912043|NCT01641991|10028173|P1|Overall Study|Protocol Violation|1
2912044|NCT01641991|10028170|P4|Overall Study|Lost to Follow-up|1
2912045|NCT01641991|10028171|P3|Overall Study|Lost to Follow-up|3
2912046|NCT01641991|10028172|P2|Overall Study|Lost to Follow-up|2
2912047|NCT01641991|10028173|P1|Overall Study|Lost to Follow-up|0
2912048|NCT01641991|10028170|P4|Overall Study|Adverse Event|1
2912049|NCT01641991|10028171|P3|Overall Study|Adverse Event|2
2912050|NCT01641991|10028172|P2|Overall Study|Adverse Event|1
2912051|NCT01641991|10028173|P1|Overall Study|Adverse Event|2
2912052|NCT01641991|10028170|P4|Overall Study|Withdrawal by Subject|5
2912053|NCT01641991|10028171|P3|Overall Study|Withdrawal by Subject|1
2912054|NCT01641991|10028172|P2|Overall Study|Withdrawal by Subject|2
2912055|NCT01641991|10028173|P1|Overall Study|Withdrawal by Subject|4
2912056|NCT01641991|10028170|P4|Overall Study|Physician Decision|5
2912057|NCT01641991|10028171|P3|Overall Study|Physician Decision|7
2912058|NCT01641991|10028172|P2|Overall Study|Physician Decision|1
2912059|NCT01641991|10028173|P1|Overall Study|Physician Decision|0
2912060|NCT01641952|10028257|P1|Overall Study|Adverse Event|6
2912061|NCT01641952|10028257|P1|Overall Study|Lost to Follow-up|28
2912062|NCT01641939|10028273|P3|Overall Study|Study Terminated by Sponsor|3
2912063|NCT01641939|10028274|P2|Overall Study|Study Terminated by Sponsor|28
2912064|NCT01641939|10028275|P1|Overall Study|Study Terminated by Sponsor|10
2912065|NCT01641939|10028273|P3|Overall Study|Withdrawal by Subject|5
2912066|NCT01641939|10028274|P2|Overall Study|Withdrawal by Subject|11
2912067|NCT01641939|10028275|P1|Overall Study|Withdrawal by Subject|14
2912068|NCT01641939|10028273|P3|Overall Study|Lost to Follow-up|1
2912069|NCT01641939|10028274|P2|Overall Study|Lost to Follow-up|2
2912070|NCT01641939|10028275|P1|Overall Study|Lost to Follow-up|3
2912071|NCT01641939|10028273|P3|Overall Study|Death|61
2912072|NCT01641939|10028274|P2|Overall Study|Death|187
2912073|NCT01641939|10028275|P1|Overall Study|Death|90
2912074|NCT01641926|10028318|P4|Overall Study|Not Treated|0
2912075|NCT01641926|10028319|P3|Overall Study|Not Treated|1
2912076|NCT01641926|10028320|P2|Overall Study|Not Treated|1
2912077|NCT01641926|10028321|P1|Overall Study|Not Treated|1
2912078|NCT01641926|10028318|P4|Overall Study|Withdrawal by Subject|1
2912079|NCT01641926|10028319|P3|Overall Study|Withdrawal by Subject|6
2912080|NCT01641926|10028320|P2|Overall Study|Withdrawal by Subject|5
2912081|NCT01641926|10028321|P1|Overall Study|Withdrawal by Subject|13
2912082|NCT01641926|10028318|P4|Overall Study|Protocol Violation|1
2912083|NCT01641926|10028319|P3|Overall Study|Protocol Violation|0
2912084|NCT01641926|10028320|P2|Overall Study|Protocol Violation|0
2912085|NCT01641926|10028321|P1|Overall Study|Protocol Violation|1
2912086|NCT01641926|10028318|P4|Overall Study|Physician Decision|1
2912087|NCT01641926|10028319|P3|Overall Study|Physician Decision|0
2912088|NCT01641926|10028320|P2|Overall Study|Physician Decision|5
2912089|NCT01641926|10028321|P1|Overall Study|Physician Decision|6
2912091|NCT01641926|10028319|P3|Overall Study|Lost to Follow-up|1
2912092|NCT01641926|10028320|P2|Overall Study|Lost to Follow-up|2
2912093|NCT01641926|10028321|P1|Overall Study|Lost to Follow-up|2
2912094|NCT01641926|10028318|P4|Overall Study|Adverse Event|1
2912095|NCT01641926|10028319|P3|Overall Study|Adverse Event|3
2912096|NCT01641926|10028320|P2|Overall Study|Adverse Event|2
2912097|NCT01641926|10028321|P1|Overall Study|Adverse Event|5
2912098|NCT01641900|10028349|P2|Overall Study|Withdrawal by Subject|2
2912099|NCT01641900|10028350|P1|Overall Study|Withdrawal by Subject|2
2912100|NCT01641861|10028362|P2|Overall Study|Died due to drowning|1
2912101|NCT01641861|10028363|P1|Overall Study|Died due to drowning|0
2912102|NCT01641861|10028362|P2|Overall Study|Lost the tooth due to normal exfoliation|8
2912103|NCT01641861|10028363|P1|Overall Study|Lost the tooth due to normal exfoliation|14
2912104|NCT01641861|10028362|P2|Overall Study|Lost to Follow-up|16
2912105|NCT01641861|10028363|P1|Overall Study|Lost to Follow-up|21
2912106|NCT01641822|10028384|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
2912107|NCT01641822|10028385|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
2912108|NCT01641822|10028386|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
2912109|NCT01641822|10028384|P3|Comparative Phase|Withdrew consent|7
2912110|NCT01641822|10028385|P2|Comparative Phase|Withdrew consent|3
2912111|NCT01641822|10028386|P1|Comparative Phase|Withdrew consent|0
2912112|NCT01641822|10028384|P3|Comparative Phase|Adverse event, serious fatal|0
2912113|NCT01641822|10028385|P2|Comparative Phase|Adverse event, serious fatal|1
2912114|NCT01641822|10028386|P1|Comparative Phase|Adverse event, serious fatal|0
2912115|NCT01641822|10028384|P3|Comparative Phase|Pregnancy|1
2912116|NCT01641822|10028385|P2|Comparative Phase|Pregnancy|0
2912117|NCT01641822|10028386|P1|Comparative Phase|Pregnancy|0
2912118|NCT01641822|10028384|P3|Comparative Phase|Investigator's discretion|1
2912119|NCT01641822|10028385|P2|Comparative Phase|Investigator's discretion|0
2912120|NCT01641822|10028386|P1|Comparative Phase|Investigator's discretion|0
2912121|NCT01641822|10028384|P3|Comparative Phase|Noncompliance with study drug|0
2912122|NCT01641822|10028385|P2|Comparative Phase|Noncompliance with study drug|1
2912123|NCT01641822|10028386|P1|Comparative Phase|Noncompliance with study drug|0
2912124|NCT01641822|10028384|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
2912125|NCT01641822|10028385|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
2912126|NCT01641822|10028386|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
2912127|NCT01641822|10028384|P3|Run-in Phase|Withdrew consent|0
2912128|NCT01641822|10028385|P2|Run-in Phase|Withdrew consent|0
2912129|NCT01641822|10028386|P1|Run-in Phase|Withdrew consent|1
2912130|NCT01641822|10028384|P3|Run-in Phase|Adverse Event|0
2912131|NCT01641822|10028385|P2|Run-in Phase|Adverse Event|0
2912132|NCT01641822|10028386|P1|Run-in Phase|Adverse Event|3
2912133|NCT01641822|10028384|P3|Run-in Phase|Noncompliance with study drug|0
2912134|NCT01641822|10028385|P2|Run-in Phase|Noncompliance with study drug|0
2912135|NCT01641822|10028386|P1|Run-in Phase|Noncompliance with study drug|1
2912136|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
2912137|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
2912138|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
2912139|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
2912140|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2912141|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2912142|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
2912143|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
2912144|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
2912145|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
2912146|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
2912147|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
2912148|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Site closed|0
2912149|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Site closed|0
2912150|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Site closed|0
2912151|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Site closed|1
2912152|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
2912153|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2912154|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
2912155|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2912156|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
2912157|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
2912158|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
2912159|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
2912160|NCT01641809|10028407|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
2912161|NCT01641809|10028408|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
2912162|NCT01641809|10028409|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
2912163|NCT01641809|10028410|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
2912164|NCT01641809|10028407|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
2912165|NCT01641809|10028408|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2912166|NCT01641809|10028409|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
2912167|NCT01641809|10028410|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2912168|NCT01641809|10028407|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
2912169|NCT01641809|10028408|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
2912170|NCT01641809|10028409|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2912171|NCT01641809|10028410|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2912172|NCT01641809|10028407|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2912173|NCT01641809|10028408|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
2912174|NCT01641809|10028409|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
2912175|NCT01641809|10028410|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2912176|NCT01641809|10028407|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2912177|NCT01641809|10028408|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2912178|NCT01641809|10028409|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
2912179|NCT01641809|10028410|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2912180|NCT01641809|10028407|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
2912181|NCT01641809|10028408|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
2912182|NCT01641809|10028409|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
2912183|NCT01641809|10028410|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
2912184|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
2912185|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
2912186|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
2912187|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
2912188|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
2912189|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
2912190|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
2912191|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
2912192|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
2912193|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2912194|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2912195|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
2912196|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
2912197|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
2912198|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
2912199|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
2912200|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2912201|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2912202|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2912203|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2912204|NCT01641809|10028407|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2912205|NCT01641809|10028408|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
2912206|NCT01641809|10028409|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2912207|NCT01641809|10028410|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2912208|NCT01641692|10028594|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2912209|NCT01641692|10028595|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2912210|NCT01641692|10028596|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2912211|NCT01641692|10028597|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2912212|NCT01641692|10028598|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2912213|NCT01641692|10028599|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2912214|NCT01641692|10028600|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2912215|NCT01641692|10028601|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2912216|NCT01641692|10028594|P8|Washout Period 3 or Follow-up|Protocol Violation|0
2912217|NCT01641692|10028595|P7|Washout Period 3 or Follow-up|Protocol Violation|0
2912218|NCT01641692|10028596|P6|Washout Period 3 or Follow-up|Protocol Violation|1
2912219|NCT01641692|10028597|P5|Washout Period 3 or Follow-up|Protocol Violation|0
2912220|NCT01641692|10028598|P4|Washout Period 3 or Follow-up|Protocol Violation|0
2912221|NCT01641692|10028599|P3|Washout Period 3 or Follow-up|Protocol Violation|0
2912222|NCT01641692|10028600|P2|Washout Period 3 or Follow-up|Protocol Violation|0
2912223|NCT01641692|10028601|P1|Washout Period 3 or Follow-up|Protocol Violation|0
2912224|NCT01641692|10028594|P8|Treatment Period 3|Lost to Follow-up|0
2912225|NCT01641692|10028595|P7|Treatment Period 3|Lost to Follow-up|0
2912226|NCT01641692|10028596|P6|Treatment Period 3|Lost to Follow-up|0
2912227|NCT01641692|10028597|P5|Treatment Period 3|Lost to Follow-up|0
2912228|NCT01641692|10028598|P4|Treatment Period 3|Lost to Follow-up|0
2912229|NCT01641692|10028599|P3|Treatment Period 3|Lost to Follow-up|0
2912230|NCT01641692|10028600|P2|Treatment Period 3|Lost to Follow-up|1
2912231|NCT01641692|10028601|P1|Treatment Period 3|Lost to Follow-up|0
2912232|NCT01641692|10028594|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912233|NCT01641692|10028595|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
2912234|NCT01641692|10028596|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912235|NCT01641692|10028597|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912236|NCT01641692|10028598|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912237|NCT01641692|10028599|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912238|NCT01641692|10028600|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912239|NCT01641692|10028601|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
2912240|NCT01641692|10028594|P8|Treatment Period 3|Protocol Violation|0
2912241|NCT01641692|10028595|P7|Treatment Period 3|Protocol Violation|0
2912242|NCT01641692|10028596|P6|Treatment Period 3|Protocol Violation|0
2912243|NCT01641692|10028597|P5|Treatment Period 3|Protocol Violation|0
2912244|NCT01641692|10028598|P4|Treatment Period 3|Protocol Violation|0
2912245|NCT01641692|10028599|P3|Treatment Period 3|Protocol Violation|1
2912246|NCT01641692|10028600|P2|Treatment Period 3|Protocol Violation|0
2912247|NCT01641692|10028601|P1|Treatment Period 3|Protocol Violation|0
2912248|NCT01641692|10028594|P8|Treatment Period 3|Adverse Event|0
2912249|NCT01641692|10028595|P7|Treatment Period 3|Adverse Event|1
2912250|NCT01641692|10028596|P6|Treatment Period 3|Adverse Event|0
2912251|NCT01641692|10028597|P5|Treatment Period 3|Adverse Event|0
2912252|NCT01641692|10028598|P4|Treatment Period 3|Adverse Event|0
2912253|NCT01641692|10028599|P3|Treatment Period 3|Adverse Event|0
2912254|NCT01641692|10028600|P2|Treatment Period 3|Adverse Event|0
2912255|NCT01641692|10028601|P1|Treatment Period 3|Adverse Event|0
2912256|NCT01641692|10028594|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2912257|NCT01641692|10028595|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2912258|NCT01641692|10028596|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2912259|NCT01641692|10028597|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2912260|NCT01641692|10028598|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2912261|NCT01641692|10028599|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2912262|NCT01641692|10028600|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2912263|NCT01641692|10028601|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2912264|NCT01641692|10028594|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912265|NCT01641692|10028595|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
2912266|NCT01641692|10028596|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912267|NCT01641692|10028597|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
2912268|NCT01641692|10028598|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912269|NCT01641692|10028599|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912270|NCT01641692|10028600|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912271|NCT01641692|10028601|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912272|NCT01641692|10028594|P8|Treatment Period 2|Withdrawal by Subject|1
2912273|NCT01641692|10028595|P7|Treatment Period 2|Withdrawal by Subject|0
2912274|NCT01641692|10028596|P6|Treatment Period 2|Withdrawal by Subject|1
2912275|NCT01641692|10028597|P5|Treatment Period 2|Withdrawal by Subject|0
2912276|NCT01641692|10028598|P4|Treatment Period 2|Withdrawal by Subject|0
2912277|NCT01641692|10028599|P3|Treatment Period 2|Withdrawal by Subject|0
2912278|NCT01641692|10028600|P2|Treatment Period 2|Withdrawal by Subject|0
2912279|NCT01641692|10028601|P1|Treatment Period 2|Withdrawal by Subject|1
2912280|NCT01641692|10028594|P8|Treatment Period 2|Lost to Follow-up|0
2912281|NCT01641692|10028595|P7|Treatment Period 2|Lost to Follow-up|0
2912282|NCT01641692|10028596|P6|Treatment Period 2|Lost to Follow-up|1
2912283|NCT01641692|10028597|P5|Treatment Period 2|Lost to Follow-up|0
2912284|NCT01641692|10028598|P4|Treatment Period 2|Lost to Follow-up|0
2912285|NCT01641692|10028599|P3|Treatment Period 2|Lost to Follow-up|0
2912286|NCT01641692|10028600|P2|Treatment Period 2|Lost to Follow-up|0
2912287|NCT01641692|10028601|P1|Treatment Period 2|Lost to Follow-up|0
2912288|NCT01641692|10028594|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912289|NCT01641692|10028595|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912290|NCT01641692|10028596|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912291|NCT01641692|10028597|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912292|NCT01641692|10028598|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912293|NCT01641692|10028599|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912294|NCT01641692|10028600|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
2912295|NCT01641692|10028601|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
2912296|NCT01641692|10028594|P8|Treatment Period 2|Lack of Efficacy|0
2912297|NCT01641692|10028595|P7|Treatment Period 2|Lack of Efficacy|0
2912298|NCT01641692|10028596|P6|Treatment Period 2|Lack of Efficacy|0
2912299|NCT01641692|10028597|P5|Treatment Period 2|Lack of Efficacy|0
2912300|NCT01641692|10028598|P4|Treatment Period 2|Lack of Efficacy|0
2912301|NCT01641692|10028599|P3|Treatment Period 2|Lack of Efficacy|0
2912302|NCT01641692|10028600|P2|Treatment Period 2|Lack of Efficacy|0
2912303|NCT01641692|10028601|P1|Treatment Period 2|Lack of Efficacy|1
2912304|NCT01641692|10028594|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2912305|NCT01641692|10028595|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2912306|NCT01641692|10028596|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2912307|NCT01641692|10028597|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2912308|NCT01641692|10028598|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2912309|NCT01641692|10028599|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2912310|NCT01641692|10028600|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2912311|NCT01641692|10028601|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2912312|NCT01641692|10028594|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2912313|NCT01641692|10028595|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912314|NCT01641692|10028596|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912315|NCT01641692|10028597|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2912316|NCT01641692|10028598|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2912317|NCT01641692|10028599|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2912318|NCT01641692|10028600|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2912319|NCT01641692|10028601|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2912320|NCT01641692|10028594|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912321|NCT01641692|10028595|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
2912322|NCT01641692|10028596|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912323|NCT01641692|10028597|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912324|NCT01641692|10028598|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912325|NCT01641692|10028599|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912326|NCT01641692|10028600|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912327|NCT01641692|10028601|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
2912328|NCT01641692|10028594|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
2912329|NCT01641692|10028595|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
2912330|NCT01641692|10028596|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
2912331|NCT01641692|10028597|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
2912332|NCT01641692|10028598|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
2912333|NCT01641692|10028599|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
2912334|NCT01641692|10028600|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
2912335|NCT01641692|10028601|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
2912336|NCT01641692|10028594|P8|Treatment Period 1|Withdrawal by Subject|1
2912337|NCT01641692|10028595|P7|Treatment Period 1|Withdrawal by Subject|0
2912338|NCT01641692|10028596|P6|Treatment Period 1|Withdrawal by Subject|2
2912339|NCT01641692|10028597|P5|Treatment Period 1|Withdrawal by Subject|0
2912340|NCT01641692|10028598|P4|Treatment Period 1|Withdrawal by Subject|0
2912341|NCT01641692|10028599|P3|Treatment Period 1|Withdrawal by Subject|0
2912342|NCT01641692|10028600|P2|Treatment Period 1|Withdrawal by Subject|0
2912343|NCT01641692|10028601|P1|Treatment Period 1|Withdrawal by Subject|0
2912344|NCT01641692|10028594|P8|Treatment Period 1|Physician Decision|0
2912345|NCT01641692|10028595|P7|Treatment Period 1|Physician Decision|0
2912346|NCT01641692|10028596|P6|Treatment Period 1|Physician Decision|0
2912347|NCT01641692|10028597|P5|Treatment Period 1|Physician Decision|1
2912348|NCT01641692|10028598|P4|Treatment Period 1|Physician Decision|0
2912349|NCT01641692|10028599|P3|Treatment Period 1|Physician Decision|0
2912350|NCT01641692|10028600|P2|Treatment Period 1|Physician Decision|0
2912351|NCT01641692|10028601|P1|Treatment Period 1|Physician Decision|0
2912352|NCT01641692|10028594|P8|Treatment Period 1|Lost to Follow-up|0
2912353|NCT01641692|10028595|P7|Treatment Period 1|Lost to Follow-up|0
2912354|NCT01641692|10028596|P6|Treatment Period 1|Lost to Follow-up|0
2912355|NCT01641692|10028597|P5|Treatment Period 1|Lost to Follow-up|0
2912356|NCT01641692|10028598|P4|Treatment Period 1|Lost to Follow-up|0
2912357|NCT01641692|10028599|P3|Treatment Period 1|Lost to Follow-up|1
2912358|NCT01641692|10028600|P2|Treatment Period 1|Lost to Follow-up|0
2912359|NCT01641692|10028601|P1|Treatment Period 1|Lost to Follow-up|0
2912360|NCT01641692|10028594|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
2912361|NCT01641692|10028595|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912362|NCT01641692|10028596|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912363|NCT01641692|10028597|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
2912364|NCT01641692|10028598|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912365|NCT01641692|10028599|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912366|NCT01641692|10028600|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912367|NCT01641692|10028601|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
2912368|NCT01641692|10028594|P8|Treatment Period 1|Protocol Violation|0
2912369|NCT01641692|10028595|P7|Treatment Period 1|Protocol Violation|0
2912370|NCT01641692|10028596|P6|Treatment Period 1|Protocol Violation|0
2912371|NCT01641692|10028597|P5|Treatment Period 1|Protocol Violation|2
2912372|NCT01641692|10028598|P4|Treatment Period 1|Protocol Violation|0
2912373|NCT01641692|10028599|P3|Treatment Period 1|Protocol Violation|0
2912374|NCT01641692|10028600|P2|Treatment Period 1|Protocol Violation|0
2912375|NCT01641692|10028601|P1|Treatment Period 1|Protocol Violation|1
2912376|NCT01641692|10028594|P8|Treatment Period 1|Lack of Efficacy|1
2912377|NCT01641692|10028595|P7|Treatment Period 1|Lack of Efficacy|0
2912378|NCT01641692|10028596|P6|Treatment Period 1|Lack of Efficacy|0
2912379|NCT01641692|10028597|P5|Treatment Period 1|Lack of Efficacy|0
2912380|NCT01641692|10028598|P4|Treatment Period 1|Lack of Efficacy|0
2912381|NCT01641692|10028599|P3|Treatment Period 1|Lack of Efficacy|0
2912382|NCT01641692|10028600|P2|Treatment Period 1|Lack of Efficacy|0
2912383|NCT01641692|10028601|P1|Treatment Period 1|Lack of Efficacy|0
2912384|NCT01641692|10028594|P8|Treatment Period 1|Adverse Event|0
2912385|NCT01641692|10028595|P7|Treatment Period 1|Adverse Event|0
2912386|NCT01641692|10028596|P6|Treatment Period 1|Adverse Event|0
2912387|NCT01641692|10028597|P5|Treatment Period 1|Adverse Event|0
2912388|NCT01641692|10028598|P4|Treatment Period 1|Adverse Event|0
2912389|NCT01641692|10028599|P3|Treatment Period 1|Adverse Event|0
2912390|NCT01641692|10028600|P2|Treatment Period 1|Adverse Event|0
2912391|NCT01641692|10028601|P1|Treatment Period 1|Adverse Event|1
2912392|NCT01641640|10028801|P1|Overall Study|Adverse Event|1
2912393|NCT01641640|10028801|P1|Overall Study|Withdrawal by Subject|2
2912394|NCT01641640|10028801|P1|Overall Study|Lost to Follow-up|3
2912395|NCT01641640|10028801|P1|Overall Study|Efficacy failure|29
2912396|NCT01641640|10028801|P1|Overall Study|Enrolled but not treated|1
2912397|NCT01641471|10028812|P2|Overall Study|Protocol Violation|4
2912398|NCT01641471|10028813|P1|Overall Study|Protocol Violation|2
2912399|NCT01641471|10028812|P2|Overall Study|Lost to Follow-up|4
2912400|NCT01641471|10028813|P1|Overall Study|Lost to Follow-up|2
2912401|NCT01641471|10028812|P2|Overall Study|Withdrawal by Subject|19
2912402|NCT01641471|10028813|P1|Overall Study|Withdrawal by Subject|19
2912403|NCT01641367|10028845|P8|Randomized Adherence Intervention|Lost to Follow-up|12
2912404|NCT01641367|10028846|P7|Randomized Adherence Intervention|Lost to Follow-up|8
2912405|NCT01641367|10028847|P6|Randomized Adherence Intervention|Lost to Follow-up|0
2912406|NCT01641367|10028848|P5|Randomized Adherence Intervention|Lost to Follow-up|0
2912407|NCT01641367|10028849|P4|Randomized Adherence Intervention|Lost to Follow-up|0
2912408|NCT01641367|10028850|P3|Randomized Adherence Intervention|Lost to Follow-up|0
2912409|NCT01641367|10028851|P2|Randomized Adherence Intervention|Lost to Follow-up|0
2912410|NCT01641367|10028852|P1|Randomized Adherence Intervention|Lost to Follow-up|0
2912411|NCT01641367|10028845|P8|Randomized Adherence Intervention|Death|12
2912412|NCT01641367|10028846|P7|Randomized Adherence Intervention|Death|11
2912413|NCT01641367|10028847|P6|Randomized Adherence Intervention|Death|0
2912414|NCT01641367|10028848|P5|Randomized Adherence Intervention|Death|0
2912415|NCT01641367|10028849|P4|Randomized Adherence Intervention|Death|0
2912416|NCT01641367|10028850|P3|Randomized Adherence Intervention|Death|0
2912417|NCT01641367|10028851|P2|Randomized Adherence Intervention|Death|0
2912418|NCT01641367|10028852|P1|Randomized Adherence Intervention|Death|0
2912419|NCT01641367|10028845|P8|Cohorts|Lost to Follow-up|0
2912420|NCT01641367|10028846|P7|Cohorts|Lost to Follow-up|0
2912421|NCT01641367|10028847|P6|Cohorts|Lost to Follow-up|0
2912422|NCT01641367|10028848|P5|Cohorts|Lost to Follow-up|2
2912423|NCT01641367|10028849|P4|Cohorts|Lost to Follow-up|0
2912424|NCT01641367|10028850|P3|Cohorts|Lost to Follow-up|2
2912425|NCT01641367|10028851|P2|Cohorts|Lost to Follow-up|0
2912426|NCT01641367|10028852|P1|Cohorts|Lost to Follow-up|16
2912427|NCT01641367|10028845|P8|Cohorts|Death|0
2912428|NCT01641367|10028846|P7|Cohorts|Death|0
2912429|NCT01641367|10028847|P6|Cohorts|Death|1
2912430|NCT01641367|10028848|P5|Cohorts|Death|1
2912431|NCT01641367|10028849|P4|Cohorts|Death|0
2912432|NCT01641367|10028850|P3|Cohorts|Death|2
2912433|NCT01641367|10028851|P2|Cohorts|Death|1
2912434|NCT01641367|10028852|P1|Cohorts|Death|18
2912435|NCT01641237|10029103|P4|Period III|Lost to Follow-up|0
2912436|NCT01641237|10029104|P3|Period III|Lost to Follow-up|0
2912437|NCT01641237|10029105|P2|Period III|Lost to Follow-up|0
2912438|NCT01641237|10029106|P1|Period III|Lost to Follow-up|1
2912439|NCT01641237|10029103|P4|Period II|Withdrawal by Subject|0
2912440|NCT01641237|10029104|P3|Period II|Withdrawal by Subject|0
2912441|NCT01641237|10029105|P2|Period II|Withdrawal by Subject|0
2912442|NCT01641237|10029106|P1|Period II|Withdrawal by Subject|1
2912443|NCT01641198|10029131|P3|At 15-20 Years of Function|Death|1
2912444|NCT01641198|10029132|P2|At 15-20 Years of Function|Death|0
2912445|NCT01641198|10029133|P1|At 15-20 Years of Function|Death|1
2912446|NCT01641198|10029131|P3|At 15-20 Years of Function|Lost to Follow-up|1
2912447|NCT01641198|10029132|P2|At 15-20 Years of Function|Lost to Follow-up|1
2912448|NCT01641198|10029133|P1|At 15-20 Years of Function|Lost to Follow-up|5
2912449|NCT01641198|10029131|P3|After 24 Months of Function|Lost to Follow-up|6
2912450|NCT01641198|10029132|P2|After 24 Months of Function|Lost to Follow-up|9
2912451|NCT01641198|10029133|P1|After 24 Months of Function|Lost to Follow-up|4
2912452|NCT01641198|10029131|P3|After 12 Months of Function|Adverse Event|0
2912453|NCT01641198|10029132|P2|After 12 Months of Function|Adverse Event|1
2912454|NCT01641198|10029133|P1|After 12 Months of Function|Adverse Event|0
2912455|NCT01641198|10029131|P3|After 12 Months of Function|Protocol Violation|0
2912456|NCT01641198|10029132|P2|After 12 Months of Function|Protocol Violation|0
2912457|NCT01641198|10029133|P1|After 12 Months of Function|Protocol Violation|1
2912458|NCT01641198|10029131|P3|After 12 Months of Function|Lost to Follow-up|2
2912459|NCT01641198|10029132|P2|After 12 Months of Function|Lost to Follow-up|2
2912460|NCT01641198|10029133|P1|After 12 Months of Function|Lost to Follow-up|3
2912461|NCT01641159|10029149|P2|Overall Study|Withdrawal by Subject|1
2912462|NCT01641159|10029150|P1|Overall Study|Withdrawal by Subject|0
2912463|NCT01641159|10029149|P2|Overall Study|Lost to Follow-up|1
2912464|NCT01641159|10029150|P1|Overall Study|Lost to Follow-up|2
2912465|NCT01641133|10029161|P3|Overall Study|Lost to Follow-up|2
2912466|NCT01641133|10029162|P2|Overall Study|Lost to Follow-up|2
2912467|NCT01641133|10029163|P1|Overall Study|Lost to Follow-up|0
2912468|NCT01641133|10029161|P3|Overall Study|Withdrawal by Subject|3
2912469|NCT01641133|10029162|P2|Overall Study|Withdrawal by Subject|3
2912470|NCT01641133|10029163|P1|Overall Study|Withdrawal by Subject|5
2912471|NCT01641133|10029161|P3|Overall Study|Adverse Event|1
2912472|NCT01641133|10029162|P2|Overall Study|Adverse Event|0
2912473|NCT01641133|10029163|P1|Overall Study|Adverse Event|0
2912474|NCT01641133|10029161|P3|Overall Study|Migrated/moved from study area|1
2912475|NCT01641133|10029162|P2|Overall Study|Migrated/moved from study area|3
2912476|NCT01641133|10029163|P1|Overall Study|Migrated/moved from study area|5
2912477|NCT01641133|10029161|P3|Overall Study|Protocol Violation|1
2912478|NCT01641133|10029162|P2|Overall Study|Protocol Violation|1
2912479|NCT01641133|10029163|P1|Overall Study|Protocol Violation|0
2912480|NCT01641081|10029216|P10|Period 5|Adverse Event|0
2912481|NCT01641081|10029217|P9|Period 5|Adverse Event|0
2912482|NCT01641081|10029218|P8|Period 5|Adverse Event|0
2912483|NCT01641081|10029219|P7|Period 5|Adverse Event|0
2912484|NCT01641081|10029220|P6|Period 5|Adverse Event|0
2912485|NCT01641081|10029221|P5|Period 5|Adverse Event|0
2912486|NCT01641081|10029222|P4|Period 5|Adverse Event|0
2912487|NCT01641081|10029223|P3|Period 5|Adverse Event|2
2912488|NCT01641081|10029224|P2|Period 5|Adverse Event|0
2912489|NCT01641081|10029225|P1|Period 5|Adverse Event|0
2912490|NCT01641081|10029216|P10|Period 4|Adverse Event|0
2912491|NCT01641081|10029217|P9|Period 4|Adverse Event|0
2912492|NCT01641081|10029218|P8|Period 4|Adverse Event|0
2912493|NCT01641081|10029219|P7|Period 4|Adverse Event|0
2912494|NCT01641081|10029220|P6|Period 4|Adverse Event|0
2912495|NCT01641081|10029221|P5|Period 4|Adverse Event|0
2912496|NCT01641081|10029222|P4|Period 4|Adverse Event|1
2912497|NCT01641081|10029223|P3|Period 4|Adverse Event|0
2912498|NCT01641081|10029224|P2|Period 4|Adverse Event|1
2912499|NCT01641081|10029225|P1|Period 4|Adverse Event|0
2912500|NCT01641081|10029216|P10|Period 3|Withdrawal by Subject|0
2912501|NCT01641081|10029217|P9|Period 3|Withdrawal by Subject|1
2912502|NCT01641081|10029218|P8|Period 3|Withdrawal by Subject|0
2912503|NCT01641081|10029219|P7|Period 3|Withdrawal by Subject|0
2912504|NCT01641081|10029220|P6|Period 3|Withdrawal by Subject|0
2912505|NCT01641081|10029221|P5|Period 3|Withdrawal by Subject|0
2912506|NCT01641081|10029222|P4|Period 3|Withdrawal by Subject|0
2912507|NCT01641081|10029223|P3|Period 3|Withdrawal by Subject|0
2912508|NCT01641081|10029224|P2|Period 3|Withdrawal by Subject|0
2912509|NCT01641081|10029225|P1|Period 3|Withdrawal by Subject|0
2912510|NCT01641081|10029216|P10|Period 3|Adverse Event|0
2912511|NCT01641081|10029217|P9|Period 3|Adverse Event|0
2912512|NCT01641081|10029218|P8|Period 3|Adverse Event|0
2912513|NCT01641081|10029219|P7|Period 3|Adverse Event|0
2912514|NCT01641081|10029220|P6|Period 3|Adverse Event|0
2912515|NCT01641081|10029221|P5|Period 3|Adverse Event|0
2912516|NCT01641081|10029222|P4|Period 3|Adverse Event|0
2912517|NCT01641081|10029223|P3|Period 3|Adverse Event|1
2912518|NCT01641081|10029224|P2|Period 3|Adverse Event|0
2912519|NCT01641081|10029225|P1|Period 3|Adverse Event|0
2912520|NCT01641081|10029216|P10|Period 2|Protocol Violation|0
2912521|NCT01641081|10029217|P9|Period 2|Protocol Violation|0
2912522|NCT01641081|10029218|P8|Period 2|Protocol Violation|0
2912523|NCT01641081|10029219|P7|Period 2|Protocol Violation|0
2912524|NCT01641081|10029220|P6|Period 2|Protocol Violation|0
2912525|NCT01641081|10029221|P5|Period 2|Protocol Violation|0
2912526|NCT01641081|10029222|P4|Period 2|Protocol Violation|0
2912527|NCT01641081|10029223|P3|Period 2|Protocol Violation|0
2912528|NCT01641081|10029224|P2|Period 2|Protocol Violation|0
2912529|NCT01641081|10029225|P1|Period 2|Protocol Violation|1
2912530|NCT01641081|10029216|P10|Period 2|Withdrawal by Subject|0
2912531|NCT01641081|10029217|P9|Period 2|Withdrawal by Subject|0
2912532|NCT01641081|10029218|P8|Period 2|Withdrawal by Subject|0
2912533|NCT01641081|10029219|P7|Period 2|Withdrawal by Subject|2
2912534|NCT01641081|10029220|P6|Period 2|Withdrawal by Subject|0
2912535|NCT01641081|10029221|P5|Period 2|Withdrawal by Subject|0
2912536|NCT01641081|10029222|P4|Period 2|Withdrawal by Subject|1
2912537|NCT01641081|10029223|P3|Period 2|Withdrawal by Subject|0
2912538|NCT01641081|10029224|P2|Period 2|Withdrawal by Subject|0
2912539|NCT01641081|10029225|P1|Period 2|Withdrawal by Subject|0
2912540|NCT01641081|10029216|P10|Period 2|Adverse Event|0
2912541|NCT01641081|10029217|P9|Period 2|Adverse Event|0
2912542|NCT01641081|10029218|P8|Period 2|Adverse Event|0
2912543|NCT01641081|10029219|P7|Period 2|Adverse Event|0
2912544|NCT01641081|10029220|P6|Period 2|Adverse Event|1
2912545|NCT01641081|10029221|P5|Period 2|Adverse Event|0
2912546|NCT01641081|10029222|P4|Period 2|Adverse Event|0
2912547|NCT01641081|10029223|P3|Period 2|Adverse Event|0
2912548|NCT01641081|10029224|P2|Period 2|Adverse Event|0
2912549|NCT01641081|10029225|P1|Period 2|Adverse Event|0
2912550|NCT01641081|10029216|P10|Period 1|Adverse Event|0
2912551|NCT01641081|10029217|P9|Period 1|Adverse Event|0
2912552|NCT01641081|10029218|P8|Period 1|Adverse Event|2
2912553|NCT01641081|10029219|P7|Period 1|Adverse Event|0
2912554|NCT01641081|10029220|P6|Period 1|Adverse Event|0
2912555|NCT01641081|10029221|P5|Period 1|Adverse Event|0
2912556|NCT01641081|10029222|P4|Period 1|Adverse Event|0
2912557|NCT01641081|10029223|P3|Period 1|Adverse Event|0
2912558|NCT01641081|10029224|P2|Period 1|Adverse Event|0
2912559|NCT01641081|10029225|P1|Period 1|Adverse Event|1
2912560|NCT01641081|10029216|P10|Period 1|Protocol Violation|0
2912561|NCT01641081|10029217|P9|Period 1|Protocol Violation|0
2912562|NCT01641081|10029218|P8|Period 1|Protocol Violation|1
2912563|NCT01641081|10029219|P7|Period 1|Protocol Violation|0
2912564|NCT01641081|10029220|P6|Period 1|Protocol Violation|0
2912565|NCT01641081|10029221|P5|Period 1|Protocol Violation|1
2912566|NCT01641081|10029222|P4|Period 1|Protocol Violation|0
2912567|NCT01641081|10029223|P3|Period 1|Protocol Violation|0
2912568|NCT01641081|10029224|P2|Period 1|Protocol Violation|0
2912569|NCT01641081|10029225|P1|Period 1|Protocol Violation|0
2912570|NCT01641081|10029216|P10|Period 1|Sponsor request (potential unblinding)|0
2912571|NCT01641081|10029217|P9|Period 1|Sponsor request (potential unblinding)|0
2912572|NCT01641081|10029218|P8|Period 1|Sponsor request (potential unblinding)|0
2912573|NCT01641081|10029219|P7|Period 1|Sponsor request (potential unblinding)|1
2912574|NCT01641081|10029220|P6|Period 1|Sponsor request (potential unblinding)|0
2912575|NCT01641081|10029221|P5|Period 1|Sponsor request (potential unblinding)|0
2912576|NCT01641081|10029222|P4|Period 1|Sponsor request (potential unblinding)|0
2912577|NCT01641081|10029223|P3|Period 1|Sponsor request (potential unblinding)|0
2912578|NCT01641081|10029224|P2|Period 1|Sponsor request (potential unblinding)|0
2912579|NCT01641081|10029225|P1|Period 1|Sponsor request (potential unblinding)|0
2912580|NCT01640964|10029294|P3|Overall Study|Protocol Deviation|2
2912581|NCT01640964|10029295|P2|Overall Study|Protocol Deviation|1
2912582|NCT01640964|10029296|P1|Overall Study|Protocol Deviation|1
2912583|NCT01640964|10029294|P3|Overall Study|Lost to Follow-up|1
2912584|NCT01640964|10029295|P2|Overall Study|Lost to Follow-up|0
2912585|NCT01640964|10029296|P1|Overall Study|Lost to Follow-up|0
2912586|NCT01640951|10029319|P8|Overall Study|Death|2
2912587|NCT01640951|10029320|P7|Overall Study|Death|0
2912588|NCT01640951|10029321|P6|Overall Study|Death|0
2912589|NCT01640951|10029322|P5|Overall Study|Death|0
2912590|NCT01640951|10029323|P4|Overall Study|Death|0
2912591|NCT01640951|10029324|P3|Overall Study|Death|1
2912592|NCT01640951|10029325|P2|Overall Study|Death|1
2912593|NCT01640951|10029326|P1|Overall Study|Death|0
2912594|NCT01640951|10029319|P8|Overall Study|Subject/Guardian decision|4
2912595|NCT01640951|10029320|P7|Overall Study|Subject/Guardian decision|5
2912596|NCT01640951|10029321|P6|Overall Study|Subject/Guardian decision|19
2912597|NCT01640951|10029322|P5|Overall Study|Subject/Guardian decision|7
2912598|NCT01640951|10029323|P4|Overall Study|Subject/Guardian decision|15
2912599|NCT01640951|10029324|P3|Overall Study|Subject/Guardian decision|13
2912600|NCT01640951|10029325|P2|Overall Study|Subject/Guardian decision|4
2912601|NCT01640951|10029326|P1|Overall Study|Subject/Guardian decision|12
2912602|NCT01640951|10029319|P8|Overall Study|Protocol Deviation|0
2912603|NCT01640951|10029320|P7|Overall Study|Protocol Deviation|0
2912604|NCT01640951|10029321|P6|Overall Study|Protocol Deviation|1
2912605|NCT01640951|10029322|P5|Overall Study|Protocol Deviation|0
2912606|NCT01640951|10029323|P4|Overall Study|Protocol Deviation|1
2912607|NCT01640951|10029324|P3|Overall Study|Protocol Deviation|2
2912608|NCT01640951|10029325|P2|Overall Study|Protocol Deviation|1
2912609|NCT01640951|10029326|P1|Overall Study|Protocol Deviation|0
2912610|NCT01640951|10029319|P8|Overall Study|Pregnancy|0
2912611|NCT01640951|10029320|P7|Overall Study|Pregnancy|2
2912612|NCT01640951|10029321|P6|Overall Study|Pregnancy|0
2912613|NCT01640951|10029322|P5|Overall Study|Pregnancy|0
2912614|NCT01640951|10029323|P4|Overall Study|Pregnancy|4
2912615|NCT01640951|10029324|P3|Overall Study|Pregnancy|0
2912616|NCT01640951|10029325|P2|Overall Study|Pregnancy|0
2912617|NCT01640951|10029326|P1|Overall Study|Pregnancy|3
2912618|NCT01640951|10029319|P8|Overall Study|Physician Decision|0
2912619|NCT01640951|10029320|P7|Overall Study|Physician Decision|3
2912620|NCT01640951|10029321|P6|Overall Study|Physician Decision|3
2912621|NCT01640951|10029322|P5|Overall Study|Physician Decision|2
2912622|NCT01640951|10029323|P4|Overall Study|Physician Decision|2
2912623|NCT01640951|10029324|P3|Overall Study|Physician Decision|2
2912624|NCT01640951|10029325|P2|Overall Study|Physician Decision|5
2912625|NCT01640951|10029326|P1|Overall Study|Physician Decision|2
2912626|NCT01640951|10029319|P8|Overall Study|Non-compliance with study treatment|0
2912627|NCT01640951|10029320|P7|Overall Study|Non-compliance with study treatment|1
2912628|NCT01640951|10029321|P6|Overall Study|Non-compliance with study treatment|4
2912629|NCT01640951|10029322|P5|Overall Study|Non-compliance with study treatment|1
2912630|NCT01640951|10029323|P4|Overall Study|Non-compliance with study treatment|1
2912631|NCT01640951|10029324|P3|Overall Study|Non-compliance with study treatment|1
2912632|NCT01640951|10029325|P2|Overall Study|Non-compliance with study treatment|0
2912633|NCT01640951|10029326|P1|Overall Study|Non-compliance with study treatment|0
2912634|NCT01640951|10029319|P8|Overall Study|Lost to Follow-up|1
2912635|NCT01640951|10029320|P7|Overall Study|Lost to Follow-up|1
2912636|NCT01640951|10029321|P6|Overall Study|Lost to Follow-up|3
2912637|NCT01640951|10029322|P5|Overall Study|Lost to Follow-up|2
2912638|NCT01640951|10029323|P4|Overall Study|Lost to Follow-up|2
2912639|NCT01640951|10029324|P3|Overall Study|Lost to Follow-up|6
2912640|NCT01640951|10029325|P2|Overall Study|Lost to Follow-up|0
2912641|NCT01640951|10029326|P1|Overall Study|Lost to Follow-up|1
2912642|NCT01640951|10029319|P8|Overall Study|Lack of Efficacy|6
2912643|NCT01640951|10029320|P7|Overall Study|Lack of Efficacy|5
2912644|NCT01640951|10029321|P6|Overall Study|Lack of Efficacy|6
2912645|NCT01640951|10029322|P5|Overall Study|Lack of Efficacy|0
2912646|NCT01640951|10029323|P4|Overall Study|Lack of Efficacy|14
2912647|NCT01640951|10029324|P3|Overall Study|Lack of Efficacy|7
2912648|NCT01640951|10029325|P2|Overall Study|Lack of Efficacy|1
2912649|NCT01640951|10029326|P1|Overall Study|Lack of Efficacy|20
2912650|NCT01640951|10029319|P8|Overall Study|Adverse Event|3
2912651|NCT01640951|10029320|P7|Overall Study|Adverse Event|1
2912652|NCT01640951|10029321|P6|Overall Study|Adverse Event|11
2912653|NCT01640951|10029322|P5|Overall Study|Adverse Event|1
2912654|NCT01640951|10029323|P4|Overall Study|Adverse Event|6
2912655|NCT01640951|10029324|P3|Overall Study|Adverse Event|10
2912656|NCT01640951|10029325|P2|Overall Study|Adverse Event|3
2912657|NCT01640951|10029326|P1|Overall Study|Adverse Event|8
2912658|NCT01640925|10029428|P2|Overall Study|Previously enrolled in this trial|11
2912659|NCT01640925|10029429|P1|Overall Study|Previously enrolled in this trial|13
2912660|NCT01640925|10029428|P2|Overall Study|Withdrawal by Subject|0
2912661|NCT01640925|10029429|P1|Overall Study|Withdrawal by Subject|1
2912662|NCT01640873|10029443|P2|Overall Study|Protocol Violation|1
2912663|NCT01640873|10029444|P1|Overall Study|Protocol Violation|2
2912664|NCT01640366|10029517|P1|Overall Study|Lost to Follow-up|5
2912665|NCT01640366|10029517|P1|Overall Study|Protocol Violation|16
2912666|NCT01640366|10029517|P1|Overall Study|Withdrawal by Subject|1
2912667|NCT01640353|10029530|P1|Overall Study|Physician Decision|1
2912668|NCT01640353|10029530|P1|Overall Study|Lost to Follow-up|12
2912669|NCT01640353|10029530|P1|Overall Study|Early site termination|3
2912670|NCT01640353|10029530|P1|Overall Study|Death|2
2912671|NCT01640353|10029530|P1|Overall Study|Withdrawal by Subject|5
2912672|NCT01640353|10029530|P1|Overall Study|Withdrawn from analysis at term site|12
2912673|NCT01640353|10029530|P1|Overall Study|Withdrew prior to treatment|10
2912674|NCT01640314|10029578|P2|Overall Study|Protocol Violation|1
2912675|NCT01640314|10029579|P1|Overall Study|Protocol Violation|0
2912676|NCT01640249|10029600|P7|Period 1|Withdrawal by Subject|0
2912677|NCT01640249|10029601|P6|Period 1|Withdrawal by Subject|1
2912678|NCT01640249|10029602|P5|Period 1|Withdrawal by Subject|0
2912679|NCT01640249|10029603|P4|Period 1|Withdrawal by Subject|0
2912680|NCT01640249|10029604|P3|Period 1|Withdrawal by Subject|0
2912681|NCT01640249|10029605|P2|Period 1|Withdrawal by Subject|0
2912682|NCT01640249|10029606|P1|Period 1|Withdrawal by Subject|1
2912683|NCT01640184|10029654|P3|Overall Study|Protocol Violation|1
2912684|NCT01640184|10029655|P2|Overall Study|Protocol Violation|0
2912685|NCT01640184|10029656|P1|Overall Study|Protocol Violation|0
2912686|NCT01640184|10029654|P3|Overall Study|Withdrawal by Subject|1
2912687|NCT01640184|10029655|P2|Overall Study|Withdrawal by Subject|1
2912688|NCT01640184|10029656|P1|Overall Study|Withdrawal by Subject|0
2912689|NCT01640184|10029654|P3|Overall Study|Physician Decision|0
2912690|NCT01640184|10029655|P2|Overall Study|Physician Decision|0
2912691|NCT01640184|10029656|P1|Overall Study|Physician Decision|3
2912692|NCT01640184|10029654|P3|Overall Study|Lost to Follow-up|0
2912693|NCT01640184|10029655|P2|Overall Study|Lost to Follow-up|1
2912694|NCT01640184|10029656|P1|Overall Study|Lost to Follow-up|4
2912695|NCT01640184|10029654|P3|Overall Study|Death|0
2912696|NCT01640184|10029655|P2|Overall Study|Death|0
2912697|NCT01640184|10029656|P1|Overall Study|Death|1
2912698|NCT01640054|10029685|P1|Overall Study|Adverse Event|2
2912699|NCT01640054|10029685|P1|Overall Study|Lack of Efficacy|3
2912700|NCT01640054|10029685|P1|Overall Study|Study-specific disc criteria|1
2912701|NCT01639833|10029706|P2|Overall Study|Withdrawal by Subject|2
2912702|NCT01639833|10029707|P1|Overall Study|Withdrawal by Subject|2
2912703|NCT01639833|10029706|P2|Overall Study|Death|2
2912704|NCT01639833|10029707|P1|Overall Study|Death|4
2912705|NCT01639755|10029715|P1|Overall Study|Patient had device explantation|4
2912706|NCT01639755|10029715|P1|Overall Study|Study Ongoing|15
2912707|NCT01639742|10029723|P1|Overall Study|Lost to Follow-up|1
2912708|NCT01639742|10029723|P1|Overall Study|Study Ongoing|17
2912709|NCT01639729|10029731|P6|Overall Study|Withdrawal by Subject|0
2912710|NCT01639729|10029732|P5|Overall Study|Withdrawal by Subject|0
2912711|NCT01639729|10029733|P4|Overall Study|Withdrawal by Subject|1
2912712|NCT01639729|10029734|P3|Overall Study|Withdrawal by Subject|1
2912713|NCT01639729|10029735|P2|Overall Study|Withdrawal by Subject|0
2912714|NCT01639729|10029736|P1|Overall Study|Withdrawal by Subject|1
2912715|NCT01639703|10029758|P1|Overall Study|Other reason|7
2912716|NCT01639703|10029758|P1|Overall Study|Withdrawal by Subject|5
2912717|NCT01639560|10029801|P2|Overall Study|Adverse Event|2
2912718|NCT01639560|10029802|P1|Overall Study|Adverse Event|0
2912719|NCT01639560|10029801|P2|Overall Study|Lost to Follow-up|11
2912720|NCT01639560|10029802|P1|Overall Study|Lost to Follow-up|9
2912721|NCT01639560|10029801|P2|Overall Study|Lack of Efficacy|2
2912722|NCT01639560|10029802|P1|Overall Study|Lack of Efficacy|1
2912723|NCT01639560|10029801|P2|Overall Study|Withdrawal by Subject|14
2912724|NCT01639560|10029802|P1|Overall Study|Withdrawal by Subject|9
2912725|NCT01639495|10029814|P1|Overall Study|No radiofrequency energy applied|2
2912726|NCT01639495|10029814|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
2912727|NCT01639495|10029814|P1|Overall Study|Consented but didn’t have study catheter|4
2912728|NCT01639495|10029814|P1|Overall Study|Lost to Follow-up|6
2912729|NCT01639469|10029824|P2|Overall Study|Lost to Follow-up|1
2912730|NCT01639469|10029825|P1|Overall Study|Lost to Follow-up|1
2912731|NCT01639469|10029824|P2|Overall Study|Death|2
2912732|NCT01639469|10029825|P1|Overall Study|Death|4
2912733|NCT01639144|10029930|P2|Overall Study|Met postoperative exclusion criteria|3
2912734|NCT01639144|10029931|P1|Overall Study|Met postoperative exclusion criteria|4
2912735|NCT01639144|10029930|P2|Overall Study|Physician Decision|0
2912736|NCT01639144|10029931|P1|Overall Study|Physician Decision|2
2912737|NCT01639144|10029930|P2|Overall Study|Withdrawal by Subject|2
2912738|NCT01639144|10029931|P1|Overall Study|Withdrawal by Subject|4
2912739|NCT01639040|10029939|P2|Overall Study|Adverse Event|0
2912740|NCT01639040|10029940|P1|Overall Study|Adverse Event|1
2912741|NCT01639001|10029958|P2|Overall Study|Death|35
2912742|NCT01639001|10029959|P1|Overall Study|Death|35
2912743|NCT01639001|10029958|P2|Overall Study|Lost to Follow-up|0
2912744|NCT01639001|10029959|P1|Overall Study|Lost to Follow-up|1
2912745|NCT01639001|10029958|P2|Overall Study|Refused further follow-up|6
2912746|NCT01639001|10029959|P1|Overall Study|Refused further follow-up|3
2912747|NCT01639001|10029958|P2|Overall Study|Ongoing at date of cutoff|60
2912748|NCT01639001|10029959|P1|Overall Study|Ongoing at date of cutoff|65
2912749|NCT01639001|10029958|P2|Overall Study|Randomized but not treated|2
2912750|NCT01639001|10029959|P1|Overall Study|Randomized but not treated|0
2912751|NCT01638819|10030005|P2|Overall Study|Lost to Follow-up|0
2912752|NCT01638819|10030006|P1|Overall Study|Lost to Follow-up|1
2912753|NCT01638559|10030015|P1|Overall Study|Subject declined to travel for biopsy|1
2912754|NCT01638559|10030015|P1|Overall Study|Withdrawal by Subject|1
2912755|NCT01638559|10030015|P1|Overall Study|Lost to Follow-up|1
2912756|NCT01638546|10030033|P2|Overall Study|Adverse Event|3
2912757|NCT01638546|10030034|P1|Overall Study|Adverse Event|1
2912758|NCT01638429|10030073|P1|Overall Study|Withdrawal by Subject|1
2912759|NCT01638390|10030101|P1|Overall Study|screening failures|21
2912760|NCT01638000|10030124|P2|Overall Study|Miscellaneous|2
2912761|NCT01638000|10030125|P1|Overall Study|Miscellaneous|2
2912762|NCT01638000|10030124|P2|Overall Study|Withdrawal by Subject|24
2912763|NCT01638000|10030125|P1|Overall Study|Withdrawal by Subject|21
2912764|NCT01638000|10030124|P2|Overall Study|Protocol Violation|13
2912765|NCT01638000|10030125|P1|Overall Study|Protocol Violation|11
2912766|NCT01638000|10030124|P2|Overall Study|Lack of Efficacy|6
2912767|NCT01638000|10030125|P1|Overall Study|Lack of Efficacy|5
2912768|NCT01638000|10030124|P2|Overall Study|Adverse Event|16
2912769|NCT01638000|10030125|P1|Overall Study|Adverse Event|14
2912770|NCT01638000|10030124|P2|Overall Study|Randomized but Never Received Drug|10
2912771|NCT01638000|10030125|P1|Overall Study|Randomized but Never Received Drug|7
2912772|NCT01637961|10030223|P1|Overall Study|Ineligible: inadequate pathology|1
2912773|NCT01637961|10030223|P1|Overall Study|Ineligible: wrong primary|1
2912774|NCT01637922|10030255|P2|Overall Study|Lost to Follow-up|0
2912775|NCT01637922|10030256|P1|Overall Study|Lost to Follow-up|2
2912776|NCT01637922|10030255|P2|Overall Study|Withdrawal by Subject|3
2912777|NCT01637922|10030256|P1|Overall Study|Withdrawal by Subject|0
2912778|NCT01637922|10030255|P2|Overall Study|Protocol Violation|1
2912779|NCT01637922|10030256|P1|Overall Study|Protocol Violation|0
2912780|NCT01637922|10030255|P2|Overall Study|Adverse Event|1
2912781|NCT01637922|10030256|P1|Overall Study|Adverse Event|0
2912782|NCT01637584|10030285|P2|Overall Study|Withdrawal by Subject|3
2912783|NCT01637584|10030286|P1|Overall Study|Withdrawal by Subject|1
2912784|NCT01637272|10030293|P1|Overall Study|Protocol Violation|2
2912785|NCT01637272|10030293|P1|Overall Study|Administrative problems|1
2912786|NCT01637272|10030293|P1|Overall Study|completed core, did not enter ext. phase|4
2912787|NCT01637272|10030293|P1|Overall Study|Lost to Follow-up|2
2912788|NCT01637272|10030293|P1|Overall Study|Withdrawal by Subject|3
2912789|NCT01637272|10030293|P1|Overall Study|Unsatisfactory therapeutic effect|2
2912790|NCT01637272|10030293|P1|Overall Study|Adverse Event|6
2912791|NCT01637077|10030373|P2|Overall Study|No cycle 1 questionnaire data|0
2912792|NCT01637077|10030374|P1|Overall Study|No cycle 1 questionnaire data|2
2912793|NCT01637077|10030373|P2|Overall Study|Withdrawal by Subject|0
2912794|NCT01637077|10030374|P1|Overall Study|Withdrawal by Subject|1
2912795|NCT01637077|10030373|P2|Overall Study|Cancel|1
2912796|NCT01637077|10030374|P1|Overall Study|Cancel|1
2912797|NCT01636986|10030402|P2|Overall Study|Corneal Staining|1
2912798|NCT01636986|10030403|P1|Overall Study|Corneal Staining|0
2912799|NCT01636986|10030402|P2|Overall Study|Withdrawal by Subject|1
2912800|NCT01636986|10030403|P1|Overall Study|Withdrawal by Subject|0
2912801|NCT01636960|10030409|P1|Maintenance Phase|Progressive disease|1
2912802|NCT01636960|10030409|P1|Maintenance Phase|Adverse Event|3
2912803|NCT01636960|10030409|P1|Maintenance Phase|Continued drug after regulatory approval|3
2912804|NCT01636960|10030409|P1|Induction Phase|Adverse Event|2
2912805|NCT01636947|10030417|P2|Overall Study|Did Not Meet Eligibility Criteria|4
2912806|NCT01636947|10030418|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2912807|NCT01636947|10030417|P2|Overall Study|Adverse Event|1
2912808|NCT01636947|10030418|P1|Overall Study|Adverse Event|1
2912809|NCT01636947|10030417|P2|Overall Study|Withdrawal by Subject|3
2912810|NCT01636947|10030418|P1|Overall Study|Withdrawal by Subject|3
2912811|NCT01636947|10030417|P2|Overall Study|Protocol Violation|1
2912812|NCT01636947|10030418|P1|Overall Study|Protocol Violation|1
2912813|NCT01636947|10030417|P2|Overall Study|Lost to Follow-up|0
2912814|NCT01636947|10030418|P1|Overall Study|Lost to Follow-up|4
2912815|NCT01636947|10030417|P2|Overall Study|Not Treated|2
2912816|NCT01636947|10030418|P1|Overall Study|Not Treated|2
2912817|NCT01636778|10030442|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
2912818|NCT01636778|10030443|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
2912819|NCT01636778|10030444|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
2912820|NCT01636778|10030442|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
2912821|NCT01636778|10030443|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2912822|NCT01636778|10030444|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2912823|NCT01636778|10030442|P3|Follow-up Period After Part 2|Other|1
2912824|NCT01636778|10030443|P2|Follow-up Period After Part 2|Other|0
2912825|NCT01636778|10030444|P1|Follow-up Period After Part 2|Other|0
2912826|NCT01636778|10030442|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
2912827|NCT01636778|10030443|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
2912828|NCT01636778|10030444|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
2912829|NCT01636778|10030442|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2912830|NCT01636778|10030443|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
2912831|NCT01636778|10030444|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2912832|NCT01636778|10030442|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
2912833|NCT01636778|10030443|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
2912834|NCT01636778|10030444|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
2912835|NCT01636778|10030442|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2912836|NCT01636778|10030443|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2912837|NCT01636778|10030444|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
2912838|NCT01636778|10030442|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2912839|NCT01636778|10030443|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2912840|NCT01636778|10030444|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
2912841|NCT01636713|10030515|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
2912842|NCT01636713|10030516|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
2912843|NCT01636713|10030517|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
2912844|NCT01636713|10030515|P3|Overall Study|Withdrawal by Subject|8
2912845|NCT01636713|10030516|P2|Overall Study|Withdrawal by Subject|4
2912846|NCT01636713|10030517|P1|Overall Study|Withdrawal by Subject|5
2912847|NCT01636713|10030515|P3|Overall Study|Lost to Follow-up|1
2912848|NCT01636713|10030516|P2|Overall Study|Lost to Follow-up|0
2912849|NCT01636713|10030517|P1|Overall Study|Lost to Follow-up|0
2912850|NCT01636713|10030515|P3|Overall Study|Protocol Violation|1
2912851|NCT01636713|10030516|P2|Overall Study|Protocol Violation|0
2912852|NCT01636713|10030517|P1|Overall Study|Protocol Violation|3
2912853|NCT01636713|10030515|P3|Overall Study|Lack of Efficacy|2
2912854|NCT01636713|10030516|P2|Overall Study|Lack of Efficacy|6
2912855|NCT01636713|10030517|P1|Overall Study|Lack of Efficacy|6
2912856|NCT01636713|10030515|P3|Overall Study|Adverse Event|7
2912857|NCT01636713|10030516|P2|Overall Study|Adverse Event|16
2912858|NCT01636713|10030517|P1|Overall Study|Adverse Event|16
2912859|NCT01636687|10030534|P5|Follow-up Period|Withdrawal by Subject|1
2912860|NCT01636687|10030535|P4|Follow-up Period|Withdrawal by Subject|0
2912861|NCT01636687|10030536|P3|Follow-up Period|Withdrawal by Subject|0
2912862|NCT01636687|10030537|P2|Follow-up Period|Withdrawal by Subject|0
2912863|NCT01636687|10030538|P1|Follow-up Period|Withdrawal by Subject|1
2912864|NCT01636687|10030534|P5|Extension Period|Withdrawal by Subject|0
2912865|NCT01636687|10030535|P4|Extension Period|Withdrawal by Subject|1
2912866|NCT01636687|10030536|P3|Extension Period|Withdrawal by Subject|1
2912867|NCT01636687|10030537|P2|Extension Period|Withdrawal by Subject|0
2912868|NCT01636687|10030538|P1|Extension Period|Withdrawal by Subject|1
2912869|NCT01636687|10030534|P5|Extension Period|study terminated by sponsor|0
2912870|NCT01636687|10030535|P4|Extension Period|study terminated by sponsor|23
2912871|NCT01636687|10030536|P3|Extension Period|study terminated by sponsor|17
2912872|NCT01636687|10030537|P2|Extension Period|study terminated by sponsor|50
2912873|NCT01636687|10030538|P1|Extension Period|study terminated by sponsor|33
2912874|NCT01636687|10030534|P5|Extension Period|Physician Decision|0
2912875|NCT01636687|10030535|P4|Extension Period|Physician Decision|1
2912876|NCT01636687|10030536|P3|Extension Period|Physician Decision|0
2912877|NCT01636687|10030537|P2|Extension Period|Physician Decision|0
2912878|NCT01636687|10030538|P1|Extension Period|Physician Decision|1
2912879|NCT01636687|10030534|P5|Extension Period|Lost to Follow-up|0
2912880|NCT01636687|10030535|P4|Extension Period|Lost to Follow-up|0
2912881|NCT01636687|10030536|P3|Extension Period|Lost to Follow-up|1
2912882|NCT01636687|10030537|P2|Extension Period|Lost to Follow-up|0
2912883|NCT01636687|10030538|P1|Extension Period|Lost to Follow-up|1
2912884|NCT01636687|10030534|P5|Extension Period|Lack of Efficacy|0
2912885|NCT01636687|10030535|P4|Extension Period|Lack of Efficacy|1
2912886|NCT01636687|10030536|P3|Extension Period|Lack of Efficacy|2
2912887|NCT01636687|10030537|P2|Extension Period|Lack of Efficacy|0
2912888|NCT01636687|10030538|P1|Extension Period|Lack of Efficacy|7
2912889|NCT01636687|10030534|P5|Extension Period|Adverse Event|0
2912890|NCT01636687|10030535|P4|Extension Period|Adverse Event|1
2912891|NCT01636687|10030536|P3|Extension Period|Adverse Event|2
2912892|NCT01636687|10030537|P2|Extension Period|Adverse Event|3
2912893|NCT01636687|10030538|P1|Extension Period|Adverse Event|4
2912894|NCT01636687|10030534|P5|Extension Period|technical problems|0
2912895|NCT01636687|10030535|P4|Extension Period|technical problems|1
2912896|NCT01636687|10030536|P3|Extension Period|technical problems|2
2912897|NCT01636687|10030537|P2|Extension Period|technical problems|1
2912898|NCT01636687|10030538|P1|Extension Period|technical problems|0
2912899|NCT01636687|10030534|P5|Maintenance Period|Physician Decision|1
2912900|NCT01636687|10030535|P4|Maintenance Period|Physician Decision|0
2912901|NCT01636687|10030536|P3|Maintenance Period|Physician Decision|0
2912902|NCT01636687|10030537|P2|Maintenance Period|Physician Decision|0
2912903|NCT01636687|10030538|P1|Maintenance Period|Physician Decision|0
2912904|NCT01636687|10030534|P5|Maintenance Period|Lost to Follow-up|1
2912905|NCT01636687|10030535|P4|Maintenance Period|Lost to Follow-up|0
2912906|NCT01636687|10030536|P3|Maintenance Period|Lost to Follow-up|0
2912907|NCT01636687|10030537|P2|Maintenance Period|Lost to Follow-up|1
2912908|NCT01636687|10030538|P1|Maintenance Period|Lost to Follow-up|1
2912909|NCT01636687|10030534|P5|Maintenance Period|Lack of Efficacy|0
2912910|NCT01636687|10030535|P4|Maintenance Period|Lack of Efficacy|0
2912911|NCT01636687|10030536|P3|Maintenance Period|Lack of Efficacy|0
2912912|NCT01636687|10030537|P2|Maintenance Period|Lack of Efficacy|1
2912913|NCT01636687|10030538|P1|Maintenance Period|Lack of Efficacy|4
2912914|NCT01636687|10030534|P5|Maintenance Period|Adverse Event|0
2912915|NCT01636687|10030535|P4|Maintenance Period|Adverse Event|0
2912916|NCT01636687|10030536|P3|Maintenance Period|Adverse Event|0
2912917|NCT01636687|10030537|P2|Maintenance Period|Adverse Event|0
2912918|NCT01636687|10030538|P1|Maintenance Period|Adverse Event|1
2912919|NCT01636687|10030534|P5|Maintenance Period|Withdrawal by Subject|0
2912920|NCT01636687|10030535|P4|Maintenance Period|Withdrawal by Subject|0
2912921|NCT01636687|10030536|P3|Maintenance Period|Withdrawal by Subject|2
2912922|NCT01636687|10030537|P2|Maintenance Period|Withdrawal by Subject|0
2912923|NCT01636687|10030538|P1|Maintenance Period|Withdrawal by Subject|2
2912924|NCT01636687|10030534|P5|Induction Period|Physician Decision|0
2912925|NCT01636687|10030535|P4|Induction Period|Physician Decision|0
2912926|NCT01636687|10030536|P3|Induction Period|Physician Decision|0
2912927|NCT01636687|10030537|P2|Induction Period|Physician Decision|0
2912928|NCT01636687|10030538|P1|Induction Period|Physician Decision|1
2912929|NCT01636687|10030534|P5|Induction Period|Lack of Efficacy|1
2912930|NCT01636687|10030535|P4|Induction Period|Lack of Efficacy|0
2912931|NCT01636687|10030536|P3|Induction Period|Lack of Efficacy|0
2912932|NCT01636687|10030537|P2|Induction Period|Lack of Efficacy|0
2912933|NCT01636687|10030538|P1|Induction Period|Lack of Efficacy|0
2912934|NCT01636687|10030534|P5|Induction Period|Adverse Event|1
2912935|NCT01636687|10030535|P4|Induction Period|Adverse Event|0
2912936|NCT01636687|10030536|P3|Induction Period|Adverse Event|0
2912937|NCT01636687|10030537|P2|Induction Period|Adverse Event|0
2912938|NCT01636687|10030538|P1|Induction Period|Adverse Event|1
2912939|NCT01636687|10030534|P5|Induction Period|Withdrawal by Subject|0
2912940|NCT01636687|10030535|P4|Induction Period|Withdrawal by Subject|0
2912941|NCT01636687|10030536|P3|Induction Period|Withdrawal by Subject|0
2912942|NCT01636687|10030537|P2|Induction Period|Withdrawal by Subject|0
2912943|NCT01636687|10030538|P1|Induction Period|Withdrawal by Subject|1
2912944|NCT01636362|10030679|P1|Overall Study|Withdrawal by Subject|1
2912945|NCT01636362|10030679|P1|Overall Study|Subject healed, not returning|1
2912946|NCT01636362|10030679|P1|Overall Study|Physician Decision|6
2912947|NCT01636258|10030706|P2|Overall Study|Lost to Follow-up|0
2912948|NCT01636258|10030707|P1|Overall Study|Lost to Follow-up|1
2912949|NCT01636076|10030747|P2|Overall Study|Withdrawal by Subject|10
2912950|NCT01636076|10030748|P1|Overall Study|Withdrawal by Subject|7
2912951|NCT01636076|10030747|P2|Overall Study|Adverse Event|11
2912952|NCT01636076|10030748|P1|Overall Study|Adverse Event|6
2912953|NCT01636076|10030747|P2|Overall Study|Non-compliance with study treatment|1
2912954|NCT01636076|10030748|P1|Overall Study|Non-compliance with study treatment|1
2912955|NCT01636076|10030747|P2|Overall Study|Physician Decision|1
2912956|NCT01636076|10030748|P1|Overall Study|Physician Decision|1
2912957|NCT01636076|10030747|P2|Overall Study|Lost to Follow-up|0
2912958|NCT01636076|10030748|P1|Overall Study|Lost to Follow-up|1
2912959|NCT01636076|10030747|P2|Overall Study|Lack of Efficacy|1
2912960|NCT01636076|10030748|P1|Overall Study|Lack of Efficacy|0
2912961|NCT01636076|10030747|P2|Overall Study|Terminated by sponsor|1
2912962|NCT01636076|10030748|P1|Overall Study|Terminated by sponsor|1
2912963|NCT01635933|10030819|P2|Overall Study|No longer had transportation|1
2912964|NCT01635933|10030820|P1|Overall Study|No longer had transportation|0
2912965|NCT01635933|10030819|P2|Overall Study|Noncompliance|1
2912966|NCT01635933|10030820|P1|Overall Study|Noncompliance|0
2912967|NCT01635933|10030819|P2|Overall Study|Subject decision|1
2912968|NCT01635933|10030820|P1|Overall Study|Subject decision|1
2912969|NCT01635933|10030819|P2|Overall Study|Lost to Follow-up|5
2912970|NCT01635933|10030820|P1|Overall Study|Lost to Follow-up|0
2912971|NCT01635933|10030819|P2|Overall Study|Adverse Event|0
2912972|NCT01635933|10030820|P1|Overall Study|Adverse Event|1
2912973|NCT01635920|10030832|P2|Overall Study|Subject decision|0
2912974|NCT01635920|10030833|P1|Overall Study|Subject decision|2
2912975|NCT01635920|10030832|P2|Overall Study|Lost to Follow-up|1
2912976|NCT01635920|10030833|P1|Overall Study|Lost to Follow-up|0
2912977|NCT01635920|10030832|P2|Overall Study|Adverse Event|0
2912978|NCT01635920|10030833|P1|Overall Study|Adverse Event|1
2912979|NCT01635855|10030846|P1|Overall Study|Withdrawal by Subject|4
2912980|NCT01635764|10030855|P1|Overall Study|Other|28
2912981|NCT01635764|10030855|P1|Overall Study|Lost to Follow-up|53
2912982|NCT01635764|10030855|P1|Overall Study|Withdrew Consent|67
2912983|NCT01635764|10030855|P1|Overall Study|Protocol Deviation|1
2912984|NCT01635764|10030855|P1|Overall Study|Exceed Protocol-specified Interventions|2
2912985|NCT01635764|10030855|P1|Overall Study|Lack of Efficacy|76
2912986|NCT01635764|10030855|P1|Overall Study|Adverse Event|46
2912987|NCT01635218|10030921|P3|Overall Study|Lost to Follow-up|6
2912988|NCT01635218|10030922|P2|Overall Study|Lost to Follow-up|7
2912989|NCT01635218|10030923|P1|Overall Study|Lost to Follow-up|3
2912990|NCT01634854|10030986|P2|Overall Study|Cesarean delivery|7
2912991|NCT01634854|10030987|P1|Overall Study|Cesarean delivery|2
2912992|NCT01634659|10031007|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
2912993|NCT01634659|10031008|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
2912994|NCT01634659|10031007|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
2912995|NCT01634659|10031008|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
2912996|NCT01634555|10031038|P1|Overall Study|Physician Decision|1
2912997|NCT01634555|10031038|P1|Overall Study|Adverse Event|3
2912998|NCT01634360|10031049|P2|Overall Study|Study termination by sponsor|44
2912999|NCT01634360|10031050|P1|Overall Study|Study termination by sponsor|18
2913000|NCT01634360|10031049|P2|Overall Study|Other|20
2913001|NCT01634360|10031050|P1|Overall Study|Other|3
2913002|NCT01634360|10031049|P2|Overall Study|Lack of Efficacy|14
2913003|NCT01634360|10031050|P1|Overall Study|Lack of Efficacy|4
2913004|NCT01634360|10031049|P2|Overall Study|Protocol Violation|1
2913005|NCT01634360|10031050|P1|Overall Study|Protocol Violation|1
2913006|NCT01634360|10031049|P2|Overall Study|subject withdrew consent|23
2913007|NCT01634360|10031050|P1|Overall Study|subject withdrew consent|13
2913008|NCT01634360|10031049|P2|Overall Study|Adverse Event|34
2913009|NCT01634360|10031050|P1|Overall Study|Adverse Event|10
2913010|NCT01634243|10031124|P2|Overall Study|Lack of Efficacy|0
2913011|NCT01634243|10031125|P1|Overall Study|Lack of Efficacy|1
2913012|NCT01634243|10031124|P2|Overall Study|Adverse Event|5
2913013|NCT01634243|10031125|P1|Overall Study|Adverse Event|5
2913014|NCT01634165|10031151|P4|Period 2|Adverse Event|0
2913015|NCT01634165|10031152|P3|Period 2|Adverse Event|0
2913016|NCT01634165|10031153|P2|Period 2|Adverse Event|1
2913017|NCT01634165|10031154|P1|Period 2|Adverse Event|0
2913018|NCT01634152|10031187|P3|Overall Study|Other reason not defined above|1
2913019|NCT01634152|10031188|P2|Overall Study|Other reason not defined above|0
2913020|NCT01634152|10031189|P1|Overall Study|Other reason not defined above|1
2913021|NCT01634152|10031187|P3|Overall Study|Not treated|0
2913022|NCT01634152|10031188|P2|Overall Study|Not treated|1
2913023|NCT01634152|10031189|P1|Overall Study|Not treated|0
2913024|NCT01634152|10031187|P3|Overall Study|Consent withdrawn not due to AE|1
2913025|NCT01634152|10031188|P2|Overall Study|Consent withdrawn not due to AE|0
2913026|NCT01634152|10031189|P1|Overall Study|Consent withdrawn not due to AE|1
2913027|NCT01634152|10031187|P3|Overall Study|Adverse Event|2
2913028|NCT01634152|10031188|P2|Overall Study|Adverse Event|0
2913029|NCT01634152|10031189|P1|Overall Study|Adverse Event|2
2913030|NCT01634139|10031272|P3|Overall Study|Not treated|0
2913031|NCT01634139|10031273|P2|Overall Study|Not treated|1
2913032|NCT01634139|10031274|P1|Overall Study|Not treated|1
2913033|NCT01634139|10031272|P3|Overall Study|Lost to Follow-up|0
2913034|NCT01634139|10031273|P2|Overall Study|Lost to Follow-up|2
2913035|NCT01634139|10031274|P1|Overall Study|Lost to Follow-up|0
2913036|NCT01634139|10031272|P3|Overall Study|Other|3
2913037|NCT01634139|10031273|P2|Overall Study|Other|0
2913038|NCT01634139|10031274|P1|Overall Study|Other|4
2913039|NCT01634139|10031272|P3|Overall Study|Consent withdrawn not due to AE|2
2913040|NCT01634139|10031273|P2|Overall Study|Consent withdrawn not due to AE|3
2913041|NCT01634139|10031274|P1|Overall Study|Consent withdrawn not due to AE|4
2913042|NCT01634139|10031272|P3|Overall Study|Non compliant with protocol|0
2913043|NCT01634139|10031273|P2|Overall Study|Non compliant with protocol|0
2913044|NCT01634139|10031274|P1|Overall Study|Non compliant with protocol|1
2913045|NCT01634113|10031375|P3|Overall Study|Not treated|1
2913046|NCT01634113|10031376|P2|Overall Study|Not treated|0
2913047|NCT01634113|10031377|P1|Overall Study|Not treated|0
2913048|NCT01634100|10031421|P6|Overall Study|Withdrawal by Subject|0
2913049|NCT01634100|10031422|P5|Overall Study|Withdrawal by Subject|0
2913050|NCT01634100|10031423|P4|Overall Study|Withdrawal by Subject|0
2913051|NCT01634100|10031424|P3|Overall Study|Withdrawal by Subject|1
2913052|NCT01634100|10031425|P2|Overall Study|Withdrawal by Subject|0
2913053|NCT01634100|10031426|P1|Overall Study|Withdrawal by Subject|1
2913054|NCT01633944|10031442|P3|Double-blind Treatment Phase|Other|0
2913055|NCT01633944|10031443|P2|Double-blind Treatment Phase|Other|7
2913056|NCT01633944|10031444|P1|Double-blind Treatment Phase|Other|0
2913057|NCT01633944|10031442|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
2913058|NCT01633944|10031443|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
2913059|NCT01633944|10031444|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
2913060|NCT01633944|10031442|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2913061|NCT01633944|10031443|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
2913062|NCT01633944|10031444|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2913063|NCT01633944|10031442|P3|Double-blind Treatment Phase|Lost to Follow-up|9
2913064|NCT01633944|10031443|P2|Double-blind Treatment Phase|Lost to Follow-up|4
2913065|NCT01633944|10031444|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2913066|NCT01633944|10031442|P3|Double-blind Treatment Phase|Protocol Violation|10
2913067|NCT01633944|10031443|P2|Double-blind Treatment Phase|Protocol Violation|7
2913068|NCT01633944|10031444|P1|Double-blind Treatment Phase|Protocol Violation|0
2913069|NCT01633944|10031442|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
2913070|NCT01633944|10031443|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
2913071|NCT01633944|10031444|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
2913072|NCT01633944|10031442|P3|Double-blind Treatment Phase|Lack of Efficacy|23
2913073|NCT01633944|10031443|P2|Double-blind Treatment Phase|Lack of Efficacy|8
2913074|NCT01633944|10031444|P1|Double-blind Treatment Phase|Lack of Efficacy|0
2913075|NCT01633944|10031442|P3|Double-blind Treatment Phase|Adverse Event|7
2913076|NCT01633944|10031443|P2|Double-blind Treatment Phase|Adverse Event|13
2913077|NCT01633944|10031444|P1|Double-blind Treatment Phase|Adverse Event|0
2913078|NCT01633944|10031442|P3|Open-label Titration Phase|Other|0
2913079|NCT01633944|10031443|P2|Open-label Titration Phase|Other|0
2913080|NCT01633944|10031444|P1|Open-label Titration Phase|Other|68
2913081|NCT01633944|10031442|P3|Open-label Titration Phase|Lost to Follow-up|0
2913082|NCT01633944|10031443|P2|Open-label Titration Phase|Lost to Follow-up|0
2913083|NCT01633944|10031444|P1|Open-label Titration Phase|Lost to Follow-up|22
2913084|NCT01633944|10031442|P3|Open-label Titration Phase|Protocol Violation|0
2913085|NCT01633944|10031443|P2|Open-label Titration Phase|Protocol Violation|0
2913086|NCT01633944|10031444|P1|Open-label Titration Phase|Protocol Violation|24
2913087|NCT01633944|10031442|P3|Open-label Titration Phase|Withdrawal by Subject|0
2913088|NCT01633944|10031443|P2|Open-label Titration Phase|Withdrawal by Subject|0
2913089|NCT01633944|10031444|P1|Open-label Titration Phase|Withdrawal by Subject|34
2913090|NCT01633944|10031442|P3|Open-label Titration Phase|Lack of Efficacy|0
2913091|NCT01633944|10031443|P2|Open-label Titration Phase|Lack of Efficacy|0
2913092|NCT01633944|10031444|P1|Open-label Titration Phase|Lack of Efficacy|33
2913093|NCT01633944|10031442|P3|Open-label Titration Phase|Adverse Event|0
2913094|NCT01633944|10031443|P2|Open-label Titration Phase|Adverse Event|0
2913095|NCT01633944|10031444|P1|Open-label Titration Phase|Adverse Event|109
2913096|NCT01633788|10031512|P4|Overall Study|Other Reasons|7
2913097|NCT01633788|10031513|P3|Overall Study|Other Reasons|3
2913098|NCT01633788|10031514|P2|Overall Study|Other Reasons|2
2913099|NCT01633788|10031515|P1|Overall Study|Other Reasons|0
2913100|NCT01633788|10031512|P4|Overall Study|Protocol Violation|0
2913101|NCT01633788|10031513|P3|Overall Study|Protocol Violation|1
2913102|NCT01633788|10031514|P2|Overall Study|Protocol Violation|0
2913103|NCT01633788|10031515|P1|Overall Study|Protocol Violation|1
2913104|NCT01633788|10031512|P4|Overall Study|Personal Reasons|3
2913105|NCT01633788|10031513|P3|Overall Study|Personal Reasons|1
2913106|NCT01633788|10031514|P2|Overall Study|Personal Reasons|1
2913107|NCT01633788|10031515|P1|Overall Study|Personal Reasons|3
2913108|NCT01633788|10031512|P4|Overall Study|Lost to Follow-up|0
2913109|NCT01633788|10031513|P3|Overall Study|Lost to Follow-up|2
2913110|NCT01633788|10031514|P2|Overall Study|Lost to Follow-up|2
2913111|NCT01633788|10031515|P1|Overall Study|Lost to Follow-up|2
2913112|NCT01633788|10031512|P4|Overall Study|Adverse Event|3
2913113|NCT01633788|10031513|P3|Overall Study|Adverse Event|3
2913114|NCT01633788|10031514|P2|Overall Study|Adverse Event|3
2913115|NCT01633788|10031515|P1|Overall Study|Adverse Event|1
2913116|NCT01633112|10031547|P3|Overall Study|missing Study Completion CRF|4
2913117|NCT01633112|10031548|P2|Overall Study|missing Study Completion CRF|1
2913118|NCT01633112|10031549|P1|Overall Study|missing Study Completion CRF|1
2913119|NCT01633112|10031547|P3|Overall Study|Withdrawal by Subject|41
2913120|NCT01633112|10031548|P2|Overall Study|Withdrawal by Subject|12
2913121|NCT01633112|10031549|P1|Overall Study|Withdrawal by Subject|20
2913122|NCT01633112|10031547|P3|Overall Study|Subject no longer requires study drug|1
2913123|NCT01633112|10031548|P2|Overall Study|Subject no longer requires study drug|0
2913124|NCT01633112|10031549|P1|Overall Study|Subject no longer requires study drug|0
2913125|NCT01633112|10031547|P3|Overall Study|Protocol Violation|2
2913126|NCT01633112|10031548|P2|Overall Study|Protocol Violation|0
2913127|NCT01633112|10031549|P1|Overall Study|Protocol Violation|4
2913128|NCT01633112|10031547|P3|Overall Study|Lost to Follow-up|6
2913129|NCT01633112|10031548|P2|Overall Study|Lost to Follow-up|19
2913130|NCT01633112|10031549|P1|Overall Study|Lost to Follow-up|7
2913131|NCT01633112|10031547|P3|Overall Study|Adverse Event|20
2913132|NCT01633112|10031548|P2|Overall Study|Adverse Event|18
2913133|NCT01633112|10031549|P1|Overall Study|Adverse Event|16
2913134|NCT01633112|10031547|P3|Overall Study|Administrative problems|5
2913135|NCT01633112|10031548|P2|Overall Study|Administrative problems|2
2913136|NCT01633112|10031549|P1|Overall Study|Administrative problems|1
2913137|NCT01633112|10031547|P3|Overall Study|Abnormal test procedure result(s)|0
2913138|NCT01633112|10031548|P2|Overall Study|Abnormal test procedure result(s)|1
2913139|NCT01633112|10031549|P1|Overall Study|Abnormal test procedure result(s)|0
2913140|NCT01633112|10031547|P3|Overall Study|Abnormal laboratory value(s)|0
2913141|NCT01633112|10031548|P2|Overall Study|Abnormal laboratory value(s)|1
2913142|NCT01633112|10031549|P1|Overall Study|Abnormal laboratory value(s)|3
2913143|NCT01633112|10031547|P3|Overall Study|Lack of Efficacy|13
2913144|NCT01633112|10031548|P2|Overall Study|Lack of Efficacy|6
2913145|NCT01633112|10031549|P1|Overall Study|Lack of Efficacy|1
2913146|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
2913147|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
2913148|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2913149|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2913150|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
2913151|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
2913152|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
2913153|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
2913154|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
2913155|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
2913156|NCT01633060|10031584|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2913157|NCT01633060|10031585|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
2913158|NCT01633060|10031584|P2|Treatment Phase|Death|3
2913159|NCT01633060|10031585|P1|Treatment Phase|Death|4
2913160|NCT01633060|10031584|P2|Treatment Phase|Subject/guardian decision|4
2913161|NCT01633060|10031585|P1|Treatment Phase|Subject/guardian decision|25
2913162|NCT01633060|10031584|P2|Treatment Phase|Study Terminated by sponsor|3
2913163|NCT01633060|10031585|P1|Treatment Phase|Study Terminated by sponsor|7
2913164|NCT01633060|10031584|P2|Treatment Phase|Protocol Deviation|0
2913165|NCT01633060|10031585|P1|Treatment Phase|Protocol Deviation|1
2913166|NCT01633060|10031584|P2|Treatment Phase|Progressive Disease|120
2913167|NCT01633060|10031585|P1|Treatment Phase|Progressive Disease|210
2913168|NCT01633060|10031584|P2|Treatment Phase|Physician Decision|7
2913169|NCT01633060|10031585|P1|Treatment Phase|Physician Decision|16
2913170|NCT01633060|10031584|P2|Treatment Phase|Lost to Follow-up|0
2913171|NCT01633060|10031585|P1|Treatment Phase|Lost to Follow-up|1
2913172|NCT01633060|10031584|P2|Treatment Phase|Adverse Event|3
2913173|NCT01633060|10031585|P1|Treatment Phase|Adverse Event|24
2913174|NCT01633060|10031584|P2|Randomization Phase|Technical problem|1
2913175|NCT01633060|10031585|P1|Randomization Phase|Technical problem|0
2913176|NCT01633060|10031584|P2|Randomization Phase|Protocol deviation|2
2913177|NCT01633060|10031585|P1|Randomization Phase|Protocol deviation|1
2913178|NCT01632904|10031625|P2|Overall Study|Reason for discontinuation not available|1
2913179|NCT01632904|10031626|P1|Overall Study|Reason for discontinuation not available|0
2913180|NCT01632904|10031625|P2|Overall Study|Disease Progression|1
2913181|NCT01632904|10031626|P1|Overall Study|Disease Progression|0
2913182|NCT01632904|10031625|P2|Overall Study|Subject decision|2
2913183|NCT01632904|10031626|P1|Overall Study|Subject decision|3
2913184|NCT01632904|10031625|P2|Overall Study|Physician Decision|1
2913185|NCT01632904|10031626|P1|Overall Study|Physician Decision|0
2913186|NCT01632904|10031625|P2|Overall Study|Adverse Event|1
2913187|NCT01632904|10031626|P1|Overall Study|Adverse Event|4
2913188|NCT01632891|10031637|P2|Overall Study|Withdrawal by Subject|0
2913189|NCT01632891|10031638|P1|Overall Study|Withdrawal by Subject|1
2913190|NCT01632891|10031637|P2|Overall Study|Lost to Follow-up|1
2913191|NCT01632891|10031638|P1|Overall Study|Lost to Follow-up|0
2913192|NCT01632878|10031662|P1|Treatment|no information on study completion|43
2913193|NCT01632878|10031662|P1|Treatment|missing information|4
2913194|NCT01632878|10031662|P1|Treatment|Physician Decision|34
2913195|NCT01632878|10031662|P1|Treatment|Withdrawal by Subject|36
2913196|NCT01632878|10031662|P1|Treatment|Lost to Follow-up|41
2913197|NCT01632878|10031662|P1|Screening|Physician Decision|268
2913198|NCT01632800|10031666|P1|Overall Study|Subject did not fit in apparatus|1
2913199|NCT01632579|10031733|P9|Period 2 (Second Intervention)|Adverse Event|0
2913200|NCT01632579|10031734|P8|Period 2 (Second Intervention)|Adverse Event|0
2913201|NCT01632579|10031735|P7|Period 2 (Second Intervention)|Adverse Event|0
2913202|NCT01632579|10031736|P6|Period 2 (Second Intervention)|Adverse Event|0
2913203|NCT01632579|10031737|P5|Period 2 (Second Intervention)|Adverse Event|0
2913204|NCT01632579|10031738|P4|Period 2 (Second Intervention)|Adverse Event|0
2913205|NCT01632579|10031739|P3|Period 2 (Second Intervention)|Adverse Event|0
2913206|NCT01632579|10031740|P2|Period 2 (Second Intervention)|Adverse Event|0
2913207|NCT01632579|10031741|P1|Period 2 (Second Intervention)|Adverse Event|1
2913208|NCT01632579|10031733|P9|Washout Period|Adverse Event|0
2913209|NCT01632579|10031734|P8|Washout Period|Adverse Event|0
2913210|NCT01632579|10031735|P7|Washout Period|Adverse Event|0
2913211|NCT01632579|10031736|P6|Washout Period|Adverse Event|0
2913212|NCT01632579|10031737|P5|Washout Period|Adverse Event|0
2913213|NCT01632579|10031738|P4|Washout Period|Adverse Event|0
2913214|NCT01632579|10031739|P3|Washout Period|Adverse Event|0
2913215|NCT01632579|10031740|P2|Washout Period|Adverse Event|0
2913216|NCT01632579|10031741|P1|Washout Period|Adverse Event|1
2913217|NCT01632566|10031808|P5|Overall Study|Sponsor Decision|2
2913218|NCT01632566|10031809|P4|Overall Study|Sponsor Decision|2
2913219|NCT01632566|10031810|P3|Overall Study|Sponsor Decision|9
2913220|NCT01632566|10031811|P2|Overall Study|Sponsor Decision|2
2913221|NCT01632566|10031812|P1|Overall Study|Sponsor Decision|0
2913222|NCT01632566|10031808|P5|Overall Study|Withdrawal by Subject|0
2913223|NCT01632566|10031809|P4|Overall Study|Withdrawal by Subject|0
2913224|NCT01632566|10031810|P3|Overall Study|Withdrawal by Subject|0
2913225|NCT01632566|10031811|P2|Overall Study|Withdrawal by Subject|1
2913226|NCT01632566|10031812|P1|Overall Study|Withdrawal by Subject|0
2913227|NCT01632345|10031863|P7|Treatment: Part II|Withdrawal by Subject|2
2913228|NCT01632345|10031864|P6|Treatment: Part II|Withdrawal by Subject|2
2913229|NCT01632345|10031865|P5|Treatment: Part II|Withdrawal by Subject|0
2913230|NCT01632345|10031866|P4|Treatment: Part II|Withdrawal by Subject|0
2913231|NCT01632345|10031867|P3|Treatment: Part II|Withdrawal by Subject|0
2913232|NCT01632345|10031868|P2|Treatment: Part II|Withdrawal by Subject|0
2913233|NCT01632345|10031869|P1|Treatment: Part II|Withdrawal by Subject|0
2913234|NCT01632345|10031863|P7|Treatment: Part II|Non-Compliance with Study Drug|0
2913235|NCT01632345|10031864|P6|Treatment: Part II|Non-Compliance with Study Drug|3
2913236|NCT01632345|10031865|P5|Treatment: Part II|Non-Compliance with Study Drug|0
2913237|NCT01632345|10031866|P4|Treatment: Part II|Non-Compliance with Study Drug|0
2913238|NCT01632345|10031867|P3|Treatment: Part II|Non-Compliance with Study Drug|0
2913239|NCT01632345|10031868|P2|Treatment: Part II|Non-Compliance with Study Drug|0
2913240|NCT01632345|10031869|P1|Treatment: Part II|Non-Compliance with Study Drug|0
2913241|NCT01632345|10031863|P7|Treatment: Part II|Lost to Follow-up|1
2913242|NCT01632345|10031864|P6|Treatment: Part II|Lost to Follow-up|3
2913243|NCT01632345|10031865|P5|Treatment: Part II|Lost to Follow-up|0
2913244|NCT01632345|10031866|P4|Treatment: Part II|Lost to Follow-up|0
2913245|NCT01632345|10031867|P3|Treatment: Part II|Lost to Follow-up|0
2913246|NCT01632345|10031868|P2|Treatment: Part II|Lost to Follow-up|0
2913247|NCT01632345|10031869|P1|Treatment: Part II|Lost to Follow-up|0
2913248|NCT01632345|10031863|P7|Treatment: Part II|Adverse Event|8
2913249|NCT01632345|10031864|P6|Treatment: Part II|Adverse Event|3
2913250|NCT01632345|10031865|P5|Treatment: Part II|Adverse Event|0
2913251|NCT01632345|10031866|P4|Treatment: Part II|Adverse Event|0
2913252|NCT01632345|10031867|P3|Treatment: Part II|Adverse Event|0
2913253|NCT01632345|10031868|P2|Treatment: Part II|Adverse Event|0
2913254|NCT01632345|10031869|P1|Treatment: Part II|Adverse Event|0
2913255|NCT01632345|10031863|P7|Treatment: Part I|Withdrawal by Subject|0
2913256|NCT01632345|10031864|P6|Treatment: Part I|Withdrawal by Subject|0
2913257|NCT01632345|10031865|P5|Treatment: Part I|Withdrawal by Subject|4
2913258|NCT01632345|10031866|P4|Treatment: Part I|Withdrawal by Subject|1
2913259|NCT01632345|10031867|P3|Treatment: Part I|Withdrawal by Subject|4
2913260|NCT01632345|10031868|P2|Treatment: Part I|Withdrawal by Subject|4
2913261|NCT01632345|10031869|P1|Treatment: Part I|Withdrawal by Subject|3
2913262|NCT01632345|10031863|P7|Treatment: Part I|Protocol Deviation|0
2913263|NCT01632345|10031864|P6|Treatment: Part I|Protocol Deviation|0
2913264|NCT01632345|10031865|P5|Treatment: Part I|Protocol Deviation|0
2913265|NCT01632345|10031866|P4|Treatment: Part I|Protocol Deviation|1
2913266|NCT01632345|10031867|P3|Treatment: Part I|Protocol Deviation|1
2913267|NCT01632345|10031868|P2|Treatment: Part I|Protocol Deviation|0
2913268|NCT01632345|10031869|P1|Treatment: Part I|Protocol Deviation|0
2913269|NCT01632345|10031863|P7|Treatment: Part I|Pregnancy|0
2913270|NCT01632345|10031864|P6|Treatment: Part I|Pregnancy|0
2913271|NCT01632345|10031865|P5|Treatment: Part I|Pregnancy|0
2913272|NCT01632345|10031866|P4|Treatment: Part I|Pregnancy|0
2913273|NCT01632345|10031867|P3|Treatment: Part I|Pregnancy|0
2913274|NCT01632345|10031868|P2|Treatment: Part I|Pregnancy|1
2913275|NCT01632345|10031869|P1|Treatment: Part I|Pregnancy|0
2913276|NCT01632345|10031863|P7|Treatment: Part I|Physician Decision|0
2913277|NCT01632345|10031864|P6|Treatment: Part I|Physician Decision|0
2913278|NCT01632345|10031865|P5|Treatment: Part I|Physician Decision|1
2913279|NCT01632345|10031866|P4|Treatment: Part I|Physician Decision|0
2913280|NCT01632345|10031867|P3|Treatment: Part I|Physician Decision|0
2913281|NCT01632345|10031868|P2|Treatment: Part I|Physician Decision|1
2913282|NCT01632345|10031869|P1|Treatment: Part I|Physician Decision|2
2913283|NCT01632345|10031863|P7|Treatment: Part I|Non-Compliance with Study Drug|0
2913284|NCT01632345|10031864|P6|Treatment: Part I|Non-Compliance with Study Drug|0
2913285|NCT01632345|10031865|P5|Treatment: Part I|Non-Compliance with Study Drug|0
2913286|NCT01632345|10031866|P4|Treatment: Part I|Non-Compliance with Study Drug|1
2913287|NCT01632345|10031867|P3|Treatment: Part I|Non-Compliance with Study Drug|2
2913288|NCT01632345|10031868|P2|Treatment: Part I|Non-Compliance with Study Drug|2
2913289|NCT01632345|10031869|P1|Treatment: Part I|Non-Compliance with Study Drug|3
2913290|NCT01632345|10031863|P7|Treatment: Part I|Lost to Follow-up|0
2913291|NCT01632345|10031864|P6|Treatment: Part I|Lost to Follow-up|0
2913292|NCT01632345|10031865|P5|Treatment: Part I|Lost to Follow-up|4
2913293|NCT01632345|10031866|P4|Treatment: Part I|Lost to Follow-up|3
2913294|NCT01632345|10031867|P3|Treatment: Part I|Lost to Follow-up|1
2913295|NCT01632345|10031868|P2|Treatment: Part I|Lost to Follow-up|2
2913296|NCT01632345|10031869|P1|Treatment: Part I|Lost to Follow-up|3
2913297|NCT01632345|10031863|P7|Treatment: Part I|Lack of Efficacy|0
2913298|NCT01632345|10031864|P6|Treatment: Part I|Lack of Efficacy|0
2913299|NCT01632345|10031865|P5|Treatment: Part I|Lack of Efficacy|1
2913300|NCT01632345|10031866|P4|Treatment: Part I|Lack of Efficacy|1
2913301|NCT01632345|10031867|P3|Treatment: Part I|Lack of Efficacy|0
2913302|NCT01632345|10031868|P2|Treatment: Part I|Lack of Efficacy|1
2913303|NCT01632345|10031869|P1|Treatment: Part I|Lack of Efficacy|0
2913304|NCT01632345|10031863|P7|Treatment: Part I|Adverse Event|0
2913305|NCT01632345|10031864|P6|Treatment: Part I|Adverse Event|0
2913306|NCT01632345|10031865|P5|Treatment: Part I|Adverse Event|3
2913307|NCT01632345|10031866|P4|Treatment: Part I|Adverse Event|1
2913308|NCT01632345|10031867|P3|Treatment: Part I|Adverse Event|2
2913309|NCT01632345|10031868|P2|Treatment: Part I|Adverse Event|4
2913310|NCT01632345|10031869|P1|Treatment: Part I|Adverse Event|1
2913311|NCT01632306|10031931|P3|Overall Study|Protocol Violation|0
2913312|NCT01632306|10031932|P2|Overall Study|Protocol Violation|0
2913313|NCT01632306|10031933|P1|Overall Study|Protocol Violation|1
2913314|NCT01632280|10031949|P2|Overall Study|Withdrawal by Subject|0
2913315|NCT01632280|10031950|P1|Overall Study|Withdrawal by Subject|1
2913316|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
2913317|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
2913318|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
2913319|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
2913320|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
2913321|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
2913322|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Site Closed|8
2913323|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Site Closed|2
2913324|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
2913325|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
2913326|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
2913327|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
2913328|NCT01632241|10031966|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
2913329|NCT01632241|10031967|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
2913330|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Adverse Event|19
2913331|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Adverse Event|10
2913332|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
2913333|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
2913334|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
2913335|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
2913336|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Physician Decision|12
2913337|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Physician Decision|9
2913338|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
2913339|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
2913340|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
2913341|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
2913342|NCT01632241|10031966|P2|Double-blinded (Up to Week 52)|Site Closed|5
2913343|NCT01632241|10031967|P1|Double-blinded (Up to Week 52)|Site Closed|3
2913344|NCT01632150|10032026|P1|Overall Study|Moved to compassionate program|2
2913345|NCT01632150|10032026|P1|Overall Study|Patient underwent autologous transplant|1
2913346|NCT01632150|10032026|P1|Overall Study|Withdrawal by Subject|2
2913347|NCT01632150|10032026|P1|Overall Study|Unrelated adverse event|7
2913348|NCT01632150|10032026|P1|Overall Study|Study drug toxicity|1
2913349|NCT01632150|10032026|P1|Overall Study|Disease progression|27
2913350|NCT01632020|10032035|P2|Overall Study|Adverse Event|0
2913351|NCT01632020|10032036|P1|Overall Study|Adverse Event|1
2913352|NCT01632020|10032035|P2|Overall Study|Withdrawal by Subject|0
2913353|NCT01632020|10032036|P1|Overall Study|Withdrawal by Subject|1
2913354|NCT01631864|10032055|P2|Overall Study|Adverse Event|3
2913355|NCT01631864|10032056|P1|Overall Study|Adverse Event|2
2913356|NCT01631864|10032055|P2|Overall Study|Withdrawal by Subject|1
2913357|NCT01631864|10032056|P1|Overall Study|Withdrawal by Subject|0
2913358|NCT01631825|10032068|P1|Overall Study|Physician Decision|2
2913359|NCT01631825|10032068|P1|Overall Study|Discontinuation criteria|1
2913360|NCT01631825|10032068|P1|Overall Study|Protocol Violation|4
2913361|NCT01631825|10032068|P1|Overall Study|Withdrawal by Subject|9
2913362|NCT01631825|10032068|P1|Overall Study|Lack of Efficacy|7
2913363|NCT01631825|10032068|P1|Overall Study|Adverse Event|42
2913364|NCT01631812|10032088|P1|Overall Study|Physician Decision|3
2913365|NCT01631812|10032088|P1|Overall Study|Withdrawal by Subject|4
2913366|NCT01631812|10032088|P1|Overall Study|Lack of Efficacy|5
2913367|NCT01631812|10032088|P1|Overall Study|Adverse Event|25
2913368|NCT01631747|10032098|P2|One Year Infant Outcomes|Patient Refused|9
2913369|NCT01631747|10032099|P1|One Year Infant Outcomes|Patient Refused|13
2913370|NCT01631747|10032098|P2|Live Birth|Stillbirth|1
2913371|NCT01631747|10032099|P1|Live Birth|Stillbirth|1
2913372|NCT01631747|10032098|P2|Live Birth|MIscarriage|0
2913373|NCT01631747|10032099|P1|Live Birth|MIscarriage|2
2913374|NCT01631747|10032098|P2|Live Birth|Pregnancy Termination|0
2913375|NCT01631747|10032099|P1|Live Birth|Pregnancy Termination|1
2913376|NCT01631747|10032098|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
2913377|NCT01631747|10032099|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
2913378|NCT01631435|10032276|P1|Overall Study|incomplete study procedure|5
2913379|NCT01631435|10032276|P1|Overall Study|Withdrawal by Subject|2
2913380|NCT01631435|10032276|P1|Overall Study|Adverse Event|2
2913381|NCT01631227|10032290|P2|Overall Study|administrative|1
2913382|NCT01631227|10032291|P1|Overall Study|administrative|2
2913383|NCT01631227|10032290|P2|Overall Study|Adverse Event|0
2913384|NCT01631227|10032291|P1|Overall Study|Adverse Event|1
2913385|NCT01631227|10032290|P2|Overall Study|withdrawn consent|21
2913386|NCT01631227|10032291|P1|Overall Study|withdrawn consent|27
2913387|NCT01631214|10032299|P2|Overall Study|Administrative Decision|0
2913388|NCT01631214|10032300|P1|Overall Study|Administrative Decision|1
2913389|NCT01631214|10032299|P2|Overall Study|Ineligibility determined|2
2913390|NCT01631214|10032300|P1|Overall Study|Ineligibility determined|5
2913391|NCT01631214|10032299|P2|Overall Study|Protocol Deviation|3
2913392|NCT01631214|10032300|P1|Overall Study|Protocol Deviation|4
2913393|NCT01631214|10032299|P2|Overall Study|Requirement for Alternative Therapy|3
2913394|NCT01631214|10032300|P1|Overall Study|Requirement for Alternative Therapy|8
2913395|NCT01631214|10032299|P2|Overall Study|Noncompliance|15
2913396|NCT01631214|10032300|P1|Overall Study|Noncompliance|16
2913397|NCT01631214|10032299|P2|Overall Study|Other|19
2913398|NCT01631214|10032300|P1|Overall Study|Other|22
2913399|NCT01631214|10032299|P2|Overall Study|Adverse Event|45
2913400|NCT01631214|10032300|P1|Overall Study|Adverse Event|45
2913401|NCT01631214|10032299|P2|Overall Study|Lost to Follow-up|40
2913402|NCT01631214|10032300|P1|Overall Study|Lost to Follow-up|54
2913403|NCT01631214|10032299|P2|Overall Study|Death|106
2913404|NCT01631214|10032300|P1|Overall Study|Death|113
2913405|NCT01631214|10032299|P2|Overall Study|Withdrawal by Subject|290
2913406|NCT01631214|10032300|P1|Overall Study|Withdrawal by Subject|276
2913407|NCT01630811|10032409|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2913408|NCT01630811|10032410|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2913409|NCT01630616|10032437|P6|Overall Study|Withdrawal by Subject|0
2913410|NCT01630616|10032438|P5|Overall Study|Withdrawal by Subject|0
2913411|NCT01630616|10032439|P4|Overall Study|Withdrawal by Subject|2
2913412|NCT01630616|10032440|P3|Overall Study|Withdrawal by Subject|0
2913413|NCT01630616|10032441|P2|Overall Study|Withdrawal by Subject|0
2913414|NCT01630616|10032442|P1|Overall Study|Withdrawal by Subject|0
2913415|NCT01630616|10032437|P6|Overall Study|Adverse Event|0
2913416|NCT01630616|10032438|P5|Overall Study|Adverse Event|0
2913417|NCT01630616|10032439|P4|Overall Study|Adverse Event|1
2913418|NCT01630616|10032440|P3|Overall Study|Adverse Event|0
2913419|NCT01630616|10032441|P2|Overall Study|Adverse Event|0
2913420|NCT01630616|10032442|P1|Overall Study|Adverse Event|0
2913421|NCT01630135|10032542|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
2913422|NCT01630135|10032543|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
2913423|NCT01629966|10032607|P3|Overall Study|Adverse Event|30
2913424|NCT01629966|10032608|P2|Overall Study|Adverse Event|18
2913425|NCT01629966|10032609|P1|Overall Study|Adverse Event|11
2913426|NCT01629966|10032607|P3|Overall Study|Lack of Efficacy|4
2913427|NCT01629966|10032608|P2|Overall Study|Lack of Efficacy|2
2913428|NCT01629966|10032609|P1|Overall Study|Lack of Efficacy|5
2913429|NCT01629966|10032607|P3|Overall Study|Protocol Violation|7
2913430|NCT01629966|10032608|P2|Overall Study|Protocol Violation|9
2913431|NCT01629966|10032609|P1|Overall Study|Protocol Violation|7
2913432|NCT01629966|10032607|P3|Overall Study|Withdrawal by Subject|16
2913433|NCT01629966|10032608|P2|Overall Study|Withdrawal by Subject|9
2913434|NCT01629966|10032609|P1|Overall Study|Withdrawal by Subject|8
2913435|NCT01629966|10032607|P3|Overall Study|Lost to Follow-up|9
2913436|NCT01629966|10032608|P2|Overall Study|Lost to Follow-up|13
2913437|NCT01629966|10032609|P1|Overall Study|Lost to Follow-up|10
2913438|NCT01629966|10032607|P3|Overall Study|Pregnancy|0
2913439|NCT01629966|10032608|P2|Overall Study|Pregnancy|1
2913440|NCT01629966|10032609|P1|Overall Study|Pregnancy|0
2913441|NCT01629953|10032622|P2|Overall Study|Lost to Follow-up|14
2913442|NCT01629953|10032623|P1|Overall Study|Lost to Follow-up|10
2913443|NCT01629953|10032622|P2|Overall Study|Death|1
2913444|NCT01629953|10032623|P1|Overall Study|Death|3
2913445|NCT01629823|10032643|P3|Washout Period|Protocol Violation|0
2913446|NCT01629823|10032644|P2|Washout Period|Protocol Violation|1
2913447|NCT01629823|10032645|P1|Washout Period|Protocol Violation|0
2913448|NCT01629823|10032643|P3|Washout Period|Pregnancy|0
2913449|NCT01629823|10032644|P2|Washout Period|Pregnancy|0
2913450|NCT01629823|10032645|P1|Washout Period|Pregnancy|1
2913451|NCT01629823|10032643|P3|Washout Period|Safety|0
2913452|NCT01629823|10032644|P2|Washout Period|Safety|5
2913453|NCT01629823|10032645|P1|Washout Period|Safety|2
2913454|NCT01629823|10032643|P3|Trial Period|Failed to hold medication|1
2913455|NCT01629823|10032644|P2|Trial Period|Failed to hold medication|0
2913456|NCT01629823|10032645|P1|Trial Period|Failed to hold medication|0
2913457|NCT01629823|10032643|P3|Trial Period|Out-of-window visit|0
2913458|NCT01629823|10032644|P2|Trial Period|Out-of-window visit|2
2913459|NCT01629823|10032645|P1|Trial Period|Out-of-window visit|0
2913460|NCT01629823|10032643|P3|Trial Period|Adverse Event|0
2913461|NCT01629823|10032644|P2|Trial Period|Adverse Event|1
2913462|NCT01629823|10032645|P1|Trial Period|Adverse Event|0
2913463|NCT01629823|10032643|P3|Trial Period|Pregnancy|0
2913464|NCT01629823|10032644|P2|Trial Period|Pregnancy|0
2913465|NCT01629823|10032645|P1|Trial Period|Pregnancy|1
2913466|NCT01629823|10032643|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2913467|NCT01629823|10032644|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2913468|NCT01629823|10032645|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2913469|NCT01629823|10032643|P3|Trial Period|Missed visit|8
2913470|NCT01629823|10032644|P2|Trial Period|Missed visit|9
2913471|NCT01629823|10032645|P1|Trial Period|Missed visit|11
2913472|NCT01629706|10032680|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
2913473|NCT01629706|10032680|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
2913474|NCT01629706|10032680|P1|Phase 2 Habitual|Relocation prior to Dispense|1
2913475|NCT01629706|10032680|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
2913476|NCT01629706|10032680|P1|Phase 2 Habitual|Screen Failure|6
2913477|NCT01629706|10032680|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
2913478|NCT01629706|10032680|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
2913479|NCT01629706|10032680|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
2913480|NCT01629706|10032680|P1|Phase 1 PureVision|Screen Failure|4
2913481|NCT01629693|10032708|P2|Overall Study|Subject decision unrelated to AE|1
2913482|NCT01629693|10032709|P1|Overall Study|Subject decision unrelated to AE|0
2913483|NCT01629693|10032708|P2|Overall Study|Poor comfort of study lenses|2
2913484|NCT01629693|10032709|P1|Overall Study|Poor comfort of study lenses|0
2913485|NCT01629693|10032708|P2|Overall Study|Investigator decision|1
2913486|NCT01629693|10032709|P1|Overall Study|Investigator decision|0
2913487|NCT01629693|10032708|P2|Overall Study|Adverse Event|0
2913488|NCT01629693|10032709|P1|Overall Study|Adverse Event|1
2913489|NCT01629693|10032708|P2|Overall Study|Withdrawal by Subject|2
2913490|NCT01629693|10032709|P1|Overall Study|Withdrawal by Subject|2
2913491|NCT01629693|10032708|P2|Overall Study|Lost to Follow-up|4
2913492|NCT01629693|10032709|P1|Overall Study|Lost to Follow-up|2
2913493|NCT01629667|10032718|P3|Overall Study|Code break|0
2913494|NCT01629667|10032719|P2|Overall Study|Code break|0
2913495|NCT01629667|10032720|P1|Overall Study|Code break|1
2913496|NCT01629667|10032718|P3|Overall Study|Enrolled in another clinical study|0
2913497|NCT01629667|10032719|P2|Overall Study|Enrolled in another clinical study|1
2913498|NCT01629667|10032720|P1|Overall Study|Enrolled in another clinical study|0
2913499|NCT01629667|10032718|P3|Overall Study|Site error in safety follow-up|1
2913500|NCT01629667|10032719|P2|Overall Study|Site error in safety follow-up|0
2913501|NCT01629667|10032720|P1|Overall Study|Site error in safety follow-up|0
2913502|NCT01629667|10032718|P3|Overall Study|Started other medicine|1
2913503|NCT01629667|10032719|P2|Overall Study|Started other medicine|0
2913504|NCT01629667|10032720|P1|Overall Study|Started other medicine|1
2913505|NCT01629667|10032718|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
2913506|NCT01629667|10032719|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
2913507|NCT01629667|10032720|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
2913508|NCT01629667|10032718|P3|Overall Study|Requiring lung transplant|3
2913509|NCT01629667|10032719|P2|Overall Study|Requiring lung transplant|1
2913510|NCT01629667|10032720|P1|Overall Study|Requiring lung transplant|2
2913511|NCT01629667|10032718|P3|Overall Study|Ongoing AE worsening right heart failure|0
2913512|NCT01629667|10032719|P2|Overall Study|Ongoing AE worsening right heart failure|1
2913513|NCT01629667|10032720|P1|Overall Study|Ongoing AE worsening right heart failure|0
2913514|NCT01629667|10032718|P3|Overall Study|Randomized, not treated|0
2913515|NCT01629667|10032719|P2|Overall Study|Randomized, not treated|1
2913516|NCT01629667|10032720|P1|Overall Study|Randomized, not treated|2
2913517|NCT01629667|10032718|P3|Overall Study|Death|3
2913518|NCT01629667|10032719|P2|Overall Study|Death|5
2913519|NCT01629667|10032720|P1|Overall Study|Death|1
2913520|NCT01629667|10032718|P3|Overall Study|Withdrawal by Subject|28
2913521|NCT01629667|10032719|P2|Overall Study|Withdrawal by Subject|20
2913522|NCT01629667|10032720|P1|Overall Study|Withdrawal by Subject|31
2913523|NCT01629667|10032718|P3|Overall Study|Lost to Follow-up|1
2913524|NCT01629667|10032719|P2|Overall Study|Lost to Follow-up|1
2913525|NCT01629667|10032720|P1|Overall Study|Lost to Follow-up|0
2913526|NCT01629589|10032804|P2|Overall Study|Did not receive study vaccine|1
2913527|NCT01629589|10032805|P1|Overall Study|Did not receive study vaccine|0
2913528|NCT01629589|10032804|P2|Overall Study|Withdrawal by Subject|3
2913529|NCT01629589|10032805|P1|Overall Study|Withdrawal by Subject|2
2913530|NCT01629589|10032804|P2|Overall Study|Lost to Follow-up|1
2913531|NCT01629589|10032805|P1|Overall Study|Lost to Follow-up|2
2913532|NCT01629589|10032804|P2|Overall Study|Protocol Violation|2
2913533|NCT01629589|10032805|P1|Overall Study|Protocol Violation|4
2913534|NCT01629563|10032823|P2|Overall Study|Protocol Violation|1
2913535|NCT01629563|10032824|P1|Overall Study|Protocol Violation|0
2913536|NCT01629563|10032823|P2|Overall Study|Lack of return of menses|7
2913537|NCT01629563|10032824|P1|Overall Study|Lack of return of menses|12
2913538|NCT01629563|10032823|P2|Overall Study|surgery|3
2913539|NCT01629563|10032824|P1|Overall Study|surgery|0
2913540|NCT01629563|10032823|P2|Overall Study|Withdrawal by Subject|20
2913541|NCT01629563|10032824|P1|Overall Study|Withdrawal by Subject|27
2913542|NCT01629563|10032823|P2|Overall Study|Protocol Violation|1
2913543|NCT01629563|10032824|P1|Overall Study|Protocol Violation|0
2913544|NCT01629563|10032823|P2|Overall Study|Pregnancy|2
2913545|NCT01629563|10032824|P1|Overall Study|Pregnancy|1
2913546|NCT01629563|10032823|P2|Overall Study|Lost to Follow-up|0
2913547|NCT01629563|10032824|P1|Overall Study|Lost to Follow-up|1
2913548|NCT01629563|10032823|P2|Overall Study|Lack of Efficacy|3
2913549|NCT01629563|10032824|P1|Overall Study|Lack of Efficacy|2
2913550|NCT01629563|10032823|P2|Overall Study|Death|0
2913551|NCT01629563|10032824|P1|Overall Study|Death|2
2913552|NCT01629563|10032823|P2|Overall Study|Adverse Event|16
2913553|NCT01629563|10032824|P1|Overall Study|Adverse Event|16
2913554|NCT01628965|10032913|P1|Overall Study|Discontinuation criteria|8
2913555|NCT01628965|10032913|P1|Overall Study|Lost to Follow-up|1
2913556|NCT01628965|10032913|P1|Overall Study|Withdrawal by Subject|3
2913557|NCT01628965|10032913|P1|Overall Study|Lack of Efficacy|7
2913558|NCT01628965|10032913|P1|Overall Study|Adverse Event|30
2913559|NCT01628926|10032922|P3|Overall Study|Physician Decision|1
2913560|NCT01628926|10032923|P2|Overall Study|Physician Decision|2
2913561|NCT01628926|10032924|P1|Overall Study|Physician Decision|2
2913562|NCT01628926|10032922|P3|Overall Study|Discontinuation criteria|0
2913563|NCT01628926|10032923|P2|Overall Study|Discontinuation criteria|4
2913564|NCT01628926|10032924|P1|Overall Study|Discontinuation criteria|3
2913565|NCT01628926|10032922|P3|Overall Study|Protocol Violation|0
2913566|NCT01628926|10032923|P2|Overall Study|Protocol Violation|1
2913567|NCT01628926|10032924|P1|Overall Study|Protocol Violation|0
2913568|NCT01628926|10032922|P3|Overall Study|Withdrawal by Subject|2
2913569|NCT01628926|10032923|P2|Overall Study|Withdrawal by Subject|4
2913570|NCT01628926|10032924|P1|Overall Study|Withdrawal by Subject|6
2913571|NCT01628926|10032922|P3|Overall Study|Lack of Efficacy|5
2913572|NCT01628926|10032923|P2|Overall Study|Lack of Efficacy|1
2913573|NCT01628926|10032924|P1|Overall Study|Lack of Efficacy|2
2913574|NCT01628926|10032922|P3|Overall Study|Adverse Event|9
2913575|NCT01628926|10032923|P2|Overall Study|Adverse Event|11
2913576|NCT01628926|10032924|P1|Overall Study|Adverse Event|13
2913577|NCT01628913|10032973|P2|Overall Study|Physician Decision|3
2913578|NCT01628913|10032974|P1|Overall Study|Physician Decision|1
2913579|NCT01628913|10032973|P2|Overall Study|Withdrawal by Subject|0
2913580|NCT01628913|10032974|P1|Overall Study|Withdrawal by Subject|1
2913581|NCT01628913|10032973|P2|Overall Study|study terminated by Sponsor|9
2913582|NCT01628913|10032974|P1|Overall Study|study terminated by Sponsor|4
2913583|NCT01628913|10032973|P2|Overall Study|Death|0
2913584|NCT01628913|10032974|P1|Overall Study|Death|1
2913585|NCT01628913|10032973|P2|Overall Study|Protocol Violation|0
2913586|NCT01628913|10032974|P1|Overall Study|Protocol Violation|1
2913587|NCT01628913|10032973|P2|Overall Study|Disease Progression|14
2913588|NCT01628913|10032974|P1|Overall Study|Disease Progression|11
2913589|NCT01628913|10032973|P2|Overall Study|Adverse Event|5
2913590|NCT01628913|10032974|P1|Overall Study|Adverse Event|12
2913591|NCT01628874|10032988|P2|Overall Study|Age >4 months|2
2913592|NCT01628874|10032989|P1|Overall Study|Age >4 months|4
2913593|NCT01628874|10032988|P2|Overall Study|Physician Decision|1
2913594|NCT01628874|10032989|P1|Overall Study|Physician Decision|1
2913595|NCT01628848|10033005|P2|Overall Study|Physician Decision|1
2913596|NCT01628848|10033006|P1|Overall Study|Physician Decision|3
2913597|NCT01628848|10033005|P2|Overall Study|Withdrawal by Subject|2
2913598|NCT01628848|10033006|P1|Overall Study|Withdrawal by Subject|0
2913599|NCT01628848|10033005|P2|Overall Study|Lack of Efficacy|4
2913600|NCT01628848|10033006|P1|Overall Study|Lack of Efficacy|0
2913601|NCT01628848|10033005|P2|Overall Study|Adverse Event|7
2913602|NCT01628848|10033006|P1|Overall Study|Adverse Event|9
2913603|NCT01628692|10033049|P6|Overall Study|Completed 12 Week only|1
2913604|NCT01628692|10033050|P5|Overall Study|Completed 12 Week only|0
2913605|NCT01628692|10033051|P4|Overall Study|Completed 12 Week only|0
2913606|NCT01628692|10033052|P3|Overall Study|Completed 12 Week only|0
2913607|NCT01628692|10033053|P2|Overall Study|Completed 12 Week only|0
2913608|NCT01628692|10033054|P1|Overall Study|Completed 12 Week only|0
2913609|NCT01628692|10033049|P6|Overall Study|Administrative reason by sponsor|1
2913610|NCT01628692|10033050|P5|Overall Study|Administrative reason by sponsor|0
2913611|NCT01628692|10033051|P4|Overall Study|Administrative reason by sponsor|0
2913612|NCT01628692|10033052|P3|Overall Study|Administrative reason by sponsor|0
2913613|NCT01628692|10033053|P2|Overall Study|Administrative reason by sponsor|0
2913614|NCT01628692|10033054|P1|Overall Study|Administrative reason by sponsor|0
2913615|NCT01628692|10033049|P6|Overall Study|Poor compliance/noncompliance|0
2913616|NCT01628692|10033050|P5|Overall Study|Poor compliance/noncompliance|0
2913617|NCT01628692|10033051|P4|Overall Study|Poor compliance/noncompliance|0
2913618|NCT01628692|10033052|P3|Overall Study|Poor compliance/noncompliance|0
2913619|NCT01628692|10033053|P2|Overall Study|Poor compliance/noncompliance|0
2913620|NCT01628692|10033054|P1|Overall Study|Poor compliance/noncompliance|1
2913621|NCT01628692|10033049|P6|Overall Study|Death|0
2913622|NCT01628692|10033050|P5|Overall Study|Death|0
2913623|NCT01628692|10033051|P4|Overall Study|Death|0
2913624|NCT01628692|10033052|P3|Overall Study|Death|0
2913625|NCT01628692|10033053|P2|Overall Study|Death|1
2913626|NCT01628692|10033054|P1|Overall Study|Death|0
2913627|NCT01628692|10033049|P6|Overall Study|Withdrawal by Subject|0
2913628|NCT01628692|10033050|P5|Overall Study|Withdrawal by Subject|0
2913629|NCT01628692|10033051|P4|Overall Study|Withdrawal by Subject|0
2913630|NCT01628692|10033052|P3|Overall Study|Withdrawal by Subject|1
2913631|NCT01628692|10033053|P2|Overall Study|Withdrawal by Subject|1
2913632|NCT01628692|10033054|P1|Overall Study|Withdrawal by Subject|0
2913633|NCT01628692|10033049|P6|Overall Study|Adverse Event|0
2913634|NCT01628692|10033050|P5|Overall Study|Adverse Event|0
2913635|NCT01628692|10033051|P4|Overall Study|Adverse Event|0
2913636|NCT01628692|10033052|P3|Overall Study|Adverse Event|2
2913637|NCT01628692|10033053|P2|Overall Study|Adverse Event|0
2913638|NCT01628692|10033054|P1|Overall Study|Adverse Event|2
2913639|NCT01628692|10033049|P6|Overall Study|Lack of Efficacy|7
2913640|NCT01628692|10033050|P5|Overall Study|Lack of Efficacy|4
2913641|NCT01628692|10033051|P4|Overall Study|Lack of Efficacy|1
2913642|NCT01628692|10033052|P3|Overall Study|Lack of Efficacy|5
2913643|NCT01628692|10033053|P2|Overall Study|Lack of Efficacy|4
2913644|NCT01628692|10033054|P1|Overall Study|Lack of Efficacy|4
2913645|NCT01628549|10033124|P4|Overall Study|positive pregnancy test|1
2913646|NCT01628549|10033125|P3|Overall Study|positive pregnancy test|0
2913647|NCT01628549|10033126|P2|Overall Study|positive pregnancy test|0
2913648|NCT01628549|10033127|P1|Overall Study|positive pregnancy test|0
2913649|NCT01628549|10033124|P4|Overall Study|abnormal laboratory test results|0
2913650|NCT01628549|10033125|P3|Overall Study|abnormal laboratory test results|1
2913651|NCT01628549|10033126|P2|Overall Study|abnormal laboratory test results|0
2913652|NCT01628549|10033127|P1|Overall Study|abnormal laboratory test results|0
2913653|NCT01628549|10033124|P4|Overall Study|withdrawn for noncompliance|0
2913654|NCT01628549|10033125|P3|Overall Study|withdrawn for noncompliance|1
2913655|NCT01628549|10033126|P2|Overall Study|withdrawn for noncompliance|2
2913656|NCT01628549|10033127|P1|Overall Study|withdrawn for noncompliance|0
2913657|NCT01628549|10033124|P4|Overall Study|Protocol Violation|0
2913658|NCT01628549|10033125|P3|Overall Study|Protocol Violation|1
2913659|NCT01628549|10033126|P2|Overall Study|Protocol Violation|1
2913660|NCT01628549|10033127|P1|Overall Study|Protocol Violation|2
2913661|NCT01628549|10033124|P4|Overall Study|Withdrawal by Subject|1
2913662|NCT01628549|10033125|P3|Overall Study|Withdrawal by Subject|4
2913663|NCT01628549|10033126|P2|Overall Study|Withdrawal by Subject|4
2913664|NCT01628549|10033127|P1|Overall Study|Withdrawal by Subject|3
2913665|NCT01628549|10033124|P4|Overall Study|Lost to Follow-up|3
2913666|NCT01628549|10033125|P3|Overall Study|Lost to Follow-up|3
2913667|NCT01628549|10033126|P2|Overall Study|Lost to Follow-up|4
2913668|NCT01628549|10033127|P1|Overall Study|Lost to Follow-up|3
2913669|NCT01628549|10033124|P4|Overall Study|Adverse Event|4
2913670|NCT01628549|10033125|P3|Overall Study|Adverse Event|0
2913671|NCT01628549|10033126|P2|Overall Study|Adverse Event|1
2913672|NCT01628549|10033127|P1|Overall Study|Adverse Event|1
2913673|NCT01628510|10033168|P2|Overall Study|Death|1
2913674|NCT01628510|10033169|P1|Overall Study|Death|3
2913675|NCT01628510|10033168|P2|Overall Study|Withdrawal by Subject|4
2913676|NCT01628510|10033169|P1|Overall Study|Withdrawal by Subject|0
2913677|NCT01628367|10033179|P2|Overall Study|Adverse Event|0
2913678|NCT01628367|10033180|P1|Overall Study|Adverse Event|1
2913679|NCT01628198|10033199|P1|Overall Study|Screen failure|1
2913680|NCT01628198|10033199|P1|Overall Study|Withdrawal by Subject|10
2913681|NCT01628198|10033199|P1|Overall Study|Lost to Follow-up|7
2913682|NCT01628120|10033226|P1|Overall Study|Use of Standard of Care|1
2913683|NCT01628120|10033226|P1|Overall Study|Kidney Transplant|2
2913684|NCT01628120|10033226|P1|Overall Study|Moved or Relocated|5
2913685|NCT01628120|10033226|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
2913686|NCT01628120|10033226|P1|Overall Study|Switched Dialysis Method|2
2913687|NCT01628120|10033226|P1|Overall Study|Sponsor Decision|5
2913688|NCT01628120|10033226|P1|Overall Study|Not Treated|3
2913689|NCT01628120|10033226|P1|Overall Study|Non-compliant with Study Procedures|1
2913690|NCT01628120|10033226|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
2913691|NCT01628120|10033226|P1|Overall Study|Lost to Follow-up|1
2913692|NCT01628120|10033226|P1|Overall Study|Adverse Event|12
2913693|NCT01628120|10033226|P1|Overall Study|Withdrawal by Subject|7
2913694|NCT01628107|10033251|P1|Overall Study|Use of Standard of Care|9
2913695|NCT01628107|10033251|P1|Overall Study|Kidney Transplant|9
2913696|NCT01628107|10033251|P1|Overall Study|Relocated|8
2913697|NCT01628107|10033251|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
2913698|NCT01628107|10033251|P1|Overall Study|Sponsor Decision|11
2913699|NCT01628107|10033251|P1|Overall Study|Not Treated|8
2913700|NCT01628107|10033251|P1|Overall Study|Non-compliant with Study Procedures|10
2913701|NCT01628107|10033251|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
2913702|NCT01628107|10033251|P1|Overall Study|Physician Decision|2
2913703|NCT01628107|10033251|P1|Overall Study|Adverse Event|33
2913704|NCT01628107|10033251|P1|Overall Study|Lost to Follow-up|4
2913705|NCT01628107|10033251|P1|Overall Study|Withdrawal by Subject|17
2913706|NCT01627899|10033317|P1|Overall Study|Study terminated early by sponsor.|5
2913707|NCT01627860|10033327|P2|Overall Study|Protocol Violation|0
2913708|NCT01627860|10033328|P1|Overall Study|Protocol Violation|1
2913709|NCT01627860|10033327|P2|Overall Study|Seizure frequency doubled|1
2913710|NCT01627860|10033328|P1|Overall Study|Seizure frequency doubled|0
2913711|NCT01627860|10033327|P2|Overall Study|Withdrawal by Subject|1
2913712|NCT01627860|10033328|P1|Overall Study|Withdrawal by Subject|2
2913713|NCT01627860|10033327|P2|Overall Study|Adverse Event|4
2913714|NCT01627860|10033328|P1|Overall Study|Adverse Event|9
2913715|NCT01627782|10033342|P4|Overall Study|Randomized But Not Treated|0
2913716|NCT01627782|10033343|P3|Overall Study|Randomized But Not Treated|0
2913717|NCT01627782|10033344|P2|Overall Study|Randomized But Not Treated|0
2913718|NCT01627782|10033345|P1|Overall Study|Randomized But Not Treated|1
2913719|NCT01627782|10033342|P4|Overall Study|Other|3
2913720|NCT01627782|10033343|P3|Overall Study|Other|0
2913721|NCT01627782|10033344|P2|Overall Study|Other|2
2913722|NCT01627782|10033345|P1|Overall Study|Other|0
2913723|NCT01627782|10033342|P4|Overall Study|Withdrawal by Subject|0
2913724|NCT01627782|10033343|P3|Overall Study|Withdrawal by Subject|0
2913725|NCT01627782|10033344|P2|Overall Study|Withdrawal by Subject|1
2913726|NCT01627782|10033345|P1|Overall Study|Withdrawal by Subject|2
2913727|NCT01627782|10033342|P4|Overall Study|Protocol Violation|0
2913728|NCT01627782|10033343|P3|Overall Study|Protocol Violation|0
2913729|NCT01627782|10033344|P2|Overall Study|Protocol Violation|0
2913730|NCT01627782|10033345|P1|Overall Study|Protocol Violation|1
2913731|NCT01627782|10033342|P4|Overall Study|Lack of Efficacy|2
2913732|NCT01627782|10033343|P3|Overall Study|Lack of Efficacy|15
2913733|NCT01627782|10033344|P2|Overall Study|Lack of Efficacy|1
2913734|NCT01627782|10033345|P1|Overall Study|Lack of Efficacy|11
2913735|NCT01627782|10033342|P4|Overall Study|Adverse Event|1
2913736|NCT01627782|10033343|P3|Overall Study|Adverse Event|0
2913737|NCT01627782|10033344|P2|Overall Study|Adverse Event|2
2913738|NCT01627782|10033345|P1|Overall Study|Adverse Event|1
2913739|NCT01627691|10033401|P1|Overall Study|Missed the visit|3
2913740|NCT01627691|10033401|P1|Overall Study|Withdrawal by Subject|1
2913741|NCT01627691|10033401|P1|Overall Study|Lost to Follow-up|3
2913742|NCT01627691|10033401|P1|Overall Study|Death|11
2913743|NCT01627561|10033414|P2|Overall Study|Migrated/moved from study area|2
2913744|NCT01627561|10033415|P1|Overall Study|Migrated/moved from study area|0
2913745|NCT01627561|10033414|P2|Overall Study|Withdrawal by Subject|1
2913746|NCT01627561|10033415|P1|Overall Study|Withdrawal by Subject|0
2913747|NCT01627561|10033414|P2|Overall Study|Lost to Follow-up|0
2913748|NCT01627561|10033415|P1|Overall Study|Lost to Follow-up|1
2913749|NCT01627340|10033481|P2|Overall Study|Withdrawal by Subject|0
2913750|NCT01627340|10033482|P1|Overall Study|Withdrawal by Subject|2
2913751|NCT01627340|10033481|P2|Overall Study|Pregnancy|0
2913752|NCT01627340|10033482|P1|Overall Study|Pregnancy|1
2913753|NCT01627340|10033481|P2|Overall Study|Lost to Follow-up|4
2913754|NCT01627340|10033482|P1|Overall Study|Lost to Follow-up|8
2913755|NCT01627340|10033481|P2|Overall Study|Adverse Event|0
2913756|NCT01627340|10033482|P1|Overall Study|Adverse Event|1
2913757|NCT01627327|10033500|P2|Overall Study|Withdrawal by Subject|3
2913758|NCT01627327|10033501|P1|Overall Study|Withdrawal by Subject|3
2913759|NCT01627327|10033500|P2|Overall Study|Physician Decision|0
2913760|NCT01627327|10033501|P1|Overall Study|Physician Decision|1
2913761|NCT01627327|10033500|P2|Overall Study|Lost to Follow-up|3
2913762|NCT01627327|10033501|P1|Overall Study|Lost to Follow-up|1
2913763|NCT01627327|10033500|P2|Overall Study|Protocol Violation|10
2913764|NCT01627327|10033501|P1|Overall Study|Protocol Violation|4
2913765|NCT01627327|10033500|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
2913766|NCT01627327|10033501|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
2913767|NCT01627327|10033500|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
2913768|NCT01627327|10033501|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
2913769|NCT01627327|10033500|P2|Overall Study|Adverse Event|12
2913770|NCT01627327|10033501|P1|Overall Study|Adverse Event|6
2913771|NCT01627249|10033551|P3|Overall Study|Missed Visit|0
2913772|NCT01627249|10033552|P2|Overall Study|Missed Visit|1
2913773|NCT01627249|10033553|P1|Overall Study|Missed Visit|1
2913774|NCT01627249|10033551|P3|Overall Study|Withdrawal by Subject|9
2913775|NCT01627249|10033552|P2|Overall Study|Withdrawal by Subject|6
2913776|NCT01627249|10033553|P1|Overall Study|Withdrawal by Subject|12
2913777|NCT01627249|10033551|P3|Overall Study|Death|3
2913778|NCT01627249|10033552|P2|Overall Study|Death|5
2913779|NCT01627249|10033553|P1|Overall Study|Death|3
2913780|NCT01626989|10033649|P3|Screening Period|Withdrawal by Subject|0
2913781|NCT01626989|10033650|P2|Screening Period|Withdrawal by Subject|0
2913782|NCT01626989|10033651|P1|Screening Period|Withdrawal by Subject|2
2913783|NCT01626989|10033649|P3|Screening Period|Screen Failure|0
2913784|NCT01626989|10033650|P2|Screening Period|Screen Failure|0
2913785|NCT01626989|10033651|P1|Screening Period|Screen Failure|15
2913786|NCT01626690|10033723|P2|Overall Study|Adverse Event|0
2913787|NCT01626690|10033724|P1|Overall Study|Adverse Event|1
2913788|NCT01626690|10033723|P2|Overall Study|Protocol Violation|0
2913789|NCT01626690|10033724|P1|Overall Study|Protocol Violation|1
2913790|NCT01626495|10033761|P1|Overall Study|Manufacturing failure|1
2913791|NCT01626495|10033761|P1|Overall Study|New cancer therapy|16
2913792|NCT01626495|10033761|P1|Overall Study|Physician Decision|1
2913793|NCT01626495|10033761|P1|Overall Study|Death|2
2913794|NCT01626495|10033761|P1|Overall Study|Administrative problem|1
2913795|NCT01626495|10033761|P1|Overall Study|Withdrawal by Subject|1
2913796|NCT01626495|10033761|P1|Overall Study|Disease progression|27
2913797|NCT01626495|10033761|P1|Overall Study|Adverse Event|3
2913798|NCT01626456|10033770|P2|Overall Study|Incarceration|2
2913799|NCT01626456|10033771|P1|Overall Study|Incarceration|0
2913800|NCT01626456|10033770|P2|Overall Study|Site Closure|3
2913801|NCT01626456|10033771|P1|Overall Study|Site Closure|2
2913802|NCT01626456|10033770|P2|Overall Study|Protocol Violation|1
2913803|NCT01626456|10033771|P1|Overall Study|Protocol Violation|1
2913804|NCT01626456|10033770|P2|Overall Study|Physician Decision|4
2913805|NCT01626456|10033771|P1|Overall Study|Physician Decision|1
2913806|NCT01626456|10033770|P2|Overall Study|Lack of Efficacy|7
2913807|NCT01626456|10033771|P1|Overall Study|Lack of Efficacy|6
2913808|NCT01626456|10033770|P2|Overall Study|Lost to Follow-up|27
2913809|NCT01626456|10033771|P1|Overall Study|Lost to Follow-up|2
2913810|NCT01626456|10033770|P2|Overall Study|Adverse Event|27
2913811|NCT01626456|10033771|P1|Overall Study|Adverse Event|2
2913812|NCT01626456|10033770|P2|Overall Study|Withdrawal by Subject|46
2913813|NCT01626456|10033771|P1|Overall Study|Withdrawal by Subject|21
2913814|NCT01626391|10033801|P2|Overall Study|Withdrawal by Subject|0
2913815|NCT01626391|10033802|P1|Overall Study|Withdrawal by Subject|1
2913816|NCT01626391|10033801|P2|Overall Study|Physician Decision|0
2913817|NCT01626391|10033802|P1|Overall Study|Physician Decision|1
2913818|NCT01626352|10033808|P1|Overall Study|Never Treated|1
2913819|NCT01626352|10033808|P1|Overall Study|Non-Compliance|1
2913820|NCT01626352|10033808|P1|Overall Study|Withdrawal by Subject|1
2913821|NCT01626352|10033808|P1|Overall Study|Death|2
2913822|NCT01626352|10033808|P1|Overall Study|Intercurrent Illness|2
2913823|NCT01626352|10033808|P1|Overall Study|Disease Progression|3
2913824|NCT01626118|10033822|P4|Overall Study|Investigator Decision|0
2913825|NCT01626118|10033823|P3|Overall Study|Investigator Decision|0
2913826|NCT01626118|10033824|P2|Overall Study|Investigator Decision|1
2913827|NCT01626118|10033825|P1|Overall Study|Investigator Decision|0
2913828|NCT01626118|10033822|P4|Overall Study|Adverse Event|0
2913829|NCT01626118|10033823|P3|Overall Study|Adverse Event|1
2913830|NCT01626118|10033824|P2|Overall Study|Adverse Event|1
2913831|NCT01626118|10033825|P1|Overall Study|Adverse Event|0
2913832|NCT01626118|10033822|P4|Overall Study|Lost to Follow-up|0
2913833|NCT01626118|10033823|P3|Overall Study|Lost to Follow-up|0
2913834|NCT01626118|10033824|P2|Overall Study|Lost to Follow-up|0
2913835|NCT01626118|10033825|P1|Overall Study|Lost to Follow-up|1
2913836|NCT01626118|10033822|P4|Overall Study|Lack of Efficacy|3
2913837|NCT01626118|10033823|P3|Overall Study|Lack of Efficacy|1
2913838|NCT01626118|10033824|P2|Overall Study|Lack of Efficacy|0
2913839|NCT01626118|10033825|P1|Overall Study|Lack of Efficacy|1
2913840|NCT01626079|10033871|P2|Overall Study|Visits Expected or Not Due|69
2913841|NCT01626079|10033872|P1|Overall Study|Visits Expected or Not Due|74
2913842|NCT01626079|10033871|P2|Overall Study|Lost to Follow-up|3
2913843|NCT01626079|10033872|P1|Overall Study|Lost to Follow-up|3
2913844|NCT01626079|10033871|P2|Overall Study|Withdrawal by Subject|29
2913845|NCT01626079|10033872|P1|Overall Study|Withdrawal by Subject|12
2913846|NCT01626079|10033871|P2|Overall Study|Death|115
2913847|NCT01626079|10033872|P1|Overall Study|Death|78
2913848|NCT01625988|10034245|P2|Overall Study|Protocol Violation|2
2913849|NCT01625988|10034246|P1|Overall Study|Protocol Violation|0
2913850|NCT01625988|10034245|P2|Overall Study|Randomized Inappropriately|0
2913851|NCT01625988|10034246|P1|Overall Study|Randomized Inappropriately|1
2913852|NCT01625988|10034245|P2|Overall Study|Lack of Efficacy|1
2913853|NCT01625988|10034246|P1|Overall Study|Lack of Efficacy|0
2913854|NCT01625988|10034245|P2|Overall Study|Adverse Event|1
2913855|NCT01625988|10034246|P1|Overall Study|Adverse Event|0
2913856|NCT01625988|10034245|P2|Overall Study|Withdrawal by Subject|3
2913857|NCT01625988|10034246|P1|Overall Study|Withdrawal by Subject|8
2913858|NCT01625988|10034245|P2|Overall Study|Lost to Follow-up|6
2913859|NCT01625988|10034246|P1|Overall Study|Lost to Follow-up|5
2913860|NCT01625910|10034270|P2|Overall Study|Lost to Follow-up|4
2913861|NCT01625910|10034271|P1|Overall Study|Lost to Follow-up|3
2913862|NCT01625845|10034281|P2|Overall Study|Withdrawal by Subject|0
2913863|NCT01625845|10034282|P1|Overall Study|Withdrawal by Subject|2
2913864|NCT01625845|10034281|P2|Overall Study|Lost to Follow-up|1
2913865|NCT01625845|10034282|P1|Overall Study|Lost to Follow-up|2
2913866|NCT01625845|10034281|P2|Overall Study|Adverse Event|2
2913867|NCT01625845|10034282|P1|Overall Study|Adverse Event|1
2913868|NCT01625689|10034302|P2|Overall Study|Migration|1
2913869|NCT01625689|10034303|P1|Overall Study|Migration|2
2913870|NCT01625377|10034358|P2|Overall Study|Abnormal laboratory values|0
2913871|NCT01625377|10034359|P1|Overall Study|Abnormal laboratory values|1
2913872|NCT01625377|10034358|P2|Overall Study|Unsatisfactory therapeutic effect|1
2913873|NCT01625377|10034359|P1|Overall Study|Unsatisfactory therapeutic effect|0
2913874|NCT01625377|10034358|P2|Overall Study|Graft loss|0
2913875|NCT01625377|10034359|P1|Overall Study|Graft loss|1
2913876|NCT01625377|10034358|P2|Overall Study|Adverse Event|16
2913877|NCT01625377|10034359|P1|Overall Study|Adverse Event|3
2913878|NCT01625377|10034358|P2|Overall Study|Protocol Violation|3
2913879|NCT01625377|10034359|P1|Overall Study|Protocol Violation|0
2913880|NCT01625377|10034358|P2|Overall Study|Administrative Problem|1
2913881|NCT01625377|10034359|P1|Overall Study|Administrative Problem|1
2913882|NCT01625377|10034358|P2|Overall Study|Death|1
2913883|NCT01625377|10034359|P1|Overall Study|Death|1
2913884|NCT01625338|10034392|P3|Overall Study|Study Discontinued by Sponsor|1
2913885|NCT01625338|10034393|P2|Overall Study|Study Discontinued by Sponsor|0
2913886|NCT01625338|10034394|P1|Overall Study|Study Discontinued by Sponsor|0
2913887|NCT01625338|10034392|P3|Overall Study|Adverse Event|1
2913888|NCT01625338|10034393|P2|Overall Study|Adverse Event|0
2913889|NCT01625338|10034394|P1|Overall Study|Adverse Event|1
2913890|NCT01625338|10034392|P3|Overall Study|Subject Withdrew Consent|2
2913891|NCT01625338|10034393|P2|Overall Study|Subject Withdrew Consent|0
2913892|NCT01625338|10034394|P1|Overall Study|Subject Withdrew Consent|1
2913893|NCT01625338|10034392|P3|Overall Study|Investigator Decision|1
2913894|NCT01625338|10034393|P2|Overall Study|Investigator Decision|2
2913895|NCT01625338|10034394|P1|Overall Study|Investigator Decision|0
2913896|NCT01625338|10034392|P3|Overall Study|Lost to Follow-up|2
2913897|NCT01625338|10034393|P2|Overall Study|Lost to Follow-up|3
2913898|NCT01625338|10034394|P1|Overall Study|Lost to Follow-up|3
2913899|NCT01625338|10034392|P3|Overall Study|Efficacy Failure|31
2913900|NCT01625338|10034393|P2|Overall Study|Efficacy Failure|39
2913901|NCT01625338|10034394|P1|Overall Study|Efficacy Failure|27
2913902|NCT01625338|10034392|P3|Overall Study|Enrolled but not Treated|1
2913903|NCT01625338|10034393|P2|Overall Study|Enrolled but not Treated|0
2913904|NCT01625338|10034394|P1|Overall Study|Enrolled but not Treated|0
2913905|NCT01625286|10034421|P7|Overall Study|Ongoing on-treatment at DCO|6
2913906|NCT01625286|10034422|P6|Overall Study|Ongoing on-treatment at DCO|8
2913907|NCT01625286|10034423|P5|Overall Study|Ongoing on-treatment at DCO|0
2913908|NCT01625286|10034424|P4|Overall Study|Ongoing on-treatment at DCO|0
2913909|NCT01625286|10034425|P3|Overall Study|Ongoing on-treatment at DCO|0
2913910|NCT01625286|10034426|P2|Overall Study|Ongoing on-treatment at DCO|4
2913911|NCT01625286|10034427|P1|Overall Study|Ongoing on-treatment at DCO|6
2913912|NCT01625286|10034421|P7|Overall Study|Ongoing off-treatment at DCO|31
2913913|NCT01625286|10034422|P6|Overall Study|Ongoing off-treatment at DCO|32
2913914|NCT01625286|10034423|P5|Overall Study|Ongoing off-treatment at DCO|0
2913915|NCT01625286|10034424|P4|Overall Study|Ongoing off-treatment at DCO|0
2913916|NCT01625286|10034425|P3|Overall Study|Ongoing off-treatment at DCO|0
2913917|NCT01625286|10034426|P2|Overall Study|Ongoing off-treatment at DCO|0
2913918|NCT01625286|10034427|P1|Overall Study|Ongoing off-treatment at DCO|0
2913919|NCT01625286|10034421|P7|Overall Study|Lost to Follow-up|1
2913920|NCT01625286|10034422|P6|Overall Study|Lost to Follow-up|0
2913921|NCT01625286|10034423|P5|Overall Study|Lost to Follow-up|0
2913922|NCT01625286|10034424|P4|Overall Study|Lost to Follow-up|0
2913923|NCT01625286|10034425|P3|Overall Study|Lost to Follow-up|0
2913924|NCT01625286|10034426|P2|Overall Study|Lost to Follow-up|0
2913925|NCT01625286|10034427|P1|Overall Study|Lost to Follow-up|0
2913926|NCT01625286|10034421|P7|Overall Study|Progressive disease|0
2913927|NCT01625286|10034422|P6|Overall Study|Progressive disease|0
2913928|NCT01625286|10034423|P5|Overall Study|Progressive disease|5
2913929|NCT01625286|10034424|P4|Overall Study|Progressive disease|5
2913930|NCT01625286|10034425|P3|Overall Study|Progressive disease|4
2913931|NCT01625286|10034426|P2|Overall Study|Progressive disease|3
2913932|NCT01625286|10034427|P1|Overall Study|Progressive disease|6
2913933|NCT01625286|10034421|P7|Overall Study|Any reason not specifically recorded|0
2913934|NCT01625286|10034422|P6|Overall Study|Any reason not specifically recorded|1
2913935|NCT01625286|10034423|P5|Overall Study|Any reason not specifically recorded|0
2913936|NCT01625286|10034424|P4|Overall Study|Any reason not specifically recorded|0
2913937|NCT01625286|10034425|P3|Overall Study|Any reason not specifically recorded|0
2913938|NCT01625286|10034426|P2|Overall Study|Any reason not specifically recorded|0
2913939|NCT01625286|10034427|P1|Overall Study|Any reason not specifically recorded|0
2913940|NCT01625286|10034421|P7|Overall Study|Withdrawal by Subject|1
2913941|NCT01625286|10034422|P6|Overall Study|Withdrawal by Subject|0
2913942|NCT01625286|10034423|P5|Overall Study|Withdrawal by Subject|0
2913943|NCT01625286|10034424|P4|Overall Study|Withdrawal by Subject|1
2913944|NCT01625286|10034425|P3|Overall Study|Withdrawal by Subject|0
2913945|NCT01625286|10034426|P2|Overall Study|Withdrawal by Subject|1
2913946|NCT01625286|10034427|P1|Overall Study|Withdrawal by Subject|0
2913947|NCT01625286|10034421|P7|Overall Study|Death|16
2913948|NCT01625286|10034422|P6|Overall Study|Death|11
2913949|NCT01625286|10034423|P5|Overall Study|Death|0
2913950|NCT01625286|10034424|P4|Overall Study|Death|1
2913951|NCT01625286|10034425|P3|Overall Study|Death|1
2913952|NCT01625286|10034426|P2|Overall Study|Death|0
2913953|NCT01625286|10034427|P1|Overall Study|Death|0
2913954|NCT01625286|10034421|P7|Overall Study|Adverse Event|1
2913955|NCT01625286|10034422|P6|Overall Study|Adverse Event|2
2913956|NCT01625286|10034423|P5|Overall Study|Adverse Event|1
2913957|NCT01625286|10034424|P4|Overall Study|Adverse Event|0
2913958|NCT01625286|10034425|P3|Overall Study|Adverse Event|0
2913959|NCT01625286|10034426|P2|Overall Study|Adverse Event|0
2913960|NCT01625286|10034427|P1|Overall Study|Adverse Event|0
2913961|NCT01625182|10034513|P2|Overall Study|Lack of Efficacy|8
2913962|NCT01625182|10034514|P1|Overall Study|Lack of Efficacy|12
2913963|NCT01625182|10034513|P2|Overall Study|Withdrawal by Subject|1
2913964|NCT01625182|10034514|P1|Overall Study|Withdrawal by Subject|5
2913965|NCT01625182|10034513|P2|Overall Study|Adverse Event|0
2913966|NCT01625182|10034514|P1|Overall Study|Adverse Event|2
2913967|NCT01625182|10034513|P2|Overall Study|Protocol deviation|2
2913968|NCT01625182|10034514|P1|Overall Study|Protocol deviation|0
2913969|NCT01625182|10034513|P2|Overall Study|Administrative problems|0
2913970|NCT01625182|10034514|P1|Overall Study|Administrative problems|1
2913971|NCT01625091|10034551|P2|Post-intervention|Study termination|1
2913972|NCT01625091|10034552|P1|Post-intervention|Study termination|2
2913973|NCT01625091|10034551|P2|Post-intervention|Lost to Follow-up|0
2913974|NCT01625091|10034552|P1|Post-intervention|Lost to Follow-up|2
2913975|NCT01625091|10034551|P2|Post-intervention|Death|1
2913976|NCT01625091|10034552|P1|Post-intervention|Death|0
2913977|NCT01625091|10034551|P2|Intervention|Study termination|3
2913978|NCT01625091|10034552|P1|Intervention|Study termination|2
2913979|NCT01625091|10034551|P2|Intervention|Lost to Follow-up|4
2913980|NCT01625091|10034552|P1|Intervention|Lost to Follow-up|4
2913981|NCT01625091|10034551|P2|Intervention|Adverse Event|2
2913982|NCT01625091|10034552|P1|Intervention|Adverse Event|0
2913983|NCT01625091|10034551|P2|Intervention|Withdrawal by Subject|1
2913984|NCT01625091|10034552|P1|Intervention|Withdrawal by Subject|4
2913985|NCT01625091|10034551|P2|Intervention|Death|1
2913986|NCT01625091|10034552|P1|Intervention|Death|1
2913987|NCT01624974|10034570|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
2913988|NCT01624974|10034571|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
2913989|NCT01624974|10034570|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
2913990|NCT01624974|10034571|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
2913991|NCT01624974|10034570|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
2913992|NCT01624974|10034571|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
2913993|NCT01624974|10034570|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
2913994|NCT01624974|10034571|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
2913995|NCT01624974|10034570|P2|Period IV Washout (4 Weeks)|Adverse Event|0
2913996|NCT01624974|10034571|P1|Period IV Washout (4 Weeks)|Adverse Event|2
2913997|NCT01624974|10034570|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
2913998|NCT01624974|10034571|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
2913999|NCT01624974|10034570|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2914000|NCT01624974|10034571|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2914001|NCT01624974|10034570|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
2914002|NCT01624974|10034571|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
2914003|NCT01624974|10034570|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
2914004|NCT01624974|10034571|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
2914005|NCT01624974|10034570|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
2914006|NCT01624974|10034571|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
2914007|NCT01624974|10034570|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
2914008|NCT01624974|10034571|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
2914009|NCT01624974|10034570|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
2914010|NCT01624974|10034571|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
2914011|NCT01624870|10034612|P1|Overall Study|Lost to follow up|1
2914012|NCT01624870|10034612|P1|Overall Study|CoreValve not implanted|6
2914013|NCT01624870|10034612|P1|Overall Study|Withdrawal by Subject|1
2914014|NCT01624870|10034612|P1|Overall Study|Death|19
2914015|NCT01624662|10034632|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2914016|NCT01624662|10034633|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2914017|NCT01624662|10034634|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2914018|NCT01624662|10034635|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2914019|NCT01624662|10034632|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914020|NCT01624662|10034633|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914021|NCT01624662|10034634|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2914022|NCT01624662|10034635|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914023|NCT01624662|10034632|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2914024|NCT01624662|10034633|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2914025|NCT01624662|10034634|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2914026|NCT01624662|10034635|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2914027|NCT01624662|10034632|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2914028|NCT01624662|10034633|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2914029|NCT01624662|10034634|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2914030|NCT01624662|10034635|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2914031|NCT01624662|10034632|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2914032|NCT01624662|10034633|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2914033|NCT01624662|10034634|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2914034|NCT01624662|10034635|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2914035|NCT01624662|10034632|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2914036|NCT01624662|10034633|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2914037|NCT01624662|10034634|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
2914038|NCT01624662|10034635|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
2914039|NCT01624662|10034632|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
2914040|NCT01624662|10034633|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2914041|NCT01624662|10034634|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2914042|NCT01624662|10034635|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2914043|NCT01624467|10034706|P1|Overall Study|Subject Withdrew from Treatment|1
2914044|NCT01624467|10034706|P1|Overall Study|Per Sponsor Requirement|1
2914045|NCT01624467|10034706|P1|Overall Study|Progressive Disease|19
2914046|NCT01624467|10034706|P1|Overall Study|Adverse Event|7
2914047|NCT01624467|10034706|P1|Overall Study|Lost to Follow-up|1
2914048|NCT01624467|10034706|P1|Overall Study|Withdrawal by Subject|2
2914049|NCT01624259|10034745|P2|Overall Study|Abnormal laboratory measure|0
2914050|NCT01624259|10034746|P1|Overall Study|Abnormal laboratory measure|3
2914051|NCT01624259|10034745|P2|Overall Study|Lost to Follow-up|3
2914052|NCT01624259|10034746|P1|Overall Study|Lost to Follow-up|2
2914053|NCT01624259|10034745|P2|Overall Study|Physician Decision|1
2914054|NCT01624259|10034746|P1|Overall Study|Physician Decision|1
2914055|NCT01624259|10034745|P2|Overall Study|Withdrawal by Subject|7
2914056|NCT01624259|10034746|P1|Overall Study|Withdrawal by Subject|5
2914057|NCT01624259|10034745|P2|Overall Study|Protocol Violation|2
2914058|NCT01624259|10034746|P1|Overall Study|Protocol Violation|1
2914059|NCT01624259|10034745|P2|Overall Study|Adverse Event|18
2914060|NCT01624259|10034746|P1|Overall Study|Adverse Event|18
2914061|NCT01624233|10034795|P1|Period 6: Follow-up|Withdrawal by Subject|3
2914062|NCT01624233|10034795|P1|Period 6: Follow-up|Physician Decision|1
2914063|NCT01624233|10034795|P1|Period 6: Follow-up|Lack of Efficacy|2
2914064|NCT01624233|10034795|P1|Period 6: Follow-up|Adverse Event|3
2914065|NCT01624233|10034795|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
2914066|NCT01624233|10034795|P1|Period 5 - Retreatment Period|Physician Decision|1
2914067|NCT01624233|10034795|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
2914068|NCT01624233|10034795|P1|Period 5 - Retreatment Period|Adverse Event|5
2914069|NCT01624233|10034795|P1|Period 4 - Drug Free Period|Relapsed|61
2914070|NCT01624233|10034795|P1|Period 3 - Maintenance|Withdrawal by Subject|2
2914071|NCT01624233|10034795|P1|Period 3 - Maintenance|Physician Decision|2
2914072|NCT01624233|10034795|P1|Period 3 - Maintenance|Lack of Efficacy|1
2914073|NCT01624233|10034795|P1|Period 3 - Maintenance|Adverse Event|2
2914074|NCT01624233|10034795|P1|Period 2 - Induction|Adverse Event|1
2914075|NCT01624194|10034827|P2|Overall Study|Withdrawal by Subject|0
2914076|NCT01624194|10034828|P1|Overall Study|Withdrawal by Subject|1
2914077|NCT01624194|10034827|P2|Overall Study|Lost to Follow-up|0
2914078|NCT01624194|10034828|P1|Overall Study|Lost to Follow-up|1
2914079|NCT01624142|10034896|P2|Overall Study|Other|0
2914080|NCT01624142|10034897|P1|Overall Study|Other|1
2914081|NCT01624142|10034896|P2|Overall Study|Lost to Follow-up|0
2914082|NCT01624142|10034897|P1|Overall Study|Lost to Follow-up|2
2914083|NCT01624142|10034896|P2|Overall Study|Study Closure|6
2914084|NCT01624142|10034897|P1|Overall Study|Study Closure|12
2914085|NCT01624142|10034896|P2|Overall Study|Death|6
2914086|NCT01624142|10034897|P1|Overall Study|Death|3
2914087|NCT01624142|10034896|P2|Overall Study|Withdrawal by Subject|4
2914088|NCT01624142|10034897|P1|Overall Study|Withdrawal by Subject|14
2914089|NCT01624090|10034922|P4|Overall Study|Dose escalated|0
2914090|NCT01624090|10034923|P3|Overall Study|Dose escalated|3
2914091|NCT01624090|10034924|P2|Overall Study|Dose escalated|0
2914092|NCT01624090|10034925|P1|Overall Study|Dose escalated|0
2914093|NCT01624090|10034922|P4|Overall Study|Did not complete 1 crse of therapy|0
2914094|NCT01624090|10034923|P3|Overall Study|Did not complete 1 crse of therapy|2
2914095|NCT01624090|10034924|P2|Overall Study|Did not complete 1 crse of therapy|0
2914096|NCT01624090|10034925|P1|Overall Study|Did not complete 1 crse of therapy|0
2914097|NCT01624090|10034922|P4|Overall Study|Died on study|0
2914098|NCT01624090|10034923|P3|Overall Study|Died on study|2
2914099|NCT01624090|10034924|P2|Overall Study|Died on study|0
2914100|NCT01624090|10034925|P1|Overall Study|Died on study|0
2914101|NCT01624090|10034922|P4|Overall Study|Withdrew prior to treatment|0
2914102|NCT01624090|10034923|P3|Overall Study|Withdrew prior to treatment|0
2914103|NCT01624090|10034924|P2|Overall Study|Withdrew prior to treatment|1
2914104|NCT01624090|10034925|P1|Overall Study|Withdrew prior to treatment|0
2914105|NCT01624090|10034922|P4|Overall Study|DLT, taken off therapy|0
2914106|NCT01624090|10034923|P3|Overall Study|DLT, taken off therapy|0
2914107|NCT01624090|10034924|P2|Overall Study|DLT, taken off therapy|1
2914108|NCT01624090|10034925|P1|Overall Study|DLT, taken off therapy|0
2914109|NCT01623830|10034947|P2|Overall Study|Exclusion from Study|2
2914110|NCT01623830|10034948|P1|Overall Study|Exclusion from Study|1
2914111|NCT01623830|10034947|P2|Overall Study|Withdrawal by Subject|7
2914112|NCT01623830|10034948|P1|Overall Study|Withdrawal by Subject|6
2914113|NCT01623752|10034965|P3|Phase 2 (78 Weeks)|Adverse Event|0
2914114|NCT01623752|10034966|P2|Phase 2 (78 Weeks)|Adverse Event|4
2914115|NCT01623752|10034967|P1|Phase 2 (78 Weeks)|Adverse Event|4
2914116|NCT01623752|10034965|P3|Phase 2 (78 Weeks)|No Data|0
2914117|NCT01623752|10034966|P2|Phase 2 (78 Weeks)|No Data|11
2914118|NCT01623752|10034967|P1|Phase 2 (78 Weeks)|No Data|43
2914119|NCT01623752|10034965|P3|Phase 2 (78 Weeks)|Other|0
2914120|NCT01623752|10034966|P2|Phase 2 (78 Weeks)|Other|1
2914121|NCT01623752|10034967|P1|Phase 2 (78 Weeks)|Other|5
2914122|NCT01623752|10034965|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
2914123|NCT01623752|10034966|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
2914124|NCT01623752|10034967|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
2914125|NCT01623752|10034965|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
2914126|NCT01623752|10034966|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
2914127|NCT01623752|10034967|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
2914128|NCT01623752|10034965|P3|Phase 1 (78 Weeks)|Adverse Event|0
2914129|NCT01623752|10034966|P2|Phase 1 (78 Weeks)|Adverse Event|39
2914130|NCT01623752|10034967|P1|Phase 1 (78 Weeks)|Adverse Event|122
2914131|NCT01623752|10034965|P3|Phase 1 (78 Weeks)|Other|0
2914132|NCT01623752|10034966|P2|Phase 1 (78 Weeks)|Other|20
2914133|NCT01623752|10034967|P1|Phase 1 (78 Weeks)|Other|33
2914134|NCT01623752|10034965|P3|Phase 1 (78 Weeks)|No Data|2
2914135|NCT01623752|10034966|P2|Phase 1 (78 Weeks)|No Data|66
2914136|NCT01623752|10034967|P1|Phase 1 (78 Weeks)|No Data|249
2914137|NCT01623596|10035070|P2|Overall Study|Lack of Efficacy|3
2914138|NCT01623596|10035071|P1|Overall Study|Lack of Efficacy|5
2914139|NCT01623596|10035070|P2|Overall Study|Protocol Violation|6
2914140|NCT01623596|10035071|P1|Overall Study|Protocol Violation|0
2914141|NCT01623596|10035070|P2|Overall Study|Patient no longer requires study drug|0
2914142|NCT01623596|10035071|P1|Overall Study|Patient no longer requires study drug|1
2914143|NCT01623596|10035070|P2|Overall Study|Withdrawal by Subject|31
2914144|NCT01623596|10035071|P1|Overall Study|Withdrawal by Subject|13
2914145|NCT01623596|10035070|P2|Overall Study|Lost to Follow-up|16
2914146|NCT01623596|10035071|P1|Overall Study|Lost to Follow-up|12
2914147|NCT01623596|10035070|P2|Overall Study|Death|2
2914148|NCT01623596|10035071|P1|Overall Study|Death|0
2914149|NCT01623596|10035070|P2|Overall Study|Adverse Event|29
2914150|NCT01623596|10035071|P1|Overall Study|Adverse Event|20
2914151|NCT01623596|10035070|P2|Overall Study|Administrative problems|13
2914152|NCT01623596|10035071|P1|Overall Study|Administrative problems|9
2914153|NCT01623596|10035070|P2|Overall Study|Abnormal laboratory values|0
2914154|NCT01623596|10035071|P1|Overall Study|Abnormal laboratory values|2
2914155|NCT01623531|10035089|P2|Overall Study|Missing data at primary outcome time poi|1
2914156|NCT01623531|10035090|P1|Overall Study|Missing data at primary outcome time poi|1
2914157|NCT01623531|10035089|P2|Overall Study|Protocol Violation|1
2914158|NCT01623531|10035090|P1|Overall Study|Protocol Violation|2
2914159|NCT01623531|10035089|P2|Overall Study|Death|0
2914160|NCT01623531|10035090|P1|Overall Study|Death|1
2914161|NCT01623310|10035157|P1|Overall Study|Investigators Discretion-Noncompliant|1
2914162|NCT01623310|10035157|P1|Overall Study|Diagnoses of bilateral cateracts|1
2914163|NCT01623310|10035157|P1|Overall Study|Became potentially child-bearing|1
2914164|NCT01623310|10035157|P1|Overall Study|Withdrawal by Subject|25
2914165|NCT01623310|10035157|P1|Overall Study|Protocol Violation|6
2914166|NCT01623310|10035157|P1|Overall Study|Lack of Efficacy|6
2914167|NCT01623310|10035157|P1|Overall Study|Lost to Follow-up|18
2914168|NCT01623310|10035157|P1|Overall Study|Adverse Event|21
2914169|NCT01623271|10035166|P1|Overall Study|Withdrawal by Subject|2
2914170|NCT01623154|10035170|P1|Overall Study|Did not drink Pranactin Citric|4
2914171|NCT01623115|10035178|P2|Overall Study|Other than specified above|3
2914172|NCT01623115|10035179|P1|Overall Study|Other than specified above|0
2914173|NCT01623115|10035178|P2|Overall Study|Death|4
2914174|NCT01623115|10035179|P1|Overall Study|Death|0
2914175|NCT01623115|10035178|P2|Overall Study|Site closure|7
2914176|NCT01623115|10035179|P1|Overall Study|Site closure|1
2914177|NCT01623115|10035178|P2|Overall Study|Last visit outside protocol visit window|26
2914178|NCT01623115|10035179|P1|Overall Study|Last visit outside protocol visit window|14
2914179|NCT01623115|10035178|P2|Overall Study|Related to study drug administration|2
2914180|NCT01623115|10035179|P1|Overall Study|Related to study drug administration|0
2914181|NCT01623115|10035178|P2|Overall Study|Consent withdrawn by participant|6
2914182|NCT01623115|10035179|P1|Overall Study|Consent withdrawn by participant|2
2914183|NCT01623115|10035178|P2|Overall Study|Poor compliance to protocol|10
2914184|NCT01623115|10035179|P1|Overall Study|Poor compliance to protocol|4
2914185|NCT01623115|10035178|P2|Overall Study|Adverse Event|13
2914186|NCT01623115|10035179|P1|Overall Study|Adverse Event|10
2914187|NCT01623115|10035178|P2|Overall Study|Participants moved|5
2914188|NCT01623115|10035179|P1|Overall Study|Participants moved|1
2914189|NCT01623115|10035178|P2|Overall Study|Physician Decision|0
2914190|NCT01623115|10035179|P1|Overall Study|Physician Decision|1
2914191|NCT01623115|10035178|P2|Overall Study|Randomized but not treated|1
2914192|NCT01623115|10035179|P1|Overall Study|Randomized but not treated|0
2914193|NCT01623050|10035239|P1|Overall Study|Lost to Follow-up|9
2914194|NCT01622673|10035268|P6|Treatment Period 3|Protocol Violation|0
2914195|NCT01622673|10035269|P5|Treatment Period 3|Protocol Violation|0
2914196|NCT01622673|10035270|P4|Treatment Period 3|Protocol Violation|0
2914197|NCT01622673|10035271|P3|Treatment Period 3|Protocol Violation|0
2914198|NCT01622673|10035272|P2|Treatment Period 3|Protocol Violation|1
2914199|NCT01622673|10035273|P1|Treatment Period 3|Protocol Violation|0
2914200|NCT01622673|10035268|P6|Treatment Period 2|Withdrawal by Subject|0
2914201|NCT01622673|10035269|P5|Treatment Period 2|Withdrawal by Subject|0
2914202|NCT01622673|10035270|P4|Treatment Period 2|Withdrawal by Subject|1
2914203|NCT01622673|10035271|P3|Treatment Period 2|Withdrawal by Subject|0
2914204|NCT01622673|10035272|P2|Treatment Period 2|Withdrawal by Subject|0
2914205|NCT01622673|10035273|P1|Treatment Period 2|Withdrawal by Subject|0
2914206|NCT01622673|10035268|P6|Treatment Period 1|Protocol Violation|0
2914207|NCT01622673|10035269|P5|Treatment Period 1|Protocol Violation|0
2914208|NCT01622673|10035270|P4|Treatment Period 1|Protocol Violation|0
2914209|NCT01622673|10035271|P3|Treatment Period 1|Protocol Violation|0
2914210|NCT01622673|10035272|P2|Treatment Period 1|Protocol Violation|1
2914211|NCT01622673|10035273|P1|Treatment Period 1|Protocol Violation|0
2914212|NCT01622673|10035268|P6|Treatment Period 1|Withdrawal by Subject|0
2914213|NCT01622673|10035269|P5|Treatment Period 1|Withdrawal by Subject|0
2914214|NCT01622673|10035270|P4|Treatment Period 1|Withdrawal by Subject|1
2914215|NCT01622673|10035271|P3|Treatment Period 1|Withdrawal by Subject|0
2914216|NCT01622673|10035272|P2|Treatment Period 1|Withdrawal by Subject|0
2914217|NCT01622673|10035273|P1|Treatment Period 1|Withdrawal by Subject|0
2914218|NCT01622660|10035308|P1|Overall Study|Adverse Event|1
2914219|NCT01622569|10035316|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2914220|NCT01622569|10035317|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914221|NCT01622569|10035318|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914222|NCT01622569|10035319|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2914223|NCT01622569|10035316|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2914224|NCT01622569|10035317|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
2914225|NCT01622569|10035318|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2914226|NCT01622569|10035319|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2914227|NCT01622569|10035316|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2914228|NCT01622569|10035317|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2914229|NCT01622569|10035318|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
2914230|NCT01622569|10035319|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2914231|NCT01622569|10035316|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2914232|NCT01622569|10035317|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2914233|NCT01622569|10035318|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2914234|NCT01622569|10035319|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2914235|NCT01622569|10035316|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2914236|NCT01622569|10035317|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2914237|NCT01622569|10035318|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
2914238|NCT01622569|10035319|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2914239|NCT01622569|10035316|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
2914240|NCT01622569|10035317|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
2914241|NCT01622569|10035318|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2914242|NCT01622569|10035319|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
2914243|NCT01622569|10035316|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2914244|NCT01622569|10035317|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
2914245|NCT01622569|10035318|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2914246|NCT01622569|10035319|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2914247|NCT01622569|10035316|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2914248|NCT01622569|10035317|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
2914249|NCT01622569|10035318|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2914250|NCT01622569|10035319|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
2914251|NCT01622348|10035404|P3|Overall Study|Withdrawal by Subject|1
2914252|NCT01622348|10035405|P2|Overall Study|Withdrawal by Subject|0
2914253|NCT01622348|10035406|P1|Overall Study|Withdrawal by Subject|1
2914254|NCT01622231|10035445|P1|Overall Study|Withdrawal by Subject|1
2914255|NCT01622231|10035445|P1|Overall Study|Physician Decision|1
2914256|NCT01621880|10035475|P2|Overall Study|Withdrawal by Subject|4
2914257|NCT01621880|10035476|P1|Overall Study|Withdrawal by Subject|5
2914258|NCT01621880|10035475|P2|Overall Study|Adverse Event|1
2914259|NCT01621880|10035476|P1|Overall Study|Adverse Event|5
2914260|NCT01621802|10035490|P6|Overall Study|Lost to Follow-up|11
2914261|NCT01621802|10035491|P5|Overall Study|Lost to Follow-up|31
2914262|NCT01621802|10035492|P4|Overall Study|Lost to Follow-up|7
2914263|NCT01621802|10035493|P3|Overall Study|Lost to Follow-up|24
2914264|NCT01621802|10035494|P2|Overall Study|Lost to Follow-up|16
2914265|NCT01621802|10035495|P1|Overall Study|Lost to Follow-up|36
2914266|NCT01621802|10035490|P6|Overall Study|Others|0
2914267|NCT01621802|10035491|P5|Overall Study|Others|1
2914268|NCT01621802|10035492|P4|Overall Study|Others|2
2914269|NCT01621802|10035493|P3|Overall Study|Others|3
2914270|NCT01621802|10035494|P2|Overall Study|Others|3
2914271|NCT01621802|10035495|P1|Overall Study|Others|3
2914272|NCT01621802|10035490|P6|Overall Study|Migrated/moved from study area|0
2914273|NCT01621802|10035491|P5|Overall Study|Migrated/moved from study area|1
2914274|NCT01621802|10035492|P4|Overall Study|Migrated/moved from study area|0
2914275|NCT01621802|10035493|P3|Overall Study|Migrated/moved from study area|2
2914276|NCT01621802|10035494|P2|Overall Study|Migrated/moved from study area|0
2914277|NCT01621802|10035495|P1|Overall Study|Migrated/moved from study area|0
2914278|NCT01621802|10035490|P6|Overall Study|Withdrawal by Subject|0
2914279|NCT01621802|10035491|P5|Overall Study|Withdrawal by Subject|2
2914280|NCT01621802|10035492|P4|Overall Study|Withdrawal by Subject|2
2914281|NCT01621802|10035493|P3|Overall Study|Withdrawal by Subject|4
2914282|NCT01621802|10035494|P2|Overall Study|Withdrawal by Subject|4
2914283|NCT01621802|10035495|P1|Overall Study|Withdrawal by Subject|8
2914284|NCT01621802|10035490|P6|Overall Study|Protocol Violation|1
2914285|NCT01621802|10035491|P5|Overall Study|Protocol Violation|0
2914286|NCT01621802|10035492|P4|Overall Study|Protocol Violation|0
2914287|NCT01621802|10035493|P3|Overall Study|Protocol Violation|0
2914288|NCT01621802|10035494|P2|Overall Study|Protocol Violation|0
2914289|NCT01621802|10035495|P1|Overall Study|Protocol Violation|0
2914290|NCT01621542|10035680|P6|Overall Study|study stopped by sponsor|0
2914291|NCT01621542|10035681|P5|Overall Study|study stopped by sponsor|0
2914292|NCT01621542|10035682|P4|Overall Study|study stopped by sponsor|1
2914293|NCT01621542|10035683|P3|Overall Study|study stopped by sponsor|0
2914294|NCT01621542|10035684|P2|Overall Study|study stopped by sponsor|0
2914295|NCT01621542|10035685|P1|Overall Study|study stopped by sponsor|0
2914296|NCT01621542|10035680|P6|Overall Study|Protocol Violation|0
2914297|NCT01621542|10035681|P5|Overall Study|Protocol Violation|0
2914298|NCT01621542|10035682|P4|Overall Study|Protocol Violation|1
2914299|NCT01621542|10035683|P3|Overall Study|Protocol Violation|0
2914300|NCT01621542|10035684|P2|Overall Study|Protocol Violation|0
2914301|NCT01621542|10035685|P1|Overall Study|Protocol Violation|0
2914302|NCT01621542|10035680|P6|Overall Study|progression/treatment failure|5
2914303|NCT01621542|10035681|P5|Overall Study|progression/treatment failure|3
2914304|NCT01621542|10035682|P4|Overall Study|progression/treatment failure|7
2914305|NCT01621542|10035683|P3|Overall Study|progression/treatment failure|3
2914306|NCT01621542|10035684|P2|Overall Study|progression/treatment failure|4
2914307|NCT01621542|10035685|P1|Overall Study|progression/treatment failure|2
2914308|NCT01621542|10035680|P6|Overall Study|Withdrawal by Subject|3
2914309|NCT01621542|10035681|P5|Overall Study|Withdrawal by Subject|3
2914310|NCT01621542|10035682|P4|Overall Study|Withdrawal by Subject|3
2914311|NCT01621542|10035683|P3|Overall Study|Withdrawal by Subject|1
2914312|NCT01621542|10035684|P2|Overall Study|Withdrawal by Subject|0
2914313|NCT01621542|10035685|P1|Overall Study|Withdrawal by Subject|2
2914314|NCT01621542|10035680|P6|Overall Study|Physician Decision|1
2914315|NCT01621542|10035681|P5|Overall Study|Physician Decision|3
2914316|NCT01621542|10035682|P4|Overall Study|Physician Decision|13
2914317|NCT01621542|10035683|P3|Overall Study|Physician Decision|1
2914318|NCT01621542|10035684|P2|Overall Study|Physician Decision|0
2914319|NCT01621542|10035685|P1|Overall Study|Physician Decision|1
2914320|NCT01621542|10035680|P6|Overall Study|Death|0
2914321|NCT01621542|10035681|P5|Overall Study|Death|0
2914322|NCT01621542|10035682|P4|Overall Study|Death|0
2914323|NCT01621542|10035683|P3|Overall Study|Death|0
2914324|NCT01621542|10035684|P2|Overall Study|Death|1
2914325|NCT01621542|10035685|P1|Overall Study|Death|0
2914326|NCT01621542|10035680|P6|Overall Study|Adverse Event|0
2914327|NCT01621542|10035681|P5|Overall Study|Adverse Event|0
2914328|NCT01621542|10035682|P4|Overall Study|Adverse Event|3
2914329|NCT01621542|10035683|P3|Overall Study|Adverse Event|1
2914330|NCT01621542|10035684|P2|Overall Study|Adverse Event|0
2914331|NCT01621542|10035685|P1|Overall Study|Adverse Event|0
2914332|NCT01621490|10035726|P9|Overall Study|Patient delayed due to toxicity|0
2914333|NCT01621490|10035727|P8|Overall Study|Patient delayed due to toxicity|0
2914334|NCT01621490|10035728|P7|Overall Study|Patient delayed due to toxicity|0
2914335|NCT01621490|10035729|P6|Overall Study|Patient delayed due to toxicity|1
2914336|NCT01621490|10035730|P5|Overall Study|Patient delayed due to toxicity|0
2914337|NCT01621490|10035731|P4|Overall Study|Patient delayed due to toxicity|0
2914338|NCT01621490|10035732|P3|Overall Study|Patient delayed due to toxicity|0
2914339|NCT01621490|10035733|P2|Overall Study|Patient delayed due to toxicity|0
2914340|NCT01621490|10035734|P1|Overall Study|Patient delayed due to toxicity|0
2914341|NCT01621490|10035726|P9|Overall Study|Complete response|1
2914342|NCT01621490|10035727|P8|Overall Study|Complete response|0
2914343|NCT01621490|10035728|P7|Overall Study|Complete response|0
2914344|NCT01621490|10035729|P6|Overall Study|Complete response|0
2914345|NCT01621490|10035730|P5|Overall Study|Complete response|0
2914346|NCT01621490|10035731|P4|Overall Study|Complete response|0
2914347|NCT01621490|10035732|P3|Overall Study|Complete response|0
2914348|NCT01621490|10035733|P2|Overall Study|Complete response|0
2914349|NCT01621490|10035734|P1|Overall Study|Complete response|0
2914350|NCT01621490|10035726|P9|Overall Study|Clinical deterioration|0
2914351|NCT01621490|10035727|P8|Overall Study|Clinical deterioration|0
2914352|NCT01621490|10035728|P7|Overall Study|Clinical deterioration|0
2914353|NCT01621490|10035729|P6|Overall Study|Clinical deterioration|0
2914354|NCT01621490|10035730|P5|Overall Study|Clinical deterioration|0
2914355|NCT01621490|10035731|P4|Overall Study|Clinical deterioration|0
2914356|NCT01621490|10035732|P3|Overall Study|Clinical deterioration|0
2914357|NCT01621490|10035733|P2|Overall Study|Clinical deterioration|1
2914358|NCT01621490|10035734|P1|Overall Study|Clinical deterioration|0
2914359|NCT01621490|10035726|P9|Overall Study|Patient reached treatment 2 yr limit|0
2914360|NCT01621490|10035727|P8|Overall Study|Patient reached treatment 2 yr limit|0
2914361|NCT01621490|10035728|P7|Overall Study|Patient reached treatment 2 yr limit|0
2914362|NCT01621490|10035729|P6|Overall Study|Patient reached treatment 2 yr limit|0
2914363|NCT01621490|10035730|P5|Overall Study|Patient reached treatment 2 yr limit|0
2914364|NCT01621490|10035731|P4|Overall Study|Patient reached treatment 2 yr limit|0
2914365|NCT01621490|10035732|P3|Overall Study|Patient reached treatment 2 yr limit|0
2914366|NCT01621490|10035733|P2|Overall Study|Patient reached treatment 2 yr limit|1
2914367|NCT01621490|10035734|P1|Overall Study|Patient reached treatment 2 yr limit|0
2914368|NCT01621490|10035726|P9|Overall Study|Documented disease progression|0
2914369|NCT01621490|10035727|P8|Overall Study|Documented disease progression|0
2914370|NCT01621490|10035728|P7|Overall Study|Documented disease progression|0
2914371|NCT01621490|10035729|P6|Overall Study|Documented disease progression|0
2914372|NCT01621490|10035730|P5|Overall Study|Documented disease progression|0
2914373|NCT01621490|10035731|P4|Overall Study|Documented disease progression|0
2914374|NCT01621490|10035732|P3|Overall Study|Documented disease progression|1
2914375|NCT01621490|10035733|P2|Overall Study|Documented disease progression|0
2914376|NCT01621490|10035734|P1|Overall Study|Documented disease progression|0
2914377|NCT01621490|10035726|P9|Overall Study|Investigator decision|0
2914378|NCT01621490|10035727|P8|Overall Study|Investigator decision|0
2914379|NCT01621490|10035728|P7|Overall Study|Investigator decision|1
2914380|NCT01621490|10035729|P6|Overall Study|Investigator decision|0
2914381|NCT01621490|10035730|P5|Overall Study|Investigator decision|1
2914382|NCT01621490|10035731|P4|Overall Study|Investigator decision|0
2914383|NCT01621490|10035732|P3|Overall Study|Investigator decision|1
2914384|NCT01621490|10035733|P2|Overall Study|Investigator decision|0
2914385|NCT01621490|10035734|P1|Overall Study|Investigator decision|0
2914386|NCT01621490|10035726|P9|Overall Study|BMS informed of patient status|0
2914387|NCT01621490|10035727|P8|Overall Study|BMS informed of patient status|0
2914388|NCT01621490|10035728|P7|Overall Study|BMS informed of patient status|0
2914389|NCT01621490|10035729|P6|Overall Study|BMS informed of patient status|0
2914390|NCT01621490|10035730|P5|Overall Study|BMS informed of patient status|0
2914391|NCT01621490|10035731|P4|Overall Study|BMS informed of patient status|0
2914392|NCT01621490|10035732|P3|Overall Study|BMS informed of patient status|1
2914393|NCT01621490|10035733|P2|Overall Study|BMS informed of patient status|0
2914394|NCT01621490|10035734|P1|Overall Study|BMS informed of patient status|0
2914395|NCT01621490|10035726|P9|Overall Study|Grade 4 Lipase elevation|0
2914396|NCT01621490|10035727|P8|Overall Study|Grade 4 Lipase elevation|0
2914397|NCT01621490|10035728|P7|Overall Study|Grade 4 Lipase elevation|0
2914398|NCT01621490|10035729|P6|Overall Study|Grade 4 Lipase elevation|0
2914399|NCT01621490|10035730|P5|Overall Study|Grade 4 Lipase elevation|0
2914400|NCT01621490|10035731|P4|Overall Study|Grade 4 Lipase elevation|0
2914401|NCT01621490|10035732|P3|Overall Study|Grade 4 Lipase elevation|0
2914402|NCT01621490|10035733|P2|Overall Study|Grade 4 Lipase elevation|0
2914403|NCT01621490|10035734|P1|Overall Study|Grade 4 Lipase elevation|1
2914404|NCT01621490|10035726|P9|Overall Study|Death|0
2914405|NCT01621490|10035727|P8|Overall Study|Death|1
2914406|NCT01621490|10035728|P7|Overall Study|Death|0
2914407|NCT01621490|10035729|P6|Overall Study|Death|0
2914408|NCT01621490|10035730|P5|Overall Study|Death|0
2914409|NCT01621490|10035731|P4|Overall Study|Death|0
2914410|NCT01621490|10035732|P3|Overall Study|Death|0
2914411|NCT01621490|10035733|P2|Overall Study|Death|0
2914412|NCT01621490|10035734|P1|Overall Study|Death|0
2914413|NCT01621490|10035726|P9|Overall Study|Study drug toxicity|1
2914414|NCT01621490|10035727|P8|Overall Study|Study drug toxicity|4
2914415|NCT01621490|10035728|P7|Overall Study|Study drug toxicity|1
2914416|NCT01621490|10035729|P6|Overall Study|Study drug toxicity|10
2914417|NCT01621490|10035730|P5|Overall Study|Study drug toxicity|1
2914418|NCT01621490|10035731|P4|Overall Study|Study drug toxicity|3
2914419|NCT01621490|10035732|P3|Overall Study|Study drug toxicity|5
2914420|NCT01621490|10035733|P2|Overall Study|Study drug toxicity|4
2914421|NCT01621490|10035734|P1|Overall Study|Study drug toxicity|1
2914422|NCT01621490|10035726|P9|Overall Study|Disease progression|4
2914423|NCT01621490|10035727|P8|Overall Study|Disease progression|0
2914424|NCT01621490|10035728|P7|Overall Study|Disease progression|7
2914425|NCT01621490|10035729|P6|Overall Study|Disease progression|8
2914426|NCT01621490|10035730|P5|Overall Study|Disease progression|3
2914427|NCT01621490|10035731|P4|Overall Study|Disease progression|5
2914428|NCT01621490|10035732|P3|Overall Study|Disease progression|1
2914429|NCT01621490|10035733|P2|Overall Study|Disease progression|28
2914430|NCT01621490|10035734|P1|Overall Study|Disease progression|27
2914431|NCT01621490|10035726|P9|Overall Study|Adverse event unrelated to study drug|1
2914432|NCT01621490|10035727|P8|Overall Study|Adverse event unrelated to study drug|2
2914433|NCT01621490|10035728|P7|Overall Study|Adverse event unrelated to study drug|0
2914434|NCT01621490|10035729|P6|Overall Study|Adverse event unrelated to study drug|0
2914435|NCT01621490|10035730|P5|Overall Study|Adverse event unrelated to study drug|0
2914436|NCT01621490|10035731|P4|Overall Study|Adverse event unrelated to study drug|0
2914437|NCT01621490|10035732|P3|Overall Study|Adverse event unrelated to study drug|0
2914438|NCT01621490|10035733|P2|Overall Study|Adverse event unrelated to study drug|1
2914439|NCT01621490|10035734|P1|Overall Study|Adverse event unrelated to study drug|2
2914440|NCT01621490|10035726|P9|Overall Study|Subject request to discontinue study|1
2914441|NCT01621490|10035727|P8|Overall Study|Subject request to discontinue study|0
2914442|NCT01621490|10035728|P7|Overall Study|Subject request to discontinue study|1
2914443|NCT01621490|10035729|P6|Overall Study|Subject request to discontinue study|2
2914444|NCT01621490|10035730|P5|Overall Study|Subject request to discontinue study|0
2914445|NCT01621490|10035731|P4|Overall Study|Subject request to discontinue study|1
2914446|NCT01621490|10035732|P3|Overall Study|Subject request to discontinue study|1
2914447|NCT01621490|10035733|P2|Overall Study|Subject request to discontinue study|3
2914448|NCT01621490|10035734|P1|Overall Study|Subject request to discontinue study|1
2914449|NCT01621490|10035726|P9|Overall Study|Withdrawal by Subject|0
2914450|NCT01621490|10035727|P8|Overall Study|Withdrawal by Subject|0
2914451|NCT01621490|10035728|P7|Overall Study|Withdrawal by Subject|0
2914452|NCT01621490|10035729|P6|Overall Study|Withdrawal by Subject|3
2914453|NCT01621490|10035730|P5|Overall Study|Withdrawal by Subject|0
2914454|NCT01621490|10035731|P4|Overall Study|Withdrawal by Subject|0
2914455|NCT01621490|10035732|P3|Overall Study|Withdrawal by Subject|0
2914456|NCT01621490|10035733|P2|Overall Study|Withdrawal by Subject|0
2914457|NCT01621490|10035734|P1|Overall Study|Withdrawal by Subject|1
2914458|NCT01621490|10035726|P9|Overall Study|Maximum clinical benefit|0
2914459|NCT01621490|10035727|P8|Overall Study|Maximum clinical benefit|2
2914460|NCT01621490|10035728|P7|Overall Study|Maximum clinical benefit|1
2914461|NCT01621490|10035729|P6|Overall Study|Maximum clinical benefit|0
2914462|NCT01621490|10035730|P5|Overall Study|Maximum clinical benefit|0
2914463|NCT01621490|10035731|P4|Overall Study|Maximum clinical benefit|0
2914464|NCT01621490|10035732|P3|Overall Study|Maximum clinical benefit|0
2914465|NCT01621490|10035733|P2|Overall Study|Maximum clinical benefit|2
2914466|NCT01621490|10035734|P1|Overall Study|Maximum clinical benefit|3
2914467|NCT01621490|10035726|P9|Overall Study|Subject no longer meets study criteria|0
2914468|NCT01621490|10035727|P8|Overall Study|Subject no longer meets study criteria|0
2914469|NCT01621490|10035728|P7|Overall Study|Subject no longer meets study criteria|0
2914470|NCT01621490|10035729|P6|Overall Study|Subject no longer meets study criteria|0
2914471|NCT01621490|10035730|P5|Overall Study|Subject no longer meets study criteria|1
2914472|NCT01621490|10035731|P4|Overall Study|Subject no longer meets study criteria|0
2914473|NCT01621490|10035732|P3|Overall Study|Subject no longer meets study criteria|0
2914474|NCT01621490|10035733|P2|Overall Study|Subject no longer meets study criteria|0
2914475|NCT01621490|10035734|P1|Overall Study|Subject no longer meets study criteria|0
2914476|NCT01621490|10035726|P9|Overall Study|Patient could not travel|0
2914477|NCT01621490|10035727|P8|Overall Study|Patient could not travel|0
2914478|NCT01621490|10035728|P7|Overall Study|Patient could not travel|0
2914479|NCT01621490|10035729|P6|Overall Study|Patient could not travel|0
2914480|NCT01621490|10035730|P5|Overall Study|Patient could not travel|0
2914481|NCT01621490|10035731|P4|Overall Study|Patient could not travel|0
2914482|NCT01621490|10035732|P3|Overall Study|Patient could not travel|0
2914483|NCT01621490|10035733|P2|Overall Study|Patient could not travel|0
2914484|NCT01621490|10035734|P1|Overall Study|Patient could not travel|1
2914485|NCT01621490|10035726|P9|Overall Study|Participant completed treatment|0
2914486|NCT01621490|10035727|P8|Overall Study|Participant completed treatment|1
2914487|NCT01621490|10035728|P7|Overall Study|Participant completed treatment|0
2914488|NCT01621490|10035729|P6|Overall Study|Participant completed treatment|0
2914489|NCT01621490|10035730|P5|Overall Study|Participant completed treatment|0
2914490|NCT01621490|10035731|P4|Overall Study|Participant completed treatment|0
2914491|NCT01621490|10035732|P3|Overall Study|Participant completed treatment|1
2914492|NCT01621490|10035733|P2|Overall Study|Participant completed treatment|4
2914493|NCT01621490|10035734|P1|Overall Study|Participant completed treatment|4
2914494|NCT01621191|10035970|P1|Overall Study|Site Removed From Study|1
2914495|NCT01621191|10035970|P1|Overall Study|Lost to Follow-up|1
2914496|NCT01621191|10035970|P1|Overall Study|Lack of Efficacy|6
2914497|NCT01621191|10035970|P1|Overall Study|Withdrawal by Subject|8
2914498|NCT01621191|10035970|P1|Overall Study|Adverse Event|9
2914499|NCT01621178|10035984|P3|Overall Study|Physician Decision|7
2914500|NCT01621178|10035985|P2|Overall Study|Physician Decision|2
2914501|NCT01621178|10035986|P1|Overall Study|Physician Decision|5
2914502|NCT01621178|10035984|P3|Overall Study|Withdrawal by Subject|18
2914503|NCT01621178|10035985|P2|Overall Study|Withdrawal by Subject|17
2914504|NCT01621178|10035986|P1|Overall Study|Withdrawal by Subject|14
2914505|NCT01621178|10035984|P3|Overall Study|Lost to Follow-up|1
2914506|NCT01621178|10035985|P2|Overall Study|Lost to Follow-up|2
2914507|NCT01621178|10035986|P1|Overall Study|Lost to Follow-up|1
2914508|NCT01621178|10035984|P3|Overall Study|Death|2
2914509|NCT01621178|10035985|P2|Overall Study|Death|7
2914510|NCT01621178|10035986|P1|Overall Study|Death|6
2914511|NCT01621178|10035984|P3|Overall Study|Adverse Event|8
2914512|NCT01621178|10035985|P2|Overall Study|Adverse Event|2
2914513|NCT01621178|10035986|P1|Overall Study|Adverse Event|5
2914514|NCT01621126|10036078|P1|Overall Study|Physician Decision|6
2914515|NCT01620983|10036100|P3|Overall Study|Physician Decision|5
2914516|NCT01620983|10036101|P2|Overall Study|Physician Decision|10
2914517|NCT01620983|10036102|P1|Overall Study|Physician Decision|3
2914518|NCT01620983|10036100|P3|Overall Study|Death|0
2914519|NCT01620983|10036101|P2|Overall Study|Death|0
2914520|NCT01620983|10036102|P1|Overall Study|Death|2
2914521|NCT01620983|10036100|P3|Overall Study|Withdrawal by Subject|1
2914522|NCT01620983|10036101|P2|Overall Study|Withdrawal by Subject|8
2914523|NCT01620983|10036102|P1|Overall Study|Withdrawal by Subject|6
2914524|NCT01620983|10036100|P3|Overall Study|Lost to Follow-up|9
2914525|NCT01620983|10036101|P2|Overall Study|Lost to Follow-up|4
2914526|NCT01620983|10036102|P1|Overall Study|Lost to Follow-up|8
2914527|NCT01620762|10036131|P3|Overall Study|Use of prohibted therapies|1
2914528|NCT01620762|10036132|P2|Overall Study|Use of prohibted therapies|1
2914529|NCT01620762|10036133|P1|Overall Study|Use of prohibted therapies|0
2914530|NCT01620762|10036131|P3|Overall Study|Non-specified|5
2914531|NCT01620762|10036132|P2|Overall Study|Non-specified|6
2914532|NCT01620762|10036133|P1|Overall Study|Non-specified|3
2914533|NCT01620762|10036131|P3|Overall Study|Subject deterioration|1
2914534|NCT01620762|10036132|P2|Overall Study|Subject deterioration|1
2914535|NCT01620762|10036133|P1|Overall Study|Subject deterioration|0
2914536|NCT01620762|10036131|P3|Overall Study|Protocol deviation|6
2914537|NCT01620762|10036132|P2|Overall Study|Protocol deviation|1
2914538|NCT01620762|10036133|P1|Overall Study|Protocol deviation|1
2914539|NCT01620762|10036131|P3|Overall Study|Lost to Follow-up|10
2914540|NCT01620762|10036132|P2|Overall Study|Lost to Follow-up|17
2914541|NCT01620762|10036133|P1|Overall Study|Lost to Follow-up|11
2914542|NCT01620762|10036131|P3|Overall Study|Withdrawal by Subject|27
2914543|NCT01620762|10036132|P2|Overall Study|Withdrawal by Subject|26
2914544|NCT01620762|10036133|P1|Overall Study|Withdrawal by Subject|23
2914545|NCT01620762|10036131|P3|Overall Study|Adverse Event|2
2914546|NCT01620762|10036132|P2|Overall Study|Adverse Event|5
2914547|NCT01620762|10036133|P1|Overall Study|Adverse Event|9
2914548|NCT01620762|10036131|P3|Overall Study|Protocol Violation|1
2914549|NCT01620762|10036132|P2|Overall Study|Protocol Violation|1
2914550|NCT01620762|10036133|P1|Overall Study|Protocol Violation|1
2914551|NCT01620528|10036194|P3|Post-Treatment Follow-Up Period|Other|2
2914552|NCT01620528|10036195|P2|Post-Treatment Follow-Up Period|Other|4
2914553|NCT01620528|10036196|P1|Post-Treatment Follow-Up Period|Other|6
2914554|NCT01620528|10036194|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
2914555|NCT01620528|10036195|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
2914556|NCT01620528|10036196|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
2914557|NCT01620528|10036194|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2914558|NCT01620528|10036195|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2914559|NCT01620528|10036196|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
2914560|NCT01620528|10036194|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
2914561|NCT01620528|10036195|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2914562|NCT01620528|10036196|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2914563|NCT01620528|10036194|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2914564|NCT01620528|10036195|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
2914565|NCT01620528|10036196|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2914566|NCT01620528|10036194|P3|Treatment Period|Exclusionary Medication Received|0
2914567|NCT01620528|10036195|P2|Treatment Period|Exclusionary Medication Received|1
2914568|NCT01620528|10036196|P1|Treatment Period|Exclusionary Medication Received|0
2914569|NCT01620528|10036194|P3|Treatment Period|Surgery/Invasive Intervention|3
2914570|NCT01620528|10036195|P2|Treatment Period|Surgery/Invasive Intervention|1
2914571|NCT01620528|10036196|P1|Treatment Period|Surgery/Invasive Intervention|5
2914572|NCT01620528|10036194|P3|Treatment Period|Pregnancy|2
2914573|NCT01620528|10036195|P2|Treatment Period|Pregnancy|2
2914574|NCT01620528|10036196|P1|Treatment Period|Pregnancy|7
2914575|NCT01620528|10036194|P3|Treatment Period|Subject Noncompliant|2
2914576|NCT01620528|10036195|P2|Treatment Period|Subject Noncompliant|2
2914577|NCT01620528|10036196|P1|Treatment Period|Subject Noncompliant|11
2914578|NCT01620528|10036194|P3|Treatment Period|Other|7
2914579|NCT01620528|10036195|P2|Treatment Period|Other|5
2914580|NCT01620528|10036196|P1|Treatment Period|Other|9
2914581|NCT01620528|10036194|P3|Treatment Period|Lost to Follow-up|14
2914582|NCT01620528|10036195|P2|Treatment Period|Lost to Follow-up|8
2914583|NCT01620528|10036196|P1|Treatment Period|Lost to Follow-up|16
2914584|NCT01620528|10036194|P3|Treatment Period|Adverse Event|21
2914585|NCT01620528|10036195|P2|Treatment Period|Adverse Event|13
2914586|NCT01620528|10036196|P1|Treatment Period|Adverse Event|17
2914587|NCT01620528|10036194|P3|Treatment Period|Withdrawal by Subject|16
2914588|NCT01620528|10036195|P2|Treatment Period|Withdrawal by Subject|21
2914589|NCT01620528|10036196|P1|Treatment Period|Withdrawal by Subject|35
2914590|NCT01620528|10036194|P3|Treatment Period|Did Not Receive Study Drug|1
2914591|NCT01620528|10036195|P2|Treatment Period|Did Not Receive Study Drug|0
2914592|NCT01620528|10036196|P1|Treatment Period|Did Not Receive Study Drug|0
2914593|NCT01620489|10036536|P2|Overall Study|Unclassified|2
2914594|NCT01620489|10036537|P1|Overall Study|Unclassified|1
2914595|NCT01620489|10036536|P2|Overall Study|Withdrawal Criteria|25
2914596|NCT01620489|10036537|P1|Overall Study|Withdrawal Criteria|17
2914597|NCT01620489|10036536|P2|Overall Study|Protocol Violation|3
2914598|NCT01620489|10036537|P1|Overall Study|Protocol Violation|0
2914599|NCT01620489|10036536|P2|Overall Study|Adverse Event|4
2914600|NCT01620489|10036537|P1|Overall Study|Adverse Event|17
2914601|NCT01620255|10036558|P5|Overall Study|Withdrawn at discretion of investigator|1
2914602|NCT01620255|10036559|P4|Overall Study|Withdrawn at discretion of investigator|0
2914603|NCT01620255|10036560|P3|Overall Study|Withdrawn at discretion of investigator|0
2914604|NCT01620255|10036561|P2|Overall Study|Withdrawn at discretion of investigator|0
2914605|NCT01620255|10036562|P1|Overall Study|Withdrawn at discretion of investigator|0
2914606|NCT01620255|10036558|P5|Overall Study|Adverse Event|1
2914607|NCT01620255|10036559|P4|Overall Study|Adverse Event|1
2914608|NCT01620255|10036560|P3|Overall Study|Adverse Event|0
2914609|NCT01620255|10036561|P2|Overall Study|Adverse Event|4
2914610|NCT01620255|10036562|P1|Overall Study|Adverse Event|0
2914611|NCT01620255|10036558|P5|Overall Study|Non-compliance|0
2914612|NCT01620255|10036559|P4|Overall Study|Non-compliance|0
2914613|NCT01620255|10036560|P3|Overall Study|Non-compliance|0
2914614|NCT01620255|10036561|P2|Overall Study|Non-compliance|1
2914615|NCT01620255|10036562|P1|Overall Study|Non-compliance|0
2914616|NCT01620255|10036558|P5|Overall Study|Participant underwent fecal transplant|0
2914617|NCT01620255|10036559|P4|Overall Study|Participant underwent fecal transplant|0
2914618|NCT01620255|10036560|P3|Overall Study|Participant underwent fecal transplant|1
2914619|NCT01620255|10036561|P2|Overall Study|Participant underwent fecal transplant|0
2914620|NCT01620255|10036562|P1|Overall Study|Participant underwent fecal transplant|0
2914621|NCT01620255|10036558|P5|Overall Study|Withdrawal by Subject|4
2914622|NCT01620255|10036559|P4|Overall Study|Withdrawal by Subject|2
2914623|NCT01620255|10036560|P3|Overall Study|Withdrawal by Subject|1
2914624|NCT01620255|10036561|P2|Overall Study|Withdrawal by Subject|1
2914625|NCT01620255|10036562|P1|Overall Study|Withdrawal by Subject|4
2914626|NCT01620177|10036639|P1|Overall Study|Randomized, Not Active due to Scheduling|1
2914627|NCT01620177|10036639|P1|Overall Study|Physician Decision|2
2914628|NCT01620177|10036639|P1|Overall Study|Lost to Follow-up|7
2914629|NCT01620177|10036639|P1|Overall Study|Withdrawal by Subject|26
2914630|NCT01620177|10036639|P1|Overall Study|Failure at Screening Visit|43
2914631|NCT01620138|10036664|P2|Overall Study|Adverse Event|0
2914632|NCT01620138|10036665|P1|Overall Study|Adverse Event|2
2914633|NCT01620138|10036664|P2|Overall Study|Lack of Efficacy|0
2914634|NCT01620138|10036665|P1|Overall Study|Lack of Efficacy|1
2914635|NCT01620138|10036664|P2|Overall Study|Withdrawal by Subject|0
2914636|NCT01620138|10036665|P1|Overall Study|Withdrawal by Subject|3
2914637|NCT01620086|10036673|P3|Overall Study|Physician Decision|0
2914638|NCT01620086|10036674|P2|Overall Study|Physician Decision|0
2914639|NCT01620086|10036675|P1|Overall Study|Physician Decision|1
2914640|NCT01620086|10036673|P3|Overall Study|failed study criteria|0
2914641|NCT01620086|10036674|P2|Overall Study|failed study criteria|4
2914642|NCT01620086|10036675|P1|Overall Study|failed study criteria|1
2914643|NCT01620086|10036673|P3|Overall Study|Withdrawal by Subject|0
2914644|NCT01620086|10036674|P2|Overall Study|Withdrawal by Subject|3
2914645|NCT01620086|10036675|P1|Overall Study|Withdrawal by Subject|3
2914646|NCT01620060|10036694|P1|Overall Study|Per Sponsor Decision|2
2914647|NCT01620060|10036694|P1|Overall Study|Family emergency|1
2914648|NCT01620060|10036694|P1|Overall Study|Did not comply with Study Produre|1
2914649|NCT01620060|10036694|P1|Overall Study|Withdrawal by Subject|1
2914650|NCT01620060|10036694|P1|Overall Study|Protocol Violation|1
2914651|NCT01620060|10036694|P1|Overall Study|Adverse Event|9
2914652|NCT01619878|10036732|P1|Follow-up at 12 Months of Age|Death|2
2914653|NCT01619878|10036732|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
2914654|NCT01619878|10036732|P1|6 Week Follow-up Phase|Adverse Event|1
2914655|NCT01619852|10036746|P2|3 Month Follow up|Lost to Follow-up|34
2914656|NCT01619852|10036747|P1|3 Month Follow up|Lost to Follow-up|31
2914657|NCT01619852|10036746|P2|24 Hour Assessment|Withdrawal by Subject|1
2914658|NCT01619852|10036747|P1|24 Hour Assessment|Withdrawal by Subject|1
2914659|NCT01619800|10036763|P2|Overall Study|study terminated|0
2914660|NCT01619800|10036764|P1|Overall Study|study terminated|2
2914661|NCT01619787|10036772|P1|Overall Study|Lost to Follow-up|5
2914662|NCT01619579|10036789|P2|Overall Study|Withdrawal by Subject|3
2914663|NCT01619579|10036790|P1|Overall Study|Withdrawal by Subject|0
2914664|NCT01619423|10036804|P4|Part 1 (Dose Escalation)|High basal Mn|0
2914665|NCT01619423|10036805|P3|Part 1 (Dose Escalation)|High basal Mn|0
2914666|NCT01619423|10036806|P2|Part 1 (Dose Escalation)|High basal Mn|2
2914667|NCT01619423|10036807|P1|Part 1 (Dose Escalation)|High basal Mn|0
2914668|NCT01619410|10036820|P2|Overall Study|Lost to Follow-up|4
2914669|NCT01619410|10036821|P1|Overall Study|Lost to Follow-up|7
2914670|NCT01619085|10036833|P1|Overall Study|Ongoing on trial|27
2914671|NCT01619085|10036833|P1|Overall Study|Not treated|1
2914672|NCT01619085|10036833|P1|Overall Study|Other than specified|94
2914673|NCT01619085|10036833|P1|Overall Study|Withdrawal by Subject|15
2914674|NCT01619085|10036833|P1|Overall Study|Lost to Follow-up|10
2914675|NCT01619085|10036833|P1|Overall Study|Protocol Violation|10
2914676|NCT01619085|10036833|P1|Overall Study|Adverse Event|212
2914677|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
2914678|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
2914679|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2914680|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2914681|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Death|0
2914682|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Death|1
2914683|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
2914684|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
2914685|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Adverse Event|3
2914686|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Adverse Event|2
2914687|NCT01619059|10036839|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
2914688|NCT01619059|10036840|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
2914689|NCT01619059|10036839|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
2914690|NCT01619059|10036840|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
2914691|NCT01619059|10036839|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
2914692|NCT01619059|10036840|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
2914693|NCT01619059|10036839|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
2914694|NCT01619059|10036840|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
2914695|NCT01619059|10036839|P2|Short-Term (ST) Treatment Period|Adverse Event|0
2914696|NCT01619059|10036840|P1|Short-Term (ST) Treatment Period|Adverse Event|1
2914697|NCT01618968|10036856|P4|Overall Study|Death|1
2914698|NCT01618968|10036857|P3|Overall Study|Death|0
2914699|NCT01618968|10036858|P2|Overall Study|Death|0
2914700|NCT01618968|10036859|P1|Overall Study|Death|0
2914701|NCT01618968|10036856|P4|Overall Study|Adverse Event|0
2914702|NCT01618968|10036857|P3|Overall Study|Adverse Event|0
2914703|NCT01618968|10036858|P2|Overall Study|Adverse Event|0
2914704|NCT01618968|10036859|P1|Overall Study|Adverse Event|1
2914705|NCT01618916|10036932|P6|Overall Study|Lost to Follow-up|0
2914706|NCT01618916|10036933|P5|Overall Study|Lost to Follow-up|0
2914707|NCT01618916|10036934|P4|Overall Study|Lost to Follow-up|2
2914708|NCT01618916|10036935|P3|Overall Study|Lost to Follow-up|0
2914709|NCT01618916|10036936|P2|Overall Study|Lost to Follow-up|0
2914710|NCT01618916|10036937|P1|Overall Study|Lost to Follow-up|1
2914711|NCT01618916|10036932|P6|Overall Study|Withdrawal by Subject|0
2914712|NCT01618916|10036933|P5|Overall Study|Withdrawal by Subject|1
2914713|NCT01618916|10036934|P4|Overall Study|Withdrawal by Subject|0
2914714|NCT01618916|10036935|P3|Overall Study|Withdrawal by Subject|1
2914715|NCT01618916|10036936|P2|Overall Study|Withdrawal by Subject|1
2914716|NCT01618916|10036937|P1|Overall Study|Withdrawal by Subject|0
2914717|NCT01618916|10036932|P6|Overall Study|Adverse Event|0
2914718|NCT01618916|10036933|P5|Overall Study|Adverse Event|0
2914719|NCT01618916|10036934|P4|Overall Study|Adverse Event|0
2914720|NCT01618916|10036935|P3|Overall Study|Adverse Event|0
2914721|NCT01618916|10036936|P2|Overall Study|Adverse Event|0
2914722|NCT01618916|10036937|P1|Overall Study|Adverse Event|1
2914723|NCT01618864|10036967|P1|Overall Study|Lost to Follow-up|2
2914724|NCT01618864|10036967|P1|Overall Study|Withdrawal by Subject|2
2914725|NCT01618838|10036976|P1|Overall Study|slow accrual, trial closed prematurely.|4
2914726|NCT01618708|10036984|P2|Overall Study|Randomized but not treated|2
2914727|NCT01618708|10036985|P1|Overall Study|Randomized but not treated|3
2914728|NCT01618708|10036984|P2|Overall Study|Other than specified above|1
2914729|NCT01618708|10036985|P1|Overall Study|Other than specified above|1
2914730|NCT01618708|10036984|P2|Overall Study|Technical problems|0
2914731|NCT01618708|10036985|P1|Overall Study|Technical problems|2
2914732|NCT01618708|10036984|P2|Overall Study|Lack of Efficacy|8
2914733|NCT01618708|10036985|P1|Overall Study|Lack of Efficacy|8
2914734|NCT01618708|10036984|P2|Overall Study|Withdrawal by Subject|22
2914735|NCT01618708|10036985|P1|Overall Study|Withdrawal by Subject|17
2914736|NCT01618708|10036984|P2|Overall Study|Lost to Follow-up|3
2914737|NCT01618708|10036985|P1|Overall Study|Lost to Follow-up|3
2914738|NCT01618708|10036984|P2|Overall Study|Adverse Event|10
2914739|NCT01618708|10036985|P1|Overall Study|Adverse Event|10
2914740|NCT01618669|10036999|P2|Overall Study|Miscellaneous Reason|1
2914741|NCT01618669|10037000|P1|Overall Study|Miscellaneous Reason|0
2914742|NCT01618669|10036999|P2|Overall Study|Withdrawal by Subject|9
2914743|NCT01618669|10037000|P1|Overall Study|Withdrawal by Subject|9
2914744|NCT01618669|10036999|P2|Overall Study|Protocol Violation|3
2914745|NCT01618669|10037000|P1|Overall Study|Protocol Violation|5
2914746|NCT01618669|10036999|P2|Overall Study|Adverse Event|7
2914747|NCT01618669|10037000|P1|Overall Study|Adverse Event|16
2914748|NCT01618669|10036999|P2|Overall Study|Randomized but Never Received Study Drug|2
2914749|NCT01618669|10037000|P1|Overall Study|Randomized but Never Received Study Drug|3
2914750|NCT01618669|10036999|P2|Overall Study|Lost to Follow-up|1
2914751|NCT01618669|10037000|P1|Overall Study|Lost to Follow-up|1
2914752|NCT01618305|10037059|P2|Overall Study|Withdrawal by Subject|2
2914753|NCT01618305|10037060|P1|Overall Study|Withdrawal by Subject|3
2914754|NCT01618305|10037059|P2|Overall Study|Protocol Violation|0
2914755|NCT01618305|10037060|P1|Overall Study|Protocol Violation|1
2914756|NCT01618305|10037059|P2|Overall Study|Lost to Follow-up|7
2914757|NCT01618305|10037060|P1|Overall Study|Lost to Follow-up|11
2914758|NCT01618305|10037059|P2|Overall Study|Death|1
2914759|NCT01618305|10037060|P1|Overall Study|Death|0
2914760|NCT01618266|10037102|P1|Overall Study|Protocol Violation|43
2914761|NCT01618266|10037102|P1|Overall Study|Lack of Efficacy|23
2914762|NCT01618266|10037102|P1|Overall Study|Other reasons|11
2914763|NCT01618266|10037102|P1|Overall Study|Treatment satisfaction|10
2914764|NCT01618266|10037102|P1|Overall Study|Lost to Follow-up|9
2914765|NCT01618214|10037139|P2|Overall Study|Unclassified|5
2914766|NCT01618214|10037140|P1|Overall Study|Unclassified|4
2914767|NCT01618214|10037139|P2|Overall Study|Withdrawal Criteria|2
2914768|NCT01618214|10037140|P1|Overall Study|Withdrawal Criteria|1
2914769|NCT01618214|10037139|P2|Overall Study|Protocol Violation|4
2914770|NCT01618214|10037140|P1|Overall Study|Protocol Violation|1
2914771|NCT01618214|10037139|P2|Overall Study|Lack of Efficacy|1
2914772|NCT01618214|10037140|P1|Overall Study|Lack of Efficacy|1
2914773|NCT01618214|10037139|P2|Overall Study|Adverse Event|1
2914774|NCT01618214|10037140|P1|Overall Study|Adverse Event|3
2914775|NCT01618162|10037156|P2|Overall Study|Unclassified|13
2914776|NCT01618162|10037157|P1|Overall Study|Unclassified|14
2914777|NCT01618162|10037156|P2|Overall Study|Withdrawal Criteria|10
2914778|NCT01618162|10037157|P1|Overall Study|Withdrawal Criteria|2
2914779|NCT01618162|10037156|P2|Overall Study|Adverse Event|2
2914780|NCT01618162|10037157|P1|Overall Study|Adverse Event|9
2914781|NCT01618162|10037156|P2|Overall Study|Protocol Violation|10
2914782|NCT01618162|10037157|P1|Overall Study|Protocol Violation|13
2914783|NCT01618019|10037177|P2|Overall Study|Withdrawal by Subject|14
2914784|NCT01618019|10037178|P1|Overall Study|Withdrawal by Subject|14
2914785|NCT01617967|10037204|P6|Overall Study|Dosing Suspended by Sponsor|0
2914786|NCT01617967|10037205|P5|Overall Study|Dosing Suspended by Sponsor|0
2914787|NCT01617967|10037206|P4|Overall Study|Dosing Suspended by Sponsor|0
2914788|NCT01617967|10037207|P3|Overall Study|Dosing Suspended by Sponsor|0
2914789|NCT01617967|10037208|P2|Overall Study|Dosing Suspended by Sponsor|0
2914790|NCT01617967|10037209|P1|Overall Study|Dosing Suspended by Sponsor|1
2914791|NCT01617967|10037204|P6|Overall Study|Withdrawal by Subject|1
2914792|NCT01617967|10037205|P5|Overall Study|Withdrawal by Subject|0
2914793|NCT01617967|10037206|P4|Overall Study|Withdrawal by Subject|0
2914794|NCT01617967|10037207|P3|Overall Study|Withdrawal by Subject|0
2914795|NCT01617967|10037208|P2|Overall Study|Withdrawal by Subject|0
2914796|NCT01617967|10037209|P1|Overall Study|Withdrawal by Subject|0
2914797|NCT01617967|10037204|P6|Overall Study|Protocol Violation|0
2914798|NCT01617967|10037205|P5|Overall Study|Protocol Violation|0
2914799|NCT01617967|10037206|P4|Overall Study|Protocol Violation|1
2914800|NCT01617967|10037207|P3|Overall Study|Protocol Violation|0
2914801|NCT01617967|10037208|P2|Overall Study|Protocol Violation|0
2914802|NCT01617967|10037209|P1|Overall Study|Protocol Violation|0
2914803|NCT01617681|10037263|P5|Period 2 Open Label|Withdrawal by Subject|3
2914804|NCT01617681|10037264|P4|Period 2 Open Label|Withdrawal by Subject|0
2914805|NCT01617681|10037265|P3|Period 2 Open Label|Withdrawal by Subject|0
2914806|NCT01617681|10037266|P2|Period 2 Open Label|Withdrawal by Subject|0
2914807|NCT01617681|10037267|P1|Period 2 Open Label|Withdrawal by Subject|0
2914808|NCT01617681|10037263|P5|Period 2 Open Label|Adverse Event|3
2914809|NCT01617681|10037264|P4|Period 2 Open Label|Adverse Event|0
2914810|NCT01617681|10037265|P3|Period 2 Open Label|Adverse Event|0
2914811|NCT01617681|10037266|P2|Period 2 Open Label|Adverse Event|0
2914812|NCT01617681|10037267|P1|Period 2 Open Label|Adverse Event|0
2914813|NCT01617681|10037263|P5|Period 1 Double Blind|Withdrawal by Subject|0
2914814|NCT01617681|10037264|P4|Period 1 Double Blind|Withdrawal by Subject|0
2914815|NCT01617681|10037265|P3|Period 1 Double Blind|Withdrawal by Subject|1
2914816|NCT01617681|10037266|P2|Period 1 Double Blind|Withdrawal by Subject|1
2914817|NCT01617681|10037267|P1|Period 1 Double Blind|Withdrawal by Subject|1
2914818|NCT01617681|10037263|P5|Period 1 Double Blind|Adverse Event|0
2914819|NCT01617681|10037264|P4|Period 1 Double Blind|Adverse Event|2
2914820|NCT01617681|10037265|P3|Period 1 Double Blind|Adverse Event|0
2914821|NCT01617681|10037266|P2|Period 1 Double Blind|Adverse Event|0
2914822|NCT01617681|10037267|P1|Period 1 Double Blind|Adverse Event|2
2914823|NCT01617668|10037288|P4|Overall Study|Subject/guardian decision|1
2914824|NCT01617668|10037289|P3|Overall Study|Subject/guardian decision|2
2914825|NCT01617668|10037290|P2|Overall Study|Subject/guardian decision|3
2914826|NCT01617668|10037291|P1|Overall Study|Subject/guardian decision|1
2914827|NCT01617668|10037288|P4|Overall Study|Progressive Disease|9
2914828|NCT01617668|10037289|P3|Overall Study|Progressive Disease|6
2914829|NCT01617668|10037290|P2|Overall Study|Progressive Disease|4
2914830|NCT01617668|10037291|P1|Overall Study|Progressive Disease|4
2914831|NCT01617668|10037288|P4|Overall Study|Physician Decision|0
2914832|NCT01617668|10037289|P3|Overall Study|Physician Decision|3
2914833|NCT01617668|10037290|P2|Overall Study|Physician Decision|2
2914834|NCT01617668|10037291|P1|Overall Study|Physician Decision|1
2914835|NCT01617668|10037288|P4|Overall Study|Adverse Event|5
2914836|NCT01617668|10037289|P3|Overall Study|Adverse Event|12
2914837|NCT01617668|10037290|P2|Overall Study|Adverse Event|0
2914838|NCT01617668|10037291|P1|Overall Study|Adverse Event|7
2914839|NCT01617655|10037332|P2|Overall Study|Other than specified above|2
2914840|NCT01617655|10037333|P1|Overall Study|Other than specified above|1
2914841|NCT01617655|10037332|P2|Overall Study|Site closure|5
2914842|NCT01617655|10037333|P1|Overall Study|Site closure|3
2914843|NCT01617655|10037332|P2|Overall Study|Last visit outside protocol visit window|10
2914844|NCT01617655|10037333|P1|Overall Study|Last visit outside protocol visit window|1
2914845|NCT01617655|10037332|P2|Overall Study|Consent withdrawn by participant|1
2914846|NCT01617655|10037333|P1|Overall Study|Consent withdrawn by participant|1
2914847|NCT01617655|10037332|P2|Overall Study|Participants moved|4
2914848|NCT01617655|10037333|P1|Overall Study|Participants moved|0
2914849|NCT01617655|10037332|P2|Overall Study|Poor compliance to protocol|4
2914850|NCT01617655|10037333|P1|Overall Study|Poor compliance to protocol|1
2914851|NCT01617655|10037332|P2|Overall Study|Adverse Event|3
2914852|NCT01617655|10037333|P1|Overall Study|Adverse Event|2
2914853|NCT01617629|10037393|P1|Overall Study|Participant Withdrew Consent|2
2914854|NCT01617629|10037393|P1|Overall Study|Reason Not Specified|1
2914855|NCT01617629|10037393|P1|Overall Study|Investigator's Clinical Judgement|1
2914856|NCT01617629|10037393|P1|Overall Study|Death|2
2914857|NCT01617460|10037421|P1|Overall Study|Withdrawal by Subject|9
2914858|NCT01617460|10037421|P1|Overall Study|Protocol Violation|5
2914859|NCT01617460|10037421|P1|Overall Study|Physician Decision|16
2914860|NCT01617460|10037421|P1|Overall Study|Adverse Event|10
2914861|NCT01617447|10037427|P2|Overall Study|Physician Decision|2
2914862|NCT01617447|10037428|P1|Overall Study|Physician Decision|0
2914863|NCT01617447|10037427|P2|Overall Study|Adverse Event|1
2914864|NCT01617447|10037428|P1|Overall Study|Adverse Event|0
2914865|NCT01617434|10037436|P2|Overall Study|Unclassified|4
2914866|NCT01617434|10037437|P1|Overall Study|Unclassified|3
2914867|NCT01617434|10037436|P2|Overall Study|Withdrawal Criteria|37
2914868|NCT01617434|10037437|P1|Overall Study|Withdrawal Criteria|12
2914869|NCT01617434|10037436|P2|Overall Study|Protocol Violation|7
2914870|NCT01617434|10037437|P1|Overall Study|Protocol Violation|8
2914871|NCT01617434|10037436|P2|Overall Study|Adverse Event|3
2914872|NCT01617434|10037437|P1|Overall Study|Adverse Event|12
2914873|NCT01617187|10037476|P4|Treatment Through Study Completion|Protocol Violation|1
2914874|NCT01617187|10037477|P3|Treatment Through Study Completion|Protocol Violation|0
2914875|NCT01617187|10037478|P2|Treatment Through Study Completion|Protocol Violation|0
2914876|NCT01617187|10037479|P1|Treatment Through Study Completion|Protocol Violation|1
2914877|NCT01617187|10037476|P4|Treatment Through Study Completion|Withdrawal by Subject|6
2914878|NCT01617187|10037477|P3|Treatment Through Study Completion|Withdrawal by Subject|3
2914879|NCT01617187|10037478|P2|Treatment Through Study Completion|Withdrawal by Subject|8
2914880|NCT01617187|10037479|P1|Treatment Through Study Completion|Withdrawal by Subject|5
2914881|NCT01617187|10037476|P4|Treatment Through Study Completion|Lost to Follow-up|2
2914882|NCT01617187|10037477|P3|Treatment Through Study Completion|Lost to Follow-up|2
2914883|NCT01617187|10037478|P2|Treatment Through Study Completion|Lost to Follow-up|2
2914884|NCT01617187|10037479|P1|Treatment Through Study Completion|Lost to Follow-up|4
2914885|NCT01617187|10037476|P4|Treatment Through Study Completion|Adverse Event|1
2914886|NCT01617187|10037477|P3|Treatment Through Study Completion|Adverse Event|0
2914887|NCT01617187|10037478|P2|Treatment Through Study Completion|Adverse Event|1
2914888|NCT01617187|10037479|P1|Treatment Through Study Completion|Adverse Event|1
2914889|NCT01617187|10037476|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2914890|NCT01617187|10037477|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2914974|NCT01615198|10037966|P1|Overall Study|Physician Decision|5
2914891|NCT01617187|10037478|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2914892|NCT01617187|10037479|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
2914893|NCT01617187|10037476|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
2914894|NCT01617187|10037477|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2914895|NCT01617187|10037478|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2914896|NCT01617187|10037479|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2914897|NCT01617187|10037476|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
2914898|NCT01617187|10037477|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2914899|NCT01617187|10037478|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2914900|NCT01617187|10037479|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2914901|NCT01617070|10037576|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
2914902|NCT01617005|10037594|P1|Overall Study|Lack of motivation for treatment|1
2914903|NCT01617005|10037594|P1|Overall Study|Pregnancy|1
2914904|NCT01616953|10037603|P2|Overall Study|lack of bone and soft tissue|0
2914905|NCT01616953|10037604|P1|Overall Study|lack of bone and soft tissue|1
2914906|NCT01616953|10037603|P2|Overall Study|Lost to Follow-up|0
2914907|NCT01616953|10037604|P1|Overall Study|Lost to Follow-up|1
2914908|NCT01616771|10037612|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
2914909|NCT01616693|10037625|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
2914910|NCT01616693|10037626|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
2914911|NCT01616693|10037627|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
2914912|NCT01616693|10037628|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
2914913|NCT01616693|10037625|P4|Received Both Vaccines|Lost to Follow-up|4
2914914|NCT01616693|10037626|P3|Received Both Vaccines|Lost to Follow-up|4
2914915|NCT01616693|10037627|P2|Received Both Vaccines|Lost to Follow-up|3
2914916|NCT01616693|10037628|P1|Received Both Vaccines|Lost to Follow-up|4
2914917|NCT01616693|10037625|P4|Received Both Vaccines|Withdrawal by Subject|15
2914918|NCT01616693|10037626|P3|Received Both Vaccines|Withdrawal by Subject|8
2914919|NCT01616693|10037627|P2|Received Both Vaccines|Withdrawal by Subject|7
2914920|NCT01616693|10037628|P1|Received Both Vaccines|Withdrawal by Subject|7
2914921|NCT01616693|10037625|P4|Received Both Vaccines|Adverse Event|0
2914922|NCT01616693|10037626|P3|Received Both Vaccines|Adverse Event|0
2914923|NCT01616693|10037627|P2|Received Both Vaccines|Adverse Event|0
2914924|NCT01616693|10037628|P1|Received Both Vaccines|Adverse Event|2
2914925|NCT01616693|10037625|P4|Evaluated for Safety|Physician Decision|0
2914926|NCT01616693|10037626|P3|Evaluated for Safety|Physician Decision|1
2914927|NCT01616693|10037627|P2|Evaluated for Safety|Physician Decision|0
2914928|NCT01616693|10037628|P1|Evaluated for Safety|Physician Decision|1
2914929|NCT01616459|10037694|P4|Overall Study|Other reason|0
2914930|NCT01616459|10037695|P3|Overall Study|Other reason|1
2914931|NCT01616459|10037696|P2|Overall Study|Other reason|1
2914932|NCT01616459|10037697|P1|Overall Study|Other reason|0
2914933|NCT01616459|10037694|P4|Overall Study|Withdrawal by Subject|4
2914934|NCT01616459|10037695|P3|Overall Study|Withdrawal by Subject|4
2914935|NCT01616459|10037696|P2|Overall Study|Withdrawal by Subject|4
2914936|NCT01616459|10037697|P1|Overall Study|Withdrawal by Subject|2
2914937|NCT01616459|10037694|P4|Overall Study|Protocol Violation|2
2914938|NCT01616459|10037695|P3|Overall Study|Protocol Violation|0
2914939|NCT01616459|10037696|P2|Overall Study|Protocol Violation|0
2914940|NCT01616459|10037697|P1|Overall Study|Protocol Violation|0
2914941|NCT01616459|10037694|P4|Overall Study|Lost to Follow-up|2
2914942|NCT01616459|10037695|P3|Overall Study|Lost to Follow-up|3
2914943|NCT01616459|10037696|P2|Overall Study|Lost to Follow-up|11
2914944|NCT01616459|10037697|P1|Overall Study|Lost to Follow-up|1
2914945|NCT01616459|10037694|P4|Overall Study|Adverse Event|0
2914946|NCT01616459|10037695|P3|Overall Study|Adverse Event|2
2914947|NCT01616459|10037696|P2|Overall Study|Adverse Event|1
2914948|NCT01616459|10037697|P1|Overall Study|Adverse Event|1
2914949|NCT01616173|10037798|P3|Overall Study|Lost to Follow-up|0
2914950|NCT01616173|10037799|P2|Overall Study|Lost to Follow-up|2
2914951|NCT01616173|10037800|P1|Overall Study|Lost to Follow-up|0
2914952|NCT01615939|10037833|P2|Overall Study|Lost to Follow-up|0
2914953|NCT01615939|10037834|P1|Overall Study|Lost to Follow-up|5
2914954|NCT01615822|10037847|P3|Period 2|Lost to Follow-up|2
2914955|NCT01615822|10037848|P2|Period 2|Lost to Follow-up|1
2914956|NCT01615822|10037849|P1|Period 2|Lost to Follow-up|0
2914957|NCT01615822|10037847|P3|Period 1|Adverse Event|0
2914958|NCT01615822|10037848|P2|Period 1|Adverse Event|1
2914959|NCT01615822|10037849|P1|Period 1|Adverse Event|1
2914960|NCT01615822|10037847|P3|Period 1|Withdrawal by Subject|0
2914961|NCT01615822|10037848|P2|Period 1|Withdrawal by Subject|1
2914962|NCT01615822|10037849|P1|Period 1|Withdrawal by Subject|0
2914963|NCT01615328|10037937|P2|Overall Study|Lost to Follow-up|5
2914964|NCT01615328|10037938|P1|Overall Study|Lost to Follow-up|3
2914965|NCT01615263|10037950|P2|Overall Study|Post-randomization exclusion|2
2914966|NCT01615263|10037951|P1|Overall Study|Post-randomization exclusion|0
2914967|NCT01615198|10037965|P2|Overall Study|Adverse Event|5
2914968|NCT01615198|10037966|P1|Overall Study|Adverse Event|11
2914969|NCT01615198|10037965|P2|Overall Study|Lack of Efficacy|6
2914970|NCT01615198|10037966|P1|Overall Study|Lack of Efficacy|1
2914971|NCT01615198|10037965|P2|Overall Study|Lost to Follow-up|1
2914972|NCT01615198|10037966|P1|Overall Study|Lost to Follow-up|1
2914973|NCT01615198|10037965|P2|Overall Study|Physician Decision|1
2914975|NCT01615198|10037965|P2|Overall Study|Protocol deviation|1
2914976|NCT01615198|10037966|P1|Overall Study|Protocol deviation|1
2914977|NCT01615198|10037965|P2|Overall Study|Withdrawal by Subject|5
2914978|NCT01615198|10037966|P1|Overall Study|Withdrawal by Subject|5
2914979|NCT01615029|10037999|P5|Overall Study|Ongoing|23
2914980|NCT01615029|10038000|P4|Overall Study|Ongoing|2
2914981|NCT01615029|10038001|P3|Overall Study|Ongoing|3
2914982|NCT01615029|10038002|P2|Overall Study|Ongoing|2
2914983|NCT01615029|10038003|P1|Overall Study|Ongoing|1
2914984|NCT01615029|10037999|P5|Overall Study|Physician Decision|1
2914985|NCT01615029|10038000|P4|Overall Study|Physician Decision|0
2914986|NCT01615029|10038001|P3|Overall Study|Physician Decision|0
2914987|NCT01615029|10038002|P2|Overall Study|Physician Decision|0
2914988|NCT01615029|10038003|P1|Overall Study|Physician Decision|0
2914989|NCT01615029|10037999|P5|Overall Study|Progressive disease|5
2914990|NCT01615029|10038000|P4|Overall Study|Progressive disease|1
2914991|NCT01615029|10038001|P3|Overall Study|Progressive disease|1
2914992|NCT01615029|10038002|P2|Overall Study|Progressive disease|1
2914993|NCT01615029|10038003|P1|Overall Study|Progressive disease|2
2914994|NCT01615029|10037999|P5|Overall Study|Lost to Follow-up|1
2914995|NCT01615029|10038000|P4|Overall Study|Lost to Follow-up|0
2914996|NCT01615029|10038001|P3|Overall Study|Lost to Follow-up|0
2914997|NCT01615029|10038002|P2|Overall Study|Lost to Follow-up|0
2914998|NCT01615029|10038003|P1|Overall Study|Lost to Follow-up|0
2914999|NCT01615029|10037999|P5|Overall Study|Death|1
2915000|NCT01615029|10038000|P4|Overall Study|Death|0
2915001|NCT01615029|10038001|P3|Overall Study|Death|0
2915002|NCT01615029|10038002|P2|Overall Study|Death|0
2915003|NCT01615029|10038003|P1|Overall Study|Death|0
2915004|NCT01615029|10037999|P5|Overall Study|Adverse Event|1
2915005|NCT01615029|10038000|P4|Overall Study|Adverse Event|0
2915006|NCT01615029|10038001|P3|Overall Study|Adverse Event|0
2915007|NCT01615029|10038002|P2|Overall Study|Adverse Event|0
2915008|NCT01615029|10038003|P1|Overall Study|Adverse Event|0
2915009|NCT01614886|10038071|P2|Overall Study|Protocol deviation|2
2915010|NCT01614886|10038072|P1|Overall Study|Protocol deviation|0
2915011|NCT01614886|10038071|P2|Overall Study|Death|0
2915012|NCT01614886|10038072|P1|Overall Study|Death|1
2915013|NCT01614886|10038071|P2|Overall Study|Withdrawal by Subject|4
2915014|NCT01614886|10038072|P1|Overall Study|Withdrawal by Subject|4
2915015|NCT01614886|10038071|P2|Overall Study|Adverse Event|20
2915016|NCT01614886|10038072|P1|Overall Study|Adverse Event|15
2915017|NCT01614795|10038113|P4|Overall Study|Ineligible|0
2915018|NCT01614795|10038114|P3|Overall Study|Ineligible|0
2915019|NCT01614795|10038115|P2|Overall Study|Ineligible|1
2915020|NCT01614795|10038116|P1|Overall Study|Ineligible|0
2915021|NCT01614795|10038113|P4|Overall Study|Withdrawal by Subject|2
2915022|NCT01614795|10038114|P3|Overall Study|Withdrawal by Subject|0
2915023|NCT01614795|10038115|P2|Overall Study|Withdrawal by Subject|1
2915024|NCT01614795|10038116|P1|Overall Study|Withdrawal by Subject|0
2915025|NCT01614795|10038113|P4|Overall Study|Physician Decision|1
2915026|NCT01614795|10038114|P3|Overall Study|Physician Decision|1
2915027|NCT01614795|10038115|P2|Overall Study|Physician Decision|0
2915028|NCT01614795|10038116|P1|Overall Study|Physician Decision|1
2915029|NCT01614795|10038113|P4|Overall Study|Lack of Efficacy|8
2915030|NCT01614795|10038114|P3|Overall Study|Lack of Efficacy|9
2915031|NCT01614795|10038115|P2|Overall Study|Lack of Efficacy|10
2915032|NCT01614795|10038116|P1|Overall Study|Lack of Efficacy|10
2915033|NCT01614795|10038113|P4|Overall Study|Adverse Event|1
2915034|NCT01614795|10038114|P3|Overall Study|Adverse Event|1
2915035|NCT01614795|10038115|P2|Overall Study|Adverse Event|0
2915036|NCT01614795|10038116|P1|Overall Study|Adverse Event|0
2915037|NCT01614769|10038136|P6|Period 3|Withdrawal by Subject|0
2915038|NCT01614769|10038137|P5|Period 3|Withdrawal by Subject|0
2915039|NCT01614769|10038138|P4|Period 3|Withdrawal by Subject|0
2915040|NCT01614769|10038139|P3|Period 3|Withdrawal by Subject|1
2915041|NCT01614769|10038140|P2|Period 3|Withdrawal by Subject|0
2915042|NCT01614769|10038141|P1|Period 3|Withdrawal by Subject|0
2915043|NCT01614769|10038136|P6|Period 1|Withdrawal by Subject|0
2915044|NCT01614769|10038137|P5|Period 1|Withdrawal by Subject|0
2915045|NCT01614769|10038138|P4|Period 1|Withdrawal by Subject|0
2915046|NCT01614769|10038139|P3|Period 1|Withdrawal by Subject|0
2915047|NCT01614769|10038140|P2|Period 1|Withdrawal by Subject|0
2915048|NCT01614769|10038141|P1|Period 1|Withdrawal by Subject|1
2915049|NCT01614769|10038136|P6|Period 1|Protocol Violation|0
2915050|NCT01614769|10038137|P5|Period 1|Protocol Violation|0
2915051|NCT01614769|10038138|P4|Period 1|Protocol Violation|1
2915052|NCT01614769|10038139|P3|Period 1|Protocol Violation|0
2915053|NCT01614769|10038140|P2|Period 1|Protocol Violation|0
2915054|NCT01614769|10038141|P1|Period 1|Protocol Violation|0
2915055|NCT01614769|10038136|P6|Period 1|Discontinued due to Hypoglycemia|1
2915056|NCT01614769|10038137|P5|Period 1|Discontinued due to Hypoglycemia|0
2915057|NCT01614769|10038138|P4|Period 1|Discontinued due to Hypoglycemia|1
2915058|NCT01614769|10038139|P3|Period 1|Discontinued due to Hypoglycemia|0
2915059|NCT01614769|10038140|P2|Period 1|Discontinued due to Hypoglycemia|0
2915060|NCT01614769|10038141|P1|Period 1|Discontinued due to Hypoglycemia|0
2915061|NCT01614600|10038163|P1|Overall Study|Protocol deviation|1
2915062|NCT01614600|10038163|P1|Overall Study|Unable to remove lens at the end of day|1
2915063|NCT01614600|10038163|P1|Overall Study|Discomfort|1
2915064|NCT01614600|10038163|P1|Overall Study|Unacceptable fit|1
2915065|NCT01614470|10038194|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
2915066|NCT01614470|10038195|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2915067|NCT01614470|10038196|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2915068|NCT01614470|10038194|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2915069|NCT01614470|10038195|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2915070|NCT01614470|10038196|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2915071|NCT01614457|10038218|P2|Overall Study|Pregnancy (Self or Partner)|0
2915072|NCT01614457|10038219|P1|Overall Study|Pregnancy (Self or Partner)|1
2915073|NCT01614457|10038218|P2|Overall Study|Non-Compliance|0
2915074|NCT01614457|10038219|P1|Overall Study|Non-Compliance|1
2915075|NCT01614249|10038246|P2|Overall Study|Lost to Follow-up|23
2915076|NCT01614249|10038247|P1|Overall Study|Lost to Follow-up|11
2915077|NCT01614093|10038261|P1|Overall Study|Withdrawal by Subject|1
2915078|NCT01613716|10038274|P1|Overall Study|Lost to Follow-up|4
2915079|NCT01613716|10038274|P1|Overall Study|screen failures|3
2915080|NCT01613599|10038279|P1|Overall Study|Reason not specified|3
2915081|NCT01613599|10038279|P1|Overall Study|Withdrawal by Subject|8
2915082|NCT01613599|10038279|P1|Overall Study|Lost to Follow-up|5
2915083|NCT01613599|10038279|P1|Overall Study|Death|9
2915084|NCT01613417|10038294|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
2915085|NCT01613417|10038295|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
2915086|NCT01613378|10038332|P1|Overall Study|Other Reason|4
2915087|NCT01613378|10038332|P1|Overall Study|Lost to Follow-up|1
2915088|NCT01613378|10038332|P1|Overall Study|Death|2
2915089|NCT01613378|10038332|P1|Overall Study|Withdrawal by Subject|8
2915090|NCT01613378|10038332|P1|Overall Study|Adverse Event|11
2915091|NCT01613378|10038332|P1|Overall Study|Lack of Efficacy|13
2915092|NCT01613326|10038362|P2|Overall Study|Protocol Violation|1
2915093|NCT01613326|10038363|P1|Overall Study|Protocol Violation|0
2915094|NCT01613326|10038362|P2|Overall Study|Administrative|2
2915095|NCT01613326|10038363|P1|Overall Study|Administrative|0
2915096|NCT01613326|10038362|P2|Overall Study|Lost to Follow-up|1
2915097|NCT01613326|10038363|P1|Overall Study|Lost to Follow-up|0
2915098|NCT01613326|10038362|P2|Overall Study|Lack of Efficacy|1
2915099|NCT01613326|10038363|P1|Overall Study|Lack of Efficacy|0
2915100|NCT01613326|10038362|P2|Overall Study|inability to use device|0
2915101|NCT01613326|10038363|P1|Overall Study|inability to use device|1
2915102|NCT01613326|10038362|P2|Overall Study|Abnormal test procedure result(s)|0
2915103|NCT01613326|10038363|P1|Overall Study|Abnormal test procedure result(s)|2
2915104|NCT01613326|10038362|P2|Overall Study|Withdrawal by Subject|4
2915105|NCT01613326|10038363|P1|Overall Study|Withdrawal by Subject|3
2915106|NCT01613326|10038362|P2|Overall Study|Adverse Event|5
2915107|NCT01613326|10038363|P1|Overall Study|Adverse Event|7
2915108|NCT01613248|10038420|P6|Overall Study|Pregnancy|0
2915109|NCT01613248|10038421|P5|Overall Study|Pregnancy|0
2915110|NCT01613248|10038422|P4|Overall Study|Pregnancy|1
2915111|NCT01613248|10038423|P3|Overall Study|Pregnancy|0
2915112|NCT01613248|10038424|P2|Overall Study|Pregnancy|0
2915113|NCT01613248|10038425|P1|Overall Study|Pregnancy|0
2915114|NCT01613248|10038420|P6|Overall Study|Lack of Qualifying Event|18
2915115|NCT01613248|10038421|P5|Overall Study|Lack of Qualifying Event|15
2915116|NCT01613248|10038422|P4|Overall Study|Lack of Qualifying Event|11
2915117|NCT01613248|10038423|P3|Overall Study|Lack of Qualifying Event|10
2915118|NCT01613248|10038424|P2|Overall Study|Lack of Qualifying Event|11
2915119|NCT01613248|10038425|P1|Overall Study|Lack of Qualifying Event|9
2915120|NCT01613248|10038420|P6|Overall Study|Physician Decision|6
2915121|NCT01613248|10038421|P5|Overall Study|Physician Decision|7
2915122|NCT01613248|10038422|P4|Overall Study|Physician Decision|4
2915123|NCT01613248|10038423|P3|Overall Study|Physician Decision|9
2915124|NCT01613248|10038424|P2|Overall Study|Physician Decision|8
2915125|NCT01613248|10038425|P1|Overall Study|Physician Decision|8
2915126|NCT01613248|10038420|P6|Overall Study|Study Terminated by Sponsor|11
2915127|NCT01613248|10038421|P5|Overall Study|Study Terminated by Sponsor|9
2915128|NCT01613248|10038422|P4|Overall Study|Study Terminated by Sponsor|8
2915129|NCT01613248|10038423|P3|Overall Study|Study Terminated by Sponsor|8
2915130|NCT01613248|10038424|P2|Overall Study|Study Terminated by Sponsor|6
2915131|NCT01613248|10038425|P1|Overall Study|Study Terminated by Sponsor|4
2915132|NCT01613248|10038420|P6|Overall Study|Lost to Follow-up|2
2915133|NCT01613248|10038421|P5|Overall Study|Lost to Follow-up|4
2915134|NCT01613248|10038422|P4|Overall Study|Lost to Follow-up|8
2915135|NCT01613248|10038423|P3|Overall Study|Lost to Follow-up|4
2915136|NCT01613248|10038424|P2|Overall Study|Lost to Follow-up|7
2915137|NCT01613248|10038425|P1|Overall Study|Lost to Follow-up|5
2915138|NCT01613248|10038420|P6|Overall Study|Withdrawal by Subject|1
2915139|NCT01613248|10038421|P5|Overall Study|Withdrawal by Subject|0
2915140|NCT01613248|10038422|P4|Overall Study|Withdrawal by Subject|5
2915141|NCT01613248|10038423|P3|Overall Study|Withdrawal by Subject|2
2915142|NCT01613248|10038424|P2|Overall Study|Withdrawal by Subject|2
2915143|NCT01613248|10038425|P1|Overall Study|Withdrawal by Subject|3
2915144|NCT01613248|10038420|P6|Overall Study|Adverse Event|0
2915145|NCT01613248|10038421|P5|Overall Study|Adverse Event|0
2915146|NCT01613248|10038422|P4|Overall Study|Adverse Event|1
2915147|NCT01613248|10038423|P3|Overall Study|Adverse Event|0
2915148|NCT01613248|10038424|P2|Overall Study|Adverse Event|0
2915149|NCT01613248|10038425|P1|Overall Study|Adverse Event|0
2915150|NCT01613222|10038523|P1|Overall Study|Reused disposable sensors|10
2915151|NCT01613222|10038523|P1|Overall Study|Unable to place arterial line|1
2915152|NCT01613222|10038523|P1|Overall Study|Physician Decision|1
2915153|NCT01613131|10038538|P2|Overall Study|Withdrawal by Subject|5
2915154|NCT01613131|10038539|P1|Overall Study|Withdrawal by Subject|3
2915155|NCT01613027|10038567|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
2915156|NCT01613027|10038567|P1|Overall Study|Lack of Efficacy|1
2915157|NCT01613027|10038567|P1|Overall Study|Switched Physician|1
2915158|NCT01613027|10038567|P1|Overall Study|Lost to Follow-up|5
2915159|NCT01612858|10038610|P2|Overall Study|Withdrawal by Subject|1
2915160|NCT01612858|10038611|P1|Overall Study|Withdrawal by Subject|5
2915161|NCT01612702|10038684|P2|Overall Study|Protocol Violation|11
2915162|NCT01612702|10038685|P1|Overall Study|Protocol Violation|11
2915163|NCT01612676|10038699|P4|Overall Study|Protocol Violation|0
2915164|NCT01612676|10038700|P3|Overall Study|Protocol Violation|0
2915165|NCT01612676|10038701|P2|Overall Study|Protocol Violation|1
2915166|NCT01612676|10038702|P1|Overall Study|Protocol Violation|0
2915167|NCT01612676|10038699|P4|Overall Study|Adverse Event|3
2915168|NCT01612676|10038700|P3|Overall Study|Adverse Event|1
2915169|NCT01612676|10038701|P2|Overall Study|Adverse Event|3
2915170|NCT01612676|10038702|P1|Overall Study|Adverse Event|2
2915171|NCT01612156|10038800|P2|Overall Study|Protocol Violation|0
2915172|NCT01612156|10038801|P1|Overall Study|Protocol Violation|2
2915173|NCT01612000|10038813|P4|Overall Study|Withdrawal by Subject|2
2915174|NCT01612000|10038814|P3|Overall Study|Withdrawal by Subject|2
2915175|NCT01612000|10038815|P2|Overall Study|Withdrawal by Subject|1
2915176|NCT01612000|10038816|P1|Overall Study|Withdrawal by Subject|3
2915177|NCT01612000|10038813|P4|Overall Study|Physician Decision|0
2915178|NCT01612000|10038814|P3|Overall Study|Physician Decision|1
2915179|NCT01612000|10038815|P2|Overall Study|Physician Decision|0
2915180|NCT01612000|10038816|P1|Overall Study|Physician Decision|0
2915181|NCT01612000|10038813|P4|Overall Study|Lost to Follow-up|8
2915182|NCT01612000|10038814|P3|Overall Study|Lost to Follow-up|4
2915183|NCT01612000|10038815|P2|Overall Study|Lost to Follow-up|4
2915184|NCT01612000|10038816|P1|Overall Study|Lost to Follow-up|6
2915185|NCT01611974|10038841|P3|Overall Study|Withdrawal by Subject|4
2915186|NCT01611974|10038842|P2|Overall Study|Withdrawal by Subject|1
2915187|NCT01611974|10038843|P1|Overall Study|Withdrawal by Subject|0
2915188|NCT01611974|10038841|P3|Overall Study|Physician Decision|2
2915189|NCT01611974|10038842|P2|Overall Study|Physician Decision|1
2915190|NCT01611974|10038843|P1|Overall Study|Physician Decision|5
2915191|NCT01611974|10038841|P3|Overall Study|Lost to Follow-up|0
2915192|NCT01611974|10038842|P2|Overall Study|Lost to Follow-up|1
2915193|NCT01611974|10038843|P1|Overall Study|Lost to Follow-up|0
2915194|NCT01611974|10038841|P3|Overall Study|Death|10
2915195|NCT01611974|10038842|P2|Overall Study|Death|12
2915196|NCT01611974|10038843|P1|Overall Study|Death|10
2915197|NCT01611935|10038889|P2|Overall Study|Family Declined Participation|0
2915198|NCT01611935|10038890|P1|Overall Study|Family Declined Participation|1
2915199|NCT01611883|10038902|P2|Overall Study|Adverse Event|1
2915200|NCT01611883|10038903|P1|Overall Study|Adverse Event|1
2915201|NCT01611857|10038929|P2|Overall Study|Withdrawal by Subject|2
2915202|NCT01611857|10038930|P1|Overall Study|Withdrawal by Subject|0
2915203|NCT01611792|10038942|P2|Followup: at 6 Months|Lost to Follow-up|13
2915204|NCT01611792|10038943|P1|Followup: at 6 Months|Lost to Follow-up|6
2915205|NCT01611792|10038942|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
2915206|NCT01611792|10038943|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
2915207|NCT01611558|10038997|P1|Maintenance Phase|Study drug toxicity|1
2915208|NCT01611558|10038997|P1|Maintenance Phase|Withdrawal by Subject|1
2915209|NCT01611558|10038997|P1|Induction Phase|Death|1
2915210|NCT01611558|10038997|P1|Induction Phase|Adverse event unrelated to study drug|1
2915211|NCT01611558|10038997|P1|Induction Phase|Not reported|5
2915212|NCT01611558|10038997|P1|Induction Phase|Disease progression|14
2915213|NCT01611558|10038997|P1|Induction Phase|Study drug toxicity|17
2915214|NCT01611298|10039003|P1|Overall Study|Relapsed|2
2915215|NCT01611259|10039008|P1|Overall Study|Withdrawal by Subject|7
2915216|NCT01611259|10039008|P1|Overall Study|Adverse Event|4
2915217|NCT01611259|10039008|P1|Overall Study|Lack of Efficacy|2
2915218|NCT01611259|10039008|P1|Overall Study|Physician Decision|1
2915219|NCT01611194|10039014|P2|Overall Study|drug use|1
2915220|NCT01611194|10039015|P1|Overall Study|drug use|0
2915221|NCT01611194|10039014|P2|Overall Study|Withdrawal by Subject|1
2915222|NCT01611194|10039015|P1|Overall Study|Withdrawal by Subject|0
2915223|NCT01611194|10039014|P2|Overall Study|Lost to Follow-up|1
2915224|NCT01611194|10039015|P1|Overall Study|Lost to Follow-up|0
2915225|NCT01611155|10039053|P2|Overall Study|Ineligible patient|1
2915226|NCT01611155|10039054|P1|Overall Study|Ineligible patient|0
2915227|NCT01611155|10039053|P2|Overall Study|Alternative treatment|1
2915228|NCT01611155|10039054|P1|Overall Study|Alternative treatment|0
2915229|NCT01611155|10039053|P2|Overall Study|Withdrawal by Subject|0
2915230|NCT01611155|10039054|P1|Overall Study|Withdrawal by Subject|1
2915231|NCT01611155|10039053|P2|Overall Study|Disease progression|0
2915232|NCT01611155|10039054|P1|Overall Study|Disease progression|1
2915233|NCT01611155|10039053|P2|Overall Study|Refused further treatment|4
2915234|NCT01611155|10039054|P1|Overall Study|Refused further treatment|6
2915235|NCT01611155|10039053|P2|Overall Study|Adverse Event|1
2915236|NCT01611155|10039054|P1|Overall Study|Adverse Event|1
2915237|NCT01611090|10039064|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
2915238|NCT01611090|10039065|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2915320|NCT01610414|10039416|P2|Study Start - Month 13|Lost to Follow-up|6
2915239|NCT01611090|10039066|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2915240|NCT01611090|10039064|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
2915241|NCT01611090|10039065|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2915242|NCT01611090|10039066|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2915243|NCT01611090|10039064|P3|Randomized Period|Withdrawal by Subject|0
2915244|NCT01611090|10039065|P2|Randomized Period|Withdrawal by Subject|26
2915245|NCT01611090|10039066|P1|Randomized Period|Withdrawal by Subject|22
2915246|NCT01611090|10039064|P3|Randomized Period|Lost to Follow-up|0
2915247|NCT01611090|10039065|P2|Randomized Period|Lost to Follow-up|3
2915248|NCT01611090|10039066|P1|Randomized Period|Lost to Follow-up|8
2915249|NCT01610791|10039099|P1|Overall Study|Not determined|5
2915250|NCT01610791|10039099|P1|Overall Study|Death|1
2915251|NCT01610791|10039099|P1|Overall Study|Adverse event and Investigator decision|1
2915252|NCT01610791|10039099|P1|Overall Study|Physician Decision|1
2915253|NCT01610791|10039099|P1|Overall Study|Adverse Event|6
2915254|NCT01610791|10039099|P1|Overall Study|Lost to Follow-up|7
2915255|NCT01610752|10039123|P3|Overall Study|Miscarriage/Pregnancy loss|4
2915256|NCT01610752|10039124|P2|Overall Study|Miscarriage/Pregnancy loss|0
2915257|NCT01610752|10039125|P1|Overall Study|Miscarriage/Pregnancy loss|0
2915258|NCT01610713|10039147|P2|Overall Study|Lost to Follow-up|1
2915259|NCT01610713|10039148|P1|Overall Study|Lost to Follow-up|0
2915260|NCT01610713|10039147|P2|Overall Study|adv. to use original dose/amitriptyline|0
2915261|NCT01610713|10039148|P1|Overall Study|adv. to use original dose/amitriptyline|1
2915262|NCT01610713|10039147|P2|Overall Study|low mood and poor motivation|0
2915263|NCT01610713|10039148|P1|Overall Study|low mood and poor motivation|1
2915264|NCT01610713|10039147|P2|Overall Study|Lack of Efficacy|0
2915265|NCT01610713|10039148|P1|Overall Study|Lack of Efficacy|1
2915266|NCT01610713|10039147|P2|Overall Study|Adverse Event|0
2915267|NCT01610713|10039148|P1|Overall Study|Adverse Event|3
2915268|NCT01610700|10039206|P2|Overall Study|subject took one dose of street cannabis|1
2915269|NCT01610700|10039207|P1|Overall Study|subject took one dose of street cannabis|0
2915270|NCT01610700|10039206|P2|Overall Study|Withdrawal by Subject|1
2915271|NCT01610700|10039207|P1|Overall Study|Withdrawal by Subject|0
2915272|NCT01610700|10039206|P2|Overall Study|Adverse Event|1
2915273|NCT01610700|10039207|P1|Overall Study|Adverse Event|3
2915274|NCT01610687|10039261|P1|Overall Study|Felt more alter without study medication|1
2915275|NCT01610687|10039261|P1|Overall Study|Cannabis affecting job|1
2915276|NCT01610687|10039261|P1|Overall Study|Death|1
2915277|NCT01610687|10039261|P1|Overall Study|Unable to make journey|1
2915278|NCT01610687|10039261|P1|Overall Study|Symptom control without study medication|2
2915279|NCT01610687|10039261|P1|Overall Study|Lost to Follow-up|4
2915280|NCT01610687|10039261|P1|Overall Study|Withdrawal by Subject|7
2915281|NCT01610687|10039261|P1|Overall Study|Moved out of area|6
2915282|NCT01610687|10039261|P1|Overall Study|Adverse Event|18
2915283|NCT01610687|10039261|P1|Overall Study|Lack of Efficacy|26
2915284|NCT01610596|10039274|P2|Overall Study|Lost to Follow-up|1
2915285|NCT01610596|10039275|P1|Overall Study|Lost to Follow-up|0
2915286|NCT01610557|10039333|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
2915287|NCT01610557|10039334|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
2915288|NCT01610557|10039335|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
2915289|NCT01610557|10039336|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
2915290|NCT01610557|10039337|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
2915291|NCT01610557|10039333|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2915292|NCT01610557|10039334|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2915293|NCT01610557|10039335|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2915294|NCT01610557|10039336|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
2915295|NCT01610557|10039337|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2915296|NCT01610492|10039350|P1|Overall Study|Other:Treatment stopped due to remission|1
2915297|NCT01610492|10039350|P1|Overall Study|Other: Reached stopping criteria|1
2915298|NCT01610492|10039350|P1|Overall Study|Lack of Efficacy|3
2915299|NCT01610492|10039350|P1|Overall Study|Adverse Event|1
2915300|NCT01610414|10039416|P2|After Month 25|Study end not reached|53
2915301|NCT01610414|10039417|P1|After Month 25|Study end not reached|48
2915302|NCT01610414|10039416|P2|Month 13 - Month 25|Other reasons for withdrawal|7
2915303|NCT01610414|10039417|P1|Month 13 - Month 25|Other reasons for withdrawal|6
2915304|NCT01610414|10039416|P2|Month 13 - Month 25|Lost to Follow-up|9
2915305|NCT01610414|10039417|P1|Month 13 - Month 25|Lost to Follow-up|5
2915306|NCT01610414|10039416|P2|Month 13 - Month 25|Protocol Violation|2
2915307|NCT01610414|10039417|P1|Month 13 - Month 25|Protocol Violation|0
2915308|NCT01610414|10039416|P2|Month 13 - Month 25|Migrated/moved from study area|2
2915309|NCT01610414|10039417|P1|Month 13 - Month 25|Migrated/moved from study area|4
2915310|NCT01610414|10039416|P2|Month 13 - Month 25|Withdrawal by Subject|8
2915311|NCT01610414|10039417|P1|Month 13 - Month 25|Withdrawal by Subject|7
2915312|NCT01610414|10039416|P2|Month 13 - Month 25|Adverse Event|4
2915313|NCT01610414|10039417|P1|Month 13 - Month 25|Adverse Event|8
2915314|NCT01610414|10039416|P2|Month 13 - Month 25|Serious Adverse Event|38
2915315|NCT01610414|10039417|P1|Month 13 - Month 25|Serious Adverse Event|35
2915316|NCT01610414|10039416|P2|Study Start - Month 13|Other reasons for withdrawal|4
2915317|NCT01610414|10039417|P1|Study Start - Month 13|Other reasons for withdrawal|3
2915318|NCT01610414|10039416|P2|Study Start - Month 13|Suspected HZ episode|3
2915319|NCT01610414|10039417|P1|Study Start - Month 13|Suspected HZ episode|1
2915321|NCT01610414|10039417|P1|Study Start - Month 13|Lost to Follow-up|4
2915322|NCT01610414|10039416|P2|Study Start - Month 13|Migrated/moved from study area|4
2915323|NCT01610414|10039417|P1|Study Start - Month 13|Migrated/moved from study area|2
2915324|NCT01610414|10039416|P2|Study Start - Month 13|Withdrawal by Subject|30
2915325|NCT01610414|10039417|P1|Study Start - Month 13|Withdrawal by Subject|23
2915326|NCT01610414|10039416|P2|Study Start - Month 13|Protocol Violation|1
2915327|NCT01610414|10039417|P1|Study Start - Month 13|Protocol Violation|3
2915328|NCT01610414|10039416|P2|Study Start - Month 13|Adverse Event|14
2915329|NCT01610414|10039417|P1|Study Start - Month 13|Adverse Event|14
2915330|NCT01610414|10039416|P2|Study Start - Month 13|Serious Adverse Event|67
2915331|NCT01610414|10039417|P1|Study Start - Month 13|Serious Adverse Event|65
2915332|NCT01610297|10039446|P1|Overall Study|Lost to Follow-up|1
2915333|NCT01610271|10039456|P2|Overall Study|Prosthesis not implanted|3
2915334|NCT01610271|10039457|P1|Overall Study|Prosthesis not implanted|2
2915335|NCT01610271|10039456|P2|Overall Study|Surgery not complete|1
2915336|NCT01610271|10039457|P1|Overall Study|Surgery not complete|0
2915337|NCT01610167|10039472|P3|Overall Study|Scheduling conflict.|2
2915338|NCT01610167|10039473|P2|Overall Study|Scheduling conflict.|0
2915339|NCT01610167|10039474|P1|Overall Study|Scheduling conflict.|0
2915340|NCT01610076|10039511|P2|Overall Study|Lost to Follow-up|4
2915341|NCT01610076|10039512|P1|Overall Study|Lost to Follow-up|3
2915342|NCT01610076|10039511|P2|Overall Study|Technical issue with video|1
2915343|NCT01610076|10039512|P1|Overall Study|Technical issue with video|0
2915344|NCT01610063|10039523|P2|Overall Study|Lost to Follow-up|20
2915345|NCT01610063|10039524|P1|Overall Study|Lost to Follow-up|42
2915346|NCT01610037|10039547|P3|Treatment and Follow up Period|Lost to Follow-up|4
2915347|NCT01610037|10039548|P2|Treatment and Follow up Period|Lost to Follow-up|6
2915348|NCT01610037|10039549|P1|Treatment and Follow up Period|Lost to Follow-up|1
2915349|NCT01610037|10039547|P3|Treatment and Follow up Period|Administrative problems|2
2915350|NCT01610037|10039548|P2|Treatment and Follow up Period|Administrative problems|3
2915351|NCT01610037|10039549|P1|Treatment and Follow up Period|Administrative problems|1
2915352|NCT01610037|10039547|P3|Treatment and Follow up Period|Death|4
2915353|NCT01610037|10039548|P2|Treatment and Follow up Period|Death|5
2915354|NCT01610037|10039549|P1|Treatment and Follow up Period|Death|10
2915355|NCT01610037|10039547|P3|Treatment and Follow up Period|Subject withdrew consent|16
2915356|NCT01610037|10039548|P2|Treatment and Follow up Period|Subject withdrew consent|14
2915357|NCT01610037|10039549|P1|Treatment and Follow up Period|Subject withdrew consent|13
2915358|NCT01610037|10039547|P3|All Patients|Abnormal test procedure result(s)|3
2915359|NCT01610037|10039548|P2|All Patients|Abnormal test procedure result(s)|1
2915360|NCT01610037|10039549|P1|All Patients|Abnormal test procedure result(s)|0
2915361|NCT01610037|10039547|P3|All Patients|Lost to Follow-up|0
2915362|NCT01610037|10039548|P2|All Patients|Lost to Follow-up|0
2915363|NCT01610037|10039549|P1|All Patients|Lost to Follow-up|1
2915364|NCT01610037|10039547|P3|All Patients|Administrative problems|4
2915365|NCT01610037|10039548|P2|All Patients|Administrative problems|4
2915366|NCT01610037|10039549|P1|All Patients|Administrative problems|1
2915367|NCT01610037|10039547|P3|All Patients|Abnormal laboratory value|0
2915368|NCT01610037|10039548|P2|All Patients|Abnormal laboratory value|1
2915369|NCT01610037|10039549|P1|All Patients|Abnormal laboratory value|1
2915370|NCT01610037|10039547|P3|All Patients|Protocol deviation|3
2915371|NCT01610037|10039548|P2|All Patients|Protocol deviation|3
2915372|NCT01610037|10039549|P1|All Patients|Protocol deviation|4
2915373|NCT01610037|10039547|P3|All Patients|Death|1
2915374|NCT01610037|10039548|P2|All Patients|Death|2
2915375|NCT01610037|10039549|P1|All Patients|Death|4
2915376|NCT01610037|10039547|P3|All Patients|Unsatisfactory therapeutic effect|27
2915377|NCT01610037|10039548|P2|All Patients|Unsatisfactory therapeutic effect|8
2915378|NCT01610037|10039549|P1|All Patients|Unsatisfactory therapeutic effect|9
2915379|NCT01610037|10039547|P3|All Patients|Withdrawal by Subject|20
2915380|NCT01610037|10039548|P2|All Patients|Withdrawal by Subject|10
2915381|NCT01610037|10039549|P1|All Patients|Withdrawal by Subject|12
2915382|NCT01610037|10039547|P3|All Patients|Adverse Event|26
2915383|NCT01610037|10039548|P2|All Patients|Adverse Event|22
2915384|NCT01610037|10039549|P1|All Patients|Adverse Event|27
2915385|NCT01609933|10039599|P1|Overall Study|Withdrawal by Subject|3
2915386|NCT01609933|10039599|P1|Overall Study|Adverse Event|1
2915387|NCT01609842|10039610|P2|Concurrent Intervention Control|pharmacy data not available|0
2915388|NCT01609842|10039611|P1|Concurrent Intervention Control|pharmacy data not available|2
2915389|NCT01609790|10039638|P3|Overall Study|Protocol Violation|8
2915390|NCT01609790|10039639|P2|Overall Study|Protocol Violation|7
2915391|NCT01609790|10039640|P1|Overall Study|Protocol Violation|1
2915392|NCT01609582|10039659|P2|Overall Study|Randomized, but not treated|3
2915393|NCT01609582|10039660|P1|Overall Study|Randomized, but not treated|0
2915394|NCT01609582|10039659|P2|Overall Study|Other|10
2915395|NCT01609582|10039660|P1|Overall Study|Other|9
2915396|NCT01609582|10039659|P2|Overall Study|Study Terminated by Sponsor|1548
2915397|NCT01609582|10039660|P1|Overall Study|Study Terminated by Sponsor|1543
2915398|NCT01609582|10039659|P2|Overall Study|Withdrawal by Subject|15
2915399|NCT01609582|10039660|P1|Overall Study|Withdrawal by Subject|21
2915400|NCT01609582|10039659|P2|Overall Study|Lost to Follow-up|10
2915401|NCT01609582|10039660|P1|Overall Study|Lost to Follow-up|10
2915402|NCT01609582|10039659|P2|Overall Study|Adverse Event|18
2915403|NCT01609582|10039660|P1|Overall Study|Adverse Event|20
2915404|NCT01609543|10039668|P1|Overall Study|Death|7
2915405|NCT01609543|10039668|P1|Overall Study|Protocol Violation|1
2915406|NCT01609543|10039668|P1|Overall Study|Withdrawal by Subject|1
2915407|NCT01609543|10039668|P1|Overall Study|Adverse Event|5
2915408|NCT01609543|10039668|P1|Overall Study|Disease Progression|28
2915409|NCT01609478|10039677|P3|Overall Study|Withdrawal by Subject|2
2915410|NCT01609478|10039678|P2|Overall Study|Withdrawal by Subject|0
2915411|NCT01609478|10039679|P1|Overall Study|Withdrawal by Subject|2
2915412|NCT01609478|10039677|P3|Overall Study|Physician Decision|1
2915413|NCT01609478|10039678|P2|Overall Study|Physician Decision|0
2915414|NCT01609478|10039679|P1|Overall Study|Physician Decision|1
2915415|NCT01609478|10039677|P3|Overall Study|Non-Compliance with study treatment|0
2915416|NCT01609478|10039678|P2|Overall Study|Non-Compliance with study treatment|0
2915417|NCT01609478|10039679|P1|Overall Study|Non-Compliance with study treatment|1
2915418|NCT01609478|10039677|P3|Overall Study|Protocol Deviation|1
2915419|NCT01609478|10039678|P2|Overall Study|Protocol Deviation|1
2915420|NCT01609478|10039679|P1|Overall Study|Protocol Deviation|0
2915421|NCT01609478|10039677|P3|Overall Study|Adverse Event|5
2915422|NCT01609478|10039678|P2|Overall Study|Adverse Event|1
2915423|NCT01609478|10039679|P1|Overall Study|Adverse Event|3
2915424|NCT01609296|10039752|P1|Overall Study|Withdrawal by Subject|71
2915425|NCT01609296|10039752|P1|Overall Study|Death|49
2915426|NCT01609257|10039765|P2|Overall Study|Non-compliance/Protocol deviation|6
2915427|NCT01609257|10039766|P1|Overall Study|Non-compliance/Protocol deviation|4
2915428|NCT01609257|10039765|P2|Overall Study|Voluntary Withdrawal by Subject|1
2915429|NCT01609257|10039766|P1|Overall Study|Voluntary Withdrawal by Subject|0
2915430|NCT01609257|10039765|P2|Overall Study|Lost to Follow-up|1
2915431|NCT01609257|10039766|P1|Overall Study|Lost to Follow-up|2
2915432|NCT01609231|10039838|P2|Overall Study|Withdrawal by Subject|0
2915433|NCT01609231|10039839|P1|Overall Study|Withdrawal by Subject|1
2915434|NCT01609231|10039838|P2|Overall Study|Physician Decision|0
2915435|NCT01609231|10039839|P1|Overall Study|Physician Decision|1
2915436|NCT01609231|10039838|P2|Overall Study|Adverse Event|3
2915437|NCT01609231|10039839|P1|Overall Study|Adverse Event|1
2915438|NCT01609062|10039849|P2|Extension Phase|Anticipated surgery & transition to EAP|1
2915439|NCT01609062|10039850|P1|Extension Phase|Anticipated surgery & transition to EAP|0
2915440|NCT01609062|10039849|P2|Extension Phase|Discontinued drug and then was pregnant|0
2915441|NCT01609062|10039850|P1|Extension Phase|Discontinued drug and then was pregnant|1
2915442|NCT01609062|10039849|P2|Extension Phase|Terminated by Sponsor|9
2915443|NCT01609062|10039850|P1|Extension Phase|Terminated by Sponsor|14
2915444|NCT01609023|10039893|P1|Overall Study|Personal reasons|1
2915445|NCT01609023|10039893|P1|Overall Study|Death|2
2915446|NCT01609023|10039893|P1|Overall Study|Physician Decision|2
2915447|NCT01609023|10039893|P1|Overall Study|Disease progression|10
2915448|NCT01609023|10039893|P1|Overall Study|Toxicity|3
2915449|NCT01609023|10039893|P1|Overall Study|Lost to Follow-up|8
2915450|NCT01609023|10039893|P1|Overall Study|Withdrawal by Subject|4
2915451|NCT01609023|10039893|P1|Overall Study|Lack of Efficacy|3
2915452|NCT01609010|10039905|P2|Overall Study|Lost to Follow-up|1
2915453|NCT01609010|10039906|P1|Overall Study|Lost to Follow-up|1
2915454|NCT01609010|10039905|P2|Overall Study|New cancer|0
2915455|NCT01609010|10039906|P1|Overall Study|New cancer|1
2915456|NCT01609010|10039905|P2|Overall Study|Protocol Violation|1
2915457|NCT01609010|10039906|P1|Overall Study|Protocol Violation|1
2915458|NCT01609010|10039905|P2|Overall Study|Pathology review|1
2915459|NCT01609010|10039906|P1|Overall Study|Pathology review|2
2915460|NCT01609010|10039905|P2|Overall Study|Other malignancy|0
2915461|NCT01609010|10039906|P1|Overall Study|Other malignancy|1
2915462|NCT01609010|10039905|P2|Overall Study|Other|0
2915463|NCT01609010|10039906|P1|Overall Study|Other|2
2915464|NCT01609010|10039905|P2|Overall Study|Withdrawal by Subject|2
2915465|NCT01609010|10039906|P1|Overall Study|Withdrawal by Subject|2
2915466|NCT01609010|10039905|P2|Overall Study|Adverse Event|6
2915467|NCT01609010|10039906|P1|Overall Study|Adverse Event|3
2915468|NCT01609010|10039905|P2|Overall Study|Progressive disease (PD)|10
2915469|NCT01609010|10039906|P1|Overall Study|Progressive disease (PD)|8
2915470|NCT01609010|10039905|P2|Overall Study|Stable disease (SD)|16
2915471|NCT01609010|10039906|P1|Overall Study|Stable disease (SD)|22
2915472|NCT01608724|10039967|P1|Overall Study|Safety reasons|1
2915473|NCT01608724|10039967|P1|Overall Study|bood sugar too high, etc.|3
2915474|NCT01608724|10039967|P1|Overall Study|Protocol Violation|6
2915475|NCT01608724|10039967|P1|Overall Study|Adverse Event|29
2915476|NCT01608724|10039967|P1|Overall Study|Study-specific discontinuation criteria|32
2915477|NCT01608724|10039967|P1|Overall Study|Lost to Follow-up|41
2915478|NCT01608724|10039967|P1|Overall Study|Withdrawal by Subject|131
2915479|NCT01608321|10039999|P2|Overall Study|Withdrawal by Subject|0
2915480|NCT01608321|10040000|P1|Overall Study|Withdrawal by Subject|1
2915481|NCT01608308|10040008|P2|Overall Study|pretreatment medical and billing reasons|2
2915482|NCT01608308|10040009|P1|Overall Study|pretreatment medical and billing reasons|0
2915483|NCT01608087|10040072|P3|Overall Study|Other Reason|0
2915484|NCT01608087|10040073|P2|Overall Study|Other Reason|1
2915485|NCT01608087|10040074|P1|Overall Study|Other Reason|0
2915486|NCT01608087|10040072|P3|Overall Study|Lost to Follow-up|0
2915487|NCT01608087|10040073|P2|Overall Study|Lost to Follow-up|1
2915488|NCT01608087|10040074|P1|Overall Study|Lost to Follow-up|0
2915489|NCT01607957|10040090|P2|Overall Study|Participant refusal|0
2915490|NCT01607957|10040091|P1|Overall Study|Participant refusal|1
2915491|NCT01607957|10040090|P2|Overall Study|Lost to Follow-up|3
2915492|NCT01607957|10040091|P1|Overall Study|Lost to Follow-up|3
2915493|NCT01607957|10040090|P2|Overall Study|Death|211
2915494|NCT01607957|10040091|P1|Overall Study|Death|367
2915495|NCT01607957|10040090|P2|Overall Study|Not treated|1
2915496|NCT01607957|10040091|P1|Overall Study|Not treated|1
2915497|NCT01607593|10040270|P1|Overall Study|Other|4
2915498|NCT01607593|10040270|P1|Overall Study|Continuation|33
2915499|NCT01607593|10040270|P1|Overall Study|Lost to Follow-up|25
2915500|NCT01607593|10040270|P1|Overall Study|Lack of Efficacy|16
2915501|NCT01607593|10040270|P1|Overall Study|Adverse Event|15
2915502|NCT01607554|10040276|P1|Overall Study|Disease progression|2
2915503|NCT01607476|10040289|P3|Overall Study|Lost to Follow-up|2
2915504|NCT01607476|10040290|P2|Overall Study|Lost to Follow-up|0
2915505|NCT01607476|10040291|P1|Overall Study|Lost to Follow-up|0
2915506|NCT01607476|10040289|P3|Overall Study|Withdrawal by Subject|1
2915507|NCT01607476|10040290|P2|Overall Study|Withdrawal by Subject|0
2915508|NCT01607476|10040291|P1|Overall Study|Withdrawal by Subject|1
2915509|NCT01607398|10040385|P2|Overall Study|Severe COPD|0
2915510|NCT01607398|10040386|P1|Overall Study|Severe COPD|2
2915511|NCT01607398|10040385|P2|Overall Study|Adverse Event|2
2915512|NCT01607398|10040386|P1|Overall Study|Adverse Event|0
2915513|NCT01607346|10040430|P1|Overall Study|Adverse Event|3
2915514|NCT01606800|10040528|P2|Overall Study|Missing completion status|0
2915515|NCT01606800|10040529|P1|Overall Study|Missing completion status|2
2915516|NCT01606800|10040528|P2|Overall Study|Participant withdrew consent|1
2915517|NCT01606800|10040529|P1|Overall Study|Participant withdrew consent|0
2915518|NCT01606800|10040528|P2|Overall Study|Adverse Event|1
2915519|NCT01606800|10040529|P1|Overall Study|Adverse Event|3
2915520|NCT01606787|10040537|P2|Overall Study|Surgery canceled|2
2915521|NCT01606787|10040538|P1|Overall Study|Surgery canceled|0
2915522|NCT01606787|10040537|P2|Overall Study|Withdrawal by Subject|5
2915523|NCT01606787|10040538|P1|Overall Study|Withdrawal by Subject|4
2915524|NCT01606761|10040549|P5|Safety Follow-up Period (Week 52-68)|Other|3
2915525|NCT01606761|10040550|P4|Safety Follow-up Period (Week 52-68)|Other|1
2915526|NCT01606761|10040551|P3|Safety Follow-up Period (Week 52-68)|Other|9
2915527|NCT01606761|10040552|P2|Safety Follow-up Period (Week 52-68)|Other|3
2915528|NCT01606761|10040553|P1|Safety Follow-up Period (Week 52-68)|Other|0
2915529|NCT01606761|10040549|P5|Safety Follow-up Period (Week 52-68)|Death|1
2915530|NCT01606761|10040550|P4|Safety Follow-up Period (Week 52-68)|Death|0
2915531|NCT01606761|10040551|P3|Safety Follow-up Period (Week 52-68)|Death|0
2915532|NCT01606761|10040552|P2|Safety Follow-up Period (Week 52-68)|Death|0
2915533|NCT01606761|10040553|P1|Safety Follow-up Period (Week 52-68)|Death|0
2915534|NCT01606761|10040549|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
2915535|NCT01606761|10040550|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
2915536|NCT01606761|10040551|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2915537|NCT01606761|10040552|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2915538|NCT01606761|10040553|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
2915539|NCT01606761|10040549|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2915540|NCT01606761|10040550|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2915541|NCT01606761|10040551|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
2915542|NCT01606761|10040552|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2915543|NCT01606761|10040553|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2915544|NCT01606761|10040549|P5|Week 24 to Week 52|Other|2
2915545|NCT01606761|10040550|P4|Week 24 to Week 52|Other|2
2915546|NCT01606761|10040551|P3|Week 24 to Week 52|Other|5
2915547|NCT01606761|10040552|P2|Week 24 to Week 52|Other|1
2915548|NCT01606761|10040553|P1|Week 24 to Week 52|Other|0
2915549|NCT01606761|10040549|P5|Week 24 to Week 52|Physician Decision|0
2915550|NCT01606761|10040550|P4|Week 24 to Week 52|Physician Decision|0
2915551|NCT01606761|10040551|P3|Week 24 to Week 52|Physician Decision|1
2915552|NCT01606761|10040552|P2|Week 24 to Week 52|Physician Decision|1
2915553|NCT01606761|10040553|P1|Week 24 to Week 52|Physician Decision|0
2915554|NCT01606761|10040549|P5|Week 24 to Week 52|Lack of Efficacy|3
2915555|NCT01606761|10040550|P4|Week 24 to Week 52|Lack of Efficacy|10
2915556|NCT01606761|10040551|P3|Week 24 to Week 52|Lack of Efficacy|7
2915557|NCT01606761|10040552|P2|Week 24 to Week 52|Lack of Efficacy|13
2915558|NCT01606761|10040553|P1|Week 24 to Week 52|Lack of Efficacy|0
2915559|NCT01606761|10040549|P5|Week 24 to Week 52|Death|0
2915560|NCT01606761|10040550|P4|Week 24 to Week 52|Death|1
2915561|NCT01606761|10040551|P3|Week 24 to Week 52|Death|2
2915562|NCT01606761|10040552|P2|Week 24 to Week 52|Death|0
2915563|NCT01606761|10040553|P1|Week 24 to Week 52|Death|0
2915564|NCT01606761|10040549|P5|Week 24 to Week 52|Adverse Event|15
2915565|NCT01606761|10040550|P4|Week 24 to Week 52|Adverse Event|3
2915566|NCT01606761|10040551|P3|Week 24 to Week 52|Adverse Event|14
2915567|NCT01606761|10040552|P2|Week 24 to Week 52|Adverse Event|11
2915568|NCT01606761|10040553|P1|Week 24 to Week 52|Adverse Event|0
2915569|NCT01606761|10040549|P5|Week 24 to Week 52|Withdrawal by Subject|0
2915570|NCT01606761|10040550|P4|Week 24 to Week 52|Withdrawal by Subject|0
2915571|NCT01606761|10040551|P3|Week 24 to Week 52|Withdrawal by Subject|3
2915572|NCT01606761|10040552|P2|Week 24 to Week 52|Withdrawal by Subject|6
2915573|NCT01606761|10040553|P1|Week 24 to Week 52|Withdrawal by Subject|0
2915574|NCT01606761|10040549|P5|Week 24 to Week 52|Lost to Follow-up|0
2915575|NCT01606761|10040550|P4|Week 24 to Week 52|Lost to Follow-up|1
2915576|NCT01606761|10040551|P3|Week 24 to Week 52|Lost to Follow-up|1
2915577|NCT01606761|10040552|P2|Week 24 to Week 52|Lost to Follow-up|1
2915578|NCT01606761|10040553|P1|Week 24 to Week 52|Lost to Follow-up|0
2915579|NCT01606761|10040549|P5|Prior to Week 24|Other|0
2915580|NCT01606761|10040550|P4|Prior to Week 24|Other|0
2915581|NCT01606761|10040551|P3|Prior to Week 24|Other|5
2915582|NCT01606761|10040552|P2|Prior to Week 24|Other|7
2915583|NCT01606761|10040553|P1|Prior to Week 24|Other|4
2915584|NCT01606761|10040549|P5|Prior to Week 24|Physician Decision|0
2915585|NCT01606761|10040550|P4|Prior to Week 24|Physician Decision|0
2915586|NCT01606761|10040551|P3|Prior to Week 24|Physician Decision|1
2915587|NCT01606761|10040552|P2|Prior to Week 24|Physician Decision|3
2915588|NCT01606761|10040553|P1|Prior to Week 24|Physician Decision|0
2915589|NCT01606761|10040549|P5|Prior to Week 24|Lack of Efficacy|0
2915590|NCT01606761|10040550|P4|Prior to Week 24|Lack of Efficacy|0
2915591|NCT01606761|10040551|P3|Prior to Week 24|Lack of Efficacy|8
2915592|NCT01606761|10040552|P2|Prior to Week 24|Lack of Efficacy|14
2915593|NCT01606761|10040553|P1|Prior to Week 24|Lack of Efficacy|15
2915594|NCT01606761|10040549|P5|Prior to Week 24|Adverse Event|0
2915595|NCT01606761|10040550|P4|Prior to Week 24|Adverse Event|0
2915596|NCT01606761|10040551|P3|Prior to Week 24|Adverse Event|22
2915597|NCT01606761|10040552|P2|Prior to Week 24|Adverse Event|18
2915598|NCT01606761|10040553|P1|Prior to Week 24|Adverse Event|11
2915599|NCT01606761|10040549|P5|Prior to Week 24|Withdrawal by Subject|0
2915600|NCT01606761|10040550|P4|Prior to Week 24|Withdrawal by Subject|0
2915601|NCT01606761|10040551|P3|Prior to Week 24|Withdrawal by Subject|9
2915602|NCT01606761|10040552|P2|Prior to Week 24|Withdrawal by Subject|10
2915603|NCT01606761|10040553|P1|Prior to Week 24|Withdrawal by Subject|12
2915604|NCT01606761|10040549|P5|Prior to Week 24|Lost to Follow-up|0
2915605|NCT01606761|10040550|P4|Prior to Week 24|Lost to Follow-up|0
2915606|NCT01606761|10040551|P3|Prior to Week 24|Lost to Follow-up|2
2915607|NCT01606761|10040552|P2|Prior to Week 24|Lost to Follow-up|3
2915608|NCT01606761|10040553|P1|Prior to Week 24|Lost to Follow-up|0
2915609|NCT01606748|10040579|P2|Overall Study|Withdrawal by Subject|0
2915610|NCT01606748|10040580|P1|Overall Study|Withdrawal by Subject|1
2915611|NCT01606748|10040579|P2|Overall Study|Progressive Disease|0
2915612|NCT01606748|10040580|P1|Overall Study|Progressive Disease|1
2915613|NCT01606748|10040579|P2|Overall Study|Adverse Event|0
2915614|NCT01606748|10040580|P1|Overall Study|Adverse Event|1
2915615|NCT01606670|10040632|P1|Overall Study|Other Reason|2
2915616|NCT01606670|10040632|P1|Overall Study|Withdrawal by Subject|3
2915617|NCT01606670|10040632|P1|Overall Study|Lost to Follow-up|3
2915618|NCT01606670|10040632|P1|Overall Study|Lack of Efficacy|2
2915619|NCT01606670|10040632|P1|Overall Study|Adverse Event|6
2915620|NCT01606319|10040642|P2|Overall Study|Adverse Event|4
2915621|NCT01606319|10040643|P1|Overall Study|Adverse Event|1
2915622|NCT01606319|10040642|P2|Overall Study|Lack of Efficacy|8
2915623|NCT01606319|10040643|P1|Overall Study|Lack of Efficacy|6
2915624|NCT01606319|10040642|P2|Overall Study|Physician Decision|2
2915625|NCT01606319|10040643|P1|Overall Study|Physician Decision|1
2915626|NCT01606319|10040642|P2|Overall Study|Withdrawal by Subject|12
2915627|NCT01606319|10040643|P1|Overall Study|Withdrawal by Subject|9
2915628|NCT01606319|10040642|P2|Overall Study|Lost to Follow-up|14
2915629|NCT01606319|10040643|P1|Overall Study|Lost to Follow-up|17
2915630|NCT01606306|10040661|P6|Overall Study|Physician Decision|0
2915631|NCT01606306|10040662|P5|Overall Study|Physician Decision|0
2915632|NCT01606306|10040663|P4|Overall Study|Physician Decision|0
2915633|NCT01606306|10040664|P3|Overall Study|Physician Decision|0
2915634|NCT01606306|10040665|P2|Overall Study|Physician Decision|2
2915635|NCT01606306|10040666|P1|Overall Study|Physician Decision|1
2915636|NCT01606306|10040661|P6|Overall Study|Withdrawal by Subject|4
2915637|NCT01606306|10040662|P5|Overall Study|Withdrawal by Subject|5
2915638|NCT01606306|10040663|P4|Overall Study|Withdrawal by Subject|4
2915639|NCT01606306|10040664|P3|Overall Study|Withdrawal by Subject|4
2915640|NCT01606306|10040665|P2|Overall Study|Withdrawal by Subject|3
2915641|NCT01606306|10040666|P1|Overall Study|Withdrawal by Subject|4
2915642|NCT01606306|10040661|P6|Overall Study|Lost to Follow-up|5
2915643|NCT01606306|10040662|P5|Overall Study|Lost to Follow-up|3
2915644|NCT01606306|10040663|P4|Overall Study|Lost to Follow-up|4
2915645|NCT01606306|10040664|P3|Overall Study|Lost to Follow-up|5
2915646|NCT01606306|10040665|P2|Overall Study|Lost to Follow-up|4
2915647|NCT01606306|10040666|P1|Overall Study|Lost to Follow-up|7
2915648|NCT01606306|10040661|P6|Overall Study|Adverse Event|0
2915649|NCT01606306|10040662|P5|Overall Study|Adverse Event|2
2915650|NCT01606306|10040663|P4|Overall Study|Adverse Event|1
2915651|NCT01606306|10040664|P3|Overall Study|Adverse Event|1
2915652|NCT01606306|10040665|P2|Overall Study|Adverse Event|0
2915653|NCT01606306|10040666|P1|Overall Study|Adverse Event|1
2915654|NCT01606306|10040661|P6|Overall Study|Lack of Efficacy|2
2915655|NCT01606306|10040662|P5|Overall Study|Lack of Efficacy|1
2915656|NCT01606306|10040663|P4|Overall Study|Lack of Efficacy|4
2915657|NCT01606306|10040664|P3|Overall Study|Lack of Efficacy|4
2915658|NCT01606306|10040665|P2|Overall Study|Lack of Efficacy|1
2915659|NCT01606306|10040666|P1|Overall Study|Lack of Efficacy|2
2915660|NCT01606254|10040676|P4|Overall Study|Adverse Event|1
2915661|NCT01606254|10040677|P3|Overall Study|Adverse Event|0
2915662|NCT01606254|10040678|P2|Overall Study|Adverse Event|1
2915663|NCT01606254|10040679|P1|Overall Study|Adverse Event|1
2915664|NCT01606254|10040676|P4|Overall Study|Withdrawal by Subject|2
2915665|NCT01606254|10040677|P3|Overall Study|Withdrawal by Subject|0
2915666|NCT01606254|10040678|P2|Overall Study|Withdrawal by Subject|3
2915667|NCT01606254|10040679|P1|Overall Study|Withdrawal by Subject|1
2915668|NCT01606228|10040761|P1|Overall Study|Adverse Event|1
2915669|NCT01606228|10040761|P1|Overall Study|Lack of Efficacy|2
2915670|NCT01606228|10040761|P1|Overall Study|Non-compliant|3
2915671|NCT01606228|10040761|P1|Overall Study|Withdrawal by Subject|3
2915672|NCT01606228|10040761|P1|Overall Study|Lost to Follow-up|20
2915673|NCT01606202|10040778|P2|Overall Study|Problems with administration|1
2915674|NCT01606202|10040779|P1|Overall Study|Problems with administration|0
2915675|NCT01606202|10040778|P2|Overall Study|Personal problems|1
2915676|NCT01606202|10040779|P1|Overall Study|Personal problems|0
2915677|NCT01606202|10040778|P2|Overall Study|Withdrawal by Subject|1
2915678|NCT01606202|10040779|P1|Overall Study|Withdrawal by Subject|2
2915679|NCT01606202|10040778|P2|Overall Study|Adverse Event|0
2915680|NCT01606202|10040779|P1|Overall Study|Adverse Event|5
2915681|NCT01606189|10040811|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
2915682|NCT01606189|10040812|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2915683|NCT01606189|10040813|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2915684|NCT01606189|10040814|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2915685|NCT01606189|10040815|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2915686|NCT01606189|10040816|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2915687|NCT01606189|10040811|P6|Second Intenvention (14-20 Days)|Adverse Event|1
2915688|NCT01606189|10040812|P5|Second Intenvention (14-20 Days)|Adverse Event|0
2915689|NCT01606189|10040813|P4|Second Intenvention (14-20 Days)|Adverse Event|0
2915690|NCT01606189|10040814|P3|Second Intenvention (14-20 Days)|Adverse Event|0
2915691|NCT01606189|10040815|P2|Second Intenvention (14-20 Days)|Adverse Event|0
2915692|NCT01606189|10040816|P1|Second Intenvention (14-20 Days)|Adverse Event|0
2915693|NCT01606176|10040850|P2|Overall Study|Withdrawal by Subject|0
2915694|NCT01606176|10040851|P1|Overall Study|Withdrawal by Subject|1
2915695|NCT01606176|10040850|P2|Overall Study|Disease progression|0
2915696|NCT01606176|10040851|P1|Overall Study|Disease progression|1
2915697|NCT01606176|10040850|P2|Overall Study|Adverse Event|3
2915698|NCT01606176|10040851|P1|Overall Study|Adverse Event|2
2915699|NCT01606137|10040896|P1|Overall Study|Unable to collect consistent data|1
2915700|NCT01606137|10040896|P1|Overall Study|Patient moving|1
2915701|NCT01606137|10040896|P1|Overall Study|Unable to tolerate study med. taste|1
2915702|NCT01606137|10040896|P1|Overall Study|Personal reasons|1
2915703|NCT01606137|10040896|P1|Overall Study|Patient leaving country|1
2915704|NCT01606137|10040896|P1|Overall Study|Wanted to try another treatment|1
2915705|NCT01606137|10040896|P1|Overall Study|Not enough improvement|4
2915706|NCT01606137|10040896|P1|Overall Study|Spray causes nausea|1
2915707|NCT01606137|10040896|P1|Overall Study|Increased bilirubin|1
2915708|NCT01606137|10040896|P1|Overall Study|multiple sclerosis less stable|1
2915709|NCT01606137|10040896|P1|Overall Study|Issues with driving|4
2915710|NCT01606137|10040896|P1|Overall Study|Decreased/no pain|4
2915711|NCT01606137|10040896|P1|Overall Study|Death|1
2915712|NCT01606137|10040896|P1|Overall Study|Patient non-compliance|9
2915713|NCT01606137|10040896|P1|Overall Study|Protocol Violation|1
2915714|NCT01606137|10040896|P1|Overall Study|Lost to Follow-up|15
2915715|NCT01606137|10040896|P1|Overall Study|Lack of Efficacy|56
2915716|NCT01606137|10040896|P1|Overall Study|Withdrawal by Subject|74
2915717|NCT01606137|10040896|P1|Overall Study|Adverse Event|85
2915718|NCT01606007|10040930|P3|Overall Study|Poor/Non-compliance|0
2915719|NCT01606007|10040931|P2|Overall Study|Poor/Non-compliance|0
2915720|NCT01606007|10040932|P1|Overall Study|Poor/Non-compliance|1
2915721|NCT01606007|10040930|P3|Overall Study|Lost to Follow-up|5
2915722|NCT01606007|10040931|P2|Overall Study|Lost to Follow-up|8
2915723|NCT01606007|10040932|P1|Overall Study|Lost to Follow-up|6
2915724|NCT01606007|10040930|P3|Overall Study|discontinue study treatment|1
2915725|NCT01606007|10040931|P2|Overall Study|discontinue study treatment|2
2915726|NCT01606007|10040932|P1|Overall Study|discontinue study treatment|0
2915727|NCT01606007|10040930|P3|Overall Study|Adverse Event|1
2915728|NCT01606007|10040931|P2|Overall Study|Adverse Event|1
2915729|NCT01606007|10040932|P1|Overall Study|Adverse Event|0
2915730|NCT01606007|10040930|P3|Overall Study|Withdrawal by Subject|1
2915731|NCT01606007|10040931|P2|Overall Study|Withdrawal by Subject|6
2915732|NCT01606007|10040932|P1|Overall Study|Withdrawal by Subject|8
2915733|NCT01606007|10040930|P3|Overall Study|Pregnancy|1
2915734|NCT01606007|10040931|P2|Overall Study|Pregnancy|1
2915735|NCT01606007|10040932|P1|Overall Study|Pregnancy|0
2915736|NCT01606007|10040930|P3|Overall Study|Reason 'Other' in the protocol|1
2915737|NCT01606007|10040931|P2|Overall Study|Reason 'Other' in the protocol|1
2915738|NCT01606007|10040932|P1|Overall Study|Reason 'Other' in the protocol|0
2915739|NCT01605916|10040967|P5|Overall Study|Withdrawal by Subject|2
2915740|NCT01605916|10040968|P4|Overall Study|Withdrawal by Subject|0
2915741|NCT01605916|10040969|P3|Overall Study|Withdrawal by Subject|0
2915742|NCT01605916|10040970|P2|Overall Study|Withdrawal by Subject|1
2915743|NCT01605916|10040971|P1|Overall Study|Withdrawal by Subject|1
2915744|NCT01605916|10040967|P5|Overall Study|Lack of Efficacy|4
2915745|NCT01605916|10040968|P4|Overall Study|Lack of Efficacy|5
2915746|NCT01605916|10040969|P3|Overall Study|Lack of Efficacy|3
2915747|NCT01605916|10040970|P2|Overall Study|Lack of Efficacy|3
2915748|NCT01605916|10040971|P1|Overall Study|Lack of Efficacy|2
2915749|NCT01605916|10040967|P5|Overall Study|Adverse Event|0
2915750|NCT01605916|10040968|P4|Overall Study|Adverse Event|1
2915751|NCT01605916|10040969|P3|Overall Study|Adverse Event|0
2915752|NCT01605916|10040970|P2|Overall Study|Adverse Event|0
2915753|NCT01605916|10040971|P1|Overall Study|Adverse Event|1
2915754|NCT01605877|10041068|P1|Overall Study|Withdrawal by Subject|1
2915755|NCT01605825|10041132|P2|Overall Study|Non-Compliance with Protocol|0
2915756|NCT01605825|10041133|P1|Overall Study|Non-Compliance with Protocol|3
2915757|NCT01605825|10041132|P2|Overall Study|Non-Compliance -Investigational Drug|0
2915758|NCT01605825|10041133|P1|Overall Study|Non-Compliance -Investigational Drug|3
2915759|NCT01605825|10041132|P2|Overall Study|Withdrawal by Subject|1
2915760|NCT01605825|10041133|P1|Overall Study|Withdrawal by Subject|0
2915761|NCT01605825|10041132|P2|Overall Study|Adverse Event|2
2915762|NCT01605825|10041133|P1|Overall Study|Adverse Event|4
2915763|NCT01605799|10041141|P2|Overall Study|Withdrawal by Subject|1
2915764|NCT01605799|10041142|P1|Overall Study|Withdrawal by Subject|2
2915765|NCT01605617|10041157|P2|Washout Period of 4 Weeks|Study Terminated|1
2915766|NCT01605617|10041158|P1|Washout Period of 4 Weeks|Study Terminated|2
2915767|NCT01605617|10041157|P2|First Intervention|Adverse Event|1
2915768|NCT01605617|10041158|P1|First Intervention|Adverse Event|0
2915769|NCT01605461|10041217|P1|Overall Study|Withdrawal by Subject|1
2915770|NCT01605461|10041217|P1|Overall Study|Lost to Follow-up|3
2915771|NCT01605396|10041276|P2|Overall Study|Transfer Off Study|5
2915772|NCT01605396|10041277|P1|Overall Study|Transfer Off Study|4
2915773|NCT01605396|10041276|P2|Overall Study|Withdrawal by Subject|2
2915774|NCT01605396|10041277|P1|Overall Study|Withdrawal by Subject|4
2915775|NCT01605396|10041276|P2|Overall Study|Progressive Disease|27
2915776|NCT01605396|10041277|P1|Overall Study|Progressive Disease|23
2915777|NCT01605396|10041276|P2|Overall Study|Physician Decision|2
2915778|NCT01605396|10041277|P1|Overall Study|Physician Decision|2
2915779|NCT01605396|10041276|P2|Overall Study|Non-Compliance With Study Drug|1
2915780|NCT01605396|10041277|P1|Overall Study|Non-Compliance With Study Drug|1
2915781|NCT01605396|10041276|P2|Overall Study|Lost to Follow-up|0
2915782|NCT01605396|10041277|P1|Overall Study|Lost to Follow-up|1
2915783|NCT01605396|10041276|P2|Overall Study|Adverse Event|3
2915784|NCT01605396|10041277|P1|Overall Study|Adverse Event|5
2915785|NCT01605370|10041291|P2|Overall Study|Adverse Event|0
2915786|NCT01605370|10041292|P1|Overall Study|Adverse Event|1
2915787|NCT01605227|10041327|P2|Overall Study|Dose Held >6 weeks|1
2915788|NCT01605227|10041328|P1|Overall Study|Dose Held >6 weeks|0
2915789|NCT01605227|10041327|P2|Overall Study|Subject Decision|1
2915790|NCT01605227|10041328|P1|Overall Study|Subject Decision|0
2915791|NCT01605227|10041327|P2|Overall Study|Started New Therapy|0
2915792|NCT01605227|10041328|P1|Overall Study|Started New Therapy|1
2915793|NCT01605227|10041327|P2|Overall Study|Sponsor Decision|0
2915794|NCT01605227|10041328|P1|Overall Study|Sponsor Decision|2
2915795|NCT01605227|10041327|P2|Overall Study|Withdrawal by Subject|14
2915796|NCT01605227|10041328|P1|Overall Study|Withdrawal by Subject|18
2915797|NCT01605227|10041327|P2|Overall Study|Physician Decision|7
2915798|NCT01605227|10041328|P1|Overall Study|Physician Decision|9
2915799|NCT01605227|10041327|P2|Overall Study|Protocol Violation|0
2915800|NCT01605227|10041328|P1|Overall Study|Protocol Violation|1
2915801|NCT01605227|10041327|P2|Overall Study|Lost to Follow-up|0
2915802|NCT01605227|10041328|P1|Overall Study|Lost to Follow-up|1
2915803|NCT01605227|10041327|P2|Overall Study|Clinical Deterioration|133
2915804|NCT01605227|10041328|P1|Overall Study|Clinical Deterioration|227
2915805|NCT01605227|10041327|P2|Overall Study|Progressive Disease|128
2915806|NCT01605227|10041328|P1|Overall Study|Progressive Disease|132
2915807|NCT01605227|10041327|P2|Overall Study|Adverse Event|42
2915808|NCT01605227|10041328|P1|Overall Study|Adverse Event|228
2915809|NCT01605227|10041327|P2|Overall Study|Did not receive study treatment|3
2915810|NCT01605227|10041328|P1|Overall Study|Did not receive study treatment|2
2915811|NCT01605136|10041340|P2|Safety Follow-Up Period|Withdrawal by Subject|2
2915812|NCT01605136|10041341|P1|Safety Follow-Up Period|Withdrawal by Subject|1
2915813|NCT01605136|10041340|P2|Study Period|Lost to Follow-up|2
2915814|NCT01605136|10041341|P1|Study Period|Lost to Follow-up|0
2915815|NCT01605136|10041340|P2|Study Period|Physician Decision|1
2915816|NCT01605136|10041341|P1|Study Period|Physician Decision|1
2915817|NCT01605136|10041340|P2|Study Period|Withdrawal by Subject|0
2915818|NCT01605136|10041341|P1|Study Period|Withdrawal by Subject|2
2915819|NCT01605019|10041361|P2|Overall Study|pt did not meet transplant endpoint|0
2915820|NCT01605019|10041362|P1|Overall Study|pt did not meet transplant endpoint|3
2915821|NCT01604941|10041372|P6|Overall Study|Early Study Termination|0
2915822|NCT01604941|10041373|P5|Overall Study|Early Study Termination|0
2915823|NCT01604941|10041374|P4|Overall Study|Early Study Termination|3
2915824|NCT01604941|10041375|P3|Overall Study|Early Study Termination|3
2915825|NCT01604941|10041376|P2|Overall Study|Early Study Termination|2
2915826|NCT01604941|10041377|P1|Overall Study|Early Study Termination|9
2915827|NCT01604941|10041372|P6|Overall Study|Participant Decision|2
2915828|NCT01604941|10041373|P5|Overall Study|Participant Decision|0
2915829|NCT01604941|10041374|P4|Overall Study|Participant Decision|0
2915830|NCT01604941|10041375|P3|Overall Study|Participant Decision|0
2915831|NCT01604941|10041376|P2|Overall Study|Participant Decision|0
2915832|NCT01604941|10041377|P1|Overall Study|Participant Decision|0
2915833|NCT01604941|10041372|P6|Overall Study|Non-compliance|0
2915834|NCT01604941|10041373|P5|Overall Study|Non-compliance|0
2915835|NCT01604941|10041374|P4|Overall Study|Non-compliance|0
2915836|NCT01604941|10041375|P3|Overall Study|Non-compliance|0
2915837|NCT01604941|10041376|P2|Overall Study|Non-compliance|0
2915838|NCT01604941|10041377|P1|Overall Study|Non-compliance|1
2915839|NCT01604941|10041372|P6|Overall Study|Adverse Event|5
2915840|NCT01604941|10041373|P5|Overall Study|Adverse Event|1
2915841|NCT01604941|10041374|P4|Overall Study|Adverse Event|0
2915842|NCT01604941|10041375|P3|Overall Study|Adverse Event|0
2915843|NCT01604941|10041376|P2|Overall Study|Adverse Event|2
2915844|NCT01604941|10041377|P1|Overall Study|Adverse Event|1
2915845|NCT01604850|10041405|P2|Overall Study|Subject withdrew consent|0
2915846|NCT01604850|10041406|P1|Overall Study|Subject withdrew consent|1
2915847|NCT01604850|10041405|P2|Overall Study|Lost to Follow-up|0
2915848|NCT01604850|10041406|P1|Overall Study|Lost to Follow-up|1
2915849|NCT01604850|10041405|P2|Overall Study|Efficacy Failure|29
2915850|NCT01604850|10041406|P1|Overall Study|Efficacy Failure|50
2915851|NCT01604850|10041405|P2|Overall Study|Enrolled but never treated|1
2915852|NCT01604850|10041406|P1|Overall Study|Enrolled but never treated|0
2915853|NCT01604785|10041424|P2|Overall Study|Repeat Visits Not Included in Analysis|1
2915854|NCT01604785|10041425|P1|Overall Study|Repeat Visits Not Included in Analysis|7
2915855|NCT01604408|10041444|P2|Observation Period|Withdrawal by Subject|2
2915856|NCT01604408|10041445|P1|Observation Period|Withdrawal by Subject|0
2915857|NCT01604408|10041444|P2|Observation Period|Adverse Event|1
2915858|NCT01604408|10041445|P1|Observation Period|Adverse Event|1
2915859|NCT01604408|10041444|P2|Treatment Period 6|Sponsor decision|1
2915860|NCT01604408|10041445|P1|Treatment Period 6|Sponsor decision|0
2915861|NCT01604408|10041444|P2|Treatment Period 6|Adverse Event|0
2915862|NCT01604408|10041445|P1|Treatment Period 6|Adverse Event|2
2915863|NCT01604408|10041444|P2|Treatment Period 6|Lost to Follow-up|1
2915864|NCT01604408|10041445|P1|Treatment Period 6|Lost to Follow-up|0
2915865|NCT01604408|10041444|P2|Treatment Period 5|Adverse Event|0
2915866|NCT01604408|10041445|P1|Treatment Period 5|Adverse Event|4
2915867|NCT01604408|10041444|P2|Treatment Period 4|Adverse Event|1
2915868|NCT01604408|10041445|P1|Treatment Period 4|Adverse Event|0
2915869|NCT01604408|10041444|P2|Treatment Period 4|Withdrawal by Subject|1
2915870|NCT01604408|10041445|P1|Treatment Period 4|Withdrawal by Subject|2
2915871|NCT01604408|10041444|P2|Treatment Period 4|Death|0
2915872|NCT01604408|10041445|P1|Treatment Period 4|Death|1
2915873|NCT01604408|10041444|P2|Treatment Period 3|Sponsor Decision|0
2915874|NCT01604408|10041445|P1|Treatment Period 3|Sponsor Decision|1
2915875|NCT01604408|10041444|P2|Treatment Period 3|Withdrawal by Subject|1
2915876|NCT01604408|10041445|P1|Treatment Period 3|Withdrawal by Subject|3
2915877|NCT01604408|10041444|P2|Treatment Period 3|Adverse Event|3
2915878|NCT01604408|10041445|P1|Treatment Period 3|Adverse Event|0
2915879|NCT01604408|10041444|P2|Treatment Period 3|Protocol Violation|1
2915880|NCT01604408|10041445|P1|Treatment Period 3|Protocol Violation|1
2915881|NCT01604408|10041444|P2|Treatment Period 2|Adverse Event|1
2915882|NCT01604408|10041445|P1|Treatment Period 2|Adverse Event|0
2915883|NCT01604408|10041444|P2|Treatment Period 2|Protocol Violation|0
2915884|NCT01604408|10041445|P1|Treatment Period 2|Protocol Violation|1
2915885|NCT01604408|10041444|P2|Treatment Period 2|Withdrawal by Subject|1
2915886|NCT01604408|10041445|P1|Treatment Period 2|Withdrawal by Subject|1
2915887|NCT01604408|10041444|P2|Treatment Period 1|Protocol Violation|1
2915888|NCT01604408|10041445|P1|Treatment Period 1|Protocol Violation|0
2915889|NCT01604343|10041460|P5|Safety Follow-up Period (Week 104-120)|Other|14
2915890|NCT01604343|10041461|P4|Safety Follow-up Period (Week 104-120)|Other|6
2915891|NCT01604343|10041462|P3|Safety Follow-up Period (Week 104-120)|Other|20
2915892|NCT01604343|10041463|P2|Safety Follow-up Period (Week 104-120)|Other|2
2915893|NCT01604343|10041464|P1|Safety Follow-up Period (Week 104-120)|Other|15
2915894|NCT01604343|10041460|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
2915895|NCT01604343|10041461|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
2915896|NCT01604343|10041462|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
2915897|NCT01604343|10041463|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
2915898|NCT01604343|10041464|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
2915899|NCT01604343|10041460|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2915900|NCT01604343|10041461|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2915901|NCT01604343|10041462|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
2915902|NCT01604343|10041463|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2915903|NCT01604343|10041464|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
2915904|NCT01604343|10041460|P5|Week 52 to Week 104|Other|3
2915905|NCT01604343|10041461|P4|Week 52 to Week 104|Other|6
2915906|NCT01604343|10041462|P3|Week 52 to Week 104|Other|11
2915907|NCT01604343|10041463|P2|Week 52 to Week 104|Other|11
2915908|NCT01604343|10041464|P1|Week 52 to Week 104|Other|0
2915909|NCT01604343|10041460|P5|Week 52 to Week 104|Pregnancy|1
2915910|NCT01604343|10041461|P4|Week 52 to Week 104|Pregnancy|2
2915911|NCT01604343|10041462|P3|Week 52 to Week 104|Pregnancy|1
2915912|NCT01604343|10041463|P2|Week 52 to Week 104|Pregnancy|0
2915913|NCT01604343|10041464|P1|Week 52 to Week 104|Pregnancy|0
2915914|NCT01604343|10041460|P5|Week 52 to Week 104|Physician Decision|2
2915915|NCT01604343|10041461|P4|Week 52 to Week 104|Physician Decision|0
2915916|NCT01604343|10041462|P3|Week 52 to Week 104|Physician Decision|0
2915917|NCT01604343|10041463|P2|Week 52 to Week 104|Physician Decision|1
2915918|NCT01604343|10041464|P1|Week 52 to Week 104|Physician Decision|0
2915919|NCT01604343|10041460|P5|Week 52 to Week 104|Lack of Efficacy|3
2915920|NCT01604343|10041461|P4|Week 52 to Week 104|Lack of Efficacy|2
2915921|NCT01604343|10041462|P3|Week 52 to Week 104|Lack of Efficacy|11
2915922|NCT01604343|10041463|P2|Week 52 to Week 104|Lack of Efficacy|6
2915923|NCT01604343|10041464|P1|Week 52 to Week 104|Lack of Efficacy|0
2915924|NCT01604343|10041460|P5|Week 52 to Week 104|Death|0
2915925|NCT01604343|10041461|P4|Week 52 to Week 104|Death|5
2915926|NCT01604343|10041462|P3|Week 52 to Week 104|Death|2
2915927|NCT01604343|10041463|P2|Week 52 to Week 104|Death|4
2915928|NCT01604343|10041464|P1|Week 52 to Week 104|Death|0
2915929|NCT01604343|10041460|P5|Week 52 to Week 104|Adverse Event|27
2915930|NCT01604343|10041461|P4|Week 52 to Week 104|Adverse Event|21
2915931|NCT01604343|10041462|P3|Week 52 to Week 104|Adverse Event|26
2915932|NCT01604343|10041463|P2|Week 52 to Week 104|Adverse Event|12
2915933|NCT01604343|10041464|P1|Week 52 to Week 104|Adverse Event|0
2915934|NCT01604343|10041460|P5|Week 52 to Week 104|Withdrawal by Subject|4
2915935|NCT01604343|10041461|P4|Week 52 to Week 104|Withdrawal by Subject|8
2915936|NCT01604343|10041462|P3|Week 52 to Week 104|Withdrawal by Subject|12
2915937|NCT01604343|10041463|P2|Week 52 to Week 104|Withdrawal by Subject|7
2915938|NCT01604343|10041464|P1|Week 52 to Week 104|Withdrawal by Subject|0
2915939|NCT01604343|10041460|P5|Week 52 to Week 104|Lost to Follow-up|1
2915940|NCT01604343|10041461|P4|Week 52 to Week 104|Lost to Follow-up|2
2915941|NCT01604343|10041462|P3|Week 52 to Week 104|Lost to Follow-up|4
2915942|NCT01604343|10041463|P2|Week 52 to Week 104|Lost to Follow-up|2
2915943|NCT01604343|10041464|P1|Week 52 to Week 104|Lost to Follow-up|0
2915944|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Other|6
2915945|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Other|0
2915946|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Other|10
2915947|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Other|0
2915948|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Other|15
2915949|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
2915950|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
2915951|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
2915952|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
2915953|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
2915954|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
2915955|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
2915956|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
2915957|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
2915958|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
2915959|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
2915960|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2915961|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
2915962|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2915963|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
2915964|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Death|4
2915965|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Death|0
2915966|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Death|2
2915967|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Death|0
2915968|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Death|5
2915969|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
2915970|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
2915971|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
2915972|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
2915973|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
2915974|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
2915975|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2915976|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
2915977|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2915978|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
2915979|NCT01604343|10041460|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
2915980|NCT01604343|10041461|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2915981|NCT01604343|10041462|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
2915982|NCT01604343|10041463|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2915983|NCT01604343|10041464|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
2915984|NCT01604278|10041629|P2|Overall Study|Protocol Deviation|3
2915985|NCT01604278|10041630|P1|Overall Study|Protocol Deviation|5
2915986|NCT01604278|10041629|P2|Overall Study|Adverse Event|5
2915987|NCT01604278|10041630|P1|Overall Study|Adverse Event|3
2915988|NCT01604278|10041629|P2|Overall Study|Withdrawal by Subject|3
2915989|NCT01604278|10041630|P1|Overall Study|Withdrawal by Subject|3
2915990|NCT01604278|10041629|P2|Overall Study|Administrative problems|1
2915991|NCT01604278|10041630|P1|Overall Study|Administrative problems|2
2915992|NCT01604278|10041629|P2|Overall Study|Lost to Follow-up|0
2915993|NCT01604278|10041630|P1|Overall Study|Lost to Follow-up|1
2915994|NCT01604278|10041629|P2|Overall Study|Lack of Efficacy|1
2915995|NCT01604278|10041630|P1|Overall Study|Lack of Efficacy|0
2915996|NCT01604265|10041656|P2|Overall Study|Withdrawal by Subject|0
2915997|NCT01604265|10041657|P1|Overall Study|Withdrawal by Subject|1
2915998|NCT01604265|10041656|P2|Overall Study|Adverse Event|0
2915999|NCT01604265|10041657|P1|Overall Study|Adverse Event|1
2916000|NCT01603875|10041768|P3|Overall Study|Protocol Violation|0
2916001|NCT01603875|10041769|P2|Overall Study|Protocol Violation|1
2916002|NCT01603875|10041770|P1|Overall Study|Protocol Violation|0
2916003|NCT01603875|10041768|P3|Overall Study|Lost to Follow-up|6
2916004|NCT01603875|10041769|P2|Overall Study|Lost to Follow-up|3
2916005|NCT01603875|10041770|P1|Overall Study|Lost to Follow-up|4
2916006|NCT01603875|10041768|P3|Overall Study|Preexisting rabies antibody|3
2916007|NCT01603875|10041769|P2|Overall Study|Preexisting rabies antibody|4
2916008|NCT01603875|10041770|P1|Overall Study|Preexisting rabies antibody|3
2916009|NCT01603641|10041790|P1|Overall Study|Other Miscellaneous Reasons|6
2916010|NCT01603641|10041790|P1|Overall Study|Personal Reasons|18
2916011|NCT01603641|10041790|P1|Overall Study|Lost to Follow-up|6
2916012|NCT01603641|10041790|P1|Overall Study|Lack of Efficacy|1
2916013|NCT01603641|10041790|P1|Overall Study|Adverse Event|1
2916014|NCT01603641|10041790|P1|Overall Study|Did not Receive Treatment|3
2916015|NCT01603628|10041797|P3|Overall Study|Other Miscellaneous Reason|0
2916016|NCT01603628|10041798|P2|Overall Study|Other Miscellaneous Reason|0
2916017|NCT01603628|10041799|P1|Overall Study|Other Miscellaneous Reason|1
2916018|NCT01603628|10041797|P3|Overall Study|Lost to Follow-up|0
2916019|NCT01603628|10041798|P2|Overall Study|Lost to Follow-up|1
2916020|NCT01603628|10041799|P1|Overall Study|Lost to Follow-up|0
2916021|NCT01603628|10041797|P3|Overall Study|Protocol Violation|0
2916022|NCT01603628|10041798|P2|Overall Study|Protocol Violation|1
2916023|NCT01603628|10041799|P1|Overall Study|Protocol Violation|1
2916024|NCT01603628|10041797|P3|Overall Study|Personal Reasons|2
2916025|NCT01603628|10041798|P2|Overall Study|Personal Reasons|1
2916026|NCT01603628|10041799|P1|Overall Study|Personal Reasons|1
2916027|NCT01603615|10041816|P1|Overall Study|Other Miscellaneous|1
2916028|NCT01603615|10041816|P1|Overall Study|Personal Reasons|17
2916029|NCT01603615|10041816|P1|Overall Study|Lost to Follow-up|9
2916030|NCT01603615|10041816|P1|Overall Study|Did not Receive Treatment|7
2916031|NCT01603602|10041823|P3|Overall Study|Personal Reasons|1
2916032|NCT01603602|10041824|P2|Overall Study|Personal Reasons|0
2916033|NCT01603602|10041825|P1|Overall Study|Personal Reasons|1
2916034|NCT01603602|10041823|P3|Overall Study|Adverse Event|0
2916035|NCT01603602|10041824|P2|Overall Study|Adverse Event|0
2916036|NCT01603602|10041825|P1|Overall Study|Adverse Event|1
2916037|NCT01603459|10041845|P1|Overall Study|Administrative reason|1
2916038|NCT01603459|10041845|P1|Overall Study|Non-compliance|1
2916039|NCT01603459|10041845|P1|Overall Study|Predefined discontinuation criteria|3
2916040|NCT01603459|10041845|P1|Overall Study|Lost to Follow-up|3
2916041|NCT01603459|10041845|P1|Overall Study|Withdrawal by Subject|5
2916042|NCT01603459|10041845|P1|Overall Study|Adverse Event|5
2916043|NCT01603394|10041996|P1|Overall Study|Adverse Event|1
2916044|NCT01603355|10042050|P1|Overall Study|Lack of Efficacy|2
2916045|NCT01603277|10042056|P2|Overall Study|Non-Compliance|1
2916046|NCT01603277|10042057|P1|Overall Study|Non-Compliance|2
2916047|NCT01603277|10042056|P2|Overall Study|Withdrawal by Subject|4
2916048|NCT01603277|10042057|P1|Overall Study|Withdrawal by Subject|5
2916049|NCT01603277|10042056|P2|Overall Study|Protocol Violation|10
2916050|NCT01603277|10042057|P1|Overall Study|Protocol Violation|6
2916051|NCT01603277|10042056|P2|Overall Study|Physician Decision|1
2916052|NCT01603277|10042057|P1|Overall Study|Physician Decision|0
2916053|NCT01603277|10042056|P2|Overall Study|Adverse Event|2
2916054|NCT01603277|10042057|P1|Overall Study|Adverse Event|1
2916055|NCT01603121|10042063|P2|Second Intervention, 10 Hours|Adverse Event|0
2916056|NCT01603121|10042064|P1|Second Intervention, 10 Hours|Adverse Event|1
2916057|NCT01603082|10042076|P2|Overall Study|Failed inclusion criterion after dosed|0
2916058|NCT01603082|10042077|P1|Overall Study|Failed inclusion criterion after dosed|1
2916059|NCT01603082|10042076|P2|Overall Study|Withdrawal by Subject|0
2916060|NCT01603082|10042077|P1|Overall Study|Withdrawal by Subject|1
2916061|NCT01603082|10042076|P2|Overall Study|Adverse Event|1
2916062|NCT01603082|10042077|P1|Overall Study|Adverse Event|0
2916063|NCT01603043|10042118|P2|Overall Study|Study Futility|3
2916064|NCT01603043|10042119|P1|Overall Study|Study Futility|7
2916065|NCT01602965|10042131|P2|Overall Study|Lost to Follow-up|2
2916066|NCT01602965|10042132|P1|Overall Study|Lost to Follow-up|4
2916067|NCT01602744|10042140|P2|Overall Study|Lost to Follow-up|8
2916068|NCT01602744|10042141|P1|Overall Study|Lost to Follow-up|13
2916069|NCT01602744|10042140|P2|Overall Study|Death|15
2916070|NCT01602744|10042141|P1|Overall Study|Death|17
2916071|NCT01602562|10042251|P2|Overall Study|Withdrawal by Subject|1
2916072|NCT01602562|10042252|P1|Overall Study|Withdrawal by Subject|1
2916073|NCT01602562|10042251|P2|Overall Study|Physician Decision|1
2916074|NCT01602562|10042252|P1|Overall Study|Physician Decision|1
2916075|NCT01602562|10042251|P2|Overall Study|Adverse Event|1
2916076|NCT01602562|10042252|P1|Overall Study|Adverse Event|3
2916077|NCT01602549|10042288|P2|Overall Study|Withdrawal by Subject|0
2916078|NCT01602549|10042289|P1|Overall Study|Withdrawal by Subject|1
2916079|NCT01602549|10042288|P2|Overall Study|Protocol Violation|1
2916080|NCT01602549|10042289|P1|Overall Study|Protocol Violation|0
2916081|NCT01602510|10042368|P3|Randomized Phase|Withdrawal by Subject|7
2916082|NCT01602510|10042369|P2|Randomized Phase|Withdrawal by Subject|6
2916083|NCT01602510|10042370|P1|Randomized Phase|Withdrawal by Subject|0
2916084|NCT01602510|10042368|P3|Randomized Phase|Physician Decision|2
2916085|NCT01602510|10042369|P2|Randomized Phase|Physician Decision|0
2916086|NCT01602510|10042370|P1|Randomized Phase|Physician Decision|0
2916087|NCT01602510|10042368|P3|Randomized Phase|Lost to Follow-up|3
2916088|NCT01602510|10042369|P2|Randomized Phase|Lost to Follow-up|1
2916089|NCT01602510|10042370|P1|Randomized Phase|Lost to Follow-up|0
2916090|NCT01602510|10042368|P3|Randomized Phase|Met protocol-defined stopping criteria|48
2916091|NCT01602510|10042369|P2|Randomized Phase|Met protocol-defined stopping criteria|58
2916092|NCT01602510|10042370|P1|Randomized Phase|Met protocol-defined stopping criteria|0
2916093|NCT01602510|10042368|P3|Randomized Phase|Protocol Violation|3
2916094|NCT01602510|10042369|P2|Randomized Phase|Protocol Violation|3
2916095|NCT01602510|10042370|P1|Randomized Phase|Protocol Violation|0
2916096|NCT01602510|10042368|P3|Randomized Phase|Lack of Efficacy|4
2916097|NCT01602510|10042369|P2|Randomized Phase|Lack of Efficacy|4
2916098|NCT01602510|10042370|P1|Randomized Phase|Lack of Efficacy|0
2916099|NCT01602510|10042368|P3|Randomized Phase|Adverse Event|6
2916100|NCT01602510|10042369|P2|Randomized Phase|Adverse Event|2
2916101|NCT01602510|10042370|P1|Randomized Phase|Adverse Event|0
2916102|NCT01602510|10042368|P3|Open Label Phase|Withdrawal by Subject|0
2916103|NCT01602510|10042369|P2|Open Label Phase|Withdrawal by Subject|0
2916104|NCT01602510|10042370|P1|Open Label Phase|Withdrawal by Subject|57
2916105|NCT01602510|10042368|P3|Open Label Phase|Physician Decision|0
2916106|NCT01602510|10042369|P2|Open Label Phase|Physician Decision|0
2916107|NCT01602510|10042370|P1|Open Label Phase|Physician Decision|19
2916108|NCT01602510|10042368|P3|Open Label Phase|Lost to Follow-up|0
2916109|NCT01602510|10042369|P2|Open Label Phase|Lost to Follow-up|0
2916110|NCT01602510|10042370|P1|Open Label Phase|Lost to Follow-up|22
2916111|NCT01602510|10042368|P3|Open Label Phase|Met protocol-defined stopping criteria|0
2916112|NCT01602510|10042369|P2|Open Label Phase|Met protocol-defined stopping criteria|0
2916113|NCT01602510|10042370|P1|Open Label Phase|Met protocol-defined stopping criteria|122
2916114|NCT01602510|10042368|P3|Open Label Phase|Protocol Violation|0
2916115|NCT01602510|10042369|P2|Open Label Phase|Protocol Violation|0
2916116|NCT01602510|10042370|P1|Open Label Phase|Protocol Violation|15
2916117|NCT01602510|10042368|P3|Open Label Phase|Lack of Efficacy|0
2916118|NCT01602510|10042369|P2|Open Label Phase|Lack of Efficacy|0
2916119|NCT01602510|10042370|P1|Open Label Phase|Lack of Efficacy|22
2916120|NCT01602510|10042368|P3|Open Label Phase|Adverse Event|0
2916121|NCT01602510|10042369|P2|Open Label Phase|Adverse Event|0
2916122|NCT01602510|10042370|P1|Open Label Phase|Adverse Event|46
2916123|NCT01602484|10042396|P2|Overall Study|Airway issues unrelated to study|1
2916124|NCT01602484|10042397|P1|Overall Study|Airway issues unrelated to study|0
2916125|NCT01602419|10042413|P1|Overall Study|Lost to Follow-up|6
2916126|NCT01602419|10042413|P1|Overall Study|Withdrawal by Subject|5
2916127|NCT01602419|10042413|P1|Overall Study|Treatment centre closed|1
2916128|NCT01602419|10042413|P1|Overall Study|Changed treatment centre|1
2916129|NCT01602419|10042413|P1|Overall Study|Insurance issues|3
2916130|NCT01602419|10042413|P1|Overall Study|Adverse Drug Reaction|4
2916131|NCT01602419|10042413|P1|Overall Study|Not treated with Wilate|9
2916132|NCT01602380|10042468|P2|Overall Study|Eligibility criteria not fulfilled|3
2916133|NCT01602380|10042469|P1|Overall Study|Eligibility criteria not fulfilled|2
2916134|NCT01602380|10042468|P2|Overall Study|Lost to Follow-up|1
2916135|NCT01602380|10042469|P1|Overall Study|Lost to Follow-up|6
2916136|NCT01602380|10042468|P2|Overall Study|Withdrawal by Subject|29
2916137|NCT01602380|10042469|P1|Overall Study|Withdrawal by Subject|22
2916138|NCT01602380|10042468|P2|Overall Study|Death|68
2916139|NCT01602380|10042469|P1|Overall Study|Death|63
2916140|NCT01602341|10042493|P2|Overall Study|Adverse Event|1
2916141|NCT01602341|10042494|P1|Overall Study|Adverse Event|0
2916142|NCT01602315|10042535|P7|Overall Study|Cross-over patients to combo treatment|0
2916143|NCT01602315|10042536|P6|Overall Study|Cross-over patients to combo treatment|16
2916144|NCT01602315|10042537|P5|Overall Study|Cross-over patients to combo treatment|0
2916145|NCT01602315|10042538|P4|Overall Study|Cross-over patients to combo treatment|0
2916146|NCT01602315|10042539|P3|Overall Study|Cross-over patients to combo treatment|0
2916147|NCT01602315|10042540|P2|Overall Study|Cross-over patients to combo treatment|0
2916148|NCT01602315|10042541|P1|Overall Study|Cross-over patients to combo treatment|0
2916149|NCT01602315|10042535|P7|Overall Study|Subject/guardian decision|1
2916150|NCT01602315|10042536|P6|Overall Study|Subject/guardian decision|0
2916151|NCT01602315|10042537|P5|Overall Study|Subject/guardian decision|0
2916152|NCT01602315|10042538|P4|Overall Study|Subject/guardian decision|0
2916153|NCT01602315|10042539|P3|Overall Study|Subject/guardian decision|0
2916154|NCT01602315|10042540|P2|Overall Study|Subject/guardian decision|0
2916155|NCT01602315|10042541|P1|Overall Study|Subject/guardian decision|0
2916156|NCT01602315|10042535|P7|Overall Study|Adverse Event|9
2916157|NCT01602315|10042536|P6|Overall Study|Adverse Event|3
2916158|NCT01602315|10042537|P5|Overall Study|Adverse Event|15
2916159|NCT01602315|10042538|P4|Overall Study|Adverse Event|4
2916160|NCT01602315|10042539|P3|Overall Study|Adverse Event|5
2916161|NCT01602315|10042540|P2|Overall Study|Adverse Event|1
2916162|NCT01602315|10042541|P1|Overall Study|Adverse Event|5
2916163|NCT01602315|10042535|P7|Overall Study|Withdrawal by Subject|1
2916164|NCT01602315|10042536|P6|Overall Study|Withdrawal by Subject|0
2916165|NCT01602315|10042537|P5|Overall Study|Withdrawal by Subject|6
2916166|NCT01602315|10042538|P4|Overall Study|Withdrawal by Subject|0
2916167|NCT01602315|10042539|P3|Overall Study|Withdrawal by Subject|2
2916168|NCT01602315|10042540|P2|Overall Study|Withdrawal by Subject|0
2916169|NCT01602315|10042541|P1|Overall Study|Withdrawal by Subject|2
2916170|NCT01602315|10042535|P7|Overall Study|Death|2
2916171|NCT01602315|10042536|P6|Overall Study|Death|2
2916172|NCT01602315|10042537|P5|Overall Study|Death|7
2916173|NCT01602315|10042538|P4|Overall Study|Death|1
2916174|NCT01602315|10042539|P3|Overall Study|Death|1
2916175|NCT01602315|10042540|P2|Overall Study|Death|1
2916176|NCT01602315|10042541|P1|Overall Study|Death|1
2916177|NCT01602315|10042535|P7|Overall Study|Disease progression|15
2916178|NCT01602315|10042536|P6|Overall Study|Disease progression|12
2916179|NCT01602315|10042537|P5|Overall Study|Disease progression|41
2916180|NCT01602315|10042538|P4|Overall Study|Disease progression|1
2916181|NCT01602315|10042539|P3|Overall Study|Disease progression|10
2916182|NCT01602315|10042540|P2|Overall Study|Disease progression|3
2916183|NCT01602315|10042541|P1|Overall Study|Disease progression|6
2916184|NCT01602315|10042535|P7|Overall Study|Physician Decision|1
2916185|NCT01602315|10042536|P6|Overall Study|Physician Decision|1
2916186|NCT01602315|10042537|P5|Overall Study|Physician Decision|2
2916187|NCT01602315|10042538|P4|Overall Study|Physician Decision|0
2916188|NCT01602315|10042539|P3|Overall Study|Physician Decision|0
2916189|NCT01602315|10042540|P2|Overall Study|Physician Decision|0
2916190|NCT01602315|10042541|P1|Overall Study|Physician Decision|2
2916191|NCT01602315|10042535|P7|Overall Study|Protocol Violation|0
2916192|NCT01602315|10042536|P6|Overall Study|Protocol Violation|1
2916193|NCT01602315|10042537|P5|Overall Study|Protocol Violation|0
2916194|NCT01602315|10042538|P4|Overall Study|Protocol Violation|0
2916195|NCT01602315|10042539|P3|Overall Study|Protocol Violation|0
2916196|NCT01602315|10042540|P2|Overall Study|Protocol Violation|0
2916197|NCT01602315|10042541|P1|Overall Study|Protocol Violation|0
2916198|NCT01602224|10042630|P3|Overall Study|Withdrawal by Subject|3
2916199|NCT01602224|10042631|P2|Overall Study|Withdrawal by Subject|3
2916200|NCT01602224|10042632|P1|Overall Study|Withdrawal by Subject|5
2916201|NCT01602224|10042630|P3|Overall Study|Sponsor Decision|2
2916202|NCT01602224|10042631|P2|Overall Study|Sponsor Decision|3
2916203|NCT01602224|10042632|P1|Overall Study|Sponsor Decision|2
2916204|NCT01602224|10042630|P3|Overall Study|Protocol Violation|0
2916205|NCT01602224|10042631|P2|Overall Study|Protocol Violation|1
2916206|NCT01602224|10042632|P1|Overall Study|Protocol Violation|0
2916207|NCT01602224|10042630|P3|Overall Study|Lost to Follow-up|1
2916208|NCT01602224|10042631|P2|Overall Study|Lost to Follow-up|0
2916209|NCT01602224|10042632|P1|Overall Study|Lost to Follow-up|0
2916210|NCT01602224|10042630|P3|Overall Study|Investigator Decison|0
2916211|NCT01602224|10042631|P2|Overall Study|Investigator Decison|0
2916212|NCT01602224|10042632|P1|Overall Study|Investigator Decison|1
2916213|NCT01602224|10042630|P3|Overall Study|Adverse Event|0
2916214|NCT01602224|10042631|P2|Overall Study|Adverse Event|1
2916215|NCT01602224|10042632|P1|Overall Study|Adverse Event|0
2916216|NCT01602120|10042717|P4|Overall Study|Unspecified Reason|2
2916217|NCT01602120|10042718|P3|Overall Study|Unspecified Reason|0
2916218|NCT01602120|10042719|P2|Overall Study|Unspecified Reason|1
2916219|NCT01602120|10042720|P1|Overall Study|Unspecified Reason|3
2916220|NCT01602120|10042717|P4|Overall Study|Physician Decision|0
2916221|NCT01602120|10042718|P3|Overall Study|Physician Decision|0
2916222|NCT01602120|10042719|P2|Overall Study|Physician Decision|3
2916223|NCT01602120|10042720|P1|Overall Study|Physician Decision|2
2916224|NCT01602120|10042717|P4|Overall Study|Study Terminated by Sponsor|44
2916225|NCT01602120|10042718|P3|Overall Study|Study Terminated by Sponsor|17
2916226|NCT01602120|10042719|P2|Overall Study|Study Terminated by Sponsor|24
2916227|NCT01602120|10042720|P1|Overall Study|Study Terminated by Sponsor|12
2916228|NCT01602120|10042717|P4|Overall Study|Withdrawal by Subject|3
2916229|NCT01602120|10042718|P3|Overall Study|Withdrawal by Subject|0
2916230|NCT01602120|10042719|P2|Overall Study|Withdrawal by Subject|17
2916231|NCT01602120|10042720|P1|Overall Study|Withdrawal by Subject|8
2916232|NCT01602120|10042717|P4|Overall Study|Non-compliance|1
2916233|NCT01602120|10042718|P3|Overall Study|Non-compliance|0
2916234|NCT01602120|10042719|P2|Overall Study|Non-compliance|3
2916235|NCT01602120|10042720|P1|Overall Study|Non-compliance|0
2916236|NCT01602120|10042717|P4|Overall Study|Protocol Violation|0
2916237|NCT01602120|10042718|P3|Overall Study|Protocol Violation|0
2916238|NCT01602120|10042719|P2|Overall Study|Protocol Violation|1
2916239|NCT01602120|10042720|P1|Overall Study|Protocol Violation|1
2916240|NCT01602120|10042717|P4|Overall Study|Lost to Follow-up|1
2916241|NCT01602120|10042718|P3|Overall Study|Lost to Follow-up|0
2916242|NCT01602120|10042719|P2|Overall Study|Lost to Follow-up|1
2916243|NCT01602120|10042720|P1|Overall Study|Lost to Follow-up|0
2916244|NCT01602120|10042717|P4|Overall Study|Death|0
2916245|NCT01602120|10042718|P3|Overall Study|Death|0
2916246|NCT01602120|10042719|P2|Overall Study|Death|4
2916247|NCT01602120|10042720|P1|Overall Study|Death|0
2916248|NCT01602120|10042717|P4|Overall Study|Adverse Event|2
2916249|NCT01602120|10042718|P3|Overall Study|Adverse Event|0
2916250|NCT01602120|10042719|P2|Overall Study|Adverse Event|6
2916251|NCT01602120|10042720|P1|Overall Study|Adverse Event|3
2916252|NCT01601873|10042768|P2|Overall Study|Lost to Follow-up|3
2916253|NCT01601873|10042769|P1|Overall Study|Lost to Follow-up|2
2916254|NCT01601847|10042795|P2|Overall Study|Lost to Follow-up|3
2916255|NCT01601847|10042796|P1|Overall Study|Lost to Follow-up|1
2916256|NCT01601847|10042795|P2|Overall Study|Withdrawal by Subject|7
2916257|NCT01601847|10042796|P1|Overall Study|Withdrawal by Subject|11
2916258|NCT01601847|10042795|P2|Overall Study|Death|0
2916259|NCT01601847|10042796|P1|Overall Study|Death|1
2916260|NCT01601821|10042808|P2|Overall Study|Other|1
2916261|NCT01601821|10042809|P1|Overall Study|Other|5
2916262|NCT01601821|10042808|P2|Overall Study|Study Events|1
2916263|NCT01601821|10042809|P1|Overall Study|Study Events|7
2916264|NCT01601821|10042808|P2|Overall Study|Graft Loss|6
2916265|NCT01601821|10042809|P1|Overall Study|Graft Loss|6
2916266|NCT01601821|10042808|P2|Overall Study|Withdrawal by Subject|0
2916267|NCT01601821|10042809|P1|Overall Study|Withdrawal by Subject|1
2916268|NCT01601821|10042808|P2|Overall Study|Lost to Follow-up|14
2916269|NCT01601821|10042809|P1|Overall Study|Lost to Follow-up|6
2916270|NCT01601821|10042808|P2|Overall Study|Protocol Violation|2
2916271|NCT01601821|10042809|P1|Overall Study|Protocol Violation|2
2916272|NCT01601821|10042808|P2|Overall Study|Death|5
2916273|NCT01601821|10042809|P1|Overall Study|Death|2
2916274|NCT01601704|10042845|P2|Overall Study|Randomized but not dispensed study med|4
2916275|NCT01601704|10042846|P1|Overall Study|Randomized but not dispensed study med|1
2916276|NCT01601626|10042867|P3|Overall Study|Not Willing to Adhere to Requirements|0
2916277|NCT01601626|10042868|P2|Overall Study|Not Willing to Adhere to Requirements|0
2916278|NCT01601626|10042869|P1|Overall Study|Not Willing to Adhere to Requirements|1
2916279|NCT01601626|10042867|P3|Overall Study|Withdrawal by Subject|1
2916280|NCT01601626|10042868|P2|Overall Study|Withdrawal by Subject|1
2916281|NCT01601626|10042869|P1|Overall Study|Withdrawal by Subject|0
2916282|NCT01601626|10042867|P3|Overall Study|Unable to Get to Clinic|0
2916283|NCT01601626|10042868|P2|Overall Study|Unable to Get to Clinic|1
2916284|NCT01601626|10042869|P1|Overall Study|Unable to Get to Clinic|0
2916285|NCT01601626|10042867|P3|Overall Study|Lost to Follow-up|0
2916286|NCT01601626|10042868|P2|Overall Study|Lost to Follow-up|2
2916287|NCT01601626|10042869|P1|Overall Study|Lost to Follow-up|1
2916288|NCT01601626|10042867|P3|Overall Study|Death|1
2916289|NCT01601626|10042868|P2|Overall Study|Death|1
2916290|NCT01601626|10042869|P1|Overall Study|Death|1
2916291|NCT01601535|10042958|P6|Phase 2|Started Another Treatment|2
2916292|NCT01601535|10042959|P5|Phase 2|Started Another Treatment|1
2916293|NCT01601535|10042960|P4|Phase 2|Started Another Treatment|0
2916294|NCT01601535|10042961|P3|Phase 2|Started Another Treatment|0
2916295|NCT01601535|10042962|P2|Phase 2|Started Another Treatment|0
2916296|NCT01601535|10042963|P1|Phase 2|Started Another Treatment|0
2916297|NCT01601535|10042958|P6|Phase 2|Progressive Disease|7
2916298|NCT01601535|10042959|P5|Phase 2|Progressive Disease|5
2916299|NCT01601535|10042960|P4|Phase 2|Progressive Disease|0
2916300|NCT01601535|10042961|P3|Phase 2|Progressive Disease|0
2916301|NCT01601535|10042962|P2|Phase 2|Progressive Disease|0
2916302|NCT01601535|10042963|P1|Phase 2|Progressive Disease|0
2916303|NCT01601535|10042958|P6|Phase 2|Withdrawal by Subject|2
2916304|NCT01601535|10042959|P5|Phase 2|Withdrawal by Subject|8
2916305|NCT01601535|10042960|P4|Phase 2|Withdrawal by Subject|0
2916306|NCT01601535|10042961|P3|Phase 2|Withdrawal by Subject|0
2916307|NCT01601535|10042962|P2|Phase 2|Withdrawal by Subject|0
2916308|NCT01601535|10042963|P1|Phase 2|Withdrawal by Subject|0
2916309|NCT01601535|10042958|P6|Phase 2|Adverse Event|1
2916310|NCT01601535|10042959|P5|Phase 2|Adverse Event|5
2916311|NCT01601535|10042960|P4|Phase 2|Adverse Event|0
2916312|NCT01601535|10042961|P3|Phase 2|Adverse Event|0
2916313|NCT01601535|10042962|P2|Phase 2|Adverse Event|0
2916314|NCT01601535|10042963|P1|Phase 2|Adverse Event|0
2916315|NCT01601535|10042958|P6|Phase 1|Started Another Treatment|0
2916316|NCT01601535|10042959|P5|Phase 1|Started Another Treatment|0
2916317|NCT01601535|10042960|P4|Phase 1|Started Another Treatment|0
2916318|NCT01601535|10042961|P3|Phase 1|Started Another Treatment|0
2916319|NCT01601535|10042962|P2|Phase 1|Started Another Treatment|2
2916320|NCT01601535|10042963|P1|Phase 1|Started Another Treatment|1
2916321|NCT01601535|10042958|P6|Phase 1|Progressive Disease|0
2916322|NCT01601535|10042959|P5|Phase 1|Progressive Disease|0
2916323|NCT01601535|10042960|P4|Phase 1|Progressive Disease|1
2916324|NCT01601535|10042961|P3|Phase 1|Progressive Disease|2
2916325|NCT01601535|10042962|P2|Phase 1|Progressive Disease|3
2916326|NCT01601535|10042963|P1|Phase 1|Progressive Disease|2
2916327|NCT01601535|10042958|P6|Phase 1|Withdrawal by Subject|0
2916328|NCT01601535|10042959|P5|Phase 1|Withdrawal by Subject|0
2916329|NCT01601535|10042960|P4|Phase 1|Withdrawal by Subject|2
2916330|NCT01601535|10042961|P3|Phase 1|Withdrawal by Subject|1
2916331|NCT01601535|10042962|P2|Phase 1|Withdrawal by Subject|1
2916332|NCT01601535|10042963|P1|Phase 1|Withdrawal by Subject|2
2916333|NCT01601535|10042958|P6|Phase 1|Adverse Event|0
2916334|NCT01601535|10042959|P5|Phase 1|Adverse Event|0
2916335|NCT01601535|10042960|P4|Phase 1|Adverse Event|1
2916336|NCT01601535|10042961|P3|Phase 1|Adverse Event|2
2916337|NCT01601535|10042962|P2|Phase 1|Adverse Event|0
2916338|NCT01601535|10042963|P1|Phase 1|Adverse Event|1
2916339|NCT01601470|10043019|P1|Period 2 - LCZ696|Physician Decision|1
2916340|NCT01601132|10043090|P1|Overall Study|Protocol deviation|1
2916341|NCT01601132|10043090|P1|Overall Study|Patient withdrew consent|1
2916342|NCT01600885|10043135|P2|First Period|moved out of area|0
2916343|NCT01600885|10043136|P1|First Period|moved out of area|1
2916344|NCT01600885|10043135|P2|First Period|Adverse Event|1
2916345|NCT01600885|10043136|P1|First Period|Adverse Event|1
2916346|NCT01600716|10043153|P2|Overall Study|Adverse Event|1
2916347|NCT01600716|10043154|P1|Overall Study|Adverse Event|1
2916348|NCT01600716|10043153|P2|Overall Study|Lack of Efficacy|1
2916349|NCT01600716|10043154|P1|Overall Study|Lack of Efficacy|2
2916350|NCT01600716|10043153|P2|Overall Study|Pregnancy|0
2916351|NCT01600716|10043154|P1|Overall Study|Pregnancy|1
2916352|NCT01600716|10043153|P2|Overall Study|Lost to Follow-up|2
2916353|NCT01600716|10043154|P1|Overall Study|Lost to Follow-up|0
2916354|NCT01600716|10043153|P2|Overall Study|Personal Reasons|2
2916355|NCT01600716|10043154|P1|Overall Study|Personal Reasons|0
2916356|NCT01600716|10043153|P2|Overall Study|Other Reasons|1
2916357|NCT01600716|10043154|P1|Overall Study|Other Reasons|3
2916358|NCT01600586|10043194|P2|Overall Study|Physician Decision|3
2916359|NCT01600586|10043195|P1|Overall Study|Physician Decision|3
2916360|NCT01600326|10043247|P2|Overall Study|Lost to Follow-up|1
2916361|NCT01600326|10043248|P1|Overall Study|Lost to Follow-up|1
2916362|NCT01600105|10043324|P2|Sub Study V|Poor Image Quality|0
2916363|NCT01600105|10043325|P1|Sub Study V|Poor Image Quality|2
2916364|NCT01600105|10043324|P2|Sub Study III|Insufficient image quality|0
2916365|NCT01600105|10043325|P1|Sub Study III|Insufficient image quality|5
2916366|NCT01600105|10043324|P2|Sub Study II|Insufficient image quality|0
2916367|NCT01600105|10043325|P1|Sub Study II|Insufficient image quality|3
2916368|NCT01600105|10043324|P2|Sub Study II|No images in PACS|0
2916369|NCT01600105|10043325|P1|Sub Study II|No images in PACS|1
2916370|NCT01600105|10043324|P2|Sub Study II|Withdrawal by Subject|0
2916371|NCT01600105|10043325|P1|Sub Study II|Withdrawal by Subject|1
2916372|NCT01600105|10043324|P2|Sub Study I|Insufficient image quality|10
2916373|NCT01600105|10043325|P1|Sub Study I|Insufficient image quality|0
2916374|NCT01600105|10043324|P2|Total Participants|Insufficient image quality|10
2916375|NCT01600105|10043325|P1|Total Participants|Insufficient image quality|30
2916376|NCT01600105|10043324|P2|Total Participants|No images in PACS|0
2916377|NCT01600105|10043325|P1|Total Participants|No images in PACS|10
2916378|NCT01600105|10043324|P2|Total Participants|Withdrawal by Subject|0
2916379|NCT01600105|10043325|P1|Total Participants|Withdrawal by Subject|1
2916380|NCT01600092|10043353|P2|Overall Study|Randomized but not vaccinated|3
2916381|NCT01600092|10043354|P1|Overall Study|Randomized but not vaccinated|3
2916382|NCT01600092|10043353|P2|Overall Study|Physician Decision|1
2916383|NCT01600092|10043354|P1|Overall Study|Physician Decision|1
2916384|NCT01600092|10043353|P2|Overall Study|Withdrawal by parent/guardian|6
2916385|NCT01600092|10043354|P1|Overall Study|Withdrawal by parent/guardian|8
2916386|NCT01600092|10043353|P2|Overall Study|Lost to Follow-up|6
2916387|NCT01600092|10043354|P1|Overall Study|Lost to Follow-up|4
2916388|NCT01600092|10043353|P2|Overall Study|Adverse Event|0
2916389|NCT01600092|10043354|P1|Overall Study|Adverse Event|2
2916390|NCT01600053|10043368|P1|Overall Study|trial will not meet the interim endpoint|9
2916391|NCT01600053|10043368|P1|Overall Study|Adverse Event|2
2916392|NCT01600014|10043373|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
2916393|NCT01600014|10043374|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
2916394|NCT01600014|10043373|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
2916395|NCT01600014|10043374|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
2916396|NCT01600014|10043373|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
2916397|NCT01600014|10043374|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
2916398|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
2916399|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
2916400|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2916401|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2916402|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
2916403|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
2916404|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
2916405|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
2916406|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
2916407|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
2916408|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
2916409|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
2916410|NCT01600014|10043373|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
2916411|NCT01600014|10043374|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
2916412|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
2916413|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
2916414|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
2916415|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
2916416|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
2916417|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
2916418|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Other|0
2916419|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Other|27
2916420|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
2916421|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
2916422|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
2916423|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
2916424|NCT01600014|10043373|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
2916425|NCT01600014|10043374|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
2916426|NCT01599806|10043402|P2|Overall Study|Other Eligibility criteria|9
2916427|NCT01599806|10043403|P1|Overall Study|Other Eligibility criteria|11
2916428|NCT01599806|10043402|P2|Overall Study|Withdrawal by Subject|12
2916429|NCT01599806|10043403|P1|Overall Study|Withdrawal by Subject|12
2916430|NCT01599806|10043402|P2|Overall Study|Lost to Follow-up|20
2916431|NCT01599806|10043403|P1|Overall Study|Lost to Follow-up|20
2916432|NCT01599793|10043527|P1|Overall Study|Adverse Event|2
2916433|NCT01599754|10043539|P2|Overall Study|Study terminated by sponsor|285
2916434|NCT01599754|10043540|P1|Overall Study|Study terminated by sponsor|282
2916435|NCT01599754|10043539|P2|Overall Study|Withdrawal by Subject|25
2916436|NCT01599754|10043540|P1|Overall Study|Withdrawal by Subject|24
2916437|NCT01599754|10043539|P2|Overall Study|Investigator decision|3
2916438|NCT01599754|10043540|P1|Overall Study|Investigator decision|1
2916439|NCT01599754|10043539|P2|Overall Study|Adverse Event|2
2916440|NCT01599754|10043540|P1|Overall Study|Adverse Event|3
2916441|NCT01599754|10043539|P2|Overall Study|Death|33
2916442|NCT01599754|10043540|P1|Overall Study|Death|31
2916443|NCT01599754|10043539|P2|Overall Study|Lost to Follow-up|6
2916444|NCT01599754|10043540|P1|Overall Study|Lost to Follow-up|13
2916445|NCT01599754|10043539|P2|Overall Study|Participant noncompliance|4
2916446|NCT01599754|10043540|P1|Overall Study|Participant noncompliance|4
2916447|NCT01599754|10043539|P2|Overall Study|Anticancer therapy need not in protocol|2
2916448|NCT01599754|10043540|P1|Overall Study|Anticancer therapy need not in protocol|5
2916449|NCT01599650|10043571|P3|Overall Study|Adverse Event|4
2916450|NCT01599650|10043572|P2|Overall Study|Adverse Event|8
2916451|NCT01599650|10043573|P1|Overall Study|Adverse Event|3
2916452|NCT01599650|10043571|P3|Overall Study|Withdrawal by Subject|10
2916453|NCT01599650|10043572|P2|Overall Study|Withdrawal by Subject|11
2916454|NCT01599650|10043573|P1|Overall Study|Withdrawal by Subject|11
2916455|NCT01599650|10043571|P3|Overall Study|Lost to Follow-up|3
2916456|NCT01599650|10043572|P2|Overall Study|Lost to Follow-up|3
2916457|NCT01599650|10043573|P1|Overall Study|Lost to Follow-up|3
2916458|NCT01599650|10043571|P3|Overall Study|Death|2
2916459|NCT01599650|10043572|P2|Overall Study|Death|1
2916460|NCT01599650|10043573|P1|Overall Study|Death|2
2916461|NCT01599650|10043571|P3|Overall Study|Protocol Violation|0
2916462|NCT01599650|10043572|P2|Overall Study|Protocol Violation|3
2916463|NCT01599650|10043573|P1|Overall Study|Protocol Violation|0
2916464|NCT01599650|10043571|P3|Overall Study|Physician Decision|7
2916465|NCT01599650|10043572|P2|Overall Study|Physician Decision|0
2916466|NCT01599650|10043573|P1|Overall Study|Physician Decision|2
2916467|NCT01599650|10043571|P3|Overall Study|Administrative issue|1
2916468|NCT01599650|10043572|P2|Overall Study|Administrative issue|0
2916469|NCT01599650|10043573|P1|Overall Study|Administrative issue|1
2916470|NCT01599637|10043612|P3|Overall Study|Adverse Event|0
2916471|NCT01599637|10043613|P2|Overall Study|Adverse Event|0
2916472|NCT01599637|10043614|P1|Overall Study|Adverse Event|1
2916473|NCT01599637|10043612|P3|Overall Study|administrative problems|0
2916474|NCT01599637|10043613|P2|Overall Study|administrative problems|2
2916475|NCT01599637|10043614|P1|Overall Study|administrative problems|0
2916476|NCT01599585|10043661|P2|Overall Study|randomized did not start treatment|3
2916477|NCT01599585|10043662|P1|Overall Study|randomized did not start treatment|3
2916478|NCT01599585|10043661|P2|Overall Study|Lost to Follow-up|5
2916479|NCT01599585|10043662|P1|Overall Study|Lost to Follow-up|3
2916480|NCT01599585|10043661|P2|Overall Study|Withdrawal by Subject|9
2916481|NCT01599585|10043662|P1|Overall Study|Withdrawal by Subject|16
2916482|NCT01599325|10043700|P1|Extension Phase|Withdrawal by Subject|8
2916483|NCT01599325|10043700|P1|Extension Phase|Disease Progression|1
2916484|NCT01599325|10043700|P1|Extension Phase|Lack of Therapeutic Effect|4
2916485|NCT01599325|10043700|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
2916486|NCT01599325|10043700|P1|Extension Phase|Study Closure|1
2916487|NCT01599325|10043700|P1|Primary Parent Phase|Other|2
2916488|NCT01599325|10043700|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
2916489|NCT01599325|10043700|P1|Primary Parent Phase|Protocol Violation|1
2916490|NCT01599325|10043700|P1|Primary Parent Phase|Death|13
2916491|NCT01599325|10043700|P1|Primary Parent Phase|Withdrawal by Subject|20
2916492|NCT01599325|10043700|P1|Primary Parent Phase|Disease Progression|7
2916493|NCT01599325|10043700|P1|Primary Parent Phase|Adverse Event|5
2916494|NCT01599234|10043724|P2|Overall Study|Pregnancy|1
2916495|NCT01599234|10043725|P1|Overall Study|Pregnancy|0
2916496|NCT01599234|10043724|P2|Overall Study|Contra-indication discovered|1
2916497|NCT01599234|10043725|P1|Overall Study|Contra-indication discovered|0
2916498|NCT01599234|10043724|P2|Overall Study|Patient would not stop driving|0
2916499|NCT01599234|10043725|P1|Overall Study|Patient would not stop driving|1
2916500|NCT01599234|10043724|P2|Overall Study|Death|0
2916501|NCT01599234|10043725|P1|Overall Study|Death|1
2916502|NCT01599234|10043724|P2|Overall Study|Sponsor request as creatinine levels <50|1
2916503|NCT01599234|10043725|P1|Overall Study|Sponsor request as creatinine levels <50|0
2916504|NCT01599234|10043724|P2|Overall Study|Unable to operate spray|0
2916505|NCT01599234|10043725|P1|Overall Study|Unable to operate spray|1
2916506|NCT01599234|10043724|P2|Overall Study|Lack of Efficacy|4
2916507|NCT01599234|10043725|P1|Overall Study|Lack of Efficacy|2
2916508|NCT01599234|10043724|P2|Overall Study|Lost to Follow-up|2
2916509|NCT01599234|10043725|P1|Overall Study|Lost to Follow-up|1
2916510|NCT01599234|10043724|P2|Overall Study|Withdrawal by Subject|1
2916511|NCT01599234|10043725|P1|Overall Study|Withdrawal by Subject|2
2916512|NCT01599234|10043724|P2|Overall Study|Adverse Event|5
2916513|NCT01599234|10043725|P1|Overall Study|Adverse Event|9
2916514|NCT01599104|10043750|P3|Overall Study|Adverse Event|12
2916515|NCT01599104|10043751|P2|Overall Study|Adverse Event|6
2916516|NCT01599104|10043752|P1|Overall Study|Adverse Event|7
2916517|NCT01599104|10043750|P3|Overall Study|Lack of Efficacy|10
2916518|NCT01599104|10043751|P2|Overall Study|Lack of Efficacy|4
2916519|NCT01599104|10043752|P1|Overall Study|Lack of Efficacy|4
2916520|NCT01599104|10043750|P3|Overall Study|Non-compliance with study treatment|0
2916521|NCT01599104|10043751|P2|Overall Study|Non-compliance with study treatment|1
2916522|NCT01599104|10043752|P1|Overall Study|Non-compliance with study treatment|0
2916523|NCT01599104|10043750|P3|Overall Study|Physician Decision|2
2916524|NCT01599104|10043751|P2|Overall Study|Physician Decision|2
2916525|NCT01599104|10043752|P1|Overall Study|Physician Decision|3
2916526|NCT01599104|10043750|P3|Overall Study|Technical Problems|0
2916527|NCT01599104|10043751|P2|Overall Study|Technical Problems|0
2916528|NCT01599104|10043752|P1|Overall Study|Technical Problems|1
2916529|NCT01599104|10043750|P3|Overall Study|Withdrawal by Subject|2
2916530|NCT01599104|10043751|P2|Overall Study|Withdrawal by Subject|1
2916531|NCT01599104|10043752|P1|Overall Study|Withdrawal by Subject|1
2916532|NCT01598987|10043790|P1|Baseline to 24 Month|Lost to Follow-up|1
2916533|NCT01598987|10043790|P1|Baseline to 24 Month|Administrative problems|2
2916534|NCT01598987|10043790|P1|Baseline to 24 Month|Withdrawal by Subject|5
2916535|NCT01598987|10043790|P1|Baseline to Month 12|Withdrawal by Subject|4
2916536|NCT01598987|10043790|P1|Baseline to Month 12|Administrative problems|2
2916537|NCT01598896|10043826|P2|Overall Study|Lack of Efficacy|1
2916538|NCT01598896|10043827|P1|Overall Study|Lack of Efficacy|0
2916539|NCT01598896|10043826|P2|Overall Study|Withdrawal by Subject|1
2916540|NCT01598896|10043827|P1|Overall Study|Withdrawal by Subject|0
2916541|NCT01598753|10043866|P4|Overall Study|Withdrawal by Subject|1
2916542|NCT01598753|10043867|P3|Overall Study|Withdrawal by Subject|0
2916543|NCT01598753|10043868|P2|Overall Study|Withdrawal by Subject|2
2916544|NCT01598753|10043869|P1|Overall Study|Withdrawal by Subject|7
2916545|NCT01598753|10043866|P4|Overall Study|Physician Decision|2
2916546|NCT01598753|10043867|P3|Overall Study|Physician Decision|0
2916547|NCT01598753|10043868|P2|Overall Study|Physician Decision|1
2916548|NCT01598753|10043869|P1|Overall Study|Physician Decision|0
2916549|NCT01598753|10043866|P4|Overall Study|Lost to Follow-up|5
2916550|NCT01598753|10043867|P3|Overall Study|Lost to Follow-up|7
2916551|NCT01598753|10043868|P2|Overall Study|Lost to Follow-up|3
2916552|NCT01598753|10043869|P1|Overall Study|Lost to Follow-up|4
2916553|NCT01598753|10043866|P4|Overall Study|Adverse Event|7
2916554|NCT01598753|10043867|P3|Overall Study|Adverse Event|1
2916555|NCT01598753|10043868|P2|Overall Study|Adverse Event|9
2916556|NCT01598753|10043869|P1|Overall Study|Adverse Event|1
2916557|NCT01598662|10043909|P2|Overall Study|IUD expelled before month 6|2
2916558|NCT01598662|10043910|P1|Overall Study|IUD expelled before month 6|0
2916559|NCT01598662|10043909|P2|Overall Study|Physician Decision|2
2916560|NCT01598662|10043910|P1|Overall Study|Physician Decision|1
2916561|NCT01598662|10043909|P2|Overall Study|Lost to Follow-up|17
2916562|NCT01598662|10043910|P1|Overall Study|Lost to Follow-up|10
2916563|NCT01598610|10043916|P1|Overall Study|Adverse Event|1
2916564|NCT01598532|10043933|P1|Overall Study|Did not meet inclusion criteria|8
2916565|NCT01598532|10043933|P1|Overall Study|Lost to Follow-up|3
2916566|NCT01598506|10043942|P1|Overall Study|Withdrawal by Subject|2
2916567|NCT01598311|10043962|P2|Overall Study|Assigned to CB but received vancomycin|0
2916568|NCT01598311|10043963|P1|Overall Study|Assigned to CB but received vancomycin|1
2916569|NCT01598311|10043962|P2|Overall Study|Treated but no confirmed CDAD|8
2916570|NCT01598311|10043963|P1|Overall Study|Treated but no confirmed CDAD|9
2916571|NCT01598311|10043962|P2|Overall Study|Randomized but never treated|5
2916572|NCT01598311|10043963|P1|Overall Study|Randomized but never treated|8
2916573|NCT01598311|10043962|P2|Overall Study|No reason provided.|5
2916574|NCT01598311|10043963|P1|Overall Study|No reason provided.|0
2916575|NCT01598311|10043962|P2|Overall Study|Withdrawal by Subject|13
2916576|NCT01598311|10043963|P1|Overall Study|Withdrawal by Subject|9
2916577|NCT01598311|10043962|P2|Overall Study|Lost to Follow-up|12
2916578|NCT01598311|10043963|P1|Overall Study|Lost to Follow-up|7
2916579|NCT01598311|10043962|P2|Overall Study|Adverse Event|13
2916580|NCT01598311|10043963|P1|Overall Study|Adverse Event|9
2916581|NCT01598311|10043962|P2|Overall Study|Physician Decision|5
2916582|NCT01598311|10043963|P1|Overall Study|Physician Decision|4
2916583|NCT01598298|10043979|P2|Overall Study|Other reason (not protocol specified)|0
2916584|NCT01598298|10043980|P1|Overall Study|Other reason (not protocol specified)|4
2916585|NCT01598298|10043979|P2|Overall Study|Withdrawal by Subject|15
2916586|NCT01598298|10043980|P1|Overall Study|Withdrawal by Subject|10
2916587|NCT01598298|10043979|P2|Overall Study|Progression/relapse|2
2916588|NCT01598298|10043980|P1|Overall Study|Progression/relapse|0
2916589|NCT01598298|10043979|P2|Overall Study|Adverse Event|19
2916590|NCT01598298|10043980|P1|Overall Study|Adverse Event|21
2916591|NCT01598298|10043979|P2|Overall Study|Not eligible|5
2916592|NCT01598298|10043980|P1|Overall Study|Not eligible|5
2916593|NCT01598129|10044024|P1|Overall Study|Withdrawal by Subject|1
2916594|NCT01598129|10044024|P1|Overall Study|Deterioration of WHO status to WHO 4|2
2916595|NCT01598129|10044024|P1|Overall Study|Disease progression|6
2916596|NCT01598090|10044036|P3|Follow-up Period|Lost to Follow-up|12
2916597|NCT01598090|10044037|P2|Follow-up Period|Lost to Follow-up|10
2916598|NCT01598090|10044038|P1|Follow-up Period|Lost to Follow-up|2
2916599|NCT01598090|10044036|P3|Follow-up Period|Other reasons|8
2916600|NCT01598090|10044037|P2|Follow-up Period|Other reasons|8
2916601|NCT01598090|10044038|P1|Follow-up Period|Other reasons|2
2916602|NCT01598090|10044036|P3|Follow-up Period|Withdrawal by Subject|2
2916603|NCT01598090|10044037|P2|Follow-up Period|Withdrawal by Subject|3
2916604|NCT01598090|10044038|P1|Follow-up Period|Withdrawal by Subject|0
2916605|NCT01598090|10044036|P3|Follow-up Period|Not reported|4
2916606|NCT01598090|10044037|P2|Follow-up Period|Not reported|10
2916607|NCT01598090|10044038|P1|Follow-up Period|Not reported|0
2916608|NCT01598090|10044036|P3|Follow-up Period|No longer required per protocol|2
2916609|NCT01598090|10044037|P2|Follow-up Period|No longer required per protocol|3
2916610|NCT01598090|10044038|P1|Follow-up Period|No longer required per protocol|1
2916611|NCT01598090|10044036|P3|Follow-up Period|Death|0
2916612|NCT01598090|10044037|P2|Follow-up Period|Death|1
2916613|NCT01598090|10044038|P1|Follow-up Period|Death|0
2916614|NCT01598090|10044036|P3|Treatment Period|Lost to Follow-up|1
2916615|NCT01598090|10044037|P2|Treatment Period|Lost to Follow-up|5
2916616|NCT01598090|10044038|P1|Treatment Period|Lost to Follow-up|1
2916617|NCT01598090|10044036|P3|Treatment Period|Withdrawal by Subject|10
2916618|NCT01598090|10044037|P2|Treatment Period|Withdrawal by Subject|13
2916619|NCT01598090|10044038|P1|Treatment Period|Withdrawal by Subject|3
2916620|NCT01598090|10044036|P3|Treatment Period|Other reasons|1
2916621|NCT01598090|10044037|P2|Treatment Period|Other reasons|4
2916622|NCT01598090|10044038|P1|Treatment Period|Other reasons|0
2916623|NCT01598090|10044036|P3|Treatment Period|Adverse Event|17
2916624|NCT01598090|10044037|P2|Treatment Period|Adverse Event|33
2916625|NCT01598090|10044038|P1|Treatment Period|Adverse Event|2
2916626|NCT01598090|10044036|P3|Treatment Period|Lack of Efficacy|6
2916627|NCT01598090|10044037|P2|Treatment Period|Lack of Efficacy|14
2916628|NCT01598090|10044038|P1|Treatment Period|Lack of Efficacy|5
2916629|NCT01598090|10044036|P3|Treatment Period|No longer meet study criteria|0
2916630|NCT01598090|10044037|P2|Treatment Period|No longer meet study criteria|1
2916631|NCT01598090|10044038|P1|Treatment Period|No longer meet study criteria|0
2916632|NCT01598090|10044036|P3|Treatment Period|Poor/non-compliance|0
2916633|NCT01598090|10044037|P2|Treatment Period|Poor/non-compliance|2
2916634|NCT01598090|10044038|P1|Treatment Period|Poor/non-compliance|0
2916635|NCT01597908|10044085|P2|Overall Study|Ongoing|202
2916636|NCT01597908|10044086|P1|Overall Study|Ongoing|236
2916637|NCT01597908|10044085|P2|Overall Study|Withdrawal by Subject|18
2916638|NCT01597908|10044086|P1|Overall Study|Withdrawal by Subject|10
2916639|NCT01597908|10044085|P2|Overall Study|Physician Decision|1
2916640|NCT01597908|10044086|P1|Overall Study|Physician Decision|2
2916641|NCT01597908|10044085|P2|Overall Study|Lost to Follow-up|9
2916642|NCT01597908|10044086|P1|Overall Study|Lost to Follow-up|4
2916643|NCT01597908|10044085|P2|Overall Study|Death|122
2916644|NCT01597908|10044086|P1|Overall Study|Death|100
2916645|NCT01597791|10044132|P2|Overall Study|Protocol Violation|1
2916646|NCT01597791|10044133|P1|Overall Study|Protocol Violation|0
2916647|NCT01597791|10044132|P2|Overall Study|Subject withdrawal|1
2916648|NCT01597791|10044133|P1|Overall Study|Subject withdrawal|0
2916649|NCT01597791|10044132|P2|Overall Study|Cesarean Section|7
2916650|NCT01597791|10044133|P1|Overall Study|Cesarean Section|6
2916651|NCT01597791|10044132|P2|Overall Study|Physician Decision|1
2916652|NCT01597791|10044133|P1|Overall Study|Physician Decision|2
2916653|NCT01597635|10044220|P3|Part B|Withdrawal by Subject|0
2916654|NCT01597635|10044221|P2|Part B|Withdrawal by Subject|1
2916655|NCT01597635|10044222|P1|Part B|Withdrawal by Subject|0
2916656|NCT01597635|10044220|P3|Part B|Protocol-defined stopping criteria|3
2916657|NCT01597635|10044221|P2|Part B|Protocol-defined stopping criteria|4
2916658|NCT01597635|10044222|P1|Part B|Protocol-defined stopping criteria|0
2916659|NCT01597635|10044220|P3|Part B|Protocol Violation|0
2916660|NCT01597635|10044221|P2|Part B|Protocol Violation|1
2916661|NCT01597635|10044222|P1|Part B|Protocol Violation|0
2916662|NCT01597635|10044220|P3|Part B|Adverse Event|1
2916663|NCT01597635|10044221|P2|Part B|Adverse Event|0
2916664|NCT01597635|10044222|P1|Part B|Adverse Event|0
2916665|NCT01597635|10044220|P3|Part A|Adverse Event|0
2916666|NCT01597635|10044221|P2|Part A|Adverse Event|0
2916667|NCT01597635|10044222|P1|Part A|Adverse Event|3
2916668|NCT01597622|10044285|P1|Overall Study|Death|1
2916669|NCT01597622|10044285|P1|Overall Study|Withdrawal by Subject|20
2916670|NCT01597622|10044285|P1|Overall Study|Investigator Discretion|5
2916671|NCT01597622|10044285|P1|Overall Study|Lost to Follow-up|1
2916672|NCT01597622|10044285|P1|Overall Study|Protocol Violation|1
2916673|NCT01597622|10044285|P1|Overall Study|Lack of Efficacy|3
2916674|NCT01597622|10044285|P1|Overall Study|Adverse Event|7
2916675|NCT01597596|10044292|P2|Overall Study|Physician Decision|1
2916676|NCT01597596|10044293|P1|Overall Study|Physician Decision|0
2916677|NCT01597596|10044292|P2|Overall Study|Study terminated by sponsor|0
2916678|NCT01597596|10044293|P1|Overall Study|Study terminated by sponsor|1
2916679|NCT01597505|10044307|P2|Overall Study|Missing|0
2916680|NCT01597505|10044308|P1|Overall Study|Missing|1
2916681|NCT01597505|10044307|P2|Overall Study|Other|6
2916682|NCT01597505|10044308|P1|Overall Study|Other|5
2916683|NCT01597505|10044307|P2|Overall Study|Withdrawal by Subject|18
2916684|NCT01597505|10044308|P1|Overall Study|Withdrawal by Subject|10
2916685|NCT01597505|10044307|P2|Overall Study|Lost to Follow-up|2
2916686|NCT01597505|10044308|P1|Overall Study|Lost to Follow-up|4
2916687|NCT01597505|10044307|P2|Overall Study|Adverse Event|7
2916688|NCT01597505|10044308|P1|Overall Study|Adverse Event|19
2916689|NCT01597505|10044307|P2|Overall Study|Physician Decision|0
2916690|NCT01597505|10044308|P1|Overall Study|Physician Decision|5
2916691|NCT01597492|10044342|P2|Overall Study|Other Reason|0
2916692|NCT01597492|10044343|P1|Overall Study|Other Reason|2
2916693|NCT01597492|10044342|P2|Overall Study|Lost to Follow-up|2
2916694|NCT01597492|10044343|P1|Overall Study|Lost to Follow-up|0
2916695|NCT01597492|10044342|P2|Overall Study|Adverse Event|0
2916696|NCT01597492|10044343|P1|Overall Study|Adverse Event|3
2916697|NCT01597492|10044342|P2|Overall Study|Withdrawal by Subject|2
2916698|NCT01597492|10044343|P1|Overall Study|Withdrawal by Subject|1
2916699|NCT01597479|10044351|P2|Overall Study|Lost to Follow-up|0
2916700|NCT01597479|10044352|P1|Overall Study|Lost to Follow-up|1
2916701|NCT01597479|10044351|P2|Overall Study|Protocol Violation|0
2916702|NCT01597479|10044352|P1|Overall Study|Protocol Violation|1
2916703|NCT01597375|10044638|P2|Second Intervention|Failed to react at both Aspirin|1
2916704|NCT01597375|10044639|P1|Second Intervention|Failed to react at both Aspirin|1
2916705|NCT01597375|10044638|P2|Washout (2 Weeks)|Adverse Event|0
2916706|NCT01597375|10044639|P1|Washout (2 Weeks)|Adverse Event|1
2916707|NCT01597375|10044638|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
2916708|NCT01597375|10044639|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
2916709|NCT01597375|10044638|P2|First Intervention (4 Weeks)|Needed surgery|0
2916710|NCT01597375|10044639|P1|First Intervention (4 Weeks)|Needed surgery|1
2916711|NCT01597375|10044638|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
2916712|NCT01597375|10044639|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
2916713|NCT01597258|10044656|P1|Overall Study|No Drug Administration|1
2916714|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916715|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916716|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
2916717|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916718|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916719|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916720|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916721|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916722|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916723|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916724|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916725|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916726|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2916727|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916728|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2916729|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2916730|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2916731|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2916732|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916733|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2916734|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916735|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916736|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916737|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916738|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916739|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2916740|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2916741|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2916742|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2916743|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2916744|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2916745|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2916746|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
2916747|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2916748|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
2916749|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2916750|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2916751|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2916752|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2916753|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2916754|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916755|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
2916756|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2916757|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
2916758|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916759|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916760|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916761|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2916762|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916763|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916764|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916765|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2916766|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2916767|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
2916768|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
2916769|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2916770|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2916994|NCT01595009|10045403|P1|Extension|Patients completed per protocol|0
2916771|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2916772|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2916773|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2916774|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2916775|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2916776|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2916777|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2916778|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2916779|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2916780|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2916781|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2916782|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2916783|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2916784|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2916785|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2916786|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2916787|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
2916788|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2916789|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2916790|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2916791|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2916792|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
2916793|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
2916794|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
2916795|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916796|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
2916797|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916798|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
2916799|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916800|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916801|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916802|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916803|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916804|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2916805|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916806|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916807|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916808|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
2916809|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916810|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
2916811|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
2916812|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
2916813|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
2916814|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916815|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916816|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916817|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2916818|NCT01597245|10044665|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916819|NCT01597245|10044666|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916820|NCT01597245|10044667|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916821|NCT01597245|10044668|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916822|NCT01597245|10044669|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916823|NCT01597245|10044670|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916824|NCT01597245|10044671|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2916825|NCT01597245|10044672|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2916826|NCT01597245|10044673|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916827|NCT01597245|10044674|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916828|NCT01597245|10044675|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916829|NCT01597245|10044676|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916830|NCT01597245|10044677|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2916831|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916832|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916833|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916834|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916835|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916836|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916837|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916838|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916839|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916840|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2916841|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
2916842|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2916843|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2916844|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916845|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916846|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916847|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916848|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916849|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916850|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916851|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916852|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916853|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
2916854|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916855|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
2916856|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
2916857|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916858|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916859|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916860|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916861|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916862|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916863|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916864|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916865|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916866|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2916867|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
2916868|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
2916869|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
2916870|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916871|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916872|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916873|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916874|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916875|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916876|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916877|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916878|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2916879|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2916880|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
2916881|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
2916882|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2916883|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916884|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916885|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916886|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916887|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916888|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916889|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916890|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916891|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2916892|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2916893|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
2916894|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
2916895|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2916896|NCT01597245|10044665|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916897|NCT01597245|10044666|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916898|NCT01597245|10044667|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916899|NCT01597245|10044668|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916900|NCT01597245|10044669|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916901|NCT01597245|10044670|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916902|NCT01597245|10044671|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916903|NCT01597245|10044672|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916904|NCT01597245|10044673|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
2916905|NCT01597245|10044674|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
2916906|NCT01597245|10044675|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
2916907|NCT01597245|10044676|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
2916908|NCT01597245|10044677|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
2916909|NCT01597193|10044767|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2916910|NCT01597193|10044768|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2916911|NCT01597193|10044769|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2916912|NCT01597193|10044770|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2916913|NCT01597193|10044771|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2916914|NCT01597193|10044772|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2916915|NCT01597193|10044773|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2916916|NCT01597193|10044767|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
2916917|NCT01597193|10044768|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
2916918|NCT01597193|10044769|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
2916919|NCT01597193|10044770|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
2916920|NCT01597193|10044771|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
2916921|NCT01597193|10044772|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
2916922|NCT01597193|10044773|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
2916923|NCT01597193|10044767|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
2916924|NCT01597193|10044768|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2916925|NCT01597193|10044769|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2916926|NCT01597193|10044770|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2916927|NCT01597193|10044771|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2916928|NCT01597193|10044772|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2916929|NCT01597193|10044773|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2916930|NCT01597193|10044767|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2916931|NCT01597193|10044768|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
2916932|NCT01597193|10044769|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
2916933|NCT01597193|10044770|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
2916934|NCT01597193|10044771|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2916935|NCT01597193|10044772|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2916936|NCT01597193|10044773|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2916937|NCT01597193|10044767|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2916938|NCT01597193|10044768|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2916939|NCT01597193|10044769|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2916940|NCT01597193|10044770|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2916941|NCT01597193|10044771|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2916942|NCT01597193|10044772|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
2916943|NCT01597193|10044773|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
2916944|NCT01597050|10044892|P2|Overall Study|Withdrawal by Subject|0
2916945|NCT01597050|10044893|P1|Overall Study|Withdrawal by Subject|1
2916946|NCT01596972|10044901|P2|Overall Study|Withdrawal by Subject|1
2916947|NCT01596972|10044902|P1|Overall Study|Withdrawal by Subject|0
2916948|NCT01596972|10044901|P2|Overall Study|Lost to Follow-up|4
2916949|NCT01596972|10044902|P1|Overall Study|Lost to Follow-up|0
2916950|NCT01596972|10044901|P2|Overall Study|Physician Decision|9
2916951|NCT01596972|10044902|P1|Overall Study|Physician Decision|1
2916952|NCT01596582|10044971|P2|Overall Study|Missing all outcome data|1
2916953|NCT01596582|10044972|P1|Overall Study|Missing all outcome data|1
2916954|NCT01596582|10044971|P2|Overall Study|Deemed ineligible after study visit|6
2916955|NCT01596582|10044972|P1|Overall Study|Deemed ineligible after study visit|3
2916956|NCT01596504|10044999|P3|Overall Study|Withdrawal by Subject|0
2916957|NCT01596504|10045000|P2|Overall Study|Withdrawal by Subject|0
2916958|NCT01596504|10045001|P1|Overall Study|Withdrawal by Subject|1
2916959|NCT01596504|10044999|P3|Overall Study|Adverse Event|1
2916960|NCT01596504|10045000|P2|Overall Study|Adverse Event|2
2916961|NCT01596504|10045001|P1|Overall Study|Adverse Event|1
2916962|NCT01596504|10044999|P3|Overall Study|Participant's Private Reason|0
2916963|NCT01596504|10045000|P2|Overall Study|Participant's Private Reason|1
2916964|NCT01596504|10045001|P1|Overall Study|Participant's Private Reason|0
2916965|NCT01596335|10045059|P2|Overall Study|exacerbation of primary disease|9
2916966|NCT01596335|10045060|P1|Overall Study|exacerbation of primary disease|5
2916967|NCT01596127|10045096|P1|Overall Study|Patient Ineligible|1
2916968|NCT01596062|10045108|P3|Overall Study|Lack of Efficacy|1
2916969|NCT01596062|10045109|P2|Overall Study|Lack of Efficacy|0
2916970|NCT01596062|10045110|P1|Overall Study|Lack of Efficacy|0
2916971|NCT01596062|10045108|P3|Overall Study|Adverse Event|2
2916972|NCT01596062|10045109|P2|Overall Study|Adverse Event|0
2916973|NCT01596062|10045110|P1|Overall Study|Adverse Event|1
2916974|NCT01595646|10045174|P3|Overall Study|Withdrawal by Subject|0
2916975|NCT01595646|10045175|P2|Overall Study|Withdrawal by Subject|0
2916976|NCT01595646|10045176|P1|Overall Study|Withdrawal by Subject|1
2916977|NCT01595438|10045231|P2|Overall Study|Other Eligibility criteria|9
2916978|NCT01595438|10045232|P1|Overall Study|Other Eligibility criteria|11
2916979|NCT01595438|10045231|P2|Overall Study|Withdrawal by Subject|12
2916980|NCT01595438|10045232|P1|Overall Study|Withdrawal by Subject|12
2916981|NCT01595438|10045231|P2|Overall Study|Lost to Follow-up|20
2916982|NCT01595438|10045232|P1|Overall Study|Lost to Follow-up|20
2916983|NCT01595009|10045400|P4|Extension|Adverse Event|1
2916984|NCT01595009|10045401|P3|Extension|Adverse Event|0
2916985|NCT01595009|10045402|P2|Extension|Adverse Event|0
2916986|NCT01595009|10045403|P1|Extension|Adverse Event|0
2916987|NCT01595009|10045400|P4|Extension|Disease progression|7
2916988|NCT01595009|10045401|P3|Extension|Disease progression|4
2916989|NCT01595009|10045402|P2|Extension|Disease progression|0
2916990|NCT01595009|10045403|P1|Extension|Disease progression|0
2916991|NCT01595009|10045400|P4|Extension|Patients completed per protocol|2
2916992|NCT01595009|10045401|P3|Extension|Patients completed per protocol|0
2916993|NCT01595009|10045402|P2|Extension|Patients completed per protocol|0
2916995|NCT01595009|10045400|P4|Extension|Administrative problems|1
2916996|NCT01595009|10045401|P3|Extension|Administrative problems|0
2916997|NCT01595009|10045402|P2|Extension|Administrative problems|0
2916998|NCT01595009|10045403|P1|Extension|Administrative problems|0
2916999|NCT01595009|10045400|P4|Core|Administrative problems|0
2917000|NCT01595009|10045401|P3|Core|Administrative problems|0
2917001|NCT01595009|10045402|P2|Core|Administrative problems|1
2917002|NCT01595009|10045403|P1|Core|Administrative problems|0
2917003|NCT01595009|10045400|P4|Core|Protocol deviation|0
2917004|NCT01595009|10045401|P3|Core|Protocol deviation|0
2917005|NCT01595009|10045402|P2|Core|Protocol deviation|1
2917006|NCT01595009|10045403|P1|Core|Protocol deviation|0
2917007|NCT01595009|10045400|P4|Core|Lost to Follow-up|0
2917008|NCT01595009|10045401|P3|Core|Lost to Follow-up|0
2917009|NCT01595009|10045402|P2|Core|Lost to Follow-up|2
2917010|NCT01595009|10045403|P1|Core|Lost to Follow-up|1
2917011|NCT01595009|10045400|P4|Core|Death|0
2917012|NCT01595009|10045401|P3|Core|Death|0
2917013|NCT01595009|10045402|P2|Core|Death|6
2917014|NCT01595009|10045403|P1|Core|Death|3
2917015|NCT01595009|10045400|P4|Core|Withdrawal by Subject|0
2917016|NCT01595009|10045401|P3|Core|Withdrawal by Subject|0
2917017|NCT01595009|10045402|P2|Core|Withdrawal by Subject|17
2917018|NCT01595009|10045403|P1|Core|Withdrawal by Subject|4
2917019|NCT01595009|10045400|P4|Core|Disease progression|0
2917020|NCT01595009|10045401|P3|Core|Disease progression|0
2917021|NCT01595009|10045402|P2|Core|Disease progression|26
2917022|NCT01595009|10045403|P1|Core|Disease progression|14
2917023|NCT01595009|10045400|P4|Core|Adverse Event|0
2917024|NCT01595009|10045401|P3|Core|Adverse Event|0
2917025|NCT01595009|10045402|P2|Core|Adverse Event|23
2917026|NCT01595009|10045403|P1|Core|Adverse Event|19
2917027|NCT01595009|10045400|P4|Core|Patients completed per protocol|0
2917028|NCT01595009|10045401|P3|Core|Patients completed per protocol|0
2917029|NCT01595009|10045402|P2|Core|Patients completed per protocol|44
2917030|NCT01595009|10045403|P1|Core|Patients completed per protocol|85
2917031|NCT01594970|10045438|P3|Overall Study|Lost to Follow-up|37
2917032|NCT01594970|10045439|P2|Overall Study|Lost to Follow-up|54
2917033|NCT01594970|10045440|P1|Overall Study|Lost to Follow-up|54
2917034|NCT01594970|10045438|P3|Overall Study|Adverse Event|23
2917035|NCT01594970|10045439|P2|Overall Study|Adverse Event|23
2917036|NCT01594970|10045440|P1|Overall Study|Adverse Event|17
2917037|NCT01594970|10045438|P3|Overall Study|Non-Adverse Event Related|6
2917038|NCT01594970|10045439|P2|Overall Study|Non-Adverse Event Related|5
2917039|NCT01594970|10045440|P1|Overall Study|Non-Adverse Event Related|4
2917040|NCT01594853|10045459|P2|Overall Study|noncompliance with exercise|1
2917041|NCT01594853|10045460|P1|Overall Study|noncompliance with exercise|0
2917042|NCT01594853|10045459|P2|Overall Study|Lost to Follow-up|1
2917043|NCT01594853|10045460|P1|Overall Study|Lost to Follow-up|1
2917044|NCT01594853|10045459|P2|Overall Study|Withdrawal by Subject|1
2917045|NCT01594853|10045460|P1|Overall Study|Withdrawal by Subject|1
2917046|NCT01594827|10045468|P2|Overall Study|Physician Decision|0
2917047|NCT01594827|10045469|P1|Overall Study|Physician Decision|3
2917048|NCT01594827|10045468|P2|Overall Study|Adverse Event|0
2917049|NCT01594827|10045469|P1|Overall Study|Adverse Event|1
2917050|NCT01594762|10045493|P2|Overall Study|Lost to Follow-up|10
2917051|NCT01594762|10045494|P1|Overall Study|Lost to Follow-up|10
2917052|NCT01594762|10045493|P2|Overall Study|Withdrawal by Subject|0
2917053|NCT01594762|10045494|P1|Overall Study|Withdrawal by Subject|1
2917054|NCT01594749|10045506|P2|Overall Study|Lost Source Documentation|0
2917055|NCT01594749|10045507|P1|Overall Study|Lost Source Documentation|1
2917056|NCT01594749|10045506|P2|Overall Study|Not Treated|10
2917057|NCT01594749|10045507|P1|Overall Study|Not Treated|4
2917058|NCT01594749|10045506|P2|Overall Study|Death|3
2917059|NCT01594749|10045507|P1|Overall Study|Death|9
2917060|NCT01594749|10045506|P2|Overall Study|Lost to Follow-up|0
2917061|NCT01594749|10045507|P1|Overall Study|Lost to Follow-up|1
2917062|NCT01594749|10045506|P2|Overall Study|Non-compliance with Protocol|1
2917063|NCT01594749|10045507|P1|Overall Study|Non-compliance with Protocol|0
2917064|NCT01594749|10045506|P2|Overall Study|Physician Decision|1
2917065|NCT01594749|10045507|P1|Overall Study|Physician Decision|1
2917066|NCT01594749|10045506|P2|Overall Study|Protocol Violation|0
2917067|NCT01594749|10045507|P1|Overall Study|Protocol Violation|2
2917068|NCT01594749|10045506|P2|Overall Study|Withdrawal by Subject|2
2917069|NCT01594749|10045507|P1|Overall Study|Withdrawal by Subject|2
2917070|NCT01594749|10045506|P2|Overall Study|Adverse Event|1
2917071|NCT01594749|10045507|P1|Overall Study|Adverse Event|2
2917072|NCT01594476|10045645|P2|Overall Study|Protocol Violation|3
2917073|NCT01594476|10045646|P1|Overall Study|Protocol Violation|1
2917074|NCT01594411|10045668|P1|Overall Study|Lost to Follow-up|2
2917075|NCT01594281|10045720|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2917076|NCT01594281|10045721|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
2917077|NCT01594281|10045722|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2917078|NCT01594281|10045720|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
2917079|NCT01594281|10045721|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
2917080|NCT01594281|10045722|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
2917081|NCT01594281|10045720|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
2917082|NCT01594281|10045721|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2917083|NCT01594281|10045722|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2917084|NCT01594281|10045720|P3|Interventional Core Phase|Adverse Event|4
2917085|NCT01594281|10045721|P2|Interventional Core Phase|Adverse Event|4
2917086|NCT01594281|10045722|P1|Interventional Core Phase|Adverse Event|4
2917087|NCT01594281|10045720|P3|Interventional Core Phase|Lost to Follow-up|1
2917088|NCT01594281|10045721|P2|Interventional Core Phase|Lost to Follow-up|4
2917089|NCT01594281|10045722|P1|Interventional Core Phase|Lost to Follow-up|1
2917090|NCT01594281|10045720|P3|Interventional Core Phase|Death|2
2917091|NCT01594281|10045721|P2|Interventional Core Phase|Death|1
2917092|NCT01594281|10045722|P1|Interventional Core Phase|Death|1
2917093|NCT01594281|10045720|P3|Interventional Core Phase|Subject Withdrew Consent|1
2917094|NCT01594281|10045721|P2|Interventional Core Phase|Subject Withdrew Consent|1
2917095|NCT01594281|10045722|P1|Interventional Core Phase|Subject Withdrew Consent|0
2917096|NCT01594281|10045720|P3|Interventional Core Phase|Protocol Deviation|0
2917097|NCT01594281|10045721|P2|Interventional Core Phase|Protocol Deviation|0
2917098|NCT01594281|10045722|P1|Interventional Core Phase|Protocol Deviation|1
2917099|NCT01594125|10045762|P5|Overall Study|Progressive Disease|7
2917100|NCT01594125|10045763|P4|Overall Study|Progressive Disease|3
2917101|NCT01594125|10045764|P3|Overall Study|Progressive Disease|3
2917102|NCT01594125|10045765|P2|Overall Study|Progressive Disease|12
2917103|NCT01594125|10045766|P1|Overall Study|Progressive Disease|3
2917104|NCT01594125|10045762|P5|Overall Study|Withdrawal by Subject|0
2917105|NCT01594125|10045763|P4|Overall Study|Withdrawal by Subject|1
2917106|NCT01594125|10045764|P3|Overall Study|Withdrawal by Subject|0
2917107|NCT01594125|10045765|P2|Overall Study|Withdrawal by Subject|0
2917108|NCT01594125|10045766|P1|Overall Study|Withdrawal by Subject|1
2917109|NCT01593787|10045826|P3|Overall Study|Adverse Event|0
2917110|NCT01593787|10045827|P2|Overall Study|Adverse Event|0
2917111|NCT01593787|10045828|P1|Overall Study|Adverse Event|1
2917112|NCT01593254|10045923|P2|Follow-Up Period|Study Drug Side Effects|1
2917113|NCT01593254|10045924|P1|Follow-Up Period|Study Drug Side Effects|0
2917114|NCT01593254|10045923|P2|Follow-Up Period|Disease Progression|1
2917115|NCT01593254|10045924|P1|Follow-Up Period|Disease Progression|0
2917116|NCT01593254|10045923|P2|Follow-Up Period|Fundus Hemorrhage|1
2917117|NCT01593254|10045924|P1|Follow-Up Period|Fundus Hemorrhage|0
2917118|NCT01593254|10045923|P2|Follow-Up Period|Patient refused to return|1
2917119|NCT01593254|10045924|P1|Follow-Up Period|Patient refused to return|0
2917120|NCT01593254|10045923|P2|Follow-Up Period|Study Drug Toxicity|1
2917121|NCT01593254|10045924|P1|Follow-Up Period|Study Drug Toxicity|0
2917122|NCT01593254|10045923|P2|Follow-Up Period|Pregnancy|1
2917123|NCT01593254|10045924|P1|Follow-Up Period|Pregnancy|0
2917124|NCT01593254|10045923|P2|Follow-Up Period|Subject request to Discontinue|1
2917125|NCT01593254|10045924|P1|Follow-Up Period|Subject request to Discontinue|0
2917126|NCT01593254|10045923|P2|Follow-Up Period|Death|2
2917127|NCT01593254|10045924|P1|Follow-Up Period|Death|2
2917128|NCT01593254|10045923|P2|Follow-Up Period|Non-Compliance|0
2917129|NCT01593254|10045924|P1|Follow-Up Period|Non-Compliance|1
2917130|NCT01593254|10045923|P2|Follow-Up Period|Withdrawal by Subject|2
2917131|NCT01593254|10045924|P1|Follow-Up Period|Withdrawal by Subject|0
2917132|NCT01593254|10045923|P2|Treatment Period|Investigator Decision|1
2917133|NCT01593254|10045924|P1|Treatment Period|Investigator Decision|2
2917134|NCT01593254|10045923|P2|Treatment Period|T315I MUTATION|1
2917135|NCT01593254|10045924|P1|Treatment Period|T315I MUTATION|0
2917136|NCT01593254|10045923|P2|Treatment Period|No Response|0
2917137|NCT01593254|10045924|P1|Treatment Period|No Response|1
2917138|NCT01593254|10045923|P2|Treatment Period|Patient Refused to Return|1
2917139|NCT01593254|10045924|P1|Treatment Period|Patient Refused to Return|0
2917140|NCT01593254|10045923|P2|Treatment Period|Did Not Achieve RCC|1
2917141|NCT01593254|10045924|P1|Treatment Period|Did Not Achieve RCC|0
2917142|NCT01593254|10045923|P2|Treatment Period|Disease Progression|6
2917143|NCT01593254|10045924|P1|Treatment Period|Disease Progression|1
2917144|NCT01593254|10045923|P2|Treatment Period|Study Drug Toxicity|9
2917145|NCT01593254|10045924|P1|Treatment Period|Study Drug Toxicity|3
2917146|NCT01593254|10045923|P2|Treatment Period|Death|1
2917147|NCT01593254|10045924|P1|Treatment Period|Death|2
2917148|NCT01593254|10045923|P2|Treatment Period|AE unrelated to Study Drug|1
2917149|NCT01593254|10045924|P1|Treatment Period|AE unrelated to Study Drug|0
2917150|NCT01593254|10045923|P2|Treatment Period|Subject Request to Discontinue|1
2917151|NCT01593254|10045924|P1|Treatment Period|Subject Request to Discontinue|1
2917152|NCT01593254|10045923|P2|Treatment Period|Subject withdrew consent|5
2917153|NCT01593254|10045924|P1|Treatment Period|Subject withdrew consent|0
2917154|NCT01593254|10045923|P2|Treatment Period|Maximum clinical benefit|0
2917155|NCT01593254|10045924|P1|Treatment Period|Maximum clinical benefit|1
2917156|NCT01593254|10045923|P2|Treatment Period|Poor/Non-Compliance|1
2917157|NCT01593254|10045924|P1|Treatment Period|Poor/Non-Compliance|2
2917158|NCT01593254|10045923|P2|Treatment Period|Pregnancy|1
2917159|NCT01593254|10045924|P1|Treatment Period|Pregnancy|0
2917160|NCT01593254|10045923|P2|Treatment Period|Treatment Failure|2
2917161|NCT01593254|10045924|P1|Treatment Period|Treatment Failure|1
2917162|NCT01592864|10045942|P2|Overall Study|Withdrawal by Subject|1
2917163|NCT01592864|10045943|P1|Overall Study|Withdrawal by Subject|0
2917164|NCT01592786|10046004|P1|Overall Study|Other|3
2917165|NCT01592786|10046004|P1|Overall Study|Lost to Follow-up|19
2917166|NCT01592786|10046004|P1|Overall Study|Withdrawal by Subject|23
2917167|NCT01592786|10046004|P1|Overall Study|Protocol Violation|14
2917168|NCT01592786|10046004|P1|Overall Study|Lack of Efficacy|19
2917169|NCT01592786|10046004|P1|Overall Study|Adverse Event|60
2917170|NCT01592773|10046008|P1|Overall Study|Other Reason|1
2917171|NCT01592773|10046008|P1|Overall Study|Inclusion/exclusion not meet|1
2917172|NCT01592773|10046008|P1|Overall Study|Protocol Violation|2
2917173|NCT01592773|10046008|P1|Overall Study|Lack of Efficacy|9
2917174|NCT01592773|10046008|P1|Overall Study|Adverse Event|17
2917175|NCT01592773|10046008|P1|Overall Study|Lost to Follow-up|19
2917176|NCT01592773|10046008|P1|Overall Study|Withdrawal by Subject|35
2917177|NCT01592773|10046008|P1|Overall Study|Study Terminated by Sponsor|582
2917178|NCT01592760|10046015|P3|24-hour Follow-Up|Lost to Follow-up|2
2917179|NCT01592760|10046016|P2|24-hour Follow-Up|Lost to Follow-up|3
2917180|NCT01592760|10046017|P1|24-hour Follow-Up|Lost to Follow-up|4
2917181|NCT01592747|10046061|P3|Overall Study|Other Reasons|0
2917182|NCT01592747|10046062|P2|Overall Study|Other Reasons|1
2917183|NCT01592747|10046063|P1|Overall Study|Other Reasons|1
2917184|NCT01592747|10046061|P3|Overall Study|Lost to Follow-up|1
2917185|NCT01592747|10046062|P2|Overall Study|Lost to Follow-up|0
2917186|NCT01592747|10046063|P1|Overall Study|Lost to Follow-up|1
2917187|NCT01592747|10046061|P3|Overall Study|Withdrawal by Subject|2
2917188|NCT01592747|10046062|P2|Overall Study|Withdrawal by Subject|0
2917189|NCT01592747|10046063|P1|Overall Study|Withdrawal by Subject|2
2917190|NCT01592747|10046061|P3|Overall Study|Lack of Efficacy|0
2917191|NCT01592747|10046062|P2|Overall Study|Lack of Efficacy|1
2917192|NCT01592747|10046063|P1|Overall Study|Lack of Efficacy|0
2917193|NCT01592747|10046061|P3|Overall Study|Protocol Violation|4
2917194|NCT01592747|10046062|P2|Overall Study|Protocol Violation|0
2917195|NCT01592747|10046063|P1|Overall Study|Protocol Violation|4
2917196|NCT01592747|10046061|P3|Overall Study|Adverse Event|0
2917197|NCT01592747|10046062|P2|Overall Study|Adverse Event|0
2917198|NCT01592747|10046063|P1|Overall Study|Adverse Event|1
2917199|NCT01592747|10046061|P3|Overall Study|Inclusion/Exclusion criteria not met|1
2917200|NCT01592747|10046062|P2|Overall Study|Inclusion/Exclusion criteria not met|1
2917201|NCT01592747|10046063|P1|Overall Study|Inclusion/Exclusion criteria not met|0
2917202|NCT01592747|10046061|P3|Overall Study|Loss of Therapeutic Response|100
2917203|NCT01592747|10046062|P2|Overall Study|Loss of Therapeutic Response|108
2917204|NCT01592747|10046063|P1|Overall Study|Loss of Therapeutic Response|107
2917205|NCT01592708|10046106|P2|Overall Study|Protocol Violation|0
2917206|NCT01592708|10046107|P1|Overall Study|Protocol Violation|3
2917207|NCT01592695|10046123|P2|Overall Study|Lost to Follow-up|4
2917208|NCT01592695|10046124|P1|Overall Study|Lost to Follow-up|8
2917209|NCT01592409|10046179|P2|Overall Study|Withdrawal by Subject|1
2917210|NCT01592409|10046180|P1|Overall Study|Withdrawal by Subject|0
2917211|NCT01592383|10046204|P1|Overall Study|Adverse Event|1
2917212|NCT01592344|10046215|P2|Overall Study|not available at primary outcome visit|4
2917213|NCT01592344|10046216|P1|Overall Study|not available at primary outcome visit|2
2917214|NCT01592344|10046215|P2|Overall Study|Lack of Efficacy|0
2917215|NCT01592344|10046216|P1|Overall Study|Lack of Efficacy|1
2917216|NCT01592344|10046215|P2|Overall Study|Adverse Event|1
2917217|NCT01592344|10046216|P1|Overall Study|Adverse Event|1
2917218|NCT01592292|10046230|P4|Overall Study|Other|1
2917219|NCT01592292|10046231|P3|Overall Study|Other|2
2917220|NCT01592292|10046232|P2|Overall Study|Other|1
2917221|NCT01592292|10046233|P1|Overall Study|Other|1
2917222|NCT01592292|10046230|P4|Overall Study|Withdrew consent|0
2917223|NCT01592292|10046231|P3|Overall Study|Withdrew consent|0
2917224|NCT01592292|10046232|P2|Overall Study|Withdrew consent|1
2917225|NCT01592292|10046233|P1|Overall Study|Withdrew consent|2
2917226|NCT01592292|10046230|P4|Overall Study|Follow-up loss|0
2917227|NCT01592292|10046231|P3|Overall Study|Follow-up loss|1
2917228|NCT01592292|10046232|P2|Overall Study|Follow-up loss|3
2917229|NCT01592292|10046233|P1|Overall Study|Follow-up loss|3
2917230|NCT01592240|10046272|P7|Overall Study|Did Not Meet Entrance Criteria|0
2917231|NCT01592240|10046273|P6|Overall Study|Did Not Meet Entrance Criteria|0
2917232|NCT01592240|10046274|P5|Overall Study|Did Not Meet Entrance Criteria|0
2917233|NCT01592240|10046275|P4|Overall Study|Did Not Meet Entrance Criteria|0
2917234|NCT01592240|10046276|P3|Overall Study|Did Not Meet Entrance Criteria|1
2917235|NCT01592240|10046277|P2|Overall Study|Did Not Meet Entrance Criteria|0
2917236|NCT01592240|10046278|P1|Overall Study|Did Not Meet Entrance Criteria|1
2917237|NCT01592240|10046272|P7|Overall Study|Other|1
2917238|NCT01592240|10046273|P6|Overall Study|Other|0
2917239|NCT01592240|10046274|P5|Overall Study|Other|0
2917240|NCT01592240|10046275|P4|Overall Study|Other|1
2917241|NCT01592240|10046276|P3|Overall Study|Other|1
2917242|NCT01592240|10046277|P2|Overall Study|Other|3
2917243|NCT01592240|10046278|P1|Overall Study|Other|0
2917244|NCT01592240|10046272|P7|Overall Study|Withdrawal by Subject|2
2917245|NCT01592240|10046273|P6|Overall Study|Withdrawal by Subject|0
2917246|NCT01592240|10046274|P5|Overall Study|Withdrawal by Subject|3
2917247|NCT01592240|10046275|P4|Overall Study|Withdrawal by Subject|1
2917248|NCT01592240|10046276|P3|Overall Study|Withdrawal by Subject|4
2917249|NCT01592240|10046277|P2|Overall Study|Withdrawal by Subject|4
2917250|NCT01592240|10046278|P1|Overall Study|Withdrawal by Subject|0
2917251|NCT01592240|10046272|P7|Overall Study|Protocol Violation|0
2917252|NCT01592240|10046273|P6|Overall Study|Protocol Violation|1
2917253|NCT01592240|10046274|P5|Overall Study|Protocol Violation|0
2917254|NCT01592240|10046275|P4|Overall Study|Protocol Violation|0
2917255|NCT01592240|10046276|P3|Overall Study|Protocol Violation|0
2917256|NCT01592240|10046277|P2|Overall Study|Protocol Violation|0
2917257|NCT01592240|10046278|P1|Overall Study|Protocol Violation|0
2917258|NCT01592240|10046272|P7|Overall Study|Lost to Follow-up|0
2917259|NCT01592240|10046273|P6|Overall Study|Lost to Follow-up|2
2917260|NCT01592240|10046274|P5|Overall Study|Lost to Follow-up|3
2917261|NCT01592240|10046275|P4|Overall Study|Lost to Follow-up|0
2917262|NCT01592240|10046276|P3|Overall Study|Lost to Follow-up|1
2917263|NCT01592240|10046277|P2|Overall Study|Lost to Follow-up|3
2917264|NCT01592240|10046278|P1|Overall Study|Lost to Follow-up|1
2917265|NCT01592240|10046272|P7|Overall Study|Death|0
2917266|NCT01592240|10046273|P6|Overall Study|Death|0
2917267|NCT01592240|10046274|P5|Overall Study|Death|0
2917268|NCT01592240|10046275|P4|Overall Study|Death|0
2917269|NCT01592240|10046276|P3|Overall Study|Death|0
2917270|NCT01592240|10046277|P2|Overall Study|Death|1
2917271|NCT01592240|10046278|P1|Overall Study|Death|0
2917272|NCT01592240|10046272|P7|Overall Study|Adverse Event|0
2917273|NCT01592240|10046273|P6|Overall Study|Adverse Event|0
2917274|NCT01592240|10046274|P5|Overall Study|Adverse Event|1
2917275|NCT01592240|10046275|P4|Overall Study|Adverse Event|1
2917276|NCT01592240|10046276|P3|Overall Study|Adverse Event|0
2917277|NCT01592240|10046277|P2|Overall Study|Adverse Event|0
2917278|NCT01592240|10046278|P1|Overall Study|Adverse Event|1
2917279|NCT01592045|10046471|P2|Overall Study|Moved out of country|0
2917280|NCT01592045|10046472|P1|Overall Study|Moved out of country|2
2917281|NCT01592045|10046471|P2|Overall Study|Withdrawal by Subject|0
2917282|NCT01592045|10046472|P1|Overall Study|Withdrawal by Subject|1
2917283|NCT01592045|10046471|P2|Overall Study|Adverse Event|1
2917284|NCT01592045|10046472|P1|Overall Study|Adverse Event|1
2917285|NCT01592045|10046471|P2|Overall Study|Disease Progression|1
2917286|NCT01592045|10046472|P1|Overall Study|Disease Progression|1
2917287|NCT01591863|10046490|P1|Overall Study|Lack of Efficacy|1
2917288|NCT01591863|10046490|P1|Overall Study|recurrence|9
2917289|NCT01591863|10046490|P1|Overall Study|Withdrawal by Subject|1
2917290|NCT01591863|10046490|P1|Overall Study|Adverse Event|3
2917291|NCT01591681|10046547|P1|Overall Study|Failed to use system during run-in|1
2917292|NCT01591681|10046547|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
2917293|NCT01591616|10046573|P1|Overall Study|Withdrawal by Subject|1
2917294|NCT01591499|10046714|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2917295|NCT01591499|10046715|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
2917296|NCT01591499|10046716|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2917297|NCT01591499|10046717|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
2917298|NCT01591499|10046714|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2917299|NCT01591499|10046715|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2917300|NCT01591499|10046716|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2917301|NCT01591499|10046717|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2917302|NCT01591499|10046714|P4|Baseline Visit|Withdrawal by Subject|2
2917303|NCT01591499|10046715|P3|Baseline Visit|Withdrawal by Subject|0
2917304|NCT01591499|10046716|P2|Baseline Visit|Withdrawal by Subject|2
2917305|NCT01591499|10046717|P1|Baseline Visit|Withdrawal by Subject|0
2917306|NCT01591460|10046783|P1|Overall Study|Protocol Violation|1
2917307|NCT01591460|10046783|P1|Overall Study|Withdrawal by Subject|1
2917308|NCT01591460|10046783|P1|Overall Study|Participant Refusal|3
2917309|NCT01591460|10046783|P1|Overall Study|Noncompliance|1
2917310|NCT01591460|10046783|P1|Overall Study|Lost to Follow-up|1
2917311|NCT01591460|10046783|P1|Overall Study|Treatment Discontinued by Error|1
2917312|NCT01591460|10046783|P1|Overall Study|Rebound or Breakthrough|3
2917313|NCT01591460|10046783|P1|Overall Study|Futility Rule (Week 24)|3
2917314|NCT01591460|10046783|P1|Overall Study|Futility Rule (Week 12)|7
2917315|NCT01591460|10046783|P1|Overall Study|Adverse Event or Intercurrent Illness|5
2917316|NCT01591382|10046874|P2|Overall Study|Participant Opted for Morphine PCA|1
2917317|NCT01591382|10046875|P1|Overall Study|Participant Opted for Morphine PCA|1
2917318|NCT01591382|10046874|P2|Overall Study|Discharged Prior to Study Completion|1
2917319|NCT01591382|10046875|P1|Overall Study|Discharged Prior to Study Completion|2
2917320|NCT01591096|10046920|P1|Overall Study|Adverse Event|1
2917321|NCT01590888|10047005|P3|Overall Study|Lost to Follow-up|0
2917322|NCT01590888|10047006|P2|Overall Study|Lost to Follow-up|0
2917323|NCT01590888|10047007|P1|Overall Study|Lost to Follow-up|1
2917324|NCT01590888|10047005|P3|Overall Study|Adverse Event|1
2917325|NCT01590888|10047006|P2|Overall Study|Adverse Event|0
2917326|NCT01590888|10047007|P1|Overall Study|Adverse Event|3
2917327|NCT01590810|10047067|P5|Overall Study|Physician Decision|0
2917328|NCT01590810|10047068|P4|Overall Study|Physician Decision|0
2917329|NCT01590810|10047069|P3|Overall Study|Physician Decision|1
2917330|NCT01590810|10047070|P2|Overall Study|Physician Decision|1
2917331|NCT01590810|10047071|P1|Overall Study|Physician Decision|0
2917332|NCT01590797|10047216|P2|Overall Study|Other Protocol Specified Criteria|4
2917333|NCT01590797|10047217|P1|Overall Study|Other Protocol Specified Criteria|2
2917334|NCT01590797|10047216|P2|Overall Study|Withdrawal by Subject|5
2917335|NCT01590797|10047217|P1|Overall Study|Withdrawal by Subject|7
2917336|NCT01590797|10047216|P2|Overall Study|Protocol Violation|1
2917337|NCT01590797|10047217|P1|Overall Study|Protocol Violation|4
2917338|NCT01590797|10047216|P2|Overall Study|Lost to Follow-up|1
2917339|NCT01590797|10047217|P1|Overall Study|Lost to Follow-up|0
2917340|NCT01590797|10047216|P2|Overall Study|Lack of Efficacy|2
2917341|NCT01590797|10047217|P1|Overall Study|Lack of Efficacy|0
2917342|NCT01590797|10047216|P2|Overall Study|Adverse Event|3
2917343|NCT01590797|10047217|P1|Overall Study|Adverse Event|4
2917344|NCT01590771|10047233|P2|Overall Study|Adverse Event|7
2917345|NCT01590771|10047234|P1|Overall Study|Adverse Event|3
2917346|NCT01590771|10047233|P2|Overall Study|Lack of Efficacy|0
2917347|NCT01590771|10047234|P1|Overall Study|Lack of Efficacy|1
2917348|NCT01590771|10047233|P2|Overall Study|Lost to Follow-up|1
2917349|NCT01590771|10047234|P1|Overall Study|Lost to Follow-up|1
2917350|NCT01590771|10047233|P2|Overall Study|Protocol Violation|2
2917351|NCT01590771|10047234|P1|Overall Study|Protocol Violation|1
2917352|NCT01590771|10047233|P2|Overall Study|Withdrawal by Subject|15
2917353|NCT01590771|10047234|P1|Overall Study|Withdrawal by Subject|8
2917354|NCT01590771|10047233|P2|Overall Study|Other Protocol Specified Criteria|14
2917355|NCT01590771|10047234|P1|Overall Study|Other Protocol Specified Criteria|5
2917356|NCT01590758|10047262|P2|Overall Study|Lost to Follow-up|2
2917357|NCT01590758|10047263|P1|Overall Study|Lost to Follow-up|4
2917358|NCT01590758|10047262|P2|Overall Study|Physician Decision|2
2917359|NCT01590758|10047263|P1|Overall Study|Physician Decision|1
2917360|NCT01590758|10047262|P2|Overall Study|Withdrawal by Subject|3
2917361|NCT01590758|10047263|P1|Overall Study|Withdrawal by Subject|0
2917362|NCT01590563|10047273|P1|Overall Study|simple uterine hyperplasia - not related|1
2917363|NCT01590433|10047287|P2|Overall Study|Adverse Event|3
2917364|NCT01590433|10047288|P1|Overall Study|Adverse Event|11
2917365|NCT01590433|10047287|P2|Overall Study|Withdrawal by Subject|11
2917366|NCT01590433|10047288|P1|Overall Study|Withdrawal by Subject|21
2917367|NCT01590433|10047287|P2|Overall Study|Lost to Follow-up|8
2917368|NCT01590433|10047288|P1|Overall Study|Lost to Follow-up|20
2917369|NCT01590212|10047310|P3|Overall Study|Lost to Follow-up|3
2917370|NCT01590212|10047311|P2|Overall Study|Lost to Follow-up|2
2917371|NCT01590212|10047312|P1|Overall Study|Lost to Follow-up|1
2917372|NCT01590212|10047310|P3|Overall Study|Withdrawal by Subject|2
2917373|NCT01590212|10047311|P2|Overall Study|Withdrawal by Subject|2
2917374|NCT01590212|10047312|P1|Overall Study|Withdrawal by Subject|2
2917375|NCT01590017|10047329|P1|Overall Study|Physician Decision|1
2917376|NCT01590017|10047329|P1|Overall Study|Lack of Efficacy|1
2917377|NCT01590017|10047329|P1|Overall Study|Withdrawal by Subject|1
2917378|NCT01590017|10047329|P1|Overall Study|Adverse Event|1
2917379|NCT01589822|10047382|P3|Overall Study|Missed 90 day visit|1
2917380|NCT01589822|10047383|P2|Overall Study|Missed 90 day visit|1
2917381|NCT01589822|10047384|P1|Overall Study|Missed 90 day visit|2
2917382|NCT01589822|10047382|P3|Overall Study|Death|0
2917383|NCT01589822|10047383|P2|Overall Study|Death|0
2917384|NCT01589822|10047384|P1|Overall Study|Death|1
2917385|NCT01589822|10047382|P3|Overall Study|Withdrawal by Subject|0
2917386|NCT01589822|10047383|P2|Overall Study|Withdrawal by Subject|2
2917387|NCT01589822|10047384|P1|Overall Study|Withdrawal by Subject|1
2917388|NCT01589770|10047403|P2|Overall Study|claustrophobic when entering cardiac MRI|1
2917389|NCT01589770|10047404|P1|Overall Study|claustrophobic when entering cardiac MRI|2
2917390|NCT01589770|10047403|P2|Overall Study|EGFR <60ml/min|4
2917391|NCT01589770|10047404|P1|Overall Study|EGFR <60ml/min|6
2917392|NCT01589653|10047414|P2|Overall Study|Unclassified|3
2917393|NCT01589653|10047415|P1|Overall Study|Unclassified|0
2917394|NCT01589653|10047414|P2|Overall Study|Withdrawal criteria|7
2917395|NCT01589653|10047415|P1|Overall Study|Withdrawal criteria|4
2917396|NCT01589653|10047414|P2|Overall Study|Protocol Violation|1
2917397|NCT01589653|10047415|P1|Overall Study|Protocol Violation|3
2917398|NCT01589497|10047465|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
2917399|NCT01589497|10047466|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
2917400|NCT01589497|10047467|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
2917401|NCT01589497|10047468|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
2917402|NCT01589497|10047465|P4|Overall Study|Death|0
2917403|NCT01589497|10047466|P3|Overall Study|Death|0
2917404|NCT01589497|10047467|P2|Overall Study|Death|0
2917405|NCT01589497|10047468|P1|Overall Study|Death|1
2917406|NCT01589497|10047465|P4|Overall Study|Withdrawal by Subject|1
2917407|NCT01589497|10047466|P3|Overall Study|Withdrawal by Subject|0
2917408|NCT01589497|10047467|P2|Overall Study|Withdrawal by Subject|1
2917409|NCT01589497|10047468|P1|Overall Study|Withdrawal by Subject|0
2917410|NCT01589445|10047574|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
2917411|NCT01589445|10047574|P1|002 (Metformin)-3 Months|Adverse Event|2
2917412|NCT01589445|10047574|P1|002 (Metformin)-3 Months|Protocol Violation|2
2917413|NCT01589445|10047574|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
2917414|NCT01589445|10047574|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
2917415|NCT01589445|10047574|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
2917416|NCT01589445|10047574|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
2917417|NCT01589445|10047574|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
2917418|NCT01589445|10047574|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
2917419|NCT01589445|10047574|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
2917420|NCT01589237|10047617|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
2917421|NCT01589237|10047618|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2917422|NCT01589237|10047619|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2917423|NCT01589237|10047620|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2917424|NCT01589237|10047617|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
2917425|NCT01589237|10047618|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
2917426|NCT01589237|10047619|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2917427|NCT01589237|10047620|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2917428|NCT01589237|10047617|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2917429|NCT01589237|10047618|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2917430|NCT01589237|10047619|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
2917431|NCT01589237|10047620|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2917432|NCT01589237|10047617|P4|Part A (52 Weeks)|Subject/guardian decision|0
2917433|NCT01589237|10047618|P3|Part A (52 Weeks)|Subject/guardian decision|2
2917434|NCT01589237|10047619|P2|Part A (52 Weeks)|Subject/guardian decision|3
2917435|NCT01589237|10047620|P1|Part A (52 Weeks)|Subject/guardian decision|2
2917436|NCT01589185|10047671|P5|Overall Study|Lost to Follow-up|0
2917437|NCT01589185|10047672|P4|Overall Study|Lost to Follow-up|3
2917438|NCT01589185|10047673|P3|Overall Study|Lost to Follow-up|2
2917439|NCT01589185|10047674|P2|Overall Study|Lost to Follow-up|0
2917440|NCT01589185|10047675|P1|Overall Study|Lost to Follow-up|1
2917441|NCT01589185|10047671|P5|Overall Study|Death|1
2917442|NCT01589185|10047672|P4|Overall Study|Death|0
2917443|NCT01589185|10047673|P3|Overall Study|Death|2
2917444|NCT01589185|10047674|P2|Overall Study|Death|2
2917445|NCT01589185|10047675|P1|Overall Study|Death|1
2917446|NCT01589094|10047708|P1|Overall Study|Did not receive treatment|2
2917447|NCT01588990|10047715|P1|Phase B|Other|2
2917448|NCT01588990|10047715|P1|Phase B|Physician Decision|4
2917449|NCT01588990|10047715|P1|Phase B|Withdrawal by Subject|3
2917450|NCT01588990|10047715|P1|Phase B|Still on therapy at end of study|5
2917451|NCT01588990|10047715|P1|Phase B|Adverse Event|2
2917452|NCT01588990|10047715|P1|Phase A|Still on therapy at end of study|6
2917453|NCT01588990|10047715|P1|Phase A|Adverse Event|28
2917454|NCT01588990|10047715|P1|Phase A|Death|5
2917455|NCT01588990|10047715|P1|Phase A|Lost to Follow-up|1
2917456|NCT01588990|10047715|P1|Phase A|Other|14
2917457|NCT01588990|10047715|P1|Phase A|Physician Decision|11
2917458|NCT01588990|10047715|P1|Phase A|Withdrawal by Subject|5
2917459|NCT01588951|10047743|P3|Overall Study|Ineligible in retrospect|1
2917460|NCT01588951|10047744|P2|Overall Study|Ineligible in retrospect|0
2917461|NCT01588951|10047745|P1|Overall Study|Ineligible in retrospect|0
2917462|NCT01588548|10047776|P6|Overall Study|Condition Under Investigation Worsened|3
2917463|NCT01588548|10047777|P5|Overall Study|Condition Under Investigation Worsened|3
2917464|NCT01588548|10047778|P4|Overall Study|Condition Under Investigation Worsened|4
2917465|NCT01588548|10047779|P3|Overall Study|Condition Under Investigation Worsened|4
2917466|NCT01588548|10047780|P2|Overall Study|Condition Under Investigation Worsened|6
2917467|NCT01588548|10047781|P1|Overall Study|Condition Under Investigation Worsened|3
2917468|NCT01588548|10047776|P6|Overall Study|Adverse Event|0
2917469|NCT01588548|10047777|P5|Overall Study|Adverse Event|1
2917470|NCT01588548|10047778|P4|Overall Study|Adverse Event|2
2917471|NCT01588548|10047779|P3|Overall Study|Adverse Event|1
2917472|NCT01588548|10047780|P2|Overall Study|Adverse Event|0
2917473|NCT01588548|10047781|P1|Overall Study|Adverse Event|0
2917474|NCT01588548|10047776|P6|Overall Study|Withdrawal by Subject|3
2917475|NCT01588548|10047777|P5|Overall Study|Withdrawal by Subject|2
2917476|NCT01588548|10047778|P4|Overall Study|Withdrawal by Subject|1
2917477|NCT01588548|10047779|P3|Overall Study|Withdrawal by Subject|1
2917478|NCT01588548|10047780|P2|Overall Study|Withdrawal by Subject|1
2917479|NCT01588548|10047781|P1|Overall Study|Withdrawal by Subject|0
2917480|NCT01588509|10047797|P2|Overall Study|Lost to Follow-up|0
2917481|NCT01588509|10047798|P1|Overall Study|Lost to Follow-up|1
2917482|NCT01588496|10047821|P3|Overall Study|Withdrawal by Subject|0
2917483|NCT01588496|10047822|P2|Overall Study|Withdrawal by Subject|1
2917484|NCT01588496|10047823|P1|Overall Study|Withdrawal by Subject|0
2917485|NCT01588405|10047873|P1|Overall Study|Clinical Worsening|1
2917486|NCT01588405|10047873|P1|Overall Study|Adverse Event|1
2917487|NCT01588366|10047902|P6|Overall Study|Adverse Event|2
2917488|NCT01588366|10047903|P5|Overall Study|Adverse Event|0
2917489|NCT01588366|10047904|P4|Overall Study|Adverse Event|1
2917490|NCT01588366|10047905|P3|Overall Study|Adverse Event|0
2917491|NCT01588366|10047906|P2|Overall Study|Adverse Event|1
2917492|NCT01588366|10047907|P1|Overall Study|Adverse Event|0
2917493|NCT01588353|10047935|P3|Step3|Adverse Event|2
2917494|NCT01588353|10047936|P2|Step3|Adverse Event|0
2917495|NCT01588353|10047937|P1|Step3|Adverse Event|0
2917496|NCT01588353|10047935|P3|Step2|Withdrawal by Subject|0
2917497|NCT01588353|10047936|P2|Step2|Withdrawal by Subject|1
2917498|NCT01588353|10047937|P1|Step2|Withdrawal by Subject|0
2917499|NCT01588197|10047986|P2|Overall Study|No MRI|0
2917500|NCT01588197|10047987|P1|Overall Study|No MRI|1
2917501|NCT01588197|10047986|P2|Overall Study|Lack of Efficacy|1
2917502|NCT01588197|10047987|P1|Overall Study|Lack of Efficacy|0
2917503|NCT01588106|10048024|P2|Overall Study|Withdrawal by Subject|4
2917504|NCT01588106|10048025|P1|Overall Study|Withdrawal by Subject|5
2917505|NCT01587989|10048033|P3|Randomized Study Treatment|Physician Decision|1
2917506|NCT01587989|10048034|P2|Randomized Study Treatment|Physician Decision|0
2917507|NCT01587989|10048035|P1|Randomized Study Treatment|Physician Decision|0
2917508|NCT01587989|10048033|P3|Randomized Study Treatment|Screening failure|0
2917509|NCT01587989|10048034|P2|Randomized Study Treatment|Screening failure|1
2917510|NCT01587989|10048035|P1|Randomized Study Treatment|Screening failure|0
2917511|NCT01587989|10048033|P3|Randomized Study Treatment|Withdrawal by Subject|0
2917512|NCT01587989|10048034|P2|Randomized Study Treatment|Withdrawal by Subject|1
2917513|NCT01587989|10048035|P1|Randomized Study Treatment|Withdrawal by Subject|0
2917514|NCT01587989|10048033|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
2917515|NCT01587989|10048034|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
2917516|NCT01587989|10048035|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
2917517|NCT01587989|10048033|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2917518|NCT01587989|10048034|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2917519|NCT01587989|10048035|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
2917520|NCT01587989|10048033|P3|12-Week Open-Label Run-In Period|Physician Decision|0
2917521|NCT01587989|10048034|P2|12-Week Open-Label Run-In Period|Physician Decision|0
2917522|NCT01587989|10048035|P1|12-Week Open-Label Run-In Period|Physician Decision|7
2917523|NCT01587924|10048100|P4|Overall Study|Withdrawal by Subject|0
2917524|NCT01587924|10048101|P3|Overall Study|Withdrawal by Subject|1
2917525|NCT01587924|10048102|P2|Overall Study|Withdrawal by Subject|1
2917526|NCT01587924|10048103|P1|Overall Study|Withdrawal by Subject|0
2917527|NCT01587924|10048100|P4|Overall Study|Met Hemoglobin stopping criteria|0
2917528|NCT01587924|10048101|P3|Overall Study|Met Hemoglobin stopping criteria|1
2917529|NCT01587924|10048102|P2|Overall Study|Met Hemoglobin stopping criteria|0
2917530|NCT01587924|10048103|P1|Overall Study|Met Hemoglobin stopping criteria|2
2917531|NCT01587924|10048100|P4|Overall Study|Protocol Violation|1
2917532|NCT01587924|10048101|P3|Overall Study|Protocol Violation|2
2917533|NCT01587924|10048102|P2|Overall Study|Protocol Violation|1
2917534|NCT01587924|10048103|P1|Overall Study|Protocol Violation|2
2917535|NCT01587924|10048100|P4|Overall Study|Adverse Event|0
2917536|NCT01587924|10048101|P3|Overall Study|Adverse Event|0
2917537|NCT01587924|10048102|P2|Overall Study|Adverse Event|2
2917538|NCT01587924|10048103|P1|Overall Study|Adverse Event|0
2917539|NCT01587898|10048204|P4|Overall Study|Met haemoglobin stopping criteria|0
2917540|NCT01587898|10048205|P3|Overall Study|Met haemoglobin stopping criteria|1
2917541|NCT01587898|10048206|P2|Overall Study|Met haemoglobin stopping criteria|1
2917542|NCT01587898|10048207|P1|Overall Study|Met haemoglobin stopping criteria|1
2917543|NCT01587898|10048204|P4|Overall Study|Withdrawal by Subject|0
2917544|NCT01587898|10048205|P3|Overall Study|Withdrawal by Subject|0
2917545|NCT01587898|10048206|P2|Overall Study|Withdrawal by Subject|1
2917546|NCT01587898|10048207|P1|Overall Study|Withdrawal by Subject|2
2917547|NCT01587898|10048204|P4|Overall Study|Lost to Follow-up|1
2917548|NCT01587898|10048205|P3|Overall Study|Lost to Follow-up|0
2917549|NCT01587898|10048206|P2|Overall Study|Lost to Follow-up|0
2917550|NCT01587898|10048207|P1|Overall Study|Lost to Follow-up|0
2917551|NCT01587898|10048204|P4|Overall Study|Protocol Violation|1
2917552|NCT01587898|10048205|P3|Overall Study|Protocol Violation|1
2917553|NCT01587898|10048206|P2|Overall Study|Protocol Violation|2
2917554|NCT01587898|10048207|P1|Overall Study|Protocol Violation|0
2917555|NCT01587898|10048204|P4|Overall Study|Adverse Event|0
2917556|NCT01587898|10048205|P3|Overall Study|Adverse Event|0
2917557|NCT01587898|10048206|P2|Overall Study|Adverse Event|1
2917558|NCT01587898|10048207|P1|Overall Study|Adverse Event|1
2917559|NCT01587885|10048383|P2|Treatment Period 1|Protocol Violation|2
2917560|NCT01587885|10048384|P1|Treatment Period 1|Protocol Violation|0
2917561|NCT01587885|10048383|P2|Treatment Period 1|Failure to Return|1
2917562|NCT01587885|10048384|P1|Treatment Period 1|Failure to Return|0
2917563|NCT01587703|10048415|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917564|NCT01587703|10048416|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917565|NCT01587703|10048417|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917566|NCT01587703|10048418|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917567|NCT01587703|10048419|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917568|NCT01587703|10048420|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917569|NCT01587703|10048421|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917570|NCT01587703|10048422|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
2917571|NCT01587703|10048423|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917572|NCT01587703|10048424|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917573|NCT01587703|10048425|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917574|NCT01587703|10048426|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917575|NCT01587703|10048427|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917576|NCT01587703|10048428|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917577|NCT01587703|10048429|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917578|NCT01587703|10048430|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917579|NCT01587703|10048431|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917580|NCT01587703|10048432|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917581|NCT01587703|10048433|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2917582|NCT01587703|10048415|P19|Part2(Median Exposure of 1.41 Months)|Death|0
2917583|NCT01587703|10048416|P18|Part2(Median Exposure of 1.41 Months)|Death|0
2917584|NCT01587703|10048417|P17|Part2(Median Exposure of 1.41 Months)|Death|5
2917585|NCT01587703|10048418|P16|Part2(Median Exposure of 1.41 Months)|Death|17
2917586|NCT01587703|10048419|P15|Part2(Median Exposure of 1.41 Months)|Death|16
2917587|NCT01587703|10048420|P14|Part2(Median Exposure of 1.41 Months)|Death|21
2917588|NCT01587703|10048421|P13|Part2(Median Exposure of 1.41 Months)|Death|12
2917589|NCT01587703|10048422|P12|Part2(Median Exposure of 1.41 Months)|Death|8
2917590|NCT01587703|10048423|P11|Part2(Median Exposure of 1.41 Months)|Death|0
2917591|NCT01587703|10048424|P10|Part2(Median Exposure of 1.41 Months)|Death|0
2917592|NCT01587703|10048425|P9|Part2(Median Exposure of 1.41 Months)|Death|0
2917593|NCT01587703|10048426|P8|Part2(Median Exposure of 1.41 Months)|Death|0
2917594|NCT01587703|10048427|P7|Part2(Median Exposure of 1.41 Months)|Death|0
2917595|NCT01587703|10048428|P6|Part2(Median Exposure of 1.41 Months)|Death|0
2917596|NCT01587703|10048429|P5|Part2(Median Exposure of 1.41 Months)|Death|0
2917597|NCT01587703|10048430|P4|Part2(Median Exposure of 1.41 Months)|Death|0
2917598|NCT01587703|10048431|P3|Part2(Median Exposure of 1.41 Months)|Death|0
2917599|NCT01587703|10048432|P2|Part2(Median Exposure of 1.41 Months)|Death|0
2917600|NCT01587703|10048433|P1|Part2(Median Exposure of 1.41 Months)|Death|0
2917601|NCT01587703|10048415|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917602|NCT01587703|10048416|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917603|NCT01587703|10048417|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
2917604|NCT01587703|10048418|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
2917605|NCT01587703|10048419|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
2917606|NCT01587703|10048420|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
2917607|NCT01587703|10048421|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
2917608|NCT01587703|10048422|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
2917609|NCT01587703|10048423|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917610|NCT01587703|10048424|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917611|NCT01587703|10048425|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917612|NCT01587703|10048426|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917613|NCT01587703|10048427|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917614|NCT01587703|10048428|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917615|NCT01587703|10048429|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917616|NCT01587703|10048430|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917617|NCT01587703|10048431|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917618|NCT01587703|10048432|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917619|NCT01587703|10048433|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
2917620|NCT01587703|10048415|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917621|NCT01587703|10048416|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917622|NCT01587703|10048417|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917623|NCT01587703|10048418|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917624|NCT01587703|10048419|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
2917625|NCT01587703|10048420|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917626|NCT01587703|10048421|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917627|NCT01587703|10048422|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
2917628|NCT01587703|10048423|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917629|NCT01587703|10048424|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917630|NCT01587703|10048425|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917631|NCT01587703|10048426|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917632|NCT01587703|10048427|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917633|NCT01587703|10048428|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917634|NCT01587703|10048429|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917635|NCT01587703|10048430|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917636|NCT01587703|10048431|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917637|NCT01587703|10048432|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917638|NCT01587703|10048433|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2917639|NCT01587703|10048415|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917640|NCT01587703|10048416|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917641|NCT01587703|10048417|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917642|NCT01587703|10048418|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
2917643|NCT01587703|10048419|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917644|NCT01587703|10048420|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917645|NCT01587703|10048421|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917646|NCT01587703|10048422|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917647|NCT01587703|10048423|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917648|NCT01587703|10048424|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917649|NCT01587703|10048425|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917650|NCT01587703|10048426|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917651|NCT01587703|10048427|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917652|NCT01587703|10048428|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917653|NCT01587703|10048429|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917654|NCT01587703|10048430|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917655|NCT01587703|10048431|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917656|NCT01587703|10048432|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917657|NCT01587703|10048433|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2917658|NCT01587703|10048415|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
2917659|NCT01587703|10048416|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
2917660|NCT01587703|10048417|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917661|NCT01587703|10048418|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917662|NCT01587703|10048419|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917663|NCT01587703|10048420|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917664|NCT01587703|10048421|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917665|NCT01587703|10048422|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917666|NCT01587703|10048423|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917667|NCT01587703|10048424|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917668|NCT01587703|10048425|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917669|NCT01587703|10048426|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917670|NCT01587703|10048427|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917893|NCT01586910|10049099|P2|Overall Study|Withdrawal by Subject|43
2917671|NCT01587703|10048428|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917672|NCT01587703|10048429|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917673|NCT01587703|10048430|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917674|NCT01587703|10048431|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917675|NCT01587703|10048432|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917676|NCT01587703|10048433|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2917677|NCT01587703|10048415|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
2917678|NCT01587703|10048416|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917679|NCT01587703|10048417|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917680|NCT01587703|10048418|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917681|NCT01587703|10048419|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917682|NCT01587703|10048420|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917683|NCT01587703|10048421|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917684|NCT01587703|10048422|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917685|NCT01587703|10048423|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917686|NCT01587703|10048424|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917687|NCT01587703|10048425|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917688|NCT01587703|10048426|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917689|NCT01587703|10048427|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917690|NCT01587703|10048428|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917691|NCT01587703|10048429|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917692|NCT01587703|10048430|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917693|NCT01587703|10048431|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917694|NCT01587703|10048432|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917695|NCT01587703|10048433|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2917696|NCT01587703|10048415|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917697|NCT01587703|10048416|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917698|NCT01587703|10048417|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917699|NCT01587703|10048418|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917700|NCT01587703|10048419|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917701|NCT01587703|10048420|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917702|NCT01587703|10048421|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917703|NCT01587703|10048422|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917704|NCT01587703|10048423|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917705|NCT01587703|10048424|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917706|NCT01587703|10048425|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
2917707|NCT01587703|10048426|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917708|NCT01587703|10048427|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917709|NCT01587703|10048428|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917710|NCT01587703|10048429|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917711|NCT01587703|10048430|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917712|NCT01587703|10048431|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917713|NCT01587703|10048432|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917714|NCT01587703|10048433|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2917715|NCT01587703|10048415|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917716|NCT01587703|10048416|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917717|NCT01587703|10048417|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917718|NCT01587703|10048418|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917719|NCT01587703|10048419|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917720|NCT01587703|10048420|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917721|NCT01587703|10048421|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917722|NCT01587703|10048422|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917723|NCT01587703|10048423|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2917724|NCT01587703|10048424|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2917725|NCT01587703|10048425|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917726|NCT01587703|10048426|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917727|NCT01587703|10048427|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917728|NCT01587703|10048428|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917729|NCT01587703|10048429|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917730|NCT01587703|10048430|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917731|NCT01587703|10048431|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917732|NCT01587703|10048432|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917733|NCT01587703|10048433|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2917734|NCT01587703|10048415|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917735|NCT01587703|10048416|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917736|NCT01587703|10048417|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917737|NCT01587703|10048418|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917738|NCT01587703|10048419|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917739|NCT01587703|10048420|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917740|NCT01587703|10048421|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917741|NCT01587703|10048422|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917742|NCT01587703|10048423|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2917743|NCT01587703|10048424|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917744|NCT01587703|10048425|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2917745|NCT01587703|10048426|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917746|NCT01587703|10048427|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917747|NCT01587703|10048428|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917748|NCT01587703|10048429|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917749|NCT01587703|10048430|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917750|NCT01587703|10048431|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917751|NCT01587703|10048432|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917752|NCT01587703|10048433|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2917753|NCT01587703|10048415|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
2917754|NCT01587703|10048416|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
2917755|NCT01587703|10048417|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
2917756|NCT01587703|10048418|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
2917757|NCT01587703|10048419|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
2917758|NCT01587703|10048420|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
2917759|NCT01587703|10048421|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
2917760|NCT01587703|10048422|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
2917761|NCT01587703|10048423|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
2917762|NCT01587703|10048424|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
2917763|NCT01587703|10048425|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
2917764|NCT01587703|10048426|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
2917765|NCT01587703|10048427|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
2917766|NCT01587703|10048428|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
2917767|NCT01587703|10048429|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
2917768|NCT01587703|10048430|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
2917769|NCT01587703|10048431|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
2917770|NCT01587703|10048432|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
2917771|NCT01587703|10048433|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
2917772|NCT01587703|10048415|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
2917773|NCT01587703|10048416|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
2917774|NCT01587703|10048417|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
2917775|NCT01587703|10048418|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
2917776|NCT01587703|10048419|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
2917777|NCT01587703|10048420|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
2917778|NCT01587703|10048421|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
2917779|NCT01587703|10048422|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
2917780|NCT01587703|10048423|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
2917781|NCT01587703|10048424|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
2917782|NCT01587703|10048425|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
2917783|NCT01587703|10048426|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
2917784|NCT01587703|10048427|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
2917785|NCT01587703|10048428|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
2917786|NCT01587703|10048429|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
2917787|NCT01587703|10048430|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
2917788|NCT01587703|10048431|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
2917789|NCT01587703|10048432|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
2917790|NCT01587703|10048433|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
2917791|NCT01587703|10048415|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917792|NCT01587703|10048416|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917793|NCT01587703|10048417|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917794|NCT01587703|10048418|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917795|NCT01587703|10048419|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917796|NCT01587703|10048420|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917797|NCT01587703|10048421|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917798|NCT01587703|10048422|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917799|NCT01587703|10048423|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917800|NCT01587703|10048424|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917801|NCT01587703|10048425|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917802|NCT01587703|10048426|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917803|NCT01587703|10048427|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
2917804|NCT01587703|10048428|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917805|NCT01587703|10048429|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917806|NCT01587703|10048430|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917807|NCT01587703|10048431|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917808|NCT01587703|10048432|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917809|NCT01587703|10048433|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2917810|NCT01587703|10048415|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917811|NCT01587703|10048416|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917812|NCT01587703|10048417|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917813|NCT01587703|10048418|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917814|NCT01587703|10048419|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917815|NCT01587703|10048420|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917816|NCT01587703|10048421|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917817|NCT01587703|10048422|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917818|NCT01587703|10048423|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917819|NCT01587703|10048424|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917820|NCT01587703|10048425|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917821|NCT01587703|10048426|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
2917822|NCT01587703|10048427|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917823|NCT01587703|10048428|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
2917824|NCT01587703|10048429|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917825|NCT01587703|10048430|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917826|NCT01587703|10048431|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917827|NCT01587703|10048432|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917828|NCT01587703|10048433|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2917829|NCT01587703|10048415|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917830|NCT01587703|10048416|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917831|NCT01587703|10048417|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917832|NCT01587703|10048418|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917833|NCT01587703|10048419|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917834|NCT01587703|10048420|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917835|NCT01587703|10048421|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917836|NCT01587703|10048422|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917837|NCT01587703|10048423|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917838|NCT01587703|10048424|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917839|NCT01587703|10048425|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917840|NCT01587703|10048426|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917841|NCT01587703|10048427|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917842|NCT01587703|10048428|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917843|NCT01587703|10048429|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917844|NCT01587703|10048430|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917845|NCT01587703|10048431|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917846|NCT01587703|10048432|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2917847|NCT01587703|10048433|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
2917848|NCT01587651|10048840|P3|Overall Study|Withdrawal by Subject|0
2917849|NCT01587651|10048841|P2|Overall Study|Withdrawal by Subject|1
2917850|NCT01587651|10048842|P1|Overall Study|Withdrawal by Subject|0
2917851|NCT01587651|10048840|P3|Overall Study|Protocol Violation|1
2917852|NCT01587651|10048841|P2|Overall Study|Protocol Violation|1
2917853|NCT01587651|10048842|P1|Overall Study|Protocol Violation|0
2917854|NCT01587651|10048840|P3|Overall Study|Adverse Event|0
2917855|NCT01587651|10048841|P2|Overall Study|Adverse Event|1
2917856|NCT01587651|10048842|P1|Overall Study|Adverse Event|0
2917857|NCT01587274|10048872|P3|Overall Study|Lost to Follow-up|3
2917858|NCT01587274|10048873|P2|Overall Study|Lost to Follow-up|5
2917859|NCT01587274|10048874|P1|Overall Study|Lost to Follow-up|4
2917860|NCT01587118|10048882|P1|Overall Study|nonresponse|1
2917861|NCT01587118|10048882|P1|Overall Study|Relocation|1
2917862|NCT01587118|10048882|P1|Overall Study|Lost to Follow-up|2
2917863|NCT01587118|10048882|P1|Overall Study|Adverse Event|3
2917864|NCT01587079|10048906|P1|Overall Study|Adverse Event|14
2917865|NCT01587079|10048906|P1|Overall Study|Withdrawal by Subject|7
2917866|NCT01587079|10048906|P1|Overall Study|Physician Decision|2
2917867|NCT01587079|10048906|P1|Overall Study|Lost to Follow-up|2
2917868|NCT01587079|10048906|P1|Overall Study|Protocol Violation|5
2917869|NCT01587079|10048906|P1|Overall Study|Protocol-specified criteria|9
2917870|NCT01587040|10049032|P4|Overall Study|Other than specified|1
2917871|NCT01587040|10049033|P3|Overall Study|Other than specified|11
2917872|NCT01587040|10049034|P2|Overall Study|Other than specified|1
2917873|NCT01587040|10049035|P1|Overall Study|Other than specified|5
2917874|NCT01587040|10049032|P4|Overall Study|Disease progression|3
2917875|NCT01587040|10049033|P3|Overall Study|Disease progression|15
2917876|NCT01587040|10049034|P2|Overall Study|Disease progression|1
2917877|NCT01587040|10049035|P1|Overall Study|Disease progression|12
2917878|NCT01587040|10049032|P4|Overall Study|Adverse Event|0
2917879|NCT01587040|10049033|P3|Overall Study|Adverse Event|10
2917880|NCT01587040|10049034|P2|Overall Study|Adverse Event|1
2917881|NCT01587040|10049035|P1|Overall Study|Adverse Event|0
2917882|NCT01587040|10049032|P4|Overall Study|Protocol Violation|0
2917883|NCT01587040|10049033|P3|Overall Study|Protocol Violation|1
2917884|NCT01587040|10049034|P2|Overall Study|Protocol Violation|0
2917885|NCT01587040|10049035|P1|Overall Study|Protocol Violation|0
2917886|NCT01587014|10049062|P1|Overall Study|Death|2
2917887|NCT01587001|10049069|P2|Overall Study|Insufficient samples to complete testing|1
2917888|NCT01587001|10049070|P1|Overall Study|Insufficient samples to complete testing|4
2917889|NCT01587001|10049069|P2|Overall Study|Lost to Follow-up|0
2917890|NCT01587001|10049070|P1|Overall Study|Lost to Follow-up|2
2917891|NCT01586910|10049099|P2|Overall Study|Physician withdrew Subject|24
2917892|NCT01586910|10049100|P1|Overall Study|Physician withdrew Subject|5
2917894|NCT01586910|10049100|P1|Overall Study|Withdrawal by Subject|6
2917895|NCT01586910|10049099|P2|Overall Study|Death|4
2917896|NCT01586910|10049100|P1|Overall Study|Death|4
2917897|NCT01586819|10049174|P2|Overall Study|Withdrawal by Subject|0
2917898|NCT01586819|10049175|P1|Overall Study|Withdrawal by Subject|1
2917899|NCT01586806|10049186|P3|Overall Study|Lost to Follow-up|2
2917900|NCT01586806|10049187|P2|Overall Study|Lost to Follow-up|3
2917901|NCT01586806|10049188|P1|Overall Study|Lost to Follow-up|2
2917902|NCT01586806|10049186|P3|Overall Study|Withdrawal by Subject|0
2917903|NCT01586806|10049187|P2|Overall Study|Withdrawal by Subject|0
2917904|NCT01586806|10049188|P1|Overall Study|Withdrawal by Subject|1
2917905|NCT01586806|10049186|P3|Overall Study|Protocol Violation|0
2917906|NCT01586806|10049187|P2|Overall Study|Protocol Violation|1
2917907|NCT01586806|10049188|P1|Overall Study|Protocol Violation|0
2917908|NCT01586364|10049208|P1|Overall Study|Other-Not specified|1
2917909|NCT01586364|10049208|P1|Overall Study|Other-PI discretion, site closing|2
2917910|NCT01586364|10049208|P1|Overall Study|Other-Site closure due to PI illness|1
2917911|NCT01586364|10049208|P1|Overall Study|Other-Subject wasn't getting much relief|1
2917912|NCT01586364|10049208|P1|Overall Study|Other-Did not feel better post-treatment|1
2917913|NCT01586364|10049208|P1|Overall Study|Lack of Efficacy|1
2917914|NCT01586364|10049208|P1|Overall Study|Protocol Violation|16
2917915|NCT01586364|10049208|P1|Overall Study|Lost to Follow-up|17
2917916|NCT01586364|10049208|P1|Overall Study|Adverse Event|37
2917917|NCT01586364|10049208|P1|Overall Study|Withdrawal by Subject|40
2917918|NCT01586338|10049261|P1|Overall Study|Other|1
2917919|NCT01586338|10049261|P1|Overall Study|Withdrawal by participant|3
2917920|NCT01586338|10049261|P1|Overall Study|Lost to Follow-up|1
2917921|NCT01586338|10049261|P1|Overall Study|Adverse Event|3
2917922|NCT01586195|10049284|P1|Overall Study|Reason not specified|9
2917923|NCT01586195|10049284|P1|Overall Study|Started new anti-melanoma therapy|1
2917924|NCT01586195|10049284|P1|Overall Study|Withdrawal of Consent|5
2917925|NCT01586195|10049284|P1|Overall Study|Death|11
2917926|NCT01586156|10049298|P3|Overall Study|Pregnancy|0
2917927|NCT01586156|10049299|P2|Overall Study|Pregnancy|1
2917928|NCT01586156|10049300|P1|Overall Study|Pregnancy|0
2917929|NCT01585987|10049357|P2|Treated|Poor/Non-Compliance|1
2917930|NCT01585987|10049358|P1|Treated|Poor/Non-Compliance|0
2917931|NCT01585987|10049357|P2|Treated|Subject Request|1
2917932|NCT01585987|10049358|P1|Treated|Subject Request|0
2917933|NCT01585987|10049357|P2|Treated|Non-Specified|2
2917934|NCT01585987|10049358|P1|Treated|Non-Specified|1
2917935|NCT01585987|10049357|P2|Treated|Maximum Clinical Benefit|1
2917936|NCT01585987|10049358|P1|Treated|Maximum Clinical Benefit|0
2917937|NCT01585987|10049357|P2|Treated|Lost to Follow-up|1
2917938|NCT01585987|10049358|P1|Treated|Lost to Follow-up|0
2917939|NCT01585987|10049357|P2|Treated|Death|0
2917940|NCT01585987|10049358|P1|Treated|Death|1
2917941|NCT01585987|10049357|P2|Treated|Withdrawal by Subject|2
2917942|NCT01585987|10049358|P1|Treated|Withdrawal by Subject|1
2917943|NCT01585987|10049357|P2|Treated|Adverse Event|0
2917944|NCT01585987|10049358|P1|Treated|Adverse Event|3
2917945|NCT01585987|10049357|P2|Treated|Study Drug Toxicity|5
2917946|NCT01585987|10049358|P1|Treated|Study Drug Toxicity|9
2917947|NCT01585987|10049357|P2|Treated|Disease Progression|36
2917948|NCT01585987|10049358|P1|Treated|Disease Progression|39
2917949|NCT01585987|10049357|P2|Randomized|No longer met criteria|2
2917950|NCT01585987|10049358|P1|Randomized|No longer met criteria|0
2917951|NCT01585987|10049357|P2|Randomized|Withdrawal by Subject|4
2917952|NCT01585987|10049358|P1|Randomized|Withdrawal by Subject|0
2917953|NCT01585961|10049373|P1|Overall Study|Ablation cancelled for slow-heal wound|1
2917954|NCT01585961|10049373|P1|Overall Study|Lost to Follow-up|23
2917955|NCT01585961|10049373|P1|Overall Study|Withdrawal by Subject|1
2917956|NCT01585961|10049373|P1|Overall Study|Decision to use non-study catheter|1
2917957|NCT01585961|10049373|P1|Overall Study|Physician Decision|1
2917958|NCT01585961|10049373|P1|Overall Study|Death|6
2917959|NCT01585766|10049451|P6|Overall Study|Physician Decision|0
2917960|NCT01585766|10049452|P5|Overall Study|Physician Decision|0
2917961|NCT01585766|10049453|P4|Overall Study|Physician Decision|0
2917962|NCT01585766|10049454|P3|Overall Study|Physician Decision|1
2917963|NCT01585766|10049455|P2|Overall Study|Physician Decision|0
2917964|NCT01585766|10049456|P1|Overall Study|Physician Decision|0
2917965|NCT01585766|10049451|P6|Overall Study|Death|0
2917966|NCT01585766|10049452|P5|Overall Study|Death|0
2917967|NCT01585766|10049453|P4|Overall Study|Death|0
2917968|NCT01585766|10049454|P3|Overall Study|Death|0
2917969|NCT01585766|10049455|P2|Overall Study|Death|1
2917970|NCT01585766|10049456|P1|Overall Study|Death|0
2917971|NCT01585766|10049451|P6|Overall Study|Withdrawal by Subject|0
2917972|NCT01585766|10049452|P5|Overall Study|Withdrawal by Subject|0
2917973|NCT01585766|10049453|P4|Overall Study|Withdrawal by Subject|0
2917974|NCT01585766|10049454|P3|Overall Study|Withdrawal by Subject|1
2917975|NCT01585766|10049455|P2|Overall Study|Withdrawal by Subject|1
2917976|NCT01585766|10049456|P1|Overall Study|Withdrawal by Subject|0
2917977|NCT01585584|10049560|P1|Overall Study|Physician Decision|2
2917978|NCT01585584|10049560|P1|Overall Study|Withdrawal by Subject|1
2917979|NCT01585584|10049560|P1|Overall Study|Lack of Efficacy|1
2917980|NCT01585558|10049567|P3|Overall Study|Lack of Efficacy|1
2917981|NCT01585558|10049568|P2|Overall Study|Lack of Efficacy|0
2917982|NCT01585558|10049569|P1|Overall Study|Lack of Efficacy|0
2917983|NCT01585558|10049567|P3|Overall Study|Protocol Violation|2
2917984|NCT01585558|10049568|P2|Overall Study|Protocol Violation|3
2917985|NCT01585558|10049569|P1|Overall Study|Protocol Violation|4
2917986|NCT01585558|10049567|P3|Overall Study|Adverse Event|1
2917987|NCT01585558|10049568|P2|Overall Study|Adverse Event|4
2917988|NCT01585558|10049569|P1|Overall Study|Adverse Event|3
2917989|NCT01585558|10049567|P3|Overall Study|Lost to Follow-up|3
2917990|NCT01585558|10049568|P2|Overall Study|Lost to Follow-up|0
2917991|NCT01585558|10049569|P1|Overall Study|Lost to Follow-up|2
2917992|NCT01585558|10049567|P3|Overall Study|Withdrawal by Subject|8
2917993|NCT01585558|10049568|P2|Overall Study|Withdrawal by Subject|5
2917994|NCT01585558|10049569|P1|Overall Study|Withdrawal by Subject|4
2917995|NCT01585428|10049803|P2|Overall Study|Death during treatment|0
2917996|NCT01585428|10049804|P1|Overall Study|Death during treatment|1
2917997|NCT01585298|10049828|P1|Overall Study|Adverse Event|24
2917998|NCT01585298|10049828|P1|Overall Study|Abnormal test procedure results|1
2917999|NCT01585298|10049828|P1|Overall Study|Withdrawal by Subject|4
2918000|NCT01585298|10049828|P1|Overall Study|Lost to Follow-up|2
2918001|NCT01585298|10049828|P1|Overall Study|Administrative problems|4
2918002|NCT01585298|10049828|P1|Overall Study|Protocol deviation|1
2918003|NCT01585298|10049828|P1|Overall Study|Study completion was not documented.|1
2918004|NCT01585272|10049836|P1|Overall Study|Withdrawal by Subject|10
2918005|NCT01585272|10049836|P1|Overall Study|Protocol Violation|7
2918006|NCT01585272|10049836|P1|Overall Study|Adverse Event|22
2918007|NCT01585246|10049849|P5|Overall Study|Other|0
2918008|NCT01585246|10049850|P4|Overall Study|Other|1
2918009|NCT01585246|10049851|P3|Overall Study|Other|1
2918010|NCT01585246|10049852|P2|Overall Study|Other|1
2918011|NCT01585246|10049853|P1|Overall Study|Other|0
2918012|NCT01585246|10049849|P5|Overall Study|Withdrawal by Subject|1
2918013|NCT01585246|10049850|P4|Overall Study|Withdrawal by Subject|2
2918014|NCT01585246|10049851|P3|Overall Study|Withdrawal by Subject|1
2918015|NCT01585246|10049852|P2|Overall Study|Withdrawal by Subject|0
2918016|NCT01585246|10049853|P1|Overall Study|Withdrawal by Subject|0
2918017|NCT01585246|10049849|P5|Overall Study|Protocol Violation|1
2918018|NCT01585246|10049850|P4|Overall Study|Protocol Violation|0
2918019|NCT01585246|10049851|P3|Overall Study|Protocol Violation|0
2918020|NCT01585246|10049852|P2|Overall Study|Protocol Violation|0
2918021|NCT01585246|10049853|P1|Overall Study|Protocol Violation|0
2918022|NCT01585246|10049849|P5|Overall Study|Lost to Follow-up|0
2918023|NCT01585246|10049850|P4|Overall Study|Lost to Follow-up|1
2918024|NCT01585246|10049851|P3|Overall Study|Lost to Follow-up|2
2918025|NCT01585246|10049852|P2|Overall Study|Lost to Follow-up|0
2918026|NCT01585246|10049853|P1|Overall Study|Lost to Follow-up|0
2918027|NCT01585168|10049874|P4|Overall Study|Lost to Follow-up|1
2918028|NCT01585168|10049875|P3|Overall Study|Lost to Follow-up|1
2918029|NCT01585168|10049876|P2|Overall Study|Lost to Follow-up|1
2918030|NCT01585168|10049877|P1|Overall Study|Lost to Follow-up|3
2918031|NCT01585155|10049897|P1|Overall Study|Worsening ulcerative colitis|2
2918032|NCT01585155|10049897|P1|Overall Study|Lack of Efficacy|2
2918033|NCT01585155|10049897|P1|Overall Study|Adverse Event|1
2918034|NCT01585038|10049919|P2|Overall Study|Adverse Event|2
2918035|NCT01585038|10049920|P1|Overall Study|Adverse Event|2
2918036|NCT01585025|10049935|P3|Overall Study|Withdrawal by Subject|4
2918037|NCT01585025|10049936|P2|Overall Study|Withdrawal by Subject|3
2918038|NCT01585025|10049937|P1|Overall Study|Withdrawal by Subject|0
2918039|NCT01584843|10049967|P6|Second Treatment Period|Withdrawal by Subject|1
2918040|NCT01584843|10049968|P5|Second Treatment Period|Withdrawal by Subject|0
2918041|NCT01584843|10049969|P4|Second Treatment Period|Withdrawal by Subject|0
2918042|NCT01584843|10049970|P3|Second Treatment Period|Withdrawal by Subject|0
2918043|NCT01584843|10049971|P2|Second Treatment Period|Withdrawal by Subject|0
2918044|NCT01584843|10049972|P1|Second Treatment Period|Withdrawal by Subject|0
2918045|NCT01584843|10049967|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
2918046|NCT01584843|10049968|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2918047|NCT01584843|10049969|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2918048|NCT01584843|10049970|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2918049|NCT01584843|10049971|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2918050|NCT01584843|10049972|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2918051|NCT01584843|10049967|P6|First Treatment Period|Protocol Violation|1
2918052|NCT01584843|10049968|P5|First Treatment Period|Protocol Violation|0
2918053|NCT01584843|10049969|P4|First Treatment Period|Protocol Violation|0
2918054|NCT01584843|10049970|P3|First Treatment Period|Protocol Violation|0
2918055|NCT01584843|10049971|P2|First Treatment Period|Protocol Violation|0
2918056|NCT01584843|10049972|P1|First Treatment Period|Protocol Violation|0
2918057|NCT01584843|10049967|P6|First Treatment Period|Adverse Event|0
2918058|NCT01584843|10049968|P5|First Treatment Period|Adverse Event|0
2918059|NCT01584843|10049969|P4|First Treatment Period|Adverse Event|0
2918060|NCT01584843|10049970|P3|First Treatment Period|Adverse Event|1
2918061|NCT01584843|10049971|P2|First Treatment Period|Adverse Event|0
2918062|NCT01584843|10049972|P1|First Treatment Period|Adverse Event|0
2918063|NCT01584648|10050083|P2|Overall Study|Ongoing|147
2918064|NCT01584648|10050084|P1|Overall Study|Ongoing|154
2918065|NCT01584648|10050083|P2|Overall Study|Death|55
2918066|NCT01584648|10050084|P1|Overall Study|Death|40
2918067|NCT01584648|10050083|P2|Overall Study|Withdrawal by Subject|5
2918068|NCT01584648|10050084|P1|Overall Study|Withdrawal by Subject|11
2918069|NCT01584648|10050083|P2|Overall Study|Physician Decision|2
2918070|NCT01584648|10050084|P1|Overall Study|Physician Decision|2
2918071|NCT01584648|10050083|P2|Overall Study|Lost to Follow-up|3
2918072|NCT01584648|10050084|P1|Overall Study|Lost to Follow-up|4
2918073|NCT01584232|10050212|P2|Overall Study|Lost to Follow-up|0
2918074|NCT01584232|10050213|P1|Overall Study|Lost to Follow-up|1
2918075|NCT01584232|10050212|P2|Overall Study|Physician Decision|1
2918076|NCT01584232|10050213|P1|Overall Study|Physician Decision|2
2918077|NCT01584232|10050212|P2|Overall Study|Withdrawal by Subject|1
2918078|NCT01584232|10050213|P1|Overall Study|Withdrawal by Subject|2
2918079|NCT01584232|10050212|P2|Overall Study|Adverse Event|1
2918080|NCT01584232|10050213|P1|Overall Study|Adverse Event|3
2918081|NCT01584024|10050229|P1|Overall Study|Withdrawal by Subject|3
2918082|NCT01584024|10050229|P1|Overall Study|Lost to Follow-up|10
2918083|NCT01583530|10050309|P6|Overall Study|Lack of compliance|0
2918084|NCT01583530|10050310|P5|Overall Study|Lack of compliance|1
2918085|NCT01583530|10050311|P4|Overall Study|Lack of compliance|0
2918086|NCT01583530|10050312|P3|Overall Study|Lack of compliance|0
2918087|NCT01583530|10050313|P2|Overall Study|Lack of compliance|0
2918088|NCT01583530|10050314|P1|Overall Study|Lack of compliance|0
2918089|NCT01583530|10050309|P6|Overall Study|Lost to Follow-up|0
2918090|NCT01583530|10050310|P5|Overall Study|Lost to Follow-up|3
2918091|NCT01583530|10050311|P4|Overall Study|Lost to Follow-up|0
2918092|NCT01583530|10050312|P3|Overall Study|Lost to Follow-up|0
2918093|NCT01583530|10050313|P2|Overall Study|Lost to Follow-up|0
2918094|NCT01583530|10050314|P1|Overall Study|Lost to Follow-up|0
2918095|NCT01583530|10050309|P6|Overall Study|Withdrawal by Subject|2
2918096|NCT01583530|10050310|P5|Overall Study|Withdrawal by Subject|1
2918097|NCT01583530|10050311|P4|Overall Study|Withdrawal by Subject|1
2918098|NCT01583530|10050312|P3|Overall Study|Withdrawal by Subject|0
2918099|NCT01583530|10050313|P2|Overall Study|Withdrawal by Subject|3
2918100|NCT01583530|10050314|P1|Overall Study|Withdrawal by Subject|0
2918101|NCT01583530|10050309|P6|Overall Study|Adverse Event|1
2918102|NCT01583530|10050310|P5|Overall Study|Adverse Event|0
2918103|NCT01583530|10050311|P4|Overall Study|Adverse Event|0
2918104|NCT01583530|10050312|P3|Overall Study|Adverse Event|0
2918105|NCT01583530|10050313|P2|Overall Study|Adverse Event|0
2918106|NCT01583530|10050314|P1|Overall Study|Adverse Event|0
2918107|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2918108|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2918109|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2918110|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2918111|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2918112|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
2918113|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2918114|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2918115|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2918116|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2918117|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2918118|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2918119|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2918120|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2918121|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2918122|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2918123|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2918124|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2918125|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Death|0
2918126|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Death|0
2918127|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Death|1
2918128|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Death|0
2918129|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Death|1
2918130|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Death|0
2918131|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Death|0
2918132|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Death|0
2918133|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Death|0
2918134|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2918135|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2918136|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
2918137|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
2918138|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
2918139|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
2918140|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2918141|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2918142|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
2918143|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2918144|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2918145|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918146|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918147|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2918148|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918149|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918150|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918151|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2918152|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2918153|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
2918154|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2918155|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2918156|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
2918157|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2918158|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
2918159|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2918160|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
2918161|NCT01583374|10050376|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
2918162|NCT01583374|10050377|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
2918163|NCT01583374|10050378|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2918164|NCT01583374|10050379|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2918165|NCT01583374|10050380|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
2918166|NCT01583374|10050381|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2918167|NCT01583374|10050382|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2918168|NCT01583374|10050383|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
2918169|NCT01583374|10050384|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
2918170|NCT01583374|10050376|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918171|NCT01583374|10050377|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918172|NCT01583374|10050378|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918173|NCT01583374|10050379|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
2918174|NCT01583374|10050380|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2918175|NCT01583374|10050381|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918176|NCT01583374|10050382|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2918177|NCT01583374|10050383|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918178|NCT01583374|10050384|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2918179|NCT01583374|10050376|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918180|NCT01583374|10050377|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918181|NCT01583374|10050378|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918182|NCT01583374|10050379|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918183|NCT01583374|10050380|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2918184|NCT01583374|10050381|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918185|NCT01583374|10050382|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2918186|NCT01583374|10050383|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
2918187|NCT01583374|10050384|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2918188|NCT01583374|10050376|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2918189|NCT01583374|10050377|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
2918190|NCT01583374|10050378|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
2918191|NCT01583374|10050379|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2918192|NCT01583374|10050380|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
2918193|NCT01583374|10050381|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
2918194|NCT01583374|10050382|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2918195|NCT01583374|10050383|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2918196|NCT01583374|10050384|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2918197|NCT01583374|10050376|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2918198|NCT01583374|10050377|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2918199|NCT01583374|10050378|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2918200|NCT01583374|10050379|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2918201|NCT01583374|10050380|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2918202|NCT01583374|10050381|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2918203|NCT01583374|10050382|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
2918204|NCT01583374|10050383|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2918205|NCT01583374|10050384|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2918206|NCT01583374|10050376|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918207|NCT01583374|10050377|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
2918208|NCT01583374|10050378|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918209|NCT01583374|10050379|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918210|NCT01583374|10050380|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918211|NCT01583374|10050381|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918212|NCT01583374|10050382|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918213|NCT01583374|10050383|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918214|NCT01583374|10050384|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2918215|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Other|0
2918216|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Other|0
2918217|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Other|0
2918218|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Other|0
2918219|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Other|0
2918220|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Other|0
2918221|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Other|0
2918222|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Other|1
2918223|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Other|0
2918224|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918225|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918226|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918227|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918228|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918229|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918230|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
2918231|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918232|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2918233|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918234|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918235|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918236|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918237|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918238|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918239|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2918240|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
2918241|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
2918242|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918243|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918244|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918245|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918246|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918247|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2918248|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2918249|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2918250|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
2918251|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918252|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918253|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918254|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918255|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918256|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918257|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2918258|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2918259|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2918260|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918261|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918262|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918263|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918264|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918265|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2918266|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2918267|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
2918268|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
2918269|NCT01583374|10050376|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918270|NCT01583374|10050377|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918271|NCT01583374|10050378|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918272|NCT01583374|10050379|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918273|NCT01583374|10050380|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918274|NCT01583374|10050381|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2918275|NCT01583374|10050382|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
2918276|NCT01583374|10050383|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
2918277|NCT01583374|10050384|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
2918278|NCT01583218|10050426|P2|Overall Study|Withdraw of consent on day of random|0
2918279|NCT01583218|10050427|P1|Overall Study|Withdraw of consent on day of random|1
2918280|NCT01583218|10050426|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
2918281|NCT01583218|10050427|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
2918282|NCT01583218|10050426|P2|Overall Study|Patient was randomized due to mistake|0
2918283|NCT01583218|10050427|P1|Overall Study|Patient was randomized due to mistake|1
2918284|NCT01583218|10050426|P2|Overall Study|Patient was early terminated from study|1
2918285|NCT01583218|10050427|P1|Overall Study|Patient was early terminated from study|0
2918286|NCT01583218|10050426|P2|Overall Study|Patient deemed ineligible after random|0
2918287|NCT01583218|10050427|P1|Overall Study|Patient deemed ineligible after random|2
2918288|NCT01583218|10050426|P2|Overall Study|Patient was assessed via phone in person|0
2918289|NCT01583218|10050427|P1|Overall Study|Patient was assessed via phone in person|1
2918290|NCT01583218|10050426|P2|Overall Study|Patient randomized but not dosed|16
2918291|NCT01583218|10050427|P1|Overall Study|Patient randomized but not dosed|17
2918292|NCT01583218|10050426|P2|Overall Study|Patient did not wish to attend visits|1
2918293|NCT01583218|10050427|P1|Overall Study|Patient did not wish to attend visits|0
2918294|NCT01583218|10050426|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
2918295|NCT01583218|10050427|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
2918296|NCT01583218|10050426|P2|Overall Study|Cannot contact patient directly|2
2918297|NCT01583218|10050427|P1|Overall Study|Cannot contact patient directly|1
2918298|NCT01583218|10050426|P2|Overall Study|Patient /Family decision|0
2918299|NCT01583218|10050427|P1|Overall Study|Patient /Family decision|3
2918300|NCT01583218|10050426|P2|Overall Study|Adverse event or serious adverse event|3
2918301|NCT01583218|10050427|P1|Overall Study|Adverse event or serious adverse event|3
2918302|NCT01583218|10050426|P2|Overall Study|Lost to Follow-up|17
2918303|NCT01583218|10050427|P1|Overall Study|Lost to Follow-up|11
2918304|NCT01583218|10050426|P2|Overall Study|Death|211
2918305|NCT01583218|10050427|P1|Overall Study|Death|206
2918306|NCT01583218|10050426|P2|Overall Study|Withdrawal by Subject|29
2918307|NCT01583218|10050427|P1|Overall Study|Withdrawal by Subject|43
2918308|NCT01583179|10050447|P2|Overall Study|Screen failure|2
2918309|NCT01583179|10050448|P1|Overall Study|Screen failure|1
2918310|NCT01583166|10050458|P2|Overall Study|Withdrawal by Subject|6
2918311|NCT01583166|10050459|P1|Overall Study|Withdrawal by Subject|4
2918312|NCT01582971|10050482|P2|Overall Study|Other|13
2918313|NCT01582971|10050483|P1|Overall Study|Other|15
2918314|NCT01582971|10050482|P2|Overall Study|Withdrawal by Subject|2
2918315|NCT01582971|10050483|P1|Overall Study|Withdrawal by Subject|4
2918316|NCT01582971|10050482|P2|Overall Study|Lost to Follow-up|21
2918317|NCT01582971|10050483|P1|Overall Study|Lost to Follow-up|18
2918318|NCT01582971|10050482|P2|Overall Study|Death|1
2918319|NCT01582971|10050483|P1|Overall Study|Death|2
2918320|NCT01582945|10050501|P1|Overall Study|Scheduling conflicts|1
2918321|NCT01582945|10050501|P1|Overall Study|Intolerable side-effects|1
2918322|NCT01582854|10050515|P2|Overall Study|Other Miscellaneous Reason|0
2918323|NCT01582854|10050516|P1|Overall Study|Other Miscellaneous Reason|1
2918324|NCT01582854|10050515|P2|Overall Study|General Anaesthesia|1
2918325|NCT01582854|10050516|P1|Overall Study|General Anaesthesia|0
2918326|NCT01582854|10050515|P2|Overall Study|Carotid or Neurosurgery|1
2918327|NCT01582854|10050516|P1|Overall Study|Carotid or Neurosurgery|0
2918328|NCT01582854|10050515|P2|Overall Study|Disallowed Concomitant Medication|2
2918329|NCT01582854|10050516|P1|Overall Study|Disallowed Concomitant Medication|3
2918330|NCT01582854|10050515|P2|Overall Study|Recurrent Stroke|8
2918331|NCT01582854|10050516|P1|Overall Study|Recurrent Stroke|13
2918332|NCT01582854|10050515|P2|Overall Study|Physician Decision|1
2918333|NCT01582854|10050516|P1|Overall Study|Physician Decision|0
2918334|NCT01582854|10050515|P2|Overall Study|Lost to Follow-up|2
2918335|NCT01582854|10050516|P1|Overall Study|Lost to Follow-up|1
2918336|NCT01582854|10050515|P2|Overall Study|Withdrawal by Participant|11
2918337|NCT01582854|10050516|P1|Overall Study|Withdrawal by Participant|8
2918338|NCT01582854|10050515|P2|Overall Study|Adverse Event|3
2918339|NCT01582854|10050516|P1|Overall Study|Adverse Event|2
2918340|NCT01582854|10050515|P2|Overall Study|Death|5
2918341|NCT01582854|10050516|P1|Overall Study|Death|8
2918342|NCT01582789|10050544|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
2918343|NCT01582789|10050545|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
2918344|NCT01582451|10050605|P2|Overall Study|Sponsor Decision|0
2918345|NCT01582451|10050606|P1|Overall Study|Sponsor Decision|1
2918346|NCT01582451|10050605|P2|Overall Study|Physician Decision|0
2918347|NCT01582451|10050606|P1|Overall Study|Physician Decision|3
2918348|NCT01582451|10050605|P2|Overall Study|Withdrawal by Subject|9
2918349|NCT01582451|10050606|P1|Overall Study|Withdrawal by Subject|13
2918350|NCT01582451|10050605|P2|Overall Study|Protocol Violation|3
2918351|NCT01582451|10050606|P1|Overall Study|Protocol Violation|11
2918352|NCT01582451|10050605|P2|Overall Study|Lost to Follow-up|2
2918353|NCT01582451|10050606|P1|Overall Study|Lost to Follow-up|0
2918354|NCT01582451|10050605|P2|Overall Study|Death|3
2918355|NCT01582451|10050606|P1|Overall Study|Death|3
2918356|NCT01582451|10050605|P2|Overall Study|Adverse Event|3
2918357|NCT01582451|10050606|P1|Overall Study|Adverse Event|1
2918358|NCT01582308|10050648|P10|Period 4|Physician Decision|1
2918359|NCT01582308|10050649|P9|Period 4|Physician Decision|0
2918360|NCT01582308|10050650|P8|Period 4|Physician Decision|0
2918361|NCT01582308|10050651|P7|Period 4|Physician Decision|0
2918362|NCT01582308|10050652|P6|Period 4|Physician Decision|1
2918363|NCT01582308|10050653|P5|Period 4|Physician Decision|0
2918364|NCT01582308|10050654|P4|Period 4|Physician Decision|0
2918365|NCT01582308|10050655|P3|Period 4|Physician Decision|0
2918366|NCT01582308|10050656|P2|Period 4|Physician Decision|0
2918367|NCT01582308|10050657|P1|Period 4|Physician Decision|1
2918368|NCT01582308|10050648|P10|10-day Washout Following Period 1|Physician Decision|0
2918369|NCT01582308|10050649|P9|10-day Washout Following Period 1|Physician Decision|0
2918370|NCT01582308|10050650|P8|10-day Washout Following Period 1|Physician Decision|0
2918371|NCT01582308|10050651|P7|10-day Washout Following Period 1|Physician Decision|0
2918372|NCT01582308|10050652|P6|10-day Washout Following Period 1|Physician Decision|0
2918373|NCT01582308|10050653|P5|10-day Washout Following Period 1|Physician Decision|1
2918374|NCT01582308|10050654|P4|10-day Washout Following Period 1|Physician Decision|0
2918375|NCT01582308|10050655|P3|10-day Washout Following Period 1|Physician Decision|0
2918376|NCT01582308|10050656|P2|10-day Washout Following Period 1|Physician Decision|0
2918377|NCT01582308|10050657|P1|10-day Washout Following Period 1|Physician Decision|0
2918378|NCT01582308|10050648|P10|Period 1|Withdrawal by Subject|0
2918379|NCT01582308|10050649|P9|Period 1|Withdrawal by Subject|0
2918380|NCT01582308|10050650|P8|Period 1|Withdrawal by Subject|0
2918381|NCT01582308|10050651|P7|Period 1|Withdrawal by Subject|1
2918382|NCT01582308|10050652|P6|Period 1|Withdrawal by Subject|0
2918383|NCT01582308|10050653|P5|Period 1|Withdrawal by Subject|0
2918384|NCT01582308|10050654|P4|Period 1|Withdrawal by Subject|0
2918385|NCT01582308|10050655|P3|Period 1|Withdrawal by Subject|0
2918386|NCT01582308|10050656|P2|Period 1|Withdrawal by Subject|0
2918387|NCT01582308|10050657|P1|Period 1|Withdrawal by Subject|0
2918388|NCT01582282|10050685|P3|Overall Study|fasting blood glucose outside Protocol|0
2918389|NCT01582282|10050686|P2|Overall Study|fasting blood glucose outside Protocol|1
2918390|NCT01582282|10050687|P1|Overall Study|fasting blood glucose outside Protocol|0
2918391|NCT01582282|10050685|P3|Overall Study|Lost to Follow-up|0
2918392|NCT01582282|10050686|P2|Overall Study|Lost to Follow-up|0
2918393|NCT01582282|10050687|P1|Overall Study|Lost to Follow-up|1
2918394|NCT01582282|10050685|P3|Overall Study|Adverse Event|0
2918395|NCT01582282|10050686|P2|Overall Study|Adverse Event|1
2918396|NCT01582282|10050687|P1|Overall Study|Adverse Event|1
2918397|NCT01582243|10050710|P1|Overall Study|Lost to Follow-up|1
2918398|NCT01582243|10050710|P1|Overall Study|Adverse Event|1
2918399|NCT01582243|10050710|P1|Overall Study|Withdrawal by Subject|1
2918400|NCT01582178|10050721|P2|Overall Study|Physician Decision|5
2918401|NCT01582178|10050722|P1|Overall Study|Physician Decision|6
2918402|NCT01582152|10050730|P2|Overall Study|Adverse Event|1
2918403|NCT01582152|10050731|P1|Overall Study|Adverse Event|2
2918404|NCT01582152|10050730|P2|Overall Study|Disease Progression|5
2918405|NCT01582152|10050731|P1|Overall Study|Disease Progression|4
2918406|NCT01582100|10050754|P1|Overall Study|Withdrawal by Subject|1
2918407|NCT01582100|10050754|P1|Overall Study|Adverse Event|1
2918408|NCT01582061|10050760|P2|Overall Study|Lost to Follow-up|0
2918409|NCT01582061|10050761|P1|Overall Study|Lost to Follow-up|1
2918410|NCT01582061|10050760|P2|Overall Study|condition no longer requires study drug|0
2918411|NCT01582061|10050761|P1|Overall Study|condition no longer requires study drug|1
2918412|NCT01582061|10050760|P2|Overall Study|Death|1
2918413|NCT01582061|10050761|P1|Overall Study|Death|0
2918414|NCT01582061|10050760|P2|Overall Study|Abnormal laboratory value(s)|0
2918415|NCT01582061|10050761|P1|Overall Study|Abnormal laboratory value(s)|1
2918416|NCT01582061|10050760|P2|Overall Study|Withdrawal by Subject|4
2918417|NCT01582061|10050761|P1|Overall Study|Withdrawal by Subject|10
2918418|NCT01582061|10050760|P2|Overall Study|Adverse Event|8
2918419|NCT01582061|10050761|P1|Overall Study|Adverse Event|12
2918420|NCT01582061|10050760|P2|Overall Study|Lack of Efficacy|23
2918421|NCT01582061|10050761|P1|Overall Study|Lack of Efficacy|3
2918422|NCT01582009|10050811|P1|Overall Study|Physician Decision|1
2918423|NCT01582009|10050811|P1|Overall Study|Withdrawal by Subject|1
2918424|NCT01581931|10050828|P2|Washout|Adverse Event|1
2918425|NCT01581931|10050829|P1|Washout|Adverse Event|0
2918426|NCT01581684|10050882|P10|Overall Study|Other reason not defined|0
2918427|NCT01581684|10050883|P9|Overall Study|Other reason not defined|1
2918428|NCT01581684|10050884|P8|Overall Study|Other reason not defined|0
2918429|NCT01581684|10050885|P7|Overall Study|Other reason not defined|0
2918430|NCT01581684|10050886|P6|Overall Study|Other reason not defined|0
2918431|NCT01581684|10050887|P5|Overall Study|Other reason not defined|0
2918432|NCT01581684|10050888|P4|Overall Study|Other reason not defined|0
2918433|NCT01581684|10050889|P3|Overall Study|Other reason not defined|0
2918434|NCT01581684|10050890|P2|Overall Study|Other reason not defined|0
2918435|NCT01581684|10050891|P1|Overall Study|Other reason not defined|0
2918436|NCT01581619|10050987|P1|Overall Study|Lost to Follow-up|1
2918437|NCT01581619|10050987|P1|Overall Study|Withdrawal by Subject|1
2918438|NCT01581307|10051140|P1|Overall Study|Withdrawal by Subject|1
2918439|NCT01581281|10051149|P3|Overall Study|Early Study Closure|12
2918440|NCT01581281|10051150|P2|Overall Study|Early Study Closure|6
2918441|NCT01581281|10051151|P1|Overall Study|Early Study Closure|15
2918442|NCT01581021|10051173|P2|Overall Study|Lack of Efficacy|1
2918443|NCT01581021|10051174|P1|Overall Study|Lack of Efficacy|0
2918444|NCT01581021|10051173|P2|Overall Study|Lenke 6 Classification|1
2918445|NCT01581021|10051174|P1|Overall Study|Lenke 6 Classification|0
2918446|NCT01581021|10051173|P2|Overall Study|Not Randomized|2
2918447|NCT01581021|10051174|P1|Overall Study|Not Randomized|1
2918448|NCT01581021|10051173|P2|Overall Study|Neuromuscular|1
2918449|NCT01581021|10051174|P1|Overall Study|Neuromuscular|2
2918450|NCT01581021|10051173|P2|Overall Study|More than 2 hooks in thoracic|0
2918451|NCT01581021|10051174|P1|Overall Study|More than 2 hooks in thoracic|3
2918452|NCT01581021|10051173|P2|Overall Study|Lost to Follow-up|6
2918453|NCT01581021|10051174|P1|Overall Study|Lost to Follow-up|4
2918454|NCT01580995|10051201|P2|Overall Study|Lost to Follow-up|2
2918455|NCT01580995|10051202|P1|Overall Study|Lost to Follow-up|2
2918456|NCT01580969|10051211|P3|Overall Study|Physician Decision|0
2918457|NCT01580969|10051212|P2|Overall Study|Physician Decision|0
2918458|NCT01580969|10051213|P1|Overall Study|Physician Decision|3
2918459|NCT01580670|10051260|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
2918460|NCT01580670|10051260|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
2918461|NCT01580488|10051301|P1|Overall Study|Withdrawal by Subject|1
2918462|NCT01580293|10051407|P3|Part B|Part B ongoing|1
2918463|NCT01580293|10051408|P2|Part B|Part B ongoing|0
2918464|NCT01580293|10051409|P1|Part B|Part B ongoing|0
2918465|NCT01580293|10051407|P3|Part B|Other reason|1
2918466|NCT01580293|10051408|P2|Part B|Other reason|0
2918467|NCT01580293|10051409|P1|Part B|Other reason|0
2918468|NCT01580293|10051407|P3|Part B|Withdrawal by Subject|1
2918469|NCT01580293|10051408|P2|Part B|Withdrawal by Subject|0
2918470|NCT01580293|10051409|P1|Part B|Withdrawal by Subject|0
2918471|NCT01580293|10051407|P3|Part A_Extension|Extension ongoing|0
2918472|NCT01580293|10051408|P2|Part A_Extension|Extension ongoing|69
2918473|NCT01580293|10051409|P1|Part A_Extension|Extension ongoing|9
2918474|NCT01580293|10051407|P3|Part A_Extension|Other Reason|0
2918475|NCT01580293|10051408|P2|Part A_Extension|Other Reason|1
2918476|NCT01580293|10051409|P1|Part A_Extension|Other Reason|0
2918477|NCT01580293|10051407|P3|Part A_Extension|Lost to Follow-up|0
2918478|NCT01580293|10051408|P2|Part A_Extension|Lost to Follow-up|1
2918479|NCT01580293|10051409|P1|Part A_Extension|Lost to Follow-up|0
2918480|NCT01580293|10051407|P3|Part A_Extension|Withdrawal by Subject|0
2918481|NCT01580293|10051408|P2|Part A_Extension|Withdrawal by Subject|2
2918482|NCT01580293|10051409|P1|Part A_Extension|Withdrawal by Subject|0
2918483|NCT01580293|10051407|P3|Part A_Extension|Adverse Event|0
2918484|NCT01580293|10051408|P2|Part A_Extension|Adverse Event|2
2918485|NCT01580293|10051409|P1|Part A_Extension|Adverse Event|0
2918486|NCT01580293|10051407|P3|Part A_Main Trial|Non-adherence to the protocol|0
2918487|NCT01580293|10051408|P2|Part A_Main Trial|Non-adherence to the protocol|0
2918488|NCT01580293|10051409|P1|Part A_Main Trial|Non-adherence to the protocol|1
2918489|NCT01580293|10051407|P3|Part A_Main Trial|Withdrawal by Subject|0
2918490|NCT01580293|10051408|P2|Part A_Main Trial|Withdrawal by Subject|4
2918491|NCT01580293|10051409|P1|Part A_Main Trial|Withdrawal by Subject|1
2918492|NCT01580293|10051407|P3|Part A_Main Trial|Adverse Event|0
2918493|NCT01580293|10051408|P2|Part A_Main Trial|Adverse Event|2
2918494|NCT01580293|10051409|P1|Part A_Main Trial|Adverse Event|0
2918495|NCT01580020|10051549|P4|Overall Study|Lost to Follow-up|0
2918496|NCT01580020|10051550|P3|Overall Study|Lost to Follow-up|1
2918497|NCT01580020|10051551|P2|Overall Study|Lost to Follow-up|0
2918498|NCT01580020|10051552|P1|Overall Study|Lost to Follow-up|0
2918499|NCT01580020|10051549|P4|Overall Study|Administrative Problems|0
2918500|NCT01580020|10051550|P3|Overall Study|Administrative Problems|1
2918501|NCT01580020|10051551|P2|Overall Study|Administrative Problems|0
2918502|NCT01580020|10051552|P1|Overall Study|Administrative Problems|0
2918503|NCT01580020|10051549|P4|Overall Study|Adverse Event|1
2918504|NCT01580020|10051550|P3|Overall Study|Adverse Event|1
2918505|NCT01580020|10051551|P2|Overall Study|Adverse Event|1
2918506|NCT01580020|10051552|P1|Overall Study|Adverse Event|1
2918507|NCT01580020|10051549|P4|Overall Study|Withdrawal by Subject|0
2918508|NCT01580020|10051550|P3|Overall Study|Withdrawal by Subject|1
2918509|NCT01580020|10051551|P2|Overall Study|Withdrawal by Subject|1
2918510|NCT01580020|10051552|P1|Overall Study|Withdrawal by Subject|0
2918511|NCT01580020|10051549|P4|Overall Study|Lack of Efficacy|1
2918512|NCT01580020|10051550|P3|Overall Study|Lack of Efficacy|0
2918513|NCT01580020|10051551|P2|Overall Study|Lack of Efficacy|5
2918514|NCT01580020|10051552|P1|Overall Study|Lack of Efficacy|0
2918515|NCT01579916|10051596|P2|Overall Study|Death|0
2918516|NCT01579916|10051597|P1|Overall Study|Death|1
2918517|NCT01579916|10051596|P2|Overall Study|Withdrawal by Subject|1
2918518|NCT01579916|10051597|P1|Overall Study|Withdrawal by Subject|1
2918519|NCT01579916|10051596|P2|Overall Study|Lost to Follow-up|1
2918520|NCT01579916|10051597|P1|Overall Study|Lost to Follow-up|6
2918521|NCT01579812|10051623|P1|Overall Study|Withdrawal by Subject|6
2918522|NCT01579812|10051623|P1|Overall Study|Noncompliance|3
2918523|NCT01579812|10051623|P1|Overall Study|Patient choice|3
2918524|NCT01579812|10051623|P1|Overall Study|Ineligible after treatment start|40
2918525|NCT01579578|10051657|P2|Overall Study|Ongoing|0
2918526|NCT01579578|10051658|P1|Overall Study|Ongoing|3
2918527|NCT01579578|10051657|P2|Overall Study|Eligibility criteria|9
2918528|NCT01579578|10051658|P1|Overall Study|Eligibility criteria|3
2918529|NCT01579578|10051657|P2|Overall Study|Withdrawal by Subject|1
2918530|NCT01579578|10051658|P1|Overall Study|Withdrawal by Subject|2
2918531|NCT01579578|10051657|P2|Overall Study|Lost to Follow-up|1
2918532|NCT01579578|10051658|P1|Overall Study|Lost to Follow-up|1
2918533|NCT01579578|10051657|P2|Overall Study|Death|1
2918534|NCT01579578|10051658|P1|Overall Study|Death|4
2918535|NCT01579565|10051670|P2|Treated|declined to return for final visit|1
2918536|NCT01579565|10051671|P1|Treated|declined to return for final visit|0
2918537|NCT01579565|10051670|P2|Treated|Lost to Follow-up|1
2918538|NCT01579565|10051671|P1|Treated|Lost to Follow-up|2
2918539|NCT01579565|10051670|P2|Treated|Physician Decision|1
2918540|NCT01579565|10051671|P1|Treated|Physician Decision|0
2918541|NCT01579565|10051670|P2|Randomized|prohibited preoperative medication|1
2918542|NCT01579565|10051671|P1|Randomized|prohibited preoperative medication|0
2918543|NCT01579565|10051670|P2|Randomized|prohibited preoperative eating|0
2918544|NCT01579565|10051671|P1|Randomized|prohibited preoperative eating|1
2918545|NCT01579565|10051670|P2|Randomized|inadequate preoperative pupil dilation|1
2918546|NCT01579565|10051671|P1|Randomized|inadequate preoperative pupil dilation|0
2918547|NCT01579565|10051670|P2|Randomized|Withdrawal by Subject|0
2918548|NCT01579565|10051671|P1|Randomized|Withdrawal by Subject|3
2918549|NCT01579565|10051670|P2|Randomized|Adverse Event|3
2918550|NCT01579565|10051671|P1|Randomized|Adverse Event|1
2918551|NCT01579474|10051722|P6|Overall Study|Withdrawal by Subject|0
2918552|NCT01579474|10051723|P5|Overall Study|Withdrawal by Subject|0
2918553|NCT01579474|10051724|P4|Overall Study|Withdrawal by Subject|0
2918554|NCT01579474|10051725|P3|Overall Study|Withdrawal by Subject|0
2918555|NCT01579474|10051726|P2|Overall Study|Withdrawal by Subject|0
2918556|NCT01579474|10051727|P1|Overall Study|Withdrawal by Subject|1
2918557|NCT01579474|10051722|P6|Overall Study|Lack of Efficacy|0
2918558|NCT01579474|10051723|P5|Overall Study|Lack of Efficacy|1
2918559|NCT01579474|10051724|P4|Overall Study|Lack of Efficacy|0
2918560|NCT01579474|10051725|P3|Overall Study|Lack of Efficacy|0
2918561|NCT01579474|10051726|P2|Overall Study|Lack of Efficacy|0
2918562|NCT01579474|10051727|P1|Overall Study|Lack of Efficacy|1
2918563|NCT01579474|10051722|P6|Overall Study|Adverse Event|1
2918564|NCT01579474|10051723|P5|Overall Study|Adverse Event|0
2918565|NCT01579474|10051724|P4|Overall Study|Adverse Event|0
2918566|NCT01579474|10051725|P3|Overall Study|Adverse Event|2
2918567|NCT01579474|10051726|P2|Overall Study|Adverse Event|13
2918568|NCT01579474|10051727|P1|Overall Study|Adverse Event|1
2918569|NCT01579318|10051801|P1|Overall Study|Disease Progression|1
2918570|NCT01579006|10051896|P1|Overall Study|Scheduled surgery|1
2918571|NCT01579006|10051896|P1|Overall Study|Due to participant's health fund|1
2918572|NCT01579006|10051896|P1|Overall Study|Non-compliance|3
2918573|NCT01579006|10051896|P1|Overall Study|Withdrawal by Subject|5
2918574|NCT01579006|10051896|P1|Overall Study|Adverse Event|13
2918575|NCT01579006|10051896|P1|Overall Study|Lack of Efficacy|10
2918576|NCT01578850|10051955|P3|Period 2|Unspecified Reasons|0
2918577|NCT01578850|10051956|P2|Period 2|Unspecified Reasons|1
2918578|NCT01578850|10051957|P1|Period 2|Unspecified Reasons|0
2918579|NCT01578850|10051955|P3|Period 2|Study Terminated by Sponsor|4
2918580|NCT01578850|10051956|P2|Period 2|Study Terminated by Sponsor|5
2918581|NCT01578850|10051957|P1|Period 2|Study Terminated by Sponsor|0
2918582|NCT01578850|10051955|P3|Period 2|Withdrawal by Subject|2
2918583|NCT01578850|10051956|P2|Period 2|Withdrawal by Subject|2
2918584|NCT01578850|10051957|P1|Period 2|Withdrawal by Subject|0
2918585|NCT01578850|10051955|P3|Period 2|Lost to Follow-up|2
2918586|NCT01578850|10051956|P2|Period 2|Lost to Follow-up|1
2918587|NCT01578850|10051957|P1|Period 2|Lost to Follow-up|0
2918588|NCT01578850|10051955|P3|Period 2|Adverse Event|6
2918589|NCT01578850|10051956|P2|Period 2|Adverse Event|3
2918590|NCT01578850|10051957|P1|Period 2|Adverse Event|0
2918591|NCT01578850|10051955|P3|Period 2|Insufficient Clinical Response|0
2918592|NCT01578850|10051956|P2|Period 2|Insufficient Clinical Response|1
2918593|NCT01578850|10051957|P1|Period 2|Insufficient Clinical Response|0
2918594|NCT01578850|10051955|P3|Period 1|Study Terminated by Sponsor|0
2918595|NCT01578850|10051956|P2|Period 1|Study Terminated by Sponsor|0
2918596|NCT01578850|10051957|P1|Period 1|Study Terminated by Sponsor|3
2918597|NCT01578850|10051955|P3|Period 1|Withdrawal by Subject|0
2918598|NCT01578850|10051956|P2|Period 1|Withdrawal by Subject|0
2918599|NCT01578850|10051957|P1|Period 1|Withdrawal by Subject|9
2918600|NCT01578850|10051955|P3|Period 1|Does Not Meet Entrance Criteria|0
2918601|NCT01578850|10051956|P2|Period 1|Does Not Meet Entrance Criteria|0
2918602|NCT01578850|10051957|P1|Period 1|Does Not Meet Entrance Criteria|12
2918603|NCT01578850|10051955|P3|Period 1|Death|0
2918604|NCT01578850|10051956|P2|Period 1|Death|0
2918605|NCT01578850|10051957|P1|Period 1|Death|1
2918606|NCT01578850|10051955|P3|Period 1|Adverse Event|0
2918607|NCT01578850|10051956|P2|Period 1|Adverse Event|0
2918608|NCT01578850|10051957|P1|Period 1|Adverse Event|11
2918609|NCT01578850|10051955|P3|Period 1|Insufficient Clinical Response|0
2918610|NCT01578850|10051956|P2|Period 1|Insufficient Clinical Response|0
2918611|NCT01578850|10051957|P1|Period 1|Insufficient Clinical Response|1
2918612|NCT01578785|10052009|P2|Overall Study|Study terminated by sponsor|118
2918613|NCT01578785|10052010|P1|Overall Study|Study terminated by sponsor|59
2918614|NCT01578785|10052009|P2|Overall Study|Withdrawal by Subject|1
2918615|NCT01578785|10052010|P1|Overall Study|Withdrawal by Subject|0
2918616|NCT01578551|10052075|P2|Overall Study|Adverse Event|0
2918617|NCT01578551|10052076|P1|Overall Study|Adverse Event|1
2918618|NCT01578499|10052088|P2|Overall Study|Died and End of Study Page not Completed|0
2918619|NCT01578499|10052089|P1|Overall Study|Died and End of Study Page not Completed|2
2918620|NCT01578499|10052088|P2|Overall Study|Death|25
2918621|NCT01578499|10052089|P1|Overall Study|Death|20
2918622|NCT01578499|10052088|P2|Overall Study|Withdrawal by Subject|16
2918623|NCT01578499|10052089|P1|Overall Study|Withdrawal by Subject|10
2918624|NCT01578499|10052088|P2|Overall Study|Lost to Follow-up|1
2918625|NCT01578499|10052089|P1|Overall Study|Lost to Follow-up|2
2918626|NCT01578499|10052088|P2|Overall Study|Reason not Specified|1
2918627|NCT01578499|10052089|P1|Overall Study|Reason not Specified|0
2918628|NCT01578486|10052123|P1|Overall Study|Withdrawal by Subject|2
2918629|NCT01578486|10052123|P1|Overall Study|Physician Decision|3
2918630|NCT01578330|10052134|P1|Overall Study|Protocol Violation|5
2918631|NCT01578330|10052134|P1|Overall Study|Adverse Event|2
2918632|NCT01578187|10052159|P1|Usability Phase|Withdrawal by Subject|1
2918633|NCT01577758|10052201|P8|mCRC Expansion Phase|Progression Disease|19
2918634|NCT01577758|10052202|P7|mCRC Expansion Phase|Progression Disease|0
2918635|NCT01577758|10052203|P6|mCRC Expansion Phase|Progression Disease|0
2918636|NCT01577758|10052204|P5|mCRC Expansion Phase|Progression Disease|0
2918637|NCT01577758|10052205|P4|mCRC Expansion Phase|Progression Disease|0
2918638|NCT01577758|10052206|P3|mCRC Expansion Phase|Progression Disease|0
2918639|NCT01577758|10052207|P2|mCRC Expansion Phase|Progression Disease|0
2918640|NCT01577758|10052208|P1|mCRC Expansion Phase|Progression Disease|0
2918641|NCT01577758|10052201|P8|mCRC Expansion Phase|Withdrawal by Subject|2
2918642|NCT01577758|10052202|P7|mCRC Expansion Phase|Withdrawal by Subject|0
2918643|NCT01577758|10052203|P6|mCRC Expansion Phase|Withdrawal by Subject|0
2918644|NCT01577758|10052204|P5|mCRC Expansion Phase|Withdrawal by Subject|0
2918645|NCT01577758|10052205|P4|mCRC Expansion Phase|Withdrawal by Subject|0
2918646|NCT01577758|10052206|P3|mCRC Expansion Phase|Withdrawal by Subject|0
2918647|NCT01577758|10052207|P2|mCRC Expansion Phase|Withdrawal by Subject|0
2918648|NCT01577758|10052208|P1|mCRC Expansion Phase|Withdrawal by Subject|0
2918649|NCT01577758|10052201|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
2918650|NCT01577758|10052202|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
2918651|NCT01577758|10052203|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
2918652|NCT01577758|10052204|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
2918653|NCT01577758|10052205|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
2918654|NCT01577758|10052206|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
2918655|NCT01577758|10052207|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
2918656|NCT01577758|10052208|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
2918657|NCT01577758|10052201|P8|Dose Escalation Phase|Progression Disease|0
2918658|NCT01577758|10052202|P7|Dose Escalation Phase|Progression Disease|0
2918659|NCT01577758|10052203|P6|Dose Escalation Phase|Progression Disease|0
2918660|NCT01577758|10052204|P5|Dose Escalation Phase|Progression Disease|5
2918661|NCT01577758|10052205|P4|Dose Escalation Phase|Progression Disease|2
2918662|NCT01577758|10052206|P3|Dose Escalation Phase|Progression Disease|1
2918663|NCT01577758|10052207|P2|Dose Escalation Phase|Progression Disease|2
2918664|NCT01577758|10052208|P1|Dose Escalation Phase|Progression Disease|2
2918665|NCT01577758|10052201|P8|Dose Escalation Phase|Withdrawal by Subject|0
2918666|NCT01577758|10052202|P7|Dose Escalation Phase|Withdrawal by Subject|0
2918667|NCT01577758|10052203|P6|Dose Escalation Phase|Withdrawal by Subject|1
2918668|NCT01577758|10052204|P5|Dose Escalation Phase|Withdrawal by Subject|0
2918669|NCT01577758|10052205|P4|Dose Escalation Phase|Withdrawal by Subject|0
2918670|NCT01577758|10052206|P3|Dose Escalation Phase|Withdrawal by Subject|0
2918671|NCT01577758|10052207|P2|Dose Escalation Phase|Withdrawal by Subject|0
2918672|NCT01577758|10052208|P1|Dose Escalation Phase|Withdrawal by Subject|0
2918673|NCT01577758|10052201|P8|Dose Escalation Phase|Symptomatic Deterioration|0
2918674|NCT01577758|10052202|P7|Dose Escalation Phase|Symptomatic Deterioration|0
2918675|NCT01577758|10052203|P6|Dose Escalation Phase|Symptomatic Deterioration|1
2918676|NCT01577758|10052204|P5|Dose Escalation Phase|Symptomatic Deterioration|1
2918677|NCT01577758|10052205|P4|Dose Escalation Phase|Symptomatic Deterioration|0
2918678|NCT01577758|10052206|P3|Dose Escalation Phase|Symptomatic Deterioration|1
2918679|NCT01577758|10052207|P2|Dose Escalation Phase|Symptomatic Deterioration|0
2918680|NCT01577758|10052208|P1|Dose Escalation Phase|Symptomatic Deterioration|0
2918681|NCT01577758|10052201|P8|Dose Escalation Phase|Adverse Event|0
2918682|NCT01577758|10052202|P7|Dose Escalation Phase|Adverse Event|1
2918683|NCT01577758|10052203|P6|Dose Escalation Phase|Adverse Event|2
2918684|NCT01577758|10052204|P5|Dose Escalation Phase|Adverse Event|0
2918685|NCT01577758|10052205|P4|Dose Escalation Phase|Adverse Event|0
2918686|NCT01577758|10052206|P3|Dose Escalation Phase|Adverse Event|0
2918687|NCT01577758|10052207|P2|Dose Escalation Phase|Adverse Event|0
2918688|NCT01577758|10052208|P1|Dose Escalation Phase|Adverse Event|0
2918689|NCT01577745|10052247|P6|Overall Study|Alternative Therapy|0
2918690|NCT01577745|10052248|P5|Overall Study|Alternative Therapy|1
2918691|NCT01577745|10052249|P4|Overall Study|Alternative Therapy|1
2918692|NCT01577745|10052250|P3|Overall Study|Alternative Therapy|0
2918693|NCT01577745|10052251|P2|Overall Study|Alternative Therapy|0
2918694|NCT01577745|10052252|P1|Overall Study|Alternative Therapy|0
2918695|NCT01577745|10052247|P6|Overall Study|Lost to Follow-up|1
2918696|NCT01577745|10052248|P5|Overall Study|Lost to Follow-up|0
2918697|NCT01577745|10052249|P4|Overall Study|Lost to Follow-up|0
2918698|NCT01577745|10052250|P3|Overall Study|Lost to Follow-up|0
2918699|NCT01577745|10052251|P2|Overall Study|Lost to Follow-up|0
2918700|NCT01577745|10052252|P1|Overall Study|Lost to Follow-up|0
2918701|NCT01577745|10052247|P6|Overall Study|Physician Decision|0
2918702|NCT01577745|10052248|P5|Overall Study|Physician Decision|1
2918703|NCT01577745|10052249|P4|Overall Study|Physician Decision|1
2918704|NCT01577745|10052250|P3|Overall Study|Physician Decision|0
2918705|NCT01577745|10052251|P2|Overall Study|Physician Decision|0
2918706|NCT01577745|10052252|P1|Overall Study|Physician Decision|0
2918707|NCT01577745|10052247|P6|Overall Study|Death|3
2918708|NCT01577745|10052248|P5|Overall Study|Death|1
2918709|NCT01577745|10052249|P4|Overall Study|Death|1
2918710|NCT01577745|10052250|P3|Overall Study|Death|2
2918711|NCT01577745|10052251|P2|Overall Study|Death|2
2918712|NCT01577745|10052252|P1|Overall Study|Death|3
2918713|NCT01577745|10052247|P6|Overall Study|Withdrawal by Subject|0
2918714|NCT01577745|10052248|P5|Overall Study|Withdrawal by Subject|2
2918715|NCT01577745|10052249|P4|Overall Study|Withdrawal by Subject|3
2918716|NCT01577745|10052250|P3|Overall Study|Withdrawal by Subject|0
2918717|NCT01577745|10052251|P2|Overall Study|Withdrawal by Subject|1
2918718|NCT01577745|10052252|P1|Overall Study|Withdrawal by Subject|0
2918719|NCT01577381|10052453|P4|Overall Study|Ongoing at Date of Cut-Off|0
2918720|NCT01577381|10052454|P3|Overall Study|Ongoing at Date of Cut-Off|1
2918721|NCT01577381|10052455|P2|Overall Study|Ongoing at Date of Cut-Off|2
2918722|NCT01577381|10052456|P1|Overall Study|Ongoing at Date of Cut-Off|0
2918723|NCT01577381|10052453|P4|Overall Study|Discontinued|2
2918724|NCT01577381|10052454|P3|Overall Study|Discontinued|2
2918725|NCT01577381|10052455|P2|Overall Study|Discontinued|1
2918726|NCT01577381|10052456|P1|Overall Study|Discontinued|2
2918727|NCT01577186|10052611|P1|Overall Study|Other|2
2918728|NCT01577186|10052611|P1|Overall Study|Non-Compliant|8
2918729|NCT01577186|10052611|P1|Overall Study|Ineligible to Continue|15
2918730|NCT01577186|10052611|P1|Overall Study|Insufficient Response|18
2918731|NCT01577186|10052611|P1|Overall Study|Withdrawal by Subject|35
2918732|NCT01577186|10052611|P1|Overall Study|Lost to Follow-up|28
2918733|NCT01577186|10052611|P1|Overall Study|Death|1
2918734|NCT01577186|10052611|P1|Overall Study|Adverse Event|23
2918735|NCT01577160|10052619|P1|Overall Study|Other|9
2918736|NCT01577160|10052619|P1|Overall Study|Subject Uncooperative|7
2918737|NCT01577160|10052619|P1|Overall Study|Withdrawal by Subject|18
2918738|NCT01577160|10052619|P1|Overall Study|Lost to Follow-up|40
2918739|NCT01577160|10052619|P1|Overall Study|Lack of Efficacy|15
2918740|NCT01577160|10052619|P1|Overall Study|Adverse Event|9
2918741|NCT01576783|10052674|P2|Overall Study|Withdrawal by Subject|1
2918742|NCT01576783|10052675|P1|Overall Study|Withdrawal by Subject|5
2918743|NCT01576783|10052674|P2|Overall Study|Lost to Follow-up|16
2918744|NCT01576783|10052675|P1|Overall Study|Lost to Follow-up|14
2918745|NCT01576783|10052674|P2|Overall Study|Change in Medical Care|0
2918746|NCT01576783|10052675|P1|Overall Study|Change in Medical Care|1
2918747|NCT01576718|10052701|P7|Treatment Period|Noncompliance to study medication|1
2918748|NCT01576718|10052702|P6|Treatment Period|Noncompliance to study medication|1
2918749|NCT01576718|10052703|P5|Treatment Period|Noncompliance to study medication|0
2918750|NCT01576718|10052704|P4|Treatment Period|Noncompliance to study medication|0
2918751|NCT01576718|10052705|P3|Treatment Period|Noncompliance to study medication|0
2918752|NCT01576718|10052706|P2|Treatment Period|Noncompliance to study medication|0
2918753|NCT01576718|10052707|P1|Treatment Period|Noncompliance to study medication|0
2918754|NCT01576718|10052701|P7|Treatment Period|Lost to Follow-up|0
2918755|NCT01576718|10052702|P6|Treatment Period|Lost to Follow-up|0
2918756|NCT01576718|10052703|P5|Treatment Period|Lost to Follow-up|1
2918757|NCT01576718|10052704|P4|Treatment Period|Lost to Follow-up|0
2918758|NCT01576718|10052705|P3|Treatment Period|Lost to Follow-up|0
2918759|NCT01576718|10052706|P2|Treatment Period|Lost to Follow-up|0
2918760|NCT01576718|10052707|P1|Treatment Period|Lost to Follow-up|0
2918761|NCT01576718|10052701|P7|Treatment Period|Met stopping criteria|15
2918762|NCT01576718|10052702|P6|Treatment Period|Met stopping criteria|33
2918763|NCT01576718|10052703|P5|Treatment Period|Met stopping criteria|16
2918764|NCT01576718|10052704|P4|Treatment Period|Met stopping criteria|19
2918765|NCT01576718|10052705|P3|Treatment Period|Met stopping criteria|13
2918766|NCT01576718|10052706|P2|Treatment Period|Met stopping criteria|16
2918767|NCT01576718|10052707|P1|Treatment Period|Met stopping criteria|0
2918768|NCT01576718|10052701|P7|Treatment Period|Sponsor request|0
2918769|NCT01576718|10052702|P6|Treatment Period|Sponsor request|1
2918770|NCT01576718|10052703|P5|Treatment Period|Sponsor request|0
2918771|NCT01576718|10052704|P4|Treatment Period|Sponsor request|0
2918772|NCT01576718|10052705|P3|Treatment Period|Sponsor request|0
2918773|NCT01576718|10052706|P2|Treatment Period|Sponsor request|1
2918774|NCT01576718|10052707|P1|Treatment Period|Sponsor request|0
2918775|NCT01576718|10052701|P7|Treatment Period|Protocol Violation|12
2918776|NCT01576718|10052702|P6|Treatment Period|Protocol Violation|8
2918777|NCT01576718|10052703|P5|Treatment Period|Protocol Violation|6
2918778|NCT01576718|10052704|P4|Treatment Period|Protocol Violation|10
2918779|NCT01576718|10052705|P3|Treatment Period|Protocol Violation|4
2918780|NCT01576718|10052706|P2|Treatment Period|Protocol Violation|5
2918781|NCT01576718|10052707|P1|Treatment Period|Protocol Violation|0
2918782|NCT01576718|10052701|P7|Treatment Period|Physician Decision|0
2918783|NCT01576718|10052702|P6|Treatment Period|Physician Decision|0
2918784|NCT01576718|10052703|P5|Treatment Period|Physician Decision|1
2918785|NCT01576718|10052704|P4|Treatment Period|Physician Decision|1
2918786|NCT01576718|10052705|P3|Treatment Period|Physician Decision|1
2918787|NCT01576718|10052706|P2|Treatment Period|Physician Decision|1
2918788|NCT01576718|10052707|P1|Treatment Period|Physician Decision|0
2918789|NCT01576718|10052701|P7|Treatment Period|Withdrawal by Subject|2
2918790|NCT01576718|10052702|P6|Treatment Period|Withdrawal by Subject|4
2918791|NCT01576718|10052703|P5|Treatment Period|Withdrawal by Subject|2
2918792|NCT01576718|10052704|P4|Treatment Period|Withdrawal by Subject|0
2918793|NCT01576718|10052705|P3|Treatment Period|Withdrawal by Subject|1
2918794|NCT01576718|10052706|P2|Treatment Period|Withdrawal by Subject|1
2918795|NCT01576718|10052707|P1|Treatment Period|Withdrawal by Subject|0
2918796|NCT01576718|10052701|P7|Treatment Period|Adverse Event|0
2918797|NCT01576718|10052702|P6|Treatment Period|Adverse Event|1
2918798|NCT01576718|10052703|P5|Treatment Period|Adverse Event|1
2918799|NCT01576718|10052704|P4|Treatment Period|Adverse Event|1
2918800|NCT01576718|10052705|P3|Treatment Period|Adverse Event|1
2918801|NCT01576718|10052706|P2|Treatment Period|Adverse Event|1
2918802|NCT01576718|10052707|P1|Treatment Period|Adverse Event|0
2918803|NCT01576718|10052701|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
2918804|NCT01576718|10052702|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
2918805|NCT01576718|10052703|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
2918806|NCT01576718|10052704|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
2918807|NCT01576718|10052705|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
2918808|NCT01576718|10052706|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
2918809|NCT01576718|10052707|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
2918810|NCT01576718|10052701|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918811|NCT01576718|10052702|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918812|NCT01576718|10052703|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918813|NCT01576718|10052704|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918814|NCT01576718|10052705|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918815|NCT01576718|10052706|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2918816|NCT01576718|10052707|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
2918817|NCT01576718|10052701|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918818|NCT01576718|10052702|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918819|NCT01576718|10052703|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918820|NCT01576718|10052704|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918821|NCT01576718|10052705|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918822|NCT01576718|10052706|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2918823|NCT01576718|10052707|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
2918824|NCT01576718|10052701|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918825|NCT01576718|10052702|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918826|NCT01576718|10052703|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918827|NCT01576718|10052704|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918828|NCT01576718|10052705|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918829|NCT01576718|10052706|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2918830|NCT01576718|10052707|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
2918831|NCT01576718|10052701|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918832|NCT01576718|10052702|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918833|NCT01576718|10052703|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918834|NCT01576718|10052704|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918835|NCT01576718|10052705|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918836|NCT01576718|10052706|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2918837|NCT01576718|10052707|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
2918838|NCT01576705|10052803|P4|Overall Study|invalid ICF|0
2918839|NCT01576705|10052804|P3|Overall Study|invalid ICF|0
2918840|NCT01576705|10052805|P2|Overall Study|invalid ICF|1
2918841|NCT01576705|10052806|P1|Overall Study|invalid ICF|0
2918842|NCT01576705|10052803|P4|Overall Study|TSH > 7 mIU/L at baseline|3
2918843|NCT01576705|10052804|P3|Overall Study|TSH > 7 mIU/L at baseline|5
2918844|NCT01576705|10052805|P2|Overall Study|TSH > 7 mIU/L at baseline|7
2918845|NCT01576705|10052806|P1|Overall Study|TSH > 7 mIU/L at baseline|3
2918846|NCT01576575|10052827|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
2918847|NCT01576575|10052827|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
2918848|NCT01576575|10052827|P1|Buprenorphine Control|Withdrawal by Subject|3
2918849|NCT01576549|10052837|P1|Overall Study|Sponsor Decision|2
2918850|NCT01576406|10052866|P6|Overall Study|Other|0
2918851|NCT01576406|10052867|P5|Overall Study|Other|0
2918852|NCT01576406|10052868|P4|Overall Study|Other|2
2918853|NCT01576406|10052869|P3|Overall Study|Other|2
2918854|NCT01576406|10052870|P2|Overall Study|Other|0
2918855|NCT01576406|10052871|P1|Overall Study|Other|0
2918856|NCT01576406|10052866|P6|Overall Study|Withdrawal the consent|3
2918857|NCT01576406|10052867|P5|Overall Study|Withdrawal the consent|1
2918858|NCT01576406|10052868|P4|Overall Study|Withdrawal the consent|1
2918859|NCT01576406|10052869|P3|Overall Study|Withdrawal the consent|5
2918860|NCT01576406|10052870|P2|Overall Study|Withdrawal the consent|2
2918861|NCT01576406|10052871|P1|Overall Study|Withdrawal the consent|2
2918862|NCT01576406|10052866|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
2918863|NCT01576406|10052867|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
2918864|NCT01576406|10052868|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
2918865|NCT01576406|10052869|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
2918866|NCT01576406|10052870|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
2918867|NCT01576406|10052871|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
2918868|NCT01576406|10052866|P6|Overall Study|Death|9
2918869|NCT01576406|10052867|P5|Overall Study|Death|7
2918870|NCT01576406|10052868|P4|Overall Study|Death|5
2918871|NCT01576406|10052869|P3|Overall Study|Death|8
2918872|NCT01576406|10052870|P2|Overall Study|Death|4
2918873|NCT01576406|10052871|P1|Overall Study|Death|3
2918874|NCT01576406|10052866|P6|Overall Study|Lost to Follow-up|0
2918875|NCT01576406|10052867|P5|Overall Study|Lost to Follow-up|0
2918876|NCT01576406|10052868|P4|Overall Study|Lost to Follow-up|0
2918877|NCT01576406|10052869|P3|Overall Study|Lost to Follow-up|0
2918878|NCT01576406|10052870|P2|Overall Study|Lost to Follow-up|2
2918879|NCT01576406|10052871|P1|Overall Study|Lost to Follow-up|1
2918880|NCT01576367|10053119|P1|Overall Study|Moved to commercial use after 6 months|1
2918881|NCT01576367|10053119|P1|Overall Study|Unsatisfactory therapeutic effect|2
2918882|NCT01576341|10053127|P1|Overall Study|Other|12
2918883|NCT01576341|10053127|P1|Overall Study|Protocol Violation|12
2918884|NCT01576341|10053127|P1|Overall Study|Kidney transplantation|10
2918885|NCT01576341|10053127|P1|Overall Study|Lost to Follow-up|2
2918886|NCT01576341|10053127|P1|Overall Study|Physician Decision|2
2918887|NCT01576341|10053127|P1|Overall Study|Death|21
2918888|NCT01576341|10053127|P1|Overall Study|Adverse Event|10
2918889|NCT01576341|10053127|P1|Overall Study|Withdrawal by Subject|24
2918890|NCT01576159|10053148|P4|Overall Study|Protocol Violation|0
2918891|NCT01576159|10053149|P3|Overall Study|Protocol Violation|0
2918892|NCT01576159|10053150|P2|Overall Study|Protocol Violation|0
2918893|NCT01576159|10053151|P1|Overall Study|Protocol Violation|1
2918894|NCT01576159|10053148|P4|Overall Study|Lost to Follow-up|1
2918895|NCT01576159|10053149|P3|Overall Study|Lost to Follow-up|0
2918896|NCT01576159|10053150|P2|Overall Study|Lost to Follow-up|0
2918897|NCT01576159|10053151|P1|Overall Study|Lost to Follow-up|0
2918898|NCT01576159|10053148|P4|Overall Study|Physician Decision|0
2918899|NCT01576159|10053149|P3|Overall Study|Physician Decision|1
2918900|NCT01576159|10053150|P2|Overall Study|Physician Decision|0
2918901|NCT01576159|10053151|P1|Overall Study|Physician Decision|0
2918902|NCT01576159|10053148|P4|Overall Study|Withdrawal by Subject|0
2918903|NCT01576159|10053149|P3|Overall Study|Withdrawal by Subject|0
2918904|NCT01576159|10053150|P2|Overall Study|Withdrawal by Subject|1
2918905|NCT01576159|10053151|P1|Overall Study|Withdrawal by Subject|0
2918906|NCT01576146|10053169|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
2918907|NCT01576146|10053169|P1|Extension Period 2|Renal Transplant|1
2918908|NCT01576146|10053169|P1|Extension Period 2|Adverse Event|1
2918909|NCT01576146|10053169|P1|Extension Period 2|Death|1
2918910|NCT01576146|10053169|P1|Extension Period 2|Sponsor Decision|13
2918911|NCT01576146|10053169|P1|Extension Period 1|Renal Transplant|1
2918912|NCT01576146|10053169|P1|Extension Period 1|Parathyroidectomy|1
2918913|NCT01576146|10053169|P1|Extension Period 1|Lost to Follow-up|1
2918914|NCT01576146|10053169|P1|Extension Period 1|Withdrawal by Subject|1
2918915|NCT01576146|10053169|P1|Extension Period 1|Physician Decision|2
2918916|NCT01576146|10053169|P1|Extension Period 1|Death|2
2918917|NCT01576146|10053169|P1|Extension Period 1|Adverse Event|2
2918918|NCT01576042|10053202|P2|Overall Study|Physician Decision|0
2918919|NCT01576042|10053203|P1|Overall Study|Physician Decision|2
2918920|NCT01575899|10053239|P3|Overall Study|Protocol Violation|0
2918921|NCT01575899|10053240|P2|Overall Study|Protocol Violation|1
2918922|NCT01575899|10053241|P1|Overall Study|Protocol Violation|2
2918923|NCT01575899|10053239|P3|Overall Study|Lost to Follow-up|2
2918924|NCT01575899|10053240|P2|Overall Study|Lost to Follow-up|4
2918925|NCT01575899|10053241|P1|Overall Study|Lost to Follow-up|3
2918926|NCT01575873|10053255|P4|Overall Study|Other|2
2918927|NCT01575873|10053256|P3|Overall Study|Other|4
2918928|NCT01575873|10053257|P2|Overall Study|Other|0
2918929|NCT01575873|10053258|P1|Overall Study|Other|0
2918930|NCT01575873|10053255|P4|Overall Study|Requirement for Alternative Therapy|1
2918931|NCT01575873|10053256|P3|Overall Study|Requirement for Alternative Therapy|1
2918932|NCT01575873|10053257|P2|Overall Study|Requirement for Alternative Therapy|0
2918933|NCT01575873|10053258|P1|Overall Study|Requirement for Alternative Therapy|0
2918934|NCT01575873|10053255|P4|Overall Study|Protocol deviation|1
2918935|NCT01575873|10053256|P3|Overall Study|Protocol deviation|0
2918936|NCT01575873|10053257|P2|Overall Study|Protocol deviation|1
2918937|NCT01575873|10053258|P1|Overall Study|Protocol deviation|0
2918938|NCT01575873|10053255|P4|Overall Study|Administrative decision|0
2918939|NCT01575873|10053256|P3|Overall Study|Administrative decision|1
2918940|NCT01575873|10053257|P2|Overall Study|Administrative decision|1
2918941|NCT01575873|10053258|P1|Overall Study|Administrative decision|1
2918942|NCT01575873|10053255|P4|Overall Study|Noncompliance|3
2918943|NCT01575873|10053256|P3|Overall Study|Noncompliance|4
2918944|NCT01575873|10053257|P2|Overall Study|Noncompliance|2
2918945|NCT01575873|10053258|P1|Overall Study|Noncompliance|1
2918946|NCT01575873|10053255|P4|Overall Study|Death|9
2918947|NCT01575873|10053256|P3|Overall Study|Death|8
2918948|NCT01575873|10053257|P2|Overall Study|Death|2
2918949|NCT01575873|10053258|P1|Overall Study|Death|3
2918950|NCT01575873|10053255|P4|Overall Study|Lost to Follow-up|5
2918951|NCT01575873|10053256|P3|Overall Study|Lost to Follow-up|13
2918952|NCT01575873|10053257|P2|Overall Study|Lost to Follow-up|3
2918953|NCT01575873|10053258|P1|Overall Study|Lost to Follow-up|1
2918954|NCT01575873|10053255|P4|Overall Study|Adverse Event|12
2918955|NCT01575873|10053256|P3|Overall Study|Adverse Event|9
2918956|NCT01575873|10053257|P2|Overall Study|Adverse Event|7
2918957|NCT01575873|10053258|P1|Overall Study|Adverse Event|7
2918958|NCT01575873|10053255|P4|Overall Study|Withdrawal by Subject|34
2918959|NCT01575873|10053256|P3|Overall Study|Withdrawal by Subject|34
2918960|NCT01575873|10053257|P2|Overall Study|Withdrawal by Subject|20
2918961|NCT01575873|10053258|P1|Overall Study|Withdrawal by Subject|15
2918962|NCT01575834|10053284|P2|Overall Study|Requirement for Alternative Therapy|4
2918963|NCT01575834|10053285|P1|Overall Study|Requirement for Alternative Therapy|2
2918964|NCT01575834|10053284|P2|Overall Study|Protocol Deviation|3
2918965|NCT01575834|10053285|P1|Overall Study|Protocol Deviation|4
2918966|NCT01575834|10053284|P2|Overall Study|Ineligibility Determined|8
2918967|NCT01575834|10053285|P1|Overall Study|Ineligibility Determined|5
2918968|NCT01575834|10053284|P2|Overall Study|Administrative decision|33
2918969|NCT01575834|10053285|P1|Overall Study|Administrative decision|15
2918970|NCT01575834|10053284|P2|Overall Study|Noncompliance|27
2918971|NCT01575834|10053285|P1|Overall Study|Noncompliance|52
2918972|NCT01575834|10053284|P2|Overall Study|Lost to Follow-up|68
2918973|NCT01575834|10053285|P1|Overall Study|Lost to Follow-up|55
2918974|NCT01575834|10053284|P2|Overall Study|Adverse Event|61
2918975|NCT01575834|10053285|P1|Overall Study|Adverse Event|63
2918976|NCT01575834|10053284|P2|Overall Study|Other|70
2918977|NCT01575834|10053285|P1|Overall Study|Other|70
2918978|NCT01575834|10053284|P2|Overall Study|Death|74
2918979|NCT01575834|10053285|P1|Overall Study|Death|81
2918980|NCT01575834|10053284|P2|Overall Study|Withdrawal by Subject|390
2918981|NCT01575834|10053285|P1|Overall Study|Withdrawal by Subject|352
2918982|NCT01575808|10053337|P2|Overall Study|Withdrawal by Subject|0
2918983|NCT01575808|10053338|P1|Overall Study|Withdrawal by Subject|1
2918984|NCT01575808|10053337|P2|Overall Study|Death|0
2918985|NCT01575808|10053338|P1|Overall Study|Death|2
2918986|NCT01575769|10053385|P1|Overall Study|Study terminated by sponsor|40
2918987|NCT01575769|10053385|P1|Overall Study|Adverse Event|1
2918988|NCT01575561|10053443|P1|Overall Study|administration|1
2918989|NCT01575561|10053443|P1|Overall Study|Withdrawal by Subject|11
2918990|NCT01575561|10053443|P1|Overall Study|Protocol Violation|4
2918991|NCT01575561|10053443|P1|Overall Study|Lost to Follow-up|6
2918992|NCT01575561|10053443|P1|Overall Study|Lack of Efficacy|8
2918993|NCT01575561|10053443|P1|Overall Study|Adverse Event|9
2918994|NCT01575197|10053473|P3|Overall Study|Protocol Violation|1
2918995|NCT01575197|10053474|P2|Overall Study|Protocol Violation|1
2918996|NCT01575197|10053475|P1|Overall Study|Protocol Violation|2
2918997|NCT01575197|10053473|P3|Overall Study|Withdrawal by Subject|1
2918998|NCT01575197|10053474|P2|Overall Study|Withdrawal by Subject|1
2918999|NCT01575197|10053475|P1|Overall Study|Withdrawal by Subject|0
2919000|NCT01575197|10053473|P3|Overall Study|Lost to Follow-up|0
2919001|NCT01575197|10053474|P2|Overall Study|Lost to Follow-up|1
2919002|NCT01575197|10053475|P1|Overall Study|Lost to Follow-up|0
2919003|NCT01575197|10053473|P3|Overall Study|SAE|0
2919004|NCT01575197|10053474|P2|Overall Study|SAE|1
2919005|NCT01575197|10053475|P1|Overall Study|SAE|0
2919006|NCT01575197|10053473|P3|Overall Study|Migration out of study area|4
2919007|NCT01575197|10053474|P2|Overall Study|Migration out of study area|5
2919008|NCT01575197|10053475|P1|Overall Study|Migration out of study area|1
2919009|NCT01575054|10053503|P2|Overall Study|Adverse Event|8
2919010|NCT01575054|10053504|P1|Overall Study|Adverse Event|9
2919011|NCT01575054|10053503|P2|Overall Study|Lost to Follow-up|3
2919012|NCT01575054|10053504|P1|Overall Study|Lost to Follow-up|3
2919013|NCT01575054|10053503|P2|Overall Study|Personal Reasons|11
2919014|NCT01575054|10053504|P1|Overall Study|Personal Reasons|10
2919015|NCT01575054|10053503|P2|Overall Study|Protocol Violation|1
2919016|NCT01575054|10053504|P1|Overall Study|Protocol Violation|2
2919017|NCT01575054|10053503|P2|Overall Study|Other Reasons|3
2919018|NCT01575054|10053504|P1|Overall Study|Other Reasons|5
2919019|NCT01575028|10053520|P2|Overall Study|Physician Decision|1
2919020|NCT01575028|10053521|P1|Overall Study|Physician Decision|0
2919021|NCT01574716|10053532|P5|Part 2|Lost to Follow-up|0
2919022|NCT01574716|10053533|P4|Part 2|Lost to Follow-up|3
2919023|NCT01574716|10053534|P3|Part 2|Lost to Follow-up|0
2919024|NCT01574716|10053535|P2|Part 2|Lost to Follow-up|0
2919025|NCT01574716|10053536|P1|Part 2|Lost to Follow-up|0
2919026|NCT01574716|10053532|P5|Part 2|Brain metastases|0
2919027|NCT01574716|10053533|P4|Part 2|Brain metastases|1
2919028|NCT01574716|10053534|P3|Part 2|Brain metastases|0
2919029|NCT01574716|10053535|P2|Part 2|Brain metastases|0
2919030|NCT01574716|10053536|P1|Part 2|Brain metastases|0
2919031|NCT01574716|10053532|P5|Part 2|Withdrawal by Subject|4
2919032|NCT01574716|10053533|P4|Part 2|Withdrawal by Subject|5
2919033|NCT01574716|10053534|P3|Part 2|Withdrawal by Subject|0
2919034|NCT01574716|10053535|P2|Part 2|Withdrawal by Subject|0
2919035|NCT01574716|10053536|P1|Part 2|Withdrawal by Subject|0
2919036|NCT01574716|10053532|P5|Part 2|Discontinuation of study by sponsor|31
2919037|NCT01574716|10053533|P4|Part 2|Discontinuation of study by sponsor|51
2919038|NCT01574716|10053534|P3|Part 2|Discontinuation of study by sponsor|0
2919039|NCT01574716|10053535|P2|Part 2|Discontinuation of study by sponsor|0
2919040|NCT01574716|10053536|P1|Part 2|Discontinuation of study by sponsor|0
2919041|NCT01574716|10053532|P5|Part 2|Death|35
2919042|NCT01574716|10053533|P4|Part 2|Death|76
2919043|NCT01574716|10053534|P3|Part 2|Death|0
2919044|NCT01574716|10053535|P2|Part 2|Death|0
2919045|NCT01574716|10053536|P1|Part 2|Death|0
2919046|NCT01574716|10053532|P5|Part 2|Progressive disease|0
2919047|NCT01574716|10053533|P4|Part 2|Progressive disease|1
2919048|NCT01574716|10053534|P3|Part 2|Progressive disease|0
2919049|NCT01574716|10053535|P2|Part 2|Progressive disease|0
2919050|NCT01574716|10053536|P1|Part 2|Progressive disease|0
2919051|NCT01574716|10053532|P5|Part 1|Lost to Follow-up|0
2919052|NCT01574716|10053533|P4|Part 1|Lost to Follow-up|0
2919053|NCT01574716|10053534|P3|Part 1|Lost to Follow-up|0
2919054|NCT01574716|10053535|P2|Part 1|Lost to Follow-up|1
2919055|NCT01574716|10053536|P1|Part 1|Lost to Follow-up|0
2919056|NCT01574716|10053532|P5|Part 1|Withdrawal by Subject|0
2919057|NCT01574716|10053533|P4|Part 1|Withdrawal by Subject|0
2919058|NCT01574716|10053534|P3|Part 1|Withdrawal by Subject|0
2919059|NCT01574716|10053535|P2|Part 1|Withdrawal by Subject|2
2919060|NCT01574716|10053536|P1|Part 1|Withdrawal by Subject|0
2919061|NCT01574716|10053532|P5|Part 1|Discontinuation of study by sponsor|0
2919062|NCT01574716|10053533|P4|Part 1|Discontinuation of study by sponsor|0
2919063|NCT01574716|10053534|P3|Part 1|Discontinuation of study by sponsor|1
2919064|NCT01574716|10053535|P2|Part 1|Discontinuation of study by sponsor|0
2919065|NCT01574716|10053536|P1|Part 1|Discontinuation of study by sponsor|0
2919066|NCT01574716|10053532|P5|Part 1|Death|0
2919067|NCT01574716|10053533|P4|Part 1|Death|0
2919068|NCT01574716|10053534|P3|Part 1|Death|8
2919069|NCT01574716|10053535|P2|Part 1|Death|1
2919070|NCT01574716|10053536|P1|Part 1|Death|3
2919071|NCT01574703|10053559|P4|Overall Study|Death|0
2919072|NCT01574703|10053560|P3|Overall Study|Death|1
2919073|NCT01574703|10053561|P2|Overall Study|Death|1
2919074|NCT01574703|10053562|P1|Overall Study|Death|2
2919075|NCT01574703|10053559|P4|Overall Study|Lost to Follow-up|35
2919076|NCT01574703|10053560|P3|Overall Study|Lost to Follow-up|46
2919077|NCT01574703|10053561|P2|Overall Study|Lost to Follow-up|41
2919078|NCT01574703|10053562|P1|Overall Study|Lost to Follow-up|43
2919079|NCT01574703|10053559|P4|Overall Study|Met Withdrawal Criteria|0
2919080|NCT01574703|10053560|P3|Overall Study|Met Withdrawal Criteria|1
2919081|NCT01574703|10053561|P2|Overall Study|Met Withdrawal Criteria|1
2919082|NCT01574703|10053562|P1|Overall Study|Met Withdrawal Criteria|0
2919083|NCT01574703|10053559|P4|Overall Study|Withdrawal by Subject|61
2919084|NCT01574703|10053560|P3|Overall Study|Withdrawal by Subject|36
2919085|NCT01574703|10053561|P2|Overall Study|Withdrawal by Subject|52
2919086|NCT01574703|10053562|P1|Overall Study|Withdrawal by Subject|53
2919087|NCT01574703|10053559|P4|Overall Study|Unspecified Reason|16
2919088|NCT01574703|10053560|P3|Overall Study|Unspecified Reason|20
2919089|NCT01574703|10053561|P2|Overall Study|Unspecified Reason|15
2919090|NCT01574703|10053562|P1|Overall Study|Unspecified Reason|27
2919091|NCT01574703|10053559|P4|Overall Study|Protocol Violation|1
2919092|NCT01574703|10053560|P3|Overall Study|Protocol Violation|0
2919093|NCT01574703|10053561|P2|Overall Study|Protocol Violation|0
2919094|NCT01574703|10053562|P1|Overall Study|Protocol Violation|0
2919095|NCT01574703|10053559|P4|Overall Study|Adverse Event|1
2919096|NCT01574703|10053560|P3|Overall Study|Adverse Event|1
2919097|NCT01574703|10053561|P2|Overall Study|Adverse Event|2
2919098|NCT01574703|10053562|P1|Overall Study|Adverse Event|0
2919099|NCT01574651|10053606|P2|Overall Study|Withdrawal by Subject|10
2919100|NCT01574651|10053607|P1|Overall Study|Withdrawal by Subject|9
2919101|NCT01574651|10053606|P2|Overall Study|Protocol Violation|5
2919102|NCT01574651|10053607|P1|Overall Study|Protocol Violation|3
2919103|NCT01574651|10053606|P2|Overall Study|Unsatisfactory therapeutic effect|0
2919104|NCT01574651|10053607|P1|Overall Study|Unsatisfactory therapeutic effect|6
2919105|NCT01574651|10053606|P2|Overall Study|Abnormal test procedure result(s)|1
2919106|NCT01574651|10053607|P1|Overall Study|Abnormal test procedure result(s)|1
2919107|NCT01574651|10053606|P2|Overall Study|Abnormal laboratory value(s)|0
2919108|NCT01574651|10053607|P1|Overall Study|Abnormal laboratory value(s)|1
2919109|NCT01574651|10053606|P2|Overall Study|Adverse Event|27
2919110|NCT01574651|10053607|P1|Overall Study|Adverse Event|36
2919111|NCT01574651|10053606|P2|Overall Study|Patient's inability to use the device|1
2919112|NCT01574651|10053607|P1|Overall Study|Patient's inability to use the device|0
2919113|NCT01574651|10053606|P2|Overall Study|Death|3
2919114|NCT01574651|10053607|P1|Overall Study|Death|3
2919115|NCT01574651|10053606|P2|Overall Study|Administrative problems|1
2919116|NCT01574651|10053607|P1|Overall Study|Administrative problems|0
2919117|NCT01574651|10053606|P2|Overall Study|Lost to Follow-up|4
2919118|NCT01574651|10053607|P1|Overall Study|Lost to Follow-up|2
2919119|NCT01574612|10053629|P1|Overall Study|Lost to Follow-up|2
2919120|NCT01574612|10053629|P1|Overall Study|Withdrawal by Subject|1
2919121|NCT01574612|10053629|P1|Overall Study|non compliant with drug|2
2919122|NCT01574612|10053629|P1|Overall Study|Adverse Event|3
2919123|NCT01574326|10053635|P2|Overall Study|Other: Mainly kidney transplant|8
2919124|NCT01574326|10053636|P1|Overall Study|Other: Mainly kidney transplant|8
2919125|NCT01574326|10053635|P2|Overall Study|Adverse Event|3
2919126|NCT01574326|10053636|P1|Overall Study|Adverse Event|1
2919127|NCT01574326|10053635|P2|Overall Study|Physician Decision|3
2919128|NCT01574326|10053636|P1|Overall Study|Physician Decision|5
2919129|NCT01574326|10053635|P2|Overall Study|Withdrawal by Participant|4
2919130|NCT01574326|10053636|P1|Overall Study|Withdrawal by Participant|2
2919131|NCT01574326|10053635|P2|Overall Study|Randomized but not treated|1
2919132|NCT01574326|10053636|P1|Overall Study|Randomized but not treated|0
2919133|NCT01574248|10053654|P2|Overall Study|Missing primary endpoint data|0
2919134|NCT01574248|10053655|P1|Overall Study|Missing primary endpoint data|1
2919135|NCT01574248|10053654|P2|Overall Study|Withdrawal by Subject|0
2919136|NCT01574248|10053655|P1|Overall Study|Withdrawal by Subject|2
2919137|NCT01574157|10053688|P2|Overall Study|Lost to Follow-up|3
2919138|NCT01574157|10053689|P1|Overall Study|Lost to Follow-up|0
2919139|NCT01574157|10053688|P2|Overall Study|Withdrawal by Subject|5
2919140|NCT01574157|10053689|P1|Overall Study|Withdrawal by Subject|4
2919141|NCT01574079|10053723|P2|Overall Study|Lost to Follow-up|0
2919142|NCT01574079|10053724|P1|Overall Study|Lost to Follow-up|1
2919143|NCT01574079|10053723|P2|Overall Study|Physician Decision|2
2919144|NCT01574079|10053724|P1|Overall Study|Physician Decision|0
2919145|NCT01573910|10053736|P2|Overall Study|Patient decision unrelated to Advs Event|11
2919146|NCT01573910|10053737|P1|Overall Study|Patient decision unrelated to Advs Event|11
2919147|NCT01573910|10053736|P2|Overall Study|Protocol Violation|0
2919148|NCT01573910|10053737|P1|Overall Study|Protocol Violation|3
2919149|NCT01573910|10053736|P2|Overall Study|Withdrawal by Subject|1
2919150|NCT01573910|10053737|P1|Overall Study|Withdrawal by Subject|0
2919151|NCT01573910|10053736|P2|Overall Study|Lost to Follow-up|1
2919152|NCT01573910|10053737|P1|Overall Study|Lost to Follow-up|2
2919153|NCT01573910|10053736|P2|Overall Study|Adverse Event|4
2919154|NCT01573910|10053737|P1|Overall Study|Adverse Event|4
2919155|NCT01573767|10053749|P4|Overall Study|Withdrawal by Subject|0
2919156|NCT01573767|10053750|P3|Overall Study|Withdrawal by Subject|0
2919157|NCT01573767|10053751|P2|Overall Study|Withdrawal by Subject|1
2919158|NCT01573767|10053752|P1|Overall Study|Withdrawal by Subject|0
2919159|NCT01573767|10053749|P4|Overall Study|Physician Decision|2
2919160|NCT01573767|10053750|P3|Overall Study|Physician Decision|0
2919161|NCT01573767|10053751|P2|Overall Study|Physician Decision|2
2919162|NCT01573767|10053752|P1|Overall Study|Physician Decision|1
2919163|NCT01573767|10053749|P4|Overall Study|Lost to Follow-up|1
2919164|NCT01573767|10053750|P3|Overall Study|Lost to Follow-up|1
2919165|NCT01573767|10053751|P2|Overall Study|Lost to Follow-up|1
2919166|NCT01573767|10053752|P1|Overall Study|Lost to Follow-up|0
2919167|NCT01573767|10053749|P4|Overall Study|Protocol Violation|3
2919168|NCT01573767|10053750|P3|Overall Study|Protocol Violation|1
2919169|NCT01573767|10053751|P2|Overall Study|Protocol Violation|1
2919170|NCT01573767|10053752|P1|Overall Study|Protocol Violation|3
2919171|NCT01573767|10053749|P4|Overall Study|Lack of Efficacy|17
2919172|NCT01573767|10053750|P3|Overall Study|Lack of Efficacy|12
2919173|NCT01573767|10053751|P2|Overall Study|Lack of Efficacy|15
2919174|NCT01573767|10053752|P1|Overall Study|Lack of Efficacy|18
2919175|NCT01573767|10053749|P4|Overall Study|Adverse Event|1
2919176|NCT01573767|10053750|P3|Overall Study|Adverse Event|0
2919177|NCT01573767|10053751|P2|Overall Study|Adverse Event|1
2919178|NCT01573767|10053752|P1|Overall Study|Adverse Event|0
2919179|NCT01573624|10053786|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919180|NCT01573624|10053787|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919181|NCT01573624|10053788|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919182|NCT01573624|10053789|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919183|NCT01573624|10053790|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919184|NCT01573624|10053791|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2919185|NCT01573624|10053792|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
2919186|NCT01573624|10053786|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2919187|NCT01573624|10053787|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
2919188|NCT01573624|10053788|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
2919189|NCT01573624|10053789|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2919190|NCT01573624|10053790|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2919191|NCT01573624|10053791|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2919192|NCT01573624|10053792|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2919193|NCT01573624|10053786|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919194|NCT01573624|10053787|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919195|NCT01573624|10053788|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919196|NCT01573624|10053789|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919197|NCT01573624|10053790|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919198|NCT01573624|10053791|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2919199|NCT01573624|10053792|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
2919200|NCT01573624|10053786|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2919201|NCT01573624|10053787|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2919202|NCT01573624|10053788|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2919203|NCT01573624|10053789|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2919204|NCT01573624|10053790|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2919205|NCT01573624|10053791|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2919206|NCT01573624|10053792|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2919207|NCT01573624|10053786|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
2919208|NCT01573624|10053787|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2919209|NCT01573624|10053788|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2919210|NCT01573624|10053789|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2919211|NCT01573624|10053790|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2919212|NCT01573624|10053791|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2919213|NCT01573624|10053792|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
2919214|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2919215|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2919216|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2919217|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2919218|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2919219|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2919220|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2919221|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2919222|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2919223|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2919224|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2919225|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2919226|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2919227|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2919228|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919229|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919230|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919231|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919232|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919233|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
2919234|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2919235|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919236|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919237|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919238|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919239|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919240|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
2919241|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2919242|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2919243|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2919244|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2919245|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2919246|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2919247|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2919248|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2919249|NCT01573624|10053786|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2919250|NCT01573624|10053787|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2919251|NCT01573624|10053788|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2919252|NCT01573624|10053789|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2919253|NCT01573624|10053790|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2919254|NCT01573624|10053791|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2919255|NCT01573624|10053792|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2919256|NCT01573624|10053786|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919257|NCT01573624|10053787|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919258|NCT01573624|10053788|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919259|NCT01573624|10053789|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919260|NCT01573624|10053790|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919261|NCT01573624|10053791|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2919262|NCT01573624|10053792|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
2919263|NCT01573624|10053786|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2919264|NCT01573624|10053787|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2919265|NCT01573624|10053788|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2919266|NCT01573624|10053789|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2919267|NCT01573624|10053790|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2919268|NCT01573624|10053791|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2919269|NCT01573624|10053792|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2919270|NCT01573624|10053786|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919271|NCT01573624|10053787|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919272|NCT01573624|10053788|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919273|NCT01573624|10053789|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919274|NCT01573624|10053790|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919275|NCT01573624|10053791|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2919276|NCT01573624|10053792|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
2919277|NCT01573624|10053786|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2919278|NCT01573624|10053787|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
2919279|NCT01573624|10053788|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2919280|NCT01573624|10053789|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2919281|NCT01573624|10053790|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2919282|NCT01573624|10053791|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
2919283|NCT01573624|10053792|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2919284|NCT01573624|10053786|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
2919285|NCT01573624|10053787|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2919286|NCT01573624|10053788|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
2919287|NCT01573624|10053789|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
2919288|NCT01573624|10053790|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2919289|NCT01573624|10053791|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
2919290|NCT01573624|10053792|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
2919291|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2919292|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2919293|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2919294|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2919295|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2919296|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2919297|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2919298|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2919299|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2919300|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2919301|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
2919302|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2919303|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2919304|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2919305|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919306|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
2919307|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919308|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919309|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919310|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919311|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2919312|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2919313|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2919314|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2919315|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2919316|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
2919317|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2919318|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2919319|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2919320|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2919321|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2919322|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2919323|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2919324|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2919325|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2919326|NCT01573624|10053786|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919327|NCT01573624|10053787|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
2919328|NCT01573624|10053788|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919329|NCT01573624|10053789|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919330|NCT01573624|10053790|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919331|NCT01573624|10053791|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919332|NCT01573624|10053792|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2919333|NCT01573624|10053786|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2919334|NCT01573624|10053787|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2919335|NCT01573624|10053788|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2919336|NCT01573624|10053789|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2919337|NCT01573624|10053790|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2919338|NCT01573624|10053791|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2919339|NCT01573624|10053792|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2919340|NCT01573624|10053786|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2919341|NCT01573624|10053787|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2919342|NCT01573624|10053788|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2919343|NCT01573624|10053789|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2919344|NCT01573624|10053790|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2919345|NCT01573624|10053791|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2919346|NCT01573624|10053792|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2919347|NCT01573624|10053786|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919348|NCT01573624|10053787|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919349|NCT01573624|10053788|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919350|NCT01573624|10053789|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919351|NCT01573624|10053790|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919352|NCT01573624|10053791|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2919353|NCT01573624|10053792|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
2919354|NCT01573624|10053786|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2919355|NCT01573624|10053787|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
2919356|NCT01573624|10053788|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
2919357|NCT01573624|10053789|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2919358|NCT01573624|10053790|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
2919359|NCT01573624|10053791|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
2919360|NCT01573624|10053792|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
2919361|NCT01573624|10053786|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2919362|NCT01573624|10053787|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2919363|NCT01573624|10053788|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2919364|NCT01573624|10053789|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2919365|NCT01573624|10053790|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2919366|NCT01573624|10053791|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2919367|NCT01573624|10053792|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2919368|NCT01573442|10053848|P2|Overall Study|Cancels|10
2919369|NCT01573442|10053849|P1|Overall Study|Cancels|9
2919370|NCT01573000|10053980|P2|Long-Term Follow-Up|Lost to Follow-up|1
2919371|NCT01573000|10053981|P1|Long-Term Follow-Up|Lost to Follow-up|0
2919372|NCT01573000|10053980|P2|Long-Term Follow-Up|Death|0
2919373|NCT01573000|10053981|P1|Long-Term Follow-Up|Death|3
2919374|NCT01573000|10053980|P2|Crossover Phase|Death|3
2919375|NCT01573000|10053981|P1|Crossover Phase|Death|0
2919376|NCT01573000|10053980|P2|Crossover Phase|Lost to Follow-up|2
2919377|NCT01573000|10053981|P1|Crossover Phase|Lost to Follow-up|0
2919378|NCT01573000|10053980|P2|Crossover Phase|Lack of Efficacy|13
2919379|NCT01573000|10053981|P1|Crossover Phase|Lack of Efficacy|0
2919380|NCT01573000|10053980|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
2919381|NCT01573000|10053981|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
2919382|NCT01573000|10053980|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
2919383|NCT01573000|10053981|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
2919384|NCT01573000|10053980|P2|Dosimetric and Therapeutic Treatment|Death|1
2919385|NCT01573000|10053981|P1|Dosimetric and Therapeutic Treatment|Death|0
2919386|NCT01573000|10053980|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2919387|NCT01573000|10053981|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
2919388|NCT01573000|10053980|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
2919389|NCT01573000|10053981|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
2919390|NCT01572948|10054077|P2|Overall Study|unable to contact|1
2919391|NCT01572948|10054078|P1|Overall Study|unable to contact|0
2919392|NCT01572948|10054077|P2|Overall Study|Lost to Follow-up|0
2919393|NCT01572948|10054078|P1|Overall Study|Lost to Follow-up|1
2919394|NCT01572922|10054094|P1|Overall Study|Death|1
2919395|NCT01572922|10054094|P1|Overall Study|Protocol Violation|1
2919396|NCT01572922|10054094|P1|Overall Study|Adverse Event|1
2919397|NCT01572844|10054104|P2|Overall Study|Physician Decision|1
2919398|NCT01572844|10054105|P1|Overall Study|Physician Decision|1
2919399|NCT01572792|10054123|P5|Extension Study|Site termination/COPD exacerbation/other|6
2919400|NCT01572792|10054124|P4|Extension Study|Site termination/COPD exacerbation/other|6
2919401|NCT01572792|10054125|P3|Extension Study|Site termination/COPD exacerbation/other|4
2919402|NCT01572792|10054126|P2|Extension Study|Site termination/COPD exacerbation/other|8
2919403|NCT01572792|10054127|P1|Extension Study|Site termination/COPD exacerbation/other|3
2919404|NCT01572792|10054123|P5|Extension Study|Adverse Event|4
2919405|NCT01572792|10054124|P4|Extension Study|Adverse Event|6
2919406|NCT01572792|10054125|P3|Extension Study|Adverse Event|5
2919407|NCT01572792|10054126|P2|Extension Study|Adverse Event|6
2919408|NCT01572792|10054127|P1|Extension Study|Adverse Event|7
2919409|NCT01572792|10054123|P5|Extension Study|Lack of Efficacy|2
2919410|NCT01572792|10054124|P4|Extension Study|Lack of Efficacy|2
2919411|NCT01572792|10054125|P3|Extension Study|Lack of Efficacy|3
2919412|NCT01572792|10054126|P2|Extension Study|Lack of Efficacy|3
2919413|NCT01572792|10054127|P1|Extension Study|Lack of Efficacy|2
2919414|NCT01572792|10054123|P5|Extension Study|Protocol Violation|3
2919415|NCT01572792|10054124|P4|Extension Study|Protocol Violation|4
2919416|NCT01572792|10054125|P3|Extension Study|Protocol Violation|3
2919417|NCT01572792|10054126|P2|Extension Study|Protocol Violation|4
2919418|NCT01572792|10054127|P1|Extension Study|Protocol Violation|0
2919419|NCT01572792|10054123|P5|Extension Study|Withdrawal by Subject|14
2919420|NCT01572792|10054124|P4|Extension Study|Withdrawal by Subject|8
2919421|NCT01572792|10054125|P3|Extension Study|Withdrawal by Subject|11
2919422|NCT01572792|10054126|P2|Extension Study|Withdrawal by Subject|6
2919423|NCT01572792|10054127|P1|Extension Study|Withdrawal by Subject|7
2919424|NCT01572792|10054123|P5|Extension Study|Lost to Follow-up|3
2919425|NCT01572792|10054124|P4|Extension Study|Lost to Follow-up|3
2919426|NCT01572792|10054125|P3|Extension Study|Lost to Follow-up|0
2919427|NCT01572792|10054126|P2|Extension Study|Lost to Follow-up|2
2919428|NCT01572792|10054127|P1|Extension Study|Lost to Follow-up|6
2919429|NCT01572792|10054123|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
2919430|NCT01572792|10054124|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
2919431|NCT01572792|10054125|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
2919432|NCT01572792|10054126|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
2919433|NCT01572792|10054127|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
2919434|NCT01572792|10054123|P5|Lead-in Study|Adverse Event|14
2919435|NCT01572792|10054124|P4|Lead-in Study|Adverse Event|16
2919436|NCT01572792|10054125|P3|Lead-in Study|Adverse Event|22
2919437|NCT01572792|10054126|P2|Lead-in Study|Adverse Event|21
2919438|NCT01572792|10054127|P1|Lead-in Study|Adverse Event|21
2919439|NCT01572792|10054123|P5|Lead-in Study|Lack of Efficacy|10
2919440|NCT01572792|10054124|P4|Lead-in Study|Lack of Efficacy|8
2919441|NCT01572792|10054125|P3|Lead-in Study|Lack of Efficacy|4
2919442|NCT01572792|10054126|P2|Lead-in Study|Lack of Efficacy|5
2919443|NCT01572792|10054127|P1|Lead-in Study|Lack of Efficacy|20
2919444|NCT01572792|10054123|P5|Lead-in Study|Protocol Violation|21
2919445|NCT01572792|10054124|P4|Lead-in Study|Protocol Violation|13
2919446|NCT01572792|10054125|P3|Lead-in Study|Protocol Violation|12
2919447|NCT01572792|10054126|P2|Lead-in Study|Protocol Violation|10
2919448|NCT01572792|10054127|P1|Lead-in Study|Protocol Violation|19
2919449|NCT01572792|10054123|P5|Lead-in Study|Withdrawal by Subject|11
2919450|NCT01572792|10054124|P4|Lead-in Study|Withdrawal by Subject|24
2919451|NCT01572792|10054125|P3|Lead-in Study|Withdrawal by Subject|12
2919452|NCT01572792|10054126|P2|Lead-in Study|Withdrawal by Subject|11
2919453|NCT01572792|10054127|P1|Lead-in Study|Withdrawal by Subject|22
2919454|NCT01572792|10054123|P5|Lead-in Study|Lost to Follow-up|4
2919455|NCT01572792|10054124|P4|Lead-in Study|Lost to Follow-up|2
2919456|NCT01572792|10054125|P3|Lead-in Study|Lost to Follow-up|4
2919457|NCT01572792|10054126|P2|Lead-in Study|Lost to Follow-up|9
2919458|NCT01572792|10054127|P1|Lead-in Study|Lost to Follow-up|5
2919459|NCT01572740|10054176|P2|Overall Study|unclassified|3
2919460|NCT01572740|10054177|P1|Overall Study|unclassified|4
2919461|NCT01572740|10054176|P2|Overall Study|Withdrawal by Subject|1
2919462|NCT01572740|10054177|P1|Overall Study|Withdrawal by Subject|1
2919463|NCT01572740|10054176|P2|Overall Study|Adverse Event|1
2919464|NCT01572740|10054177|P1|Overall Study|Adverse Event|1
2919465|NCT01572727|10054207|P2|Overall Study|Untreated|7
2919466|NCT01572727|10054208|P1|Overall Study|Untreated|4
2919467|NCT01572727|10054207|P2|Overall Study|Death|2
2919468|NCT01572727|10054208|P1|Overall Study|Death|2
2919469|NCT01572727|10054207|P2|Overall Study|Parent/guardian decision|9
2919470|NCT01572727|10054208|P1|Overall Study|Parent/guardian decision|14
2919471|NCT01572727|10054207|P2|Overall Study|Study terminated by sponsor|83
2919472|NCT01572727|10054208|P1|Overall Study|Study terminated by sponsor|61
2919473|NCT01572727|10054207|P2|Overall Study|Protocol Violation|1
2919474|NCT01572727|10054208|P1|Overall Study|Protocol Violation|0
2919475|NCT01572727|10054207|P2|Overall Study|Progressive disease|82
2919476|NCT01572727|10054208|P1|Overall Study|Progressive disease|59
2919477|NCT01572727|10054207|P2|Overall Study|Physician Decision|9
2919478|NCT01572727|10054208|P1|Overall Study|Physician Decision|23
2919479|NCT01572727|10054207|P2|Overall Study|Lost to Follow-up|1
2919480|NCT01572727|10054208|P1|Overall Study|Lost to Follow-up|1
2919481|NCT01572727|10054207|P2|Overall Study|Adverse Event|15
2919482|NCT01572727|10054208|P1|Overall Study|Adverse Event|43
2919483|NCT01572675|10054230|P2|Overall Study|Lost to Follow-up|27
2919484|NCT01572675|10054231|P1|Overall Study|Lost to Follow-up|22
2919485|NCT01572675|10054230|P2|Overall Study|Missing data|4
2919486|NCT01572675|10054231|P1|Overall Study|Missing data|1
2919487|NCT01572675|10054230|P2|Overall Study|Rheumatologist new evaluation|1
2919488|NCT01572675|10054231|P1|Overall Study|Rheumatologist new evaluation|0
2919489|NCT01572675|10054230|P2|Overall Study|Unknown reason|1
2919490|NCT01572675|10054231|P1|Overall Study|Unknown reason|1
2919491|NCT01572675|10054230|P2|Overall Study|Other disease detected|1
2919492|NCT01572675|10054231|P1|Overall Study|Other disease detected|1
2919493|NCT01572675|10054230|P2|Overall Study|Death unrelated to coxibs|1
2919494|NCT01572675|10054231|P1|Overall Study|Death unrelated to coxibs|1
2919495|NCT01572675|10054230|P2|Overall Study|Physician Decision|2
2919496|NCT01572675|10054231|P1|Overall Study|Physician Decision|2
2919497|NCT01572675|10054230|P2|Overall Study|Withdrawal by Subject|1
2919498|NCT01572675|10054231|P1|Overall Study|Withdrawal by Subject|5
2919499|NCT01572675|10054230|P2|Overall Study|Surgical intervention|6
2919500|NCT01572675|10054231|P1|Overall Study|Surgical intervention|3
2919501|NCT01572675|10054230|P2|Overall Study|Improved symptoms|2
2919502|NCT01572675|10054231|P1|Overall Study|Improved symptoms|8
2919503|NCT01572675|10054230|P2|Overall Study|Intolerance|5
2919504|NCT01572675|10054231|P1|Overall Study|Intolerance|6
2919505|NCT01572675|10054230|P2|Overall Study|Lack of Efficacy|31
2919506|NCT01572675|10054231|P1|Overall Study|Lack of Efficacy|31
2919507|NCT01572675|10054230|P2|Overall Study|Recovery|23
2919508|NCT01572675|10054231|P1|Overall Study|Recovery|16
2919509|NCT01572675|10054230|P2|Overall Study|End of prescribed treatment|118
2919510|NCT01572675|10054231|P1|Overall Study|End of prescribed treatment|140
2919511|NCT01572389|10054349|P2|Overall Study|Only A1C or Assessment was Collected|2
2919512|NCT01572389|10054350|P1|Overall Study|Only A1C or Assessment was Collected|6
2919513|NCT01572389|10054349|P2|Overall Study|Lost to Follow-up|14
2919514|NCT01572389|10054350|P1|Overall Study|Lost to Follow-up|25
2919515|NCT01572389|10054349|P2|Overall Study|Withdrawal by Subject|2
2919516|NCT01572389|10054350|P1|Overall Study|Withdrawal by Subject|14
2919517|NCT01572389|10054349|P2|Overall Study|Death|3
2919518|NCT01572389|10054350|P1|Overall Study|Death|1
2919519|NCT01571453|10054391|P2|Overall Study|Administrative or other reason(s)|3
2919520|NCT01571453|10054392|P1|Overall Study|Administrative or other reason(s)|4
2919521|NCT01571453|10054391|P2|Overall Study|Lost to Follow-up|2
2919522|NCT01571453|10054392|P1|Overall Study|Lost to Follow-up|4
2919523|NCT01571453|10054391|P2|Overall Study|Withdrawal of consent|13
2919524|NCT01571453|10054392|P1|Overall Study|Withdrawal of consent|5
2919525|NCT01571453|10054391|P2|Overall Study|Protocol Violation|5
2919526|NCT01571453|10054392|P1|Overall Study|Protocol Violation|1
2919527|NCT01571453|10054391|P2|Overall Study|Non-compliance|4
2919528|NCT01571453|10054392|P1|Overall Study|Non-compliance|2
2919529|NCT01571453|10054391|P2|Overall Study|Lack of Efficacy|3
2919530|NCT01571453|10054392|P1|Overall Study|Lack of Efficacy|8
2919531|NCT01571453|10054391|P2|Overall Study|Adverse Event|32
2919532|NCT01571453|10054392|P1|Overall Study|Adverse Event|14
2919533|NCT01571362|10054439|P3|Double-Blind Treatment Period|Other - unspecified|1
2919534|NCT01571362|10054440|P2|Double-Blind Treatment Period|Other - unspecified|6
2919535|NCT01571362|10054441|P1|Double-Blind Treatment Period|Other - unspecified|0
2919536|NCT01571362|10054439|P3|Double-Blind Treatment Period|Insufficient clinical response|4
2919537|NCT01571362|10054440|P2|Double-Blind Treatment Period|Insufficient clinical response|16
2919538|NCT01571362|10054441|P1|Double-Blind Treatment Period|Insufficient clinical response|0
2919539|NCT01571362|10054439|P3|Double-Blind Treatment Period|Lost to Follow-up|6
2919540|NCT01571362|10054440|P2|Double-Blind Treatment Period|Lost to Follow-up|3
2919541|NCT01571362|10054441|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2919542|NCT01571362|10054439|P3|Double-Blind Treatment Period|Adverse Event|14
2919543|NCT01571362|10054440|P2|Double-Blind Treatment Period|Adverse Event|9
2919544|NCT01571362|10054441|P1|Double-Blind Treatment Period|Adverse Event|0
2919545|NCT01571362|10054439|P3|Double-Blind Treatment Period|Protocol Violation|9
2919546|NCT01571362|10054440|P2|Double-Blind Treatment Period|Protocol Violation|8
2919547|NCT01571362|10054441|P1|Double-Blind Treatment Period|Protocol Violation|0
2919548|NCT01571362|10054439|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
2919549|NCT01571362|10054440|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
2919550|NCT01571362|10054441|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2919551|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
2919552|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
2919553|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
2919554|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2919555|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2919556|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
2919557|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2919558|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2919559|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
2919560|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Adverse Event|0
2919561|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Adverse Event|0
2919562|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Adverse Event|57
2919563|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
2919564|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
2919565|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
2919566|NCT01571362|10054439|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2919567|NCT01571362|10054440|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2919568|NCT01571362|10054441|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
2919569|NCT01571284|10054611|P1|Overall Study|Other than specified above|80
2919570|NCT01571284|10054611|P1|Overall Study|Enrolled but not treated|2
2919571|NCT01571284|10054611|P1|Overall Study|Lost to Follow-up|3
2919572|NCT01571284|10054611|P1|Overall Study|Participant's decision|84
2919573|NCT01571232|10054634|P2|Overall Study|Withdrawal by Subject|0
2919574|NCT01571232|10054635|P1|Overall Study|Withdrawal by Subject|1
2919575|NCT01571232|10054634|P2|Overall Study|Lost to Follow-up|1
2919576|NCT01571232|10054635|P1|Overall Study|Lost to Follow-up|0
2919577|NCT01570868|10054647|P2|Overall Study|Withdrawal by Subject|0
2919578|NCT01570868|10054648|P1|Overall Study|Withdrawal by Subject|1
2919579|NCT01570868|10054647|P2|Overall Study|Lost to Follow-up|0
2919580|NCT01570868|10054648|P1|Overall Study|Lost to Follow-up|1
2919581|NCT01570868|10054647|P2|Overall Study|Physician Decision|4
2919582|NCT01570868|10054648|P1|Overall Study|Physician Decision|10
2919583|NCT01570868|10054647|P2|Overall Study|FDA Recommendation|3
2919584|NCT01570868|10054648|P1|Overall Study|FDA Recommendation|23
2919585|NCT01570868|10054647|P2|Overall Study|Adverse Event|1
2919586|NCT01570868|10054648|P1|Overall Study|Adverse Event|8
2919587|NCT01570751|10054660|P2|Period B (16 Weeks)|Protocol Violation|1
2919588|NCT01570751|10054661|P1|Period B (16 Weeks)|Protocol Violation|0
2919589|NCT01570751|10054660|P2|Period B (16 Weeks)|Adverse Event|0
2919590|NCT01570751|10054661|P1|Period B (16 Weeks)|Adverse Event|1
2919591|NCT01570751|10054660|P2|Period A (16 Weeks)|Unclassified|3
2919592|NCT01570751|10054661|P1|Period A (16 Weeks)|Unclassified|2
2919593|NCT01570751|10054660|P2|Period A (16 Weeks)|Withdrawal criteria|1
2919594|NCT01570751|10054661|P1|Period A (16 Weeks)|Withdrawal criteria|0
2919595|NCT01570751|10054660|P2|Period A (16 Weeks)|Protocol Violation|1
2919596|NCT01570751|10054661|P1|Period A (16 Weeks)|Protocol Violation|1
2919597|NCT01570686|10054679|P2|Overall Study|Unsatisfactory therapeutic effect|1
2919598|NCT01570686|10054680|P1|Overall Study|Unsatisfactory therapeutic effect|2
2919599|NCT01570686|10054679|P2|Overall Study|Withdrawal by Subject|4
2919600|NCT01570686|10054680|P1|Overall Study|Withdrawal by Subject|4
2919601|NCT01570686|10054679|P2|Overall Study|Protocol Deviation|0
2919602|NCT01570686|10054680|P1|Overall Study|Protocol Deviation|3
2919603|NCT01570686|10054679|P2|Overall Study|Lost to Follow-up|3
2919604|NCT01570686|10054680|P1|Overall Study|Lost to Follow-up|4
2919605|NCT01570686|10054679|P2|Overall Study|Adverse Event|6
2919606|NCT01570686|10054680|P1|Overall Study|Adverse Event|8
2919607|NCT01570686|10054679|P2|Overall Study|Administrative problems|1
2919608|NCT01570686|10054680|P1|Overall Study|Administrative problems|0
2919609|NCT01570686|10054679|P2|Overall Study|Abnormal test procedure result(s)|1
2919610|NCT01570686|10054680|P1|Overall Study|Abnormal test procedure result(s)|1
2919611|NCT01570491|10054716|P2|Overall Study|treatment: not given or discontinued|0
2919612|NCT01570491|10054717|P1|Overall Study|treatment: not given or discontinued|2
2919613|NCT01570491|10054716|P2|Overall Study|Lost to Follow-up|1
2919614|NCT01570491|10054717|P1|Overall Study|Lost to Follow-up|3
2919615|NCT01570387|10054733|P4|Overall Study|Withdrawal by Subject|1
2919616|NCT01570387|10054734|P3|Overall Study|Withdrawal by Subject|0
2919617|NCT01570387|10054735|P2|Overall Study|Withdrawal by Subject|0
2919618|NCT01570387|10054736|P1|Overall Study|Withdrawal by Subject|0
2919619|NCT01570387|10054733|P4|Overall Study|Death|1
2919620|NCT01570387|10054734|P3|Overall Study|Death|0
2919621|NCT01570387|10054735|P2|Overall Study|Death|0
2919622|NCT01570387|10054736|P1|Overall Study|Death|0
2919623|NCT01570387|10054733|P4|Overall Study|Adverse Event|0
2919624|NCT01570387|10054734|P3|Overall Study|Adverse Event|0
2919625|NCT01570387|10054735|P2|Overall Study|Adverse Event|0
2919626|NCT01570387|10054736|P1|Overall Study|Adverse Event|1
2919627|NCT01570361|10054748|P2|Overall Study|Other|2
2919628|NCT01570361|10054749|P1|Overall Study|Other|0
2919629|NCT01570361|10054748|P2|Overall Study|Death|4
2919630|NCT01570361|10054749|P1|Overall Study|Death|5
2919631|NCT01570361|10054748|P2|Overall Study|Lost to Follow-up|4
2919632|NCT01570361|10054749|P1|Overall Study|Lost to Follow-up|4
2919633|NCT01570361|10054748|P2|Overall Study|Adverse Event|1
2919634|NCT01570361|10054749|P1|Overall Study|Adverse Event|2
2919635|NCT01570361|10054748|P2|Overall Study|Subject withdrew consent|9
2919636|NCT01570361|10054749|P1|Overall Study|Subject withdrew consent|14
2919637|NCT01570361|10054748|P2|Overall Study|Subject excluded|3
2919638|NCT01570361|10054749|P1|Overall Study|Subject excluded|5
2919639|NCT01570361|10054748|P2|Overall Study|Sponsor closing the study|50
2919640|NCT01570361|10054749|P1|Overall Study|Sponsor closing the study|51
2919641|NCT01570361|10054748|P2|Overall Study|Subject discontinued|2
2919642|NCT01570361|10054749|P1|Overall Study|Subject discontinued|1
2919643|NCT01570309|10054792|P2|Overall Study|Withdrawal by Subject|3
2919644|NCT01570309|10054793|P1|Overall Study|Withdrawal by Subject|3
2919645|NCT01570283|10054810|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
2919646|NCT01570283|10054811|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2919647|NCT01570283|10054812|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2919648|NCT01570283|10054813|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2919649|NCT01570283|10054814|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2919650|NCT01570283|10054815|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2919651|NCT01570283|10054810|P6|Cohort 3: Dose Level 3|Death|1
2919652|NCT01570283|10054811|P5|Cohort 3: Dose Level 3|Death|0
2919653|NCT01570283|10054812|P4|Cohort 3: Dose Level 3|Death|0
2919654|NCT01570283|10054813|P3|Cohort 3: Dose Level 3|Death|0
2919655|NCT01570283|10054814|P2|Cohort 3: Dose Level 3|Death|0
2919656|NCT01570283|10054815|P1|Cohort 3: Dose Level 3|Death|0
2919657|NCT01570283|10054810|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2919658|NCT01570283|10054811|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2919659|NCT01570283|10054812|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
2919660|NCT01570283|10054813|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2919661|NCT01570283|10054814|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2919662|NCT01570283|10054815|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2919663|NCT01570283|10054810|P6|Cohort 2: Dose Level 2|Death|0
2919664|NCT01570283|10054811|P5|Cohort 2: Dose Level 2|Death|0
2919665|NCT01570283|10054812|P4|Cohort 2: Dose Level 2|Death|0
2919666|NCT01570283|10054813|P3|Cohort 2: Dose Level 2|Death|1
2919667|NCT01570283|10054814|P2|Cohort 2: Dose Level 2|Death|0
2919668|NCT01570283|10054815|P1|Cohort 2: Dose Level 2|Death|0
2919669|NCT01570283|10054810|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2919670|NCT01570283|10054811|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2919671|NCT01570283|10054812|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2919672|NCT01570283|10054813|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2919673|NCT01570283|10054814|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
2919674|NCT01570283|10054815|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2919675|NCT01570283|10054810|P6|Cohort 1: Dose Level 1|Death|0
2919676|NCT01570283|10054811|P5|Cohort 1: Dose Level 1|Death|0
2919677|NCT01570283|10054812|P4|Cohort 1: Dose Level 1|Death|0
2919678|NCT01570283|10054813|P3|Cohort 1: Dose Level 1|Death|0
2919679|NCT01570283|10054814|P2|Cohort 1: Dose Level 1|Death|1
2919680|NCT01570283|10054815|P1|Cohort 1: Dose Level 1|Death|0
2919681|NCT01570244|10054832|P1|Microgynon+Faldaprevir|Adverse Event|1
2919682|NCT01570192|10054854|P2|Overall Study|Physician Decision|1
2919683|NCT01570192|10054855|P1|Overall Study|Physician Decision|0
2919684|NCT01570192|10054854|P2|Overall Study|changed to palliative care|0
2919685|NCT01570192|10054855|P1|Overall Study|changed to palliative care|1
2919686|NCT01570192|10054854|P2|Overall Study|no qualifying organism|12
2919687|NCT01570192|10054855|P1|Overall Study|no qualifying organism|6
2919688|NCT01569841|10054893|P2|Period A (6 Weeks)|Withdrawal by Subject|1
2919689|NCT01569841|10054894|P1|Period A (6 Weeks)|Withdrawal by Subject|0
2919690|NCT01569763|10054983|P2|Overall Study|Adverse Event|0
2919691|NCT01569763|10054984|P1|Overall Study|Adverse Event|1
2919692|NCT01569763|10054983|P2|Overall Study|Lack of Efficacy|7
2919693|NCT01569763|10054984|P1|Overall Study|Lack of Efficacy|2
2919694|NCT01569594|10055023|P1|Overall Study|No ECM used|9
2919695|NCT01569594|10055023|P1|Overall Study|Other|4
2919696|NCT01569594|10055023|P1|Overall Study|Withdrawal by Subject|13
2919697|NCT01569594|10055023|P1|Overall Study|Adverse Event|2
2919698|NCT01569594|10055023|P1|Overall Study|Lost to Follow-up|22
2919699|NCT01569594|10055023|P1|Overall Study|Death|13
2919700|NCT01569594|10055023|P1|Overall Study|Physician Decision|4
2919701|NCT01569568|10055029|P2|Overall Study|Physician Decision|2
2919702|NCT01569568|10055030|P1|Overall Study|Physician Decision|0
2919703|NCT01569464|10055053|P2|Overall Study|Other|1
2919704|NCT01569464|10055054|P1|Overall Study|Other|1
2919705|NCT01569464|10055053|P2|Overall Study|Withdrawal by Subject|1
2919706|NCT01569464|10055054|P1|Overall Study|Withdrawal by Subject|1
2919707|NCT01569464|10055053|P2|Overall Study|Lost to Follow-up|3
2919708|NCT01569464|10055054|P1|Overall Study|Lost to Follow-up|2
2919709|NCT01569464|10055053|P2|Overall Study|Protocol Violation|0
2919710|NCT01569464|10055054|P1|Overall Study|Protocol Violation|1
2919711|NCT01569464|10055053|P2|Overall Study|Lack of Efficacy|0
2919712|NCT01569464|10055054|P1|Overall Study|Lack of Efficacy|1
2919713|NCT01569464|10055053|P2|Overall Study|Adverse Event|0
2919714|NCT01569464|10055054|P1|Overall Study|Adverse Event|4
2919715|NCT01569438|10055121|P2|Overall Study|Protocol Violation|0
2919716|NCT01569438|10055122|P1|Overall Study|Protocol Violation|1
2919717|NCT01569438|10055121|P2|Overall Study|Withdrawal by Subject|1
2919718|NCT01569438|10055122|P1|Overall Study|Withdrawal by Subject|0
2919719|NCT01569438|10055121|P2|Overall Study|Lack of Efficacy|1
2919720|NCT01569438|10055122|P1|Overall Study|Lack of Efficacy|1
2919721|NCT01569438|10055121|P2|Overall Study|Adverse Event|7
2919722|NCT01569438|10055122|P1|Overall Study|Adverse Event|0
2919723|NCT01569295|10055136|P2|Overall Study|Lost to Follow-up|1
2919724|NCT01569295|10055137|P1|Overall Study|Lost to Follow-up|1
2919725|NCT01569295|10055136|P2|Overall Study|Other Anticancer/Experimental Therapy|2
2919726|NCT01569295|10055137|P1|Overall Study|Other Anticancer/Experimental Therapy|2
2919727|NCT01569295|10055136|P2|Overall Study|Non-Compliance with Study Drug|1
2919728|NCT01569295|10055137|P1|Overall Study|Non-Compliance with Study Drug|6
2919729|NCT01569295|10055136|P2|Overall Study|Other Reason not Specified|5
2919730|NCT01569295|10055137|P1|Overall Study|Other Reason not Specified|3
2919731|NCT01569295|10055136|P2|Overall Study|Study Terminated by Sponsor|2
2919732|NCT01569295|10055137|P1|Overall Study|Study Terminated by Sponsor|24
2919733|NCT01569295|10055136|P2|Overall Study|Physician Decision|18
2919734|NCT01569295|10055137|P1|Overall Study|Physician Decision|13
2919735|NCT01569295|10055136|P2|Overall Study|Death|15
2919736|NCT01569295|10055137|P1|Overall Study|Death|19
2919737|NCT01569295|10055136|P2|Overall Study|Withdrawal by Subject|12
2919738|NCT01569295|10055137|P1|Overall Study|Withdrawal by Subject|25
2919739|NCT01569295|10055136|P2|Overall Study|Adverse Event|14
2919740|NCT01569295|10055137|P1|Overall Study|Adverse Event|39
2919741|NCT01569295|10055136|P2|Overall Study|Progressive Disease|139
2919742|NCT01569295|10055137|P1|Overall Study|Progressive Disease|75
2919743|NCT01569152|10055174|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
2919744|NCT01569152|10055175|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
2919745|NCT01569152|10055176|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
2919746|NCT01569152|10055174|P3|Safety Extension, Period 3|Physician Decision|2
2919747|NCT01569152|10055175|P2|Safety Extension, Period 3|Physician Decision|0
2919748|NCT01569152|10055176|P1|Safety Extension, Period 3|Physician Decision|0
2919749|NCT01569152|10055174|P3|Safety Extension, Period 3|Withdrawal by Subject|2
2919750|NCT01569152|10055175|P2|Safety Extension, Period 3|Withdrawal by Subject|0
2919751|NCT01569152|10055176|P1|Safety Extension, Period 3|Withdrawal by Subject|0
2919752|NCT01569152|10055174|P3|Safety Extension, Period 3|Adverse Event|4
2919753|NCT01569152|10055175|P2|Safety Extension, Period 3|Adverse Event|0
2919754|NCT01569152|10055176|P1|Safety Extension, Period 3|Adverse Event|0
2919755|NCT01569152|10055174|P3|Phase IIa, Period 1|Withdrawal by Subject|0
2919756|NCT01569152|10055175|P2|Phase IIa, Period 1|Withdrawal by Subject|1
2919757|NCT01569152|10055176|P1|Phase IIa, Period 1|Withdrawal by Subject|2
2919758|NCT01569152|10055174|P3|Phase IIa, Period 1|Protocol Violation|0
2919759|NCT01569152|10055175|P2|Phase IIa, Period 1|Protocol Violation|1
2919760|NCT01569152|10055176|P1|Phase IIa, Period 1|Protocol Violation|0
2919761|NCT01569152|10055174|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
2919762|NCT01569152|10055175|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
2919763|NCT01569152|10055176|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
2919764|NCT01569152|10055174|P3|Phase IIa, Period 1|Lost to Follow-up|0
2919765|NCT01569152|10055175|P2|Phase IIa, Period 1|Lost to Follow-up|0
2919766|NCT01569152|10055176|P1|Phase IIa, Period 1|Lost to Follow-up|1
2919767|NCT01569152|10055174|P3|Phase IIa, Period 1|Adverse Event|0
2919768|NCT01569152|10055175|P2|Phase IIa, Period 1|Adverse Event|0
2919769|NCT01569152|10055176|P1|Phase IIa, Period 1|Adverse Event|4
2919770|NCT01569152|10055174|P3|Phase IIa, Period 1|Early Escape|0
2919771|NCT01569152|10055175|P2|Phase IIa, Period 1|Early Escape|22
2919772|NCT01569152|10055176|P1|Phase IIa, Period 1|Early Escape|5
2919773|NCT01569074|10055312|P5|Overall Study|Adverse Event|0
2919774|NCT01569074|10055313|P4|Overall Study|Adverse Event|0
2919775|NCT01569074|10055314|P3|Overall Study|Adverse Event|3
2919776|NCT01569074|10055315|P2|Overall Study|Adverse Event|0
2919777|NCT01569074|10055316|P1|Overall Study|Adverse Event|1
2919778|NCT01569074|10055312|P5|Overall Study|eg change in circumstances|1
2919779|NCT01569074|10055313|P4|Overall Study|eg change in circumstances|1
2919780|NCT01569074|10055314|P3|Overall Study|eg change in circumstances|0
2919781|NCT01569074|10055315|P2|Overall Study|eg change in circumstances|2
2919782|NCT01569074|10055316|P1|Overall Study|eg change in circumstances|0
2919783|NCT01569074|10055312|P5|Overall Study|Severe non-compliance to protocol|0
2919784|NCT01569074|10055313|P4|Overall Study|Severe non-compliance to protocol|0
2919785|NCT01569074|10055314|P3|Overall Study|Severe non-compliance to protocol|1
2919786|NCT01569074|10055315|P2|Overall Study|Severe non-compliance to protocol|0
2919787|NCT01569074|10055316|P1|Overall Study|Severe non-compliance to protocol|0
2919788|NCT01569074|10055312|P5|Overall Study|Study-specific discontinuation criteria|0
2919789|NCT01569074|10055313|P4|Overall Study|Study-specific discontinuation criteria|0
2919790|NCT01569074|10055314|P3|Overall Study|Study-specific discontinuation criteria|0
2919791|NCT01569074|10055315|P2|Overall Study|Study-specific discontinuation criteria|1
2919792|NCT01569074|10055316|P1|Overall Study|Study-specific discontinuation criteria|0
2919793|NCT01569074|10055312|P5|Overall Study|Study stopped|7
2919794|NCT01569074|10055313|P4|Overall Study|Study stopped|7
2919795|NCT01569074|10055314|P3|Overall Study|Study stopped|8
2919796|NCT01569074|10055315|P2|Overall Study|Study stopped|6
2919797|NCT01569074|10055316|P1|Overall Study|Study stopped|6
2919798|NCT01569022|10055372|P2|Second Intervention|Lost to Follow-up|2
2919799|NCT01569022|10055373|P1|Second Intervention|Lost to Follow-up|2
2919800|NCT01569022|10055372|P2|First Intervention|Lost to Follow-up|1
2919801|NCT01569022|10055373|P1|First Intervention|Lost to Follow-up|2
2919802|NCT01568892|10055428|P2|Open-label Phase|Lost to Follow-up|1
2919803|NCT01568892|10055429|P1|Open-label Phase|Lost to Follow-up|0
2919804|NCT01568892|10055428|P2|Open-label Phase|Lack of Efficacy|2
2919805|NCT01568892|10055429|P1|Open-label Phase|Lack of Efficacy|4
2919806|NCT01568892|10055428|P2|Open-label Phase|Adverse Event|0
2919807|NCT01568892|10055429|P1|Open-label Phase|Adverse Event|2
2919808|NCT01568866|10055499|P2|Overall Study|Randomized but Not Dosed|1
2919809|NCT01568866|10055500|P1|Overall Study|Randomized but Not Dosed|9
2919810|NCT01568866|10055499|P2|Overall Study|Lost to Follow-up|0
2919811|NCT01568866|10055500|P1|Overall Study|Lost to Follow-up|1
2919812|NCT01568866|10055499|P2|Overall Study|Protocol Non-compliance|4
2919813|NCT01568866|10055500|P1|Overall Study|Protocol Non-compliance|2
2919814|NCT01568866|10055499|P2|Overall Study|Death|18
2919815|NCT01568866|10055500|P1|Overall Study|Death|10
2919816|NCT01568866|10055499|P2|Overall Study|Withdrawal by Subject|11
2919817|NCT01568866|10055500|P1|Overall Study|Withdrawal by Subject|19
2919818|NCT01568866|10055499|P2|Overall Study|Physician Decision|32
2919819|NCT01568866|10055500|P1|Overall Study|Physician Decision|40
2919820|NCT01568866|10055499|P2|Overall Study|Patient Request|71
2919821|NCT01568866|10055500|P1|Overall Study|Patient Request|55
2919822|NCT01568866|10055499|P2|Overall Study|Adverse Event|96
2919823|NCT01568866|10055500|P1|Overall Study|Adverse Event|94
2919824|NCT01568866|10055499|P2|Overall Study|Disease Progression|183
2919825|NCT01568866|10055500|P1|Overall Study|Disease Progression|208
2919826|NCT01568593|10055535|P2|Overall Study|Adverse Event|2
2919827|NCT01568593|10055536|P1|Overall Study|Adverse Event|3
2919828|NCT01568593|10055535|P2|Overall Study|Lack of Efficacy|1
2919829|NCT01568593|10055536|P1|Overall Study|Lack of Efficacy|4
2919830|NCT01568112|10055581|P4|Overall Study|Withdrawal by Physician|1
2919831|NCT01568112|10055582|P3|Overall Study|Withdrawal by Physician|1
2919832|NCT01568112|10055583|P2|Overall Study|Withdrawal by Physician|0
2919833|NCT01568112|10055584|P1|Overall Study|Withdrawal by Physician|1
2919834|NCT01568112|10055581|P4|Overall Study|Withdrawal by Subject|7
2919835|NCT01568112|10055582|P3|Overall Study|Withdrawal by Subject|0
2919836|NCT01568112|10055583|P2|Overall Study|Withdrawal by Subject|3
2919837|NCT01568112|10055584|P1|Overall Study|Withdrawal by Subject|2
2919838|NCT01568112|10055581|P4|Overall Study|Lost to Follow-up|1
2919839|NCT01568112|10055582|P3|Overall Study|Lost to Follow-up|0
2919840|NCT01568112|10055583|P2|Overall Study|Lost to Follow-up|0
2919841|NCT01568112|10055584|P1|Overall Study|Lost to Follow-up|0
2919842|NCT01568112|10055581|P4|Overall Study|Withdrew due to Adverse Event|3
2919843|NCT01568112|10055582|P3|Overall Study|Withdrew due to Adverse Event|6
2919844|NCT01568112|10055583|P2|Overall Study|Withdrew due to Adverse Event|4
2919845|NCT01568112|10055584|P1|Overall Study|Withdrew due to Adverse Event|2
2919846|NCT01568112|10055581|P4|Overall Study|Randomized But Not Treated|0
2919847|NCT01568112|10055582|P3|Overall Study|Randomized But Not Treated|0
2919848|NCT01568112|10055583|P2|Overall Study|Randomized But Not Treated|1
2919849|NCT01568112|10055584|P1|Overall Study|Randomized But Not Treated|0
2919850|NCT01568047|10055742|P4|Overall Study|Adverse Event|1
2919851|NCT01568047|10055743|P3|Overall Study|Adverse Event|1
2919852|NCT01568047|10055744|P2|Overall Study|Adverse Event|0
2919853|NCT01568047|10055745|P1|Overall Study|Adverse Event|0
2919854|NCT01568047|10055742|P4|Overall Study|Withdrawal by Subject|0
2919855|NCT01568047|10055743|P3|Overall Study|Withdrawal by Subject|0
2919856|NCT01568047|10055744|P2|Overall Study|Withdrawal by Subject|1
2919857|NCT01568047|10055745|P1|Overall Study|Withdrawal by Subject|0
2919858|NCT01568047|10055742|P4|Overall Study|Ineligibility|0
2919859|NCT01568047|10055743|P3|Overall Study|Ineligibility|0
2919860|NCT01568047|10055744|P2|Overall Study|Ineligibility|0
2919861|NCT01568047|10055745|P1|Overall Study|Ineligibility|1
2919862|NCT01568034|10055763|P4|Overall Study|Withdrawal by Subject|0
2919863|NCT01568034|10055764|P3|Overall Study|Withdrawal by Subject|0
2919864|NCT01568034|10055765|P2|Overall Study|Withdrawal by Subject|0
2919865|NCT01568034|10055766|P1|Overall Study|Withdrawal by Subject|1
2919866|NCT01567865|10055829|P4|Evaluated for Immunogenicity|Missing blood sample|28
2919867|NCT01567865|10055830|P3|Evaluated for Immunogenicity|Missing blood sample|16
2919868|NCT01567865|10055831|P2|Evaluated for Immunogenicity|Missing blood sample|24
2919869|NCT01567865|10055832|P1|Evaluated for Immunogenicity|Missing blood sample|17
2919870|NCT01567865|10055829|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
2919871|NCT01567865|10055830|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
2919872|NCT01567865|10055831|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
2919873|NCT01567865|10055832|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
2919874|NCT01567852|10055862|P2|Overall Study|ECT discontinued|1
2919875|NCT01567852|10055863|P1|Overall Study|ECT discontinued|1
2919876|NCT01567852|10055862|P2|Overall Study|Withdrawal by Subject|6
2919877|NCT01567852|10055863|P1|Overall Study|Withdrawal by Subject|3
2919878|NCT01567826|10055881|P2|Overall Study|Lost to Follow-up|2
2919879|NCT01567826|10055882|P1|Overall Study|Lost to Follow-up|3
2919880|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
2919881|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
2919882|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2919883|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2919884|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2919885|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
2919886|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
2919887|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2919888|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2919889|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2919890|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
2919891|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
2919892|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2919893|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2919894|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2919895|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
2919896|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
2919897|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2919898|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2919899|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2919900|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
2919901|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
2919902|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2919903|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2919904|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2919905|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
2919906|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
2919907|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2919908|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2919909|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2919910|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
2919911|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
2919912|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2919913|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2919914|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2919915|NCT01567527|10055908|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2919916|NCT01567527|10055909|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2919917|NCT01567527|10055910|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2919918|NCT01567527|10055911|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2919919|NCT01567527|10055912|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2919920|NCT01567527|10055908|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
2919921|NCT01567527|10055909|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
2919922|NCT01567527|10055910|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
2919923|NCT01567527|10055911|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
2919924|NCT01567527|10055912|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
2919925|NCT01567527|10055908|P5|IM Depot Stabilization.|Adverse Event|0
2919926|NCT01567527|10055909|P4|IM Depot Stabilization.|Adverse Event|0
2919927|NCT01567527|10055910|P3|IM Depot Stabilization.|Adverse Event|37
2919928|NCT01567527|10055911|P2|IM Depot Stabilization.|Adverse Event|0
2919929|NCT01567527|10055912|P1|IM Depot Stabilization.|Adverse Event|0
2919930|NCT01567527|10055908|P5|IM Depot Stabilization.|Lack of Efficacy|0
2919931|NCT01567527|10055909|P4|IM Depot Stabilization.|Lack of Efficacy|0
2919932|NCT01567527|10055910|P3|IM Depot Stabilization.|Lack of Efficacy|7
2919933|NCT01567527|10055911|P2|IM Depot Stabilization.|Lack of Efficacy|0
2919934|NCT01567527|10055912|P1|IM Depot Stabilization.|Lack of Efficacy|0
2919935|NCT01567527|10055908|P5|IM Depot Stabilization.|Lost to Follow-up|0
2919936|NCT01567527|10055909|P4|IM Depot Stabilization.|Lost to Follow-up|0
2919937|NCT01567527|10055910|P3|IM Depot Stabilization.|Lost to Follow-up|21
2919938|NCT01567527|10055911|P2|IM Depot Stabilization.|Lost to Follow-up|0
2919939|NCT01567527|10055912|P1|IM Depot Stabilization.|Lost to Follow-up|0
2919940|NCT01567527|10055908|P5|IM Depot Stabilization.|Sponsor discontinued study|0
2919941|NCT01567527|10055909|P4|IM Depot Stabilization.|Sponsor discontinued study|0
2919942|NCT01567527|10055910|P3|IM Depot Stabilization.|Sponsor discontinued study|1
2919943|NCT01567527|10055911|P2|IM Depot Stabilization.|Sponsor discontinued study|0
2919944|NCT01567527|10055912|P1|IM Depot Stabilization.|Sponsor discontinued study|0
2919945|NCT01567527|10055908|P5|IM Depot Stabilization.|Withdrawal by Subject|0
2919946|NCT01567527|10055909|P4|IM Depot Stabilization.|Withdrawal by Subject|0
2919947|NCT01567527|10055910|P3|IM Depot Stabilization.|Withdrawal by Subject|56
2919948|NCT01567527|10055911|P2|IM Depot Stabilization.|Withdrawal by Subject|0
2919949|NCT01567527|10055912|P1|IM Depot Stabilization.|Withdrawal by Subject|0
2919950|NCT01567527|10055908|P5|IM Depot Stabilization.|Met withdrawal criteria|0
2919951|NCT01567527|10055909|P4|IM Depot Stabilization.|Met withdrawal criteria|0
2919952|NCT01567527|10055910|P3|IM Depot Stabilization.|Met withdrawal criteria|26
2919953|NCT01567527|10055911|P2|IM Depot Stabilization.|Met withdrawal criteria|0
2919954|NCT01567527|10055912|P1|IM Depot Stabilization.|Met withdrawal criteria|0
2919955|NCT01567527|10055908|P5|IM Depot Stabilization.|Protocol deviation|0
2919956|NCT01567527|10055909|P4|IM Depot Stabilization.|Protocol deviation|0
2919957|NCT01567527|10055910|P3|IM Depot Stabilization.|Protocol deviation|5
2919958|NCT01567527|10055911|P2|IM Depot Stabilization.|Protocol deviation|0
2919959|NCT01567527|10055912|P1|IM Depot Stabilization.|Protocol deviation|0
2919960|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2919961|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2919962|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2919963|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
2919964|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2919965|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2919966|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2919967|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2919968|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
2919969|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2919970|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2919971|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2919972|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2919973|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
2919974|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2919975|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2919976|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2919977|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2919978|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
2919979|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2919980|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2919981|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2919982|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2919983|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
2919984|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2919985|NCT01567527|10055908|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2919986|NCT01567527|10055909|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2919987|NCT01567527|10055910|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2919988|NCT01567527|10055911|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
2919989|NCT01567527|10055912|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2919990|NCT01567527|10055908|P5|Conversion Phase.|Withdrawn by the investigator|0
2919991|NCT01567527|10055909|P4|Conversion Phase.|Withdrawn by the investigator|0
2919992|NCT01567527|10055910|P3|Conversion Phase.|Withdrawn by the investigator|0
2919993|NCT01567527|10055911|P2|Conversion Phase.|Withdrawn by the investigator|0
2919994|NCT01567527|10055912|P1|Conversion Phase.|Withdrawn by the investigator|3
2919995|NCT01567527|10055908|P5|Conversion Phase.|Adverse Event|0
2919996|NCT01567527|10055909|P4|Conversion Phase.|Adverse Event|0
2919997|NCT01567527|10055910|P3|Conversion Phase.|Adverse Event|0
2919998|NCT01567527|10055911|P2|Conversion Phase.|Adverse Event|0
2919999|NCT01567527|10055912|P1|Conversion Phase.|Adverse Event|33
2920000|NCT01567527|10055908|P5|Conversion Phase.|Lack of Efficacy|0
2920001|NCT01567527|10055909|P4|Conversion Phase.|Lack of Efficacy|0
2920002|NCT01567527|10055910|P3|Conversion Phase.|Lack of Efficacy|0
2920003|NCT01567527|10055911|P2|Conversion Phase.|Lack of Efficacy|0
2920004|NCT01567527|10055912|P1|Conversion Phase.|Lack of Efficacy|2
2920005|NCT01567527|10055908|P5|Conversion Phase.|Lost to Follow-up|0
2920006|NCT01567527|10055909|P4|Conversion Phase.|Lost to Follow-up|0
2920007|NCT01567527|10055910|P3|Conversion Phase.|Lost to Follow-up|0
2920008|NCT01567527|10055911|P2|Conversion Phase.|Lost to Follow-up|0
2920009|NCT01567527|10055912|P1|Conversion Phase.|Lost to Follow-up|16
2920010|NCT01567527|10055908|P5|Conversion Phase.|Withdrawal by Subject|0
2920011|NCT01567527|10055909|P4|Conversion Phase.|Withdrawal by Subject|0
2920012|NCT01567527|10055910|P3|Conversion Phase.|Withdrawal by Subject|0
2920013|NCT01567527|10055911|P2|Conversion Phase.|Withdrawal by Subject|0
2920014|NCT01567527|10055912|P1|Conversion Phase.|Withdrawal by Subject|32
2920015|NCT01567527|10055908|P5|Conversion Phase.|Met withdrawal criteria|0
2920016|NCT01567527|10055909|P4|Conversion Phase.|Met withdrawal criteria|0
2920017|NCT01567527|10055910|P3|Conversion Phase.|Met withdrawal criteria|0
2920018|NCT01567527|10055911|P2|Conversion Phase.|Met withdrawal criteria|0
2920019|NCT01567527|10055912|P1|Conversion Phase.|Met withdrawal criteria|10
2920020|NCT01567527|10055908|P5|Conversion Phase.|Protocol deviation|0
2920021|NCT01567527|10055909|P4|Conversion Phase.|Protocol deviation|0
2920022|NCT01567527|10055910|P3|Conversion Phase.|Protocol deviation|0
2920023|NCT01567527|10055911|P2|Conversion Phase.|Protocol deviation|0
2920024|NCT01567527|10055912|P1|Conversion Phase.|Protocol deviation|3
2920025|NCT01567462|10055929|P2|Overall Study|Withdrawal by Subject|7
2920026|NCT01567462|10055930|P1|Overall Study|Withdrawal by Subject|4
2920027|NCT01567306|10055953|P6|Overall Study|Withdrawal by Subject|1
2920028|NCT01567306|10055954|P5|Overall Study|Withdrawal by Subject|0
2920029|NCT01567306|10055955|P4|Overall Study|Withdrawal by Subject|0
2920030|NCT01567306|10055956|P3|Overall Study|Withdrawal by Subject|0
2920031|NCT01567306|10055957|P2|Overall Study|Withdrawal by Subject|0
2920032|NCT01567306|10055958|P1|Overall Study|Withdrawal by Subject|0
2920033|NCT01567306|10055953|P6|Overall Study|Lost to Follow-up|0
2920034|NCT01567306|10055954|P5|Overall Study|Lost to Follow-up|2
2920035|NCT01567306|10055955|P4|Overall Study|Lost to Follow-up|0
2920036|NCT01567306|10055956|P3|Overall Study|Lost to Follow-up|0
2920037|NCT01567306|10055957|P2|Overall Study|Lost to Follow-up|0
2920038|NCT01567306|10055958|P1|Overall Study|Lost to Follow-up|0
2920039|NCT01567306|10055953|P6|Overall Study|Adverse Event|1
2920040|NCT01567306|10055954|P5|Overall Study|Adverse Event|4
2920041|NCT01567306|10055955|P4|Overall Study|Adverse Event|2
2920042|NCT01567306|10055956|P3|Overall Study|Adverse Event|0
2920043|NCT01567306|10055957|P2|Overall Study|Adverse Event|0
2920044|NCT01567306|10055958|P1|Overall Study|Adverse Event|0
2920045|NCT01567306|10055953|P6|Overall Study|Change site living|0
2920046|NCT01567306|10055954|P5|Overall Study|Change site living|0
2920047|NCT01567306|10055955|P4|Overall Study|Change site living|0
2920048|NCT01567306|10055956|P3|Overall Study|Change site living|0
2920049|NCT01567306|10055957|P2|Overall Study|Change site living|0
2920050|NCT01567306|10055958|P1|Overall Study|Change site living|1
2920051|NCT01567306|10055953|P6|Overall Study|Protocol Violation|1
2920052|NCT01567306|10055954|P5|Overall Study|Protocol Violation|1
2920053|NCT01567306|10055955|P4|Overall Study|Protocol Violation|3
2920054|NCT01567306|10055956|P3|Overall Study|Protocol Violation|0
2920055|NCT01567306|10055957|P2|Overall Study|Protocol Violation|2
2920056|NCT01567306|10055958|P1|Overall Study|Protocol Violation|2
2920057|NCT01567163|10055972|P1|Overall Study|Lost to Follow-up|2
2920058|NCT01567163|10055972|P1|Overall Study|Progressive Disease|2
2920059|NCT01567085|10055993|P1|Overall Study|Terminal chronic kidney dysfunction|1
2920060|NCT01567085|10055993|P1|Overall Study|Returned to chronic dialysis|1
2920061|NCT01567085|10055993|P1|Overall Study|Renal transplantectomy|1
2920062|NCT01567085|10055993|P1|Overall Study|Graft loss|2
2920063|NCT01567085|10055993|P1|Overall Study|Lost to Follow-up|3
2920064|NCT01567085|10055993|P1|Overall Study|Adverse Event|6
2920065|NCT01567085|10055993|P1|Overall Study|Death|6
2920066|NCT01566981|10056030|P2|Overall Study|Lost to Follow-up|8
2920067|NCT01566981|10056031|P1|Overall Study|Lost to Follow-up|5
2920068|NCT01566773|10056060|P1|Overall Study|Physician Decision|2
2920069|NCT01566773|10056060|P1|Overall Study|Adverse Event|10
2920070|NCT01566773|10056060|P1|Overall Study|Administrative reason|1
2920071|NCT01566773|10056060|P1|Overall Study|Withdrawal by Subject|9
2920072|NCT01566773|10056060|P1|Overall Study|Protocol Violation|4
2920073|NCT01566773|10056060|P1|Overall Study|Protocol specified criteria|4
2920074|NCT01566721|10056269|P2|Overall Study|Withdrew Prior to Treatment|1
2920075|NCT01566721|10056270|P1|Overall Study|Withdrew Prior to Treatment|3
2920076|NCT01566721|10056269|P2|Overall Study|Other|4
2920077|NCT01566721|10056270|P1|Overall Study|Other|10
2920078|NCT01566721|10056269|P2|Overall Study|Death|3
2920079|NCT01566721|10056270|P1|Overall Study|Death|6
2920080|NCT01566721|10056269|P2|Overall Study|Lost to Follow-up|0
2920081|NCT01566721|10056270|P1|Overall Study|Lost to Follow-up|18
2920082|NCT01566721|10056269|P2|Overall Study|Disease Progression/Recurrence|28
2920083|NCT01566721|10056270|P1|Overall Study|Disease Progression/Recurrence|123
2920084|NCT01566721|10056269|P2|Overall Study|Withdrawal by Subject|15
2920085|NCT01566721|10056270|P1|Overall Study|Withdrawal by Subject|58
2920086|NCT01566721|10056269|P2|Overall Study|Ongoing Study|659
2920087|NCT01566721|10056270|P1|Overall Study|Ongoing Study|1649
2920088|NCT01566695|10056295|P2|Overall Study|Miscellaneous|6
2920089|NCT01566695|10056296|P1|Overall Study|Miscellaneous|4
2920090|NCT01566695|10056295|P2|Overall Study|Progressive Disease|6
2920091|NCT01566695|10056296|P1|Overall Study|Progressive Disease|11
2920092|NCT01566695|10056295|P2|Overall Study|Withdrawal by Subject|7
2920093|NCT01566695|10056296|P1|Overall Study|Withdrawal by Subject|14
2920094|NCT01566695|10056295|P2|Overall Study|Death|8
2920095|NCT01566695|10056296|P1|Overall Study|Death|20
2920096|NCT01566695|10056295|P2|Overall Study|Adverse Event|27
2920097|NCT01566695|10056296|P1|Overall Study|Adverse Event|28
2920098|NCT01566695|10056295|P2|Overall Study|Lack of Efficacy|45
2920099|NCT01566695|10056296|P1|Overall Study|Lack of Efficacy|18
2920100|NCT01566604|10056461|P2|Overall Study|Withdrawal by Subject|6
2920101|NCT01566604|10056462|P1|Overall Study|Withdrawal by Subject|9
2920102|NCT01566604|10056461|P2|Overall Study|Adverse Event|2
2920103|NCT01566604|10056462|P1|Overall Study|Adverse Event|4
2920104|NCT01566604|10056461|P2|Overall Study|Death|1
2920105|NCT01566604|10056462|P1|Overall Study|Death|4
2920106|NCT01566604|10056461|P2|Overall Study|Abnormal laboratory value|0
2920107|NCT01566604|10056462|P1|Overall Study|Abnormal laboratory value|2
2920108|NCT01566604|10056461|P2|Overall Study|Protocol deviation|0
2920109|NCT01566604|10056462|P1|Overall Study|Protocol deviation|2
2920110|NCT01566604|10056461|P2|Overall Study|Lack of Efficacy|2
2920111|NCT01566604|10056462|P1|Overall Study|Lack of Efficacy|1
2920112|NCT01566604|10056461|P2|Overall Study|Administrative problems|0
2920113|NCT01566604|10056462|P1|Overall Study|Administrative problems|1
2920114|NCT01566604|10056461|P2|Overall Study|Patient's inability to use the device|0
2920115|NCT01566604|10056462|P1|Overall Study|Patient's inability to use the device|1
2920116|NCT01566435|10056618|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
2920117|NCT01566214|10056679|P2|Overall Study|Lost to Follow-up|0
2920118|NCT01566214|10056680|P1|Overall Study|Lost to Follow-up|3
2920119|NCT01566149|10056724|P2|Overall Study|Withdrawal by Subject|0
2920120|NCT01566149|10056725|P1|Overall Study|Withdrawal by Subject|1
2920121|NCT01566149|10056724|P2|Overall Study|Protocol Violation|1
2920122|NCT01566149|10056725|P1|Overall Study|Protocol Violation|0
2920123|NCT01566149|10056724|P2|Overall Study|Non-compliance with study medication|0
2920124|NCT01566149|10056725|P1|Overall Study|Non-compliance with study medication|2
2920125|NCT01566149|10056724|P2|Overall Study|Adverse Event|1
2920126|NCT01566149|10056725|P1|Overall Study|Adverse Event|0
2920127|NCT01565993|10056758|P2|Overall Study|Physician Decision|3
2920128|NCT01565993|10056759|P1|Overall Study|Physician Decision|0
2920129|NCT01565980|10056767|P2|Overall Study|Withdrawal by Subject|3
2920130|NCT01565980|10056768|P1|Overall Study|Withdrawal by Subject|0
2920131|NCT01565980|10056767|P2|Overall Study|stopped medical treatment|0
2920132|NCT01565980|10056768|P1|Overall Study|stopped medical treatment|1
2920133|NCT01565980|10056767|P2|Overall Study|health complications|1
2920134|NCT01565980|10056768|P1|Overall Study|health complications|1
2920135|NCT01565980|10056767|P2|Overall Study|Lost to Follow-up|0
2920136|NCT01565980|10056768|P1|Overall Study|Lost to Follow-up|1
2920137|NCT01565980|10056767|P2|Overall Study|Death|0
2920138|NCT01565980|10056768|P1|Overall Study|Death|1
2920139|NCT01565941|10056788|P2|Overall Study|Randomized; did not receive intevention|2
2920140|NCT01565941|10056789|P1|Overall Study|Randomized; did not receive intevention|8
2920141|NCT01565941|10056788|P2|Overall Study|Withdrawn by parent/guardian|2
2920142|NCT01565941|10056789|P1|Overall Study|Withdrawn by parent/guardian|3
2920143|NCT01565928|10056831|P1|Overall Study|Death|2
2920144|NCT01565928|10056831|P1|Overall Study|Withdrawal by Subject|1
2920145|NCT01565928|10056831|P1|Overall Study|Progressive Disease|13
2920146|NCT01565928|10056831|P1|Overall Study|Other|3
2920147|NCT01565928|10056831|P1|Overall Study|Adverse Event|3
2920148|NCT01565889|10056885|P6|Part B|Lost to Follow-up|1
2920149|NCT01565889|10056886|P5|Part B|Lost to Follow-up|0
2920150|NCT01565889|10056887|P4|Part B|Lost to Follow-up|0
2920151|NCT01565889|10056888|P3|Part B|Lost to Follow-up|0
2920152|NCT01565889|10056889|P2|Part B|Lost to Follow-up|0
2920153|NCT01565889|10056890|P1|Part B|Lost to Follow-up|0
2920154|NCT01565889|10056885|P6|Part B|Lack of Efficacy|2
2920155|NCT01565889|10056886|P5|Part B|Lack of Efficacy|0
2920156|NCT01565889|10056887|P4|Part B|Lack of Efficacy|0
2920157|NCT01565889|10056888|P3|Part B|Lack of Efficacy|0
2920158|NCT01565889|10056889|P2|Part B|Lack of Efficacy|0
2920159|NCT01565889|10056890|P1|Part B|Lack of Efficacy|0
2920160|NCT01565889|10056885|P6|Part B|Withdrawal by Subject|1
2920161|NCT01565889|10056886|P5|Part B|Withdrawal by Subject|0
2920162|NCT01565889|10056887|P4|Part B|Withdrawal by Subject|0
2920163|NCT01565889|10056888|P3|Part B|Withdrawal by Subject|0
2920164|NCT01565889|10056889|P2|Part B|Withdrawal by Subject|0
2920165|NCT01565889|10056890|P1|Part B|Withdrawal by Subject|0
2920166|NCT01565889|10056885|P6|Part A|Withdrawal by Subject|0
2920167|NCT01565889|10056886|P5|Part A|Withdrawal by Subject|0
2920168|NCT01565889|10056887|P4|Part A|Withdrawal by Subject|0
2920169|NCT01565889|10056888|P3|Part A|Withdrawal by Subject|0
2920170|NCT01565889|10056889|P2|Part A|Withdrawal by Subject|0
2920171|NCT01565889|10056890|P1|Part A|Withdrawal by Subject|1
2920172|NCT01565850|10056921|P2|Overall Study|Withdrew Consent|2
2920173|NCT01565850|10056922|P1|Overall Study|Withdrew Consent|4
2920174|NCT01565850|10056921|P2|Overall Study|Participant noncompliance|0
2920175|NCT01565850|10056922|P1|Overall Study|Participant noncompliance|2
2920176|NCT01565850|10056921|P2|Overall Study|Investigator’s Discretion|1
2920177|NCT01565850|10056922|P1|Overall Study|Investigator’s Discretion|2
2920178|NCT01565850|10056921|P2|Overall Study|Lost to Follow-up|4
2920179|NCT01565850|10056922|P1|Overall Study|Lost to Follow-up|12
2920180|NCT01565850|10056921|P2|Overall Study|Adverse Event|1
2920181|NCT01565850|10056922|P1|Overall Study|Adverse Event|0
2920182|NCT01565707|10056942|P4|Overall Study|Miscellaneous|2
2920183|NCT01565707|10056943|P3|Overall Study|Miscellaneous|0
2920184|NCT01565707|10056944|P2|Overall Study|Miscellaneous|1
2920185|NCT01565707|10056945|P1|Overall Study|Miscellaneous|1
2920186|NCT01565707|10056942|P4|Overall Study|Randomized but not evaluable|0
2920187|NCT01565707|10056943|P3|Overall Study|Randomized but not evaluable|0
2920188|NCT01565707|10056944|P2|Overall Study|Randomized but not evaluable|0
2920189|NCT01565707|10056945|P1|Overall Study|Randomized but not evaluable|2
2920190|NCT01565707|10056942|P4|Overall Study|Withdrawal by Subject|1
2920191|NCT01565707|10056943|P3|Overall Study|Withdrawal by Subject|1
2920192|NCT01565707|10056944|P2|Overall Study|Withdrawal by Subject|1
2920193|NCT01565707|10056945|P1|Overall Study|Withdrawal by Subject|3
2920194|NCT01565707|10056942|P4|Overall Study|Protocol Violation|1
2920195|NCT01565707|10056943|P3|Overall Study|Protocol Violation|0
2920196|NCT01565707|10056944|P2|Overall Study|Protocol Violation|0
2920197|NCT01565707|10056945|P1|Overall Study|Protocol Violation|1
2920198|NCT01565707|10056942|P4|Overall Study|Lost to Follow-up|0
2920199|NCT01565707|10056943|P3|Overall Study|Lost to Follow-up|0
2920200|NCT01565707|10056944|P2|Overall Study|Lost to Follow-up|0
2920201|NCT01565707|10056945|P1|Overall Study|Lost to Follow-up|1
2920202|NCT01565707|10056942|P4|Overall Study|Adverse Event|1
2920203|NCT01565707|10056943|P3|Overall Study|Adverse Event|2
2920204|NCT01565707|10056944|P2|Overall Study|Adverse Event|6
2920205|NCT01565707|10056945|P1|Overall Study|Adverse Event|1
2920206|NCT01565694|10057036|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
2920207|NCT01565694|10057036|P1|Dose-Titration Period|Protocol Violation|10
2920208|NCT01565694|10057036|P1|Dose-Titration Period|Adverse Event|4
2920209|NCT01565668|10057057|P2|Overall Study|HSCT Transplant|15
2920210|NCT01565668|10057058|P1|Overall Study|HSCT Transplant|11
2920211|NCT01565668|10057057|P2|Overall Study|Withdrawal by Subject|3
2920212|NCT01565668|10057058|P1|Overall Study|Withdrawal by Subject|1
2920213|NCT01565668|10057057|P2|Overall Study|Progressive disease|14
2920214|NCT01565668|10057058|P1|Overall Study|Progressive disease|13
2920215|NCT01565668|10057057|P2|Overall Study|Randomized, but never received drug|2
2920216|NCT01565668|10057058|P1|Overall Study|Randomized, but never received drug|0
2920217|NCT01565668|10057057|P2|Overall Study|Adverse Event|1
2920218|NCT01565668|10057058|P1|Overall Study|Adverse Event|6
2920219|NCT01565668|10057057|P2|Overall Study|Participant went on Hospice Care|0
2920220|NCT01565668|10057058|P1|Overall Study|Participant went on Hospice Care|1
2920221|NCT01565668|10057057|P2|Overall Study|Lack of Efficacy|2
2920222|NCT01565668|10057058|P1|Overall Study|Lack of Efficacy|4
2920223|NCT01565668|10057057|P2|Overall Study|Death|1
2920224|NCT01565668|10057058|P1|Overall Study|Death|2
2920225|NCT01565642|10057082|P2|Overall Study|Withdrawal by Subject|1
2920226|NCT01565642|10057083|P1|Overall Study|Withdrawal by Subject|2
2920227|NCT01565564|10057118|P2|Overall Study|Lost to Follow-up|1
2920228|NCT01565564|10057119|P1|Overall Study|Lost to Follow-up|5
2920229|NCT01565343|10057169|P3|Overall Study|Administrative decision/technical issues|0
2920230|NCT01565343|10057170|P2|Overall Study|Administrative decision/technical issues|0
2920231|NCT01565343|10057171|P1|Overall Study|Administrative decision/technical issues|1
2920232|NCT01565291|10057201|P2|Overall Study|Withdrawal by Subject|0
2920233|NCT01565291|10057202|P1|Overall Study|Withdrawal by Subject|1
2920234|NCT01565148|10057214|P4|Overall Study|Physician Decision|0
2920235|NCT01565148|10057215|P3|Overall Study|Physician Decision|0
2920236|NCT01565148|10057216|P2|Overall Study|Physician Decision|5
2920237|NCT01565148|10057217|P1|Overall Study|Physician Decision|2
2920238|NCT01565148|10057214|P4|Overall Study|Death|0
2920239|NCT01565148|10057215|P3|Overall Study|Death|1
2920240|NCT01565148|10057216|P2|Overall Study|Death|0
2920241|NCT01565148|10057217|P1|Overall Study|Death|0
2920242|NCT01565148|10057214|P4|Overall Study|Rescue Therapy|8
2920243|NCT01565148|10057215|P3|Overall Study|Rescue Therapy|5
2920244|NCT01565148|10057216|P2|Overall Study|Rescue Therapy|5
2920245|NCT01565148|10057217|P1|Overall Study|Rescue Therapy|8
2920246|NCT01565148|10057214|P4|Overall Study|Lost to Follow-up|3
2920247|NCT01565148|10057215|P3|Overall Study|Lost to Follow-up|0
2920248|NCT01565148|10057216|P2|Overall Study|Lost to Follow-up|4
2920249|NCT01565148|10057217|P1|Overall Study|Lost to Follow-up|4
2920250|NCT01565148|10057214|P4|Overall Study|Withdrawal by Subject|2
2920251|NCT01565148|10057215|P3|Overall Study|Withdrawal by Subject|1
2920252|NCT01565148|10057216|P2|Overall Study|Withdrawal by Subject|1
2920253|NCT01565148|10057217|P1|Overall Study|Withdrawal by Subject|1
2920254|NCT01565083|10057253|P2|Overall Study|Other|5
2920255|NCT01565083|10057254|P1|Overall Study|Other|3
2920256|NCT01565083|10057253|P2|Overall Study|Death|23
2920257|NCT01565083|10057254|P1|Overall Study|Death|22
2920258|NCT01565083|10057253|P2|Overall Study|Lost to Follow-up|7
2920259|NCT01565083|10057254|P1|Overall Study|Lost to Follow-up|2
2920260|NCT01565083|10057253|P2|Overall Study|Withdrawal by Subject|4
2920261|NCT01565083|10057254|P1|Overall Study|Withdrawal by Subject|6
2920262|NCT01564862|10057305|P3|Overall Study|Other reason(s)|0
2920263|NCT01564862|10057306|P2|Overall Study|Other reason(s)|0
2920264|NCT01564862|10057307|P1|Overall Study|Other reason(s)|1
2920265|NCT01564862|10057305|P3|Overall Study|Lack of Efficacy|6
2920266|NCT01564862|10057306|P2|Overall Study|Lack of Efficacy|5
2920267|NCT01564862|10057307|P1|Overall Study|Lack of Efficacy|1
2920268|NCT01564862|10057305|P3|Overall Study|Voluntary Withdrawal|8
2920269|NCT01564862|10057306|P2|Overall Study|Voluntary Withdrawal|6
2920270|NCT01564862|10057307|P1|Overall Study|Voluntary Withdrawal|9
2920271|NCT01564862|10057305|P3|Overall Study|Lost to Follow-up|6
2920272|NCT01564862|10057306|P2|Overall Study|Lost to Follow-up|8
2920273|NCT01564862|10057307|P1|Overall Study|Lost to Follow-up|10
2920274|NCT01564862|10057305|P3|Overall Study|Major Protocol Deviation|4
2920275|NCT01564862|10057306|P2|Overall Study|Major Protocol Deviation|3
2920276|NCT01564862|10057307|P1|Overall Study|Major Protocol Deviation|3
2920277|NCT01564862|10057305|P3|Overall Study|Pretreatment Event or Adverse Event|6
2920278|NCT01564862|10057306|P2|Overall Study|Pretreatment Event or Adverse Event|12
2920279|NCT01564862|10057307|P1|Overall Study|Pretreatment Event or Adverse Event|6
2920280|NCT01564784|10057358|P2|Overall Study|Death|126
2920281|NCT01564784|10057359|P1|Overall Study|Death|131
2920282|NCT01564784|10057358|P2|Overall Study|Lost to Follow-up|1
2920283|NCT01564784|10057359|P1|Overall Study|Lost to Follow-up|1
2920284|NCT01564784|10057358|P2|Overall Study|Subject refused further follow-up|6
2920285|NCT01564784|10057359|P1|Overall Study|Subject refused further follow-up|1
2920286|NCT01564784|10057358|P2|Overall Study|Other|0
2920287|NCT01564784|10057359|P1|Overall Study|Other|1
2920288|NCT01564758|10057386|P1|Overall Study|Other|3
2920289|NCT01564758|10057386|P1|Overall Study|Adverse Event|3
2920290|NCT01564758|10057386|P1|Overall Study|Death|8
2920291|NCT01564732|10057393|P2|Overall Study|Early termination by the study sponsor|5
2920292|NCT01564732|10057394|P1|Overall Study|Early termination by the study sponsor|6
2920293|NCT01564537|10057435|P2|Overall Study|Other Miscellaneous Reasons|2
2920294|NCT01564537|10057436|P1|Overall Study|Other Miscellaneous Reasons|1
2920295|NCT01564537|10057435|P2|Overall Study|Lost to Follow-up|0
2920296|NCT01564537|10057436|P1|Overall Study|Lost to Follow-up|1
2920297|NCT01564537|10057435|P2|Overall Study|Withdrawal by Participant|4
2920298|NCT01564537|10057436|P1|Overall Study|Withdrawal by Participant|4
2920299|NCT01564459|10057459|P3|Double-blind Treatment|Adverse Event|1
2920300|NCT01564459|10057460|P2|Double-blind Treatment|Adverse Event|0
2920301|NCT01564459|10057461|P1|Double-blind Treatment|Adverse Event|0
2920302|NCT01564459|10057459|P3|Run-In|Withdrawal by Subject|0
2920303|NCT01564459|10057460|P2|Run-In|Withdrawal by Subject|0
2920304|NCT01564459|10057461|P1|Run-In|Withdrawal by Subject|1
2920305|NCT01564459|10057459|P3|Run-In|Protocol Violation|0
2920306|NCT01564459|10057460|P2|Run-In|Protocol Violation|0
2920307|NCT01564459|10057461|P1|Run-In|Protocol Violation|1
2920308|NCT01564459|10057459|P3|Run-In|Non-compliance with study drug|0
2920309|NCT01564459|10057460|P2|Run-In|Non-compliance with study drug|0
2920310|NCT01564459|10057461|P1|Run-In|Non-compliance with study drug|2
2920311|NCT01564459|10057459|P3|Run-In|Lost to Follow-up|0
2920312|NCT01564459|10057460|P2|Run-In|Lost to Follow-up|0
2920313|NCT01564459|10057461|P1|Run-In|Lost to Follow-up|1
2920314|NCT01564459|10057459|P3|Run-In|Adverse Event|0
2920315|NCT01564459|10057460|P2|Run-In|Adverse Event|0
2920316|NCT01564459|10057461|P1|Run-In|Adverse Event|7
2920317|NCT01564407|10057485|P5|Overall Study|funding lost, study ended|0
2920318|NCT01564407|10057486|P4|Overall Study|funding lost, study ended|1
2920319|NCT01564407|10057487|P3|Overall Study|funding lost, study ended|0
2920320|NCT01564407|10057488|P2|Overall Study|funding lost, study ended|0
2920321|NCT01564407|10057489|P1|Overall Study|funding lost, study ended|0
2920322|NCT01564407|10057485|P5|Overall Study|Withdrawal by Subject|0
2920323|NCT01564407|10057486|P4|Overall Study|Withdrawal by Subject|0
2920324|NCT01564407|10057487|P3|Overall Study|Withdrawal by Subject|0
2920325|NCT01564407|10057488|P2|Overall Study|Withdrawal by Subject|1
2920326|NCT01564407|10057489|P1|Overall Study|Withdrawal by Subject|0
2920327|NCT01564407|10057485|P5|Overall Study|Lost to Follow-up|0
2920328|NCT01564407|10057486|P4|Overall Study|Lost to Follow-up|0
2920329|NCT01564407|10057487|P3|Overall Study|Lost to Follow-up|0
2920330|NCT01564407|10057488|P2|Overall Study|Lost to Follow-up|1
2920331|NCT01564407|10057489|P1|Overall Study|Lost to Follow-up|0
2920332|NCT01564394|10057530|P2|Overall Study|Withdrawal by Subject|10
2920333|NCT01564394|10057531|P1|Overall Study|Withdrawal by Subject|6
2920334|NCT01564277|10057545|P2|Overall Study|Physician Decision|0
2920335|NCT01564277|10057546|P1|Overall Study|Physician Decision|1
2920336|NCT01564277|10057545|P2|Overall Study|Protocol Violation|1
2920337|NCT01564277|10057546|P1|Overall Study|Protocol Violation|0
2920338|NCT01563978|10057564|P2|Overall Study|Adverse Event|2
2920339|NCT01563978|10057565|P1|Overall Study|Adverse Event|1
2920340|NCT01563978|10057564|P2|Overall Study|Dev. of study specific discont. criteria|0
2920341|NCT01563978|10057565|P1|Overall Study|Dev. of study specific discont. criteria|1
2920342|NCT01563978|10057564|P2|Overall Study|Lost to Follow-up|0
2920343|NCT01563978|10057565|P1|Overall Study|Lost to Follow-up|1
2920344|NCT01563978|10057564|P2|Overall Study|Physician Decision|0
2920345|NCT01563978|10057565|P1|Overall Study|Physician Decision|1
2920346|NCT01563913|10057591|P2|Overall Study|Spouse Passed Away|0
2920347|NCT01563913|10057592|P1|Overall Study|Spouse Passed Away|1
2920348|NCT01563913|10057591|P2|Overall Study|Physician Decision|0
2920349|NCT01563913|10057592|P1|Overall Study|Physician Decision|1
2920350|NCT01563536|10057604|P2|Overall Study|Lost to Follow-up|0
2920351|NCT01563536|10057605|P1|Overall Study|Lost to Follow-up|1
2920352|NCT01563536|10057604|P2|Overall Study|Withdrawal by Subject|2
2920353|NCT01563536|10057605|P1|Overall Study|Withdrawal by Subject|0
2920354|NCT01563185|10057664|P1|Overall Study|Non-Compliance with study drug|1
2920355|NCT01563185|10057664|P1|Overall Study|Withdrawal by Subject|1
2920356|NCT01563172|10057678|P1|Overall Study|Other (Not specified)|1
2920357|NCT01563172|10057678|P1|Overall Study|Other (Protocol deviation)|5
2920358|NCT01563172|10057678|P1|Overall Study|Lost to Follow-up|2
2920359|NCT01563172|10057678|P1|Overall Study|Adverse Event|5
2920360|NCT01563029|10057784|P5|Overall Study|Withdrawal by Subject|3
2920361|NCT01563029|10057785|P4|Overall Study|Withdrawal by Subject|4
2920362|NCT01563029|10057786|P3|Overall Study|Withdrawal by Subject|3
2920363|NCT01563029|10057787|P2|Overall Study|Withdrawal by Subject|1
2920364|NCT01563029|10057788|P1|Overall Study|Withdrawal by Subject|4
2920365|NCT01563029|10057784|P5|Overall Study|Physician Decision|2
2920366|NCT01563029|10057785|P4|Overall Study|Physician Decision|4
2920367|NCT01563029|10057786|P3|Overall Study|Physician Decision|2
2920368|NCT01563029|10057787|P2|Overall Study|Physician Decision|5
2920369|NCT01563029|10057788|P1|Overall Study|Physician Decision|3
2920370|NCT01563029|10057784|P5|Overall Study|Lost to Follow-up|1
2920371|NCT01563029|10057785|P4|Overall Study|Lost to Follow-up|1
2920372|NCT01563029|10057786|P3|Overall Study|Lost to Follow-up|1
2920373|NCT01563029|10057787|P2|Overall Study|Lost to Follow-up|0
2920374|NCT01563029|10057788|P1|Overall Study|Lost to Follow-up|1
2920375|NCT01563029|10057784|P5|Overall Study|Protocol defined stopping criteria|0
2920376|NCT01563029|10057785|P4|Overall Study|Protocol defined stopping criteria|0
2920377|NCT01563029|10057786|P3|Overall Study|Protocol defined stopping criteria|0
2920378|NCT01563029|10057787|P2|Overall Study|Protocol defined stopping criteria|0
2920379|NCT01563029|10057788|P1|Overall Study|Protocol defined stopping criteria|1
2920380|NCT01563029|10057784|P5|Overall Study|Protocol Violation|3
2920381|NCT01563029|10057785|P4|Overall Study|Protocol Violation|1
2920382|NCT01563029|10057786|P3|Overall Study|Protocol Violation|3
2920383|NCT01563029|10057787|P2|Overall Study|Protocol Violation|2
2920384|NCT01563029|10057788|P1|Overall Study|Protocol Violation|1
2920385|NCT01563029|10057784|P5|Overall Study|Lack of Efficacy|19
2920386|NCT01563029|10057785|P4|Overall Study|Lack of Efficacy|21
2920387|NCT01563029|10057786|P3|Overall Study|Lack of Efficacy|23
2920388|NCT01563029|10057787|P2|Overall Study|Lack of Efficacy|16
2920389|NCT01563029|10057788|P1|Overall Study|Lack of Efficacy|42
2920390|NCT01563029|10057784|P5|Overall Study|Adverse Event|1
2920391|NCT01563029|10057785|P4|Overall Study|Adverse Event|2
2920392|NCT01563029|10057786|P3|Overall Study|Adverse Event|1
2920393|NCT01563029|10057787|P2|Overall Study|Adverse Event|0
2920394|NCT01563029|10057788|P1|Overall Study|Adverse Event|1
2920395|NCT01562873|10057854|P2|Overall Study|Clinical PD and adverse event|0
2920396|NCT01562873|10057855|P1|Overall Study|Clinical PD and adverse event|1
2920397|NCT01562873|10057854|P2|Overall Study|Clinical Disease Progression|0
2920398|NCT01562873|10057855|P1|Overall Study|Clinical Disease Progression|9
2920399|NCT01562873|10057854|P2|Overall Study|Adverse Event|0
2920400|NCT01562873|10057855|P1|Overall Study|Adverse Event|1
2920401|NCT01562873|10057854|P2|Overall Study|Disease Progression per RECIST|0
2920402|NCT01562873|10057855|P1|Overall Study|Disease Progression per RECIST|10
2920403|NCT01562782|10057864|P2|Overall Study|screen failure|2
2920404|NCT01562782|10057865|P1|Overall Study|screen failure|1
2920405|NCT01562782|10057864|P2|Overall Study|Withdrawal by Subject|3
2920406|NCT01562782|10057865|P1|Overall Study|Withdrawal by Subject|3
2920407|NCT01562743|10057894|P1|Overall Study|Physician Decision|2
2920408|NCT01562743|10057894|P1|Overall Study|Lost to Follow-up|2
2920409|NCT01562743|10057894|P1|Overall Study|Discontinuation criteria|2
2920410|NCT01562743|10057894|P1|Overall Study|Protocol Violation|1
2920411|NCT01562743|10057894|P1|Overall Study|Withdrawal by Subject|13
2920412|NCT01562743|10057894|P1|Overall Study|Lack of Efficacy|3
2920413|NCT01562743|10057894|P1|Overall Study|Adverse Event|29
2920414|NCT01562613|10057913|P1|Overall Study|Withdrawal by Subject|2
2920415|NCT01562613|10057913|P1|Overall Study|Lost to Follow-up|2
2920416|NCT01562548|10057923|P4|Overall Study|Lost to Follow-up|0
2920417|NCT01562548|10057924|P3|Overall Study|Lost to Follow-up|1
2920418|NCT01562548|10057925|P2|Overall Study|Lost to Follow-up|0
2920419|NCT01562548|10057926|P1|Overall Study|Lost to Follow-up|0
2920420|NCT01562444|10057979|P3|Overall Study|Protocol forbidden medication|0
2920421|NCT01562444|10057980|P2|Overall Study|Protocol forbidden medication|0
2920422|NCT01562444|10057981|P1|Overall Study|Protocol forbidden medication|1
2920423|NCT01562444|10057979|P3|Overall Study|Protocol forbidden concomitant vaccine|1
2920424|NCT01562444|10057980|P2|Overall Study|Protocol forbidden concomitant vaccine|0
2920425|NCT01562444|10057981|P1|Overall Study|Protocol forbidden concomitant vaccine|1
2920426|NCT01562444|10057979|P3|Overall Study|Unavailable serological results|2
2920427|NCT01562444|10057980|P2|Overall Study|Unavailable serological results|2
2920428|NCT01562444|10057981|P1|Overall Study|Unavailable serological results|0
2920429|NCT01562444|10057979|P3|Overall Study|Did not comply with blood draw schedule|1
2920430|NCT01562444|10057980|P2|Overall Study|Did not comply with blood draw schedule|0
2920431|NCT01562444|10057981|P1|Overall Study|Did not comply with blood draw schedule|1
2920432|NCT01562444|10057979|P3|Overall Study|Did not meet entry criteria|3
2920433|NCT01562444|10057980|P2|Overall Study|Did not meet entry criteria|0
2920434|NCT01562444|10057981|P1|Overall Study|Did not meet entry criteria|2
2920435|NCT01562327|10058247|P1|Overall Study|Infusion not received at 6 month window|4
2920436|NCT01562327|10058247|P1|Overall Study|Participant drop-out|1
2920437|NCT01562327|10058247|P1|Overall Study|Lack of Efficacy|1
2920438|NCT01562327|10058247|P1|Overall Study|Adverse Event|2
2920439|NCT01562314|10058277|P2|Overall Study|Withdrawal by Subject|1
2920440|NCT01562314|10058278|P1|Overall Study|Withdrawal by Subject|0
2920441|NCT01562314|10058277|P2|Overall Study|Met Withdrawal Criteria|2
2920442|NCT01562314|10058278|P1|Overall Study|Met Withdrawal Criteria|3
2920443|NCT01562314|10058277|P2|Overall Study|Adverse Event|5
2920444|NCT01562314|10058278|P1|Overall Study|Adverse Event|10
2920445|NCT01562275|10058335|P13|Stage 2|Progression of Disease|4
2920446|NCT01562275|10058336|P12|Stage 2|Progression of Disease|12
2920447|NCT01562275|10058337|P11|Stage 2|Progression of Disease|0
2920448|NCT01562275|10058338|P10|Stage 2|Progression of Disease|0
2920449|NCT01562275|10058339|P9|Stage 2|Progression of Disease|0
2920450|NCT01562275|10058340|P8|Stage 2|Progression of Disease|0
2920451|NCT01562275|10058341|P7|Stage 2|Progression of Disease|0
2920452|NCT01562275|10058342|P6|Stage 2|Progression of Disease|0
2920453|NCT01562275|10058343|P5|Stage 2|Progression of Disease|0
2920454|NCT01562275|10058344|P4|Stage 2|Progression of Disease|0
2920455|NCT01562275|10058345|P3|Stage 2|Progression of Disease|0
2920456|NCT01562275|10058346|P2|Stage 2|Progression of Disease|0
2920457|NCT01562275|10058347|P1|Stage 2|Progression of Disease|0
2920458|NCT01562275|10058335|P13|Stage 2|Death|1
2920459|NCT01562275|10058336|P12|Stage 2|Death|2
2920460|NCT01562275|10058337|P11|Stage 2|Death|0
2920461|NCT01562275|10058338|P10|Stage 2|Death|0
2920462|NCT01562275|10058339|P9|Stage 2|Death|0
2920463|NCT01562275|10058340|P8|Stage 2|Death|0
2920464|NCT01562275|10058341|P7|Stage 2|Death|0
2920465|NCT01562275|10058342|P6|Stage 2|Death|0
2920466|NCT01562275|10058343|P5|Stage 2|Death|0
2920467|NCT01562275|10058344|P4|Stage 2|Death|0
2920468|NCT01562275|10058345|P3|Stage 2|Death|0
2920469|NCT01562275|10058346|P2|Stage 2|Death|0
2920470|NCT01562275|10058347|P1|Stage 2|Death|0
2920471|NCT01562275|10058335|P13|Stage 1|Withdrawal by Subject|0
2920472|NCT01562275|10058336|P12|Stage 1|Withdrawal by Subject|0
2920473|NCT01562275|10058337|P11|Stage 1|Withdrawal by Subject|0
2920474|NCT01562275|10058338|P10|Stage 1|Withdrawal by Subject|1
2920475|NCT01562275|10058339|P9|Stage 1|Withdrawal by Subject|0
2920476|NCT01562275|10058340|P8|Stage 1|Withdrawal by Subject|0
2920477|NCT01562275|10058341|P7|Stage 1|Withdrawal by Subject|1
2920478|NCT01562275|10058342|P6|Stage 1|Withdrawal by Subject|0
2920479|NCT01562275|10058343|P5|Stage 1|Withdrawal by Subject|0
2920480|NCT01562275|10058344|P4|Stage 1|Withdrawal by Subject|2
2920481|NCT01562275|10058345|P3|Stage 1|Withdrawal by Subject|0
2920482|NCT01562275|10058346|P2|Stage 1|Withdrawal by Subject|1
2920483|NCT01562275|10058347|P1|Stage 1|Withdrawal by Subject|0
2920484|NCT01562275|10058335|P13|Stage 1|Progression of Disease|0
2920485|NCT01562275|10058336|P12|Stage 1|Progression of Disease|0
2920486|NCT01562275|10058337|P11|Stage 1|Progression of Disease|3
2920487|NCT01562275|10058338|P10|Stage 1|Progression of Disease|5
2920488|NCT01562275|10058339|P9|Stage 1|Progression of Disease|2
2920489|NCT01562275|10058340|P8|Stage 1|Progression of Disease|7
2920490|NCT01562275|10058341|P7|Stage 1|Progression of Disease|1
2920491|NCT01562275|10058342|P6|Stage 1|Progression of Disease|4
2920492|NCT01562275|10058343|P5|Stage 1|Progression of Disease|2
2920493|NCT01562275|10058344|P4|Stage 1|Progression of Disease|1
2920494|NCT01562275|10058345|P3|Stage 1|Progression of Disease|2
2920495|NCT01562275|10058346|P2|Stage 1|Progression of Disease|6
2920496|NCT01562275|10058347|P1|Stage 1|Progression of Disease|2
2920497|NCT01562275|10058335|P13|Stage 1|Physician Decision|0
2920498|NCT01562275|10058336|P12|Stage 1|Physician Decision|0
2920499|NCT01562275|10058337|P11|Stage 1|Physician Decision|0
2920500|NCT01562275|10058338|P10|Stage 1|Physician Decision|0
2920501|NCT01562275|10058339|P9|Stage 1|Physician Decision|1
2920502|NCT01562275|10058340|P8|Stage 1|Physician Decision|0
2920503|NCT01562275|10058341|P7|Stage 1|Physician Decision|1
2920504|NCT01562275|10058342|P6|Stage 1|Physician Decision|0
2920505|NCT01562275|10058343|P5|Stage 1|Physician Decision|1
2920506|NCT01562275|10058344|P4|Stage 1|Physician Decision|0
2920507|NCT01562275|10058345|P3|Stage 1|Physician Decision|0
2920508|NCT01562275|10058346|P2|Stage 1|Physician Decision|0
2920509|NCT01562275|10058347|P1|Stage 1|Physician Decision|0
2920510|NCT01562275|10058335|P13|Stage 1|Non Compliance|0
2920511|NCT01562275|10058336|P12|Stage 1|Non Compliance|0
2920512|NCT01562275|10058337|P11|Stage 1|Non Compliance|0
2920513|NCT01562275|10058338|P10|Stage 1|Non Compliance|0
2920514|NCT01562275|10058339|P9|Stage 1|Non Compliance|0
2920515|NCT01562275|10058340|P8|Stage 1|Non Compliance|0
2920516|NCT01562275|10058341|P7|Stage 1|Non Compliance|0
2920517|NCT01562275|10058342|P6|Stage 1|Non Compliance|0
2920518|NCT01562275|10058343|P5|Stage 1|Non Compliance|0
2920519|NCT01562275|10058344|P4|Stage 1|Non Compliance|0
2920520|NCT01562275|10058345|P3|Stage 1|Non Compliance|1
2920521|NCT01562275|10058346|P2|Stage 1|Non Compliance|0
2920522|NCT01562275|10058347|P1|Stage 1|Non Compliance|0
2920523|NCT01562275|10058335|P13|Stage 1|Death|0
2920524|NCT01562275|10058336|P12|Stage 1|Death|0
2920525|NCT01562275|10058337|P11|Stage 1|Death|0
2920526|NCT01562275|10058338|P10|Stage 1|Death|0
2920527|NCT01562275|10058339|P9|Stage 1|Death|0
2920528|NCT01562275|10058340|P8|Stage 1|Death|0
2920529|NCT01562275|10058341|P7|Stage 1|Death|0
2920530|NCT01562275|10058342|P6|Stage 1|Death|0
2920531|NCT01562275|10058343|P5|Stage 1|Death|0
2920532|NCT01562275|10058344|P4|Stage 1|Death|0
2920533|NCT01562275|10058345|P3|Stage 1|Death|0
2920534|NCT01562275|10058346|P2|Stage 1|Death|0
2920535|NCT01562275|10058347|P1|Stage 1|Death|1
2920536|NCT01562275|10058335|P13|Stage 1|Adverse Event|0
2920537|NCT01562275|10058336|P12|Stage 1|Adverse Event|0
2920538|NCT01562275|10058337|P11|Stage 1|Adverse Event|0
2920539|NCT01562275|10058338|P10|Stage 1|Adverse Event|1
2920540|NCT01562275|10058339|P9|Stage 1|Adverse Event|0
2920541|NCT01562275|10058340|P8|Stage 1|Adverse Event|0
2920542|NCT01562275|10058341|P7|Stage 1|Adverse Event|0
2920543|NCT01562275|10058342|P6|Stage 1|Adverse Event|0
2920544|NCT01562275|10058343|P5|Stage 1|Adverse Event|1
2920545|NCT01562275|10058344|P4|Stage 1|Adverse Event|1
2920546|NCT01562275|10058345|P3|Stage 1|Adverse Event|0
2920547|NCT01562275|10058346|P2|Stage 1|Adverse Event|0
2920548|NCT01562275|10058347|P1|Stage 1|Adverse Event|0
2920549|NCT01562028|10058488|P2|Overall Study|Lost to Follow-up|1
2920550|NCT01562028|10058489|P1|Overall Study|Lost to Follow-up|2
2920551|NCT01562028|10058488|P2|Overall Study|Withdrawal by Subject|1
2920552|NCT01562028|10058489|P1|Overall Study|Withdrawal by Subject|1
2920553|NCT01561989|10058509|P2|Overall Study|accural target not met.|6
2920554|NCT01561989|10058510|P1|Overall Study|accural target not met.|5
2920555|NCT01561976|10058532|P6|Washout Period 2 (7 Days)|Non-compliance|0
2920556|NCT01561976|10058533|P5|Washout Period 2 (7 Days)|Non-compliance|0
2920557|NCT01561976|10058534|P4|Washout Period 2 (7 Days)|Non-compliance|0
2920558|NCT01561976|10058535|P3|Washout Period 2 (7 Days)|Non-compliance|1
2920559|NCT01561976|10058536|P2|Washout Period 2 (7 Days)|Non-compliance|0
2920560|NCT01561976|10058537|P1|Washout Period 2 (7 Days)|Non-compliance|1
2920561|NCT01561976|10058532|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2920562|NCT01561976|10058533|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2920563|NCT01561976|10058534|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2920564|NCT01561976|10058535|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2920565|NCT01561976|10058536|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2920566|NCT01561976|10058537|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2920567|NCT01561976|10058532|P6|Washout Period 1 (7 Days)|Adverse Event|0
2920568|NCT01561976|10058533|P5|Washout Period 1 (7 Days)|Adverse Event|0
2920569|NCT01561976|10058534|P4|Washout Period 1 (7 Days)|Adverse Event|1
2920570|NCT01561976|10058535|P3|Washout Period 1 (7 Days)|Adverse Event|0
2920571|NCT01561976|10058536|P2|Washout Period 1 (7 Days)|Adverse Event|0
2920572|NCT01561976|10058537|P1|Washout Period 1 (7 Days)|Adverse Event|0
2920573|NCT01561976|10058532|P6|Period 1|Adverse Event|0
2920574|NCT01561976|10058533|P5|Period 1|Adverse Event|0
2920575|NCT01561976|10058534|P4|Period 1|Adverse Event|0
2920576|NCT01561976|10058535|P3|Period 1|Adverse Event|1
2920577|NCT01561976|10058536|P2|Period 1|Adverse Event|0
2920578|NCT01561976|10058537|P1|Period 1|Adverse Event|0
2920579|NCT01561898|10058570|P4|Overall Study|Physician Decision|1
2920580|NCT01561898|10058571|P3|Overall Study|Physician Decision|7
2920581|NCT01561898|10058572|P2|Overall Study|Physician Decision|5
2920582|NCT01561898|10058573|P1|Overall Study|Physician Decision|1
2920583|NCT01561898|10058570|P4|Overall Study|Adverse Event|9
2920584|NCT01561898|10058571|P3|Overall Study|Adverse Event|14
2920585|NCT01561898|10058572|P2|Overall Study|Adverse Event|19
2920586|NCT01561898|10058573|P1|Overall Study|Adverse Event|1
2920587|NCT01561898|10058570|P4|Overall Study|Lost to Follow-up|0
2920588|NCT01561898|10058571|P3|Overall Study|Lost to Follow-up|1
2920589|NCT01561898|10058572|P2|Overall Study|Lost to Follow-up|0
2920590|NCT01561898|10058573|P1|Overall Study|Lost to Follow-up|0
2920591|NCT01561898|10058570|P4|Overall Study|Worsening of complications|0
2920592|NCT01561898|10058571|P3|Overall Study|Worsening of complications|0
2920593|NCT01561898|10058572|P2|Overall Study|Worsening of complications|1
2920594|NCT01561898|10058573|P1|Overall Study|Worsening of complications|0
2920595|NCT01561898|10058570|P4|Overall Study|Lack of Efficacy|5
2920596|NCT01561898|10058571|P3|Overall Study|Lack of Efficacy|10
2920597|NCT01561898|10058572|P2|Overall Study|Lack of Efficacy|8
2920598|NCT01561898|10058573|P1|Overall Study|Lack of Efficacy|0
2920599|NCT01561898|10058570|P4|Overall Study|Withdrawal by Subject|5
2920600|NCT01561898|10058571|P3|Overall Study|Withdrawal by Subject|12
2920601|NCT01561898|10058572|P2|Overall Study|Withdrawal by Subject|8
2920602|NCT01561898|10058573|P1|Overall Study|Withdrawal by Subject|0
2920603|NCT01561755|10058587|P2|Overall Study|Lost to Follow-up|1
2920604|NCT01561755|10058588|P1|Overall Study|Lost to Follow-up|0
2920605|NCT01561560|10058640|P2|Second Two Weeks of Wear|Adverse Event|1
2920606|NCT01561560|10058641|P1|Second Two Weeks of Wear|Adverse Event|0
2920607|NCT01561560|10058640|P2|First Two Weeks of Wear|Adverse Event|1
2920608|NCT01561560|10058641|P1|First Two Weeks of Wear|Adverse Event|0
2920609|NCT01561560|10058640|P2|First Two Weeks of Wear|Time/job conflict|1
2920610|NCT01561560|10058641|P1|First Two Weeks of Wear|Time/job conflict|0
2920611|NCT01561430|10058676|P4|Overall Study|Sponsor Decision|12
2920612|NCT01561430|10058677|P3|Overall Study|Sponsor Decision|13
2920613|NCT01561430|10058678|P2|Overall Study|Sponsor Decision|14
2920614|NCT01561430|10058679|P1|Overall Study|Sponsor Decision|1
2920615|NCT01561430|10058676|P4|Overall Study|Physician Decision|0
2920616|NCT01561430|10058677|P3|Overall Study|Physician Decision|0
2920617|NCT01561430|10058678|P2|Overall Study|Physician Decision|1
2920618|NCT01561430|10058679|P1|Overall Study|Physician Decision|0
2920619|NCT01561430|10058676|P4|Overall Study|Withdrawal by Subject|0
2920620|NCT01561430|10058677|P3|Overall Study|Withdrawal by Subject|1
2920621|NCT01561430|10058678|P2|Overall Study|Withdrawal by Subject|0
2920622|NCT01561430|10058679|P1|Overall Study|Withdrawal by Subject|0
2920623|NCT01561430|10058676|P4|Overall Study|Adverse Event|1
2920624|NCT01561430|10058677|P3|Overall Study|Adverse Event|3
2920625|NCT01561430|10058678|P2|Overall Study|Adverse Event|0
2920626|NCT01561430|10058679|P1|Overall Study|Adverse Event|0
2920627|NCT01561313|10058719|P2|Overall Study|Adverse event and withdrawal by subject|0
2920628|NCT01561313|10058720|P1|Overall Study|Adverse event and withdrawal by subject|1
2920629|NCT01561313|10058719|P2|Overall Study|Withdrawal by Subject|0
2920630|NCT01561313|10058720|P1|Overall Study|Withdrawal by Subject|1
2920631|NCT01561300|10058738|P2|Run in on Placebo|Adverse Event|0
2920632|NCT01561300|10058739|P1|Run in on Placebo|Adverse Event|1
2920633|NCT01561079|10058750|P1|Overall Study|Protocol Violation|2
2920634|NCT01561079|10058750|P1|Overall Study|Withdrawal by Subject|59
2920635|NCT01561079|10058750|P1|Overall Study|Physician Decision|17
2920636|NCT01560988|10058836|P2|Washout (Six Weeks)|Lost to Follow-up|2
2920637|NCT01560988|10058837|P1|Washout (Six Weeks)|Lost to Follow-up|2
2920638|NCT01560988|10058836|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
2920639|NCT01560988|10058837|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
2920640|NCT01560988|10058836|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
2920641|NCT01560988|10058837|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
2920642|NCT01560871|10058894|P2|Overall Study|Lost to Follow-up|0
2920643|NCT01560871|10058895|P1|Overall Study|Lost to Follow-up|1
2920644|NCT01560871|10058894|P2|Overall Study|readmission to a hospital|1
2920645|NCT01560871|10058895|P1|Overall Study|readmission to a hospital|2
2920646|NCT01560871|10058894|P2|Overall Study|relocation|0
2920647|NCT01560871|10058895|P1|Overall Study|relocation|1
2920648|NCT01560871|10058894|P2|Overall Study|transportation issues|1
2920649|NCT01560871|10058895|P1|Overall Study|transportation issues|2
2920650|NCT01560819|10058911|P2|Overall Study|Physician Decision|0
2920651|NCT01560819|10058912|P1|Overall Study|Physician Decision|1
2920652|NCT01560780|10058918|P2|Overall Study|Patient Preference|11
2920653|NCT01560780|10058919|P1|Overall Study|Patient Preference|11
2920654|NCT01560780|10058918|P2|Overall Study|Death|1
2920655|NCT01560780|10058919|P1|Overall Study|Death|2
2920656|NCT01560507|10058955|P3|Overall Study|Withdrawal by Subject|0
2920657|NCT01560507|10058956|P2|Overall Study|Withdrawal by Subject|1
2920658|NCT01560507|10058957|P1|Overall Study|Withdrawal by Subject|1
2920659|NCT01560507|10058955|P3|Overall Study|Lost to Follow-up|2
2920660|NCT01560507|10058956|P2|Overall Study|Lost to Follow-up|1
2920661|NCT01560507|10058957|P1|Overall Study|Lost to Follow-up|3
2920662|NCT01560429|10058970|P2|Overall Study|Protocol Violation|6
2920663|NCT01560429|10058971|P1|Overall Study|Protocol Violation|3
2920664|NCT01560416|10058981|P2|Randomized Phase|Crossover Participants|0
2920665|NCT01560416|10058982|P1|Randomized Phase|Crossover Participants|7
2920666|NCT01560403|10059000|P2|Overall Study|Lost to Follow-up|1
2920667|NCT01560403|10059001|P1|Overall Study|Lost to Follow-up|0
2920668|NCT01560234|10059049|P8|Overall Study|Lost to Follow-up|2
2920669|NCT01560234|10059050|P7|Overall Study|Lost to Follow-up|0
2920670|NCT01560234|10059051|P6|Overall Study|Lost to Follow-up|2
2920671|NCT01560234|10059052|P5|Overall Study|Lost to Follow-up|0
2920672|NCT01560234|10059053|P4|Overall Study|Lost to Follow-up|0
2920673|NCT01560234|10059054|P3|Overall Study|Lost to Follow-up|1
2920674|NCT01560234|10059055|P2|Overall Study|Lost to Follow-up|0
2920675|NCT01560234|10059056|P1|Overall Study|Lost to Follow-up|3
2920676|NCT01559935|10059151|P1|Maintenance Phase|Non-compliance|2
2920677|NCT01559935|10059151|P1|Maintenance Phase|Withdrawal by Subject|5
2920678|NCT01559935|10059151|P1|Maintenance Phase|Lack of Efficacy|18
2920679|NCT01559935|10059151|P1|Maintenance Phase|Toxicity|1
2920680|NCT01559935|10059151|P1|Maintenance Phase|Remains on study|28
2920681|NCT01559935|10059151|P1|BiRD Phase|Withdrawal by Subject|2
2920682|NCT01559935|10059151|P1|BiRD Phase|Lack of Efficacy|1
2920683|NCT01559935|10059151|P1|BiRD Phase|Toxicity|1
2920684|NCT01559935|10059151|P1|Car Phase|non-compliance|1
2920685|NCT01559935|10059151|P1|Car Phase|Insurance|1
2920686|NCT01559935|10059151|P1|Car Phase|Per protocol|1
2920687|NCT01559935|10059151|P1|Car Phase|Withdrawal by Subject|2
2920688|NCT01559935|10059151|P1|Car Phase|Physician Decision|1
2920689|NCT01559935|10059151|P1|Car Phase|Lost to Follow-up|1
2920690|NCT01559935|10059151|P1|Car Phase|Lack of Efficacy|2
2920691|NCT01559935|10059151|P1|Car Phase|Death|1
2920692|NCT01559935|10059151|P1|Car Phase|Toxicity|4
2920693|NCT01559844|10059187|P1|Overall Study|No Longer A Transplant Candidate|3
2920694|NCT01559844|10059187|P1|Overall Study|Efficacy Failure|10
2920695|NCT01559844|10059187|P1|Overall Study|Death|5
2920696|NCT01559844|10059187|P1|Overall Study|Consent Withdrawn|7
2920697|NCT01559675|10059200|P2|Overall Study|2nd operation on same patient excluded|12
2920698|NCT01559675|10059201|P1|Overall Study|2nd operation on same patient excluded|14
2920699|NCT01559675|10059200|P2|Overall Study|Protocol Violation|2
2920700|NCT01559675|10059201|P1|Overall Study|Protocol Violation|1
2920701|NCT01559454|10059232|P2|Overall Study|Lack of Efficacy|1
2920702|NCT01559454|10059233|P1|Overall Study|Lack of Efficacy|0
2920703|NCT01559454|10059232|P2|Overall Study|Protocol Violation|1
2920704|NCT01559454|10059233|P1|Overall Study|Protocol Violation|0
2920705|NCT01559454|10059232|P2|Overall Study|Physician Decision|1
2920706|NCT01559454|10059233|P1|Overall Study|Physician Decision|0
2920707|NCT01559454|10059232|P2|Overall Study|Withdrawal by Subject|1
2920708|NCT01559454|10059233|P1|Overall Study|Withdrawal by Subject|0
2920709|NCT01559454|10059232|P2|Overall Study|Lost to Follow-up|2
2920710|NCT01559454|10059233|P1|Overall Study|Lost to Follow-up|3
2920711|NCT01559389|10059251|P2|Overall Study|Withdrawal by Subject|20
2920712|NCT01559389|10059252|P1|Overall Study|Withdrawal by Subject|20
2920713|NCT01559311|10059265|P3|Overall Study|Adverse Event|1
2920714|NCT01559311|10059266|P2|Overall Study|Adverse Event|0
2920715|NCT01559311|10059267|P1|Overall Study|Adverse Event|0
2920716|NCT01559311|10059265|P3|Overall Study|Lost to Follow-up|2
2920717|NCT01559311|10059266|P2|Overall Study|Lost to Follow-up|3
2920718|NCT01559311|10059267|P1|Overall Study|Lost to Follow-up|0
2920719|NCT01559311|10059265|P3|Overall Study|Death|3
2920720|NCT01559311|10059266|P2|Overall Study|Death|2
2920721|NCT01559311|10059267|P1|Overall Study|Death|0
2920722|NCT01559311|10059265|P3|Overall Study|Withdrawal by Subject|0
2920723|NCT01559311|10059266|P2|Overall Study|Withdrawal by Subject|1
2920724|NCT01559311|10059267|P1|Overall Study|Withdrawal by Subject|2
2920725|NCT01559311|10059265|P3|Overall Study|Difficulty in cannulating the lateral ve|0
2920726|NCT01559311|10059266|P2|Overall Study|Difficulty in cannulating the lateral ve|0
2920727|NCT01559311|10059267|P1|Overall Study|Difficulty in cannulating the lateral ve|1
2920728|NCT01559311|10059265|P3|Overall Study|Protocol Violation|2
2920729|NCT01559311|10059266|P2|Overall Study|Protocol Violation|0
2920730|NCT01559311|10059267|P1|Overall Study|Protocol Violation|0
2920731|NCT01559259|10059283|P5|Overall Study|Adverse Event|0
2920732|NCT01559259|10059284|P4|Overall Study|Adverse Event|0
2920733|NCT01559259|10059285|P3|Overall Study|Adverse Event|1
2920734|NCT01559259|10059286|P2|Overall Study|Adverse Event|1
2920735|NCT01559259|10059287|P1|Overall Study|Adverse Event|0
2920736|NCT01559259|10059283|P5|Overall Study|Withdrawal by Subject|0
2920737|NCT01559259|10059284|P4|Overall Study|Withdrawal by Subject|1
2920738|NCT01559259|10059285|P3|Overall Study|Withdrawal by Subject|0
2920739|NCT01559259|10059286|P2|Overall Study|Withdrawal by Subject|0
2920740|NCT01559259|10059287|P1|Overall Study|Withdrawal by Subject|0
2920741|NCT01559129|10059376|P2|Open-label Extension Period|Study Terminated by Sponsor|2
2920742|NCT01559129|10059377|P1|Open-label Extension Period|Study Terminated by Sponsor|5
2920743|NCT01559129|10059376|P2|Open-label Extension Period|Adverse Event|0
2920744|NCT01559129|10059377|P1|Open-label Extension Period|Adverse Event|1
2920745|NCT01559129|10059376|P2|Treatment Phase|Did Not Receive Study Drug|1
2920746|NCT01559129|10059377|P1|Treatment Phase|Did Not Receive Study Drug|0
2920747|NCT01559129|10059376|P2|Treatment Phase|Protocol Exclusion Criteria|0
2920748|NCT01559129|10059377|P1|Treatment Phase|Protocol Exclusion Criteria|1
2920749|NCT01559129|10059376|P2|Treatment Phase|Study Terminated by Sponsor|2
2920750|NCT01559129|10059377|P1|Treatment Phase|Study Terminated by Sponsor|3
2920751|NCT01559129|10059376|P2|Treatment Phase|Lack of Efficacy|1
2920752|NCT01559129|10059377|P1|Treatment Phase|Lack of Efficacy|0
2920753|NCT01559129|10059376|P2|Treatment Phase|Progressive Disease|1
2920754|NCT01559129|10059377|P1|Treatment Phase|Progressive Disease|1
2920755|NCT01559129|10059376|P2|Treatment Phase|Adverse Event|2
2920756|NCT01559129|10059377|P1|Treatment Phase|Adverse Event|0
2920757|NCT01559116|10059453|P1|Overall Study|other than stated above|9
2920758|NCT01559116|10059453|P1|Overall Study|Withdrawal by Subject|4
2920759|NCT01559116|10059453|P1|Overall Study|Protocol Violation|1
2920760|NCT01559116|10059453|P1|Overall Study|Lost to Follow-up|1
2920761|NCT01559116|10059453|P1|Overall Study|Lack of Efficacy|1
2920762|NCT01559116|10059453|P1|Overall Study|Adverse Event|10
2920763|NCT01559090|10059524|P3|Stage II|Withdrawal by Subject|0
2920764|NCT01559090|10059525|P2|Stage II|Withdrawal by Subject|0
2920765|NCT01559090|10059526|P1|Stage II|Withdrawal by Subject|1
2920766|NCT01559090|10059524|P3|Stage I|Withdrawal by Subject|3
2920767|NCT01559090|10059525|P2|Stage I|Withdrawal by Subject|2
2920768|NCT01559090|10059526|P1|Stage I|Withdrawal by Subject|2
2920769|NCT01559012|10059558|P2|Overall Study|Withdrawal by Subject|1
2920770|NCT01559012|10059559|P1|Overall Study|Withdrawal by Subject|0
2920771|NCT01558739|10059597|P1|Overall Study|Protocol Violation|1
2920772|NCT01558739|10059597|P1|Overall Study|Disease Progression|4
2920773|NCT01558739|10059597|P1|Overall Study|Death|3
2920774|NCT01558739|10059597|P1|Overall Study|Withdrawal by Subject|2
2920775|NCT01558739|10059597|P1|Overall Study|Adverse Event|7
2920776|NCT01558674|10059622|P2|Part 1|Withdrawal by Subject|0
2920777|NCT01558674|10059623|P1|Part 1|Withdrawal by Subject|1
2920778|NCT01558674|10059622|P2|Part 1|Study Terminated by Sponsor|0
2920779|NCT01558674|10059623|P1|Part 1|Study Terminated by Sponsor|10
2920780|NCT01558635|10059674|P1|Overall Study|Reveal XT was explanted|1
2920781|NCT01558635|10059674|P1|Overall Study|Subject received other treatment|1
2920782|NCT01558635|10059674|P1|Overall Study|Physician Decision|1
2920783|NCT01558635|10059674|P1|Overall Study|Withdrawal by Subject|2
2920784|NCT01558635|10059674|P1|Overall Study|Death|1
2920785|NCT01558596|10059691|P2|Overall Study|Protocol Violation|0
2920786|NCT01558596|10059692|P1|Overall Study|Protocol Violation|1
2920787|NCT01558596|10059691|P2|Overall Study|surgery elsewhere or cancelled|1
2920788|NCT01558596|10059692|P1|Overall Study|surgery elsewhere or cancelled|1
2920789|NCT01558596|10059691|P2|Overall Study|Withdrawal by Subject|0
2920790|NCT01558596|10059692|P1|Overall Study|Withdrawal by Subject|1
2920791|NCT01558297|10059707|P3|Overall Study|Withdrawal by Subject|1
2920792|NCT01558297|10059708|P2|Overall Study|Withdrawal by Subject|2
2920793|NCT01558297|10059709|P1|Overall Study|Withdrawal by Subject|2
2920794|NCT01558271|10059726|P3|Overall Study|Physician Decision|1
2920795|NCT01558271|10059727|P2|Overall Study|Physician Decision|2
2920796|NCT01558271|10059728|P1|Overall Study|Physician Decision|0
2920797|NCT01558271|10059726|P3|Overall Study|Withdrawal by Subject|12
2920798|NCT01558271|10059727|P2|Overall Study|Withdrawal by Subject|6
2920799|NCT01558271|10059728|P1|Overall Study|Withdrawal by Subject|10
2920800|NCT01558271|10059726|P3|Overall Study|Protocol Violation|0
2920801|NCT01558271|10059727|P2|Overall Study|Protocol Violation|0
2920802|NCT01558271|10059728|P1|Overall Study|Protocol Violation|1
2920803|NCT01558271|10059726|P3|Overall Study|Lost to Follow-up|0
2920804|NCT01558271|10059727|P2|Overall Study|Lost to Follow-up|0
2920805|NCT01558271|10059728|P1|Overall Study|Lost to Follow-up|1
2920806|NCT01558271|10059726|P3|Overall Study|Adverse Event|4
2920807|NCT01558271|10059727|P2|Overall Study|Adverse Event|3
2920808|NCT01558271|10059728|P1|Overall Study|Adverse Event|6
2920809|NCT01558089|10059794|P1|Overall Study|Withdrawal by Subject|6
2920810|NCT01558089|10059794|P1|Overall Study|Lost to Follow-up|5
2920811|NCT01558089|10059794|P1|Overall Study|Lack of Efficacy|1
2920812|NCT01558089|10059794|P1|Overall Study|Adverse Event|1
2920813|NCT01557946|10059847|P2|Overall Study|Adverse Event|0
2920814|NCT01557946|10059848|P1|Overall Study|Adverse Event|3
2920815|NCT01557920|10059854|P2|Overall Study|Lack of Efficacy|0
2920816|NCT01557920|10059855|P1|Overall Study|Lack of Efficacy|1
2920817|NCT01557920|10059854|P2|Overall Study|Withdrawal by Subject|3
2920818|NCT01557920|10059855|P1|Overall Study|Withdrawal by Subject|2
2920819|NCT01557842|10059924|P2|Overall Study|Not Ablated|0
2920820|NCT01557842|10059925|P1|Overall Study|Not Ablated|2
2920821|NCT01557842|10059924|P2|Overall Study|Study Terminated by Sponsor|4
2920822|NCT01557842|10059925|P1|Overall Study|Study Terminated by Sponsor|3
2920823|NCT01557842|10059924|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
2920824|NCT01557842|10059925|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
2920825|NCT01557842|10059924|P2|Overall Study|Lack of Efficacy|1
2920826|NCT01557842|10059925|P1|Overall Study|Lack of Efficacy|0
2920827|NCT01557842|10059924|P2|Overall Study|Death|0
2920828|NCT01557842|10059925|P1|Overall Study|Death|1
2920829|NCT01557842|10059924|P2|Overall Study|Lost to Follow-up|1
2920830|NCT01557842|10059925|P1|Overall Study|Lost to Follow-up|0
2920831|NCT01557751|10059937|P1|Overall Study|Physician Decision|3
2920832|NCT01557582|10059982|P1|Overall Study|Operator error|2
2920833|NCT01557582|10059982|P1|Overall Study|Protocol Violation|4
2920834|NCT01557569|10059990|P2|Overall Study|noncompliance with rules of residential|1
2920835|NCT01557569|10059991|P1|Overall Study|noncompliance with rules of residential|0
2920836|NCT01557569|10059990|P2|Overall Study|Withdrawal by Subject|5
2920837|NCT01557569|10059991|P1|Overall Study|Withdrawal by Subject|3
2920838|NCT01557569|10059990|P2|Overall Study|high blood pressure|1
2920839|NCT01557569|10059991|P1|Overall Study|high blood pressure|0
2920840|NCT01557569|10059990|P2|Overall Study|Adverse Event|0
2920841|NCT01557569|10059991|P1|Overall Study|Adverse Event|2
2920842|NCT01557517|10059999|P2|Overall Study|Pt declined before treatment started|0
2920843|NCT01557517|10060000|P1|Overall Study|Pt declined before treatment started|1
2920844|NCT01557517|10059999|P2|Overall Study|Adverse Event|2
2920845|NCT01557517|10060000|P1|Overall Study|Adverse Event|0
2920846|NCT01557517|10059999|P2|Overall Study|Refused further treatment|2
2920847|NCT01557517|10060000|P1|Overall Study|Refused further treatment|0
2920848|NCT01557517|10059999|P2|Overall Study|Death|0
2920849|NCT01557517|10060000|P1|Overall Study|Death|1
2920850|NCT01557504|10060026|P2|Overall Study|Physician Decision|0
2920851|NCT01557504|10060027|P1|Overall Study|Physician Decision|1
2920852|NCT01557348|10060052|P2|Overall Study|Administrative|11
2920853|NCT01557348|10060053|P1|Overall Study|Administrative|18
2920854|NCT01557348|10060052|P2|Overall Study|Lost to Follow-up|22
2920855|NCT01557348|10060053|P1|Overall Study|Lost to Follow-up|26
2920856|NCT01557348|10060052|P2|Overall Study|Withdrawal by Subject|4
2920857|NCT01557348|10060053|P1|Overall Study|Withdrawal by Subject|5
2920858|NCT01557348|10060052|P2|Overall Study|Insufficient Therapeutic Response|28
2920859|NCT01557348|10060053|P1|Overall Study|Insufficient Therapeutic Response|13
2920860|NCT01557348|10060052|P2|Overall Study|Death|4
2920861|NCT01557348|10060053|P1|Overall Study|Death|7
2920862|NCT01557348|10060052|P2|Overall Study|Infusion reaction event|5
2920863|NCT01557348|10060053|P1|Overall Study|Infusion reaction event|5
2920864|NCT01557348|10060052|P2|Overall Study|Adverse Event|16
2920865|NCT01557348|10060053|P1|Overall Study|Adverse Event|6
2920866|NCT01557283|10060170|P1|Overall Study|Other|6
2920867|NCT01557283|10060170|P1|Overall Study|Worsening of psoriasis|1
2920868|NCT01557283|10060170|P1|Overall Study|Participant’s weight too high for dose|1
2920869|NCT01557283|10060170|P1|Overall Study|Withdrawal by Subject|1
2920870|NCT01557283|10060170|P1|Overall Study|Non-compliance|1
2920871|NCT01557283|10060170|P1|Overall Study|Lack of Efficacy|1
2920872|NCT01557283|10060170|P1|Overall Study|Adverse Event|7
2920873|NCT01557283|10060170|P1|Overall Study|Non-responder|19
2920874|NCT01557283|10060170|P1|Overall Study|Lost to Follow-up|7
2920875|NCT01557166|10060182|P2|Overall Study|Unclassified|5
2920876|NCT01557166|10060183|P1|Overall Study|Unclassified|2
2920877|NCT01557166|10060182|P2|Overall Study|Psychiatric disorder|0
2920878|NCT01557166|10060183|P1|Overall Study|Psychiatric disorder|1
2920879|NCT01557166|10060182|P2|Overall Study|Target dose not tolerated|0
2920880|NCT01557166|10060183|P1|Overall Study|Target dose not tolerated|1
2920881|NCT01557166|10060182|P2|Overall Study|Withdrawn consent|20
2920882|NCT01557166|10060183|P1|Overall Study|Withdrawn consent|12
2920883|NCT01557166|10060182|P2|Overall Study|Protocol Violation|5
2920884|NCT01557166|10060183|P1|Overall Study|Protocol Violation|8
2920885|NCT01557166|10060182|P2|Overall Study|Lack of Efficacy|1
2920886|NCT01557166|10060183|P1|Overall Study|Lack of Efficacy|2
2920887|NCT01557166|10060182|P2|Overall Study|Adverse Event|6
2920888|NCT01557166|10060183|P1|Overall Study|Adverse Event|20
2920889|NCT01556997|10060198|P3|Overall Study|Other|7
2920890|NCT01556997|10060199|P2|Overall Study|Other|3
2920891|NCT01556997|10060200|P1|Overall Study|Other|2
2920892|NCT01556997|10060198|P3|Overall Study|Withdrawal by Subject|8
2920893|NCT01556997|10060199|P2|Overall Study|Withdrawal by Subject|6
2920894|NCT01556997|10060200|P1|Overall Study|Withdrawal by Subject|7
2920895|NCT01556997|10060198|P3|Overall Study|Physician Decision|1
2920896|NCT01556997|10060199|P2|Overall Study|Physician Decision|1
2920897|NCT01556997|10060200|P1|Overall Study|Physician Decision|1
2920898|NCT01556997|10060198|P3|Overall Study|Lost to Follow-up|4
2920899|NCT01556997|10060199|P2|Overall Study|Lost to Follow-up|6
2920900|NCT01556997|10060200|P1|Overall Study|Lost to Follow-up|6
2920901|NCT01556997|10060198|P3|Overall Study|Adverse Event|12
2920902|NCT01556997|10060199|P2|Overall Study|Adverse Event|12
2920903|NCT01556997|10060200|P1|Overall Study|Adverse Event|10
2920904|NCT01556932|10060211|P2|Time Point 60 Minutes|Withdrawal by Subject|1
2920905|NCT01556932|10060212|P1|Time Point 60 Minutes|Withdrawal by Subject|1
2920906|NCT01556763|10060238|P3|Overall Study|Withdrawal by Subject|0
2920907|NCT01556763|10060239|P2|Overall Study|Withdrawal by Subject|1
2920908|NCT01556763|10060240|P1|Overall Study|Withdrawal by Subject|0
2920909|NCT01556438|10060366|P2|Overall Study|Death|1
2920910|NCT01556438|10060367|P1|Overall Study|Death|0
2920911|NCT01556438|10060366|P2|Overall Study|Progressive Disease|6
2920912|NCT01556438|10060367|P1|Overall Study|Progressive Disease|0
2920913|NCT01556438|10060366|P2|Overall Study|Sponsor Decision|2
2920914|NCT01556438|10060367|P1|Overall Study|Sponsor Decision|0
2920915|NCT01556438|10060366|P2|Overall Study|Adverse Event|2
2920916|NCT01556438|10060367|P1|Overall Study|Adverse Event|4
2920917|NCT01556165|10060454|P2|Overall Study|Withdrawal of Consent|1
2920918|NCT01556165|10060455|P1|Overall Study|Withdrawal of Consent|7
2920919|NCT01556165|10060454|P2|Overall Study|Protocol Violation|3
2920920|NCT01556165|10060455|P1|Overall Study|Protocol Violation|0
2920921|NCT01556165|10060454|P2|Overall Study|Adverse Event|3
2920922|NCT01556165|10060455|P1|Overall Study|Adverse Event|5
2920923|NCT01555983|10060485|P6|Overall Study|Withdrawal by Subject|1
2920924|NCT01555983|10060486|P5|Overall Study|Withdrawal by Subject|1
2920925|NCT01555983|10060487|P4|Overall Study|Withdrawal by Subject|0
2920926|NCT01555983|10060488|P3|Overall Study|Withdrawal by Subject|0
2920927|NCT01555983|10060489|P2|Overall Study|Withdrawal by Subject|0
2920928|NCT01555983|10060490|P1|Overall Study|Withdrawal by Subject|1
2920929|NCT01555931|10060500|P2|Overall Study|Lost to Follow-up|5
2920930|NCT01555931|10060501|P1|Overall Study|Lost to Follow-up|2
2920931|NCT01555762|10060509|P1|Overall Study|Death linked to an adverse event|14
2920932|NCT01555762|10060509|P1|Overall Study|Missing data|1
2920933|NCT01555762|10060509|P1|Overall Study|Participant not wishing to continue|5
2920934|NCT01555762|10060509|P1|Overall Study|Investigator's decision|10
2920935|NCT01555762|10060509|P1|Overall Study|Lost follow-up/moved house/changed team|35
2920936|NCT01555762|10060509|P1|Overall Study|Death linked to progression of disease|165
2920937|NCT01555762|10060509|P1|Overall Study|Treatment with Bevacizumab ticked No|24
2920938|NCT01555762|10060509|P1|Overall Study|75 years old or more ticked No|1
2920939|NCT01555762|10060509|P1|Overall Study|Missing start date of infusion|8
2920940|NCT01555762|10060509|P1|Overall Study|No information on Bevacizumab intake|11
2920941|NCT01555463|10060554|P2|Follow up|Other reason|3
2920942|NCT01555463|10060555|P1|Follow up|Other reason|3
2920943|NCT01555463|10060554|P2|Follow up|Protocol Violation|4
2920944|NCT01555463|10060555|P1|Follow up|Protocol Violation|2
2920945|NCT01555463|10060554|P2|Follow up|Lost to Follow-up|10
2920946|NCT01555463|10060555|P1|Follow up|Lost to Follow-up|9
2920947|NCT01555463|10060554|P2|Follow up|Withdrawal by Subject|22
2920948|NCT01555463|10060555|P1|Follow up|Withdrawal by Subject|22
2920949|NCT01555463|10060554|P2|Follow up|Death|1
2920950|NCT01555463|10060555|P1|Follow up|Death|0
2920951|NCT01555463|10060554|P2|Follow up|Adverse Event|5
2920952|NCT01555463|10060555|P1|Follow up|Adverse Event|2
2920953|NCT01555463|10060554|P2|Treatment|Other reason|3
2920954|NCT01555463|10060555|P1|Treatment|Other reason|2
2920955|NCT01555463|10060554|P2|Treatment|Protocol Violation|5
2920956|NCT01555463|10060555|P1|Treatment|Protocol Violation|4
2920957|NCT01555463|10060554|P2|Treatment|Lost to Follow-up|23
2920958|NCT01555463|10060555|P1|Treatment|Lost to Follow-up|28
2920959|NCT01555463|10060554|P2|Treatment|Withdrawal by Subject|36
2920960|NCT01555463|10060555|P1|Treatment|Withdrawal by Subject|24
2920961|NCT01555463|10060554|P2|Treatment|Adverse Event|12
2920962|NCT01555463|10060555|P1|Treatment|Adverse Event|6
2920963|NCT01555164|10060597|P2|Overall Study|Subject Withdrew Consent|11
2920964|NCT01555164|10060598|P1|Overall Study|Subject Withdrew Consent|6
2920965|NCT01555164|10060597|P2|Overall Study|Subject Non-compliance|6
2920966|NCT01555164|10060598|P1|Overall Study|Subject Non-compliance|14
2920967|NCT01555164|10060597|P2|Overall Study|Protocol Violation|5
2920968|NCT01555164|10060598|P1|Overall Study|Protocol Violation|9
2920969|NCT01555164|10060597|P2|Overall Study|Lost to Follow-up|3
2920970|NCT01555164|10060598|P1|Overall Study|Lost to Follow-up|4
2920971|NCT01555164|10060597|P2|Overall Study|Investigator's Discretion|2
2920972|NCT01555164|10060598|P1|Overall Study|Investigator's Discretion|2
2920973|NCT01555164|10060597|P2|Overall Study|Hyperglycemia|1
2920974|NCT01555164|10060598|P1|Overall Study|Hyperglycemia|0
2920975|NCT01555164|10060597|P2|Overall Study|Adverse Event|7
2920976|NCT01555164|10060598|P1|Overall Study|Adverse Event|5
2920977|NCT01555151|10060612|P4|Overall Study|Lost to Follow-up|1
2920978|NCT01555151|10060613|P3|Overall Study|Lost to Follow-up|0
2920979|NCT01555151|10060614|P2|Overall Study|Lost to Follow-up|0
2920980|NCT01555151|10060615|P1|Overall Study|Lost to Follow-up|0
2920981|NCT01555151|10060612|P4|Overall Study|Adverse Event|2
2920982|NCT01555151|10060613|P3|Overall Study|Adverse Event|1
2920983|NCT01555151|10060614|P2|Overall Study|Adverse Event|2
2920984|NCT01555151|10060615|P1|Overall Study|Adverse Event|1
2920985|NCT01555151|10060612|P4|Overall Study|Protocol Violation|5
2920986|NCT01555151|10060613|P3|Overall Study|Protocol Violation|3
2920987|NCT01555151|10060614|P2|Overall Study|Protocol Violation|3
2920988|NCT01555151|10060615|P1|Overall Study|Protocol Violation|3
2920989|NCT01555151|10060612|P4|Overall Study|Administrative|0
2920990|NCT01555151|10060613|P3|Overall Study|Administrative|2
2920991|NCT01555151|10060614|P2|Overall Study|Administrative|1
2920992|NCT01555151|10060615|P1|Overall Study|Administrative|3
2920993|NCT01555151|10060612|P4|Overall Study|Withdrawal by Subject|2
2920994|NCT01555151|10060613|P3|Overall Study|Withdrawal by Subject|0
2920995|NCT01555151|10060614|P2|Overall Study|Withdrawal by Subject|2
2920996|NCT01555151|10060615|P1|Overall Study|Withdrawal by Subject|6
2920997|NCT01555138|10060668|P2|Overall Study|Adverse Event|14
2920998|NCT01555138|10060669|P1|Overall Study|Adverse Event|14
2920999|NCT01555138|10060668|P2|Overall Study|Withdrawal by Subject|15
2921000|NCT01555138|10060669|P1|Overall Study|Withdrawal by Subject|16
2921001|NCT01555138|10060668|P2|Overall Study|Administrative problems|0
2921002|NCT01555138|10060669|P1|Overall Study|Administrative problems|8
2921003|NCT01555138|10060668|P2|Overall Study|Protocol Violation|3
2921004|NCT01555138|10060669|P1|Overall Study|Protocol Violation|5
2921005|NCT01555138|10060668|P2|Overall Study|Lack of Efficacy|2
2921006|NCT01555138|10060669|P1|Overall Study|Lack of Efficacy|2
2921007|NCT01555138|10060668|P2|Overall Study|Abnormal Lab reults|3
2921008|NCT01555138|10060669|P1|Overall Study|Abnormal Lab reults|1
2921009|NCT01555138|10060668|P2|Overall Study|Lost to Follow-up|0
2921010|NCT01555138|10060669|P1|Overall Study|Lost to Follow-up|1
2921011|NCT01555138|10060668|P2|Overall Study|Death|1
2921012|NCT01555138|10060669|P1|Overall Study|Death|0
2921013|NCT01555125|10060698|P5|Follow-Up Period|Subject / guardian decision|0
2921014|NCT01555125|10060699|P4|Follow-Up Period|Subject / guardian decision|1
2921015|NCT01555125|10060700|P3|Follow-Up Period|Subject / guardian decision|1
2921016|NCT01555125|10060701|P2|Follow-Up Period|Subject / guardian decision|1
2921017|NCT01555125|10060702|P1|Follow-Up Period|Subject / guardian decision|3
2921018|NCT01555125|10060698|P5|Follow-Up Period|Lost to Follow-up|0
2921019|NCT01555125|10060699|P4|Follow-Up Period|Lost to Follow-up|0
2921020|NCT01555125|10060700|P3|Follow-Up Period|Lost to Follow-up|0
2921021|NCT01555125|10060701|P2|Follow-Up Period|Lost to Follow-up|0
2921022|NCT01555125|10060702|P1|Follow-Up Period|Lost to Follow-up|1
2921023|NCT01555125|10060698|P5|Extension|Technical Problems|0
2921024|NCT01555125|10060699|P4|Extension|Technical Problems|1
2921025|NCT01555125|10060700|P3|Extension|Technical Problems|0
2921026|NCT01555125|10060701|P2|Extension|Technical Problems|0
2921027|NCT01555125|10060702|P1|Extension|Technical Problems|1
2921028|NCT01555125|10060698|P5|Extension|Subject/guardian decision|0
2921029|NCT01555125|10060699|P4|Extension|Subject/guardian decision|0
2921030|NCT01555125|10060700|P3|Extension|Subject/guardian decision|1
2921031|NCT01555125|10060701|P2|Extension|Subject/guardian decision|9
2921032|NCT01555125|10060702|P1|Extension|Subject/guardian decision|1
2921033|NCT01555125|10060698|P5|Extension|Study terminated by sponsor|0
2921034|NCT01555125|10060699|P4|Extension|Study terminated by sponsor|20
2921035|NCT01555125|10060700|P3|Extension|Study terminated by sponsor|16
2921036|NCT01555125|10060701|P2|Extension|Study terminated by sponsor|33
2921037|NCT01555125|10060702|P1|Extension|Study terminated by sponsor|32
2921038|NCT01555125|10060698|P5|Extension|Lost to Follow-up|0
2921039|NCT01555125|10060699|P4|Extension|Lost to Follow-up|0
2921040|NCT01555125|10060700|P3|Extension|Lost to Follow-up|2
2921041|NCT01555125|10060701|P2|Extension|Lost to Follow-up|1
2921042|NCT01555125|10060702|P1|Extension|Lost to Follow-up|2
2921043|NCT01555125|10060698|P5|Extension|Lack of Efficacy|0
2921044|NCT01555125|10060699|P4|Extension|Lack of Efficacy|0
2921045|NCT01555125|10060700|P3|Extension|Lack of Efficacy|3
2921046|NCT01555125|10060701|P2|Extension|Lack of Efficacy|6
2921047|NCT01555125|10060702|P1|Extension|Lack of Efficacy|7
2921048|NCT01555125|10060698|P5|Extension|Protocol deviation|0
2921049|NCT01555125|10060699|P4|Extension|Protocol deviation|0
2921050|NCT01555125|10060700|P3|Extension|Protocol deviation|0
2921051|NCT01555125|10060701|P2|Extension|Protocol deviation|0
2921052|NCT01555125|10060702|P1|Extension|Protocol deviation|1
2921053|NCT01555125|10060698|P5|Extension|Adverse Event|0
2921054|NCT01555125|10060699|P4|Extension|Adverse Event|1
2921055|NCT01555125|10060700|P3|Extension|Adverse Event|1
2921056|NCT01555125|10060701|P2|Extension|Adverse Event|2
2921057|NCT01555125|10060702|P1|Extension|Adverse Event|1
2921058|NCT01555125|10060698|P5|Maintenance Period|Death|0
2921059|NCT01555125|10060699|P4|Maintenance Period|Death|1
2921060|NCT01555125|10060700|P3|Maintenance Period|Death|0
2921061|NCT01555125|10060701|P2|Maintenance Period|Death|0
2921062|NCT01555125|10060702|P1|Maintenance Period|Death|0
2921063|NCT01555125|10060698|P5|Maintenance Period|Physician Decision|0
2921064|NCT01555125|10060699|P4|Maintenance Period|Physician Decision|0
2921065|NCT01555125|10060700|P3|Maintenance Period|Physician Decision|1
2921066|NCT01555125|10060701|P2|Maintenance Period|Physician Decision|0
2921067|NCT01555125|10060702|P1|Maintenance Period|Physician Decision|0
2921068|NCT01555125|10060698|P5|Maintenance Period|Lack of Efficacy|0
2921069|NCT01555125|10060699|P4|Maintenance Period|Lack of Efficacy|0
2921070|NCT01555125|10060700|P3|Maintenance Period|Lack of Efficacy|3
2921071|NCT01555125|10060701|P2|Maintenance Period|Lack of Efficacy|1
2921072|NCT01555125|10060702|P1|Maintenance Period|Lack of Efficacy|6
2921073|NCT01555125|10060698|P5|Maintenance Period|Lost to Follow-up|0
2921074|NCT01555125|10060699|P4|Maintenance Period|Lost to Follow-up|1
2921075|NCT01555125|10060700|P3|Maintenance Period|Lost to Follow-up|0
2921076|NCT01555125|10060701|P2|Maintenance Period|Lost to Follow-up|0
2921077|NCT01555125|10060702|P1|Maintenance Period|Lost to Follow-up|2
2921078|NCT01555125|10060698|P5|Maintenance Period|Subject / guardian decision|0
2921079|NCT01555125|10060699|P4|Maintenance Period|Subject / guardian decision|0
2921080|NCT01555125|10060700|P3|Maintenance Period|Subject / guardian decision|0
2921081|NCT01555125|10060701|P2|Maintenance Period|Subject / guardian decision|2
2921082|NCT01555125|10060702|P1|Maintenance Period|Subject / guardian decision|1
2921083|NCT01555125|10060698|P5|Maintenance Period|Adverse Event|0
2921084|NCT01555125|10060699|P4|Maintenance Period|Adverse Event|0
2921085|NCT01555125|10060700|P3|Maintenance Period|Adverse Event|0
2921086|NCT01555125|10060701|P2|Maintenance Period|Adverse Event|1
2921087|NCT01555125|10060702|P1|Maintenance Period|Adverse Event|1
2921088|NCT01555125|10060698|P5|Induction Period|Death|0
2921089|NCT01555125|10060699|P4|Induction Period|Death|0
2921090|NCT01555125|10060700|P3|Induction Period|Death|0
2921091|NCT01555125|10060701|P2|Induction Period|Death|0
2921092|NCT01555125|10060702|P1|Induction Period|Death|1
2921093|NCT01555125|10060698|P5|Induction Period|Subject / guardian decision|2
2921094|NCT01555125|10060699|P4|Induction Period|Subject / guardian decision|0
2921095|NCT01555125|10060700|P3|Induction Period|Subject / guardian decision|0
2921096|NCT01555125|10060701|P2|Induction Period|Subject / guardian decision|0
2921097|NCT01555125|10060702|P1|Induction Period|Subject / guardian decision|0
2921098|NCT01555125|10060698|P5|Induction Period|Adverse Event|1
2921099|NCT01555125|10060699|P4|Induction Period|Adverse Event|0
2921100|NCT01555125|10060700|P3|Induction Period|Adverse Event|0
2921101|NCT01555125|10060701|P2|Induction Period|Adverse Event|1
2921102|NCT01555125|10060702|P1|Induction Period|Adverse Event|0
2921103|NCT01555125|10060698|P5|Induction Period|Lost to Follow-up|0
2921104|NCT01555125|10060699|P4|Induction Period|Lost to Follow-up|0
2921105|NCT01555125|10060700|P3|Induction Period|Lost to Follow-up|0
2921106|NCT01555125|10060701|P2|Induction Period|Lost to Follow-up|2
2921107|NCT01555125|10060702|P1|Induction Period|Lost to Follow-up|0
2921108|NCT01555073|10060795|P4|Overall Study|Lost to Follow-up|5
2921109|NCT01555073|10060796|P3|Overall Study|Lost to Follow-up|0
2921110|NCT01555073|10060797|P2|Overall Study|Lost to Follow-up|2
2921111|NCT01555073|10060798|P1|Overall Study|Lost to Follow-up|1
2921112|NCT01555021|10060814|P2|Overall Study|Lost to Follow-up|2
2921113|NCT01555021|10060815|P1|Overall Study|Lost to Follow-up|1
2921114|NCT01554904|10060840|P1|Overall Study|Had sleep apnea on Home Study 1|1
2921115|NCT01554904|10060840|P1|Overall Study|Withdrawal by Subject|3
2921116|NCT01554579|10060860|P2|Overall Study|Withdrawal by Subject|1
2921117|NCT01554579|10060861|P1|Overall Study|Withdrawal by Subject|2
2921118|NCT01554579|10060860|P2|Overall Study|Lack of Efficacy|1
2921119|NCT01554579|10060861|P1|Overall Study|Lack of Efficacy|2
2921120|NCT01554579|10060860|P2|Overall Study|Adverse Event|25
2921121|NCT01554579|10060861|P1|Overall Study|Adverse Event|6
2921122|NCT01554527|10060874|P3|Overall Study|Physician Decision|1
2921123|NCT01554527|10060875|P2|Overall Study|Physician Decision|0
2921124|NCT01554527|10060876|P1|Overall Study|Physician Decision|0
2921125|NCT01554527|10060874|P3|Overall Study|Lost to Follow-up|4
2921126|NCT01554527|10060875|P2|Overall Study|Lost to Follow-up|0
2921127|NCT01554527|10060876|P1|Overall Study|Lost to Follow-up|0
2921128|NCT01554527|10060874|P3|Overall Study|Withdrawal by Subject|3
2921129|NCT01554527|10060875|P2|Overall Study|Withdrawal by Subject|0
2921130|NCT01554527|10060876|P1|Overall Study|Withdrawal by Subject|1
2921131|NCT01554241|10060932|P4|Overall Study|Withdrawal by Subject|0
2921132|NCT01554241|10060933|P3|Overall Study|Withdrawal by Subject|2
2921133|NCT01554241|10060934|P2|Overall Study|Withdrawal by Subject|0
2921134|NCT01554241|10060935|P1|Overall Study|Withdrawal by Subject|0
2921135|NCT01554241|10060932|P4|Overall Study|protocol specified change in eGFR|0
2921136|NCT01554241|10060933|P3|Overall Study|protocol specified change in eGFR|1
2921137|NCT01554241|10060934|P2|Overall Study|protocol specified change in eGFR|0
2921138|NCT01554241|10060935|P1|Overall Study|protocol specified change in eGFR|0
2921139|NCT01554241|10060932|P4|Overall Study|protocol specified renal stone|1
2921140|NCT01554241|10060933|P3|Overall Study|protocol specified renal stone|0
2921141|NCT01554241|10060934|P2|Overall Study|protocol specified renal stone|0
2921142|NCT01554241|10060935|P1|Overall Study|protocol specified renal stone|0
2921143|NCT01554241|10060932|P4|Overall Study|Death|0
2921144|NCT01554241|10060933|P3|Overall Study|Death|1
2921145|NCT01554241|10060934|P2|Overall Study|Death|1
2921146|NCT01554241|10060935|P1|Overall Study|Death|3
2921147|NCT01554176|10060951|P5|Run-out Phase|Protocol Violation|0
2921148|NCT01554176|10060952|P4|Run-out Phase|Protocol Violation|1
2921149|NCT01554176|10060953|P3|Run-out Phase|Protocol Violation|0
2921150|NCT01554176|10060954|P2|Run-out Phase|Protocol Violation|0
2921151|NCT01554176|10060955|P1|Run-out Phase|Protocol Violation|0
2921152|NCT01554176|10060951|P5|Treatment Phase|Lost to Follow-up|0
2921153|NCT01554176|10060952|P4|Treatment Phase|Lost to Follow-up|0
2921154|NCT01554176|10060953|P3|Treatment Phase|Lost to Follow-up|0
2921155|NCT01554176|10060954|P2|Treatment Phase|Lost to Follow-up|0
2921156|NCT01554176|10060955|P1|Treatment Phase|Lost to Follow-up|3
2921157|NCT01554176|10060951|P5|Treatment Phase|Withdrawal by Subject|0
2921158|NCT01554176|10060952|P4|Treatment Phase|Withdrawal by Subject|0
2921159|NCT01554176|10060953|P3|Treatment Phase|Withdrawal by Subject|0
2921160|NCT01554176|10060954|P2|Treatment Phase|Withdrawal by Subject|0
2921161|NCT01554176|10060955|P1|Treatment Phase|Withdrawal by Subject|1
2921162|NCT01554176|10060951|P5|Treatment Phase|Non-compliance with study drug|0
2921163|NCT01554176|10060952|P4|Treatment Phase|Non-compliance with study drug|0
2921164|NCT01554176|10060953|P3|Treatment Phase|Non-compliance with study drug|0
2921165|NCT01554176|10060954|P2|Treatment Phase|Non-compliance with study drug|0
2921166|NCT01554176|10060955|P1|Treatment Phase|Non-compliance with study drug|1
2921167|NCT01554176|10060951|P5|Treatment Phase|Adverse event, non-fatal|0
2921168|NCT01554176|10060952|P4|Treatment Phase|Adverse event, non-fatal|0
2921169|NCT01554176|10060953|P3|Treatment Phase|Adverse event, non-fatal|0
2921170|NCT01554176|10060954|P2|Treatment Phase|Adverse event, non-fatal|1
2921171|NCT01554176|10060955|P1|Treatment Phase|Adverse event, non-fatal|1
2921172|NCT01554176|10060951|P5|Treatment Phase|Lack of Efficacy|0
2921173|NCT01554176|10060952|P4|Treatment Phase|Lack of Efficacy|0
2921174|NCT01554176|10060953|P3|Treatment Phase|Lack of Efficacy|0
2921175|NCT01554176|10060954|P2|Treatment Phase|Lack of Efficacy|1
2921176|NCT01554176|10060955|P1|Treatment Phase|Lack of Efficacy|0
2921177|NCT01554176|10060951|P5|Treatment Phase|Physician Decision|0
2921178|NCT01554176|10060952|P4|Treatment Phase|Physician Decision|0
2921179|NCT01554176|10060953|P3|Treatment Phase|Physician Decision|0
2921180|NCT01554176|10060954|P2|Treatment Phase|Physician Decision|1
2921181|NCT01554176|10060955|P1|Treatment Phase|Physician Decision|1
2921182|NCT01554176|10060951|P5|Treatment Phase|Protocol Violation|0
2921183|NCT01554176|10060952|P4|Treatment Phase|Protocol Violation|0
2921184|NCT01554176|10060953|P3|Treatment Phase|Protocol Violation|0
2921185|NCT01554176|10060954|P2|Treatment Phase|Protocol Violation|2
2921186|NCT01554176|10060955|P1|Treatment Phase|Protocol Violation|1
2921187|NCT01554163|10060982|P2|Overall Study|Not Treated|0
2921188|NCT01554163|10060983|P1|Overall Study|Not Treated|1
2921189|NCT01554163|10060982|P2|Overall Study|Withdrawal by Subject|5
2921190|NCT01554163|10060983|P1|Overall Study|Withdrawal by Subject|1
2921191|NCT01554163|10060982|P2|Overall Study|Protocol Violation|4
2921192|NCT01554163|10060983|P1|Overall Study|Protocol Violation|0
2921193|NCT01554163|10060982|P2|Overall Study|Non-Compliance With Study Drug|1
2921194|NCT01554163|10060983|P1|Overall Study|Non-Compliance With Study Drug|1
2921195|NCT01554163|10060982|P2|Overall Study|Lost to Follow-up|0
2921196|NCT01554163|10060983|P1|Overall Study|Lost to Follow-up|1
2921197|NCT01554163|10060982|P2|Overall Study|Lack of Efficacy|0
2921198|NCT01554163|10060983|P1|Overall Study|Lack of Efficacy|1
2921199|NCT01554163|10060982|P2|Overall Study|Adverse Event|0
2921200|NCT01554163|10060983|P1|Overall Study|Adverse Event|3
2921201|NCT01553916|10061001|P1|Overall Study|Pre-treatment MRI metastatic disease|1
2921202|NCT01553916|10061001|P1|Overall Study|Withdrawal by Subject|2
2921203|NCT01553851|10061018|P1|Overall Study|constipation|1
2921204|NCT01553851|10061018|P1|Overall Study|Adverse Event|2
2921205|NCT01553747|10061033|P3|Overall Study|Physician decision: lack of efficacy|3
2921206|NCT01553747|10061034|P2|Overall Study|Physician decision: lack of efficacy|5
2921207|NCT01553747|10061035|P1|Overall Study|Physician decision: lack of efficacy|1
2921208|NCT01553747|10061033|P3|Overall Study|Sponsor decision, specify|0
2921209|NCT01553747|10061034|P2|Overall Study|Sponsor decision, specify|5
2921210|NCT01553747|10061035|P1|Overall Study|Sponsor decision, specify|7
2921211|NCT01553747|10061033|P3|Overall Study|Lost to Follow-up|6
2921212|NCT01553747|10061034|P2|Overall Study|Lost to Follow-up|5
2921213|NCT01553747|10061035|P1|Overall Study|Lost to Follow-up|11
2921214|NCT01553747|10061033|P3|Overall Study|Physician decision: other|7
2921215|NCT01553747|10061034|P2|Overall Study|Physician decision: other|8
2921216|NCT01553747|10061035|P1|Overall Study|Physician decision: other|10
2921217|NCT01553747|10061033|P3|Overall Study|Adverse event or SAE|19
2921218|NCT01553747|10061034|P2|Overall Study|Adverse event or SAE|28
2921219|NCT01553747|10061035|P1|Overall Study|Adverse event or SAE|32
2921220|NCT01553747|10061033|P3|Overall Study|Voluntarily withdrew|74
2921221|NCT01553747|10061034|P2|Overall Study|Voluntarily withdrew|66
2921222|NCT01553747|10061035|P1|Overall Study|Voluntarily withdrew|70
2921223|NCT01553747|10061033|P3|Overall Study|Protocol Violation|0
2921224|NCT01553747|10061034|P2|Overall Study|Protocol Violation|2
2921225|NCT01553747|10061035|P1|Overall Study|Protocol Violation|0
2921226|NCT01553591|10061097|P3|Overall Study|Randomized and never dispensed drug|0
2921227|NCT01553591|10061098|P2|Overall Study|Randomized and never dispensed drug|1
2921228|NCT01553591|10061099|P1|Overall Study|Randomized and never dispensed drug|0
2921229|NCT01553591|10061097|P3|Overall Study|Sponsor decision|3
2921230|NCT01553591|10061098|P2|Overall Study|Sponsor decision|0
2921231|NCT01553591|10061099|P1|Overall Study|Sponsor decision|1
2921232|NCT01553591|10061097|P3|Overall Study|Protocol Violation|4
2921233|NCT01553591|10061098|P2|Overall Study|Protocol Violation|4
2921234|NCT01553591|10061099|P1|Overall Study|Protocol Violation|3
2921235|NCT01553591|10061097|P3|Overall Study|Physician decision: lack of efficacy|7
2921236|NCT01553591|10061098|P2|Overall Study|Physician decision: lack of efficacy|3
2921237|NCT01553591|10061099|P1|Overall Study|Physician decision: lack of efficacy|2
2921238|NCT01553591|10061097|P3|Overall Study|Physician decision: other|16
2921239|NCT01553591|10061098|P2|Overall Study|Physician decision: other|14
2921240|NCT01553591|10061099|P1|Overall Study|Physician decision: other|11
2921241|NCT01553591|10061097|P3|Overall Study|Lost to Follow-up|16
2921242|NCT01553591|10061098|P2|Overall Study|Lost to Follow-up|23
2921243|NCT01553591|10061099|P1|Overall Study|Lost to Follow-up|25
2921244|NCT01553591|10061097|P3|Overall Study|Adverse Event|16
2921245|NCT01553591|10061098|P2|Overall Study|Adverse Event|45
2921246|NCT01553591|10061099|P1|Overall Study|Adverse Event|36
2921247|NCT01553591|10061097|P3|Overall Study|Voluntarily withdrew|96
2921248|NCT01553591|10061098|P2|Overall Study|Voluntarily withdrew|79
2921249|NCT01553591|10061099|P1|Overall Study|Voluntarily withdrew|94
2921250|NCT01553318|10061159|P2|Overall Study|Protocol Violation|2
2921251|NCT01553318|10061160|P1|Overall Study|Protocol Violation|3
2921252|NCT01553279|10061190|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
2921253|NCT01553279|10061191|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
2921254|NCT01553279|10061190|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
2921255|NCT01553279|10061191|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
2921256|NCT01553279|10061190|P2|Interim Period|Lost to Follow-up|0
2921257|NCT01553279|10061191|P1|Interim Period|Lost to Follow-up|1
2921258|NCT01553279|10061190|P2|Interim Period|Withdrawal by Subject|2
2921259|NCT01553279|10061191|P1|Interim Period|Withdrawal by Subject|2
2921260|NCT01553279|10061190|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2921261|NCT01553279|10061191|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2921262|NCT01553279|10061190|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
2921263|NCT01553279|10061191|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
2921264|NCT01553188|10061257|P4|Overall Study|Intercurrent illness and adverse event|0
2921265|NCT01553188|10061258|P3|Overall Study|Intercurrent illness and adverse event|2
2921266|NCT01553188|10061259|P2|Overall Study|Intercurrent illness and adverse event|1
2921267|NCT01553188|10061260|P1|Overall Study|Intercurrent illness and adverse event|0
2921268|NCT01553188|10061257|P4|Overall Study|Patient choice|0
2921269|NCT01553188|10061258|P3|Overall Study|Patient choice|0
2921270|NCT01553188|10061259|P2|Overall Study|Patient choice|0
2921271|NCT01553188|10061260|P1|Overall Study|Patient choice|1
2921272|NCT01553136|10061287|P2|Overall Study|Scheduling Difficulties|4
2921273|NCT01553136|10061288|P1|Overall Study|Scheduling Difficulties|5
2921274|NCT01553136|10061287|P2|Overall Study|Physician Decision|3
2921275|NCT01553136|10061288|P1|Overall Study|Physician Decision|2
2921276|NCT01553136|10061287|P2|Overall Study|Lost to Follow-up|10
2921277|NCT01553136|10061288|P1|Overall Study|Lost to Follow-up|4
2921278|NCT01553136|10061287|P2|Overall Study|Withdrawal by Subject|3
2921279|NCT01553136|10061288|P1|Overall Study|Withdrawal by Subject|2
2921280|NCT01553136|10061287|P2|Overall Study|Adverse Event|2
2921281|NCT01553136|10061288|P1|Overall Study|Adverse Event|3
2921282|NCT01553084|10061305|P3|Overall Study|Withdrawal by Subject|35
2921283|NCT01553084|10061306|P2|Overall Study|Withdrawal by Subject|13
2921284|NCT01553084|10061307|P1|Overall Study|Withdrawal by Subject|15
2921285|NCT01552954|10061389|P2|Overall Study|diagnosed DM|0
2921286|NCT01552954|10061390|P1|Overall Study|diagnosed DM|1
2921287|NCT01552954|10061389|P2|Overall Study|Protocol Violation|2
2921288|NCT01552954|10061390|P1|Overall Study|Protocol Violation|1
2921289|NCT01552954|10061389|P2|Overall Study|Withdrawal by Subject|1
2921290|NCT01552954|10061390|P1|Overall Study|Withdrawal by Subject|1
2921291|NCT01552954|10061389|P2|Overall Study|Lost to Follow-up|1
2921292|NCT01552954|10061390|P1|Overall Study|Lost to Follow-up|1
2921293|NCT01552954|10061389|P2|Overall Study|Adverse Event|2
2921294|NCT01552954|10061390|P1|Overall Study|Adverse Event|1
2921295|NCT01552928|10061406|P4|Period 3|Adverse Event|0
2921296|NCT01552928|10061407|P3|Period 3|Adverse Event|1
2921297|NCT01552928|10061408|P2|Period 3|Adverse Event|0
2921298|NCT01552928|10061409|P1|Period 3|Adverse Event|0
2921299|NCT01552915|10061456|P3|Overall Study|Other|6
2921300|NCT01552915|10061457|P2|Overall Study|Other|0
2921301|NCT01552915|10061458|P1|Overall Study|Other|2
2921302|NCT01552915|10061456|P3|Overall Study|Lack of Efficacy|4
2921303|NCT01552915|10061457|P2|Overall Study|Lack of Efficacy|1
2921304|NCT01552915|10061458|P1|Overall Study|Lack of Efficacy|8
2921305|NCT01552915|10061456|P3|Overall Study|Protocol Violation|4
2921306|NCT01552915|10061457|P2|Overall Study|Protocol Violation|4
2921307|NCT01552915|10061458|P1|Overall Study|Protocol Violation|0
2921308|NCT01552915|10061456|P3|Overall Study|Withdrawal by Subject|5
2921309|NCT01552915|10061457|P2|Overall Study|Withdrawal by Subject|4
2921310|NCT01552915|10061458|P1|Overall Study|Withdrawal by Subject|6
2921311|NCT01552915|10061456|P3|Overall Study|Lost to Follow-up|5
2921312|NCT01552915|10061457|P2|Overall Study|Lost to Follow-up|6
2921313|NCT01552915|10061458|P1|Overall Study|Lost to Follow-up|4
2921314|NCT01552915|10061456|P3|Overall Study|Adverse Event|3
2921315|NCT01552915|10061457|P2|Overall Study|Adverse Event|14
2921316|NCT01552915|10061458|P1|Overall Study|Adverse Event|3
2921317|NCT01552902|10061481|P3|Overall Study|Other|3
2921318|NCT01552902|10061482|P2|Overall Study|Other|4
2921319|NCT01552902|10061483|P1|Overall Study|Other|3
2921320|NCT01552902|10061481|P3|Overall Study|Lost to Follow-up|6
2921321|NCT01552902|10061482|P2|Overall Study|Lost to Follow-up|3
2921322|NCT01552902|10061483|P1|Overall Study|Lost to Follow-up|1
2921323|NCT01552902|10061481|P3|Overall Study|Withdrawal by Subject|6
2921324|NCT01552902|10061482|P2|Overall Study|Withdrawal by Subject|9
2921325|NCT01552902|10061483|P1|Overall Study|Withdrawal by Subject|1
2921326|NCT01552902|10061481|P3|Overall Study|Lack of Efficacy|1
2921327|NCT01552902|10061482|P2|Overall Study|Lack of Efficacy|3
2921328|NCT01552902|10061483|P1|Overall Study|Lack of Efficacy|4
2921329|NCT01552902|10061481|P3|Overall Study|Protocol Violation|3
2921330|NCT01552902|10061482|P2|Overall Study|Protocol Violation|3
2921331|NCT01552902|10061483|P1|Overall Study|Protocol Violation|3
2921332|NCT01552902|10061481|P3|Overall Study|Adverse Event|14
2921333|NCT01552902|10061482|P2|Overall Study|Adverse Event|15
2921334|NCT01552902|10061483|P1|Overall Study|Adverse Event|1
2921335|NCT01552772|10061533|P1|Overall Study|Protocol Deviation|1
2921336|NCT01552772|10061533|P1|Overall Study|Adverse Event|1
2921337|NCT01552772|10061533|P1|Overall Study|Lost to Follow-up|2
2921338|NCT01552694|10061549|P2|Overall Study|Protocol Violation|1
2921339|NCT01552694|10061550|P1|Overall Study|Protocol Violation|0
2921340|NCT01552694|10061549|P2|Overall Study|Lost to Follow-up|1
2921341|NCT01552694|10061550|P1|Overall Study|Lost to Follow-up|0
2921342|NCT01552681|10061566|P2|Overall Study|Subject moved away|1
2921343|NCT01552681|10061567|P1|Overall Study|Subject moved away|0
2921344|NCT01552681|10061566|P2|Overall Study|Physician Decision|0
2921345|NCT01552681|10061567|P1|Overall Study|Physician Decision|1
2921346|NCT01552681|10061566|P2|Overall Study|Withdrawal by Subject|0
2921347|NCT01552681|10061567|P1|Overall Study|Withdrawal by Subject|4
2921348|NCT01552603|10061615|P1|Overall Study|Physician Decision|1
2921349|NCT01552408|10061622|P2|Overall Study|Withdrawal by Subject|1
2921350|NCT01552408|10061623|P1|Overall Study|Withdrawal by Subject|2
2921351|NCT01552408|10061622|P2|Overall Study|Relocation|1
2921352|NCT01552408|10061623|P1|Overall Study|Relocation|0
2921353|NCT01552408|10061622|P2|Overall Study|Lost to Follow-up|0
2921354|NCT01552408|10061623|P1|Overall Study|Lost to Follow-up|2
2921355|NCT01552369|10061645|P2|Overall Study|Did not consent to extended follow up|9
2921356|NCT01552369|10061646|P1|Overall Study|Did not consent to extended follow up|8
2921357|NCT01552057|10061735|P2|Overall Study|Physician Decision|0
2921358|NCT01552057|10061736|P1|Overall Study|Physician Decision|1
2921359|NCT01552057|10061735|P2|Overall Study|Entry Criteria Not Met|2
2921360|NCT01552057|10061736|P1|Overall Study|Entry Criteria Not Met|2
2921361|NCT01552057|10061735|P2|Overall Study|Withdrawal by Subject|8
2921362|NCT01552057|10061736|P1|Overall Study|Withdrawal by Subject|5
2921363|NCT01552057|10061735|P2|Overall Study|Lack of Efficacy|23
2921364|NCT01552057|10061736|P1|Overall Study|Lack of Efficacy|8
2921365|NCT01552057|10061735|P2|Overall Study|Adverse Event|15
2921366|NCT01552057|10061736|P1|Overall Study|Adverse Event|14
2921367|NCT01551758|10061802|P2|Overall Study|Withdrawal by Subject|17
2921368|NCT01551758|10061803|P1|Overall Study|Withdrawal by Subject|14
2921369|NCT01551758|10061802|P2|Overall Study|Physician Decision|3
2921370|NCT01551758|10061803|P1|Overall Study|Physician Decision|9
2921371|NCT01551758|10061802|P2|Overall Study|Lost to Follow-up|25
2921372|NCT01551758|10061803|P1|Overall Study|Lost to Follow-up|29
2921373|NCT01551758|10061802|P2|Overall Study|Met Protocol-defined stopping criteria|10
2921374|NCT01551758|10061803|P1|Overall Study|Met Protocol-defined stopping criteria|8
2921375|NCT01551758|10061802|P2|Overall Study|Protocol Violation|6
2921376|NCT01551758|10061803|P1|Overall Study|Protocol Violation|5
2921377|NCT01551758|10061802|P2|Overall Study|Lack of Efficacy|1
2921378|NCT01551758|10061803|P1|Overall Study|Lack of Efficacy|0
2921379|NCT01551758|10061802|P2|Overall Study|Adverse Event|43
2921380|NCT01551758|10061803|P1|Overall Study|Adverse Event|29
2921381|NCT01551745|10061841|P1|Overall Study|Disease Progression|2
2921382|NCT01551745|10061841|P1|Overall Study|Withdrawal by Subject|1
2921383|NCT01551693|10061850|P2|Overall Study|Withdrawal by Subject|1
2921384|NCT01551693|10061851|P1|Overall Study|Withdrawal by Subject|0
2921385|NCT01551693|10061850|P2|Overall Study|Adverse Event|1
2921386|NCT01551693|10061851|P1|Overall Study|Adverse Event|0
2921387|NCT01551693|10061850|P2|Overall Study|Disease Progression|0
2921388|NCT01551693|10061851|P1|Overall Study|Disease Progression|1
2921389|NCT01551420|10061872|P2|Home Use (Part B)|Withdrawal by staff|1
2921390|NCT01551420|10061873|P1|Home Use (Part B)|Withdrawal by staff|0
2921391|NCT01551420|10061872|P2|Home Use (Part B)|Withdrawal by Subject|0
2921392|NCT01551420|10061873|P1|Home Use (Part B)|Withdrawal by Subject|6
2921393|NCT01551420|10061872|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
2921394|NCT01551420|10061873|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
2921395|NCT01551420|10061872|P2|Screened for Part B Eligibility|Declined participation|1
2921396|NCT01551420|10061873|P1|Screened for Part B Eligibility|Declined participation|8
2921397|NCT01551420|10061872|P2|In-laboratory (Part A)|Scheduling conflict|1
2921398|NCT01551420|10061873|P1|In-laboratory (Part A)|Scheduling conflict|2
2921399|NCT01551420|10061872|P2|In-laboratory (Part A)|Withdrawal by Subject|0
2921400|NCT01551420|10061873|P1|In-laboratory (Part A)|Withdrawal by Subject|2
2921401|NCT01551420|10061872|P2|In-laboratory (Part A)|Lost to Follow-up|1
2921402|NCT01551420|10061873|P1|In-laboratory (Part A)|Lost to Follow-up|2
2921403|NCT01551355|10061903|P6|Overall Study|Lost to Follow-up|6
2921404|NCT01551355|10061904|P5|Overall Study|Lost to Follow-up|9
2921405|NCT01551355|10061905|P4|Overall Study|Lost to Follow-up|24
2921406|NCT01551355|10061906|P3|Overall Study|Lost to Follow-up|34
2921407|NCT01551355|10061907|P2|Overall Study|Lost to Follow-up|49
2921408|NCT01551355|10061908|P1|Overall Study|Lost to Follow-up|51
2921409|NCT01551303|10061922|P2|Overall Study|failed awareness check on vision test|7
2921410|NCT01551303|10061923|P1|Overall Study|failed awareness check on vision test|4
2921411|NCT01551212|10061931|P2|Overall Study|Never Received Study Treatment|4
2921412|NCT01551212|10061932|P1|Overall Study|Never Received Study Treatment|2
2921413|NCT01551212|10061931|P2|Overall Study|Death|4
2921414|NCT01551212|10061932|P1|Overall Study|Death|2
2921415|NCT01551212|10061931|P2|Overall Study|Withdrawal by Subject|7
2921416|NCT01551212|10061932|P1|Overall Study|Withdrawal by Subject|0
2921417|NCT01551212|10061931|P2|Overall Study|Protocol Violation|1
2921418|NCT01551212|10061932|P1|Overall Study|Protocol Violation|0
2921419|NCT01551212|10061931|P2|Overall Study|Lost to Follow-up|1
2921420|NCT01551212|10061932|P1|Overall Study|Lost to Follow-up|0
2921421|NCT01551212|10061931|P2|Overall Study|Administrative problems|2
2921422|NCT01551212|10061932|P1|Overall Study|Administrative problems|1
2921423|NCT01551212|10061931|P2|Overall Study|Graft loss/Retransplantation|1
2921424|NCT01551212|10061932|P1|Overall Study|Graft loss/Retransplantation|0
2921425|NCT01551173|10061967|P2|Overall Study|Other|3
2921426|NCT01551173|10061968|P1|Overall Study|Other|5
2921427|NCT01551173|10061967|P2|Overall Study|Lost to Follow-up|7
2921428|NCT01551173|10061968|P1|Overall Study|Lost to Follow-up|5
2921429|NCT01551173|10061967|P2|Overall Study|Adverse Event|6
2921430|NCT01551173|10061968|P1|Overall Study|Adverse Event|7
2921431|NCT01551173|10061967|P2|Overall Study|Withdrawal by Subject|16
2921432|NCT01551173|10061968|P1|Overall Study|Withdrawal by Subject|11
2921433|NCT01550965|10062045|P1|Overall Study|Other|13
2921434|NCT01550965|10062045|P1|Overall Study|Lack of Efficacy|59
2921435|NCT01550965|10062045|P1|Overall Study|Lost to Follow-up|2
2921436|NCT01550965|10062045|P1|Overall Study|Withdrawal by Subject|10
2921437|NCT01550965|10062045|P1|Overall Study|Adverse Event|26
2921438|NCT01550757|10062089|P4|Overall Study|Withdrawal by Subject|1
2921439|NCT01550757|10062090|P3|Overall Study|Withdrawal by Subject|3
2921440|NCT01550757|10062091|P2|Overall Study|Withdrawal by Subject|0
2921441|NCT01550757|10062092|P1|Overall Study|Withdrawal by Subject|2
2921442|NCT01550757|10062089|P4|Overall Study|Lost to Follow-up|53
2921443|NCT01550757|10062090|P3|Overall Study|Lost to Follow-up|42
2921444|NCT01550757|10062091|P2|Overall Study|Lost to Follow-up|14
2921445|NCT01550757|10062092|P1|Overall Study|Lost to Follow-up|21
2921446|NCT01550744|10062102|P3|Double-Blind|Other|10
2921447|NCT01550744|10062103|P2|Double-Blind|Other|2
2921448|NCT01550744|10062104|P1|Double-Blind|Other|0
2921449|NCT01550744|10062102|P3|Double-Blind|Pregnancy|3
2921450|NCT01550744|10062103|P2|Double-Blind|Pregnancy|0
2921451|NCT01550744|10062104|P1|Double-Blind|Pregnancy|0
2921452|NCT01550744|10062102|P3|Double-Blind|Protocol Violation|4
2921453|NCT01550744|10062103|P2|Double-Blind|Protocol Violation|0
2921454|NCT01550744|10062104|P1|Double-Blind|Protocol Violation|0
2921455|NCT01550744|10062102|P3|Double-Blind|Lack of Efficacy|8
2921456|NCT01550744|10062103|P2|Double-Blind|Lack of Efficacy|2
2921457|NCT01550744|10062104|P1|Double-Blind|Lack of Efficacy|0
2921458|NCT01550744|10062102|P3|Double-Blind|Death|0
2921459|NCT01550744|10062103|P2|Double-Blind|Death|1
2921460|NCT01550744|10062104|P1|Double-Blind|Death|0
2921461|NCT01550744|10062102|P3|Double-Blind|Adverse Event|15
2921462|NCT01550744|10062103|P2|Double-Blind|Adverse Event|4
2921463|NCT01550744|10062104|P1|Double-Blind|Adverse Event|0
2921464|NCT01550744|10062102|P3|Double-Blind|Withdrawal by Subject|15
2921465|NCT01550744|10062103|P2|Double-Blind|Withdrawal by Subject|2
2921466|NCT01550744|10062104|P1|Double-Blind|Withdrawal by Subject|0
2921467|NCT01550744|10062102|P3|Double-Blind|Lost to Follow-up|12
2921468|NCT01550744|10062103|P2|Double-Blind|Lost to Follow-up|6
2921469|NCT01550744|10062104|P1|Double-Blind|Lost to Follow-up|0
2921470|NCT01550744|10062102|P3|Open-Label|Other|0
2921471|NCT01550744|10062103|P2|Open-Label|Other|0
2921472|NCT01550744|10062104|P1|Open-Label|Other|1
2921473|NCT01550744|10062102|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
2921474|NCT01550744|10062103|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
2921475|NCT01550744|10062104|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
2921476|NCT01550744|10062102|P3|Open-Label|Not all 3 study drug injections received|0
2921477|NCT01550744|10062103|P2|Open-Label|Not all 3 study drug injections received|0
2921478|NCT01550744|10062104|P1|Open-Label|Not all 3 study drug injections received|2
2921479|NCT01550744|10062102|P3|Open-Label|Protocol Violation|0
2921480|NCT01550744|10062103|P2|Open-Label|Protocol Violation|0
2921481|NCT01550744|10062104|P1|Open-Label|Protocol Violation|4
2921482|NCT01550744|10062102|P3|Open-Label|Lack of Efficacy|0
2921483|NCT01550744|10062103|P2|Open-Label|Lack of Efficacy|0
2921484|NCT01550744|10062104|P1|Open-Label|Lack of Efficacy|4
2921485|NCT01550744|10062102|P3|Open-Label|Adverse Event|0
2921486|NCT01550744|10062103|P2|Open-Label|Adverse Event|0
2921487|NCT01550744|10062104|P1|Open-Label|Adverse Event|11
2921488|NCT01550744|10062102|P3|Open-Label|Withdrawal by Subject|0
2921489|NCT01550744|10062103|P2|Open-Label|Withdrawal by Subject|0
2921490|NCT01550744|10062104|P1|Open-Label|Withdrawal by Subject|13
2921491|NCT01550744|10062102|P3|Open-Label|Lost to Follow-up|0
2921492|NCT01550744|10062103|P2|Open-Label|Lost to Follow-up|0
2921493|NCT01550744|10062104|P1|Open-Label|Lost to Follow-up|7
2921494|NCT01550289|10062239|P2|Overall Study|Withdrawal by Subject|3
2921495|NCT01550289|10062240|P1|Overall Study|Withdrawal by Subject|11
2921496|NCT01550289|10062239|P2|Overall Study|Lost to Follow-up|1
2921497|NCT01550289|10062240|P1|Overall Study|Lost to Follow-up|1
2921498|NCT01550289|10062239|P2|Overall Study|Protocol Violation|0
2921499|NCT01550289|10062240|P1|Overall Study|Protocol Violation|1
2921500|NCT01549964|10062316|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
2921501|NCT01549964|10062317|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
2921502|NCT01549964|10062318|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2921503|NCT01549964|10062319|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2921504|NCT01549964|10062316|P4|80-Week Extension Period|Lost to Follow-up|1
2921505|NCT01549964|10062317|P3|80-Week Extension Period|Lost to Follow-up|2
2921506|NCT01549964|10062318|P2|80-Week Extension Period|Lost to Follow-up|0
2921507|NCT01549964|10062319|P1|80-Week Extension Period|Lost to Follow-up|1
2921508|NCT01549964|10062316|P4|80-Week Extension Period|Voluntary Withdrawal|2
2921509|NCT01549964|10062317|P3|80-Week Extension Period|Voluntary Withdrawal|4
2921510|NCT01549964|10062318|P2|80-Week Extension Period|Voluntary Withdrawal|1
2921511|NCT01549964|10062319|P1|80-Week Extension Period|Voluntary Withdrawal|0
2921512|NCT01549964|10062316|P4|80-Week Extension Period|Study Terminated by Sponsor|132
2921513|NCT01549964|10062317|P3|80-Week Extension Period|Study Terminated by Sponsor|132
2921514|NCT01549964|10062318|P2|80-Week Extension Period|Study Terminated by Sponsor|137
2921515|NCT01549964|10062319|P1|80-Week Extension Period|Study Terminated by Sponsor|65
2921516|NCT01549964|10062316|P4|80-Week Extension Period|Pregnancy|0
2921517|NCT01549964|10062317|P3|80-Week Extension Period|Pregnancy|1
2921518|NCT01549964|10062318|P2|80-Week Extension Period|Pregnancy|0
2921519|NCT01549964|10062319|P1|80-Week Extension Period|Pregnancy|0
2921520|NCT01549964|10062316|P4|24-Week Treatment Period|Completion Status Unknown|0
2921521|NCT01549964|10062317|P3|24-Week Treatment Period|Completion Status Unknown|1
2921522|NCT01549964|10062318|P2|24-Week Treatment Period|Completion Status Unknown|0
2921523|NCT01549964|10062319|P1|24-Week Treatment Period|Completion Status Unknown|1
2921524|NCT01549964|10062316|P4|24-Week Treatment Period|Randomized but Not Treated|1
2921525|NCT01549964|10062317|P3|24-Week Treatment Period|Randomized but Not Treated|0
2921526|NCT01549964|10062318|P2|24-Week Treatment Period|Randomized but Not Treated|0
2921527|NCT01549964|10062319|P1|24-Week Treatment Period|Randomized but Not Treated|0
2921528|NCT01549964|10062316|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2921529|NCT01549964|10062317|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
2921530|NCT01549964|10062318|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2921531|NCT01549964|10062319|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2921532|NCT01549964|10062316|P4|24-Week Treatment Period|Other|0
2921533|NCT01549964|10062317|P3|24-Week Treatment Period|Other|1
2921534|NCT01549964|10062318|P2|24-Week Treatment Period|Other|0
2921535|NCT01549964|10062319|P1|24-Week Treatment Period|Other|1
2921536|NCT01549964|10062316|P4|24-Week Treatment Period|Lack of Efficacy|1
2921537|NCT01549964|10062317|P3|24-Week Treatment Period|Lack of Efficacy|1
2921538|NCT01549964|10062318|P2|24-Week Treatment Period|Lack of Efficacy|0
2921539|NCT01549964|10062319|P1|24-Week Treatment Period|Lack of Efficacy|1
2921540|NCT01549964|10062316|P4|24-Week Treatment Period|Lost to Follow-up|2
2921541|NCT01549964|10062317|P3|24-Week Treatment Period|Lost to Follow-up|1
2921542|NCT01549964|10062318|P2|24-Week Treatment Period|Lost to Follow-up|0
2921543|NCT01549964|10062319|P1|24-Week Treatment Period|Lost to Follow-up|1
2921544|NCT01549964|10062316|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2921545|NCT01549964|10062317|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2921546|NCT01549964|10062318|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2921547|NCT01549964|10062319|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
2921548|NCT01549964|10062316|P4|24-Week Treatment Period|Voluntary Withdrawal|8
2921549|NCT01549964|10062317|P3|24-Week Treatment Period|Voluntary Withdrawal|3
2921550|NCT01549964|10062318|P2|24-Week Treatment Period|Voluntary Withdrawal|3
2921551|NCT01549964|10062319|P1|24-Week Treatment Period|Voluntary Withdrawal|6
2921552|NCT01549964|10062316|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
2921553|NCT01549964|10062317|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
2921554|NCT01549964|10062318|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
2921555|NCT01549964|10062319|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
2921556|NCT01549951|10062337|P1|Overall Study|Other|2
2921557|NCT01549951|10062337|P1|Overall Study|Symptomatic deterioration|1
2921558|NCT01549951|10062337|P1|Overall Study|Progressive disease|29
2921559|NCT01549951|10062337|P1|Overall Study|Unsatisfactory therapeutic response|1
2921560|NCT01549951|10062337|P1|Overall Study|Withdrawal by Subject|2
2921561|NCT01549951|10062337|P1|Overall Study|Adverse Event|15
2921562|NCT01549873|10062364|P2|Overall Study|Physician Decision|1
2921563|NCT01549873|10062365|P1|Overall Study|Physician Decision|0
2921564|NCT01549860|10062377|P2|Overall Study|Physician Decision|1
2921565|NCT01549860|10062378|P1|Overall Study|Physician Decision|1
2921566|NCT01549860|10062377|P2|Overall Study|Withdrawal by Subject|0
2921567|NCT01549860|10062378|P1|Overall Study|Withdrawal by Subject|1
2921568|NCT01549652|10062391|P4|Overall Study|Withdrawal by Subject|3
2921569|NCT01549652|10062392|P3|Overall Study|Withdrawal by Subject|5
2921570|NCT01549652|10062393|P2|Overall Study|Withdrawal by Subject|0
2921571|NCT01549652|10062394|P1|Overall Study|Withdrawal by Subject|0
2921572|NCT01549652|10062391|P4|Overall Study|Titration Side Effects|3
2921573|NCT01549652|10062392|P3|Overall Study|Titration Side Effects|6
2921574|NCT01549652|10062393|P2|Overall Study|Titration Side Effects|0
2921575|NCT01549652|10062394|P1|Overall Study|Titration Side Effects|0
2921576|NCT01549652|10062391|P4|Overall Study|Titration Non-Compliance|5
2921577|NCT01549652|10062392|P3|Overall Study|Titration Non-Compliance|4
2921578|NCT01549652|10062393|P2|Overall Study|Titration Non-Compliance|3
2921579|NCT01549652|10062394|P1|Overall Study|Titration Non-Compliance|1
2921580|NCT01549652|10062391|P4|Overall Study|Problem with Infusion|0
2921581|NCT01549652|10062392|P3|Overall Study|Problem with Infusion|0
2921582|NCT01549652|10062393|P2|Overall Study|Problem with Infusion|0
2921583|NCT01549652|10062394|P1|Overall Study|Problem with Infusion|1
2921584|NCT01549652|10062391|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
2921585|NCT01549652|10062392|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
2921586|NCT01549652|10062393|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
2921587|NCT01549652|10062394|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
2921588|NCT01549652|10062391|P4|Overall Study|Withdrawal Effect|0
2921589|NCT01549652|10062392|P3|Overall Study|Withdrawal Effect|0
2921590|NCT01549652|10062393|P2|Overall Study|Withdrawal Effect|2
2921591|NCT01549652|10062394|P1|Overall Study|Withdrawal Effect|0
2921592|NCT01549652|10062391|P4|Overall Study|Study Drug Titration Failure|0
2921593|NCT01549652|10062392|P3|Overall Study|Study Drug Titration Failure|0
2921594|NCT01549652|10062393|P2|Overall Study|Study Drug Titration Failure|6
2921595|NCT01549652|10062394|P1|Overall Study|Study Drug Titration Failure|5
2921596|NCT01549652|10062391|P4|Overall Study|Did Not Receive Allocated Intervention|0
2921597|NCT01549652|10062392|P3|Overall Study|Did Not Receive Allocated Intervention|2
2921598|NCT01549652|10062393|P2|Overall Study|Did Not Receive Allocated Intervention|0
2921599|NCT01549652|10062394|P1|Overall Study|Did Not Receive Allocated Intervention|0
2921600|NCT01549613|10062412|P2|Overall Study|Lost to Follow-up|11
2921601|NCT01549613|10062413|P1|Overall Study|Lost to Follow-up|11
2921602|NCT01549392|10062432|P2|Overall Study|Withdrawal by Subject|0
2921603|NCT01549392|10062433|P1|Overall Study|Withdrawal by Subject|1
2921604|NCT01549275|10062471|P2|Overall Study|Lost to Follow-up|0
2921605|NCT01549275|10062472|P1|Overall Study|Lost to Follow-up|1
2921606|NCT01549041|10062495|P2|Overall Study|Adverse Event|4
2921607|NCT01549041|10062496|P1|Overall Study|Adverse Event|0
2921608|NCT01549041|10062495|P2|Overall Study|Lack of Efficacy|4
2921609|NCT01549041|10062496|P1|Overall Study|Lack of Efficacy|2
2921610|NCT01549002|10062506|P2|Overall Study|Moderate sedation required|2
2921611|NCT01549002|10062507|P1|Overall Study|Moderate sedation required|0
2921612|NCT01549002|10062506|P2|Overall Study|Excessive pain|2
2921613|NCT01549002|10062507|P1|Overall Study|Excessive pain|0
2921614|NCT01548638|10062593|P1|Overall Study|Withdrawal by Subject|1
2921615|NCT01548638|10062593|P1|Overall Study|Protocol Violation|3
2921616|NCT01548599|10062605|P2|Overall Study|Death|1
2921617|NCT01548599|10062606|P1|Overall Study|Death|2
2921618|NCT01548599|10062605|P2|Overall Study|Withdrawal by Subject|0
2921619|NCT01548599|10062606|P1|Overall Study|Withdrawal by Subject|4
2921620|NCT01548599|10062605|P2|Overall Study|Lost to Follow-up|1
2921621|NCT01548599|10062606|P1|Overall Study|Lost to Follow-up|0
2921622|NCT01548573|10062622|P1|Overall Study|Withdrawal by Subject|2
2921623|NCT01548573|10062622|P1|Overall Study|Death|3
2921624|NCT01548417|10062631|P2|Overall Study|Withdrawal by Subject|2
2921625|NCT01548417|10062632|P1|Overall Study|Withdrawal by Subject|0
2921626|NCT01548404|10062642|P2|Overall Study|Other than specified above|2
2921627|NCT01548404|10062643|P1|Overall Study|Other than specified above|0
2921628|NCT01548404|10062642|P2|Overall Study|Withdrawal by Subject|3
2921629|NCT01548404|10062643|P1|Overall Study|Withdrawal by Subject|0
2921630|NCT01548404|10062642|P2|Overall Study|Lost to Follow-up|0
2921631|NCT01548404|10062643|P1|Overall Study|Lost to Follow-up|2
2921632|NCT01548404|10062642|P2|Overall Study|Inadequate response to study treatment|7
2921633|NCT01548404|10062643|P1|Overall Study|Inadequate response to study treatment|23
2921634|NCT01548404|10062642|P2|Overall Study|Physician Decision|1
2921635|NCT01548404|10062643|P1|Overall Study|Physician Decision|2
2921636|NCT01548404|10062642|P2|Overall Study|Adverse Event|1
2921637|NCT01548404|10062643|P1|Overall Study|Adverse Event|3
2921638|NCT01548287|10062682|P5|Randomized Period|Adverse Event|0
2921639|NCT01548287|10062683|P4|Randomized Period|Adverse Event|0
2921640|NCT01548287|10062684|P3|Randomized Period|Adverse Event|5
2921641|NCT01548287|10062685|P2|Randomized Period|Adverse Event|2
2921642|NCT01548287|10062686|P1|Randomized Period|Adverse Event|0
2921643|NCT01548287|10062682|P5|Randomized Period|Did not meet inclusion criteria|0
2921644|NCT01548287|10062683|P4|Randomized Period|Did not meet inclusion criteria|0
2921645|NCT01548287|10062684|P3|Randomized Period|Did not meet inclusion criteria|2
2921646|NCT01548287|10062685|P2|Randomized Period|Did not meet inclusion criteria|0
2921647|NCT01548287|10062686|P1|Randomized Period|Did not meet inclusion criteria|0
2921648|NCT01548287|10062682|P5|Screening|Did not meet eligibility criteria|74
2921649|NCT01548287|10062683|P4|Screening|Did not meet eligibility criteria|0
2921650|NCT01548287|10062684|P3|Screening|Did not meet eligibility criteria|0
2921651|NCT01548287|10062685|P2|Screening|Did not meet eligibility criteria|0
2921652|NCT01548287|10062686|P1|Screening|Did not meet eligibility criteria|0
2921653|NCT01548287|10062682|P5|Screening|No reason provided|9
2921654|NCT01548287|10062683|P4|Screening|No reason provided|0
2921655|NCT01548287|10062684|P3|Screening|No reason provided|0
2921656|NCT01548287|10062685|P2|Screening|No reason provided|0
2921657|NCT01548287|10062686|P1|Screening|No reason provided|0
2921658|NCT01547728|10062743|P1|Overall Study|Screen failure|39
2921659|NCT01547728|10062743|P1|Overall Study|Drug not ready for subject|1
2921660|NCT01547728|10062743|P1|Overall Study|Change in procedure and equipment|1
2921661|NCT01547598|10062852|P2|Overall Study|Other Miscellaneous Reasons|1
2921662|NCT01547598|10062853|P1|Overall Study|Other Miscellaneous Reasons|2
2921663|NCT01547598|10062852|P2|Overall Study|Protocol Violation|1
2921664|NCT01547598|10062853|P1|Overall Study|Protocol Violation|1
2921665|NCT01547598|10062852|P2|Overall Study|Adverse Event|1
2921666|NCT01547598|10062853|P1|Overall Study|Adverse Event|1
2921667|NCT01547598|10062852|P2|Overall Study|Lost to Follow-up|1
2921668|NCT01547598|10062853|P1|Overall Study|Lost to Follow-up|1
2921669|NCT01547598|10062852|P2|Overall Study|Withdrew consent|1
2921670|NCT01547598|10062853|P1|Overall Study|Withdrew consent|1
2921671|NCT01547390|10062870|P2|Overall Study|Adverse Event|0
2921672|NCT01547390|10062871|P1|Overall Study|Adverse Event|3
2921673|NCT01547390|10062870|P2|Overall Study|Lost to Follow-up|2
2921674|NCT01547390|10062871|P1|Overall Study|Lost to Follow-up|0
2921675|NCT01547390|10062870|P2|Overall Study|termination of pregnancy|1
2921676|NCT01547390|10062871|P1|Overall Study|termination of pregnancy|0
2921677|NCT01547390|10062870|P2|Overall Study|Withdrawal by Subject|7
2921678|NCT01547390|10062871|P1|Overall Study|Withdrawal by Subject|10
2921679|NCT01547299|10062881|P2|Overall Study|Withdrawal by Subject|2
2921680|NCT01547299|10062882|P1|Overall Study|Withdrawal by Subject|2
2921681|NCT01547286|10062948|P1|Overall Study|Physician Decision|1
2921682|NCT01547286|10062948|P1|Overall Study|Did not meet all eligibility criteria|1
2921683|NCT01547130|10062968|P2|Overall Study|Lost to Follow-up|5
2921684|NCT01547130|10062969|P1|Overall Study|Lost to Follow-up|9
2921685|NCT01546922|10062992|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
2921686|NCT01546922|10062993|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
2921687|NCT01546922|10062992|P2|Second Period of 10 Weeks|Protocol Violation|1
2921688|NCT01546922|10062993|P1|Second Period of 10 Weeks|Protocol Violation|3
2921689|NCT01546922|10062992|P2|First Period of 10 Weeks|Investigator's judgment|0
2921690|NCT01546922|10062993|P1|First Period of 10 Weeks|Investigator's judgment|1
2921691|NCT01546922|10062992|P2|First Period of 10 Weeks|Withdrawal by Subject|1
2921692|NCT01546922|10062993|P1|First Period of 10 Weeks|Withdrawal by Subject|1
2921693|NCT01546922|10062992|P2|First Period of 10 Weeks|Protocol Violation|1
2921694|NCT01546922|10062993|P1|First Period of 10 Weeks|Protocol Violation|3
2921695|NCT01546883|10062999|P1|Overall Study|other unrelated illness|1
2921696|NCT01546883|10062999|P1|Overall Study|early closure of study|2
2921697|NCT01546883|10062999|P1|Overall Study|Lost to Follow-up|2
2921698|NCT01546883|10062999|P1|Overall Study|Adverse Event|4
2921699|NCT01546883|10062999|P1|Overall Study|Withdrawal by Subject|3
2921700|NCT01546688|10063005|P2|Overall Study|Lack of Efficacy|0
2921701|NCT01546688|10063006|P1|Overall Study|Lack of Efficacy|1
2921702|NCT01546688|10063005|P2|Overall Study|Withdrawal by Subject|1
2921703|NCT01546688|10063006|P1|Overall Study|Withdrawal by Subject|2
2921704|NCT01546688|10063005|P2|Overall Study|Adverse Event|4
2921705|NCT01546688|10063006|P1|Overall Study|Adverse Event|0
2921706|NCT01546649|10063038|P2|Overall Study|Withdrawal by Subject|2
2921707|NCT01546649|10063039|P1|Overall Study|Withdrawal by Subject|1
2921708|NCT01546649|10063038|P2|Overall Study|Discovery of secondary cancer|1
2921709|NCT01546649|10063039|P1|Overall Study|Discovery of secondary cancer|0
2921710|NCT01546649|10063038|P2|Overall Study|Recurrence|1
2921711|NCT01546649|10063039|P1|Overall Study|Recurrence|1
2921712|NCT01546649|10063038|P2|Overall Study|Lack of Efficacy|0
2921713|NCT01546649|10063039|P1|Overall Study|Lack of Efficacy|1
2921714|NCT01546649|10063038|P2|Overall Study|Protocol Violation|0
2921715|NCT01546649|10063039|P1|Overall Study|Protocol Violation|1
2921716|NCT01546649|10063038|P2|Overall Study|Adverse Event|5
2921717|NCT01546649|10063039|P1|Overall Study|Adverse Event|4
2921718|NCT01546623|10063074|P2|Overall Study|Did Not Receive Study Drug|1
2921719|NCT01546623|10063075|P1|Overall Study|Did Not Receive Study Drug|1
2921720|NCT01546623|10063074|P2|Overall Study|High Prostate specific antigen|1
2921721|NCT01546623|10063075|P1|Overall Study|High Prostate specific antigen|2
2921722|NCT01546623|10063074|P2|Overall Study|Major Protocol Deviation|1
2921723|NCT01546623|10063075|P1|Overall Study|Major Protocol Deviation|1
2921724|NCT01546623|10063074|P2|Overall Study|Adverse Event|3
2921725|NCT01546623|10063075|P1|Overall Study|Adverse Event|2
2921726|NCT01546519|10063105|P4|Overall Study|Withdrawal by Subject|0
2921727|NCT01546519|10063106|P3|Overall Study|Withdrawal by Subject|0
2921728|NCT01546519|10063107|P2|Overall Study|Withdrawal by Subject|0
2921729|NCT01546519|10063108|P1|Overall Study|Withdrawal by Subject|1
2921730|NCT01546519|10063105|P4|Overall Study|Physician Decision|3
2921731|NCT01546519|10063106|P3|Overall Study|Physician Decision|2
2921732|NCT01546519|10063107|P2|Overall Study|Physician Decision|5
2921733|NCT01546519|10063108|P1|Overall Study|Physician Decision|6
2921734|NCT01546519|10063105|P4|Overall Study|related to disease progression|1
2921735|NCT01546519|10063106|P3|Overall Study|related to disease progression|2
2921736|NCT01546519|10063107|P2|Overall Study|related to disease progression|2
2921737|NCT01546519|10063108|P1|Overall Study|related to disease progression|2
2921738|NCT01546519|10063105|P4|Overall Study|Death|1
2921739|NCT01546519|10063106|P3|Overall Study|Death|3
2921740|NCT01546519|10063107|P2|Overall Study|Death|1
2921741|NCT01546519|10063108|P1|Overall Study|Death|0
2921742|NCT01546519|10063105|P4|Overall Study|Adverse Event|1
2921743|NCT01546519|10063106|P3|Overall Study|Adverse Event|1
2921744|NCT01546519|10063107|P2|Overall Study|Adverse Event|0
2921745|NCT01546519|10063108|P1|Overall Study|Adverse Event|0
2921746|NCT01546207|10063173|P1|Overall Study|Death|1
2921747|NCT01546168|10063188|P2|Overall Study|ineligible after signing consent|0
2921748|NCT01546168|10063189|P1|Overall Study|ineligible after signing consent|2
2921749|NCT01546168|10063188|P2|Overall Study|Withdrawal by Subject|0
2921750|NCT01546168|10063189|P1|Overall Study|Withdrawal by Subject|1
2921751|NCT01546168|10063188|P2|Overall Study|Lost to Follow-up|0
2921752|NCT01546168|10063189|P1|Overall Study|Lost to Follow-up|1
2921753|NCT01546155|10063201|P1|Overall Study|could not tolerate long scan duration|3
2921754|NCT01546142|10063207|P2|Overall Study|Subject Randomized but Not Treated|0
2921755|NCT01546142|10063208|P1|Overall Study|Subject Randomized but Not Treated|1
2921756|NCT01546142|10063207|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
2921757|NCT01546142|10063208|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
2921758|NCT01546142|10063207|P2|Overall Study|Lost to Follow-up|15
2921759|NCT01546142|10063208|P1|Overall Study|Lost to Follow-up|20
2921760|NCT01546142|10063207|P2|Overall Study|Adverse Event|3
2921761|NCT01546142|10063208|P1|Overall Study|Adverse Event|6
2921762|NCT01546142|10063207|P2|Overall Study|Subject Noncompliance|1
2921763|NCT01546142|10063208|P1|Overall Study|Subject Noncompliance|1
2921764|NCT01546142|10063207|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
2921765|NCT01546142|10063208|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
2921766|NCT01546038|10063226|P9|Overall Study|: Randomized, not treated|3
2921767|NCT01546038|10063227|P8|Overall Study|: Randomized, not treated|4
2921768|NCT01546038|10063228|P7|Overall Study|: Randomized, not treated|2
2921769|NCT01546038|10063229|P6|Overall Study|: Randomized, not treated|0
2921770|NCT01546038|10063230|P5|Overall Study|: Randomized, not treated|0
2921771|NCT01546038|10063231|P4|Overall Study|: Randomized, not treated|0
2921772|NCT01546038|10063232|P3|Overall Study|: Randomized, not treated|0
2921773|NCT01546038|10063233|P2|Overall Study|: Randomized, not treated|0
2921774|NCT01546038|10063234|P1|Overall Study|: Randomized, not treated|0
2921775|NCT01546038|10063226|P9|Overall Study|Withdrawal by Subject|1
2921776|NCT01546038|10063227|P8|Overall Study|Withdrawal by Subject|3
2921777|NCT01546038|10063228|P7|Overall Study|Withdrawal by Subject|3
2921778|NCT01546038|10063229|P6|Overall Study|Withdrawal by Subject|1
2921779|NCT01546038|10063230|P5|Overall Study|Withdrawal by Subject|0
2921780|NCT01546038|10063231|P4|Overall Study|Withdrawal by Subject|1
2921781|NCT01546038|10063232|P3|Overall Study|Withdrawal by Subject|0
2921782|NCT01546038|10063233|P2|Overall Study|Withdrawal by Subject|0
2921783|NCT01546038|10063234|P1|Overall Study|Withdrawal by Subject|1
2921784|NCT01546038|10063226|P9|Overall Study|Lost to Follow-up|0
2921785|NCT01546038|10063227|P8|Overall Study|Lost to Follow-up|1
2921786|NCT01546038|10063228|P7|Overall Study|Lost to Follow-up|2
2921787|NCT01546038|10063229|P6|Overall Study|Lost to Follow-up|0
2921788|NCT01546038|10063230|P5|Overall Study|Lost to Follow-up|1
2921789|NCT01546038|10063231|P4|Overall Study|Lost to Follow-up|0
2921790|NCT01546038|10063232|P3|Overall Study|Lost to Follow-up|0
2921791|NCT01546038|10063233|P2|Overall Study|Lost to Follow-up|0
2921792|NCT01546038|10063234|P1|Overall Study|Lost to Follow-up|0
2921793|NCT01546038|10063226|P9|Overall Study|Death|39
2921794|NCT01546038|10063227|P8|Overall Study|Death|76
2921795|NCT01546038|10063228|P7|Overall Study|Death|46
2921796|NCT01546038|10063229|P6|Overall Study|Death|3
2921797|NCT01546038|10063230|P5|Overall Study|Death|9
2921798|NCT01546038|10063231|P4|Overall Study|Death|2
2921799|NCT01546038|10063232|P3|Overall Study|Death|4
2921800|NCT01546038|10063233|P2|Overall Study|Death|6
2921801|NCT01546038|10063234|P1|Overall Study|Death|15
2921802|NCT01545817|10063428|P2|Everolimus|Adverse Event|6
2921803|NCT01545817|10063429|P1|Everolimus|Adverse Event|0
2921804|NCT01545817|10063428|P2|Everolimus|Disease progression|25
2921805|NCT01545817|10063429|P1|Everolimus|Disease progression|0
2921806|NCT01545817|10063428|P2|Everolimus|Other reason|7
2921807|NCT01545817|10063429|P1|Everolimus|Other reason|0
2921808|NCT01545817|10063428|P2|Pazopanib|Other reason|0
2921809|NCT01545817|10063429|P1|Pazopanib|Other reason|4
2921810|NCT01545817|10063428|P2|Pazopanib|Adverse Event|0
2921811|NCT01545817|10063429|P1|Pazopanib|Adverse Event|19
2921812|NCT01545817|10063428|P2|Pazopanib|Disease progression|0
2921813|NCT01545817|10063429|P1|Pazopanib|Disease progression|51
2921814|NCT01545388|10063578|P3|Overall Study|Other|0
2921815|NCT01545388|10063579|P2|Overall Study|Other|1
2921816|NCT01545388|10063580|P1|Overall Study|Other|1
2921817|NCT01545388|10063578|P3|Overall Study|Withdrawal by Subject|2
2921818|NCT01545388|10063579|P2|Overall Study|Withdrawal by Subject|4
2921819|NCT01545388|10063580|P1|Overall Study|Withdrawal by Subject|1
2921820|NCT01545388|10063578|P3|Overall Study|Participant moved or relocated|0
2921821|NCT01545388|10063579|P2|Overall Study|Participant moved or relocated|0
2921822|NCT01545388|10063580|P1|Overall Study|Participant moved or relocated|1
2921823|NCT01545388|10063578|P3|Overall Study|Lack of Efficacy|5
2921824|NCT01545388|10063579|P2|Overall Study|Lack of Efficacy|2
2921825|NCT01545388|10063580|P1|Overall Study|Lack of Efficacy|3
2921826|NCT01545388|10063578|P3|Overall Study|Adverse Event|1
2921827|NCT01545388|10063579|P2|Overall Study|Adverse Event|4
2921828|NCT01545388|10063580|P1|Overall Study|Adverse Event|2
2921829|NCT01545375|10063599|P2|Overall Study|Withdrawal by Subject|55
2921830|NCT01545375|10063600|P1|Overall Study|Withdrawal by Subject|58
2921831|NCT01545375|10063599|P2|Overall Study|Protocol Violation|3
2921832|NCT01545375|10063600|P1|Overall Study|Protocol Violation|3
2921833|NCT01545375|10063599|P2|Overall Study|Lost to Follow-up|31
2921834|NCT01545375|10063600|P1|Overall Study|Lost to Follow-up|34
2921835|NCT01545375|10063599|P2|Overall Study|Adverse Event|1
2921836|NCT01545375|10063600|P1|Overall Study|Adverse Event|2
2921837|NCT01545076|10063715|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2921838|NCT01545076|10063716|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
2921839|NCT01545076|10063717|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
2921840|NCT01545076|10063718|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
2921841|NCT01545076|10063719|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2921842|NCT01545076|10063715|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2921843|NCT01545076|10063716|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2921844|NCT01545076|10063717|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2921845|NCT01545076|10063718|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2921846|NCT01545076|10063719|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2921847|NCT01545076|10063715|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2921848|NCT01545076|10063716|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
2921849|NCT01545076|10063717|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
2921850|NCT01545076|10063718|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
2921851|NCT01545076|10063719|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2921852|NCT01545076|10063715|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2921853|NCT01545076|10063716|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
2921854|NCT01545076|10063717|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2921855|NCT01545076|10063718|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2921856|NCT01545076|10063719|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2921857|NCT01545076|10063715|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
2921858|NCT01545076|10063716|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
2921859|NCT01545076|10063717|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
2921860|NCT01545076|10063718|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
2921861|NCT01545076|10063719|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
2921862|NCT01545076|10063715|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2921863|NCT01545076|10063716|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2921864|NCT01545076|10063717|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2921865|NCT01545076|10063718|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2921866|NCT01545076|10063719|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
2921867|NCT01545076|10063715|P5|IgPro10 Restabilization Period|Protocol Violation|0
2921868|NCT01545076|10063716|P4|IgPro10 Restabilization Period|Protocol Violation|0
2921869|NCT01545076|10063717|P3|IgPro10 Restabilization Period|Protocol Violation|0
2921870|NCT01545076|10063718|P2|IgPro10 Restabilization Period|Protocol Violation|0
2921871|NCT01545076|10063719|P1|IgPro10 Restabilization Period|Protocol Violation|1
2921872|NCT01545076|10063715|P5|IgPro10 Restabilization Period|Physician Decision|0
2921873|NCT01545076|10063716|P4|IgPro10 Restabilization Period|Physician Decision|0
2921874|NCT01545076|10063717|P3|IgPro10 Restabilization Period|Physician Decision|0
2921875|NCT01545076|10063718|P2|IgPro10 Restabilization Period|Physician Decision|0
2921876|NCT01545076|10063719|P1|IgPro10 Restabilization Period|Physician Decision|2
2921877|NCT01545076|10063715|P5|IgPro10 Restabilization Period|Adverse Event|0
2921878|NCT01545076|10063716|P4|IgPro10 Restabilization Period|Adverse Event|0
2921879|NCT01545076|10063717|P3|IgPro10 Restabilization Period|Adverse Event|0
2921880|NCT01545076|10063718|P2|IgPro10 Restabilization Period|Adverse Event|0
2921881|NCT01545076|10063719|P1|IgPro10 Restabilization Period|Adverse Event|4
2921882|NCT01544920|10063790|P2|Overall Study|Withdrawal by Subject|4
2921883|NCT01544920|10063791|P1|Overall Study|Withdrawal by Subject|4
2921884|NCT01544920|10063790|P2|Overall Study|Physician Decision|1
2921885|NCT01544920|10063791|P1|Overall Study|Physician Decision|4
2921886|NCT01544920|10063790|P2|Overall Study|Protocol Violation|2
2921887|NCT01544920|10063791|P1|Overall Study|Protocol Violation|0
2921888|NCT01544920|10063790|P2|Overall Study|Lost to Follow-up|12
2921889|NCT01544920|10063791|P1|Overall Study|Lost to Follow-up|11
2921890|NCT01544920|10063790|P2|Overall Study|Death|1
2921891|NCT01544920|10063791|P1|Overall Study|Death|0
2921892|NCT01544920|10063790|P2|Overall Study|Adverse Event|3
2921893|NCT01544920|10063791|P1|Overall Study|Adverse Event|0
2921894|NCT01544595|10063805|P6|Status at Week 156|Lack of Efficacy|5
2921895|NCT01544595|10063806|P5|Status at Week 156|Lack of Efficacy|10
2921896|NCT01544595|10063807|P4|Status at Week 156|Lack of Efficacy|4
2921897|NCT01544595|10063808|P3|Status at Week 156|Lack of Efficacy|1
2921898|NCT01544595|10063809|P2|Status at Week 156|Lack of Efficacy|0
2921899|NCT01544595|10063810|P1|Status at Week 156|Lack of Efficacy|1
2921900|NCT01544595|10063805|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
2921901|NCT01544595|10063806|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
2921902|NCT01544595|10063807|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
2921903|NCT01544595|10063808|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
2921904|NCT01544595|10063809|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
2921905|NCT01544595|10063810|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
2921906|NCT01544595|10063805|P6|Status at Week 156|Technical problems|0
2921907|NCT01544595|10063806|P5|Status at Week 156|Technical problems|0
2921908|NCT01544595|10063807|P4|Status at Week 156|Technical problems|1
2921909|NCT01544595|10063808|P3|Status at Week 156|Technical problems|0
2921910|NCT01544595|10063809|P2|Status at Week 156|Technical problems|1
2921911|NCT01544595|10063810|P1|Status at Week 156|Technical problems|3
2921912|NCT01544595|10063805|P6|Status at Week 156|Protocol Violation|0
2921913|NCT01544595|10063806|P5|Status at Week 156|Protocol Violation|0
2921914|NCT01544595|10063807|P4|Status at Week 156|Protocol Violation|2
2921915|NCT01544595|10063808|P3|Status at Week 156|Protocol Violation|2
2921916|NCT01544595|10063809|P2|Status at Week 156|Protocol Violation|1
2921917|NCT01544595|10063810|P1|Status at Week 156|Protocol Violation|3
2921918|NCT01544595|10063805|P6|Status at Week 156|Pregnancy|0
2921919|NCT01544595|10063806|P5|Status at Week 156|Pregnancy|0
2921920|NCT01544595|10063807|P4|Status at Week 156|Pregnancy|0
2921921|NCT01544595|10063808|P3|Status at Week 156|Pregnancy|0
2921922|NCT01544595|10063809|P2|Status at Week 156|Pregnancy|3
2921923|NCT01544595|10063810|P1|Status at Week 156|Pregnancy|2
2921924|NCT01544595|10063805|P6|Status at Week 156|Physician Decision|0
2921925|NCT01544595|10063806|P5|Status at Week 156|Physician Decision|0
2921926|NCT01544595|10063807|P4|Status at Week 156|Physician Decision|0
2921927|NCT01544595|10063808|P3|Status at Week 156|Physician Decision|1
2921928|NCT01544595|10063809|P2|Status at Week 156|Physician Decision|3
2921929|NCT01544595|10063810|P1|Status at Week 156|Physician Decision|0
2921930|NCT01544595|10063805|P6|Status at Week 156|Non-compliance with study treatement|1
2921931|NCT01544595|10063806|P5|Status at Week 156|Non-compliance with study treatement|0
2921932|NCT01544595|10063807|P4|Status at Week 156|Non-compliance with study treatement|1
2921933|NCT01544595|10063808|P3|Status at Week 156|Non-compliance with study treatement|0
2921934|NCT01544595|10063809|P2|Status at Week 156|Non-compliance with study treatement|1
2921935|NCT01544595|10063810|P1|Status at Week 156|Non-compliance with study treatement|0
2921936|NCT01544595|10063805|P6|Status at Week 156|Lost to Follow-up|1
2921937|NCT01544595|10063806|P5|Status at Week 156|Lost to Follow-up|4
2921938|NCT01544595|10063807|P4|Status at Week 156|Lost to Follow-up|1
2921939|NCT01544595|10063808|P3|Status at Week 156|Lost to Follow-up|0
2921940|NCT01544595|10063809|P2|Status at Week 156|Lost to Follow-up|4
2921941|NCT01544595|10063810|P1|Status at Week 156|Lost to Follow-up|4
2921942|NCT01544595|10063805|P6|Status at Week 156|Adverse Event|2
2921943|NCT01544595|10063806|P5|Status at Week 156|Adverse Event|4
2921944|NCT01544595|10063807|P4|Status at Week 156|Adverse Event|3
2921945|NCT01544595|10063808|P3|Status at Week 156|Adverse Event|1
2921946|NCT01544595|10063809|P2|Status at Week 156|Adverse Event|11
2921947|NCT01544595|10063810|P1|Status at Week 156|Adverse Event|9
2921948|NCT01544595|10063805|P6|Status at Week 156|Withdrawal by Subject|6
2921949|NCT01544595|10063806|P5|Status at Week 156|Withdrawal by Subject|20
2921950|NCT01544595|10063807|P4|Status at Week 156|Withdrawal by Subject|9
2921951|NCT01544595|10063808|P3|Status at Week 156|Withdrawal by Subject|4
2921952|NCT01544595|10063809|P2|Status at Week 156|Withdrawal by Subject|10
2921953|NCT01544595|10063810|P1|Status at Week 156|Withdrawal by Subject|9
2921954|NCT01544595|10063805|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
2921955|NCT01544595|10063806|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
2921956|NCT01544595|10063807|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
2921957|NCT01544595|10063808|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
2921958|NCT01544595|10063809|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
2921959|NCT01544595|10063810|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
2921960|NCT01544595|10063805|P6|Status at Week 68|Withdrawal by Subject|0
2921961|NCT01544595|10063806|P5|Status at Week 68|Withdrawal by Subject|0
2921962|NCT01544595|10063807|P4|Status at Week 68|Withdrawal by Subject|2
2921963|NCT01544595|10063808|P3|Status at Week 68|Withdrawal by Subject|1
2921964|NCT01544595|10063809|P2|Status at Week 68|Withdrawal by Subject|1
2921965|NCT01544595|10063810|P1|Status at Week 68|Withdrawal by Subject|0
2921966|NCT01544595|10063805|P6|Status at Week 68|Technical problems|0
2921967|NCT01544595|10063806|P5|Status at Week 68|Technical problems|0
2921968|NCT01544595|10063807|P4|Status at Week 68|Technical problems|1
2921969|NCT01544595|10063808|P3|Status at Week 68|Technical problems|0
2921970|NCT01544595|10063809|P2|Status at Week 68|Technical problems|0
2921971|NCT01544595|10063810|P1|Status at Week 68|Technical problems|1
2921972|NCT01544595|10063805|P6|Status at Week 68|Protocol Violation|0
2921973|NCT01544595|10063806|P5|Status at Week 68|Protocol Violation|0
2921974|NCT01544595|10063807|P4|Status at Week 68|Protocol Violation|1
2921975|NCT01544595|10063808|P3|Status at Week 68|Protocol Violation|1
2921976|NCT01544595|10063809|P2|Status at Week 68|Protocol Violation|0
2921977|NCT01544595|10063810|P1|Status at Week 68|Protocol Violation|2
2921978|NCT01544595|10063805|P6|Status at Week 68|Non-compliance with study treatment|0
2921979|NCT01544595|10063806|P5|Status at Week 68|Non-compliance with study treatment|0
2921980|NCT01544595|10063807|P4|Status at Week 68|Non-compliance with study treatment|1
2921981|NCT01544595|10063808|P3|Status at Week 68|Non-compliance with study treatment|0
2921982|NCT01544595|10063809|P2|Status at Week 68|Non-compliance with study treatment|0
2921983|NCT01544595|10063810|P1|Status at Week 68|Non-compliance with study treatment|1
2921984|NCT01544595|10063805|P6|Status at Week 68|Lost to Follow-up|0
2921985|NCT01544595|10063806|P5|Status at Week 68|Lost to Follow-up|0
2921986|NCT01544595|10063807|P4|Status at Week 68|Lost to Follow-up|0
2921987|NCT01544595|10063808|P3|Status at Week 68|Lost to Follow-up|0
2921988|NCT01544595|10063809|P2|Status at Week 68|Lost to Follow-up|1
2921989|NCT01544595|10063810|P1|Status at Week 68|Lost to Follow-up|1
2921990|NCT01544595|10063805|P6|Status at Week 68|Lack of Efficacy|0
2921991|NCT01544595|10063806|P5|Status at Week 68|Lack of Efficacy|0
2921992|NCT01544595|10063807|P4|Status at Week 68|Lack of Efficacy|0
2921993|NCT01544595|10063808|P3|Status at Week 68|Lack of Efficacy|0
2921994|NCT01544595|10063809|P2|Status at Week 68|Lack of Efficacy|0
2921995|NCT01544595|10063810|P1|Status at Week 68|Lack of Efficacy|1
2921996|NCT01544595|10063805|P6|Status at Week 68|Adverse Event|0
2921997|NCT01544595|10063806|P5|Status at Week 68|Adverse Event|0
2921998|NCT01544595|10063807|P4|Status at Week 68|Adverse Event|0
2921999|NCT01544595|10063808|P3|Status at Week 68|Adverse Event|1
2922000|NCT01544595|10063809|P2|Status at Week 68|Adverse Event|2
2922001|NCT01544595|10063810|P1|Status at Week 68|Adverse Event|3
2922002|NCT01544582|10063886|P4|Analysis Population|Participant in Jail|0
2922003|NCT01544582|10063887|P3|Analysis Population|Participant in Jail|1
2922004|NCT01544582|10063888|P2|Analysis Population|Participant in Jail|0
2922005|NCT01544582|10063889|P1|Analysis Population|Participant in Jail|0
2922006|NCT01544582|10063886|P4|Analysis Population|Programmed Surgery|0
2922007|NCT01544582|10063887|P3|Analysis Population|Programmed Surgery|0
2922008|NCT01544582|10063888|P2|Analysis Population|Programmed Surgery|1
2922009|NCT01544582|10063889|P1|Analysis Population|Programmed Surgery|0
2922010|NCT01544582|10063886|P4|Analysis Population|Poor Participant Compliance|0
2922011|NCT01544582|10063887|P3|Analysis Population|Poor Participant Compliance|0
2922012|NCT01544582|10063888|P2|Analysis Population|Poor Participant Compliance|1
2922013|NCT01544582|10063889|P1|Analysis Population|Poor Participant Compliance|0
2922014|NCT01544582|10063886|P4|Analysis Population|Poor Adherence|0
2922015|NCT01544582|10063887|P3|Analysis Population|Poor Adherence|1
2922016|NCT01544582|10063888|P2|Analysis Population|Poor Adherence|0
2922017|NCT01544582|10063889|P1|Analysis Population|Poor Adherence|0
2922018|NCT01544582|10063886|P4|Analysis Population|No Social Insurance|0
2922019|NCT01544582|10063887|P3|Analysis Population|No Social Insurance|1
2922020|NCT01544582|10063888|P2|Analysis Population|No Social Insurance|0
2922021|NCT01544582|10063889|P1|Analysis Population|No Social Insurance|0
2922022|NCT01544582|10063886|P4|Analysis Population|Liver Transplantation|0
2922023|NCT01544582|10063887|P3|Analysis Population|Liver Transplantation|1
2922024|NCT01544582|10063888|P2|Analysis Population|Liver Transplantation|0
2922025|NCT01544582|10063889|P1|Analysis Population|Liver Transplantation|0
2922026|NCT01544582|10063886|P4|Analysis Population|Intolerance|0
2922027|NCT01544582|10063887|P3|Analysis Population|Intolerance|0
2922028|NCT01544582|10063888|P2|Analysis Population|Intolerance|1
2922029|NCT01544582|10063889|P1|Analysis Population|Intolerance|0
2922030|NCT01544582|10063886|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
2922031|NCT01544582|10063887|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
2922032|NCT01544582|10063888|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
2922033|NCT01544582|10063889|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
2922034|NCT01544582|10063886|P4|Analysis Population|Bad Tolerance to Treatment|0
2922035|NCT01544582|10063887|P3|Analysis Population|Bad Tolerance to Treatment|2
2922036|NCT01544582|10063888|P2|Analysis Population|Bad Tolerance to Treatment|0
2922037|NCT01544582|10063889|P1|Analysis Population|Bad Tolerance to Treatment|0
2922038|NCT01544582|10063886|P4|Analysis Population|Lost to Follow-up|5
2922039|NCT01544582|10063887|P3|Analysis Population|Lost to Follow-up|6
2922040|NCT01544582|10063888|P2|Analysis Population|Lost to Follow-up|6
2922041|NCT01544582|10063889|P1|Analysis Population|Lost to Follow-up|0
2922042|NCT01544582|10063886|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
2922043|NCT01544582|10063887|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
2922044|NCT01544582|10063888|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
2922045|NCT01544582|10063889|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
2922046|NCT01544582|10063886|P4|Analysis Population|Effectiveness Reason|12
2922047|NCT01544582|10063887|P3|Analysis Population|Effectiveness Reason|29
2922048|NCT01544582|10063888|P2|Analysis Population|Effectiveness Reason|48
2922049|NCT01544582|10063889|P1|Analysis Population|Effectiveness Reason|0
2922050|NCT01544582|10063886|P4|Analysis Population|Safety Reason|8
2922051|NCT01544582|10063887|P3|Analysis Population|Safety Reason|31
2922052|NCT01544582|10063888|P2|Analysis Population|Safety Reason|33
2922053|NCT01544582|10063889|P1|Analysis Population|Safety Reason|0
2922054|NCT01544582|10063886|P4|Analysis Population|Physician Decision|9
2922055|NCT01544582|10063887|P3|Analysis Population|Physician Decision|10
2922056|NCT01544582|10063888|P2|Analysis Population|Physician Decision|13
2922057|NCT01544582|10063889|P1|Analysis Population|Physician Decision|0
2922058|NCT01544582|10063886|P4|Analysis Population|Participant Refuses to Continue Study|4
2922059|NCT01544582|10063887|P3|Analysis Population|Participant Refuses to Continue Study|17
2922060|NCT01544582|10063888|P2|Analysis Population|Participant Refuses to Continue Study|15
2922061|NCT01544582|10063889|P1|Analysis Population|Participant Refuses to Continue Study|0
2922062|NCT01544582|10063886|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
2922063|NCT01544582|10063887|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
2922064|NCT01544582|10063888|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
2922065|NCT01544582|10063889|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
2922066|NCT01544582|10063886|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
2922067|NCT01544582|10063887|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
2922068|NCT01544582|10063888|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
2922069|NCT01544582|10063889|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
2922070|NCT01544491|10063949|P2|Overall Study|administrative problems|0
2922071|NCT01544491|10063950|P1|Overall Study|administrative problems|2
2922072|NCT01544491|10063949|P2|Overall Study|Lost to Follow-up|1
2922073|NCT01544491|10063950|P1|Overall Study|Lost to Follow-up|0
2922074|NCT01544491|10063949|P2|Overall Study|Withdrawal by Subject|2
2922075|NCT01544491|10063950|P1|Overall Study|Withdrawal by Subject|3
2922076|NCT01544478|10063976|P1|Overall Study|Withdrawal by Subject|52
2922077|NCT01544478|10063976|P1|Overall Study|Pregnancy|1
2922078|NCT01544478|10063976|P1|Overall Study|Physician Decision|15
2922079|NCT01544478|10063976|P1|Overall Study|Lost to Follow-up|48
2922080|NCT01544478|10063976|P1|Overall Study|Death|1
2922081|NCT01544478|10063976|P1|Overall Study|Adverse Event|1
2922082|NCT01544348|10064019|P8|Overall Study|Physician Decision|0
2922083|NCT01544348|10064020|P7|Overall Study|Physician Decision|0
2922084|NCT01544348|10064021|P6|Overall Study|Physician Decision|1
2922085|NCT01544348|10064022|P5|Overall Study|Physician Decision|0
2922086|NCT01544348|10064023|P4|Overall Study|Physician Decision|0
2922087|NCT01544348|10064024|P3|Overall Study|Physician Decision|0
2922088|NCT01544348|10064025|P2|Overall Study|Physician Decision|0
2922089|NCT01544348|10064026|P1|Overall Study|Physician Decision|0
2922090|NCT01544348|10064019|P8|Overall Study|Withdrawal by Subject|0
2922091|NCT01544348|10064020|P7|Overall Study|Withdrawal by Subject|1
2922092|NCT01544348|10064021|P6|Overall Study|Withdrawal by Subject|2
2922093|NCT01544348|10064022|P5|Overall Study|Withdrawal by Subject|1
2922094|NCT01544348|10064023|P4|Overall Study|Withdrawal by Subject|0
2922095|NCT01544348|10064024|P3|Overall Study|Withdrawal by Subject|0
2922096|NCT01544348|10064025|P2|Overall Study|Withdrawal by Subject|0
2922097|NCT01544348|10064026|P1|Overall Study|Withdrawal by Subject|1
2922098|NCT01544348|10064019|P8|Overall Study|Lost to Follow-up|0
2922099|NCT01544348|10064020|P7|Overall Study|Lost to Follow-up|1
2922100|NCT01544348|10064021|P6|Overall Study|Lost to Follow-up|0
2922101|NCT01544348|10064022|P5|Overall Study|Lost to Follow-up|0
2922102|NCT01544348|10064023|P4|Overall Study|Lost to Follow-up|0
2922103|NCT01544348|10064024|P3|Overall Study|Lost to Follow-up|0
2922104|NCT01544348|10064025|P2|Overall Study|Lost to Follow-up|0
2922105|NCT01544348|10064026|P1|Overall Study|Lost to Follow-up|1
2922106|NCT01544309|10064068|P2|Overall Study|Administered prohibit prior medication|0
2922107|NCT01544309|10064069|P1|Overall Study|Administered prohibit prior medication|1
2922108|NCT01544309|10064068|P2|Overall Study|Not performed pre-dose examination|2
2922109|NCT01544309|10064069|P1|Overall Study|Not performed pre-dose examination|1
2922110|NCT01544309|10064068|P2|Overall Study|Physician Decision|1
2922111|NCT01544309|10064069|P1|Overall Study|Physician Decision|4
2922112|NCT01544309|10064068|P2|Overall Study|Protocol Violation|1
2922113|NCT01544309|10064069|P1|Overall Study|Protocol Violation|2
2922114|NCT01544309|10064068|P2|Overall Study|Withdrawal by Subject|7
2922115|NCT01544309|10064069|P1|Overall Study|Withdrawal by Subject|12
2922116|NCT01544179|10064107|P2|Overall Study|Eligibility criteria not fulfilled|0
2922117|NCT01544179|10064108|P1|Overall Study|Eligibility criteria not fulfilled|1
2922118|NCT01544179|10064107|P2|Overall Study|Withdrawal by Subject|7
2922119|NCT01544179|10064108|P1|Overall Study|Withdrawal by Subject|12
2922120|NCT01544179|10064107|P2|Overall Study|Adverse Event|1
2922121|NCT01544179|10064108|P1|Overall Study|Adverse Event|0
2922122|NCT01544179|10064107|P2|Overall Study|Lost to Follow-up|1
2922123|NCT01544179|10064108|P1|Overall Study|Lost to Follow-up|0
2922124|NCT01544179|10064107|P2|Overall Study|Death|37
2922125|NCT01544179|10064108|P1|Overall Study|Death|50
2922126|NCT01544153|10064201|P4|Overall Study|Non-smoker|0
2922127|NCT01544153|10064202|P3|Overall Study|Non-smoker|1
2922128|NCT01544153|10064203|P2|Overall Study|Non-smoker|0
2922129|NCT01544153|10064204|P1|Overall Study|Non-smoker|0
2922130|NCT01544153|10064201|P4|Overall Study|Under 18|0
2922131|NCT01544153|10064202|P3|Overall Study|Under 18|0
2922132|NCT01544153|10064203|P2|Overall Study|Under 18|1
2922133|NCT01544153|10064204|P1|Overall Study|Under 18|0
2922134|NCT01544127|10064221|P3|Overall Study|Went active duty|1
2922135|NCT01544127|10064222|P2|Overall Study|Went active duty|0
2922136|NCT01544127|10064223|P1|Overall Study|Went active duty|0
2922137|NCT01544127|10064221|P3|Overall Study|Researcher withdrew|0
2922138|NCT01544127|10064222|P2|Overall Study|Researcher withdrew|0
2922139|NCT01544127|10064223|P1|Overall Study|Researcher withdrew|1
2922140|NCT01544127|10064221|P3|Overall Study|Became Psychotic|0
2922141|NCT01544127|10064222|P2|Overall Study|Became Psychotic|0
2922142|NCT01544127|10064223|P1|Overall Study|Became Psychotic|1
2922143|NCT01544127|10064221|P3|Overall Study|Jail or Prison|2
2922144|NCT01544127|10064222|P2|Overall Study|Jail or Prison|1
2922145|NCT01544127|10064223|P1|Overall Study|Jail or Prison|1
2922146|NCT01544127|10064221|P3|Overall Study|Death|0
2922147|NCT01544127|10064222|P2|Overall Study|Death|0
2922148|NCT01544127|10064223|P1|Overall Study|Death|1
2922149|NCT01544127|10064221|P3|Overall Study|Discharged out of catchment area|1
2922150|NCT01544127|10064222|P2|Overall Study|Discharged out of catchment area|1
2922151|NCT01544127|10064223|P1|Overall Study|Discharged out of catchment area|1
2922152|NCT01544127|10064221|P3|Overall Study|Withdrawal by Subject|1
2922153|NCT01544127|10064222|P2|Overall Study|Withdrawal by Subject|2
2922154|NCT01544127|10064223|P1|Overall Study|Withdrawal by Subject|2
2922155|NCT01544127|10064221|P3|Overall Study|Lost to Follow-up|9
2922156|NCT01544127|10064222|P2|Overall Study|Lost to Follow-up|2
2922157|NCT01544127|10064223|P1|Overall Study|Lost to Follow-up|4
2922158|NCT01544114|10064243|P3|Overall Study|Protocol Violation|0
2922159|NCT01544114|10064244|P2|Overall Study|Protocol Violation|1
2922160|NCT01544114|10064245|P1|Overall Study|Protocol Violation|0
2922161|NCT01544114|10064243|P3|Overall Study|Adverse Event|2
2922162|NCT01544114|10064244|P2|Overall Study|Adverse Event|1
2922163|NCT01544114|10064245|P1|Overall Study|Adverse Event|1
2922164|NCT01544114|10064243|P3|Overall Study|Lost to Follow-up|0
2922165|NCT01544114|10064244|P2|Overall Study|Lost to Follow-up|2
2922166|NCT01544114|10064245|P1|Overall Study|Lost to Follow-up|0
2922167|NCT01544114|10064243|P3|Overall Study|Withdrawal by Subject|3
2922168|NCT01544114|10064244|P2|Overall Study|Withdrawal by Subject|0
2922169|NCT01544114|10064245|P1|Overall Study|Withdrawal by Subject|0
2922170|NCT01543958|10064343|P1|Overall Study|ART initiation|1
2922171|NCT01543958|10064343|P1|Overall Study|Loss to follow-up|3
2922172|NCT01543828|10064398|P2|Treatment 2|Lost to Follow-up|0
2922173|NCT01543828|10064399|P1|Treatment 2|Lost to Follow-up|1
2922174|NCT01543776|10064409|P2|Overall Study|Withdrawal by Subject|2
2922175|NCT01543776|10064410|P1|Overall Study|Withdrawal by Subject|2
2922176|NCT01543685|10064429|P5|Overall Study|Adverse Event|2
2922177|NCT01543685|10064430|P4|Overall Study|Adverse Event|0
2922178|NCT01543685|10064431|P3|Overall Study|Adverse Event|0
2922179|NCT01543685|10064432|P2|Overall Study|Adverse Event|1
2922180|NCT01543685|10064433|P1|Overall Study|Adverse Event|2
2922181|NCT01543685|10064429|P5|Overall Study|Lack of Efficacy|2
2922182|NCT01543685|10064430|P4|Overall Study|Lack of Efficacy|0
2922183|NCT01543685|10064431|P3|Overall Study|Lack of Efficacy|2
2922184|NCT01543685|10064432|P2|Overall Study|Lack of Efficacy|2
2922185|NCT01543685|10064433|P1|Overall Study|Lack of Efficacy|1
2922186|NCT01543503|10064505|P2|Overall Study|Screen failure|0
2922187|NCT01543503|10064506|P1|Overall Study|Screen failure|1
2922188|NCT01543503|10064505|P2|Overall Study|Participant went to United States|0
2922189|NCT01543503|10064506|P1|Overall Study|Participant went to United States|1
2922190|NCT01543503|10064505|P2|Overall Study|Participant consented to another study|2
2922191|NCT01543503|10064506|P1|Overall Study|Participant consented to another study|0
2922192|NCT01543503|10064505|P2|Overall Study|Moved to other rheumatologic site|1
2922193|NCT01543503|10064506|P1|Overall Study|Moved to other rheumatologic site|0
2922194|NCT01543503|10064505|P2|Overall Study|Participant did not attend a visit|0
2922195|NCT01543503|10064506|P1|Overall Study|Participant did not attend a visit|1
2922196|NCT01543503|10064505|P2|Overall Study|Site stopped participation|1
2922197|NCT01543503|10064506|P1|Overall Study|Site stopped participation|5
2922198|NCT01543503|10064505|P2|Overall Study|Participant recruited after closing date|1
2922199|NCT01543503|10064506|P1|Overall Study|Participant recruited after closing date|0
2922200|NCT01543503|10064505|P2|Overall Study|Investigator did not wish to participate|1
2922201|NCT01543503|10064506|P1|Overall Study|Investigator did not wish to participate|1
2922202|NCT01543503|10064505|P2|Overall Study|Participant decision to stop treatment|0
2922203|NCT01543503|10064506|P1|Overall Study|Participant decision to stop treatment|1
2922204|NCT01543503|10064505|P2|Overall Study|Participant moved to Scotland|0
2922205|NCT01543503|10064506|P1|Overall Study|Participant moved to Scotland|1
2922206|NCT01543503|10064505|P2|Overall Study|Participant transferred to another city|0
2922207|NCT01543503|10064506|P1|Overall Study|Participant transferred to another city|1
2922208|NCT01543503|10064505|P2|Overall Study|Participant will not return for visits|2
2922209|NCT01543503|10064506|P1|Overall Study|Participant will not return for visits|0
2922210|NCT01543503|10064505|P2|Overall Study|Participant moved to another city|0
2922211|NCT01543503|10064506|P1|Overall Study|Participant moved to another city|2
2922212|NCT01543503|10064505|P2|Overall Study|Incorrect medication received|0
2922213|NCT01543503|10064506|P1|Overall Study|Incorrect medication received|1
2922214|NCT01543503|10064505|P2|Overall Study|Refused to continue treatment|0
2922215|NCT01543503|10064506|P1|Overall Study|Refused to continue treatment|7
2922216|NCT01543503|10064505|P2|Overall Study|Participant did not complete last visit|2
2922217|NCT01543503|10064506|P1|Overall Study|Participant did not complete last visit|0
2922218|NCT01543503|10064505|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
2922219|NCT01543503|10064506|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
2922220|NCT01543503|10064505|P2|Overall Study|Intolerance to the biologic treatment|1
2922221|NCT01543503|10064506|P1|Overall Study|Intolerance to the biologic treatment|0
2922222|NCT01543503|10064505|P2|Overall Study|Change of jobs|1
2922223|NCT01543503|10064506|P1|Overall Study|Change of jobs|0
2922224|NCT01543503|10064505|P2|Overall Study|Participant withdrew informed consent|10
2922225|NCT01543503|10064506|P1|Overall Study|Participant withdrew informed consent|8
2922226|NCT01543503|10064505|P2|Overall Study|Lack of Efficacy|16
2922227|NCT01543503|10064506|P1|Overall Study|Lack of Efficacy|4
2922228|NCT01543503|10064505|P2|Overall Study|Adverse Event|13
2922229|NCT01543503|10064506|P1|Overall Study|Adverse Event|9
2922230|NCT01543503|10064505|P2|Overall Study|Lost to Follow-up|36
2922231|NCT01543503|10064506|P1|Overall Study|Lost to Follow-up|32
2922232|NCT01543204|10064550|P1|Overall Study|Lost to Follow-up|1
2922233|NCT01543204|10064550|P1|Overall Study|Requirement for Alternative Therapy|1
2922234|NCT01543204|10064550|P1|Overall Study|Withdrawal by Subject|4
2922235|NCT01543204|10064550|P1|Overall Study|Adverse Event|1
2922236|NCT01543204|10064550|P1|Overall Study|Non-compliance|1
2922237|NCT01543087|10064612|P6|Booster Stage (26 Months)|Lost to Follow-up|0
2922238|NCT01543087|10064613|P5|Booster Stage (26 Months)|Lost to Follow-up|0
2922239|NCT01543087|10064614|P4|Booster Stage (26 Months)|Lost to Follow-up|0
2922240|NCT01543087|10064615|P3|Booster Stage (26 Months)|Lost to Follow-up|1
2922241|NCT01543087|10064616|P2|Booster Stage (26 Months)|Lost to Follow-up|0
2922242|NCT01543087|10064617|P1|Booster Stage (26 Months)|Lost to Follow-up|0
2922243|NCT01543087|10064612|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2922244|NCT01543087|10064613|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
2922245|NCT01543087|10064614|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2922246|NCT01543087|10064615|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2922247|NCT01543087|10064616|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
2922248|NCT01543087|10064617|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2922249|NCT01543087|10064612|P6|Stage 1 (48 Months)|Protocol Violation|0
2922250|NCT01543087|10064613|P5|Stage 1 (48 Months)|Protocol Violation|0
2922251|NCT01543087|10064614|P4|Stage 1 (48 Months)|Protocol Violation|0
2922252|NCT01543087|10064615|P3|Stage 1 (48 Months)|Protocol Violation|0
2922253|NCT01543087|10064616|P2|Stage 1 (48 Months)|Protocol Violation|3
2922254|NCT01543087|10064617|P1|Stage 1 (48 Months)|Protocol Violation|0
2922255|NCT01543087|10064612|P6|Stage 1 (48 Months)|Other than specified|0
2922256|NCT01543087|10064613|P5|Stage 1 (48 Months)|Other than specified|0
2922257|NCT01543087|10064614|P4|Stage 1 (48 Months)|Other than specified|0
2922258|NCT01543087|10064615|P3|Stage 1 (48 Months)|Other than specified|9
2922259|NCT01543087|10064616|P2|Stage 1 (48 Months)|Other than specified|0
2922260|NCT01543087|10064617|P1|Stage 1 (48 Months)|Other than specified|5
2922261|NCT01543087|10064612|P6|Stage 1 (48 Months)|No longer willing to participate|0
2922262|NCT01543087|10064613|P5|Stage 1 (48 Months)|No longer willing to participate|3
2922263|NCT01543087|10064614|P4|Stage 1 (48 Months)|No longer willing to participate|6
2922264|NCT01543087|10064615|P3|Stage 1 (48 Months)|No longer willing to participate|18
2922265|NCT01543087|10064616|P2|Stage 1 (48 Months)|No longer willing to participate|3
2922266|NCT01543087|10064617|P1|Stage 1 (48 Months)|No longer willing to participate|5
2922267|NCT01543087|10064612|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
2922268|NCT01543087|10064613|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
2922269|NCT01543087|10064614|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
2922270|NCT01543087|10064615|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
2922271|NCT01543087|10064616|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
2922272|NCT01543087|10064617|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
2922273|NCT01543087|10064612|P6|Stage 1 (48 Months)|Lost to Follow-up|0
2922274|NCT01543087|10064613|P5|Stage 1 (48 Months)|Lost to Follow-up|0
2922275|NCT01543087|10064614|P4|Stage 1 (48 Months)|Lost to Follow-up|0
2922276|NCT01543087|10064615|P3|Stage 1 (48 Months)|Lost to Follow-up|12
2922277|NCT01543087|10064616|P2|Stage 1 (48 Months)|Lost to Follow-up|4
2922278|NCT01543087|10064617|P1|Stage 1 (48 Months)|Lost to Follow-up|3
2922279|NCT01542788|10064794|P2|Overall Study|Withdrawal by Subject|0
2922280|NCT01542788|10064795|P1|Overall Study|Withdrawal by Subject|1
2922281|NCT01542788|10064794|P2|Overall Study|Physician Decision|0
2922282|NCT01542788|10064795|P1|Overall Study|Physician Decision|1
2922283|NCT01542788|10064794|P2|Overall Study|Protocol Violation|0
2922284|NCT01542788|10064795|P1|Overall Study|Protocol Violation|2
2922285|NCT01542788|10064794|P2|Overall Study|Death|0
2922286|NCT01542788|10064795|P1|Overall Study|Death|3
2922287|NCT01542788|10064794|P2|Overall Study|Lost to Follow-up|0
2922288|NCT01542788|10064795|P1|Overall Study|Lost to Follow-up|5
2922289|NCT01542788|10064794|P2|Overall Study|Lack of Efficacy|71
2922290|NCT01542788|10064795|P1|Overall Study|Lack of Efficacy|41
2922291|NCT01542788|10064794|P2|Overall Study|Randomized but Not Treated|0
2922292|NCT01542788|10064795|P1|Overall Study|Randomized but Not Treated|2
2922293|NCT01542632|10064842|P6|Overall Study|Sponsor/Investigator Decision|0
2922294|NCT01542632|10064843|P5|Overall Study|Sponsor/Investigator Decision|1
2922295|NCT01542632|10064844|P4|Overall Study|Sponsor/Investigator Decision|0
2922296|NCT01542632|10064845|P3|Overall Study|Sponsor/Investigator Decision|0
2922297|NCT01542632|10064846|P2|Overall Study|Sponsor/Investigator Decision|0
2922298|NCT01542632|10064847|P1|Overall Study|Sponsor/Investigator Decision|0
2922299|NCT01542632|10064842|P6|Overall Study|Lost to Follow-up|0
2922300|NCT01542632|10064843|P5|Overall Study|Lost to Follow-up|0
2922301|NCT01542632|10064844|P4|Overall Study|Lost to Follow-up|0
2922302|NCT01542632|10064845|P3|Overall Study|Lost to Follow-up|0
2922303|NCT01542632|10064846|P2|Overall Study|Lost to Follow-up|1
2922304|NCT01542632|10064847|P1|Overall Study|Lost to Follow-up|0
2922305|NCT01542632|10064842|P6|Overall Study|Adverse Event|0
2922306|NCT01542632|10064843|P5|Overall Study|Adverse Event|0
2922307|NCT01542632|10064844|P4|Overall Study|Adverse Event|0
2922308|NCT01542632|10064845|P3|Overall Study|Adverse Event|1
2922309|NCT01542632|10064846|P2|Overall Study|Adverse Event|0
2922310|NCT01542632|10064847|P1|Overall Study|Adverse Event|0
2922311|NCT01542632|10064842|P6|Overall Study|Withdrawal of Consent|0
2922312|NCT01542632|10064843|P5|Overall Study|Withdrawal of Consent|3
2922313|NCT01542632|10064844|P4|Overall Study|Withdrawal of Consent|2
2922314|NCT01542632|10064845|P3|Overall Study|Withdrawal of Consent|0
2922315|NCT01542632|10064846|P2|Overall Study|Withdrawal of Consent|0
2922316|NCT01542632|10064847|P1|Overall Study|Withdrawal of Consent|0
2922317|NCT01542528|10064904|P2|Overall Study|Withdrawal by Subject|6
2922318|NCT01542528|10064905|P1|Overall Study|Withdrawal by Subject|9
2922319|NCT01542528|10064904|P2|Overall Study|Physician Decision|0
2922320|NCT01542528|10064905|P1|Overall Study|Physician Decision|1
2922321|NCT01542528|10064904|P2|Overall Study|Lost to Follow-up|1
2922322|NCT01542528|10064905|P1|Overall Study|Lost to Follow-up|2
2922323|NCT01542034|10065013|P2|Overall Study|Lost to Follow-up|6
2922324|NCT01542034|10065014|P1|Overall Study|Lost to Follow-up|7
2922325|NCT01542034|10065013|P2|Overall Study|Adverse Event|2
2922326|NCT01542034|10065014|P1|Overall Study|Adverse Event|2
2922327|NCT01542034|10065013|P2|Overall Study|Subject Noncompliance|0
2922328|NCT01542034|10065014|P1|Overall Study|Subject Noncompliance|1
2922329|NCT01542034|10065013|P2|Overall Study|Administrative decision|3
2922330|NCT01542034|10065014|P1|Overall Study|Administrative decision|0
2922331|NCT01542034|10065013|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
2922332|NCT01542034|10065014|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
2922333|NCT01541969|10065028|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
2922334|NCT01541969|10065029|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
2922335|NCT01541969|10065028|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
2922336|NCT01541969|10065029|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
2922337|NCT01541969|10065028|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2922338|NCT01541969|10065029|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2922339|NCT01541969|10065028|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
2922340|NCT01541969|10065029|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
2922341|NCT01541969|10065028|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2922342|NCT01541969|10065029|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2922343|NCT01541969|10065028|P2|Double-blind (0-12 Weeks)|Adverse Event|0
2922344|NCT01541969|10065029|P1|Double-blind (0-12 Weeks)|Adverse Event|2
2922345|NCT01541969|10065028|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
2922346|NCT01541969|10065029|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
2922347|NCT01541969|10065028|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
2922348|NCT01541969|10065029|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
2922349|NCT01541969|10065028|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2922350|NCT01541969|10065029|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2922351|NCT01541969|10065028|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
2922352|NCT01541969|10065029|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
2922353|NCT01541930|10065045|P1|Overall Study|Withdrawal by Subject|1
2922354|NCT01541917|10065067|P2|Overall Study|Withdrawal by Subject|7
2922355|NCT01541917|10065068|P1|Overall Study|Withdrawal by Subject|13
2922356|NCT01541917|10065067|P2|Overall Study|Lost to Follow-up|2
2922357|NCT01541917|10065068|P1|Overall Study|Lost to Follow-up|2
2922358|NCT01541865|10065097|P1|Overall Study|Protocol Violation|1
2922359|NCT01541865|10065097|P1|Overall Study|Adverse Event|1
2922360|NCT01541865|10065097|P1|Overall Study|Withdrawal by Subject|9
2922361|NCT01541865|10065097|P1|Overall Study|Lost to Follow-up|11
2922362|NCT01541826|10065115|P3|Overall Study|Withdrawal by Subject|0
2922363|NCT01541826|10065116|P2|Overall Study|Withdrawal by Subject|0
2922364|NCT01541826|10065117|P1|Overall Study|Withdrawal by Subject|2
2922365|NCT01541826|10065115|P3|Overall Study|Lost to Follow-up|0
2922366|NCT01541826|10065116|P2|Overall Study|Lost to Follow-up|3
2922367|NCT01541826|10065117|P1|Overall Study|Lost to Follow-up|2
2922368|NCT01541644|10065199|P1|Overall Study|Withdrawal by Subject|3
2922369|NCT01541397|10065218|P2|Overall Study|Study ended prior to data collection|2
2922370|NCT01541397|10065219|P1|Overall Study|Study ended prior to data collection|4
2922371|NCT01541371|10065244|P1|Overall Study|Other|6
2922372|NCT01541371|10065244|P1|Overall Study|Study medication non-compliance|3
2922373|NCT01541371|10065244|P1|Overall Study|Protocol Violation|6
2922374|NCT01541371|10065244|P1|Overall Study|Lack of Efficacy|12
2922375|NCT01541371|10065244|P1|Overall Study|Adverse Event|15
2922376|NCT01541371|10065244|P1|Overall Study|Lost to Follow-up|21
2922377|NCT01541371|10065244|P1|Overall Study|Withdrawal by Subject|14
2922378|NCT01541254|10065273|P1|Overall Study|alternate stent used|1
2922379|NCT01541254|10065273|P1|Overall Study|stent not required|1
2922380|NCT01541254|10065273|P1|Overall Study|GI bleed prior to procedure|1
2922381|NCT01541254|10065273|P1|Overall Study|enrolled after study closed|1
2922382|NCT01541254|10065273|P1|Overall Study|excluded - metal allergy|1
2922383|NCT01541254|10065273|P1|Overall Study|Withdrawal by Subject|1
2922384|NCT01541215|10065280|P2|Overall Study|Unclassified|3
2922385|NCT01541215|10065281|P1|Overall Study|Unclassified|0
2922386|NCT01541215|10065280|P2|Overall Study|Adverse Event|1
2922387|NCT01541215|10065281|P1|Overall Study|Adverse Event|0
2922388|NCT01541215|10065280|P2|Overall Study|Non-compliance|4
2922389|NCT01541215|10065281|P1|Overall Study|Non-compliance|4
2922390|NCT01541215|10065280|P2|Overall Study|Withdrawal criteria|8
2922391|NCT01541215|10065281|P1|Overall Study|Withdrawal criteria|6
2922392|NCT01540981|10065419|P2|Overall Study|Withdrawal by Subject|0
2922393|NCT01540981|10065420|P1|Overall Study|Withdrawal by Subject|1
2922394|NCT01540851|10065430|P2|Overall Study|Withdrawal by Subject|3
2922395|NCT01540851|10065431|P1|Overall Study|Withdrawal by Subject|7
2922396|NCT01540851|10065430|P2|Overall Study|Lost to Follow-up|15
2922397|NCT01540851|10065431|P1|Overall Study|Lost to Follow-up|14
2922398|NCT01540838|10065443|P2|Overall Study|Not BM. Other treatment|1
2922399|NCT01540838|10065444|P1|Overall Study|Not BM. Other treatment|3
2922400|NCT01540838|10065443|P2|Overall Study|Died before treatment initiation|1
2922401|NCT01540838|10065444|P1|Overall Study|Died before treatment initiation|1
2922402|NCT01540838|10065443|P2|Overall Study|Additional antibiotic treatment|2
2922403|NCT01540838|10065444|P1|Overall Study|Additional antibiotic treatment|1
2922404|NCT01540838|10065443|P2|Overall Study|Treatment doses missing|12
2922405|NCT01540838|10065444|P1|Overall Study|Treatment doses missing|8
2922406|NCT01540838|10065443|P2|Overall Study|Open nasogastric tube|7
2922407|NCT01540838|10065444|P1|Overall Study|Open nasogastric tube|9
2922408|NCT01540565|10065594|P1|Overall Study|Ineligible|2
2922409|NCT01540487|10065613|P2|Overall Study|Protocol Violation|0
2922410|NCT01540487|10065614|P1|Overall Study|Protocol Violation|1
2922411|NCT01539759|10065761|P2|Overall Study|Lost to Follow-up|8
2922412|NCT01539759|10065762|P1|Overall Study|Lost to Follow-up|6
2922413|NCT01539642|10065774|P2|Overall Study|Withdrawal by Subject|2
2922414|NCT01539642|10065775|P1|Overall Study|Withdrawal by Subject|2
2922415|NCT01539642|10065774|P2|Overall Study|Adverse Event|4
2922416|NCT01539642|10065775|P1|Overall Study|Adverse Event|6
2922417|NCT01539642|10065774|P2|Overall Study|Patient ready for early discharge|7
2922418|NCT01539642|10065775|P1|Overall Study|Patient ready for early discharge|8
2922419|NCT01539642|10065774|P2|Overall Study|Lack of Efficacy|18
2922420|NCT01539642|10065775|P1|Overall Study|Lack of Efficacy|20
2922421|NCT01539538|10065792|P2|Overall Study|PCA no longer required or PCA problem|7
2922422|NCT01539538|10065793|P1|Overall Study|PCA no longer required or PCA problem|3
2922423|NCT01539538|10065792|P2|Overall Study|Withdrawal by Subject|3
2922424|NCT01539538|10065793|P1|Overall Study|Withdrawal by Subject|2
2922425|NCT01539538|10065792|P2|Overall Study|Lack of Efficacy|16
2922426|NCT01539538|10065793|P1|Overall Study|Lack of Efficacy|13
2922427|NCT01539538|10065792|P2|Overall Study|Adverse Event|18
2922428|NCT01539538|10065793|P1|Overall Study|Adverse Event|13
2922429|NCT01539525|10065802|P3|Overall Study|Protocol Violation|4
2922430|NCT01539525|10065803|P2|Overall Study|Protocol Violation|1
2922431|NCT01539525|10065804|P1|Overall Study|Protocol Violation|1
2922432|NCT01539525|10065802|P3|Overall Study|Withdrawal by Subject|2
2922433|NCT01539525|10065803|P2|Overall Study|Withdrawal by Subject|3
2922434|NCT01539525|10065804|P1|Overall Study|Withdrawal by Subject|0
2922435|NCT01539525|10065802|P3|Overall Study|Lost to Follow-up|11
2922436|NCT01539525|10065803|P2|Overall Study|Lost to Follow-up|12
2922437|NCT01539525|10065804|P1|Overall Study|Lost to Follow-up|19
2922438|NCT01539512|10065823|P2|Overall Study|Richter's Transformation|0
2922439|NCT01539512|10065824|P1|Overall Study|Richter's Transformation|1
2922440|NCT01539512|10065823|P2|Overall Study|Withdrawal by Subject|5
2922441|NCT01539512|10065824|P1|Overall Study|Withdrawal by Subject|12
2922442|NCT01539512|10065823|P2|Overall Study|Physician Decision|1
2922443|NCT01539512|10065824|P1|Overall Study|Physician Decision|1
2922444|NCT01539512|10065823|P2|Overall Study|Adverse Event|7
2922445|NCT01539512|10065824|P1|Overall Study|Adverse Event|9
2922446|NCT01539317|10065840|P2|Overall Study|Screening Error. Deleted from analysis.|0
2922447|NCT01539317|10065841|P1|Overall Study|Screening Error. Deleted from analysis.|1
2922448|NCT01539291|10065859|P4|Study GS-US-312-0117|Other|1
2922449|NCT01539291|10065860|P3|Study GS-US-312-0117|Other|1
2922450|NCT01539291|10065861|P2|Study GS-US-312-0117|Other|1
2922451|NCT01539291|10065862|P1|Study GS-US-312-0117|Other|2
2922452|NCT01539291|10065859|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
2922453|NCT01539291|10065860|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
2922454|NCT01539291|10065861|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
2922455|NCT01539291|10065862|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
2922456|NCT01539291|10065859|P4|Study GS-US-312-0117|Withdrawal by Subject|4
2922457|NCT01539291|10065860|P3|Study GS-US-312-0117|Withdrawal by Subject|6
2922458|NCT01539291|10065861|P2|Study GS-US-312-0117|Withdrawal by Subject|0
2922459|NCT01539291|10065862|P1|Study GS-US-312-0117|Withdrawal by Subject|5
2922460|NCT01539291|10065859|P4|Study GS-US-312-0117|Physician Decision|4
2922461|NCT01539291|10065860|P3|Study GS-US-312-0117|Physician Decision|6
2922462|NCT01539291|10065861|P2|Study GS-US-312-0117|Physician Decision|0
2922463|NCT01539291|10065862|P1|Study GS-US-312-0117|Physician Decision|9
2922464|NCT01539291|10065859|P4|Study GS-US-312-0117|Adverse Event|12
2922465|NCT01539291|10065860|P3|Study GS-US-312-0117|Adverse Event|9
2922466|NCT01539291|10065861|P2|Study GS-US-312-0117|Adverse Event|1
2922467|NCT01539291|10065862|P1|Study GS-US-312-0117|Adverse Event|22
2922468|NCT01539291|10065859|P4|Study GS-US-312-0116|Other|0
2922469|NCT01539291|10065860|P3|Study GS-US-312-0116|Other|0
2922470|NCT01539291|10065861|P2|Study GS-US-312-0116|Other|0
2922471|NCT01539291|10065862|P1|Study GS-US-312-0116|Other|1
2922472|NCT01539291|10065859|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
2922473|NCT01539291|10065860|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
2922474|NCT01539291|10065861|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
2922475|NCT01539291|10065862|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
2922476|NCT01539291|10065859|P4|Study GS-US-312-0116|Withdrawal by Subject|0
2922477|NCT01539291|10065860|P3|Study GS-US-312-0116|Withdrawal by Subject|0
2922478|NCT01539291|10065861|P2|Study GS-US-312-0116|Withdrawal by Subject|0
2922479|NCT01539291|10065862|P1|Study GS-US-312-0116|Withdrawal by Subject|12
2922480|NCT01539291|10065859|P4|Study GS-US-312-0116|Physician Decision|0
2922481|NCT01539291|10065860|P3|Study GS-US-312-0116|Physician Decision|0
2922482|NCT01539291|10065861|P2|Study GS-US-312-0116|Physician Decision|0
2922483|NCT01539291|10065862|P1|Study GS-US-312-0116|Physician Decision|1
2922484|NCT01539291|10065859|P4|Study GS-US-312-0116|Adverse Event|0
2922485|NCT01539291|10065860|P3|Study GS-US-312-0116|Adverse Event|0
2922486|NCT01539291|10065861|P2|Study GS-US-312-0116|Adverse Event|0
2922487|NCT01539291|10065862|P1|Study GS-US-312-0116|Adverse Event|9
2922488|NCT01539239|10065934|P2|Overall Study|Lost to Follow-up|12
2922489|NCT01539239|10065935|P1|Overall Study|Lost to Follow-up|7
2922490|NCT01539239|10065934|P2|Overall Study|Death|5
2922491|NCT01539239|10065935|P1|Overall Study|Death|5
2922492|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Death|11
2922493|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Death|6
2922494|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Death|0
2922495|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Progressive Disease|3
2922496|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Progressive Disease|6
2922497|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Progressive Disease|0
2922498|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
2922499|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
2922500|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
2922501|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
2922502|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
2922503|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
2922504|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Adverse Event|1
2922505|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Adverse Event|1
2922506|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Adverse Event|0
2922507|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Other|1
2922508|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Other|1
2922509|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Other|0
2922510|NCT01539083|10065958|P3|After Randomization (TP and VTP)|Physician Decision|1
2922511|NCT01539083|10065959|P2|After Randomization (TP and VTP)|Physician Decision|0
2922512|NCT01539083|10065960|P1|After Randomization (TP and VTP)|Physician Decision|0
2922513|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Other|0
2922514|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Other|0
2922515|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Other|5
2922516|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Progressive Disease|0
2922517|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Progressive Disease|0
2922518|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Progressive Disease|8
2922519|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Physician Decision|0
2922520|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Physician Decision|0
2922521|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Physician Decision|14
2922522|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Protocol Violation|0
2922523|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Protocol Violation|0
2922524|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Protocol Violation|2
2922525|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Death|0
2922526|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Death|0
2922527|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Death|6
2922528|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Adverse Event|0
2922529|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Adverse Event|0
2922530|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Adverse Event|14
2922531|NCT01539083|10065958|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2922532|NCT01539083|10065959|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2922533|NCT01539083|10065960|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
2922534|NCT01538719|10066004|P2|Overall Study|Lost to Follow-up|0
2922535|NCT01538719|10066005|P1|Overall Study|Lost to Follow-up|2
2922536|NCT01538472|10066028|P1|Overall Study|Death|1
2922537|NCT01538472|10066028|P1|Overall Study|Disease Progression|3
2922538|NCT01538199|10066039|P4|Overall Study|Lack of Efficacy|0
2922539|NCT01538199|10066040|P3|Overall Study|Lack of Efficacy|0
2922540|NCT01538199|10066041|P2|Overall Study|Lack of Efficacy|1
2922541|NCT01538199|10066042|P1|Overall Study|Lack of Efficacy|0
2922542|NCT01538199|10066039|P4|Overall Study|participant did not have time|2
2922543|NCT01538199|10066040|P3|Overall Study|participant did not have time|0
2922544|NCT01538199|10066041|P2|Overall Study|participant did not have time|0
2922545|NCT01538199|10066042|P1|Overall Study|participant did not have time|1
2922546|NCT01538199|10066039|P4|Overall Study|Lost to Follow-up|0
2922547|NCT01538199|10066040|P3|Overall Study|Lost to Follow-up|1
2922548|NCT01538199|10066041|P2|Overall Study|Lost to Follow-up|2
2922549|NCT01538199|10066042|P1|Overall Study|Lost to Follow-up|1
2922550|NCT01537887|10066076|P6|Period 3|Withdrawal by Subject|0
2922551|NCT01537887|10066077|P5|Period 3|Withdrawal by Subject|0
2922552|NCT01537887|10066078|P4|Period 3|Withdrawal by Subject|0
2922553|NCT01537887|10066079|P3|Period 3|Withdrawal by Subject|0
2922554|NCT01537887|10066080|P2|Period 3|Withdrawal by Subject|1
2922555|NCT01537887|10066081|P1|Period 3|Withdrawal by Subject|0
2922556|NCT01537887|10066076|P6|Period 3|Adverse Event|0
2922557|NCT01537887|10066077|P5|Period 3|Adverse Event|0
2922558|NCT01537887|10066078|P4|Period 3|Adverse Event|0
2922559|NCT01537887|10066079|P3|Period 3|Adverse Event|1
2922560|NCT01537887|10066080|P2|Period 3|Adverse Event|0
2922561|NCT01537887|10066081|P1|Period 3|Adverse Event|0
2922562|NCT01537887|10066076|P6|Period 2|Withdrawal by Subject|0
2922563|NCT01537887|10066077|P5|Period 2|Withdrawal by Subject|0
2922564|NCT01537887|10066078|P4|Period 2|Withdrawal by Subject|0
2922565|NCT01537887|10066079|P3|Period 2|Withdrawal by Subject|0
2922566|NCT01537887|10066080|P2|Period 2|Withdrawal by Subject|1
2922567|NCT01537887|10066081|P1|Period 2|Withdrawal by Subject|0
2922568|NCT01537887|10066076|P6|Period 1|Did not receive treatment|0
2922569|NCT01537887|10066077|P5|Period 1|Did not receive treatment|0
2922570|NCT01537887|10066078|P4|Period 1|Did not receive treatment|0
2922571|NCT01537887|10066079|P3|Period 1|Did not receive treatment|1
2922572|NCT01537887|10066080|P2|Period 1|Did not receive treatment|0
2922573|NCT01537887|10066081|P1|Period 1|Did not receive treatment|0
2922574|NCT01537887|10066076|P6|Period 1|Physician Decision|1
2922575|NCT01537887|10066077|P5|Period 1|Physician Decision|1
2922576|NCT01537887|10066078|P4|Period 1|Physician Decision|0
2922577|NCT01537887|10066079|P3|Period 1|Physician Decision|0
2922578|NCT01537887|10066080|P2|Period 1|Physician Decision|0
2922579|NCT01537887|10066081|P1|Period 1|Physician Decision|0
2922580|NCT01537783|10066110|P2|Overall Study|Lost to Follow-up|2
2922581|NCT01537783|10066111|P1|Overall Study|Lost to Follow-up|11
2922582|NCT01537549|10066162|P1|Overall Study|Withdrawal by Subject|2
2922583|NCT01537549|10066162|P1|Overall Study|Lost to Follow-up|1
2922584|NCT01537432|10066170|P2|Overall Study|Unsatisfactory therapeutic effect|0
2922585|NCT01537432|10066171|P1|Overall Study|Unsatisfactory therapeutic effect|1
2922586|NCT01537432|10066170|P2|Overall Study|Adverse Event|0
2922587|NCT01537432|10066171|P1|Overall Study|Adverse Event|1
2922588|NCT01537432|10066170|P2|Overall Study|Administrative problems|0
2922589|NCT01537432|10066171|P1|Overall Study|Administrative problems|1
2922590|NCT01537432|10066170|P2|Overall Study|Withdrawal by Subject|1
2922591|NCT01537432|10066171|P1|Overall Study|Withdrawal by Subject|0
2922592|NCT01537432|10066170|P2|Overall Study|Lost to Follow-up|1
2922593|NCT01537432|10066171|P1|Overall Study|Lost to Follow-up|3
2922594|NCT01537393|10066194|P2|Overall Study|Censored (severe event unrelated to PT)|1
2922595|NCT01537393|10066195|P1|Overall Study|Censored (severe event unrelated to PT)|1
2922596|NCT01537393|10066194|P2|Overall Study|Failure - Not regrafted|6
2922597|NCT01537393|10066195|P1|Overall Study|Failure - Not regrafted|2
2922598|NCT01537393|10066194|P2|Overall Study|Failure - Regrafted|43
2922599|NCT01537393|10066195|P1|Overall Study|Failure - Regrafted|28
2922600|NCT01537393|10066194|P2|Overall Study|Lost to Follow-up|48
2922601|NCT01537393|10066195|P1|Overall Study|Lost to Follow-up|53
2922602|NCT01537393|10066194|P2|Overall Study|Withdrawal by Subject|17
2922603|NCT01537393|10066195|P1|Overall Study|Withdrawal by Subject|18
2922604|NCT01537393|10066194|P2|Overall Study|Death|32
2922605|NCT01537393|10066195|P1|Overall Study|Death|20
2922606|NCT01537393|10066194|P2|Overall Study|Exclude prior to study|44
2922607|NCT01537393|10066195|P1|Overall Study|Exclude prior to study|32
2922608|NCT01537302|10066231|P1|Overall Study|Withdrawal by Subject|1
2922609|NCT01537302|10066231|P1|Overall Study|Lost to Follow-up|1
2922610|NCT01537211|10066240|P2|Overall Study|Lost to Follow-up|1
2922611|NCT01537211|10066241|P1|Overall Study|Lost to Follow-up|0
2922612|NCT01537198|10066275|P1|Overall Study|Other|111
2922613|NCT01537198|10066275|P1|Overall Study|No Further Visits to the Clinic|37
2922614|NCT01537198|10066275|P1|Overall Study|Adverse Event|4
2922615|NCT01537198|10066275|P1|Overall Study|RSV infection|2
2922616|NCT01537133|10066304|P4|Overall Study|Lost to Follow-up|0
2922617|NCT01537133|10066305|P3|Overall Study|Lost to Follow-up|0
2922618|NCT01537133|10066306|P2|Overall Study|Lost to Follow-up|0
2922619|NCT01537133|10066307|P1|Overall Study|Lost to Follow-up|1
2922620|NCT01537133|10066304|P4|Overall Study|Withdrawal by Subject|0
2922621|NCT01537133|10066305|P3|Overall Study|Withdrawal by Subject|0
2922622|NCT01537133|10066306|P2|Overall Study|Withdrawal by Subject|0
2922623|NCT01537133|10066307|P1|Overall Study|Withdrawal by Subject|2
2922624|NCT01537120|10066323|P1|3 Weeks Placebo|Withdrawal by Subject|1
2922625|NCT01537120|10066323|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
2922626|NCT01537081|10066336|P3|Overall Study|Assigned but never dosed|0
2922627|NCT01537081|10066337|P2|Overall Study|Assigned but never dosed|0
2922628|NCT01537081|10066338|P1|Overall Study|Assigned but never dosed|1
2922629|NCT01537081|10066336|P3|Overall Study|Sponsor decision|0
2922630|NCT01537081|10066337|P2|Overall Study|Sponsor decision|1
2922631|NCT01537081|10066338|P1|Overall Study|Sponsor decision|0
2922632|NCT01537081|10066336|P3|Overall Study|Physician Decision|0
2922633|NCT01537081|10066337|P2|Overall Study|Physician Decision|6
2922634|NCT01537081|10066338|P1|Overall Study|Physician Decision|5
2922635|NCT01537081|10066336|P3|Overall Study|Withdrawal by Subject|3
2922636|NCT01537081|10066337|P2|Overall Study|Withdrawal by Subject|11
2922637|NCT01537081|10066338|P1|Overall Study|Withdrawal by Subject|6
2922638|NCT01537081|10066336|P3|Overall Study|Protocol Violation|2
2922639|NCT01537081|10066337|P2|Overall Study|Protocol Violation|2
2922640|NCT01537081|10066338|P1|Overall Study|Protocol Violation|3
2922641|NCT01537081|10066336|P3|Overall Study|Lost to Follow-up|9
2922642|NCT01537081|10066337|P2|Overall Study|Lost to Follow-up|15
2922643|NCT01537081|10066338|P1|Overall Study|Lost to Follow-up|17
2922644|NCT01537081|10066336|P3|Overall Study|Lack of Efficacy|0
2922645|NCT01537081|10066337|P2|Overall Study|Lack of Efficacy|1
2922646|NCT01537081|10066338|P1|Overall Study|Lack of Efficacy|2
2922647|NCT01537081|10066336|P3|Overall Study|Adverse Event|2
2922648|NCT01537081|10066337|P2|Overall Study|Adverse Event|2
2922649|NCT01537081|10066338|P1|Overall Study|Adverse Event|5
2922650|NCT01537068|10066351|P2|Overall Study|Lack of Efficacy|0
2922651|NCT01537068|10066352|P1|Overall Study|Lack of Efficacy|1
2922652|NCT01537068|10066351|P2|Overall Study|Withdrawal by Subject|1
2922653|NCT01537068|10066352|P1|Overall Study|Withdrawal by Subject|1
2922654|NCT01537068|10066351|P2|Overall Study|Adverse Event|1
2922655|NCT01537068|10066352|P1|Overall Study|Adverse Event|0
2922656|NCT01537068|10066351|P2|Overall Study|Lost to Follow-up|1
2922657|NCT01537068|10066352|P1|Overall Study|Lost to Follow-up|2
2922658|NCT01537042|10066364|P2|Overall Study|Other|1
2922659|NCT01537042|10066365|P1|Overall Study|Other|0
2922660|NCT01537042|10066364|P2|Overall Study|Protocol Violation|1
2922661|NCT01537042|10066365|P1|Overall Study|Protocol Violation|0
2922662|NCT01537042|10066364|P2|Overall Study|Lack of Efficacy|1
2922663|NCT01537042|10066365|P1|Overall Study|Lack of Efficacy|0
2922664|NCT01537042|10066364|P2|Overall Study|Adverse Event|2
2922665|NCT01537042|10066365|P1|Overall Study|Adverse Event|0
2922666|NCT01536951|10066407|P9|Second Intervention and Washout Period 2|Adverse Event|0
2922667|NCT01536951|10066408|P8|Second Intervention and Washout Period 2|Adverse Event|1
2922668|NCT01536951|10066409|P7|Second Intervention and Washout Period 2|Adverse Event|0
2922669|NCT01536951|10066410|P6|Second Intervention and Washout Period 2|Adverse Event|0
2922670|NCT01536951|10066411|P5|Second Intervention and Washout Period 2|Adverse Event|0
2922671|NCT01536951|10066412|P4|Second Intervention and Washout Period 2|Adverse Event|0
2922672|NCT01536951|10066413|P3|Second Intervention and Washout Period 2|Adverse Event|0
2922673|NCT01536951|10066414|P2|Second Intervention and Washout Period 2|Adverse Event|0
2922674|NCT01536951|10066415|P1|Second Intervention and Washout Period 2|Adverse Event|0
2922675|NCT01536951|10066407|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922676|NCT01536951|10066408|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922677|NCT01536951|10066409|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922678|NCT01536951|10066410|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922679|NCT01536951|10066411|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922680|NCT01536951|10066412|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922681|NCT01536951|10066413|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
2922682|NCT01536951|10066414|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922683|NCT01536951|10066415|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
2922684|NCT01536860|10066472|P3|Washout Period (3 Days)|Lost to Follow-up|0
2922685|NCT01536860|10066473|P2|Washout Period (3 Days)|Lost to Follow-up|0
2922686|NCT01536860|10066474|P1|Washout Period (3 Days)|Lost to Follow-up|1
2922687|NCT01536704|10066482|P4|Washout Period 3|Adverse Event|0
2922688|NCT01536704|10066483|P3|Washout Period 3|Adverse Event|1
2922689|NCT01536704|10066484|P2|Washout Period 3|Adverse Event|0
2922690|NCT01536704|10066485|P1|Washout Period 3|Adverse Event|0
2922691|NCT01536704|10066482|P4|Period 3|Adverse Event|1
2922692|NCT01536704|10066483|P3|Period 3|Adverse Event|0
2922693|NCT01536704|10066484|P2|Period 3|Adverse Event|0
2922694|NCT01536704|10066485|P1|Period 3|Adverse Event|0
2922695|NCT01536704|10066482|P4|Washout Period 2|Withdrawal by Subject|1
2922696|NCT01536704|10066483|P3|Washout Period 2|Withdrawal by Subject|0
2922697|NCT01536704|10066484|P2|Washout Period 2|Withdrawal by Subject|0
2922698|NCT01536704|10066485|P1|Washout Period 2|Withdrawal by Subject|0
2922699|NCT01536704|10066482|P4|Washout Period 2|Adverse Event|0
2922700|NCT01536704|10066483|P3|Washout Period 2|Adverse Event|0
2922701|NCT01536704|10066484|P2|Washout Period 2|Adverse Event|0
2922702|NCT01536704|10066485|P1|Washout Period 2|Adverse Event|1
2922703|NCT01536704|10066482|P4|Washout Period 1|Withdrawal by Subject|0
2922704|NCT01536704|10066483|P3|Washout Period 1|Withdrawal by Subject|0
2922705|NCT01536704|10066484|P2|Washout Period 1|Withdrawal by Subject|2
2922706|NCT01536704|10066485|P1|Washout Period 1|Withdrawal by Subject|1
2922707|NCT01536587|10066515|P1|Overall Study|Adverse Event|2
2922708|NCT01536574|10066554|P2|Overall Study|Lack of Efficacy|0
2922709|NCT01536574|10066555|P1|Overall Study|Lack of Efficacy|1
2922710|NCT01536574|10066554|P2|Overall Study|Withdrawal by Subject|2
2922711|NCT01536574|10066555|P1|Overall Study|Withdrawal by Subject|1
2922712|NCT01536574|10066554|P2|Overall Study|Adverse Event|5
2922713|NCT01536574|10066555|P1|Overall Study|Adverse Event|4
2922714|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
2922715|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Death|2
2922716|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
2922717|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
2922718|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
2922719|NCT01536561|10066573|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
2922720|NCT01536535|10066613|P2|Overall Study|Participant moved|1
2922721|NCT01536535|10066614|P1|Overall Study|Participant moved|0
2922722|NCT01536535|10066613|P2|Overall Study|Physician Decision|1
2922723|NCT01536535|10066614|P1|Overall Study|Physician Decision|1
2922724|NCT01536535|10066613|P2|Overall Study|Lost to Follow-up|6
2922725|NCT01536535|10066614|P1|Overall Study|Lost to Follow-up|4
2922726|NCT01536535|10066613|P2|Overall Study|Withdrawal by Subject|5
2922727|NCT01536535|10066614|P1|Overall Study|Withdrawal by Subject|10
2922728|NCT01536418|10066663|P2|Overall Study|Withdrawal by Subject|3
2922729|NCT01536418|10066664|P1|Overall Study|Withdrawal by Subject|5
2922730|NCT01536418|10066663|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
2922731|NCT01536418|10066664|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
2922732|NCT01536418|10066663|P2|Overall Study|Adverse Event|4
2922733|NCT01536418|10066664|P1|Overall Study|Adverse Event|9
2922734|NCT01536418|10066663|P2|Overall Study|Lack of Efficacy|16
2922735|NCT01536418|10066664|P1|Overall Study|Lack of Efficacy|10
2922736|NCT01536418|10066663|P2|Overall Study|Study closed/terminated|37
2922737|NCT01536418|10066664|P1|Overall Study|Study closed/terminated|41
2922738|NCT01536418|10066663|P2|Overall Study|Physician Decision|3
2922739|NCT01536418|10066664|P1|Overall Study|Physician Decision|1
2922740|NCT01536418|10066663|P2|Overall Study|Protocol Violation|3
2922741|NCT01536418|10066664|P1|Overall Study|Protocol Violation|2
2922742|NCT01536405|10066684|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2922743|NCT01536405|10066685|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2922744|NCT01536405|10066684|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
2922745|NCT01536405|10066685|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
2922746|NCT01536405|10066684|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
2922747|NCT01536405|10066685|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
2922748|NCT01536405|10066684|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
2922749|NCT01536405|10066685|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
2922750|NCT01536405|10066684|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
2922751|NCT01536405|10066685|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
2922752|NCT01536405|10066684|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
2922753|NCT01536405|10066685|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
2922754|NCT01536405|10066684|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2922755|NCT01536405|10066685|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2922756|NCT01536405|10066684|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
2922757|NCT01536405|10066685|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
2922758|NCT01536405|10066684|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2922759|NCT01536405|10066685|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2922760|NCT01536405|10066684|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
2922761|NCT01536405|10066685|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
2922762|NCT01536405|10066684|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
2922763|NCT01536405|10066685|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
2922764|NCT01536405|10066684|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
2922765|NCT01536405|10066685|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
2922766|NCT01536405|10066684|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
2922767|NCT01536405|10066685|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
2922768|NCT01536379|10066723|P2|Overall Study|Withdrawal by Subject|1
2922769|NCT01536379|10066724|P1|Overall Study|Withdrawal by Subject|1
2922770|NCT01536379|10066723|P2|Overall Study|Adverse Event|2
2922771|NCT01536379|10066724|P1|Overall Study|Adverse Event|1
2922772|NCT01536262|10066816|P3|Overall Study|Other than stated above|0
2922773|NCT01536262|10066817|P2|Overall Study|Other than stated above|0
2922774|NCT01536262|10066818|P1|Overall Study|Other than stated above|1
2922775|NCT01536262|10066816|P3|Overall Study|Withdrawal by Subject|0
2922776|NCT01536262|10066817|P2|Overall Study|Withdrawal by Subject|1
2922777|NCT01536262|10066818|P1|Overall Study|Withdrawal by Subject|1
2922778|NCT01536262|10066816|P3|Overall Study|Adverse Event|2
2922779|NCT01536262|10066817|P2|Overall Study|Adverse Event|1
2922780|NCT01536262|10066818|P1|Overall Study|Adverse Event|6
2922781|NCT01536171|10066860|P1|Overall Study|Withdrawal by Subject|1
2922782|NCT01536145|10066865|P11|Overall Study|Adverse Event|3
2922783|NCT01536145|10066866|P10|Overall Study|Adverse Event|0
2922784|NCT01536145|10066867|P9|Overall Study|Adverse Event|0
2922785|NCT01536145|10066868|P8|Overall Study|Adverse Event|2
2922786|NCT01536145|10066869|P7|Overall Study|Adverse Event|0
2922787|NCT01536145|10066870|P6|Overall Study|Adverse Event|0
2922788|NCT01536145|10066871|P5|Overall Study|Adverse Event|0
2922789|NCT01536145|10066872|P4|Overall Study|Adverse Event|0
2922790|NCT01536145|10066873|P3|Overall Study|Adverse Event|0
2922791|NCT01536145|10066874|P2|Overall Study|Adverse Event|0
2922792|NCT01536145|10066875|P1|Overall Study|Adverse Event|0
2922793|NCT01536145|10066865|P11|Overall Study|Death|0
2922794|NCT01536145|10066866|P10|Overall Study|Death|0
2922795|NCT01536145|10066867|P9|Overall Study|Death|0
2922796|NCT01536145|10066868|P8|Overall Study|Death|0
2922797|NCT01536145|10066869|P7|Overall Study|Death|1
2922798|NCT01536145|10066870|P6|Overall Study|Death|0
2922799|NCT01536145|10066871|P5|Overall Study|Death|0
2922800|NCT01536145|10066872|P4|Overall Study|Death|0
2922801|NCT01536145|10066873|P3|Overall Study|Death|0
2922802|NCT01536145|10066874|P2|Overall Study|Death|0
2922803|NCT01536145|10066875|P1|Overall Study|Death|0
2922804|NCT01536145|10066865|P11|Overall Study|Other|2
2922805|NCT01536145|10066866|P10|Overall Study|Other|3
2922806|NCT01536145|10066867|P9|Overall Study|Other|0
2922807|NCT01536145|10066868|P8|Overall Study|Other|0
2922808|NCT01536145|10066869|P7|Overall Study|Other|0
2922809|NCT01536145|10066870|P6|Overall Study|Other|0
2922810|NCT01536145|10066871|P5|Overall Study|Other|1
2922811|NCT01536145|10066872|P4|Overall Study|Other|0
2922812|NCT01536145|10066873|P3|Overall Study|Other|0
2922813|NCT01536145|10066874|P2|Overall Study|Other|0
2922814|NCT01536145|10066875|P1|Overall Study|Other|0
2922815|NCT01536145|10066865|P11|Overall Study|Withdrawal by Subject|2
2922816|NCT01536145|10066866|P10|Overall Study|Withdrawal by Subject|0
2922817|NCT01536145|10066867|P9|Overall Study|Withdrawal by Subject|2
2922818|NCT01536145|10066868|P8|Overall Study|Withdrawal by Subject|0
2922819|NCT01536145|10066869|P7|Overall Study|Withdrawal by Subject|0
2922820|NCT01536145|10066870|P6|Overall Study|Withdrawal by Subject|1
2922821|NCT01536145|10066871|P5|Overall Study|Withdrawal by Subject|0
2922822|NCT01536145|10066872|P4|Overall Study|Withdrawal by Subject|0
2922823|NCT01536145|10066873|P3|Overall Study|Withdrawal by Subject|1
2922824|NCT01536145|10066874|P2|Overall Study|Withdrawal by Subject|0
2922825|NCT01536145|10066875|P1|Overall Study|Withdrawal by Subject|0
2922826|NCT01536145|10066865|P11|Overall Study|Progressive disease|3
2922827|NCT01536145|10066866|P10|Overall Study|Progressive disease|3
2922828|NCT01536145|10066867|P9|Overall Study|Progressive disease|1
2922829|NCT01536145|10066868|P8|Overall Study|Progressive disease|2
2922830|NCT01536145|10066869|P7|Overall Study|Progressive disease|1
2922831|NCT01536145|10066870|P6|Overall Study|Progressive disease|2
2922832|NCT01536145|10066871|P5|Overall Study|Progressive disease|1
2922833|NCT01536145|10066872|P4|Overall Study|Progressive disease|2
2922834|NCT01536145|10066873|P3|Overall Study|Progressive disease|1
2922835|NCT01536145|10066874|P2|Overall Study|Progressive disease|4
2922836|NCT01536145|10066875|P1|Overall Study|Progressive disease|3
2922837|NCT01536119|10066982|P2|Overall Study|Lost to Follow-up|14
2922838|NCT01536119|10066983|P1|Overall Study|Lost to Follow-up|17
2922839|NCT01536093|10067009|P2|Overall Study|Withdrawal by Subject|1
2922840|NCT01536093|10067010|P1|Overall Study|Withdrawal by Subject|0
2922841|NCT01536093|10067009|P2|Overall Study|absence of maternal colostrum|0
2922842|NCT01536093|10067010|P1|Overall Study|absence of maternal colostrum|2
2922843|NCT01536093|10067009|P2|Overall Study|Death|2
2922844|NCT01536093|10067010|P1|Overall Study|Death|1
2922845|NCT01536067|10067026|P1|Overall Study|Disease Progression|1
2922846|NCT01536015|10067039|P2|Overall Study|Study closure|5
2922847|NCT01536015|10067040|P1|Overall Study|Study closure|5
2922848|NCT01536015|10067039|P2|Overall Study|Inclusion Criterion not met|0
2922849|NCT01536015|10067040|P1|Overall Study|Inclusion Criterion not met|2
2922850|NCT01536015|10067039|P2|Overall Study|Lost to Follow-up|1
2922851|NCT01536015|10067040|P1|Overall Study|Lost to Follow-up|0
2922852|NCT01536015|10067039|P2|Overall Study|Adverse Event|4
2922853|NCT01536015|10067040|P1|Overall Study|Adverse Event|1
2922854|NCT01535807|10067078|P2|Overall Study|Data collection error|1
2922855|NCT01535807|10067079|P1|Overall Study|Data collection error|1
2922856|NCT01535807|10067078|P2|Overall Study|Withdrawal by Subject|1
2922857|NCT01535807|10067079|P1|Overall Study|Withdrawal by Subject|1
2922858|NCT01535729|10067085|P1|Overall Study|No participant record available|5
2922859|NCT01535729|10067085|P1|Overall Study|Not treated|9
2922860|NCT01535729|10067085|P1|Overall Study|Screening failure|1
2922861|NCT01535729|10067085|P1|Overall Study|Protocol Violation|11
2922862|NCT01535729|10067085|P1|Overall Study|NSCLC grade IV histology not confirmed|20
2922863|NCT01535729|10067085|P1|Overall Study|No previous chemotherapy|33
2922864|NCT01535729|10067085|P1|Overall Study|Did not sign informed consent|1
2922865|NCT01535729|10067085|P1|Overall Study|Other|19
2922866|NCT01535729|10067085|P1|Overall Study|Death|52
2922867|NCT01535729|10067085|P1|Overall Study|Lost to Follow-up|8
2922868|NCT01535729|10067085|P1|Overall Study|Discontinued treatment|25
2922869|NCT01535729|10067085|P1|Overall Study|Disease progression|230
2922870|NCT01535729|10067085|P1|Overall Study|Withdrawal by Subject|2
2922871|NCT01535638|10067126|P6|Treatment 3 (Single Dose)|Protocol Violation|0
2922872|NCT01535638|10067127|P5|Treatment 3 (Single Dose)|Protocol Violation|0
2922873|NCT01535638|10067128|P4|Treatment 3 (Single Dose)|Protocol Violation|1
2922874|NCT01535638|10067129|P3|Treatment 3 (Single Dose)|Protocol Violation|0
2922875|NCT01535638|10067130|P2|Treatment 3 (Single Dose)|Protocol Violation|0
2922876|NCT01535638|10067131|P1|Treatment 3 (Single Dose)|Protocol Violation|0
2922877|NCT01535638|10067126|P6|Treatment 1 (Single Dose)|Protocol Violation|1
2922878|NCT01535638|10067127|P5|Treatment 1 (Single Dose)|Protocol Violation|0
2922879|NCT01535638|10067128|P4|Treatment 1 (Single Dose)|Protocol Violation|0
2922880|NCT01535638|10067129|P3|Treatment 1 (Single Dose)|Protocol Violation|0
2922881|NCT01535638|10067130|P2|Treatment 1 (Single Dose)|Protocol Violation|0
2922882|NCT01535638|10067131|P1|Treatment 1 (Single Dose)|Protocol Violation|0
2922883|NCT01535599|10067145|P2|Overall Study|Noncompliance|1
2922884|NCT01535599|10067146|P1|Overall Study|Noncompliance|0
2922885|NCT01535599|10067145|P2|Overall Study|Stopped medication|1
2922886|NCT01535599|10067146|P1|Overall Study|Stopped medication|0
2922887|NCT01535599|10067145|P2|Overall Study|Other|0
2922888|NCT01535599|10067146|P1|Overall Study|Other|1
2922889|NCT01535599|10067145|P2|Overall Study|Did not use product|0
2922890|NCT01535599|10067146|P1|Overall Study|Did not use product|1
2922891|NCT01535599|10067145|P2|Overall Study|Randomized in Error|4
2922892|NCT01535599|10067146|P1|Overall Study|Randomized in Error|2
2922893|NCT01535599|10067145|P2|Overall Study|BL Culture + for Yeast//Fungi|1
2922894|NCT01535599|10067146|P1|Overall Study|BL Culture + for Yeast//Fungi|0
2922895|NCT01535599|10067145|P2|Overall Study|BL Culture + for Group A Strep|1
2922896|NCT01535599|10067146|P1|Overall Study|BL Culture + for Group A Strep|0
2922897|NCT01535599|10067145|P2|Overall Study|Treatment Failure|66
2922898|NCT01535599|10067146|P1|Overall Study|Treatment Failure|33
2922899|NCT01535599|10067145|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
2922900|NCT01535599|10067146|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
2922901|NCT01535599|10067145|P2|Overall Study|Lost to Follow-up|4
2922902|NCT01535599|10067146|P1|Overall Study|Lost to Follow-up|3
2922903|NCT01535599|10067145|P2|Overall Study|Adverse Event|15
2922904|NCT01535599|10067146|P1|Overall Study|Adverse Event|6
2922905|NCT01535560|10067158|P2|Overall Study|Randomized in Error|1
2922906|NCT01535560|10067159|P1|Overall Study|Randomized in Error|0
2922907|NCT01535560|10067158|P2|Overall Study|Other|1
2922908|NCT01535560|10067159|P1|Overall Study|Other|0
2922909|NCT01535560|10067158|P2|Overall Study|Treatment Failure|83
2922910|NCT01535560|10067159|P1|Overall Study|Treatment Failure|21
2922911|NCT01535560|10067158|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
2922912|NCT01535560|10067159|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
2922913|NCT01535560|10067158|P2|Overall Study|Lost to Follow-up|3
2922914|NCT01535560|10067159|P1|Overall Study|Lost to Follow-up|1
2922915|NCT01535560|10067158|P2|Overall Study|Adverse Event|7
2922916|NCT01535560|10067159|P1|Overall Study|Adverse Event|12
2922917|NCT01535443|10067169|P1|Overall Study|Physician Decision|3
2922918|NCT01535287|10067219|P2|Overall Study|drug not prepared in time|6
2922919|NCT01535287|10067220|P1|Overall Study|drug not prepared in time|5
2922920|NCT01535261|10067236|P1|Overall Study|Adverse Event|12
2922921|NCT01535261|10067236|P1|Overall Study|Withdrawal by Subject|14
2922922|NCT01535261|10067236|P1|Overall Study|Lost to Follow-up|8
2922923|NCT01535261|10067236|P1|Overall Study|Death|5
2922924|NCT01535261|10067236|P1|Overall Study|Protocol Violation|3
2922925|NCT01535261|10067236|P1|Overall Study|Physician Decision|8
2922926|NCT01535235|10067249|P2|Overall Study|Adverse Event|0
2922927|NCT01535235|10067250|P1|Overall Study|Adverse Event|1
2922928|NCT01535222|10067264|P6|Overall Study|Inclusion/exclusion|0
2922929|NCT01535222|10067265|P5|Overall Study|Inclusion/exclusion|0
2922930|NCT01535222|10067266|P4|Overall Study|Inclusion/exclusion|0
2922931|NCT01535222|10067267|P3|Overall Study|Inclusion/exclusion|1
2922932|NCT01535222|10067268|P2|Overall Study|Inclusion/exclusion|0
2922933|NCT01535222|10067269|P1|Overall Study|Inclusion/exclusion|0
2922934|NCT01535053|10067300|P2|Overall Study|Ineligible|2
2922935|NCT01535053|10067301|P1|Overall Study|Ineligible|1
2922936|NCT01535040|10067319|P2|Overall Study|Multiple Reasons|1
2922937|NCT01535040|10067320|P1|Overall Study|Multiple Reasons|1
2922938|NCT01535040|10067319|P2|Overall Study|Toxicity|5
2922939|NCT01535040|10067320|P1|Overall Study|Toxicity|7
2922940|NCT01535040|10067319|P2|Overall Study|Never Started|4
2922941|NCT01535040|10067320|P1|Overall Study|Never Started|9
2922942|NCT01535040|10067319|P2|Overall Study|Withdrawal by Subject|10
2922943|NCT01535040|10067320|P1|Overall Study|Withdrawal by Subject|13
2922944|NCT01535040|10067319|P2|Overall Study|Physician Decision|1
2922945|NCT01535040|10067320|P1|Overall Study|Physician Decision|0
2922946|NCT01534962|10067417|P4|Overall Study|Discontinued at AF recurrence|31
2922947|NCT01534962|10067418|P3|Overall Study|Discontinued at AF recurrence|24
2922948|NCT01534962|10067419|P2|Overall Study|Discontinued at AF recurrence|26
2922949|NCT01534962|10067420|P1|Overall Study|Discontinued at AF recurrence|35
2922950|NCT01534962|10067417|P4|Overall Study|Randomized but did not start treatment|1
2922951|NCT01534962|10067418|P3|Overall Study|Randomized but did not start treatment|0
2922952|NCT01534962|10067419|P2|Overall Study|Randomized but did not start treatment|0
2922953|NCT01534962|10067420|P1|Overall Study|Randomized but did not start treatment|2
2922954|NCT01534676|10067477|P2|Overall Study|Study closed due to poor enrollment|1
2922955|NCT01534676|10067478|P1|Overall Study|Study closed due to poor enrollment|2
2922956|NCT01534637|10067484|P1|Overall Study|Liver Mets before treatment|1
2922957|NCT01534637|10067484|P1|Overall Study|Adverse Event|1
2922958|NCT01534637|10067484|P1|Overall Study|Withdrawal by Subject|1
2922959|NCT01534637|10067484|P1|Overall Study|Lack of Efficacy|3
2922960|NCT01534637|10067484|P1|Overall Study|Physician Decision|3
2922961|NCT01534533|10067494|P4|Overall Study|Withdrawal by Subject|1
2922962|NCT01534533|10067495|P3|Overall Study|Withdrawal by Subject|4
2922963|NCT01534533|10067496|P2|Overall Study|Withdrawal by Subject|3
2922964|NCT01534533|10067497|P1|Overall Study|Withdrawal by Subject|5
2922965|NCT01534533|10067494|P4|Overall Study|Lost to Follow-up|3
2922966|NCT01534533|10067495|P3|Overall Study|Lost to Follow-up|4
2922967|NCT01534533|10067496|P2|Overall Study|Lost to Follow-up|0
2922968|NCT01534533|10067497|P1|Overall Study|Lost to Follow-up|3
2922969|NCT01534520|10067525|P2|Overall Study|Adverse Event|1
2922970|NCT01534520|10067526|P1|Overall Study|Adverse Event|0
2922971|NCT01534351|10067560|P3|Overall Study|Study Terminated Early|0
2922972|NCT01534351|10067561|P2|Overall Study|Study Terminated Early|0
2922973|NCT01534351|10067562|P1|Overall Study|Study Terminated Early|1
2922974|NCT01534273|10067583|P7|Period 1|Physician Decision|0
2922975|NCT01534273|10067584|P6|Period 1|Physician Decision|0
2922976|NCT01534273|10067585|P5|Period 1|Physician Decision|0
2922977|NCT01534273|10067586|P4|Period 1|Physician Decision|1
2922978|NCT01534273|10067587|P3|Period 1|Physician Decision|0
2922979|NCT01534273|10067588|P2|Period 1|Physician Decision|0
2922980|NCT01534273|10067589|P1|Period 1|Physician Decision|0
2922981|NCT01534260|10067616|P2|Overall Study|No treatment, per protocol|1
2922982|NCT01534260|10067617|P1|Overall Study|No treatment, per protocol|0
2922983|NCT01534260|10067616|P2|Overall Study|Physician Decision|1
2922984|NCT01534260|10067617|P1|Overall Study|Physician Decision|3
2922985|NCT01534260|10067616|P2|Overall Study|Disease Progression|6
2922986|NCT01534260|10067617|P1|Overall Study|Disease Progression|8
2922987|NCT01534260|10067616|P2|Overall Study|Withdrawal by Subject|3
2922988|NCT01534260|10067617|P1|Overall Study|Withdrawal by Subject|1
2922989|NCT01534260|10067616|P2|Overall Study|Lack of Efficacy|1
2922990|NCT01534260|10067617|P1|Overall Study|Lack of Efficacy|1
2922991|NCT01534260|10067616|P2|Overall Study|Death|0
2922992|NCT01534260|10067617|P1|Overall Study|Death|2
2922993|NCT01534260|10067616|P2|Overall Study|Adverse Event|8
2922994|NCT01534260|10067617|P1|Overall Study|Adverse Event|1
2922995|NCT01534208|10067627|P2|Overall Study|Needed prohibited meds|0
2922996|NCT01534208|10067628|P1|Overall Study|Needed prohibited meds|1
2922997|NCT01534208|10067627|P2|Overall Study|PCP decision|0
2922998|NCT01534208|10067628|P1|Overall Study|PCP decision|1
2922999|NCT01534208|10067627|P2|Overall Study|Eligibility error|0
2923000|NCT01534208|10067628|P1|Overall Study|Eligibility error|3
2923001|NCT01534208|10067627|P2|Overall Study|Lab assessment|1
2923002|NCT01534208|10067628|P1|Overall Study|Lab assessment|2
2923003|NCT01534208|10067627|P2|Overall Study|Subject relocation|0
2923004|NCT01534208|10067628|P1|Overall Study|Subject relocation|2
2923005|NCT01534208|10067627|P2|Overall Study|Sponsor decision|1
2923006|NCT01534208|10067628|P1|Overall Study|Sponsor decision|4
2923007|NCT01534208|10067627|P2|Overall Study|Protocol Violation|2
2923008|NCT01534208|10067628|P1|Overall Study|Protocol Violation|2
2923009|NCT01534208|10067627|P2|Overall Study|Lack of Efficacy|3
2923010|NCT01534208|10067628|P1|Overall Study|Lack of Efficacy|0
2923011|NCT01534208|10067627|P2|Overall Study|Physician Decision|0
2923012|NCT01534208|10067628|P1|Overall Study|Physician Decision|2
2923013|NCT01534208|10067627|P2|Overall Study|Adverse Event|8
2923014|NCT01534208|10067628|P1|Overall Study|Adverse Event|15
2923015|NCT01534208|10067627|P2|Overall Study|Withdrawal by Subject|20
2923016|NCT01534208|10067628|P1|Overall Study|Withdrawal by Subject|6
2923017|NCT01534208|10067627|P2|Overall Study|Lost to Follow-up|14
2923018|NCT01534208|10067628|P1|Overall Study|Lost to Follow-up|19
2923019|NCT01534195|10067646|P2|Overall Study|Withdrawal by Subject|1
2923020|NCT01534195|10067647|P1|Overall Study|Withdrawal by Subject|1
2923021|NCT01534182|10067661|P2|Overall Study|Adverse Event|3
2923022|NCT01534182|10067662|P1|Overall Study|Adverse Event|7
2923023|NCT01534182|10067661|P2|Overall Study|Withdrawal by Subject|7
2923024|NCT01534182|10067662|P1|Overall Study|Withdrawal by Subject|4
2923025|NCT01534182|10067661|P2|Overall Study|Administrative problems|0
2923026|NCT01534182|10067662|P1|Overall Study|Administrative problems|1
2923027|NCT01534078|10067693|P1|Overall Study|Withdrawal by Subject|1
2923028|NCT01534078|10067693|P1|Overall Study|Death|1
2923029|NCT01533935|10067730|P5|Overall Study|Other reason not defined above|1
2923030|NCT01533935|10067731|P4|Overall Study|Other reason not defined above|0
2923031|NCT01533935|10067732|P3|Overall Study|Other reason not defined above|1
2923032|NCT01533935|10067733|P2|Overall Study|Other reason not defined above|0
2923033|NCT01533935|10067734|P1|Overall Study|Other reason not defined above|1
2923034|NCT01533935|10067730|P5|Overall Study|Withdrawal by Subject|4
2923035|NCT01533935|10067731|P4|Overall Study|Withdrawal by Subject|2
2923036|NCT01533935|10067732|P3|Overall Study|Withdrawal by Subject|5
2923037|NCT01533935|10067733|P2|Overall Study|Withdrawal by Subject|4
2923038|NCT01533935|10067734|P1|Overall Study|Withdrawal by Subject|0
2923039|NCT01533935|10067730|P5|Overall Study|Lost to Follow-up|0
2923040|NCT01533935|10067731|P4|Overall Study|Lost to Follow-up|0
2923041|NCT01533935|10067732|P3|Overall Study|Lost to Follow-up|1
2923042|NCT01533935|10067733|P2|Overall Study|Lost to Follow-up|0
2923043|NCT01533935|10067734|P1|Overall Study|Lost to Follow-up|0
2923044|NCT01533935|10067730|P5|Overall Study|Protocol Violation|0
2923045|NCT01533935|10067731|P4|Overall Study|Protocol Violation|0
2923046|NCT01533935|10067732|P3|Overall Study|Protocol Violation|0
2923047|NCT01533935|10067733|P2|Overall Study|Protocol Violation|2
2923048|NCT01533935|10067734|P1|Overall Study|Protocol Violation|0
2923049|NCT01533935|10067730|P5|Overall Study|Adverse Event|3
2923050|NCT01533935|10067731|P4|Overall Study|Adverse Event|5
2923051|NCT01533935|10067732|P3|Overall Study|Adverse Event|1
2923052|NCT01533935|10067733|P2|Overall Study|Adverse Event|7
2923053|NCT01533935|10067734|P1|Overall Study|Adverse Event|5
2923054|NCT01533922|10067761|P5|Overall Study|Other reason not defined above|0
2923055|NCT01533922|10067762|P4|Overall Study|Other reason not defined above|0
2923056|NCT01533922|10067763|P3|Overall Study|Other reason not defined above|1
2923057|NCT01533922|10067764|P2|Overall Study|Other reason not defined above|0
2923058|NCT01533922|10067765|P1|Overall Study|Other reason not defined above|2
2923059|NCT01533922|10067761|P5|Overall Study|Withdrawal by Subject|1
2923060|NCT01533922|10067762|P4|Overall Study|Withdrawal by Subject|2
2923061|NCT01533922|10067763|P3|Overall Study|Withdrawal by Subject|2
2923062|NCT01533922|10067764|P2|Overall Study|Withdrawal by Subject|1
2923063|NCT01533922|10067765|P1|Overall Study|Withdrawal by Subject|3
2923064|NCT01533922|10067761|P5|Overall Study|Protocol Violation|1
2923065|NCT01533922|10067762|P4|Overall Study|Protocol Violation|0
2923066|NCT01533922|10067763|P3|Overall Study|Protocol Violation|0
2923067|NCT01533922|10067764|P2|Overall Study|Protocol Violation|3
2923068|NCT01533922|10067765|P1|Overall Study|Protocol Violation|0
2923069|NCT01533922|10067761|P5|Overall Study|Lack of Efficacy|0
2923070|NCT01533922|10067762|P4|Overall Study|Lack of Efficacy|0
2923071|NCT01533922|10067763|P3|Overall Study|Lack of Efficacy|1
2923072|NCT01533922|10067764|P2|Overall Study|Lack of Efficacy|0
2923073|NCT01533922|10067765|P1|Overall Study|Lack of Efficacy|0
2923074|NCT01533922|10067761|P5|Overall Study|Adverse Event|4
2923075|NCT01533922|10067762|P4|Overall Study|Adverse Event|3
2923076|NCT01533922|10067763|P3|Overall Study|Adverse Event|6
2923077|NCT01533922|10067764|P2|Overall Study|Adverse Event|8
2923078|NCT01533922|10067765|P1|Overall Study|Adverse Event|5
2923079|NCT01533688|10067810|P3|Overall Study|Had colonoscopy at outside hospital|2
2923080|NCT01533688|10067811|P2|Overall Study|Had colonoscopy at outside hospital|3
2923081|NCT01533688|10067812|P1|Overall Study|Had colonoscopy at outside hospital|2
2923082|NCT01533688|10067810|P3|Overall Study|Medically unstable|3
2923083|NCT01533688|10067811|P2|Overall Study|Medically unstable|3
2923084|NCT01533688|10067812|P1|Overall Study|Medically unstable|1
2923085|NCT01533688|10067810|P3|Overall Study|Withdrawal by Subject|3
2923086|NCT01533688|10067811|P2|Overall Study|Withdrawal by Subject|4
2923087|NCT01533688|10067812|P1|Overall Study|Withdrawal by Subject|5
2923088|NCT01533493|10067844|P2|Overall Study|Lost to Follow-up|0
2923089|NCT01533493|10067845|P1|Overall Study|Lost to Follow-up|2
2923090|NCT01533493|10067844|P2|Overall Study|Withdrawal by Subject|2
2923091|NCT01533493|10067845|P1|Overall Study|Withdrawal by Subject|1
2923092|NCT01533493|10067844|P2|Overall Study|Adverse Event|1
2923093|NCT01533493|10067845|P1|Overall Study|Adverse Event|2
2923094|NCT01533428|10067853|P2|Overall Study|Withdrawal by Subject|6
2923095|NCT01533428|10067854|P1|Overall Study|Withdrawal by Subject|7
2923096|NCT01533428|10067853|P2|Overall Study|Lost to Follow-up|1
2923097|NCT01533428|10067854|P1|Overall Study|Lost to Follow-up|2
2923098|NCT01533428|10067853|P2|Overall Study|Adverse Event|1
2923099|NCT01533428|10067854|P1|Overall Study|Adverse Event|0
2923100|NCT01533246|10067900|P1|Overall Study|Withdrawal by Subject|1
2923101|NCT01533246|10067900|P1|Overall Study|Adverse Event|1
2923102|NCT01533181|10067924|P2|Overall Study|Patient withdrawal pre-active treatment|0
2923103|NCT01533181|10067925|P1|Overall Study|Patient withdrawal pre-active treatment|1
2923104|NCT01533181|10067924|P2|Overall Study|Disease progression pre-active treatment|1
2923105|NCT01533181|10067925|P1|Overall Study|Disease progression pre-active treatment|0
2923106|NCT01532999|10068042|P2|Overall Study|New job|2
2923107|NCT01532999|10068043|P1|Overall Study|New job|0
2923108|NCT01532999|10068042|P2|Overall Study|incarcerated|1
2923109|NCT01532999|10068043|P1|Overall Study|incarcerated|0
2923110|NCT01532999|10068042|P2|Overall Study|Adverse Event|1
2923111|NCT01532999|10068043|P1|Overall Study|Adverse Event|0
2923112|NCT01532999|10068042|P2|Overall Study|no show for week 9 assessments|4
2923113|NCT01532999|10068043|P1|Overall Study|no show for week 9 assessments|6
2923114|NCT01532999|10068042|P2|Overall Study|substantial noncompliance|0
2923115|NCT01532999|10068043|P1|Overall Study|substantial noncompliance|2
2923116|NCT01532999|10068042|P2|Overall Study|should not have been randomized|0
2923117|NCT01532999|10068043|P1|Overall Study|should not have been randomized|1
2923118|NCT01532999|10068042|P2|Overall Study|Relocated|0
2923119|NCT01532999|10068043|P1|Overall Study|Relocated|2
2923120|NCT01532999|10068042|P2|Overall Study|Withdrawal by Subject|0
2923121|NCT01532999|10068043|P1|Overall Study|Withdrawal by Subject|5
2923122|NCT01532999|10068042|P2|Overall Study|Physician Decision|2
2923123|NCT01532999|10068043|P1|Overall Study|Physician Decision|1
2923124|NCT01532999|10068042|P2|Overall Study|Lost to Follow-up|8
2923125|NCT01532999|10068043|P1|Overall Study|Lost to Follow-up|14
2923126|NCT01532986|10068067|P2|Overall Study|Physician Decision|5
2923127|NCT01532986|10068068|P1|Overall Study|Physician Decision|7
2923128|NCT01532986|10068067|P2|Overall Study|Withdrawal by Subject|10
2923129|NCT01532986|10068068|P1|Overall Study|Withdrawal by Subject|7
2923130|NCT01532986|10068067|P2|Overall Study|Death|9
2923131|NCT01532986|10068068|P1|Overall Study|Death|9
2923132|NCT01532934|10068152|P2|Overall Study|In controlled environment|2
2923133|NCT01532934|10068153|P1|Overall Study|In controlled environment|3
2923134|NCT01532934|10068152|P2|Overall Study|Lost to Follow-up|11
2923135|NCT01532934|10068153|P1|Overall Study|Lost to Follow-up|11
2923136|NCT01532921|10068163|P1|Overall Study|Device was explanted during procedure|1
2923137|NCT01532921|10068163|P1|Overall Study|Physician Decision|7
2923138|NCT01532921|10068163|P1|Overall Study|Lost to Follow-up|3
2923139|NCT01532921|10068163|P1|Overall Study|Withdrawal by Subject|2
2923140|NCT01532921|10068163|P1|Overall Study|Death|3
2923141|NCT01532869|10068185|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2923142|NCT01532869|10068186|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2923143|NCT01532869|10068185|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2923144|NCT01532869|10068186|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2923145|NCT01532869|10068185|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
2923146|NCT01532869|10068186|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
2923147|NCT01532869|10068185|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
2923148|NCT01532869|10068186|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
2923149|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
2923150|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
2923151|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
2923152|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
2923153|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
2923154|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
2923155|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
2923156|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
2923157|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
2923158|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
2923159|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
2923160|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
2923161|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
2923162|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
2923163|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
2923164|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
2923165|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2923166|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2923167|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
2923168|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
2923169|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
2923170|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
2923171|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
2923172|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
2923173|NCT01532869|10068185|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
2923174|NCT01532869|10068186|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
2923175|NCT01532648|10068245|P2|Overall Study|Withdrawal by Subject|2
2923176|NCT01532648|10068246|P1|Overall Study|Withdrawal by Subject|16
2923177|NCT01532648|10068245|P2|Overall Study|Adverse Event|9
2923178|NCT01532648|10068246|P1|Overall Study|Adverse Event|12
2923179|NCT01532648|10068245|P2|Overall Study|Protocol Violation|1
2923180|NCT01532648|10068246|P1|Overall Study|Protocol Violation|1
2923181|NCT01532648|10068245|P2|Overall Study|Lack of Efficacy|1
2923182|NCT01532648|10068246|P1|Overall Study|Lack of Efficacy|4
2923183|NCT01532648|10068245|P2|Overall Study|Lost to Follow-up|4
2923184|NCT01532648|10068246|P1|Overall Study|Lost to Follow-up|3
2923185|NCT01532570|10068280|P4|Overall Study|Withdrawal by Subject|0
2923186|NCT01532570|10068281|P3|Overall Study|Withdrawal by Subject|0
2923187|NCT01532570|10068282|P2|Overall Study|Withdrawal by Subject|1
2923188|NCT01532570|10068283|P1|Overall Study|Withdrawal by Subject|0
2923189|NCT01532570|10068280|P4|Overall Study|Lack of Efficacy|0
2923190|NCT01532570|10068281|P3|Overall Study|Lack of Efficacy|0
2923191|NCT01532570|10068282|P2|Overall Study|Lack of Efficacy|0
2923192|NCT01532570|10068283|P1|Overall Study|Lack of Efficacy|1
2923193|NCT01532414|10068328|P3|Overall Study|Withdrawn by sponsor|0
2923194|NCT01532414|10068329|P2|Overall Study|Withdrawn by sponsor|0
2923195|NCT01532414|10068330|P1|Overall Study|Withdrawn by sponsor|1
2923196|NCT01532414|10068328|P3|Overall Study|Unable to complete 24 hour PK|1
2923197|NCT01532414|10068329|P2|Overall Study|Unable to complete 24 hour PK|0
2923198|NCT01532414|10068330|P1|Overall Study|Unable to complete 24 hour PK|0
2923199|NCT01532414|10068328|P3|Overall Study|Adverse Event|1
2923200|NCT01532414|10068329|P2|Overall Study|Adverse Event|1
2923201|NCT01532414|10068330|P1|Overall Study|Adverse Event|0
2923202|NCT01532414|10068328|P3|Overall Study|No V6 semen sample|0
2923203|NCT01532414|10068329|P2|Overall Study|No V6 semen sample|1
2923204|NCT01532414|10068330|P1|Overall Study|No V6 semen sample|0
2923205|NCT01532414|10068328|P3|Overall Study|Withdrawal by Subject|0
2923206|NCT01532414|10068329|P2|Overall Study|Withdrawal by Subject|0
2923207|NCT01532414|10068330|P1|Overall Study|Withdrawal by Subject|3
2923208|NCT01532414|10068328|P3|Overall Study|Lost to Follow-up|1
2923209|NCT01532414|10068329|P2|Overall Study|Lost to Follow-up|0
2923210|NCT01532414|10068330|P1|Overall Study|Lost to Follow-up|3
2923211|NCT01531998|10068413|P1|Overall Study|Withdrawal by Subject|3
2923212|NCT01531894|10068418|P1|Overall Study|Death|1
2923213|NCT01531894|10068418|P1|Overall Study|Physician Decision|8
2923214|NCT01531725|10068422|P1|Overall Study|Protocol Violation|5
2923215|NCT01531673|10068440|P13|Overall Study|Other|0
2923216|NCT01531673|10068441|P12|Overall Study|Other|0
2923217|NCT01531673|10068442|P11|Overall Study|Other|0
2923218|NCT01531673|10068443|P10|Overall Study|Other|1
2923219|NCT01531673|10068444|P9|Overall Study|Other|0
2923220|NCT01531673|10068445|P8|Overall Study|Other|0
2923221|NCT01531673|10068446|P7|Overall Study|Other|0
2923222|NCT01531673|10068447|P6|Overall Study|Other|0
2923223|NCT01531673|10068448|P5|Overall Study|Other|0
2923224|NCT01531673|10068449|P4|Overall Study|Other|1
2923225|NCT01531673|10068450|P3|Overall Study|Other|0
2923226|NCT01531673|10068451|P2|Overall Study|Other|0
2923227|NCT01531673|10068452|P1|Overall Study|Other|0
2923228|NCT01531673|10068440|P13|Overall Study|Lost to Follow-up|0
2923229|NCT01531673|10068441|P12|Overall Study|Lost to Follow-up|0
2923230|NCT01531673|10068442|P11|Overall Study|Lost to Follow-up|0
2923231|NCT01531673|10068443|P10|Overall Study|Lost to Follow-up|0
2923232|NCT01531673|10068444|P9|Overall Study|Lost to Follow-up|0
2923233|NCT01531673|10068445|P8|Overall Study|Lost to Follow-up|0
2923234|NCT01531673|10068446|P7|Overall Study|Lost to Follow-up|0
2923235|NCT01531673|10068447|P6|Overall Study|Lost to Follow-up|0
2923236|NCT01531673|10068448|P5|Overall Study|Lost to Follow-up|1
2923237|NCT01531673|10068449|P4|Overall Study|Lost to Follow-up|0
2923238|NCT01531673|10068450|P3|Overall Study|Lost to Follow-up|0
2923239|NCT01531673|10068451|P2|Overall Study|Lost to Follow-up|0
2923240|NCT01531673|10068452|P1|Overall Study|Lost to Follow-up|0
2923241|NCT01531673|10068440|P13|Overall Study|Adverse Event|0
2923242|NCT01531673|10068441|P12|Overall Study|Adverse Event|0
2923243|NCT01531673|10068442|P11|Overall Study|Adverse Event|0
2923244|NCT01531673|10068443|P10|Overall Study|Adverse Event|0
2923245|NCT01531673|10068444|P9|Overall Study|Adverse Event|0
2923246|NCT01531673|10068445|P8|Overall Study|Adverse Event|0
2923247|NCT01531673|10068446|P7|Overall Study|Adverse Event|0
2923248|NCT01531673|10068447|P6|Overall Study|Adverse Event|0
2923249|NCT01531673|10068448|P5|Overall Study|Adverse Event|0
2923250|NCT01531673|10068449|P4|Overall Study|Adverse Event|0
2923251|NCT01531673|10068450|P3|Overall Study|Adverse Event|0
2923252|NCT01531673|10068451|P2|Overall Study|Adverse Event|1
2923253|NCT01531673|10068452|P1|Overall Study|Adverse Event|0
2923254|NCT01531673|10068440|P13|Overall Study|Non-Compliance|0
2923255|NCT01531673|10068441|P12|Overall Study|Non-Compliance|0
2923256|NCT01531673|10068442|P11|Overall Study|Non-Compliance|0
2923257|NCT01531673|10068443|P10|Overall Study|Non-Compliance|0
2923258|NCT01531673|10068444|P9|Overall Study|Non-Compliance|0
2923259|NCT01531673|10068445|P8|Overall Study|Non-Compliance|0
2923260|NCT01531673|10068446|P7|Overall Study|Non-Compliance|0
2923261|NCT01531673|10068447|P6|Overall Study|Non-Compliance|1
2923262|NCT01531673|10068448|P5|Overall Study|Non-Compliance|0
2923263|NCT01531673|10068449|P4|Overall Study|Non-Compliance|0
2923264|NCT01531673|10068450|P3|Overall Study|Non-Compliance|0
2923265|NCT01531673|10068451|P2|Overall Study|Non-Compliance|0
2923266|NCT01531673|10068452|P1|Overall Study|Non-Compliance|0
2923267|NCT01531387|10068563|P2|Overall Study|Early termination of study|11
2923268|NCT01531387|10068564|P1|Overall Study|Early termination of study|11
2923269|NCT01531205|10068656|P1|Overall Study|Did not proceed to surgery|1
2923270|NCT01531153|10068668|P3|Overall Study|Withdrawal by Subject|15
2923271|NCT01531153|10068669|P2|Overall Study|Withdrawal by Subject|9
2923272|NCT01531153|10068670|P1|Overall Study|Withdrawal by Subject|10
2923273|NCT01530997|10068726|P1|Overall Study|Withdrawal by Subject|1
2923274|NCT01530997|10068726|P1|Overall Study|Physician Decision|1
2923275|NCT01530464|10068770|P2|Washout (24h)|Withdrawal by Subject|1
2923276|NCT01530464|10068771|P1|Washout (24h)|Withdrawal by Subject|0
2923277|NCT01530464|10068770|P2|Washout (24h)|Withdrawal by Subject|0
2923278|NCT01530464|10068771|P1|Washout (24h)|Withdrawal by Subject|1
2923279|NCT01530334|10068823|P1|Overall Study|Progressive disease|47
2923280|NCT01530334|10068823|P1|Overall Study|unknown reason|1
2923281|NCT01530334|10068823|P1|Overall Study|Adverse Event|3
2923282|NCT01530087|10068870|P1|Overall Study|Physician Decision|2
2923283|NCT01529749|10068886|P4|Overall Study|Protocol Violation|1
2923284|NCT01529749|10068887|P3|Overall Study|Protocol Violation|0
2923285|NCT01529749|10068888|P2|Overall Study|Protocol Violation|0
2923286|NCT01529749|10068889|P1|Overall Study|Protocol Violation|0
2923287|NCT01529749|10068886|P4|Overall Study|Withdrawal by Subject|0
2923288|NCT01529749|10068887|P3|Overall Study|Withdrawal by Subject|1
2923289|NCT01529749|10068888|P2|Overall Study|Withdrawal by Subject|1
2923290|NCT01529749|10068889|P1|Overall Study|Withdrawal by Subject|0
2923291|NCT01529749|10068886|P4|Overall Study|Physician Decision|1
2923292|NCT01529749|10068887|P3|Overall Study|Physician Decision|0
2923293|NCT01529749|10068888|P2|Overall Study|Physician Decision|0
2923294|NCT01529749|10068889|P1|Overall Study|Physician Decision|0
2923295|NCT01529749|10068886|P4|Overall Study|Lost to Follow-up|0
2923296|NCT01529749|10068887|P3|Overall Study|Lost to Follow-up|1
2923297|NCT01529749|10068888|P2|Overall Study|Lost to Follow-up|1
2923298|NCT01529749|10068889|P1|Overall Study|Lost to Follow-up|0
2923299|NCT01529645|10068973|P10|Overall Study|Withdrawal by Subject|0
2923300|NCT01529645|10068974|P9|Overall Study|Withdrawal by Subject|0
2923301|NCT01529645|10068975|P8|Overall Study|Withdrawal by Subject|0
2923302|NCT01529645|10068976|P7|Overall Study|Withdrawal by Subject|0
2923303|NCT01529645|10068977|P6|Overall Study|Withdrawal by Subject|1
2923304|NCT01529645|10068978|P5|Overall Study|Withdrawal by Subject|1
2923305|NCT01529645|10068979|P4|Overall Study|Withdrawal by Subject|1
2923306|NCT01529645|10068980|P3|Overall Study|Withdrawal by Subject|0
2923307|NCT01529645|10068981|P2|Overall Study|Withdrawal by Subject|0
2923308|NCT01529645|10068982|P1|Overall Study|Withdrawal by Subject|2
2923309|NCT01529645|10068973|P10|Overall Study|SAE - Premature contractions|0
2923310|NCT01529645|10068974|P9|Overall Study|SAE - Premature contractions|0
2923311|NCT01529645|10068975|P8|Overall Study|SAE - Premature contractions|0
2923312|NCT01529645|10068976|P7|Overall Study|SAE - Premature contractions|0
2923313|NCT01529645|10068977|P6|Overall Study|SAE - Premature contractions|0
2923314|NCT01529645|10068978|P5|Overall Study|SAE - Premature contractions|0
2923315|NCT01529645|10068979|P4|Overall Study|SAE - Premature contractions|0
2923316|NCT01529645|10068980|P3|Overall Study|SAE - Premature contractions|1
2923317|NCT01529645|10068981|P2|Overall Study|SAE - Premature contractions|0
2923318|NCT01529645|10068982|P1|Overall Study|SAE - Premature contractions|0
2923319|NCT01529645|10068973|P10|Overall Study|Lost to Follow-up|0
2923320|NCT01529645|10068974|P9|Overall Study|Lost to Follow-up|1
2923321|NCT01529645|10068975|P8|Overall Study|Lost to Follow-up|0
2923322|NCT01529645|10068976|P7|Overall Study|Lost to Follow-up|2
2923323|NCT01529645|10068977|P6|Overall Study|Lost to Follow-up|0
2923324|NCT01529645|10068978|P5|Overall Study|Lost to Follow-up|1
2923325|NCT01529645|10068979|P4|Overall Study|Lost to Follow-up|1
2923326|NCT01529645|10068980|P3|Overall Study|Lost to Follow-up|1
2923327|NCT01529645|10068981|P2|Overall Study|Lost to Follow-up|1
2923328|NCT01529645|10068982|P1|Overall Study|Lost to Follow-up|0
2923329|NCT01529632|10069080|P2|Overall Study|Adverse Event|1
2923330|NCT01529632|10069081|P1|Overall Study|Adverse Event|1
2923331|NCT01529632|10069080|P2|Overall Study|Protocol Violation|1
2923332|NCT01529632|10069081|P1|Overall Study|Protocol Violation|0
2923333|NCT01529632|10069080|P2|Overall Study|Administrative problem|1
2923334|NCT01529632|10069081|P1|Overall Study|Administrative problem|2
2923335|NCT01529606|10069101|P2|Overall Study|Lost to Follow-up|18
2923336|NCT01529606|10069102|P1|Overall Study|Lost to Follow-up|21
2923337|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Other|2
2923338|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Other|9
2923339|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Other|0
2923340|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Other|0
2923341|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Protocol Violation|0
2923342|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Protocol Violation|1
2923343|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Protocol Violation|0
2923344|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Protocol Violation|0
2923345|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
2923346|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
2923347|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2923348|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2923349|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Pregnancy|0
2923350|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Pregnancy|1
2923351|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Pregnancy|0
2923352|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Pregnancy|0
2923353|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
2923354|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
2923355|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
2923356|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
2923357|NCT01529515|10069114|P4|DOUBLE BLIND PHASE|Adverse Event|0
2923358|NCT01529515|10069115|P3|DOUBLE BLIND PHASE|Adverse Event|1
2923359|NCT01529515|10069116|P2|DOUBLE BLIND PHASE|Adverse Event|0
2923360|NCT01529515|10069117|P1|DOUBLE BLIND PHASE|Adverse Event|0
2923361|NCT01529515|10069114|P4|MAINTENANCE PHASE|Other|0
2923362|NCT01529515|10069115|P3|MAINTENANCE PHASE|Other|0
2923363|NCT01529515|10069116|P2|MAINTENANCE PHASE|Other|10
2923364|NCT01529515|10069117|P1|MAINTENANCE PHASE|Other|0
2923365|NCT01529515|10069114|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
2923366|NCT01529515|10069115|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
2923367|NCT01529515|10069116|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
2923368|NCT01529515|10069117|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
2923369|NCT01529515|10069114|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
2923370|NCT01529515|10069115|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
2923371|NCT01529515|10069116|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
2923372|NCT01529515|10069117|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
2923373|NCT01529515|10069114|P4|MAINTENANCE PHASE|Protocol Violation|0
2923374|NCT01529515|10069115|P3|MAINTENANCE PHASE|Protocol Violation|0
2923375|NCT01529515|10069116|P2|MAINTENANCE PHASE|Protocol Violation|12
2923376|NCT01529515|10069117|P1|MAINTENANCE PHASE|Protocol Violation|0
2923377|NCT01529515|10069114|P4|MAINTENANCE PHASE|Lost to Follow-up|0
2923378|NCT01529515|10069115|P3|MAINTENANCE PHASE|Lost to Follow-up|0
2923379|NCT01529515|10069116|P2|MAINTENANCE PHASE|Lost to Follow-up|5
2923380|NCT01529515|10069117|P1|MAINTENANCE PHASE|Lost to Follow-up|0
2923381|NCT01529515|10069114|P4|MAINTENANCE PHASE|Lack of Efficacy|0
2923382|NCT01529515|10069115|P3|MAINTENANCE PHASE|Lack of Efficacy|0
2923383|NCT01529515|10069116|P2|MAINTENANCE PHASE|Lack of Efficacy|9
2923384|NCT01529515|10069117|P1|MAINTENANCE PHASE|Lack of Efficacy|0
2923385|NCT01529515|10069114|P4|MAINTENANCE PHASE|Adverse Event|0
2923386|NCT01529515|10069115|P3|MAINTENANCE PHASE|Adverse Event|0
2923387|NCT01529515|10069116|P2|MAINTENANCE PHASE|Adverse Event|10
2923388|NCT01529515|10069117|P1|MAINTENANCE PHASE|Adverse Event|0
2923389|NCT01529515|10069114|P4|TRANSITION PHASE|Other|0
2923390|NCT01529515|10069115|P3|TRANSITION PHASE|Other|0
2923391|NCT01529515|10069116|P2|TRANSITION PHASE|Other|0
2923392|NCT01529515|10069117|P1|TRANSITION PHASE|Other|9
2923393|NCT01529515|10069114|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2923394|NCT01529515|10069115|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2923395|NCT01529515|10069116|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2923396|NCT01529515|10069117|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
2923397|NCT01529515|10069114|P4|TRANSITION PHASE|Withdrawal by Subject|0
2923398|NCT01529515|10069115|P3|TRANSITION PHASE|Withdrawal by Subject|0
2923399|NCT01529515|10069116|P2|TRANSITION PHASE|Withdrawal by Subject|0
2923400|NCT01529515|10069117|P1|TRANSITION PHASE|Withdrawal by Subject|51
2923401|NCT01529515|10069114|P4|TRANSITION PHASE|Protocol Violation|0
2923402|NCT01529515|10069115|P3|TRANSITION PHASE|Protocol Violation|0
2923403|NCT01529515|10069116|P2|TRANSITION PHASE|Protocol Violation|0
2923404|NCT01529515|10069117|P1|TRANSITION PHASE|Protocol Violation|4
2923405|NCT01529515|10069114|P4|TRANSITION PHASE|Lost to Follow-up|0
2923406|NCT01529515|10069115|P3|TRANSITION PHASE|Lost to Follow-up|0
2923407|NCT01529515|10069116|P2|TRANSITION PHASE|Lost to Follow-up|0
2923408|NCT01529515|10069117|P1|TRANSITION PHASE|Lost to Follow-up|19
2923409|NCT01529515|10069114|P4|TRANSITION PHASE|Lack of Efficacy|0
2923410|NCT01529515|10069115|P3|TRANSITION PHASE|Lack of Efficacy|0
2923411|NCT01529515|10069116|P2|TRANSITION PHASE|Lack of Efficacy|0
2923412|NCT01529515|10069117|P1|TRANSITION PHASE|Lack of Efficacy|19
2923413|NCT01529515|10069114|P4|TRANSITION PHASE|Death|0
2923414|NCT01529515|10069115|P3|TRANSITION PHASE|Death|0
2923415|NCT01529515|10069116|P2|TRANSITION PHASE|Death|0
2923416|NCT01529515|10069117|P1|TRANSITION PHASE|Death|1
2923417|NCT01529515|10069114|P4|TRANSITION PHASE|Adverse Event|0
2923418|NCT01529515|10069115|P3|TRANSITION PHASE|Adverse Event|0
2923419|NCT01529515|10069116|P2|TRANSITION PHASE|Adverse Event|0
2923420|NCT01529515|10069117|P1|TRANSITION PHASE|Adverse Event|16
2923421|NCT01529385|10069164|P2|Overall Study|Lost to Follow-up|1
2923422|NCT01529385|10069165|P1|Overall Study|Lost to Follow-up|2
2923423|NCT01529346|10069194|P5|Overall Study|Other|0
2923424|NCT01529346|10069195|P4|Overall Study|Other|0
2923425|NCT01529346|10069196|P3|Overall Study|Other|1
2923426|NCT01529346|10069197|P2|Overall Study|Other|1
2923427|NCT01529346|10069198|P1|Overall Study|Other|0
2923428|NCT01529346|10069194|P5|Overall Study|Lost to Follow-up|0
2923429|NCT01529346|10069195|P4|Overall Study|Lost to Follow-up|0
2923430|NCT01529346|10069196|P3|Overall Study|Lost to Follow-up|1
2923431|NCT01529346|10069197|P2|Overall Study|Lost to Follow-up|0
2923432|NCT01529346|10069198|P1|Overall Study|Lost to Follow-up|2
2923433|NCT01529268|10069286|P2|Overall Study|Moved|0
2923434|NCT01529268|10069287|P1|Overall Study|Moved|3
2923435|NCT01529268|10069286|P2|Overall Study|Lost to Follow-up|3
2923436|NCT01529268|10069287|P1|Overall Study|Lost to Follow-up|9
2923437|NCT01529112|10069349|P2|Overall Study|Withdrawal by Subject|3
2923438|NCT01529112|10069350|P1|Overall Study|Withdrawal by Subject|7
2923439|NCT01529112|10069349|P2|Overall Study|Protocol Violation|0
2923440|NCT01529112|10069350|P1|Overall Study|Protocol Violation|1
2923441|NCT01529112|10069349|P2|Overall Study|Death|38
2923442|NCT01529112|10069350|P1|Overall Study|Death|59
2923443|NCT01529112|10069349|P2|Overall Study|Adverse Event|0
2923444|NCT01529112|10069350|P1|Overall Study|Adverse Event|2
2923445|NCT01529034|10069386|P1|Overall Study|Study drug not available|2
2923446|NCT01529034|10069386|P1|Overall Study|Investigator no longer available|2
2923447|NCT01529034|10069386|P1|Overall Study|Lack of Efficacy|4
2923448|NCT01529034|10069386|P1|Overall Study|Protocol Violation|4
2923449|NCT01529034|10069386|P1|Overall Study|Adverse Event|4
2923450|NCT01529034|10069386|P1|Overall Study|Caregiver no longer available|7
2923451|NCT01529034|10069386|P1|Overall Study|Noncompliance|8
2923452|NCT01529034|10069386|P1|Overall Study|No treated SCs within protocol window|13
2923453|NCT01529034|10069386|P1|Overall Study|Withdrawal by Subject|25
2923454|NCT01529034|10069386|P1|Overall Study|Study termination|29
2923455|NCT01529034|10069386|P1|Overall Study|Site closure|62
2923456|NCT01529034|10069386|P1|Overall Study|Discontinued prior to study treatment|14
2923457|NCT01528969|10069401|P2|Overall Study|absent from the school at baseline|0
2923458|NCT01528969|10069402|P1|Overall Study|absent from the school at baseline|2
2923459|NCT01528787|10069435|P4|Overall Study|Family Emergency|0
2923460|NCT01528787|10069436|P3|Overall Study|Family Emergency|1
2923461|NCT01528787|10069437|P2|Overall Study|Family Emergency|0
2923462|NCT01528787|10069438|P1|Overall Study|Family Emergency|0
2923463|NCT01528787|10069435|P4|Overall Study|Withdrawal by Subject|1
2923464|NCT01528787|10069436|P3|Overall Study|Withdrawal by Subject|0
2923465|NCT01528787|10069437|P2|Overall Study|Withdrawal by Subject|0
2923466|NCT01528787|10069438|P1|Overall Study|Withdrawal by Subject|0
2923467|NCT01528735|10069450|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
2923468|NCT01528735|10069451|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
2923469|NCT01528735|10069450|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2923470|NCT01528735|10069451|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2923471|NCT01528709|10069553|P2|Overall Study|allergy|0
2923472|NCT01528709|10069554|P1|Overall Study|allergy|1
2923473|NCT01528709|10069553|P2|Overall Study|Withdrawal by Subject|15
2923474|NCT01528709|10069554|P1|Overall Study|Withdrawal by Subject|10
2923475|NCT01528709|10069553|P2|Overall Study|Death|0
2923476|NCT01528709|10069554|P1|Overall Study|Death|2
2923477|NCT01528696|10069564|P2|Overall Study|See detailed description|19
2923478|NCT01528696|10069565|P1|Overall Study|See detailed description|18
2923479|NCT01528605|10069581|P6|Overall Study|Death|0
2923480|NCT01528605|10069582|P5|Overall Study|Death|0
2923481|NCT01528605|10069583|P4|Overall Study|Death|0
2923482|NCT01528605|10069584|P3|Overall Study|Death|0
2923483|NCT01528605|10069585|P2|Overall Study|Death|0
2923484|NCT01528605|10069586|P1|Overall Study|Death|1
2923485|NCT01528605|10069581|P6|Overall Study|Lost to Follow-up|0
2923486|NCT01528605|10069582|P5|Overall Study|Lost to Follow-up|0
2923487|NCT01528605|10069583|P4|Overall Study|Lost to Follow-up|1
2923488|NCT01528605|10069584|P3|Overall Study|Lost to Follow-up|1
2923489|NCT01528605|10069585|P2|Overall Study|Lost to Follow-up|0
2923490|NCT01528605|10069586|P1|Overall Study|Lost to Follow-up|1
2923491|NCT01528345|10069616|P2|Overall Study|Subject/Guardian Decision|0
2923492|NCT01528345|10069617|P1|Overall Study|Subject/Guardian Decision|5
2923493|NCT01528345|10069616|P2|Overall Study|Study Terminated by Sponsor|8
2923494|NCT01528345|10069617|P1|Overall Study|Study Terminated by Sponsor|4
2923495|NCT01528345|10069616|P2|Overall Study|Progressive Disease|40
2923496|NCT01528345|10069617|P1|Overall Study|Progressive Disease|26
2923497|NCT01528345|10069616|P2|Overall Study|Non-compliance with study treatment|0
2923498|NCT01528345|10069617|P1|Overall Study|Non-compliance with study treatment|1
2923499|NCT01528345|10069616|P2|Overall Study|Death|1
2923500|NCT01528345|10069617|P1|Overall Study|Death|1
2923501|NCT01528345|10069616|P2|Overall Study|Adverse Event|1
2923502|NCT01528345|10069617|P1|Overall Study|Adverse Event|10
2923503|NCT01528254|10069668|P2|Overall Study|No longer requires study drug|1
2923504|NCT01528254|10069669|P1|Overall Study|No longer requires study drug|1
2923505|NCT01528254|10069668|P2|Overall Study|Abnormal test procedure result(s)|0
2923506|NCT01528254|10069669|P1|Overall Study|Abnormal test procedure result(s)|1
2923507|NCT01528254|10069668|P2|Overall Study|Abnormal laboratory value(s)|7
2923508|NCT01528254|10069669|P1|Overall Study|Abnormal laboratory value(s)|3
2923509|NCT01528254|10069668|P2|Overall Study|Withdrawal by Subject|4
2923510|NCT01528254|10069669|P1|Overall Study|Withdrawal by Subject|5
2923511|NCT01528254|10069668|P2|Overall Study|Unsatisfactory therapeutic effect|8
2923512|NCT01528254|10069669|P1|Overall Study|Unsatisfactory therapeutic effect|6
2923513|NCT01528254|10069668|P2|Overall Study|New therapy for study indication|6
2923514|NCT01528254|10069669|P1|Overall Study|New therapy for study indication|8
2923515|NCT01528254|10069668|P2|Overall Study|Protocol deviation|19
2923516|NCT01528254|10069669|P1|Overall Study|Protocol deviation|9
2923517|NCT01528254|10069668|P2|Overall Study|Death|9
2923518|NCT01528254|10069669|P1|Overall Study|Death|13
2923519|NCT01528254|10069668|P2|Overall Study|Lost to Follow-up|24
2923520|NCT01528254|10069669|P1|Overall Study|Lost to Follow-up|17
2923521|NCT01528254|10069668|P2|Overall Study|Adverse Event|44
2923522|NCT01528254|10069669|P1|Overall Study|Adverse Event|28
2923523|NCT01528254|10069668|P2|Overall Study|Administrative problems|94
2923524|NCT01528254|10069669|P1|Overall Study|Administrative problems|96
2923525|NCT01528215|10069701|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
2923526|NCT01528215|10069702|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
2923527|NCT01528215|10069701|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
2923528|NCT01528215|10069702|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
2923529|NCT01528215|10069701|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2923530|NCT01528215|10069702|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2923531|NCT01528215|10069701|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
2923532|NCT01528215|10069702|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
2923533|NCT01528072|10069761|P1|Overall Study|Early Termination of Study|52
2923534|NCT01528072|10069761|P1|Overall Study|Death|2
2923535|NCT01528072|10069761|P1|Overall Study|Site Closure|4
2923536|NCT01528072|10069761|P1|Overall Study|Explanted|2
2923537|NCT01528072|10069761|P1|Overall Study|Lost to Follow-up|5
2923538|NCT01528072|10069761|P1|Overall Study|Missed Visit|2
2923539|NCT01528072|10069761|P1|Overall Study|Determined not eligible by AEAC|1
2923540|NCT01528072|10069761|P1|Overall Study|Physician Decision|1
2923541|NCT01528072|10069761|P1|Overall Study|Withdrawal by Subject|5
2923542|NCT01527682|10069778|P1|Overall Study|Protocol Violation|8
2923543|NCT01527500|10069801|P2|Part B|Adverse Event|0
2923544|NCT01527500|10069802|P1|Part B|Adverse Event|1
2923545|NCT01527500|10069801|P2|Part A|Withdrawal by Subject|0
2923546|NCT01527500|10069802|P1|Part A|Withdrawal by Subject|2
2923547|NCT01527500|10069801|P2|Part A|Protocol Deviation|2
2923548|NCT01527500|10069802|P1|Part A|Protocol Deviation|9
2923549|NCT01527500|10069801|P2|Part A|Lost to Follow-up|1
2923550|NCT01527500|10069802|P1|Part A|Lost to Follow-up|0
2923551|NCT01527500|10069801|P2|Part A|Death|1
2923552|NCT01527500|10069802|P1|Part A|Death|4
2923553|NCT01527500|10069801|P2|Part A|Adverse Event|2
2923554|NCT01527500|10069802|P1|Part A|Adverse Event|4
2923555|NCT01527500|10069801|P2|Part A|Administrative|7
2923556|NCT01527500|10069802|P1|Part A|Administrative|11
2923557|NCT01527487|10069832|P2|Overall Study|Death|1
2923558|NCT01527487|10069833|P1|Overall Study|Death|0
2923559|NCT01527487|10069832|P2|Overall Study|Adverse Event|1
2923560|NCT01527487|10069833|P1|Overall Study|Adverse Event|1
2923561|NCT01527487|10069832|P2|Overall Study|Disease Progression|1
2923562|NCT01527487|10069833|P1|Overall Study|Disease Progression|4
2923563|NCT01527487|10069832|P2|Overall Study|MD Discretion/Lack of Efficacy|4
2923564|NCT01527487|10069833|P1|Overall Study|MD Discretion/Lack of Efficacy|3
2923565|NCT01527383|10069847|P2|Overall Study|Withdrawal by Subject|3
2923566|NCT01527383|10069848|P1|Overall Study|Withdrawal by Subject|2
2923567|NCT01527383|10069847|P2|Overall Study|Participant moved|1
2923568|NCT01527383|10069848|P1|Overall Study|Participant moved|0
2923569|NCT01527383|10069847|P2|Overall Study|Screen failure|0
2923570|NCT01527383|10069848|P1|Overall Study|Screen failure|1
2923571|NCT01527383|10069847|P2|Overall Study|Protocol Violation|0
2923572|NCT01527383|10069848|P1|Overall Study|Protocol Violation|1
2923573|NCT01527383|10069847|P2|Overall Study|Pregnancy|0
2923574|NCT01527383|10069848|P1|Overall Study|Pregnancy|1
2923575|NCT01527383|10069847|P2|Overall Study|Physician Decision|0
2923576|NCT01527383|10069848|P1|Overall Study|Physician Decision|2
2923577|NCT01527383|10069847|P2|Overall Study|Lost to Follow-up|0
2923578|NCT01527383|10069848|P1|Overall Study|Lost to Follow-up|3
2923579|NCT01527383|10069847|P2|Overall Study|Adverse Event|0
2923580|NCT01527383|10069848|P1|Overall Study|Adverse Event|5
2923581|NCT01527370|10069862|P1|Overall Study|Death|1
2923582|NCT01527370|10069862|P1|Overall Study|Physician Decision|1
2923583|NCT01527370|10069862|P1|Overall Study|Withdrawal by Subject|4
2923584|NCT01527357|10069870|P2|Overall Study|Did Not Receive Treatment|0
2923585|NCT01527357|10069871|P1|Overall Study|Did Not Receive Treatment|2
2923586|NCT01527357|10069870|P2|Overall Study|No Day 29 Visit|1
2923587|NCT01527357|10069871|P1|Overall Study|No Day 29 Visit|0
2923588|NCT01527357|10069870|P2|Overall Study|Non-compliance|1
2923589|NCT01527357|10069871|P1|Overall Study|Non-compliance|0
2923590|NCT01527357|10069870|P2|Overall Study|Withdrew Consent|1
2923591|NCT01527357|10069871|P1|Overall Study|Withdrew Consent|1
2923592|NCT01527357|10069870|P2|Overall Study|Lost to Follow-up|4
2923593|NCT01527357|10069871|P1|Overall Study|Lost to Follow-up|6
2923594|NCT01527357|10069870|P2|Overall Study|Death|2
2923595|NCT01527357|10069871|P1|Overall Study|Death|8
2923596|NCT01527292|10069893|P2|Overall Study|Physician Decision|3
2923597|NCT01527292|10069894|P1|Overall Study|Physician Decision|0
2923598|NCT01527110|10069921|P1|Overall Study|Adverse Event|1
2923599|NCT01527006|10070002|P2|Extension Phase|Other|3
2923600|NCT01527006|10070003|P1|Extension Phase|Other|0
2923601|NCT01527006|10070002|P2|Extension Phase|Inadequate therapeutic effect|1
2923602|NCT01527006|10070003|P1|Extension Phase|Inadequate therapeutic effect|1
2923603|NCT01527006|10070002|P2|Extension Phase|Subject Choice|1
2923604|NCT01527006|10070003|P1|Extension Phase|Subject Choice|1
2923605|NCT01527006|10070002|P2|Extension Phase|Lost to Follow-up|1
2923606|NCT01527006|10070003|P1|Extension Phase|Lost to Follow-up|0
2923607|NCT01527006|10070002|P2|Extension Phase|Adverse Event|2
2923608|NCT01527006|10070003|P1|Extension Phase|Adverse Event|4
2923609|NCT01527006|10070002|P2|Core Study|Other|2
2923610|NCT01527006|10070003|P1|Core Study|Other|0
2923611|NCT01527006|10070002|P2|Core Study|Withdrawal by Subject|1
2923612|NCT01527006|10070003|P1|Core Study|Withdrawal by Subject|0
2923613|NCT01527006|10070002|P2|Core Study|Inadequate Therapeutic Effect|0
2923614|NCT01527006|10070003|P1|Core Study|Inadequate Therapeutic Effect|1
2923615|NCT01527006|10070002|P2|Core Study|Subject Choice|0
2923616|NCT01527006|10070003|P1|Core Study|Subject Choice|1
2923617|NCT01527006|10070002|P2|Core Study|Lost to Follow-up|1
2923618|NCT01527006|10070003|P1|Core Study|Lost to Follow-up|0
2923619|NCT01527006|10070002|P2|Core Study|Adverse Event|2
2923620|NCT01527006|10070003|P1|Core Study|Adverse Event|0
2923621|NCT01526928|10070059|P6|Overall Study|Missing|0
2923622|NCT01526928|10070060|P5|Overall Study|Missing|2
2923623|NCT01526928|10070061|P4|Overall Study|Missing|0
2923624|NCT01526928|10070062|P3|Overall Study|Missing|1
2923625|NCT01526928|10070063|P2|Overall Study|Missing|0
2923626|NCT01526928|10070064|P1|Overall Study|Missing|0
2923627|NCT01526928|10070059|P6|Overall Study|Protocol Deviation|0
2923628|NCT01526928|10070060|P5|Overall Study|Protocol Deviation|0
2923629|NCT01526928|10070061|P4|Overall Study|Protocol Deviation|2
2923630|NCT01526928|10070062|P3|Overall Study|Protocol Deviation|0
2923631|NCT01526928|10070063|P2|Overall Study|Protocol Deviation|0
2923632|NCT01526928|10070064|P1|Overall Study|Protocol Deviation|0
2923633|NCT01526928|10070059|P6|Overall Study|Lost to Follow-up|0
2923634|NCT01526928|10070060|P5|Overall Study|Lost to Follow-up|0
2923635|NCT01526928|10070061|P4|Overall Study|Lost to Follow-up|1
2923636|NCT01526928|10070062|P3|Overall Study|Lost to Follow-up|0
2923637|NCT01526928|10070063|P2|Overall Study|Lost to Follow-up|0
2923638|NCT01526928|10070064|P1|Overall Study|Lost to Follow-up|0
2923639|NCT01526928|10070059|P6|Overall Study|Other Reason|0
2923640|NCT01526928|10070060|P5|Overall Study|Other Reason|1
2923641|NCT01526928|10070061|P4|Overall Study|Other Reason|4
2923642|NCT01526928|10070062|P3|Overall Study|Other Reason|11
2923643|NCT01526928|10070063|P2|Overall Study|Other Reason|1
2923644|NCT01526928|10070064|P1|Overall Study|Other Reason|0
2923645|NCT01526928|10070059|P6|Overall Study|Physician Decision|0
2923646|NCT01526928|10070060|P5|Overall Study|Physician Decision|0
2923647|NCT01526928|10070061|P4|Overall Study|Physician Decision|5
2923648|NCT01526928|10070062|P3|Overall Study|Physician Decision|2
2923649|NCT01526928|10070063|P2|Overall Study|Physician Decision|0
2923650|NCT01526928|10070064|P1|Overall Study|Physician Decision|0
2923651|NCT01526928|10070059|P6|Overall Study|Withdrawal by Subject|0
2923652|NCT01526928|10070060|P5|Overall Study|Withdrawal by Subject|3
2923653|NCT01526928|10070061|P4|Overall Study|Withdrawal by Subject|11
2923654|NCT01526928|10070062|P3|Overall Study|Withdrawal by Subject|13
2923655|NCT01526928|10070063|P2|Overall Study|Withdrawal by Subject|0
2923656|NCT01526928|10070064|P1|Overall Study|Withdrawal by Subject|1
2923657|NCT01526928|10070059|P6|Overall Study|Death|0
2923658|NCT01526928|10070060|P5|Overall Study|Death|0
2923659|NCT01526928|10070061|P4|Overall Study|Death|0
2923660|NCT01526928|10070062|P3|Overall Study|Death|3
2923661|NCT01526928|10070063|P2|Overall Study|Death|0
2923662|NCT01526928|10070064|P1|Overall Study|Death|0
2923663|NCT01526928|10070059|P6|Overall Study|Adverse Event|2
2923664|NCT01526928|10070060|P5|Overall Study|Adverse Event|13
2923665|NCT01526928|10070061|P4|Overall Study|Adverse Event|40
2923666|NCT01526928|10070062|P3|Overall Study|Adverse Event|29
2923667|NCT01526928|10070063|P2|Overall Study|Adverse Event|1
2923668|NCT01526928|10070064|P1|Overall Study|Adverse Event|2
2923669|NCT01526928|10070059|P6|Overall Study|Progressive Disease|4
2923670|NCT01526928|10070060|P5|Overall Study|Progressive Disease|76
2923671|NCT01526928|10070061|P4|Overall Study|Progressive Disease|182
2923672|NCT01526928|10070062|P3|Overall Study|Progressive Disease|150
2923673|NCT01526928|10070063|P2|Overall Study|Progressive Disease|17
2923674|NCT01526928|10070064|P1|Overall Study|Progressive Disease|35
2923675|NCT01526889|10070202|P2|Treatment Extension Period|Administrative problems|0
2923676|NCT01526889|10070203|P1|Treatment Extension Period|Administrative problems|1
2923677|NCT01526889|10070202|P2|Treatment Period|Adverse Event|0
2923678|NCT01526889|10070203|P1|Treatment Period|Adverse Event|2
2923679|NCT01526785|10070224|P1|Overall Study|Withdrawal by Subject|2
2923680|NCT01526785|10070224|P1|Overall Study|Physician Decision|1
2923681|NCT01526785|10070224|P1|Overall Study|Death|2
2923682|NCT01526785|10070224|P1|Overall Study|Study Terminated by Sponsor|8
2923683|NCT01526733|10070234|P2|Phase 1|Withdrawal by Subject|1
2923684|NCT01526733|10070235|P1|Phase 1|Withdrawal by Subject|1
2923685|NCT01526733|10070234|P2|Phase 1|Protocol Violation|0
2923686|NCT01526733|10070235|P1|Phase 1|Protocol Violation|1
2923687|NCT01526551|10070274|P1|Overall Study|Lack of returned parental consent form|424
2923688|NCT01526148|10070321|P2|Overall Study|Incarcerated|2
2923689|NCT01526148|10070322|P1|Overall Study|Incarcerated|0
2923690|NCT01526148|10070321|P2|Overall Study|Moved out of state|0
2923691|NCT01526148|10070322|P1|Overall Study|Moved out of state|1
2923692|NCT01526148|10070321|P2|Overall Study|Unable to discontinue concomitant med|0
2923693|NCT01526148|10070322|P1|Overall Study|Unable to discontinue concomitant med|1
2923694|NCT01526148|10070321|P2|Overall Study|Unstable Medical Condition|0
2923695|NCT01526148|10070322|P1|Overall Study|Unstable Medical Condition|1
2923696|NCT01526148|10070321|P2|Overall Study|Withdrawal by Subject|0
2923697|NCT01526148|10070322|P1|Overall Study|Withdrawal by Subject|2
2923698|NCT01526148|10070321|P2|Overall Study|Lost to Follow-up|6
2923699|NCT01526148|10070322|P1|Overall Study|Lost to Follow-up|3
2923700|NCT01526148|10070321|P2|Overall Study|Adverse Event|5
2923701|NCT01526148|10070322|P1|Overall Study|Adverse Event|6
2923702|NCT01526057|10070333|P3|Overall Study|Protocol Violation|1
2923703|NCT01526057|10070334|P2|Overall Study|Protocol Violation|0
2923704|NCT01526057|10070335|P1|Overall Study|Protocol Violation|0
2923705|NCT01526057|10070333|P3|Overall Study|Other|1
2923706|NCT01526057|10070334|P2|Overall Study|Other|0
2923707|NCT01526057|10070335|P1|Overall Study|Other|1
2923708|NCT01526057|10070333|P3|Overall Study|Lost to Follow-up|1
2923709|NCT01526057|10070334|P2|Overall Study|Lost to Follow-up|0
2923710|NCT01526057|10070335|P1|Overall Study|Lost to Follow-up|1
2923711|NCT01526057|10070333|P3|Overall Study|Death|0
2923712|NCT01526057|10070334|P2|Overall Study|Death|0
2923713|NCT01526057|10070335|P1|Overall Study|Death|1
2923714|NCT01526057|10070333|P3|Overall Study|Adverse Event|1
2923715|NCT01526057|10070334|P2|Overall Study|Adverse Event|1
2923716|NCT01526057|10070335|P1|Overall Study|Adverse Event|3
2923717|NCT01526057|10070333|P3|Overall Study|Withdrawal by Subject|2
2923718|NCT01526057|10070334|P2|Overall Study|Withdrawal by Subject|2
2923719|NCT01526057|10070335|P1|Overall Study|Withdrawal by Subject|3
2923720|NCT01525875|10070434|P2|Open-label Period|Lost to Follow-up|2
2923721|NCT01525875|10070435|P1|Open-label Period|Lost to Follow-up|0
2923722|NCT01525875|10070434|P2|Placebo-controlled Period|Withdrawal by Subject|2
2923723|NCT01525875|10070435|P1|Placebo-controlled Period|Withdrawal by Subject|1
2923724|NCT01525849|10070451|P2|Overall Study|Anatomic exclusion criteria identified|3
2923725|NCT01525849|10070452|P1|Overall Study|Anatomic exclusion criteria identified|0
2923726|NCT01525849|10070451|P2|Overall Study|Unrelated medical issue (not treated)|2
2923727|NCT01525849|10070452|P1|Overall Study|Unrelated medical issue (not treated)|1
2923728|NCT01525849|10070451|P2|Overall Study|Withdrawal by Subject|9
2923729|NCT01525849|10070452|P1|Overall Study|Withdrawal by Subject|1
2923730|NCT01525849|10070451|P2|Overall Study|Lost to Follow-up|2
2923731|NCT01525849|10070452|P1|Overall Study|Lost to Follow-up|3
2923732|NCT01525641|10070508|P1|Overall Study|Other than stated above|7
2923733|NCT01525641|10070508|P1|Overall Study|Lost to follow-up (Changing hospital)|19
2923734|NCT01525641|10070508|P1|Overall Study|Lost to follow-up (Unknown reason)|10
2923735|NCT01525641|10070508|P1|Overall Study|Lost to follow-up (relocation)|1
2923736|NCT01525641|10070508|P1|Overall Study|Improvement|5
2923737|NCT01525641|10070508|P1|Overall Study|Lack of Efficacy|24
2923738|NCT01525641|10070508|P1|Overall Study|Adverse Event|73
2923739|NCT01525641|10070508|P1|Overall Study|No visit since the first visit|16
2923740|NCT01525641|10070508|P1|Overall Study|Case report form not collected|25
2923741|NCT01525628|10070522|P5|Overall Study|Other reason not defined above|0
2923742|NCT01525628|10070523|P4|Overall Study|Other reason not defined above|3
2923743|NCT01525628|10070524|P3|Overall Study|Other reason not defined above|0
2923744|NCT01525628|10070525|P2|Overall Study|Other reason not defined above|0
2923745|NCT01525628|10070526|P1|Overall Study|Other reason not defined above|0
2923746|NCT01525628|10070522|P5|Overall Study|Withdrawal by Subject|0
2923747|NCT01525628|10070523|P4|Overall Study|Withdrawal by Subject|0
2923748|NCT01525628|10070524|P3|Overall Study|Withdrawal by Subject|0
2923749|NCT01525628|10070525|P2|Overall Study|Withdrawal by Subject|1
2923750|NCT01525628|10070526|P1|Overall Study|Withdrawal by Subject|0
2923751|NCT01525628|10070522|P5|Overall Study|Lost to Follow-up|0
2923752|NCT01525628|10070523|P4|Overall Study|Lost to Follow-up|0
2923753|NCT01525628|10070524|P3|Overall Study|Lost to Follow-up|0
2923754|NCT01525628|10070525|P2|Overall Study|Lost to Follow-up|1
2923755|NCT01525628|10070526|P1|Overall Study|Lost to Follow-up|1
2923756|NCT01525628|10070522|P5|Overall Study|Protocol Violation|0
2923757|NCT01525628|10070523|P4|Overall Study|Protocol Violation|0
2923758|NCT01525628|10070524|P3|Overall Study|Protocol Violation|1
2923759|NCT01525628|10070525|P2|Overall Study|Protocol Violation|0
2923760|NCT01525628|10070526|P1|Overall Study|Protocol Violation|0
2923761|NCT01525628|10070522|P5|Overall Study|Lack of Efficacy|2
2923762|NCT01525628|10070523|P4|Overall Study|Lack of Efficacy|1
2923763|NCT01525628|10070524|P3|Overall Study|Lack of Efficacy|2
2923764|NCT01525628|10070525|P2|Overall Study|Lack of Efficacy|2
2923765|NCT01525628|10070526|P1|Overall Study|Lack of Efficacy|0
2923766|NCT01525628|10070522|P5|Overall Study|Adverse Event|1
2923767|NCT01525628|10070523|P4|Overall Study|Adverse Event|0
2923768|NCT01525628|10070524|P3|Overall Study|Adverse Event|2
2923769|NCT01525628|10070525|P2|Overall Study|Adverse Event|1
2923770|NCT01525628|10070526|P1|Overall Study|Adverse Event|1
2923771|NCT01525615|10070593|P3|Overall Study|Other reason not described above|1
2923772|NCT01525615|10070594|P2|Overall Study|Other reason not described above|0
2923773|NCT01525615|10070595|P1|Overall Study|Other reason not described above|1
2923774|NCT01525615|10070593|P3|Overall Study|Withdrawal by Subject|0
2923775|NCT01525615|10070594|P2|Overall Study|Withdrawal by Subject|0
2923776|NCT01525615|10070595|P1|Overall Study|Withdrawal by Subject|1
2923777|NCT01525615|10070593|P3|Overall Study|Lost to Follow-up|0
2923778|NCT01525615|10070594|P2|Overall Study|Lost to Follow-up|0
2923779|NCT01525615|10070595|P1|Overall Study|Lost to Follow-up|1
2923780|NCT01525615|10070593|P3|Overall Study|Adverse Event|5
2923781|NCT01525615|10070594|P2|Overall Study|Adverse Event|7
2923782|NCT01525615|10070595|P1|Overall Study|Adverse Event|11
2923783|NCT01525550|10070651|P2|Overall Study|Withdrawal by Subject|0
2923784|NCT01525550|10070652|P1|Overall Study|Withdrawal by Subject|4
2923785|NCT01525550|10070651|P2|Overall Study|Sponsor's Decision|11
2923786|NCT01525550|10070652|P1|Overall Study|Sponsor's Decision|30
2923787|NCT01525550|10070651|P2|Overall Study|Other|4
2923788|NCT01525550|10070652|P1|Overall Study|Other|0
2923789|NCT01525550|10070651|P2|Overall Study|Death|28
2923790|NCT01525550|10070652|P1|Overall Study|Death|19
2923791|NCT01525550|10070651|P2|Overall Study|Lost to Follow-up|2
2923792|NCT01525550|10070652|P1|Overall Study|Lost to Follow-up|8
2923793|NCT01525407|10070723|P2|Overall Study|Delay in Transplant|0
2923794|NCT01525407|10070724|P1|Overall Study|Delay in Transplant|1
2923795|NCT01525407|10070723|P2|Overall Study|Transplant was delayed|1
2923796|NCT01525407|10070724|P1|Overall Study|Transplant was delayed|0
2923797|NCT01525407|10070723|P2|Overall Study|Withdrawal by Subject|1
2923798|NCT01525407|10070724|P1|Overall Study|Withdrawal by Subject|0
2923799|NCT01525407|10070723|P2|Overall Study|Change in recipient treatment plan|2
2923800|NCT01525407|10070724|P1|Overall Study|Change in recipient treatment plan|2
2923801|NCT01525238|10070756|P3|Overall Study|Withdrawal by Subject|0
2923802|NCT01525238|10070757|P2|Overall Study|Withdrawal by Subject|0
2923803|NCT01525238|10070758|P1|Overall Study|Withdrawal by Subject|1
2923804|NCT01525225|10070823|P1|Enrollment|Other|1
2923805|NCT01525225|10070823|P1|Enrollment|No longer met study criteria|1
2923806|NCT01524991|10070837|P1|Overall Study|Symptomatic Deterioration|1
2923807|NCT01524991|10070837|P1|Overall Study|Withdrawal by Subject|2
2923808|NCT01524991|10070837|P1|Overall Study|Other complicating disease|1
2923809|NCT01524991|10070837|P1|Overall Study|Disease ProgressionDu|17
2923810|NCT01524991|10070837|P1|Overall Study|Death|1
2923811|NCT01524991|10070837|P1|Overall Study|Adverse Event|12
2923812|NCT01524978|10070855|P11|Overall Study|Death|17
2923813|NCT01524978|10070856|P10|Overall Study|Death|6
2923814|NCT01524978|10070857|P9|Overall Study|Death|5
2923815|NCT01524978|10070858|P8|Overall Study|Death|9
2923816|NCT01524978|10070859|P7|Overall Study|Death|1
2923817|NCT01524978|10070860|P6|Overall Study|Death|4
2923818|NCT01524978|10070861|P5|Overall Study|Death|4
2923819|NCT01524978|10070862|P4|Overall Study|Death|24
2923820|NCT01524978|10070863|P3|Overall Study|Death|5
2923821|NCT01524978|10070864|P2|Overall Study|Death|2
2923822|NCT01524978|10070865|P1|Overall Study|Death|34
2923823|NCT01524978|10070855|P11|Overall Study|Lost to Follow-up|1
2923824|NCT01524978|10070856|P10|Overall Study|Lost to Follow-up|1
2923825|NCT01524978|10070857|P9|Overall Study|Lost to Follow-up|1
2923826|NCT01524978|10070858|P8|Overall Study|Lost to Follow-up|0
2923827|NCT01524978|10070859|P7|Overall Study|Lost to Follow-up|2
2923828|NCT01524978|10070860|P6|Overall Study|Lost to Follow-up|1
2923829|NCT01524978|10070861|P5|Overall Study|Lost to Follow-up|1
2923830|NCT01524978|10070862|P4|Overall Study|Lost to Follow-up|0
2923831|NCT01524978|10070863|P3|Overall Study|Lost to Follow-up|3
2923832|NCT01524978|10070864|P2|Overall Study|Lost to Follow-up|0
2923833|NCT01524978|10070865|P1|Overall Study|Lost to Follow-up|0
2923834|NCT01524978|10070855|P11|Overall Study|Withdrawal by Subject|5
2923835|NCT01524978|10070856|P10|Overall Study|Withdrawal by Subject|0
2923836|NCT01524978|10070857|P9|Overall Study|Withdrawal by Subject|4
2923837|NCT01524978|10070858|P8|Overall Study|Withdrawal by Subject|2
2923838|NCT01524978|10070859|P7|Overall Study|Withdrawal by Subject|6
2923839|NCT01524978|10070860|P6|Overall Study|Withdrawal by Subject|1
2923840|NCT01524978|10070861|P5|Overall Study|Withdrawal by Subject|3
2923841|NCT01524978|10070862|P4|Overall Study|Withdrawal by Subject|1
2923842|NCT01524978|10070863|P3|Overall Study|Withdrawal by Subject|1
2923843|NCT01524978|10070864|P2|Overall Study|Withdrawal by Subject|0
2923844|NCT01524978|10070865|P1|Overall Study|Withdrawal by Subject|12
2923845|NCT01524978|10070855|P11|Overall Study|Other|5
2923846|NCT01524978|10070856|P10|Overall Study|Other|2
2923847|NCT01524978|10070857|P9|Overall Study|Other|2
2923848|NCT01524978|10070858|P8|Overall Study|Other|1
2923849|NCT01524978|10070859|P7|Overall Study|Other|17
2923850|NCT01524978|10070860|P6|Overall Study|Other|3
2923851|NCT01524978|10070861|P5|Overall Study|Other|1
2923852|NCT01524978|10070862|P4|Overall Study|Other|2
2923853|NCT01524978|10070863|P3|Overall Study|Other|1
2923854|NCT01524978|10070864|P2|Overall Study|Other|2
2923855|NCT01524978|10070865|P1|Overall Study|Other|16
2923856|NCT01524913|10070993|P3|Overall Study|Lost to Follow-up|0
2923857|NCT01524913|10070994|P2|Overall Study|Lost to Follow-up|0
2923858|NCT01524913|10070995|P1|Overall Study|Lost to Follow-up|4
2923859|NCT01524900|10071017|P5|Overall Study|No reason documented|0
2923860|NCT01524900|10071018|P4|Overall Study|No reason documented|1
2923861|NCT01524900|10071019|P3|Overall Study|No reason documented|0
2923862|NCT01524900|10071020|P2|Overall Study|No reason documented|1
2923863|NCT01524900|10071021|P1|Overall Study|No reason documented|2
2923864|NCT01524900|10071017|P5|Overall Study|Other reason than stated above|0
2923865|NCT01524900|10071018|P4|Overall Study|Other reason than stated above|0
2923866|NCT01524900|10071019|P3|Overall Study|Other reason than stated above|0
2923867|NCT01524900|10071020|P2|Overall Study|Other reason than stated above|1
2923868|NCT01524900|10071021|P1|Overall Study|Other reason than stated above|1
2923869|NCT01524900|10071017|P5|Overall Study|Lost to Follow-up|0
2923870|NCT01524900|10071018|P4|Overall Study|Lost to Follow-up|0
2923871|NCT01524900|10071019|P3|Overall Study|Lost to Follow-up|1
2923872|NCT01524900|10071020|P2|Overall Study|Lost to Follow-up|12
2923873|NCT01524900|10071021|P1|Overall Study|Lost to Follow-up|3
2923874|NCT01524887|10071066|P3|Overall Study|Use of prohibited medication|0
2923875|NCT01524887|10071067|P2|Overall Study|Use of prohibited medication|0
2923876|NCT01524887|10071068|P1|Overall Study|Use of prohibited medication|1
2923877|NCT01524887|10071066|P3|Overall Study|Withdrawal by Caregiver|2
2923878|NCT01524887|10071067|P2|Overall Study|Withdrawal by Caregiver|0
2923879|NCT01524887|10071068|P1|Overall Study|Withdrawal by Caregiver|0
2923880|NCT01524887|10071066|P3|Overall Study|Study termination|79
2923881|NCT01524887|10071067|P2|Overall Study|Study termination|87
2923882|NCT01524887|10071068|P1|Overall Study|Study termination|73
2923883|NCT01524887|10071066|P3|Overall Study|Protocol Violation|1
2923884|NCT01524887|10071067|P2|Overall Study|Protocol Violation|0
2923885|NCT01524887|10071068|P1|Overall Study|Protocol Violation|0
2923886|NCT01524887|10071066|P3|Overall Study|Adverse Event|1
2923887|NCT01524887|10071067|P2|Overall Study|Adverse Event|1
2923888|NCT01524887|10071068|P1|Overall Study|Adverse Event|5
2923889|NCT01524887|10071066|P3|Overall Study|Withdrawal by Subject|3
2923890|NCT01524887|10071067|P2|Overall Study|Withdrawal by Subject|2
2923891|NCT01524887|10071068|P1|Overall Study|Withdrawal by Subject|6
2923892|NCT01524796|10071112|P1|Overall Study|Adverse Event and Lack of Efficacy|1
2923893|NCT01524796|10071112|P1|Overall Study|Switch to carbamazapine|1
2923894|NCT01524796|10071112|P1|Overall Study|Nervous about confidentiality|1
2923895|NCT01524796|10071112|P1|Overall Study|Gall stone surgery|1
2923896|NCT01524796|10071112|P1|Overall Study|Deterioration of pains|1
2923897|NCT01524796|10071112|P1|Overall Study|Move|1
2923898|NCT01524796|10071112|P1|Overall Study|Withdrawal by Subject|4
2923899|NCT01524796|10071112|P1|Overall Study|The price|1
2923900|NCT01524796|10071112|P1|Overall Study|Lost to Follow-up|1
2923901|NCT01524796|10071112|P1|Overall Study|Lack of Efficacy|3
2923902|NCT01524796|10071112|P1|Overall Study|Adverse Event|13
2923903|NCT01524783|10071127|P2|Randomized and Treated|Death|1
2923904|NCT01524783|10071128|P1|Randomized and Treated|Death|4
2923905|NCT01524783|10071127|P2|Randomized and Treated|Protocol Violation|1
2923906|NCT01524783|10071128|P1|Randomized and Treated|Protocol Violation|1
2923907|NCT01524783|10071127|P2|Randomized and Treated|Withdrawal by Subject|5
2923908|NCT01524783|10071128|P1|Randomized and Treated|Withdrawal by Subject|15
2923909|NCT01524783|10071127|P2|Randomized and Treated|Disease Progression|70
2923910|NCT01524783|10071128|P1|Randomized and Treated|Disease Progression|76
2923911|NCT01524783|10071127|P2|Randomized and Treated|Adverse Event|7
2923912|NCT01524783|10071128|P1|Randomized and Treated|Adverse Event|59
2923913|NCT01524783|10071127|P2|Randomized But Not Treated|Randomized, did not receive drug|0
2923914|NCT01524783|10071128|P1|Randomized But Not Treated|Randomized, did not receive drug|2
2923915|NCT01524770|10071136|P2|First Intervention|Protocol Violation|0
2923916|NCT01524770|10071137|P1|First Intervention|Protocol Violation|1
2923917|NCT01524770|10071136|P2|First Intervention|Adverse Event|1
2923918|NCT01524770|10071137|P1|First Intervention|Adverse Event|1
2923919|NCT01524770|10071136|P2|First Intervention|Withdrawal by Subject|0
2923920|NCT01524770|10071137|P1|First Intervention|Withdrawal by Subject|1
2923921|NCT01524692|10071147|P1|Overall Study|Withdrawal by Subject|3
2923922|NCT01524679|10071157|P2|Overall Study|e.g.wish for children, relocation|1
2923923|NCT01524679|10071158|P1|Overall Study|e.g.wish for children, relocation|6
2923924|NCT01524679|10071157|P2|Overall Study|Lack of Efficacy|0
2923925|NCT01524679|10071158|P1|Overall Study|Lack of Efficacy|2
2923926|NCT01524679|10071157|P2|Overall Study|Protocol Violation|0
2923927|NCT01524679|10071158|P1|Overall Study|Protocol Violation|1
2923928|NCT01524679|10071157|P2|Overall Study|Adverse Event|0
2923929|NCT01524679|10071158|P1|Overall Study|Adverse Event|9
2923930|NCT01524679|10071157|P2|Overall Study|Withdrawal by Subject|4
2923931|NCT01524679|10071158|P1|Overall Study|Withdrawal by Subject|4
2923932|NCT01524679|10071157|P2|Overall Study|Lost to Follow-up|4
2923933|NCT01524679|10071158|P1|Overall Study|Lost to Follow-up|1
2923934|NCT01524627|10071170|P2|Overall Study|Lost to Follow-up|1
2923935|NCT01524627|10071171|P1|Overall Study|Lost to Follow-up|1
2923936|NCT01524627|10071170|P2|Overall Study|Physician Decision|1
2923937|NCT01524627|10071171|P1|Overall Study|Physician Decision|0
2923938|NCT01524289|10071198|P2|Overall Study|Did not take study medication|0
2923939|NCT01524289|10071199|P1|Overall Study|Did not take study medication|1
2923940|NCT01524289|10071198|P2|Overall Study|Adverse Event|5
2923941|NCT01524289|10071199|P1|Overall Study|Adverse Event|12
2923942|NCT01524289|10071198|P2|Overall Study|Withdrawal by Subject|7
2923943|NCT01524289|10071199|P1|Overall Study|Withdrawal by Subject|11
2923944|NCT01524289|10071198|P2|Overall Study|Protocol Violation|1
2923945|NCT01524289|10071199|P1|Overall Study|Protocol Violation|5
2923946|NCT01524289|10071198|P2|Overall Study|Physician Decision|0
2923947|NCT01524289|10071199|P1|Overall Study|Physician Decision|1
2923948|NCT01524289|10071198|P2|Overall Study|Lost to Follow-up|1
2923949|NCT01524289|10071199|P1|Overall Study|Lost to Follow-up|0
2923950|NCT01524224|10071257|P8|Overall Study|Sponsor Decision|0
2923951|NCT01524224|10071258|P7|Overall Study|Sponsor Decision|0
2923952|NCT01524224|10071259|P6|Overall Study|Sponsor Decision|0
2923953|NCT01524224|10071260|P5|Overall Study|Sponsor Decision|1
2923954|NCT01524224|10071261|P4|Overall Study|Sponsor Decision|0
2923955|NCT01524224|10071262|P3|Overall Study|Sponsor Decision|0
2923956|NCT01524224|10071263|P2|Overall Study|Sponsor Decision|0
2923957|NCT01524224|10071264|P1|Overall Study|Sponsor Decision|0
2923958|NCT01524224|10071257|P8|Overall Study|Physician Decision|1
2923959|NCT01524224|10071258|P7|Overall Study|Physician Decision|0
2923960|NCT01524224|10071259|P6|Overall Study|Physician Decision|0
2923961|NCT01524224|10071260|P5|Overall Study|Physician Decision|1
2923962|NCT01524224|10071261|P4|Overall Study|Physician Decision|1
2923963|NCT01524224|10071262|P3|Overall Study|Physician Decision|0
2923964|NCT01524224|10071263|P2|Overall Study|Physician Decision|0
2923965|NCT01524224|10071264|P1|Overall Study|Physician Decision|0
2923966|NCT01524224|10071257|P8|Overall Study|Adverse Event|0
2923967|NCT01524224|10071258|P7|Overall Study|Adverse Event|0
2923968|NCT01524224|10071259|P6|Overall Study|Adverse Event|1
2923969|NCT01524224|10071260|P5|Overall Study|Adverse Event|0
2923970|NCT01524224|10071261|P4|Overall Study|Adverse Event|0
2923971|NCT01524224|10071262|P3|Overall Study|Adverse Event|0
2923972|NCT01524224|10071263|P2|Overall Study|Adverse Event|1
2923973|NCT01524224|10071264|P1|Overall Study|Adverse Event|0
2923974|NCT01524224|10071257|P8|Overall Study|Withdrawal by Subject|0
2923975|NCT01524224|10071258|P7|Overall Study|Withdrawal by Subject|2
2923976|NCT01524224|10071259|P6|Overall Study|Withdrawal by Subject|0
2923977|NCT01524224|10071260|P5|Overall Study|Withdrawal by Subject|0
2923978|NCT01524224|10071261|P4|Overall Study|Withdrawal by Subject|0
2923979|NCT01524224|10071262|P3|Overall Study|Withdrawal by Subject|0
2923980|NCT01524224|10071263|P2|Overall Study|Withdrawal by Subject|0
2923981|NCT01524224|10071264|P1|Overall Study|Withdrawal by Subject|2
2923982|NCT01524224|10071257|P8|Overall Study|Progressive Disease|5
2923983|NCT01524224|10071258|P7|Overall Study|Progressive Disease|1
2923984|NCT01524224|10071259|P6|Overall Study|Progressive Disease|1
2923985|NCT01524224|10071260|P5|Overall Study|Progressive Disease|2
2923986|NCT01524224|10071261|P4|Overall Study|Progressive Disease|1
2923987|NCT01524224|10071262|P3|Overall Study|Progressive Disease|2
2923988|NCT01524224|10071263|P2|Overall Study|Progressive Disease|0
2923989|NCT01524224|10071264|P1|Overall Study|Progressive Disease|1
2923990|NCT01524198|10071300|P2|Overall Study|Withdrawal by Subject|10
2923991|NCT01524198|10071301|P1|Overall Study|Withdrawal by Subject|15
2923992|NCT01524198|10071300|P2|Overall Study|Protocol Violation|6
2923993|NCT01524198|10071301|P1|Overall Study|Protocol Violation|8
2923994|NCT01524133|10071312|P3|Overall Study 52 Weeks|Lost to Follow-up|15
2923995|NCT01524133|10071313|P2|Overall Study 52 Weeks|Lost to Follow-up|15
2923996|NCT01524133|10071314|P1|Overall Study 52 Weeks|Lost to Follow-up|16
2923997|NCT01524133|10071312|P3|Overall Study 52 Weeks|Physician Decision|2
2923998|NCT01524133|10071313|P2|Overall Study 52 Weeks|Physician Decision|0
2923999|NCT01524133|10071314|P1|Overall Study 52 Weeks|Physician Decision|1
2924000|NCT01524133|10071312|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
2924001|NCT01524133|10071313|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
2924002|NCT01524133|10071314|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
2924003|NCT01524133|10071312|P3|Treatment Phase|Lost to Follow-up|2
2924004|NCT01524133|10071313|P2|Treatment Phase|Lost to Follow-up|1
2924005|NCT01524133|10071314|P1|Treatment Phase|Lost to Follow-up|0
2924006|NCT01524133|10071312|P3|Treatment Phase|Physician Decision|3
2924007|NCT01524133|10071313|P2|Treatment Phase|Physician Decision|3
2924008|NCT01524133|10071314|P1|Treatment Phase|Physician Decision|6
2924009|NCT01524133|10071312|P3|Treatment Phase|Withdrawal by Subject|31
2924010|NCT01524133|10071313|P2|Treatment Phase|Withdrawal by Subject|28
2924011|NCT01524133|10071314|P1|Treatment Phase|Withdrawal by Subject|13
2924012|NCT01523886|10071357|P2|Overall Study|surgery cancelled|1
2924013|NCT01523886|10071358|P1|Overall Study|surgery cancelled|0
2924014|NCT01523873|10071364|P1|Overall Study|Protocol Violation|422
2924015|NCT01523756|10071459|P2|Test Period 2|Withdrawal by Subject|1
2924016|NCT01523756|10071460|P1|Test Period 2|Withdrawal by Subject|0
2924017|NCT01523756|10071459|P2|Test Period 1|Adverse Event|0
2924018|NCT01523756|10071460|P1|Test Period 1|Adverse Event|1
2924019|NCT01523756|10071459|P2|Baseline Period|Adverse Event|1
2924020|NCT01523756|10071460|P1|Baseline Period|Adverse Event|0
2924021|NCT01523743|10071468|P2|Period 2|Adverse Event|0
2924022|NCT01523743|10071469|P1|Period 2|Adverse Event|1
2924023|NCT01523743|10071468|P2|Period 2|Withdrawal by Subject|2
2924024|NCT01523743|10071469|P1|Period 2|Withdrawal by Subject|0
2924025|NCT01523743|10071468|P2|Period 1|Felt unable to empty bladder|0
2924026|NCT01523743|10071469|P1|Period 1|Felt unable to empty bladder|1
2924027|NCT01523743|10071468|P2|Period 1|Lack of Efficacy|0
2924028|NCT01523743|10071469|P1|Period 1|Lack of Efficacy|1
2924029|NCT01523743|10071468|P2|Period 1|Lost to Follow-up|0
2924030|NCT01523743|10071469|P1|Period 1|Lost to Follow-up|1
2924031|NCT01523743|10071468|P2|Period 1|Withdrawal by Subject|2
2924032|NCT01523743|10071469|P1|Period 1|Withdrawal by Subject|6
2924033|NCT01523743|10071468|P2|Period 1|Adverse Event|0
2924034|NCT01523743|10071469|P1|Period 1|Adverse Event|1
2924035|NCT01523587|10071492|P2|Overall Study|Randomised but bot treated|2
2924036|NCT01523587|10071493|P1|Overall Study|Randomised but bot treated|6
2924037|NCT01523587|10071492|P2|Overall Study|Withdrew due to Progressive disease|279
2924038|NCT01523587|10071493|P1|Overall Study|Withdrew due to Progressive disease|265
2924039|NCT01523587|10071492|P2|Overall Study|Withdrawal by Subject|20
2924040|NCT01523587|10071493|P1|Overall Study|Withdrawal by Subject|28
2924041|NCT01523587|10071492|P2|Overall Study|Lost to Follow-up|2
2924042|NCT01523587|10071493|P1|Overall Study|Lost to Follow-up|2
2924043|NCT01523587|10071492|P2|Overall Study|Protocol Violation|3
2924044|NCT01523587|10071493|P1|Overall Study|Protocol Violation|5
2924045|NCT01523587|10071492|P2|Overall Study|Adverse Event|52
2924046|NCT01523587|10071493|P1|Overall Study|Adverse Event|68
2924047|NCT01523587|10071492|P2|Overall Study|Worsening of underlying cancer disease|34
2924048|NCT01523587|10071493|P1|Overall Study|Worsening of underlying cancer disease|19
2924049|NCT01523587|10071492|P2|Overall Study|Other than listed|5
2924050|NCT01523587|10071493|P1|Overall Study|Other than listed|5
2924051|NCT01523457|10071536|P2|Overall Study|Withdrawal by Subject|2
2924052|NCT01523457|10071537|P1|Overall Study|Withdrawal by Subject|7
2924053|NCT01523392|10071555|P2|Washout Period - 10 to 14 Days|Adverse Event|0
2924054|NCT01523392|10071556|P1|Washout Period - 10 to 14 Days|Adverse Event|1
2924055|NCT01523392|10071555|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
2924056|NCT01523392|10071556|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
2924057|NCT01523392|10071555|P2|Treatment Period 1|Withdrawal by Subject|0
2924058|NCT01523392|10071556|P1|Treatment Period 1|Withdrawal by Subject|2
2924059|NCT01523366|10071572|P2|Treatment Period 2|Not completed at least 7 days treatment|0
2924060|NCT01523366|10071573|P1|Treatment Period 2|Not completed at least 7 days treatment|1
2924061|NCT01523366|10071572|P2|Treatment Period 1|Withdrawal by Subject|0
2924062|NCT01523366|10071573|P1|Treatment Period 1|Withdrawal by Subject|1
2924063|NCT01523301|10071589|P2|Overall Study|Other Reason|2
2924064|NCT01523301|10071590|P1|Overall Study|Other Reason|0
2924065|NCT01523301|10071589|P2|Overall Study|Withdrawal by Subject|8
2924066|NCT01523301|10071590|P1|Overall Study|Withdrawal by Subject|6
2924067|NCT01523301|10071589|P2|Overall Study|Lost to Follow-up|0
2924068|NCT01523301|10071590|P1|Overall Study|Lost to Follow-up|1
2924069|NCT01523301|10071589|P2|Overall Study|Protocol Violation|4
2924070|NCT01523301|10071590|P1|Overall Study|Protocol Violation|3
2924071|NCT01523301|10071589|P2|Overall Study|Lack of Efficacy|2
2924072|NCT01523301|10071590|P1|Overall Study|Lack of Efficacy|0
2924073|NCT01523301|10071589|P2|Overall Study|Adverse Event|16
2924074|NCT01523301|10071590|P1|Overall Study|Adverse Event|25
2924075|NCT01523275|10071610|P2|Overall Study|Withdrawal by Subject|0
2924076|NCT01523275|10071611|P1|Overall Study|Withdrawal by Subject|1
2924077|NCT01523275|10071610|P2|Overall Study|Lost to Follow-up|2
2924078|NCT01523275|10071611|P1|Overall Study|Lost to Follow-up|1
2924079|NCT01522976|10071624|P3|Overall Study|Not protocol specified|27
2924080|NCT01522976|10071625|P2|Overall Study|Not protocol specified|27
2924081|NCT01522976|10071626|P1|Overall Study|Not protocol specified|22
2924082|NCT01522976|10071624|P3|Overall Study|Refusal unrelated to adverse event|14
2924083|NCT01522976|10071625|P2|Overall Study|Refusal unrelated to adverse event|13
2924084|NCT01522976|10071626|P1|Overall Study|Refusal unrelated to adverse event|10
2924085|NCT01522976|10071624|P3|Overall Study|Adverse Event|18
2924086|NCT01522976|10071625|P2|Overall Study|Adverse Event|7
2924087|NCT01522976|10071626|P1|Overall Study|Adverse Event|17
2924088|NCT01522976|10071624|P3|Overall Study|Disease progression|25
2924089|NCT01522976|10071625|P2|Overall Study|Disease progression|30
2924090|NCT01522976|10071626|P1|Overall Study|Disease progression|28
2924091|NCT01522976|10071624|P3|Overall Study|Still on treatment|6
2924092|NCT01522976|10071625|P2|Overall Study|Still on treatment|9
2924093|NCT01522976|10071626|P1|Overall Study|Still on treatment|9
2924094|NCT01522976|10071624|P3|Overall Study|Death|2
2924095|NCT01522976|10071625|P2|Overall Study|Death|6
2924096|NCT01522976|10071626|P1|Overall Study|Death|7
2924097|NCT01522976|10071624|P3|Overall Study|Ineligible|1
2924098|NCT01522976|10071625|P2|Overall Study|Ineligible|0
2924099|NCT01522976|10071626|P1|Overall Study|Ineligible|4
2924100|NCT01522950|10071671|P3|Overall Study|Study Medication Sensitivity|0
2924101|NCT01522950|10071672|P2|Overall Study|Study Medication Sensitivity|1
2924102|NCT01522950|10071673|P1|Overall Study|Study Medication Sensitivity|0
2924103|NCT01522950|10071671|P3|Overall Study|Death|1
2924104|NCT01522950|10071672|P2|Overall Study|Death|1
2924105|NCT01522950|10071673|P1|Overall Study|Death|0
2924106|NCT01522950|10071671|P3|Overall Study|Protocol Violation|2
2924107|NCT01522950|10071672|P2|Overall Study|Protocol Violation|0
2924108|NCT01522950|10071673|P1|Overall Study|Protocol Violation|0
2924109|NCT01522950|10071671|P3|Overall Study|Adverse Event|1
2924110|NCT01522950|10071672|P2|Overall Study|Adverse Event|1
2924111|NCT01522950|10071673|P1|Overall Study|Adverse Event|3
2924112|NCT01522950|10071671|P3|Overall Study|Withdrawal by Subject|1
2924113|NCT01522950|10071672|P2|Overall Study|Withdrawal by Subject|2
2924114|NCT01522950|10071673|P1|Overall Study|Withdrawal by Subject|3
2924115|NCT01522456|10071736|P1|Overall Study|Tolerability Assessment|1
2924116|NCT01522456|10071736|P1|Overall Study|Pregnancy|1
2924117|NCT01522456|10071736|P1|Overall Study|Withdrawal by Subject|2
2924118|NCT01522456|10071736|P1|Overall Study|Lost to Follow-up|2
2924119|NCT01522456|10071736|P1|Overall Study|Adverse Event|2
2924120|NCT01522443|10071799|P2|Overall Study|Other|3
2924121|NCT01522443|10071800|P1|Overall Study|Other|1
2924122|NCT01522443|10071799|P2|Overall Study|No study treatment given|1
2924123|NCT01522443|10071800|P1|Overall Study|No study treatment given|1
2924124|NCT01522443|10071799|P2|Overall Study|Withdrawal by Subject|8
2924125|NCT01522443|10071800|P1|Overall Study|Withdrawal by Subject|5
2924126|NCT01522443|10071799|P2|Overall Study|Adverse Event|15
2924127|NCT01522443|10071800|P1|Overall Study|Adverse Event|10
2924128|NCT01522443|10071799|P2|Overall Study|No longer receiving clinical benefit|28
2924129|NCT01522443|10071800|P1|Overall Study|No longer receiving clinical benefit|36
2924130|NCT01522404|10071812|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
2924131|NCT01522404|10071813|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
2924132|NCT01522404|10071812|P2|First Intervention (up to Week 29)|Adverse Event|0
2924133|NCT01522404|10071813|P1|First Intervention (up to Week 29)|Adverse Event|1
2924134|NCT01522404|10071812|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
2924135|NCT01522404|10071813|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
2924136|NCT01522248|10071899|P2|Overall Study|Lost to Follow-up|0
2924137|NCT01522248|10071900|P1|Overall Study|Lost to Follow-up|1
2924138|NCT01522235|10071915|P2|Overall Study|Physician Decision|1
2924139|NCT01522235|10071916|P1|Overall Study|Physician Decision|1
2924140|NCT01521923|10071952|P4|Overall Study|AE, captured in Period 1|1
2924141|NCT01521923|10071953|P3|Overall Study|AE, captured in Period 1|0
2924142|NCT01521923|10071954|P2|Overall Study|AE, captured in Period 1|1
2924143|NCT01521923|10071955|P1|Overall Study|AE, captured in Period 1|0
2924144|NCT01521923|10071952|P4|Overall Study|Other|6
2924145|NCT01521923|10071953|P3|Overall Study|Other|3
2924146|NCT01521923|10071954|P2|Overall Study|Other|1
2924147|NCT01521923|10071955|P1|Overall Study|Other|2
2924148|NCT01521923|10071952|P4|Overall Study|Withdrawal by Subject|2
2924149|NCT01521923|10071953|P3|Overall Study|Withdrawal by Subject|1
2924150|NCT01521923|10071954|P2|Overall Study|Withdrawal by Subject|1
2924151|NCT01521923|10071955|P1|Overall Study|Withdrawal by Subject|1
2924152|NCT01521923|10071952|P4|Overall Study|Lost to Follow-up|1
2924153|NCT01521923|10071953|P3|Overall Study|Lost to Follow-up|2
2924154|NCT01521923|10071954|P2|Overall Study|Lost to Follow-up|0
2924155|NCT01521923|10071955|P1|Overall Study|Lost to Follow-up|1
2924156|NCT01521923|10071952|P4|Overall Study|Protocol Violation|0
2924157|NCT01521923|10071953|P3|Overall Study|Protocol Violation|1
2924158|NCT01521923|10071954|P2|Overall Study|Protocol Violation|0
2924159|NCT01521923|10071955|P1|Overall Study|Protocol Violation|0
2924160|NCT01521923|10071952|P4|Overall Study|Lack of Efficacy|0
2924161|NCT01521923|10071953|P3|Overall Study|Lack of Efficacy|0
2924162|NCT01521923|10071954|P2|Overall Study|Lack of Efficacy|1
2924163|NCT01521923|10071955|P1|Overall Study|Lack of Efficacy|1
2924164|NCT01521923|10071952|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
2924165|NCT01521923|10071953|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2924166|NCT01521923|10071954|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2924167|NCT01521923|10071955|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2924168|NCT01521923|10071952|P4|Overall Study|AE, non-serious, non-fatal|2
2924169|NCT01521923|10071953|P3|Overall Study|AE, non-serious, non-fatal|6
2924170|NCT01521923|10071954|P2|Overall Study|AE, non-serious, non-fatal|3
2924171|NCT01521923|10071955|P1|Overall Study|AE, non-serious, non-fatal|1
2924172|NCT01521923|10071952|P4|Overall Study|SAE, non-fatal|0
2924173|NCT01521923|10071953|P3|Overall Study|SAE, non-fatal|2
2924174|NCT01521923|10071954|P2|Overall Study|SAE, non-fatal|2
2924175|NCT01521923|10071955|P1|Overall Study|SAE, non-fatal|0
2924176|NCT01521923|10071952|P4|Overall Study|AE, serious fatal|0
2924177|NCT01521923|10071953|P3|Overall Study|AE, serious fatal|0
2924178|NCT01521923|10071954|P2|Overall Study|AE, serious fatal|0
2924179|NCT01521923|10071955|P1|Overall Study|AE, serious fatal|1
2924180|NCT01521897|10072075|P1|Overall Study|Lost to Follow-up|5
2924181|NCT01521897|10072075|P1|Overall Study|Protocol Violation|18
2924182|NCT01521884|10072087|P1|Overall Study|Lost to Follow-up|4
2924183|NCT01521884|10072087|P1|Overall Study|Participant non-eligible|1
2924184|NCT01521884|10072087|P1|Overall Study|Protocol Violation|3
2924185|NCT01521884|10072087|P1|Overall Study|Physician Decision|2
2924186|NCT01521884|10072087|P1|Overall Study|Withdrawal by Subject|1
2924187|NCT01521884|10072087|P1|Overall Study|Pregnancy|1
2924188|NCT01521884|10072087|P1|Overall Study|Adverse Event|5
2924189|NCT01521884|10072087|P1|Overall Study|Non Responders|10
2924190|NCT01521559|10072184|P2|Overall Study|Other|2
2924191|NCT01521559|10072185|P1|Overall Study|Other|1
2924192|NCT01521559|10072184|P2|Overall Study|Protocol Violation|0
2924193|NCT01521559|10072185|P1|Overall Study|Protocol Violation|1
2924194|NCT01521559|10072184|P2|Overall Study|Lost to Follow-up|1
2924195|NCT01521559|10072185|P1|Overall Study|Lost to Follow-up|3
2924196|NCT01521559|10072184|P2|Overall Study|Withdrawal by Subject|11
2924197|NCT01521559|10072185|P1|Overall Study|Withdrawal by Subject|9
2924198|NCT01521559|10072184|P2|Overall Study|Death|0
2924199|NCT01521559|10072185|P1|Overall Study|Death|1
2924200|NCT01521559|10072184|P2|Overall Study|Adverse Event|4
2924201|NCT01521559|10072185|P1|Overall Study|Adverse Event|0
2924202|NCT01521507|10072208|P2|Stage 2: Observational Design|Physician Decision|0
2924203|NCT01521507|10072209|P1|Stage 2: Observational Design|Physician Decision|1
2924204|NCT01521507|10072208|P2|Stage 2: Observational Design|Withdrawal by Subject|1
2924205|NCT01521507|10072209|P1|Stage 2: Observational Design|Withdrawal by Subject|3
2924206|NCT01521507|10072208|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
2924207|NCT01521507|10072209|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
2924208|NCT01521507|10072208|P2|Stage 1: Randomized Design|Lost to Follow-up|2
2924209|NCT01521507|10072209|P1|Stage 1: Randomized Design|Lost to Follow-up|0
2924210|NCT01521507|10072208|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
2924211|NCT01521507|10072209|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
2924212|NCT01521507|10072208|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
2924213|NCT01521507|10072209|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
2924214|NCT01521494|10072231|P5|Overall Study|Physician Decision|2
2924215|NCT01521494|10072232|P4|Overall Study|Physician Decision|0
2924216|NCT01521494|10072233|P3|Overall Study|Physician Decision|0
2924217|NCT01521494|10072234|P2|Overall Study|Physician Decision|0
2924218|NCT01521494|10072235|P1|Overall Study|Physician Decision|0
2924219|NCT01521494|10072231|P5|Overall Study|Decrease in serum calcium|1
2924220|NCT01521494|10072232|P4|Overall Study|Decrease in serum calcium|1
2924221|NCT01521494|10072233|P3|Overall Study|Decrease in serum calcium|0
2924222|NCT01521494|10072234|P2|Overall Study|Decrease in serum calcium|0
2924223|NCT01521494|10072235|P1|Overall Study|Decrease in serum calcium|0
2924224|NCT01521494|10072231|P5|Overall Study|Decrease in serum phosphate|0
2924225|NCT01521494|10072232|P4|Overall Study|Decrease in serum phosphate|12
2924226|NCT01521494|10072233|P3|Overall Study|Decrease in serum phosphate|3
2924227|NCT01521494|10072234|P2|Overall Study|Decrease in serum phosphate|2
2924228|NCT01521494|10072235|P1|Overall Study|Decrease in serum phosphate|0
2924229|NCT01521494|10072231|P5|Overall Study|Withdrawal by Subject|0
2924230|NCT01521494|10072232|P4|Overall Study|Withdrawal by Subject|2
2924231|NCT01521494|10072233|P3|Overall Study|Withdrawal by Subject|0
2924232|NCT01521494|10072234|P2|Overall Study|Withdrawal by Subject|1
2924233|NCT01521494|10072235|P1|Overall Study|Withdrawal by Subject|1
2924234|NCT01521494|10072231|P5|Overall Study|Lack of Efficacy|2
2924235|NCT01521494|10072232|P4|Overall Study|Lack of Efficacy|0
2924236|NCT01521494|10072233|P3|Overall Study|Lack of Efficacy|0
2924237|NCT01521494|10072234|P2|Overall Study|Lack of Efficacy|0
2924238|NCT01521494|10072235|P1|Overall Study|Lack of Efficacy|0
2924239|NCT01521494|10072231|P5|Overall Study|Adverse Event|2
2924240|NCT01521494|10072232|P4|Overall Study|Adverse Event|6
2924241|NCT01521494|10072233|P3|Overall Study|Adverse Event|9
2924242|NCT01521494|10072234|P2|Overall Study|Adverse Event|2
2924243|NCT01521494|10072235|P1|Overall Study|Adverse Event|1
2924244|NCT01521364|10072257|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
2924245|NCT01521364|10072257|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
2924246|NCT01520987|10072333|P8|Overall Study|Withdrawal by Subject|0
2924247|NCT01520987|10072334|P7|Overall Study|Withdrawal by Subject|0
2924248|NCT01520987|10072335|P6|Overall Study|Withdrawal by Subject|1
2924249|NCT01520987|10072336|P5|Overall Study|Withdrawal by Subject|0
2924250|NCT01520987|10072337|P4|Overall Study|Withdrawal by Subject|0
2924251|NCT01520987|10072338|P3|Overall Study|Withdrawal by Subject|0
2924252|NCT01520987|10072339|P2|Overall Study|Withdrawal by Subject|0
2924253|NCT01520987|10072340|P1|Overall Study|Withdrawal by Subject|1
2924254|NCT01520922|10072400|P2|Survival Follow-up|Withdrawal by Subject|0
2924255|NCT01520922|10072401|P1|Survival Follow-up|Withdrawal by Subject|1
2924256|NCT01520922|10072400|P2|Follow up|Lost to Follow-up|1
2924257|NCT01520922|10072401|P1|Follow up|Lost to Follow-up|0
2924258|NCT01520922|10072400|P2|Treatment Phase|Adverse Event|5
2924259|NCT01520922|10072401|P1|Treatment Phase|Adverse Event|3
2924260|NCT01520922|10072400|P2|Treatment Phase|Progression|2
2924261|NCT01520922|10072401|P1|Treatment Phase|Progression|0
2924262|NCT01520922|10072400|P2|Treatment Phase|Physician Decision|1
2924263|NCT01520922|10072401|P1|Treatment Phase|Physician Decision|2
2924264|NCT01520909|10072463|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
2924265|NCT01520909|10072464|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2924266|NCT01520909|10072465|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2924267|NCT01520909|10072463|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
2924268|NCT01520909|10072464|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2924269|NCT01520909|10072465|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2924270|NCT01520909|10072463|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
2924271|NCT01520909|10072464|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2924272|NCT01520909|10072465|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2924273|NCT01520909|10072463|P3|Part 1 (Randomized Period)|Adverse Event|0
2924274|NCT01520909|10072464|P2|Part 1 (Randomized Period)|Adverse Event|2
2924275|NCT01520909|10072465|P1|Part 1 (Randomized Period)|Adverse Event|1
2924276|NCT01520714|10072582|P2|Overall Study|Lack of Efficacy|1
2924277|NCT01520714|10072583|P1|Overall Study|Lack of Efficacy|0
2924278|NCT01520714|10072582|P2|Overall Study|Adverse Event|2
2924279|NCT01520714|10072583|P1|Overall Study|Adverse Event|0
2924280|NCT01520714|10072582|P2|Overall Study|Protocol Violation|3
2924281|NCT01520714|10072583|P1|Overall Study|Protocol Violation|0
2924282|NCT01520506|10072613|P1|Overall Study|Withdrawal by Subject|1
2924283|NCT01520506|10072613|P1|Overall Study|Lost to Follow-up|1
2924284|NCT01520506|10072613|P1|Overall Study|Missed Visit|4
2924285|NCT01520402|10072668|P1|Overall Study|Physician Decision|3
2924286|NCT01520402|10072668|P1|Overall Study|Withdrawal by Subject|2
2924287|NCT01520363|10072681|P2|Overall Study|Withdrawal by Subject|0
2924288|NCT01520363|10072682|P1|Overall Study|Withdrawal by Subject|2
2924289|NCT01520324|10072756|P1|Overall Study|Subject discontinued (moderate illness)|1
2924290|NCT01519960|10072785|P3|Overall Study|Lost to Follow-up|0
2924291|NCT01519960|10072786|P2|Overall Study|Lost to Follow-up|1
2924292|NCT01519960|10072787|P1|Overall Study|Lost to Follow-up|0
2924293|NCT01519960|10072785|P3|Overall Study|Withdrawal by Subject|0
2924294|NCT01519960|10072786|P2|Overall Study|Withdrawal by Subject|4
2924295|NCT01519960|10072787|P1|Overall Study|Withdrawal by Subject|0
2924296|NCT01519960|10072785|P3|Overall Study|Adverse Event|0
2924297|NCT01519960|10072786|P2|Overall Study|Adverse Event|1
2924298|NCT01519960|10072787|P1|Overall Study|Adverse Event|0
2924299|NCT01519960|10072785|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
2924300|NCT01519960|10072786|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
2924301|NCT01519960|10072787|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
2924302|NCT01519960|10072785|P3|Overall Study|Ongoing in Follow-Up|10
2924303|NCT01519960|10072786|P2|Overall Study|Ongoing in Follow-Up|11
2924304|NCT01519960|10072787|P1|Overall Study|Ongoing in Follow-Up|101
2924305|NCT01519947|10072897|P4|Overall Study|Adverse Event|1
2924306|NCT01519947|10072898|P3|Overall Study|Adverse Event|1
2924307|NCT01519947|10072899|P2|Overall Study|Adverse Event|0
2924308|NCT01519947|10072900|P1|Overall Study|Adverse Event|1
2924309|NCT01519947|10072897|P4|Overall Study|Poor Response|1
2924310|NCT01519947|10072898|P3|Overall Study|Poor Response|0
2924311|NCT01519947|10072899|P2|Overall Study|Poor Response|0
2924312|NCT01519947|10072900|P1|Overall Study|Poor Response|1
2924313|NCT01519947|10072897|P4|Overall Study|Lost to Follow-up|2
2924314|NCT01519947|10072898|P3|Overall Study|Lost to Follow-up|3
2924315|NCT01519947|10072899|P2|Overall Study|Lost to Follow-up|0
2924316|NCT01519947|10072900|P1|Overall Study|Lost to Follow-up|0
2924317|NCT01519947|10072897|P4|Overall Study|Withdrawal by Subject|1
2924318|NCT01519947|10072898|P3|Overall Study|Withdrawal by Subject|0
2924319|NCT01519947|10072899|P2|Overall Study|Withdrawal by Subject|1
2924320|NCT01519947|10072900|P1|Overall Study|Withdrawal by Subject|0
2924321|NCT01519947|10072897|P4|Overall Study|Blood Transfusion|0
2924322|NCT01519947|10072898|P3|Overall Study|Blood Transfusion|1
2924323|NCT01519947|10072899|P2|Overall Study|Blood Transfusion|1
2924324|NCT01519947|10072900|P1|Overall Study|Blood Transfusion|0
2924325|NCT01519947|10072897|P4|Overall Study|Development of Anemia|1
2924326|NCT01519947|10072898|P3|Overall Study|Development of Anemia|0
2924327|NCT01519947|10072899|P2|Overall Study|Development of Anemia|1
2924328|NCT01519947|10072900|P1|Overall Study|Development of Anemia|0
2924329|NCT01519947|10072897|P4|Overall Study|Peritoneal Dialysis Needed|0
2924330|NCT01519947|10072898|P3|Overall Study|Peritoneal Dialysis Needed|0
2924331|NCT01519947|10072899|P2|Overall Study|Peritoneal Dialysis Needed|1
2924332|NCT01519947|10072900|P1|Overall Study|Peritoneal Dialysis Needed|0
2924333|NCT01519947|10072897|P4|Overall Study|Protocol Violation|1
2924334|NCT01519947|10072898|P3|Overall Study|Protocol Violation|2
2924335|NCT01519947|10072899|P2|Overall Study|Protocol Violation|0
2924336|NCT01519947|10072900|P1|Overall Study|Protocol Violation|0
2924337|NCT01519947|10072897|P4|Overall Study|Death|1
2924338|NCT01519947|10072898|P3|Overall Study|Death|0
2924339|NCT01519947|10072899|P2|Overall Study|Death|0
2924340|NCT01519947|10072900|P1|Overall Study|Death|0
2924341|NCT01519934|10072930|P1|Overall Study|Lost to Follow-up|3
2924342|NCT01519921|10072939|P2|Overall Study|High alanine aminotransferase (ALT)|1
2924343|NCT01519921|10072940|P1|Overall Study|High alanine aminotransferase (ALT)|0
2924344|NCT01519921|10072939|P2|Overall Study|Treatment refusal|1
2924345|NCT01519921|10072940|P1|Overall Study|Treatment refusal|2
2924346|NCT01519921|10072939|P2|Overall Study|Lost to Follow-up|1
2924347|NCT01519921|10072940|P1|Overall Study|Lost to Follow-up|2
2924348|NCT01519921|10072939|P2|Overall Study|Withdrawal by Subject|0
2924349|NCT01519921|10072940|P1|Overall Study|Withdrawal by Subject|3
2924350|NCT01519921|10072939|P2|Overall Study|Lack of Efficacy|3
2924351|NCT01519921|10072940|P1|Overall Study|Lack of Efficacy|4
2924352|NCT01519921|10072939|P2|Overall Study|Adverse Event|9
2924353|NCT01519921|10072940|P1|Overall Study|Adverse Event|10
2924354|NCT01519817|10072989|P4|Overall Study|Off study due to infection|1
2924355|NCT01519817|10072990|P3|Overall Study|Off study due to infection|0
2924356|NCT01519817|10072991|P2|Overall Study|Off study due to infection|0
2924357|NCT01519817|10072992|P1|Overall Study|Off study due to infection|0
2924358|NCT01519817|10072989|P4|Overall Study|Withdrawal by Subject|0
2924359|NCT01519817|10072990|P3|Overall Study|Withdrawal by Subject|0
2924360|NCT01519817|10072991|P2|Overall Study|Withdrawal by Subject|0
2924361|NCT01519817|10072992|P1|Overall Study|Withdrawal by Subject|1
2924362|NCT01519791|10073032|P2|Overall Study|Lost to Follow-up|14
2924363|NCT01519791|10073033|P1|Overall Study|Lost to Follow-up|6
2924364|NCT01519791|10073032|P2|Overall Study|Withdrawal by Subject|37
2924365|NCT01519791|10073033|P1|Overall Study|Withdrawal by Subject|15
2924366|NCT01519791|10073032|P2|Overall Study|AE, non-serious non-fatal|31
2924367|NCT01519791|10073033|P1|Overall Study|AE, non-serious non-fatal|12
2924368|NCT01519791|10073032|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
2924369|NCT01519791|10073033|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
2924370|NCT01519791|10073032|P2|Overall Study|AE, serious fatal|1
2924371|NCT01519791|10073033|P1|Overall Study|AE, serious fatal|0
2924372|NCT01519791|10073032|P2|Overall Study|SAE, non-fatal|22
2924373|NCT01519791|10073033|P1|Overall Study|SAE, non-fatal|6
2924374|NCT01519791|10073032|P2|Overall Study|Lack of Efficacy|20
2924375|NCT01519791|10073033|P1|Overall Study|Lack of Efficacy|16
2924376|NCT01519791|10073032|P2|Overall Study|subjects randomized in error|0
2924377|NCT01519791|10073033|P1|Overall Study|subjects randomized in error|2
2924378|NCT01519791|10073032|P2|Overall Study|Other Reason|222
2924379|NCT01519791|10073033|P1|Overall Study|Other Reason|87
2924380|NCT01519791|10073032|P2|Overall Study|Protocol Violation|19
2924381|NCT01519791|10073033|P1|Overall Study|Protocol Violation|6
2924382|NCT01519791|10073032|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
2924383|NCT01519791|10073033|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
2924384|NCT01519778|10073097|P1|Overall Study|Physician Decision|1
2924385|NCT01519778|10073097|P1|Overall Study|Lost to Follow-up|10
2924386|NCT01519778|10073097|P1|Overall Study|Withdrawal by Subject|3
2924387|NCT01519765|10073103|P2|Overall Study|Withdrawal by Subject|1
2924388|NCT01519765|10073104|P1|Overall Study|Withdrawal by Subject|0
2924389|NCT01519765|10073103|P2|Overall Study|Protocol Violation|0
2924390|NCT01519765|10073104|P1|Overall Study|Protocol Violation|1
2924391|NCT01519765|10073103|P2|Overall Study|Lack of Efficacy|0
2924392|NCT01519765|10073104|P1|Overall Study|Lack of Efficacy|2
2924393|NCT01519765|10073103|P2|Overall Study|Adverse Event|1
2924394|NCT01519765|10073104|P1|Overall Study|Adverse Event|0
2924395|NCT01519700|10073182|P4|Overall Study|Other Reason|4
2924396|NCT01519700|10073183|P3|Overall Study|Other Reason|0
2924397|NCT01519700|10073184|P2|Overall Study|Other Reason|2
2924398|NCT01519700|10073185|P1|Overall Study|Other Reason|2
2924399|NCT01519700|10073182|P4|Overall Study|Withdrawal by Subject|2
2924400|NCT01519700|10073183|P3|Overall Study|Withdrawal by Subject|3
2924401|NCT01519700|10073184|P2|Overall Study|Withdrawal by Subject|3
2924402|NCT01519700|10073185|P1|Overall Study|Withdrawal by Subject|5
2924403|NCT01519700|10073182|P4|Overall Study|Physician Decision|0
2924404|NCT01519700|10073183|P3|Overall Study|Physician Decision|3
2924405|NCT01519700|10073184|P2|Overall Study|Physician Decision|1
2924406|NCT01519700|10073185|P1|Overall Study|Physician Decision|1
2924407|NCT01519700|10073182|P4|Overall Study|Lost to Follow-up|1
2924408|NCT01519700|10073183|P3|Overall Study|Lost to Follow-up|1
2924409|NCT01519700|10073184|P2|Overall Study|Lost to Follow-up|0
2924410|NCT01519700|10073185|P1|Overall Study|Lost to Follow-up|0
2924411|NCT01519700|10073182|P4|Overall Study|Death|0
2924412|NCT01519700|10073183|P3|Overall Study|Death|0
2924413|NCT01519700|10073184|P2|Overall Study|Death|0
2924414|NCT01519700|10073185|P1|Overall Study|Death|1
2924415|NCT01519674|10073220|P3|Overall Study|Unsclassified|3
2924416|NCT01519674|10073221|P2|Overall Study|Unsclassified|4
2924417|NCT01519674|10073222|P1|Overall Study|Unsclassified|10
2924418|NCT01519674|10073220|P3|Overall Study|Withdrawal Criteria|7
2924419|NCT01519674|10073221|P2|Overall Study|Withdrawal Criteria|2
2924420|NCT01519674|10073222|P1|Overall Study|Withdrawal Criteria|7
2924421|NCT01519674|10073220|P3|Overall Study|Protocol Violation|1
2924422|NCT01519674|10073221|P2|Overall Study|Protocol Violation|3
2924423|NCT01519674|10073222|P1|Overall Study|Protocol Violation|0
2924424|NCT01519674|10073220|P3|Overall Study|Lack of Efficacy|1
2924425|NCT01519674|10073221|P2|Overall Study|Lack of Efficacy|1
2924426|NCT01519674|10073222|P1|Overall Study|Lack of Efficacy|1
2924427|NCT01519674|10073220|P3|Overall Study|Adverse Event|0
2924428|NCT01519674|10073221|P2|Overall Study|Adverse Event|3
2924429|NCT01519674|10073222|P1|Overall Study|Adverse Event|3
2924430|NCT01519661|10073260|P1|Overall Study|Adverse Event|29
2924431|NCT01519661|10073260|P1|Overall Study|Lack of Efficacy|6
2924432|NCT01519661|10073260|P1|Overall Study|Withdrawal by Subject|17
2924433|NCT01519661|10073260|P1|Overall Study|Lost to Follow-up|3
2924434|NCT01519661|10073260|P1|Overall Study|Protocol deviation|6
2924435|NCT01519635|10073286|P2|Overall Study|No possibility to put a catheter|2
2924436|NCT01519635|10073287|P1|Overall Study|No possibility to put a catheter|1
2924437|NCT01519635|10073286|P2|Overall Study|Withdrawal by Subject|1
2924438|NCT01519635|10073287|P1|Overall Study|Withdrawal by Subject|0
2924439|NCT01519518|10073304|P2|Overall Study|Consent not available|10
2924440|NCT01519518|10073305|P1|Overall Study|Consent not available|7
2924441|NCT01519427|10073330|P1|Overall Study|disease progression|2
2924442|NCT01519323|10073362|P2|Overall Study|Study terminated by sponsor|1
2924443|NCT01519323|10073363|P1|Overall Study|Study terminated by sponsor|0
2924444|NCT01519323|10073362|P2|Overall Study|Death|2
2924445|NCT01519323|10073363|P1|Overall Study|Death|3
2924446|NCT01519245|10073423|P2|Overall Study|Met exclusion criteria, not analysed|2
2924447|NCT01519245|10073424|P1|Overall Study|Met exclusion criteria, not analysed|1
2924448|NCT01519206|10073436|P1|Overall Study|Missed Visit|2
2924449|NCT01519206|10073436|P1|Overall Study|Lost to Follow-up|3
2924450|NCT01519167|10073450|P2|Overall Study|Physician Decision|1
2924451|NCT01519167|10073451|P1|Overall Study|Physician Decision|0
2924452|NCT01519167|10073450|P2|Overall Study|Medical condition changes&deep sedation|2
2924453|NCT01519167|10073451|P1|Overall Study|Medical condition changes&deep sedation|0
2924454|NCT01519167|10073450|P2|Overall Study|Lack of Efficacy|1
2924455|NCT01519167|10073451|P1|Overall Study|Lack of Efficacy|0
2924456|NCT01519167|10073450|P2|Overall Study|Adverse Event|1
2924457|NCT01519167|10073451|P1|Overall Study|Adverse Event|0
2924458|NCT01519167|10073450|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
2924459|NCT01519167|10073451|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
2924460|NCT01519089|10073477|P2|Overall Study|Not received study drug|1
2924461|NCT01519089|10073478|P1|Overall Study|Not received study drug|0
2924462|NCT01519089|10073477|P2|Overall Study|Other|6
2924463|NCT01519089|10073478|P1|Overall Study|Other|2
2924464|NCT01519089|10073477|P2|Overall Study|Withdrawal by Subject|2
2924465|NCT01519089|10073478|P1|Overall Study|Withdrawal by Subject|0
2924466|NCT01519089|10073477|P2|Overall Study|Lost to Follow-up|0
2924467|NCT01519089|10073478|P1|Overall Study|Lost to Follow-up|1
2924468|NCT01519089|10073477|P2|Overall Study|Lack of Efficacy|2
2924469|NCT01519089|10073478|P1|Overall Study|Lack of Efficacy|0
2924470|NCT01519089|10073477|P2|Overall Study|Adverse Event|4
2924471|NCT01519089|10073478|P1|Overall Study|Adverse Event|4
2924472|NCT01518946|10073620|P3|Randomized Phase (First Intervention)|Other|0
2924473|NCT01518946|10073621|P2|Randomized Phase (First Intervention)|Other|1
2924474|NCT01518946|10073622|P1|Randomized Phase (First Intervention)|Other|0
2924475|NCT01518946|10073620|P3|Open-label Phase|Other|0
2924476|NCT01518946|10073621|P2|Open-label Phase|Other|0
2924477|NCT01518946|10073622|P1|Open-label Phase|Other|4
2924478|NCT01518374|10073633|P1|Overall Study|Lost to Follow-up|2
2924479|NCT01518374|10073633|P1|Overall Study|Protocol Violation|3
2924480|NCT01518374|10073633|P1|Overall Study|Withdrawal by Subject|2
2924481|NCT01518322|10073637|P1|Overall Study|FeNO measurement was missing|13
2924482|NCT01518257|10073658|P2|Overall Study|Other Miscellaneous Reason|0
2924483|NCT01518257|10073659|P1|Overall Study|Other Miscellaneous Reason|1
2924484|NCT01518257|10073658|P2|Overall Study|Lost to Follow-up|0
2924485|NCT01518257|10073659|P1|Overall Study|Lost to Follow-up|1
2924486|NCT01518244|10073681|P1|Overall Study|Adverse Event|3
2924487|NCT01518192|10073689|P3|Overall Study|Lost to Follow-up|35
2924488|NCT01518192|10073690|P2|Overall Study|Lost to Follow-up|26
2924489|NCT01518192|10073691|P1|Overall Study|Lost to Follow-up|29
2924490|NCT01518153|10073712|P3|Donor Lymphocyte Infusion|Death|1
2924491|NCT01518153|10073713|P2|Donor Lymphocyte Infusion|Death|2
2924492|NCT01518153|10073714|P1|Donor Lymphocyte Infusion|Death|0
2924493|NCT01518153|10073712|P3|Stem Cell Transplant|Adverse Event|0
2924494|NCT01518153|10073713|P2|Stem Cell Transplant|Adverse Event|0
2924495|NCT01518153|10073714|P1|Stem Cell Transplant|Adverse Event|1
2924496|NCT01518153|10073712|P3|Stem Cell Transplant|Secondary graft failure|0
2924497|NCT01518153|10073713|P2|Stem Cell Transplant|Secondary graft failure|0
2924498|NCT01518153|10073714|P1|Stem Cell Transplant|Secondary graft failure|1
2924499|NCT01518153|10073712|P3|Stem Cell Transplant|Death|0
2924500|NCT01518153|10073713|P2|Stem Cell Transplant|Death|0
2924501|NCT01518153|10073714|P1|Stem Cell Transplant|Death|2
2924502|NCT01518153|10073712|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2924503|NCT01518153|10073713|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2924504|NCT01518153|10073714|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
2924505|NCT01517984|10073725|P4|Overall Study|Ineligible for randomization|0
2924506|NCT01517984|10073726|P3|Overall Study|Ineligible for randomization|0
2924507|NCT01517984|10073727|P2|Overall Study|Ineligible for randomization|14
2924508|NCT01517984|10073728|P1|Overall Study|Ineligible for randomization|0
2924509|NCT01517984|10073725|P4|Overall Study|Screen Failure|0
2924510|NCT01517984|10073726|P3|Overall Study|Screen Failure|0
2924511|NCT01517984|10073727|P2|Overall Study|Screen Failure|0
2924512|NCT01517984|10073728|P1|Overall Study|Screen Failure|4
2924513|NCT01517984|10073725|P4|Overall Study|Withdrawal by Subject|1
2924514|NCT01517984|10073726|P3|Overall Study|Withdrawal by Subject|4
2924515|NCT01517984|10073727|P2|Overall Study|Withdrawal by Subject|8
2924516|NCT01517984|10073728|P1|Overall Study|Withdrawal by Subject|1
2924517|NCT01517984|10073725|P4|Overall Study|Lost to Follow-up|0
2924518|NCT01517984|10073726|P3|Overall Study|Lost to Follow-up|0
2924519|NCT01517984|10073727|P2|Overall Study|Lost to Follow-up|1
2924520|NCT01517984|10073728|P1|Overall Study|Lost to Follow-up|0
2924521|NCT01517893|10073754|P2|Overall Study|Withdrawal by Subject|0
2924522|NCT01517893|10073755|P1|Overall Study|Withdrawal by Subject|3
2924523|NCT01517867|10073777|P2|Overall Study|Still in treatment at study end|3
2924524|NCT01517867|10073778|P1|Overall Study|Still in treatment at study end|0
2924525|NCT01517867|10073777|P2|Overall Study|Withdrawal by Subject|30
2924526|NCT01517867|10073778|P1|Overall Study|Withdrawal by Subject|34
2924527|NCT01517867|10073777|P2|Overall Study|never started treatment|32
2924528|NCT01517867|10073778|P1|Overall Study|never started treatment|29
2924529|NCT01517750|10073806|P4|Overall Study|Lost to Follow-up|1
2924530|NCT01517750|10073807|P3|Overall Study|Lost to Follow-up|4
2924531|NCT01517750|10073808|P2|Overall Study|Lost to Follow-up|2
2924532|NCT01517750|10073809|P1|Overall Study|Lost to Follow-up|1
2924533|NCT01517412|10073846|P2|Overall Study|Other than specified above|5
2924534|NCT01517412|10073847|P1|Overall Study|Other than specified above|8
2924535|NCT01517412|10073846|P2|Overall Study|Poor compliance to protocol|3
2924536|NCT01517412|10073847|P1|Overall Study|Poor compliance to protocol|8
2924537|NCT01517412|10073846|P2|Overall Study|Lack of Efficacy|5
2924538|NCT01517412|10073847|P1|Overall Study|Lack of Efficacy|10
2924539|NCT01517412|10073846|P2|Overall Study|Adverse Event|11
2924540|NCT01517412|10073847|P1|Overall Study|Adverse Event|10
2924541|NCT01517373|10073876|P6|Treatment Period|Medication error without AEs|2
2924542|NCT01517373|10073877|P5|Treatment Period|Medication error without AEs|0
2924543|NCT01517373|10073878|P4|Treatment Period|Medication error without AEs|1
2924544|NCT01517373|10073879|P3|Treatment Period|Medication error without AEs|2
2924545|NCT01517373|10073880|P2|Treatment Period|Medication error without AEs|0
2924546|NCT01517373|10073881|P1|Treatment Period|Medication error without AEs|0
2924547|NCT01517373|10073876|P6|Treatment Period|Lack of Efficacy|0
2924548|NCT01517373|10073877|P5|Treatment Period|Lack of Efficacy|2
2924549|NCT01517373|10073878|P4|Treatment Period|Lack of Efficacy|3
2924550|NCT01517373|10073879|P3|Treatment Period|Lack of Efficacy|1
2924551|NCT01517373|10073880|P2|Treatment Period|Lack of Efficacy|1
2924552|NCT01517373|10073881|P1|Treatment Period|Lack of Efficacy|0
2924553|NCT01517373|10073876|P6|Treatment Period|Protocol Violation|0
2924554|NCT01517373|10073877|P5|Treatment Period|Protocol Violation|1
2924555|NCT01517373|10073878|P4|Treatment Period|Protocol Violation|0
2924556|NCT01517373|10073879|P3|Treatment Period|Protocol Violation|0
2924557|NCT01517373|10073880|P2|Treatment Period|Protocol Violation|0
2924558|NCT01517373|10073881|P1|Treatment Period|Protocol Violation|0
2924559|NCT01517373|10073876|P6|Treatment Period|Other|0
2924560|NCT01517373|10073877|P5|Treatment Period|Other|1
2924561|NCT01517373|10073878|P4|Treatment Period|Other|0
2924562|NCT01517373|10073879|P3|Treatment Period|Other|0
2924563|NCT01517373|10073880|P2|Treatment Period|Other|0
2924564|NCT01517373|10073881|P1|Treatment Period|Other|0
2924565|NCT01517373|10073876|P6|Treatment Period|Withdrawal by Subject|3
2924566|NCT01517373|10073877|P5|Treatment Period|Withdrawal by Subject|2
2924567|NCT01517373|10073878|P4|Treatment Period|Withdrawal by Subject|2
2924568|NCT01517373|10073879|P3|Treatment Period|Withdrawal by Subject|2
2924569|NCT01517373|10073880|P2|Treatment Period|Withdrawal by Subject|3
2924570|NCT01517373|10073881|P1|Treatment Period|Withdrawal by Subject|0
2924571|NCT01517373|10073876|P6|Treatment Period|Lost to Follow-up|0
2924572|NCT01517373|10073877|P5|Treatment Period|Lost to Follow-up|0
2924573|NCT01517373|10073878|P4|Treatment Period|Lost to Follow-up|1
2924574|NCT01517373|10073879|P3|Treatment Period|Lost to Follow-up|1
2924575|NCT01517373|10073880|P2|Treatment Period|Lost to Follow-up|0
2924576|NCT01517373|10073881|P1|Treatment Period|Lost to Follow-up|0
2924577|NCT01517373|10073876|P6|Treatment Period|Adverse Event|2
2924578|NCT01517373|10073877|P5|Treatment Period|Adverse Event|0
2924579|NCT01517373|10073878|P4|Treatment Period|Adverse Event|0
2924580|NCT01517373|10073879|P3|Treatment Period|Adverse Event|0
2924581|NCT01517373|10073880|P2|Treatment Period|Adverse Event|0
2924582|NCT01517373|10073881|P1|Treatment Period|Adverse Event|0
2924583|NCT01517373|10073876|P6|Run-in Period|Other|0
2924584|NCT01517373|10073877|P5|Run-in Period|Other|0
2924585|NCT01517373|10073878|P4|Run-in Period|Other|0
2924586|NCT01517373|10073879|P3|Run-in Period|Other|0
2924587|NCT01517373|10073880|P2|Run-in Period|Other|0
2924588|NCT01517373|10073881|P1|Run-in Period|Other|1
2924589|NCT01517373|10073876|P6|Run-in Period|Sponsor Decision|0
2924590|NCT01517373|10073877|P5|Run-in Period|Sponsor Decision|0
2924591|NCT01517373|10073878|P4|Run-in Period|Sponsor Decision|0
2924592|NCT01517373|10073879|P3|Run-in Period|Sponsor Decision|0
2924593|NCT01517373|10073880|P2|Run-in Period|Sponsor Decision|0
2924594|NCT01517373|10073881|P1|Run-in Period|Sponsor Decision|3
2924595|NCT01517373|10073876|P6|Run-in Period|Withdrawal by Subject|0
2924596|NCT01517373|10073877|P5|Run-in Period|Withdrawal by Subject|0
2924597|NCT01517373|10073878|P4|Run-in Period|Withdrawal by Subject|0
2924598|NCT01517373|10073879|P3|Run-in Period|Withdrawal by Subject|0
2924599|NCT01517373|10073880|P2|Run-in Period|Withdrawal by Subject|0
2924600|NCT01517373|10073881|P1|Run-in Period|Withdrawal by Subject|12
2924601|NCT01517373|10073876|P6|Run-in Period|Lost to Follow-up|0
2924602|NCT01517373|10073877|P5|Run-in Period|Lost to Follow-up|0
2924603|NCT01517373|10073878|P4|Run-in Period|Lost to Follow-up|0
2924604|NCT01517373|10073879|P3|Run-in Period|Lost to Follow-up|0
2924605|NCT01517373|10073880|P2|Run-in Period|Lost to Follow-up|0
2924606|NCT01517373|10073881|P1|Run-in Period|Lost to Follow-up|1
2924607|NCT01517373|10073876|P6|Run-in Period|Did not meet eligibility criteria|0
2924608|NCT01517373|10073877|P5|Run-in Period|Did not meet eligibility criteria|0
2924609|NCT01517373|10073878|P4|Run-in Period|Did not meet eligibility criteria|0
2924610|NCT01517373|10073879|P3|Run-in Period|Did not meet eligibility criteria|0
2924611|NCT01517373|10073880|P2|Run-in Period|Did not meet eligibility criteria|0
2924612|NCT01517373|10073881|P1|Run-in Period|Did not meet eligibility criteria|34
2924613|NCT01517373|10073876|P6|Run-in Period|Adverse Event|0
2924614|NCT01517373|10073877|P5|Run-in Period|Adverse Event|0
2924615|NCT01517373|10073878|P4|Run-in Period|Adverse Event|0
2924616|NCT01517373|10073879|P3|Run-in Period|Adverse Event|0
2924617|NCT01517373|10073880|P2|Run-in Period|Adverse Event|0
2924618|NCT01517373|10073881|P1|Run-in Period|Adverse Event|5
2924619|NCT01517373|10073876|P6|Run-in Period|Death|0
2924620|NCT01517373|10073877|P5|Run-in Period|Death|0
2924621|NCT01517373|10073878|P4|Run-in Period|Death|0
2924622|NCT01517373|10073879|P3|Run-in Period|Death|0
2924623|NCT01517373|10073880|P2|Run-in Period|Death|0
2924624|NCT01517373|10073881|P1|Run-in Period|Death|1
2924625|NCT01517295|10073951|P2|Overall Study|Physician Decision|0
2924626|NCT01517295|10073952|P1|Overall Study|Physician Decision|1
2924627|NCT01517282|10073966|P4|Overall Study|Physician Decision|0
2924628|NCT01517282|10073967|P3|Overall Study|Physician Decision|0
2924629|NCT01517282|10073968|P2|Overall Study|Physician Decision|0
2924630|NCT01517282|10073969|P1|Overall Study|Physician Decision|1
2924631|NCT01517282|10073966|P4|Overall Study|Consent withdrawn|1
2924632|NCT01517282|10073967|P3|Overall Study|Consent withdrawn|1
2924633|NCT01517282|10073968|P2|Overall Study|Consent withdrawn|1
2924634|NCT01517282|10073969|P1|Overall Study|Consent withdrawn|0
2924635|NCT01517178|10074003|P2|Period 2|E.g. study termination|2
2924636|NCT01517178|10074004|P1|Period 2|E.g. study termination|2
2924637|NCT01517178|10074003|P2|Period 2|Withdrawal by Subject|0
2924638|NCT01517178|10074004|P1|Period 2|Withdrawal by Subject|3
2924639|NCT01517178|10074003|P2|Period 2|Adverse Event|0
2924640|NCT01517178|10074004|P1|Period 2|Adverse Event|1
2924641|NCT01517178|10074003|P2|Period 1|Withdrawal by Subject|1
2924642|NCT01517178|10074004|P1|Period 1|Withdrawal by Subject|0
2924643|NCT01517178|10074003|P2|Period 1|E.g. study termination|1
2924644|NCT01517178|10074004|P1|Period 1|E.g. study termination|3
2924645|NCT01517178|10074003|P2|Period 1|Lack of Efficacy|1
2924646|NCT01517178|10074004|P1|Period 1|Lack of Efficacy|0
2924647|NCT01517178|10074003|P2|Period 1|Adverse Event|2
2924648|NCT01517178|10074004|P1|Period 1|Adverse Event|1
2924649|NCT01516970|10074023|P2|Overall Study|Other|7
2924650|NCT01516970|10074024|P1|Overall Study|Other|9
2924651|NCT01516970|10074023|P2|Overall Study|Withdrawal by Subject|1
2924652|NCT01516970|10074024|P1|Overall Study|Withdrawal by Subject|1
2924653|NCT01516970|10074023|P2|Overall Study|Adverse Event|5
2924654|NCT01516970|10074024|P1|Overall Study|Adverse Event|1
2924655|NCT01516970|10074023|P2|Overall Study|Lost to Follow-up|8
2924656|NCT01516970|10074024|P1|Overall Study|Lost to Follow-up|7
2924657|NCT01516892|10074036|P1|Overall Study|Missing|1
2924658|NCT01516892|10074036|P1|Overall Study|Other Miscellaneous Reasons|43
2924659|NCT01516892|10074036|P1|Overall Study|Protocol Violation|60
2924660|NCT01516892|10074036|P1|Overall Study|Subject Withdrew Consent|92
2924661|NCT01516892|10074036|P1|Overall Study|Lost to Follow-up|82
2924662|NCT01516892|10074036|P1|Overall Study|Pregnancy|5
2924663|NCT01516892|10074036|P1|Overall Study|Lack of Efficacy|35
2924664|NCT01516892|10074036|P1|Overall Study|Adverse Event|25
2924665|NCT01516879|10074044|P2|Overall Study|Other|10
2924666|NCT01516879|10074045|P1|Overall Study|Other|5
2924667|NCT01516879|10074044|P2|Overall Study|Lost to Follow-up|11
2924668|NCT01516879|10074045|P1|Overall Study|Lost to Follow-up|2
2924669|NCT01516879|10074044|P2|Overall Study|Death|2
2924670|NCT01516879|10074045|P1|Overall Study|Death|0
2924671|NCT01516879|10074044|P2|Overall Study|Withdrawal by Subject|11
2924672|NCT01516879|10074045|P1|Overall Study|Withdrawal by Subject|9
2924673|NCT01516749|10074079|P1|Follow-up Off Therapy|Lost to Follow-up|1
2924674|NCT01516749|10074079|P1|Active Therapy|Lost to Follow-up|1
2924675|NCT01516736|10074088|P2|Overall Study|Other (not specified)|1
2924676|NCT01516736|10074089|P1|Overall Study|Other (not specified)|0
2924677|NCT01516736|10074088|P2|Overall Study|Protocol Violation|1
2924678|NCT01516736|10074089|P1|Overall Study|Protocol Violation|0
2924679|NCT01516736|10074088|P2|Overall Study|Lack of Efficacy|0
2924680|NCT01516736|10074089|P1|Overall Study|Lack of Efficacy|1
2924681|NCT01516736|10074088|P2|Overall Study|Physician Decision|1
2924682|NCT01516736|10074089|P1|Overall Study|Physician Decision|2
2924683|NCT01516736|10074088|P2|Overall Study|Death|1
2924684|NCT01516736|10074089|P1|Overall Study|Death|3
2924685|NCT01516736|10074088|P2|Overall Study|Adverse Event|5
2924686|NCT01516736|10074089|P1|Overall Study|Adverse Event|4
2924687|NCT01516736|10074088|P2|Overall Study|Withdrawal by Subject|4
2924688|NCT01516736|10074089|P1|Overall Study|Withdrawal by Subject|10
2924689|NCT01516437|10074143|P4|Overall Study|Reason not specified|1
2924690|NCT01516437|10074144|P3|Overall Study|Reason not specified|1
2924691|NCT01516437|10074145|P2|Overall Study|Reason not specified|0
2924692|NCT01516437|10074146|P1|Overall Study|Reason not specified|0
2924693|NCT01516034|10074218|P1|Overall Study|Lack of Efficacy|7
2924694|NCT01516034|10074218|P1|Overall Study|Physician Decision|1
2924695|NCT01516008|10074225|P3|Overall Study|Reason not specified|1
2924696|NCT01516008|10074226|P2|Overall Study|Reason not specified|0
2924697|NCT01516008|10074227|P1|Overall Study|Reason not specified|0
2924698|NCT01516008|10074225|P3|Overall Study|Protocol Violation|0
2924699|NCT01516008|10074226|P2|Overall Study|Protocol Violation|0
2924700|NCT01516008|10074227|P1|Overall Study|Protocol Violation|1
2924701|NCT01516008|10074225|P3|Overall Study|Lack of Efficacy|10
2924702|NCT01516008|10074226|P2|Overall Study|Lack of Efficacy|14
2924703|NCT01516008|10074227|P1|Overall Study|Lack of Efficacy|44
2924704|NCT01516008|10074225|P3|Overall Study|Adverse Event|7
2924705|NCT01516008|10074226|P2|Overall Study|Adverse Event|2
2924706|NCT01516008|10074227|P1|Overall Study|Adverse Event|0
2924707|NCT01515865|10074332|P3|Part B (Open-label)|Other|0
2924708|NCT01515865|10074333|P2|Part B (Open-label)|Other|0
2924709|NCT01515865|10074334|P1|Part B (Open-label)|Other|1
2924710|NCT01515865|10074332|P3|Part B (Open-label)|Withdrawal by Subject|0
2924711|NCT01515865|10074333|P2|Part B (Open-label)|Withdrawal by Subject|0
2924712|NCT01515865|10074334|P1|Part B (Open-label)|Withdrawal by Subject|1
2924713|NCT01515865|10074332|P3|Part A (Open-label)|Other|0
2924714|NCT01515865|10074333|P2|Part A (Open-label)|Other|0
2924715|NCT01515865|10074334|P1|Part A (Open-label)|Other|3
2924716|NCT01515748|10074344|P2|Overall Study|Ongoing|90
2924717|NCT01515748|10074345|P1|Overall Study|Ongoing|86
2924718|NCT01515748|10074344|P2|Overall Study|Lost to Follow-up|4
2924719|NCT01515748|10074345|P1|Overall Study|Lost to Follow-up|2
2924720|NCT01515748|10074344|P2|Overall Study|Withdrawal by Subject|41
2924721|NCT01515748|10074345|P1|Overall Study|Withdrawal by Subject|32
2924722|NCT01515475|10074428|P4|Overall Study|Lost to Follow-up|12
2924723|NCT01515475|10074429|P3|Overall Study|Lost to Follow-up|12
2924724|NCT01515475|10074430|P2|Overall Study|Lost to Follow-up|15
2924725|NCT01515475|10074431|P1|Overall Study|Lost to Follow-up|20
2924726|NCT01515423|10074505|P3|DOUBLE BLIND|Blind broken by investigator|0
2924727|NCT01515423|10074506|P2|DOUBLE BLIND|Blind broken by investigator|1
2924728|NCT01515423|10074507|P1|DOUBLE BLIND|Blind broken by investigator|0
2924729|NCT01515423|10074505|P3|DOUBLE BLIND|Other|12
2924730|NCT01515423|10074506|P2|DOUBLE BLIND|Other|6
2924731|NCT01515423|10074507|P1|DOUBLE BLIND|Other|0
2924732|NCT01515423|10074505|P3|DOUBLE BLIND|Withdrawal by Subject|53
2924733|NCT01515423|10074506|P2|DOUBLE BLIND|Withdrawal by Subject|50
2924734|NCT01515423|10074507|P1|DOUBLE BLIND|Withdrawal by Subject|0
2924735|NCT01515423|10074505|P3|DOUBLE BLIND|Pregnancy|0
2924736|NCT01515423|10074506|P2|DOUBLE BLIND|Pregnancy|2
2924737|NCT01515423|10074507|P1|DOUBLE BLIND|Pregnancy|0
2924738|NCT01515423|10074505|P3|DOUBLE BLIND|Lost to Follow-up|12
2924739|NCT01515423|10074506|P2|DOUBLE BLIND|Lost to Follow-up|7
2924740|NCT01515423|10074507|P1|DOUBLE BLIND|Lost to Follow-up|0
2924741|NCT01515423|10074505|P3|DOUBLE BLIND|Death|2
2924742|NCT01515423|10074506|P2|DOUBLE BLIND|Death|1
2924743|NCT01515423|10074507|P1|DOUBLE BLIND|Death|0
2924744|NCT01515423|10074505|P3|DOUBLE BLIND|Adverse Event|13
2924745|NCT01515423|10074506|P2|DOUBLE BLIND|Adverse Event|15
2924746|NCT01515423|10074507|P1|DOUBLE BLIND|Adverse Event|0
2924747|NCT01515423|10074505|P3|Open Label Phase|Other|0
2924748|NCT01515423|10074506|P2|Open Label Phase|Other|0
2924749|NCT01515423|10074507|P1|Open Label Phase|Other|28
2924750|NCT01515423|10074505|P3|Open Label Phase|excluded from DB Phase|0
2924751|NCT01515423|10074506|P2|Open Label Phase|excluded from DB Phase|0
2924752|NCT01515423|10074507|P1|Open Label Phase|excluded from DB Phase|70
2924753|NCT01515423|10074505|P3|Open Label Phase|Withdrawal by Subject|0
2924754|NCT01515423|10074506|P2|Open Label Phase|Withdrawal by Subject|0
2924755|NCT01515423|10074507|P1|Open Label Phase|Withdrawal by Subject|118
2924756|NCT01515423|10074505|P3|Open Label Phase|Lost to Follow-up|0
2924757|NCT01515423|10074506|P2|Open Label Phase|Lost to Follow-up|0
2924758|NCT01515423|10074507|P1|Open Label Phase|Lost to Follow-up|21
2924759|NCT01515423|10074505|P3|Open Label Phase|Lack of Efficacy|0
2924760|NCT01515423|10074506|P2|Open Label Phase|Lack of Efficacy|0
2924761|NCT01515423|10074507|P1|Open Label Phase|Lack of Efficacy|117
2924762|NCT01515423|10074505|P3|Open Label Phase|Death|0
2924763|NCT01515423|10074506|P2|Open Label Phase|Death|0
2924764|NCT01515423|10074507|P1|Open Label Phase|Death|2
2924765|NCT01515423|10074505|P3|Open Label Phase|Adverse Event|0
2924766|NCT01515423|10074506|P2|Open Label Phase|Adverse Event|0
2924767|NCT01515423|10074507|P1|Open Label Phase|Adverse Event|57
2924768|NCT01515306|10074548|P2|Overall Study|Ongoing receiving treatment|14
2924769|NCT01515306|10074549|P1|Overall Study|Ongoing receiving treatment|9
2924770|NCT01515306|10074548|P2|Overall Study|Progressive Disease|0
2924771|NCT01515306|10074549|P1|Overall Study|Progressive Disease|1
2924772|NCT01515306|10074548|P2|Overall Study|Adverse Event|0
2924773|NCT01515306|10074549|P1|Overall Study|Adverse Event|2
2924774|NCT01515189|10074562|P2|First Re-Induction Phase|Other|0
2924775|NCT01515189|10074563|P1|First Re-Induction Phase|Other|1
2924776|NCT01515189|10074562|P2|First Re-Induction Phase|No longer meets study criteria|0
2924777|NCT01515189|10074563|P1|First Re-Induction Phase|No longer meets study criteria|1
2924778|NCT01515189|10074562|P2|First Re-Induction Phase|Withdrawal by Subject|1
2924779|NCT01515189|10074563|P1|First Re-Induction Phase|Withdrawal by Subject|1
2924780|NCT01515189|10074562|P2|First Re-Induction Phase|Study drug toxicity|0
2924781|NCT01515189|10074563|P1|First Re-Induction Phase|Study drug toxicity|5
2924782|NCT01515189|10074562|P2|First Re-Induction Phase|Disease progression|14
2924783|NCT01515189|10074563|P1|First Re-Induction Phase|Disease progression|6
2924784|NCT01515189|10074562|P2|Induction|Other|4
2924785|NCT01515189|10074563|P1|Induction|Other|0
2924786|NCT01515189|10074562|P2|Induction|Lost to Follow-up|0
2924787|NCT01515189|10074563|P1|Induction|Lost to Follow-up|1
2924788|NCT01515189|10074562|P2|Induction|No longer meets study criteria|2
2924789|NCT01515189|10074563|P1|Induction|No longer meets study criteria|0
2924790|NCT01515189|10074562|P2|Induction|Withdrawal by Subject|9
2924791|NCT01515189|10074563|P1|Induction|Withdrawal by Subject|3
2924792|NCT01515189|10074562|P2|Induction|Adverse Event|9
2924793|NCT01515189|10074563|P1|Induction|Adverse Event|14
2924794|NCT01515189|10074562|P2|Induction|Death|17
2924795|NCT01515189|10074563|P1|Induction|Death|24
2924796|NCT01515189|10074562|P2|Induction|Study drug toxicity|36
2924797|NCT01515189|10074563|P1|Induction|Study drug toxicity|86
2924798|NCT01515189|10074562|P2|Induction|Disease Progression|155
2924799|NCT01515189|10074563|P1|Induction|Disease Progression|109
2924800|NCT01514864|10074651|P2|Overall Study|Study drug toxicity|0
2924801|NCT01514864|10074652|P1|Overall Study|Study drug toxicity|2
2924802|NCT01514864|10074651|P2|Overall Study|Disease progression|5
2924803|NCT01514864|10074652|P1|Overall Study|Disease progression|7
2924804|NCT01514760|10074677|P1|Overall Study|Lost to Follow-up|2
2924805|NCT01514682|10074690|P2|Overall Study|Physician Decision|3
2924806|NCT01514682|10074691|P1|Overall Study|Physician Decision|4
2924807|NCT01514682|10074690|P2|Overall Study|Withdrawal by Subject|3
2924808|NCT01514682|10074691|P1|Overall Study|Withdrawal by Subject|2
2924809|NCT01514461|10074725|P3|Overall Study|Death|0
2924810|NCT01514461|10074726|P2|Overall Study|Death|0
2924811|NCT01514461|10074727|P1|Overall Study|Death|1
2924812|NCT01514461|10074725|P3|Overall Study|Patient/guardian decision|1
2924813|NCT01514461|10074726|P2|Overall Study|Patient/guardian decision|1
2924814|NCT01514461|10074727|P1|Overall Study|Patient/guardian decision|1
2924815|NCT01514461|10074725|P3|Overall Study|Physician Decision|0
2924816|NCT01514461|10074726|P2|Overall Study|Physician Decision|1
2924817|NCT01514461|10074727|P1|Overall Study|Physician Decision|1
2924818|NCT01514461|10074725|P3|Overall Study|Adverse Event|3
2924819|NCT01514461|10074726|P2|Overall Study|Adverse Event|1
2924820|NCT01514461|10074727|P1|Overall Study|Adverse Event|2
2924821|NCT01514448|10074766|P2|Overall Study|New Cancer Therapy|0
2924822|NCT01514448|10074767|P1|Overall Study|New Cancer Therapy|1
2924823|NCT01514448|10074766|P2|Overall Study|Lost to Follow-up|0
2924824|NCT01514448|10074767|P1|Overall Study|Lost to Follow-up|2
2924825|NCT01514448|10074766|P2|Overall Study|Withdrawal by Subject|0
2924826|NCT01514448|10074767|P1|Overall Study|Withdrawal by Subject|2
2924827|NCT01514448|10074766|P2|Overall Study|Death|8
2924828|NCT01514448|10074767|P1|Overall Study|Death|7
2924829|NCT01514422|10074782|P1|Overall Study|Lost to Follow-up|1
2924830|NCT01514370|10074800|P2|Overall Study|Other|7
2924831|NCT01514370|10074801|P1|Overall Study|Other|6
2924832|NCT01514370|10074800|P2|Overall Study|Adverse Event|3
2924833|NCT01514370|10074801|P1|Overall Study|Adverse Event|1
2924834|NCT01514370|10074800|P2|Overall Study|Withdrawal by Subject|1
2924835|NCT01514370|10074801|P1|Overall Study|Withdrawal by Subject|2
2924836|NCT01514370|10074800|P2|Overall Study|Lost to Follow-up|2
2924837|NCT01514370|10074801|P1|Overall Study|Lost to Follow-up|0
2924838|NCT01514370|10074800|P2|Overall Study|Protocol Violation|3
2924839|NCT01514370|10074801|P1|Overall Study|Protocol Violation|2
2924840|NCT01514357|10074847|P2|Overall Study|Withdrawal by Subject|0
2924841|NCT01514357|10074848|P1|Overall Study|Withdrawal by Subject|2
2924842|NCT01514357|10074847|P2|Overall Study|Screen failure|0
2924843|NCT01514357|10074848|P1|Overall Study|Screen failure|2
2924844|NCT01514240|10074866|P2|Overall Study|Subject Decision|7
2924845|NCT01514240|10074867|P1|Overall Study|Subject Decision|2
2924846|NCT01514240|10074866|P2|Overall Study|Adverse Event|4
2924847|NCT01514240|10074867|P1|Overall Study|Adverse Event|4
2924848|NCT01514201|10074945|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
2924849|NCT01514201|10074946|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2924850|NCT01514201|10074947|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2924851|NCT01514201|10074948|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2924852|NCT01514201|10074945|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
2924853|NCT01514201|10074946|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2924854|NCT01514201|10074947|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2924855|NCT01514201|10074948|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2924856|NCT01514201|10074945|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
2924857|NCT01514201|10074946|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2924858|NCT01514201|10074947|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2924859|NCT01514201|10074948|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2924860|NCT01514201|10074945|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
2924861|NCT01514201|10074946|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2924862|NCT01514201|10074947|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2924863|NCT01514201|10074948|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2924864|NCT01514201|10074945|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
2924865|NCT01514201|10074946|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924866|NCT01514201|10074947|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924867|NCT01514201|10074948|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924868|NCT01514201|10074945|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
2924869|NCT01514201|10074946|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
2924870|NCT01514201|10074947|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
2924871|NCT01514201|10074948|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
2924872|NCT01514201|10074945|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
2924873|NCT01514201|10074946|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2924874|NCT01514201|10074947|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2924875|NCT01514201|10074948|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2924876|NCT01514201|10074945|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
2924877|NCT01514201|10074946|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2924878|NCT01514201|10074947|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2924879|NCT01514201|10074948|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2924880|NCT01514201|10074945|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2924881|NCT01514201|10074946|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2924882|NCT01514201|10074947|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2924883|NCT01514201|10074948|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2924884|NCT01514201|10074945|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2924885|NCT01514201|10074946|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
2924886|NCT01514201|10074947|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2924887|NCT01514201|10074948|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2924888|NCT01514201|10074945|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2924889|NCT01514201|10074946|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2924890|NCT01514201|10074947|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2924891|NCT01514201|10074948|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2924892|NCT01514201|10074945|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924974|NCT01514136|10075052|P2|Test Period 1; Test A|Protocol Violation|0
2924893|NCT01514201|10074946|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924894|NCT01514201|10074947|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2924895|NCT01514201|10074948|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
2924896|NCT01514136|10075046|P8|Test Period 2; Test C*|Protocol Violation|0
2924897|NCT01514136|10075047|P7|Test Period 2; Test C*|Protocol Violation|1
2924898|NCT01514136|10075048|P6|Test Period 2; Test C*|Protocol Violation|0
2924899|NCT01514136|10075049|P5|Test Period 2; Test C*|Protocol Violation|0
2924900|NCT01514136|10075050|P4|Test Period 2; Test C*|Protocol Violation|0
2924901|NCT01514136|10075051|P3|Test Period 2; Test C*|Protocol Violation|0
2924902|NCT01514136|10075052|P2|Test Period 2; Test C*|Protocol Violation|0
2924903|NCT01514136|10075053|P1|Test Period 2; Test C*|Protocol Violation|0
2924904|NCT01514136|10075046|P8|Test Period 2; Test C*|holiday|0
2924905|NCT01514136|10075047|P7|Test Period 2; Test C*|holiday|1
2924906|NCT01514136|10075048|P6|Test Period 2; Test C*|holiday|0
2924907|NCT01514136|10075049|P5|Test Period 2; Test C*|holiday|0
2924908|NCT01514136|10075050|P4|Test Period 2; Test C*|holiday|0
2924909|NCT01514136|10075051|P3|Test Period 2; Test C*|holiday|0
2924910|NCT01514136|10075052|P2|Test Period 2; Test C*|holiday|0
2924911|NCT01514136|10075053|P1|Test Period 2; Test C*|holiday|0
2924912|NCT01514136|10075046|P8|Test Period 2; Test C*|Withdrawal by Subject|0
2924913|NCT01514136|10075047|P7|Test Period 2; Test C*|Withdrawal by Subject|1
2924914|NCT01514136|10075048|P6|Test Period 2; Test C*|Withdrawal by Subject|0
2924915|NCT01514136|10075049|P5|Test Period 2; Test C*|Withdrawal by Subject|0
2924916|NCT01514136|10075050|P4|Test Period 2; Test C*|Withdrawal by Subject|0
2924917|NCT01514136|10075051|P3|Test Period 2; Test C*|Withdrawal by Subject|0
2924918|NCT01514136|10075052|P2|Test Period 2; Test C*|Withdrawal by Subject|0
2924919|NCT01514136|10075053|P1|Test Period 2; Test C*|Withdrawal by Subject|0
2924920|NCT01514136|10075046|P8|Test Period 2; Test B*|Withdrawal by Subject|0
2924921|NCT01514136|10075047|P7|Test Period 2; Test B*|Withdrawal by Subject|0
2924922|NCT01514136|10075048|P6|Test Period 2; Test B*|Withdrawal by Subject|2
2924923|NCT01514136|10075049|P5|Test Period 2; Test B*|Withdrawal by Subject|0
2924924|NCT01514136|10075050|P4|Test Period 2; Test B*|Withdrawal by Subject|0
2924925|NCT01514136|10075051|P3|Test Period 2; Test B*|Withdrawal by Subject|0
2924926|NCT01514136|10075052|P2|Test Period 2; Test B*|Withdrawal by Subject|0
2924927|NCT01514136|10075053|P1|Test Period 2; Test B*|Withdrawal by Subject|0
2924928|NCT01514136|10075046|P8|Test Period 2; Test A*|Holiday|0
2924929|NCT01514136|10075047|P7|Test Period 2; Test A*|Holiday|0
2924930|NCT01514136|10075048|P6|Test Period 2; Test A*|Holiday|0
2924931|NCT01514136|10075049|P5|Test Period 2; Test A*|Holiday|1
2924932|NCT01514136|10075050|P4|Test Period 2; Test A*|Holiday|0
2924933|NCT01514136|10075051|P3|Test Period 2; Test A*|Holiday|0
2924934|NCT01514136|10075052|P2|Test Period 2; Test A*|Holiday|0
2924935|NCT01514136|10075053|P1|Test Period 2; Test A*|Holiday|0
2924936|NCT01514136|10075046|P8|Test Period 2; Test A*|Adverse Event|0
2924937|NCT01514136|10075047|P7|Test Period 2; Test A*|Adverse Event|0
2924938|NCT01514136|10075048|P6|Test Period 2; Test A*|Adverse Event|0
2924939|NCT01514136|10075049|P5|Test Period 2; Test A*|Adverse Event|1
2924940|NCT01514136|10075050|P4|Test Period 2; Test A*|Adverse Event|0
2924941|NCT01514136|10075051|P3|Test Period 2; Test A*|Adverse Event|0
2924942|NCT01514136|10075052|P2|Test Period 2; Test A*|Adverse Event|0
2924943|NCT01514136|10075053|P1|Test Period 2; Test A*|Adverse Event|0
2924944|NCT01514136|10075046|P8|Test Period 1; Test D|Subject took a break due to holiday|0
2924945|NCT01514136|10075047|P7|Test Period 1; Test D|Subject took a break due to holiday|0
2924946|NCT01514136|10075048|P6|Test Period 1; Test D|Subject took a break due to holiday|0
2924947|NCT01514136|10075049|P5|Test Period 1; Test D|Subject took a break due to holiday|0
2924948|NCT01514136|10075050|P4|Test Period 1; Test D|Subject took a break due to holiday|2
2924949|NCT01514136|10075051|P3|Test Period 1; Test D|Subject took a break due to holiday|0
2924950|NCT01514136|10075052|P2|Test Period 1; Test D|Subject took a break due to holiday|0
2924951|NCT01514136|10075053|P1|Test Period 1; Test D|Subject took a break due to holiday|0
2924952|NCT01514136|10075046|P8|Test Period 1; Test B|Withdrawal by Subject|0
2924953|NCT01514136|10075047|P7|Test Period 1; Test B|Withdrawal by Subject|0
2924954|NCT01514136|10075048|P6|Test Period 1; Test B|Withdrawal by Subject|0
2924955|NCT01514136|10075049|P5|Test Period 1; Test B|Withdrawal by Subject|0
2924956|NCT01514136|10075050|P4|Test Period 1; Test B|Withdrawal by Subject|0
2924957|NCT01514136|10075051|P3|Test Period 1; Test B|Withdrawal by Subject|0
2924958|NCT01514136|10075052|P2|Test Period 1; Test B|Withdrawal by Subject|1
2924959|NCT01514136|10075053|P1|Test Period 1; Test B|Withdrawal by Subject|0
2924960|NCT01514136|10075046|P8|Test Period 1; Test A|Break from study holiday|0
2924961|NCT01514136|10075047|P7|Test Period 1; Test A|Break from study holiday|0
2924962|NCT01514136|10075048|P6|Test Period 1; Test A|Break from study holiday|0
2924963|NCT01514136|10075049|P5|Test Period 1; Test A|Break from study holiday|0
2924964|NCT01514136|10075050|P4|Test Period 1; Test A|Break from study holiday|0
2924965|NCT01514136|10075051|P3|Test Period 1; Test A|Break from study holiday|0
2924966|NCT01514136|10075052|P2|Test Period 1; Test A|Break from study holiday|0
2924967|NCT01514136|10075053|P1|Test Period 1; Test A|Break from study holiday|2
2924968|NCT01514136|10075046|P8|Test Period 1; Test A|Protocol Violation|0
2924969|NCT01514136|10075047|P7|Test Period 1; Test A|Protocol Violation|0
2924970|NCT01514136|10075048|P6|Test Period 1; Test A|Protocol Violation|0
2924971|NCT01514136|10075049|P5|Test Period 1; Test A|Protocol Violation|0
2924972|NCT01514136|10075050|P4|Test Period 1; Test A|Protocol Violation|0
2924973|NCT01514136|10075051|P3|Test Period 1; Test A|Protocol Violation|0
2924975|NCT01514136|10075053|P1|Test Period 1; Test A|Protocol Violation|1
2924976|NCT01513967|10075087|P8|Overall Study|Physician Decision|0
2924977|NCT01513967|10075088|P7|Overall Study|Physician Decision|0
2924978|NCT01513967|10075089|P6|Overall Study|Physician Decision|1
2924979|NCT01513967|10075090|P5|Overall Study|Physician Decision|0
2924980|NCT01513967|10075091|P4|Overall Study|Physician Decision|0
2924981|NCT01513967|10075092|P3|Overall Study|Physician Decision|0
2924982|NCT01513967|10075093|P2|Overall Study|Physician Decision|0
2924983|NCT01513967|10075094|P1|Overall Study|Physician Decision|0
2924984|NCT01513967|10075087|P8|Overall Study|excluded due to positive drug screen|2
2924985|NCT01513967|10075088|P7|Overall Study|excluded due to positive drug screen|0
2924986|NCT01513967|10075089|P6|Overall Study|excluded due to positive drug screen|0
2924987|NCT01513967|10075090|P5|Overall Study|excluded due to positive drug screen|0
2924988|NCT01513967|10075091|P4|Overall Study|excluded due to positive drug screen|0
2924989|NCT01513967|10075092|P3|Overall Study|excluded due to positive drug screen|0
2924990|NCT01513967|10075093|P2|Overall Study|excluded due to positive drug screen|0
2924991|NCT01513967|10075094|P1|Overall Study|excluded due to positive drug screen|0
2924992|NCT01513967|10075087|P8|Overall Study|missed a study visit|0
2924993|NCT01513967|10075088|P7|Overall Study|missed a study visit|1
2924994|NCT01513967|10075089|P6|Overall Study|missed a study visit|0
2924995|NCT01513967|10075090|P5|Overall Study|missed a study visit|0
2924996|NCT01513967|10075091|P4|Overall Study|missed a study visit|0
2924997|NCT01513967|10075092|P3|Overall Study|missed a study visit|0
2924998|NCT01513967|10075093|P2|Overall Study|missed a study visit|0
2924999|NCT01513967|10075094|P1|Overall Study|missed a study visit|0
2925000|NCT01513967|10075087|P8|Overall Study|Pregnancy|0
2925001|NCT01513967|10075088|P7|Overall Study|Pregnancy|1
2925002|NCT01513967|10075089|P6|Overall Study|Pregnancy|0
2925003|NCT01513967|10075090|P5|Overall Study|Pregnancy|0
2925004|NCT01513967|10075091|P4|Overall Study|Pregnancy|0
2925005|NCT01513967|10075092|P3|Overall Study|Pregnancy|0
2925006|NCT01513967|10075093|P2|Overall Study|Pregnancy|0
2925007|NCT01513967|10075094|P1|Overall Study|Pregnancy|0
2925008|NCT01513759|10075152|P1|Overall Study|Death during catheter placement|1
2925009|NCT01513759|10075152|P1|Overall Study|Protocol Violation|4
2925010|NCT01513590|10075163|P2|Overall Study|Unclassified|10
2925011|NCT01513590|10075164|P1|Overall Study|Unclassified|5
2925012|NCT01513590|10075163|P2|Overall Study|Withdrawal Criteria|0
2925013|NCT01513590|10075164|P1|Overall Study|Withdrawal Criteria|3
2925014|NCT01513590|10075163|P2|Overall Study|Adverse Event|3
2925015|NCT01513590|10075164|P1|Overall Study|Adverse Event|2
2925016|NCT01513551|10075185|P3|Overall Study|Randomized but not vaccinated|1
2925017|NCT01513551|10075186|P2|Overall Study|Randomized but not vaccinated|0
2925018|NCT01513551|10075187|P1|Overall Study|Randomized but not vaccinated|0
2925019|NCT01513551|10075185|P3|Overall Study|Withdrawal by Subject|2
2925020|NCT01513551|10075186|P2|Overall Study|Withdrawal by Subject|0
2925021|NCT01513551|10075187|P1|Overall Study|Withdrawal by Subject|1
2925022|NCT01513551|10075185|P3|Overall Study|Lost to Follow-up|2
2925023|NCT01513551|10075186|P2|Overall Study|Lost to Follow-up|5
2925024|NCT01513551|10075187|P1|Overall Study|Lost to Follow-up|3
2925025|NCT01513551|10075185|P3|Overall Study|Death|0
2925026|NCT01513551|10075186|P2|Overall Study|Death|1
2925027|NCT01513551|10075187|P1|Overall Study|Death|0
2925028|NCT01513473|10075219|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
2925029|NCT01513473|10075220|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
2925030|NCT01513473|10075219|P2|Extension Trial (26 Weeks)|Adverse Event|1
2925031|NCT01513473|10075220|P1|Extension Trial (26 Weeks)|Adverse Event|0
2925032|NCT01513473|10075219|P2|Main Trial (26 Weeks)|Unclassified|2
2925033|NCT01513473|10075220|P1|Main Trial (26 Weeks)|Unclassified|0
2925034|NCT01513473|10075219|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
2925035|NCT01513473|10075220|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
2925036|NCT01513473|10075219|P2|Main Trial (26 Weeks)|Adverse Event|2
2925037|NCT01513473|10075220|P1|Main Trial (26 Weeks)|Adverse Event|0
2925038|NCT01513460|10075247|P3|Overall Study|Abnormal test procedure|0
2925039|NCT01513460|10075248|P2|Overall Study|Abnormal test procedure|0
2925040|NCT01513460|10075249|P1|Overall Study|Abnormal test procedure|1
2925041|NCT01513460|10075247|P3|Overall Study|Adverse Event|23
2925042|NCT01513460|10075248|P2|Overall Study|Adverse Event|18
2925043|NCT01513460|10075249|P1|Overall Study|Adverse Event|16
2925044|NCT01513460|10075247|P3|Overall Study|Withdrawal by Subject|21
2925045|NCT01513460|10075248|P2|Overall Study|Withdrawal by Subject|8
2925046|NCT01513460|10075249|P1|Overall Study|Withdrawal by Subject|7
2925047|NCT01513460|10075247|P3|Overall Study|Protocol deviations|3
2925048|NCT01513460|10075248|P2|Overall Study|Protocol deviations|4
2925049|NCT01513460|10075249|P1|Overall Study|Protocol deviations|3
2925050|NCT01513460|10075247|P3|Overall Study|Lack of Efficacy|5
2925051|NCT01513460|10075248|P2|Overall Study|Lack of Efficacy|2
2925052|NCT01513460|10075249|P1|Overall Study|Lack of Efficacy|1
2925053|NCT01513460|10075247|P3|Overall Study|Abnormal laboratory value|1
2925054|NCT01513460|10075248|P2|Overall Study|Abnormal laboratory value|0
2925055|NCT01513460|10075249|P1|Overall Study|Abnormal laboratory value|1
2925056|NCT01513460|10075247|P3|Overall Study|Lost to Follow-up|2
2925057|NCT01513460|10075248|P2|Overall Study|Lost to Follow-up|0
2925058|NCT01513460|10075249|P1|Overall Study|Lost to Follow-up|0
2925059|NCT01513460|10075247|P3|Overall Study|Death|1
2925060|NCT01513460|10075248|P2|Overall Study|Death|0
2925061|NCT01513460|10075249|P1|Overall Study|Death|0
2925062|NCT01513330|10075284|P2|Standard Care First,|Other|0
2925063|NCT01513330|10075285|P1|Standard Care First,|Other|1
2925064|NCT01513330|10075284|P2|Standard Care First,|Withdrawal by Subject|2
2925065|NCT01513330|10075285|P1|Standard Care First,|Withdrawal by Subject|1
2925066|NCT01513330|10075284|P2|Standard Care First,|Lack of Efficacy|2
2925067|NCT01513330|10075285|P1|Standard Care First,|Lack of Efficacy|2
2925068|NCT01513330|10075284|P2|SenSura Mio First,|Other|0
2925069|NCT01513330|10075285|P1|SenSura Mio First,|Other|1
2925070|NCT01513330|10075284|P2|SenSura Mio First,|Withdrawal by Subject|1
2925071|NCT01513330|10075285|P1|SenSura Mio First,|Withdrawal by Subject|1
2925072|NCT01513330|10075284|P2|SenSura Mio First,|Lack of Efficacy|1
2925073|NCT01513330|10075285|P1|SenSura Mio First,|Lack of Efficacy|0
2925074|NCT01513330|10075284|P2|SenSura Mio First,|Adverse Event|0
2925075|NCT01513330|10075285|P1|SenSura Mio First,|Adverse Event|2
2925076|NCT01513317|10075293|P2|Overall Study|Other|1
2925077|NCT01513317|10075294|P1|Overall Study|Other|0
2925078|NCT01513317|10075293|P2|Overall Study|Study terminated by sponsor|18
2925079|NCT01513317|10075294|P1|Overall Study|Study terminated by sponsor|18
2925080|NCT01513317|10075293|P2|Overall Study|Death|1
2925081|NCT01513317|10075294|P1|Overall Study|Death|1
2925082|NCT01513317|10075293|P2|Overall Study|Withdrawal by Subject|4
2925083|NCT01513317|10075294|P1|Overall Study|Withdrawal by Subject|15
2925084|NCT01513291|10075312|P5|Run-out Period|Withdrawal by Subject|0
2925085|NCT01513291|10075313|P4|Run-out Period|Withdrawal by Subject|1
2925086|NCT01513291|10075314|P3|Run-out Period|Withdrawal by Subject|0
2925087|NCT01513291|10075315|P2|Run-out Period|Withdrawal by Subject|0
2925088|NCT01513291|10075316|P1|Run-out Period|Withdrawal by Subject|0
2925089|NCT01513291|10075312|P5|Run-out Period|Lost to Follow-up|0
2925090|NCT01513291|10075313|P4|Run-out Period|Lost to Follow-up|1
2925091|NCT01513291|10075314|P3|Run-out Period|Lost to Follow-up|0
2925092|NCT01513291|10075315|P2|Run-out Period|Lost to Follow-up|0
2925093|NCT01513291|10075316|P1|Run-out Period|Lost to Follow-up|0
2925094|NCT01513291|10075312|P5|Treatment Period|Randomized not treated|0
2925095|NCT01513291|10075313|P4|Treatment Period|Randomized not treated|0
2925096|NCT01513291|10075314|P3|Treatment Period|Randomized not treated|0
2925097|NCT01513291|10075315|P2|Treatment Period|Randomized not treated|2
2925098|NCT01513291|10075316|P1|Treatment Period|Randomized not treated|0
2925099|NCT01513291|10075312|P5|Treatment Period|Withdrawal by Subject|0
2925100|NCT01513291|10075313|P4|Treatment Period|Withdrawal by Subject|0
2925101|NCT01513291|10075314|P3|Treatment Period|Withdrawal by Subject|0
2925102|NCT01513291|10075315|P2|Treatment Period|Withdrawal by Subject|5
2925103|NCT01513291|10075316|P1|Treatment Period|Withdrawal by Subject|8
2925104|NCT01513291|10075312|P5|Treatment Period|Protocol Violation|0
2925105|NCT01513291|10075313|P4|Treatment Period|Protocol Violation|0
2925106|NCT01513291|10075314|P3|Treatment Period|Protocol Violation|0
2925107|NCT01513291|10075315|P2|Treatment Period|Protocol Violation|2
2925108|NCT01513291|10075316|P1|Treatment Period|Protocol Violation|1
2925109|NCT01513291|10075312|P5|Treatment Period|Physician Decision|0
2925110|NCT01513291|10075313|P4|Treatment Period|Physician Decision|0
2925111|NCT01513291|10075314|P3|Treatment Period|Physician Decision|0
2925112|NCT01513291|10075315|P2|Treatment Period|Physician Decision|0
2925113|NCT01513291|10075316|P1|Treatment Period|Physician Decision|1
2925114|NCT01513291|10075312|P5|Treatment Period|Lost to Follow-up|0
2925115|NCT01513291|10075313|P4|Treatment Period|Lost to Follow-up|0
2925116|NCT01513291|10075314|P3|Treatment Period|Lost to Follow-up|0
2925117|NCT01513291|10075315|P2|Treatment Period|Lost to Follow-up|3
2925118|NCT01513291|10075316|P1|Treatment Period|Lost to Follow-up|2
2925119|NCT01513291|10075312|P5|Treatment Period|Lack of Efficacy|0
2925120|NCT01513291|10075313|P4|Treatment Period|Lack of Efficacy|0
2925121|NCT01513291|10075314|P3|Treatment Period|Lack of Efficacy|0
2925122|NCT01513291|10075315|P2|Treatment Period|Lack of Efficacy|0
2925123|NCT01513291|10075316|P1|Treatment Period|Lack of Efficacy|3
2925124|NCT01513291|10075312|P5|Treatment Period|Adverse Event|0
2925125|NCT01513291|10075313|P4|Treatment Period|Adverse Event|0
2925126|NCT01513291|10075314|P3|Treatment Period|Adverse Event|0
2925127|NCT01513291|10075315|P2|Treatment Period|Adverse Event|4
2925128|NCT01513291|10075316|P1|Treatment Period|Adverse Event|8
2925129|NCT01513239|10075344|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
2925130|NCT01513239|10075345|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
2925131|NCT01513239|10075346|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
2925132|NCT01513239|10075347|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
2925133|NCT01513239|10075348|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
2925134|NCT01513239|10075349|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
2925135|NCT01513239|10075344|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
2925136|NCT01513239|10075345|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
2925137|NCT01513239|10075346|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
2925138|NCT01513239|10075347|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
2925139|NCT01513239|10075348|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
2925140|NCT01513239|10075349|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
2925141|NCT01513239|10075344|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2925142|NCT01513239|10075345|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
2925143|NCT01513239|10075346|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
2925144|NCT01513239|10075347|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2925145|NCT01513239|10075348|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2925146|NCT01513239|10075349|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2925147|NCT01513239|10075344|P6|Period 2: 9 Month Extension Phase|Death|2
2925148|NCT01513239|10075345|P5|Period 2: 9 Month Extension Phase|Death|5
2925149|NCT01513239|10075346|P4|Period 2: 9 Month Extension Phase|Death|2
2925150|NCT01513239|10075347|P3|Period 2: 9 Month Extension Phase|Death|0
2925151|NCT01513239|10075348|P2|Period 2: 9 Month Extension Phase|Death|0
2925152|NCT01513239|10075349|P1|Period 2: 9 Month Extension Phase|Death|0
2925153|NCT01513239|10075344|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
2925154|NCT01513239|10075345|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
2925155|NCT01513239|10075346|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
2925156|NCT01513239|10075347|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2925157|NCT01513239|10075348|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2925158|NCT01513239|10075349|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2925159|NCT01513239|10075344|P6|Period 1: Main Phase|Withdrawal by Subject|0
2925160|NCT01513239|10075345|P5|Period 1: Main Phase|Withdrawal by Subject|0
2925161|NCT01513239|10075346|P4|Period 1: Main Phase|Withdrawal by Subject|0
2925162|NCT01513239|10075347|P3|Period 1: Main Phase|Withdrawal by Subject|42
2925163|NCT01513239|10075348|P2|Period 1: Main Phase|Withdrawal by Subject|29
2925164|NCT01513239|10075349|P1|Period 1: Main Phase|Withdrawal by Subject|27
2925165|NCT01513239|10075344|P6|Period 1: Main Phase|Technical Problems|0
2925166|NCT01513239|10075345|P5|Period 1: Main Phase|Technical Problems|0
2925167|NCT01513239|10075346|P4|Period 1: Main Phase|Technical Problems|0
2925168|NCT01513239|10075347|P3|Period 1: Main Phase|Technical Problems|0
2925169|NCT01513239|10075348|P2|Period 1: Main Phase|Technical Problems|2
2925170|NCT01513239|10075349|P1|Period 1: Main Phase|Technical Problems|1
2925171|NCT01513239|10075344|P6|Period 1: Main Phase|Protocol Violation|0
2925172|NCT01513239|10075345|P5|Period 1: Main Phase|Protocol Violation|0
2925173|NCT01513239|10075346|P4|Period 1: Main Phase|Protocol Violation|0
2925174|NCT01513239|10075347|P3|Period 1: Main Phase|Protocol Violation|2
2925175|NCT01513239|10075348|P2|Period 1: Main Phase|Protocol Violation|2
2925176|NCT01513239|10075349|P1|Period 1: Main Phase|Protocol Violation|2
2925177|NCT01513239|10075344|P6|Period 1: Main Phase|Physician Decision|0
2925178|NCT01513239|10075345|P5|Period 1: Main Phase|Physician Decision|0
2925179|NCT01513239|10075346|P4|Period 1: Main Phase|Physician Decision|0
2925180|NCT01513239|10075347|P3|Period 1: Main Phase|Physician Decision|4
2925181|NCT01513239|10075348|P2|Period 1: Main Phase|Physician Decision|4
2925182|NCT01513239|10075349|P1|Period 1: Main Phase|Physician Decision|4
2925183|NCT01513239|10075344|P6|Period 1: Main Phase|Lost to Follow-up|0
2925184|NCT01513239|10075345|P5|Period 1: Main Phase|Lost to Follow-up|0
2925185|NCT01513239|10075346|P4|Period 1: Main Phase|Lost to Follow-up|0
2925186|NCT01513239|10075347|P3|Period 1: Main Phase|Lost to Follow-up|6
2925187|NCT01513239|10075348|P2|Period 1: Main Phase|Lost to Follow-up|10
2925188|NCT01513239|10075349|P1|Period 1: Main Phase|Lost to Follow-up|11
2925189|NCT01513239|10075344|P6|Period 1: Main Phase|Death|0
2925190|NCT01513239|10075345|P5|Period 1: Main Phase|Death|0
2925191|NCT01513239|10075346|P4|Period 1: Main Phase|Death|0
2925192|NCT01513239|10075347|P3|Period 1: Main Phase|Death|32
2925193|NCT01513239|10075348|P2|Period 1: Main Phase|Death|22
2925194|NCT01513239|10075349|P1|Period 1: Main Phase|Death|29
2925195|NCT01513239|10075344|P6|Period 1: Main Phase|Adverse Event|0
2925196|NCT01513239|10075345|P5|Period 1: Main Phase|Adverse Event|0
2925197|NCT01513239|10075346|P4|Period 1: Main Phase|Adverse Event|0
2925198|NCT01513239|10075347|P3|Period 1: Main Phase|Adverse Event|2
2925199|NCT01513239|10075348|P2|Period 1: Main Phase|Adverse Event|1
2925200|NCT01513239|10075349|P1|Period 1: Main Phase|Adverse Event|1
2925201|NCT01513148|10075402|P2|Overall Study|Protocol Violation|2
2925202|NCT01513148|10075403|P1|Overall Study|Protocol Violation|2
2925203|NCT01512979|10075470|P2|Overall Study|Reason other than stated above|9
2925204|NCT01512979|10075471|P1|Overall Study|Reason other than stated above|13
2925205|NCT01512979|10075470|P2|Overall Study|Withdrawal by Subject|2
2925206|NCT01512979|10075471|P1|Overall Study|Withdrawal by Subject|1
2925207|NCT01512979|10075470|P2|Overall Study|Lost to Follow-up|5
2925208|NCT01512979|10075471|P1|Overall Study|Lost to Follow-up|2
2925209|NCT01512979|10075470|P2|Overall Study|Protocol Violation|4
2925210|NCT01512979|10075471|P1|Overall Study|Protocol Violation|1
2925211|NCT01512979|10075470|P2|Overall Study|Adverse Event|2
2925212|NCT01512979|10075471|P1|Overall Study|Adverse Event|2
2925213|NCT01512745|10075571|P2|Overall Study|Protocol Violation|0
2925214|NCT01512745|10075572|P1|Overall Study|Protocol Violation|1
2925215|NCT01512745|10075571|P2|Overall Study|Lack of Efficacy|2
2925216|NCT01512745|10075572|P1|Overall Study|Lack of Efficacy|2
2925217|NCT01512745|10075571|P2|Overall Study|Lost to Follow-up|0
2925218|NCT01512745|10075572|P1|Overall Study|Lost to Follow-up|4
2925219|NCT01512745|10075571|P2|Overall Study|Withdrawal by Subject|2
2925220|NCT01512745|10075572|P1|Overall Study|Withdrawal by Subject|2
2925221|NCT01512745|10075571|P2|Overall Study|Death|13
2925222|NCT01512745|10075572|P1|Overall Study|Death|9
2925223|NCT01512745|10075571|P2|Overall Study|Adverse Event|3
2925224|NCT01512745|10075572|P1|Overall Study|Adverse Event|22
2925225|NCT01512693|10075588|P2|Overall Study|Withdrawal by Subject|1
2925226|NCT01512693|10075589|P1|Overall Study|Withdrawal by Subject|0
2925227|NCT01512368|10075629|P1|Overall Study|Protocol Violation|3
2925228|NCT01512264|10075642|P4|Overall Study|Lost to Follow-up|1
2925229|NCT01512264|10075643|P3|Overall Study|Lost to Follow-up|0
2925230|NCT01512264|10075644|P2|Overall Study|Lost to Follow-up|0
2925231|NCT01512264|10075645|P1|Overall Study|Lost to Follow-up|0
2925232|NCT01512160|10075784|P4|Overall Study|Withdrawal by Subject|1
2925233|NCT01512160|10075785|P3|Overall Study|Withdrawal by Subject|0
2925234|NCT01512160|10075786|P2|Overall Study|Withdrawal by Subject|0
2925235|NCT01512160|10075787|P1|Overall Study|Withdrawal by Subject|1
2925236|NCT01512160|10075784|P4|Overall Study|Lost to Follow-up|0
2925237|NCT01512160|10075785|P3|Overall Study|Lost to Follow-up|0
2925238|NCT01512160|10075786|P2|Overall Study|Lost to Follow-up|0
2925239|NCT01512160|10075787|P1|Overall Study|Lost to Follow-up|1
2925240|NCT01512108|10075879|P2|Overall Study|Unclassified|3
2925241|NCT01512108|10075880|P1|Overall Study|Unclassified|11
2925242|NCT01512108|10075879|P2|Overall Study|Withdrawal Criteria|0
2925243|NCT01512108|10075880|P1|Overall Study|Withdrawal Criteria|1
2925244|NCT01512108|10075879|P2|Overall Study|Protocol Violation|2
2925245|NCT01512108|10075880|P1|Overall Study|Protocol Violation|1
2925246|NCT01512108|10075879|P2|Overall Study|Adverse Event|4
2925247|NCT01512108|10075880|P1|Overall Study|Adverse Event|9
2925248|NCT01511939|10075906|P3|Overall Study|Withdrawal by Subject|0
2925249|NCT01511939|10075907|P2|Overall Study|Withdrawal by Subject|1
2925250|NCT01511939|10075908|P1|Overall Study|Withdrawal by Subject|2
2925251|NCT01511536|10075937|P3|Phase 2|Other|9
2925252|NCT01511536|10075938|P2|Phase 2|Other|0
2925253|NCT01511536|10075939|P1|Phase 2|Other|0
2925254|NCT01511536|10075937|P3|Phase 1|Other|0
2925255|NCT01511536|10075938|P2|Phase 1|Other|1
2925256|NCT01511536|10075939|P1|Phase 1|Other|0
2925257|NCT01511445|10075961|P2|Overall Study|Protocol Violation|0
2925258|NCT01511445|10075962|P1|Overall Study|Protocol Violation|1
2925259|NCT01511445|10075961|P2|Overall Study|Protocol Violation|3
2925260|NCT01511445|10075962|P1|Overall Study|Protocol Violation|1
2925261|NCT01511445|10075961|P2|Overall Study|Lost to Follow-up|1
2925262|NCT01511445|10075962|P1|Overall Study|Lost to Follow-up|3
2925263|NCT01511419|10075972|P2|Dose 2|Physician Decision|0
2925264|NCT01511419|10075973|P1|Dose 2|Physician Decision|1
2925265|NCT01511250|10076085|P10|Overall Study|Protocol Violation|0
2925266|NCT01511250|10076086|P9|Overall Study|Protocol Violation|0
2925267|NCT01511250|10076087|P8|Overall Study|Protocol Violation|0
2925268|NCT01511250|10076088|P7|Overall Study|Protocol Violation|0
2925269|NCT01511250|10076089|P6|Overall Study|Protocol Violation|0
2925270|NCT01511250|10076090|P5|Overall Study|Protocol Violation|0
2925271|NCT01511250|10076091|P4|Overall Study|Protocol Violation|0
2925272|NCT01511250|10076092|P3|Overall Study|Protocol Violation|1
2925273|NCT01511250|10076093|P2|Overall Study|Protocol Violation|2
2925274|NCT01511250|10076094|P1|Overall Study|Protocol Violation|0
2925275|NCT01511250|10076085|P10|Overall Study|Lost to Follow-up|5
2925276|NCT01511250|10076086|P9|Overall Study|Lost to Follow-up|13
2925277|NCT01511250|10076087|P8|Overall Study|Lost to Follow-up|3
2925278|NCT01511250|10076088|P7|Overall Study|Lost to Follow-up|2
2925279|NCT01511250|10076089|P6|Overall Study|Lost to Follow-up|0
2925280|NCT01511250|10076090|P5|Overall Study|Lost to Follow-up|0
2925281|NCT01511250|10076091|P4|Overall Study|Lost to Follow-up|3
2925282|NCT01511250|10076092|P3|Overall Study|Lost to Follow-up|3
2925283|NCT01511250|10076093|P2|Overall Study|Lost to Follow-up|3
2925284|NCT01511250|10076094|P1|Overall Study|Lost to Follow-up|7
2925285|NCT01511250|10076085|P10|Overall Study|Sponsor/Investigator Decision|0
2925286|NCT01511250|10076086|P9|Overall Study|Sponsor/Investigator Decision|0
2925287|NCT01511250|10076087|P8|Overall Study|Sponsor/Investigator Decision|0
2925288|NCT01511250|10076088|P7|Overall Study|Sponsor/Investigator Decision|0
2925289|NCT01511250|10076089|P6|Overall Study|Sponsor/Investigator Decision|0
2925290|NCT01511250|10076090|P5|Overall Study|Sponsor/Investigator Decision|0
2925291|NCT01511250|10076091|P4|Overall Study|Sponsor/Investigator Decision|0
2925292|NCT01511250|10076092|P3|Overall Study|Sponsor/Investigator Decision|0
2925293|NCT01511250|10076093|P2|Overall Study|Sponsor/Investigator Decision|0
2925294|NCT01511250|10076094|P1|Overall Study|Sponsor/Investigator Decision|1
2925295|NCT01511250|10076085|P10|Overall Study|Withdrawal of Consent|0
2925296|NCT01511250|10076086|P9|Overall Study|Withdrawal of Consent|1
2925297|NCT01511250|10076087|P8|Overall Study|Withdrawal of Consent|1
2925298|NCT01511250|10076088|P7|Overall Study|Withdrawal of Consent|0
2925299|NCT01511250|10076089|P6|Overall Study|Withdrawal of Consent|0
2925300|NCT01511250|10076090|P5|Overall Study|Withdrawal of Consent|0
2925301|NCT01511250|10076091|P4|Overall Study|Withdrawal of Consent|0
2925302|NCT01511250|10076092|P3|Overall Study|Withdrawal of Consent|0
2925303|NCT01511250|10076093|P2|Overall Study|Withdrawal of Consent|0
2925304|NCT01511250|10076094|P1|Overall Study|Withdrawal of Consent|1
2925305|NCT01511107|10076242|P2|Overall Study|Withdrawal by Subject|20
2925306|NCT01511107|10076243|P1|Overall Study|Withdrawal by Subject|9
2925307|NCT01511107|10076242|P2|Overall Study|Lost to Follow-up|19
2925308|NCT01511107|10076243|P1|Overall Study|Lost to Follow-up|10
2925309|NCT01511107|10076242|P2|Overall Study|Ineligible|2
2925310|NCT01511107|10076243|P1|Overall Study|Ineligible|3
2925311|NCT01510912|10076321|P1|Overall Study|Other, including joint replacement|5
2925312|NCT01510912|10076321|P1|Overall Study|Lost to Follow-up|26
2925313|NCT01510912|10076321|P1|Overall Study|Protocol Violation|27
2925314|NCT01510912|10076321|P1|Overall Study|Physician Decision|1
2925315|NCT01510912|10076321|P1|Overall Study|Withdrawal by Subject|49
2925316|NCT01510912|10076321|P1|Overall Study|Non-compliance with trial drug|23
2925317|NCT01510912|10076321|P1|Overall Study|Lack of Efficacy|12
2925318|NCT01510912|10076321|P1|Overall Study|Adverse Event|99
2925319|NCT01510769|10076337|P3|Overall Study|Death|0
2925320|NCT01510769|10076338|P2|Overall Study|Death|1
2925321|NCT01510769|10076339|P1|Overall Study|Death|1
2925322|NCT01510769|10076337|P3|Overall Study|Withdrawal by Subject|3
2925323|NCT01510769|10076338|P2|Overall Study|Withdrawal by Subject|4
2925324|NCT01510769|10076339|P1|Overall Study|Withdrawal by Subject|3
2925325|NCT01510769|10076337|P3|Overall Study|Lost to Follow-up|5
2925326|NCT01510769|10076338|P2|Overall Study|Lost to Follow-up|1
2925327|NCT01510769|10076339|P1|Overall Study|Lost to Follow-up|5
2925328|NCT01510769|10076337|P3|Overall Study|Protocol Violation|9
2925329|NCT01510769|10076338|P2|Overall Study|Protocol Violation|10
2925330|NCT01510769|10076339|P1|Overall Study|Protocol Violation|11
2925331|NCT01510769|10076337|P3|Overall Study|Gout Flare|1
2925332|NCT01510769|10076338|P2|Overall Study|Gout Flare|3
2925333|NCT01510769|10076339|P1|Overall Study|Gout Flare|0
2925334|NCT01510769|10076337|P3|Overall Study|Adverse Event|4
2925335|NCT01510769|10076338|P2|Overall Study|Adverse Event|6
2925336|NCT01510769|10076339|P1|Overall Study|Adverse Event|7
2925337|NCT01510756|10076356|P1|Overall Study|Physician Decision|1
2925338|NCT01510756|10076356|P1|Overall Study|Lack of Efficacy|2
2925339|NCT01510756|10076356|P1|Overall Study|Death|1
2925340|NCT01510717|10076364|P2|Overall Study|Withdrawal by Subject|2
2925341|NCT01510717|10076365|P1|Overall Study|Withdrawal by Subject|0
2925342|NCT01510717|10076364|P2|Overall Study|Lost to Follow-up|1
2925343|NCT01510717|10076365|P1|Overall Study|Lost to Follow-up|0
2925344|NCT01510717|10076364|P2|Overall Study|Death|0
2925345|NCT01510717|10076365|P1|Overall Study|Death|1
2925346|NCT01510717|10076364|P2|Overall Study|Adverse Event|2
2925347|NCT01510717|10076365|P1|Overall Study|Adverse Event|1
2925348|NCT01510158|10076485|P3|Overall Study|Death|0
2925349|NCT01510158|10076486|P2|Overall Study|Death|0
2925350|NCT01510158|10076487|P1|Overall Study|Death|1
2925351|NCT01510158|10076485|P3|Overall Study|Withdrawal by Subject|10
2925352|NCT01510158|10076486|P2|Overall Study|Withdrawal by Subject|13
2925353|NCT01510158|10076487|P1|Overall Study|Withdrawal by Subject|10
2925354|NCT01510158|10076485|P3|Overall Study|Lost to Follow-up|9
2925355|NCT01510158|10076486|P2|Overall Study|Lost to Follow-up|16
2925356|NCT01510158|10076487|P1|Overall Study|Lost to Follow-up|13
2925357|NCT01510158|10076485|P3|Overall Study|Sponsor terminated study.|2
2925358|NCT01510158|10076486|P2|Overall Study|Sponsor terminated study.|0
2925359|NCT01510158|10076487|P1|Overall Study|Sponsor terminated study.|2
2925360|NCT01510158|10076485|P3|Overall Study|Protocol Violation|24
2925361|NCT01510158|10076486|P2|Overall Study|Protocol Violation|16
2925362|NCT01510158|10076487|P1|Overall Study|Protocol Violation|17
2925363|NCT01510158|10076485|P3|Overall Study|Gout flare|0
2925364|NCT01510158|10076486|P2|Overall Study|Gout flare|0
2925365|NCT01510158|10076487|P1|Overall Study|Gout flare|1
2925366|NCT01510158|10076485|P3|Overall Study|Adverse Event|5
2925367|NCT01510158|10076486|P2|Overall Study|Adverse Event|8
2925368|NCT01510158|10076487|P1|Overall Study|Adverse Event|7
2925369|NCT01510145|10076501|P1|Overall Study|Relative reported subject withdrew|1
2925370|NCT01510145|10076501|P1|Overall Study|Withdrawal by Subject|6
2925371|NCT01510145|10076501|P1|Overall Study|Lost to Follow-up|5
2925372|NCT01510145|10076501|P1|Overall Study|Adverse Event|6
2925373|NCT01510028|10076510|P4|Overall Study|Lack of Efficacy|0
2925374|NCT01510028|10076511|P3|Overall Study|Lack of Efficacy|0
2925375|NCT01510028|10076512|P2|Overall Study|Lack of Efficacy|0
2925376|NCT01510028|10076513|P1|Overall Study|Lack of Efficacy|1
2925377|NCT01509664|10076774|P2|Overall Study|Lost to Follow-up|21
2925378|NCT01509664|10076775|P1|Overall Study|Lost to Follow-up|15
2925379|NCT01509547|10076835|P2|Overall Study|Physician Decision|1
2925380|NCT01509547|10076836|P1|Overall Study|Physician Decision|0
2925381|NCT01509547|10076835|P2|Overall Study|Withdrawal by Subject|24
2925382|NCT01509547|10076836|P1|Overall Study|Withdrawal by Subject|11
2925383|NCT01509547|10076835|P2|Overall Study|Lost to Follow-up|14
2925384|NCT01509547|10076836|P1|Overall Study|Lost to Follow-up|24
2925385|NCT01509079|10076903|P2|Overall Study|started an excluded medication|1
2925386|NCT01509079|10076904|P1|Overall Study|started an excluded medication|0
2925387|NCT01509079|10076903|P2|Overall Study|Lack of Efficacy|2
2925388|NCT01509079|10076904|P1|Overall Study|Lack of Efficacy|0
2925389|NCT01509053|10076924|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
2925390|NCT01509053|10076924|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
2925391|NCT01509053|10076924|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
2925392|NCT01509053|10076924|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
2925393|NCT01509053|10076924|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
2925394|NCT01509053|10076924|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
2925395|NCT01508936|10076986|P2|Overall Study|Data from 2 sites deemed invalid|11
2925396|NCT01508936|10076987|P1|Overall Study|Data from 2 sites deemed invalid|4
2925397|NCT01508936|10076986|P2|Overall Study|Other|5
2925398|NCT01508936|10076987|P1|Overall Study|Other|0
2925399|NCT01508936|10076986|P2|Overall Study|Lost to Follow-up|9
2925400|NCT01508936|10076987|P1|Overall Study|Lost to Follow-up|2
2925401|NCT01508936|10076986|P2|Overall Study|Protocol Violation|3
2925402|NCT01508936|10076987|P1|Overall Study|Protocol Violation|2
2925403|NCT01508936|10076986|P2|Overall Study|Withdrawal by Subject|18
2925404|NCT01508936|10076987|P1|Overall Study|Withdrawal by Subject|4
2925405|NCT01508936|10076986|P2|Overall Study|Lack of Efficacy|1
2925406|NCT01508936|10076987|P1|Overall Study|Lack of Efficacy|0
2925407|NCT01508936|10076986|P2|Overall Study|Adverse Event|32
2925408|NCT01508936|10076987|P1|Overall Study|Adverse Event|11
2925409|NCT01508910|10077026|P4|Treatment|Sponsor Decision|1
2925410|NCT01508910|10077027|P3|Treatment|Sponsor Decision|0
2925411|NCT01508910|10077028|P2|Treatment|Sponsor Decision|0
2925412|NCT01508910|10077029|P1|Treatment|Sponsor Decision|0
2925413|NCT01508910|10077026|P4|Treatment|Withdrawal by Subject|1
2925414|NCT01508910|10077027|P3|Treatment|Withdrawal by Subject|6
2925415|NCT01508910|10077028|P2|Treatment|Withdrawal by Subject|1
2925416|NCT01508910|10077029|P1|Treatment|Withdrawal by Subject|0
2925417|NCT01508910|10077026|P4|Treatment|Lost to Follow-up|1
2925418|NCT01508910|10077027|P3|Treatment|Lost to Follow-up|2
2925419|NCT01508910|10077028|P2|Treatment|Lost to Follow-up|0
2925420|NCT01508910|10077029|P1|Treatment|Lost to Follow-up|0
2925421|NCT01508910|10077026|P4|Treatment|Death|0
2925422|NCT01508910|10077027|P3|Treatment|Death|2
2925423|NCT01508910|10077028|P2|Treatment|Death|3
2925424|NCT01508910|10077029|P1|Treatment|Death|2
2925425|NCT01508702|10077062|P2|Overall Study|Withdrawal by Subject|7
2925426|NCT01508702|10077063|P1|Overall Study|Withdrawal by Subject|11
2925427|NCT01508702|10077062|P2|Overall Study|Lost to Follow-up|2
2925428|NCT01508702|10077063|P1|Overall Study|Lost to Follow-up|1
2925429|NCT01508702|10077062|P2|Overall Study|Protocol Violation|1
2925430|NCT01508702|10077063|P1|Overall Study|Protocol Violation|2
2925431|NCT01508702|10077062|P2|Overall Study|Gout flare|0
2925432|NCT01508702|10077063|P1|Overall Study|Gout flare|2
2925433|NCT01508702|10077062|P2|Overall Study|Adverse Event|3
2925434|NCT01508702|10077063|P1|Overall Study|Adverse Event|7
2925435|NCT01508676|10077071|P2|Phase II (2 Weeks)|Medication Exclusion|0
2925436|NCT01508676|10077072|P1|Phase II (2 Weeks)|Medication Exclusion|1
2925437|NCT01508676|10077071|P2|Phase II (2 Weeks)|Skin Sensitivity|1
2925438|NCT01508676|10077072|P1|Phase II (2 Weeks)|Skin Sensitivity|0
2925439|NCT01508676|10077071|P2|Phase I (2 Weeks)|Positive Drug Screen|2
2925440|NCT01508676|10077072|P1|Phase I (2 Weeks)|Positive Drug Screen|0
2925441|NCT01508676|10077071|P2|Phase I (2 Weeks)|Wrong Pain Type|0
2925442|NCT01508676|10077072|P1|Phase I (2 Weeks)|Wrong Pain Type|1
2925443|NCT01508676|10077071|P2|Phase I (2 Weeks)|Medication Exclusion|1
2925444|NCT01508676|10077072|P1|Phase I (2 Weeks)|Medication Exclusion|1
2925445|NCT01508650|10077084|P2|Overall Study|Lost to Follow-up|3
2925446|NCT01508650|10077085|P1|Overall Study|Lost to Follow-up|0
2925447|NCT01508325|10077104|P2|Overall Study|Other|2
2925448|NCT01508325|10077105|P1|Overall Study|Other|2
2925449|NCT01508325|10077104|P2|Overall Study|Lost to Follow-up|6
2925450|NCT01508325|10077105|P1|Overall Study|Lost to Follow-up|5
2925451|NCT01508325|10077104|P2|Overall Study|Adverse Event|0
2925452|NCT01508325|10077105|P1|Overall Study|Adverse Event|1
2925453|NCT01508325|10077104|P2|Overall Study|Physician Decision|1
2925454|NCT01508325|10077105|P1|Overall Study|Physician Decision|2
2925455|NCT01508325|10077104|P2|Overall Study|Protocol Violation|3
2925456|NCT01508325|10077105|P1|Overall Study|Protocol Violation|0
2925457|NCT01508325|10077104|P2|Overall Study|Withdrawal by Subject|9
2925458|NCT01508325|10077105|P1|Overall Study|Withdrawal by Subject|8
2925459|NCT01508169|10077135|P2|Overall Study|Lost to Follow-up|2
2925460|NCT01508169|10077136|P1|Overall Study|Lost to Follow-up|1
2925461|NCT01508169|10077135|P2|Overall Study|Withdrawal by Subject|0
2925462|NCT01508169|10077136|P1|Overall Study|Withdrawal by Subject|1
2925463|NCT01508169|10077135|P2|Overall Study|Adverse Event|0
2925464|NCT01508169|10077136|P1|Overall Study|Adverse Event|1
2925465|NCT01508130|10077150|P2|Overall Study|Administrative|3
2925466|NCT01508130|10077151|P1|Overall Study|Administrative|14
2925467|NCT01508130|10077150|P2|Overall Study|Insufficient therapeutic response|23
2925468|NCT01508130|10077151|P1|Overall Study|Insufficient therapeutic response|74
2925469|NCT01508130|10077150|P2|Overall Study|Subject’s substantial non-compliance|9
2925470|NCT01508130|10077151|P1|Overall Study|Subject’s substantial non-compliance|25
2925471|NCT01508130|10077150|P2|Overall Study|Withdrawal by Subject|3
2925472|NCT01508130|10077151|P1|Overall Study|Withdrawal by Subject|3
2925473|NCT01508130|10077150|P2|Overall Study|Lost to Follow-up|2
2925474|NCT01508130|10077151|P1|Overall Study|Lost to Follow-up|25
2925475|NCT01508130|10077150|P2|Overall Study|Protocol Violation|0
2925476|NCT01508130|10077151|P1|Overall Study|Protocol Violation|2
2925477|NCT01508130|10077150|P2|Overall Study|Death|1
2925478|NCT01508130|10077151|P1|Overall Study|Death|3
2925479|NCT01508130|10077150|P2|Overall Study|Adverse Event|28
2925480|NCT01508130|10077151|P1|Overall Study|Adverse Event|81
2925481|NCT01507896|10077219|P1|Overall Study|The surgery was denied by the sponsor.|1
2925482|NCT01507896|10077219|P1|Overall Study|Withdrawal by Subject|1
2925483|NCT01507831|10077262|P2|Overall Study|Other|6
2925484|NCT01507831|10077263|P1|Overall Study|Other|3
2925485|NCT01507831|10077262|P2|Overall Study|Potential lost to follow-up|0
2925486|NCT01507831|10077263|P1|Overall Study|Potential lost to follow-up|3
2925487|NCT01507831|10077262|P2|Overall Study|Site closure|3
2925488|NCT01507831|10077263|P1|Overall Study|Site closure|0
2925489|NCT01507831|10077262|P2|Overall Study|Selection criteria finally not met|1
2925490|NCT01507831|10077263|P1|Overall Study|Selection criteria finally not met|0
2925491|NCT01507831|10077262|P2|Overall Study|Last visit outside protocol visit window|143
2925492|NCT01507831|10077263|P1|Overall Study|Last visit outside protocol visit window|51
2925493|NCT01507831|10077262|P2|Overall Study|Related to study drug administration|14
2925494|NCT01507831|10077263|P1|Overall Study|Related to study drug administration|5
2925495|NCT01507831|10077262|P2|Overall Study|Consent withdrawn by participant|72
2925496|NCT01507831|10077263|P1|Overall Study|Consent withdrawn by participant|34
2925497|NCT01507831|10077262|P2|Overall Study|Participant moved|19
2925498|NCT01507831|10077263|P1|Overall Study|Participant moved|5
2925499|NCT01507831|10077262|P2|Overall Study|Physician Decision|4
2925500|NCT01507831|10077263|P1|Overall Study|Physician Decision|0
2925501|NCT01507831|10077262|P2|Overall Study|Poor compliance to protocol|60
2925502|NCT01507831|10077263|P1|Overall Study|Poor compliance to protocol|38
2925503|NCT01507831|10077262|P2|Overall Study|Death|2
2925504|NCT01507831|10077263|P1|Overall Study|Death|6
2925505|NCT01507831|10077262|P2|Overall Study|Adverse Event|113
2925506|NCT01507831|10077263|P1|Overall Study|Adverse Event|48
2925507|NCT01507831|10077262|P2|Overall Study|Randomized but not treated|3
2925508|NCT01507831|10077263|P1|Overall Study|Randomized but not treated|0
2925509|NCT01507662|10077383|P2|Overall Study|Proxy interview done|3
2925510|NCT01507662|10077384|P1|Overall Study|Proxy interview done|2
2925511|NCT01507662|10077383|P2|Overall Study|Lost to Follow-up|523
2925512|NCT01507662|10077384|P1|Overall Study|Lost to Follow-up|498
2925513|NCT01507662|10077383|P2|Overall Study|Withdrawal by Subject|287
2925514|NCT01507662|10077384|P1|Overall Study|Withdrawal by Subject|290
2925515|NCT01507662|10077383|P2|Overall Study|Death|18
2925516|NCT01507662|10077384|P1|Overall Study|Death|26
2925517|NCT01507298|10077415|P2|Overall Study|Protocol Violation|6
2925518|NCT01507298|10077416|P1|Overall Study|Protocol Violation|0
2925519|NCT01507246|10077426|P2|Overall Study|Required different surgical procedures|1
2925520|NCT01507246|10077427|P1|Overall Study|Required different surgical procedures|2
2925521|NCT01507090|10077525|P1|Overall Study|incomplete dataset|18
2925522|NCT01507051|10077564|P4|Overall Study|Adverse Event|0
2925523|NCT01507051|10077565|P3|Overall Study|Adverse Event|0
2925524|NCT01507051|10077566|P2|Overall Study|Adverse Event|0
2925525|NCT01507051|10077567|P1|Overall Study|Adverse Event|1
2925526|NCT01507051|10077564|P4|Overall Study|Physician Decision|1
2925527|NCT01507051|10077565|P3|Overall Study|Physician Decision|0
2925528|NCT01507051|10077566|P2|Overall Study|Physician Decision|0
2925529|NCT01507051|10077567|P1|Overall Study|Physician Decision|0
2925530|NCT01507051|10077564|P4|Overall Study|Withdrawal by Subject|6
2925531|NCT01507051|10077565|P3|Overall Study|Withdrawal by Subject|1
2925532|NCT01507051|10077566|P2|Overall Study|Withdrawal by Subject|3
2925533|NCT01507051|10077567|P1|Overall Study|Withdrawal by Subject|1
2925534|NCT01506960|10077685|P1|Overall Study|Did not meet angiographic criteria|47
2925535|NCT01506947|10077691|P1|Overall Study|Did Not Meet Eligibility Criteria|3
2925536|NCT01506947|10077691|P1|Overall Study|Death|1
2925537|NCT01506947|10077691|P1|Overall Study|Adverse Event|5
2925538|NCT01506947|10077691|P1|Overall Study|Lost to Follow-up|7
2925539|NCT01506908|10077709|P2|Overall Study|Adverse Event|0
2925540|NCT01506908|10077710|P1|Overall Study|Adverse Event|1
2925541|NCT01506882|10077728|P2|Overall Study|Other Reason|0
2925542|NCT01506882|10077729|P1|Overall Study|Other Reason|2
2925543|NCT01506882|10077728|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2925544|NCT01506882|10077729|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2925545|NCT01506882|10077728|P2|Overall Study|AE, non-serious non-fatal|1
2925546|NCT01506882|10077729|P1|Overall Study|AE, non-serious non-fatal|3
2925547|NCT01506882|10077728|P2|Overall Study|SAE, non-fatal|0
2925548|NCT01506882|10077729|P1|Overall Study|SAE, non-fatal|2
2925549|NCT01506882|10077728|P2|Overall Study|Withdrawal by Subject|3
2925550|NCT01506882|10077729|P1|Overall Study|Withdrawal by Subject|9
2925551|NCT01506882|10077728|P2|Overall Study|Lost to Follow-up|0
2925552|NCT01506882|10077729|P1|Overall Study|Lost to Follow-up|1
2925553|NCT01506882|10077728|P2|Overall Study|Lack of Efficacy|3
2925554|NCT01506882|10077729|P1|Overall Study|Lack of Efficacy|4
2925555|NCT01506726|10077743|P2|Overall Study|Adverse Event|2
2925556|NCT01506726|10077744|P1|Overall Study|Adverse Event|1
2925557|NCT01506596|10077784|P1|Overall Study|ineligible pathology|1
2925558|NCT01506479|10077795|P3|Overall Study|Adverse Event|0
2925559|NCT01506479|10077796|P2|Overall Study|Adverse Event|1
2925560|NCT01506479|10077797|P1|Overall Study|Adverse Event|0
2925561|NCT01506479|10077795|P3|Overall Study|Missing assessment|0
2925562|NCT01506479|10077796|P2|Overall Study|Missing assessment|0
2925563|NCT01506479|10077797|P1|Overall Study|Missing assessment|1
2925564|NCT01506479|10077795|P3|Overall Study|Withdrawal by Subject|1
2925565|NCT01506479|10077796|P2|Overall Study|Withdrawal by Subject|2
2925566|NCT01506479|10077797|P1|Overall Study|Withdrawal by Subject|1
2925567|NCT01506479|10077795|P3|Overall Study|Lost to Follow-up|2
2925568|NCT01506479|10077796|P2|Overall Study|Lost to Follow-up|2
2925569|NCT01506479|10077797|P1|Overall Study|Lost to Follow-up|1
2925570|NCT01506453|10077811|P2|Overall Study|Withdrawal prior to treatment|2
2925571|NCT01506453|10077812|P1|Overall Study|Withdrawal prior to treatment|0
2925572|NCT01506323|10077828|P2|Overall Study|Started another treatment|0
2925573|NCT01506323|10077829|P1|Overall Study|Started another treatment|1
2925574|NCT01506323|10077828|P2|Overall Study|Schedule or Transportation conflict|0
2925575|NCT01506323|10077829|P1|Overall Study|Schedule or Transportation conflict|8
2925576|NCT01506323|10077828|P2|Overall Study|Moved out of area|2
2925577|NCT01506323|10077829|P1|Overall Study|Moved out of area|5
2925578|NCT01506323|10077828|P2|Overall Study|Lack of Efficacy|3
2925579|NCT01506323|10077829|P1|Overall Study|Lack of Efficacy|1
2925580|NCT01506323|10077828|P2|Overall Study|Withdrawal by Subject|4
2925581|NCT01506323|10077829|P1|Overall Study|Withdrawal by Subject|4
2925582|NCT01506323|10077828|P2|Overall Study|Lost to Follow-up|4
2925583|NCT01506323|10077829|P1|Overall Study|Lost to Follow-up|5
2925584|NCT01506271|10077858|P3|Overall Study|Lost to Follow-up|2
2925585|NCT01506271|10077859|P2|Overall Study|Lost to Follow-up|1
2925586|NCT01506271|10077860|P1|Overall Study|Lost to Follow-up|0
2925587|NCT01506271|10077858|P3|Overall Study|Withdrawal by Subject|1
2925588|NCT01506271|10077859|P2|Overall Study|Withdrawal by Subject|1
2925589|NCT01506271|10077860|P1|Overall Study|Withdrawal by Subject|0
2925590|NCT01506271|10077858|P3|Overall Study|Insufficient supply of study drug|0
2925591|NCT01506271|10077859|P2|Overall Study|Insufficient supply of study drug|0
2925592|NCT01506271|10077860|P1|Overall Study|Insufficient supply of study drug|1
2925593|NCT01506271|10077858|P3|Overall Study|Adverse Event|0
2925594|NCT01506271|10077859|P2|Overall Study|Adverse Event|2
2925595|NCT01506271|10077860|P1|Overall Study|Adverse Event|0
2925596|NCT01506271|10077858|P3|Overall Study|Death|0
2925597|NCT01506271|10077859|P2|Overall Study|Death|1
2925598|NCT01506271|10077860|P1|Overall Study|Death|0
2925599|NCT01506271|10077858|P3|Overall Study|Protocol Violation|0
2925600|NCT01506271|10077859|P2|Overall Study|Protocol Violation|1
2925601|NCT01506271|10077860|P1|Overall Study|Protocol Violation|3
2925602|NCT01506271|10077858|P3|Overall Study|Progressive disease|0
2925603|NCT01506271|10077859|P2|Overall Study|Progressive disease|1
2925604|NCT01506271|10077860|P1|Overall Study|Progressive disease|0
2925605|NCT01506193|10077922|P3|Overall Study|Lost to Follow-up|3
2925606|NCT01506193|10077923|P2|Overall Study|Lost to Follow-up|3
2925607|NCT01506193|10077924|P1|Overall Study|Lost to Follow-up|8
2925608|NCT01506193|10077922|P3|Overall Study|Withdrawal by Subject|8
2925609|NCT01506193|10077923|P2|Overall Study|Withdrawal by Subject|1
2925610|NCT01506193|10077924|P1|Overall Study|Withdrawal by Subject|5
2925611|NCT01506193|10077922|P3|Overall Study|Adverse event, non-fatal|1
2925612|NCT01506193|10077923|P2|Overall Study|Adverse event, non-fatal|0
2925613|NCT01506193|10077924|P1|Overall Study|Adverse event, non-fatal|0
2925614|NCT01506193|10077922|P3|Overall Study|Migrated/moved from study area|1
2925615|NCT01506193|10077923|P2|Overall Study|Migrated/moved from study area|0
2925616|NCT01506193|10077924|P1|Overall Study|Migrated/moved from study area|0
2925617|NCT01506193|10077922|P3|Overall Study|Protocol Violation|1
2925618|NCT01506193|10077923|P2|Overall Study|Protocol Violation|0
2925619|NCT01506193|10077924|P1|Overall Study|Protocol Violation|1
2925620|NCT01505881|10077970|P2|Overall Study|Withdrawal by Subject|0
2925621|NCT01505881|10077971|P1|Overall Study|Withdrawal by Subject|2
2925622|NCT01505881|10077970|P2|Overall Study|Lost to Follow-up|0
2925623|NCT01505881|10077971|P1|Overall Study|Lost to Follow-up|2
2925624|NCT01505881|10077970|P2|Overall Study|Adverse Event|1
2925625|NCT01505881|10077971|P1|Overall Study|Adverse Event|0
2925626|NCT01505647|10078077|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
2925627|NCT01505647|10078078|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
2925628|NCT01505647|10078077|P2|Day 43 Through Day 182 Follow-up|Death|1
2925629|NCT01505647|10078078|P1|Day 43 Through Day 182 Follow-up|Death|0
2925630|NCT01505647|10078077|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
2925631|NCT01505647|10078078|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
2925632|NCT01505647|10078077|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
2925633|NCT01505647|10078078|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
2925634|NCT01505647|10078077|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
2925635|NCT01505647|10078078|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
2925636|NCT01505634|10078095|P3|Overall Study|In a conflict zone|1
2925637|NCT01505634|10078096|P2|Overall Study|In a conflict zone|0
2925638|NCT01505634|10078097|P1|Overall Study|In a conflict zone|0
2925639|NCT01505634|10078095|P3|Overall Study|Death|0
2925640|NCT01505634|10078096|P2|Overall Study|Death|0
2925641|NCT01505634|10078097|P1|Overall Study|Death|1
2925642|NCT01505634|10078095|P3|Overall Study|Lost to Follow-up|4
2925643|NCT01505634|10078096|P2|Overall Study|Lost to Follow-up|4
2925644|NCT01505634|10078097|P1|Overall Study|Lost to Follow-up|1
2925645|NCT01505634|10078095|P3|Overall Study|Protocol Violation|0
2925646|NCT01505634|10078096|P2|Overall Study|Protocol Violation|0
2925647|NCT01505634|10078097|P1|Overall Study|Protocol Violation|2
2925648|NCT01505634|10078095|P3|Overall Study|Insufficient supply of drug at site|0
2925649|NCT01505634|10078096|P2|Overall Study|Insufficient supply of drug at site|0
2925650|NCT01505634|10078097|P1|Overall Study|Insufficient supply of drug at site|1
2925651|NCT01505634|10078095|P3|Overall Study|Adverse Event|0
2925652|NCT01505634|10078096|P2|Overall Study|Adverse Event|0
2925653|NCT01505634|10078097|P1|Overall Study|Adverse Event|1
2925654|NCT01505634|10078095|P3|Overall Study|Physician Decision|0
2925655|NCT01505634|10078096|P2|Overall Study|Physician Decision|1
2925656|NCT01505634|10078097|P1|Overall Study|Physician Decision|1
2925657|NCT01505634|10078095|P3|Overall Study|Withdrawal by Subject|1
2925658|NCT01505634|10078096|P2|Overall Study|Withdrawal by Subject|5
2925659|NCT01505634|10078097|P1|Overall Study|Withdrawal by Subject|2
2925660|NCT01505608|10078152|P2|Phase II|Protocol Violation|1
2925661|NCT01505608|10078153|P1|Phase II|Protocol Violation|0
2925662|NCT01505608|10078152|P2|Phase II|Lack of Efficacy|1
2925663|NCT01505608|10078153|P1|Phase II|Lack of Efficacy|2
2925664|NCT01505608|10078152|P2|Phase I|Withdrawal by Subject|1
2925665|NCT01505608|10078153|P1|Phase I|Withdrawal by Subject|0
2925666|NCT01505608|10078152|P2|Phase I|Adverse Event|1
2925667|NCT01505608|10078153|P1|Phase I|Adverse Event|0
2925668|NCT01505608|10078152|P2|Phase I|Lack of Efficacy|4
2925669|NCT01505608|10078153|P1|Phase I|Lack of Efficacy|0
2925670|NCT01505530|10078172|P3|Overall Study|entry criteria not met|0
2925671|NCT01505530|10078173|P2|Overall Study|entry criteria not met|1
2925672|NCT01505530|10078174|P1|Overall Study|entry criteria not met|0
2925673|NCT01505530|10078172|P3|Overall Study|Death|5
2925674|NCT01505530|10078173|P2|Overall Study|Death|6
2925675|NCT01505530|10078174|P1|Overall Study|Death|7
2925676|NCT01505530|10078172|P3|Overall Study|Sponsor Decision|7
2925677|NCT01505530|10078173|P2|Overall Study|Sponsor Decision|8
2925678|NCT01505530|10078174|P1|Overall Study|Sponsor Decision|1
2925679|NCT01505530|10078172|P3|Overall Study|Physician Decision|5
2925680|NCT01505530|10078173|P2|Overall Study|Physician Decision|2
2925681|NCT01505530|10078174|P1|Overall Study|Physician Decision|6
2925682|NCT01505530|10078172|P3|Overall Study|Withdrawal by Subject|6
2925683|NCT01505530|10078173|P2|Overall Study|Withdrawal by Subject|8
2925684|NCT01505530|10078174|P1|Overall Study|Withdrawal by Subject|7
2925685|NCT01505530|10078172|P3|Overall Study|Adverse Event|0
2925686|NCT01505530|10078173|P2|Overall Study|Adverse Event|1
2925687|NCT01505530|10078174|P1|Overall Study|Adverse Event|1
2925688|NCT01505530|10078172|P3|Overall Study|Progressive Disease|18
2925689|NCT01505530|10078173|P2|Overall Study|Progressive Disease|17
2925690|NCT01505530|10078174|P1|Overall Study|Progressive Disease|19
2925691|NCT01505491|10078218|P3|Overall Study|Lost to Follow-up|1
2925692|NCT01505491|10078219|P2|Overall Study|Lost to Follow-up|0
2925693|NCT01505491|10078220|P1|Overall Study|Lost to Follow-up|0
2925694|NCT01505491|10078218|P3|Overall Study|Withdrawal by Subject|4
2925695|NCT01505491|10078219|P2|Overall Study|Withdrawal by Subject|1
2925696|NCT01505491|10078220|P1|Overall Study|Withdrawal by Subject|1
2925697|NCT01505491|10078218|P3|Overall Study|Other reason not listed|0
2925698|NCT01505491|10078219|P2|Overall Study|Other reason not listed|0
2925699|NCT01505491|10078220|P1|Overall Study|Other reason not listed|1
2925700|NCT01505387|10078259|P2|Overall Study|Withdrawal by Subject|1
2925701|NCT01505387|10078260|P1|Overall Study|Withdrawal by Subject|1
2925702|NCT01505387|10078259|P2|Overall Study|Protocol Violation|0
2925703|NCT01505387|10078260|P1|Overall Study|Protocol Violation|1
2925704|NCT01505374|10078266|P2|Overall Study|Lost to Follow-up|0
2925705|NCT01505374|10078267|P1|Overall Study|Lost to Follow-up|1
2925706|NCT01505114|10078317|P4|Overall Study|investigator decision|0
2925707|NCT01505114|10078318|P3|Overall Study|investigator decision|1
2925708|NCT01505114|10078319|P2|Overall Study|investigator decision|0
2925709|NCT01505114|10078320|P1|Overall Study|investigator decision|1
2925710|NCT01505114|10078317|P4|Overall Study|staff safety concerns|1
2925711|NCT01505114|10078318|P3|Overall Study|staff safety concerns|0
2925712|NCT01505114|10078319|P2|Overall Study|staff safety concerns|0
2925713|NCT01505114|10078320|P1|Overall Study|staff safety concerns|0
2925714|NCT01505114|10078317|P4|Overall Study|inadvertent enrollment due to peanut all|1
2925715|NCT01505114|10078318|P3|Overall Study|inadvertent enrollment due to peanut all|0
2925716|NCT01505114|10078319|P2|Overall Study|inadvertent enrollment due to peanut all|0
2925717|NCT01505114|10078320|P1|Overall Study|inadvertent enrollment due to peanut all|0
2925718|NCT01505114|10078317|P4|Overall Study|relocated|3
2925719|NCT01505114|10078318|P3|Overall Study|relocated|2
2925720|NCT01505114|10078319|P2|Overall Study|relocated|2
2925721|NCT01505114|10078320|P1|Overall Study|relocated|4
2925722|NCT01505114|10078317|P4|Overall Study|Lost to Follow-up|7
2925723|NCT01505114|10078318|P3|Overall Study|Lost to Follow-up|8
2925724|NCT01505114|10078319|P2|Overall Study|Lost to Follow-up|5
2925725|NCT01505114|10078320|P1|Overall Study|Lost to Follow-up|11
2925726|NCT01505114|10078317|P4|Overall Study|unable to adhere to visit schedule|3
2925727|NCT01505114|10078318|P3|Overall Study|unable to adhere to visit schedule|3
2925728|NCT01505114|10078319|P2|Overall Study|unable to adhere to visit schedule|2
2925729|NCT01505114|10078320|P1|Overall Study|unable to adhere to visit schedule|3
2925730|NCT01505114|10078317|P4|Overall Study|Death|1
2925731|NCT01505114|10078318|P3|Overall Study|Death|0
2925732|NCT01505114|10078319|P2|Overall Study|Death|0
2925733|NCT01505114|10078320|P1|Overall Study|Death|1
2925734|NCT01505114|10078317|P4|Overall Study|Withdrawal by Subject|7
2925735|NCT01505114|10078318|P3|Overall Study|Withdrawal by Subject|4
2925736|NCT01505114|10078319|P2|Overall Study|Withdrawal by Subject|4
2925737|NCT01505114|10078320|P1|Overall Study|Withdrawal by Subject|5
2925738|NCT01505010|10078348|P2|Overall Study|Lost to Follow-up|1
2925739|NCT01505010|10078349|P1|Overall Study|Lost to Follow-up|0
2925740|NCT01505010|10078348|P2|Overall Study|Protocol Violation|1
2925741|NCT01505010|10078349|P1|Overall Study|Protocol Violation|0
2925742|NCT01504971|10078363|P1|Overall Study|Physician Decision|13
2925743|NCT01504867|10078392|P2|Overall Study|Consent revoked|1
2925744|NCT01504867|10078393|P1|Overall Study|Consent revoked|5
2925745|NCT01504867|10078392|P2|Overall Study|Inclusion criteria not met|2
2925746|NCT01504867|10078393|P1|Overall Study|Inclusion criteria not met|2
2925747|NCT01504841|10078431|P3|Overall Study|On study due to Long-term Follow-up|0
2925748|NCT01504841|10078432|P2|Overall Study|On study due to Long-term Follow-up|3
2925749|NCT01504841|10078433|P1|Overall Study|On study due to Long-term Follow-up|15
2925750|NCT01504841|10078431|P3|Overall Study|Withdrawal by Subject|0
2925751|NCT01504841|10078432|P2|Overall Study|Withdrawal by Subject|1
2925752|NCT01504841|10078433|P1|Overall Study|Withdrawal by Subject|1
2925753|NCT01504412|10078479|P5|Overall Study|Death|0
2925754|NCT01504412|10078480|P4|Overall Study|Death|1
2925755|NCT01504412|10078481|P3|Overall Study|Death|0
2925756|NCT01504412|10078482|P2|Overall Study|Death|0
2925757|NCT01504412|10078483|P1|Overall Study|Death|0
2925758|NCT01504412|10078479|P5|Overall Study|Lack of Efficacy|1
2925759|NCT01504412|10078480|P4|Overall Study|Lack of Efficacy|0
2925760|NCT01504412|10078481|P3|Overall Study|Lack of Efficacy|1
2925761|NCT01504412|10078482|P2|Overall Study|Lack of Efficacy|0
2925762|NCT01504412|10078483|P1|Overall Study|Lack of Efficacy|0
2925763|NCT01504412|10078479|P5|Overall Study|Lost to Follow-up|0
2925764|NCT01504412|10078480|P4|Overall Study|Lost to Follow-up|0
2925765|NCT01504412|10078481|P3|Overall Study|Lost to Follow-up|0
2925766|NCT01504412|10078482|P2|Overall Study|Lost to Follow-up|2
2925767|NCT01504412|10078483|P1|Overall Study|Lost to Follow-up|0
2925768|NCT01504412|10078479|P5|Overall Study|Other|1
2925769|NCT01504412|10078480|P4|Overall Study|Other|6
2925770|NCT01504412|10078481|P3|Overall Study|Other|1
2925771|NCT01504412|10078482|P2|Overall Study|Other|1
2925772|NCT01504412|10078483|P1|Overall Study|Other|2
2925773|NCT01504412|10078479|P5|Overall Study|Withdrawal by Subject|1
2925774|NCT01504412|10078480|P4|Overall Study|Withdrawal by Subject|5
2925775|NCT01504412|10078481|P3|Overall Study|Withdrawal by Subject|1
2925776|NCT01504412|10078482|P2|Overall Study|Withdrawal by Subject|1
2925777|NCT01504412|10078483|P1|Overall Study|Withdrawal by Subject|2
2925778|NCT01504412|10078479|P5|Overall Study|Adverse Event|10
2925779|NCT01504412|10078480|P4|Overall Study|Adverse Event|7
2925780|NCT01504412|10078481|P3|Overall Study|Adverse Event|1
2925781|NCT01504412|10078482|P2|Overall Study|Adverse Event|8
2925782|NCT01504412|10078483|P1|Overall Study|Adverse Event|1
2925783|NCT01504204|10078502|P2|Overall Study|Lost to Follow-up|1
2925784|NCT01504204|10078503|P1|Overall Study|Lost to Follow-up|1
2925785|NCT01503164|10078560|P2|Overall Study|Withdrawal by Subject|1
2925786|NCT01503164|10078561|P1|Overall Study|Withdrawal by Subject|2
2925787|NCT01503021|10078591|P2|Overall Study|Moved, received transplant, etc.|7
2925788|NCT01503021|10078592|P1|Overall Study|Moved, received transplant, etc.|5
2925789|NCT01503021|10078591|P2|Overall Study|Withdrawal by Subject|8
2925790|NCT01503021|10078592|P1|Overall Study|Withdrawal by Subject|9
2925791|NCT01503021|10078591|P2|Overall Study|Protocol Violation|3
2925792|NCT01503021|10078592|P1|Overall Study|Protocol Violation|1
2925793|NCT01503021|10078591|P2|Overall Study|Physician Decision|0
2925794|NCT01503021|10078592|P1|Overall Study|Physician Decision|3
2925795|NCT01503021|10078591|P2|Overall Study|Lost to Follow-up|0
2925796|NCT01503021|10078592|P1|Overall Study|Lost to Follow-up|2
2925797|NCT01503021|10078591|P2|Overall Study|Death|2
2925798|NCT01503021|10078592|P1|Overall Study|Death|0
2925799|NCT01503021|10078591|P2|Overall Study|Adverse Event|6
2925800|NCT01503021|10078592|P1|Overall Study|Adverse Event|7
2925801|NCT01502956|10078641|P2|Overall Study|Withdrawal by Subject|10
2925802|NCT01502956|10078642|P1|Overall Study|Withdrawal by Subject|8
2925803|NCT01502956|10078641|P2|Overall Study|Physician Decision|3
2925804|NCT01502956|10078642|P1|Overall Study|Physician Decision|2
2925805|NCT01502956|10078641|P2|Overall Study|Lost to Follow-up|11
2925806|NCT01502956|10078642|P1|Overall Study|Lost to Follow-up|14
2925807|NCT01502956|10078641|P2|Overall Study|Death|2
2925808|NCT01502956|10078642|P1|Overall Study|Death|0
2925809|NCT01502709|10078700|P2|Overall Study|Lost to Follow-up|0
2925810|NCT01502709|10078701|P1|Overall Study|Lost to Follow-up|4
2925811|NCT01502644|10078714|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2925812|NCT01502644|10078715|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2925813|NCT01502644|10078716|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2925814|NCT01502644|10078717|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2925815|NCT01502644|10078714|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
2925816|NCT01502644|10078715|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
2925817|NCT01502644|10078716|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
2925818|NCT01502644|10078717|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
2925819|NCT01502644|10078714|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2925820|NCT01502644|10078715|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2925821|NCT01502644|10078716|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2925822|NCT01502644|10078717|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
2925823|NCT01502644|10078714|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2925824|NCT01502644|10078715|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2925825|NCT01502644|10078716|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2925826|NCT01502644|10078717|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
2925827|NCT01502644|10078714|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2925828|NCT01502644|10078715|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2925829|NCT01502644|10078716|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2925830|NCT01502644|10078717|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
2925831|NCT01502423|10078727|P2|Overall Study|Withdrawal by Subject|1
2925832|NCT01502423|10078728|P1|Overall Study|Withdrawal by Subject|0
2925833|NCT01502410|10078750|P4|Overall Study|Withdrawal by Subject|0
2925834|NCT01502410|10078751|P3|Overall Study|Withdrawal by Subject|0
2925835|NCT01502410|10078752|P2|Overall Study|Withdrawal by Subject|0
2925836|NCT01502410|10078753|P1|Overall Study|Withdrawal by Subject|2
2925837|NCT01502410|10078750|P4|Overall Study|Physician Decision|0
2925838|NCT01502410|10078751|P3|Overall Study|Physician Decision|0
2925839|NCT01502410|10078752|P2|Overall Study|Physician Decision|1
2925840|NCT01502410|10078753|P1|Overall Study|Physician Decision|0
2925841|NCT01502410|10078750|P4|Overall Study|Lack of Efficacy|0
2925842|NCT01502410|10078751|P3|Overall Study|Lack of Efficacy|0
2925843|NCT01502410|10078752|P2|Overall Study|Lack of Efficacy|7
2925844|NCT01502410|10078753|P1|Overall Study|Lack of Efficacy|7
2925845|NCT01502410|10078750|P4|Overall Study|Adverse Event|0
2925846|NCT01502410|10078751|P3|Overall Study|Adverse Event|0
2925847|NCT01502410|10078752|P2|Overall Study|Adverse Event|2
2925848|NCT01502410|10078753|P1|Overall Study|Adverse Event|1
2925849|NCT01502371|10078771|P5|Overall Study|Excluded Medication|1
2925850|NCT01502371|10078772|P4|Overall Study|Excluded Medication|0
2925851|NCT01502371|10078773|P3|Overall Study|Excluded Medication|1
2925852|NCT01502371|10078774|P2|Overall Study|Excluded Medication|1
2925853|NCT01502371|10078775|P1|Overall Study|Excluded Medication|0
2925854|NCT01502371|10078771|P5|Overall Study|Protocol Violation|10
2925855|NCT01502371|10078772|P4|Overall Study|Protocol Violation|5
2925856|NCT01502371|10078773|P3|Overall Study|Protocol Violation|6
2925857|NCT01502371|10078774|P2|Overall Study|Protocol Violation|5
2925858|NCT01502371|10078775|P1|Overall Study|Protocol Violation|9
2925859|NCT01502371|10078771|P5|Overall Study|Technical Problems|1
2925860|NCT01502371|10078772|P4|Overall Study|Technical Problems|4
2925861|NCT01502371|10078773|P3|Overall Study|Technical Problems|2
2925862|NCT01502371|10078774|P2|Overall Study|Technical Problems|0
2925863|NCT01502371|10078775|P1|Overall Study|Technical Problems|1
2925864|NCT01502371|10078771|P5|Overall Study|Noncompliance with Study Drug|1
2925865|NCT01502371|10078772|P4|Overall Study|Noncompliance with Study Drug|2
2925866|NCT01502371|10078773|P3|Overall Study|Noncompliance with Study Drug|1
2925867|NCT01502371|10078774|P2|Overall Study|Noncompliance with Study Drug|0
2925868|NCT01502371|10078775|P1|Overall Study|Noncompliance with Study Drug|0
2925869|NCT01502371|10078771|P5|Overall Study|Physician Decision|1
2925870|NCT01502371|10078772|P4|Overall Study|Physician Decision|0
2925871|NCT01502371|10078773|P3|Overall Study|Physician Decision|0
2925872|NCT01502371|10078774|P2|Overall Study|Physician Decision|0
2925873|NCT01502371|10078775|P1|Overall Study|Physician Decision|3
2925874|NCT01502371|10078771|P5|Overall Study|Lack of Efficacy|4
2925875|NCT01502371|10078772|P4|Overall Study|Lack of Efficacy|2
2925876|NCT01502371|10078773|P3|Overall Study|Lack of Efficacy|2
2925877|NCT01502371|10078774|P2|Overall Study|Lack of Efficacy|3
2925878|NCT01502371|10078775|P1|Overall Study|Lack of Efficacy|3
2925879|NCT01502371|10078771|P5|Overall Study|Treatment Failure|30
2925880|NCT01502371|10078772|P4|Overall Study|Treatment Failure|19
2925881|NCT01502371|10078773|P3|Overall Study|Treatment Failure|12
2925882|NCT01502371|10078774|P2|Overall Study|Treatment Failure|20
2925883|NCT01502371|10078775|P1|Overall Study|Treatment Failure|22
2925884|NCT01502371|10078771|P5|Overall Study|Adverse Event|3
2925885|NCT01502371|10078772|P4|Overall Study|Adverse Event|4
2925886|NCT01502371|10078773|P3|Overall Study|Adverse Event|0
2925887|NCT01502371|10078774|P2|Overall Study|Adverse Event|1
2925888|NCT01502371|10078775|P1|Overall Study|Adverse Event|2
2925889|NCT01502371|10078771|P5|Overall Study|Withdrawal by Subject|1
2925890|NCT01502371|10078772|P4|Overall Study|Withdrawal by Subject|1
2925891|NCT01502371|10078773|P3|Overall Study|Withdrawal by Subject|1
2925892|NCT01502371|10078774|P2|Overall Study|Withdrawal by Subject|2
2925893|NCT01502371|10078775|P1|Overall Study|Withdrawal by Subject|1
2925894|NCT01502293|10078840|P3|Overall Study|Physician Decision|1
2925895|NCT01502293|10078841|P2|Overall Study|Physician Decision|0
2925896|NCT01502293|10078842|P1|Overall Study|Physician Decision|0
2925897|NCT01502293|10078840|P3|Overall Study|Reason Not Specified|0
2925898|NCT01502293|10078841|P2|Overall Study|Reason Not Specified|0
2925899|NCT01502293|10078842|P1|Overall Study|Reason Not Specified|2
2925900|NCT01502293|10078840|P3|Overall Study|Adverse Event|0
2925901|NCT01502293|10078841|P2|Overall Study|Adverse Event|2
2925902|NCT01502293|10078842|P1|Overall Study|Adverse Event|0
2925903|NCT01502293|10078840|P3|Overall Study|Withdrawal by Subject|1
2925904|NCT01502293|10078841|P2|Overall Study|Withdrawal by Subject|3
2925905|NCT01502293|10078842|P1|Overall Study|Withdrawal by Subject|3
2925906|NCT01502293|10078840|P3|Overall Study|Progressive Disease|2
2925907|NCT01502293|10078841|P2|Overall Study|Progressive Disease|12
2925908|NCT01502293|10078842|P1|Overall Study|Progressive Disease|20
2925909|NCT01502228|10078871|P1|Overall Study|Death|1
2925910|NCT01502033|10078876|P1|Overall Study|1 participant went back to school|1
2925911|NCT01502033|10078876|P1|Overall Study|1 participant had worsening depression|1
2925912|NCT01502033|10078876|P1|Overall Study|1 participant had scalp discomfort|1
2925913|NCT01501955|10078884|P2|Overall Study|Adverse Event|3
2925914|NCT01501955|10078885|P1|Overall Study|Adverse Event|1
2925915|NCT01501955|10078884|P2|Overall Study|Withdrawal by Subject|0
2925916|NCT01501955|10078885|P1|Overall Study|Withdrawal by Subject|1
2925917|NCT01501110|10078949|P2|Overall Study|Death|1
2925918|NCT01501110|10078950|P1|Overall Study|Death|0
2925919|NCT01500720|10078983|P2|Overall Study|Other|8
2925920|NCT01500720|10078984|P1|Overall Study|Other|4
2925921|NCT01500720|10078983|P2|Overall Study|Randomized But Not Treated|1
2925922|NCT01500720|10078984|P1|Overall Study|Randomized But Not Treated|1
2925923|NCT01500694|10078998|P2|Overall Study|Other|3
2925924|NCT01500694|10078999|P1|Overall Study|Other|9
2925925|NCT01500694|10078998|P2|Overall Study|Lack of Efficacy|5
2925926|NCT01500694|10078999|P1|Overall Study|Lack of Efficacy|14
2925927|NCT01500694|10078998|P2|Overall Study|Lost to Follow-up|3
2925928|NCT01500694|10078999|P1|Overall Study|Lost to Follow-up|2
2925929|NCT01500694|10078998|P2|Overall Study|Withdrawal by Subject|14
2925930|NCT01500694|10078999|P1|Overall Study|Withdrawal by Subject|23
2925931|NCT01500694|10078998|P2|Overall Study|Protocol Violation|1
2925932|NCT01500694|10078999|P1|Overall Study|Protocol Violation|0
2925933|NCT01500694|10078998|P2|Overall Study|Adverse Event|3
2925934|NCT01500694|10078999|P1|Overall Study|Adverse Event|4
2925935|NCT01500629|10079025|P2|Washout Period of 14 to 30 Days|Pregnancy|0
2925936|NCT01500629|10079026|P1|Washout Period of 14 to 30 Days|Pregnancy|1
2925937|NCT01500434|10079110|P1|Overall Study|Missed 12-month follow-up|5
2925938|NCT01500434|10079110|P1|Overall Study|Withdrawal by Subject|1
2925939|NCT01500434|10079110|P1|Overall Study|Death|1
2925940|NCT01500382|10079143|P4|Washout Period|Study site went out of business|0
2925941|NCT01500382|10079144|P3|Washout Period|Study site went out of business|1
2925942|NCT01500382|10079145|P2|Washout Period|Study site went out of business|0
2925943|NCT01500382|10079146|P1|Washout Period|Study site went out of business|0
2925944|NCT01500317|10079171|P3|Overall Study|Withdrawal by Subject|0
2925945|NCT01500317|10079172|P2|Overall Study|Withdrawal by Subject|2
2925946|NCT01500317|10079173|P1|Overall Study|Withdrawal by Subject|3
2925947|NCT01500278|10079195|P2|Week 13 - Week 104|Adverse Event|54
2925948|NCT01500278|10079196|P1|Week 13 - Week 104|Adverse Event|54
2925949|NCT01500278|10079195|P2|Week 13 - Week 104|Death|4
2925950|NCT01500278|10079196|P1|Week 13 - Week 104|Death|2
2925951|NCT01500278|10079195|P2|Week 13 - Week 104|Not completed|1
2925952|NCT01500278|10079196|P1|Week 13 - Week 104|Not completed|0
2925953|NCT01500278|10079195|P2|Week 13 - Week 104|Personal reason|1
2925954|NCT01500278|10079196|P1|Week 13 - Week 104|Personal reason|0
2925955|NCT01500278|10079195|P2|Week 13 - Week 104|Medical monitor decision|2
2925956|NCT01500278|10079196|P1|Week 13 - Week 104|Medical monitor decision|0
2925957|NCT01500278|10079195|P2|Week 13 - Week 104|Sponsor decision|2
2925958|NCT01500278|10079196|P1|Week 13 - Week 104|Sponsor decision|0
2925959|NCT01500278|10079195|P2|Week 13 - Week 104|Relocation|1
2925960|NCT01500278|10079196|P1|Week 13 - Week 104|Relocation|0
2925961|NCT01500278|10079195|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
2925962|NCT01500278|10079196|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
2925963|NCT01500278|10079195|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
2925964|NCT01500278|10079196|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
2925965|NCT01500278|10079195|P2|Week 13 - Week 104|Principal investigator retiring|0
2925966|NCT01500278|10079196|P1|Week 13 - Week 104|Principal investigator retiring|1
2925967|NCT01500278|10079195|P2|Week 13 - Week 104|Protocol deviation|0
2925968|NCT01500278|10079196|P1|Week 13 - Week 104|Protocol deviation|1
2925969|NCT01500278|10079195|P2|Week 13 - Week 104|Exclusion criteria not met|0
2925970|NCT01500278|10079196|P1|Week 13 - Week 104|Exclusion criteria not met|1
2925971|NCT01500278|10079195|P2|Week 13 - Week 104|Withdrawn in error|0
2925972|NCT01500278|10079196|P1|Week 13 - Week 104|Withdrawn in error|1
2925973|NCT01500278|10079195|P2|Week 13 - Week 104|Sponsor request|0
2925974|NCT01500278|10079196|P1|Week 13 - Week 104|Sponsor request|4
2925975|NCT01500278|10079195|P2|Week 13 - Week 104|False positive test|2
2925976|NCT01500278|10079196|P1|Week 13 - Week 104|False positive test|1
2925977|NCT01500278|10079195|P2|Week 13 - Week 104|Recurrent infections|0
2925978|NCT01500278|10079196|P1|Week 13 - Week 104|Recurrent infections|1
2925979|NCT01500278|10079195|P2|Week 13 - Week 104|Non/bad compliance|5
2925980|NCT01500278|10079196|P1|Week 13 - Week 104|Non/bad compliance|7
2925981|NCT01500278|10079195|P2|Week 13 - Week 104|Week 24 Non-Responder|16
2925982|NCT01500278|10079196|P1|Week 13 - Week 104|Week 24 Non-Responder|20
2925983|NCT01500278|10079195|P2|Week 13 - Week 104|Withdrawal by Subject|13
2925984|NCT01500278|10079196|P1|Week 13 - Week 104|Withdrawal by Subject|22
2925985|NCT01500278|10079195|P2|Week 13 - Week 104|Lost to Follow-up|5
2925986|NCT01500278|10079196|P1|Week 13 - Week 104|Lost to Follow-up|6
2925987|NCT01500278|10079195|P2|Week 13 - Week 104|Protocol Violation|6
2925988|NCT01500278|10079196|P1|Week 13 - Week 104|Protocol Violation|6
2925989|NCT01500278|10079195|P2|Week 13 - Week 104|Lack of Efficacy|12
2925990|NCT01500278|10079196|P1|Week 13 - Week 104|Lack of Efficacy|11
2925991|NCT01500278|10079195|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
2925992|NCT01500278|10079196|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
2925993|NCT01500278|10079195|P2|Week 0 - Week 12|Other serious disease|1
2925994|NCT01500278|10079196|P1|Week 0 - Week 12|Other serious disease|0
2925995|NCT01500278|10079195|P2|Week 0 - Week 12|Personal reason|1
2925996|NCT01500278|10079196|P1|Week 0 - Week 12|Personal reason|0
2925997|NCT01500278|10079195|P2|Week 0 - Week 12|Sponsor decision|0
2925998|NCT01500278|10079196|P1|Week 0 - Week 12|Sponsor decision|1
2925999|NCT01500278|10079195|P2|Week 0 - Week 12|Prior history of serious disease|0
2926000|NCT01500278|10079196|P1|Week 0 - Week 12|Prior history of serious disease|1
2926001|NCT01500278|10079195|P2|Week 0 - Week 12|Investigator decision|0
2926002|NCT01500278|10079196|P1|Week 0 - Week 12|Investigator decision|1
2926003|NCT01500278|10079195|P2|Week 0 - Week 12|Exclusion criteria not met|0
2926004|NCT01500278|10079196|P1|Week 0 - Week 12|Exclusion criteria not met|1
2926005|NCT01500278|10079195|P2|Week 0 - Week 12|Patient decision|0
2926006|NCT01500278|10079196|P1|Week 0 - Week 12|Patient decision|1
2926007|NCT01500278|10079195|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
2926008|NCT01500278|10079196|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
2926009|NCT01500278|10079195|P2|Week 0 - Week 12|Withdrawal by Subject|2
2926010|NCT01500278|10079196|P1|Week 0 - Week 12|Withdrawal by Subject|7
2926011|NCT01500278|10079195|P2|Week 0 - Week 12|Lost to Follow-up|1
2926012|NCT01500278|10079196|P1|Week 0 - Week 12|Lost to Follow-up|1
2926013|NCT01500278|10079195|P2|Week 0 - Week 12|Protocol Violation|16
2926014|NCT01500278|10079196|P1|Week 0 - Week 12|Protocol Violation|10
2926015|NCT01500278|10079195|P2|Week 0 - Week 12|Lack of Efficacy|1
2926016|NCT01500278|10079196|P1|Week 0 - Week 12|Lack of Efficacy|0
2926017|NCT01500252|10079220|P2|Overall Study|Lost to Follow-up|4
2926018|NCT01500252|10079221|P1|Overall Study|Lost to Follow-up|5
2926019|NCT01500252|10079220|P2|Overall Study|Death|2
2926020|NCT01500252|10079221|P1|Overall Study|Death|4
2926021|NCT01500226|10079247|P2|Overall Study|Other Reasons|16
2926022|NCT01500226|10079248|P1|Overall Study|Other Reasons|19
2926023|NCT01500226|10079247|P2|Overall Study|Lost to Follow-up|5
2926024|NCT01500226|10079248|P1|Overall Study|Lost to Follow-up|9
2926025|NCT01500226|10079247|P2|Overall Study|Lack of Efficacy|30
2926026|NCT01500226|10079248|P1|Overall Study|Lack of Efficacy|14
2926027|NCT01500226|10079247|P2|Overall Study|Physician Decision|15
2926028|NCT01500226|10079248|P1|Overall Study|Physician Decision|17
2926029|NCT01500226|10079247|P2|Overall Study|Protocol Violation|39
2926030|NCT01500226|10079248|P1|Overall Study|Protocol Violation|53
2926031|NCT01500226|10079247|P2|Overall Study|Disease Progression|14
2926032|NCT01500226|10079248|P1|Overall Study|Disease Progression|16
2926033|NCT01500226|10079247|P2|Overall Study|Death|4
2926034|NCT01500226|10079248|P1|Overall Study|Death|12
2926035|NCT01500226|10079247|P2|Overall Study|Withdrawal by Subject|96
2926036|NCT01500226|10079248|P1|Overall Study|Withdrawal by Subject|93
2926037|NCT01500226|10079247|P2|Overall Study|Chemo Completed or Change in Therapy|237
2926038|NCT01500226|10079248|P1|Overall Study|Chemo Completed or Change in Therapy|235
2926039|NCT01500226|10079247|P2|Overall Study|Adverse Event|38
2926040|NCT01500226|10079248|P1|Overall Study|Adverse Event|31
2926041|NCT01500213|10079260|P2|Overall Study|Other Reasons|5
2926042|NCT01500213|10079261|P1|Overall Study|Other Reasons|7
2926043|NCT01500213|10079260|P2|Overall Study|Lost to Follow-up|6
2926044|NCT01500213|10079261|P1|Overall Study|Lost to Follow-up|3
2926045|NCT01500213|10079260|P2|Overall Study|Lack of Efficacy|7
2926046|NCT01500213|10079261|P1|Overall Study|Lack of Efficacy|9
2926047|NCT01500213|10079260|P2|Overall Study|Physician Decision|10
2926048|NCT01500213|10079261|P1|Overall Study|Physician Decision|12
2926049|NCT01500213|10079260|P2|Overall Study|Protocol Violation|19
2926050|NCT01500213|10079261|P1|Overall Study|Protocol Violation|19
2926051|NCT01500213|10079260|P2|Overall Study|Disease Progression|21
2926052|NCT01500213|10079261|P1|Overall Study|Disease Progression|13
2926053|NCT01500213|10079260|P2|Overall Study|Death|3
2926054|NCT01500213|10079261|P1|Overall Study|Death|7
2926055|NCT01500213|10079260|P2|Overall Study|Withdrawal by Subject|37
2926056|NCT01500213|10079261|P1|Overall Study|Withdrawal by Subject|28
2926057|NCT01500213|10079260|P2|Overall Study|Chemo Completed or Change in Therapy|81
2926058|NCT01500213|10079261|P1|Overall Study|Chemo Completed or Change in Therapy|84
2926059|NCT01500213|10079260|P2|Overall Study|Adverse Event|35
2926060|NCT01500213|10079261|P1|Overall Study|Adverse Event|35
2926061|NCT01500200|10079274|P6|Stage 2|Adverse Event|4
2926062|NCT01500200|10079275|P5|Stage 2|Adverse Event|5
2926063|NCT01500200|10079276|P4|Stage 2|Adverse Event|0
2926064|NCT01500200|10079277|P3|Stage 2|Adverse Event|0
2926065|NCT01500200|10079278|P2|Stage 2|Adverse Event|0
2926066|NCT01500200|10079279|P1|Stage 2|Adverse Event|0
2926067|NCT01500200|10079274|P6|Stage 1|Physician Decision|0
2926068|NCT01500200|10079275|P5|Stage 1|Physician Decision|0
2926069|NCT01500200|10079276|P4|Stage 1|Physician Decision|0
2926070|NCT01500200|10079277|P3|Stage 1|Physician Decision|0
2926071|NCT01500200|10079278|P2|Stage 1|Physician Decision|0
2926072|NCT01500200|10079279|P1|Stage 1|Physician Decision|1
2926073|NCT01500200|10079274|P6|Stage 1|Noncompliance with Study Drug|0
2926074|NCT01500200|10079275|P5|Stage 1|Noncompliance with Study Drug|0
2926075|NCT01500200|10079276|P4|Stage 1|Noncompliance with Study Drug|0
2926076|NCT01500200|10079277|P3|Stage 1|Noncompliance with Study Drug|0
2926077|NCT01500200|10079278|P2|Stage 1|Noncompliance with Study Drug|0
2926078|NCT01500200|10079279|P1|Stage 1|Noncompliance with Study Drug|1
2926079|NCT01500200|10079274|P6|Stage 1|Withdrawal by Subject|0
2926080|NCT01500200|10079275|P5|Stage 1|Withdrawal by Subject|0
2926081|NCT01500200|10079276|P4|Stage 1|Withdrawal by Subject|0
2926082|NCT01500200|10079277|P3|Stage 1|Withdrawal by Subject|0
2926083|NCT01500200|10079278|P2|Stage 1|Withdrawal by Subject|0
2926084|NCT01500200|10079279|P1|Stage 1|Withdrawal by Subject|3
2926085|NCT01500200|10079274|P6|Stage 1|Lost to Follow-up|0
2926086|NCT01500200|10079275|P5|Stage 1|Lost to Follow-up|0
2926087|NCT01500200|10079276|P4|Stage 1|Lost to Follow-up|0
2926088|NCT01500200|10079277|P3|Stage 1|Lost to Follow-up|1
2926089|NCT01500200|10079278|P2|Stage 1|Lost to Follow-up|2
2926090|NCT01500200|10079279|P1|Stage 1|Lost to Follow-up|2
2926091|NCT01500200|10079274|P6|Stage 1|Adverse Event|0
2926092|NCT01500200|10079275|P5|Stage 1|Adverse Event|0
2926093|NCT01500200|10079276|P4|Stage 1|Adverse Event|0
2926094|NCT01500200|10079277|P3|Stage 1|Adverse Event|5
2926095|NCT01500200|10079278|P2|Stage 1|Adverse Event|4
2926096|NCT01500200|10079279|P1|Stage 1|Adverse Event|1
2926097|NCT01500187|10079313|P2|Overall Study|Lost to Follow-up|0
2926098|NCT01500187|10079314|P1|Overall Study|Lost to Follow-up|6
2926099|NCT01500135|10079322|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
2926100|NCT01500135|10079323|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
2926101|NCT01500135|10079322|P2|Overall Study|Participant was a Safety Concern|0
2926102|NCT01500135|10079323|P1|Overall Study|Participant was a Safety Concern|1
2926103|NCT01500135|10079322|P2|Overall Study|Patient Missed Scheduled Appointments|1
2926104|NCT01500135|10079323|P1|Overall Study|Patient Missed Scheduled Appointments|0
2926105|NCT01500135|10079322|P2|Overall Study|Principal Investigator (PI) Discretion|0
2926106|NCT01500135|10079323|P1|Overall Study|Principal Investigator (PI) Discretion|1
2926107|NCT01500135|10079322|P2|Overall Study|Fatal Adverse Event (AE)|5
2926108|NCT01500135|10079323|P1|Overall Study|Fatal Adverse Event (AE)|5
2926109|NCT01500135|10079322|P2|Overall Study|Lost to Follow-up|4
2926110|NCT01500135|10079323|P1|Overall Study|Lost to Follow-up|6
2926111|NCT01500135|10079322|P2|Overall Study|Withdrawal of Consent|0
2926112|NCT01500135|10079323|P1|Overall Study|Withdrawal of Consent|4
2926113|NCT01500096|10079350|P4|Overall Study|Lost to Follow-up|2
2926114|NCT01500096|10079351|P3|Overall Study|Lost to Follow-up|0
2926115|NCT01500096|10079352|P2|Overall Study|Lost to Follow-up|0
2926116|NCT01500096|10079353|P1|Overall Study|Lost to Follow-up|1
2926117|NCT01500083|10079409|P2|Overall Study|Other Reasons|5
2926118|NCT01500083|10079410|P1|Overall Study|Other Reasons|2
2926119|NCT01500083|10079409|P2|Overall Study|Investigator Discretion|8
2926120|NCT01500083|10079410|P1|Overall Study|Investigator Discretion|3
2926121|NCT01500083|10079409|P2|Overall Study|Disease Progression|10
2926122|NCT01500083|10079410|P1|Overall Study|Disease Progression|2
2926123|NCT01500083|10079409|P2|Overall Study|Withdrawal of Consent|1
2926124|NCT01500083|10079410|P1|Overall Study|Withdrawal of Consent|0
2926125|NCT01500083|10079409|P2|Overall Study|Lost to Follow-up|0
2926126|NCT01500083|10079410|P1|Overall Study|Lost to Follow-up|1
2926127|NCT01500083|10079409|P2|Overall Study|Death|2
2926128|NCT01500083|10079410|P1|Overall Study|Death|0
2926129|NCT01500083|10079409|P2|Overall Study|Adverse Event|17
2926130|NCT01500083|10079410|P1|Overall Study|Adverse Event|4
2926131|NCT01500057|10079418|P2|Overall Study|Lost to Follow-up|4
2926132|NCT01500057|10079419|P1|Overall Study|Lost to Follow-up|6
2926133|NCT01500031|10079429|P1|Overall Study|Withdrawal by Subject|4
2926134|NCT01500031|10079429|P1|Overall Study|Death|1
2926135|NCT01499849|10079464|P2|Overall Study|Other Reasons|30
2926136|NCT01499849|10079465|P1|Overall Study|Other Reasons|27
2926137|NCT01499849|10079464|P2|Overall Study|Lost to Follow-up|3
2926138|NCT01499849|10079465|P1|Overall Study|Lost to Follow-up|6
2926139|NCT01499849|10079464|P2|Overall Study|Lack of Efficacy|4
2926140|NCT01499849|10079465|P1|Overall Study|Lack of Efficacy|3
2926141|NCT01499849|10079464|P2|Overall Study|Physician Decision|19
2926142|NCT01499849|10079465|P1|Overall Study|Physician Decision|20
2926143|NCT01499849|10079464|P2|Overall Study|Protocol Violation|11
2926144|NCT01499849|10079465|P1|Overall Study|Protocol Violation|11
2926145|NCT01499849|10079464|P2|Overall Study|Disease Progression|10
2926146|NCT01499849|10079465|P1|Overall Study|Disease Progression|11
2926147|NCT01499849|10079464|P2|Overall Study|Death|7
2926148|NCT01499849|10079465|P1|Overall Study|Death|5
2926149|NCT01499849|10079464|P2|Overall Study|Withdrawal by Subject|43
2926150|NCT01499849|10079465|P1|Overall Study|Withdrawal by Subject|43
2926151|NCT01499849|10079464|P2|Overall Study|Chemo completed or Change in Therapy|67
2926152|NCT01499849|10079465|P1|Overall Study|Chemo completed or Change in Therapy|70
2926153|NCT01499849|10079464|P2|Overall Study|Adverse Event|32
2926154|NCT01499849|10079465|P1|Overall Study|Adverse Event|28
2926155|NCT01499810|10079475|P1|Overall Study|Withdrawal by Subject|1
2926156|NCT01499810|10079475|P1|Overall Study|Protocol Violation|1
2926157|NCT01499810|10079475|P1|Overall Study|Lost to Follow-up|10
2926158|NCT01499667|10079525|P3|Overall Study|Lack of Efficacy|0
2926159|NCT01499667|10079526|P2|Overall Study|Lack of Efficacy|0
2926160|NCT01499667|10079527|P1|Overall Study|Lack of Efficacy|2
2926161|NCT01499667|10079525|P3|Overall Study|Withdrawal by Subject|1
2926162|NCT01499667|10079526|P2|Overall Study|Withdrawal by Subject|1
2926163|NCT01499667|10079527|P1|Overall Study|Withdrawal by Subject|2
2926164|NCT01499667|10079525|P3|Overall Study|Adverse Event|2
2926165|NCT01499667|10079526|P2|Overall Study|Adverse Event|2
2926166|NCT01499667|10079527|P1|Overall Study|Adverse Event|0
2926167|NCT01499667|10079525|P3|Overall Study|Protocol Violation|2
2926168|NCT01499667|10079526|P2|Overall Study|Protocol Violation|3
2926169|NCT01499667|10079527|P1|Overall Study|Protocol Violation|1
2926170|NCT01499667|10079525|P3|Overall Study|administrative problems|5
2926171|NCT01499667|10079526|P2|Overall Study|administrative problems|5
2926172|NCT01499667|10079527|P1|Overall Study|administrative problems|4
2926173|NCT01499576|10079575|P1|Overall Study|Withdrawal by Subject|9
2926174|NCT01499576|10079575|P1|Overall Study|Physician Decision|12
2926175|NCT01499511|10079583|P2|Overall Study|Death|0
2926176|NCT01499511|10079584|P1|Overall Study|Death|1
2926177|NCT01499355|10079609|P4|Double-Blind Period|Lost to Follow-up|0
2926178|NCT01499355|10079610|P3|Double-Blind Period|Lost to Follow-up|0
2926179|NCT01499355|10079611|P2|Double-Blind Period|Lost to Follow-up|1
2926180|NCT01499355|10079612|P1|Double-Blind Period|Lost to Follow-up|0
2926181|NCT01499355|10079609|P4|Double-Blind Period|Consent Withdrawn|2
2926182|NCT01499355|10079610|P3|Double-Blind Period|Consent Withdrawn|1
2926183|NCT01499355|10079611|P2|Double-Blind Period|Consent Withdrawn|0
2926184|NCT01499355|10079612|P1|Double-Blind Period|Consent Withdrawn|0
2926185|NCT01499355|10079609|P4|Double-Blind Period|Investigator Decision|3
2926186|NCT01499355|10079610|P3|Double-Blind Period|Investigator Decision|3
2926187|NCT01499355|10079611|P2|Double-Blind Period|Investigator Decision|0
2926188|NCT01499355|10079612|P1|Double-Blind Period|Investigator Decision|0
2926189|NCT01499355|10079609|P4|Double-Blind Period|Death|0
2926190|NCT01499355|10079610|P3|Double-Blind Period|Death|0
2926191|NCT01499355|10079611|P2|Double-Blind Period|Death|1
2926192|NCT01499355|10079612|P1|Double-Blind Period|Death|0
2926193|NCT01499355|10079609|P4|Double-Blind Period|Other|2
2926194|NCT01499355|10079610|P3|Double-Blind Period|Other|2
2926195|NCT01499355|10079611|P2|Double-Blind Period|Other|1
2926196|NCT01499355|10079612|P1|Double-Blind Period|Other|0
2926197|NCT01499355|10079609|P4|Double-Blind Period|Study Termination|14
2926198|NCT01499355|10079610|P3|Double-Blind Period|Study Termination|16
2926199|NCT01499355|10079611|P2|Double-Blind Period|Study Termination|18
2926200|NCT01499355|10079612|P1|Double-Blind Period|Study Termination|0
2926201|NCT01499355|10079609|P4|Double-Blind Period|Adverse Event|2
2926202|NCT01499355|10079610|P3|Double-Blind Period|Adverse Event|3
2926203|NCT01499355|10079611|P2|Double-Blind Period|Adverse Event|2
2926204|NCT01499355|10079612|P1|Double-Blind Period|Adverse Event|0
2926205|NCT01499355|10079609|P4|Run-In Period|Adverse Event|0
2926206|NCT01499355|10079610|P3|Run-In Period|Adverse Event|0
2926207|NCT01499355|10079611|P2|Run-In Period|Adverse Event|0
2926208|NCT01499355|10079612|P1|Run-In Period|Adverse Event|8
2926209|NCT01499355|10079609|P4|Run-In Period|Consent Withdrawn|0
2926210|NCT01499355|10079610|P3|Run-In Period|Consent Withdrawn|0
2926211|NCT01499355|10079611|P2|Run-In Period|Consent Withdrawn|0
2926212|NCT01499355|10079612|P1|Run-In Period|Consent Withdrawn|1
2926213|NCT01499355|10079609|P4|Run-In Period|Investigator Decision|0
2926214|NCT01499355|10079610|P3|Run-In Period|Investigator Decision|0
2926215|NCT01499355|10079611|P2|Run-In Period|Investigator Decision|0
2926216|NCT01499355|10079612|P1|Run-In Period|Investigator Decision|2
2926217|NCT01499355|10079609|P4|Run-In Period|Death|0
2926218|NCT01499355|10079610|P3|Run-In Period|Death|0
2926219|NCT01499355|10079611|P2|Run-In Period|Death|0
2926220|NCT01499355|10079612|P1|Run-In Period|Death|2
2926221|NCT01499355|10079609|P4|Run-In Period|Other|0
2926222|NCT01499355|10079610|P3|Run-In Period|Other|0
2926223|NCT01499355|10079611|P2|Run-In Period|Other|0
2926224|NCT01499355|10079612|P1|Run-In Period|Other|3
2926225|NCT01499355|10079609|P4|Run-In Period|Study Termination|0
2926226|NCT01499355|10079610|P3|Run-In Period|Study Termination|0
2926227|NCT01499355|10079611|P2|Run-In Period|Study Termination|0
2926228|NCT01499355|10079612|P1|Run-In Period|Study Termination|15
2926229|NCT01499303|10079645|P2|Overall Study|Other|1
2926230|NCT01499303|10079646|P1|Overall Study|Other|0
2926231|NCT01499303|10079645|P2|Overall Study|Adverse Event|4
2926232|NCT01499303|10079646|P1|Overall Study|Adverse Event|1
2926233|NCT01499303|10079645|P2|Overall Study|Withdrawal by Subject|1
2926234|NCT01499303|10079646|P1|Overall Study|Withdrawal by Subject|0
2926235|NCT01499303|10079645|P2|Overall Study|Ongoing|1
2926236|NCT01499303|10079646|P1|Overall Study|Ongoing|2
2926237|NCT01499290|10079654|P2|Overall Study|Adverse Event|7
2926238|NCT01499290|10079655|P1|Overall Study|Adverse Event|14
2926239|NCT01499290|10079654|P2|Overall Study|Lack of Efficacy|8
2926240|NCT01499290|10079655|P1|Overall Study|Lack of Efficacy|7
2926241|NCT01499290|10079654|P2|Overall Study|Condition improved/subject recovered|0
2926242|NCT01499290|10079655|P1|Overall Study|Condition improved/subject recovered|1
2926243|NCT01499290|10079654|P2|Overall Study|Not specified in study report|5
2926244|NCT01499290|10079655|P1|Overall Study|Not specified in study report|11
2926245|NCT01499290|10079654|P2|Overall Study|Withdrawal by Subject|15
2926246|NCT01499290|10079655|P1|Overall Study|Withdrawal by Subject|22
2926247|NCT01499277|10079705|P2|Overall Study|Lack of therapeutic response and other|7
2926248|NCT01499277|10079706|P1|Overall Study|Lack of therapeutic response and other|8
2926249|NCT01499277|10079705|P2|Overall Study|Withdrawal by Subject|6
2926250|NCT01499277|10079706|P1|Overall Study|Withdrawal by Subject|16
2926251|NCT01499277|10079705|P2|Overall Study|Protocol Violation|3
2926252|NCT01499277|10079706|P1|Overall Study|Protocol Violation|2
2926253|NCT01499277|10079705|P2|Overall Study|Lost to Follow-up|8
2926254|NCT01499277|10079706|P1|Overall Study|Lost to Follow-up|15
2926255|NCT01499277|10079705|P2|Overall Study|Death|2
2926256|NCT01499277|10079706|P1|Overall Study|Death|3
2926257|NCT01499277|10079705|P2|Overall Study|Adverse Event|6
2926258|NCT01499277|10079706|P1|Overall Study|Adverse Event|3
2926259|NCT01499199|10079728|P1|Overall Study|Lack of Efficacy|1
2926260|NCT01499199|10079728|P1|Overall Study|Adverse Event|1
2926261|NCT01499160|10079757|P1|Overall Study|Withdrawal by Subject|1
2926262|NCT01499160|10079757|P1|Overall Study|Adverse Event|1
2926263|NCT01499134|10079780|P2|Overall Study|Withdrawal by Subject|1
2926264|NCT01499134|10079781|P1|Overall Study|Withdrawal by Subject|0
2926265|NCT01499095|10079803|P2|Overall Study|Perceived Lack of Efficacy|1
2926266|NCT01499095|10079804|P1|Overall Study|Perceived Lack of Efficacy|1
2926267|NCT01499095|10079803|P2|Overall Study|Change in Injection Schedule|0
2926268|NCT01499095|10079804|P1|Overall Study|Change in Injection Schedule|2
2926269|NCT01499095|10079803|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
2926270|NCT01499095|10079804|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
2926271|NCT01499095|10079803|P2|Overall Study|Hypoglycemia|1
2926272|NCT01499095|10079804|P1|Overall Study|Hypoglycemia|3
2926273|NCT01499095|10079803|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
2926274|NCT01499095|10079804|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
2926275|NCT01499095|10079803|P2|Overall Study|Lost to Follow-up|4
2926276|NCT01499095|10079804|P1|Overall Study|Lost to Follow-up|6
2926277|NCT01499095|10079803|P2|Overall Study|Diverse Reasons|25
2926278|NCT01499095|10079804|P1|Overall Study|Diverse Reasons|22
2926279|NCT01499095|10079803|P2|Overall Study|Received Rescue Therapy|40
2926280|NCT01499095|10079804|P1|Overall Study|Received Rescue Therapy|32
2926281|NCT01499095|10079803|P2|Overall Study|Protocol Violation|7
2926282|NCT01499095|10079804|P1|Overall Study|Protocol Violation|6
2926283|NCT01499095|10079803|P2|Overall Study|Lack of Efficacy|1
2926284|NCT01499095|10079804|P1|Overall Study|Lack of Efficacy|2
2926285|NCT01499095|10079803|P2|Overall Study|Adverse Event|7
2926286|NCT01499095|10079804|P1|Overall Study|Adverse Event|12
2926287|NCT01499095|10079803|P2|Overall Study|Randomized But Not Treated|1
2926288|NCT01499095|10079804|P1|Overall Study|Randomized But Not Treated|1
2926289|NCT01499082|10079834|P2|Overall Study|Lost to Follow-up|3
2926290|NCT01499082|10079835|P1|Overall Study|Lost to Follow-up|1
2926291|NCT01499082|10079834|P2|Overall Study|Hypoglycemia|3
2926292|NCT01499082|10079835|P1|Overall Study|Hypoglycemia|2
2926293|NCT01499082|10079834|P2|Overall Study|Site Closure for Noncompliance|2
2926294|NCT01499082|10079835|P1|Overall Study|Site Closure for Noncompliance|5
2926295|NCT01499082|10079834|P2|Overall Study|Diverse Reasons|14
2926296|NCT01499082|10079835|P1|Overall Study|Diverse Reasons|18
2926297|NCT01499082|10079834|P2|Overall Study|Protocol Violation|8
2926298|NCT01499082|10079835|P1|Overall Study|Protocol Violation|6
2926299|NCT01499082|10079834|P2|Overall Study|Lack of Efficacy|1
2926300|NCT01499082|10079835|P1|Overall Study|Lack of Efficacy|1
2926301|NCT01499082|10079834|P2|Overall Study|Adverse Event|16
2926302|NCT01499082|10079835|P1|Overall Study|Adverse Event|12
2926303|NCT01499082|10079834|P2|Overall Study|Randomized but not Treated|1
2926304|NCT01499082|10079835|P1|Overall Study|Randomized but not Treated|0
2926305|NCT01499043|10079863|P1|Overall Study|Adverse Event|1
2926306|NCT01499043|10079863|P1|Overall Study|Withdrawal by Subject|2
2926307|NCT01499043|10079863|P1|Overall Study|Progressive disease (clinical)|1
2926308|NCT01499043|10079863|P1|Overall Study|Progressive disease (radiographic)|2
2926309|NCT01498952|10079906|P5|Overall Study|Death|0
2926310|NCT01498952|10079907|P4|Overall Study|Death|0
2926311|NCT01498952|10079908|P3|Overall Study|Death|0
2926312|NCT01498952|10079909|P2|Overall Study|Death|2
2926313|NCT01498952|10079910|P1|Overall Study|Death|2
2926314|NCT01498887|10079952|P2|Overall Study|Adverse Event|1
2926315|NCT01498887|10079953|P1|Overall Study|Adverse Event|4
2926316|NCT01498887|10079952|P2|Overall Study|Abnormal laboratory value|2
2926317|NCT01498887|10079953|P1|Overall Study|Abnormal laboratory value|2
2926318|NCT01498887|10079952|P2|Overall Study|Abnormal result from test procedure|1
2926319|NCT01498887|10079953|P1|Overall Study|Abnormal result from test procedure|1
2926320|NCT01498887|10079952|P2|Overall Study|Lack of Efficacy|3
2926321|NCT01498887|10079953|P1|Overall Study|Lack of Efficacy|5
2926322|NCT01498887|10079952|P2|Overall Study|Protocol Violation|3
2926323|NCT01498887|10079953|P1|Overall Study|Protocol Violation|1
2926324|NCT01498887|10079952|P2|Overall Study|Withdrawal by Subject|0
2926325|NCT01498887|10079953|P1|Overall Study|Withdrawal by Subject|1
2926326|NCT01498887|10079952|P2|Overall Study|Lost to Follow-up|1
2926327|NCT01498887|10079953|P1|Overall Study|Lost to Follow-up|1
2926328|NCT01498887|10079952|P2|Overall Study|Administrative problems|0
2926329|NCT01498887|10079953|P1|Overall Study|Administrative problems|1
2926330|NCT01498822|10079974|P2|Overall Study|Lost to Follow-up|3
2926331|NCT01498822|10079975|P1|Overall Study|Lost to Follow-up|8
2926332|NCT01498822|10079974|P2|Overall Study|Withdrawal by Subject|25
2926333|NCT01498822|10079975|P1|Overall Study|Withdrawal by Subject|15
2926334|NCT01498822|10079974|P2|Overall Study|Adverse Event, serious fatal|1
2926335|NCT01498822|10079975|P1|Overall Study|Adverse Event, serious fatal|1
2926336|NCT01498822|10079974|P2|Overall Study|SAE, non-fatal|2
2926337|NCT01498822|10079975|P1|Overall Study|SAE, non-fatal|2
2926338|NCT01498822|10079974|P2|Overall Study|AE, non-serious non-fatal|17
2926339|NCT01498822|10079975|P1|Overall Study|AE, non-serious non-fatal|8
2926340|NCT01498822|10079974|P2|Overall Study|Lack of Efficacy|2
2926341|NCT01498822|10079975|P1|Overall Study|Lack of Efficacy|7
2926342|NCT01498822|10079974|P2|Overall Study|Other Reason|2
2926343|NCT01498822|10079975|P1|Overall Study|Other Reason|5
2926344|NCT01498822|10079974|P2|Overall Study|Protocol Violation|4
2926345|NCT01498822|10079975|P1|Overall Study|Protocol Violation|8
2926346|NCT01498692|10080002|P1|Overall Study|Missed 12-month visit|3
2926347|NCT01498692|10080002|P1|Overall Study|Withdrawal by Subject|1
2926348|NCT01498692|10080002|P1|Overall Study|Death|4
2926349|NCT01498679|10080033|P2|Overall Study|Withdrawal by Subject|4
2926350|NCT01498679|10080034|P1|Overall Study|Withdrawal by Subject|12
2926351|NCT01498679|10080033|P2|Overall Study|Physician Decision|2
2926352|NCT01498679|10080034|P1|Overall Study|Physician Decision|0
2926353|NCT01498679|10080033|P2|Overall Study|Protocol Violation|0
2926354|NCT01498679|10080034|P1|Overall Study|Protocol Violation|4
2926355|NCT01498679|10080033|P2|Overall Study|Lack of Efficacy|12
2926356|NCT01498679|10080034|P1|Overall Study|Lack of Efficacy|72
2926357|NCT01498679|10080033|P2|Overall Study|Adverse Event|4
2926358|NCT01498679|10080034|P1|Overall Study|Adverse Event|1
2926359|NCT01498653|10080050|P2|Overall Study|Withdrawal by Subject|3
2926360|NCT01498653|10080051|P1|Overall Study|Withdrawal by Subject|2
2926361|NCT01498653|10080050|P2|Overall Study|Physician Decision|0
2926362|NCT01498653|10080051|P1|Overall Study|Physician Decision|2
2926363|NCT01498653|10080050|P2|Overall Study|Lost to Follow-up|0
2926364|NCT01498653|10080051|P1|Overall Study|Lost to Follow-up|1
2926365|NCT01498653|10080050|P2|Overall Study|Protocol Violation|4
2926366|NCT01498653|10080051|P1|Overall Study|Protocol Violation|0
2926367|NCT01498653|10080050|P2|Overall Study|Lack of Efficacy|26
2926368|NCT01498653|10080051|P1|Overall Study|Lack of Efficacy|12
2926369|NCT01498653|10080050|P2|Overall Study|Adverse Event|2
2926370|NCT01498653|10080051|P1|Overall Study|Adverse Event|2
2926371|NCT01498640|10080065|P1|Overall Study|Other|3
2926372|NCT01498640|10080065|P1|Overall Study|Death|1
2926373|NCT01498640|10080065|P1|Overall Study|Lost to Follow-up|1
2926374|NCT01498575|10080095|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
2926375|NCT01498575|10080096|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
2926376|NCT01498575|10080095|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
2926377|NCT01498575|10080096|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
2926378|NCT01498575|10080095|P2|Overall Sample|Withdrawal by Subject|14
2926379|NCT01498575|10080096|P1|Overall Sample|Withdrawal by Subject|60
2926380|NCT01498458|10080113|P1|Overall Study|Physician Decision|3
2926381|NCT01498458|10080113|P1|Overall Study|Adverse Event|4
2926382|NCT01498289|10080165|P2|Overall Study|Reason under review|1
2926383|NCT01498289|10080166|P1|Overall Study|Reason under review|0
2926384|NCT01498289|10080165|P2|Overall Study|Not protocol specified|2
2926385|NCT01498289|10080166|P1|Overall Study|Not protocol specified|7
2926386|NCT01498289|10080165|P2|Overall Study|Progression/relapse|59
2926387|NCT01498289|10080166|P1|Overall Study|Progression/relapse|53
2926388|NCT01498289|10080165|P2|Overall Study|Withdrawal unrelated to AE|16
2926389|NCT01498289|10080166|P1|Overall Study|Withdrawal unrelated to AE|16
2926390|NCT01498289|10080165|P2|Overall Study|Death|8
2926391|NCT01498289|10080166|P1|Overall Study|Death|6
2926392|NCT01498289|10080165|P2|Overall Study|Adverse Event|18
2926393|NCT01498289|10080166|P1|Overall Study|Adverse Event|16
2926394|NCT01498185|10080187|P5|Overall Study|No longer met criteria, etc|2
2926395|NCT01498185|10080188|P4|Overall Study|No longer met criteria, etc|0
2926396|NCT01498185|10080189|P3|Overall Study|No longer met criteria, etc|0
2926397|NCT01498185|10080190|P2|Overall Study|No longer met criteria, etc|0
2926398|NCT01498185|10080191|P1|Overall Study|No longer met criteria, etc|0
2926399|NCT01498185|10080187|P5|Overall Study|Withdrawal by Subject|1
2926400|NCT01498185|10080188|P4|Overall Study|Withdrawal by Subject|2
2926401|NCT01498185|10080189|P3|Overall Study|Withdrawal by Subject|0
2926402|NCT01498185|10080190|P2|Overall Study|Withdrawal by Subject|1
2926403|NCT01498185|10080191|P1|Overall Study|Withdrawal by Subject|1
2926404|NCT01498185|10080187|P5|Overall Study|Adverse Event|0
2926405|NCT01498185|10080188|P4|Overall Study|Adverse Event|1
2926406|NCT01498185|10080189|P3|Overall Study|Adverse Event|0
2926407|NCT01498185|10080190|P2|Overall Study|Adverse Event|0
2926408|NCT01498185|10080191|P1|Overall Study|Adverse Event|0
2926409|NCT01498120|10080231|P1|Overall Study|Other|4
2926410|NCT01498120|10080231|P1|Overall Study|AE, non-serious non-fatal|3
2926411|NCT01498120|10080231|P1|Overall Study|Withdrawal by Subject|5
2926412|NCT01498120|10080231|P1|Overall Study|Lost to Follow-up|1
2926413|NCT01498068|10080238|P2|Overall Study|Withdrawal by Subject|1
2926414|NCT01498068|10080239|P1|Overall Study|Withdrawal by Subject|1
2926415|NCT01497938|10080257|P2|Overall Study|Device Violation|0
2926416|NCT01497938|10080258|P1|Overall Study|Device Violation|1
2926417|NCT01497938|10080257|P2|Overall Study|Withdrawal by Subject|0
2926418|NCT01497938|10080258|P1|Overall Study|Withdrawal by Subject|4
2926419|NCT01497938|10080257|P2|Overall Study|Physician Decision|1
2926420|NCT01497938|10080258|P1|Overall Study|Physician Decision|0
2926421|NCT01497938|10080257|P2|Overall Study|Adverse Event|1
2926422|NCT01497938|10080258|P1|Overall Study|Adverse Event|0
2926423|NCT01497899|10080270|P4|Open-Label Extension Phase|Lost to Follow-up|5
2926424|NCT01497899|10080271|P3|Open-Label Extension Phase|Lost to Follow-up|5
2926425|NCT01497899|10080272|P2|Open-Label Extension Phase|Lost to Follow-up|3
2926426|NCT01497899|10080273|P1|Open-Label Extension Phase|Lost to Follow-up|9
2926427|NCT01497899|10080270|P4|Open-Label Extension Phase|Protocol Violation|0
2926428|NCT01497899|10080271|P3|Open-Label Extension Phase|Protocol Violation|1
2926429|NCT01497899|10080272|P2|Open-Label Extension Phase|Protocol Violation|0
2926430|NCT01497899|10080273|P1|Open-Label Extension Phase|Protocol Violation|0
2926431|NCT01497899|10080270|P4|Open-Label Extension Phase|Pregnancy|0
2926432|NCT01497899|10080271|P3|Open-Label Extension Phase|Pregnancy|1
2926433|NCT01497899|10080272|P2|Open-Label Extension Phase|Pregnancy|1
2926434|NCT01497899|10080273|P1|Open-Label Extension Phase|Pregnancy|0
2926435|NCT01497899|10080270|P4|Open-Label Extension Phase|Withdrew Consent|0
2926436|NCT01497899|10080271|P3|Open-Label Extension Phase|Withdrew Consent|2
2926437|NCT01497899|10080272|P2|Open-Label Extension Phase|Withdrew Consent|3
2926438|NCT01497899|10080273|P1|Open-Label Extension Phase|Withdrew Consent|8
2926439|NCT01497899|10080270|P4|Open-Label Extension Phase|Death|0
2926440|NCT01497899|10080271|P3|Open-Label Extension Phase|Death|0
2926441|NCT01497899|10080272|P2|Open-Label Extension Phase|Death|0
2926442|NCT01497899|10080273|P1|Open-Label Extension Phase|Death|1
2926443|NCT01497899|10080270|P4|Open-Label Extension Phase|Adverse Event|0
2926444|NCT01497899|10080271|P3|Open-Label Extension Phase|Adverse Event|0
2926445|NCT01497899|10080272|P2|Open-Label Extension Phase|Adverse Event|0
2926446|NCT01497899|10080273|P1|Open-Label Extension Phase|Adverse Event|1
2926447|NCT01497899|10080270|P4|Double-Blind Phase|Subject Non-Compliance|0
2926448|NCT01497899|10080271|P3|Double-Blind Phase|Subject Non-Compliance|0
2926449|NCT01497899|10080272|P2|Double-Blind Phase|Subject Non-Compliance|1
2926450|NCT01497899|10080273|P1|Double-Blind Phase|Subject Non-Compliance|0
2926451|NCT01497899|10080270|P4|Double-Blind Phase|Lost to Follow-up|0
2926452|NCT01497899|10080271|P3|Double-Blind Phase|Lost to Follow-up|0
2926453|NCT01497899|10080272|P2|Double-Blind Phase|Lost to Follow-up|2
2926454|NCT01497899|10080273|P1|Double-Blind Phase|Lost to Follow-up|3
2926455|NCT01497899|10080270|P4|Double-Blind Phase|Withdrew Consent|0
2926456|NCT01497899|10080271|P3|Double-Blind Phase|Withdrew Consent|0
2926457|NCT01497899|10080272|P2|Double-Blind Phase|Withdrew Consent|1
2926458|NCT01497899|10080273|P1|Double-Blind Phase|Withdrew Consent|0
2926459|NCT01497899|10080270|P4|Double-Blind Phase|Investigator's Discretion|0
2926460|NCT01497899|10080271|P3|Double-Blind Phase|Investigator's Discretion|0
2926461|NCT01497899|10080272|P2|Double-Blind Phase|Investigator's Discretion|0
2926462|NCT01497899|10080273|P1|Double-Blind Phase|Investigator's Discretion|1
2926463|NCT01497899|10080270|P4|Double-Blind Phase|Lack of Efficacy|0
2926464|NCT01497899|10080271|P3|Double-Blind Phase|Lack of Efficacy|0
2926465|NCT01497899|10080272|P2|Double-Blind Phase|Lack of Efficacy|1
2926466|NCT01497899|10080273|P1|Double-Blind Phase|Lack of Efficacy|0
2926467|NCT01497899|10080270|P4|Double-Blind Phase|Adverse Event|0
2926468|NCT01497899|10080271|P3|Double-Blind Phase|Adverse Event|0
2926469|NCT01497899|10080272|P2|Double-Blind Phase|Adverse Event|0
2926470|NCT01497899|10080273|P1|Double-Blind Phase|Adverse Event|1
2926471|NCT01497899|10080270|P4|Double-Blind Phase|Randomized but not Treated|0
2926472|NCT01497899|10080271|P3|Double-Blind Phase|Randomized but not Treated|0
2926473|NCT01497899|10080272|P2|Double-Blind Phase|Randomized but not Treated|0
2926474|NCT01497899|10080273|P1|Double-Blind Phase|Randomized but not Treated|1
2926475|NCT01497366|10080344|P2|Overall Study|Randomized but not treated|21
2926476|NCT01497366|10080345|P1|Overall Study|Randomized but not treated|7
2926477|NCT01497366|10080344|P2|Overall Study|Death|1
2926478|NCT01497366|10080345|P1|Overall Study|Death|1
2926479|NCT01497366|10080344|P2|Overall Study|Other|0
2926480|NCT01497366|10080345|P1|Overall Study|Other|5
2926481|NCT01497366|10080344|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
2926482|NCT01497366|10080345|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
2926483|NCT01497366|10080344|P2|Overall Study|Withdrawal by Subject|6
2926484|NCT01497366|10080345|P1|Overall Study|Withdrawal by Subject|6
2926485|NCT01497366|10080344|P2|Overall Study|Lost to Follow-up|10
2926486|NCT01497366|10080345|P1|Overall Study|Lost to Follow-up|11
2926487|NCT01497366|10080344|P2|Overall Study|Virologic failure|50
2926488|NCT01497366|10080345|P1|Overall Study|Virologic failure|2
2926489|NCT01497275|10080363|P1|Overall Study|Adverse Event|1
2926490|NCT01497275|10080363|P1|Overall Study|Death|1
2926491|NCT01497262|10080370|P1|Overall Study|Protocol Violation|1
2926492|NCT01497262|10080370|P1|Overall Study|Adverse Event|2
2926493|NCT01497262|10080370|P1|Overall Study|Withdrawal by Subject|2
2926494|NCT01497262|10080370|P1|Overall Study|Physician Decision|1
2926495|NCT01497262|10080370|P1|Overall Study|Abnormal Test Procedure Result|1
2926496|NCT01497262|10080370|P1|Overall Study|Abnormal Lab Values|4
2926497|NCT01497197|10080377|P2|Overall Study|Other|1
2926498|NCT01497197|10080378|P1|Overall Study|Other|3
2926499|NCT01497197|10080377|P2|Overall Study|All embryos discarded|3
2926500|NCT01497197|10080378|P1|Overall Study|All embryos discarded|0
2926501|NCT01497197|10080377|P2|Overall Study|Intention to freeze all embryos|1
2926502|NCT01497197|10080378|P1|Overall Study|Intention to freeze all embryos|0
2926503|NCT01497197|10080377|P2|Overall Study|No fertilisation|5
2926504|NCT01497197|10080378|P1|Overall Study|No fertilisation|6
2926505|NCT01497197|10080377|P2|Overall Study|No oocytes retrieved|2
2926506|NCT01497197|10080378|P1|Overall Study|No oocytes retrieved|3
2926507|NCT01497197|10080377|P2|Overall Study|Risk of OHSS|0
2926508|NCT01497197|10080378|P1|Overall Study|Risk of OHSS|1
2926509|NCT01497197|10080377|P2|Overall Study|Excessive/lack of response to treatment|0
2926510|NCT01497197|10080378|P1|Overall Study|Excessive/lack of response to treatment|1
2926511|NCT01497197|10080377|P2|Overall Study|Withdrawal by Subject|1
2926512|NCT01497197|10080378|P1|Overall Study|Withdrawal by Subject|2
2926513|NCT01497197|10080377|P2|Overall Study|Protocol Violation|2
2926514|NCT01497197|10080378|P1|Overall Study|Protocol Violation|0
2926515|NCT01497197|10080377|P2|Overall Study|Lost to Follow-up|0
2926516|NCT01497197|10080378|P1|Overall Study|Lost to Follow-up|1
2926517|NCT01497067|10080413|P1|Overall Study|Other|13
2926518|NCT01497067|10080413|P1|Overall Study|Patient decision unrel to Adverse Event|10
2926519|NCT01497067|10080413|P1|Overall Study|Adverse Event|3
2926520|NCT01497067|10080413|P1|Overall Study|Lost to Follow-up|56
2926521|NCT01496846|10080424|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2926522|NCT01496846|10080425|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2926523|NCT01496846|10080426|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2926524|NCT01496846|10080427|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2926525|NCT01496846|10080428|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2926526|NCT01496846|10080429|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2926527|NCT01496807|10080440|P1|Overall Study|Change in diagnosis|1
2926528|NCT01496807|10080440|P1|Overall Study|Participant preference/toxicity|8
2926529|NCT01496807|10080440|P1|Overall Study|Progressive Disease|21
2926530|NCT01496469|10080452|P2|Overall Study|Other|1
2926531|NCT01496469|10080453|P1|Overall Study|Other|1
2926532|NCT01496469|10080452|P2|Overall Study|BP exceeds protocol limits|2
2926533|NCT01496469|10080453|P1|Overall Study|BP exceeds protocol limits|1
2926534|NCT01496469|10080452|P2|Overall Study|Withdrawal by Subject|4
2926535|NCT01496469|10080453|P1|Overall Study|Withdrawal by Subject|4
2926536|NCT01496469|10080452|P2|Overall Study|Lost to Follow-up|1
2926537|NCT01496469|10080453|P1|Overall Study|Lost to Follow-up|1
2926538|NCT01496469|10080452|P2|Overall Study|Protocol Violation|0
2926539|NCT01496469|10080453|P1|Overall Study|Protocol Violation|2
2926540|NCT01496469|10080452|P2|Overall Study|Adverse Event|0
2926541|NCT01496469|10080453|P1|Overall Study|Adverse Event|1
2926542|NCT01496456|10080463|P1|Overall Study|Lost to Follow-up|7
2926543|NCT01496456|10080463|P1|Overall Study|Protocol Violation|1
2926544|NCT01496430|10080476|P3|Overall Study|Other|0
2926545|NCT01496430|10080477|P2|Overall Study|Other|0
2926546|NCT01496430|10080478|P1|Overall Study|Other|2
2926547|NCT01496430|10080476|P3|Overall Study|Principal Investigator Discretion|1
2926548|NCT01496430|10080477|P2|Overall Study|Principal Investigator Discretion|1
2926549|NCT01496430|10080478|P1|Overall Study|Principal Investigator Discretion|0
2926550|NCT01496430|10080476|P3|Overall Study|Voluntary Withdrawal|6
2926551|NCT01496430|10080477|P2|Overall Study|Voluntary Withdrawal|1
2926552|NCT01496430|10080478|P1|Overall Study|Voluntary Withdrawal|2
2926553|NCT01496430|10080476|P3|Overall Study|Lost to Follow-up|1
2926554|NCT01496430|10080477|P2|Overall Study|Lost to Follow-up|3
2926555|NCT01496430|10080478|P1|Overall Study|Lost to Follow-up|2
2926556|NCT01496430|10080476|P3|Overall Study|Major Protocol Deviation|1
2926557|NCT01496430|10080477|P2|Overall Study|Major Protocol Deviation|0
2926558|NCT01496430|10080478|P1|Overall Study|Major Protocol Deviation|0
2926559|NCT01496430|10080476|P3|Overall Study|Adverse Event|1
2926560|NCT01496430|10080477|P2|Overall Study|Adverse Event|0
2926561|NCT01496430|10080478|P1|Overall Study|Adverse Event|0
2926562|NCT01496287|10080590|P1|Overall Study|Incomplete anesthesia|5
2926563|NCT01496287|10080590|P1|Overall Study|Lost to Follow-up|1
2926564|NCT01496274|10080600|P2|Overall Study|Lost to Follow-up|3
2926565|NCT01496274|10080601|P1|Overall Study|Lost to Follow-up|0
2926566|NCT01496274|10080600|P2|Overall Study|Withdrawal by Subject|0
2926567|NCT01496274|10080601|P1|Overall Study|Withdrawal by Subject|2
2926568|NCT01496274|10080600|P2|Overall Study|Adverse Event|1
2926569|NCT01496274|10080601|P1|Overall Study|Adverse Event|1
2926570|NCT01496274|10080600|P2|Overall Study|Protocol Violation|1
2926571|NCT01496274|10080601|P1|Overall Study|Protocol Violation|0
2926572|NCT01496183|10080646|P2|Overall Study|Withdrawal by Subject|1
2926573|NCT01496183|10080647|P1|Overall Study|Withdrawal by Subject|0
2926574|NCT01496183|10080646|P2|Overall Study|Physician Decision|1
2926575|NCT01496183|10080647|P1|Overall Study|Physician Decision|3
2926576|NCT01496066|10080699|P2|Overall Study|Death|4
2926577|NCT01496066|10080700|P1|Overall Study|Death|1
2926578|NCT01496066|10080699|P2|Overall Study|Explant|0
2926579|NCT01496066|10080700|P1|Overall Study|Explant|3
2926580|NCT01496066|10080699|P2|Overall Study|Lost to Follow-up|5
2926581|NCT01496066|10080700|P1|Overall Study|Lost to Follow-up|8
2926582|NCT01495975|10080762|P2|Overall Study|Lost to Follow-up|0
2926583|NCT01495975|10080763|P1|Overall Study|Lost to Follow-up|1
2926584|NCT01495793|10080887|P1|Overall Study|Violation of inclusion criteria|1
2926585|NCT01495793|10080887|P1|Overall Study|Lost to Follow-up|1
2926586|NCT01495702|10080900|P2|Randomized Phase|Protocol Violation|1
2926587|NCT01495702|10080901|P1|Randomized Phase|Protocol Violation|3
2926588|NCT01495702|10080900|P2|Randomized Phase|Participant Noncompliance|0
2926589|NCT01495702|10080901|P1|Randomized Phase|Participant Noncompliance|1
2926590|NCT01495702|10080900|P2|Randomized Phase|Lost to Follow-up|3
2926591|NCT01495702|10080901|P1|Randomized Phase|Lost to Follow-up|4
2926592|NCT01495702|10080900|P2|Randomized Phase|Withdrew Consent|18
2926593|NCT01495702|10080901|P1|Randomized Phase|Withdrew Consent|10
2926594|NCT01495702|10080900|P2|Randomized Phase|Investigators Discretion|0
2926595|NCT01495702|10080901|P1|Randomized Phase|Investigators Discretion|2
2926596|NCT01495702|10080900|P2|Randomized Phase|Lack of Efficacy|0
2926597|NCT01495702|10080901|P1|Randomized Phase|Lack of Efficacy|2
2926598|NCT01495702|10080900|P2|Randomized Phase|Death|0
2926599|NCT01495702|10080901|P1|Randomized Phase|Death|1
2926600|NCT01495702|10080900|P2|Randomized Phase|Adverse Event|2
2926601|NCT01495702|10080901|P1|Randomized Phase|Adverse Event|2
2926602|NCT01495702|10080900|P2|Randomized Phase|Randomized But Not Treated|4
2926603|NCT01495702|10080901|P1|Randomized Phase|Randomized But Not Treated|1
2926604|NCT01495000|10080979|P2|Overall Study|Withdrawal by Subject|10
2926605|NCT01495000|10080980|P1|Overall Study|Withdrawal by Subject|10
2926606|NCT01495000|10080979|P2|Overall Study|Protocol Violation|0
2926607|NCT01495000|10080980|P1|Overall Study|Protocol Violation|1
2926608|NCT01495000|10080979|P2|Overall Study|Lost to Follow-up|2
2926609|NCT01495000|10080980|P1|Overall Study|Lost to Follow-up|2
2926610|NCT01494987|10081022|P2|Overall Study|Subject Withdrew Consent|3
2926611|NCT01494987|10081023|P1|Overall Study|Subject Withdrew Consent|2
2926612|NCT01494987|10081022|P2|Overall Study|Subject Non-Compliance|10
2926613|NCT01494987|10081023|P1|Overall Study|Subject Non-Compliance|9
2926614|NCT01494987|10081022|P2|Overall Study|Protocol Violation|3
2926615|NCT01494987|10081023|P1|Overall Study|Protocol Violation|3
2926616|NCT01494987|10081022|P2|Overall Study|Lost to Follow-up|1
2926617|NCT01494987|10081023|P1|Overall Study|Lost to Follow-up|1
2926618|NCT01494987|10081022|P2|Overall Study|Investigator's Discretion|2
2926619|NCT01494987|10081023|P1|Overall Study|Investigator's Discretion|1
2926620|NCT01494987|10081022|P2|Overall Study|Hyperglycemia|4
2926621|NCT01494987|10081023|P1|Overall Study|Hyperglycemia|6
2926622|NCT01494987|10081022|P2|Overall Study|Adverse Event|5
2926623|NCT01494987|10081023|P1|Overall Study|Adverse Event|6
2926624|NCT01494818|10081037|P2|Overall Study|Lost to Follow-up|0
2926625|NCT01494818|10081038|P1|Overall Study|Lost to Follow-up|1
2926626|NCT01494818|10081037|P2|Overall Study|Relocation|2
2926627|NCT01494818|10081038|P1|Overall Study|Relocation|1
2926628|NCT01494649|10081069|P2|Overall Study|Lost to Follow-up|1
2926629|NCT01494649|10081070|P1|Overall Study|Lost to Follow-up|0
2926630|NCT01494610|10081086|P2|Period 4|Protocol Violation|0
2926631|NCT01494610|10081087|P1|Period 4|Protocol Violation|1
2926632|NCT01494610|10081086|P2|Period 3|Withdrawal by Subject|0
2926633|NCT01494610|10081087|P1|Period 3|Withdrawal by Subject|1
2926634|NCT01494610|10081086|P2|Period 3|Adverse Event|0
2926635|NCT01494610|10081087|P1|Period 3|Adverse Event|1
2926636|NCT01494610|10081086|P2|Period 1|Withdrawal by Subject|1
2926637|NCT01494610|10081087|P1|Period 1|Withdrawal by Subject|1
2926638|NCT01494584|10081155|P1|Overall Study|Study Closed/Terminated|1
2926639|NCT01494532|10081287|P6|Overall Study|Withdrawal by Subject|0
2926640|NCT01494532|10081288|P5|Overall Study|Withdrawal by Subject|2
2926641|NCT01494532|10081289|P4|Overall Study|Withdrawal by Subject|3
2926642|NCT01494532|10081290|P3|Overall Study|Withdrawal by Subject|4
2926643|NCT01494532|10081291|P2|Overall Study|Withdrawal by Subject|1
2926644|NCT01494532|10081292|P1|Overall Study|Withdrawal by Subject|3
2926645|NCT01494532|10081287|P6|Overall Study|Physician Decision|0
2926646|NCT01494532|10081288|P5|Overall Study|Physician Decision|0
2926647|NCT01494532|10081289|P4|Overall Study|Physician Decision|2
2926648|NCT01494532|10081290|P3|Overall Study|Physician Decision|1
2926649|NCT01494532|10081291|P2|Overall Study|Physician Decision|1
2926650|NCT01494532|10081292|P1|Overall Study|Physician Decision|0
2926651|NCT01494532|10081287|P6|Overall Study|Lost to Follow-up|0
2926652|NCT01494532|10081288|P5|Overall Study|Lost to Follow-up|0
2926653|NCT01494532|10081289|P4|Overall Study|Lost to Follow-up|2
2926654|NCT01494532|10081290|P3|Overall Study|Lost to Follow-up|0
2926655|NCT01494532|10081291|P2|Overall Study|Lost to Follow-up|0
2926656|NCT01494532|10081292|P1|Overall Study|Lost to Follow-up|1
2926657|NCT01494532|10081287|P6|Overall Study|Protocol-defined stopping criteria|0
2926658|NCT01494532|10081288|P5|Overall Study|Protocol-defined stopping criteria|0
2926659|NCT01494532|10081289|P4|Overall Study|Protocol-defined stopping criteria|0
2926660|NCT01494532|10081290|P3|Overall Study|Protocol-defined stopping criteria|1
2926661|NCT01494532|10081291|P2|Overall Study|Protocol-defined stopping criteria|0
2926662|NCT01494532|10081292|P1|Overall Study|Protocol-defined stopping criteria|0
2926663|NCT01494532|10081287|P6|Overall Study|Protocol deviation|0
2926664|NCT01494532|10081288|P5|Overall Study|Protocol deviation|3
2926665|NCT01494532|10081289|P4|Overall Study|Protocol deviation|2
2926666|NCT01494532|10081290|P3|Overall Study|Protocol deviation|3
2926667|NCT01494532|10081291|P2|Overall Study|Protocol deviation|1
2926668|NCT01494532|10081292|P1|Overall Study|Protocol deviation|2
2926669|NCT01494532|10081287|P6|Overall Study|Lack of Efficacy|0
2926670|NCT01494532|10081288|P5|Overall Study|Lack of Efficacy|2
2926671|NCT01494532|10081289|P4|Overall Study|Lack of Efficacy|0
2926672|NCT01494532|10081290|P3|Overall Study|Lack of Efficacy|0
2926673|NCT01494532|10081291|P2|Overall Study|Lack of Efficacy|0
2926674|NCT01494532|10081292|P1|Overall Study|Lack of Efficacy|0
2926675|NCT01494532|10081287|P6|Overall Study|Adverse Event|0
2926676|NCT01494532|10081288|P5|Overall Study|Adverse Event|5
2926677|NCT01494532|10081289|P4|Overall Study|Adverse Event|6
2926678|NCT01494532|10081290|P3|Overall Study|Adverse Event|8
2926679|NCT01494532|10081291|P2|Overall Study|Adverse Event|1
2926680|NCT01494532|10081292|P1|Overall Study|Adverse Event|4
2926681|NCT01494506|10081447|P3|Overall Study|Other|1
2926682|NCT01494506|10081448|P2|Overall Study|Other|3
2926683|NCT01494506|10081449|P1|Overall Study|Other|0
2926684|NCT01494506|10081447|P3|Overall Study|Sponsor Decision|1
2926685|NCT01494506|10081448|P2|Overall Study|Sponsor Decision|0
2926686|NCT01494506|10081449|P1|Overall Study|Sponsor Decision|0
2926687|NCT01494506|10081447|P3|Overall Study|Clinical Deterioration|13
2926688|NCT01494506|10081448|P2|Overall Study|Clinical Deterioration|17
2926689|NCT01494506|10081449|P1|Overall Study|Clinical Deterioration|21
2926690|NCT01494506|10081447|P3|Overall Study|Withdrawal by Subject|14
2926691|NCT01494506|10081448|P2|Overall Study|Withdrawal by Subject|20
2926692|NCT01494506|10081449|P1|Overall Study|Withdrawal by Subject|17
2926693|NCT01494506|10081447|P3|Overall Study|Physician Decision|4
2926694|NCT01494506|10081448|P2|Overall Study|Physician Decision|5
2926695|NCT01494506|10081449|P1|Overall Study|Physician Decision|7
2926696|NCT01494506|10081447|P3|Overall Study|Death|2
2926697|NCT01494506|10081448|P2|Overall Study|Death|5
2926698|NCT01494506|10081449|P1|Overall Study|Death|9
2926699|NCT01494506|10081447|P3|Overall Study|Adverse Event|11
2926700|NCT01494506|10081448|P2|Overall Study|Adverse Event|10
2926701|NCT01494506|10081449|P1|Overall Study|Adverse Event|17
2926702|NCT01494506|10081447|P3|Overall Study|Lack of Efficacy|57
2926703|NCT01494506|10081448|P2|Overall Study|Lack of Efficacy|83
2926704|NCT01494506|10081449|P1|Overall Study|Lack of Efficacy|77
2926705|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
2926706|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
2926707|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2926708|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
2926709|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
2926710|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
2926711|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
2926712|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
2926713|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2926714|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
2926715|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2926716|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
2926717|NCT01494467|10081486|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
2926718|NCT01494467|10081487|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
2926719|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2926720|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2926721|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Other|1
2926722|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Other|1
2926723|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2926724|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2926725|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
2926726|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
2926727|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
2926728|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
2926729|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2926730|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
2926731|NCT01494467|10081486|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2926732|NCT01494467|10081487|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
2926733|NCT01494350|10081503|P1|Overall Study|Worsening of lesion|1
2926734|NCT01494298|10081513|P2|Overall Study|Protocol Violation|8
2926735|NCT01494298|10081514|P1|Overall Study|Protocol Violation|2
2926736|NCT01494038|10081537|P2|Overall Study|Death|4
2926737|NCT01494038|10081538|P1|Overall Study|Death|2
2926738|NCT01494038|10081537|P2|Overall Study|Not willing to adhere to reqs|9
2926739|NCT01494038|10081538|P1|Overall Study|Not willing to adhere to reqs|2
2926740|NCT01494038|10081537|P2|Overall Study|Not able to get to clinic|15
2926741|NCT01494038|10081538|P1|Overall Study|Not able to get to clinic|21
2926742|NCT01494038|10081537|P2|Overall Study|Withdrawal by Subject|34
2926743|NCT01494038|10081538|P1|Overall Study|Withdrawal by Subject|44
2926744|NCT01494038|10081537|P2|Overall Study|Lost to Follow-up|20
2926745|NCT01494038|10081538|P1|Overall Study|Lost to Follow-up|18
2926746|NCT01494038|10081537|P2|Overall Study|Protocol Violation|1
2926747|NCT01494038|10081538|P1|Overall Study|Protocol Violation|1
2926748|NCT01493960|10081626|P2|Overall Study|Non-specified|4
2926749|NCT01493960|10081627|P1|Overall Study|Non-specified|4
2926750|NCT01493960|10081626|P2|Overall Study|Withdrawal by Subject|4
2926751|NCT01493960|10081627|P1|Overall Study|Withdrawal by Subject|10
2926752|NCT01493960|10081626|P2|Overall Study|Protocol Violation|0
2926753|NCT01493960|10081627|P1|Overall Study|Protocol Violation|3
2926754|NCT01493960|10081626|P2|Overall Study|Lack of Efficacy|9
2926755|NCT01493960|10081627|P1|Overall Study|Lack of Efficacy|15
2926756|NCT01493960|10081626|P2|Overall Study|Adverse Event|1
2926757|NCT01493960|10081627|P1|Overall Study|Adverse Event|0
2926758|NCT01493778|10081658|P1|Overall Study|Withdrawal by Subject|8
2926759|NCT01493687|10081720|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
2926760|NCT01493687|10081721|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
2926761|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
2926762|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
2926763|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2926764|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
2926765|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
2926766|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
2926767|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
2926768|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
2926769|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
2926770|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2926771|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2926772|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
2926773|NCT01493687|10081720|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
2926774|NCT01493687|10081721|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
2926775|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2926776|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2926777|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2926778|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
2926779|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
2926780|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
2926781|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
2926782|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
2926783|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2926784|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
2926785|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2926786|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2926787|NCT01493687|10081720|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2926788|NCT01493687|10081721|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
2926789|NCT01493557|10081740|P3|Adding the Second Strategy|Withdrawal by Subject|0
2926790|NCT01493557|10081741|P2|Adding the Second Strategy|Withdrawal by Subject|1
2926791|NCT01493557|10081742|P1|Adding the Second Strategy|Withdrawal by Subject|0
2926792|NCT01493557|10081740|P3|Adding the Second Strategy|Other adverse event|0
2926793|NCT01493557|10081741|P2|Adding the Second Strategy|Other adverse event|2
2926794|NCT01493557|10081742|P1|Adding the Second Strategy|Other adverse event|1
2926795|NCT01493557|10081740|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
2926796|NCT01493557|10081741|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
2926797|NCT01493557|10081742|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
2926798|NCT01493557|10081740|P3|Randomized to Management Strategies|Other than stated above|0
2926799|NCT01493557|10081741|P2|Randomized to Management Strategies|Other than stated above|3
2926800|NCT01493557|10081742|P1|Randomized to Management Strategies|Other than stated above|1
2926801|NCT01493557|10081740|P3|Randomized to Management Strategies|Withdrawal by Subject|0
2926802|NCT01493557|10081741|P2|Randomized to Management Strategies|Withdrawal by Subject|1
2926803|NCT01493557|10081742|P1|Randomized to Management Strategies|Withdrawal by Subject|0
2926804|NCT01493557|10081740|P3|Randomized to Management Strategies|Protocol Violation|0
2926805|NCT01493557|10081741|P2|Randomized to Management Strategies|Protocol Violation|0
2926806|NCT01493557|10081742|P1|Randomized to Management Strategies|Protocol Violation|3
2926807|NCT01493557|10081740|P3|Randomized to Management Strategies|Other adverse event|0
2926808|NCT01493557|10081741|P2|Randomized to Management Strategies|Other adverse event|5
2926809|NCT01493557|10081742|P1|Randomized to Management Strategies|Other adverse event|8
2926810|NCT01493557|10081740|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
2926811|NCT01493557|10081741|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
2926812|NCT01493557|10081742|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
2926813|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Other than stated above|21
2926814|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Other than stated above|0
2926815|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Other than stated above|0
2926816|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Early termination|34
2926817|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Early termination|0
2926818|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Early termination|0
2926819|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
2926820|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
2926821|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
2926822|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
2926823|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
2926824|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
2926825|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Protocol Violation|1
2926826|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Protocol Violation|0
2926827|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Protocol Violation|0
2926828|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Other adverse event|54
2926829|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Other adverse event|0
2926830|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Other adverse event|0
2926831|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
2926832|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
2926833|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
2926834|NCT01493557|10081740|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
2926835|NCT01493557|10081741|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2926836|NCT01493557|10081742|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2926837|NCT01493531|10081770|P3|Overall Study|Death|0
2926838|NCT01493531|10081771|P2|Overall Study|Death|1
2926839|NCT01493531|10081772|P1|Overall Study|Death|0
2926840|NCT01493531|10081770|P3|Overall Study|Withdrawal by Subject|11
2926841|NCT01493531|10081771|P2|Overall Study|Withdrawal by Subject|13
2926842|NCT01493531|10081772|P1|Overall Study|Withdrawal by Subject|16
2926843|NCT01493531|10081770|P3|Overall Study|Lost to Follow-up|11
2926844|NCT01493531|10081771|P2|Overall Study|Lost to Follow-up|7
2926845|NCT01493531|10081772|P1|Overall Study|Lost to Follow-up|5
2926846|NCT01493531|10081770|P3|Overall Study|Sponsor terminated study|3
2926847|NCT01493531|10081771|P2|Overall Study|Sponsor terminated study|2
2926848|NCT01493531|10081772|P1|Overall Study|Sponsor terminated study|5
2926849|NCT01493531|10081770|P3|Overall Study|Protocol Violation|12
2926850|NCT01493531|10081771|P2|Overall Study|Protocol Violation|15
2926851|NCT01493531|10081772|P1|Overall Study|Protocol Violation|8
2926852|NCT01493531|10081770|P3|Overall Study|Gout flare|2
2926853|NCT01493531|10081771|P2|Overall Study|Gout flare|0
2926854|NCT01493531|10081772|P1|Overall Study|Gout flare|3
2926855|NCT01493531|10081770|P3|Overall Study|Adverse Event|9
2926856|NCT01493531|10081771|P2|Overall Study|Adverse Event|12
2926857|NCT01493531|10081772|P1|Overall Study|Adverse Event|4
2926858|NCT01493427|10081786|P1|Overall Study|Other|2
2926859|NCT01493427|10081786|P1|Overall Study|Inability to Follow Instructions|2
2926860|NCT01493427|10081786|P1|Overall Study|Lost to Follow-up|2
2926861|NCT01493427|10081786|P1|Overall Study|Personal Reasons|4
2926862|NCT01493427|10081786|P1|Overall Study|Adverse Event|10
2926863|NCT01493414|10081791|P1|Overall Study|Lost to Follow-up|16
2926864|NCT01493414|10081791|P1|Overall Study|Administrative problems|25
2926865|NCT01493414|10081791|P1|Overall Study|Protocol deviation|27
2926866|NCT01493414|10081791|P1|Overall Study|Withdrawal by Subject|79
2926867|NCT01493414|10081791|P1|Overall Study|Physician Decision|93
2926868|NCT01493414|10081791|P1|Overall Study|Death|101
2926869|NCT01493414|10081791|P1|Overall Study|Disease progression|204
2926870|NCT01493414|10081791|P1|Overall Study|Adverse Event|405
2926871|NCT01493284|10081804|P1|Overall Study|Withdrawal by Subject|32
2926872|NCT01493284|10081804|P1|Overall Study|Death|29
2926873|NCT01493089|10081826|P2|Overall Study|Physician Decision|1
2926874|NCT01493089|10081827|P1|Overall Study|Physician Decision|0
2926875|NCT01493089|10081826|P2|Overall Study|Withdrawal by Subject|0
2926876|NCT01493089|10081827|P1|Overall Study|Withdrawal by Subject|1
2926877|NCT01493089|10081826|P2|Overall Study|Protocol Violation|2
2926878|NCT01493089|10081827|P1|Overall Study|Protocol Violation|2
2926879|NCT01492686|10081926|P2|Open-label Phase|Due to a discontinuation criterion|9
2926880|NCT01492686|10081927|P1|Open-label Phase|Due to a discontinuation criterion|4
2926881|NCT01492686|10081926|P2|Open-label Phase|Withdrawal by Subject|7
2926882|NCT01492686|10081927|P1|Open-label Phase|Withdrawal by Subject|6
2926883|NCT01492686|10081926|P2|Open-label Phase|Physician Decision|0
2926884|NCT01492686|10081927|P1|Open-label Phase|Physician Decision|1
2926885|NCT01492686|10081926|P2|Open-label Phase|Adverse Event|2
2926886|NCT01492686|10081927|P1|Open-label Phase|Adverse Event|1
2926887|NCT01492686|10081926|P2|Double-blind Phase|Due to a discontinuation criterion|3
2926888|NCT01492686|10081927|P1|Double-blind Phase|Due to a discontinuation criterion|2
2926889|NCT01492686|10081926|P2|Double-blind Phase|Withdrawal by Subject|2
2926890|NCT01492686|10081927|P1|Double-blind Phase|Withdrawal by Subject|0
2926891|NCT01492686|10081926|P2|Double-blind Phase|Physician Decision|1
2926892|NCT01492686|10081927|P1|Double-blind Phase|Physician Decision|0
2926893|NCT01492686|10081926|P2|Double-blind Phase|Adverse Event|2
2926894|NCT01492686|10081927|P1|Double-blind Phase|Adverse Event|0
2926895|NCT01492439|10081984|P2|Overall Study|Withdrew from RTE|9
2926896|NCT01492439|10081985|P1|Overall Study|Withdrew from RTE|4
2926897|NCT01492426|10082033|P2|Follow-Up|Lost to Follow-up|6
2926898|NCT01492426|10082034|P1|Follow-Up|Lost to Follow-up|12
2926899|NCT01492426|10082033|P2|Follow-Up|Participant Withdrew Consent|1
2926900|NCT01492426|10082034|P1|Follow-Up|Participant Withdrew Consent|6
2926901|NCT01492426|10082033|P2|Follow-Up|Other|2
2926902|NCT01492426|10082034|P1|Follow-Up|Other|4
2926903|NCT01492426|10082033|P2|Follow-Up|Death|0
2926904|NCT01492426|10082034|P1|Follow-Up|Death|1
2926905|NCT01492426|10082033|P2|Follow-Up|Protocol Requires no Follow-Up|1
2926906|NCT01492426|10082034|P1|Follow-Up|Protocol Requires no Follow-Up|2
2926907|NCT01492426|10082033|P2|Treatment|Participant does not meet study criteria|0
2926908|NCT01492426|10082034|P1|Treatment|Participant does not meet study criteria|1
2926909|NCT01492426|10082033|P2|Treatment|Lost to Follow-up|4
2926910|NCT01492426|10082034|P1|Treatment|Lost to Follow-up|9
2926911|NCT01492426|10082033|P2|Treatment|Subject requested discontinue study drug|3
2926912|NCT01492426|10082034|P1|Treatment|Subject requested discontinue study drug|7
2926913|NCT01492426|10082033|P2|Treatment|Poor compliance/noncompliance|0
2926914|NCT01492426|10082034|P1|Treatment|Poor compliance/noncompliance|1
2926915|NCT01492426|10082033|P2|Treatment|Participant withdrew consent|2
2926916|NCT01492426|10082034|P1|Treatment|Participant withdrew consent|1
2926917|NCT01492426|10082033|P2|Treatment|Lack of Efficacy|5
2926918|NCT01492426|10082034|P1|Treatment|Lack of Efficacy|38
2926919|NCT01492426|10082033|P2|Treatment|Adverse Event|25
2926920|NCT01492426|10082034|P1|Treatment|Adverse Event|25
2926921|NCT01492426|10082033|P2|Treatment|Other|0
2926922|NCT01492426|10082034|P1|Treatment|Other|1
2926923|NCT01492426|10082033|P2|Treatment|Death|1
2926924|NCT01492426|10082034|P1|Treatment|Death|0
2926925|NCT01492400|10082052|P2|Overall Study|Adverse Event|5
2926926|NCT01492400|10082053|P1|Overall Study|Adverse Event|10
2926927|NCT01492400|10082052|P2|Overall Study|Lack of Efficacy|1
2926928|NCT01492400|10082053|P1|Overall Study|Lack of Efficacy|1
2926929|NCT01492400|10082052|P2|Overall Study|Pregnancy|1
2926930|NCT01492400|10082053|P1|Overall Study|Pregnancy|0
2926931|NCT01492400|10082052|P2|Overall Study|Lost to Follow-up|1
2926932|NCT01492400|10082053|P1|Overall Study|Lost to Follow-up|3
2926933|NCT01492400|10082052|P2|Overall Study|Personal Reasons|5
2926934|NCT01492400|10082053|P1|Overall Study|Personal Reasons|0
2926935|NCT01492400|10082052|P2|Overall Study|Miscellaneous Reasons|3
2926936|NCT01492400|10082053|P1|Overall Study|Miscellaneous Reasons|2
2926937|NCT01492088|10082077|P3|Overall Study|Alive at Last Follow-up|11
2926938|NCT01492088|10082078|P2|Overall Study|Alive at Last Follow-up|6
2926939|NCT01492088|10082079|P1|Overall Study|Alive at Last Follow-up|0
2926940|NCT01492088|10082077|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
2926941|NCT01492088|10082078|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
2926942|NCT01492088|10082079|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
2926943|NCT01492088|10082077|P3|Overall Study|Death|2
2926944|NCT01492088|10082078|P2|Overall Study|Death|6
2926945|NCT01492088|10082079|P1|Overall Study|Death|1
2926946|NCT01492088|10082077|P3|Overall Study|Withdrawal by Patient|0
2926947|NCT01492088|10082078|P2|Overall Study|Withdrawal by Patient|2
2926948|NCT01492088|10082079|P1|Overall Study|Withdrawal by Patient|0
2926949|NCT01491919|10082160|P3|Overall Study|Insufficient PK sampling|1
2926950|NCT01491919|10082161|P2|Overall Study|Insufficient PK sampling|2
2926951|NCT01491919|10082162|P1|Overall Study|Insufficient PK sampling|1
2926952|NCT01491854|10082233|P1|Overall Study|Lost to Follow-up|33
2926953|NCT01491854|10082233|P1|Overall Study|Withdrawal by Subject|3
2926954|NCT01491854|10082233|P1|Overall Study|Death|1
2926955|NCT01491854|10082233|P1|Overall Study|mainly due to premature termination|93
2926956|NCT01491841|10082244|P1|Overall Study|Withdrawal by Subject|1
2926957|NCT01491841|10082244|P1|Overall Study|Screen Failure|10
2926958|NCT01491802|10082258|P2|Overall Study|Withdrawal by Subject|1
2926959|NCT01491802|10082259|P1|Overall Study|Withdrawal by Subject|0
2926960|NCT01491802|10082258|P2|Overall Study|Adverse Event|1
2926961|NCT01491802|10082259|P1|Overall Study|Adverse Event|1
2926962|NCT01491737|10082286|P2|Overall Study|Reason not specified|3
2926963|NCT01491737|10082287|P1|Overall Study|Reason not specified|2
2926964|NCT01491737|10082286|P2|Overall Study|Death|28
2926965|NCT01491737|10082287|P1|Overall Study|Death|33
2926966|NCT01491737|10082286|P2|Overall Study|Lost to Follow-up|6
2926967|NCT01491737|10082287|P1|Overall Study|Lost to Follow-up|1
2926968|NCT01491737|10082286|P2|Overall Study|Withdrawal of consent|13
2926969|NCT01491737|10082287|P1|Overall Study|Withdrawal of consent|13
2926970|NCT01491672|10082310|P3|Overall Study|Death|0
2926971|NCT01491672|10082311|P2|Overall Study|Death|4
2926972|NCT01491672|10082312|P1|Overall Study|Death|0
2926973|NCT01491672|10082310|P3|Overall Study|Protocol deviation|0
2926974|NCT01491672|10082311|P2|Overall Study|Protocol deviation|1
2926975|NCT01491672|10082312|P1|Overall Study|Protocol deviation|0
2926976|NCT01491672|10082310|P3|Overall Study|Disease progression|6
2926977|NCT01491672|10082311|P2|Overall Study|Disease progression|34
2926978|NCT01491672|10082312|P1|Overall Study|Disease progression|42
2926979|NCT01491672|10082310|P3|Overall Study|Adverse Event|4
2926980|NCT01491672|10082311|P2|Overall Study|Adverse Event|10
2926981|NCT01491672|10082312|P1|Overall Study|Adverse Event|8
2926982|NCT01491672|10082310|P3|Overall Study|Withdrawal by Subject|0
2926983|NCT01491672|10082311|P2|Overall Study|Withdrawal by Subject|7
2926984|NCT01491672|10082312|P1|Overall Study|Withdrawal by Subject|6
2926985|NCT01491672|10082310|P3|Overall Study|Lost to Follow-up|1
2926986|NCT01491672|10082311|P2|Overall Study|Lost to Follow-up|4
2926987|NCT01491672|10082312|P1|Overall Study|Lost to Follow-up|0
2926988|NCT01491607|10082349|P1|Overall Study|Withdrawal by Subject|3
2926989|NCT01491607|10082349|P1|Overall Study|Lost to Follow-up|7
2926990|NCT01491178|10082454|P1|Overall Study|Other than specified above|657
2926991|NCT01491178|10082454|P1|Overall Study|To take a contraindication|20
2926992|NCT01491178|10082454|P1|Overall Study|Lost to follow−up (changing hospital)|545
2926993|NCT01491178|10082454|P1|Overall Study|Lost to follow−up (unknown reason)|287
2926994|NCT01491178|10082454|P1|Overall Study|To conduct invasive treatment|59
2926995|NCT01491178|10082454|P1|Overall Study|Improvement of NVAF|210
2926996|NCT01491178|10082454|P1|Overall Study|Adverse Event|1016
2926997|NCT01491035|10082563|P8|Overall Study|Lost to Follow-up|0
2926998|NCT01491035|10082564|P7|Overall Study|Lost to Follow-up|0
2926999|NCT01491035|10082565|P6|Overall Study|Lost to Follow-up|0
2927000|NCT01491035|10082566|P5|Overall Study|Lost to Follow-up|1
2927001|NCT01491035|10082567|P4|Overall Study|Lost to Follow-up|0
2927002|NCT01491035|10082568|P3|Overall Study|Lost to Follow-up|0
2927003|NCT01491035|10082569|P2|Overall Study|Lost to Follow-up|0
2927004|NCT01491035|10082570|P1|Overall Study|Lost to Follow-up|0
2927005|NCT01490866|10082676|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
2927006|NCT01490866|10082676|P1|Axitinib Maintenance Therapy|Protocol Violation|2
2927007|NCT01490866|10082676|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
2927008|NCT01490866|10082676|P1|Axitinib Maintenance Therapy|Adverse Event|12
2927009|NCT01490866|10082676|P1|Axitinib Maintenance Therapy|Disease Progression|30
2927010|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
2927011|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
2927012|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
2927013|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
2927014|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
2927015|NCT01490866|10082676|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
2927016|NCT01490840|10082687|P2|Phase 2|Adverse Event|1
2927017|NCT01490840|10082688|P1|Phase 2|Adverse Event|1
2927018|NCT01490840|10082687|P2|Phase 2|Lost to Follow-up|1
2927019|NCT01490840|10082688|P1|Phase 2|Lost to Follow-up|1
2927020|NCT01490840|10082687|P2|Phase 2|Permanent interruption of fingolimod|1
2927021|NCT01490840|10082688|P1|Phase 2|Permanent interruption of fingolimod|0
2927022|NCT01490840|10082687|P2|Phase 2|Withdrawal by Subject|3
2927023|NCT01490840|10082688|P1|Phase 2|Withdrawal by Subject|4
2927024|NCT01490840|10082687|P2|Phase 1|Visit 6a omitted|0
2927025|NCT01490840|10082688|P1|Phase 1|Visit 6a omitted|1
2927026|NCT01490840|10082687|P2|Phase 1|Withdrawal by Subject|5
2927027|NCT01490840|10082688|P1|Phase 1|Withdrawal by Subject|6
2927028|NCT01490840|10082687|P2|Phase 1|Adverse Event|1
2927029|NCT01490840|10082688|P1|Phase 1|Adverse Event|2
2927030|NCT01490840|10082687|P2|Phase 1|Lost to Follow-up|0
2927031|NCT01490840|10082688|P1|Phase 1|Lost to Follow-up|1
2927032|NCT01490814|10082712|P2|Overall Study|Withdrawal by Subject|5
2927033|NCT01490814|10082713|P1|Overall Study|Withdrawal by Subject|0
2927034|NCT01490814|10082712|P2|Overall Study|Physician Decision|0
2927035|NCT01490814|10082713|P1|Overall Study|Physician Decision|1
2927036|NCT01490814|10082712|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
2927037|NCT01490814|10082713|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
2927038|NCT01490697|10082756|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
2927039|NCT01490697|10082757|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
2927040|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
2927041|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
2927042|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
2927043|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927044|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927045|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927046|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927047|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927048|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927049|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927050|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927051|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927052|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927053|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927054|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927055|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927056|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927057|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927058|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927059|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
2927060|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Protocol Violation|0
2927061|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Protocol Violation|1
2927062|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Protocol Violation|0
2927063|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Protocol Violation|0
2927064|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Protocol Violation|0
2927065|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Protocol Violation|0
2927066|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Protocol Violation|0
2927067|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Protocol Violation|0
2927068|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Protocol Violation|0
2927069|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Protocol Violation|0
2927070|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Protocol Violation|0
2927071|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Protocol Violation|0
2927072|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Protocol Violation|0
2927073|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Protocol Violation|0
2927074|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Protocol Violation|0
2927075|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Protocol Violation|0
2927076|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Protocol Violation|0
2927077|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Protocol Violation|0
2927078|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Protocol Violation|0
2927079|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Protocol Violation|0
2927080|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Physician Decision|1
2927081|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Physician Decision|1
2927082|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Physician Decision|0
2927083|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Physician Decision|0
2927084|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Physician Decision|0
2927085|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Physician Decision|0
2927086|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Physician Decision|0
2927087|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Physician Decision|0
2927088|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Physician Decision|0
2927089|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Physician Decision|0
2927090|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Physician Decision|0
2927091|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Physician Decision|0
2927092|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Physician Decision|0
2927093|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Physician Decision|0
2927094|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Physician Decision|0
2927095|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Physician Decision|0
2927096|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Physician Decision|0
2927097|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Physician Decision|0
2927098|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Physician Decision|0
2927099|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Physician Decision|0
2927100|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
2927101|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
2927102|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
2927103|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
2927104|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
2927105|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
2927106|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
2927107|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
2927108|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
2927109|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
2927110|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
2927111|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
2927112|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
2927113|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
2927114|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
2927115|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
2927116|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
2927117|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
2927118|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
2927119|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
2927120|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
2927121|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
2927122|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
2927123|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
2927124|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
2927125|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
2927126|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
2927127|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
2927128|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
2927129|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
2927130|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
2927131|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
2927132|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
2927133|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
2927134|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
2927135|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
2927136|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
2927137|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
2927138|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
2927139|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
2927140|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Death|0
2927141|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Death|1
2927142|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Death|0
2927143|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Death|0
2927144|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Death|0
2927145|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Death|0
2927146|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Death|0
2927147|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Death|0
2927148|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Death|0
2927149|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Death|0
2927150|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Death|0
2927151|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Death|0
2927152|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Death|0
2927153|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Death|0
2927154|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Death|0
2927155|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Death|0
2927156|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Death|0
2927157|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Death|0
2927158|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Death|0
2927159|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Death|0
2927160|NCT01490632|10082777|P20|Part D: Re-Treatment Period|Adverse Event|3
2927161|NCT01490632|10082778|P19|Part D: Re-Treatment Period|Adverse Event|1
2927162|NCT01490632|10082779|P18|Part D: Re-Treatment Period|Adverse Event|1
2927163|NCT01490632|10082780|P17|Part D: Re-Treatment Period|Adverse Event|0
2927164|NCT01490632|10082781|P16|Part D: Re-Treatment Period|Adverse Event|0
2927165|NCT01490632|10082782|P15|Part D: Re-Treatment Period|Adverse Event|0
2927166|NCT01490632|10082783|P14|Part D: Re-Treatment Period|Adverse Event|0
2927167|NCT01490632|10082784|P13|Part D: Re-Treatment Period|Adverse Event|0
2927168|NCT01490632|10082785|P12|Part D: Re-Treatment Period|Adverse Event|0
2927169|NCT01490632|10082786|P11|Part D: Re-Treatment Period|Adverse Event|0
2927170|NCT01490632|10082787|P10|Part D: Re-Treatment Period|Adverse Event|0
2927171|NCT01490632|10082788|P9|Part D: Re-Treatment Period|Adverse Event|0
2927172|NCT01490632|10082789|P8|Part D: Re-Treatment Period|Adverse Event|0
2927173|NCT01490632|10082790|P7|Part D: Re-Treatment Period|Adverse Event|0
2927174|NCT01490632|10082791|P6|Part D: Re-Treatment Period|Adverse Event|0
2927175|NCT01490632|10082792|P5|Part D: Re-Treatment Period|Adverse Event|0
2927176|NCT01490632|10082793|P4|Part D: Re-Treatment Period|Adverse Event|0
2927177|NCT01490632|10082794|P3|Part D: Re-Treatment Period|Adverse Event|0
2927178|NCT01490632|10082795|P2|Part D: Re-Treatment Period|Adverse Event|0
2927179|NCT01490632|10082796|P1|Part D: Re-Treatment Period|Adverse Event|0
2927180|NCT01490632|10082777|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927181|NCT01490632|10082778|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927182|NCT01490632|10082779|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927183|NCT01490632|10082780|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927184|NCT01490632|10082781|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
2927185|NCT01490632|10082782|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
2927186|NCT01490632|10082783|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
2927187|NCT01490632|10082784|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
2927188|NCT01490632|10082785|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927189|NCT01490632|10082786|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927190|NCT01490632|10082787|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927191|NCT01490632|10082788|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927192|NCT01490632|10082789|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927193|NCT01490632|10082790|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927194|NCT01490632|10082791|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927195|NCT01490632|10082792|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927196|NCT01490632|10082793|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927197|NCT01490632|10082794|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927198|NCT01490632|10082795|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927199|NCT01490632|10082796|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2927200|NCT01490632|10082777|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927201|NCT01490632|10082778|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927202|NCT01490632|10082779|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927203|NCT01490632|10082780|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927204|NCT01490632|10082781|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
2927205|NCT01490632|10082782|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
2927206|NCT01490632|10082783|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927207|NCT01490632|10082784|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927208|NCT01490632|10082785|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927209|NCT01490632|10082786|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927210|NCT01490632|10082787|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927211|NCT01490632|10082788|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927212|NCT01490632|10082789|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927213|NCT01490632|10082790|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927214|NCT01490632|10082791|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927215|NCT01490632|10082792|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927216|NCT01490632|10082793|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927217|NCT01490632|10082794|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927218|NCT01490632|10082795|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927219|NCT01490632|10082796|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2927220|NCT01490632|10082777|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927221|NCT01490632|10082778|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927222|NCT01490632|10082779|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927223|NCT01490632|10082780|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927224|NCT01490632|10082781|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927225|NCT01490632|10082782|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927226|NCT01490632|10082783|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
2927227|NCT01490632|10082784|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927228|NCT01490632|10082785|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927229|NCT01490632|10082786|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927230|NCT01490632|10082787|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927231|NCT01490632|10082788|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927232|NCT01490632|10082789|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927233|NCT01490632|10082790|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927234|NCT01490632|10082791|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927235|NCT01490632|10082792|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927236|NCT01490632|10082793|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927237|NCT01490632|10082794|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927238|NCT01490632|10082795|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927239|NCT01490632|10082796|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2927240|NCT01490632|10082777|P20|Part C: Washout or Step-Down Period|Adverse Event|0
2927241|NCT01490632|10082778|P19|Part C: Washout or Step-Down Period|Adverse Event|0
2927242|NCT01490632|10082779|P18|Part C: Washout or Step-Down Period|Adverse Event|0
2927243|NCT01490632|10082780|P17|Part C: Washout or Step-Down Period|Adverse Event|0
2927244|NCT01490632|10082781|P16|Part C: Washout or Step-Down Period|Adverse Event|2
2927245|NCT01490632|10082782|P15|Part C: Washout or Step-Down Period|Adverse Event|2
2927246|NCT01490632|10082783|P14|Part C: Washout or Step-Down Period|Adverse Event|0
2927247|NCT01490632|10082784|P13|Part C: Washout or Step-Down Period|Adverse Event|0
2927248|NCT01490632|10082785|P12|Part C: Washout or Step-Down Period|Adverse Event|0
2927249|NCT01490632|10082786|P11|Part C: Washout or Step-Down Period|Adverse Event|0
2927250|NCT01490632|10082787|P10|Part C: Washout or Step-Down Period|Adverse Event|0
2927251|NCT01490632|10082788|P9|Part C: Washout or Step-Down Period|Adverse Event|0
2927252|NCT01490632|10082789|P8|Part C: Washout or Step-Down Period|Adverse Event|0
2927253|NCT01490632|10082790|P7|Part C: Washout or Step-Down Period|Adverse Event|0
2927254|NCT01490632|10082791|P6|Part C: Washout or Step-Down Period|Adverse Event|0
2927255|NCT01490632|10082792|P5|Part C: Washout or Step-Down Period|Adverse Event|0
2927256|NCT01490632|10082793|P4|Part C: Washout or Step-Down Period|Adverse Event|0
2927257|NCT01490632|10082794|P3|Part C: Washout or Step-Down Period|Adverse Event|0
2927258|NCT01490632|10082795|P2|Part C: Washout or Step-Down Period|Adverse Event|0
2927259|NCT01490632|10082796|P1|Part C: Washout or Step-Down Period|Adverse Event|0
2927260|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927261|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927262|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927263|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927264|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927265|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927266|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927267|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927557|NCT01490125|10083238|P6|Period III|Lack of Efficacy|0
2927268|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
2927269|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
2927270|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
2927271|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
2927272|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2927273|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2927274|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
2927275|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927276|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927277|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927278|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927279|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2927280|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927281|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927282|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927283|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927284|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927285|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927286|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927287|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927288|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
2927289|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2927290|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927291|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2927292|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927293|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2927294|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927295|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927296|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927297|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927298|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927299|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2927300|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927301|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927302|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927303|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927304|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927305|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927306|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927307|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927308|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927309|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927310|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927311|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927312|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927313|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927314|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
2927315|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927316|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927317|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927318|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927319|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
2927320|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Physician Decision|0
2927321|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Physician Decision|0
2927322|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Physician Decision|0
2927323|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Physician Decision|0
2927324|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Physician Decision|0
2927325|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Physician Decision|0
2927326|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Physician Decision|0
2927327|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Physician Decision|0
2927328|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Physician Decision|0
2927329|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Physician Decision|0
2927330|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Physician Decision|0
2927331|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Physician Decision|0
2927332|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Physician Decision|0
2927333|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Physician Decision|1
2927334|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Physician Decision|0
2927335|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Physician Decision|0
2927336|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Physician Decision|0
2927337|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Physician Decision|0
2927338|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Physician Decision|0
2927339|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Physician Decision|0
2927340|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927341|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927342|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927343|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927344|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927345|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927346|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927347|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927348|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927349|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927350|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
2927351|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927352|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927353|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
2927354|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927355|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927356|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927357|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927358|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927359|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2927360|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927361|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927362|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927363|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927364|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927365|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927366|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927367|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927368|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927369|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2927370|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
2927371|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2927372|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927373|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2927374|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927375|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927376|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927377|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927378|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927379|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2927380|NCT01490632|10082777|P20|Part B: Extension or Step-Up Period|Adverse Event|0
2927381|NCT01490632|10082778|P19|Part B: Extension or Step-Up Period|Adverse Event|0
2927382|NCT01490632|10082779|P18|Part B: Extension or Step-Up Period|Adverse Event|0
2927383|NCT01490632|10082780|P17|Part B: Extension or Step-Up Period|Adverse Event|0
2927384|NCT01490632|10082781|P16|Part B: Extension or Step-Up Period|Adverse Event|0
2927385|NCT01490632|10082782|P15|Part B: Extension or Step-Up Period|Adverse Event|0
2927386|NCT01490632|10082783|P14|Part B: Extension or Step-Up Period|Adverse Event|0
2927387|NCT01490632|10082784|P13|Part B: Extension or Step-Up Period|Adverse Event|0
2927388|NCT01490632|10082785|P12|Part B: Extension or Step-Up Period|Adverse Event|1
2927389|NCT01490632|10082786|P11|Part B: Extension or Step-Up Period|Adverse Event|3
2927390|NCT01490632|10082787|P10|Part B: Extension or Step-Up Period|Adverse Event|2
2927391|NCT01490632|10082788|P9|Part B: Extension or Step-Up Period|Adverse Event|0
2927392|NCT01490632|10082789|P8|Part B: Extension or Step-Up Period|Adverse Event|0
2927393|NCT01490632|10082790|P7|Part B: Extension or Step-Up Period|Adverse Event|2
2927394|NCT01490632|10082791|P6|Part B: Extension or Step-Up Period|Adverse Event|2
2927395|NCT01490632|10082792|P5|Part B: Extension or Step-Up Period|Adverse Event|0
2927396|NCT01490632|10082793|P4|Part B: Extension or Step-Up Period|Adverse Event|0
2927397|NCT01490632|10082794|P3|Part B: Extension or Step-Up Period|Adverse Event|0
2927398|NCT01490632|10082795|P2|Part B: Extension or Step-Up Period|Adverse Event|0
2927399|NCT01490632|10082796|P1|Part B: Extension or Step-Up Period|Adverse Event|0
2927400|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927401|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927402|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927403|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927404|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927405|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927406|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927407|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927408|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927409|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927410|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927411|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927412|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927413|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927414|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927415|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
2927416|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927417|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927418|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927419|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2927420|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927421|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927422|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927423|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927424|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927425|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927426|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927427|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927428|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927429|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927430|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927431|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927432|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927433|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927434|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927435|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
2927436|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
2927437|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
2927438|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
2927439|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
2927440|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Sponsor Decision|0
2927441|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Sponsor Decision|0
2927442|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Sponsor Decision|0
2927443|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Sponsor Decision|0
2927444|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Sponsor Decision|0
2927445|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Sponsor Decision|0
2927446|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Sponsor Decision|0
2927447|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Sponsor Decision|0
2927448|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Sponsor Decision|0
2927449|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Sponsor Decision|0
2927450|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Sponsor Decision|0
2927451|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Sponsor Decision|0
2927452|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Sponsor Decision|0
2927453|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Sponsor Decision|0
2927454|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Sponsor Decision|0
2927455|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Sponsor Decision|0
2927456|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Sponsor Decision|0
2927457|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Sponsor Decision|0
2927458|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Sponsor Decision|0
2927459|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Sponsor Decision|2
2927460|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Physician Decision|0
2927461|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Physician Decision|0
2927462|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Physician Decision|0
2927463|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Physician Decision|0
2927464|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Physician Decision|0
2927465|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Physician Decision|0
2927466|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Physician Decision|0
2927467|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Physician Decision|0
2927468|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Physician Decision|0
2927469|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Physician Decision|0
2927470|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Physician Decision|0
2927471|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Physician Decision|0
2927472|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Physician Decision|0
2927473|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Physician Decision|0
2927474|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Physician Decision|0
2927475|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Physician Decision|0
2927476|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Physician Decision|1
2927477|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Physician Decision|0
2927478|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Physician Decision|1
2927479|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Physician Decision|0
2927480|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
2927481|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
2927482|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
2927483|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
2927484|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
2927485|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
2927486|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
2927487|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
2927488|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
2927489|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
2927490|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
2927491|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
2927492|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
2927493|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
2927494|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
2927495|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
2927496|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
2927497|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
2927498|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
2927499|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
2927500|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
2927501|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
2927502|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
2927503|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
2927504|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
2927505|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
2927506|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
2927507|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
2927508|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
2927509|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
2927510|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
2927511|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
2927512|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
2927513|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
2927514|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
2927515|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
2927516|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
2927517|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
2927518|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
2927519|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
2927520|NCT01490632|10082777|P20|Part A: Initial Treatment Period|Adverse Event|0
2927521|NCT01490632|10082778|P19|Part A: Initial Treatment Period|Adverse Event|0
2927522|NCT01490632|10082779|P18|Part A: Initial Treatment Period|Adverse Event|0
2927523|NCT01490632|10082780|P17|Part A: Initial Treatment Period|Adverse Event|0
2927524|NCT01490632|10082781|P16|Part A: Initial Treatment Period|Adverse Event|0
2927525|NCT01490632|10082782|P15|Part A: Initial Treatment Period|Adverse Event|0
2927526|NCT01490632|10082783|P14|Part A: Initial Treatment Period|Adverse Event|0
2927527|NCT01490632|10082784|P13|Part A: Initial Treatment Period|Adverse Event|0
2927528|NCT01490632|10082785|P12|Part A: Initial Treatment Period|Adverse Event|0
2927529|NCT01490632|10082786|P11|Part A: Initial Treatment Period|Adverse Event|0
2927530|NCT01490632|10082787|P10|Part A: Initial Treatment Period|Adverse Event|0
2927531|NCT01490632|10082788|P9|Part A: Initial Treatment Period|Adverse Event|0
2927532|NCT01490632|10082789|P8|Part A: Initial Treatment Period|Adverse Event|0
2927533|NCT01490632|10082790|P7|Part A: Initial Treatment Period|Adverse Event|0
2927534|NCT01490632|10082791|P6|Part A: Initial Treatment Period|Adverse Event|0
2927535|NCT01490632|10082792|P5|Part A: Initial Treatment Period|Adverse Event|4
2927536|NCT01490632|10082793|P4|Part A: Initial Treatment Period|Adverse Event|4
2927537|NCT01490632|10082794|P3|Part A: Initial Treatment Period|Adverse Event|2
2927538|NCT01490632|10082795|P2|Part A: Initial Treatment Period|Adverse Event|0
2927539|NCT01490632|10082796|P1|Part A: Initial Treatment Period|Adverse Event|0
2927540|NCT01490580|10082926|P2|Overall Study|Parents withdrew consent|2
2927541|NCT01490580|10082927|P1|Overall Study|Parents withdrew consent|0
2927542|NCT01490294|10082974|P4|Overall Study|Adverse Event|0
2927543|NCT01490294|10082975|P3|Overall Study|Adverse Event|0
2927544|NCT01490294|10082976|P2|Overall Study|Adverse Event|0
2927545|NCT01490294|10082977|P1|Overall Study|Adverse Event|1
2927546|NCT01490294|10082974|P4|Overall Study|Prematurely discontinuation|1
2927547|NCT01490294|10082975|P3|Overall Study|Prematurely discontinuation|1
2927548|NCT01490294|10082976|P2|Overall Study|Prematurely discontinuation|0
2927549|NCT01490294|10082977|P1|Overall Study|Prematurely discontinuation|4
2927550|NCT01490190|10083211|P1|Overall Study|Ring expulsion|2
2927551|NCT01490190|10083211|P1|Overall Study|Inconvenience|1
2927552|NCT01490190|10083211|P1|Overall Study|Relocation|1
2927553|NCT01490190|10083211|P1|Overall Study|Lost to Follow-up|13
2927554|NCT01490190|10083211|P1|Overall Study|Protocol Violation|5
2927555|NCT01490190|10083211|P1|Overall Study|Adverse Event|17
2927556|NCT01490190|10083211|P1|Overall Study|Withdrawal by Subject|9
2927558|NCT01490125|10083239|P5|Period III|Lack of Efficacy|1
2927559|NCT01490125|10083240|P4|Period III|Lack of Efficacy|0
2927560|NCT01490125|10083241|P3|Period III|Lack of Efficacy|0
2927561|NCT01490125|10083242|P2|Period III|Lack of Efficacy|0
2927562|NCT01490125|10083243|P1|Period III|Lack of Efficacy|0
2927563|NCT01490125|10083238|P6|Period III|Death|0
2927564|NCT01490125|10083239|P5|Period III|Death|0
2927565|NCT01490125|10083240|P4|Period III|Death|1
2927566|NCT01490125|10083241|P3|Period III|Death|0
2927567|NCT01490125|10083242|P2|Period III|Death|0
2927568|NCT01490125|10083243|P1|Period III|Death|0
2927569|NCT01490125|10083238|P6|Period III|Adverse Event|0
2927570|NCT01490125|10083239|P5|Period III|Adverse Event|0
2927571|NCT01490125|10083240|P4|Period III|Adverse Event|1
2927572|NCT01490125|10083241|P3|Period III|Adverse Event|0
2927573|NCT01490125|10083242|P2|Period III|Adverse Event|1
2927574|NCT01490125|10083243|P1|Period III|Adverse Event|3
2927575|NCT01490125|10083238|P6|Period II|Withdrawal by Subject|0
2927576|NCT01490125|10083239|P5|Period II|Withdrawal by Subject|0
2927577|NCT01490125|10083240|P4|Period II|Withdrawal by Subject|0
2927578|NCT01490125|10083241|P3|Period II|Withdrawal by Subject|0
2927579|NCT01490125|10083242|P2|Period II|Withdrawal by Subject|0
2927580|NCT01490125|10083243|P1|Period II|Withdrawal by Subject|1
2927581|NCT01490125|10083238|P6|Period II|Lost to Follow-up|0
2927582|NCT01490125|10083239|P5|Period II|Lost to Follow-up|0
2927583|NCT01490125|10083240|P4|Period II|Lost to Follow-up|0
2927584|NCT01490125|10083241|P3|Period II|Lost to Follow-up|0
2927585|NCT01490125|10083242|P2|Period II|Lost to Follow-up|1
2927586|NCT01490125|10083243|P1|Period II|Lost to Follow-up|0
2927587|NCT01490125|10083238|P6|Period II|Protocol Violation|0
2927588|NCT01490125|10083239|P5|Period II|Protocol Violation|0
2927589|NCT01490125|10083240|P4|Period II|Protocol Violation|1
2927590|NCT01490125|10083241|P3|Period II|Protocol Violation|1
2927591|NCT01490125|10083242|P2|Period II|Protocol Violation|0
2927592|NCT01490125|10083243|P1|Period II|Protocol Violation|0
2927593|NCT01490125|10083238|P6|Period II|Adverse Event|2
2927594|NCT01490125|10083239|P5|Period II|Adverse Event|4
2927595|NCT01490125|10083240|P4|Period II|Adverse Event|2
2927596|NCT01490125|10083241|P3|Period II|Adverse Event|2
2927597|NCT01490125|10083242|P2|Period II|Adverse Event|3
2927598|NCT01490125|10083243|P1|Period II|Adverse Event|2
2927599|NCT01490125|10083238|P6|Period I|Withdrawal by Subject|1
2927600|NCT01490125|10083239|P5|Period I|Withdrawal by Subject|2
2927601|NCT01490125|10083240|P4|Period I|Withdrawal by Subject|1
2927602|NCT01490125|10083241|P3|Period I|Withdrawal by Subject|2
2927603|NCT01490125|10083242|P2|Period I|Withdrawal by Subject|3
2927604|NCT01490125|10083243|P1|Period I|Withdrawal by Subject|1
2927605|NCT01490125|10083238|P6|Period I|Protocol Violation|0
2927606|NCT01490125|10083239|P5|Period I|Protocol Violation|0
2927607|NCT01490125|10083240|P4|Period I|Protocol Violation|1
2927608|NCT01490125|10083241|P3|Period I|Protocol Violation|1
2927609|NCT01490125|10083242|P2|Period I|Protocol Violation|1
2927610|NCT01490125|10083243|P1|Period I|Protocol Violation|1
2927611|NCT01490125|10083238|P6|Period I|Adverse Event|4
2927612|NCT01490125|10083239|P5|Period I|Adverse Event|2
2927613|NCT01490125|10083240|P4|Period I|Adverse Event|3
2927614|NCT01490125|10083241|P3|Period I|Adverse Event|1
2927615|NCT01490125|10083242|P2|Period I|Adverse Event|1
2927616|NCT01490125|10083243|P1|Period I|Adverse Event|4
2927617|NCT01490086|10083271|P5|Overall Study|Subject left hospital|0
2927618|NCT01490086|10083272|P4|Overall Study|Subject left hospital|1
2927619|NCT01490086|10083273|P3|Overall Study|Subject left hospital|0
2927620|NCT01490086|10083274|P2|Overall Study|Subject left hospital|1
2927621|NCT01490086|10083275|P1|Overall Study|Subject left hospital|0
2927622|NCT01490086|10083271|P5|Overall Study|Subject uncontrollable and abusive|0
2927623|NCT01490086|10083272|P4|Overall Study|Subject uncontrollable and abusive|0
2927624|NCT01490086|10083273|P3|Overall Study|Subject uncontrollable and abusive|0
2927625|NCT01490086|10083274|P2|Overall Study|Subject uncontrollable and abusive|1
2927626|NCT01490086|10083275|P1|Overall Study|Subject uncontrollable and abusive|0
2927627|NCT01490086|10083271|P5|Overall Study|Worsening of symptoms|0
2927628|NCT01490086|10083272|P4|Overall Study|Worsening of symptoms|1
2927629|NCT01490086|10083273|P3|Overall Study|Worsening of symptoms|0
2927630|NCT01490086|10083274|P2|Overall Study|Worsening of symptoms|1
2927631|NCT01490086|10083275|P1|Overall Study|Worsening of symptoms|0
2927632|NCT01490086|10083271|P5|Overall Study|Lack of Efficacy|8
2927633|NCT01490086|10083272|P4|Overall Study|Lack of Efficacy|0
2927634|NCT01490086|10083273|P3|Overall Study|Lack of Efficacy|1
2927635|NCT01490086|10083274|P2|Overall Study|Lack of Efficacy|3
2927636|NCT01490086|10083275|P1|Overall Study|Lack of Efficacy|0
2927637|NCT01490086|10083271|P5|Overall Study|Adverse Event|0
2927638|NCT01490086|10083272|P4|Overall Study|Adverse Event|2
2927639|NCT01490086|10083273|P3|Overall Study|Adverse Event|1
2927640|NCT01490086|10083274|P2|Overall Study|Adverse Event|0
2927641|NCT01490086|10083275|P1|Overall Study|Adverse Event|0
2927642|NCT01490086|10083271|P5|Overall Study|Physician Decision|1
2927643|NCT01490086|10083272|P4|Overall Study|Physician Decision|3
2927644|NCT01490086|10083273|P3|Overall Study|Physician Decision|2
2927645|NCT01490086|10083274|P2|Overall Study|Physician Decision|4
2927646|NCT01490086|10083275|P1|Overall Study|Physician Decision|3
2927647|NCT01490086|10083271|P5|Overall Study|Lost to Follow-up|1
2927648|NCT01490086|10083272|P4|Overall Study|Lost to Follow-up|0
2927649|NCT01490086|10083273|P3|Overall Study|Lost to Follow-up|0
2927650|NCT01490086|10083274|P2|Overall Study|Lost to Follow-up|0
2927651|NCT01490086|10083275|P1|Overall Study|Lost to Follow-up|0
2927652|NCT01490086|10083271|P5|Overall Study|Abnormal laboratory findings|0
2927653|NCT01490086|10083272|P4|Overall Study|Abnormal laboratory findings|0
2927654|NCT01490086|10083273|P3|Overall Study|Abnormal laboratory findings|0
2927655|NCT01490086|10083274|P2|Overall Study|Abnormal laboratory findings|0
2927656|NCT01490086|10083275|P1|Overall Study|Abnormal laboratory findings|1
2927657|NCT01490086|10083271|P5|Overall Study|Non-compliance|0
2927658|NCT01490086|10083272|P4|Overall Study|Non-compliance|0
2927659|NCT01490086|10083273|P3|Overall Study|Non-compliance|0
2927660|NCT01490086|10083274|P2|Overall Study|Non-compliance|1
2927661|NCT01490086|10083275|P1|Overall Study|Non-compliance|0
2927662|NCT01490086|10083271|P5|Overall Study|Consent withdrawn|1
2927663|NCT01490086|10083272|P4|Overall Study|Consent withdrawn|0
2927664|NCT01490086|10083273|P3|Overall Study|Consent withdrawn|3
2927665|NCT01490086|10083274|P2|Overall Study|Consent withdrawn|4
2927666|NCT01490086|10083275|P1|Overall Study|Consent withdrawn|4
2927667|NCT01490060|10083320|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
2927668|NCT01490060|10083321|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
2927669|NCT01490060|10083322|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
2927670|NCT01490060|10083323|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
2927671|NCT01490060|10083320|P4|Cycle 2|Non-Compliance|0
2927672|NCT01490060|10083321|P3|Cycle 2|Non-Compliance|1
2927673|NCT01490060|10083322|P2|Cycle 2|Non-Compliance|0
2927674|NCT01490060|10083323|P1|Cycle 2|Non-Compliance|0
2927675|NCT01490060|10083320|P4|Cycle 2|Change of Treatment|0
2927676|NCT01490060|10083321|P3|Cycle 2|Change of Treatment|0
2927677|NCT01490060|10083322|P2|Cycle 2|Change of Treatment|1
2927678|NCT01490060|10083323|P1|Cycle 2|Change of Treatment|1
2927679|NCT01490060|10083320|P4|Cycle 1|Treatment at Another Facility|1
2927680|NCT01490060|10083321|P3|Cycle 1|Treatment at Another Facility|0
2927681|NCT01490060|10083322|P2|Cycle 1|Treatment at Another Facility|0
2927682|NCT01490060|10083323|P1|Cycle 1|Treatment at Another Facility|0
2927683|NCT01490060|10083320|P4|Cycle 1|Withdrawal by Subject|1
2927684|NCT01490060|10083321|P3|Cycle 1|Withdrawal by Subject|0
2927685|NCT01490060|10083322|P2|Cycle 1|Withdrawal by Subject|0
2927686|NCT01490060|10083323|P1|Cycle 1|Withdrawal by Subject|0
2927687|NCT01490060|10083320|P4|Cycle 1|Insurance Denied|0
2927688|NCT01490060|10083321|P3|Cycle 1|Insurance Denied|2
2927689|NCT01490060|10083322|P2|Cycle 1|Insurance Denied|0
2927690|NCT01490060|10083323|P1|Cycle 1|Insurance Denied|0
2927691|NCT01490060|10083320|P4|Cycle 1|Change of Treatment|1
2927692|NCT01490060|10083321|P3|Cycle 1|Change of Treatment|1
2927693|NCT01490060|10083322|P2|Cycle 1|Change of Treatment|1
2927694|NCT01490060|10083323|P1|Cycle 1|Change of Treatment|0
2927695|NCT01489956|10083352|P3|Overall Study|Withdrawal by Subject|1
2927696|NCT01489956|10083353|P2|Overall Study|Withdrawal by Subject|0
2927697|NCT01489956|10083354|P1|Overall Study|Withdrawal by Subject|0
2927698|NCT01489956|10083352|P3|Overall Study|Lost to Follow-up|0
2927699|NCT01489956|10083353|P2|Overall Study|Lost to Follow-up|0
2927700|NCT01489956|10083354|P1|Overall Study|Lost to Follow-up|1
2927701|NCT01489891|10083391|P2|Overall Study|Endoscopy failure|0
2927702|NCT01489891|10083392|P1|Overall Study|Endoscopy failure|1
2927703|NCT01489527|10083547|P2|Overall Study|Not compliant|0
2927704|NCT01489527|10083548|P1|Overall Study|Not compliant|1
2927705|NCT01489527|10083547|P2|Overall Study|Procedures|0
2927706|NCT01489527|10083548|P1|Overall Study|Procedures|1
2927707|NCT01489527|10083547|P2|Overall Study|Lost to Follow-up|1
2927708|NCT01489527|10083548|P1|Overall Study|Lost to Follow-up|5
2927709|NCT01489527|10083547|P2|Overall Study|Withdrawal by Subject|4
2927710|NCT01489527|10083548|P1|Overall Study|Withdrawal by Subject|0
2927711|NCT01489527|10083547|P2|Overall Study|Participant moved|7
2927712|NCT01489527|10083548|P1|Overall Study|Participant moved|6
2927713|NCT01489527|10083547|P2|Overall Study|Pregnancy|14
2927714|NCT01489527|10083548|P1|Overall Study|Pregnancy|9
2927715|NCT01489358|10083565|P3|Overall Study|Lost to Follow-up|2
2927716|NCT01489358|10083566|P2|Overall Study|Lost to Follow-up|0
2927717|NCT01489358|10083567|P1|Overall Study|Lost to Follow-up|0
2927718|NCT01489254|10083617|P4|Open-label Extension Part|Other reasons for not completing study|5
2927719|NCT01489254|10083618|P3|Open-label Extension Part|Other reasons for not completing study|0
2927720|NCT01489254|10083619|P2|Open-label Extension Part|Other reasons for not completing study|0
2927721|NCT01489254|10083620|P1|Open-label Extension Part|Other reasons for not completing study|0
2927722|NCT01489254|10083617|P4|Open-label Extension Part|Lost to Follow-up|9
2927723|NCT01489254|10083618|P3|Open-label Extension Part|Lost to Follow-up|0
2927724|NCT01489254|10083619|P2|Open-label Extension Part|Lost to Follow-up|0
2927725|NCT01489254|10083620|P1|Open-label Extension Part|Lost to Follow-up|0
2927726|NCT01489254|10083617|P4|Open-label Extension Part|Protocol Violation|1
2927727|NCT01489254|10083618|P3|Open-label Extension Part|Protocol Violation|0
2927728|NCT01489254|10083619|P2|Open-label Extension Part|Protocol Violation|0
2927729|NCT01489254|10083620|P1|Open-label Extension Part|Protocol Violation|0
2927730|NCT01489254|10083617|P4|Open-label Extension Part|Withdrawal by Subject|30
2927731|NCT01489254|10083618|P3|Open-label Extension Part|Withdrawal by Subject|0
2927732|NCT01489254|10083619|P2|Open-label Extension Part|Withdrawal by Subject|0
2927733|NCT01489254|10083620|P1|Open-label Extension Part|Withdrawal by Subject|0
2927734|NCT01489254|10083617|P4|Open-label Extension Part|Pregnancy|3
2927735|NCT01489254|10083618|P3|Open-label Extension Part|Pregnancy|0
2927736|NCT01489254|10083619|P2|Open-label Extension Part|Pregnancy|0
2927737|NCT01489254|10083620|P1|Open-label Extension Part|Pregnancy|0
2927738|NCT01489254|10083617|P4|Open-label Extension Part|Adverse Event|10
2927739|NCT01489254|10083618|P3|Open-label Extension Part|Adverse Event|0
2927740|NCT01489254|10083619|P2|Open-label Extension Part|Adverse Event|0
2927741|NCT01489254|10083620|P1|Open-label Extension Part|Adverse Event|0
2927742|NCT01489254|10083617|P4|Double-blind Part|Other reasons for not completing study|0
2927743|NCT01489254|10083618|P3|Double-blind Part|Other reasons for not completing study|0
2927744|NCT01489254|10083619|P2|Double-blind Part|Other reasons for not completing study|6
2927745|NCT01489254|10083620|P1|Double-blind Part|Other reasons for not completing study|4
2927746|NCT01489254|10083617|P4|Double-blind Part|Lost to Follow-up|0
2927747|NCT01489254|10083618|P3|Double-blind Part|Lost to Follow-up|0
2927748|NCT01489254|10083619|P2|Double-blind Part|Lost to Follow-up|2
2927749|NCT01489254|10083620|P1|Double-blind Part|Lost to Follow-up|1
2927750|NCT01489254|10083617|P4|Double-blind Part|Withdrawal by Subject|0
2927751|NCT01489254|10083618|P3|Double-blind Part|Withdrawal by Subject|1
2927752|NCT01489254|10083619|P2|Double-blind Part|Withdrawal by Subject|20
2927753|NCT01489254|10083620|P1|Double-blind Part|Withdrawal by Subject|12
2927754|NCT01489254|10083617|P4|Double-blind Part|Pregnancy|0
2927755|NCT01489254|10083618|P3|Double-blind Part|Pregnancy|0
2927756|NCT01489254|10083619|P2|Double-blind Part|Pregnancy|3
2927757|NCT01489254|10083620|P1|Double-blind Part|Pregnancy|1
2927758|NCT01489254|10083617|P4|Double-blind Part|Adverse Event|0
2927759|NCT01489254|10083618|P3|Double-blind Part|Adverse Event|2
2927760|NCT01489254|10083619|P2|Double-blind Part|Adverse Event|2
2927761|NCT01489254|10083620|P1|Double-blind Part|Adverse Event|7
2927762|NCT01489189|10083631|P2|Overall Study|Missed Visit|4
2927763|NCT01489189|10083632|P1|Overall Study|Missed Visit|1
2927764|NCT01489189|10083631|P2|Overall Study|Death|8
2927765|NCT01489189|10083632|P1|Overall Study|Death|10
2927766|NCT01489189|10083631|P2|Overall Study|Withdrawal by Subject|23
2927767|NCT01489189|10083632|P1|Overall Study|Withdrawal by Subject|20
2927768|NCT01489111|10083657|P1|Overall Study|Withdrawal criterion|1
2927769|NCT01489020|10083678|P6|Overall Study|Concomitant disease|0
2927770|NCT01489020|10083679|P5|Overall Study|Concomitant disease|3
2927771|NCT01489020|10083680|P4|Overall Study|Concomitant disease|0
2927772|NCT01489020|10083681|P3|Overall Study|Concomitant disease|0
2927773|NCT01489020|10083682|P2|Overall Study|Concomitant disease|0
2927774|NCT01489020|10083683|P1|Overall Study|Concomitant disease|0
2927775|NCT01489020|10083678|P6|Overall Study|Adverse Event|0
2927776|NCT01489020|10083679|P5|Overall Study|Adverse Event|3
2927777|NCT01489020|10083680|P4|Overall Study|Adverse Event|0
2927778|NCT01489020|10083681|P3|Overall Study|Adverse Event|3
2927779|NCT01489020|10083682|P2|Overall Study|Adverse Event|0
2927780|NCT01489020|10083683|P1|Overall Study|Adverse Event|0
2927781|NCT01489020|10083678|P6|Overall Study|Withdrawal by Subject|0
2927782|NCT01489020|10083679|P5|Overall Study|Withdrawal by Subject|0
2927783|NCT01489020|10083680|P4|Overall Study|Withdrawal by Subject|0
2927784|NCT01489020|10083681|P3|Overall Study|Withdrawal by Subject|0
2927785|NCT01489020|10083682|P2|Overall Study|Withdrawal by Subject|0
2927786|NCT01489020|10083683|P1|Overall Study|Withdrawal by Subject|1
2927787|NCT01488994|10083717|P2|Overall Study|Withdrawal by Subject|1
2927788|NCT01488994|10083718|P1|Overall Study|Withdrawal by Subject|0
2927789|NCT01488890|10083809|P4|Overall Study|Withdrawal by Subject|2
2927790|NCT01488890|10083810|P3|Overall Study|Withdrawal by Subject|11
2927791|NCT01488890|10083811|P2|Overall Study|Withdrawal by Subject|10
2927792|NCT01488890|10083812|P1|Overall Study|Withdrawal by Subject|14
2927793|NCT01488890|10083809|P4|Overall Study|Lost to Follow-up|3
2927794|NCT01488890|10083810|P3|Overall Study|Lost to Follow-up|20
2927795|NCT01488890|10083811|P2|Overall Study|Lost to Follow-up|10
2927796|NCT01488890|10083812|P1|Overall Study|Lost to Follow-up|13
2927797|NCT01488890|10083809|P4|Overall Study|Protocol Violation|0
2927798|NCT01488890|10083810|P3|Overall Study|Protocol Violation|4
2927799|NCT01488890|10083811|P2|Overall Study|Protocol Violation|0
2927800|NCT01488890|10083812|P1|Overall Study|Protocol Violation|3
2927801|NCT01488890|10083809|P4|Overall Study|Serious adverse event|0
2927802|NCT01488890|10083810|P3|Overall Study|Serious adverse event|0
2927803|NCT01488890|10083811|P2|Overall Study|Serious adverse event|0
2927804|NCT01488890|10083812|P1|Overall Study|Serious adverse event|2
2927805|NCT01488578|10083890|P1|Overall Study|Protocol Violation|1836
2927806|NCT01488487|10083924|P1|Overall Study|Withdrawal by Subject|2
2927807|NCT01488487|10083924|P1|Overall Study|Death|1
2927808|NCT01488487|10083924|P1|Overall Study|Adverse Event|6
2927809|NCT01488448|10083933|P2|Overall Study|Protocol Violation|3
2927810|NCT01488448|10083934|P1|Overall Study|Protocol Violation|4
2927811|NCT01488448|10083933|P2|Overall Study|Physician Decision|9
2927812|NCT01488448|10083934|P1|Overall Study|Physician Decision|4
2927813|NCT01488448|10083933|P2|Overall Study|Adverse Event|4
2927814|NCT01488448|10083934|P1|Overall Study|Adverse Event|9
2927815|NCT01488448|10083933|P2|Overall Study|Withdrawal by Subject|1
2927816|NCT01488448|10083934|P1|Overall Study|Withdrawal by Subject|3
2927817|NCT01488370|10083976|P3|Overall Study|Protocol Violation|1
2927818|NCT01488370|10083977|P2|Overall Study|Protocol Violation|1
2927819|NCT01488370|10083978|P1|Overall Study|Protocol Violation|0
2927820|NCT01488097|10084037|P1|Overall Study|Lost to Follow-up|1
2927821|NCT01488071|10084050|P2|Overall Study|Administrative or Other Reason(s)|4
2927822|NCT01488071|10084051|P1|Overall Study|Administrative or Other Reason(s)|5
2927823|NCT01488071|10084050|P2|Overall Study|Lost to Follow-up|0
2927824|NCT01488071|10084051|P1|Overall Study|Lost to Follow-up|1
2927825|NCT01488071|10084050|P2|Overall Study|Withdrawal of Consent|12
2927826|NCT01488071|10084051|P1|Overall Study|Withdrawal of Consent|14
2927827|NCT01488071|10084050|P2|Overall Study|Protocol Violation|7
2927828|NCT01488071|10084051|P1|Overall Study|Protocol Violation|5
2927829|NCT01488071|10084050|P2|Overall Study|Non-compliance with study drug|0
2927830|NCT01488071|10084051|P1|Overall Study|Non-compliance with study drug|2
2927831|NCT01488071|10084050|P2|Overall Study|Lack of Efficacy|17
2927832|NCT01488071|10084051|P1|Overall Study|Lack of Efficacy|11
2927833|NCT01488071|10084050|P2|Overall Study|Adverse Event|23
2927834|NCT01488071|10084051|P1|Overall Study|Adverse Event|15
2927835|NCT01487863|10084131|P2|Overall Study|Death|19
2927836|NCT01487863|10084132|P1|Overall Study|Death|19
2927837|NCT01487577|10084149|P1|Overall Study|Became ineligible after signing consent|1
2927838|NCT01487525|10084163|P2|Overall Study|Withdrawal by Subject|1
2927839|NCT01487525|10084164|P1|Overall Study|Withdrawal by Subject|0
2927840|NCT01487265|10084180|P1|Overall Study|Still on Treatment|1
2927841|NCT01487265|10084180|P1|Overall Study|Death|2
2927842|NCT01487265|10084180|P1|Overall Study|Disease Progression|21
2927843|NCT01487265|10084180|P1|Overall Study|Withdrawal by Subject|5
2927844|NCT01487265|10084180|P1|Overall Study|Adverse Event|8
2927845|NCT01487200|10084192|P4|Overall Study|Withdrawal by Subject|0
2927846|NCT01487200|10084193|P3|Overall Study|Withdrawal by Subject|0
2927847|NCT01487200|10084194|P2|Overall Study|Withdrawal by Subject|1
2927848|NCT01487200|10084195|P1|Overall Study|Withdrawal by Subject|0
2927849|NCT01487161|10084225|P4|Overall Study|missing data|0
2927850|NCT01487161|10084226|P3|Overall Study|missing data|0
2927851|NCT01487161|10084227|P2|Overall Study|missing data|1
2927852|NCT01487161|10084228|P1|Overall Study|missing data|0
2927853|NCT01487161|10084225|P4|Overall Study|Withdrawal by Subject|2
2927854|NCT01487161|10084226|P3|Overall Study|Withdrawal by Subject|1
2927855|NCT01487161|10084227|P2|Overall Study|Withdrawal by Subject|1
2927856|NCT01487161|10084228|P1|Overall Study|Withdrawal by Subject|1
2927857|NCT01487161|10084225|P4|Overall Study|Adverse Event|0
2927858|NCT01487161|10084226|P3|Overall Study|Adverse Event|0
2927859|NCT01487161|10084227|P2|Overall Study|Adverse Event|0
2927860|NCT01487161|10084228|P1|Overall Study|Adverse Event|1
2927861|NCT01486966|10084293|P2|Overall Study|Withdrawal by Subject|1
2927862|NCT01486966|10084294|P1|Overall Study|Withdrawal by Subject|0
2927863|NCT01486966|10084293|P2|Overall Study|Adverse Event|1
2927864|NCT01486966|10084294|P1|Overall Study|Adverse Event|0
2927865|NCT01486927|10084318|P1|Overall Study|Subject did not reach 6 mo of treatment|1
2927866|NCT01486927|10084318|P1|Overall Study|Withdrawal by Subject|8
2927867|NCT01486927|10084318|P1|Overall Study|50 Exposure days not reached|2
2927868|NCT01486927|10084318|P1|Overall Study|Physician Decision|1
2927869|NCT01486927|10084318|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
2927870|NCT01486758|10084356|P2|Overall Study|Lost to Follow-up|1
2927871|NCT01486758|10084357|P1|Overall Study|Lost to Follow-up|0
2927872|NCT01486446|10084424|P2|Overall Study|Adverse Event|0
2927873|NCT01486446|10084425|P1|Overall Study|Adverse Event|1
2927874|NCT01486316|10084448|P4|Overall Study|Death|0
2927875|NCT01486316|10084449|P3|Overall Study|Death|0
2927876|NCT01486316|10084450|P2|Overall Study|Death|1
2927877|NCT01486316|10084451|P1|Overall Study|Death|0
2927878|NCT01486316|10084448|P4|Overall Study|Physician Decision|0
2927879|NCT01486316|10084449|P3|Overall Study|Physician Decision|1
2927880|NCT01486316|10084450|P2|Overall Study|Physician Decision|0
2927881|NCT01486316|10084451|P1|Overall Study|Physician Decision|0
2927882|NCT01486316|10084448|P4|Overall Study|Withdrawal by Subject|0
2927883|NCT01486316|10084449|P3|Overall Study|Withdrawal by Subject|3
2927884|NCT01486316|10084450|P2|Overall Study|Withdrawal by Subject|0
2927885|NCT01486316|10084451|P1|Overall Study|Withdrawal by Subject|1
2927886|NCT01486316|10084448|P4|Overall Study|Not meeting eligibility criteria|0
2927887|NCT01486316|10084449|P3|Overall Study|Not meeting eligibility criteria|1
2927888|NCT01486316|10084450|P2|Overall Study|Not meeting eligibility criteria|0
2927889|NCT01486316|10084451|P1|Overall Study|Not meeting eligibility criteria|0
2927890|NCT01486316|10084448|P4|Overall Study|Device explanted with/without re-implant|2
2927891|NCT01486316|10084449|P3|Overall Study|Device explanted with/without re-implant|0
2927892|NCT01486316|10084450|P2|Overall Study|Device explanted with/without re-implant|2
2927893|NCT01486316|10084451|P1|Overall Study|Device explanted with/without re-implant|3
2927894|NCT01486264|10084463|P2|Overall Study|Not treated|1
2927895|NCT01486264|10084464|P1|Overall Study|Not treated|0
2927896|NCT01486264|10084463|P2|Overall Study|Other|11
2927897|NCT01486264|10084464|P1|Overall Study|Other|5
2927898|NCT01486264|10084463|P2|Overall Study|Lost to Follow-up|2
2927899|NCT01486264|10084464|P1|Overall Study|Lost to Follow-up|3
2927900|NCT01486264|10084463|P2|Overall Study|Protocol Violation|0
2927901|NCT01486264|10084464|P1|Overall Study|Protocol Violation|3
2927902|NCT01486264|10084463|P2|Overall Study|Physician Decision|1
2927903|NCT01486264|10084464|P1|Overall Study|Physician Decision|1
2927904|NCT01486264|10084463|P2|Overall Study|Withdrawal by Subject|18
2927905|NCT01486264|10084464|P1|Overall Study|Withdrawal by Subject|7
2927906|NCT01486264|10084463|P2|Overall Study|Lack of Efficacy|10
2927907|NCT01486264|10084464|P1|Overall Study|Lack of Efficacy|6
2927908|NCT01486264|10084463|P2|Overall Study|Adverse Event|3
2927909|NCT01486264|10084464|P1|Overall Study|Adverse Event|3
2927910|NCT01486264|10084463|P2|Overall Study|Death|1
2927911|NCT01486264|10084464|P1|Overall Study|Death|1
2927912|NCT01486238|10084496|P2|Overall Study|Lost to Follow-up|3
2927913|NCT01486238|10084497|P1|Overall Study|Lost to Follow-up|0
2927914|NCT01486238|10084496|P2|Overall Study|Withdrawal by Subject|1
2927915|NCT01486238|10084497|P1|Overall Study|Withdrawal by Subject|2
2927916|NCT01486238|10084496|P2|Overall Study|Death|2
2927917|NCT01486238|10084497|P1|Overall Study|Death|0
2927918|NCT01486199|10084505|P2|Two Year Period Between Study Days|Physician Decision|0
2927919|NCT01486199|10084506|P1|Two Year Period Between Study Days|Physician Decision|1
2927920|NCT01485991|10084526|P2|Overall Study|randomized but not treated|2
2927921|NCT01485991|10084527|P1|Overall Study|randomized but not treated|6
2927922|NCT01485991|10084526|P2|Overall Study|Withdrawal by Subject|20
2927923|NCT01485991|10084527|P1|Overall Study|Withdrawal by Subject|13
2927924|NCT01485991|10084526|P2|Overall Study|Lost to Follow-up|10
2927925|NCT01485991|10084527|P1|Overall Study|Lost to Follow-up|13
2927926|NCT01485991|10084526|P2|Overall Study|Adverse Event|4
2927927|NCT01485991|10084527|P1|Overall Study|Adverse Event|0
2927928|NCT01485887|10084537|P1|Overall Study|Primary disease markedly improved|1
2927929|NCT01485887|10084537|P1|Overall Study|Deterioration of primary disease|1
2927930|NCT01485887|10084537|P1|Overall Study|Adverse Event|8
2927931|NCT01485887|10084537|P1|Overall Study|Withdrawal by Subject|2
2927932|NCT01485796|10084549|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
2927933|NCT01485796|10084549|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
2927934|NCT01485796|10084549|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
2927935|NCT01485796|10084549|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
2927936|NCT01485796|10084549|P1|Period 2: Epoch 2|Switch to safety follow-up|26
2927937|NCT01485796|10084549|P1|Period 2: Epoch 2|Adverse Event|3
2927938|NCT01485796|10084549|P1|Period 2: Epoch 2|Withdrawal by Subject|6
2927939|NCT01485796|10084549|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
2927940|NCT01485640|10084571|P1|Overall Study|Terminated by Sponsor|95
2927941|NCT01485640|10084571|P1|Overall Study|Withdrawal by Subject|14
2927942|NCT01485640|10084571|P1|Overall Study|Protocol Violation|1
2927943|NCT01485640|10084571|P1|Overall Study|Lack of Efficacy|2
2927944|NCT01485640|10084571|P1|Overall Study|Adverse Event|10
2927945|NCT01485627|10084578|P2|Overall Study|caregiver was not bereaved|35
2927946|NCT01485627|10084579|P1|Overall Study|caregiver was not bereaved|42
2927947|NCT01485627|10084578|P2|Overall Study|Caregiver died|0
2927948|NCT01485627|10084579|P1|Overall Study|Caregiver died|1
2927949|NCT01485627|10084578|P2|Overall Study|Caregiver lost to follow up|12
2927950|NCT01485627|10084579|P1|Overall Study|Caregiver lost to follow up|11
2927951|NCT01485627|10084578|P2|Overall Study|Caregiver withdrew|3
2927952|NCT01485627|10084579|P1|Overall Study|Caregiver withdrew|3
2927953|NCT01485627|10084578|P2|Overall Study|Patient lost to followup|1
2927954|NCT01485627|10084579|P1|Overall Study|Patient lost to followup|0
2927955|NCT01485627|10084578|P2|Overall Study|Patient died|1
2927956|NCT01485627|10084579|P1|Overall Study|Patient died|3
2927957|NCT01485627|10084578|P2|Overall Study|Patient withdrew|5
2927958|NCT01485627|10084579|P1|Overall Study|Patient withdrew|6
2927959|NCT01485536|10084597|P1|Overall Study|Adverse Event|1
2927960|NCT01485536|10084597|P1|Overall Study|Withdrawal by Subject|3
2927961|NCT01485354|10084615|P1|Overall Study|Withdrawal by Subject|5
2927962|NCT01485172|10084629|P6|Overall Study|Withdrawal by Subject|1
2927963|NCT01485172|10084630|P5|Overall Study|Withdrawal by Subject|1
2927964|NCT01485172|10084631|P4|Overall Study|Withdrawal by Subject|1
2927965|NCT01485172|10084632|P3|Overall Study|Withdrawal by Subject|0
2927966|NCT01485172|10084633|P2|Overall Study|Withdrawal by Subject|0
2927967|NCT01485172|10084634|P1|Overall Study|Withdrawal by Subject|2
2927968|NCT01485172|10084629|P6|Overall Study|Physician Decision|0
2927969|NCT01485172|10084630|P5|Overall Study|Physician Decision|1
2927970|NCT01485172|10084631|P4|Overall Study|Physician Decision|0
2927971|NCT01485172|10084632|P3|Overall Study|Physician Decision|0
2927972|NCT01485172|10084633|P2|Overall Study|Physician Decision|0
2927973|NCT01485172|10084634|P1|Overall Study|Physician Decision|0
2927974|NCT01485172|10084629|P6|Overall Study|Lost to Follow-up|1
2927975|NCT01485172|10084630|P5|Overall Study|Lost to Follow-up|0
2927976|NCT01485172|10084631|P4|Overall Study|Lost to Follow-up|0
2927977|NCT01485172|10084632|P3|Overall Study|Lost to Follow-up|1
2927978|NCT01485172|10084633|P2|Overall Study|Lost to Follow-up|0
2927979|NCT01485172|10084634|P1|Overall Study|Lost to Follow-up|0
2927980|NCT01485172|10084629|P6|Overall Study|Protocol defined stopping criteria|0
2927981|NCT01485172|10084630|P5|Overall Study|Protocol defined stopping criteria|1
2927982|NCT01485172|10084631|P4|Overall Study|Protocol defined stopping criteria|0
2927983|NCT01485172|10084632|P3|Overall Study|Protocol defined stopping criteria|0
2927984|NCT01485172|10084633|P2|Overall Study|Protocol defined stopping criteria|0
2927985|NCT01485172|10084634|P1|Overall Study|Protocol defined stopping criteria|1
2927986|NCT01485172|10084629|P6|Overall Study|Protocol Violation|0
2927987|NCT01485172|10084630|P5|Overall Study|Protocol Violation|1
2927988|NCT01485172|10084631|P4|Overall Study|Protocol Violation|5
2927989|NCT01485172|10084632|P3|Overall Study|Protocol Violation|4
2927990|NCT01485172|10084633|P2|Overall Study|Protocol Violation|0
2927991|NCT01485172|10084634|P1|Overall Study|Protocol Violation|0
2927992|NCT01485172|10084629|P6|Overall Study|Lack of Efficacy|0
2927993|NCT01485172|10084630|P5|Overall Study|Lack of Efficacy|0
2927994|NCT01485172|10084631|P4|Overall Study|Lack of Efficacy|0
2927995|NCT01485172|10084632|P3|Overall Study|Lack of Efficacy|0
2927996|NCT01485172|10084633|P2|Overall Study|Lack of Efficacy|0
2927997|NCT01485172|10084634|P1|Overall Study|Lack of Efficacy|2
2927998|NCT01485172|10084629|P6|Overall Study|Adverse Event|2
2927999|NCT01485172|10084630|P5|Overall Study|Adverse Event|1
2928000|NCT01485172|10084631|P4|Overall Study|Adverse Event|2
2928001|NCT01485172|10084632|P3|Overall Study|Adverse Event|2
2928002|NCT01485172|10084633|P2|Overall Study|Adverse Event|1
2928003|NCT01485172|10084634|P1|Overall Study|Adverse Event|2
2928004|NCT01485120|10084708|P1|Overall Study|Withdrawal by Subject|2
2928005|NCT01485094|10084716|P3|Overall Study|Withdrawal by Subject|0
2928006|NCT01485094|10084717|P2|Overall Study|Withdrawal by Subject|1
2928007|NCT01485094|10084718|P1|Overall Study|Withdrawal by Subject|1
2928008|NCT01485094|10084716|P3|Overall Study|Lost to Follow-up|0
2928009|NCT01485094|10084717|P2|Overall Study|Lost to Follow-up|0
2928010|NCT01485094|10084718|P1|Overall Study|Lost to Follow-up|1
2928011|NCT01485094|10084716|P3|Overall Study|Adverse Event|1
2928012|NCT01485094|10084717|P2|Overall Study|Adverse Event|1
2928013|NCT01485094|10084718|P1|Overall Study|Adverse Event|1
2928014|NCT01484977|10084763|P1|Overall Study|Lack of Compliance|1
2928015|NCT01484977|10084763|P1|Overall Study|Low White Blood Cell Count|1
2928016|NCT01484977|10084763|P1|Overall Study|Moving Overseas|1
2928017|NCT01484977|10084763|P1|Overall Study|Subject Protocol Non-compliant|1
2928018|NCT01484977|10084763|P1|Overall Study|Withdrawal by Subject|4
2928019|NCT01484977|10084763|P1|Overall Study|Lost to Follow-up|1
2928020|NCT01484977|10084763|P1|Overall Study|Protocol Violation|6
2928021|NCT01484977|10084763|P1|Overall Study|Lack of Efficacy|4
2928022|NCT01484977|10084763|P1|Overall Study|Adverse Event|8
2928023|NCT01484951|10084767|P1|Overall Study|Non-Compliance|1
2928024|NCT01484951|10084767|P1|Overall Study|Personal Reasons|1
2928025|NCT01484951|10084767|P1|Overall Study|Adverse Event|3
2928026|NCT01484938|10084772|P1|Overall Study|Noncompliance|1
2928027|NCT01484938|10084772|P1|Overall Study|Lost to Follow-up|1
2928028|NCT01484938|10084772|P1|Overall Study|Adverse Event|2
2928029|NCT01484912|10084779|P2|Overall Study|Physician Decision|1
2928030|NCT01484912|10084780|P1|Overall Study|Physician Decision|0
2928031|NCT01484912|10084779|P2|Overall Study|Withdrawal by Subject|0
2928032|NCT01484912|10084780|P1|Overall Study|Withdrawal by Subject|1
2928033|NCT01484873|10084790|P1|Overall Study|Withdrawal by Subject|2
2928034|NCT01484834|10084802|P4|Overall Study|Lost to Follow-up|4
2928035|NCT01484834|10084803|P3|Overall Study|Lost to Follow-up|1
2928036|NCT01484834|10084804|P2|Overall Study|Lost to Follow-up|8
2928037|NCT01484834|10084805|P1|Overall Study|Lost to Follow-up|5
2928038|NCT01484561|10084846|P2|Overall Study|Adverse Event|4
2928039|NCT01484561|10084847|P1|Overall Study|Adverse Event|1
2928040|NCT01484561|10084846|P2|Overall Study|Other|1
2928041|NCT01484561|10084847|P1|Overall Study|Other|1
2928042|NCT01484561|10084846|P2|Overall Study|Withdrawal by Subject|0
2928043|NCT01484561|10084847|P1|Overall Study|Withdrawal by Subject|3
2928044|NCT01484561|10084846|P2|Overall Study|Lost to Follow-up|0
2928045|NCT01484561|10084847|P1|Overall Study|Lost to Follow-up|1
2928046|NCT01484561|10084846|P2|Overall Study|Lack of Efficacy|1
2928047|NCT01484561|10084847|P1|Overall Study|Lack of Efficacy|3
2928048|NCT01484496|10084937|P4|Period 2|Other|6
2928049|NCT01484496|10084938|P3|Period 2|Other|9
2928050|NCT01484496|10084939|P2|Period 2|Other|0
2928051|NCT01484496|10084940|P1|Period 2|Other|0
2928052|NCT01484496|10084937|P4|Period 2|Adverse Event|13
2928053|NCT01484496|10084938|P3|Period 2|Adverse Event|5
2928054|NCT01484496|10084939|P2|Period 2|Adverse Event|0
2928055|NCT01484496|10084940|P1|Period 2|Adverse Event|0
2928056|NCT01484496|10084937|P4|Period 2|Lack of Efficacy|3
2928057|NCT01484496|10084938|P3|Period 2|Lack of Efficacy|1
2928058|NCT01484496|10084939|P2|Period 2|Lack of Efficacy|0
2928059|NCT01484496|10084940|P1|Period 2|Lack of Efficacy|0
2928060|NCT01484496|10084937|P4|Period 1|Unable to Visit Site|0
2928061|NCT01484496|10084938|P3|Period 1|Unable to Visit Site|0
2928062|NCT01484496|10084939|P2|Period 1|Unable to Visit Site|2
2928063|NCT01484496|10084940|P1|Period 1|Unable to Visit Site|0
2928064|NCT01484496|10084937|P4|Period 1|Lack of Compliance|0
2928065|NCT01484496|10084938|P3|Period 1|Lack of Compliance|0
2928066|NCT01484496|10084939|P2|Period 1|Lack of Compliance|1
2928067|NCT01484496|10084940|P1|Period 1|Lack of Compliance|2
2928068|NCT01484496|10084937|P4|Period 1|Treatment Failure|0
2928069|NCT01484496|10084938|P3|Period 1|Treatment Failure|0
2928070|NCT01484496|10084939|P2|Period 1|Treatment Failure|6
2928071|NCT01484496|10084940|P1|Period 1|Treatment Failure|3
2928072|NCT01484496|10084937|P4|Period 1|Positive Pregnancy|0
2928073|NCT01484496|10084938|P3|Period 1|Positive Pregnancy|0
2928074|NCT01484496|10084939|P2|Period 1|Positive Pregnancy|6
2928075|NCT01484496|10084940|P1|Period 1|Positive Pregnancy|1
2928076|NCT01484496|10084937|P4|Period 1|Lost to Follow-up|0
2928077|NCT01484496|10084938|P3|Period 1|Lost to Follow-up|0
2928078|NCT01484496|10084939|P2|Period 1|Lost to Follow-up|6
2928079|NCT01484496|10084940|P1|Period 1|Lost to Follow-up|2
2928080|NCT01484496|10084937|P4|Period 1|Withdrawal by Subject|0
2928081|NCT01484496|10084938|P3|Period 1|Withdrawal by Subject|0
2928082|NCT01484496|10084939|P2|Period 1|Withdrawal by Subject|12
2928083|NCT01484496|10084940|P1|Period 1|Withdrawal by Subject|15
2928084|NCT01484496|10084937|P4|Period 1|Adverse Event|0
2928085|NCT01484496|10084938|P3|Period 1|Adverse Event|0
2928086|NCT01484496|10084939|P2|Period 1|Adverse Event|40
2928087|NCT01484496|10084940|P1|Period 1|Adverse Event|25
2928088|NCT01484496|10084937|P4|Period 1|Lack of Efficacy|0
2928089|NCT01484496|10084938|P3|Period 1|Lack of Efficacy|0
2928090|NCT01484496|10084939|P2|Period 1|Lack of Efficacy|15
2928091|NCT01484496|10084940|P1|Period 1|Lack of Efficacy|10
2928092|NCT01484496|10084937|P4|Period 1|Physician Decision|0
2928093|NCT01484496|10084938|P3|Period 1|Physician Decision|0
2928094|NCT01484496|10084939|P2|Period 1|Physician Decision|1
2928095|NCT01484496|10084940|P1|Period 1|Physician Decision|5
2928096|NCT01484496|10084937|P4|Period 1|Protocol Violation|0
2928097|NCT01484496|10084938|P3|Period 1|Protocol Violation|0
2928098|NCT01484496|10084939|P2|Period 1|Protocol Violation|4
2928099|NCT01484496|10084940|P1|Period 1|Protocol Violation|3
2928100|NCT01484431|10084955|P3|Period 2|Non-Compliance with Study Drug|0
2928101|NCT01484431|10084956|P2|Period 2|Non-Compliance with Study Drug|0
2928102|NCT01484431|10084957|P1|Period 2|Non-Compliance with Study Drug|1
2928103|NCT01484431|10084955|P3|Period 2|Physician Decision|1
2928104|NCT01484431|10084956|P2|Period 2|Physician Decision|0
2928105|NCT01484431|10084957|P1|Period 2|Physician Decision|0
2928106|NCT01484431|10084955|P3|Period 2|Death|1
2928107|NCT01484431|10084956|P2|Period 2|Death|1
2928108|NCT01484431|10084957|P1|Period 2|Death|0
2928109|NCT01484431|10084955|P3|Period 1: High Dose|Physician Decision|0
2928110|NCT01484431|10084956|P2|Period 1: High Dose|Physician Decision|1
2928111|NCT01484431|10084957|P1|Period 1: High Dose|Physician Decision|0
2928112|NCT01484275|10084995|P2|Overall Study|Lost to Follow-up|1
2928113|NCT01484275|10084996|P1|Overall Study|Lost to Follow-up|1
2928114|NCT01484275|10084995|P2|Overall Study|Withdrawal by Subject|5
2928115|NCT01484275|10084996|P1|Overall Study|Withdrawal by Subject|1
2928116|NCT01484275|10084995|P2|Overall Study|Death|4
2928117|NCT01484275|10084996|P1|Overall Study|Death|3
2928118|NCT01484275|10084995|P2|Overall Study|Other|0
2928119|NCT01484275|10084996|P1|Overall Study|Other|10
2928120|NCT01484275|10084995|P2|Overall Study|Study terminated by sponsor|32
2928121|NCT01484275|10084996|P1|Overall Study|Study terminated by sponsor|28
2928122|NCT01484197|10085018|P4|Treatment Period 2|Subject withdrew consent|1
2928123|NCT01484197|10085019|P3|Treatment Period 2|Subject withdrew consent|0
2928124|NCT01484197|10085020|P2|Treatment Period 2|Subject withdrew consent|0
2928125|NCT01484197|10085021|P1|Treatment Period 2|Subject withdrew consent|0
2928126|NCT01484197|10085018|P4|Treatment Period 1|Adverse Event|0
2928127|NCT01484197|10085019|P3|Treatment Period 1|Adverse Event|0
2928128|NCT01484197|10085020|P2|Treatment Period 1|Adverse Event|0
2928129|NCT01484197|10085021|P1|Treatment Period 1|Adverse Event|1
2928130|NCT01484132|10085104|P1|Overall Study|No post-treatment urine sample collected|10
2928131|NCT01484132|10085104|P1|Overall Study|No pre-treatment urine sample collected|1
2928132|NCT01484132|10085104|P1|Overall Study|Ineligible|1
2928133|NCT01484132|10085104|P1|Overall Study|Difficulty with time commitment|2
2928134|NCT01484132|10085104|P1|Overall Study|Lost to Follow-up|8
2928135|NCT01484054|10085112|P2|Period 1|Withdrawal by Subject|1
2928136|NCT01484054|10085113|P1|Period 1|Withdrawal by Subject|0
2928137|NCT01484028|10085131|P4|Period 1|Lens Discomfort|0
2928138|NCT01484028|10085132|P3|Period 1|Lens Discomfort|0
2928139|NCT01484028|10085133|P2|Period 1|Lens Discomfort|1
2928140|NCT01484028|10085134|P1|Period 1|Lens Discomfort|0
2928141|NCT01484028|10085131|P4|Period 1|Non-Compliance to Protocol|1
2928142|NCT01484028|10085132|P3|Period 1|Non-Compliance to Protocol|0
2928143|NCT01484028|10085133|P2|Period 1|Non-Compliance to Protocol|1
2928144|NCT01484028|10085134|P1|Period 1|Non-Compliance to Protocol|0
2928145|NCT01484028|10085131|P4|Period 1|Lost to Follow-up|0
2928146|NCT01484028|10085132|P3|Period 1|Lost to Follow-up|0
2928147|NCT01484028|10085133|P2|Period 1|Lost to Follow-up|1
2928148|NCT01484028|10085134|P1|Period 1|Lost to Follow-up|0
2928149|NCT01483937|10085227|P2|Overall Study|Withdrawal by Subject|3
2928150|NCT01483937|10085228|P1|Overall Study|Withdrawal by Subject|4
2928151|NCT01483924|10085255|P5|Overall Study|Sponsor concern over ECG result|0
2928152|NCT01483924|10085256|P4|Overall Study|Sponsor concern over ECG result|1
2928153|NCT01483924|10085257|P3|Overall Study|Sponsor concern over ECG result|0
2928154|NCT01483924|10085258|P2|Overall Study|Sponsor concern over ECG result|0
2928155|NCT01483924|10085259|P1|Overall Study|Sponsor concern over ECG result|0
2928156|NCT01483924|10085255|P5|Overall Study|Non-compliance|1
2928157|NCT01483924|10085256|P4|Overall Study|Non-compliance|1
2928158|NCT01483924|10085257|P3|Overall Study|Non-compliance|0
2928159|NCT01483924|10085258|P2|Overall Study|Non-compliance|0
2928160|NCT01483924|10085259|P1|Overall Study|Non-compliance|0
2928161|NCT01483924|10085255|P5|Overall Study|Adverse Event|0
2928162|NCT01483924|10085256|P4|Overall Study|Adverse Event|1
2928163|NCT01483924|10085257|P3|Overall Study|Adverse Event|1
2928164|NCT01483924|10085258|P2|Overall Study|Adverse Event|0
2928165|NCT01483924|10085259|P1|Overall Study|Adverse Event|0
2928166|NCT01483924|10085255|P5|Overall Study|Withdrawal by Subject|1
2928167|NCT01483924|10085256|P4|Overall Study|Withdrawal by Subject|1
2928168|NCT01483924|10085257|P3|Overall Study|Withdrawal by Subject|0
2928169|NCT01483924|10085258|P2|Overall Study|Withdrawal by Subject|0
2928170|NCT01483924|10085259|P1|Overall Study|Withdrawal by Subject|2
2928171|NCT01483820|10085312|P1|Overall Study|Death|1
2928172|NCT01483820|10085312|P1|Overall Study|Adverse Event|1
2928173|NCT01483820|10085312|P1|Overall Study|Lack of Efficacy|6
2928174|NCT01483651|10085333|P6|Overall Study|Withdrawal by Subject|1
2928175|NCT01483651|10085334|P5|Overall Study|Withdrawal by Subject|0
2928176|NCT01483651|10085335|P4|Overall Study|Withdrawal by Subject|0
2928177|NCT01483651|10085336|P3|Overall Study|Withdrawal by Subject|1
2928178|NCT01483651|10085337|P2|Overall Study|Withdrawal by Subject|1
2928179|NCT01483651|10085338|P1|Overall Study|Withdrawal by Subject|0
2928180|NCT01483625|10085348|P2|Overall Study|Due to other reason|0
2928181|NCT01483625|10085349|P1|Overall Study|Due to other reason|1
2928182|NCT01483625|10085348|P2|Overall Study|Refused to continue medication|1
2928183|NCT01483625|10085349|P1|Overall Study|Refused to continue medication|2
2928184|NCT01483625|10085348|P2|Overall Study|Adverse Event|1
2928185|NCT01483625|10085349|P1|Overall Study|Adverse Event|1
2928186|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Other|0
2928187|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Other|1
2928188|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Other|0
2928189|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Other|0
2928190|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Other|4
2928191|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Other|0
2928192|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Other|1
2928193|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Other|0
2928194|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Other|0
2928195|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Other|0
2928196|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Other|0
2928197|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Other|0
2928198|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Other|0
2928199|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Other|0
2928200|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
2928201|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
2928202|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928203|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928204|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928205|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
2928206|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928207|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928208|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928209|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928210|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928211|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928212|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928213|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2928214|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2928215|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928216|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928217|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
2928218|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928219|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2928220|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928221|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928222|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928223|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928224|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928225|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928226|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928227|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2928228|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2928229|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928230|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2928231|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928232|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928233|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2928234|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928235|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928236|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928237|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928238|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928239|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928240|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928241|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2928242|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2928243|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2928244|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928245|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928246|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928247|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2928248|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2928249|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928250|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928251|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928252|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928253|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928254|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928255|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2928256|NCT01483599|10085372|P14|After Controlled Period(Week 16-Week 40)|Death|0
2928257|NCT01483599|10085373|P13|After Controlled Period(Week 16-Week 40)|Death|0
2928258|NCT01483599|10085374|P12|After Controlled Period(Week 16-Week 40)|Death|0
2928259|NCT01483599|10085375|P11|After Controlled Period(Week 16-Week 40)|Death|0
2928260|NCT01483599|10085376|P10|After Controlled Period(Week 16-Week 40)|Death|0
2928261|NCT01483599|10085377|P9|After Controlled Period(Week 16-Week 40)|Death|1
2928262|NCT01483599|10085378|P8|After Controlled Period(Week 16-Week 40)|Death|0
2928263|NCT01483599|10085379|P7|After Controlled Period(Week 16-Week 40)|Death|0
2928264|NCT01483599|10085380|P6|After Controlled Period(Week 16-Week 40)|Death|0
2928265|NCT01483599|10085381|P5|After Controlled Period(Week 16-Week 40)|Death|0
2928266|NCT01483599|10085382|P4|After Controlled Period(Week 16-Week 40)|Death|0
2928267|NCT01483599|10085383|P3|After Controlled Period(Week 16-Week 40)|Death|0
2928268|NCT01483599|10085384|P2|After Controlled Period(Week 16-Week 40)|Death|0
2928269|NCT01483599|10085385|P1|After Controlled Period(Week 16-Week 40)|Death|0
2928270|NCT01483599|10085372|P14|Controlled Period (CP) (up to Week 16)|Other|0
2928271|NCT01483599|10085373|P13|Controlled Period (CP) (up to Week 16)|Other|0
2928272|NCT01483599|10085374|P12|Controlled Period (CP) (up to Week 16)|Other|0
2928273|NCT01483599|10085375|P11|Controlled Period (CP) (up to Week 16)|Other|0
2928274|NCT01483599|10085376|P10|Controlled Period (CP) (up to Week 16)|Other|0
2928275|NCT01483599|10085377|P9|Controlled Period (CP) (up to Week 16)|Other|0
2928276|NCT01483599|10085378|P8|Controlled Period (CP) (up to Week 16)|Other|0
2928277|NCT01483599|10085379|P7|Controlled Period (CP) (up to Week 16)|Other|0
2928278|NCT01483599|10085380|P6|Controlled Period (CP) (up to Week 16)|Other|0
2928279|NCT01483599|10085381|P5|Controlled Period (CP) (up to Week 16)|Other|1
2928280|NCT01483599|10085382|P4|Controlled Period (CP) (up to Week 16)|Other|1
2928281|NCT01483599|10085383|P3|Controlled Period (CP) (up to Week 16)|Other|0
2928282|NCT01483599|10085384|P2|Controlled Period (CP) (up to Week 16)|Other|2
2928283|NCT01483599|10085385|P1|Controlled Period (CP) (up to Week 16)|Other|0
2928284|NCT01483599|10085372|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928285|NCT01483599|10085373|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928286|NCT01483599|10085374|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928287|NCT01483599|10085375|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928288|NCT01483599|10085376|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928289|NCT01483599|10085377|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928290|NCT01483599|10085378|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928291|NCT01483599|10085379|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928292|NCT01483599|10085380|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928293|NCT01483599|10085381|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928294|NCT01483599|10085382|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928295|NCT01483599|10085383|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928296|NCT01483599|10085384|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2928297|NCT01483599|10085385|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
2928298|NCT01483599|10085372|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928299|NCT01483599|10085373|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928300|NCT01483599|10085374|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928301|NCT01483599|10085375|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928302|NCT01483599|10085376|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928303|NCT01483599|10085377|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928304|NCT01483599|10085378|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928305|NCT01483599|10085379|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2928306|NCT01483599|10085380|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928307|NCT01483599|10085381|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928308|NCT01483599|10085382|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2928309|NCT01483599|10085383|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928310|NCT01483599|10085384|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2928311|NCT01483599|10085385|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2928312|NCT01483599|10085372|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928313|NCT01483599|10085373|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928314|NCT01483599|10085374|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928315|NCT01483599|10085375|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928316|NCT01483599|10085376|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928317|NCT01483599|10085377|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928318|NCT01483599|10085378|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928319|NCT01483599|10085379|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
2928320|NCT01483599|10085380|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
2928321|NCT01483599|10085381|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2928322|NCT01483599|10085382|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2928323|NCT01483599|10085383|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928324|NCT01483599|10085384|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2928325|NCT01483599|10085385|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
2928326|NCT01483183|10085498|P10|Overall Study|Withdrawal by Subject|1
2928327|NCT01483183|10085499|P9|Overall Study|Withdrawal by Subject|0
2928328|NCT01483183|10085500|P8|Overall Study|Withdrawal by Subject|0
2928329|NCT01483183|10085501|P7|Overall Study|Withdrawal by Subject|0
2928330|NCT01483183|10085502|P6|Overall Study|Withdrawal by Subject|0
2928331|NCT01483183|10085503|P5|Overall Study|Withdrawal by Subject|0
2928332|NCT01483183|10085504|P4|Overall Study|Withdrawal by Subject|0
2928333|NCT01483183|10085505|P3|Overall Study|Withdrawal by Subject|0
2928334|NCT01483183|10085506|P2|Overall Study|Withdrawal by Subject|0
2928335|NCT01483183|10085507|P1|Overall Study|Withdrawal by Subject|0
2928336|NCT01483183|10085498|P10|Overall Study|Physician Decision|0
2928337|NCT01483183|10085499|P9|Overall Study|Physician Decision|0
2928338|NCT01483183|10085500|P8|Overall Study|Physician Decision|0
2928339|NCT01483183|10085501|P7|Overall Study|Physician Decision|2
2928340|NCT01483183|10085502|P6|Overall Study|Physician Decision|0
2928341|NCT01483183|10085503|P5|Overall Study|Physician Decision|0
2928342|NCT01483183|10085504|P4|Overall Study|Physician Decision|0
2928343|NCT01483183|10085505|P3|Overall Study|Physician Decision|0
2928344|NCT01483183|10085506|P2|Overall Study|Physician Decision|0
2928345|NCT01483183|10085507|P1|Overall Study|Physician Decision|0
2928346|NCT01483118|10085577|P2|Overall Study|Lost to Follow-up|16
2928347|NCT01483118|10085578|P1|Overall Study|Lost to Follow-up|12
2928348|NCT01482962|10085590|P2|Overall Study|Did not Receive Study Drug|6
2928349|NCT01482962|10085591|P1|Overall Study|Did not Receive Study Drug|1
2928350|NCT01482962|10085590|P2|Overall Study|Study Terminated by Sponsor|2
2928351|NCT01482962|10085591|P1|Overall Study|Study Terminated by Sponsor|5
2928352|NCT01482962|10085590|P2|Overall Study|Other Reason|5
2928353|NCT01482962|10085591|P1|Overall Study|Other Reason|1
2928354|NCT01482962|10085590|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
2928355|NCT01482962|10085591|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
2928356|NCT01482962|10085590|P2|Overall Study|Withdrawal by Participant|13
2928357|NCT01482962|10085591|P1|Overall Study|Withdrawal by Participant|8
2928358|NCT01482962|10085590|P2|Overall Study|Adverse Event|22
2928359|NCT01482962|10085591|P1|Overall Study|Adverse Event|18
2928360|NCT01482962|10085590|P2|Overall Study|Unsatisfactory Therapeutic Response|23
2928361|NCT01482962|10085591|P1|Overall Study|Unsatisfactory Therapeutic Response|37
2928362|NCT01482962|10085590|P2|Overall Study|Progressive Disease|53
2928363|NCT01482962|10085591|P1|Overall Study|Progressive Disease|65
2928364|NCT01482910|10085624|P2|Overall Study|Death|0
2928365|NCT01482910|10085625|P1|Overall Study|Death|1
2928366|NCT01482910|10085624|P2|Overall Study|Withdrawal by Subject|2
2928367|NCT01482910|10085625|P1|Overall Study|Withdrawal by Subject|7
2928368|NCT01482910|10085624|P2|Overall Study|Protocol Violation|1
2928369|NCT01482910|10085625|P1|Overall Study|Protocol Violation|1
2928370|NCT01482910|10085624|P2|Overall Study|Lost to Follow-up|1
2928371|NCT01482910|10085625|P1|Overall Study|Lost to Follow-up|0
2928372|NCT01482910|10085624|P2|Overall Study|Adverse Event|5
2928373|NCT01482910|10085625|P1|Overall Study|Adverse Event|6
2928374|NCT01482884|10085637|P2|Overall Study|Withdrawal by Subject|13
2928375|NCT01482884|10085638|P1|Overall Study|Withdrawal by Subject|8
2928376|NCT01482884|10085637|P2|Overall Study|Adverse Event|1
2928377|NCT01482884|10085638|P1|Overall Study|Adverse Event|2
2928378|NCT01482884|10085637|P2|Overall Study|Lack of Efficacy|1
2928379|NCT01482884|10085638|P1|Overall Study|Lack of Efficacy|0
2928380|NCT01482884|10085637|P2|Overall Study|Lost to Follow-up|2
2928381|NCT01482884|10085638|P1|Overall Study|Lost to Follow-up|2
2928382|NCT01482884|10085637|P2|Overall Study|Protocol Violation|0
2928383|NCT01482884|10085638|P1|Overall Study|Protocol Violation|1
2928384|NCT01482884|10085637|P2|Overall Study|Medical decision due to lack of efficacy|1
2928385|NCT01482884|10085638|P1|Overall Study|Medical decision due to lack of efficacy|0
2928386|NCT01482819|10085664|P1|Overall Study|Lost to Follow-up|2
2928387|NCT01482767|10085684|P2|Overall Study|Nurse error|0
2928388|NCT01482767|10085685|P1|Overall Study|Nurse error|1
2928389|NCT01482767|10085684|P2|Overall Study|Ineligible|5
2928390|NCT01482767|10085685|P1|Overall Study|Ineligible|0
2928391|NCT01482767|10085684|P2|Overall Study|Alternate HCV treatment|8
2928392|NCT01482767|10085685|P1|Overall Study|Alternate HCV treatment|7
2928393|NCT01482767|10085684|P2|Overall Study|Non-adherence to study requirements|7
2928394|NCT01482767|10085685|P1|Overall Study|Non-adherence to study requirements|4
2928395|NCT01482767|10085684|P2|Overall Study|Site closure|14
2928396|NCT01482767|10085685|P1|Overall Study|Site closure|22
2928397|NCT01482767|10085684|P2|Overall Study|Adverse Event|3
2928398|NCT01482767|10085685|P1|Overall Study|Adverse Event|0
2928399|NCT01482767|10085684|P2|Overall Study|Lost to Follow-up|6
2928400|NCT01482767|10085685|P1|Overall Study|Lost to Follow-up|12
2928401|NCT01482767|10085684|P2|Overall Study|Withdrawal by Subject|5
2928402|NCT01482767|10085685|P1|Overall Study|Withdrawal by Subject|7
2928403|NCT01482767|10085684|P2|Overall Study|Death|1
2928404|NCT01482767|10085685|P1|Overall Study|Death|1
2928405|NCT01482429|10085707|P2|Protocol|Protocol Violation|0
2928406|NCT01482429|10085708|P1|Protocol|Protocol Violation|275
2928407|NCT01482429|10085707|P2|Care Usual|Lost to Follow-up|1
2928408|NCT01482429|10085708|P1|Care Usual|Lost to Follow-up|0
2928409|NCT01482429|10085707|P2|Care Usual|Protocol Violation|172
2928410|NCT01482429|10085708|P1|Care Usual|Protocol Violation|0
2928411|NCT01482312|10085744|P3|Period 2, 90 Minutes of Wear|Other|0
2928412|NCT01482312|10085745|P2|Period 2, 90 Minutes of Wear|Other|0
2928413|NCT01482312|10085746|P1|Period 2, 90 Minutes of Wear|Other|1
2928414|NCT01482312|10085744|P3|Period 1, 90 Minutes of Wear|Other|0
2928415|NCT01482312|10085745|P2|Period 1, 90 Minutes of Wear|Other|0
2928416|NCT01482312|10085746|P1|Period 1, 90 Minutes of Wear|Other|1
2928417|NCT01482221|10085760|P3|Overall Study|Physician Decision|0
2928418|NCT01482221|10085761|P2|Overall Study|Physician Decision|1
2928419|NCT01482221|10085762|P1|Overall Study|Physician Decision|0
2928420|NCT01482221|10085760|P3|Overall Study|Incorrect randomization|0
2928421|NCT01482221|10085761|P2|Overall Study|Incorrect randomization|1
2928422|NCT01482221|10085762|P1|Overall Study|Incorrect randomization|0
2928423|NCT01482221|10085760|P3|Overall Study|Withdrawal by Subject|12
2928424|NCT01482221|10085761|P2|Overall Study|Withdrawal by Subject|7
2928425|NCT01482221|10085762|P1|Overall Study|Withdrawal by Subject|10
2928426|NCT01482221|10085760|P3|Overall Study|Adverse Event|3
2928427|NCT01482221|10085761|P2|Overall Study|Adverse Event|7
2928428|NCT01482221|10085762|P1|Overall Study|Adverse Event|1
2928429|NCT01482221|10085760|P3|Overall Study|Severe Non-Compliance to Protocol|1
2928430|NCT01482221|10085761|P2|Overall Study|Severe Non-Compliance to Protocol|0
2928431|NCT01482221|10085762|P1|Overall Study|Severe Non-Compliance to Protocol|1
2928432|NCT01482221|10085760|P3|Overall Study|Condition under Investigation Worsened|4
2928433|NCT01482221|10085761|P2|Overall Study|Condition under Investigation Worsened|2
2928434|NCT01482221|10085762|P1|Overall Study|Condition under Investigation Worsened|3
2928435|NCT01482221|10085760|P3|Overall Study|Study-Specific Withdrawal Criteria|1
2928436|NCT01482221|10085761|P2|Overall Study|Study-Specific Withdrawal Criteria|0
2928437|NCT01482221|10085762|P1|Overall Study|Study-Specific Withdrawal Criteria|2
2928438|NCT01482221|10085760|P3|Overall Study|Lost to Follow-up|1
2928439|NCT01482221|10085761|P2|Overall Study|Lost to Follow-up|2
2928440|NCT01482221|10085762|P1|Overall Study|Lost to Follow-up|3
2928441|NCT01482221|10085760|P3|Overall Study|Lack of Efficacy|1
2928442|NCT01482221|10085761|P2|Overall Study|Lack of Efficacy|0
2928443|NCT01482221|10085762|P1|Overall Study|Lack of Efficacy|1
2928444|NCT01482169|10085803|P1|Overall Study|Physician Decision|2
2928445|NCT01482065|10085845|P2|Overall Study|Withdrawal by Subject|1
2928446|NCT01482065|10085846|P1|Overall Study|Withdrawal by Subject|0
2928447|NCT01481896|10085867|P1|Overall Study|Lost to Follow-up|12
2928448|NCT01481779|10085883|P2|Overall Study|Sponsor Decision|1
2928449|NCT01481779|10085884|P1|Overall Study|Sponsor Decision|3
2928450|NCT01481779|10085883|P2|Overall Study|Physician Decision|4
2928451|NCT01481779|10085884|P1|Overall Study|Physician Decision|13
2928452|NCT01481779|10085883|P2|Overall Study|Withdrawal by Subject|13
2928453|NCT01481779|10085884|P1|Overall Study|Withdrawal by Subject|26
2928454|NCT01481779|10085883|P2|Overall Study|Protocol Violation|3
2928455|NCT01481779|10085884|P1|Overall Study|Protocol Violation|2
2928456|NCT01481779|10085883|P2|Overall Study|Lost to Follow-up|2
2928457|NCT01481779|10085884|P1|Overall Study|Lost to Follow-up|3
2928458|NCT01481779|10085883|P2|Overall Study|Adverse Event|5
2928459|NCT01481779|10085884|P1|Overall Study|Adverse Event|23
2928460|NCT01481324|10085969|P3|Overall Study|Missing Data|2
2928461|NCT01481324|10085970|P2|Overall Study|Missing Data|2
2928462|NCT01481324|10085971|P1|Overall Study|Missing Data|0
2928463|NCT01481116|10085990|P3|Overall Study|Hypoglycemic Event|0
2928464|NCT01481116|10085991|P2|Overall Study|Hypoglycemic Event|0
2928465|NCT01481116|10085992|P1|Overall Study|Hypoglycemic Event|4
2928466|NCT01481116|10085990|P3|Overall Study|Death|0
2928467|NCT01481116|10085991|P2|Overall Study|Death|1
2928468|NCT01481116|10085992|P1|Overall Study|Death|2
2928469|NCT01481116|10085990|P3|Overall Study|Investigator's Discretion|0
2928470|NCT01481116|10085991|P2|Overall Study|Investigator's Discretion|0
2928471|NCT01481116|10085992|P1|Overall Study|Investigator's Discretion|2
2928472|NCT01481116|10085990|P3|Overall Study|Non-Compliant With Study Drug|1
2928473|NCT01481116|10085991|P2|Overall Study|Non-Compliant With Study Drug|1
2928474|NCT01481116|10085992|P1|Overall Study|Non-Compliant With Study Drug|0
2928475|NCT01481116|10085990|P3|Overall Study|Sponsor Decision|3
2928476|NCT01481116|10085991|P2|Overall Study|Sponsor Decision|1
2928477|NCT01481116|10085992|P1|Overall Study|Sponsor Decision|0
2928478|NCT01481116|10085990|P3|Overall Study|Investigator Decision|1
2928479|NCT01481116|10085991|P2|Overall Study|Investigator Decision|2
2928480|NCT01481116|10085992|P1|Overall Study|Investigator Decision|3
2928481|NCT01481116|10085990|P3|Overall Study|Participant Moved Out of Country|1
2928482|NCT01481116|10085991|P2|Overall Study|Participant Moved Out of Country|0
2928483|NCT01481116|10085992|P1|Overall Study|Participant Moved Out of Country|1
2928484|NCT01481116|10085990|P3|Overall Study|Participant Moved Out of Area|1
2928485|NCT01481116|10085991|P2|Overall Study|Participant Moved Out of Area|0
2928486|NCT01481116|10085992|P1|Overall Study|Participant Moved Out of Area|2
2928487|NCT01481116|10085990|P3|Overall Study|Participant Started Taking Glipizide|0
2928488|NCT01481116|10085991|P2|Overall Study|Participant Started Taking Glipizide|0
2928489|NCT01481116|10085992|P1|Overall Study|Participant Started Taking Glipizide|1
2928490|NCT01481116|10085990|P3|Overall Study|Other|0
2928491|NCT01481116|10085991|P2|Overall Study|Other|1
2928492|NCT01481116|10085992|P1|Overall Study|Other|1
2928493|NCT01481116|10085990|P3|Overall Study|Contraindications|0
2928494|NCT01481116|10085991|P2|Overall Study|Contraindications|1
2928495|NCT01481116|10085992|P1|Overall Study|Contraindications|1
2928496|NCT01481116|10085990|P3|Overall Study|Lack of Efficacy|1
2928497|NCT01481116|10085991|P2|Overall Study|Lack of Efficacy|3
2928498|NCT01481116|10085992|P1|Overall Study|Lack of Efficacy|3
2928499|NCT01481116|10085990|P3|Overall Study|Pregnancy|1
2928500|NCT01481116|10085991|P2|Overall Study|Pregnancy|0
2928501|NCT01481116|10085992|P1|Overall Study|Pregnancy|0
2928502|NCT01481116|10085990|P3|Overall Study|Study Termination|713
2928503|NCT01481116|10085991|P2|Overall Study|Study Termination|729
2928504|NCT01481116|10085992|P1|Overall Study|Study Termination|730
2928505|NCT01481116|10085990|P3|Overall Study|Withdrawal by Subject|37
2928506|NCT01481116|10085991|P2|Overall Study|Withdrawal by Subject|33
2928507|NCT01481116|10085992|P1|Overall Study|Withdrawal by Subject|37
2928508|NCT01481116|10085990|P3|Overall Study|Lost to Follow-up|11
2928509|NCT01481116|10085991|P2|Overall Study|Lost to Follow-up|12
2928510|NCT01481116|10085992|P1|Overall Study|Lost to Follow-up|8
2928511|NCT01481116|10085990|P3|Overall Study|Major Protocol Deviation|1
2928512|NCT01481116|10085991|P2|Overall Study|Major Protocol Deviation|7
2928513|NCT01481116|10085992|P1|Overall Study|Major Protocol Deviation|3
2928514|NCT01481116|10085990|P3|Overall Study|Adverse Event|42
2928515|NCT01481116|10085991|P2|Overall Study|Adverse Event|26
2928516|NCT01481116|10085992|P1|Overall Study|Adverse Event|26
2928517|NCT01480674|10086023|P1|Overall Study|visit not done|10
2928518|NCT01480674|10086023|P1|Overall Study|Lost to Follow-up|2
2928519|NCT01480674|10086023|P1|Overall Study|Death|23
2928520|NCT01480596|10086037|P2|Overall Study|MG exacerbation or change in medication|2
2928521|NCT01480596|10086038|P1|Overall Study|MG exacerbation or change in medication|2
2928522|NCT01480596|10086037|P2|Overall Study|Adverse Event|0
2928523|NCT01480596|10086038|P1|Overall Study|Adverse Event|3
2928524|NCT01480284|10086086|P2|Overall Study|Physician Decision|0
2928525|NCT01480284|10086087|P1|Overall Study|Physician Decision|1
2928526|NCT01480284|10086086|P2|Overall Study|Lost to Follow-up|0
2928527|NCT01480284|10086087|P1|Overall Study|Lost to Follow-up|1
2928528|NCT01480284|10086086|P2|Overall Study|Study closed/terminated|0
2928529|NCT01480284|10086087|P1|Overall Study|Study closed/terminated|3
2928530|NCT01480284|10086086|P2|Overall Study|Adverse Event|0
2928531|NCT01480284|10086087|P1|Overall Study|Adverse Event|1
2928532|NCT01480284|10086086|P2|Overall Study|Withdrawal by Subject|0
2928533|NCT01480284|10086087|P1|Overall Study|Withdrawal by Subject|2
2928534|NCT01480258|10086117|P2|Interim Period|Withdrawal by Subject|6
2928535|NCT01480258|10086118|P1|Interim Period|Withdrawal by Subject|9
2928536|NCT01480258|10086117|P2|Interim Period|Protocol Violation|1
2928537|NCT01480258|10086118|P1|Interim Period|Protocol Violation|0
2928538|NCT01480258|10086117|P2|Interim Period|Physician Decision|0
2928539|NCT01480258|10086118|P1|Interim Period|Physician Decision|1
2928540|NCT01480258|10086117|P2|Interim Period|Lost to Follow-up|2
2928541|NCT01480258|10086118|P1|Interim Period|Lost to Follow-up|0
2928542|NCT01480258|10086117|P2|Infant Series|Withdrawal by Subject|6
2928543|NCT01480258|10086118|P1|Infant Series|Withdrawal by Subject|1
2928544|NCT01480258|10086117|P2|Infant Series|Adverse Event|1
2928545|NCT01480258|10086118|P1|Infant Series|Adverse Event|1
2928546|NCT01480258|10086117|P2|Infant Series|Not Vaccinated|0
2928547|NCT01480258|10086118|P1|Infant Series|Not Vaccinated|3
2928548|NCT01480258|10086117|P2|Infant Series|Physician Decision|1
2928549|NCT01480258|10086118|P1|Infant Series|Physician Decision|0
2928550|NCT01480258|10086117|P2|Infant Series|Protocol Violation|0
2928551|NCT01480258|10086118|P1|Infant Series|Protocol Violation|2
2928552|NCT01480180|10086184|P6|Extension Phase, Part 2|Unclassified|0
2928553|NCT01480180|10086185|P5|Extension Phase, Part 2|Unclassified|1
2928554|NCT01480180|10086186|P4|Extension Phase, Part 2|Unclassified|1
2928555|NCT01480180|10086187|P3|Extension Phase, Part 2|Unclassified|3
2928556|NCT01480180|10086188|P2|Extension Phase, Part 2|Unclassified|0
2928557|NCT01480180|10086189|P1|Extension Phase, Part 2|Unclassified|0
2928558|NCT01480180|10086184|P6|Extension Phase, Part 2|Lack of Efficacy|0
2928559|NCT01480180|10086185|P5|Extension Phase, Part 2|Lack of Efficacy|0
2928560|NCT01480180|10086186|P4|Extension Phase, Part 2|Lack of Efficacy|0
2928561|NCT01480180|10086187|P3|Extension Phase, Part 2|Lack of Efficacy|4
2928562|NCT01480180|10086188|P2|Extension Phase, Part 2|Lack of Efficacy|0
2928563|NCT01480180|10086189|P1|Extension Phase, Part 2|Lack of Efficacy|0
2928564|NCT01480180|10086184|P6|Extension Phase, Part 2|Withdrawal criteria|0
2928565|NCT01480180|10086185|P5|Extension Phase, Part 2|Withdrawal criteria|1
2928566|NCT01480180|10086186|P4|Extension Phase, Part 2|Withdrawal criteria|6
2928567|NCT01480180|10086187|P3|Extension Phase, Part 2|Withdrawal criteria|10
2928568|NCT01480180|10086188|P2|Extension Phase, Part 2|Withdrawal criteria|0
2928569|NCT01480180|10086189|P1|Extension Phase, Part 2|Withdrawal criteria|0
2928570|NCT01480180|10086184|P6|Extension Phase, Part 1|Change of treatment|0
2928571|NCT01480180|10086185|P5|Extension Phase, Part 1|Change of treatment|0
2928572|NCT01480180|10086186|P4|Extension Phase, Part 1|Change of treatment|9
2928573|NCT01480180|10086187|P3|Extension Phase, Part 1|Change of treatment|0
2928574|NCT01480180|10086188|P2|Extension Phase, Part 1|Change of treatment|0
2928575|NCT01480180|10086189|P1|Extension Phase, Part 1|Change of treatment|0
2928576|NCT01480180|10086184|P6|Extension Phase, Part 1|Adverse Event|0
2928577|NCT01480180|10086185|P5|Extension Phase, Part 1|Adverse Event|0
2928578|NCT01480180|10086186|P4|Extension Phase, Part 1|Adverse Event|1
2928579|NCT01480180|10086187|P3|Extension Phase, Part 1|Adverse Event|4
2928580|NCT01480180|10086188|P2|Extension Phase, Part 1|Adverse Event|0
2928581|NCT01480180|10086189|P1|Extension Phase, Part 1|Adverse Event|0
2928582|NCT01480180|10086184|P6|Extension Phase, Part 1|Unclassified|0
2928583|NCT01480180|10086185|P5|Extension Phase, Part 1|Unclassified|0
2928584|NCT01480180|10086186|P4|Extension Phase, Part 1|Unclassified|0
2928585|NCT01480180|10086187|P3|Extension Phase, Part 1|Unclassified|1
2928586|NCT01480180|10086188|P2|Extension Phase, Part 1|Unclassified|0
2928587|NCT01480180|10086189|P1|Extension Phase, Part 1|Unclassified|0
2928588|NCT01480180|10086184|P6|Extension Phase, Part 1|Withdrawal criteria|0
2928589|NCT01480180|10086185|P5|Extension Phase, Part 1|Withdrawal criteria|0
2928590|NCT01480180|10086186|P4|Extension Phase, Part 1|Withdrawal criteria|0
2928591|NCT01480180|10086187|P3|Extension Phase, Part 1|Withdrawal criteria|5
2928592|NCT01480180|10086188|P2|Extension Phase, Part 1|Withdrawal criteria|0
2928593|NCT01480180|10086189|P1|Extension Phase, Part 1|Withdrawal criteria|0
2928594|NCT01480180|10086184|P6|Main Phase|Unclassified|0
2928595|NCT01480180|10086185|P5|Main Phase|Unclassified|0
2928596|NCT01480180|10086186|P4|Main Phase|Unclassified|0
2928597|NCT01480180|10086187|P3|Main Phase|Unclassified|0
2928598|NCT01480180|10086188|P2|Main Phase|Unclassified|0
2928599|NCT01480180|10086189|P1|Main Phase|Unclassified|3
2928600|NCT01480180|10086184|P6|Main Phase|Non-compliance|0
2928601|NCT01480180|10086185|P5|Main Phase|Non-compliance|0
2928602|NCT01480180|10086186|P4|Main Phase|Non-compliance|0
2928603|NCT01480180|10086187|P3|Main Phase|Non-compliance|0
2928604|NCT01480180|10086188|P2|Main Phase|Non-compliance|0
2928605|NCT01480180|10086189|P1|Main Phase|Non-compliance|3
2928606|NCT01480180|10086184|P6|Main Phase|Lack of Efficacy|0
2928607|NCT01480180|10086185|P5|Main Phase|Lack of Efficacy|0
2928608|NCT01480180|10086186|P4|Main Phase|Lack of Efficacy|0
2928609|NCT01480180|10086187|P3|Main Phase|Lack of Efficacy|0
2928610|NCT01480180|10086188|P2|Main Phase|Lack of Efficacy|0
2928611|NCT01480180|10086189|P1|Main Phase|Lack of Efficacy|1
2928612|NCT01480180|10086184|P6|Main Phase|Withdrawal criteria|0
2928613|NCT01480180|10086185|P5|Main Phase|Withdrawal criteria|0
2928614|NCT01480180|10086186|P4|Main Phase|Withdrawal criteria|0
2928615|NCT01480180|10086187|P3|Main Phase|Withdrawal criteria|0
2928616|NCT01480180|10086188|P2|Main Phase|Withdrawal criteria|1
2928617|NCT01480180|10086189|P1|Main Phase|Withdrawal criteria|12
2928618|NCT01480076|10086357|P1|Overall Study|Other|52
2928619|NCT01480076|10086357|P1|Overall Study|Investigator Decision|13
2928620|NCT01480076|10086357|P1|Overall Study|Lost to Follow-up|7
2928621|NCT01480076|10086357|P1|Overall Study|Withdrawal by Subject|105
2928622|NCT01480076|10086357|P1|Overall Study|Non-compliance With Study Protocol|15
2928623|NCT01480076|10086357|P1|Overall Study|Disease Progression|5
2928624|NCT01480076|10086357|P1|Overall Study|Death|2
2928625|NCT01480076|10086357|P1|Overall Study|Adverse Event|39
2928626|NCT01480076|10086357|P1|Overall Study|Run-in Failure|52
2928627|NCT01479868|10086487|P1|Overall Study|Initiation of new HCV Therapy|1
2928628|NCT01479868|10086487|P1|Overall Study|Sponsor's Decision|1
2928629|NCT01479868|10086487|P1|Overall Study|Withdrawal by Subject|1
2928630|NCT01479868|10086487|P1|Overall Study|Protocol Violation|1
2928631|NCT01479868|10086487|P1|Overall Study|Lost to Follow-up|4
2928632|NCT01479868|10086487|P1|Overall Study|Adverse Event|1
2928633|NCT01479777|10086502|P1|Overall Study|Physician Decision|2
2928634|NCT01479764|10086514|P2|Treated|Lost to Follow-up|2
2928635|NCT01479764|10086515|P1|Treated|Lost to Follow-up|0
2928636|NCT01479764|10086514|P2|Randomized|Withdrawal by Subject|0
2928637|NCT01479764|10086515|P1|Randomized|Withdrawal by Subject|1
2928638|NCT01479764|10086514|P2|Randomized|Adverse Event|1
2928639|NCT01479764|10086515|P1|Randomized|Adverse Event|1
2928640|NCT01479621|10086538|P7|Treatment Period|Met stopping criteria|6
2928641|NCT01479621|10086539|P6|Treatment Period|Met stopping criteria|20
2928642|NCT01479621|10086540|P5|Treatment Period|Met stopping criteria|9
2928643|NCT01479621|10086541|P4|Treatment Period|Met stopping criteria|4
2928644|NCT01479621|10086542|P3|Treatment Period|Met stopping criteria|7
2928645|NCT01479621|10086543|P2|Treatment Period|Met stopping criteria|8
2928646|NCT01479621|10086544|P1|Treatment Period|Met stopping criteria|0
2928647|NCT01479621|10086538|P7|Treatment Period|Lost to Follow-up|1
2928648|NCT01479621|10086539|P6|Treatment Period|Lost to Follow-up|2
2928649|NCT01479621|10086540|P5|Treatment Period|Lost to Follow-up|2
2928650|NCT01479621|10086541|P4|Treatment Period|Lost to Follow-up|0
2928651|NCT01479621|10086542|P3|Treatment Period|Lost to Follow-up|1
2928652|NCT01479621|10086543|P2|Treatment Period|Lost to Follow-up|0
2928653|NCT01479621|10086544|P1|Treatment Period|Lost to Follow-up|0
2928654|NCT01479621|10086538|P7|Treatment Period|Sponsor request subject to be withdrawn|3
2928655|NCT01479621|10086539|P6|Treatment Period|Sponsor request subject to be withdrawn|1
2928656|NCT01479621|10086540|P5|Treatment Period|Sponsor request subject to be withdrawn|1
2928657|NCT01479621|10086541|P4|Treatment Period|Sponsor request subject to be withdrawn|1
2928658|NCT01479621|10086542|P3|Treatment Period|Sponsor request subject to be withdrawn|3
2928659|NCT01479621|10086543|P2|Treatment Period|Sponsor request subject to be withdrawn|2
2928660|NCT01479621|10086544|P1|Treatment Period|Sponsor request subject to be withdrawn|0
2928661|NCT01479621|10086538|P7|Treatment Period|Pregnancy|0
2928662|NCT01479621|10086539|P6|Treatment Period|Pregnancy|0
2928663|NCT01479621|10086540|P5|Treatment Period|Pregnancy|0
2928664|NCT01479621|10086541|P4|Treatment Period|Pregnancy|0
2928665|NCT01479621|10086542|P3|Treatment Period|Pregnancy|2
2928666|NCT01479621|10086543|P2|Treatment Period|Pregnancy|0
2928667|NCT01479621|10086544|P1|Treatment Period|Pregnancy|0
2928668|NCT01479621|10086538|P7|Treatment Period|Protocol Violation|6
2928669|NCT01479621|10086539|P6|Treatment Period|Protocol Violation|10
2928670|NCT01479621|10086540|P5|Treatment Period|Protocol Violation|2
2928671|NCT01479621|10086541|P4|Treatment Period|Protocol Violation|5
2928672|NCT01479621|10086542|P3|Treatment Period|Protocol Violation|6
2928673|NCT01479621|10086543|P2|Treatment Period|Protocol Violation|9
2928674|NCT01479621|10086544|P1|Treatment Period|Protocol Violation|0
2928675|NCT01479621|10086538|P7|Treatment Period|Non-compliance to study drug|1
2928676|NCT01479621|10086539|P6|Treatment Period|Non-compliance to study drug|0
2928677|NCT01479621|10086540|P5|Treatment Period|Non-compliance to study drug|0
2928678|NCT01479621|10086541|P4|Treatment Period|Non-compliance to study drug|0
2928679|NCT01479621|10086542|P3|Treatment Period|Non-compliance to study drug|0
2928680|NCT01479621|10086543|P2|Treatment Period|Non-compliance to study drug|1
2928681|NCT01479621|10086544|P1|Treatment Period|Non-compliance to study drug|0
2928682|NCT01479621|10086538|P7|Treatment Period|Physician Decision|0
2928683|NCT01479621|10086539|P6|Treatment Period|Physician Decision|1
2928684|NCT01479621|10086540|P5|Treatment Period|Physician Decision|1
2928685|NCT01479621|10086541|P4|Treatment Period|Physician Decision|0
2928686|NCT01479621|10086542|P3|Treatment Period|Physician Decision|0
2928687|NCT01479621|10086543|P2|Treatment Period|Physician Decision|0
2928688|NCT01479621|10086544|P1|Treatment Period|Physician Decision|0
2928689|NCT01479621|10086538|P7|Treatment Period|Withdrawal by Subject|1
2928690|NCT01479621|10086539|P6|Treatment Period|Withdrawal by Subject|5
2928691|NCT01479621|10086540|P5|Treatment Period|Withdrawal by Subject|5
2928692|NCT01479621|10086541|P4|Treatment Period|Withdrawal by Subject|2
2928693|NCT01479621|10086542|P3|Treatment Period|Withdrawal by Subject|2
2928694|NCT01479621|10086543|P2|Treatment Period|Withdrawal by Subject|4
2928695|NCT01479621|10086544|P1|Treatment Period|Withdrawal by Subject|0
2928696|NCT01479621|10086538|P7|Treatment Period|Adverse Event|2
2928697|NCT01479621|10086539|P6|Treatment Period|Adverse Event|2
2928698|NCT01479621|10086540|P5|Treatment Period|Adverse Event|1
2928699|NCT01479621|10086541|P4|Treatment Period|Adverse Event|0
2928700|NCT01479621|10086542|P3|Treatment Period|Adverse Event|0
2928701|NCT01479621|10086543|P2|Treatment Period|Adverse Event|0
2928702|NCT01479621|10086544|P1|Treatment Period|Adverse Event|0
2928703|NCT01479621|10086538|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
2928704|NCT01479621|10086539|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
2928705|NCT01479621|10086540|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
2928706|NCT01479621|10086541|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
2928707|NCT01479621|10086542|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
2928708|NCT01479621|10086543|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
2928709|NCT01479621|10086544|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
2928710|NCT01479621|10086538|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928711|NCT01479621|10086539|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928712|NCT01479621|10086540|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928713|NCT01479621|10086541|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928714|NCT01479621|10086542|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928715|NCT01479621|10086543|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2928716|NCT01479621|10086544|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
2928717|NCT01479621|10086538|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928718|NCT01479621|10086539|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928719|NCT01479621|10086540|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928720|NCT01479621|10086541|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928721|NCT01479621|10086542|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928722|NCT01479621|10086543|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2928723|NCT01479621|10086544|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
2928724|NCT01479621|10086538|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928725|NCT01479621|10086539|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928726|NCT01479621|10086540|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928727|NCT01479621|10086541|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928728|NCT01479621|10086542|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928729|NCT01479621|10086543|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2928730|NCT01479621|10086544|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
2928731|NCT01479621|10086538|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928732|NCT01479621|10086539|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928733|NCT01479621|10086540|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928734|NCT01479621|10086541|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928735|NCT01479621|10086542|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928736|NCT01479621|10086543|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2928737|NCT01479621|10086544|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
2928738|NCT01479595|10086632|P2|Overall Study|Adverse Event|1
2928739|NCT01479595|10086633|P1|Overall Study|Adverse Event|2
2928740|NCT01479595|10086632|P2|Overall Study|Protocol deviation|1
2928741|NCT01479595|10086633|P1|Overall Study|Protocol deviation|0
2928742|NCT01479530|10086678|P2|Overall Study|Withdrawal of Consent|2
2928743|NCT01479530|10086679|P1|Overall Study|Withdrawal of Consent|3
2928744|NCT01479530|10086678|P2|Overall Study|Protocol Violation|3
2928745|NCT01479530|10086679|P1|Overall Study|Protocol Violation|2
2928746|NCT01479530|10086678|P2|Overall Study|Lack of Efficacy|1
2928747|NCT01479530|10086679|P1|Overall Study|Lack of Efficacy|0
2928748|NCT01479530|10086678|P2|Overall Study|Adverse Event|6
2928749|NCT01479530|10086679|P1|Overall Study|Adverse Event|5
2928750|NCT01479465|10086760|P4|Overall Study|Lost to Follow-up|0
2928751|NCT01479465|10086761|P3|Overall Study|Lost to Follow-up|1
2928752|NCT01479465|10086762|P2|Overall Study|Lost to Follow-up|0
2928753|NCT01479465|10086763|P1|Overall Study|Lost to Follow-up|0
2928754|NCT01479465|10086760|P4|Overall Study|Death|1
2928755|NCT01479465|10086761|P3|Overall Study|Death|0
2928756|NCT01479465|10086762|P2|Overall Study|Death|0
2928757|NCT01479465|10086763|P1|Overall Study|Death|0
2928758|NCT01479465|10086760|P4|Overall Study|Protocol Violation|0
2928759|NCT01479465|10086761|P3|Overall Study|Protocol Violation|1
2928760|NCT01479465|10086762|P2|Overall Study|Protocol Violation|1
2928761|NCT01479465|10086763|P1|Overall Study|Protocol Violation|0
2928762|NCT01479465|10086760|P4|Overall Study|Subject Withdrew Consent|1
2928763|NCT01479465|10086761|P3|Overall Study|Subject Withdrew Consent|2
2928764|NCT01479465|10086762|P2|Overall Study|Subject Withdrew Consent|5
2928765|NCT01479465|10086763|P1|Overall Study|Subject Withdrew Consent|0
2928766|NCT01479465|10086760|P4|Overall Study|Subject Request|2
2928767|NCT01479465|10086761|P3|Overall Study|Subject Request|4
2928768|NCT01479465|10086762|P2|Overall Study|Subject Request|3
2928769|NCT01479465|10086763|P1|Overall Study|Subject Request|1
2928770|NCT01479465|10086760|P4|Overall Study|Investigator Discretion|4
2928771|NCT01479465|10086761|P3|Overall Study|Investigator Discretion|2
2928772|NCT01479465|10086762|P2|Overall Study|Investigator Discretion|4
2928773|NCT01479465|10086763|P1|Overall Study|Investigator Discretion|1
2928774|NCT01479465|10086760|P4|Overall Study|Adverse Event|4
2928775|NCT01479465|10086761|P3|Overall Study|Adverse Event|6
2928776|NCT01479465|10086762|P2|Overall Study|Adverse Event|3
2928777|NCT01479465|10086763|P1|Overall Study|Adverse Event|0
2928778|NCT01479465|10086760|P4|Overall Study|Study Discontinued by Sponsor|3
2928779|NCT01479465|10086761|P3|Overall Study|Study Discontinued by Sponsor|5
2928780|NCT01479465|10086762|P2|Overall Study|Study Discontinued by Sponsor|7
2928781|NCT01479465|10086763|P1|Overall Study|Study Discontinued by Sponsor|0
2928782|NCT01479465|10086760|P4|Overall Study|Disease Progression|70
2928783|NCT01479465|10086761|P3|Overall Study|Disease Progression|65
2928784|NCT01479465|10086762|P2|Overall Study|Disease Progression|61
2928785|NCT01479465|10086763|P1|Overall Study|Disease Progression|9
2928786|NCT01479374|10086799|P3|Overall Study|Other|5
2928787|NCT01479374|10086800|P2|Overall Study|Other|4
2928788|NCT01479374|10086801|P1|Overall Study|Other|0
2928789|NCT01479374|10086799|P3|Overall Study|Decision Unrelated to Adverse Event|0
2928790|NCT01479374|10086800|P2|Overall Study|Decision Unrelated to Adverse Event|1
2928791|NCT01479374|10086801|P1|Overall Study|Decision Unrelated to Adverse Event|0
2928792|NCT01479374|10086799|P3|Overall Study|Lost to Follow-up|0
2928793|NCT01479374|10086800|P2|Overall Study|Lost to Follow-up|2
2928794|NCT01479374|10086801|P1|Overall Study|Lost to Follow-up|1
2928795|NCT01479374|10086799|P3|Overall Study|Adverse Event|0
2928796|NCT01479374|10086800|P2|Overall Study|Adverse Event|1
2928797|NCT01479374|10086801|P1|Overall Study|Adverse Event|2
2928798|NCT01478971|10086895|P1|Peginesatide Treatment Period|Other|4
2928799|NCT01478971|10086895|P1|Peginesatide Treatment Period|Lost to Follow-up|4
2928800|NCT01478971|10086895|P1|Peginesatide Treatment Period|Death|4
2928801|NCT01478971|10086895|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
2928802|NCT01478971|10086895|P1|Peginesatide Treatment Period|Adverse Event|1
2928803|NCT01478971|10086895|P1|Standard of Care Period|Other|4
2928804|NCT01478971|10086895|P1|Standard of Care Period|Lost to Follow-up|9
2928805|NCT01478971|10086895|P1|Standard of Care Period|Death|8
2928806|NCT01478971|10086895|P1|Standard of Care Period|Withdrawal by Subject|3
2928807|NCT01478971|10086895|P1|Standard of Care Period|Adverse Event|1
2928808|NCT01478958|10086912|P3|Overall Study|Unable to comply|2
2928809|NCT01478958|10086913|P2|Overall Study|Unable to comply|0
2928810|NCT01478958|10086914|P1|Overall Study|Unable to comply|0
2928811|NCT01478958|10086912|P3|Overall Study|Re-located|0
2928812|NCT01478958|10086913|P2|Overall Study|Re-located|1
2928813|NCT01478958|10086914|P1|Overall Study|Re-located|0
2928814|NCT01478958|10086912|P3|Overall Study|Weight loss|0
2928815|NCT01478958|10086913|P2|Overall Study|Weight loss|0
2928816|NCT01478958|10086914|P1|Overall Study|Weight loss|1
2928817|NCT01478958|10086912|P3|Overall Study|Withdrawal by Subject|1
2928818|NCT01478958|10086913|P2|Overall Study|Withdrawal by Subject|1
2928819|NCT01478958|10086914|P1|Overall Study|Withdrawal by Subject|1
2928820|NCT01478828|10086934|P1|Overall Study|Adverse Event|1
2928821|NCT01478620|10086945|P1|Overall Study|Lost to Follow-up|6
2928822|NCT01478594|10086951|P2|Overall Study|Study Closed by Sponsor|5
2928823|NCT01478594|10086952|P1|Overall Study|Study Closed by Sponsor|8
2928824|NCT01478594|10086951|P2|Overall Study|Withdrawal by Subject|3
2928825|NCT01478594|10086952|P1|Overall Study|Withdrawal by Subject|9
2928826|NCT01478594|10086951|P2|Overall Study|Lost to Follow-up|1
2928827|NCT01478594|10086952|P1|Overall Study|Lost to Follow-up|3
2928828|NCT01478594|10086951|P2|Overall Study|Death|18
2928829|NCT01478594|10086952|P1|Overall Study|Death|45
2928830|NCT01478594|10086951|P2|Overall Study|Randomized but Never Received Study Drug|1
2928831|NCT01478594|10086952|P1|Overall Study|Randomized but Never Received Study Drug|0
2928832|NCT01478373|10087081|P1|Survival Phase|Progressive Disease|27
2928833|NCT01478373|10087081|P1|Survival Phase|crossover to another study|2
2928834|NCT01478373|10087081|P1|Survival Phase|Protocol Violation|1
2928835|NCT01478373|10087081|P1|Survival Phase|Adverse Event|8
2928836|NCT01478373|10087081|P1|Treatment Phase|Protocol Violation|1
2928837|NCT01478360|10087094|P2|Overall Study|Administrative problems|2
2928838|NCT01478360|10087095|P1|Overall Study|Administrative problems|1
2928839|NCT01478360|10087094|P2|Overall Study|Adverse Event|1
2928840|NCT01478360|10087095|P1|Overall Study|Adverse Event|0
2928841|NCT01478360|10087094|P2|Overall Study|Lost to Follow-up|0
2928842|NCT01478360|10087095|P1|Overall Study|Lost to Follow-up|1
2928843|NCT01478347|10087101|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
2928844|NCT01478347|10087101|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
2928845|NCT01478347|10087101|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
2928846|NCT01478321|10087106|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
2928847|NCT01478321|10087106|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
2928848|NCT01478321|10087106|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
2928849|NCT01478321|10087106|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
2928850|NCT01478321|10087106|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
2928851|NCT01478321|10087106|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
2928852|NCT01478321|10087106|P1|Concurrent Therapy (5 Weeks)|Death|2
2928853|NCT01478321|10087106|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
2928854|NCT01478113|10087129|P2|Overall Study|Physician Decision|0
2928855|NCT01478113|10087130|P1|Overall Study|Physician Decision|1
2928856|NCT01478113|10087129|P2|Overall Study|Withdrawal by Subject|1
2928857|NCT01478113|10087130|P1|Overall Study|Withdrawal by Subject|0
2928858|NCT01478087|10087148|P1|Overall Study|due to sponsor closing study|1
2928859|NCT01478048|10087155|P2|Overall Study|no longer meets study criteria|0
2928860|NCT01478048|10087156|P1|Overall Study|no longer meets study criteria|1
2928861|NCT01478048|10087155|P2|Overall Study|poor/non-compliance|1
2928862|NCT01478048|10087156|P1|Overall Study|poor/non-compliance|0
2928863|NCT01478048|10087155|P2|Overall Study|non-specified|4
2928864|NCT01478048|10087156|P1|Overall Study|non-specified|6
2928865|NCT01478048|10087155|P2|Overall Study|Withdrawal by Subject|5
2928866|NCT01478048|10087156|P1|Overall Study|Withdrawal by Subject|2
2928867|NCT01478048|10087155|P2|Overall Study|subject request to discontinue treatment|5
2928868|NCT01478048|10087156|P1|Overall Study|subject request to discontinue treatment|3
2928869|NCT01478048|10087155|P2|Overall Study|Adverse Event|11
2928870|NCT01478048|10087156|P1|Overall Study|Adverse Event|2
2928871|NCT01478048|10087155|P2|Overall Study|study drug toxicity|14
2928872|NCT01478048|10087156|P1|Overall Study|study drug toxicity|11
2928873|NCT01478048|10087155|P2|Overall Study|Disease Progression|35
2928874|NCT01478048|10087156|P1|Overall Study|Disease Progression|52
2928875|NCT01477892|10087185|P2|Overall Study|Withdrawal by Subject|2
2928876|NCT01477892|10087186|P1|Overall Study|Withdrawal by Subject|0
2928877|NCT01477853|10087197|P3|Phase B|Study terminated by sponsor|11
2928878|NCT01477853|10087198|P2|Phase B|Study terminated by sponsor|10
2928879|NCT01477853|10087199|P1|Phase B|Study terminated by sponsor|12
2928880|NCT01477853|10087197|P3|Phase B|Lost to Follow-up|0
2928881|NCT01477853|10087198|P2|Phase B|Lost to Follow-up|1
2928882|NCT01477853|10087199|P1|Phase B|Lost to Follow-up|0
2928883|NCT01477853|10087197|P3|Phase A|Study terminated by sponsor|39
2928884|NCT01477853|10087198|P2|Phase A|Study terminated by sponsor|40
2928885|NCT01477853|10087199|P1|Phase A|Study terminated by sponsor|37
2928886|NCT01477853|10087197|P3|Phase A|Physician Decision|1
2928887|NCT01477853|10087198|P2|Phase A|Physician Decision|0
2928888|NCT01477853|10087199|P1|Phase A|Physician Decision|1
2928889|NCT01477853|10087197|P3|Phase A|Lost to Follow-up|2
2928890|NCT01477853|10087198|P2|Phase A|Lost to Follow-up|3
2928891|NCT01477853|10087199|P1|Phase A|Lost to Follow-up|4
2928892|NCT01477853|10087197|P3|Phase A|Adverse Event|2
2928893|NCT01477853|10087198|P2|Phase A|Adverse Event|2
2928894|NCT01477853|10087199|P1|Phase A|Adverse Event|1
2928895|NCT01477749|10087266|P1|Overall Study|Physician Decision|4
2928896|NCT01477333|10087374|P1|Overall Study|Clinical Deterioration|1
2928897|NCT01477333|10087374|P1|Overall Study|Withdrawal by Subject|1
2928898|NCT01477333|10087374|P1|Overall Study|Adverse Event|1
2928899|NCT01476722|10087425|P1|Overall Study|Adverse Event|1
2928900|NCT01476696|10087432|P3|Overall Study|Withdrawal by Subject|0
2928901|NCT01476696|10087433|P2|Overall Study|Withdrawal by Subject|0
2928902|NCT01476696|10087434|P1|Overall Study|Withdrawal by Subject|1
2928903|NCT01476696|10087432|P3|Overall Study|Sponsor decision|0
2928904|NCT01476696|10087433|P2|Overall Study|Sponsor decision|1
2928905|NCT01476696|10087434|P1|Overall Study|Sponsor decision|2
2928906|NCT01476644|10087448|P1|Overall Study|Withdrawal by Subject|13
2928907|NCT01476644|10087448|P1|Overall Study|Lost to Follow-up|19
2928908|NCT01476644|10087448|P1|Overall Study|moved to another state|2
2928909|NCT01476644|10087448|P1|Overall Study|Death|5
2928910|NCT01476475|10087455|P2|Overall Study|Other reasons|2
2928911|NCT01476475|10087456|P1|Overall Study|Other reasons|4
2928912|NCT01476475|10087455|P2|Overall Study|Poor compliance to protocol|1
2928913|NCT01476475|10087456|P1|Overall Study|Poor compliance to protocol|1
2928914|NCT01476475|10087455|P2|Overall Study|Adverse Event|0
2928915|NCT01476475|10087456|P1|Overall Study|Adverse Event|6
2928916|NCT01475851|10087907|P2|Overall Study|Protocol defined stopping criteria|0
2928917|NCT01475851|10087908|P1|Overall Study|Protocol defined stopping criteria|1
2928918|NCT01475838|10087936|P2|Extension Phase|Participant Noncompliance|0
2928919|NCT01475838|10087937|P1|Extension Phase|Participant Noncompliance|1
2928920|NCT01475838|10087936|P2|Randomized Phase|Protocol Violation|4
2928921|NCT01475838|10087937|P1|Randomized Phase|Protocol Violation|9
2928922|NCT01475838|10087936|P2|Randomized Phase|Participant Noncompliance|5
2928923|NCT01475838|10087937|P1|Randomized Phase|Participant Noncompliance|1
2928924|NCT01475838|10087936|P2|Randomized Phase|Lost to Follow-up|4
2928925|NCT01475838|10087937|P1|Randomized Phase|Lost to Follow-up|3
2928926|NCT01475838|10087936|P2|Randomized Phase|Withdrew Consent|14
2928927|NCT01475838|10087937|P1|Randomized Phase|Withdrew Consent|10
2928928|NCT01475838|10087936|P2|Randomized Phase|Investigators Discretion|2
2928929|NCT01475838|10087937|P1|Randomized Phase|Investigators Discretion|1
2928930|NCT01475838|10087936|P2|Randomized Phase|Pregnancy|1
2928931|NCT01475838|10087937|P1|Randomized Phase|Pregnancy|0
2928932|NCT01475838|10087936|P2|Randomized Phase|Adverse Event|1
2928933|NCT01475838|10087937|P1|Randomized Phase|Adverse Event|6
2928934|NCT01475838|10087936|P2|Randomized Phase|Randomized but Not Treated|5
2928935|NCT01475838|10087937|P1|Randomized Phase|Randomized but Not Treated|0
2928936|NCT01475825|10087954|P4|Overall Study|Did not enter OLC|11
2928937|NCT01475825|10087955|P3|Overall Study|Did not enter OLC|15
2928938|NCT01475825|10087956|P2|Overall Study|Did not enter OLC|11
2928939|NCT01475825|10087957|P1|Overall Study|Did not enter OLC|15
2928940|NCT01475825|10087954|P4|Overall Study|Withdrawal by Subject|7
2928941|NCT01475825|10087955|P3|Overall Study|Withdrawal by Subject|11
2928942|NCT01475825|10087956|P2|Overall Study|Withdrawal by Subject|3
2928943|NCT01475825|10087957|P1|Overall Study|Withdrawal by Subject|8
2928944|NCT01475825|10087954|P4|Overall Study|Physician Decision|0
2928945|NCT01475825|10087955|P3|Overall Study|Physician Decision|0
2928946|NCT01475825|10087956|P2|Overall Study|Physician Decision|1
2928947|NCT01475825|10087957|P1|Overall Study|Physician Decision|0
2928948|NCT01475825|10087954|P4|Overall Study|Protocol Violation|0
2928949|NCT01475825|10087955|P3|Overall Study|Protocol Violation|0
2928950|NCT01475825|10087956|P2|Overall Study|Protocol Violation|0
2928951|NCT01475825|10087957|P1|Overall Study|Protocol Violation|1
2928952|NCT01475825|10087954|P4|Overall Study|Other: Not available|0
2928953|NCT01475825|10087955|P3|Overall Study|Other: Not available|2
2928954|NCT01475825|10087956|P2|Overall Study|Other: Not available|0
2928955|NCT01475825|10087957|P1|Overall Study|Other: Not available|0
2928956|NCT01475825|10087954|P4|Overall Study|Non-compliance with Study Drug|0
2928957|NCT01475825|10087955|P3|Overall Study|Non-compliance with Study Drug|4
2928958|NCT01475825|10087956|P2|Overall Study|Non-compliance with Study Drug|2
2928959|NCT01475825|10087957|P1|Overall Study|Non-compliance with Study Drug|1
2928960|NCT01475825|10087954|P4|Overall Study|Lost to Follow-up|1
2928961|NCT01475825|10087955|P3|Overall Study|Lost to Follow-up|3
2928962|NCT01475825|10087956|P2|Overall Study|Lost to Follow-up|0
2928963|NCT01475825|10087957|P1|Overall Study|Lost to Follow-up|0
2928964|NCT01475825|10087954|P4|Overall Study|Lack of Efficacy|0
2928965|NCT01475825|10087955|P3|Overall Study|Lack of Efficacy|1
2928966|NCT01475825|10087956|P2|Overall Study|Lack of Efficacy|0
2928967|NCT01475825|10087957|P1|Overall Study|Lack of Efficacy|0
2928968|NCT01475825|10087954|P4|Overall Study|Death|0
2928969|NCT01475825|10087955|P3|Overall Study|Death|1
2928970|NCT01475825|10087956|P2|Overall Study|Death|0
2928971|NCT01475825|10087957|P1|Overall Study|Death|1
2928972|NCT01475825|10087954|P4|Overall Study|Adverse Event|11
2928973|NCT01475825|10087955|P3|Overall Study|Adverse Event|27
2928974|NCT01475825|10087956|P2|Overall Study|Adverse Event|15
2928975|NCT01475825|10087957|P1|Overall Study|Adverse Event|41
2928976|NCT01475734|10087989|P2|Overall Study|Physician Decision|1
2928977|NCT01475734|10087990|P1|Overall Study|Physician Decision|0
2928978|NCT01475734|10087989|P2|Overall Study|Protocol Violation|0
2928979|NCT01475734|10087990|P1|Overall Study|Protocol Violation|1
2928980|NCT01475734|10087989|P2|Overall Study|Withdrawal by Subject|0
2928981|NCT01475734|10087990|P1|Overall Study|Withdrawal by Subject|1
2928982|NCT01475721|10088018|P2|Overall Study|Withdrawal by Subject|8
2928983|NCT01475721|10088019|P1|Overall Study|Withdrawal by Subject|8
2928984|NCT01475721|10088018|P2|Overall Study|Death|6
2928985|NCT01475721|10088019|P1|Overall Study|Death|3
2928986|NCT01475487|10088085|P2|Overall Study|had to leave early for personal reasons|1
2928987|NCT01475487|10088086|P1|Overall Study|had to leave early for personal reasons|2
2928988|NCT01475474|10088098|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
2928989|NCT01475474|10088098|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
2928990|NCT01475461|10088109|P7|Treatment Period|Adverse Event|0
2928991|NCT01475461|10088110|P6|Treatment Period|Adverse Event|0
2928992|NCT01475461|10088111|P5|Treatment Period|Adverse Event|0
2928993|NCT01475461|10088112|P4|Treatment Period|Adverse Event|1
2928994|NCT01475461|10088113|P3|Treatment Period|Adverse Event|0
2928995|NCT01475461|10088114|P2|Treatment Period|Adverse Event|0
2928996|NCT01475461|10088115|P1|Treatment Period|Adverse Event|0
2928997|NCT01475461|10088109|P7|Treatment Period|Medication Error|0
2928998|NCT01475461|10088110|P6|Treatment Period|Medication Error|0
2928999|NCT01475461|10088111|P5|Treatment Period|Medication Error|0
2929000|NCT01475461|10088112|P4|Treatment Period|Medication Error|1
2929001|NCT01475461|10088113|P3|Treatment Period|Medication Error|0
2929002|NCT01475461|10088114|P2|Treatment Period|Medication Error|0
2929003|NCT01475461|10088115|P1|Treatment Period|Medication Error|0
2929004|NCT01475461|10088109|P7|Treatment Period|Lack of Efficacy|0
2929005|NCT01475461|10088110|P6|Treatment Period|Lack of Efficacy|1
2929006|NCT01475461|10088111|P5|Treatment Period|Lack of Efficacy|1
2929007|NCT01475461|10088112|P4|Treatment Period|Lack of Efficacy|2
2929008|NCT01475461|10088113|P3|Treatment Period|Lack of Efficacy|0
2929009|NCT01475461|10088114|P2|Treatment Period|Lack of Efficacy|2
2929010|NCT01475461|10088115|P1|Treatment Period|Lack of Efficacy|0
2929011|NCT01475461|10088109|P7|Treatment Period|Protocol Violation|1
2929012|NCT01475461|10088110|P6|Treatment Period|Protocol Violation|0
2929013|NCT01475461|10088111|P5|Treatment Period|Protocol Violation|0
2929014|NCT01475461|10088112|P4|Treatment Period|Protocol Violation|0
2929015|NCT01475461|10088113|P3|Treatment Period|Protocol Violation|0
2929016|NCT01475461|10088114|P2|Treatment Period|Protocol Violation|1
2929017|NCT01475461|10088115|P1|Treatment Period|Protocol Violation|0
2929018|NCT01475461|10088109|P7|Treatment Period|Other|0
2929019|NCT01475461|10088110|P6|Treatment Period|Other|0
2929020|NCT01475461|10088111|P5|Treatment Period|Other|0
2929021|NCT01475461|10088112|P4|Treatment Period|Other|0
2929022|NCT01475461|10088113|P3|Treatment Period|Other|0
2929023|NCT01475461|10088114|P2|Treatment Period|Other|1
2929024|NCT01475461|10088115|P1|Treatment Period|Other|0
2929025|NCT01475461|10088109|P7|Treatment Period|Withdrawal by Subject|0
2929026|NCT01475461|10088110|P6|Treatment Period|Withdrawal by Subject|2
2929027|NCT01475461|10088111|P5|Treatment Period|Withdrawal by Subject|2
2929028|NCT01475461|10088112|P4|Treatment Period|Withdrawal by Subject|0
2929029|NCT01475461|10088113|P3|Treatment Period|Withdrawal by Subject|2
2929030|NCT01475461|10088114|P2|Treatment Period|Withdrawal by Subject|2
2929031|NCT01475461|10088115|P1|Treatment Period|Withdrawal by Subject|0
2929032|NCT01475461|10088109|P7|Treatment Period|Lost to Follow-up|1
2929033|NCT01475461|10088110|P6|Treatment Period|Lost to Follow-up|2
2929034|NCT01475461|10088111|P5|Treatment Period|Lost to Follow-up|1
2929035|NCT01475461|10088112|P4|Treatment Period|Lost to Follow-up|3
2929036|NCT01475461|10088113|P3|Treatment Period|Lost to Follow-up|2
2929037|NCT01475461|10088114|P2|Treatment Period|Lost to Follow-up|3
2929038|NCT01475461|10088115|P1|Treatment Period|Lost to Follow-up|0
2929039|NCT01475461|10088109|P7|Treatment Period|Death|0
2929040|NCT01475461|10088110|P6|Treatment Period|Death|0
2929041|NCT01475461|10088111|P5|Treatment Period|Death|0
2929042|NCT01475461|10088112|P4|Treatment Period|Death|1
2929043|NCT01475461|10088113|P3|Treatment Period|Death|0
2929044|NCT01475461|10088114|P2|Treatment Period|Death|0
2929045|NCT01475461|10088115|P1|Treatment Period|Death|0
2929046|NCT01475461|10088109|P7|Run-in Period|Protocol Violation|0
2929047|NCT01475461|10088110|P6|Run-in Period|Protocol Violation|0
2929048|NCT01475461|10088111|P5|Run-in Period|Protocol Violation|0
2929049|NCT01475461|10088112|P4|Run-in Period|Protocol Violation|0
2929050|NCT01475461|10088113|P3|Run-in Period|Protocol Violation|0
2929051|NCT01475461|10088114|P2|Run-in Period|Protocol Violation|0
2929052|NCT01475461|10088115|P1|Run-in Period|Protocol Violation|4
2929053|NCT01475461|10088109|P7|Run-in Period|Other|0
2929054|NCT01475461|10088110|P6|Run-in Period|Other|0
2929055|NCT01475461|10088111|P5|Run-in Period|Other|0
2929056|NCT01475461|10088112|P4|Run-in Period|Other|0
2929057|NCT01475461|10088113|P3|Run-in Period|Other|0
2929058|NCT01475461|10088114|P2|Run-in Period|Other|0
2929059|NCT01475461|10088115|P1|Run-in Period|Other|3
2929060|NCT01475461|10088109|P7|Run-in Period|Withdrawal by Subject|0
2929061|NCT01475461|10088110|P6|Run-in Period|Withdrawal by Subject|0
2929062|NCT01475461|10088111|P5|Run-in Period|Withdrawal by Subject|0
2929063|NCT01475461|10088112|P4|Run-in Period|Withdrawal by Subject|0
2929064|NCT01475461|10088113|P3|Run-in Period|Withdrawal by Subject|0
2929065|NCT01475461|10088114|P2|Run-in Period|Withdrawal by Subject|0
2929066|NCT01475461|10088115|P1|Run-in Period|Withdrawal by Subject|11
2929067|NCT01475461|10088109|P7|Run-in Period|Lost to Follow-up|0
2929068|NCT01475461|10088110|P6|Run-in Period|Lost to Follow-up|0
2929069|NCT01475461|10088111|P5|Run-in Period|Lost to Follow-up|0
2929070|NCT01475461|10088112|P4|Run-in Period|Lost to Follow-up|0
2929071|NCT01475461|10088113|P3|Run-in Period|Lost to Follow-up|0
2929072|NCT01475461|10088114|P2|Run-in Period|Lost to Follow-up|0
2929073|NCT01475461|10088115|P1|Run-in Period|Lost to Follow-up|7
2929074|NCT01475461|10088109|P7|Run-in Period|Not meet eligibility criteria|0
2929075|NCT01475461|10088110|P6|Run-in Period|Not meet eligibility criteria|0
2929076|NCT01475461|10088111|P5|Run-in Period|Not meet eligibility criteria|0
2929077|NCT01475461|10088112|P4|Run-in Period|Not meet eligibility criteria|0
2929078|NCT01475461|10088113|P3|Run-in Period|Not meet eligibility criteria|0
2929079|NCT01475461|10088114|P2|Run-in Period|Not meet eligibility criteria|0
2929080|NCT01475461|10088115|P1|Run-in Period|Not meet eligibility criteria|16
2929081|NCT01475331|10088195|P2|Overall Study|cyst found to be prohibitively small|1
2929082|NCT01475331|10088196|P1|Overall Study|cyst found to be prohibitively small|0
2929083|NCT01475331|10088195|P2|Overall Study|Sign of malignancy during the procedure|0
2929084|NCT01475331|10088196|P1|Overall Study|Sign of malignancy during the procedure|2
2929085|NCT01475331|10088195|P2|Overall Study|Loss of needle positioning due pt. cough|0
2929086|NCT01475331|10088196|P1|Overall Study|Loss of needle positioning due pt. cough|1
2929087|NCT01475331|10088195|P2|Overall Study|excessive main duct communication|1
2929088|NCT01475331|10088196|P1|Overall Study|excessive main duct communication|1
2929089|NCT01475331|10088195|P2|Overall Study|Osteophyte obstruction of the proximal|0
2929090|NCT01475331|10088196|P1|Overall Study|Osteophyte obstruction of the proximal|1
2929091|NCT01475253|10088248|P4|Randomized, Blinded Study|Lost to Follow-up|0
2929092|NCT01475253|10088249|P3|Randomized, Blinded Study|Lost to Follow-up|0
2929093|NCT01475253|10088250|P2|Randomized, Blinded Study|Lost to Follow-up|0
2929094|NCT01475253|10088251|P1|Randomized, Blinded Study|Lost to Follow-up|1
2929095|NCT01475253|10088248|P4|Randomized, Blinded Study|Withdrawal by Subject|0
2929096|NCT01475253|10088249|P3|Randomized, Blinded Study|Withdrawal by Subject|0
2929097|NCT01475253|10088250|P2|Randomized, Blinded Study|Withdrawal by Subject|1
2929098|NCT01475253|10088251|P1|Randomized, Blinded Study|Withdrawal by Subject|1
2929099|NCT01475214|10088280|P3|Overall Study|Withdrawal by Subject|1
2929100|NCT01475214|10088281|P2|Overall Study|Withdrawal by Subject|4
2929101|NCT01475214|10088282|P1|Overall Study|Withdrawal by Subject|2
2929102|NCT01475214|10088280|P3|Overall Study|Physician Decision|0
2929103|NCT01475214|10088281|P2|Overall Study|Physician Decision|0
2929104|NCT01475214|10088282|P1|Overall Study|Physician Decision|2
2929105|NCT01475214|10088280|P3|Overall Study|Lost to Follow-up|1
2929106|NCT01475214|10088281|P2|Overall Study|Lost to Follow-up|0
2929107|NCT01475214|10088282|P1|Overall Study|Lost to Follow-up|1
2929108|NCT01475162|10088305|P1|Overall Study|Study closed for safety|3
2929109|NCT01475162|10088305|P1|Overall Study|Death|10
2929110|NCT01475162|10088305|P1|Overall Study|Physician Decision|1
2929111|NCT01475097|10088318|P2|Overall Study|Protocol Violation|1
2929112|NCT01475097|10088319|P1|Overall Study|Protocol Violation|1
2929113|NCT01475071|10088327|P1|Overall Study|Lost to Follow-up|1
2929114|NCT01475071|10088327|P1|Overall Study|Withdrawal by Subject|6
2929115|NCT01475071|10088327|P1|Overall Study|Physician Decision|1
2929116|NCT01474993|10088337|P2|Overall Study|Adverse Event|1
2929117|NCT01474993|10088338|P1|Overall Study|Adverse Event|0
2929118|NCT01474993|10088337|P2|Overall Study|Lost to Follow-up|2
2929119|NCT01474993|10088338|P1|Overall Study|Lost to Follow-up|1
2929120|NCT01474876|10088380|P3|Overall Study|Investigator's decision and pt request|0
2929121|NCT01474876|10088381|P2|Overall Study|Investigator's decision and pt request|0
2929122|NCT01474876|10088382|P1|Overall Study|Investigator's decision and pt request|1
2929123|NCT01474876|10088380|P3|Overall Study|Patient's request|0
2929124|NCT01474876|10088381|P2|Overall Study|Patient's request|5
2929125|NCT01474876|10088382|P1|Overall Study|Patient's request|19
2929126|NCT01474876|10088380|P3|Overall Study|Investigator's decision|0
2929127|NCT01474876|10088381|P2|Overall Study|Investigator's decision|6
2929128|NCT01474876|10088382|P1|Overall Study|Investigator's decision|28
2929129|NCT01474876|10088380|P3|Overall Study|Lost to Follow-up|0
2929130|NCT01474876|10088381|P2|Overall Study|Lost to Follow-up|4
2929131|NCT01474876|10088382|P1|Overall Study|Lost to Follow-up|5
2929132|NCT01474876|10088380|P3|Overall Study|Serious Adverse Event|0
2929133|NCT01474876|10088381|P2|Overall Study|Serious Adverse Event|3
2929134|NCT01474876|10088382|P1|Overall Study|Serious Adverse Event|2
2929135|NCT01474876|10088380|P3|Overall Study|Adverse Event|0
2929136|NCT01474876|10088381|P2|Overall Study|Adverse Event|5
2929137|NCT01474876|10088382|P1|Overall Study|Adverse Event|11
2929138|NCT01474772|10088428|P2|Follow-up|AE not Related to Study Drug|1
2929139|NCT01474772|10088429|P1|Follow-up|AE not Related to Study Drug|0
2929140|NCT01474772|10088428|P2|Period 2|Reason not Specified|2
2929141|NCT01474772|10088429|P1|Period 2|Reason not Specified|0
2929142|NCT01474772|10088428|P2|Period 2|Lost to Follow-up|1
2929143|NCT01474772|10088429|P1|Period 2|Lost to Follow-up|1
2929144|NCT01474772|10088428|P2|Period 2|Withdrawal by Subject|4
2929145|NCT01474772|10088429|P1|Period 2|Withdrawal by Subject|3
2929146|NCT01474772|10088428|P2|Period 2|Lack of Efficacy|0
2929147|NCT01474772|10088429|P1|Period 2|Lack of Efficacy|1
2929148|NCT01474772|10088428|P2|Period 2|AE not Related to Study Drug|1
2929149|NCT01474772|10088429|P1|Period 2|AE not Related to Study Drug|4
2929150|NCT01474772|10088428|P2|Period 2|AE Related to Study Drug|1
2929151|NCT01474772|10088429|P1|Period 2|AE Related to Study Drug|0
2929152|NCT01474772|10088428|P2|Period 2|Death|1
2929153|NCT01474772|10088429|P1|Period 2|Death|0
2929154|NCT01474772|10088428|P2|Washout|Reason not Specified|1
2929155|NCT01474772|10088429|P1|Washout|Reason not Specified|0
2929156|NCT01474772|10088428|P2|Washout|Lost to Follow-up|1
2929157|NCT01474772|10088429|P1|Washout|Lost to Follow-up|0
2929158|NCT01474772|10088428|P2|Washout|Withdrawal by Subject|0
2929159|NCT01474772|10088429|P1|Washout|Withdrawal by Subject|1
2929160|NCT01474772|10088428|P2|Washout|AE not Related to Study Drug|0
2929161|NCT01474772|10088429|P1|Washout|AE not Related to Study Drug|2
2929162|NCT01474772|10088428|P2|Period 1|Reason not Specified|1
2929163|NCT01474772|10088429|P1|Period 1|Reason not Specified|1
2929164|NCT01474772|10088428|P2|Period 1|Lost to Follow-up|0
2929165|NCT01474772|10088429|P1|Period 1|Lost to Follow-up|1
2929166|NCT01474772|10088428|P2|Period 1|Withdrawal by Subject|1
2929167|NCT01474772|10088429|P1|Period 1|Withdrawal by Subject|3
2929168|NCT01474772|10088428|P2|Period 1|AE not Related to Study Drug|0
2929169|NCT01474772|10088429|P1|Period 1|AE not Related to Study Drug|1
2929170|NCT01474772|10088428|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
2929171|NCT01474772|10088429|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
2929172|NCT01474746|10088479|P2|Overall Study|Withdrawal by Subject|1
2929173|NCT01474746|10088480|P1|Overall Study|Withdrawal by Subject|2
2929174|NCT01474746|10088479|P2|Overall Study|Lost to Follow-up|1
2929175|NCT01474746|10088480|P1|Overall Study|Lost to Follow-up|1
2929176|NCT01474681|10088544|P4|Overall Study|Death|6
2929177|NCT01474681|10088545|P3|Overall Study|Death|2
2929178|NCT01474681|10088546|P2|Overall Study|Death|3
2929179|NCT01474681|10088547|P1|Overall Study|Death|0
2929180|NCT01474551|10088598|P1|Overall Study|Death|1
2929181|NCT01474538|10088604|P2|Treatment Period 2|Protocol Violation|0
2929182|NCT01474538|10088605|P1|Treatment Period 2|Protocol Violation|1
2929183|NCT01474538|10088604|P2|Treatment Period 2|Physician Decision|1
2929184|NCT01474538|10088605|P1|Treatment Period 2|Physician Decision|0
2929185|NCT01474538|10088604|P2|Treatment Period 2|Sponsor decision|0
2929186|NCT01474538|10088605|P1|Treatment Period 2|Sponsor decision|1
2929187|NCT01474538|10088604|P2|Treatment Period 2|Withdrawal by Subject|0
2929188|NCT01474538|10088605|P1|Treatment Period 2|Withdrawal by Subject|2
2929189|NCT01474538|10088604|P2|Treatment Period 2|Adverse Event|1
2929190|NCT01474538|10088605|P1|Treatment Period 2|Adverse Event|1
2929191|NCT01474538|10088604|P2|Treatment Period 2|Death|0
2929192|NCT01474538|10088605|P1|Treatment Period 2|Death|1
2929193|NCT01474538|10088604|P2|Treatment Period 1|Protocol Violation|1
2929194|NCT01474538|10088605|P1|Treatment Period 1|Protocol Violation|0
2929195|NCT01474538|10088604|P2|Treatment Period 1|Withdrawal by Subject|3
2929196|NCT01474538|10088605|P1|Treatment Period 1|Withdrawal by Subject|1
2929197|NCT01474538|10088604|P2|Treatment Period 1|Physician Decision|0
2929198|NCT01474538|10088605|P1|Treatment Period 1|Physician Decision|1
2929199|NCT01474538|10088604|P2|Treatment Period 1|Death|0
2929200|NCT01474538|10088605|P1|Treatment Period 1|Death|1
2929201|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Death|0
2929202|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Death|1
2929203|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Death|0
2929204|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Death|0
2929205|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Death|0
2929206|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Death|0
2929207|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Death|0
2929208|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Death|0
2929209|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Death|0
2929210|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Death|0
2929211|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Death|0
2929212|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Death|0
2929213|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Death|0
2929214|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Death|0
2929215|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Death|0
2929216|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Death|0
2929217|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Death|0
2929218|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Death|0
2929219|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2929220|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929221|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929222|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2929223|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929224|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929225|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929226|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929227|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929228|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929229|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929230|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929231|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929232|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929233|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929234|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929235|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929236|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2929237|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Sponsor Decision|0
2929238|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Sponsor Decision|4
2929239|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Sponsor Decision|0
2929240|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Sponsor Decision|1
2929241|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Sponsor Decision|0
2929242|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Sponsor Decision|0
2929243|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Sponsor Decision|0
2929244|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Sponsor Decision|0
2929245|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Sponsor Decision|0
2929246|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Sponsor Decision|0
2929247|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Sponsor Decision|0
2929248|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Sponsor Decision|0
2929249|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Sponsor Decision|0
2929250|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Sponsor Decision|0
2929251|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Sponsor Decision|0
2929252|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Sponsor Decision|0
2929253|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Sponsor Decision|0
2929254|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Sponsor Decision|0
2929255|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Protocol Violation|0
2929256|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Protocol Violation|4
2929257|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Protocol Violation|2
2929258|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Protocol Violation|2
2929259|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Protocol Violation|0
2929260|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Protocol Violation|0
2929261|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Protocol Violation|0
2929262|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Protocol Violation|0
2929263|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Protocol Violation|0
2929264|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Protocol Violation|0
2929265|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Protocol Violation|0
2929266|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Protocol Violation|0
2929267|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Protocol Violation|0
2929268|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Protocol Violation|0
2929269|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Protocol Violation|0
2929270|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Protocol Violation|0
2929271|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Protocol Violation|0
2929272|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Protocol Violation|0
2929273|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Clinical Relapse|2
2929274|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Clinical Relapse|6
2929275|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Clinical Relapse|0
2929276|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Clinical Relapse|0
2929277|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Clinical Relapse|0
2929278|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Clinical Relapse|0
2929279|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Clinical Relapse|0
2929280|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Clinical Relapse|0
2929281|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Clinical Relapse|0
2929282|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Clinical Relapse|0
2929283|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Clinical Relapse|0
2929284|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Clinical Relapse|0
2929285|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Clinical Relapse|0
2929286|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Clinical Relapse|0
2929287|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Clinical Relapse|0
2929288|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Clinical Relapse|0
2929289|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Clinical Relapse|0
2929290|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Clinical Relapse|0
2929291|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Physician Decision|5
2929292|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Physician Decision|4
2929293|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Physician Decision|0
2929294|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Physician Decision|0
2929295|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Physician Decision|0
2929296|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Physician Decision|0
2929297|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Physician Decision|0
2929298|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Physician Decision|0
2929299|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Physician Decision|0
2929300|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Physician Decision|0
2929301|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Physician Decision|0
2929302|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Physician Decision|0
2929303|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Physician Decision|0
2929304|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Physician Decision|0
2929305|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Physician Decision|0
2929306|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Physician Decision|0
2929307|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Physician Decision|0
2929308|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Physician Decision|0
2929309|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
2929310|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
2929311|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
2929312|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
2929313|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
2929314|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
2929315|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
2929316|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
2929317|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
2929318|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
2929319|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
2929320|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
2929321|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
2929322|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
2929323|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
2929324|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
2929325|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
2929326|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
2929327|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
2929328|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
2929329|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
2929330|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
2929331|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
2929332|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
2929333|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
2929334|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
2929335|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
2929336|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
2929337|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
2929338|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
2929339|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
2929340|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
2929341|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
2929342|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
2929343|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
2929344|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
2929345|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
2929346|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
2929347|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
2929348|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
2929349|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929350|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929351|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929352|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929353|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929354|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929355|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929356|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929357|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929358|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929359|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929360|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929361|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929362|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
2929363|NCT01474512|10088622|P18|Post-Treatment Follow-Up|Adverse Event|11
2929364|NCT01474512|10088623|P17|Post-Treatment Follow-Up|Adverse Event|58
2929365|NCT01474512|10088624|P16|Post-Treatment Follow-Up|Adverse Event|2
2929366|NCT01474512|10088625|P15|Post-Treatment Follow-Up|Adverse Event|8
2929367|NCT01474512|10088626|P14|Post-Treatment Follow-Up|Adverse Event|0
2929368|NCT01474512|10088627|P13|Post-Treatment Follow-Up|Adverse Event|0
2929369|NCT01474512|10088628|P12|Post-Treatment Follow-Up|Adverse Event|0
2929370|NCT01474512|10088629|P11|Post-Treatment Follow-Up|Adverse Event|0
2929371|NCT01474512|10088630|P10|Post-Treatment Follow-Up|Adverse Event|0
2929372|NCT01474512|10088631|P9|Post-Treatment Follow-Up|Adverse Event|0
2929373|NCT01474512|10088632|P8|Post-Treatment Follow-Up|Adverse Event|0
2929374|NCT01474512|10088633|P7|Post-Treatment Follow-Up|Adverse Event|0
2929375|NCT01474512|10088634|P6|Post-Treatment Follow-Up|Adverse Event|0
2929376|NCT01474512|10088635|P5|Post-Treatment Follow-Up|Adverse Event|0
2929377|NCT01474512|10088636|P4|Post-Treatment Follow-Up|Adverse Event|0
2929378|NCT01474512|10088637|P3|Post-Treatment Follow-Up|Adverse Event|0
2929379|NCT01474512|10088638|P2|Post-Treatment Follow-Up|Adverse Event|0
2929380|NCT01474512|10088639|P1|Post-Treatment Follow-Up|Adverse Event|0
2929381|NCT01474512|10088622|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
2929382|NCT01474512|10088623|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
2929383|NCT01474512|10088624|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
2929384|NCT01474512|10088625|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
2929385|NCT01474512|10088626|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
2929386|NCT01474512|10088627|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
2929387|NCT01474512|10088628|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
2929388|NCT01474512|10088629|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
2929389|NCT01474512|10088630|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
2929390|NCT01474512|10088631|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
2929391|NCT01474512|10088632|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
2929392|NCT01474512|10088633|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
2929393|NCT01474512|10088634|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
2929394|NCT01474512|10088635|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
2929395|NCT01474512|10088636|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
2929396|NCT01474512|10088637|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
2929397|NCT01474512|10088638|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
2929398|NCT01474512|10088639|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
2929399|NCT01474512|10088622|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
2929400|NCT01474512|10088623|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
2929401|NCT01474512|10088624|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
2929402|NCT01474512|10088625|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
2929403|NCT01474512|10088626|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
2929404|NCT01474512|10088627|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
2929405|NCT01474512|10088628|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
2929406|NCT01474512|10088629|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
2929407|NCT01474512|10088630|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
2929408|NCT01474512|10088631|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
2929409|NCT01474512|10088632|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
2929410|NCT01474512|10088633|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
2929411|NCT01474512|10088634|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
2929412|NCT01474512|10088635|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
2929413|NCT01474512|10088636|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
2929414|NCT01474512|10088637|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
2929415|NCT01474512|10088638|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
2929416|NCT01474512|10088639|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
2929417|NCT01474512|10088622|P18|Long-Term Extension Period|Protocol Violation|0
2929418|NCT01474512|10088623|P17|Long-Term Extension Period|Protocol Violation|0
2929419|NCT01474512|10088624|P16|Long-Term Extension Period|Protocol Violation|0
2929420|NCT01474512|10088625|P15|Long-Term Extension Period|Protocol Violation|0
2929421|NCT01474512|10088626|P14|Long-Term Extension Period|Protocol Violation|5
2929422|NCT01474512|10088627|P13|Long-Term Extension Period|Protocol Violation|5
2929423|NCT01474512|10088628|P12|Long-Term Extension Period|Protocol Violation|0
2929424|NCT01474512|10088629|P11|Long-Term Extension Period|Protocol Violation|0
2929425|NCT01474512|10088630|P10|Long-Term Extension Period|Protocol Violation|0
2929426|NCT01474512|10088631|P9|Long-Term Extension Period|Protocol Violation|0
2929427|NCT01474512|10088632|P8|Long-Term Extension Period|Protocol Violation|0
2929428|NCT01474512|10088633|P7|Long-Term Extension Period|Protocol Violation|0
2929429|NCT01474512|10088634|P6|Long-Term Extension Period|Protocol Violation|0
2929430|NCT01474512|10088635|P5|Long-Term Extension Period|Protocol Violation|0
2929431|NCT01474512|10088636|P4|Long-Term Extension Period|Protocol Violation|0
2929432|NCT01474512|10088637|P3|Long-Term Extension Period|Protocol Violation|0
2929433|NCT01474512|10088638|P2|Long-Term Extension Period|Protocol Violation|0
2929434|NCT01474512|10088639|P1|Long-Term Extension Period|Protocol Violation|0
2929435|NCT01474512|10088622|P18|Long-Term Extension Period|Sponsor Decision|0
2929436|NCT01474512|10088623|P17|Long-Term Extension Period|Sponsor Decision|0
2929437|NCT01474512|10088624|P16|Long-Term Extension Period|Sponsor Decision|0
2929438|NCT01474512|10088625|P15|Long-Term Extension Period|Sponsor Decision|0
2929439|NCT01474512|10088626|P14|Long-Term Extension Period|Sponsor Decision|6
2929440|NCT01474512|10088627|P13|Long-Term Extension Period|Sponsor Decision|6
2929441|NCT01474512|10088628|P12|Long-Term Extension Period|Sponsor Decision|0
2929442|NCT01474512|10088629|P11|Long-Term Extension Period|Sponsor Decision|0
2929443|NCT01474512|10088630|P10|Long-Term Extension Period|Sponsor Decision|0
2929444|NCT01474512|10088631|P9|Long-Term Extension Period|Sponsor Decision|0
2929445|NCT01474512|10088632|P8|Long-Term Extension Period|Sponsor Decision|0
2929446|NCT01474512|10088633|P7|Long-Term Extension Period|Sponsor Decision|0
2929447|NCT01474512|10088634|P6|Long-Term Extension Period|Sponsor Decision|0
2929448|NCT01474512|10088635|P5|Long-Term Extension Period|Sponsor Decision|0
2929449|NCT01474512|10088636|P4|Long-Term Extension Period|Sponsor Decision|0
2929450|NCT01474512|10088637|P3|Long-Term Extension Period|Sponsor Decision|0
2929451|NCT01474512|10088638|P2|Long-Term Extension Period|Sponsor Decision|0
2929452|NCT01474512|10088639|P1|Long-Term Extension Period|Sponsor Decision|0
2929453|NCT01474512|10088622|P18|Long-Term Extension Period|Death|0
2929454|NCT01474512|10088623|P17|Long-Term Extension Period|Death|0
2929455|NCT01474512|10088624|P16|Long-Term Extension Period|Death|0
2929456|NCT01474512|10088625|P15|Long-Term Extension Period|Death|0
2929457|NCT01474512|10088626|P14|Long-Term Extension Period|Death|9
2929458|NCT01474512|10088627|P13|Long-Term Extension Period|Death|9
2929459|NCT01474512|10088628|P12|Long-Term Extension Period|Death|0
2929460|NCT01474512|10088629|P11|Long-Term Extension Period|Death|0
2929461|NCT01474512|10088630|P10|Long-Term Extension Period|Death|0
2929462|NCT01474512|10088631|P9|Long-Term Extension Period|Death|0
2929463|NCT01474512|10088632|P8|Long-Term Extension Period|Death|0
2929464|NCT01474512|10088633|P7|Long-Term Extension Period|Death|0
2929465|NCT01474512|10088634|P6|Long-Term Extension Period|Death|0
2929466|NCT01474512|10088635|P5|Long-Term Extension Period|Death|0
2929467|NCT01474512|10088636|P4|Long-Term Extension Period|Death|0
2929468|NCT01474512|10088637|P3|Long-Term Extension Period|Death|0
2929469|NCT01474512|10088638|P2|Long-Term Extension Period|Death|0
2929470|NCT01474512|10088639|P1|Long-Term Extension Period|Death|0
2929471|NCT01474512|10088622|P18|Long-Term Extension Period|Clinical Relapse|0
2929472|NCT01474512|10088623|P17|Long-Term Extension Period|Clinical Relapse|0
2929473|NCT01474512|10088624|P16|Long-Term Extension Period|Clinical Relapse|0
2929474|NCT01474512|10088625|P15|Long-Term Extension Period|Clinical Relapse|0
2929475|NCT01474512|10088626|P14|Long-Term Extension Period|Clinical Relapse|9
2929476|NCT01474512|10088627|P13|Long-Term Extension Period|Clinical Relapse|9
2929477|NCT01474512|10088628|P12|Long-Term Extension Period|Clinical Relapse|0
2929478|NCT01474512|10088629|P11|Long-Term Extension Period|Clinical Relapse|0
2929479|NCT01474512|10088630|P10|Long-Term Extension Period|Clinical Relapse|0
2929480|NCT01474512|10088631|P9|Long-Term Extension Period|Clinical Relapse|0
2929481|NCT01474512|10088632|P8|Long-Term Extension Period|Clinical Relapse|0
2929482|NCT01474512|10088633|P7|Long-Term Extension Period|Clinical Relapse|0
2929483|NCT01474512|10088634|P6|Long-Term Extension Period|Clinical Relapse|0
2929484|NCT01474512|10088635|P5|Long-Term Extension Period|Clinical Relapse|0
2929485|NCT01474512|10088636|P4|Long-Term Extension Period|Clinical Relapse|0
2929486|NCT01474512|10088637|P3|Long-Term Extension Period|Clinical Relapse|0
2929487|NCT01474512|10088638|P2|Long-Term Extension Period|Clinical Relapse|0
2929488|NCT01474512|10088639|P1|Long-Term Extension Period|Clinical Relapse|0
2929489|NCT01474512|10088622|P18|Long-Term Extension Period|Physician Decision|0
2929490|NCT01474512|10088623|P17|Long-Term Extension Period|Physician Decision|0
2929491|NCT01474512|10088624|P16|Long-Term Extension Period|Physician Decision|0
2929492|NCT01474512|10088625|P15|Long-Term Extension Period|Physician Decision|0
2929493|NCT01474512|10088626|P14|Long-Term Extension Period|Physician Decision|21
2929494|NCT01474512|10088627|P13|Long-Term Extension Period|Physician Decision|21
2929495|NCT01474512|10088628|P12|Long-Term Extension Period|Physician Decision|0
2929496|NCT01474512|10088629|P11|Long-Term Extension Period|Physician Decision|0
2929497|NCT01474512|10088630|P10|Long-Term Extension Period|Physician Decision|0
2929498|NCT01474512|10088631|P9|Long-Term Extension Period|Physician Decision|0
2929499|NCT01474512|10088632|P8|Long-Term Extension Period|Physician Decision|0
2929500|NCT01474512|10088633|P7|Long-Term Extension Period|Physician Decision|0
2929501|NCT01474512|10088634|P6|Long-Term Extension Period|Physician Decision|0
2929502|NCT01474512|10088635|P5|Long-Term Extension Period|Physician Decision|0
2929503|NCT01474512|10088636|P4|Long-Term Extension Period|Physician Decision|0
2929504|NCT01474512|10088637|P3|Long-Term Extension Period|Physician Decision|0
2929505|NCT01474512|10088638|P2|Long-Term Extension Period|Physician Decision|0
2929506|NCT01474512|10088639|P1|Long-Term Extension Period|Physician Decision|0
2929507|NCT01474512|10088622|P18|Long-Term Extension Period|Lack of Efficacy|0
2929508|NCT01474512|10088623|P17|Long-Term Extension Period|Lack of Efficacy|0
2929509|NCT01474512|10088624|P16|Long-Term Extension Period|Lack of Efficacy|0
2929510|NCT01474512|10088625|P15|Long-Term Extension Period|Lack of Efficacy|0
2929511|NCT01474512|10088626|P14|Long-Term Extension Period|Lack of Efficacy|25
2929512|NCT01474512|10088627|P13|Long-Term Extension Period|Lack of Efficacy|24
2929513|NCT01474512|10088628|P12|Long-Term Extension Period|Lack of Efficacy|1
2929514|NCT01474512|10088629|P11|Long-Term Extension Period|Lack of Efficacy|0
2929515|NCT01474512|10088630|P10|Long-Term Extension Period|Lack of Efficacy|0
2929516|NCT01474512|10088631|P9|Long-Term Extension Period|Lack of Efficacy|0
2929517|NCT01474512|10088632|P8|Long-Term Extension Period|Lack of Efficacy|0
2929518|NCT01474512|10088633|P7|Long-Term Extension Period|Lack of Efficacy|0
2929519|NCT01474512|10088634|P6|Long-Term Extension Period|Lack of Efficacy|0
2929520|NCT01474512|10088635|P5|Long-Term Extension Period|Lack of Efficacy|0
2929521|NCT01474512|10088636|P4|Long-Term Extension Period|Lack of Efficacy|0
2929522|NCT01474512|10088637|P3|Long-Term Extension Period|Lack of Efficacy|0
2929523|NCT01474512|10088638|P2|Long-Term Extension Period|Lack of Efficacy|0
2929524|NCT01474512|10088639|P1|Long-Term Extension Period|Lack of Efficacy|0
2929525|NCT01474512|10088622|P18|Long-Term Extension Period|Lost to Follow-up|0
2929526|NCT01474512|10088623|P17|Long-Term Extension Period|Lost to Follow-up|0
2929527|NCT01474512|10088624|P16|Long-Term Extension Period|Lost to Follow-up|0
2929528|NCT01474512|10088625|P15|Long-Term Extension Period|Lost to Follow-up|0
2929529|NCT01474512|10088626|P14|Long-Term Extension Period|Lost to Follow-up|25
2929530|NCT01474512|10088627|P13|Long-Term Extension Period|Lost to Follow-up|25
2929531|NCT01474512|10088628|P12|Long-Term Extension Period|Lost to Follow-up|0
2929532|NCT01474512|10088629|P11|Long-Term Extension Period|Lost to Follow-up|0
2929533|NCT01474512|10088630|P10|Long-Term Extension Period|Lost to Follow-up|0
2929534|NCT01474512|10088631|P9|Long-Term Extension Period|Lost to Follow-up|0
2929535|NCT01474512|10088632|P8|Long-Term Extension Period|Lost to Follow-up|0
2929536|NCT01474512|10088633|P7|Long-Term Extension Period|Lost to Follow-up|0
2929537|NCT01474512|10088634|P6|Long-Term Extension Period|Lost to Follow-up|0
2929538|NCT01474512|10088635|P5|Long-Term Extension Period|Lost to Follow-up|0
2929539|NCT01474512|10088636|P4|Long-Term Extension Period|Lost to Follow-up|0
2929540|NCT01474512|10088637|P3|Long-Term Extension Period|Lost to Follow-up|0
2929541|NCT01474512|10088638|P2|Long-Term Extension Period|Lost to Follow-up|0
2929542|NCT01474512|10088639|P1|Long-Term Extension Period|Lost to Follow-up|0
2929543|NCT01474512|10088622|P18|Long-Term Extension Period|Adverse Event|0
2929544|NCT01474512|10088623|P17|Long-Term Extension Period|Adverse Event|0
2929545|NCT01474512|10088624|P16|Long-Term Extension Period|Adverse Event|0
2929546|NCT01474512|10088625|P15|Long-Term Extension Period|Adverse Event|0
2929547|NCT01474512|10088626|P14|Long-Term Extension Period|Adverse Event|58
2929548|NCT01474512|10088627|P13|Long-Term Extension Period|Adverse Event|57
2929549|NCT01474512|10088628|P12|Long-Term Extension Period|Adverse Event|1
2929550|NCT01474512|10088629|P11|Long-Term Extension Period|Adverse Event|0
2929551|NCT01474512|10088630|P10|Long-Term Extension Period|Adverse Event|0
2929552|NCT01474512|10088631|P9|Long-Term Extension Period|Adverse Event|0
2929553|NCT01474512|10088632|P8|Long-Term Extension Period|Adverse Event|0
2929554|NCT01474512|10088633|P7|Long-Term Extension Period|Adverse Event|0
2929555|NCT01474512|10088634|P6|Long-Term Extension Period|Adverse Event|0
2929556|NCT01474512|10088635|P5|Long-Term Extension Period|Adverse Event|0
2929557|NCT01474512|10088636|P4|Long-Term Extension Period|Adverse Event|0
2929558|NCT01474512|10088637|P3|Long-Term Extension Period|Adverse Event|0
2929559|NCT01474512|10088638|P2|Long-Term Extension Period|Adverse Event|0
2929560|NCT01474512|10088639|P1|Long-Term Extension Period|Adverse Event|0
2929561|NCT01474512|10088622|P18|Long-Term Extension Period|Withdrawal by Subject|0
2929562|NCT01474512|10088623|P17|Long-Term Extension Period|Withdrawal by Subject|0
2929563|NCT01474512|10088624|P16|Long-Term Extension Period|Withdrawal by Subject|0
2929564|NCT01474512|10088625|P15|Long-Term Extension Period|Withdrawal by Subject|0
2929565|NCT01474512|10088626|P14|Long-Term Extension Period|Withdrawal by Subject|61
2929566|NCT01474512|10088627|P13|Long-Term Extension Period|Withdrawal by Subject|61
2929567|NCT01474512|10088628|P12|Long-Term Extension Period|Withdrawal by Subject|3
2929568|NCT01474512|10088629|P11|Long-Term Extension Period|Withdrawal by Subject|0
2929569|NCT01474512|10088630|P10|Long-Term Extension Period|Withdrawal by Subject|0
2929570|NCT01474512|10088631|P9|Long-Term Extension Period|Withdrawal by Subject|0
2929571|NCT01474512|10088632|P8|Long-Term Extension Period|Withdrawal by Subject|0
2929572|NCT01474512|10088633|P7|Long-Term Extension Period|Withdrawal by Subject|0
2929573|NCT01474512|10088634|P6|Long-Term Extension Period|Withdrawal by Subject|0
2929574|NCT01474512|10088635|P5|Long-Term Extension Period|Withdrawal by Subject|0
2929575|NCT01474512|10088636|P4|Long-Term Extension Period|Withdrawal by Subject|0
2929576|NCT01474512|10088637|P3|Long-Term Extension Period|Withdrawal by Subject|0
2929577|NCT01474512|10088638|P2|Long-Term Extension Period|Withdrawal by Subject|0
2929578|NCT01474512|10088639|P1|Long-Term Extension Period|Withdrawal by Subject|0
2929579|NCT01474512|10088622|P18|Maintenance Period|Treated but Discontinued in Induction|0
2929580|NCT01474512|10088623|P17|Maintenance Period|Treated but Discontinued in Induction|0
2929581|NCT01474512|10088624|P16|Maintenance Period|Treated but Discontinued in Induction|0
2929582|NCT01474512|10088625|P15|Maintenance Period|Treated but Discontinued in Induction|0
2929583|NCT01474512|10088626|P14|Maintenance Period|Treated but Discontinued in Induction|0
2929584|NCT01474512|10088627|P13|Maintenance Period|Treated but Discontinued in Induction|0
2929585|NCT01474512|10088628|P12|Maintenance Period|Treated but Discontinued in Induction|0
2929586|NCT01474512|10088629|P11|Maintenance Period|Treated but Discontinued in Induction|0
2929587|NCT01474512|10088630|P10|Maintenance Period|Treated but Discontinued in Induction|0
2929588|NCT01474512|10088631|P9|Maintenance Period|Treated but Discontinued in Induction|0
2929589|NCT01474512|10088632|P8|Maintenance Period|Treated but Discontinued in Induction|0
2929590|NCT01474512|10088633|P7|Maintenance Period|Treated but Discontinued in Induction|0
2929591|NCT01474512|10088634|P6|Maintenance Period|Treated but Discontinued in Induction|0
2929592|NCT01474512|10088635|P5|Maintenance Period|Treated but Discontinued in Induction|1
2929593|NCT01474512|10088636|P4|Maintenance Period|Treated but Discontinued in Induction|0
2929594|NCT01474512|10088637|P3|Maintenance Period|Treated but Discontinued in Induction|0
2929595|NCT01474512|10088638|P2|Maintenance Period|Treated but Discontinued in Induction|0
2929596|NCT01474512|10088639|P1|Maintenance Period|Treated but Discontinued in Induction|0
2929597|NCT01474512|10088622|P18|Maintenance Period|Protocol Violation|0
2929598|NCT01474512|10088623|P17|Maintenance Period|Protocol Violation|0
2929599|NCT01474512|10088624|P16|Maintenance Period|Protocol Violation|0
2929600|NCT01474512|10088625|P15|Maintenance Period|Protocol Violation|0
2929601|NCT01474512|10088626|P14|Maintenance Period|Protocol Violation|0
2929602|NCT01474512|10088627|P13|Maintenance Period|Protocol Violation|0
2929603|NCT01474512|10088628|P12|Maintenance Period|Protocol Violation|0
2929604|NCT01474512|10088629|P11|Maintenance Period|Protocol Violation|0
2929605|NCT01474512|10088630|P10|Maintenance Period|Protocol Violation|1
2929606|NCT01474512|10088631|P9|Maintenance Period|Protocol Violation|0
2929607|NCT01474512|10088632|P8|Maintenance Period|Protocol Violation|1
2929608|NCT01474512|10088633|P7|Maintenance Period|Protocol Violation|0
2929609|NCT01474512|10088634|P6|Maintenance Period|Protocol Violation|0
2929610|NCT01474512|10088635|P5|Maintenance Period|Protocol Violation|0
2929611|NCT01474512|10088636|P4|Maintenance Period|Protocol Violation|1
2929612|NCT01474512|10088637|P3|Maintenance Period|Protocol Violation|0
2929613|NCT01474512|10088638|P2|Maintenance Period|Protocol Violation|0
2929614|NCT01474512|10088639|P1|Maintenance Period|Protocol Violation|0
2929615|NCT01474512|10088622|P18|Maintenance Period|Lack of Efficacy|0
2929616|NCT01474512|10088623|P17|Maintenance Period|Lack of Efficacy|0
2929617|NCT01474512|10088624|P16|Maintenance Period|Lack of Efficacy|0
2929618|NCT01474512|10088625|P15|Maintenance Period|Lack of Efficacy|0
2929619|NCT01474512|10088626|P14|Maintenance Period|Lack of Efficacy|0
2929620|NCT01474512|10088627|P13|Maintenance Period|Lack of Efficacy|0
2929621|NCT01474512|10088628|P12|Maintenance Period|Lack of Efficacy|0
2929622|NCT01474512|10088629|P11|Maintenance Period|Lack of Efficacy|0
2929623|NCT01474512|10088630|P10|Maintenance Period|Lack of Efficacy|12
2929624|NCT01474512|10088631|P9|Maintenance Period|Lack of Efficacy|11
2929625|NCT01474512|10088632|P8|Maintenance Period|Lack of Efficacy|11
2929626|NCT01474512|10088633|P7|Maintenance Period|Lack of Efficacy|0
2929627|NCT01474512|10088634|P6|Maintenance Period|Lack of Efficacy|0
2929628|NCT01474512|10088635|P5|Maintenance Period|Lack of Efficacy|0
2929629|NCT01474512|10088636|P4|Maintenance Period|Lack of Efficacy|1
2929630|NCT01474512|10088637|P3|Maintenance Period|Lack of Efficacy|0
2929631|NCT01474512|10088638|P2|Maintenance Period|Lack of Efficacy|0
2929632|NCT01474512|10088639|P1|Maintenance Period|Lack of Efficacy|0
2929633|NCT01474512|10088622|P18|Maintenance Period|Clinical Relapse|0
2929634|NCT01474512|10088623|P17|Maintenance Period|Clinical Relapse|0
2929635|NCT01474512|10088624|P16|Maintenance Period|Clinical Relapse|0
2929636|NCT01474512|10088625|P15|Maintenance Period|Clinical Relapse|0
2929637|NCT01474512|10088626|P14|Maintenance Period|Clinical Relapse|0
2929638|NCT01474512|10088627|P13|Maintenance Period|Clinical Relapse|0
2929639|NCT01474512|10088628|P12|Maintenance Period|Clinical Relapse|0
2929640|NCT01474512|10088629|P11|Maintenance Period|Clinical Relapse|0
2929641|NCT01474512|10088630|P10|Maintenance Period|Clinical Relapse|0
2929642|NCT01474512|10088631|P9|Maintenance Period|Clinical Relapse|0
2929643|NCT01474512|10088632|P8|Maintenance Period|Clinical Relapse|0
2929644|NCT01474512|10088633|P7|Maintenance Period|Clinical Relapse|0
2929645|NCT01474512|10088634|P6|Maintenance Period|Clinical Relapse|0
2929646|NCT01474512|10088635|P5|Maintenance Period|Clinical Relapse|0
2929647|NCT01474512|10088636|P4|Maintenance Period|Clinical Relapse|1
2929648|NCT01474512|10088637|P3|Maintenance Period|Clinical Relapse|0
2929649|NCT01474512|10088638|P2|Maintenance Period|Clinical Relapse|0
2929650|NCT01474512|10088639|P1|Maintenance Period|Clinical Relapse|0
2929651|NCT01474512|10088622|P18|Maintenance Period|Physician Decision|0
2929652|NCT01474512|10088623|P17|Maintenance Period|Physician Decision|0
2929653|NCT01474512|10088624|P16|Maintenance Period|Physician Decision|0
2929654|NCT01474512|10088625|P15|Maintenance Period|Physician Decision|0
2929655|NCT01474512|10088626|P14|Maintenance Period|Physician Decision|0
2929656|NCT01474512|10088627|P13|Maintenance Period|Physician Decision|0
2929657|NCT01474512|10088628|P12|Maintenance Period|Physician Decision|0
2929658|NCT01474512|10088629|P11|Maintenance Period|Physician Decision|0
2929659|NCT01474512|10088630|P10|Maintenance Period|Physician Decision|0
2929660|NCT01474512|10088631|P9|Maintenance Period|Physician Decision|0
2929661|NCT01474512|10088632|P8|Maintenance Period|Physician Decision|2
2929662|NCT01474512|10088633|P7|Maintenance Period|Physician Decision|0
2929663|NCT01474512|10088634|P6|Maintenance Period|Physician Decision|1
2929664|NCT01474512|10088635|P5|Maintenance Period|Physician Decision|0
2929665|NCT01474512|10088636|P4|Maintenance Period|Physician Decision|0
2929666|NCT01474512|10088637|P3|Maintenance Period|Physician Decision|0
2929667|NCT01474512|10088638|P2|Maintenance Period|Physician Decision|0
2929668|NCT01474512|10088639|P1|Maintenance Period|Physician Decision|0
2929669|NCT01474512|10088622|P18|Maintenance Period|Death|0
2929670|NCT01474512|10088623|P17|Maintenance Period|Death|0
2929671|NCT01474512|10088624|P16|Maintenance Period|Death|0
2929672|NCT01474512|10088625|P15|Maintenance Period|Death|0
2929673|NCT01474512|10088626|P14|Maintenance Period|Death|0
2929674|NCT01474512|10088627|P13|Maintenance Period|Death|0
2929675|NCT01474512|10088628|P12|Maintenance Period|Death|0
2929676|NCT01474512|10088629|P11|Maintenance Period|Death|0
2929677|NCT01474512|10088630|P10|Maintenance Period|Death|0
2929678|NCT01474512|10088631|P9|Maintenance Period|Death|0
2929679|NCT01474512|10088632|P8|Maintenance Period|Death|0
2929680|NCT01474512|10088633|P7|Maintenance Period|Death|0
2929681|NCT01474512|10088634|P6|Maintenance Period|Death|2
2929682|NCT01474512|10088635|P5|Maintenance Period|Death|0
2929683|NCT01474512|10088636|P4|Maintenance Period|Death|0
2929684|NCT01474512|10088637|P3|Maintenance Period|Death|0
2929685|NCT01474512|10088638|P2|Maintenance Period|Death|0
2929686|NCT01474512|10088639|P1|Maintenance Period|Death|0
2929687|NCT01474512|10088622|P18|Maintenance Period|Lost to Follow-up|0
2929688|NCT01474512|10088623|P17|Maintenance Period|Lost to Follow-up|0
2929689|NCT01474512|10088624|P16|Maintenance Period|Lost to Follow-up|0
2929690|NCT01474512|10088625|P15|Maintenance Period|Lost to Follow-up|0
2929691|NCT01474512|10088626|P14|Maintenance Period|Lost to Follow-up|0
2929692|NCT01474512|10088627|P13|Maintenance Period|Lost to Follow-up|0
2929693|NCT01474512|10088628|P12|Maintenance Period|Lost to Follow-up|0
2929694|NCT01474512|10088629|P11|Maintenance Period|Lost to Follow-up|0
2929695|NCT01474512|10088630|P10|Maintenance Period|Lost to Follow-up|1
2929696|NCT01474512|10088631|P9|Maintenance Period|Lost to Follow-up|1
2929697|NCT01474512|10088632|P8|Maintenance Period|Lost to Follow-up|2
2929698|NCT01474512|10088633|P7|Maintenance Period|Lost to Follow-up|0
2929699|NCT01474512|10088634|P6|Maintenance Period|Lost to Follow-up|0
2929700|NCT01474512|10088635|P5|Maintenance Period|Lost to Follow-up|3
2929701|NCT01474512|10088636|P4|Maintenance Period|Lost to Follow-up|3
2929702|NCT01474512|10088637|P3|Maintenance Period|Lost to Follow-up|0
2929703|NCT01474512|10088638|P2|Maintenance Period|Lost to Follow-up|0
2929704|NCT01474512|10088639|P1|Maintenance Period|Lost to Follow-up|0
2929705|NCT01474512|10088622|P18|Maintenance Period|Withdrawal by Subject|0
2929706|NCT01474512|10088623|P17|Maintenance Period|Withdrawal by Subject|0
2929707|NCT01474512|10088624|P16|Maintenance Period|Withdrawal by Subject|0
2929708|NCT01474512|10088625|P15|Maintenance Period|Withdrawal by Subject|0
2929709|NCT01474512|10088626|P14|Maintenance Period|Withdrawal by Subject|0
2929710|NCT01474512|10088627|P13|Maintenance Period|Withdrawal by Subject|0
2929711|NCT01474512|10088628|P12|Maintenance Period|Withdrawal by Subject|0
2929712|NCT01474512|10088629|P11|Maintenance Period|Withdrawal by Subject|0
2929713|NCT01474512|10088630|P10|Maintenance Period|Withdrawal by Subject|1
2929714|NCT01474512|10088631|P9|Maintenance Period|Withdrawal by Subject|3
2929715|NCT01474512|10088632|P8|Maintenance Period|Withdrawal by Subject|6
2929716|NCT01474512|10088633|P7|Maintenance Period|Withdrawal by Subject|1
2929717|NCT01474512|10088634|P6|Maintenance Period|Withdrawal by Subject|3
2929718|NCT01474512|10088635|P5|Maintenance Period|Withdrawal by Subject|2
2929719|NCT01474512|10088636|P4|Maintenance Period|Withdrawal by Subject|6
2929720|NCT01474512|10088637|P3|Maintenance Period|Withdrawal by Subject|0
2929721|NCT01474512|10088638|P2|Maintenance Period|Withdrawal by Subject|0
2929722|NCT01474512|10088639|P1|Maintenance Period|Withdrawal by Subject|0
2929723|NCT01474512|10088622|P18|Maintenance Period|Adverse Event|0
2929724|NCT01474512|10088623|P17|Maintenance Period|Adverse Event|0
2929725|NCT01474512|10088624|P16|Maintenance Period|Adverse Event|0
2929726|NCT01474512|10088625|P15|Maintenance Period|Adverse Event|0
2929727|NCT01474512|10088626|P14|Maintenance Period|Adverse Event|0
2929728|NCT01474512|10088627|P13|Maintenance Period|Adverse Event|0
2929729|NCT01474512|10088628|P12|Maintenance Period|Adverse Event|0
2929730|NCT01474512|10088629|P11|Maintenance Period|Adverse Event|0
2929731|NCT01474512|10088630|P10|Maintenance Period|Adverse Event|3
2929732|NCT01474512|10088631|P9|Maintenance Period|Adverse Event|1
2929733|NCT01474512|10088632|P8|Maintenance Period|Adverse Event|19
2929734|NCT01474512|10088633|P7|Maintenance Period|Adverse Event|0
2929735|NCT01474512|10088634|P6|Maintenance Period|Adverse Event|7
2929736|NCT01474512|10088635|P5|Maintenance Period|Adverse Event|2
2929737|NCT01474512|10088636|P4|Maintenance Period|Adverse Event|4
2929738|NCT01474512|10088637|P3|Maintenance Period|Adverse Event|0
2929739|NCT01474512|10088638|P2|Maintenance Period|Adverse Event|0
2929740|NCT01474512|10088639|P1|Maintenance Period|Adverse Event|0
2929741|NCT01474512|10088622|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
2929742|NCT01474512|10088623|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
2929743|NCT01474512|10088624|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
2929744|NCT01474512|10088625|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
2929745|NCT01474512|10088626|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
2929746|NCT01474512|10088627|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
2929747|NCT01474512|10088628|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
2929748|NCT01474512|10088629|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
2929749|NCT01474512|10088630|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
2929750|NCT01474512|10088631|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
2929751|NCT01474512|10088632|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
2929752|NCT01474512|10088633|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
2929753|NCT01474512|10088634|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
2929754|NCT01474512|10088635|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
2929755|NCT01474512|10088636|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
2929756|NCT01474512|10088637|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
2929757|NCT01474512|10088638|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
2929758|NCT01474512|10088639|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
2929759|NCT01474512|10088622|P18|Induction Period|Lost to Follow-up|0
2929760|NCT01474512|10088623|P17|Induction Period|Lost to Follow-up|0
2929761|NCT01474512|10088624|P16|Induction Period|Lost to Follow-up|0
2929762|NCT01474512|10088625|P15|Induction Period|Lost to Follow-up|0
2929763|NCT01474512|10088626|P14|Induction Period|Lost to Follow-up|0
2929764|NCT01474512|10088627|P13|Induction Period|Lost to Follow-up|0
2929765|NCT01474512|10088628|P12|Induction Period|Lost to Follow-up|0
2929766|NCT01474512|10088629|P11|Induction Period|Lost to Follow-up|0
2929767|NCT01474512|10088630|P10|Induction Period|Lost to Follow-up|0
2929768|NCT01474512|10088631|P9|Induction Period|Lost to Follow-up|0
2929769|NCT01474512|10088632|P8|Induction Period|Lost to Follow-up|0
2929770|NCT01474512|10088633|P7|Induction Period|Lost to Follow-up|0
2929771|NCT01474512|10088634|P6|Induction Period|Lost to Follow-up|0
2929772|NCT01474512|10088635|P5|Induction Period|Lost to Follow-up|0
2929773|NCT01474512|10088636|P4|Induction Period|Lost to Follow-up|0
2929774|NCT01474512|10088637|P3|Induction Period|Lost to Follow-up|2
2929775|NCT01474512|10088638|P2|Induction Period|Lost to Follow-up|0
2929776|NCT01474512|10088639|P1|Induction Period|Lost to Follow-up|1
2929777|NCT01474512|10088622|P18|Induction Period|Sponsor Decision|0
2929778|NCT01474512|10088623|P17|Induction Period|Sponsor Decision|0
2929779|NCT01474512|10088624|P16|Induction Period|Sponsor Decision|0
2929780|NCT01474512|10088625|P15|Induction Period|Sponsor Decision|0
2929781|NCT01474512|10088626|P14|Induction Period|Sponsor Decision|0
2929782|NCT01474512|10088627|P13|Induction Period|Sponsor Decision|0
2929783|NCT01474512|10088628|P12|Induction Period|Sponsor Decision|0
2929784|NCT01474512|10088629|P11|Induction Period|Sponsor Decision|0
2929785|NCT01474512|10088630|P10|Induction Period|Sponsor Decision|0
2929786|NCT01474512|10088631|P9|Induction Period|Sponsor Decision|0
2929787|NCT01474512|10088632|P8|Induction Period|Sponsor Decision|0
2929788|NCT01474512|10088633|P7|Induction Period|Sponsor Decision|0
2929789|NCT01474512|10088634|P6|Induction Period|Sponsor Decision|0
2929790|NCT01474512|10088635|P5|Induction Period|Sponsor Decision|0
2929791|NCT01474512|10088636|P4|Induction Period|Sponsor Decision|0
2929792|NCT01474512|10088637|P3|Induction Period|Sponsor Decision|1
2929793|NCT01474512|10088638|P2|Induction Period|Sponsor Decision|1
2929794|NCT01474512|10088639|P1|Induction Period|Sponsor Decision|1
2929795|NCT01474512|10088622|P18|Induction Period|Protocol Violation|0
2929796|NCT01474512|10088623|P17|Induction Period|Protocol Violation|0
2929797|NCT01474512|10088624|P16|Induction Period|Protocol Violation|0
2929798|NCT01474512|10088625|P15|Induction Period|Protocol Violation|0
2929799|NCT01474512|10088626|P14|Induction Period|Protocol Violation|0
2929800|NCT01474512|10088627|P13|Induction Period|Protocol Violation|0
2929801|NCT01474512|10088628|P12|Induction Period|Protocol Violation|0
2929802|NCT01474512|10088629|P11|Induction Period|Protocol Violation|0
2929803|NCT01474512|10088630|P10|Induction Period|Protocol Violation|0
2929804|NCT01474512|10088631|P9|Induction Period|Protocol Violation|0
2929805|NCT01474512|10088632|P8|Induction Period|Protocol Violation|0
2929806|NCT01474512|10088633|P7|Induction Period|Protocol Violation|0
2929807|NCT01474512|10088634|P6|Induction Period|Protocol Violation|0
2929808|NCT01474512|10088635|P5|Induction Period|Protocol Violation|0
2929809|NCT01474512|10088636|P4|Induction Period|Protocol Violation|0
2929810|NCT01474512|10088637|P3|Induction Period|Protocol Violation|0
2929811|NCT01474512|10088638|P2|Induction Period|Protocol Violation|6
2929812|NCT01474512|10088639|P1|Induction Period|Protocol Violation|3
2929813|NCT01474512|10088622|P18|Induction Period|Withdrawal by Subject|0
2929814|NCT01474512|10088623|P17|Induction Period|Withdrawal by Subject|0
2929815|NCT01474512|10088624|P16|Induction Period|Withdrawal by Subject|0
2929816|NCT01474512|10088625|P15|Induction Period|Withdrawal by Subject|0
2929817|NCT01474512|10088626|P14|Induction Period|Withdrawal by Subject|0
2929818|NCT01474512|10088627|P13|Induction Period|Withdrawal by Subject|0
2929819|NCT01474512|10088628|P12|Induction Period|Withdrawal by Subject|0
2929820|NCT01474512|10088629|P11|Induction Period|Withdrawal by Subject|0
2929821|NCT01474512|10088630|P10|Induction Period|Withdrawal by Subject|0
2929822|NCT01474512|10088631|P9|Induction Period|Withdrawal by Subject|0
2929823|NCT01474512|10088632|P8|Induction Period|Withdrawal by Subject|0
2929824|NCT01474512|10088633|P7|Induction Period|Withdrawal by Subject|0
2929825|NCT01474512|10088634|P6|Induction Period|Withdrawal by Subject|0
2929826|NCT01474512|10088635|P5|Induction Period|Withdrawal by Subject|0
2929827|NCT01474512|10088636|P4|Induction Period|Withdrawal by Subject|0
2929828|NCT01474512|10088637|P3|Induction Period|Withdrawal by Subject|5
2929829|NCT01474512|10088638|P2|Induction Period|Withdrawal by Subject|6
2929830|NCT01474512|10088639|P1|Induction Period|Withdrawal by Subject|6
2929831|NCT01474512|10088622|P18|Induction Period|Lack of Efficacy|0
2929832|NCT01474512|10088623|P17|Induction Period|Lack of Efficacy|0
2929833|NCT01474512|10088624|P16|Induction Period|Lack of Efficacy|0
2929834|NCT01474512|10088625|P15|Induction Period|Lack of Efficacy|0
2929835|NCT01474512|10088626|P14|Induction Period|Lack of Efficacy|0
2929836|NCT01474512|10088627|P13|Induction Period|Lack of Efficacy|0
2929837|NCT01474512|10088628|P12|Induction Period|Lack of Efficacy|0
2929838|NCT01474512|10088629|P11|Induction Period|Lack of Efficacy|0
2929839|NCT01474512|10088630|P10|Induction Period|Lack of Efficacy|0
2929840|NCT01474512|10088631|P9|Induction Period|Lack of Efficacy|0
2929841|NCT01474512|10088632|P8|Induction Period|Lack of Efficacy|0
2929842|NCT01474512|10088633|P7|Induction Period|Lack of Efficacy|0
2929843|NCT01474512|10088634|P6|Induction Period|Lack of Efficacy|0
2929844|NCT01474512|10088635|P5|Induction Period|Lack of Efficacy|0
2929845|NCT01474512|10088636|P4|Induction Period|Lack of Efficacy|0
2929846|NCT01474512|10088637|P3|Induction Period|Lack of Efficacy|0
2929847|NCT01474512|10088638|P2|Induction Period|Lack of Efficacy|1
2929848|NCT01474512|10088639|P1|Induction Period|Lack of Efficacy|7
2929849|NCT01474512|10088622|P18|Induction Period|Adverse Event|0
2929850|NCT01474512|10088623|P17|Induction Period|Adverse Event|0
2929851|NCT01474512|10088624|P16|Induction Period|Adverse Event|0
2929852|NCT01474512|10088625|P15|Induction Period|Adverse Event|0
2929853|NCT01474512|10088626|P14|Induction Period|Adverse Event|0
2929854|NCT01474512|10088627|P13|Induction Period|Adverse Event|0
2929855|NCT01474512|10088628|P12|Induction Period|Adverse Event|0
2929856|NCT01474512|10088629|P11|Induction Period|Adverse Event|0
2929857|NCT01474512|10088630|P10|Induction Period|Adverse Event|0
2929858|NCT01474512|10088631|P9|Induction Period|Adverse Event|0
2929859|NCT01474512|10088632|P8|Induction Period|Adverse Event|0
2929860|NCT01474512|10088633|P7|Induction Period|Adverse Event|0
2929861|NCT01474512|10088634|P6|Induction Period|Adverse Event|0
2929862|NCT01474512|10088635|P5|Induction Period|Adverse Event|0
2929863|NCT01474512|10088636|P4|Induction Period|Adverse Event|0
2929864|NCT01474512|10088637|P3|Induction Period|Adverse Event|10
2929865|NCT01474512|10088638|P2|Induction Period|Adverse Event|10
2929866|NCT01474512|10088639|P1|Induction Period|Adverse Event|6
2929867|NCT01474434|10088715|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2929868|NCT01474434|10088716|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2929869|NCT01474434|10088717|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2929870|NCT01474434|10088718|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
2929871|NCT01474434|10088715|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
2929872|NCT01474434|10088716|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2929873|NCT01474434|10088717|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2929874|NCT01474434|10088718|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2929875|NCT01474434|10088715|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2929876|NCT01474434|10088716|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2929877|NCT01474434|10088717|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2929878|NCT01474434|10088718|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2929879|NCT01474317|10088760|P1|Overall Study|Subject ineligible for study|1
2929880|NCT01474317|10088760|P1|Overall Study|Adverse Event|1
2929881|NCT01474291|10088769|P1|Overall Study|Death|2
2929882|NCT01474291|10088769|P1|Overall Study|No Reason Reported|10
2929883|NCT01474291|10088769|P1|Overall Study|Patient No Longer Wanted to Participate|12
2929884|NCT01474291|10088769|P1|Overall Study|Lost to Follow-up|29
2929885|NCT01474291|10088769|P1|Overall Study|Adverse Event|53
2929886|NCT01474291|10088769|P1|Overall Study|Lack of Treatment Efficacy|88
2929887|NCT01474291|10088769|P1|Overall Study|Not Evaluable for Efficacy|26
2929888|NCT01474239|10088813|P2|Overall Study|Withdrawal for Economic Reason|0
2929889|NCT01474239|10088814|P1|Overall Study|Withdrawal for Economic Reason|1
2929890|NCT01474239|10088813|P2|Overall Study|Clinical Disease Progression|1
2929891|NCT01474239|10088814|P1|Overall Study|Clinical Disease Progression|7
2929892|NCT01474239|10088813|P2|Overall Study|Death|1
2929893|NCT01474239|10088814|P1|Overall Study|Death|1
2929894|NCT01474239|10088813|P2|Overall Study|Withdrawal by Subject|2
2929895|NCT01474239|10088814|P1|Overall Study|Withdrawal by Subject|1
2929896|NCT01474239|10088813|P2|Overall Study|Adverse Event|3
2929897|NCT01474239|10088814|P1|Overall Study|Adverse Event|12
2929898|NCT01474239|10088813|P2|Overall Study|Disease Progression|25
2929899|NCT01474239|10088814|P1|Overall Study|Disease Progression|37
2929900|NCT01474018|10088986|P2|Overall Study|Withdrawal by Subject|2
2929901|NCT01474018|10088987|P1|Overall Study|Withdrawal by Subject|0
2929902|NCT01474018|10088986|P2|Overall Study|Lost to Follow-up|1
2929903|NCT01474018|10088987|P1|Overall Study|Lost to Follow-up|0
2929904|NCT01473953|10089019|P5|Overall Study|Other|0
2929905|NCT01473953|10089020|P4|Overall Study|Other|0
2929906|NCT01473953|10089021|P3|Overall Study|Other|0
2929907|NCT01473953|10089022|P2|Overall Study|Other|0
2929908|NCT01473953|10089023|P1|Overall Study|Other|1
2929909|NCT01473940|10089069|P4|Maintenance Therapy|Progressive Disease|4
2929910|NCT01473940|10089070|P3|Maintenance Therapy|Progressive Disease|1
2929911|NCT01473940|10089071|P2|Maintenance Therapy|Progressive Disease|2
2929912|NCT01473940|10089072|P1|Maintenance Therapy|Progressive Disease|1
2929913|NCT01473940|10089069|P4|Induction Therapy|Progressive Disease|0
2929914|NCT01473940|10089070|P3|Induction Therapy|Progressive Disease|1
2929915|NCT01473940|10089071|P2|Induction Therapy|Progressive Disease|1
2929916|NCT01473940|10089072|P1|Induction Therapy|Progressive Disease|0
2929917|NCT01473940|10089069|P4|Induction Therapy|Death|1
2929918|NCT01473940|10089070|P3|Induction Therapy|Death|1
2929919|NCT01473940|10089071|P2|Induction Therapy|Death|0
2929920|NCT01473940|10089072|P1|Induction Therapy|Death|0
2929921|NCT01473836|10089102|P1|Overall Study|Does not meet entrance criteria|1
2929922|NCT01473836|10089102|P1|Overall Study|Lack of Efficacy|1
2929923|NCT01473836|10089102|P1|Overall Study|Adverse Event|4
2929924|NCT01473758|10089113|P4|Cycle 2|Adverse Event|0
2929925|NCT01473758|10089114|P3|Cycle 2|Adverse Event|5
2929926|NCT01473758|10089115|P2|Cycle 2|Adverse Event|0
2929927|NCT01473758|10089116|P1|Cycle 2|Adverse Event|0
2929928|NCT01473758|10089113|P4|Cycle 1|Withdrawal by Subject|0
2929929|NCT01473758|10089114|P3|Cycle 1|Withdrawal by Subject|0
2929930|NCT01473758|10089115|P2|Cycle 1|Withdrawal by Subject|1
2929931|NCT01473758|10089116|P1|Cycle 1|Withdrawal by Subject|1
2929932|NCT01473758|10089113|P4|Cycle 1|Adverse Event|0
2929933|NCT01473758|10089114|P3|Cycle 1|Adverse Event|0
2929934|NCT01473758|10089115|P2|Cycle 1|Adverse Event|2
2929935|NCT01473758|10089116|P1|Cycle 1|Adverse Event|10
2929936|NCT01473732|10089253|P2|Overall Study|Death|0
2929937|NCT01473732|10089254|P1|Overall Study|Death|1
2929938|NCT01473732|10089253|P2|Overall Study|Adverse Event|0
2929939|NCT01473732|10089254|P1|Overall Study|Adverse Event|1
2929940|NCT01473602|10089262|P2|Overall Study|Physician Decision|0
2929941|NCT01473602|10089263|P1|Overall Study|Physician Decision|1
2929942|NCT01473602|10089262|P2|Overall Study|Withdrawal by Subject|4
2929943|NCT01473602|10089263|P1|Overall Study|Withdrawal by Subject|5
2929944|NCT01473602|10089262|P2|Overall Study|Lost to Follow-up|1
2929945|NCT01473602|10089263|P1|Overall Study|Lost to Follow-up|1
2929946|NCT01473602|10089262|P2|Overall Study|Death|1
2929947|NCT01473602|10089263|P1|Overall Study|Death|0
2929948|NCT01473602|10089262|P2|Overall Study|Adverse Event|2
2929949|NCT01473602|10089263|P1|Overall Study|Adverse Event|1
2929950|NCT01473589|10089299|P2|Overall Study|Entry criteria not met|1
2929951|NCT01473589|10089300|P1|Overall Study|Entry criteria not met|0
2929952|NCT01473589|10089299|P2|Overall Study|Physician Decision|1
2929953|NCT01473589|10089300|P1|Overall Study|Physician Decision|0
2929954|NCT01473589|10089299|P2|Overall Study|Withdrawal by Subject|11
2929955|NCT01473589|10089300|P1|Overall Study|Withdrawal by Subject|5
2929956|NCT01473589|10089299|P2|Overall Study|Protocol Violation|0
2929957|NCT01473589|10089300|P1|Overall Study|Protocol Violation|1
2929958|NCT01473589|10089299|P2|Overall Study|Lost to Follow-up|2
2929959|NCT01473589|10089300|P1|Overall Study|Lost to Follow-up|2
2929960|NCT01473589|10089299|P2|Overall Study|Death|0
2929961|NCT01473589|10089300|P1|Overall Study|Death|2
2929962|NCT01473589|10089299|P2|Overall Study|Adverse Event|1
2929963|NCT01473589|10089300|P1|Overall Study|Adverse Event|1
2929964|NCT01473563|10089334|P1|Overall Study|Lost to FU post tx discontinuation|1
2929965|NCT01473524|10089356|P3|Overall Study|Withdrawal by Subject|1
2929966|NCT01473524|10089357|P2|Overall Study|Withdrawal by Subject|1
2929967|NCT01473524|10089358|P1|Overall Study|Withdrawal by Subject|2
2929968|NCT01473524|10089356|P3|Overall Study|Death|0
2929969|NCT01473524|10089357|P2|Overall Study|Death|0
2929970|NCT01473524|10089358|P1|Overall Study|Death|1
2929971|NCT01473524|10089356|P3|Overall Study|Adverse Event|2
2929972|NCT01473524|10089357|P2|Overall Study|Adverse Event|8
2929973|NCT01473524|10089358|P1|Overall Study|Adverse Event|4
2929974|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
2929975|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
2929976|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
2929977|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
2929978|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
2929979|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
2929980|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
2929981|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
2929982|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Site closure|1
2929983|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Site closure|3
2929984|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
2929985|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
2929986|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
2929987|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
2929988|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
2929989|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
2929990|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
2929991|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
2929992|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Physician Decision|2
2929993|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Physician Decision|1
2929994|NCT01473420|10089391|P2|Maintenance Period (16 Weeks)|Adverse Event|2
2929995|NCT01473420|10089392|P1|Maintenance Period (16 Weeks)|Adverse Event|3
2929996|NCT01473420|10089391|P2|Titration Period (18 Weeks)|Did not meet criteria|32
2929997|NCT01473420|10089392|P1|Titration Period (18 Weeks)|Did not meet criteria|32
2929998|NCT01473420|10089391|P2|Titration Period (18 Weeks)|Adverse Event|6
2929999|NCT01473420|10089392|P1|Titration Period (18 Weeks)|Adverse Event|4
2930000|NCT01473407|10089476|P2|Overall Study|Site Closure|0
2930001|NCT01473407|10089477|P1|Overall Study|Site Closure|1
2930002|NCT01473407|10089476|P2|Overall Study|Sponsor's Decision|10
2930003|NCT01473407|10089477|P1|Overall Study|Sponsor's Decision|10
2930004|NCT01473407|10089476|P2|Overall Study|Transfer to Another Facility/Unit|3
2930005|NCT01473407|10089477|P1|Overall Study|Transfer to Another Facility/Unit|4
2930006|NCT01473407|10089476|P2|Overall Study|Temperature Excursion|3
2930007|NCT01473407|10089477|P1|Overall Study|Temperature Excursion|2
2930008|NCT01473407|10089476|P2|Overall Study|Patient Lost Green Card Status|0
2930009|NCT01473407|10089477|P1|Overall Study|Patient Lost Green Card Status|1
2930010|NCT01473407|10089476|P2|Overall Study|Patient Received Aranesp|0
2930011|NCT01473407|10089477|P1|Overall Study|Patient Received Aranesp|1
2930012|NCT01473407|10089476|P2|Overall Study|Elevated Hemoglobin|0
2930013|NCT01473407|10089477|P1|Overall Study|Elevated Hemoglobin|1
2930014|NCT01473407|10089476|P2|Overall Study|Vacation/Travel|1
2930015|NCT01473407|10089477|P1|Overall Study|Vacation/Travel|1
2930016|NCT01473407|10089476|P2|Overall Study|Kidney Transplant|6
2930017|NCT01473407|10089477|P1|Overall Study|Kidney Transplant|7
2930018|NCT01473407|10089476|P2|Overall Study|Withdrawal by Subject|7
2930019|NCT01473407|10089477|P1|Overall Study|Withdrawal by Subject|4
2930020|NCT01473407|10089476|P2|Overall Study|Randomization Error|1
2930021|NCT01473407|10089477|P1|Overall Study|Randomization Error|3
2930022|NCT01473407|10089476|P2|Overall Study|Adverse Event|8
2930023|NCT01473407|10089477|P1|Overall Study|Adverse Event|8
2930024|NCT01473407|10089476|P2|Overall Study|Lost to Follow-up|4
2930025|NCT01473407|10089477|P1|Overall Study|Lost to Follow-up|10
2930026|NCT01473407|10089476|P2|Overall Study|Physician Decision|4
2930027|NCT01473407|10089477|P1|Overall Study|Physician Decision|1
2930028|NCT01473394|10089531|P2|Overall Study|Lost to Follow-up|11
2930029|NCT01473394|10089532|P1|Overall Study|Lost to Follow-up|9
2930030|NCT01473394|10089531|P2|Overall Study|Withdrew Consent|10
2930031|NCT01473394|10089532|P1|Overall Study|Withdrew Consent|12
2930032|NCT01473394|10089531|P2|Overall Study|Protocol Violation|5
2930033|NCT01473394|10089532|P1|Overall Study|Protocol Violation|7
2930034|NCT01473394|10089531|P2|Overall Study|Insufficient Therapeutic Response|1
2930035|NCT01473394|10089532|P1|Overall Study|Insufficient Therapeutic Response|4
2930036|NCT01473394|10089531|P2|Overall Study|Adverse Event|16
2930037|NCT01473394|10089532|P1|Overall Study|Adverse Event|13
2930038|NCT01473381|10089546|P4|Overall Study|Other Reasons|3
2930039|NCT01473381|10089547|P3|Overall Study|Other Reasons|1
2930040|NCT01473381|10089548|P2|Overall Study|Other Reasons|0
2930041|NCT01473381|10089549|P1|Overall Study|Other Reasons|0
2930042|NCT01473381|10089546|P4|Overall Study|Lost to Follow-up|23
2930043|NCT01473381|10089547|P3|Overall Study|Lost to Follow-up|35
2930044|NCT01473381|10089548|P2|Overall Study|Lost to Follow-up|28
2930045|NCT01473381|10089549|P1|Overall Study|Lost to Follow-up|25
2930046|NCT01473381|10089546|P4|Overall Study|Withdrawal of Consent|26
2930047|NCT01473381|10089547|P3|Overall Study|Withdrawal of Consent|20
2930048|NCT01473381|10089548|P2|Overall Study|Withdrawal of Consent|21
2930049|NCT01473381|10089549|P1|Overall Study|Withdrawal of Consent|20
2930050|NCT01473381|10089546|P4|Overall Study|Protocol Violation|17
2930051|NCT01473381|10089547|P3|Overall Study|Protocol Violation|19
2930052|NCT01473381|10089548|P2|Overall Study|Protocol Violation|23
2930053|NCT01473381|10089549|P1|Overall Study|Protocol Violation|17
2930054|NCT01473381|10089546|P4|Overall Study|Insufficient Therapeutic Response|3
2930055|NCT01473381|10089547|P3|Overall Study|Insufficient Therapeutic Response|2
2930056|NCT01473381|10089548|P2|Overall Study|Insufficient Therapeutic Response|1
2930057|NCT01473381|10089549|P1|Overall Study|Insufficient Therapeutic Response|10
2930058|NCT01473381|10089546|P4|Overall Study|Adverse Event|17
2930059|NCT01473381|10089547|P3|Overall Study|Adverse Event|25
2930060|NCT01473381|10089548|P2|Overall Study|Adverse Event|20
2930061|NCT01473381|10089549|P1|Overall Study|Adverse Event|8
2930062|NCT01473355|10089611|P1|Overall Study|Lost to Follow-up|2
2930063|NCT01473355|10089611|P1|Overall Study|Adverse Event|2
2930064|NCT01473355|10089611|P1|Overall Study|Protocol Violation|2
2930065|NCT01472965|10089640|P2|Overall Study|Withdrawal by Subject|0
2930066|NCT01472965|10089641|P1|Overall Study|Withdrawal by Subject|1
2930067|NCT01472939|10089661|P4|Overall Study|Withdrawal by Subject|4
2930068|NCT01472939|10089662|P3|Overall Study|Withdrawal by Subject|1
2930069|NCT01472939|10089663|P2|Overall Study|Withdrawal by Subject|3
2930070|NCT01472939|10089664|P1|Overall Study|Withdrawal by Subject|9
2930071|NCT01472939|10089661|P4|Overall Study|Protocol Violation|1
2930072|NCT01472939|10089662|P3|Overall Study|Protocol Violation|0
2930073|NCT01472939|10089663|P2|Overall Study|Protocol Violation|3
2930074|NCT01472939|10089664|P1|Overall Study|Protocol Violation|3
2930075|NCT01472939|10089661|P4|Overall Study|Withdrawal By PI|0
2930076|NCT01472939|10089662|P3|Overall Study|Withdrawal By PI|0
2930077|NCT01472939|10089663|P2|Overall Study|Withdrawal By PI|0
2930078|NCT01472939|10089664|P1|Overall Study|Withdrawal By PI|1
2930079|NCT01472939|10089661|P4|Overall Study|Prohibited Medication|0
2930080|NCT01472939|10089662|P3|Overall Study|Prohibited Medication|0
2930081|NCT01472939|10089663|P2|Overall Study|Prohibited Medication|1
2930082|NCT01472939|10089664|P1|Overall Study|Prohibited Medication|0
2930083|NCT01472939|10089661|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
2930084|NCT01472939|10089662|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
2930085|NCT01472939|10089663|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
2930086|NCT01472939|10089664|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
2930087|NCT01472939|10089661|P4|Overall Study|Lost to Follow-up|0
2930088|NCT01472939|10089662|P3|Overall Study|Lost to Follow-up|2
2930089|NCT01472939|10089663|P2|Overall Study|Lost to Follow-up|0
2930090|NCT01472939|10089664|P1|Overall Study|Lost to Follow-up|3
2930091|NCT01472939|10089661|P4|Overall Study|Lack of Efficacy|1
2930092|NCT01472939|10089662|P3|Overall Study|Lack of Efficacy|0
2930093|NCT01472939|10089663|P2|Overall Study|Lack of Efficacy|0
2930094|NCT01472939|10089664|P1|Overall Study|Lack of Efficacy|1
2930095|NCT01472939|10089661|P4|Overall Study|Adverse Event|14
2930096|NCT01472939|10089662|P3|Overall Study|Adverse Event|7
2930097|NCT01472939|10089663|P2|Overall Study|Adverse Event|7
2930098|NCT01472939|10089664|P1|Overall Study|Adverse Event|3
2930099|NCT01472835|10089708|P2|Overall Study|Lost to Follow-up|0
2930100|NCT01472835|10089709|P1|Overall Study|Lost to Follow-up|2
2930101|NCT01472757|10089744|P4|Overall Study|Other reasons|2
2930102|NCT01472757|10089745|P3|Overall Study|Other reasons|2
2930103|NCT01472757|10089746|P2|Overall Study|Other reasons|0
2930104|NCT01472757|10089747|P1|Overall Study|Other reasons|1
2930105|NCT01472757|10089744|P4|Overall Study|Protocol Violation|4
2930106|NCT01472757|10089745|P3|Overall Study|Protocol Violation|4
2930107|NCT01472757|10089746|P2|Overall Study|Protocol Violation|2
2930108|NCT01472757|10089747|P1|Overall Study|Protocol Violation|3
2930109|NCT01472757|10089744|P4|Overall Study|Treatment period withdrawal criteria met|12
2930110|NCT01472757|10089745|P3|Overall Study|Treatment period withdrawal criteria met|9
2930111|NCT01472757|10089746|P2|Overall Study|Treatment period withdrawal criteria met|8
2930112|NCT01472757|10089747|P1|Overall Study|Treatment period withdrawal criteria met|21
2930113|NCT01472757|10089744|P4|Overall Study|Asthma exacerbation|1
2930114|NCT01472757|10089745|P3|Overall Study|Asthma exacerbation|2
2930115|NCT01472757|10089746|P2|Overall Study|Asthma exacerbation|1
2930116|NCT01472757|10089747|P1|Overall Study|Asthma exacerbation|4
2930117|NCT01472757|10089744|P4|Overall Study|Withdrawal by Subject|0
2930118|NCT01472757|10089745|P3|Overall Study|Withdrawal by Subject|2
2930119|NCT01472757|10089746|P2|Overall Study|Withdrawal by Subject|2
2930120|NCT01472757|10089747|P1|Overall Study|Withdrawal by Subject|1
2930121|NCT01472380|10089862|P1|1 Day Period Between Dosing|Protocol Violation|1
2930122|NCT01472380|10089862|P1|Efavirenz Alone|Withdrawal by Subject|1
2930123|NCT01472341|10089873|P1|Overall Study|Death|9
2930124|NCT01472341|10089873|P1|Overall Study|Laboratory parameters unavailable|25
2930125|NCT01472341|10089873|P1|Overall Study|Lost to Follow-up|52
2930126|NCT01472341|10089873|P1|Overall Study|Withdrawal by Subject|39
2930127|NCT01472341|10089873|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
2930128|NCT01472341|10089873|P1|Overall Study|Started insulin therapy|55
2930129|NCT01472289|10089879|P1|Overall Study|Death|2
2930130|NCT01472185|10089891|P2|Overall Study|Subject Withdrew Consent|3
2930131|NCT01472185|10089892|P1|Overall Study|Subject Withdrew Consent|6
2930132|NCT01472185|10089891|P2|Overall Study|Subject Noncompliance|15
2930133|NCT01472185|10089892|P1|Overall Study|Subject Noncompliance|8
2930134|NCT01472185|10089891|P2|Overall Study|Protocol Violation|1
2930135|NCT01472185|10089892|P1|Overall Study|Protocol Violation|5
2930136|NCT01472185|10089891|P2|Overall Study|Lost to Follow-up|1
2930137|NCT01472185|10089892|P1|Overall Study|Lost to Follow-up|4
2930138|NCT01472185|10089891|P2|Overall Study|Investigator’s Discretion|1
2930139|NCT01472185|10089892|P1|Overall Study|Investigator’s Discretion|3
2930140|NCT01472185|10089891|P2|Overall Study|Hyperglycemia|2
2930141|NCT01472185|10089892|P1|Overall Study|Hyperglycemia|5
2930142|NCT01472185|10089891|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
2930143|NCT01472185|10089892|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
2930144|NCT01472185|10089891|P2|Overall Study|Randomized but Not Treated|1
2930145|NCT01472185|10089892|P1|Overall Study|Randomized but Not Treated|0
2930146|NCT01472081|10089912|P6|Overall Study|Subject request to discontinue treatment|0
2930147|NCT01472081|10089913|P5|Overall Study|Subject request to discontinue treatment|0
2930148|NCT01472081|10089914|P4|Overall Study|Subject request to discontinue treatment|1
2930149|NCT01472081|10089915|P3|Overall Study|Subject request to discontinue treatment|1
2930150|NCT01472081|10089916|P2|Overall Study|Subject request to discontinue treatment|3
2930151|NCT01472081|10089917|P1|Overall Study|Subject request to discontinue treatment|0
2930152|NCT01472081|10089912|P6|Overall Study|No longer meets study criteria|0
2930153|NCT01472081|10089913|P5|Overall Study|No longer meets study criteria|0
2930154|NCT01472081|10089914|P4|Overall Study|No longer meets study criteria|0
2930155|NCT01472081|10089915|P3|Overall Study|No longer meets study criteria|1
2930156|NCT01472081|10089916|P2|Overall Study|No longer meets study criteria|0
2930157|NCT01472081|10089917|P1|Overall Study|No longer meets study criteria|0
2930158|NCT01472081|10089912|P6|Overall Study|Poor/non-compliance|0
2930159|NCT01472081|10089913|P5|Overall Study|Poor/non-compliance|1
2930160|NCT01472081|10089914|P4|Overall Study|Poor/non-compliance|0
2930161|NCT01472081|10089915|P3|Overall Study|Poor/non-compliance|1
2930162|NCT01472081|10089916|P2|Overall Study|Poor/non-compliance|0
2930163|NCT01472081|10089917|P1|Overall Study|Poor/non-compliance|0
2930164|NCT01472081|10089912|P6|Overall Study|Withdrawal by Subject|1
2930165|NCT01472081|10089913|P5|Overall Study|Withdrawal by Subject|0
2930166|NCT01472081|10089914|P4|Overall Study|Withdrawal by Subject|0
2930167|NCT01472081|10089915|P3|Overall Study|Withdrawal by Subject|0
2930168|NCT01472081|10089916|P2|Overall Study|Withdrawal by Subject|0
2930169|NCT01472081|10089917|P1|Overall Study|Withdrawal by Subject|0
2930170|NCT01472081|10089912|P6|Overall Study|Adverse Event unrelated to study drug|0
2930171|NCT01472081|10089913|P5|Overall Study|Adverse Event unrelated to study drug|1
2930172|NCT01472081|10089914|P4|Overall Study|Adverse Event unrelated to study drug|0
2930173|NCT01472081|10089915|P3|Overall Study|Adverse Event unrelated to study drug|0
2930174|NCT01472081|10089916|P2|Overall Study|Adverse Event unrelated to study drug|0
2930175|NCT01472081|10089917|P1|Overall Study|Adverse Event unrelated to study drug|0
2930176|NCT01472081|10089912|P6|Overall Study|Death|0
2930177|NCT01472081|10089913|P5|Overall Study|Death|1
2930178|NCT01472081|10089914|P4|Overall Study|Death|0
2930179|NCT01472081|10089915|P3|Overall Study|Death|0
2930180|NCT01472081|10089916|P2|Overall Study|Death|0
2930181|NCT01472081|10089917|P1|Overall Study|Death|0
2930182|NCT01472081|10089912|P6|Overall Study|Study drug toxicity|2
2930183|NCT01472081|10089913|P5|Overall Study|Study drug toxicity|13
2930184|NCT01472081|10089914|P4|Overall Study|Study drug toxicity|6
2930185|NCT01472081|10089915|P3|Overall Study|Study drug toxicity|4
2930186|NCT01472081|10089916|P2|Overall Study|Study drug toxicity|9
2930187|NCT01472081|10089917|P1|Overall Study|Study drug toxicity|2
2930188|NCT01472081|10089912|P6|Overall Study|Disease Progression|3
2930189|NCT01472081|10089913|P5|Overall Study|Disease Progression|22
2930190|NCT01472081|10089914|P4|Overall Study|Disease Progression|31
2930191|NCT01472081|10089915|P3|Overall Study|Disease Progression|12
2930192|NCT01472081|10089916|P2|Overall Study|Disease Progression|10
2930193|NCT01472081|10089917|P1|Overall Study|Disease Progression|4
2930194|NCT01472081|10089912|P6|Overall Study|Continuing treatment at time of analysis|0
2930195|NCT01472081|10089913|P5|Overall Study|Continuing treatment at time of analysis|9
2930196|NCT01472081|10089914|P4|Overall Study|Continuing treatment at time of analysis|8
2930197|NCT01472081|10089915|P3|Overall Study|Continuing treatment at time of analysis|1
2930198|NCT01472081|10089916|P2|Overall Study|Continuing treatment at time of analysis|4
2930199|NCT01472081|10089917|P1|Overall Study|Continuing treatment at time of analysis|1
2930200|NCT01471782|10089966|P6|Overall Study|Death|1
2930201|NCT01471782|10089967|P5|Overall Study|Death|0
2930202|NCT01471782|10089968|P4|Overall Study|Death|0
2930203|NCT01471782|10089969|P3|Overall Study|Death|0
2930204|NCT01471782|10089970|P2|Overall Study|Death|0
2930205|NCT01471782|10089971|P1|Overall Study|Death|0
2930206|NCT01471782|10089966|P6|Overall Study|Withdrawal by Parent/Guardian|0
2930207|NCT01471782|10089967|P5|Overall Study|Withdrawal by Parent/Guardian|1
2930208|NCT01471782|10089968|P4|Overall Study|Withdrawal by Parent/Guardian|0
2930209|NCT01471782|10089969|P3|Overall Study|Withdrawal by Parent/Guardian|0
2930210|NCT01471782|10089970|P2|Overall Study|Withdrawal by Parent/Guardian|0
2930211|NCT01471782|10089971|P1|Overall Study|Withdrawal by Parent/Guardian|0
2930212|NCT01471782|10089966|P6|Overall Study|Physician Decision|8
2930213|NCT01471782|10089967|P5|Overall Study|Physician Decision|3
2930214|NCT01471782|10089968|P4|Overall Study|Physician Decision|0
2930215|NCT01471782|10089969|P3|Overall Study|Physician Decision|0
2930216|NCT01471782|10089970|P2|Overall Study|Physician Decision|0
2930217|NCT01471782|10089971|P1|Overall Study|Physician Decision|0
2930218|NCT01471782|10089966|P6|Overall Study|Disease Relapse|1
2930219|NCT01471782|10089967|P5|Overall Study|Disease Relapse|2
2930220|NCT01471782|10089968|P4|Overall Study|Disease Relapse|1
2930221|NCT01471782|10089969|P3|Overall Study|Disease Relapse|0
2930222|NCT01471782|10089970|P2|Overall Study|Disease Relapse|0
2930223|NCT01471782|10089971|P1|Overall Study|Disease Relapse|0
2930224|NCT01471782|10089966|P6|Overall Study|Change of Chemotherapy|4
2930225|NCT01471782|10089967|P5|Overall Study|Change of Chemotherapy|1
2930226|NCT01471782|10089968|P4|Overall Study|Change of Chemotherapy|0
2930227|NCT01471782|10089969|P3|Overall Study|Change of Chemotherapy|0
2930228|NCT01471782|10089970|P2|Overall Study|Change of Chemotherapy|1
2930229|NCT01471782|10089971|P1|Overall Study|Change of Chemotherapy|1
2930230|NCT01471782|10089966|P6|Overall Study|Other|5
2930231|NCT01471782|10089967|P5|Overall Study|Other|6
2930232|NCT01471782|10089968|P4|Overall Study|Other|1
2930233|NCT01471782|10089969|P3|Overall Study|Other|1
2930234|NCT01471782|10089970|P2|Overall Study|Other|0
2930235|NCT01471782|10089971|P1|Overall Study|Other|0
2930236|NCT01471782|10089966|P6|Overall Study|Adverse Event|1
2930237|NCT01471782|10089967|P5|Overall Study|Adverse Event|3
2930238|NCT01471782|10089968|P4|Overall Study|Adverse Event|2
2930239|NCT01471782|10089969|P3|Overall Study|Adverse Event|2
2930240|NCT01471782|10089970|P2|Overall Study|Adverse Event|1
2930241|NCT01471782|10089971|P1|Overall Study|Adverse Event|1
2930242|NCT01471782|10089966|P6|Overall Study|Lack of Efficacy|18
2930243|NCT01471782|10089967|P5|Overall Study|Lack of Efficacy|5
2930244|NCT01471782|10089968|P4|Overall Study|Lack of Efficacy|1
2930245|NCT01471782|10089969|P3|Overall Study|Lack of Efficacy|1
2930246|NCT01471782|10089970|P2|Overall Study|Lack of Efficacy|2
2930247|NCT01471782|10089971|P1|Overall Study|Lack of Efficacy|1
2930248|NCT01471782|10089966|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
2930249|NCT01471782|10089967|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
2930250|NCT01471782|10089968|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
2930251|NCT01471782|10089969|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
2930252|NCT01471782|10089970|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
2930253|NCT01471782|10089971|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
2930254|NCT01471691|10090025|P2|Overall Study|Lack of Efficacy|1
2930255|NCT01471691|10090026|P1|Overall Study|Lack of Efficacy|0
2930256|NCT01471379|10090035|P3|Overall Study|Study terminated|0
2930257|NCT01471379|10090036|P2|Overall Study|Study terminated|1
2930258|NCT01471379|10090037|P1|Overall Study|Study terminated|0
2930259|NCT01471379|10090035|P3|Overall Study|Adverse Event|0
2930260|NCT01471379|10090036|P2|Overall Study|Adverse Event|0
2930261|NCT01471379|10090037|P1|Overall Study|Adverse Event|1
2930262|NCT01471353|10090057|P1|Overall Study|remain on study|3
2930263|NCT01471340|10090068|P2|Overall Study|Invalid informed consent|0
2930264|NCT01471340|10090069|P1|Overall Study|Invalid informed consent|1
2930265|NCT01471340|10090068|P2|Overall Study|Investigational site closure|1
2930266|NCT01471340|10090069|P1|Overall Study|Investigational site closure|0
2930267|NCT01471340|10090068|P2|Overall Study|Lost to Follow-up|1
2930268|NCT01471340|10090069|P1|Overall Study|Lost to Follow-up|0
2930269|NCT01471340|10090068|P2|Overall Study|Death|4
2930270|NCT01471340|10090069|P1|Overall Study|Death|5
2930271|NCT01471574|10090092|P4|Follow-up Period|Follow-up no longer required|0
2930272|NCT01471574|10090093|P3|Follow-up Period|Follow-up no longer required|0
2930273|NCT01471574|10090094|P2|Follow-up Period|Follow-up no longer required|1
2930274|NCT01471574|10090095|P1|Follow-up Period|Follow-up no longer required|0
2930275|NCT01471574|10090092|P4|Follow-up Period|Death|0
2930276|NCT01471574|10090093|P3|Follow-up Period|Death|1
2930277|NCT01471574|10090094|P2|Follow-up Period|Death|0
2930278|NCT01471574|10090095|P1|Follow-up Period|Death|0
2930279|NCT01471574|10090092|P4|Follow-up Period|Lost to Follow-up|2
2930280|NCT01471574|10090093|P3|Follow-up Period|Lost to Follow-up|3
2930281|NCT01471574|10090094|P2|Follow-up Period|Lost to Follow-up|1
2930282|NCT01471574|10090095|P1|Follow-up Period|Lost to Follow-up|4
2930283|NCT01471574|10090092|P4|Follow-up Period|Withdrawal by Subject|1
2930284|NCT01471574|10090093|P3|Follow-up Period|Withdrawal by Subject|3
2930285|NCT01471574|10090094|P2|Follow-up Period|Withdrawal by Subject|0
2930286|NCT01471574|10090095|P1|Follow-up Period|Withdrawal by Subject|3
2930287|NCT01471574|10090092|P4|Treatment Period|Other|0
2930288|NCT01471574|10090093|P3|Treatment Period|Other|0
2930289|NCT01471574|10090094|P2|Treatment Period|Other|0
2930290|NCT01471574|10090095|P1|Treatment Period|Other|1
2930291|NCT01471574|10090092|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
2930292|NCT01471574|10090093|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
2930293|NCT01471574|10090094|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
2930294|NCT01471574|10090095|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
2930295|NCT01471574|10090092|P4|Treatment Period|Lost to Follow-up|0
2930296|NCT01471574|10090093|P3|Treatment Period|Lost to Follow-up|2
2930297|NCT01471574|10090094|P2|Treatment Period|Lost to Follow-up|2
2930298|NCT01471574|10090095|P1|Treatment Period|Lost to Follow-up|1
2930299|NCT01471574|10090092|P4|Treatment Period|Patient Requested Discontinue Study drug|1
2930300|NCT01471574|10090093|P3|Treatment Period|Patient Requested Discontinue Study drug|1
2930301|NCT01471574|10090094|P2|Treatment Period|Patient Requested Discontinue Study drug|0
2930302|NCT01471574|10090095|P1|Treatment Period|Patient Requested Discontinue Study drug|4
2930303|NCT01471574|10090092|P4|Treatment Period|Withdrawal by Subject|0
2930304|NCT01471574|10090093|P3|Treatment Period|Withdrawal by Subject|1
2930305|NCT01471574|10090094|P2|Treatment Period|Withdrawal by Subject|1
2930306|NCT01471574|10090095|P1|Treatment Period|Withdrawal by Subject|5
2930307|NCT01471574|10090092|P4|Treatment Period|Adverse Event|1
2930308|NCT01471574|10090093|P3|Treatment Period|Adverse Event|6
2930309|NCT01471574|10090094|P2|Treatment Period|Adverse Event|3
2930310|NCT01471574|10090095|P1|Treatment Period|Adverse Event|7
2930311|NCT01471574|10090092|P4|Treatment Period|Lack of Efficacy|1
2930312|NCT01471574|10090093|P3|Treatment Period|Lack of Efficacy|14
2930313|NCT01471574|10090094|P2|Treatment Period|Lack of Efficacy|4
2930314|NCT01471574|10090095|P1|Treatment Period|Lack of Efficacy|12
2930315|NCT01471197|10090137|P2|Overall Study|Study Drug Toxicity|0
2930316|NCT01471197|10090138|P1|Overall Study|Study Drug Toxicity|1
2930317|NCT01471197|10090137|P2|Overall Study|Death|0
2930318|NCT01471197|10090138|P1|Overall Study|Death|1
2930319|NCT01471197|10090137|P2|Overall Study|Disease Progression|2
2930320|NCT01471197|10090138|P1|Overall Study|Disease Progression|4
2930321|NCT01471171|10090148|P2|Treatment Period 2|Adverse Event|0
2930322|NCT01471171|10090149|P1|Treatment Period 2|Adverse Event|1
2930323|NCT01471171|10090148|P2|Treatment Period 1|Adverse Event|1
2930324|NCT01471171|10090149|P1|Treatment Period 1|Adverse Event|4
2930325|NCT01471054|10090161|P2|Overall Study|Study terminated prematurely|0
2930326|NCT01471054|10090162|P1|Overall Study|Study terminated prematurely|4
2930327|NCT01471028|10090185|P2|VTI-208E|Lost to Follow-up|2
2930328|NCT01471028|10090186|P1|VTI-208E|Lost to Follow-up|0
2930329|NCT01471028|10090185|P2|VTI-208E|Withdrawal by Subject|0
2930330|NCT01471028|10090186|P1|VTI-208E|Withdrawal by Subject|1
2930331|NCT01471028|10090185|P2|VTI-208E|Death|10
2930332|NCT01471028|10090186|P1|VTI-208E|Death|7
2930333|NCT01471028|10090185|P2|VTI-208|Lost to Follow-up|1
2930334|NCT01471028|10090186|P1|VTI-208|Lost to Follow-up|1
2930335|NCT01471028|10090185|P2|VTI-208|Withdrawal by Subject|2
2930336|NCT01471028|10090186|P1|VTI-208|Withdrawal by Subject|0
2930337|NCT01471028|10090185|P2|VTI-208|Adverse Event|41
2930338|NCT01471028|10090186|P1|VTI-208|Adverse Event|39
2930339|NCT01471015|10090201|P3|Overall Study|Death|1
2930340|NCT01471015|10090202|P2|Overall Study|Death|1
2930341|NCT01471015|10090203|P1|Overall Study|Death|0
2930342|NCT01470599|10090264|P2|Overall Study|Adverse event not related to study drug|5
2930343|NCT01470599|10090265|P1|Overall Study|Adverse event not related to study drug|1
2930344|NCT01470599|10090264|P2|Overall Study|Insufficient clinical response|27
2930345|NCT01470599|10090265|P1|Overall Study|Insufficient clinical response|6
2930346|NCT01470599|10090264|P2|Overall Study|Adverse event related to study drug|5
2930347|NCT01470599|10090265|P1|Overall Study|Adverse event related to study drug|2
2930348|NCT01470599|10090264|P2|Overall Study|Protocol Violation|1
2930349|NCT01470599|10090265|P1|Overall Study|Protocol Violation|3
2930350|NCT01470599|10090264|P2|Overall Study|Other|0
2930351|NCT01470599|10090265|P1|Overall Study|Other|1
2930352|NCT01470599|10090264|P2|Overall Study|Withdrawal by Subject|4
2930353|NCT01470599|10090265|P1|Overall Study|Withdrawal by Subject|3
2930354|NCT01470599|10090264|P2|Overall Study|Lost to Follow-up|1
2930355|NCT01470599|10090265|P1|Overall Study|Lost to Follow-up|2
2930356|NCT01470599|10090264|P2|Overall Study|Did not meet entrance criteria|0
2930357|NCT01470599|10090265|P1|Overall Study|Did not meet entrance criteria|1
2930358|NCT01470469|10090329|P2|Overall Study|Other|1
2930359|NCT01470469|10090330|P1|Overall Study|Other|2
2930360|NCT01470469|10090329|P2|Overall Study|Protocol Violation|1
2930361|NCT01470469|10090330|P1|Overall Study|Protocol Violation|1
2930362|NCT01470469|10090329|P2|Overall Study|Lost to Follow-up|2
2930363|NCT01470469|10090330|P1|Overall Study|Lost to Follow-up|2
2930364|NCT01470469|10090329|P2|Overall Study|Adverse Event|7
2930365|NCT01470469|10090330|P1|Overall Study|Adverse Event|0
2930366|NCT01470469|10090329|P2|Overall Study|Lack of Efficacy|7
2930367|NCT01470469|10090330|P1|Overall Study|Lack of Efficacy|1
2930368|NCT01470469|10090329|P2|Overall Study|Withdrawal by Subject|6
2930369|NCT01470469|10090330|P1|Overall Study|Withdrawal by Subject|4
2930370|NCT01470417|10090350|P2|Overall Study|Disease progression|2
2930371|NCT01470417|10090351|P1|Overall Study|Disease progression|0
2930372|NCT01470326|10090363|P1|Overall Study|No Visit After 1st Day of Treatment|119
2930373|NCT01470326|10090363|P1|Overall Study|No Drug Administration Information|2
2930374|NCT01470326|10090363|P1|Overall Study|Protocol Violation|32
2930375|NCT01470248|10090374|P1|Overall Study|Withdrawal by Subject|1
2930376|NCT01470144|10090430|P1|Overall Study|Patient’s and investigator’s decision|1
2930377|NCT01470144|10090430|P1|Overall Study|Lung transplant|6
2930378|NCT01470144|10090430|P1|Overall Study|Death|1
2930379|NCT01470144|10090430|P1|Overall Study|Adverse Event|2
2930380|NCT01470001|10090535|P2|Overall Study|Withdrawal by Subject|1
2930381|NCT01470001|10090536|P1|Overall Study|Withdrawal by Subject|2
2930382|NCT01470001|10090535|P2|Overall Study|Physician Decision|0
2930383|NCT01470001|10090536|P1|Overall Study|Physician Decision|2
2930384|NCT01470001|10090535|P2|Overall Study|Lost to Follow-up|1
2930385|NCT01470001|10090536|P1|Overall Study|Lost to Follow-up|1
2930386|NCT01469819|10090546|P1|Overall Study|Technical malfunction of SmartPill data|3
2930387|NCT01469819|10090546|P1|Overall Study|Could not swallow SmartPill|2
2930388|NCT01469819|10090546|P1|Overall Study|Did not meet inclusionary criteria|2
2930389|NCT01469819|10090546|P1|Overall Study|Withdrawal by Subject|1
2930390|NCT01469637|10090570|P2|Second Intervention|Incarcerated|0
2930391|NCT01469637|10090571|P1|Second Intervention|Incarcerated|1
2930392|NCT01469637|10090570|P2|First Intervention|Unacceptable behavior|1
2930393|NCT01469637|10090571|P1|First Intervention|Unacceptable behavior|0
2930394|NCT01469546|10090579|P1|Received 5 mg Dose|Physician Decision|3
2930395|NCT01469546|10090579|P1|Received 5 mg Dose|Progressive Disease|3
2930396|NCT01469546|10090579|P1|Received 5 mg Dose|Protocol Violation|2
2930397|NCT01469546|10090579|P1|Received 5 mg Dose|Death|2
2930398|NCT01469546|10090579|P1|Received 5 mg Dose|Adverse Event|13
2930399|NCT01469377|10090589|P3|Overall Study|Other Miscellaneous Reasons|0
2930400|NCT01469377|10090590|P2|Overall Study|Other Miscellaneous Reasons|0
2930401|NCT01469377|10090591|P1|Overall Study|Other Miscellaneous Reasons|2
2930402|NCT01469377|10090589|P3|Overall Study|Insufficient Therapeutic Response|0
2930403|NCT01469377|10090590|P2|Overall Study|Insufficient Therapeutic Response|4
2930404|NCT01469377|10090591|P1|Overall Study|Insufficient Therapeutic Response|3
2930405|NCT01469377|10090589|P3|Overall Study|Adverse Event|36
2930406|NCT01469377|10090590|P2|Overall Study|Adverse Event|18
2930407|NCT01469377|10090591|P1|Overall Study|Adverse Event|8
2930408|NCT01469377|10090589|P3|Overall Study|Withdrawal of Consent|15
2930409|NCT01469377|10090590|P2|Overall Study|Withdrawal of Consent|14
2930410|NCT01469377|10090591|P1|Overall Study|Withdrawal of Consent|12
2930411|NCT01469377|10090589|P3|Overall Study|Lost to Follow-up|5
2930412|NCT01469377|10090590|P2|Overall Study|Lost to Follow-up|2
2930413|NCT01469377|10090591|P1|Overall Study|Lost to Follow-up|3
2930414|NCT01469377|10090589|P3|Overall Study|Protocol Deviation|10
2930415|NCT01469377|10090590|P2|Overall Study|Protocol Deviation|10
2930416|NCT01469377|10090591|P1|Overall Study|Protocol Deviation|7
2930417|NCT01469364|10090602|P1|Overall Study|Withdrawal by Subject|1
2930418|NCT01469364|10090602|P1|Overall Study|Adverse Event|1
2930419|NCT01469221|10090653|P3|Double Blind Phase|Sponsor Terminate Study|0
2930420|NCT01469221|10090654|P2|Double Blind Phase|Sponsor Terminate Study|16
2930421|NCT01469221|10090655|P1|Double Blind Phase|Sponsor Terminate Study|12
2930422|NCT01469221|10090653|P3|Double Blind Phase|Physician Decision|0
2930423|NCT01469221|10090654|P2|Double Blind Phase|Physician Decision|1
2930424|NCT01469221|10090655|P1|Double Blind Phase|Physician Decision|1
2930425|NCT01469221|10090653|P3|Double Blind Phase|Protocol Violation|0
2930426|NCT01469221|10090654|P2|Double Blind Phase|Protocol Violation|0
2930427|NCT01469221|10090655|P1|Double Blind Phase|Protocol Violation|1
2930428|NCT01469182|10090666|P2|Overall Study|Did not meet Protocol Eligibility|0
2930429|NCT01469182|10090667|P1|Overall Study|Did not meet Protocol Eligibility|3
2930430|NCT01469182|10090666|P2|Overall Study|Protocol Violation|2
2930431|NCT01469182|10090667|P1|Overall Study|Protocol Violation|4
2930432|NCT01469182|10090666|P2|Overall Study|Withdrawal by Subject|1
2930433|NCT01469182|10090667|P1|Overall Study|Withdrawal by Subject|4
2930434|NCT01469182|10090666|P2|Overall Study|Lost to Follow-up|0
2930435|NCT01469182|10090667|P1|Overall Study|Lost to Follow-up|3
2930436|NCT01469182|10090666|P2|Overall Study|Adverse Event|3
2930437|NCT01469182|10090667|P1|Overall Study|Adverse Event|21
2930438|NCT01469065|10090694|P5|Overall Study|Other|0
2930439|NCT01469065|10090695|P4|Overall Study|Other|0
2930440|NCT01469065|10090696|P3|Overall Study|Other|0
2930441|NCT01469065|10090697|P2|Overall Study|Other|1
2930442|NCT01469065|10090698|P1|Overall Study|Other|0
2930443|NCT01469065|10090694|P5|Overall Study|Lack of Efficacy|1
2930444|NCT01469065|10090695|P4|Overall Study|Lack of Efficacy|0
2930445|NCT01469065|10090696|P3|Overall Study|Lack of Efficacy|0
2930446|NCT01469065|10090697|P2|Overall Study|Lack of Efficacy|0
2930447|NCT01469065|10090698|P1|Overall Study|Lack of Efficacy|0
2930448|NCT01469052|10090794|P6|Overall Study|Other|0
2930449|NCT01469052|10090795|P5|Overall Study|Other|1
2930450|NCT01469052|10090796|P4|Overall Study|Other|0
2930451|NCT01469052|10090797|P3|Overall Study|Other|0
2930452|NCT01469052|10090798|P2|Overall Study|Other|1
2930453|NCT01469052|10090799|P1|Overall Study|Other|0
2930454|NCT01469052|10090794|P6|Overall Study|Moved to rollover protocol|1
2930455|NCT01469052|10090795|P5|Overall Study|Moved to rollover protocol|0
2930456|NCT01469052|10090796|P4|Overall Study|Moved to rollover protocol|0
2930457|NCT01469052|10090797|P3|Overall Study|Moved to rollover protocol|1
2930458|NCT01469052|10090798|P2|Overall Study|Moved to rollover protocol|0
2930459|NCT01469052|10090799|P1|Overall Study|Moved to rollover protocol|1
2930460|NCT01469052|10090794|P6|Overall Study|Lack of Efficacy|2
2930461|NCT01469052|10090795|P5|Overall Study|Lack of Efficacy|0
2930462|NCT01469052|10090796|P4|Overall Study|Lack of Efficacy|0
2930463|NCT01469052|10090797|P3|Overall Study|Lack of Efficacy|0
2930464|NCT01469052|10090798|P2|Overall Study|Lack of Efficacy|0
2930465|NCT01469052|10090799|P1|Overall Study|Lack of Efficacy|0
2930466|NCT01469052|10090794|P6|Overall Study|Progressive disease|2
2930467|NCT01469052|10090795|P5|Overall Study|Progressive disease|7
2930468|NCT01469052|10090796|P4|Overall Study|Progressive disease|3
2930469|NCT01469052|10090797|P3|Overall Study|Progressive disease|5
2930470|NCT01469052|10090798|P2|Overall Study|Progressive disease|0
2930471|NCT01469052|10090799|P1|Overall Study|Progressive disease|3
2930472|NCT01469052|10090794|P6|Overall Study|Adverse Event|1
2930473|NCT01469052|10090795|P5|Overall Study|Adverse Event|0
2930474|NCT01469052|10090796|P4|Overall Study|Adverse Event|2
2930475|NCT01469052|10090797|P3|Overall Study|Adverse Event|0
2930476|NCT01469052|10090798|P2|Overall Study|Adverse Event|3
2930477|NCT01469052|10090799|P1|Overall Study|Adverse Event|2
2930478|NCT01469013|10090864|P13|Part B (Extension Period)|Withdrawal by Subject|3
2930479|NCT01469013|10090865|P12|Part B (Extension Period)|Withdrawal by Subject|0
2930480|NCT01469013|10090866|P11|Part B (Extension Period)|Withdrawal by Subject|1
2930481|NCT01469013|10090867|P10|Part B (Extension Period)|Withdrawal by Subject|0
2930482|NCT01469013|10090868|P9|Part B (Extension Period)|Withdrawal by Subject|1
2930483|NCT01469013|10090869|P8|Part B (Extension Period)|Withdrawal by Subject|0
2930484|NCT01469013|10090870|P7|Part B (Extension Period)|Withdrawal by Subject|0
2930485|NCT01469013|10090871|P6|Part B (Extension Period)|Withdrawal by Subject|0
2930486|NCT01469013|10090872|P5|Part B (Extension Period)|Withdrawal by Subject|0
2930487|NCT01469013|10090873|P4|Part B (Extension Period)|Withdrawal by Subject|0
2930488|NCT01469013|10090874|P3|Part B (Extension Period)|Withdrawal by Subject|0
2930489|NCT01469013|10090875|P2|Part B (Extension Period)|Withdrawal by Subject|0
2930490|NCT01469013|10090876|P1|Part B (Extension Period)|Withdrawal by Subject|0
2930491|NCT01469013|10090864|P13|Part B (Extension Period)|Adverse Event|3
2930492|NCT01469013|10090865|P12|Part B (Extension Period)|Adverse Event|6
2930493|NCT01469013|10090866|P11|Part B (Extension Period)|Adverse Event|1
2930494|NCT01469013|10090867|P10|Part B (Extension Period)|Adverse Event|3
2930495|NCT01469013|10090868|P9|Part B (Extension Period)|Adverse Event|3
2930496|NCT01469013|10090869|P8|Part B (Extension Period)|Adverse Event|5
2930497|NCT01469013|10090870|P7|Part B (Extension Period)|Adverse Event|5
2930498|NCT01469013|10090871|P6|Part B (Extension Period)|Adverse Event|2
2930499|NCT01469013|10090872|P5|Part B (Extension Period)|Adverse Event|0
2930500|NCT01469013|10090873|P4|Part B (Extension Period)|Adverse Event|0
2930501|NCT01469013|10090874|P3|Part B (Extension Period)|Adverse Event|0
2930502|NCT01469013|10090875|P2|Part B (Extension Period)|Adverse Event|0
2930503|NCT01469013|10090876|P1|Part B (Extension Period)|Adverse Event|0
2930504|NCT01469013|10090864|P13|Part A (Treatment Period)|Withdrawal by Subject|0
2930505|NCT01469013|10090865|P12|Part A (Treatment Period)|Withdrawal by Subject|0
2930506|NCT01469013|10090866|P11|Part A (Treatment Period)|Withdrawal by Subject|0
2930507|NCT01469013|10090867|P10|Part A (Treatment Period)|Withdrawal by Subject|0
2930508|NCT01469013|10090868|P9|Part A (Treatment Period)|Withdrawal by Subject|0
2930509|NCT01469013|10090869|P8|Part A (Treatment Period)|Withdrawal by Subject|0
2930510|NCT01469013|10090870|P7|Part A (Treatment Period)|Withdrawal by Subject|0
2930511|NCT01469013|10090871|P6|Part A (Treatment Period)|Withdrawal by Subject|0
2930512|NCT01469013|10090872|P5|Part A (Treatment Period)|Withdrawal by Subject|0
2930513|NCT01469013|10090873|P4|Part A (Treatment Period)|Withdrawal by Subject|0
2930514|NCT01469013|10090874|P3|Part A (Treatment Period)|Withdrawal by Subject|1
2930515|NCT01469013|10090875|P2|Part A (Treatment Period)|Withdrawal by Subject|0
2930516|NCT01469013|10090876|P1|Part A (Treatment Period)|Withdrawal by Subject|0
2930517|NCT01469013|10090864|P13|Part A (Treatment Period)|Adverse Event|0
2930518|NCT01469013|10090865|P12|Part A (Treatment Period)|Adverse Event|0
2930519|NCT01469013|10090866|P11|Part A (Treatment Period)|Adverse Event|0
2930520|NCT01469013|10090867|P10|Part A (Treatment Period)|Adverse Event|0
2930521|NCT01469013|10090868|P9|Part A (Treatment Period)|Adverse Event|0
2930522|NCT01469013|10090869|P8|Part A (Treatment Period)|Adverse Event|0
2930523|NCT01469013|10090870|P7|Part A (Treatment Period)|Adverse Event|0
2930524|NCT01469013|10090871|P6|Part A (Treatment Period)|Adverse Event|0
2930525|NCT01469013|10090872|P5|Part A (Treatment Period)|Adverse Event|1
2930526|NCT01469013|10090873|P4|Part A (Treatment Period)|Adverse Event|0
2930527|NCT01469013|10090874|P3|Part A (Treatment Period)|Adverse Event|0
2930528|NCT01469013|10090875|P2|Part A (Treatment Period)|Adverse Event|0
2930529|NCT01469013|10090876|P1|Part A (Treatment Period)|Adverse Event|1
2930530|NCT01469000|10090961|P2|Overall Study|Sponsor Decision|1
2930531|NCT01469000|10090962|P1|Overall Study|Sponsor Decision|4
2930532|NCT01469000|10090961|P2|Overall Study|Withdrawal by Subject|3
2930533|NCT01469000|10090962|P1|Overall Study|Withdrawal by Subject|16
2930534|NCT01468987|10090982|P2|Overall Study|Sponsor Decision|0
2930535|NCT01468987|10090983|P1|Overall Study|Sponsor Decision|1
2930536|NCT01468987|10090982|P2|Overall Study|Physician Decision|15
2930537|NCT01468987|10090983|P1|Overall Study|Physician Decision|8
2930538|NCT01468987|10090982|P2|Overall Study|Withdrawal by Subject|28
2930539|NCT01468987|10090983|P1|Overall Study|Withdrawal by Subject|28
2930540|NCT01468987|10090982|P2|Overall Study|Protocol Violation|2
2930541|NCT01468987|10090983|P1|Overall Study|Protocol Violation|8
2930542|NCT01468987|10090982|P2|Overall Study|Lost to Follow-up|5
2930543|NCT01468987|10090983|P1|Overall Study|Lost to Follow-up|10
2930544|NCT01468987|10090982|P2|Overall Study|Death|1
2930545|NCT01468987|10090983|P1|Overall Study|Death|4
2930546|NCT01468987|10090982|P2|Overall Study|Adverse Event|9
2930547|NCT01468987|10090983|P1|Overall Study|Adverse Event|12
2930548|NCT01468909|10091160|P2|Overall Study|Never Treated|2
2930549|NCT01468909|10091161|P1|Overall Study|Never Treated|2
2930550|NCT01468818|10091194|P1|Overall Study|Death during treatment|2
2930551|NCT01468311|10091252|P1|Overall Study|Withdrawal by Subject|1
2930552|NCT01468311|10091252|P1|Overall Study|mobilization failure|1
2930553|NCT01468233|10091264|P6|Treatment Period 2|Other|0
2930554|NCT01468233|10091265|P5|Treatment Period 2|Other|1
2930555|NCT01468233|10091266|P4|Treatment Period 2|Other|0
2930556|NCT01468233|10091267|P3|Treatment Period 2|Other|3
2930557|NCT01468233|10091268|P2|Treatment Period 2|Other|0
2930558|NCT01468233|10091269|P1|Treatment Period 2|Other|0
2930559|NCT01468233|10091264|P6|Treatment Period 2|Lost to Follow-up|0
2930560|NCT01468233|10091265|P5|Treatment Period 2|Lost to Follow-up|2
2930561|NCT01468233|10091266|P4|Treatment Period 2|Lost to Follow-up|0
2930562|NCT01468233|10091267|P3|Treatment Period 2|Lost to Follow-up|3
2930563|NCT01468233|10091268|P2|Treatment Period 2|Lost to Follow-up|0
2930564|NCT01468233|10091269|P1|Treatment Period 2|Lost to Follow-up|0
2930565|NCT01468233|10091264|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
2930566|NCT01468233|10091265|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
2930567|NCT01468233|10091266|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
2930568|NCT01468233|10091267|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
2930569|NCT01468233|10091268|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
2930570|NCT01468233|10091269|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
2930571|NCT01468233|10091264|P6|Treatment Period 2|Withdrawal by Subject|1
2930572|NCT01468233|10091265|P5|Treatment Period 2|Withdrawal by Subject|1
2930573|NCT01468233|10091266|P4|Treatment Period 2|Withdrawal by Subject|1
2930574|NCT01468233|10091267|P3|Treatment Period 2|Withdrawal by Subject|9
2930575|NCT01468233|10091268|P2|Treatment Period 2|Withdrawal by Subject|0
2930576|NCT01468233|10091269|P1|Treatment Period 2|Withdrawal by Subject|0
2930577|NCT01468233|10091264|P6|Treatment Period 2|Lack of Efficacy|1
2930578|NCT01468233|10091265|P5|Treatment Period 2|Lack of Efficacy|0
2930579|NCT01468233|10091266|P4|Treatment Period 2|Lack of Efficacy|2
2930580|NCT01468233|10091267|P3|Treatment Period 2|Lack of Efficacy|9
2930581|NCT01468233|10091268|P2|Treatment Period 2|Lack of Efficacy|0
2930582|NCT01468233|10091269|P1|Treatment Period 2|Lack of Efficacy|0
2930583|NCT01468233|10091264|P6|Treatment Period 2|Adverse Event|1
2930584|NCT01468233|10091265|P5|Treatment Period 2|Adverse Event|2
2930585|NCT01468233|10091266|P4|Treatment Period 2|Adverse Event|0
2930586|NCT01468233|10091267|P3|Treatment Period 2|Adverse Event|3
2930587|NCT01468233|10091268|P2|Treatment Period 2|Adverse Event|0
2930588|NCT01468233|10091269|P1|Treatment Period 2|Adverse Event|0
2930589|NCT01468233|10091264|P6|Treatment Period 1|Other|0
2930590|NCT01468233|10091265|P5|Treatment Period 1|Other|0
2930591|NCT01468233|10091266|P4|Treatment Period 1|Other|0
2930592|NCT01468233|10091267|P3|Treatment Period 1|Other|0
2930593|NCT01468233|10091268|P2|Treatment Period 1|Other|1
2930594|NCT01468233|10091269|P1|Treatment Period 1|Other|1
2930595|NCT01468233|10091264|P6|Treatment Period 1|Lost to Follow-up|0
2930596|NCT01468233|10091265|P5|Treatment Period 1|Lost to Follow-up|0
2930597|NCT01468233|10091266|P4|Treatment Period 1|Lost to Follow-up|0
2930598|NCT01468233|10091267|P3|Treatment Period 1|Lost to Follow-up|0
2930599|NCT01468233|10091268|P2|Treatment Period 1|Lost to Follow-up|0
2930600|NCT01468233|10091269|P1|Treatment Period 1|Lost to Follow-up|3
2930601|NCT01468233|10091264|P6|Treatment Period 1|Withdrawal by Subject|0
2930602|NCT01468233|10091265|P5|Treatment Period 1|Withdrawal by Subject|0
2930603|NCT01468233|10091266|P4|Treatment Period 1|Withdrawal by Subject|0
2930604|NCT01468233|10091267|P3|Treatment Period 1|Withdrawal by Subject|0
2930605|NCT01468233|10091268|P2|Treatment Period 1|Withdrawal by Subject|4
2930606|NCT01468233|10091269|P1|Treatment Period 1|Withdrawal by Subject|3
2930607|NCT01468233|10091264|P6|Treatment Period 1|Adverse Event|0
2930608|NCT01468233|10091265|P5|Treatment Period 1|Adverse Event|0
2930609|NCT01468233|10091266|P4|Treatment Period 1|Adverse Event|0
2930610|NCT01468233|10091267|P3|Treatment Period 1|Adverse Event|0
2930611|NCT01468233|10091268|P2|Treatment Period 1|Adverse Event|3
2930612|NCT01468233|10091269|P1|Treatment Period 1|Adverse Event|5
2930613|NCT01468207|10091291|P6|Treatment Period 2|Other|2
2930614|NCT01468207|10091292|P5|Treatment Period 2|Other|1
2930615|NCT01468207|10091293|P4|Treatment Period 2|Other|1
2930616|NCT01468207|10091294|P3|Treatment Period 2|Other|5
2930617|NCT01468207|10091295|P2|Treatment Period 2|Other|0
2930618|NCT01468207|10091296|P1|Treatment Period 2|Other|0
2930619|NCT01468207|10091291|P6|Treatment Period 2|Lost to Follow-up|0
2930620|NCT01468207|10091292|P5|Treatment Period 2|Lost to Follow-up|0
2930621|NCT01468207|10091293|P4|Treatment Period 2|Lost to Follow-up|1
2930622|NCT01468207|10091294|P3|Treatment Period 2|Lost to Follow-up|5
2930623|NCT01468207|10091295|P2|Treatment Period 2|Lost to Follow-up|0
2930624|NCT01468207|10091296|P1|Treatment Period 2|Lost to Follow-up|0
2930625|NCT01468207|10091291|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
2930626|NCT01468207|10091292|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
2930627|NCT01468207|10091293|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
2930628|NCT01468207|10091294|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
2930629|NCT01468207|10091295|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
2930630|NCT01468207|10091296|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
2930631|NCT01468207|10091291|P6|Treatment Period 2|Withdrawal by Subject|2
2930632|NCT01468207|10091292|P5|Treatment Period 2|Withdrawal by Subject|0
2930633|NCT01468207|10091293|P4|Treatment Period 2|Withdrawal by Subject|0
2930634|NCT01468207|10091294|P3|Treatment Period 2|Withdrawal by Subject|5
2930635|NCT01468207|10091295|P2|Treatment Period 2|Withdrawal by Subject|0
2930636|NCT01468207|10091296|P1|Treatment Period 2|Withdrawal by Subject|0
2930637|NCT01468207|10091291|P6|Treatment Period 2|Lack of Efficacy|2
2930638|NCT01468207|10091292|P5|Treatment Period 2|Lack of Efficacy|0
2930639|NCT01468207|10091293|P4|Treatment Period 2|Lack of Efficacy|1
2930640|NCT01468207|10091294|P3|Treatment Period 2|Lack of Efficacy|1
2930641|NCT01468207|10091295|P2|Treatment Period 2|Lack of Efficacy|0
2930642|NCT01468207|10091296|P1|Treatment Period 2|Lack of Efficacy|0
2930643|NCT01468207|10091291|P6|Treatment Period 2|Adverse Event|1
2930644|NCT01468207|10091292|P5|Treatment Period 2|Adverse Event|2
2930645|NCT01468207|10091293|P4|Treatment Period 2|Adverse Event|1
2930646|NCT01468207|10091294|P3|Treatment Period 2|Adverse Event|6
2930647|NCT01468207|10091295|P2|Treatment Period 2|Adverse Event|0
2930648|NCT01468207|10091296|P1|Treatment Period 2|Adverse Event|0
2930649|NCT01468207|10091291|P6|Treatment Period 1|Other|0
2930650|NCT01468207|10091292|P5|Treatment Period 1|Other|0
2930651|NCT01468207|10091293|P4|Treatment Period 1|Other|0
2930652|NCT01468207|10091294|P3|Treatment Period 1|Other|0
2930653|NCT01468207|10091295|P2|Treatment Period 1|Other|2
2930654|NCT01468207|10091296|P1|Treatment Period 1|Other|0
2930655|NCT01468207|10091291|P6|Treatment Period 1|Lost to Follow-up|0
2930656|NCT01468207|10091292|P5|Treatment Period 1|Lost to Follow-up|0
2930657|NCT01468207|10091293|P4|Treatment Period 1|Lost to Follow-up|0
2930658|NCT01468207|10091294|P3|Treatment Period 1|Lost to Follow-up|0
2930659|NCT01468207|10091295|P2|Treatment Period 1|Lost to Follow-up|1
2930660|NCT01468207|10091296|P1|Treatment Period 1|Lost to Follow-up|2
2930661|NCT01468207|10091291|P6|Treatment Period 1|Withdrawal by Subject|0
2930662|NCT01468207|10091292|P5|Treatment Period 1|Withdrawal by Subject|0
2930663|NCT01468207|10091293|P4|Treatment Period 1|Withdrawal by Subject|0
2930664|NCT01468207|10091294|P3|Treatment Period 1|Withdrawal by Subject|0
2930665|NCT01468207|10091295|P2|Treatment Period 1|Withdrawal by Subject|4
2930666|NCT01468207|10091296|P1|Treatment Period 1|Withdrawal by Subject|5
2930667|NCT01468207|10091291|P6|Treatment Period 1|Protocol Violation|0
2930668|NCT01468207|10091292|P5|Treatment Period 1|Protocol Violation|0
2930669|NCT01468207|10091293|P4|Treatment Period 1|Protocol Violation|0
2930670|NCT01468207|10091294|P3|Treatment Period 1|Protocol Violation|0
2930671|NCT01468207|10091295|P2|Treatment Period 1|Protocol Violation|1
2930672|NCT01468207|10091296|P1|Treatment Period 1|Protocol Violation|1
2930673|NCT01468207|10091291|P6|Treatment Period 1|Adverse Event|0
2930674|NCT01468207|10091292|P5|Treatment Period 1|Adverse Event|0
2930675|NCT01468207|10091293|P4|Treatment Period 1|Adverse Event|0
2930676|NCT01468207|10091294|P3|Treatment Period 1|Adverse Event|0
2930677|NCT01468207|10091295|P2|Treatment Period 1|Adverse Event|0
2930678|NCT01468207|10091296|P1|Treatment Period 1|Adverse Event|1
2930679|NCT01468181|10091321|P5|Overall Study|Withdrawal by Subject|0
2930680|NCT01468181|10091322|P4|Overall Study|Withdrawal by Subject|0
2930681|NCT01468181|10091323|P3|Overall Study|Withdrawal by Subject|0
2930682|NCT01468181|10091324|P2|Overall Study|Withdrawal by Subject|1
2930683|NCT01468181|10091325|P1|Overall Study|Withdrawal by Subject|0
2930684|NCT01468181|10091321|P5|Overall Study|Lost to Follow-up|1
2930685|NCT01468181|10091322|P4|Overall Study|Lost to Follow-up|0
2930686|NCT01468181|10091323|P3|Overall Study|Lost to Follow-up|1
2930687|NCT01468181|10091324|P2|Overall Study|Lost to Follow-up|0
2930688|NCT01468181|10091325|P1|Overall Study|Lost to Follow-up|0
2930689|NCT01468181|10091321|P5|Overall Study|Physician Decision|1
2930690|NCT01468181|10091322|P4|Overall Study|Physician Decision|1
2930691|NCT01468181|10091323|P3|Overall Study|Physician Decision|0
2930692|NCT01468181|10091324|P2|Overall Study|Physician Decision|0
2930693|NCT01468181|10091325|P1|Overall Study|Physician Decision|0
2930694|NCT01468181|10091321|P5|Overall Study|Protocol Violation|1
2930695|NCT01468181|10091322|P4|Overall Study|Protocol Violation|0
2930696|NCT01468181|10091323|P3|Overall Study|Protocol Violation|1
2930697|NCT01468181|10091324|P2|Overall Study|Protocol Violation|0
2930698|NCT01468181|10091325|P1|Overall Study|Protocol Violation|2
2930699|NCT01468181|10091321|P5|Overall Study|Adverse Event|2
2930700|NCT01468181|10091322|P4|Overall Study|Adverse Event|2
2930701|NCT01468181|10091323|P3|Overall Study|Adverse Event|6
2930702|NCT01468181|10091324|P2|Overall Study|Adverse Event|1
2930703|NCT01468181|10091325|P1|Overall Study|Adverse Event|8
2930704|NCT01468077|10091374|P2|Overall Study|Physician Decision|0
2930705|NCT01468077|10091375|P1|Overall Study|Physician Decision|1
2930706|NCT01468077|10091374|P2|Overall Study|Lack of Efficacy|1
2930707|NCT01468077|10091375|P1|Overall Study|Lack of Efficacy|1
2930708|NCT01468077|10091374|P2|Overall Study|Adverse Event|2
2930709|NCT01468077|10091375|P1|Overall Study|Adverse Event|2
2930710|NCT01467960|10091437|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
2930711|NCT01467960|10091438|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
2930712|NCT01467960|10091439|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
2930713|NCT01467960|10091440|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
2930714|NCT01467960|10091441|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
2930715|NCT01467960|10091442|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
2930716|NCT01467713|10091501|P4|Overall Study|Reason not Specified|7
2930717|NCT01467713|10091502|P3|Overall Study|Reason not Specified|8
2930718|NCT01467713|10091503|P2|Overall Study|Reason not Specified|11
2930719|NCT01467713|10091504|P1|Overall Study|Reason not Specified|6
2930720|NCT01467713|10091501|P4|Overall Study|Relapse|35
2930721|NCT01467713|10091502|P3|Overall Study|Relapse|28
2930722|NCT01467713|10091503|P2|Overall Study|Relapse|25
2930723|NCT01467713|10091504|P1|Overall Study|Relapse|35
2930724|NCT01467713|10091501|P4|Overall Study|Pregnancy|3
2930725|NCT01467713|10091502|P3|Overall Study|Pregnancy|1
2930726|NCT01467713|10091503|P2|Overall Study|Pregnancy|1
2930727|NCT01467713|10091504|P1|Overall Study|Pregnancy|0
2930728|NCT01467713|10091501|P4|Overall Study|Study Termination|29
2930729|NCT01467713|10091502|P3|Overall Study|Study Termination|28
2930730|NCT01467713|10091503|P2|Overall Study|Study Termination|33
2930731|NCT01467713|10091504|P1|Overall Study|Study Termination|23
2930732|NCT01467713|10091501|P4|Overall Study|Voluntary Withdrawal|20
2930733|NCT01467713|10091502|P3|Overall Study|Voluntary Withdrawal|21
2930734|NCT01467713|10091503|P2|Overall Study|Voluntary Withdrawal|14
2930735|NCT01467713|10091504|P1|Overall Study|Voluntary Withdrawal|18
2930736|NCT01467713|10091501|P4|Overall Study|Lost to Follow-up|9
2930737|NCT01467713|10091502|P3|Overall Study|Lost to Follow-up|6
2930738|NCT01467713|10091503|P2|Overall Study|Lost to Follow-up|12
2930739|NCT01467713|10091504|P1|Overall Study|Lost to Follow-up|9
2930740|NCT01467713|10091501|P4|Overall Study|Major Protocol Deviation|1
2930741|NCT01467713|10091502|P3|Overall Study|Major Protocol Deviation|4
2930742|NCT01467713|10091503|P2|Overall Study|Major Protocol Deviation|4
2930743|NCT01467713|10091504|P1|Overall Study|Major Protocol Deviation|2
2930744|NCT01467713|10091501|P4|Overall Study|Pretreatment Event or Adverse Event|5
2930745|NCT01467713|10091502|P3|Overall Study|Pretreatment Event or Adverse Event|6
2930746|NCT01467713|10091503|P2|Overall Study|Pretreatment Event or Adverse Event|4
2930747|NCT01467713|10091504|P1|Overall Study|Pretreatment Event or Adverse Event|9
2930748|NCT01467700|10091558|P4|Overall Study|Reason not Specified|8
2930749|NCT01467700|10091559|P3|Overall Study|Reason not Specified|2
2930750|NCT01467700|10091560|P2|Overall Study|Reason not Specified|3
2930751|NCT01467700|10091561|P1|Overall Study|Reason not Specified|1
2930752|NCT01467700|10091558|P4|Overall Study|Lack of Efficacy|1
2930753|NCT01467700|10091559|P3|Overall Study|Lack of Efficacy|2
2930754|NCT01467700|10091560|P2|Overall Study|Lack of Efficacy|0
2930755|NCT01467700|10091561|P1|Overall Study|Lack of Efficacy|2
2930756|NCT01467700|10091558|P4|Overall Study|Pregnancy|0
2930757|NCT01467700|10091559|P3|Overall Study|Pregnancy|1
2930758|NCT01467700|10091560|P2|Overall Study|Pregnancy|1
2930759|NCT01467700|10091561|P1|Overall Study|Pregnancy|0
2930760|NCT01467700|10091558|P4|Overall Study|Study Termination|7
2930761|NCT01467700|10091559|P3|Overall Study|Study Termination|10
2930762|NCT01467700|10091560|P2|Overall Study|Study Termination|5
2930763|NCT01467700|10091561|P1|Overall Study|Study Termination|6
2930764|NCT01467700|10091558|P4|Overall Study|Voluntary Withdrawal|2
2930765|NCT01467700|10091559|P3|Overall Study|Voluntary Withdrawal|6
2930766|NCT01467700|10091560|P2|Overall Study|Voluntary Withdrawal|7
2930767|NCT01467700|10091561|P1|Overall Study|Voluntary Withdrawal|5
2930768|NCT01467700|10091558|P4|Overall Study|Lost to Follow-up|3
2930769|NCT01467700|10091559|P3|Overall Study|Lost to Follow-up|2
2930770|NCT01467700|10091560|P2|Overall Study|Lost to Follow-up|5
2930771|NCT01467700|10091561|P1|Overall Study|Lost to Follow-up|6
2930772|NCT01467700|10091558|P4|Overall Study|Major Protocol Deviation|3
2930773|NCT01467700|10091559|P3|Overall Study|Major Protocol Deviation|2
2930774|NCT01467700|10091560|P2|Overall Study|Major Protocol Deviation|3
2930775|NCT01467700|10091561|P1|Overall Study|Major Protocol Deviation|3
2930776|NCT01467700|10091558|P4|Overall Study|Pretreatment Event or Adverse Event|3
2930777|NCT01467700|10091559|P3|Overall Study|Pretreatment Event or Adverse Event|2
2930778|NCT01467700|10091560|P2|Overall Study|Pretreatment Event or Adverse Event|4
2930779|NCT01467700|10091561|P1|Overall Study|Pretreatment Event or Adverse Event|6
2930780|NCT01467661|10091603|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
2930781|NCT01467661|10091603|P1|Overall Study|Lack of Efficacy|3
2930782|NCT01467661|10091603|P1|Overall Study|Withdrawal by Subject|1
2930783|NCT01467661|10091603|P1|Overall Study|Adverse Event|16
2930784|NCT01467583|10091623|P3|Overall Study|Protocol Violation|2
2930785|NCT01467583|10091624|P2|Overall Study|Protocol Violation|0
2930786|NCT01467583|10091625|P1|Overall Study|Protocol Violation|0
2930787|NCT01467583|10091623|P3|Overall Study|Withdrawal by Subject|0
2930788|NCT01467583|10091624|P2|Overall Study|Withdrawal by Subject|0
2930789|NCT01467583|10091625|P1|Overall Study|Withdrawal by Subject|1
2930790|NCT01467583|10091623|P3|Overall Study|Death|0
2930791|NCT01467583|10091624|P2|Overall Study|Death|1
2930792|NCT01467583|10091625|P1|Overall Study|Death|1
2930793|NCT01467570|10091638|P2|Overall Study|Lost to Follow-up|9
2930794|NCT01467570|10091639|P1|Overall Study|Lost to Follow-up|8
2930795|NCT01467505|10091676|P2|Overall Study|Study Terminated by Sponsor|3
2930796|NCT01467505|10091677|P1|Overall Study|Study Terminated by Sponsor|28
2930797|NCT01467505|10091676|P2|Overall Study|Withdrawal by Subject|0
2930798|NCT01467505|10091677|P1|Overall Study|Withdrawal by Subject|4
2930799|NCT01467505|10091676|P2|Overall Study|Adverse Event|0
2930800|NCT01467505|10091677|P1|Overall Study|Adverse Event|1
2930801|NCT01467492|10091709|P2|Overall Study|Enrolled But Not Treated|0
2930802|NCT01467492|10091710|P1|Overall Study|Enrolled But Not Treated|1
2930803|NCT01467492|10091709|P2|Overall Study|Undefined|0
2930804|NCT01467492|10091710|P1|Overall Study|Undefined|2
2930805|NCT01467492|10091709|P2|Overall Study|Lost to Follow-up|2
2930806|NCT01467492|10091710|P1|Overall Study|Lost to Follow-up|3
2930807|NCT01467492|10091709|P2|Overall Study|Adverse Event|3
2930808|NCT01467492|10091710|P1|Overall Study|Adverse Event|4
2930809|NCT01467492|10091709|P2|Overall Study|Study Terminated by Sponsor|4
2930810|NCT01467492|10091710|P1|Overall Study|Study Terminated by Sponsor|6
2930811|NCT01467492|10091709|P2|Overall Study|Withdrawal by Subject|4
2930812|NCT01467492|10091710|P1|Overall Study|Withdrawal by Subject|6
2930813|NCT01467479|10091734|P3|Overall Study|Other|0
2930814|NCT01467479|10091735|P2|Overall Study|Other|0
2930815|NCT01467479|10091736|P1|Overall Study|Other|1
2930816|NCT01467479|10091734|P3|Overall Study|Study Terminated by Sponsor|3
2930817|NCT01467479|10091735|P2|Overall Study|Study Terminated by Sponsor|3
2930818|NCT01467479|10091736|P1|Overall Study|Study Terminated by Sponsor|1
2930819|NCT01467479|10091734|P3|Overall Study|Withdrawal of Consent|7
2930820|NCT01467479|10091735|P2|Overall Study|Withdrawal of Consent|7
2930821|NCT01467479|10091736|P1|Overall Study|Withdrawal of Consent|3
2930822|NCT01467479|10091734|P3|Overall Study|Lost to Follow-up|3
2930823|NCT01467479|10091735|P2|Overall Study|Lost to Follow-up|5
2930824|NCT01467479|10091736|P1|Overall Study|Lost to Follow-up|2
2930825|NCT01467479|10091734|P3|Overall Study|Death|1
2930826|NCT01467479|10091735|P2|Overall Study|Death|0
2930827|NCT01467479|10091736|P1|Overall Study|Death|0
2930828|NCT01467479|10091734|P3|Overall Study|Adverse Event|0
2930829|NCT01467479|10091735|P2|Overall Study|Adverse Event|2
2930830|NCT01467479|10091736|P1|Overall Study|Adverse Event|1
2930831|NCT01467479|10091734|P3|Overall Study|No Study Medication|2
2930832|NCT01467479|10091735|P2|Overall Study|No Study Medication|0
2930833|NCT01467479|10091736|P1|Overall Study|No Study Medication|1
2930834|NCT01467466|10091767|P4|Overall Study|No Endpoint Blood Draw|43
2930835|NCT01467466|10091768|P3|Overall Study|No Endpoint Blood Draw|51
2930836|NCT01467466|10091769|P2|Overall Study|No Endpoint Blood Draw|32
2930837|NCT01467466|10091770|P1|Overall Study|No Endpoint Blood Draw|38
2930838|NCT01467466|10091767|P4|Overall Study|Procedure Cancelled|29
2930839|NCT01467466|10091768|P3|Overall Study|Procedure Cancelled|25
2930840|NCT01467466|10091769|P2|Overall Study|Procedure Cancelled|45
2930841|NCT01467466|10091770|P1|Overall Study|Procedure Cancelled|46
2930842|NCT01467466|10091767|P4|Overall Study|Revoked Consent Prior To Procedure|5
2930843|NCT01467466|10091768|P3|Overall Study|Revoked Consent Prior To Procedure|15
2930844|NCT01467466|10091769|P2|Overall Study|Revoked Consent Prior To Procedure|9
2930845|NCT01467466|10091770|P1|Overall Study|Revoked Consent Prior To Procedure|10
2930846|NCT01467466|10091767|P4|Overall Study|Withdrawal by Subject|11
2930847|NCT01467466|10091768|P3|Overall Study|Withdrawal by Subject|13
2930848|NCT01467466|10091769|P2|Overall Study|Withdrawal by Subject|18
2930849|NCT01467466|10091770|P1|Overall Study|Withdrawal by Subject|15
2930850|NCT01467427|10091782|P2|Overall Study|Not continuing in extension phase|2
2930851|NCT01467427|10091783|P1|Overall Study|Not continuing in extension phase|0
2930852|NCT01467427|10091782|P2|Overall Study|Entered extension phase|11
2930853|NCT01467427|10091783|P1|Overall Study|Entered extension phase|11
2930854|NCT01467427|10091782|P2|Overall Study|Withdrawal by Subject|0
2930855|NCT01467427|10091783|P1|Overall Study|Withdrawal by Subject|1
2930856|NCT01467271|10091801|P1|Overall Study|Other reason|14
2930857|NCT01467271|10091801|P1|Overall Study|Retraction of patient's consent|21
2930858|NCT01467271|10091801|P1|Overall Study|Lost to Follow-up|83
2930859|NCT01467271|10091801|P1|Overall Study|Death|84
2930860|NCT01467076|10091808|P3|Overall Study|Lost to Follow-up|0
2930861|NCT01467076|10091809|P2|Overall Study|Lost to Follow-up|0
2930862|NCT01467076|10091810|P1|Overall Study|Lost to Follow-up|1
2930863|NCT01466881|10091876|P1|Overall Study|Other reason not protocol specified|5
2930864|NCT01466881|10091876|P1|Overall Study|Death|4
2930865|NCT01466881|10091876|P1|Overall Study|Progression/relapse|20
2930866|NCT01466881|10091876|P1|Overall Study|Adverse Event|6
2930867|NCT01466881|10091876|P1|Overall Study|Ineligible|5
2930868|NCT01466790|10091893|P8|Overall Study|Withdrawal by Subject|1
2930869|NCT01466790|10091894|P7|Overall Study|Withdrawal by Subject|1
2930870|NCT01466790|10091895|P6|Overall Study|Withdrawal by Subject|0
2930871|NCT01466790|10091896|P5|Overall Study|Withdrawal by Subject|1
2930872|NCT01466790|10091897|P4|Overall Study|Withdrawal by Subject|0
2930873|NCT01466790|10091898|P3|Overall Study|Withdrawal by Subject|0
2930874|NCT01466790|10091899|P2|Overall Study|Withdrawal by Subject|1
2930875|NCT01466790|10091900|P1|Overall Study|Withdrawal by Subject|1
2930876|NCT01466790|10091893|P8|Overall Study|Lost to Follow-up|0
2930877|NCT01466790|10091894|P7|Overall Study|Lost to Follow-up|0
2930878|NCT01466790|10091895|P6|Overall Study|Lost to Follow-up|0
2930879|NCT01466790|10091896|P5|Overall Study|Lost to Follow-up|0
2930880|NCT01466790|10091897|P4|Overall Study|Lost to Follow-up|0
2930881|NCT01466790|10091898|P3|Overall Study|Lost to Follow-up|0
2930882|NCT01466790|10091899|P2|Overall Study|Lost to Follow-up|0
2930883|NCT01466790|10091900|P1|Overall Study|Lost to Follow-up|2
2930884|NCT01466790|10091893|P8|Overall Study|Adverse Event|0
2930885|NCT01466790|10091894|P7|Overall Study|Adverse Event|0
2930886|NCT01466790|10091895|P6|Overall Study|Adverse Event|0
2930887|NCT01466790|10091896|P5|Overall Study|Adverse Event|2
2930888|NCT01466790|10091897|P4|Overall Study|Adverse Event|0
2930889|NCT01466790|10091898|P3|Overall Study|Adverse Event|0
2930890|NCT01466790|10091899|P2|Overall Study|Adverse Event|0
2930891|NCT01466790|10091900|P1|Overall Study|Adverse Event|1
2930892|NCT01466673|10091996|P2|Overall Study|Adverse Event|1
2930893|NCT01466673|10091997|P1|Overall Study|Adverse Event|2
2930894|NCT01466673|10091996|P2|Overall Study|Lost to Follow-up|5
2930895|NCT01466673|10091997|P1|Overall Study|Lost to Follow-up|3
2930896|NCT01466673|10091996|P2|Overall Study|Non-compliance with study treatment|0
2930897|NCT01466673|10091997|P1|Overall Study|Non-compliance with study treatment|2
2930898|NCT01466660|10092023|P2|Overall Study|Other reason not defined above|8
2930899|NCT01466660|10092024|P1|Overall Study|Other reason not defined above|10
2930900|NCT01466660|10092023|P2|Overall Study|Refused continuation of trial medication|3
2930901|NCT01466660|10092024|P1|Overall Study|Refused continuation of trial medication|4
2930902|NCT01466660|10092023|P2|Overall Study|Protocol Violation|1
2930903|NCT01466660|10092024|P1|Overall Study|Protocol Violation|2
2930904|NCT01466660|10092023|P2|Overall Study|Other adverse event|18
2930905|NCT01466660|10092024|P1|Overall Study|Other adverse event|19
2930906|NCT01466660|10092023|P2|Overall Study|Worsening of underlying cancer disease|2
2930907|NCT01466660|10092024|P1|Overall Study|Worsening of underlying cancer disease|5
2930908|NCT01466660|10092023|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
2930909|NCT01466660|10092024|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
2930910|NCT01466595|10092050|P2|Overall Study|Withdrawal by Subject|1
2930911|NCT01466595|10092051|P1|Overall Study|Withdrawal by Subject|0
2930912|NCT01466491|10092145|P4|Overall Study|Missing Data|0
2930913|NCT01466491|10092146|P3|Overall Study|Missing Data|1
2930914|NCT01466491|10092147|P2|Overall Study|Missing Data|0
2930915|NCT01466491|10092148|P1|Overall Study|Missing Data|0
2930916|NCT01466491|10092145|P4|Overall Study|Protocol Violation|0
2930917|NCT01466491|10092146|P3|Overall Study|Protocol Violation|2
2930918|NCT01466491|10092147|P2|Overall Study|Protocol Violation|3
2930919|NCT01466491|10092148|P1|Overall Study|Protocol Violation|0
2930920|NCT01466387|10092168|P6|Overall Study|Protocol Violation|0
2930921|NCT01466387|10092169|P5|Overall Study|Protocol Violation|0
2930922|NCT01466387|10092170|P4|Overall Study|Protocol Violation|1
2930923|NCT01466387|10092171|P3|Overall Study|Protocol Violation|0
2930924|NCT01466387|10092172|P2|Overall Study|Protocol Violation|0
2930925|NCT01466387|10092173|P1|Overall Study|Protocol Violation|1
2930926|NCT01466387|10092168|P6|Overall Study|Lost to Follow-up|1
2930927|NCT01466387|10092169|P5|Overall Study|Lost to Follow-up|0
2930928|NCT01466387|10092170|P4|Overall Study|Lost to Follow-up|0
2930929|NCT01466387|10092171|P3|Overall Study|Lost to Follow-up|0
2930930|NCT01466387|10092172|P2|Overall Study|Lost to Follow-up|0
2930931|NCT01466387|10092173|P1|Overall Study|Lost to Follow-up|0
2930932|NCT01466387|10092168|P6|Overall Study|Adverse Event|0
2930933|NCT01466387|10092169|P5|Overall Study|Adverse Event|0
2930934|NCT01466387|10092170|P4|Overall Study|Adverse Event|1
2930935|NCT01466387|10092171|P3|Overall Study|Adverse Event|1
2930936|NCT01466387|10092172|P2|Overall Study|Adverse Event|0
2930937|NCT01466387|10092173|P1|Overall Study|Adverse Event|0
2930938|NCT01466348|10092234|P2|Period I - First Intervention|Withdrawal by Subject|1
2930939|NCT01466348|10092235|P1|Period I - First Intervention|Withdrawal by Subject|0
2930940|NCT01466270|10092263|P2|Overall Study|Multiple|1
2930941|NCT01466270|10092264|P1|Overall Study|Multiple|1
2930942|NCT01466270|10092263|P2|Overall Study|Toxicity|1
2930943|NCT01466270|10092264|P1|Overall Study|Toxicity|4
2930944|NCT01466270|10092263|P2|Overall Study|Progression|0
2930945|NCT01466270|10092264|P1|Overall Study|Progression|1
2930946|NCT01466270|10092263|P2|Overall Study|Lost to Follow-up|3
2930947|NCT01466270|10092264|P1|Overall Study|Lost to Follow-up|1
2930948|NCT01466270|10092263|P2|Overall Study|Physician Decision|0
2930949|NCT01466270|10092264|P1|Overall Study|Physician Decision|1
2930950|NCT01466270|10092263|P2|Overall Study|Withdrawal by Subject|1
2930951|NCT01466270|10092264|P1|Overall Study|Withdrawal by Subject|4
2930952|NCT01466192|10092276|P1|Overall Study|Withdrawal by Subject|3
2930953|NCT01466192|10092276|P1|Overall Study|Physician Decision|1
2930954|NCT01466179|10092280|P1|Overall Study|Other|3
2930955|NCT01466179|10092280|P1|Overall Study|Protocol Violation|2
2930956|NCT01466179|10092280|P1|Overall Study|Withdrawal by Subject|7
2930957|NCT01466179|10092280|P1|Overall Study|Death|7
2930958|NCT01466179|10092280|P1|Overall Study|Lack of Efficacy|14
2930959|NCT01466179|10092280|P1|Overall Study|Disease relapse|23
2930960|NCT01466179|10092280|P1|Overall Study|Adverse Event|32
2930961|NCT01466179|10092280|P1|Overall Study|Progressive disease|43
2930962|NCT01466179|10092280|P1|Overall Study|Physician Decision|46
2930963|NCT01466179|10092280|P1|Overall Study|Ongoing in core study|2
2930964|NCT01466166|10092300|P1|Overall Study|Other|20
2930965|NCT01466166|10092300|P1|Overall Study|Protocol Violation/Noncompliance|2
2930966|NCT01466166|10092300|P1|Overall Study|Sponsor Decision|4
2930967|NCT01466166|10092300|P1|Overall Study|Withdrawal by Subject|13
2930968|NCT01466166|10092300|P1|Overall Study|Elevated Serum Uric Acid|78
2930969|NCT01466166|10092300|P1|Overall Study|Adverse Event (Other than IR)|11
2930970|NCT01466166|10092300|P1|Overall Study|Infusion Reaction (IR)|27
2930971|NCT01466166|10092300|P1|Overall Study|Lost to Follow-up|7
2930972|NCT01466166|10092300|P1|Overall Study|Death|1
2930973|NCT01466153|10092314|P3|Overall Study|Other-Unspecified|2
2930974|NCT01466153|10092315|P2|Overall Study|Other-Unspecified|4
2930975|NCT01466153|10092316|P1|Overall Study|Other-Unspecified|6
2930976|NCT01466153|10092314|P3|Overall Study|Randomized-Not Treated|4
2930977|NCT01466153|10092315|P2|Overall Study|Randomized-Not Treated|3
2930978|NCT01466153|10092316|P1|Overall Study|Randomized-Not Treated|2
2930979|NCT01466153|10092314|P3|Overall Study|Investigator Discretion|2
2930980|NCT01466153|10092315|P2|Overall Study|Investigator Discretion|2
2930981|NCT01466153|10092316|P1|Overall Study|Investigator Discretion|3
2930982|NCT01466153|10092314|P3|Overall Study|Withdrawal of Consent|0
2930983|NCT01466153|10092315|P2|Overall Study|Withdrawal of Consent|0
2930984|NCT01466153|10092316|P1|Overall Study|Withdrawal of Consent|2
2930985|NCT01466153|10092314|P3|Overall Study|Adverse Event|17
2930986|NCT01466153|10092315|P2|Overall Study|Adverse Event|13
2930987|NCT01466153|10092316|P1|Overall Study|Adverse Event|14
2930988|NCT01466153|10092314|P3|Overall Study|Disease Progression|0
2930989|NCT01466153|10092315|P2|Overall Study|Disease Progression|2
2930990|NCT01466153|10092316|P1|Overall Study|Disease Progression|2
2930991|NCT01466062|10092371|P1|Overall Study|Withdrawal by Subject|1
2930992|NCT01466062|10092371|P1|Overall Study|Adverse Event|1
2930993|NCT01465997|10092394|P2|Overall Study|subject left participation SP0993|1
2930994|NCT01465997|10092395|P1|Overall Study|subject left participation SP0993|0
2930995|NCT01465997|10092394|P2|Overall Study|decision by site staff|1
2930996|NCT01465997|10092395|P1|Overall Study|decision by site staff|0
2930997|NCT01465997|10092394|P2|Overall Study|withdrew before follow-up|13
2930998|NCT01465997|10092395|P1|Overall Study|withdrew before follow-up|0
2930999|NCT01465997|10092394|P2|Overall Study|local lab unblinded site|0
2931000|NCT01465997|10092395|P1|Overall Study|local lab unblinded site|1
2931001|NCT01465997|10092394|P2|Overall Study|subject withdrew consent|0
2931002|NCT01465997|10092395|P1|Overall Study|subject withdrew consent|1
2931003|NCT01465997|10092394|P2|Overall Study|sponsor's decision|1
2931004|NCT01465997|10092395|P1|Overall Study|sponsor's decision|1
2931005|NCT01465997|10092394|P2|Overall Study|Death|1
2931006|NCT01465997|10092395|P1|Overall Study|Death|0
2931007|NCT01465997|10092394|P2|Overall Study|investigator's decision|1
2931008|NCT01465997|10092395|P1|Overall Study|investigator's decision|1
2931009|NCT01465997|10092394|P2|Overall Study|Withdrawal by Subject|35
2931010|NCT01465997|10092395|P1|Overall Study|Withdrawal by Subject|32
2931011|NCT01465997|10092394|P2|Overall Study|Lost to Follow-up|9
2931012|NCT01465997|10092395|P1|Overall Study|Lost to Follow-up|6
2931013|NCT01465997|10092394|P2|Overall Study|Protocol Violation|4
2931014|NCT01465997|10092395|P1|Overall Study|Protocol Violation|1
2931015|NCT01465997|10092394|P2|Overall Study|Lack of Efficacy|1
2931016|NCT01465997|10092395|P1|Overall Study|Lack of Efficacy|13
2931017|NCT01465997|10092394|P2|Overall Study|Adverse Event|22
2931018|NCT01465997|10092395|P1|Overall Study|Adverse Event|12
2931019|NCT01465958|10092405|P2|Subcutaneous (SC) Phase|Adverse Event|1
2931020|NCT01465958|10092406|P1|Subcutaneous (SC) Phase|Adverse Event|0
2931021|NCT01465958|10092405|P2|Run-in Phase|Protocol Violation|0
2931022|NCT01465958|10092406|P1|Run-in Phase|Protocol Violation|1
2931023|NCT01465802|10092419|P5|Overall Study|Death|2
2931024|NCT01465802|10092420|P4|Overall Study|Death|10
2931025|NCT01465802|10092421|P3|Overall Study|Death|0
2931026|NCT01465802|10092422|P2|Overall Study|Death|12
2931027|NCT01465802|10092423|P1|Overall Study|Death|15
2931028|NCT01465802|10092419|P5|Overall Study|Reason not specified|2
2931029|NCT01465802|10092420|P4|Overall Study|Reason not specified|10
2931030|NCT01465802|10092421|P3|Overall Study|Reason not specified|0
2931031|NCT01465802|10092422|P2|Overall Study|Reason not specified|4
2931032|NCT01465802|10092423|P1|Overall Study|Reason not specified|9
2931033|NCT01465802|10092419|P5|Overall Study|Lost to Follow-up|0
2931034|NCT01465802|10092420|P4|Overall Study|Lost to Follow-up|0
2931035|NCT01465802|10092421|P3|Overall Study|Lost to Follow-up|0
2931036|NCT01465802|10092422|P2|Overall Study|Lost to Follow-up|1
2931037|NCT01465802|10092423|P1|Overall Study|Lost to Follow-up|1
2931038|NCT01465802|10092419|P5|Overall Study|Withdrawal by Subject|1
2931039|NCT01465802|10092420|P4|Overall Study|Withdrawal by Subject|8
2931040|NCT01465802|10092421|P3|Overall Study|Withdrawal by Subject|0
2931041|NCT01465802|10092422|P2|Overall Study|Withdrawal by Subject|7
2931042|NCT01465802|10092423|P1|Overall Study|Withdrawal by Subject|7
2931043|NCT01465802|10092419|P5|Overall Study|Study terminated by sponsor|7
2931044|NCT01465802|10092420|P4|Overall Study|Study terminated by sponsor|1
2931045|NCT01465802|10092421|P3|Overall Study|Study terminated by sponsor|0
2931046|NCT01465802|10092422|P2|Overall Study|Study terminated by sponsor|0
2931047|NCT01465802|10092423|P1|Overall Study|Study terminated by sponsor|1
2931048|NCT01465763|10092475|P3|Overall Study|Death|0
2931049|NCT01465763|10092476|P2|Overall Study|Death|0
2931050|NCT01465763|10092477|P1|Overall Study|Death|1
2931051|NCT01465763|10092475|P3|Overall Study|Protocol Violation|1
2931052|NCT01465763|10092476|P2|Overall Study|Protocol Violation|1
2931053|NCT01465763|10092477|P1|Overall Study|Protocol Violation|4
2931054|NCT01465763|10092475|P3|Overall Study|Other|0
2931055|NCT01465763|10092476|P2|Overall Study|Other|0
2931056|NCT01465763|10092477|P1|Overall Study|Other|2
2931057|NCT01465763|10092475|P3|Overall Study|Adverse Event|1
2931058|NCT01465763|10092476|P2|Overall Study|Adverse Event|0
2931059|NCT01465763|10092477|P1|Overall Study|Adverse Event|9
2931060|NCT01465763|10092475|P3|Overall Study|Insufficient Clinical Response|1
2931061|NCT01465763|10092476|P2|Overall Study|Insufficient Clinical Response|0
2931062|NCT01465763|10092477|P1|Overall Study|Insufficient Clinical Response|11
2931063|NCT01465763|10092475|P3|Overall Study|Withdrawal by Subject|1
2931064|NCT01465763|10092476|P2|Overall Study|Withdrawal by Subject|0
2931065|NCT01465763|10092477|P1|Overall Study|Withdrawal by Subject|4
2931066|NCT01465464|10092504|P2|Overall Study|Ongoing treatment at cutoff date|166
2931067|NCT01465464|10092505|P1|Overall Study|Ongoing treatment at cutoff date|140
2931068|NCT01465464|10092504|P2|Overall Study|Other|3
2931069|NCT01465464|10092505|P1|Overall Study|Other|9
2931070|NCT01465464|10092504|P2|Overall Study|Withdrawal by Subject|30
2931071|NCT01465464|10092505|P1|Overall Study|Withdrawal by Subject|46
2931072|NCT01465464|10092504|P2|Overall Study|Protocol Violation|1
2931073|NCT01465464|10092505|P1|Overall Study|Protocol Violation|1
2931074|NCT01465464|10092504|P2|Overall Study|Physician Decision|5
2931075|NCT01465464|10092505|P1|Overall Study|Physician Decision|13
2931076|NCT01465464|10092504|P2|Overall Study|Lack of Efficacy|190
2931077|NCT01465464|10092505|P1|Overall Study|Lack of Efficacy|139
2931078|NCT01465464|10092504|P2|Overall Study|Adverse Event|49
2931079|NCT01465464|10092505|P1|Overall Study|Adverse Event|96
2931080|NCT01465386|10092558|P1|Overall Study|Adverse Event|1
2931081|NCT01465386|10092558|P1|Overall Study|Lack of Efficacy|3
2931082|NCT01465347|10092562|P2|Overall Study|Admitted to hospice|1
2931083|NCT01465347|10092563|P1|Overall Study|Admitted to hospice|0
2931084|NCT01465347|10092562|P2|Overall Study|Physician Decision|1
2931085|NCT01465347|10092563|P1|Overall Study|Physician Decision|0
2931086|NCT01465347|10092562|P2|Overall Study|Withdrawal by Subject|1
2931087|NCT01465347|10092563|P1|Overall Study|Withdrawal by Subject|1
2931088|NCT01465334|10092575|P2|Overall Study|Refractory Disease|3
2931089|NCT01465334|10092576|P1|Overall Study|Refractory Disease|0
2931090|NCT01465334|10092575|P2|Overall Study|Richter's transformation|3
2931091|NCT01465334|10092576|P1|Overall Study|Richter's transformation|0
2931092|NCT01465334|10092575|P2|Overall Study|Adverse Event|0
2931093|NCT01465334|10092576|P1|Overall Study|Adverse Event|1
2931094|NCT01465334|10092575|P2|Overall Study|Disease Progression|0
2931095|NCT01465334|10092576|P1|Overall Study|Disease Progression|1
2931096|NCT01465230|10092602|P1|Overall Study|Withdrawal by Subject|2
2931097|NCT01465178|10092608|P2|Overall Study|Withdrawal by Subject|0
2931098|NCT01465178|10092609|P1|Overall Study|Withdrawal by Subject|1
2931099|NCT01465022|10092633|P3|Overall Study|Not Randomized|70
2931100|NCT01465022|10092634|P2|Overall Study|Not Randomized|0
2931101|NCT01465022|10092635|P1|Overall Study|Not Randomized|0
2931102|NCT01465022|10092633|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
2931103|NCT01465022|10092634|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
2931104|NCT01465022|10092635|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
2931105|NCT01465022|10092633|P3|Overall Study|Lost to Follow-up|0
2931106|NCT01465022|10092634|P2|Overall Study|Lost to Follow-up|14
2931107|NCT01465022|10092635|P1|Overall Study|Lost to Follow-up|15
2931108|NCT01464931|10092669|P2|Overall Study|Withdrawal by Subject|0
2931109|NCT01464931|10092670|P1|Overall Study|Withdrawal by Subject|1
2931110|NCT01464879|10092707|P1|Overall Study|Non-compliance|1
2931111|NCT01464879|10092707|P1|Overall Study|Physician Decision|1
2931112|NCT01464827|10092768|P14|Overall Study|Not Treated|2
2931113|NCT01464827|10092769|P13|Overall Study|Not Treated|0
2931114|NCT01464827|10092770|P12|Overall Study|Not Treated|1
2931115|NCT01464827|10092771|P11|Overall Study|Not Treated|0
2931116|NCT01464827|10092772|P10|Overall Study|Not Treated|2
2931117|NCT01464827|10092773|P9|Overall Study|Not Treated|0
2931118|NCT01464827|10092774|P8|Overall Study|Not Treated|0
2931119|NCT01464827|10092775|P7|Overall Study|Not Treated|1
2931120|NCT01464827|10092776|P6|Overall Study|Not Treated|0
2931121|NCT01464827|10092777|P5|Overall Study|Not Treated|1
2931122|NCT01464827|10092778|P4|Overall Study|Not Treated|0
2931123|NCT01464827|10092779|P3|Overall Study|Not Treated|0
2931124|NCT01464827|10092780|P2|Overall Study|Not Treated|2
2931125|NCT01464827|10092781|P1|Overall Study|Not Treated|0
2931126|NCT01464827|10092768|P14|Overall Study|Other|0
2931127|NCT01464827|10092769|P13|Overall Study|Other|1
2931128|NCT01464827|10092770|P12|Overall Study|Other|0
2931129|NCT01464827|10092771|P11|Overall Study|Other|2
2931130|NCT01464827|10092772|P10|Overall Study|Other|1
2931131|NCT01464827|10092773|P9|Overall Study|Other|3
2931132|NCT01464827|10092774|P8|Overall Study|Other|0
2931133|NCT01464827|10092775|P7|Overall Study|Other|1
2931134|NCT01464827|10092776|P6|Overall Study|Other|0
2931135|NCT01464827|10092777|P5|Overall Study|Other|3
2931136|NCT01464827|10092778|P4|Overall Study|Other|2
2931137|NCT01464827|10092779|P3|Overall Study|Other|0
2931138|NCT01464827|10092780|P2|Overall Study|Other|3
2931139|NCT01464827|10092781|P1|Overall Study|Other|2
2931140|NCT01464827|10092768|P14|Overall Study|Lost to Follow-up|1
2931141|NCT01464827|10092769|P13|Overall Study|Lost to Follow-up|0
2931142|NCT01464827|10092770|P12|Overall Study|Lost to Follow-up|1
2931143|NCT01464827|10092771|P11|Overall Study|Lost to Follow-up|0
2931144|NCT01464827|10092772|P10|Overall Study|Lost to Follow-up|0
2931145|NCT01464827|10092773|P9|Overall Study|Lost to Follow-up|0
2931146|NCT01464827|10092774|P8|Overall Study|Lost to Follow-up|2
2931147|NCT01464827|10092775|P7|Overall Study|Lost to Follow-up|2
2931148|NCT01464827|10092776|P6|Overall Study|Lost to Follow-up|1
2931149|NCT01464827|10092777|P5|Overall Study|Lost to Follow-up|3
2931150|NCT01464827|10092778|P4|Overall Study|Lost to Follow-up|2
2931151|NCT01464827|10092779|P3|Overall Study|Lost to Follow-up|0
2931152|NCT01464827|10092780|P2|Overall Study|Lost to Follow-up|2
2931153|NCT01464827|10092781|P1|Overall Study|Lost to Follow-up|0
2931154|NCT01464827|10092768|P14|Overall Study|Withdrawal by Subject|0
2931155|NCT01464827|10092769|P13|Overall Study|Withdrawal by Subject|0
2931156|NCT01464827|10092770|P12|Overall Study|Withdrawal by Subject|0
2931157|NCT01464827|10092771|P11|Overall Study|Withdrawal by Subject|0
2931158|NCT01464827|10092772|P10|Overall Study|Withdrawal by Subject|0
2931159|NCT01464827|10092773|P9|Overall Study|Withdrawal by Subject|0
2931160|NCT01464827|10092774|P8|Overall Study|Withdrawal by Subject|1
2931161|NCT01464827|10092775|P7|Overall Study|Withdrawal by Subject|0
2931162|NCT01464827|10092776|P6|Overall Study|Withdrawal by Subject|0
2931163|NCT01464827|10092777|P5|Overall Study|Withdrawal by Subject|1
2931164|NCT01464827|10092778|P4|Overall Study|Withdrawal by Subject|0
2931165|NCT01464827|10092779|P3|Overall Study|Withdrawal by Subject|0
2931166|NCT01464827|10092780|P2|Overall Study|Withdrawal by Subject|0
2931167|NCT01464827|10092781|P1|Overall Study|Withdrawal by Subject|1
2931168|NCT01464827|10092768|P14|Overall Study|Adverse Event|0
2931169|NCT01464827|10092769|P13|Overall Study|Adverse Event|1
2931170|NCT01464827|10092770|P12|Overall Study|Adverse Event|0
2931171|NCT01464827|10092771|P11|Overall Study|Adverse Event|0
2931172|NCT01464827|10092772|P10|Overall Study|Adverse Event|0
2931173|NCT01464827|10092773|P9|Overall Study|Adverse Event|0
2931174|NCT01464827|10092774|P8|Overall Study|Adverse Event|0
2931175|NCT01464827|10092775|P7|Overall Study|Adverse Event|0
2931176|NCT01464827|10092776|P6|Overall Study|Adverse Event|0
2931177|NCT01464827|10092777|P5|Overall Study|Adverse Event|0
2931178|NCT01464827|10092778|P4|Overall Study|Adverse Event|0
2931179|NCT01464827|10092779|P3|Overall Study|Adverse Event|0
2931180|NCT01464827|10092780|P2|Overall Study|Adverse Event|0
2931181|NCT01464827|10092781|P1|Overall Study|Adverse Event|0
2931182|NCT01464788|10092828|P3|Overall Study|Patient had hemorrhage after tPA started|0
2931183|NCT01464788|10092829|P2|Overall Study|Patient had hemorrhage after tPA started|1
2931184|NCT01464788|10092830|P1|Overall Study|Patient had hemorrhage after tPA started|0
2931185|NCT01464788|10092828|P3|Overall Study|Lost to Follow-up|0
2931186|NCT01464788|10092829|P2|Overall Study|Lost to Follow-up|1
2931187|NCT01464788|10092830|P1|Overall Study|Lost to Follow-up|0
2931188|NCT01464619|10092916|P2|Overall Study|Lost to Follow-up|4
2931189|NCT01464619|10092917|P1|Overall Study|Lost to Follow-up|3
2931190|NCT01464424|10092937|P2|Period 1, First 6 Weeks|Adverse Event|1
2931191|NCT01464424|10092938|P1|Period 1, First 6 Weeks|Adverse Event|0
2931192|NCT01464346|10092958|P3|Overall Study|Withdrawal by Subject|1
2931193|NCT01464346|10092959|P2|Overall Study|Withdrawal by Subject|0
2931194|NCT01464346|10092960|P1|Overall Study|Withdrawal by Subject|0
2931195|NCT01464333|10092969|P1|Overall Study|No Hospital Visit|42
2931196|NCT01464333|10092969|P1|Overall Study|Other|4
2931197|NCT01464333|10092969|P1|Overall Study|Withdrawal by Subject|11
2931198|NCT01464333|10092969|P1|Overall Study|Lack of Efficacy|72
2931199|NCT01464333|10092969|P1|Overall Study|Adverse Event|34
2931200|NCT01464307|10092982|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
2931201|NCT01464307|10092983|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
2931202|NCT01464307|10092982|P2|Open-Label Extension Period|Non-compliance|0
2931203|NCT01464307|10092983|P1|Open-Label Extension Period|Non-compliance|9
2931204|NCT01464307|10092982|P2|Open-Label Extension Period|Lost to Follow-up|0
2931205|NCT01464307|10092983|P1|Open-Label Extension Period|Lost to Follow-up|1
2931206|NCT01464307|10092982|P2|Open-Label Extension Period|Death|0
2931207|NCT01464307|10092983|P1|Open-Label Extension Period|Death|1
2931208|NCT01464307|10092982|P2|Open-Label Extension Period|Lack of Efficacy|0
2931209|NCT01464307|10092983|P1|Open-Label Extension Period|Lack of Efficacy|5
2931210|NCT01464307|10092982|P2|Open-Label Extension Period|Withdrawal by Subject|0
2931211|NCT01464307|10092983|P1|Open-Label Extension Period|Withdrawal by Subject|14
2931212|NCT01464307|10092982|P2|Open-Label Extension Period|Adverse Event|0
2931213|NCT01464307|10092983|P1|Open-Label Extension Period|Adverse Event|15
2931214|NCT01464307|10092982|P2|Main Period|Predefined discontinuation criteria|1
2931215|NCT01464307|10092983|P1|Main Period|Predefined discontinuation criteria|2
2931216|NCT01464307|10092982|P2|Main Period|Withdrawal by Subject|2
2931217|NCT01464307|10092983|P1|Main Period|Withdrawal by Subject|5
2931218|NCT01464307|10092982|P2|Main Period|Lack of Efficacy|0
2931219|NCT01464307|10092983|P1|Main Period|Lack of Efficacy|2
2931220|NCT01464307|10092982|P2|Main Period|Adverse Event|1
2931221|NCT01464307|10092983|P1|Main Period|Adverse Event|6
2931222|NCT01464307|10092982|P2|Main Period|Death|1
2931223|NCT01464307|10092983|P1|Main Period|Death|0
2931224|NCT01464255|10092998|P2|Overall Study|unresolve corneal staining|1
2931225|NCT01464255|10092999|P1|Overall Study|unresolve corneal staining|0
2931226|NCT01464021|10093044|P1|Overall Study|various|11
2931227|NCT01464021|10093044|P1|Overall Study|Lack of Efficacy|1
2931228|NCT01464021|10093044|P1|Overall Study|Lost to Follow-up|1
2931229|NCT01464021|10093044|P1|Overall Study|Withdrawal by Subject|13
2931230|NCT01463982|10093060|P4|Overall Study|Treatment delay over 5 week|0
2931231|NCT01463982|10093061|P3|Overall Study|Treatment delay over 5 week|1
2931232|NCT01463982|10093062|P2|Overall Study|Treatment delay over 5 week|0
2931233|NCT01463982|10093063|P1|Overall Study|Treatment delay over 5 week|0
2931234|NCT01463982|10093060|P4|Overall Study|Withdrawal by Subject|0
2931235|NCT01463982|10093061|P3|Overall Study|Withdrawal by Subject|1
2931236|NCT01463982|10093062|P2|Overall Study|Withdrawal by Subject|1
2931237|NCT01463982|10093063|P1|Overall Study|Withdrawal by Subject|0
2931238|NCT01463878|10093079|P2|Overall Study|no longer met criteria for tube feed|2
2931239|NCT01463878|10093080|P1|Overall Study|no longer met criteria for tube feed|2
2931240|NCT01463696|10093094|P8|Overall Study|Not Treated|0
2931241|NCT01463696|10093095|P7|Overall Study|Not Treated|1
2931242|NCT01463696|10093096|P6|Overall Study|Not Treated|0
2931243|NCT01463696|10093097|P5|Overall Study|Not Treated|0
2931244|NCT01463696|10093098|P4|Overall Study|Not Treated|0
2931245|NCT01463696|10093099|P3|Overall Study|Not Treated|0
2931246|NCT01463696|10093100|P2|Overall Study|Not Treated|0
2931247|NCT01463696|10093101|P1|Overall Study|Not Treated|0
2931248|NCT01463696|10093094|P8|Overall Study|Withdrawal by Subject|0
2931249|NCT01463696|10093095|P7|Overall Study|Withdrawal by Subject|2
2931250|NCT01463696|10093096|P6|Overall Study|Withdrawal by Subject|1
2931251|NCT01463696|10093097|P5|Overall Study|Withdrawal by Subject|1
2931252|NCT01463696|10093098|P4|Overall Study|Withdrawal by Subject|1
2931253|NCT01463696|10093099|P3|Overall Study|Withdrawal by Subject|0
2931254|NCT01463696|10093100|P2|Overall Study|Withdrawal by Subject|0
2931255|NCT01463696|10093101|P1|Overall Study|Withdrawal by Subject|0
2931256|NCT01463696|10093094|P8|Overall Study|Progressive Disease|2
2931257|NCT01463696|10093095|P7|Overall Study|Progressive Disease|4
2931258|NCT01463696|10093096|P6|Overall Study|Progressive Disease|1
2931259|NCT01463696|10093097|P5|Overall Study|Progressive Disease|0
2931260|NCT01463696|10093098|P4|Overall Study|Progressive Disease|1
2931261|NCT01463696|10093099|P3|Overall Study|Progressive Disease|0
2931262|NCT01463696|10093100|P2|Overall Study|Progressive Disease|1
2931263|NCT01463696|10093101|P1|Overall Study|Progressive Disease|0
2931264|NCT01463696|10093094|P8|Overall Study|Lost to Follow-up|0
2931265|NCT01463696|10093095|P7|Overall Study|Lost to Follow-up|0
2931266|NCT01463696|10093096|P6|Overall Study|Lost to Follow-up|0
2931267|NCT01463696|10093097|P5|Overall Study|Lost to Follow-up|0
2931268|NCT01463696|10093098|P4|Overall Study|Lost to Follow-up|0
2931269|NCT01463696|10093099|P3|Overall Study|Lost to Follow-up|1
2931270|NCT01463696|10093100|P2|Overall Study|Lost to Follow-up|0
2931271|NCT01463696|10093101|P1|Overall Study|Lost to Follow-up|0
2931272|NCT01463696|10093094|P8|Overall Study|Adverse Event|2
2931273|NCT01463696|10093095|P7|Overall Study|Adverse Event|3
2931274|NCT01463696|10093096|P6|Overall Study|Adverse Event|1
2931275|NCT01463696|10093097|P5|Overall Study|Adverse Event|0
2931276|NCT01463696|10093098|P4|Overall Study|Adverse Event|2
2931277|NCT01463696|10093099|P3|Overall Study|Adverse Event|0
2931278|NCT01463696|10093100|P2|Overall Study|Adverse Event|1
2931279|NCT01463696|10093101|P1|Overall Study|Adverse Event|0
2931280|NCT01463683|10093154|P3|Overall Study|Withdrawal by Subject|2
2931281|NCT01463683|10093155|P2|Overall Study|Withdrawal by Subject|17
2931282|NCT01463683|10093156|P1|Overall Study|Withdrawal by Subject|5
2931283|NCT01463683|10093154|P3|Overall Study|Pregnancy|1
2931284|NCT01463683|10093155|P2|Overall Study|Pregnancy|2
2931285|NCT01463683|10093156|P1|Overall Study|Pregnancy|2
2931286|NCT01463683|10093154|P3|Overall Study|Physician Decision|1
2931287|NCT01463683|10093155|P2|Overall Study|Physician Decision|3
2931288|NCT01463683|10093156|P1|Overall Study|Physician Decision|0
2931289|NCT01463683|10093154|P3|Overall Study|Lost to Follow-up|7
2931290|NCT01463683|10093155|P2|Overall Study|Lost to Follow-up|9
2931291|NCT01463683|10093156|P1|Overall Study|Lost to Follow-up|10
2931292|NCT01463683|10093154|P3|Overall Study|Adverse Event|0
2931293|NCT01463683|10093155|P2|Overall Study|Adverse Event|0
2931294|NCT01463683|10093156|P1|Overall Study|Adverse Event|2
2931295|NCT01463631|10093173|P4|Overall Study|Progressive Disease|5
2931296|NCT01463631|10093174|P3|Overall Study|Progressive Disease|0
2931297|NCT01463631|10093175|P2|Overall Study|Progressive Disease|0
2931298|NCT01463631|10093176|P1|Overall Study|Progressive Disease|0
2931299|NCT01463631|10093173|P4|Overall Study|Death|0
2931300|NCT01463631|10093174|P3|Overall Study|Death|1
2931301|NCT01463631|10093175|P2|Overall Study|Death|0
2931302|NCT01463631|10093176|P1|Overall Study|Death|0
2931303|NCT01463631|10093173|P4|Overall Study|Withdrawal by Subject|1
2931304|NCT01463631|10093174|P3|Overall Study|Withdrawal by Subject|0
2931305|NCT01463631|10093175|P2|Overall Study|Withdrawal by Subject|0
2931306|NCT01463631|10093176|P1|Overall Study|Withdrawal by Subject|0
2931307|NCT01463527|10093198|P2|Overall Study|Crying >20% of sedation|6
2931308|NCT01463527|10093199|P1|Overall Study|Crying >20% of sedation|5
2931309|NCT01463527|10093198|P2|Overall Study|Protocol Violation|1
2931310|NCT01463527|10093199|P1|Overall Study|Protocol Violation|1
2931311|NCT01463306|10093222|P3|Overall Study|Approval expiry at site|0
2931312|NCT01463306|10093223|P2|Overall Study|Approval expiry at site|0
2931313|NCT01463306|10093224|P1|Overall Study|Approval expiry at site|1
2931314|NCT01463306|10093222|P3|Overall Study|Other|0
2931315|NCT01463306|10093223|P2|Overall Study|Other|13
2931316|NCT01463306|10093224|P1|Overall Study|Other|26
2931317|NCT01463306|10093222|P3|Overall Study|Withdrawal by Subject|1
2931318|NCT01463306|10093223|P2|Overall Study|Withdrawal by Subject|9
2931319|NCT01463306|10093224|P1|Overall Study|Withdrawal by Subject|19
2931320|NCT01463306|10093222|P3|Overall Study|Protocol Violation|0
2931321|NCT01463306|10093223|P2|Overall Study|Protocol Violation|0
2931322|NCT01463306|10093224|P1|Overall Study|Protocol Violation|4
2931323|NCT01463306|10093222|P3|Overall Study|Lost to Follow-up|0
2931324|NCT01463306|10093223|P2|Overall Study|Lost to Follow-up|2
2931325|NCT01463306|10093224|P1|Overall Study|Lost to Follow-up|5
2931326|NCT01463306|10093222|P3|Overall Study|Lack of Efficacy|1
2931327|NCT01463306|10093223|P2|Overall Study|Lack of Efficacy|16
2931328|NCT01463306|10093224|P1|Overall Study|Lack of Efficacy|22
2931329|NCT01463306|10093222|P3|Overall Study|Death|0
2931330|NCT01463306|10093223|P2|Overall Study|Death|3
2931331|NCT01463306|10093224|P1|Overall Study|Death|3
2931332|NCT01463306|10093222|P3|Overall Study|Adverse Event|3
2931333|NCT01463306|10093223|P2|Overall Study|Adverse Event|9
2931334|NCT01463306|10093224|P1|Overall Study|Adverse Event|6
2931335|NCT01463293|10093295|P3|Overall Study|Other|2
2931336|NCT01463293|10093296|P2|Overall Study|Other|0
2931337|NCT01463293|10093297|P1|Overall Study|Other|0
2931338|NCT01463293|10093295|P3|Overall Study|Withdrawal by Subject|5
2931339|NCT01463293|10093296|P2|Overall Study|Withdrawal by Subject|10
2931340|NCT01463293|10093297|P1|Overall Study|Withdrawal by Subject|4
2931341|NCT01463293|10093295|P3|Overall Study|Adverse Event|0
2931342|NCT01463293|10093296|P2|Overall Study|Adverse Event|2
2931343|NCT01463293|10093297|P1|Overall Study|Adverse Event|1
2931344|NCT01463293|10093295|P3|Overall Study|Lost to Follow-up|5
2931345|NCT01463293|10093296|P2|Overall Study|Lost to Follow-up|4
2931346|NCT01463293|10093297|P1|Overall Study|Lost to Follow-up|1
2931347|NCT01463111|10093320|P1|Overall Study|Physician Decision|2
2931348|NCT01463111|10093320|P1|Overall Study|Lost to Follow-up|5
2931349|NCT01463111|10093320|P1|Overall Study|Withdrawal by Subject|2
2931350|NCT01463098|10093342|P14|Part B (11 Days)|Participant Choice|0
2931351|NCT01463098|10093343|P13|Part B (11 Days)|Participant Choice|0
2931352|NCT01463098|10093344|P12|Part B (11 Days)|Participant Choice|1
2931353|NCT01463098|10093345|P11|Part B (11 Days)|Participant Choice|0
2931354|NCT01463098|10093346|P10|Part B (11 Days)|Participant Choice|0
2931355|NCT01463098|10093347|P9|Part B (11 Days)|Participant Choice|0
2931356|NCT01463098|10093348|P8|Part B (11 Days)|Participant Choice|0
2931357|NCT01463098|10093349|P7|Part B (11 Days)|Participant Choice|0
2931358|NCT01463098|10093350|P6|Part B (11 Days)|Participant Choice|0
2931359|NCT01463098|10093351|P5|Part B (11 Days)|Participant Choice|0
2931360|NCT01463098|10093352|P4|Part B (11 Days)|Participant Choice|0
2931361|NCT01463098|10093353|P3|Part B (11 Days)|Participant Choice|0
2931362|NCT01463098|10093354|P2|Part B (11 Days)|Participant Choice|0
2931363|NCT01463098|10093355|P1|Part B (11 Days)|Participant Choice|0
2931364|NCT01463098|10093342|P14|Part A (11 Days)|Lost to Follow-up|0
2931365|NCT01463098|10093343|P13|Part A (11 Days)|Lost to Follow-up|0
2931366|NCT01463098|10093344|P12|Part A (11 Days)|Lost to Follow-up|0
2931367|NCT01463098|10093345|P11|Part A (11 Days)|Lost to Follow-up|0
2931368|NCT01463098|10093346|P10|Part A (11 Days)|Lost to Follow-up|0
2931369|NCT01463098|10093347|P9|Part A (11 Days)|Lost to Follow-up|0
2931370|NCT01463098|10093348|P8|Part A (11 Days)|Lost to Follow-up|0
2931371|NCT01463098|10093349|P7|Part A (11 Days)|Lost to Follow-up|0
2931372|NCT01463098|10093350|P6|Part A (11 Days)|Lost to Follow-up|0
2931373|NCT01463098|10093351|P5|Part A (11 Days)|Lost to Follow-up|1
2931374|NCT01463098|10093352|P4|Part A (11 Days)|Lost to Follow-up|0
2931375|NCT01463098|10093353|P3|Part A (11 Days)|Lost to Follow-up|0
2931376|NCT01463098|10093354|P2|Part A (11 Days)|Lost to Follow-up|0
2931377|NCT01463098|10093355|P1|Part A (11 Days)|Lost to Follow-up|0
2931378|NCT01463098|10093342|P14|Part A (11 Days)|Participant Choice|0
2931379|NCT01463098|10093343|P13|Part A (11 Days)|Participant Choice|0
2931380|NCT01463098|10093344|P12|Part A (11 Days)|Participant Choice|0
2931381|NCT01463098|10093345|P11|Part A (11 Days)|Participant Choice|0
2931382|NCT01463098|10093346|P10|Part A (11 Days)|Participant Choice|0
2931383|NCT01463098|10093347|P9|Part A (11 Days)|Participant Choice|1
2931384|NCT01463098|10093348|P8|Part A (11 Days)|Participant Choice|0
2931385|NCT01463098|10093349|P7|Part A (11 Days)|Participant Choice|0
2931386|NCT01463098|10093350|P6|Part A (11 Days)|Participant Choice|0
2931387|NCT01463098|10093351|P5|Part A (11 Days)|Participant Choice|0
2931388|NCT01463098|10093352|P4|Part A (11 Days)|Participant Choice|0
2931389|NCT01463098|10093353|P3|Part A (11 Days)|Participant Choice|0
2931390|NCT01463098|10093354|P2|Part A (11 Days)|Participant Choice|0
2931391|NCT01463098|10093355|P1|Part A (11 Days)|Participant Choice|2
2931392|NCT01463033|10093678|P2|Overall Study|Death|2
2931393|NCT01463033|10093679|P1|Overall Study|Death|3
2931394|NCT01463033|10093678|P2|Overall Study|Lost to Follow-up|4
2931395|NCT01463033|10093679|P1|Overall Study|Lost to Follow-up|4
2931396|NCT01463007|10093686|P1|Overall Study|Physician Decision|1
2931397|NCT01462942|10093697|P5|Overall Study|Protocol Violation|6
2931398|NCT01462942|10093698|P4|Overall Study|Protocol Violation|9
2931399|NCT01462942|10093699|P3|Overall Study|Protocol Violation|9
2931400|NCT01462942|10093700|P2|Overall Study|Protocol Violation|6
2931401|NCT01462942|10093701|P1|Overall Study|Protocol Violation|4
2931402|NCT01462942|10093697|P5|Overall Study|Lost to Follow-up|1
2931403|NCT01462942|10093698|P4|Overall Study|Lost to Follow-up|1
2931404|NCT01462942|10093699|P3|Overall Study|Lost to Follow-up|1
2931405|NCT01462942|10093700|P2|Overall Study|Lost to Follow-up|1
2931406|NCT01462942|10093701|P1|Overall Study|Lost to Follow-up|0
2931407|NCT01462942|10093697|P5|Overall Study|Lack of Efficacy|3
2931408|NCT01462942|10093698|P4|Overall Study|Lack of Efficacy|5
2931409|NCT01462942|10093699|P3|Overall Study|Lack of Efficacy|4
2931410|NCT01462942|10093700|P2|Overall Study|Lack of Efficacy|0
2931411|NCT01462942|10093701|P1|Overall Study|Lack of Efficacy|6
2931412|NCT01462942|10093697|P5|Overall Study|Withdrawal by Subject|19
2931413|NCT01462942|10093698|P4|Overall Study|Withdrawal by Subject|16
2931414|NCT01462942|10093699|P3|Overall Study|Withdrawal by Subject|14
2931415|NCT01462942|10093700|P2|Overall Study|Withdrawal by Subject|10
2931416|NCT01462942|10093701|P1|Overall Study|Withdrawal by Subject|14
2931417|NCT01462942|10093697|P5|Overall Study|Other, including COPD exacerbation|5
2931418|NCT01462942|10093698|P4|Overall Study|Other, including COPD exacerbation|8
2931419|NCT01462942|10093699|P3|Overall Study|Other, including COPD exacerbation|2
2931420|NCT01462942|10093700|P2|Overall Study|Other, including COPD exacerbation|5
2931421|NCT01462942|10093701|P1|Overall Study|Other, including COPD exacerbation|3
2931422|NCT01462942|10093697|P5|Overall Study|Adverse Event|11
2931423|NCT01462942|10093698|P4|Overall Study|Adverse Event|11
2931424|NCT01462942|10093699|P3|Overall Study|Adverse Event|10
2931425|NCT01462942|10093700|P2|Overall Study|Adverse Event|12
2931426|NCT01462942|10093701|P1|Overall Study|Adverse Event|7
2931427|NCT01462929|10093731|P3|Overall Study|Lack of Efficacy|1
2931428|NCT01462929|10093732|P2|Overall Study|Lack of Efficacy|0
2931429|NCT01462929|10093733|P1|Overall Study|Lack of Efficacy|0
2931430|NCT01462929|10093731|P3|Overall Study|Withdrawal by Subject|0
2931431|NCT01462929|10093732|P2|Overall Study|Withdrawal by Subject|1
2931432|NCT01462929|10093733|P1|Overall Study|Withdrawal by Subject|2
2931433|NCT01462929|10093731|P3|Overall Study|Adverse Event|4
2931434|NCT01462929|10093732|P2|Overall Study|Adverse Event|3
2931435|NCT01462929|10093733|P1|Overall Study|Adverse Event|3
2931436|NCT01462695|10093774|P2|Overall Study|Inevaluable (did not receive study drug)|0
2931437|NCT01462695|10093775|P1|Overall Study|Inevaluable (did not receive study drug)|1
2931438|NCT01462695|10093774|P2|Overall Study|Withdrawal by Subject|0
2931439|NCT01462695|10093775|P1|Overall Study|Withdrawal by Subject|2
2931440|NCT01462695|10093774|P2|Overall Study|Physician Decision|0
2931441|NCT01462695|10093775|P1|Overall Study|Physician Decision|5
2931442|NCT01462695|10093774|P2|Overall Study|Lack of Efficacy|12
2931443|NCT01462695|10093775|P1|Overall Study|Lack of Efficacy|6
2931444|NCT01462695|10093774|P2|Overall Study|Death|0
2931445|NCT01462695|10093775|P1|Overall Study|Death|2
2931446|NCT01462695|10093774|P2|Overall Study|Adverse Event|1
2931447|NCT01462695|10093775|P1|Overall Study|Adverse Event|1
2931448|NCT01462435|10093803|P4|Overall Study|Lost to Follow-up|1
2931449|NCT01462435|10093804|P3|Overall Study|Lost to Follow-up|0
2931450|NCT01462435|10093805|P2|Overall Study|Lost to Follow-up|0
2931451|NCT01462435|10093806|P1|Overall Study|Lost to Follow-up|0
2931452|NCT01462435|10093803|P4|Overall Study|Withdrawal by Subject|1
2931453|NCT01462435|10093804|P3|Overall Study|Withdrawal by Subject|0
2931454|NCT01462435|10093805|P2|Overall Study|Withdrawal by Subject|0
2931455|NCT01462435|10093806|P1|Overall Study|Withdrawal by Subject|0
2931456|NCT01462435|10093803|P4|Overall Study|Physician Decision|0
2931457|NCT01462435|10093804|P3|Overall Study|Physician Decision|1
2931458|NCT01462435|10093805|P2|Overall Study|Physician Decision|0
2931459|NCT01462435|10093806|P1|Overall Study|Physician Decision|0
2931460|NCT01462435|10093803|P4|Overall Study|Lack of Efficacy|3
2931461|NCT01462435|10093804|P3|Overall Study|Lack of Efficacy|0
2931462|NCT01462435|10093805|P2|Overall Study|Lack of Efficacy|0
2931463|NCT01462435|10093806|P1|Overall Study|Lack of Efficacy|1
2931464|NCT01462370|10093844|P2|Overall Study|Withdrawal by Subject|3
2931465|NCT01462370|10093845|P1|Overall Study|Withdrawal by Subject|0
2931466|NCT01462370|10093844|P2|Overall Study|Physician Decision|1
2931467|NCT01462370|10093845|P1|Overall Study|Physician Decision|0
2931468|NCT01462370|10093844|P2|Overall Study|Lack of Qualifying Event|1
2931469|NCT01462370|10093845|P1|Overall Study|Lack of Qualifying Event|1
2931470|NCT01462357|10093880|P3|Overall Study|Lost to Follow-up|7
2931471|NCT01462357|10093881|P2|Overall Study|Lost to Follow-up|5
2931472|NCT01462357|10093882|P1|Overall Study|Lost to Follow-up|3
2931473|NCT01462357|10093880|P3|Overall Study|Migrated/moved from study area|1
2931474|NCT01462357|10093881|P2|Overall Study|Migrated/moved from study area|3
2931475|NCT01462357|10093882|P1|Overall Study|Migrated/moved from study area|2
2931476|NCT01462357|10093880|P3|Overall Study|Withdrawal by Subject|3
2931477|NCT01462357|10093881|P2|Overall Study|Withdrawal by Subject|11
2931478|NCT01462357|10093882|P1|Overall Study|Withdrawal by Subject|3
2931479|NCT01462357|10093880|P3|Overall Study|Death|1
2931480|NCT01462357|10093881|P2|Overall Study|Death|0
2931481|NCT01462357|10093882|P1|Overall Study|Death|0
2931482|NCT01462344|10093955|P2|Overall Study|Lost to Follow-up|7
2931483|NCT01462344|10093956|P1|Overall Study|Lost to Follow-up|7
2931484|NCT01462344|10093955|P2|Overall Study|Protocol Violation|53
2931485|NCT01462344|10093956|P1|Overall Study|Protocol Violation|68
2931486|NCT01462344|10093955|P2|Overall Study|Lack of Efficacy|6
2931487|NCT01462344|10093956|P1|Overall Study|Lack of Efficacy|5
2931488|NCT01462344|10093955|P2|Overall Study|Asthma Exacerbation|35
2931489|NCT01462344|10093956|P1|Overall Study|Asthma Exacerbation|34
2931490|NCT01462344|10093955|P2|Overall Study|Adverse Event|23
2931491|NCT01462344|10093956|P1|Overall Study|Adverse Event|24
2931492|NCT01462344|10093955|P2|Overall Study|Withdrawal by Subject|226
2931493|NCT01462344|10093956|P1|Overall Study|Withdrawal by Subject|245
2931494|NCT01462318|10093978|P3|Extension Phase|Adverse Event|22
2931495|NCT01462318|10093979|P2|Extension Phase|Adverse Event|0
2931496|NCT01462318|10093980|P1|Extension Phase|Adverse Event|0
2931497|NCT01462318|10093978|P3|Extension Phase|Investigator Decision|5
2931498|NCT01462318|10093979|P2|Extension Phase|Investigator Decision|0
2931499|NCT01462318|10093980|P1|Extension Phase|Investigator Decision|0
2931500|NCT01462318|10093978|P3|Extension Phase|Withdrawal by Subject|15
2931501|NCT01462318|10093979|P2|Extension Phase|Withdrawal by Subject|0
2931502|NCT01462318|10093980|P1|Extension Phase|Withdrawal by Subject|0
2931503|NCT01462318|10093978|P3|Extension Phase|Disease Progression|1
2931504|NCT01462318|10093979|P2|Extension Phase|Disease Progression|0
2931505|NCT01462318|10093980|P1|Extension Phase|Disease Progression|0
2931506|NCT01462318|10093978|P3|Extension Phase|Other|1
2931507|NCT01462318|10093979|P2|Extension Phase|Other|0
2931508|NCT01462318|10093980|P1|Extension Phase|Other|0
2931509|NCT01462318|10093978|P3|Extension Phase|Lost to Follow-up|1
2931510|NCT01462318|10093979|P2|Extension Phase|Lost to Follow-up|0
2931511|NCT01462318|10093980|P1|Extension Phase|Lost to Follow-up|0
2931512|NCT01462318|10093978|P3|Main Study / TP-DI Study|Adverse Event|0
2931513|NCT01462318|10093979|P2|Main Study / TP-DI Study|Adverse Event|0
2931514|NCT01462318|10093980|P1|Main Study / TP-DI Study|Adverse Event|4
2931515|NCT01462318|10093978|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
2931516|NCT01462318|10093979|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
2931517|NCT01462318|10093980|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
2931518|NCT01462318|10093978|P3|Main Study / TP-DI Study|Other|0
2931519|NCT01462318|10093979|P2|Main Study / TP-DI Study|Other|0
2931520|NCT01462318|10093980|P1|Main Study / TP-DI Study|Other|2
2931521|NCT01462266|10094081|P2|Overall Study|Screen failure|1
2931522|NCT01462266|10094082|P1|Overall Study|Screen failure|1
2931523|NCT01462266|10094081|P2|Overall Study|Withdrawal by Subject|2
2931524|NCT01462266|10094082|P1|Overall Study|Withdrawal by Subject|7
2931525|NCT01462266|10094081|P2|Overall Study|Protocol Violation|3
2931526|NCT01462266|10094082|P1|Overall Study|Protocol Violation|1
2931527|NCT01462266|10094081|P2|Overall Study|Physician Decision|5
2931528|NCT01462266|10094082|P1|Overall Study|Physician Decision|2
2931529|NCT01462266|10094081|P2|Overall Study|Creatinine and eGFR, excluded medication|4
2931530|NCT01462266|10094082|P1|Overall Study|Creatinine and eGFR, excluded medication|8
2931531|NCT01462266|10094081|P2|Overall Study|Non-compliance with study drug|0
2931532|NCT01462266|10094082|P1|Overall Study|Non-compliance with study drug|3
2931533|NCT01462266|10094081|P2|Overall Study|Lost to Follow-up|3
2931534|NCT01462266|10094082|P1|Overall Study|Lost to Follow-up|4
2931535|NCT01462266|10094081|P2|Overall Study|Lack of Efficacy|2
2931536|NCT01462266|10094082|P1|Overall Study|Lack of Efficacy|0
2931537|NCT01462266|10094081|P2|Overall Study|Death|1
2931538|NCT01462266|10094082|P1|Overall Study|Death|2
2931539|NCT01462266|10094081|P2|Overall Study|Adverse Event|6
2931540|NCT01462266|10094082|P1|Overall Study|Adverse Event|7
2931541|NCT01462227|10094107|P4|Second Assignment|Protocol Violation|0
2931542|NCT01462227|10094108|P3|Second Assignment|Protocol Violation|1
2931543|NCT01462227|10094109|P2|Second Assignment|Protocol Violation|1
2931544|NCT01462227|10094110|P1|Second Assignment|Protocol Violation|0
2931545|NCT01462227|10094107|P4|Second Assignment|Lost to Follow-up|0
2931546|NCT01462227|10094108|P3|Second Assignment|Lost to Follow-up|0
2931547|NCT01462227|10094109|P2|Second Assignment|Lost to Follow-up|0
2931548|NCT01462227|10094110|P1|Second Assignment|Lost to Follow-up|1
2931549|NCT01462162|10094128|P1|Overall Study|Other|2
2931550|NCT01462162|10094128|P1|Overall Study|Abnormal laboratory parameters|1
2931551|NCT01462162|10094128|P1|Overall Study|Lack of Efficacy|4
2931552|NCT01462162|10094128|P1|Overall Study|Adverse Event|5
2931553|NCT01462110|10094155|P2|Overall Study|Adverse Event|0
2931554|NCT01462110|10094156|P1|Overall Study|Adverse Event|1
2931555|NCT01462084|10094176|P2|Overall Study|Protocol Violation|1
2931556|NCT01462084|10094177|P1|Overall Study|Protocol Violation|1
2931557|NCT01462084|10094176|P2|Overall Study|Withdrawal by Subject|0
2931558|NCT01462084|10094177|P1|Overall Study|Withdrawal by Subject|1
2931559|NCT01462045|10094188|P3|Overall Study|Family matter|0
2931560|NCT01462045|10094189|P2|Overall Study|Family matter|1
2931561|NCT01462045|10094190|P1|Overall Study|Family matter|0
2931562|NCT01461993|10094204|P3|Overall Study|Other|6
2931563|NCT01461993|10094205|P2|Overall Study|Other|15
2931564|NCT01461993|10094206|P1|Overall Study|Other|13
2931565|NCT01461993|10094204|P3|Overall Study|Did not meet entrance criteria|0
2931566|NCT01461993|10094205|P2|Overall Study|Did not meet entrance criteria|3
2931567|NCT01461993|10094206|P1|Overall Study|Did not meet entrance criteria|2
2931568|NCT01461993|10094204|P3|Overall Study|No longer met eligibility criteria|10
2931569|NCT01461993|10094205|P2|Overall Study|No longer met eligibility criteria|18
2931570|NCT01461993|10094206|P1|Overall Study|No longer met eligibility criteria|13
2931571|NCT01461993|10094204|P3|Overall Study|Adverse Event|3
2931572|NCT01461993|10094205|P2|Overall Study|Adverse Event|11
2931573|NCT01461993|10094206|P1|Overall Study|Adverse Event|9
2931574|NCT01461993|10094204|P3|Overall Study|Protocol Violation|7
2931575|NCT01461993|10094205|P2|Overall Study|Protocol Violation|9
2931576|NCT01461993|10094206|P1|Overall Study|Protocol Violation|10
2931577|NCT01461993|10094204|P3|Overall Study|Lost to Follow-up|22
2931578|NCT01461993|10094205|P2|Overall Study|Lost to Follow-up|48
2931579|NCT01461993|10094206|P1|Overall Study|Lost to Follow-up|44
2931580|NCT01461993|10094204|P3|Overall Study|Withdrawal by Subject|16
2931581|NCT01461993|10094205|P2|Overall Study|Withdrawal by Subject|53
2931582|NCT01461993|10094206|P1|Overall Study|Withdrawal by Subject|60
2931583|NCT01461980|10094231|P3|Overall Study|Randomized but not vaccinated|7
2931584|NCT01461980|10094232|P2|Overall Study|Randomized but not vaccinated|8
2931585|NCT01461980|10094233|P1|Overall Study|Randomized but not vaccinated|4
2931586|NCT01461980|10094231|P3|Overall Study|No longer willing to participate|54
2931587|NCT01461980|10094232|P2|Overall Study|No longer willing to participate|38
2931588|NCT01461980|10094233|P1|Overall Study|No longer willing to participate|52
2931589|NCT01461980|10094231|P3|Overall Study|Lost to Follow-up|51
2931590|NCT01461980|10094232|P2|Overall Study|Lost to Follow-up|53
2931591|NCT01461980|10094233|P1|Overall Study|Lost to Follow-up|52
2931746|NCT01461538|10094409|P1|Overall Study|Death|15
2931592|NCT01461980|10094231|P3|Overall Study|No longer meets eligibility criteria|19
2931593|NCT01461980|10094232|P2|Overall Study|No longer meets eligibility criteria|9
2931594|NCT01461980|10094233|P1|Overall Study|No longer meets eligibility criteria|18
2931595|NCT01461980|10094231|P3|Overall Study|Protocol Violation|16
2931596|NCT01461980|10094232|P2|Overall Study|Protocol Violation|19
2931597|NCT01461980|10094233|P1|Overall Study|Protocol Violation|12
2931598|NCT01461980|10094231|P3|Overall Study|Adverse Event|6
2931599|NCT01461980|10094232|P2|Overall Study|Adverse Event|5
2931600|NCT01461980|10094233|P1|Overall Study|Adverse Event|12
2931601|NCT01461980|10094231|P3|Overall Study|Medication error|6
2931602|NCT01461980|10094232|P2|Overall Study|Medication error|5
2931603|NCT01461980|10094233|P1|Overall Study|Medication error|7
2931604|NCT01461980|10094231|P3|Overall Study|Other|6
2931605|NCT01461980|10094232|P2|Overall Study|Other|8
2931606|NCT01461980|10094233|P1|Overall Study|Other|9
2931607|NCT01461928|10094263|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
2931608|NCT01461928|10094264|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
2931609|NCT01461928|10094265|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
2931610|NCT01461928|10094263|P3|Maintenance II (15 Months)|Withdrew informed consent|1
2931611|NCT01461928|10094264|P2|Maintenance II (15 Months)|Withdrew informed consent|0
2931612|NCT01461928|10094265|P1|Maintenance II (15 Months)|Withdrew informed consent|0
2931613|NCT01461928|10094263|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
2931614|NCT01461928|10094264|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
2931615|NCT01461928|10094265|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
2931616|NCT01461928|10094263|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
2931617|NCT01461928|10094264|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
2931618|NCT01461928|10094265|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
2931619|NCT01461928|10094263|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
2931620|NCT01461928|10094264|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
2931621|NCT01461928|10094265|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
2931622|NCT01461928|10094263|P3|Maintenance II (15 Months)|Disease progression|3
2931623|NCT01461928|10094264|P2|Maintenance II (15 Months)|Disease progression|0
2931624|NCT01461928|10094265|P1|Maintenance II (15 Months)|Disease progression|0
2931625|NCT01461928|10094263|P3|Maintenance II (15 Months)|Moved to another town|0
2931626|NCT01461928|10094264|P2|Maintenance II (15 Months)|Moved to another town|1
2931627|NCT01461928|10094265|P1|Maintenance II (15 Months)|Moved to another town|0
2931628|NCT01461928|10094263|P3|Maintenance II (15 Months)|Lost to Follow-up|0
2931629|NCT01461928|10094264|P2|Maintenance II (15 Months)|Lost to Follow-up|1
2931630|NCT01461928|10094265|P1|Maintenance II (15 Months)|Lost to Follow-up|0
2931631|NCT01461928|10094263|P3|Maintenance II (15 Months)|Physician Decision|4
2931632|NCT01461928|10094264|P2|Maintenance II (15 Months)|Physician Decision|0
2931633|NCT01461928|10094265|P1|Maintenance II (15 Months)|Physician Decision|0
2931634|NCT01461928|10094263|P3|Maintenance II (15 Months)|Death|8
2931635|NCT01461928|10094264|P2|Maintenance II (15 Months)|Death|10
2931636|NCT01461928|10094265|P1|Maintenance II (15 Months)|Death|0
2931637|NCT01461928|10094263|P3|Maintenance II (15 Months)|Adverse Event|0
2931638|NCT01461928|10094264|P2|Maintenance II (15 Months)|Adverse Event|2
2931639|NCT01461928|10094265|P1|Maintenance II (15 Months)|Adverse Event|0
2931640|NCT01461928|10094263|P3|Maintenance I (24 Months)|Did not meet criteria|0
2931641|NCT01461928|10094264|P2|Maintenance I (24 Months)|Did not meet criteria|0
2931642|NCT01461928|10094265|P1|Maintenance I (24 Months)|Did not meet criteria|5
2931643|NCT01461928|10094263|P3|Maintenance I (24 Months)|Not compliant|0
2931644|NCT01461928|10094264|P2|Maintenance I (24 Months)|Not compliant|0
2931645|NCT01461928|10094265|P1|Maintenance I (24 Months)|Not compliant|1
2931646|NCT01461928|10094263|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
2931647|NCT01461928|10094264|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
2931648|NCT01461928|10094265|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
2931649|NCT01461928|10094263|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2931650|NCT01461928|10094264|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2931651|NCT01461928|10094265|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
2931652|NCT01461928|10094263|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
2931653|NCT01461928|10094264|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
2931654|NCT01461928|10094265|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
2931655|NCT01461928|10094263|P3|Maintenance I (24 Months)|Physician Decision|0
2931656|NCT01461928|10094264|P2|Maintenance I (24 Months)|Physician Decision|0
2931657|NCT01461928|10094265|P1|Maintenance I (24 Months)|Physician Decision|9
2931658|NCT01461928|10094263|P3|Maintenance I (24 Months)|Adverse Event|0
2931659|NCT01461928|10094264|P2|Maintenance I (24 Months)|Adverse Event|0
2931660|NCT01461928|10094265|P1|Maintenance I (24 Months)|Adverse Event|70
2931661|NCT01461928|10094263|P3|Maintenance I (24 Months)|Diseases progression|0
2931662|NCT01461928|10094264|P2|Maintenance I (24 Months)|Diseases progression|0
2931663|NCT01461928|10094265|P1|Maintenance I (24 Months)|Diseases progression|91
2931664|NCT01461928|10094263|P3|Maintenance I (24 Months)|Lost to Follow-up|0
2931665|NCT01461928|10094264|P2|Maintenance I (24 Months)|Lost to Follow-up|0
2931666|NCT01461928|10094265|P1|Maintenance I (24 Months)|Lost to Follow-up|2
2931667|NCT01461928|10094263|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
2931668|NCT01461928|10094264|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
2931669|NCT01461928|10094265|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
2931670|NCT01461928|10094263|P3|Maintenance I (24 Months)|Death|0
2931671|NCT01461928|10094264|P2|Maintenance I (24 Months)|Death|0
2931672|NCT01461928|10094265|P1|Maintenance I (24 Months)|Death|3
2931673|NCT01461928|10094263|P3|Induction (up to 8 Months)|Medical advisor request|0
2931674|NCT01461928|10094264|P2|Induction (up to 8 Months)|Medical advisor request|0
2931675|NCT01461928|10094265|P1|Induction (up to 8 Months)|Medical advisor request|1
2931676|NCT01461928|10094263|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2931677|NCT01461928|10094264|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2931678|NCT01461928|10094265|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
2931679|NCT01461928|10094263|P3|Induction (up to 8 Months)|Promotor request|0
2931680|NCT01461928|10094264|P2|Induction (up to 8 Months)|Promotor request|0
2931681|NCT01461928|10094265|P1|Induction (up to 8 Months)|Promotor request|1
2931682|NCT01461928|10094263|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2931683|NCT01461928|10094264|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2931684|NCT01461928|10094265|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
2931685|NCT01461928|10094263|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2931686|NCT01461928|10094264|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2931687|NCT01461928|10094265|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
2931688|NCT01461928|10094263|P3|Induction (up to 8 Months)|Protocol deviation|0
2931689|NCT01461928|10094264|P2|Induction (up to 8 Months)|Protocol deviation|0
2931690|NCT01461928|10094265|P1|Induction (up to 8 Months)|Protocol deviation|2
2931691|NCT01461928|10094263|P3|Induction (up to 8 Months)|Sponsor decision|0
2931692|NCT01461928|10094264|P2|Induction (up to 8 Months)|Sponsor decision|0
2931693|NCT01461928|10094265|P1|Induction (up to 8 Months)|Sponsor decision|1
2931694|NCT01461928|10094263|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2931695|NCT01461928|10094264|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2931696|NCT01461928|10094265|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
2931697|NCT01461928|10094263|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
2931698|NCT01461928|10094264|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
2931699|NCT01461928|10094265|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
2931700|NCT01461928|10094263|P3|Induction (up to 8 Months)|Not responding to treatment|0
2931701|NCT01461928|10094264|P2|Induction (up to 8 Months)|Not responding to treatment|0
2931702|NCT01461928|10094265|P1|Induction (up to 8 Months)|Not responding to treatment|11
2931703|NCT01461928|10094263|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2931704|NCT01461928|10094264|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2931705|NCT01461928|10094265|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
2931706|NCT01461928|10094263|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
2931707|NCT01461928|10094264|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
2931708|NCT01461928|10094265|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
2931709|NCT01461928|10094263|P3|Induction (up to 8 Months)|Disease progression|0
2931710|NCT01461928|10094264|P2|Induction (up to 8 Months)|Disease progression|0
2931711|NCT01461928|10094265|P1|Induction (up to 8 Months)|Disease progression|45
2931712|NCT01461928|10094263|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
2931713|NCT01461928|10094264|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
2931714|NCT01461928|10094265|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
2931715|NCT01461928|10094263|P3|Induction (up to 8 Months)|Physician Decision|0
2931716|NCT01461928|10094264|P2|Induction (up to 8 Months)|Physician Decision|0
2931717|NCT01461928|10094265|P1|Induction (up to 8 Months)|Physician Decision|9
2931718|NCT01461928|10094263|P3|Induction (up to 8 Months)|Lost to Follow-up|0
2931719|NCT01461928|10094264|P2|Induction (up to 8 Months)|Lost to Follow-up|0
2931720|NCT01461928|10094265|P1|Induction (up to 8 Months)|Lost to Follow-up|5
2931721|NCT01461928|10094263|P3|Induction (up to 8 Months)|Death|0
2931722|NCT01461928|10094264|P2|Induction (up to 8 Months)|Death|0
2931723|NCT01461928|10094265|P1|Induction (up to 8 Months)|Death|3
2931724|NCT01461928|10094263|P3|Induction (up to 8 Months)|Adverse Event|0
2931725|NCT01461928|10094264|P2|Induction (up to 8 Months)|Adverse Event|0
2931726|NCT01461928|10094265|P1|Induction (up to 8 Months)|Adverse Event|76
2931727|NCT01461811|10094316|P2|Overall Study|Noncompliance|1
2931728|NCT01461811|10094317|P1|Overall Study|Noncompliance|1
2931729|NCT01461811|10094316|P2|Overall Study|Subject decision unrelated to an AE|1
2931730|NCT01461811|10094317|P1|Overall Study|Subject decision unrelated to an AE|1
2931731|NCT01461811|10094316|P2|Overall Study|Adverse Event|1
2931732|NCT01461811|10094317|P1|Overall Study|Adverse Event|2
2931733|NCT01461707|10094356|P2|Overall Study|Withdrawal by Subject|0
2931734|NCT01461707|10094357|P1|Overall Study|Withdrawal by Subject|1
2931735|NCT01461551|10094394|P3|Overall Study|Physician Decision|2
2931736|NCT01461551|10094395|P2|Overall Study|Physician Decision|1
2931737|NCT01461551|10094396|P1|Overall Study|Physician Decision|2
2931738|NCT01461538|10094407|P3|Overall Study|Withdrawal by Subject|0
2931739|NCT01461538|10094408|P2|Overall Study|Withdrawal by Subject|1
2931740|NCT01461538|10094409|P1|Overall Study|Withdrawal by Subject|1
2931741|NCT01461538|10094407|P3|Overall Study|Study Stopped by Sponsor|0
2931742|NCT01461538|10094408|P2|Overall Study|Study Stopped by Sponsor|1
2931743|NCT01461538|10094409|P1|Overall Study|Study Stopped by Sponsor|2
2931744|NCT01461538|10094407|P3|Overall Study|Death|2
2931745|NCT01461538|10094408|P2|Overall Study|Death|6
2931747|NCT01461369|10094478|P3|Overall Study|Withdrawal by Subject|2
2931748|NCT01461369|10094479|P2|Overall Study|Withdrawal by Subject|3
2931749|NCT01461369|10094480|P1|Overall Study|Withdrawal by Subject|1
2931750|NCT01461369|10094478|P3|Overall Study|Protocol Violation|2
2931751|NCT01461369|10094479|P2|Overall Study|Protocol Violation|2
2931752|NCT01461369|10094480|P1|Overall Study|Protocol Violation|1
2931753|NCT01461369|10094478|P3|Overall Study|Adverse Event|4
2931754|NCT01461369|10094479|P2|Overall Study|Adverse Event|12
2931755|NCT01461369|10094480|P1|Overall Study|Adverse Event|9
2931756|NCT01461369|10094478|P3|Overall Study|Lost to Follow-up|3
2931757|NCT01461369|10094479|P2|Overall Study|Lost to Follow-up|0
2931758|NCT01461369|10094480|P1|Overall Study|Lost to Follow-up|0
2931759|NCT01461369|10094478|P3|Overall Study|Lack of Efficacy|6
2931760|NCT01461369|10094479|P2|Overall Study|Lack of Efficacy|0
2931761|NCT01461369|10094480|P1|Overall Study|Lack of Efficacy|2
2931762|NCT01461096|10094505|P2|Overall Study|Lost to Follow-up|4
2931763|NCT01461096|10094506|P1|Overall Study|Lost to Follow-up|8
2931764|NCT01461096|10094505|P2|Overall Study|Subj not willing to adhere to reqs|4
2931765|NCT01461096|10094506|P1|Overall Study|Subj not willing to adhere to reqs|3
2931766|NCT01461096|10094505|P2|Overall Study|Withdrawal by Subject|3
2931767|NCT01461096|10094506|P1|Overall Study|Withdrawal by Subject|5
2931768|NCT01461096|10094505|P2|Overall Study|Site is closing|30
2931769|NCT01461096|10094506|P1|Overall Study|Site is closing|27
2931770|NCT01461096|10094505|P2|Overall Study|Subj not able to get to clinic|13
2931771|NCT01461096|10094506|P1|Overall Study|Subj not able to get to clinic|15
2931772|NCT01461096|10094505|P2|Overall Study|Severe debilitation, unable to continue|1
2931773|NCT01461096|10094506|P1|Overall Study|Severe debilitation, unable to continue|1
2931774|NCT01461096|10094505|P2|Overall Study|Death|6
2931775|NCT01461096|10094506|P1|Overall Study|Death|3
2931776|NCT01461057|10094522|P2|Overall Study|Study Terminated by Sponsor|0
2931777|NCT01461057|10094523|P1|Overall Study|Study Terminated by Sponsor|2
2931778|NCT01461057|10094522|P2|Overall Study|Progression of Disease|0
2931779|NCT01461057|10094523|P1|Overall Study|Progression of Disease|1
2931780|NCT01461057|10094522|P2|Overall Study|Adverse Event|1
2931781|NCT01461057|10094523|P1|Overall Study|Adverse Event|0
2931782|NCT01461057|10094522|P2|Overall Study|Physician Decision|2
2931783|NCT01461057|10094523|P1|Overall Study|Physician Decision|0
2931784|NCT01461057|10094522|P2|Overall Study|Withdrawal by Subject|3
2931785|NCT01461057|10094523|P1|Overall Study|Withdrawal by Subject|2
2931786|NCT01461057|10094522|P2|Overall Study|Death|9
2931787|NCT01461057|10094523|P1|Overall Study|Death|10
2931788|NCT01461044|10094533|P2|Overall Study|Lost to Follow-up|5
2931789|NCT01461044|10094534|P1|Overall Study|Lost to Follow-up|12
2931790|NCT01461044|10094533|P2|Overall Study|Death|35
2931791|NCT01461044|10094534|P1|Overall Study|Death|58
2931792|NCT01461005|10094607|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
2931793|NCT01460901|10094630|P1|Overall Study|Withdrawal by Subject|2
2931794|NCT01460719|10094662|P1|Overall Study|Withdrawal by Subject|1
2931795|NCT01460719|10094662|P1|Overall Study|Adverse Event|1
2931796|NCT01460628|10094672|P1|Overall Study|Withdrawal by Subject|2
2931797|NCT01460628|10094672|P1|Overall Study|Adverse Event|3
2931798|NCT01460446|10094684|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
2931799|NCT01460446|10094685|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
2931800|NCT01460446|10094684|P2|Overall Study|Pregnancy|0
2931801|NCT01460446|10094685|P1|Overall Study|Pregnancy|1
2931802|NCT01460446|10094684|P2|Overall Study|Surgery/Illness|1
2931803|NCT01460446|10094685|P1|Overall Study|Surgery/Illness|1
2931804|NCT01460446|10094684|P2|Overall Study|Non-compliance & Consent Withdrawn|3
2931805|NCT01460446|10094685|P1|Overall Study|Non-compliance & Consent Withdrawn|1
2931806|NCT01460446|10094684|P2|Overall Study|Consent Withdrawn|4
2931807|NCT01460446|10094685|P1|Overall Study|Consent Withdrawn|0
2931808|NCT01460446|10094684|P2|Overall Study|Non-compliance|9
2931809|NCT01460446|10094685|P1|Overall Study|Non-compliance|2
2931810|NCT01460407|10094712|P2|Period 2: Day 6 to Day 14|Adverse Event|1
2931811|NCT01460407|10094713|P1|Period 2: Day 6 to Day 14|Adverse Event|0
2931812|NCT01460381|10094726|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
2931813|NCT01460381|10094727|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
2931814|NCT01460368|10094743|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2931815|NCT01460368|10094744|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2931816|NCT01460368|10094745|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2931817|NCT01460368|10094746|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2931818|NCT01460368|10094747|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2931819|NCT01460368|10094748|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2931820|NCT01460368|10094749|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2931821|NCT01460368|10094743|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931822|NCT01460368|10094744|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931823|NCT01460368|10094745|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931824|NCT01460368|10094746|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931825|NCT01460368|10094747|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
2931826|NCT01460368|10094748|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931827|NCT01460368|10094749|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
2931828|NCT01460368|10094743|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931829|NCT01460368|10094744|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931830|NCT01460368|10094745|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931831|NCT01460368|10094746|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931832|NCT01460368|10094747|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931833|NCT01460368|10094748|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
2931834|NCT01460368|10094749|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2931835|NCT01460368|10094743|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2931836|NCT01460368|10094744|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2931837|NCT01460368|10094745|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2931838|NCT01460368|10094746|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2931839|NCT01460368|10094747|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2931840|NCT01460368|10094748|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2931841|NCT01460368|10094749|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2931842|NCT01460368|10094743|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931843|NCT01460368|10094744|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931844|NCT01460368|10094745|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
2931845|NCT01460368|10094746|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931846|NCT01460368|10094747|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931847|NCT01460368|10094748|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931848|NCT01460368|10094749|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2931849|NCT01460342|10094761|P2|Overall Study|Lack of Efficacy|0
2931850|NCT01460342|10094762|P1|Overall Study|Lack of Efficacy|1
2931851|NCT01460342|10094761|P2|Overall Study|Physician Decision|3
2931852|NCT01460342|10094762|P1|Overall Study|Physician Decision|1
2931853|NCT01460342|10094761|P2|Overall Study|Withdrawal by Subject|4
2931854|NCT01460342|10094762|P1|Overall Study|Withdrawal by Subject|3
2931855|NCT01460342|10094761|P2|Overall Study|Protocol Violation|1
2931856|NCT01460342|10094762|P1|Overall Study|Protocol Violation|0
2931857|NCT01460342|10094761|P2|Overall Study|Lost to Follow-up|2
2931858|NCT01460342|10094762|P1|Overall Study|Lost to Follow-up|1
2931859|NCT01460342|10094761|P2|Overall Study|Adverse Event|4
2931860|NCT01460342|10094762|P1|Overall Study|Adverse Event|5
2931861|NCT01460290|10094793|P1|Overall Study|Elevated liver function|1
2931862|NCT01460290|10094793|P1|Overall Study|Adverse Event|3
2931863|NCT01460160|10094820|P2|Follow-up|Lost to Follow-up|0
2931864|NCT01460160|10094821|P1|Follow-up|Lost to Follow-up|1
2931865|NCT01460160|10094820|P2|Follow-up|Death|2
2931866|NCT01460160|10094821|P1|Follow-up|Death|7
2931867|NCT01460160|10094820|P2|Follow-up|Withdrawal by Subject|0
2931868|NCT01460160|10094821|P1|Follow-up|Withdrawal by Subject|3
2931869|NCT01460160|10094820|P2|Treatment|Subject refused to continue Chemo|0
2931870|NCT01460160|10094821|P1|Treatment|Subject refused to continue Chemo|1
2931871|NCT01460160|10094820|P2|Treatment|Family did not wish to restart after SCT|0
2931872|NCT01460160|10094821|P1|Treatment|Family did not wish to restart after SCT|1
2931873|NCT01460160|10094820|P2|Treatment|PI decision to pursue other options|1
2931874|NCT01460160|10094821|P1|Treatment|PI decision to pursue other options|1
2931875|NCT01460160|10094820|P2|Treatment|PI not to follow protocol therapy|0
2931876|NCT01460160|10094821|P1|Treatment|PI not to follow protocol therapy|1
2931877|NCT01460160|10094820|P2|Treatment|PI decision to not re-initiate after SCT|2
2931878|NCT01460160|10094821|P1|Treatment|PI decision to not re-initiate after SCT|2
2931879|NCT01460160|10094820|P2|Treatment|Death|2
2931880|NCT01460160|10094821|P1|Treatment|Death|0
2931881|NCT01460160|10094820|P2|Treatment|Withdrawal by Subject|0
2931882|NCT01460160|10094821|P1|Treatment|Withdrawal by Subject|4
2931883|NCT01460160|10094820|P2|Treatment|Adverse Event|0
2931884|NCT01460160|10094821|P1|Treatment|Adverse Event|8
2931885|NCT01460160|10094820|P2|Treatment|Study Drug Toxicity|0
2931886|NCT01460160|10094821|P1|Treatment|Study Drug Toxicity|2
2931887|NCT01460160|10094820|P2|Treatment|Lack of Efficacy|0
2931888|NCT01460160|10094821|P1|Treatment|Lack of Efficacy|3
2931889|NCT01459913|10094862|P4|Overall Study|Did Not Meet Inclusion Criteria|1
2931890|NCT01459913|10094863|P3|Overall Study|Did Not Meet Inclusion Criteria|0
2931891|NCT01459913|10094864|P2|Overall Study|Did Not Meet Inclusion Criteria|0
2931892|NCT01459913|10094865|P1|Overall Study|Did Not Meet Inclusion Criteria|0
2931893|NCT01459913|10094862|P4|Overall Study|Other|1
2931894|NCT01459913|10094863|P3|Overall Study|Other|3
2931895|NCT01459913|10094864|P2|Overall Study|Other|0
2931896|NCT01459913|10094865|P1|Overall Study|Other|0
2931897|NCT01459913|10094862|P4|Overall Study|Study Terminated by Sponsor|11
2931898|NCT01459913|10094863|P3|Overall Study|Study Terminated by Sponsor|9
2931899|NCT01459913|10094864|P2|Overall Study|Study Terminated by Sponsor|15
2931900|NCT01459913|10094865|P1|Overall Study|Study Terminated by Sponsor|30
2931901|NCT01459913|10094862|P4|Overall Study|Physician Decision|0
2931902|NCT01459913|10094863|P3|Overall Study|Physician Decision|0
2931903|NCT01459913|10094864|P2|Overall Study|Physician Decision|1
2931904|NCT01459913|10094865|P1|Overall Study|Physician Decision|0
2931905|NCT01459913|10094862|P4|Overall Study|Non- Compliance|3
2931906|NCT01459913|10094863|P3|Overall Study|Non- Compliance|0
2931907|NCT01459913|10094864|P2|Overall Study|Non- Compliance|0
2931908|NCT01459913|10094865|P1|Overall Study|Non- Compliance|0
2931909|NCT01459913|10094862|P4|Overall Study|Death|1
2931910|NCT01459913|10094863|P3|Overall Study|Death|0
2931911|NCT01459913|10094864|P2|Overall Study|Death|0
2931912|NCT01459913|10094865|P1|Overall Study|Death|0
2931913|NCT01459913|10094862|P4|Overall Study|Lost to Follow-up|8
2931914|NCT01459913|10094863|P3|Overall Study|Lost to Follow-up|1
2931915|NCT01459913|10094864|P2|Overall Study|Lost to Follow-up|4
2931916|NCT01459913|10094865|P1|Overall Study|Lost to Follow-up|7
2931917|NCT01459913|10094862|P4|Overall Study|Withdrawal by Subject|5
2931918|NCT01459913|10094863|P3|Overall Study|Withdrawal by Subject|0
2931919|NCT01459913|10094864|P2|Overall Study|Withdrawal by Subject|0
2931920|NCT01459913|10094865|P1|Overall Study|Withdrawal by Subject|4
2931921|NCT01459913|10094862|P4|Overall Study|Adverse Event|3
2931922|NCT01459913|10094863|P3|Overall Study|Adverse Event|0
2931923|NCT01459913|10094864|P2|Overall Study|Adverse Event|0
2931924|NCT01459913|10094865|P1|Overall Study|Adverse Event|0
2931925|NCT01459796|10094896|P2|Overall Study|Decision by the sponsor|108
2931926|NCT01459796|10094897|P1|Overall Study|Decision by the sponsor|75
2931927|NCT01459796|10094896|P2|Overall Study|Reason unspecified|2
2931928|NCT01459796|10094897|P1|Overall Study|Reason unspecified|1
2931929|NCT01459796|10094896|P2|Overall Study|Lost to Follow-up|4
2931930|NCT01459796|10094897|P1|Overall Study|Lost to Follow-up|5
2931931|NCT01459796|10094896|P2|Overall Study|Withdrawal by Subject|3
2931932|NCT01459796|10094897|P1|Overall Study|Withdrawal by Subject|6
2931933|NCT01459796|10094896|P2|Overall Study|Adverse Event|5
2931934|NCT01459796|10094897|P1|Overall Study|Adverse Event|5
2931935|NCT01459796|10094896|P2|Overall Study|Non compliance with protocol|4
2931936|NCT01459796|10094897|P1|Overall Study|Non compliance with protocol|2
2931937|NCT01459783|10094915|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
2931938|NCT01459783|10094916|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
2931939|NCT01459783|10094915|P2|6 Months to 12 Months|Lost to Follow-up|7
2931940|NCT01459783|10094916|P1|6 Months to 12 Months|Lost to Follow-up|2
2931941|NCT01459783|10094915|P2|6 Months to 12 Months|Withdrawal by Subject|5
2931942|NCT01459783|10094916|P1|6 Months to 12 Months|Withdrawal by Subject|6
2931943|NCT01459783|10094915|P2|6 Months to 12 Months|Death|1
2931944|NCT01459783|10094916|P1|6 Months to 12 Months|Death|0
2931945|NCT01459783|10094915|P2|Baseline to 6 Months|Lost to Follow-up|14
2931946|NCT01459783|10094916|P1|Baseline to 6 Months|Lost to Follow-up|19
2931947|NCT01459783|10094915|P2|Baseline to 6 Months|Withdrawal by Subject|6
2931948|NCT01459783|10094916|P1|Baseline to 6 Months|Withdrawal by Subject|12
2931949|NCT01459783|10094915|P2|Baseline to 6 Months|Death|0
2931950|NCT01459783|10094916|P1|Baseline to 6 Months|Death|1
2931951|NCT01459718|10094924|P1|Overall Study|Adverse Event|1
2931952|NCT01459718|10094924|P1|Overall Study|Lost to Follow-up|1
2931953|NCT01459718|10094924|P1|Overall Study|Physician Decision|1
2931954|NCT01459614|10095106|P2|Overall Study|Adverse Event|0
2931955|NCT01459614|10095107|P1|Overall Study|Adverse Event|1
2931956|NCT01459068|10095154|P2|Overall Study|Death|1
2931957|NCT01459068|10095155|P1|Overall Study|Death|0
2931958|NCT01459068|10095154|P2|Overall Study|Lost to Follow-up|15
2931959|NCT01459068|10095155|P1|Overall Study|Lost to Follow-up|31
2931960|NCT01459068|10095154|P2|Overall Study|Withdrawal by Subject|18
2931961|NCT01459068|10095155|P1|Overall Study|Withdrawal by Subject|8
2931962|NCT01459016|10095171|P1|Overall Study|Amendment Discontinuation Criteria|4
2931963|NCT01459016|10095171|P1|Overall Study|Withdrawal by Subject|11
2931964|NCT01458951|10095199|P3|Overall Study|Insufficient Clinical Response|11
2931965|NCT01458951|10095200|P2|Overall Study|Insufficient Clinical Response|0
2931966|NCT01458951|10095201|P1|Overall Study|Insufficient Clinical Response|17
2931967|NCT01458951|10095199|P3|Overall Study|Adverse Event|2
2931968|NCT01458951|10095200|P2|Overall Study|Adverse Event|0
2931969|NCT01458951|10095201|P1|Overall Study|Adverse Event|7
2931970|NCT01458951|10095199|P3|Overall Study|Withdrawal by Subject|2
2931971|NCT01458951|10095200|P2|Overall Study|Withdrawal by Subject|0
2931972|NCT01458951|10095201|P1|Overall Study|Withdrawal by Subject|2
2931973|NCT01458951|10095199|P3|Overall Study|Protocol Violation|0
2931974|NCT01458951|10095200|P2|Overall Study|Protocol Violation|1
2931975|NCT01458951|10095201|P1|Overall Study|Protocol Violation|5
2931976|NCT01458951|10095199|P3|Overall Study|Other|0
2931977|NCT01458951|10095200|P2|Overall Study|Other|0
2931978|NCT01458951|10095201|P1|Overall Study|Other|1
2931979|NCT01458639|10095226|P1|Overall Study|Inability to obtain subject blood sample|1
2931980|NCT01458639|10095226|P1|Overall Study|Equipment issue|1
2931981|NCT01458639|10095226|P1|Overall Study|Physician Decision|4
2931982|NCT01458587|10095238|P2|Overall Study|Withdrawal by Subject|0
2931983|NCT01458587|10095239|P1|Overall Study|Withdrawal by Subject|1
2931984|NCT01458574|10095402|P3|Overall Study|Randomized but not treated|0
2931985|NCT01458574|10095403|P2|Overall Study|Randomized but not treated|1
2931986|NCT01458574|10095404|P1|Overall Study|Randomized but not treated|0
2931987|NCT01458574|10095402|P3|Overall Study|Other|0
2931988|NCT01458574|10095403|P2|Overall Study|Other|1
2931989|NCT01458574|10095404|P1|Overall Study|Other|2
2931990|NCT01458574|10095402|P3|Overall Study|Withdrawal by Subject|5
2931991|NCT01458574|10095403|P2|Overall Study|Withdrawal by Subject|3
2931992|NCT01458574|10095404|P1|Overall Study|Withdrawal by Subject|6
2931993|NCT01458574|10095402|P3|Overall Study|Protocol Violation|0
2931994|NCT01458574|10095403|P2|Overall Study|Protocol Violation|1
2931995|NCT01458574|10095404|P1|Overall Study|Protocol Violation|0
2931996|NCT01458574|10095402|P3|Overall Study|Pregnancy|0
2931997|NCT01458574|10095403|P2|Overall Study|Pregnancy|1
2931998|NCT01458574|10095404|P1|Overall Study|Pregnancy|1
2931999|NCT01458574|10095402|P3|Overall Study|Lost to Follow-up|1
2932000|NCT01458574|10095403|P2|Overall Study|Lost to Follow-up|2
2932001|NCT01458574|10095404|P1|Overall Study|Lost to Follow-up|3
2932002|NCT01458574|10095402|P3|Overall Study|Lack of Efficacy|132
2932003|NCT01458574|10095403|P2|Overall Study|Lack of Efficacy|53
2932004|NCT01458574|10095404|P1|Overall Study|Lack of Efficacy|70
2932005|NCT01458574|10095402|P3|Overall Study|Adverse Event|7
2932006|NCT01458574|10095403|P2|Overall Study|Adverse Event|9
2932007|NCT01458574|10095404|P1|Overall Study|Adverse Event|5
2932008|NCT01458535|10095534|P6|Overall Study|Adverse Event|0
2932009|NCT01458535|10095535|P5|Overall Study|Adverse Event|0
2932010|NCT01458535|10095536|P4|Overall Study|Adverse Event|1
2932011|NCT01458535|10095537|P3|Overall Study|Adverse Event|0
2932012|NCT01458535|10095538|P2|Overall Study|Adverse Event|0
2932013|NCT01458535|10095539|P1|Overall Study|Adverse Event|0
2932014|NCT01458535|10095534|P6|Overall Study|Lost to Follow-up|2
2932015|NCT01458535|10095535|P5|Overall Study|Lost to Follow-up|2
2932016|NCT01458535|10095536|P4|Overall Study|Lost to Follow-up|3
2932017|NCT01458535|10095537|P3|Overall Study|Lost to Follow-up|0
2932018|NCT01458535|10095538|P2|Overall Study|Lost to Follow-up|2
2932019|NCT01458535|10095539|P1|Overall Study|Lost to Follow-up|0
2932020|NCT01458535|10095534|P6|Overall Study|Withdrawal by Subject|1
2932021|NCT01458535|10095535|P5|Overall Study|Withdrawal by Subject|1
2932022|NCT01458535|10095536|P4|Overall Study|Withdrawal by Subject|0
2932023|NCT01458535|10095537|P3|Overall Study|Withdrawal by Subject|2
2932024|NCT01458535|10095538|P2|Overall Study|Withdrawal by Subject|0
2932025|NCT01458535|10095539|P1|Overall Study|Withdrawal by Subject|0
2932026|NCT01458535|10095534|P6|Overall Study|Other|1
2932027|NCT01458535|10095535|P5|Overall Study|Other|1
2932028|NCT01458535|10095536|P4|Overall Study|Other|0
2932029|NCT01458535|10095537|P3|Overall Study|Other|0
2932030|NCT01458535|10095538|P2|Overall Study|Other|0
2932031|NCT01458535|10095539|P1|Overall Study|Other|0
2932032|NCT01458522|10095591|P2|Overall Study|Physician Decision|9
2932033|NCT01458522|10095592|P1|Overall Study|Physician Decision|1
2932034|NCT01458522|10095591|P2|Overall Study|Withdrawal by Subject|2
2932035|NCT01458522|10095592|P1|Overall Study|Withdrawal by Subject|2
2932036|NCT01458392|10095621|P3|Overall Study|Patient unwilling to comply with protoco|2
2932037|NCT01458392|10095622|P2|Overall Study|Patient unwilling to comply with protoco|0
2932038|NCT01458392|10095623|P1|Overall Study|Patient unwilling to comply with protoco|0
2932039|NCT01458392|10095621|P3|Overall Study|At the discretion of the sponsor|7
2932040|NCT01458392|10095622|P2|Overall Study|At the discretion of the sponsor|2
2932041|NCT01458392|10095623|P1|Overall Study|At the discretion of the sponsor|0
2932042|NCT01458392|10095621|P3|Overall Study|Death|22
2932043|NCT01458392|10095622|P2|Overall Study|Death|11
2932044|NCT01458392|10095623|P1|Overall Study|Death|2
2932045|NCT01458366|10095648|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
2932046|NCT01458366|10095649|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2932047|NCT01458366|10095650|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2932048|NCT01458366|10095651|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2932049|NCT01458366|10095652|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2932050|NCT01458366|10095648|P5|Period 1: 70mg/m^2|Physician Decision|0
2932051|NCT01458366|10095649|P4|Period 1: 70mg/m^2|Physician Decision|0
2932052|NCT01458366|10095650|P3|Period 1: 70mg/m^2|Physician Decision|0
2932053|NCT01458366|10095651|P2|Period 1: 70mg/m^2|Physician Decision|0
2932054|NCT01458366|10095652|P1|Period 1: 70mg/m^2|Physician Decision|2
2932055|NCT01458275|10095679|P3|Overall Study|Withdrawal by Subject|1
2932056|NCT01458275|10095680|P2|Overall Study|Withdrawal by Subject|2
2932057|NCT01458275|10095681|P1|Overall Study|Withdrawal by Subject|3
2932058|NCT01458275|10095679|P3|Overall Study|Protocol Violation|2
2932059|NCT01458275|10095680|P2|Overall Study|Protocol Violation|5
2932060|NCT01458275|10095681|P1|Overall Study|Protocol Violation|5
2932061|NCT01458275|10095679|P3|Overall Study|Lost to Follow-up|5
2932062|NCT01458275|10095680|P2|Overall Study|Lost to Follow-up|2
2932063|NCT01458275|10095681|P1|Overall Study|Lost to Follow-up|3
2932064|NCT01458275|10095679|P3|Overall Study|Adverse Event|1
2932065|NCT01458275|10095680|P2|Overall Study|Adverse Event|4
2932066|NCT01458275|10095681|P1|Overall Study|Adverse Event|3
2932067|NCT01458249|10095723|P1|Overall Study|Ongoing|1
2932068|NCT01458249|10095723|P1|Overall Study|Other|2
2932069|NCT01458249|10095723|P1|Overall Study|Adverse Event|4
2932070|NCT01458249|10095723|P1|Overall Study|Not treated|1
2932071|NCT01458210|10095742|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
2932072|NCT01458210|10095742|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
2932073|NCT01458210|10095742|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
2932074|NCT01458210|10095742|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
2932075|NCT01458171|10095759|P1|Overall Study|Adverse Event|1
2932076|NCT01458132|10095782|P2|Overall Study|Other|3
2932077|NCT01458132|10095783|P1|Overall Study|Other|15
2932078|NCT01458119|10095791|P1|Overall Study|Non-compliance With Study Drug|3
2932079|NCT01458119|10095791|P1|Overall Study|Consent Withdrawn by Participant|8
2932080|NCT01458119|10095791|P1|Overall Study|Adverse Event|1
2932081|NCT01458119|10095791|P1|Overall Study|Death|2
2932082|NCT01458119|10095791|P1|Overall Study|Pregnancy|1
2932083|NCT01458119|10095791|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
2932084|NCT01458119|10095791|P1|Overall Study|Physician Decision|4
2932085|NCT01458106|10095798|P2|Overall Study|Withdrawn Per Protocol|1
2932086|NCT01458106|10095799|P1|Overall Study|Withdrawn Per Protocol|0
2932087|NCT01458106|10095798|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
2932088|NCT01458106|10095799|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
2932089|NCT01458106|10095798|P2|Overall Study|Withdrawal by Subject|0
2932090|NCT01458106|10095799|P1|Overall Study|Withdrawal by Subject|2
2932091|NCT01457950|10095876|P4|Open-Label Phase|Withdrawal by Subject|0
2932092|NCT01457950|10095877|P3|Open-Label Phase|Withdrawal by Subject|2
2932093|NCT01457950|10095878|P2|Open-Label Phase|Withdrawal by Subject|0
2932094|NCT01457950|10095879|P1|Open-Label Phase|Withdrawal by Subject|0
2932095|NCT01457950|10095876|P4|Open-Label Phase|Protocol Violation|1
2932096|NCT01457950|10095877|P3|Open-Label Phase|Protocol Violation|0
2932097|NCT01457950|10095878|P2|Open-Label Phase|Protocol Violation|0
2932098|NCT01457950|10095879|P1|Open-Label Phase|Protocol Violation|0
2932099|NCT01457950|10095876|P4|Open-Label Phase|Adverse Event|1
2932100|NCT01457950|10095877|P3|Open-Label Phase|Adverse Event|0
2932101|NCT01457950|10095878|P2|Open-Label Phase|Adverse Event|0
2932102|NCT01457950|10095879|P1|Open-Label Phase|Adverse Event|0
2932103|NCT01457950|10095876|P4|Double-Blind Phase|Withdrawal by Subject|0
2932104|NCT01457950|10095877|P3|Double-Blind Phase|Withdrawal by Subject|0
2932105|NCT01457950|10095878|P2|Double-Blind Phase|Withdrawal by Subject|2
2932106|NCT01457950|10095879|P1|Double-Blind Phase|Withdrawal by Subject|6
2932107|NCT01457950|10095876|P4|Double-Blind Phase|Protocol Violation|0
2932108|NCT01457950|10095877|P3|Double-Blind Phase|Protocol Violation|0
2932109|NCT01457950|10095878|P2|Double-Blind Phase|Protocol Violation|1
2932110|NCT01457950|10095879|P1|Double-Blind Phase|Protocol Violation|2
2932111|NCT01457950|10095876|P4|Double-Blind Phase|Continuation Criteria Not Met|0
2932112|NCT01457950|10095877|P3|Double-Blind Phase|Continuation Criteria Not Met|0
2932113|NCT01457950|10095878|P2|Double-Blind Phase|Continuation Criteria Not Met|0
2932114|NCT01457950|10095879|P1|Double-Blind Phase|Continuation Criteria Not Met|1
2932115|NCT01457924|10095958|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2932116|NCT01457924|10095959|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
2932117|NCT01457924|10095960|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2932118|NCT01457924|10095961|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
2932119|NCT01457924|10095962|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2932120|NCT01457924|10095958|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
2932121|NCT01457924|10095959|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2932122|NCT01457924|10095960|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
2932123|NCT01457924|10095961|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
2932124|NCT01457924|10095962|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2932125|NCT01457924|10095958|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2932126|NCT01457924|10095959|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2932127|NCT01457924|10095960|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2932128|NCT01457924|10095961|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2932129|NCT01457924|10095962|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2932130|NCT01457924|10095958|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
2932131|NCT01457924|10095959|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
2932132|NCT01457924|10095960|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
2932133|NCT01457924|10095961|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
2932134|NCT01457924|10095962|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
2932135|NCT01457924|10095958|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
2932136|NCT01457924|10095959|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
2932137|NCT01457924|10095960|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
2932138|NCT01457924|10095961|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
2932139|NCT01457924|10095962|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
2932140|NCT01457924|10095958|P5|FUP (Weeks 24-48)|Physician Decision|0
2932141|NCT01457924|10095959|P4|FUP (Weeks 24-48)|Physician Decision|0
2932142|NCT01457924|10095960|P3|FUP (Weeks 24-48)|Physician Decision|1
2932143|NCT01457924|10095961|P2|FUP (Weeks 24-48)|Physician Decision|0
2932144|NCT01457924|10095962|P1|FUP (Weeks 24-48)|Physician Decision|1
2932145|NCT01457924|10095958|P5|FUP (Weeks 24-48)|Adverse Event|0
2932146|NCT01457924|10095959|P4|FUP (Weeks 24-48)|Adverse Event|0
2932147|NCT01457924|10095960|P3|FUP (Weeks 24-48)|Adverse Event|1
2932148|NCT01457924|10095961|P2|FUP (Weeks 24-48)|Adverse Event|0
2932149|NCT01457924|10095962|P1|FUP (Weeks 24-48)|Adverse Event|0
2932150|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
2932151|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2932152|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2932153|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2932154|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2932155|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2932156|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2932157|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2932158|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2932159|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2932160|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2932161|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2932162|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2932163|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2932164|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2932165|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2932166|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2932167|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2932168|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2932169|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
2932170|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
2932171|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
2932172|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
2932173|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
2932174|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
2932175|NCT01457924|10095958|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
2932176|NCT01457924|10095959|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
2932177|NCT01457924|10095960|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
2932178|NCT01457924|10095961|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
2932179|NCT01457924|10095962|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
2932180|NCT01457846|10096032|P2|Overall Study|Lost to Follow-up|0
2932181|NCT01457846|10096033|P1|Overall Study|Lost to Follow-up|1
2932182|NCT01457846|10096032|P2|Overall Study|Withdrawal by Subject|1
2932183|NCT01457846|10096033|P1|Overall Study|Withdrawal by Subject|1
2932184|NCT01457846|10096032|P2|Overall Study|Unclassified reason for not completed|10
2932185|NCT01457846|10096033|P1|Overall Study|Unclassified reason for not completed|11
2932186|NCT01457846|10096032|P2|Overall Study|Death|16
2932187|NCT01457846|10096033|P1|Overall Study|Death|27
2932188|NCT01457846|10096032|P2|Overall Study|Did not receive treatment|1
2932189|NCT01457846|10096033|P1|Overall Study|Did not receive treatment|0
2932190|NCT01457846|10096032|P2|Overall Study|Death before treatment|2
2932191|NCT01457846|10096033|P1|Overall Study|Death before treatment|1
2932192|NCT01457703|10096049|P2|Overall Study|Withdrawal by Subject|4
2932193|NCT01457703|10096050|P1|Overall Study|Withdrawal by Subject|1
2932194|NCT01457703|10096049|P2|Overall Study|Screen Failure|7
2932195|NCT01457703|10096050|P1|Overall Study|Screen Failure|5
2932196|NCT01457352|10096161|P2|Period 3|Sponsor's withdrawal|1
2932197|NCT01457352|10096162|P1|Period 3|Sponsor's withdrawal|0
2932198|NCT01457352|10096161|P2|Period 3|incorrect treatment|1
2932199|NCT01457352|10096162|P1|Period 3|incorrect treatment|0
2932200|NCT01457352|10096161|P2|Period 3|Withdrawal by Subject|2
2932201|NCT01457352|10096162|P1|Period 3|Withdrawal by Subject|0
2932202|NCT01457352|10096161|P2|Period 3|Adverse Event|1
2932203|NCT01457352|10096162|P1|Period 3|Adverse Event|1
2932204|NCT01457352|10096161|P2|Period 2|Did not meet eligibility criteria|0
2932205|NCT01457352|10096162|P1|Period 2|Did not meet eligibility criteria|3
2932206|NCT01457352|10096161|P2|Period 2|Physician Decision|0
2932207|NCT01457352|10096162|P1|Period 2|Physician Decision|1
2932208|NCT01457352|10096161|P2|Period 2|dose change|0
2932209|NCT01457352|10096162|P1|Period 2|dose change|1
2932210|NCT01457352|10096161|P2|Period 2|Lost to Follow-up|0
2932211|NCT01457352|10096162|P1|Period 2|Lost to Follow-up|1
2932212|NCT01457352|10096161|P2|Period 2|Sponsor's withdrawal|0
2932213|NCT01457352|10096162|P1|Period 2|Sponsor's withdrawal|7
2932214|NCT01457352|10096161|P2|Period 2|Protocol Violation|0
2932215|NCT01457352|10096162|P1|Period 2|Protocol Violation|4
2932216|NCT01457352|10096161|P2|Period 2|Lack of Efficacy|0
2932217|NCT01457352|10096162|P1|Period 2|Lack of Efficacy|8
2932218|NCT01457352|10096161|P2|Period 2|no analysis|0
2932219|NCT01457352|10096162|P1|Period 2|no analysis|10
2932220|NCT01457352|10096161|P2|Period 2|Adverse Event|0
2932221|NCT01457352|10096162|P1|Period 2|Adverse Event|22
2932222|NCT01457352|10096161|P2|Period 2|Withdrawal by Subject|0
2932223|NCT01457352|10096162|P1|Period 2|Withdrawal by Subject|23
2932224|NCT01457352|10096161|P2|Period 1|Did not meet eligibility criteria|0
2932225|NCT01457352|10096162|P1|Period 1|Did not meet eligibility criteria|3
2932226|NCT01457352|10096161|P2|Period 1|Protocol Violation|0
2932227|NCT01457352|10096162|P1|Period 1|Protocol Violation|4
2932228|NCT01457352|10096161|P2|Period 1|withdrew per sponsor|0
2932229|NCT01457352|10096162|P1|Period 1|withdrew per sponsor|1
2932230|NCT01457352|10096161|P2|Period 1|Withdrawn|0
2932231|NCT01457352|10096162|P1|Period 1|Withdrawn|1
2932232|NCT01457352|10096161|P2|Period 1|MS related disease progression|0
2932233|NCT01457352|10096162|P1|Period 1|MS related disease progression|1
2932234|NCT01457352|10096161|P2|Period 1|Physician Decision|0
2932235|NCT01457352|10096162|P1|Period 1|Physician Decision|2
2932236|NCT01457352|10096161|P2|Period 1|Withdrawal by Subject|0
2932237|NCT01457352|10096162|P1|Period 1|Withdrawal by Subject|2
2932238|NCT01457352|10096161|P2|Period 1|Adverse Event|0
2932239|NCT01457352|10096162|P1|Period 1|Adverse Event|2
2932240|NCT01457339|10096174|P2|Period 6 (250 mg)|Personal appointment|1
2932241|NCT01457339|10096175|P1|Period 6 (250 mg)|Personal appointment|0
2932242|NCT01457339|10096174|P2|Period 6 (250 mg)|Family Emergency|0
2932243|NCT01457339|10096175|P1|Period 6 (250 mg)|Family Emergency|1
2932244|NCT01457339|10096174|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
2932245|NCT01457339|10096175|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
2932246|NCT01457339|10096174|P2|Period 3 (100 mg)|Adverse Event|1
2932247|NCT01457339|10096175|P1|Period 3 (100 mg)|Adverse Event|0
2932248|NCT01457053|10096347|P2|Overall Study|Unable to undergo selected treatment|1
2932249|NCT01457053|10096348|P1|Overall Study|Unable to undergo selected treatment|1
2932250|NCT01457014|10096354|P4|First Night|Withdrawal by Subject|0
2932251|NCT01457014|10096355|P3|First Night|Withdrawal by Subject|0
2932252|NCT01457014|10096356|P2|First Night|Withdrawal by Subject|0
2932253|NCT01457014|10096357|P1|First Night|Withdrawal by Subject|3
2932254|NCT01457014|10096354|P4|First Night|Didn't meet inclusion/exclusion criteria|0
2932255|NCT01457014|10096355|P3|First Night|Didn't meet inclusion/exclusion criteria|0
2932256|NCT01457014|10096356|P2|First Night|Didn't meet inclusion/exclusion criteria|0
2932257|NCT01457014|10096357|P1|First Night|Didn't meet inclusion/exclusion criteria|37
2932258|NCT01456962|10096374|P2|Overall Study|Lost to Follow-up|1
2932259|NCT01456962|10096375|P1|Overall Study|Lost to Follow-up|2
2932260|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
2932261|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
2932262|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
2932263|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
2932264|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
2932265|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
2932266|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
2932267|NCT01456949|10096381|P1|Study Cryoablation Procedure & Follow-up|Death|5
2932268|NCT01456949|10096381|P1|Enrollment|Withdrawal by Subject|7
2932269|NCT01456949|10096381|P1|Enrollment|Physician Decision|10
2932270|NCT01456949|10096381|P1|Enrollment|I/E criteria not met prior to procedure|13
2932271|NCT01456949|10096381|P1|Enrollment|Death|1
2932272|NCT01456949|10096381|P1|Enrollment|PI death- incomplete data|6
2932273|NCT01456936|10096392|P4|Overall Study|Randomized but not treated|21
2932274|NCT01456936|10096393|P3|Overall Study|Randomized but not treated|16
2932275|NCT01456936|10096394|P2|Overall Study|Randomized but not treated|28
2932276|NCT01456936|10096395|P1|Overall Study|Randomized but not treated|21
2932277|NCT01456936|10096392|P4|Overall Study|Death|3
2932278|NCT01456936|10096393|P3|Overall Study|Death|1
2932279|NCT01456936|10096394|P2|Overall Study|Death|3
2932280|NCT01456936|10096395|P1|Overall Study|Death|0
2932281|NCT01456936|10096392|P4|Overall Study|Adverse event (study drug unrelated)|9
2932282|NCT01456936|10096393|P3|Overall Study|Adverse event (study drug unrelated)|9
2932283|NCT01456936|10096394|P2|Overall Study|Adverse event (study drug unrelated)|7
2932284|NCT01456936|10096395|P1|Overall Study|Adverse event (study drug unrelated)|9
2932285|NCT01456936|10096392|P4|Overall Study|Adverse event (study drug)|17
2932286|NCT01456936|10096393|P3|Overall Study|Adverse event (study drug)|26
2932287|NCT01456936|10096394|P2|Overall Study|Adverse event (study drug)|21
2932288|NCT01456936|10096395|P1|Overall Study|Adverse event (study drug)|25
2932289|NCT01456936|10096392|P4|Overall Study|Medication error|1
2932290|NCT01456936|10096393|P3|Overall Study|Medication error|0
2932291|NCT01456936|10096394|P2|Overall Study|Medication error|1
2932292|NCT01456936|10096395|P1|Overall Study|Medication error|0
2932293|NCT01456936|10096392|P4|Overall Study|Lost to Follow-up|127
2932294|NCT01456936|10096393|P3|Overall Study|Lost to Follow-up|144
2932295|NCT01456936|10096394|P2|Overall Study|Lost to Follow-up|126
2932296|NCT01456936|10096395|P1|Overall Study|Lost to Follow-up|135
2932297|NCT01456936|10096392|P4|Overall Study|No longer willing to participate|248
2932298|NCT01456936|10096393|P3|Overall Study|No longer willing to participate|224
2932299|NCT01456936|10096394|P2|Overall Study|No longer willing to participate|218
2932300|NCT01456936|10096395|P1|Overall Study|No longer willing to participate|195
2932301|NCT01456936|10096392|P4|Overall Study|Insufficient clinical response|13
2932302|NCT01456936|10096393|P3|Overall Study|Insufficient clinical response|14
2932303|NCT01456936|10096394|P2|Overall Study|Insufficient clinical response|4
2932304|NCT01456936|10096395|P1|Overall Study|Insufficient clinical response|4
2932305|NCT01456936|10096392|P4|Overall Study|Pregnancy|1
2932306|NCT01456936|10096393|P3|Overall Study|Pregnancy|0
2932307|NCT01456936|10096394|P2|Overall Study|Pregnancy|0
2932308|NCT01456936|10096395|P1|Overall Study|Pregnancy|1
2932309|NCT01456936|10096392|P4|Overall Study|Protocol Violation|5
2932310|NCT01456936|10096393|P3|Overall Study|Protocol Violation|5
2932311|NCT01456936|10096394|P2|Overall Study|Protocol Violation|2
2932312|NCT01456936|10096395|P1|Overall Study|Protocol Violation|4
2932313|NCT01456936|10096392|P4|Overall Study|No longer meets eligibility criteria|5
2932314|NCT01456936|10096393|P3|Overall Study|No longer meets eligibility criteria|6
2932315|NCT01456936|10096394|P2|Overall Study|No longer meets eligibility criteria|8
2932316|NCT01456936|10096395|P1|Overall Study|No longer meets eligibility criteria|4
2932317|NCT01456936|10096392|P4|Overall Study|Other reason|33
2932318|NCT01456936|10096393|P3|Overall Study|Other reason|36
2932319|NCT01456936|10096394|P2|Overall Study|Other reason|30
2932320|NCT01456936|10096395|P1|Overall Study|Other reason|41
2932321|NCT01456897|10096503|P2|Overall Study|Lack of Efficacy|11
2932322|NCT01456897|10096504|P1|Overall Study|Lack of Efficacy|4
2932323|NCT01456897|10096503|P2|Overall Study|Withdrawal by Subject|17
2932324|NCT01456897|10096504|P1|Overall Study|Withdrawal by Subject|44
2932325|NCT01456897|10096503|P2|Overall Study|Physician Decision|3
2932326|NCT01456897|10096504|P1|Overall Study|Physician Decision|5
2932327|NCT01456897|10096503|P2|Overall Study|Protocol Violation|4
2932328|NCT01456897|10096504|P1|Overall Study|Protocol Violation|3
2932329|NCT01456897|10096503|P2|Overall Study|Adverse Event|22
2932330|NCT01456897|10096504|P1|Overall Study|Adverse Event|19
2932331|NCT01456780|10096523|P3|Overall Study|Lost to Follow-up|0
2932332|NCT01456780|10096524|P2|Overall Study|Lost to Follow-up|3
2932333|NCT01456780|10096525|P1|Overall Study|Lost to Follow-up|3
2932334|NCT01456221|10096574|P2|Overall Study|Incomplete data|2
2932335|NCT01456221|10096575|P1|Overall Study|Incomplete data|4
2932336|NCT01456221|10096574|P2|Overall Study|Received medication|2
2932337|NCT01456221|10096575|P1|Overall Study|Received medication|3
2932338|NCT01456221|10096574|P2|Overall Study|Lost to Follow-up|4
2932339|NCT01456221|10096575|P1|Overall Study|Lost to Follow-up|1
2932340|NCT01456221|10096574|P2|Overall Study|Withdrawal by Subject|49
2932341|NCT01456221|10096575|P1|Overall Study|Withdrawal by Subject|56
2932342|NCT01456195|10096590|P3|Overall Study|Other Reasons|3
2932343|NCT01456195|10096591|P2|Overall Study|Other Reasons|1
2932344|NCT01456195|10096592|P1|Overall Study|Other Reasons|2
2932345|NCT01456195|10096590|P3|Overall Study|Lack of Efficacy|0
2932346|NCT01456195|10096591|P2|Overall Study|Lack of Efficacy|1
2932347|NCT01456195|10096592|P1|Overall Study|Lack of Efficacy|0
2932348|NCT01456195|10096590|P3|Overall Study|Voluntary Withdrawal|7
2932349|NCT01456195|10096591|P2|Overall Study|Voluntary Withdrawal|3
2932350|NCT01456195|10096592|P1|Overall Study|Voluntary Withdrawal|5
2932351|NCT01456195|10096590|P3|Overall Study|Lost to Follow-up|3
2932352|NCT01456195|10096591|P2|Overall Study|Lost to Follow-up|1
2932353|NCT01456195|10096592|P1|Overall Study|Lost to Follow-up|3
2932354|NCT01456195|10096590|P3|Overall Study|Pretreatment Event/Adverse Event|1
2932355|NCT01456195|10096591|P2|Overall Study|Pretreatment Event/Adverse Event|4
2932356|NCT01456195|10096592|P1|Overall Study|Pretreatment Event/Adverse Event|1
2932357|NCT01456169|10096612|P3|Overall Study|Other|0
2932358|NCT01456169|10096613|P2|Overall Study|Other|1
2932359|NCT01456169|10096614|P1|Overall Study|Other|1
2932360|NCT01456169|10096612|P3|Overall Study|Lack of Efficacy|0
2932361|NCT01456169|10096613|P2|Overall Study|Lack of Efficacy|0
2932362|NCT01456169|10096614|P1|Overall Study|Lack of Efficacy|2
2932363|NCT01456169|10096612|P3|Overall Study|Voluntary Withdrawal|2
2932364|NCT01456169|10096613|P2|Overall Study|Voluntary Withdrawal|0
2932365|NCT01456169|10096614|P1|Overall Study|Voluntary Withdrawal|3
2932366|NCT01456169|10096612|P3|Overall Study|Major Protocol Deviation|3
2932367|NCT01456169|10096613|P2|Overall Study|Major Protocol Deviation|2
2932368|NCT01456169|10096614|P1|Overall Study|Major Protocol Deviation|3
2932369|NCT01456169|10096612|P3|Overall Study|Adverse Event|7
2932370|NCT01456169|10096613|P2|Overall Study|Adverse Event|2
2932371|NCT01456169|10096614|P1|Overall Study|Adverse Event|1
2932372|NCT01456130|10096674|P1|Overall Study|Other|1
2932373|NCT01456130|10096674|P1|Overall Study|Lack of Efficacy|4
2932374|NCT01456130|10096674|P1|Overall Study|Voluntary Withdrawal|1
2932375|NCT01456130|10096674|P1|Overall Study|Adverse Event|4
2932376|NCT01456052|10096684|P3|Overall Study|Treatment Failure|1
2932377|NCT01456052|10096685|P2|Overall Study|Treatment Failure|1
2932378|NCT01456052|10096686|P1|Overall Study|Treatment Failure|0
2932379|NCT01456052|10096684|P3|Overall Study|Physician Decision|1
2932380|NCT01456052|10096685|P2|Overall Study|Physician Decision|0
2932381|NCT01456052|10096686|P1|Overall Study|Physician Decision|1
2932382|NCT01456052|10096684|P3|Overall Study|Protocol Violation|0
2932383|NCT01456052|10096685|P2|Overall Study|Protocol Violation|1
2932384|NCT01456052|10096686|P1|Overall Study|Protocol Violation|0
2932385|NCT01456052|10096684|P3|Overall Study|Consent withdrawn|1
2932386|NCT01456052|10096685|P2|Overall Study|Consent withdrawn|2
2932387|NCT01456052|10096686|P1|Overall Study|Consent withdrawn|0
2932388|NCT01456052|10096684|P3|Overall Study|Adverse Event|2
2932389|NCT01456052|10096685|P2|Overall Study|Adverse Event|1
2932390|NCT01456052|10096686|P1|Overall Study|Adverse Event|1
2932391|NCT01456039|10096706|P3|Phase 2 (Second Step)|Other|1
2932392|NCT01456039|10096707|P2|Phase 2 (Second Step)|Other|0
2932393|NCT01456039|10096708|P1|Phase 2 (Second Step)|Other|0
2932394|NCT01456039|10096706|P3|Phase 2 (Second Step)|Protocol Violation|1
2932395|NCT01456039|10096707|P2|Phase 2 (Second Step)|Protocol Violation|0
2932396|NCT01456039|10096708|P1|Phase 2 (Second Step)|Protocol Violation|0
2932397|NCT01456039|10096706|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
2932398|NCT01456039|10096707|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
2932399|NCT01456039|10096708|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
2932400|NCT01456039|10096706|P3|Phase 2 (Second Step)|Adverse Event|10
2932401|NCT01456039|10096707|P2|Phase 2 (Second Step)|Adverse Event|0
2932402|NCT01456039|10096708|P1|Phase 2 (Second Step)|Adverse Event|0
2932403|NCT01456039|10096706|P3|Phase 2 (Second Step)|Disease Progression|17
2932404|NCT01456039|10096707|P2|Phase 2 (Second Step)|Disease Progression|0
2932405|NCT01456039|10096708|P1|Phase 2 (Second Step)|Disease Progression|0
2932406|NCT01456039|10096706|P3|Phase 1 (First Step)|Other|0
2932407|NCT01456039|10096707|P2|Phase 1 (First Step)|Other|1
2932408|NCT01456039|10096708|P1|Phase 1 (First Step)|Other|0
2932409|NCT01456039|10096706|P3|Phase 1 (First Step)|Adverse Event|0
2932410|NCT01456039|10096707|P2|Phase 1 (First Step)|Adverse Event|3
2932411|NCT01456039|10096708|P1|Phase 1 (First Step)|Adverse Event|0
2932412|NCT01456039|10096706|P3|Phase 1 (First Step)|Withdrawal by Subject|0
2932413|NCT01456039|10096707|P2|Phase 1 (First Step)|Withdrawal by Subject|2
2932414|NCT01456039|10096708|P1|Phase 1 (First Step)|Withdrawal by Subject|1
2932415|NCT01456039|10096706|P3|Phase 1 (First Step)|Disease Progression|0
2932416|NCT01456039|10096707|P2|Phase 1 (First Step)|Disease Progression|1
2932417|NCT01456039|10096708|P1|Phase 1 (First Step)|Disease Progression|1
2932418|NCT01455428|10096851|P2|Overall Study|Other|4
2932419|NCT01455428|10096852|P1|Overall Study|Other|2
2932420|NCT01455428|10096851|P2|Overall Study|Did not receive treatment|1
2932421|NCT01455428|10096852|P1|Overall Study|Did not receive treatment|1
2932422|NCT01455428|10096851|P2|Overall Study|Insufficient clinical response|2
2932423|NCT01455428|10096852|P1|Overall Study|Insufficient clinical response|0
2932424|NCT01455428|10096851|P2|Overall Study|Did not meet entrance criteria|2
2932425|NCT01455428|10096852|P1|Overall Study|Did not meet entrance criteria|0
2932426|NCT01455428|10096851|P2|Overall Study|Withdrawal by Subject|5
2932427|NCT01455428|10096852|P1|Overall Study|Withdrawal by Subject|2
2932428|NCT01455428|10096851|P2|Overall Study|Lost to Follow-up|1
2932429|NCT01455428|10096852|P1|Overall Study|Lost to Follow-up|1
2932430|NCT01455428|10096851|P2|Overall Study|Adverse Event|2
2932431|NCT01455428|10096852|P1|Overall Study|Adverse Event|6
2932432|NCT01455428|10096851|P2|Overall Study|Protocol Violation|1
2932433|NCT01455428|10096852|P1|Overall Study|Protocol Violation|2
2932434|NCT01455415|10096908|P2|Follow-up|Unspecified Reason|0
2932435|NCT01455415|10096909|P1|Follow-up|Unspecified Reason|1
2932436|NCT01455415|10096908|P2|Follow-up|Withdrawal by Subject|0
2932437|NCT01455415|10096909|P1|Follow-up|Withdrawal by Subject|2
2932438|NCT01455415|10096908|P2|Follow-up|Lack of Efficacy|1
2932439|NCT01455415|10096909|P1|Follow-up|Lack of Efficacy|0
2932440|NCT01455415|10096908|P2|Follow-up|AE Related to Study Drug|1
2932441|NCT01455415|10096909|P1|Follow-up|AE Related to Study Drug|0
2932442|NCT01455415|10096908|P2|Period 2|Protocol Violation|0
2932443|NCT01455415|10096909|P1|Period 2|Protocol Violation|2
2932444|NCT01455415|10096908|P2|Period 2|Unspecified Reason|3
2932445|NCT01455415|10096909|P1|Period 2|Unspecified Reason|2
2932446|NCT01455415|10096908|P2|Period 2|Withdrawal by Subject|3
2932447|NCT01455415|10096909|P1|Period 2|Withdrawal by Subject|2
2932448|NCT01455415|10096908|P2|Period 2|Lack of Efficacy|0
2932449|NCT01455415|10096909|P1|Period 2|Lack of Efficacy|2
2932450|NCT01455415|10096908|P2|Period 2|AE Not Related to Study Drug|1
2932451|NCT01455415|10096909|P1|Period 2|AE Not Related to Study Drug|2
2932452|NCT01455415|10096908|P2|Period 2|Lost to Follow-up|1
2932453|NCT01455415|10096909|P1|Period 2|Lost to Follow-up|2
2932454|NCT01455415|10096908|P2|Period 2|AE Related to Study Drug|2
2932455|NCT01455415|10096909|P1|Period 2|AE Related to Study Drug|1
2932456|NCT01455415|10096908|P2|Washout|Protocol Violation|1
2932457|NCT01455415|10096909|P1|Washout|Protocol Violation|0
2932458|NCT01455415|10096908|P2|Washout|Unspecified Reason|2
2932459|NCT01455415|10096909|P1|Washout|Unspecified Reason|1
2932460|NCT01455415|10096908|P2|Washout|AE Not Related to Study Drug|3
2932461|NCT01455415|10096909|P1|Washout|AE Not Related to Study Drug|2
2932462|NCT01455415|10096908|P2|Washout|Drug Error not Associated to AE|1
2932463|NCT01455415|10096909|P1|Washout|Drug Error not Associated to AE|2
2932464|NCT01455415|10096908|P2|Washout|Lost to Follow-up|0
2932465|NCT01455415|10096909|P1|Washout|Lost to Follow-up|1
2932466|NCT01455415|10096908|P2|Washout|AE Related to Study Drug|0
2932467|NCT01455415|10096909|P1|Washout|AE Related to Study Drug|2
2932468|NCT01455415|10096908|P2|Period 1|Protocol Violation|2
2932469|NCT01455415|10096909|P1|Period 1|Protocol Violation|0
2932470|NCT01455415|10096908|P2|Period 1|Unspecified Reason|1
2932471|NCT01455415|10096909|P1|Period 1|Unspecified Reason|1
2932472|NCT01455415|10096908|P2|Period 1|Withdrawal by Subject|5
2932473|NCT01455415|10096909|P1|Period 1|Withdrawal by Subject|4
2932474|NCT01455415|10096908|P2|Period 1|AE Not Related to Study Drug|6
2932475|NCT01455415|10096909|P1|Period 1|AE Not Related to Study Drug|2
2932476|NCT01455415|10096908|P2|Period 1|Drug Error not Associated to AE|1
2932477|NCT01455415|10096909|P1|Period 1|Drug Error not Associated to AE|0
2932478|NCT01455415|10096908|P2|Period 1|Lost To Follow-up Related to Study Drug|3
2932479|NCT01455415|10096909|P1|Period 1|Lost To Follow-up Related to Study Drug|3
2932480|NCT01455415|10096908|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
2932481|NCT01455415|10096909|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
2932482|NCT01455220|10096959|P1|Overall Study|screen fail|30
2932483|NCT01455194|10096969|P4|Overall Study|Miscellaneous|4
2932484|NCT01455194|10096970|P3|Overall Study|Miscellaneous|1
2932485|NCT01455194|10096971|P2|Overall Study|Miscellaneous|5
2932486|NCT01455194|10096972|P1|Overall Study|Miscellaneous|4
2932487|NCT01455194|10096969|P4|Overall Study|Discontinuation criterion fulfilled|2
2932488|NCT01455194|10096970|P3|Overall Study|Discontinuation criterion fulfilled|0
2932489|NCT01455194|10096971|P2|Overall Study|Discontinuation criterion fulfilled|2
2932490|NCT01455194|10096972|P1|Overall Study|Discontinuation criterion fulfilled|3
2932491|NCT01455194|10096969|P4|Overall Study|Pregnancy|0
2932492|NCT01455194|10096970|P3|Overall Study|Pregnancy|1
2932493|NCT01455194|10096971|P2|Overall Study|Pregnancy|1
2932494|NCT01455194|10096972|P1|Overall Study|Pregnancy|0
2932495|NCT01455194|10096969|P4|Overall Study|Lost to Follow-up|1
2932496|NCT01455194|10096970|P3|Overall Study|Lost to Follow-up|1
2932497|NCT01455194|10096971|P2|Overall Study|Lost to Follow-up|0
2932498|NCT01455194|10096972|P1|Overall Study|Lost to Follow-up|2
2932499|NCT01455194|10096969|P4|Overall Study|Withdrawal by Subject|9
2932500|NCT01455194|10096970|P3|Overall Study|Withdrawal by Subject|12
2932501|NCT01455194|10096971|P2|Overall Study|Withdrawal by Subject|16
2932502|NCT01455194|10096972|P1|Overall Study|Withdrawal by Subject|21
2932503|NCT01455194|10096969|P4|Overall Study|Adverse Event|3
2932504|NCT01455194|10096970|P3|Overall Study|Adverse Event|1
2932505|NCT01455194|10096971|P2|Overall Study|Adverse Event|1
2932506|NCT01455194|10096972|P1|Overall Study|Adverse Event|1
2932507|NCT01455194|10096969|P4|Overall Study|Deterioration in asthma|9
2932508|NCT01455194|10096970|P3|Overall Study|Deterioration in asthma|14
2932509|NCT01455194|10096971|P2|Overall Study|Deterioration in asthma|6
2932510|NCT01455194|10096972|P1|Overall Study|Deterioration in asthma|12
2932511|NCT01455194|10096969|P4|Overall Study|Randomisation Failure|0
2932512|NCT01455194|10096970|P3|Overall Study|Randomisation Failure|0
2932513|NCT01455194|10096971|P2|Overall Study|Randomisation Failure|0
2932514|NCT01455194|10096972|P1|Overall Study|Randomisation Failure|90
2932515|NCT01455194|10096969|P4|Overall Study|Screen Failure|0
2932516|NCT01455194|10096970|P3|Overall Study|Screen Failure|0
2932517|NCT01455194|10096971|P2|Overall Study|Screen Failure|0
2932518|NCT01455194|10096972|P1|Overall Study|Screen Failure|20
2932519|NCT01455012|10097035|P2|Overall Study|Unknown reason|0
2932520|NCT01455012|10097036|P1|Overall Study|Unknown reason|2
2932521|NCT01455012|10097035|P2|Overall Study|Withdrawal by Subject|1
2932522|NCT01455012|10097036|P1|Overall Study|Withdrawal by Subject|3
2932523|NCT01455012|10097035|P2|Overall Study|Lack of Efficacy|1
2932524|NCT01455012|10097036|P1|Overall Study|Lack of Efficacy|6
2932525|NCT01455012|10097035|P2|Overall Study|Adverse Event|2
2932526|NCT01455012|10097036|P1|Overall Study|Adverse Event|0
2932527|NCT01454934|10097103|P2|Overall Study|Not treated|2
2932528|NCT01454934|10097104|P1|Overall Study|Not treated|1
2932529|NCT01454934|10097103|P2|Overall Study|Lost to Follow-up|1
2932530|NCT01454934|10097104|P1|Overall Study|Lost to Follow-up|0
2932531|NCT01454934|10097103|P2|Overall Study|Disease progression|181
2932532|NCT01454934|10097104|P1|Overall Study|Disease progression|194
2932533|NCT01454934|10097103|P2|Overall Study|Withdrawal by Subject|15
2932534|NCT01454934|10097104|P1|Overall Study|Withdrawal by Subject|11
2932535|NCT01454934|10097103|P2|Overall Study|Withdrawn consent|5
2932536|NCT01454934|10097104|P1|Overall Study|Withdrawn consent|2
2932537|NCT01454934|10097103|P2|Overall Study|Adverse Event|24
2932538|NCT01454934|10097104|P1|Overall Study|Adverse Event|28
2932539|NCT01454934|10097103|P2|Overall Study|Other|17
2932540|NCT01454934|10097104|P1|Overall Study|Other|6
2932541|NCT01454934|10097103|P2|Overall Study|Clinical progression|25
2932542|NCT01454934|10097104|P1|Overall Study|Clinical progression|28
2932543|NCT01454830|10097116|P2|Overall Study|Withdrawal - no polysomnography|2
2932544|NCT01454830|10097117|P1|Overall Study|Withdrawal - no polysomnography|3
2932545|NCT01454830|10097116|P2|Overall Study|Post-allocation Exclude-other treatment|7
2932546|NCT01454830|10097117|P1|Overall Study|Post-allocation Exclude-other treatment|6
2932547|NCT01454830|10097116|P2|Overall Study|Post-allocation Exclude-refused PAP|2
2932548|NCT01454830|10097117|P1|Overall Study|Post-allocation Exclude-refused PAP|0
2932549|NCT01454830|10097116|P2|Overall Study|Post-allocation Exclude- AHI<10|12
2932550|NCT01454830|10097117|P1|Overall Study|Post-allocation Exclude- AHI<10|18
2932551|NCT01454830|10097116|P2|Overall Study|Withdrawal by Subject|4
2932552|NCT01454830|10097117|P1|Overall Study|Withdrawal by Subject|4
2932553|NCT01454778|10097148|P1|Overall Study|Death|1
2932554|NCT01454778|10097148|P1|Overall Study|Lost to Follow-up|2
2932555|NCT01454739|10097159|P2|Overall Study|Adverse Event|1
2932556|NCT01454739|10097160|P1|Overall Study|Adverse Event|0
2932557|NCT01454739|10097159|P2|Overall Study|Lost to Follow-up|1
2932558|NCT01454739|10097160|P1|Overall Study|Lost to Follow-up|0
2932559|NCT01454739|10097159|P2|Overall Study|Physician Decision|5
2932560|NCT01454739|10097160|P1|Overall Study|Physician Decision|0
2932561|NCT01454739|10097159|P2|Overall Study|Other|5
2932562|NCT01454739|10097160|P1|Overall Study|Other|3
2932563|NCT01454739|10097159|P2|Overall Study|Withdrawal by Subject|6
2932564|NCT01454739|10097160|P1|Overall Study|Withdrawal by Subject|2
2932565|NCT01454739|10097159|P2|Overall Study|Protocol Violation|3
2932566|NCT01454739|10097160|P1|Overall Study|Protocol Violation|2
2932567|NCT01454726|10097189|P2|Overall Study|Withdrawal by Subject|1
2932568|NCT01454726|10097190|P1|Overall Study|Withdrawal by Subject|0
2932569|NCT01454596|10097208|P12|Overall Study|Death|0
2932570|NCT01454596|10097209|P11|Overall Study|Death|1
2932571|NCT01454596|10097210|P10|Overall Study|Death|1
2932572|NCT01454596|10097211|P9|Overall Study|Death|0
2932573|NCT01454596|10097212|P8|Overall Study|Death|0
2932574|NCT01454596|10097213|P7|Overall Study|Death|0
2932575|NCT01454596|10097214|P6|Overall Study|Death|0
2932576|NCT01454596|10097215|P5|Overall Study|Death|0
2932577|NCT01454596|10097216|P4|Overall Study|Death|0
2932578|NCT01454596|10097217|P3|Overall Study|Death|0
2932579|NCT01454596|10097218|P2|Overall Study|Death|0
2932580|NCT01454596|10097219|P1|Overall Study|Death|0
2932581|NCT01454583|10097296|P3|3rd Year|Lost to Follow-up|297
2932582|NCT01454583|10097297|P2|3rd Year|Lost to Follow-up|512
2932583|NCT01454583|10097298|P1|3rd Year|Lost to Follow-up|1959
2932584|NCT01454583|10097296|P3|2nd Year|Lost to Follow-up|737
2932585|NCT01454583|10097297|P2|2nd Year|Lost to Follow-up|1049
2932586|NCT01454583|10097298|P1|2nd Year|Lost to Follow-up|3965
2932587|NCT01454583|10097296|P3|1st Year|Lost to Follow-up|180
2932588|NCT01454583|10097297|P2|1st Year|Lost to Follow-up|318
2932589|NCT01454583|10097298|P1|1st Year|Lost to Follow-up|1057
2932590|NCT01454531|10097366|P1|Overall Study|Other|1
2932591|NCT01454531|10097366|P1|Overall Study|Delay in IMP administration|1
2932592|NCT01454531|10097366|P1|Overall Study|Physician Decision|1
2932593|NCT01454531|10097366|P1|Overall Study|Lost to Follow-up|1
2932594|NCT01454531|10097366|P1|Overall Study|Withdrawal by Subject|5
2932595|NCT01454531|10097366|P1|Overall Study|Adverse Event|14
2932596|NCT01454401|10097402|P1|Overall Study|non-adherence|1
2932597|NCT01454401|10097402|P1|Overall Study|osteomyelitis|2
2932598|NCT01454401|10097402|P1|Overall Study|hospitalised|1
2932599|NCT01454401|10097402|P1|Overall Study|Death|1
2932600|NCT01454284|10097426|P2|Overall Study|Sponsor Decision|2
2932601|NCT01454284|10097427|P1|Overall Study|Sponsor Decision|0
2932602|NCT01454284|10097426|P2|Overall Study|Physician Decision|11
2932603|NCT01454284|10097427|P1|Overall Study|Physician Decision|16
2932604|NCT01454284|10097426|P2|Overall Study|Withdrawal by Subject|36
2932605|NCT01454284|10097427|P1|Overall Study|Withdrawal by Subject|58
2932606|NCT01454284|10097426|P2|Overall Study|Protocol Violation|6
2932607|NCT01454284|10097427|P1|Overall Study|Protocol Violation|9
2932608|NCT01454284|10097426|P2|Overall Study|Lost to Follow-up|8
2932609|NCT01454284|10097427|P1|Overall Study|Lost to Follow-up|13
2932610|NCT01454284|10097426|P2|Overall Study|Death|3
2932611|NCT01454284|10097427|P1|Overall Study|Death|0
2932612|NCT01454284|10097426|P2|Overall Study|Adverse Event|7
2932613|NCT01454284|10097427|P1|Overall Study|Adverse Event|20
2932614|NCT01454102|10097497|P16|Overall Study|Continuing in the treatment period|1
2932615|NCT01454102|10097498|P15|Overall Study|Continuing in the treatment period|3
2932616|NCT01454102|10097499|P14|Overall Study|Continuing in the treatment period|4
2932617|NCT01454102|10097500|P13|Overall Study|Continuing in the treatment period|7
2932618|NCT01454102|10097501|P12|Overall Study|Continuing in the treatment period|4
2932619|NCT01454102|10097502|P11|Overall Study|Continuing in the treatment period|0
2932620|NCT01454102|10097503|P10|Overall Study|Continuing in the treatment period|0
2932621|NCT01454102|10097504|P9|Overall Study|Continuing in the treatment period|1
2932622|NCT01454102|10097505|P8|Overall Study|Continuing in the treatment period|0
2932623|NCT01454102|10097506|P7|Overall Study|Continuing in the treatment period|2
2932624|NCT01454102|10097507|P6|Overall Study|Continuing in the treatment period|3
2932625|NCT01454102|10097508|P5|Overall Study|Continuing in the treatment period|3
2932626|NCT01454102|10097509|P4|Overall Study|Continuing in the treatment period|0
2932627|NCT01454102|10097510|P3|Overall Study|Continuing in the treatment period|0
2932628|NCT01454102|10097511|P2|Overall Study|Continuing in the treatment period|0
2932629|NCT01454102|10097512|P1|Overall Study|Continuing in the treatment period|0
2932630|NCT01454076|10097632|P5|Overall Study|Adverse Event|2
2932631|NCT01454076|10097633|P4|Overall Study|Adverse Event|0
2932632|NCT01454076|10097634|P3|Overall Study|Adverse Event|7
2932633|NCT01454076|10097635|P2|Overall Study|Adverse Event|2
2932634|NCT01454076|10097636|P1|Overall Study|Adverse Event|8
2932635|NCT01454076|10097632|P5|Overall Study|Withdrawal by Subject|2
2932636|NCT01454076|10097633|P4|Overall Study|Withdrawal by Subject|1
2932637|NCT01454076|10097634|P3|Overall Study|Withdrawal by Subject|2
2932638|NCT01454076|10097635|P2|Overall Study|Withdrawal by Subject|4
2932639|NCT01454076|10097636|P1|Overall Study|Withdrawal by Subject|3
2932640|NCT01454076|10097632|P5|Overall Study|Other|2
2932641|NCT01454076|10097633|P4|Overall Study|Other|1
2932642|NCT01454076|10097634|P3|Overall Study|Other|0
2932643|NCT01454076|10097635|P2|Overall Study|Other|0
2932644|NCT01454076|10097636|P1|Overall Study|Other|2
2932645|NCT01454063|10097689|P2|Randomized|Protocol Violation|1
2932646|NCT01454063|10097690|P1|Randomized|Protocol Violation|0
2932647|NCT01454063|10097689|P2|Randomized|Adverse Event|1
2932648|NCT01454063|10097690|P1|Randomized|Adverse Event|1
2932649|NCT01453998|10097711|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
2932650|NCT01453998|10097712|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
2932651|NCT01453998|10097713|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
2932652|NCT01453946|10097778|P1|Overall Study|Adverse Event|3
2932653|NCT01453946|10097778|P1|Overall Study|Lack of Efficacy|3
2932654|NCT01453946|10097778|P1|Overall Study|Protocol Violation|2
2932655|NCT01453946|10097778|P1|Overall Study|Did not receive drug for the taper phase|1
2932656|NCT01453855|10097795|P2|Overall Study|Other|1
2932657|NCT01453855|10097796|P1|Overall Study|Other|0
2932658|NCT01453855|10097795|P2|Overall Study|Inadequate Control of IOP|5
2932659|NCT01453855|10097796|P1|Overall Study|Inadequate Control of IOP|1
2932660|NCT01453855|10097795|P2|Overall Study|Noncompliance|0
2932661|NCT01453855|10097796|P1|Overall Study|Noncompliance|1
2932662|NCT01453855|10097795|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
2932663|NCT01453855|10097796|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
2932664|NCT01453855|10097795|P2|Overall Study|Lost to Follow-up|1
2932665|NCT01453855|10097796|P1|Overall Study|Lost to Follow-up|2
2932666|NCT01453855|10097795|P2|Overall Study|Adverse Event|4
2932667|NCT01453855|10097796|P1|Overall Study|Adverse Event|3
2932668|NCT01453725|10097804|P2|Overall Study|Physician Decision|1
2932669|NCT01453725|10097805|P1|Overall Study|Physician Decision|1
2932670|NCT01453725|10097804|P2|Overall Study|Pregnancy|0
2932671|NCT01453725|10097805|P1|Overall Study|Pregnancy|1
2932672|NCT01453725|10097804|P2|Overall Study|Pregnancy Wish|2
2932673|NCT01453725|10097805|P1|Overall Study|Pregnancy Wish|0
2932674|NCT01453725|10097804|P2|Overall Study|Withdrawal by Subject|3
2932675|NCT01453725|10097805|P1|Overall Study|Withdrawal by Subject|2
2932676|NCT01453725|10097804|P2|Overall Study|Protocol Violation|0
2932677|NCT01453725|10097805|P1|Overall Study|Protocol Violation|1
2932678|NCT01453725|10097804|P2|Overall Study|Non-compliance With Protocol|2
2932679|NCT01453725|10097805|P1|Overall Study|Non-compliance With Protocol|1
2932680|NCT01453725|10097804|P2|Overall Study|Lost to Follow-up|0
2932681|NCT01453725|10097805|P1|Overall Study|Lost to Follow-up|4
2932682|NCT01453725|10097804|P2|Overall Study|Adverse Event|3
2932683|NCT01453725|10097805|P1|Overall Study|Adverse Event|3
2932684|NCT01453595|10097828|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
2932685|NCT01453595|10097829|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
2932686|NCT01453595|10097830|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
2932687|NCT01453374|10097949|P1|Overall Study|Incarcerated|2
2932688|NCT01453374|10097949|P1|Overall Study|Withdrawal by Subject|5
2932689|NCT01453374|10097949|P1|Overall Study|Lost to Follow-up|3
2932690|NCT01453374|10097949|P1|Overall Study|Lack of Efficacy|1
2932691|NCT01453374|10097949|P1|Overall Study|Adverse Event|7
2932692|NCT01453361|10097965|P1|Overall Study|Screen-Failures|10
2932693|NCT01453361|10097965|P1|Overall Study|Disease Progression|6
2932694|NCT01453348|10097973|P3|Overall Study|Protocol Violation|0
2932695|NCT01453348|10097974|P2|Overall Study|Protocol Violation|0
2932696|NCT01453348|10097975|P1|Overall Study|Protocol Violation|1
2932697|NCT01453348|10097973|P3|Overall Study|Withdrawal by Subject|0
2932698|NCT01453348|10097974|P2|Overall Study|Withdrawal by Subject|1
2932699|NCT01453348|10097975|P1|Overall Study|Withdrawal by Subject|0
2932700|NCT01453348|10097973|P3|Overall Study|Death|1
2932701|NCT01453348|10097974|P2|Overall Study|Death|0
2932702|NCT01453348|10097975|P1|Overall Study|Death|0
2932703|NCT01453296|10097991|P2|Treatment Period 2|Withdrawal by Subject|0
2932704|NCT01453296|10097992|P1|Treatment Period 2|Withdrawal by Subject|1
2932705|NCT01453296|10097991|P2|Treatment Period 2|Adverse Event|0
2932706|NCT01453296|10097992|P1|Treatment Period 2|Adverse Event|1
2932707|NCT01453296|10097991|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
2932708|NCT01453296|10097992|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
2932709|NCT01453296|10097991|P2|Treatment Period 1|Adverse Event|1
2932710|NCT01453296|10097992|P1|Treatment Period 1|Adverse Event|0
2932711|NCT01453205|10098059|P3|Overall Study|Other|35
2932712|NCT01453205|10098060|P2|Overall Study|Other|27
2932713|NCT01453205|10098061|P1|Overall Study|Other|45
2932714|NCT01453205|10098059|P3|Overall Study|Death|18
2932715|NCT01453205|10098060|P2|Overall Study|Death|22
2932716|NCT01453205|10098061|P1|Overall Study|Death|24
2932717|NCT01453205|10098059|P3|Overall Study|Withdrawal by Subject|0
2932718|NCT01453205|10098060|P2|Overall Study|Withdrawal by Subject|3
2932719|NCT01453205|10098061|P1|Overall Study|Withdrawal by Subject|8
2932720|NCT01453205|10098059|P3|Overall Study|Lost to Follow-up|1
2932721|NCT01453205|10098060|P2|Overall Study|Lost to Follow-up|0
2932722|NCT01453205|10098061|P1|Overall Study|Lost to Follow-up|3
2932723|NCT01453153|10098137|P3|Overall Study|Adverse Event|1
2932724|NCT01453153|10098138|P2|Overall Study|Adverse Event|1
2932725|NCT01453153|10098139|P1|Overall Study|Adverse Event|1
2932726|NCT01453153|10098137|P3|Overall Study|Withdrawal by Subject|2
2932727|NCT01453153|10098138|P2|Overall Study|Withdrawal by Subject|1
2932728|NCT01453153|10098139|P1|Overall Study|Withdrawal by Subject|0
2932729|NCT01453153|10098137|P3|Overall Study|Progressive Disease|16
2932730|NCT01453153|10098138|P2|Overall Study|Progressive Disease|2
2932731|NCT01453153|10098139|P1|Overall Study|Progressive Disease|3
2932732|NCT01453153|10098137|P3|Overall Study|Physician Decision|1
2932733|NCT01453153|10098138|P2|Overall Study|Physician Decision|0
2932734|NCT01453153|10098139|P1|Overall Study|Physician Decision|0
2932735|NCT01453049|10098221|P2|Overall Study|Randomized in Error|0
2932736|NCT01453049|10098222|P1|Overall Study|Randomized in Error|1
2932737|NCT01453049|10098221|P2|Overall Study|Withdrawal by Subject|0
2932738|NCT01453049|10098222|P1|Overall Study|Withdrawal by Subject|1
2932739|NCT01453049|10098221|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
2932740|NCT01453049|10098222|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
2932741|NCT01453049|10098221|P2|Overall Study|Lost to Follow-up|1
2932742|NCT01453049|10098222|P1|Overall Study|Lost to Follow-up|2
2932743|NCT01453049|10098221|P2|Overall Study|Protocol Violation|5
2932744|NCT01453049|10098222|P1|Overall Study|Protocol Violation|2
2932745|NCT01453036|10098295|P3|Overall Study|Lost to Follow-up|31
2932746|NCT01453036|10098296|P2|Overall Study|Lost to Follow-up|115
2932747|NCT01453036|10098297|P1|Overall Study|Lost to Follow-up|26
2932748|NCT01453023|10098305|P2|Treatment Period 2|Protocol Violation|1
2932749|NCT01453023|10098306|P1|Treatment Period 2|Protocol Violation|0
2932750|NCT01453023|10098305|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
2932751|NCT01453023|10098306|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
2932752|NCT01453023|10098305|P2|Treatment Period (TP) 1|Protocol Violation|0
2932753|NCT01453023|10098306|P1|Treatment Period (TP) 1|Protocol Violation|1
2932754|NCT01452789|10098380|P2|Overall Study|Withdrawal by Subject|2
2932755|NCT01452789|10098381|P1|Overall Study|Withdrawal by Subject|3
2932756|NCT01452529|10098395|P3|Double-blind (DB) Period|Administrative|7
2932757|NCT01452529|10098396|P2|Double-blind (DB) Period|Administrative|11
2932758|NCT01452529|10098397|P1|Double-blind (DB) Period|Administrative|0
2932759|NCT01452529|10098395|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
2932760|NCT01452529|10098396|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
2932761|NCT01452529|10098397|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
2932762|NCT01452529|10098395|P3|Double-blind (DB) Period|Lack of Efficacy|44
2932763|NCT01452529|10098396|P2|Double-blind (DB) Period|Lack of Efficacy|16
2932764|NCT01452529|10098397|P1|Double-blind (DB) Period|Lack of Efficacy|0
2932765|NCT01452529|10098395|P3|Double-blind (DB) Period|Lost to Follow-up|3
2932766|NCT01452529|10098396|P2|Double-blind (DB) Period|Lost to Follow-up|5
2932767|NCT01452529|10098397|P1|Double-blind (DB) Period|Lost to Follow-up|0
2932768|NCT01452529|10098395|P3|Double-blind (DB) Period|Withdrawal by Subject|14
2932769|NCT01452529|10098396|P2|Double-blind (DB) Period|Withdrawal by Subject|15
2932770|NCT01452529|10098397|P1|Double-blind (DB) Period|Withdrawal by Subject|0
2932771|NCT01452529|10098395|P3|Double-blind (DB) Period|Adverse Event|11
2932772|NCT01452529|10098396|P2|Double-blind (DB) Period|Adverse Event|18
2932773|NCT01452529|10098397|P1|Double-blind (DB) Period|Adverse Event|0
2932774|NCT01452529|10098395|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
2932775|NCT01452529|10098396|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
2932776|NCT01452529|10098397|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
2932777|NCT01452529|10098395|P3|Run-in Period|Administrative|0
2932778|NCT01452529|10098396|P2|Run-in Period|Administrative|0
2932779|NCT01452529|10098397|P1|Run-in Period|Administrative|21
2932780|NCT01452529|10098395|P3|Run-in Period|Confirmed or suspected diversion|0
2932781|NCT01452529|10098396|P2|Run-in Period|Confirmed or suspected diversion|0
2932782|NCT01452529|10098397|P1|Run-in Period|Confirmed or suspected diversion|23
2932783|NCT01452529|10098395|P3|Run-in Period|Lack of Efficacy|0
2932784|NCT01452529|10098396|P2|Run-in Period|Lack of Efficacy|0
2932785|NCT01452529|10098397|P1|Run-in Period|Lack of Efficacy|46
2932786|NCT01452529|10098395|P3|Run-in Period|Lost to Follow-up|0
2932787|NCT01452529|10098396|P2|Run-in Period|Lost to Follow-up|0
2932788|NCT01452529|10098397|P1|Run-in Period|Lost to Follow-up|19
2932789|NCT01452529|10098395|P3|Run-in Period|Withdrawal by Subject|0
2932790|NCT01452529|10098396|P2|Run-in Period|Withdrawal by Subject|0
2932791|NCT01452529|10098397|P1|Run-in Period|Withdrawal by Subject|49
2932792|NCT01452529|10098395|P3|Run-in Period|Adverse Event|0
2932793|NCT01452529|10098396|P2|Run-in Period|Adverse Event|0
2932794|NCT01452529|10098397|P1|Run-in Period|Adverse Event|96
2932795|NCT01452412|10098419|P2|Overall Study|Other|0
2932796|NCT01452412|10098420|P1|Overall Study|Other|2
2932797|NCT01452412|10098419|P2|Overall Study|Initiated dialysis|0
2932798|NCT01452412|10098420|P1|Overall Study|Initiated dialysis|1
2932799|NCT01452412|10098419|P2|Overall Study|Death|0
2932800|NCT01452412|10098420|P1|Overall Study|Death|1
2932801|NCT01452412|10098419|P2|Overall Study|Lost to Follow-up|3
2932802|NCT01452412|10098420|P1|Overall Study|Lost to Follow-up|5
2932803|NCT01452412|10098419|P2|Overall Study|Adverse Event|3
2932804|NCT01452412|10098420|P1|Overall Study|Adverse Event|4
2932805|NCT01452412|10098419|P2|Overall Study|Withdrawal by Subject|11
2932806|NCT01452412|10098420|P1|Overall Study|Withdrawal by Subject|15
2932807|NCT01452347|10098436|P2|Overall Study|Other reason not defined above|0
2932808|NCT01452347|10098437|P1|Overall Study|Other reason not defined above|2
2932809|NCT01452347|10098436|P2|Overall Study|Not treated|3
2932810|NCT01452347|10098437|P1|Overall Study|Not treated|6
2932811|NCT01452347|10098436|P2|Overall Study|Withdrawal by Subject|3
2932812|NCT01452347|10098437|P1|Overall Study|Withdrawal by Subject|3
2932813|NCT01452347|10098436|P2|Overall Study|Lost to Follow-up|0
2932814|NCT01452347|10098437|P1|Overall Study|Lost to Follow-up|2
2932815|NCT01452347|10098436|P2|Overall Study|Non compliance protocol|0
2932816|NCT01452347|10098437|P1|Overall Study|Non compliance protocol|2
2932817|NCT01452347|10098436|P2|Overall Study|Adverse Event|1
2932818|NCT01452347|10098437|P1|Overall Study|Adverse Event|2
2932819|NCT01452152|10098497|P3|Overall Study|Study termination by sponsor|4
2932820|NCT01452152|10098498|P2|Overall Study|Study termination by sponsor|0
2932821|NCT01452152|10098499|P1|Overall Study|Study termination by sponsor|5
2932822|NCT01451931|10098571|P3|Overall Study|Withdrawal by Subject|22
2932823|NCT01451931|10098572|P2|Overall Study|Withdrawal by Subject|22
2932824|NCT01451931|10098573|P1|Overall Study|Withdrawal by Subject|16
2932825|NCT01451931|10098571|P3|Overall Study|Lost to Follow-up|21
2932826|NCT01451931|10098572|P2|Overall Study|Lost to Follow-up|36
2932827|NCT01451931|10098573|P1|Overall Study|Lost to Follow-up|17
2932828|NCT01451827|10098597|P4|Overall Study|Withdrawal by Subject|1
2932829|NCT01451827|10098598|P3|Overall Study|Withdrawal by Subject|1
2932830|NCT01451827|10098599|P2|Overall Study|Withdrawal by Subject|0
2932831|NCT01451827|10098600|P1|Overall Study|Withdrawal by Subject|0
2932832|NCT01451827|10098597|P4|Overall Study|Participant met withdrawal criteria|0
2932833|NCT01451827|10098598|P3|Overall Study|Participant met withdrawal criteria|0
2932834|NCT01451827|10098599|P2|Overall Study|Participant met withdrawal criteria|2
2932835|NCT01451827|10098600|P1|Overall Study|Participant met withdrawal criteria|0
2932836|NCT01451827|10098597|P4|Overall Study|Lost to Follow-up|2
2932837|NCT01451827|10098598|P3|Overall Study|Lost to Follow-up|0
2932838|NCT01451827|10098599|P2|Overall Study|Lost to Follow-up|3
2932839|NCT01451827|10098600|P1|Overall Study|Lost to Follow-up|0
2932840|NCT01451827|10098597|P4|Overall Study|Protocol deviation|0
2932841|NCT01451827|10098598|P3|Overall Study|Protocol deviation|0
2932842|NCT01451827|10098599|P2|Overall Study|Protocol deviation|0
2932843|NCT01451827|10098600|P1|Overall Study|Protocol deviation|1
2932844|NCT01451827|10098597|P4|Overall Study|Adverse Event|1
2932845|NCT01451827|10098598|P3|Overall Study|Adverse Event|1
2932846|NCT01451827|10098599|P2|Overall Study|Adverse Event|0
2932847|NCT01451827|10098600|P1|Overall Study|Adverse Event|2
2932848|NCT01451814|10098620|P2|Overall Study|Lost to Follow-up|4
2932849|NCT01451814|10098621|P1|Overall Study|Lost to Follow-up|5
2932850|NCT01451814|10098620|P2|Overall Study|Withdrawal by Subject|1
2932851|NCT01451814|10098621|P1|Overall Study|Withdrawal by Subject|1
2932852|NCT01451762|10098653|P3|Overall Study|Lost to Follow-up|6
2932853|NCT01451762|10098654|P2|Overall Study|Lost to Follow-up|6
2932854|NCT01451762|10098655|P1|Overall Study|Lost to Follow-up|3
2932855|NCT01451749|10098665|P2|Overall Study|Withdrawal by Subject|1
2932856|NCT01451749|10098666|P1|Overall Study|Withdrawal by Subject|0
2932857|NCT01451749|10098665|P2|Overall Study|Adverse Event|0
2932858|NCT01451749|10098666|P1|Overall Study|Adverse Event|2
2932859|NCT01451749|10098665|P2|Overall Study|Meet the exclusion criteria,and|1
2932860|NCT01451749|10098666|P1|Overall Study|Meet the exclusion criteria,and|1
2932861|NCT01451749|10098665|P2|Overall Study|Lost to Follow-up|5
2932862|NCT01451749|10098666|P1|Overall Study|Lost to Follow-up|15
2932863|NCT01451749|10098665|P2|Overall Study|Protocol Violation|7
2932864|NCT01451749|10098666|P1|Overall Study|Protocol Violation|14
2932865|NCT01451723|10098678|P2|Overall Study|study halted|5
2932866|NCT01451723|10098679|P1|Overall Study|study halted|6
2932867|NCT01451645|10098689|P2|Overall Study|Lost to Follow-up|3
2932868|NCT01451645|10098690|P1|Overall Study|Lost to Follow-up|4
2932869|NCT01451645|10098689|P2|Overall Study|Withdrawal by Subject|2
2932870|NCT01451645|10098690|P1|Overall Study|Withdrawal by Subject|4
2932871|NCT01451645|10098689|P2|Overall Study|Adverse Event|3
2932872|NCT01451645|10098690|P1|Overall Study|Adverse Event|0
2932873|NCT01451645|10098689|P2|Overall Study|Protocol Violation|0
2932874|NCT01451645|10098690|P1|Overall Study|Protocol Violation|1
2932875|NCT01451606|10098761|P2|Overall Study|Withdrawal by Subject|3
2932876|NCT01451606|10098762|P1|Overall Study|Withdrawal by Subject|4
2932877|NCT01451554|10098772|P2|Overall Study|Withdrawal by Subject|9
2932878|NCT01451554|10098773|P1|Overall Study|Withdrawal by Subject|14
2932879|NCT01451541|10098784|P3|Overall Study|randomization error, noncompliance|8
2932880|NCT01451541|10098785|P2|Overall Study|randomization error, noncompliance|10
2932881|NCT01451541|10098786|P1|Overall Study|randomization error, noncompliance|11
2932882|NCT01451541|10098784|P3|Overall Study|Withdrawal by Subject|6
2932883|NCT01451541|10098785|P2|Overall Study|Withdrawal by Subject|8
2932884|NCT01451541|10098786|P1|Overall Study|Withdrawal by Subject|15
2932885|NCT01451541|10098784|P3|Overall Study|Lost to Follow-up|7
2932886|NCT01451541|10098785|P2|Overall Study|Lost to Follow-up|4
2932887|NCT01451541|10098786|P1|Overall Study|Lost to Follow-up|4
2932888|NCT01451541|10098784|P3|Overall Study|Lack of Efficacy|0
2932889|NCT01451541|10098785|P2|Overall Study|Lack of Efficacy|0
2932890|NCT01451541|10098786|P1|Overall Study|Lack of Efficacy|2
2932891|NCT01451541|10098784|P3|Overall Study|Adverse Event|6
2932892|NCT01451541|10098785|P2|Overall Study|Adverse Event|3
2932893|NCT01451541|10098786|P1|Overall Study|Adverse Event|4
2932894|NCT01451437|10098844|P9|Overall Study|Withdrawal by Subject|0
2932895|NCT01451437|10098845|P8|Overall Study|Withdrawal by Subject|0
2932896|NCT01451437|10098846|P7|Overall Study|Withdrawal by Subject|1
2932897|NCT01451437|10098847|P6|Overall Study|Withdrawal by Subject|0
2932898|NCT01451437|10098848|P5|Overall Study|Withdrawal by Subject|1
2932899|NCT01451437|10098849|P4|Overall Study|Withdrawal by Subject|0
2932900|NCT01451437|10098850|P3|Overall Study|Withdrawal by Subject|0
2932901|NCT01451437|10098851|P2|Overall Study|Withdrawal by Subject|0
2932902|NCT01451437|10098852|P1|Overall Study|Withdrawal by Subject|0
2932903|NCT01451437|10098844|P9|Overall Study|Protocol Violation|0
2932904|NCT01451437|10098845|P8|Overall Study|Protocol Violation|0
2932905|NCT01451437|10098846|P7|Overall Study|Protocol Violation|1
2932906|NCT01451437|10098847|P6|Overall Study|Protocol Violation|0
2932907|NCT01451437|10098848|P5|Overall Study|Protocol Violation|0
2932908|NCT01451437|10098849|P4|Overall Study|Protocol Violation|0
2932909|NCT01451437|10098850|P3|Overall Study|Protocol Violation|0
2932910|NCT01451437|10098851|P2|Overall Study|Protocol Violation|0
2932911|NCT01451437|10098852|P1|Overall Study|Protocol Violation|0
2932912|NCT01451437|10098844|P9|Overall Study|Disease Progression|3
2932913|NCT01451437|10098845|P8|Overall Study|Disease Progression|1
2932914|NCT01451437|10098846|P7|Overall Study|Disease Progression|3
2932915|NCT01451437|10098847|P6|Overall Study|Disease Progression|2
2932916|NCT01451437|10098848|P5|Overall Study|Disease Progression|3
2932917|NCT01451437|10098849|P4|Overall Study|Disease Progression|1
2932918|NCT01451437|10098850|P3|Overall Study|Disease Progression|1
2932919|NCT01451437|10098851|P2|Overall Study|Disease Progression|0
2932920|NCT01451437|10098852|P1|Overall Study|Disease Progression|0
2932921|NCT01451437|10098844|P9|Overall Study|Physician Decision|0
2932922|NCT01451437|10098845|P8|Overall Study|Physician Decision|0
2932923|NCT01451437|10098846|P7|Overall Study|Physician Decision|0
2932924|NCT01451437|10098847|P6|Overall Study|Physician Decision|0
2932925|NCT01451437|10098848|P5|Overall Study|Physician Decision|0
2932926|NCT01451437|10098849|P4|Overall Study|Physician Decision|0
2932927|NCT01451437|10098850|P3|Overall Study|Physician Decision|2
2932928|NCT01451437|10098851|P2|Overall Study|Physician Decision|1
2932929|NCT01451437|10098852|P1|Overall Study|Physician Decision|1
2932930|NCT01451437|10098844|P9|Overall Study|Adverse Event|1
2932931|NCT01451437|10098845|P8|Overall Study|Adverse Event|2
2932932|NCT01451437|10098846|P7|Overall Study|Adverse Event|1
2932933|NCT01451437|10098847|P6|Overall Study|Adverse Event|1
2932934|NCT01451437|10098848|P5|Overall Study|Adverse Event|0
2932935|NCT01451437|10098849|P4|Overall Study|Adverse Event|0
2932936|NCT01451437|10098850|P3|Overall Study|Adverse Event|0
2932937|NCT01451437|10098851|P2|Overall Study|Adverse Event|0
2932938|NCT01451437|10098852|P1|Overall Study|Adverse Event|0
2932939|NCT01451424|10098984|P4|Overall Study|Adverse Event|1
2932940|NCT01451424|10098985|P3|Overall Study|Adverse Event|0
2932941|NCT01451424|10098986|P2|Overall Study|Adverse Event|0
2932942|NCT01451424|10098987|P1|Overall Study|Adverse Event|0
2932943|NCT01451424|10098984|P4|Overall Study|Physician Decision|1
2932944|NCT01451424|10098985|P3|Overall Study|Physician Decision|1
2932945|NCT01451424|10098986|P2|Overall Study|Physician Decision|0
2932946|NCT01451424|10098987|P1|Overall Study|Physician Decision|0
2932947|NCT01451424|10098984|P4|Overall Study|Lost to Follow-up|1
2932948|NCT01451424|10098985|P3|Overall Study|Lost to Follow-up|0
2932949|NCT01451424|10098986|P2|Overall Study|Lost to Follow-up|1
2932950|NCT01451424|10098987|P1|Overall Study|Lost to Follow-up|0
2932951|NCT01451424|10098984|P4|Overall Study|Withdrawal by Subject|2
2932952|NCT01451424|10098985|P3|Overall Study|Withdrawal by Subject|0
2932953|NCT01451424|10098986|P2|Overall Study|Withdrawal by Subject|1
2932954|NCT01451424|10098987|P1|Overall Study|Withdrawal by Subject|1
2932955|NCT01451398|10099045|P2|Overall Study|Lack of Efficacy|1
2932956|NCT01451398|10099046|P1|Overall Study|Lack of Efficacy|0
2932957|NCT01451398|10099045|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
2932958|NCT01451398|10099046|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
2932959|NCT01451398|10099045|P2|Overall Study|Moved out of country|1
2932960|NCT01451398|10099046|P1|Overall Study|Moved out of country|0
2932961|NCT01451398|10099045|P2|Overall Study|Non-compliance with protocol|1
2932962|NCT01451398|10099046|P1|Overall Study|Non-compliance with protocol|1
2932963|NCT01451398|10099045|P2|Overall Study|Non-compliance with study drug|3
2932964|NCT01451398|10099046|P1|Overall Study|Non-compliance with study drug|1
2932965|NCT01451398|10099045|P2|Overall Study|Lost to Follow-up|4
2932966|NCT01451398|10099046|P1|Overall Study|Lost to Follow-up|6
2932967|NCT01451398|10099045|P2|Overall Study|Withdrawal by Subject|14
2932968|NCT01451398|10099046|P1|Overall Study|Withdrawal by Subject|10
2932969|NCT01451398|10099045|P2|Overall Study|Physician Decision|1
2932970|NCT01451398|10099046|P1|Overall Study|Physician Decision|1
2932971|NCT01451398|10099045|P2|Overall Study|Protocol Violation|2
2932972|NCT01451398|10099046|P1|Overall Study|Protocol Violation|1
2932973|NCT01451398|10099045|P2|Overall Study|Adverse Event|9
2932974|NCT01451398|10099046|P1|Overall Study|Adverse Event|7
2932975|NCT01451203|10099085|P2|Post-treatment Period|Investigator decision|1
2932976|NCT01451203|10099086|P1|Post-treatment Period|Investigator decision|0
2932977|NCT01451203|10099085|P2|Post-treatment Period|Adverse Event|1
2932978|NCT01451203|10099086|P1|Post-treatment Period|Adverse Event|0
2932979|NCT01451203|10099085|P2|Post-treatment Period|Lack of Efficacy|28
2932980|NCT01451203|10099086|P1|Post-treatment Period|Lack of Efficacy|12
2932981|NCT01451203|10099085|P2|Post-treatment Period|Consent withdrawn|4
2932982|NCT01451203|10099086|P1|Post-treatment Period|Consent withdrawn|2
2932983|NCT01451203|10099085|P2|Double-blind Treatment Period|Investigator decision|0
2932984|NCT01451203|10099086|P1|Double-blind Treatment Period|Investigator decision|2
2932985|NCT01451203|10099085|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
2932986|NCT01451203|10099086|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
2932987|NCT01451203|10099085|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
2932988|NCT01451203|10099086|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
2932989|NCT01451203|10099085|P2|Double-blind Treatment Period|Adverse Event|9
2932990|NCT01451203|10099086|P1|Double-blind Treatment Period|Adverse Event|6
2932991|NCT01451203|10099085|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
2932992|NCT01451203|10099086|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
2932993|NCT01451203|10099085|P2|Double-blind Treatment Period|Lack of Efficacy|36
2932994|NCT01451203|10099086|P1|Double-blind Treatment Period|Lack of Efficacy|71
2932995|NCT01451203|10099085|P2|Double-blind Treatment Period|Consent Withdrawn|2
2932996|NCT01451203|10099086|P1|Double-blind Treatment Period|Consent Withdrawn|3
2932997|NCT01451203|10099085|P2|Double-blind Treatment Period|Did not receive treatment|2
2932998|NCT01451203|10099086|P1|Double-blind Treatment Period|Did not receive treatment|1
2932999|NCT01451164|10099104|P4|Overall Study|Lack of Efficacy|7
2933000|NCT01451164|10099105|P3|Overall Study|Lack of Efficacy|9
2933001|NCT01451164|10099106|P2|Overall Study|Lack of Efficacy|9
2933002|NCT01451164|10099107|P1|Overall Study|Lack of Efficacy|7
2933003|NCT01451164|10099104|P4|Overall Study|Protocol Violation|0
2933004|NCT01451164|10099105|P3|Overall Study|Protocol Violation|0
2933005|NCT01451164|10099106|P2|Overall Study|Protocol Violation|1
2933006|NCT01451164|10099107|P1|Overall Study|Protocol Violation|0
2933007|NCT01451164|10099104|P4|Overall Study|Withdrawal by Subject|17
2933008|NCT01451164|10099105|P3|Overall Study|Withdrawal by Subject|16
2933009|NCT01451164|10099106|P2|Overall Study|Withdrawal by Subject|11
2933010|NCT01451164|10099107|P1|Overall Study|Withdrawal by Subject|14
2933011|NCT01451164|10099104|P4|Overall Study|Physician Decision|0
2933012|NCT01451164|10099105|P3|Overall Study|Physician Decision|1
2933013|NCT01451164|10099106|P2|Overall Study|Physician Decision|0
2933014|NCT01451164|10099107|P1|Overall Study|Physician Decision|2
2933015|NCT01451164|10099104|P4|Overall Study|Withdrawal Criteria|1
2933016|NCT01451164|10099105|P3|Overall Study|Withdrawal Criteria|1
2933017|NCT01451164|10099106|P2|Overall Study|Withdrawal Criteria|1
2933018|NCT01451164|10099107|P1|Overall Study|Withdrawal Criteria|1
2933019|NCT01451164|10099104|P4|Overall Study|Adverse Event|21
2933020|NCT01451164|10099105|P3|Overall Study|Adverse Event|18
2933021|NCT01451164|10099106|P2|Overall Study|Adverse Event|12
2933022|NCT01451164|10099107|P1|Overall Study|Adverse Event|19
2933023|NCT01450943|10099136|P3|Overall Study|Screen failure, loss to follow-up|6
2933024|NCT01450943|10099137|P2|Overall Study|Screen failure, loss to follow-up|7
2933025|NCT01450943|10099138|P1|Overall Study|Screen failure, loss to follow-up|2
2933026|NCT01450813|10099171|P4|Overall Study|Physician Decision|3
2933027|NCT01450813|10099172|P3|Overall Study|Physician Decision|0
2933028|NCT01450813|10099173|P2|Overall Study|Physician Decision|1
2933029|NCT01450813|10099174|P1|Overall Study|Physician Decision|1
2933030|NCT01450800|10099188|P2|Overall Study|Protocol Violation|3
2933031|NCT01450800|10099189|P1|Overall Study|Protocol Violation|1
2933032|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
2933033|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
2933034|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
2933035|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
2933036|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Not reported|2
2933037|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Not reported|2
2933038|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
2933039|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
2933040|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
2933041|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
2933042|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
2933043|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
2933044|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
2933045|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
2933046|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Death|6
2933047|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Death|5
2933048|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
2933049|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
2933050|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
2933051|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
2933052|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
2933053|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
2933054|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
2933055|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
2933056|NCT01450761|10099224|P2|Treatment With Blinded Study Therapy|Disease progression|415
2933057|NCT01450761|10099225|P1|Treatment With Blinded Study Therapy|Disease progression|318
2933058|NCT01450761|10099224|P2|Lead-in Chemotherapy|Lost to Follow-up|0
2933059|NCT01450761|10099225|P1|Lead-in Chemotherapy|Lost to Follow-up|2
2933060|NCT01450761|10099224|P2|Lead-in Chemotherapy|Other|2
2933061|NCT01450761|10099225|P1|Lead-in Chemotherapy|Other|2
2933062|NCT01450761|10099224|P2|Lead-in Chemotherapy|Death|3
2933063|NCT01450761|10099225|P1|Lead-in Chemotherapy|Death|3
2933064|NCT01450761|10099224|P2|Lead-in Chemotherapy|No longer meets study criteria|7
2933065|NCT01450761|10099225|P1|Lead-in Chemotherapy|No longer meets study criteria|3
2933066|NCT01450761|10099224|P2|Lead-in Chemotherapy|Study drug toxicity|10
2933067|NCT01450761|10099225|P1|Lead-in Chemotherapy|Study drug toxicity|6
2933068|NCT01450761|10099224|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
2933069|NCT01450761|10099225|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
2933070|NCT01450761|10099224|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
2933071|NCT01450761|10099225|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
2933072|NCT01450761|10099224|P2|Lead-in Chemotherapy|Disease progression|32
2933073|NCT01450761|10099225|P1|Lead-in Chemotherapy|Disease progression|33
2933074|NCT01450761|10099224|P2|Randomization|Other|1
2933075|NCT01450761|10099225|P1|Randomization|Other|0
2933076|NCT01450761|10099224|P2|Randomization|Adverse Event unrelated to study drug|0
2933077|NCT01450761|10099225|P1|Randomization|Adverse Event unrelated to study drug|1
2933078|NCT01450761|10099224|P2|Randomization|Disease progression|2
2933079|NCT01450761|10099225|P1|Randomization|Disease progression|0
2933080|NCT01450761|10099224|P2|Randomization|Withdrawal by Subject|0
2933081|NCT01450761|10099225|P1|Randomization|Withdrawal by Subject|2
2933082|NCT01450761|10099224|P2|Randomization|Subject no longer meets study criteria|2
2933083|NCT01450761|10099225|P1|Randomization|Subject no longer meets study criteria|1
2933084|NCT01450696|10099237|P2|Overall Study|Study Terminated by Sponsor|58
2933085|NCT01450696|10099238|P1|Overall Study|Study Terminated by Sponsor|53
2933086|NCT01450696|10099237|P2|Overall Study|Withdrawal by Subject|2
2933087|NCT01450696|10099238|P1|Overall Study|Withdrawal by Subject|13
2933088|NCT01450696|10099237|P2|Overall Study|Non-Compliance|0
2933089|NCT01450696|10099238|P1|Overall Study|Non-Compliance|1
2933090|NCT01450696|10099237|P2|Overall Study|Lost to Follow-up|3
2933091|NCT01450696|10099238|P1|Overall Study|Lost to Follow-up|3
2933092|NCT01450696|10099237|P2|Overall Study|Death|84
2933093|NCT01450696|10099238|P1|Overall Study|Death|77
2933094|NCT01450696|10099237|P2|Overall Study|Never Treated|1
2933095|NCT01450696|10099238|P1|Overall Study|Never Treated|1
2933096|NCT01450683|10099260|P1|Overall Study|Adverse Event|2
2933097|NCT01450631|10099266|P2|Overall Study|Withdrawal by Subject|0
2933098|NCT01450631|10099267|P1|Overall Study|Withdrawal by Subject|1
2933099|NCT01450631|10099266|P2|Overall Study|Lost to Follow-up|4
2933100|NCT01450631|10099267|P1|Overall Study|Lost to Follow-up|2
2933101|NCT01450137|10099397|P2|Week 12 to Study End|Withdrawal by Subject|1
2933102|NCT01450137|10099398|P1|Week 12 to Study End|Withdrawal by Subject|0
2933103|NCT01450137|10099397|P2|Week 12 to Study End|Death|1
2933104|NCT01450137|10099398|P1|Week 12 to Study End|Death|0
2933105|NCT01450137|10099397|P2|Up to Week 12|Withdrawal by Subject|2
2933106|NCT01450137|10099398|P1|Up to Week 12|Withdrawal by Subject|0
2933107|NCT01450137|10099397|P2|Up to Week 12|Adverse Event|1
2933108|NCT01450137|10099398|P1|Up to Week 12|Adverse Event|2
2933109|NCT01450098|10099412|P2|Period 3|Withdrawal by Subject|2
2933110|NCT01450098|10099413|P1|Period 3|Withdrawal by Subject|0
2933111|NCT01450098|10099412|P2|Period 3|Protocol Violation|1
2933112|NCT01450098|10099413|P1|Period 3|Protocol Violation|0
2933113|NCT01450007|10099432|P3|Overall Study|Adverse Event|0
2933114|NCT01450007|10099433|P2|Overall Study|Adverse Event|1
2933115|NCT01450007|10099434|P1|Overall Study|Adverse Event|0
2933116|NCT01450007|10099432|P3|Overall Study|Protocol Violation|1
2933117|NCT01450007|10099433|P2|Overall Study|Protocol Violation|1
2933118|NCT01450007|10099434|P1|Overall Study|Protocol Violation|0
2933119|NCT01450007|10099432|P3|Overall Study|Late exclusion before treatment|2
2933120|NCT01450007|10099433|P2|Overall Study|Late exclusion before treatment|3
2933121|NCT01450007|10099434|P1|Overall Study|Late exclusion before treatment|2
2933122|NCT01449955|10099453|P2|Overall Study|Withdrawal by Subject|2
2933123|NCT01449955|10099454|P1|Overall Study|Withdrawal by Subject|1
2933208|NCT01449539|10099771|P1|Overall Study|Withdrawal by Subject|3
2933124|NCT01449929|10099482|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
2933125|NCT01449929|10099483|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2933126|NCT01449929|10099484|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2933127|NCT01449929|10099482|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
2933128|NCT01449929|10099483|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2933129|NCT01449929|10099484|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2933130|NCT01449929|10099482|P3|Extension Phase Approximately 3 Years|Adverse Event|2
2933131|NCT01449929|10099483|P2|Extension Phase Approximately 3 Years|Adverse Event|0
2933132|NCT01449929|10099484|P1|Extension Phase Approximately 3 Years|Adverse Event|0
2933133|NCT01449929|10099482|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
2933134|NCT01449929|10099483|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
2933135|NCT01449929|10099484|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
2933136|NCT01449929|10099482|P3|Randomization Phase 96 Week|Physician Decision|0
2933137|NCT01449929|10099483|P2|Randomization Phase 96 Week|Physician Decision|3
2933138|NCT01449929|10099484|P1|Randomization Phase 96 Week|Physician Decision|2
2933139|NCT01449929|10099482|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
2933140|NCT01449929|10099483|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
2933141|NCT01449929|10099484|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
2933142|NCT01449929|10099482|P3|Randomization Phase 96 Week|Lost to Follow-up|0
2933143|NCT01449929|10099483|P2|Randomization Phase 96 Week|Lost to Follow-up|18
2933144|NCT01449929|10099484|P1|Randomization Phase 96 Week|Lost to Follow-up|15
2933145|NCT01449929|10099482|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2933146|NCT01449929|10099483|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2933147|NCT01449929|10099484|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
2933148|NCT01449929|10099482|P3|Randomization Phase 96 Week|Protocol Violation|0
2933149|NCT01449929|10099483|P2|Randomization Phase 96 Week|Protocol Violation|6
2933150|NCT01449929|10099484|P1|Randomization Phase 96 Week|Protocol Violation|5
2933151|NCT01449929|10099482|P3|Randomization Phase 96 Week|Lack of Efficacy|0
2933152|NCT01449929|10099483|P2|Randomization Phase 96 Week|Lack of Efficacy|4
2933153|NCT01449929|10099484|P1|Randomization Phase 96 Week|Lack of Efficacy|3
2933154|NCT01449929|10099482|P3|Randomization Phase 96 Week|Adverse Event|0
2933155|NCT01449929|10099483|P2|Randomization Phase 96 Week|Adverse Event|13
2933156|NCT01449929|10099484|P1|Randomization Phase 96 Week|Adverse Event|5
2933157|NCT01449812|10099529|P3|Overall Study|Lost to Follow-up|0
2933158|NCT01449812|10099530|P2|Overall Study|Lost to Follow-up|0
2933159|NCT01449812|10099531|P1|Overall Study|Lost to Follow-up|1
2933160|NCT01449812|10099529|P3|Overall Study|Withdrawal by Subject|1
2933161|NCT01449812|10099530|P2|Overall Study|Withdrawal by Subject|0
2933162|NCT01449812|10099531|P1|Overall Study|Withdrawal by Subject|0
2933163|NCT01449812|10099529|P3|Overall Study|Migrated/moved from study area|0
2933164|NCT01449812|10099530|P2|Overall Study|Migrated/moved from study area|0
2933165|NCT01449812|10099531|P1|Overall Study|Migrated/moved from study area|1
2933166|NCT01449721|10099646|P2|Overall Study|Physician Decision|1
2933167|NCT01449721|10099647|P1|Overall Study|Physician Decision|0
2933168|NCT01449721|10099646|P2|Overall Study|Physician Decision|1
2933169|NCT01449721|10099647|P1|Overall Study|Physician Decision|0
2933170|NCT01449708|10099659|P2|Overall Study|respiratory failure|0
2933171|NCT01449708|10099660|P1|Overall Study|respiratory failure|1
2933172|NCT01449708|10099659|P2|Overall Study|surgical complication|2
2933173|NCT01449708|10099660|P1|Overall Study|surgical complication|1
2933174|NCT01449708|10099659|P2|Overall Study|Protocol Violation|1
2933175|NCT01449708|10099660|P1|Overall Study|Protocol Violation|0
2933176|NCT01449682|10099671|P2|Overall Study|Adverse Event|0
2933177|NCT01449682|10099672|P1|Overall Study|Adverse Event|1
2933178|NCT01449682|10099671|P2|Overall Study|Death|1
2933179|NCT01449682|10099672|P1|Overall Study|Death|0
2933180|NCT01449630|10099693|P9|Period 2|Sponsor Decision|0
2933181|NCT01449630|10099694|P8|Period 2|Sponsor Decision|0
2933182|NCT01449630|10099695|P7|Period 2|Sponsor Decision|1
2933183|NCT01449630|10099696|P6|Period 2|Sponsor Decision|0
2933184|NCT01449630|10099697|P5|Period 2|Sponsor Decision|0
2933185|NCT01449630|10099698|P4|Period 2|Sponsor Decision|0
2933186|NCT01449630|10099699|P3|Period 2|Sponsor Decision|0
2933187|NCT01449630|10099700|P2|Period 2|Sponsor Decision|0
2933188|NCT01449630|10099701|P1|Period 2|Sponsor Decision|0
2933189|NCT01449630|10099693|P9|Period 1|Sponsor Decision|0
2933190|NCT01449630|10099694|P8|Period 1|Sponsor Decision|0
2933191|NCT01449630|10099695|P7|Period 1|Sponsor Decision|0
2933192|NCT01449630|10099696|P6|Period 1|Sponsor Decision|1
2933193|NCT01449630|10099697|P5|Period 1|Sponsor Decision|0
2933194|NCT01449630|10099698|P4|Period 1|Sponsor Decision|0
2933195|NCT01449630|10099699|P3|Period 1|Sponsor Decision|0
2933196|NCT01449630|10099700|P2|Period 1|Sponsor Decision|0
2933197|NCT01449630|10099701|P1|Period 1|Sponsor Decision|0
2933198|NCT01449630|10099693|P9|Period 1|Physician Decision|0
2933199|NCT01449630|10099694|P8|Period 1|Physician Decision|0
2933200|NCT01449630|10099695|P7|Period 1|Physician Decision|0
2933201|NCT01449630|10099696|P6|Period 1|Physician Decision|0
2933202|NCT01449630|10099697|P5|Period 1|Physician Decision|0
2933203|NCT01449630|10099698|P4|Period 1|Physician Decision|1
2933204|NCT01449630|10099699|P3|Period 1|Physician Decision|0
2933205|NCT01449630|10099700|P2|Period 1|Physician Decision|0
2933206|NCT01449630|10099701|P1|Period 1|Physician Decision|1
2933207|NCT01449539|10099771|P1|Overall Study|Toxicity not study related|1
2933209|NCT01449526|10099777|P2|Overall Study|Cannot maintain visits|1
2933210|NCT01449526|10099778|P1|Overall Study|Cannot maintain visits|0
2933211|NCT01449526|10099777|P2|Overall Study|Lack of Motivation|1
2933212|NCT01449526|10099778|P1|Overall Study|Lack of Motivation|0
2933213|NCT01449526|10099777|P2|Overall Study|Symptoms/complaints|1
2933214|NCT01449526|10099778|P1|Overall Study|Symptoms/complaints|0
2933215|NCT01449526|10099777|P2|Overall Study|Withdrawal by Subject|1
2933216|NCT01449526|10099778|P1|Overall Study|Withdrawal by Subject|1
2933217|NCT01449526|10099777|P2|Overall Study|Lost to Follow-up|2
2933218|NCT01449526|10099778|P1|Overall Study|Lost to Follow-up|1
2933219|NCT01449461|10099847|P6|Overall Study|Reason not specified|1
2933220|NCT01449461|10099848|P5|Overall Study|Reason not specified|0
2933221|NCT01449461|10099849|P4|Overall Study|Reason not specified|3
2933222|NCT01449461|10099850|P3|Overall Study|Reason not specified|0
2933223|NCT01449461|10099851|P2|Overall Study|Reason not specified|1
2933224|NCT01449461|10099852|P1|Overall Study|Reason not specified|0
2933225|NCT01449461|10099847|P6|Overall Study|Clinical progressive disease|3
2933226|NCT01449461|10099848|P5|Overall Study|Clinical progressive disease|3
2933227|NCT01449461|10099849|P4|Overall Study|Clinical progressive disease|0
2933228|NCT01449461|10099850|P3|Overall Study|Clinical progressive disease|0
2933229|NCT01449461|10099851|P2|Overall Study|Clinical progressive disease|1
2933230|NCT01449461|10099852|P1|Overall Study|Clinical progressive disease|2
2933231|NCT01449461|10099847|P6|Overall Study|Documented progressive disease|5
2933232|NCT01449461|10099848|P5|Overall Study|Documented progressive disease|21
2933233|NCT01449461|10099849|P4|Overall Study|Documented progressive disease|11
2933234|NCT01449461|10099850|P3|Overall Study|Documented progressive disease|14
2933235|NCT01449461|10099851|P2|Overall Study|Documented progressive disease|6
2933236|NCT01449461|10099852|P1|Overall Study|Documented progressive disease|4
2933237|NCT01449461|10099847|P6|Overall Study|Death|1
2933238|NCT01449461|10099848|P5|Overall Study|Death|4
2933239|NCT01449461|10099849|P4|Overall Study|Death|0
2933240|NCT01449461|10099850|P3|Overall Study|Death|0
2933241|NCT01449461|10099851|P2|Overall Study|Death|1
2933242|NCT01449461|10099852|P1|Overall Study|Death|0
2933243|NCT01449461|10099847|P6|Overall Study|Adverse Event|3
2933244|NCT01449461|10099848|P5|Overall Study|Adverse Event|3
2933245|NCT01449461|10099849|P4|Overall Study|Adverse Event|3
2933246|NCT01449461|10099850|P3|Overall Study|Adverse Event|2
2933247|NCT01449461|10099851|P2|Overall Study|Adverse Event|3
2933248|NCT01449461|10099852|P1|Overall Study|Adverse Event|0
2933249|NCT01449461|10099847|P6|Overall Study|Ongoing|2
2933250|NCT01449461|10099848|P5|Overall Study|Ongoing|17
2933251|NCT01449461|10099849|P4|Overall Study|Ongoing|15
2933252|NCT01449461|10099850|P3|Overall Study|Ongoing|2
2933253|NCT01449461|10099851|P2|Overall Study|Ongoing|6
2933254|NCT01449461|10099852|P1|Overall Study|Ongoing|0
2933255|NCT01449370|10099989|P25|Overall Study|Death|1
2933256|NCT01449370|10099990|P24|Overall Study|Death|0
2933257|NCT01449370|10099991|P23|Overall Study|Death|0
2933258|NCT01449370|10099992|P22|Overall Study|Death|0
2933259|NCT01449370|10099993|P21|Overall Study|Death|0
2933260|NCT01449370|10099994|P20|Overall Study|Death|0
2933261|NCT01449370|10099995|P19|Overall Study|Death|0
2933262|NCT01449370|10099996|P18|Overall Study|Death|0
2933263|NCT01449370|10099997|P17|Overall Study|Death|0
2933264|NCT01449370|10099998|P16|Overall Study|Death|0
2933265|NCT01449370|10099999|P15|Overall Study|Death|0
2933266|NCT01449370|10100000|P14|Overall Study|Death|0
2933267|NCT01449370|10100001|P13|Overall Study|Death|0
2933268|NCT01449370|10100002|P12|Overall Study|Death|0
2933269|NCT01449370|10100003|P11|Overall Study|Death|0
2933270|NCT01449370|10100004|P10|Overall Study|Death|0
2933271|NCT01449370|10100005|P9|Overall Study|Death|0
2933272|NCT01449370|10100006|P8|Overall Study|Death|0
2933273|NCT01449370|10100007|P7|Overall Study|Death|0
2933274|NCT01449370|10100008|P6|Overall Study|Death|0
2933275|NCT01449370|10100009|P5|Overall Study|Death|0
2933276|NCT01449370|10100010|P4|Overall Study|Death|0
2933277|NCT01449370|10100011|P3|Overall Study|Death|0
2933278|NCT01449370|10100012|P2|Overall Study|Death|0
2933279|NCT01449370|10100013|P1|Overall Study|Death|0
2933280|NCT01449370|10099989|P25|Overall Study|Medication Prohibited by Protocol|0
2933281|NCT01449370|10099990|P24|Overall Study|Medication Prohibited by Protocol|1
2933282|NCT01449370|10099991|P23|Overall Study|Medication Prohibited by Protocol|0
2933283|NCT01449370|10099992|P22|Overall Study|Medication Prohibited by Protocol|0
2933284|NCT01449370|10099993|P21|Overall Study|Medication Prohibited by Protocol|0
2933285|NCT01449370|10099994|P20|Overall Study|Medication Prohibited by Protocol|0
2933286|NCT01449370|10099995|P19|Overall Study|Medication Prohibited by Protocol|0
2933287|NCT01449370|10099996|P18|Overall Study|Medication Prohibited by Protocol|0
2933288|NCT01449370|10099997|P17|Overall Study|Medication Prohibited by Protocol|0
2933289|NCT01449370|10099998|P16|Overall Study|Medication Prohibited by Protocol|0
2933290|NCT01449370|10099999|P15|Overall Study|Medication Prohibited by Protocol|0
2933291|NCT01449370|10100000|P14|Overall Study|Medication Prohibited by Protocol|0
2933292|NCT01449370|10100001|P13|Overall Study|Medication Prohibited by Protocol|0
2933293|NCT01449370|10100002|P12|Overall Study|Medication Prohibited by Protocol|0
2933294|NCT01449370|10100003|P11|Overall Study|Medication Prohibited by Protocol|0
2933295|NCT01449370|10100004|P10|Overall Study|Medication Prohibited by Protocol|0
2933296|NCT01449370|10100005|P9|Overall Study|Medication Prohibited by Protocol|0
2933297|NCT01449370|10100006|P8|Overall Study|Medication Prohibited by Protocol|0
2933298|NCT01449370|10100007|P7|Overall Study|Medication Prohibited by Protocol|0
2933299|NCT01449370|10100008|P6|Overall Study|Medication Prohibited by Protocol|0
2933300|NCT01449370|10100009|P5|Overall Study|Medication Prohibited by Protocol|0
2933301|NCT01449370|10100010|P4|Overall Study|Medication Prohibited by Protocol|0
2933302|NCT01449370|10100011|P3|Overall Study|Medication Prohibited by Protocol|0
2933303|NCT01449370|10100012|P2|Overall Study|Medication Prohibited by Protocol|0
2933304|NCT01449370|10100013|P1|Overall Study|Medication Prohibited by Protocol|0
2933305|NCT01449370|10099989|P25|Overall Study|Other|0
2933306|NCT01449370|10099990|P24|Overall Study|Other|1
2933307|NCT01449370|10099991|P23|Overall Study|Other|1
2933308|NCT01449370|10099992|P22|Overall Study|Other|0
2933309|NCT01449370|10099993|P21|Overall Study|Other|0
2933310|NCT01449370|10099994|P20|Overall Study|Other|0
2933311|NCT01449370|10099995|P19|Overall Study|Other|0
2933312|NCT01449370|10099996|P18|Overall Study|Other|0
2933313|NCT01449370|10099997|P17|Overall Study|Other|0
2933314|NCT01449370|10099998|P16|Overall Study|Other|0
2933315|NCT01449370|10099999|P15|Overall Study|Other|0
2933316|NCT01449370|10100000|P14|Overall Study|Other|0
2933317|NCT01449370|10100001|P13|Overall Study|Other|0
2933318|NCT01449370|10100002|P12|Overall Study|Other|0
2933319|NCT01449370|10100003|P11|Overall Study|Other|0
2933320|NCT01449370|10100004|P10|Overall Study|Other|1
2933321|NCT01449370|10100005|P9|Overall Study|Other|1
2933322|NCT01449370|10100006|P8|Overall Study|Other|0
2933323|NCT01449370|10100007|P7|Overall Study|Other|0
2933324|NCT01449370|10100008|P6|Overall Study|Other|0
2933325|NCT01449370|10100009|P5|Overall Study|Other|0
2933326|NCT01449370|10100010|P4|Overall Study|Other|0
2933327|NCT01449370|10100011|P3|Overall Study|Other|0
2933328|NCT01449370|10100012|P2|Overall Study|Other|0
2933329|NCT01449370|10100013|P1|Overall Study|Other|0
2933330|NCT01449370|10099989|P25|Overall Study|Lost to Follow-up|0
2933331|NCT01449370|10099990|P24|Overall Study|Lost to Follow-up|0
2933332|NCT01449370|10099991|P23|Overall Study|Lost to Follow-up|0
2933333|NCT01449370|10099992|P22|Overall Study|Lost to Follow-up|0
2933334|NCT01449370|10099993|P21|Overall Study|Lost to Follow-up|1
2933335|NCT01449370|10099994|P20|Overall Study|Lost to Follow-up|0
2933336|NCT01449370|10099995|P19|Overall Study|Lost to Follow-up|0
2933337|NCT01449370|10099996|P18|Overall Study|Lost to Follow-up|0
2933338|NCT01449370|10099997|P17|Overall Study|Lost to Follow-up|0
2933339|NCT01449370|10099998|P16|Overall Study|Lost to Follow-up|0
2933340|NCT01449370|10099999|P15|Overall Study|Lost to Follow-up|0
2933341|NCT01449370|10100000|P14|Overall Study|Lost to Follow-up|0
2933342|NCT01449370|10100001|P13|Overall Study|Lost to Follow-up|0
2933343|NCT01449370|10100002|P12|Overall Study|Lost to Follow-up|0
2933344|NCT01449370|10100003|P11|Overall Study|Lost to Follow-up|0
2933345|NCT01449370|10100004|P10|Overall Study|Lost to Follow-up|0
2933346|NCT01449370|10100005|P9|Overall Study|Lost to Follow-up|0
2933347|NCT01449370|10100006|P8|Overall Study|Lost to Follow-up|0
2933348|NCT01449370|10100007|P7|Overall Study|Lost to Follow-up|0
2933349|NCT01449370|10100008|P6|Overall Study|Lost to Follow-up|0
2933350|NCT01449370|10100009|P5|Overall Study|Lost to Follow-up|0
2933351|NCT01449370|10100010|P4|Overall Study|Lost to Follow-up|0
2933352|NCT01449370|10100011|P3|Overall Study|Lost to Follow-up|0
2933353|NCT01449370|10100012|P2|Overall Study|Lost to Follow-up|0
2933354|NCT01449370|10100013|P1|Overall Study|Lost to Follow-up|0
2933355|NCT01449370|10099989|P25|Overall Study|Participant Decision|1
2933356|NCT01449370|10099990|P24|Overall Study|Participant Decision|0
2933357|NCT01449370|10099991|P23|Overall Study|Participant Decision|0
2933358|NCT01449370|10099992|P22|Overall Study|Participant Decision|1
2933359|NCT01449370|10099993|P21|Overall Study|Participant Decision|0
2933360|NCT01449370|10099994|P20|Overall Study|Participant Decision|0
2933361|NCT01449370|10099995|P19|Overall Study|Participant Decision|1
2933362|NCT01449370|10099996|P18|Overall Study|Participant Decision|0
2933363|NCT01449370|10099997|P17|Overall Study|Participant Decision|3
2933364|NCT01449370|10099998|P16|Overall Study|Participant Decision|1
2933365|NCT01449370|10099999|P15|Overall Study|Participant Decision|0
2933366|NCT01449370|10100000|P14|Overall Study|Participant Decision|1
2933367|NCT01449370|10100001|P13|Overall Study|Participant Decision|1
2933368|NCT01449370|10100002|P12|Overall Study|Participant Decision|0
2933369|NCT01449370|10100003|P11|Overall Study|Participant Decision|0
2933370|NCT01449370|10100004|P10|Overall Study|Participant Decision|0
2933371|NCT01449370|10100005|P9|Overall Study|Participant Decision|1
2933372|NCT01449370|10100006|P8|Overall Study|Participant Decision|1
2933373|NCT01449370|10100007|P7|Overall Study|Participant Decision|0
2933374|NCT01449370|10100008|P6|Overall Study|Participant Decision|0
2933375|NCT01449370|10100009|P5|Overall Study|Participant Decision|0
2933376|NCT01449370|10100010|P4|Overall Study|Participant Decision|0
2933377|NCT01449370|10100011|P3|Overall Study|Participant Decision|0
2933378|NCT01449370|10100012|P2|Overall Study|Participant Decision|0
2933379|NCT01449370|10100013|P1|Overall Study|Participant Decision|0
2933380|NCT01449370|10099989|P25|Overall Study|Adverse Event|3
2933381|NCT01449370|10099990|P24|Overall Study|Adverse Event|1
2933382|NCT01449370|10099991|P23|Overall Study|Adverse Event|0
2933383|NCT01449370|10099992|P22|Overall Study|Adverse Event|1
2933384|NCT01449370|10099993|P21|Overall Study|Adverse Event|0
2933385|NCT01449370|10099994|P20|Overall Study|Adverse Event|1
2933386|NCT01449370|10099995|P19|Overall Study|Adverse Event|1
2933387|NCT01449370|10099996|P18|Overall Study|Adverse Event|0
2933388|NCT01449370|10099997|P17|Overall Study|Adverse Event|0
2933389|NCT01449370|10099998|P16|Overall Study|Adverse Event|1
2933390|NCT01449370|10099999|P15|Overall Study|Adverse Event|0
2933391|NCT01449370|10100000|P14|Overall Study|Adverse Event|2
2933392|NCT01449370|10100001|P13|Overall Study|Adverse Event|0
2933393|NCT01449370|10100002|P12|Overall Study|Adverse Event|0
2933394|NCT01449370|10100003|P11|Overall Study|Adverse Event|0
2933395|NCT01449370|10100004|P10|Overall Study|Adverse Event|1
2933396|NCT01449370|10100005|P9|Overall Study|Adverse Event|1
2933397|NCT01449370|10100006|P8|Overall Study|Adverse Event|0
2933398|NCT01449370|10100007|P7|Overall Study|Adverse Event|0
2933399|NCT01449370|10100008|P6|Overall Study|Adverse Event|0
2933400|NCT01449370|10100009|P5|Overall Study|Adverse Event|0
2933401|NCT01449370|10100010|P4|Overall Study|Adverse Event|1
2933402|NCT01449370|10100011|P3|Overall Study|Adverse Event|0
2933403|NCT01449370|10100012|P2|Overall Study|Adverse Event|2
2933404|NCT01449370|10100013|P1|Overall Study|Adverse Event|1
2933405|NCT01449370|10099989|P25|Overall Study|Disease Progression|3
2933406|NCT01449370|10099990|P24|Overall Study|Disease Progression|7
2933407|NCT01449370|10099991|P23|Overall Study|Disease Progression|3
2933408|NCT01449370|10099992|P22|Overall Study|Disease Progression|2
2933409|NCT01449370|10099993|P21|Overall Study|Disease Progression|5
2933410|NCT01449370|10099994|P20|Overall Study|Disease Progression|2
2933411|NCT01449370|10099995|P19|Overall Study|Disease Progression|1
2933412|NCT01449370|10099996|P18|Overall Study|Disease Progression|3
2933413|NCT01449370|10099997|P17|Overall Study|Disease Progression|4
2933414|NCT01449370|10099998|P16|Overall Study|Disease Progression|1
2933415|NCT01449370|10099999|P15|Overall Study|Disease Progression|3
2933416|NCT01449370|10100000|P14|Overall Study|Disease Progression|8
2933417|NCT01449370|10100001|P13|Overall Study|Disease Progression|2
2933418|NCT01449370|10100002|P12|Overall Study|Disease Progression|3
2933419|NCT01449370|10100003|P11|Overall Study|Disease Progression|3
2933420|NCT01449370|10100004|P10|Overall Study|Disease Progression|1
2933421|NCT01449370|10100005|P9|Overall Study|Disease Progression|9
2933422|NCT01449370|10100006|P8|Overall Study|Disease Progression|2
2933423|NCT01449370|10100007|P7|Overall Study|Disease Progression|3
2933424|NCT01449370|10100008|P6|Overall Study|Disease Progression|3
2933425|NCT01449370|10100009|P5|Overall Study|Disease Progression|3
2933426|NCT01449370|10100010|P4|Overall Study|Disease Progression|3
2933427|NCT01449370|10100011|P3|Overall Study|Disease Progression|8
2933428|NCT01449370|10100012|P2|Overall Study|Disease Progression|4
2933429|NCT01449370|10100013|P1|Overall Study|Disease Progression|5
2933430|NCT01449279|10100391|P1|Overall Study|Toxicity|2
2933431|NCT01449279|10100391|P1|Overall Study|Lack of Efficacy|5
2933432|NCT01449006|10100416|P2|Overall Study|Protocol Violation|0
2933433|NCT01449006|10100417|P1|Overall Study|Protocol Violation|1
2933434|NCT01449006|10100416|P2|Overall Study|Withdrawal by Subject|0
2933435|NCT01449006|10100417|P1|Overall Study|Withdrawal by Subject|1
2933436|NCT01449006|10100416|P2|Overall Study|Lost to Follow-up|0
2933437|NCT01449006|10100417|P1|Overall Study|Lost to Follow-up|1
2933438|NCT01448850|10100431|P2|Overall Study|Other|12
2933439|NCT01448850|10100432|P1|Overall Study|Other|15
2933440|NCT01448850|10100431|P2|Overall Study|Lost to Follow-up|1
2933441|NCT01448850|10100432|P1|Overall Study|Lost to Follow-up|3
2933442|NCT01448850|10100431|P2|Overall Study|Withdrawal by Subject|21
2933443|NCT01448850|10100432|P1|Overall Study|Withdrawal by Subject|13
2933444|NCT01448850|10100431|P2|Overall Study|Death|6
2933445|NCT01448850|10100432|P1|Overall Study|Death|3
2933446|NCT01448824|10100463|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
2933447|NCT01448824|10100464|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933448|NCT01448824|10100465|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933449|NCT01448824|10100466|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933450|NCT01448824|10100467|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933451|NCT01448824|10100468|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933452|NCT01448824|10100469|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933453|NCT01448824|10100470|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2933454|NCT01448824|10100463|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
2933455|NCT01448824|10100464|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933456|NCT01448824|10100465|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933457|NCT01448824|10100466|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933458|NCT01448824|10100467|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933459|NCT01448824|10100468|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933460|NCT01448824|10100469|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933461|NCT01448824|10100470|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2933462|NCT01448824|10100463|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
2933463|NCT01448824|10100464|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933464|NCT01448824|10100465|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933465|NCT01448824|10100466|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933466|NCT01448824|10100467|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933467|NCT01448824|10100468|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933468|NCT01448824|10100469|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933469|NCT01448824|10100470|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2933470|NCT01448824|10100463|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
2933471|NCT01448824|10100464|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933472|NCT01448824|10100465|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933473|NCT01448824|10100466|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933474|NCT01448824|10100467|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933475|NCT01448824|10100468|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933476|NCT01448824|10100469|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933477|NCT01448824|10100470|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2933478|NCT01448824|10100463|P8|Part 1: Washout Period|Lost to Follow-up|0
2933479|NCT01448824|10100464|P7|Part 1: Washout Period|Lost to Follow-up|0
2933480|NCT01448824|10100465|P6|Part 1: Washout Period|Lost to Follow-up|0
2933481|NCT01448824|10100466|P5|Part 1: Washout Period|Lost to Follow-up|0
2933482|NCT01448824|10100467|P4|Part 1: Washout Period|Lost to Follow-up|0
2933483|NCT01448824|10100468|P3|Part 1: Washout Period|Lost to Follow-up|0
2933484|NCT01448824|10100469|P2|Part 1: Washout Period|Lost to Follow-up|0
2933485|NCT01448824|10100470|P1|Part 1: Washout Period|Lost to Follow-up|1
2933486|NCT01448824|10100463|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933487|NCT01448824|10100464|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933488|NCT01448824|10100465|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
2933489|NCT01448824|10100466|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933490|NCT01448824|10100467|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933491|NCT01448824|10100468|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933492|NCT01448824|10100469|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933493|NCT01448824|10100470|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2933494|NCT01448824|10100463|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2933495|NCT01448824|10100464|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2933496|NCT01448824|10100465|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2933497|NCT01448824|10100466|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
2933498|NCT01448824|10100467|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2933499|NCT01448824|10100468|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2933500|NCT01448824|10100469|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2933501|NCT01448824|10100470|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2933502|NCT01448824|10100463|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933503|NCT01448824|10100464|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
2933504|NCT01448824|10100465|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933505|NCT01448824|10100466|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933506|NCT01448824|10100467|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933507|NCT01448824|10100468|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933508|NCT01448824|10100469|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933509|NCT01448824|10100470|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2933510|NCT01448707|10100521|P2|Overall Study|Other|4
2933511|NCT01448707|10100522|P1|Overall Study|Other|7
2933512|NCT01448707|10100521|P2|Overall Study|Withdrawal by Subject|7
2933513|NCT01448707|10100522|P1|Overall Study|Withdrawal by Subject|6
2933514|NCT01448707|10100521|P2|Overall Study|Lost to Follow-up|6
2933515|NCT01448707|10100522|P1|Overall Study|Lost to Follow-up|2
2933516|NCT01448707|10100521|P2|Overall Study|Adverse Event|1
2933517|NCT01448707|10100522|P1|Overall Study|Adverse Event|3
2933518|NCT01448616|10100543|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2933519|NCT01448616|10100544|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2933520|NCT01448616|10100545|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
2933521|NCT01448616|10100546|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
2933522|NCT01448616|10100543|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
2933523|NCT01448616|10100544|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
2933524|NCT01448616|10100545|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
2933525|NCT01448616|10100546|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
2933526|NCT01448616|10100543|P4|Study Drug (Treatment Phase)|Adverse Event|0
2933527|NCT01448616|10100544|P3|Study Drug (Treatment Phase)|Adverse Event|1
2933528|NCT01448616|10100545|P2|Study Drug (Treatment Phase)|Adverse Event|1
2933529|NCT01448616|10100546|P1|Study Drug (Treatment Phase)|Adverse Event|0
2933530|NCT01448616|10100543|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2933531|NCT01448616|10100544|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2933532|NCT01448616|10100545|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2933533|NCT01448616|10100546|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
2933534|NCT01448616|10100543|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
2933535|NCT01448616|10100544|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
2933536|NCT01448616|10100545|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
2933537|NCT01448616|10100546|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
2933538|NCT01448213|10100593|P2|Overall Study|Protocol Violation|2
2933539|NCT01448213|10100594|P1|Overall Study|Protocol Violation|1
2933540|NCT01448213|10100593|P2|Overall Study|Adverse Event|10
2933541|NCT01448213|10100594|P1|Overall Study|Adverse Event|4
2933542|NCT01448213|10100593|P2|Overall Study|Lost to Follow-up|10
2933543|NCT01448213|10100594|P1|Overall Study|Lost to Follow-up|12
2933544|NCT01448057|10100604|P2|Overall Study|Withdrawal by Subject|0
2933545|NCT01448057|10100605|P1|Overall Study|Withdrawal by Subject|2
2933546|NCT01448057|10100604|P2|Overall Study|Adverse Event|2
2933547|NCT01448057|10100605|P1|Overall Study|Adverse Event|0
2933548|NCT01448057|10100604|P2|Overall Study|Lost to Follow-up|0
2933549|NCT01448057|10100605|P1|Overall Study|Lost to Follow-up|3
2933550|NCT01448057|10100604|P2|Overall Study|Protocol Violation|2
2933551|NCT01448057|10100605|P1|Overall Study|Protocol Violation|3
2933552|NCT01448044|10100615|P2|Follow Up Period|Other|11
2933553|NCT01448044|10100616|P1|Follow Up Period|Other|5
2933554|NCT01448044|10100615|P2|Follow Up Period|Lost to Follow-up|2
2933555|NCT01448044|10100616|P1|Follow Up Period|Lost to Follow-up|6
2933556|NCT01448044|10100615|P2|Follow Up Period|Withdrawal by Subject|1
2933557|NCT01448044|10100616|P1|Follow Up Period|Withdrawal by Subject|1
2933558|NCT01448044|10100615|P2|Treatment Period|Other reason|0
2933559|NCT01448044|10100616|P1|Treatment Period|Other reason|2
2933560|NCT01448044|10100615|P2|Treatment Period|Lost to Follow-up|1
2933561|NCT01448044|10100616|P1|Treatment Period|Lost to Follow-up|2
2933562|NCT01448044|10100615|P2|Treatment Period|Participant does not meet study criteria|0
2933563|NCT01448044|10100616|P1|Treatment Period|Participant does not meet study criteria|1
2933564|NCT01448044|10100615|P2|Treatment Period|Completed 24 weeks treatment period only|0
2933565|NCT01448044|10100616|P1|Treatment Period|Completed 24 weeks treatment period only|8
2933566|NCT01448044|10100615|P2|Treatment Period|Subject requested discontinue study drug|0
2933567|NCT01448044|10100616|P1|Treatment Period|Subject requested discontinue study drug|1
2933568|NCT01448044|10100615|P2|Treatment Period|Lack of Efficacy|12
2933569|NCT01448044|10100616|P1|Treatment Period|Lack of Efficacy|5
2933570|NCT01448044|10100615|P2|Treatment Period|Adverse Event|3
2933571|NCT01448044|10100616|P1|Treatment Period|Adverse Event|4
2933572|NCT01447927|10100632|P2|Overall Study|Withdrawal by Subject|0
2933573|NCT01447927|10100633|P1|Overall Study|Withdrawal by Subject|1
2933574|NCT01447927|10100632|P2|Overall Study|Adverse Event|3
2933575|NCT01447927|10100633|P1|Overall Study|Adverse Event|4
2933576|NCT01447719|10100678|P1|Overall Study|Family withdrew autopsy consent|7
2933577|NCT01447719|10100678|P1|Overall Study|Withdrawal by Subject|2
2933578|NCT01447719|10100678|P1|Overall Study|Subject still living at end of study|79
2933579|NCT01447719|10100678|P1|Overall Study|Invalid image or not imaged|3
2933580|NCT01447719|10100678|P1|Overall Study|Image acquisition failure|2
2933581|NCT01447576|10100704|P1|Overall Study|Physician Decision|6
2933582|NCT01447576|10100704|P1|Overall Study|Lack of Efficacy|68
2933583|NCT01447576|10100704|P1|Overall Study|Protocol deviation|83
2933584|NCT01447576|10100704|P1|Overall Study|Withdrawal by Subject|100
2933585|NCT01447576|10100704|P1|Overall Study|Participant met withdrawal criteria|40
2933586|NCT01447576|10100704|P1|Overall Study|Adverse Event|127
2933587|NCT01447576|10100704|P1|Overall Study|Lost to Follow-up|52
2933588|NCT01447446|10100737|P6|Overall Study|Reason not Specified|0
2933589|NCT01447446|10100738|P5|Overall Study|Reason not Specified|1
2933590|NCT01447446|10100739|P4|Overall Study|Reason not Specified|1
2933591|NCT01447446|10100740|P3|Overall Study|Reason not Specified|1
2933592|NCT01447446|10100741|P2|Overall Study|Reason not Specified|1
2933593|NCT01447446|10100742|P1|Overall Study|Reason not Specified|1
2933594|NCT01447446|10100737|P6|Overall Study|New Treatment Started|0
2933595|NCT01447446|10100738|P5|Overall Study|New Treatment Started|2
2933596|NCT01447446|10100739|P4|Overall Study|New Treatment Started|0
2933597|NCT01447446|10100740|P3|Overall Study|New Treatment Started|1
2933598|NCT01447446|10100741|P2|Overall Study|New Treatment Started|2
2933599|NCT01447446|10100742|P1|Overall Study|New Treatment Started|8
2933600|NCT01447446|10100737|P6|Overall Study|SVR12 Assessment|5
2933601|NCT01447446|10100738|P5|Overall Study|SVR12 Assessment|5
2933602|NCT01447446|10100739|P4|Overall Study|SVR12 Assessment|1
2933603|NCT01447446|10100740|P3|Overall Study|SVR12 Assessment|2
2933604|NCT01447446|10100741|P2|Overall Study|SVR12 Assessment|1
2933605|NCT01447446|10100742|P1|Overall Study|SVR12 Assessment|13
2933606|NCT01447446|10100737|P6|Overall Study|Administrative/Other|4
2933607|NCT01447446|10100738|P5|Overall Study|Administrative/Other|33
2933608|NCT01447446|10100739|P4|Overall Study|Administrative/Other|2
2933609|NCT01447446|10100740|P3|Overall Study|Administrative/Other|10
2933610|NCT01447446|10100741|P2|Overall Study|Administrative/Other|9
2933611|NCT01447446|10100742|P1|Overall Study|Administrative/Other|34
2933612|NCT01447446|10100737|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
2933613|NCT01447446|10100738|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
2933614|NCT01447446|10100739|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
2933615|NCT01447446|10100740|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
2933616|NCT01447446|10100741|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
2933617|NCT01447446|10100742|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
2933618|NCT01447446|10100737|P6|Overall Study|Failure to Return/Consent Withdrawn|9
2933619|NCT01447446|10100738|P5|Overall Study|Failure to Return/Consent Withdrawn|69
2933620|NCT01447446|10100739|P4|Overall Study|Failure to Return/Consent Withdrawn|7
2933621|NCT01447446|10100740|P3|Overall Study|Failure to Return/Consent Withdrawn|31
2933622|NCT01447446|10100741|P2|Overall Study|Failure to Return/Consent Withdrawn|78
2933623|NCT01447446|10100742|P1|Overall Study|Failure to Return/Consent Withdrawn|357
2933624|NCT01447446|10100737|P6|Overall Study|Adverse Event|0
2933625|NCT01447446|10100738|P5|Overall Study|Adverse Event|2
2933626|NCT01447446|10100739|P4|Overall Study|Adverse Event|0
2933627|NCT01447446|10100740|P3|Overall Study|Adverse Event|1
2933628|NCT01447446|10100741|P2|Overall Study|Adverse Event|0
2933629|NCT01447446|10100742|P1|Overall Study|Adverse Event|3
2933630|NCT01447446|10100737|P6|Overall Study|Death|0
2933631|NCT01447446|10100738|P5|Overall Study|Death|7
2933632|NCT01447446|10100739|P4|Overall Study|Death|1
2933633|NCT01447446|10100740|P3|Overall Study|Death|2
2933634|NCT01447446|10100741|P2|Overall Study|Death|3
2933635|NCT01447446|10100742|P1|Overall Study|Death|6
2933636|NCT01447433|10100832|P2|Overall Study|Protocol Violation|1
2933637|NCT01447433|10100833|P1|Overall Study|Protocol Violation|1
2933638|NCT01447433|10100832|P2|Overall Study|Withdrawal by Subject|3
2933639|NCT01447433|10100833|P1|Overall Study|Withdrawal by Subject|3
2933640|NCT01447433|10100832|P2|Overall Study|Lost to Follow-up|2
2933641|NCT01447433|10100833|P1|Overall Study|Lost to Follow-up|0
2933642|NCT01447420|10100860|P3|Overall Study|Lack of Efficacy|8
2933643|NCT01447420|10100861|P2|Overall Study|Lack of Efficacy|19
2933644|NCT01447420|10100862|P1|Overall Study|Lack of Efficacy|1
2933645|NCT01447420|10100860|P3|Overall Study|Withdrawal by Subject|0
2933646|NCT01447420|10100861|P2|Overall Study|Withdrawal by Subject|1
2933647|NCT01447420|10100862|P1|Overall Study|Withdrawal by Subject|4
2933648|NCT01447420|10100860|P3|Overall Study|Protocol Violation|0
2933649|NCT01447420|10100861|P2|Overall Study|Protocol Violation|3
2933650|NCT01447420|10100862|P1|Overall Study|Protocol Violation|3
2933651|NCT01447420|10100860|P3|Overall Study|Adverse Event|2
2933652|NCT01447420|10100861|P2|Overall Study|Adverse Event|4
2933653|NCT01447420|10100862|P1|Overall Study|Adverse Event|2
2933654|NCT01447407|10100882|P4|Overall Study|Physician Decision|1
2933655|NCT01447407|10100883|P3|Overall Study|Physician Decision|1
2933656|NCT01447407|10100884|P2|Overall Study|Physician Decision|0
2933657|NCT01447407|10100885|P1|Overall Study|Physician Decision|0
2933658|NCT01447407|10100882|P4|Overall Study|Withdrawal by Subject|1
2933659|NCT01447407|10100883|P3|Overall Study|Withdrawal by Subject|0
2933660|NCT01447407|10100884|P2|Overall Study|Withdrawal by Subject|0
2933661|NCT01447407|10100885|P1|Overall Study|Withdrawal by Subject|2
2933662|NCT01446874|10101019|P3|Overall Study|Withdrawal by Subject|4
2933663|NCT01446874|10101020|P2|Overall Study|Withdrawal by Subject|0
2933664|NCT01446874|10101021|P1|Overall Study|Withdrawal by Subject|0
2933665|NCT01446874|10101019|P3|Overall Study|Antibiotics for pre-op infection|2
2933666|NCT01446874|10101020|P2|Overall Study|Antibiotics for pre-op infection|0
2933667|NCT01446874|10101021|P1|Overall Study|Antibiotics for pre-op infection|0
2933668|NCT01446874|10101019|P3|Overall Study|Non-compliance|0
2933669|NCT01446874|10101020|P2|Overall Study|Non-compliance|4
2933670|NCT01446874|10101021|P1|Overall Study|Non-compliance|0
2933671|NCT01446874|10101019|P3|Overall Study|No surgery/No qualifying surgery|12
2933672|NCT01446874|10101020|P2|Overall Study|No surgery/No qualifying surgery|0
2933673|NCT01446874|10101021|P1|Overall Study|No surgery/No qualifying surgery|1
2933674|NCT01446874|10101019|P3|Overall Study|Not eligible|0
2933675|NCT01446874|10101020|P2|Overall Study|Not eligible|0
2933676|NCT01446874|10101021|P1|Overall Study|Not eligible|1
2933677|NCT01446809|10101049|P3|Overall Study|Failure to complete study procedures|1
2933678|NCT01446809|10101050|P2|Overall Study|Failure to complete study procedures|0
2933679|NCT01446809|10101051|P1|Overall Study|Failure to complete study procedures|0
2933680|NCT01446809|10101049|P3|Overall Study|Adverse Event|1
2933681|NCT01446809|10101050|P2|Overall Study|Adverse Event|0
2933682|NCT01446809|10101051|P1|Overall Study|Adverse Event|0
2933683|NCT01446796|10101074|P2|Overall Study|Withdrawal by Subject|0
2933684|NCT01446796|10101075|P1|Overall Study|Withdrawal by Subject|1
2933685|NCT01446419|10101121|P2|Overall Study|Terminated per protocol|0
2933686|NCT01446419|10101122|P1|Overall Study|Terminated per protocol|3
2933687|NCT01446419|10101121|P2|Overall Study|Withdrawal by Subject|1
2933688|NCT01446419|10101122|P1|Overall Study|Withdrawal by Subject|1
2933689|NCT01446419|10101121|P2|Overall Study|Death|0
2933690|NCT01446419|10101122|P1|Overall Study|Death|1
2933691|NCT01446289|10101136|P4|Overall Study|Withdrawal by Subject|0
2933692|NCT01446289|10101137|P3|Overall Study|Withdrawal by Subject|1
2933693|NCT01446289|10101138|P2|Overall Study|Withdrawal by Subject|0
2933694|NCT01446289|10101139|P1|Overall Study|Withdrawal by Subject|1
2933695|NCT01446237|10101182|P1|Overall Study|Withdrawal by Subject|7
2933696|NCT01446237|10101182|P1|Overall Study|Lost to Follow-up|2
2933697|NCT01446237|10101182|P1|Overall Study|Adverse Event|1
2933698|NCT01446159|10101194|P4|Overall Study|Other|13
2933699|NCT01446159|10101195|P3|Overall Study|Other|14
2933700|NCT01446159|10101196|P2|Overall Study|Other|0
2933701|NCT01446159|10101197|P1|Overall Study|Other|0
2933702|NCT01446159|10101194|P4|Overall Study|Death|36
2933703|NCT01446159|10101195|P3|Overall Study|Death|43
2933704|NCT01446159|10101196|P2|Overall Study|Death|3
2933705|NCT01446159|10101197|P1|Overall Study|Death|2
2933706|NCT01446159|10101194|P4|Overall Study|Lost to Follow-up|2
2933707|NCT01446159|10101195|P3|Overall Study|Lost to Follow-up|1
2933708|NCT01446159|10101196|P2|Overall Study|Lost to Follow-up|0
2933709|NCT01446159|10101197|P1|Overall Study|Lost to Follow-up|0
2933710|NCT01446159|10101194|P4|Overall Study|Withdrawal by Subject|11
2933711|NCT01446159|10101195|P3|Overall Study|Withdrawal by Subject|14
2933712|NCT01446159|10101196|P2|Overall Study|Withdrawal by Subject|0
2933713|NCT01446159|10101197|P1|Overall Study|Withdrawal by Subject|1
2933714|NCT01446042|10101272|P3|Overall Study|Other reasons|1
2933715|NCT01446042|10101273|P2|Overall Study|Other reasons|1
2933716|NCT01446042|10101274|P1|Overall Study|Other reasons|2
2933717|NCT01446042|10101272|P3|Overall Study|Lost to Follow-up|0
2933718|NCT01446042|10101273|P2|Overall Study|Lost to Follow-up|0
2933719|NCT01446042|10101274|P1|Overall Study|Lost to Follow-up|5
2933720|NCT01446042|10101272|P3|Overall Study|Adverse Event|4
2933721|NCT01446042|10101273|P2|Overall Study|Adverse Event|0
2933722|NCT01446042|10101274|P1|Overall Study|Adverse Event|1
2933723|NCT01446042|10101272|P3|Overall Study|Withdrawal by Subject|4
2933724|NCT01446042|10101273|P2|Overall Study|Withdrawal by Subject|2
2933725|NCT01446042|10101274|P1|Overall Study|Withdrawal by Subject|12
2933726|NCT01446003|10101285|P2|Period 2|Adverse Event|0
2933727|NCT01446003|10101286|P1|Period 2|Adverse Event|1
2933728|NCT01446003|10101285|P2|Period 1|Protocol Violation|0
2933729|NCT01446003|10101286|P1|Period 1|Protocol Violation|2
2933730|NCT01445951|10101307|P3|Overall Study|Cough|0
2933731|NCT01445951|10101308|P2|Overall Study|Cough|1
2933732|NCT01445951|10101309|P1|Overall Study|Cough|0
2933733|NCT01445951|10101307|P3|Overall Study|Sponsor decision - subject travel|0
2933734|NCT01445951|10101308|P2|Overall Study|Sponsor decision - subject travel|1
2933735|NCT01445951|10101309|P1|Overall Study|Sponsor decision - subject travel|0
2933736|NCT01445951|10101307|P3|Overall Study|Non-compliance with protocol|0
2933737|NCT01445951|10101308|P2|Overall Study|Non-compliance with protocol|1
2933738|NCT01445951|10101309|P1|Overall Study|Non-compliance with protocol|0
2933739|NCT01445951|10101307|P3|Overall Study|Non-compliance with study drug|0
2933740|NCT01445951|10101308|P2|Overall Study|Non-compliance with study drug|2
2933741|NCT01445951|10101309|P1|Overall Study|Non-compliance with study drug|1
2933742|NCT01445951|10101307|P3|Overall Study|Death|1
2933743|NCT01445951|10101308|P2|Overall Study|Death|0
2933744|NCT01445951|10101309|P1|Overall Study|Death|0
2933745|NCT01445951|10101307|P3|Overall Study|Pregnancy|4
2933746|NCT01445951|10101308|P2|Overall Study|Pregnancy|1
2933747|NCT01445951|10101309|P1|Overall Study|Pregnancy|0
2933748|NCT01445951|10101307|P3|Overall Study|Lost to Follow-up|4
2933749|NCT01445951|10101308|P2|Overall Study|Lost to Follow-up|2
2933750|NCT01445951|10101309|P1|Overall Study|Lost to Follow-up|1
2933751|NCT01445951|10101307|P3|Overall Study|Physician Decision|0
2933752|NCT01445951|10101308|P2|Overall Study|Physician Decision|1
2933753|NCT01445951|10101309|P1|Overall Study|Physician Decision|3
2933754|NCT01445951|10101307|P3|Overall Study|Withdrawal by Subject|8
2933755|NCT01445951|10101308|P2|Overall Study|Withdrawal by Subject|16
2933756|NCT01445951|10101309|P1|Overall Study|Withdrawal by Subject|21
2933757|NCT01445951|10101307|P3|Overall Study|Protocol Violation|2
2933758|NCT01445951|10101308|P2|Overall Study|Protocol Violation|2
2933759|NCT01445951|10101309|P1|Overall Study|Protocol Violation|2
2933760|NCT01445951|10101307|P3|Overall Study|Adverse Event|0
2933761|NCT01445951|10101308|P2|Overall Study|Adverse Event|9
2933762|NCT01445951|10101309|P1|Overall Study|Adverse Event|16
2933763|NCT01445886|10101347|P1|Overall Study|Protocol Violation|3
2933764|NCT01445886|10101347|P1|Overall Study|Lost to Follow-up|2
2933765|NCT01445847|10101387|P2|Overall Study|Missed Data|0
2933766|NCT01445847|10101388|P1|Overall Study|Missed Data|1
2933767|NCT01445847|10101387|P2|Overall Study|Protocol Violation|14
2933768|NCT01445847|10101388|P1|Overall Study|Protocol Violation|13
2933769|NCT01445769|10101394|P1|Overall Study|Lost to Follow-up|5
2933770|NCT01445769|10101394|P1|Overall Study|Disease Progression|1
2933771|NCT01445769|10101394|P1|Overall Study|Consent Withdrawn|2
2933772|NCT01445678|10101414|P2|Overall Study|Withdrawal by Subject|5
2933773|NCT01445678|10101415|P1|Overall Study|Withdrawal by Subject|9
2933774|NCT01445678|10101414|P2|Overall Study|Protocol Violation|1
2933775|NCT01445678|10101415|P1|Overall Study|Protocol Violation|1
2933776|NCT01445678|10101414|P2|Overall Study|Lost to Follow-up|5
2933777|NCT01445678|10101415|P1|Overall Study|Lost to Follow-up|8
2933778|NCT01445678|10101414|P2|Overall Study|Lack of Efficacy|2
2933779|NCT01445678|10101415|P1|Overall Study|Lack of Efficacy|0
2933780|NCT01445678|10101414|P2|Overall Study|Adverse Event|8
2933781|NCT01445678|10101415|P1|Overall Study|Adverse Event|12
2933782|NCT01445652|10101433|P2|Overall Study|Adverse Event|0
2933783|NCT01445652|10101434|P1|Overall Study|Adverse Event|1
2933784|NCT01445652|10101433|P2|Overall Study|Failed teach session|0
2933785|NCT01445652|10101434|P1|Overall Study|Failed teach session|2
2933786|NCT01445652|10101433|P2|Overall Study|Failed to attend scheduled visit|3
2933787|NCT01445652|10101434|P1|Overall Study|Failed to attend scheduled visit|2
2933788|NCT01445652|10101433|P2|Overall Study|Not comfortable in lenses|0
2933789|NCT01445652|10101434|P1|Overall Study|Not comfortable in lenses|5
2933790|NCT01445613|10101452|P1|1-year Follow-up|Received a non-study stent|2
2933791|NCT01445613|10101452|P1|1-year Follow-up|Physician Decision|2
2933792|NCT01445613|10101452|P1|1-year Follow-up|Death|30
2933793|NCT01445613|10101452|P1|1-year Follow-up|Lost to Follow-up|2
2933794|NCT01445613|10101452|P1|1-year Follow-up|Missed visit|29
2933795|NCT01445613|10101452|P1|1-year Follow-up|Withdrawal by Subject|12
2933796|NCT01445613|10101452|P1|30-day Follow-up|Death|3
2933797|NCT01445613|10101452|P1|30-day Follow-up|Missed visit|23
2933798|NCT01445613|10101452|P1|30-day Follow-up|Physician Decision|3
2933799|NCT01445613|10101452|P1|30-day Follow-up|Withdrawal by Subject|6
2933800|NCT01445548|10101470|P1|Overall Study|Adverse Event|1
2933801|NCT01445301|10101495|P3|Overall Study|Withdrawal by Subject|4
2933802|NCT01445301|10101496|P2|Overall Study|Withdrawal by Subject|6
2933803|NCT01445301|10101497|P1|Overall Study|Withdrawal by Subject|5
2933804|NCT01445301|10101495|P3|Overall Study|Physician Decision|0
2933805|NCT01445301|10101496|P2|Overall Study|Physician Decision|2
2933806|NCT01445301|10101497|P1|Overall Study|Physician Decision|0
2933807|NCT01445301|10101495|P3|Overall Study|Protocol-Defined Stopping Criteria|1
2933808|NCT01445301|10101496|P2|Overall Study|Protocol-Defined Stopping Criteria|1
2933809|NCT01445301|10101497|P1|Overall Study|Protocol-Defined Stopping Criteria|0
2933810|NCT01445301|10101495|P3|Overall Study|Protocol Violation|0
2933811|NCT01445301|10101496|P2|Overall Study|Protocol Violation|0
2933812|NCT01445301|10101497|P1|Overall Study|Protocol Violation|1
2933813|NCT01445301|10101495|P3|Overall Study|Lack of Efficacy|0
2933814|NCT01445301|10101496|P2|Overall Study|Lack of Efficacy|1
2933815|NCT01445301|10101497|P1|Overall Study|Lack of Efficacy|0
2933816|NCT01445301|10101495|P3|Overall Study|Adverse Event|4
2933817|NCT01445301|10101496|P2|Overall Study|Adverse Event|25
2933818|NCT01445301|10101497|P1|Overall Study|Adverse Event|15
2933819|NCT01445171|10101532|P1|Overall Study|Consented but did not receive device|8
2933820|NCT01445171|10101532|P1|Overall Study|Subjects declined to return for followup|9
2933821|NCT01445171|10101532|P1|Overall Study|Death|51
2933822|NCT01445171|10101532|P1|Overall Study|Withdrawal by Subject|16
2933823|NCT01445171|10101532|P1|Overall Study|Lost to Follow-up|11
2933824|NCT01444898|10101588|P1|Overall Study|Withdrawal by Subject|1
2933825|NCT01444781|10101603|P3|Overall Study|Withdrawal by Subject|2
2933826|NCT01444781|10101604|P2|Overall Study|Withdrawal by Subject|1
2933827|NCT01444781|10101605|P1|Overall Study|Withdrawal by Subject|3
2933828|NCT01444781|10101603|P3|Overall Study|Lost to Follow-up|1
2933829|NCT01444781|10101604|P2|Overall Study|Lost to Follow-up|3
2933830|NCT01444781|10101605|P1|Overall Study|Lost to Follow-up|0
2933831|NCT01444742|10101643|P1|Overall Study|Death|1
2933832|NCT01444651|10101650|P2|Overall Study|Missing data|1
2933833|NCT01444651|10101651|P1|Overall Study|Missing data|1
2933834|NCT01444651|10101650|P2|Overall Study|Non-fasting|1
2933835|NCT01444651|10101651|P1|Overall Study|Non-fasting|2
2933836|NCT01444651|10101650|P2|Overall Study|Lost to Follow-up|5
2933837|NCT01444651|10101651|P1|Overall Study|Lost to Follow-up|5
2933838|NCT01444651|10101650|P2|Overall Study|Adverse Event|2
2933839|NCT01444651|10101651|P1|Overall Study|Adverse Event|3
2933840|NCT01444456|10101667|P1|Overall Study|Not treated|104
2933841|NCT01444456|10101667|P1|Overall Study|Other|18
2933842|NCT01444456|10101667|P1|Overall Study|Ineligibility determined|23
2933843|NCT01444456|10101667|P1|Overall Study|Death|73
2933844|NCT01444456|10101667|P1|Overall Study|Lost to Follow-up|37
2933845|NCT01444456|10101667|P1|Overall Study|Physician Decision|9
2933846|NCT01444456|10101667|P1|Overall Study|Withdrawal by Subject|21
2933847|NCT01444430|10101678|P2|Overall Study|CRF termination module not completed.|1
2933848|NCT01444430|10101679|P1|Overall Study|CRF termination module not completed.|0
2933849|NCT01444430|10101678|P2|Overall Study|Lost to Follow-up|0
2933850|NCT01444430|10101679|P1|Overall Study|Lost to Follow-up|2
2933851|NCT01444430|10101678|P2|Overall Study|Death|8
2933852|NCT01444430|10101679|P1|Overall Study|Death|6
2933853|NCT01444430|10101678|P2|Overall Study|Withdrawal by Subject|72
2933854|NCT01444430|10101679|P1|Overall Study|Withdrawal by Subject|53
2933855|NCT01444417|10101701|P2|Overall Study|Withdrawal by Subject|0
2933856|NCT01444417|10101702|P1|Overall Study|Withdrawal by Subject|2
2933857|NCT01444417|10101701|P2|Overall Study|Ineligibility Determined|1
2933858|NCT01444417|10101702|P1|Overall Study|Ineligibility Determined|0
2933859|NCT01444391|10101718|P1|Overall Study|Death|1
2933860|NCT01444378|10101726|P1|Overall Study|Missed Visits|10
2933861|NCT01444378|10101726|P1|Overall Study|Administrative Closure Of The Study|2
2933862|NCT01444378|10101726|P1|Overall Study|Death|3
2933863|NCT01444378|10101726|P1|Overall Study|Withdrawal by Subject|1
2933864|NCT01444378|10101726|P1|Overall Study|Lost to Follow-up|1
2933865|NCT01444300|10101838|P2|Overall Study|Adverse Event|0
2933866|NCT01444300|10101839|P1|Overall Study|Adverse Event|4
2933867|NCT01444092|10101871|P1|Overall Study|Other Eligibility criteria|7
2933868|NCT01444092|10101871|P1|Overall Study|Withdrawal by Subject|1
2933869|NCT01444092|10101871|P1|Overall Study|Protocol Violation|1
2933870|NCT01444092|10101871|P1|Overall Study|Adverse Event|8
2933871|NCT01444027|10101880|P3|Overall Study|Lost to Follow-up|14
2933872|NCT01444027|10101881|P2|Overall Study|Lost to Follow-up|20
2933873|NCT01444027|10101882|P1|Overall Study|Lost to Follow-up|26
2933874|NCT01444027|10101880|P3|Overall Study|Withdrawal by Subject|24
2933875|NCT01444027|10101881|P2|Overall Study|Withdrawal by Subject|10
2933876|NCT01444027|10101882|P1|Overall Study|Withdrawal by Subject|4
2933877|NCT01443923|10101904|P2|Overall Study|Adverse Event|0
2933878|NCT01443923|10101905|P1|Overall Study|Adverse Event|1
2933879|NCT01443858|10101922|P3|Overall Study|Lost to Follow-up|2
2933880|NCT01443858|10101923|P2|Overall Study|Lost to Follow-up|5
2933881|NCT01443858|10101924|P1|Overall Study|Lost to Follow-up|5
2933882|NCT01443858|10101922|P3|Overall Study|Lack of Efficacy|0
2933883|NCT01443858|10101923|P2|Overall Study|Lack of Efficacy|0
2933884|NCT01443858|10101924|P1|Overall Study|Lack of Efficacy|1
2933885|NCT01443858|10101922|P3|Overall Study|Withdrawal by Subject|5
2933886|NCT01443858|10101923|P2|Overall Study|Withdrawal by Subject|8
2933887|NCT01443858|10101924|P1|Overall Study|Withdrawal by Subject|9
2933888|NCT01443845|10101946|P2|Overall Study|Lost to Follow-up|13
2933889|NCT01443845|10101947|P1|Overall Study|Lost to Follow-up|9
2933890|NCT01443845|10101946|P2|Overall Study|Military Conflict - Site Terminated|21
2933891|NCT01443845|10101947|P1|Overall Study|Military Conflict - Site Terminated|20
2933892|NCT01443845|10101946|P2|Overall Study|Withdrawal by Subject|67
2933893|NCT01443845|10101947|P1|Overall Study|Withdrawal by Subject|63
2933894|NCT01443845|10101946|P2|Overall Study|Adverse Event|138
2933895|NCT01443845|10101947|P1|Overall Study|Adverse Event|64
2933896|NCT01443845|10101946|P2|Overall Study|Lack of Efficacy|5
2933897|NCT01443845|10101947|P1|Overall Study|Lack of Efficacy|10
2933898|NCT01443845|10101946|P2|Overall Study|Deterioration in pulmonary function|4
2933899|NCT01443845|10101947|P1|Overall Study|Deterioration in pulmonary function|1
2933900|NCT01443845|10101946|P2|Overall Study|Other reasons, such as COPD exacerbation|44
2933901|NCT01443845|10101947|P1|Overall Study|Other reasons, such as COPD exacerbation|44
2933902|NCT01443845|10101946|P2|Overall Study|Protocol Violation|45
2933903|NCT01443845|10101947|P1|Overall Study|Protocol Violation|43
2933904|NCT01443403|10102002|P4|Overall Study|Other - Miscellaneous|1
2933905|NCT01443403|10102003|P3|Overall Study|Other - Miscellaneous|0
2933906|NCT01443403|10102004|P2|Overall Study|Other - Miscellaneous|0
2933907|NCT01443403|10102005|P1|Overall Study|Other - Miscellaneous|1
2933908|NCT01443403|10102002|P4|Overall Study|Use of Prohibited Treatment|0
2933909|NCT01443403|10102003|P3|Overall Study|Use of Prohibited Treatment|0
2933910|NCT01443403|10102004|P2|Overall Study|Use of Prohibited Treatment|3
2933911|NCT01443403|10102005|P1|Overall Study|Use of Prohibited Treatment|2
2933912|NCT01443403|10102002|P4|Overall Study|Protocol Violation|1
2933913|NCT01443403|10102003|P3|Overall Study|Protocol Violation|1
2933914|NCT01443403|10102004|P2|Overall Study|Protocol Violation|1
2933915|NCT01443403|10102005|P1|Overall Study|Protocol Violation|2
2933916|NCT01443403|10102002|P4|Overall Study|Lost to Follow-up|1
2933917|NCT01443403|10102003|P3|Overall Study|Lost to Follow-up|0
2933918|NCT01443403|10102004|P2|Overall Study|Lost to Follow-up|0
2933919|NCT01443403|10102005|P1|Overall Study|Lost to Follow-up|0
2933920|NCT01443403|10102002|P4|Overall Study|Withdrawal by Subject|1
2933921|NCT01443403|10102003|P3|Overall Study|Withdrawal by Subject|2
2933922|NCT01443403|10102004|P2|Overall Study|Withdrawal by Subject|1
2933923|NCT01443403|10102005|P1|Overall Study|Withdrawal by Subject|0
2933924|NCT01443403|10102002|P4|Overall Study|Adverse Event|5
2933925|NCT01443403|10102003|P3|Overall Study|Adverse Event|4
2933926|NCT01443403|10102004|P2|Overall Study|Adverse Event|1
2933927|NCT01443403|10102005|P1|Overall Study|Adverse Event|1
2933928|NCT01443364|10102152|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2933929|NCT01443364|10102152|P1|Overall Study|AE, non-serious non-fatal|8
2933930|NCT01443364|10102152|P1|Overall Study|SAE, non-fatal|6
2933931|NCT01443364|10102152|P1|Overall Study|Other Reason|4
2933932|NCT01443364|10102152|P1|Overall Study|Withdrawal by Subject|5
2933933|NCT01443364|10102152|P1|Overall Study|Lost to Follow-up|3
2933934|NCT01443364|10102152|P1|Overall Study|Lack of Efficacy|14
2933935|NCT01443130|10102281|P6|Overall Study|Death of Subject's Infant|0
2933936|NCT01443130|10102282|P5|Overall Study|Death of Subject's Infant|0
2933937|NCT01443130|10102283|P4|Overall Study|Death of Subject's Infant|0
2933938|NCT01443130|10102284|P3|Overall Study|Death of Subject's Infant|11
2933939|NCT01443130|10102285|P2|Overall Study|Death of Subject's Infant|10
2933940|NCT01443130|10102286|P1|Overall Study|Death of Subject's Infant|5
2933941|NCT01443130|10102281|P6|Overall Study|Withdrawal by Subject|2
2933942|NCT01443130|10102282|P5|Overall Study|Withdrawal by Subject|7
2933943|NCT01443130|10102283|P4|Overall Study|Withdrawal by Subject|7
2933944|NCT01443130|10102284|P3|Overall Study|Withdrawal by Subject|12
2933945|NCT01443130|10102285|P2|Overall Study|Withdrawal by Subject|14
2933946|NCT01443130|10102286|P1|Overall Study|Withdrawal by Subject|15
2933947|NCT01443130|10102281|P6|Overall Study|Protocol Violation|3
2933948|NCT01443130|10102282|P5|Overall Study|Protocol Violation|2
2933949|NCT01443130|10102283|P4|Overall Study|Protocol Violation|2
2933950|NCT01443130|10102284|P3|Overall Study|Protocol Violation|3
2933951|NCT01443130|10102285|P2|Overall Study|Protocol Violation|1
2933952|NCT01443130|10102286|P1|Overall Study|Protocol Violation|2
2933953|NCT01443130|10102281|P6|Overall Study|Adverse Event|0
2933954|NCT01443130|10102282|P5|Overall Study|Adverse Event|0
2933955|NCT01443130|10102283|P4|Overall Study|Adverse Event|0
2933956|NCT01443130|10102284|P3|Overall Study|Adverse Event|1
2933957|NCT01443130|10102285|P2|Overall Study|Adverse Event|1
2933958|NCT01443130|10102286|P1|Overall Study|Adverse Event|2
2933959|NCT01443130|10102281|P6|Overall Study|Death|8
2933960|NCT01443130|10102282|P5|Overall Study|Death|10
2933961|NCT01443130|10102283|P4|Overall Study|Death|7
2933962|NCT01443130|10102284|P3|Overall Study|Death|0
2933963|NCT01443130|10102285|P2|Overall Study|Death|1
2933964|NCT01443130|10102286|P1|Overall Study|Death|0
2933965|NCT01443130|10102281|P6|Overall Study|Lost to Follow-up|21
2933966|NCT01443130|10102282|P5|Overall Study|Lost to Follow-up|25
2933967|NCT01443130|10102283|P4|Overall Study|Lost to Follow-up|23
2933968|NCT01443130|10102284|P3|Overall Study|Lost to Follow-up|50
2933969|NCT01443130|10102285|P2|Overall Study|Lost to Follow-up|42
2933970|NCT01443130|10102286|P1|Overall Study|Lost to Follow-up|44
2933971|NCT01443078|10102336|P1|Overall Study|Patient had brain mets|1
2933972|NCT01443078|10102336|P1|Overall Study|Withdrawal by Subject|1
2933973|NCT01443078|10102336|P1|Overall Study|Responded to neoadjuvant platinum txt|27
2933974|NCT01443026|10102343|P2|Overall Study|Lost to Follow-up|1
2933975|NCT01443026|10102344|P1|Overall Study|Lost to Follow-up|2
2933976|NCT01443026|10102343|P2|Overall Study|Withdrawal by Subject|3
2933977|NCT01443026|10102344|P1|Overall Study|Withdrawal by Subject|0
2933978|NCT01443026|10102343|P2|Overall Study|Death|1
2933979|NCT01443026|10102344|P1|Overall Study|Death|0
2933980|NCT01443026|10102343|P2|Overall Study|Physician Decision|0
2933981|NCT01443026|10102344|P1|Overall Study|Physician Decision|1
2933982|NCT01442779|10102359|P1|Overall Study|Non-compliance|1
2933983|NCT01442779|10102359|P1|Overall Study|Death|3
2933984|NCT01442779|10102359|P1|Overall Study|Withdrawal by Subject|3
2933985|NCT01442714|10102365|P1|Overall Study|Withdrawal by Subject|1
2933986|NCT01442714|10102365|P1|Overall Study|Death|11
2933987|NCT01442688|10102373|P2|Second Intervention|Adverse Event|0
2933988|NCT01442688|10102374|P1|Second Intervention|Adverse Event|1
2933989|NCT01442688|10102373|P2|First Intervention|subject incarcerated|0
2933990|NCT01442688|10102374|P1|First Intervention|subject incarcerated|1
2933991|NCT01442688|10102373|P2|First Intervention|Withdrawal by Subject|0
2933992|NCT01442688|10102374|P1|First Intervention|Withdrawal by Subject|1
2933993|NCT01442675|10102382|P1|Overall Study|Withdrawal by Subject|4
2933994|NCT01442675|10102382|P1|Overall Study|Lost to Follow-up|2
2933995|NCT01442675|10102382|P1|Overall Study|Protocol Violation|6
2933996|NCT01442493|10102394|P2|Overall Study|withdrawn from study|2
2933997|NCT01442493|10102395|P1|Overall Study|withdrawn from study|3
2933998|NCT01442376|10102416|P3|Overall Study|Not eligible for subsequent cycles|0
2933999|NCT01442376|10102417|P2|Overall Study|Not eligible for subsequent cycles|2
2934000|NCT01442376|10102418|P1|Overall Study|Not eligible for subsequent cycles|1
2934001|NCT01442376|10102416|P3|Overall Study|Patients not treated|1
2934002|NCT01442376|10102417|P2|Overall Study|Patients not treated|3
2934003|NCT01442376|10102418|P1|Overall Study|Patients not treated|2
2934004|NCT01442376|10102416|P3|Overall Study|Withdrawal of consent|1
2934005|NCT01442376|10102417|P2|Overall Study|Withdrawal of consent|0
2934006|NCT01442376|10102418|P1|Overall Study|Withdrawal of consent|0
2934007|NCT01442376|10102416|P3|Overall Study|Death|1
2934008|NCT01442376|10102417|P2|Overall Study|Death|1
2934009|NCT01442376|10102418|P1|Overall Study|Death|0
2934010|NCT01442376|10102416|P3|Overall Study|Adverse Event|2
2934011|NCT01442376|10102417|P2|Overall Study|Adverse Event|3
2934012|NCT01442376|10102418|P1|Overall Study|Adverse Event|0
2934013|NCT01442181|10102431|P2|Overall Study|atrial fibrillation not noted|1
2934014|NCT01442181|10102432|P1|Overall Study|atrial fibrillation not noted|0
2934015|NCT01442181|10102431|P2|Overall Study|patient in an additional study|0
2934016|NCT01442181|10102432|P1|Overall Study|patient in an additional study|1
2934017|NCT01442181|10102431|P2|Overall Study|Lost to Follow-up|1
2934018|NCT01442181|10102432|P1|Overall Study|Lost to Follow-up|1
2934019|NCT01442181|10102431|P2|Overall Study|low ejection factor|1
2934020|NCT01442181|10102432|P1|Overall Study|low ejection factor|0
2934021|NCT01442181|10102431|P2|Overall Study|no insurance for surgery|0
2934022|NCT01442181|10102432|P1|Overall Study|no insurance for surgery|1
2934023|NCT01442181|10102431|P2|Overall Study|patient refused surgery|0
2934024|NCT01442181|10102432|P1|Overall Study|patient refused surgery|1
2934025|NCT01442155|10102456|P1|Overall Study|Lost to Follow-up|2
2934026|NCT01442155|10102456|P1|Overall Study|Adverse Event|2
2934027|NCT01442155|10102456|P1|Overall Study|Recurrence|26
2934028|NCT01442155|10102456|P1|Overall Study|Complete remission|35
2934029|NCT01442103|10102472|P1|Overall Study|Lost to Follow-up|2
2934030|NCT01442064|10102482|P6|Overall Study|Condition mandated other intervention|2
2934031|NCT01442064|10102483|P5|Overall Study|Condition mandated other intervention|0
2934032|NCT01442064|10102484|P4|Overall Study|Condition mandated other intervention|0
2934033|NCT01442064|10102485|P3|Overall Study|Condition mandated other intervention|2
2934034|NCT01442064|10102486|P2|Overall Study|Condition mandated other intervention|1
2934035|NCT01442064|10102487|P1|Overall Study|Condition mandated other intervention|1
2934036|NCT01442064|10102482|P6|Overall Study|Subject non-compliance|2
2934037|NCT01442064|10102483|P5|Overall Study|Subject non-compliance|0
2934038|NCT01442064|10102484|P4|Overall Study|Subject non-compliance|0
2934039|NCT01442064|10102485|P3|Overall Study|Subject non-compliance|0
2934040|NCT01442064|10102486|P2|Overall Study|Subject non-compliance|0
2934041|NCT01442064|10102487|P1|Overall Study|Subject non-compliance|0
2934042|NCT01442064|10102482|P6|Overall Study|Sponsor decision|87
2934043|NCT01442064|10102483|P5|Overall Study|Sponsor decision|95
2934044|NCT01442064|10102484|P4|Overall Study|Sponsor decision|88
2934045|NCT01442064|10102485|P3|Overall Study|Sponsor decision|92
2934046|NCT01442064|10102486|P2|Overall Study|Sponsor decision|88
2934047|NCT01442064|10102487|P1|Overall Study|Sponsor decision|82
2934048|NCT01442064|10102482|P6|Overall Study|Withdrawal by Subject|1
2934049|NCT01442064|10102483|P5|Overall Study|Withdrawal by Subject|2
2934050|NCT01442064|10102484|P4|Overall Study|Withdrawal by Subject|2
2934051|NCT01442064|10102485|P3|Overall Study|Withdrawal by Subject|2
2934052|NCT01442064|10102486|P2|Overall Study|Withdrawal by Subject|3
2934053|NCT01442064|10102487|P1|Overall Study|Withdrawal by Subject|6
2934054|NCT01442064|10102482|P6|Overall Study|Physician Decision|1
2934055|NCT01442064|10102483|P5|Overall Study|Physician Decision|3
2934056|NCT01442064|10102484|P4|Overall Study|Physician Decision|3
2934057|NCT01442064|10102485|P3|Overall Study|Physician Decision|2
2934058|NCT01442064|10102486|P2|Overall Study|Physician Decision|1
2934059|NCT01442064|10102487|P1|Overall Study|Physician Decision|1
2934060|NCT01442064|10102482|P6|Overall Study|Lost to Follow-up|3
2934061|NCT01442064|10102483|P5|Overall Study|Lost to Follow-up|3
2934062|NCT01442064|10102484|P4|Overall Study|Lost to Follow-up|1
2934063|NCT01442064|10102485|P3|Overall Study|Lost to Follow-up|1
2934064|NCT01442064|10102486|P2|Overall Study|Lost to Follow-up|5
2934065|NCT01442064|10102487|P1|Overall Study|Lost to Follow-up|5
2934066|NCT01442064|10102482|P6|Overall Study|Death|3
2934067|NCT01442064|10102483|P5|Overall Study|Death|1
2934068|NCT01442064|10102484|P4|Overall Study|Death|3
2934069|NCT01442064|10102485|P3|Overall Study|Death|3
2934070|NCT01442064|10102486|P2|Overall Study|Death|1
2934071|NCT01442064|10102487|P1|Overall Study|Death|0
2934072|NCT01442064|10102482|P6|Overall Study|Adverse Event|0
2934073|NCT01442064|10102483|P5|Overall Study|Adverse Event|2
2934074|NCT01442064|10102484|P4|Overall Study|Adverse Event|1
2934075|NCT01442064|10102485|P3|Overall Study|Adverse Event|2
2934076|NCT01442064|10102486|P2|Overall Study|Adverse Event|2
2934077|NCT01442064|10102487|P1|Overall Study|Adverse Event|2
2934078|NCT01442038|10102524|P2|Overall Study|Study Terminated By Sponsor|3
2934079|NCT01442038|10102525|P1|Overall Study|Study Terminated By Sponsor|2
2934080|NCT01442038|10102524|P2|Overall Study|Investigator's Discretion|16
2934081|NCT01442038|10102525|P1|Overall Study|Investigator's Discretion|13
2934082|NCT01442038|10102524|P2|Overall Study|Protocol Deviation|20
2934083|NCT01442038|10102525|P1|Overall Study|Protocol Deviation|9
2934084|NCT01442038|10102524|P2|Overall Study|Adverse Event|15
2934085|NCT01442038|10102525|P1|Overall Study|Adverse Event|26
2934086|NCT01442038|10102524|P2|Overall Study|Lost to Follow-up|51
2934087|NCT01442038|10102525|P1|Overall Study|Lost to Follow-up|37
2934088|NCT01442038|10102524|P2|Overall Study|Participant Withdrew Consent|102
2934089|NCT01442038|10102525|P1|Overall Study|Participant Withdrew Consent|137
2934090|NCT01442038|10102524|P2|Overall Study|Investigator-Initiated Early Closure|43
2934091|NCT01442038|10102525|P1|Overall Study|Investigator-Initiated Early Closure|44
2934092|NCT01442038|10102524|P2|Overall Study|Death|29
2934093|NCT01442038|10102525|P1|Overall Study|Death|35
2934094|NCT01441973|10102539|P2|Overall Study|Participant withdrew consent|1
2934095|NCT01441973|10102540|P1|Overall Study|Participant withdrew consent|0
2934096|NCT01441973|10102539|P2|Overall Study|Administrative reason by sponsor|5
2934097|NCT01441973|10102540|P1|Overall Study|Administrative reason by sponsor|3
2934098|NCT01441973|10102539|P2|Overall Study|Poor compliance/noncompliance|1
2934099|NCT01441973|10102540|P1|Overall Study|Poor compliance/noncompliance|0
2934100|NCT01441973|10102539|P2|Overall Study|Participant request to discontinue|1
2934101|NCT01441973|10102540|P1|Overall Study|Participant request to discontinue|1
2934102|NCT01441973|10102539|P2|Overall Study|Adverse event unrelated to study drug|2
2934103|NCT01441973|10102540|P1|Overall Study|Adverse event unrelated to study drug|3
2934104|NCT01441973|10102539|P2|Overall Study|Disease progression|6
2934105|NCT01441973|10102540|P1|Overall Study|Disease progression|8
2934106|NCT01441960|10102562|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
2934107|NCT01441960|10102563|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
2934108|NCT01441960|10102562|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
2934109|NCT01441960|10102563|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
2934110|NCT01441960|10102562|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
2934111|NCT01441960|10102563|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
2934112|NCT01441765|10102588|P2|Overall Study|Death|0
2934113|NCT01441765|10102589|P1|Overall Study|Death|1
2934114|NCT01441596|10102606|P3|Overall Study|Not treated|1
2934115|NCT01441596|10102607|P2|Overall Study|Not treated|1
2934116|NCT01441596|10102608|P1|Overall Study|Not treated|0
2934117|NCT01441596|10102606|P3|Overall Study|Withdrawal by Subject|2
2934118|NCT01441596|10102607|P2|Overall Study|Withdrawal by Subject|0
2934119|NCT01441596|10102608|P1|Overall Study|Withdrawal by Subject|4
2934120|NCT01441596|10102606|P3|Overall Study|Other reason not defined below|1
2934121|NCT01441596|10102607|P2|Overall Study|Other reason not defined below|2
2934122|NCT01441596|10102608|P1|Overall Study|Other reason not defined below|0
2934123|NCT01441440|10102655|P3|Overall Study|Difficllty in keeping the schedule|0
2934124|NCT01441440|10102656|P2|Overall Study|Difficllty in keeping the schedule|1
2934125|NCT01441440|10102657|P1|Overall Study|Difficllty in keeping the schedule|1
2934126|NCT01441440|10102655|P3|Overall Study|Work-related matter|0
2934127|NCT01441440|10102656|P2|Overall Study|Work-related matter|1
2934128|NCT01441440|10102657|P1|Overall Study|Work-related matter|0
2934129|NCT01441440|10102655|P3|Overall Study|Moving|1
2934130|NCT01441440|10102656|P2|Overall Study|Moving|1
2934131|NCT01441440|10102657|P1|Overall Study|Moving|0
2934132|NCT01441440|10102655|P3|Overall Study|Lack of Efficacy|1
2934133|NCT01441440|10102656|P2|Overall Study|Lack of Efficacy|0
2934134|NCT01441440|10102657|P1|Overall Study|Lack of Efficacy|1
2934135|NCT01441440|10102655|P3|Overall Study|Pregnancy|0
2934136|NCT01441440|10102656|P2|Overall Study|Pregnancy|0
2934137|NCT01441440|10102657|P1|Overall Study|Pregnancy|1
2934138|NCT01441440|10102655|P3|Overall Study|Withdrawal by Subject|9
2934139|NCT01441440|10102656|P2|Overall Study|Withdrawal by Subject|9
2934140|NCT01441440|10102657|P1|Overall Study|Withdrawal by Subject|11
2934141|NCT01441440|10102655|P3|Overall Study|Lost to Follow-up|1
2934142|NCT01441440|10102656|P2|Overall Study|Lost to Follow-up|2
2934143|NCT01441440|10102657|P1|Overall Study|Lost to Follow-up|0
2934144|NCT01441440|10102655|P3|Overall Study|Adverse Event|9
2934145|NCT01441440|10102656|P2|Overall Study|Adverse Event|9
2934146|NCT01441440|10102657|P1|Overall Study|Adverse Event|2
2934147|NCT01441440|10102655|P3|Overall Study|Death|1
2934148|NCT01441440|10102656|P2|Overall Study|Death|0
2934149|NCT01441440|10102657|P1|Overall Study|Death|1
2934150|NCT01441414|10102680|P1|Overall Study|Subject refused further follow-up|1
2934151|NCT01441414|10102680|P1|Overall Study|Study terminated by sponsor|2
2934152|NCT01441414|10102680|P1|Overall Study|Other reasons|3
2934153|NCT01441414|10102680|P1|Overall Study|Participant died|9
2934154|NCT01441180|10102759|P3|Overall Study|Discontinued|2
2934155|NCT01441180|10102760|P2|Overall Study|Discontinued|0
2934156|NCT01441180|10102761|P1|Overall Study|Discontinued|0
2934157|NCT01441180|10102759|P3|Overall Study|Lost to Follow-up|1
2934158|NCT01441180|10102760|P2|Overall Study|Lost to Follow-up|1
2934159|NCT01441180|10102761|P1|Overall Study|Lost to Follow-up|1
2934160|NCT01441102|10102772|P1|Overall Study|Withdrawal by Subject|2
2934161|NCT01441102|10102772|P1|Overall Study|Adverse Event|1
2934162|NCT01440972|10102816|P2|Overall Study|Withdrawal by Subject|2
2934163|NCT01440972|10102817|P1|Overall Study|Withdrawal by Subject|3
2934164|NCT01440946|10102841|P2|Overall Study|Physician Decision|0
2934165|NCT01440946|10102842|P1|Overall Study|Physician Decision|1
2934166|NCT01440946|10102841|P2|Overall Study|Lost to Follow-up|1
2934167|NCT01440946|10102842|P1|Overall Study|Lost to Follow-up|1
2934168|NCT01440881|10102881|P2|Overall Study|Death|1
2934169|NCT01440881|10102882|P1|Overall Study|Death|0
2934170|NCT01440816|10102896|P2|Overall Study|To Be Seen By Local Oncologist|2
2934171|NCT01440816|10102897|P1|Overall Study|To Be Seen By Local Oncologist|1
2934172|NCT01440816|10102896|P2|Overall Study|Disease Progression|9
2934173|NCT01440816|10102897|P1|Overall Study|Disease Progression|0
2934174|NCT01440803|10102913|P2|Overall Study|Withdrawal by Subject|1
2934175|NCT01440803|10102914|P1|Overall Study|Withdrawal by Subject|0
2934176|NCT01440803|10102913|P2|Overall Study|Lost to Follow-up|2
2934177|NCT01440803|10102914|P1|Overall Study|Lost to Follow-up|0
2934178|NCT01440803|10102913|P2|Overall Study|Met study stopping rule|1
2934179|NCT01440803|10102914|P1|Overall Study|Met study stopping rule|2
2934180|NCT01440647|10102950|P2|Overall Study|Death|3
2934181|NCT01440647|10102951|P1|Overall Study|Death|2
2934182|NCT01440595|10102970|P3|Overall Study|Study terminated by sponsor.|1
2934183|NCT01440595|10102971|P2|Overall Study|Study terminated by sponsor.|2
2934184|NCT01440595|10102972|P1|Overall Study|Study terminated by sponsor.|1
2934185|NCT01440595|10102970|P3|Overall Study|Lost to Follow-up|0
2934186|NCT01440595|10102971|P2|Overall Study|Lost to Follow-up|1
2934187|NCT01440595|10102972|P1|Overall Study|Lost to Follow-up|0
2934188|NCT01440569|10102992|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
2934189|NCT01440569|10102993|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
2934190|NCT01440569|10102992|P2|Open-Label Rollover Phase|Lost to Follow-up|3
2934191|NCT01440569|10102993|P1|Open-Label Rollover Phase|Lost to Follow-up|26
2934192|NCT01440569|10102992|P2|Open-Label Rollover Phase|Withdrew Consent|1
2934193|NCT01440569|10102993|P1|Open-Label Rollover Phase|Withdrew Consent|11
2934194|NCT01440569|10102992|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
2934195|NCT01440569|10102993|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
2934196|NCT01440569|10102992|P2|Open-Label Rollover Phase|Lack of Efficacy|0
2934197|NCT01440569|10102993|P1|Open-Label Rollover Phase|Lack of Efficacy|2
2934198|NCT01440569|10102992|P2|Open-Label Rollover Phase|Pregnancy|0
2934199|NCT01440569|10102993|P1|Open-Label Rollover Phase|Pregnancy|1
2934200|NCT01440569|10102992|P2|Open-Label Rollover Phase|Adverse Event|0
2934201|NCT01440569|10102993|P1|Open-Label Rollover Phase|Adverse Event|3
2934202|NCT01440569|10102992|P2|Main Study|Protocol Violation|0
2934203|NCT01440569|10102993|P1|Main Study|Protocol Violation|1
2934204|NCT01440569|10102992|P2|Main Study|Subject Non-Compliance|0
2934205|NCT01440569|10102993|P1|Main Study|Subject Non-Compliance|3
2934206|NCT01440569|10102992|P2|Main Study|Lost to Follow-up|2
2934207|NCT01440569|10102993|P1|Main Study|Lost to Follow-up|13
2934208|NCT01440569|10102992|P2|Main Study|Withdrew Consent|1
2934209|NCT01440569|10102993|P1|Main Study|Withdrew Consent|7
2934210|NCT01440569|10102992|P2|Main Study|Investigator's Discretion|1
2934211|NCT01440569|10102993|P1|Main Study|Investigator's Discretion|1
2934212|NCT01440569|10102992|P2|Main Study|Pregnancy|0
2934213|NCT01440569|10102993|P1|Main Study|Pregnancy|1
2934214|NCT01440569|10102992|P2|Main Study|Adverse Event|0
2934215|NCT01440569|10102993|P1|Main Study|Adverse Event|9
2934216|NCT01440569|10102992|P2|Main Study|Enrolled but not treated|0
2934217|NCT01440569|10102993|P1|Main Study|Enrolled but not treated|1
2934218|NCT01440517|10103028|P1|Overall Study|Subject withdrawn prior to dosing|1
2934219|NCT01440374|10103059|P4|Part 3: Extension|Physician Decision|14
2934220|NCT01440374|10103060|P3|Part 3: Extension|Physician Decision|0
2934221|NCT01440374|10103061|P2|Part 3: Extension|Physician Decision|0
2934222|NCT01440374|10103062|P1|Part 3: Extension|Physician Decision|0
2934223|NCT01440374|10103059|P4|Part 3: Extension|Adverse Event|13
2934224|NCT01440374|10103060|P3|Part 3: Extension|Adverse Event|0
2934225|NCT01440374|10103061|P2|Part 3: Extension|Adverse Event|0
2934226|NCT01440374|10103062|P1|Part 3: Extension|Adverse Event|0
2934227|NCT01440374|10103059|P4|Part 3: Extension|Withdrawal by Subject|5
2934228|NCT01440374|10103060|P3|Part 3: Extension|Withdrawal by Subject|0
2934229|NCT01440374|10103061|P2|Part 3: Extension|Withdrawal by Subject|0
2934230|NCT01440374|10103062|P1|Part 3: Extension|Withdrawal by Subject|0
2934231|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Not treated|0
2934232|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Not treated|1
2934233|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Not treated|0
2934234|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Not treated|0
2934235|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Adverse Event|0
2934236|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Adverse Event|31
2934237|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Adverse Event|7
2934238|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Adverse Event|0
2934239|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
2934240|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
2934241|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
2934242|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
2934243|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Protocol Violation|0
2934244|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Protocol Violation|1
2934245|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Protocol Violation|0
2934246|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Protocol Violation|0
2934247|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
2934248|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
2934249|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
2934250|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
2934251|NCT01440374|10103059|P4|Part 2; Double-blind Phase|Physician Decision|0
2934252|NCT01440374|10103060|P3|Part 2; Double-blind Phase|Physician Decision|17
2934253|NCT01440374|10103061|P2|Part 2; Double-blind Phase|Physician Decision|8
2934254|NCT01440374|10103062|P1|Part 2; Double-blind Phase|Physician Decision|0
2934255|NCT01440374|10103059|P4|Part 1: Open-label Phase|Physician Decision|0
2934256|NCT01440374|10103060|P3|Part 1: Open-label Phase|Physician Decision|0
2934257|NCT01440374|10103061|P2|Part 1: Open-label Phase|Physician Decision|0
2934258|NCT01440374|10103062|P1|Part 1: Open-label Phase|Physician Decision|1
2934259|NCT01440374|10103059|P4|Part 1: Open-label Phase|Adverse Event|0
2934260|NCT01440374|10103060|P3|Part 1: Open-label Phase|Adverse Event|0
2934261|NCT01440374|10103061|P2|Part 1: Open-label Phase|Adverse Event|0
2934262|NCT01440374|10103062|P1|Part 1: Open-label Phase|Adverse Event|5
2934263|NCT01440322|10103097|P2|Overall Study|Other Non-Product Related|0
2934264|NCT01440322|10103098|P1|Overall Study|Other Non-Product Related|1
2934265|NCT01440322|10103097|P2|Overall Study|Unrelated Medical Problem|1
2934266|NCT01440322|10103098|P1|Overall Study|Unrelated Medical Problem|0
2934267|NCT01440322|10103097|P2|Overall Study|Other Product Related|0
2934268|NCT01440322|10103098|P1|Overall Study|Other Product Related|1
2934269|NCT01440322|10103097|P2|Overall Study|Unacceptable Subjective Vision|0
2934270|NCT01440322|10103098|P1|Overall Study|Unacceptable Subjective Vision|1
2934271|NCT01440322|10103097|P2|Overall Study|Symptoms and Problems|0
2934272|NCT01440322|10103098|P1|Overall Study|Symptoms and Problems|1
2934273|NCT01440322|10103097|P2|Overall Study|Biomicroscopy|0
2934274|NCT01440322|10103098|P1|Overall Study|Biomicroscopy|1
2934275|NCT01440322|10103097|P2|Overall Study|Discomfort|0
2934276|NCT01440322|10103098|P1|Overall Study|Discomfort|2
2934277|NCT01440283|10103120|P1|Overall Study|Physician Decision|3
2934278|NCT01440283|10103120|P1|Overall Study|Withdrawal by Subject|4
2934279|NCT01440283|10103120|P1|Overall Study|Death|3
2934280|NCT01440101|10103135|P3|Overall Study|Other|0
2934281|NCT01440101|10103136|P2|Overall Study|Other|1
2934282|NCT01440101|10103137|P1|Overall Study|Other|0
2934283|NCT01440101|10103135|P3|Overall Study|Withdrawal by Subject|1
2934284|NCT01440101|10103136|P2|Overall Study|Withdrawal by Subject|3
2934285|NCT01440101|10103137|P1|Overall Study|Withdrawal by Subject|0
2934286|NCT01440101|10103135|P3|Overall Study|Adverse Event|0
2934287|NCT01440101|10103136|P2|Overall Study|Adverse Event|0
2934288|NCT01440101|10103137|P1|Overall Study|Adverse Event|2
2934289|NCT01440049|10103170|P1|Overall Study|Adverse Event|5
2934290|NCT01439971|10103202|P5|Overall Study|Required number in cohort dosed|1
2934291|NCT01439971|10103203|P4|Overall Study|Required number in cohort dosed|0
2934292|NCT01439971|10103204|P3|Overall Study|Required number in cohort dosed|2
2934293|NCT01439971|10103205|P2|Overall Study|Required number in cohort dosed|1
2934294|NCT01439971|10103206|P1|Overall Study|Required number in cohort dosed|0
2934295|NCT01439945|10103386|P4|Double-Blind Treatment Phase|Ineligible|1
2934296|NCT01439945|10103387|P3|Double-Blind Treatment Phase|Ineligible|0
2934297|NCT01439945|10103388|P2|Double-Blind Treatment Phase|Ineligible|2
2934298|NCT01439945|10103389|P1|Double-Blind Treatment Phase|Ineligible|1
2934299|NCT01439945|10103386|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
2934300|NCT01439945|10103387|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
2934301|NCT01439945|10103388|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
2934302|NCT01439945|10103389|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
2934303|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
2934304|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
2934305|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Other|31
2934306|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Other|14
2934307|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
2934308|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
2934309|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Death|13
2934310|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Death|3
2934311|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
2934312|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
2934313|NCT01439880|10103414|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
2934314|NCT01439880|10103415|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
2934315|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Reason Missing|2
2934316|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Reason Missing|0
2934317|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Other|13
2934318|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Other|8
2934319|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
2934320|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
2934321|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
2934322|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
2934323|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Death|1
2934324|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Death|2
2934325|NCT01439880|10103414|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
2934326|NCT01439880|10103415|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
2934327|NCT01439867|10103458|P2|Overall Study|Protocol-specified Criteria|0
2934328|NCT01439867|10103459|P1|Overall Study|Protocol-specified Criteria|1
2934329|NCT01439867|10103458|P2|Overall Study|Administrative Decision|5
2934330|NCT01439867|10103459|P1|Overall Study|Administrative Decision|4
2934331|NCT01439867|10103458|P2|Overall Study|Withdrawal by Subject|2
2934332|NCT01439867|10103459|P1|Overall Study|Withdrawal by Subject|1
2934333|NCT01439867|10103458|P2|Overall Study|Non-compliance|1
2934334|NCT01439867|10103459|P1|Overall Study|Non-compliance|0
2934335|NCT01439724|10103511|P2|Overall Study|missing consultation|8
2934336|NCT01439724|10103512|P1|Overall Study|missing consultation|9
2934337|NCT01439711|10103518|P1|Overall Study|No MRI|9
2934338|NCT01439711|10103518|P1|Overall Study|Noncompliance|3
2934339|NCT01439711|10103518|P1|Overall Study|Progression During Active Tx|3
2934340|NCT01439711|10103518|P1|Overall Study|Withdrawal by Subject|3
2934341|NCT01439711|10103518|P1|Overall Study|Adverse Event|5
2934342|NCT01439711|10103518|P1|Overall Study|Progression Prior to Beginning Tx|1
2934343|NCT01439711|10103518|P1|Overall Study|Cancel|3
2934344|NCT01439711|10103518|P1|Overall Study|Ineligible|13
2934345|NCT01439568|10103556|P2|Overall Study|Withdrawal by Subject|2
2934346|NCT01439568|10103557|P1|Overall Study|Withdrawal by Subject|2
2934347|NCT01439568|10103556|P2|Overall Study|Lost to Follow-up|0
2934348|NCT01439568|10103557|P1|Overall Study|Lost to Follow-up|1
2934349|NCT01439555|10103569|P1|Overall Study|Protocol Violation|1
2934350|NCT01439373|10103581|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
2934351|NCT01439373|10103582|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
2934352|NCT01439373|10103581|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
2934353|NCT01439373|10103582|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
2934354|NCT01439360|10103625|P2|Overall Study|Withdrawal by Subject|129
2934355|NCT01439360|10103626|P1|Overall Study|Withdrawal by Subject|140
2934356|NCT01439360|10103625|P2|Overall Study|Protocol Violation|0
2934357|NCT01439360|10103626|P1|Overall Study|Protocol Violation|1
2934358|NCT01439360|10103625|P2|Overall Study|Others|5
2934359|NCT01439360|10103626|P1|Overall Study|Others|10
2934360|NCT01439360|10103625|P2|Overall Study|Lost to Follow-up|58
2934361|NCT01439360|10103626|P1|Overall Study|Lost to Follow-up|43
2934362|NCT01439360|10103625|P2|Overall Study|Adverse Event|16
2934363|NCT01439360|10103626|P1|Overall Study|Adverse Event|4
2934364|NCT01439282|10103676|P2|Overall Study|Other|1
2934365|NCT01439282|10103677|P1|Overall Study|Other|1
2934366|NCT01439282|10103676|P2|Overall Study|Withdrawal by Subject|0
2934367|NCT01439282|10103677|P1|Overall Study|Withdrawal by Subject|2
2934368|NCT01439282|10103676|P2|Overall Study|Adverse Event|0
2934369|NCT01439282|10103677|P1|Overall Study|Adverse Event|5
2934370|NCT01439204|10103689|P2|Overall Study|poor/non-compliance|0
2934371|NCT01439204|10103690|P1|Overall Study|poor/non-compliance|3
2934372|NCT01439204|10103689|P2|Overall Study|No longer meets study criteria|0
2934373|NCT01439204|10103690|P1|Overall Study|No longer meets study criteria|1
2934374|NCT01439204|10103689|P2|Overall Study|Lost to Follow-up|2
2934375|NCT01439204|10103690|P1|Overall Study|Lost to Follow-up|0
2934376|NCT01439204|10103689|P2|Overall Study|Withdrawal by Subject|1
2934377|NCT01439204|10103690|P1|Overall Study|Withdrawal by Subject|0
2934378|NCT01439165|10103724|P2|Overall Study|Withdrawal by Subject|1
2934379|NCT01439165|10103725|P1|Overall Study|Withdrawal by Subject|7
2934380|NCT01439165|10103724|P2|Overall Study|Lost to Follow-up|1
2934381|NCT01439165|10103725|P1|Overall Study|Lost to Follow-up|11
2934382|NCT01439165|10103724|P2|Overall Study|Protocol Violation|0
2934383|NCT01439165|10103725|P1|Overall Study|Protocol Violation|3
2934384|NCT01439126|10103739|P2|Overall Study|Other-Miscellaneous|12
2934385|NCT01439126|10103740|P1|Overall Study|Other-Miscellaneous|12
2934386|NCT01439126|10103739|P2|Overall Study|Other-Use of prohibited treatment|2
2934387|NCT01439126|10103740|P1|Overall Study|Other-Use of prohibited treatment|0
2934388|NCT01439126|10103739|P2|Overall Study|Lost to Follow-up|3
2934389|NCT01439126|10103740|P1|Overall Study|Lost to Follow-up|6
2934390|NCT01439126|10103739|P2|Overall Study|Protocol Violation|4
2934391|NCT01439126|10103740|P1|Overall Study|Protocol Violation|6
2934392|NCT01439126|10103739|P2|Overall Study|Withdrawal by Subject|21
2934393|NCT01439126|10103740|P1|Overall Study|Withdrawal by Subject|5
2934394|NCT01439126|10103739|P2|Overall Study|Adverse Event|0
2934395|NCT01439126|10103740|P1|Overall Study|Adverse Event|2
2934396|NCT01439074|10103766|P2|Overall Study|Other|4
2934397|NCT01439074|10103767|P1|Overall Study|Other|4
2934398|NCT01439074|10103766|P2|Overall Study|Withdrawal by Subject|5
2934399|NCT01439074|10103767|P1|Overall Study|Withdrawal by Subject|1
2934400|NCT01439074|10103766|P2|Overall Study|Subject shedding|0
2934401|NCT01439074|10103767|P1|Overall Study|Subject shedding|1
2934402|NCT01439074|10103766|P2|Overall Study|Lost to Follow-up|4
2934403|NCT01439074|10103767|P1|Overall Study|Lost to Follow-up|3
2934404|NCT01439009|10103785|P2|Overall Study|Deviation of exclusion criteria|0
2934405|NCT01439009|10103786|P1|Overall Study|Deviation of exclusion criteria|1
2934406|NCT01439009|10103785|P2|Overall Study|Protocol Violation|0
2934407|NCT01439009|10103786|P1|Overall Study|Protocol Violation|2
2934408|NCT01439009|10103785|P2|Overall Study|Physician Decision|3
2934409|NCT01439009|10103786|P1|Overall Study|Physician Decision|5
2934410|NCT01438996|10103819|P3|Overall Study|Not meeting Inclusion Criteria|0
2934411|NCT01438996|10103820|P2|Overall Study|Not meeting Inclusion Criteria|1
2934412|NCT01438996|10103821|P1|Overall Study|Not meeting Inclusion Criteria|4
2934413|NCT01438840|10103855|P3|Extension Phase|Other|1
2934414|NCT01438840|10103856|P2|Extension Phase|Other|0
2934415|NCT01438840|10103857|P1|Extension Phase|Other|0
2934416|NCT01438840|10103855|P3|Extension Phase|Lack of Efficacy|2
2934417|NCT01438840|10103856|P2|Extension Phase|Lack of Efficacy|0
2934418|NCT01438840|10103857|P1|Extension Phase|Lack of Efficacy|0
2934419|NCT01438840|10103855|P3|Extension Phase|Withdrawal by Subject|3
2934420|NCT01438840|10103856|P2|Extension Phase|Withdrawal by Subject|0
2934421|NCT01438840|10103857|P1|Extension Phase|Withdrawal by Subject|0
2934422|NCT01438840|10103855|P3|Extension Phase|Lost to Follow-up|1
2934423|NCT01438840|10103856|P2|Extension Phase|Lost to Follow-up|0
2934424|NCT01438840|10103857|P1|Extension Phase|Lost to Follow-up|0
2934425|NCT01438840|10103855|P3|Extension Phase|Adverse Event|3
2934426|NCT01438840|10103856|P2|Extension Phase|Adverse Event|0
2934427|NCT01438840|10103857|P1|Extension Phase|Adverse Event|0
2934428|NCT01438840|10103855|P3|Core Study|Withdrawal of consent|0
2934429|NCT01438840|10103856|P2|Core Study|Withdrawal of consent|0
2934430|NCT01438840|10103857|P1|Core Study|Withdrawal of consent|1
2934431|NCT01438840|10103855|P3|Core Study|Lack of Efficacy|0
2934432|NCT01438840|10103856|P2|Core Study|Lack of Efficacy|7
2934433|NCT01438840|10103857|P1|Core Study|Lack of Efficacy|15
2934434|NCT01438840|10103855|P3|Core Study|Adverse Event|0
2934435|NCT01438840|10103856|P2|Core Study|Adverse Event|3
2934436|NCT01438840|10103857|P1|Core Study|Adverse Event|0
2934437|NCT01438814|10103870|P2|Overall Study|Other|4
2934438|NCT01438814|10103871|P1|Overall Study|Other|2
2934439|NCT01438814|10103870|P2|Overall Study|Withdrawal by Subject|2
2934440|NCT01438814|10103871|P1|Overall Study|Withdrawal by Subject|4
2934441|NCT01438814|10103870|P2|Overall Study|Lost to Follow-up|3
2934442|NCT01438814|10103871|P1|Overall Study|Lost to Follow-up|4
2934443|NCT01438814|10103870|P2|Overall Study|Protocol Violation|2
2934444|NCT01438814|10103871|P1|Overall Study|Protocol Violation|1
2934445|NCT01438814|10103870|P2|Overall Study|Adverse Event|3
2934446|NCT01438814|10103871|P1|Overall Study|Adverse Event|3
2934447|NCT01438541|10103907|P1|Overall Study|discharge from the hospital|5
2934448|NCT01438541|10103907|P1|Overall Study|Withdrawal by Subject|1
2934449|NCT01438541|10103907|P1|Overall Study|Physician Decision|1
2934450|NCT01438489|10103916|P3|Overall Study|Inadequate venous access|0
2934451|NCT01438489|10103917|P2|Overall Study|Inadequate venous access|2
2934452|NCT01438489|10103918|P1|Overall Study|Inadequate venous access|0
2934453|NCT01438489|10103916|P3|Overall Study|Did not complete all 3 follow-up visits|2
2934454|NCT01438489|10103917|P2|Overall Study|Did not complete all 3 follow-up visits|5
2934455|NCT01438489|10103918|P1|Overall Study|Did not complete all 3 follow-up visits|2
2934456|NCT01438489|10103916|P3|Overall Study|Received prohibited medication|0
2934457|NCT01438489|10103917|P2|Overall Study|Received prohibited medication|0
2934458|NCT01438489|10103918|P1|Overall Study|Received prohibited medication|1
2934459|NCT01438489|10103916|P3|Overall Study|AE/SAEs|1
2934460|NCT01438489|10103917|P2|Overall Study|AE/SAEs|1
2934461|NCT01438489|10103918|P1|Overall Study|AE/SAEs|2
2934462|NCT01438489|10103916|P3|Overall Study|Investigator decision|0
2934463|NCT01438489|10103917|P2|Overall Study|Investigator decision|1
2934464|NCT01438489|10103918|P1|Overall Study|Investigator decision|0
2934465|NCT01438489|10103916|P3|Overall Study|Subject choice/Subject moved|1
2934466|NCT01438489|10103917|P2|Overall Study|Subject choice/Subject moved|1
2934467|NCT01438489|10103918|P1|Overall Study|Subject choice/Subject moved|2
2934468|NCT01438489|10103916|P3|Overall Study|Sponsor decision|4
2934469|NCT01438489|10103917|P2|Overall Study|Sponsor decision|1
2934470|NCT01438489|10103918|P1|Overall Study|Sponsor decision|4
2934471|NCT01438489|10103916|P3|Overall Study|Death|1
2934472|NCT01438489|10103917|P2|Overall Study|Death|0
2934473|NCT01438489|10103918|P1|Overall Study|Death|0
2934474|NCT01438489|10103916|P3|Overall Study|Withdrawal by Subject|8
2934475|NCT01438489|10103917|P2|Overall Study|Withdrawal by Subject|3
2934476|NCT01438489|10103918|P1|Overall Study|Withdrawal by Subject|11
2934477|NCT01438489|10103916|P3|Overall Study|Lost to Follow-up|2
2934478|NCT01438489|10103917|P2|Overall Study|Lost to Follow-up|2
2934479|NCT01438489|10103918|P1|Overall Study|Lost to Follow-up|4
2934480|NCT01438476|10103963|P2|Overall Study|Communication barrier|1
2934481|NCT01438476|10103964|P1|Overall Study|Communication barrier|0
2934482|NCT01438476|10103963|P2|Overall Study|No Surgery- Disease|10
2934483|NCT01438476|10103964|P1|Overall Study|No Surgery- Disease|8
2934484|NCT01438476|10103963|P2|Overall Study|Withdrawal by Subject|0
2934485|NCT01438476|10103964|P1|Overall Study|Withdrawal by Subject|1
2934486|NCT01438476|10103963|P2|Overall Study|Protocol Violation|0
2934487|NCT01438476|10103964|P1|Overall Study|Protocol Violation|1
2934488|NCT01438424|10103970|P1|Overall Study|Participant noncompliance|20
2934489|NCT01438424|10103970|P1|Overall Study|No longer met inclusion criteria|1
2934490|NCT01438424|10103970|P1|Overall Study|Pregnancy|7
2934491|NCT01438424|10103970|P1|Overall Study|Need for drug prohibited by protocol|14
2934492|NCT01438424|10103970|P1|Overall Study|Abnormal laboratory test result|14
2934493|NCT01438424|10103970|P1|Overall Study|Lost to Follow-up|17
2934494|NCT01438424|10103970|P1|Overall Study|Adverse Event|17
2934495|NCT01438424|10103970|P1|Overall Study|Death|22
2934496|NCT01438424|10103970|P1|Overall Study|Progression of chronic hepatitis B|22
2934497|NCT01438424|10103970|P1|Overall Study|Withdrawal by Subject|104
2934498|NCT01438424|10103970|P1|Overall Study|Not identified|55
2934499|NCT01438424|10103970|P1|Overall Study|Minimal virologic response|95
2934500|NCT01438424|10103970|P1|Overall Study|Continuing treatment|29
2934501|NCT01438307|10104008|P2|Overall Study|Death|1
2934502|NCT01438307|10104009|P1|Overall Study|Death|1
2934503|NCT01438294|10104023|P2|Overall Study|Lost to Follow-up|7
2934504|NCT01438294|10104024|P1|Overall Study|Lost to Follow-up|3
2934505|NCT01438177|10104067|P1|Overall Study|Initiation of new therapy|1
2934506|NCT01438177|10104067|P1|Overall Study|Withdrawal by Subject|1
2934507|NCT01438151|10104074|P1|Overall Study|study terminated|8
2934508|NCT01438060|10104080|P2|On Study Beyond Week 140|Other Reason|3
2934509|NCT01438060|10104081|P1|On Study Beyond Week 140|Other Reason|0
2934510|NCT01438060|10104080|P2|On Study Beyond Week 140|Death|1
2934511|NCT01438060|10104081|P1|On Study Beyond Week 140|Death|0
2934512|NCT01438060|10104080|P2|On Study Beyond Week 140|Withdrawal by Subject|1
2934513|NCT01438060|10104081|P1|On Study Beyond Week 140|Withdrawal by Subject|0
2934514|NCT01438060|10104080|P2|On Study Beyond Week 140|Lack of Efficacy|1
2934515|NCT01438060|10104081|P1|On Study Beyond Week 140|Lack of Efficacy|0
2934516|NCT01438060|10104080|P2|On Study Beyond Week 140|Adverse Event|2
2934517|NCT01438060|10104081|P1|On Study Beyond Week 140|Adverse Event|0
2934518|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
2934519|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
2934520|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Death|12
2934521|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Death|22
2934522|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
2934523|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
2934524|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
2934525|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
2934526|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
2934527|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
2934528|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2934529|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2934530|NCT01438060|10104080|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
2934531|NCT01438060|10104081|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
2934532|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
2934533|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
2934534|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
2934535|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
2934536|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
2934537|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
2934538|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
2934539|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
2934540|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
2934541|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
2934542|NCT01438060|10104080|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
2934543|NCT01438060|10104081|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
2934544|NCT01437995|10104162|P3|Overall Study|Lost to Follow-up|20
2934545|NCT01437995|10104163|P2|Overall Study|Lost to Follow-up|18
2934546|NCT01437995|10104164|P1|Overall Study|Lost to Follow-up|11
2934547|NCT01437943|10104186|P2|Overall Study|Adverse Event|0
2934548|NCT01437943|10104187|P1|Overall Study|Adverse Event|2
2934549|NCT01437943|10104186|P2|Overall Study|Subject expressed pregnancy plans|0
2934550|NCT01437943|10104187|P1|Overall Study|Subject expressed pregnancy plans|1
2934551|NCT01437943|10104186|P2|Overall Study|Aliskiren trials terminated by Novartis|2
2934552|NCT01437943|10104187|P1|Overall Study|Aliskiren trials terminated by Novartis|4
2934553|NCT01437878|10104195|P2|Overall Study|Withdrawal by Subject|0
2934554|NCT01437878|10104196|P1|Overall Study|Withdrawal by Subject|1
2934555|NCT01437540|10104263|P2|Overall Study|Withdrawal by Subject|15
2934556|NCT01437540|10104264|P1|Overall Study|Withdrawal by Subject|31
2934557|NCT01437540|10104263|P2|Overall Study|Adverse Event|13
2934558|NCT01437540|10104264|P1|Overall Study|Adverse Event|26
2934559|NCT01437540|10104263|P2|Overall Study|Protocol Violation|12
2934560|NCT01437540|10104264|P1|Overall Study|Protocol Violation|24
2934561|NCT01437540|10104263|P2|Overall Study|Lack of Efficacy|11
2934562|NCT01437540|10104264|P1|Overall Study|Lack of Efficacy|23
2934563|NCT01437540|10104263|P2|Overall Study|Lost to Follow-up|5
2934564|NCT01437540|10104264|P1|Overall Study|Lost to Follow-up|3
2934565|NCT01437540|10104263|P2|Overall Study|COPD exacerbation|3
2934566|NCT01437540|10104264|P1|Overall Study|COPD exacerbation|13
2934567|NCT01437540|10104263|P2|Overall Study|Not listed below|6
2934568|NCT01437540|10104264|P1|Overall Study|Not listed below|7
2934569|NCT01437423|10104301|P1|Overall Study|Off label usage|3
2934570|NCT01437423|10104301|P1|Overall Study|Lost to Follow-up|12
2934571|NCT01437397|10104313|P5|Overall Study|Site termination/COPD exacerbation/other|14
2934572|NCT01437397|10104314|P4|Overall Study|Site termination/COPD exacerbation/other|9
2934573|NCT01437397|10104315|P3|Overall Study|Site termination/COPD exacerbation/other|9
2934574|NCT01437397|10104316|P2|Overall Study|Site termination/COPD exacerbation/other|8
2934575|NCT01437397|10104317|P1|Overall Study|Site termination/COPD exacerbation/other|10
2934576|NCT01437397|10104313|P5|Overall Study|Adverse Event|21
2934577|NCT01437397|10104314|P4|Overall Study|Adverse Event|14
2934578|NCT01437397|10104315|P3|Overall Study|Adverse Event|16
2934579|NCT01437397|10104316|P2|Overall Study|Adverse Event|22
2934580|NCT01437397|10104317|P1|Overall Study|Adverse Event|21
2934581|NCT01437397|10104313|P5|Overall Study|Lack of Efficacy|20
2934582|NCT01437397|10104314|P4|Overall Study|Lack of Efficacy|10
2934583|NCT01437397|10104315|P3|Overall Study|Lack of Efficacy|8
2934584|NCT01437397|10104316|P2|Overall Study|Lack of Efficacy|4
2934585|NCT01437397|10104317|P1|Overall Study|Lack of Efficacy|5
2934586|NCT01437397|10104313|P5|Overall Study|Protocol Violation|19
2934587|NCT01437397|10104314|P4|Overall Study|Protocol Violation|21
2934588|NCT01437397|10104315|P3|Overall Study|Protocol Violation|13
2934589|NCT01437397|10104316|P2|Overall Study|Protocol Violation|12
2934590|NCT01437397|10104317|P1|Overall Study|Protocol Violation|10
2934591|NCT01437397|10104313|P5|Overall Study|Withdrawal by Subject|22
2934592|NCT01437397|10104314|P4|Overall Study|Withdrawal by Subject|11
2934593|NCT01437397|10104315|P3|Overall Study|Withdrawal by Subject|24
2934594|NCT01437397|10104316|P2|Overall Study|Withdrawal by Subject|12
2934595|NCT01437397|10104317|P1|Overall Study|Withdrawal by Subject|11
2934596|NCT01437397|10104313|P5|Overall Study|Lost to Follow-up|5
2934597|NCT01437397|10104314|P4|Overall Study|Lost to Follow-up|4
2934598|NCT01437397|10104315|P3|Overall Study|Lost to Follow-up|2
2934599|NCT01437397|10104316|P2|Overall Study|Lost to Follow-up|4
2934600|NCT01437397|10104317|P1|Overall Study|Lost to Follow-up|9
2934601|NCT01437319|10104344|P3|Phase II|Protocol Violation|0
2934602|NCT01437319|10104345|P2|Phase II|Protocol Violation|1
2934603|NCT01437319|10104346|P1|Phase II|Protocol Violation|0
2934604|NCT01437319|10104344|P3|Phase II|Study related symptoms/complaints|19
2934605|NCT01437319|10104345|P2|Phase II|Study related symptoms/complaints|28
2934606|NCT01437319|10104346|P1|Phase II|Study related symptoms/complaints|0
2934607|NCT01437319|10104344|P3|Phase II|Lost to Follow-up|2
2934608|NCT01437319|10104345|P2|Phase II|Lost to Follow-up|7
2934609|NCT01437319|10104346|P1|Phase II|Lost to Follow-up|0
2934610|NCT01437319|10104344|P3|Phase II|Withdrawal by Subject|16
2934611|NCT01437319|10104345|P2|Phase II|Withdrawal by Subject|8
2934612|NCT01437319|10104346|P1|Phase II|Withdrawal by Subject|0
2934613|NCT01437319|10104344|P3|Phase I|Withdrawal by Subject|0
2934614|NCT01437319|10104345|P2|Phase I|Withdrawal by Subject|0
2934615|NCT01437319|10104346|P1|Phase I|Withdrawal by Subject|25
2934616|NCT01437319|10104344|P3|Phase I|Study related symptoms/complaints|0
2934617|NCT01437319|10104345|P2|Phase I|Study related symptoms/complaints|0
2934618|NCT01437319|10104346|P1|Phase I|Study related symptoms/complaints|27
2934619|NCT01437319|10104344|P3|Phase I|Protocol Violation|0
2934620|NCT01437319|10104345|P2|Phase I|Protocol Violation|0
2934621|NCT01437319|10104346|P1|Phase I|Protocol Violation|1
2934622|NCT01437319|10104344|P3|Phase I|Lost to Follow-up|0
2934623|NCT01437319|10104345|P2|Phase I|Lost to Follow-up|0
2934624|NCT01437319|10104346|P1|Phase I|Lost to Follow-up|2
2934625|NCT01437267|10104361|P6|Overall Study|Protocol Violation|0
2934626|NCT01437267|10104362|P5|Overall Study|Protocol Violation|0
2934627|NCT01437267|10104363|P4|Overall Study|Protocol Violation|0
2934628|NCT01437267|10104364|P3|Overall Study|Protocol Violation|0
2934629|NCT01437267|10104365|P2|Overall Study|Protocol Violation|1
2934630|NCT01437267|10104366|P1|Overall Study|Protocol Violation|0
2934631|NCT01437267|10104361|P6|Overall Study|Withdrawal by Subject|0
2934632|NCT01437267|10104362|P5|Overall Study|Withdrawal by Subject|0
2934633|NCT01437267|10104363|P4|Overall Study|Withdrawal by Subject|1
2934634|NCT01437267|10104364|P3|Overall Study|Withdrawal by Subject|0
2934635|NCT01437267|10104365|P2|Overall Study|Withdrawal by Subject|0
2934636|NCT01437267|10104366|P1|Overall Study|Withdrawal by Subject|0
2934637|NCT01437111|10104409|P1|Overall Study|Protocol Violation|1
2934638|NCT01437111|10104409|P1|Overall Study|Lost to Follow-up|5
2934639|NCT01437111|10104409|P1|Overall Study|Physician Decision|1
2934640|NCT01437111|10104409|P1|Overall Study|Not reported|5
2934641|NCT01437111|10104409|P1|Overall Study|Withdrawal by Subject|4
2934642|NCT01437111|10104409|P1|Overall Study|Adverse Event|2
2934643|NCT01436643|10104487|P4|Core Phase (16 Weeks)|Protocol Violation|0
2934644|NCT01436643|10104488|P3|Core Phase (16 Weeks)|Protocol Violation|1
2934645|NCT01436643|10104489|P2|Core Phase (16 Weeks)|Protocol Violation|1
2934646|NCT01436643|10104490|P1|Core Phase (16 Weeks)|Protocol Violation|1
2934647|NCT01436643|10104487|P4|Core Phase (16 Weeks)|Abnormal Test result|0
2934648|NCT01436643|10104488|P3|Core Phase (16 Weeks)|Abnormal Test result|1
2934649|NCT01436643|10104489|P2|Core Phase (16 Weeks)|Abnormal Test result|0
2934650|NCT01436643|10104490|P1|Core Phase (16 Weeks)|Abnormal Test result|0
2934651|NCT01436643|10104487|P4|Core Phase (16 Weeks)|Adverse Event|0
2934652|NCT01436643|10104488|P3|Core Phase (16 Weeks)|Adverse Event|1
2934653|NCT01436643|10104489|P2|Core Phase (16 Weeks)|Adverse Event|3
2934654|NCT01436643|10104490|P1|Core Phase (16 Weeks)|Adverse Event|0
2934655|NCT01436643|10104487|P4|2-week Pre-treatment|Protocol Violation|4
2934656|NCT01436643|10104488|P3|2-week Pre-treatment|Protocol Violation|0
2934657|NCT01436643|10104489|P2|2-week Pre-treatment|Protocol Violation|0
2934658|NCT01436643|10104490|P1|2-week Pre-treatment|Protocol Violation|0
2934659|NCT01436643|10104487|P4|2-week Pre-treatment|Adverse Event|5
2934660|NCT01436643|10104488|P3|2-week Pre-treatment|Adverse Event|0
2934661|NCT01436643|10104489|P2|2-week Pre-treatment|Adverse Event|0
2934662|NCT01436643|10104490|P1|2-week Pre-treatment|Adverse Event|0
2934663|NCT01436643|10104487|P4|2-week Pre-treatment|Abnormal test result|1
2934664|NCT01436643|10104488|P3|2-week Pre-treatment|Abnormal test result|0
2934665|NCT01436643|10104489|P2|2-week Pre-treatment|Abnormal test result|0
2934666|NCT01436643|10104490|P1|2-week Pre-treatment|Abnormal test result|0
2934667|NCT01436500|10104525|P5|Overall Study|Other|0
2934668|NCT01436500|10104526|P4|Overall Study|Other|1
2934669|NCT01436500|10104527|P3|Overall Study|Other|0
2934670|NCT01436500|10104528|P2|Overall Study|Other|1
2934671|NCT01436500|10104529|P1|Overall Study|Other|0
2934672|NCT01436500|10104525|P5|Overall Study|discontinued study drug|0
2934673|NCT01436500|10104526|P4|Overall Study|discontinued study drug|0
2934674|NCT01436500|10104527|P3|Overall Study|discontinued study drug|0
2934675|NCT01436500|10104528|P2|Overall Study|discontinued study drug|0
2934676|NCT01436500|10104529|P1|Overall Study|discontinued study drug|1
2934677|NCT01436500|10104525|P5|Overall Study|initiation of dialysis|1
2934678|NCT01436500|10104526|P4|Overall Study|initiation of dialysis|0
2934679|NCT01436500|10104527|P3|Overall Study|initiation of dialysis|0
2934680|NCT01436500|10104528|P2|Overall Study|initiation of dialysis|0
2934681|NCT01436500|10104529|P1|Overall Study|initiation of dialysis|0
2934682|NCT01436500|10104525|P5|Overall Study|liver transplant|0
2934683|NCT01436500|10104526|P4|Overall Study|liver transplant|0
2934684|NCT01436500|10104527|P3|Overall Study|liver transplant|0
2934685|NCT01436500|10104528|P2|Overall Study|liver transplant|0
2934686|NCT01436500|10104529|P1|Overall Study|liver transplant|1
2934687|NCT01436500|10104525|P5|Overall Study|Physician Decision|0
2934688|NCT01436500|10104526|P4|Overall Study|Physician Decision|0
2934689|NCT01436500|10104527|P3|Overall Study|Physician Decision|1
2934690|NCT01436500|10104528|P2|Overall Study|Physician Decision|0
2934691|NCT01436500|10104529|P1|Overall Study|Physician Decision|0
2934692|NCT01436500|10104525|P5|Overall Study|Withdrawal by Subject|2
2934693|NCT01436500|10104526|P4|Overall Study|Withdrawal by Subject|0
2934694|NCT01436500|10104527|P3|Overall Study|Withdrawal by Subject|2
2934695|NCT01436500|10104528|P2|Overall Study|Withdrawal by Subject|0
2934696|NCT01436500|10104529|P1|Overall Study|Withdrawal by Subject|0
2934697|NCT01436500|10104525|P5|Overall Study|Adverse Event|1
2934698|NCT01436500|10104526|P4|Overall Study|Adverse Event|0
2934699|NCT01436500|10104527|P3|Overall Study|Adverse Event|2
2934700|NCT01436500|10104528|P2|Overall Study|Adverse Event|2
2934701|NCT01436500|10104529|P1|Overall Study|Adverse Event|0
2934702|NCT01436500|10104525|P5|Overall Study|Death|0
2934703|NCT01436500|10104526|P4|Overall Study|Death|0
2934704|NCT01436500|10104527|P3|Overall Study|Death|0
2934705|NCT01436500|10104528|P2|Overall Study|Death|0
2934706|NCT01436500|10104529|P1|Overall Study|Death|1
2934707|NCT01436396|10104573|P2|Overall Study|Lost to Follow-up|3
2934708|NCT01436396|10104574|P1|Overall Study|Lost to Follow-up|3
2934709|NCT01436396|10104573|P2|Overall Study|Serious adverse event|3
2934710|NCT01436396|10104574|P1|Overall Study|Serious adverse event|2
2934711|NCT01436396|10104573|P2|Overall Study|Withdrawal by Subject|29
2934712|NCT01436396|10104574|P1|Overall Study|Withdrawal by Subject|19
2934713|NCT01436396|10104573|P2|Overall Study|Adverse Event|2
2934714|NCT01436396|10104574|P1|Overall Study|Adverse Event|1
2934715|NCT01436396|10104573|P2|Overall Study|Protocol Violation|5
2934716|NCT01436396|10104574|P1|Overall Study|Protocol Violation|7
2934717|NCT01436370|10104614|P8|Overall Study|Lost to Follow-up|0
2934718|NCT01436370|10104615|P7|Overall Study|Lost to Follow-up|0
2934719|NCT01436370|10104616|P6|Overall Study|Lost to Follow-up|0
2934720|NCT01436370|10104617|P5|Overall Study|Lost to Follow-up|1
2934721|NCT01436370|10104618|P4|Overall Study|Lost to Follow-up|0
2934722|NCT01436370|10104619|P3|Overall Study|Lost to Follow-up|0
2934723|NCT01436370|10104620|P2|Overall Study|Lost to Follow-up|0
2934724|NCT01436370|10104621|P1|Overall Study|Lost to Follow-up|0
2934725|NCT01436357|10104701|P2|Overall Study|Subject in rehab|1
2934726|NCT01436357|10104702|P1|Overall Study|Subject in rehab|0
2934727|NCT01436357|10104701|P2|Overall Study|Moved out of area|2
2934728|NCT01436357|10104702|P1|Overall Study|Moved out of area|1
2934729|NCT01436357|10104701|P2|Overall Study|Physician Decision|4
2934730|NCT01436357|10104702|P1|Overall Study|Physician Decision|3
2934731|NCT01436357|10104701|P2|Overall Study|Withdrawal by Subject|38
2934732|NCT01436357|10104702|P1|Overall Study|Withdrawal by Subject|26
2934733|NCT01436357|10104701|P2|Overall Study|Protocol Violation|0
2934734|NCT01436357|10104702|P1|Overall Study|Protocol Violation|1
2934735|NCT01436357|10104701|P2|Overall Study|Lost to Follow-up|61
2934736|NCT01436357|10104702|P1|Overall Study|Lost to Follow-up|67
2934737|NCT01436357|10104701|P2|Overall Study|Incarceration|20
2934738|NCT01436357|10104702|P1|Overall Study|Incarceration|18
2934739|NCT01436357|10104701|P2|Overall Study|Enrolled but not vaccinated|1
2934740|NCT01436357|10104702|P1|Overall Study|Enrolled but not vaccinated|1
2934741|NCT01436357|10104701|P2|Overall Study|Death|1
2934742|NCT01436357|10104702|P1|Overall Study|Death|5
2934743|NCT01436305|10104723|P3|Overall Study|Withdrawal by Subject|0
2934744|NCT01436305|10104724|P2|Overall Study|Withdrawal by Subject|3
2934745|NCT01436305|10104725|P1|Overall Study|Withdrawal by Subject|1
2934746|NCT01436305|10104723|P3|Overall Study|Lost to Follow-up|0
2934747|NCT01436305|10104724|P2|Overall Study|Lost to Follow-up|1
2934748|NCT01436305|10104725|P1|Overall Study|Lost to Follow-up|0
2934749|NCT01436305|10104723|P3|Overall Study|Death|0
2934750|NCT01436305|10104724|P2|Overall Study|Death|0
2934751|NCT01436305|10104725|P1|Overall Study|Death|1
2934752|NCT01436253|10104852|P1|Overall Study|Not meeting all eligibility criteria|117
2934753|NCT01436253|10104852|P1|Overall Study|Lost to Follow-up|182
2934754|NCT01436201|10104857|P1|Overall Study|Protocol Violation|1
2934755|NCT01436201|10104857|P1|Overall Study|Withdrawal by Subject|1
2934756|NCT01436201|10104857|P1|Overall Study|Adverse Event|2
2934757|NCT01436175|10104867|P1|Overall Study|Other|826
2934758|NCT01436175|10104867|P1|Overall Study|Met blood pressure or pulse withdrawal|63
2934759|NCT01436175|10104867|P1|Overall Study|Lack of Efficacy|24
2934760|NCT01436175|10104867|P1|Overall Study|Lost to Follow-up|89
2934761|NCT01436175|10104867|P1|Overall Study|Withdrawal by Subject|108
2934762|NCT01436175|10104867|P1|Overall Study|Protocol Violation|49
2934763|NCT01436175|10104867|P1|Overall Study|Adverse Event|111
2934764|NCT01436162|10104894|P3|Randomized Phase|Other|4
2934765|NCT01436162|10104895|P2|Randomized Phase|Other|5
2934766|NCT01436162|10104896|P1|Randomized Phase|Other|2
2934767|NCT01436162|10104894|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
2934768|NCT01436162|10104895|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2934769|NCT01436162|10104896|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
2934770|NCT01436162|10104894|P3|Randomized Phase|Lack of Efficacy|1
2934771|NCT01436162|10104895|P2|Randomized Phase|Lack of Efficacy|1
2934772|NCT01436162|10104896|P1|Randomized Phase|Lack of Efficacy|0
2934773|NCT01436162|10104894|P3|Randomized Phase|Lost to Follow-up|4
2934774|NCT01436162|10104895|P2|Randomized Phase|Lost to Follow-up|5
2934775|NCT01436162|10104896|P1|Randomized Phase|Lost to Follow-up|17
2934776|NCT01436162|10104894|P3|Randomized Phase|Withdrawal by Subject|8
2934777|NCT01436162|10104895|P2|Randomized Phase|Withdrawal by Subject|9
2934778|NCT01436162|10104896|P1|Randomized Phase|Withdrawal by Subject|16
2934779|NCT01436162|10104894|P3|Randomized Phase|Protocol Violation|2
2934780|NCT01436162|10104895|P2|Randomized Phase|Protocol Violation|4
2934781|NCT01436162|10104896|P1|Randomized Phase|Protocol Violation|4
2934782|NCT01436162|10104894|P3|Randomized Phase|Adverse Event|6
2934783|NCT01436162|10104895|P2|Randomized Phase|Adverse Event|5
2934784|NCT01436162|10104896|P1|Randomized Phase|Adverse Event|1
2934785|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Other|0
2934786|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Other|0
2934787|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Other|107
2934788|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934789|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934790|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
2934791|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
2934792|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
2934793|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
2934794|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
2934795|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
2934796|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
2934797|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Protocol Violation|0
2934798|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Protocol Violation|0
2934799|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Protocol Violation|24
2934800|NCT01436162|10104894|P3|Single-blind Lead-in Phase|Adverse Event|0
2934801|NCT01436162|10104895|P2|Single-blind Lead-in Phase|Adverse Event|0
2934802|NCT01436162|10104896|P1|Single-blind Lead-in Phase|Adverse Event|26
2934803|NCT01436149|10104930|P3|Randomized Phase|Other|11
2934804|NCT01436149|10104931|P2|Randomized Phase|Other|5
2934805|NCT01436149|10104932|P1|Randomized Phase|Other|12
2934806|NCT01436149|10104930|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2934807|NCT01436149|10104931|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2934808|NCT01436149|10104932|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2934809|NCT01436149|10104930|P3|Randomized Phase|Lack of Efficacy|1
2934810|NCT01436149|10104931|P2|Randomized Phase|Lack of Efficacy|0
2934811|NCT01436149|10104932|P1|Randomized Phase|Lack of Efficacy|0
2934812|NCT01436149|10104930|P3|Randomized Phase|Lost to Follow-up|6
2934813|NCT01436149|10104931|P2|Randomized Phase|Lost to Follow-up|5
2934814|NCT01436149|10104932|P1|Randomized Phase|Lost to Follow-up|34
2934815|NCT01436149|10104930|P3|Randomized Phase|Withdrawal by Subject|10
2934816|NCT01436149|10104931|P2|Randomized Phase|Withdrawal by Subject|10
2934817|NCT01436149|10104932|P1|Randomized Phase|Withdrawal by Subject|16
2934818|NCT01436149|10104930|P3|Randomized Phase|Protocol Violation|0
2934819|NCT01436149|10104931|P2|Randomized Phase|Protocol Violation|5
2934820|NCT01436149|10104932|P1|Randomized Phase|Protocol Violation|4
2934821|NCT01436149|10104930|P3|Randomized Phase|Adverse Event|11
2934822|NCT01436149|10104931|P2|Randomized Phase|Adverse Event|10
2934823|NCT01436149|10104932|P1|Randomized Phase|Adverse Event|9
2934824|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Other|0
2934825|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Other|0
2934826|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Other|119
2934827|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2934828|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2934829|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
2934830|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934831|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934832|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
2934833|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934834|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934835|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
2934836|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Protocol Violation|0
2934837|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Protocol Violation|0
2934838|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Protocol Violation|29
2934839|NCT01436149|10104930|P3|Antidepressant Lead-in Phase|Adverse Event|0
2934840|NCT01436149|10104931|P2|Antidepressant Lead-in Phase|Adverse Event|0
2934841|NCT01436149|10104932|P1|Antidepressant Lead-in Phase|Adverse Event|39
2934842|NCT01436110|10104963|P3|Overall Study|Did Not Receive Trial Medication|3
2934843|NCT01436110|10104964|P2|Overall Study|Did Not Receive Trial Medication|0
2934844|NCT01436110|10104965|P1|Overall Study|Did Not Receive Trial Medication|1
2934845|NCT01436110|10104963|P3|Overall Study|Protocol Violation|1
2934846|NCT01436110|10104964|P2|Overall Study|Protocol Violation|1
2934847|NCT01436110|10104965|P1|Overall Study|Protocol Violation|3
2934848|NCT01436110|10104963|P3|Overall Study|Lost to Follow-up|3
2934849|NCT01436110|10104964|P2|Overall Study|Lost to Follow-up|1
2934850|NCT01436110|10104965|P1|Overall Study|Lost to Follow-up|1
2934851|NCT01436110|10104963|P3|Overall Study|Physician Decision|1
2934852|NCT01436110|10104964|P2|Overall Study|Physician Decision|1
2934853|NCT01436110|10104965|P1|Overall Study|Physician Decision|3
2934854|NCT01436110|10104963|P3|Overall Study|Adverse Event|2
2934855|NCT01436110|10104964|P2|Overall Study|Adverse Event|1
2934856|NCT01436110|10104965|P1|Overall Study|Adverse Event|2
2934857|NCT01436110|10104963|P3|Overall Study|Withdrawal by Subject|4
2934858|NCT01436110|10104964|P2|Overall Study|Withdrawal by Subject|8
2934859|NCT01436110|10104965|P1|Overall Study|Withdrawal by Subject|6
2934860|NCT01436110|10104963|P3|Overall Study|Lack of Efficacy|9
2934861|NCT01436110|10104964|P2|Overall Study|Lack of Efficacy|14
2934862|NCT01436110|10104965|P1|Overall Study|Lack of Efficacy|23
2934863|NCT01436084|10104988|P1|Overall Study|Early Closure of Study|1
2934864|NCT01436084|10104988|P1|Overall Study|Withdrawal by Subject|1
2934865|NCT01436084|10104988|P1|Overall Study|Disease Progression|2
2934866|NCT01436071|10104994|P2|Overall Study|Did Not Receive Trial Medication|3
2934867|NCT01436071|10104995|P1|Overall Study|Did Not Receive Trial Medication|3
2934868|NCT01436071|10104994|P2|Overall Study|Withdrawal by Subject|2
2934869|NCT01436071|10104995|P1|Overall Study|Withdrawal by Subject|2
2934870|NCT01436071|10104994|P2|Overall Study|Physician Decision|0
2934871|NCT01436071|10104995|P1|Overall Study|Physician Decision|1
2934872|NCT01436071|10104994|P2|Overall Study|Lost to Follow-up|1
2934873|NCT01436071|10104995|P1|Overall Study|Lost to Follow-up|3
2934874|NCT01436071|10104994|P2|Overall Study|Protocol Violation|1
2934875|NCT01436071|10104995|P1|Overall Study|Protocol Violation|0
2934876|NCT01436071|10104994|P2|Overall Study|Lack of Efficacy|7
2934877|NCT01436071|10104995|P1|Overall Study|Lack of Efficacy|16
2934878|NCT01436071|10104994|P2|Overall Study|Adverse Event|0
2934879|NCT01436071|10104995|P1|Overall Study|Adverse Event|1
2934880|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Administrative|2
2934881|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Administrative|5
2934882|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Administrative|0
2934883|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
2934884|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
2934885|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
2934886|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
2934887|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
2934888|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
2934889|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
2934890|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
2934891|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
2934892|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
2934893|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
2934894|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
2934895|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
2934896|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
2934897|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
2934898|NCT01435928|10105037|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
2934899|NCT01435928|10105038|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
2934900|NCT01435928|10105039|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
2934901|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Administrative|0
2934902|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Administrative|0
2934903|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Administrative|14
2934904|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2934905|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2934906|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
2934907|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2934908|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2934909|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
2934910|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2934911|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2934912|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
2934913|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2934914|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2934915|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
2934916|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2934917|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2934918|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
2934919|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2934920|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2934921|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
2934922|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Death|0
2934923|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Death|0
2934924|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Death|1
2934925|NCT01435928|10105037|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
2934926|NCT01435928|10105038|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
2934927|NCT01435928|10105039|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
2934928|NCT01435798|10105085|P1|Overall Study|Withdrawal by Subject|1
2934929|NCT01435772|10105102|P3|Overall Study|Other - study termination|10
2934930|NCT01435772|10105103|P2|Overall Study|Other - study termination|2
2934931|NCT01435772|10105104|P1|Overall Study|Other - study termination|2
2934932|NCT01435772|10105102|P3|Overall Study|Withdrawal by Subject|3
2934933|NCT01435772|10105103|P2|Overall Study|Withdrawal by Subject|1
2934934|NCT01435772|10105104|P1|Overall Study|Withdrawal by Subject|0
2934935|NCT01435772|10105102|P3|Overall Study|Adverse Event|2
2934936|NCT01435772|10105103|P2|Overall Study|Adverse Event|0
2934937|NCT01435772|10105104|P1|Overall Study|Adverse Event|1
2934938|NCT01435759|10105154|P6|Double-blind Phase|Other|0
2934939|NCT01435759|10105155|P5|Double-blind Phase|Other|0
2934940|NCT01435759|10105156|P4|Double-blind Phase|Other|2
2934941|NCT01435759|10105157|P3|Double-blind Phase|Other|0
2934942|NCT01435759|10105158|P2|Double-blind Phase|Other|2
2934943|NCT01435759|10105159|P1|Double-blind Phase|Other|8
2934944|NCT01435759|10105154|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2934945|NCT01435759|10105155|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
2934946|NCT01435759|10105156|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2934947|NCT01435759|10105157|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2934948|NCT01435759|10105158|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2934949|NCT01435759|10105159|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
2934950|NCT01435759|10105154|P6|Double-blind Phase|Lost to Follow-up|3
2934951|NCT01435759|10105155|P5|Double-blind Phase|Lost to Follow-up|3
2934952|NCT01435759|10105156|P4|Double-blind Phase|Lost to Follow-up|0
2934953|NCT01435759|10105157|P3|Double-blind Phase|Lost to Follow-up|2
2934954|NCT01435759|10105158|P2|Double-blind Phase|Lost to Follow-up|1
2934955|NCT01435759|10105159|P1|Double-blind Phase|Lost to Follow-up|31
2934956|NCT01435759|10105154|P6|Double-blind Phase|Withdrawal by Subject|2
2934957|NCT01435759|10105155|P5|Double-blind Phase|Withdrawal by Subject|2
2934958|NCT01435759|10105156|P4|Double-blind Phase|Withdrawal by Subject|4
2934959|NCT01435759|10105157|P3|Double-blind Phase|Withdrawal by Subject|3
2934960|NCT01435759|10105158|P2|Double-blind Phase|Withdrawal by Subject|4
2934961|NCT01435759|10105159|P1|Double-blind Phase|Withdrawal by Subject|17
2934962|NCT01435759|10105154|P6|Double-blind Phase|Protocol Violation|1
2934963|NCT01435759|10105155|P5|Double-blind Phase|Protocol Violation|0
2934964|NCT01435759|10105156|P4|Double-blind Phase|Protocol Violation|2
2934965|NCT01435759|10105157|P3|Double-blind Phase|Protocol Violation|1
2934966|NCT01435759|10105158|P2|Double-blind Phase|Protocol Violation|0
2934967|NCT01435759|10105159|P1|Double-blind Phase|Protocol Violation|2
2934968|NCT01435759|10105154|P6|Double-blind Phase|Adverse Event|3
2934969|NCT01435759|10105155|P5|Double-blind Phase|Adverse Event|1
2934970|NCT01435759|10105156|P4|Double-blind Phase|Adverse Event|1
2934971|NCT01435759|10105157|P3|Double-blind Phase|Adverse Event|1
2934972|NCT01435759|10105158|P2|Double-blind Phase|Adverse Event|0
2934973|NCT01435759|10105159|P1|Double-blind Phase|Adverse Event|7
2934974|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Other|0
2934975|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Other|0
2934976|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Other|0
2934977|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Other|0
2934978|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Other|0
2934979|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Other|119
2934980|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934981|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934982|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934983|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934984|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2934985|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
2934986|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934987|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934988|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934989|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934990|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
2934991|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
2934992|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934993|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934994|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934995|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934996|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2934997|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
2934998|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Protocol Violation|0
2934999|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Protocol Violation|0
2935000|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Protocol Violation|0
2935001|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Protocol Violation|0
2935002|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Protocol Violation|0
2935003|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Protocol Violation|16
2935004|NCT01435759|10105154|P6|Antidepressant Lead-in Phase|Adverse Event|0
2935005|NCT01435759|10105155|P5|Antidepressant Lead-in Phase|Adverse Event|0
2935006|NCT01435759|10105156|P4|Antidepressant Lead-in Phase|Adverse Event|0
2935007|NCT01435759|10105157|P3|Antidepressant Lead-in Phase|Adverse Event|0
2935008|NCT01435759|10105158|P2|Antidepressant Lead-in Phase|Adverse Event|0
2935009|NCT01435759|10105159|P1|Antidepressant Lead-in Phase|Adverse Event|40
2935010|NCT01435655|10105186|P1|Overall Study|Other|1
2935011|NCT01435655|10105186|P1|Overall Study|Death|2
2935012|NCT01435616|10105200|P2|Overall Study|Sponsor Decision|0
2935013|NCT01435616|10105201|P1|Overall Study|Sponsor Decision|1
2935014|NCT01435616|10105200|P2|Overall Study|Physician Decision|7
2935015|NCT01435616|10105201|P1|Overall Study|Physician Decision|20
2935016|NCT01435616|10105200|P2|Overall Study|Withdrawal by Subject|24
2935017|NCT01435616|10105201|P1|Overall Study|Withdrawal by Subject|66
2935018|NCT01435616|10105200|P2|Overall Study|Protocol Violation|13
2935019|NCT01435616|10105201|P1|Overall Study|Protocol Violation|16
2935020|NCT01435616|10105200|P2|Overall Study|Lost to Follow-up|13
2935021|NCT01435616|10105201|P1|Overall Study|Lost to Follow-up|22
2935022|NCT01435616|10105200|P2|Overall Study|Death|2
2935023|NCT01435616|10105201|P1|Overall Study|Death|7
2935024|NCT01435616|10105200|P2|Overall Study|Adverse Event|21
2935025|NCT01435616|10105201|P1|Overall Study|Adverse Event|39
2935026|NCT01435577|10105256|P2|Overall Study|Alternative treatment started|1
2935027|NCT01435577|10105257|P1|Overall Study|Alternative treatment started|0
2935028|NCT01435577|10105256|P2|Overall Study|Lack of Efficacy|51
2935029|NCT01435577|10105257|P1|Overall Study|Lack of Efficacy|7
2935030|NCT01435577|10105256|P2|Overall Study|Adverse Event|0
2935031|NCT01435577|10105257|P1|Overall Study|Adverse Event|10
2935032|NCT01435460|10105307|P2|Overall Study|Did not meet eligibility criteria|0
2935033|NCT01435460|10105308|P1|Overall Study|Did not meet eligibility criteria|2
2935034|NCT01435460|10105307|P2|Overall Study|Protocol Violation|1
2935035|NCT01435460|10105308|P1|Overall Study|Protocol Violation|0
2935036|NCT01435460|10105307|P2|Overall Study|Withdrawal by Subject|3
2935037|NCT01435460|10105308|P1|Overall Study|Withdrawal by Subject|1
2935038|NCT01435460|10105307|P2|Overall Study|Lost to Follow-up|1
2935039|NCT01435460|10105308|P1|Overall Study|Lost to Follow-up|6
2935040|NCT01435460|10105307|P2|Overall Study|Adverse Event|1
2935041|NCT01435460|10105308|P1|Overall Study|Adverse Event|2
2935042|NCT01435382|10105324|P4|Overall Study|Withdrawal by Subject|1
2935043|NCT01435382|10105325|P3|Overall Study|Withdrawal by Subject|0
2935044|NCT01435382|10105326|P2|Overall Study|Withdrawal by Subject|2
2935045|NCT01435382|10105327|P1|Overall Study|Withdrawal by Subject|0
2935046|NCT01435382|10105324|P4|Overall Study|Lost to Follow-up|0
2935047|NCT01435382|10105325|P3|Overall Study|Lost to Follow-up|1
2935048|NCT01435382|10105326|P2|Overall Study|Lost to Follow-up|0
2935049|NCT01435382|10105327|P1|Overall Study|Lost to Follow-up|1
2935050|NCT01435356|10105416|P2|Overall Study|Patient moved to another city|1
2935051|NCT01435356|10105417|P1|Overall Study|Patient moved to another city|1
2935052|NCT01435356|10105416|P2|Overall Study|Patient decision|0
2935053|NCT01435356|10105417|P1|Overall Study|Patient decision|3
2935054|NCT01435356|10105416|P2|Overall Study|Physician Decision|0
2935055|NCT01435356|10105417|P1|Overall Study|Physician Decision|1
2935056|NCT01435356|10105416|P2|Overall Study|IC withdrawal due to study cancellation|0
2935057|NCT01435356|10105417|P1|Overall Study|IC withdrawal due to study cancellation|1
2935058|NCT01435356|10105416|P2|Overall Study|Facial palsy|0
2935059|NCT01435356|10105417|P1|Overall Study|Facial palsy|1
2935060|NCT01435356|10105416|P2|Overall Study|Withdrawal by Subject|1
2935061|NCT01435356|10105417|P1|Overall Study|Withdrawal by Subject|1
2935062|NCT01435356|10105416|P2|Overall Study|Study Discontinuation, amendment 4|11
2935063|NCT01435356|10105417|P1|Overall Study|Study Discontinuation, amendment 4|5
2935064|NCT01435356|10105416|P2|Overall Study|Protocol Violation|1
2935065|NCT01435356|10105417|P1|Overall Study|Protocol Violation|0
2935066|NCT01435356|10105416|P2|Overall Study|Disease progression/recurrence|10
2935067|NCT01435356|10105417|P1|Overall Study|Disease progression/recurrence|17
2935068|NCT01435356|10105416|P2|Overall Study|Adverse Event|0
2935069|NCT01435356|10105417|P1|Overall Study|Adverse Event|2
2935070|NCT01435265|10105450|P2|Overall Study|Lost to Follow-up|1
2935071|NCT01435265|10105451|P1|Overall Study|Lost to Follow-up|0
2935072|NCT01435122|10105465|P1|Overall Study|Early withdrawal due to toxicity|8
2935073|NCT01435031|10105474|P1|ITT at 4 Years|Lost to Follow-up|1
2935074|NCT01435031|10105474|P1|ITT at 4 Years|Withdrawal by Subject|2
2935075|NCT01435031|10105474|P1|ITT at 4 Years|Death|4
2935076|NCT01435031|10105474|P1|ITT at 3 Years|Lost to Follow-up|4
2935077|NCT01435031|10105474|P1|ITT at 3 Years|Withdrawal by Subject|2
2935078|NCT01435031|10105474|P1|ITT at 3 Years|Death|5
2935079|NCT01435031|10105474|P1|ITT at 2 Years|Lost to Follow-up|4
2935080|NCT01435031|10105474|P1|ITT at 2 Years|Withdrawal by Subject|2
2935081|NCT01435031|10105474|P1|ITT at 2 Years|Death|7
2935082|NCT01435031|10105474|P1|ITT at 1 Year|Lost to Follow-up|6
2935083|NCT01435031|10105474|P1|ITT at 1 Year|Withdrawal by Subject|2
2935084|NCT01435031|10105474|P1|ITT at 1 Year|Death|1
2935085|NCT01435031|10105474|P1|ITT at 6 Months|Lost to Follow-up|3
2935086|NCT01435031|10105474|P1|ITT at 6 Months|Death|2
2935087|NCT01435031|10105474|P1|ITT at 1 Month|Lost to Follow-up|4
2935088|NCT01435031|10105474|P1|ITT at 1 Month|Death|1
2935089|NCT01435031|10105474|P1|ITT at 1 Month|Withdrawal by Subject|1
2935090|NCT01435018|10105575|P3|Overall Study|Never started chemotherapy|1
2935091|NCT01435018|10105576|P2|Overall Study|Never started chemotherapy|0
2935092|NCT01435018|10105577|P1|Overall Study|Never started chemotherapy|3
2935093|NCT01435018|10105575|P3|Overall Study|Enrollment Violation|0
2935094|NCT01435018|10105576|P2|Overall Study|Enrollment Violation|1
2935095|NCT01435018|10105577|P1|Overall Study|Enrollment Violation|0
2935096|NCT01435018|10105575|P3|Overall Study|Unable to contact participant/parent|0
2935097|NCT01435018|10105576|P2|Overall Study|Unable to contact participant/parent|1
2935098|NCT01435018|10105577|P1|Overall Study|Unable to contact participant/parent|1
2935099|NCT01435018|10105575|P3|Overall Study|Severe debilitation, unable to continue|1
2935100|NCT01435018|10105576|P2|Overall Study|Severe debilitation, unable to continue|0
2935101|NCT01435018|10105577|P1|Overall Study|Severe debilitation, unable to continue|0
2935102|NCT01435018|10105575|P3|Overall Study|Not able to get to clinic|2
2935103|NCT01435018|10105576|P2|Overall Study|Not able to get to clinic|0
2935104|NCT01435018|10105577|P1|Overall Study|Not able to get to clinic|2
2935105|NCT01435018|10105575|P3|Overall Study|Not willing to adhere to requirements|1
2935106|NCT01435018|10105576|P2|Overall Study|Not willing to adhere to requirements|2
2935107|NCT01435018|10105577|P1|Overall Study|Not willing to adhere to requirements|0
2935108|NCT01435018|10105575|P3|Overall Study|Withdrew consent|1
2935109|NCT01435018|10105576|P2|Overall Study|Withdrew consent|3
2935110|NCT01435018|10105577|P1|Overall Study|Withdrew consent|0
2935111|NCT01435018|10105575|P3|Overall Study|Site is closing|7
2935112|NCT01435018|10105576|P2|Overall Study|Site is closing|9
2935113|NCT01435018|10105577|P1|Overall Study|Site is closing|4
2935114|NCT01435018|10105575|P3|Overall Study|Death|22
2935115|NCT01435018|10105576|P2|Overall Study|Death|18
2935116|NCT01435018|10105577|P1|Overall Study|Death|31
2935117|NCT01435018|10105575|P3|Overall Study|On study|73
2935118|NCT01435018|10105576|P2|Overall Study|On study|16
2935119|NCT01435018|10105577|P1|Overall Study|On study|69
2935120|NCT01434823|10105662|P2|Overall Study|Incomplete data in medical record|7
2935121|NCT01434823|10105663|P1|Overall Study|Incomplete data in medical record|4
2935122|NCT01434810|10105681|P2|Overall Study|Missing data/received <5hr phototherapy|7
2935123|NCT01434810|10105682|P1|Overall Study|Missing data/received <5hr phototherapy|12
2935124|NCT01434810|10105681|P2|Overall Study|Did not receive treatment|3
2935125|NCT01434810|10105682|P1|Overall Study|Did not receive treatment|11
2935126|NCT01434693|10105717|P4|Overall Study|Lost to Follow-up|0
2935127|NCT01434693|10105718|P3|Overall Study|Lost to Follow-up|0
2935128|NCT01434693|10105719|P2|Overall Study|Lost to Follow-up|0
2935129|NCT01434693|10105720|P1|Overall Study|Lost to Follow-up|1
2935130|NCT01434693|10105717|P4|Overall Study|Withdrawal by Subject|1
2935131|NCT01434693|10105718|P3|Overall Study|Withdrawal by Subject|1
2935132|NCT01434693|10105719|P2|Overall Study|Withdrawal by Subject|0
2935133|NCT01434693|10105720|P1|Overall Study|Withdrawal by Subject|1
2935134|NCT01434693|10105717|P4|Overall Study|Adverse Event|0
2935135|NCT01434693|10105718|P3|Overall Study|Adverse Event|0
2935136|NCT01434693|10105719|P2|Overall Study|Adverse Event|0
2935137|NCT01434693|10105720|P1|Overall Study|Adverse Event|1
2935138|NCT01434680|10105734|P4|Overall Study|Protocol Violation|0
2935139|NCT01434680|10105735|P3|Overall Study|Protocol Violation|0
2935140|NCT01434680|10105736|P2|Overall Study|Protocol Violation|1
2935141|NCT01434680|10105737|P1|Overall Study|Protocol Violation|1
2935142|NCT01434680|10105734|P4|Overall Study|Lost to Follow-up|0
2935143|NCT01434680|10105735|P3|Overall Study|Lost to Follow-up|0
2935144|NCT01434680|10105736|P2|Overall Study|Lost to Follow-up|1
2935145|NCT01434680|10105737|P1|Overall Study|Lost to Follow-up|1
2935146|NCT01434680|10105734|P4|Overall Study|Withdrawal by Subject|0
2935147|NCT01434680|10105735|P3|Overall Study|Withdrawal by Subject|2
2935148|NCT01434680|10105736|P2|Overall Study|Withdrawal by Subject|0
2935149|NCT01434680|10105737|P1|Overall Study|Withdrawal by Subject|1
2935150|NCT01434667|10105754|P2|Overall Study|Lost to Follow-up|10
2935151|NCT01434667|10105755|P1|Overall Study|Lost to Follow-up|5
2935152|NCT01434654|10105781|P2|Overall Study|Lost to Follow-up|0
2935153|NCT01434654|10105782|P1|Overall Study|Lost to Follow-up|1
2935154|NCT01434654|10105781|P2|Overall Study|Withdrawal by Subject|0
2935155|NCT01434654|10105782|P1|Overall Study|Withdrawal by Subject|1
2935156|NCT01434290|10105829|P2|Overall Study|No protocol treatment|4
2935157|NCT01434290|10105830|P1|Overall Study|No protocol treatment|2
2935158|NCT01434290|10105829|P2|Overall Study|Protocol Violation|3
2935159|NCT01434290|10105830|P1|Overall Study|Protocol Violation|6
2935160|NCT01433978|10105903|P3|Extension Phase|Study Terminated by Sponsor|4
2935161|NCT01433978|10105904|P2|Extension Phase|Study Terminated by Sponsor|0
2935162|NCT01433978|10105905|P1|Extension Phase|Study Terminated by Sponsor|0
2935163|NCT01433978|10105903|P3|Extension Phase|Lack of Efficacy|1
2935164|NCT01433978|10105904|P2|Extension Phase|Lack of Efficacy|0
2935165|NCT01433978|10105905|P1|Extension Phase|Lack of Efficacy|0
2935166|NCT01433978|10105903|P3|Extension Phase|Adverse Event, Non-Fatal|1
2935167|NCT01433978|10105904|P2|Extension Phase|Adverse Event, Non-Fatal|0
2935168|NCT01433978|10105905|P1|Extension Phase|Adverse Event, Non-Fatal|0
2935169|NCT01433978|10105903|P3|Core Study|Study Terminated by Sponsor|0
2935170|NCT01433978|10105904|P2|Core Study|Study Terminated by Sponsor|9
2935171|NCT01433978|10105905|P1|Core Study|Study Terminated by Sponsor|6
2935172|NCT01433978|10105903|P3|Core Study|Lack of Efficacy|0
2935173|NCT01433978|10105904|P2|Core Study|Lack of Efficacy|1
2935174|NCT01433978|10105905|P1|Core Study|Lack of Efficacy|5
2935175|NCT01433978|10105903|P3|Core Study|Adverse Event, Non-Fatal|0
2935176|NCT01433978|10105904|P2|Core Study|Adverse Event, Non-Fatal|1
2935177|NCT01433978|10105905|P1|Core Study|Adverse Event, Non-Fatal|0
2935178|NCT01433549|10105962|P2|Phase 2: Second Study Product|Adverse Event|1
2935179|NCT01433549|10105963|P1|Phase 2: Second Study Product|Adverse Event|0
2935180|NCT01433471|10105973|P2|Overall Study|Withdrawal by Subject|1
2935181|NCT01433471|10105974|P1|Overall Study|Withdrawal by Subject|0
2935182|NCT01433354|10105990|P1|Overall Study|Subject Withdrew Consent|3
2935183|NCT01433354|10105990|P1|Overall Study|Lack of Efficacy|17
2935184|NCT01433354|10105990|P1|Overall Study|Protocol Violation|2
2935185|NCT01433354|10105990|P1|Overall Study|Administrative problems|90
2935186|NCT01433354|10105990|P1|Overall Study|Lost to Follow-up|1
2935187|NCT01433354|10105990|P1|Overall Study|Adverse Event|6
2935188|NCT01433263|10106006|P2|Overall Study|Withdrawal by Subject|7
2935189|NCT01433263|10106007|P1|Overall Study|Withdrawal by Subject|10
2935190|NCT01433263|10106006|P2|Overall Study|Protocol Deviation|0
2935191|NCT01433263|10106007|P1|Overall Study|Protocol Deviation|1
2935192|NCT01433263|10106006|P2|Overall Study|Lost to Follow-up|1
2935193|NCT01433263|10106007|P1|Overall Study|Lost to Follow-up|0
2935194|NCT01433263|10106006|P2|Overall Study|Death|3
2935195|NCT01433263|10106007|P1|Overall Study|Death|5
2935196|NCT01433263|10106006|P2|Overall Study|Adverse Event|1
2935197|NCT01433263|10106007|P1|Overall Study|Adverse Event|3
2935198|NCT01433250|10106036|P2|Overall Study|Withdrawal by Subject|2
2935199|NCT01433250|10106037|P1|Overall Study|Withdrawal by Subject|3
2935200|NCT01433250|10106036|P2|Overall Study|Protocol Violation|1
2935201|NCT01433250|10106037|P1|Overall Study|Protocol Violation|0
2935202|NCT01433172|10106056|P3|Overall Study|Death|0
2935203|NCT01433172|10106057|P2|Overall Study|Death|2
2935204|NCT01433172|10106058|P1|Overall Study|Death|0
2935205|NCT01433172|10106056|P3|Overall Study|Disease Progression|1
2935206|NCT01433172|10106057|P2|Overall Study|Disease Progression|0
2935207|NCT01433172|10106058|P1|Overall Study|Disease Progression|0
2935208|NCT01433172|10106056|P3|Overall Study|Withdrawal by Subject|0
2935209|NCT01433172|10106057|P2|Overall Study|Withdrawal by Subject|1
2935210|NCT01433172|10106058|P1|Overall Study|Withdrawal by Subject|0
2935211|NCT01433159|10106070|P2|Overall Study|Protocol Violation|1
2935212|NCT01433159|10106071|P1|Overall Study|Protocol Violation|0
2935213|NCT01433159|10106070|P2|Overall Study|Physician Decision|0
2935214|NCT01433159|10106071|P1|Overall Study|Physician Decision|1
2935215|NCT01433159|10106070|P2|Overall Study|Adverse Event|0
2935216|NCT01433159|10106071|P1|Overall Study|Adverse Event|1
2935217|NCT01433055|10106103|P2|Overall Study|Severely elevated triglycerides at entry|0
2935218|NCT01433055|10106104|P1|Overall Study|Severely elevated triglycerides at entry|1
2935219|NCT01433055|10106103|P2|Overall Study|Diagnosed with cancer unrelated to study|0
2935220|NCT01433055|10106104|P1|Overall Study|Diagnosed with cancer unrelated to study|1
2935221|NCT01432938|10106126|P2|Second Intervention|Adverse Event|0
2935222|NCT01432938|10106127|P1|Second Intervention|Adverse Event|1
2935223|NCT01432938|10106126|P2|First Intervention|Physician Decision|0
2935224|NCT01432938|10106127|P1|First Intervention|Physician Decision|1
2935225|NCT01432938|10106126|P2|First Intervention|Protocol Violation|0
2935226|NCT01432938|10106127|P1|First Intervention|Protocol Violation|1
2935227|NCT01432756|10106157|P4|Overall Study|Lost to Follow-up|1
2935228|NCT01432756|10106158|P3|Overall Study|Lost to Follow-up|2
2935229|NCT01432756|10106159|P2|Overall Study|Lost to Follow-up|0
2935230|NCT01432756|10106160|P1|Overall Study|Lost to Follow-up|1
2935231|NCT01432626|10106168|P1|Overall Study|Imaging agent not available|1
2935232|NCT01432626|10106168|P1|Overall Study|Only 1 image competed|2
2935233|NCT01432626|10106168|P1|Overall Study|Withdrawal by Subject|2
2935234|NCT01432626|10106168|P1|Overall Study|LV function recovered|2
2935235|NCT01432600|10106175|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
2935236|NCT01432600|10106176|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
2935237|NCT01432600|10106177|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
2935238|NCT01432574|10106193|P1|Overall Study|Not interested|1
2935239|NCT01432574|10106193|P1|Overall Study|Moved|2
2935240|NCT01432457|10106239|P3|Overall Study|Did not take study drug|3
2935241|NCT01432457|10106240|P2|Overall Study|Did not take study drug|6
2935242|NCT01432457|10106241|P1|Overall Study|Did not take study drug|6
2935243|NCT01432457|10106239|P3|Overall Study|Reasons not defined|4
2935244|NCT01432457|10106240|P2|Overall Study|Reasons not defined|3
2935245|NCT01432457|10106241|P1|Overall Study|Reasons not defined|2
2935246|NCT01432457|10106239|P3|Overall Study|Withdrawal by Subject|9
2935247|NCT01432457|10106240|P2|Overall Study|Withdrawal by Subject|11
2935248|NCT01432457|10106241|P1|Overall Study|Withdrawal by Subject|6
2935249|NCT01432457|10106239|P3|Overall Study|Protocol Violation|6
2935250|NCT01432457|10106240|P2|Overall Study|Protocol Violation|2
2935251|NCT01432457|10106241|P1|Overall Study|Protocol Violation|3
2935252|NCT01432457|10106239|P3|Overall Study|Lost to Follow-up|20
2935253|NCT01432457|10106240|P2|Overall Study|Lost to Follow-up|15
2935254|NCT01432457|10106241|P1|Overall Study|Lost to Follow-up|11
2935255|NCT01432457|10106239|P3|Overall Study|Lack of Efficacy|1
2935256|NCT01432457|10106240|P2|Overall Study|Lack of Efficacy|1
2935257|NCT01432457|10106241|P1|Overall Study|Lack of Efficacy|2
2935258|NCT01432457|10106239|P3|Overall Study|Adverse Event|16
2935259|NCT01432457|10106240|P2|Overall Study|Adverse Event|10
2935260|NCT01432457|10106241|P1|Overall Study|Adverse Event|7
2935261|NCT01432444|10106270|P3|Extension Phase|Withdrawal by Subject|13
2935262|NCT01432444|10106271|P2|Extension Phase|Withdrawal by Subject|0
2935263|NCT01432444|10106272|P1|Extension Phase|Withdrawal by Subject|0
2935264|NCT01432444|10106270|P3|Extension Phase|Physician Decision|1
2935265|NCT01432444|10106271|P2|Extension Phase|Physician Decision|0
2935266|NCT01432444|10106272|P1|Extension Phase|Physician Decision|0
2935267|NCT01432444|10106270|P3|Extension Phase|Met Withdrawal Criteria|144
2935268|NCT01432444|10106271|P2|Extension Phase|Met Withdrawal Criteria|0
2935269|NCT01432444|10106272|P1|Extension Phase|Met Withdrawal Criteria|0
2935270|NCT01432444|10106270|P3|Extension Phase|Sponsor Discontinued Trial|7
2935271|NCT01432444|10106271|P2|Extension Phase|Sponsor Discontinued Trial|0
2935272|NCT01432444|10106272|P1|Extension Phase|Sponsor Discontinued Trial|0
2935273|NCT01432444|10106270|P3|Extension Phase|Adverse Event|10
2935274|NCT01432444|10106271|P2|Extension Phase|Adverse Event|0
2935275|NCT01432444|10106272|P1|Extension Phase|Adverse Event|0
2935276|NCT01432444|10106270|P3|Extension Phase|Lost to Follow-up|17
2935277|NCT01432444|10106271|P2|Extension Phase|Lost to Follow-up|0
2935278|NCT01432444|10106272|P1|Extension Phase|Lost to Follow-up|0
2935279|NCT01432444|10106270|P3|Treatment Phase|Lack of Efficacy|0
2935280|NCT01432444|10106271|P2|Treatment Phase|Lack of Efficacy|10
2935281|NCT01432444|10106272|P1|Treatment Phase|Lack of Efficacy|0
2935282|NCT01432444|10106270|P3|Treatment Phase|Protocol Deviation|0
2935283|NCT01432444|10106271|P2|Treatment Phase|Protocol Deviation|3
2935284|NCT01432444|10106272|P1|Treatment Phase|Protocol Deviation|0
2935285|NCT01432444|10106270|P3|Treatment Phase|Withdrawal by Subject|0
2935286|NCT01432444|10106271|P2|Treatment Phase|Withdrawal by Subject|41
2935287|NCT01432444|10106272|P1|Treatment Phase|Withdrawal by Subject|0
2935288|NCT01432444|10106270|P3|Treatment Phase|Physician Decision|0
2935289|NCT01432444|10106271|P2|Treatment Phase|Physician Decision|5
2935290|NCT01432444|10106272|P1|Treatment Phase|Physician Decision|0
2935291|NCT01432444|10106270|P3|Treatment Phase|Met Withdrawal Criteria|0
2935292|NCT01432444|10106271|P2|Treatment Phase|Met Withdrawal Criteria|11
2935293|NCT01432444|10106272|P1|Treatment Phase|Met Withdrawal Criteria|0
2935294|NCT01432444|10106270|P3|Treatment Phase|Adverse Event|0
2935295|NCT01432444|10106271|P2|Treatment Phase|Adverse Event|37
2935296|NCT01432444|10106272|P1|Treatment Phase|Adverse Event|0
2935297|NCT01432444|10106270|P3|Treatment Phase|Lost to Follow-up|0
2935298|NCT01432444|10106271|P2|Treatment Phase|Lost to Follow-up|33
2935299|NCT01432444|10106272|P1|Treatment Phase|Lost to Follow-up|0
2935300|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2935301|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2935302|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
2935303|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
2935304|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
2935305|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
2935306|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2935307|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2935308|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
2935309|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Physician Decision|0
2935310|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Physician Decision|0
2935311|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Physician Decision|8
2935312|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2935313|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2935314|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
2935315|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Adverse Event|0
2935316|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Adverse Event|0
2935317|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Adverse Event|16
2935318|NCT01432444|10106270|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2935319|NCT01432444|10106271|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2935320|NCT01432444|10106272|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
2935321|NCT01432366|10106298|P1|Overall Study|Other|14
2935322|NCT01432366|10106298|P1|Overall Study|Investigator Forget to Complete Visits|1
2935323|NCT01432366|10106298|P1|Overall Study|Site Closed|20
2935324|NCT01432366|10106298|P1|Overall Study|Lack of Efficacy|1
2935325|NCT01432366|10106298|P1|Overall Study|Lost to Follow-up|13
2935326|NCT01432366|10106298|P1|Overall Study|Pregnancy|1
2935327|NCT01432366|10106298|P1|Overall Study|Withdrawal Due to Non-Compliance|3
2935328|NCT01432366|10106298|P1|Overall Study|Adverse Event|8
2935329|NCT01432366|10106298|P1|Overall Study|Non-Responder|7
2935330|NCT01432327|10106320|P4|Posttest 1 Year|Allergic reaction|1
2935331|NCT01432327|10106321|P3|Posttest 1 Year|Allergic reaction|1
2935332|NCT01432327|10106322|P2|Posttest 1 Year|Allergic reaction|0
2935333|NCT01432327|10106323|P1|Posttest 1 Year|Allergic reaction|0
2935334|NCT01432327|10106320|P4|Posttest 1 Year|Lost to Follow-up|2
2935335|NCT01432327|10106321|P3|Posttest 1 Year|Lost to Follow-up|4
2935336|NCT01432327|10106322|P2|Posttest 1 Year|Lost to Follow-up|0
2935337|NCT01432327|10106323|P1|Posttest 1 Year|Lost to Follow-up|0
2935338|NCT01432327|10106320|P4|Posttest 1 Year|Measurement have to take place in future|20
2935339|NCT01432327|10106321|P3|Posttest 1 Year|Measurement have to take place in future|15
2935340|NCT01432327|10106322|P2|Posttest 1 Year|Measurement have to take place in future|28
2935341|NCT01432327|10106323|P1|Posttest 1 Year|Measurement have to take place in future|24
2935342|NCT01432327|10106320|P4|Posttest 6 Months|Withdrawal by Subject|0
2935343|NCT01432327|10106321|P3|Posttest 6 Months|Withdrawal by Subject|1
2935344|NCT01432327|10106322|P2|Posttest 6 Months|Withdrawal by Subject|0
2935345|NCT01432327|10106323|P1|Posttest 6 Months|Withdrawal by Subject|0
2935346|NCT01432327|10106320|P4|Posttest 6 Months|Allergic reaction|0
2935347|NCT01432327|10106321|P3|Posttest 6 Months|Allergic reaction|1
2935348|NCT01432327|10106322|P2|Posttest 6 Months|Allergic reaction|0
2935349|NCT01432327|10106323|P1|Posttest 6 Months|Allergic reaction|0
2935350|NCT01432327|10106320|P4|Posttest 6 Months|Lost to Follow-up|2
2935351|NCT01432327|10106321|P3|Posttest 6 Months|Lost to Follow-up|3
2935352|NCT01432327|10106322|P2|Posttest 6 Months|Lost to Follow-up|0
2935353|NCT01432327|10106323|P1|Posttest 6 Months|Lost to Follow-up|0
2935354|NCT01432327|10106320|P4|Posttest 3 Months|Allergic reaction|0
2935355|NCT01432327|10106321|P3|Posttest 3 Months|Allergic reaction|0
2935356|NCT01432327|10106322|P2|Posttest 3 Months|Allergic reaction|2
2935357|NCT01432327|10106323|P1|Posttest 3 Months|Allergic reaction|0
2935358|NCT01432327|10106320|P4|Posttest 3 Months|Lost to Follow-up|1
2935359|NCT01432327|10106321|P3|Posttest 3 Months|Lost to Follow-up|2
2935360|NCT01432327|10106322|P2|Posttest 3 Months|Lost to Follow-up|0
2935361|NCT01432327|10106323|P1|Posttest 3 Months|Lost to Follow-up|1
2935362|NCT01432327|10106320|P4|Posttest 3 Months|depression|0
2935363|NCT01432327|10106321|P3|Posttest 3 Months|depression|0
2935364|NCT01432327|10106322|P2|Posttest 3 Months|depression|0
2935365|NCT01432327|10106323|P1|Posttest 3 Months|depression|3
2935366|NCT01432275|10106333|P2|ADC With Calculator (10 Days)|Protocol Violation|1
2935367|NCT01432275|10106334|P1|ADC With Calculator (10 Days)|Protocol Violation|0
2935368|NCT01432275|10106333|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
2935369|NCT01432275|10106334|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
2935370|NCT01432275|10106333|P2|ADC With Calculator (10 Days)|Physician Decision|1
2935371|NCT01432275|10106334|P1|ADC With Calculator (10 Days)|Physician Decision|1
2935372|NCT01432275|10106333|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
2935373|NCT01432275|10106334|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
2935374|NCT01432275|10106333|P2|Second BG Meter System (7 Days)|Physician Decision|1
2935375|NCT01432275|10106334|P1|Second BG Meter System (7 Days)|Physician Decision|0
2935376|NCT01432275|10106333|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
2935377|NCT01432275|10106334|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
2935378|NCT01432275|10106333|P2|Second BG Meter System (7 Days)|Adverse Event|1
2935379|NCT01432275|10106334|P1|Second BG Meter System (7 Days)|Adverse Event|1
2935380|NCT01432275|10106333|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
2935381|NCT01432275|10106334|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
2935382|NCT01432275|10106333|P2|First BG Meter System (7 Days)|Adverse Event|2
2935383|NCT01432275|10106334|P1|First BG Meter System (7 Days)|Adverse Event|0
2935384|NCT01432262|10106343|P2|Overall Study|Withdrawal by Subject|1
2935385|NCT01432262|10106344|P1|Overall Study|Withdrawal by Subject|2
2935386|NCT01432171|10106410|P2|Overall Study|Patient moved to palliative care|0
2935387|NCT01432171|10106411|P1|Overall Study|Patient moved to palliative care|1
2935388|NCT01432171|10106410|P2|Overall Study|Insurance denial trial coverage|0
2935389|NCT01432171|10106411|P1|Overall Study|Insurance denial trial coverage|1
2935390|NCT01432171|10106410|P2|Overall Study|Noncompliance|3
2935391|NCT01432171|10106411|P1|Overall Study|Noncompliance|2
2935392|NCT01432171|10106410|P2|Overall Study|Withdrawal by Subject|1
2935393|NCT01432171|10106411|P1|Overall Study|Withdrawal by Subject|3
2935394|NCT01432171|10106410|P2|Overall Study|Lost to Follow-up|5
2935395|NCT01432171|10106411|P1|Overall Study|Lost to Follow-up|6
2935396|NCT01432171|10106410|P2|Overall Study|Death|2
2935397|NCT01432171|10106411|P1|Overall Study|Death|1
2935398|NCT01431976|10106452|P1|Overall Study|Withdrawal by Subject|1
2935399|NCT01431976|10106452|P1|Overall Study|Physician Decision|1
2935400|NCT01431976|10106452|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
2935401|NCT01431976|10106452|P1|Overall Study|Lack of Efficacy|2
2935402|NCT01431976|10106452|P1|Overall Study|Adverse Event|6
2935403|NCT01431963|10106463|P1|Overall Study|Withdrawal by Subject|3
2935404|NCT01431963|10106463|P1|Overall Study|Physician Decision|4
2935405|NCT01431963|10106463|P1|Overall Study|Protocol-defined Stopping Criteria|2
2935406|NCT01431963|10106463|P1|Overall Study|Protocol Violation|1
2935407|NCT01431963|10106463|P1|Overall Study|Lack of Efficacy|7
2935408|NCT01431963|10106463|P1|Overall Study|Adverse Event|18
2935409|NCT01431950|10106471|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
2935410|NCT01431950|10106472|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
2935411|NCT01431950|10106471|P2|Overall Study|Lost to Follow-up|1
2935412|NCT01431950|10106472|P1|Overall Study|Lost to Follow-up|0
2935413|NCT01431950|10106471|P2|Overall Study|Lack of Efficacy|1
2935414|NCT01431950|10106472|P1|Overall Study|Lack of Efficacy|2
2935415|NCT01431950|10106471|P2|Overall Study|Physician Decision|1
2935416|NCT01431950|10106472|P1|Overall Study|Physician Decision|2
2935417|NCT01431950|10106471|P2|Overall Study|Adverse Event|2
2935418|NCT01431950|10106472|P1|Overall Study|Adverse Event|2
2935419|NCT01431950|10106471|P2|Overall Study|Protocol Violation|3
2935420|NCT01431950|10106472|P1|Overall Study|Protocol Violation|2
2935421|NCT01431950|10106471|P2|Overall Study|Withdrawal by Subject|3
2935422|NCT01431950|10106472|P1|Overall Study|Withdrawal by Subject|4
2935423|NCT01431950|10106471|P2|Overall Study|Study Site Closed/Terminated|3
2935424|NCT01431950|10106472|P1|Overall Study|Study Site Closed/Terminated|7
2935425|NCT01431716|10106537|P1|Overall Study|Withdrawal of consent|1
2935426|NCT01431534|10106561|P3|Treatment Phase|Progressive Disease|10
2935427|NCT01431534|10106562|P2|Treatment Phase|Progressive Disease|3
2935428|NCT01431534|10106563|P1|Treatment Phase|Progressive Disease|4
2935429|NCT01431534|10106561|P3|Treatment Phase|Adverse Event|1
2935430|NCT01431534|10106562|P2|Treatment Phase|Adverse Event|0
2935431|NCT01431534|10106563|P1|Treatment Phase|Adverse Event|0
2935432|NCT01431521|10106578|P4|Overall Study|Withdrawal by Subject|0
2935433|NCT01431521|10106579|P3|Overall Study|Withdrawal by Subject|1
2935434|NCT01431521|10106580|P2|Overall Study|Withdrawal by Subject|0
2935435|NCT01431521|10106581|P1|Overall Study|Withdrawal by Subject|0
2935436|NCT01431508|10106602|P1|Overall Study|Unable to Follow Protocol Procedures|1
2935437|NCT01431508|10106602|P1|Overall Study|Lack of Efficacy|1
2935438|NCT01431287|10106687|P5|Overall Study|not stated above|1
2935439|NCT01431287|10106688|P4|Overall Study|not stated above|2
2935440|NCT01431287|10106689|P3|Overall Study|not stated above|2
2935441|NCT01431287|10106690|P2|Overall Study|not stated above|2
2935442|NCT01431287|10106691|P1|Overall Study|not stated above|4
2935530|NCT01430468|10107286|P1|Overall Study|Physician Decision|2
2935443|NCT01431287|10106687|P5|Overall Study|Consent withdrawn not due to AE|29
2935444|NCT01431287|10106688|P4|Overall Study|Consent withdrawn not due to AE|19
2935445|NCT01431287|10106689|P3|Overall Study|Consent withdrawn not due to AE|34
2935446|NCT01431287|10106690|P2|Overall Study|Consent withdrawn not due to AE|30
2935447|NCT01431287|10106691|P1|Overall Study|Consent withdrawn not due to AE|29
2935448|NCT01431287|10106687|P5|Overall Study|Lost to Follow-up|1
2935449|NCT01431287|10106688|P4|Overall Study|Lost to Follow-up|3
2935450|NCT01431287|10106689|P3|Overall Study|Lost to Follow-up|2
2935451|NCT01431287|10106690|P2|Overall Study|Lost to Follow-up|3
2935452|NCT01431287|10106691|P1|Overall Study|Lost to Follow-up|0
2935453|NCT01431287|10106687|P5|Overall Study|Non compliant with protocol|5
2935454|NCT01431287|10106688|P4|Overall Study|Non compliant with protocol|6
2935455|NCT01431287|10106689|P3|Overall Study|Non compliant with protocol|5
2935456|NCT01431287|10106690|P2|Overall Study|Non compliant with protocol|6
2935457|NCT01431287|10106691|P1|Overall Study|Non compliant with protocol|6
2935458|NCT01431287|10106687|P5|Overall Study|Adverse Event|41
2935459|NCT01431287|10106688|P4|Overall Study|Adverse Event|33
2935460|NCT01431287|10106689|P3|Overall Study|Adverse Event|53
2935461|NCT01431287|10106690|P2|Overall Study|Adverse Event|57
2935462|NCT01431287|10106691|P1|Overall Study|Adverse Event|59
2935463|NCT01431287|10106687|P5|Overall Study|not treated|0
2935464|NCT01431287|10106688|P4|Overall Study|not treated|0
2935465|NCT01431287|10106689|P3|Overall Study|not treated|1
2935466|NCT01431287|10106690|P2|Overall Study|not treated|0
2935467|NCT01431287|10106691|P1|Overall Study|not treated|0
2935468|NCT01431274|10106853|P5|Overall Study|Other reason not stated above|4
2935469|NCT01431274|10106854|P4|Overall Study|Other reason not stated above|2
2935470|NCT01431274|10106855|P3|Overall Study|Other reason not stated above|7
2935471|NCT01431274|10106856|P2|Overall Study|Other reason not stated above|5
2935472|NCT01431274|10106857|P1|Overall Study|Other reason not stated above|6
2935473|NCT01431274|10106853|P5|Overall Study|Lost to Follow-up|0
2935474|NCT01431274|10106854|P4|Overall Study|Lost to Follow-up|4
2935475|NCT01431274|10106855|P3|Overall Study|Lost to Follow-up|1
2935476|NCT01431274|10106856|P2|Overall Study|Lost to Follow-up|7
2935477|NCT01431274|10106857|P1|Overall Study|Lost to Follow-up|6
2935478|NCT01431274|10106853|P5|Overall Study|Non compliant with protocol|4
2935479|NCT01431274|10106854|P4|Overall Study|Non compliant with protocol|4
2935480|NCT01431274|10106855|P3|Overall Study|Non compliant with protocol|4
2935481|NCT01431274|10106856|P2|Overall Study|Non compliant with protocol|8
2935482|NCT01431274|10106857|P1|Overall Study|Non compliant with protocol|5
2935483|NCT01431274|10106853|P5|Overall Study|Consent withdrawn not due to AE|11
2935484|NCT01431274|10106854|P4|Overall Study|Consent withdrawn not due to AE|20
2935485|NCT01431274|10106855|P3|Overall Study|Consent withdrawn not due to AE|17
2935486|NCT01431274|10106856|P2|Overall Study|Consent withdrawn not due to AE|20
2935487|NCT01431274|10106857|P1|Overall Study|Consent withdrawn not due to AE|29
2935488|NCT01431274|10106853|P5|Overall Study|Adverse Event|37
2935489|NCT01431274|10106854|P4|Overall Study|Adverse Event|30
2935490|NCT01431274|10106855|P3|Overall Study|Adverse Event|43
2935491|NCT01431274|10106856|P2|Overall Study|Adverse Event|37
2935492|NCT01431274|10106857|P1|Overall Study|Adverse Event|51
2935493|NCT01431144|10107035|P2|Overall Study|Implant mobility and removal|0
2935494|NCT01431144|10107036|P1|Overall Study|Implant mobility and removal|2
2935495|NCT01431079|10107059|P2|Overall Study|Lost to Follow-up|39
2935496|NCT01431079|10107060|P1|Overall Study|Lost to Follow-up|35
2935497|NCT01430754|10107139|P2|Run-In Phase|Lost to Follow-up|0
2935498|NCT01430754|10107140|P1|Run-In Phase|Lost to Follow-up|1
2935499|NCT01430754|10107139|P2|Run-In Phase|Withdrawal by Subject|0
2935500|NCT01430754|10107140|P1|Run-In Phase|Withdrawal by Subject|2
2935501|NCT01430754|10107139|P2|Run-In Phase|Other|0
2935502|NCT01430754|10107140|P1|Run-In Phase|Other|2
2935503|NCT01430754|10107139|P2|Run-In Phase|Adverse Event|0
2935504|NCT01430754|10107140|P1|Run-In Phase|Adverse Event|2
2935505|NCT01430754|10107139|P2|Run-In Phase|Protocol Violation|0
2935506|NCT01430754|10107140|P1|Run-In Phase|Protocol Violation|6
2935507|NCT01430754|10107139|P2|Run-In Phase|Circadian Period Ineligible|0
2935508|NCT01430754|10107140|P1|Run-In Phase|Circadian Period Ineligible|24
2935509|NCT01430624|10107198|P3|Overall Study|technical or eligibility|2
2935510|NCT01430624|10107199|P2|Overall Study|technical or eligibility|5
2935511|NCT01430624|10107200|P1|Overall Study|technical or eligibility|5
2935512|NCT01430624|10107198|P3|Overall Study|Lost to Follow-up|27
2935513|NCT01430624|10107199|P2|Overall Study|Lost to Follow-up|29
2935514|NCT01430624|10107200|P1|Overall Study|Lost to Follow-up|23
2935515|NCT01430611|10107231|P2|Overall Study|Withdrawal by Subject|14
2935516|NCT01430611|10107232|P1|Overall Study|Withdrawal by Subject|15
2935517|NCT01430611|10107231|P2|Overall Study|Lost to Follow-up|0
2935518|NCT01430611|10107232|P1|Overall Study|Lost to Follow-up|1
2935519|NCT01430611|10107231|P2|Overall Study|Protocol Violation|0
2935520|NCT01430611|10107232|P1|Overall Study|Protocol Violation|1
2935521|NCT01430611|10107231|P2|Overall Study|Adverse Event|1
2935522|NCT01430611|10107232|P1|Overall Study|Adverse Event|0
2935523|NCT01430585|10107250|P1|Overall Study|Other|7
2935524|NCT01430585|10107250|P1|Overall Study|Study Terminated by Sponsor|3
2935525|NCT01430585|10107250|P1|Overall Study|Objective Progression or Relapse|3
2935526|NCT01430585|10107250|P1|Overall Study|Death|1
2935527|NCT01430468|10107285|P2|Overall Study|Withdrawal by Subject|1
2935528|NCT01430468|10107286|P1|Overall Study|Withdrawal by Subject|1
2935529|NCT01430468|10107285|P2|Overall Study|Physician Decision|1
2935531|NCT01430455|10107292|P1|Overall Study|Switched to follow-up phase|1
2935532|NCT01430455|10107292|P1|Overall Study|Withdrawal by Subject|1
2935533|NCT01430403|10107299|P3|Overall Study|Withdrawal by Subject|3
2935534|NCT01430403|10107300|P2|Overall Study|Withdrawal by Subject|1
2935535|NCT01430403|10107301|P1|Overall Study|Withdrawal by Subject|9
2935536|NCT01430403|10107299|P3|Overall Study|Protocol Violation|2
2935537|NCT01430403|10107300|P2|Overall Study|Protocol Violation|3
2935538|NCT01430403|10107301|P1|Overall Study|Protocol Violation|2
2935539|NCT01430403|10107299|P3|Overall Study|Physician Decision|0
2935540|NCT01430403|10107300|P2|Overall Study|Physician Decision|0
2935541|NCT01430403|10107301|P1|Overall Study|Physician Decision|1
2935542|NCT01430403|10107299|P3|Overall Study|Lost to Follow-up|3
2935543|NCT01430403|10107300|P2|Overall Study|Lost to Follow-up|5
2935544|NCT01430403|10107301|P1|Overall Study|Lost to Follow-up|5
2935545|NCT01430130|10107408|P1|Overall Study|Infection on Control Side of Incision|1
2935546|NCT01430130|10107408|P1|Overall Study|Lost to Follow-up|1
2935547|NCT01430104|10107414|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
2935548|NCT01429792|10107481|P1|Overall Study|Lost to Follow-up|88
2935549|NCT01429792|10107481|P1|Overall Study|Withdrawal by Subject|70
2935550|NCT01429792|10107481|P1|Overall Study|Positive HCV-RNA at Week 24|50
2935551|NCT01429792|10107481|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
2935552|NCT01429792|10107481|P1|Overall Study|Negative HCV-RNA at Week 12|4
2935553|NCT01429792|10107481|P1|Overall Study|Negative HCV-RNA at Week 4|1
2935554|NCT01429792|10107481|P1|Overall Study|Unknown Disposition|94
2935555|NCT01429792|10107481|P1|Overall Study|Other Reasons|67
2935556|NCT01429623|10107495|P2|Overall Study|No post baseline data|4
2935557|NCT01429623|10107496|P1|Overall Study|No post baseline data|4
2935558|NCT01429623|10107495|P2|Overall Study|Conversion to Alzheimer's disease|21
2935559|NCT01429623|10107496|P1|Overall Study|Conversion to Alzheimer's disease|14
2935560|NCT01429623|10107495|P2|Overall Study|Assorted|2
2935561|NCT01429623|10107496|P1|Overall Study|Assorted|1
2935562|NCT01429623|10107495|P2|Overall Study|Protocol Violation|2
2935563|NCT01429623|10107496|P1|Overall Study|Protocol Violation|3
2935564|NCT01429623|10107495|P2|Overall Study|Physician Decision|3
2935565|NCT01429623|10107496|P1|Overall Study|Physician Decision|2
2935566|NCT01429623|10107495|P2|Overall Study|Withdrawal by Subject|13
2935567|NCT01429623|10107496|P1|Overall Study|Withdrawal by Subject|19
2935568|NCT01429623|10107495|P2|Overall Study|Adverse Event|14
2935569|NCT01429623|10107496|P1|Overall Study|Adverse Event|7
2935570|NCT01429623|10107495|P2|Overall Study|Death|0
2935571|NCT01429623|10107496|P1|Overall Study|Death|1
2935572|NCT01429584|10107510|P2|Overall Study|Protocol Violation|1
2935573|NCT01429584|10107511|P1|Overall Study|Protocol Violation|0
2935574|NCT01429584|10107510|P2|Overall Study|Withdrawal by Subject|0
2935575|NCT01429584|10107511|P1|Overall Study|Withdrawal by Subject|1
2935576|NCT01429441|10107553|P2|Overall Study|Withdrawal by Subject|18
2935577|NCT01429441|10107554|P1|Overall Study|Withdrawal by Subject|27
2935578|NCT01429441|10107553|P2|Overall Study|Physician Decision|0
2935579|NCT01429441|10107554|P1|Overall Study|Physician Decision|1
2935580|NCT01429441|10107553|P2|Overall Study|Lost to Follow-up|2
2935581|NCT01429441|10107554|P1|Overall Study|Lost to Follow-up|5
2935582|NCT01429441|10107553|P2|Overall Study|Death|2
2935583|NCT01429441|10107554|P1|Overall Study|Death|0
2935584|NCT01429441|10107553|P2|Overall Study|Adverse Event|1
2935585|NCT01429441|10107554|P1|Overall Study|Adverse Event|5
2935586|NCT01429298|10107564|P2|Overall Study|Protocol Violation|6
2935587|NCT01429298|10107565|P1|Overall Study|Protocol Violation|4
2935588|NCT01429285|10107581|P2|Overall Study|Erroneously Enrolled Twice|2
2935589|NCT01429285|10107582|P1|Overall Study|Erroneously Enrolled Twice|8
2935590|NCT01429285|10107581|P2|Overall Study|Missing Data|3
2935591|NCT01429285|10107582|P1|Overall Study|Missing Data|5
2935592|NCT01429285|10107581|P2|Overall Study|Protocol Violation|4
2935593|NCT01429285|10107582|P1|Overall Study|Protocol Violation|9
2935594|NCT01429077|10107628|P2|Overall Study|Lost to Follow-up|3
2935595|NCT01429077|10107629|P1|Overall Study|Lost to Follow-up|0
2935596|NCT01429051|10107652|P1|Tolerability Phase|Other|2
2935597|NCT01429051|10107652|P1|Tolerability Phase|Physician Decision|1
2935598|NCT01429051|10107652|P1|Tolerability Phase|Withdrawal by Subject|5
2935599|NCT01429051|10107652|P1|Tolerability Phase|Adverse Event|2
2935600|NCT01429051|10107652|P1|Tolerability Phase|Death|5
2935601|NCT01429051|10107652|P1|Efficacy Phase|Death|1
2935602|NCT01429051|10107652|P1|Efficacy Phase|Adverse Event|1
2935603|NCT01429051|10107652|P1|Titration Phase|Less than 3 BTP episodes per week|2
2935604|NCT01429051|10107652|P1|Titration Phase|Unsuccessful titration at any dose|1
2935605|NCT01429051|10107652|P1|Titration Phase|Physician Decision|1
2935606|NCT01429051|10107652|P1|Titration Phase|Withdrawal by Subject|7
2935607|NCT01429051|10107652|P1|Titration Phase|Death|1
2935608|NCT01428882|10107675|P2|Overall Study|Protocol Violation|3
2935609|NCT01428882|10107676|P1|Overall Study|Protocol Violation|4
2935610|NCT01428882|10107675|P2|Overall Study|Lack of Efficacy|7
2935611|NCT01428882|10107676|P1|Overall Study|Lack of Efficacy|2
2935612|NCT01428713|10107699|P2|Overall Study|Adverse Event|2
2935613|NCT01428713|10107700|P1|Overall Study|Adverse Event|0
2935614|NCT01428713|10107699|P2|Overall Study|Withdrawal by Subject|1
2935615|NCT01428713|10107700|P1|Overall Study|Withdrawal by Subject|1
2935616|NCT01428713|10107699|P2|Overall Study|Non-compliance|2
2935617|NCT01428713|10107700|P1|Overall Study|Non-compliance|2
2935618|NCT01428661|10107709|P3|Open Label Extension|**Various|185
2935619|NCT01428661|10107710|P2|Open Label Extension|**Various|0
2935620|NCT01428661|10107711|P1|Open Label Extension|**Various|0
2935621|NCT01428661|10107709|P3|Open Label Extension|Lack of Efficacy|24
2935622|NCT01428661|10107710|P2|Open Label Extension|Lack of Efficacy|0
2935623|NCT01428661|10107711|P1|Open Label Extension|Lack of Efficacy|0
2935624|NCT01428661|10107709|P3|Open Label Extension|Withdrawal by Subject|49
2935625|NCT01428661|10107710|P2|Open Label Extension|Withdrawal by Subject|0
2935626|NCT01428661|10107711|P1|Open Label Extension|Withdrawal by Subject|0
2935627|NCT01428661|10107709|P3|Open Label Extension|Lost to Follow-up|38
2935628|NCT01428661|10107710|P2|Open Label Extension|Lost to Follow-up|0
2935629|NCT01428661|10107711|P1|Open Label Extension|Lost to Follow-up|0
2935630|NCT01428661|10107709|P3|Open Label Extension|Adverse Event|15
2935631|NCT01428661|10107710|P2|Open Label Extension|Adverse Event|0
2935632|NCT01428661|10107711|P1|Open Label Extension|Adverse Event|0
2935633|NCT01428661|10107709|P3|Open Label Extension|Protocol Violation|9
2935634|NCT01428661|10107710|P2|Open Label Extension|Protocol Violation|0
2935635|NCT01428661|10107711|P1|Open Label Extension|Protocol Violation|0
2935636|NCT01428661|10107709|P3|Double-Masked Phase|*Various|0
2935637|NCT01428661|10107710|P2|Double-Masked Phase|*Various|6
2935638|NCT01428661|10107711|P1|Double-Masked Phase|*Various|1
2935639|NCT01428661|10107709|P3|Double-Masked Phase|Lack of Efficacy|0
2935640|NCT01428661|10107710|P2|Double-Masked Phase|Lack of Efficacy|1
2935641|NCT01428661|10107711|P1|Double-Masked Phase|Lack of Efficacy|2
2935642|NCT01428661|10107709|P3|Double-Masked Phase|Withdrawal by Subject|0
2935643|NCT01428661|10107710|P2|Double-Masked Phase|Withdrawal by Subject|20
2935644|NCT01428661|10107711|P1|Double-Masked Phase|Withdrawal by Subject|18
2935645|NCT01428661|10107709|P3|Double-Masked Phase|Lost to Follow-up|0
2935646|NCT01428661|10107710|P2|Double-Masked Phase|Lost to Follow-up|14
2935647|NCT01428661|10107711|P1|Double-Masked Phase|Lost to Follow-up|14
2935648|NCT01428661|10107709|P3|Double-Masked Phase|Adverse Event|0
2935649|NCT01428661|10107710|P2|Double-Masked Phase|Adverse Event|4
2935650|NCT01428661|10107711|P1|Double-Masked Phase|Adverse Event|13
2935651|NCT01428661|10107709|P3|Double-Masked Phase|Protocol Violation|0
2935652|NCT01428661|10107710|P2|Double-Masked Phase|Protocol Violation|4
2935653|NCT01428661|10107711|P1|Double-Masked Phase|Protocol Violation|9
2935654|NCT01428583|10107719|P1|Overall Study|Other|6
2935655|NCT01428583|10107719|P1|Overall Study|Sponsor’s request|3
2935656|NCT01428583|10107719|P1|Overall Study|Confirmed positive urine drug test|8
2935657|NCT01428583|10107719|P1|Overall Study|Non-compliant|25
2935658|NCT01428583|10107719|P1|Overall Study|Physician Decision|12
2935659|NCT01428583|10107719|P1|Overall Study|Protocol Violation|1
2935660|NCT01428583|10107719|P1|Overall Study|Pregnancy|1
2935661|NCT01428583|10107719|P1|Overall Study|Death|1
2935662|NCT01428583|10107719|P1|Overall Study|Lost to Follow-up|17
2935663|NCT01428583|10107719|P1|Overall Study|Lack of Efficacy|37
2935664|NCT01428583|10107719|P1|Overall Study|Withdrawal by Subject|51
2935665|NCT01428583|10107719|P1|Overall Study|Adverse Event|75
2935666|NCT01428453|10107743|P2|Overall Study|Withdrawal by Subject|1
2935667|NCT01428453|10107744|P1|Overall Study|Withdrawal by Subject|3
2935668|NCT01428453|10107743|P2|Overall Study|Lost to Follow-up|1
2935669|NCT01428453|10107744|P1|Overall Study|Lost to Follow-up|0
2935670|NCT01428453|10107743|P2|Overall Study|Protocol Violation|0
2935671|NCT01428453|10107744|P1|Overall Study|Protocol Violation|1
2935672|NCT01428453|10107743|P2|Overall Study|Adverse Event|7
2935673|NCT01428453|10107744|P1|Overall Study|Adverse Event|2
2935674|NCT01428258|10107783|P2|Intervention 1|Withdrawal by Subject|0
2935675|NCT01428258|10107784|P1|Intervention 1|Withdrawal by Subject|2
2935676|NCT01428219|10107802|P1|Overall Study|25 patients enrolled, 3 were not treated|3
2935677|NCT01428193|10107813|P1|Overall Study|Elevated screening liver enzymes|1
2935678|NCT01428193|10107813|P1|Overall Study|Physician Decision|1
2935679|NCT01428128|10107817|P1|Overall Study|Adverse Event|1
2935680|NCT01428128|10107817|P1|Overall Study|Received Neulasta in one cycle|2
2935681|NCT01428128|10107817|P1|Overall Study|Screen failure by p53|10
2935682|NCT01428128|10107817|P1|Overall Study|Withdrawal by Subject|4
2935683|NCT01428115|10107822|P1|Overall Study|Withdrawal by Subject|4
2935684|NCT01428115|10107822|P1|Overall Study|Protocol Violation|3
2935685|NCT01428115|10107822|P1|Overall Study|Pregnancy|1
2935686|NCT01428115|10107822|P1|Overall Study|Lost to Follow-up|10
2935687|NCT01428115|10107822|P1|Overall Study|Lack of Efficacy|3
2935688|NCT01428076|10107837|P2|Overall Study|Adverse Event|1
2935689|NCT01428076|10107838|P1|Overall Study|Adverse Event|0
2935690|NCT01428063|10107849|P3|Overall Study|No longer meets study criteria|0
2935691|NCT01428063|10107850|P2|Overall Study|No longer meets study criteria|1
2935692|NCT01428063|10107851|P1|Overall Study|No longer meets study criteria|0
2935693|NCT01428063|10107849|P3|Overall Study|Lost to Follow-up|0
2935694|NCT01428063|10107850|P2|Overall Study|Lost to Follow-up|2
2935695|NCT01428063|10107851|P1|Overall Study|Lost to Follow-up|0
2935696|NCT01428063|10107849|P3|Overall Study|Adverse Event|0
2935697|NCT01428063|10107850|P2|Overall Study|Adverse Event|3
2935698|NCT01428063|10107851|P1|Overall Study|Adverse Event|2
2935699|NCT01428063|10107849|P3|Overall Study|Lack of Efficacy|1
2935700|NCT01428063|10107850|P2|Overall Study|Lack of Efficacy|4
2935701|NCT01428063|10107851|P1|Overall Study|Lack of Efficacy|8
2935702|NCT01427972|10107952|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935703|NCT01427972|10107953|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935704|NCT01427972|10107954|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935705|NCT01427972|10107955|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935706|NCT01427972|10107956|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935707|NCT01427972|10107957|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935708|NCT01427972|10107958|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935709|NCT01427972|10107959|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935710|NCT01427972|10107960|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935711|NCT01427972|10107961|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935712|NCT01427972|10107962|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
2935713|NCT01427972|10107963|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2935714|NCT01427972|10107952|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935715|NCT01427972|10107953|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935716|NCT01427972|10107954|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935717|NCT01427972|10107955|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935718|NCT01427972|10107956|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935719|NCT01427972|10107957|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935720|NCT01427972|10107958|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
2935721|NCT01427972|10107959|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935722|NCT01427972|10107960|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935723|NCT01427972|10107961|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935724|NCT01427972|10107962|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935725|NCT01427972|10107963|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
2935726|NCT01427972|10107952|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
2935727|NCT01427972|10107953|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
2935728|NCT01427972|10107954|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
2935729|NCT01427972|10107955|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
2935730|NCT01427972|10107956|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
2935731|NCT01427972|10107957|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
2935732|NCT01427972|10107958|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
2935733|NCT01427972|10107959|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
2935734|NCT01427972|10107960|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
2935735|NCT01427972|10107961|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
2935736|NCT01427972|10107962|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
2935737|NCT01427972|10107963|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
2935738|NCT01427933|10107989|P2|Overall Study|Investigator's Decision|0
2935739|NCT01427933|10107990|P1|Overall Study|Investigator's Decision|1
2935740|NCT01427933|10107989|P2|Overall Study|Other|0
2935741|NCT01427933|10107990|P1|Overall Study|Other|1
2935742|NCT01427933|10107989|P2|Overall Study|Lost to Follow-up|5
2935743|NCT01427933|10107990|P1|Overall Study|Lost to Follow-up|1
2935744|NCT01427933|10107989|P2|Overall Study|Withdrawal by Subject|8
2935745|NCT01427933|10107990|P1|Overall Study|Withdrawal by Subject|5
2935746|NCT01427920|10108010|P2|Overall Study|Unclassified|8
2935747|NCT01427920|10108011|P1|Overall Study|Unclassified|2
2935748|NCT01427920|10108010|P2|Overall Study|Withdrawal Criteria|4
2935749|NCT01427920|10108011|P1|Overall Study|Withdrawal Criteria|4
2935750|NCT01427920|10108010|P2|Overall Study|Protocol Violation|3
2935751|NCT01427920|10108011|P1|Overall Study|Protocol Violation|1
2935752|NCT01427920|10108010|P2|Overall Study|Lack of Efficacy|0
2935753|NCT01427920|10108011|P1|Overall Study|Lack of Efficacy|1
2935754|NCT01427920|10108010|P2|Overall Study|Adverse Event|2
2935755|NCT01427920|10108011|P1|Overall Study|Adverse Event|1
2935756|NCT01427907|10108031|P2|Overall Study|Withdrawal by Subject|4
2935757|NCT01427907|10108032|P1|Overall Study|Withdrawal by Subject|3
2935758|NCT01427803|10108053|P2|Overall Study|did not take product|0
2935759|NCT01427803|10108054|P1|Overall Study|did not take product|1
2935760|NCT01427803|10108053|P2|Overall Study|Physician Decision|0
2935761|NCT01427803|10108054|P1|Overall Study|Physician Decision|3
2935762|NCT01427803|10108053|P2|Overall Study|Protocol Violation|0
2935763|NCT01427803|10108054|P1|Overall Study|Protocol Violation|1
2935764|NCT01427803|10108053|P2|Overall Study|Unable to complete full treatment period|0
2935765|NCT01427803|10108054|P1|Overall Study|Unable to complete full treatment period|6
2935766|NCT01427803|10108053|P2|Overall Study|Withdrawal by Subject|0
2935767|NCT01427803|10108054|P1|Overall Study|Withdrawal by Subject|20
2935768|NCT01427803|10108053|P2|Overall Study|Lost to Follow-up|26
2935769|NCT01427803|10108054|P1|Overall Study|Lost to Follow-up|32
2935770|NCT01427751|10108068|P2|Overall Study|Other miscellaneous reasons|4
2935771|NCT01427751|10108069|P1|Overall Study|Other miscellaneous reasons|6
2935772|NCT01427751|10108068|P2|Overall Study|Death|0
2935773|NCT01427751|10108069|P1|Overall Study|Death|2
2935774|NCT01427751|10108068|P2|Overall Study|Protocol Violation|4
2935775|NCT01427751|10108069|P1|Overall Study|Protocol Violation|6
2935776|NCT01427751|10108068|P2|Overall Study|Withdrawal of consent|2
2935777|NCT01427751|10108069|P1|Overall Study|Withdrawal of consent|2
2935778|NCT01427751|10108068|P2|Overall Study|Lost to Follow-up|1
2935779|NCT01427751|10108069|P1|Overall Study|Lost to Follow-up|3
2935780|NCT01427751|10108068|P2|Overall Study|No further treatment benefit expected|1
2935781|NCT01427751|10108069|P1|Overall Study|No further treatment benefit expected|5
2935782|NCT01427751|10108068|P2|Overall Study|Adverse Event|2
2935783|NCT01427751|10108069|P1|Overall Study|Adverse Event|18
2935784|NCT01427738|10108089|P2|Overall Study|Lost to Follow-up|5
2935785|NCT01427738|10108090|P1|Overall Study|Lost to Follow-up|1
2935786|NCT01427738|10108089|P2|Overall Study|Subject not willing to adhere to reqs|2
2935787|NCT01427738|10108090|P1|Overall Study|Subject not willing to adhere to reqs|1
2935788|NCT01427738|10108089|P2|Overall Study|Withdrawal by Subject|2
2935789|NCT01427738|10108090|P1|Overall Study|Withdrawal by Subject|0
2935790|NCT01427738|10108089|P2|Overall Study|Subject unable to get to clinic|2
2935791|NCT01427738|10108090|P1|Overall Study|Subject unable to get to clinic|5
2935792|NCT01427738|10108089|P2|Overall Study|Severe debilitation, unable to continue|1
2935793|NCT01427738|10108090|P1|Overall Study|Severe debilitation, unable to continue|0
2935794|NCT01427738|10108089|P2|Overall Study|Death|9
2935795|NCT01427738|10108090|P1|Overall Study|Death|12
2935796|NCT01427608|10108110|P2|Overall Study|Events not attributed to study meds|1
2935797|NCT01427608|10108111|P1|Overall Study|Events not attributed to study meds|0
2935798|NCT01427608|10108110|P2|Overall Study|Relapsed-all cause|34
2935799|NCT01427608|10108111|P1|Overall Study|Relapsed-all cause|13
2935800|NCT01427608|10108110|P2|Overall Study|Withdrawal by Subject|3
2935801|NCT01427608|10108111|P1|Overall Study|Withdrawal by Subject|7
2935802|NCT01427608|10108110|P2|Overall Study|Death|0
2935803|NCT01427608|10108111|P1|Overall Study|Death|1
2935804|NCT01427309|10108168|P4|Overall Study|Withdrawal by Subject|55
2935805|NCT01427309|10108169|P3|Overall Study|Withdrawal by Subject|61
2935806|NCT01427309|10108170|P2|Overall Study|Withdrawal by Subject|148
2935807|NCT01427309|10108171|P1|Overall Study|Withdrawal by Subject|148
2935808|NCT01427309|10108168|P4|Overall Study|Serious adverse event|61
2935809|NCT01427309|10108169|P3|Overall Study|Serious adverse event|50
2935810|NCT01427309|10108170|P2|Overall Study|Serious adverse event|45
2935811|NCT01427309|10108171|P1|Overall Study|Serious adverse event|52
2935812|NCT01427309|10108168|P4|Overall Study|Adverse Event|1
2935813|NCT01427309|10108169|P3|Overall Study|Adverse Event|3
2935814|NCT01427309|10108170|P2|Overall Study|Adverse Event|0
2935815|NCT01427309|10108171|P1|Overall Study|Adverse Event|0
2935816|NCT01427309|10108168|P4|Overall Study|Protocol Violation|124
2935817|NCT01427309|10108169|P3|Overall Study|Protocol Violation|125
2935818|NCT01427309|10108170|P2|Overall Study|Protocol Violation|69
2935819|NCT01427309|10108171|P1|Overall Study|Protocol Violation|42
2935820|NCT01427309|10108168|P4|Overall Study|Lost to Follow-up|135
2935821|NCT01427309|10108169|P3|Overall Study|Lost to Follow-up|122
2935822|NCT01427309|10108170|P2|Overall Study|Lost to Follow-up|145
2935823|NCT01427309|10108171|P1|Overall Study|Lost to Follow-up|130
2935824|NCT01426958|10108218|P1|Overall Study|Adverse Event|2
2935825|NCT01426854|10108247|P2|Overall Study|Other|2
2935826|NCT01426854|10108248|P1|Overall Study|Other|3
2935827|NCT01426854|10108247|P2|Overall Study|Protocol Deviation|1
2935828|NCT01426854|10108248|P1|Overall Study|Protocol Deviation|0
2935829|NCT01426854|10108247|P2|Overall Study|Treatment Failure|16
2935830|NCT01426854|10108248|P1|Overall Study|Treatment Failure|0
2935831|NCT01426854|10108247|P2|Overall Study|Noncompliance|1
2935832|NCT01426854|10108248|P1|Overall Study|Noncompliance|0
2935833|NCT01426854|10108247|P2|Overall Study|Lost to Follow-up|0
2935834|NCT01426854|10108248|P1|Overall Study|Lost to Follow-up|3
2935835|NCT01426854|10108247|P2|Overall Study|Subject Decision Unrelated to AE|6
2935836|NCT01426854|10108248|P1|Overall Study|Subject Decision Unrelated to AE|5
2935837|NCT01426854|10108247|P2|Overall Study|Adverse Event|5
2935838|NCT01426854|10108248|P1|Overall Study|Adverse Event|1
2935839|NCT01426789|10108258|P6|Part 2|Adverse Event|0
2935840|NCT01426789|10108259|P5|Part 2|Adverse Event|1
2935841|NCT01426789|10108260|P4|Part 2|Adverse Event|0
2935842|NCT01426789|10108261|P3|Part 2|Adverse Event|2
2935843|NCT01426789|10108262|P2|Part 2|Adverse Event|0
2935844|NCT01426789|10108263|P1|Part 2|Adverse Event|0
2935845|NCT01426789|10108258|P6|Part 2|Lack of Efficacy|0
2935846|NCT01426789|10108259|P5|Part 2|Lack of Efficacy|2
2935847|NCT01426789|10108260|P4|Part 2|Lack of Efficacy|0
2935848|NCT01426789|10108261|P3|Part 2|Lack of Efficacy|5
2935849|NCT01426789|10108262|P2|Part 2|Lack of Efficacy|0
2935850|NCT01426789|10108263|P1|Part 2|Lack of Efficacy|0
2935851|NCT01426789|10108258|P6|Part 2|Withdrawal by Subject|0
2935852|NCT01426789|10108259|P5|Part 2|Withdrawal by Subject|2
2935853|NCT01426789|10108260|P4|Part 2|Withdrawal by Subject|1
2935854|NCT01426789|10108261|P3|Part 2|Withdrawal by Subject|0
2935855|NCT01426789|10108262|P2|Part 2|Withdrawal by Subject|0
2935856|NCT01426789|10108263|P1|Part 2|Withdrawal by Subject|0
2935857|NCT01426789|10108258|P6|Part 2|Lost to Follow-up|0
2935858|NCT01426789|10108259|P5|Part 2|Lost to Follow-up|1
2935859|NCT01426789|10108260|P4|Part 2|Lost to Follow-up|0
2935860|NCT01426789|10108261|P3|Part 2|Lost to Follow-up|4
2935861|NCT01426789|10108262|P2|Part 2|Lost to Follow-up|0
2935862|NCT01426789|10108263|P1|Part 2|Lost to Follow-up|0
2935863|NCT01426789|10108258|P6|Part 2|Administrative problems|0
2935864|NCT01426789|10108259|P5|Part 2|Administrative problems|1
2935865|NCT01426789|10108260|P4|Part 2|Administrative problems|0
2935866|NCT01426789|10108261|P3|Part 2|Administrative problems|2
2935867|NCT01426789|10108262|P2|Part 2|Administrative problems|0
2935868|NCT01426789|10108263|P1|Part 2|Administrative problems|0
2935869|NCT01426789|10108258|P6|Part 2|Death|0
2935870|NCT01426789|10108259|P5|Part 2|Death|1
2935871|NCT01426789|10108260|P4|Part 2|Death|0
2935872|NCT01426789|10108261|P3|Part 2|Death|1
2935873|NCT01426789|10108262|P2|Part 2|Death|0
2935874|NCT01426789|10108263|P1|Part 2|Death|0
2935875|NCT01426789|10108258|P6|Part 2|Protocol deviation|0
2935876|NCT01426789|10108259|P5|Part 2|Protocol deviation|0
2935877|NCT01426789|10108260|P4|Part 2|Protocol deviation|0
2935878|NCT01426789|10108261|P3|Part 2|Protocol deviation|1
2935879|NCT01426789|10108262|P2|Part 2|Protocol deviation|0
2935880|NCT01426789|10108263|P1|Part 2|Protocol deviation|0
2935881|NCT01426789|10108258|P6|Part 1|Adverse Event|0
2935882|NCT01426789|10108259|P5|Part 1|Adverse Event|0
2935883|NCT01426789|10108260|P4|Part 1|Adverse Event|0
2935884|NCT01426789|10108261|P3|Part 1|Adverse Event|0
2935885|NCT01426789|10108262|P2|Part 1|Adverse Event|0
2935886|NCT01426789|10108263|P1|Part 1|Adverse Event|3
2935887|NCT01426789|10108258|P6|Part 1|Lack of Efficacy|0
2935888|NCT01426789|10108259|P5|Part 1|Lack of Efficacy|0
2935889|NCT01426789|10108260|P4|Part 1|Lack of Efficacy|0
2935890|NCT01426789|10108261|P3|Part 1|Lack of Efficacy|0
2935891|NCT01426789|10108262|P2|Part 1|Lack of Efficacy|1
2935892|NCT01426789|10108263|P1|Part 1|Lack of Efficacy|2
2935893|NCT01426789|10108258|P6|Part 1|Lost to Follow-up|0
2935894|NCT01426789|10108259|P5|Part 1|Lost to Follow-up|0
2935895|NCT01426789|10108260|P4|Part 1|Lost to Follow-up|0
2935896|NCT01426789|10108261|P3|Part 1|Lost to Follow-up|0
2935897|NCT01426789|10108262|P2|Part 1|Lost to Follow-up|2
2935898|NCT01426789|10108263|P1|Part 1|Lost to Follow-up|1
2935899|NCT01426789|10108258|P6|Part 1|Protocol deviation|0
2935900|NCT01426789|10108259|P5|Part 1|Protocol deviation|0
2935901|NCT01426789|10108260|P4|Part 1|Protocol deviation|0
2935902|NCT01426789|10108261|P3|Part 1|Protocol deviation|0
2935903|NCT01426789|10108262|P2|Part 1|Protocol deviation|1
2935904|NCT01426789|10108263|P1|Part 1|Protocol deviation|0
2935905|NCT01426438|10108325|P2|Overall Study|Missed Scan|2
2935906|NCT01426438|10108326|P1|Overall Study|Missed Scan|2
2935907|NCT01426438|10108325|P2|Overall Study|Poor scan quality|2
2935908|NCT01426438|10108326|P1|Overall Study|Poor scan quality|3
2935909|NCT01426438|10108325|P2|Overall Study|Off study Treatment|3
2935910|NCT01426438|10108326|P1|Overall Study|Off study Treatment|9
2935911|NCT01426438|10108325|P2|Overall Study|Lost to Follow-up|3
2935912|NCT01426438|10108326|P1|Overall Study|Lost to Follow-up|1
2935913|NCT01426425|10108358|P1|Overall Study|Met inclusion/exclusion, not treated|2
2935914|NCT01426425|10108358|P1|Overall Study|Inclusion/exclusion criteria not met|151
2935915|NCT01426425|10108358|P1|Overall Study|Exited prior to EP study|22
2935916|NCT01426412|10108373|P9|Overall Study|Withdrawal by Subject|1
2935917|NCT01426412|10108374|P8|Overall Study|Withdrawal by Subject|3
2935918|NCT01426412|10108375|P7|Overall Study|Withdrawal by Subject|0
2935919|NCT01426412|10108376|P6|Overall Study|Withdrawal by Subject|0
2935920|NCT01426412|10108377|P5|Overall Study|Withdrawal by Subject|1
2935921|NCT01426412|10108378|P4|Overall Study|Withdrawal by Subject|0
2935922|NCT01426412|10108379|P3|Overall Study|Withdrawal by Subject|0
2935923|NCT01426412|10108380|P2|Overall Study|Withdrawal by Subject|0
2935924|NCT01426412|10108381|P1|Overall Study|Withdrawal by Subject|1
2935925|NCT01426386|10108444|P6|Overall Study|Personal reasons|0
2935926|NCT01426386|10108445|P5|Overall Study|Personal reasons|1
2935927|NCT01426386|10108446|P4|Overall Study|Personal reasons|0
2935928|NCT01426386|10108447|P3|Overall Study|Personal reasons|0
2935929|NCT01426386|10108448|P2|Overall Study|Personal reasons|0
2935930|NCT01426386|10108449|P1|Overall Study|Personal reasons|0
2935931|NCT01426386|10108444|P6|Overall Study|Poor response|0
2935932|NCT01426386|10108445|P5|Overall Study|Poor response|1
2935933|NCT01426386|10108446|P4|Overall Study|Poor response|0
2935934|NCT01426386|10108447|P3|Overall Study|Poor response|2
2935935|NCT01426386|10108448|P2|Overall Study|Poor response|1
2935936|NCT01426386|10108449|P1|Overall Study|Poor response|2
2935937|NCT01426386|10108444|P6|Overall Study|Did not attend scheduled visit|1
2935938|NCT01426386|10108445|P5|Overall Study|Did not attend scheduled visit|2
2935939|NCT01426386|10108446|P4|Overall Study|Did not attend scheduled visit|0
2935940|NCT01426386|10108447|P3|Overall Study|Did not attend scheduled visit|0
2935941|NCT01426386|10108448|P2|Overall Study|Did not attend scheduled visit|4
2935942|NCT01426386|10108449|P1|Overall Study|Did not attend scheduled visit|1
2935943|NCT01426386|10108444|P6|Overall Study|Adverse Event|0
2935944|NCT01426386|10108445|P5|Overall Study|Adverse Event|0
2935945|NCT01426386|10108446|P4|Overall Study|Adverse Event|0
2935946|NCT01426386|10108447|P3|Overall Study|Adverse Event|0
2935947|NCT01426386|10108448|P2|Overall Study|Adverse Event|1
2935948|NCT01426386|10108449|P1|Overall Study|Adverse Event|0
2935949|NCT01426373|10108505|P1|Overall Study|Miscellaneous Reasons|4
2935950|NCT01426373|10108505|P1|Overall Study|Participant Convenience|10
2935951|NCT01426373|10108505|P1|Overall Study|Lost to Follow-up|14
2935952|NCT01426373|10108505|P1|Overall Study|Adverse Event|6
2935953|NCT01426347|10108538|P2|Overall Study|Withdrawal by Subject|0
2935954|NCT01426347|10108539|P1|Overall Study|Withdrawal by Subject|5
2935955|NCT01426347|10108538|P2|Overall Study|Protocol Violation|0
2935956|NCT01426347|10108539|P1|Overall Study|Protocol Violation|2
2935957|NCT01426347|10108538|P2|Overall Study|Lost to Follow-up|3
2935958|NCT01426347|10108539|P1|Overall Study|Lost to Follow-up|0
2935959|NCT01426269|10108547|P3|Period 2: 40 Weeks|Relapsed|18
2935960|NCT01426269|10108548|P2|Period 2: 40 Weeks|Relapsed|9
2935961|NCT01426269|10108549|P1|Period 2: 40 Weeks|Relapsed|0
2935962|NCT01426269|10108547|P3|Period 2: 40 Weeks|Site closed|5
2935963|NCT01426269|10108548|P2|Period 2: 40 Weeks|Site closed|6
2935964|NCT01426269|10108549|P1|Period 2: 40 Weeks|Site closed|0
2935965|NCT01426269|10108547|P3|Period 2: 40 Weeks|Lost to Follow-up|6
2935966|NCT01426269|10108548|P2|Period 2: 40 Weeks|Lost to Follow-up|8
2935967|NCT01426269|10108549|P1|Period 2: 40 Weeks|Lost to Follow-up|0
2935968|NCT01426269|10108547|P3|Period 2: 40 Weeks|Protocol Violation|5
2935969|NCT01426269|10108548|P2|Period 2: 40 Weeks|Protocol Violation|5
2935970|NCT01426269|10108549|P1|Period 2: 40 Weeks|Protocol Violation|0
2935971|NCT01426269|10108547|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
2935972|NCT01426269|10108548|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
2935973|NCT01426269|10108549|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
2935974|NCT01426269|10108547|P3|Period 2: 40 Weeks|Adverse Event|2
2935975|NCT01426269|10108548|P2|Period 2: 40 Weeks|Adverse Event|1
2935976|NCT01426269|10108549|P1|Period 2: 40 Weeks|Adverse Event|0
2935977|NCT01426269|10108547|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
2935978|NCT01426269|10108548|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
2935979|NCT01426269|10108549|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
2935980|NCT01426269|10108547|P3|Eligibility for Period 2, Randomization|Did not qualify|0
2935981|NCT01426269|10108548|P2|Eligibility for Period 2, Randomization|Did not qualify|0
2935982|NCT01426269|10108549|P1|Eligibility for Period 2, Randomization|Did not qualify|42
2935983|NCT01426269|10108547|P3|Period 1: 12 Weeks|Pregnancy|0
2935984|NCT01426269|10108548|P2|Period 1: 12 Weeks|Pregnancy|0
2935985|NCT01426269|10108549|P1|Period 1: 12 Weeks|Pregnancy|1
2935986|NCT01426269|10108547|P3|Period 1: 12 Weeks|Lost to Follow-up|0
2935987|NCT01426269|10108548|P2|Period 1: 12 Weeks|Lost to Follow-up|0
2935988|NCT01426269|10108549|P1|Period 1: 12 Weeks|Lost to Follow-up|22
2935989|NCT01426269|10108547|P3|Period 1: 12 Weeks|Protocol Violation|0
2935990|NCT01426269|10108548|P2|Period 1: 12 Weeks|Protocol Violation|0
2935991|NCT01426269|10108549|P1|Period 1: 12 Weeks|Protocol Violation|5
2935992|NCT01426269|10108547|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
2935993|NCT01426269|10108548|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
2935994|NCT01426269|10108549|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
2935995|NCT01426269|10108547|P3|Period 1: 12 Weeks|Adverse Event|0
2935996|NCT01426269|10108548|P2|Period 1: 12 Weeks|Adverse Event|0
2935997|NCT01426269|10108549|P1|Period 1: 12 Weeks|Adverse Event|5
2935998|NCT01426217|10108584|P2|Overall Study|lost sample|14
2935999|NCT01426217|10108585|P1|Overall Study|lost sample|8
2936000|NCT01426113|10108598|P2|Overall Study|Adverse Event|1
2936001|NCT01426113|10108599|P1|Overall Study|Adverse Event|0
2936002|NCT01426113|10108598|P2|Overall Study|Study Discontinued|1
2936003|NCT01426113|10108599|P1|Overall Study|Study Discontinued|1
2936004|NCT01426009|10108605|P1|Washout 4|Lost to Follow-up|1
2936005|NCT01426009|10108605|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
2936006|NCT01426009|10108605|P1|Washout 3|personal reasons|1
2936007|NCT01426009|10108605|P1|Washout 2|electrive surgery|1
2936008|NCT01426009|10108605|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
2936009|NCT01426009|10108605|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
2936010|NCT01426009|10108605|P1|Washout 1|Personal Reasons|1
2936011|NCT01426009|10108605|P1|Washout 1|Withdrawal by Subject|1
2936012|NCT01426009|10108605|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
2936013|NCT01426009|10108605|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
2936014|NCT01425814|10108701|P6|Period 5|Stability criteria not fulfilled|1
2936015|NCT01425814|10108702|P5|Period 5|Stability criteria not fulfilled|0
2936016|NCT01425814|10108703|P4|Period 5|Stability criteria not fulfilled|0
2936017|NCT01425814|10108704|P3|Period 5|Stability criteria not fulfilled|1
2936018|NCT01425814|10108705|P2|Period 5|Stability criteria not fulfilled|0
2936019|NCT01425814|10108706|P1|Period 5|Stability criteria not fulfilled|0
2936020|NCT01425814|10108701|P6|Period 4|Adverse Event|0
2936021|NCT01425814|10108702|P5|Period 4|Adverse Event|0
2936022|NCT01425814|10108703|P4|Period 4|Adverse Event|0
2936023|NCT01425814|10108704|P3|Period 4|Adverse Event|1
2936024|NCT01425814|10108705|P2|Period 4|Adverse Event|0
2936025|NCT01425814|10108706|P1|Period 4|Adverse Event|1
2936026|NCT01425814|10108701|P6|Period 3|Adverse Event|1
2936027|NCT01425814|10108702|P5|Period 3|Adverse Event|0
2936028|NCT01425814|10108703|P4|Period 3|Adverse Event|0
2936029|NCT01425814|10108704|P3|Period 3|Adverse Event|0
2936030|NCT01425814|10108705|P2|Period 3|Adverse Event|0
2936031|NCT01425814|10108706|P1|Period 3|Adverse Event|0
2936032|NCT01425814|10108701|P6|Period 2|Stability criteria not fulfilled|0
2936033|NCT01425814|10108702|P5|Period 2|Stability criteria not fulfilled|0
2936034|NCT01425814|10108703|P4|Period 2|Stability criteria not fulfilled|0
2936035|NCT01425814|10108704|P3|Period 2|Stability criteria not fulfilled|0
2936036|NCT01425814|10108705|P2|Period 2|Stability criteria not fulfilled|1
2936037|NCT01425814|10108706|P1|Period 2|Stability criteria not fulfilled|0
2936038|NCT01425814|10108701|P6|Period 1|Stability criteria not fulfilled|0
2936039|NCT01425814|10108702|P5|Period 1|Stability criteria not fulfilled|0
2936040|NCT01425814|10108703|P4|Period 1|Stability criteria not fulfilled|0
2936041|NCT01425814|10108704|P3|Period 1|Stability criteria not fulfilled|0
2936042|NCT01425814|10108705|P2|Period 1|Stability criteria not fulfilled|1
2936043|NCT01425814|10108706|P1|Period 1|Stability criteria not fulfilled|0
2936044|NCT01425801|10108798|P6|Period 4|Not able to maintain visit schedule|0
2936045|NCT01425801|10108799|P5|Period 4|Not able to maintain visit schedule|0
2936046|NCT01425801|10108800|P4|Period 4|Not able to maintain visit schedule|0
2936047|NCT01425801|10108801|P3|Period 4|Not able to maintain visit schedule|1
2936048|NCT01425801|10108802|P2|Period 4|Not able to maintain visit schedule|0
2936049|NCT01425801|10108803|P1|Period 4|Not able to maintain visit schedule|0
2936050|NCT01425801|10108798|P6|Period 3|Stability criteria not fullfilled|0
2936051|NCT01425801|10108799|P5|Period 3|Stability criteria not fullfilled|0
2936052|NCT01425801|10108800|P4|Period 3|Stability criteria not fullfilled|0
2936053|NCT01425801|10108801|P3|Period 3|Stability criteria not fullfilled|1
2936054|NCT01425801|10108802|P2|Period 3|Stability criteria not fullfilled|0
2936055|NCT01425801|10108803|P1|Period 3|Stability criteria not fullfilled|0
2936056|NCT01425801|10108798|P6|Period 2|Withdrawal by Subject|0
2936057|NCT01425801|10108799|P5|Period 2|Withdrawal by Subject|1
2936058|NCT01425801|10108800|P4|Period 2|Withdrawal by Subject|0
2936059|NCT01425801|10108801|P3|Period 2|Withdrawal by Subject|0
2936060|NCT01425801|10108802|P2|Period 2|Withdrawal by Subject|0
2936061|NCT01425801|10108803|P1|Period 2|Withdrawal by Subject|0
2936062|NCT01425801|10108798|P6|Period 1|Withdrawal by Subject|0
2936063|NCT01425801|10108799|P5|Period 1|Withdrawal by Subject|1
2936064|NCT01425801|10108800|P4|Period 1|Withdrawal by Subject|0
2936065|NCT01425801|10108801|P3|Period 1|Withdrawal by Subject|0
2936066|NCT01425801|10108802|P2|Period 1|Withdrawal by Subject|0
2936067|NCT01425801|10108803|P1|Period 1|Withdrawal by Subject|0
2936068|NCT01425749|10108909|P2|Overall Study|progression of melanoma|1
2936069|NCT01425749|10108910|P1|Overall Study|progression of melanoma|0
2936070|NCT01425723|10108927|P2|Overall Study|Other|10
2936071|NCT01425723|10108928|P1|Overall Study|Other|1
2936072|NCT01425723|10108927|P2|Overall Study|Physician Decision|0
2936073|NCT01425723|10108928|P1|Overall Study|Physician Decision|2
2936074|NCT01425723|10108927|P2|Overall Study|Lost to Follow-up|3
2936075|NCT01425723|10108928|P1|Overall Study|Lost to Follow-up|0
2936076|NCT01425723|10108927|P2|Overall Study|Withdrawal by Subject|4
2936077|NCT01425723|10108928|P1|Overall Study|Withdrawal by Subject|1
2936078|NCT01425723|10108927|P2|Overall Study|Lack of Efficacy|1
2936079|NCT01425723|10108928|P1|Overall Study|Lack of Efficacy|0
2936080|NCT01425632|10108958|P3|Overall Study|Withdrawal by Subject|1
2936081|NCT01425632|10108959|P2|Overall Study|Withdrawal by Subject|0
2936082|NCT01425632|10108960|P1|Overall Study|Withdrawal by Subject|0
2936083|NCT01425632|10108958|P3|Overall Study|Protocol Violation|2
2936084|NCT01425632|10108959|P2|Overall Study|Protocol Violation|0
2936085|NCT01425632|10108960|P1|Overall Study|Protocol Violation|0
2936086|NCT01425632|10108958|P3|Overall Study|Physician Decision|0
2936087|NCT01425632|10108959|P2|Overall Study|Physician Decision|0
2936088|NCT01425632|10108960|P1|Overall Study|Physician Decision|1
2936089|NCT01425632|10108958|P3|Overall Study|Adverse Event|1
2936090|NCT01425632|10108959|P2|Overall Study|Adverse Event|1
2936091|NCT01425632|10108960|P1|Overall Study|Adverse Event|0
2936092|NCT01425528|10108970|P2|Overall Study|Withdrawal by Subject|1
2936093|NCT01425528|10108971|P1|Overall Study|Withdrawal by Subject|1
2936094|NCT01425463|10108979|P2|Overall Study|Unknown Reason|7
2936095|NCT01425463|10108980|P1|Overall Study|Unknown Reason|4
2936096|NCT01425463|10108979|P2|Overall Study|Withdrawal by Subject|5
2936097|NCT01425463|10108980|P1|Overall Study|Withdrawal by Subject|7
2936098|NCT01425463|10108979|P2|Overall Study|Lost to Follow-up|2
2936099|NCT01425463|10108980|P1|Overall Study|Lost to Follow-up|5
2936100|NCT01425463|10108979|P2|Overall Study|Protocol Violation|2
2936101|NCT01425463|10108980|P1|Overall Study|Protocol Violation|2
2936102|NCT01425463|10108979|P2|Overall Study|Lack of Efficacy|1
2936103|NCT01425463|10108980|P1|Overall Study|Lack of Efficacy|1
2936104|NCT01425463|10108979|P2|Overall Study|Adverse Event|7
2936105|NCT01425463|10108980|P1|Overall Study|Adverse Event|5
2936106|NCT01425359|10108996|P2|Overall Study|Did Not Meet Qualifying Criteria|5
2936107|NCT01425359|10108997|P1|Overall Study|Did Not Meet Qualifying Criteria|3
2936108|NCT01425359|10108996|P2|Overall Study|Investigator’s Discretion|0
2936109|NCT01425359|10108997|P1|Overall Study|Investigator’s Discretion|2
2936110|NCT01425359|10108996|P2|Overall Study|Subject Withdrew Consent|2
2936111|NCT01425359|10108997|P1|Overall Study|Subject Withdrew Consent|1
2936112|NCT01425359|10108996|P2|Overall Study|Protocol Violation|2
2936113|NCT01425359|10108997|P1|Overall Study|Protocol Violation|1
2936114|NCT01425359|10108996|P2|Overall Study|Unsatisfactory Response|0
2936115|NCT01425359|10108997|P1|Overall Study|Unsatisfactory Response|1
2936116|NCT01425359|10108996|P2|Overall Study|Death|1
2936117|NCT01425359|10108997|P1|Overall Study|Death|0
2936118|NCT01425359|10108996|P2|Overall Study|Revascularization|1
2936119|NCT01425359|10108997|P1|Overall Study|Revascularization|0
2936120|NCT01425359|10108996|P2|Overall Study|Adverse Event|8
2936121|NCT01425359|10108997|P1|Overall Study|Adverse Event|9
2936122|NCT01425359|10108996|P2|Overall Study|Randomized but Not Treated|3
2936123|NCT01425359|10108997|P1|Overall Study|Randomized but Not Treated|2
2936124|NCT01425281|10109028|P2|At 5-year Clinical Follow-up|Refused/terminated|3
2936125|NCT01425281|10109029|P1|At 5-year Clinical Follow-up|Refused/terminated|9
2936126|NCT01425281|10109028|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
2936127|NCT01425281|10109029|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
2936128|NCT01425281|10109028|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
2936129|NCT01425281|10109029|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
2936130|NCT01425281|10109028|P2|At 5-year Clinical Follow-up|Death|0
2936131|NCT01425281|10109029|P1|At 5-year Clinical Follow-up|Death|2
2936132|NCT01425281|10109028|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
2936133|NCT01425281|10109029|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
2936134|NCT01425281|10109028|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
2936135|NCT01425281|10109029|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
2936136|NCT01425281|10109028|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2936137|NCT01425281|10109029|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2936138|NCT01425281|10109028|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
2936139|NCT01425281|10109029|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
2936140|NCT01425281|10109028|P2|At 4-year Clinical Follow-up|Death|3
2936141|NCT01425281|10109029|P1|At 4-year Clinical Follow-up|Death|7
2936142|NCT01425281|10109028|P2|At 3-year Clinical Follow-up|Death|3
2936143|NCT01425281|10109029|P1|At 3-year Clinical Follow-up|Death|2
2936144|NCT01425281|10109028|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2936145|NCT01425281|10109029|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2936146|NCT01425281|10109028|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
2936147|NCT01425281|10109029|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
2936148|NCT01425281|10109028|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
2936149|NCT01425281|10109029|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
2936150|NCT01425281|10109028|P2|At 2-year Clinical Follow-up|Death|0
2936151|NCT01425281|10109029|P1|At 2-year Clinical Follow-up|Death|2
2936152|NCT01425281|10109028|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
2936153|NCT01425281|10109029|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
2936154|NCT01425281|10109028|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
2936155|NCT01425281|10109029|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
2936156|NCT01425281|10109028|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2936157|NCT01425281|10109029|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2936158|NCT01425281|10109028|P2|At 180-day Clinical Follow-up|Death|1
2936159|NCT01425281|10109029|P1|At 180-day Clinical Follow-up|Death|0
2936160|NCT01425281|10109028|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
2936161|NCT01425281|10109029|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
2936162|NCT01425281|10109028|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
2936163|NCT01425281|10109029|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
2936164|NCT01425268|10109247|P2|Overall Study|Physician Decision|0
2936165|NCT01425268|10109248|P1|Overall Study|Physician Decision|1
2936166|NCT01425268|10109247|P2|Overall Study|Sponsor Decision|0
2936167|NCT01425268|10109248|P1|Overall Study|Sponsor Decision|5
2936168|NCT01425268|10109247|P2|Overall Study|Withdrawal by Subject|0
2936169|NCT01425268|10109248|P1|Overall Study|Withdrawal by Subject|2
2936170|NCT01425203|10109269|P3|Crossover Phase|Other virologic failure criteria|3
2936171|NCT01425203|10109270|P2|Crossover Phase|Other virologic failure criteria|0
2936172|NCT01425203|10109271|P1|Crossover Phase|Other virologic failure criteria|0
2936173|NCT01425203|10109269|P3|Crossover Phase|Failure at futility timepoint|3
2936174|NCT01425203|10109270|P2|Crossover Phase|Failure at futility timepoint|0
2936175|NCT01425203|10109271|P1|Crossover Phase|Failure at futility timepoint|0
2936176|NCT01425203|10109269|P3|Treatment Phase|Did not receive treatment|0
2936177|NCT01425203|10109270|P2|Treatment Phase|Did not receive treatment|1
2936178|NCT01425203|10109271|P1|Treatment Phase|Did not receive treatment|0
2936179|NCT01425203|10109269|P3|Treatment Phase|Unidentified reasons|0
2936180|NCT01425203|10109270|P2|Treatment Phase|Unidentified reasons|5
2936181|NCT01425203|10109271|P1|Treatment Phase|Unidentified reasons|11
2936182|NCT01425203|10109269|P3|Treatment Phase|Other virologic failure criteria|0
2936183|NCT01425203|10109270|P2|Treatment Phase|Other virologic failure criteria|3
2936184|NCT01425203|10109271|P1|Treatment Phase|Other virologic failure criteria|5
2936185|NCT01425203|10109269|P3|Treatment Phase|Failure at futility timepoint|0
2936186|NCT01425203|10109270|P2|Treatment Phase|Failure at futility timepoint|27
2936187|NCT01425203|10109271|P1|Treatment Phase|Failure at futility timepoint|8
2936188|NCT01425203|10109269|P3|Treatment Phase|DC during PR Lead-in Phase|0
2936189|NCT01425203|10109270|P2|Treatment Phase|DC during PR Lead-in Phase|1
2936190|NCT01425203|10109271|P1|Treatment Phase|DC during PR Lead-in Phase|3
2936191|NCT01425190|10109288|P3|Overall Study|Full dose not consumed.|0
2936192|NCT01425190|10109289|P2|Overall Study|Full dose not consumed.|0
2936193|NCT01425190|10109290|P1|Overall Study|Full dose not consumed.|1
2936194|NCT01424930|10109326|P2|Overall Study|Reason not specified|6
2936195|NCT01424930|10109327|P1|Overall Study|Reason not specified|0
2936196|NCT01424930|10109326|P2|Overall Study|Screen Failure|1
2936197|NCT01424930|10109327|P1|Overall Study|Screen Failure|0
2936198|NCT01424930|10109326|P2|Overall Study|Progressive Disease|6
2936199|NCT01424930|10109327|P1|Overall Study|Progressive Disease|3
2936200|NCT01424930|10109326|P2|Overall Study|Death|0
2936201|NCT01424930|10109327|P1|Overall Study|Death|1
2936202|NCT01424930|10109326|P2|Overall Study|Adverse Event|1
2936203|NCT01424930|10109327|P1|Overall Study|Adverse Event|0
2936204|NCT01424813|10109341|P2|Overall Study|Other|2
2936205|NCT01424813|10109342|P1|Overall Study|Other|1
2936206|NCT01424813|10109341|P2|Overall Study|Protocol Violation|0
2936207|NCT01424813|10109342|P1|Overall Study|Protocol Violation|1
2936208|NCT01424813|10109341|P2|Overall Study|Withdrawal by Subject|0
2936209|NCT01424813|10109342|P1|Overall Study|Withdrawal by Subject|3
2936210|NCT01424670|10109362|P2|Continuation Period|Withdrawal by Subject|4
2936211|NCT01424670|10109363|P1|Continuation Period|Withdrawal by Subject|13
2936212|NCT01424670|10109362|P2|Continuation Period|Physician Decision|4
2936213|NCT01424670|10109363|P1|Continuation Period|Physician Decision|5
2936214|NCT01424670|10109362|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
2936215|NCT01424670|10109363|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
2936216|NCT01424670|10109362|P2|Continuation Period|Lost to Follow-up|0
2936217|NCT01424670|10109363|P1|Continuation Period|Lost to Follow-up|2
2936218|NCT01424670|10109362|P2|Continuation Period|Adverse Event|5
2936219|NCT01424670|10109363|P1|Continuation Period|Adverse Event|13
2936220|NCT01424670|10109362|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
2936221|NCT01424670|10109363|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
2936302|NCT01424306|10109715|P4|Overall Study|Protocol Violation|0
2936222|NCT01424670|10109362|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
2936223|NCT01424670|10109363|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
2936224|NCT01424670|10109362|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
2936225|NCT01424670|10109363|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
2936226|NCT01424670|10109362|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
2936227|NCT01424670|10109363|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
2936228|NCT01424670|10109362|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
2936229|NCT01424670|10109363|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
2936230|NCT01424644|10109385|P2|Overall Study|Unable to Classify|0
2936231|NCT01424644|10109386|P1|Overall Study|Unable to Classify|1
2936232|NCT01424644|10109385|P2|Overall Study|Administrative Reason|0
2936233|NCT01424644|10109386|P1|Overall Study|Administrative Reason|1
2936234|NCT01424644|10109385|P2|Overall Study|Protocol Violation|3
2936235|NCT01424644|10109386|P1|Overall Study|Protocol Violation|4
2936236|NCT01424644|10109385|P2|Overall Study|Lost to Follow-up|12
2936237|NCT01424644|10109386|P1|Overall Study|Lost to Follow-up|16
2936238|NCT01424644|10109385|P2|Overall Study|Withdrawal by Subject|12
2936239|NCT01424644|10109386|P1|Overall Study|Withdrawal by Subject|9
2936240|NCT01424644|10109385|P2|Overall Study|Adverse Event|0
2936241|NCT01424644|10109386|P1|Overall Study|Adverse Event|2
2936242|NCT01424566|10109400|P3|Double-blind Treatment|Lack of Efficacy|1
2936243|NCT01424566|10109401|P2|Double-blind Treatment|Lack of Efficacy|1
2936244|NCT01424566|10109402|P1|Double-blind Treatment|Lack of Efficacy|0
2936245|NCT01424566|10109400|P3|Double-blind Treatment|Withdrawal by Investigator|1
2936246|NCT01424566|10109401|P2|Double-blind Treatment|Withdrawal by Investigator|1
2936247|NCT01424566|10109402|P1|Double-blind Treatment|Withdrawal by Investigator|0
2936248|NCT01424566|10109400|P3|Double-blind Treatment|Withdrawal by Subject|0
2936249|NCT01424566|10109401|P2|Double-blind Treatment|Withdrawal by Subject|2
2936250|NCT01424566|10109402|P1|Double-blind Treatment|Withdrawal by Subject|0
2936251|NCT01424566|10109400|P3|Double-blind Treatment|Adverse Event|13
2936252|NCT01424566|10109401|P2|Double-blind Treatment|Adverse Event|21
2936253|NCT01424566|10109402|P1|Double-blind Treatment|Adverse Event|0
2936254|NCT01424566|10109400|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
2936255|NCT01424566|10109401|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
2936256|NCT01424566|10109402|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
2936257|NCT01424566|10109400|P3|Single-blind Treatment|Met Exclusion Criteria|0
2936258|NCT01424566|10109401|P2|Single-blind Treatment|Met Exclusion Criteria|0
2936259|NCT01424566|10109402|P1|Single-blind Treatment|Met Exclusion Criteria|1
2936260|NCT01424566|10109400|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2936261|NCT01424566|10109401|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2936262|NCT01424566|10109402|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
2936263|NCT01424566|10109400|P3|Single-blind Treatment|Withdrawal by Investigator|0
2936264|NCT01424566|10109401|P2|Single-blind Treatment|Withdrawal by Investigator|0
2936265|NCT01424566|10109402|P1|Single-blind Treatment|Withdrawal by Investigator|2
2936266|NCT01424566|10109400|P3|Single-blind Treatment|Withdrawal by Subject|0
2936267|NCT01424566|10109401|P2|Single-blind Treatment|Withdrawal by Subject|0
2936268|NCT01424566|10109402|P1|Single-blind Treatment|Withdrawal by Subject|16
2936269|NCT01424566|10109400|P3|Single-blind Treatment|Adverse Event|0
2936270|NCT01424566|10109401|P2|Single-blind Treatment|Adverse Event|0
2936271|NCT01424566|10109402|P1|Single-blind Treatment|Adverse Event|71
2936272|NCT01424514|10109429|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
2936273|NCT01424514|10109430|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
2936274|NCT01424514|10109429|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2936275|NCT01424514|10109430|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2936276|NCT01424501|10109475|P6|Overall Study|Lost to Follow-up|0
2936277|NCT01424501|10109476|P5|Overall Study|Lost to Follow-up|0
2936278|NCT01424501|10109477|P4|Overall Study|Lost to Follow-up|0
2936279|NCT01424501|10109478|P3|Overall Study|Lost to Follow-up|1
2936280|NCT01424501|10109479|P2|Overall Study|Lost to Follow-up|1
2936281|NCT01424501|10109480|P1|Overall Study|Lost to Follow-up|0
2936282|NCT01424501|10109475|P6|Overall Study|Withdrawal by Subject|0
2936283|NCT01424501|10109476|P5|Overall Study|Withdrawal by Subject|0
2936284|NCT01424501|10109477|P4|Overall Study|Withdrawal by Subject|0
2936285|NCT01424501|10109478|P3|Overall Study|Withdrawal by Subject|1
2936286|NCT01424501|10109479|P2|Overall Study|Withdrawal by Subject|0
2936287|NCT01424501|10109480|P1|Overall Study|Withdrawal by Subject|1
2936288|NCT01424397|10109656|P12|Period-2 (8 Days)|Withdrawal by Subject|0
2936289|NCT01424397|10109657|P11|Period-2 (8 Days)|Withdrawal by Subject|0
2936290|NCT01424397|10109658|P10|Period-2 (8 Days)|Withdrawal by Subject|0
2936291|NCT01424397|10109659|P9|Period-2 (8 Days)|Withdrawal by Subject|0
2936292|NCT01424397|10109660|P8|Period-2 (8 Days)|Withdrawal by Subject|0
2936293|NCT01424397|10109661|P7|Period-2 (8 Days)|Withdrawal by Subject|0
2936294|NCT01424397|10109662|P6|Period-2 (8 Days)|Withdrawal by Subject|0
2936295|NCT01424397|10109663|P5|Period-2 (8 Days)|Withdrawal by Subject|0
2936296|NCT01424397|10109664|P4|Period-2 (8 Days)|Withdrawal by Subject|0
2936297|NCT01424397|10109665|P3|Period-2 (8 Days)|Withdrawal by Subject|1
2936298|NCT01424397|10109666|P2|Period-2 (8 Days)|Withdrawal by Subject|0
2936299|NCT01424397|10109667|P1|Period-2 (8 Days)|Withdrawal by Subject|0
2936300|NCT01424306|10109713|P6|Overall Study|Protocol Violation|0
2936301|NCT01424306|10109714|P5|Overall Study|Protocol Violation|1
2936303|NCT01424306|10109716|P3|Overall Study|Protocol Violation|0
2936304|NCT01424306|10109717|P2|Overall Study|Protocol Violation|0
2936305|NCT01424306|10109718|P1|Overall Study|Protocol Violation|0
2936306|NCT01424228|10109767|P2|Overall Study|Unplanned journey|1
2936307|NCT01424228|10109768|P1|Overall Study|Unplanned journey|0
2936308|NCT01424228|10109767|P2|Overall Study|Worsening of symptoms|0
2936309|NCT01424228|10109768|P1|Overall Study|Worsening of symptoms|1
2936310|NCT01424228|10109767|P2|Overall Study|Non-compliance|0
2936311|NCT01424228|10109768|P1|Overall Study|Non-compliance|2
2936312|NCT01424228|10109767|P2|Overall Study|inclusion/exclusion criteria not met|2
2936313|NCT01424228|10109768|P1|Overall Study|inclusion/exclusion criteria not met|2
2936314|NCT01424228|10109767|P2|Overall Study|Lack of Efficacy|7
2936315|NCT01424228|10109768|P1|Overall Study|Lack of Efficacy|5
2936316|NCT01424228|10109767|P2|Overall Study|Sponsor's decision|12
2936317|NCT01424228|10109768|P1|Overall Study|Sponsor's decision|9
2936318|NCT01424228|10109767|P2|Overall Study|Adverse Event|14
2936319|NCT01424228|10109768|P1|Overall Study|Adverse Event|10
2936320|NCT01424228|10109767|P2|Overall Study|Withdrawal by Subject|11
2936321|NCT01424228|10109768|P1|Overall Study|Withdrawal by Subject|27
2936322|NCT01424189|10109819|P2|Overall Study|Death|1
2936323|NCT01424189|10109820|P1|Overall Study|Death|3
2936324|NCT01424189|10109819|P2|Overall Study|Subject moved|0
2936325|NCT01424189|10109820|P1|Overall Study|Subject moved|1
2936326|NCT01424189|10109819|P2|Overall Study|Withdrawal by Subject|4
2936327|NCT01424189|10109820|P1|Overall Study|Withdrawal by Subject|4
2936328|NCT01424189|10109819|P2|Overall Study|Lost to Follow-up|1
2936329|NCT01424189|10109820|P1|Overall Study|Lost to Follow-up|4
2936330|NCT01424189|10109819|P2|Overall Study|Adverse Event|0
2936331|NCT01424189|10109820|P1|Overall Study|Adverse Event|1
2936332|NCT01423916|10109861|P3|Overall Study|Protocol Deviation|0
2936333|NCT01423916|10109862|P2|Overall Study|Protocol Deviation|0
2936334|NCT01423916|10109863|P1|Overall Study|Protocol Deviation|1
2936335|NCT01423916|10109861|P3|Overall Study|Withdrawal by Subject|3
2936336|NCT01423916|10109862|P2|Overall Study|Withdrawal by Subject|10
2936337|NCT01423916|10109863|P1|Overall Study|Withdrawal by Subject|3
2936338|NCT01423916|10109861|P3|Overall Study|Physician Decision|1
2936339|NCT01423916|10109862|P2|Overall Study|Physician Decision|0
2936340|NCT01423916|10109863|P1|Overall Study|Physician Decision|1
2936341|NCT01423916|10109861|P3|Overall Study|Met Withdrawal Criteria|1
2936342|NCT01423916|10109862|P2|Overall Study|Met Withdrawal Criteria|1
2936343|NCT01423916|10109863|P1|Overall Study|Met Withdrawal Criteria|1
2936344|NCT01423916|10109861|P3|Overall Study|Adverse Event|2
2936345|NCT01423916|10109862|P2|Overall Study|Adverse Event|9
2936346|NCT01423916|10109863|P1|Overall Study|Adverse Event|5
2936347|NCT01423812|10109919|P2|Overall Study|Withdrawal by Subject|2
2936348|NCT01423812|10109920|P1|Overall Study|Withdrawal by Subject|1
2936349|NCT01423812|10109919|P2|Overall Study|Lost to Follow-up|2
2936350|NCT01423812|10109920|P1|Overall Study|Lost to Follow-up|2
2936351|NCT01423617|10109948|P2|Overall Study|Lost to Follow-up|1
2936352|NCT01423617|10109949|P1|Overall Study|Lost to Follow-up|0
2936353|NCT01423604|10109966|P2|Randomized|Patient decision|9
2936354|NCT01423604|10109967|P1|Randomized|Patient decision|5
2936355|NCT01423604|10109966|P2|Randomized|Other - unspecified|31
2936356|NCT01423604|10109967|P1|Randomized|Other - unspecified|37
2936357|NCT01423604|10109966|P2|Randomized|Physician Decision|13
2936358|NCT01423604|10109967|P1|Randomized|Physician Decision|16
2936359|NCT01423604|10109966|P2|Randomized|Death|0
2936360|NCT01423604|10109967|P1|Randomized|Death|1
2936361|NCT01423604|10109966|P2|Randomized|Adverse Event|10
2936362|NCT01423604|10109967|P1|Randomized|Adverse Event|4
2936363|NCT01423604|10109966|P2|Safety Run-In|Patient decision|0
2936364|NCT01423604|10109967|P1|Safety Run-In|Patient decision|1
2936365|NCT01423604|10109966|P2|Safety Run-In|Disease progression|0
2936366|NCT01423604|10109967|P1|Safety Run-In|Disease progression|3
2936367|NCT01423604|10109966|P2|Safety Run-In|Physician Decision|0
2936368|NCT01423604|10109967|P1|Safety Run-In|Physician Decision|1
2936369|NCT01423604|10109966|P2|Safety Run-In|Death|0
2936370|NCT01423604|10109967|P1|Safety Run-In|Death|1
2936371|NCT01423604|10109966|P2|Safety Run-In|Adverse Event|0
2936372|NCT01423604|10109967|P1|Safety Run-In|Adverse Event|3
2936373|NCT01423253|10109982|P1|Overall Study|Withdrawal by Subject|2
2936374|NCT01423253|10109982|P1|Overall Study|Protocol Violation|2
2936375|NCT01423253|10109982|P1|Overall Study|Lost to Follow-up|1
2936376|NCT01423253|10109982|P1|Overall Study|Lack of Efficacy|2
2936377|NCT01423253|10109982|P1|Overall Study|Adverse Event|2
2936378|NCT01423084|10110004|P2|Overall Study|Withdrawal by Subject|3
2936379|NCT01423084|10110005|P1|Overall Study|Withdrawal by Subject|2
2936380|NCT01423084|10110004|P2|Overall Study|Adverse Event|1
2936381|NCT01423084|10110005|P1|Overall Study|Adverse Event|0
2936382|NCT01422915|10110035|P1|Overall Study|Adverse Event|1
2936383|NCT01422889|10110040|P1|Overall Study|No Data Entered for Study Stent|9
2936384|NCT01422876|10110055|P10|Week 52|Death|0
2936385|NCT01422876|10110056|P9|Week 52|Death|1
2936386|NCT01422876|10110057|P8|Week 52|Death|3
2936387|NCT01422876|10110058|P7|Week 52|Death|1
2936388|NCT01422876|10110059|P6|Week 52|Death|0
2936389|NCT01422876|10110060|P5|Week 52|Death|0
2936390|NCT01422876|10110061|P4|Week 52|Death|1
2936391|NCT01422876|10110062|P3|Week 52|Death|0
2936392|NCT01422876|10110063|P2|Week 52|Death|1
2936393|NCT01422876|10110064|P1|Week 52|Death|0
2936394|NCT01422876|10110055|P10|Week 52|Consent withdrawn|9
2936395|NCT01422876|10110056|P9|Week 52|Consent withdrawn|13
2936396|NCT01422876|10110057|P8|Week 52|Consent withdrawn|12
2936397|NCT01422876|10110058|P7|Week 52|Consent withdrawn|10
2936398|NCT01422876|10110059|P6|Week 52|Consent withdrawn|12
2936399|NCT01422876|10110060|P5|Week 52|Consent withdrawn|7
2936400|NCT01422876|10110061|P4|Week 52|Consent withdrawn|12
2936401|NCT01422876|10110062|P3|Week 52|Consent withdrawn|6
2936402|NCT01422876|10110063|P2|Week 52|Consent withdrawn|4
2936403|NCT01422876|10110064|P1|Week 52|Consent withdrawn|9
2936404|NCT01422876|10110055|P10|Week 52|Lost to Follow-up|8
2936405|NCT01422876|10110056|P9|Week 52|Lost to Follow-up|7
2936406|NCT01422876|10110057|P8|Week 52|Lost to Follow-up|8
2936407|NCT01422876|10110058|P7|Week 52|Lost to Follow-up|5
2936408|NCT01422876|10110059|P6|Week 52|Lost to Follow-up|5
2936409|NCT01422876|10110060|P5|Week 52|Lost to Follow-up|8
2936410|NCT01422876|10110061|P4|Week 52|Lost to Follow-up|5
2936411|NCT01422876|10110062|P3|Week 52|Lost to Follow-up|7
2936412|NCT01422876|10110063|P2|Week 52|Lost to Follow-up|5
2936413|NCT01422876|10110064|P1|Week 52|Lost to Follow-up|3
2936414|NCT01422876|10110055|P10|Week 24|Death|0
2936415|NCT01422876|10110056|P9|Week 24|Death|0
2936416|NCT01422876|10110057|P8|Week 24|Death|0
2936417|NCT01422876|10110058|P7|Week 24|Death|0
2936418|NCT01422876|10110059|P6|Week 24|Death|0
2936419|NCT01422876|10110060|P5|Week 24|Death|0
2936420|NCT01422876|10110061|P4|Week 24|Death|0
2936421|NCT01422876|10110062|P3|Week 24|Death|0
2936422|NCT01422876|10110063|P2|Week 24|Death|1
2936423|NCT01422876|10110064|P1|Week 24|Death|0
2936424|NCT01422876|10110055|P10|Week 24|Consent withdrawn|6
2936425|NCT01422876|10110056|P9|Week 24|Consent withdrawn|3
2936426|NCT01422876|10110057|P8|Week 24|Consent withdrawn|4
2936427|NCT01422876|10110058|P7|Week 24|Consent withdrawn|5
2936428|NCT01422876|10110059|P6|Week 24|Consent withdrawn|6
2936429|NCT01422876|10110060|P5|Week 24|Consent withdrawn|5
2936430|NCT01422876|10110061|P4|Week 24|Consent withdrawn|4
2936431|NCT01422876|10110062|P3|Week 24|Consent withdrawn|3
2936432|NCT01422876|10110063|P2|Week 24|Consent withdrawn|1
2936433|NCT01422876|10110064|P1|Week 24|Consent withdrawn|5
2936434|NCT01422876|10110055|P10|Week 24|Lost to Follow-up|4
2936435|NCT01422876|10110056|P9|Week 24|Lost to Follow-up|3
2936436|NCT01422876|10110057|P8|Week 24|Lost to Follow-up|3
2936437|NCT01422876|10110058|P7|Week 24|Lost to Follow-up|1
2936438|NCT01422876|10110059|P6|Week 24|Lost to Follow-up|0
2936439|NCT01422876|10110060|P5|Week 24|Lost to Follow-up|2
2936440|NCT01422876|10110061|P4|Week 24|Lost to Follow-up|4
2936441|NCT01422876|10110062|P3|Week 24|Lost to Follow-up|2
2936442|NCT01422876|10110063|P2|Week 24|Lost to Follow-up|1
2936443|NCT01422876|10110064|P1|Week 24|Lost to Follow-up|1
2936444|NCT01422850|10110111|P1|Overall Study|Physician Decision|3
2936445|NCT01422824|10110117|P1|Overall Study|Lost to Follow-up|37
2936446|NCT01422824|10110117|P1|Overall Study|Case record form not evaluated|1
2936447|NCT01422720|10110122|P1|Overall Study|Ineligibility|1
2936448|NCT01422720|10110122|P1|Overall Study|Withdrawal by Subject|4
2936449|NCT01422720|10110122|P1|Overall Study|Lack of Efficacy|1
2936450|NCT01422720|10110122|P1|Overall Study|Adverse Event|16
2936451|NCT01422538|10110133|P3|Overall Study|Missed visit|1
2936452|NCT01422538|10110134|P2|Overall Study|Missed visit|1
2936453|NCT01422538|10110135|P1|Overall Study|Missed visit|0
2936454|NCT01422538|10110133|P3|Overall Study|Lost to Follow-up|1
2936455|NCT01422538|10110134|P2|Overall Study|Lost to Follow-up|1
2936456|NCT01422538|10110135|P1|Overall Study|Lost to Follow-up|0
2936457|NCT01422408|10110179|P1|Overall Study|Withdrawal by Subject|3
2936458|NCT01422408|10110179|P1|Overall Study|Adverse Event|1
2936459|NCT01422382|10110208|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
2936460|NCT01422304|10110224|P2|Overall Study|Not Treated|11
2936461|NCT01422304|10110225|P1|Overall Study|Not Treated|3
2936462|NCT01422304|10110224|P2|Overall Study|Did Not Meet Protocol Eligibility|2
2936463|NCT01422304|10110225|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2936464|NCT01422304|10110224|P2|Overall Study|Withdrawal by Subject|2
2936465|NCT01422304|10110225|P1|Overall Study|Withdrawal by Subject|4
2936466|NCT01422304|10110224|P2|Overall Study|Protocol Violation|0
2936467|NCT01422304|10110225|P1|Overall Study|Protocol Violation|1
2936468|NCT01422304|10110224|P2|Overall Study|Never Entered Follow-up|1
2936469|NCT01422304|10110225|P1|Overall Study|Never Entered Follow-up|2
2936470|NCT01422304|10110224|P2|Overall Study|Lost to Follow-up|20
2936471|NCT01422304|10110225|P1|Overall Study|Lost to Follow-up|14
2936472|NCT01422304|10110224|P2|Overall Study|Adverse Event|1
2936473|NCT01422304|10110225|P1|Overall Study|Adverse Event|0
2936474|NCT01422239|10110257|P2|Overall Study|Lost to Follow-up|3
2936475|NCT01422239|10110258|P1|Overall Study|Lost to Follow-up|4
2936476|NCT01422213|10110280|P3|Overall Study|Administrative or Other Reason(s)|2
2936477|NCT01422213|10110281|P2|Overall Study|Administrative or Other Reason(s)|4
2936478|NCT01422213|10110282|P1|Overall Study|Administrative or Other Reason(s)|5
2936479|NCT01422213|10110280|P3|Overall Study|Lost to Follow-up|5
2936480|NCT01422213|10110281|P2|Overall Study|Lost to Follow-up|3
2936481|NCT01422213|10110282|P1|Overall Study|Lost to Follow-up|3
2936482|NCT01422213|10110280|P3|Overall Study|Withdrawal of Consent|5
2936483|NCT01422213|10110281|P2|Overall Study|Withdrawal of Consent|3
2936484|NCT01422213|10110282|P1|Overall Study|Withdrawal of Consent|7
2936485|NCT01422213|10110280|P3|Overall Study|Protocol Violation|4
2936486|NCT01422213|10110281|P2|Overall Study|Protocol Violation|2
2936487|NCT01422213|10110282|P1|Overall Study|Protocol Violation|0
2936488|NCT01422213|10110280|P3|Overall Study|Non-compliance with study drug|0
2936489|NCT01422213|10110281|P2|Overall Study|Non-compliance with study drug|1
2936490|NCT01422213|10110282|P1|Overall Study|Non-compliance with study drug|0
2936491|NCT01422213|10110280|P3|Overall Study|Lack of Efficacy|2
2936492|NCT01422213|10110281|P2|Overall Study|Lack of Efficacy|2
2936493|NCT01422213|10110282|P1|Overall Study|Lack of Efficacy|10
2936494|NCT01422213|10110280|P3|Overall Study|Adverse Event|11
2936495|NCT01422213|10110281|P2|Overall Study|Adverse Event|7
2936496|NCT01422213|10110282|P1|Overall Study|Adverse Event|8
2936497|NCT01422187|10110343|P3|Overall Study|Lost to Follow-up|0
2936498|NCT01422187|10110344|P2|Overall Study|Lost to Follow-up|1
2936499|NCT01422187|10110345|P1|Overall Study|Lost to Follow-up|0
2936500|NCT01422187|10110343|P3|Overall Study|Personal reason|0
2936501|NCT01422187|10110344|P2|Overall Study|Personal reason|0
2936502|NCT01422187|10110345|P1|Overall Study|Personal reason|1
2936503|NCT01421719|10110409|P1|Overall Study|Withdrawal by Subject|4
2936504|NCT01421667|10110418|P4|Overall Study|Lost to Follow-up|0
2936505|NCT01421667|10110419|P3|Overall Study|Lost to Follow-up|0
2936506|NCT01421667|10110420|P2|Overall Study|Lost to Follow-up|1
2936507|NCT01421667|10110421|P1|Overall Study|Lost to Follow-up|0
2936508|NCT01421667|10110418|P4|Overall Study|Withdrawal by Subject|1
2936509|NCT01421667|10110419|P3|Overall Study|Withdrawal by Subject|2
2936510|NCT01421667|10110420|P2|Overall Study|Withdrawal by Subject|1
2936511|NCT01421667|10110421|P1|Overall Study|Withdrawal by Subject|0
2936512|NCT01421641|10110482|P2|Overall Study|Protocol Violation|2
2936513|NCT01421641|10110483|P1|Overall Study|Protocol Violation|2
2936514|NCT01421511|10110505|P2|Overall Study|Death|1
2936515|NCT01421511|10110506|P1|Overall Study|Death|1
2936516|NCT01421511|10110505|P2|Overall Study|Withdrawal by Subject|5
2936517|NCT01421511|10110506|P1|Overall Study|Withdrawal by Subject|6
2936518|NCT01421511|10110505|P2|Overall Study|Physician Decision|1
2936519|NCT01421511|10110506|P1|Overall Study|Physician Decision|0
2936520|NCT01421511|10110505|P2|Overall Study|Randomized but didn't receive study drug|7
2936521|NCT01421511|10110506|P1|Overall Study|Randomized but didn't receive study drug|1
2936522|NCT01421511|10110505|P2|Overall Study|Lost to Follow-up|14
2936523|NCT01421511|10110506|P1|Overall Study|Lost to Follow-up|11
2936524|NCT01421459|10110556|P2|Overall Study|Withdrawal by Subject|16
2936525|NCT01421459|10110557|P1|Overall Study|Withdrawal by Subject|12
2936526|NCT01421459|10110556|P2|Overall Study|Protocol Violation|5
2936527|NCT01421459|10110557|P1|Overall Study|Protocol Violation|8
2936528|NCT01421459|10110556|P2|Overall Study|Physician Decision|9
2936529|NCT01421459|10110557|P1|Overall Study|Physician Decision|9
2936530|NCT01421459|10110556|P2|Overall Study|Lost to Follow-up|9
2936531|NCT01421459|10110557|P1|Overall Study|Lost to Follow-up|8
2936532|NCT01421459|10110556|P2|Overall Study|Lack of Efficacy|2
2936533|NCT01421459|10110557|P1|Overall Study|Lack of Efficacy|1
2936534|NCT01421459|10110556|P2|Overall Study|Death|1
2936535|NCT01421459|10110557|P1|Overall Study|Death|1
2936536|NCT01421459|10110556|P2|Overall Study|Adverse Event|10
2936537|NCT01421459|10110557|P1|Overall Study|Adverse Event|6
2936538|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
2936539|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
2936540|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
2936541|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2936542|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2936543|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2936544|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
2936545|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
2936546|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
2936547|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
2936548|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
2936549|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
2936550|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
2936551|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
2936552|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
2936553|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
2936554|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
2936555|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
2936556|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
2936557|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
2936558|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
2936559|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
2936560|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
2936561|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
2936562|NCT01421342|10110598|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2936563|NCT01421342|10110599|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
2936564|NCT01421342|10110600|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2936565|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
2936566|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2936567|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2936568|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
2936569|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2936570|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2936571|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2936572|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2936573|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
2936574|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
2936575|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
2936576|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
2936577|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2936578|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
2936579|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2936580|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2936581|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2936582|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
2936583|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
2936584|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
2936585|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
2936586|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
2936587|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
2936588|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
2936589|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
2936590|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
2936591|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
2936592|NCT01421342|10110598|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
2936593|NCT01421342|10110599|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
2936594|NCT01421342|10110600|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
2936595|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
2936596|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
2936597|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
2936598|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2936599|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
2936600|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2936601|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
2936602|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
2936603|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
2936604|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
2936605|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
2936606|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
2936607|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
2936608|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
2936609|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
2936610|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Death|3
2936611|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Death|0
2936612|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Death|0
2936613|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
2936614|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
2936615|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
2936616|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
2936617|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
2936618|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
2936619|NCT01421342|10110598|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
2936620|NCT01421342|10110599|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
2936621|NCT01421342|10110600|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
2936622|NCT01421303|10110617|P1|Overall Study|Withdrawal by Subject|1
2936623|NCT01421303|10110617|P1|Overall Study|Other|7
2936624|NCT01421303|10110617|P1|Overall Study|Non compliance with study procedure|1
2936625|NCT01421303|10110617|P1|Overall Study|Lost to Follow-up|13
2936626|NCT01421277|10110644|P2|Overall Study|Incomplete baseline data|31
2936627|NCT01421277|10110645|P1|Overall Study|Incomplete baseline data|0
2936628|NCT01421277|10110644|P2|Overall Study|Lack of qualifying event|61
2936629|NCT01421277|10110645|P1|Overall Study|Lack of qualifying event|0
2936630|NCT01421225|10110657|P2|Overall Study|Withdrawal by Subject|1
2936631|NCT01421225|10110658|P1|Overall Study|Withdrawal by Subject|0
2936632|NCT01421147|10110672|P2|Extension Period|Withdrawal by Subject|3
2936633|NCT01421147|10110673|P1|Extension Period|Withdrawal by Subject|5
2936634|NCT01421147|10110672|P2|Extension Period|Physician Decision|0
2936635|NCT01421147|10110673|P1|Extension Period|Physician Decision|1
2936636|NCT01421147|10110672|P2|Extension Period|Lost to Follow-up|5
2936637|NCT01421147|10110673|P1|Extension Period|Lost to Follow-up|2
2936638|NCT01421147|10110672|P2|Extension Period|Death|1
2936639|NCT01421147|10110673|P1|Extension Period|Death|0
2936640|NCT01421147|10110672|P2|Extension Period|Adverse Event|2
2936641|NCT01421147|10110673|P1|Extension Period|Adverse Event|0
2936642|NCT01421147|10110672|P2|Treatment Period|Withdrawal by Subject|5
2936643|NCT01421147|10110673|P1|Treatment Period|Withdrawal by Subject|10
2936644|NCT01421147|10110672|P2|Treatment Period|Physician Decision|2
2936645|NCT01421147|10110673|P1|Treatment Period|Physician Decision|2
2936646|NCT01421147|10110672|P2|Treatment Period|Lost to Follow-up|1
2936647|NCT01421147|10110673|P1|Treatment Period|Lost to Follow-up|2
2936648|NCT01421147|10110672|P2|Treatment Period|Adverse Event|3
2936649|NCT01421147|10110673|P1|Treatment Period|Adverse Event|2
2936650|NCT01421134|10110705|P2|Overall Study|Lost to Follow-up|1
2936651|NCT01421134|10110706|P1|Overall Study|Lost to Follow-up|1
2936652|NCT01421134|10110705|P2|Overall Study|Administrative|1
2936653|NCT01421134|10110706|P1|Overall Study|Administrative|0
2936654|NCT01421134|10110705|P2|Overall Study|Withdrawal by Subject|1
2936655|NCT01421134|10110706|P1|Overall Study|Withdrawal by Subject|1
2936656|NCT01421134|10110705|P2|Overall Study|Protocol Violation|3
2936657|NCT01421134|10110706|P1|Overall Study|Protocol Violation|0
2936658|NCT01421134|10110705|P2|Overall Study|Lack of Efficacy|4
2936659|NCT01421134|10110706|P1|Overall Study|Lack of Efficacy|2
2936660|NCT01421134|10110705|P2|Overall Study|Adverse Event|5
2936661|NCT01421134|10110706|P1|Overall Study|Adverse Event|3
2936662|NCT01420965|10110727|P3|Overall Study|Adverse Event|0
2936663|NCT01420965|10110728|P2|Overall Study|Adverse Event|1
2936664|NCT01420965|10110729|P1|Overall Study|Adverse Event|0
2936665|NCT01420965|10110727|P3|Overall Study|Withdrawal by Subject|0
2936666|NCT01420965|10110728|P2|Overall Study|Withdrawal by Subject|0
2936667|NCT01420965|10110729|P1|Overall Study|Withdrawal by Subject|1
2936668|NCT01420926|10110742|P2|Overall Study|Continues on active treatment|3
2936669|NCT01420926|10110743|P1|Overall Study|Continues on active treatment|1
2936670|NCT01420926|10110742|P2|Overall Study|Physician Decision|5
2936671|NCT01420926|10110743|P1|Overall Study|Physician Decision|7
2936672|NCT01420926|10110742|P2|Overall Study|Non-protocol treatment|20
2936673|NCT01420926|10110743|P1|Overall Study|Non-protocol treatment|17
2936674|NCT01420926|10110742|P2|Overall Study|Withdrawal by Subject|16
2936675|NCT01420926|10110743|P1|Overall Study|Withdrawal by Subject|11
2936676|NCT01420926|10110742|P2|Overall Study|Death|17
2936677|NCT01420926|10110743|P1|Overall Study|Death|18
2936678|NCT01420926|10110742|P2|Overall Study|Adverse Event|4
2936679|NCT01420926|10110743|P1|Overall Study|Adverse Event|6
2936680|NCT01420627|10110790|P1|EZN-2279 Treatment Period|Adverse Event|1
2936681|NCT01420549|10110806|P2|Overall Study|Non-adherence to medication|1
2936682|NCT01420549|10110807|P1|Overall Study|Non-adherence to medication|4
2936683|NCT01420549|10110806|P2|Overall Study|Protocol Violation|1
2936684|NCT01420549|10110807|P1|Overall Study|Protocol Violation|0
2936685|NCT01420549|10110806|P2|Overall Study|Lost to Follow-up|2
2936686|NCT01420549|10110807|P1|Overall Study|Lost to Follow-up|2
2936687|NCT01420549|10110806|P2|Overall Study|Adverse Event|1
2936688|NCT01420549|10110807|P1|Overall Study|Adverse Event|1
2936689|NCT01420081|10110841|P9|Overall Study|Other Reasons|0
2936690|NCT01420081|10110842|P8|Overall Study|Other Reasons|0
2936691|NCT01420081|10110843|P7|Overall Study|Other Reasons|0
2936692|NCT01420081|10110844|P6|Overall Study|Other Reasons|0
2936693|NCT01420081|10110845|P5|Overall Study|Other Reasons|0
2936694|NCT01420081|10110846|P4|Overall Study|Other Reasons|0
2936695|NCT01420081|10110847|P3|Overall Study|Other Reasons|1
2936696|NCT01420081|10110848|P2|Overall Study|Other Reasons|0
2936697|NCT01420081|10110849|P1|Overall Study|Other Reasons|0
2936698|NCT01420081|10110841|P9|Overall Study|Subject Refused Futher Follow-up|0
2936699|NCT01420081|10110842|P8|Overall Study|Subject Refused Futher Follow-up|0
2936700|NCT01420081|10110843|P7|Overall Study|Subject Refused Futher Follow-up|0
2936701|NCT01420081|10110844|P6|Overall Study|Subject Refused Futher Follow-up|0
2936702|NCT01420081|10110845|P5|Overall Study|Subject Refused Futher Follow-up|1
2936703|NCT01420081|10110846|P4|Overall Study|Subject Refused Futher Follow-up|0
2936704|NCT01420081|10110847|P3|Overall Study|Subject Refused Futher Follow-up|1
2936705|NCT01420081|10110848|P2|Overall Study|Subject Refused Futher Follow-up|0
2936706|NCT01420081|10110849|P1|Overall Study|Subject Refused Futher Follow-up|0
2936707|NCT01420081|10110841|P9|Overall Study|Study Terminated by Sponsor|2
2936708|NCT01420081|10110842|P8|Overall Study|Study Terminated by Sponsor|2
2936709|NCT01420081|10110843|P7|Overall Study|Study Terminated by Sponsor|3
2936710|NCT01420081|10110844|P6|Overall Study|Study Terminated by Sponsor|7
2936711|NCT01420081|10110845|P5|Overall Study|Study Terminated by Sponsor|11
2936712|NCT01420081|10110846|P4|Overall Study|Study Terminated by Sponsor|3
2936713|NCT01420081|10110847|P3|Overall Study|Study Terminated by Sponsor|1
2936714|NCT01420081|10110848|P2|Overall Study|Study Terminated by Sponsor|1
2936715|NCT01420081|10110849|P1|Overall Study|Study Terminated by Sponsor|2
2936716|NCT01420081|10110841|P9|Overall Study|Lost to Follow-up|0
2936717|NCT01420081|10110842|P8|Overall Study|Lost to Follow-up|0
2936718|NCT01420081|10110843|P7|Overall Study|Lost to Follow-up|0
2936719|NCT01420081|10110844|P6|Overall Study|Lost to Follow-up|1
2936720|NCT01420081|10110845|P5|Overall Study|Lost to Follow-up|1
2936721|NCT01420081|10110846|P4|Overall Study|Lost to Follow-up|0
2936722|NCT01420081|10110847|P3|Overall Study|Lost to Follow-up|0
2936723|NCT01420081|10110848|P2|Overall Study|Lost to Follow-up|0
2936724|NCT01420081|10110849|P1|Overall Study|Lost to Follow-up|0
2936725|NCT01420081|10110841|P9|Overall Study|Death|1
2936726|NCT01420081|10110842|P8|Overall Study|Death|1
2936727|NCT01420081|10110843|P7|Overall Study|Death|0
2936728|NCT01420081|10110844|P6|Overall Study|Death|12
2936729|NCT01420081|10110845|P5|Overall Study|Death|7
2936730|NCT01420081|10110846|P4|Overall Study|Death|0
2936731|NCT01420081|10110847|P3|Overall Study|Death|8
2936732|NCT01420081|10110848|P2|Overall Study|Death|0
2936733|NCT01420081|10110849|P1|Overall Study|Death|1
2936734|NCT01420068|10110930|P2|Overall Study|Withdrawal by Subject|2
2936735|NCT01420068|10110931|P1|Overall Study|Withdrawal by Subject|1
2936736|NCT01420068|10110930|P2|Overall Study|Administrative problems|3
2936737|NCT01420068|10110931|P1|Overall Study|Administrative problems|1
2936738|NCT01419769|10111002|P1|Overall Study|Not evaluable due to pigtail stents|1
2936739|NCT01419769|10111002|P1|Overall Study|Did not receive the AXIOS stent|3
2936740|NCT01419717|10111015|P1|Overall Study|Noncompliance|1
2936741|NCT01419717|10111015|P1|Overall Study|Administrative Decision|1
2936742|NCT01419717|10111015|P1|Overall Study|Lost to Follow-up|2
2936743|NCT01419717|10111015|P1|Overall Study|Other|4
2936744|NCT01419717|10111015|P1|Overall Study|Disease Progression|9
2936745|NCT01419717|10111015|P1|Overall Study|Withdrawal by Subject|10
2936746|NCT01419717|10111015|P1|Overall Study|Death|17
2936747|NCT01419717|10111015|P1|Overall Study|Adverse Event|19
2936748|NCT01419717|10111015|P1|Overall Study|Protocol-specified Criteria|62
2936749|NCT01419626|10111029|P3|Overall Study|Lost to Follow-up|1
2936750|NCT01419626|10111030|P2|Overall Study|Lost to Follow-up|1
2936751|NCT01419626|10111031|P1|Overall Study|Lost to Follow-up|0
2936752|NCT01419626|10111029|P3|Overall Study|Withdrawal by Subject|0
2936753|NCT01419626|10111030|P2|Overall Study|Withdrawal by Subject|0
2936754|NCT01419626|10111031|P1|Overall Study|Withdrawal by Subject|1
2936755|NCT01419626|10111029|P3|Overall Study|Protocol Violation|2
2936756|NCT01419626|10111030|P2|Overall Study|Protocol Violation|2
2936757|NCT01419626|10111031|P1|Overall Study|Protocol Violation|3
2936758|NCT01419314|10111062|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
2936759|NCT01419314|10111063|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
2936760|NCT01419314|10111062|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
2936761|NCT01419314|10111063|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
2936762|NCT01419314|10111062|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
2936763|NCT01419314|10111063|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
2936764|NCT01419236|10111104|P2|Overall Study|Entry Criteria Not Met|0
2936765|NCT01419236|10111105|P1|Overall Study|Entry Criteria Not Met|1
2936766|NCT01419236|10111104|P2|Overall Study|Withdrawal by Subject|4
2936767|NCT01419236|10111105|P1|Overall Study|Withdrawal by Subject|1
2936768|NCT01419236|10111104|P2|Overall Study|Physician Decision|0
2936769|NCT01419236|10111105|P1|Overall Study|Physician Decision|1
2936770|NCT01419236|10111104|P2|Overall Study|Lost to Follow-up|0
2936771|NCT01419236|10111105|P1|Overall Study|Lost to Follow-up|1
2936772|NCT01419236|10111104|P2|Overall Study|Lack of Efficacy|1
2936773|NCT01419236|10111105|P1|Overall Study|Lack of Efficacy|0
2936774|NCT01419236|10111104|P2|Overall Study|Adverse Event|0
2936775|NCT01419236|10111105|P1|Overall Study|Adverse Event|1
2936776|NCT01419197|10111129|P2|Overall Study|Lost to Follow-up|4
2936777|NCT01419197|10111130|P1|Overall Study|Lost to Follow-up|14
2936778|NCT01419197|10111129|P2|Overall Study|Reason Not Specified|1
2936779|NCT01419197|10111130|P1|Overall Study|Reason Not Specified|0
2936780|NCT01419197|10111129|P2|Overall Study|Study Completed by Sponsor|34
2936781|NCT01419197|10111130|P1|Overall Study|Study Completed by Sponsor|103
2936782|NCT01419197|10111129|P2|Overall Study|Withdrawal by Subject|32
2936783|NCT01419197|10111130|P1|Overall Study|Withdrawal by Subject|33
2936784|NCT01419197|10111129|P2|Overall Study|Non-compliance|1
2936785|NCT01419197|10111130|P1|Overall Study|Non-compliance|3
2936786|NCT01419197|10111129|P2|Overall Study|Physician Decision|4
2936787|NCT01419197|10111130|P1|Overall Study|Physician Decision|4
2936788|NCT01419197|10111129|P2|Overall Study|Death|122
2936789|NCT01419197|10111130|P1|Overall Study|Death|247
2936790|NCT01419184|10111155|P2|Overall Study|Participant randomized, not treated|0
2936791|NCT01419184|10111156|P1|Overall Study|Participant randomized, not treated|1
2936792|NCT01419184|10111155|P2|Overall Study|No IRLOS-No adverse event treatment date|1
2936793|NCT01419184|10111156|P1|Overall Study|No IRLOS-No adverse event treatment date|0
2936794|NCT01419184|10111155|P2|Overall Study|No IRLOS-non trial antibiotic used|2
2936795|NCT01419184|10111156|P1|Overall Study|No IRLOS-non trial antibiotic used|1
2936796|NCT01419184|10111155|P2|Overall Study|No IRLOS-randomized, not treated|4
2936797|NCT01419184|10111156|P1|Overall Study|No IRLOS-randomized, not treated|2
2936798|NCT01419184|10111155|P2|Overall Study|No IRLOS-No in-patient end date reported|6
2936799|NCT01419184|10111156|P1|Overall Study|No IRLOS-No in-patient end date reported|3
2936800|NCT01419184|10111155|P2|Overall Study|Site data not available|2
2936801|NCT01419184|10111156|P1|Overall Study|Site data not available|3
2936802|NCT01419080|10111189|P1|Overall Study|Too Ill|3
2936803|NCT01419080|10111189|P1|Overall Study|Lost to Follow-up|23
2936804|NCT01419080|10111189|P1|Overall Study|Death|30
2936805|NCT01419080|10111189|P1|Overall Study|Withdrawal by Subject|75
2936806|NCT01418937|10111200|P1|Overall Study|Withdrawal by Subject|1
2936807|NCT01418937|10111200|P1|Overall Study|Pregnancy|1
2936808|NCT01418937|10111200|P1|Overall Study|Protocol Violation|1
2936809|NCT01418937|10111200|P1|Overall Study|Lost to Follow-up|5
2936810|NCT01418378|10111231|P2|Overall Study|developed chronic myopathy|1
2936811|NCT01418378|10111232|P1|Overall Study|developed chronic myopathy|0
2936812|NCT01418378|10111231|P2|Overall Study|ligament imbalance|1
2936813|NCT01418378|10111232|P1|Overall Study|ligament imbalance|0
2936814|NCT01418378|10111231|P2|Overall Study|Physician Decision|1
2936815|NCT01418378|10111232|P1|Overall Study|Physician Decision|0
2936816|NCT01418378|10111231|P2|Overall Study|Death|2
2936817|NCT01418378|10111232|P1|Overall Study|Death|1
2936818|NCT01418365|10111306|P2|Second Intervention|Withdrawal by Subject|1
2936819|NCT01418365|10111307|P1|Second Intervention|Withdrawal by Subject|0
2936820|NCT01418365|10111306|P2|First Intervention|Non-compliance|0
2936821|NCT01418365|10111307|P1|First Intervention|Non-compliance|1
2936822|NCT01418365|10111306|P2|First Intervention|Withdrawal by Subject|1
2936823|NCT01418365|10111307|P1|First Intervention|Withdrawal by Subject|0
2936824|NCT01418209|10111318|P3|Overall Study|Did not provide hot flash diary data|3
2936825|NCT01418209|10111319|P2|Overall Study|Did not provide hot flash diary data|3
2936826|NCT01418209|10111320|P1|Overall Study|Did not provide hot flash diary data|1
2936827|NCT01418209|10111318|P3|Overall Study|Withdrawal by Subject|1
2936828|NCT01418209|10111319|P2|Overall Study|Withdrawal by Subject|0
2936829|NCT01418209|10111320|P1|Overall Study|Withdrawal by Subject|1
2936830|NCT01417481|10111384|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
2936831|NCT01417481|10111385|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
2936832|NCT01417377|10111450|P1|Overall Study|Enrolled, but not treated|1
2936833|NCT01417377|10111450|P1|Overall Study|Lost to Follow-up|12
2936834|NCT01417195|10111459|P2|Overall Study|No transfer due to elevated progesterone|0
2936835|NCT01417195|10111460|P1|Overall Study|No transfer due to elevated progesterone|1
2936836|NCT01417195|10111459|P2|Overall Study|No transfer due to risk of OHSS|0
2936837|NCT01417195|10111460|P1|Overall Study|No transfer due to risk of OHSS|1
2936838|NCT01417195|10111459|P2|Overall Study|No embryos for transfer|1
2936839|NCT01417195|10111460|P1|Overall Study|No embryos for transfer|0
2936840|NCT01417195|10111459|P2|Overall Study|Stimulation failure|0
2936841|NCT01417195|10111460|P1|Overall Study|Stimulation failure|1
2936842|NCT01417156|10111476|P1|Overall Study|Protocol Violation|2
2936843|NCT01417156|10111476|P1|Overall Study|Adverse Event|12
2936844|NCT01417104|10111486|P2|Overall Study|Adverse Event|0
2936845|NCT01417104|10111487|P1|Overall Study|Adverse Event|1
2936846|NCT01417104|10111486|P2|Overall Study|Failure to make contact|1
2936847|NCT01417104|10111487|P1|Overall Study|Failure to make contact|0
2936848|NCT01417104|10111486|P2|Overall Study|Withdrawal by Subject|1
2936849|NCT01417104|10111487|P1|Overall Study|Withdrawal by Subject|5
2936850|NCT01417078|10111497|P1|Overall Study|Withdrawal by Subject|1
2936851|NCT01417000|10111522|P2|Overall Study|Study Terminated by Sponsor|1
2936852|NCT01417000|10111523|P1|Overall Study|Study Terminated by Sponsor|1
2936853|NCT01417000|10111522|P2|Overall Study|Lost to Follow-up|0
2936854|NCT01417000|10111523|P1|Overall Study|Lost to Follow-up|1
2936855|NCT01417000|10111522|P2|Overall Study|Death|28
2936856|NCT01417000|10111523|P1|Overall Study|Death|59
2936857|NCT01416805|10111540|P2|Overall Study|Lost to Follow-up|4
2936858|NCT01416805|10111541|P1|Overall Study|Lost to Follow-up|4
2936859|NCT01416610|10111580|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
2936860|NCT01416610|10111580|P1|Overall Study|Lost to Follow-up|7
2936861|NCT01416610|10111580|P1|Overall Study|Withdrawal by Subject|13
2936862|NCT01416610|10111580|P1|Overall Study|No reason given|5
2936863|NCT01416610|10111580|P1|Overall Study|Lack of Efficacy|4
2936864|NCT01416610|10111580|P1|Overall Study|Adverse Event -Patient decision|3
2936865|NCT01416610|10111580|P1|Overall Study|Adverse Event|4
2936866|NCT01416571|10111634|P1|Overall Study|Lost to Follow-up|2
2936867|NCT01416389|10111663|P2|Overall Study|Started New Therapy|0
2936868|NCT01416389|10111664|P1|Overall Study|Started New Therapy|2
2936869|NCT01416389|10111663|P2|Overall Study|Lost to Follow-up|0
2936870|NCT01416389|10111664|P1|Overall Study|Lost to Follow-up|1
2936871|NCT01416272|10111681|P1|Overall Study|Study related complaints|1
2936872|NCT01416272|10111681|P1|Overall Study|Lost to Follow-up|1
2936873|NCT01416272|10111681|P1|Overall Study|Unacceptable distance visual acuity|2
2936874|NCT01416181|10111738|P2|Part 2|Lost to Follow-up|2
2936875|NCT01416181|10111739|P1|Part 2|Lost to Follow-up|2
2936876|NCT01416181|10111738|P2|Part 2|Lack of Efficacy|1
2936877|NCT01416181|10111739|P1|Part 2|Lack of Efficacy|4
2936878|NCT01416181|10111738|P2|Part 2|Withdrawal by Subject|5
2936879|NCT01416181|10111739|P1|Part 2|Withdrawal by Subject|14
2936880|NCT01416181|10111738|P2|Part 2|Investigator Decision|7
2936881|NCT01416181|10111739|P1|Part 2|Investigator Decision|6
2936882|NCT01416181|10111738|P2|Part 2|Other|267
2936883|NCT01416181|10111739|P1|Part 2|Other|234
2936884|NCT01416181|10111738|P2|Part 2|Adverse Event|4
2936885|NCT01416181|10111739|P1|Part 2|Adverse Event|11
2936886|NCT01416181|10111738|P2|Part 1|Ongoing in Follow-Up|8
2936887|NCT01416181|10111739|P1|Part 1|Ongoing in Follow-Up|14
2936888|NCT01416181|10111738|P2|Part 1|Adverse Event|18
2936889|NCT01416181|10111739|P1|Part 1|Adverse Event|15
2936890|NCT01416181|10111738|P2|Part 1|Lost to Follow-up|1
2936891|NCT01416181|10111739|P1|Part 1|Lost to Follow-up|1
2936892|NCT01416181|10111738|P2|Part 1|Lack of Efficacy|8
2936893|NCT01416181|10111739|P1|Part 1|Lack of Efficacy|16
2936894|NCT01416181|10111738|P2|Part 1|Withdrawal by Subject|48
2936895|NCT01416181|10111739|P1|Part 1|Withdrawal by Subject|74
2936896|NCT01416181|10111738|P2|Part 1|Investigator Decision|6
2936897|NCT01416181|10111739|P1|Part 1|Investigator Decision|7
2936898|NCT01416181|10111738|P2|Part 1|Death|1
2936899|NCT01416181|10111739|P1|Part 1|Death|0
2936900|NCT01416181|10111738|P2|Part 1|Other|24
2936901|NCT01416181|10111739|P1|Part 1|Other|10
2936902|NCT01416155|10111801|P1|Overall Study|Other|7
2936903|NCT01416155|10111801|P1|Overall Study|Investigator decision|8
2936904|NCT01416155|10111801|P1|Overall Study|Withdrawal by Subject|33
2936905|NCT01416155|10111801|P1|Overall Study|Positive for anti-BG00002 antibodies|2
2936906|NCT01416155|10111801|P1|Overall Study|Adverse Event|8
2936907|NCT01416142|10111808|P3|PureVision2 HD|Inability to maintain lens wear|1
2936908|NCT01416142|10111809|P2|PureVision2 HD|Inability to maintain lens wear|0
2936909|NCT01416142|10111810|P1|PureVision2 HD|Inability to maintain lens wear|0
2936910|NCT01415986|10111837|P1|Overall Study|Lost to Follow-up|1
2936911|NCT01415921|10111863|P2|Overall Study|Other|0
2936912|NCT01415921|10111864|P1|Overall Study|Other|2
2936913|NCT01415921|10111863|P2|Overall Study|Withdrawal by Subject|1
2936914|NCT01415921|10111864|P1|Overall Study|Withdrawal by Subject|0
2936915|NCT01415921|10111863|P2|Overall Study|Physician Decision|1
2936916|NCT01415921|10111864|P1|Overall Study|Physician Decision|1
2936917|NCT01415921|10111863|P2|Overall Study|Adverse Event|1
2936918|NCT01415921|10111864|P1|Overall Study|Adverse Event|0
2936919|NCT01415908|10111874|P2|Overall Study|Withdrawal by Subject|0
2936920|NCT01415908|10111875|P1|Overall Study|Withdrawal by Subject|1
2936921|NCT01415531|10111912|P2|Overall Study|Other Reasons|2
2936922|NCT01415531|10111913|P1|Overall Study|Other Reasons|3
2936923|NCT01415531|10111912|P2|Overall Study|Lack of Compliance|4
2936924|NCT01415531|10111913|P1|Overall Study|Lack of Compliance|1
2936925|NCT01415531|10111912|P2|Overall Study|Lost to Follow-up|14
2936926|NCT01415531|10111913|P1|Overall Study|Lost to Follow-up|6
2936927|NCT01415531|10111912|P2|Overall Study|Withdrawal by Subject|4
2936928|NCT01415531|10111913|P1|Overall Study|Withdrawal by Subject|5
2936929|NCT01415531|10111912|P2|Overall Study|Protocol Violation|1
2936930|NCT01415531|10111913|P1|Overall Study|Protocol Violation|0
2936931|NCT01415531|10111912|P2|Overall Study|Lack of Efficacy|2
2936932|NCT01415531|10111913|P1|Overall Study|Lack of Efficacy|3
2936933|NCT01415531|10111912|P2|Overall Study|Adverse Event|10
2936934|NCT01415531|10111913|P1|Overall Study|Adverse Event|7
2936935|NCT01415518|10111923|P2|Overall Study|Condition under Investigation Worsened|1
2936936|NCT01415518|10111924|P1|Overall Study|Condition under Investigation Worsened|1
2936937|NCT01415518|10111923|P2|Overall Study|Death|1
2936938|NCT01415518|10111924|P1|Overall Study|Death|1
2936939|NCT01415518|10111923|P2|Overall Study|Adverse Event|4
2936940|NCT01415518|10111924|P1|Overall Study|Adverse Event|3
2936941|NCT01415518|10111923|P2|Overall Study|Lost to Follow-up|5
2936942|NCT01415518|10111924|P1|Overall Study|Lost to Follow-up|3
2936943|NCT01415518|10111923|P2|Overall Study|Protocol Violation|8
2936944|NCT01415518|10111924|P1|Overall Study|Protocol Violation|6
2936945|NCT01415518|10111923|P2|Overall Study|Withdrawal by Subject|12
2936946|NCT01415518|10111924|P1|Overall Study|Withdrawal by Subject|2
2936947|NCT01415440|10111983|P3|Overall Study|Withdrawal by Subject|0
2936948|NCT01415440|10111984|P2|Overall Study|Withdrawal by Subject|0
2936949|NCT01415440|10111985|P1|Overall Study|Withdrawal by Subject|1
2936950|NCT01415440|10111983|P3|Overall Study|Physician Decision|0
2936951|NCT01415440|10111984|P2|Overall Study|Physician Decision|0
2936952|NCT01415440|10111985|P1|Overall Study|Physician Decision|3
2936953|NCT01415440|10111983|P3|Overall Study|Lost to Follow-up|2
2936954|NCT01415440|10111984|P2|Overall Study|Lost to Follow-up|1
2936955|NCT01415440|10111985|P1|Overall Study|Lost to Follow-up|0
2936956|NCT01415401|10112036|P1|Overall Study|Terminated by Sponsor|1
2936957|NCT01415401|10112036|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
2936958|NCT01415401|10112036|P1|Overall Study|Adverse Event|5
2936959|NCT01415349|10112041|P2|Treatment Period 1|Withdrawal by Subject|1
2936960|NCT01415349|10112042|P1|Treatment Period 1|Withdrawal by Subject|0
2936961|NCT01415349|10112041|P2|Treatment Period 1|Adverse Event|1
2936962|NCT01415349|10112042|P1|Treatment Period 1|Adverse Event|0
2936963|NCT01414855|10112054|P1|Overall Study|Withdrawal by Subject|7
2936964|NCT01414855|10112054|P1|Overall Study|Lost to Follow-up|5
2936965|NCT01414855|10112054|P1|Overall Study|Death|17
2936966|NCT01414257|10112103|P1|Overall Study|Protocol Violation|10
2936967|NCT01414257|10112103|P1|Overall Study|No Visit After First Day of Treatment|12
2936968|NCT01414205|10112131|P2|Overall Study|Randomized but not Treated|1
2936969|NCT01414205|10112132|P1|Overall Study|Randomized but not Treated|1
2936970|NCT01414205|10112131|P2|Overall Study|Physician Decision|1
2936971|NCT01414205|10112132|P1|Overall Study|Physician Decision|0
2936972|NCT01414205|10112131|P2|Overall Study|Lost to Follow-up|4
2936973|NCT01414205|10112132|P1|Overall Study|Lost to Follow-up|1
2936974|NCT01414205|10112131|P2|Overall Study|Death|1
2936975|NCT01414205|10112132|P1|Overall Study|Death|5
2936976|NCT01414166|10112201|P2|Overall Study|Withdrawal by Subject|5
2936977|NCT01414166|10112202|P1|Overall Study|Withdrawal by Subject|3
2936978|NCT01414166|10112201|P2|Overall Study|Study terminated by Sponsor|75
2936979|NCT01414166|10112202|P1|Overall Study|Study terminated by Sponsor|68
2936980|NCT01414166|10112201|P2|Overall Study|Protocol Violation|0
2936981|NCT01414166|10112202|P1|Overall Study|Protocol Violation|2
2936982|NCT01414166|10112201|P2|Overall Study|Physician Decision|0
2936983|NCT01414166|10112202|P1|Overall Study|Physician Decision|2
2936984|NCT01414166|10112201|P2|Overall Study|Non-compliance with study drug|0
2936985|NCT01414166|10112202|P1|Overall Study|Non-compliance with study drug|2
2936986|NCT01414166|10112201|P2|Overall Study|Lost to Follow-up|1
2936987|NCT01414166|10112202|P1|Overall Study|Lost to Follow-up|4
2936988|NCT01414166|10112201|P2|Overall Study|Adverse Event|2
2936989|NCT01414166|10112202|P1|Overall Study|Adverse Event|10
2936990|NCT01414114|10112265|P1|Overall Study|Other|2
2936991|NCT01414114|10112265|P1|Overall Study|Withdrawal by Subject|1
2936992|NCT01414114|10112265|P1|Overall Study|Adverse Event|2
2936993|NCT01413958|10112321|P2|Overall Study|Lost to Follow-up|1
2936994|NCT01413958|10112322|P1|Overall Study|Lost to Follow-up|0
2936995|NCT01413542|10112373|P4|Overall Study|Adverse Event|1
2936996|NCT01413542|10112374|P3|Overall Study|Adverse Event|0
2936997|NCT01413542|10112375|P2|Overall Study|Adverse Event|0
2936998|NCT01413542|10112376|P1|Overall Study|Adverse Event|0
2936999|NCT01413542|10112373|P4|Overall Study|Physician Decision|0
2937000|NCT01413542|10112374|P3|Overall Study|Physician Decision|3
2937001|NCT01413542|10112375|P2|Overall Study|Physician Decision|0
2937002|NCT01413542|10112376|P1|Overall Study|Physician Decision|1
2937003|NCT01413503|10112398|P1|Overall Study|Lost to Follow-up|1
2937004|NCT01413360|10112402|P1|Overall Study|Adverse Event|1
2937005|NCT01413360|10112402|P1|Overall Study|Lost to Follow-up|2
2937006|NCT01413204|10112410|P3|Overall Study|Fasting plasma glucose level increased|10
2937007|NCT01413204|10112411|P2|Overall Study|Fasting plasma glucose level increased|0
2937008|NCT01413204|10112412|P1|Overall Study|Fasting plasma glucose level increased|1
2937009|NCT01413204|10112410|P3|Overall Study|Clearly not eligible for the study|1
2937010|NCT01413204|10112411|P2|Overall Study|Clearly not eligible for the study|0
2937011|NCT01413204|10112412|P1|Overall Study|Clearly not eligible for the study|0
2937012|NCT01413204|10112410|P3|Overall Study|Withdrawal by Subject|4
2937013|NCT01413204|10112411|P2|Overall Study|Withdrawal by Subject|4
2937014|NCT01413204|10112412|P1|Overall Study|Withdrawal by Subject|1
2937015|NCT01413204|10112410|P3|Overall Study|Physician Decision|2
2937016|NCT01413204|10112411|P2|Overall Study|Physician Decision|0
2937017|NCT01413204|10112412|P1|Overall Study|Physician Decision|3
2937018|NCT01413204|10112410|P3|Overall Study|Adverse Event|2
2937019|NCT01413204|10112411|P2|Overall Study|Adverse Event|2
2937020|NCT01413204|10112412|P1|Overall Study|Adverse Event|1
2937021|NCT01413191|10112420|P1|Overall Study|Death|1
2937022|NCT01413191|10112420|P1|Overall Study|Disease Progression|5
2937023|NCT01413191|10112420|P1|Overall Study|Lost to Follow-up|5
2937024|NCT01413178|10112432|P2|Overall Study|Ineligible|2
2937025|NCT01413178|10112433|P1|Overall Study|Ineligible|0
2937026|NCT01413178|10112432|P2|Overall Study|Toxicity|0
2937027|NCT01413178|10112433|P1|Overall Study|Toxicity|1
2937028|NCT01412983|10112476|P2|1st Period|Inability to maintain wear|1
2937029|NCT01412983|10112477|P1|1st Period|Inability to maintain wear|0
2937030|NCT01412983|10112476|P2|1st Period|Unacceptable lens movement|1
2937031|NCT01412983|10112477|P1|1st Period|Unacceptable lens movement|0
2937032|NCT01412983|10112476|P2|1st Period|Positive slit lamp finding|1
2937033|NCT01412983|10112477|P1|1st Period|Positive slit lamp finding|0
2937034|NCT01412983|10112476|P2|1st Period|Ineligible|1
2937035|NCT01412983|10112477|P1|1st Period|Ineligible|0
2937036|NCT01412957|10112487|P2|Overall Study|Death|133
2937037|NCT01412957|10112488|P1|Overall Study|Death|136
2937038|NCT01412957|10112487|P2|Overall Study|Lost to Follow-up|2
2937039|NCT01412957|10112488|P1|Overall Study|Lost to Follow-up|7
2937040|NCT01412957|10112487|P2|Overall Study|Withdrawal by Subject|22
2937041|NCT01412957|10112488|P1|Overall Study|Withdrawal by Subject|6
2937042|NCT01412944|10112510|P6|Entire: IV + Maintenance|Adverse Event|0
2937043|NCT01412944|10112511|P5|Entire: IV + Maintenance|Adverse Event|0
2937044|NCT01412944|10112512|P4|Entire: IV + Maintenance|Adverse Event|0
2937045|NCT01412944|10112513|P3|Entire: IV + Maintenance|Adverse Event|0
2937046|NCT01412944|10112514|P2|Entire: IV + Maintenance|Adverse Event|1
2937047|NCT01412944|10112515|P1|Entire: IV + Maintenance|Adverse Event|0
2937048|NCT01412944|10112510|P6|Entire: IV + Maintenance|Lack of Efficacy|0
2937049|NCT01412944|10112511|P5|Entire: IV + Maintenance|Lack of Efficacy|0
2937050|NCT01412944|10112512|P4|Entire: IV + Maintenance|Lack of Efficacy|0
2937051|NCT01412944|10112513|P3|Entire: IV + Maintenance|Lack of Efficacy|0
2937052|NCT01412944|10112514|P2|Entire: IV + Maintenance|Lack of Efficacy|1
2937053|NCT01412944|10112515|P1|Entire: IV + Maintenance|Lack of Efficacy|0
2937054|NCT01412944|10112510|P6|Entire: IV + Maintenance|Lost to Follow-up|0
2937055|NCT01412944|10112511|P5|Entire: IV + Maintenance|Lost to Follow-up|0
2937056|NCT01412944|10112512|P4|Entire: IV + Maintenance|Lost to Follow-up|0
2937057|NCT01412944|10112513|P3|Entire: IV + Maintenance|Lost to Follow-up|0
2937058|NCT01412944|10112514|P2|Entire: IV + Maintenance|Lost to Follow-up|1
2937059|NCT01412944|10112515|P1|Entire: IV + Maintenance|Lost to Follow-up|0
2937060|NCT01412944|10112510|P6|Entire: IV + Maintenance|Protocol deviation|0
2937061|NCT01412944|10112511|P5|Entire: IV + Maintenance|Protocol deviation|0
2937062|NCT01412944|10112512|P4|Entire: IV + Maintenance|Protocol deviation|0
2937063|NCT01412944|10112513|P3|Entire: IV + Maintenance|Protocol deviation|0
2937064|NCT01412944|10112514|P2|Entire: IV + Maintenance|Protocol deviation|1
2937065|NCT01412944|10112515|P1|Entire: IV + Maintenance|Protocol deviation|0
2937066|NCT01412944|10112510|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
2937067|NCT01412944|10112511|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
2937068|NCT01412944|10112512|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
2937069|NCT01412944|10112513|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
2937070|NCT01412944|10112514|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
2937071|NCT01412944|10112515|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
2937072|NCT01412944|10112510|P6|Entire: IV + Maintenance|Lack of Efficacy|0
2937073|NCT01412944|10112511|P5|Entire: IV + Maintenance|Lack of Efficacy|1
2937074|NCT01412944|10112512|P4|Entire: IV + Maintenance|Lack of Efficacy|0
2937075|NCT01412944|10112513|P3|Entire: IV + Maintenance|Lack of Efficacy|0
2937076|NCT01412944|10112514|P2|Entire: IV + Maintenance|Lack of Efficacy|0
2937077|NCT01412944|10112515|P1|Entire: IV + Maintenance|Lack of Efficacy|0
2937078|NCT01412944|10112510|P6|Entire: IV + Maintenance|Lost to Follow-up|1
2937079|NCT01412944|10112511|P5|Entire: IV + Maintenance|Lost to Follow-up|0
2937080|NCT01412944|10112512|P4|Entire: IV + Maintenance|Lost to Follow-up|0
2937081|NCT01412944|10112513|P3|Entire: IV + Maintenance|Lost to Follow-up|0
2937082|NCT01412944|10112514|P2|Entire: IV + Maintenance|Lost to Follow-up|0
2937083|NCT01412944|10112515|P1|Entire: IV + Maintenance|Lost to Follow-up|0
2937084|NCT01412944|10112510|P6|Entire: IV + Maintenance|Protocol deviation|1
2937085|NCT01412944|10112511|P5|Entire: IV + Maintenance|Protocol deviation|0
2937086|NCT01412944|10112512|P4|Entire: IV + Maintenance|Protocol deviation|0
2937087|NCT01412944|10112513|P3|Entire: IV + Maintenance|Protocol deviation|0
2937088|NCT01412944|10112514|P2|Entire: IV + Maintenance|Protocol deviation|0
2937089|NCT01412944|10112515|P1|Entire: IV + Maintenance|Protocol deviation|0
2937090|NCT01412944|10112510|P6|Entire: IV + Maintenance|Adverse Event|0
2937091|NCT01412944|10112511|P5|Entire: IV + Maintenance|Adverse Event|1
2937092|NCT01412944|10112512|P4|Entire: IV + Maintenance|Adverse Event|0
2937093|NCT01412944|10112513|P3|Entire: IV + Maintenance|Adverse Event|0
2937094|NCT01412944|10112514|P2|Entire: IV + Maintenance|Adverse Event|0
2937095|NCT01412944|10112515|P1|Entire: IV + Maintenance|Adverse Event|0
2937096|NCT01412944|10112510|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
2937097|NCT01412944|10112511|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
2937098|NCT01412944|10112512|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
2937099|NCT01412944|10112513|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
2937100|NCT01412944|10112514|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
2937101|NCT01412944|10112515|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
2937102|NCT01412944|10112510|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
2937103|NCT01412944|10112511|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
2937104|NCT01412944|10112512|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
2937105|NCT01412944|10112513|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
2937106|NCT01412944|10112514|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
2937107|NCT01412944|10112515|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
2937108|NCT01412944|10112510|P6|IV: Per CAIN457A2307|Protocol deviation|0
2937109|NCT01412944|10112511|P5|IV: Per CAIN457A2307|Protocol deviation|0
2937110|NCT01412944|10112512|P4|IV: Per CAIN457A2307|Protocol deviation|0
2937111|NCT01412944|10112513|P3|IV: Per CAIN457A2307|Protocol deviation|0
2937112|NCT01412944|10112514|P2|IV: Per CAIN457A2307|Protocol deviation|1
2937113|NCT01412944|10112515|P1|IV: Per CAIN457A2307|Protocol deviation|0
2937114|NCT01412944|10112510|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
2937115|NCT01412944|10112511|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
2937116|NCT01412944|10112512|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
2937117|NCT01412944|10112513|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
2937118|NCT01412944|10112514|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
2937119|NCT01412944|10112515|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
2937120|NCT01412944|10112510|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
2937121|NCT01412944|10112511|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2937122|NCT01412944|10112512|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2937123|NCT01412944|10112513|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2937124|NCT01412944|10112514|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2937125|NCT01412944|10112515|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2937126|NCT01412944|10112510|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
2937127|NCT01412944|10112511|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2937128|NCT01412944|10112512|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2937129|NCT01412944|10112513|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2937130|NCT01412944|10112514|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2937131|NCT01412944|10112515|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2937132|NCT01412944|10112510|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2937133|NCT01412944|10112511|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2937134|NCT01412944|10112512|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2937135|NCT01412944|10112513|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
2937136|NCT01412944|10112514|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2937137|NCT01412944|10112515|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2937138|NCT01412879|10112561|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
2937139|NCT01412879|10112562|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
2937140|NCT01412879|10112563|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
2937141|NCT01412879|10112561|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
2937142|NCT01412879|10112562|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
2937143|NCT01412879|10112563|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
2937144|NCT01412879|10112561|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
2937145|NCT01412879|10112562|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
2937146|NCT01412879|10112563|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
2937147|NCT01412879|10112561|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
2937148|NCT01412879|10112562|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
2937149|NCT01412879|10112563|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
2937150|NCT01412879|10112561|P3|Initial Registration (Induction Therapy)|Adverse Event|0
2937151|NCT01412879|10112562|P2|Initial Registration (Induction Therapy)|Adverse Event|3
2937152|NCT01412879|10112563|P1|Initial Registration (Induction Therapy)|Adverse Event|5
2937153|NCT01412801|10112592|P6|Overall Study|Relocated to another area|0
2937154|NCT01412801|10112593|P5|Overall Study|Relocated to another area|0
2937155|NCT01412801|10112594|P4|Overall Study|Relocated to another area|0
2937156|NCT01412801|10112595|P3|Overall Study|Relocated to another area|2
2937157|NCT01412801|10112596|P2|Overall Study|Relocated to another area|0
2937158|NCT01412801|10112597|P1|Overall Study|Relocated to another area|0
2937159|NCT01412801|10112592|P6|Overall Study|Withdrawal by Subject|0
2937160|NCT01412801|10112593|P5|Overall Study|Withdrawal by Subject|0
2937161|NCT01412801|10112594|P4|Overall Study|Withdrawal by Subject|0
2937162|NCT01412801|10112595|P3|Overall Study|Withdrawal by Subject|1
2937163|NCT01412801|10112596|P2|Overall Study|Withdrawal by Subject|2
2937164|NCT01412801|10112597|P1|Overall Study|Withdrawal by Subject|3
2937165|NCT01412801|10112592|P6|Overall Study|Lost to Follow-up|1
2937166|NCT01412801|10112593|P5|Overall Study|Lost to Follow-up|1
2937167|NCT01412801|10112594|P4|Overall Study|Lost to Follow-up|0
2937168|NCT01412801|10112595|P3|Overall Study|Lost to Follow-up|4
2937169|NCT01412801|10112596|P2|Overall Study|Lost to Follow-up|2
2937170|NCT01412801|10112597|P1|Overall Study|Lost to Follow-up|1
2937171|NCT01412801|10112592|P6|Overall Study|Death|2
2937172|NCT01412801|10112593|P5|Overall Study|Death|2
2937173|NCT01412801|10112594|P4|Overall Study|Death|4
2937174|NCT01412801|10112595|P3|Overall Study|Death|0
2937175|NCT01412801|10112596|P2|Overall Study|Death|1
2937176|NCT01412801|10112597|P1|Overall Study|Death|0
2937177|NCT01412424|10112692|P1|Extension Treatment Period|Patient Request|2
2937178|NCT01412424|10112692|P1|Extension Treatment Period|Treatment Failure|2
2937179|NCT01412424|10112692|P1|Extension Treatment Period|Adverse Event|2
2937180|NCT01412424|10112692|P1|Core Treatment Period|Sponsor Request|1
2937181|NCT01412424|10112692|P1|Core Treatment Period|Lost to Follow-up|2
2937182|NCT01412424|10112692|P1|Core Treatment Period|Patient Request|5
2937183|NCT01412424|10112692|P1|Core Treatment Period|Adverse Event|21
2937184|NCT01412424|10112692|P1|Core Treatment Period|Treatment Failure|24
2937185|NCT01412333|10112710|P2|Overall Study|Lost to Follow-up|6
2937186|NCT01412333|10112711|P1|Overall Study|Lost to Follow-up|10
2937187|NCT01412333|10112710|P2|Overall Study|Adverse Event|16
2937188|NCT01412333|10112711|P1|Overall Study|Adverse Event|25
2937189|NCT01412333|10112710|P2|Overall Study|Consent withdrawn by participant|12
2937190|NCT01412333|10112711|P1|Overall Study|Consent withdrawn by participant|25
2937191|NCT01412333|10112710|P2|Overall Study|Pregnancy|0
2937192|NCT01412333|10112711|P1|Overall Study|Pregnancy|3
2937193|NCT01412333|10112710|P2|Overall Study|Lack of Efficacy|6
2937194|NCT01412333|10112711|P1|Overall Study|Lack of Efficacy|15
2937195|NCT01412333|10112710|P2|Overall Study|Non-compliance|3
2937196|NCT01412333|10112711|P1|Overall Study|Non-compliance|1
2937197|NCT01412333|10112710|P2|Overall Study|Protocol Violation|1
2937198|NCT01412333|10112711|P1|Overall Study|Protocol Violation|1
2937199|NCT01412333|10112710|P2|Overall Study|Non-compliance with study drug|1
2937200|NCT01412333|10112711|P1|Overall Study|Non-compliance with study drug|1
2937201|NCT01412333|10112710|P2|Overall Study|Reason not specified|10
2937202|NCT01412333|10112711|P1|Overall Study|Reason not specified|16
2937203|NCT01412333|10112710|P2|Overall Study|Physician Decision|1
2937204|NCT01412333|10112711|P1|Overall Study|Physician Decision|0
2937205|NCT01412333|10112710|P2|Overall Study|Death|1
2937206|NCT01412333|10112711|P1|Overall Study|Death|1
2937207|NCT01412229|10112771|P1|Overall Study|Physician Decision|1
2937208|NCT01412151|10112794|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
2937209|NCT01412151|10112794|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
2937210|NCT01412151|10112794|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
2937211|NCT01412151|10112794|P1|Week 0 - 306 - Treatment Period|Death|1
2937212|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Relapse|25
2937213|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Relapse|47
2937214|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Relapse|0
2937215|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
2937216|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
2937217|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
2937218|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
2937219|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
2937220|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
2937221|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
2937222|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
2937223|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
2937224|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
2937225|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
2937226|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
2937227|NCT01412060|10112805|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
2937228|NCT01412060|10112806|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
2937229|NCT01412060|10112807|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
2937230|NCT01412060|10112805|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
2937231|NCT01412060|10112806|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
2937232|NCT01412060|10112807|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
2937233|NCT01412060|10112805|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2937234|NCT01412060|10112806|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2937235|NCT01412060|10112807|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
2937236|NCT01412060|10112805|P3|Period Between SP and DBP|Lost to Follow-up|0
2937237|NCT01412060|10112806|P2|Period Between SP and DBP|Lost to Follow-up|0
2937238|NCT01412060|10112807|P1|Period Between SP and DBP|Lost to Follow-up|1
2937239|NCT01412060|10112805|P3|Period Between SP and DBP|Withdrawal of Consent|0
2937240|NCT01412060|10112806|P2|Period Between SP and DBP|Withdrawal of Consent|0
2937241|NCT01412060|10112807|P1|Period Between SP and DBP|Withdrawal of Consent|2
2937242|NCT01412060|10112805|P3|Period Between SP and DBP|Protocol Violation|0
2937243|NCT01412060|10112806|P2|Period Between SP and DBP|Protocol Violation|0
2937244|NCT01412060|10112807|P1|Period Between SP and DBP|Protocol Violation|2
2937245|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2937246|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2937247|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
2937248|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2937249|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2937250|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
2937251|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2937252|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2937253|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
2937254|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
2937255|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
2937256|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
2937257|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2937258|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2937259|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
2937260|NCT01412060|10112805|P3|Open-label Stabilization Period (SP)|Adverse Event|0
2937261|NCT01412060|10112806|P2|Open-label Stabilization Period (SP)|Adverse Event|0
2937262|NCT01412060|10112807|P1|Open-label Stabilization Period (SP)|Adverse Event|9
2937263|NCT01412060|10112805|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
2937264|NCT01412060|10112806|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
2937265|NCT01412060|10112807|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
2937266|NCT01412060|10112805|P3|Period Between RIP and SP|Lost to Follow-up|0
2937267|NCT01412060|10112806|P2|Period Between RIP and SP|Lost to Follow-up|0
2937268|NCT01412060|10112807|P1|Period Between RIP and SP|Lost to Follow-up|5
2937269|NCT01412060|10112805|P3|Period Between RIP and SP|Withdrawal of Consent|0
2937270|NCT01412060|10112806|P2|Period Between RIP and SP|Withdrawal of Consent|0
2937271|NCT01412060|10112807|P1|Period Between RIP and SP|Withdrawal of Consent|1
2937272|NCT01412060|10112805|P3|Period Between RIP and SP|Protocol Violation|0
2937273|NCT01412060|10112806|P2|Period Between RIP and SP|Protocol Violation|0
2937274|NCT01412060|10112807|P1|Period Between RIP and SP|Protocol Violation|2
2937275|NCT01412060|10112805|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
2937276|NCT01412060|10112806|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
2937277|NCT01412060|10112807|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
2937278|NCT01412060|10112805|P3|Period Between RIP and SP|Adverse Event|0
2937279|NCT01412060|10112806|P2|Period Between RIP and SP|Adverse Event|0
2937280|NCT01412060|10112807|P1|Period Between RIP and SP|Adverse Event|4
2937281|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2937282|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2937283|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
2937284|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2937285|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2937286|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
2937287|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2937288|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2937289|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
2937290|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
2937291|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
2937292|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
2937293|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2937294|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2937295|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
2937296|NCT01412060|10112805|P3|Open-label Run-in Period (RIP)|Adverse Event|0
2937297|NCT01412060|10112806|P2|Open-label Run-in Period (RIP)|Adverse Event|0
2937298|NCT01412060|10112807|P1|Open-label Run-in Period (RIP)|Adverse Event|86
2937299|NCT01412021|10112817|P1|Overall Study|Transferred to Other Hospital|9
2937300|NCT01412021|10112817|P1|Overall Study|Treatment Prior to Approval|3
2937301|NCT01412021|10112817|P1|Overall Study|Case Report Forms Not Retrieved|7
2937302|NCT01411995|10112854|P2|Overall Study|Failed IUD insertion|1
2937303|NCT01411995|10112855|P1|Overall Study|Failed IUD insertion|0
2937304|NCT01411917|10112863|P2|Overall Study|Patient did not undergo scheduled surger|1
2937305|NCT01411917|10112864|P1|Overall Study|Patient did not undergo scheduled surger|0
2937306|NCT01411891|10112886|P2|Overall Study|Catheter dislodgement or loss to follow-|2
2937307|NCT01411891|10112887|P1|Overall Study|Catheter dislodgement or loss to follow-|3
2937308|NCT01411852|10112897|P2|Hospital Intervention Phase|Vascular access failed|0
2937309|NCT01411852|10112898|P1|Hospital Intervention Phase|Vascular access failed|1
2937310|NCT01411852|10112897|P2|Hospital Intervention Phase|Withdrawal by Subject|0
2937311|NCT01411852|10112898|P1|Hospital Intervention Phase|Withdrawal by Subject|1
2937312|NCT01411852|10112897|P2|Hospital Intervention Phase|Spinal cord injury|0
2937313|NCT01411852|10112898|P1|Hospital Intervention Phase|Spinal cord injury|2
2937314|NCT01411852|10112897|P2|Hospital Intervention Phase|Other ineligible|2
2937315|NCT01411852|10112898|P1|Hospital Intervention Phase|Other ineligible|2
2937316|NCT01411852|10112897|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
2937317|NCT01411852|10112898|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
2937318|NCT01411852|10112897|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
2937319|NCT01411852|10112898|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
2937320|NCT01411852|10112897|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
2937321|NCT01411852|10112898|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
2937322|NCT01411852|10112897|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
2937323|NCT01411852|10112898|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
2937324|NCT01411852|10112897|P2|Hospital Intervention Phase|CPR administered|1
2937325|NCT01411852|10112898|P1|Hospital Intervention Phase|CPR administered|3
2937326|NCT01411852|10112897|P2|Hospital Intervention Phase|Miscommunication error|2
2937327|NCT01411852|10112898|P1|Hospital Intervention Phase|Miscommunication error|1
2937328|NCT01411852|10112897|P2|Hospital Intervention Phase|No qualifying SBP|1
2937329|NCT01411852|10112898|P1|Hospital Intervention Phase|No qualifying SBP|5
2937330|NCT01411852|10112897|P2|Hospital Intervention Phase|Severe head injury|4
2937331|NCT01411852|10112898|P1|Hospital Intervention Phase|Severe head injury|5
2937332|NCT01411852|10112897|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
2937333|NCT01411852|10112898|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
2937334|NCT01411852|10112897|P2|Prehospital Intervention Phase|Found to be under age|1
2937335|NCT01411852|10112898|P1|Prehospital Intervention Phase|Found to be under age|0
2937336|NCT01411852|10112897|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2937337|NCT01411852|10112898|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2937338|NCT01411852|10112897|P2|Prehospital Intervention Phase|No qualifying SBP|4
2937339|NCT01411852|10112898|P1|Prehospital Intervention Phase|No qualifying SBP|5
2937340|NCT01411839|10112943|P2|Overall Study|Lost to Follow-up|3
2937341|NCT01411839|10112944|P1|Overall Study|Lost to Follow-up|4
2937342|NCT01411774|10112956|P2|Overall Study|Withdrawal by Subject|3
2937343|NCT01411774|10112957|P1|Overall Study|Withdrawal by Subject|0
2937344|NCT01411241|10113072|P2|Overall Study|Lost to Follow-up|4
2937345|NCT01411241|10113073|P1|Overall Study|Lost to Follow-up|2
2937346|NCT01411241|10113072|P2|Overall Study|Serious Adverse Event|3
2937347|NCT01411241|10113073|P1|Overall Study|Serious Adverse Event|0
2937348|NCT01411241|10113072|P2|Overall Study|Withdrawal by Subject|10
2937349|NCT01411241|10113073|P1|Overall Study|Withdrawal by Subject|9
2937350|NCT01411241|10113072|P2|Overall Study|Protocol Violation|5
2937351|NCT01411241|10113073|P1|Overall Study|Protocol Violation|0
2937352|NCT01411228|10113098|P3|Overall Study|Withdrawal by Subject|0
2937353|NCT01411228|10113099|P2|Overall Study|Withdrawal by Subject|0
2937354|NCT01411228|10113100|P1|Overall Study|Withdrawal by Subject|1
2937355|NCT01411228|10113098|P3|Overall Study|Lost to Follow-up|1
2937356|NCT01411228|10113099|P2|Overall Study|Lost to Follow-up|0
2937357|NCT01411228|10113100|P1|Overall Study|Lost to Follow-up|0
2937358|NCT01411215|10113122|P2|Overall Study|Screen failure|1
2937359|NCT01411215|10113123|P1|Overall Study|Screen failure|0
2937360|NCT01411215|10113122|P2|Overall Study|Other|17
2937361|NCT01411215|10113123|P1|Overall Study|Other|12
2937362|NCT01411215|10113122|P2|Overall Study|Withdrawal by Subject|21
2937363|NCT01411215|10113123|P1|Overall Study|Withdrawal by Subject|34
2937364|NCT01411215|10113122|P2|Overall Study|Protocol Violation|5
2937365|NCT01411215|10113123|P1|Overall Study|Protocol Violation|3
2937366|NCT01411215|10113122|P2|Overall Study|Study terminated by sponsor|15
2937367|NCT01411215|10113123|P1|Overall Study|Study terminated by sponsor|2
2937368|NCT01411215|10113122|P2|Overall Study|Did not meet entrance criteria|1
2937369|NCT01411215|10113123|P1|Overall Study|Did not meet entrance criteria|0
2937370|NCT01411215|10113122|P2|Overall Study|Lost to Follow-up|18
2937371|NCT01411215|10113123|P1|Overall Study|Lost to Follow-up|12
2937372|NCT01411215|10113122|P2|Overall Study|Lack of Efficacy|4
2937373|NCT01411215|10113123|P1|Overall Study|Lack of Efficacy|2
2937374|NCT01411215|10113122|P2|Overall Study|Adverse Event|2
2937375|NCT01411215|10113123|P1|Overall Study|Adverse Event|1
2937376|NCT01411085|10113175|P1|Overall Study|Adverse Event|1
2937377|NCT01411085|10113175|P1|Overall Study|Protocol Violation|1
2937378|NCT01411085|10113175|P1|Overall Study|Physician Decision|1
2937379|NCT01410799|10113195|P1|Overall Study|PI decision|13
2937380|NCT01410604|10113211|P2|Overall Study|Physician Decision|1
2937381|NCT01410604|10113212|P1|Overall Study|Physician Decision|0
2937382|NCT01410604|10113211|P2|Overall Study|Lost to Follow-up|0
2937383|NCT01410604|10113212|P1|Overall Study|Lost to Follow-up|1
2937384|NCT01410604|10113211|P2|Overall Study|Adverse Event|1
2937385|NCT01410604|10113212|P1|Overall Study|Adverse Event|2
2937386|NCT01410474|10113253|P2|Overall Study|Withdrawal by Subject|1
2937387|NCT01410474|10113254|P1|Overall Study|Withdrawal by Subject|0
2937388|NCT01410448|10113277|P2|Overall Study|Death|3
2937389|NCT01410448|10113278|P1|Overall Study|Death|2
2937390|NCT01410448|10113277|P2|Overall Study|Protocol Violation|4
2937391|NCT01410448|10113278|P1|Overall Study|Protocol Violation|0
2937392|NCT01410448|10113277|P2|Overall Study|Withdrawal by Subject|2
2937393|NCT01410448|10113278|P1|Overall Study|Withdrawal by Subject|3
2937394|NCT01410448|10113277|P2|Overall Study|Lost to Follow-up|0
2937395|NCT01410448|10113278|P1|Overall Study|Lost to Follow-up|1
2937396|NCT01410448|10113277|P2|Overall Study|Administrative issues|1
2937397|NCT01410448|10113278|P1|Overall Study|Administrative issues|2
2937398|NCT01410448|10113277|P2|Overall Study|Graft loss|1
2937399|NCT01410448|10113278|P1|Overall Study|Graft loss|4
2937400|NCT01410448|10113277|P2|Overall Study|No conversion to everolimus|24
2937401|NCT01410448|10113278|P1|Overall Study|No conversion to everolimus|0
2937402|NCT01410357|10113343|P2|Overall Study|Lost to Follow-up|21
2937403|NCT01410357|10113344|P1|Overall Study|Lost to Follow-up|23
2937404|NCT01410357|10113343|P2|Overall Study|Withdrawal by Subject|2
2937405|NCT01410357|10113344|P1|Overall Study|Withdrawal by Subject|1
2937406|NCT01410357|10113343|P2|Overall Study|Death|1
2937407|NCT01410357|10113344|P1|Overall Study|Death|2
2937408|NCT01410240|10113415|P3|Overall Study|Missed week 6 assessments|1
2937409|NCT01410240|10113416|P2|Overall Study|Missed week 6 assessments|1
2937410|NCT01410240|10113417|P1|Overall Study|Missed week 6 assessments|1
2937411|NCT01410240|10113415|P3|Overall Study|Physician Decision|1
2937412|NCT01410240|10113416|P2|Overall Study|Physician Decision|0
2937413|NCT01410240|10113417|P1|Overall Study|Physician Decision|0
2937414|NCT01410227|10113488|P4|Overall Study|Met Excl. Criteria After Starting Study|0
2937415|NCT01410227|10113489|P3|Overall Study|Met Excl. Criteria After Starting Study|1
2937416|NCT01410227|10113490|P2|Overall Study|Met Excl. Criteria After Starting Study|0
2937417|NCT01410227|10113491|P1|Overall Study|Met Excl. Criteria After Starting Study|0
2937418|NCT01410227|10113488|P4|Overall Study|Pregnancy|1
2937419|NCT01410227|10113489|P3|Overall Study|Pregnancy|0
2937420|NCT01410227|10113490|P2|Overall Study|Pregnancy|0
2937421|NCT01410227|10113491|P1|Overall Study|Pregnancy|0
2937422|NCT01410227|10113488|P4|Overall Study|Withdrawal by Subject|0
2937423|NCT01410227|10113489|P3|Overall Study|Withdrawal by Subject|1
2937424|NCT01410227|10113490|P2|Overall Study|Withdrawal by Subject|0
2937425|NCT01410227|10113491|P1|Overall Study|Withdrawal by Subject|3
2937426|NCT01410227|10113488|P4|Overall Study|Adverse Event|0
2937427|NCT01410227|10113489|P3|Overall Study|Adverse Event|0
2937428|NCT01410227|10113490|P2|Overall Study|Adverse Event|0
2937429|NCT01410227|10113491|P1|Overall Study|Adverse Event|1
2937430|NCT01410110|10113563|P2|Overall Study|Withdrawal by Subject|2
2937431|NCT01410110|10113564|P1|Overall Study|Withdrawal by Subject|4
2937432|NCT01409993|10113639|P4|Overall Study|Lost to Follow-up|0
2937433|NCT01409993|10113640|P3|Overall Study|Lost to Follow-up|0
2937434|NCT01409993|10113641|P2|Overall Study|Lost to Follow-up|1
2937435|NCT01409993|10113642|P1|Overall Study|Lost to Follow-up|0
2937436|NCT01409993|10113639|P4|Overall Study|Withdrawal by Subject|4
2937437|NCT01409993|10113640|P3|Overall Study|Withdrawal by Subject|0
2937438|NCT01409993|10113641|P2|Overall Study|Withdrawal by Subject|0
2937439|NCT01409993|10113642|P1|Overall Study|Withdrawal by Subject|0
2937440|NCT01409993|10113639|P4|Overall Study|Adverse Event|1
2937441|NCT01409993|10113640|P3|Overall Study|Adverse Event|3
2937442|NCT01409993|10113641|P2|Overall Study|Adverse Event|4
2937443|NCT01409993|10113642|P1|Overall Study|Adverse Event|4
2937444|NCT01409928|10113660|P1|Overall Study|Physician Decision|12
2937445|NCT01409837|10113666|P2|Overall Study|Physician Decision|1
2937446|NCT01409837|10113667|P1|Overall Study|Physician Decision|0
2937447|NCT01409837|10113666|P2|Overall Study|Lost to Follow-up|0
2937448|NCT01409837|10113667|P1|Overall Study|Lost to Follow-up|1
2937449|NCT01409837|10113666|P2|Overall Study|Withdrawal by Subject|1
2937450|NCT01409837|10113667|P1|Overall Study|Withdrawal by Subject|2
2937451|NCT01409811|10113689|P1|Overall Study|Insurance denial|1
2937452|NCT01409707|10113696|P3|Overall Study|Withdrawal by Subject|16
2937453|NCT01409707|10113697|P2|Overall Study|Withdrawal by Subject|17
2937454|NCT01409707|10113698|P1|Overall Study|Withdrawal by Subject|5
2937455|NCT01409564|10113710|P2|Overall Study|brain abnormalities found in T1 MR|2
2937456|NCT01409564|10113711|P1|Overall Study|brain abnormalities found in T1 MR|1
2937457|NCT01409564|10113710|P2|Overall Study|low medication compliance|3
2937458|NCT01409564|10113711|P1|Overall Study|low medication compliance|4
2937459|NCT01409434|10113729|P1|Overall Study|Protocol Violation|4
2937460|NCT01409382|10113739|P2|Overall Study|Had a 2nd trimester loss after accident|0
2937461|NCT01409382|10113740|P1|Overall Study|Had a 2nd trimester loss after accident|1
2937462|NCT01409382|10113739|P2|Overall Study|Did not manage to get pregnant|70
2937463|NCT01409382|10113740|P1|Overall Study|Did not manage to get pregnant|64
2937464|NCT01409382|10113739|P2|Overall Study|Still pregnant when study ended|2
2937465|NCT01409382|10113740|P1|Overall Study|Still pregnant when study ended|13
2937466|NCT01409382|10113739|P2|Overall Study|Multiple pregnancy|4
2937467|NCT01409382|10113740|P1|Overall Study|Multiple pregnancy|2
2937468|NCT01409382|10113739|P2|Overall Study|Protocol Violation|3
2937469|NCT01409382|10113740|P1|Overall Study|Protocol Violation|0
2937470|NCT01409382|10113739|P2|Overall Study|Lost to Follow-up|1
2937471|NCT01409382|10113740|P1|Overall Study|Lost to Follow-up|1
2937472|NCT01409031|10113794|P2|Overall Study|transferred to other hosp|0
2937473|NCT01409031|10113795|P1|Overall Study|transferred to other hosp|1
2937474|NCT01408914|10113826|P3|Overall Study|Change in local TB/HIV norms|1
2937475|NCT01408914|10113827|P2|Overall Study|Change in local TB/HIV norms|1
2937476|NCT01408914|10113828|P1|Overall Study|Change in local TB/HIV norms|0
2937477|NCT01408914|10113826|P3|Overall Study|Late exclusion|3
2937478|NCT01408914|10113827|P2|Overall Study|Late exclusion|3
2937479|NCT01408914|10113828|P1|Overall Study|Late exclusion|0
2937480|NCT01408914|10113826|P3|Overall Study|Moved out of study jurisdiction|0
2937481|NCT01408914|10113827|P2|Overall Study|Moved out of study jurisdiction|1
2937482|NCT01408914|10113828|P1|Overall Study|Moved out of study jurisdiction|1
2937483|NCT01408914|10113826|P3|Overall Study|Withdrawal by Subject|1
2937484|NCT01408914|10113827|P2|Overall Study|Withdrawal by Subject|0
2937485|NCT01408914|10113828|P1|Overall Study|Withdrawal by Subject|1
2937486|NCT01408914|10113826|P3|Overall Study|Physician Decision|0
2937487|NCT01408914|10113827|P2|Overall Study|Physician Decision|1
2937488|NCT01408914|10113828|P1|Overall Study|Physician Decision|1
2937489|NCT01408914|10113826|P3|Overall Study|Lost to Follow-up|2
2937490|NCT01408914|10113827|P2|Overall Study|Lost to Follow-up|1
2937491|NCT01408914|10113828|P1|Overall Study|Lost to Follow-up|4
2937492|NCT01408914|10113826|P3|Overall Study|Could not complete tx in protocol period|6
2937493|NCT01408914|10113827|P2|Overall Study|Could not complete tx in protocol period|5
2937494|NCT01408914|10113828|P1|Overall Study|Could not complete tx in protocol period|5
2937495|NCT01408901|10113846|P4|26-Week Follow-Up|Death|0
2937496|NCT01408901|10113847|P3|26-Week Follow-Up|Death|0
2937497|NCT01408901|10113848|P2|26-Week Follow-Up|Death|1
2937498|NCT01408901|10113849|P1|26-Week Follow-Up|Death|0
2937499|NCT01408901|10113846|P4|26-Week Follow-Up|Lost to Follow-up|1
2937500|NCT01408901|10113847|P3|26-Week Follow-Up|Lost to Follow-up|0
2937501|NCT01408901|10113848|P2|26-Week Follow-Up|Lost to Follow-up|1
2937502|NCT01408901|10113849|P1|26-Week Follow-Up|Lost to Follow-up|1
2937503|NCT01408901|10113846|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
2937504|NCT01408901|10113847|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2937505|NCT01408901|10113848|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
2937506|NCT01408901|10113849|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2937507|NCT01408901|10113846|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
2937508|NCT01408901|10113847|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
2937509|NCT01408901|10113848|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
2937510|NCT01408901|10113849|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
2937511|NCT01408901|10113846|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
2937512|NCT01408901|10113847|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2937513|NCT01408901|10113848|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2937514|NCT01408901|10113849|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2937515|NCT01408901|10113846|P4|6-Week Follow-Up|Cancelled visit|2
2937516|NCT01408901|10113847|P3|6-Week Follow-Up|Cancelled visit|0
2937517|NCT01408901|10113848|P2|6-Week Follow-Up|Cancelled visit|1
2937518|NCT01408901|10113849|P1|6-Week Follow-Up|Cancelled visit|0
2937519|NCT01408901|10113846|P4|6-Week Follow-Up|Death|0
2937520|NCT01408901|10113847|P3|6-Week Follow-Up|Death|0
2937521|NCT01408901|10113848|P2|6-Week Follow-Up|Death|0
2937522|NCT01408901|10113849|P1|6-Week Follow-Up|Death|1
2937523|NCT01408901|10113846|P4|6-Week Follow-Up|Lost to Follow-up|2
2937524|NCT01408901|10113847|P3|6-Week Follow-Up|Lost to Follow-up|3
2937525|NCT01408901|10113848|P2|6-Week Follow-Up|Lost to Follow-up|1
2937526|NCT01408901|10113849|P1|6-Week Follow-Up|Lost to Follow-up|2
2937527|NCT01408888|10113875|P2|Second Intervention|Adverse Event|0
2937528|NCT01408888|10113876|P1|Second Intervention|Adverse Event|1
2937529|NCT01408888|10113875|P2|Second Intervention|Withdrawal by Subject|0
2937530|NCT01408888|10113876|P1|Second Intervention|Withdrawal by Subject|1
2937531|NCT01408888|10113875|P2|First Intervention|Withdrawal by Subject|2
2937532|NCT01408888|10113876|P1|First Intervention|Withdrawal by Subject|0
2937533|NCT01408888|10113875|P2|First Intervention|Adverse Event|1
2937534|NCT01408888|10113876|P1|First Intervention|Adverse Event|0
2937535|NCT01408732|10113904|P2|Overall Study|Withdrawal by Subject|2
2937536|NCT01408732|10113905|P1|Overall Study|Withdrawal by Subject|2
2937537|NCT01408706|10113962|P2|Overall Study|Physician Decision|0
2937538|NCT01408706|10113963|P1|Overall Study|Physician Decision|1
2937539|NCT01408641|10113975|P2|Overall Study|Physician Decision|0
2937540|NCT01408641|10113976|P1|Overall Study|Physician Decision|1
2937541|NCT01408628|10113984|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
2937542|NCT01408628|10113984|P1|Completed 6 Month Follow-Up|Protocol Violation|6
2937543|NCT01408628|10113984|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
2937544|NCT01408628|10113984|P1|Consented|Withdrawal by Subject|12
2937545|NCT01408576|10113993|P3|Overall Study|Other|18
2937546|NCT01408576|10113994|P2|Overall Study|Other|16
2937547|NCT01408576|10113995|P1|Overall Study|Other|10
2937548|NCT01408576|10113993|P3|Overall Study|AE, unknown type|0
2937549|NCT01408576|10113994|P2|Overall Study|AE, unknown type|1
2937550|NCT01408576|10113995|P1|Overall Study|AE, unknown type|0
2937551|NCT01408576|10113993|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2937552|NCT01408576|10113994|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2937553|NCT01408576|10113995|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2937554|NCT01408576|10113993|P3|Overall Study|AE, non-serious non-fatal|11
2937555|NCT01408576|10113994|P2|Overall Study|AE, non-serious non-fatal|19
2937556|NCT01408576|10113995|P1|Overall Study|AE, non-serious non-fatal|12
2937557|NCT01408576|10113993|P3|Overall Study|SAE, non-fatal|14
2937558|NCT01408576|10113994|P2|Overall Study|SAE, non-fatal|23
2937559|NCT01408576|10113995|P1|Overall Study|SAE, non-fatal|11
2937560|NCT01408576|10113993|P3|Overall Study|AE, serious fatal|1
2937561|NCT01408576|10113994|P2|Overall Study|AE, serious fatal|4
2937562|NCT01408576|10113995|P1|Overall Study|AE, serious fatal|4
2937563|NCT01408576|10113993|P3|Overall Study|Sponsor terminated study|330
2937564|NCT01408576|10113994|P2|Overall Study|Sponsor terminated study|333
2937565|NCT01408576|10113995|P1|Overall Study|Sponsor terminated study|89
2937566|NCT01408576|10113993|P3|Overall Study|Withdrawal by Subject|66
2937567|NCT01408576|10113994|P2|Overall Study|Withdrawal by Subject|60
2937568|NCT01408576|10113995|P1|Overall Study|Withdrawal by Subject|34
2937569|NCT01408576|10113993|P3|Overall Study|Lost to Follow-up|17
2937570|NCT01408576|10113994|P2|Overall Study|Lost to Follow-up|9
2937571|NCT01408576|10113995|P1|Overall Study|Lost to Follow-up|10
2937572|NCT01408576|10113993|P3|Overall Study|Protocol Violation|2
2937573|NCT01408576|10113994|P2|Overall Study|Protocol Violation|2
2937574|NCT01408576|10113995|P1|Overall Study|Protocol Violation|1
2937575|NCT01408576|10113993|P3|Overall Study|Lack of Efficacy|48
2937576|NCT01408576|10113994|P2|Overall Study|Lack of Efficacy|30
2937577|NCT01408576|10113995|P1|Overall Study|Lack of Efficacy|17
2937578|NCT01408563|10114042|P1|Overall Study|Ineligible after consent/ registration|2
2937579|NCT01408537|10114058|P1|Overall Study|Lost to Follow-up|3
2937580|NCT01408537|10114058|P1|Overall Study|Protocol Violation|3
2937581|NCT01408537|10114058|P1|Overall Study|Withdrawal by Subject|2
2937582|NCT01408485|10114074|P1|Overall Study|Withdrawal by Subject|21
2937583|NCT01408303|10114092|P3|Overall Study|Noncompliance|1
2937584|NCT01408303|10114093|P2|Overall Study|Noncompliance|0
2937585|NCT01408303|10114094|P1|Overall Study|Noncompliance|1
2937586|NCT01408303|10114092|P3|Overall Study|Protocol Violation|0
2937587|NCT01408303|10114093|P2|Overall Study|Protocol Violation|1
2937588|NCT01408303|10114094|P1|Overall Study|Protocol Violation|0
2937589|NCT01408303|10114092|P3|Overall Study|Withdrawal by Subject|1
2937590|NCT01408303|10114093|P2|Overall Study|Withdrawal by Subject|3
2937591|NCT01408303|10114094|P1|Overall Study|Withdrawal by Subject|2
2937592|NCT01408303|10114092|P3|Overall Study|Lost to Follow-up|2
2937593|NCT01408303|10114093|P2|Overall Study|Lost to Follow-up|1
2937594|NCT01408303|10114094|P1|Overall Study|Lost to Follow-up|0
2937595|NCT01408303|10114092|P3|Overall Study|Adverse Event|2
2937596|NCT01408303|10114093|P2|Overall Study|Adverse Event|7
2937597|NCT01408303|10114094|P1|Overall Study|Adverse Event|3
2937598|NCT01408277|10114104|P2|Overall Study|Protocol Violation|0
2937599|NCT01408277|10114105|P1|Overall Study|Protocol Violation|2
2937600|NCT01408277|10114104|P2|Overall Study|Withdrawal by Subject|0
2937601|NCT01408277|10114105|P1|Overall Study|Withdrawal by Subject|2
2937602|NCT01408277|10114104|P2|Overall Study|Lost to Follow-up|0
2937603|NCT01408277|10114105|P1|Overall Study|Lost to Follow-up|1
2937604|NCT01408277|10114104|P2|Overall Study|Adverse Event|4
2937605|NCT01408277|10114105|P1|Overall Study|Adverse Event|3
2937606|NCT01408043|10114111|P1|Overall Study|unable to collect cells|1
2937607|NCT01408030|10114130|P4|Observation Phase (Off Drug)|Other|1
2937608|NCT01408030|10114131|P3|Observation Phase (Off Drug)|Other|1
2937609|NCT01408030|10114132|P2|Observation Phase (Off Drug)|Other|1
2937610|NCT01408030|10114133|P1|Observation Phase (Off Drug)|Other|1
2937611|NCT01408030|10114130|P4|Observation Phase (Off Drug)|Physician Decision|0
2937612|NCT01408030|10114131|P3|Observation Phase (Off Drug)|Physician Decision|2
2937613|NCT01408030|10114132|P2|Observation Phase (Off Drug)|Physician Decision|1
2937614|NCT01408030|10114133|P1|Observation Phase (Off Drug)|Physician Decision|0
2937615|NCT01408030|10114130|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
2937616|NCT01408030|10114131|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
2937617|NCT01408030|10114132|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
2937618|NCT01408030|10114133|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
2937619|NCT01408030|10114130|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
2937620|NCT01408030|10114131|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
2937621|NCT01408030|10114132|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
2937622|NCT01408030|10114133|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
2937623|NCT01408030|10114130|P4|Treatment Phase (on Drug)|Protocol Violation|0
2937624|NCT01408030|10114131|P3|Treatment Phase (on Drug)|Protocol Violation|0
2937625|NCT01408030|10114132|P2|Treatment Phase (on Drug)|Protocol Violation|1
2937626|NCT01408030|10114133|P1|Treatment Phase (on Drug)|Protocol Violation|0
2937627|NCT01408030|10114130|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
2937628|NCT01408030|10114131|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
2937629|NCT01408030|10114132|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
2937630|NCT01408030|10114133|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
2937631|NCT01408030|10114130|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
2937632|NCT01408030|10114131|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
2937633|NCT01408030|10114132|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
2937634|NCT01408030|10114133|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
2937635|NCT01407926|10114192|P1|Overall Study|Lost to Follow-up|55
2937636|NCT01407367|10114240|P2|Overall Study|Lost to Follow-up|2
2937637|NCT01407367|10114241|P1|Overall Study|Lost to Follow-up|0
2937638|NCT01407367|10114240|P2|Overall Study|Withdrawal by Subject|15
2937639|NCT01407367|10114241|P1|Overall Study|Withdrawal by Subject|4
2937640|NCT01407367|10114240|P2|Overall Study|Renal Replacement Therapy (RRT)|29
2937641|NCT01407367|10114241|P1|Overall Study|Renal Replacement Therapy (RRT)|12
2937642|NCT01407367|10114240|P2|Overall Study|Death|32
2937643|NCT01407367|10114241|P1|Overall Study|Death|24
2937644|NCT01407354|10114255|P2|First Intervention|Physician Decision|0
2937645|NCT01407354|10114256|P1|First Intervention|Physician Decision|1
2937646|NCT01407354|10114255|P2|First Intervention|Adverse Event|0
2937647|NCT01407354|10114256|P1|First Intervention|Adverse Event|1
2937648|NCT01407354|10114255|P2|First Intervention|Withdrawal by Subject|2
2937649|NCT01407354|10114256|P1|First Intervention|Withdrawal by Subject|0
2937650|NCT01407276|10114272|P8|Overall Study|Withdrawal by Subject|1
2937651|NCT01407276|10114273|P7|Overall Study|Withdrawal by Subject|0
2937652|NCT01407276|10114274|P6|Overall Study|Withdrawal by Subject|0
2937653|NCT01407276|10114275|P5|Overall Study|Withdrawal by Subject|0
2937654|NCT01407276|10114276|P4|Overall Study|Withdrawal by Subject|0
2937655|NCT01407276|10114277|P3|Overall Study|Withdrawal by Subject|0
2937656|NCT01407276|10114278|P2|Overall Study|Withdrawal by Subject|0
2937657|NCT01407276|10114279|P1|Overall Study|Withdrawal by Subject|0
2937658|NCT01406938|10114431|P6|Follow up|Lost to Follow-up|1
2937659|NCT01406938|10114432|P5|Follow up|Lost to Follow-up|2
2937660|NCT01406938|10114433|P4|Follow up|Lost to Follow-up|1
2937661|NCT01406938|10114434|P3|Follow up|Lost to Follow-up|0
2937662|NCT01406938|10114435|P2|Follow up|Lost to Follow-up|1
2937663|NCT01406938|10114436|P1|Follow up|Lost to Follow-up|1
2937664|NCT01406938|10114431|P6|Follow up|Physician Decision|1
2937665|NCT01406938|10114432|P5|Follow up|Physician Decision|3
2937666|NCT01406938|10114433|P4|Follow up|Physician Decision|0
2937667|NCT01406938|10114434|P3|Follow up|Physician Decision|2
2937668|NCT01406938|10114435|P2|Follow up|Physician Decision|0
2937669|NCT01406938|10114436|P1|Follow up|Physician Decision|0
2937670|NCT01406938|10114431|P6|Follow up|Protocol Violation|0
2937671|NCT01406938|10114432|P5|Follow up|Protocol Violation|0
2937672|NCT01406938|10114433|P4|Follow up|Protocol Violation|0
2937673|NCT01406938|10114434|P3|Follow up|Protocol Violation|1
2937674|NCT01406938|10114435|P2|Follow up|Protocol Violation|0
2937675|NCT01406938|10114436|P1|Follow up|Protocol Violation|0
2937676|NCT01406938|10114431|P6|Follow up|Patient/guardian decision|1
2937677|NCT01406938|10114432|P5|Follow up|Patient/guardian decision|4
2937678|NCT01406938|10114433|P4|Follow up|Patient/guardian decision|2
2937679|NCT01406938|10114434|P3|Follow up|Patient/guardian decision|4
2937680|NCT01406938|10114435|P2|Follow up|Patient/guardian decision|2
2937681|NCT01406938|10114436|P1|Follow up|Patient/guardian decision|4
2937682|NCT01406938|10114431|P6|Follow up|Lack of Efficacy|0
2937683|NCT01406938|10114432|P5|Follow up|Lack of Efficacy|0
2937684|NCT01406938|10114433|P4|Follow up|Lack of Efficacy|0
2937685|NCT01406938|10114434|P3|Follow up|Lack of Efficacy|1
2937686|NCT01406938|10114435|P2|Follow up|Lack of Efficacy|2
2937687|NCT01406938|10114436|P1|Follow up|Lack of Efficacy|3
2937688|NCT01406938|10114431|P6|Maintenance Period|Lack of Efficacy|5
2937689|NCT01406938|10114432|P5|Maintenance Period|Lack of Efficacy|3
2937690|NCT01406938|10114433|P4|Maintenance Period|Lack of Efficacy|1
2937691|NCT01406938|10114434|P3|Maintenance Period|Lack of Efficacy|2
2937692|NCT01406938|10114435|P2|Maintenance Period|Lack of Efficacy|0
2937693|NCT01406938|10114436|P1|Maintenance Period|Lack of Efficacy|0
2937694|NCT01406938|10114431|P6|Maintenance Period|Lost to Follow-up|0
2937695|NCT01406938|10114432|P5|Maintenance Period|Lost to Follow-up|4
2937696|NCT01406938|10114433|P4|Maintenance Period|Lost to Follow-up|0
2937697|NCT01406938|10114434|P3|Maintenance Period|Lost to Follow-up|0
2937698|NCT01406938|10114435|P2|Maintenance Period|Lost to Follow-up|0
2937699|NCT01406938|10114436|P1|Maintenance Period|Lost to Follow-up|0
2937700|NCT01406938|10114431|P6|Maintenance Period|Pregnancy|0
2937701|NCT01406938|10114432|P5|Maintenance Period|Pregnancy|1
2937702|NCT01406938|10114433|P4|Maintenance Period|Pregnancy|0
2937703|NCT01406938|10114434|P3|Maintenance Period|Pregnancy|0
2937704|NCT01406938|10114435|P2|Maintenance Period|Pregnancy|0
2937705|NCT01406938|10114436|P1|Maintenance Period|Pregnancy|0
2937706|NCT01406938|10114431|P6|Maintenance Period|Protocol Violation|2
2937707|NCT01406938|10114432|P5|Maintenance Period|Protocol Violation|2
2937708|NCT01406938|10114433|P4|Maintenance Period|Protocol Violation|2
2937709|NCT01406938|10114434|P3|Maintenance Period|Protocol Violation|2
2937710|NCT01406938|10114435|P2|Maintenance Period|Protocol Violation|0
2937711|NCT01406938|10114436|P1|Maintenance Period|Protocol Violation|0
2937712|NCT01406938|10114431|P6|Maintenance Period|Subject/guardian decision|7
2937713|NCT01406938|10114432|P5|Maintenance Period|Subject/guardian decision|10
2937714|NCT01406938|10114433|P4|Maintenance Period|Subject/guardian decision|7
2937715|NCT01406938|10114434|P3|Maintenance Period|Subject/guardian decision|11
2937716|NCT01406938|10114435|P2|Maintenance Period|Subject/guardian decision|0
2937717|NCT01406938|10114436|P1|Maintenance Period|Subject/guardian decision|0
2937718|NCT01406938|10114431|P6|Maintenance Period|Death|0
2937719|NCT01406938|10114432|P5|Maintenance Period|Death|1
2937720|NCT01406938|10114433|P4|Maintenance Period|Death|0
2937721|NCT01406938|10114434|P3|Maintenance Period|Death|0
2937722|NCT01406938|10114435|P2|Maintenance Period|Death|0
2937723|NCT01406938|10114436|P1|Maintenance Period|Death|0
2937724|NCT01406938|10114431|P6|Maintenance Period|Adverse Event|2
2937725|NCT01406938|10114432|P5|Maintenance Period|Adverse Event|4
2937726|NCT01406938|10114433|P4|Maintenance Period|Adverse Event|8
2937727|NCT01406938|10114434|P3|Maintenance Period|Adverse Event|2
2937728|NCT01406938|10114435|P2|Maintenance Period|Adverse Event|0
2937729|NCT01406938|10114436|P1|Maintenance Period|Adverse Event|0
2937730|NCT01406938|10114431|P6|Induction Period|Lost to Follow-up|0
2937731|NCT01406938|10114432|P5|Induction Period|Lost to Follow-up|0
2937732|NCT01406938|10114433|P4|Induction Period|Lost to Follow-up|0
2937733|NCT01406938|10114434|P3|Induction Period|Lost to Follow-up|0
2937734|NCT01406938|10114435|P2|Induction Period|Lost to Follow-up|3
2937735|NCT01406938|10114436|P1|Induction Period|Lost to Follow-up|2
2937736|NCT01406938|10114431|P6|Induction Period|Lack of Efficacy|0
2937737|NCT01406938|10114432|P5|Induction Period|Lack of Efficacy|0
2937738|NCT01406938|10114433|P4|Induction Period|Lack of Efficacy|0
2937739|NCT01406938|10114434|P3|Induction Period|Lack of Efficacy|0
2937740|NCT01406938|10114435|P2|Induction Period|Lack of Efficacy|0
2937741|NCT01406938|10114436|P1|Induction Period|Lack of Efficacy|1
2937742|NCT01406938|10114431|P6|Induction Period|Adverse Event|0
2937743|NCT01406938|10114432|P5|Induction Period|Adverse Event|0
2937744|NCT01406938|10114433|P4|Induction Period|Adverse Event|0
2937745|NCT01406938|10114434|P3|Induction Period|Adverse Event|0
2937746|NCT01406938|10114435|P2|Induction Period|Adverse Event|9
2937747|NCT01406938|10114436|P1|Induction Period|Adverse Event|8
2937748|NCT01406938|10114431|P6|Induction Period|Protocol deviation|0
2937749|NCT01406938|10114432|P5|Induction Period|Protocol deviation|0
2937750|NCT01406938|10114433|P4|Induction Period|Protocol deviation|0
2937751|NCT01406938|10114434|P3|Induction Period|Protocol deviation|0
2937752|NCT01406938|10114435|P2|Induction Period|Protocol deviation|0
2937753|NCT01406938|10114436|P1|Induction Period|Protocol deviation|1
2937754|NCT01406938|10114431|P6|Induction Period|Subject/guardian decision|0
2937755|NCT01406938|10114432|P5|Induction Period|Subject/guardian decision|0
2937756|NCT01406938|10114433|P4|Induction Period|Subject/guardian decision|0
2937757|NCT01406938|10114434|P3|Induction Period|Subject/guardian decision|0
2937758|NCT01406938|10114435|P2|Induction Period|Subject/guardian decision|8
2937759|NCT01406938|10114436|P1|Induction Period|Subject/guardian decision|6
2937760|NCT01406873|10114554|P2|Overall Study|Withdrawal by Subject|1
2937761|NCT01406873|10114555|P1|Overall Study|Withdrawal by Subject|1
2937762|NCT01406795|10114586|P1|Overall Study|Withdrawal by Subject|1
2937763|NCT01406717|10114602|P2|Overall Study|Non-completion of visit activity|1
2937764|NCT01406717|10114603|P1|Overall Study|Non-completion of visit activity|0
2937765|NCT01406717|10114602|P2|Overall Study|Lack of Efficacy|1
2937766|NCT01406717|10114603|P1|Overall Study|Lack of Efficacy|0
2937767|NCT01406717|10114602|P2|Overall Study|Adverse Event|2
2937768|NCT01406717|10114603|P1|Overall Study|Adverse Event|1
2937769|NCT01406717|10114602|P2|Overall Study|Withdrawal by Subject|15
2937770|NCT01406717|10114603|P1|Overall Study|Withdrawal by Subject|19
2937771|NCT01406717|10114602|P2|Overall Study|Lost to Follow-up|8
2937772|NCT01406717|10114603|P1|Overall Study|Lost to Follow-up|14
2937773|NCT01406717|10114602|P2|Overall Study|Protocol Violation|1
2937774|NCT01406717|10114603|P1|Overall Study|Protocol Violation|5
2937775|NCT01406717|10114602|P2|Overall Study|Subject non-compliance|3
2937776|NCT01406717|10114603|P1|Overall Study|Subject non-compliance|4
2937777|NCT01406652|10114633|P2|Overall Study|Infection not sure|10
2937778|NCT01406652|10114634|P1|Overall Study|Infection not sure|10
2937779|NCT01406652|10114633|P2|Overall Study|Insufficient follow-up|4
2937780|NCT01406652|10114634|P1|Overall Study|Insufficient follow-up|5
2937781|NCT01406652|10114633|P2|Overall Study|Withdrawal by Subject|2
2937782|NCT01406652|10114634|P1|Overall Study|Withdrawal by Subject|2
2937783|NCT01406652|10114633|P2|Overall Study|Lost-to-follow-up|4
2937784|NCT01406652|10114634|P1|Overall Study|Lost-to-follow-up|3
2937785|NCT01406574|10114642|P4|Overall Study|Definite progression of primary disease|0
2937786|NCT01406574|10114643|P3|Overall Study|Definite progression of primary disease|0
2937787|NCT01406574|10114644|P2|Overall Study|Definite progression of primary disease|0
2937788|NCT01406574|10114645|P1|Overall Study|Definite progression of primary disease|1
2937789|NCT01406574|10114642|P4|Overall Study|Withdrawal by Subject|0
2937790|NCT01406574|10114643|P3|Overall Study|Withdrawal by Subject|0
2937791|NCT01406574|10114644|P2|Overall Study|Withdrawal by Subject|1
2937792|NCT01406574|10114645|P1|Overall Study|Withdrawal by Subject|0
2937793|NCT01406574|10114642|P4|Overall Study|Physician Decision|1
2937794|NCT01406574|10114643|P3|Overall Study|Physician Decision|0
2937795|NCT01406574|10114644|P2|Overall Study|Physician Decision|0
2937796|NCT01406574|10114645|P1|Overall Study|Physician Decision|0
2937797|NCT01406574|10114642|P4|Overall Study|Adverse Event|3
2937798|NCT01406574|10114643|P3|Overall Study|Adverse Event|1
2937799|NCT01406574|10114644|P2|Overall Study|Adverse Event|0
2937800|NCT01406574|10114645|P1|Overall Study|Adverse Event|0
2937801|NCT01406015|10114680|P2|Overall Study|Withdrawal by Subject|3
2937802|NCT01406015|10114681|P1|Overall Study|Withdrawal by Subject|3
2937803|NCT01405950|10114697|P4|Overall Study|Withdrawal by Subject|0
2937804|NCT01405950|10114698|P3|Overall Study|Withdrawal by Subject|0
2937805|NCT01405950|10114699|P2|Overall Study|Withdrawal by Subject|0
2937806|NCT01405950|10114700|P1|Overall Study|Withdrawal by Subject|1
2937807|NCT01405924|10114735|P1|Overall Study|Missing/Incomplete Data|2
2937808|NCT01405924|10114735|P1|Overall Study|Protocol Violation|8
2937809|NCT01405911|10114748|P3|Overall Study|Withdrawal by Subject|1
2937810|NCT01405911|10114749|P2|Overall Study|Withdrawal by Subject|1
2937811|NCT01405911|10114750|P1|Overall Study|Withdrawal by Subject|3
2937812|NCT01405911|10114748|P3|Overall Study|Protocol Violation|0
2937813|NCT01405911|10114749|P2|Overall Study|Protocol Violation|0
2937814|NCT01405911|10114750|P1|Overall Study|Protocol Violation|1
2937815|NCT01405911|10114748|P3|Overall Study|Lost to Follow-up|0
2937816|NCT01405911|10114749|P2|Overall Study|Lost to Follow-up|1
2937817|NCT01405911|10114750|P1|Overall Study|Lost to Follow-up|0
2937818|NCT01405911|10114748|P3|Overall Study|Pre-treatment lab AE|0
2937819|NCT01405911|10114749|P2|Overall Study|Pre-treatment lab AE|1
2937820|NCT01405911|10114750|P1|Overall Study|Pre-treatment lab AE|0
2937821|NCT01405898|10114769|P2|Overall Study|Withdrawal by Subject|2
2937822|NCT01405898|10114770|P1|Overall Study|Withdrawal by Subject|2
2937823|NCT01405820|10114794|P6|Open-Label Treatment Period|Adverse Event|0
2937824|NCT01405820|10114795|P5|Open-Label Treatment Period|Adverse Event|0
2937825|NCT01405820|10114796|P4|Open-Label Treatment Period|Adverse Event|1
2937826|NCT01405820|10114797|P3|Open-Label Treatment Period|Adverse Event|0
2937827|NCT01405820|10114798|P2|Open-Label Treatment Period|Adverse Event|0
2937828|NCT01405820|10114799|P1|Open-Label Treatment Period|Adverse Event|0
2937829|NCT01405820|10114794|P6|Open-Label Treatment Period|Physician Decision|0
2937830|NCT01405820|10114795|P5|Open-Label Treatment Period|Physician Decision|1
2937831|NCT01405820|10114796|P4|Open-Label Treatment Period|Physician Decision|2
2937832|NCT01405820|10114797|P3|Open-Label Treatment Period|Physician Decision|1
2937833|NCT01405820|10114798|P2|Open-Label Treatment Period|Physician Decision|0
2937834|NCT01405820|10114799|P1|Open-Label Treatment Period|Physician Decision|0
2937835|NCT01405820|10114794|P6|Open-Label Treatment Period|Other|1
2937836|NCT01405820|10114795|P5|Open-Label Treatment Period|Other|1
2937837|NCT01405820|10114796|P4|Open-Label Treatment Period|Other|1
2937838|NCT01405820|10114797|P3|Open-Label Treatment Period|Other|1
2937839|NCT01405820|10114798|P2|Open-Label Treatment Period|Other|1
2937840|NCT01405820|10114799|P1|Open-Label Treatment Period|Other|1
2937841|NCT01405820|10114794|P6|Open-Label Treatment Period|Withdrawal by Subject|1
2937842|NCT01405820|10114795|P5|Open-Label Treatment Period|Withdrawal by Subject|0
2937843|NCT01405820|10114796|P4|Open-Label Treatment Period|Withdrawal by Subject|1
2937844|NCT01405820|10114797|P3|Open-Label Treatment Period|Withdrawal by Subject|1
2937845|NCT01405820|10114798|P2|Open-Label Treatment Period|Withdrawal by Subject|1
2937846|NCT01405820|10114799|P1|Open-Label Treatment Period|Withdrawal by Subject|3
2937847|NCT01405820|10114794|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
2937848|NCT01405820|10114795|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
2937849|NCT01405820|10114796|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
2937850|NCT01405820|10114797|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
2937851|NCT01405820|10114798|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
2937852|NCT01405820|10114799|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
2937853|NCT01405820|10114794|P6|Randomized Treatment Period|Death|0
2937854|NCT01405820|10114795|P5|Randomized Treatment Period|Death|0
2937855|NCT01405820|10114796|P4|Randomized Treatment Period|Death|1
2937856|NCT01405820|10114797|P3|Randomized Treatment Period|Death|0
2937857|NCT01405820|10114798|P2|Randomized Treatment Period|Death|0
2937858|NCT01405820|10114799|P1|Randomized Treatment Period|Death|0
2937859|NCT01405820|10114794|P6|Randomized Treatment Period|Treatment Arm Closed|28
2937860|NCT01405820|10114795|P5|Randomized Treatment Period|Treatment Arm Closed|33
2937861|NCT01405820|10114796|P4|Randomized Treatment Period|Treatment Arm Closed|36
2937862|NCT01405820|10114797|P3|Randomized Treatment Period|Treatment Arm Closed|20
2937863|NCT01405820|10114798|P2|Randomized Treatment Period|Treatment Arm Closed|0
2937864|NCT01405820|10114799|P1|Randomized Treatment Period|Treatment Arm Closed|0
2937865|NCT01405820|10114794|P6|Randomized Treatment Period|Incorrect Study Treatment|0
2937866|NCT01405820|10114795|P5|Randomized Treatment Period|Incorrect Study Treatment|2
2937867|NCT01405820|10114796|P4|Randomized Treatment Period|Incorrect Study Treatment|0
2937868|NCT01405820|10114797|P3|Randomized Treatment Period|Incorrect Study Treatment|3
2937869|NCT01405820|10114798|P2|Randomized Treatment Period|Incorrect Study Treatment|0
2937870|NCT01405820|10114799|P1|Randomized Treatment Period|Incorrect Study Treatment|0
2937871|NCT01405820|10114794|P6|Randomized Treatment Period|Rescue|8
2937872|NCT01405820|10114795|P5|Randomized Treatment Period|Rescue|8
2937873|NCT01405820|10114796|P4|Randomized Treatment Period|Rescue|10
2937874|NCT01405820|10114797|P3|Randomized Treatment Period|Rescue|13
2937875|NCT01405820|10114798|P2|Randomized Treatment Period|Rescue|1
2937876|NCT01405820|10114799|P1|Randomized Treatment Period|Rescue|0
2937877|NCT01405820|10114794|P6|Randomized Treatment Period|Physician Decision|0
2937878|NCT01405820|10114795|P5|Randomized Treatment Period|Physician Decision|0
2937879|NCT01405820|10114796|P4|Randomized Treatment Period|Physician Decision|0
2937880|NCT01405820|10114797|P3|Randomized Treatment Period|Physician Decision|1
2937881|NCT01405820|10114798|P2|Randomized Treatment Period|Physician Decision|2
2937882|NCT01405820|10114799|P1|Randomized Treatment Period|Physician Decision|0
2937883|NCT01405820|10114794|P6|Randomized Treatment Period|Other|0
2937884|NCT01405820|10114795|P5|Randomized Treatment Period|Other|0
2937885|NCT01405820|10114796|P4|Randomized Treatment Period|Other|1
2937886|NCT01405820|10114797|P3|Randomized Treatment Period|Other|1
2937887|NCT01405820|10114798|P2|Randomized Treatment Period|Other|2
2937888|NCT01405820|10114799|P1|Randomized Treatment Period|Other|2
2937889|NCT01405820|10114794|P6|Randomized Treatment Period|Withdrawal by Subject|0
2937890|NCT01405820|10114795|P5|Randomized Treatment Period|Withdrawal by Subject|0
2937891|NCT01405820|10114796|P4|Randomized Treatment Period|Withdrawal by Subject|2
2937892|NCT01405820|10114797|P3|Randomized Treatment Period|Withdrawal by Subject|2
2937893|NCT01405820|10114798|P2|Randomized Treatment Period|Withdrawal by Subject|2
2937894|NCT01405820|10114799|P1|Randomized Treatment Period|Withdrawal by Subject|6
2937895|NCT01405820|10114794|P6|Randomized Treatment Period|Adverse Event|1
2937896|NCT01405820|10114795|P5|Randomized Treatment Period|Adverse Event|2
2937897|NCT01405820|10114796|P4|Randomized Treatment Period|Adverse Event|0
2937898|NCT01405820|10114797|P3|Randomized Treatment Period|Adverse Event|3
2937899|NCT01405820|10114798|P2|Randomized Treatment Period|Adverse Event|3
2937900|NCT01405820|10114799|P1|Randomized Treatment Period|Adverse Event|3
2937901|NCT01405768|10114895|P2|Overall Study|Didn't complete questionnaire correctly|0
2937902|NCT01405768|10114896|P1|Overall Study|Didn't complete questionnaire correctly|4
2937903|NCT01405742|10114908|P2|Overall Study|Lost to Follow-up|0
2937904|NCT01405742|10114909|P1|Overall Study|Lost to Follow-up|1
2937905|NCT01405560|10114919|P1|Overall Study|Physician Decision|1
2937906|NCT01405508|10114934|P4|Overall Study|AE, non-serious non-fatal|0
2937907|NCT01405508|10114935|P3|Overall Study|AE, non-serious non-fatal|0
2937908|NCT01405508|10114936|P2|Overall Study|AE, non-serious non-fatal|1
2937909|NCT01405508|10114937|P1|Overall Study|AE, non-serious non-fatal|1
2937910|NCT01405456|10114969|P2|Overall Study|Physician Decision|0
2937911|NCT01405456|10114970|P1|Overall Study|Physician Decision|1
2937912|NCT01405456|10114969|P2|Overall Study|Lost to Follow-up|1
2937913|NCT01405456|10114970|P1|Overall Study|Lost to Follow-up|2
2937914|NCT01405196|10115010|P4|Overall Study|Lost to Follow-up|1
2937915|NCT01405196|10115011|P3|Overall Study|Lost to Follow-up|3
2937916|NCT01405196|10115012|P2|Overall Study|Lost to Follow-up|2
2937917|NCT01405196|10115013|P1|Overall Study|Lost to Follow-up|2
2937918|NCT01405196|10115010|P4|Overall Study|Death|0
2937919|NCT01405196|10115011|P3|Overall Study|Death|3
2937920|NCT01405196|10115012|P2|Overall Study|Death|0
2937921|NCT01405196|10115013|P1|Overall Study|Death|1
2937922|NCT01405196|10115010|P4|Overall Study|Adverse Event|2
2937923|NCT01405196|10115011|P3|Overall Study|Adverse Event|0
2937924|NCT01405196|10115012|P2|Overall Study|Adverse Event|2
2937925|NCT01405196|10115013|P1|Overall Study|Adverse Event|2
2937926|NCT01405196|10115010|P4|Overall Study|Withdrawal by Subject|6
2937927|NCT01405196|10115011|P3|Overall Study|Withdrawal by Subject|3
2937928|NCT01405196|10115012|P2|Overall Study|Withdrawal by Subject|6
2937929|NCT01405196|10115013|P1|Overall Study|Withdrawal by Subject|4
2937930|NCT01405196|10115010|P4|Overall Study|Other|0
2937931|NCT01405196|10115011|P3|Overall Study|Other|5
2937932|NCT01405196|10115012|P2|Overall Study|Other|2
2937933|NCT01405196|10115013|P1|Overall Study|Other|2
2937934|NCT01405196|10115010|P4|Overall Study|Study Terminated by Sponsor|0
2937935|NCT01405196|10115011|P3|Overall Study|Study Terminated by Sponsor|9
2937936|NCT01405196|10115012|P2|Overall Study|Study Terminated by Sponsor|0
2937937|NCT01405196|10115013|P1|Overall Study|Study Terminated by Sponsor|0
2937938|NCT01405053|10115100|P2|Overall Study|Other|1
2937939|NCT01405053|10115101|P1|Overall Study|Other|0
2937940|NCT01405053|10115100|P2|Overall Study|Withdrawal by Subject|4
2937941|NCT01405053|10115101|P1|Overall Study|Withdrawal by Subject|3
2937942|NCT01405053|10115100|P2|Overall Study|Inadequate therapeutic effect|1
2937943|NCT01405053|10115101|P1|Overall Study|Inadequate therapeutic effect|2
2937944|NCT01405053|10115100|P2|Overall Study|Participant choice|1
2937945|NCT01405053|10115101|P1|Overall Study|Participant choice|2
2937946|NCT01405053|10115100|P2|Overall Study|Lost to Follow-up|1
2937947|NCT01405053|10115101|P1|Overall Study|Lost to Follow-up|0
2937948|NCT01405053|10115100|P2|Overall Study|Adverse Event|0
2937949|NCT01405053|10115101|P1|Overall Study|Adverse Event|3
2937950|NCT01405027|10115127|P2|Overall Study|Other or Unknown|25
2937951|NCT01405027|10115128|P1|Overall Study|Other or Unknown|12
2937952|NCT01405027|10115127|P2|Overall Study|Death|0
2937953|NCT01405027|10115128|P1|Overall Study|Death|1
2937954|NCT01405027|10115127|P2|Overall Study|Investigator judgement|2
2937955|NCT01405027|10115128|P1|Overall Study|Investigator judgement|0
2937956|NCT01405027|10115127|P2|Overall Study|Lost to Follow-up|24
2937957|NCT01405027|10115128|P1|Overall Study|Lost to Follow-up|16
2937958|NCT01405027|10115127|P2|Overall Study|Withdrawn consent|0
2937959|NCT01405027|10115128|P1|Overall Study|Withdrawn consent|3
2937960|NCT01404988|10115145|P3|Overall Study|Lost to Follow-up|1
2937961|NCT01404988|10115146|P2|Overall Study|Lost to Follow-up|2
2937962|NCT01404988|10115147|P1|Overall Study|Lost to Follow-up|1
2937963|NCT01404988|10115145|P3|Overall Study|Withdrawal by Subject|0
2937964|NCT01404988|10115146|P2|Overall Study|Withdrawal by Subject|2
2937965|NCT01404988|10115147|P1|Overall Study|Withdrawal by Subject|2
2937966|NCT01404988|10115145|P3|Overall Study|Adverse Event|0
2937967|NCT01404988|10115146|P2|Overall Study|Adverse Event|0
2937968|NCT01404988|10115147|P1|Overall Study|Adverse Event|1
2937969|NCT01404988|10115145|P3|Overall Study|Death|2
2937970|NCT01404988|10115146|P2|Overall Study|Death|0
2937971|NCT01404988|10115147|P1|Overall Study|Death|2
2937972|NCT01404325|10115268|P2|Overall Study|non-specified reason|2
2937973|NCT01404325|10115269|P1|Overall Study|non-specified reason|0
2937974|NCT01404325|10115268|P2|Overall Study|Graft loss/Retransplantation|0
2937975|NCT01404325|10115269|P1|Overall Study|Graft loss/Retransplantation|1
2937976|NCT01404325|10115268|P2|Overall Study|Death|0
2937977|NCT01404325|10115269|P1|Overall Study|Death|2
2937978|NCT01404325|10115268|P2|Overall Study|Lost to Follow-up|0
2937979|NCT01404325|10115269|P1|Overall Study|Lost to Follow-up|1
2937980|NCT01404312|10115327|P2|Overall Study|Severe debilitation, unable to continue|2
2937981|NCT01404312|10115328|P1|Overall Study|Severe debilitation, unable to continue|1
2937982|NCT01404312|10115327|P2|Overall Study|Participant not willing to adhere to req|29
2937983|NCT01404312|10115328|P1|Overall Study|Participant not willing to adhere to req|31
2937984|NCT01404312|10115327|P2|Overall Study|Site closed|21
2937985|NCT01404312|10115328|P1|Overall Study|Site closed|22
2937986|NCT01404312|10115327|P2|Overall Study|Lost to Follow-up|111
2937987|NCT01404312|10115328|P1|Overall Study|Lost to Follow-up|115
2937988|NCT01404312|10115327|P2|Overall Study|Participant Unable to get to clinic|103
2937989|NCT01404312|10115328|P1|Overall Study|Participant Unable to get to clinic|93
2937990|NCT01404312|10115327|P2|Overall Study|Withdrawal by Subject|18
2937991|NCT01404312|10115328|P1|Overall Study|Withdrawal by Subject|15
2937992|NCT01404312|10115327|P2|Overall Study|Death|27
2937993|NCT01404312|10115328|P1|Overall Study|Death|21
2937994|NCT01404234|10115357|P1|Overall Study|Withdrawal by Subject|2
2937995|NCT01404208|10115373|P2|Overall Study|Discontinued|0
2937996|NCT01404208|10115374|P1|Overall Study|Discontinued|3
2937997|NCT01403987|10115439|P3|Overall Study|Residents forgot their secret PIN|18
2937998|NCT01403987|10115440|P2|Overall Study|Residents forgot their secret PIN|17
2937999|NCT01403987|10115441|P1|Overall Study|Residents forgot their secret PIN|18
2938000|NCT01403805|10115457|P2|Overall Study|Death|1
2938001|NCT01403805|10115458|P1|Overall Study|Death|0
2938002|NCT01403805|10115457|P2|Overall Study|Lost to Follow-up|2
2938003|NCT01403805|10115458|P1|Overall Study|Lost to Follow-up|0
2938004|NCT01403805|10115457|P2|Overall Study|Withdrawal by Subject|4
2938005|NCT01403805|10115458|P1|Overall Study|Withdrawal by Subject|0
2938006|NCT01403610|10115474|P4|Overall Study|Didn't recover from surgery sufficiently|0
2938007|NCT01403610|10115475|P3|Overall Study|Didn't recover from surgery sufficiently|0
2938008|NCT01403610|10115476|P2|Overall Study|Didn't recover from surgery sufficiently|3
2938009|NCT01403610|10115477|P1|Overall Study|Didn't recover from surgery sufficiently|0
2938010|NCT01403610|10115474|P4|Overall Study|Withdrawal by Subject|0
2938011|NCT01403610|10115475|P3|Overall Study|Withdrawal by Subject|0
2938012|NCT01403610|10115476|P2|Overall Study|Withdrawal by Subject|0
2938013|NCT01403610|10115477|P1|Overall Study|Withdrawal by Subject|2
2938014|NCT01403194|10115523|P1|Overall Study|Lost to Follow-up|8
2938015|NCT01403194|10115523|P1|Overall Study|Screen Failure|2
2938016|NCT01403116|10115531|P2|Overall Study|unable to keep appointments|2
2938017|NCT01403116|10115532|P1|Overall Study|unable to keep appointments|0
2938018|NCT01403116|10115531|P2|Overall Study|Hct >54%|0
2938019|NCT01403116|10115532|P1|Overall Study|Hct >54%|2
2938020|NCT01403116|10115531|P2|Overall Study|undisclosed Hx of Prostate Ca|0
2938021|NCT01403116|10115532|P1|Overall Study|undisclosed Hx of Prostate Ca|1
2938022|NCT01403116|10115531|P2|Overall Study|Protocol Violation|1
2938023|NCT01403116|10115532|P1|Overall Study|Protocol Violation|0
2938024|NCT01403116|10115531|P2|Overall Study|Non-compliance of study drug|0
2938025|NCT01403116|10115532|P1|Overall Study|Non-compliance of study drug|3
2938026|NCT01403116|10115531|P2|Overall Study|Withdrawal by Subject|15
2938027|NCT01403116|10115532|P1|Overall Study|Withdrawal by Subject|12
2938028|NCT01403116|10115531|P2|Overall Study|Lost to Follow-up|5
2938029|NCT01403116|10115532|P1|Overall Study|Lost to Follow-up|7
2938030|NCT01403116|10115531|P2|Overall Study|Adverse Event|4
2938031|NCT01403116|10115532|P1|Overall Study|Adverse Event|7
2938032|NCT01403051|10115545|P2|Overall Study|Lost to Follow-up|5
2938033|NCT01403051|10115546|P1|Overall Study|Lost to Follow-up|5
2938034|NCT01403051|10115545|P2|Overall Study|Withdrawal by Subject|1
2938035|NCT01403051|10115546|P1|Overall Study|Withdrawal by Subject|2
2938036|NCT01403051|10115545|P2|Overall Study|Death|0
2938037|NCT01403051|10115546|P1|Overall Study|Death|1
2938038|NCT01403051|10115545|P2|Overall Study|Protocol Violation|0
2938039|NCT01403051|10115546|P1|Overall Study|Protocol Violation|2
2938040|NCT01402986|10115582|P4|Overall Study|Other|6
2938041|NCT01402986|10115583|P3|Overall Study|Other|1
2938042|NCT01402986|10115584|P2|Overall Study|Other|5
2938043|NCT01402986|10115585|P1|Overall Study|Other|2
2938044|NCT01402986|10115582|P4|Overall Study|Lost to Follow-up|1
2938045|NCT01402986|10115583|P3|Overall Study|Lost to Follow-up|0
2938046|NCT01402986|10115584|P2|Overall Study|Lost to Follow-up|0
2938047|NCT01402986|10115585|P1|Overall Study|Lost to Follow-up|0
2938048|NCT01402986|10115582|P4|Overall Study|Death|2
2938049|NCT01402986|10115583|P3|Overall Study|Death|0
2938050|NCT01402986|10115584|P2|Overall Study|Death|0
2938051|NCT01402986|10115585|P1|Overall Study|Death|0
2938052|NCT01402986|10115582|P4|Overall Study|Withdrawal by Subject|13
2938053|NCT01402986|10115583|P3|Overall Study|Withdrawal by Subject|7
2938054|NCT01402986|10115584|P2|Overall Study|Withdrawal by Subject|10
2938055|NCT01402986|10115585|P1|Overall Study|Withdrawal by Subject|7
2938056|NCT01402947|10115720|P2|First Intervention|Adverse Event|1
2938057|NCT01402947|10115721|P1|First Intervention|Adverse Event|0
2938058|NCT01402869|10115732|P3|Overall Study|Required Tooth Extraction|1
2938059|NCT01402869|10115733|P2|Overall Study|Required Tooth Extraction|0
2938060|NCT01402869|10115734|P1|Overall Study|Required Tooth Extraction|0
2938061|NCT01402817|10115748|P1|Overall Study|Study Suspended by FDA|8
2938062|NCT01402817|10115748|P1|Overall Study|Withdrawal by Subject|3
2938063|NCT01402700|10115753|P1|Overall Study|Missed Visit|1
2938064|NCT01402700|10115753|P1|Overall Study|Withdrawal by Subject|3
2938065|NCT01402700|10115753|P1|Overall Study|Death|3
2938066|NCT01402570|10115757|P1|Overall Study|Adverse Event|1
2938067|NCT01402544|10115764|P1|Overall Study|Withdrawal by Subject|6
2938068|NCT01402284|10115838|P1|Overall Study|Disease progression on study|10
2938069|NCT01402284|10115838|P1|Overall Study|Physician Decision|1
2938070|NCT01402284|10115838|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
2938071|NCT01402284|10115838|P1|Overall Study|Withdrawal consent|2
2938072|NCT01402102|10115920|P2|Overall Study|Withdrawal by Subject|2
2938073|NCT01402102|10115921|P1|Overall Study|Withdrawal by Subject|0
2938074|NCT01402102|10115920|P2|Overall Study|Insufficiency of compliance|1
2938075|NCT01402102|10115921|P1|Overall Study|Insufficiency of compliance|1
2938076|NCT01402102|10115920|P2|Overall Study|Protocol Violation|0
2938077|NCT01402102|10115921|P1|Overall Study|Protocol Violation|1
2938078|NCT01402063|10115941|P2|Overall Study|Withdrawal by Subject|3
2938079|NCT01402063|10115942|P1|Overall Study|Withdrawal by Subject|3
2938080|NCT01402011|10115960|P3|Nine Month Follow-up|Withdrawal by Subject|0
2938081|NCT01402011|10115961|P2|Nine Month Follow-up|Withdrawal by Subject|1
2938082|NCT01402011|10115962|P1|Nine Month Follow-up|Withdrawal by Subject|0
2938083|NCT01402011|10115960|P3|Active Treatment Period|Withdrawal by Subject|0
2938084|NCT01402011|10115961|P2|Active Treatment Period|Withdrawal by Subject|3
2938085|NCT01402011|10115962|P1|Active Treatment Period|Withdrawal by Subject|1
2938086|NCT01402011|10115960|P3|Delayed Treatment Period|Withdrawal by Subject|0
2938087|NCT01402011|10115961|P2|Delayed Treatment Period|Withdrawal by Subject|0
2938088|NCT01402011|10115962|P1|Delayed Treatment Period|Withdrawal by Subject|1
2938089|NCT01401959|10115991|P3|Treated|Protocol Violation|0
2938090|NCT01401959|10115992|P2|Treated|Protocol Violation|1
2938091|NCT01401959|10115993|P1|Treated|Protocol Violation|0
2938092|NCT01401959|10115991|P3|Treated|Withdrawal by Subject|2
2938093|NCT01401959|10115992|P2|Treated|Withdrawal by Subject|2
2938094|NCT01401959|10115993|P1|Treated|Withdrawal by Subject|1
2938095|NCT01401959|10115991|P3|Treated|Adverse Event|2
2938096|NCT01401959|10115992|P2|Treated|Adverse Event|3
2938097|NCT01401959|10115993|P1|Treated|Adverse Event|4
2938098|NCT01401959|10115991|P3|Treated|Disease Progression|1
2938099|NCT01401959|10115992|P2|Treated|Disease Progression|2
2938100|NCT01401959|10115993|P1|Treated|Disease Progression|2
2938101|NCT01401959|10115991|P3|Enrolled|Withdrawal by Subject|0
2938102|NCT01401959|10115992|P2|Enrolled|Withdrawal by Subject|0
2938103|NCT01401959|10115993|P1|Enrolled|Withdrawal by Subject|1
2938104|NCT01401842|10116030|P2|Overall Study|other/unknown|17
2938105|NCT01401842|10116031|P1|Overall Study|other/unknown|28
2938106|NCT01401842|10116030|P2|Overall Study|on profile|5
2938107|NCT01401842|10116031|P1|Overall Study|on profile|9
2938108|NCT01401842|10116030|P2|Overall Study|invalid follow-up strength data|4
2938109|NCT01401842|10116031|P1|Overall Study|invalid follow-up strength data|1
2938110|NCT01401842|10116030|P2|Overall Study|discharged from US Army|4
2938111|NCT01401842|10116031|P1|Overall Study|discharged from US Army|3
2938112|NCT01401842|10116030|P2|Overall Study|changed companies|34
2938113|NCT01401842|10116031|P1|Overall Study|changed companies|20
2938114|NCT01401842|10116030|P2|Overall Study|academic reason|1
2938115|NCT01401842|10116031|P1|Overall Study|academic reason|4
2938116|NCT01401842|10116030|P2|Overall Study|Withdrawal by Subject|2
2938117|NCT01401842|10116031|P1|Overall Study|Withdrawal by Subject|3
2938118|NCT01401647|10116048|P3|Overall Study|Lost to Follow-up|1
2938119|NCT01401647|10116049|P2|Overall Study|Lost to Follow-up|3
2938120|NCT01401647|10116050|P1|Overall Study|Lost to Follow-up|3
2938121|NCT01401647|10116048|P3|Overall Study|Withdrawal by Subject|2
2938122|NCT01401647|10116049|P2|Overall Study|Withdrawal by Subject|5
2938123|NCT01401647|10116050|P1|Overall Study|Withdrawal by Subject|1
2938124|NCT01401530|10116120|P3|Overall Study|Physician Decision|0
2938125|NCT01401530|10116121|P2|Overall Study|Physician Decision|1
2938126|NCT01401530|10116122|P1|Overall Study|Physician Decision|0
2938127|NCT01401530|10116120|P3|Overall Study|Participant Choice|1
2938128|NCT01401530|10116121|P2|Overall Study|Participant Choice|2
2938129|NCT01401530|10116122|P1|Overall Study|Participant Choice|1
2938130|NCT01401530|10116120|P3|Overall Study|Adverse Event|1
2938131|NCT01401530|10116121|P2|Overall Study|Adverse Event|1
2938132|NCT01401530|10116122|P1|Overall Study|Adverse Event|1
2938133|NCT01401530|10116120|P3|Overall Study|Disease Progression|1
2938134|NCT01401530|10116121|P2|Overall Study|Disease Progression|2
2938135|NCT01401530|10116122|P1|Overall Study|Disease Progression|1
2938136|NCT01401478|10116181|P1|Overall Study|Serious adverse event|1
2938137|NCT01401478|10116181|P1|Overall Study|Low intact parathyroid hormone|1
2938138|NCT01401478|10116181|P1|Overall Study|Hyperphosphatemia and adverse event|1
2938139|NCT01401478|10116181|P1|Overall Study|Blood samples not available|1
2938140|NCT01401478|10116181|P1|Overall Study|Withdrawal by Subject|3
2938141|NCT01401478|10116181|P1|Overall Study|Kidney transplantation|3
2938142|NCT01401478|10116181|P1|Overall Study|Lost to Follow-up|5
2938143|NCT01401478|10116181|P1|Overall Study|Hyperphosphatemia|5
2938144|NCT01401478|10116181|P1|Overall Study|Adverse Event|5
2938145|NCT01401478|10116181|P1|Overall Study|Study drug not available|6
2938146|NCT01401465|10116194|P2|Treatment Period 2|Withdrawal by Subject|1
2938147|NCT01401465|10116195|P1|Treatment Period 2|Withdrawal by Subject|0
2938148|NCT01401465|10116194|P2|Treatment Period 2|Lost to Follow-up|1
2938149|NCT01401465|10116195|P1|Treatment Period 2|Lost to Follow-up|0
2938150|NCT01401465|10116194|P2|Treatment Period 1|Scheduling Difficulties|1
2938151|NCT01401465|10116195|P1|Treatment Period 1|Scheduling Difficulties|1
2938152|NCT01401465|10116194|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
2938153|NCT01401465|10116195|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
2938154|NCT01401465|10116194|P2|Treatment Period 1|Non-Compliance to Study Drug|0
2938155|NCT01401465|10116195|P1|Treatment Period 1|Non-Compliance to Study Drug|1
2938156|NCT01401465|10116194|P2|Treatment Period 1|Withdrawal by Subject|4
2938157|NCT01401465|10116195|P1|Treatment Period 1|Withdrawal by Subject|1
2938158|NCT01401465|10116194|P2|Treatment Period 1|Protocol Violation|0
2938159|NCT01401465|10116195|P1|Treatment Period 1|Protocol Violation|5
2938160|NCT01401465|10116194|P2|Treatment Period 1|Pregnancy|1
2938161|NCT01401465|10116195|P1|Treatment Period 1|Pregnancy|0
2938162|NCT01401465|10116194|P2|Treatment Period 1|Adverse Event|1
2938163|NCT01401465|10116195|P1|Treatment Period 1|Adverse Event|4
2938164|NCT01401452|10116258|P1|Overall Study|Participant withdrew consent|1
2938165|NCT01401452|10116258|P1|Overall Study|Subject chose to discontinue treatment|1
2938166|NCT01401452|10116258|P1|Overall Study|Subject withdrew because of Tx success|1
2938167|NCT01401452|10116258|P1|Overall Study|Unsatisfactory output|1
2938168|NCT01401452|10116258|P1|Overall Study|Treatment failure|1
2938169|NCT01401452|10116258|P1|Overall Study|Discontinuation for personal reasons|1
2938170|NCT01401452|10116258|P1|Overall Study|Participant stopped Tx|2
2938171|NCT01401452|10116258|P1|Overall Study|Psoriatic arthritis|1
2938172|NCT01401452|10116258|P1|Overall Study|Subject's wife wants to get pregnant|1
2938173|NCT01401452|10116258|P1|Overall Study|Subject moved to another city|1
2938174|NCT01401452|10116258|P1|Overall Study|Subject didn't return for routine visits|1
2938175|NCT01401452|10116258|P1|Overall Study|Subject did not come to follow up visits|2
2938176|NCT01401452|10116258|P1|Overall Study|No more visits within the 36 wk followup|4
2938177|NCT01401452|10116258|P1|Overall Study|Tx stopped by psychiatrist|1
2938178|NCT01401452|10116258|P1|Overall Study|Tx stopped due to financial reasons|1
2938179|NCT01401452|10116258|P1|Overall Study|Participant developed breast cancer|1
2938180|NCT01401452|10116258|P1|Overall Study|Lack of Efficacy|30
2938181|NCT01401452|10116258|P1|Overall Study|Lost to Follow-up|12
2938182|NCT01401452|10116258|P1|Overall Study|Adverse reaction|9
2938183|NCT01401361|10116270|P1|Overall Study|Subject/family decision post procedure|2
2938184|NCT01401361|10116270|P1|Overall Study|Lost to Follow-up|3
2938185|NCT01401361|10116270|P1|Overall Study|Physician Decision|1
2938186|NCT01401361|10116270|P1|Overall Study|Lack of Efficacy|6
2938187|NCT01401361|10116270|P1|Overall Study|Withdrawal by Subject|16
2938188|NCT01401322|10116276|P1|Overall Study|Physician Decision|1
2938189|NCT01401322|10116276|P1|Overall Study|Withdrawal by Subject|1
2938190|NCT01401283|10116282|P2|Overall Study|suspicion of malignant hyperthermia|1
2938191|NCT01401283|10116283|P1|Overall Study|suspicion of malignant hyperthermia|0
2938192|NCT01401283|10116282|P2|Overall Study|no central venous access|1
2938193|NCT01401283|10116283|P1|Overall Study|no central venous access|0
2938194|NCT01401283|10116282|P2|Overall Study|preoperative arrhythmia|0
2938195|NCT01401283|10116283|P1|Overall Study|preoperative arrhythmia|5
2938196|NCT01401283|10116282|P2|Overall Study|surgery cancelled|8
2938197|NCT01401283|10116283|P1|Overall Study|surgery cancelled|5
2938198|NCT01401153|10116349|P2|Second Test Day|illness|5
2938199|NCT01401153|10116350|P1|Second Test Day|illness|0
2938200|NCT01401153|10116349|P2|First Test Day|Learning disabilities; illness|10
2938201|NCT01401153|10116350|P1|First Test Day|Learning disabilities; illness|1
2938202|NCT01401062|10116397|P2|Overall Study|Withdrawal by Subject|1
2938203|NCT01401062|10116398|P1|Overall Study|Withdrawal by Subject|1
2938204|NCT01401062|10116397|P2|Overall Study|Physician Decision|0
2938205|NCT01401062|10116398|P1|Overall Study|Physician Decision|1
2938206|NCT01401062|10116397|P2|Overall Study|Death|7
2938207|NCT01401062|10116398|P1|Overall Study|Death|9
2938208|NCT01401010|10116425|P2|Overall Study|Could not interpret assay results|0
2938209|NCT01401010|10116426|P1|Overall Study|Could not interpret assay results|1
2938210|NCT01400971|10116449|P1|Overall Study|Other|422
2938211|NCT01400971|10116449|P1|Overall Study|Withdrawal by Subject|158
2938212|NCT01400971|10116449|P1|Overall Study|Physician Decision|57
2938213|NCT01400971|10116449|P1|Overall Study|Lost to follow up + Subject Decision|2
2938214|NCT01400971|10116449|P1|Overall Study|Lost to Follow-up|196
2938215|NCT01400971|10116449|P1|Overall Study|Death|82
2938216|NCT01400958|10116458|P2|Overall Study|Adverse Event|0
2938217|NCT01400958|10116459|P1|Overall Study|Adverse Event|1
2938218|NCT01400958|10116458|P2|Overall Study|Withdrawal by Subject|1
2938219|NCT01400958|10116459|P1|Overall Study|Withdrawal by Subject|0
2938220|NCT01400958|10116458|P2|Overall Study|Physician Decision|1
2938221|NCT01400958|10116459|P1|Overall Study|Physician Decision|0
2938222|NCT01400932|10116469|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
2938223|NCT01400932|10116470|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2938224|NCT01400932|10116469|P2|Overall Study|Protocol Deviation|1
2938225|NCT01400932|10116470|P1|Overall Study|Protocol Deviation|0
2938226|NCT01400932|10116469|P2|Overall Study|Lost to Follow-up|0
2938227|NCT01400932|10116470|P1|Overall Study|Lost to Follow-up|1
2938228|NCT01400932|10116469|P2|Overall Study|Withdrawal by Subject|6
2938229|NCT01400932|10116470|P1|Overall Study|Withdrawal by Subject|2
2938230|NCT01400932|10116469|P2|Overall Study|Lack of Efficacy|3
2938231|NCT01400932|10116470|P1|Overall Study|Lack of Efficacy|0
2938232|NCT01400932|10116469|P2|Overall Study|Adverse Event|5
2938233|NCT01400932|10116470|P1|Overall Study|Adverse Event|10
2938234|NCT01400919|10116492|P1|Overall Study|Missed visit|2
2938235|NCT01400919|10116492|P1|Overall Study|Lost to Follow-up|2
2938236|NCT01400919|10116492|P1|Overall Study|Withdrawal by Subject|4
2938237|NCT01400893|10116535|P2|Overall Study|Lost to Follow-up|6
2938238|NCT01400893|10116536|P1|Overall Study|Lost to Follow-up|0
2938239|NCT01400893|10116535|P2|Overall Study|Death|21
2938240|NCT01400893|10116536|P1|Overall Study|Death|27
2938241|NCT01400841|10116548|P1|Extended Study Phase (2 Years)|Adverse Event|2
2938242|NCT01400841|10116548|P1|Initial Study Phase (6 Months)|Death|1
2938243|NCT01400698|10116586|P6|Overall Study|Other|0
2938244|NCT01400698|10116587|P5|Overall Study|Other|1
2938245|NCT01400698|10116588|P4|Overall Study|Other|2
2938246|NCT01400698|10116589|P3|Overall Study|Other|0
2938247|NCT01400698|10116590|P2|Overall Study|Other|2
2938248|NCT01400698|10116591|P1|Overall Study|Other|4
2938249|NCT01400698|10116586|P6|Overall Study|Adverse Event|0
2938250|NCT01400698|10116587|P5|Overall Study|Adverse Event|0
2938251|NCT01400698|10116588|P4|Overall Study|Adverse Event|0
2938252|NCT01400698|10116589|P3|Overall Study|Adverse Event|0
2938253|NCT01400698|10116590|P2|Overall Study|Adverse Event|0
2938254|NCT01400698|10116591|P1|Overall Study|Adverse Event|1
2938255|NCT01400698|10116586|P6|Overall Study|Non-compliance|0
2938256|NCT01400698|10116587|P5|Overall Study|Non-compliance|0
2938257|NCT01400698|10116588|P4|Overall Study|Non-compliance|1
2938258|NCT01400698|10116589|P3|Overall Study|Non-compliance|0
2938259|NCT01400698|10116590|P2|Overall Study|Non-compliance|1
2938260|NCT01400698|10116591|P1|Overall Study|Non-compliance|0
2938261|NCT01400698|10116586|P6|Overall Study|Protocol Violation|0
2938262|NCT01400698|10116587|P5|Overall Study|Protocol Violation|1
2938263|NCT01400698|10116588|P4|Overall Study|Protocol Violation|0
2938264|NCT01400698|10116589|P3|Overall Study|Protocol Violation|0
2938265|NCT01400698|10116590|P2|Overall Study|Protocol Violation|1
2938266|NCT01400698|10116591|P1|Overall Study|Protocol Violation|0
2938267|NCT01400698|10116586|P6|Overall Study|Withdrawal by Subject|3
2938268|NCT01400698|10116587|P5|Overall Study|Withdrawal by Subject|1
2938269|NCT01400698|10116588|P4|Overall Study|Withdrawal by Subject|4
2938270|NCT01400698|10116589|P3|Overall Study|Withdrawal by Subject|0
2938271|NCT01400698|10116590|P2|Overall Study|Withdrawal by Subject|2
2938272|NCT01400698|10116591|P1|Overall Study|Withdrawal by Subject|8
2938273|NCT01400698|10116586|P6|Overall Study|Lost to Follow-up|3
2938274|NCT01400698|10116587|P5|Overall Study|Lost to Follow-up|4
2938275|NCT01400698|10116588|P4|Overall Study|Lost to Follow-up|1
2938276|NCT01400698|10116589|P3|Overall Study|Lost to Follow-up|2
2938277|NCT01400698|10116590|P2|Overall Study|Lost to Follow-up|5
2938278|NCT01400698|10116591|P1|Overall Study|Lost to Follow-up|2
2938279|NCT01400516|10116615|P2|Primary Trial|Withdrawal by Subject|2
2938280|NCT01400516|10116616|P1|Primary Trial|Withdrawal by Subject|0
2938281|NCT01400503|10116626|P1|Overall Study|Other|1
2938282|NCT01400503|10116626|P1|Overall Study|Study Terminated by Sponsor|58
2938283|NCT01400503|10116626|P1|Overall Study|Withdrawal by Subject|1
2938284|NCT01400451|10116649|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2938285|NCT01400451|10116650|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
2938286|NCT01400451|10116651|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2938287|NCT01400451|10116649|P3|Combination Treatment (or Intended)|Disease Progression|1
2938288|NCT01400451|10116650|P2|Combination Treatment (or Intended)|Disease Progression|1
2938289|NCT01400451|10116651|P1|Combination Treatment (or Intended)|Disease Progression|3
2938290|NCT01400451|10116649|P3|Combination Treatment (or Intended)|Adverse Event|0
2938291|NCT01400451|10116650|P2|Combination Treatment (or Intended)|Adverse Event|0
2938292|NCT01400451|10116651|P1|Combination Treatment (or Intended)|Adverse Event|1
2938293|NCT01400451|10116649|P3|Combination Treatment (or Intended)|Drug Toxicity|0
2938294|NCT01400451|10116650|P2|Combination Treatment (or Intended)|Drug Toxicity|1
2938295|NCT01400451|10116651|P1|Combination Treatment (or Intended)|Drug Toxicity|0
2938296|NCT01400451|10116649|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
2938297|NCT01400451|10116650|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
2938298|NCT01400451|10116651|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
2938299|NCT01400425|10116665|P1|Overall Study|Withdrawal by Subject|10
2938300|NCT01400412|10116678|P2|Overall Study|Never started study treatment|3
2938301|NCT01400412|10116679|P1|Overall Study|Never started study treatment|0
2938302|NCT01400412|10116678|P2|Overall Study|Unable to complete|3
2938303|NCT01400412|10116679|P1|Overall Study|Unable to complete|3
2938304|NCT01400412|10116678|P2|Overall Study|Withdrawal by Subject|4
2938305|NCT01400412|10116679|P1|Overall Study|Withdrawal by Subject|3
2938306|NCT01400412|10116678|P2|Overall Study|Lost to Follow-up|7
2938307|NCT01400412|10116679|P1|Overall Study|Lost to Follow-up|4
2938308|NCT01400243|10116725|P2|Overall Study|Protocol Violation|11
2938309|NCT01400243|10116726|P1|Overall Study|Protocol Violation|8
2938310|NCT01400139|10116748|P1|HYD Extension Period|Administrative|10
2938311|NCT01400139|10116748|P1|HYD Extension Period|Withdrawal by Subject|5
2938312|NCT01400139|10116748|P1|HYD Extension Period|Adverse Event|8
2938313|NCT01400139|10116748|P1|HYD Core Study|Did not qualify for Maintenance Period|14
2938314|NCT01400139|10116748|P1|HYD Core Study|Administrative|56
2938315|NCT01400139|10116748|P1|HYD Core Study|Confirmed or suspected diversion|20
2938316|NCT01400139|10116748|P1|HYD Core Study|Lost to Follow-up|39
2938317|NCT01400139|10116748|P1|HYD Core Study|Withdrawal by Subject|114
2938318|NCT01400139|10116748|P1|HYD Core Study|Lack of Efficacy|59
2938319|NCT01400139|10116748|P1|HYD Core Study|Adverse Event|210
2938320|NCT01400113|10116771|P2|Overall Study|Withdrawal by Subject|1
2938321|NCT01400113|10116772|P1|Overall Study|Withdrawal by Subject|1
2938322|NCT01399905|10116780|P2|Overall Study|Withdrawal by Subject|1
2938323|NCT01399905|10116781|P1|Overall Study|Withdrawal by Subject|1
2938324|NCT01399788|10116829|P2|First Intervention Period|Adverse Event|0
2938325|NCT01399788|10116830|P1|First Intervention Period|Adverse Event|1
2938326|NCT01399723|10116852|P2|Overall Study|Lost to Follow-up|1
2938327|NCT01399723|10116853|P1|Overall Study|Lost to Follow-up|0
2938328|NCT01399697|10116866|P3|Overall Study|Sponsor Decision|0
2938329|NCT01399697|10116867|P2|Overall Study|Sponsor Decision|0
2938330|NCT01399697|10116868|P1|Overall Study|Sponsor Decision|1
2938331|NCT01399697|10116866|P3|Overall Study|Clinical RA remission|0
2938332|NCT01399697|10116867|P2|Overall Study|Clinical RA remission|0
2938333|NCT01399697|10116868|P1|Overall Study|Clinical RA remission|1
2938334|NCT01399697|10116866|P3|Overall Study|Positive result for hepatitis B|0
2938335|NCT01399697|10116867|P2|Overall Study|Positive result for hepatitis B|0
2938336|NCT01399697|10116868|P1|Overall Study|Positive result for hepatitis B|1
2938337|NCT01399697|10116866|P3|Overall Study|Inclusion Error|0
2938338|NCT01399697|10116867|P2|Overall Study|Inclusion Error|0
2938339|NCT01399697|10116868|P1|Overall Study|Inclusion Error|2
2938340|NCT01399697|10116866|P3|Overall Study|Non-Compliant|0
2938341|NCT01399697|10116867|P2|Overall Study|Non-Compliant|0
2938342|NCT01399697|10116868|P1|Overall Study|Non-Compliant|1
2938343|NCT01399697|10116866|P3|Overall Study|Protocol Violation|0
2938344|NCT01399697|10116867|P2|Overall Study|Protocol Violation|0
2938345|NCT01399697|10116868|P1|Overall Study|Protocol Violation|2
2938346|NCT01399697|10116866|P3|Overall Study|Lack of Efficacy|1
2938347|NCT01399697|10116867|P2|Overall Study|Lack of Efficacy|0
2938348|NCT01399697|10116868|P1|Overall Study|Lack of Efficacy|9
2938349|NCT01399697|10116866|P3|Overall Study|Investigator Decisión|2
2938350|NCT01399697|10116867|P2|Overall Study|Investigator Decisión|0
2938351|NCT01399697|10116868|P1|Overall Study|Investigator Decisión|1
2938352|NCT01399697|10116866|P3|Overall Study|Withdrawal by Subject|0
2938353|NCT01399697|10116867|P2|Overall Study|Withdrawal by Subject|0
2938354|NCT01399697|10116868|P1|Overall Study|Withdrawal by Subject|8
2938355|NCT01399697|10116866|P3|Overall Study|Lost to Follow-up|0
2938356|NCT01399697|10116867|P2|Overall Study|Lost to Follow-up|0
2938357|NCT01399697|10116868|P1|Overall Study|Lost to Follow-up|2
2938358|NCT01399697|10116866|P3|Overall Study|Adverse Event|1
2938359|NCT01399697|10116867|P2|Overall Study|Adverse Event|3
2938360|NCT01399697|10116868|P1|Overall Study|Adverse Event|13
2938361|NCT01399619|10116895|P4|Overall Study|Not treated|2
2938362|NCT01399619|10116896|P3|Overall Study|Not treated|0
2938363|NCT01399619|10116897|P2|Overall Study|Not treated|0
2938364|NCT01399619|10116898|P1|Overall Study|Not treated|0
2938365|NCT01399619|10116895|P4|Overall Study|Protocol Violation|1
2938366|NCT01399619|10116896|P3|Overall Study|Protocol Violation|0
2938367|NCT01399619|10116897|P2|Overall Study|Protocol Violation|0
2938368|NCT01399619|10116898|P1|Overall Study|Protocol Violation|0
2938369|NCT01399619|10116895|P4|Overall Study|Withdrawal by Subject|4
2938370|NCT01399619|10116896|P3|Overall Study|Withdrawal by Subject|3
2938371|NCT01399619|10116897|P2|Overall Study|Withdrawal by Subject|0
2938372|NCT01399619|10116898|P1|Overall Study|Withdrawal by Subject|6
2938373|NCT01399619|10116895|P4|Overall Study|Lack of Efficacy|0
2938374|NCT01399619|10116896|P3|Overall Study|Lack of Efficacy|5
2938375|NCT01399619|10116897|P2|Overall Study|Lack of Efficacy|0
2938376|NCT01399619|10116898|P1|Overall Study|Lack of Efficacy|9
2938377|NCT01399619|10116895|P4|Overall Study|Adverse Event|10
2938378|NCT01399619|10116896|P3|Overall Study|Adverse Event|4
2938379|NCT01399619|10116897|P2|Overall Study|Adverse Event|0
2938380|NCT01399619|10116898|P1|Overall Study|Adverse Event|10
2938381|NCT01399593|10116961|P2|Overall Study|Transplantectomy|1
2938382|NCT01399593|10116962|P1|Overall Study|Transplantectomy|0
2938383|NCT01399593|10116961|P2|Overall Study|Death|1
2938384|NCT01399593|10116962|P1|Overall Study|Death|1
2938385|NCT01399593|10116961|P2|Overall Study|Adverse Event|0
2938386|NCT01399593|10116962|P1|Overall Study|Adverse Event|1
2938387|NCT01399593|10116961|P2|Overall Study|Physician Decision|0
2938388|NCT01399593|10116962|P1|Overall Study|Physician Decision|1
2938389|NCT01399190|10116995|P1|Overall Study|Physician Decision|2
2938390|NCT01399190|10116995|P1|Overall Study|Participant's Request|5
2938391|NCT01399190|10116995|P1|Overall Study|Adverse Event|8
2938392|NCT01399190|10116995|P1|Overall Study|Not Eligible for Final Analysis|5
2938393|NCT01399125|10117003|P2|Overall Study|Protocol Deviation|2
2938394|NCT01399125|10117004|P1|Overall Study|Protocol Deviation|5
2938395|NCT01399125|10117003|P2|Overall Study|Death|1
2938396|NCT01399125|10117004|P1|Overall Study|Death|0
2938397|NCT01399125|10117003|P2|Overall Study|Administrative Problems|11
2938398|NCT01399125|10117004|P1|Overall Study|Administrative Problems|7
2938399|NCT01399125|10117003|P2|Overall Study|Lost to Follow-up|3
2938400|NCT01399125|10117004|P1|Overall Study|Lost to Follow-up|2
2938401|NCT01399125|10117003|P2|Overall Study|Withdrawal by Subject|8
2938402|NCT01399125|10117004|P1|Overall Study|Withdrawal by Subject|5
2938403|NCT01399125|10117003|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
2938404|NCT01399125|10117004|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
2938405|NCT01399125|10117003|P2|Overall Study|Abnormal Lab values|1
2938406|NCT01399125|10117004|P1|Overall Study|Abnormal Lab values|0
2938407|NCT01399125|10117003|P2|Overall Study|Adverse Event|30
2938408|NCT01399125|10117004|P1|Overall Study|Adverse Event|32
2938409|NCT01399099|10117018|P1|Overall Study|Miscellaneous|4
2938410|NCT01399099|10117018|P1|Overall Study|Infection|1
2938411|NCT01399099|10117018|P1|Overall Study|Skin Irritation|13
2938412|NCT01399099|10117018|P1|Overall Study|Protocol Violation|1
2938413|NCT01399099|10117018|P1|Overall Study|Physician Decision|1
2938414|NCT01399099|10117018|P1|Overall Study|Lost to Follow-up|11
2938415|NCT01399047|10117025|P2|Overall Study|Withdrawal by Subject|1
2938416|NCT01399047|10117026|P1|Overall Study|Withdrawal by Subject|0
2938417|NCT01398956|10117062|P1|Overall Study|Subject moved a long distance|1
2938418|NCT01398956|10117062|P1|Overall Study|Withdrawal Criteria No.3|1
2938419|NCT01398956|10117062|P1|Overall Study|AE, non-serious non-fatal|4
2938420|NCT01398956|10117062|P1|Overall Study|Withdrawal by Subject|4
2938421|NCT01398787|10117094|P1|Overall Study|Adverse Event|1
2938422|NCT01398514|10117112|P2|Overall Study|Failure to show a conditioned response|3
2938423|NCT01398514|10117113|P1|Overall Study|Failure to show a conditioned response|4
2938424|NCT01398514|10117112|P2|Overall Study|Physiologic non-responsiveness|3
2938425|NCT01398514|10117113|P1|Overall Study|Physiologic non-responsiveness|1
2938426|NCT01398514|10117112|P2|Overall Study|Non-compliance with study procedures|0
2938427|NCT01398514|10117113|P1|Overall Study|Non-compliance with study procedures|2
2938428|NCT01398514|10117112|P2|Overall Study|Adverse Event|0
2938429|NCT01398514|10117113|P1|Overall Study|Adverse Event|1
2938430|NCT01398410|10117148|P2|Overall Study|Other|29
2938431|NCT01398410|10117149|P1|Overall Study|Other|36
2938432|NCT01398410|10117148|P2|Overall Study|Inadequate Therapeutic Effect|0
2938433|NCT01398410|10117149|P1|Overall Study|Inadequate Therapeutic Effect|2
2938434|NCT01398410|10117148|P2|Overall Study|Participants Choice|11
2938435|NCT01398410|10117149|P1|Overall Study|Participants Choice|8
2938436|NCT01398410|10117148|P2|Overall Study|Adverse Event|16
2938437|NCT01398410|10117149|P1|Overall Study|Adverse Event|12
2938438|NCT01398358|10117160|P3|Overall Study|no longer eligible|1
2938439|NCT01398358|10117161|P2|Overall Study|no longer eligible|0
2938440|NCT01398358|10117162|P1|Overall Study|no longer eligible|1
2938441|NCT01398358|10117160|P3|Overall Study|Withdrawal by Subject|2
2938442|NCT01398358|10117161|P2|Overall Study|Withdrawal by Subject|2
2938443|NCT01398358|10117162|P1|Overall Study|Withdrawal by Subject|3
2938444|NCT01398358|10117160|P3|Overall Study|Lost to Follow-up|18
2938445|NCT01398358|10117161|P2|Overall Study|Lost to Follow-up|21
2938446|NCT01398358|10117162|P1|Overall Study|Lost to Follow-up|11
2938447|NCT01398176|10117184|P2|Overall Study|Physician Decision|3
2938448|NCT01398176|10117185|P1|Overall Study|Physician Decision|2
2938449|NCT01398176|10117184|P2|Overall Study|Lost to Follow-up|3
2938450|NCT01398176|10117185|P1|Overall Study|Lost to Follow-up|1
2938451|NCT01397890|10117218|P2|Overall Study|Others|1
2938452|NCT01397890|10117219|P1|Overall Study|Others|2
2938453|NCT01397890|10117218|P2|Overall Study|Severe Non-Compliance to Protocol|1
2938454|NCT01397890|10117219|P1|Overall Study|Severe Non-Compliance to Protocol|2
2938455|NCT01397890|10117218|P2|Overall Study|Adverse Event|2
2938456|NCT01397890|10117219|P1|Overall Study|Adverse Event|1
2938457|NCT01397890|10117218|P2|Overall Study|Condition under Investigation Worsened|3
2938458|NCT01397890|10117219|P1|Overall Study|Condition under Investigation Worsened|1
2938459|NCT01397890|10117218|P2|Overall Study|Lost to Follow-up|4
2938460|NCT01397890|10117219|P1|Overall Study|Lost to Follow-up|1
2938461|NCT01397890|10117218|P2|Overall Study|Death|3
2938462|NCT01397890|10117219|P1|Overall Study|Death|2
2938463|NCT01397890|10117218|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
2938464|NCT01397890|10117219|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
2938465|NCT01397890|10117218|P2|Overall Study|Withdrawal by Subject|11
2938466|NCT01397890|10117219|P1|Overall Study|Withdrawal by Subject|7
2938467|NCT01397825|10117290|P5|Overall Study|Withdrawal by Subject|0
2938468|NCT01397825|10117291|P4|Overall Study|Withdrawal by Subject|1
2938469|NCT01397825|10117292|P3|Overall Study|Withdrawal by Subject|5
2938470|NCT01397825|10117293|P2|Overall Study|Withdrawal by Subject|0
2938471|NCT01397825|10117294|P1|Overall Study|Withdrawal by Subject|1
2938472|NCT01397825|10117290|P5|Overall Study|Adverse Event|0
2938473|NCT01397825|10117291|P4|Overall Study|Adverse Event|1
2938474|NCT01397825|10117292|P3|Overall Study|Adverse Event|5
2938475|NCT01397825|10117293|P2|Overall Study|Adverse Event|1
2938476|NCT01397825|10117294|P1|Overall Study|Adverse Event|0
2938477|NCT01397825|10117290|P5|Overall Study|Symptomatic Deterioration|0
2938478|NCT01397825|10117291|P4|Overall Study|Symptomatic Deterioration|0
2938479|NCT01397825|10117292|P3|Overall Study|Symptomatic Deterioration|4
2938480|NCT01397825|10117293|P2|Overall Study|Symptomatic Deterioration|0
2938481|NCT01397825|10117294|P1|Overall Study|Symptomatic Deterioration|2
2938482|NCT01397825|10117290|P5|Overall Study|Progressive Disease|0
2938483|NCT01397825|10117291|P4|Overall Study|Progressive Disease|1
2938484|NCT01397825|10117292|P3|Overall Study|Progressive Disease|11
2938485|NCT01397825|10117293|P2|Overall Study|Progressive Disease|3
2938486|NCT01397825|10117294|P1|Overall Study|Progressive Disease|10
2938487|NCT01397786|10117364|P3|Phase B|Lack of Efficacy|14
2938488|NCT01397786|10117365|P2|Phase B|Lack of Efficacy|7
2938489|NCT01397786|10117366|P1|Phase B|Lack of Efficacy|22
2938490|NCT01397786|10117364|P3|Phase B|Protocol Deviation|4
2938491|NCT01397786|10117365|P2|Phase B|Protocol Deviation|2
2938492|NCT01397786|10117366|P1|Phase B|Protocol Deviation|1
2938493|NCT01397786|10117364|P3|Phase B|Withdrawal by Subject|30
2938494|NCT01397786|10117365|P2|Phase B|Withdrawal by Subject|45
2938495|NCT01397786|10117366|P1|Phase B|Withdrawal by Subject|102
2938496|NCT01397786|10117364|P3|Phase B|Physician Decision|3
2938497|NCT01397786|10117365|P2|Phase B|Physician Decision|1
2938498|NCT01397786|10117366|P1|Phase B|Physician Decision|9
2938499|NCT01397786|10117364|P3|Phase B|Subject Met Withdrawal Criteria|38
2938500|NCT01397786|10117365|P2|Phase B|Subject Met Withdrawal Criteria|5
2938501|NCT01397786|10117366|P1|Phase B|Subject Met Withdrawal Criteria|38
2938502|NCT01397786|10117364|P3|Phase B|Adverse Event|27
2938503|NCT01397786|10117365|P2|Phase B|Adverse Event|23
2938504|NCT01397786|10117366|P1|Phase B|Adverse Event|109
2938505|NCT01397786|10117364|P3|Phase B|Lost to Follow-up|22
2938506|NCT01397786|10117365|P2|Phase B|Lost to Follow-up|12
2938507|NCT01397786|10117366|P1|Phase B|Lost to Follow-up|22
2938508|NCT01397786|10117364|P3|Phase A|Lack of Efficacy|1
2938509|NCT01397786|10117365|P2|Phase A|Lack of Efficacy|0
2938510|NCT01397786|10117366|P1|Phase A|Lack of Efficacy|0
2938511|NCT01397786|10117364|P3|Phase A|Withdrawal by Subject|5
2938512|NCT01397786|10117365|P2|Phase A|Withdrawal by Subject|0
2938513|NCT01397786|10117366|P1|Phase A|Withdrawal by Subject|0
2938514|NCT01397786|10117364|P3|Phase A|Physician Decision|1
2938515|NCT01397786|10117365|P2|Phase A|Physician Decision|0
2938516|NCT01397786|10117366|P1|Phase A|Physician Decision|0
2938517|NCT01397786|10117364|P3|Phase A|Subject Met Withdrawal Criteria|7
2938518|NCT01397786|10117365|P2|Phase A|Subject Met Withdrawal Criteria|0
2938519|NCT01397786|10117366|P1|Phase A|Subject Met Withdrawal Criteria|0
2938520|NCT01397786|10117364|P3|Phase A|Adverse Event|8
2938521|NCT01397786|10117365|P2|Phase A|Adverse Event|0
2938522|NCT01397786|10117366|P1|Phase A|Adverse Event|0
2938523|NCT01397786|10117364|P3|Phase A|Lost to Follow-up|6
2938524|NCT01397786|10117365|P2|Phase A|Lost to Follow-up|0
2938525|NCT01397786|10117366|P1|Phase A|Lost to Follow-up|0
2938526|NCT01397747|10117432|P1|Overall Study|FIT excluded|34
2938527|NCT01397747|10117432|P1|Overall Study|Colonoscopy excluded|304
2938528|NCT01397747|10117432|P1|Overall Study|Multitarget DNA test excluded|689
2938529|NCT01397552|10117482|P2|Overall Study|Withdrawal by Subject|1
2938530|NCT01397552|10117483|P1|Overall Study|Withdrawal by Subject|2
2938531|NCT01397552|10117482|P2|Overall Study|Adverse Event|0
2938532|NCT01397552|10117483|P1|Overall Study|Adverse Event|1
2938533|NCT01397461|10117492|P3|Overall Study|Not treated|1
2938534|NCT01397461|10117493|P2|Overall Study|Not treated|0
2938535|NCT01397461|10117494|P1|Overall Study|Not treated|0
2938536|NCT01397461|10117492|P3|Overall Study|Lack of Efficacy|0
2938537|NCT01397461|10117493|P2|Overall Study|Lack of Efficacy|3
2938538|NCT01397461|10117494|P1|Overall Study|Lack of Efficacy|0
2938539|NCT01397461|10117492|P3|Overall Study|Lost to Follow-up|1
2938540|NCT01397461|10117493|P2|Overall Study|Lost to Follow-up|2
2938541|NCT01397461|10117494|P1|Overall Study|Lost to Follow-up|0
2938542|NCT01397461|10117492|P3|Overall Study|Withdrawal by Subject|0
2938543|NCT01397461|10117493|P2|Overall Study|Withdrawal by Subject|1
2938544|NCT01397461|10117494|P1|Overall Study|Withdrawal by Subject|2
2938545|NCT01397448|10117505|P3|Overall Study|Other|4
2938546|NCT01397448|10117506|P2|Overall Study|Other|7
2938547|NCT01397448|10117507|P1|Overall Study|Other|8
2938548|NCT01397448|10117505|P3|Overall Study|Lack of Efficacy|5
2938549|NCT01397448|10117506|P2|Overall Study|Lack of Efficacy|0
2938550|NCT01397448|10117507|P1|Overall Study|Lack of Efficacy|2
2938551|NCT01397448|10117505|P3|Overall Study|Withdrawal by Subject|3
2938552|NCT01397448|10117506|P2|Overall Study|Withdrawal by Subject|4
2938553|NCT01397448|10117507|P1|Overall Study|Withdrawal by Subject|4
2938554|NCT01397448|10117505|P3|Overall Study|Adverse Event|6
2938555|NCT01397448|10117506|P2|Overall Study|Adverse Event|4
2938556|NCT01397448|10117507|P1|Overall Study|Adverse Event|4
2938557|NCT01397422|10117522|P4|Overall Study|Increased bradykinesia related to PD|0
2938558|NCT01397422|10117523|P3|Overall Study|Increased bradykinesia related to PD|0
2938559|NCT01397422|10117524|P2|Overall Study|Increased bradykinesia related to PD|0
2938560|NCT01397422|10117525|P1|Overall Study|Increased bradykinesia related to PD|1
2938561|NCT01397422|10117522|P4|Overall Study|Withdrawal by Subject|0
2938562|NCT01397422|10117523|P3|Overall Study|Withdrawal by Subject|0
2938563|NCT01397422|10117524|P2|Overall Study|Withdrawal by Subject|0
2938564|NCT01397422|10117525|P1|Overall Study|Withdrawal by Subject|1
2938565|NCT01397422|10117522|P4|Overall Study|Adverse Event|8
2938566|NCT01397422|10117523|P3|Overall Study|Adverse Event|3
2938567|NCT01397422|10117524|P2|Overall Study|Adverse Event|3
2938568|NCT01397422|10117525|P1|Overall Study|Adverse Event|0
2938569|NCT01397409|10117565|P10|Stage 3|Other Miscellaneous Reasons|0
2938570|NCT01397409|10117566|P9|Stage 3|Other Miscellaneous Reasons|0
2938571|NCT01397409|10117567|P8|Stage 3|Other Miscellaneous Reasons|1
2938572|NCT01397409|10117568|P7|Stage 3|Other Miscellaneous Reasons|0
2938573|NCT01397409|10117569|P6|Stage 3|Other Miscellaneous Reasons|0
2938574|NCT01397409|10117570|P5|Stage 3|Other Miscellaneous Reasons|0
2938575|NCT01397409|10117571|P4|Stage 3|Other Miscellaneous Reasons|0
2938576|NCT01397409|10117572|P3|Stage 3|Other Miscellaneous Reasons|0
2938577|NCT01397409|10117573|P2|Stage 3|Other Miscellaneous Reasons|0
2938578|NCT01397409|10117574|P1|Stage 3|Other Miscellaneous Reasons|0
2938579|NCT01397409|10117565|P10|Stage 3|Adverse Event|0
2938580|NCT01397409|10117566|P9|Stage 3|Adverse Event|0
2938581|NCT01397409|10117567|P8|Stage 3|Adverse Event|1
2938582|NCT01397409|10117568|P7|Stage 3|Adverse Event|0
2938583|NCT01397409|10117569|P6|Stage 3|Adverse Event|0
2938584|NCT01397409|10117570|P5|Stage 3|Adverse Event|0
2938585|NCT01397409|10117571|P4|Stage 3|Adverse Event|0
2938586|NCT01397409|10117572|P3|Stage 3|Adverse Event|0
2938587|NCT01397409|10117573|P2|Stage 3|Adverse Event|0
2938588|NCT01397409|10117574|P1|Stage 3|Adverse Event|0
2938589|NCT01397409|10117565|P10|Stage 2|Other Miscellaneous Reasons|0
2938590|NCT01397409|10117566|P9|Stage 2|Other Miscellaneous Reasons|0
2938591|NCT01397409|10117567|P8|Stage 2|Other Miscellaneous Reasons|0
2938592|NCT01397409|10117568|P7|Stage 2|Other Miscellaneous Reasons|0
2938593|NCT01397409|10117569|P6|Stage 2|Other Miscellaneous Reasons|1
2938594|NCT01397409|10117570|P5|Stage 2|Other Miscellaneous Reasons|1
2938595|NCT01397409|10117571|P4|Stage 2|Other Miscellaneous Reasons|0
2938596|NCT01397409|10117572|P3|Stage 2|Other Miscellaneous Reasons|0
2938597|NCT01397409|10117573|P2|Stage 2|Other Miscellaneous Reasons|0
2938598|NCT01397409|10117574|P1|Stage 2|Other Miscellaneous Reasons|0
2938599|NCT01397409|10117565|P10|Stage 2|Personal Reasons|0
2938600|NCT01397409|10117566|P9|Stage 2|Personal Reasons|0
2938601|NCT01397409|10117567|P8|Stage 2|Personal Reasons|0
2938602|NCT01397409|10117568|P7|Stage 2|Personal Reasons|0
2938603|NCT01397409|10117569|P6|Stage 2|Personal Reasons|0
2938604|NCT01397409|10117570|P5|Stage 2|Personal Reasons|1
2938605|NCT01397409|10117571|P4|Stage 2|Personal Reasons|0
2938606|NCT01397409|10117572|P3|Stage 2|Personal Reasons|0
2938607|NCT01397409|10117573|P2|Stage 2|Personal Reasons|0
2938608|NCT01397409|10117574|P1|Stage 2|Personal Reasons|0
2938609|NCT01397409|10117565|P10|Stage 2|Adverse Event|0
2938610|NCT01397409|10117566|P9|Stage 2|Adverse Event|0
2938611|NCT01397409|10117567|P8|Stage 2|Adverse Event|0
2938612|NCT01397409|10117568|P7|Stage 2|Adverse Event|0
2938613|NCT01397409|10117569|P6|Stage 2|Adverse Event|3
2938614|NCT01397409|10117570|P5|Stage 2|Adverse Event|6
2938615|NCT01397409|10117571|P4|Stage 2|Adverse Event|0
2938616|NCT01397409|10117572|P3|Stage 2|Adverse Event|0
2938617|NCT01397409|10117573|P2|Stage 2|Adverse Event|0
2938618|NCT01397409|10117574|P1|Stage 2|Adverse Event|0
2938619|NCT01397253|10117614|P2|Overall Study|Reviewed by only 1 pharmacist|149
2938620|NCT01397253|10117615|P1|Overall Study|Reviewed by only 1 pharmacist|126
2938621|NCT01397084|10117621|P1|Overall Study|Used other proton pump inhibitor|1
2938622|NCT01397084|10117621|P1|Overall Study|Lost to Follow-up|1
2938623|NCT01397084|10117621|P1|Overall Study|Withdrawal by Subject|1
2938624|NCT01397084|10117621|P1|Overall Study|Adverse Event|2
2938625|NCT01397084|10117621|P1|Overall Study|Protocol Violation|2
2938626|NCT01397084|10117621|P1|Overall Study|Severe Non-Compliance to Protocol|1
2938627|NCT01396525|10117640|P1|Overall Study|Lost to Follow-up|4
2938628|NCT01396525|10117640|P1|Overall Study|Death|14
2938629|NCT01396525|10117640|P1|Overall Study|Withdrawal by Subject|8
2938630|NCT01396512|10117740|P2|Overall Study|Withdrawal by Subject|1
2938631|NCT01396512|10117741|P1|Overall Study|Withdrawal by Subject|0
2938632|NCT01396447|10117773|P4|Overall Study|Other Miscellaneous Reasons|0
2938633|NCT01396447|10117774|P3|Overall Study|Other Miscellaneous Reasons|1
2938634|NCT01396447|10117775|P2|Overall Study|Other Miscellaneous Reasons|2
2938635|NCT01396447|10117776|P1|Overall Study|Other Miscellaneous Reasons|0
2938636|NCT01396447|10117773|P4|Overall Study|Lost to Follow-up|9
2938637|NCT01396447|10117774|P3|Overall Study|Lost to Follow-up|7
2938638|NCT01396447|10117775|P2|Overall Study|Lost to Follow-up|8
2938639|NCT01396447|10117776|P1|Overall Study|Lost to Follow-up|4
2938640|NCT01396447|10117773|P4|Overall Study|Withdrawal of Consent|15
2938641|NCT01396447|10117774|P3|Overall Study|Withdrawal of Consent|4
2938642|NCT01396447|10117775|P2|Overall Study|Withdrawal of Consent|9
2938643|NCT01396447|10117776|P1|Overall Study|Withdrawal of Consent|11
2938644|NCT01396447|10117773|P4|Overall Study|Protocol Violation|7
2938645|NCT01396447|10117774|P3|Overall Study|Protocol Violation|3
2938646|NCT01396447|10117775|P2|Overall Study|Protocol Violation|2
2938647|NCT01396447|10117776|P1|Overall Study|Protocol Violation|5
2938648|NCT01396447|10117773|P4|Overall Study|Insufficient Therapeutic Response|4
2938649|NCT01396447|10117774|P3|Overall Study|Insufficient Therapeutic Response|2
2938650|NCT01396447|10117775|P2|Overall Study|Insufficient Therapeutic Response|5
2938651|NCT01396447|10117776|P1|Overall Study|Insufficient Therapeutic Response|5
2938652|NCT01396447|10117773|P4|Overall Study|Adverse Event|17
2938653|NCT01396447|10117774|P3|Overall Study|Adverse Event|12
2938654|NCT01396447|10117775|P2|Overall Study|Adverse Event|12
2938655|NCT01396447|10117776|P1|Overall Study|Adverse Event|15
2938656|NCT01396447|10117773|P4|Overall Study|Did Not Receive Treatment|0
2938657|NCT01396447|10117774|P3|Overall Study|Did Not Receive Treatment|1
2938658|NCT01396447|10117775|P2|Overall Study|Did Not Receive Treatment|2
2938659|NCT01396447|10117776|P1|Overall Study|Did Not Receive Treatment|3
2938660|NCT01396434|10117793|P3|Overall Study|Other|0
2938661|NCT01396434|10117794|P2|Overall Study|Other|0
2938662|NCT01396434|10117795|P1|Overall Study|Other|10
2938663|NCT01396434|10117793|P3|Overall Study|Lost to Follow-up|0
2938664|NCT01396434|10117794|P2|Overall Study|Lost to Follow-up|0
2938665|NCT01396434|10117795|P1|Overall Study|Lost to Follow-up|1
2938666|NCT01396421|10117807|P4|Overall Study|Lack of Efficacy|18
2938667|NCT01396421|10117808|P3|Overall Study|Lack of Efficacy|7
2938668|NCT01396421|10117809|P2|Overall Study|Lack of Efficacy|17
2938669|NCT01396421|10117810|P1|Overall Study|Lack of Efficacy|7
2938670|NCT01396421|10117807|P4|Overall Study|Protocol Deviation|0
2938671|NCT01396421|10117808|P3|Overall Study|Protocol Deviation|1
2938672|NCT01396421|10117809|P2|Overall Study|Protocol Deviation|1
2938673|NCT01396421|10117810|P1|Overall Study|Protocol Deviation|2
2938674|NCT01396421|10117807|P4|Overall Study|Withdrawal by Subject|21
2938675|NCT01396421|10117808|P3|Overall Study|Withdrawal by Subject|13
2938676|NCT01396421|10117809|P2|Overall Study|Withdrawal by Subject|24
2938677|NCT01396421|10117810|P1|Overall Study|Withdrawal by Subject|31
2938678|NCT01396421|10117807|P4|Overall Study|Physician Decision|3
2938679|NCT01396421|10117808|P3|Overall Study|Physician Decision|0
2938680|NCT01396421|10117809|P2|Overall Study|Physician Decision|1
2938681|NCT01396421|10117810|P1|Overall Study|Physician Decision|1
2938682|NCT01396421|10117807|P4|Overall Study|Participant Met Withdrawal Criteria|0
2938683|NCT01396421|10117808|P3|Overall Study|Participant Met Withdrawal Criteria|1
2938684|NCT01396421|10117809|P2|Overall Study|Participant Met Withdrawal Criteria|0
2938685|NCT01396421|10117810|P1|Overall Study|Participant Met Withdrawal Criteria|1
2938686|NCT01396421|10117807|P4|Overall Study|Adverse Event|32
2938687|NCT01396421|10117808|P3|Overall Study|Adverse Event|12
2938688|NCT01396421|10117809|P2|Overall Study|Adverse Event|15
2938689|NCT01396421|10117810|P1|Overall Study|Adverse Event|17
2938690|NCT01396421|10117807|P4|Overall Study|Lost to Follow-up|1
2938691|NCT01396421|10117808|P3|Overall Study|Lost to Follow-up|0
2938692|NCT01396421|10117809|P2|Overall Study|Lost to Follow-up|0
2938693|NCT01396421|10117810|P1|Overall Study|Lost to Follow-up|0
2938694|NCT01396395|10117882|P2|Overall Study|Other|1
2938695|NCT01396395|10117883|P1|Overall Study|Other|0
2938696|NCT01396395|10117882|P2|Overall Study|Lost to Follow-up|11
2938697|NCT01396395|10117883|P1|Overall Study|Lost to Follow-up|17
2938698|NCT01396395|10117882|P2|Overall Study|Adverse Event|2
2938699|NCT01396395|10117883|P1|Overall Study|Adverse Event|10
2938700|NCT01396395|10117882|P2|Overall Study|Protocol Violation|1
2938701|NCT01396395|10117883|P1|Overall Study|Protocol Violation|3
2938702|NCT01396395|10117882|P2|Overall Study|Withdrawal by Subject|12
2938703|NCT01396395|10117883|P1|Overall Study|Withdrawal by Subject|10
2938704|NCT01396317|10117925|P2|Overall Study|Adverse Event|0
2938705|NCT01396317|10117926|P1|Overall Study|Adverse Event|1
2938706|NCT01396265|10117940|P1|Rifa+Afatinib|Withdrawal by Subject|1
2938707|NCT01396187|10118029|P5|Overall Study|Other|1
2938708|NCT01396187|10118030|P4|Overall Study|Other|0
2938709|NCT01396187|10118031|P3|Overall Study|Other|0
2938710|NCT01396187|10118032|P2|Overall Study|Other|1
2938711|NCT01396187|10118033|P1|Overall Study|Other|1
2938712|NCT01396187|10118029|P5|Overall Study|Withdrawal by Subject|0
2938713|NCT01396187|10118030|P4|Overall Study|Withdrawal by Subject|0
2938714|NCT01396187|10118031|P3|Overall Study|Withdrawal by Subject|1
2938715|NCT01396187|10118032|P2|Overall Study|Withdrawal by Subject|1
2938716|NCT01396187|10118033|P1|Overall Study|Withdrawal by Subject|0
2938717|NCT01396187|10118029|P5|Overall Study|Adverse Event|0
2938718|NCT01396187|10118030|P4|Overall Study|Adverse Event|0
2938719|NCT01396187|10118031|P3|Overall Study|Adverse Event|0
2938720|NCT01396187|10118032|P2|Overall Study|Adverse Event|1
2938721|NCT01396187|10118033|P1|Overall Study|Adverse Event|0
2938722|NCT01396161|10118133|P7|Overall Study|Other|1
2938723|NCT01396161|10118134|P6|Overall Study|Other|0
2938724|NCT01396161|10118135|P5|Overall Study|Other|0
2938725|NCT01396161|10118136|P4|Overall Study|Other|0
2938726|NCT01396161|10118137|P3|Overall Study|Other|0
2938727|NCT01396161|10118138|P2|Overall Study|Other|0
2938728|NCT01396161|10118139|P1|Overall Study|Other|0
2938729|NCT01396161|10118133|P7|Overall Study|Withdrawal by Subject|0
2938730|NCT01396161|10118134|P6|Overall Study|Withdrawal by Subject|0
2938731|NCT01396161|10118135|P5|Overall Study|Withdrawal by Subject|1
2938732|NCT01396161|10118136|P4|Overall Study|Withdrawal by Subject|0
2938733|NCT01396161|10118137|P3|Overall Study|Withdrawal by Subject|0
2938734|NCT01396161|10118138|P2|Overall Study|Withdrawal by Subject|0
2938735|NCT01396161|10118139|P1|Overall Study|Withdrawal by Subject|0
2938736|NCT01396148|10118192|P1|Overall Study|Patient Decision|1
2938737|NCT01396083|10118222|P2|Overall Study|Lost to Follow-up|0
2938738|NCT01396083|10118223|P1|Overall Study|Lost to Follow-up|1
2938739|NCT01396083|10118222|P2|Overall Study|Administrative problems|0
2938740|NCT01396083|10118223|P1|Overall Study|Administrative problems|1
2938741|NCT01396083|10118222|P2|Overall Study|Abnormal laboratory value(s)|0
2938742|NCT01396083|10118223|P1|Overall Study|Abnormal laboratory value(s)|1
2938743|NCT01396083|10118222|P2|Overall Study|Protocol deviation(s)|1
2938744|NCT01396083|10118223|P1|Overall Study|Protocol deviation(s)|0
2938745|NCT01396083|10118222|P2|Overall Study|Consent withdrawn|5
2938746|NCT01396083|10118223|P1|Overall Study|Consent withdrawn|4
2938747|NCT01396083|10118222|P2|Overall Study|Unsatisfactory therapeutic effect|13
2938748|NCT01396083|10118223|P1|Overall Study|Unsatisfactory therapeutic effect|2
2938749|NCT01396083|10118222|P2|Overall Study|Adverse Event|28
2938750|NCT01396083|10118223|P1|Overall Study|Adverse Event|2
2938751|NCT01396070|10118247|P1|Overall Study|Lack of Efficacy|4
2938752|NCT01396070|10118247|P1|Overall Study|Physician Decision|3
2938753|NCT01396070|10118247|P1|Overall Study|Adverse Event|8
2938754|NCT01396070|10118247|P1|Overall Study|Death|2
2938755|NCT01396070|10118247|P1|Overall Study|Withdrawal by Subject|2
2938756|NCT01396057|10118256|P2|Overall Study|Consent withdrawn|2
2938757|NCT01396057|10118257|P1|Overall Study|Consent withdrawn|3
2938758|NCT01396057|10118256|P2|Overall Study|Protocol deviation|4
2938759|NCT01396057|10118257|P1|Overall Study|Protocol deviation|4
2938760|NCT01396057|10118256|P2|Overall Study|Unsatisfactory therapeutic effect|6
2938761|NCT01396057|10118257|P1|Overall Study|Unsatisfactory therapeutic effect|2
2938762|NCT01396057|10118256|P2|Overall Study|Adverse Event|6
2938763|NCT01396057|10118257|P1|Overall Study|Adverse Event|2
2938764|NCT01396005|10118306|P2|Overall Study|Non-compliance with protocol|1
2938765|NCT01396005|10118307|P1|Overall Study|Non-compliance with protocol|0
2938766|NCT01396005|10118306|P2|Overall Study|Withdrawal by Subject|1
2938767|NCT01396005|10118307|P1|Overall Study|Withdrawal by Subject|0
2938768|NCT01395914|10118338|P2|Overall Study|Lost to Follow-up|2
2938769|NCT01395914|10118339|P1|Overall Study|Lost to Follow-up|6
2938770|NCT01395914|10118338|P2|Overall Study|Study drug-related AE|0
2938771|NCT01395914|10118339|P1|Overall Study|Study drug-related AE|1
2938772|NCT01395914|10118338|P2|Overall Study|Withdrawal by patient|14
2938773|NCT01395914|10118339|P1|Overall Study|Withdrawal by patient|27
2938774|NCT01395914|10118338|P2|Overall Study|Other|3
2938775|NCT01395914|10118339|P1|Overall Study|Other|9
2938776|NCT01395914|10118338|P2|Overall Study|Death|17
2938777|NCT01395914|10118339|P1|Overall Study|Death|23
2938778|NCT01395914|10118338|P2|Overall Study|Unrelated to study drug AE|1
2938779|NCT01395914|10118339|P1|Overall Study|Unrelated to study drug AE|6
2938780|NCT01395901|10118353|P2|Overall Study|Withdrawal of consent|0
2938781|NCT01395901|10118354|P1|Overall Study|Withdrawal of consent|1
2938782|NCT01395901|10118353|P2|Overall Study|Adverse Event|1
2938783|NCT01395901|10118354|P1|Overall Study|Adverse Event|0
2938784|NCT01395901|10118353|P2|Overall Study|Randomized but not received study drug|4
2938785|NCT01395901|10118354|P1|Overall Study|Randomized but not received study drug|5
2938786|NCT01395901|10118353|P2|Overall Study|Lost to Follow-up|0
2938787|NCT01395901|10118354|P1|Overall Study|Lost to Follow-up|4
2938788|NCT01395888|10118370|P3|Treatment Period (TP)|Withdrawal by Subject|3
2938789|NCT01395888|10118371|P2|Treatment Period (TP)|Withdrawal by Subject|2
2938790|NCT01395888|10118372|P1|Treatment Period (TP)|Withdrawal by Subject|0
2938791|NCT01395888|10118370|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2938792|NCT01395888|10118371|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
2938793|NCT01395888|10118372|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2938794|NCT01395888|10118370|P3|Treatment Period (TP)|Protocol Violation|5
2938795|NCT01395888|10118371|P2|Treatment Period (TP)|Protocol Violation|1
2938796|NCT01395888|10118372|P1|Treatment Period (TP)|Protocol Violation|0
2938797|NCT01395888|10118370|P3|Treatment Period (TP)|Lack of Efficacy|3
2938798|NCT01395888|10118371|P2|Treatment Period (TP)|Lack of Efficacy|4
2938799|NCT01395888|10118372|P1|Treatment Period (TP)|Lack of Efficacy|0
2938800|NCT01395888|10118370|P3|Treatment Period (TP)|Adverse Event|6
2938801|NCT01395888|10118371|P2|Treatment Period (TP)|Adverse Event|7
2938802|NCT01395888|10118372|P1|Treatment Period (TP)|Adverse Event|0
2938803|NCT01395888|10118370|P3|2-week Run-in Period|Withdrawal by Subject|0
2938804|NCT01395888|10118371|P2|2-week Run-in Period|Withdrawal by Subject|0
2938805|NCT01395888|10118372|P1|2-week Run-in Period|Withdrawal by Subject|4
2938806|NCT01395888|10118370|P3|2-week Run-in Period|Protocol Violation|0
2938807|NCT01395888|10118371|P2|2-week Run-in Period|Protocol Violation|0
2938808|NCT01395888|10118372|P1|2-week Run-in Period|Protocol Violation|2
2938809|NCT01395888|10118370|P3|2-week Run-in Period|Lost to Follow-up|0
2938810|NCT01395888|10118371|P2|2-week Run-in Period|Lost to Follow-up|0
2938811|NCT01395888|10118372|P1|2-week Run-in Period|Lost to Follow-up|1
2938812|NCT01395888|10118370|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2938813|NCT01395888|10118371|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2938814|NCT01395888|10118372|P1|2-week Run-in Period|Continuation Criteria Not Met|13
2938815|NCT01395888|10118370|P3|2-week Run-in Period|Adverse Event|0
2938816|NCT01395888|10118371|P2|2-week Run-in Period|Adverse Event|0
2938817|NCT01395888|10118372|P1|2-week Run-in Period|Adverse Event|2
2938818|NCT01395823|10118380|P2|Overall Study|Withdrawal by Subject|4
2938819|NCT01395823|10118381|P1|Overall Study|Withdrawal by Subject|5
2938820|NCT01395823|10118380|P2|Overall Study|GI symptoms|0
2938821|NCT01395823|10118381|P1|Overall Study|GI symptoms|1
2938822|NCT01395823|10118380|P2|Overall Study|Transplant|0
2938823|NCT01395823|10118381|P1|Overall Study|Transplant|1
2938824|NCT01395823|10118380|P2|Overall Study|Lost to Follow-up|0
2938825|NCT01395823|10118381|P1|Overall Study|Lost to Follow-up|1
2938826|NCT01395823|10118380|P2|Overall Study|Physician Decision|1
2938827|NCT01395823|10118381|P1|Overall Study|Physician Decision|3
2938828|NCT01395823|10118380|P2|Overall Study|Death|4
2938829|NCT01395823|10118381|P1|Overall Study|Death|4
2938830|NCT01395810|10118391|P4|Overall Study|Unclassified|0
2938831|NCT01395810|10118392|P3|Overall Study|Unclassified|0
2938832|NCT01395810|10118393|P2|Overall Study|Unclassified|0
2938833|NCT01395810|10118394|P1|Overall Study|Unclassified|2
2938834|NCT01395810|10118391|P4|Overall Study|Withdrawal criteria|0
2938835|NCT01395810|10118392|P3|Overall Study|Withdrawal criteria|0
2938836|NCT01395810|10118393|P2|Overall Study|Withdrawal criteria|2
2938837|NCT01395810|10118394|P1|Overall Study|Withdrawal criteria|0
2938838|NCT01395810|10118391|P4|Overall Study|Lack of Efficacy|0
2938839|NCT01395810|10118392|P3|Overall Study|Lack of Efficacy|0
2938840|NCT01395810|10118393|P2|Overall Study|Lack of Efficacy|1
2938841|NCT01395810|10118394|P1|Overall Study|Lack of Efficacy|0
2938842|NCT01395810|10118391|P4|Overall Study|Adverse Event|0
2938843|NCT01395810|10118392|P3|Overall Study|Adverse Event|0
2938844|NCT01395810|10118393|P2|Overall Study|Adverse Event|1
2938845|NCT01395810|10118394|P1|Overall Study|Adverse Event|0
2938846|NCT01395784|10118453|P1|Overall Study|Physician Decision|5
2938847|NCT01395784|10118453|P1|Overall Study|Withdrawal by Subject|3
2938848|NCT01395784|10118453|P1|Overall Study|Lost to Follow-up|7
2938849|NCT01395758|10118460|P3|Open-label Treatment Period|Withdrawal by Subject|0
2938850|NCT01395758|10118461|P2|Open-label Treatment Period|Withdrawal by Subject|0
2938851|NCT01395758|10118462|P1|Open-label Treatment Period|Withdrawal by Subject|4
2938852|NCT01395524|10118482|P3|Overall Study|Subject had spinal surgery|1
2938853|NCT01395524|10118483|P2|Overall Study|Subject had spinal surgery|0
2938854|NCT01395524|10118484|P1|Overall Study|Subject had spinal surgery|0
2938855|NCT01395524|10118482|P3|Overall Study|Did not receive treatment|3
2938856|NCT01395524|10118483|P2|Overall Study|Did not receive treatment|1
2938857|NCT01395524|10118484|P1|Overall Study|Did not receive treatment|1
2938858|NCT01395524|10118482|P3|Overall Study|Withdrawal by Subject|8
2938859|NCT01395524|10118483|P2|Overall Study|Withdrawal by Subject|8
2938860|NCT01395524|10118484|P1|Overall Study|Withdrawal by Subject|4
2938861|NCT01395524|10118482|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
2938862|NCT01395524|10118483|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2938863|NCT01395524|10118484|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
2938864|NCT01395524|10118482|P3|Overall Study|Death|0
2938865|NCT01395524|10118483|P2|Overall Study|Death|0
2938866|NCT01395524|10118484|P1|Overall Study|Death|1
2938867|NCT01395524|10118482|P3|Overall Study|Adverse Event|3
2938868|NCT01395524|10118483|P2|Overall Study|Adverse Event|4
2938869|NCT01395524|10118484|P1|Overall Study|Adverse Event|4
2938870|NCT01395524|10118482|P3|Overall Study|Severe noncompliance with protocol|0
2938871|NCT01395524|10118483|P2|Overall Study|Severe noncompliance with protocol|0
2938872|NCT01395524|10118484|P1|Overall Study|Severe noncompliance with protocol|1
2938873|NCT01395524|10118482|P3|Overall Study|Study-Specific Withdrawal Criteria|0
2938874|NCT01395524|10118483|P2|Overall Study|Study-Specific Withdrawal Criteria|2
2938875|NCT01395524|10118484|P1|Overall Study|Study-Specific Withdrawal Criteria|1
2938876|NCT01395524|10118482|P3|Overall Study|Lost to Follow-up|1
2938877|NCT01395524|10118483|P2|Overall Study|Lost to Follow-up|1
2938878|NCT01395524|10118484|P1|Overall Study|Lost to Follow-up|3
2938879|NCT01395524|10118482|P3|Overall Study|Non-compliance with study schedule|1
2938880|NCT01395524|10118483|P2|Overall Study|Non-compliance with study schedule|0
2938881|NCT01395524|10118484|P1|Overall Study|Non-compliance with study schedule|1
2938882|NCT01395394|10118507|P3|Baseline Study Visit|Protocol Violation|0
2938883|NCT01395394|10118508|P2|Baseline Study Visit|Protocol Violation|0
2938884|NCT01395394|10118509|P1|Baseline Study Visit|Protocol Violation|1
2938885|NCT01395368|10118520|P1|Overall Study|Withdrawal by Subject|2
2938886|NCT01395368|10118520|P1|Overall Study|Physician Decision|14
2938887|NCT01395316|10118576|P1|Overall Study|poor MRI quality|1
2938888|NCT01395316|10118576|P1|Overall Study|Lost to Follow-up|2
2938889|NCT01395030|10118596|P1|Overall Study|Did not complete FCH PET/CT|7
2938890|NCT01395017|10118606|P2|Overall Study|Sponsor discontinued study|4
2938891|NCT01395017|10118607|P1|Overall Study|Sponsor discontinued study|1
2938892|NCT01395017|10118606|P2|Overall Study|Disease progression|58
2938893|NCT01395017|10118607|P1|Overall Study|Disease progression|42
2938894|NCT01395017|10118606|P2|Overall Study|Death|3
2938895|NCT01395017|10118607|P1|Overall Study|Death|4
2938896|NCT01395017|10118606|P2|Overall Study|Protocol deviation|2
2938897|NCT01395017|10118607|P1|Overall Study|Protocol deviation|1
2938898|NCT01395017|10118606|P2|Overall Study|Withdrawal by Subject|8
2938899|NCT01395017|10118607|P1|Overall Study|Withdrawal by Subject|14
2938900|NCT01395017|10118606|P2|Overall Study|Physician Decision|15
2938901|NCT01395017|10118607|P1|Overall Study|Physician Decision|11
2938902|NCT01395017|10118606|P2|Overall Study|Adverse Event|12
2938903|NCT01395017|10118607|P1|Overall Study|Adverse Event|26
2938904|NCT01395017|10118606|P2|Overall Study|Lost to Follow-up|0
2938905|NCT01395017|10118607|P1|Overall Study|Lost to Follow-up|1
2938906|NCT01394991|10118617|P2|Overall Study|Prematurely Termination of Trial|10
2938907|NCT01394991|10118618|P1|Overall Study|Prematurely Termination of Trial|9
2938908|NCT01394991|10118617|P2|Overall Study|Disease Progression|7
2938909|NCT01394991|10118618|P1|Overall Study|Disease Progression|7
2938910|NCT01394991|10118617|P2|Overall Study|Chemotherapy Termination|15
2938911|NCT01394991|10118618|P1|Overall Study|Chemotherapy Termination|10
2938912|NCT01394991|10118617|P2|Overall Study|Withdrawal by Subject|17
2938913|NCT01394991|10118618|P1|Overall Study|Withdrawal by Subject|20
2938914|NCT01394991|10118617|P2|Overall Study|Protocol Violation|1
2938915|NCT01394991|10118618|P1|Overall Study|Protocol Violation|1
2938916|NCT01394991|10118617|P2|Overall Study|Physician Decision|3
2938917|NCT01394991|10118618|P1|Overall Study|Physician Decision|1
2938918|NCT01394991|10118617|P2|Overall Study|Lost to Follow-up|8
2938919|NCT01394991|10118618|P1|Overall Study|Lost to Follow-up|6
2938920|NCT01394991|10118617|P2|Overall Study|Lack of Efficacy|7
2938921|NCT01394991|10118618|P1|Overall Study|Lack of Efficacy|5
2938922|NCT01394991|10118617|P2|Overall Study|Adverse Event|4
2938923|NCT01394991|10118618|P1|Overall Study|Adverse Event|0
2938924|NCT01394978|10118640|P2|Overall Study|Death|7
2938925|NCT01394978|10118641|P1|Overall Study|Death|6
2938926|NCT01394978|10118640|P2|Overall Study|Lost to Follow-up|20
2938927|NCT01394978|10118641|P1|Overall Study|Lost to Follow-up|13
2938928|NCT01394978|10118640|P2|Overall Study|Withdrawal by Subject|4
2938929|NCT01394978|10118641|P1|Overall Study|Withdrawal by Subject|2
2938930|NCT01394952|10118649|P2|Overall Study|Sponsor Decision|7
2938931|NCT01394952|10118650|P1|Overall Study|Sponsor Decision|5
2938932|NCT01394952|10118649|P2|Overall Study|Physician Decision|0
2938933|NCT01394952|10118650|P1|Overall Study|Physician Decision|2
2938934|NCT01394952|10118649|P2|Overall Study|Withdrawal by Subject|5
2938935|NCT01394952|10118650|P1|Overall Study|Withdrawal by Subject|10
2938936|NCT01394952|10118649|P2|Overall Study|Lost to Follow-up|5
2938937|NCT01394952|10118650|P1|Overall Study|Lost to Follow-up|0
2938938|NCT01394718|10118677|P2|Overall Study|Met protocol-specific stopping criteria|1
2938939|NCT01394718|10118678|P1|Overall Study|Met protocol-specific stopping criteria|2
2938940|NCT01394627|10118710|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
2938941|NCT01394627|10118711|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
2938942|NCT01394627|10118710|P2|First Intervention (1 Day)|poor intravenous access|1
2938943|NCT01394627|10118711|P1|First Intervention (1 Day)|poor intravenous access|0
2938944|NCT01394523|10118731|P3|Overall Study|Unable to place block|0
2938945|NCT01394523|10118732|P2|Overall Study|Unable to place block|0
2938946|NCT01394523|10118733|P1|Overall Study|Unable to place block|1
2938947|NCT01394276|10118747|P1|Overall Study|Symptoms of concurrent diseases|1
2938948|NCT01394276|10118747|P1|Overall Study|unavailability of drug at the Hospital|2
2938949|NCT01394276|10118747|P1|Overall Study|Pregnancy|1
2938950|NCT01394276|10118747|P1|Overall Study|Participant moved to another site|1
2938951|NCT01394276|10118747|P1|Overall Study|Lost to Follow-up|5
2938952|NCT01394276|10118747|P1|Overall Study|Insufficient compliance|9
2938953|NCT01394276|10118747|P1|Overall Study|Insufficient therapeutic effect|17
2938954|NCT01394276|10118747|P1|Overall Study|Remission of disease|2
2938955|NCT01394276|10118747|P1|Overall Study|Not related AEs|9
2938956|NCT01394276|10118747|P1|Overall Study|Related Adverse event (AEs)|15
2938957|NCT01394250|10118771|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
2938958|NCT01394250|10118772|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
2939134|NCT01393743|10119118|P2|Core Study|Participant's Choice|3
2938959|NCT01394250|10118771|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
2938960|NCT01394250|10118772|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
2938961|NCT01394185|10118786|P6|Overall Study|Protocol Violation|1
2938962|NCT01394185|10118787|P5|Overall Study|Protocol Violation|0
2938963|NCT01394185|10118788|P4|Overall Study|Protocol Violation|1
2938964|NCT01394185|10118789|P3|Overall Study|Protocol Violation|0
2938965|NCT01394185|10118790|P2|Overall Study|Protocol Violation|0
2938966|NCT01394185|10118791|P1|Overall Study|Protocol Violation|1
2938967|NCT01394185|10118786|P6|Overall Study|Change in protocol|0
2938968|NCT01394185|10118787|P5|Overall Study|Change in protocol|3
2938969|NCT01394185|10118788|P4|Overall Study|Change in protocol|0
2938970|NCT01394185|10118789|P3|Overall Study|Change in protocol|0
2938971|NCT01394185|10118790|P2|Overall Study|Change in protocol|0
2938972|NCT01394185|10118791|P1|Overall Study|Change in protocol|3
2938973|NCT01394185|10118786|P6|Overall Study|Withdrawal by Subject|0
2938974|NCT01394185|10118787|P5|Overall Study|Withdrawal by Subject|1
2938975|NCT01394185|10118788|P4|Overall Study|Withdrawal by Subject|0
2938976|NCT01394185|10118789|P3|Overall Study|Withdrawal by Subject|0
2938977|NCT01394185|10118790|P2|Overall Study|Withdrawal by Subject|0
2938978|NCT01394185|10118791|P1|Overall Study|Withdrawal by Subject|2
2938979|NCT01393990|10118895|P18|Overall Study|Withdrawal by Subject|0
2938980|NCT01393990|10118896|P17|Overall Study|Withdrawal by Subject|0
2938981|NCT01393990|10118897|P16|Overall Study|Withdrawal by Subject|1
2938982|NCT01393990|10118898|P15|Overall Study|Withdrawal by Subject|1
2938983|NCT01393990|10118899|P14|Overall Study|Withdrawal by Subject|0
2938984|NCT01393990|10118900|P13|Overall Study|Withdrawal by Subject|0
2938985|NCT01393990|10118901|P12|Overall Study|Withdrawal by Subject|0
2938986|NCT01393990|10118902|P11|Overall Study|Withdrawal by Subject|0
2938987|NCT01393990|10118903|P10|Overall Study|Withdrawal by Subject|0
2938988|NCT01393990|10118904|P9|Overall Study|Withdrawal by Subject|0
2938989|NCT01393990|10118905|P8|Overall Study|Withdrawal by Subject|0
2938990|NCT01393990|10118906|P7|Overall Study|Withdrawal by Subject|0
2938991|NCT01393990|10118907|P6|Overall Study|Withdrawal by Subject|0
2938992|NCT01393990|10118908|P5|Overall Study|Withdrawal by Subject|0
2938993|NCT01393990|10118909|P4|Overall Study|Withdrawal by Subject|0
2938994|NCT01393990|10118910|P3|Overall Study|Withdrawal by Subject|0
2938995|NCT01393990|10118911|P2|Overall Study|Withdrawal by Subject|0
2938996|NCT01393990|10118912|P1|Overall Study|Withdrawal by Subject|0
2938997|NCT01393990|10118895|P18|Overall Study|Death|0
2938998|NCT01393990|10118896|P17|Overall Study|Death|0
2938999|NCT01393990|10118897|P16|Overall Study|Death|0
2939000|NCT01393990|10118898|P15|Overall Study|Death|1
2939001|NCT01393990|10118899|P14|Overall Study|Death|1
2939002|NCT01393990|10118900|P13|Overall Study|Death|0
2939003|NCT01393990|10118901|P12|Overall Study|Death|0
2939004|NCT01393990|10118902|P11|Overall Study|Death|0
2939005|NCT01393990|10118903|P10|Overall Study|Death|0
2939006|NCT01393990|10118904|P9|Overall Study|Death|0
2939007|NCT01393990|10118905|P8|Overall Study|Death|0
2939008|NCT01393990|10118906|P7|Overall Study|Death|0
2939009|NCT01393990|10118907|P6|Overall Study|Death|0
2939010|NCT01393990|10118908|P5|Overall Study|Death|1
2939011|NCT01393990|10118909|P4|Overall Study|Death|0
2939012|NCT01393990|10118910|P3|Overall Study|Death|0
2939013|NCT01393990|10118911|P2|Overall Study|Death|0
2939014|NCT01393990|10118912|P1|Overall Study|Death|0
2939015|NCT01393990|10118895|P18|Overall Study|Progressive Disease|0
2939016|NCT01393990|10118896|P17|Overall Study|Progressive Disease|0
2939017|NCT01393990|10118897|P16|Overall Study|Progressive Disease|1
2939018|NCT01393990|10118898|P15|Overall Study|Progressive Disease|6
2939019|NCT01393990|10118899|P14|Overall Study|Progressive Disease|1
2939020|NCT01393990|10118900|P13|Overall Study|Progressive Disease|0
2939021|NCT01393990|10118901|P12|Overall Study|Progressive Disease|0
2939022|NCT01393990|10118902|P11|Overall Study|Progressive Disease|0
2939023|NCT01393990|10118903|P10|Overall Study|Progressive Disease|1
2939024|NCT01393990|10118904|P9|Overall Study|Progressive Disease|3
2939025|NCT01393990|10118905|P8|Overall Study|Progressive Disease|1
2939026|NCT01393990|10118906|P7|Overall Study|Progressive Disease|1
2939027|NCT01393990|10118907|P6|Overall Study|Progressive Disease|1
2939028|NCT01393990|10118908|P5|Overall Study|Progressive Disease|1
2939029|NCT01393990|10118909|P4|Overall Study|Progressive Disease|1
2939030|NCT01393990|10118910|P3|Overall Study|Progressive Disease|0
2939031|NCT01393990|10118911|P2|Overall Study|Progressive Disease|0
2939032|NCT01393990|10118912|P1|Overall Study|Progressive Disease|1
2939033|NCT01393990|10118895|P18|Overall Study|Adverse Event|0
2939034|NCT01393990|10118896|P17|Overall Study|Adverse Event|0
2939035|NCT01393990|10118897|P16|Overall Study|Adverse Event|1
2939036|NCT01393990|10118898|P15|Overall Study|Adverse Event|1
2939037|NCT01393990|10118899|P14|Overall Study|Adverse Event|0
2939038|NCT01393990|10118900|P13|Overall Study|Adverse Event|0
2939039|NCT01393990|10118901|P12|Overall Study|Adverse Event|0
2939040|NCT01393990|10118902|P11|Overall Study|Adverse Event|0
2939041|NCT01393990|10118903|P10|Overall Study|Adverse Event|0
2939042|NCT01393990|10118904|P9|Overall Study|Adverse Event|0
2939043|NCT01393990|10118905|P8|Overall Study|Adverse Event|0
2939044|NCT01393990|10118906|P7|Overall Study|Adverse Event|0
2939045|NCT01393990|10118907|P6|Overall Study|Adverse Event|0
2939046|NCT01393990|10118908|P5|Overall Study|Adverse Event|0
2939047|NCT01393990|10118909|P4|Overall Study|Adverse Event|0
2939048|NCT01393990|10118910|P3|Overall Study|Adverse Event|0
2939049|NCT01393990|10118911|P2|Overall Study|Adverse Event|0
2939050|NCT01393990|10118912|P1|Overall Study|Adverse Event|0
2939051|NCT01393964|10119003|P3|Overall Study|Subject to receive non-protocol therapy|1
2939052|NCT01393964|10119004|P2|Overall Study|Subject to receive non-protocol therapy|0
2939053|NCT01393964|10119005|P1|Overall Study|Subject to receive non-protocol therapy|0
2939054|NCT01393964|10119003|P3|Overall Study|Subject converted to roll-over study|0
2939055|NCT01393964|10119004|P2|Overall Study|Subject converted to roll-over study|1
2939056|NCT01393964|10119005|P1|Overall Study|Subject converted to roll-over study|0
2939057|NCT01393964|10119003|P3|Overall Study|Investigator removed subject from study|0
2939058|NCT01393964|10119004|P2|Overall Study|Investigator removed subject from study|1
2939059|NCT01393964|10119005|P1|Overall Study|Investigator removed subject from study|0
2939060|NCT01393964|10119003|P3|Overall Study|Subject plateaued in terms of effect|0
2939061|NCT01393964|10119004|P2|Overall Study|Subject plateaued in terms of effect|0
2939062|NCT01393964|10119005|P1|Overall Study|Subject plateaued in terms of effect|1
2939063|NCT01393964|10119003|P3|Overall Study|Subject switched to commercial supply|2
2939064|NCT01393964|10119004|P2|Overall Study|Subject switched to commercial supply|0
2939065|NCT01393964|10119005|P1|Overall Study|Subject switched to commercial supply|1
2939066|NCT01393964|10119003|P3|Overall Study|Subject decided to move to transplant|0
2939067|NCT01393964|10119004|P2|Overall Study|Subject decided to move to transplant|0
2939068|NCT01393964|10119005|P1|Overall Study|Subject decided to move to transplant|1
2939069|NCT01393964|10119003|P3|Overall Study|Subject request stop study treatment|0
2939070|NCT01393964|10119004|P2|Overall Study|Subject request stop study treatment|1
2939071|NCT01393964|10119005|P1|Overall Study|Subject request stop study treatment|0
2939072|NCT01393964|10119003|P3|Overall Study|Adverse event unrelated to study drug|0
2939073|NCT01393964|10119004|P2|Overall Study|Adverse event unrelated to study drug|3
2939074|NCT01393964|10119005|P1|Overall Study|Adverse event unrelated to study drug|0
2939075|NCT01393964|10119003|P3|Overall Study|Withdrawal by Subject|1
2939076|NCT01393964|10119004|P2|Overall Study|Withdrawal by Subject|0
2939077|NCT01393964|10119005|P1|Overall Study|Withdrawal by Subject|0
2939078|NCT01393964|10119003|P3|Overall Study|Study drug toxicity|0
2939079|NCT01393964|10119004|P2|Overall Study|Study drug toxicity|0
2939080|NCT01393964|10119005|P1|Overall Study|Study drug toxicity|1
2939081|NCT01393964|10119003|P3|Overall Study|Disease Progression|5
2939082|NCT01393964|10119004|P2|Overall Study|Disease Progression|3
2939083|NCT01393964|10119005|P1|Overall Study|Disease Progression|4
2939084|NCT01393899|10119046|P3|Overall Study|Adverse Event|3
2939085|NCT01393899|10119047|P2|Overall Study|Adverse Event|5
2939086|NCT01393899|10119048|P1|Overall Study|Adverse Event|1
2939087|NCT01393899|10119046|P3|Overall Study|Lack of Efficacy|16
2939088|NCT01393899|10119047|P2|Overall Study|Lack of Efficacy|21
2939089|NCT01393899|10119048|P1|Overall Study|Lack of Efficacy|26
2939090|NCT01393899|10119046|P3|Overall Study|Does not meet entrance criteria|1
2939091|NCT01393899|10119047|P2|Overall Study|Does not meet entrance criteria|0
2939092|NCT01393899|10119048|P1|Overall Study|Does not meet entrance criteria|1
2939093|NCT01393899|10119046|P3|Overall Study|Lost to Follow-up|1
2939094|NCT01393899|10119047|P2|Overall Study|Lost to Follow-up|0
2939095|NCT01393899|10119048|P1|Overall Study|Lost to Follow-up|0
2939096|NCT01393899|10119046|P3|Overall Study|Withdrawal by Subject|1
2939097|NCT01393899|10119047|P2|Overall Study|Withdrawal by Subject|2
2939098|NCT01393899|10119048|P1|Overall Study|Withdrawal by Subject|2
2939099|NCT01393899|10119046|P3|Overall Study|Other|0
2939100|NCT01393899|10119047|P2|Overall Study|Other|0
2939101|NCT01393899|10119048|P1|Overall Study|Other|1
2939102|NCT01393899|10119046|P3|Overall Study|Study terminated by sponsor|1
2939103|NCT01393899|10119047|P2|Overall Study|Study terminated by sponsor|0
2939104|NCT01393899|10119048|P1|Overall Study|Study terminated by sponsor|1
2939105|NCT01393821|10119102|P2|Overall Study|not evaluable for primary endpoint|2
2939106|NCT01393821|10119103|P1|Overall Study|not evaluable for primary endpoint|4
2939107|NCT01393821|10119102|P2|Overall Study|Cancel|1
2939108|NCT01393821|10119103|P1|Overall Study|Cancel|1
2939109|NCT01393743|10119117|P3|Extension Phase|Other|14
2939110|NCT01393743|10119118|P2|Extension Phase|Other|0
2939111|NCT01393743|10119119|P1|Extension Phase|Other|0
2939112|NCT01393743|10119117|P3|Extension Phase|Pregnancy|1
2939113|NCT01393743|10119118|P2|Extension Phase|Pregnancy|0
2939114|NCT01393743|10119119|P1|Extension Phase|Pregnancy|0
2939115|NCT01393743|10119117|P3|Extension Phase|Withdrawal by Subject|8
2939116|NCT01393743|10119118|P2|Extension Phase|Withdrawal by Subject|0
2939117|NCT01393743|10119119|P1|Extension Phase|Withdrawal by Subject|0
2939118|NCT01393743|10119117|P3|Extension Phase|Inadequate therapeutic effect|7
2939119|NCT01393743|10119118|P2|Extension Phase|Inadequate therapeutic effect|0
2939120|NCT01393743|10119119|P1|Extension Phase|Inadequate therapeutic effect|0
2939121|NCT01393743|10119117|P3|Extension Phase|Participant choice|16
2939122|NCT01393743|10119118|P2|Extension Phase|Participant choice|0
2939123|NCT01393743|10119119|P1|Extension Phase|Participant choice|0
2939124|NCT01393743|10119117|P3|Extension Phase|Lost to Follow-up|2
2939125|NCT01393743|10119118|P2|Extension Phase|Lost to Follow-up|0
2939126|NCT01393743|10119119|P1|Extension Phase|Lost to Follow-up|0
2939127|NCT01393743|10119117|P3|Extension Phase|Adverse Event|12
2939128|NCT01393743|10119118|P2|Extension Phase|Adverse Event|0
2939129|NCT01393743|10119119|P1|Extension Phase|Adverse Event|0
2939130|NCT01393743|10119117|P3|Core Study|Inadequate therapeutic effect|0
2939131|NCT01393743|10119118|P2|Core Study|Inadequate therapeutic effect|0
2939132|NCT01393743|10119119|P1|Core Study|Inadequate therapeutic effect|2
2939133|NCT01393743|10119117|P3|Core Study|Participant's Choice|0
2939135|NCT01393743|10119119|P1|Core Study|Participant's Choice|2
2939136|NCT01393743|10119117|P3|Core Study|Lost to Follow-up|0
2939137|NCT01393743|10119118|P2|Core Study|Lost to Follow-up|1
2939138|NCT01393743|10119119|P1|Core Study|Lost to Follow-up|1
2939139|NCT01393743|10119117|P3|Core Study|Adverse Event|0
2939140|NCT01393743|10119118|P2|Core Study|Adverse Event|9
2939141|NCT01393743|10119119|P1|Core Study|Adverse Event|5
2939142|NCT01393730|10119142|P1|Overall Study|Adverse Event|1
2939143|NCT01393730|10119142|P1|Overall Study|Other|2
2939144|NCT01393730|10119142|P1|Overall Study|Withdrawal by Subject|3
2939145|NCT01393626|10119188|P4|Overall Study|Protocol Violation|0
2939146|NCT01393626|10119189|P3|Overall Study|Protocol Violation|2
2939147|NCT01393626|10119190|P2|Overall Study|Protocol Violation|0
2939148|NCT01393626|10119191|P1|Overall Study|Protocol Violation|1
2939149|NCT01393626|10119188|P4|Overall Study|Other|0
2939150|NCT01393626|10119189|P3|Overall Study|Other|0
2939151|NCT01393626|10119190|P2|Overall Study|Other|0
2939152|NCT01393626|10119191|P1|Overall Study|Other|1
2939153|NCT01393626|10119188|P4|Overall Study|Withdrawal by Subject|0
2939154|NCT01393626|10119189|P3|Overall Study|Withdrawal by Subject|0
2939155|NCT01393626|10119190|P2|Overall Study|Withdrawal by Subject|4
2939156|NCT01393626|10119191|P1|Overall Study|Withdrawal by Subject|6
2939157|NCT01393626|10119188|P4|Overall Study|Lost to Follow-up|0
2939158|NCT01393626|10119189|P3|Overall Study|Lost to Follow-up|1
2939159|NCT01393626|10119190|P2|Overall Study|Lost to Follow-up|1
2939160|NCT01393626|10119191|P1|Overall Study|Lost to Follow-up|1
2939161|NCT01393626|10119188|P4|Overall Study|Lack of Efficacy|1
2939162|NCT01393626|10119189|P3|Overall Study|Lack of Efficacy|4
2939163|NCT01393626|10119190|P2|Overall Study|Lack of Efficacy|6
2939164|NCT01393626|10119191|P1|Overall Study|Lack of Efficacy|6
2939165|NCT01393626|10119188|P4|Overall Study|Did not meet entrance criteria|0
2939166|NCT01393626|10119189|P3|Overall Study|Did not meet entrance criteria|0
2939167|NCT01393626|10119190|P2|Overall Study|Did not meet entrance criteria|0
2939168|NCT01393626|10119191|P1|Overall Study|Did not meet entrance criteria|1
2939169|NCT01393626|10119188|P4|Overall Study|Adverse Event|0
2939170|NCT01393626|10119189|P3|Overall Study|Adverse Event|5
2939171|NCT01393626|10119190|P2|Overall Study|Adverse Event|1
2939172|NCT01393626|10119191|P1|Overall Study|Adverse Event|2
2939173|NCT01393613|10119271|P4|Overall Study|Lack of Efficacy|21
2939174|NCT01393613|10119272|P3|Overall Study|Lack of Efficacy|16
2939175|NCT01393613|10119273|P2|Overall Study|Lack of Efficacy|20
2939176|NCT01393613|10119274|P1|Overall Study|Lack of Efficacy|9
2939177|NCT01393613|10119271|P4|Overall Study|Protocol Deviation|0
2939178|NCT01393613|10119272|P3|Overall Study|Protocol Deviation|0
2939179|NCT01393613|10119273|P2|Overall Study|Protocol Deviation|1
2939180|NCT01393613|10119274|P1|Overall Study|Protocol Deviation|2
2939181|NCT01393613|10119271|P4|Overall Study|Withdrawal by Subject|21
2939182|NCT01393613|10119272|P3|Overall Study|Withdrawal by Subject|23
2939183|NCT01393613|10119273|P2|Overall Study|Withdrawal by Subject|25
2939184|NCT01393613|10119274|P1|Overall Study|Withdrawal by Subject|15
2939185|NCT01393613|10119271|P4|Overall Study|Physician Decision|1
2939186|NCT01393613|10119272|P3|Overall Study|Physician Decision|0
2939187|NCT01393613|10119273|P2|Overall Study|Physician Decision|0
2939188|NCT01393613|10119274|P1|Overall Study|Physician Decision|2
2939189|NCT01393613|10119271|P4|Overall Study|Participant Met Withdrawal Criteria|1
2939190|NCT01393613|10119272|P3|Overall Study|Participant Met Withdrawal Criteria|2
2939191|NCT01393613|10119273|P2|Overall Study|Participant Met Withdrawal Criteria|0
2939192|NCT01393613|10119274|P1|Overall Study|Participant Met Withdrawal Criteria|0
2939193|NCT01393613|10119271|P4|Overall Study|Adverse Event|22
2939194|NCT01393613|10119272|P3|Overall Study|Adverse Event|13
2939195|NCT01393613|10119273|P2|Overall Study|Adverse Event|11
2939196|NCT01393613|10119274|P1|Overall Study|Adverse Event|11
2939197|NCT01393600|10119336|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2939198|NCT01393600|10119337|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
2939199|NCT01393600|10119338|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2939200|NCT01393600|10119339|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2939201|NCT01393600|10119336|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2939202|NCT01393600|10119337|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
2939203|NCT01393600|10119338|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2939204|NCT01393600|10119339|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2939205|NCT01393600|10119336|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2939206|NCT01393600|10119337|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
2939207|NCT01393600|10119338|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2939208|NCT01393600|10119339|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2939209|NCT01393600|10119336|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
2939210|NCT01393600|10119337|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2939211|NCT01393600|10119338|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2939212|NCT01393600|10119339|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2939213|NCT01393600|10119336|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
2939214|NCT01393600|10119337|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2939215|NCT01393600|10119338|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2939216|NCT01393600|10119339|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2939217|NCT01393600|10119336|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2939218|NCT01393600|10119337|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
2939303|NCT01392495|10119609|P1|Overall Study|Withdrawal by Subject|2
2939219|NCT01393600|10119338|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2939220|NCT01393600|10119339|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2939221|NCT01393600|10119336|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2939222|NCT01393600|10119337|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2939223|NCT01393600|10119338|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
2939224|NCT01393600|10119339|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2939225|NCT01393444|10119375|P1|Overall Study|Determined ineligible during screening.|2
2939226|NCT01393444|10119375|P1|Overall Study|Withdrawal by Subject|1
2939227|NCT01393405|10119380|P3|Maintenance Period Week|Lost to Follow-up|0
2939228|NCT01393405|10119381|P2|Maintenance Period Week|Lost to Follow-up|1
2939229|NCT01393405|10119382|P1|Maintenance Period Week|Lost to Follow-up|0
2939230|NCT01393405|10119380|P3|Maintenance Period Week|Withdrawal by Subject|0
2939231|NCT01393405|10119381|P2|Maintenance Period Week|Withdrawal by Subject|1
2939232|NCT01393405|10119382|P1|Maintenance Period Week|Withdrawal by Subject|0
2939233|NCT01393405|10119380|P3|Maintenance Period Week|Adverse Event|2
2939234|NCT01393405|10119381|P2|Maintenance Period Week|Adverse Event|5
2939235|NCT01393405|10119382|P1|Maintenance Period Week|Adverse Event|0
2939236|NCT01393405|10119380|P3|Maintenance Period Week|Lack of Efficacy|22
2939237|NCT01393405|10119381|P2|Maintenance Period Week|Lack of Efficacy|22
2939238|NCT01393405|10119382|P1|Maintenance Period Week|Lack of Efficacy|0
2939239|NCT01393405|10119380|P3|Induction Period (week1-16)|Withdrawal by Subject|0
2939240|NCT01393405|10119381|P2|Induction Period (week1-16)|Withdrawal by Subject|0
2939241|NCT01393405|10119382|P1|Induction Period (week1-16)|Withdrawal by Subject|9
2939242|NCT01393405|10119380|P3|Induction Period (week1-16)|Adverse Event|0
2939243|NCT01393405|10119381|P2|Induction Period (week1-16)|Adverse Event|0
2939244|NCT01393405|10119382|P1|Induction Period (week1-16)|Adverse Event|16
2939245|NCT01393405|10119380|P3|Induction Period (week1-16)|Lack of Efficacy|0
2939246|NCT01393405|10119381|P2|Induction Period (week1-16)|Lack of Efficacy|0
2939247|NCT01393405|10119382|P1|Induction Period (week1-16)|Lack of Efficacy|70
2939248|NCT01393301|10119420|P2|Overall Study|Completed <7 sessions (intervention)|0
2939249|NCT01393301|10119421|P1|Overall Study|Completed <7 sessions (intervention)|2
2939250|NCT01393301|10119420|P2|Overall Study|Withdrawal by Subject|0
2939251|NCT01393301|10119421|P1|Overall Study|Withdrawal by Subject|2
2939252|NCT01393301|10119420|P2|Overall Study|Lost to Follow-up|3
2939253|NCT01393301|10119421|P1|Overall Study|Lost to Follow-up|5
2939254|NCT01393158|10119434|P2|Overall Study|Adverse Event|0
2939255|NCT01393158|10119435|P1|Overall Study|Adverse Event|1
2939256|NCT01393106|10119462|P1|Overall Study|Lack of Efficacy|1
2939257|NCT01393106|10119462|P1|Overall Study|Withdrawal by Subject|1
2939258|NCT01393106|10119462|P1|Overall Study|Adverse Event|3
2939259|NCT01392963|10119489|P2|Week 24 Follow-up|Lost to Follow-up|0
2939260|NCT01392963|10119490|P1|Week 24 Follow-up|Lost to Follow-up|2
2939261|NCT01392963|10119489|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
2939262|NCT01392963|10119490|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
2939263|NCT01392963|10119489|P2|Week 0 (First Intervention)|Lost to Follow-up|1
2939264|NCT01392963|10119490|P1|Week 0 (First Intervention)|Lost to Follow-up|0
2939265|NCT01392742|10119498|P1|Overall Study|Missing information|13
2939266|NCT01392742|10119498|P1|Overall Study|Other|3
2939267|NCT01392742|10119498|P1|Overall Study|Protocol Violation|14
2939268|NCT01392742|10119498|P1|Overall Study|Adverse event/intercurrent illness|17
2939269|NCT01392742|10119498|P1|Overall Study|ITR and Protocol deviation|1
2939270|NCT01392742|10119498|P1|Overall Study|Insufficient therapeutic response (ITR)|30
2939271|NCT01392742|10119498|P1|Overall Study|Lost to Follow-up|34
2939272|NCT01392742|10119498|P1|Overall Study|No treatment/no cooperation/withdrew|12
2939273|NCT01392742|10119498|P1|Overall Study|Failure to return|35
2939274|NCT01392742|10119498|P1|Overall Study|Premature study termination|42
2939275|NCT01392677|10119544|P2|Overall Study|Other reason|2
2939276|NCT01392677|10119545|P1|Overall Study|Other reason|3
2939277|NCT01392677|10119544|P2|Overall Study|Incorrect enrollment|3
2939278|NCT01392677|10119545|P1|Overall Study|Incorrect enrollment|2
2939279|NCT01392677|10119544|P2|Overall Study|Withdrawal by Subject|2
2939280|NCT01392677|10119545|P1|Overall Study|Withdrawal by Subject|0
2939281|NCT01392677|10119544|P2|Overall Study|Adverse Event|1
2939282|NCT01392677|10119545|P1|Overall Study|Adverse Event|3
2939283|NCT01392573|10119580|P2|Overall Study|Unclassified|6
2939284|NCT01392573|10119581|P1|Overall Study|Unclassified|9
2939285|NCT01392573|10119580|P2|Overall Study|Site closure|7
2939286|NCT01392573|10119581|P1|Overall Study|Site closure|8
2939287|NCT01392573|10119580|P2|Overall Study|Withdrawal Criteria|15
2939288|NCT01392573|10119581|P1|Overall Study|Withdrawal Criteria|13
2939289|NCT01392573|10119580|P2|Overall Study|Protocol Violation|2
2939290|NCT01392573|10119581|P1|Overall Study|Protocol Violation|0
2939291|NCT01392573|10119580|P2|Overall Study|Lack of Efficacy|2
2939292|NCT01392573|10119581|P1|Overall Study|Lack of Efficacy|1
2939293|NCT01392573|10119580|P2|Overall Study|Adverse Event|3
2939294|NCT01392573|10119581|P1|Overall Study|Adverse Event|1
2939295|NCT01392560|10119589|P1|Overall Study|discontinued during placebo run-in|2
2939296|NCT01392560|10119589|P1|Overall Study|not entered|8
2939297|NCT01392560|10119589|P1|Overall Study|Adverse Event|2
2939298|NCT01392547|10119595|P1|Overall Study|Unclassified|1
2939299|NCT01392547|10119595|P1|Overall Study|Withdrawal criteria|3
2939300|NCT01392547|10119595|P1|Overall Study|Non-compliance|2
2939301|NCT01392547|10119595|P1|Overall Study|Adverse Event|2
2939302|NCT01392495|10119609|P1|Overall Study|Adverse Event|3
2939304|NCT01392495|10119609|P1|Overall Study|Administrative problems|8
2939305|NCT01392495|10119609|P1|Overall Study|Death|3
2939306|NCT01392443|10119621|P1|Overall Study|Protocol Violation|1
2939307|NCT01392443|10119621|P1|Overall Study|Lost to Follow-up|1
2939308|NCT01392443|10119621|P1|Overall Study|Withdrawal by Subject|5
2939309|NCT01392443|10119621|P1|Overall Study|Death|7
2939310|NCT01392443|10119621|P1|Overall Study|Adverse Event|24
2939311|NCT01392443|10119621|P1|Overall Study|Disease progression|30
2939312|NCT01392378|10119634|P5|Toddler Dose|Withdrawal by Parent|1
2939313|NCT01392378|10119635|P4|Toddler Dose|Withdrawal by Parent|1
2939314|NCT01392378|10119636|P3|Toddler Dose|Withdrawal by Parent|0
2939315|NCT01392378|10119637|P2|Toddler Dose|Withdrawal by Parent|1
2939316|NCT01392378|10119638|P1|Toddler Dose|Withdrawal by Parent|0
2939317|NCT01392378|10119634|P5|Toddler Dose|Lost to Follow-up|0
2939318|NCT01392378|10119635|P4|Toddler Dose|Lost to Follow-up|1
2939319|NCT01392378|10119636|P3|Toddler Dose|Lost to Follow-up|0
2939320|NCT01392378|10119637|P2|Toddler Dose|Lost to Follow-up|0
2939321|NCT01392378|10119638|P1|Toddler Dose|Lost to Follow-up|0
2939322|NCT01392378|10119634|P5|After Infant Series|Withdrawal by Parent|1
2939323|NCT01392378|10119635|P4|After Infant Series|Withdrawal by Parent|0
2939324|NCT01392378|10119636|P3|After Infant Series|Withdrawal by Parent|1
2939325|NCT01392378|10119637|P2|After Infant Series|Withdrawal by Parent|1
2939326|NCT01392378|10119638|P1|After Infant Series|Withdrawal by Parent|0
2939327|NCT01392378|10119634|P5|After Infant Series|Lost to Follow-up|0
2939328|NCT01392378|10119635|P4|After Infant Series|Lost to Follow-up|0
2939329|NCT01392378|10119636|P3|After Infant Series|Lost to Follow-up|1
2939330|NCT01392378|10119637|P2|After Infant Series|Lost to Follow-up|0
2939331|NCT01392378|10119638|P1|After Infant Series|Lost to Follow-up|0
2939332|NCT01392378|10119634|P5|Infant Series|Withdrawal by Parent|0
2939333|NCT01392378|10119635|P4|Infant Series|Withdrawal by Parent|0
2939334|NCT01392378|10119636|P3|Infant Series|Withdrawal by Parent|0
2939335|NCT01392378|10119637|P2|Infant Series|Withdrawal by Parent|1
2939336|NCT01392378|10119638|P1|Infant Series|Withdrawal by Parent|4
2939337|NCT01392378|10119634|P5|Infant Series|Protocol Violation|0
2939338|NCT01392378|10119635|P4|Infant Series|Protocol Violation|0
2939339|NCT01392378|10119636|P3|Infant Series|Protocol Violation|0
2939340|NCT01392378|10119637|P2|Infant Series|Protocol Violation|1
2939341|NCT01392378|10119638|P1|Infant Series|Protocol Violation|0
2939342|NCT01392378|10119634|P5|Infant Series|Lost to Follow-up|0
2939343|NCT01392378|10119635|P4|Infant Series|Lost to Follow-up|1
2939344|NCT01392378|10119636|P3|Infant Series|Lost to Follow-up|0
2939345|NCT01392378|10119637|P2|Infant Series|Lost to Follow-up|0
2939346|NCT01392378|10119638|P1|Infant Series|Lost to Follow-up|0
2939347|NCT01392378|10119634|P5|Infant Series|Adverse Event|0
2939348|NCT01392378|10119635|P4|Infant Series|Adverse Event|1
2939349|NCT01392378|10119636|P3|Infant Series|Adverse Event|0
2939350|NCT01392378|10119637|P2|Infant Series|Adverse Event|0
2939351|NCT01392378|10119638|P1|Infant Series|Adverse Event|0
2939352|NCT01392326|10119778|P3|Overall Study|Adverse Event|11
2939353|NCT01392326|10119779|P2|Overall Study|Adverse Event|6
2939354|NCT01392326|10119780|P1|Overall Study|Adverse Event|9
2939355|NCT01392326|10119778|P3|Overall Study|Lack of Efficacy|15
2939356|NCT01392326|10119779|P2|Overall Study|Lack of Efficacy|10
2939357|NCT01392326|10119780|P1|Overall Study|Lack of Efficacy|14
2939358|NCT01392326|10119778|P3|Overall Study|Lost to Follow-up|4
2939359|NCT01392326|10119779|P2|Overall Study|Lost to Follow-up|3
2939360|NCT01392326|10119780|P1|Overall Study|Lost to Follow-up|1
2939361|NCT01392326|10119778|P3|Overall Study|Physician Decision|2
2939362|NCT01392326|10119779|P2|Overall Study|Physician Decision|5
2939363|NCT01392326|10119780|P1|Overall Study|Physician Decision|7
2939364|NCT01392326|10119778|P3|Overall Study|Pregnancy|1
2939365|NCT01392326|10119779|P2|Overall Study|Pregnancy|0
2939366|NCT01392326|10119780|P1|Overall Study|Pregnancy|0
2939367|NCT01392326|10119778|P3|Overall Study|Protocol Violation|0
2939368|NCT01392326|10119779|P2|Overall Study|Protocol Violation|0
2939369|NCT01392326|10119780|P1|Overall Study|Protocol Violation|2
2939370|NCT01392326|10119778|P3|Overall Study|Withdrawal by Subject|15
2939371|NCT01392326|10119779|P2|Overall Study|Withdrawal by Subject|11
2939372|NCT01392326|10119780|P1|Overall Study|Withdrawal by Subject|12
2939373|NCT01392326|10119778|P3|Overall Study|Death|0
2939374|NCT01392326|10119779|P2|Overall Study|Death|0
2939375|NCT01392326|10119780|P1|Overall Study|Death|2
2939376|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
2939377|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2939378|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2939379|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
2939380|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2939381|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2939382|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Adverse Event|7
2939383|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Adverse Event|0
2939384|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Adverse Event|0
2939385|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Death|4
2939386|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Death|0
2939387|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Death|0
2939388|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Non-compliance|1
2939389|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Non-compliance|0
2939390|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Non-compliance|0
2939391|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
2939392|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2939393|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2939394|NCT01392300|10119817|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
2939395|NCT01392300|10119818|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
2939396|NCT01392300|10119819|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
2939397|NCT01392300|10119817|P3|Main Period (MP)|Non-compliance|0
2939398|NCT01392300|10119818|P2|Main Period (MP)|Non-compliance|0
2939399|NCT01392300|10119819|P1|Main Period (MP)|Non-compliance|1
2939400|NCT01392300|10119817|P3|Main Period (MP)|Lost to Follow-up|0
2939401|NCT01392300|10119818|P2|Main Period (MP)|Lost to Follow-up|3
2939402|NCT01392300|10119819|P1|Main Period (MP)|Lost to Follow-up|3
2939403|NCT01392300|10119817|P3|Main Period (MP)|Withdrawal by Subject|0
2939404|NCT01392300|10119818|P2|Main Period (MP)|Withdrawal by Subject|1
2939405|NCT01392300|10119819|P1|Main Period (MP)|Withdrawal by Subject|5
2939406|NCT01392300|10119817|P3|Main Period (MP)|Predefined discontinuation criteria|0
2939407|NCT01392300|10119818|P2|Main Period (MP)|Predefined discontinuation criteria|3
2939408|NCT01392300|10119819|P1|Main Period (MP)|Predefined discontinuation criteria|2
2939409|NCT01392170|10119924|P1|Overall Study|Ineligible|1
2939410|NCT01392170|10119924|P1|Overall Study|Withdrawal by Subject|1
2939411|NCT01391819|10119972|P1|Overall Study|Other|9
2939412|NCT01391819|10119972|P1|Overall Study|Death|3
2939413|NCT01391819|10119972|P1|Overall Study|Lost to Follow-up|252
2939414|NCT01391819|10119972|P1|Overall Study|Migrated/moved from study area|82
2939415|NCT01391819|10119972|P1|Overall Study|Withdrawal by Subject|56
2939416|NCT01391793|10120016|P2|Overall Study|No DMSA|57
2939417|NCT01391793|10120017|P1|Overall Study|No DMSA|73
2939418|NCT01391793|10120016|P2|Overall Study|Urine Culture Negative or Indeterminate|87
2939419|NCT01391793|10120017|P1|Overall Study|Urine Culture Negative or Indeterminate|71
2939420|NCT01391793|10120016|P2|Overall Study|Ineligible|0
2939421|NCT01391793|10120017|P1|Overall Study|Ineligible|3
2939422|NCT01391663|10120031|P4|Overall Study|Withdrawal by Subject|0
2939423|NCT01391663|10120032|P3|Overall Study|Withdrawal by Subject|1
2939424|NCT01391663|10120033|P2|Overall Study|Withdrawal by Subject|0
2939425|NCT01391663|10120034|P1|Overall Study|Withdrawal by Subject|0
2939426|NCT01391546|10120078|P2|Overall Study|History of Herpes Zoster (HZ)|0
2939427|NCT01391546|10120079|P1|Overall Study|History of Herpes Zoster (HZ)|1
2939428|NCT01391507|10120101|P4|Overall Study|Protocol Violation|2
2939429|NCT01391507|10120102|P3|Overall Study|Protocol Violation|1
2939430|NCT01391507|10120103|P2|Overall Study|Protocol Violation|1
2939431|NCT01391507|10120104|P1|Overall Study|Protocol Violation|2
2939432|NCT01391507|10120101|P4|Overall Study|Lack of Efficacy|1
2939433|NCT01391507|10120102|P3|Overall Study|Lack of Efficacy|0
2939434|NCT01391507|10120103|P2|Overall Study|Lack of Efficacy|0
2939435|NCT01391507|10120104|P1|Overall Study|Lack of Efficacy|0
2939436|NCT01391507|10120101|P4|Overall Study|Withdrawal by Subject|1
2939437|NCT01391507|10120102|P3|Overall Study|Withdrawal by Subject|1
2939438|NCT01391507|10120103|P2|Overall Study|Withdrawal by Subject|2
2939439|NCT01391507|10120104|P1|Overall Study|Withdrawal by Subject|1
2939440|NCT01391507|10120101|P4|Overall Study|Adverse Event|2
2939441|NCT01391507|10120102|P3|Overall Study|Adverse Event|2
2939442|NCT01391507|10120103|P2|Overall Study|Adverse Event|1
2939443|NCT01391507|10120104|P1|Overall Study|Adverse Event|1
2939444|NCT01391507|10120101|P4|Overall Study|Death|1
2939445|NCT01391507|10120102|P3|Overall Study|Death|0
2939446|NCT01391507|10120103|P2|Overall Study|Death|0
2939447|NCT01391507|10120104|P1|Overall Study|Death|0
2939448|NCT01391130|10120242|P2|Overall Study|Did not Receive Drug|1
2939449|NCT01391130|10120243|P1|Overall Study|Did not Receive Drug|1
2939450|NCT01391130|10120242|P2|Overall Study|Physician Decision|3
2939451|NCT01391130|10120243|P1|Overall Study|Physician Decision|2
2939452|NCT01391130|10120242|P2|Overall Study|Withdrawal by Subject|2
2939453|NCT01391130|10120243|P1|Overall Study|Withdrawal by Subject|3
2939454|NCT01391000|10120300|P2|Overall Study|Lost to Follow-up|0
2939455|NCT01391000|10120301|P1|Overall Study|Lost to Follow-up|2
2939456|NCT01390948|10120314|P3|Overall Study|Withdrew consent from survival follow-up|0
2939457|NCT01390948|10120315|P2|Overall Study|Withdrew consent from survival follow-up|5
2939458|NCT01390948|10120316|P1|Overall Study|Withdrew consent from survival follow-up|3
2939459|NCT01390948|10120314|P3|Overall Study|Ongoing|0
2939460|NCT01390948|10120315|P2|Overall Study|Ongoing|6
2939461|NCT01390948|10120316|P1|Overall Study|Ongoing|6
2939462|NCT01390948|10120314|P3|Overall Study|Death|2
2939463|NCT01390948|10120315|P2|Overall Study|Death|34
2939464|NCT01390948|10120316|P1|Overall Study|Death|30
2939465|NCT01390948|10120314|P3|Overall Study|Alive in follow-up|1
2939466|NCT01390948|10120315|P2|Overall Study|Alive in follow-up|17
2939467|NCT01390948|10120316|P1|Overall Study|Alive in follow-up|20
2939468|NCT01390857|10120382|P1|Overall Study|No Visit after the First Visit|7
2939469|NCT01390857|10120382|P1|Overall Study|Lost to Follow-up|1
2939470|NCT01390857|10120382|P1|Overall Study|Protocol Violation|2
2939471|NCT01390844|10120393|P4|Follow-Up Phase|Non-Medical Reasons|0
2939472|NCT01390844|10120394|P3|Follow-Up Phase|Non-Medical Reasons|1
2939473|NCT01390844|10120395|P2|Follow-Up Phase|Non-Medical Reasons|1
2939474|NCT01390844|10120396|P1|Follow-Up Phase|Non-Medical Reasons|1
2939475|NCT01390844|10120393|P4|Treatment Phase|Non-GCP Compliant|3
2939476|NCT01390844|10120394|P3|Treatment Phase|Non-GCP Compliant|10
2939477|NCT01390844|10120395|P2|Treatment Phase|Non-GCP Compliant|0
2939478|NCT01390844|10120396|P1|Treatment Phase|Non-GCP Compliant|0
2939479|NCT01390844|10120393|P4|Treatment Phase|Non-Medical Reasons|1
2939480|NCT01390844|10120394|P3|Treatment Phase|Non-Medical Reasons|8
2939481|NCT01390844|10120395|P2|Treatment Phase|Non-Medical Reasons|1
2939482|NCT01390844|10120396|P1|Treatment Phase|Non-Medical Reasons|5
2939483|NCT01390844|10120393|P4|Treatment Phase|Treatment Failure|13
2939484|NCT01390844|10120394|P3|Treatment Phase|Treatment Failure|10
2939485|NCT01390844|10120395|P2|Treatment Phase|Treatment Failure|25
2939486|NCT01390844|10120396|P1|Treatment Phase|Treatment Failure|23
2939487|NCT01390844|10120393|P4|Treatment Phase|Adverse Event|2
2939488|NCT01390844|10120394|P3|Treatment Phase|Adverse Event|3
2939489|NCT01390844|10120395|P2|Treatment Phase|Adverse Event|2
2939490|NCT01390844|10120396|P1|Treatment Phase|Adverse Event|12
2939491|NCT01390779|10120723|P1|Overall Study|Physician Decision|1
2939492|NCT01390649|10120728|P1|Overall Study|Physician Decision|1
2939493|NCT01390441|10120738|P5|Extension Period|Protocol Violation|0
2939494|NCT01390441|10120739|P4|Extension Period|Protocol Violation|1
2939495|NCT01390441|10120740|P3|Extension Period|Protocol Violation|0
2939496|NCT01390441|10120741|P2|Extension Period|Protocol Violation|1
2939497|NCT01390441|10120742|P1|Extension Period|Protocol Violation|3
2939498|NCT01390441|10120738|P5|Treatment Period|Lost to Follow-up|0
2939499|NCT01390441|10120739|P4|Treatment Period|Lost to Follow-up|0
2939500|NCT01390441|10120740|P3|Treatment Period|Lost to Follow-up|0
2939501|NCT01390441|10120741|P2|Treatment Period|Lost to Follow-up|0
2939502|NCT01390441|10120742|P1|Treatment Period|Lost to Follow-up|1
2939503|NCT01390441|10120738|P5|Treatment Period|Withdrawal by Subject|1
2939504|NCT01390441|10120739|P4|Treatment Period|Withdrawal by Subject|0
2939505|NCT01390441|10120740|P3|Treatment Period|Withdrawal by Subject|1
2939506|NCT01390441|10120741|P2|Treatment Period|Withdrawal by Subject|0
2939507|NCT01390441|10120742|P1|Treatment Period|Withdrawal by Subject|0
2939508|NCT01390441|10120738|P5|Treatment Period|Adverse Event|2
2939509|NCT01390441|10120739|P4|Treatment Period|Adverse Event|1
2939510|NCT01390441|10120740|P3|Treatment Period|Adverse Event|1
2939511|NCT01390441|10120741|P2|Treatment Period|Adverse Event|0
2939512|NCT01390441|10120742|P1|Treatment Period|Adverse Event|0
2939513|NCT01390441|10120738|P5|Treatment Period|Unknown due to early stopping of study|7
2939514|NCT01390441|10120739|P4|Treatment Period|Unknown due to early stopping of study|11
2939515|NCT01390441|10120740|P3|Treatment Period|Unknown due to early stopping of study|8
2939516|NCT01390441|10120741|P2|Treatment Period|Unknown due to early stopping of study|0
2939517|NCT01390441|10120742|P1|Treatment Period|Unknown due to early stopping of study|0
2939518|NCT01390441|10120738|P5|Treatment Period|Lack of Efficacy|1
2939519|NCT01390441|10120739|P4|Treatment Period|Lack of Efficacy|0
2939520|NCT01390441|10120740|P3|Treatment Period|Lack of Efficacy|0
2939521|NCT01390441|10120741|P2|Treatment Period|Lack of Efficacy|0
2939522|NCT01390441|10120742|P1|Treatment Period|Lack of Efficacy|0
2939523|NCT01390441|10120738|P5|Treatment Period|Physician Decision|0
2939524|NCT01390441|10120739|P4|Treatment Period|Physician Decision|1
2939525|NCT01390441|10120740|P3|Treatment Period|Physician Decision|0
2939526|NCT01390441|10120741|P2|Treatment Period|Physician Decision|0
2939527|NCT01390441|10120742|P1|Treatment Period|Physician Decision|0
2939528|NCT01390441|10120738|P5|Treatment Period|Protocol Violation|0
2939529|NCT01390441|10120739|P4|Treatment Period|Protocol Violation|0
2939530|NCT01390441|10120740|P3|Treatment Period|Protocol Violation|0
2939531|NCT01390441|10120741|P2|Treatment Period|Protocol Violation|1
2939532|NCT01390441|10120742|P1|Treatment Period|Protocol Violation|0
2939533|NCT01390428|10120807|P6|Overall Study|Withdrawal by Subject|0
2939534|NCT01390428|10120808|P5|Overall Study|Withdrawal by Subject|0
2939535|NCT01390428|10120809|P4|Overall Study|Withdrawal by Subject|0
2939536|NCT01390428|10120810|P3|Overall Study|Withdrawal by Subject|1
2939537|NCT01390428|10120811|P2|Overall Study|Withdrawal by Subject|0
2939538|NCT01390428|10120812|P1|Overall Study|Withdrawal by Subject|0
2939539|NCT01390428|10120807|P6|Overall Study|Elective Surgery|0
2939540|NCT01390428|10120808|P5|Overall Study|Elective Surgery|1
2939541|NCT01390428|10120809|P4|Overall Study|Elective Surgery|0
2939542|NCT01390428|10120810|P3|Overall Study|Elective Surgery|0
2939543|NCT01390428|10120811|P2|Overall Study|Elective Surgery|0
2939544|NCT01390428|10120812|P1|Overall Study|Elective Surgery|0
2939545|NCT01390402|10120875|P1|Overall Study|Disease Progression|4
2939546|NCT01390402|10120875|P1|Overall Study|Death|1
2939547|NCT01390389|10120881|P2|Overall Study|Screen Fail|1
2939548|NCT01390389|10120882|P1|Overall Study|Screen Fail|2
2939549|NCT01390389|10120881|P2|Overall Study|Withdrawal by Subject|0
2939550|NCT01390389|10120882|P1|Overall Study|Withdrawal by Subject|2
2939551|NCT01390298|10120892|P1|Overall Study|Surgery cancelled|1
2939552|NCT01390298|10120892|P1|Overall Study|Lost to Follow-up|7
2939553|NCT01390298|10120892|P1|Overall Study|Withdrawal by Subject|14
2939554|NCT01390298|10120892|P1|Overall Study|long term ICU admission|1
2939555|NCT01390298|10120892|P1|Overall Study|Death|1
2939556|NCT01390272|10120898|P2|Overall Study|Patient moved, no longer eligible|8
2939557|NCT01390272|10120899|P1|Overall Study|Patient moved, no longer eligible|5
2939558|NCT01390272|10120898|P2|Overall Study|Withdrawal by Subject|5
2939559|NCT01390272|10120899|P1|Overall Study|Withdrawal by Subject|9
2939560|NCT01390272|10120898|P2|Overall Study|Death|2
2939561|NCT01390272|10120899|P1|Overall Study|Death|3
2939562|NCT01390220|10120967|P3|Comparative Phase|Withdrawal by Subject|0
2939563|NCT01390220|10120968|P2|Comparative Phase|Withdrawal by Subject|1
2939564|NCT01390220|10120969|P1|Comparative Phase|Withdrawal by Subject|0
2939565|NCT01390220|10120967|P3|Test Dose Phase|Logistical|0
2939566|NCT01390220|10120968|P2|Test Dose Phase|Logistical|0
2939567|NCT01390220|10120969|P1|Test Dose Phase|Logistical|6
2939568|NCT01390220|10120967|P3|Test Dose Phase|Noncompliance|0
2939569|NCT01390220|10120968|P2|Test Dose Phase|Noncompliance|0
2939570|NCT01390220|10120969|P1|Test Dose Phase|Noncompliance|2
2939571|NCT01390220|10120967|P3|Test Dose Phase|Caregiver no longer available|0
2939572|NCT01390220|10120968|P2|Test Dose Phase|Caregiver no longer available|0
2939573|NCT01390220|10120969|P1|Test Dose Phase|Caregiver no longer available|5
2939574|NCT01390220|10120967|P3|Test Dose Phase|Study/Site closure|0
2939575|NCT01390220|10120968|P2|Test Dose Phase|Study/Site closure|0
2939576|NCT01390220|10120969|P1|Test Dose Phase|Study/Site closure|6
2939577|NCT01390220|10120967|P3|Test Dose Phase|No treated seizure cluster episode|0
2939578|NCT01390220|10120968|P2|Test Dose Phase|No treated seizure cluster episode|0
2939579|NCT01390220|10120969|P1|Test Dose Phase|No treated seizure cluster episode|37
2939580|NCT01390220|10120967|P3|Test Dose Phase|Protocol Violation|0
2939581|NCT01390220|10120968|P2|Test Dose Phase|Protocol Violation|0
2939582|NCT01390220|10120969|P1|Test Dose Phase|Protocol Violation|8
2939583|NCT01390220|10120967|P3|Test Dose Phase|Lost to Follow-up|0
2939584|NCT01390220|10120968|P2|Test Dose Phase|Lost to Follow-up|0
2939585|NCT01390220|10120969|P1|Test Dose Phase|Lost to Follow-up|2
2939586|NCT01390220|10120967|P3|Test Dose Phase|Withdrawal by Subject|0
2939587|NCT01390220|10120968|P2|Test Dose Phase|Withdrawal by Subject|0
2939588|NCT01390220|10120969|P1|Test Dose Phase|Withdrawal by Subject|8
2939589|NCT01390220|10120967|P3|Test Dose Phase|Adverse Event|0
2939590|NCT01390220|10120968|P2|Test Dose Phase|Adverse Event|0
2939591|NCT01390220|10120969|P1|Test Dose Phase|Adverse Event|17
2939592|NCT01390181|10120984|P1|Overall Study|Study Terminated due to Low Accrual|3
2939593|NCT01390181|10120984|P1|Overall Study|Lost to Follow-up|1
2939594|NCT01390038|10120997|P1|Overall Study|Simpliciti System Removal|2
2939595|NCT01390038|10120997|P1|Overall Study|Withdrawal by Subject|4
2939596|NCT01390038|10120997|P1|Overall Study|Lost to Follow-up|1
2939597|NCT01390038|10120997|P1|Overall Study|Death|1
2939598|NCT01389973|10121007|P1|Overall Study|Other|10
2939599|NCT01389973|10121007|P1|Overall Study|Trial Stopped by Sponsor|9
2939600|NCT01389973|10121007|P1|Overall Study|Lost to Follow-up|1
2939601|NCT01389882|10121017|P2|Overall Study|Withdrawal by Subject|1
2939602|NCT01389882|10121018|P1|Overall Study|Withdrawal by Subject|0
2939603|NCT01389882|10121017|P2|Overall Study|Respiratory rate > 80/min during study|3
2939604|NCT01389882|10121018|P1|Overall Study|Respiratory rate > 80/min during study|1
2939605|NCT01389817|10121106|P2|Overall Study|Withdrawal by Subject|0
2939606|NCT01389817|10121107|P1|Overall Study|Withdrawal by Subject|2
2939607|NCT01389817|10121106|P2|Overall Study|Lost to Follow-up|0
2939608|NCT01389817|10121107|P1|Overall Study|Lost to Follow-up|1
2939609|NCT01389817|10121106|P2|Overall Study|Physician Decision|0
2939610|NCT01389817|10121107|P1|Overall Study|Physician Decision|1
2939611|NCT01389752|10121124|P2|Study Period 2|Sponsor decision|0
2939612|NCT01389752|10121125|P1|Study Period 2|Sponsor decision|1
2939613|NCT01389752|10121124|P2|Study Period 1|Sponsor decision|2
2939614|NCT01389752|10121125|P1|Study Period 1|Sponsor decision|0
2939615|NCT01389596|10121138|P3|Overall Study|Other Unspecified|0
2939616|NCT01389596|10121139|P2|Overall Study|Other Unspecified|1
2939617|NCT01389596|10121140|P1|Overall Study|Other Unspecified|2
2939618|NCT01389596|10121138|P3|Overall Study|Death|0
2939619|NCT01389596|10121139|P2|Overall Study|Death|1
2939620|NCT01389596|10121140|P1|Overall Study|Death|0
2939621|NCT01389596|10121138|P3|Overall Study|Adverse Event|0
2939622|NCT01389596|10121139|P2|Overall Study|Adverse Event|4
2939623|NCT01389596|10121140|P1|Overall Study|Adverse Event|1
2939624|NCT01389596|10121138|P3|Overall Study|Insufficient Clinical Response|5
2939625|NCT01389596|10121139|P2|Overall Study|Insufficient Clinical Response|4
2939626|NCT01389596|10121140|P1|Overall Study|Insufficient Clinical Response|3
2939627|NCT01389596|10121138|P3|Overall Study|Withdrawal by Subject|2
2939628|NCT01389596|10121139|P2|Overall Study|Withdrawal by Subject|2
2939629|NCT01389596|10121140|P1|Overall Study|Withdrawal by Subject|1
2939630|NCT01389596|10121138|P3|Overall Study|Protocol Violation|3
2939631|NCT01389596|10121139|P2|Overall Study|Protocol Violation|4
2939632|NCT01389596|10121140|P1|Overall Study|Protocol Violation|3
2939633|NCT01389323|10121199|P1|Follow-up Period (up to 48 Weeks)|Other|3
2939634|NCT01389323|10121199|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
2939635|NCT01389323|10121199|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
2939636|NCT01389323|10121199|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
2939637|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
2939638|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
2939639|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
2939640|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
2939641|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
2939642|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
2939643|NCT01389323|10121199|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
2939644|NCT01389258|10121256|P1|Overall Study|Lost to Follow-up|5
2939645|NCT01389245|10121266|P1|Overall Study|Withdrawal by Subject|2
2939646|NCT01389245|10121266|P1|Overall Study|Lost to Follow-up|3
2939647|NCT01389245|10121266|P1|Overall Study|Protocol Violation|10
2939648|NCT01389128|10121276|P2|Overall Study|Intolerance to procedure|2
2939649|NCT01389128|10121277|P1|Overall Study|Intolerance to procedure|0
2939650|NCT01389128|10121276|P2|Overall Study|Rapid labor evolution|2
2939651|NCT01389128|10121277|P1|Overall Study|Rapid labor evolution|3
2939652|NCT01389128|10121276|P2|Overall Study|Cervix dilation stop|2
2939653|NCT01389128|10121277|P1|Overall Study|Cervix dilation stop|1
2939654|NCT01389128|10121276|P2|Overall Study|Fetal distress|0
2939655|NCT01389128|10121277|P1|Overall Study|Fetal distress|1
2939656|NCT01389102|10121301|P6|Overall Study|Investigator Judgement|0
2939657|NCT01389102|10121302|P5|Overall Study|Investigator Judgement|0
2939658|NCT01389102|10121303|P4|Overall Study|Investigator Judgement|0
2939659|NCT01389102|10121304|P3|Overall Study|Investigator Judgement|0
2939660|NCT01389102|10121305|P2|Overall Study|Investigator Judgement|1
2939661|NCT01389102|10121306|P1|Overall Study|Investigator Judgement|0
2939662|NCT01389102|10121301|P6|Overall Study|Unavailable due to husband's illness|0
2939663|NCT01389102|10121302|P5|Overall Study|Unavailable due to husband's illness|0
2939664|NCT01389102|10121303|P4|Overall Study|Unavailable due to husband's illness|0
2939665|NCT01389102|10121304|P3|Overall Study|Unavailable due to husband's illness|0
2939666|NCT01389102|10121305|P2|Overall Study|Unavailable due to husband's illness|1
2939667|NCT01389102|10121306|P1|Overall Study|Unavailable due to husband's illness|0
2939668|NCT01389102|10121301|P6|Overall Study|Subject Moved|0
2939669|NCT01389102|10121302|P5|Overall Study|Subject Moved|0
2939670|NCT01389102|10121303|P4|Overall Study|Subject Moved|0
2939671|NCT01389102|10121304|P3|Overall Study|Subject Moved|1
2939672|NCT01389102|10121305|P2|Overall Study|Subject Moved|0
2939673|NCT01389102|10121306|P1|Overall Study|Subject Moved|2
2939674|NCT01389102|10121301|P6|Overall Study|Subject Traveling Out of Country|0
2939675|NCT01389102|10121302|P5|Overall Study|Subject Traveling Out of Country|0
2939676|NCT01389102|10121303|P4|Overall Study|Subject Traveling Out of Country|1
2939677|NCT01389102|10121304|P3|Overall Study|Subject Traveling Out of Country|0
2939678|NCT01389102|10121305|P2|Overall Study|Subject Traveling Out of Country|0
2939679|NCT01389102|10121306|P1|Overall Study|Subject Traveling Out of Country|0
2939680|NCT01389102|10121301|P6|Overall Study|Withdrawal by Subject|3
2939681|NCT01389102|10121302|P5|Overall Study|Withdrawal by Subject|3
2939682|NCT01389102|10121303|P4|Overall Study|Withdrawal by Subject|2
2939683|NCT01389102|10121304|P3|Overall Study|Withdrawal by Subject|9
2939684|NCT01389102|10121305|P2|Overall Study|Withdrawal by Subject|4
2939685|NCT01389102|10121306|P1|Overall Study|Withdrawal by Subject|7
2939686|NCT01389102|10121301|P6|Overall Study|Protocol Violation|1
2939687|NCT01389102|10121302|P5|Overall Study|Protocol Violation|1
2939688|NCT01389102|10121303|P4|Overall Study|Protocol Violation|0
2939689|NCT01389102|10121304|P3|Overall Study|Protocol Violation|3
2939690|NCT01389102|10121305|P2|Overall Study|Protocol Violation|0
2939691|NCT01389102|10121306|P1|Overall Study|Protocol Violation|0
2939692|NCT01389102|10121301|P6|Overall Study|Lost to Follow-up|1
2939693|NCT01389102|10121302|P5|Overall Study|Lost to Follow-up|4
2939694|NCT01389102|10121303|P4|Overall Study|Lost to Follow-up|2
2939695|NCT01389102|10121304|P3|Overall Study|Lost to Follow-up|1
2939696|NCT01389102|10121305|P2|Overall Study|Lost to Follow-up|1
2939697|NCT01389102|10121306|P1|Overall Study|Lost to Follow-up|4
2939698|NCT01389102|10121301|P6|Overall Study|Hurricane Katrina|1
2939699|NCT01389102|10121302|P5|Overall Study|Hurricane Katrina|3
2939700|NCT01389102|10121303|P4|Overall Study|Hurricane Katrina|0
2939701|NCT01389102|10121304|P3|Overall Study|Hurricane Katrina|3
2939702|NCT01389102|10121305|P2|Overall Study|Hurricane Katrina|2
2939703|NCT01389102|10121306|P1|Overall Study|Hurricane Katrina|4
2939704|NCT01389102|10121301|P6|Overall Study|Adverse Event|2
2939705|NCT01389102|10121302|P5|Overall Study|Adverse Event|2
2939706|NCT01389102|10121303|P4|Overall Study|Adverse Event|2
2939707|NCT01389102|10121304|P3|Overall Study|Adverse Event|2
2939708|NCT01389102|10121305|P2|Overall Study|Adverse Event|3
2939709|NCT01389102|10121306|P1|Overall Study|Adverse Event|1
2939710|NCT01388985|10121336|P2|Overall Study|Error of nurse|1
2939711|NCT01388985|10121337|P1|Overall Study|Error of nurse|5
2939712|NCT01388985|10121336|P2|Overall Study|Other (no reason)|1
2939713|NCT01388985|10121337|P1|Overall Study|Other (no reason)|0
2939714|NCT01388985|10121336|P2|Overall Study|Subject unavailable|1
2939715|NCT01388985|10121337|P1|Overall Study|Subject unavailable|1
2939716|NCT01388985|10121336|P2|Overall Study|Withdrawal by Subject|4
2939717|NCT01388985|10121337|P1|Overall Study|Withdrawal by Subject|13
2939718|NCT01388985|10121336|P2|Overall Study|Lost to Follow-up|30
2939719|NCT01388985|10121337|P1|Overall Study|Lost to Follow-up|30
2939720|NCT01388985|10121336|P2|Overall Study|Death|1
2939721|NCT01388985|10121337|P1|Overall Study|Death|0
2939722|NCT01388907|10121401|P2|Overall Study|Adverse Event|0
2939723|NCT01388907|10121402|P1|Overall Study|Adverse Event|2
2939724|NCT01388816|10121418|P4|Overall Study|Protocol Violation|0
2939725|NCT01388816|10121419|P3|Overall Study|Protocol Violation|2
2939726|NCT01388816|10121420|P2|Overall Study|Protocol Violation|0
2939727|NCT01388816|10121421|P1|Overall Study|Protocol Violation|0
2939728|NCT01388816|10121418|P4|Overall Study|Withdrawal by Subject|0
2939729|NCT01388816|10121419|P3|Overall Study|Withdrawal by Subject|1
2939730|NCT01388816|10121420|P2|Overall Study|Withdrawal by Subject|1
2939731|NCT01388816|10121421|P1|Overall Study|Withdrawal by Subject|2
2939732|NCT01388816|10121418|P4|Overall Study|Lost to Follow-up|0
2939733|NCT01388816|10121419|P3|Overall Study|Lost to Follow-up|0
2939734|NCT01388816|10121420|P2|Overall Study|Lost to Follow-up|1
2939735|NCT01388816|10121421|P1|Overall Study|Lost to Follow-up|0
2939736|NCT01388816|10121418|P4|Overall Study|Adverse Event|0
2939737|NCT01388816|10121419|P3|Overall Study|Adverse Event|0
2939738|NCT01388816|10121420|P2|Overall Study|Adverse Event|2
2939739|NCT01388816|10121421|P1|Overall Study|Adverse Event|0
2939740|NCT01388790|10121450|P1|Overall Study|Ongoing at data cut−off date|8
2939741|NCT01388647|10121461|P2|Overall Study|Adverse Event|2
2939742|NCT01388647|10121462|P1|Overall Study|Adverse Event|1
2939743|NCT01388543|10121475|P2|Day 14|Adverse Event|4
2939744|NCT01388543|10121476|P1|Day 14|Adverse Event|1
2939745|NCT01388530|10121482|P1|Overall Study|Lost to Follow-up|5
2939746|NCT01388491|10121491|P2|Overall Study|Pregnancy|0
2939747|NCT01388491|10121492|P1|Overall Study|Pregnancy|1
2939748|NCT01388491|10121491|P2|Overall Study|Noncompliance|0
2939749|NCT01388491|10121492|P1|Overall Study|Noncompliance|2
2939750|NCT01388491|10121491|P2|Overall Study|Protocol Violation|0
2939751|NCT01388491|10121492|P1|Overall Study|Protocol Violation|2
2939752|NCT01388491|10121491|P2|Overall Study|Lost to Follow-up|3
2939753|NCT01388491|10121492|P1|Overall Study|Lost to Follow-up|4
2939754|NCT01388491|10121491|P2|Overall Study|Withdrawal by Subject|10
2939755|NCT01388491|10121492|P1|Overall Study|Withdrawal by Subject|6
2939756|NCT01388491|10121491|P2|Overall Study|Sponsor Request|7
2939757|NCT01388491|10121492|P1|Overall Study|Sponsor Request|9
2939758|NCT01388491|10121491|P2|Overall Study|Adverse Event|9
2939759|NCT01388491|10121492|P1|Overall Study|Adverse Event|10
2939760|NCT01388361|10121527|P3|Overall Study|Unclassified|1
2939761|NCT01388361|10121528|P2|Overall Study|Unclassified|0
2939762|NCT01388361|10121529|P1|Overall Study|Unclassified|0
2939763|NCT01388361|10121527|P3|Overall Study|Withdrawal criteria|10
2939764|NCT01388361|10121528|P2|Overall Study|Withdrawal criteria|7
2939765|NCT01388361|10121529|P1|Overall Study|Withdrawal criteria|12
2939766|NCT01388361|10121527|P3|Overall Study|Protocol Violation|2
2939767|NCT01388361|10121528|P2|Overall Study|Protocol Violation|0
2939768|NCT01388361|10121529|P1|Overall Study|Protocol Violation|0
2939769|NCT01388361|10121527|P3|Overall Study|Adverse Event|1
2939770|NCT01388361|10121528|P2|Overall Study|Adverse Event|5
2939771|NCT01388361|10121529|P1|Overall Study|Adverse Event|0
2939772|NCT01388166|10121546|P1|Overall Study|Others than specified above|13
2939773|NCT01388166|10121546|P1|Overall Study|Lost to Follow-up|30
2939774|NCT01388166|10121546|P1|Overall Study|Adverse Event|16
2939775|NCT01387789|10121849|P1|Overall Study|Lost to Follow-up|1
2939776|NCT01387789|10121849|P1|Overall Study|Lack of Efficacy|2
2939777|NCT01387789|10121849|P1|Overall Study|Adverse Event|5
2939778|NCT01387737|10121863|P2|Overall Study|Clearly not eligible for the study|3
2939779|NCT01387737|10121864|P1|Overall Study|Clearly not eligible for the study|1
2939780|NCT01387737|10121863|P2|Overall Study|Withdrawal by Subject|31
2939781|NCT01387737|10121864|P1|Overall Study|Withdrawal by Subject|27
2939782|NCT01387737|10121863|P2|Overall Study|Physician Decision|10
2939783|NCT01387737|10121864|P1|Overall Study|Physician Decision|3
2939784|NCT01387737|10121863|P2|Overall Study|Lack of Efficacy|0
2939785|NCT01387737|10121864|P1|Overall Study|Lack of Efficacy|1
2939786|NCT01387737|10121863|P2|Overall Study|Adverse Event|30
2939787|NCT01387737|10121864|P1|Overall Study|Adverse Event|20
2939788|NCT01387607|10121898|P2|Overall Study|Randomized, not treated|6
2939789|NCT01387607|10121899|P1|Overall Study|Randomized, not treated|3
2939790|NCT01387607|10121898|P2|Overall Study|Other|1
2939791|NCT01387607|10121899|P1|Overall Study|Other|1
2939792|NCT01387607|10121898|P2|Overall Study|Withdrawal by Subject|14
2939793|NCT01387607|10121899|P1|Overall Study|Withdrawal by Subject|13
2939794|NCT01387607|10121898|P2|Overall Study|Protocol Violation|5
2939795|NCT01387607|10121899|P1|Overall Study|Protocol Violation|1
2939796|NCT01387607|10121898|P2|Overall Study|No longer meets eligibility criteria|1
2939797|NCT01387607|10121899|P1|Overall Study|No longer meets eligibility criteria|0
2939798|NCT01387607|10121898|P2|Overall Study|Lost to Follow-up|1
2939799|NCT01387607|10121899|P1|Overall Study|Lost to Follow-up|2
2939800|NCT01387607|10121898|P2|Overall Study|Lack of Efficacy|6
2939801|NCT01387607|10121899|P1|Overall Study|Lack of Efficacy|8
2939802|NCT01387607|10121898|P2|Overall Study|Adverse Event|11
2939803|NCT01387607|10121899|P1|Overall Study|Adverse Event|23
2939804|NCT01387594|10121953|P2|Overall Study|Lost to Follow-up|1
2939805|NCT01387594|10121954|P1|Overall Study|Lost to Follow-up|0
2939806|NCT01387594|10121953|P2|Overall Study|Withdrawal by Subject|2
2939807|NCT01387594|10121954|P1|Overall Study|Withdrawal by Subject|0
2939808|NCT01387542|10121982|P1|Overall Study|Lost to Follow-up|1
2939809|NCT01387542|10121982|P1|Overall Study|Non-compliant|1
2939810|NCT01387542|10121982|P1|Overall Study|Insufficient response|1
2939811|NCT01387542|10121982|P1|Overall Study|Changed diagnosis|1
2939812|NCT01387542|10121982|P1|Overall Study|Withdrawal by Subject|1
2939813|NCT01387542|10121982|P1|Overall Study|Adverse Event|3
2939814|NCT01387516|10121993|P4|Overall Study|Death|1
2939815|NCT01387516|10121994|P3|Overall Study|Death|0
2939816|NCT01387516|10121995|P2|Overall Study|Death|0
2939817|NCT01387516|10121996|P1|Overall Study|Death|0
2939818|NCT01387516|10121993|P4|Overall Study|Withdrawal by Subject|0
2939819|NCT01387516|10121994|P3|Overall Study|Withdrawal by Subject|2
2939820|NCT01387516|10121995|P2|Overall Study|Withdrawal by Subject|1
2939821|NCT01387516|10121996|P1|Overall Study|Withdrawal by Subject|1
2939822|NCT01387516|10121993|P4|Overall Study|Lost to Follow-up|3
2939823|NCT01387516|10121994|P3|Overall Study|Lost to Follow-up|2
2939824|NCT01387516|10121995|P2|Overall Study|Lost to Follow-up|4
2939825|NCT01387516|10121996|P1|Overall Study|Lost to Follow-up|4
2939826|NCT01387347|10122029|P2|Overall Study|Lost to Follow-up|1
2939827|NCT01387347|10122030|P1|Overall Study|Lost to Follow-up|2
2939828|NCT01387282|10122042|P2|Overall Study|Lost to Follow-up|1
2939829|NCT01387282|10122043|P1|Overall Study|Lost to Follow-up|4
2939830|NCT01387282|10122042|P2|Overall Study|Study drug-related AE|2
2939831|NCT01387282|10122043|P1|Overall Study|Study drug-related AE|2
2939832|NCT01387282|10122042|P2|Overall Study|Withdrawal by patient|23
2939833|NCT01387282|10122043|P1|Overall Study|Withdrawal by patient|33
2939834|NCT01387282|10122042|P2|Overall Study|Unrelated AE|4
2939835|NCT01387282|10122043|P1|Overall Study|Unrelated AE|6
2939836|NCT01387282|10122042|P2|Overall Study|Other|1
2939837|NCT01387282|10122043|P1|Overall Study|Other|5
2939838|NCT01387282|10122042|P2|Overall Study|Death|16
2939839|NCT01387282|10122043|P1|Overall Study|Death|47
2939840|NCT01387269|10122059|P2|Overall Study|Lost to Follow-up|0
2939841|NCT01387269|10122060|P1|Overall Study|Lost to Follow-up|1
2939842|NCT01387269|10122059|P2|Overall Study|Study drug-related AE|0
2939843|NCT01387269|10122060|P1|Overall Study|Study drug-related AE|1
2939844|NCT01387269|10122059|P2|Overall Study|Withdrawal by patient|10
2939845|NCT01387269|10122060|P1|Overall Study|Withdrawal by patient|32
2939846|NCT01387269|10122059|P2|Overall Study|Unrelated AE|3
2939847|NCT01387269|10122060|P1|Overall Study|Unrelated AE|12
2939848|NCT01387269|10122059|P2|Overall Study|Other|7
2939849|NCT01387269|10122060|P1|Overall Study|Other|8
2939850|NCT01387269|10122059|P2|Overall Study|Death|20
2939851|NCT01387269|10122060|P1|Overall Study|Death|38
2939852|NCT01387230|10122077|P3|Overall Study|Withdrawal by Subject|0
2939853|NCT01387230|10122078|P2|Overall Study|Withdrawal by Subject|1
2939854|NCT01387230|10122079|P1|Overall Study|Withdrawal by Subject|4
2939855|NCT01387230|10122077|P3|Overall Study|Lost to Follow-up|1
2939856|NCT01387230|10122078|P2|Overall Study|Lost to Follow-up|0
2939857|NCT01387230|10122079|P1|Overall Study|Lost to Follow-up|0
2939858|NCT01387230|10122077|P3|Overall Study|Protocol-defined Stopping Criteria|5
2939859|NCT01387230|10122078|P2|Overall Study|Protocol-defined Stopping Criteria|0
2939860|NCT01387230|10122079|P1|Overall Study|Protocol-defined Stopping Criteria|6
2939861|NCT01387230|10122077|P3|Overall Study|Lack of Efficacy|4
2939862|NCT01387230|10122078|P2|Overall Study|Lack of Efficacy|5
2939863|NCT01387230|10122079|P1|Overall Study|Lack of Efficacy|8
2939864|NCT01387230|10122077|P3|Overall Study|Adverse Event|3
2939865|NCT01387230|10122078|P2|Overall Study|Adverse Event|1
2939866|NCT01387230|10122079|P1|Overall Study|Adverse Event|0
2939867|NCT01387074|10122125|P1|Overall Study|Lack of Efficacy|1
2939868|NCT01387074|10122125|P1|Overall Study|Lost to Follow-up|7
2939869|NCT01387022|10122138|P2|Overall Study|Lost to Follow-up|3
2939870|NCT01387022|10122139|P1|Overall Study|Lost to Follow-up|0
2939871|NCT01387022|10122138|P2|Overall Study|Death|1
2939872|NCT01387022|10122139|P1|Overall Study|Death|1
2939873|NCT01386970|10122168|P2|Overall Study|Adverse Event|1
2939874|NCT01386970|10122169|P1|Overall Study|Adverse Event|4
2939875|NCT01386970|10122168|P2|Overall Study|Withdrawal by Subject|1
2939876|NCT01386970|10122169|P1|Overall Study|Withdrawal by Subject|0
2939877|NCT01386944|10122177|P1|Overall Study|Unspecified reason|8
2939878|NCT01386944|10122177|P1|Overall Study|Lost to Follow-up|8
2939879|NCT01386944|10122177|P1|Overall Study|Lack of Efficacy|14
2939880|NCT01386944|10122177|P1|Overall Study|Adverse Event|26
2939881|NCT01386788|10122187|P1|Overall Study|Lost to Follow-up|2
2939882|NCT01386684|10122192|P1|Overall Study|Missing|3
2939883|NCT01386684|10122192|P1|Overall Study|Protocol Violation|4
2939884|NCT01386684|10122192|P1|Overall Study|Noncompliance|8
2939885|NCT01386684|10122192|P1|Overall Study|Adverse Event|20
2939886|NCT01386684|10122192|P1|Overall Study|Disease Progression|28
2939887|NCT01386684|10122192|P1|Overall Study|Alternative Therapy Required|37
2939888|NCT01386684|10122192|P1|Overall Study|Withdrawal of Consent|44
2939889|NCT01386684|10122192|P1|Overall Study|Death|47
2939890|NCT01386684|10122192|P1|Overall Study|Other|51
2939891|NCT01386684|10122192|P1|Overall Study|Lost to Follow-up|51
2939892|NCT01386658|10122233|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
2939893|NCT01386658|10122234|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
2939894|NCT01386658|10122233|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
2939895|NCT01386658|10122234|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
2939896|NCT01386606|10122312|P4|Overall Study|T levels too high|0
2939897|NCT01386606|10122313|P3|Overall Study|T levels too high|1
2939898|NCT01386606|10122314|P2|Overall Study|T levels too high|1
2939899|NCT01386606|10122315|P1|Overall Study|T levels too high|0
2939900|NCT01386606|10122312|P4|Overall Study|Unable to draw PK|0
2939901|NCT01386606|10122313|P3|Overall Study|Unable to draw PK|0
2939902|NCT01386606|10122314|P2|Overall Study|Unable to draw PK|0
2939903|NCT01386606|10122315|P1|Overall Study|Unable to draw PK|1
2939904|NCT01386606|10122312|P4|Overall Study|Subject incarcerated|0
2939905|NCT01386606|10122313|P3|Overall Study|Subject incarcerated|0
2939906|NCT01386606|10122314|P2|Overall Study|Subject incarcerated|1
2939907|NCT01386606|10122315|P1|Overall Study|Subject incarcerated|0
2939908|NCT01386606|10122312|P4|Overall Study|Lost to Follow-up|0
2939909|NCT01386606|10122313|P3|Overall Study|Lost to Follow-up|0
2939910|NCT01386606|10122314|P2|Overall Study|Lost to Follow-up|0
2939911|NCT01386606|10122315|P1|Overall Study|Lost to Follow-up|2
2939912|NCT01386606|10122312|P4|Overall Study|Protocol Violation|1
2939913|NCT01386606|10122313|P3|Overall Study|Protocol Violation|1
2939914|NCT01386606|10122314|P2|Overall Study|Protocol Violation|0
2939915|NCT01386606|10122315|P1|Overall Study|Protocol Violation|1
2939916|NCT01386606|10122312|P4|Overall Study|Withdrawal by Subject|0
2939917|NCT01386606|10122313|P3|Overall Study|Withdrawal by Subject|1
2939918|NCT01386606|10122314|P2|Overall Study|Withdrawal by Subject|1
2939919|NCT01386606|10122315|P1|Overall Study|Withdrawal by Subject|0
2939920|NCT01386606|10122312|P4|Overall Study|Adverse Event|0
2939921|NCT01386606|10122313|P3|Overall Study|Adverse Event|0
2939922|NCT01386606|10122314|P2|Overall Study|Adverse Event|1
2939923|NCT01386606|10122315|P1|Overall Study|Adverse Event|0
2939924|NCT01386554|10122346|P3|Overall Study|Reason not collected|0
2939925|NCT01386554|10122347|P2|Overall Study|Reason not collected|1
2939926|NCT01386554|10122348|P1|Overall Study|Reason not collected|0
2939927|NCT01386554|10122346|P3|Overall Study|Investigator discretion|1
2939928|NCT01386554|10122347|P2|Overall Study|Investigator discretion|0
2939929|NCT01386554|10122348|P1|Overall Study|Investigator discretion|0
2939930|NCT01386554|10122346|P3|Overall Study|Administration of live vaccines|0
2939931|NCT01386554|10122347|P2|Overall Study|Administration of live vaccines|1
2939932|NCT01386554|10122348|P1|Overall Study|Administration of live vaccines|0
2939933|NCT01386554|10122346|P3|Overall Study|Progressive disease|2
2939934|NCT01386554|10122347|P2|Overall Study|Progressive disease|2
2939935|NCT01386554|10122348|P1|Overall Study|Progressive disease|1
2939936|NCT01386554|10122346|P3|Overall Study|Adverse Event|2
2939937|NCT01386554|10122347|P2|Overall Study|Adverse Event|5
2939938|NCT01386554|10122348|P1|Overall Study|Adverse Event|2
2939939|NCT01386554|10122346|P3|Overall Study|Lost to Follow-up|1
2939940|NCT01386554|10122347|P2|Overall Study|Lost to Follow-up|0
2939941|NCT01386554|10122348|P1|Overall Study|Lost to Follow-up|0
2939942|NCT01386125|10122371|P2|Overall Study|Participant Leaving Country|0
2939943|NCT01386125|10122372|P1|Overall Study|Participant Leaving Country|1
2939944|NCT01386125|10122371|P2|Overall Study|Lack of Efficacy|1
2939945|NCT01386125|10122372|P1|Overall Study|Lack of Efficacy|0
2939946|NCT01386125|10122371|P2|Overall Study|Adverse Event|5
2939947|NCT01386125|10122372|P1|Overall Study|Adverse Event|2
2939948|NCT01386125|10122371|P2|Overall Study|Withdrawal by Subject|12
2939949|NCT01386125|10122372|P1|Overall Study|Withdrawal by Subject|13
2939950|NCT01386125|10122371|P2|Overall Study|Disease Progress|2
2939951|NCT01386125|10122372|P1|Overall Study|Disease Progress|1
2939952|NCT01386125|10122371|P2|Overall Study|Protocol Violation|7
2939953|NCT01386125|10122372|P1|Overall Study|Protocol Violation|5
2939954|NCT01386125|10122371|P2|Overall Study|Physician Decision|1
2939955|NCT01386125|10122372|P1|Overall Study|Physician Decision|0
2939956|NCT01386125|10122371|P2|Overall Study|Lost to Follow-up|9
2939957|NCT01386125|10122372|P1|Overall Study|Lost to Follow-up|3
2939958|NCT01386008|10122380|P1|Overall Study|Adverse Event|3
2939959|NCT01386008|10122380|P1|Overall Study|exited w/o incident /study discontinued|17
2939960|NCT01385995|10122389|P2|Period 1, 2 Months|Physician Decision|0
2939961|NCT01385995|10122390|P1|Period 1, 2 Months|Physician Decision|1
2939962|NCT01385748|10122407|P3|Overall Study|Adverse Event|1
2939963|NCT01385748|10122408|P2|Overall Study|Adverse Event|2
2939964|NCT01385748|10122409|P1|Overall Study|Adverse Event|4
2939965|NCT01385748|10122407|P3|Overall Study|Other|1
2939966|NCT01385748|10122408|P2|Overall Study|Other|7
2939967|NCT01385748|10122409|P1|Overall Study|Other|1
2939968|NCT01385748|10122407|P3|Overall Study|Noncompliance|6
2939969|NCT01385748|10122408|P2|Overall Study|Noncompliance|1
2939970|NCT01385748|10122409|P1|Overall Study|Noncompliance|3
2939971|NCT01385748|10122407|P3|Overall Study|Withdrawal by Subject|5
2939972|NCT01385748|10122408|P2|Overall Study|Withdrawal by Subject|4
2939973|NCT01385748|10122409|P1|Overall Study|Withdrawal by Subject|7
2939974|NCT01385566|10122494|P6|Overall Study|Withdrawal by Subject|0
2939975|NCT01385566|10122495|P5|Overall Study|Withdrawal by Subject|0
2939976|NCT01385566|10122496|P4|Overall Study|Withdrawal by Subject|1
2939977|NCT01385566|10122497|P3|Overall Study|Withdrawal by Subject|0
2939978|NCT01385566|10122498|P2|Overall Study|Withdrawal by Subject|0
2939979|NCT01385566|10122499|P1|Overall Study|Withdrawal by Subject|0
2939980|NCT01385566|10122494|P6|Overall Study|Lost to Follow-up|0
2939981|NCT01385566|10122495|P5|Overall Study|Lost to Follow-up|0
2939982|NCT01385566|10122496|P4|Overall Study|Lost to Follow-up|0
2939983|NCT01385566|10122497|P3|Overall Study|Lost to Follow-up|0
2939984|NCT01385566|10122498|P2|Overall Study|Lost to Follow-up|0
2939985|NCT01385566|10122499|P1|Overall Study|Lost to Follow-up|1
2939986|NCT01385371|10122553|P2|Overall Study|Administrative|2
2939987|NCT01385371|10122554|P1|Overall Study|Administrative|2
2939988|NCT01385371|10122553|P2|Overall Study|Protocol Violation|21
2939989|NCT01385371|10122554|P1|Overall Study|Protocol Violation|25
2939990|NCT01385371|10122553|P2|Overall Study|Withdrawal by Subject|39
2939991|NCT01385371|10122554|P1|Overall Study|Withdrawal by Subject|52
2939992|NCT01385371|10122553|P2|Overall Study|Lost to Follow-up|16
2939993|NCT01385371|10122554|P1|Overall Study|Lost to Follow-up|16
2939994|NCT01385371|10122553|P2|Overall Study|Adverse Event|19
2939995|NCT01385371|10122554|P1|Overall Study|Adverse Event|54
2939996|NCT01385202|10122602|P1|Overall Study|Withdrawn|1
2939997|NCT01385202|10122602|P1|Overall Study|Not Eligible|11
2939998|NCT01385202|10122602|P1|Overall Study|Lost to Follow-up|6
2939999|NCT01385176|10122639|P2|6-18 Month All VNS Active|Heart Transplant|0
2940000|NCT01385176|10122640|P1|6-18 Month All VNS Active|Heart Transplant|1
2940001|NCT01385176|10122639|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
2940002|NCT01385176|10122640|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
2940003|NCT01385176|10122639|P2|6-18 Month All VNS Active|Physician Decision|1
2940004|NCT01385176|10122640|P1|6-18 Month All VNS Active|Physician Decision|0
2940005|NCT01385176|10122639|P2|6-18 Month All VNS Active|Death|2
2940006|NCT01385176|10122640|P1|6-18 Month All VNS Active|Death|1
2940007|NCT01385176|10122639|P2|Randomization Phase|Death|2
2940008|NCT01385176|10122640|P1|Randomization Phase|Death|1
2940009|NCT01385098|10122671|P1|Overall Study|Lost to Follow-up|4
2940010|NCT01385098|10122671|P1|Overall Study|Adverse Event|10
2940011|NCT01384877|10122693|P2|Treatment 2|Lost to Follow-up|2
2940012|NCT01384877|10122694|P1|Treatment 2|Lost to Follow-up|2
2940013|NCT01384760|10122720|P2|Overall Study|Protocol Violation|0
2940014|NCT01384760|10122721|P1|Overall Study|Protocol Violation|16
2940015|NCT01384760|10122720|P2|Overall Study|Lost to Follow-up|6
2940016|NCT01384760|10122721|P1|Overall Study|Lost to Follow-up|0
2940017|NCT01384734|10122734|P5|Overall Study|Physician Decision|0
2940018|NCT01384734|10122735|P4|Overall Study|Physician Decision|0
2940019|NCT01384734|10122736|P3|Overall Study|Physician Decision|0
2940020|NCT01384734|10122737|P2|Overall Study|Physician Decision|0
2940021|NCT01384734|10122738|P1|Overall Study|Physician Decision|1
2940022|NCT01384734|10122734|P5|Overall Study|Early termination|1
2940023|NCT01384734|10122735|P4|Overall Study|Early termination|0
2940024|NCT01384734|10122736|P3|Overall Study|Early termination|0
2940025|NCT01384734|10122737|P2|Overall Study|Early termination|0
2940026|NCT01384734|10122738|P1|Overall Study|Early termination|0
2940027|NCT01384734|10122734|P5|Overall Study|Adhesion problem|0
2940028|NCT01384734|10122735|P4|Overall Study|Adhesion problem|1
2940029|NCT01384734|10122736|P3|Overall Study|Adhesion problem|0
2940030|NCT01384734|10122737|P2|Overall Study|Adhesion problem|0
2940031|NCT01384734|10122738|P1|Overall Study|Adhesion problem|0
2940032|NCT01384734|10122734|P5|Overall Study|Missed End of treatment visit|0
2940033|NCT01384734|10122735|P4|Overall Study|Missed End of treatment visit|1
2940034|NCT01384734|10122736|P3|Overall Study|Missed End of treatment visit|0
2940035|NCT01384734|10122737|P2|Overall Study|Missed End of treatment visit|0
2940036|NCT01384734|10122738|P1|Overall Study|Missed End of treatment visit|0
2940037|NCT01384734|10122734|P5|Overall Study|As per Exclusion criteria|0
2940038|NCT01384734|10122735|P4|Overall Study|As per Exclusion criteria|0
2940039|NCT01384734|10122736|P3|Overall Study|As per Exclusion criteria|0
2940040|NCT01384734|10122737|P2|Overall Study|As per Exclusion criteria|1
2940041|NCT01384734|10122738|P1|Overall Study|As per Exclusion criteria|0
2940042|NCT01384734|10122734|P5|Overall Study|Prison|0
2940043|NCT01384734|10122735|P4|Overall Study|Prison|0
2940044|NCT01384734|10122736|P3|Overall Study|Prison|1
2940045|NCT01384734|10122737|P2|Overall Study|Prison|0
2940046|NCT01384734|10122738|P1|Overall Study|Prison|0
2940047|NCT01384734|10122734|P5|Overall Study|Unable to come back for visit|0
2940048|NCT01384734|10122735|P4|Overall Study|Unable to come back for visit|1
2940049|NCT01384734|10122736|P3|Overall Study|Unable to come back for visit|1
2940050|NCT01384734|10122737|P2|Overall Study|Unable to come back for visit|0
2940051|NCT01384734|10122738|P1|Overall Study|Unable to come back for visit|1
2940052|NCT01384734|10122734|P5|Overall Study|Investigator relocating|1
2940053|NCT01384734|10122735|P4|Overall Study|Investigator relocating|3
2940054|NCT01384734|10122736|P3|Overall Study|Investigator relocating|0
2940055|NCT01384734|10122737|P2|Overall Study|Investigator relocating|2
2940056|NCT01384734|10122738|P1|Overall Study|Investigator relocating|0
2940057|NCT01384734|10122734|P5|Overall Study|Withdrawal by Subject|9
2940058|NCT01384734|10122735|P4|Overall Study|Withdrawal by Subject|7
2940059|NCT01384734|10122736|P3|Overall Study|Withdrawal by Subject|6
2940060|NCT01384734|10122737|P2|Overall Study|Withdrawal by Subject|5
2940061|NCT01384734|10122738|P1|Overall Study|Withdrawal by Subject|5
2940062|NCT01384734|10122734|P5|Overall Study|Sponsor terminated|1
2940063|NCT01384734|10122735|P4|Overall Study|Sponsor terminated|0
2940064|NCT01384734|10122736|P3|Overall Study|Sponsor terminated|0
2940065|NCT01384734|10122737|P2|Overall Study|Sponsor terminated|0
2940066|NCT01384734|10122738|P1|Overall Study|Sponsor terminated|0
2940067|NCT01384734|10122734|P5|Overall Study|Pregnancy|1
2940068|NCT01384734|10122735|P4|Overall Study|Pregnancy|0
2940069|NCT01384734|10122736|P3|Overall Study|Pregnancy|0
2940070|NCT01384734|10122737|P2|Overall Study|Pregnancy|1
2940071|NCT01384734|10122738|P1|Overall Study|Pregnancy|0
2940072|NCT01384734|10122734|P5|Overall Study|Non-compliance with study drug|2
2940073|NCT01384734|10122735|P4|Overall Study|Non-compliance with study drug|0
2940074|NCT01384734|10122736|P3|Overall Study|Non-compliance with study drug|6
2940075|NCT01384734|10122737|P2|Overall Study|Non-compliance with study drug|2
2940076|NCT01384734|10122738|P1|Overall Study|Non-compliance with study drug|1
2940077|NCT01384734|10122734|P5|Overall Study|Lost to Follow-up|5
2940078|NCT01384734|10122735|P4|Overall Study|Lost to Follow-up|8
2940079|NCT01384734|10122736|P3|Overall Study|Lost to Follow-up|3
2940080|NCT01384734|10122737|P2|Overall Study|Lost to Follow-up|3
2940081|NCT01384734|10122738|P1|Overall Study|Lost to Follow-up|5
2940082|NCT01384734|10122734|P5|Overall Study|Lack of Efficacy|2
2940083|NCT01384734|10122735|P4|Overall Study|Lack of Efficacy|4
2940084|NCT01384734|10122736|P3|Overall Study|Lack of Efficacy|4
2940085|NCT01384734|10122737|P2|Overall Study|Lack of Efficacy|7
2940086|NCT01384734|10122738|P1|Overall Study|Lack of Efficacy|3
2940087|NCT01384734|10122734|P5|Overall Study|Continuation criteria not met|0
2940088|NCT01384734|10122735|P4|Overall Study|Continuation criteria not met|1
2940089|NCT01384734|10122736|P3|Overall Study|Continuation criteria not met|1
2940090|NCT01384734|10122737|P2|Overall Study|Continuation criteria not met|0
2940091|NCT01384734|10122738|P1|Overall Study|Continuation criteria not met|0
2940092|NCT01384734|10122734|P5|Overall Study|Death|0
2940093|NCT01384734|10122735|P4|Overall Study|Death|0
2940094|NCT01384734|10122736|P3|Overall Study|Death|1
2940095|NCT01384734|10122737|P2|Overall Study|Death|0
2940096|NCT01384734|10122738|P1|Overall Study|Death|1
2940097|NCT01384734|10122734|P5|Overall Study|Adverse Event|7
2940098|NCT01384734|10122735|P4|Overall Study|Adverse Event|2
2940099|NCT01384734|10122736|P3|Overall Study|Adverse Event|0
2940100|NCT01384734|10122737|P2|Overall Study|Adverse Event|3
2940101|NCT01384734|10122738|P1|Overall Study|Adverse Event|0
2940102|NCT01384292|10122967|P3|Part B|Severe non-compliance to protocol|0
2940103|NCT01384292|10122968|P2|Part B|Severe non-compliance to protocol|0
2940104|NCT01384292|10122969|P1|Part B|Severe non-compliance to protocol|1
2940105|NCT01384019|10122981|P2|Overall Study|MRI refusal|6
2940106|NCT01384019|10122982|P1|Overall Study|MRI refusal|6
2940107|NCT01384019|10122981|P2|Overall Study|Death|0
2940108|NCT01384019|10122982|P1|Overall Study|Death|1
2940109|NCT01384019|10122981|P2|Overall Study|Withdrawal by Subject|0
2940110|NCT01384019|10122982|P1|Overall Study|Withdrawal by Subject|3
2940111|NCT01383993|10122991|P3|Overall Study|Marketed voriconazole in post-therapy|0
2940112|NCT01383993|10122992|P2|Overall Study|Marketed voriconazole in post-therapy|0
2940113|NCT01383993|10122993|P1|Overall Study|Marketed voriconazole in post-therapy|2
2940114|NCT01383993|10122991|P3|Overall Study|Withdrawal by Subject|1
2940115|NCT01383993|10122992|P2|Overall Study|Withdrawal by Subject|0
2940116|NCT01383993|10122993|P1|Overall Study|Withdrawal by Subject|0
2940117|NCT01383993|10122991|P3|Overall Study|Adverse Event|0
2940118|NCT01383993|10122992|P2|Overall Study|Adverse Event|1
2940119|NCT01383993|10122993|P1|Overall Study|Adverse Event|1
2940120|NCT01383954|10123040|P1|Overall Study|Reason Not Specified|9
2940121|NCT01383954|10123040|P1|Overall Study|Adverse Event|1
2940122|NCT01383954|10123040|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
2940123|NCT01383954|10123040|P1|Overall Study|Lack of Efficacy|2
2940124|NCT01383928|10123048|P3|Overall Study|Unsatisfactory Therapeutic Response|1
2940125|NCT01383928|10123049|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2940126|NCT01383928|10123050|P1|Overall Study|Unsatisfactory Therapeutic Response|0
2940127|NCT01383928|10123048|P3|Overall Study|Withdrawal by Subject|4
2940128|NCT01383928|10123049|P2|Overall Study|Withdrawal by Subject|0
2940129|NCT01383928|10123050|P1|Overall Study|Withdrawal by Subject|0
2940130|NCT01383928|10123048|P3|Overall Study|Progressive Disease|5
2940131|NCT01383928|10123049|P2|Overall Study|Progressive Disease|1
2940132|NCT01383928|10123050|P1|Overall Study|Progressive Disease|1
2940133|NCT01383928|10123048|P3|Overall Study|Other|4
2940134|NCT01383928|10123049|P2|Overall Study|Other|3
2940135|NCT01383928|10123050|P1|Overall Study|Other|1
2940136|NCT01383928|10123048|P3|Overall Study|Adverse Event|8
2940137|NCT01383928|10123049|P2|Overall Study|Adverse Event|2
2940138|NCT01383928|10123050|P1|Overall Study|Adverse Event|1
2940139|NCT01383928|10123048|P3|Overall Study|Initiation of ASCT|18
2940140|NCT01383928|10123049|P2|Overall Study|Initiation of ASCT|1
2940141|NCT01383928|10123050|P1|Overall Study|Initiation of ASCT|2
2940142|NCT01383707|10123131|P1|Overall Study|Progressive disease|23
2940143|NCT01383707|10123131|P1|Overall Study|Adverse Event|14
2940144|NCT01383707|10123131|P1|Overall Study|Sponsor's decision|2
2940145|NCT01383707|10123131|P1|Overall Study|Other|8
2940146|NCT01383707|10123131|P1|Overall Study|Death|19
2940147|NCT01383707|10123131|P1|Overall Study|Consent withdrawal|6
2940148|NCT01383499|10123171|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
2940149|NCT01383499|10123172|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
2940150|NCT01383499|10123173|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
2940151|NCT01383499|10123174|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
2940152|NCT01383486|10123224|P1|Overall Study|Did not take any product|6
2940153|NCT01383486|10123224|P1|Overall Study|Incomplete information for analysis|2
2940154|NCT01383486|10123224|P1|Overall Study|Lost to Follow-up|10
2940155|NCT01383356|10123301|P2|Period 1|Personal|2
2940156|NCT01383356|10123302|P1|Period 1|Personal|0
2940157|NCT01383356|10123301|P2|Period 1|Out of Range Mid-study-Test|1
2940158|NCT01383356|10123302|P1|Period 1|Out of Range Mid-study-Test|0
2940159|NCT01383356|10123301|P2|Period 1|Non-compliance|0
2940160|NCT01383356|10123302|P1|Period 1|Non-compliance|3
2940161|NCT01383356|10123301|P2|Period 1|Adverse Event|3
2940162|NCT01383356|10123302|P1|Period 1|Adverse Event|5
2940163|NCT01383317|10123314|P2|Overall Study|Adverse Event|1
2940164|NCT01383317|10123315|P1|Overall Study|Adverse Event|0
2940165|NCT01383317|10123314|P2|Overall Study|Death|0
2940166|NCT01383317|10123315|P1|Overall Study|Death|1
2940167|NCT01383317|10123314|P2|Overall Study|Lost to Follow-up|1
2940168|NCT01383317|10123315|P1|Overall Study|Lost to Follow-up|2
2940169|NCT01383174|10123357|P2|6 Month Assessment|Refused to complete|0
2940170|NCT01383174|10123358|P1|6 Month Assessment|Refused to complete|4
2940171|NCT01383174|10123357|P2|6 Month Assessment|Lost to Follow-up|1
2940172|NCT01383174|10123358|P1|6 Month Assessment|Lost to Follow-up|1
2940173|NCT01383174|10123357|P2|3 Month Assessment|Refused to complete|0
2940174|NCT01383174|10123358|P1|3 Month Assessment|Refused to complete|4
2940175|NCT01383174|10123357|P2|3 Month Assessment|Lost to Follow-up|0
2940176|NCT01383174|10123358|P1|3 Month Assessment|Lost to Follow-up|2
2940177|NCT01383174|10123357|P2|3 Month Assessment|Death|1
2940178|NCT01383174|10123358|P1|3 Month Assessment|Death|0
2940179|NCT01383161|10123384|P2|Overall Study|Lack of Efficacy|1
2940180|NCT01383161|10123385|P1|Overall Study|Lack of Efficacy|0
2940181|NCT01383161|10123384|P2|Overall Study|Withdrawal by Subject|2
2940182|NCT01383161|10123385|P1|Overall Study|Withdrawal by Subject|0
2940183|NCT01383161|10123384|P2|Overall Study|Adverse Event|1
2940184|NCT01383161|10123385|P1|Overall Study|Adverse Event|5
2940185|NCT01383096|10123404|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2940186|NCT01383096|10123405|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2940187|NCT01383096|10123406|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
2940188|NCT01383096|10123404|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2940189|NCT01383096|10123405|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2940190|NCT01383096|10123406|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
2940191|NCT01383096|10123404|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2940192|NCT01383096|10123405|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2940193|NCT01383096|10123406|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
2940194|NCT01383096|10123404|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2940195|NCT01383096|10123405|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2940196|NCT01383096|10123406|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2940197|NCT01383096|10123404|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2940198|NCT01383096|10123405|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2940199|NCT01383096|10123406|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
2940200|NCT01383096|10123404|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
2940201|NCT01383096|10123405|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
2940202|NCT01383096|10123406|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
2940203|NCT01383096|10123404|P3|Third Intervention (8 Days)|Adverse Event|0
2940204|NCT01383096|10123405|P2|Third Intervention (8 Days)|Adverse Event|0
2940205|NCT01383096|10123406|P1|Third Intervention (8 Days)|Adverse Event|1
2940206|NCT01383096|10123404|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2940207|NCT01383096|10123405|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
2940208|NCT01383096|10123406|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2940209|NCT01383096|10123404|P3|Third Intervention (8 Days)|Elevated AST|0
2940210|NCT01383096|10123405|P2|Third Intervention (8 Days)|Elevated AST|1
2940211|NCT01383096|10123406|P1|Third Intervention (8 Days)|Elevated AST|0
2940212|NCT01383096|10123404|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2940213|NCT01383096|10123405|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2940214|NCT01383096|10123406|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2940215|NCT01383096|10123404|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2940216|NCT01383096|10123405|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2940217|NCT01383096|10123406|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2940218|NCT01383018|10123452|P1|Overall Study|Subject Incarcerated|1
2940219|NCT01383018|10123452|P1|Overall Study|Patient moved away from site|1
2940220|NCT01383018|10123452|P1|Overall Study|Site closed early-not compliance related|7
2940221|NCT01383018|10123452|P1|Overall Study|Missed Visit|247
2940222|NCT01383018|10123452|P1|Overall Study|Subject not implanted|76
2940223|NCT01383018|10123452|P1|Overall Study|Withdrawal by Subject|9
2940224|NCT01383018|10123452|P1|Overall Study|Physician Decision|5
2940225|NCT01383018|10123452|P1|Overall Study|Lost to Follow-up|5
2940226|NCT01383018|10123452|P1|Overall Study|Death|10
2940227|NCT01383018|10123452|P1|Overall Study|Adverse Event|14
2940228|NCT01382940|10123514|P1|Overall Study|Protocol Violation|20
2940229|NCT01382940|10123514|P1|Overall Study|Withdrawal by Subject|23
2940230|NCT01382940|10123514|P1|Overall Study|Physician Decision|7
2940231|NCT01382940|10123514|P1|Overall Study|Lost to Follow-up|4
2940232|NCT01382940|10123514|P1|Overall Study|Adverse Event|19
2940233|NCT01382602|10123576|P2|Overall Study|Withdrawal by Subject|1
2940234|NCT01382602|10123577|P1|Overall Study|Withdrawal by Subject|0
2940235|NCT01382602|10123576|P2|Overall Study|Protocol Violation|3
2940236|NCT01382602|10123577|P1|Overall Study|Protocol Violation|0
2940237|NCT01382446|10123585|P2|Overall Study|Removal from Mechanical Ventilation|3
2940238|NCT01382446|10123586|P1|Overall Study|Removal from Mechanical Ventilation|3
2940239|NCT01382446|10123585|P2|Overall Study|Withdrawal by Subject|1
2940240|NCT01382446|10123586|P1|Overall Study|Withdrawal by Subject|0
2940241|NCT01382251|10123613|P2|Overall Study|Contacted after study closed|1
2940242|NCT01382251|10123614|P1|Overall Study|Contacted after study closed|1
2940243|NCT01382251|10123613|P2|Overall Study|Lost to Follow-up|4
2940244|NCT01382251|10123614|P1|Overall Study|Lost to Follow-up|4
2940245|NCT01382251|10123613|P2|Overall Study|Surgeries cancelled or delayed|16
2940246|NCT01382251|10123614|P1|Overall Study|Surgeries cancelled or delayed|16
2940247|NCT01382225|10123627|P2|Overall Study|Other|2
2940248|NCT01382225|10123628|P1|Overall Study|Other|4
2940249|NCT01382225|10123627|P2|Overall Study|Subject Withdrew Consent|2
2940250|NCT01382225|10123628|P1|Overall Study|Subject Withdrew Consent|5
2940251|NCT01382225|10123627|P2|Overall Study|Protocol Violation|1
2940252|NCT01382225|10123628|P1|Overall Study|Protocol Violation|2
2940253|NCT01382225|10123627|P2|Overall Study|Adverse Event|2
2940254|NCT01382225|10123628|P1|Overall Study|Adverse Event|3
2940255|NCT01382212|10123650|P1|Overall Study|Withdrew consent|1
2940256|NCT01382212|10123650|P1|Overall Study|Kidney transplant|1
2940257|NCT01381926|10123713|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
2940258|NCT01381926|10123714|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
2940259|NCT01381926|10123713|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
2940260|NCT01381926|10123714|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
2940261|NCT01381900|10123727|P3|Overall Study|Early withdraw|1
2940262|NCT01381900|10123728|P2|Overall Study|Early withdraw|1
2940263|NCT01381900|10123729|P1|Overall Study|Early withdraw|3
2940264|NCT01381900|10123727|P3|Overall Study|Withdrawal by Subject|1
2940265|NCT01381900|10123728|P2|Overall Study|Withdrawal by Subject|0
2940266|NCT01381900|10123729|P1|Overall Study|Withdrawal by Subject|0
2940267|NCT01381900|10123727|P3|Overall Study|Protocol Violation|1
2940268|NCT01381900|10123728|P2|Overall Study|Protocol Violation|1
2940269|NCT01381900|10123729|P1|Overall Study|Protocol Violation|0
2940270|NCT01381900|10123727|P3|Overall Study|Physician Decision|1
2940271|NCT01381900|10123728|P2|Overall Study|Physician Decision|1
2940272|NCT01381900|10123729|P1|Overall Study|Physician Decision|0
2940273|NCT01381900|10123727|P3|Overall Study|Noncompliance with study drug|1
2940274|NCT01381900|10123728|P2|Overall Study|Noncompliance with study drug|0
2940275|NCT01381900|10123729|P1|Overall Study|Noncompliance with study drug|0
2940276|NCT01381900|10123727|P3|Overall Study|Adverse Event|7
2940277|NCT01381900|10123728|P2|Overall Study|Adverse Event|6
2940278|NCT01381900|10123729|P1|Overall Study|Adverse Event|4
2940279|NCT01381900|10123727|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
2940280|NCT01381900|10123728|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
2940281|NCT01381900|10123729|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
2940282|NCT01381874|10123752|P3|Overall Study|Other|67
2940283|NCT01381874|10123753|P2|Overall Study|Other|52
2940284|NCT01381874|10123754|P1|Overall Study|Other|67
2940285|NCT01381874|10123752|P3|Overall Study|Withdrawal by Subject|9
2940286|NCT01381874|10123753|P2|Overall Study|Withdrawal by Subject|10
2940287|NCT01381874|10123754|P1|Overall Study|Withdrawal by Subject|9
2940288|NCT01381874|10123752|P3|Overall Study|Lost to Follow-up|0
2940289|NCT01381874|10123753|P2|Overall Study|Lost to Follow-up|1
2940290|NCT01381874|10123754|P1|Overall Study|Lost to Follow-up|1
2940291|NCT01381679|10123791|P1|Overall Study|Lost to Follow-up|885
2940292|NCT01381679|10123791|P1|Overall Study|Adverse Event|3
2940293|NCT01381575|10123806|P3|Overall Study|Lost to Follow-up|9
2940294|NCT01381575|10123807|P2|Overall Study|Lost to Follow-up|17
2940295|NCT01381575|10123808|P1|Overall Study|Lost to Follow-up|8
2940296|NCT01381575|10123806|P3|Overall Study|Migrated/moved from study area|2
2940297|NCT01381575|10123807|P2|Overall Study|Migrated/moved from study area|12
2940298|NCT01381575|10123808|P1|Overall Study|Migrated/moved from study area|2
2940299|NCT01381575|10123806|P3|Overall Study|Withdrawal by Subject|7
2940300|NCT01381575|10123807|P2|Overall Study|Withdrawal by Subject|9
2940301|NCT01381575|10123808|P1|Overall Study|Withdrawal by Subject|15
2940302|NCT01381575|10123806|P3|Overall Study|Protocol Violation|1
2940303|NCT01381575|10123807|P2|Overall Study|Protocol Violation|1
2940304|NCT01381575|10123808|P1|Overall Study|Protocol Violation|0
2940305|NCT01381575|10123806|P3|Overall Study|Non-Serious Adverse Event|1
2940306|NCT01381575|10123807|P2|Overall Study|Non-Serious Adverse Event|0
2940307|NCT01381575|10123808|P1|Overall Study|Non-Serious Adverse Event|0
2940308|NCT01381575|10123806|P3|Overall Study|Serious Adverse Event|0
2940309|NCT01381575|10123807|P2|Overall Study|Serious Adverse Event|0
2940310|NCT01381575|10123808|P1|Overall Study|Serious Adverse Event|1
2940311|NCT01381562|10123865|P3|Overall Study|Adverse Event|0
2940312|NCT01381562|10123866|P2|Overall Study|Adverse Event|1
2940313|NCT01381562|10123867|P1|Overall Study|Adverse Event|0
2940314|NCT01381549|10123935|P3|Overall Study|Ineligible: No organisms isolated|1
2940315|NCT01381549|10123936|P2|Overall Study|Ineligible: No organisms isolated|0
2940316|NCT01381549|10123937|P1|Overall Study|Ineligible: No organisms isolated|0
2940317|NCT01381068|10124063|P2|Overall Study|Death|0
2940318|NCT01381068|10124064|P1|Overall Study|Death|1
2940319|NCT01381016|10124084|P2|Overall Study|Physician Decision|2
2940320|NCT01381016|10124085|P1|Overall Study|Physician Decision|0
2940321|NCT01381016|10124084|P2|Overall Study|Withdrawal by Subject|1
2940322|NCT01381016|10124085|P1|Overall Study|Withdrawal by Subject|0
2940323|NCT01381016|10124084|P2|Overall Study|Screen Failure|2
2940324|NCT01381016|10124085|P1|Overall Study|Screen Failure|2
2940325|NCT01381016|10124084|P2|Overall Study|Lost to Follow-up|1
2940326|NCT01381016|10124085|P1|Overall Study|Lost to Follow-up|1
2940327|NCT01380834|10124095|P2|Overall Study|Physician Decision|0
2940328|NCT01380834|10124096|P1|Overall Study|Physician Decision|1
2940329|NCT01380782|10124108|P4|Overall Study|Withdrawal by Subject|1
2940330|NCT01380782|10124109|P3|Overall Study|Withdrawal by Subject|1
2940331|NCT01380782|10124110|P2|Overall Study|Withdrawal by Subject|0
2940332|NCT01380782|10124111|P1|Overall Study|Withdrawal by Subject|0
2940333|NCT01380782|10124108|P4|Overall Study|Physician Decision|0
2940334|NCT01380782|10124109|P3|Overall Study|Physician Decision|0
2940335|NCT01380782|10124110|P2|Overall Study|Physician Decision|0
2940336|NCT01380782|10124111|P1|Overall Study|Physician Decision|1
2940337|NCT01380782|10124108|P4|Overall Study|Lack of Efficacy|3
2940338|NCT01380782|10124109|P3|Overall Study|Lack of Efficacy|10
2940339|NCT01380782|10124110|P2|Overall Study|Lack of Efficacy|9
2940340|NCT01380782|10124111|P1|Overall Study|Lack of Efficacy|10
2940341|NCT01380782|10124108|P4|Overall Study|Death|0
2940342|NCT01380782|10124109|P3|Overall Study|Death|0
2940343|NCT01380782|10124110|P2|Overall Study|Death|0
2940344|NCT01380782|10124111|P1|Overall Study|Death|1
2940345|NCT01380782|10124108|P4|Overall Study|Adverse Event|0
2940346|NCT01380782|10124109|P3|Overall Study|Adverse Event|0
2940347|NCT01380782|10124110|P2|Overall Study|Adverse Event|1
2940348|NCT01380782|10124111|P1|Overall Study|Adverse Event|0
2940349|NCT01380769|10124134|P2|Overall Study|Protocol Violation|1
2940350|NCT01380769|10124135|P1|Overall Study|Protocol Violation|0
2940351|NCT01380769|10124134|P2|Overall Study|Adverse Event|1
2940352|NCT01380769|10124135|P1|Overall Study|Adverse Event|1
2940353|NCT01380769|10124134|P2|Overall Study|Physician Decision|1
2940354|NCT01380769|10124135|P1|Overall Study|Physician Decision|1
2940355|NCT01380769|10124134|P2|Overall Study|Withdrawal by Subject|11
2940356|NCT01380769|10124135|P1|Overall Study|Withdrawal by Subject|7
2940357|NCT01380730|10124196|P8|Overall Study|Death|0
2940358|NCT01380730|10124197|P7|Overall Study|Death|0
2940359|NCT01380730|10124198|P6|Overall Study|Death|0
2940360|NCT01380730|10124199|P5|Overall Study|Death|1
2940361|NCT01380730|10124200|P4|Overall Study|Death|0
2940362|NCT01380730|10124201|P3|Overall Study|Death|0
2940363|NCT01380730|10124202|P2|Overall Study|Death|0
2940364|NCT01380730|10124203|P1|Overall Study|Death|0
2940365|NCT01380691|10124261|P4|Washout (7 Days)|Withdrawal by Subject|0
2940366|NCT01380691|10124262|P3|Washout (7 Days)|Withdrawal by Subject|1
2940367|NCT01380691|10124263|P2|Washout (7 Days)|Withdrawal by Subject|0
2940368|NCT01380691|10124264|P1|Washout (7 Days)|Withdrawal by Subject|0
2940369|NCT01380691|10124261|P4|Washout (7 Days)|Protocol Violation|1
2940370|NCT01380691|10124262|P3|Washout (7 Days)|Protocol Violation|0
2940371|NCT01380691|10124263|P2|Washout (7 Days)|Protocol Violation|0
2940372|NCT01380691|10124264|P1|Washout (7 Days)|Protocol Violation|0
2940373|NCT01380535|10124325|P2|Overall Study|Lack of Efficacy|3
2940374|NCT01380535|10124326|P1|Overall Study|Lack of Efficacy|0
2940375|NCT01380535|10124325|P2|Overall Study|Protocol Violation|2
2940376|NCT01380535|10124326|P1|Overall Study|Protocol Violation|0
2940377|NCT01380535|10124325|P2|Overall Study|Withdrawal by Subject|2
2940378|NCT01380535|10124326|P1|Overall Study|Withdrawal by Subject|1
2940379|NCT01380535|10124325|P2|Overall Study|Study site closed|5
2940380|NCT01380535|10124326|P1|Overall Study|Study site closed|0
2940381|NCT01380535|10124325|P2|Overall Study|Death|0
2940382|NCT01380535|10124326|P1|Overall Study|Death|3
2940383|NCT01380535|10124325|P2|Overall Study|Adverse Event|3
2940384|NCT01380535|10124326|P1|Overall Study|Adverse Event|3
2940385|NCT01380379|10124332|P1|Overall Study|Pregnancy|1
2940386|NCT01380327|10124345|P3|Overall Study|Questionable onset of epilepsy|1
2940387|NCT01380327|10124346|P2|Overall Study|Questionable onset of epilepsy|0
2940388|NCT01380327|10124347|P1|Overall Study|Questionable onset of epilepsy|0
2940389|NCT01380327|10124345|P3|Overall Study|Housing situation precluded ability to k|1
2940390|NCT01380327|10124346|P2|Overall Study|Housing situation precluded ability to k|0
2940391|NCT01380327|10124347|P1|Overall Study|Housing situation precluded ability to k|0
2940392|NCT01380327|10124345|P3|Overall Study|Withdrawal by Subject|1
2940393|NCT01380327|10124346|P2|Overall Study|Withdrawal by Subject|0
2940394|NCT01380327|10124347|P1|Overall Study|Withdrawal by Subject|0
2940395|NCT01380327|10124345|P3|Overall Study|Protocol Violation|3
2940396|NCT01380327|10124346|P2|Overall Study|Protocol Violation|2
2940397|NCT01380327|10124347|P1|Overall Study|Protocol Violation|3
2940398|NCT01380327|10124345|P3|Overall Study|Lost to Follow-up|1
2940399|NCT01380327|10124346|P2|Overall Study|Lost to Follow-up|1
2940400|NCT01380327|10124347|P1|Overall Study|Lost to Follow-up|0
2940401|NCT01380184|10124378|P1|Part 2|Lost to Follow-up|1
2940402|NCT01380184|10124378|P1|Part 2|Disease Progression|8
2940403|NCT01380184|10124378|P1|Part 2|Adverse Event|5
2940404|NCT01380184|10124378|P1|Part 1 (19 Days)|Adverse Event|1
2940405|NCT01380145|10124389|P1|Overall Study|Progressive disease|4
2940406|NCT01380093|10124397|P9|Treatment Phase: Third Intervention|Other|1
2940407|NCT01380093|10124398|P8|Treatment Phase: Third Intervention|Other|0
2940408|NCT01380093|10124399|P7|Treatment Phase: Third Intervention|Other|0
2940409|NCT01380093|10124400|P6|Treatment Phase: Third Intervention|Other|0
2940410|NCT01380093|10124401|P5|Treatment Phase: Third Intervention|Other|0
2940411|NCT01380093|10124402|P4|Treatment Phase: Third Intervention|Other|0
2940412|NCT01380093|10124403|P3|Treatment Phase: Third Intervention|Other|0
2940413|NCT01380093|10124404|P2|Treatment Phase: Third Intervention|Other|0
2940414|NCT01380093|10124405|P1|Treatment Phase: Third Intervention|Other|0
2940415|NCT01380093|10124397|P9|Treatment Phase: Third Intervention|Non-compliance|1
2940416|NCT01380093|10124398|P8|Treatment Phase: Third Intervention|Non-compliance|0
2940417|NCT01380093|10124399|P7|Treatment Phase: Third Intervention|Non-compliance|0
2940418|NCT01380093|10124400|P6|Treatment Phase: Third Intervention|Non-compliance|0
2940419|NCT01380093|10124401|P5|Treatment Phase: Third Intervention|Non-compliance|0
2940420|NCT01380093|10124402|P4|Treatment Phase: Third Intervention|Non-compliance|0
2940421|NCT01380093|10124403|P3|Treatment Phase: Third Intervention|Non-compliance|0
2940422|NCT01380093|10124404|P2|Treatment Phase: Third Intervention|Non-compliance|0
2940423|NCT01380093|10124405|P1|Treatment Phase: Third Intervention|Non-compliance|0
2940424|NCT01380093|10124397|P9|Treatment Phase: Second Intervention|Other|0
2940425|NCT01380093|10124398|P8|Treatment Phase: Second Intervention|Other|0
2940426|NCT01380093|10124399|P7|Treatment Phase: Second Intervention|Other|0
2940427|NCT01380093|10124400|P6|Treatment Phase: Second Intervention|Other|0
2940428|NCT01380093|10124401|P5|Treatment Phase: Second Intervention|Other|0
2940429|NCT01380093|10124402|P4|Treatment Phase: Second Intervention|Other|1
2940430|NCT01380093|10124403|P3|Treatment Phase: Second Intervention|Other|0
2940431|NCT01380093|10124404|P2|Treatment Phase: Second Intervention|Other|0
2940432|NCT01380093|10124405|P1|Treatment Phase: Second Intervention|Other|0
2940433|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940434|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940435|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940436|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940437|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940438|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940439|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
2940440|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940441|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
2940442|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Backup participant|0
2940443|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Backup participant|0
2940444|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Backup participant|0
2940445|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Backup participant|0
2940446|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Backup participant|0
2940447|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Backup participant|0
2940448|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Backup participant|1
2940449|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Backup participant|0
2940450|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Backup participant|0
2940451|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940452|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940453|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940454|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940455|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940456|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940457|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2940458|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2940459|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2940460|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940461|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940462|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940463|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940464|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940465|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940466|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
2940467|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
2940468|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
2940469|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940470|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940471|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940472|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940473|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940474|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940475|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940476|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
2940477|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2940478|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
2940479|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
2940480|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
2940481|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
2940482|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
2940483|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
2940484|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
2940485|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
2940486|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
2940487|NCT01380093|10124397|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940488|NCT01380093|10124398|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940489|NCT01380093|10124399|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940490|NCT01380093|10124400|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940491|NCT01380093|10124401|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940492|NCT01380093|10124402|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940493|NCT01380093|10124403|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940494|NCT01380093|10124404|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
2940495|NCT01380093|10124405|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
2940496|NCT01380093|10124397|P9|Naloxone Challenge Phase|Screen failures|0
2940497|NCT01380093|10124398|P8|Naloxone Challenge Phase|Screen failures|0
2940498|NCT01380093|10124399|P7|Naloxone Challenge Phase|Screen failures|0
2940499|NCT01380093|10124400|P6|Naloxone Challenge Phase|Screen failures|0
2940500|NCT01380093|10124401|P5|Naloxone Challenge Phase|Screen failures|0
2940501|NCT01380093|10124402|P4|Naloxone Challenge Phase|Screen failures|0
2940502|NCT01380093|10124403|P3|Naloxone Challenge Phase|Screen failures|0
2940503|NCT01380093|10124404|P2|Naloxone Challenge Phase|Screen failures|0
2940504|NCT01380093|10124405|P1|Naloxone Challenge Phase|Screen failures|21
2940505|NCT01380080|10124697|P2|Overall Study|Lost to Follow-up|0
2940506|NCT01380080|10124698|P1|Overall Study|Lost to Follow-up|2
2940507|NCT01380080|10124697|P2|Overall Study|Not willing to adhere to requirements|1
2940508|NCT01380080|10124698|P1|Overall Study|Not willing to adhere to requirements|3
2940509|NCT01380080|10124697|P2|Overall Study|Not able to get to clinic|0
2940510|NCT01380080|10124698|P1|Overall Study|Not able to get to clinic|4
2940511|NCT01380080|10124697|P2|Overall Study|Withdrawal by Subject|0
2940512|NCT01380080|10124698|P1|Overall Study|Withdrawal by Subject|4
2940513|NCT01380080|10124697|P2|Overall Study|Death|22
2940514|NCT01380080|10124698|P1|Overall Study|Death|20
2940515|NCT01379937|10124723|P4|Overall Study|Lost to Follow-up|0
2940516|NCT01379937|10124724|P3|Overall Study|Lost to Follow-up|2
2940517|NCT01379937|10124725|P2|Overall Study|Lost to Follow-up|2
2940518|NCT01379937|10124726|P1|Overall Study|Lost to Follow-up|1
2940519|NCT01379937|10124723|P4|Overall Study|Consent withdrawal|0
2940520|NCT01379937|10124724|P3|Overall Study|Consent withdrawal|0
2940521|NCT01379937|10124725|P2|Overall Study|Consent withdrawal|1
2940522|NCT01379937|10124726|P1|Overall Study|Consent withdrawal|0
2940523|NCT01379937|10124723|P4|Overall Study|Protocol Violation|1
2940524|NCT01379937|10124724|P3|Overall Study|Protocol Violation|0
2940525|NCT01379937|10124725|P2|Overall Study|Protocol Violation|0
2940526|NCT01379937|10124726|P1|Overall Study|Protocol Violation|0
2940527|NCT01379781|10124808|P2|Overall Study|Lost to Follow-up|8
2940528|NCT01379781|10124809|P1|Overall Study|Lost to Follow-up|11
2940529|NCT01379768|10124818|P3|Overall Study|Lost to Follow-up|0
2940530|NCT01379768|10124819|P2|Overall Study|Lost to Follow-up|0
2940531|NCT01379768|10124820|P1|Overall Study|Lost to Follow-up|2
2940532|NCT01379768|10124818|P3|Overall Study|Adverse Event|0
2940533|NCT01379768|10124819|P2|Overall Study|Adverse Event|1
2940534|NCT01379768|10124820|P1|Overall Study|Adverse Event|1
2940535|NCT01379703|10124843|P3|9 Months Through 18 Months|Reason Unknown|0
2940536|NCT01379703|10124844|P2|9 Months Through 18 Months|Reason Unknown|23
2940537|NCT01379703|10124845|P1|9 Months Through 18 Months|Reason Unknown|0
2940538|NCT01379703|10124843|P3|9 Months Through 18 Months|Fatigue|0
2940539|NCT01379703|10124844|P2|9 Months Through 18 Months|Fatigue|1
2940540|NCT01379703|10124845|P1|9 Months Through 18 Months|Fatigue|0
2940541|NCT01379703|10124843|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2940542|NCT01379703|10124844|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
2940543|NCT01379703|10124845|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2940544|NCT01379703|10124843|P3|9 Months Through 18 Months|Patient Noncompliance|0
2940545|NCT01379703|10124844|P2|9 Months Through 18 Months|Patient Noncompliance|4
2940546|NCT01379703|10124845|P1|9 Months Through 18 Months|Patient Noncompliance|0
2940547|NCT01379703|10124843|P3|9 Months Through 18 Months|Treatment failure|0
2940548|NCT01379703|10124844|P2|9 Months Through 18 Months|Treatment failure|5
2940549|NCT01379703|10124845|P1|9 Months Through 18 Months|Treatment failure|0
2940550|NCT01379703|10124843|P3|9 Months Through 18 Months|Adverse Event|0
2940551|NCT01379703|10124844|P2|9 Months Through 18 Months|Adverse Event|6
2940552|NCT01379703|10124845|P1|9 Months Through 18 Months|Adverse Event|0
2940553|NCT01379703|10124843|P3|9 Months Through 18 Months|Withdrawal by Subject|0
2940554|NCT01379703|10124844|P2|9 Months Through 18 Months|Withdrawal by Subject|11
2940555|NCT01379703|10124845|P1|9 Months Through 18 Months|Withdrawal by Subject|0
2940556|NCT01379703|10124843|P3|9 Months Through 18 Months|Lost to Follow-up|0
2940557|NCT01379703|10124844|P2|9 Months Through 18 Months|Lost to Follow-up|178
2940558|NCT01379703|10124845|P1|9 Months Through 18 Months|Lost to Follow-up|0
2940559|NCT01379703|10124843|P3|Study Start Through 9 Months|Reason unknown|24
2940560|NCT01379703|10124844|P2|Study Start Through 9 Months|Reason unknown|31
2940561|NCT01379703|10124845|P1|Study Start Through 9 Months|Reason unknown|2
2940562|NCT01379703|10124843|P3|Study Start Through 9 Months|Increased triglycerides|0
2940563|NCT01379703|10124844|P2|Study Start Through 9 Months|Increased triglycerides|1
2940564|NCT01379703|10124845|P1|Study Start Through 9 Months|Increased triglycerides|0
2940565|NCT01379703|10124843|P3|Study Start Through 9 Months|Poor general condition|0
2940566|NCT01379703|10124844|P2|Study Start Through 9 Months|Poor general condition|1
2940567|NCT01379703|10124845|P1|Study Start Through 9 Months|Poor general condition|0
2940568|NCT01379703|10124843|P3|Study Start Through 9 Months|Medication not available|1
2940569|NCT01379703|10124844|P2|Study Start Through 9 Months|Medication not available|2
2940570|NCT01379703|10124845|P1|Study Start Through 9 Months|Medication not available|0
2940571|NCT01379703|10124843|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2940572|NCT01379703|10124844|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
2940573|NCT01379703|10124845|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2940574|NCT01379703|10124843|P3|Study Start Through 9 Months|Patient Noncompliance|1
2940575|NCT01379703|10124844|P2|Study Start Through 9 Months|Patient Noncompliance|0
2940576|NCT01379703|10124845|P1|Study Start Through 9 Months|Patient Noncompliance|0
2940577|NCT01379703|10124843|P3|Study Start Through 9 Months|Treatment Failure|2
2940578|NCT01379703|10124844|P2|Study Start Through 9 Months|Treatment Failure|2
2940579|NCT01379703|10124845|P1|Study Start Through 9 Months|Treatment Failure|0
2940580|NCT01379703|10124843|P3|Study Start Through 9 Months|Withdrawal by Subject|1
2940581|NCT01379703|10124844|P2|Study Start Through 9 Months|Withdrawal by Subject|6
2940582|NCT01379703|10124845|P1|Study Start Through 9 Months|Withdrawal by Subject|0
2940583|NCT01379703|10124843|P3|Study Start Through 9 Months|Adverse Event|10
2940584|NCT01379703|10124844|P2|Study Start Through 9 Months|Adverse Event|14
2940585|NCT01379703|10124845|P1|Study Start Through 9 Months|Adverse Event|0
2940586|NCT01379703|10124843|P3|Study Start Through 9 Months|Lost to Follow-up|104
2940587|NCT01379703|10124844|P2|Study Start Through 9 Months|Lost to Follow-up|61
2940588|NCT01379703|10124845|P1|Study Start Through 9 Months|Lost to Follow-up|2
2940589|NCT01379573|10124943|P1|Overall Study|Screen Failure|10
2940590|NCT01379573|10124943|P1|Overall Study|Lost to Follow-up|1
2940591|NCT01379534|10124957|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
2940592|NCT01379534|10124958|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
2940593|NCT01379534|10124957|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
2940594|NCT01379534|10124958|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
2940595|NCT01379534|10124957|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
2940596|NCT01379534|10124958|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
2940597|NCT01379534|10124957|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
2940598|NCT01379534|10124958|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
2940599|NCT01379534|10124957|P2|Treatment Phase|Adverse Event|7
2940600|NCT01379534|10124958|P1|Treatment Phase|Adverse Event|7
2940601|NCT01379534|10124957|P2|Treatment Phase|Progressive disease|22
2940602|NCT01379534|10124958|P1|Treatment Phase|Progressive disease|13
2940603|NCT01379534|10124957|P2|Treatment Phase|Withdrawal by Subject|2
2940604|NCT01379534|10124958|P1|Treatment Phase|Withdrawal by Subject|2
2940605|NCT01379521|10124978|P2|Post-Treatment Evaluations|Death|0
2940606|NCT01379521|10124979|P1|Post-Treatment Evaluations|Death|1
2940607|NCT01379521|10124978|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
2940608|NCT01379521|10124979|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
2940609|NCT01379521|10124978|P2|Post-Treatment Evaluations|Disease Progression|20
2940610|NCT01379521|10124979|P1|Post-Treatment Evaluations|Disease Progression|22
2940611|NCT01379521|10124978|P2|Overall Study -Treatment Period|Death|1
2940612|NCT01379521|10124979|P1|Overall Study -Treatment Period|Death|2
2940613|NCT01379521|10124978|P2|Overall Study -Treatment Period|Administrative Problems|0
2940614|NCT01379521|10124979|P1|Overall Study -Treatment Period|Administrative Problems|1
2940615|NCT01379521|10124978|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
2940616|NCT01379521|10124979|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
2940617|NCT01379521|10124978|P2|Overall Study -Treatment Period|Protocol Deviation|2
2940618|NCT01379521|10124979|P1|Overall Study -Treatment Period|Protocol Deviation|0
2940619|NCT01379521|10124978|P2|Overall Study -Treatment Period|New Cancer Therapy|0
2940620|NCT01379521|10124979|P1|Overall Study -Treatment Period|New Cancer Therapy|1
2940621|NCT01379521|10124978|P2|Overall Study -Treatment Period|Disease Progression|22
2940622|NCT01379521|10124979|P1|Overall Study -Treatment Period|Disease Progression|23
2940623|NCT01379521|10124978|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
2940624|NCT01379521|10124979|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
2940625|NCT01379521|10124978|P2|Overall Study -Treatment Period|Adverse Event|0
2940626|NCT01379521|10124979|P1|Overall Study -Treatment Period|Adverse Event|3
2940627|NCT01379508|10125001|P4|Extension Period Weeks 109-156|Protocol Violation|0
2940628|NCT01379508|10125002|P3|Extension Period Weeks 109-156|Protocol Violation|0
2940629|NCT01379508|10125003|P2|Extension Period Weeks 109-156|Protocol Violation|1
2940630|NCT01379508|10125004|P1|Extension Period Weeks 109-156|Protocol Violation|2
2940631|NCT01379508|10125001|P4|Extension Period Weeks 109-156|Administrative problems|0
2940632|NCT01379508|10125002|P3|Extension Period Weeks 109-156|Administrative problems|1
2940633|NCT01379508|10125003|P2|Extension Period Weeks 109-156|Administrative problems|0
2940634|NCT01379508|10125004|P1|Extension Period Weeks 109-156|Administrative problems|3
2940635|NCT01379508|10125001|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
2940636|NCT01379508|10125002|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
2940637|NCT01379508|10125003|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
2940638|NCT01379508|10125004|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
2940639|NCT01379508|10125001|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
2940640|NCT01379508|10125002|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
2940641|NCT01379508|10125003|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
2940642|NCT01379508|10125004|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
2940643|NCT01379508|10125001|P4|Treatment to Week 104|Protocol Violation|0
2940644|NCT01379508|10125002|P3|Treatment to Week 104|Protocol Violation|1
2940645|NCT01379508|10125003|P2|Treatment to Week 104|Protocol Violation|1
2940646|NCT01379508|10125004|P1|Treatment to Week 104|Protocol Violation|1
2940647|NCT01379508|10125001|P4|Treatment to Week 104|Administrative problems|0
2940648|NCT01379508|10125002|P3|Treatment to Week 104|Administrative problems|0
2940649|NCT01379508|10125003|P2|Treatment to Week 104|Administrative problems|1
2940650|NCT01379508|10125004|P1|Treatment to Week 104|Administrative problems|3
2940651|NCT01379508|10125001|P4|Treatment to Week 104|Lost to Follow-up|0
2940652|NCT01379508|10125002|P3|Treatment to Week 104|Lost to Follow-up|3
2940653|NCT01379508|10125003|P2|Treatment to Week 104|Lost to Follow-up|0
2940654|NCT01379508|10125004|P1|Treatment to Week 104|Lost to Follow-up|5
2940655|NCT01379508|10125001|P4|Treatment to Week 104|Withdrawal by Subject|0
2940656|NCT01379508|10125002|P3|Treatment to Week 104|Withdrawal by Subject|4
2940657|NCT01379508|10125003|P2|Treatment to Week 104|Withdrawal by Subject|1
2940658|NCT01379508|10125004|P1|Treatment to Week 104|Withdrawal by Subject|6
2940659|NCT01379508|10125001|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
2940660|NCT01379508|10125002|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
2940661|NCT01379508|10125003|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
2940662|NCT01379508|10125004|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
2940663|NCT01379508|10125001|P4|Treatment to Week 104|Abnormal lab value|0
2940664|NCT01379508|10125002|P3|Treatment to Week 104|Abnormal lab value|0
2940665|NCT01379508|10125003|P2|Treatment to Week 104|Abnormal lab value|0
2940666|NCT01379508|10125004|P1|Treatment to Week 104|Abnormal lab value|1
2940667|NCT01379508|10125001|P4|Treatment to Week 104|Adverse Event|0
2940668|NCT01379508|10125002|P3|Treatment to Week 104|Adverse Event|5
2940669|NCT01379508|10125003|P2|Treatment to Week 104|Adverse Event|0
2940670|NCT01379508|10125004|P1|Treatment to Week 104|Adverse Event|2
2940671|NCT01378975|10125086|P2|Overall Study|Withdrew Consent|3
2940672|NCT01378975|10125087|P1|Overall Study|Withdrew Consent|4
2940673|NCT01378975|10125086|P2|Overall Study|Lost to Follow-up|1
2940674|NCT01378975|10125087|P1|Overall Study|Lost to Follow-up|4
2940675|NCT01378975|10125086|P2|Overall Study|Investigator Request|0
2940676|NCT01378975|10125087|P1|Overall Study|Investigator Request|1
2940677|NCT01378975|10125086|P2|Overall Study|Death|46
2940678|NCT01378975|10125087|P1|Overall Study|Death|77
2940679|NCT01378962|10125113|P1|Overall Study|Other|2
2940680|NCT01378962|10125113|P1|Overall Study|Lost to Follow-up|1
2940681|NCT01378962|10125113|P1|Overall Study|Death|14
2940682|NCT01378429|10125139|P2|Overall Study|Noncompliance with study drug|0
2940683|NCT01378429|10125140|P1|Overall Study|Noncompliance with study drug|1
2940684|NCT01378325|10125253|P2|Overall Study|Protocol Violation|1
2940685|NCT01378325|10125254|P1|Overall Study|Protocol Violation|0
2940686|NCT01378195|10125308|P2|Overall Study|Lost to Follow-up|18
2940687|NCT01378195|10125309|P1|Overall Study|Lost to Follow-up|29
2940688|NCT01378117|10125322|P3|Overall Study|discharged before med given|1
2940689|NCT01378117|10125323|P2|Overall Study|discharged before med given|0
2940690|NCT01378117|10125324|P1|Overall Study|discharged before med given|2
2940691|NCT01378117|10125322|P3|Overall Study|withdrawal|2
2940692|NCT01378117|10125323|P2|Overall Study|withdrawal|1
2940693|NCT01378117|10125324|P1|Overall Study|withdrawal|2
2940694|NCT01378104|10125358|P2|Overall Study|Withdrawal by Subject|13
2940695|NCT01378104|10125359|P1|Overall Study|Withdrawal by Subject|12
2940696|NCT01378104|10125358|P2|Overall Study|Lack of Efficacy|5
2940697|NCT01378104|10125359|P1|Overall Study|Lack of Efficacy|7
2940698|NCT01378104|10125358|P2|Overall Study|Adverse Event|8
2940699|NCT01378104|10125359|P1|Overall Study|Adverse Event|8
2940700|NCT01377987|10125404|P2|Washout (7 Days)|Withdrawal by Subject|1
2940701|NCT01377987|10125405|P1|Washout (7 Days)|Withdrawal by Subject|1
2940702|NCT01377922|10125423|P2|Overall Study|rescue tx after part 2, entered part 4|0
2940703|NCT01377922|10125424|P1|Overall Study|rescue tx after part 2, entered part 4|1
2940704|NCT01377480|10125509|P4|Overall Study|Other|6
2940705|NCT01377480|10125510|P3|Overall Study|Other|7
2940706|NCT01377480|10125511|P2|Overall Study|Other|0
2940707|NCT01377480|10125512|P1|Overall Study|Other|0
2940708|NCT01377480|10125509|P4|Overall Study|Serious adverse event|1
2940709|NCT01377480|10125510|P3|Overall Study|Serious adverse event|1
2940710|NCT01377480|10125511|P2|Overall Study|Serious adverse event|0
2940711|NCT01377480|10125512|P1|Overall Study|Serious adverse event|0
2940712|NCT01377480|10125509|P4|Overall Study|Withdrawal by Subject|0
2940713|NCT01377480|10125510|P3|Overall Study|Withdrawal by Subject|1
2940714|NCT01377480|10125511|P2|Overall Study|Withdrawal by Subject|0
2940715|NCT01377480|10125512|P1|Overall Study|Withdrawal by Subject|0
2940716|NCT01377480|10125509|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
2940717|NCT01377480|10125510|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
2940718|NCT01377480|10125511|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
2940719|NCT01377480|10125512|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
2940720|NCT01377480|10125509|P4|Overall Study|Protocol Violation|4
2940721|NCT01377480|10125510|P3|Overall Study|Protocol Violation|0
2940722|NCT01377480|10125511|P2|Overall Study|Protocol Violation|0
2940723|NCT01377480|10125512|P1|Overall Study|Protocol Violation|0
2940724|NCT01377389|10125588|P1|Overall Study|Screen failure|2
2940725|NCT01377389|10125588|P1|Overall Study|Withdrawal by Subject|1
2940726|NCT01377233|10125602|P5|Double-blind|Administrative or other|1
2940727|NCT01377233|10125603|P4|Double-blind|Administrative or other|1
2940728|NCT01377233|10125604|P3|Double-blind|Administrative or other|0
2940729|NCT01377233|10125605|P2|Double-blind|Administrative or other|0
2940730|NCT01377233|10125606|P1|Double-blind|Administrative or other|0
2940731|NCT01377233|10125602|P5|Double-blind|Withdrawal by Subject|0
2940732|NCT01377233|10125603|P4|Double-blind|Withdrawal by Subject|1
2940733|NCT01377233|10125604|P3|Double-blind|Withdrawal by Subject|0
2940734|NCT01377233|10125605|P2|Double-blind|Withdrawal by Subject|0
2940735|NCT01377233|10125606|P1|Double-blind|Withdrawal by Subject|0
2940736|NCT01377233|10125602|P5|Double-blind|Protocol Violation|1
2940737|NCT01377233|10125603|P4|Double-blind|Protocol Violation|0
2940738|NCT01377233|10125604|P3|Double-blind|Protocol Violation|0
2940739|NCT01377233|10125605|P2|Double-blind|Protocol Violation|0
2940740|NCT01377233|10125606|P1|Double-blind|Protocol Violation|0
2940741|NCT01377233|10125602|P5|Double-blind|Adverse Event|0
2940742|NCT01377233|10125603|P4|Double-blind|Adverse Event|2
2940743|NCT01377233|10125604|P3|Double-blind|Adverse Event|2
2940744|NCT01377233|10125605|P2|Double-blind|Adverse Event|1
2940745|NCT01377233|10125606|P1|Double-blind|Adverse Event|0
2940746|NCT01377233|10125602|P5|Open-label|Withdrawal by Subject|0
2940747|NCT01377233|10125603|P4|Open-label|Withdrawal by Subject|0
2940748|NCT01377233|10125604|P3|Open-label|Withdrawal by Subject|0
2940749|NCT01377233|10125605|P2|Open-label|Withdrawal by Subject|0
2940750|NCT01377233|10125606|P1|Open-label|Withdrawal by Subject|3
2940751|NCT01377233|10125602|P5|Open-label|Adverse Event|0
2940752|NCT01377233|10125603|P4|Open-label|Adverse Event|0
2940753|NCT01377233|10125604|P3|Open-label|Adverse Event|0
2940754|NCT01377233|10125605|P2|Open-label|Adverse Event|0
2940755|NCT01377233|10125606|P1|Open-label|Adverse Event|1
2940756|NCT01377194|10125633|P3|Overall Study|Lost to Follow-up|11
2940757|NCT01377194|10125634|P2|Overall Study|Lost to Follow-up|8
2940758|NCT01377194|10125635|P1|Overall Study|Lost to Follow-up|14
2940759|NCT01377194|10125633|P3|Overall Study|Withdrawal by Subject|7
2940760|NCT01377194|10125634|P2|Overall Study|Withdrawal by Subject|10
2940761|NCT01377194|10125635|P1|Overall Study|Withdrawal by Subject|8
2940762|NCT01377194|10125633|P3|Overall Study|Protocol Violation|6
2940763|NCT01377194|10125634|P2|Overall Study|Protocol Violation|10
2940764|NCT01377194|10125635|P1|Overall Study|Protocol Violation|4
2940765|NCT01377194|10125633|P3|Overall Study|Lack of Efficacy|3
2940766|NCT01377194|10125634|P2|Overall Study|Lack of Efficacy|3
2940767|NCT01377194|10125635|P1|Overall Study|Lack of Efficacy|3
2940768|NCT01377194|10125633|P3|Overall Study|Adverse Event|19
2940769|NCT01377194|10125634|P2|Overall Study|Adverse Event|12
2940770|NCT01377194|10125635|P1|Overall Study|Adverse Event|3
2940771|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Adverse Event|1
2940772|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Adverse Event|2
2940773|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Adverse Event|0
2940774|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
2940775|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
2940776|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
2940777|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Physician Decision|0
2940778|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Physician Decision|0
2940779|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Physician Decision|1
2940780|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
2940781|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
2940782|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
2940783|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
2940784|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
2940785|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
2940786|NCT01377012|10125649|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
2940787|NCT01377012|10125650|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
2940788|NCT01377012|10125651|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
2940789|NCT01377012|10125649|P3|Core Study|Adverse Event|13
2940790|NCT01377012|10125650|P2|Core Study|Adverse Event|14
2940791|NCT01377012|10125651|P1|Core Study|Adverse Event|10
2940792|NCT01377012|10125649|P3|Core Study|Death|1
2940793|NCT01377012|10125650|P2|Core Study|Death|1
2940794|NCT01377012|10125651|P1|Core Study|Death|1
2940795|NCT01377012|10125649|P3|Core Study|Lack of Efficacy|37
2940796|NCT01377012|10125650|P2|Core Study|Lack of Efficacy|28
2940797|NCT01377012|10125651|P1|Core Study|Lack of Efficacy|41
2940798|NCT01377012|10125649|P3|Core Study|Lost to Follow-up|4
2940799|NCT01377012|10125650|P2|Core Study|Lost to Follow-up|5
2940800|NCT01377012|10125651|P1|Core Study|Lost to Follow-up|7
2940801|NCT01377012|10125649|P3|Core Study|No Longer require treatment|1
2940802|NCT01377012|10125650|P2|Core Study|No Longer require treatment|0
2940803|NCT01377012|10125651|P1|Core Study|No Longer require treatment|0
2940804|NCT01377012|10125649|P3|Core Study|Non-Compliant with study treatment|1
2940805|NCT01377012|10125650|P2|Core Study|Non-Compliant with study treatment|0
2940806|NCT01377012|10125651|P1|Core Study|Non-Compliant with study treatment|0
2940807|NCT01377012|10125649|P3|Core Study|Physician Decision|10
2940808|NCT01377012|10125650|P2|Core Study|Physician Decision|4
2940809|NCT01377012|10125651|P1|Core Study|Physician Decision|5
2940810|NCT01377012|10125649|P3|Core Study|Pregnancy|1
2940811|NCT01377012|10125650|P2|Core Study|Pregnancy|0
2940812|NCT01377012|10125651|P1|Core Study|Pregnancy|0
2940813|NCT01377012|10125649|P3|Core Study|Protocol Violation|2
2940814|NCT01377012|10125650|P2|Core Study|Protocol Violation|3
2940815|NCT01377012|10125651|P1|Core Study|Protocol Violation|7
2940816|NCT01377012|10125649|P3|Core Study|Withdrawal by Subject|18
2940817|NCT01377012|10125650|P2|Core Study|Withdrawal by Subject|23
2940818|NCT01377012|10125651|P1|Core Study|Withdrawal by Subject|15
2940819|NCT01377012|10125649|P3|Core Study|Technical problems|0
2940820|NCT01377012|10125650|P2|Core Study|Technical problems|0
2940821|NCT01377012|10125651|P1|Core Study|Technical problems|1
2940822|NCT01377012|10125649|P3|Core Study|Study terminated by Sponsor|46
2940823|NCT01377012|10125650|P2|Core Study|Study terminated by Sponsor|54
2940824|NCT01377012|10125651|P1|Core Study|Study terminated by Sponsor|47
2940825|NCT01376908|10125688|P2|Overall Study|Withdrawal by Subject|2
2940826|NCT01376908|10125689|P1|Overall Study|Withdrawal by Subject|1
2940827|NCT01376908|10125688|P2|Overall Study|Protocol Violation|1
2940828|NCT01376908|10125689|P1|Overall Study|Protocol Violation|1
2940829|NCT01376804|10125722|P1|Treatment Period|Patient did not receive study drug|1
2940830|NCT01376804|10125722|P1|Treatment Period|Adverse Event|6
2940831|NCT01376804|10125722|P1|Treatment Period|Withdrawal by Subject|1
2940832|NCT01376700|10125733|P1|Overall Study|Low or high titer inhibitor|8
2940833|NCT01376700|10125733|P1|Overall Study|Sponsor terminated study early|8
2940834|NCT01376388|10125795|P1|Overall Study|Withdrawal by Subject|3
2940835|NCT01376388|10125795|P1|Overall Study|Lack of Efficacy|2
2940836|NCT01376388|10125795|P1|Overall Study|Adverse Event|13
2940837|NCT01376349|10125833|P3|Raondomized Treatment|Alternative Treatment|1
2940838|NCT01376349|10125834|P2|Raondomized Treatment|Alternative Treatment|0
2940839|NCT01376349|10125835|P1|Raondomized Treatment|Alternative Treatment|0
2940840|NCT01376349|10125833|P3|Raondomized Treatment|Unkown|1
2940841|NCT01376349|10125834|P2|Raondomized Treatment|Unkown|2
2940842|NCT01376349|10125835|P1|Raondomized Treatment|Unkown|1
2940843|NCT01376349|10125833|P3|Raondomized Treatment|Adverse Event|14
2940844|NCT01376349|10125834|P2|Raondomized Treatment|Adverse Event|17
2940845|NCT01376349|10125835|P1|Raondomized Treatment|Adverse Event|13
2940846|NCT01376349|10125833|P3|Raondomized Treatment|Withdrawal by Subject|13
2940847|NCT01376349|10125834|P2|Raondomized Treatment|Withdrawal by Subject|16
2940848|NCT01376349|10125835|P1|Raondomized Treatment|Withdrawal by Subject|10
2940849|NCT01376323|10125849|P5|Overall Study|Withdrawal by Subject|0
2940850|NCT01376323|10125850|P4|Overall Study|Withdrawal by Subject|0
2940851|NCT01376323|10125851|P3|Overall Study|Withdrawal by Subject|1
2940852|NCT01376323|10125852|P2|Overall Study|Withdrawal by Subject|1
2940853|NCT01376323|10125853|P1|Overall Study|Withdrawal by Subject|0
2940854|NCT01376323|10125849|P5|Overall Study|Physician Decision|1
2940855|NCT01376323|10125850|P4|Overall Study|Physician Decision|1
2940856|NCT01376323|10125851|P3|Overall Study|Physician Decision|2
2940857|NCT01376323|10125852|P2|Overall Study|Physician Decision|0
2940858|NCT01376323|10125853|P1|Overall Study|Physician Decision|1
2940859|NCT01376323|10125849|P5|Overall Study|Lost to Follow-up|0
2940860|NCT01376323|10125850|P4|Overall Study|Lost to Follow-up|2
2940861|NCT01376323|10125851|P3|Overall Study|Lost to Follow-up|0
2940862|NCT01376323|10125852|P2|Overall Study|Lost to Follow-up|0
2940863|NCT01376323|10125853|P1|Overall Study|Lost to Follow-up|0
2940864|NCT01376323|10125849|P5|Overall Study|Adverse Event|0
2940865|NCT01376323|10125850|P4|Overall Study|Adverse Event|2
2940866|NCT01376323|10125851|P3|Overall Study|Adverse Event|0
2940867|NCT01376323|10125852|P2|Overall Study|Adverse Event|0
2940868|NCT01376323|10125853|P1|Overall Study|Adverse Event|1
2940869|NCT01376310|10125937|P2|Overall Study|Lost to Follow-up|0
2940870|NCT01376310|10125938|P1|Overall Study|Lost to Follow-up|1
2940871|NCT01376310|10125937|P2|Overall Study|Physician Decision|7
2940872|NCT01376310|10125938|P1|Overall Study|Physician Decision|26
2940873|NCT01376310|10125937|P2|Overall Study|Withdrawal by Subject|2
2940874|NCT01376310|10125938|P1|Overall Study|Withdrawal by Subject|8
2940875|NCT01376310|10125937|P2|Overall Study|Study closed/terminated|2
2940876|NCT01376310|10125938|P1|Overall Study|Study closed/terminated|1
2940877|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2940878|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2940879|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2940880|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2940881|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2940882|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Physician Decision|0
2940883|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Physician Decision|1
2940884|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2940885|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Physician Decision|0
2940886|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2940887|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2940888|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2940889|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2940890|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2940891|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2940892|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2940893|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
2940894|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
2940895|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
2940896|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2940897|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
2940898|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2940899|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
2940900|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
2940901|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2940902|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
2940903|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2940904|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
2940905|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2940906|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
2940907|NCT01376245|10125957|P5|24-week, Double-blind Treatment Period|Adverse Event|18
2940908|NCT01376245|10125958|P4|24-week, Double-blind Treatment Period|Adverse Event|8
2940909|NCT01376245|10125959|P3|24-week, Double-blind Treatment Period|Adverse Event|7
2940910|NCT01376245|10125960|P2|24-week, Double-blind Treatment Period|Adverse Event|16
2940911|NCT01376245|10125961|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2940912|NCT01376245|10125957|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2940913|NCT01376245|10125958|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2940914|NCT01376245|10125959|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2940915|NCT01376245|10125960|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2940916|NCT01376245|10125961|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
2940917|NCT01376245|10125957|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2940918|NCT01376245|10125958|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2940919|NCT01376245|10125959|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2940920|NCT01376245|10125960|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2940921|NCT01376245|10125961|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
2940922|NCT01376245|10125957|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2940923|NCT01376245|10125958|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2940924|NCT01376245|10125959|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2940925|NCT01376245|10125960|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2940926|NCT01376245|10125961|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
2940927|NCT01376245|10125957|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2940928|NCT01376245|10125958|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2940929|NCT01376245|10125959|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2940930|NCT01376245|10125960|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2940931|NCT01376245|10125961|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
2940932|NCT01376245|10125957|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2940933|NCT01376245|10125958|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2940934|NCT01376245|10125959|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2940935|NCT01376245|10125960|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2940936|NCT01376245|10125961|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
2940937|NCT01376167|10125978|P3|Overall Study|Withdrawal by Subject|4
2940938|NCT01376167|10125979|P2|Overall Study|Withdrawal by Subject|5
2940939|NCT01376167|10125980|P1|Overall Study|Withdrawal by Subject|1
2940940|NCT01376167|10125978|P3|Overall Study|Physician Decision|0
2940941|NCT01376167|10125979|P2|Overall Study|Physician Decision|1
2940942|NCT01376167|10125980|P1|Overall Study|Physician Decision|1
2940943|NCT01376167|10125978|P3|Overall Study|Lost to Follow-up|2
2940944|NCT01376167|10125979|P2|Overall Study|Lost to Follow-up|4
2940945|NCT01376167|10125980|P1|Overall Study|Lost to Follow-up|2
2940946|NCT01376089|10126051|P2|Overall Study|Patient received no contrast media|4
2940947|NCT01376089|10126052|P1|Overall Study|Patient received no contrast media|3
2940948|NCT01376037|10126075|P2|Overall Study|Lost to Follow-up|2
2940949|NCT01376037|10126076|P1|Overall Study|Lost to Follow-up|0
2940950|NCT01375777|10126104|P9|Overall Study|Other|1
2940951|NCT01375777|10126105|P8|Overall Study|Other|0
2940952|NCT01375777|10126106|P7|Overall Study|Other|0
2940953|NCT01375777|10126107|P6|Overall Study|Other|0
2940954|NCT01375777|10126108|P5|Overall Study|Other|0
2940955|NCT01375777|10126109|P4|Overall Study|Other|0
2940956|NCT01375777|10126110|P3|Overall Study|Other|0
2940957|NCT01375777|10126111|P2|Overall Study|Other|1
2940958|NCT01375777|10126112|P1|Overall Study|Other|1
2940959|NCT01375777|10126104|P9|Overall Study|Lost to Follow-up|0
2940960|NCT01375777|10126105|P8|Overall Study|Lost to Follow-up|0
2940961|NCT01375777|10126106|P7|Overall Study|Lost to Follow-up|1
2940962|NCT01375777|10126107|P6|Overall Study|Lost to Follow-up|0
2940963|NCT01375777|10126108|P5|Overall Study|Lost to Follow-up|0
2940964|NCT01375777|10126109|P4|Overall Study|Lost to Follow-up|0
2940965|NCT01375777|10126110|P3|Overall Study|Lost to Follow-up|0
2940966|NCT01375777|10126111|P2|Overall Study|Lost to Follow-up|0
2940967|NCT01375777|10126112|P1|Overall Study|Lost to Follow-up|1
2940968|NCT01375777|10126104|P9|Overall Study|Withdrawal by Subject|1
2940969|NCT01375777|10126105|P8|Overall Study|Withdrawal by Subject|2
2940970|NCT01375777|10126106|P7|Overall Study|Withdrawal by Subject|1
2940971|NCT01375777|10126107|P6|Overall Study|Withdrawal by Subject|1
2940972|NCT01375777|10126108|P5|Overall Study|Withdrawal by Subject|1
2940973|NCT01375777|10126109|P4|Overall Study|Withdrawal by Subject|0
2940974|NCT01375777|10126110|P3|Overall Study|Withdrawal by Subject|1
2940975|NCT01375777|10126111|P2|Overall Study|Withdrawal by Subject|2
2940976|NCT01375777|10126112|P1|Overall Study|Withdrawal by Subject|0
2940977|NCT01375764|10126182|P5|Overall Study|Other|0
2940978|NCT01375764|10126183|P4|Overall Study|Other|1
2940979|NCT01375764|10126184|P3|Overall Study|Other|0
2940980|NCT01375764|10126185|P2|Overall Study|Other|0
2940981|NCT01375764|10126186|P1|Overall Study|Other|0
2940982|NCT01375764|10126182|P5|Overall Study|Withdrawal by Subject|1
2940983|NCT01375764|10126183|P4|Overall Study|Withdrawal by Subject|0
2940984|NCT01375764|10126184|P3|Overall Study|Withdrawal by Subject|0
2940985|NCT01375764|10126185|P2|Overall Study|Withdrawal by Subject|0
2940986|NCT01375764|10126186|P1|Overall Study|Withdrawal by Subject|2
2940987|NCT01375764|10126182|P5|Overall Study|Lost to Follow-up|0
2940988|NCT01375764|10126183|P4|Overall Study|Lost to Follow-up|0
2940989|NCT01375764|10126184|P3|Overall Study|Lost to Follow-up|0
2940990|NCT01375764|10126185|P2|Overall Study|Lost to Follow-up|1
2940991|NCT01375764|10126186|P1|Overall Study|Lost to Follow-up|0
2940992|NCT01375751|10126232|P3|Overall Study|Other|0
2940993|NCT01375751|10126233|P2|Overall Study|Other|1
2940994|NCT01375751|10126234|P1|Overall Study|Other|0
2940995|NCT01375608|10126278|P1|Overall Study|Withdrawal by Subject|2
2940996|NCT01375374|10126306|P1|Overall Study|Adverse Event|1
2940997|NCT01375205|10126315|P2|Overall Study|Withdrawal by Subject|1
2940998|NCT01375205|10126316|P1|Overall Study|Withdrawal by Subject|6
2940999|NCT01375205|10126315|P2|Overall Study|Lost to Follow-up|12
2941000|NCT01375205|10126316|P1|Overall Study|Lost to Follow-up|15
2941001|NCT01375075|10126389|P6|Overall Study|Withdrawal by Subject|1
2941002|NCT01375075|10126390|P5|Overall Study|Withdrawal by Subject|0
2941003|NCT01375075|10126391|P4|Overall Study|Withdrawal by Subject|0
2941004|NCT01375075|10126392|P3|Overall Study|Withdrawal by Subject|0
2941005|NCT01375075|10126393|P2|Overall Study|Withdrawal by Subject|1
2941006|NCT01375075|10126394|P1|Overall Study|Withdrawal by Subject|0
2941007|NCT01375075|10126389|P6|Overall Study|Entry Criterion Not Met|1
2941008|NCT01375075|10126390|P5|Overall Study|Entry Criterion Not Met|0
2941009|NCT01375075|10126391|P4|Overall Study|Entry Criterion Not Met|0
2941010|NCT01375075|10126392|P3|Overall Study|Entry Criterion Not Met|0
2941011|NCT01375075|10126393|P2|Overall Study|Entry Criterion Not Met|0
2941012|NCT01375075|10126394|P1|Overall Study|Entry Criterion Not Met|1
2941013|NCT01375075|10126389|P6|Overall Study|Adverse Event|1
2941014|NCT01375075|10126390|P5|Overall Study|Adverse Event|0
2941015|NCT01375075|10126391|P4|Overall Study|Adverse Event|1
2941016|NCT01375075|10126392|P3|Overall Study|Adverse Event|3
2941017|NCT01375075|10126393|P2|Overall Study|Adverse Event|0
2941018|NCT01375075|10126394|P1|Overall Study|Adverse Event|0
2941019|NCT01375049|10126478|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
2941020|NCT01375049|10126478|P1|Overall Study|Withdrawal by Subject|2
2941021|NCT01375049|10126478|P1|Overall Study|Lost to Follow-up|1
2941022|NCT01375049|10126478|P1|Overall Study|Adverse Event|2
2941023|NCT01375010|10126495|P2|Overall Study|Withdrawal by Subject|2
2941024|NCT01375010|10126496|P1|Overall Study|Withdrawal by Subject|4
2941025|NCT01375010|10126495|P2|Overall Study|Lost to Follow-up|2
2941026|NCT01375010|10126496|P1|Overall Study|Lost to Follow-up|8
2941027|NCT01374971|10126510|P1|Overall Study|Withdrawal by Subject|1
2941028|NCT01374919|10126515|P1|Overall Study|Withdrawal by Subject|2
2941029|NCT01374906|10126522|P2|Overall Study|Unsatisfactory therapeutic effect|19
2941030|NCT01374906|10126523|P1|Overall Study|Unsatisfactory therapeutic effect|11
2941031|NCT01374906|10126522|P2|Overall Study|Withdrawal by Subject|9
2941032|NCT01374906|10126523|P1|Overall Study|Withdrawal by Subject|15
2941033|NCT01374906|10126522|P2|Overall Study|Protocol Violation|2
2941034|NCT01374906|10126523|P1|Overall Study|Protocol Violation|2
2941035|NCT01374906|10126522|P2|Overall Study|Death|2
2941036|NCT01374906|10126523|P1|Overall Study|Death|0
2941037|NCT01374906|10126522|P2|Overall Study|Adverse Event|11
2941038|NCT01374906|10126523|P1|Overall Study|Adverse Event|10
2941039|NCT01374906|10126522|P2|Overall Study|Administrative problems|2
2941040|NCT01374906|10126523|P1|Overall Study|Administrative problems|2
2941041|NCT01374906|10126522|P2|Overall Study|Abnormal laboratory value(s)|3
2941042|NCT01374906|10126523|P1|Overall Study|Abnormal laboratory value(s)|0
2941043|NCT01374568|10126604|P2|Overall Study|Lab unable to analyze BTM|2
2941044|NCT01374568|10126605|P1|Overall Study|Lab unable to analyze BTM|0
2941045|NCT01374516|10126615|P2|Surveillance Expansion Period|Serious adverse event|5
2941046|NCT01374516|10126616|P1|Surveillance Expansion Period|Serious adverse event|20
2941047|NCT01374516|10126615|P2|Surveillance Expansion Period|Lost to Follow-up|45
2941048|NCT01374516|10126616|P1|Surveillance Expansion Period|Lost to Follow-up|73
2941049|NCT01374516|10126615|P2|Surveillance Expansion Period|Withdrawal by Subject|986
2941050|NCT01374516|10126616|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
2941051|NCT01374516|10126615|P2|Surveillance Expansion Period|Protocol Violation|217
2941052|NCT01374516|10126616|P1|Surveillance Expansion Period|Protocol Violation|386
2941053|NCT01374516|10126615|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
2941054|NCT01374516|10126616|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
2941055|NCT01374516|10126615|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
2941056|NCT01374516|10126616|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
2941057|NCT01374516|10126615|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
2941058|NCT01374516|10126616|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
2941059|NCT01374516|10126615|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
2941060|NCT01374516|10126616|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
2941061|NCT01374516|10126615|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
2941062|NCT01374516|10126616|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
2941063|NCT01374451|10126650|P2|Overall Study|Administrative problems|0
2941064|NCT01374451|10126651|P1|Overall Study|Administrative problems|1
2941065|NCT01374425|10126697|P2|Overall Study|Other|43
2941066|NCT01374425|10126698|P1|Overall Study|Other|41
2941067|NCT01374425|10126697|P2|Overall Study|Lost to Follow-up|1
2941068|NCT01374425|10126698|P1|Overall Study|Lost to Follow-up|2
2941069|NCT01374425|10126697|P2|Overall Study|Sponsor Decision|1
2941070|NCT01374425|10126698|P1|Overall Study|Sponsor Decision|0
2941071|NCT01374425|10126697|P2|Overall Study|Protocol Violation|3
2941072|NCT01374425|10126698|P1|Overall Study|Protocol Violation|2
2941073|NCT01374425|10126697|P2|Overall Study|Refused Treatment|24
2941074|NCT01374425|10126698|P1|Overall Study|Refused Treatment|10
2941075|NCT01374425|10126697|P2|Overall Study|Withdrawal by Subject|7
2941076|NCT01374425|10126698|P1|Overall Study|Withdrawal by Subject|6
2941077|NCT01374425|10126697|P2|Overall Study|Death (Adverse Event)|4
2941078|NCT01374425|10126698|P1|Overall Study|Death (Adverse Event)|2
2941079|NCT01374425|10126697|P2|Overall Study|Death (Progression of Disease)|0
2941080|NCT01374425|10126698|P1|Overall Study|Death (Progression of Disease)|1
2941081|NCT01374425|10126697|P2|Overall Study|Adverse Event|18
2941082|NCT01374425|10126698|P1|Overall Study|Adverse Event|29
2941083|NCT01374425|10126697|P2|Overall Study|Clinical Disease Progression|6
2941084|NCT01374425|10126698|P1|Overall Study|Clinical Disease Progression|9
2941085|NCT01374425|10126697|P2|Overall Study|Radiographic Disease Progression|81
2941086|NCT01374425|10126698|P1|Overall Study|Radiographic Disease Progression|86
2941087|NCT01374269|10126778|P2|Overall Study|closed research|2
2941088|NCT01374269|10126779|P1|Overall Study|closed research|1
2941089|NCT01374269|10126778|P2|Overall Study|Lost to Follow-up|3
2941090|NCT01374269|10126779|P1|Overall Study|Lost to Follow-up|1
2941091|NCT01374269|10126778|P2|Overall Study|Withdrawal by Subject|0
2941092|NCT01374269|10126779|P1|Overall Study|Withdrawal by Subject|4
2941093|NCT01374217|10126907|P1|Overall Study|Lack of Efficacy|13
2941094|NCT01374178|10126915|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
2941095|NCT01374178|10126916|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
2941096|NCT01374178|10126915|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
2941097|NCT01374178|10126916|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
2941098|NCT01374087|10126934|P2|Overall Study|Study discontinued|13
2941099|NCT01374087|10126935|P1|Overall Study|Study discontinued|13
2941100|NCT01374087|10126934|P2|Overall Study|Disease progression|2
2941101|NCT01374087|10126935|P1|Overall Study|Disease progression|2
2941102|NCT01374087|10126934|P2|Overall Study|Adverse Event|0
2941103|NCT01374087|10126935|P1|Overall Study|Adverse Event|1
2941104|NCT01373931|10126955|P2|Period 1|Withdrawal by Subject|2
2941105|NCT01373931|10126956|P1|Period 1|Withdrawal by Subject|0
2941106|NCT01373931|10126955|P2|Period 1|Adverse Event|0
2941107|NCT01373931|10126956|P1|Period 1|Adverse Event|2
2941108|NCT01373931|10126955|P2|Lead-in Period|Adverse Event|0
2941109|NCT01373931|10126956|P1|Lead-in Period|Adverse Event|2
2941110|NCT01373918|10126969|P2|Overall Study|Physician Decision|1
2941111|NCT01373918|10126970|P1|Overall Study|Physician Decision|0
2941112|NCT01373346|10127029|P1|Overall Study|Death|1
2941113|NCT01373294|10127052|P2|Overall Study|Adverse Event|0
2941114|NCT01373294|10127053|P1|Overall Study|Adverse Event|1
2941115|NCT01373281|10127062|P2|Surveillance Expansion Period|Serious adverse event|4
2941116|NCT01373281|10127063|P1|Surveillance Expansion Period|Serious adverse event|3
2941117|NCT01373281|10127062|P2|Surveillance Expansion Period|Lost to Follow-up|8
2941118|NCT01373281|10127063|P1|Surveillance Expansion Period|Lost to Follow-up|10
2941119|NCT01373281|10127062|P2|Surveillance Expansion Period|Protocol Violation|1
2941120|NCT01373281|10127063|P1|Surveillance Expansion Period|Protocol Violation|9
2941121|NCT01373281|10127062|P2|Surveillance Expansion Period|Withdrawal by Subject|105
2941122|NCT01373281|10127063|P1|Surveillance Expansion Period|Withdrawal by Subject|180
2941123|NCT01373281|10127062|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
2941124|NCT01373281|10127063|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
2941125|NCT01373281|10127062|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
2941126|NCT01373281|10127063|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
2941127|NCT01373281|10127062|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
2941128|NCT01373281|10127063|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
2941129|NCT01373281|10127062|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
2941130|NCT01373281|10127063|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
2941131|NCT01373229|10127111|P1|Overall Study|Physician Decision|3
2941132|NCT01373229|10127111|P1|Overall Study|Death|3
2941133|NCT01373164|10127125|P5|Overall Study|Withdrawal by Subject|2
2941134|NCT01373164|10127126|P4|Overall Study|Withdrawal by Subject|10
2941135|NCT01373164|10127127|P3|Overall Study|Withdrawal by Subject|0
2941136|NCT01373164|10127128|P2|Overall Study|Withdrawal by Subject|1
2941137|NCT01373164|10127129|P1|Overall Study|Withdrawal by Subject|0
2941138|NCT01373164|10127125|P5|Overall Study|Lost to Follow-up|0
2941139|NCT01373164|10127126|P4|Overall Study|Lost to Follow-up|2
2941140|NCT01373164|10127127|P3|Overall Study|Lost to Follow-up|1
2941141|NCT01373164|10127128|P2|Overall Study|Lost to Follow-up|0
2941142|NCT01373164|10127129|P1|Overall Study|Lost to Follow-up|0
2941143|NCT01372995|10127163|P3|Overall Study|Physician Decision|1
2941144|NCT01372995|10127164|P2|Overall Study|Physician Decision|0
2941145|NCT01372995|10127165|P1|Overall Study|Physician Decision|0
2941146|NCT01372995|10127163|P3|Overall Study|Spouse withdrew participant from study|0
2941147|NCT01372995|10127164|P2|Overall Study|Spouse withdrew participant from study|1
2941148|NCT01372995|10127165|P1|Overall Study|Spouse withdrew participant from study|0
2941149|NCT01372878|10127212|P1|Overall Study|incomplete study procedure|104
2941150|NCT01372878|10127212|P1|Overall Study|Protocol Violation|17
2941151|NCT01372878|10127212|P1|Overall Study|Withdrawal by Subject|63
2941152|NCT01372774|10127232|P2|Overall Study|Withdrawal prior to treatment|5
2941153|NCT01372774|10127233|P1|Overall Study|Withdrawal prior to treatment|4
2941154|NCT01372748|10127249|P2|Overall Study|Withdrawal by Subject|5
2941155|NCT01372748|10127250|P1|Overall Study|Withdrawal by Subject|7
2941156|NCT01372748|10127249|P2|Overall Study|Lost to Follow-up|34
2941157|NCT01372748|10127250|P1|Overall Study|Lost to Follow-up|16
2941158|NCT01372618|10127258|P1|Overall Study|PI Died. Study Terminated|9
2941159|NCT01372605|10127266|P2|Overall Study|Changed medical home|0
2941160|NCT01372605|10127267|P1|Overall Study|Changed medical home|2
2941161|NCT01372605|10127266|P2|Overall Study|Moved|0
2941162|NCT01372605|10127267|P1|Overall Study|Moved|3
2941163|NCT01372605|10127266|P2|Overall Study|Withdrawal by Subject|7
2941164|NCT01372605|10127267|P1|Overall Study|Withdrawal by Subject|4
2941165|NCT01372605|10127266|P2|Overall Study|Lost to Follow-up|1
2941166|NCT01372605|10127267|P1|Overall Study|Lost to Follow-up|2
2941167|NCT01372605|10127266|P2|Overall Study|Death|2
2941168|NCT01372605|10127267|P1|Overall Study|Death|1
2941169|NCT01372501|10127293|P1|Overall Study|Device migration|1
2941170|NCT01372501|10127293|P1|Overall Study|Adverse Event|4
2941171|NCT01372410|10127316|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941172|NCT01372410|10127317|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941173|NCT01372410|10127318|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
2941174|NCT01372410|10127319|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941175|NCT01372410|10127320|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941176|NCT01372410|10127321|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941177|NCT01372410|10127322|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941178|NCT01372410|10127323|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
2941179|NCT01372410|10127316|P8|Treatment Period 3 (7 Days)|Adverse Event|0
2941180|NCT01372410|10127317|P7|Treatment Period 3 (7 Days)|Adverse Event|0
2941181|NCT01372410|10127318|P6|Treatment Period 3 (7 Days)|Adverse Event|0
2941182|NCT01372410|10127319|P5|Treatment Period 3 (7 Days)|Adverse Event|0
2941183|NCT01372410|10127320|P4|Treatment Period 3 (7 Days)|Adverse Event|0
2941184|NCT01372410|10127321|P3|Treatment Period 3 (7 Days)|Adverse Event|1
2941185|NCT01372410|10127322|P2|Treatment Period 3 (7 Days)|Adverse Event|0
2941186|NCT01372410|10127323|P1|Treatment Period 3 (7 Days)|Adverse Event|0
2941187|NCT01372410|10127316|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
2941188|NCT01372410|10127317|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941189|NCT01372410|10127318|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941190|NCT01372410|10127319|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941191|NCT01372410|10127320|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941192|NCT01372410|10127321|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941193|NCT01372410|10127322|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941194|NCT01372410|10127323|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2941195|NCT01372410|10127316|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2941196|NCT01372410|10127317|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2941197|NCT01372410|10127318|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2941198|NCT01372410|10127319|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2941199|NCT01372410|10127320|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2941200|NCT01372410|10127321|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2941201|NCT01372410|10127322|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2941202|NCT01372410|10127323|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2941203|NCT01372410|10127316|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
2941204|NCT01372410|10127317|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
2941205|NCT01372410|10127318|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
2941206|NCT01372410|10127319|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
2941207|NCT01372410|10127320|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
2941208|NCT01372410|10127321|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
2941209|NCT01372410|10127322|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
2941210|NCT01372410|10127323|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
2941211|NCT01372410|10127316|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2941212|NCT01372410|10127317|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941213|NCT01372410|10127318|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941214|NCT01372410|10127319|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941215|NCT01372410|10127320|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941216|NCT01372410|10127321|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941217|NCT01372410|10127322|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2941218|NCT01372410|10127323|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2941219|NCT01372410|10127316|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941220|NCT01372410|10127317|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
2941221|NCT01372410|10127318|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941222|NCT01372410|10127319|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941223|NCT01372410|10127320|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941224|NCT01372410|10127321|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941225|NCT01372410|10127322|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941226|NCT01372410|10127323|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2941227|NCT01372410|10127316|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941228|NCT01372410|10127317|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941229|NCT01372410|10127318|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941230|NCT01372410|10127319|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2941231|NCT01372410|10127320|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941232|NCT01372410|10127321|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941233|NCT01372410|10127322|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941234|NCT01372410|10127323|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2941235|NCT01372410|10127316|P8|Treatment Period 1 (7 Days)|Adverse Event|0
2941236|NCT01372410|10127317|P7|Treatment Period 1 (7 Days)|Adverse Event|1
2941237|NCT01372410|10127318|P6|Treatment Period 1 (7 Days)|Adverse Event|0
2941238|NCT01372410|10127319|P5|Treatment Period 1 (7 Days)|Adverse Event|0
2941239|NCT01372410|10127320|P4|Treatment Period 1 (7 Days)|Adverse Event|0
2941240|NCT01372410|10127321|P3|Treatment Period 1 (7 Days)|Adverse Event|0
2941241|NCT01372410|10127322|P2|Treatment Period 1 (7 Days)|Adverse Event|1
2941242|NCT01372410|10127323|P1|Treatment Period 1 (7 Days)|Adverse Event|0
2941243|NCT01372410|10127316|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2941244|NCT01372410|10127317|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2941245|NCT01372410|10127318|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2941246|NCT01372410|10127319|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2941247|NCT01372410|10127320|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2941248|NCT01372410|10127321|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2941249|NCT01372410|10127322|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2941250|NCT01372410|10127323|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2941251|NCT01372384|10127360|P1|Overall Study|Progression of disease|3
2941252|NCT01372150|10127392|P3|Overall Study|Randomized but not treated|0
2941253|NCT01372150|10127393|P2|Overall Study|Randomized but not treated|1
2941254|NCT01372150|10127394|P1|Overall Study|Randomized but not treated|0
2941255|NCT01372150|10127392|P3|Overall Study|Adverse Event|2
2941256|NCT01372150|10127393|P2|Overall Study|Adverse Event|1
2941257|NCT01372150|10127394|P1|Overall Study|Adverse Event|2
2941258|NCT01372150|10127392|P3|Overall Study|Other|2
2941259|NCT01372150|10127393|P2|Overall Study|Other|0
2941260|NCT01372150|10127394|P1|Overall Study|Other|1
2941261|NCT01372150|10127392|P3|Overall Study|Withdrawal by Subject|2
2941262|NCT01372150|10127393|P2|Overall Study|Withdrawal by Subject|7
2941263|NCT01372150|10127394|P1|Overall Study|Withdrawal by Subject|2
2941264|NCT01372150|10127392|P3|Overall Study|Protocol Violation|3
2941265|NCT01372150|10127393|P2|Overall Study|Protocol Violation|0
2941266|NCT01372150|10127394|P1|Overall Study|Protocol Violation|1
2941267|NCT01372150|10127392|P3|Overall Study|Lost to Follow-up|6
2941268|NCT01372150|10127393|P2|Overall Study|Lost to Follow-up|5
2941269|NCT01372150|10127394|P1|Overall Study|Lost to Follow-up|4
2941270|NCT01372150|10127392|P3|Overall Study|Lack of Efficacy|1
2941271|NCT01372150|10127393|P2|Overall Study|Lack of Efficacy|0
2941272|NCT01372150|10127394|P1|Overall Study|Lack of Efficacy|3
2941273|NCT01372085|10127421|P10|Washout Period 3|Withdrawal by Subject|0
2941274|NCT01372085|10127422|P9|Washout Period 3|Withdrawal by Subject|0
2941275|NCT01372085|10127423|P8|Washout Period 3|Withdrawal by Subject|0
2941276|NCT01372085|10127424|P7|Washout Period 3|Withdrawal by Subject|0
2941277|NCT01372085|10127425|P6|Washout Period 3|Withdrawal by Subject|2
2941278|NCT01372085|10127426|P5|Washout Period 3|Withdrawal by Subject|0
2941279|NCT01372085|10127427|P4|Washout Period 3|Withdrawal by Subject|0
2941280|NCT01372085|10127428|P3|Washout Period 3|Withdrawal by Subject|0
2941281|NCT01372085|10127429|P2|Washout Period 3|Withdrawal by Subject|0
2941282|NCT01372085|10127430|P1|Washout Period 3|Withdrawal by Subject|0
2941283|NCT01372085|10127421|P10|Washout Period 2|Physician Decision|0
2941284|NCT01372085|10127422|P9|Washout Period 2|Physician Decision|0
2941285|NCT01372085|10127423|P8|Washout Period 2|Physician Decision|0
2941286|NCT01372085|10127424|P7|Washout Period 2|Physician Decision|0
2941287|NCT01372085|10127425|P6|Washout Period 2|Physician Decision|0
2941288|NCT01372085|10127426|P5|Washout Period 2|Physician Decision|1
2941289|NCT01372085|10127427|P4|Washout Period 2|Physician Decision|0
2941290|NCT01372085|10127428|P3|Washout Period 2|Physician Decision|0
2941291|NCT01372085|10127429|P2|Washout Period 2|Physician Decision|0
2941292|NCT01372085|10127430|P1|Washout Period 2|Physician Decision|0
2941293|NCT01371994|10127462|P2|Overall Study|Miscellaneous Reasons|4
2941294|NCT01371994|10127463|P1|Overall Study|Miscellaneous Reasons|6
2941295|NCT01371994|10127462|P2|Overall Study|Physician Decision|1
2941296|NCT01371994|10127463|P1|Overall Study|Physician Decision|1
2941297|NCT01371994|10127462|P2|Overall Study|Randomized but Never Received Study Drug|6
2941298|NCT01371994|10127463|P1|Overall Study|Randomized but Never Received Study Drug|6
2941299|NCT01371994|10127462|P2|Overall Study|Protocol Violation|17
2941300|NCT01371994|10127463|P1|Overall Study|Protocol Violation|24
2941301|NCT01371994|10127462|P2|Overall Study|Lost to Follow-up|1
2941302|NCT01371994|10127463|P1|Overall Study|Lost to Follow-up|1
2941303|NCT01371994|10127462|P2|Overall Study|Withdrawal by Subject|7
2941304|NCT01371994|10127463|P1|Overall Study|Withdrawal by Subject|13
2941305|NCT01371994|10127462|P2|Overall Study|Lack of Efficacy|0
2941306|NCT01371994|10127463|P1|Overall Study|Lack of Efficacy|3
2941307|NCT01371994|10127462|P2|Overall Study|Adverse Event|6
2941308|NCT01371994|10127463|P1|Overall Study|Adverse Event|3
2941309|NCT01371877|10127507|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
2941310|NCT01371877|10127508|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
2941311|NCT01371851|10127520|P2|Overall Study|Blood Pressure outside study parameters|0
2941312|NCT01371851|10127521|P1|Overall Study|Blood Pressure outside study parameters|2
2941313|NCT01371851|10127520|P2|Overall Study|non study related adverse event|0
2941314|NCT01371851|10127521|P1|Overall Study|non study related adverse event|1
2941315|NCT01371851|10127520|P2|Overall Study|was arrested and put in jail|1
2941316|NCT01371851|10127521|P1|Overall Study|was arrested and put in jail|0
2941317|NCT01371851|10127520|P2|Overall Study|Lost to Follow-up|8
2941318|NCT01371851|10127521|P1|Overall Study|Lost to Follow-up|5
2941319|NCT01371838|10127529|P2|Overall Study|Surgery|0
2941320|NCT01371838|10127530|P1|Overall Study|Surgery|1
2941321|NCT01371838|10127529|P2|Overall Study|Lack of therapeutic response|1
2941322|NCT01371838|10127530|P1|Overall Study|Lack of therapeutic response|0
2941323|NCT01371838|10127529|P2|Overall Study|Last follow-up visit not conducted|0
2941324|NCT01371838|10127530|P1|Overall Study|Last follow-up visit not conducted|2
2941325|NCT01371838|10127529|P2|Overall Study|Investigator Decision|8
2941326|NCT01371838|10127530|P1|Overall Study|Investigator Decision|3
2941327|NCT01371838|10127529|P2|Overall Study|Protocol Violation|0
2941328|NCT01371838|10127530|P1|Overall Study|Protocol Violation|3
2941329|NCT01371838|10127529|P2|Overall Study|Death|4
2941330|NCT01371838|10127530|P1|Overall Study|Death|3
2941331|NCT01371838|10127529|P2|Overall Study|Lost to Follow-up|20
2941332|NCT01371838|10127530|P1|Overall Study|Lost to Follow-up|10
2941333|NCT01371838|10127529|P2|Overall Study|Withdrawal by Subject|33
2941334|NCT01371838|10127530|P1|Overall Study|Withdrawal by Subject|27
2941335|NCT01371825|10127566|P1|Overall Study|Death|4
2941336|NCT01371747|10127600|P6|Overall Study|Other Reasons|1
2941337|NCT01371747|10127601|P5|Overall Study|Other Reasons|0
2941338|NCT01371747|10127602|P4|Overall Study|Other Reasons|0
2941339|NCT01371747|10127603|P3|Overall Study|Other Reasons|2
2941340|NCT01371747|10127604|P2|Overall Study|Other Reasons|1
2941341|NCT01371747|10127605|P1|Overall Study|Other Reasons|2
2941342|NCT01371747|10127600|P6|Overall Study|Withdrawal by Subject|4
2941343|NCT01371747|10127601|P5|Overall Study|Withdrawal by Subject|2
2941344|NCT01371747|10127602|P4|Overall Study|Withdrawal by Subject|2
2941345|NCT01371747|10127603|P3|Overall Study|Withdrawal by Subject|5
2941346|NCT01371747|10127604|P2|Overall Study|Withdrawal by Subject|12
2941347|NCT01371747|10127605|P1|Overall Study|Withdrawal by Subject|6
2941348|NCT01371747|10127600|P6|Overall Study|Physician Decision|0
2941349|NCT01371747|10127601|P5|Overall Study|Physician Decision|1
2941350|NCT01371747|10127602|P4|Overall Study|Physician Decision|0
2941351|NCT01371747|10127603|P3|Overall Study|Physician Decision|0
2941352|NCT01371747|10127604|P2|Overall Study|Physician Decision|0
2941353|NCT01371747|10127605|P1|Overall Study|Physician Decision|0
2941354|NCT01371747|10127600|P6|Overall Study|Non-Compliance|1
2941355|NCT01371747|10127601|P5|Overall Study|Non-Compliance|0
2941356|NCT01371747|10127602|P4|Overall Study|Non-Compliance|0
2941357|NCT01371747|10127603|P3|Overall Study|Non-Compliance|3
2941358|NCT01371747|10127604|P2|Overall Study|Non-Compliance|4
2941359|NCT01371747|10127605|P1|Overall Study|Non-Compliance|3
2941360|NCT01371747|10127600|P6|Overall Study|Protocol Violation|0
2941361|NCT01371747|10127601|P5|Overall Study|Protocol Violation|0
2941362|NCT01371747|10127602|P4|Overall Study|Protocol Violation|0
2941363|NCT01371747|10127603|P3|Overall Study|Protocol Violation|1
2941364|NCT01371747|10127604|P2|Overall Study|Protocol Violation|0
2941365|NCT01371747|10127605|P1|Overall Study|Protocol Violation|0
2941366|NCT01371747|10127600|P6|Overall Study|Low Serum Potassium Results|3
2941367|NCT01371747|10127601|P5|Overall Study|Low Serum Potassium Results|0
2941368|NCT01371747|10127602|P4|Overall Study|Low Serum Potassium Results|1
2941369|NCT01371747|10127603|P3|Overall Study|Low Serum Potassium Results|1
2941370|NCT01371747|10127604|P2|Overall Study|Low Serum Potassium Results|1
2941371|NCT01371747|10127605|P1|Overall Study|Low Serum Potassium Results|1
2941372|NCT01371747|10127600|P6|Overall Study|High Serum Potassium Results|2
2941373|NCT01371747|10127601|P5|Overall Study|High Serum Potassium Results|0
2941374|NCT01371747|10127602|P4|Overall Study|High Serum Potassium Results|2
2941375|NCT01371747|10127603|P3|Overall Study|High Serum Potassium Results|1
2941376|NCT01371747|10127604|P2|Overall Study|High Serum Potassium Results|1
2941377|NCT01371747|10127605|P1|Overall Study|High Serum Potassium Results|1
2941378|NCT01371747|10127600|P6|Overall Study|Abnormal Renal Function|1
2941379|NCT01371747|10127601|P5|Overall Study|Abnormal Renal Function|0
2941380|NCT01371747|10127602|P4|Overall Study|Abnormal Renal Function|1
2941381|NCT01371747|10127603|P3|Overall Study|Abnormal Renal Function|0
2941382|NCT01371747|10127604|P2|Overall Study|Abnormal Renal Function|2
2941383|NCT01371747|10127605|P1|Overall Study|Abnormal Renal Function|0
2941384|NCT01371747|10127600|P6|Overall Study|Death|0
2941385|NCT01371747|10127601|P5|Overall Study|Death|2
2941386|NCT01371747|10127602|P4|Overall Study|Death|1
2941387|NCT01371747|10127603|P3|Overall Study|Death|4
2941388|NCT01371747|10127604|P2|Overall Study|Death|0
2941389|NCT01371747|10127605|P1|Overall Study|Death|1
2941390|NCT01371747|10127600|P6|Overall Study|Adverse Event|2
2941391|NCT01371747|10127601|P5|Overall Study|Adverse Event|2
2941392|NCT01371747|10127602|P4|Overall Study|Adverse Event|2
2941393|NCT01371747|10127603|P3|Overall Study|Adverse Event|7
2941394|NCT01371747|10127604|P2|Overall Study|Adverse Event|2
2941395|NCT01371747|10127605|P1|Overall Study|Adverse Event|4
2941396|NCT01371734|10127670|P3|Overall Study|Lack of Efficacy|0
2941397|NCT01371734|10127671|P2|Overall Study|Lack of Efficacy|2
2941398|NCT01371734|10127672|P1|Overall Study|Lack of Efficacy|2
2941399|NCT01371734|10127670|P3|Overall Study|Adverse Event|3
2941400|NCT01371734|10127671|P2|Overall Study|Adverse Event|8
2941401|NCT01371734|10127672|P1|Overall Study|Adverse Event|8
2941402|NCT01371734|10127670|P3|Overall Study|Protocol Violation|2
2941403|NCT01371734|10127671|P2|Overall Study|Protocol Violation|1
2941404|NCT01371734|10127672|P1|Overall Study|Protocol Violation|3
2941405|NCT01371734|10127670|P3|Overall Study|Lost to Follow-up|1
2941406|NCT01371734|10127671|P2|Overall Study|Lost to Follow-up|3
2941407|NCT01371734|10127672|P1|Overall Study|Lost to Follow-up|5
2941408|NCT01371734|10127670|P3|Overall Study|Withdrawal by Subject|9
2941409|NCT01371734|10127671|P2|Overall Study|Withdrawal by Subject|4
2941410|NCT01371734|10127672|P1|Overall Study|Withdrawal by Subject|3
2941411|NCT01371734|10127670|P3|Overall Study|Other|2
2941412|NCT01371734|10127671|P2|Overall Study|Other|1
2941413|NCT01371734|10127672|P1|Overall Study|Other|2
2941414|NCT01371721|10127692|P3|Overall Study|Randomized but not treated|0
2941415|NCT01371721|10127693|P2|Overall Study|Randomized but not treated|0
2941416|NCT01371721|10127694|P1|Overall Study|Randomized but not treated|1
2941417|NCT01371721|10127692|P3|Overall Study|Lack of Efficacy|3
2941418|NCT01371721|10127693|P2|Overall Study|Lack of Efficacy|4
2941419|NCT01371721|10127694|P1|Overall Study|Lack of Efficacy|2
2941420|NCT01371721|10127692|P3|Overall Study|Other|0
2941421|NCT01371721|10127693|P2|Overall Study|Other|3
2941422|NCT01371721|10127694|P1|Overall Study|Other|2
2941423|NCT01371721|10127692|P3|Overall Study|Withdrawal by Subject|11
2941424|NCT01371721|10127693|P2|Overall Study|Withdrawal by Subject|7
2941425|NCT01371721|10127694|P1|Overall Study|Withdrawal by Subject|5
2941426|NCT01371721|10127692|P3|Overall Study|Lost to Follow-up|6
2941427|NCT01371721|10127693|P2|Overall Study|Lost to Follow-up|2
2941428|NCT01371721|10127694|P1|Overall Study|Lost to Follow-up|8
2941429|NCT01371721|10127692|P3|Overall Study|Protocol Violation|5
2941430|NCT01371721|10127693|P2|Overall Study|Protocol Violation|4
2941431|NCT01371721|10127694|P1|Overall Study|Protocol Violation|6
2941432|NCT01371721|10127692|P3|Overall Study|Adverse Event|5
2941433|NCT01371721|10127693|P2|Overall Study|Adverse Event|4
2941434|NCT01371721|10127694|P1|Overall Study|Adverse Event|5
2941435|NCT01371708|10127727|P3|Overall Study|Started but did not receive treatment|1
2941436|NCT01371708|10127728|P2|Overall Study|Started but did not receive treatment|0
2941437|NCT01371708|10127729|P1|Overall Study|Started but did not receive treatment|1
2941438|NCT01371708|10127727|P3|Overall Study|Adverse Event|12
2941439|NCT01371708|10127728|P2|Overall Study|Adverse Event|8
2941440|NCT01371708|10127729|P1|Overall Study|Adverse Event|5
2941441|NCT01371708|10127727|P3|Overall Study|Other|4
2941442|NCT01371708|10127728|P2|Overall Study|Other|2
2941443|NCT01371708|10127729|P1|Overall Study|Other|3
2941444|NCT01371708|10127727|P3|Overall Study|Medication error/not related to AE|0
2941445|NCT01371708|10127728|P2|Overall Study|Medication error/not related to AE|1
2941446|NCT01371708|10127729|P1|Overall Study|Medication error/not related to AE|0
2941447|NCT01371708|10127727|P3|Overall Study|No longer willing to participate|13
2941448|NCT01371708|10127728|P2|Overall Study|No longer willing to participate|7
2941449|NCT01371708|10127729|P1|Overall Study|No longer willing to participate|7
2941450|NCT01371708|10127727|P3|Overall Study|Protocol Violation|2
2941451|NCT01371708|10127728|P2|Overall Study|Protocol Violation|1
2941452|NCT01371708|10127729|P1|Overall Study|Protocol Violation|2
2941453|NCT01371708|10127727|P3|Overall Study|Lost to Follow-up|7
2941454|NCT01371708|10127728|P2|Overall Study|Lost to Follow-up|9
2941455|NCT01371708|10127729|P1|Overall Study|Lost to Follow-up|5
2941456|NCT01371708|10127727|P3|Overall Study|Insufficient clinical response|0
2941457|NCT01371708|10127728|P2|Overall Study|Insufficient clinical response|2
2941458|NCT01371708|10127729|P1|Overall Study|Insufficient clinical response|3
2941459|NCT01371656|10127761|P2|Overall Study|Ineligible|3
2941460|NCT01371656|10127762|P1|Overall Study|Ineligible|4
2941461|NCT01371656|10127761|P2|Overall Study|Withdrawal by Subject|0
2941462|NCT01371656|10127762|P1|Overall Study|Withdrawal by Subject|7
2941463|NCT01371656|10127761|P2|Overall Study|Physician Decision|7
2941464|NCT01371656|10127762|P1|Overall Study|Physician Decision|46
2941465|NCT01371656|10127761|P2|Overall Study|Death|4
2941466|NCT01371656|10127762|P1|Overall Study|Death|7
2941467|NCT01371643|10127782|P2|Overall Study|Withdrawal by Subject|0
2941468|NCT01371643|10127783|P1|Overall Study|Withdrawal by Subject|3
2941469|NCT01371565|10127793|P1|Overall Study|Resection of neuroendocrine tumor|1
2941470|NCT01371565|10127793|P1|Overall Study|Death|1
2941471|NCT01371565|10127793|P1|Overall Study|Withdrawal by Subject|1
2941472|NCT01371552|10127797|P6|Part 1, First 3 Days|Inconvenience|0
2941473|NCT01371552|10127798|P5|Part 1, First 3 Days|Inconvenience|0
2941474|NCT01371552|10127799|P4|Part 1, First 3 Days|Inconvenience|0
2941475|NCT01371552|10127800|P3|Part 1, First 3 Days|Inconvenience|1
2941476|NCT01371552|10127801|P2|Part 1, First 3 Days|Inconvenience|0
2941477|NCT01371552|10127802|P1|Part 1, First 3 Days|Inconvenience|0
2941478|NCT01371539|10127829|P2|Period Two: One Week|Time/job conflict|1
2941479|NCT01371539|10127830|P1|Period Two: One Week|Time/job conflict|0
2941480|NCT01371539|10127829|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
2941481|NCT01371539|10127830|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
2941482|NCT01371539|10127829|P2|Period Two: One Week|Lost to Follow-up|1
2941483|NCT01371539|10127830|P1|Period Two: One Week|Lost to Follow-up|0
2941484|NCT01371539|10127829|P2|Period One: One Week|Lost to Follow-up|1
2941485|NCT01371539|10127830|P1|Period One: One Week|Lost to Follow-up|0
2941486|NCT01371305|10127844|P6|Overall Study|Subject request|1
2941487|NCT01371305|10127845|P5|Overall Study|Subject request|0
2941488|NCT01371305|10127846|P4|Overall Study|Subject request|0
2941489|NCT01371305|10127847|P3|Overall Study|Subject request|0
2941490|NCT01371305|10127848|P2|Overall Study|Subject request|0
2941491|NCT01371305|10127849|P1|Overall Study|Subject request|0
2941492|NCT01371305|10127844|P6|Overall Study|Study terminated by sponsor|1
2941493|NCT01371305|10127845|P5|Overall Study|Study terminated by sponsor|3
2941494|NCT01371305|10127846|P4|Overall Study|Study terminated by sponsor|0
2941495|NCT01371305|10127847|P3|Overall Study|Study terminated by sponsor|0
2941496|NCT01371305|10127848|P2|Overall Study|Study terminated by sponsor|0
2941497|NCT01371305|10127849|P1|Overall Study|Study terminated by sponsor|0
2941498|NCT01371305|10127844|P6|Overall Study|Adverse Event|0
2941499|NCT01371305|10127845|P5|Overall Study|Adverse Event|1
2941500|NCT01371305|10127846|P4|Overall Study|Adverse Event|2
2941501|NCT01371305|10127847|P3|Overall Study|Adverse Event|0
2941502|NCT01371305|10127848|P2|Overall Study|Adverse Event|0
2941503|NCT01371305|10127849|P1|Overall Study|Adverse Event|0
2941504|NCT01371006|10127933|P2|Overall Study|Adverse Event|0
2941505|NCT01371006|10127934|P1|Overall Study|Adverse Event|1
2941506|NCT01370863|10127975|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2941507|NCT01370863|10127976|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
2941508|NCT01370863|10127975|P2|Overall Study|Did not want second pH/MII monitoring|1
2941509|NCT01370863|10127976|P1|Overall Study|Did not want second pH/MII monitoring|1
2941510|NCT01370863|10127975|P2|Overall Study|Adverse Event|1
2941511|NCT01370863|10127976|P1|Overall Study|Adverse Event|1
2941512|NCT01370733|10128001|P2|Overall Study|Protocol Violation|3
2941513|NCT01370733|10128002|P1|Overall Study|Protocol Violation|1
2941514|NCT01370733|10128001|P2|Overall Study|Physician Decision|2
2941515|NCT01370733|10128002|P1|Overall Study|Physician Decision|0
2941516|NCT01370733|10128001|P2|Overall Study|Lack of Efficacy|5
2941517|NCT01370733|10128002|P1|Overall Study|Lack of Efficacy|3
2941518|NCT01370733|10128001|P2|Overall Study|Adverse Event|4
2941519|NCT01370733|10128002|P1|Overall Study|Adverse Event|2
2941520|NCT01370733|10128001|P2|Overall Study|Lost to Follow-up|0
2941521|NCT01370733|10128002|P1|Overall Study|Lost to Follow-up|3
2941522|NCT01370733|10128001|P2|Overall Study|Withdrawal by Subject|8
2941523|NCT01370733|10128002|P1|Overall Study|Withdrawal by Subject|8
2941524|NCT01370694|10128024|P1|Overall Study|Progressive disease|2
2941525|NCT01370694|10128024|P1|Overall Study|Switched to rituximab|4
2941526|NCT01370655|10128046|P12|Period 2|Withdrawal by Subject|0
2941527|NCT01370655|10128047|P11|Period 2|Withdrawal by Subject|0
2941528|NCT01370655|10128048|P10|Period 2|Withdrawal by Subject|0
2941529|NCT01370655|10128049|P9|Period 2|Withdrawal by Subject|1
2941530|NCT01370655|10128050|P8|Period 2|Withdrawal by Subject|0
2941531|NCT01370655|10128051|P7|Period 2|Withdrawal by Subject|0
2941532|NCT01370655|10128052|P6|Period 2|Withdrawal by Subject|0
2941533|NCT01370655|10128053|P5|Period 2|Withdrawal by Subject|0
2941534|NCT01370655|10128054|P4|Period 2|Withdrawal by Subject|0
2941535|NCT01370655|10128055|P3|Period 2|Withdrawal by Subject|0
2941536|NCT01370655|10128056|P2|Period 2|Withdrawal by Subject|0
2941537|NCT01370655|10128057|P1|Period 2|Withdrawal by Subject|0
2941538|NCT01370655|10128046|P12|Period 2|met protocol specified stopping criteria|0
2941539|NCT01370655|10128047|P11|Period 2|met protocol specified stopping criteria|1
2941540|NCT01370655|10128048|P10|Period 2|met protocol specified stopping criteria|0
2941541|NCT01370655|10128049|P9|Period 2|met protocol specified stopping criteria|1
2941542|NCT01370655|10128050|P8|Period 2|met protocol specified stopping criteria|0
2941543|NCT01370655|10128051|P7|Period 2|met protocol specified stopping criteria|1
2941544|NCT01370655|10128052|P6|Period 2|met protocol specified stopping criteria|0
2941545|NCT01370655|10128053|P5|Period 2|met protocol specified stopping criteria|0
2941546|NCT01370655|10128054|P4|Period 2|met protocol specified stopping criteria|0
2941547|NCT01370655|10128055|P3|Period 2|met protocol specified stopping criteria|1
2941548|NCT01370655|10128056|P2|Period 2|met protocol specified stopping criteria|0
2941549|NCT01370655|10128057|P1|Period 2|met protocol specified stopping criteria|0
2941550|NCT01370655|10128046|P12|Period 2|Adverse Event|0
2941551|NCT01370655|10128047|P11|Period 2|Adverse Event|0
2941552|NCT01370655|10128048|P10|Period 2|Adverse Event|0
2941553|NCT01370655|10128049|P9|Period 2|Adverse Event|0
2941554|NCT01370655|10128050|P8|Period 2|Adverse Event|1
2941555|NCT01370655|10128051|P7|Period 2|Adverse Event|0
2941556|NCT01370655|10128052|P6|Period 2|Adverse Event|0
2941557|NCT01370655|10128053|P5|Period 2|Adverse Event|1
2941558|NCT01370655|10128054|P4|Period 2|Adverse Event|0
2941559|NCT01370655|10128055|P3|Period 2|Adverse Event|1
2941560|NCT01370655|10128056|P2|Period 2|Adverse Event|0
2941561|NCT01370655|10128057|P1|Period 2|Adverse Event|0
2941562|NCT01370655|10128046|P12|Period 1|Adverse Event|0
2941563|NCT01370655|10128047|P11|Period 1|Adverse Event|0
2941564|NCT01370655|10128048|P10|Period 1|Adverse Event|0
2941565|NCT01370655|10128049|P9|Period 1|Adverse Event|0
2941566|NCT01370655|10128050|P8|Period 1|Adverse Event|0
2941567|NCT01370655|10128051|P7|Period 1|Adverse Event|1
2941568|NCT01370655|10128052|P6|Period 1|Adverse Event|0
2941569|NCT01370655|10128053|P5|Period 1|Adverse Event|0
2941570|NCT01370655|10128054|P4|Period 1|Adverse Event|0
2941571|NCT01370655|10128055|P3|Period 1|Adverse Event|0
2941572|NCT01370655|10128056|P2|Period 1|Adverse Event|0
2941573|NCT01370655|10128057|P1|Period 1|Adverse Event|2
2941574|NCT01370642|10128094|P3|Overall Study|Withdrawal by Subject|3
2941575|NCT01370642|10128095|P2|Overall Study|Withdrawal by Subject|4
2941576|NCT01370642|10128096|P1|Overall Study|Withdrawal by Subject|2
2941577|NCT01370642|10128094|P3|Overall Study|Physician Decision|2
2941578|NCT01370642|10128095|P2|Overall Study|Physician Decision|1
2941579|NCT01370642|10128096|P1|Overall Study|Physician Decision|4
2941580|NCT01370642|10128094|P3|Overall Study|Lost to Follow-up|1
2941581|NCT01370642|10128095|P2|Overall Study|Lost to Follow-up|0
2941582|NCT01370642|10128096|P1|Overall Study|Lost to Follow-up|0
2941583|NCT01370642|10128094|P3|Overall Study|Detectable HCV RNA|22
2941584|NCT01370642|10128095|P2|Overall Study|Detectable HCV RNA|0
2941585|NCT01370642|10128096|P1|Overall Study|Detectable HCV RNA|0
2941586|NCT01370642|10128094|P3|Overall Study|Adverse Event|1
2941587|NCT01370642|10128095|P2|Overall Study|Adverse Event|1
2941588|NCT01370642|10128096|P1|Overall Study|Adverse Event|2
2941589|NCT01370616|10128135|P2|Overall Study|Withdrawal by Subject|34
2941590|NCT01370616|10128136|P1|Overall Study|Withdrawal by Subject|34
2941591|NCT01370616|10128135|P2|Overall Study|Technical Problems|5
2941592|NCT01370616|10128136|P1|Overall Study|Technical Problems|3
2941593|NCT01370616|10128135|P2|Overall Study|Recovery|0
2941594|NCT01370616|10128136|P1|Overall Study|Recovery|1
2941595|NCT01370616|10128135|P2|Overall Study|Progressive Disease|1
2941596|NCT01370616|10128136|P1|Overall Study|Progressive Disease|0
2941597|NCT01370616|10128135|P2|Overall Study|Physician Decision|6
2941598|NCT01370616|10128136|P1|Overall Study|Physician Decision|6
2941599|NCT01370616|10128135|P2|Overall Study|Lost to Follow-up|3
2941600|NCT01370616|10128136|P1|Overall Study|Lost to Follow-up|0
2941601|NCT01370616|10128135|P2|Overall Study|Lack of Efficacy|2
2941602|NCT01370616|10128136|P1|Overall Study|Lack of Efficacy|6
2941603|NCT01370616|10128135|P2|Overall Study|Death|0
2941604|NCT01370616|10128136|P1|Overall Study|Death|1
2941605|NCT01370616|10128135|P2|Overall Study|Adverse Event|16
2941606|NCT01370616|10128136|P1|Overall Study|Adverse Event|11
2941607|NCT01370603|10128160|P2|Period 2|Withdrawal by Subject|0
2941608|NCT01370603|10128161|P1|Period 2|Withdrawal by Subject|1
2941609|NCT01370603|10128160|P2|Period 2|Lost to Follow-up|0
2941610|NCT01370603|10128161|P1|Period 2|Lost to Follow-up|1
2941611|NCT01370603|10128160|P2|Period 2|Adverse Event|4
2941612|NCT01370603|10128161|P1|Period 2|Adverse Event|1
2941613|NCT01370603|10128160|P2|Crossover Washout|Non-compliance with Study Drug|2
2941614|NCT01370603|10128161|P1|Crossover Washout|Non-compliance with Study Drug|0
2941615|NCT01370603|10128160|P2|Crossover Washout|Withdrawal by Subject|1
2941616|NCT01370603|10128161|P1|Crossover Washout|Withdrawal by Subject|4
2941617|NCT01370603|10128160|P2|Crossover Washout|Protocol Violation|0
2941618|NCT01370603|10128161|P1|Crossover Washout|Protocol Violation|1
2941619|NCT01370603|10128160|P2|Crossover Washout|Lost to Follow-up|0
2941620|NCT01370603|10128161|P1|Crossover Washout|Lost to Follow-up|2
2941621|NCT01370603|10128160|P2|Crossover Washout|Adverse Event|1
2941622|NCT01370603|10128161|P1|Crossover Washout|Adverse Event|2
2941623|NCT01370603|10128160|P2|Period 1|Withdrawal by Subject|5
2941624|NCT01370603|10128161|P1|Period 1|Withdrawal by Subject|5
2941625|NCT01370603|10128160|P2|Period 1|Protocol Violation|2
2941626|NCT01370603|10128161|P1|Period 1|Protocol Violation|2
2941627|NCT01370603|10128160|P2|Period 1|Lost to Follow-up|0
2941628|NCT01370603|10128161|P1|Period 1|Lost to Follow-up|2
2941629|NCT01370603|10128160|P2|Period 1|Adverse Event|3
2941630|NCT01370603|10128161|P1|Period 1|Adverse Event|5
2941631|NCT01370590|10128179|P2|Period 2|Withdrawal by Subject|1
2941632|NCT01370590|10128180|P1|Period 2|Withdrawal by Subject|1
2941633|NCT01370590|10128179|P2|Period 2|Adverse Event|1
2941634|NCT01370590|10128180|P1|Period 2|Adverse Event|0
2941635|NCT01370590|10128179|P2|Crossover Washout Period|Withdrawal by Subject|2
2941636|NCT01370590|10128180|P1|Crossover Washout Period|Withdrawal by Subject|2
2941637|NCT01370590|10128179|P2|Crossover Washout Period|Non-compliance with Study Drug|0
2941638|NCT01370590|10128180|P1|Crossover Washout Period|Non-compliance with Study Drug|1
2941639|NCT01370590|10128179|P2|Crossover Washout Period|Lost to Follow-up|0
2941640|NCT01370590|10128180|P1|Crossover Washout Period|Lost to Follow-up|2
2941641|NCT01370590|10128179|P2|Crossover Washout Period|Adverse Event|4
2941642|NCT01370590|10128180|P1|Crossover Washout Period|Adverse Event|1
2941643|NCT01370590|10128179|P2|Period 1|Could not access randomization system|1
2941644|NCT01370590|10128180|P1|Period 1|Could not access randomization system|0
2941645|NCT01370590|10128179|P2|Period 1|Withdrawal by Subject|2
2941646|NCT01370590|10128180|P1|Period 1|Withdrawal by Subject|4
2941647|NCT01370590|10128179|P2|Period 1|Protocol Violation|2
2941648|NCT01370590|10128180|P1|Period 1|Protocol Violation|2
2941649|NCT01370590|10128179|P2|Period 1|Lost to Follow-up|2
2941650|NCT01370590|10128180|P1|Period 1|Lost to Follow-up|2
2941651|NCT01370590|10128179|P2|Period 1|Adverse Event|4
2941652|NCT01370590|10128180|P1|Period 1|Adverse Event|8
2941653|NCT01370538|10128208|P2|Overall Study|Lost to follow up|10
2941654|NCT01370538|10128209|P1|Overall Study|Lost to follow up|6
2941655|NCT01370538|10128208|P2|Overall Study|Development of study specific withdrawal|1
2941656|NCT01370538|10128209|P1|Overall Study|Development of study specific withdrawal|1
2941657|NCT01370538|10128208|P2|Overall Study|Protocol Violation|5
2941658|NCT01370538|10128209|P1|Overall Study|Protocol Violation|8
2941659|NCT01370538|10128208|P2|Overall Study|Adverse Event|0
2941660|NCT01370538|10128209|P1|Overall Study|Adverse Event|1
2941661|NCT01370538|10128208|P2|Overall Study|Eligibility criteria not fulfilled|1
2941662|NCT01370538|10128209|P1|Overall Study|Eligibility criteria not fulfilled|0
2941663|NCT01370538|10128208|P2|Overall Study|Voluntary Discontinuation by Subject|2
2941664|NCT01370538|10128209|P1|Overall Study|Voluntary Discontinuation by Subject|3
2941665|NCT01370525|10128225|P2|Overall Study|Lost to follow up|6
2941666|NCT01370525|10128226|P1|Overall Study|Lost to follow up|2
2941667|NCT01370525|10128225|P2|Overall Study|Protocol Violation|1
2941668|NCT01370525|10128226|P1|Overall Study|Protocol Violation|2
2941669|NCT01370525|10128225|P2|Overall Study|Adverse Event|1
2941670|NCT01370525|10128226|P1|Overall Study|Adverse Event|0
2941671|NCT01370525|10128225|P2|Overall Study|Eligibility criteria not fulfilled|0
2941672|NCT01370525|10128226|P1|Overall Study|Eligibility criteria not fulfilled|2
2941673|NCT01370525|10128225|P2|Overall Study|Voluntary Discontinuation by Subject|3
2941674|NCT01370525|10128226|P1|Overall Study|Voluntary Discontinuation by Subject|2
2941675|NCT01370499|10128242|P2|Overall Study|Sponsor Decision|15
2941676|NCT01370499|10128243|P1|Overall Study|Sponsor Decision|41
2941677|NCT01370499|10128242|P2|Overall Study|Withdrawal by Subject|7
2941678|NCT01370499|10128243|P1|Overall Study|Withdrawal by Subject|18
2941679|NCT01370499|10128242|P2|Overall Study|Protocol Violation|4
2941680|NCT01370499|10128243|P1|Overall Study|Protocol Violation|5
2941681|NCT01370499|10128242|P2|Overall Study|Physician Decision|3
2941682|NCT01370499|10128243|P1|Overall Study|Physician Decision|3
2941683|NCT01370499|10128242|P2|Overall Study|Lost to Follow-up|1
2941684|NCT01370499|10128243|P1|Overall Study|Lost to Follow-up|2
2941685|NCT01370499|10128242|P2|Overall Study|Lack of Efficacy|2
2941686|NCT01370499|10128243|P1|Overall Study|Lack of Efficacy|4
2941687|NCT01370499|10128242|P2|Overall Study|Adverse Event|12
2941688|NCT01370499|10128243|P1|Overall Study|Adverse Event|38
2941689|NCT01370408|10128285|P1|Overall Study|treatment failure|9
2941690|NCT01370356|10128345|P2|Overall Study|AE Not Related to Study Drug|4
2941691|NCT01370356|10128346|P1|Overall Study|AE Not Related to Study Drug|1
2941692|NCT01370356|10128345|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
2941693|NCT01370356|10128346|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
2941694|NCT01370356|10128345|P2|Overall Study|Protocol Violation|3
2941695|NCT01370356|10128346|P1|Overall Study|Protocol Violation|3
2941696|NCT01370356|10128345|P2|Overall Study|Reason not specified|43
2941697|NCT01370356|10128346|P1|Overall Study|Reason not specified|39
2941698|NCT01370356|10128345|P2|Overall Study|Withdrawal by Subject|59
2941699|NCT01370356|10128346|P1|Overall Study|Withdrawal by Subject|54
2941700|NCT01370356|10128345|P2|Overall Study|Lost to Follow-up|81
2941701|NCT01370356|10128346|P1|Overall Study|Lost to Follow-up|76
2941702|NCT01370356|10128345|P2|Overall Study|Lack of Efficacy|28
2941703|NCT01370356|10128346|P1|Overall Study|Lack of Efficacy|6
2941704|NCT01370356|10128345|P2|Overall Study|Death|0
2941705|NCT01370356|10128346|P1|Overall Study|Death|1
2941706|NCT01370317|10128362|P2|Overall Study|Protocol deviation|1
2941707|NCT01370317|10128363|P1|Overall Study|Protocol deviation|0
2941708|NCT01370317|10128362|P2|Overall Study|Participant withdrew consent|0
2941709|NCT01370317|10128363|P1|Overall Study|Participant withdrew consent|1
2941710|NCT01370265|10128374|P2|First Intervention|Adverse Event|1
2941711|NCT01370265|10128375|P1|First Intervention|Adverse Event|1
2941712|NCT01370213|10128395|P3|Overall Study|Not evaluable|0
2941713|NCT01370213|10128396|P2|Overall Study|Not evaluable|2
2941714|NCT01370213|10128397|P1|Overall Study|Not evaluable|0
2941715|NCT01370213|10128395|P3|Overall Study|Early Death|0
2941716|NCT01370213|10128396|P2|Overall Study|Early Death|0
2941717|NCT01370213|10128397|P1|Overall Study|Early Death|1
2941718|NCT01370083|10128417|P2|Overall Study|Adverse Event|1
2941719|NCT01370083|10128418|P1|Overall Study|Adverse Event|0
2941720|NCT01370083|10128417|P2|Overall Study|Lost to Follow-up|0
2941721|NCT01370083|10128418|P1|Overall Study|Lost to Follow-up|2
2941722|NCT01370005|10128431|P3|Overall Study|Other reason not defined above|2
2941723|NCT01370005|10128432|P2|Overall Study|Other reason not defined above|0
2941724|NCT01370005|10128433|P1|Overall Study|Other reason not defined above|3
2941725|NCT01370005|10128431|P3|Overall Study|Patient refusal to continue,not due toAE|0
2941726|NCT01370005|10128432|P2|Overall Study|Patient refusal to continue,not due toAE|4
2941727|NCT01370005|10128433|P1|Overall Study|Patient refusal to continue,not due toAE|5
2941728|NCT01370005|10128431|P3|Overall Study|Lost to Follow-up|1
2941729|NCT01370005|10128432|P2|Overall Study|Lost to Follow-up|1
2941730|NCT01370005|10128433|P1|Overall Study|Lost to Follow-up|1
2941731|NCT01370005|10128431|P3|Overall Study|Non compliant with protocol|2
2941732|NCT01370005|10128432|P2|Overall Study|Non compliant with protocol|1
2941733|NCT01370005|10128433|P1|Overall Study|Non compliant with protocol|0
2941734|NCT01370005|10128431|P3|Overall Study|Lack of Efficacy|0
2941735|NCT01370005|10128432|P2|Overall Study|Lack of Efficacy|0
2941736|NCT01370005|10128433|P1|Overall Study|Lack of Efficacy|1
2941737|NCT01370005|10128431|P3|Overall Study|Adverse Event|6
2941738|NCT01370005|10128432|P2|Overall Study|Adverse Event|5
2941739|NCT01370005|10128433|P1|Overall Study|Adverse Event|5
2941740|NCT01370005|10128431|P3|Overall Study|Not treated|0
2941741|NCT01370005|10128432|P2|Overall Study|Not treated|0
2941742|NCT01370005|10128433|P1|Overall Study|Not treated|1
2941743|NCT01369849|10128515|P3|Overall Study|Ineligible after receiving treatment|0
2941744|NCT01369849|10128516|P2|Overall Study|Ineligible after receiving treatment|1
2941745|NCT01369849|10128517|P1|Overall Study|Ineligible after receiving treatment|0
2941746|NCT01369849|10128515|P3|Overall Study|Ineligible prior to treatment|1
2941747|NCT01369849|10128516|P2|Overall Study|Ineligible prior to treatment|0
2941748|NCT01369849|10128517|P1|Overall Study|Ineligible prior to treatment|0
2941749|NCT01369784|10128539|P1|Overall Study|Protocol Violation|12
2941750|NCT01369680|10128627|P4|Overall Study|Lost to Follow-up|2
2941751|NCT01369680|10128628|P3|Overall Study|Lost to Follow-up|1
2941752|NCT01369680|10128629|P2|Overall Study|Lost to Follow-up|0
2941753|NCT01369680|10128630|P1|Overall Study|Lost to Follow-up|0
2941754|NCT01369641|10128651|P1|Overall Study|Withdrawal by Subject|1
2941755|NCT01369615|10128657|P2|Overall Study|Lost to Follow-up|1
2941756|NCT01369615|10128658|P1|Overall Study|Lost to Follow-up|0
2941757|NCT01369615|10128657|P2|Overall Study|Withdrawal by Subject|1
2941758|NCT01369615|10128658|P1|Overall Study|Withdrawal by Subject|0
2941759|NCT01369511|10128668|P4|Overall Study|Withdrawal by Subject|6
2941760|NCT01369511|10128669|P3|Overall Study|Withdrawal by Subject|4
2941761|NCT01369511|10128670|P2|Overall Study|Withdrawal by Subject|6
2941762|NCT01369511|10128671|P1|Overall Study|Withdrawal by Subject|5
2941763|NCT01369511|10128668|P4|Overall Study|Sponsor decision|0
2941764|NCT01369511|10128669|P3|Overall Study|Sponsor decision|1
2941765|NCT01369511|10128670|P2|Overall Study|Sponsor decision|0
2941766|NCT01369511|10128671|P1|Overall Study|Sponsor decision|2
2941767|NCT01369511|10128668|P4|Overall Study|Physician Decision|0
2941768|NCT01369511|10128669|P3|Overall Study|Physician Decision|0
2941769|NCT01369511|10128670|P2|Overall Study|Physician Decision|4
2941770|NCT01369511|10128671|P1|Overall Study|Physician Decision|3
2941771|NCT01369511|10128668|P4|Overall Study|Protocol Violation|2
2941772|NCT01369511|10128669|P3|Overall Study|Protocol Violation|0
2941773|NCT01369511|10128670|P2|Overall Study|Protocol Violation|1
2941774|NCT01369511|10128671|P1|Overall Study|Protocol Violation|0
2941775|NCT01369511|10128668|P4|Overall Study|Lost to Follow-up|2
2941776|NCT01369511|10128669|P3|Overall Study|Lost to Follow-up|1
2941777|NCT01369511|10128670|P2|Overall Study|Lost to Follow-up|1
2941778|NCT01369511|10128671|P1|Overall Study|Lost to Follow-up|0
2941779|NCT01369511|10128668|P4|Overall Study|Entry criteria not met|1
2941780|NCT01369511|10128669|P3|Overall Study|Entry criteria not met|0
2941781|NCT01369511|10128670|P2|Overall Study|Entry criteria not met|0
2941782|NCT01369511|10128671|P1|Overall Study|Entry criteria not met|2
2941783|NCT01369511|10128668|P4|Overall Study|Adverse Event|0
2941784|NCT01369511|10128669|P3|Overall Study|Adverse Event|5
2941785|NCT01369511|10128670|P2|Overall Study|Adverse Event|1
2941786|NCT01369511|10128671|P1|Overall Study|Adverse Event|1
2941787|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
2941788|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
2941789|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|Death|1
2941790|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|Death|0
2941791|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
2941792|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
2941793|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
2941794|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
2941795|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
2941796|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
2941797|NCT01369485|10128687|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
2941798|NCT01369485|10128688|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
2941799|NCT01369485|10128687|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
2941800|NCT01369485|10128688|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
2941801|NCT01369485|10128687|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
2941802|NCT01369485|10128688|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
2941803|NCT01369485|10128687|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
2941804|NCT01369485|10128688|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
2941805|NCT01369485|10128687|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
2941806|NCT01369485|10128688|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
2941807|NCT01369355|10128734|P6|Overall Study|Not Treated|0
2941808|NCT01369355|10128735|P5|Overall Study|Not Treated|0
2941809|NCT01369355|10128736|P4|Overall Study|Not Treated|0
2941810|NCT01369355|10128737|P3|Overall Study|Not Treated|1
2941811|NCT01369355|10128738|P2|Overall Study|Not Treated|0
2941812|NCT01369355|10128739|P1|Overall Study|Not Treated|0
2941813|NCT01369355|10128734|P6|Overall Study|Other|0
2941814|NCT01369355|10128735|P5|Overall Study|Other|1
2941815|NCT01369355|10128736|P4|Overall Study|Other|0
2941816|NCT01369355|10128737|P3|Overall Study|Other|0
2941817|NCT01369355|10128738|P2|Overall Study|Other|0
2941818|NCT01369355|10128739|P1|Overall Study|Other|0
2941819|NCT01369355|10128734|P6|Overall Study|Withdrawal by Subject|22
2941820|NCT01369355|10128735|P5|Overall Study|Withdrawal by Subject|8
2941821|NCT01369355|10128736|P4|Overall Study|Withdrawal by Subject|6
2941822|NCT01369355|10128737|P3|Overall Study|Withdrawal by Subject|7
2941823|NCT01369355|10128738|P2|Overall Study|Withdrawal by Subject|2
2941824|NCT01369355|10128739|P1|Overall Study|Withdrawal by Subject|6
2941825|NCT01369355|10128734|P6|Overall Study|Lost to Follow-up|6
2941826|NCT01369355|10128735|P5|Overall Study|Lost to Follow-up|5
2941827|NCT01369355|10128736|P4|Overall Study|Lost to Follow-up|2
2941828|NCT01369355|10128737|P3|Overall Study|Lost to Follow-up|1
2941829|NCT01369355|10128738|P2|Overall Study|Lost to Follow-up|0
2941830|NCT01369355|10128739|P1|Overall Study|Lost to Follow-up|1
2941831|NCT01369355|10128734|P6|Overall Study|Protocol Violation|2
2941832|NCT01369355|10128735|P5|Overall Study|Protocol Violation|0
2941833|NCT01369355|10128736|P4|Overall Study|Protocol Violation|0
2941834|NCT01369355|10128737|P3|Overall Study|Protocol Violation|1
2941835|NCT01369355|10128738|P2|Overall Study|Protocol Violation|1
2941836|NCT01369355|10128739|P1|Overall Study|Protocol Violation|0
2941837|NCT01369355|10128734|P6|Overall Study|Lack of Efficacy|217
2941838|NCT01369355|10128735|P5|Overall Study|Lack of Efficacy|126
2941839|NCT01369355|10128736|P4|Overall Study|Lack of Efficacy|15
2941840|NCT01369355|10128737|P3|Overall Study|Lack of Efficacy|15
2941841|NCT01369355|10128738|P2|Overall Study|Lack of Efficacy|14
2941842|NCT01369355|10128739|P1|Overall Study|Lack of Efficacy|15
2941843|NCT01369355|10128734|P6|Overall Study|Adverse Event|25
2941844|NCT01369355|10128735|P5|Overall Study|Adverse Event|14
2941845|NCT01369355|10128736|P4|Overall Study|Adverse Event|7
2941846|NCT01369355|10128737|P3|Overall Study|Adverse Event|6
2941847|NCT01369355|10128738|P2|Overall Study|Adverse Event|12
2941848|NCT01369355|10128739|P1|Overall Study|Adverse Event|9
2941849|NCT01369342|10128768|P3|Overall Study|Not Treated|0
2941850|NCT01369342|10128769|P2|Overall Study|Not Treated|0
2941851|NCT01369342|10128770|P1|Overall Study|Not Treated|1
2941852|NCT01369342|10128768|P3|Overall Study|Lost to Follow-up|1
2941853|NCT01369342|10128769|P2|Overall Study|Lost to Follow-up|2
2941854|NCT01369342|10128770|P1|Overall Study|Lost to Follow-up|5
2941855|NCT01369342|10128768|P3|Overall Study|Withdrawal by Subject|2
2941856|NCT01369342|10128769|P2|Overall Study|Withdrawal by Subject|7
2941857|NCT01369342|10128770|P1|Overall Study|Withdrawal by Subject|7
2941858|NCT01369329|10128793|P3|Overall Study|Other|2
2941859|NCT01369329|10128794|P2|Overall Study|Other|3
2941860|NCT01369329|10128795|P1|Overall Study|Other|2
2941861|NCT01369329|10128793|P3|Overall Study|Lost to Follow-up|2
2941862|NCT01369329|10128794|P2|Overall Study|Lost to Follow-up|2
2941863|NCT01369329|10128795|P1|Overall Study|Lost to Follow-up|2
2941864|NCT01369329|10128793|P3|Overall Study|Withdrawal by Subject|10
2941865|NCT01369329|10128794|P2|Overall Study|Withdrawal by Subject|6
2941866|NCT01369329|10128795|P1|Overall Study|Withdrawal by Subject|8
2941867|NCT01369225|10128821|P6|Overall Study|Adverse Event|0
2941868|NCT01369225|10128822|P5|Overall Study|Adverse Event|1
2941869|NCT01369225|10128823|P4|Overall Study|Adverse Event|1
2941870|NCT01369225|10128824|P3|Overall Study|Adverse Event|0
2941871|NCT01369225|10128825|P2|Overall Study|Adverse Event|0
2941872|NCT01369225|10128826|P1|Overall Study|Adverse Event|0
2941873|NCT01369225|10128821|P6|Overall Study|Other|0
2941874|NCT01369225|10128822|P5|Overall Study|Other|1
2941875|NCT01369225|10128823|P4|Overall Study|Other|0
2941876|NCT01369225|10128824|P3|Overall Study|Other|0
2941877|NCT01369225|10128825|P2|Overall Study|Other|0
2941878|NCT01369225|10128826|P1|Overall Study|Other|1
2941879|NCT01369225|10128821|P6|Overall Study|Does Not Meet Entrance Criteria|0
2941880|NCT01369225|10128822|P5|Overall Study|Does Not Meet Entrance Criteria|0
2941881|NCT01369225|10128823|P4|Overall Study|Does Not Meet Entrance Criteria|0
2941882|NCT01369225|10128824|P3|Overall Study|Does Not Meet Entrance Criteria|1
2941883|NCT01369225|10128825|P2|Overall Study|Does Not Meet Entrance Criteria|0
2941884|NCT01369225|10128826|P1|Overall Study|Does Not Meet Entrance Criteria|0
2941885|NCT01369225|10128821|P6|Overall Study|Withdrawal by Subject|0
2941886|NCT01369225|10128822|P5|Overall Study|Withdrawal by Subject|0
2941887|NCT01369225|10128823|P4|Overall Study|Withdrawal by Subject|1
2941888|NCT01369225|10128824|P3|Overall Study|Withdrawal by Subject|2
2941889|NCT01369225|10128825|P2|Overall Study|Withdrawal by Subject|0
2941890|NCT01369225|10128826|P1|Overall Study|Withdrawal by Subject|1
2941891|NCT01369199|10128918|P1|Overall Study|Lost to Follow-up|2
2941892|NCT01369199|10128918|P1|Overall Study|Withdrawal by Subject|1
2941893|NCT01369069|10128949|P2|Overall Study|Withdrawal by Subject|7
2941894|NCT01369069|10128950|P1|Overall Study|Withdrawal by Subject|9
2941895|NCT01369069|10128949|P2|Overall Study|Lost to Follow-up|9
2941896|NCT01369069|10128950|P1|Overall Study|Lost to Follow-up|8
2941897|NCT01368965|10128972|P1|Overall Study|Lost to Follow-up|12
2941898|NCT01368900|10128981|P1|Overall Study|Lost to Follow-up|7
2941899|NCT01368835|10129056|P1|Overall Study|Lost to Follow-up|11
2941900|NCT01368835|10129056|P1|Overall Study|Inclusion criteria/photography quality|22
2941901|NCT01368614|10129095|P4|Study Period|Lost to Follow-up|0
2941902|NCT01368614|10129096|P3|Study Period|Lost to Follow-up|1
2941903|NCT01368614|10129097|P2|Study Period|Lost to Follow-up|0
2941904|NCT01368614|10129098|P1|Study Period|Lost to Follow-up|0
2941905|NCT01368614|10129095|P4|Study Period|Withdrawal by Subject|3
2941906|NCT01368614|10129096|P3|Study Period|Withdrawal by Subject|1
2941907|NCT01368614|10129097|P2|Study Period|Withdrawal by Subject|1
2941908|NCT01368614|10129098|P1|Study Period|Withdrawal by Subject|0
2941909|NCT01368614|10129095|P4|Screening Period|Screen Failure|0
2941910|NCT01368614|10129096|P3|Screening Period|Screen Failure|0
2941911|NCT01368614|10129097|P2|Screening Period|Screen Failure|0
2941912|NCT01368614|10129098|P1|Screening Period|Screen Failure|58
2941913|NCT01368562|10129151|P1|Overall Study|Other than specified|2
2941914|NCT01368562|10129151|P1|Overall Study|Other|3
2941915|NCT01368562|10129151|P1|Overall Study|Unresponsive to treatment|5
2941916|NCT01368562|10129151|P1|Overall Study|Death|6
2941917|NCT01368562|10129151|P1|Overall Study|Lost to Follow-up|1
2941918|NCT01368562|10129151|P1|Overall Study|Disease progression|1
2941919|NCT01368562|10129151|P1|Overall Study|Adverse Event|1
2941920|NCT01368536|10129158|P3|Overall Study|Protocol deviation|1
2941921|NCT01368536|10129159|P2|Overall Study|Protocol deviation|3
2941922|NCT01368536|10129160|P1|Overall Study|Protocol deviation|0
2941923|NCT01368536|10129158|P3|Overall Study|Administrative problems|35
2941924|NCT01368536|10129159|P2|Overall Study|Administrative problems|39
2941925|NCT01368536|10129160|P1|Overall Study|Administrative problems|34
2941926|NCT01368536|10129158|P3|Overall Study|Lost to Follow-up|5
2941927|NCT01368536|10129159|P2|Overall Study|Lost to Follow-up|3
2941928|NCT01368536|10129160|P1|Overall Study|Lost to Follow-up|3
2941929|NCT01368536|10129158|P3|Overall Study|Withdrawal by Subject|4
2941930|NCT01368536|10129159|P2|Overall Study|Withdrawal by Subject|5
2941931|NCT01368536|10129160|P1|Overall Study|Withdrawal by Subject|2
2941932|NCT01368536|10129158|P3|Overall Study|No longer required study medication|1
2941933|NCT01368536|10129159|P2|Overall Study|No longer required study medication|0
2941934|NCT01368536|10129160|P1|Overall Study|No longer required study medication|0
2941935|NCT01368536|10129158|P3|Overall Study|Unsatisfactory therapeutic effect|2
2941936|NCT01368536|10129159|P2|Overall Study|Unsatisfactory therapeutic effect|2
2941937|NCT01368536|10129160|P1|Overall Study|Unsatisfactory therapeutic effect|7
2941938|NCT01368536|10129158|P3|Overall Study|Abnormal test procedure result(s)|1
2941939|NCT01368536|10129159|P2|Overall Study|Abnormal test procedure result(s)|0
2941940|NCT01368536|10129160|P1|Overall Study|Abnormal test procedure result(s)|0
2941941|NCT01368536|10129158|P3|Overall Study|Abnormal laboratory value(s)|2
2941942|NCT01368536|10129159|P2|Overall Study|Abnormal laboratory value(s)|1
2941943|NCT01368536|10129160|P1|Overall Study|Abnormal laboratory value(s)|0
2941944|NCT01368536|10129158|P3|Overall Study|Adverse Event|8
2941945|NCT01368536|10129159|P2|Overall Study|Adverse Event|6
2941946|NCT01368536|10129160|P1|Overall Study|Adverse Event|5
2941947|NCT01368497|10129181|P1|Overall Study|Lost to Follow-up|2
2941948|NCT01368432|10129209|P2|Overall Study|Lost to Follow-up|1
2941949|NCT01368432|10129210|P1|Overall Study|Lost to Follow-up|0
2941950|NCT01368406|10129244|P2|Overall Study|started working|3
2941951|NCT01368406|10129245|P1|Overall Study|started working|2
2941952|NCT01368406|10129244|P2|Overall Study|relapse of the disease|2
2941953|NCT01368406|10129245|P1|Overall Study|relapse of the disease|3
2941954|NCT01368406|10129244|P2|Overall Study|Withdrawal by Subject|4
2941955|NCT01368406|10129245|P1|Overall Study|Withdrawal by Subject|8
2941956|NCT01368406|10129244|P2|Overall Study|Lost to Follow-up|4
2941957|NCT01368406|10129245|P1|Overall Study|Lost to Follow-up|8
2941958|NCT01368276|10129253|P2|Overall Study|Death|10
2941959|NCT01368276|10129254|P1|Overall Study|Death|1
2941960|NCT01368211|10129291|P2|Second Platelets Transfusion|No need for additional transfusion|2
2941961|NCT01368211|10129292|P1|Second Platelets Transfusion|No need for additional transfusion|1
2941962|NCT01368081|10129320|P13|Overall Study|Other reason not defined above|3
2941963|NCT01368081|10129321|P12|Overall Study|Other reason not defined above|0
2941964|NCT01368081|10129322|P11|Overall Study|Other reason not defined above|0
2941965|NCT01368081|10129323|P10|Overall Study|Other reason not defined above|1
2941966|NCT01368081|10129324|P9|Overall Study|Other reason not defined above|0
2941967|NCT01368081|10129325|P8|Overall Study|Other reason not defined above|0
2941968|NCT01368081|10129326|P7|Overall Study|Other reason not defined above|2
2941969|NCT01368081|10129327|P6|Overall Study|Other reason not defined above|1
2941970|NCT01368081|10129328|P5|Overall Study|Other reason not defined above|0
2941971|NCT01368081|10129329|P4|Overall Study|Other reason not defined above|1
2941972|NCT01368081|10129330|P3|Overall Study|Other reason not defined above|0
2941973|NCT01368081|10129331|P2|Overall Study|Other reason not defined above|0
2941974|NCT01368081|10129332|P1|Overall Study|Other reason not defined above|2
2941975|NCT01368081|10129320|P13|Overall Study|Withdrawal by Subject|0
2941976|NCT01368081|10129321|P12|Overall Study|Withdrawal by Subject|2
2941977|NCT01368081|10129322|P11|Overall Study|Withdrawal by Subject|3
2941978|NCT01368081|10129323|P10|Overall Study|Withdrawal by Subject|4
2941979|NCT01368081|10129324|P9|Overall Study|Withdrawal by Subject|5
2941980|NCT01368081|10129325|P8|Overall Study|Withdrawal by Subject|2
2941981|NCT01368081|10129326|P7|Overall Study|Withdrawal by Subject|4
2941982|NCT01368081|10129327|P6|Overall Study|Withdrawal by Subject|3
2941983|NCT01368081|10129328|P5|Overall Study|Withdrawal by Subject|0
2941984|NCT01368081|10129329|P4|Overall Study|Withdrawal by Subject|1
2941985|NCT01368081|10129330|P3|Overall Study|Withdrawal by Subject|1
2941986|NCT01368081|10129331|P2|Overall Study|Withdrawal by Subject|4
2941987|NCT01368081|10129332|P1|Overall Study|Withdrawal by Subject|4
2941988|NCT01368081|10129320|P13|Overall Study|Lost to Follow-up|1
2941989|NCT01368081|10129321|P12|Overall Study|Lost to Follow-up|0
2941990|NCT01368081|10129322|P11|Overall Study|Lost to Follow-up|0
2941991|NCT01368081|10129323|P10|Overall Study|Lost to Follow-up|0
2941992|NCT01368081|10129324|P9|Overall Study|Lost to Follow-up|0
2941993|NCT01368081|10129325|P8|Overall Study|Lost to Follow-up|0
2941994|NCT01368081|10129326|P7|Overall Study|Lost to Follow-up|0
2941995|NCT01368081|10129327|P6|Overall Study|Lost to Follow-up|0
2941996|NCT01368081|10129328|P5|Overall Study|Lost to Follow-up|0
2941997|NCT01368081|10129329|P4|Overall Study|Lost to Follow-up|0
2941998|NCT01368081|10129330|P3|Overall Study|Lost to Follow-up|0
2941999|NCT01368081|10129331|P2|Overall Study|Lost to Follow-up|0
2942000|NCT01368081|10129332|P1|Overall Study|Lost to Follow-up|0
2942001|NCT01368081|10129320|P13|Overall Study|Protocol Violation|0
2942002|NCT01368081|10129321|P12|Overall Study|Protocol Violation|0
2942003|NCT01368081|10129322|P11|Overall Study|Protocol Violation|0
2942004|NCT01368081|10129323|P10|Overall Study|Protocol Violation|0
2942005|NCT01368081|10129324|P9|Overall Study|Protocol Violation|0
2942006|NCT01368081|10129325|P8|Overall Study|Protocol Violation|1
2942007|NCT01368081|10129326|P7|Overall Study|Protocol Violation|0
2942008|NCT01368081|10129327|P6|Overall Study|Protocol Violation|1
2942009|NCT01368081|10129328|P5|Overall Study|Protocol Violation|0
2942010|NCT01368081|10129329|P4|Overall Study|Protocol Violation|0
2942011|NCT01368081|10129330|P3|Overall Study|Protocol Violation|0
2942012|NCT01368081|10129331|P2|Overall Study|Protocol Violation|0
2942013|NCT01368081|10129332|P1|Overall Study|Protocol Violation|0
2942014|NCT01368081|10129320|P13|Overall Study|Lack of Efficacy|0
2942015|NCT01368081|10129321|P12|Overall Study|Lack of Efficacy|0
2942016|NCT01368081|10129322|P11|Overall Study|Lack of Efficacy|0
2942017|NCT01368081|10129323|P10|Overall Study|Lack of Efficacy|0
2942018|NCT01368081|10129324|P9|Overall Study|Lack of Efficacy|0
2942019|NCT01368081|10129325|P8|Overall Study|Lack of Efficacy|2
2942020|NCT01368081|10129326|P7|Overall Study|Lack of Efficacy|0
2942021|NCT01368081|10129327|P6|Overall Study|Lack of Efficacy|0
2942022|NCT01368081|10129328|P5|Overall Study|Lack of Efficacy|0
2942023|NCT01368081|10129329|P4|Overall Study|Lack of Efficacy|1
2942024|NCT01368081|10129330|P3|Overall Study|Lack of Efficacy|0
2942025|NCT01368081|10129331|P2|Overall Study|Lack of Efficacy|1
2942026|NCT01368081|10129332|P1|Overall Study|Lack of Efficacy|0
2942027|NCT01368081|10129320|P13|Overall Study|Adverse Event|3
2942028|NCT01368081|10129321|P12|Overall Study|Adverse Event|1
2942029|NCT01368081|10129322|P11|Overall Study|Adverse Event|6
2942030|NCT01368081|10129323|P10|Overall Study|Adverse Event|5
2942031|NCT01368081|10129324|P9|Overall Study|Adverse Event|3
2942032|NCT01368081|10129325|P8|Overall Study|Adverse Event|2
2942033|NCT01368081|10129326|P7|Overall Study|Adverse Event|6
2942034|NCT01368081|10129327|P6|Overall Study|Adverse Event|5
2942035|NCT01368081|10129328|P5|Overall Study|Adverse Event|2
2942036|NCT01368081|10129329|P4|Overall Study|Adverse Event|2
2942037|NCT01368081|10129330|P3|Overall Study|Adverse Event|3
2942038|NCT01368081|10129331|P2|Overall Study|Adverse Event|4
2942039|NCT01368081|10129332|P1|Overall Study|Adverse Event|4
2942040|NCT01368042|10129386|P1|Overall Study|Transplanted|1
2942041|NCT01368042|10129386|P1|Overall Study|Lost to Follow-up|4
2942042|NCT01368042|10129386|P1|Overall Study|Protocol Violation|11
2942043|NCT01368042|10129386|P1|Overall Study|Death|14
2942044|NCT01367886|10129406|P1|Overall Study|Death|1
2942045|NCT01367886|10129406|P1|Overall Study|Lack of Efficacy|2
2942046|NCT01367886|10129406|P1|Overall Study|Lost to Follow-up|4
2942047|NCT01367847|10129456|P2|Overall Study|Withdrawal by Subject|2
2942048|NCT01367847|10129457|P1|Overall Study|Withdrawal by Subject|2
2942049|NCT01367834|10129473|P2|Overall Study|Study was ended.|1
2942050|NCT01367834|10129474|P1|Overall Study|Study was ended.|0
2942051|NCT01367834|10129473|P2|Overall Study|Withdrawal by Subject|2
2942052|NCT01367834|10129474|P1|Overall Study|Withdrawal by Subject|2
2942053|NCT01367704|10129498|P2|Overall Study|Lost to Follow-up|161
2942054|NCT01367704|10129499|P1|Overall Study|Lost to Follow-up|47
2942055|NCT01367665|10129511|P2|Overall Study|Not Done|14
2942056|NCT01367665|10129512|P1|Overall Study|Not Done|118
2942057|NCT01367665|10129511|P2|Overall Study|Lost to Follow-up|22
2942058|NCT01367665|10129512|P1|Overall Study|Lost to Follow-up|222
2942059|NCT01367665|10129511|P2|Overall Study|Death|19
2942060|NCT01367665|10129512|P1|Overall Study|Death|102
2942061|NCT01367457|10129543|P3|Overall Study|Suspected DP/suspected active infection|0
2942062|NCT01367457|10129544|P2|Overall Study|Suspected DP/suspected active infection|0
2942063|NCT01367457|10129545|P1|Overall Study|Suspected DP/suspected active infection|1
2942064|NCT01367457|10129543|P3|Overall Study|Palliative. Overall decline|0
2942065|NCT01367457|10129544|P2|Overall Study|Palliative. Overall decline|0
2942066|NCT01367457|10129545|P1|Overall Study|Palliative. Overall decline|1
2942067|NCT01367457|10129543|P3|Overall Study|Patient's Wish|0
2942068|NCT01367457|10129544|P2|Overall Study|Patient's Wish|0
2942069|NCT01367457|10129545|P1|Overall Study|Patient's Wish|1
2942070|NCT01367457|10129543|P3|Overall Study|CD, Suspected disease progression (DP)|0
2942071|NCT01367457|10129544|P2|Overall Study|CD, Suspected disease progression (DP)|0
2942072|NCT01367457|10129545|P1|Overall Study|CD, Suspected disease progression (DP)|1
2942073|NCT01367457|10129543|P3|Overall Study|Death from septic shock|0
2942074|NCT01367457|10129544|P2|Overall Study|Death from septic shock|0
2942075|NCT01367457|10129545|P1|Overall Study|Death from septic shock|1
2942076|NCT01367457|10129543|P3|Overall Study|Lost to Follow-up|0
2942077|NCT01367457|10129544|P2|Overall Study|Lost to Follow-up|0
2942078|NCT01367457|10129545|P1|Overall Study|Lost to Follow-up|1
2942079|NCT01367457|10129543|P3|Overall Study|Rejection of treatment|0
2942080|NCT01367457|10129544|P2|Overall Study|Rejection of treatment|0
2942081|NCT01367457|10129545|P1|Overall Study|Rejection of treatment|1
2942082|NCT01367457|10129543|P3|Overall Study|Overall decline|0
2942083|NCT01367457|10129544|P2|Overall Study|Overall decline|0
2942084|NCT01367457|10129545|P1|Overall Study|Overall decline|1
2942085|NCT01367457|10129543|P3|Overall Study|Intestinal obstruction with necrosis|0
2942086|NCT01367457|10129544|P2|Overall Study|Intestinal obstruction with necrosis|0
2942087|NCT01367457|10129545|P1|Overall Study|Intestinal obstruction with necrosis|1
2942088|NCT01367457|10129543|P3|Overall Study|No clinical benefit|0
2942089|NCT01367457|10129544|P2|Overall Study|No clinical benefit|0
2942090|NCT01367457|10129545|P1|Overall Study|No clinical benefit|1
2942091|NCT01367457|10129543|P3|Overall Study|Stabilisation + frequent infections|0
2942092|NCT01367457|10129544|P2|Overall Study|Stabilisation + frequent infections|0
2942093|NCT01367457|10129545|P1|Overall Study|Stabilisation + frequent infections|1
2942094|NCT01367457|10129543|P3|Overall Study|Overall status worsens to grade 4|0
2942095|NCT01367457|10129544|P2|Overall Study|Overall status worsens to grade 4|0
2942096|NCT01367457|10129545|P1|Overall Study|Overall status worsens to grade 4|1
2942097|NCT01367457|10129543|P3|Overall Study|Uncontrolled pain|0
2942098|NCT01367457|10129544|P2|Overall Study|Uncontrolled pain|0
2942099|NCT01367457|10129545|P1|Overall Study|Uncontrolled pain|1
2942100|NCT01367457|10129543|P3|Overall Study|CD, associated leukaemia|0
2942101|NCT01367457|10129544|P2|Overall Study|CD, associated leukaemia|0
2942102|NCT01367457|10129545|P1|Overall Study|CD, associated leukaemia|1
2942103|NCT01367457|10129543|P3|Overall Study|Withdrawal by Subject|0
2942104|NCT01367457|10129544|P2|Overall Study|Withdrawal by Subject|0
2942105|NCT01367457|10129545|P1|Overall Study|Withdrawal by Subject|1
2942106|NCT01367457|10129543|P3|Overall Study|Choledocolithiasis and pancreatitis|0
2942107|NCT01367457|10129544|P2|Overall Study|Choledocolithiasis and pancreatitis|0
2942108|NCT01367457|10129545|P1|Overall Study|Choledocolithiasis and pancreatitis|1
2942109|NCT01367457|10129543|P3|Overall Study|low grade toxicities + stable disease|0
2942110|NCT01367457|10129544|P2|Overall Study|low grade toxicities + stable disease|0
2942111|NCT01367457|10129545|P1|Overall Study|low grade toxicities + stable disease|1
2942112|NCT01367457|10129543|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2942113|NCT01367457|10129544|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2942114|NCT01367457|10129545|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
2942115|NCT01367457|10129543|P3|Overall Study|Bleeding from cavernous haemangioma|0
2942116|NCT01367457|10129544|P2|Overall Study|Bleeding from cavernous haemangioma|0
2942117|NCT01367457|10129545|P1|Overall Study|Bleeding from cavernous haemangioma|1
2942118|NCT01367457|10129543|P3|Overall Study|Investigator's opinion, stable disease|0
2942119|NCT01367457|10129544|P2|Overall Study|Investigator's opinion, stable disease|0
2942120|NCT01367457|10129545|P1|Overall Study|Investigator's opinion, stable disease|1
2942121|NCT01367457|10129543|P3|Overall Study|Patient asks for rest + slow progression|0
2942122|NCT01367457|10129544|P2|Overall Study|Patient asks for rest + slow progression|0
2942123|NCT01367457|10129545|P1|Overall Study|Patient asks for rest + slow progression|1
2942124|NCT01367457|10129543|P3|Overall Study|Progression|0
2942125|NCT01367457|10129544|P2|Overall Study|Progression|0
2942126|NCT01367457|10129545|P1|Overall Study|Progression|137
2942127|NCT01367457|10129543|P3|Overall Study|Toxicity|0
2942128|NCT01367457|10129544|P2|Overall Study|Toxicity|0
2942129|NCT01367457|10129545|P1|Overall Study|Toxicity|16
2942130|NCT01367457|10129543|P3|Overall Study|Progression and death|0
2942131|NCT01367457|10129544|P2|Overall Study|Progression and death|0
2942132|NCT01367457|10129545|P1|Overall Study|Progression and death|8
2942133|NCT01367457|10129543|P3|Overall Study|Clinical decline (CD)|0
2942134|NCT01367457|10129544|P2|Overall Study|Clinical decline (CD)|0
2942135|NCT01367457|10129545|P1|Overall Study|Clinical decline (CD)|2
2942136|NCT01367457|10129543|P3|Overall Study|Investigator's decision|0
2942137|NCT01367457|10129544|P2|Overall Study|Investigator's decision|0
2942138|NCT01367457|10129545|P1|Overall Study|Investigator's decision|2
2942139|NCT01367457|10129543|P3|Overall Study|Death|0
2942140|NCT01367457|10129544|P2|Overall Study|Death|0
2942141|NCT01367457|10129545|P1|Overall Study|Death|2
2942142|NCT01367249|10129578|P2|Overall Study|Other|10
2942143|NCT01367249|10129579|P1|Overall Study|Other|3
2942144|NCT01367249|10129578|P2|Overall Study|Withdrawal by Subject|6
2942145|NCT01367249|10129579|P1|Overall Study|Withdrawal by Subject|6
2942146|NCT01367236|10129589|P2|Overall Study|Withdrawal by Subject|1
2942147|NCT01367236|10129590|P1|Overall Study|Withdrawal by Subject|3
2942148|NCT01367158|10129609|P11|Overall Study|Protocol Violation|0
2942149|NCT01367158|10129610|P10|Overall Study|Protocol Violation|0
2942150|NCT01367158|10129611|P9|Overall Study|Protocol Violation|0
2942151|NCT01367158|10129612|P8|Overall Study|Protocol Violation|0
2942152|NCT01367158|10129613|P7|Overall Study|Protocol Violation|0
2942153|NCT01367158|10129614|P6|Overall Study|Protocol Violation|0
2942154|NCT01367158|10129615|P5|Overall Study|Protocol Violation|0
2942155|NCT01367158|10129616|P4|Overall Study|Protocol Violation|0
2942156|NCT01367158|10129617|P3|Overall Study|Protocol Violation|0
2942157|NCT01367158|10129618|P2|Overall Study|Protocol Violation|1
2942158|NCT01367158|10129619|P1|Overall Study|Protocol Violation|0
2942159|NCT01367158|10129609|P11|Overall Study|Lost to Follow-up|1
2942160|NCT01367158|10129610|P10|Overall Study|Lost to Follow-up|0
2942161|NCT01367158|10129611|P9|Overall Study|Lost to Follow-up|0
2942162|NCT01367158|10129612|P8|Overall Study|Lost to Follow-up|1
2942163|NCT01367158|10129613|P7|Overall Study|Lost to Follow-up|0
2942164|NCT01367158|10129614|P6|Overall Study|Lost to Follow-up|2
2942165|NCT01367158|10129615|P5|Overall Study|Lost to Follow-up|0
2942166|NCT01367158|10129616|P4|Overall Study|Lost to Follow-up|1
2942167|NCT01367158|10129617|P3|Overall Study|Lost to Follow-up|0
2942168|NCT01367158|10129618|P2|Overall Study|Lost to Follow-up|0
2942169|NCT01367158|10129619|P1|Overall Study|Lost to Follow-up|0
2942170|NCT01367158|10129609|P11|Overall Study|Withdrew consent|0
2942171|NCT01367158|10129610|P10|Overall Study|Withdrew consent|0
2942172|NCT01367158|10129611|P9|Overall Study|Withdrew consent|0
2942173|NCT01367158|10129612|P8|Overall Study|Withdrew consent|1
2942174|NCT01367158|10129613|P7|Overall Study|Withdrew consent|0
2942175|NCT01367158|10129614|P6|Overall Study|Withdrew consent|0
2942176|NCT01367158|10129615|P5|Overall Study|Withdrew consent|2
2942177|NCT01367158|10129616|P4|Overall Study|Withdrew consent|0
2942178|NCT01367158|10129617|P3|Overall Study|Withdrew consent|1
2942179|NCT01367158|10129618|P2|Overall Study|Withdrew consent|2
2942180|NCT01367158|10129619|P1|Overall Study|Withdrew consent|0
2942181|NCT01367119|10129763|P2|Overall Study|Withdrawal by Subject|1
2942182|NCT01367119|10129764|P1|Overall Study|Withdrawal by Subject|1
2942183|NCT01367119|10129763|P2|Overall Study|Adverse Event|0
2942184|NCT01367119|10129764|P1|Overall Study|Adverse Event|1
2942185|NCT01366846|10129819|P4|Overall Study|Scheduling Conflicts|0
2942186|NCT01366846|10129820|P3|Overall Study|Scheduling Conflicts|1
2942187|NCT01366846|10129821|P2|Overall Study|Scheduling Conflicts|0
2942188|NCT01366846|10129822|P1|Overall Study|Scheduling Conflicts|0
2942189|NCT01366846|10129819|P4|Overall Study|Communication Difficulties|1
2942190|NCT01366846|10129820|P3|Overall Study|Communication Difficulties|0
2942191|NCT01366846|10129821|P2|Overall Study|Communication Difficulties|4
2942192|NCT01366846|10129822|P1|Overall Study|Communication Difficulties|1
2942193|NCT01366846|10129819|P4|Overall Study|Withdrawal by Subject|0
2942194|NCT01366846|10129820|P3|Overall Study|Withdrawal by Subject|0
2942195|NCT01366846|10129821|P2|Overall Study|Withdrawal by Subject|0
2942196|NCT01366846|10129822|P1|Overall Study|Withdrawal by Subject|2
2942197|NCT01366638|10129845|P3|Overall Study|Other|0
2942198|NCT01366638|10129846|P2|Overall Study|Other|0
2942199|NCT01366638|10129847|P1|Overall Study|Other|1
2942200|NCT01366638|10129845|P3|Overall Study|Withdrawal by Subject|6
2942201|NCT01366638|10129846|P2|Overall Study|Withdrawal by Subject|0
2942202|NCT01366638|10129847|P1|Overall Study|Withdrawal by Subject|0
2942203|NCT01366534|10129884|P3|Overall Study|Declined challenged|0
2942204|NCT01366534|10129885|P2|Overall Study|Declined challenged|1
2942205|NCT01366534|10129886|P1|Overall Study|Declined challenged|0
2942206|NCT01366534|10129884|P3|Overall Study|Migrated|0
2942207|NCT01366534|10129885|P2|Overall Study|Migrated|1
2942208|NCT01366534|10129886|P1|Overall Study|Migrated|1
2942209|NCT01366534|10129884|P3|Overall Study|Lost to Follow-up|0
2942210|NCT01366534|10129885|P2|Overall Study|Lost to Follow-up|0
2942211|NCT01366534|10129886|P1|Overall Study|Lost to Follow-up|1
2942212|NCT01366521|10129936|P4|Overall Study|Withdrawal by Subject|0
2942213|NCT01366521|10129937|P3|Overall Study|Withdrawal by Subject|0
2942214|NCT01366521|10129938|P2|Overall Study|Withdrawal by Subject|1
2942215|NCT01366521|10129939|P1|Overall Study|Withdrawal by Subject|0
2942216|NCT01366521|10129936|P4|Overall Study|Physician Decision|0
2942217|NCT01366521|10129937|P3|Overall Study|Physician Decision|1
2942218|NCT01366521|10129938|P2|Overall Study|Physician Decision|0
2942219|NCT01366521|10129939|P1|Overall Study|Physician Decision|0
2942220|NCT01366521|10129936|P4|Overall Study|Protocol Violation|0
2942221|NCT01366521|10129937|P3|Overall Study|Protocol Violation|1
2942222|NCT01366521|10129938|P2|Overall Study|Protocol Violation|0
2942223|NCT01366521|10129939|P1|Overall Study|Protocol Violation|0
2942224|NCT01366521|10129936|P4|Overall Study|Adverse Event|0
2942225|NCT01366521|10129937|P3|Overall Study|Adverse Event|0
2942226|NCT01366521|10129938|P2|Overall Study|Adverse Event|0
2942227|NCT01366521|10129939|P1|Overall Study|Adverse Event|1
2942228|NCT01366443|10130035|P1|Overall Study|Under 18 yo|1
2942229|NCT01366443|10130035|P1|Overall Study|Lost to Follow-up|2
2942230|NCT01366209|10130049|P2|Overall Study|Withdrew consent|3
2942231|NCT01366209|10130050|P1|Overall Study|Withdrew consent|4
2942232|NCT01366209|10130049|P2|Overall Study|Sponsors decision|1
2942233|NCT01366209|10130050|P1|Overall Study|Sponsors decision|0
2942234|NCT01366209|10130049|P2|Overall Study|Physician Decision|0
2942235|NCT01366209|10130050|P1|Overall Study|Physician Decision|1
2942236|NCT01366209|10130049|P2|Overall Study|Lost to Follow-up|1
2942237|NCT01366209|10130050|P1|Overall Study|Lost to Follow-up|2
2942238|NCT01366209|10130049|P2|Overall Study|Lung transplantation|1
2942239|NCT01366209|10130050|P1|Overall Study|Lung transplantation|6
2942240|NCT01366209|10130049|P2|Overall Study|Death|19
2942241|NCT01366209|10130050|P1|Overall Study|Death|12
2942242|NCT01366209|10130049|P2|Overall Study|Withdrawal by Subject|4
2942243|NCT01366209|10130050|P1|Overall Study|Withdrawal by Subject|4
2942244|NCT01366209|10130049|P2|Overall Study|Adverse Event|7
2942245|NCT01366209|10130050|P1|Overall Study|Adverse Event|6
2942246|NCT01366092|10130073|P1|Overall Study|Withdrawal by Subject|1
2942247|NCT01366092|10130073|P1|Overall Study|Physician Decision|1
2942248|NCT01366092|10130073|P1|Overall Study|Progressive cGVHD|2
2942249|NCT01365910|10130082|P1|Overall Study|pt did not get tx, nausea/vomiting|1
2942250|NCT01365910|10130082|P1|Overall Study|other complicating disease|1
2942251|NCT01365910|10130082|P1|Overall Study|Adverse Event|3
2942252|NCT01365910|10130082|P1|Overall Study|disease progression|18
2942253|NCT01365910|10130082|P1|Overall Study|Withdrawal by Subject|7
2942254|NCT01365546|10130218|P1|Overall Study|Study termination|1
2942255|NCT01365546|10130218|P1|Overall Study|Screen failure|9
2942256|NCT01365546|10130218|P1|Overall Study|Withdrawal by Subject|1
2942257|NCT01365507|10130228|P2|Overall Study|Unclassified|4
2942258|NCT01365507|10130229|P1|Overall Study|Unclassified|1
2942259|NCT01365507|10130228|P2|Overall Study|Withdrawal Criteria|5
2942260|NCT01365507|10130229|P1|Overall Study|Withdrawal Criteria|8
2942261|NCT01365494|10130245|P2|Overall Study|Lost to Follow-up|2
2942262|NCT01365494|10130246|P1|Overall Study|Lost to Follow-up|1
2942263|NCT01365494|10130245|P2|Overall Study|Withdrawal by Subject|1
2942264|NCT01365494|10130246|P1|Overall Study|Withdrawal by Subject|0
2942265|NCT01365494|10130245|P2|Overall Study|Adverse Event|0
2942266|NCT01365494|10130246|P1|Overall Study|Adverse Event|1
2942267|NCT01365481|10130262|P4|Overall Study|Unsatisfactory therapeutic effect|0
2942268|NCT01365481|10130263|P3|Overall Study|Unsatisfactory therapeutic effect|1
2942269|NCT01365481|10130264|P2|Overall Study|Unsatisfactory therapeutic effect|0
2942270|NCT01365481|10130265|P1|Overall Study|Unsatisfactory therapeutic effect|0
2942271|NCT01365481|10130262|P4|Overall Study|Protocol deviation|1
2942272|NCT01365481|10130263|P3|Overall Study|Protocol deviation|0
2942273|NCT01365481|10130264|P2|Overall Study|Protocol deviation|1
2942274|NCT01365481|10130265|P1|Overall Study|Protocol deviation|0
2942275|NCT01365481|10130262|P4|Overall Study|Administrative problems|0
2942276|NCT01365481|10130263|P3|Overall Study|Administrative problems|0
2942277|NCT01365481|10130264|P2|Overall Study|Administrative problems|1
2942278|NCT01365481|10130265|P1|Overall Study|Administrative problems|0
2942279|NCT01365481|10130262|P4|Overall Study|Abnormal laboratory value(s)|0
2942280|NCT01365481|10130263|P3|Overall Study|Abnormal laboratory value(s)|0
2942281|NCT01365481|10130264|P2|Overall Study|Abnormal laboratory value(s)|1
2942282|NCT01365481|10130265|P1|Overall Study|Abnormal laboratory value(s)|0
2942283|NCT01365481|10130262|P4|Overall Study|Lost to Follow-up|3
2942284|NCT01365481|10130263|P3|Overall Study|Lost to Follow-up|2
2942285|NCT01365481|10130264|P2|Overall Study|Lost to Follow-up|1
2942286|NCT01365481|10130265|P1|Overall Study|Lost to Follow-up|1
2942287|NCT01365481|10130262|P4|Overall Study|Withdrawal by Subject|1
2942288|NCT01365481|10130263|P3|Overall Study|Withdrawal by Subject|1
2942289|NCT01365481|10130264|P2|Overall Study|Withdrawal by Subject|2
2942290|NCT01365481|10130265|P1|Overall Study|Withdrawal by Subject|0
2942291|NCT01365481|10130262|P4|Overall Study|Adverse Event|2
2942292|NCT01365481|10130263|P3|Overall Study|Adverse Event|0
2942293|NCT01365481|10130264|P2|Overall Study|Adverse Event|9
2942294|NCT01365481|10130265|P1|Overall Study|Adverse Event|6
2942295|NCT01365468|10130285|P2|Overall Study|Lost to Follow-up|0
2942296|NCT01365468|10130286|P1|Overall Study|Lost to Follow-up|2
2942297|NCT01365468|10130285|P2|Overall Study|Disease progression|0
2942298|NCT01365468|10130286|P1|Overall Study|Disease progression|1
2942299|NCT01365468|10130285|P2|Overall Study|Physician Decision|0
2942300|NCT01365468|10130286|P1|Overall Study|Physician Decision|1
2942301|NCT01365455|10130301|P5|Maintenance Period|Subject/guardian decision|1
2942302|NCT01365455|10130302|P4|Maintenance Period|Subject/guardian decision|4
2942303|NCT01365455|10130303|P3|Maintenance Period|Subject/guardian decision|2
2942304|NCT01365455|10130304|P2|Maintenance Period|Subject/guardian decision|6
2942305|NCT01365455|10130305|P1|Maintenance Period|Subject/guardian decision|4
2942306|NCT01365455|10130301|P5|Maintenance Period|Protocol deviation|0
2942307|NCT01365455|10130302|P4|Maintenance Period|Protocol deviation|0
2942308|NCT01365455|10130303|P3|Maintenance Period|Protocol deviation|0
2942309|NCT01365455|10130304|P2|Maintenance Period|Protocol deviation|1
2942310|NCT01365455|10130305|P1|Maintenance Period|Protocol deviation|1
2942311|NCT01365455|10130301|P5|Maintenance Period|Pregnancy|2
2942312|NCT01365455|10130302|P4|Maintenance Period|Pregnancy|0
2942313|NCT01365455|10130303|P3|Maintenance Period|Pregnancy|0
2942314|NCT01365455|10130304|P2|Maintenance Period|Pregnancy|4
2942315|NCT01365455|10130305|P1|Maintenance Period|Pregnancy|0
2942316|NCT01365455|10130301|P5|Maintenance Period|Physician Decision|1
2942317|NCT01365455|10130302|P4|Maintenance Period|Physician Decision|0
2942318|NCT01365455|10130303|P3|Maintenance Period|Physician Decision|0
2942319|NCT01365455|10130304|P2|Maintenance Period|Physician Decision|1
2942320|NCT01365455|10130305|P1|Maintenance Period|Physician Decision|0
2942321|NCT01365455|10130301|P5|Maintenance Period|Non-compliance with study treatment|0
2942322|NCT01365455|10130302|P4|Maintenance Period|Non-compliance with study treatment|1
2942323|NCT01365455|10130303|P3|Maintenance Period|Non-compliance with study treatment|0
2942324|NCT01365455|10130304|P2|Maintenance Period|Non-compliance with study treatment|0
2942325|NCT01365455|10130305|P1|Maintenance Period|Non-compliance with study treatment|0
2942326|NCT01365455|10130301|P5|Maintenance Period|Lost to Follow-up|3
2942327|NCT01365455|10130302|P4|Maintenance Period|Lost to Follow-up|0
2942328|NCT01365455|10130303|P3|Maintenance Period|Lost to Follow-up|0
2942329|NCT01365455|10130304|P2|Maintenance Period|Lost to Follow-up|4
2942330|NCT01365455|10130305|P1|Maintenance Period|Lost to Follow-up|2
2942331|NCT01365455|10130301|P5|Maintenance Period|Lack of Efficacy|2
2942332|NCT01365455|10130302|P4|Maintenance Period|Lack of Efficacy|2
2942333|NCT01365455|10130303|P3|Maintenance Period|Lack of Efficacy|0
2942334|NCT01365455|10130304|P2|Maintenance Period|Lack of Efficacy|2
2942335|NCT01365455|10130305|P1|Maintenance Period|Lack of Efficacy|10
2942336|NCT01365455|10130301|P5|Maintenance Period|Adverse Event|4
2942337|NCT01365455|10130302|P4|Maintenance Period|Adverse Event|2
2942338|NCT01365455|10130303|P3|Maintenance Period|Adverse Event|1
2942339|NCT01365455|10130304|P2|Maintenance Period|Adverse Event|5
2942340|NCT01365455|10130305|P1|Maintenance Period|Adverse Event|12
2942341|NCT01365455|10130301|P5|Induction Period|Lost to Follow-up|0
2942342|NCT01365455|10130302|P4|Induction Period|Lost to Follow-up|0
2942343|NCT01365455|10130303|P3|Induction Period|Lost to Follow-up|3
2942344|NCT01365455|10130304|P2|Induction Period|Lost to Follow-up|0
2942345|NCT01365455|10130305|P1|Induction Period|Lost to Follow-up|0
2942346|NCT01365455|10130301|P5|Induction Period|Subject/guardian decision|0
2942347|NCT01365455|10130302|P4|Induction Period|Subject/guardian decision|0
2942348|NCT01365455|10130303|P3|Induction Period|Subject/guardian decision|8
2942349|NCT01365455|10130304|P2|Induction Period|Subject/guardian decision|1
2942350|NCT01365455|10130305|P1|Induction Period|Subject/guardian decision|9
2942351|NCT01365455|10130301|P5|Induction Period|Protocol deviation|0
2942352|NCT01365455|10130302|P4|Induction Period|Protocol deviation|0
2942353|NCT01365455|10130303|P3|Induction Period|Protocol deviation|1
2942354|NCT01365455|10130304|P2|Induction Period|Protocol deviation|1
2942355|NCT01365455|10130305|P1|Induction Period|Protocol deviation|0
2942356|NCT01365455|10130301|P5|Induction Period|Pregnancy|0
2942357|NCT01365455|10130302|P4|Induction Period|Pregnancy|0
2942358|NCT01365455|10130303|P3|Induction Period|Pregnancy|0
2942359|NCT01365455|10130304|P2|Induction Period|Pregnancy|1
2942360|NCT01365455|10130305|P1|Induction Period|Pregnancy|0
2942361|NCT01365455|10130301|P5|Induction Period|Lack of Efficacy|0
2942362|NCT01365455|10130302|P4|Induction Period|Lack of Efficacy|0
2942363|NCT01365455|10130303|P3|Induction Period|Lack of Efficacy|0
2942364|NCT01365455|10130304|P2|Induction Period|Lack of Efficacy|1
2942365|NCT01365455|10130305|P1|Induction Period|Lack of Efficacy|1
2942366|NCT01365455|10130301|P5|Induction Period|Adverse Event|0
2942367|NCT01365455|10130302|P4|Induction Period|Adverse Event|0
2942368|NCT01365455|10130303|P3|Induction Period|Adverse Event|4
2942369|NCT01365455|10130304|P2|Induction Period|Adverse Event|3
2942370|NCT01365455|10130305|P1|Induction Period|Adverse Event|5
2942371|NCT01365273|10130395|P2|Overall Study|Physician Decision|0
2942372|NCT01365273|10130396|P1|Overall Study|Physician Decision|1
2942373|NCT01365273|10130395|P2|Overall Study|Protocol Violation|1
2942374|NCT01365273|10130396|P1|Overall Study|Protocol Violation|0
2942375|NCT01365273|10130395|P2|Overall Study|Lost to Follow-up|0
2942376|NCT01365273|10130396|P1|Overall Study|Lost to Follow-up|1
2942377|NCT01365130|10130406|P1|Overall Study|Progression/worsening of Dx prior to txt|2
2942378|NCT01365091|10130415|P4|Period 2|Adverse Event|0
2942379|NCT01365091|10130416|P3|Period 2|Adverse Event|1
2942380|NCT01365091|10130417|P2|Period 2|Adverse Event|0
2942381|NCT01365091|10130418|P1|Period 2|Adverse Event|0
2942382|NCT01365091|10130415|P4|Period 2|Withdrawal by Subject|0
2942383|NCT01365091|10130416|P3|Period 2|Withdrawal by Subject|0
2942384|NCT01365091|10130417|P2|Period 2|Withdrawal by Subject|0
2942385|NCT01365091|10130418|P1|Period 2|Withdrawal by Subject|1
2942386|NCT01365091|10130415|P4|Period 1|Personal reasons|0
2942387|NCT01365091|10130416|P3|Period 1|Personal reasons|1
2942388|NCT01365091|10130417|P2|Period 1|Personal reasons|0
2942389|NCT01365091|10130418|P1|Period 1|Personal reasons|0
2942390|NCT01365091|10130415|P4|Period 1|Withdrawal by Subject|0
2942391|NCT01365091|10130416|P3|Period 1|Withdrawal by Subject|0
2942392|NCT01365091|10130417|P2|Period 1|Withdrawal by Subject|1
2942393|NCT01365091|10130418|P1|Period 1|Withdrawal by Subject|0
2942394|NCT01365091|10130415|P4|Period 1|No longer met study criteria|0
2942395|NCT01365091|10130416|P3|Period 1|No longer met study criteria|0
2942396|NCT01365091|10130417|P2|Period 1|No longer met study criteria|1
2942397|NCT01365091|10130418|P1|Period 1|No longer met study criteria|0
2942398|NCT01365091|10130415|P4|Period 1|Positive test result for drugs of abuse|0
2942399|NCT01365091|10130416|P3|Period 1|Positive test result for drugs of abuse|0
2942400|NCT01365091|10130417|P2|Period 1|Positive test result for drugs of abuse|0
2942401|NCT01365091|10130418|P1|Period 1|Positive test result for drugs of abuse|1
2942402|NCT01365091|10130415|P4|Period 1|Adverse Event|3
2942403|NCT01365091|10130416|P3|Period 1|Adverse Event|2
2942404|NCT01365091|10130417|P2|Period 1|Adverse Event|0
2942405|NCT01365091|10130418|P1|Period 1|Adverse Event|1
2942406|NCT01365052|10130446|P2|Overall Study|Adverse Event|4
2942407|NCT01365052|10130447|P1|Overall Study|Adverse Event|4
2942408|NCT01365039|10130463|P2|Overall Study|Study related symptoms and complaints|0
2942409|NCT01365039|10130464|P1|Overall Study|Study related symptoms and complaints|1
2942410|NCT01364922|10130475|P3|Double-Blind (DB) Period|Other, Unspecified|0
2942411|NCT01364922|10130476|P2|Double-Blind (DB) Period|Other, Unspecified|1
2942412|NCT01364922|10130477|P1|Double-Blind (DB) Period|Other, Unspecified|0
2942413|NCT01364922|10130475|P3|Double-Blind (DB) Period|Adverse Event|1
2942414|NCT01364922|10130476|P2|Double-Blind (DB) Period|Adverse Event|0
2942415|NCT01364922|10130477|P1|Double-Blind (DB) Period|Adverse Event|0
2942416|NCT01364922|10130475|P3|Double-Blind (DB) Period|Subject Noncompliant|0
2942417|NCT01364922|10130476|P2|Double-Blind (DB) Period|Subject Noncompliant|1
2942418|NCT01364922|10130477|P1|Double-Blind (DB) Period|Subject Noncompliant|0
2942419|NCT01364922|10130475|P3|Double-Blind (DB) Period|Lack of Efficacy|4
2942420|NCT01364922|10130476|P2|Double-Blind (DB) Period|Lack of Efficacy|3
2942421|NCT01364922|10130477|P1|Double-Blind (DB) Period|Lack of Efficacy|0
2942422|NCT01364922|10130475|P3|Open-label (OL) Period|Other, Unspecified|0
2942423|NCT01364922|10130476|P2|Open-label (OL) Period|Other, Unspecified|0
2942424|NCT01364922|10130477|P1|Open-label (OL) Period|Other, Unspecified|1
2942425|NCT01364922|10130475|P3|Open-label (OL) Period|Lost to Follow-up|0
2942426|NCT01364922|10130476|P2|Open-label (OL) Period|Lost to Follow-up|0
2942427|NCT01364922|10130477|P1|Open-label (OL) Period|Lost to Follow-up|1
2942428|NCT01364922|10130475|P3|Open-label (OL) Period|Lack of Efficacy|0
2942429|NCT01364922|10130476|P2|Open-label (OL) Period|Lack of Efficacy|0
2942430|NCT01364922|10130477|P1|Open-label (OL) Period|Lack of Efficacy|3
2942431|NCT01364922|10130475|P3|Open-label (OL) Period|Withdrawal by Subject|0
2942432|NCT01364922|10130476|P2|Open-label (OL) Period|Withdrawal by Subject|0
2942433|NCT01364922|10130477|P1|Open-label (OL) Period|Withdrawal by Subject|4
2942434|NCT01364922|10130475|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2942435|NCT01364922|10130476|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2942436|NCT01364922|10130477|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
2942437|NCT01364922|10130475|P3|Open-label (OL) Period|Adverse Event|0
2942438|NCT01364922|10130476|P2|Open-label (OL) Period|Adverse Event|0
2942439|NCT01364922|10130477|P1|Open-label (OL) Period|Adverse Event|7
2942440|NCT01364870|10130499|P3|Overall Study|Protocol Violation|0
2942441|NCT01364870|10130500|P2|Overall Study|Protocol Violation|0
2942442|NCT01364870|10130501|P1|Overall Study|Protocol Violation|1
2942443|NCT01364870|10130499|P3|Overall Study|Adverse Event|4
2942444|NCT01364870|10130500|P2|Overall Study|Adverse Event|6
2942445|NCT01364870|10130501|P1|Overall Study|Adverse Event|8
2942446|NCT01364870|10130499|P3|Overall Study|Withdrawal by Subject|10
2942447|NCT01364870|10130500|P2|Overall Study|Withdrawal by Subject|24
2942448|NCT01364870|10130501|P1|Overall Study|Withdrawal by Subject|13
2942449|NCT01364727|10130520|P1|Overall Study|Not Eligible|2
2942450|NCT01364649|10130528|P2|Overall Study|Other|1
2942451|NCT01364649|10130529|P1|Overall Study|Other|4
2942452|NCT01364649|10130528|P2|Overall Study|Lost to Follow-up|13
2942453|NCT01364649|10130529|P1|Overall Study|Lost to Follow-up|12
2942454|NCT01364649|10130528|P2|Overall Study|Withdrawal of Consent|7
2942455|NCT01364649|10130529|P1|Overall Study|Withdrawal of Consent|9
2942456|NCT01364649|10130528|P2|Overall Study|Protocol Deviations|8
2942457|NCT01364649|10130529|P1|Overall Study|Protocol Deviations|4
2942458|NCT01364649|10130528|P2|Overall Study|Non-compliance with Investigational Drug|0
2942459|NCT01364649|10130529|P1|Overall Study|Non-compliance with Investigational Drug|1
2942460|NCT01364649|10130528|P2|Overall Study|Lack of Efficacy|0
2942461|NCT01364649|10130529|P1|Overall Study|Lack of Efficacy|6
2942462|NCT01364649|10130528|P2|Overall Study|Pretreatment Event or Adverse Event|14
2942463|NCT01364649|10130529|P1|Overall Study|Pretreatment Event or Adverse Event|20
2942464|NCT01364467|10130617|P2|Overall Study|Lost to Follow-up|2
2942465|NCT01364467|10130618|P1|Overall Study|Lost to Follow-up|1
2942466|NCT01364428|10130630|P2|Overall Study|Other|3
2942467|NCT01364428|10130631|P1|Overall Study|Other|3
2942468|NCT01364428|10130630|P2|Overall Study|Withdrawal Criteria|10
2942469|NCT01364428|10130631|P1|Overall Study|Withdrawal Criteria|14
2942470|NCT01364428|10130630|P2|Overall Study|Protocol Violation|0
2942471|NCT01364428|10130631|P1|Overall Study|Protocol Violation|2
2942472|NCT01364428|10130630|P2|Overall Study|Adverse Event|2
2942473|NCT01364428|10130631|P1|Overall Study|Adverse Event|1
2942474|NCT01364389|10130648|P3|Overall Study|Adverse Event|0
2942475|NCT01364389|10130649|P2|Overall Study|Adverse Event|0
2942476|NCT01364389|10130650|P1|Overall Study|Adverse Event|1
2942477|NCT01364389|10130648|P3|Overall Study|Administrative problems|0
2942478|NCT01364389|10130649|P2|Overall Study|Administrative problems|0
2942479|NCT01364389|10130650|P1|Overall Study|Administrative problems|1
2942480|NCT01364389|10130648|P3|Overall Study|Protocol deviation|1
2942481|NCT01364389|10130649|P2|Overall Study|Protocol deviation|0
2942482|NCT01364389|10130650|P1|Overall Study|Protocol deviation|0
2942483|NCT01364389|10130648|P3|Overall Study|Withdrawal by Subject|0
2942484|NCT01364389|10130649|P2|Overall Study|Withdrawal by Subject|1
2942485|NCT01364389|10130650|P1|Overall Study|Withdrawal by Subject|0
2942486|NCT01364298|10130669|P2|Overall Study|Other|3
2942487|NCT01364298|10130670|P1|Overall Study|Other|1
2942488|NCT01364298|10130669|P2|Overall Study|Withdrawal by Subject|3
2942489|NCT01364298|10130670|P1|Overall Study|Withdrawal by Subject|3
2942490|NCT01364298|10130669|P2|Overall Study|Lost to Follow-up|10
2942491|NCT01364298|10130670|P1|Overall Study|Lost to Follow-up|5
2942492|NCT01364298|10130669|P2|Overall Study|Lack of Efficacy|0
2942493|NCT01364298|10130670|P1|Overall Study|Lack of Efficacy|1
2942494|NCT01364298|10130669|P2|Overall Study|Lack of adherence to treatment|3
2942495|NCT01364298|10130670|P1|Overall Study|Lack of adherence to treatment|1
2942496|NCT01364298|10130669|P2|Overall Study|Adverse Event|4
2942497|NCT01364298|10130670|P1|Overall Study|Adverse Event|3
2942498|NCT01364233|10130703|P1|Overall Study|Lost to Follow-up|1
2942499|NCT01363986|10130748|P1|Overall Study|Disease progression|1
2942500|NCT01363908|10130758|P2|Chronic Dosing (CD) Phase|Early study termination|3
2942501|NCT01363908|10130759|P1|Chronic Dosing (CD) Phase|Early study termination|9
2942502|NCT01363908|10130758|P2|Chronic Dosing (CD) Phase|Physician Decision|1
2942503|NCT01363908|10130759|P1|Chronic Dosing (CD) Phase|Physician Decision|0
2942504|NCT01363908|10130758|P2|Chronic Dosing (CD) Phase|Patient decision|1
2942505|NCT01363908|10130759|P1|Chronic Dosing (CD) Phase|Patient decision|0
2942506|NCT01363908|10130758|P2|Chronic Dosing (CD) Phase|Adverse Event|1
2942507|NCT01363908|10130759|P1|Chronic Dosing (CD) Phase|Adverse Event|1
2942508|NCT01363765|10130796|P2|Overall Study|smear during intervention|0
2942509|NCT01363765|10130797|P1|Overall Study|smear during intervention|2170
2942510|NCT01363765|10130796|P2|Overall Study|age not recorded (used for cross-linkage|354
2942511|NCT01363765|10130797|P1|Overall Study|age not recorded (used for cross-linkage|117
2942512|NCT01363765|10130796|P2|Overall Study|non-resident|76
2942513|NCT01363765|10130797|P1|Overall Study|non-resident|156
2942514|NCT01363765|10130796|P2|Overall Study|duplicate records|3177
2942515|NCT01363765|10130797|P1|Overall Study|duplicate records|736
2942516|NCT01363765|10130796|P2|Overall Study|non-diagnostic|1124
2942517|NCT01363765|10130797|P1|Overall Study|non-diagnostic|2621
2942518|NCT01363713|10130809|P1|Overall Study|Withdrawal by Subject|2
2942519|NCT01363713|10130809|P1|Overall Study|Protocol Violation|3
2942520|NCT01363713|10130809|P1|Overall Study|Adverse Event|1
2942521|NCT01363700|10130818|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2942522|NCT01363700|10130819|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2942523|NCT01363700|10130820|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2942524|NCT01363700|10130821|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
2942525|NCT01363700|10130822|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2942526|NCT01363661|10130841|P2|Overall Study|Lost to Follow-up|1
2942527|NCT01363661|10130842|P1|Overall Study|Lost to Follow-up|3
2942528|NCT01363661|10130841|P2|Overall Study|Protocol Violation|0
2942529|NCT01363661|10130842|P1|Overall Study|Protocol Violation|1
2942530|NCT01363661|10130841|P2|Overall Study|Withdrawal by Subject|1
2942531|NCT01363661|10130842|P1|Overall Study|Withdrawal by Subject|1
2942532|NCT01363661|10130841|P2|Overall Study|Adverse Event|2
2942533|NCT01363661|10130842|P1|Overall Study|Adverse Event|9
2942534|NCT01363440|10130883|P3|Overall Study|Other|2
2942535|NCT01363440|10130884|P2|Overall Study|Other|5
2942536|NCT01363440|10130885|P1|Overall Study|Other|4
2942537|NCT01363440|10130883|P3|Overall Study|Lost to Follow-up|5
2942538|NCT01363440|10130884|P2|Overall Study|Lost to Follow-up|4
2942539|NCT01363440|10130885|P1|Overall Study|Lost to Follow-up|2
2942540|NCT01363440|10130883|P3|Overall Study|Withdrawal by Subject|11
2942541|NCT01363440|10130884|P2|Overall Study|Withdrawal by Subject|11
2942542|NCT01363440|10130885|P1|Overall Study|Withdrawal by Subject|9
2942543|NCT01363440|10130883|P3|Overall Study|Death|5
2942544|NCT01363440|10130884|P2|Overall Study|Death|7
2942545|NCT01363440|10130885|P1|Overall Study|Death|3
2942546|NCT01363440|10130883|P3|Overall Study|Adverse Event|4
2942547|NCT01363440|10130884|P2|Overall Study|Adverse Event|4
2942548|NCT01363440|10130885|P1|Overall Study|Adverse Event|5
2942549|NCT01363349|10130931|P2|Overall Study|missing|2
2942550|NCT01363349|10130932|P1|Overall Study|missing|1
2942551|NCT01363349|10130931|P2|Overall Study|Not reported|37
2942552|NCT01363349|10130932|P1|Overall Study|Not reported|36
2942553|NCT01363349|10130931|P2|Overall Study|Lost to Follow-up|6
2942554|NCT01363349|10130932|P1|Overall Study|Lost to Follow-up|5
2942555|NCT01363349|10130931|P2|Overall Study|Withdrawal by Subject|6
2942556|NCT01363349|10130932|P1|Overall Study|Withdrawal by Subject|14
2942557|NCT01363349|10130931|P2|Overall Study|Non compliance/Protocol deviations|2
2942558|NCT01363349|10130932|P1|Overall Study|Non compliance/Protocol deviations|2
2942559|NCT01363349|10130931|P2|Overall Study|Lack of Efficacy|10
2942560|NCT01363349|10130932|P1|Overall Study|Lack of Efficacy|3
2942561|NCT01363349|10130931|P2|Overall Study|Adverse Event|7
2942562|NCT01363349|10130932|P1|Overall Study|Adverse Event|6
2942563|NCT01363297|10130943|P5|Overall Study|Death|30
2942564|NCT01363297|10130944|P4|Overall Study|Death|10
2942565|NCT01363297|10130945|P3|Overall Study|Death|6
2942566|NCT01363297|10130946|P2|Overall Study|Death|6
2942567|NCT01363297|10130947|P1|Overall Study|Death|3
2942568|NCT01363297|10130943|P5|Overall Study|Other|1
2942569|NCT01363297|10130944|P4|Overall Study|Other|0
2942570|NCT01363297|10130945|P3|Overall Study|Other|0
2942571|NCT01363297|10130946|P2|Overall Study|Other|0
2942572|NCT01363297|10130947|P1|Overall Study|Other|0
2942573|NCT01363076|10131050|P2|Overall Study|Withdrawal by Subject|1
2942574|NCT01363076|10131051|P1|Overall Study|Withdrawal by Subject|0
2942575|NCT01363011|10131083|P2|Extension Phase|Rolled Over to Another Gilead Study|1
2942576|NCT01363011|10131084|P1|Extension Phase|Rolled Over to Another Gilead Study|2
2942577|NCT01363011|10131083|P2|Extension Phase|Lost to Follow-up|2
2942578|NCT01363011|10131084|P1|Extension Phase|Lost to Follow-up|0
2942579|NCT01363011|10131083|P2|Extension Phase|Withdrew Consent|1
2942580|NCT01363011|10131084|P1|Extension Phase|Withdrew Consent|0
2942581|NCT01363011|10131083|P2|Extension Phase|Investigator's Discretion|2
2942582|NCT01363011|10131084|P1|Extension Phase|Investigator's Discretion|2
2942583|NCT01363011|10131083|P2|Extension Phase|Lack of Efficacy|1
2942584|NCT01363011|10131084|P1|Extension Phase|Lack of Efficacy|0
2942585|NCT01363011|10131083|P2|Extension Phase|Adverse Event|1
2942586|NCT01363011|10131084|P1|Extension Phase|Adverse Event|1
2942587|NCT01363011|10131083|P2|Main Study|Protocol Violation|1
2942588|NCT01363011|10131084|P1|Main Study|Protocol Violation|0
2942589|NCT01363011|10131083|P2|Main Study|Withdrew Consent|4
2942590|NCT01363011|10131084|P1|Main Study|Withdrew Consent|1
2942591|NCT01363011|10131083|P2|Main Study|Investigator's Discretion|1
2942592|NCT01363011|10131084|P1|Main Study|Investigator's Discretion|1
2942593|NCT01363011|10131083|P2|Main Study|Adverse Event|3
2942594|NCT01363011|10131084|P1|Main Study|Adverse Event|2
2942595|NCT01362790|10131211|P7|Dose De-escalation of Regimen A|Progressive disease|0
2942596|NCT01362790|10131212|P6|Dose De-escalation of Regimen A|Progressive disease|0
2942597|NCT01362790|10131213|P5|Dose De-escalation of Regimen A|Progressive disease|2
2942598|NCT01362790|10131214|P4|Dose De-escalation of Regimen A|Progressive disease|0
2942599|NCT01362790|10131215|P3|Dose De-escalation of Regimen A|Progressive disease|0
2942600|NCT01362790|10131216|P2|Dose De-escalation of Regimen A|Progressive disease|0
2942601|NCT01362790|10131217|P1|Dose De-escalation of Regimen A|Progressive disease|0
2942602|NCT01362790|10131211|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942603|NCT01362790|10131212|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942604|NCT01362790|10131213|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
2942605|NCT01362790|10131214|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942606|NCT01362790|10131215|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942607|NCT01362790|10131216|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942608|NCT01362790|10131217|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
2942609|NCT01362790|10131211|P7|Dose De-escalation of Regimen A|Adverse Event|0
2942610|NCT01362790|10131212|P6|Dose De-escalation of Regimen A|Adverse Event|0
2942611|NCT01362790|10131213|P5|Dose De-escalation of Regimen A|Adverse Event|1
2942612|NCT01362790|10131214|P4|Dose De-escalation of Regimen A|Adverse Event|0
2942613|NCT01362790|10131215|P3|Dose De-escalation of Regimen A|Adverse Event|0
2942614|NCT01362790|10131216|P2|Dose De-escalation of Regimen A|Adverse Event|0
2942615|NCT01362790|10131217|P1|Dose De-escalation of Regimen A|Adverse Event|0
2942616|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Death on study|0
2942617|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Death on study|0
2942618|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Death on study|0
2942619|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Death on study|1
2942620|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Death on study|0
2942621|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Death on study|0
2942622|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Death on study|0
2942623|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942624|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942625|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942626|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942627|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942628|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
2942629|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2942630|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942631|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942632|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942633|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942634|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942635|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2942636|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
2942637|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Progressive disease|0
2942638|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Progressive disease|2
2942639|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Progressive disease|0
2942640|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Progressive disease|3
2942641|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Progressive disease|2
2942642|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Progressive disease|2
2942643|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Progressive disease|1
2942644|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Refused further treatment|0
2942645|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Refused further treatment|0
2942646|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Refused further treatment|0
2942647|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Refused further treatment|0
2942648|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Refused further treatment|0
2942649|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Refused further treatment|1
2942650|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Refused further treatment|0
2942651|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Developed antibodies|0
2942652|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Developed antibodies|0
2942653|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Developed antibodies|0
2942654|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Developed antibodies|8
2942655|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Developed antibodies|3
2942656|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Developed antibodies|2
2942657|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Developed antibodies|7
2942658|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Physician Decision|0
2942659|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Physician Decision|0
2942660|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Physician Decision|0
2942661|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Physician Decision|1
2942662|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Physician Decision|0
2942663|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Physician Decision|0
2942664|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Physician Decision|0
2942665|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Adverse Event|0
2942666|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Adverse Event|2
2942667|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Adverse Event|0
2942668|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Adverse Event|1
2942669|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Adverse Event|0
2942670|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Adverse Event|1
2942671|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Adverse Event|0
2942672|NCT01362790|10131211|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942673|NCT01362790|10131212|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942674|NCT01362790|10131213|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942675|NCT01362790|10131214|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942676|NCT01362790|10131215|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942677|NCT01362790|10131216|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2942678|NCT01362790|10131217|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
2942679|NCT01362608|10131285|P2|Overall Study|Adverse Event|2
2942680|NCT01362608|10131286|P1|Overall Study|Adverse Event|0
2942681|NCT01362608|10131285|P2|Overall Study|Lack of Efficacy|2
2942682|NCT01362608|10131286|P1|Overall Study|Lack of Efficacy|0
2942683|NCT01362608|10131285|P2|Overall Study|Withdrawal by Subject|2
2942684|NCT01362608|10131286|P1|Overall Study|Withdrawal by Subject|1
2942685|NCT01362608|10131285|P2|Overall Study|Lost to Follow-up|1
2942686|NCT01362608|10131286|P1|Overall Study|Lost to Follow-up|3
2942687|NCT01362608|10131285|P2|Overall Study|Protocol Violation|1
2942688|NCT01362608|10131286|P1|Overall Study|Protocol Violation|0
2942689|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
2942690|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
2942691|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
2942692|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
2942693|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
2942694|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
2942695|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
2942696|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
2942697|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
2942698|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
2942699|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
2942700|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
2942701|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
2942702|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
2942703|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
2942704|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
2942705|NCT01362530|10131324|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
2942706|NCT01362530|10131325|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
2942707|NCT01362530|10131324|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
2942708|NCT01362530|10131325|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
2942709|NCT01362530|10131324|P2|Base Study (Cycle 1)|Protocol Violation|0
2942710|NCT01362530|10131325|P1|Base Study (Cycle 1)|Protocol Violation|2
2942711|NCT01362530|10131324|P2|Base Study (Cycle 1)|Physician Decision|1
2942712|NCT01362530|10131325|P1|Base Study (Cycle 1)|Physician Decision|0
2942713|NCT01362530|10131324|P2|Base Study (Cycle 1)|Adverse Event|0
2942714|NCT01362530|10131325|P1|Base Study (Cycle 1)|Adverse Event|2
2942715|NCT01362517|10131338|P1|Overall Study|Lost to Follow-up|1
2942716|NCT01362517|10131338|P1|Overall Study|Protocol Violation|1
2942717|NCT01362491|10131349|P3|Overall Study|Ineligible|0
2942718|NCT01362491|10131350|P2|Overall Study|Ineligible|0
2942719|NCT01362491|10131351|P1|Overall Study|Ineligible|1
2942720|NCT01362439|10131399|P1|Overall Study|Participant who withdrew consent|8
2942721|NCT01362439|10131399|P1|Overall Study|Study medication non-compliant|1
2942722|NCT01362439|10131399|P1|Overall Study|Lost to Follow-up|2
2942723|NCT01362439|10131399|P1|Overall Study|Lack of Efficacy|3
2942724|NCT01362439|10131399|P1|Overall Study|Adverse Event|1
2942725|NCT01362348|10131414|P1|Overall Study|Study closed/terminated|5
2942726|NCT01362348|10131414|P1|Overall Study|Protocol-defined stopping criteria|9
2942727|NCT01362322|10131433|P2|Overall Study|Lost to Follow-up|6
2942728|NCT01362322|10131434|P1|Overall Study|Lost to Follow-up|2
2942729|NCT01362322|10131433|P2|Overall Study|Withdrawal by Subject|1
2942730|NCT01362322|10131434|P1|Overall Study|Withdrawal by Subject|3
2942731|NCT01362296|10131466|P4|Crossover Phase|Study Closed/Terminated|0
2942732|NCT01362296|10131467|P3|Crossover Phase|Study Closed/Terminated|1
2942733|NCT01362296|10131468|P2|Crossover Phase|Study Closed/Terminated|0
2942734|NCT01362296|10131469|P1|Crossover Phase|Study Closed/Terminated|0
2942735|NCT01362296|10131466|P4|Crossover Phase|Adverse Event|0
2942736|NCT01362296|10131467|P3|Crossover Phase|Adverse Event|4
2942737|NCT01362296|10131468|P2|Crossover Phase|Adverse Event|0
2942738|NCT01362296|10131469|P1|Crossover Phase|Adverse Event|0
2942739|NCT01362296|10131466|P4|Crossover Phase|Withdrawal by Subject|1
2942740|NCT01362296|10131467|P3|Crossover Phase|Withdrawal by Subject|2
2942741|NCT01362296|10131468|P2|Crossover Phase|Withdrawal by Subject|0
2942742|NCT01362296|10131469|P1|Crossover Phase|Withdrawal by Subject|0
2942743|NCT01362296|10131466|P4|Crossover Phase|PD including Death due to PD|1
2942744|NCT01362296|10131467|P3|Crossover Phase|PD including Death due to PD|16
2942745|NCT01362296|10131468|P2|Crossover Phase|PD including Death due to PD|0
2942746|NCT01362296|10131469|P1|Crossover Phase|PD including Death due to PD|0
2942747|NCT01362296|10131466|P4|Randomized Phase (RP)|Study Closed/Terminated|0
2942748|NCT01362296|10131467|P3|Randomized Phase (RP)|Study Closed/Terminated|0
2942749|NCT01362296|10131468|P2|Randomized Phase (RP)|Study Closed/Terminated|1
2942750|NCT01362296|10131469|P1|Randomized Phase (RP)|Study Closed/Terminated|8
2942751|NCT01362296|10131466|P4|Randomized Phase (RP)|Adverse Event|0
2942752|NCT01362296|10131467|P3|Randomized Phase (RP)|Adverse Event|0
2942753|NCT01362296|10131468|P2|Randomized Phase (RP)|Adverse Event|4
2942754|NCT01362296|10131469|P1|Randomized Phase (RP)|Adverse Event|20
2942755|NCT01362296|10131466|P4|Randomized Phase (RP)|Withdrawal by Subject|0
2942756|NCT01362296|10131467|P3|Randomized Phase (RP)|Withdrawal by Subject|0
2942757|NCT01362296|10131468|P2|Randomized Phase (RP)|Withdrawal by Subject|1
2942758|NCT01362296|10131469|P1|Randomized Phase (RP)|Withdrawal by Subject|2
2942759|NCT01362296|10131466|P4|Randomized Phase (RP)|Physician Decision|0
2942760|NCT01362296|10131467|P3|Randomized Phase (RP)|Physician Decision|0
2942761|NCT01362296|10131468|P2|Randomized Phase (RP)|Physician Decision|9
2942762|NCT01362296|10131469|P1|Randomized Phase (RP)|Physician Decision|1
2942763|NCT01362296|10131466|P4|Randomized Phase (RP)|PD including Death due to PD|0
2942764|NCT01362296|10131467|P3|Randomized Phase (RP)|PD including Death due to PD|0
2942765|NCT01362296|10131468|P2|Randomized Phase (RP)|PD including Death due to PD|28
2942766|NCT01362296|10131469|P1|Randomized Phase (RP)|PD including Death due to PD|56
2942767|NCT01362270|10131517|P2|Overall Study|Met excl. criteria before 1st session|1
2942768|NCT01362270|10131518|P1|Overall Study|Met excl. criteria before 1st session|1
2942769|NCT01362270|10131517|P2|Overall Study|Met exclusion criteria after 1st session|1
2942770|NCT01362270|10131518|P1|Overall Study|Met exclusion criteria after 1st session|0
2942771|NCT01362270|10131517|P2|Overall Study|Withdrawal by Subject|0
2942772|NCT01362270|10131518|P1|Overall Study|Withdrawal by Subject|1
2942773|NCT01362244|10131530|P2|Overall Study|Protocol Defined Stopping Criteria|1
2942774|NCT01362244|10131531|P1|Overall Study|Protocol Defined Stopping Criteria|0
2942775|NCT01362244|10131530|P2|Overall Study|Did not Meet Continuation Criteria|11
2942776|NCT01362244|10131531|P1|Overall Study|Did not Meet Continuation Criteria|17
2942777|NCT01362244|10131530|P2|Overall Study|Withdrawal by Subject|1
2942778|NCT01362244|10131531|P1|Overall Study|Withdrawal by Subject|2
2942779|NCT01362244|10131530|P2|Overall Study|Protocol Violation|1
2942780|NCT01362244|10131531|P1|Overall Study|Protocol Violation|5
2942781|NCT01362244|10131530|P2|Overall Study|Lost to Follow-up|2
2942782|NCT01362244|10131531|P1|Overall Study|Lost to Follow-up|0
2942783|NCT01362244|10131530|P2|Overall Study|Lack of Efficacy|11
2942784|NCT01362244|10131531|P1|Overall Study|Lack of Efficacy|5
2942785|NCT01362244|10131530|P2|Overall Study|Adverse Event|5
2942786|NCT01362244|10131531|P1|Overall Study|Adverse Event|3
2942787|NCT01362140|10131643|P2|Overall Study|Discontinued Without Receiving Treatment|1
2942788|NCT01362140|10131644|P1|Overall Study|Discontinued Without Receiving Treatment|0
2942789|NCT01362140|10131643|P2|Overall Study|Protocol-specified Criteria|2
2942790|NCT01362140|10131644|P1|Overall Study|Protocol-specified Criteria|1
2942791|NCT01362140|10131643|P2|Overall Study|Other|1
2942792|NCT01362140|10131644|P1|Overall Study|Other|1
2942793|NCT01362140|10131643|P2|Overall Study|Death|1
2942794|NCT01362140|10131644|P1|Overall Study|Death|2
2942795|NCT01362140|10131643|P2|Overall Study|Administrative Decision|1
2942796|NCT01362140|10131644|P1|Overall Study|Administrative Decision|0
2942797|NCT01362140|10131643|P2|Overall Study|Withdrawal by Subject|3
2942798|NCT01362140|10131644|P1|Overall Study|Withdrawal by Subject|3
2942799|NCT01362140|10131643|P2|Overall Study|Adverse Event|2
2942800|NCT01362140|10131644|P1|Overall Study|Adverse Event|2
2942801|NCT01362140|10131643|P2|Overall Study|Noncompliance|0
2942802|NCT01362140|10131644|P1|Overall Study|Noncompliance|1
2942803|NCT01362062|10131681|P2|Overall Study|Had significant improvement|0
2942804|NCT01362062|10131682|P1|Overall Study|Had significant improvement|9
2942805|NCT01362062|10131681|P2|Overall Study|Detected with Spondylo-arthritis|0
2942806|NCT01362062|10131682|P1|Overall Study|Detected with Spondylo-arthritis|1
2942807|NCT01362062|10131681|P2|Overall Study|Non-compliant participant|0
2942808|NCT01362062|10131682|P1|Overall Study|Non-compliant participant|2
2942809|NCT01362062|10131681|P2|Overall Study|Withdrawal by Subject|0
2942810|NCT01362062|10131682|P1|Overall Study|Withdrawal by Subject|2
2942811|NCT01362062|10131681|P2|Overall Study|Lost to Follow-up|0
2942812|NCT01362062|10131682|P1|Overall Study|Lost to Follow-up|11
2942813|NCT01362062|10131681|P2|Overall Study|Adverse Event|0
2942814|NCT01362062|10131682|P1|Overall Study|Adverse Event|1
2942815|NCT01362049|10131703|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2942816|NCT01362049|10131704|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
2942817|NCT01362049|10131705|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2942818|NCT01362049|10131706|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
2942819|NCT01362049|10131703|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
2942820|NCT01362049|10131704|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
2942821|NCT01362049|10131705|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
2942822|NCT01362049|10131706|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
2942823|NCT01361919|10131747|P3|Overall Study|technical issues|10
2942824|NCT01361919|10131748|P2|Overall Study|technical issues|12
2942825|NCT01361919|10131749|P1|Overall Study|technical issues|10
2942826|NCT01361607|10131790|P2|Overall Study|Met Withdrawal Criteria|1
2942827|NCT01361607|10131791|P1|Overall Study|Met Withdrawal Criteria|1
2942828|NCT01361607|10131790|P2|Overall Study|Lost to Follow-up|0
2942829|NCT01361607|10131791|P1|Overall Study|Lost to Follow-up|1
2942830|NCT01361607|10131790|P2|Overall Study|Withdrawal by Investigator|3
2942831|NCT01361607|10131791|P1|Overall Study|Withdrawal by Investigator|5
2942832|NCT01361607|10131790|P2|Overall Study|Withdrawal by Subject|8
2942833|NCT01361607|10131791|P1|Overall Study|Withdrawal by Subject|19
2942834|NCT01361607|10131790|P2|Overall Study|Adverse Event|29
2942835|NCT01361607|10131791|P1|Overall Study|Adverse Event|38
2942836|NCT01361594|10131819|P2|Overall Study|Withdrawal by Subject|2
2942837|NCT01361594|10131820|P1|Overall Study|Withdrawal by Subject|1
2942838|NCT01361568|10131834|P6|Overall Study|Withdrawal by Subject|1
2942839|NCT01361568|10131835|P5|Overall Study|Withdrawal by Subject|0
2942840|NCT01361568|10131836|P4|Overall Study|Withdrawal by Subject|0
2942841|NCT01361568|10131837|P3|Overall Study|Withdrawal by Subject|0
2942842|NCT01361568|10131838|P2|Overall Study|Withdrawal by Subject|1
2942843|NCT01361568|10131839|P1|Overall Study|Withdrawal by Subject|2
2942844|NCT01361568|10131834|P6|Overall Study|Physician Decision|1
2942845|NCT01361568|10131835|P5|Overall Study|Physician Decision|0
2942846|NCT01361568|10131836|P4|Overall Study|Physician Decision|0
2942847|NCT01361568|10131837|P3|Overall Study|Physician Decision|0
2942848|NCT01361568|10131838|P2|Overall Study|Physician Decision|0
2942849|NCT01361568|10131839|P1|Overall Study|Physician Decision|0
2942850|NCT01361568|10131834|P6|Overall Study|Adverse Event|0
2942851|NCT01361568|10131835|P5|Overall Study|Adverse Event|1
2942852|NCT01361568|10131836|P4|Overall Study|Adverse Event|0
2942853|NCT01361568|10131837|P3|Overall Study|Adverse Event|0
2942854|NCT01361568|10131838|P2|Overall Study|Adverse Event|0
2942855|NCT01361568|10131839|P1|Overall Study|Adverse Event|0
2942856|NCT01361464|10131869|P1|Overall Study|Withdrawal by Subject|2
2942857|NCT01361464|10131869|P1|Overall Study|Death|1
2942858|NCT01361308|10131878|P2|Overall Study|Other|1
2942859|NCT01361308|10131879|P1|Overall Study|Other|0
2942860|NCT01361308|10131878|P2|Overall Study|Failed C-SSRS|2
2942861|NCT01361308|10131879|P1|Overall Study|Failed C-SSRS|5
2942862|NCT01361308|10131878|P2|Overall Study|Eligibility Criteria Not Met|3
2942863|NCT01361308|10131879|P1|Overall Study|Eligibility Criteria Not Met|2
2942864|NCT01361308|10131878|P2|Overall Study|Adverse Event|4
2942865|NCT01361308|10131879|P1|Overall Study|Adverse Event|8
2942866|NCT01361308|10131878|P2|Overall Study|Lost to Follow-up|4
2942867|NCT01361308|10131879|P1|Overall Study|Lost to Follow-up|5
2942868|NCT01361308|10131878|P2|Overall Study|Protocol Violation|0
2942869|NCT01361308|10131879|P1|Overall Study|Protocol Violation|1
2942870|NCT01361308|10131878|P2|Overall Study|Lack of Efficacy|0
2942871|NCT01361308|10131879|P1|Overall Study|Lack of Efficacy|2
2942872|NCT01361308|10131878|P2|Overall Study|Physician Decision|3
2942873|NCT01361308|10131879|P1|Overall Study|Physician Decision|3
2942874|NCT01361308|10131878|P2|Overall Study|Withdrawal by Subject|13
2942875|NCT01361308|10131879|P1|Overall Study|Withdrawal by Subject|9
2942876|NCT01361178|10131927|P2|Overall Study|Death|0
2942877|NCT01361178|10131928|P1|Overall Study|Death|13
2942878|NCT01361126|10131936|P2|Overall Study|Sponsor decision|2
2942879|NCT01361126|10131937|P1|Overall Study|Sponsor decision|0
2942880|NCT01361009|10131976|P1|Overall Study|Protocol Violation|116
2942881|NCT01360996|10131986|P3|Overall Study|Noncompliant|0
2942882|NCT01360996|10131987|P2|Overall Study|Noncompliant|0
2942883|NCT01360996|10131988|P1|Overall Study|Noncompliant|2
2942884|NCT01360996|10131986|P3|Overall Study|Withdrawal by Subject|2
2942885|NCT01360996|10131987|P2|Overall Study|Withdrawal by Subject|3
2942886|NCT01360996|10131988|P1|Overall Study|Withdrawal by Subject|4
2942887|NCT01360866|10132011|P4|Overall Study|Lack of Efficacy|4
2942888|NCT01360866|10132012|P3|Overall Study|Lack of Efficacy|30
2942889|NCT01360866|10132013|P2|Overall Study|Lack of Efficacy|40
2942890|NCT01360866|10132014|P1|Overall Study|Lack of Efficacy|30
2942891|NCT01360866|10132011|P4|Overall Study|Protocol Deviation|2
2942892|NCT01360866|10132012|P3|Overall Study|Protocol Deviation|61
2942893|NCT01360866|10132013|P2|Overall Study|Protocol Deviation|33
2942894|NCT01360866|10132014|P1|Overall Study|Protocol Deviation|25
2942895|NCT01360866|10132011|P4|Overall Study|Withdrawal by participant|8
2942896|NCT01360866|10132012|P3|Overall Study|Withdrawal by participant|168
2942897|NCT01360866|10132013|P2|Overall Study|Withdrawal by participant|89
2942898|NCT01360866|10132014|P1|Overall Study|Withdrawal by participant|79
2942899|NCT01360866|10132011|P4|Overall Study|Withdrawn by Investigator|2
2942900|NCT01360866|10132012|P3|Overall Study|Withdrawn by Investigator|31
2942901|NCT01360866|10132013|P2|Overall Study|Withdrawn by Investigator|8
2942902|NCT01360866|10132014|P1|Overall Study|Withdrawn by Investigator|9
2942903|NCT01360866|10132011|P4|Overall Study|Paticipant met withdrawal criteria|0
2942904|NCT01360866|10132012|P3|Overall Study|Paticipant met withdrawal criteria|54
2942905|NCT01360866|10132013|P2|Overall Study|Paticipant met withdrawal criteria|28
2942906|NCT01360866|10132014|P1|Overall Study|Paticipant met withdrawal criteria|11
2942907|NCT01360866|10132011|P4|Overall Study|Adverse Event|6
2942908|NCT01360866|10132012|P3|Overall Study|Adverse Event|134
2942909|NCT01360866|10132013|P2|Overall Study|Adverse Event|61
2942910|NCT01360866|10132014|P1|Overall Study|Adverse Event|56
2942911|NCT01360866|10132011|P4|Overall Study|Lost to Follow-up|0
2942912|NCT01360866|10132012|P3|Overall Study|Lost to Follow-up|41
2942913|NCT01360866|10132013|P2|Overall Study|Lost to Follow-up|28
2942914|NCT01360866|10132014|P1|Overall Study|Lost to Follow-up|11
2942915|NCT01360840|10132043|P3|Overall Study|Ongoing at data cut-off|9
2942916|NCT01360840|10132044|P2|Overall Study|Ongoing at data cut-off|10
2942917|NCT01360840|10132045|P1|Overall Study|Ongoing at data cut-off|10
2942918|NCT01360762|10132095|P1|Whole Study Period|Discontinuation of study drug for safety|1
2942919|NCT01360762|10132095|P1|Whole Study Period|Patient relapsed|18
2942920|NCT01360762|10132095|P1|Whole Study Period|Death|7
2942921|NCT01360762|10132095|P1|Whole Study Period|Lost to Follow-up|10
2942922|NCT01360762|10132095|P1|Main Study Period (12-month Treatment)|Discontinuation|1
2942923|NCT01360762|10132095|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
2942924|NCT01360762|10132095|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
2942925|NCT01360762|10132095|P1|Main Study Period (12-month Treatment)|Death|5
2942926|NCT01360762|10132095|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
2942927|NCT01360645|10132105|P4|Phase A+|Protocol Deviation|4
2942928|NCT01360645|10132106|P3|Phase A+|Protocol Deviation|0
2942929|NCT01360645|10132107|P2|Phase A+|Protocol Deviation|0
2942930|NCT01360645|10132108|P1|Phase A+|Protocol Deviation|0
2942931|NCT01360645|10132105|P4|Phase A+|Withdrawal by Subject|5
2942932|NCT01360645|10132106|P3|Phase A+|Withdrawal by Subject|0
2942933|NCT01360645|10132107|P2|Phase A+|Withdrawal by Subject|0
2942934|NCT01360645|10132108|P1|Phase A+|Withdrawal by Subject|0
2942935|NCT01360645|10132105|P4|Phase A+|Physician Decision|2
2942936|NCT01360645|10132106|P3|Phase A+|Physician Decision|0
2942937|NCT01360645|10132107|P2|Phase A+|Physician Decision|0
2942938|NCT01360645|10132108|P1|Phase A+|Physician Decision|0
2942939|NCT01360645|10132105|P4|Phase A+|Met Withdrawal Criteria|4
2942940|NCT01360645|10132106|P3|Phase A+|Met Withdrawal Criteria|0
2942941|NCT01360645|10132107|P2|Phase A+|Met Withdrawal Criteria|0
2942942|NCT01360645|10132108|P1|Phase A+|Met Withdrawal Criteria|0
2942943|NCT01360645|10132105|P4|Phase A+|Adverse Event|2
2942944|NCT01360645|10132106|P3|Phase A+|Adverse Event|0
2942945|NCT01360645|10132107|P2|Phase A+|Adverse Event|0
2942946|NCT01360645|10132108|P1|Phase A+|Adverse Event|0
2942947|NCT01360645|10132105|P4|Phase A+|Lost to Follow-up|7
2942948|NCT01360645|10132106|P3|Phase A+|Lost to Follow-up|0
2942949|NCT01360645|10132107|P2|Phase A+|Lost to Follow-up|0
2942950|NCT01360645|10132108|P1|Phase A+|Lost to Follow-up|0
2942951|NCT01360645|10132105|P4|Phase B (6 Weeks)|Protocol Deviation|0
2942952|NCT01360645|10132106|P3|Phase B (6 Weeks)|Protocol Deviation|3
2942953|NCT01360645|10132107|P2|Phase B (6 Weeks)|Protocol Deviation|1
2942954|NCT01360645|10132108|P1|Phase B (6 Weeks)|Protocol Deviation|0
2942955|NCT01360645|10132105|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
2942956|NCT01360645|10132106|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
2942957|NCT01360645|10132107|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
2942958|NCT01360645|10132108|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
2942959|NCT01360645|10132105|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2942960|NCT01360645|10132106|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2942961|NCT01360645|10132107|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
2942962|NCT01360645|10132108|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2942963|NCT01360645|10132105|P4|Phase B (6 Weeks)|Adverse Event|0
2942964|NCT01360645|10132106|P3|Phase B (6 Weeks)|Adverse Event|0
2942965|NCT01360645|10132107|P2|Phase B (6 Weeks)|Adverse Event|6
2942966|NCT01360645|10132108|P1|Phase B (6 Weeks)|Adverse Event|0
2942967|NCT01360645|10132105|P4|Phase B (6 Weeks)|Lost to Follow-up|0
2942968|NCT01360645|10132106|P3|Phase B (6 Weeks)|Lost to Follow-up|0
2942969|NCT01360645|10132107|P2|Phase B (6 Weeks)|Lost to Follow-up|1
2942970|NCT01360645|10132108|P1|Phase B (6 Weeks)|Lost to Follow-up|0
2942971|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2942972|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2942973|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2942974|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
2942975|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2942976|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2942977|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2942978|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
2942979|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2942980|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2942981|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2942982|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
2942983|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2942984|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2942985|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2942986|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
2942987|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2942988|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2942989|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2942990|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
2942991|NCT01360645|10132105|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2942992|NCT01360645|10132106|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2942993|NCT01360645|10132107|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2942994|NCT01360645|10132108|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
2942995|NCT01360632|10132163|P5|Phase A+|Protocol Deviation|3
2942996|NCT01360632|10132164|P4|Phase A+|Protocol Deviation|0
2942997|NCT01360632|10132165|P3|Phase A+|Protocol Deviation|0
2942998|NCT01360632|10132166|P2|Phase A+|Protocol Deviation|0
2942999|NCT01360632|10132167|P1|Phase A+|Protocol Deviation|0
2943000|NCT01360632|10132163|P5|Phase A+|Withdrawal by Subject|8
2943001|NCT01360632|10132164|P4|Phase A+|Withdrawal by Subject|0
2943002|NCT01360632|10132165|P3|Phase A+|Withdrawal by Subject|0
2943003|NCT01360632|10132166|P2|Phase A+|Withdrawal by Subject|0
2943004|NCT01360632|10132167|P1|Phase A+|Withdrawal by Subject|0
2943005|NCT01360632|10132163|P5|Phase A+|Physician Decision|3
2943006|NCT01360632|10132164|P4|Phase A+|Physician Decision|0
2943007|NCT01360632|10132165|P3|Phase A+|Physician Decision|0
2943008|NCT01360632|10132166|P2|Phase A+|Physician Decision|0
2943009|NCT01360632|10132167|P1|Phase A+|Physician Decision|0
2943010|NCT01360632|10132163|P5|Phase A+|Met Withdrawal Criteria|7
2943011|NCT01360632|10132164|P4|Phase A+|Met Withdrawal Criteria|0
2943012|NCT01360632|10132165|P3|Phase A+|Met Withdrawal Criteria|0
2943013|NCT01360632|10132166|P2|Phase A+|Met Withdrawal Criteria|0
2943014|NCT01360632|10132167|P1|Phase A+|Met Withdrawal Criteria|0
2943015|NCT01360632|10132163|P5|Phase A+|Adverse Event|2
2943016|NCT01360632|10132164|P4|Phase A+|Adverse Event|0
2943017|NCT01360632|10132165|P3|Phase A+|Adverse Event|0
2943018|NCT01360632|10132166|P2|Phase A+|Adverse Event|0
2943019|NCT01360632|10132167|P1|Phase A+|Adverse Event|0
2943020|NCT01360632|10132163|P5|Phase A+|Lost to Follow-up|2
2943021|NCT01360632|10132164|P4|Phase A+|Lost to Follow-up|0
2943022|NCT01360632|10132165|P3|Phase A+|Lost to Follow-up|0
2943023|NCT01360632|10132166|P2|Phase A+|Lost to Follow-up|0
2943024|NCT01360632|10132167|P1|Phase A+|Lost to Follow-up|0
2943025|NCT01360632|10132163|P5|Phase B (6 Weeks)|Lack of Efficacy|0
2943026|NCT01360632|10132164|P4|Phase B (6 Weeks)|Lack of Efficacy|0
2943027|NCT01360632|10132165|P3|Phase B (6 Weeks)|Lack of Efficacy|0
2943028|NCT01360632|10132166|P2|Phase B (6 Weeks)|Lack of Efficacy|1
2943029|NCT01360632|10132167|P1|Phase B (6 Weeks)|Lack of Efficacy|0
2943030|NCT01360632|10132163|P5|Phase B (6 Weeks)|Protocol Deviation|0
2943031|NCT01360632|10132164|P4|Phase B (6 Weeks)|Protocol Deviation|1
2943032|NCT01360632|10132165|P3|Phase B (6 Weeks)|Protocol Deviation|4
2943033|NCT01360632|10132166|P2|Phase B (6 Weeks)|Protocol Deviation|1
2943034|NCT01360632|10132167|P1|Phase B (6 Weeks)|Protocol Deviation|0
2943035|NCT01360632|10132163|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
2943036|NCT01360632|10132164|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
2943037|NCT01360632|10132165|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
2943038|NCT01360632|10132166|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
2943039|NCT01360632|10132167|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
2943040|NCT01360632|10132163|P5|Phase B (6 Weeks)|Physician Decision|0
2943041|NCT01360632|10132164|P4|Phase B (6 Weeks)|Physician Decision|1
2943042|NCT01360632|10132165|P3|Phase B (6 Weeks)|Physician Decision|0
2943043|NCT01360632|10132166|P2|Phase B (6 Weeks)|Physician Decision|0
2943044|NCT01360632|10132167|P1|Phase B (6 Weeks)|Physician Decision|0
2943045|NCT01360632|10132163|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2943046|NCT01360632|10132164|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
2943047|NCT01360632|10132165|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2943048|NCT01360632|10132166|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2943049|NCT01360632|10132167|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2943050|NCT01360632|10132163|P5|Phase B (6 Weeks)|Adverse Event|0
2943051|NCT01360632|10132164|P4|Phase B (6 Weeks)|Adverse Event|3
2943052|NCT01360632|10132165|P3|Phase B (6 Weeks)|Adverse Event|9
2943053|NCT01360632|10132166|P2|Phase B (6 Weeks)|Adverse Event|3
2943054|NCT01360632|10132167|P1|Phase B (6 Weeks)|Adverse Event|0
2943055|NCT01360632|10132163|P5|Phase B (6 Weeks)|Lost to Follow-up|0
2943056|NCT01360632|10132164|P4|Phase B (6 Weeks)|Lost to Follow-up|0
2943057|NCT01360632|10132165|P3|Phase B (6 Weeks)|Lost to Follow-up|1
2943058|NCT01360632|10132166|P2|Phase B (6 Weeks)|Lost to Follow-up|1
2943059|NCT01360632|10132167|P1|Phase B (6 Weeks)|Lost to Follow-up|0
2943060|NCT01360632|10132163|P5|Phase A (8 Weeks)|Protocol Deviation|0
2943061|NCT01360632|10132164|P4|Phase A (8 Weeks)|Protocol Deviation|0
2943062|NCT01360632|10132165|P3|Phase A (8 Weeks)|Protocol Deviation|0
2943063|NCT01360632|10132166|P2|Phase A (8 Weeks)|Protocol Deviation|0
2943064|NCT01360632|10132167|P1|Phase A (8 Weeks)|Protocol Deviation|39
2943065|NCT01360632|10132163|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
2943066|NCT01360632|10132164|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
2943067|NCT01360632|10132165|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
2943068|NCT01360632|10132166|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
2943069|NCT01360632|10132167|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
2943070|NCT01360632|10132163|P5|Phase A (8 Weeks)|Physician Decision|0
2943071|NCT01360632|10132164|P4|Phase A (8 Weeks)|Physician Decision|0
2943072|NCT01360632|10132165|P3|Phase A (8 Weeks)|Physician Decision|0
2943073|NCT01360632|10132166|P2|Phase A (8 Weeks)|Physician Decision|0
2943074|NCT01360632|10132167|P1|Phase A (8 Weeks)|Physician Decision|10
2943075|NCT01360632|10132163|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2943076|NCT01360632|10132164|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2943077|NCT01360632|10132165|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2943078|NCT01360632|10132166|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2943079|NCT01360632|10132167|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
2943080|NCT01360632|10132163|P5|Phase A (8 Weeks)|Adverse Event|0
2943081|NCT01360632|10132164|P4|Phase A (8 Weeks)|Adverse Event|0
2943082|NCT01360632|10132165|P3|Phase A (8 Weeks)|Adverse Event|0
2943083|NCT01360632|10132166|P2|Phase A (8 Weeks)|Adverse Event|0
2943084|NCT01360632|10132167|P1|Phase A (8 Weeks)|Adverse Event|60
2943085|NCT01360632|10132163|P5|Phase A (8 Weeks)|Lost to Follow-up|0
2943086|NCT01360632|10132164|P4|Phase A (8 Weeks)|Lost to Follow-up|0
2943087|NCT01360632|10132165|P3|Phase A (8 Weeks)|Lost to Follow-up|0
2943088|NCT01360632|10132166|P2|Phase A (8 Weeks)|Lost to Follow-up|0
2943089|NCT01360632|10132167|P1|Phase A (8 Weeks)|Lost to Follow-up|27
2943090|NCT01360554|10132246|P2|Overall Study|Randomized but not treated.|3
2943091|NCT01360554|10132247|P1|Overall Study|Randomized but not treated.|3
2943092|NCT01360554|10132246|P2|Overall Study|Other, not specified|0
2943093|NCT01360554|10132247|P1|Overall Study|Other, not specified|1
2943094|NCT01360554|10132246|P2|Overall Study|Study terminated by sponsor|37
2943095|NCT01360554|10132247|P1|Overall Study|Study terminated by sponsor|49
2943096|NCT01360554|10132246|P2|Overall Study|Withdrawal by Subject|24
2943097|NCT01360554|10132247|P1|Overall Study|Withdrawal by Subject|23
2943098|NCT01360554|10132246|P2|Overall Study|Lost to Follow-up|4
2943099|NCT01360554|10132247|P1|Overall Study|Lost to Follow-up|4
2943100|NCT01360554|10132246|P2|Overall Study|Death|371
2943101|NCT01360554|10132247|P1|Overall Study|Death|359
2943102|NCT01360398|10132296|P1|Overall Study|Migrated/moved from study area|1
2943103|NCT01360398|10132296|P1|Overall Study|Other|7
2943104|NCT01360398|10132296|P1|Overall Study|Withdrawal by Subject|14
2943105|NCT01360021|10132330|P3|Overall Study|Adverse Event|3
2943106|NCT01360021|10132331|P2|Overall Study|Adverse Event|3
2943107|NCT01360021|10132332|P1|Overall Study|Adverse Event|2
2943108|NCT01360021|10132330|P3|Overall Study|Withdrawal by Subject|2
2943109|NCT01360021|10132331|P2|Overall Study|Withdrawal by Subject|0
2943110|NCT01360021|10132332|P1|Overall Study|Withdrawal by Subject|4
2943111|NCT01360021|10132330|P3|Overall Study|Protocol Violation|1
2943112|NCT01360021|10132331|P2|Overall Study|Protocol Violation|0
2943113|NCT01360021|10132332|P1|Overall Study|Protocol Violation|0
2943114|NCT01360021|10132330|P3|Overall Study|Eligibility criteria + other|1
2943115|NCT01360021|10132331|P2|Overall Study|Eligibility criteria + other|1
2943116|NCT01360021|10132332|P1|Overall Study|Eligibility criteria + other|2
2943117|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
2943118|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
2943119|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
2943120|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2943121|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
2943122|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2943123|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2943124|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2943125|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2943126|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2943127|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
2943128|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2943129|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
2943130|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
2943131|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
2943132|NCT01359943|10132358|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
2943133|NCT01359943|10132359|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
2943134|NCT01359943|10132360|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
2943135|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
2943136|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
2943137|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
2943138|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2943139|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
2943140|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2943141|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2943142|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2943143|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2943144|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2943145|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
2943146|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2943147|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
2943148|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
2943149|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
2943150|NCT01359943|10132358|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2943151|NCT01359943|10132359|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2943152|NCT01359943|10132360|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
2943153|NCT01359943|10132358|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2943154|NCT01359943|10132359|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
2943155|NCT01359943|10132360|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2943156|NCT01359943|10132358|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
2943157|NCT01359943|10132359|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
2943158|NCT01359943|10132360|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
2943159|NCT01359943|10132358|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2943160|NCT01359943|10132359|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2943161|NCT01359943|10132360|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
2943162|NCT01359904|10132408|P2|Overall Study|Withdrawal by Subject|0
2943163|NCT01359904|10132409|P1|Overall Study|Withdrawal by Subject|1
2943164|NCT01359644|10132463|P10|Follow-up Period|Lost to Follow-up|0
2943165|NCT01359644|10132464|P9|Follow-up Period|Lost to Follow-up|0
2943166|NCT01359644|10132465|P8|Follow-up Period|Lost to Follow-up|2
2943167|NCT01359644|10132466|P7|Follow-up Period|Lost to Follow-up|1
2943168|NCT01359644|10132467|P6|Follow-up Period|Lost to Follow-up|0
2943169|NCT01359644|10132468|P5|Follow-up Period|Lost to Follow-up|0
2943170|NCT01359644|10132469|P4|Follow-up Period|Lost to Follow-up|0
2943171|NCT01359644|10132470|P3|Follow-up Period|Lost to Follow-up|0
2943172|NCT01359644|10132471|P2|Follow-up Period|Lost to Follow-up|0
2943173|NCT01359644|10132472|P1|Follow-up Period|Lost to Follow-up|0
2943174|NCT01359644|10132463|P10|Follow-up Period|Withdrawal by Subject|0
2943175|NCT01359644|10132464|P9|Follow-up Period|Withdrawal by Subject|0
2943176|NCT01359644|10132465|P8|Follow-up Period|Withdrawal by Subject|0
2943177|NCT01359644|10132466|P7|Follow-up Period|Withdrawal by Subject|0
2943178|NCT01359644|10132467|P6|Follow-up Period|Withdrawal by Subject|1
2943179|NCT01359644|10132468|P5|Follow-up Period|Withdrawal by Subject|0
2943180|NCT01359644|10132469|P4|Follow-up Period|Withdrawal by Subject|0
2943181|NCT01359644|10132470|P3|Follow-up Period|Withdrawal by Subject|0
2943182|NCT01359644|10132471|P2|Follow-up Period|Withdrawal by Subject|0
2943183|NCT01359644|10132472|P1|Follow-up Period|Withdrawal by Subject|0
2943184|NCT01359644|10132463|P10|Treatment Period|Lost to Follow-up|0
2943185|NCT01359644|10132464|P9|Treatment Period|Lost to Follow-up|0
2943186|NCT01359644|10132465|P8|Treatment Period|Lost to Follow-up|0
2943187|NCT01359644|10132466|P7|Treatment Period|Lost to Follow-up|0
2943188|NCT01359644|10132467|P6|Treatment Period|Lost to Follow-up|1
2943189|NCT01359644|10132468|P5|Treatment Period|Lost to Follow-up|0
2943190|NCT01359644|10132469|P4|Treatment Period|Lost to Follow-up|0
2943191|NCT01359644|10132470|P3|Treatment Period|Lost to Follow-up|0
2943192|NCT01359644|10132471|P2|Treatment Period|Lost to Follow-up|0
2943193|NCT01359644|10132472|P1|Treatment Period|Lost to Follow-up|0
2943194|NCT01359644|10132463|P10|Treatment Period|Adverse Event|0
2943195|NCT01359644|10132464|P9|Treatment Period|Adverse Event|0
2943196|NCT01359644|10132465|P8|Treatment Period|Adverse Event|0
2943197|NCT01359644|10132466|P7|Treatment Period|Adverse Event|0
2943198|NCT01359644|10132467|P6|Treatment Period|Adverse Event|1
2943199|NCT01359644|10132468|P5|Treatment Period|Adverse Event|0
2943200|NCT01359644|10132469|P4|Treatment Period|Adverse Event|0
2943201|NCT01359644|10132470|P3|Treatment Period|Adverse Event|1
2943202|NCT01359644|10132471|P2|Treatment Period|Adverse Event|0
2943203|NCT01359644|10132472|P1|Treatment Period|Adverse Event|0
2943204|NCT01359644|10132463|P10|Treatment Period|Lack of Efficacy|0
2943205|NCT01359644|10132464|P9|Treatment Period|Lack of Efficacy|0
2943206|NCT01359644|10132465|P8|Treatment Period|Lack of Efficacy|0
2943207|NCT01359644|10132466|P7|Treatment Period|Lack of Efficacy|0
2943208|NCT01359644|10132467|P6|Treatment Period|Lack of Efficacy|0
2943209|NCT01359644|10132468|P5|Treatment Period|Lack of Efficacy|0
2943210|NCT01359644|10132469|P4|Treatment Period|Lack of Efficacy|0
2943211|NCT01359644|10132470|P3|Treatment Period|Lack of Efficacy|0
2943212|NCT01359644|10132471|P2|Treatment Period|Lack of Efficacy|1
2943213|NCT01359644|10132472|P1|Treatment Period|Lack of Efficacy|0
2943214|NCT01359449|10132516|P2|Overall Study|Withdrawal by Subject|2
2943215|NCT01359449|10132517|P1|Overall Study|Withdrawal by Subject|3
2943216|NCT01359449|10132516|P2|Overall Study|Protocol Violation|2
2943217|NCT01359449|10132517|P1|Overall Study|Protocol Violation|0
2943218|NCT01359449|10132516|P2|Overall Study|Lost to Follow-up|0
2943219|NCT01359449|10132517|P1|Overall Study|Lost to Follow-up|1
2943220|NCT01359254|10132563|P2|Overall Study|Death|0
2943221|NCT01359254|10132564|P1|Overall Study|Death|1
2943222|NCT01359150|10132574|P2|Overall Study|Other|0
2943223|NCT01359150|10132575|P1|Overall Study|Other|1
2943224|NCT01359150|10132574|P2|Overall Study|Adverse Event|3
2943225|NCT01359150|10132575|P1|Overall Study|Adverse Event|4
2943226|NCT01359150|10132574|P2|Overall Study|Withdrawal by Subject|1
2943227|NCT01359150|10132575|P1|Overall Study|Withdrawal by Subject|1
2943228|NCT01359150|10132574|P2|Overall Study|Lack of Efficacy|1
2943229|NCT01359150|10132575|P1|Overall Study|Lack of Efficacy|1
2943230|NCT01359046|10132606|P2|Overall Study|Physician Decision|11
2943231|NCT01359046|10132607|P1|Overall Study|Physician Decision|1
2943232|NCT01359046|10132606|P2|Overall Study|Did not receive allocated intervention|6
2943233|NCT01359046|10132607|P1|Overall Study|Did not receive allocated intervention|6
2943234|NCT01358981|10132630|P7|Period 1|Withdrawal by Subject|0
2943235|NCT01358981|10132631|P6|Period 1|Withdrawal by Subject|0
2943236|NCT01358981|10132632|P5|Period 1|Withdrawal by Subject|0
2943237|NCT01358981|10132633|P4|Period 1|Withdrawal by Subject|1
2943238|NCT01358981|10132634|P3|Period 1|Withdrawal by Subject|0
2943239|NCT01358981|10132635|P2|Period 1|Withdrawal by Subject|0
2943240|NCT01358981|10132636|P1|Period 1|Withdrawal by Subject|0
2943241|NCT01358968|10132697|P4|Continued Access Phase|Death|1
2943242|NCT01358968|10132698|P3|Continued Access Phase|Death|1
2943243|NCT01358968|10132699|P2|Continued Access Phase|Death|0
2943244|NCT01358968|10132700|P1|Continued Access Phase|Death|0
2943245|NCT01358968|10132697|P4|Continued Access Phase|Withdrawal by Subject|0
2943246|NCT01358968|10132698|P3|Continued Access Phase|Withdrawal by Subject|3
2943247|NCT01358968|10132699|P2|Continued Access Phase|Withdrawal by Subject|0
2943248|NCT01358968|10132700|P1|Continued Access Phase|Withdrawal by Subject|0
2943249|NCT01358968|10132697|P4|Continued Access Phase|Protocol Violation|2
2943250|NCT01358968|10132698|P3|Continued Access Phase|Protocol Violation|0
2943251|NCT01358968|10132699|P2|Continued Access Phase|Protocol Violation|0
2943252|NCT01358968|10132700|P1|Continued Access Phase|Protocol Violation|0
2943253|NCT01358968|10132697|P4|Continued Access Phase|Progression of Disease|4
2943254|NCT01358968|10132698|P3|Continued Access Phase|Progression of Disease|8
2943255|NCT01358968|10132699|P2|Continued Access Phase|Progression of Disease|0
2943256|NCT01358968|10132700|P1|Continued Access Phase|Progression of Disease|0
2943257|NCT01358968|10132697|P4|Period 2|Adverse Event|0
2943258|NCT01358968|10132698|P3|Period 2|Adverse Event|0
2943259|NCT01358968|10132699|P2|Period 2|Adverse Event|1
2943260|NCT01358968|10132700|P1|Period 2|Adverse Event|0
2943261|NCT01358877|10132716|P2|Overall Study|Other|129
2943262|NCT01358877|10132717|P1|Overall Study|Other|142
2943263|NCT01358877|10132716|P2|Overall Study|Ongoing follow-up for overall survival|5
2943264|NCT01358877|10132717|P1|Overall Study|Ongoing follow-up for overall survival|7
2943265|NCT01358877|10132716|P2|Overall Study|Ongoing follow-up for IDFS event|2073
2943266|NCT01358877|10132717|P1|Overall Study|Ongoing follow-up for IDFS event|2084
2943267|NCT01358877|10132716|P2|Overall Study|Ongoing follow-up for post-recurrence|108
2943268|NCT01358877|10132717|P1|Overall Study|Ongoing follow-up for post-recurrence|87
2943269|NCT01358877|10132716|P2|Overall Study|Death|89
2943270|NCT01358877|10132717|P1|Overall Study|Death|80
2943271|NCT01358864|10132787|P8|Overall Study|Not treated|0
2943272|NCT01358864|10132788|P7|Overall Study|Not treated|1
2943273|NCT01358864|10132789|P6|Overall Study|Not treated|0
2943274|NCT01358864|10132790|P5|Overall Study|Not treated|0
2943275|NCT01358864|10132791|P4|Overall Study|Not treated|0
2943276|NCT01358864|10132792|P3|Overall Study|Not treated|0
2943277|NCT01358864|10132793|P2|Overall Study|Not treated|0
2943278|NCT01358864|10132794|P1|Overall Study|Not treated|0
2943279|NCT01358864|10132787|P8|Overall Study|Other reason not defined above|0
2943280|NCT01358864|10132788|P7|Overall Study|Other reason not defined above|2
2943281|NCT01358864|10132789|P6|Overall Study|Other reason not defined above|0
2943282|NCT01358864|10132790|P5|Overall Study|Other reason not defined above|0
2943283|NCT01358864|10132791|P4|Overall Study|Other reason not defined above|0
2943284|NCT01358864|10132792|P3|Overall Study|Other reason not defined above|0
2943285|NCT01358864|10132793|P2|Overall Study|Other reason not defined above|0
2943286|NCT01358864|10132794|P1|Overall Study|Other reason not defined above|2
2943287|NCT01358864|10132787|P8|Overall Study|Withdrawal by Subject|3
2943288|NCT01358864|10132788|P7|Overall Study|Withdrawal by Subject|1
2943289|NCT01358864|10132789|P6|Overall Study|Withdrawal by Subject|1
2943290|NCT01358864|10132790|P5|Overall Study|Withdrawal by Subject|0
2943291|NCT01358864|10132791|P4|Overall Study|Withdrawal by Subject|0
2943292|NCT01358864|10132792|P3|Overall Study|Withdrawal by Subject|2
2943293|NCT01358864|10132793|P2|Overall Study|Withdrawal by Subject|4
2943294|NCT01358864|10132794|P1|Overall Study|Withdrawal by Subject|3
2943295|NCT01358864|10132787|P8|Overall Study|Lost to Follow-up|1
2943296|NCT01358864|10132788|P7|Overall Study|Lost to Follow-up|0
2943297|NCT01358864|10132789|P6|Overall Study|Lost to Follow-up|0
2943298|NCT01358864|10132790|P5|Overall Study|Lost to Follow-up|0
2943299|NCT01358864|10132791|P4|Overall Study|Lost to Follow-up|0
2943300|NCT01358864|10132792|P3|Overall Study|Lost to Follow-up|1
2943301|NCT01358864|10132793|P2|Overall Study|Lost to Follow-up|0
2943302|NCT01358864|10132794|P1|Overall Study|Lost to Follow-up|0
2943303|NCT01358864|10132787|P8|Overall Study|Lack of Efficacy|44
2943304|NCT01358864|10132788|P7|Overall Study|Lack of Efficacy|49
2943305|NCT01358864|10132789|P6|Overall Study|Lack of Efficacy|4
2943306|NCT01358864|10132790|P5|Overall Study|Lack of Efficacy|7
2943307|NCT01358864|10132791|P4|Overall Study|Lack of Efficacy|19
2943308|NCT01358864|10132792|P3|Overall Study|Lack of Efficacy|4
2943309|NCT01358864|10132793|P2|Overall Study|Lack of Efficacy|3
2943310|NCT01358864|10132794|P1|Overall Study|Lack of Efficacy|26
2943311|NCT01358864|10132787|P8|Overall Study|Adverse Event|7
2943312|NCT01358864|10132788|P7|Overall Study|Adverse Event|12
2943313|NCT01358864|10132789|P6|Overall Study|Adverse Event|8
2943314|NCT01358864|10132790|P5|Overall Study|Adverse Event|4
2943315|NCT01358864|10132791|P4|Overall Study|Adverse Event|0
2943316|NCT01358864|10132792|P3|Overall Study|Adverse Event|9
2943317|NCT01358864|10132793|P2|Overall Study|Adverse Event|6
2943318|NCT01358864|10132794|P1|Overall Study|Adverse Event|0
2943319|NCT01358825|10132885|P2|Overall Study|Blood sample not drawn|1
2943320|NCT01358825|10132886|P1|Overall Study|Blood sample not drawn|0
2943321|NCT01358760|10132910|P3|Overall Study|Entry criteria not met/Non-compliance|16
2943322|NCT01358760|10132911|P2|Overall Study|Entry criteria not met/Non-compliance|12
2943323|NCT01358760|10132912|P1|Overall Study|Entry criteria not met/Non-compliance|12
2943324|NCT01358760|10132910|P3|Overall Study|Physician Decision|1
2943325|NCT01358760|10132911|P2|Overall Study|Physician Decision|0
2943326|NCT01358760|10132912|P1|Overall Study|Physician Decision|1
2943327|NCT01358760|10132910|P3|Overall Study|Withdrawal by Subject|2
2943328|NCT01358760|10132911|P2|Overall Study|Withdrawal by Subject|3
2943329|NCT01358760|10132912|P1|Overall Study|Withdrawal by Subject|5
2943330|NCT01358760|10132910|P3|Overall Study|Lost to Follow-up|3
2943331|NCT01358760|10132911|P2|Overall Study|Lost to Follow-up|1
2943332|NCT01358760|10132912|P1|Overall Study|Lost to Follow-up|1
2943333|NCT01358760|10132910|P3|Overall Study|Adverse Event|3
2943334|NCT01358760|10132911|P2|Overall Study|Adverse Event|4
2943335|NCT01358760|10132912|P1|Overall Study|Adverse Event|3
2943336|NCT01358734|10132947|P3|Overall Study|Protocol Violation|2
2943337|NCT01358734|10132948|P2|Overall Study|Protocol Violation|0
2943338|NCT01358734|10132949|P1|Overall Study|Protocol Violation|0
2943339|NCT01358734|10132947|P3|Overall Study|Other|4
2943340|NCT01358734|10132948|P2|Overall Study|Other|5
2943341|NCT01358734|10132949|P1|Overall Study|Other|2
2943342|NCT01358734|10132947|P3|Overall Study|Non-compliance with study drug|1
2943343|NCT01358734|10132948|P2|Overall Study|Non-compliance with study drug|0
2943344|NCT01358734|10132949|P1|Overall Study|Non-compliance with study drug|0
2943345|NCT01358734|10132947|P3|Overall Study|Progressive Disease|16
2943346|NCT01358734|10132948|P2|Overall Study|Progressive Disease|13
2943347|NCT01358734|10132949|P1|Overall Study|Progressive Disease|5
2943348|NCT01358734|10132947|P3|Overall Study|Death|2
2943349|NCT01358734|10132948|P2|Overall Study|Death|7
2943350|NCT01358734|10132949|P1|Overall Study|Death|3
2943351|NCT01358734|10132947|P3|Overall Study|Withdrawal by Subject|3
2943352|NCT01358734|10132948|P2|Overall Study|Withdrawal by Subject|6
2943353|NCT01358734|10132949|P1|Overall Study|Withdrawal by Subject|1
2943354|NCT01358734|10132947|P3|Overall Study|Lack of Efficacy|3
2943355|NCT01358734|10132948|P2|Overall Study|Lack of Efficacy|1
2943356|NCT01358734|10132949|P1|Overall Study|Lack of Efficacy|0
2943357|NCT01358734|10132947|P3|Overall Study|Adverse Event|3
2943358|NCT01358734|10132948|P2|Overall Study|Adverse Event|7
2943359|NCT01358734|10132949|P1|Overall Study|Adverse Event|4
2943360|NCT01358721|10132997|P4|Overall Study|Out of State/Unmet Criteria|0
2943361|NCT01358721|10132998|P3|Overall Study|Out of State/Unmet Criteria|1
2943362|NCT01358721|10132999|P2|Overall Study|Out of State/Unmet Criteria|0
2943363|NCT01358721|10133000|P1|Overall Study|Out of State/Unmet Criteria|0
2943364|NCT01358721|10132997|P4|Overall Study|Disease Progression|15
2943365|NCT01358721|10132998|P3|Overall Study|Disease Progression|17
2943366|NCT01358721|10132999|P2|Overall Study|Disease Progression|15
2943367|NCT01358721|10133000|P1|Overall Study|Disease Progression|19
2943368|NCT01358721|10132997|P4|Overall Study|Adverse Event related to study drug|1
2943369|NCT01358721|10132998|P3|Overall Study|Adverse Event related to study drug|0
2943370|NCT01358721|10132999|P2|Overall Study|Adverse Event related to study drug|0
2943371|NCT01358721|10133000|P1|Overall Study|Adverse Event related to study drug|1
2943372|NCT01358721|10132997|P4|Overall Study|Subject No Longer Meets Study Criteria|1
2943373|NCT01358721|10132998|P3|Overall Study|Subject No Longer Meets Study Criteria|0
2943374|NCT01358721|10132999|P2|Overall Study|Subject No Longer Meets Study Criteria|2
2943375|NCT01358721|10133000|P1|Overall Study|Subject No Longer Meets Study Criteria|0
2943376|NCT01358721|10132997|P4|Overall Study|SUBJ request to discontinue study TRT|1
2943377|NCT01358721|10132998|P3|Overall Study|SUBJ request to discontinue study TRT|0
2943378|NCT01358721|10132999|P2|Overall Study|SUBJ request to discontinue study TRT|0
2943379|NCT01358721|10133000|P1|Overall Study|SUBJ request to discontinue study TRT|0
2943380|NCT01358721|10132997|P4|Overall Study|Study Drug Toxicity|5
2943381|NCT01358721|10132998|P3|Overall Study|Study Drug Toxicity|4
2943382|NCT01358721|10132999|P2|Overall Study|Study Drug Toxicity|3
2943383|NCT01358721|10133000|P1|Overall Study|Study Drug Toxicity|1
2943384|NCT01358721|10132997|P4|Overall Study|Death|0
2943385|NCT01358721|10132998|P3|Overall Study|Death|0
2943386|NCT01358721|10132999|P2|Overall Study|Death|2
2943387|NCT01358721|10133000|P1|Overall Study|Death|0
2943388|NCT01358721|10132997|P4|Overall Study|Withdrawal by Subject|1
2943389|NCT01358721|10132998|P3|Overall Study|Withdrawal by Subject|0
2943390|NCT01358721|10132999|P2|Overall Study|Withdrawal by Subject|0
2943391|NCT01358721|10133000|P1|Overall Study|Withdrawal by Subject|0
2943392|NCT01358708|10133052|P2|Double-Blind Treatment Phase|Protocol Violation|0
2943393|NCT01358708|10133053|P1|Double-Blind Treatment Phase|Protocol Violation|1
2943394|NCT01358708|10133052|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
2943395|NCT01358708|10133053|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
2943396|NCT01358578|10133076|P6|Follow-up Period|Physician Decision|0
2943397|NCT01358578|10133077|P5|Follow-up Period|Physician Decision|0
2943398|NCT01358578|10133078|P4|Follow-up Period|Physician Decision|2
2943399|NCT01358578|10133079|P3|Follow-up Period|Physician Decision|0
2943400|NCT01358578|10133080|P2|Follow-up Period|Physician Decision|1
2943401|NCT01358578|10133081|P1|Follow-up Period|Physician Decision|1
2943402|NCT01358578|10133076|P6|Follow-up Period|Withdrawal by Subject|0
2943403|NCT01358578|10133077|P5|Follow-up Period|Withdrawal by Subject|0
2943404|NCT01358578|10133078|P4|Follow-up Period|Withdrawal by Subject|12
2943405|NCT01358578|10133079|P3|Follow-up Period|Withdrawal by Subject|1
2943406|NCT01358578|10133080|P2|Follow-up Period|Withdrawal by Subject|3
2943407|NCT01358578|10133081|P1|Follow-up Period|Withdrawal by Subject|3
2943408|NCT01358578|10133076|P6|Follow-up Period|Pregnancy|0
2943409|NCT01358578|10133077|P5|Follow-up Period|Pregnancy|0
2943410|NCT01358578|10133078|P4|Follow-up Period|Pregnancy|0
2943411|NCT01358578|10133079|P3|Follow-up Period|Pregnancy|0
2943412|NCT01358578|10133080|P2|Follow-up Period|Pregnancy|0
2943413|NCT01358578|10133081|P1|Follow-up Period|Pregnancy|1
2943414|NCT01358578|10133076|P6|Follow-up Period|non- compliance with study treatment|0
2943415|NCT01358578|10133077|P5|Follow-up Period|non- compliance with study treatment|0
2943416|NCT01358578|10133078|P4|Follow-up Period|non- compliance with study treatment|0
2943417|NCT01358578|10133079|P3|Follow-up Period|non- compliance with study treatment|0
2943418|NCT01358578|10133080|P2|Follow-up Period|non- compliance with study treatment|0
2943419|NCT01358578|10133081|P1|Follow-up Period|non- compliance with study treatment|1
2943420|NCT01358578|10133076|P6|Follow-up Period|Lost to Follow-up|0
2943421|NCT01358578|10133077|P5|Follow-up Period|Lost to Follow-up|0
2943422|NCT01358578|10133078|P4|Follow-up Period|Lost to Follow-up|4
2943423|NCT01358578|10133079|P3|Follow-up Period|Lost to Follow-up|0
2943424|NCT01358578|10133080|P2|Follow-up Period|Lost to Follow-up|1
2943425|NCT01358578|10133081|P1|Follow-up Period|Lost to Follow-up|0
2943426|NCT01358578|10133076|P6|Follow-up Period|Lack of Efficacy|0
2943427|NCT01358578|10133077|P5|Follow-up Period|Lack of Efficacy|0
2943428|NCT01358578|10133078|P4|Follow-up Period|Lack of Efficacy|1
2943429|NCT01358578|10133079|P3|Follow-up Period|Lack of Efficacy|4
2943430|NCT01358578|10133080|P2|Follow-up Period|Lack of Efficacy|0
2943431|NCT01358578|10133081|P1|Follow-up Period|Lack of Efficacy|3
2943432|NCT01358578|10133076|P6|Follow-up Period|Adverse Event|0
2943433|NCT01358578|10133077|P5|Follow-up Period|Adverse Event|0
2943434|NCT01358578|10133078|P4|Follow-up Period|Adverse Event|0
2943435|NCT01358578|10133079|P3|Follow-up Period|Adverse Event|0
2943436|NCT01358578|10133080|P2|Follow-up Period|Adverse Event|1
2943437|NCT01358578|10133081|P1|Follow-up Period|Adverse Event|1
2943438|NCT01358578|10133076|P6|Maintenance Period|Withdrawal by Subject|3
2943439|NCT01358578|10133077|P5|Maintenance Period|Withdrawal by Subject|6
2943440|NCT01358578|10133078|P4|Maintenance Period|Withdrawal by Subject|15
2943441|NCT01358578|10133079|P3|Maintenance Period|Withdrawal by Subject|2
2943442|NCT01358578|10133080|P2|Maintenance Period|Withdrawal by Subject|7
2943443|NCT01358578|10133081|P1|Maintenance Period|Withdrawal by Subject|12
2943444|NCT01358578|10133076|P6|Maintenance Period|Protocol deviation|2
2943445|NCT01358578|10133077|P5|Maintenance Period|Protocol deviation|2
2943446|NCT01358578|10133078|P4|Maintenance Period|Protocol deviation|2
2943447|NCT01358578|10133079|P3|Maintenance Period|Protocol deviation|0
2943448|NCT01358578|10133080|P2|Maintenance Period|Protocol deviation|4
2943449|NCT01358578|10133081|P1|Maintenance Period|Protocol deviation|7
2943450|NCT01358578|10133076|P6|Maintenance Period|Pregnancy|0
2943451|NCT01358578|10133077|P5|Maintenance Period|Pregnancy|0
2943452|NCT01358578|10133078|P4|Maintenance Period|Pregnancy|0
2943453|NCT01358578|10133079|P3|Maintenance Period|Pregnancy|0
2943454|NCT01358578|10133080|P2|Maintenance Period|Pregnancy|0
2943455|NCT01358578|10133081|P1|Maintenance Period|Pregnancy|1
2943456|NCT01358578|10133076|P6|Maintenance Period|Physician Decision|0
2943457|NCT01358578|10133077|P5|Maintenance Period|Physician Decision|0
2943458|NCT01358578|10133078|P4|Maintenance Period|Physician Decision|1
2943459|NCT01358578|10133079|P3|Maintenance Period|Physician Decision|0
2943460|NCT01358578|10133080|P2|Maintenance Period|Physician Decision|1
2943461|NCT01358578|10133081|P1|Maintenance Period|Physician Decision|0
2943462|NCT01358578|10133076|P6|Maintenance Period|Non-compliance with study treatment|2
2943463|NCT01358578|10133077|P5|Maintenance Period|Non-compliance with study treatment|1
2943464|NCT01358578|10133078|P4|Maintenance Period|Non-compliance with study treatment|2
2943465|NCT01358578|10133079|P3|Maintenance Period|Non-compliance with study treatment|0
2943466|NCT01358578|10133080|P2|Maintenance Period|Non-compliance with study treatment|1
2943467|NCT01358578|10133081|P1|Maintenance Period|Non-compliance with study treatment|3
2943468|NCT01358578|10133076|P6|Maintenance Period|Lost to Follow-up|1
2943469|NCT01358578|10133077|P5|Maintenance Period|Lost to Follow-up|1
2943470|NCT01358578|10133078|P4|Maintenance Period|Lost to Follow-up|5
2943471|NCT01358578|10133079|P3|Maintenance Period|Lost to Follow-up|0
2943472|NCT01358578|10133080|P2|Maintenance Period|Lost to Follow-up|0
2943473|NCT01358578|10133081|P1|Maintenance Period|Lost to Follow-up|4
2943474|NCT01358578|10133076|P6|Maintenance Period|Lack of Efficacy|0
2943475|NCT01358578|10133077|P5|Maintenance Period|Lack of Efficacy|3
2943476|NCT01358578|10133078|P4|Maintenance Period|Lack of Efficacy|11
2943477|NCT01358578|10133079|P3|Maintenance Period|Lack of Efficacy|0
2943478|NCT01358578|10133080|P2|Maintenance Period|Lack of Efficacy|2
2943479|NCT01358578|10133081|P1|Maintenance Period|Lack of Efficacy|10
2943480|NCT01358578|10133076|P6|Maintenance Period|Adverse Event|3
2943481|NCT01358578|10133077|P5|Maintenance Period|Adverse Event|4
2943482|NCT01358578|10133078|P4|Maintenance Period|Adverse Event|6
2943483|NCT01358578|10133079|P3|Maintenance Period|Adverse Event|0
2943484|NCT01358578|10133080|P2|Maintenance Period|Adverse Event|7
2943485|NCT01358578|10133081|P1|Maintenance Period|Adverse Event|2
2943486|NCT01358578|10133076|P6|Induction Period|Withdrawal by Subject|0
2943487|NCT01358578|10133077|P5|Induction Period|Withdrawal by Subject|0
2943488|NCT01358578|10133078|P4|Induction Period|Withdrawal by Subject|6
2943489|NCT01358578|10133079|P3|Induction Period|Withdrawal by Subject|10
2943490|NCT01358578|10133080|P2|Induction Period|Withdrawal by Subject|5
2943491|NCT01358578|10133081|P1|Induction Period|Withdrawal by Subject|5
2943492|NCT01358578|10133076|P6|Induction Period|technical problems|0
2943493|NCT01358578|10133077|P5|Induction Period|technical problems|0
2943494|NCT01358578|10133078|P4|Induction Period|technical problems|1
2943495|NCT01358578|10133079|P3|Induction Period|technical problems|1
2943496|NCT01358578|10133080|P2|Induction Period|technical problems|0
2943497|NCT01358578|10133081|P1|Induction Period|technical problems|0
2943498|NCT01358578|10133076|P6|Induction Period|Protocol Deviation|0
2943499|NCT01358578|10133077|P5|Induction Period|Protocol Deviation|0
2943500|NCT01358578|10133078|P4|Induction Period|Protocol Deviation|3
2943501|NCT01358578|10133079|P3|Induction Period|Protocol Deviation|0
2943502|NCT01358578|10133080|P2|Induction Period|Protocol Deviation|5
2943503|NCT01358578|10133081|P1|Induction Period|Protocol Deviation|3
2943504|NCT01358578|10133076|P6|Induction Period|Physician Decision|0
2943505|NCT01358578|10133077|P5|Induction Period|Physician Decision|0
2943506|NCT01358578|10133078|P4|Induction Period|Physician Decision|0
2943507|NCT01358578|10133079|P3|Induction Period|Physician Decision|2
2943508|NCT01358578|10133080|P2|Induction Period|Physician Decision|1
2943509|NCT01358578|10133081|P1|Induction Period|Physician Decision|2
2943510|NCT01358578|10133076|P6|Induction Period|Lost to Follow-up|0
2943511|NCT01358578|10133077|P5|Induction Period|Lost to Follow-up|0
2943512|NCT01358578|10133078|P4|Induction Period|Lost to Follow-up|4
2943513|NCT01358578|10133079|P3|Induction Period|Lost to Follow-up|1
2943514|NCT01358578|10133080|P2|Induction Period|Lost to Follow-up|0
2943515|NCT01358578|10133081|P1|Induction Period|Lost to Follow-up|0
2943516|NCT01358578|10133076|P6|Induction Period|Lack of Efficacy|0
2943517|NCT01358578|10133077|P5|Induction Period|Lack of Efficacy|0
2943518|NCT01358578|10133078|P4|Induction Period|Lack of Efficacy|1
2943519|NCT01358578|10133079|P3|Induction Period|Lack of Efficacy|9
2943520|NCT01358578|10133080|P2|Induction Period|Lack of Efficacy|0
2943521|NCT01358578|10133081|P1|Induction Period|Lack of Efficacy|0
2943522|NCT01358578|10133076|P6|Induction Period|Adverse Event|0
2943523|NCT01358578|10133077|P5|Induction Period|Adverse Event|0
2943524|NCT01358578|10133078|P4|Induction Period|Adverse Event|6
2943525|NCT01358578|10133079|P3|Induction Period|Adverse Event|2
2943526|NCT01358578|10133080|P2|Induction Period|Adverse Event|4
2943527|NCT01358578|10133081|P1|Induction Period|Adverse Event|2
2943528|NCT01358526|10133133|P3|Double-blind Phase|Administrative|10
2943529|NCT01358526|10133134|P2|Double-blind Phase|Administrative|6
2943530|NCT01358526|10133135|P1|Double-blind Phase|Administrative|0
2943531|NCT01358526|10133133|P3|Double-blind Phase|Confirmed or suspected diversion|6
2943532|NCT01358526|10133134|P2|Double-blind Phase|Confirmed or suspected diversion|5
2943533|NCT01358526|10133135|P1|Double-blind Phase|Confirmed or suspected diversion|0
2943534|NCT01358526|10133133|P3|Double-blind Phase|Lack of Efficacy|73
2943535|NCT01358526|10133134|P2|Double-blind Phase|Lack of Efficacy|31
2943536|NCT01358526|10133135|P1|Double-blind Phase|Lack of Efficacy|0
2943537|NCT01358526|10133133|P3|Double-blind Phase|Lost to Follow-up|1
2943538|NCT01358526|10133134|P2|Double-blind Phase|Lost to Follow-up|4
2943539|NCT01358526|10133135|P1|Double-blind Phase|Lost to Follow-up|0
2943540|NCT01358526|10133133|P3|Double-blind Phase|Withdrawal by Subject|8
2943541|NCT01358526|10133134|P2|Double-blind Phase|Withdrawal by Subject|10
2943542|NCT01358526|10133135|P1|Double-blind Phase|Withdrawal by Subject|0
2943543|NCT01358526|10133133|P3|Double-blind Phase|Adverse Event|23
2943544|NCT01358526|10133134|P2|Double-blind Phase|Adverse Event|24
2943545|NCT01358526|10133135|P1|Double-blind Phase|Adverse Event|0
2943546|NCT01358526|10133133|P3|Open-label Titration Period|Did not qualify|0
2943547|NCT01358526|10133134|P2|Open-label Titration Period|Did not qualify|0
2943548|NCT01358526|10133135|P1|Open-label Titration Period|Did not qualify|178
2943549|NCT01358526|10133133|P3|Open-label Titration Period|Administrative|0
2943550|NCT01358526|10133134|P2|Open-label Titration Period|Administrative|0
2943551|NCT01358526|10133135|P1|Open-label Titration Period|Administrative|8
2943552|NCT01358526|10133133|P3|Open-label Titration Period|Confirmed or suspected diversion|0
2943553|NCT01358526|10133134|P2|Open-label Titration Period|Confirmed or suspected diversion|0
2943554|NCT01358526|10133135|P1|Open-label Titration Period|Confirmed or suspected diversion|16
2943555|NCT01358526|10133133|P3|Open-label Titration Period|Lack of Efficacy|0
2943556|NCT01358526|10133134|P2|Open-label Titration Period|Lack of Efficacy|0
2943557|NCT01358526|10133135|P1|Open-label Titration Period|Lack of Efficacy|107
2943558|NCT01358526|10133133|P3|Open-label Titration Period|Lost to Follow-up|0
2943559|NCT01358526|10133134|P2|Open-label Titration Period|Lost to Follow-up|0
2943560|NCT01358526|10133135|P1|Open-label Titration Period|Lost to Follow-up|25
2943561|NCT01358526|10133133|P3|Open-label Titration Period|Withdrawal by Subject|0
2943562|NCT01358526|10133134|P2|Open-label Titration Period|Withdrawal by Subject|0
2943563|NCT01358526|10133135|P1|Open-label Titration Period|Withdrawal by Subject|65
2943564|NCT01358526|10133133|P3|Open-label Titration Period|Adverse Event|0
2943565|NCT01358526|10133134|P2|Open-label Titration Period|Adverse Event|0
2943566|NCT01358526|10133135|P1|Open-label Titration Period|Adverse Event|95
2943567|NCT01358357|10133152|P3|Double-Blind Phase|Administrative|0
2943568|NCT01358357|10133153|P2|Double-Blind Phase|Administrative|1
2943569|NCT01358357|10133154|P1|Double-Blind Phase|Administrative|0
2943570|NCT01358357|10133152|P3|Double-Blind Phase|Recurrence of mood event|0
2943571|NCT01358357|10133153|P2|Double-Blind Phase|Recurrence of mood event|64
2943572|NCT01358357|10133154|P1|Double-Blind Phase|Recurrence of mood event|48
2943573|NCT01358357|10133152|P3|Double-Blind Phase|Terminated at study completion|0
2943574|NCT01358357|10133153|P2|Double-Blind Phase|Terminated at study completion|0
2943575|NCT01358357|10133154|P1|Double-Blind Phase|Terminated at study completion|2
2943576|NCT01358357|10133152|P3|Double-Blind Phase|Protocol Violation|0
2943577|NCT01358357|10133153|P2|Double-Blind Phase|Protocol Violation|12
2943578|NCT01358357|10133154|P1|Double-Blind Phase|Protocol Violation|16
2943579|NCT01358357|10133152|P3|Double-Blind Phase|Protocol Violation|0
2943580|NCT01358357|10133153|P2|Double-Blind Phase|Protocol Violation|11
2943581|NCT01358357|10133154|P1|Double-Blind Phase|Protocol Violation|1
2943582|NCT01358357|10133152|P3|Double-Blind Phase|Lost to Follow-up|0
2943583|NCT01358357|10133153|P2|Double-Blind Phase|Lost to Follow-up|7
2943584|NCT01358357|10133154|P1|Double-Blind Phase|Lost to Follow-up|5
2943585|NCT01358357|10133152|P3|Double-Blind Phase|Adverse Event|0
2943586|NCT01358357|10133153|P2|Double-Blind Phase|Adverse Event|5
2943587|NCT01358357|10133154|P1|Double-Blind Phase|Adverse Event|8
2943588|NCT01358357|10133152|P3|Open Label Phase|Mood episode|42
2943589|NCT01358357|10133153|P2|Open Label Phase|Mood episode|0
2943590|NCT01358357|10133154|P1|Open Label Phase|Mood episode|0
2943591|NCT01358357|10133152|P3|Open Label Phase|Terminated at study completion|5
2943592|NCT01358357|10133153|P2|Open Label Phase|Terminated at study completion|0
2943593|NCT01358357|10133154|P1|Open Label Phase|Terminated at study completion|0
2943594|NCT01358357|10133152|P3|Open Label Phase|Did not meet criteria for DB phase|16
2943595|NCT01358357|10133153|P2|Open Label Phase|Did not meet criteria for DB phase|0
2943596|NCT01358357|10133154|P1|Open Label Phase|Did not meet criteria for DB phase|0
2943597|NCT01358357|10133152|P3|Open Label Phase|Withdrawal by Subject|112
2943598|NCT01358357|10133153|P2|Open Label Phase|Withdrawal by Subject|0
2943599|NCT01358357|10133154|P1|Open Label Phase|Withdrawal by Subject|0
2943600|NCT01358357|10133152|P3|Open Label Phase|Protocol Violation|45
2943601|NCT01358357|10133153|P2|Open Label Phase|Protocol Violation|0
2943602|NCT01358357|10133154|P1|Open Label Phase|Protocol Violation|0
2943603|NCT01358357|10133152|P3|Open Label Phase|Lost to Follow-up|76
2943604|NCT01358357|10133153|P2|Open Label Phase|Lost to Follow-up|0
2943605|NCT01358357|10133154|P1|Open Label Phase|Lost to Follow-up|0
2943606|NCT01358357|10133152|P3|Open Label Phase|Lack of Efficacy|107
2943607|NCT01358357|10133153|P2|Open Label Phase|Lack of Efficacy|0
2943608|NCT01358357|10133154|P1|Open Label Phase|Lack of Efficacy|0
2943609|NCT01358357|10133152|P3|Open Label Phase|Adverse Event|59
2943610|NCT01358357|10133153|P2|Open Label Phase|Adverse Event|0
2943611|NCT01358357|10133154|P1|Open Label Phase|Adverse Event|0
2943612|NCT01358331|10133193|P6|Overall Study|Progress of disease under investigation|0
2943613|NCT01358331|10133194|P5|Overall Study|Progress of disease under investigation|3
2943614|NCT01358331|10133195|P4|Overall Study|Progress of disease under investigation|1
2943615|NCT01358331|10133196|P3|Overall Study|Progress of disease under investigation|3
2943616|NCT01358331|10133197|P2|Overall Study|Progress of disease under investigation|2
2943617|NCT01358331|10133198|P1|Overall Study|Progress of disease under investigation|1
2943618|NCT01358331|10133193|P6|Overall Study|Participants did not wish to continue|0
2943619|NCT01358331|10133194|P5|Overall Study|Participants did not wish to continue|1
2943620|NCT01358331|10133195|P4|Overall Study|Participants did not wish to continue|0
2943621|NCT01358331|10133196|P3|Overall Study|Participants did not wish to continue|0
2943622|NCT01358331|10133197|P2|Overall Study|Participants did not wish to continue|0
2943623|NCT01358331|10133198|P1|Overall Study|Participants did not wish to continue|0
2943624|NCT01358331|10133193|P6|Overall Study|Symptomatic Deterioration|0
2943625|NCT01358331|10133194|P5|Overall Study|Symptomatic Deterioration|1
2943626|NCT01358331|10133195|P4|Overall Study|Symptomatic Deterioration|0
2943627|NCT01358331|10133196|P3|Overall Study|Symptomatic Deterioration|0
2943628|NCT01358331|10133197|P2|Overall Study|Symptomatic Deterioration|0
2943629|NCT01358331|10133198|P1|Overall Study|Symptomatic Deterioration|0
2943630|NCT01358331|10133193|P6|Overall Study|Adverse Events|5
2943631|NCT01358331|10133194|P5|Overall Study|Adverse Events|1
2943632|NCT01358331|10133195|P4|Overall Study|Adverse Events|0
2943633|NCT01358331|10133196|P3|Overall Study|Adverse Events|1
2943634|NCT01358331|10133197|P2|Overall Study|Adverse Events|1
2943635|NCT01358331|10133198|P1|Overall Study|Adverse Events|1
2943636|NCT01358331|10133193|P6|Overall Study|Withdrawal by Subject|1
2943637|NCT01358331|10133194|P5|Overall Study|Withdrawal by Subject|1
2943638|NCT01358331|10133195|P4|Overall Study|Withdrawal by Subject|1
2943639|NCT01358331|10133196|P3|Overall Study|Withdrawal by Subject|0
2943640|NCT01358331|10133197|P2|Overall Study|Withdrawal by Subject|0
2943641|NCT01358331|10133198|P1|Overall Study|Withdrawal by Subject|0
2943642|NCT01358331|10133193|P6|Overall Study|Lost to Follow-up|0
2943643|NCT01358331|10133194|P5|Overall Study|Lost to Follow-up|0
2943644|NCT01358331|10133195|P4|Overall Study|Lost to Follow-up|1
2943645|NCT01358331|10133196|P3|Overall Study|Lost to Follow-up|0
2943646|NCT01358331|10133197|P2|Overall Study|Lost to Follow-up|0
2943647|NCT01358331|10133198|P1|Overall Study|Lost to Follow-up|0
2943648|NCT01358175|10133250|P3|Overall Study|Adverse Event|11
2943649|NCT01358175|10133251|P2|Overall Study|Adverse Event|11
2943650|NCT01358175|10133252|P1|Overall Study|Adverse Event|6
2943651|NCT01358175|10133250|P3|Overall Study|Lack of Efficacy|6
2943652|NCT01358175|10133251|P2|Overall Study|Lack of Efficacy|8
2943653|NCT01358175|10133252|P1|Overall Study|Lack of Efficacy|3
2943654|NCT01358175|10133250|P3|Overall Study|Lost to Follow-up|3
2943655|NCT01358175|10133251|P2|Overall Study|Lost to Follow-up|1
2943656|NCT01358175|10133252|P1|Overall Study|Lost to Follow-up|1
2943657|NCT01358175|10133250|P3|Overall Study|Non Compliance with Study Treatment|1
2943658|NCT01358175|10133251|P2|Overall Study|Non Compliance with Study Treatment|1
2943659|NCT01358175|10133252|P1|Overall Study|Non Compliance with Study Treatment|0
2943660|NCT01358175|10133250|P3|Overall Study|Physician Decision|0
2943661|NCT01358175|10133251|P2|Overall Study|Physician Decision|0
2943662|NCT01358175|10133252|P1|Overall Study|Physician Decision|1
2943663|NCT01358175|10133250|P3|Overall Study|Pregnancy|0
2943664|NCT01358175|10133251|P2|Overall Study|Pregnancy|1
2943665|NCT01358175|10133252|P1|Overall Study|Pregnancy|0
2943666|NCT01358175|10133250|P3|Overall Study|Technical issues|0
2943667|NCT01358175|10133251|P2|Overall Study|Technical issues|1
2943668|NCT01358175|10133252|P1|Overall Study|Technical issues|0
2943669|NCT01358175|10133250|P3|Overall Study|Withdrawal by Subject|10
2943670|NCT01358175|10133251|P2|Overall Study|Withdrawal by Subject|5
2943671|NCT01358175|10133252|P1|Overall Study|Withdrawal by Subject|9
2943672|NCT01358175|10133250|P3|Overall Study|Death|1
2943673|NCT01358175|10133251|P2|Overall Study|Death|0
2943674|NCT01358175|10133252|P1|Overall Study|Death|1
2943675|NCT01357980|10133289|P4|Overall Study|Consent withdrawn|0
2943676|NCT01357980|10133290|P3|Overall Study|Consent withdrawn|1
2943677|NCT01357980|10133291|P2|Overall Study|Consent withdrawn|0
2943678|NCT01357980|10133292|P1|Overall Study|Consent withdrawn|0
2943679|NCT01357980|10133289|P4|Overall Study|Lack of Efficacy|0
2943680|NCT01357980|10133290|P3|Overall Study|Lack of Efficacy|0
2943681|NCT01357980|10133291|P2|Overall Study|Lack of Efficacy|1
2943682|NCT01357980|10133292|P1|Overall Study|Lack of Efficacy|0
2943683|NCT01357915|10133336|P2|Overall Study|Lost to Follow-up|0
2943684|NCT01357915|10133337|P1|Overall Study|Lost to Follow-up|3
2943685|NCT01357889|10133355|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
2943686|NCT01357889|10133356|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
2943687|NCT01357889|10133355|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
2943688|NCT01357889|10133356|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
2943689|NCT01357889|10133355|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
2943690|NCT01357889|10133356|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
2943691|NCT01357889|10133355|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
2943692|NCT01357889|10133356|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
2943693|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2943694|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2943695|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
2943696|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
2943697|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
2943698|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
2943699|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
2943700|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
2943701|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
2943702|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
2943703|NCT01357889|10133355|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2943704|NCT01357889|10133356|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2943705|NCT01357889|10133355|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
2943706|NCT01357889|10133356|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
2943707|NCT01357889|10133355|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2943708|NCT01357889|10133356|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2943709|NCT01357889|10133355|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
2943710|NCT01357889|10133356|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
2943711|NCT01357850|10133400|P4|Overall Study|Lost to Follow-up|0
2943712|NCT01357850|10133401|P3|Overall Study|Lost to Follow-up|0
2943713|NCT01357850|10133402|P2|Overall Study|Lost to Follow-up|0
2943714|NCT01357850|10133403|P1|Overall Study|Lost to Follow-up|1
2943715|NCT01357655|10133494|P2|Overall Study|Subject Withdrew Consent|0
2943716|NCT01357655|10133495|P1|Overall Study|Subject Withdrew Consent|1
2943717|NCT01357655|10133494|P2|Overall Study|Study Drug Toxicity|0
2943718|NCT01357655|10133495|P1|Overall Study|Study Drug Toxicity|11
2943719|NCT01357655|10133494|P2|Overall Study|Reason Unspecified|0
2943720|NCT01357655|10133495|P1|Overall Study|Reason Unspecified|1
2943721|NCT01357655|10133494|P2|Overall Study|Maximum Clinical Benefit|0
2943722|NCT01357655|10133495|P1|Overall Study|Maximum Clinical Benefit|2
2943723|NCT01357655|10133494|P2|Overall Study|Lost to Follow-up|0
2943724|NCT01357655|10133495|P1|Overall Study|Lost to Follow-up|2
2943725|NCT01357655|10133494|P2|Overall Study|Disease Progression|0
2943726|NCT01357655|10133495|P1|Overall Study|Disease Progression|1
2943727|NCT01357655|10133494|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
2943728|NCT01357655|10133495|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
2943729|NCT01357655|10133494|P2|Overall Study|Administrative Reason by Sponsor|0
2943730|NCT01357655|10133495|P1|Overall Study|Administrative Reason by Sponsor|45
2943731|NCT01357616|10133512|P2|Overall Study|Withdrawal by Subject|0
2943732|NCT01357616|10133513|P1|Overall Study|Withdrawal by Subject|1
2943733|NCT01357616|10133512|P2|Overall Study|Decision Unrelated to Adverse Event|1
2943734|NCT01357616|10133513|P1|Overall Study|Decision Unrelated to Adverse Event|3
2943735|NCT01357616|10133512|P2|Overall Study|Inadequate Control of IOP|2
2943736|NCT01357616|10133513|P1|Overall Study|Inadequate Control of IOP|1
2943737|NCT01357616|10133512|P2|Overall Study|Protocol Violation|2
2943738|NCT01357616|10133513|P1|Overall Study|Protocol Violation|0
2943739|NCT01357616|10133512|P2|Overall Study|Lost to Follow-up|3
2943740|NCT01357616|10133513|P1|Overall Study|Lost to Follow-up|4
2943741|NCT01357616|10133512|P2|Overall Study|Adverse Event|1
2943742|NCT01357616|10133513|P1|Overall Study|Adverse Event|1
2943743|NCT01357577|10133527|P2|Overall Study|look at data in database?|2
2943744|NCT01357577|10133528|P1|Overall Study|look at data in database?|1
2943745|NCT01357577|10133527|P2|Overall Study|Withdrawal by Subject|8
2943746|NCT01357577|10133528|P1|Overall Study|Withdrawal by Subject|16
2943747|NCT01357577|10133527|P2|Overall Study|Lost to Follow-up|16
2943748|NCT01357577|10133528|P1|Overall Study|Lost to Follow-up|20
2943749|NCT01357551|10133555|P2|Overall Study|Lost to Follow-up|6
2943750|NCT01357551|10133556|P1|Overall Study|Lost to Follow-up|16
2943751|NCT01357551|10133555|P2|Overall Study|Death|1
2943752|NCT01357551|10133556|P1|Overall Study|Death|0
2943753|NCT01357551|10133555|P2|Overall Study|Withdrawal by Subject|4
2943754|NCT01357551|10133556|P1|Overall Study|Withdrawal by Subject|6
2943755|NCT01357239|10133583|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
2943756|NCT01357239|10133584|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
2943757|NCT01357239|10133585|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
2943758|NCT01357239|10133586|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
2943759|NCT01357239|10133583|P4|Stratum II: Partially-Methylated|Adverse Event|1
2943760|NCT01357239|10133584|P3|Stratum II: Partially-Methylated|Adverse Event|0
2943761|NCT01357239|10133585|P2|Stratum II: Partially-Methylated|Adverse Event|0
2943762|NCT01357239|10133586|P1|Stratum II: Partially-Methylated|Adverse Event|0
2943763|NCT01357239|10133583|P4|Stratum I: Fully-Methylated|Adverse Event|0
2943764|NCT01357239|10133584|P3|Stratum I: Fully-Methylated|Adverse Event|1
2943765|NCT01357239|10133585|P2|Stratum I: Fully-Methylated|Adverse Event|0
2943766|NCT01357239|10133586|P1|Stratum I: Fully-Methylated|Adverse Event|0
2943767|NCT01357239|10133583|P4|Stratum: All Patients|Subject withdrew consent|1
2943768|NCT01357239|10133584|P3|Stratum: All Patients|Subject withdrew consent|1
2943769|NCT01357239|10133585|P2|Stratum: All Patients|Subject withdrew consent|0
2943770|NCT01357239|10133586|P1|Stratum: All Patients|Subject withdrew consent|0
2943771|NCT01357239|10133583|P4|Stratum: All Patients|Adverse Event|1
2943772|NCT01357239|10133584|P3|Stratum: All Patients|Adverse Event|1
2943773|NCT01357239|10133585|P2|Stratum: All Patients|Adverse Event|0
2943774|NCT01357239|10133586|P1|Stratum: All Patients|Adverse Event|0
2943775|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
2943776|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
2943777|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
2943778|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
2943779|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
2943780|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
2943781|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
2943782|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
2943783|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
2943784|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
2943785|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
2943786|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
2943787|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
2943788|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
2943789|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
2943790|NCT01357161|10133644|P3|Part 2 (Double-Blind Comparison)|Death|19
2943791|NCT01357161|10133645|P2|Part 2 (Double-Blind Comparison)|Death|22
2943792|NCT01357161|10133646|P1|Part 2 (Double-Blind Comparison)|Death|0
2943793|NCT01357161|10133644|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2943794|NCT01357161|10133645|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2943795|NCT01357161|10133646|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
2943796|NCT01357161|10133644|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2943797|NCT01357161|10133645|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2943798|NCT01357161|10133646|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
2943799|NCT01357161|10133644|P3|Part 1 (Open Label Run-in)|Physician Decision|0
2943800|NCT01357161|10133645|P2|Part 1 (Open Label Run-in)|Physician Decision|0
2943801|NCT01357161|10133646|P1|Part 1 (Open Label Run-in)|Physician Decision|1
2943802|NCT01357161|10133644|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2943803|NCT01357161|10133645|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2943804|NCT01357161|10133646|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
2943805|NCT01357161|10133644|P3|Part 1 (Open Label Run-in)|Death|0
2943806|NCT01357161|10133645|P2|Part 1 (Open Label Run-in)|Death|0
2943807|NCT01357161|10133646|P1|Part 1 (Open Label Run-in)|Death|5
2943808|NCT01356966|10133698|P2|Overall Study|Physician Decision|0
2943809|NCT01356966|10133699|P1|Overall Study|Physician Decision|1
2943810|NCT01356966|10133698|P2|Overall Study|Withdrawal by Subject|2
2943811|NCT01356966|10133699|P1|Overall Study|Withdrawal by Subject|1
2943812|NCT01356940|10133711|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
2943813|NCT01356940|10133712|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
2943814|NCT01356940|10133711|P2|First Intervention (28 Days)|Adverse Event|0
2943815|NCT01356940|10133712|P1|First Intervention (28 Days)|Adverse Event|1
2943816|NCT01356602|10133741|P3|Overall Study|Adverse Event|1
2943817|NCT01356602|10133742|P2|Overall Study|Adverse Event|1
2943818|NCT01356602|10133743|P1|Overall Study|Adverse Event|0
2943819|NCT01356602|10133741|P3|Overall Study|Lack of Efficacy|4
2943820|NCT01356602|10133742|P2|Overall Study|Lack of Efficacy|1
2943821|NCT01356602|10133743|P1|Overall Study|Lack of Efficacy|0
2943822|NCT01356602|10133741|P3|Overall Study|Withdrawal by Subject|7
2943823|NCT01356602|10133742|P2|Overall Study|Withdrawal by Subject|3
2943824|NCT01356602|10133743|P1|Overall Study|Withdrawal by Subject|4
2943825|NCT01356602|10133741|P3|Overall Study|Lost to Follow-up|6
2943826|NCT01356602|10133742|P2|Overall Study|Lost to Follow-up|5
2943827|NCT01356602|10133743|P1|Overall Study|Lost to Follow-up|4
2943828|NCT01356602|10133741|P3|Overall Study|Administrative Problems|5
2943829|NCT01356602|10133742|P2|Overall Study|Administrative Problems|4
2943830|NCT01356602|10133743|P1|Overall Study|Administrative Problems|1
2943831|NCT01356602|10133741|P3|Overall Study|Protocol Deviation|1
2943832|NCT01356602|10133742|P2|Overall Study|Protocol Deviation|1
2943833|NCT01356602|10133743|P1|Overall Study|Protocol Deviation|0
2943834|NCT01356589|10133802|P1|Overall Study|Dose data not recorded|2
2943835|NCT01356589|10133802|P1|Overall Study|Enrolled, but not treated|3
2943836|NCT01356407|10133859|P2|Overall Study|Not complete Endoscopy|2
2943837|NCT01356407|10133860|P1|Overall Study|Not complete Endoscopy|2
2943838|NCT01356407|10133859|P2|Overall Study|Could not afford IMP administration|1
2943839|NCT01356407|10133860|P1|Overall Study|Could not afford IMP administration|0
2943840|NCT01356407|10133859|P2|Overall Study|Patient Withdrew Consent|1
2943841|NCT01356407|10133860|P1|Overall Study|Patient Withdrew Consent|2
2943842|NCT01356407|10133859|P2|Overall Study|Lost to Follow-up|0
2943843|NCT01356407|10133860|P1|Overall Study|Lost to Follow-up|2
2943844|NCT01355679|10133932|P1|Overall Study|benign tumor types found at biopsy|2
2943845|NCT01355627|10133941|P2|Overall Study|Other|1
2943846|NCT01355627|10133942|P1|Overall Study|Other|1
2943847|NCT01355627|10133941|P2|Overall Study|Fatal Adverse Event|23
2943848|NCT01355627|10133942|P1|Overall Study|Fatal Adverse Event|19
2943849|NCT01355627|10133941|P2|Overall Study|Lost to Follow-up|7
2943850|NCT01355627|10133942|P1|Overall Study|Lost to Follow-up|8
2943851|NCT01355627|10133941|P2|Overall Study|Request By the Patient to Discontinue|7
2943852|NCT01355627|10133942|P1|Overall Study|Request By the Patient to Discontinue|5
2943853|NCT01355523|10133981|P2|Overall Study|Adverse Event|2
2943854|NCT01355523|10133982|P1|Overall Study|Adverse Event|0
2943855|NCT01355523|10133981|P2|Overall Study|Protocol Violation|2
2943856|NCT01355523|10133982|P1|Overall Study|Protocol Violation|0
2943857|NCT01355523|10133981|P2|Overall Study|Lost to Follow-up|2
2943858|NCT01355523|10133982|P1|Overall Study|Lost to Follow-up|0
2943859|NCT01355523|10133981|P2|Overall Study|Withdrawal by Subject|4
2943860|NCT01355523|10133982|P1|Overall Study|Withdrawal by Subject|1
2943861|NCT01355302|10134058|P3|Phase 1b|Study terminated by sponsor|0
2943862|NCT01355302|10134059|P2|Phase 1b|Study terminated by sponsor|0
2943863|NCT01355302|10134060|P1|Phase 1b|Study terminated by sponsor|2
2943864|NCT01355302|10134058|P3|Phase 1b|Death|0
2943865|NCT01355302|10134059|P2|Phase 1b|Death|0
2943866|NCT01355302|10134060|P1|Phase 1b|Death|4
2943867|NCT01355289|10134075|P5|Open Label Extension|Other|3
2943868|NCT01355289|10134076|P4|Open Label Extension|Other|0
2943869|NCT01355289|10134077|P3|Open Label Extension|Other|0
2943870|NCT01355289|10134078|P2|Open Label Extension|Other|0
2943871|NCT01355289|10134079|P1|Open Label Extension|Other|0
2943872|NCT01355289|10134075|P5|Open Label Extension|Inadequate Therapeutic Effect|29
2943873|NCT01355289|10134076|P4|Open Label Extension|Inadequate Therapeutic Effect|0
2943874|NCT01355289|10134077|P3|Open Label Extension|Inadequate Therapeutic Effect|0
2943875|NCT01355289|10134078|P2|Open Label Extension|Inadequate Therapeutic Effect|0
2943876|NCT01355289|10134079|P1|Open Label Extension|Inadequate Therapeutic Effect|0
2943877|NCT01355289|10134075|P5|Open Label Extension|Lost to Follow-up|1
2943878|NCT01355289|10134076|P4|Open Label Extension|Lost to Follow-up|0
2943879|NCT01355289|10134077|P3|Open Label Extension|Lost to Follow-up|0
2943880|NCT01355289|10134078|P2|Open Label Extension|Lost to Follow-up|0
2943881|NCT01355289|10134079|P1|Open Label Extension|Lost to Follow-up|0
2943882|NCT01355289|10134075|P5|Open Label Extension|Adverse Event, Non-Fatal|1
2943883|NCT01355289|10134076|P4|Open Label Extension|Adverse Event, Non-Fatal|0
2943884|NCT01355289|10134077|P3|Open Label Extension|Adverse Event, Non-Fatal|0
2943885|NCT01355289|10134078|P2|Open Label Extension|Adverse Event, Non-Fatal|0
2943886|NCT01355289|10134079|P1|Open Label Extension|Adverse Event, Non-Fatal|0
2943887|NCT01355289|10134075|P5|Core Study|Other|0
2943888|NCT01355289|10134076|P4|Core Study|Other|1
2943889|NCT01355289|10134077|P3|Core Study|Other|0
2943890|NCT01355289|10134078|P2|Core Study|Other|0
2943891|NCT01355289|10134079|P1|Core Study|Other|0
2943892|NCT01355289|10134075|P5|Core Study|Inadequate Therapeutic Effect|0
2943893|NCT01355289|10134076|P4|Core Study|Inadequate Therapeutic Effect|1
2943894|NCT01355289|10134077|P3|Core Study|Inadequate Therapeutic Effect|0
2943895|NCT01355289|10134078|P2|Core Study|Inadequate Therapeutic Effect|0
2943896|NCT01355289|10134079|P1|Core Study|Inadequate Therapeutic Effect|0
2943897|NCT01355289|10134075|P5|Core Study|Adverse Event, Non-Fatal|0
2943898|NCT01355289|10134076|P4|Core Study|Adverse Event, Non-Fatal|0
2943899|NCT01355289|10134077|P3|Core Study|Adverse Event, Non-Fatal|0
2943900|NCT01355289|10134078|P2|Core Study|Adverse Event, Non-Fatal|0
2943901|NCT01355289|10134079|P1|Core Study|Adverse Event, Non-Fatal|1
2943902|NCT01355081|10134132|P3|Overall Study|Non Compliance with Study Medication|0
2943903|NCT01355081|10134133|P2|Overall Study|Non Compliance with Study Medication|1
2943904|NCT01355081|10134134|P1|Overall Study|Non Compliance with Study Medication|0
2943905|NCT01355081|10134132|P3|Overall Study|Lack of Efficacy|1
2943906|NCT01355081|10134133|P2|Overall Study|Lack of Efficacy|1
2943907|NCT01355081|10134134|P1|Overall Study|Lack of Efficacy|2
2943908|NCT01355081|10134132|P3|Overall Study|Withdrawal of Consent|3
2943909|NCT01355081|10134133|P2|Overall Study|Withdrawal of Consent|3
2943910|NCT01355081|10134134|P1|Overall Study|Withdrawal of Consent|2
2943911|NCT01355081|10134132|P3|Overall Study|Lost to Follow-up|1
2943912|NCT01355081|10134133|P2|Overall Study|Lost to Follow-up|0
2943913|NCT01355081|10134134|P1|Overall Study|Lost to Follow-up|0
2943914|NCT01355081|10134132|P3|Overall Study|Major Protocol Deviation|0
2943915|NCT01355081|10134133|P2|Overall Study|Major Protocol Deviation|1
2943916|NCT01355081|10134134|P1|Overall Study|Major Protocol Deviation|0
2943917|NCT01355081|10134132|P3|Overall Study|Pretreatment Event or Adverse Event|6
2943918|NCT01355081|10134133|P2|Overall Study|Pretreatment Event or Adverse Event|4
2943919|NCT01355081|10134134|P1|Overall Study|Pretreatment Event or Adverse Event|3
2943920|NCT01355068|10134157|P2|First Intervention Period|Withdrawal by Subject|1
2943921|NCT01355068|10134158|P1|First Intervention Period|Withdrawal by Subject|0
2943922|NCT01355068|10134157|P2|First Intervention Period|Adverse Event|1
2943923|NCT01355068|10134158|P1|First Intervention Period|Adverse Event|0
2943924|NCT01354964|10134183|P2|Overall Study|Physician Decision|0
2943925|NCT01354964|10134184|P1|Overall Study|Physician Decision|1
2943926|NCT01354964|10134183|P2|Overall Study|IV access issues|1
2943927|NCT01354964|10134184|P1|Overall Study|IV access issues|1
2943928|NCT01354964|10134183|P2|Overall Study|Lost to Follow-up|0
2943929|NCT01354964|10134184|P1|Overall Study|Lost to Follow-up|2
2943930|NCT01354938|10134207|P1|Overall Study|Lost to Follow-up|1
2943931|NCT01354899|10134213|P1|Overall Study|Protocol Violation|1
2943932|NCT01354899|10134213|P1|Overall Study|discharge from the hospital|2
2943933|NCT01354496|10134248|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
2943934|NCT01354496|10134249|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
2943935|NCT01354496|10134250|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
2943936|NCT01354496|10134251|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
2943937|NCT01354496|10134252|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
2943938|NCT01354496|10134253|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
2943939|NCT01354496|10134248|P6|Period 2|Adverse Event|0
2943940|NCT01354496|10134249|P5|Period 2|Adverse Event|0
2943941|NCT01354496|10134250|P4|Period 2|Adverse Event|1
2943942|NCT01354496|10134251|P3|Period 2|Adverse Event|0
2943943|NCT01354496|10134252|P2|Period 2|Adverse Event|0
2943944|NCT01354496|10134253|P1|Period 2|Adverse Event|0
2943945|NCT01354496|10134248|P6|Period 1|Physician Decision|0
2943946|NCT01354496|10134249|P5|Period 1|Physician Decision|0
2943947|NCT01354496|10134250|P4|Period 1|Physician Decision|0
2943948|NCT01354496|10134251|P3|Period 1|Physician Decision|1
2943949|NCT01354496|10134252|P2|Period 1|Physician Decision|0
2943950|NCT01354496|10134253|P1|Period 1|Physician Decision|0
2943951|NCT01354496|10134248|P6|Period 1|Adverse Event|0
2943952|NCT01354496|10134249|P5|Period 1|Adverse Event|0
2943953|NCT01354496|10134250|P4|Period 1|Adverse Event|0
2943954|NCT01354496|10134251|P3|Period 1|Adverse Event|1
2943955|NCT01354496|10134252|P2|Period 1|Adverse Event|0
2943956|NCT01354496|10134253|P1|Period 1|Adverse Event|0
2943957|NCT01354431|10134296|P3|Participants Treated|Withdrawal by Subject|1
2943958|NCT01354431|10134297|P2|Participants Treated|Withdrawal by Subject|2
2943959|NCT01354431|10134298|P1|Participants Treated|Withdrawal by Subject|1
2943960|NCT01354431|10134296|P3|Participants Treated|Adverse Event|4
2943961|NCT01354431|10134297|P2|Participants Treated|Adverse Event|2
2943962|NCT01354431|10134298|P1|Participants Treated|Adverse Event|1
2943963|NCT01354431|10134296|P3|Participants Treated|Death|0
2943964|NCT01354431|10134297|P2|Participants Treated|Death|1
2943965|NCT01354431|10134298|P1|Participants Treated|Death|0
2943966|NCT01354431|10134296|P3|Participants Treated|Study Drug Toxicity|4
2943967|NCT01354431|10134297|P2|Participants Treated|Study Drug Toxicity|7
2943968|NCT01354431|10134298|P1|Participants Treated|Study Drug Toxicity|2
2943969|NCT01354431|10134296|P3|Participants Treated|Disease Progression|41
2943970|NCT01354431|10134297|P2|Participants Treated|Disease Progression|40
2943971|NCT01354431|10134298|P1|Participants Treated|Disease Progression|49
2943972|NCT01354431|10134296|P3|Participants Treated|Continuing Treatment|4
2943973|NCT01354431|10134297|P2|Participants Treated|Continuing Treatment|2
2943974|NCT01354431|10134298|P1|Participants Treated|Continuing Treatment|6
2943975|NCT01354431|10134296|P3|Randomized to Enter Treatment Period|No longer met criteria|0
2943976|NCT01354431|10134297|P2|Randomized to Enter Treatment Period|No longer met criteria|0
2943977|NCT01354431|10134298|P1|Randomized to Enter Treatment Period|No longer met criteria|1
2943978|NCT01354314|10134322|P4|Overall Study|Less than 90% Adherence|4
2943979|NCT01354314|10134323|P3|Overall Study|Less than 90% Adherence|6
2943980|NCT01354314|10134324|P2|Overall Study|Less than 90% Adherence|2
2943981|NCT01354314|10134325|P1|Overall Study|Less than 90% Adherence|4
2943982|NCT01354314|10134322|P4|Overall Study|Protocol Violation|0
2943983|NCT01354314|10134323|P3|Overall Study|Protocol Violation|0
2943984|NCT01354314|10134324|P2|Overall Study|Protocol Violation|1
2943985|NCT01354314|10134325|P1|Overall Study|Protocol Violation|1
2943986|NCT01354314|10134322|P4|Overall Study|Adverse Event|1
2943987|NCT01354314|10134323|P3|Overall Study|Adverse Event|0
2943988|NCT01354314|10134324|P2|Overall Study|Adverse Event|0
2943989|NCT01354314|10134325|P1|Overall Study|Adverse Event|0
2943990|NCT01354314|10134322|P4|Overall Study|Withdrawal by Subject|0
2943991|NCT01354314|10134323|P3|Overall Study|Withdrawal by Subject|1
2943992|NCT01354314|10134324|P2|Overall Study|Withdrawal by Subject|0
2943993|NCT01354314|10134325|P1|Overall Study|Withdrawal by Subject|0
2943994|NCT01354314|10134322|P4|Overall Study|Lost to Follow-up|1
2943995|NCT01354314|10134323|P3|Overall Study|Lost to Follow-up|1
2943996|NCT01354314|10134324|P2|Overall Study|Lost to Follow-up|0
2943997|NCT01354314|10134325|P1|Overall Study|Lost to Follow-up|1
2943998|NCT01354223|10134461|P2|Overall Study|Withdrawal by Subject|1
2943999|NCT01354223|10134462|P1|Overall Study|Withdrawal by Subject|3
2944000|NCT01354132|10134521|P2|1 Month Post Study Medication|Withdrawal by Subject|3
2944001|NCT01354132|10134522|P1|1 Month Post Study Medication|Withdrawal by Subject|1
2944002|NCT01354132|10134521|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
2944003|NCT01354132|10134522|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
2944004|NCT01354132|10134521|P2|Double Blind (Visits 1-7)|Adverse Event|0
2944005|NCT01354132|10134522|P1|Double Blind (Visits 1-7)|Adverse Event|1
2944006|NCT01354132|10134521|P2|Randomization|Withdrawal by Subject|1
2944007|NCT01354132|10134522|P1|Randomization|Withdrawal by Subject|0
2944008|NCT01354132|10134521|P2|Randomization|Physician Decision|0
2944009|NCT01354132|10134522|P1|Randomization|Physician Decision|1
2944010|NCT01354106|10134560|P1|Overall Study|Withdrawal by Subject|2
2944011|NCT01354028|10134566|P2|Overall Study|No quiet alert state|1
2944012|NCT01354028|10134567|P1|Overall Study|No quiet alert state|0
2944013|NCT01354028|10134566|P2|Overall Study|Discharged before study start|2
2944014|NCT01354028|10134567|P1|Overall Study|Discharged before study start|2
2944015|NCT01354028|10134566|P2|Overall Study|Physician Decision|2
2944016|NCT01354028|10134567|P1|Overall Study|Physician Decision|0
2944017|NCT01353963|10134603|P1|Overall Study|Adverse Event|2
2944018|NCT01353911|10134621|P8|Overall Study|Status Not Recorded|0
2944019|NCT01353911|10134622|P7|Overall Study|Status Not Recorded|0
2944020|NCT01353911|10134623|P6|Overall Study|Status Not Recorded|0
2944021|NCT01353911|10134624|P5|Overall Study|Status Not Recorded|0
2944022|NCT01353911|10134625|P4|Overall Study|Status Not Recorded|0
2944023|NCT01353911|10134626|P3|Overall Study|Status Not Recorded|1
2944024|NCT01353911|10134627|P2|Overall Study|Status Not Recorded|0
2944025|NCT01353911|10134628|P1|Overall Study|Status Not Recorded|4
2944026|NCT01353911|10134621|P8|Overall Study|Withdrawal by Subject|9
2944027|NCT01353911|10134622|P7|Overall Study|Withdrawal by Subject|3
2944028|NCT01353911|10134623|P6|Overall Study|Withdrawal by Subject|3
2944029|NCT01353911|10134624|P5|Overall Study|Withdrawal by Subject|2
2944030|NCT01353911|10134625|P4|Overall Study|Withdrawal by Subject|2
2944031|NCT01353911|10134626|P3|Overall Study|Withdrawal by Subject|4
2944032|NCT01353911|10134627|P2|Overall Study|Withdrawal by Subject|3
2944033|NCT01353911|10134628|P1|Overall Study|Withdrawal by Subject|2
2944034|NCT01353911|10134621|P8|Overall Study|Lost to Follow-up|6
2944035|NCT01353911|10134622|P7|Overall Study|Lost to Follow-up|3
2944036|NCT01353911|10134623|P6|Overall Study|Lost to Follow-up|4
2944037|NCT01353911|10134624|P5|Overall Study|Lost to Follow-up|4
2944038|NCT01353911|10134625|P4|Overall Study|Lost to Follow-up|0
2944039|NCT01353911|10134626|P3|Overall Study|Lost to Follow-up|4
2944040|NCT01353911|10134627|P2|Overall Study|Lost to Follow-up|6
2944041|NCT01353911|10134628|P1|Overall Study|Lost to Follow-up|2
2944042|NCT01353898|10134708|P6|Overall Study|Study site terminated|1
2944043|NCT01353898|10134709|P5|Overall Study|Study site terminated|0
2944044|NCT01353898|10134710|P4|Overall Study|Study site terminated|0
2944045|NCT01353898|10134711|P3|Overall Study|Study site terminated|0
2944046|NCT01353898|10134712|P2|Overall Study|Study site terminated|0
2944047|NCT01353898|10134713|P1|Overall Study|Study site terminated|0
2944048|NCT01353859|10134739|P1|Overall Study|Lack of Efficacy|1
2944049|NCT01353859|10134739|P1|Overall Study|Adverse Event|3
2944050|NCT01353703|10134754|P2|Overall Study|Migrated/moved from study area|0
2944051|NCT01353703|10134755|P1|Overall Study|Migrated/moved from study area|1
2944052|NCT01353664|10134801|P1|Overall Study|Disease Progression|16
2944053|NCT01353664|10134801|P1|Overall Study|Other|3
2944054|NCT01353586|10134807|P2|Overall Study|Neurological exam not done|1
2944055|NCT01353586|10134808|P1|Overall Study|Neurological exam not done|0
2944056|NCT01353586|10134807|P2|Overall Study|Never had insertion of study catheter|1
2944057|NCT01353586|10134808|P1|Overall Study|Never had insertion of study catheter|4
2944058|NCT01353586|10134807|P2|Overall Study|Procedure terminated prior to ablation|0
2944059|NCT01353586|10134808|P1|Overall Study|Procedure terminated prior to ablation|3
2944060|NCT01353508|10134826|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2944061|NCT01353508|10134827|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2944062|NCT01353508|10134828|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2944063|NCT01353508|10134829|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
2944064|NCT01353508|10134826|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
2944065|NCT01353508|10134827|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
2944066|NCT01353508|10134828|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
2944067|NCT01353508|10134829|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
2944068|NCT01353274|10134907|P1|Overall Study|No case report form (CRF) collected|28
2944151|NCT01352715|10135171|P2|Overall Study|major ineligibility|1
2944069|NCT01353222|10134917|P2|Overall Study|Site closed research department|0
2944070|NCT01353222|10134918|P1|Overall Study|Site closed research department|1
2944071|NCT01353222|10134917|P2|Overall Study|Study Terminated|37
2944072|NCT01353222|10134918|P1|Overall Study|Study Terminated|31
2944073|NCT01353222|10134917|P2|Overall Study|Withdrawal by Subject|5
2944074|NCT01353222|10134918|P1|Overall Study|Withdrawal by Subject|8
2944075|NCT01353222|10134917|P2|Overall Study|Death|30
2944076|NCT01353222|10134918|P1|Overall Study|Death|30
2944077|NCT01352845|10134961|P2|Overall Study|Death|0
2944078|NCT01352845|10134962|P1|Overall Study|Death|3
2944079|NCT01352845|10134961|P2|Overall Study|Protocol Violation|6
2944080|NCT01352845|10134962|P1|Overall Study|Protocol Violation|12
2944081|NCT01352845|10134961|P2|Overall Study|Other|7
2944082|NCT01352845|10134962|P1|Overall Study|Other|17
2944083|NCT01352845|10134961|P2|Overall Study|Adverse Event|6
2944084|NCT01352845|10134962|P1|Overall Study|Adverse Event|22
2944085|NCT01352845|10134961|P2|Overall Study|Pregnancy|7
2944086|NCT01352845|10134962|P1|Overall Study|Pregnancy|27
2944087|NCT01352845|10134961|P2|Overall Study|No Longer Meets Eligibility Criteria|11
2944088|NCT01352845|10134962|P1|Overall Study|No Longer Meets Eligibility Criteria|24
2944089|NCT01352845|10134961|P2|Overall Study|Withdrawal by Subject|16
2944090|NCT01352845|10134962|P1|Overall Study|Withdrawal by Subject|48
2944091|NCT01352845|10134961|P2|Overall Study|No Longer Willing to Participate|58
2944092|NCT01352845|10134962|P1|Overall Study|No Longer Willing to Participate|205
2944093|NCT01352845|10134961|P2|Overall Study|Lost to Follow-up|92
2944094|NCT01352845|10134962|P1|Overall Study|Lost to Follow-up|313
2944095|NCT01352793|10135051|P2|Overall Study|No longer meets eligibility criteria|15
2944096|NCT01352793|10135052|P1|Overall Study|No longer meets eligibility criteria|25
2944097|NCT01352793|10135051|P2|Overall Study|Randomized but not vaccinated|0
2944098|NCT01352793|10135052|P1|Overall Study|Randomized but not vaccinated|8
2944099|NCT01352793|10135051|P2|Overall Study|Death|0
2944100|NCT01352793|10135052|P1|Overall Study|Death|1
2944101|NCT01352793|10135051|P2|Overall Study|Medication error|2
2944102|NCT01352793|10135052|P1|Overall Study|Medication error|2
2944103|NCT01352793|10135051|P2|Overall Study|Other|7
2944104|NCT01352793|10135052|P1|Overall Study|Other|25
2944105|NCT01352793|10135051|P2|Overall Study|Pregnancy|8
2944106|NCT01352793|10135052|P1|Overall Study|Pregnancy|26
2944107|NCT01352793|10135051|P2|Overall Study|Physician Decision|0
2944108|NCT01352793|10135052|P1|Overall Study|Physician Decision|1
2944109|NCT01352793|10135051|P2|Overall Study|Adverse Event|10
2944110|NCT01352793|10135052|P1|Overall Study|Adverse Event|44
2944111|NCT01352793|10135051|P2|Overall Study|Protocol Violation|23
2944112|NCT01352793|10135052|P1|Overall Study|Protocol Violation|44
2944113|NCT01352793|10135051|P2|Overall Study|Withdrawal by Subject|55
2944114|NCT01352793|10135052|P1|Overall Study|Withdrawal by Subject|120
2944115|NCT01352793|10135051|P2|Overall Study|Lost to Follow-up|125
2944116|NCT01352793|10135052|P1|Overall Study|Lost to Follow-up|289
2944117|NCT01352741|10135076|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
2944118|NCT01352741|10135077|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
2944119|NCT01352741|10135076|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
2944120|NCT01352741|10135077|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
2944121|NCT01352741|10135076|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
2944122|NCT01352741|10135077|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
2944123|NCT01352741|10135076|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
2944124|NCT01352741|10135077|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
2944125|NCT01352741|10135076|P2|Double-blind Comparative Period|Other|2
2944126|NCT01352741|10135077|P1|Double-blind Comparative Period|Other|1
2944127|NCT01352741|10135076|P2|Double-blind Comparative Period|Withdrawal of consent|3
2944128|NCT01352741|10135077|P1|Double-blind Comparative Period|Withdrawal of consent|8
2944129|NCT01352741|10135076|P2|Double-blind Comparative Period|Death|1
2944130|NCT01352741|10135077|P1|Double-blind Comparative Period|Death|0
2944131|NCT01352741|10135076|P2|Double-blind Comparative Period|Lost to Follow-up|0
2944132|NCT01352741|10135077|P1|Double-blind Comparative Period|Lost to Follow-up|1
2944133|NCT01352741|10135076|P2|Double-blind Comparative Period|Adverse Event|17
2944134|NCT01352741|10135077|P1|Double-blind Comparative Period|Adverse Event|16
2944135|NCT01352741|10135076|P2|Double-blind Comparative Period|Lack of Efficacy|3
2944136|NCT01352741|10135077|P1|Double-blind Comparative Period|Lack of Efficacy|0
2944137|NCT01352741|10135076|P2|Double-blind Comparative Period|Protocol Violation|0
2944138|NCT01352741|10135077|P1|Double-blind Comparative Period|Protocol Violation|2
2944139|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Other|0
2944140|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Other|4
2944141|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
2944142|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
2944143|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
2944144|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
2944145|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Adverse Event|0
2944146|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Adverse Event|34
2944147|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
2944148|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
2944149|NCT01352741|10135076|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
2944150|NCT01352741|10135077|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
2944152|NCT01352715|10135172|P1|Overall Study|major ineligibility|2
2944153|NCT01352715|10135171|P2|Overall Study|no final visit in closeout period|12
2944154|NCT01352715|10135172|P1|Overall Study|no final visit in closeout period|15
2944155|NCT01352715|10135171|P2|Overall Study|site closure|15
2944156|NCT01352715|10135172|P1|Overall Study|site closure|16
2944157|NCT01352715|10135171|P2|Overall Study|Withdrawal by Subject|8
2944158|NCT01352715|10135172|P1|Overall Study|Withdrawal by Subject|4
2944159|NCT01352715|10135171|P2|Overall Study|Lost to Follow-up|7
2944160|NCT01352715|10135172|P1|Overall Study|Lost to Follow-up|5
2944161|NCT01352715|10135171|P2|Overall Study|Death|3
2944162|NCT01352715|10135172|P1|Overall Study|Death|3
2944163|NCT01352585|10135211|P1|Overall Study|Other|7
2944164|NCT01352585|10135211|P1|Overall Study|Lost to Follow-up|1
2944165|NCT01352585|10135211|P1|Overall Study|Adverse Event|3
2944166|NCT01352507|10135228|P2|Treatment Period 2|Lack of Efficacy|0
2944167|NCT01352507|10135229|P1|Treatment Period 2|Lack of Efficacy|1
2944168|NCT01352507|10135228|P2|Treatment Period 2|Withdrawal by Subject|3
2944169|NCT01352507|10135229|P1|Treatment Period 2|Withdrawal by Subject|4
2944170|NCT01352507|10135228|P2|Treatment Period 2|Entry Criteria Not Met|0
2944171|NCT01352507|10135229|P1|Treatment Period 2|Entry Criteria Not Met|1
2944172|NCT01352507|10135228|P2|Washout Period|Withdrawal by Subject|1
2944173|NCT01352507|10135229|P1|Washout Period|Withdrawal by Subject|0
2944174|NCT01352507|10135228|P2|Treatment Period 1|Physician Decision|0
2944175|NCT01352507|10135229|P1|Treatment Period 1|Physician Decision|1
2944176|NCT01352507|10135228|P2|Treatment Period 1|Withdrawal by Subject|5
2944177|NCT01352507|10135229|P1|Treatment Period 1|Withdrawal by Subject|7
2944178|NCT01352507|10135228|P2|Treatment Period 1|Lost to Follow-up|4
2944179|NCT01352507|10135229|P1|Treatment Period 1|Lost to Follow-up|3
2944180|NCT01352507|10135228|P2|Treatment Period 1|Adverse Event|0
2944181|NCT01352507|10135229|P1|Treatment Period 1|Adverse Event|3
2944182|NCT01352416|10135282|P4|Overall Study|Physician Decision|1
2944183|NCT01352416|10135283|P3|Overall Study|Physician Decision|2
2944184|NCT01352416|10135284|P2|Overall Study|Physician Decision|2
2944185|NCT01352416|10135285|P1|Overall Study|Physician Decision|1
2944186|NCT01352221|10135307|P4|Open-label Phase|Worsening of IBD|0
2944187|NCT01352221|10135308|P3|Open-label Phase|Worsening of IBD|1
2944188|NCT01352221|10135309|P2|Open-label Phase|Worsening of IBD|0
2944189|NCT01352221|10135310|P1|Open-label Phase|Worsening of IBD|0
2944190|NCT01352221|10135307|P4|Open-label Phase|Withdrawal by Subject|6
2944191|NCT01352221|10135308|P3|Open-label Phase|Withdrawal by Subject|1
2944192|NCT01352221|10135309|P2|Open-label Phase|Withdrawal by Subject|0
2944193|NCT01352221|10135310|P1|Open-label Phase|Withdrawal by Subject|0
2944194|NCT01352221|10135307|P4|Open-label Phase|Adverse Event|4
2944195|NCT01352221|10135308|P3|Open-label Phase|Adverse Event|8
2944196|NCT01352221|10135309|P2|Open-label Phase|Adverse Event|0
2944197|NCT01352221|10135310|P1|Open-label Phase|Adverse Event|0
2944198|NCT01352221|10135307|P4|Open-label Phase|Pregnancy|0
2944199|NCT01352221|10135308|P3|Open-label Phase|Pregnancy|1
2944200|NCT01352221|10135309|P2|Open-label Phase|Pregnancy|0
2944201|NCT01352221|10135310|P1|Open-label Phase|Pregnancy|0
2944202|NCT01352221|10135307|P4|Open-label Phase|Physician Decision|1
2944203|NCT01352221|10135308|P3|Open-label Phase|Physician Decision|2
2944204|NCT01352221|10135309|P2|Open-label Phase|Physician Decision|0
2944205|NCT01352221|10135310|P1|Open-label Phase|Physician Decision|0
2944206|NCT01352221|10135307|P4|Double-blind Phase|Protocol Violation|0
2944207|NCT01352221|10135308|P3|Double-blind Phase|Protocol Violation|0
2944208|NCT01352221|10135309|P2|Double-blind Phase|Protocol Violation|1
2944209|NCT01352221|10135310|P1|Double-blind Phase|Protocol Violation|0
2944210|NCT01352221|10135307|P4|Double-blind Phase|Lost to Follow-up|0
2944211|NCT01352221|10135308|P3|Double-blind Phase|Lost to Follow-up|0
2944212|NCT01352221|10135309|P2|Double-blind Phase|Lost to Follow-up|1
2944213|NCT01352221|10135310|P1|Double-blind Phase|Lost to Follow-up|0
2944214|NCT01352221|10135307|P4|Double-blind Phase|Withdrawal by Subject|0
2944215|NCT01352221|10135308|P3|Double-blind Phase|Withdrawal by Subject|0
2944216|NCT01352221|10135309|P2|Double-blind Phase|Withdrawal by Subject|5
2944217|NCT01352221|10135310|P1|Double-blind Phase|Withdrawal by Subject|3
2944218|NCT01352221|10135307|P4|Double-blind Phase|Adverse Event|0
2944219|NCT01352221|10135308|P3|Double-blind Phase|Adverse Event|0
2944220|NCT01352221|10135309|P2|Double-blind Phase|Adverse Event|4
2944221|NCT01352221|10135310|P1|Double-blind Phase|Adverse Event|6
2944222|NCT01352117|10135370|P2|Overall Study|Ineligible (no KS diagnosis)|0
2944223|NCT01352117|10135371|P1|Overall Study|Ineligible (no KS diagnosis)|1
2944224|NCT01352117|10135370|P2|Overall Study|Did not initiate study treatment|0
2944225|NCT01352117|10135371|P1|Overall Study|Did not initiate study treatment|1
2944226|NCT01352117|10135370|P2|Overall Study|Non-adherent to study requirements|1
2944227|NCT01352117|10135371|P1|Overall Study|Non-adherent to study requirements|1
2944228|NCT01352117|10135370|P2|Overall Study|Lost to Follow-up|7
2944229|NCT01352117|10135371|P1|Overall Study|Lost to Follow-up|2
2944230|NCT01352117|10135370|P2|Overall Study|Withdrawal by Subject|0
2944231|NCT01352117|10135371|P1|Overall Study|Withdrawal by Subject|1
2944232|NCT01352117|10135370|P2|Overall Study|Death|16
2944233|NCT01352117|10135371|P1|Overall Study|Death|15
2944234|NCT01351623|10135434|P1|Overall Study|Death|2
2944235|NCT01351623|10135434|P1|Overall Study|Withdrawal by Subject|1
2944236|NCT01351623|10135434|P1|Overall Study|Adverse Event|4
2944237|NCT01351623|10135434|P1|Overall Study|Protocol Violation|2
2944238|NCT01351415|10135460|P2|Overall Study|Never Started|5
2944239|NCT01351415|10135461|P1|Overall Study|Never Started|5
2944240|NCT01351415|10135460|P2|Overall Study|Reason unknown|2
2944241|NCT01351415|10135461|P1|Overall Study|Reason unknown|0
2944242|NCT01351415|10135460|P2|Overall Study|Physician Decision|3
2944243|NCT01351415|10135461|P1|Overall Study|Physician Decision|2
2944244|NCT01351415|10135460|P2|Overall Study|Death|187
2944245|NCT01351415|10135461|P1|Overall Study|Death|190
2944246|NCT01351415|10135460|P2|Overall Study|Lost to Follow-up|7
2944247|NCT01351415|10135461|P1|Overall Study|Lost to Follow-up|5
2944248|NCT01351415|10135460|P2|Overall Study|Trial termination by the Sponsor|19
2944249|NCT01351415|10135461|P1|Overall Study|Trial termination by the Sponsor|28
2944250|NCT01351415|10135460|P2|Overall Study|Withdrawal by Subject|17
2944251|NCT01351415|10135461|P1|Overall Study|Withdrawal by Subject|15
2944252|NCT01351350|10135497|P5|Overall Study|Enrolled but not Treated|0
2944253|NCT01351350|10135498|P4|Overall Study|Enrolled but not Treated|0
2944254|NCT01351350|10135499|P3|Overall Study|Enrolled but not Treated|1
2944255|NCT01351350|10135500|P2|Overall Study|Enrolled but not Treated|0
2944256|NCT01351350|10135501|P1|Overall Study|Enrolled but not Treated|0
2944257|NCT01351350|10135497|P5|Overall Study|Participant Decision|2
2944258|NCT01351350|10135498|P4|Overall Study|Participant Decision|3
2944259|NCT01351350|10135499|P3|Overall Study|Participant Decision|3
2944260|NCT01351350|10135500|P2|Overall Study|Participant Decision|6
2944261|NCT01351350|10135501|P1|Overall Study|Participant Decision|2
2944262|NCT01351350|10135497|P5|Overall Study|Adverse Event|0
2944263|NCT01351350|10135498|P4|Overall Study|Adverse Event|2
2944264|NCT01351350|10135499|P3|Overall Study|Adverse Event|1
2944265|NCT01351350|10135500|P2|Overall Study|Adverse Event|10
2944266|NCT01351350|10135501|P1|Overall Study|Adverse Event|1
2944267|NCT01351350|10135497|P5|Overall Study|Disease Progression|5
2944268|NCT01351350|10135498|P4|Overall Study|Disease Progression|8
2944269|NCT01351350|10135499|P3|Overall Study|Disease Progression|6
2944270|NCT01351350|10135500|P2|Overall Study|Disease Progression|13
2944271|NCT01351350|10135501|P1|Overall Study|Disease Progression|5
2944272|NCT01351025|10135672|P2|Week 24 - 44|unable to get to clinic|1
2944273|NCT01351025|10135673|P1|Week 24 - 44|unable to get to clinic|1
2944274|NCT01351025|10135672|P2|Week 24 - 44|Site closed|1
2944275|NCT01351025|10135673|P1|Week 24 - 44|Site closed|0
2944276|NCT01351025|10135672|P2|Week 24 - 44|Lost to Follow-up|2
2944277|NCT01351025|10135673|P1|Week 24 - 44|Lost to Follow-up|0
2944278|NCT01351025|10135672|P2|Week 0 - 20|Withdrawal by Subject|0
2944279|NCT01351025|10135673|P1|Week 0 - 20|Withdrawal by Subject|1
2944280|NCT01351025|10135672|P2|Week 0 - 20|Lost to Follow-up|1
2944281|NCT01351025|10135673|P1|Week 0 - 20|Lost to Follow-up|2
2944282|NCT01350999|10135706|P3|Overall Study|Difficulty Making it to Study Visit|5
2944283|NCT01350999|10135707|P2|Overall Study|Difficulty Making it to Study Visit|1
2944284|NCT01350999|10135708|P1|Overall Study|Difficulty Making it to Study Visit|1
2944285|NCT01350999|10135706|P3|Overall Study|Voluntary withdrawal|6
2944286|NCT01350999|10135707|P2|Overall Study|Voluntary withdrawal|4
2944287|NCT01350999|10135708|P1|Overall Study|Voluntary withdrawal|3
2944288|NCT01350999|10135706|P3|Overall Study|Adverse Event|10
2944289|NCT01350999|10135707|P2|Overall Study|Adverse Event|9
2944290|NCT01350999|10135708|P1|Overall Study|Adverse Event|4
2944291|NCT01350973|10135746|P3|Overall Study|Voluntary Withdrawal|1
2944292|NCT01350973|10135747|P2|Overall Study|Voluntary Withdrawal|1
2944293|NCT01350973|10135748|P1|Overall Study|Voluntary Withdrawal|2
2944294|NCT01350973|10135746|P3|Overall Study|Adverse Event|7
2944295|NCT01350973|10135747|P2|Overall Study|Adverse Event|7
2944296|NCT01350973|10135748|P1|Overall Study|Adverse Event|4
2944297|NCT01350934|10135789|P2|Extension Study|Withdrawal by Subject|1
2944298|NCT01350934|10135790|P1|Extension Study|Withdrawal by Subject|0
2944299|NCT01350934|10135789|P2|Extension Study|Lack of Efficacy|1
2944300|NCT01350934|10135790|P1|Extension Study|Lack of Efficacy|0
2944301|NCT01350934|10135789|P2|Extension Study|Protocol Violation|1
2944302|NCT01350934|10135790|P1|Extension Study|Protocol Violation|1
2944303|NCT01350934|10135789|P2|Extension Study|Lost to Follow-up|0
2944304|NCT01350934|10135790|P1|Extension Study|Lost to Follow-up|2
2944305|NCT01350934|10135789|P2|Extension Study|Adverse Event|1
2944306|NCT01350934|10135790|P1|Extension Study|Adverse Event|2
2944307|NCT01350934|10135789|P2|Base Study|Non-Compliance With Study Drug|0
2944308|NCT01350934|10135790|P1|Base Study|Non-Compliance With Study Drug|2
2944309|NCT01350934|10135789|P2|Base Study|Withdrawal by Subject|2
2944310|NCT01350934|10135790|P1|Base Study|Withdrawal by Subject|1
2944311|NCT01350934|10135789|P2|Base Study|Protocol Violation|1
2944312|NCT01350934|10135790|P1|Base Study|Protocol Violation|1
2944313|NCT01350934|10135789|P2|Base Study|Lost to Follow-up|0
2944314|NCT01350934|10135790|P1|Base Study|Lost to Follow-up|1
2944315|NCT01350934|10135789|P2|Base Study|Adverse Event|0
2944316|NCT01350934|10135790|P1|Base Study|Adverse Event|6
2944317|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
2944318|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
2944319|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
2944320|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
2944321|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
2944322|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
2944323|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2944324|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2944325|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2944326|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2944327|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
2944328|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2944329|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
2944330|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
2944331|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
2944332|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
2944333|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
2944334|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
2944335|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2944336|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2944337|NCT01350804|10135812|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
2944338|NCT01350804|10135813|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
2944339|NCT01350804|10135814|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
2944340|NCT01350804|10135815|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
2944341|NCT01350804|10135812|P4|Core Study|Adverse Event|8
2944342|NCT01350804|10135813|P3|Core Study|Adverse Event|8
2944343|NCT01350804|10135814|P2|Core Study|Adverse Event|10
2944344|NCT01350804|10135815|P1|Core Study|Adverse Event|8
2944345|NCT01350804|10135812|P4|Core Study|Death|0
2944346|NCT01350804|10135813|P3|Core Study|Death|1
2944347|NCT01350804|10135814|P2|Core Study|Death|1
2944348|NCT01350804|10135815|P1|Core Study|Death|1
2944349|NCT01350804|10135812|P4|Core Study|Lack of Efficacy|5
2944350|NCT01350804|10135813|P3|Core Study|Lack of Efficacy|18
2944351|NCT01350804|10135814|P2|Core Study|Lack of Efficacy|19
2944352|NCT01350804|10135815|P1|Core Study|Lack of Efficacy|16
2944353|NCT01350804|10135812|P4|Core Study|Lost to Follow-up|1
2944354|NCT01350804|10135813|P3|Core Study|Lost to Follow-up|2
2944355|NCT01350804|10135814|P2|Core Study|Lost to Follow-up|0
2944356|NCT01350804|10135815|P1|Core Study|Lost to Follow-up|3
2944357|NCT01350804|10135812|P4|Core Study|Physician Decision|3
2944358|NCT01350804|10135813|P3|Core Study|Physician Decision|1
2944359|NCT01350804|10135814|P2|Core Study|Physician Decision|0
2944360|NCT01350804|10135815|P1|Core Study|Physician Decision|1
2944361|NCT01350804|10135812|P4|Core Study|Protocol deviation|0
2944362|NCT01350804|10135813|P3|Core Study|Protocol deviation|1
2944363|NCT01350804|10135814|P2|Core Study|Protocol deviation|0
2944364|NCT01350804|10135815|P1|Core Study|Protocol deviation|1
2944365|NCT01350804|10135812|P4|Core Study|Study terminated by Sponsor|2
2944366|NCT01350804|10135813|P3|Core Study|Study terminated by Sponsor|0
2944367|NCT01350804|10135814|P2|Core Study|Study terminated by Sponsor|0
2944368|NCT01350804|10135815|P1|Core Study|Study terminated by Sponsor|0
2944369|NCT01350804|10135812|P4|Core Study|Withdrawal by Subject|7
2944370|NCT01350804|10135813|P3|Core Study|Withdrawal by Subject|16
2944371|NCT01350804|10135814|P2|Core Study|Withdrawal by Subject|17
2944372|NCT01350804|10135815|P1|Core Study|Withdrawal by Subject|11
2944373|NCT01350544|10135912|P2|Overall Study|Lost to Follow-up|15
2944374|NCT01350544|10135913|P1|Overall Study|Lost to Follow-up|18
2944375|NCT01350544|10135912|P2|Overall Study|Incarceration|0
2944376|NCT01350544|10135913|P1|Overall Study|Incarceration|1
2944377|NCT01350544|10135912|P2|Overall Study|Withdrawal by Subject|1
2944378|NCT01350544|10135913|P1|Overall Study|Withdrawal by Subject|0
2944379|NCT01350544|10135912|P2|Overall Study|Medical Issues|1
2944380|NCT01350544|10135913|P1|Overall Study|Medical Issues|1
2944381|NCT01350544|10135912|P2|Overall Study|Moved out of LA County|2
2944382|NCT01350544|10135913|P1|Overall Study|Moved out of LA County|2
2944383|NCT01350544|10135912|P2|Overall Study|Death|2
2944384|NCT01350544|10135913|P1|Overall Study|Death|1
2944385|NCT01350544|10135912|P2|Overall Study|Administrative Withdrawal|1
2944386|NCT01350544|10135913|P1|Overall Study|Administrative Withdrawal|0
2944387|NCT01350505|10135919|P1|Overall Study|Lost to Follow-up|4
2944388|NCT01350414|10135949|P1|Overall Study|Physician Decision|2
2944389|NCT01350414|10135949|P1|Overall Study|Withdrawal by Subject|4
2944390|NCT01350414|10135949|P1|Overall Study|Lost to Follow-up|13
2944391|NCT01350271|10135998|P3|Overall Study|Lost to Follow-up|26
2944392|NCT01350271|10135999|P2|Overall Study|Lost to Follow-up|17
2944393|NCT01350271|10136000|P1|Overall Study|Lost to Follow-up|21
2944394|NCT01350141|10136042|P3|Overall Study|Randomized but not treated|0
2944395|NCT01350141|10136043|P2|Overall Study|Randomized but not treated|0
2944396|NCT01350141|10136044|P1|Overall Study|Randomized but not treated|1
2944397|NCT01350141|10136042|P3|Overall Study|Withdrawal by Subject|0
2944398|NCT01350141|10136043|P2|Overall Study|Withdrawal by Subject|0
2944399|NCT01350141|10136044|P1|Overall Study|Withdrawal by Subject|1
2944400|NCT01350141|10136042|P3|Overall Study|Lost to Follow-up|1
2944401|NCT01350141|10136043|P2|Overall Study|Lost to Follow-up|0
2944402|NCT01350141|10136044|P1|Overall Study|Lost to Follow-up|1
2944403|NCT01350128|10136078|P1|Overall Study|Lost to Follow-up|2
2944404|NCT01350128|10136078|P1|Overall Study|Physician Decision|1
2944405|NCT01350128|10136078|P1|Overall Study|Protocol discontinuation criteria|8
2944406|NCT01350128|10136078|P1|Overall Study|Withdrawal by Subject|3
2944407|NCT01350115|10136142|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
2944408|NCT01350115|10136143|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
2944409|NCT01350115|10136142|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
2944410|NCT01350115|10136143|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
2944499|NCT01349465|10136515|P1|Overall Study|Lost to Follow-up|10
2944411|NCT01350115|10136142|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
2944412|NCT01350115|10136143|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
2944413|NCT01350102|10136159|P4|Overall Study|Adverse Event|0
2944414|NCT01350102|10136160|P3|Overall Study|Adverse Event|1
2944415|NCT01350102|10136161|P2|Overall Study|Adverse Event|0
2944416|NCT01350102|10136162|P1|Overall Study|Adverse Event|0
2944417|NCT01349959|10136199|P1|Overall Study|Adverse Event|7
2944418|NCT01349907|10136240|P2|Overall Study|Administrative|1
2944419|NCT01349907|10136241|P1|Overall Study|Administrative|1
2944420|NCT01349907|10136240|P2|Overall Study|Protocol Violation|13
2944421|NCT01349907|10136241|P1|Overall Study|Protocol Violation|33
2944422|NCT01349907|10136240|P2|Overall Study|Withdrawal by Subject|8
2944423|NCT01349907|10136241|P1|Overall Study|Withdrawal by Subject|30
2944424|NCT01349907|10136240|P2|Overall Study|Lost to Follow-up|6
2944425|NCT01349907|10136241|P1|Overall Study|Lost to Follow-up|25
2944426|NCT01349907|10136240|P2|Overall Study|Treatment failure|4
2944427|NCT01349907|10136241|P1|Overall Study|Treatment failure|13
2944428|NCT01349907|10136240|P2|Overall Study|Adverse Event|11
2944429|NCT01349907|10136241|P1|Overall Study|Adverse Event|37
2944430|NCT01349829|10136279|P2|Overall Study|Migrated/moved|7
2944431|NCT01349829|10136280|P1|Overall Study|Migrated/moved|2
2944432|NCT01349829|10136279|P2|Overall Study|Consent withdrawal|8
2944433|NCT01349829|10136280|P1|Overall Study|Consent withdrawal|3
2944434|NCT01349829|10136279|P2|Overall Study|Lost to Follow-up|8
2944435|NCT01349829|10136280|P1|Overall Study|Lost to Follow-up|4
2944436|NCT01349816|10136298|P1|Overall Study|Protocol-specified criteria|8
2944437|NCT01349816|10136298|P1|Overall Study|Protocol Violation|1
2944438|NCT01349816|10136298|P1|Overall Study|Lost to Follow-up|2
2944439|NCT01349816|10136298|P1|Overall Study|Adverse Event|14
2944440|NCT01349816|10136298|P1|Overall Study|Physician Decision|1
2944441|NCT01349816|10136298|P1|Overall Study|Withdrawal by Subject|4
2944442|NCT01349803|10136364|P4|Overall Study|Protocol-specified criteria|0
2944443|NCT01349803|10136365|P3|Overall Study|Protocol-specified criteria|3
2944444|NCT01349803|10136366|P2|Overall Study|Protocol-specified criteria|1
2944445|NCT01349803|10136367|P1|Overall Study|Protocol-specified criteria|0
2944446|NCT01349803|10136364|P4|Overall Study|Withdrawal by Subject|0
2944447|NCT01349803|10136365|P3|Overall Study|Withdrawal by Subject|0
2944448|NCT01349803|10136366|P2|Overall Study|Withdrawal by Subject|0
2944449|NCT01349803|10136367|P1|Overall Study|Withdrawal by Subject|1
2944450|NCT01349803|10136364|P4|Overall Study|Adverse Event|2
2944451|NCT01349803|10136365|P3|Overall Study|Adverse Event|0
2944452|NCT01349803|10136366|P2|Overall Study|Adverse Event|0
2944453|NCT01349803|10136367|P1|Overall Study|Adverse Event|0
2944454|NCT01349790|10136437|P1|Overall Study|Lost to Follow-up|1
2944455|NCT01349790|10136437|P1|Overall Study|Adverse Event|1
2944456|NCT01349790|10136437|P1|Overall Study|Withdrawal by Patient|2
2944457|NCT01349790|10136437|P1|Overall Study|Death|2
2944458|NCT01349790|10136437|P1|Overall Study|Investigator Judgement|3
2944459|NCT01349673|10136456|P1|Overall Study|Lack of Efficacy|8
2944460|NCT01349673|10136456|P1|Overall Study|Study Terminated By Sponsor|50
2944461|NCT01349673|10136456|P1|Overall Study|Adverse Event|17
2944462|NCT01349673|10136456|P1|Overall Study|Lost to Follow-up|6
2944463|NCT01349673|10136456|P1|Overall Study|Withdrawal by Subject|21
2944464|NCT01349673|10136456|P1|Overall Study|Site Closure|10
2944465|NCT01349673|10136456|P1|Overall Study|No Longer Qualified For Study|1
2944466|NCT01349673|10136456|P1|Overall Study|Progression Of Disease Past 40 cm|1
2944467|NCT01349660|10136466|P3|Overall Study|Declining Performance Status|1
2944468|NCT01349660|10136467|P2|Overall Study|Declining Performance Status|0
2944469|NCT01349660|10136468|P1|Overall Study|Declining Performance Status|0
2944470|NCT01349660|10136466|P3|Overall Study|Study Compliance|1
2944471|NCT01349660|10136467|P2|Overall Study|Study Compliance|0
2944472|NCT01349660|10136468|P1|Overall Study|Study Compliance|0
2944473|NCT01349660|10136466|P3|Overall Study|Non-Permitted Interventions|2
2944474|NCT01349660|10136467|P2|Overall Study|Non-Permitted Interventions|0
2944475|NCT01349660|10136468|P1|Overall Study|Non-Permitted Interventions|0
2944476|NCT01349660|10136466|P3|Overall Study|Death|0
2944477|NCT01349660|10136467|P2|Overall Study|Death|1
2944478|NCT01349660|10136468|P1|Overall Study|Death|1
2944479|NCT01349660|10136466|P3|Overall Study|Withdrawal by Subject|9
2944480|NCT01349660|10136467|P2|Overall Study|Withdrawal by Subject|0
2944481|NCT01349660|10136468|P1|Overall Study|Withdrawal by Subject|2
2944482|NCT01349660|10136466|P3|Overall Study|Adverse Event|12
2944483|NCT01349660|10136467|P2|Overall Study|Adverse Event|1
2944484|NCT01349660|10136468|P1|Overall Study|Adverse Event|1
2944485|NCT01349660|10136466|P3|Overall Study|Disease Progression|50
2944486|NCT01349660|10136467|P2|Overall Study|Disease Progression|4
2944487|NCT01349660|10136468|P1|Overall Study|Disease Progression|2
2944488|NCT01349660|10136466|P3|Overall Study|Still Receiving Study Treatment|1
2944489|NCT01349660|10136467|P2|Overall Study|Still Receiving Study Treatment|0
2944490|NCT01349660|10136468|P1|Overall Study|Still Receiving Study Treatment|0
2944491|NCT01349595|10136486|P2|Overall Study|Lack of funding|2
2944492|NCT01349595|10136487|P1|Overall Study|Lack of funding|2
2944493|NCT01349569|10136493|P1|Overall Study|Lack of Efficacy|4
2944494|NCT01349465|10136514|P2|Overall Study|Subject Ineligible To Continue The Trial|19
2944495|NCT01349465|10136515|P1|Overall Study|Subject Ineligible To Continue The Trial|0
2944496|NCT01349465|10136514|P2|Overall Study|Withdrawal by Subject|2
2944497|NCT01349465|10136515|P1|Overall Study|Withdrawal by Subject|4
2944498|NCT01349465|10136514|P2|Overall Study|Lost to Follow-up|1
2944500|NCT01349465|10136514|P2|Overall Study|Death|0
2944501|NCT01349465|10136515|P1|Overall Study|Death|3
2944502|NCT01349465|10136514|P2|Overall Study|Adverse Event|0
2944503|NCT01349465|10136515|P1|Overall Study|Adverse Event|1
2944504|NCT01349192|10136536|P2|Overall Study|Failure to adhere to Protocol|0
2944505|NCT01349192|10136537|P1|Overall Study|Failure to adhere to Protocol|2
2944506|NCT01349192|10136536|P2|Overall Study|Lost to Follow-up|3
2944507|NCT01349192|10136537|P1|Overall Study|Lost to Follow-up|1
2944508|NCT01349192|10136536|P2|Overall Study|Withdrawal by Subject|2
2944509|NCT01349192|10136537|P1|Overall Study|Withdrawal by Subject|0
2944510|NCT01349192|10136536|P2|Overall Study|Protocol Violation|1
2944511|NCT01349192|10136537|P1|Overall Study|Protocol Violation|0
2944512|NCT01349049|10136569|P9|Overall Study|Withdrawal by Subject|6
2944513|NCT01349049|10136570|P8|Overall Study|Withdrawal by Subject|0
2944514|NCT01349049|10136571|P7|Overall Study|Withdrawal by Subject|0
2944515|NCT01349049|10136572|P6|Overall Study|Withdrawal by Subject|0
2944516|NCT01349049|10136573|P5|Overall Study|Withdrawal by Subject|0
2944517|NCT01349049|10136574|P4|Overall Study|Withdrawal by Subject|0
2944518|NCT01349049|10136575|P3|Overall Study|Withdrawal by Subject|0
2944519|NCT01349049|10136576|P2|Overall Study|Withdrawal by Subject|0
2944520|NCT01349049|10136577|P1|Overall Study|Withdrawal by Subject|0
2944521|NCT01349049|10136569|P9|Overall Study|Non-compliance|0
2944522|NCT01349049|10136570|P8|Overall Study|Non-compliance|0
2944523|NCT01349049|10136571|P7|Overall Study|Non-compliance|0
2944524|NCT01349049|10136572|P6|Overall Study|Non-compliance|0
2944525|NCT01349049|10136573|P5|Overall Study|Non-compliance|0
2944526|NCT01349049|10136574|P4|Overall Study|Non-compliance|1
2944527|NCT01349049|10136575|P3|Overall Study|Non-compliance|0
2944528|NCT01349049|10136576|P2|Overall Study|Non-compliance|0
2944529|NCT01349049|10136577|P1|Overall Study|Non-compliance|0
2944530|NCT01349049|10136569|P9|Overall Study|Death|5
2944531|NCT01349049|10136570|P8|Overall Study|Death|1
2944532|NCT01349049|10136571|P7|Overall Study|Death|0
2944533|NCT01349049|10136572|P6|Overall Study|Death|0
2944534|NCT01349049|10136573|P5|Overall Study|Death|0
2944535|NCT01349049|10136574|P4|Overall Study|Death|0
2944536|NCT01349049|10136575|P3|Overall Study|Death|0
2944537|NCT01349049|10136576|P2|Overall Study|Death|0
2944538|NCT01349049|10136577|P1|Overall Study|Death|0
2944539|NCT01349049|10136569|P9|Overall Study|Other|4
2944540|NCT01349049|10136570|P8|Overall Study|Other|0
2944541|NCT01349049|10136571|P7|Overall Study|Other|0
2944542|NCT01349049|10136572|P6|Overall Study|Other|1
2944543|NCT01349049|10136573|P5|Overall Study|Other|0
2944544|NCT01349049|10136574|P4|Overall Study|Other|0
2944545|NCT01349049|10136575|P3|Overall Study|Other|0
2944546|NCT01349049|10136576|P2|Overall Study|Other|0
2944547|NCT01349049|10136577|P1|Overall Study|Other|0
2944548|NCT01349049|10136569|P9|Overall Study|Hematopoietic stem cell transplant|0
2944549|NCT01349049|10136570|P8|Overall Study|Hematopoietic stem cell transplant|1
2944550|NCT01349049|10136571|P7|Overall Study|Hematopoietic stem cell transplant|1
2944551|NCT01349049|10136572|P6|Overall Study|Hematopoietic stem cell transplant|0
2944552|NCT01349049|10136573|P5|Overall Study|Hematopoietic stem cell transplant|1
2944553|NCT01349049|10136574|P4|Overall Study|Hematopoietic stem cell transplant|0
2944554|NCT01349049|10136575|P3|Overall Study|Hematopoietic stem cell transplant|0
2944555|NCT01349049|10136576|P2|Overall Study|Hematopoietic stem cell transplant|0
2944556|NCT01349049|10136577|P1|Overall Study|Hematopoietic stem cell transplant|0
2944557|NCT01349049|10136569|P9|Overall Study|Protocol Violation|1
2944558|NCT01349049|10136570|P8|Overall Study|Protocol Violation|0
2944559|NCT01349049|10136571|P7|Overall Study|Protocol Violation|0
2944560|NCT01349049|10136572|P6|Overall Study|Protocol Violation|0
2944561|NCT01349049|10136573|P5|Overall Study|Protocol Violation|0
2944562|NCT01349049|10136574|P4|Overall Study|Protocol Violation|0
2944563|NCT01349049|10136575|P3|Overall Study|Protocol Violation|0
2944564|NCT01349049|10136576|P2|Overall Study|Protocol Violation|0
2944565|NCT01349049|10136577|P1|Overall Study|Protocol Violation|0
2944566|NCT01349049|10136569|P9|Overall Study|Physician Decision|2
2944567|NCT01349049|10136570|P8|Overall Study|Physician Decision|0
2944568|NCT01349049|10136571|P7|Overall Study|Physician Decision|0
2944569|NCT01349049|10136572|P6|Overall Study|Physician Decision|0
2944570|NCT01349049|10136573|P5|Overall Study|Physician Decision|0
2944571|NCT01349049|10136574|P4|Overall Study|Physician Decision|0
2944572|NCT01349049|10136575|P3|Overall Study|Physician Decision|0
2944573|NCT01349049|10136576|P2|Overall Study|Physician Decision|1
2944574|NCT01349049|10136577|P1|Overall Study|Physician Decision|0
2944575|NCT01349049|10136569|P9|Overall Study|Adverse Event|4
2944576|NCT01349049|10136570|P8|Overall Study|Adverse Event|0
2944577|NCT01349049|10136571|P7|Overall Study|Adverse Event|1
2944578|NCT01349049|10136572|P6|Overall Study|Adverse Event|3
2944579|NCT01349049|10136573|P5|Overall Study|Adverse Event|0
2944580|NCT01349049|10136574|P4|Overall Study|Adverse Event|0
2944581|NCT01349049|10136575|P3|Overall Study|Adverse Event|0
2944582|NCT01349049|10136576|P2|Overall Study|Adverse Event|1
2944583|NCT01349049|10136577|P1|Overall Study|Adverse Event|0
2944584|NCT01349049|10136569|P9|Overall Study|Disease progression|33
2944585|NCT01349049|10136570|P8|Overall Study|Disease progression|2
2944586|NCT01349049|10136571|P7|Overall Study|Disease progression|3
2944587|NCT01349049|10136572|P6|Overall Study|Disease progression|2
2944588|NCT01349049|10136573|P5|Overall Study|Disease progression|2
2944589|NCT01349049|10136574|P4|Overall Study|Disease progression|2
2944590|NCT01349049|10136575|P3|Overall Study|Disease progression|3
2944591|NCT01349049|10136576|P2|Overall Study|Disease progression|5
2944592|NCT01349049|10136577|P1|Overall Study|Disease progression|3
2944593|NCT01349036|10136631|P2|Overall Study|Withdrawal by Subject|2
2944594|NCT01349036|10136632|P1|Overall Study|Withdrawal by Subject|0
2944595|NCT01349036|10136631|P2|Overall Study|Other|0
2944596|NCT01349036|10136632|P1|Overall Study|Other|1
2944597|NCT01349036|10136631|P2|Overall Study|Disease progression|22
2944598|NCT01349036|10136632|P1|Overall Study|Disease progression|13
2944599|NCT01348854|10136650|P2|Overall Study|Withdrawal by Subject|0
2944600|NCT01348854|10136651|P1|Overall Study|Withdrawal by Subject|1
2944601|NCT01348854|10136650|P2|Overall Study|Lost to Follow-up|1
2944602|NCT01348854|10136651|P1|Overall Study|Lost to Follow-up|2
2944603|NCT01348789|10136659|P1|Overall Study|Withdrawal by Subject|2
2944604|NCT01348789|10136659|P1|Overall Study|Protocol Violation|2
2944605|NCT01348776|10136670|P1|Overall Study|Lost to Follow-up|3
2944606|NCT01348763|10136683|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
2944607|NCT01348763|10136683|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
2944608|NCT01348698|10136688|P1|Overall Study|PI decision to close study|68
2944609|NCT01348698|10136688|P1|Overall Study|Death|3
2944610|NCT01348698|10136688|P1|Overall Study|Does not meet lesion size criteria|1
2944611|NCT01348542|10136713|P2|Overall Study|Withdrawal by Subject|0
2944612|NCT01348542|10136714|P1|Overall Study|Withdrawal by Subject|3
2944613|NCT01348490|10136730|P1|Overall Study|Other Unspecified|8
2944614|NCT01348490|10136730|P1|Overall Study|Termination of clinical trial by sponsor|1
2944615|NCT01348490|10136730|P1|Overall Study|Lost to Follow-up|1
2944616|NCT01348490|10136730|P1|Overall Study|Disease progression|3
2944617|NCT01348490|10136730|P1|Overall Study|Consent withdrawn|7
2944618|NCT01348490|10136730|P1|Overall Study|Adverse Event|3
2944619|NCT01348490|10136730|P1|Overall Study|Death|1
2944620|NCT01348425|10136788|P2|Overall Study|Imaging was not taken.|1
2944621|NCT01348425|10136789|P1|Overall Study|Imaging was not taken.|1
2944622|NCT01348347|10136797|P3|Overall Study|Progressive disease|5
2944623|NCT01348347|10136798|P2|Overall Study|Progressive disease|5
2944624|NCT01348347|10136799|P1|Overall Study|Progressive disease|2
2944625|NCT01348347|10136797|P3|Overall Study|Withdrawal by Subject|1
2944626|NCT01348347|10136798|P2|Overall Study|Withdrawal by Subject|1
2944627|NCT01348347|10136799|P1|Overall Study|Withdrawal by Subject|1
2944628|NCT01348165|10136830|P7|Overall Study|Adverse Event|1
2944629|NCT01348165|10136831|P6|Overall Study|Adverse Event|0
2944630|NCT01348165|10136832|P5|Overall Study|Adverse Event|0
2944631|NCT01348165|10136833|P4|Overall Study|Adverse Event|0
2944632|NCT01348165|10136834|P3|Overall Study|Adverse Event|0
2944633|NCT01348165|10136835|P2|Overall Study|Adverse Event|0
2944634|NCT01348165|10136836|P1|Overall Study|Adverse Event|0
2944635|NCT01348139|10136965|P6|Period 1|Adverse Event|0
2944636|NCT01348139|10136966|P5|Period 1|Adverse Event|0
2944637|NCT01348139|10136967|P4|Period 1|Adverse Event|0
2944638|NCT01348139|10136968|P3|Period 1|Adverse Event|0
2944639|NCT01348139|10136969|P2|Period 1|Adverse Event|0
2944640|NCT01348139|10136970|P1|Period 1|Adverse Event|1
2944641|NCT01348100|10137051|P7|Overall Study|Administrative Problems|1
2944642|NCT01348100|10137052|P6|Overall Study|Administrative Problems|1
2944643|NCT01348100|10137053|P5|Overall Study|Administrative Problems|0
2944644|NCT01348100|10137054|P4|Overall Study|Administrative Problems|0
2944645|NCT01348100|10137055|P3|Overall Study|Administrative Problems|0
2944646|NCT01348100|10137056|P2|Overall Study|Administrative Problems|0
2944647|NCT01348100|10137057|P1|Overall Study|Administrative Problems|0
2944648|NCT01348100|10137051|P7|Overall Study|Lost to Follow-up|1
2944649|NCT01348100|10137052|P6|Overall Study|Lost to Follow-up|0
2944650|NCT01348100|10137053|P5|Overall Study|Lost to Follow-up|0
2944651|NCT01348100|10137054|P4|Overall Study|Lost to Follow-up|0
2944652|NCT01348100|10137055|P3|Overall Study|Lost to Follow-up|0
2944653|NCT01348100|10137056|P2|Overall Study|Lost to Follow-up|0
2944654|NCT01348100|10137057|P1|Overall Study|Lost to Follow-up|0
2944655|NCT01348100|10137051|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
2944656|NCT01348100|10137052|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
2944657|NCT01348100|10137053|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
2944658|NCT01348100|10137054|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
2944659|NCT01348100|10137055|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
2944660|NCT01348100|10137056|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
2944661|NCT01348100|10137057|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
2944662|NCT01348100|10137051|P7|Overall Study|Protocol Deviation|0
2944663|NCT01348100|10137052|P6|Overall Study|Protocol Deviation|0
2944664|NCT01348100|10137053|P5|Overall Study|Protocol Deviation|0
2944665|NCT01348100|10137054|P4|Overall Study|Protocol Deviation|1
2944666|NCT01348100|10137055|P3|Overall Study|Protocol Deviation|0
2944667|NCT01348100|10137056|P2|Overall Study|Protocol Deviation|0
2944668|NCT01348100|10137057|P1|Overall Study|Protocol Deviation|0
2944669|NCT01348100|10137051|P7|Overall Study|Subject Withdrew Consent|1
2944670|NCT01348100|10137052|P6|Overall Study|Subject Withdrew Consent|0
2944671|NCT01348100|10137053|P5|Overall Study|Subject Withdrew Consent|1
2944672|NCT01348100|10137054|P4|Overall Study|Subject Withdrew Consent|0
2944673|NCT01348100|10137055|P3|Overall Study|Subject Withdrew Consent|2
2944674|NCT01348100|10137056|P2|Overall Study|Subject Withdrew Consent|0
2944675|NCT01348100|10137057|P1|Overall Study|Subject Withdrew Consent|0
2944676|NCT01348087|10137102|P1|Overall Study|Adverse Event|25
2944677|NCT01348087|10137102|P1|Overall Study|Subject withdrew consent|7
2944678|NCT01348087|10137102|P1|Overall Study|Lost to Follow-up|1
2944679|NCT01348087|10137102|P1|Overall Study|protocol deviation|1
2944680|NCT01348087|10137102|P1|Overall Study|Administrative problems|79
2944681|NCT01348087|10137102|P1|Overall Study|Unsatisfactory therapeutic effect|35
2944682|NCT01347931|10137116|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
2944683|NCT01347879|10137128|P2|Overall Study|Other|3
2944684|NCT01347879|10137129|P1|Overall Study|Other|2
2944685|NCT01347879|10137128|P2|Overall Study|Withdrawal by Subject|2
2944686|NCT01347879|10137129|P1|Overall Study|Withdrawal by Subject|3
2944687|NCT01347879|10137128|P2|Overall Study|Lost to Follow-up|0
2944688|NCT01347879|10137129|P1|Overall Study|Lost to Follow-up|2
2944689|NCT01347879|10137128|P2|Overall Study|Adverse Event|12
2944690|NCT01347879|10137129|P1|Overall Study|Adverse Event|0
2944691|NCT01347866|10137178|P17|Overall Study|Subject refused further follow-up|2
2944692|NCT01347866|10137179|P16|Overall Study|Subject refused further follow-up|0
2944693|NCT01347866|10137180|P15|Overall Study|Subject refused further follow-up|1
2944694|NCT01347866|10137181|P14|Overall Study|Subject refused further follow-up|3
2944695|NCT01347866|10137182|P13|Overall Study|Subject refused further follow-up|1
2944696|NCT01347866|10137183|P12|Overall Study|Subject refused further follow-up|0
2944697|NCT01347866|10137184|P11|Overall Study|Subject refused further follow-up|0
2944698|NCT01347866|10137185|P10|Overall Study|Subject refused further follow-up|1
2944699|NCT01347866|10137186|P9|Overall Study|Subject refused further follow-up|4
2944700|NCT01347866|10137187|P8|Overall Study|Subject refused further follow-up|0
2944701|NCT01347866|10137188|P7|Overall Study|Subject refused further follow-up|0
2944702|NCT01347866|10137189|P6|Overall Study|Subject refused further follow-up|1
2944703|NCT01347866|10137190|P5|Overall Study|Subject refused further follow-up|0
2944704|NCT01347866|10137191|P4|Overall Study|Subject refused further follow-up|2
2944705|NCT01347866|10137192|P3|Overall Study|Subject refused further follow-up|0
2944706|NCT01347866|10137193|P2|Overall Study|Subject refused further follow-up|0
2944707|NCT01347866|10137194|P1|Overall Study|Subject refused further follow-up|2
2944708|NCT01347866|10137178|P17|Overall Study|Other|0
2944709|NCT01347866|10137179|P16|Overall Study|Other|3
2944710|NCT01347866|10137180|P15|Overall Study|Other|2
2944711|NCT01347866|10137181|P14|Overall Study|Other|4
2944712|NCT01347866|10137182|P13|Overall Study|Other|4
2944713|NCT01347866|10137183|P12|Overall Study|Other|3
2944714|NCT01347866|10137184|P11|Overall Study|Other|0
2944715|NCT01347866|10137185|P10|Overall Study|Other|5
2944716|NCT01347866|10137186|P9|Overall Study|Other|22
2944717|NCT01347866|10137187|P8|Overall Study|Other|3
2944718|NCT01347866|10137188|P7|Overall Study|Other|5
2944719|NCT01347866|10137189|P6|Overall Study|Other|0
2944720|NCT01347866|10137190|P5|Overall Study|Other|5
2944721|NCT01347866|10137191|P4|Overall Study|Other|4
2944722|NCT01347866|10137192|P3|Overall Study|Other|1
2944723|NCT01347866|10137193|P2|Overall Study|Other|1
2944724|NCT01347866|10137194|P1|Overall Study|Other|3
2944725|NCT01347866|10137178|P17|Overall Study|Lost to Follow-up|0
2944726|NCT01347866|10137179|P16|Overall Study|Lost to Follow-up|0
2944727|NCT01347866|10137180|P15|Overall Study|Lost to Follow-up|0
2944728|NCT01347866|10137181|P14|Overall Study|Lost to Follow-up|0
2944729|NCT01347866|10137182|P13|Overall Study|Lost to Follow-up|0
2944730|NCT01347866|10137183|P12|Overall Study|Lost to Follow-up|0
2944731|NCT01347866|10137184|P11|Overall Study|Lost to Follow-up|0
2944732|NCT01347866|10137185|P10|Overall Study|Lost to Follow-up|0
2944733|NCT01347866|10137186|P9|Overall Study|Lost to Follow-up|1
2944734|NCT01347866|10137187|P8|Overall Study|Lost to Follow-up|1
2944735|NCT01347866|10137188|P7|Overall Study|Lost to Follow-up|0
2944736|NCT01347866|10137189|P6|Overall Study|Lost to Follow-up|0
2944737|NCT01347866|10137190|P5|Overall Study|Lost to Follow-up|0
2944738|NCT01347866|10137191|P4|Overall Study|Lost to Follow-up|0
2944739|NCT01347866|10137192|P3|Overall Study|Lost to Follow-up|0
2944740|NCT01347866|10137193|P2|Overall Study|Lost to Follow-up|0
2944741|NCT01347866|10137194|P1|Overall Study|Lost to Follow-up|0
2944742|NCT01347866|10137178|P17|Overall Study|Death|0
2944743|NCT01347866|10137179|P16|Overall Study|Death|1
2944744|NCT01347866|10137180|P15|Overall Study|Death|0
2944745|NCT01347866|10137181|P14|Overall Study|Death|0
2944746|NCT01347866|10137182|P13|Overall Study|Death|2
2944747|NCT01347866|10137183|P12|Overall Study|Death|1
2944748|NCT01347866|10137184|P11|Overall Study|Death|3
2944749|NCT01347866|10137185|P10|Overall Study|Death|1
2944750|NCT01347866|10137186|P9|Overall Study|Death|4
2944751|NCT01347866|10137187|P8|Overall Study|Death|0
2944752|NCT01347866|10137188|P7|Overall Study|Death|1
2944753|NCT01347866|10137189|P6|Overall Study|Death|2
2944754|NCT01347866|10137190|P5|Overall Study|Death|2
2944755|NCT01347866|10137191|P4|Overall Study|Death|1
2944756|NCT01347866|10137192|P3|Overall Study|Death|0
2944757|NCT01347866|10137193|P2|Overall Study|Death|0
2944758|NCT01347866|10137194|P1|Overall Study|Death|0
2944759|NCT01347840|10137568|P1|Overall Study|Withdrawal by Subject|1
2944760|NCT01347762|10137595|P4|Overall Study|Withdrawal by Subject|3
2944761|NCT01347762|10137596|P3|Overall Study|Withdrawal by Subject|3
2944762|NCT01347762|10137597|P2|Overall Study|Withdrawal by Subject|1
2944763|NCT01347762|10137598|P1|Overall Study|Withdrawal by Subject|4
2944764|NCT01347762|10137595|P4|Overall Study|Lost to Follow-up|5
2944765|NCT01347762|10137596|P3|Overall Study|Lost to Follow-up|6
2944766|NCT01347762|10137597|P2|Overall Study|Lost to Follow-up|1
2944767|NCT01347762|10137598|P1|Overall Study|Lost to Follow-up|0
2944768|NCT01347710|10137624|P1|Overall Study|Other|3
2944769|NCT01347710|10137624|P1|Overall Study|Physician Decision|2
2944770|NCT01347710|10137624|P1|Overall Study|Lost to Follow-up|1
2944771|NCT01347710|10137624|P1|Overall Study|issue with vitals prior to dosing|1
2944772|NCT01347710|10137624|P1|Overall Study|Angio or SPECT not completed|18
2944773|NCT01347710|10137624|P1|Overall Study|Adverse Event|4
2944774|NCT01347710|10137624|P1|Overall Study|Withdrawal by Subject|2
2944775|NCT01347580|10137646|P2|Overall Study|Had other reason|6
2944776|NCT01347580|10137647|P1|Overall Study|Had other reason|9
2944777|NCT01347580|10137646|P2|Overall Study|Lost to Follow-up|1
2944778|NCT01347580|10137647|P1|Overall Study|Lost to Follow-up|3
2944779|NCT01347580|10137646|P2|Overall Study|Protocol Violation|7
2944780|NCT01347580|10137647|P1|Overall Study|Protocol Violation|10
2944781|NCT01347580|10137646|P2|Overall Study|Death|19
2944782|NCT01347580|10137647|P1|Overall Study|Death|30
2944783|NCT01347580|10137646|P2|Overall Study|Withdrawal by Subject|23
2944784|NCT01347580|10137647|P1|Overall Study|Withdrawal by Subject|13
2944785|NCT01347554|10137677|P2|Overall Study|Lack of Efficacy|11
2944786|NCT01347554|10137678|P1|Overall Study|Lack of Efficacy|7
2944787|NCT01347112|10137726|P2|Overall Study|Lost to Follow-up|5
2944788|NCT01347112|10137727|P1|Overall Study|Lost to Follow-up|3
2944789|NCT01347112|10137726|P2|Overall Study|Withdrawal by Subject|7
2944790|NCT01347112|10137727|P1|Overall Study|Withdrawal by Subject|1
2944791|NCT01347086|10137747|P10|Overall Study|failed screening visit|1
2944792|NCT01347086|10137748|P9|Overall Study|failed screening visit|0
2944793|NCT01347086|10137749|P8|Overall Study|failed screening visit|1
2944794|NCT01347086|10137750|P7|Overall Study|failed screening visit|1
2944795|NCT01347086|10137751|P6|Overall Study|failed screening visit|0
2944796|NCT01347086|10137752|P5|Overall Study|failed screening visit|0
2944797|NCT01347086|10137753|P4|Overall Study|failed screening visit|0
2944798|NCT01347086|10137754|P3|Overall Study|failed screening visit|1
2944799|NCT01347086|10137755|P2|Overall Study|failed screening visit|0
2944800|NCT01347086|10137756|P1|Overall Study|failed screening visit|0
2944801|NCT01347073|10137855|P1|Overall Study|Liver Transplant|1
2944802|NCT01347073|10137855|P1|Overall Study|Adverse Event|1
2944803|NCT01346774|10137934|P2|Overall Study|Adverse Event|2
2944804|NCT01346774|10137935|P1|Overall Study|Adverse Event|1
2944805|NCT01346774|10137934|P2|Overall Study|Protocol Violation|3
2944806|NCT01346774|10137935|P1|Overall Study|Protocol Violation|2
2944807|NCT01346774|10137934|P2|Overall Study|Withdrawal by Subject|4
2944808|NCT01346774|10137935|P1|Overall Study|Withdrawal by Subject|1
2944809|NCT01346774|10137934|P2|Overall Study|Lost to Follow-up|4
2944810|NCT01346774|10137935|P1|Overall Study|Lost to Follow-up|3
2944811|NCT01346774|10137934|P2|Overall Study|Did not take a single dose|4
2944812|NCT01346774|10137935|P1|Overall Study|Did not take a single dose|6
2944813|NCT01346696|10137941|P1|Overall Study|Death|1
2944814|NCT01346592|10137963|P3|Overall Study|Unable to Classify|6
2944815|NCT01346592|10137964|P2|Overall Study|Unable to Classify|3
2944816|NCT01346592|10137965|P1|Overall Study|Unable to Classify|7
2944817|NCT01346592|10137963|P3|Overall Study|Administrative reason|0
2944818|NCT01346592|10137964|P2|Overall Study|Administrative reason|0
2944819|NCT01346592|10137965|P1|Overall Study|Administrative reason|1
2944820|NCT01346592|10137963|P3|Overall Study|Inappropriate enrollment|1
2944821|NCT01346592|10137964|P2|Overall Study|Inappropriate enrollment|1
2944822|NCT01346592|10137965|P1|Overall Study|Inappropriate enrollment|3
2944823|NCT01346592|10137963|P3|Overall Study|Withdrawal by Subject|38
2944824|NCT01346592|10137964|P2|Overall Study|Withdrawal by Subject|51
2944825|NCT01346592|10137965|P1|Overall Study|Withdrawal by Subject|77
2944826|NCT01346592|10137963|P3|Overall Study|Adverse Event|0
2944827|NCT01346592|10137964|P2|Overall Study|Adverse Event|1
2944828|NCT01346592|10137965|P1|Overall Study|Adverse Event|0
2944829|NCT01346592|10137963|P3|Overall Study|Death|4
2944830|NCT01346592|10137964|P2|Overall Study|Death|3
2944831|NCT01346592|10137965|P1|Overall Study|Death|1
2944832|NCT01346592|10137963|P3|Overall Study|Protocol Violation|0
2944833|NCT01346592|10137964|P2|Overall Study|Protocol Violation|1
2944834|NCT01346592|10137965|P1|Overall Study|Protocol Violation|2
2944835|NCT01346592|10137963|P3|Overall Study|Lost to Follow-up|29
2944836|NCT01346592|10137964|P2|Overall Study|Lost to Follow-up|29
2944837|NCT01346592|10137965|P1|Overall Study|Lost to Follow-up|62
2944838|NCT01346540|10138057|P2|Overall Study|Adverse Event|4
2944839|NCT01346540|10138058|P1|Overall Study|Adverse Event|0
2944840|NCT01346540|10138057|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
2944841|NCT01346540|10138058|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
2944842|NCT01346514|10138069|P2|Overall Study|Death|4
2944843|NCT01346514|10138070|P1|Overall Study|Death|3
2944844|NCT01346514|10138069|P2|Overall Study|Withdrawal by Subject|3
2944845|NCT01346514|10138070|P1|Overall Study|Withdrawal by Subject|7
2944846|NCT01346514|10138069|P2|Overall Study|Lost to Follow-up|30
2944847|NCT01346514|10138070|P1|Overall Study|Lost to Follow-up|19
2944848|NCT01346501|10138090|P2|Overall Study|Other|12
2944849|NCT01346501|10138091|P1|Overall Study|Other|8
2944850|NCT01346501|10138090|P2|Overall Study|Initiated Other Biological Agents|1
2944851|NCT01346501|10138091|P1|Overall Study|Initiated Other Biological Agents|3
2944852|NCT01346475|10138124|P2|First Intervention|Lost to Follow-up|3
2944853|NCT01346475|10138125|P1|First Intervention|Lost to Follow-up|4
2944854|NCT01346410|10138137|P1|Overall Study|Death|1
2944855|NCT01346371|10138155|P2|Overall Study|Lost to Follow-up|0
2944856|NCT01346371|10138156|P1|Overall Study|Lost to Follow-up|2
2944857|NCT01346293|10138164|P2|Overall Study|Other|0
2944858|NCT01346293|10138165|P1|Overall Study|Other|1
2944859|NCT01346293|10138164|P2|Overall Study|Withdrawal by Subject|4
2944860|NCT01346293|10138165|P1|Overall Study|Withdrawal by Subject|15
2944861|NCT01346293|10138164|P2|Overall Study|Lost to Follow-up|8
2944862|NCT01346293|10138165|P1|Overall Study|Lost to Follow-up|21
2944863|NCT01346293|10138164|P2|Overall Study|Protocol Violation|9
2944864|NCT01346293|10138165|P1|Overall Study|Protocol Violation|30
2944865|NCT01346189|10138195|P4|Overall Study|Travel|3
2944866|NCT01346189|10138196|P3|Overall Study|Travel|0
2944867|NCT01346189|10138197|P2|Overall Study|Travel|0
2944868|NCT01346189|10138198|P1|Overall Study|Travel|0
2944869|NCT01346189|10138195|P4|Overall Study|Non-health system primary care physician|0
2944870|NCT01346189|10138196|P3|Overall Study|Non-health system primary care physician|0
2944871|NCT01346189|10138197|P2|Overall Study|Non-health system primary care physician|5
2944872|NCT01346189|10138198|P1|Overall Study|Non-health system primary care physician|0
2944873|NCT01346189|10138195|P4|Overall Study|Death|0
2944874|NCT01346189|10138196|P3|Overall Study|Death|0
2944875|NCT01346189|10138197|P2|Overall Study|Death|3
2944876|NCT01346189|10138198|P1|Overall Study|Death|0
2944877|NCT01346189|10138195|P4|Overall Study|Other|3
2944878|NCT01346189|10138196|P3|Overall Study|Other|7
2944879|NCT01346189|10138197|P2|Overall Study|Other|4
2944880|NCT01346189|10138198|P1|Overall Study|Other|2
2944881|NCT01346189|10138195|P4|Overall Study|Moved|0
2944882|NCT01346189|10138196|P3|Overall Study|Moved|4
2944883|NCT01346189|10138197|P2|Overall Study|Moved|0
2944884|NCT01346189|10138198|P1|Overall Study|Moved|3
2944885|NCT01346189|10138195|P4|Overall Study|Physician Decision|0
2944886|NCT01346189|10138196|P3|Overall Study|Physician Decision|0
2944887|NCT01346189|10138197|P2|Overall Study|Physician Decision|0
2944888|NCT01346189|10138198|P1|Overall Study|Physician Decision|4
2944889|NCT01346189|10138195|P4|Overall Study|Withdrawal by Subject|5
2944890|NCT01346189|10138196|P3|Overall Study|Withdrawal by Subject|3
2944891|NCT01346189|10138197|P2|Overall Study|Withdrawal by Subject|5
2944892|NCT01346189|10138198|P1|Overall Study|Withdrawal by Subject|7
2944893|NCT01346176|10138215|P3|Completed Satisfaction Survey|Lost to Follow-up|4
2944894|NCT01346176|10138216|P2|Completed Satisfaction Survey|Lost to Follow-up|4
2944895|NCT01346176|10138217|P1|Completed Satisfaction Survey|Lost to Follow-up|3
2944896|NCT01346176|10138215|P3|Completed Satisfaction Survey|Death|2
2944897|NCT01346176|10138216|P2|Completed Satisfaction Survey|Death|0
2944898|NCT01346176|10138217|P1|Completed Satisfaction Survey|Death|3
2944899|NCT01346176|10138215|P3|Completed Advance Directive|Other reason did not complete AD|7
2944900|NCT01346176|10138216|P2|Completed Advance Directive|Other reason did not complete AD|12
2944901|NCT01346176|10138217|P1|Completed Advance Directive|Other reason did not complete AD|7
2944902|NCT01346176|10138215|P3|Completed Advance Directive|Became Ineligible|1
2944903|NCT01346176|10138216|P2|Completed Advance Directive|Became Ineligible|0
2944904|NCT01346176|10138217|P1|Completed Advance Directive|Became Ineligible|3
2944905|NCT01346176|10138215|P3|Completed Advance Directive|Death|2
2944906|NCT01346176|10138216|P2|Completed Advance Directive|Death|2
2944907|NCT01346176|10138217|P1|Completed Advance Directive|Death|3
2944908|NCT01346176|10138215|P3|Recruited|Protocol Violation|0
2944909|NCT01346176|10138216|P2|Recruited|Protocol Violation|0
2944910|NCT01346176|10138217|P1|Recruited|Protocol Violation|1
2944911|NCT01346059|10138246|P2|Overall Study|Withdrawal by Subject|0
2944912|NCT01346059|10138247|P1|Overall Study|Withdrawal by Subject|1
2944913|NCT01345929|10138259|P2|Overall Study|Patient withdrawal|1
2944914|NCT01345929|10138260|P1|Overall Study|Patient withdrawal|0
2944915|NCT01345929|10138259|P2|Overall Study|40,000 CFU/ML|0
2944916|NCT01345929|10138260|P1|Overall Study|40,000 CFU/ML|1
2944917|NCT01345929|10138259|P2|Overall Study|Didn't meet eligibility criteria|0
2944918|NCT01345929|10138260|P1|Overall Study|Didn't meet eligibility criteria|2
2944919|NCT01345929|10138259|P2|Overall Study|Adverse Event|1
2944920|NCT01345929|10138260|P1|Overall Study|Adverse Event|0
2944921|NCT01345929|10138259|P2|Overall Study|Lost to Follow-up|9
2944922|NCT01345929|10138260|P1|Overall Study|Lost to Follow-up|9
2944923|NCT01345929|10138259|P2|Overall Study|Withdrawal by Subject|8
2944924|NCT01345929|10138260|P1|Overall Study|Withdrawal by Subject|9
2944925|NCT01345786|10138272|P4|Overall Study|Lost to Follow-up|2
2944926|NCT01345786|10138273|P3|Overall Study|Lost to Follow-up|0
2944927|NCT01345786|10138274|P2|Overall Study|Lost to Follow-up|0
2944928|NCT01345786|10138275|P1|Overall Study|Lost to Follow-up|0
2944929|NCT01345786|10138272|P4|Overall Study|Administrative|0
2944930|NCT01345786|10138273|P3|Overall Study|Administrative|0
2944931|NCT01345786|10138274|P2|Overall Study|Administrative|5
2944932|NCT01345786|10138275|P1|Overall Study|Administrative|3
2944933|NCT01345786|10138272|P4|Overall Study|Noncompliance with protocol|0
2944934|NCT01345786|10138273|P3|Overall Study|Noncompliance with protocol|1
2944935|NCT01345786|10138274|P2|Overall Study|Noncompliance with protocol|0
2944936|NCT01345786|10138275|P1|Overall Study|Noncompliance with protocol|1
2944937|NCT01345786|10138272|P4|Overall Study|Subject withdrew consent|0
2944938|NCT01345786|10138273|P3|Overall Study|Subject withdrew consent|1
2944939|NCT01345786|10138274|P2|Overall Study|Subject withdrew consent|2
2944940|NCT01345786|10138275|P1|Overall Study|Subject withdrew consent|2
2944941|NCT01345786|10138272|P4|Overall Study|Adverse Event|1
2944942|NCT01345786|10138273|P3|Overall Study|Adverse Event|3
2944943|NCT01345786|10138274|P2|Overall Study|Adverse Event|1
2944944|NCT01345786|10138275|P1|Overall Study|Adverse Event|0
2944945|NCT01345682|10138355|P2|Overall Study|Reason other than those specified above|3
2944946|NCT01345682|10138356|P1|Overall Study|Reason other than those specified above|4
2944947|NCT01345682|10138355|P2|Overall Study|Not treated|1
2944948|NCT01345682|10138356|P1|Overall Study|Not treated|2
2944949|NCT01345682|10138355|P2|Overall Study|Refused to continue trial medication|9
2944950|NCT01345682|10138356|P1|Overall Study|Refused to continue trial medication|16
2944951|NCT01345682|10138355|P2|Overall Study|Lost to Follow-up|1
2944952|NCT01345682|10138356|P1|Overall Study|Lost to Follow-up|0
2944953|NCT01345682|10138355|P2|Overall Study|Non-compliance with protocol|1
2944954|NCT01345682|10138356|P1|Overall Study|Non-compliance with protocol|0
2944955|NCT01345682|10138355|P2|Overall Study|Adverse Event|41
2944956|NCT01345682|10138356|P1|Overall Study|Adverse Event|51
2944957|NCT01345682|10138355|P2|Overall Study|Worsening of underlying cancer disease|12
2944958|NCT01345682|10138356|P1|Overall Study|Worsening of underlying cancer disease|23
2944959|NCT01345682|10138355|P2|Overall Study|Progressive disease per RECIST|93
2944960|NCT01345682|10138356|P1|Overall Study|Progressive disease per RECIST|226
2944961|NCT01345669|10138390|P2|Overall Study|Other Reasons|60
2944962|NCT01345669|10138391|P1|Overall Study|Other Reasons|111
2944963|NCT01345669|10138390|P2|Overall Study|Withdrawal by Subject|13
2944964|NCT01345669|10138391|P1|Overall Study|Withdrawal by Subject|52
2944965|NCT01345669|10138390|P2|Overall Study|Lost to Follow-up|1
2944966|NCT01345669|10138391|P1|Overall Study|Lost to Follow-up|1
2944967|NCT01345669|10138390|P2|Overall Study|Protocol Violation|1
2944968|NCT01345669|10138391|P1|Overall Study|Protocol Violation|3
2944969|NCT01345669|10138390|P2|Overall Study|Adverse Event|9
2944970|NCT01345669|10138391|P1|Overall Study|Adverse Event|63
2944971|NCT01345669|10138390|P2|Overall Study|Second primary tumour|3
2944972|NCT01345669|10138391|P1|Overall Study|Second primary tumour|4
2944973|NCT01345669|10138390|P2|Overall Study|Primary tumour recurrence|32
2944974|NCT01345669|10138391|P1|Overall Study|Primary tumour recurrence|53
2944975|NCT01345630|10138409|P2|Overall Study|Insufficient clinical response|11
2944976|NCT01345630|10138410|P1|Overall Study|Insufficient clinical response|48
2944977|NCT01345630|10138409|P2|Overall Study|No longer willing to participate|12
2944978|NCT01345630|10138410|P1|Overall Study|No longer willing to participate|9
2944979|NCT01345630|10138409|P2|Overall Study|Withdrawn due to pregnancy|2
2944980|NCT01345630|10138410|P1|Overall Study|Withdrawn due to pregnancy|1
2944981|NCT01345630|10138409|P2|Overall Study|Other reasons|8
2944982|NCT01345630|10138410|P1|Overall Study|Other reasons|6
2944983|NCT01345630|10138409|P2|Overall Study|Study terminated by sponsor|285
2944984|NCT01345630|10138410|P1|Overall Study|Study terminated by sponsor|254
2944985|NCT01345630|10138409|P2|Overall Study|Medication error without associated AE|1
2944986|NCT01345630|10138410|P1|Overall Study|Medication error without associated AE|0
2944987|NCT01345630|10138409|P2|Overall Study|Protocol Violation|1
2944988|NCT01345630|10138410|P1|Overall Study|Protocol Violation|4
2944989|NCT01345630|10138409|P2|Overall Study|Lost to Follow-up|16
2944990|NCT01345630|10138410|P1|Overall Study|Lost to Follow-up|17
2944991|NCT01345630|10138409|P2|Overall Study|Adverse Event|23
2944992|NCT01345630|10138410|P1|Overall Study|Adverse Event|22
2944993|NCT01345591|10138466|P1|Overall Study|Lost to Follow-up|1
2944994|NCT01345318|10138482|P1|Overall Study|Other|3
2944995|NCT01345318|10138482|P1|Overall Study|Withdrawal by Subject|41
2944996|NCT01345318|10138482|P1|Overall Study|Protocol Violation|1
2944997|NCT01345318|10138482|P1|Overall Study|Lost to Follow-up|2
2944998|NCT01345318|10138482|P1|Overall Study|Lack of Efficacy|17
2944999|NCT01345318|10138482|P1|Overall Study|Adverse Event|16
2945000|NCT01345292|10138490|P3|Overall Study|Withdrawal by Subject|1
2945001|NCT01345292|10138491|P2|Overall Study|Withdrawal by Subject|0
2945002|NCT01345292|10138492|P1|Overall Study|Withdrawal by Subject|2
2945003|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2945004|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2945005|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
2945006|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
2945007|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
2945008|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
2945009|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
2945010|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
2945011|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
2945012|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
2945013|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
2945014|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
2945015|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
2945016|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
2945017|NCT01345253|10138523|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
2945018|NCT01345253|10138524|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
2945019|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
2945020|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
2945021|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
2945022|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
2945023|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
2945024|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
2945025|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
2945026|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
2945027|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
2945028|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
2945029|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
2945030|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
2945031|NCT01345253|10138523|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
2945032|NCT01345253|10138524|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
2945033|NCT01345240|10138545|P5|Overall Study|Lost to Follow-up|9
2945034|NCT01345240|10138546|P4|Overall Study|Lost to Follow-up|7
2945035|NCT01345240|10138547|P3|Overall Study|Lost to Follow-up|14
2945036|NCT01345240|10138548|P2|Overall Study|Lost to Follow-up|9
2945037|NCT01345240|10138549|P1|Overall Study|Lost to Follow-up|8
2945038|NCT01345240|10138545|P5|Overall Study|Adverse Event|1
2945039|NCT01345240|10138546|P4|Overall Study|Adverse Event|2
2945040|NCT01345240|10138547|P3|Overall Study|Adverse Event|4
2945041|NCT01345240|10138548|P2|Overall Study|Adverse Event|5
2945042|NCT01345240|10138549|P1|Overall Study|Adverse Event|3
2945043|NCT01345188|10138669|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
2945044|NCT01345188|10138669|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
2945045|NCT01345162|10138681|P2|Overall Study|Protocol Violation|4
2945046|NCT01345162|10138682|P1|Overall Study|Protocol Violation|2
2945047|NCT01345123|10138691|P3|Overall Study|participants no longer with health plan|88
2945048|NCT01345123|10138692|P2|Overall Study|participants no longer with health plan|85
2945049|NCT01345123|10138693|P1|Overall Study|participants no longer with health plan|79
2945050|NCT01345058|10138715|P2|Overall Study|Participant No-Show at Multiple Visits|0
2945051|NCT01345058|10138716|P1|Overall Study|Participant No-Show at Multiple Visits|1
2945052|NCT01345058|10138715|P2|Overall Study|Participant Stopped Taking Study Drug|0
2945053|NCT01345058|10138716|P1|Overall Study|Participant Stopped Taking Study Drug|1
2945054|NCT01345058|10138715|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
2945055|NCT01345058|10138716|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
2945056|NCT01345058|10138715|P2|Overall Study|Participant Reported Increase in Events|0
2945057|NCT01345058|10138716|P1|Overall Study|Participant Reported Increase in Events|1
2945058|NCT01345058|10138715|P2|Overall Study|Withdrawal by Subject|0
2945059|NCT01345058|10138716|P1|Overall Study|Withdrawal by Subject|1
2945060|NCT01345019|10138732|P2|Open Label Treatment Phase|Protocol Violation|1
2945061|NCT01345019|10138733|P1|Open Label Treatment Phase|Protocol Violation|0
2945062|NCT01345019|10138732|P2|Open Label Treatment Phase|Other, Not Specified|7
2945063|NCT01345019|10138733|P1|Open Label Treatment Phase|Other, Not Specified|9
2945064|NCT01345019|10138732|P2|Open Label Treatment Phase|Pregnancy|0
2945065|NCT01345019|10138733|P1|Open Label Treatment Phase|Pregnancy|1
2945066|NCT01345019|10138732|P2|Open Label Treatment Phase|Lost to Follow-up|2
2945067|NCT01345019|10138733|P1|Open Label Treatment Phase|Lost to Follow-up|1
2945068|NCT01345019|10138732|P2|Open Label Treatment Phase|Noncompliance|4
2945069|NCT01345019|10138733|P1|Open Label Treatment Phase|Noncompliance|5
2945070|NCT01345019|10138732|P2|Open Label Treatment Phase|Disease Progression|18
2945071|NCT01345019|10138733|P1|Open Label Treatment Phase|Disease Progression|17
2945072|NCT01345019|10138732|P2|Open Label Treatment Phase|Administrative Decision|15
2945073|NCT01345019|10138733|P1|Open Label Treatment Phase|Administrative Decision|30
2945074|NCT01345019|10138732|P2|Open Label Treatment Phase|Adverse Event|51
2945075|NCT01345019|10138733|P1|Open Label Treatment Phase|Adverse Event|30
2945076|NCT01345019|10138732|P2|Open Label Treatment Phase|Withdrawal by Subject|47
2945077|NCT01345019|10138733|P1|Open Label Treatment Phase|Withdrawal by Subject|49
2945078|NCT01345019|10138732|P2|Open Label Treatment Phase|Death|48
2945079|NCT01345019|10138733|P1|Open Label Treatment Phase|Death|49
2945080|NCT01345019|10138732|P2|Blinded Treatment Phase|Lost to Follow-up|3
2945081|NCT01345019|10138733|P1|Blinded Treatment Phase|Lost to Follow-up|6
2945082|NCT01345019|10138732|P2|Blinded Treatment Phase|Other, Not Specified|3
2945083|NCT01345019|10138733|P1|Blinded Treatment Phase|Other, Not Specified|2
2945084|NCT01345019|10138732|P2|Blinded Treatment Phase|Protocol Deviation|0
2945085|NCT01345019|10138733|P1|Blinded Treatment Phase|Protocol Deviation|5
2945086|NCT01345019|10138732|P2|Blinded Treatment Phase|Ineligibility Determined|6
2945087|NCT01345019|10138733|P1|Blinded Treatment Phase|Ineligibility Determined|1
2945088|NCT01345019|10138732|P2|Blinded Treatment Phase|Noncompliance|3
2945089|NCT01345019|10138733|P1|Blinded Treatment Phase|Noncompliance|5
2945090|NCT01345019|10138732|P2|Blinded Treatment Phase|Administrative Decision|8
2945091|NCT01345019|10138733|P1|Blinded Treatment Phase|Administrative Decision|10
2945092|NCT01345019|10138732|P2|Blinded Treatment Phase|Adverse Event|13
2945093|NCT01345019|10138733|P1|Blinded Treatment Phase|Adverse Event|6
2945094|NCT01345019|10138732|P2|Blinded Treatment Phase|Disease Progression|10
2945095|NCT01345019|10138733|P1|Blinded Treatment Phase|Disease Progression|12
2945096|NCT01345019|10138732|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
2945097|NCT01345019|10138733|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
2945098|NCT01345019|10138732|P2|Blinded Treatment Phase|Withdrawal by Subject|112
2945099|NCT01345019|10138733|P1|Blinded Treatment Phase|Withdrawal by Subject|103
2945100|NCT01345019|10138732|P2|Blinded Treatment Phase|Death|137
2945101|NCT01345019|10138733|P1|Blinded Treatment Phase|Death|147
2945102|NCT01344876|10138755|P5|Overall Study|Definite progression of primary disease|0
2945103|NCT01344876|10138756|P4|Overall Study|Definite progression of primary disease|3
2945104|NCT01344876|10138757|P3|Overall Study|Definite progression of primary disease|0
2945105|NCT01344876|10138758|P2|Overall Study|Definite progression of primary disease|0
2945106|NCT01344876|10138759|P1|Overall Study|Definite progression of primary disease|1
2945107|NCT01344876|10138755|P5|Overall Study|Withdrawal by Subject|0
2945108|NCT01344876|10138756|P4|Overall Study|Withdrawal by Subject|0
2945109|NCT01344876|10138757|P3|Overall Study|Withdrawal by Subject|1
2945110|NCT01344876|10138758|P2|Overall Study|Withdrawal by Subject|0
2945111|NCT01344876|10138759|P1|Overall Study|Withdrawal by Subject|0
2945112|NCT01344876|10138755|P5|Overall Study|Adverse Event|1
2945113|NCT01344876|10138756|P4|Overall Study|Adverse Event|0
2945114|NCT01344876|10138757|P3|Overall Study|Adverse Event|0
2945115|NCT01344876|10138758|P2|Overall Study|Adverse Event|0
2945116|NCT01344876|10138759|P1|Overall Study|Adverse Event|0
2945117|NCT01344824|10138773|P1|Overall Study|Progression|15
2945118|NCT01344824|10138773|P1|Overall Study|Other complicating disease|1
2945119|NCT01344824|10138773|P1|Overall Study|Withdrawal by Subject|6
2945120|NCT01344824|10138773|P1|Overall Study|Adverse Event|15
2945121|NCT01344759|10138781|P2|Overall Study|Patients failed to reach sedation level|2
2945122|NCT01344759|10138782|P1|Overall Study|Patients failed to reach sedation level|0
2945123|NCT01344629|10138814|P2|Crossover Period 2|Withdrawal by Subject|1
2945124|NCT01344629|10138815|P1|Crossover Period 2|Withdrawal by Subject|0
2945125|NCT01344538|10138844|P2|Overall Study|Lost to Follow-up|0
2945126|NCT01344538|10138845|P1|Overall Study|Lost to Follow-up|1
2945127|NCT01344538|10138844|P2|Overall Study|Adverse Event|1
2945128|NCT01344538|10138845|P1|Overall Study|Adverse Event|1
2945129|NCT01344460|10138851|P1|Overall Study|Lost to Follow-up|2
2945130|NCT01344460|10138851|P1|Overall Study|Withdrawal by Subject|1
2945131|NCT01344447|10138896|P1|Overall Study|Error of power injector|1
2945132|NCT01344447|10138896|P1|Overall Study|Bolus tracking failed|1
2945133|NCT01344447|10138896|P1|Overall Study|MRA unsuccessful|1
2945134|NCT01344447|10138896|P1|Overall Study|Physician Decision|1
2945135|NCT01344447|10138896|P1|Overall Study|The contrast was not seen|1
2945136|NCT01344447|10138896|P1|Overall Study|Withdrawal by Subject|1
2945137|NCT01344447|10138896|P1|Overall Study|Protocol Violation|1
2945138|NCT01344447|10138896|P1|Overall Study|Adverse Event|1
2945139|NCT01344369|10138940|P2|Second Intervention|Emesis within 2 x Tmax|1
2945140|NCT01344369|10138941|P1|Second Intervention|Emesis within 2 x Tmax|0
2945141|NCT01344369|10138940|P2|Washout of 28 Days|Physician Decision|1
2945142|NCT01344369|10138941|P1|Washout of 28 Days|Physician Decision|0
2945143|NCT01344369|10138940|P2|Washout of 28 Days|Withdrawal by Subject|0
2945144|NCT01344369|10138941|P1|Washout of 28 Days|Withdrawal by Subject|1
2945145|NCT01344356|10138959|P2|Overall Study|Lost to Follow-up|6
2945146|NCT01344356|10138960|P1|Overall Study|Lost to Follow-up|0
2945147|NCT01344356|10138959|P2|Overall Study|Physician Decision|3
2945148|NCT01344356|10138960|P1|Overall Study|Physician Decision|0
2945149|NCT01344226|10138972|P1|Overall Study|Lack of Efficacy|3
2945150|NCT01344226|10138972|P1|Overall Study|Withdrawal by Subject|3
2945151|NCT01344226|10138972|P1|Overall Study|Protocol Violation|2
2945152|NCT01344161|10138981|P2|Overall Study|Protocol Violation|1
2945153|NCT01344161|10138982|P1|Overall Study|Protocol Violation|1
2945154|NCT01344161|10138981|P2|Overall Study|Pregnancy|1
2945155|NCT01344161|10138982|P1|Overall Study|Pregnancy|0
2945156|NCT01344161|10138981|P2|Overall Study|Lost to Follow-up|1
2945157|NCT01344161|10138982|P1|Overall Study|Lost to Follow-up|4
2945158|NCT01344057|10138994|P1|Overall Study|Premature Withdrawal|1
2945159|NCT01343901|10139001|P1|Overall Study|Participant decision|1
2945160|NCT01343901|10139001|P1|Overall Study|Management by another medical team|11
2945161|NCT01343901|10139001|P1|Overall Study|Lost to Follow-up|12
2945162|NCT01343901|10139001|P1|Overall Study|Physician Decision|4
2945163|NCT01343901|10139001|P1|Overall Study|Death|85
2945164|NCT01343888|10139025|P3|Overall Study|other than stated above|1
2945165|NCT01343888|10139026|P2|Overall Study|other than stated above|0
2945166|NCT01343888|10139027|P1|Overall Study|other than stated above|0
2945167|NCT01343888|10139025|P3|Overall Study|Withdrawal by Subject|2
2945168|NCT01343888|10139026|P2|Overall Study|Withdrawal by Subject|4
2945169|NCT01343888|10139027|P1|Overall Study|Withdrawal by Subject|4
2945170|NCT01343888|10139025|P3|Overall Study|Protocol Violation|0
2945171|NCT01343888|10139026|P2|Overall Study|Protocol Violation|2
2945172|NCT01343888|10139027|P1|Overall Study|Protocol Violation|0
2945173|NCT01343888|10139025|P3|Overall Study|Lost to Follow-up|1
2945174|NCT01343888|10139026|P2|Overall Study|Lost to Follow-up|2
2945175|NCT01343888|10139027|P1|Overall Study|Lost to Follow-up|0
2945176|NCT01343888|10139025|P3|Overall Study|Lack of Efficacy|13
2945177|NCT01343888|10139026|P2|Overall Study|Lack of Efficacy|9
2945178|NCT01343888|10139027|P1|Overall Study|Lack of Efficacy|9
2945179|NCT01343888|10139025|P3|Overall Study|Adverse Event|5
2945180|NCT01343888|10139026|P2|Overall Study|Adverse Event|22
2945181|NCT01343888|10139027|P1|Overall Study|Adverse Event|12
2945182|NCT01343823|10139069|P4|Overall Study|Withdrawal by Subject|0
2945183|NCT01343823|10139070|P3|Overall Study|Withdrawal by Subject|0
2945184|NCT01343823|10139071|P2|Overall Study|Withdrawal by Subject|0
2945185|NCT01343823|10139072|P1|Overall Study|Withdrawal by Subject|1
2945186|NCT01343823|10139069|P4|Overall Study|Study Terminated|1
2945187|NCT01343823|10139070|P3|Overall Study|Study Terminated|0
2945188|NCT01343823|10139071|P2|Overall Study|Study Terminated|0
2945189|NCT01343823|10139072|P1|Overall Study|Study Terminated|1
2945190|NCT01343693|10139086|P1|Overall Study|Lost to Follow-up|9
2945191|NCT01343407|10139109|P6|Second Washout (Part 2)|Withdrawal by Subject|0
2945192|NCT01343407|10139110|P5|Second Washout (Part 2)|Withdrawal by Subject|0
2945193|NCT01343407|10139111|P4|Second Washout (Part 2)|Withdrawal by Subject|0
2945194|NCT01343407|10139112|P3|Second Washout (Part 2)|Withdrawal by Subject|1
2945195|NCT01343407|10139113|P2|Second Washout (Part 2)|Withdrawal by Subject|0
2945196|NCT01343407|10139114|P1|Second Washout (Part 2)|Withdrawal by Subject|0
2945197|NCT01343407|10139109|P6|Second Treatment Period (Part 2)|Adverse Event|0
2945198|NCT01343407|10139110|P5|Second Treatment Period (Part 2)|Adverse Event|0
2945199|NCT01343407|10139111|P4|Second Treatment Period (Part 2)|Adverse Event|0
2945200|NCT01343407|10139112|P3|Second Treatment Period (Part 2)|Adverse Event|1
2945201|NCT01343407|10139113|P2|Second Treatment Period (Part 2)|Adverse Event|0
2945202|NCT01343407|10139114|P1|Second Treatment Period (Part 2)|Adverse Event|0
2945203|NCT01343368|10139142|P2|Overall Study|Lost to Follow-up|0
2945204|NCT01343368|10139143|P1|Overall Study|Lost to Follow-up|1
2945205|NCT01343368|10139142|P2|Overall Study|Death|0
2945206|NCT01343368|10139143|P1|Overall Study|Death|1
2945207|NCT01343277|10139179|P2|Overall Study|Subsequent anticancer therapy|0
2945208|NCT01343277|10139180|P1|Overall Study|Subsequent anticancer therapy|1
2945209|NCT01343277|10139179|P2|Overall Study|Treatment ongoing|2
2945210|NCT01343277|10139180|P1|Overall Study|Treatment ongoing|8
2945211|NCT01343277|10139179|P2|Overall Study|Randomized not treated|21
2945212|NCT01343277|10139180|P1|Overall Study|Randomized not treated|6
2945213|NCT01343277|10139179|P2|Overall Study|Disease progression|138
2945214|NCT01343277|10139180|P1|Overall Study|Disease progression|270
2945215|NCT01343277|10139179|P2|Overall Study|Adverse Event|13
2945216|NCT01343277|10139180|P1|Overall Study|Adverse Event|67
2945217|NCT01343277|10139179|P2|Overall Study|Death|1
2945218|NCT01343277|10139180|P1|Overall Study|Death|10
2945219|NCT01343277|10139179|P2|Overall Study|Physician Decision|2
2945220|NCT01343277|10139180|P1|Overall Study|Physician Decision|1
2945221|NCT01343277|10139179|P2|Overall Study|Withdrawal by Subject|13
2945222|NCT01343277|10139180|P1|Overall Study|Withdrawal by Subject|18
2945223|NCT01343277|10139179|P2|Overall Study|Other|3
2945224|NCT01343277|10139180|P1|Overall Study|Other|3
2945225|NCT01343082|10139241|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
2945226|NCT01343082|10139242|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
2945227|NCT01343082|10139243|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
2945228|NCT01343082|10139241|P3|Treatment Period , Switched to DE-111|Physician Decision|2
2945229|NCT01343082|10139242|P2|Treatment Period , Switched to DE-111|Physician Decision|2
2945230|NCT01343082|10139243|P1|Treatment Period , Switched to DE-111|Physician Decision|0
2945231|NCT01343082|10139241|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
2945232|NCT01343082|10139242|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
2945233|NCT01343082|10139243|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
2945234|NCT01343082|10139241|P3|Treatment Period , Switched to DE-111|Adverse Event|3
2945235|NCT01343082|10139242|P2|Treatment Period , Switched to DE-111|Adverse Event|4
2945236|NCT01343082|10139243|P1|Treatment Period , Switched to DE-111|Adverse Event|1
2945237|NCT01343082|10139241|P3|The run-in Period|Not meeting criteria|5
2945238|NCT01343082|10139242|P2|The run-in Period|Not meeting criteria|4
2945239|NCT01343082|10139243|P1|The run-in Period|Not meeting criteria|3
2945240|NCT01343056|10139251|P4|Overall Study|Lost to Follow-up|9
2945241|NCT01343056|10139252|P3|Overall Study|Lost to Follow-up|3
2945242|NCT01343056|10139253|P2|Overall Study|Lost to Follow-up|5
2945243|NCT01343056|10139254|P1|Overall Study|Lost to Follow-up|7
2945244|NCT01342965|10139322|P2|Overall Study|Withdrawal by Subject|9
2945245|NCT01342965|10139323|P1|Overall Study|Withdrawal by Subject|2
2945246|NCT01342965|10139322|P2|Overall Study|Other Reasons- Unspecified|38
2945247|NCT01342965|10139323|P1|Overall Study|Other Reasons- Unspecified|44
2945248|NCT01342965|10139322|P2|Overall Study|Lost to Follow-up|3
2945249|NCT01342965|10139323|P1|Overall Study|Lost to Follow-up|5
2945250|NCT01342965|10139322|P2|Overall Study|Death|57
2945251|NCT01342965|10139323|P1|Overall Study|Death|58
2945252|NCT01342926|10139341|P4|Overall Study|Withdrawal by Subject|5
2945253|NCT01342926|10139342|P3|Overall Study|Withdrawal by Subject|3
2945254|NCT01342926|10139343|P2|Overall Study|Withdrawal by Subject|4
2945255|NCT01342926|10139344|P1|Overall Study|Withdrawal by Subject|2
2945256|NCT01342926|10139341|P4|Overall Study|Investigator Discretion|0
2945257|NCT01342926|10139342|P3|Overall Study|Investigator Discretion|0
2945258|NCT01342926|10139343|P2|Overall Study|Investigator Discretion|2
2945259|NCT01342926|10139344|P1|Overall Study|Investigator Discretion|2
2945260|NCT01342926|10139341|P4|Overall Study|Lost to Follow-up|0
2945261|NCT01342926|10139342|P3|Overall Study|Lost to Follow-up|1
2945262|NCT01342926|10139343|P2|Overall Study|Lost to Follow-up|1
2945263|NCT01342926|10139344|P1|Overall Study|Lost to Follow-up|0
2945264|NCT01342926|10139341|P4|Overall Study|Adverse Event|7
2945265|NCT01342926|10139342|P3|Overall Study|Adverse Event|10
2945266|NCT01342926|10139343|P2|Overall Study|Adverse Event|8
2945267|NCT01342926|10139344|P1|Overall Study|Adverse Event|5
2945268|NCT01342913|10139424|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
2945269|NCT01342913|10139425|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
2945270|NCT01342913|10139426|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2945271|NCT01342913|10139424|P3|Double-Blind Treatment Period|Physician Decision|0
2945272|NCT01342913|10139425|P2|Double-Blind Treatment Period|Physician Decision|2
2945273|NCT01342913|10139426|P1|Double-Blind Treatment Period|Physician Decision|0
2945274|NCT01342913|10139424|P3|Double-Blind Treatment Period|Lost to Follow-up|3
2945275|NCT01342913|10139425|P2|Double-Blind Treatment Period|Lost to Follow-up|1
2945276|NCT01342913|10139426|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2945277|NCT01342913|10139424|P3|Double-Blind Treatment Period|Protocol Violation|9
2945278|NCT01342913|10139425|P2|Double-Blind Treatment Period|Protocol Violation|6
2945279|NCT01342913|10139426|P1|Double-Blind Treatment Period|Protocol Violation|0
2945280|NCT01342913|10139424|P3|Double-Blind Treatment Period|Lack of Efficacy|3
2945281|NCT01342913|10139425|P2|Double-Blind Treatment Period|Lack of Efficacy|2
2945282|NCT01342913|10139426|P1|Double-Blind Treatment Period|Lack of Efficacy|0
2945283|NCT01342913|10139424|P3|Double-Blind Treatment Period|Adverse Event|6
2945284|NCT01342913|10139425|P2|Double-Blind Treatment Period|Adverse Event|3
2945285|NCT01342913|10139426|P1|Double-Blind Treatment Period|Adverse Event|0
2945286|NCT01342913|10139424|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2945287|NCT01342913|10139425|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2945288|NCT01342913|10139426|P1|2-week Run-in Period|Continuation Criteria Not Met|88
2945289|NCT01342913|10139424|P3|2-week Run-in Period|Protocol Violation|0
2945290|NCT01342913|10139425|P2|2-week Run-in Period|Protocol Violation|0
2945291|NCT01342913|10139426|P1|2-week Run-in Period|Protocol Violation|5
2945292|NCT01342913|10139424|P3|2-week Run-in Period|Adverse Event|0
2945293|NCT01342913|10139425|P2|2-week Run-in Period|Adverse Event|0
2945294|NCT01342913|10139426|P1|2-week Run-in Period|Adverse Event|2
2945295|NCT01342913|10139424|P3|2-week Run-in Period|Withdrawal by Subject|0
2945296|NCT01342913|10139425|P2|2-week Run-in Period|Withdrawal by Subject|0
2945297|NCT01342913|10139426|P1|2-week Run-in Period|Withdrawal by Subject|7
2945298|NCT01342913|10139424|P3|2-week Run-in Period|Physician Decision|0
2945299|NCT01342913|10139425|P2|2-week Run-in Period|Physician Decision|0
2945300|NCT01342913|10139426|P1|2-week Run-in Period|Physician Decision|6
2945301|NCT01342913|10139424|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2945302|NCT01342913|10139425|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2945303|NCT01342913|10139426|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
2945304|NCT01342887|10139436|P1|Overall Study|Death|2
2945305|NCT01342640|10139477|P1|Overall Study|Other|1
2945306|NCT01342640|10139477|P1|Overall Study|Lost to Follow-up|21
2945307|NCT01342640|10139477|P1|Overall Study|Protocol Violation|16
2945308|NCT01342640|10139477|P1|Overall Study|Adverse Event|3
2945309|NCT01342510|10139572|P4|Overall Study|Protocol Violation|11
2945310|NCT01342510|10139573|P3|Overall Study|Protocol Violation|13
2945311|NCT01342510|10139574|P2|Overall Study|Protocol Violation|6
2945312|NCT01342510|10139575|P1|Overall Study|Protocol Violation|12
2945313|NCT01342484|10139592|P3|Overall Study|Withdrawal by Subject|0
2945314|NCT01342484|10139593|P2|Overall Study|Withdrawal by Subject|0
2945315|NCT01342484|10139594|P1|Overall Study|Withdrawal by Subject|1
2945316|NCT01342484|10139592|P3|Overall Study|Protocol Violation|1
2945317|NCT01342484|10139593|P2|Overall Study|Protocol Violation|0
2945318|NCT01342484|10139594|P1|Overall Study|Protocol Violation|0
2945319|NCT01342484|10139592|P3|Overall Study|Other Reasons|0
2945320|NCT01342484|10139593|P2|Overall Study|Other Reasons|0
2945321|NCT01342484|10139594|P1|Overall Study|Other Reasons|1
2945322|NCT01342445|10139650|P2|Overall Study|Experienced side effects|2
2945323|NCT01342445|10139651|P1|Overall Study|Experienced side effects|0
2945324|NCT01342341|10139667|P2|Overall Study|Lost to Follow-up|4
2945325|NCT01342341|10139668|P1|Overall Study|Lost to Follow-up|4
2945326|NCT01342211|10139679|P5|Overall Study|Randomized, but not Treated|1
2945327|NCT01342211|10139680|P4|Overall Study|Randomized, but not Treated|0
2945328|NCT01342211|10139681|P3|Overall Study|Randomized, but not Treated|0
2945329|NCT01342211|10139682|P2|Overall Study|Randomized, but not Treated|2
2945330|NCT01342211|10139683|P1|Overall Study|Randomized, but not Treated|0
2945331|NCT01342211|10139679|P5|Overall Study|Withdrawal by Subject|0
2945332|NCT01342211|10139680|P4|Overall Study|Withdrawal by Subject|1
2945333|NCT01342211|10139681|P3|Overall Study|Withdrawal by Subject|0
2945334|NCT01342211|10139682|P2|Overall Study|Withdrawal by Subject|0
2945335|NCT01342211|10139683|P1|Overall Study|Withdrawal by Subject|0
2945336|NCT01342211|10139679|P5|Overall Study|Adverse Event|1
2945337|NCT01342211|10139680|P4|Overall Study|Adverse Event|0
2945338|NCT01342211|10139681|P3|Overall Study|Adverse Event|0
2945339|NCT01342211|10139682|P2|Overall Study|Adverse Event|0
2945340|NCT01342211|10139683|P1|Overall Study|Adverse Event|0
2945341|NCT01342211|10139679|P5|Overall Study|Lost to Follow-up|0
2945342|NCT01342211|10139680|P4|Overall Study|Lost to Follow-up|1
2945343|NCT01342211|10139681|P3|Overall Study|Lost to Follow-up|0
2945344|NCT01342211|10139682|P2|Overall Study|Lost to Follow-up|0
2945345|NCT01342211|10139683|P1|Overall Study|Lost to Follow-up|0
2945346|NCT01342094|10139771|P2|Overall Study|Withdrawal by Subject|2
2945347|NCT01342094|10139772|P1|Overall Study|Withdrawal by Subject|0
2945348|NCT01342094|10139771|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2945349|NCT01342094|10139772|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
2945350|NCT01342094|10139771|P2|Overall Study|Adverse Event|0
2945351|NCT01342094|10139772|P1|Overall Study|Adverse Event|5
2945352|NCT01342081|10139781|P3|Overall Study|Withdrawal by Subject|0
2945353|NCT01342081|10139782|P2|Overall Study|Withdrawal by Subject|1
2945354|NCT01342081|10139783|P1|Overall Study|Withdrawal by Subject|1
2945355|NCT01342081|10139781|P3|Overall Study|Physician Decision|0
2945356|NCT01342081|10139782|P2|Overall Study|Physician Decision|1
2945357|NCT01342081|10139783|P1|Overall Study|Physician Decision|0
2945358|NCT01342081|10139781|P3|Overall Study|Adverse Event|0
2945359|NCT01342081|10139782|P2|Overall Study|Adverse Event|0
2945360|NCT01342081|10139783|P1|Overall Study|Adverse Event|1
2945361|NCT01342081|10139781|P3|Overall Study|Did not receive allocated intervention|1
2945362|NCT01342081|10139782|P2|Overall Study|Did not receive allocated intervention|0
2945363|NCT01342081|10139783|P1|Overall Study|Did not receive allocated intervention|0
2945364|NCT01341990|10139802|P2|Overall Study|Withdrawal by Subject|0
2945365|NCT01341990|10139803|P1|Overall Study|Withdrawal by Subject|2
2945366|NCT01341990|10139802|P2|Overall Study|Torn Study Lens|0
2945367|NCT01341990|10139803|P1|Overall Study|Torn Study Lens|1
2945368|NCT01341990|10139802|P2|Overall Study|Adverse Event|1
2945369|NCT01341990|10139803|P1|Overall Study|Adverse Event|0
2945370|NCT01341782|10139827|P2|Overall Study|Other|0
2945371|NCT01341782|10139828|P1|Overall Study|Other|5
2945372|NCT01341782|10139827|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2945373|NCT01341782|10139828|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2945374|NCT01341782|10139827|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
2945375|NCT01341782|10139828|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
2945376|NCT01341782|10139827|P2|Overall Study|Missed 3 consecutive doses|4
2945377|NCT01341782|10139828|P1|Overall Study|Missed 3 consecutive doses|0
2945378|NCT01341782|10139827|P2|Overall Study|Withdrawal by Subject|5
2945379|NCT01341782|10139828|P1|Overall Study|Withdrawal by Subject|6
2945380|NCT01341782|10139827|P2|Overall Study|Adverse Event|1
2945381|NCT01341782|10139828|P1|Overall Study|Adverse Event|1
2945382|NCT01341639|10139846|P2|Post-Treatment|Adverse Event|2
2945383|NCT01341639|10139847|P1|Post-Treatment|Adverse Event|0
2945384|NCT01341639|10139846|P2|Post-Treatment|Withdrawal by Subject|1
2945385|NCT01341639|10139847|P1|Post-Treatment|Withdrawal by Subject|0
2945386|NCT01341639|10139846|P2|Interim Period|Protocol Violation|1
2945387|NCT01341639|10139847|P1|Interim Period|Protocol Violation|0
2945388|NCT01341639|10139846|P2|Interim Period|Physician Decision|1
2945389|NCT01341639|10139847|P1|Interim Period|Physician Decision|0
2945390|NCT01341639|10139846|P2|Interim Period|Lost to Follow-up|0
2945391|NCT01341639|10139847|P1|Interim Period|Lost to Follow-up|2
2945392|NCT01341639|10139846|P2|Interim Period|Withdrawal by Subject|7
2945393|NCT01341639|10139847|P1|Interim Period|Withdrawal by Subject|6
2945394|NCT01341639|10139846|P2|Infant Series|Site 0048 Participants|16
2945395|NCT01341639|10139847|P1|Infant Series|Site 0048 Participants|17
2945396|NCT01341639|10139846|P2|Infant Series|Lost to Follow-up|2
2945397|NCT01341639|10139847|P1|Infant Series|Lost to Follow-up|0
2945398|NCT01341639|10139846|P2|Infant Series|Withdrawal by Subject|8
2945399|NCT01341639|10139847|P1|Infant Series|Withdrawal by Subject|11
2945400|NCT01341639|10139846|P2|Infant Series|Adverse Event|5
2945401|NCT01341639|10139847|P1|Infant Series|Adverse Event|0
2945402|NCT01341639|10139846|P2|Infant Series|Not Vaccinated|1
2945403|NCT01341639|10139847|P1|Infant Series|Not Vaccinated|0
2945404|NCT01341639|10139846|P2|Infant Series|Protocol Violation|0
2945405|NCT01341639|10139847|P1|Infant Series|Protocol Violation|1
2945406|NCT01341587|10139892|P2|Overall Study|stopped using the meters|10
2945407|NCT01341587|10139893|P1|Overall Study|stopped using the meters|2
2945408|NCT01341587|10139892|P2|Overall Study|Lost to Follow-up|0
2945409|NCT01341587|10139893|P1|Overall Study|Lost to Follow-up|2
2945410|NCT01341470|10139905|P6|Overall Study|Sponsor decision|1
2945411|NCT01341470|10139906|P5|Overall Study|Sponsor decision|0
2945412|NCT01341470|10139907|P4|Overall Study|Sponsor decision|1
2945413|NCT01341470|10139908|P3|Overall Study|Sponsor decision|1
2945414|NCT01341470|10139909|P2|Overall Study|Sponsor decision|0
2945415|NCT01341470|10139910|P1|Overall Study|Sponsor decision|0
2945416|NCT01341457|10139944|P2|Overall Study|Adverse Event|0
2945417|NCT01341457|10139945|P1|Overall Study|Adverse Event|2
2945418|NCT01340976|10139990|P6|Overall Study|Adverse Event|0
2945419|NCT01340976|10139991|P5|Overall Study|Adverse Event|0
2945420|NCT01340976|10139992|P4|Overall Study|Adverse Event|0
2945421|NCT01340976|10139993|P3|Overall Study|Adverse Event|0
2945422|NCT01340976|10139994|P2|Overall Study|Adverse Event|1
2945423|NCT01340976|10139995|P1|Overall Study|Adverse Event|0
2945424|NCT01340976|10139990|P6|Overall Study|Other anemia treatment|1
2945425|NCT01340976|10139991|P5|Overall Study|Other anemia treatment|0
2945426|NCT01340976|10139992|P4|Overall Study|Other anemia treatment|1
2945427|NCT01340976|10139993|P3|Overall Study|Other anemia treatment|2
2945428|NCT01340976|10139994|P2|Overall Study|Other anemia treatment|0
2945429|NCT01340976|10139995|P1|Overall Study|Other anemia treatment|1
2945430|NCT01340976|10139990|P6|Overall Study|Withdrawal by Subject|0
2945431|NCT01340976|10139991|P5|Overall Study|Withdrawal by Subject|1
2945432|NCT01340976|10139992|P4|Overall Study|Withdrawal by Subject|1
2945433|NCT01340976|10139993|P3|Overall Study|Withdrawal by Subject|0
2945434|NCT01340976|10139994|P2|Overall Study|Withdrawal by Subject|0
2945435|NCT01340976|10139995|P1|Overall Study|Withdrawal by Subject|0
2945436|NCT01340976|10139990|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2945437|NCT01340976|10139991|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2945438|NCT01340976|10139992|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2945439|NCT01340976|10139993|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2945440|NCT01340976|10139994|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2945441|NCT01340976|10139995|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
2945442|NCT01340976|10139990|P6|Overall Study|Death|0
2945443|NCT01340976|10139991|P5|Overall Study|Death|0
2945444|NCT01340976|10139992|P4|Overall Study|Death|0
2945445|NCT01340976|10139993|P3|Overall Study|Death|0
2945446|NCT01340976|10139994|P2|Overall Study|Death|1
2945447|NCT01340976|10139995|P1|Overall Study|Death|0
2945448|NCT01340976|10139990|P6|Overall Study|Physician Decision|0
2945449|NCT01340976|10139991|P5|Overall Study|Physician Decision|1
2945450|NCT01340976|10139992|P4|Overall Study|Physician Decision|1
2945451|NCT01340976|10139993|P3|Overall Study|Physician Decision|1
2945452|NCT01340976|10139994|P2|Overall Study|Physician Decision|0
2945453|NCT01340976|10139995|P1|Overall Study|Physician Decision|2
2945454|NCT01340937|10140033|P4|Period 3: Toddler Vaccinations|Technical problem|0
2945455|NCT01340937|10140034|P3|Period 3: Toddler Vaccinations|Technical problem|1
2945456|NCT01340937|10140035|P2|Period 3: Toddler Vaccinations|Technical problem|1
2945457|NCT01340937|10140036|P1|Period 3: Toddler Vaccinations|Technical problem|1
2945458|NCT01340937|10140033|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
2945459|NCT01340937|10140034|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
2945460|NCT01340937|10140035|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
2945461|NCT01340937|10140036|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
2945462|NCT01340937|10140033|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
2945463|NCT01340937|10140034|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
2945464|NCT01340937|10140035|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
2945465|NCT01340937|10140036|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
2945466|NCT01340937|10140033|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2945467|NCT01340937|10140034|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2945468|NCT01340937|10140035|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2945469|NCT01340937|10140036|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2945470|NCT01340937|10140033|P4|Period 2: Interim Period|Technical problems|3
2945471|NCT01340937|10140034|P3|Period 2: Interim Period|Technical problems|6
2945472|NCT01340937|10140035|P2|Period 2: Interim Period|Technical problems|4
2945473|NCT01340937|10140036|P1|Period 2: Interim Period|Technical problems|4
2945474|NCT01340937|10140033|P4|Period 2: Interim Period|Protocol Violation|3
2945475|NCT01340937|10140034|P3|Period 2: Interim Period|Protocol Violation|6
2945476|NCT01340937|10140035|P2|Period 2: Interim Period|Protocol Violation|3
2945477|NCT01340937|10140036|P1|Period 2: Interim Period|Protocol Violation|5
2945478|NCT01340937|10140033|P4|Period 2: Interim Period|Physician Decision|0
2945479|NCT01340937|10140034|P3|Period 2: Interim Period|Physician Decision|1
2945480|NCT01340937|10140035|P2|Period 2: Interim Period|Physician Decision|1
2945481|NCT01340937|10140036|P1|Period 2: Interim Period|Physician Decision|0
2945482|NCT01340937|10140033|P4|Period 2: Interim Period|Lost to Follow-up|23
2945483|NCT01340937|10140034|P3|Period 2: Interim Period|Lost to Follow-up|53
2945484|NCT01340937|10140035|P2|Period 2: Interim Period|Lost to Follow-up|48
2945485|NCT01340937|10140036|P1|Period 2: Interim Period|Lost to Follow-up|29
2945486|NCT01340937|10140033|P4|Period 2: Interim Period|Adverse Event|0
2945487|NCT01340937|10140034|P3|Period 2: Interim Period|Adverse Event|1
2945488|NCT01340937|10140035|P2|Period 2: Interim Period|Adverse Event|0
2945489|NCT01340937|10140036|P1|Period 2: Interim Period|Adverse Event|1
2945490|NCT01340937|10140033|P4|Period 2: Interim Period|Withdrawal by Subject|12
2945491|NCT01340937|10140034|P3|Period 2: Interim Period|Withdrawal by Subject|17
2945492|NCT01340937|10140035|P2|Period 2: Interim Period|Withdrawal by Subject|23
2945493|NCT01340937|10140036|P1|Period 2: Interim Period|Withdrawal by Subject|28
2945494|NCT01340937|10140033|P4|Period 1: Infant Series|Randomized but not vaccinated|1
2945495|NCT01340937|10140034|P3|Period 1: Infant Series|Randomized but not vaccinated|2
2945496|NCT01340937|10140035|P2|Period 1: Infant Series|Randomized but not vaccinated|5
2945497|NCT01340937|10140036|P1|Period 1: Infant Series|Randomized but not vaccinated|0
2945498|NCT01340937|10140033|P4|Period 1: Infant Series|Withdrawal by Subject|15
2945499|NCT01340937|10140034|P3|Period 1: Infant Series|Withdrawal by Subject|30
2945500|NCT01340937|10140035|P2|Period 1: Infant Series|Withdrawal by Subject|32
2945501|NCT01340937|10140036|P1|Period 1: Infant Series|Withdrawal by Subject|33
2945502|NCT01340937|10140033|P4|Period 1: Infant Series|Protocol Violation|3
2945503|NCT01340937|10140034|P3|Period 1: Infant Series|Protocol Violation|4
2945504|NCT01340937|10140035|P2|Period 1: Infant Series|Protocol Violation|4
2945505|NCT01340937|10140036|P1|Period 1: Infant Series|Protocol Violation|1
2945506|NCT01340937|10140033|P4|Period 1: Infant Series|Physician Decision|0
2945507|NCT01340937|10140034|P3|Period 1: Infant Series|Physician Decision|1
2945508|NCT01340937|10140035|P2|Period 1: Infant Series|Physician Decision|3
2945509|NCT01340937|10140036|P1|Period 1: Infant Series|Physician Decision|2
2945510|NCT01340937|10140033|P4|Period 1: Infant Series|Lost to Follow-up|13
2945511|NCT01340937|10140034|P3|Period 1: Infant Series|Lost to Follow-up|12
2945512|NCT01340937|10140035|P2|Period 1: Infant Series|Lost to Follow-up|14
2945513|NCT01340937|10140036|P1|Period 1: Infant Series|Lost to Follow-up|20
2945514|NCT01340937|10140033|P4|Period 1: Infant Series|Death|0
2945515|NCT01340937|10140034|P3|Period 1: Infant Series|Death|2
2945516|NCT01340937|10140035|P2|Period 1: Infant Series|Death|0
2945517|NCT01340937|10140036|P1|Period 1: Infant Series|Death|2
2945518|NCT01340937|10140033|P4|Period 1: Infant Series|Adverse Event|0
2945519|NCT01340937|10140034|P3|Period 1: Infant Series|Adverse Event|4
2945520|NCT01340937|10140035|P2|Period 1: Infant Series|Adverse Event|1
2945521|NCT01340937|10140036|P1|Period 1: Infant Series|Adverse Event|0
2945522|NCT01340937|10140033|P4|Period 1: Infant Series|Other protocol criterion not met|0
2945523|NCT01340937|10140034|P3|Period 1: Infant Series|Other protocol criterion not met|1
2945524|NCT01340937|10140035|P2|Period 1: Infant Series|Other protocol criterion not met|1
2945525|NCT01340937|10140036|P1|Period 1: Infant Series|Other protocol criterion not met|0
2945526|NCT01340898|10140196|P3|Booster Phase|Lost to Follow-up|3
2945527|NCT01340898|10140197|P2|Booster Phase|Lost to Follow-up|2
2945528|NCT01340898|10140198|P1|Booster Phase|Lost to Follow-up|4
2945529|NCT01340898|10140196|P3|Booster Phase|Migrated/moved from study area|0
2945530|NCT01340898|10140197|P2|Booster Phase|Migrated/moved from study area|0
2945531|NCT01340898|10140198|P1|Booster Phase|Migrated/moved from study area|3
2945532|NCT01340898|10140196|P3|Booster Phase|Withdrawal by Subject|4
2945533|NCT01340898|10140197|P2|Booster Phase|Withdrawal by Subject|0
2945534|NCT01340898|10140198|P1|Booster Phase|Withdrawal by Subject|3
2945535|NCT01340898|10140196|P3|Primary Phase|Lost to Follow-up|0
2945536|NCT01340898|10140197|P2|Primary Phase|Lost to Follow-up|1
2945537|NCT01340898|10140198|P1|Primary Phase|Lost to Follow-up|4
2945538|NCT01340898|10140196|P3|Primary Phase|Migrated/moved from study area|0
2945539|NCT01340898|10140197|P2|Primary Phase|Migrated/moved from study area|1
2945540|NCT01340898|10140198|P1|Primary Phase|Migrated/moved from study area|4
2945541|NCT01340898|10140196|P3|Primary Phase|Withdrawal by Subject|5
2945542|NCT01340898|10140197|P2|Primary Phase|Withdrawal by Subject|7
2945543|NCT01340898|10140198|P1|Primary Phase|Withdrawal by Subject|8
2945544|NCT01340898|10140196|P3|Primary Phase|Serious Adverse Events|1
2945545|NCT01340898|10140197|P2|Primary Phase|Serious Adverse Events|0
2945546|NCT01340898|10140198|P1|Primary Phase|Serious Adverse Events|0
2945547|NCT01340872|10140300|P4|Open-label Phase|Worsening of IBD|0
2945548|NCT01340872|10140301|P3|Open-label Phase|Worsening of IBD|1
2945549|NCT01340872|10140302|P2|Open-label Phase|Worsening of IBD|0
2945550|NCT01340872|10140303|P1|Open-label Phase|Worsening of IBD|0
2945551|NCT01340872|10140300|P4|Open-label Phase|Withdrawal by Subject|6
2945552|NCT01340872|10140301|P3|Open-label Phase|Withdrawal by Subject|1
2945553|NCT01340872|10140302|P2|Open-label Phase|Withdrawal by Subject|0
2945554|NCT01340872|10140303|P1|Open-label Phase|Withdrawal by Subject|0
2945555|NCT01340872|10140300|P4|Open-label Phase|Adverse Event|4
2945556|NCT01340872|10140301|P3|Open-label Phase|Adverse Event|8
2945557|NCT01340872|10140302|P2|Open-label Phase|Adverse Event|0
2945558|NCT01340872|10140303|P1|Open-label Phase|Adverse Event|0
2945559|NCT01340872|10140300|P4|Open-label Phase|Pregnancy|0
2945560|NCT01340872|10140301|P3|Open-label Phase|Pregnancy|1
2945561|NCT01340872|10140302|P2|Open-label Phase|Pregnancy|0
2945562|NCT01340872|10140303|P1|Open-label Phase|Pregnancy|0
2945563|NCT01340872|10140300|P4|Open-label Phase|Physician Decision|1
2945564|NCT01340872|10140301|P3|Open-label Phase|Physician Decision|2
2945565|NCT01340872|10140302|P2|Open-label Phase|Physician Decision|0
2945566|NCT01340872|10140303|P1|Open-label Phase|Physician Decision|0
2945567|NCT01340872|10140300|P4|Double-blind Phase|Protocol Violation|0
2945568|NCT01340872|10140301|P3|Double-blind Phase|Protocol Violation|0
2945569|NCT01340872|10140302|P2|Double-blind Phase|Protocol Violation|1
2945570|NCT01340872|10140303|P1|Double-blind Phase|Protocol Violation|0
2945571|NCT01340872|10140300|P4|Double-blind Phase|Lost to Follow-up|0
2945572|NCT01340872|10140301|P3|Double-blind Phase|Lost to Follow-up|0
2945573|NCT01340872|10140302|P2|Double-blind Phase|Lost to Follow-up|1
2945574|NCT01340872|10140303|P1|Double-blind Phase|Lost to Follow-up|0
2945575|NCT01340872|10140300|P4|Double-blind Phase|Withdrawal by Subject|0
2945576|NCT01340872|10140301|P3|Double-blind Phase|Withdrawal by Subject|0
2945577|NCT01340872|10140302|P2|Double-blind Phase|Withdrawal by Subject|5
2945578|NCT01340872|10140303|P1|Double-blind Phase|Withdrawal by Subject|3
2945579|NCT01340872|10140300|P4|Double-blind Phase|Adverse Event|0
2945580|NCT01340872|10140301|P3|Double-blind Phase|Adverse Event|0
2945581|NCT01340872|10140302|P2|Double-blind Phase|Adverse Event|4
2945582|NCT01340872|10140303|P1|Double-blind Phase|Adverse Event|6
2945583|NCT01340794|10140363|P2|Overall Study|Withdrawal by Subject|1
2945584|NCT01340794|10140364|P1|Overall Study|Withdrawal by Subject|0
2945585|NCT01340768|10140380|P2|Overall Study|Other|0
2945586|NCT01340768|10140381|P1|Overall Study|Other|2
2945587|NCT01340768|10140380|P2|Overall Study|Withdrawal by Subject|1
2945588|NCT01340768|10140381|P1|Overall Study|Withdrawal by Subject|5
2945589|NCT01340768|10140380|P2|Overall Study|Lost to Follow-up|4
2945590|NCT01340768|10140381|P1|Overall Study|Lost to Follow-up|10
2945591|NCT01340664|10140392|P3|Overall Study|Other|2
2945592|NCT01340664|10140393|P2|Overall Study|Other|2
2945593|NCT01340664|10140394|P1|Overall Study|Other|1
2945594|NCT01340664|10140392|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
2945595|NCT01340664|10140393|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
2945596|NCT01340664|10140394|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
2945597|NCT01340664|10140392|P3|Overall Study|Glycemic withdrawal criteria|0
2945598|NCT01340664|10140393|P2|Overall Study|Glycemic withdrawal criteria|0
2945599|NCT01340664|10140394|P1|Overall Study|Glycemic withdrawal criteria|2
2945600|NCT01340664|10140392|P3|Overall Study|Withdrawal by Subject|0
2945601|NCT01340664|10140393|P2|Overall Study|Withdrawal by Subject|4
2945602|NCT01340664|10140394|P1|Overall Study|Withdrawal by Subject|2
2945603|NCT01340664|10140392|P3|Overall Study|Lost to Follow-up|2
2945604|NCT01340664|10140393|P2|Overall Study|Lost to Follow-up|0
2945605|NCT01340664|10140394|P1|Overall Study|Lost to Follow-up|2
2945606|NCT01340664|10140392|P3|Overall Study|Adverse Event|7
2945607|NCT01340664|10140393|P2|Overall Study|Adverse Event|1
2945608|NCT01340664|10140394|P1|Overall Study|Adverse Event|0
2945609|NCT01340651|10140411|P1|Overall Study|Commercial Supply per Sponsor|12
2945610|NCT01340651|10140411|P1|Overall Study|Consent Withdrawn|2
2945611|NCT01340651|10140411|P1|Overall Study|Adverse Event|3
2945612|NCT01340625|10140427|P2|Washout Period of 28 Days|Withdrawal by Subject|0
2945613|NCT01340625|10140428|P1|Washout Period of 28 Days|Withdrawal by Subject|1
2945614|NCT01340625|10140427|P2|First Intervention|Adverse Event|0
2945615|NCT01340625|10140428|P1|First Intervention|Adverse Event|1
2945616|NCT01340495|10140533|P1|Overall Study|Withdrawal by Subject|1
2945617|NCT01340300|10140544|P4|Overall Study|Unrelated sickness|1
2945618|NCT01340300|10140545|P3|Overall Study|Unrelated sickness|0
2945619|NCT01340300|10140546|P2|Overall Study|Unrelated sickness|2
2945620|NCT01340300|10140547|P1|Overall Study|Unrelated sickness|0
2945621|NCT01340300|10140544|P4|Overall Study|Physician Decision|0
2945622|NCT01340300|10140545|P3|Overall Study|Physician Decision|0
2945623|NCT01340300|10140546|P2|Overall Study|Physician Decision|1
2945624|NCT01340300|10140547|P1|Overall Study|Physician Decision|0
2945625|NCT01340300|10140544|P4|Overall Study|Adverse Event|0
2945626|NCT01340300|10140545|P3|Overall Study|Adverse Event|4
2945627|NCT01340300|10140546|P2|Overall Study|Adverse Event|0
2945628|NCT01340300|10140547|P1|Overall Study|Adverse Event|1
2945629|NCT01340300|10140544|P4|Overall Study|Withdrawal by Subject|3
2945630|NCT01340300|10140545|P3|Overall Study|Withdrawal by Subject|6
2945631|NCT01340300|10140546|P2|Overall Study|Withdrawal by Subject|6
2945632|NCT01340300|10140547|P1|Overall Study|Withdrawal by Subject|5
2945633|NCT01340300|10140544|P4|Overall Study|Lost to Follow-up|10
2945634|NCT01340300|10140545|P3|Overall Study|Lost to Follow-up|5
2945635|NCT01340300|10140546|P2|Overall Study|Lost to Follow-up|0
2945636|NCT01340300|10140547|P1|Overall Study|Lost to Follow-up|3
2945637|NCT01340209|10140580|P3|Overall Study|Other reason not defined above|4
2945638|NCT01340209|10140581|P2|Overall Study|Other reason not defined above|5
2945639|NCT01340209|10140582|P1|Overall Study|Other reason not defined above|3
2945640|NCT01340209|10140580|P3|Overall Study|Withdrawal by Subject|1
2945641|NCT01340209|10140581|P2|Overall Study|Withdrawal by Subject|0
2945642|NCT01340209|10140582|P1|Overall Study|Withdrawal by Subject|0
2945643|NCT01340209|10140580|P3|Overall Study|Protocol Violation|1
2945644|NCT01340209|10140581|P2|Overall Study|Protocol Violation|2
2945645|NCT01340209|10140582|P1|Overall Study|Protocol Violation|1
2945646|NCT01340209|10140580|P3|Overall Study|Adverse Event|2
2945647|NCT01340209|10140581|P2|Overall Study|Adverse Event|1
2945648|NCT01340209|10140582|P1|Overall Study|Adverse Event|1
2945649|NCT01340196|10140617|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
2945650|NCT01340066|10140657|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
2945651|NCT01340066|10140658|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
2945652|NCT01340066|10140659|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
2945653|NCT01340066|10140657|P3|5 Week Double Blind Randomization Period|Physician Decision|0
2945654|NCT01340066|10140658|P2|5 Week Double Blind Randomization Period|Physician Decision|1
2945655|NCT01340066|10140659|P1|5 Week Double Blind Randomization Period|Physician Decision|0
2945656|NCT01340066|10140657|P3|5 Week Double Blind Randomization Period|Adverse Event|2
2945657|NCT01340066|10140658|P2|5 Week Double Blind Randomization Period|Adverse Event|2
2945658|NCT01340066|10140659|P1|5 Week Double Blind Randomization Period|Adverse Event|0
2945659|NCT01340066|10140657|P3|Placebo Run in Period|Screen Failures|0
2945660|NCT01340066|10140658|P2|Placebo Run in Period|Screen Failures|0
2945661|NCT01340066|10140659|P1|Placebo Run in Period|Screen Failures|27
2945662|NCT01340027|10140699|P12|Overall Study|Miscellaneous|0
2945663|NCT01340027|10140700|P11|Overall Study|Miscellaneous|1
2945664|NCT01340027|10140701|P10|Overall Study|Miscellaneous|0
2945665|NCT01340027|10140702|P9|Overall Study|Miscellaneous|0
2945666|NCT01340027|10140703|P8|Overall Study|Miscellaneous|0
2945667|NCT01340027|10140704|P7|Overall Study|Miscellaneous|0
2945668|NCT01340027|10140705|P6|Overall Study|Miscellaneous|0
2945669|NCT01340027|10140706|P5|Overall Study|Miscellaneous|0
2945670|NCT01340027|10140707|P4|Overall Study|Miscellaneous|1
2945671|NCT01340027|10140708|P3|Overall Study|Miscellaneous|0
2945672|NCT01340027|10140709|P2|Overall Study|Miscellaneous|0
2945673|NCT01340027|10140710|P1|Overall Study|Miscellaneous|0
2945674|NCT01340027|10140699|P12|Overall Study|Withdrawal by Subject|1
2945675|NCT01340027|10140700|P11|Overall Study|Withdrawal by Subject|0
2945676|NCT01340027|10140701|P10|Overall Study|Withdrawal by Subject|2
2945677|NCT01340027|10140702|P9|Overall Study|Withdrawal by Subject|1
2945678|NCT01340027|10140703|P8|Overall Study|Withdrawal by Subject|4
2945679|NCT01340027|10140704|P7|Overall Study|Withdrawal by Subject|3
2945680|NCT01340027|10140705|P6|Overall Study|Withdrawal by Subject|2
2945681|NCT01340027|10140706|P5|Overall Study|Withdrawal by Subject|3
2945682|NCT01340027|10140707|P4|Overall Study|Withdrawal by Subject|3
2945683|NCT01340027|10140708|P3|Overall Study|Withdrawal by Subject|1
2945684|NCT01340027|10140709|P2|Overall Study|Withdrawal by Subject|3
2945685|NCT01340027|10140710|P1|Overall Study|Withdrawal by Subject|4
2945686|NCT01340027|10140699|P12|Overall Study|Protocol Violation|0
2945687|NCT01340027|10140700|P11|Overall Study|Protocol Violation|0
2945688|NCT01340027|10140701|P10|Overall Study|Protocol Violation|2
2945689|NCT01340027|10140702|P9|Overall Study|Protocol Violation|2
2945690|NCT01340027|10140703|P8|Overall Study|Protocol Violation|1
2945691|NCT01340027|10140704|P7|Overall Study|Protocol Violation|0
2945692|NCT01340027|10140705|P6|Overall Study|Protocol Violation|0
2945693|NCT01340027|10140706|P5|Overall Study|Protocol Violation|6
2945694|NCT01340027|10140707|P4|Overall Study|Protocol Violation|0
2945695|NCT01340027|10140708|P3|Overall Study|Protocol Violation|0
2945696|NCT01340027|10140709|P2|Overall Study|Protocol Violation|2
2945697|NCT01340027|10140710|P1|Overall Study|Protocol Violation|1
2945698|NCT01340027|10140699|P12|Overall Study|Lost to Follow-up|0
2945699|NCT01340027|10140700|P11|Overall Study|Lost to Follow-up|0
2945700|NCT01340027|10140701|P10|Overall Study|Lost to Follow-up|1
2945701|NCT01340027|10140702|P9|Overall Study|Lost to Follow-up|0
2945702|NCT01340027|10140703|P8|Overall Study|Lost to Follow-up|0
2945703|NCT01340027|10140704|P7|Overall Study|Lost to Follow-up|1
2945704|NCT01340027|10140705|P6|Overall Study|Lost to Follow-up|0
2945705|NCT01340027|10140706|P5|Overall Study|Lost to Follow-up|0
2945706|NCT01340027|10140707|P4|Overall Study|Lost to Follow-up|0
2945707|NCT01340027|10140708|P3|Overall Study|Lost to Follow-up|0
2945708|NCT01340027|10140709|P2|Overall Study|Lost to Follow-up|1
2945709|NCT01340027|10140710|P1|Overall Study|Lost to Follow-up|0
2945710|NCT01340027|10140699|P12|Overall Study|Lack of Efficacy|0
2945711|NCT01340027|10140700|P11|Overall Study|Lack of Efficacy|0
2945712|NCT01340027|10140701|P10|Overall Study|Lack of Efficacy|0
2945713|NCT01340027|10140702|P9|Overall Study|Lack of Efficacy|1
2945714|NCT01340027|10140703|P8|Overall Study|Lack of Efficacy|1
2945715|NCT01340027|10140704|P7|Overall Study|Lack of Efficacy|1
2945716|NCT01340027|10140705|P6|Overall Study|Lack of Efficacy|0
2945717|NCT01340027|10140706|P5|Overall Study|Lack of Efficacy|0
2945718|NCT01340027|10140707|P4|Overall Study|Lack of Efficacy|0
2945719|NCT01340027|10140708|P3|Overall Study|Lack of Efficacy|0
2945720|NCT01340027|10140709|P2|Overall Study|Lack of Efficacy|0
2945721|NCT01340027|10140710|P1|Overall Study|Lack of Efficacy|0
2945722|NCT01340027|10140699|P12|Overall Study|Adverse Event|3
2945723|NCT01340027|10140700|P11|Overall Study|Adverse Event|1
2945724|NCT01340027|10140701|P10|Overall Study|Adverse Event|1
2945725|NCT01340027|10140702|P9|Overall Study|Adverse Event|4
2945726|NCT01340027|10140703|P8|Overall Study|Adverse Event|1
2945727|NCT01340027|10140704|P7|Overall Study|Adverse Event|2
2945728|NCT01340027|10140705|P6|Overall Study|Adverse Event|2
2945729|NCT01340027|10140706|P5|Overall Study|Adverse Event|1
2945730|NCT01340027|10140707|P4|Overall Study|Adverse Event|0
2945731|NCT01340027|10140708|P3|Overall Study|Adverse Event|2
2945732|NCT01340027|10140709|P2|Overall Study|Adverse Event|1
2945733|NCT01340027|10140710|P1|Overall Study|Adverse Event|0
2945734|NCT01340027|10140699|P12|Overall Study|Randomized but Never Received Study Drug|0
2945735|NCT01340027|10140700|P11|Overall Study|Randomized but Never Received Study Drug|0
2945736|NCT01340027|10140701|P10|Overall Study|Randomized but Never Received Study Drug|0
2945737|NCT01340027|10140702|P9|Overall Study|Randomized but Never Received Study Drug|0
2945738|NCT01340027|10140703|P8|Overall Study|Randomized but Never Received Study Drug|0
2945739|NCT01340027|10140704|P7|Overall Study|Randomized but Never Received Study Drug|0
2945740|NCT01340027|10140705|P6|Overall Study|Randomized but Never Received Study Drug|0
2945741|NCT01340027|10140706|P5|Overall Study|Randomized but Never Received Study Drug|0
2945742|NCT01340027|10140707|P4|Overall Study|Randomized but Never Received Study Drug|0
2945743|NCT01340027|10140708|P3|Overall Study|Randomized but Never Received Study Drug|1
2945744|NCT01340027|10140709|P2|Overall Study|Randomized but Never Received Study Drug|0
2945745|NCT01340027|10140710|P1|Overall Study|Randomized but Never Received Study Drug|0
2945746|NCT01340014|10141086|P2|Period 2, Second 7 Days|Adverse Event|1
2945747|NCT01340014|10141087|P1|Period 2, Second 7 Days|Adverse Event|0
2945748|NCT01340014|10141086|P2|Period 1, First 7 Days|Personal Reasons|0
2945749|NCT01340014|10141087|P1|Period 1, First 7 Days|Personal Reasons|1
2945750|NCT01340014|10141086|P2|Period 1, First 7 Days|Adverse Event|0
2945751|NCT01340014|10141087|P1|Period 1, First 7 Days|Adverse Event|1
2945752|NCT01339923|10141108|P7|Overall Study|Withdrawal by Subject|2
2945753|NCT01339923|10141109|P6|Overall Study|Withdrawal by Subject|3
2945754|NCT01339923|10141110|P5|Overall Study|Withdrawal by Subject|4
2945755|NCT01339923|10141111|P4|Overall Study|Withdrawal by Subject|1
2945756|NCT01339923|10141112|P3|Overall Study|Withdrawal by Subject|6
2945757|NCT01339923|10141113|P2|Overall Study|Withdrawal by Subject|11
2945758|NCT01339923|10141114|P1|Overall Study|Withdrawal by Subject|7
2945759|NCT01339923|10141108|P7|Overall Study|Unable to Classify|5
2945760|NCT01339923|10141109|P6|Overall Study|Unable to Classify|1
2945761|NCT01339923|10141110|P5|Overall Study|Unable to Classify|0
2945762|NCT01339923|10141111|P4|Overall Study|Unable to Classify|0
2945763|NCT01339923|10141112|P3|Overall Study|Unable to Classify|1
2945764|NCT01339923|10141113|P2|Overall Study|Unable to Classify|0
2945765|NCT01339923|10141114|P1|Overall Study|Unable to Classify|1
2945766|NCT01339923|10141108|P7|Overall Study|Protocol Violation|1
2945767|NCT01339923|10141109|P6|Overall Study|Protocol Violation|3
2945768|NCT01339923|10141110|P5|Overall Study|Protocol Violation|0
2945769|NCT01339923|10141111|P4|Overall Study|Protocol Violation|0
2945770|NCT01339923|10141112|P3|Overall Study|Protocol Violation|0
2945771|NCT01339923|10141113|P2|Overall Study|Protocol Violation|0
2945772|NCT01339923|10141114|P1|Overall Study|Protocol Violation|0
2945773|NCT01339923|10141108|P7|Overall Study|Lost to Follow-up|5
2945774|NCT01339923|10141109|P6|Overall Study|Lost to Follow-up|1
2945775|NCT01339923|10141110|P5|Overall Study|Lost to Follow-up|1
2945776|NCT01339923|10141111|P4|Overall Study|Lost to Follow-up|3
2945777|NCT01339923|10141112|P3|Overall Study|Lost to Follow-up|0
2945778|NCT01339923|10141113|P2|Overall Study|Lost to Follow-up|4
2945779|NCT01339923|10141114|P1|Overall Study|Lost to Follow-up|4
2945780|NCT01339923|10141108|P7|Overall Study|Inappropriate Enrollment|0
2945781|NCT01339923|10141109|P6|Overall Study|Inappropriate Enrollment|1
2945782|NCT01339923|10141110|P5|Overall Study|Inappropriate Enrollment|0
2945783|NCT01339923|10141111|P4|Overall Study|Inappropriate Enrollment|0
2945784|NCT01339923|10141112|P3|Overall Study|Inappropriate Enrollment|0
2945785|NCT01339923|10141113|P2|Overall Study|Inappropriate Enrollment|0
2945786|NCT01339923|10141114|P1|Overall Study|Inappropriate Enrollment|1
2945787|NCT01339923|10141108|P7|Overall Study|Adverse Event|1
2945788|NCT01339923|10141109|P6|Overall Study|Adverse Event|0
2945789|NCT01339923|10141110|P5|Overall Study|Adverse Event|0
2945790|NCT01339923|10141111|P4|Overall Study|Adverse Event|0
2945791|NCT01339923|10141112|P3|Overall Study|Adverse Event|1
2945792|NCT01339923|10141113|P2|Overall Study|Adverse Event|1
2945793|NCT01339923|10141114|P1|Overall Study|Adverse Event|1
2945794|NCT01339910|10141185|P2|Overall Study|Disease relapse|4
2945795|NCT01339910|10141186|P1|Overall Study|Disease relapse|1
2945796|NCT01339910|10141185|P2|Overall Study|Physician Decision|0
2945797|NCT01339910|10141186|P1|Overall Study|Physician Decision|1
2945798|NCT01339910|10141185|P2|Overall Study|Withdrawal by Subject|0
2945799|NCT01339910|10141186|P1|Overall Study|Withdrawal by Subject|1
2945800|NCT01339897|10141224|P4|Overall Study|Adverse Event|1
2945801|NCT01339897|10141225|P3|Overall Study|Adverse Event|0
2945802|NCT01339897|10141226|P2|Overall Study|Adverse Event|0
2945803|NCT01339897|10141227|P1|Overall Study|Adverse Event|1
2945804|NCT01339832|10141280|P1|Overall Study|Death|11
2945805|NCT01339832|10141280|P1|Overall Study|Lost to Follow-up|3
2945806|NCT01339429|10141291|P1|Overall Study|Physician Decision|3
2945807|NCT01339429|10141291|P1|Overall Study|Withdrawal by Subject|1
2945808|NCT01339390|10141331|P2|Overall Study|Lost to Follow-up|127
2945809|NCT01339390|10141332|P1|Overall Study|Lost to Follow-up|125
2945810|NCT01339390|10141331|P2|Overall Study|Death|29
2945811|NCT01339390|10141332|P1|Overall Study|Death|32
2945812|NCT01339273|10141349|P2|Overall Study|Lost to Follow-up|8
2945813|NCT01339273|10141350|P1|Overall Study|Lost to Follow-up|8
2945814|NCT01339052|10141425|P2|Overall Study|Physician Decision|0
2945815|NCT01339052|10141426|P1|Overall Study|Physician Decision|1
2945816|NCT01339052|10141425|P2|Overall Study|Withdrawal by Subject|3
2945817|NCT01339052|10141426|P1|Overall Study|Withdrawal by Subject|0
2945818|NCT01339052|10141425|P2|Overall Study|Adverse Event|1
2945819|NCT01339052|10141426|P1|Overall Study|Adverse Event|1
2945820|NCT01339052|10141425|P2|Overall Study|Disease progression|46
2945821|NCT01339052|10141426|P1|Overall Study|Disease progression|13
2945822|NCT01339000|10141452|P2|Overall Study|study closed due to lack of drug supply|0
2945823|NCT01339000|10141453|P1|Overall Study|study closed due to lack of drug supply|1
2945824|NCT01338987|10141472|P5|Overall Study|Disease progression on study|0
2945825|NCT01338987|10141473|P4|Overall Study|Disease progression on study|0
2945826|NCT01338987|10141474|P3|Overall Study|Disease progression on study|1
2945827|NCT01338987|10141475|P2|Overall Study|Disease progression on study|1
2945828|NCT01338987|10141476|P1|Overall Study|Disease progression on study|2
2945829|NCT01338987|10141472|P5|Overall Study|enrolled on new protocol|0
2945830|NCT01338987|10141473|P4|Overall Study|enrolled on new protocol|0
2945831|NCT01338987|10141474|P3|Overall Study|enrolled on new protocol|1
2945832|NCT01338987|10141475|P2|Overall Study|enrolled on new protocol|0
2945833|NCT01338987|10141476|P1|Overall Study|enrolled on new protocol|0
2945834|NCT01338870|10141497|P6|Overall Study|Adverse Event|1
2945835|NCT01338870|10141498|P5|Overall Study|Adverse Event|4
2945836|NCT01338870|10141499|P4|Overall Study|Adverse Event|5
2945837|NCT01338870|10141500|P3|Overall Study|Adverse Event|1
2945838|NCT01338870|10141501|P2|Overall Study|Adverse Event|4
2945839|NCT01338870|10141502|P1|Overall Study|Adverse Event|4
2945840|NCT01338870|10141497|P6|Overall Study|Protocol Violation|1
2945841|NCT01338870|10141498|P5|Overall Study|Protocol Violation|1
2945842|NCT01338870|10141499|P4|Overall Study|Protocol Violation|2
2945843|NCT01338870|10141500|P3|Overall Study|Protocol Violation|2
2945844|NCT01338870|10141501|P2|Overall Study|Protocol Violation|2
2945845|NCT01338870|10141502|P1|Overall Study|Protocol Violation|0
2945846|NCT01338870|10141497|P6|Overall Study|Other|2
2945847|NCT01338870|10141498|P5|Overall Study|Other|0
2945848|NCT01338870|10141499|P4|Overall Study|Other|2
2945849|NCT01338870|10141500|P3|Overall Study|Other|3
2945850|NCT01338870|10141501|P2|Overall Study|Other|3
2945851|NCT01338870|10141502|P1|Overall Study|Other|3
2945852|NCT01338870|10141497|P6|Overall Study|Withdrawal by Subject|2
2945853|NCT01338870|10141498|P5|Overall Study|Withdrawal by Subject|0
2945854|NCT01338870|10141499|P4|Overall Study|Withdrawal by Subject|0
2945855|NCT01338870|10141500|P3|Overall Study|Withdrawal by Subject|4
2945856|NCT01338870|10141501|P2|Overall Study|Withdrawal by Subject|3
2945857|NCT01338870|10141502|P1|Overall Study|Withdrawal by Subject|2
2945858|NCT01338870|10141497|P6|Overall Study|Lost to Follow-up|0
2945859|NCT01338870|10141498|P5|Overall Study|Lost to Follow-up|1
2945860|NCT01338870|10141499|P4|Overall Study|Lost to Follow-up|0
2945861|NCT01338870|10141500|P3|Overall Study|Lost to Follow-up|1
2945862|NCT01338870|10141501|P2|Overall Study|Lost to Follow-up|0
2945863|NCT01338870|10141502|P1|Overall Study|Lost to Follow-up|0
2945864|NCT01338818|10141557|P1|Overall Study|Protocol Deviation|4
2945865|NCT01338818|10141557|P1|Overall Study|Administrative problems|3
2945866|NCT01338818|10141557|P1|Overall Study|Lost to Follow-up|4
2945867|NCT01338818|10141557|P1|Overall Study|Withdrawal by Subject|11
2945868|NCT01338818|10141557|P1|Overall Study|no longer require study drug|1
2945869|NCT01338818|10141557|P1|Overall Study|Lack of Efficacy|5
2945870|NCT01338818|10141557|P1|Overall Study|Adverse Event|8
2945871|NCT01338792|10141563|P1|Overall Study|Withdrawal by Subject|1
2945872|NCT01338792|10141563|P1|Overall Study|Death|1
2945873|NCT01338792|10141563|P1|Overall Study|Adverse Event|2
2945874|NCT01338636|10141578|P1|Overall Study|Withdrawn due to lack of improvement|8
2945875|NCT01338610|10141592|P3|Overall Study|Adverse Event|0
2945876|NCT01338610|10141593|P2|Overall Study|Adverse Event|0
2945877|NCT01338610|10141594|P1|Overall Study|Adverse Event|3
2945878|NCT01338610|10141592|P3|Overall Study|Protocol Violation|1
2945879|NCT01338610|10141593|P2|Overall Study|Protocol Violation|0
2945880|NCT01338610|10141594|P1|Overall Study|Protocol Violation|1
2945881|NCT01338610|10141592|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
2945882|NCT01338610|10141593|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
2945883|NCT01338610|10141594|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
2945884|NCT01338493|10141620|P1|12 Months Follow up|Lost to Follow-up|9
2945885|NCT01338493|10141620|P1|6 Months Follow up|Missed visit|8
2945886|NCT01338493|10141620|P1|6 Months Follow up|Lost to Follow-up|11
2945887|NCT01338493|10141620|P1|Discharge|Missed visit|1
2945888|NCT01338493|10141620|P1|Discharge|Death|1
2945889|NCT01338493|10141620|P1|Enrolled|Patient not implanted|4
2945890|NCT01338493|10141620|P1|Enrolled|Withdrawal by Subject|1
2945891|NCT01338415|10141627|P2|Overall Study|Other (administrative reason)|0
2945892|NCT01338415|10141628|P1|Overall Study|Other (administrative reason)|1
2945893|NCT01338415|10141627|P2|Overall Study|Other (PAH not the main etiology of PH)|2
2945894|NCT01338415|10141628|P1|Overall Study|Other (PAH not the main etiology of PH)|0
2945895|NCT01338415|10141627|P2|Overall Study|Withdrawal by Subject|1
2945896|NCT01338415|10141628|P1|Overall Study|Withdrawal by Subject|1
2945897|NCT01338415|10141627|P2|Overall Study|Adverse Event|6
2945898|NCT01338415|10141628|P1|Overall Study|Adverse Event|8
2945899|NCT01338298|10141650|P2|Overall Study|Non-adherence|0
2945900|NCT01338298|10141651|P1|Overall Study|Non-adherence|1
2945901|NCT01338298|10141650|P2|Overall Study|Depressive symptoms and nausea|0
2945902|NCT01338298|10141651|P1|Overall Study|Depressive symptoms and nausea|1
2945903|NCT01338298|10141650|P2|Overall Study|Positive symptom worsening|0
2945904|NCT01338298|10141651|P1|Overall Study|Positive symptom worsening|1
2945905|NCT01338298|10141650|P2|Overall Study|Administrative error|1
2945906|NCT01338298|10141651|P1|Overall Study|Administrative error|0
2945907|NCT01338298|10141650|P2|Overall Study|Abdominal Pain and scheduled surgery|1
2945908|NCT01338298|10141651|P1|Overall Study|Abdominal Pain and scheduled surgery|0
2945909|NCT01338298|10141650|P2|Overall Study|Withdrawal by Subject|1
2945910|NCT01338298|10141651|P1|Overall Study|Withdrawal by Subject|1
2945911|NCT01338025|10141661|P2|Overall Study|Found ineligible after starting|0
2945912|NCT01338025|10141662|P1|Overall Study|Found ineligible after starting|1
2945913|NCT01338025|10141661|P2|Overall Study|Withdrawal by Subject|2
2945914|NCT01338025|10141662|P1|Overall Study|Withdrawal by Subject|0
2945915|NCT01338025|10141661|P2|Overall Study|Unexpected closure of study|9
2945916|NCT01338025|10141662|P1|Overall Study|Unexpected closure of study|10
2945917|NCT01338012|10141674|P1|Overall Study|Study terminated|4
2945918|NCT01338012|10141674|P1|Overall Study|Death|4
2945919|NCT01337986|10141680|P2|Overall Study|Protocol Violation|3
2945920|NCT01337986|10141681|P1|Overall Study|Protocol Violation|0
2945921|NCT01337986|10141680|P2|Overall Study|Lost to Follow-up|0
2945922|NCT01337986|10141681|P1|Overall Study|Lost to Follow-up|1
2945923|NCT01337986|10141680|P2|Overall Study|Adverse Event|2
2945924|NCT01337986|10141681|P1|Overall Study|Adverse Event|2
2945925|NCT01337973|10141718|P3|Overall Study|missing data on primary outcome|3
2945926|NCT01337973|10141719|P2|Overall Study|missing data on primary outcome|1
2945927|NCT01337973|10141720|P1|Overall Study|missing data on primary outcome|3
2945928|NCT01337973|10141718|P3|Overall Study|Withdrawal by Subject|4
2945929|NCT01337973|10141719|P2|Overall Study|Withdrawal by Subject|8
2945930|NCT01337973|10141720|P1|Overall Study|Withdrawal by Subject|10
2945931|NCT01337973|10141718|P3|Overall Study|Death|1
2945932|NCT01337973|10141719|P2|Overall Study|Death|2
2945933|NCT01337973|10141720|P1|Overall Study|Death|1
2945934|NCT01337973|10141718|P3|Overall Study|Lost to Follow-up|3
2945935|NCT01337973|10141719|P2|Overall Study|Lost to Follow-up|4
2945936|NCT01337973|10141720|P1|Overall Study|Lost to Follow-up|2
2945937|NCT01337960|10141734|P3|Overall Study|Withdrawal by Subject|0
2945938|NCT01337960|10141735|P2|Overall Study|Withdrawal by Subject|0
2945939|NCT01337960|10141736|P1|Overall Study|Withdrawal by Subject|1
2945940|NCT01337960|10141734|P3|Overall Study|Lost to Follow-up|0
2945941|NCT01337960|10141735|P2|Overall Study|Lost to Follow-up|0
2945942|NCT01337960|10141736|P1|Overall Study|Lost to Follow-up|1
2945943|NCT01337674|10141801|P4|Treatment Period 2|Withdrawal by Subject|0
2945944|NCT01337674|10141802|P3|Treatment Period 2|Withdrawal by Subject|1
2945945|NCT01337674|10141803|P2|Treatment Period 2|Withdrawal by Subject|0
2945946|NCT01337674|10141804|P1|Treatment Period 2|Withdrawal by Subject|0
2945947|NCT01337674|10141801|P4|Treatment Period 1|Discontinued due to blood draws|1
2945948|NCT01337674|10141802|P3|Treatment Period 1|Discontinued due to blood draws|0
2945949|NCT01337674|10141803|P2|Treatment Period 1|Discontinued due to blood draws|0
2945950|NCT01337674|10141804|P1|Treatment Period 1|Discontinued due to blood draws|0
2945951|NCT01337674|10141801|P4|Treatment Period 1|Adverse Event|0
2945952|NCT01337674|10141802|P3|Treatment Period 1|Adverse Event|0
2945953|NCT01337674|10141803|P2|Treatment Period 1|Adverse Event|1
2945954|NCT01337674|10141804|P1|Treatment Period 1|Adverse Event|0
2945955|NCT01337635|10141822|P2|Overall Study|Lost to Follow-up|1
2945956|NCT01337635|10141823|P1|Overall Study|Lost to Follow-up|0
2945957|NCT01337596|10141865|P9|Overall Study|Withdrawal by Subject|0
2945958|NCT01337596|10141866|P8|Overall Study|Withdrawal by Subject|0
2945959|NCT01337596|10141867|P7|Overall Study|Withdrawal by Subject|0
2945960|NCT01337596|10141868|P6|Overall Study|Withdrawal by Subject|0
2945961|NCT01337596|10141869|P5|Overall Study|Withdrawal by Subject|2
2945962|NCT01337596|10141870|P4|Overall Study|Withdrawal by Subject|0
2945963|NCT01337596|10141871|P3|Overall Study|Withdrawal by Subject|0
2945964|NCT01337596|10141872|P2|Overall Study|Withdrawal by Subject|0
2945965|NCT01337596|10141873|P1|Overall Study|Withdrawal by Subject|0
2945966|NCT01337297|10141924|P2|Overall Study|Lost to Follow-up|3
2945967|NCT01337297|10141925|P1|Overall Study|Lost to Follow-up|1
2945968|NCT01337297|10141924|P2|Overall Study|They entered to single anodal tDCS|3
2945969|NCT01337297|10141925|P1|Overall Study|They entered to single anodal tDCS|4
2945970|NCT01337167|10141933|P2|Toddler Vaccinations|Withdrawal by Subject|0
2945971|NCT01337167|10141934|P1|Toddler Vaccinations|Withdrawal by Subject|3
2945972|NCT01337167|10141933|P2|Toddler Vaccinations|Protocol Violation|1
2945973|NCT01337167|10141934|P1|Toddler Vaccinations|Protocol Violation|0
2945974|NCT01337167|10141933|P2|Toddler Vaccinations|Lost to Follow-up|12
2945975|NCT01337167|10141934|P1|Toddler Vaccinations|Lost to Follow-up|11
2945976|NCT01337167|10141933|P2|Interim Period|Other protocol criterion not met|1
2945977|NCT01337167|10141934|P1|Interim Period|Other protocol criterion not met|0
2945978|NCT01337167|10141933|P2|Interim Period|Withdrawal by Subject|10
2945979|NCT01337167|10141934|P1|Interim Period|Withdrawal by Subject|18
2945980|NCT01337167|10141933|P2|Interim Period|Protocol Violation|3
2945981|NCT01337167|10141934|P1|Interim Period|Protocol Violation|5
2945982|NCT01337167|10141933|P2|Interim Period|Physician Decision|3
2945983|NCT01337167|10141934|P1|Interim Period|Physician Decision|6
2945984|NCT01337167|10141933|P2|Interim Period|Non-compliance with study drug|0
2945985|NCT01337167|10141934|P1|Interim Period|Non-compliance with study drug|1
2945986|NCT01337167|10141933|P2|Interim Period|Lost to Follow-up|23
2945987|NCT01337167|10141934|P1|Interim Period|Lost to Follow-up|51
2945988|NCT01337167|10141933|P2|Infant Series|Randomized but not vaccinated|3
2945989|NCT01337167|10141934|P1|Infant Series|Randomized but not vaccinated|5
2945990|NCT01337167|10141933|P2|Infant Series|Withdrawal by Subject|4
2945991|NCT01337167|10141934|P1|Infant Series|Withdrawal by Subject|15
2945992|NCT01337167|10141933|P2|Infant Series|Protocol Violation|9
2945993|NCT01337167|10141934|P1|Infant Series|Protocol Violation|22
2945994|NCT01337167|10141933|P2|Infant Series|Physician Decision|1
2945995|NCT01337167|10141934|P1|Infant Series|Physician Decision|3
2945996|NCT01337167|10141933|P2|Infant Series|Non-compliance with study drug|1
2945997|NCT01337167|10141934|P1|Infant Series|Non-compliance with study drug|2
2945998|NCT01337167|10141933|P2|Infant Series|Lost to Follow-up|7
2945999|NCT01337167|10141934|P1|Infant Series|Lost to Follow-up|13
2946000|NCT01337167|10141933|P2|Infant Series|Death|1
2946001|NCT01337167|10141934|P1|Infant Series|Death|1
2946002|NCT01337167|10141933|P2|Infant Series|Adverse Event|1
2946003|NCT01337167|10141934|P1|Infant Series|Adverse Event|1
2946004|NCT01337115|10142002|P2|Overall Study|Protocol Violation|0
2946005|NCT01337115|10142003|P1|Overall Study|Protocol Violation|2
2946006|NCT01337089|10142015|P1|Overall Study|Lost to Follow-up|2
2946007|NCT01337089|10142015|P1|Overall Study|Met Withdrawal Criteria|3
2946008|NCT01337089|10142015|P1|Overall Study|Withdrawal by Investigator|33
2946009|NCT01337089|10142015|P1|Overall Study|Withdrawal by Subject|129
2946010|NCT01337089|10142015|P1|Overall Study|Adverse Event|237
2946011|NCT01337050|10142030|P3|Overall Study|Participants refused further follow-up|7
2946012|NCT01337050|10142031|P2|Overall Study|Participants refused further follow-up|7
2946013|NCT01337050|10142032|P1|Overall Study|Participants refused further follow-up|0
2946014|NCT01337050|10142030|P3|Overall Study|Other|8
2946015|NCT01337050|10142031|P2|Overall Study|Other|6
2946016|NCT01337050|10142032|P1|Overall Study|Other|4
2946017|NCT01337050|10142030|P3|Overall Study|Death|4
2946018|NCT01337050|10142031|P2|Overall Study|Death|0
2946019|NCT01337050|10142032|P1|Overall Study|Death|0
2946020|NCT01336972|10142093|P3|Overall Study|Adverse Event|0
2946021|NCT01336972|10142094|P2|Overall Study|Adverse Event|1
2946022|NCT01336972|10142095|P1|Overall Study|Adverse Event|1
2946023|NCT01336894|10142157|P2|Follow-up|Study terminated prematurely|7
2946024|NCT01336894|10142158|P1|Follow-up|Study terminated prematurely|2
2946025|NCT01336764|10142190|P2|Overall Study|Withdrawal by Subject|5
2946026|NCT01336764|10142191|P1|Overall Study|Withdrawal by Subject|5
2946027|NCT01336738|10142202|P5|Overall Study|Other|4
2946028|NCT01336738|10142203|P4|Overall Study|Other|3
2946029|NCT01336738|10142204|P3|Overall Study|Other|2
2946030|NCT01336738|10142205|P2|Overall Study|Other|3
2946031|NCT01336738|10142206|P1|Overall Study|Other|3
2946032|NCT01336738|10142202|P5|Overall Study|Withdrawal by Subject|1
2946033|NCT01336738|10142203|P4|Overall Study|Withdrawal by Subject|1
2946034|NCT01336738|10142204|P3|Overall Study|Withdrawal by Subject|2
2946035|NCT01336738|10142205|P2|Overall Study|Withdrawal by Subject|0
2946036|NCT01336738|10142206|P1|Overall Study|Withdrawal by Subject|2
2946037|NCT01336738|10142202|P5|Overall Study|Protocol Violation|0
2946038|NCT01336738|10142203|P4|Overall Study|Protocol Violation|0
2946039|NCT01336738|10142204|P3|Overall Study|Protocol Violation|0
2946040|NCT01336738|10142205|P2|Overall Study|Protocol Violation|1
2946041|NCT01336738|10142206|P1|Overall Study|Protocol Violation|0
2946042|NCT01336738|10142202|P5|Overall Study|Did not meet entrance criteria|0
2946043|NCT01336738|10142203|P4|Overall Study|Did not meet entrance criteria|0
2946044|NCT01336738|10142204|P3|Overall Study|Did not meet entrance criteria|0
2946045|NCT01336738|10142205|P2|Overall Study|Did not meet entrance criteria|1
2946046|NCT01336738|10142206|P1|Overall Study|Did not meet entrance criteria|0
2946047|NCT01336738|10142202|P5|Overall Study|Lost to Follow-up|2
2946048|NCT01336738|10142203|P4|Overall Study|Lost to Follow-up|2
2946049|NCT01336738|10142204|P3|Overall Study|Lost to Follow-up|2
2946050|NCT01336738|10142205|P2|Overall Study|Lost to Follow-up|1
2946051|NCT01336738|10142206|P1|Overall Study|Lost to Follow-up|2
2946052|NCT01336738|10142202|P5|Overall Study|Adverse Event|3
2946053|NCT01336738|10142203|P4|Overall Study|Adverse Event|1
2946054|NCT01336738|10142204|P3|Overall Study|Adverse Event|2
2946055|NCT01336738|10142205|P2|Overall Study|Adverse Event|3
2946056|NCT01336738|10142206|P1|Overall Study|Adverse Event|0
2946057|NCT01336712|10142248|P1|Overall Study|Lack of Efficacy|1
2946058|NCT01336712|10142248|P1|Overall Study|Death|2
2946059|NCT01336647|10142261|P3|Overall Study|Lost to Follow-up|3
2946060|NCT01336647|10142262|P2|Overall Study|Lost to Follow-up|1
2946061|NCT01336647|10142263|P1|Overall Study|Lost to Follow-up|4
2946062|NCT01336634|10142277|P3|Overall Study|Ongoing|24
2946063|NCT01336634|10142278|P2|Overall Study|Ongoing|22
2946064|NCT01336634|10142279|P1|Overall Study|Ongoing|15
2946065|NCT01336634|10142277|P3|Overall Study|Physician Decision|0
2946066|NCT01336634|10142278|P2|Overall Study|Physician Decision|1
2946067|NCT01336634|10142279|P1|Overall Study|Physician Decision|1
2946068|NCT01336634|10142277|P3|Overall Study|Withdrawal by Subject|1
2946069|NCT01336634|10142278|P2|Overall Study|Withdrawal by Subject|0
2946070|NCT01336634|10142279|P1|Overall Study|Withdrawal by Subject|6
2946071|NCT01336634|10142277|P3|Overall Study|Lost to Follow-up|1
2946072|NCT01336634|10142278|P2|Overall Study|Lost to Follow-up|1
2946073|NCT01336634|10142279|P1|Overall Study|Lost to Follow-up|2
2946074|NCT01336634|10142277|P3|Overall Study|Death|10
2946075|NCT01336634|10142278|P2|Overall Study|Death|33
2946076|NCT01336634|10142279|P1|Overall Study|Death|60
2946077|NCT01336621|10142320|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
2946078|NCT01336621|10142320|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
2946079|NCT01336621|10142320|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
2946080|NCT01336621|10142320|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
2946081|NCT01336621|10142320|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
2946082|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
2946083|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
2946084|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
2946085|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
2946086|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
2946087|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
2946088|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
2946089|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
2946090|NCT01336621|10142320|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
2946091|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
2946092|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
2946093|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2946094|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2946095|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Physician Decision|1
2946096|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2946097|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Physician Decision|3
2946098|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2946099|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2946100|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2946101|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2946102|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2946103|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
2946104|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
2946105|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2946106|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2946107|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
2946108|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
2946109|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
2946110|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2946111|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
2946112|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2946113|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2946114|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2946115|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2946116|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2946117|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2946118|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2946119|NCT01336608|10142370|P4|24-week, Double-blind Treatment Period|Adverse Event|7
2946120|NCT01336608|10142371|P3|24-week, Double-blind Treatment Period|Adverse Event|6
2946121|NCT01336608|10142372|P2|24-week, Double-blind Treatment Period|Adverse Event|8
2946122|NCT01336608|10142373|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2946123|NCT01336608|10142370|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2946124|NCT01336608|10142371|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2946125|NCT01336608|10142372|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2946126|NCT01336608|10142373|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
2946127|NCT01336608|10142370|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2946128|NCT01336608|10142371|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2946129|NCT01336608|10142372|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2946130|NCT01336608|10142373|P1|2-week, Single-blind Run-In Period|Physician Decision|1
2946131|NCT01336608|10142370|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2946132|NCT01336608|10142371|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2946133|NCT01336608|10142372|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2946134|NCT01336608|10142373|P1|2-week, Single-blind Run-In Period|Adverse Event|1
2946135|NCT01336608|10142370|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2946136|NCT01336608|10142371|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2946137|NCT01336608|10142372|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2946138|NCT01336608|10142373|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
2946139|NCT01336608|10142370|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2946140|NCT01336608|10142371|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2946141|NCT01336608|10142372|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2946142|NCT01336608|10142373|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
2946143|NCT01336569|10142387|P1|Overall Study|Lost to Follow-up|4
2946144|NCT01336205|10142435|P2|Overall Study|Did not receive treatment|0
2946145|NCT01336205|10142436|P1|Overall Study|Did not receive treatment|4
2946146|NCT01336205|10142435|P2|Overall Study|Withdrawal by Subject|38
2946147|NCT01336205|10142436|P1|Overall Study|Withdrawal by Subject|72
2946148|NCT01336205|10142435|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
2946149|NCT01336205|10142436|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
2946150|NCT01336205|10142435|P2|Overall Study|Death|1
2946151|NCT01336205|10142436|P1|Overall Study|Death|1
2946152|NCT01336205|10142435|P2|Overall Study|Adverse Event|6
2946153|NCT01336205|10142436|P1|Overall Study|Adverse Event|56
2946154|NCT01336205|10142435|P2|Overall Study|Severe noncompliance with protocol|2
2946155|NCT01336205|10142436|P1|Overall Study|Severe noncompliance with protocol|9
2946156|NCT01336205|10142435|P2|Overall Study|Lack of Efficacy|0
2946157|NCT01336205|10142436|P1|Overall Study|Lack of Efficacy|4
2946158|NCT01336205|10142435|P2|Overall Study|Study-Specific Withdrawal Criteria|7
2946159|NCT01336205|10142436|P1|Overall Study|Study-Specific Withdrawal Criteria|16
2946160|NCT01336205|10142435|P2|Overall Study|Lost to Follow-up|20
2946161|NCT01336205|10142436|P1|Overall Study|Lost to Follow-up|40
2946162|NCT01336205|10142435|P2|Overall Study|Other|9
2946163|NCT01336205|10142436|P1|Overall Study|Other|22
2946164|NCT01336023|10142464|P3|Week 27 to 52|Unclassified|9
2946165|NCT01336023|10142465|P2|Week 27 to 52|Unclassified|18
2946166|NCT01336023|10142466|P1|Week 27 to 52|Unclassified|13
2946167|NCT01336023|10142464|P3|Week 27 to 52|Withdrawal Criteria|16
2946168|NCT01336023|10142465|P2|Week 27 to 52|Withdrawal Criteria|19
2946169|NCT01336023|10142466|P1|Week 27 to 52|Withdrawal Criteria|14
2946170|NCT01336023|10142464|P3|Week 27 to 52|Protocol Violation|1
2946171|NCT01336023|10142465|P2|Week 27 to 52|Protocol Violation|2
2946172|NCT01336023|10142466|P1|Week 27 to 52|Protocol Violation|0
2946173|NCT01336023|10142464|P3|Week 27 to 52|Adverse Event|2
2946174|NCT01336023|10142465|P2|Week 27 to 52|Adverse Event|5
2946175|NCT01336023|10142466|P1|Week 27 to 52|Adverse Event|1
2946176|NCT01336023|10142464|P3|Week 0 to Week 26|Unclassified|9
2946177|NCT01336023|10142465|P2|Week 0 to Week 26|Unclassified|16
2946178|NCT01336023|10142466|P1|Week 0 to Week 26|Unclassified|5
2946179|NCT01336023|10142464|P3|Week 0 to Week 26|Withdrawal Criteria|40
2946180|NCT01336023|10142465|P2|Week 0 to Week 26|Withdrawal Criteria|69
2946181|NCT01336023|10142466|P1|Week 0 to Week 26|Withdrawal Criteria|34
2946182|NCT01336023|10142464|P3|Week 0 to Week 26|Protocol Violation|0
2946183|NCT01336023|10142465|P2|Week 0 to Week 26|Protocol Violation|2
2946184|NCT01336023|10142466|P1|Week 0 to Week 26|Protocol Violation|1
2946185|NCT01336023|10142464|P3|Week 0 to Week 26|Lack of Efficacy|0
2946186|NCT01336023|10142465|P2|Week 0 to Week 26|Lack of Efficacy|1
2946187|NCT01336023|10142466|P1|Week 0 to Week 26|Lack of Efficacy|0
2946188|NCT01336023|10142464|P3|Week 0 to Week 26|Adverse Event|24
2946189|NCT01336023|10142465|P2|Week 0 to Week 26|Adverse Event|10
2946190|NCT01336023|10142466|P1|Week 0 to Week 26|Adverse Event|8
2946191|NCT01335997|10142487|P2|Period III|Lost to Follow-up|0
2946192|NCT01335997|10142488|P1|Period III|Lost to Follow-up|1
2946193|NCT01335997|10142487|P2|Period III|Protocol Violation|1
2946194|NCT01335997|10142488|P1|Period III|Protocol Violation|0
2946195|NCT01335997|10142487|P2|Period III|Study Terminated by Sponsor|76
2946196|NCT01335997|10142488|P1|Period III|Study Terminated by Sponsor|77
2946197|NCT01335997|10142487|P2|Period III|Adverse Event|2
2946198|NCT01335997|10142488|P1|Period III|Adverse Event|0
2946199|NCT01335997|10142487|P2|Period I and II|Physician Decision|1
2946200|NCT01335997|10142488|P1|Period I and II|Physician Decision|2
2946201|NCT01335997|10142487|P2|Period I and II|Protocol Violation|10
2946202|NCT01335997|10142488|P1|Period I and II|Protocol Violation|9
2946203|NCT01335997|10142487|P2|Period I and II|Study Terminated by Sponsor|415
2946204|NCT01335997|10142488|P1|Period I and II|Study Terminated by Sponsor|406
2946205|NCT01335997|10142487|P2|Period I and II|Withdrawal by Subject|4
2946206|NCT01335997|10142488|P1|Period I and II|Withdrawal by Subject|9
2946207|NCT01335997|10142487|P2|Period I and II|Lost to Follow-up|5
2946208|NCT01335997|10142488|P1|Period I and II|Lost to Follow-up|3
2946209|NCT01335997|10142487|P2|Period I and II|Noncompliance with Study Drug|1
2946210|NCT01335997|10142488|P1|Period I and II|Noncompliance with Study Drug|1
2946211|NCT01335997|10142487|P2|Period I and II|Adverse Event|43
2946212|NCT01335997|10142488|P1|Period I and II|Adverse Event|63
2946213|NCT01335971|10142501|P3|Overall Study|Did not complete bronchoscopy|1
2946214|NCT01335971|10142502|P2|Overall Study|Did not complete bronchoscopy|1
2946215|NCT01335971|10142503|P1|Overall Study|Did not complete bronchoscopy|1
2946216|NCT01335971|10142501|P3|Overall Study|Withdrawal by Subject|0
2946217|NCT01335971|10142502|P2|Overall Study|Withdrawal by Subject|0
2946218|NCT01335971|10142503|P1|Overall Study|Withdrawal by Subject|1
2946219|NCT01335698|10142746|P5|Treatment Stage 2|Switched to another formulation|0
2946220|NCT01335698|10142747|P4|Treatment Stage 2|Switched to another formulation|0
2946221|NCT01335698|10142748|P3|Treatment Stage 2|Switched to another formulation|0
2946222|NCT01335698|10142749|P2|Treatment Stage 2|Switched to another formulation|1
2946223|NCT01335698|10142750|P1|Treatment Stage 2|Switched to another formulation|1
2946224|NCT01335698|10142746|P5|Treatment Stage 2|Subject no longer meets study criteria|0
2946225|NCT01335698|10142747|P4|Treatment Stage 2|Subject no longer meets study criteria|1
2946226|NCT01335698|10142748|P3|Treatment Stage 2|Subject no longer meets study criteria|0
2946227|NCT01335698|10142749|P2|Treatment Stage 2|Subject no longer meets study criteria|0
2946228|NCT01335698|10142750|P1|Treatment Stage 2|Subject no longer meets study criteria|0
2946229|NCT01335698|10142746|P5|Treatment Stage 2|Capsules received at state hospital|0
2946230|NCT01335698|10142747|P4|Treatment Stage 2|Capsules received at state hospital|0
2946231|NCT01335698|10142748|P3|Treatment Stage 2|Capsules received at state hospital|0
2946232|NCT01335698|10142749|P2|Treatment Stage 2|Capsules received at state hospital|0
2946233|NCT01335698|10142750|P1|Treatment Stage 2|Capsules received at state hospital|1
2946234|NCT01335698|10142746|P5|Treatment Stage 2|Lost to Follow-up|0
2946235|NCT01335698|10142747|P4|Treatment Stage 2|Lost to Follow-up|0
2946236|NCT01335698|10142748|P3|Treatment Stage 2|Lost to Follow-up|0
2946237|NCT01335698|10142749|P2|Treatment Stage 2|Lost to Follow-up|0
2946238|NCT01335698|10142750|P1|Treatment Stage 2|Lost to Follow-up|1
2946239|NCT01335698|10142746|P5|Treatment Stage 2|Poor compliance/noncompliance|1
2946240|NCT01335698|10142747|P4|Treatment Stage 2|Poor compliance/noncompliance|3
2946241|NCT01335698|10142748|P3|Treatment Stage 2|Poor compliance/noncompliance|1
2946242|NCT01335698|10142749|P2|Treatment Stage 2|Poor compliance/noncompliance|0
2946243|NCT01335698|10142750|P1|Treatment Stage 2|Poor compliance/noncompliance|1
2946244|NCT01335698|10142746|P5|Treatment Stage 2|Withdrawal by Subject|0
2946245|NCT01335698|10142747|P4|Treatment Stage 2|Withdrawal by Subject|0
2946246|NCT01335698|10142748|P3|Treatment Stage 2|Withdrawal by Subject|1
2946247|NCT01335698|10142749|P2|Treatment Stage 2|Withdrawal by Subject|1
2946248|NCT01335698|10142750|P1|Treatment Stage 2|Withdrawal by Subject|3
2946249|NCT01335698|10142746|P5|Treatment Stage 2|Adverse Event|0
2946250|NCT01335698|10142747|P4|Treatment Stage 2|Adverse Event|3
2946251|NCT01335698|10142748|P3|Treatment Stage 2|Adverse Event|0
2946252|NCT01335698|10142749|P2|Treatment Stage 2|Adverse Event|0
2946253|NCT01335698|10142750|P1|Treatment Stage 2|Adverse Event|2
2946254|NCT01335698|10142746|P5|Treatment Stage 2|Lack of Efficacy|0
2946255|NCT01335698|10142747|P4|Treatment Stage 2|Lack of Efficacy|1
2946256|NCT01335698|10142748|P3|Treatment Stage 2|Lack of Efficacy|3
2946257|NCT01335698|10142749|P2|Treatment Stage 2|Lack of Efficacy|1
2946258|NCT01335698|10142750|P1|Treatment Stage 2|Lack of Efficacy|2
2946259|NCT01335698|10142746|P5|Treatment Stage 1|Other|0
2946260|NCT01335698|10142747|P4|Treatment Stage 1|Other|1
2946261|NCT01335698|10142748|P3|Treatment Stage 1|Other|0
2946262|NCT01335698|10142749|P2|Treatment Stage 1|Other|0
2946263|NCT01335698|10142750|P1|Treatment Stage 1|Other|1
2946264|NCT01335698|10142746|P5|Treatment Stage 1|No longer meets study criteria|0
2946265|NCT01335698|10142747|P4|Treatment Stage 1|No longer meets study criteria|1
2946266|NCT01335698|10142748|P3|Treatment Stage 1|No longer meets study criteria|0
2946267|NCT01335698|10142749|P2|Treatment Stage 1|No longer meets study criteria|1
2946268|NCT01335698|10142750|P1|Treatment Stage 1|No longer meets study criteria|1
2946269|NCT01335698|10142746|P5|Treatment Stage 1|Poor compliance/noncompliance|0
2946270|NCT01335698|10142747|P4|Treatment Stage 1|Poor compliance/noncompliance|2
2946271|NCT01335698|10142748|P3|Treatment Stage 1|Poor compliance/noncompliance|0
2946272|NCT01335698|10142749|P2|Treatment Stage 1|Poor compliance/noncompliance|1
2946273|NCT01335698|10142750|P1|Treatment Stage 1|Poor compliance/noncompliance|0
2946274|NCT01335698|10142746|P5|Treatment Stage 1|Lost to Follow-up|0
2946275|NCT01335698|10142747|P4|Treatment Stage 1|Lost to Follow-up|0
2946276|NCT01335698|10142748|P3|Treatment Stage 1|Lost to Follow-up|0
2946277|NCT01335698|10142749|P2|Treatment Stage 1|Lost to Follow-up|1
2946278|NCT01335698|10142750|P1|Treatment Stage 1|Lost to Follow-up|1
2946279|NCT01335698|10142746|P5|Treatment Stage 1|Withdrawal by Subject|0
2946280|NCT01335698|10142747|P4|Treatment Stage 1|Withdrawal by Subject|1
2946281|NCT01335698|10142748|P3|Treatment Stage 1|Withdrawal by Subject|0
2946282|NCT01335698|10142749|P2|Treatment Stage 1|Withdrawal by Subject|2
2946283|NCT01335698|10142750|P1|Treatment Stage 1|Withdrawal by Subject|1
2946284|NCT01335698|10142746|P5|Treatment Stage 1|Adverse Event|1
2946285|NCT01335698|10142747|P4|Treatment Stage 1|Adverse Event|1
2946286|NCT01335698|10142748|P3|Treatment Stage 1|Adverse Event|2
2946287|NCT01335698|10142749|P2|Treatment Stage 1|Adverse Event|2
2946288|NCT01335698|10142750|P1|Treatment Stage 1|Adverse Event|1
2946289|NCT01335698|10142746|P5|Treatment Stage 1|Lack of Efficacy|1
2946290|NCT01335698|10142747|P4|Treatment Stage 1|Lack of Efficacy|3
2946291|NCT01335698|10142748|P3|Treatment Stage 1|Lack of Efficacy|3
2946292|NCT01335698|10142749|P2|Treatment Stage 1|Lack of Efficacy|1
2946293|NCT01335698|10142750|P1|Treatment Stage 1|Lack of Efficacy|3
2946294|NCT01335685|10142815|P8|Overall Study|Reason not Specified|0
2946295|NCT01335685|10142816|P7|Overall Study|Reason not Specified|0
2946296|NCT01335685|10142817|P6|Overall Study|Reason not Specified|1
2946297|NCT01335685|10142818|P5|Overall Study|Reason not Specified|0
2946298|NCT01335685|10142819|P4|Overall Study|Reason not Specified|0
2946299|NCT01335685|10142820|P3|Overall Study|Reason not Specified|1
2946300|NCT01335685|10142821|P2|Overall Study|Reason not Specified|0
2946301|NCT01335685|10142822|P1|Overall Study|Reason not Specified|0
2946302|NCT01335685|10142815|P8|Overall Study|Withdrawal by Subject|0
2946303|NCT01335685|10142816|P7|Overall Study|Withdrawal by Subject|0
2946304|NCT01335685|10142817|P6|Overall Study|Withdrawal by Subject|0
2946305|NCT01335685|10142818|P5|Overall Study|Withdrawal by Subject|0
2946306|NCT01335685|10142819|P4|Overall Study|Withdrawal by Subject|1
2946307|NCT01335685|10142820|P3|Overall Study|Withdrawal by Subject|0
2946308|NCT01335685|10142821|P2|Overall Study|Withdrawal by Subject|0
2946309|NCT01335685|10142822|P1|Overall Study|Withdrawal by Subject|1
2946310|NCT01335685|10142815|P8|Overall Study|Study Terminated by Sponsor|3
2946311|NCT01335685|10142816|P7|Overall Study|Study Terminated by Sponsor|2
2946312|NCT01335685|10142817|P6|Overall Study|Study Terminated by Sponsor|4
2946313|NCT01335685|10142818|P5|Overall Study|Study Terminated by Sponsor|0
2946314|NCT01335685|10142819|P4|Overall Study|Study Terminated by Sponsor|10
2946315|NCT01335685|10142820|P3|Overall Study|Study Terminated by Sponsor|1
2946316|NCT01335685|10142821|P2|Overall Study|Study Terminated by Sponsor|1
2946317|NCT01335685|10142822|P1|Overall Study|Study Terminated by Sponsor|2
2946318|NCT01335477|10142942|P2|Overall Study|Reason other than those stated above|2
2946319|NCT01335477|10142943|P1|Overall Study|Reason other than those stated above|2
2946320|NCT01335477|10142942|P2|Overall Study|Not treated|2
2946321|NCT01335477|10142943|P1|Overall Study|Not treated|1
2946322|NCT01335477|10142942|P2|Overall Study|Consent withdrawn, not due to AE|9
2946323|NCT01335477|10142943|P1|Overall Study|Consent withdrawn, not due to AE|7
2946324|NCT01335477|10142942|P2|Overall Study|Lost to Follow-up|2
2946325|NCT01335477|10142943|P1|Overall Study|Lost to Follow-up|1
2946326|NCT01335477|10142942|P2|Overall Study|Non compliant with protocol|2
2946327|NCT01335477|10142943|P1|Overall Study|Non compliant with protocol|0
2946328|NCT01335477|10142942|P2|Overall Study|Adverse Event|42
2946329|NCT01335477|10142943|P1|Overall Study|Adverse Event|30
2946330|NCT01335464|10143007|P2|Overall Study|Reason other than those stated above|1
2946331|NCT01335464|10143008|P1|Overall Study|Reason other than those stated above|1
2946332|NCT01335464|10143007|P2|Overall Study|Not treated|0
2946333|NCT01335464|10143008|P1|Overall Study|Not treated|2
2946334|NCT01335464|10143007|P2|Overall Study|Consent withdrawn, not due to AE|23
2946335|NCT01335464|10143008|P1|Overall Study|Consent withdrawn, not due to AE|12
2946336|NCT01335464|10143007|P2|Overall Study|Non compliant with protocol|0
2946337|NCT01335464|10143008|P1|Overall Study|Non compliant with protocol|2
2946338|NCT01335464|10143007|P2|Overall Study|Adverse Event|25
2946339|NCT01335464|10143008|P1|Overall Study|Adverse Event|15
2946340|NCT01334918|10143177|P2|Overall Study|Withdrawal by Subject|1
2946341|NCT01334918|10143178|P1|Overall Study|Withdrawal by Subject|0
2946342|NCT01334918|10143177|P2|Overall Study|Adverse Event|0
2946343|NCT01334918|10143178|P1|Overall Study|Adverse Event|2
2946344|NCT01334918|10143177|P2|Overall Study|Did not receive study drug|0
2946345|NCT01334918|10143178|P1|Overall Study|Did not receive study drug|6
2946346|NCT01334866|10143204|P1|Overall Study|medically necessary post-procedure|1
2946347|NCT01334866|10143204|P1|Overall Study|medically necessary prior to procedure|2
2946348|NCT01334866|10143204|P1|Overall Study|Physician Decision|3
2946349|NCT01334866|10143204|P1|Overall Study|Lost to Follow-up|3
2946350|NCT01334866|10143204|P1|Overall Study|Withdrawal by Subject|10
2946351|NCT01334710|10143241|P1|Overall Study|Trial was terminated|3
2946352|NCT01334606|10143246|P1|Overall Study|Study Terminated due to slow enrolment|18
2946353|NCT01334554|10143254|P2|Overall Study|Adverse Event|2
2946354|NCT01334554|10143255|P1|Overall Study|Adverse Event|4
2946355|NCT01334515|10143265|P2|Overall Study|Withdrawal by Subject|1
2946356|NCT01334515|10143266|P1|Overall Study|Withdrawal by Subject|1
2946357|NCT01334515|10143265|P2|Overall Study|Physician Decision|1
2946358|NCT01334515|10143266|P1|Overall Study|Physician Decision|1
2946359|NCT01334515|10143265|P2|Overall Study|Lack of Efficacy|21
2946360|NCT01334515|10143266|P1|Overall Study|Lack of Efficacy|8
2946361|NCT01334515|10143265|P2|Overall Study|Death|0
2946362|NCT01334515|10143266|P1|Overall Study|Death|1
2946363|NCT01334515|10143265|P2|Overall Study|Adverse Event|6
2946364|NCT01334515|10143266|P1|Overall Study|Adverse Event|1
2946365|NCT01334125|10143304|P2|Overall Study|Lost to Follow-up|3
2946366|NCT01334125|10143305|P1|Overall Study|Lost to Follow-up|3
2946367|NCT01333956|10143321|P4|Overall Study|Withdrawal by Subject|0
2946368|NCT01333956|10143322|P3|Overall Study|Withdrawal by Subject|1
2946369|NCT01333956|10143323|P2|Overall Study|Withdrawal by Subject|2
2946370|NCT01333956|10143324|P1|Overall Study|Withdrawal by Subject|0
2946371|NCT01333956|10143321|P4|Overall Study|Unable to complete study procedure|1
2946372|NCT01333956|10143322|P3|Overall Study|Unable to complete study procedure|0
2946373|NCT01333956|10143323|P2|Overall Study|Unable to complete study procedure|0
2946374|NCT01333956|10143324|P1|Overall Study|Unable to complete study procedure|1
2946375|NCT01333956|10143321|P4|Overall Study|Lost to Follow-up|1
2946376|NCT01333956|10143322|P3|Overall Study|Lost to Follow-up|0
2946377|NCT01333956|10143323|P2|Overall Study|Lost to Follow-up|2
2946378|NCT01333956|10143324|P1|Overall Study|Lost to Follow-up|1
2946379|NCT01333943|10143360|P2|Overall Study|Known neuropathy|0
2946380|NCT01333943|10143361|P1|Overall Study|Known neuropathy|1
2946381|NCT01333865|10143377|P1|Overall Study|Adverse Event|2
2946382|NCT01333722|10143397|P2|Overall Study|Withdrawal by Subject|1
2946383|NCT01333722|10143398|P1|Overall Study|Withdrawal by Subject|0
2946384|NCT01333722|10143397|P2|Overall Study|Lack of Efficacy|2
2946385|NCT01333722|10143398|P1|Overall Study|Lack of Efficacy|0
2946386|NCT01333501|10143423|P2|Overall Study|Withdrawn consent|12
2946387|NCT01333501|10143424|P1|Overall Study|Withdrawn consent|3
2946388|NCT01333501|10143423|P2|Overall Study|Unsatisfactory therapeutic effect|7
2946389|NCT01333501|10143424|P1|Overall Study|Unsatisfactory therapeutic effect|1
2946390|NCT01333501|10143423|P2|Overall Study|Abnormal laboratory value|1
2946391|NCT01333501|10143424|P1|Overall Study|Abnormal laboratory value|2
2946392|NCT01333501|10143423|P2|Overall Study|Adverse Event|1
2946393|NCT01333501|10143424|P1|Overall Study|Adverse Event|3
2946394|NCT01333475|10143491|P2|Overall Study|Toxicity|3
2946395|NCT01333475|10143492|P1|Overall Study|Toxicity|1
2946396|NCT01333475|10143491|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
2946397|NCT01333475|10143492|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
2946398|NCT01333397|10143518|P5|Overall Study|Lost to Follow-up|0
2946399|NCT01333397|10143519|P4|Overall Study|Lost to Follow-up|1
2946400|NCT01333397|10143520|P3|Overall Study|Lost to Follow-up|0
2946401|NCT01333397|10143521|P2|Overall Study|Lost to Follow-up|0
2946402|NCT01333397|10143522|P1|Overall Study|Lost to Follow-up|1
2946403|NCT01333189|10143596|P2|Overall Study|Moved from region|1
2946404|NCT01333189|10143597|P1|Overall Study|Moved from region|0
2946405|NCT01333189|10143596|P2|Overall Study|Transportation difficulties|1
2946406|NCT01333189|10143597|P1|Overall Study|Transportation difficulties|0
2946407|NCT01333189|10143596|P2|Overall Study|Adverse Event|0
2946408|NCT01333189|10143597|P1|Overall Study|Adverse Event|1
2946409|NCT01333189|10143596|P2|Overall Study|Time constraints|0
2946410|NCT01333189|10143597|P1|Overall Study|Time constraints|1
2946411|NCT01333111|10143628|P3|Overall Study|Ineffective therapy|1
2946412|NCT01333111|10143629|P2|Overall Study|Ineffective therapy|0
2946413|NCT01333111|10143630|P1|Overall Study|Ineffective therapy|0
2946414|NCT01333111|10143628|P3|Overall Study|Non-compliance|0
2946415|NCT01333111|10143629|P2|Overall Study|Non-compliance|0
2946416|NCT01333111|10143630|P1|Overall Study|Non-compliance|1
2946417|NCT01333111|10143628|P3|Overall Study|withdrawal criteria|0
2946418|NCT01333111|10143629|P2|Overall Study|withdrawal criteria|1
2946419|NCT01333111|10143630|P1|Overall Study|withdrawal criteria|0
2946420|NCT01333111|10143628|P3|Overall Study|unclassified|0
2946421|NCT01333111|10143629|P2|Overall Study|unclassified|0
2946422|NCT01333111|10143630|P1|Overall Study|unclassified|1
2946423|NCT01333111|10143628|P3|Overall Study|personal reasons|1
2946424|NCT01333111|10143629|P2|Overall Study|personal reasons|0
2946425|NCT01333111|10143630|P1|Overall Study|personal reasons|0
2946426|NCT01333111|10143628|P3|Overall Study|patient undergoing major surgery|0
2946427|NCT01333111|10143629|P2|Overall Study|patient undergoing major surgery|2
2946428|NCT01333111|10143630|P1|Overall Study|patient undergoing major surgery|0
2946429|NCT01333072|10143665|P2|Overall Study|Physician Decision|0
2946430|NCT01333072|10143666|P1|Overall Study|Physician Decision|1
2946431|NCT01333072|10143665|P2|Overall Study|Adverse Event|4
2946432|NCT01333072|10143666|P1|Overall Study|Adverse Event|2
2946433|NCT01333072|10143665|P2|Overall Study|Lost to Follow-up|0
2946434|NCT01333072|10143666|P1|Overall Study|Lost to Follow-up|3
2946435|NCT01333059|10143674|P2|Overall Study|Protocol Violation|0
2946436|NCT01333059|10143675|P1|Overall Study|Protocol Violation|3
2946437|NCT01333059|10143674|P2|Overall Study|Physician Decision|3
2946438|NCT01333059|10143675|P1|Overall Study|Physician Decision|3
2946439|NCT01332994|10143685|P1|Overall Study|Other|8
2946440|NCT01332994|10143685|P1|Overall Study|Administrative Problem|2
2946441|NCT01332994|10143685|P1|Overall Study|Withdrawal by Subject|15
2946442|NCT01332994|10143685|P1|Overall Study|Protocol Violation|6
2946443|NCT01332994|10143685|P1|Overall Study|Lost to Follow-up|4
2946444|NCT01332994|10143685|P1|Overall Study|Lack of Efficacy|1
2946445|NCT01332994|10143685|P1|Overall Study|Death|1
2946446|NCT01332994|10143685|P1|Overall Study|Adverse Event|34
2946447|NCT01332968|10143754|P8|Follow-Up Period|Lost to Follow-up|2
2946448|NCT01332968|10143755|P7|Follow-Up Period|Lost to Follow-up|1
2946449|NCT01332968|10143756|P6|Follow-Up Period|Lost to Follow-up|0
2946450|NCT01332968|10143757|P5|Follow-Up Period|Lost to Follow-up|0
2946451|NCT01332968|10143758|P4|Follow-Up Period|Lost to Follow-up|0
2946452|NCT01332968|10143759|P3|Follow-Up Period|Lost to Follow-up|0
2946453|NCT01332968|10143760|P2|Follow-Up Period|Lost to Follow-up|0
2946454|NCT01332968|10143761|P1|Follow-Up Period|Lost to Follow-up|0
2946455|NCT01332968|10143754|P8|Follow-Up Period|Withdrawal by Subject|2
2946456|NCT01332968|10143755|P7|Follow-Up Period|Withdrawal by Subject|1
2946457|NCT01332968|10143756|P6|Follow-Up Period|Withdrawal by Subject|0
2946458|NCT01332968|10143757|P5|Follow-Up Period|Withdrawal by Subject|0
2946459|NCT01332968|10143758|P4|Follow-Up Period|Withdrawal by Subject|0
2946460|NCT01332968|10143759|P3|Follow-Up Period|Withdrawal by Subject|0
2946461|NCT01332968|10143760|P2|Follow-Up Period|Withdrawal by Subject|0
2946462|NCT01332968|10143761|P1|Follow-Up Period|Withdrawal by Subject|0
2946463|NCT01332968|10143754|P8|Follow-Up Period|Follow-up ongoing|505
2946464|NCT01332968|10143755|P7|Follow-Up Period|Follow-up ongoing|502
2946465|NCT01332968|10143756|P6|Follow-Up Period|Follow-up ongoing|0
2946466|NCT01332968|10143757|P5|Follow-Up Period|Follow-up ongoing|0
2946467|NCT01332968|10143758|P4|Follow-Up Period|Follow-up ongoing|0
2946468|NCT01332968|10143759|P3|Follow-Up Period|Follow-up ongoing|0
2946469|NCT01332968|10143760|P2|Follow-Up Period|Follow-up ongoing|0
2946470|NCT01332968|10143761|P1|Follow-Up Period|Follow-up ongoing|0
2946471|NCT01332968|10143754|P8|Follow-Up Period|Death|22
2946472|NCT01332968|10143755|P7|Follow-Up Period|Death|38
2946473|NCT01332968|10143756|P6|Follow-Up Period|Death|0
2946474|NCT01332968|10143757|P5|Follow-Up Period|Death|0
2946475|NCT01332968|10143758|P4|Follow-Up Period|Death|0
2946476|NCT01332968|10143759|P3|Follow-Up Period|Death|0
2946477|NCT01332968|10143760|P2|Follow-Up Period|Death|0
2946478|NCT01332968|10143761|P1|Follow-Up Period|Death|0
2946479|NCT01332968|10143754|P8|Maintenance/Observation Period|Treatment ongoing|0
2946480|NCT01332968|10143755|P7|Maintenance/Observation Period|Treatment ongoing|0
2946481|NCT01332968|10143756|P6|Maintenance/Observation Period|Treatment ongoing|8
2946482|NCT01332968|10143757|P5|Maintenance/Observation Period|Treatment ongoing|10
2946483|NCT01332968|10143758|P4|Maintenance/Observation Period|Treatment ongoing|62
2946484|NCT01332968|10143759|P3|Maintenance/Observation Period|Treatment ongoing|54
2946485|NCT01332968|10143760|P2|Maintenance/Observation Period|Treatment ongoing|0
2946486|NCT01332968|10143761|P1|Maintenance/Observation Period|Treatment ongoing|0
2946487|NCT01332968|10143754|P8|Maintenance/Observation Period|Adverse Event|0
2946488|NCT01332968|10143755|P7|Maintenance/Observation Period|Adverse Event|0
2946489|NCT01332968|10143756|P6|Maintenance/Observation Period|Adverse Event|0
2946490|NCT01332968|10143757|P5|Maintenance/Observation Period|Adverse Event|0
2946491|NCT01332968|10143758|P4|Maintenance/Observation Period|Adverse Event|65
2946492|NCT01332968|10143759|P3|Maintenance/Observation Period|Adverse Event|50
2946493|NCT01332968|10143760|P2|Maintenance/Observation Period|Adverse Event|0
2946494|NCT01332968|10143761|P1|Maintenance/Observation Period|Adverse Event|0
2946495|NCT01332968|10143754|P8|Maintenance/Observation Period|Death|0
2946496|NCT01332968|10143755|P7|Maintenance/Observation Period|Death|0
2946497|NCT01332968|10143756|P6|Maintenance/Observation Period|Death|0
2946498|NCT01332968|10143757|P5|Maintenance/Observation Period|Death|0
2946499|NCT01332968|10143758|P4|Maintenance/Observation Period|Death|6
2946500|NCT01332968|10143759|P3|Maintenance/Observation Period|Death|5
2946501|NCT01332968|10143760|P2|Maintenance/Observation Period|Death|0
2946502|NCT01332968|10143761|P1|Maintenance/Observation Period|Death|0
2946503|NCT01332968|10143754|P8|Maintenance/Observation Period|Lost to Follow-up|0
2946504|NCT01332968|10143755|P7|Maintenance/Observation Period|Lost to Follow-up|0
2946505|NCT01332968|10143756|P6|Maintenance/Observation Period|Lost to Follow-up|0
2946506|NCT01332968|10143757|P5|Maintenance/Observation Period|Lost to Follow-up|0
2946507|NCT01332968|10143758|P4|Maintenance/Observation Period|Lost to Follow-up|2
2946508|NCT01332968|10143759|P3|Maintenance/Observation Period|Lost to Follow-up|1
2946509|NCT01332968|10143760|P2|Maintenance/Observation Period|Lost to Follow-up|0
2946510|NCT01332968|10143761|P1|Maintenance/Observation Period|Lost to Follow-up|0
2946511|NCT01332968|10143754|P8|Maintenance/Observation Period|Non-compliance|0
2946512|NCT01332968|10143755|P7|Maintenance/Observation Period|Non-compliance|0
2946513|NCT01332968|10143756|P6|Maintenance/Observation Period|Non-compliance|1
2946514|NCT01332968|10143757|P5|Maintenance/Observation Period|Non-compliance|0
2946515|NCT01332968|10143758|P4|Maintenance/Observation Period|Non-compliance|3
2946516|NCT01332968|10143759|P3|Maintenance/Observation Period|Non-compliance|2
2946517|NCT01332968|10143760|P2|Maintenance/Observation Period|Non-compliance|0
2946518|NCT01332968|10143761|P1|Maintenance/Observation Period|Non-compliance|0
2946519|NCT01332968|10143754|P8|Maintenance/Observation Period|Other|0
2946520|NCT01332968|10143755|P7|Maintenance/Observation Period|Other|0
2946521|NCT01332968|10143756|P6|Maintenance/Observation Period|Other|0
2946522|NCT01332968|10143757|P5|Maintenance/Observation Period|Other|0
2946523|NCT01332968|10143758|P4|Maintenance/Observation Period|Other|5
2946524|NCT01332968|10143759|P3|Maintenance/Observation Period|Other|4
2946525|NCT01332968|10143760|P2|Maintenance/Observation Period|Other|0
2946526|NCT01332968|10143761|P1|Maintenance/Observation Period|Other|0
2946527|NCT01332968|10143754|P8|Maintenance/Observation Period|Physician Decision|0
2946528|NCT01332968|10143755|P7|Maintenance/Observation Period|Physician Decision|0
2946529|NCT01332968|10143756|P6|Maintenance/Observation Period|Physician Decision|0
2946530|NCT01332968|10143757|P5|Maintenance/Observation Period|Physician Decision|0
2946531|NCT01332968|10143758|P4|Maintenance/Observation Period|Physician Decision|19
2946532|NCT01332968|10143759|P3|Maintenance/Observation Period|Physician Decision|14
2946533|NCT01332968|10143760|P2|Maintenance/Observation Period|Physician Decision|0
2946534|NCT01332968|10143761|P1|Maintenance/Observation Period|Physician Decision|0
2946535|NCT01332968|10143754|P8|Maintenance/Observation Period|Progressive disease|0
2946536|NCT01332968|10143755|P7|Maintenance/Observation Period|Progressive disease|0
2946537|NCT01332968|10143756|P6|Maintenance/Observation Period|Progressive disease|0
2946538|NCT01332968|10143757|P5|Maintenance/Observation Period|Progressive disease|0
2946539|NCT01332968|10143758|P4|Maintenance/Observation Period|Progressive disease|39
2946540|NCT01332968|10143759|P3|Maintenance/Observation Period|Progressive disease|72
2946541|NCT01332968|10143760|P2|Maintenance/Observation Period|Progressive disease|0
2946542|NCT01332968|10143761|P1|Maintenance/Observation Period|Progressive disease|0
2946543|NCT01332968|10143754|P8|Maintenance/Observation Period|Protocol Violation|0
2946544|NCT01332968|10143755|P7|Maintenance/Observation Period|Protocol Violation|0
2946545|NCT01332968|10143756|P6|Maintenance/Observation Period|Protocol Violation|0
2946546|NCT01332968|10143757|P5|Maintenance/Observation Period|Protocol Violation|0
2946633|NCT01332851|10143827|P2|Overall Study|Withdrawal by Subject|2
2946547|NCT01332968|10143758|P4|Maintenance/Observation Period|Protocol Violation|1
2946548|NCT01332968|10143759|P3|Maintenance/Observation Period|Protocol Violation|1
2946549|NCT01332968|10143760|P2|Maintenance/Observation Period|Protocol Violation|0
2946550|NCT01332968|10143761|P1|Maintenance/Observation Period|Protocol Violation|0
2946551|NCT01332968|10143754|P8|Maintenance/Observation Period|Withdrawal by Subject|0
2946552|NCT01332968|10143755|P7|Maintenance/Observation Period|Withdrawal by Subject|0
2946553|NCT01332968|10143756|P6|Maintenance/Observation Period|Withdrawal by Subject|0
2946554|NCT01332968|10143757|P5|Maintenance/Observation Period|Withdrawal by Subject|0
2946555|NCT01332968|10143758|P4|Maintenance/Observation Period|Withdrawal by Subject|5
2946556|NCT01332968|10143759|P3|Maintenance/Observation Period|Withdrawal by Subject|10
2946557|NCT01332968|10143760|P2|Maintenance/Observation Period|Withdrawal by Subject|0
2946558|NCT01332968|10143761|P1|Maintenance/Observation Period|Withdrawal by Subject|0
2946559|NCT01332968|10143754|P8|Induction Period|Randomized, but not treated|0
2946560|NCT01332968|10143755|P7|Induction Period|Randomized, but not treated|0
2946561|NCT01332968|10143756|P6|Induction Period|Randomized, but not treated|0
2946562|NCT01332968|10143757|P5|Induction Period|Randomized, but not treated|0
2946563|NCT01332968|10143758|P4|Induction Period|Randomized, but not treated|0
2946564|NCT01332968|10143759|P3|Induction Period|Randomized, but not treated|0
2946565|NCT01332968|10143760|P2|Induction Period|Randomized, but not treated|7
2946566|NCT01332968|10143761|P1|Induction Period|Randomized, but not treated|4
2946567|NCT01332968|10143754|P8|Induction Period|Adverse Event|0
2946568|NCT01332968|10143755|P7|Induction Period|Adverse Event|0
2946569|NCT01332968|10143756|P6|Induction Period|Adverse Event|0
2946570|NCT01332968|10143757|P5|Induction Period|Adverse Event|0
2946571|NCT01332968|10143758|P4|Induction Period|Adverse Event|0
2946572|NCT01332968|10143759|P3|Induction Period|Adverse Event|0
2946573|NCT01332968|10143760|P2|Induction Period|Adverse Event|26
2946574|NCT01332968|10143761|P1|Induction Period|Adverse Event|23
2946575|NCT01332968|10143754|P8|Induction Period|Death|0
2946576|NCT01332968|10143755|P7|Induction Period|Death|0
2946577|NCT01332968|10143756|P6|Induction Period|Death|0
2946578|NCT01332968|10143757|P5|Induction Period|Death|0
2946579|NCT01332968|10143758|P4|Induction Period|Death|0
2946580|NCT01332968|10143759|P3|Induction Period|Death|0
2946581|NCT01332968|10143760|P2|Induction Period|Death|4
2946582|NCT01332968|10143761|P1|Induction Period|Death|1
2946583|NCT01332968|10143754|P8|Induction Period|Non-compliance|0
2946584|NCT01332968|10143755|P7|Induction Period|Non-compliance|0
2946585|NCT01332968|10143756|P6|Induction Period|Non-compliance|0
2946586|NCT01332968|10143757|P5|Induction Period|Non-compliance|0
2946587|NCT01332968|10143758|P4|Induction Period|Non-compliance|0
2946588|NCT01332968|10143759|P3|Induction Period|Non-compliance|0
2946589|NCT01332968|10143760|P2|Induction Period|Non-compliance|0
2946590|NCT01332968|10143761|P1|Induction Period|Non-compliance|1
2946591|NCT01332968|10143754|P8|Induction Period|Other|0
2946592|NCT01332968|10143755|P7|Induction Period|Other|0
2946593|NCT01332968|10143756|P6|Induction Period|Other|0
2946594|NCT01332968|10143757|P5|Induction Period|Other|0
2946595|NCT01332968|10143758|P4|Induction Period|Other|0
2946596|NCT01332968|10143759|P3|Induction Period|Other|0
2946597|NCT01332968|10143760|P2|Induction Period|Other|2
2946598|NCT01332968|10143761|P1|Induction Period|Other|2
2946599|NCT01332968|10143754|P8|Induction Period|Physician Decision|0
2946600|NCT01332968|10143755|P7|Induction Period|Physician Decision|0
2946601|NCT01332968|10143756|P6|Induction Period|Physician Decision|0
2946602|NCT01332968|10143757|P5|Induction Period|Physician Decision|0
2946603|NCT01332968|10143758|P4|Induction Period|Physician Decision|0
2946604|NCT01332968|10143759|P3|Induction Period|Physician Decision|0
2946605|NCT01332968|10143760|P2|Induction Period|Physician Decision|1
2946606|NCT01332968|10143761|P1|Induction Period|Physician Decision|6
2946607|NCT01332968|10143754|P8|Induction Period|Progressive disease|0
2946608|NCT01332968|10143755|P7|Induction Period|Progressive disease|0
2946609|NCT01332968|10143756|P6|Induction Period|Progressive disease|0
2946610|NCT01332968|10143757|P5|Induction Period|Progressive disease|0
2946611|NCT01332968|10143758|P4|Induction Period|Progressive disease|0
2946612|NCT01332968|10143759|P3|Induction Period|Progressive disease|0
2946613|NCT01332968|10143760|P2|Induction Period|Progressive disease|7
2946614|NCT01332968|10143761|P1|Induction Period|Progressive disease|15
2946615|NCT01332968|10143754|P8|Induction Period|Protocol Violation|0
2946616|NCT01332968|10143755|P7|Induction Period|Protocol Violation|0
2946617|NCT01332968|10143756|P6|Induction Period|Protocol Violation|0
2946618|NCT01332968|10143757|P5|Induction Period|Protocol Violation|0
2946619|NCT01332968|10143758|P4|Induction Period|Protocol Violation|0
2946620|NCT01332968|10143759|P3|Induction Period|Protocol Violation|0
2946621|NCT01332968|10143760|P2|Induction Period|Protocol Violation|4
2946622|NCT01332968|10143761|P1|Induction Period|Protocol Violation|3
2946623|NCT01332968|10143754|P8|Induction Period|Withdrawal by Subject|0
2946624|NCT01332968|10143755|P7|Induction Period|Withdrawal by Subject|0
2946625|NCT01332968|10143756|P6|Induction Period|Withdrawal by Subject|0
2946626|NCT01332968|10143757|P5|Induction Period|Withdrawal by Subject|0
2946627|NCT01332968|10143758|P4|Induction Period|Withdrawal by Subject|0
2946628|NCT01332968|10143759|P3|Induction Period|Withdrawal by Subject|0
2946629|NCT01332968|10143760|P2|Induction Period|Withdrawal by Subject|5
2946630|NCT01332968|10143761|P1|Induction Period|Withdrawal by Subject|3
2946631|NCT01332851|10143827|P2|Overall Study|Lost to Follow-up|11
2946632|NCT01332851|10143828|P1|Overall Study|Lost to Follow-up|7
2946634|NCT01332851|10143828|P1|Overall Study|Withdrawal by Subject|4
2946635|NCT01332799|10143862|P2|Overall Study|Insufficient funding|10
2946636|NCT01332799|10143863|P1|Overall Study|Insufficient funding|10
2946637|NCT01332630|10143879|P1|Overall Study|Withdrawal by Subject|3
2946638|NCT01332331|10143995|P2|Overall Study|Physician Decision|0
2946639|NCT01332331|10143996|P1|Overall Study|Physician Decision|1
2946640|NCT01332331|10143995|P2|Overall Study|Adverse Event|1
2946641|NCT01332331|10143996|P1|Overall Study|Adverse Event|1
2946642|NCT01332331|10143995|P2|Overall Study|Lost to Follow-up|1
2946643|NCT01332331|10143996|P1|Overall Study|Lost to Follow-up|0
2946644|NCT01332318|10144048|P4|Overall Study|Protocol Violation|1
2946645|NCT01332318|10144049|P3|Overall Study|Protocol Violation|1
2946646|NCT01332318|10144050|P2|Overall Study|Protocol Violation|0
2946647|NCT01332318|10144051|P1|Overall Study|Protocol Violation|1
2946648|NCT01332318|10144048|P4|Overall Study|Withdrawal by Subject|1
2946649|NCT01332318|10144049|P3|Overall Study|Withdrawal by Subject|0
2946650|NCT01332318|10144050|P2|Overall Study|Withdrawal by Subject|1
2946651|NCT01332318|10144051|P1|Overall Study|Withdrawal by Subject|1
2946652|NCT01332318|10144048|P4|Overall Study|Adverse Event|0
2946653|NCT01332318|10144049|P3|Overall Study|Adverse Event|0
2946654|NCT01332318|10144050|P2|Overall Study|Adverse Event|3
2946655|NCT01332318|10144051|P1|Overall Study|Adverse Event|0
2946656|NCT01332305|10144162|P5|Overall Study|Physician Decision|0
2946657|NCT01332305|10144163|P4|Overall Study|Physician Decision|1
2946658|NCT01332305|10144164|P3|Overall Study|Physician Decision|0
2946659|NCT01332305|10144165|P2|Overall Study|Physician Decision|0
2946660|NCT01332305|10144166|P1|Overall Study|Physician Decision|0
2946661|NCT01332305|10144162|P5|Overall Study|Treatment Failure|0
2946662|NCT01332305|10144163|P4|Overall Study|Treatment Failure|0
2946663|NCT01332305|10144164|P3|Overall Study|Treatment Failure|0
2946664|NCT01332305|10144165|P2|Overall Study|Treatment Failure|1
2946665|NCT01332305|10144166|P1|Overall Study|Treatment Failure|1
2946666|NCT01332305|10144162|P5|Overall Study|Withdrawal by Sponsor|1
2946667|NCT01332305|10144163|P4|Overall Study|Withdrawal by Sponsor|1
2946668|NCT01332305|10144164|P3|Overall Study|Withdrawal by Sponsor|0
2946669|NCT01332305|10144165|P2|Overall Study|Withdrawal by Sponsor|0
2946670|NCT01332305|10144166|P1|Overall Study|Withdrawal by Sponsor|1
2946671|NCT01332305|10144162|P5|Overall Study|Protocol Violation|3
2946672|NCT01332305|10144163|P4|Overall Study|Protocol Violation|0
2946673|NCT01332305|10144164|P3|Overall Study|Protocol Violation|1
2946674|NCT01332305|10144165|P2|Overall Study|Protocol Violation|2
2946675|NCT01332305|10144166|P1|Overall Study|Protocol Violation|1
2946676|NCT01332305|10144162|P5|Overall Study|Lost to Follow-up|3
2946677|NCT01332305|10144163|P4|Overall Study|Lost to Follow-up|2
2946678|NCT01332305|10144164|P3|Overall Study|Lost to Follow-up|3
2946679|NCT01332305|10144165|P2|Overall Study|Lost to Follow-up|2
2946680|NCT01332305|10144166|P1|Overall Study|Lost to Follow-up|0
2946681|NCT01332305|10144162|P5|Overall Study|Withdrawal by Subject|0
2946682|NCT01332305|10144163|P4|Overall Study|Withdrawal by Subject|1
2946683|NCT01332305|10144164|P3|Overall Study|Withdrawal by Subject|4
2946684|NCT01332305|10144165|P2|Overall Study|Withdrawal by Subject|5
2946685|NCT01332305|10144166|P1|Overall Study|Withdrawal by Subject|6
2946686|NCT01332305|10144162|P5|Overall Study|Adverse Event|5
2946687|NCT01332305|10144163|P4|Overall Study|Adverse Event|3
2946688|NCT01332305|10144164|P3|Overall Study|Adverse Event|6
2946689|NCT01332305|10144165|P2|Overall Study|Adverse Event|4
2946690|NCT01332305|10144166|P1|Overall Study|Adverse Event|1
2946691|NCT01332292|10144188|P2|Treatment Period 2 (14 Days)|Physician Decision|1
2946692|NCT01332292|10144189|P1|Treatment Period 2 (14 Days)|Physician Decision|1
2946693|NCT01332292|10144188|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
2946694|NCT01332292|10144189|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
2946695|NCT01332292|10144188|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2946696|NCT01332292|10144189|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2946697|NCT01332227|10144280|P2|Overall Study|Patient began prohibited medication|1
2946698|NCT01332227|10144281|P1|Overall Study|Patient began prohibited medication|0
2946699|NCT01332227|10144280|P2|Overall Study|Patient moved from area|0
2946700|NCT01332227|10144281|P1|Overall Study|Patient moved from area|1
2946701|NCT01332227|10144280|P2|Overall Study|Poor compliance/noncompliance|1
2946702|NCT01332227|10144281|P1|Overall Study|Poor compliance/noncompliance|1
2946703|NCT01332227|10144280|P2|Overall Study|Lack of Efficacy|1
2946704|NCT01332227|10144281|P1|Overall Study|Lack of Efficacy|3
2946705|NCT01332227|10144280|P2|Overall Study|Lost to Follow-up|0
2946706|NCT01332227|10144281|P1|Overall Study|Lost to Follow-up|2
2946707|NCT01332227|10144280|P2|Overall Study|Withdrawal by Subject|1
2946708|NCT01332227|10144281|P1|Overall Study|Withdrawal by Subject|5
2946709|NCT01332227|10144280|P2|Overall Study|Adverse Event|1
2946710|NCT01332227|10144281|P1|Overall Study|Adverse Event|4
2946711|NCT01332149|10144462|P2|Overall Study|Randomized but not treated|2
2946712|NCT01332149|10144463|P1|Overall Study|Randomized but not treated|1
2946713|NCT01332149|10144462|P2|Overall Study|Did not meet entrance criteria|4
2946714|NCT01332149|10144463|P1|Overall Study|Did not meet entrance criteria|3
2946715|NCT01332149|10144462|P2|Overall Study|Insufficient clinical response|7
2946716|NCT01332149|10144463|P1|Overall Study|Insufficient clinical response|4
2946717|NCT01332149|10144462|P2|Overall Study|Lost to Follow-up|1
2946718|NCT01332149|10144463|P1|Overall Study|Lost to Follow-up|1
2946719|NCT01332149|10144462|P2|Overall Study|Withdrawal by Subject|5
2946720|NCT01332149|10144463|P1|Overall Study|Withdrawal by Subject|4
2946721|NCT01332149|10144462|P2|Overall Study|Protocol Violation|3
2946722|NCT01332149|10144463|P1|Overall Study|Protocol Violation|1
2946723|NCT01332149|10144462|P2|Overall Study|Other unspecified|7
2946724|NCT01332149|10144463|P1|Overall Study|Other unspecified|5
2946725|NCT01332149|10144462|P2|Overall Study|Adverse Event|9
2946726|NCT01332149|10144463|P1|Overall Study|Adverse Event|11
2946727|NCT01332019|10144541|P2|Overall Study|Adverse Event|22
2946728|NCT01332019|10144542|P1|Overall Study|Adverse Event|13
2946729|NCT01332019|10144541|P2|Overall Study|Lost to Follow-up|7
2946730|NCT01332019|10144542|P1|Overall Study|Lost to Follow-up|4
2946731|NCT01332019|10144541|P2|Overall Study|Withdrawal by Subject|71
2946732|NCT01332019|10144542|P1|Overall Study|Withdrawal by Subject|73
2946733|NCT01332019|10144541|P2|Overall Study|Physician Decision|3
2946734|NCT01332019|10144542|P1|Overall Study|Physician Decision|4
2946735|NCT01332019|10144541|P2|Overall Study|Death|1
2946736|NCT01332019|10144542|P1|Overall Study|Death|2
2946737|NCT01332019|10144541|P2|Overall Study|Other|18
2946738|NCT01332019|10144542|P1|Overall Study|Other|16
2946739|NCT01332019|10144541|P2|Overall Study|Was Not Dosed|0
2946740|NCT01332019|10144542|P1|Overall Study|Was Not Dosed|1
2946741|NCT01331837|10144626|P2|Overall Study|Withdrawal by Subject|16
2946742|NCT01331837|10144627|P1|Overall Study|Withdrawal by Subject|13
2946743|NCT01331837|10144626|P2|Overall Study|Info not recorded|16
2946744|NCT01331837|10144627|P1|Overall Study|Info not recorded|10
2946745|NCT01331837|10144626|P2|Overall Study|Lost to Follow-up|1
2946746|NCT01331837|10144627|P1|Overall Study|Lost to Follow-up|3
2946747|NCT01331837|10144626|P2|Overall Study|Death|34
2946748|NCT01331837|10144627|P1|Overall Study|Death|30
2946749|NCT01331824|10144667|P1|Overall Study|Withdrawal by Subject|1
2946750|NCT01331824|10144667|P1|Overall Study|Disease Progression|9
2946751|NCT01331824|10144667|P1|Overall Study|Death|1
2946752|NCT01331824|10144667|P1|Overall Study|Adverse Event|2
2946753|NCT01331681|10144702|P3|Overall Study|Not Received Study Treatment|2
2946754|NCT01331681|10144703|P2|Overall Study|Not Received Study Treatment|0
2946755|NCT01331681|10144704|P1|Overall Study|Not Received Study Treatment|0
2946756|NCT01331681|10144702|P3|Overall Study|Switching to other therapy|1
2946757|NCT01331681|10144703|P2|Overall Study|Switching to other therapy|0
2946758|NCT01331681|10144704|P1|Overall Study|Switching to other therapy|0
2946759|NCT01331681|10144702|P3|Overall Study|Sponsor decision|0
2946760|NCT01331681|10144703|P2|Overall Study|Sponsor decision|1
2946761|NCT01331681|10144704|P1|Overall Study|Sponsor decision|1
2946762|NCT01331681|10144702|P3|Overall Study|Therapeutic procedure required|0
2946763|NCT01331681|10144703|P2|Overall Study|Therapeutic procedure required|0
2946764|NCT01331681|10144704|P1|Overall Study|Therapeutic procedure required|1
2946765|NCT01331681|10144702|P3|Overall Study|Physician Decision|4
2946766|NCT01331681|10144703|P2|Overall Study|Physician Decision|0
2946767|NCT01331681|10144704|P1|Overall Study|Physician Decision|2
2946768|NCT01331681|10144702|P3|Overall Study|Lost to Follow-up|1
2946769|NCT01331681|10144703|P2|Overall Study|Lost to Follow-up|4
2946770|NCT01331681|10144704|P1|Overall Study|Lost to Follow-up|2
2946771|NCT01331681|10144702|P3|Overall Study|Protocol Violation|0
2946772|NCT01331681|10144703|P2|Overall Study|Protocol Violation|1
2946773|NCT01331681|10144704|P1|Overall Study|Protocol Violation|1
2946774|NCT01331681|10144702|P3|Overall Study|Withdrawal by Subject|15
2946775|NCT01331681|10144703|P2|Overall Study|Withdrawal by Subject|8
2946776|NCT01331681|10144704|P1|Overall Study|Withdrawal by Subject|12
2946777|NCT01331681|10144702|P3|Overall Study|Lack of Efficacy|0
2946778|NCT01331681|10144703|P2|Overall Study|Lack of Efficacy|1
2946779|NCT01331681|10144704|P1|Overall Study|Lack of Efficacy|0
2946780|NCT01331681|10144702|P3|Overall Study|Death|2
2946781|NCT01331681|10144703|P2|Overall Study|Death|6
2946782|NCT01331681|10144704|P1|Overall Study|Death|6
2946783|NCT01331681|10144702|P3|Overall Study|Adverse Event|10
2946784|NCT01331681|10144703|P2|Overall Study|Adverse Event|13
2946785|NCT01331681|10144704|P1|Overall Study|Adverse Event|10
2946786|NCT01331291|10144753|P2|Overall Study|Death|1
2946787|NCT01331291|10144754|P1|Overall Study|Death|0
2946788|NCT01331291|10144753|P2|Overall Study|Lack of Efficacy|8
2946789|NCT01331291|10144754|P1|Overall Study|Lack of Efficacy|2
2946790|NCT01331161|10144788|P2|Overall Study|Pregnancy|1
2946791|NCT01331161|10144789|P1|Overall Study|Pregnancy|0
2946792|NCT01331161|10144788|P2|Overall Study|Lost to Follow-up|1
2946793|NCT01331161|10144789|P1|Overall Study|Lost to Follow-up|0
2946794|NCT01331161|10144788|P2|Overall Study|Physician Decision|0
2946795|NCT01331161|10144789|P1|Overall Study|Physician Decision|1
2946796|NCT01331109|10144797|P1|Overall Study|Study Terminated by Sponsor|38
2946797|NCT01331109|10144797|P1|Overall Study|Lost to Follow-up|1
2946798|NCT01331109|10144797|P1|Overall Study|Withdrawal by Subject|7
2946799|NCT01331109|10144797|P1|Overall Study|Protocol Violation|3
2946800|NCT01331109|10144797|P1|Overall Study|Lack of Efficacy|2
2946801|NCT01331109|10144797|P1|Overall Study|Adverse Event|6
2946802|NCT01331005|10144824|P2|Overall Study|Withdrawal by Subject|3
2946803|NCT01331005|10144825|P1|Overall Study|Withdrawal by Subject|2
2946804|NCT01331005|10144824|P2|Overall Study|Lost to Follow-up|1
2946805|NCT01331005|10144825|P1|Overall Study|Lost to Follow-up|2
2946806|NCT01330914|10144896|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
2946807|NCT01330914|10144896|P1|Overall Study|Withdrawal by Subject|4
2946808|NCT01330628|10144904|P2|Overall Study|Didn't receive study treatment|0
2946809|NCT01330628|10144905|P1|Overall Study|Didn't receive study treatment|1
2946810|NCT01330628|10144904|P2|Overall Study|Withdrawn|6
2946811|NCT01330628|10144905|P1|Overall Study|Withdrawn|18
2946812|NCT01330628|10144904|P2|Overall Study|Adverse Event|25
2946813|NCT01330628|10144905|P1|Overall Study|Adverse Event|44
2946814|NCT01330628|10144904|P2|Overall Study|Lost to Follow-up|6
2946815|NCT01330628|10144905|P1|Overall Study|Lost to Follow-up|5
2946816|NCT01330628|10144904|P2|Overall Study|Death|3
2946817|NCT01330628|10144905|P1|Overall Study|Death|2
2946818|NCT01330459|10144915|P2|Overall Study|Physician Decision|2
2946819|NCT01330459|10144916|P1|Overall Study|Physician Decision|0
2946820|NCT01330433|10144932|P2|Overall Study|Lost to Follow-up|0
2946821|NCT01330433|10144933|P1|Overall Study|Lost to Follow-up|1
2946822|NCT01330433|10144932|P2|Overall Study|Death|3
2946823|NCT01330433|10144933|P1|Overall Study|Death|1
2946824|NCT01330381|10144972|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
2946825|NCT01330381|10144973|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2946826|NCT01330381|10144974|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2946827|NCT01330381|10144972|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2946828|NCT01330381|10144973|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
2946829|NCT01330381|10144974|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2946830|NCT01330381|10144972|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2946831|NCT01330381|10144973|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2946832|NCT01330381|10144974|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
2946833|NCT01330381|10144972|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
2946834|NCT01330381|10144973|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
2946835|NCT01330381|10144974|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
2946836|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
2946837|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2946838|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2946839|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2946840|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2946841|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
2946842|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2946843|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2946844|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
2946845|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
2946846|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2946847|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2946848|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
2946849|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
2946850|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
2946851|NCT01330381|10144972|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
2946852|NCT01330381|10144973|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
2946853|NCT01330381|10144974|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
2946854|NCT01330316|10145035|P2|Overall Study|other than above|1
2946855|NCT01330316|10145036|P1|Overall Study|other than above|0
2946856|NCT01330316|10145035|P2|Overall Study|Withdrawal by Subject|1
2946857|NCT01330316|10145036|P1|Overall Study|Withdrawal by Subject|0
2946858|NCT01330316|10145035|P2|Overall Study|Lost to Follow-up|1
2946859|NCT01330316|10145036|P1|Overall Study|Lost to Follow-up|0
2946860|NCT01330316|10145035|P2|Overall Study|Lack of Efficacy|10
2946861|NCT01330316|10145036|P1|Overall Study|Lack of Efficacy|0
2946862|NCT01330316|10145035|P2|Overall Study|Adverse Event|2
2946863|NCT01330316|10145036|P1|Overall Study|Adverse Event|2
2946864|NCT01330303|10145072|P2|Period 1|Withdrawal by Subject|1
2946865|NCT01330303|10145073|P1|Period 1|Withdrawal by Subject|0
2946866|NCT01330303|10145072|P2|Period 1|Protocol Violation|1
2946867|NCT01330303|10145073|P1|Period 1|Protocol Violation|0
2946868|NCT01330303|10145072|P2|Period 1|Adverse Event|0
2946869|NCT01330303|10145073|P1|Period 1|Adverse Event|1
2946870|NCT01330108|10145120|P1|Overall Study|Withdrawal by Subject|4
2946871|NCT01330030|10145138|P2|Overall Study|Lost to Follow-up|17
2946872|NCT01330030|10145139|P1|Overall Study|Lost to Follow-up|16
2946873|NCT01330017|10145150|P5|Overall Study|Unknown Reason|2
2946874|NCT01330017|10145151|P4|Overall Study|Unknown Reason|7
2946875|NCT01330017|10145152|P3|Overall Study|Unknown Reason|5
2946876|NCT01330017|10145153|P2|Overall Study|Unknown Reason|3
2946877|NCT01330017|10145154|P1|Overall Study|Unknown Reason|5
2946878|NCT01330017|10145150|P5|Overall Study|Protocol Violation|0
2946879|NCT01330017|10145151|P4|Overall Study|Protocol Violation|1
2946880|NCT01330017|10145152|P3|Overall Study|Protocol Violation|0
2946881|NCT01330017|10145153|P2|Overall Study|Protocol Violation|0
2946882|NCT01330017|10145154|P1|Overall Study|Protocol Violation|0
2946883|NCT01330017|10145150|P5|Overall Study|Lost to Follow-up|0
2946884|NCT01330017|10145151|P4|Overall Study|Lost to Follow-up|0
2946885|NCT01330017|10145152|P3|Overall Study|Lost to Follow-up|1
2946886|NCT01330017|10145153|P2|Overall Study|Lost to Follow-up|0
2946887|NCT01330017|10145154|P1|Overall Study|Lost to Follow-up|0
2946888|NCT01330017|10145150|P5|Overall Study|Withdrawal by Subject|1
2946889|NCT01330017|10145151|P4|Overall Study|Withdrawal by Subject|0
2946890|NCT01330017|10145152|P3|Overall Study|Withdrawal by Subject|1
2946891|NCT01330017|10145153|P2|Overall Study|Withdrawal by Subject|0
2946892|NCT01330017|10145154|P1|Overall Study|Withdrawal by Subject|0
2946893|NCT01330017|10145150|P5|Overall Study|Adverse Event|0
2946894|NCT01330017|10145151|P4|Overall Study|Adverse Event|4
2946895|NCT01330017|10145152|P3|Overall Study|Adverse Event|1
2946896|NCT01330017|10145153|P2|Overall Study|Adverse Event|1
2946897|NCT01330017|10145154|P1|Overall Study|Adverse Event|0
2946898|NCT01329978|10145203|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
2946899|NCT01329978|10145204|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
2946900|NCT01329978|10145205|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
2946901|NCT01329978|10145206|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
2946902|NCT01329978|10145207|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
2946903|NCT01329978|10145203|P5|Rerandomization Treatment Period|Lost to Follow-up|3
2946904|NCT01329978|10145204|P4|Rerandomization Treatment Period|Lost to Follow-up|5
2946905|NCT01329978|10145205|P3|Rerandomization Treatment Period|Lost to Follow-up|0
2946906|NCT01329978|10145206|P2|Rerandomization Treatment Period|Lost to Follow-up|0
2946907|NCT01329978|10145207|P1|Rerandomization Treatment Period|Lost to Follow-up|0
2946908|NCT01329978|10145203|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2946909|NCT01329978|10145204|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2946910|NCT01329978|10145205|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2946911|NCT01329978|10145206|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
2946912|NCT01329978|10145207|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2946913|NCT01329978|10145203|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2946914|NCT01329978|10145204|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2946915|NCT01329978|10145205|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2946916|NCT01329978|10145206|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
2946917|NCT01329978|10145207|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2946918|NCT01329978|10145203|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2946919|NCT01329978|10145204|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2946920|NCT01329978|10145205|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
2946921|NCT01329978|10145206|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2946922|NCT01329978|10145207|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2946923|NCT01329978|10145203|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2946924|NCT01329978|10145204|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2946925|NCT01329978|10145205|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2946926|NCT01329978|10145206|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
2946927|NCT01329978|10145207|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2946928|NCT01329978|10145203|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2946929|NCT01329978|10145204|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2946930|NCT01329978|10145205|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2946931|NCT01329978|10145206|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
2946932|NCT01329978|10145207|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
2946933|NCT01329939|10145281|P4|Overall Study|Adverse Event|3
2946934|NCT01329939|10145282|P3|Overall Study|Adverse Event|0
2946935|NCT01329939|10145283|P2|Overall Study|Adverse Event|0
2946936|NCT01329939|10145284|P1|Overall Study|Adverse Event|0
2946937|NCT01329939|10145281|P4|Overall Study|Withdrawal by Subject|0
2946938|NCT01329939|10145282|P3|Overall Study|Withdrawal by Subject|0
2946939|NCT01329939|10145283|P2|Overall Study|Withdrawal by Subject|1
2946940|NCT01329939|10145284|P1|Overall Study|Withdrawal by Subject|0
2946941|NCT01329939|10145281|P4|Overall Study|Lost to Follow-up|2
2946942|NCT01329939|10145282|P3|Overall Study|Lost to Follow-up|1
2946943|NCT01329939|10145283|P2|Overall Study|Lost to Follow-up|0
2946944|NCT01329939|10145284|P1|Overall Study|Lost to Follow-up|3
2946945|NCT01329562|10145348|P2|Overall Study|Physician Decision|1
2946946|NCT01329562|10145349|P1|Overall Study|Physician Decision|0
2946947|NCT01329562|10145348|P2|Overall Study|Subject withdrew due to personal issues.|2
2946948|NCT01329562|10145349|P1|Overall Study|Subject withdrew due to personal issues.|3
2946949|NCT01329562|10145348|P2|Overall Study|Lost to Follow-up|1
2946950|NCT01329562|10145349|P1|Overall Study|Lost to Follow-up|1
2946951|NCT01329562|10145348|P2|Overall Study|Protocol Violation|3
2946952|NCT01329562|10145349|P1|Overall Study|Protocol Violation|5
2946953|NCT01329549|10145398|P1|Overall Study|Adverse Event|1
2946954|NCT01329549|10145398|P1|Overall Study|Withdrawal by Subject|1
2946955|NCT01329419|10145409|P1|Overall Study|Protocol Violation|235
2946956|NCT01329263|10145427|P2|Overall Study|Withdrawal by Subject|2
2946957|NCT01329263|10145428|P1|Overall Study|Withdrawal by Subject|1
2946958|NCT01329263|10145427|P2|Overall Study|Lost to Follow-up|21
2946959|NCT01329263|10145428|P1|Overall Study|Lost to Follow-up|4
2946960|NCT01329029|10145465|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
2946961|NCT01329029|10145466|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
2946962|NCT01329029|10145465|P2|Overall Study|Lost to Follow-up|5
2946963|NCT01329029|10145466|P1|Overall Study|Lost to Follow-up|8
2946964|NCT01329029|10145465|P2|Overall Study|Physician Decision|13
2946965|NCT01329029|10145466|P1|Overall Study|Physician Decision|16
2946966|NCT01329029|10145465|P2|Overall Study|COPD Exacerbation|18
2946967|NCT01329029|10145466|P1|Overall Study|COPD Exacerbation|11
2946968|NCT01329029|10145465|P2|Overall Study|Other|20
2946969|NCT01329029|10145466|P1|Overall Study|Other|14
2946970|NCT01329029|10145465|P2|Overall Study|Death|19
2946971|NCT01329029|10145466|P1|Overall Study|Death|16
2946972|NCT01329029|10145465|P2|Overall Study|Adverse Event|29
2946973|NCT01329029|10145466|P1|Overall Study|Adverse Event|82
2946974|NCT01329029|10145465|P2|Overall Study|Withdrawal by Subject|87
2946975|NCT01329029|10145466|P1|Overall Study|Withdrawal by Subject|117
2946976|NCT01328951|10145556|P2|Overall Study|Other|6
2946977|NCT01328951|10145557|P1|Overall Study|Other|11
2946978|NCT01328951|10145556|P2|Overall Study|Study Closed by the Sponsor|31
2946979|NCT01328951|10145557|P1|Overall Study|Study Closed by the Sponsor|36
2946980|NCT01328951|10145556|P2|Overall Study|Withdrawal by Subject|6
2946981|NCT01328951|10145557|P1|Overall Study|Withdrawal by Subject|6
2946982|NCT01328951|10145556|P2|Overall Study|Lost to Follow-up|7
2946983|NCT01328951|10145557|P1|Overall Study|Lost to Follow-up|6
2946984|NCT01328951|10145556|P2|Overall Study|Death|258
2946985|NCT01328951|10145557|P1|Overall Study|Death|243
2946986|NCT01328951|10145556|P2|Overall Study|Adverse Event|0
2946987|NCT01328951|10145557|P1|Overall Study|Adverse Event|2
2946988|NCT01328951|10145556|P2|Overall Study|Disease Progression|14
2946989|NCT01328951|10145557|P1|Overall Study|Disease Progression|17
2946990|NCT01328756|10145626|P1|Overall Study|Other|29
2946991|NCT01328756|10145626|P1|Overall Study|Lost to Follow-up|5
2946992|NCT01328756|10145626|P1|Overall Study|Withdrawal by Subject|41
2946993|NCT01328756|10145626|P1|Overall Study|Lack of Efficacy|5
2946994|NCT01328756|10145626|P1|Overall Study|Adverse Event|39
2946995|NCT01328756|10145626|P1|Overall Study|Protocol Violation|4
2946996|NCT01328717|10145662|P1|Overall Study|Adverse Event|1
2946997|NCT01328574|10145671|P1|Overall Study|Refused further treatment|1
2946998|NCT01328548|10145685|P2|Overall Study|Protocol Violation|0
2946999|NCT01328548|10145686|P1|Overall Study|Protocol Violation|1
2947000|NCT01328548|10145685|P2|Overall Study|Death|0
2947001|NCT01328548|10145686|P1|Overall Study|Death|3
2947002|NCT01328535|10145704|P1|Overall Study|Ineligible|1
2947003|NCT01328496|10145715|P2|Overall Study|Significant Change in Health Status|0
2947004|NCT01328496|10145716|P1|Overall Study|Significant Change in Health Status|1
2947005|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2947006|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2947007|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947008|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947009|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947010|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947011|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2947012|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2947013|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2947014|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2947015|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947016|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947017|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2947018|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2947019|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2947020|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2947021|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2947022|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2947023|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2947024|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2947025|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2947026|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2947027|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2947028|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2947029|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
2947030|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2947031|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2947032|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2947033|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2947034|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
2947035|NCT01328444|10145734|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
2947036|NCT01328444|10145735|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947037|NCT01328444|10145736|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947038|NCT01328444|10145737|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947039|NCT01328444|10145738|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
2947040|NCT01328444|10145739|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
2947041|NCT01328444|10145734|P6|Washout Period (14 Days)|Withdrawal by Subject|1
2947042|NCT01328444|10145735|P5|Washout Period (14 Days)|Withdrawal by Subject|0
2947043|NCT01328444|10145736|P4|Washout Period (14 Days)|Withdrawal by Subject|0
2947044|NCT01328444|10145737|P3|Washout Period (14 Days)|Withdrawal by Subject|0
2947045|NCT01328444|10145738|P2|Washout Period (14 Days)|Withdrawal by Subject|0
2947046|NCT01328444|10145739|P1|Washout Period (14 Days)|Withdrawal by Subject|0
2947047|NCT01328444|10145734|P6|Washout Period (14 Days)|Lack of Efficacy|1
2947048|NCT01328444|10145735|P5|Washout Period (14 Days)|Lack of Efficacy|0
2947049|NCT01328444|10145736|P4|Washout Period (14 Days)|Lack of Efficacy|0
2947050|NCT01328444|10145737|P3|Washout Period (14 Days)|Lack of Efficacy|0
2947051|NCT01328444|10145738|P2|Washout Period (14 Days)|Lack of Efficacy|0
2947052|NCT01328444|10145739|P1|Washout Period (14 Days)|Lack of Efficacy|0
2947053|NCT01328444|10145734|P6|Washout Period (14 Days)|Adverse Event|2
2947054|NCT01328444|10145735|P5|Washout Period (14 Days)|Adverse Event|1
2947055|NCT01328444|10145736|P4|Washout Period (14 Days)|Adverse Event|1
2947056|NCT01328444|10145737|P3|Washout Period (14 Days)|Adverse Event|0
2947057|NCT01328444|10145738|P2|Washout Period (14 Days)|Adverse Event|1
2947058|NCT01328444|10145739|P1|Washout Period (14 Days)|Adverse Event|1
2947059|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2947060|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2947061|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2947062|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2947063|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2947064|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2947065|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2947066|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947067|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2947068|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947069|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947070|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
2947071|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2947072|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
2947073|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2947074|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2947075|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
2947076|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2947077|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2947078|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2947079|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2947080|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2947081|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2947082|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2947083|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2947084|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2947085|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2947086|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2947087|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2947088|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2947089|NCT01328444|10145734|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
2947090|NCT01328444|10145735|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
2947091|NCT01328444|10145736|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
2947092|NCT01328444|10145737|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
2947093|NCT01328444|10145738|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
2947094|NCT01328444|10145739|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
2947095|NCT01328431|10145785|P2|12 Month (12M)|Lost to Follow-up|91
2947096|NCT01328431|10145786|P1|12 Month (12M)|Lost to Follow-up|82
2947097|NCT01328431|10145785|P2|12 Month (12M)|Death|6
2947098|NCT01328431|10145786|P1|12 Month (12M)|Death|2
2947099|NCT01328431|10145785|P2|3 Month (3M)|Lost to Follow-up|70
2947100|NCT01328431|10145786|P1|3 Month (3M)|Lost to Follow-up|75
2947101|NCT01328431|10145785|P2|3 Month (3M)|Death|2
2947102|NCT01328431|10145786|P1|3 Month (3M)|Death|2
2947103|NCT01328431|10145785|P2|1 Month (1M)|Lost to Follow-up|58
2947104|NCT01328431|10145786|P1|1 Month (1M)|Lost to Follow-up|55
2947105|NCT01328431|10145785|P2|Baseline|Protocol Violation|2
2947106|NCT01328431|10145786|P1|Baseline|Protocol Violation|0
2947107|NCT01328366|10145842|P1|Overall Study|Lost to Follow-up|7
2947108|NCT01328366|10145842|P1|Overall Study|Withdrawal by Subject|2
2947109|NCT01328366|10145842|P1|Overall Study|Death|1
2947110|NCT01328249|10145862|P2|Overall Study|Protocol Violation|1
2947111|NCT01328249|10145863|P1|Overall Study|Protocol Violation|0
2947112|NCT01328249|10145862|P2|Overall Study|Subject choice|1
2947113|NCT01328249|10145863|P1|Overall Study|Subject choice|1
2947114|NCT01328249|10145862|P2|Overall Study|Moved before end of treatment visit|0
2947115|NCT01328249|10145863|P1|Overall Study|Moved before end of treatment visit|1
2947116|NCT01328249|10145862|P2|Overall Study|Withdrawal by Subject|1
2947117|NCT01328249|10145863|P1|Overall Study|Withdrawal by Subject|1
2947118|NCT01328249|10145862|P2|Overall Study|Disease progression|0
2947119|NCT01328249|10145863|P1|Overall Study|Disease progression|1
2947120|NCT01328249|10145862|P2|Overall Study|Adverse Event|0
2947121|NCT01328249|10145863|P1|Overall Study|Adverse Event|3
2947122|NCT01328080|10145949|P1|Overall Study|Lost to Follow-up|5
2947123|NCT01328054|10145953|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
2947124|NCT01328054|10145954|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
2947125|NCT01328054|10145953|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
2947126|NCT01328054|10145954|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
2947127|NCT01328054|10145953|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
2947128|NCT01328054|10145954|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
2947129|NCT01328041|10145979|P1|Overall Study|Withdrawal by Subject|7
2947130|NCT01328041|10145979|P1|Overall Study|Physician Decision|2
2947131|NCT01328041|10145979|P1|Overall Study|Lost to Follow-up|7
2947132|NCT01328041|10145979|P1|Overall Study|Protocol Violation|7
2947133|NCT01328041|10145979|P1|Overall Study|Lack of Efficacy|27
2947134|NCT01328041|10145979|P1|Overall Study|Adverse Event|7
2947135|NCT01328002|10146001|P2|Double-Blind Period|Lack of Efficacy|0
2947136|NCT01328002|10146002|P1|Double-Blind Period|Lack of Efficacy|1
2947137|NCT01328002|10146001|P2|Double-Blind Period|Adverse Event|0
2947138|NCT01328002|10146002|P1|Double-Blind Period|Adverse Event|1
2947139|NCT01328002|10146001|P2|Open-Label Period|Other Reason|0
2947140|NCT01328002|10146002|P1|Open-Label Period|Other Reason|2
2947141|NCT01328002|10146001|P2|Open-Label Period|Lost to Follow-up|0
2947142|NCT01328002|10146002|P1|Open-Label Period|Lost to Follow-up|6
2947143|NCT01328002|10146001|P2|Open-Label Period|Withdrawal by Subject|0
2947144|NCT01328002|10146002|P1|Open-Label Period|Withdrawal by Subject|9
2947145|NCT01328002|10146001|P2|Open-Label Period|Protocol Violation|0
2947146|NCT01328002|10146002|P1|Open-Label Period|Protocol Violation|2
2947147|NCT01328002|10146001|P2|Open-Label Period|Lack of Efficacy|0
2947148|NCT01328002|10146002|P1|Open-Label Period|Lack of Efficacy|3
2947149|NCT01328002|10146001|P2|Open-Label Period|Adverse Event|0
2947150|NCT01328002|10146002|P1|Open-Label Period|Adverse Event|8
2947151|NCT01328002|10146001|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
2947152|NCT01328002|10146002|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
2947153|NCT01327885|10146038|P2|Overall Study|Ongoing|1
2947154|NCT01327885|10146039|P1|Overall Study|Ongoing|1
2947155|NCT01327885|10146038|P2|Overall Study|Not treated|1
2947156|NCT01327885|10146039|P1|Overall Study|Not treated|1
2947157|NCT01327885|10146038|P2|Overall Study|Withdrawal of consent from study|4
2947158|NCT01327885|10146039|P1|Overall Study|Withdrawal of consent from study|2
2947159|NCT01327885|10146038|P2|Overall Study|Other|6
2947160|NCT01327885|10146039|P1|Overall Study|Other|8
2947161|NCT01327885|10146038|P2|Overall Study|Subject choice|10
2947162|NCT01327885|10146039|P1|Overall Study|Subject choice|5
2947163|NCT01327885|10146038|P2|Overall Study|Adverse Event|10
2947164|NCT01327885|10146039|P1|Overall Study|Adverse Event|14
2947165|NCT01327885|10146038|P2|Overall Study|Clinical progression|27
2947166|NCT01327885|10146039|P1|Overall Study|Clinical progression|24
2947167|NCT01327885|10146038|P2|Overall Study|Disease progression-according to RECIST|165
2947168|NCT01327885|10146039|P1|Overall Study|Disease progression-according to RECIST|173
2947169|NCT01327846|10146055|P4|Extension Phase|Technical Problems|2
2947170|NCT01327846|10146056|P3|Extension Phase|Technical Problems|2
2947171|NCT01327846|10146057|P2|Extension Phase|Technical Problems|4
2947172|NCT01327846|10146058|P1|Extension Phase|Technical Problems|2
2947173|NCT01327846|10146055|P4|Extension Phase|Lost to Follow-up|7
2947174|NCT01327846|10146056|P3|Extension Phase|Lost to Follow-up|4
2947175|NCT01327846|10146057|P2|Extension Phase|Lost to Follow-up|3
2947176|NCT01327846|10146058|P1|Extension Phase|Lost to Follow-up|4
2947177|NCT01327846|10146055|P4|Extension Phase|Withdrawal by Subject|37
2947178|NCT01327846|10146056|P3|Extension Phase|Withdrawal by Subject|19
2947179|NCT01327846|10146057|P2|Extension Phase|Withdrawal by Subject|13
2947180|NCT01327846|10146058|P1|Extension Phase|Withdrawal by Subject|20
2947181|NCT01327846|10146055|P4|Extension Phase|Study terminated by sponsor|1660
2947182|NCT01327846|10146056|P3|Extension Phase|Study terminated by sponsor|1067
2947183|NCT01327846|10146057|P2|Extension Phase|Study terminated by sponsor|1124
2947184|NCT01327846|10146058|P1|Extension Phase|Study terminated by sponsor|1073
2947185|NCT01327846|10146055|P4|Core Phase|Lost to Follow-up|5
2947186|NCT01327846|10146056|P3|Core Phase|Lost to Follow-up|4
2947187|NCT01327846|10146057|P2|Core Phase|Lost to Follow-up|3
2947188|NCT01327846|10146058|P1|Core Phase|Lost to Follow-up|3
2947189|NCT01327846|10146055|P4|Core Phase|Subject decision (vital stat: alive)|20
2947190|NCT01327846|10146056|P3|Core Phase|Subject decision (vital stat: alive)|13
2947191|NCT01327846|10146057|P2|Core Phase|Subject decision (vital stat: alive)|24
2947192|NCT01327846|10146058|P1|Core Phase|Subject decision (vital stat: alive)|23
2947193|NCT01327846|10146055|P4|Core Phase|Subject decision (vital stat: dead)|4
2947194|NCT01327846|10146056|P3|Core Phase|Subject decision (vital stat: dead)|4
2947195|NCT01327846|10146057|P2|Core Phase|Subject decision (vital stat: dead)|3
2947196|NCT01327846|10146058|P1|Core Phase|Subject decision (vital stat: dead)|1
2947197|NCT01327846|10146055|P4|Core Phase|Subject decision (vital stat: unkn)|3
2947198|NCT01327846|10146056|P3|Core Phase|Subject decision (vital stat: unkn)|3
2947199|NCT01327846|10146057|P2|Core Phase|Subject decision (vital stat: unkn)|0
2947200|NCT01327846|10146058|P1|Core Phase|Subject decision (vital stat: unkn)|0
2947201|NCT01327846|10146055|P4|Core Phase|Subject decision (vital status: missing)|1
2947202|NCT01327846|10146056|P3|Core Phase|Subject decision (vital status: missing)|2
2947203|NCT01327846|10146057|P2|Core Phase|Subject decision (vital status: missing)|2
2947204|NCT01327846|10146058|P1|Core Phase|Subject decision (vital status: missing)|1
2947205|NCT01327703|10146133|P2|Second Treatment Period|Protocol Violation|1
2947206|NCT01327703|10146134|P1|Second Treatment Period|Protocol Violation|0
2947207|NCT01327703|10146133|P2|Second Treatment Period|Adverse Event|1
2947208|NCT01327703|10146134|P1|Second Treatment Period|Adverse Event|1
2947209|NCT01327651|10146190|P9|Post Study Follow-up|Lost to Follow-up|2
2947210|NCT01327651|10146191|P8|Post Study Follow-up|Lost to Follow-up|1
2947211|NCT01327651|10146192|P7|Post Study Follow-up|Lost to Follow-up|4
2947212|NCT01327651|10146193|P6|Post Study Follow-up|Lost to Follow-up|0
2947213|NCT01327651|10146194|P5|Post Study Follow-up|Lost to Follow-up|0
2947214|NCT01327651|10146195|P4|Post Study Follow-up|Lost to Follow-up|0
2947215|NCT01327651|10146196|P3|Post Study Follow-up|Lost to Follow-up|1
2947216|NCT01327651|10146197|P2|Post Study Follow-up|Lost to Follow-up|1
2947217|NCT01327651|10146198|P1|Post Study Follow-up|Lost to Follow-up|0
2947218|NCT01327651|10146190|P9|Self-administered Dosing Period|Withdrawal by Subject|1
2947219|NCT01327651|10146191|P8|Self-administered Dosing Period|Withdrawal by Subject|1
2947220|NCT01327651|10146192|P7|Self-administered Dosing Period|Withdrawal by Subject|2
2947221|NCT01327651|10146193|P6|Self-administered Dosing Period|Withdrawal by Subject|0
2947222|NCT01327651|10146194|P5|Self-administered Dosing Period|Withdrawal by Subject|0
2947223|NCT01327651|10146195|P4|Self-administered Dosing Period|Withdrawal by Subject|1
2947224|NCT01327651|10146196|P3|Self-administered Dosing Period|Withdrawal by Subject|0
2947225|NCT01327651|10146197|P2|Self-administered Dosing Period|Withdrawal by Subject|1
2947226|NCT01327651|10146198|P1|Self-administered Dosing Period|Withdrawal by Subject|0
2947227|NCT01327651|10146190|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947228|NCT01327651|10146191|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947229|NCT01327651|10146192|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947230|NCT01327651|10146193|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947231|NCT01327651|10146194|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947232|NCT01327651|10146195|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947233|NCT01327651|10146196|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947234|NCT01327651|10146197|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
2947235|NCT01327651|10146198|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
2947236|NCT01327651|10146190|P9|Self-administered Dosing Period|Lost to Follow-up|10
2947237|NCT01327651|10146191|P8|Self-administered Dosing Period|Lost to Follow-up|9
2947238|NCT01327651|10146192|P7|Self-administered Dosing Period|Lost to Follow-up|8
2947239|NCT01327651|10146193|P6|Self-administered Dosing Period|Lost to Follow-up|0
2947240|NCT01327651|10146194|P5|Self-administered Dosing Period|Lost to Follow-up|3
2947241|NCT01327651|10146195|P4|Self-administered Dosing Period|Lost to Follow-up|2
2947242|NCT01327651|10146196|P3|Self-administered Dosing Period|Lost to Follow-up|4
2947243|NCT01327651|10146197|P2|Self-administered Dosing Period|Lost to Follow-up|2
2947244|NCT01327651|10146198|P1|Self-administered Dosing Period|Lost to Follow-up|3
2947245|NCT01327599|10146317|P1|Overall Study|Withdrawal of Consent|1
2947246|NCT01327599|10146317|P1|Overall Study|Could Not Attend Visit|1
2947247|NCT01327599|10146317|P1|Overall Study|Adverse Event|1
2947248|NCT01327573|10146327|P2|Overall Study|Physician Decision|1
2947249|NCT01327573|10146328|P1|Overall Study|Physician Decision|3
2947250|NCT01327547|10146339|P2|Overall Study|By investigator in subject’s interest|1
2947251|NCT01327547|10146340|P1|Overall Study|By investigator in subject’s interest|0
2947252|NCT01327547|10146339|P2|Overall Study|Non-compliance with study procedures|0
2947253|NCT01327547|10146340|P1|Overall Study|Non-compliance with study procedures|1
2947254|NCT01327547|10146339|P2|Overall Study|Required prohibited medication|0
2947255|NCT01327547|10146340|P1|Overall Study|Required prohibited medication|2
2947256|NCT01327547|10146339|P2|Overall Study|Non-compliance due to alcohol intake|1
2947257|NCT01327547|10146340|P1|Overall Study|Non-compliance due to alcohol intake|0
2947258|NCT01327547|10146339|P2|Overall Study|Protocol Violation|0
2947259|NCT01327547|10146340|P1|Overall Study|Protocol Violation|1
2947260|NCT01327547|10146339|P2|Overall Study|Does Not Meet Entrance Criteria|2
2947261|NCT01327547|10146340|P1|Overall Study|Does Not Meet Entrance Criteria|2
2947262|NCT01327547|10146339|P2|Overall Study|Withdrawal by Subject|7
2947263|NCT01327547|10146340|P1|Overall Study|Withdrawal by Subject|3
2947264|NCT01327547|10146339|P2|Overall Study|Non-Compliance With Study Treatment|2
2947265|NCT01327547|10146340|P1|Overall Study|Non-Compliance With Study Treatment|0
2947266|NCT01327547|10146339|P2|Overall Study|Lost to Follow-up|6
2947267|NCT01327547|10146340|P1|Overall Study|Lost to Follow-up|6
2947268|NCT01327547|10146339|P2|Overall Study|Death|2
2947269|NCT01327547|10146340|P1|Overall Study|Death|1
2947270|NCT01327547|10146339|P2|Overall Study|Adverse Event|1
2947271|NCT01327547|10146340|P1|Overall Study|Adverse Event|4
2947272|NCT01327495|10146408|P6|Overall Study|Physician Decision|0
2947273|NCT01327495|10146409|P5|Overall Study|Physician Decision|2
2947274|NCT01327495|10146410|P4|Overall Study|Physician Decision|0
2947275|NCT01327495|10146411|P3|Overall Study|Physician Decision|0
2947276|NCT01327495|10146412|P2|Overall Study|Physician Decision|0
2947277|NCT01327495|10146413|P1|Overall Study|Physician Decision|0
2947278|NCT01327495|10146408|P6|Overall Study|Withdrawal by Subject|0
2947279|NCT01327495|10146409|P5|Overall Study|Withdrawal by Subject|1
2947280|NCT01327495|10146410|P4|Overall Study|Withdrawal by Subject|0
2947281|NCT01327495|10146411|P3|Overall Study|Withdrawal by Subject|1
2947282|NCT01327495|10146412|P2|Overall Study|Withdrawal by Subject|1
2947283|NCT01327495|10146413|P1|Overall Study|Withdrawal by Subject|0
2947284|NCT01327495|10146408|P6|Overall Study|Adverse Event|2
2947285|NCT01327495|10146409|P5|Overall Study|Adverse Event|0
2947286|NCT01327495|10146410|P4|Overall Study|Adverse Event|0
2947287|NCT01327495|10146411|P3|Overall Study|Adverse Event|1
2947288|NCT01327495|10146412|P2|Overall Study|Adverse Event|1
2947289|NCT01327495|10146413|P1|Overall Study|Adverse Event|2
2947290|NCT01327482|10146505|P1|Overall Study|Adverse Event|1
2947291|NCT01327339|10146510|P1|Overall Study|Protocol Violation|8
2947292|NCT01327300|10146645|P2|Washout (3 Weeks)|Withdrawal by Subject|0
2947293|NCT01327300|10146646|P1|Washout (3 Weeks)|Withdrawal by Subject|1
2947294|NCT01327053|10146686|P2|Overall Study|Untreated|1
2947295|NCT01327053|10146687|P1|Overall Study|Untreated|0
2947296|NCT01327053|10146686|P2|Overall Study|Protocol Violation|1
2947297|NCT01327053|10146687|P1|Overall Study|Protocol Violation|0
2947298|NCT01327053|10146686|P2|Overall Study|Progressive disease|26
2947299|NCT01327053|10146687|P1|Overall Study|Progressive disease|31
2947300|NCT01327053|10146686|P2|Overall Study|Study terminated by Sponsor|3
2947301|NCT01327053|10146687|P1|Overall Study|Study terminated by Sponsor|1
2947302|NCT01327053|10146686|P2|Overall Study|Non-compliance with study treatment|5
2947303|NCT01327053|10146687|P1|Overall Study|Non-compliance with study treatment|0
2947304|NCT01327053|10146686|P2|Overall Study|Lost to Follow-up|4
2947305|NCT01327053|10146687|P1|Overall Study|Lost to Follow-up|2
2947306|NCT01327053|10146686|P2|Overall Study|Death|5
2947307|NCT01327053|10146687|P1|Overall Study|Death|1
2947308|NCT01327053|10146686|P2|Overall Study|Physician Decision|14
2947309|NCT01327053|10146687|P1|Overall Study|Physician Decision|10
2947310|NCT01327053|10146686|P2|Overall Study|Patient/guardian decision|35
2947311|NCT01327053|10146687|P1|Overall Study|Patient/guardian decision|11
2947312|NCT01327053|10146686|P2|Overall Study|Adverse Event|57
2947313|NCT01327053|10146687|P1|Overall Study|Adverse Event|23
2947314|NCT01326962|10146761|P1|Overall Study|Other|2
2947315|NCT01326962|10146761|P1|Overall Study|Lost to Follow-up|3
2947316|NCT01326962|10146761|P1|Overall Study|Withdrawal by Subject|1
2947317|NCT01326962|10146761|P1|Overall Study|Adverse Event|1
2947318|NCT01326910|10146779|P2|Overall Study|Protocol Violation|1
2947319|NCT01326910|10146780|P1|Overall Study|Protocol Violation|1
2947320|NCT01326910|10146779|P2|Overall Study|Withdrawal by Subject|2
2947321|NCT01326910|10146780|P1|Overall Study|Withdrawal by Subject|3
2947322|NCT01326845|10146794|P2|Overall Study|Misisng|3
2947323|NCT01326845|10146795|P1|Overall Study|Misisng|1
2947324|NCT01326845|10146794|P2|Overall Study|Adverse Event|0
2947325|NCT01326845|10146795|P1|Overall Study|Adverse Event|1
2947326|NCT01326845|10146794|P2|Overall Study|Administrative Problems|2
2947327|NCT01326845|10146795|P1|Overall Study|Administrative Problems|5
2947328|NCT01326728|10146856|P2|Overall Study|Early closure of study|9
2947329|NCT01326728|10146857|P1|Overall Study|Early closure of study|34
2947330|NCT01326728|10146856|P2|Overall Study|Death|0
2947331|NCT01326728|10146857|P1|Overall Study|Death|13
2947332|NCT01326702|10146881|P7|Overall Study|Not Treated|0
2947333|NCT01326702|10146882|P6|Overall Study|Not Treated|1
2947334|NCT01326702|10146883|P5|Overall Study|Not Treated|0
2947335|NCT01326702|10146884|P4|Overall Study|Not Treated|1
2947336|NCT01326702|10146885|P3|Overall Study|Not Treated|0
2947337|NCT01326702|10146886|P2|Overall Study|Not Treated|0
2947338|NCT01326702|10146887|P1|Overall Study|Not Treated|0
2947339|NCT01326702|10146881|P7|Overall Study|Withdrawal by Subject|3
2947340|NCT01326702|10146882|P6|Overall Study|Withdrawal by Subject|1
2947341|NCT01326702|10146883|P5|Overall Study|Withdrawal by Subject|1
2947342|NCT01326702|10146884|P4|Overall Study|Withdrawal by Subject|0
2947343|NCT01326702|10146885|P3|Overall Study|Withdrawal by Subject|1
2947344|NCT01326702|10146886|P2|Overall Study|Withdrawal by Subject|0
2947345|NCT01326702|10146887|P1|Overall Study|Withdrawal by Subject|0
2947346|NCT01326702|10146881|P7|Overall Study|Adverse Event|1
2947347|NCT01326702|10146882|P6|Overall Study|Adverse Event|3
2947348|NCT01326702|10146883|P5|Overall Study|Adverse Event|0
2947349|NCT01326702|10146884|P4|Overall Study|Adverse Event|1
2947350|NCT01326702|10146885|P3|Overall Study|Adverse Event|1
2947351|NCT01326702|10146886|P2|Overall Study|Adverse Event|0
2947352|NCT01326702|10146887|P1|Overall Study|Adverse Event|0
2947353|NCT01326702|10146881|P7|Overall Study|Death|0
2947354|NCT01326702|10146882|P6|Overall Study|Death|0
2947355|NCT01326702|10146883|P5|Overall Study|Death|0
2947356|NCT01326702|10146884|P4|Overall Study|Death|0
2947357|NCT01326702|10146885|P3|Overall Study|Death|0
2947358|NCT01326702|10146886|P2|Overall Study|Death|1
2947359|NCT01326702|10146887|P1|Overall Study|Death|0
2947360|NCT01326702|10146881|P7|Overall Study|progressive disease|3
2947361|NCT01326702|10146882|P6|Overall Study|progressive disease|2
2947362|NCT01326702|10146883|P5|Overall Study|progressive disease|3
2947363|NCT01326702|10146884|P4|Overall Study|progressive disease|1
2947364|NCT01326702|10146885|P3|Overall Study|progressive disease|3
2947365|NCT01326702|10146886|P2|Overall Study|progressive disease|1
2947366|NCT01326702|10146887|P1|Overall Study|progressive disease|1
2947367|NCT01326702|10146881|P7|Overall Study|Other|0
2947368|NCT01326702|10146882|P6|Overall Study|Other|1
2947369|NCT01326702|10146883|P5|Overall Study|Other|0
2947370|NCT01326702|10146884|P4|Overall Study|Other|0
2947371|NCT01326702|10146885|P3|Overall Study|Other|0
2947372|NCT01326702|10146886|P2|Overall Study|Other|0
2947373|NCT01326702|10146887|P1|Overall Study|Other|1
2947374|NCT01326546|10146943|P2|Overall Study|Withdrawal by Subject|1
2947375|NCT01326546|10146944|P1|Overall Study|Withdrawal by Subject|5
2947376|NCT01326546|10146943|P2|Overall Study|Adverse Event|0
2947377|NCT01326546|10146944|P1|Overall Study|Adverse Event|1
2947378|NCT01326546|10146943|P2|Overall Study|Pregnancy|1
2947379|NCT01326546|10146944|P1|Overall Study|Pregnancy|0
2947380|NCT01326546|10146943|P2|Overall Study|Protocol Violation|4
2947381|NCT01326546|10146944|P1|Overall Study|Protocol Violation|3
2947382|NCT01326546|10146943|P2|Overall Study|Lost to Follow-up|7
2947383|NCT01326546|10146944|P1|Overall Study|Lost to Follow-up|8
2947384|NCT01326533|10146952|P2|Overall Study|Adverse Event|0
2947385|NCT01326533|10146953|P1|Overall Study|Adverse Event|1
2947386|NCT01326533|10146952|P2|Overall Study|Withdrawal by Subject|0
2947387|NCT01326533|10146953|P1|Overall Study|Withdrawal by Subject|1
2947388|NCT01326533|10146952|P2|Overall Study|Lost to Follow-up|0
2947389|NCT01326533|10146953|P1|Overall Study|Lost to Follow-up|2
2947390|NCT01326481|10146961|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
2947391|NCT01326026|10146970|P2|Overall Study|Other|3
2947392|NCT01326026|10146971|P1|Overall Study|Other|3
2947393|NCT01326026|10146970|P2|Overall Study|Withdrawal Criteria|7
2947394|NCT01326026|10146971|P1|Overall Study|Withdrawal Criteria|5
2947395|NCT01326026|10146970|P2|Overall Study|Adverse Event|3
2947396|NCT01326026|10146971|P1|Overall Study|Adverse Event|4
2947397|NCT01325701|10147036|P2|Overall Study|Rollerover Extension Study|0
2947398|NCT01325701|10147037|P1|Overall Study|Rollerover Extension Study|4
2947399|NCT01325701|10147036|P2|Overall Study|Withdrawal by Subject|1
2947400|NCT01325701|10147037|P1|Overall Study|Withdrawal by Subject|2
2947401|NCT01325701|10147036|P2|Overall Study|Physician Decision|2
2947402|NCT01325701|10147037|P1|Overall Study|Physician Decision|2
2947403|NCT01325701|10147036|P2|Overall Study|Protocol Violation|0
2947404|NCT01325701|10147037|P1|Overall Study|Protocol Violation|1
2947405|NCT01325701|10147036|P2|Overall Study|Adverse Event|0
2947406|NCT01325701|10147037|P1|Overall Study|Adverse Event|12
2947407|NCT01325623|10147047|P1|Overall Study|Withdrawal by Subject|3
2947408|NCT01325584|10147089|P1|Overall Study|Death|1
2947409|NCT01325532|10147099|P2|Overall Study|Withdrawal by Subject|0
2947410|NCT01325532|10147100|P1|Overall Study|Withdrawal by Subject|2
2947411|NCT01325493|10147112|P2|Overall Study|Allergy|0
2947412|NCT01325493|10147113|P1|Overall Study|Allergy|1
2947413|NCT01325493|10147112|P2|Overall Study|loss of neuromonitoring signals|2
2947414|NCT01325493|10147113|P1|Overall Study|loss of neuromonitoring signals|0
2947415|NCT01325493|10147112|P2|Overall Study|Protocol Violation|1
2947416|NCT01325493|10147113|P1|Overall Study|Protocol Violation|0
2947417|NCT01325428|10147125|P1|Part B|Other reason not defined above|1
2947418|NCT01325428|10147125|P1|Part B|Refused continue taking trial medication|2
2947419|NCT01325428|10147125|P1|Part A|Other reason not defined above|2
2947420|NCT01325428|10147125|P1|Part A|Refused continue taking trial medication|2
2947421|NCT01325428|10147125|P1|Part A|Other adverse event|1
2947422|NCT01325428|10147125|P1|Part A|Clinical signs, symptoms of progression|2
2947423|NCT01325428|10147125|P1|Part A|Progressive disease according to RECIST|9
2947424|NCT01325350|10147145|P5|Overall Study|Did Not Receive Treatment|1
2947425|NCT01325350|10147146|P4|Overall Study|Did Not Receive Treatment|0
2947426|NCT01325350|10147147|P3|Overall Study|Did Not Receive Treatment|1
2947427|NCT01325350|10147148|P2|Overall Study|Did Not Receive Treatment|1
2947428|NCT01325350|10147149|P1|Overall Study|Did Not Receive Treatment|0
2947429|NCT01325350|10147145|P5|Overall Study|Withdrawal by Subject|0
2947430|NCT01325350|10147146|P4|Overall Study|Withdrawal by Subject|1
2947431|NCT01325350|10147147|P3|Overall Study|Withdrawal by Subject|1
2947432|NCT01325350|10147148|P2|Overall Study|Withdrawal by Subject|0
2947433|NCT01325350|10147149|P1|Overall Study|Withdrawal by Subject|0
2947434|NCT01325350|10147145|P5|Overall Study|Protocol Violation|0
2947435|NCT01325350|10147146|P4|Overall Study|Protocol Violation|1
2947436|NCT01325350|10147147|P3|Overall Study|Protocol Violation|0
2947437|NCT01325350|10147148|P2|Overall Study|Protocol Violation|0
2947438|NCT01325350|10147149|P1|Overall Study|Protocol Violation|0
2947439|NCT01325350|10147145|P5|Overall Study|Personal Reasons|3
2947440|NCT01325350|10147146|P4|Overall Study|Personal Reasons|5
2947441|NCT01325350|10147147|P3|Overall Study|Personal Reasons|6
2947442|NCT01325350|10147148|P2|Overall Study|Personal Reasons|1
2947443|NCT01325350|10147149|P1|Overall Study|Personal Reasons|2
2947444|NCT01325350|10147145|P5|Overall Study|Lost to Follow-up|5
2947445|NCT01325350|10147146|P4|Overall Study|Lost to Follow-up|1
2947446|NCT01325350|10147147|P3|Overall Study|Lost to Follow-up|5
2947447|NCT01325350|10147148|P2|Overall Study|Lost to Follow-up|0
2947448|NCT01325350|10147149|P1|Overall Study|Lost to Follow-up|1
2947449|NCT01325350|10147145|P5|Overall Study|Pregnancy|1
2947450|NCT01325350|10147146|P4|Overall Study|Pregnancy|0
2947451|NCT01325350|10147147|P3|Overall Study|Pregnancy|1
2947452|NCT01325350|10147148|P2|Overall Study|Pregnancy|0
2947453|NCT01325350|10147149|P1|Overall Study|Pregnancy|0
2947454|NCT01325350|10147145|P5|Overall Study|Adverse Event|2
2947455|NCT01325350|10147146|P4|Overall Study|Adverse Event|1
2947456|NCT01325350|10147147|P3|Overall Study|Adverse Event|3
2947457|NCT01325350|10147148|P2|Overall Study|Adverse Event|3
2947458|NCT01325350|10147149|P1|Overall Study|Adverse Event|3
2947459|NCT01325337|10147191|P5|Overall Study|Withdrawal by Subject|1
2947460|NCT01325337|10147192|P4|Overall Study|Withdrawal by Subject|0
2947461|NCT01325337|10147193|P3|Overall Study|Withdrawal by Subject|1
2947462|NCT01325337|10147194|P2|Overall Study|Withdrawal by Subject|0
2947463|NCT01325337|10147195|P1|Overall Study|Withdrawal by Subject|1
2947464|NCT01325337|10147191|P5|Overall Study|Personal Reasons|3
2947465|NCT01325337|10147192|P4|Overall Study|Personal Reasons|8
2947466|NCT01325337|10147193|P3|Overall Study|Personal Reasons|4
2947467|NCT01325337|10147194|P2|Overall Study|Personal Reasons|5
2947468|NCT01325337|10147195|P1|Overall Study|Personal Reasons|2
2947469|NCT01325337|10147191|P5|Overall Study|Lost to Follow-up|2
2947470|NCT01325337|10147192|P4|Overall Study|Lost to Follow-up|1
2947471|NCT01325337|10147193|P3|Overall Study|Lost to Follow-up|2
2947472|NCT01325337|10147194|P2|Overall Study|Lost to Follow-up|2
2947473|NCT01325337|10147195|P1|Overall Study|Lost to Follow-up|2
2947474|NCT01325337|10147191|P5|Overall Study|Adverse Event|2
2947475|NCT01325337|10147192|P4|Overall Study|Adverse Event|1
2947476|NCT01325337|10147193|P3|Overall Study|Adverse Event|2
2947477|NCT01325337|10147194|P2|Overall Study|Adverse Event|2
2947478|NCT01325337|10147195|P1|Overall Study|Adverse Event|0
2947479|NCT01325207|10147275|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2947480|NCT01325207|10147276|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
2947481|NCT01325207|10147277|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2947482|NCT01325207|10147278|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2947483|NCT01325207|10147279|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2947484|NCT01325207|10147280|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2947485|NCT01325207|10147275|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
2947486|NCT01325207|10147276|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2947487|NCT01325207|10147277|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2947488|NCT01325207|10147278|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2947489|NCT01325207|10147279|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2947490|NCT01325207|10147280|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2947491|NCT01325207|10147275|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
2947492|NCT01325207|10147276|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2947493|NCT01325207|10147277|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2947494|NCT01325207|10147278|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2947495|NCT01325207|10147279|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2947496|NCT01325207|10147280|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2947497|NCT01325207|10147275|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2947498|NCT01325207|10147276|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2947499|NCT01325207|10147277|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2947500|NCT01325207|10147278|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2947501|NCT01325207|10147279|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
2947502|NCT01325207|10147280|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2947503|NCT01325207|10147275|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
2947504|NCT01325207|10147276|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
2947505|NCT01325207|10147277|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2947506|NCT01325207|10147278|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2947507|NCT01325207|10147279|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2947508|NCT01325207|10147280|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2947509|NCT01325207|10147275|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
2947510|NCT01325207|10147276|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
2947511|NCT01325207|10147277|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2947512|NCT01325207|10147278|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2947513|NCT01325207|10147279|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2947514|NCT01325207|10147280|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2947515|NCT01325207|10147275|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2947516|NCT01325207|10147276|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
2947517|NCT01325207|10147277|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2947518|NCT01325207|10147278|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2947519|NCT01325207|10147279|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2947520|NCT01325207|10147280|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2947521|NCT01324999|10147312|P1|Overall Study|Withdrawal by Subject|2
2947522|NCT01324999|10147312|P1|Overall Study|Adverse Event|3
2947523|NCT01324947|10147323|P1|Overall Study|1 discontinued before starting drug|1
2947524|NCT01324947|10147323|P1|Overall Study|Withdrawal by Subject|3
2947525|NCT01324947|10147323|P1|Overall Study|Progressive Disease|50
2947526|NCT01324947|10147323|P1|Overall Study|Other|3
2947527|NCT01324947|10147323|P1|Overall Study|Death|10
2947528|NCT01324947|10147323|P1|Overall Study|Adverse Event|7
2947529|NCT01324830|10147364|P19|Overall Study|Withdrawal by Subject|1
2947530|NCT01324830|10147365|P18|Overall Study|Withdrawal by Subject|0
2947531|NCT01324830|10147366|P17|Overall Study|Withdrawal by Subject|0
2947532|NCT01324830|10147367|P16|Overall Study|Withdrawal by Subject|0
2947533|NCT01324830|10147368|P15|Overall Study|Withdrawal by Subject|0
2947534|NCT01324830|10147369|P14|Overall Study|Withdrawal by Subject|0
2947535|NCT01324830|10147370|P13|Overall Study|Withdrawal by Subject|0
2947536|NCT01324830|10147371|P12|Overall Study|Withdrawal by Subject|0
2947537|NCT01324830|10147372|P11|Overall Study|Withdrawal by Subject|1
2947538|NCT01324830|10147373|P10|Overall Study|Withdrawal by Subject|0
2947539|NCT01324830|10147374|P9|Overall Study|Withdrawal by Subject|0
2947540|NCT01324830|10147375|P8|Overall Study|Withdrawal by Subject|0
2947541|NCT01324830|10147376|P7|Overall Study|Withdrawal by Subject|0
2947542|NCT01324830|10147377|P6|Overall Study|Withdrawal by Subject|1
2947543|NCT01324830|10147378|P5|Overall Study|Withdrawal by Subject|0
2947544|NCT01324830|10147379|P4|Overall Study|Withdrawal by Subject|0
2947545|NCT01324830|10147380|P3|Overall Study|Withdrawal by Subject|0
2947546|NCT01324830|10147381|P2|Overall Study|Withdrawal by Subject|0
2947547|NCT01324830|10147382|P1|Overall Study|Withdrawal by Subject|0
2947548|NCT01324830|10147364|P19|Overall Study|Adverse Event, non-fatal|0
2947549|NCT01324830|10147365|P18|Overall Study|Adverse Event, non-fatal|1
2947550|NCT01324830|10147366|P17|Overall Study|Adverse Event, non-fatal|0
2947551|NCT01324830|10147367|P16|Overall Study|Adverse Event, non-fatal|0
2947552|NCT01324830|10147368|P15|Overall Study|Adverse Event, non-fatal|0
2947553|NCT01324830|10147369|P14|Overall Study|Adverse Event, non-fatal|0
2947554|NCT01324830|10147370|P13|Overall Study|Adverse Event, non-fatal|0
2947555|NCT01324830|10147371|P12|Overall Study|Adverse Event, non-fatal|0
2947556|NCT01324830|10147372|P11|Overall Study|Adverse Event, non-fatal|1
2947557|NCT01324830|10147373|P10|Overall Study|Adverse Event, non-fatal|0
2947558|NCT01324830|10147374|P9|Overall Study|Adverse Event, non-fatal|2
2947559|NCT01324830|10147375|P8|Overall Study|Adverse Event, non-fatal|0
2947560|NCT01324830|10147376|P7|Overall Study|Adverse Event, non-fatal|0
2947561|NCT01324830|10147377|P6|Overall Study|Adverse Event, non-fatal|0
2947562|NCT01324830|10147378|P5|Overall Study|Adverse Event, non-fatal|0
2947563|NCT01324830|10147379|P4|Overall Study|Adverse Event, non-fatal|0
2947564|NCT01324830|10147380|P3|Overall Study|Adverse Event, non-fatal|0
2947565|NCT01324830|10147381|P2|Overall Study|Adverse Event, non-fatal|0
2947566|NCT01324830|10147382|P1|Overall Study|Adverse Event, non-fatal|0
2947567|NCT01324830|10147364|P19|Overall Study|Adverse Event, serious fatal|0
2947568|NCT01324830|10147365|P18|Overall Study|Adverse Event, serious fatal|0
2947569|NCT01324830|10147366|P17|Overall Study|Adverse Event, serious fatal|0
2947570|NCT01324830|10147367|P16|Overall Study|Adverse Event, serious fatal|0
2947571|NCT01324830|10147368|P15|Overall Study|Adverse Event, serious fatal|0
2947572|NCT01324830|10147369|P14|Overall Study|Adverse Event, serious fatal|0
2947573|NCT01324830|10147370|P13|Overall Study|Adverse Event, serious fatal|0
2947574|NCT01324830|10147371|P12|Overall Study|Adverse Event, serious fatal|0
2947575|NCT01324830|10147372|P11|Overall Study|Adverse Event, serious fatal|0
2947576|NCT01324830|10147373|P10|Overall Study|Adverse Event, serious fatal|0
2947577|NCT01324830|10147374|P9|Overall Study|Adverse Event, serious fatal|0
2947578|NCT01324830|10147375|P8|Overall Study|Adverse Event, serious fatal|0
2947579|NCT01324830|10147376|P7|Overall Study|Adverse Event, serious fatal|0
2947580|NCT01324830|10147377|P6|Overall Study|Adverse Event, serious fatal|0
2947581|NCT01324830|10147378|P5|Overall Study|Adverse Event, serious fatal|0
2947582|NCT01324830|10147379|P4|Overall Study|Adverse Event, serious fatal|0
2947583|NCT01324830|10147380|P3|Overall Study|Adverse Event, serious fatal|0
2947584|NCT01324830|10147381|P2|Overall Study|Adverse Event, serious fatal|1
2947585|NCT01324830|10147382|P1|Overall Study|Adverse Event, serious fatal|0
2947586|NCT01324830|10147364|P19|Overall Study|Reason not mentioned above|0
2947587|NCT01324830|10147365|P18|Overall Study|Reason not mentioned above|1
2947588|NCT01324830|10147366|P17|Overall Study|Reason not mentioned above|0
2947589|NCT01324830|10147367|P16|Overall Study|Reason not mentioned above|0
2947590|NCT01324830|10147368|P15|Overall Study|Reason not mentioned above|0
2947591|NCT01324830|10147369|P14|Overall Study|Reason not mentioned above|0
2947592|NCT01324830|10147370|P13|Overall Study|Reason not mentioned above|0
2947593|NCT01324830|10147371|P12|Overall Study|Reason not mentioned above|0
2947594|NCT01324830|10147372|P11|Overall Study|Reason not mentioned above|0
2947595|NCT01324830|10147373|P10|Overall Study|Reason not mentioned above|0
2947596|NCT01324830|10147374|P9|Overall Study|Reason not mentioned above|0
2947597|NCT01324830|10147375|P8|Overall Study|Reason not mentioned above|0
2947598|NCT01324830|10147376|P7|Overall Study|Reason not mentioned above|0
2947599|NCT01324830|10147377|P6|Overall Study|Reason not mentioned above|0
2947600|NCT01324830|10147378|P5|Overall Study|Reason not mentioned above|0
2947601|NCT01324830|10147379|P4|Overall Study|Reason not mentioned above|0
2947602|NCT01324830|10147380|P3|Overall Study|Reason not mentioned above|0
2947603|NCT01324830|10147381|P2|Overall Study|Reason not mentioned above|0
2947604|NCT01324830|10147382|P1|Overall Study|Reason not mentioned above|0
2947605|NCT01324830|10147364|P19|Overall Study|Dose limiting toxicity|1
2947606|NCT01324830|10147365|P18|Overall Study|Dose limiting toxicity|1
2947607|NCT01324830|10147366|P17|Overall Study|Dose limiting toxicity|1
2947608|NCT01324830|10147367|P16|Overall Study|Dose limiting toxicity|0
2947609|NCT01324830|10147368|P15|Overall Study|Dose limiting toxicity|0
2947610|NCT01324830|10147369|P14|Overall Study|Dose limiting toxicity|0
2947611|NCT01324830|10147370|P13|Overall Study|Dose limiting toxicity|0
2947612|NCT01324830|10147371|P12|Overall Study|Dose limiting toxicity|0
2947613|NCT01324830|10147372|P11|Overall Study|Dose limiting toxicity|0
2947614|NCT01324830|10147373|P10|Overall Study|Dose limiting toxicity|0
2947615|NCT01324830|10147374|P9|Overall Study|Dose limiting toxicity|0
2947616|NCT01324830|10147375|P8|Overall Study|Dose limiting toxicity|0
2947617|NCT01324830|10147376|P7|Overall Study|Dose limiting toxicity|0
2947618|NCT01324830|10147377|P6|Overall Study|Dose limiting toxicity|0
2947619|NCT01324830|10147378|P5|Overall Study|Dose limiting toxicity|1
2947620|NCT01324830|10147379|P4|Overall Study|Dose limiting toxicity|0
2947621|NCT01324830|10147380|P3|Overall Study|Dose limiting toxicity|0
2947622|NCT01324830|10147381|P2|Overall Study|Dose limiting toxicity|0
2947623|NCT01324830|10147382|P1|Overall Study|Dose limiting toxicity|0
2947624|NCT01324830|10147364|P19|Overall Study|Progressive Disease|4
2947625|NCT01324830|10147365|P18|Overall Study|Progressive Disease|3
2947626|NCT01324830|10147366|P17|Overall Study|Progressive Disease|2
2947627|NCT01324830|10147367|P16|Overall Study|Progressive Disease|3
2947628|NCT01324830|10147368|P15|Overall Study|Progressive Disease|1
2947629|NCT01324830|10147369|P14|Overall Study|Progressive Disease|1
2947630|NCT01324830|10147370|P13|Overall Study|Progressive Disease|1
2947631|NCT01324830|10147371|P12|Overall Study|Progressive Disease|1
2947632|NCT01324830|10147372|P11|Overall Study|Progressive Disease|2
2947633|NCT01324830|10147373|P10|Overall Study|Progressive Disease|6
2947634|NCT01324830|10147374|P9|Overall Study|Progressive Disease|3
2947635|NCT01324830|10147375|P8|Overall Study|Progressive Disease|3
2947636|NCT01324830|10147376|P7|Overall Study|Progressive Disease|3
2947637|NCT01324830|10147377|P6|Overall Study|Progressive Disease|6
2947638|NCT01324830|10147378|P5|Overall Study|Progressive Disease|6
2947639|NCT01324830|10147379|P4|Overall Study|Progressive Disease|3
2947640|NCT01324830|10147380|P3|Overall Study|Progressive Disease|3
2947641|NCT01324830|10147381|P2|Overall Study|Progressive Disease|2
2947642|NCT01324830|10147382|P1|Overall Study|Progressive Disease|3
2947643|NCT01324622|10147528|P2|Overall Study|Lack of Efficacy|0
2947644|NCT01324622|10147529|P1|Overall Study|Lack of Efficacy|1
2947645|NCT01324622|10147528|P2|Overall Study|Death|0
2947646|NCT01324622|10147529|P1|Overall Study|Death|1
2947647|NCT01324622|10147528|P2|Overall Study|Lost to Follow-up|7
2947648|NCT01324622|10147529|P1|Overall Study|Lost to Follow-up|7
2947649|NCT01324570|10147559|P2|Overall Study|Administrative|2
2947650|NCT01324570|10147560|P1|Overall Study|Administrative|0
2947651|NCT01324570|10147559|P2|Overall Study|Confirmed or suspected diversion|1
2947652|NCT01324570|10147560|P1|Overall Study|Confirmed or suspected diversion|0
2947653|NCT01324570|10147559|P2|Overall Study|Lack of Efficacy|1
2947654|NCT01324570|10147560|P1|Overall Study|Lack of Efficacy|0
2947655|NCT01324570|10147559|P2|Overall Study|Withdrawal by Subject|3
2947656|NCT01324570|10147560|P1|Overall Study|Withdrawal by Subject|0
2947657|NCT01324570|10147559|P2|Overall Study|Adverse Event|7
2947658|NCT01324570|10147560|P1|Overall Study|Adverse Event|4
2947659|NCT01324440|10147597|P2|Overall Study|Subject moved|1
2947660|NCT01324440|10147598|P1|Overall Study|Subject moved|0
2947661|NCT01324401|10147612|P2|Overall Study|Adverse Event|3
2947662|NCT01324401|10147613|P1|Overall Study|Adverse Event|1
2947663|NCT01324401|10147612|P2|Overall Study|Withdrawn before any treatment|3
2947664|NCT01324401|10147613|P1|Overall Study|Withdrawn before any treatment|0
2947665|NCT01324388|10147624|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2947666|NCT01324388|10147625|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
2947667|NCT01324388|10147626|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2947668|NCT01324388|10147627|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2947669|NCT01324388|10147624|P4|Part 2 of Study: First Intervention|Protocol Violation|1
2947670|NCT01324388|10147625|P3|Part 2 of Study: First Intervention|Protocol Violation|0
2947671|NCT01324388|10147626|P2|Part 2 of Study: First Intervention|Protocol Violation|0
2947672|NCT01324388|10147627|P1|Part 2 of Study: First Intervention|Protocol Violation|0
2947673|NCT01324388|10147624|P4|Part 1 of Study|Physician Decision|0
2947674|NCT01324388|10147625|P3|Part 1 of Study|Physician Decision|0
2947675|NCT01324388|10147626|P2|Part 1 of Study|Physician Decision|0
2947676|NCT01324388|10147627|P1|Part 1 of Study|Physician Decision|1
2947677|NCT01324388|10147624|P4|Part 1 of Study|Protocol Violation|0
2947678|NCT01324388|10147625|P3|Part 1 of Study|Protocol Violation|0
2947679|NCT01324388|10147626|P2|Part 1 of Study|Protocol Violation|2
2947680|NCT01324388|10147627|P1|Part 1 of Study|Protocol Violation|1
2947681|NCT01324388|10147624|P4|Part 1 of Study|Adverse Event|0
2947682|NCT01324388|10147625|P3|Part 1 of Study|Adverse Event|0
2947683|NCT01324388|10147626|P2|Part 1 of Study|Adverse Event|0
2947684|NCT01324388|10147627|P1|Part 1 of Study|Adverse Event|2
2947685|NCT01324349|10147648|P2|Overall Study|Withdrawal by Subject|1
2947686|NCT01324349|10147649|P1|Overall Study|Withdrawal by Subject|0
2947687|NCT01324349|10147648|P2|Overall Study|Death|1
2947688|NCT01324349|10147649|P1|Overall Study|Death|1
2947689|NCT01324323|10147659|P1|Overall Study|Withdrawal by Subject|1
2947690|NCT01324310|10147679|P1|Overall Study|Disease Progression|1
2947691|NCT01324310|10147679|P1|Overall Study|Adverse Event|1
2947692|NCT01324271|10147699|P2|Overall Study|Physician Decision|0
2947693|NCT01324271|10147700|P1|Overall Study|Physician Decision|1
2947694|NCT01324271|10147699|P2|Overall Study|Lost to Follow-up|0
2947695|NCT01324271|10147700|P1|Overall Study|Lost to Follow-up|3
2947696|NCT01324102|10147723|P2|Overall Study|illness|6
2947697|NCT01324102|10147724|P1|Overall Study|illness|1
2947698|NCT01324024|10147731|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2947699|NCT01324024|10147732|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
2947700|NCT01323972|10147770|P4|Overall Study|Lost to Follow-up|1
2947701|NCT01323972|10147771|P3|Overall Study|Lost to Follow-up|1
2947702|NCT01323972|10147772|P2|Overall Study|Lost to Follow-up|1
2947703|NCT01323972|10147773|P1|Overall Study|Lost to Follow-up|0
2947704|NCT01323972|10147770|P4|Overall Study|Migrated/moved from study area|0
2947705|NCT01323972|10147771|P3|Overall Study|Migrated/moved from study area|0
2947706|NCT01323972|10147772|P2|Overall Study|Migrated/moved from study area|2
2947707|NCT01323972|10147773|P1|Overall Study|Migrated/moved from study area|1
2947708|NCT01323972|10147770|P4|Overall Study|Withdrawal by Subject|0
2947709|NCT01323972|10147771|P3|Overall Study|Withdrawal by Subject|1
2947710|NCT01323972|10147772|P2|Overall Study|Withdrawal by Subject|0
2947711|NCT01323972|10147773|P1|Overall Study|Withdrawal by Subject|1
2947712|NCT01323946|10147869|P3|Overall Study|Withdrawal by Subject|0
2947713|NCT01323946|10147870|P2|Overall Study|Withdrawal by Subject|2
2947714|NCT01323946|10147871|P1|Overall Study|Withdrawal by Subject|2
2947715|NCT01323946|10147869|P3|Overall Study|Parents refused the last blood draw|0
2947716|NCT01323946|10147870|P2|Overall Study|Parents refused the last blood draw|0
2947717|NCT01323946|10147871|P1|Overall Study|Parents refused the last blood draw|1
2947718|NCT01323946|10147869|P3|Overall Study|Lost to Follow-up|0
2947719|NCT01323946|10147870|P2|Overall Study|Lost to Follow-up|1
2947720|NCT01323946|10147871|P1|Overall Study|Lost to Follow-up|0
2947721|NCT01323920|10147992|P1|Overall Study|Withdrawal by Subject|1
2947722|NCT01323920|10147992|P1|Overall Study|Death|5
2947723|NCT01323790|10148033|P3|Overall Study|Severe non-compliance with protocol|2
2947724|NCT01323790|10148034|P2|Overall Study|Severe non-compliance with protocol|2
2947725|NCT01323790|10148035|P1|Overall Study|Severe non-compliance with protocol|2
2947726|NCT01323790|10148033|P3|Overall Study|Did Not Receive Treatment|1
2947727|NCT01323790|10148034|P2|Overall Study|Did Not Receive Treatment|0
2947728|NCT01323790|10148035|P1|Overall Study|Did Not Receive Treatment|2
2947729|NCT01323790|10148033|P3|Overall Study|Withdrawal by Subject|13
2947730|NCT01323790|10148034|P2|Overall Study|Withdrawal by Subject|20
2947731|NCT01323790|10148035|P1|Overall Study|Withdrawal by Subject|23
2947732|NCT01323790|10148033|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
2947733|NCT01323790|10148034|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2947734|NCT01323790|10148035|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2947735|NCT01323790|10148033|P3|Overall Study|Adverse Event|12
2947736|NCT01323790|10148034|P2|Overall Study|Adverse Event|24
2947737|NCT01323790|10148035|P1|Overall Study|Adverse Event|11
2947738|NCT01323790|10148033|P3|Overall Study|Lack of Efficacy|3
2947739|NCT01323790|10148034|P2|Overall Study|Lack of Efficacy|0
2947740|NCT01323790|10148035|P1|Overall Study|Lack of Efficacy|3
2947741|NCT01323790|10148033|P3|Overall Study|Study-Specific Withdrawal Criteria|3
2947742|NCT01323790|10148034|P2|Overall Study|Study-Specific Withdrawal Criteria|3
2947743|NCT01323790|10148035|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2947744|NCT01323790|10148033|P3|Overall Study|Lost to Follow-up|9
2947745|NCT01323790|10148034|P2|Overall Study|Lost to Follow-up|9
2947746|NCT01323790|10148035|P1|Overall Study|Lost to Follow-up|11
2947747|NCT01323790|10148033|P3|Overall Study|Other|1
2947748|NCT01323790|10148034|P2|Overall Study|Other|2
2947749|NCT01323790|10148035|P1|Overall Study|Other|3
2947750|NCT01323673|10148086|P2|Overall Study|Withdrawal by Subject|3
2947751|NCT01323673|10148087|P1|Overall Study|Withdrawal by Subject|2
2947752|NCT01323673|10148086|P2|Overall Study|Protocol Violation|0
2947753|NCT01323673|10148087|P1|Overall Study|Protocol Violation|1
2947754|NCT01323673|10148086|P2|Overall Study|Lost to Follow-up|1
2947755|NCT01323673|10148087|P1|Overall Study|Lost to Follow-up|0
2947756|NCT01323673|10148086|P2|Overall Study|Adverse Event|1
2947757|NCT01323673|10148087|P1|Overall Study|Adverse Event|0
2947758|NCT01323660|10148107|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947759|NCT01323660|10148108|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2947760|NCT01323660|10148109|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2947761|NCT01323660|10148110|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2947762|NCT01323660|10148111|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2947763|NCT01323660|10148112|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2947764|NCT01323660|10148107|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2947765|NCT01323660|10148108|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947766|NCT01323660|10148109|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947767|NCT01323660|10148110|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947768|NCT01323660|10148111|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2947769|NCT01323660|10148112|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2947770|NCT01323660|10148107|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
2947771|NCT01323660|10148108|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2947772|NCT01323660|10148109|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2947773|NCT01323660|10148110|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2947774|NCT01323660|10148111|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2947775|NCT01323660|10148112|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2947776|NCT01323660|10148107|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2947777|NCT01323660|10148108|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2947778|NCT01323660|10148109|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2947779|NCT01323660|10148110|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2947780|NCT01323660|10148111|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2947781|NCT01323660|10148112|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
2947782|NCT01323660|10148107|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
2947783|NCT01323660|10148108|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947784|NCT01323660|10148109|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947785|NCT01323660|10148110|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
2947786|NCT01323660|10148111|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
2947787|NCT01323660|10148112|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
2947788|NCT01323660|10148107|P6|Washout Period (14 Days)|Lack of Efficacy|2
2947789|NCT01323660|10148108|P5|Washout Period (14 Days)|Lack of Efficacy|2
2947790|NCT01323660|10148109|P4|Washout Period (14 Days)|Lack of Efficacy|3
2947791|NCT01323660|10148110|P3|Washout Period (14 Days)|Lack of Efficacy|1
2947792|NCT01323660|10148111|P2|Washout Period (14 Days)|Lack of Efficacy|0
2947793|NCT01323660|10148112|P1|Washout Period (14 Days)|Lack of Efficacy|0
2947794|NCT01323660|10148107|P6|Washout Period (14 Days)|Adverse Event|0
2947795|NCT01323660|10148108|P5|Washout Period (14 Days)|Adverse Event|1
2947796|NCT01323660|10148109|P4|Washout Period (14 Days)|Adverse Event|0
2947797|NCT01323660|10148110|P3|Washout Period (14 Days)|Adverse Event|0
2947798|NCT01323660|10148111|P2|Washout Period (14 Days)|Adverse Event|0
2947799|NCT01323660|10148112|P1|Washout Period (14 Days)|Adverse Event|0
2947800|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2947801|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
2947802|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2947803|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2947804|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2947805|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
2947806|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947807|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2947808|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947809|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947810|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947811|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2947812|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2947813|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
2947814|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2947815|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2947816|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2947817|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2947818|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2947819|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2947820|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2947821|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2947822|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2947823|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2947824|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
2947825|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2947826|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2947827|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2947828|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2947829|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2947830|NCT01323660|10148107|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
2947831|NCT01323660|10148108|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
2947832|NCT01323660|10148109|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
2947833|NCT01323660|10148110|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
2947834|NCT01323660|10148111|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
2947835|NCT01323660|10148112|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
2947836|NCT01323647|10148158|P2|Overall Study|Lost to Follow-up|0
2947837|NCT01323647|10148159|P1|Overall Study|Lost to Follow-up|2
2947838|NCT01323647|10148158|P2|Overall Study|Withdrawal by Subject|0
2947839|NCT01323647|10148159|P1|Overall Study|Withdrawal by Subject|5
2947840|NCT01323647|10148158|P2|Overall Study|Migrated/moved from study area|0
2947841|NCT01323647|10148159|P1|Overall Study|Migrated/moved from study area|2
2947842|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2947843|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2947844|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
2947845|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
2947846|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
2947847|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2947848|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
2947849|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
2947850|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
2947851|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2947852|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2947853|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2947854|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
2947855|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
2947856|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
2947857|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2947858|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2947859|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2947860|NCT01323634|10148176|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
2947861|NCT01323634|10148177|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
2947862|NCT01323634|10148178|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
2947863|NCT01323634|10148176|P3|2-week Run-in Period|Adverse Event|0
2947864|NCT01323634|10148177|P2|2-week Run-in Period|Adverse Event|0
2947865|NCT01323634|10148178|P1|2-week Run-in Period|Adverse Event|1
2947866|NCT01323634|10148176|P3|2-week Run-in Period|Protocol Violation|0
2947867|NCT01323634|10148177|P2|2-week Run-in Period|Protocol Violation|0
2947868|NCT01323634|10148178|P1|2-week Run-in Period|Protocol Violation|1
2947869|NCT01323634|10148176|P3|2-week Run-in Period|Physician Decision|0
2947870|NCT01323634|10148177|P2|2-week Run-in Period|Physician Decision|0
2947871|NCT01323634|10148178|P1|2-week Run-in Period|Physician Decision|5
2947872|NCT01323634|10148176|P3|2-week Run-in Period|Withdrawal by Subject|0
2947873|NCT01323634|10148177|P2|2-week Run-in Period|Withdrawal by Subject|0
2947874|NCT01323634|10148178|P1|2-week Run-in Period|Withdrawal by Subject|7
2947875|NCT01323634|10148176|P3|2-week Run-in Period|Continuation Criteria not Met|0
2947876|NCT01323634|10148177|P2|2-week Run-in Period|Continuation Criteria not Met|0
2947877|NCT01323634|10148178|P1|2-week Run-in Period|Continuation Criteria not Met|73
2947878|NCT01323634|10148176|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2947879|NCT01323634|10148177|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2947880|NCT01323634|10148178|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
2947881|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
2947882|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
2947883|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
2947884|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Physician Decision|1
2947885|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Physician Decision|2
2947886|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Physician Decision|0
2947887|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2947888|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
2947889|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2947890|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
2947891|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
2947892|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
2947893|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
2947894|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
2947895|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
2947896|NCT01323621|10148188|P3|12-week, Double-blind Treatment Period|Adverse Event|5
2947897|NCT01323621|10148189|P2|12-week, Double-blind Treatment Period|Adverse Event|1
2947898|NCT01323621|10148190|P1|12-week, Double-blind Treatment Period|Adverse Event|0
2947899|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2947900|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2947901|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
2947902|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
2947903|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
2947904|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
2947905|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Protocol Violation|0
2947906|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Protocol Violation|0
2947907|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Protocol Violation|1
2947908|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2947909|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2947910|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
2947911|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Physician Decision|0
2947912|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Physician Decision|0
2947913|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Physician Decision|7
2947914|NCT01323621|10148188|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2947915|NCT01323621|10148189|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2947916|NCT01323621|10148190|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
2947917|NCT01323582|10148211|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
2947918|NCT01323582|10148212|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
2947919|NCT01323582|10148211|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
2947920|NCT01323582|10148212|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
2947921|NCT01323582|10148211|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2947922|NCT01323582|10148212|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2947923|NCT01323478|10148235|P1|Overall Study|Administrative or Other Reasons|8
2947924|NCT01323478|10148235|P1|Overall Study|Withdrawal of Consent|1
2947925|NCT01323478|10148235|P1|Overall Study|Protocol Violation|1
2947926|NCT01323478|10148235|P1|Overall Study|Non-compliance With Study Product|3
2947927|NCT01323478|10148235|P1|Overall Study|Lack of Efficacy|4
2947928|NCT01323478|10148235|P1|Overall Study|Adverse Event|7
2947929|NCT01323387|10148248|P1|Overall Study|Randomized but Never Treated|16
2947930|NCT01323387|10148248|P1|Overall Study|Protocol Violation|12
2947931|NCT01323387|10148248|P1|Overall Study|Revision|14
2947932|NCT01323387|10148248|P1|Overall Study|Radiographic Data Unavailable|1
2947933|NCT01323387|10148248|P1|Overall Study|Withdrawal by Subject|41
2947934|NCT01323270|10148261|P2|Overall Study|Randomized, but not vaccinated|0
2947935|NCT01323270|10148262|P1|Overall Study|Randomized, but not vaccinated|1
2947936|NCT01323270|10148261|P2|Overall Study|Death|0
2947937|NCT01323270|10148262|P1|Overall Study|Death|1
2947938|NCT01323270|10148261|P2|Overall Study|Not eligible|1
2947939|NCT01323270|10148262|P1|Overall Study|Not eligible|1
2947940|NCT01323270|10148261|P2|Overall Study|Physician Decision|2
2947941|NCT01323270|10148262|P1|Overall Study|Physician Decision|0
2947942|NCT01323270|10148261|P2|Overall Study|Other|3
2947943|NCT01323270|10148262|P1|Overall Study|Other|0
2947944|NCT01323270|10148261|P2|Overall Study|Adverse Event|0
2947945|NCT01323270|10148262|P1|Overall Study|Adverse Event|8
2947946|NCT01323270|10148261|P2|Overall Study|Lost to Follow-up|6
2947947|NCT01323270|10148262|P1|Overall Study|Lost to Follow-up|4
2947948|NCT01323270|10148261|P2|Overall Study|Protocol Violation|7
2947949|NCT01323270|10148262|P1|Overall Study|Protocol Violation|9
2947950|NCT01323270|10148261|P2|Overall Study|Withdrawal by Subject|10
2947951|NCT01323270|10148262|P1|Overall Study|Withdrawal by Subject|19
2947952|NCT01323192|10148284|P2|Overall Study|Nonmedical reasons|1
2947953|NCT01323192|10148285|P1|Overall Study|Nonmedical reasons|0
2947954|NCT01323192|10148284|P2|Overall Study|Noncompliance with study medication|3
2947955|NCT01323192|10148285|P1|Overall Study|Noncompliance with study medication|0
2947956|NCT01323192|10148284|P2|Overall Study|Withdrawal by Subject|1
2947957|NCT01323192|10148285|P1|Overall Study|Withdrawal by Subject|3
2947958|NCT01323192|10148284|P2|Overall Study|Adverse Event|1
2947959|NCT01323192|10148285|P1|Overall Study|Adverse Event|6
2947960|NCT01322490|10148534|P3|Long Term Follow-up Period|Unknown/Missing|1
2947961|NCT01322490|10148535|P2|Long Term Follow-up Period|Unknown/Missing|1
2947962|NCT01322490|10148536|P1|Long Term Follow-up Period|Unknown/Missing|0
2947963|NCT01322490|10148534|P3|Long Term Follow-up Period|Other per report|2
2947964|NCT01322490|10148535|P2|Long Term Follow-up Period|Other per report|2
2947965|NCT01322490|10148536|P1|Long Term Follow-up Period|Other per report|3
2947966|NCT01322490|10148534|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
2947967|NCT01322490|10148535|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
2947968|NCT01322490|10148536|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
2947969|NCT01322490|10148534|P3|Long Term Follow-up Period|Withdrawal by Subject|6
2947970|NCT01322490|10148535|P2|Long Term Follow-up Period|Withdrawal by Subject|6
2947971|NCT01322490|10148536|P1|Long Term Follow-up Period|Withdrawal by Subject|9
2947972|NCT01322490|10148534|P3|Long Term Follow-up Period|Lost to Follow-up|3
2947973|NCT01322490|10148535|P2|Long Term Follow-up Period|Lost to Follow-up|2
2947974|NCT01322490|10148536|P1|Long Term Follow-up Period|Lost to Follow-up|2
2947975|NCT01322490|10148534|P3|Long Term Follow-up Period|Death|236
2947976|NCT01322490|10148535|P2|Long Term Follow-up Period|Death|239
2947977|NCT01322490|10148536|P1|Long Term Follow-up Period|Death|235
2947978|NCT01322490|10148534|P3|Treatment Period|Randomized but Not Treated|5
2947979|NCT01322490|10148535|P2|Treatment Period|Randomized but Not Treated|3
2947980|NCT01322490|10148536|P1|Treatment Period|Randomized but Not Treated|3
2947981|NCT01322490|10148534|P3|Treatment Period|Other per report|1
2947982|NCT01322490|10148535|P2|Treatment Period|Other per report|2
2947983|NCT01322490|10148536|P1|Treatment Period|Other per report|2
2947984|NCT01322490|10148534|P3|Treatment Period|Non-compliance with study drug|1
2947985|NCT01322490|10148535|P2|Treatment Period|Non-compliance with study drug|0
2947986|NCT01322490|10148536|P1|Treatment Period|Non-compliance with study drug|0
2947987|NCT01322490|10148534|P3|Treatment Period|Withdrawal by Subject|11
2947988|NCT01322490|10148535|P2|Treatment Period|Withdrawal by Subject|16
2947989|NCT01322490|10148536|P1|Treatment Period|Withdrawal by Subject|14
2947990|NCT01322490|10148534|P3|Treatment Period|Protocol Violation|4
2947991|NCT01322490|10148535|P2|Treatment Period|Protocol Violation|5
2947992|NCT01322490|10148536|P1|Treatment Period|Protocol Violation|7
2947993|NCT01322490|10148534|P3|Treatment Period|Physician Decision|1
2947994|NCT01322490|10148535|P2|Treatment Period|Physician Decision|2
2947995|NCT01322490|10148536|P1|Treatment Period|Physician Decision|0
2947996|NCT01322490|10148534|P3|Treatment Period|Lack of Efficacy|112
2947997|NCT01322490|10148535|P2|Treatment Period|Lack of Efficacy|100
2947998|NCT01322490|10148536|P1|Treatment Period|Lack of Efficacy|89
2947999|NCT01322490|10148534|P3|Treatment Period|Death|3
2948000|NCT01322490|10148535|P2|Treatment Period|Death|7
2948001|NCT01322490|10148536|P1|Treatment Period|Death|5
2948002|NCT01322490|10148534|P3|Treatment Period|Adverse Event|15
2948003|NCT01322490|10148535|P2|Treatment Period|Adverse Event|18
2948004|NCT01322490|10148536|P1|Treatment Period|Adverse Event|12
2948005|NCT01322386|10148549|P2|Overall Study|Physician Decision|1
2948006|NCT01322386|10148550|P1|Overall Study|Physician Decision|0
2948007|NCT01322386|10148549|P2|Overall Study|Protocol Violation|1
2948008|NCT01322386|10148550|P1|Overall Study|Protocol Violation|0
2948009|NCT01322347|10148565|P2|Overall Study|moved/changed dialysis|4
2948010|NCT01322347|10148566|P1|Overall Study|moved/changed dialysis|2
2948011|NCT01322347|10148565|P2|Overall Study|study drug withheld > 12 wks|1
2948012|NCT01322347|10148566|P1|Overall Study|study drug withheld > 12 wks|0
2948013|NCT01322347|10148565|P2|Overall Study|kidney transplant|1
2948014|NCT01322347|10148566|P1|Overall Study|kidney transplant|3
2948015|NCT01322347|10148565|P2|Overall Study|ineligible|3
2948016|NCT01322347|10148566|P1|Overall Study|ineligible|6
2948017|NCT01322347|10148565|P2|Overall Study|sponsor decision|3
2948018|NCT01322347|10148566|P1|Overall Study|sponsor decision|1
2948019|NCT01322347|10148565|P2|Overall Study|blood transfusion|5
2948020|NCT01322347|10148566|P1|Overall Study|blood transfusion|5
2948021|NCT01322347|10148565|P2|Overall Study|non-protocol change to ESA or IV iron|6
2948022|NCT01322347|10148566|P1|Overall Study|non-protocol change to ESA or IV iron|14
2948023|NCT01322347|10148565|P2|Overall Study|Withdrawal by Subject|4
2948024|NCT01322347|10148566|P1|Overall Study|Withdrawal by Subject|1
2948025|NCT01322347|10148565|P2|Overall Study|Protocol Violation|2
2948026|NCT01322347|10148566|P1|Overall Study|Protocol Violation|5
2948027|NCT01322347|10148565|P2|Overall Study|Physician Decision|1
2948028|NCT01322347|10148566|P1|Overall Study|Physician Decision|2
2948029|NCT01322347|10148565|P2|Overall Study|Death|3
2948030|NCT01322347|10148566|P1|Overall Study|Death|5
2948031|NCT01322347|10148565|P2|Overall Study|Adverse Event|2
2948032|NCT01322347|10148566|P1|Overall Study|Adverse Event|7
2948033|NCT01322009|10148629|P2|Overall Study|ng tube discontinued|1
2948034|NCT01322009|10148630|P1|Overall Study|ng tube discontinued|0
2948035|NCT01322009|10148629|P2|Overall Study|Adverse Event|1
2948036|NCT01322009|10148630|P1|Overall Study|Adverse Event|0
2948037|NCT01322009|10148629|P2|Overall Study|Death|1
2948038|NCT01322009|10148630|P1|Overall Study|Death|0
2948039|NCT01321879|10148638|P1|Overall Study|Withdrawal by Subject|1
2948040|NCT01321879|10148638|P1|Overall Study|Death|3
2948041|NCT01321879|10148638|P1|Overall Study|Adverse Event|5
2948042|NCT01321879|10148638|P1|Overall Study|Lack of Efficacy|5
2948043|NCT01321749|10148644|P2|Overall Study|Withdrawal by Subject|4
2948044|NCT01321749|10148645|P1|Overall Study|Withdrawal by Subject|5
2948045|NCT01321749|10148644|P2|Overall Study|Protocol Violation|7
2948046|NCT01321749|10148645|P1|Overall Study|Protocol Violation|4
2948047|NCT01321749|10148644|P2|Overall Study|Lost to Follow-up|11
2948048|NCT01321749|10148645|P1|Overall Study|Lost to Follow-up|4
2948049|NCT01321723|10148654|P3|Overall Study|Withdrawal by Subject|2
2948050|NCT01321723|10148655|P2|Overall Study|Withdrawal by Subject|0
2948051|NCT01321723|10148656|P1|Overall Study|Withdrawal by Subject|2
2948052|NCT01321723|10148654|P3|Overall Study|Adverse Event|2
2948053|NCT01321723|10148655|P2|Overall Study|Adverse Event|5
2948054|NCT01321723|10148656|P1|Overall Study|Adverse Event|3
2948055|NCT01321710|10148678|P3|Overall Study|Lost to Follow-up|0
2948056|NCT01321710|10148679|P2|Overall Study|Lost to Follow-up|5
2948057|NCT01321710|10148680|P1|Overall Study|Lost to Follow-up|4
2948058|NCT01321697|10148695|P1|Overall Study|Study Terminated|7
2948059|NCT01321606|10148701|P4|Overall Study|Lost to Follow-up|1
2948060|NCT01321606|10148702|P3|Overall Study|Lost to Follow-up|0
2948061|NCT01321606|10148703|P2|Overall Study|Lost to Follow-up|0
2948062|NCT01321606|10148704|P1|Overall Study|Lost to Follow-up|0
2948063|NCT01321073|10148740|P1|Overall Study|Death|3
2948064|NCT01321073|10148740|P1|Overall Study|Did not attempt implant|4
2948065|NCT01321008|10148744|P1|Overall Study|Early Study Termination|1
2948066|NCT01320943|10148750|P2|Overall Study|Randomized but not Treated|1
2948067|NCT01320943|10148751|P1|Overall Study|Randomized but not Treated|0
2948068|NCT01320943|10148750|P2|Overall Study|Physician Decision|1
2948069|NCT01320943|10148751|P1|Overall Study|Physician Decision|0
2948070|NCT01320943|10148750|P2|Overall Study|Lost to Follow-up|0
2948071|NCT01320943|10148751|P1|Overall Study|Lost to Follow-up|1
2948072|NCT01320735|10148785|P1|Overall Study|Investigator Unable to be Contacted|17
2948073|NCT01320735|10148785|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
2948074|NCT01320735|10148785|P1|Overall Study|Other|1
2948075|NCT01320735|10148785|P1|Overall Study|Protocol Violation|1
2948076|NCT01320735|10148785|P1|Overall Study|Progression/Hormone-Refractory Pca|55
2948077|NCT01320735|10148785|P1|Overall Study|Administrative Reason|6
2948078|NCT01320735|10148785|P1|Overall Study|Lost to Follow-up|13
2948079|NCT01320735|10148785|P1|Overall Study|Withdrawal by Subject|3
2948080|NCT01320735|10148785|P1|Overall Study|Adverse Event|3
2948081|NCT01320722|10148807|P5|Overall Study|Withdrew due to Health Condition|1
2948082|NCT01320722|10148808|P4|Overall Study|Withdrew due to Health Condition|0
2948083|NCT01320722|10148809|P3|Overall Study|Withdrew due to Health Condition|0
2948084|NCT01320722|10148810|P2|Overall Study|Withdrew due to Health Condition|0
2948085|NCT01320722|10148811|P1|Overall Study|Withdrew due to Health Condition|0
2948086|NCT01320722|10148807|P5|Overall Study|Started an Exclusionary Medication|1
2948087|NCT01320722|10148808|P4|Overall Study|Started an Exclusionary Medication|0
2948088|NCT01320722|10148809|P3|Overall Study|Started an Exclusionary Medication|0
2948089|NCT01320722|10148810|P2|Overall Study|Started an Exclusionary Medication|0
2948090|NCT01320722|10148811|P1|Overall Study|Started an Exclusionary Medication|0
2948091|NCT01320722|10148807|P5|Overall Study|Pregnancy|0
2948092|NCT01320722|10148808|P4|Overall Study|Pregnancy|1
2948093|NCT01320722|10148809|P3|Overall Study|Pregnancy|0
2948094|NCT01320722|10148810|P2|Overall Study|Pregnancy|0
2948095|NCT01320722|10148811|P1|Overall Study|Pregnancy|0
2948096|NCT01320722|10148807|P5|Overall Study|Not Compliant with Study Procedures|0
2948097|NCT01320722|10148808|P4|Overall Study|Not Compliant with Study Procedures|4
2948098|NCT01320722|10148809|P3|Overall Study|Not Compliant with Study Procedures|0
2948099|NCT01320722|10148810|P2|Overall Study|Not Compliant with Study Procedures|0
2948100|NCT01320722|10148811|P1|Overall Study|Not Compliant with Study Procedures|0
2948101|NCT01320722|10148807|P5|Overall Study|Adverse Event|0
2948102|NCT01320722|10148808|P4|Overall Study|Adverse Event|6
2948103|NCT01320722|10148809|P3|Overall Study|Adverse Event|3
2948104|NCT01320722|10148810|P2|Overall Study|Adverse Event|0
2948105|NCT01320722|10148811|P1|Overall Study|Adverse Event|0
2948106|NCT01320722|10148807|P5|Overall Study|Non-compliant with Medication|0
2948107|NCT01320722|10148808|P4|Overall Study|Non-compliant with Medication|0
2948108|NCT01320722|10148809|P3|Overall Study|Non-compliant with Medication|1
2948109|NCT01320722|10148810|P2|Overall Study|Non-compliant with Medication|0
2948110|NCT01320722|10148811|P1|Overall Study|Non-compliant with Medication|0
2948111|NCT01320722|10148807|P5|Overall Study|Participant Developed a Rash|1
2948112|NCT01320722|10148808|P4|Overall Study|Participant Developed a Rash|1
2948113|NCT01320722|10148809|P3|Overall Study|Participant Developed a Rash|2
2948114|NCT01320722|10148810|P2|Overall Study|Participant Developed a Rash|0
2948115|NCT01320722|10148811|P1|Overall Study|Participant Developed a Rash|0
2948116|NCT01320722|10148807|P5|Overall Study|Not Available for the 8 Week Visit|0
2948117|NCT01320722|10148808|P4|Overall Study|Not Available for the 8 Week Visit|0
2948118|NCT01320722|10148809|P3|Overall Study|Not Available for the 8 Week Visit|0
2948119|NCT01320722|10148810|P2|Overall Study|Not Available for the 8 Week Visit|3
2948120|NCT01320722|10148811|P1|Overall Study|Not Available for the 8 Week Visit|0
2948121|NCT01320722|10148807|P5|Overall Study|Lost to Follow-up|3
2948122|NCT01320722|10148808|P4|Overall Study|Lost to Follow-up|1
2948123|NCT01320722|10148809|P3|Overall Study|Lost to Follow-up|0
2948124|NCT01320722|10148810|P2|Overall Study|Lost to Follow-up|1
2948125|NCT01320722|10148811|P1|Overall Study|Lost to Follow-up|0
2948126|NCT01320722|10148807|P5|Overall Study|Did not Receive Intervention|2
2948127|NCT01320722|10148808|P4|Overall Study|Did not Receive Intervention|1
2948128|NCT01320722|10148809|P3|Overall Study|Did not Receive Intervention|1
2948129|NCT01320722|10148810|P2|Overall Study|Did not Receive Intervention|2
2948130|NCT01320722|10148811|P1|Overall Study|Did not Receive Intervention|3
2948131|NCT01320683|10148848|P1|Overall Study|Positive antibody response|1
2948132|NCT01320293|10148874|P1|Overall Study|Adverse Event|1
2948133|NCT01320293|10148874|P1|Overall Study|Lack of Efficacy|1
2948134|NCT01320202|10148882|P2|Overall Study|regained renal function|0
2948135|NCT01320202|10148883|P1|Overall Study|regained renal function|1
2948136|NCT01320202|10148882|P2|Overall Study|ineligible|0
2948137|NCT01320202|10148883|P1|Overall Study|ineligible|3
2948138|NCT01320202|10148882|P2|Overall Study|sponsor request|0
2948139|NCT01320202|10148883|P1|Overall Study|sponsor request|2
2948140|NCT01320202|10148882|P2|Overall Study|moved/changed dialysis|2
2948141|NCT01320202|10148883|P1|Overall Study|moved/changed dialysis|5
2948142|NCT01320202|10148882|P2|Overall Study|blood transfusion|7
2948143|NCT01320202|10148883|P1|Overall Study|blood transfusion|1
2948144|NCT01320202|10148882|P2|Overall Study|kidney transplant|2
2948145|NCT01320202|10148883|P1|Overall Study|kidney transplant|1
2948146|NCT01320202|10148882|P2|Overall Study|non-protocol change to ESA or IV iron|20
2948147|NCT01320202|10148883|P1|Overall Study|non-protocol change to ESA or IV iron|17
2948148|NCT01320202|10148882|P2|Overall Study|Withdrawal by Subject|3
2948149|NCT01320202|10148883|P1|Overall Study|Withdrawal by Subject|10
2948150|NCT01320202|10148882|P2|Overall Study|Protocol Violation|1
2948151|NCT01320202|10148883|P1|Overall Study|Protocol Violation|2
2948152|NCT01320202|10148882|P2|Overall Study|Physician Decision|1
2948153|NCT01320202|10148883|P1|Overall Study|Physician Decision|3
2948154|NCT01320202|10148882|P2|Overall Study|Lost to Follow-up|0
2948155|NCT01320202|10148883|P1|Overall Study|Lost to Follow-up|1
2948156|NCT01320202|10148882|P2|Overall Study|Death|3
2948157|NCT01320202|10148883|P1|Overall Study|Death|5
2948158|NCT01320202|10148882|P2|Overall Study|Adverse Event|5
2948159|NCT01320202|10148883|P1|Overall Study|Adverse Event|5
2948160|NCT01320150|10148920|P1|Overall Study|Lost to Follow-up|44
2948161|NCT01320150|10148920|P1|Overall Study|Death|2
2948162|NCT01320150|10148920|P1|Overall Study|Withdrawal by Subject|5
2948163|NCT01320150|10148920|P1|Overall Study|Protocol Violation|15
2948164|NCT01320033|10148954|P3|Overall Study|Other|1
2948165|NCT01320033|10148955|P2|Overall Study|Other|3
2948166|NCT01320033|10148956|P1|Overall Study|Other|2
2948167|NCT01320033|10148954|P3|Overall Study|Lost to Follow-up|17
2948168|NCT01320033|10148955|P2|Overall Study|Lost to Follow-up|26
2948169|NCT01320033|10148956|P1|Overall Study|Lost to Follow-up|22
2948170|NCT01320033|10148954|P3|Overall Study|Protocol Violation|3
2948171|NCT01320033|10148955|P2|Overall Study|Protocol Violation|5
2948172|NCT01320033|10148956|P1|Overall Study|Protocol Violation|3
2948173|NCT01320033|10148954|P3|Overall Study|Withdrawal by Subject|23
2948174|NCT01320033|10148955|P2|Overall Study|Withdrawal by Subject|23
2948175|NCT01320033|10148956|P1|Overall Study|Withdrawal by Subject|22
2948176|NCT01320033|10148954|P3|Overall Study|Adverse Event|8
2948177|NCT01320033|10148955|P2|Overall Study|Adverse Event|7
2948178|NCT01320033|10148956|P1|Overall Study|Adverse Event|9
2948179|NCT01320033|10148954|P3|Overall Study|Lack of Efficacy|1
2948180|NCT01320033|10148955|P2|Overall Study|Lack of Efficacy|0
2948181|NCT01320033|10148956|P1|Overall Study|Lack of Efficacy|0
2948182|NCT01319994|10148984|P2|Overall Study|Protocol Violation|6
2948183|NCT01319994|10148985|P1|Overall Study|Protocol Violation|7
2948184|NCT01319929|10148995|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
2948185|NCT01319929|10148996|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
2948186|NCT01319929|10148995|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
2948187|NCT01319929|10148996|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
2948188|NCT01319929|10148995|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
2948189|NCT01319929|10148996|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
2948190|NCT01319929|10148995|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
2948191|NCT01319929|10148996|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
2948192|NCT01319929|10148995|P2|First Treatment Period (4 Weeks)|Adverse Event|0
2948193|NCT01319929|10148996|P1|First Treatment Period (4 Weeks)|Adverse Event|2
2948194|NCT01319877|10149028|P2|Overall Study|Reason Not Specified|5
2948195|NCT01319877|10149029|P1|Overall Study|Reason Not Specified|4
2948196|NCT01319877|10149028|P2|Overall Study|Withdrawal by Subject|1
2948197|NCT01319877|10149029|P1|Overall Study|Withdrawal by Subject|0
2948198|NCT01319877|10149028|P2|Overall Study|Disease Progression|2
2948199|NCT01319877|10149029|P1|Overall Study|Disease Progression|2
2948200|NCT01319877|10149028|P2|Overall Study|Physician Decision|0
2948201|NCT01319877|10149029|P1|Overall Study|Physician Decision|2
2948202|NCT01319877|10149028|P2|Overall Study|Lost to Follow-up|37
2948203|NCT01319877|10149029|P1|Overall Study|Lost to Follow-up|100
2948204|NCT01319721|10149197|P2|Overall Study|Lost to Follow-up|6
2948205|NCT01319721|10149198|P1|Overall Study|Lost to Follow-up|1
2948206|NCT01319422|10149251|P2|Overall Study|Withdrawal by Subject|0
2948207|NCT01319422|10149252|P1|Overall Study|Withdrawal by Subject|1
2948208|NCT01319383|10149270|P2|Overall Study|No in vivo response to interval doses|1
2948209|NCT01319383|10149271|P1|Overall Study|No in vivo response to interval doses|0
2948210|NCT01319383|10149270|P2|Overall Study|Lack of Efficacy|9
2948211|NCT01319383|10149271|P1|Overall Study|Lack of Efficacy|5
2948212|NCT01319383|10149270|P2|Overall Study|Physician Decision|0
2948213|NCT01319383|10149271|P1|Overall Study|Physician Decision|3
2948214|NCT01319383|10149270|P2|Overall Study|No ex vivo or in vivo response|0
2948215|NCT01319383|10149271|P1|Overall Study|No ex vivo or in vivo response|4
2948216|NCT01318993|10149310|P1|Overall Study|Withdrawal by Subject|24
2948217|NCT01318993|10149310|P1|Overall Study|Physician Decision|13
2948218|NCT01318993|10149310|P1|Overall Study|Lost to Follow-up|4
2948219|NCT01318993|10149310|P1|Overall Study|Study closed or terminated|174
2948220|NCT01318993|10149310|P1|Overall Study|Protocol based stopping criteria|6
2948221|NCT01318993|10149310|P1|Overall Study|Protocol Violation|3
2948222|NCT01318993|10149310|P1|Overall Study|Lack of Efficacy|121
2948223|NCT01318993|10149310|P1|Overall Study|Adverse Event|53
2948224|NCT01318915|10149331|P1|Overall Study|Lost to Follow-up|1
2948225|NCT01318902|10149360|P4|Overall Study|Terminated by Sponsor|0
2948226|NCT01318902|10149361|P3|Overall Study|Terminated by Sponsor|1
2948227|NCT01318902|10149362|P2|Overall Study|Terminated by Sponsor|0
2948228|NCT01318902|10149363|P1|Overall Study|Terminated by Sponsor|0
2948229|NCT01318902|10149360|P4|Overall Study|Adverse Event|0
2948230|NCT01318902|10149361|P3|Overall Study|Adverse Event|0
2948231|NCT01318902|10149362|P2|Overall Study|Adverse Event|1
2948232|NCT01318902|10149363|P1|Overall Study|Adverse Event|0
2948233|NCT01318902|10149360|P4|Overall Study|Unsatisfactory Therapeutic Response|1
2948234|NCT01318902|10149361|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2948235|NCT01318902|10149362|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2948236|NCT01318902|10149363|P1|Overall Study|Unsatisfactory Therapeutic Response|1
2948237|NCT01318902|10149360|P4|Overall Study|Withdrawal by Patient|3
2948238|NCT01318902|10149361|P3|Overall Study|Withdrawal by Patient|0
2948239|NCT01318902|10149362|P2|Overall Study|Withdrawal by Patient|1
2948240|NCT01318902|10149363|P1|Overall Study|Withdrawal by Patient|0
2948241|NCT01318902|10149360|P4|Overall Study|Symptomatic Deterioration|2
2948242|NCT01318902|10149361|P3|Overall Study|Symptomatic Deterioration|1
2948243|NCT01318902|10149362|P2|Overall Study|Symptomatic Deterioration|1
2948244|NCT01318902|10149363|P1|Overall Study|Symptomatic Deterioration|0
2948245|NCT01318876|10149440|P1|Day 29 Survey|survey not completed-don't know why|1825
2948246|NCT01318876|10149440|P1|Day 8 Survey|survey not completed-don't know why|1724
2948247|NCT01318876|10149440|P1|Day 8 Survey|email address invalid|96
2948248|NCT01318811|10149447|P2|Overall Study|CRRT stopped for head MRI|1
2948249|NCT01318811|10149448|P1|Overall Study|CRRT stopped for head MRI|0
2948250|NCT01318811|10149447|P2|Overall Study|Death|1
2948251|NCT01318811|10149448|P1|Overall Study|Death|0
2948252|NCT01318811|10149447|P2|Overall Study|CRRT stopped for head CT|1
2948253|NCT01318811|10149448|P1|Overall Study|CRRT stopped for head CT|0
2948254|NCT01318811|10149447|P2|Overall Study|Physician Decision|1
2948255|NCT01318811|10149448|P1|Overall Study|Physician Decision|1
2948256|NCT01318512|10149549|P1|Maintenance Period (6 Months)|Protocol Violation|9
2948257|NCT01318512|10149549|P1|Maintenance Period (6 Months)|Death|2
2948258|NCT01318499|10149568|P3|Overall Study|Other|22
2948259|NCT01318499|10149569|P2|Overall Study|Other|10
2948260|NCT01318499|10149570|P1|Overall Study|Other|7
2948261|NCT01318499|10149568|P3|Overall Study|Patient Did Not Use Study Medication|14
2948262|NCT01318499|10149569|P2|Overall Study|Patient Did Not Use Study Medication|28
2948263|NCT01318499|10149570|P1|Overall Study|Patient Did Not Use Study Medication|18
2948264|NCT01318499|10149568|P3|Overall Study|Protocol Violation|2
2948265|NCT01318499|10149569|P2|Overall Study|Protocol Violation|4
2948266|NCT01318499|10149570|P1|Overall Study|Protocol Violation|2
2948267|NCT01318499|10149568|P3|Overall Study|Treatment Failure|101
2948268|NCT01318499|10149569|P2|Overall Study|Treatment Failure|19
2948269|NCT01318499|10149570|P1|Overall Study|Treatment Failure|19
2948270|NCT01318499|10149568|P3|Overall Study|Noncompliance|0
2948271|NCT01318499|10149569|P2|Overall Study|Noncompliance|3
2948272|NCT01318499|10149570|P1|Overall Study|Noncompliance|2
2948273|NCT01318499|10149568|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
2948274|NCT01318499|10149569|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
2948275|NCT01318499|10149570|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
2948276|NCT01318499|10149568|P3|Overall Study|Adverse Event|6
2948277|NCT01318499|10149569|P2|Overall Study|Adverse Event|11
2948278|NCT01318499|10149570|P1|Overall Study|Adverse Event|16
2948279|NCT01318382|10149593|P1|Overall Study|Protocol Violation|1
2948280|NCT01318382|10149593|P1|Overall Study|Device Malfunction|10
2948281|NCT01318382|10149593|P1|Overall Study|Physician Decision|2
2948282|NCT01318135|10149651|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
2948283|NCT01318135|10149652|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948284|NCT01318135|10149653|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948285|NCT01318135|10149654|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948286|NCT01318135|10149655|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948287|NCT01318135|10149656|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948288|NCT01318135|10149657|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948289|NCT01318135|10149658|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2948290|NCT01318135|10149651|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
2948291|NCT01318135|10149652|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
2948292|NCT01318135|10149653|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
2948293|NCT01318135|10149654|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
2948294|NCT01318135|10149655|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
2948295|NCT01318135|10149656|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
2948296|NCT01318135|10149657|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
2948297|NCT01318135|10149658|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
2948298|NCT01318135|10149651|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2948299|NCT01318135|10149652|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2948300|NCT01318135|10149653|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2948301|NCT01318135|10149654|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2948302|NCT01318135|10149655|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2948303|NCT01318135|10149656|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2948304|NCT01318135|10149657|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2948305|NCT01318135|10149658|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2948306|NCT01318135|10149651|P8|Entered - Long-Term Extension Study|Protocol Violation|0
2948307|NCT01318135|10149652|P7|Entered - Long-Term Extension Study|Protocol Violation|0
2948308|NCT01318135|10149653|P6|Entered - Long-Term Extension Study|Protocol Violation|0
2948309|NCT01318135|10149654|P5|Entered - Long-Term Extension Study|Protocol Violation|1
2948310|NCT01318135|10149655|P4|Entered - Long-Term Extension Study|Protocol Violation|0
2948311|NCT01318135|10149656|P3|Entered - Long-Term Extension Study|Protocol Violation|0
2948312|NCT01318135|10149657|P2|Entered - Long-Term Extension Study|Protocol Violation|1
2948313|NCT01318135|10149658|P1|Entered - Long-Term Extension Study|Protocol Violation|1
2948314|NCT01318135|10149651|P8|Entered - Long-Term Extension Study|Adverse Event|0
2948315|NCT01318135|10149652|P7|Entered - Long-Term Extension Study|Adverse Event|0
2948316|NCT01318135|10149653|P6|Entered - Long-Term Extension Study|Adverse Event|2
2948317|NCT01318135|10149654|P5|Entered - Long-Term Extension Study|Adverse Event|4
2948318|NCT01318135|10149655|P4|Entered - Long-Term Extension Study|Adverse Event|3
2948319|NCT01318135|10149656|P3|Entered - Long-Term Extension Study|Adverse Event|4
2948320|NCT01318135|10149657|P2|Entered - Long-Term Extension Study|Adverse Event|3
2948321|NCT01318135|10149658|P1|Entered - Long-Term Extension Study|Adverse Event|9
2948322|NCT01318135|10149651|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948323|NCT01318135|10149652|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948324|NCT01318135|10149653|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948325|NCT01318135|10149654|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948326|NCT01318135|10149655|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948327|NCT01318135|10149656|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948328|NCT01318135|10149657|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
2948329|NCT01318135|10149658|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
2948330|NCT01318135|10149651|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
2948331|NCT01318135|10149652|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
2948332|NCT01318135|10149653|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
2948333|NCT01318135|10149654|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
2948334|NCT01318135|10149655|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
2948335|NCT01318135|10149656|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
2948336|NCT01318135|10149657|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2948337|NCT01318135|10149658|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
2948338|NCT01318122|10149790|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
2948339|NCT01318122|10149791|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
2948340|NCT01318122|10149792|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
2948341|NCT01318122|10149793|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
2948342|NCT01318122|10149790|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2948343|NCT01318122|10149791|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2948344|NCT01318122|10149792|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
2948345|NCT01318122|10149793|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2948346|NCT01318122|10149790|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
2948347|NCT01318122|10149791|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
2948348|NCT01318122|10149792|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
2948349|NCT01318122|10149793|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
2948350|NCT01318122|10149790|P4|Entered - Long-Term Extension Study|Adverse Event|4
2948351|NCT01318122|10149791|P3|Entered - Long-Term Extension Study|Adverse Event|2
2948352|NCT01318122|10149792|P2|Entered - Long-Term Extension Study|Adverse Event|6
2948353|NCT01318122|10149793|P1|Entered - Long-Term Extension Study|Adverse Event|6
2948354|NCT01318122|10149790|P4|Enrolled - Long-Term Extension Study|Other|0
2948355|NCT01318122|10149791|P3|Enrolled - Long-Term Extension Study|Other|0
2948356|NCT01318122|10149792|P2|Enrolled - Long-Term Extension Study|Other|0
2948357|NCT01318122|10149793|P1|Enrolled - Long-Term Extension Study|Other|1
2948358|NCT01318122|10149790|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
2948359|NCT01318122|10149791|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
2948360|NCT01318122|10149792|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2948361|NCT01318122|10149793|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
2948362|NCT01318109|10149862|P3|Overall Study|Schedule Conflict|0
2948363|NCT01318109|10149863|P2|Overall Study|Schedule Conflict|1
2948364|NCT01318109|10149864|P1|Overall Study|Schedule Conflict|0
2948365|NCT01318109|10149862|P3|Overall Study|Withdrawal by Subject|0
2948366|NCT01318109|10149863|P2|Overall Study|Withdrawal by Subject|0
2948367|NCT01318109|10149864|P1|Overall Study|Withdrawal by Subject|1
2948368|NCT01318109|10149862|P3|Overall Study|Adverse Event|0
2948369|NCT01318109|10149863|P2|Overall Study|Adverse Event|2
2948370|NCT01318109|10149864|P1|Overall Study|Adverse Event|0
2948371|NCT01318083|10149899|P3|Overall Study|Lack of Study Medication Compliance|0
2948372|NCT01318083|10149900|P2|Overall Study|Lack of Study Medication Compliance|1
2948373|NCT01318083|10149901|P1|Overall Study|Lack of Study Medication Compliance|0
2948374|NCT01318083|10149899|P3|Overall Study|Treatment Complications|0
2948375|NCT01318083|10149900|P2|Overall Study|Treatment Complications|0
2948376|NCT01318083|10149901|P1|Overall Study|Treatment Complications|1
2948377|NCT01318083|10149899|P3|Overall Study|Lack of Efficacy|1
2948378|NCT01318083|10149900|P2|Overall Study|Lack of Efficacy|0
2948379|NCT01318083|10149901|P1|Overall Study|Lack of Efficacy|0
2948380|NCT01318083|10149899|P3|Overall Study|Withdrawal by Subject|2
2948381|NCT01318083|10149900|P2|Overall Study|Withdrawal by Subject|0
2948382|NCT01318083|10149901|P1|Overall Study|Withdrawal by Subject|1
2948383|NCT01318083|10149899|P3|Overall Study|Adverse Event|2
2948384|NCT01318083|10149900|P2|Overall Study|Adverse Event|1
2948385|NCT01318083|10149901|P1|Overall Study|Adverse Event|4
2948386|NCT01318070|10149936|P3|Overall Study|Principal Investigator Discretion|0
2948387|NCT01318070|10149937|P2|Overall Study|Principal Investigator Discretion|0
2948388|NCT01318070|10149938|P1|Overall Study|Principal Investigator Discretion|1
2948389|NCT01318070|10149936|P3|Overall Study|Lack of Efficacy|1
2948390|NCT01318070|10149937|P2|Overall Study|Lack of Efficacy|0
2948391|NCT01318070|10149938|P1|Overall Study|Lack of Efficacy|0
2948392|NCT01318070|10149936|P3|Overall Study|Withdrawal by Subject|1
2948393|NCT01318070|10149937|P2|Overall Study|Withdrawal by Subject|1
2948394|NCT01318070|10149938|P1|Overall Study|Withdrawal by Subject|0
2948395|NCT01318070|10149936|P3|Overall Study|Adverse Event|5
2948396|NCT01318070|10149937|P2|Overall Study|Adverse Event|1
2948397|NCT01318070|10149938|P1|Overall Study|Adverse Event|1
2948398|NCT01317797|10149991|P3|Overall Study|Withdrawal of Patient|1
2948399|NCT01317797|10149992|P2|Overall Study|Withdrawal of Patient|0
2948400|NCT01317797|10149993|P1|Overall Study|Withdrawal of Patient|0
2948401|NCT01317797|10149991|P3|Overall Study|Other|0
2948402|NCT01317797|10149992|P2|Overall Study|Other|1
2948403|NCT01317797|10149993|P1|Overall Study|Other|0
2948404|NCT01317641|10150070|P9|Overall Study|Withdrawal by Subject|0
2948405|NCT01317641|10150071|P8|Overall Study|Withdrawal by Subject|0
2948406|NCT01317641|10150072|P7|Overall Study|Withdrawal by Subject|1
2948407|NCT01317641|10150073|P6|Overall Study|Withdrawal by Subject|0
2948408|NCT01317641|10150074|P5|Overall Study|Withdrawal by Subject|0
2948409|NCT01317641|10150075|P4|Overall Study|Withdrawal by Subject|0
2948410|NCT01317641|10150076|P3|Overall Study|Withdrawal by Subject|0
2948411|NCT01317641|10150077|P2|Overall Study|Withdrawal by Subject|0
2948412|NCT01317641|10150078|P1|Overall Study|Withdrawal by Subject|0
2948413|NCT01317641|10150070|P9|Overall Study|Disease progression|4
2948414|NCT01317641|10150071|P8|Overall Study|Disease progression|3
2948415|NCT01317641|10150072|P7|Overall Study|Disease progression|0
2948416|NCT01317641|10150073|P6|Overall Study|Disease progression|0
2948417|NCT01317641|10150074|P5|Overall Study|Disease progression|0
2948418|NCT01317641|10150075|P4|Overall Study|Disease progression|0
2948419|NCT01317641|10150076|P3|Overall Study|Disease progression|0
2948420|NCT01317641|10150077|P2|Overall Study|Disease progression|0
2948421|NCT01317641|10150078|P1|Overall Study|Disease progression|0
2948422|NCT01317641|10150070|P9|Overall Study|Protocol Violation|0
2948423|NCT01317641|10150071|P8|Overall Study|Protocol Violation|0
2948424|NCT01317641|10150072|P7|Overall Study|Protocol Violation|0
2948425|NCT01317641|10150073|P6|Overall Study|Protocol Violation|0
2948426|NCT01317641|10150074|P5|Overall Study|Protocol Violation|0
2948427|NCT01317641|10150075|P4|Overall Study|Protocol Violation|0
2948428|NCT01317641|10150076|P3|Overall Study|Protocol Violation|0
2948429|NCT01317641|10150077|P2|Overall Study|Protocol Violation|0
2948430|NCT01317641|10150078|P1|Overall Study|Protocol Violation|1
2948431|NCT01317641|10150070|P9|Overall Study|Adverse Event|0
2948432|NCT01317641|10150071|P8|Overall Study|Adverse Event|1
2948433|NCT01317641|10150072|P7|Overall Study|Adverse Event|2
2948434|NCT01317641|10150073|P6|Overall Study|Adverse Event|0
2948435|NCT01317641|10150074|P5|Overall Study|Adverse Event|0
2948436|NCT01317641|10150075|P4|Overall Study|Adverse Event|1
2948437|NCT01317641|10150076|P3|Overall Study|Adverse Event|0
2948438|NCT01317641|10150077|P2|Overall Study|Adverse Event|1
2948439|NCT01317641|10150078|P1|Overall Study|Adverse Event|0
2948440|NCT01317641|10150070|P9|Overall Study|Not treated|1
2948441|NCT01317641|10150071|P8|Overall Study|Not treated|1
2948442|NCT01317641|10150072|P7|Overall Study|Not treated|0
2948443|NCT01317641|10150073|P6|Overall Study|Not treated|0
2948444|NCT01317641|10150074|P5|Overall Study|Not treated|0
2948445|NCT01317641|10150075|P4|Overall Study|Not treated|0
2948446|NCT01317641|10150076|P3|Overall Study|Not treated|0
2948447|NCT01317641|10150077|P2|Overall Study|Not treated|0
2948448|NCT01317641|10150078|P1|Overall Study|Not treated|0
2948449|NCT01317615|10150180|P1|Overall Study|Adverse Event|7
2948450|NCT01317615|10150180|P1|Overall Study|Abnormal laboratory value(s)|1
2948451|NCT01317615|10150180|P1|Overall Study|Withdrawal by Subject|5
2948452|NCT01317615|10150180|P1|Overall Study|Death|6
2948453|NCT01317615|10150180|P1|Overall Study|New cancer therapy|5
2948454|NCT01317615|10150180|P1|Overall Study|Disease progression|25
2948455|NCT01317550|10150193|P4|Overall Study|Lack of compliance study med|0
2948456|NCT01317550|10150194|P3|Overall Study|Lack of compliance study med|0
2948457|NCT01317550|10150195|P2|Overall Study|Lack of compliance study med|0
2948458|NCT01317550|10150196|P1|Overall Study|Lack of compliance study med|1
2948459|NCT01317550|10150193|P4|Overall Study|Withdrawal by Subject|0
2948460|NCT01317550|10150194|P3|Overall Study|Withdrawal by Subject|0
2948461|NCT01317550|10150195|P2|Overall Study|Withdrawal by Subject|0
2948462|NCT01317550|10150196|P1|Overall Study|Withdrawal by Subject|1
2948463|NCT01317472|10150208|P2|Overall Study|Unrelated hospitalization|0
2948464|NCT01317472|10150209|P1|Overall Study|Unrelated hospitalization|1
2948465|NCT01317472|10150208|P2|Overall Study|Withdrawal by Subject|0
2948466|NCT01317472|10150209|P1|Overall Study|Withdrawal by Subject|1
2948467|NCT01317199|10150219|P4|Randomized Phase 2|Patient transferred to other facility|0
2948468|NCT01317199|10150220|P3|Randomized Phase 2|Patient transferred to other facility|1
2948469|NCT01317199|10150221|P2|Randomized Phase 2|Patient transferred to other facility|0
2948470|NCT01317199|10150222|P1|Randomized Phase 2|Patient transferred to other facility|0
2948471|NCT01317199|10150219|P4|Randomized Phase 2|Patient stopped taking study drug|1
2948472|NCT01317199|10150220|P3|Randomized Phase 2|Patient stopped taking study drug|0
2948473|NCT01317199|10150221|P2|Randomized Phase 2|Patient stopped taking study drug|0
2948474|NCT01317199|10150222|P1|Randomized Phase 2|Patient stopped taking study drug|0
2948475|NCT01317199|10150219|P4|Randomized Phase 2|Disenrolled before treatment|2
2948476|NCT01317199|10150220|P3|Randomized Phase 2|Disenrolled before treatment|1
2948477|NCT01317199|10150221|P2|Randomized Phase 2|Disenrolled before treatment|1
2948478|NCT01317199|10150222|P1|Randomized Phase 2|Disenrolled before treatment|0
2948479|NCT01317199|10150219|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2948480|NCT01317199|10150220|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
2948481|NCT01317199|10150221|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2948482|NCT01317199|10150222|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
2948483|NCT01317199|10150219|P4|Randomized Phase 2|Comorbidities|2
2948484|NCT01317199|10150220|P3|Randomized Phase 2|Comorbidities|2
2948485|NCT01317199|10150221|P2|Randomized Phase 2|Comorbidities|2
2948486|NCT01317199|10150222|P1|Randomized Phase 2|Comorbidities|0
2948487|NCT01317199|10150219|P4|Randomized Phase 2|Adverse Event|1
2948488|NCT01317199|10150220|P3|Randomized Phase 2|Adverse Event|0
2948489|NCT01317199|10150221|P2|Randomized Phase 2|Adverse Event|0
2948490|NCT01317199|10150222|P1|Randomized Phase 2|Adverse Event|0
2948491|NCT01317199|10150219|P4|Randomized Phase 2|Withdrawal by Subject|4
2948492|NCT01317199|10150220|P3|Randomized Phase 2|Withdrawal by Subject|5
2948493|NCT01317199|10150221|P2|Randomized Phase 2|Withdrawal by Subject|3
2948494|NCT01317199|10150222|P1|Randomized Phase 2|Withdrawal by Subject|0
2948495|NCT01317199|10150219|P4|Randomized Phase 2|Disease progression|5
2948496|NCT01317199|10150220|P3|Randomized Phase 2|Disease progression|7
2948497|NCT01317199|10150221|P2|Randomized Phase 2|Disease progression|3
2948498|NCT01317199|10150222|P1|Randomized Phase 2|Disease progression|0
2948499|NCT01317199|10150219|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2948500|NCT01317199|10150220|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2948501|NCT01317199|10150221|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2948502|NCT01317199|10150222|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
2948503|NCT01317199|10150219|P4|Dose-escalation Phase 1|Disease progression|0
2948504|NCT01317199|10150220|P3|Dose-escalation Phase 1|Disease progression|0
2948505|NCT01317199|10150221|P2|Dose-escalation Phase 1|Disease progression|0
2948506|NCT01317199|10150222|P1|Dose-escalation Phase 1|Disease progression|1
2948507|NCT01317199|10150219|P4|Dose-escalation Phase 1|Physician Decision|0
2948508|NCT01317199|10150220|P3|Dose-escalation Phase 1|Physician Decision|0
2948509|NCT01317199|10150221|P2|Dose-escalation Phase 1|Physician Decision|0
2948510|NCT01317199|10150222|P1|Dose-escalation Phase 1|Physician Decision|5
2948511|NCT01317160|10150251|P2|Overall Study|Withdrawal by Subject|2
2948512|NCT01317160|10150252|P1|Overall Study|Withdrawal by Subject|0
2948513|NCT01317160|10150251|P2|Overall Study|Lost to Follow-up|3
2948514|NCT01317160|10150252|P1|Overall Study|Lost to Follow-up|3
2948515|NCT01317160|10150251|P2|Overall Study|Incorrect inclusion|1
2948516|NCT01317160|10150252|P1|Overall Study|Incorrect inclusion|1
2948517|NCT01317004|10150286|P2|Overall Study|Adverse Event|3
2948518|NCT01317004|10150287|P1|Overall Study|Adverse Event|3
2948519|NCT01317004|10150286|P2|Overall Study|Protocol Violation|2
2948520|NCT01317004|10150287|P1|Overall Study|Protocol Violation|0
2948521|NCT01317004|10150286|P2|Overall Study|Withdrawal by Subject|4
2948522|NCT01317004|10150287|P1|Overall Study|Withdrawal by Subject|1
2948523|NCT01316939|10150308|P3|Overall Study|Protocol Violation|0
2948524|NCT01316939|10150309|P2|Overall Study|Protocol Violation|1
2948525|NCT01316939|10150310|P1|Overall Study|Protocol Violation|0
2948526|NCT01316939|10150308|P3|Overall Study|Met Liver chemistry stopping criteria|1
2948527|NCT01316939|10150309|P2|Overall Study|Met Liver chemistry stopping criteria|0
2948528|NCT01316939|10150310|P1|Overall Study|Met Liver chemistry stopping criteria|1
2948529|NCT01316939|10150308|P3|Overall Study|Lost to Follow-up|2
2948530|NCT01316939|10150309|P2|Overall Study|Lost to Follow-up|0
2948531|NCT01316939|10150310|P1|Overall Study|Lost to Follow-up|0
2948532|NCT01316939|10150308|P3|Overall Study|Physician Decision|1
2948533|NCT01316939|10150309|P2|Overall Study|Physician Decision|2
2948534|NCT01316939|10150310|P1|Overall Study|Physician Decision|2
2948535|NCT01316939|10150308|P3|Overall Study|Withdrawal by Subject|6
2948536|NCT01316939|10150309|P2|Overall Study|Withdrawal by Subject|3
2948537|NCT01316939|10150310|P1|Overall Study|Withdrawal by Subject|1
2948538|NCT01316939|10150308|P3|Overall Study|Adverse Event|11
2948539|NCT01316939|10150309|P2|Overall Study|Adverse Event|12
2948540|NCT01316939|10150310|P1|Overall Study|Adverse Event|9
2948541|NCT01316939|10150308|P3|Overall Study|Lack of Efficacy|25
2948542|NCT01316939|10150309|P2|Overall Study|Lack of Efficacy|25
2948543|NCT01316939|10150310|P1|Overall Study|Lack of Efficacy|24
2948544|NCT01316939|10150308|P3|Overall Study|Study closed/terminated|23
2948545|NCT01316939|10150309|P2|Overall Study|Study closed/terminated|25
2948546|NCT01316939|10150310|P1|Overall Study|Study closed/terminated|26
2948547|NCT01316913|10150405|P4|Overall Study|Withdrawal by Subject|6
2948548|NCT01316913|10150406|P3|Overall Study|Withdrawal by Subject|10
2948549|NCT01316913|10150407|P2|Overall Study|Withdrawal by Subject|9
2948550|NCT01316913|10150408|P1|Overall Study|Withdrawal by Subject|10
2948551|NCT01316913|10150405|P4|Overall Study|Lost to Follow-up|2
2948552|NCT01316913|10150406|P3|Overall Study|Lost to Follow-up|0
2948553|NCT01316913|10150407|P2|Overall Study|Lost to Follow-up|1
2948554|NCT01316913|10150408|P1|Overall Study|Lost to Follow-up|0
2948555|NCT01316913|10150405|P4|Overall Study|Protocol-defined Stopping Criteria|6
2948556|NCT01316913|10150406|P3|Overall Study|Protocol-defined Stopping Criteria|11
2948557|NCT01316913|10150407|P2|Overall Study|Protocol-defined Stopping Criteria|8
2948558|NCT01316913|10150408|P1|Overall Study|Protocol-defined Stopping Criteria|7
2948559|NCT01316913|10150405|P4|Overall Study|Protocol Violation|1
2948560|NCT01316913|10150406|P3|Overall Study|Protocol Violation|4
2948561|NCT01316913|10150407|P2|Overall Study|Protocol Violation|4
2948562|NCT01316913|10150408|P1|Overall Study|Protocol Violation|1
2948563|NCT01316913|10150405|P4|Overall Study|Lack of Efficacy|13
2948564|NCT01316913|10150406|P3|Overall Study|Lack of Efficacy|9
2948565|NCT01316913|10150407|P2|Overall Study|Lack of Efficacy|12
2948566|NCT01316913|10150408|P1|Overall Study|Lack of Efficacy|22
2948567|NCT01316913|10150405|P4|Overall Study|Adverse Event|11
2948568|NCT01316913|10150406|P3|Overall Study|Adverse Event|15
2948569|NCT01316913|10150407|P2|Overall Study|Adverse Event|20
2948570|NCT01316913|10150408|P1|Overall Study|Adverse Event|17
2948571|NCT01316900|10150430|P4|Overall Study|Withdrawal by Subject|9
2948572|NCT01316900|10150431|P3|Overall Study|Withdrawal by Subject|6
2948573|NCT01316900|10150432|P2|Overall Study|Withdrawal by Subject|8
2948574|NCT01316900|10150433|P1|Overall Study|Withdrawal by Subject|7
2948575|NCT01316900|10150430|P4|Overall Study|Lost to Follow-up|1
2948576|NCT01316900|10150431|P3|Overall Study|Lost to Follow-up|1
2948577|NCT01316900|10150432|P2|Overall Study|Lost to Follow-up|0
2948578|NCT01316900|10150433|P1|Overall Study|Lost to Follow-up|1
2948579|NCT01316900|10150430|P4|Overall Study|Protocol-defined Stopping Criteria|5
2948580|NCT01316900|10150431|P3|Overall Study|Protocol-defined Stopping Criteria|10
2948581|NCT01316900|10150432|P2|Overall Study|Protocol-defined Stopping Criteria|3
2948582|NCT01316900|10150433|P1|Overall Study|Protocol-defined Stopping Criteria|2
2948583|NCT01316900|10150430|P4|Overall Study|Protocol Violation|0
2948584|NCT01316900|10150431|P3|Overall Study|Protocol Violation|4
2948585|NCT01316900|10150432|P2|Overall Study|Protocol Violation|1
2948586|NCT01316900|10150433|P1|Overall Study|Protocol Violation|7
2948587|NCT01316900|10150430|P4|Overall Study|Lack of Efficacy|7
2948588|NCT01316900|10150431|P3|Overall Study|Lack of Efficacy|5
2948589|NCT01316900|10150432|P2|Overall Study|Lack of Efficacy|9
2948590|NCT01316900|10150433|P1|Overall Study|Lack of Efficacy|17
2948591|NCT01316900|10150430|P4|Overall Study|Adverse Event|9
2948592|NCT01316900|10150431|P3|Overall Study|Adverse Event|15
2948593|NCT01316900|10150432|P2|Overall Study|Adverse Event|10
2948594|NCT01316900|10150433|P1|Overall Study|Adverse Event|10
2948595|NCT01316887|10150454|P3|Overall Study|Withdrawal by Subject|15
2948596|NCT01316887|10150455|P2|Overall Study|Withdrawal by Subject|16
2948597|NCT01316887|10150456|P1|Overall Study|Withdrawal by Subject|8
2948598|NCT01316887|10150454|P3|Overall Study|Lost to Follow-up|5
2948599|NCT01316887|10150455|P2|Overall Study|Lost to Follow-up|7
2948600|NCT01316887|10150456|P1|Overall Study|Lost to Follow-up|1
2948601|NCT01316887|10150454|P3|Overall Study|Study Closed/Terminated|3
2948602|NCT01316887|10150455|P2|Overall Study|Study Closed/Terminated|4
2948603|NCT01316887|10150456|P1|Overall Study|Study Closed/Terminated|2
2948604|NCT01316887|10150454|P3|Overall Study|Protocol-defined Stopping Criteria|36
2948605|NCT01316887|10150455|P2|Overall Study|Protocol-defined Stopping Criteria|37
2948606|NCT01316887|10150456|P1|Overall Study|Protocol-defined Stopping Criteria|8
2948607|NCT01316887|10150454|P3|Overall Study|Protocol Violation|6
2948608|NCT01316887|10150455|P2|Overall Study|Protocol Violation|6
2948609|NCT01316887|10150456|P1|Overall Study|Protocol Violation|2
2948610|NCT01316887|10150454|P3|Overall Study|Lack of Efficacy|1
2948611|NCT01316887|10150455|P2|Overall Study|Lack of Efficacy|3
2948612|NCT01316887|10150456|P1|Overall Study|Lack of Efficacy|9
2948613|NCT01316887|10150454|P3|Overall Study|Adverse Event|17
2948614|NCT01316887|10150455|P2|Overall Study|Adverse Event|21
2948615|NCT01316887|10150456|P1|Overall Study|Adverse Event|13
2948616|NCT01316692|10150581|P1|Overall Study|Disease Progression|7
2948617|NCT01316692|10150581|P1|Overall Study|Adverse Event|5
2948618|NCT01316614|10150590|P1|Overall Study|Medically unstable|1
2948619|NCT01316614|10150590|P1|Overall Study|Inadequate number of passes|2
2948620|NCT01316614|10150590|P1|Overall Study|Cystic lesion|5
2948621|NCT01316614|10150590|P1|Overall Study|Cytology slides not available for review|4
2948622|NCT01316614|10150590|P1|Overall Study|No solid lesion and FNA not indicated|25
2948623|NCT01316575|10150607|P2|Overall Study|Required alternate treatment|1
2948624|NCT01316575|10150608|P1|Overall Study|Required alternate treatment|0
2948625|NCT01316575|10150607|P2|Overall Study|Withdrawal by Subject|0
2948626|NCT01316575|10150608|P1|Overall Study|Withdrawal by Subject|2
2948627|NCT01316419|10150631|P1|Overall Study|Lost to Follow-up|19
2948628|NCT01316419|10150631|P1|Overall Study|Violated inclusion/exclusion criterion|143
2948629|NCT01316419|10150631|P1|Overall Study|Not treated|103
2948630|NCT01316380|10150657|P3|Overall Study|Not treated|0
2948631|NCT01316380|10150658|P2|Overall Study|Not treated|0
2948632|NCT01316380|10150659|P1|Overall Study|Not treated|1
2948633|NCT01316380|10150657|P3|Overall Study|Other|1
2948634|NCT01316380|10150658|P2|Overall Study|Other|1
2948635|NCT01316380|10150659|P1|Overall Study|Other|0
2948636|NCT01316380|10150657|P3|Overall Study|Withdrawal by Subject|0
2948637|NCT01316380|10150658|P2|Overall Study|Withdrawal by Subject|2
2948638|NCT01316380|10150659|P1|Overall Study|Withdrawal by Subject|1
2948639|NCT01316380|10150657|P3|Overall Study|Protocol Violation|1
2948640|NCT01316380|10150658|P2|Overall Study|Protocol Violation|0
2948641|NCT01316380|10150659|P1|Overall Study|Protocol Violation|0
2948642|NCT01316380|10150657|P3|Overall Study|Adverse Event|1
2948643|NCT01316380|10150658|P2|Overall Study|Adverse Event|2
2948644|NCT01316380|10150659|P1|Overall Study|Adverse Event|0
2948645|NCT01316276|10150796|P1|Overall Study|Other|22
2948646|NCT01316276|10150796|P1|Overall Study|Lost to Follow-up|1
2948647|NCT01316276|10150796|P1|Overall Study|Withdrawal of consent|24
2948648|NCT01316276|10150796|P1|Overall Study|Adverse Event|19
2948649|NCT01316276|10150796|P1|Overall Study|Death|1
2948650|NCT01316224|10150844|P1|Overall Study|Other|1
2948651|NCT01316224|10150844|P1|Overall Study|Adverse Event With Treatment Failure|1
2948652|NCT01316224|10150844|P1|Overall Study|Withdrawal by Subject|1
2948653|NCT01316224|10150844|P1|Overall Study|Lack of Efficacy|1
2948654|NCT01316224|10150844|P1|Overall Study|Adverse Event|3
2948655|NCT01316224|10150844|P1|Overall Study|Protocol Violation|3
2948656|NCT01316055|10150861|P3|Overall Study|Lost to Follow-up|0
2948657|NCT01316055|10150862|P2|Overall Study|Lost to Follow-up|0
2948658|NCT01316055|10150863|P1|Overall Study|Lost to Follow-up|1
2948659|NCT01315847|10150894|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
2948660|NCT01315847|10150895|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
2948661|NCT01315847|10150894|P2|Part I, Period 1|Reached maximum number of arterial lines|0
2948662|NCT01315847|10150895|P1|Part I, Period 1|Reached maximum number of arterial lines|3
2948663|NCT01315678|10150909|P2|Overall Study|similar reason to those listed above|2
2948664|NCT01315678|10150910|P1|Overall Study|similar reason to those listed above|3
2948665|NCT01315678|10150909|P2|Overall Study|Lost to Follow-up|0
2948666|NCT01315678|10150910|P1|Overall Study|Lost to Follow-up|1
2948667|NCT01315678|10150909|P2|Overall Study|Adverse Event|1
2948668|NCT01315678|10150910|P1|Overall Study|Adverse Event|3
2948669|NCT01315678|10150909|P2|Overall Study|Withdrawal by Subject|3
2948670|NCT01315678|10150910|P1|Overall Study|Withdrawal by Subject|7
2948671|NCT01315353|10150961|P3|Overall Study|Inadvertent randomization/assignment|2
2948672|NCT01315353|10150962|P2|Overall Study|Inadvertent randomization/assignment|0
2948673|NCT01315353|10150963|P1|Overall Study|Inadvertent randomization/assignment|0
2948674|NCT01315353|10150961|P3|Overall Study|Taken off study by site in error|0
2948675|NCT01315353|10150962|P2|Overall Study|Taken off study by site in error|1
2948676|NCT01315353|10150963|P1|Overall Study|Taken off study by site in error|0
2948677|NCT01315353|10150961|P3|Overall Study|Site closing|0
2948678|NCT01315353|10150962|P2|Overall Study|Site closing|4
2948679|NCT01315353|10150963|P1|Overall Study|Site closing|7
2948680|NCT01315353|10150961|P3|Overall Study|Unwilling to adhere to requirements|4
2948681|NCT01315353|10150962|P2|Overall Study|Unwilling to adhere to requirements|5
2948682|NCT01315353|10150963|P1|Overall Study|Unwilling to adhere to requirements|5
2948683|NCT01315353|10150961|P3|Overall Study|Lost to Follow-up|6
2948684|NCT01315353|10150962|P2|Overall Study|Lost to Follow-up|6
2948685|NCT01315353|10150963|P1|Overall Study|Lost to Follow-up|13
2948686|NCT01315353|10150961|P3|Overall Study|Withdrawal by Subject|1
2948687|NCT01315353|10150962|P2|Overall Study|Withdrawal by Subject|6
2948688|NCT01315353|10150963|P1|Overall Study|Withdrawal by Subject|2
2948689|NCT01315353|10150961|P3|Overall Study|Death|0
2948690|NCT01315353|10150962|P2|Overall Study|Death|1
2948691|NCT01315353|10150963|P1|Overall Study|Death|2
2948692|NCT01315249|10150990|P2|Overall Study|Death|1
2948693|NCT01315249|10150991|P1|Overall Study|Death|0
2948694|NCT01315249|10150990|P2|Overall Study|Lost to Follow-up|2
2948695|NCT01315249|10150991|P1|Overall Study|Lost to Follow-up|0
2948696|NCT01315249|10150990|P2|Overall Study|Lack of Efficacy|1
2948697|NCT01315249|10150991|P1|Overall Study|Lack of Efficacy|0
2948698|NCT01315249|10150990|P2|Overall Study|inability to use device|0
2948699|NCT01315249|10150991|P1|Overall Study|inability to use device|1
2948700|NCT01315249|10150990|P2|Overall Study|Administrative problems|0
2948701|NCT01315249|10150991|P1|Overall Study|Administrative problems|1
2948702|NCT01315249|10150990|P2|Overall Study|Abnormal test results|2
2948703|NCT01315249|10150991|P1|Overall Study|Abnormal test results|1
2948704|NCT01315249|10150990|P2|Overall Study|Protocol Violation|5
2948705|NCT01315249|10150991|P1|Overall Study|Protocol Violation|8
2948706|NCT01315249|10150990|P2|Overall Study|Withdrawal by Subject|10
2948707|NCT01315249|10150991|P1|Overall Study|Withdrawal by Subject|11
2948708|NCT01315249|10150990|P2|Overall Study|Adverse Event|26
2948709|NCT01315249|10150991|P1|Overall Study|Adverse Event|22
2948710|NCT01315236|10151019|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
2948711|NCT01315236|10151020|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
2948712|NCT01315236|10151019|P2|12-Month Follow-up Period|Death|1
2948713|NCT01315236|10151020|P1|12-Month Follow-up Period|Death|0
2948714|NCT01315236|10151019|P2|Open-label Phase|Other|1
2948715|NCT01315236|10151020|P1|Open-label Phase|Other|0
2948716|NCT01315236|10151019|P2|Open-label Phase|Adverse Event|1
2948717|NCT01315236|10151020|P1|Open-label Phase|Adverse Event|0
2948718|NCT01315236|10151019|P2|Open-label Phase|Death|0
2948719|NCT01315236|10151020|P1|Open-label Phase|Death|1
2948720|NCT01315236|10151019|P2|Double-blind Phase|Lost to Follow-up|0
2948721|NCT01315236|10151020|P1|Double-blind Phase|Lost to Follow-up|1
2948722|NCT01315236|10151019|P2|Double-blind Phase|Withdrawal of Consent|0
2948723|NCT01315236|10151020|P1|Double-blind Phase|Withdrawal of Consent|1
2948724|NCT01315236|10151019|P2|Double-blind Phase|Adverse Event|0
2948725|NCT01315236|10151020|P1|Double-blind Phase|Adverse Event|1
2948726|NCT01315236|10151019|P2|Double-blind Phase|Death|0
2948727|NCT01315236|10151020|P1|Double-blind Phase|Death|1
2948728|NCT01315132|10151076|P1|Overall Study|not treated due to disease progression|1
2948729|NCT01315028|10151083|P2|Overall Study|Death|1
2948730|NCT01315028|10151084|P1|Overall Study|Death|0
2948731|NCT01315028|10151083|P2|Overall Study|Lost to Follow-up|0
2948732|NCT01315028|10151084|P1|Overall Study|Lost to Follow-up|1
2948733|NCT01314911|10151111|P2|Overall Study|Never Started Treatment|0
2948734|NCT01314911|10151112|P1|Overall Study|Never Started Treatment|1
2948735|NCT01314911|10151111|P2|Overall Study|Received Non-randomized Study Drug|1
2948736|NCT01314911|10151112|P1|Overall Study|Received Non-randomized Study Drug|0
2948737|NCT01314911|10151111|P2|Overall Study|Withdrawal by Subject|3
2948738|NCT01314911|10151112|P1|Overall Study|Withdrawal by Subject|1
2948739|NCT01314911|10151111|P2|Overall Study|Lost to Follow-up|2
2948740|NCT01314911|10151112|P1|Overall Study|Lost to Follow-up|3
2948741|NCT01314872|10151163|P15|Period 2|Lost to Follow-up|6
2948742|NCT01314872|10151164|P14|Period 2|Lost to Follow-up|2
2948743|NCT01314872|10151165|P13|Period 2|Lost to Follow-up|7
2948744|NCT01314872|10151166|P12|Period 2|Lost to Follow-up|6
2948745|NCT01314872|10151167|P11|Period 2|Lost to Follow-up|0
2948746|NCT01314872|10151168|P10|Period 2|Lost to Follow-up|0
2948747|NCT01314872|10151169|P9|Period 2|Lost to Follow-up|0
2948748|NCT01314872|10151170|P8|Period 2|Lost to Follow-up|0
2948749|NCT01314872|10151171|P7|Period 2|Lost to Follow-up|0
2948750|NCT01314872|10151172|P6|Period 2|Lost to Follow-up|0
2948751|NCT01314872|10151173|P5|Period 2|Lost to Follow-up|0
2948752|NCT01314872|10151174|P4|Period 2|Lost to Follow-up|0
2948753|NCT01314872|10151175|P3|Period 2|Lost to Follow-up|0
2948754|NCT01314872|10151176|P2|Period 2|Lost to Follow-up|0
2948755|NCT01314872|10151177|P1|Period 2|Lost to Follow-up|0
2948756|NCT01314872|10151163|P15|Period 2|Withdrawal by Subject|4
2948757|NCT01314872|10151164|P14|Period 2|Withdrawal by Subject|12
2948758|NCT01314872|10151165|P13|Period 2|Withdrawal by Subject|17
2948759|NCT01314872|10151166|P12|Period 2|Withdrawal by Subject|14
2948760|NCT01314872|10151167|P11|Period 2|Withdrawal by Subject|0
2948761|NCT01314872|10151168|P10|Period 2|Withdrawal by Subject|0
2948762|NCT01314872|10151169|P9|Period 2|Withdrawal by Subject|0
2948763|NCT01314872|10151170|P8|Period 2|Withdrawal by Subject|0
2948764|NCT01314872|10151171|P7|Period 2|Withdrawal by Subject|0
2948765|NCT01314872|10151172|P6|Period 2|Withdrawal by Subject|0
2948766|NCT01314872|10151173|P5|Period 2|Withdrawal by Subject|0
2948767|NCT01314872|10151174|P4|Period 2|Withdrawal by Subject|0
2948768|NCT01314872|10151175|P3|Period 2|Withdrawal by Subject|0
2948769|NCT01314872|10151176|P2|Period 2|Withdrawal by Subject|0
2948770|NCT01314872|10151177|P1|Period 2|Withdrawal by Subject|0
2948771|NCT01314872|10151163|P15|Period 2|Adverse event, non-fatal|9
2948772|NCT01314872|10151164|P14|Period 2|Adverse event, non-fatal|24
2948773|NCT01314872|10151165|P13|Period 2|Adverse event, non-fatal|16
2948774|NCT01314872|10151166|P12|Period 2|Adverse event, non-fatal|13
2948775|NCT01314872|10151167|P11|Period 2|Adverse event, non-fatal|0
2948776|NCT01314872|10151168|P10|Period 2|Adverse event, non-fatal|0
2948777|NCT01314872|10151169|P9|Period 2|Adverse event, non-fatal|0
2948778|NCT01314872|10151170|P8|Period 2|Adverse event, non-fatal|0
2948779|NCT01314872|10151171|P7|Period 2|Adverse event, non-fatal|0
2948780|NCT01314872|10151172|P6|Period 2|Adverse event, non-fatal|0
2948781|NCT01314872|10151173|P5|Period 2|Adverse event, non-fatal|0
2948782|NCT01314872|10151174|P4|Period 2|Adverse event, non-fatal|0
2948783|NCT01314872|10151175|P3|Period 2|Adverse event, non-fatal|0
2948784|NCT01314872|10151176|P2|Period 2|Adverse event, non-fatal|0
2948785|NCT01314872|10151177|P1|Period 2|Adverse event, non-fatal|0
2948786|NCT01314872|10151163|P15|Period 2|Study terminated by Sponsor|0
2948787|NCT01314872|10151164|P14|Period 2|Study terminated by Sponsor|3
2948788|NCT01314872|10151165|P13|Period 2|Study terminated by Sponsor|2
2948789|NCT01314872|10151166|P12|Period 2|Study terminated by Sponsor|2
2948790|NCT01314872|10151167|P11|Period 2|Study terminated by Sponsor|0
2948791|NCT01314872|10151168|P10|Period 2|Study terminated by Sponsor|0
2948792|NCT01314872|10151169|P9|Period 2|Study terminated by Sponsor|0
2948793|NCT01314872|10151170|P8|Period 2|Study terminated by Sponsor|0
2948794|NCT01314872|10151171|P7|Period 2|Study terminated by Sponsor|0
2948795|NCT01314872|10151172|P6|Period 2|Study terminated by Sponsor|0
2948796|NCT01314872|10151173|P5|Period 2|Study terminated by Sponsor|0
2948797|NCT01314872|10151174|P4|Period 2|Study terminated by Sponsor|0
2948798|NCT01314872|10151175|P3|Period 2|Study terminated by Sponsor|0
2948799|NCT01314872|10151176|P2|Period 2|Study terminated by Sponsor|0
2948800|NCT01314872|10151177|P1|Period 2|Study terminated by Sponsor|0
2948801|NCT01314872|10151163|P15|Period 2|Pregnancy|1
2948802|NCT01314872|10151164|P14|Period 2|Pregnancy|0
2948803|NCT01314872|10151165|P13|Period 2|Pregnancy|0
2948804|NCT01314872|10151166|P12|Period 2|Pregnancy|0
2948805|NCT01314872|10151167|P11|Period 2|Pregnancy|0
2948806|NCT01314872|10151168|P10|Period 2|Pregnancy|0
2948807|NCT01314872|10151169|P9|Period 2|Pregnancy|0
2948808|NCT01314872|10151170|P8|Period 2|Pregnancy|0
2948809|NCT01314872|10151171|P7|Period 2|Pregnancy|0
2948810|NCT01314872|10151172|P6|Period 2|Pregnancy|0
2948811|NCT01314872|10151173|P5|Period 2|Pregnancy|0
2948812|NCT01314872|10151174|P4|Period 2|Pregnancy|0
2948813|NCT01314872|10151175|P3|Period 2|Pregnancy|0
2948814|NCT01314872|10151176|P2|Period 2|Pregnancy|0
2948815|NCT01314872|10151177|P1|Period 2|Pregnancy|0
2948816|NCT01314872|10151163|P15|Period 2|Lack of Efficacy|2
2948817|NCT01314872|10151164|P14|Period 2|Lack of Efficacy|9
2948818|NCT01314872|10151165|P13|Period 2|Lack of Efficacy|12
2948819|NCT01314872|10151166|P12|Period 2|Lack of Efficacy|7
2948820|NCT01314872|10151167|P11|Period 2|Lack of Efficacy|0
2948821|NCT01314872|10151168|P10|Period 2|Lack of Efficacy|0
2948822|NCT01314872|10151169|P9|Period 2|Lack of Efficacy|0
2948823|NCT01314872|10151170|P8|Period 2|Lack of Efficacy|0
2948824|NCT01314872|10151171|P7|Period 2|Lack of Efficacy|0
2948825|NCT01314872|10151172|P6|Period 2|Lack of Efficacy|0
2948826|NCT01314872|10151173|P5|Period 2|Lack of Efficacy|0
2948827|NCT01314872|10151174|P4|Period 2|Lack of Efficacy|0
2948828|NCT01314872|10151175|P3|Period 2|Lack of Efficacy|0
2948829|NCT01314872|10151176|P2|Period 2|Lack of Efficacy|0
2948830|NCT01314872|10151177|P1|Period 2|Lack of Efficacy|0
2948831|NCT01314872|10151163|P15|Period 2|Non-compliance with study drug|2
2948832|NCT01314872|10151164|P14|Period 2|Non-compliance with study drug|1
2948833|NCT01314872|10151165|P13|Period 2|Non-compliance with study drug|3
2948834|NCT01314872|10151166|P12|Period 2|Non-compliance with study drug|3
2948835|NCT01314872|10151167|P11|Period 2|Non-compliance with study drug|0
2948836|NCT01314872|10151168|P10|Period 2|Non-compliance with study drug|0
2948837|NCT01314872|10151169|P9|Period 2|Non-compliance with study drug|0
2948838|NCT01314872|10151170|P8|Period 2|Non-compliance with study drug|0
2948839|NCT01314872|10151171|P7|Period 2|Non-compliance with study drug|0
2948840|NCT01314872|10151172|P6|Period 2|Non-compliance with study drug|0
2948841|NCT01314872|10151173|P5|Period 2|Non-compliance with study drug|0
2948842|NCT01314872|10151174|P4|Period 2|Non-compliance with study drug|0
2948843|NCT01314872|10151175|P3|Period 2|Non-compliance with study drug|0
2948844|NCT01314872|10151176|P2|Period 2|Non-compliance with study drug|0
2948845|NCT01314872|10151177|P1|Period 2|Non-compliance with study drug|0
2948846|NCT01314872|10151163|P15|Period 2|Protocol Violation|0
2948847|NCT01314872|10151164|P14|Period 2|Protocol Violation|2
2948848|NCT01314872|10151165|P13|Period 2|Protocol Violation|3
2948849|NCT01314872|10151166|P12|Period 2|Protocol Violation|3
2948850|NCT01314872|10151167|P11|Period 2|Protocol Violation|0
2948851|NCT01314872|10151168|P10|Period 2|Protocol Violation|0
2948852|NCT01314872|10151169|P9|Period 2|Protocol Violation|0
2948853|NCT01314872|10151170|P8|Period 2|Protocol Violation|0
2948854|NCT01314872|10151171|P7|Period 2|Protocol Violation|0
2948855|NCT01314872|10151172|P6|Period 2|Protocol Violation|0
2948856|NCT01314872|10151173|P5|Period 2|Protocol Violation|0
2948857|NCT01314872|10151174|P4|Period 2|Protocol Violation|0
2948858|NCT01314872|10151175|P3|Period 2|Protocol Violation|0
2948859|NCT01314872|10151176|P2|Period 2|Protocol Violation|0
2948860|NCT01314872|10151177|P1|Period 2|Protocol Violation|0
2948861|NCT01314872|10151163|P15|Treatment Period 1|Lost to Follow-up|0
2948862|NCT01314872|10151164|P14|Treatment Period 1|Lost to Follow-up|0
2948863|NCT01314872|10151165|P13|Treatment Period 1|Lost to Follow-up|0
2948864|NCT01314872|10151166|P12|Treatment Period 1|Lost to Follow-up|0
2948865|NCT01314872|10151167|P11|Treatment Period 1|Lost to Follow-up|0
2948866|NCT01314872|10151168|P10|Treatment Period 1|Lost to Follow-up|0
2948867|NCT01314872|10151169|P9|Treatment Period 1|Lost to Follow-up|1
2948868|NCT01314872|10151170|P8|Treatment Period 1|Lost to Follow-up|1
2948869|NCT01314872|10151171|P7|Treatment Period 1|Lost to Follow-up|1
2948870|NCT01314872|10151172|P6|Treatment Period 1|Lost to Follow-up|1
2948871|NCT01314872|10151173|P5|Treatment Period 1|Lost to Follow-up|1
2948872|NCT01314872|10151174|P4|Treatment Period 1|Lost to Follow-up|2
2948873|NCT01314872|10151175|P3|Treatment Period 1|Lost to Follow-up|2
2948874|NCT01314872|10151176|P2|Treatment Period 1|Lost to Follow-up|1
2948875|NCT01314872|10151177|P1|Treatment Period 1|Lost to Follow-up|0
2948876|NCT01314872|10151163|P15|Treatment Period 1|Withdrawal by Subject|0
2948877|NCT01314872|10151164|P14|Treatment Period 1|Withdrawal by Subject|0
2948878|NCT01314872|10151165|P13|Treatment Period 1|Withdrawal by Subject|0
2948879|NCT01314872|10151166|P12|Treatment Period 1|Withdrawal by Subject|0
2948880|NCT01314872|10151167|P11|Treatment Period 1|Withdrawal by Subject|1
2948881|NCT01314872|10151168|P10|Treatment Period 1|Withdrawal by Subject|2
2948882|NCT01314872|10151169|P9|Treatment Period 1|Withdrawal by Subject|2
2948883|NCT01314872|10151170|P8|Treatment Period 1|Withdrawal by Subject|2
2948884|NCT01314872|10151171|P7|Treatment Period 1|Withdrawal by Subject|3
2948885|NCT01314872|10151172|P6|Treatment Period 1|Withdrawal by Subject|1
2948886|NCT01314872|10151173|P5|Treatment Period 1|Withdrawal by Subject|3
2948887|NCT01314872|10151174|P4|Treatment Period 1|Withdrawal by Subject|2
2948888|NCT01314872|10151175|P3|Treatment Period 1|Withdrawal by Subject|0
2948889|NCT01314872|10151176|P2|Treatment Period 1|Withdrawal by Subject|1
2948890|NCT01314872|10151177|P1|Treatment Period 1|Withdrawal by Subject|3
2948891|NCT01314872|10151163|P15|Treatment Period 1|Adverse event, non-fatal|0
2948892|NCT01314872|10151164|P14|Treatment Period 1|Adverse event, non-fatal|0
2948893|NCT01314872|10151165|P13|Treatment Period 1|Adverse event, non-fatal|0
2948894|NCT01314872|10151166|P12|Treatment Period 1|Adverse event, non-fatal|0
2948895|NCT01314872|10151167|P11|Treatment Period 1|Adverse event, non-fatal|1
2948896|NCT01314872|10151168|P10|Treatment Period 1|Adverse event, non-fatal|0
2948897|NCT01314872|10151169|P9|Treatment Period 1|Adverse event, non-fatal|3
2948898|NCT01314872|10151170|P8|Treatment Period 1|Adverse event, non-fatal|2
2948899|NCT01314872|10151171|P7|Treatment Period 1|Adverse event, non-fatal|4
2948900|NCT01314872|10151172|P6|Treatment Period 1|Adverse event, non-fatal|4
2948901|NCT01314872|10151173|P5|Treatment Period 1|Adverse event, non-fatal|2
2948902|NCT01314872|10151174|P4|Treatment Period 1|Adverse event, non-fatal|2
2948903|NCT01314872|10151175|P3|Treatment Period 1|Adverse event, non-fatal|3
2948904|NCT01314872|10151176|P2|Treatment Period 1|Adverse event, non-fatal|2
2948905|NCT01314872|10151177|P1|Treatment Period 1|Adverse event, non-fatal|4
2948906|NCT01314872|10151163|P15|Treatment Period 1|Lack of Efficacy|0
2948907|NCT01314872|10151164|P14|Treatment Period 1|Lack of Efficacy|0
2948908|NCT01314872|10151165|P13|Treatment Period 1|Lack of Efficacy|0
2948909|NCT01314872|10151166|P12|Treatment Period 1|Lack of Efficacy|0
2948910|NCT01314872|10151167|P11|Treatment Period 1|Lack of Efficacy|0
2948911|NCT01314872|10151168|P10|Treatment Period 1|Lack of Efficacy|0
2948912|NCT01314872|10151169|P9|Treatment Period 1|Lack of Efficacy|0
2948913|NCT01314872|10151170|P8|Treatment Period 1|Lack of Efficacy|2
2948914|NCT01314872|10151171|P7|Treatment Period 1|Lack of Efficacy|0
2948915|NCT01314872|10151172|P6|Treatment Period 1|Lack of Efficacy|1
2948916|NCT01314872|10151173|P5|Treatment Period 1|Lack of Efficacy|0
2948917|NCT01314872|10151174|P4|Treatment Period 1|Lack of Efficacy|0
2948918|NCT01314872|10151175|P3|Treatment Period 1|Lack of Efficacy|0
2948919|NCT01314872|10151176|P2|Treatment Period 1|Lack of Efficacy|0
2948920|NCT01314872|10151177|P1|Treatment Period 1|Lack of Efficacy|1
2948921|NCT01314872|10151163|P15|Treatment Period 1|Physician Decision|0
2948922|NCT01314872|10151164|P14|Treatment Period 1|Physician Decision|0
2948923|NCT01314872|10151165|P13|Treatment Period 1|Physician Decision|0
2948924|NCT01314872|10151166|P12|Treatment Period 1|Physician Decision|0
2948925|NCT01314872|10151167|P11|Treatment Period 1|Physician Decision|0
2948926|NCT01314872|10151168|P10|Treatment Period 1|Physician Decision|1
2948927|NCT01314872|10151169|P9|Treatment Period 1|Physician Decision|0
2948928|NCT01314872|10151170|P8|Treatment Period 1|Physician Decision|0
2948929|NCT01314872|10151171|P7|Treatment Period 1|Physician Decision|0
2948930|NCT01314872|10151172|P6|Treatment Period 1|Physician Decision|0
2948931|NCT01314872|10151173|P5|Treatment Period 1|Physician Decision|0
2948932|NCT01314872|10151174|P4|Treatment Period 1|Physician Decision|1
2948933|NCT01314872|10151175|P3|Treatment Period 1|Physician Decision|0
2948934|NCT01314872|10151176|P2|Treatment Period 1|Physician Decision|1
2948935|NCT01314872|10151177|P1|Treatment Period 1|Physician Decision|0
2948936|NCT01314872|10151163|P15|Treatment Period 1|Protocol Violation|0
2948937|NCT01314872|10151164|P14|Treatment Period 1|Protocol Violation|0
2948938|NCT01314872|10151165|P13|Treatment Period 1|Protocol Violation|0
2948939|NCT01314872|10151166|P12|Treatment Period 1|Protocol Violation|0
2948940|NCT01314872|10151167|P11|Treatment Period 1|Protocol Violation|1
2948941|NCT01314872|10151168|P10|Treatment Period 1|Protocol Violation|1
2948942|NCT01314872|10151169|P9|Treatment Period 1|Protocol Violation|0
2948943|NCT01314872|10151170|P8|Treatment Period 1|Protocol Violation|0
2948944|NCT01314872|10151171|P7|Treatment Period 1|Protocol Violation|0
2948945|NCT01314872|10151172|P6|Treatment Period 1|Protocol Violation|0
2948946|NCT01314872|10151173|P5|Treatment Period 1|Protocol Violation|1
2948947|NCT01314872|10151174|P4|Treatment Period 1|Protocol Violation|0
2948948|NCT01314872|10151175|P3|Treatment Period 1|Protocol Violation|1
2948949|NCT01314872|10151176|P2|Treatment Period 1|Protocol Violation|1
2948950|NCT01314872|10151177|P1|Treatment Period 1|Protocol Violation|2
2948951|NCT01314716|10151281|P2|Open-Label Phase|Physician Decision|4
2948952|NCT01314716|10151282|P1|Open-Label Phase|Physician Decision|5
2948953|NCT01314716|10151281|P2|Open-Label Phase|Withdrawal by Subject|2
2948954|NCT01314716|10151282|P1|Open-Label Phase|Withdrawal by Subject|1
2948955|NCT01314716|10151281|P2|Open-Label Phase|Adverse Event|6
2948956|NCT01314716|10151282|P1|Open-Label Phase|Adverse Event|4
2948957|NCT01314716|10151281|P2|Double-Blind Phase|Physician Decision|1
2948958|NCT01314716|10151282|P1|Double-Blind Phase|Physician Decision|0
2948959|NCT01314716|10151281|P2|Double-Blind Phase|Sponsor request|2
2948960|NCT01314716|10151282|P1|Double-Blind Phase|Sponsor request|1
2948961|NCT01314716|10151281|P2|Double-Blind Phase|Lost to Follow-up|1
2948962|NCT01314716|10151282|P1|Double-Blind Phase|Lost to Follow-up|0
2948963|NCT01314716|10151281|P2|Double-Blind Phase|Withdrawal by Subject|6
2948964|NCT01314716|10151282|P1|Double-Blind Phase|Withdrawal by Subject|5
2948965|NCT01314716|10151281|P2|Double-Blind Phase|Adverse Event|4
2948966|NCT01314716|10151282|P1|Double-Blind Phase|Adverse Event|10
2948967|NCT01314716|10151281|P2|Double-Blind Phase|Randomized but not treated|1
2948968|NCT01314716|10151282|P1|Double-Blind Phase|Randomized but not treated|1
2948969|NCT01314703|10151294|P1|Overall Study|screen failure and closed enrollment|8
2948970|NCT01314443|10151303|P4|Overall Study|Protocol Violation|1
2948971|NCT01314443|10151304|P3|Overall Study|Protocol Violation|1
2948972|NCT01314443|10151305|P2|Overall Study|Protocol Violation|2
2948973|NCT01314443|10151306|P1|Overall Study|Protocol Violation|2
2948974|NCT01314443|10151303|P4|Overall Study|Withdrawal by Subject|1
2948975|NCT01314443|10151304|P3|Overall Study|Withdrawal by Subject|1
2948976|NCT01314443|10151305|P2|Overall Study|Withdrawal by Subject|1
2948977|NCT01314443|10151306|P1|Overall Study|Withdrawal by Subject|2
2948978|NCT01314261|10151376|P4|Overall Study|Virologic Failure|1
2948979|NCT01314261|10151377|P3|Overall Study|Virologic Failure|0
2948980|NCT01314261|10151378|P2|Overall Study|Virologic Failure|1
2948981|NCT01314261|10151379|P1|Overall Study|Virologic Failure|0
2948982|NCT01314261|10151376|P4|Overall Study|Lost to Follow-up|2
2948983|NCT01314261|10151377|P3|Overall Study|Lost to Follow-up|2
2948984|NCT01314261|10151378|P2|Overall Study|Lost to Follow-up|0
2948985|NCT01314261|10151379|P1|Overall Study|Lost to Follow-up|1
2948986|NCT01314261|10151376|P4|Overall Study|Withdrawal by Subject|0
2948987|NCT01314261|10151377|P3|Overall Study|Withdrawal by Subject|1
2948988|NCT01314261|10151378|P2|Overall Study|Withdrawal by Subject|3
2948989|NCT01314261|10151379|P1|Overall Study|Withdrawal by Subject|0
2948990|NCT01314261|10151376|P4|Overall Study|Adverse Event|0
2948991|NCT01314261|10151377|P3|Overall Study|Adverse Event|0
2948992|NCT01314261|10151378|P2|Overall Study|Adverse Event|0
2948993|NCT01314261|10151379|P1|Overall Study|Adverse Event|1
2948994|NCT01314118|10151430|P1|Overall Study|Ongoing|62
2948995|NCT01314118|10151430|P1|Overall Study|Other|2
2948996|NCT01314118|10151430|P1|Overall Study|Withdrawal by Subject|11
2948997|NCT01314118|10151430|P1|Overall Study|Protocol Violation|5
2948998|NCT01314118|10151430|P1|Overall Study|Death|4
2948999|NCT01314118|10151430|P1|Overall Study|Physician Decision|11
2949000|NCT01314118|10151430|P1|Overall Study|Progressive disease|27
2949001|NCT01314118|10151430|P1|Overall Study|Adverse Event|9
2949002|NCT01314105|10151439|P2|Overall Study|Other Adverse Event|1
2949003|NCT01314105|10151440|P1|Overall Study|Other Adverse Event|1
2949004|NCT01314105|10151439|P2|Overall Study|Refused to continue taking medication|1
2949005|NCT01314105|10151440|P1|Overall Study|Refused to continue taking medication|0
2949006|NCT01314105|10151439|P2|Overall Study|Progressive Disease|10
2949007|NCT01314105|10151440|P1|Overall Study|Progressive Disease|6
2949008|NCT01313923|10151558|P1|Overall Study|Physician Decision|3
2949009|NCT01313884|10151574|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
2949010|NCT01313858|10151582|P3|Overall Study|Lost to Follow-up|47
2949011|NCT01313858|10151583|P2|Overall Study|Lost to Follow-up|51
2949012|NCT01313858|10151584|P1|Overall Study|Lost to Follow-up|35
2949013|NCT01313858|10151582|P3|Overall Study|Premature Treatment Termination|191
2949014|NCT01313858|10151583|P2|Overall Study|Premature Treatment Termination|219
2949015|NCT01313858|10151584|P1|Overall Study|Premature Treatment Termination|251
2949016|NCT01313780|10151607|P2|Overall Study|missing data|3
2949017|NCT01313780|10151608|P1|Overall Study|missing data|3
2949018|NCT01313780|10151607|P2|Overall Study|Protocol Violation|4
2949019|NCT01313780|10151608|P1|Overall Study|Protocol Violation|10
2949020|NCT01313780|10151607|P2|Overall Study|Withdrawal by Subject|8
2949021|NCT01313780|10151608|P1|Overall Study|Withdrawal by Subject|2
2949022|NCT01313780|10151607|P2|Overall Study|Adverse Event|11
2949023|NCT01313780|10151608|P1|Overall Study|Adverse Event|6
2949024|NCT01313780|10151607|P2|Overall Study|Lack of Efficacy|2
2949025|NCT01313780|10151608|P1|Overall Study|Lack of Efficacy|4
2949026|NCT01313767|10151618|P2|Overall Study|Protocol Violation|1
2949027|NCT01313767|10151619|P1|Overall Study|Protocol Violation|3
2949028|NCT01313767|10151618|P2|Overall Study|Withdrawal by Subject|1
2949029|NCT01313767|10151619|P1|Overall Study|Withdrawal by Subject|2
2949030|NCT01313767|10151618|P2|Overall Study|Lost to Follow-up|0
2949031|NCT01313767|10151619|P1|Overall Study|Lost to Follow-up|1
2949032|NCT01313767|10151618|P2|Overall Study|Adverse Event|0
2949033|NCT01313767|10151619|P1|Overall Study|Adverse Event|1
2949034|NCT01313728|10151661|P1|Informed Consent to Baseline|Withdrawal by Subject|1
2949035|NCT01313689|10151681|P5|24-Week Randomization 2|Physician Decision|4
2949036|NCT01313689|10151682|P4|24-Week Randomization 2|Physician Decision|0
2949037|NCT01313689|10151683|P3|24-Week Randomization 2|Physician Decision|0
2949038|NCT01313689|10151684|P2|24-Week Randomization 2|Physician Decision|0
2949039|NCT01313689|10151685|P1|24-Week Randomization 2|Physician Decision|0
2949040|NCT01313689|10151681|P5|24-Week Randomization 2|Withdrawal by Subject|3
2949041|NCT01313689|10151682|P4|24-Week Randomization 2|Withdrawal by Subject|1
2949042|NCT01313689|10151683|P3|24-Week Randomization 2|Withdrawal by Subject|1
2949043|NCT01313689|10151684|P2|24-Week Randomization 2|Withdrawal by Subject|0
2949044|NCT01313689|10151685|P1|24-Week Randomization 2|Withdrawal by Subject|0
2949045|NCT01313689|10151681|P5|24-Week Randomization 2|Adverse Event|8
2949046|NCT01313689|10151682|P4|24-Week Randomization 2|Adverse Event|0
2949047|NCT01313689|10151683|P3|24-Week Randomization 2|Adverse Event|2
2949048|NCT01313689|10151684|P2|24-Week Randomization 2|Adverse Event|0
2949049|NCT01313689|10151685|P1|24-Week Randomization 2|Adverse Event|0
2949050|NCT01313689|10151681|P5|24-Week Randomization 1|Withdrawal by Subject|0
2949051|NCT01313689|10151682|P4|24-Week Randomization 1|Withdrawal by Subject|0
2949052|NCT01313689|10151683|P3|24-Week Randomization 1|Withdrawal by Subject|0
2949053|NCT01313689|10151684|P2|24-Week Randomization 1|Withdrawal by Subject|0
2949054|NCT01313689|10151685|P1|24-Week Randomization 1|Withdrawal by Subject|5
2949055|NCT01313689|10151681|P5|24-Week Randomization 1|Physician Decision|0
2949056|NCT01313689|10151682|P4|24-Week Randomization 1|Physician Decision|0
2949057|NCT01313689|10151683|P3|24-Week Randomization 1|Physician Decision|0
2949058|NCT01313689|10151684|P2|24-Week Randomization 1|Physician Decision|5
2949059|NCT01313689|10151685|P1|24-Week Randomization 1|Physician Decision|4
2949060|NCT01313689|10151681|P5|24-Week Randomization 1|Adverse Event|0
2949061|NCT01313689|10151682|P4|24-Week Randomization 1|Adverse Event|0
2949062|NCT01313689|10151683|P3|24-Week Randomization 1|Adverse Event|0
2949063|NCT01313689|10151684|P2|24-Week Randomization 1|Adverse Event|5
2949064|NCT01313689|10151685|P1|24-Week Randomization 1|Adverse Event|10
2949065|NCT01313676|10151764|P4|Overall Study|Missing|0
2949066|NCT01313676|10151765|P3|Overall Study|Missing|1
2949067|NCT01313676|10151766|P2|Overall Study|Missing|1
2949068|NCT01313676|10151767|P1|Overall Study|Missing|1
2949069|NCT01313676|10151764|P4|Overall Study|Investigator Site Closed|10
2949070|NCT01313676|10151765|P3|Overall Study|Investigator Site Closed|15
2949071|NCT01313676|10151766|P2|Overall Study|Investigator Site Closed|11
2949072|NCT01313676|10151767|P1|Overall Study|Investigator Site Closed|12
2949073|NCT01313676|10151764|P4|Overall Study|Sponsor Terminated Study Treatment|1
2949074|NCT01313676|10151765|P3|Overall Study|Sponsor Terminated Study Treatment|0
2949075|NCT01313676|10151766|P2|Overall Study|Sponsor Terminated Study Treatment|1
2949076|NCT01313676|10151767|P1|Overall Study|Sponsor Terminated Study Treatment|1
2949077|NCT01313676|10151764|P4|Overall Study|Decision by Participant or Proxy|492
2949078|NCT01313676|10151765|P3|Overall Study|Decision by Participant or Proxy|515
2949079|NCT01313676|10151766|P2|Overall Study|Decision by Participant or Proxy|527
2949080|NCT01313676|10151767|P1|Overall Study|Decision by Participant or Proxy|643
2949081|NCT01313676|10151764|P4|Overall Study|Physician Decision|48
2949082|NCT01313676|10151765|P3|Overall Study|Physician Decision|62
2949083|NCT01313676|10151766|P2|Overall Study|Physician Decision|64
2949084|NCT01313676|10151767|P1|Overall Study|Physician Decision|53
2949085|NCT01313676|10151764|P4|Overall Study|Lost to Follow-up|0
2949086|NCT01313676|10151765|P3|Overall Study|Lost to Follow-up|1
2949087|NCT01313676|10151766|P2|Overall Study|Lost to Follow-up|0
2949088|NCT01313676|10151767|P1|Overall Study|Lost to Follow-up|0
2949089|NCT01313676|10151764|P4|Overall Study|Study Closed/terminated|9
2949090|NCT01313676|10151765|P3|Overall Study|Study Closed/terminated|9
2949091|NCT01313676|10151766|P2|Overall Study|Study Closed/terminated|6
2949092|NCT01313676|10151767|P1|Overall Study|Study Closed/terminated|7
2949093|NCT01313676|10151764|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
2949094|NCT01313676|10151765|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
2949095|NCT01313676|10151766|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
2949096|NCT01313676|10151767|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
2949097|NCT01313676|10151764|P4|Overall Study|Protocol Violation|44
2949098|NCT01313676|10151765|P3|Overall Study|Protocol Violation|46
2949099|NCT01313676|10151766|P2|Overall Study|Protocol Violation|44
2949100|NCT01313676|10151767|P1|Overall Study|Protocol Violation|37
2949101|NCT01313676|10151764|P4|Overall Study|Lack of Efficacy|46
2949102|NCT01313676|10151765|P3|Overall Study|Lack of Efficacy|65
2949103|NCT01313676|10151766|P2|Overall Study|Lack of Efficacy|90
2949104|NCT01313676|10151767|P1|Overall Study|Lack of Efficacy|98
2949105|NCT01313676|10151764|P4|Overall Study|Adverse Event|333
2949106|NCT01313676|10151765|P3|Overall Study|Adverse Event|372
2949107|NCT01313676|10151766|P2|Overall Study|Adverse Event|365
2949108|NCT01313676|10151767|P1|Overall Study|Adverse Event|395
2949109|NCT01313663|10151787|P2|Overall Study|Withdrawal by Subject|1
2949110|NCT01313663|10151788|P1|Overall Study|Withdrawal by Subject|2
2949111|NCT01313663|10151787|P2|Overall Study|Physician Decision|2
2949112|NCT01313663|10151788|P1|Overall Study|Physician Decision|0
2949113|NCT01313663|10151787|P2|Overall Study|Lost to Follow-up|1
2949114|NCT01313663|10151788|P1|Overall Study|Lost to Follow-up|0
2949115|NCT01313663|10151787|P2|Overall Study|Study Closed/Terminated|4
2949116|NCT01313663|10151788|P1|Overall Study|Study Closed/Terminated|2
2949117|NCT01313650|10151826|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
2949118|NCT01313650|10151827|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
2949119|NCT01313650|10151828|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
2949120|NCT01313650|10151829|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
2949121|NCT01313650|10151826|P4|Overall Study|Protocol Violation|6
2949122|NCT01313650|10151827|P3|Overall Study|Protocol Violation|5
2949123|NCT01313650|10151828|P2|Overall Study|Protocol Violation|7
2949124|NCT01313650|10151829|P1|Overall Study|Protocol Violation|4
2949125|NCT01313650|10151826|P4|Overall Study|Withdrawal by Subject|15
2949126|NCT01313650|10151827|P3|Overall Study|Withdrawal by Subject|15
2949127|NCT01313650|10151828|P2|Overall Study|Withdrawal by Subject|20
2949128|NCT01313650|10151829|P1|Overall Study|Withdrawal by Subject|16
2949129|NCT01313650|10151826|P4|Overall Study|Lost to Follow-up|2
2949130|NCT01313650|10151827|P3|Overall Study|Lost to Follow-up|3
2949131|NCT01313650|10151828|P2|Overall Study|Lost to Follow-up|0
2949132|NCT01313650|10151829|P1|Overall Study|Lost to Follow-up|1
2949133|NCT01313650|10151826|P4|Overall Study|Lack of Efficacy|20
2949134|NCT01313650|10151827|P3|Overall Study|Lack of Efficacy|32
2949135|NCT01313650|10151828|P2|Overall Study|Lack of Efficacy|20
2949136|NCT01313650|10151829|P1|Overall Study|Lack of Efficacy|37
2949137|NCT01313650|10151826|P4|Overall Study|Adverse Event|23
2949138|NCT01313650|10151827|P3|Overall Study|Adverse Event|24
2949139|NCT01313650|10151828|P2|Overall Study|Adverse Event|34
2949140|NCT01313650|10151829|P1|Overall Study|Adverse Event|9
2949141|NCT01313637|10151855|P4|Overall Study|Withdrawal by Subject|15
2949142|NCT01313637|10151856|P3|Overall Study|Withdrawal by Subject|18
2949143|NCT01313637|10151857|P2|Overall Study|Withdrawal by Subject|13
2949144|NCT01313637|10151858|P1|Overall Study|Withdrawal by Subject|11
2949145|NCT01313637|10151855|P4|Overall Study|Lost to Follow-up|3
2949146|NCT01313637|10151856|P3|Overall Study|Lost to Follow-up|1
2949147|NCT01313637|10151857|P2|Overall Study|Lost to Follow-up|2
2949148|NCT01313637|10151858|P1|Overall Study|Lost to Follow-up|0
2949149|NCT01313637|10151855|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
2949150|NCT01313637|10151856|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
2949151|NCT01313637|10151857|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
2949152|NCT01313637|10151858|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
2949153|NCT01313637|10151855|P4|Overall Study|Protocol Violation|5
2949154|NCT01313637|10151856|P3|Overall Study|Protocol Violation|11
2949155|NCT01313637|10151857|P2|Overall Study|Protocol Violation|3
2949156|NCT01313637|10151858|P1|Overall Study|Protocol Violation|4
2949157|NCT01313637|10151855|P4|Overall Study|Lack of Efficacy|24
2949158|NCT01313637|10151856|P3|Overall Study|Lack of Efficacy|37
2949159|NCT01313637|10151857|P2|Overall Study|Lack of Efficacy|38
2949160|NCT01313637|10151858|P1|Overall Study|Lack of Efficacy|44
2949161|NCT01313637|10151855|P4|Overall Study|Adverse Event|18
2949162|NCT01313637|10151856|P3|Overall Study|Adverse Event|25
2949163|NCT01313637|10151857|P2|Overall Study|Adverse Event|24
2949164|NCT01313637|10151858|P1|Overall Study|Adverse Event|17
2949165|NCT01313624|10151882|P2|Open-Label Phase|Lost to Follow-up|1
2949166|NCT01313624|10151883|P1|Open-Label Phase|Lost to Follow-up|1
2949167|NCT01313624|10151882|P2|Open-Label Phase|Withdrawal by Subject|2
2949168|NCT01313624|10151883|P1|Open-Label Phase|Withdrawal by Subject|2
2949169|NCT01313624|10151882|P2|Open-Label Phase|Adverse Event|10
2949170|NCT01313624|10151883|P1|Open-Label Phase|Adverse Event|1
2949171|NCT01313624|10151882|P2|Double-Blind Phase|Lack of Efficacy|0
2949172|NCT01313624|10151883|P1|Double-Blind Phase|Lack of Efficacy|1
2949173|NCT01313624|10151882|P2|Double-Blind Phase|Physician Decision|0
2949174|NCT01313624|10151883|P1|Double-Blind Phase|Physician Decision|1
2949175|NCT01313624|10151882|P2|Double-Blind Phase|Lost to Follow-up|2
2949176|NCT01313624|10151883|P1|Double-Blind Phase|Lost to Follow-up|0
2949177|NCT01313624|10151882|P2|Double-Blind Phase|Withdrawal by Subject|4
2949178|NCT01313624|10151883|P1|Double-Blind Phase|Withdrawal by Subject|9
2949179|NCT01313624|10151882|P2|Double-Blind Phase|Adverse Event|4
2949180|NCT01313624|10151883|P1|Double-Blind Phase|Adverse Event|27
2949181|NCT01313559|10151897|P2|Overall Study|Rising PSA|0
2949182|NCT01313559|10151898|P1|Overall Study|Rising PSA|2
2949183|NCT01313559|10151897|P2|Overall Study|Disease progression|0
2949184|NCT01313559|10151898|P1|Overall Study|Disease progression|1
2949185|NCT01313559|10151897|P2|Overall Study|Withdrawal by Subject|2
2949186|NCT01313559|10151898|P1|Overall Study|Withdrawal by Subject|1
2949187|NCT01313312|10151999|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
2949188|NCT01313312|10151999|P1|Overall Study|Subject Withdrawn Early in Error|4
2949189|NCT01313312|10151999|P1|Overall Study|Observational Phase|1
2949190|NCT01313312|10151999|P1|Overall Study|Investigator Decision|1
2949191|NCT01313312|10151999|P1|Overall Study|Lack of Efficacy|3
2949192|NCT01313312|10151999|P1|Overall Study|Withdrawal by Subject|18
2949193|NCT01313312|10151999|P1|Overall Study|Adverse Event|5
2949194|NCT01313299|10152046|P3|Overall Study|Lack of subject compliance|1
2949195|NCT01313299|10152047|P2|Overall Study|Lack of subject compliance|0
2949196|NCT01313299|10152048|P1|Overall Study|Lack of subject compliance|0
2949197|NCT01313299|10152046|P3|Overall Study|Family reason and moved out of state|0
2949198|NCT01313299|10152047|P2|Overall Study|Family reason and moved out of state|2
2949199|NCT01313299|10152048|P1|Overall Study|Family reason and moved out of state|0
2949200|NCT01313299|10152046|P3|Overall Study|Withdrawal by Subject|2
2949201|NCT01313299|10152047|P2|Overall Study|Withdrawal by Subject|0
2949202|NCT01313299|10152048|P1|Overall Study|Withdrawal by Subject|1
2949203|NCT01313299|10152046|P3|Overall Study|Protocol Violation|0
2949204|NCT01313299|10152047|P2|Overall Study|Protocol Violation|0
2949205|NCT01313299|10152048|P1|Overall Study|Protocol Violation|2
2949206|NCT01313299|10152046|P3|Overall Study|Lost to Follow-up|0
2949207|NCT01313299|10152047|P2|Overall Study|Lost to Follow-up|0
2949208|NCT01313299|10152048|P1|Overall Study|Lost to Follow-up|1
2949209|NCT01313299|10152046|P3|Overall Study|Adverse Event|1
2949210|NCT01313299|10152047|P2|Overall Study|Adverse Event|1
2949211|NCT01313299|10152048|P1|Overall Study|Adverse Event|3
2949212|NCT01313286|10152062|P2|Period 1|Withdrawal by Subject|0
2949213|NCT01313286|10152063|P1|Period 1|Withdrawal by Subject|2
2949214|NCT01313273|10152073|P2|Overall Study|Screening Chromogranin A-in normal range|1
2949215|NCT01313273|10152074|P1|Overall Study|Screening Chromogranin A-in normal range|0
2949216|NCT01313273|10152073|P2|Overall Study|Withdrawal by Subject|0
2949217|NCT01313273|10152074|P1|Overall Study|Withdrawal by Subject|1
2949218|NCT01313273|10152073|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
2949219|NCT01313273|10152074|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
2949220|NCT01313221|10152089|P3|Overall Study|Pregnancy|2
2949221|NCT01313221|10152090|P2|Overall Study|Pregnancy|0
2949222|NCT01313221|10152091|P1|Overall Study|Pregnancy|0
2949223|NCT01313221|10152089|P3|Overall Study|Physician Decision|2
2949224|NCT01313221|10152090|P2|Overall Study|Physician Decision|0
2949225|NCT01313221|10152091|P1|Overall Study|Physician Decision|0
2949226|NCT01313221|10152089|P3|Overall Study|Disease progression|2
2949227|NCT01313221|10152090|P2|Overall Study|Disease progression|0
2949228|NCT01313221|10152091|P1|Overall Study|Disease progression|0
2949229|NCT01313221|10152089|P3|Overall Study|Adverse Event|7
2949230|NCT01313221|10152090|P2|Overall Study|Adverse Event|0
2949231|NCT01313221|10152091|P1|Overall Study|Adverse Event|0
2949232|NCT01313221|10152089|P3|Overall Study|Other|0
2949233|NCT01313221|10152090|P2|Overall Study|Other|0
2949234|NCT01313221|10152091|P1|Overall Study|Other|1
2949235|NCT01313221|10152089|P3|Overall Study|Lost to Follow-up|1
2949236|NCT01313221|10152090|P2|Overall Study|Lost to Follow-up|3
2949237|NCT01313221|10152091|P1|Overall Study|Lost to Follow-up|6
2949238|NCT01313221|10152089|P3|Overall Study|Requirement for alternative therapy|1
2949239|NCT01313221|10152090|P2|Overall Study|Requirement for alternative therapy|1
2949240|NCT01313221|10152091|P1|Overall Study|Requirement for alternative therapy|0
2949241|NCT01313221|10152089|P3|Overall Study|Withdrawal by Subject|5
2949242|NCT01313221|10152090|P2|Overall Study|Withdrawal by Subject|3
2949243|NCT01313221|10152091|P1|Overall Study|Withdrawal by Subject|2
2949244|NCT01313221|10152089|P3|Overall Study|Non-compliance|2
2949245|NCT01313221|10152090|P2|Overall Study|Non-compliance|0
2949246|NCT01313221|10152091|P1|Overall Study|Non-compliance|3
2949247|NCT01313221|10152089|P3|Overall Study|Protocol Violation|1
2949248|NCT01313221|10152090|P2|Overall Study|Protocol Violation|1
2949249|NCT01313221|10152091|P1|Overall Study|Protocol Violation|0
2949250|NCT01313208|10152143|P2|Open-label Phase (Weeks 13 - 24)|Other|0
2949251|NCT01313208|10152144|P1|Open-label Phase (Weeks 13 - 24)|Other|2
2949252|NCT01313208|10152143|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
2949253|NCT01313208|10152144|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
2949254|NCT01313208|10152143|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
2949255|NCT01313208|10152144|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
2949256|NCT01313208|10152143|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
2949257|NCT01313208|10152144|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
2949258|NCT01313208|10152143|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
2949259|NCT01313208|10152144|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
2949260|NCT01313208|10152143|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
2949261|NCT01313208|10152144|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
2949262|NCT01313208|10152143|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
2949263|NCT01313208|10152144|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
2949264|NCT01313208|10152143|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
2949265|NCT01313208|10152144|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
2949266|NCT01313208|10152143|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
2949267|NCT01313208|10152144|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
2949268|NCT01313182|10152234|P2|Overall Study|Protocol Violation|92
2949269|NCT01313182|10152235|P1|Overall Study|Protocol Violation|66
2949270|NCT01313117|10152247|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2949271|NCT01313117|10152247|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2949272|NCT01313078|10152254|P1|Overall Study|Withdrawal by Subject|1
2949273|NCT01313078|10152254|P1|Overall Study|Discontinued study drug|1
2949274|NCT01313078|10152254|P1|Overall Study|Death|1
2949275|NCT01313039|10152259|P1|Overall Study|Adverse Event|1
2949276|NCT01313039|10152259|P1|Overall Study|Physician Decision|1
2949277|NCT01312961|10152265|P2|Overall Study|Other than specified above|3
2949278|NCT01312961|10152266|P1|Overall Study|Other than specified above|2
2949279|NCT01312961|10152265|P2|Overall Study|Poor compliance to protocol|0
2949280|NCT01312961|10152266|P1|Overall Study|Poor compliance to protocol|1
2949281|NCT01312961|10152265|P2|Overall Study|Lack of Efficacy|1
2949282|NCT01312961|10152266|P1|Overall Study|Lack of Efficacy|11
2949283|NCT01312961|10152265|P2|Overall Study|Adverse Event|3
2949284|NCT01312961|10152266|P1|Overall Study|Adverse Event|3
2949285|NCT01312909|10152302|P3|Overall Study|Entrance criteria not met|2
2949286|NCT01312909|10152303|P2|Overall Study|Entrance criteria not met|0
2949287|NCT01312909|10152304|P1|Overall Study|Entrance criteria not met|0
2949288|NCT01312909|10152302|P3|Overall Study|Insufficient clinical response|1
2949289|NCT01312909|10152303|P2|Overall Study|Insufficient clinical response|0
2949290|NCT01312909|10152304|P1|Overall Study|Insufficient clinical response|0
2949291|NCT01312909|10152302|P3|Overall Study|Lost to Follow-up|20
2949292|NCT01312909|10152303|P2|Overall Study|Lost to Follow-up|17
2949293|NCT01312909|10152304|P1|Overall Study|Lost to Follow-up|21
2949294|NCT01312909|10152302|P3|Overall Study|Withdrawal by Subject|7
2949295|NCT01312909|10152303|P2|Overall Study|Withdrawal by Subject|10
2949296|NCT01312909|10152304|P1|Overall Study|Withdrawal by Subject|8
2949297|NCT01312909|10152302|P3|Overall Study|Other|11
2949298|NCT01312909|10152303|P2|Overall Study|Other|6
2949299|NCT01312909|10152304|P1|Overall Study|Other|9
2949300|NCT01312909|10152302|P3|Overall Study|Protocol Violation|2
2949301|NCT01312909|10152303|P2|Overall Study|Protocol Violation|0
2949302|NCT01312909|10152304|P1|Overall Study|Protocol Violation|2
2949303|NCT01312909|10152302|P3|Overall Study|Adverse Event|3
2949304|NCT01312909|10152303|P2|Overall Study|Adverse Event|0
2949305|NCT01312909|10152304|P1|Overall Study|Adverse Event|1
2949306|NCT01312909|10152302|P3|Overall Study|Randomized but not treated|1
2949307|NCT01312909|10152303|P2|Overall Study|Randomized but not treated|3
2949308|NCT01312909|10152304|P1|Overall Study|Randomized but not treated|1
2949309|NCT01312779|10152391|P1|Overall Study|Not Implanted with Device|27
2949310|NCT01312779|10152391|P1|Overall Study|Death|3
2949311|NCT01312779|10152391|P1|Overall Study|Withdrawal by Subject|2
2949312|NCT01312467|10152474|P1|Overall Study|Ineligible|4
2949313|NCT01312467|10152474|P1|Overall Study|Another medical condition|1
2949314|NCT01312467|10152474|P1|Overall Study|Deported to country of origin|1
2949315|NCT01312467|10152474|P1|Overall Study|Withdrawal by Subject|2
2949316|NCT01312467|10152474|P1|Overall Study|Lost to Follow-up|1
2949317|NCT01312467|10152474|P1|Overall Study|Adverse Event|4
2949318|NCT01312428|10152483|P2|Overall Study|Study Termination|4
2949319|NCT01312428|10152484|P1|Overall Study|Study Termination|3
2949320|NCT01312129|10152554|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
2949321|NCT01312129|10152555|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
2949322|NCT01311661|10152640|P1|Overall Study|Withdrawal by Subject|2
2949323|NCT01311661|10152640|P1|Overall Study|Protocol Violation|3
2949324|NCT01311661|10152640|P1|Overall Study|Adverse Event|2
2949325|NCT01311557|10152784|P2|Overall Study|Withdrawal by Subject|2
2949326|NCT01311557|10152785|P1|Overall Study|Withdrawal by Subject|1
2949327|NCT01311557|10152784|P2|Overall Study|Lost to Follow-up|1
2949328|NCT01311557|10152785|P1|Overall Study|Lost to Follow-up|0
2949329|NCT01311557|10152784|P2|Overall Study|Protocol Violation|2
2949330|NCT01311557|10152785|P1|Overall Study|Protocol Violation|4
2949331|NCT01311557|10152784|P2|Overall Study|Serious adverse event|1
2949332|NCT01311557|10152785|P1|Overall Study|Serious adverse event|0
2949333|NCT01311505|10152801|P2|First Intervention Period|Protocol Violation|1
2949334|NCT01311505|10152802|P1|First Intervention Period|Protocol Violation|0
2949335|NCT01311024|10152858|P2|Overall Study|Protocol Violation|22
2949336|NCT01311024|10152859|P1|Overall Study|Protocol Violation|35
2949337|NCT01310868|10152865|P1|Overall Study|Do not have histologically confirmed GBM|13
2949338|NCT01310803|10152882|P2|Overall Study|Subject terminated by Sponsor|0
2949339|NCT01310803|10152883|P1|Overall Study|Subject terminated by Sponsor|1
2949340|NCT01310777|10152894|P3|Overall Study|Other|2
2949341|NCT01310777|10152895|P2|Overall Study|Other|1
2949342|NCT01310777|10152896|P1|Overall Study|Other|4
2949343|NCT01310777|10152894|P3|Overall Study|Inadequate Control of IOP|10
2949344|NCT01310777|10152895|P2|Overall Study|Inadequate Control of IOP|7
2949345|NCT01310777|10152896|P1|Overall Study|Inadequate Control of IOP|5
2949346|NCT01310777|10152894|P3|Overall Study|Patient's Decision Unrelated to AE|2
2949347|NCT01310777|10152895|P2|Overall Study|Patient's Decision Unrelated to AE|1
2949348|NCT01310777|10152896|P1|Overall Study|Patient's Decision Unrelated to AE|1
2949349|NCT01310777|10152894|P3|Overall Study|Lost to Follow-up|1
2949350|NCT01310777|10152895|P2|Overall Study|Lost to Follow-up|4
2949351|NCT01310777|10152896|P1|Overall Study|Lost to Follow-up|0
2949352|NCT01310777|10152894|P3|Overall Study|Adverse Event|15
2949353|NCT01310777|10152895|P2|Overall Study|Adverse Event|1
2949354|NCT01310777|10152896|P1|Overall Study|Adverse Event|23
2949355|NCT01310699|10152906|P2|Overall Study|Patients did not complete tandem.|6
2949356|NCT01310699|10152907|P1|Overall Study|Patients did not complete tandem.|4
2949357|NCT01310413|10152934|P7|From Day U0 to Day U385|Lost to Follow-up|2
2949358|NCT01310413|10152935|P6|From Day U0 to Day U385|Lost to Follow-up|0
2949359|NCT01310413|10152936|P5|From Day U0 to Day U385|Lost to Follow-up|0
2949360|NCT01310413|10152937|P4|From Day U0 to Day U385|Lost to Follow-up|0
2949361|NCT01310413|10152938|P3|From Day U0 to Day U385|Lost to Follow-up|0
2949362|NCT01310413|10152939|P2|From Day U0 to Day U385|Lost to Follow-up|0
2949363|NCT01310413|10152940|P1|From Day U0 to Day U385|Lost to Follow-up|0
2949364|NCT01310413|10152934|P7|From Day U0 to Day U385|Withdrawal by Subject|1
2949365|NCT01310413|10152935|P6|From Day U0 to Day U385|Withdrawal by Subject|0
2949366|NCT01310413|10152936|P5|From Day U0 to Day U385|Withdrawal by Subject|0
2949367|NCT01310413|10152937|P4|From Day U0 to Day U385|Withdrawal by Subject|0
2949368|NCT01310413|10152938|P3|From Day U0 to Day U385|Withdrawal by Subject|0
2949369|NCT01310413|10152939|P2|From Day U0 to Day U385|Withdrawal by Subject|0
2949370|NCT01310413|10152940|P1|From Day U0 to Day U385|Withdrawal by Subject|0
2949371|NCT01310413|10152934|P7|Day 0 to Day 385|Other|0
2949372|NCT01310413|10152935|P6|Day 0 to Day 385|Other|0
2949373|NCT01310413|10152936|P5|Day 0 to Day 385|Other|0
2949374|NCT01310413|10152937|P4|Day 0 to Day 385|Other|0
2949375|NCT01310413|10152938|P3|Day 0 to Day 385|Other|3
2949376|NCT01310413|10152939|P2|Day 0 to Day 385|Other|0
2949377|NCT01310413|10152940|P1|Day 0 to Day 385|Other|1
2949378|NCT01310413|10152934|P7|Day 0 to Day 385|Migrated/moved from study area|0
2949379|NCT01310413|10152935|P6|Day 0 to Day 385|Migrated/moved from study area|0
2949380|NCT01310413|10152936|P5|Day 0 to Day 385|Migrated/moved from study area|1
2949381|NCT01310413|10152937|P4|Day 0 to Day 385|Migrated/moved from study area|1
2949382|NCT01310413|10152938|P3|Day 0 to Day 385|Migrated/moved from study area|1
2949383|NCT01310413|10152939|P2|Day 0 to Day 385|Migrated/moved from study area|3
2949384|NCT01310413|10152940|P1|Day 0 to Day 385|Migrated/moved from study area|3
2949385|NCT01310413|10152934|P7|Day 0 to Day 385|Lost to Follow-up|0
2949386|NCT01310413|10152935|P6|Day 0 to Day 385|Lost to Follow-up|2
2949387|NCT01310413|10152936|P5|Day 0 to Day 385|Lost to Follow-up|1
2949388|NCT01310413|10152937|P4|Day 0 to Day 385|Lost to Follow-up|5
2949389|NCT01310413|10152938|P3|Day 0 to Day 385|Lost to Follow-up|3
2949390|NCT01310413|10152939|P2|Day 0 to Day 385|Lost to Follow-up|3
2949391|NCT01310413|10152940|P1|Day 0 to Day 385|Lost to Follow-up|18
2949392|NCT01310413|10152934|P7|Day 0 to Day 385|Withdrawal by Subject|0
2949393|NCT01310413|10152935|P6|Day 0 to Day 385|Withdrawal by Subject|1
2949394|NCT01310413|10152936|P5|Day 0 to Day 385|Withdrawal by Subject|1
2949395|NCT01310413|10152937|P4|Day 0 to Day 385|Withdrawal by Subject|2
2949396|NCT01310413|10152938|P3|Day 0 to Day 385|Withdrawal by Subject|0
2949397|NCT01310413|10152939|P2|Day 0 to Day 385|Withdrawal by Subject|2
2949398|NCT01310413|10152940|P1|Day 0 to Day 385|Withdrawal by Subject|5
2949399|NCT01310127|10153122|P2|Overall Study|advanced psc cataract outlier|0
2949400|NCT01310127|10153123|P1|Overall Study|advanced psc cataract outlier|1
2949401|NCT01310127|10153122|P2|Overall Study|Protocol Violation|1
2949402|NCT01310127|10153123|P1|Overall Study|Protocol Violation|1
2949403|NCT01310075|10153137|P2|Overall Study|Withdrawal by Subject|1
2949404|NCT01310075|10153138|P1|Overall Study|Withdrawal by Subject|1
2949405|NCT01310075|10153137|P2|Overall Study|Protocol Violation|2
2949406|NCT01310075|10153138|P1|Overall Study|Protocol Violation|2
2949407|NCT01310075|10153137|P2|Overall Study|Physician Decision|7
2949408|NCT01310075|10153138|P1|Overall Study|Physician Decision|10
2949409|NCT01310075|10153137|P2|Overall Study|Lost to Follow-up|0
2949410|NCT01310075|10153138|P1|Overall Study|Lost to Follow-up|1
2949411|NCT01310036|10153144|P1|Overall Study|Adverse event or intercurrent illness|12
2949412|NCT01310036|10153144|P1|Overall Study|Death|1
2949413|NCT01310036|10153144|P1|Overall Study|Progression of Disease|164
2949414|NCT01310036|10153144|P1|Overall Study|Refused Treatment/Did not Cooperate|4
2949415|NCT01310036|10153144|P1|Overall Study|Withdrew Consent|11
2949416|NCT01310036|10153144|P1|Overall Study|Administrative/other|10
2949417|NCT01309997|10153157|P2|Overall Study|Withdrawal by Subject|1
2949418|NCT01309997|10153158|P1|Overall Study|Withdrawal by Subject|1
2949419|NCT01309997|10153157|P2|Overall Study|Lack of Efficacy|2
2949420|NCT01309997|10153158|P1|Overall Study|Lack of Efficacy|2
2949421|NCT01309997|10153157|P2|Overall Study|Death|3
2949422|NCT01309997|10153158|P1|Overall Study|Death|1
2949423|NCT01309997|10153157|P2|Overall Study|Adverse Event|0
2949424|NCT01309997|10153158|P1|Overall Study|Adverse Event|1
2949425|NCT01309919|10153182|P2|Overall Study|Did not receive a postpartum IUD|48
2949426|NCT01309919|10153183|P1|Overall Study|Did not receive a postpartum IUD|17
2949427|NCT01309893|10153195|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
2949428|NCT01309893|10153196|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
2949429|NCT01309893|10153195|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
2949430|NCT01309893|10153196|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
2949431|NCT01309841|10153220|P3|Overall Study|Severe non-compliance with protocol|2
2949432|NCT01309841|10153221|P2|Overall Study|Severe non-compliance with protocol|5
2949433|NCT01309841|10153222|P1|Overall Study|Severe non-compliance with protocol|0
2949434|NCT01309841|10153220|P3|Overall Study|Did Not Receive Treatment|1
2949435|NCT01309841|10153221|P2|Overall Study|Did Not Receive Treatment|0
2949436|NCT01309841|10153222|P1|Overall Study|Did Not Receive Treatment|2
2949437|NCT01309841|10153220|P3|Overall Study|Withdrawal by Subject|13
2949438|NCT01309841|10153221|P2|Overall Study|Withdrawal by Subject|6
2949439|NCT01309841|10153222|P1|Overall Study|Withdrawal by Subject|17
2949440|NCT01309841|10153220|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
2949441|NCT01309841|10153221|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2949442|NCT01309841|10153222|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2949443|NCT01309841|10153220|P3|Overall Study|Death|0
2949444|NCT01309841|10153221|P2|Overall Study|Death|0
2949445|NCT01309841|10153222|P1|Overall Study|Death|1
2949446|NCT01309841|10153220|P3|Overall Study|Adverse Event|11
2949447|NCT01309841|10153221|P2|Overall Study|Adverse Event|22
2949448|NCT01309841|10153222|P1|Overall Study|Adverse Event|9
2949449|NCT01309841|10153220|P3|Overall Study|Lack of Efficacy|2
2949450|NCT01309841|10153221|P2|Overall Study|Lack of Efficacy|0
2949451|NCT01309841|10153222|P1|Overall Study|Lack of Efficacy|0
2949452|NCT01309841|10153220|P3|Overall Study|Study-Specific Withdrawal Criteria|2
2949453|NCT01309841|10153221|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2949454|NCT01309841|10153222|P1|Overall Study|Study-Specific Withdrawal Criteria|3
2949455|NCT01309841|10153220|P3|Overall Study|Lost to Follow-up|4
2949456|NCT01309841|10153221|P2|Overall Study|Lost to Follow-up|6
2949457|NCT01309841|10153222|P1|Overall Study|Lost to Follow-up|7
2949458|NCT01309841|10153220|P3|Overall Study|Other|1
2949459|NCT01309841|10153221|P2|Overall Study|Other|1
2949460|NCT01309841|10153222|P1|Overall Study|Other|0
2949461|NCT01309828|10153262|P2|Overall Study|Other|0
2949462|NCT01309828|10153263|P1|Overall Study|Other|1
2949463|NCT01309828|10153262|P2|Overall Study|Major Protocol Deviation|1
2949464|NCT01309828|10153263|P1|Overall Study|Major Protocol Deviation|0
2949465|NCT01309828|10153262|P2|Overall Study|Voluntary Withdrawal|4
2949466|NCT01309828|10153263|P1|Overall Study|Voluntary Withdrawal|5
2949467|NCT01309828|10153262|P2|Overall Study|Adverse Event|11
2949468|NCT01309828|10153263|P1|Overall Study|Adverse Event|10
2949469|NCT01309737|10153297|P5|Week 16 to 52|Other|0
2949470|NCT01309737|10153298|P4|Week 16 to 52|Other|2
2949471|NCT01309737|10153299|P3|Week 16 to 52|Other|0
2949472|NCT01309737|10153300|P2|Week 16 to 52|Other|12
2949473|NCT01309737|10153301|P1|Week 16 to 52|Other|10
2949474|NCT01309737|10153297|P5|Week 16 to 52|Withdrawal by Subject|2
2949475|NCT01309737|10153298|P4|Week 16 to 52|Withdrawal by Subject|0
2949476|NCT01309737|10153299|P3|Week 16 to 52|Withdrawal by Subject|0
2949477|NCT01309737|10153300|P2|Week 16 to 52|Withdrawal by Subject|6
2949478|NCT01309737|10153301|P1|Week 16 to 52|Withdrawal by Subject|5
2949479|NCT01309737|10153297|P5|Week 16 to 52|Lost to Follow-up|4
2949480|NCT01309737|10153298|P4|Week 16 to 52|Lost to Follow-up|1
2949481|NCT01309737|10153299|P3|Week 16 to 52|Lost to Follow-up|0
2949482|NCT01309737|10153300|P2|Week 16 to 52|Lost to Follow-up|2
2949483|NCT01309737|10153301|P1|Week 16 to 52|Lost to Follow-up|4
2949484|NCT01309737|10153297|P5|Week 16 to 52|Lack of Efficacy|21
2949485|NCT01309737|10153298|P4|Week 16 to 52|Lack of Efficacy|25
2949486|NCT01309737|10153299|P3|Week 16 to 52|Lack of Efficacy|0
2949487|NCT01309737|10153300|P2|Week 16 to 52|Lack of Efficacy|76
2949488|NCT01309737|10153301|P1|Week 16 to 52|Lack of Efficacy|107
2949489|NCT01309737|10153297|P5|Week 16 to 52|Adverse Event|5
2949490|NCT01309737|10153298|P4|Week 16 to 52|Adverse Event|6
2949491|NCT01309737|10153299|P3|Week 16 to 52|Adverse Event|0
2949492|NCT01309737|10153300|P2|Week 16 to 52|Adverse Event|7
2949493|NCT01309737|10153301|P1|Week 16 to 52|Adverse Event|7
2949494|NCT01309737|10153297|P5|Week 16 to 52|Death|1
2949495|NCT01309737|10153298|P4|Week 16 to 52|Death|0
2949496|NCT01309737|10153299|P3|Week 16 to 52|Death|0
2949497|NCT01309737|10153300|P2|Week 16 to 52|Death|0
2949498|NCT01309737|10153301|P1|Week 16 to 52|Death|0
2949499|NCT01309737|10153297|P5|Week 0 to 16|Randomized, but not treated|0
2949500|NCT01309737|10153298|P4|Week 0 to 16|Randomized, but not treated|0
2949501|NCT01309737|10153299|P3|Week 0 to 16|Randomized, but not treated|0
2949502|NCT01309737|10153300|P2|Week 0 to 16|Randomized, but not treated|0
2949503|NCT01309737|10153301|P1|Week 0 to 16|Randomized, but not treated|1
2949504|NCT01309737|10153297|P5|Week 0 to 16|Other|0
2949505|NCT01309737|10153298|P4|Week 0 to 16|Other|0
2949506|NCT01309737|10153299|P3|Week 0 to 16|Other|4
2949507|NCT01309737|10153300|P2|Week 0 to 16|Other|14
2949508|NCT01309737|10153301|P1|Week 0 to 16|Other|10
2949509|NCT01309737|10153297|P5|Week 0 to 16|Withdrawal by Subject|0
2949510|NCT01309737|10153298|P4|Week 0 to 16|Withdrawal by Subject|0
2949511|NCT01309737|10153299|P3|Week 0 to 16|Withdrawal by Subject|7
2949512|NCT01309737|10153300|P2|Week 0 to 16|Withdrawal by Subject|6
2949513|NCT01309737|10153301|P1|Week 0 to 16|Withdrawal by Subject|7
2949514|NCT01309737|10153297|P5|Week 0 to 16|Lost to Follow-up|0
2949515|NCT01309737|10153298|P4|Week 0 to 16|Lost to Follow-up|0
2949516|NCT01309737|10153299|P3|Week 0 to 16|Lost to Follow-up|3
2949517|NCT01309737|10153300|P2|Week 0 to 16|Lost to Follow-up|8
2949518|NCT01309737|10153301|P1|Week 0 to 16|Lost to Follow-up|7
2949519|NCT01309737|10153297|P5|Week 0 to 16|Lack of Efficacy|0
2949520|NCT01309737|10153298|P4|Week 0 to 16|Lack of Efficacy|0
2949521|NCT01309737|10153299|P3|Week 0 to 16|Lack of Efficacy|24
2949522|NCT01309737|10153300|P2|Week 0 to 16|Lack of Efficacy|2
2949523|NCT01309737|10153301|P1|Week 0 to 16|Lack of Efficacy|15
2949524|NCT01309737|10153297|P5|Week 0 to 16|Adverse Event|0
2949525|NCT01309737|10153298|P4|Week 0 to 16|Adverse Event|0
2949526|NCT01309737|10153299|P3|Week 0 to 16|Adverse Event|5
2949527|NCT01309737|10153300|P2|Week 0 to 16|Adverse Event|10
2949528|NCT01309737|10153301|P1|Week 0 to 16|Adverse Event|11
2949529|NCT01309737|10153297|P5|Week 0 to 16|Death|0
2949530|NCT01309737|10153298|P4|Week 0 to 16|Death|0
2949531|NCT01309737|10153299|P3|Week 0 to 16|Death|1
2949532|NCT01309737|10153300|P2|Week 0 to 16|Death|0
2949533|NCT01309737|10153301|P1|Week 0 to 16|Death|1
2949534|NCT01309672|10153496|P1|Overall Study|Withdrawal by Subject|3
2949535|NCT01309672|10153496|P1|Overall Study|Adverse Event|5
2949536|NCT01309672|10153496|P1|Overall Study|Other|9
2949537|NCT01309672|10153496|P1|Overall Study|Lack of Efficacy|20
2949538|NCT01309659|10153506|P2|Overall Study|Protocol Violation|1
2949539|NCT01309659|10153507|P1|Overall Study|Protocol Violation|0
2949540|NCT01309386|10153612|P2|Overall Study|Adverse Event|8
2949541|NCT01309386|10153613|P1|Overall Study|Adverse Event|5
2949542|NCT01309386|10153612|P2|Overall Study|Lack of Efficacy|1
2949543|NCT01309386|10153613|P1|Overall Study|Lack of Efficacy|3
2949544|NCT01309386|10153612|P2|Overall Study|Physician Decision|1
2949545|NCT01309386|10153613|P1|Overall Study|Physician Decision|1
2949546|NCT01309386|10153612|P2|Overall Study|Progressive disease|11
2949547|NCT01309386|10153613|P1|Overall Study|Progressive disease|9
2949548|NCT01309386|10153612|P2|Overall Study|Withdrawal by Subject|0
2949549|NCT01309386|10153613|P1|Overall Study|Withdrawal by Subject|2
2949550|NCT01309386|10153612|P2|Overall Study|Other|0
2949551|NCT01309386|10153613|P1|Overall Study|Other|2
2949552|NCT01309308|10153661|P2|Overall Study|Lost to Follow-up|4
2949553|NCT01309308|10153662|P1|Overall Study|Lost to Follow-up|6
2949554|NCT01309282|10153670|P1|Overall Study|Lost to Follow-up|1
2949555|NCT01309269|10153687|P1|Overall Study|Enrolled but not Treated|107
2949556|NCT01309269|10153687|P1|Overall Study|Study Completion Data Not Recorded|95
2949557|NCT01309269|10153687|P1|Overall Study|Other|1
2949558|NCT01309269|10153687|P1|Overall Study|Other|256
2949559|NCT01309269|10153687|P1|Overall Study|Administrative Problems|141
2949560|NCT01309269|10153687|P1|Overall Study|Kidney Transplant|25
2949561|NCT01309269|10153687|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
2949562|NCT01309269|10153687|P1|Overall Study|Lack of Acceptance|15
2949563|NCT01309269|10153687|P1|Overall Study|Withdrawal by Subject|25
2949564|NCT01309269|10153687|P1|Overall Study|Adverse Event|56
2949565|NCT01309243|10153695|P2|Extension Phase|Lost to Follow-up|0
2949566|NCT01309243|10153696|P1|Extension Phase|Lost to Follow-up|6
2949567|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Protocol Violation|1
2949568|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Protocol Violation|1
2949569|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
2949570|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
2949571|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
2949572|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
2949573|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Withdrew Consent|18
2949574|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Withdrew Consent|12
2949575|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Investigators Discretion|6
2949576|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Investigators Discretion|3
2949577|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
2949578|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
2949579|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Pregnancy|0
2949580|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Pregnancy|2
2949581|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Death|1
2949582|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Death|0
2949583|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Adverse Event|43
2949584|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Adverse Event|12
2949585|NCT01309243|10153695|P2|Randomized Phase Through Week 96|Randomized but not treated|7
2949586|NCT01309243|10153696|P1|Randomized Phase Through Week 96|Randomized but not treated|6
2949587|NCT01309204|10153722|P2|Overall Study|Other|1
2949588|NCT01309204|10153723|P1|Overall Study|Other|4
2949589|NCT01309204|10153722|P2|Overall Study|Inadequate control of IOP|4
2949590|NCT01309204|10153723|P1|Overall Study|Inadequate control of IOP|4
2949591|NCT01309204|10153722|P2|Overall Study|Subject's decision unrelated to an AE|10
2949592|NCT01309204|10153723|P1|Overall Study|Subject's decision unrelated to an AE|9
2949593|NCT01309204|10153722|P2|Overall Study|Lost to Follow-up|2
2949594|NCT01309204|10153723|P1|Overall Study|Lost to Follow-up|2
2949595|NCT01309204|10153722|P2|Overall Study|Adverse Event|58
2949596|NCT01309204|10153723|P1|Overall Study|Adverse Event|48
2949597|NCT01309165|10153731|P2|Overall Study|Admitted to hospital for second stroke|0
2949598|NCT01309165|10153732|P1|Overall Study|Admitted to hospital for second stroke|1
2949599|NCT01309165|10153731|P2|Overall Study|No transportation|1
2949600|NCT01309165|10153732|P1|Overall Study|No transportation|0
2949601|NCT01309165|10153731|P2|Overall Study|Left country|1
2949602|NCT01309165|10153732|P1|Overall Study|Left country|0
2949603|NCT01309165|10153731|P2|Overall Study|Return to work|2
2949604|NCT01309165|10153732|P1|Overall Study|Return to work|1
2949605|NCT01309165|10153731|P2|Overall Study|Lost to Follow-up|3
2949606|NCT01309165|10153732|P1|Overall Study|Lost to Follow-up|4
2949607|NCT01309100|10153744|P1|Overall Study|Positive Slit lamp finding|1
2949608|NCT01309100|10153744|P1|Overall Study|Protocol Violation|1
2949609|NCT01308853|10153762|P1|Overall Study|Insertion of permanent implants|1
2949610|NCT01308853|10153762|P1|Overall Study|Lost to Follow-up|2
2949611|NCT01308853|10153762|P1|Overall Study|Adverse Event|1
2949612|NCT01308788|10153797|P2|2-year Treatment|medication change by treating physician|11
2949613|NCT01308788|10153798|P1|2-year Treatment|medication change by treating physician|4
2949614|NCT01308762|10153833|P3|Overall Study|Protocol Violation|0
2949615|NCT01308762|10153834|P2|Overall Study|Protocol Violation|1
2949616|NCT01308762|10153835|P1|Overall Study|Protocol Violation|0
2949617|NCT01308749|10153848|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
2949618|NCT01308749|10153849|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
2949619|NCT01308749|10153848|P2|Period 2: Open Label Treatment|Adverse Event|1
2949620|NCT01308749|10153849|P1|Period 2: Open Label Treatment|Adverse Event|0
2949621|NCT01308749|10153848|P2|Period 1: Double Blind Treatment|Adverse Event|0
2949622|NCT01308749|10153849|P1|Period 1: Double Blind Treatment|Adverse Event|1
2949623|NCT01308736|10153879|P2|Overall Study|Did not attend a single session|5
2949624|NCT01308736|10153880|P1|Overall Study|Did not attend a single session|6
2949625|NCT01308580|10153903|P2|Overall Study|Lost to Follow-up|7
2949626|NCT01308580|10153904|P1|Overall Study|Lost to Follow-up|12
2949627|NCT01308567|10153947|P3|Overall Study|Lost to Follow-up|4
2949628|NCT01308567|10153948|P2|Overall Study|Lost to Follow-up|4
2949629|NCT01308567|10153949|P1|Overall Study|Lost to Follow-up|2
2949630|NCT01308476|10153989|P2|Overall Study|Other|0
2949631|NCT01308476|10153990|P1|Overall Study|Other|1
2949632|NCT01308476|10153989|P2|Overall Study|Lost to Follow-up|2
2949633|NCT01308476|10153990|P1|Overall Study|Lost to Follow-up|2
2949634|NCT01308463|10154010|P1|Overall Study|Revision|2
2949635|NCT01308463|10154010|P1|Overall Study|Death|4
2949636|NCT01308463|10154010|P1|Overall Study|Study Discontinued|23
2949637|NCT01308424|10154023|P3|Randomization|Physician Decision|1
2949638|NCT01308424|10154024|P2|Randomization|Physician Decision|1
2949639|NCT01308424|10154025|P1|Randomization|Physician Decision|0
2949640|NCT01308424|10154023|P3|Randomization|Lost to Follow-up|0
2949641|NCT01308424|10154024|P2|Randomization|Lost to Follow-up|1
2949642|NCT01308424|10154025|P1|Randomization|Lost to Follow-up|0
2949643|NCT01308424|10154023|P3|Randomization|Adverse Event|1
2949644|NCT01308424|10154024|P2|Randomization|Adverse Event|1
2949645|NCT01308424|10154025|P1|Randomization|Adverse Event|0
2949646|NCT01308424|10154023|P3|Baseline Eligibility|Screen Failures|0
2949647|NCT01308424|10154024|P2|Baseline Eligibility|Screen Failures|0
2949648|NCT01308424|10154025|P1|Baseline Eligibility|Screen Failures|71
2949649|NCT01308008|10154077|P2|4 Weeks|Illness, disinterest, time|2
2949650|NCT01308008|10154078|P1|4 Weeks|Illness, disinterest, time|9
2949651|NCT01307891|10154101|P2|Overall Study|Progressive Disease|1
2949652|NCT01307891|10154102|P1|Overall Study|Progressive Disease|3
2949653|NCT01307787|10154114|P2|Overall Study|Withdrawal by Subject|0
2949654|NCT01307787|10154115|P1|Overall Study|Withdrawal by Subject|2
2949655|NCT01307579|10154184|P2|Overall Study|Ineligible|4
2949656|NCT01307579|10154185|P1|Overall Study|Ineligible|3
2949657|NCT01307579|10154184|P2|Overall Study|Refractory or relapsed AML|23
2949658|NCT01307579|10154185|P1|Overall Study|Refractory or relapsed AML|38
2949659|NCT01307579|10154184|P2|Overall Study|Begin conditioning for HSCT|44
2949660|NCT01307579|10154185|P1|Overall Study|Begin conditioning for HSCT|42
2949661|NCT01307579|10154184|P2|Overall Study|Institutional diagnosis of IFD|36
2949662|NCT01307579|10154185|P1|Overall Study|Institutional diagnosis of IFD|21
2949663|NCT01307579|10154184|P2|Overall Study|Withdrawal by Subject|3
2949664|NCT01307579|10154185|P1|Overall Study|Withdrawal by Subject|7
2949665|NCT01307579|10154184|P2|Overall Study|Physician Decision|29
2949666|NCT01307579|10154185|P1|Overall Study|Physician Decision|26
2949667|NCT01307579|10154184|P2|Overall Study|Death|6
2949668|NCT01307579|10154185|P1|Overall Study|Death|3
2949669|NCT01307501|10154197|P1|Overall Study|Starting Hospice|1
2949670|NCT01307501|10154197|P1|Overall Study|Lost to Follow-up|1
2949671|NCT01307501|10154197|P1|Overall Study|Death|20
2949672|NCT01307501|10154197|P1|Overall Study|Treatment Failure|1
2949673|NCT01307449|10154227|P4|Overall Study|Adverse Event|0
2949674|NCT01307449|10154228|P3|Overall Study|Adverse Event|0
2949675|NCT01307449|10154229|P2|Overall Study|Adverse Event|0
2949676|NCT01307449|10154230|P1|Overall Study|Adverse Event|1
2949677|NCT01307423|10154263|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
2949678|NCT01307423|10154264|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
2949679|NCT01307423|10154265|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949680|NCT01307423|10154266|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949681|NCT01307423|10154267|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949682|NCT01307423|10154268|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949683|NCT01307423|10154269|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
2949684|NCT01307423|10154270|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949685|NCT01307423|10154271|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
2949686|NCT01307423|10154263|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949687|NCT01307423|10154264|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949688|NCT01307423|10154265|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949689|NCT01307423|10154266|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949690|NCT01307423|10154267|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949691|NCT01307423|10154268|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949692|NCT01307423|10154269|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949693|NCT01307423|10154270|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
2949694|NCT01307423|10154271|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2949695|NCT01307423|10154263|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2949696|NCT01307423|10154264|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949697|NCT01307423|10154265|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949698|NCT01307423|10154266|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949699|NCT01307423|10154267|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949700|NCT01307423|10154268|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949701|NCT01307423|10154269|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2949702|NCT01307423|10154270|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
2949703|NCT01307423|10154271|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2949704|NCT01307423|10154263|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949705|NCT01307423|10154264|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949706|NCT01307423|10154265|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949707|NCT01307423|10154266|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949708|NCT01307423|10154267|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949709|NCT01307423|10154268|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949710|NCT01307423|10154269|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
2949711|NCT01307423|10154270|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
2949712|NCT01307423|10154271|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2949713|NCT01307423|10154263|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
2949714|NCT01307423|10154264|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
2949715|NCT01307423|10154265|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
2949716|NCT01307423|10154266|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
2949717|NCT01307423|10154267|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
2949718|NCT01307423|10154268|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
2949719|NCT01307423|10154269|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
2949720|NCT01307423|10154270|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
2949721|NCT01307423|10154271|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
2949722|NCT01307423|10154263|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949723|NCT01307423|10154264|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
2949724|NCT01307423|10154265|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949725|NCT01307423|10154266|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949726|NCT01307423|10154267|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949727|NCT01307423|10154268|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949728|NCT01307423|10154269|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949729|NCT01307423|10154270|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949730|NCT01307423|10154271|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
2949731|NCT01307423|10154263|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949732|NCT01307423|10154264|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949733|NCT01307423|10154265|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949734|NCT01307423|10154266|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949735|NCT01307423|10154267|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949736|NCT01307423|10154268|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949737|NCT01307423|10154269|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2949738|NCT01307423|10154270|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949739|NCT01307423|10154271|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2949740|NCT01307423|10154263|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2949741|NCT01307423|10154264|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
2949742|NCT01307423|10154265|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2949743|NCT01307423|10154266|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2949744|NCT01307423|10154267|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2949745|NCT01307423|10154268|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2949746|NCT01307423|10154269|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2949747|NCT01307423|10154270|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
2949748|NCT01307423|10154271|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2949749|NCT01307423|10154263|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2949750|NCT01307423|10154264|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949751|NCT01307423|10154265|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949752|NCT01307423|10154266|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949753|NCT01307423|10154267|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949754|NCT01307423|10154268|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949755|NCT01307423|10154269|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949756|NCT01307423|10154270|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2949757|NCT01307423|10154271|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2949758|NCT01307423|10154263|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
2949759|NCT01307423|10154264|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
2949760|NCT01307423|10154265|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
2949761|NCT01307423|10154266|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
2949762|NCT01307423|10154267|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
2949763|NCT01307423|10154268|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
2949764|NCT01307423|10154269|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
2949765|NCT01307423|10154270|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
2949766|NCT01307423|10154271|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
2949767|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949768|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
2949769|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949770|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949771|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949772|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949773|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949774|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
2949775|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
2949776|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2949777|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2949778|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2949779|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2949780|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2949781|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2949782|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
2949783|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
2949784|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2949785|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2949786|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2949787|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2949788|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2949789|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2949790|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2949791|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
2949792|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2949793|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2949794|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949795|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949796|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949797|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949798|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949799|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949800|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2949801|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2949802|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2949803|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2949804|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
2949805|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2949806|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2949807|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2949808|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2949809|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2949810|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2949811|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2949812|NCT01307423|10154263|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
2949813|NCT01307423|10154264|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
2949814|NCT01307423|10154265|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
2949815|NCT01307423|10154266|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
2949816|NCT01307423|10154267|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
2949817|NCT01307423|10154268|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
2949818|NCT01307423|10154269|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
2949819|NCT01307423|10154270|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
2949820|NCT01307423|10154271|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
2949821|NCT01307423|10154263|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
2949822|NCT01307423|10154264|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
2949823|NCT01307423|10154265|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949824|NCT01307423|10154266|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949825|NCT01307423|10154267|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949826|NCT01307423|10154268|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949827|NCT01307423|10154269|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949828|NCT01307423|10154270|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
2949829|NCT01307423|10154271|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
2949830|NCT01307423|10154263|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
2949831|NCT01307423|10154264|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2949832|NCT01307423|10154265|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2949833|NCT01307423|10154266|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2949834|NCT01307423|10154267|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2949835|NCT01307423|10154268|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2949836|NCT01307423|10154269|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
2949837|NCT01307423|10154270|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
2949838|NCT01307423|10154271|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2949839|NCT01307423|10154263|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949840|NCT01307423|10154264|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949841|NCT01307423|10154265|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949842|NCT01307423|10154266|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949843|NCT01307423|10154267|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949844|NCT01307423|10154268|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949845|NCT01307423|10154269|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
2949846|NCT01307423|10154270|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949847|NCT01307423|10154271|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2949848|NCT01307423|10154263|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
2949849|NCT01307423|10154264|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2949850|NCT01307423|10154265|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2949851|NCT01307423|10154266|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2949852|NCT01307423|10154267|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2949853|NCT01307423|10154268|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2949854|NCT01307423|10154269|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
2949855|NCT01307423|10154270|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2949856|NCT01307423|10154271|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2949857|NCT01307423|10154263|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
2949858|NCT01307423|10154264|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
2949859|NCT01307423|10154265|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
2949860|NCT01307423|10154266|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
2949861|NCT01307423|10154267|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
2949862|NCT01307423|10154268|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
2949863|NCT01307423|10154269|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
2949864|NCT01307423|10154270|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
2949865|NCT01307423|10154271|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
2949866|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949867|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949868|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949869|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
2949870|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949871|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949872|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949873|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949874|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2949875|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Other|0
2949876|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Other|0
2949877|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Other|0
2949878|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Other|0
2949879|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Other|0
2949880|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Other|1
2949881|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Other|0
2949882|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Other|0
2949883|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Other|0
2949884|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949885|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949886|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949887|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949888|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949889|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
2949890|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949891|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2950047|NCT01307267|10154521|P15|Overall Study|Withdrawal by Subject|0
2949892|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2949893|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2949894|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2949895|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2949896|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2949897|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2949898|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2949899|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
2949900|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
2949901|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2949902|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949903|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949904|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949905|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
2949906|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949907|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949908|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949909|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949910|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2949911|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2949912|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2949913|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2949914|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2949915|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
2949916|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
2949917|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2949918|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2949919|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2949920|NCT01307423|10154263|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
2949921|NCT01307423|10154264|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
2949922|NCT01307423|10154265|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
2949923|NCT01307423|10154266|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
2949924|NCT01307423|10154267|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
2949925|NCT01307423|10154268|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
2949926|NCT01307423|10154269|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
2949927|NCT01307423|10154270|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
2949928|NCT01307423|10154271|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
2949929|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949930|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949931|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949932|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949933|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949934|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949935|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2949936|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2949937|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2949938|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949939|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949940|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949941|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949942|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949943|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949944|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
2949945|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
2949946|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
2949947|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949948|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949949|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949950|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949951|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949952|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949953|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949954|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2949955|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2949956|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949957|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949958|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949959|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949960|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949961|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2949962|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2949963|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2949964|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
2949965|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949966|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949967|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949968|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949969|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949970|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949971|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2949972|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949973|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2949974|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949975|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949976|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949977|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949978|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949979|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2949980|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
2949981|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2949982|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
2949983|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949984|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949985|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949986|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949987|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949988|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2949989|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2949990|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2949991|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
2949992|NCT01307423|10154263|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949993|NCT01307423|10154264|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949994|NCT01307423|10154265|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949995|NCT01307423|10154266|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949996|NCT01307423|10154267|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949997|NCT01307423|10154268|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2949998|NCT01307423|10154269|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
2949999|NCT01307423|10154270|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2950000|NCT01307423|10154271|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2950001|NCT01307319|10154477|P3|Overall Study|Other|3
2950002|NCT01307319|10154478|P2|Overall Study|Other|4
2950003|NCT01307319|10154479|P1|Overall Study|Other|0
2950004|NCT01307319|10154477|P3|Overall Study|Withdrawal by Subject|2
2950005|NCT01307319|10154478|P2|Overall Study|Withdrawal by Subject|1
2950006|NCT01307319|10154479|P1|Overall Study|Withdrawal by Subject|0
2950007|NCT01307319|10154477|P3|Overall Study|Protocol Violation|0
2950008|NCT01307319|10154478|P2|Overall Study|Protocol Violation|1
2950009|NCT01307319|10154479|P1|Overall Study|Protocol Violation|1
2950010|NCT01307319|10154477|P3|Overall Study|Lost to Follow-up|1
2950011|NCT01307319|10154478|P2|Overall Study|Lost to Follow-up|0
2950012|NCT01307319|10154479|P1|Overall Study|Lost to Follow-up|1
2950013|NCT01307319|10154477|P3|Overall Study|Adverse Event|1
2950014|NCT01307319|10154478|P2|Overall Study|Adverse Event|2
2950015|NCT01307319|10154479|P1|Overall Study|Adverse Event|2
2950016|NCT01307267|10154513|P23|Overall Study|Other|2
2950017|NCT01307267|10154514|P22|Overall Study|Other|3
2950018|NCT01307267|10154515|P21|Overall Study|Other|2
2950019|NCT01307267|10154516|P20|Overall Study|Other|19
2950020|NCT01307267|10154517|P19|Overall Study|Other|0
2950021|NCT01307267|10154518|P18|Overall Study|Other|0
2950022|NCT01307267|10154519|P17|Overall Study|Other|0
2950023|NCT01307267|10154520|P16|Overall Study|Other|1
2950024|NCT01307267|10154521|P15|Overall Study|Other|2
2950025|NCT01307267|10154522|P14|Overall Study|Other|0
2950026|NCT01307267|10154523|P13|Overall Study|Other|1
2950027|NCT01307267|10154524|P12|Overall Study|Other|1
2950028|NCT01307267|10154525|P11|Overall Study|Other|1
2950029|NCT01307267|10154526|P10|Overall Study|Other|0
2950030|NCT01307267|10154527|P9|Overall Study|Other|3
2950031|NCT01307267|10154528|P8|Overall Study|Other|1
2950032|NCT01307267|10154529|P7|Overall Study|Other|0
2950033|NCT01307267|10154530|P6|Overall Study|Other|7
2950034|NCT01307267|10154531|P5|Overall Study|Other|0
2950035|NCT01307267|10154532|P4|Overall Study|Other|0
2950036|NCT01307267|10154533|P3|Overall Study|Other|0
2950037|NCT01307267|10154534|P2|Overall Study|Other|0
2950038|NCT01307267|10154535|P1|Overall Study|Other|0
2950039|NCT01307267|10154513|P23|Overall Study|Withdrawal by Subject|0
2950040|NCT01307267|10154514|P22|Overall Study|Withdrawal by Subject|0
2950041|NCT01307267|10154515|P21|Overall Study|Withdrawal by Subject|0
2950042|NCT01307267|10154516|P20|Overall Study|Withdrawal by Subject|3
2950043|NCT01307267|10154517|P19|Overall Study|Withdrawal by Subject|0
2950044|NCT01307267|10154518|P18|Overall Study|Withdrawal by Subject|0
2950045|NCT01307267|10154519|P17|Overall Study|Withdrawal by Subject|0
2950046|NCT01307267|10154520|P16|Overall Study|Withdrawal by Subject|0
2950048|NCT01307267|10154522|P14|Overall Study|Withdrawal by Subject|0
2950049|NCT01307267|10154523|P13|Overall Study|Withdrawal by Subject|0
2950050|NCT01307267|10154524|P12|Overall Study|Withdrawal by Subject|1
2950051|NCT01307267|10154525|P11|Overall Study|Withdrawal by Subject|1
2950052|NCT01307267|10154526|P10|Overall Study|Withdrawal by Subject|1
2950053|NCT01307267|10154527|P9|Overall Study|Withdrawal by Subject|5
2950054|NCT01307267|10154528|P8|Overall Study|Withdrawal by Subject|1
2950055|NCT01307267|10154529|P7|Overall Study|Withdrawal by Subject|0
2950056|NCT01307267|10154530|P6|Overall Study|Withdrawal by Subject|1
2950057|NCT01307267|10154531|P5|Overall Study|Withdrawal by Subject|0
2950058|NCT01307267|10154532|P4|Overall Study|Withdrawal by Subject|0
2950059|NCT01307267|10154533|P3|Overall Study|Withdrawal by Subject|0
2950060|NCT01307267|10154534|P2|Overall Study|Withdrawal by Subject|0
2950061|NCT01307267|10154535|P1|Overall Study|Withdrawal by Subject|0
2950062|NCT01307267|10154513|P23|Overall Study|Lost to Follow-up|0
2950063|NCT01307267|10154514|P22|Overall Study|Lost to Follow-up|0
2950064|NCT01307267|10154515|P21|Overall Study|Lost to Follow-up|0
2950065|NCT01307267|10154516|P20|Overall Study|Lost to Follow-up|2
2950066|NCT01307267|10154517|P19|Overall Study|Lost to Follow-up|0
2950067|NCT01307267|10154518|P18|Overall Study|Lost to Follow-up|0
2950068|NCT01307267|10154519|P17|Overall Study|Lost to Follow-up|0
2950069|NCT01307267|10154520|P16|Overall Study|Lost to Follow-up|0
2950070|NCT01307267|10154521|P15|Overall Study|Lost to Follow-up|0
2950071|NCT01307267|10154522|P14|Overall Study|Lost to Follow-up|0
2950072|NCT01307267|10154523|P13|Overall Study|Lost to Follow-up|0
2950073|NCT01307267|10154524|P12|Overall Study|Lost to Follow-up|0
2950074|NCT01307267|10154525|P11|Overall Study|Lost to Follow-up|1
2950075|NCT01307267|10154526|P10|Overall Study|Lost to Follow-up|2
2950076|NCT01307267|10154527|P9|Overall Study|Lost to Follow-up|1
2950077|NCT01307267|10154528|P8|Overall Study|Lost to Follow-up|0
2950078|NCT01307267|10154529|P7|Overall Study|Lost to Follow-up|0
2950079|NCT01307267|10154530|P6|Overall Study|Lost to Follow-up|7
2950080|NCT01307267|10154531|P5|Overall Study|Lost to Follow-up|0
2950081|NCT01307267|10154532|P4|Overall Study|Lost to Follow-up|0
2950082|NCT01307267|10154533|P3|Overall Study|Lost to Follow-up|0
2950083|NCT01307267|10154534|P2|Overall Study|Lost to Follow-up|0
2950084|NCT01307267|10154535|P1|Overall Study|Lost to Follow-up|0
2950085|NCT01307267|10154513|P23|Overall Study|Death|2
2950086|NCT01307267|10154514|P22|Overall Study|Death|2
2950087|NCT01307267|10154515|P21|Overall Study|Death|1
2950088|NCT01307267|10154516|P20|Overall Study|Death|8
2950089|NCT01307267|10154517|P19|Overall Study|Death|2
2950090|NCT01307267|10154518|P18|Overall Study|Death|1
2950091|NCT01307267|10154519|P17|Overall Study|Death|1
2950092|NCT01307267|10154520|P16|Overall Study|Death|0
2950093|NCT01307267|10154521|P15|Overall Study|Death|0
2950094|NCT01307267|10154522|P14|Overall Study|Death|0
2950095|NCT01307267|10154523|P13|Overall Study|Death|0
2950096|NCT01307267|10154524|P12|Overall Study|Death|9
2950097|NCT01307267|10154525|P11|Overall Study|Death|3
2950098|NCT01307267|10154526|P10|Overall Study|Death|2
2950099|NCT01307267|10154527|P9|Overall Study|Death|21
2950100|NCT01307267|10154528|P8|Overall Study|Death|2
2950101|NCT01307267|10154529|P7|Overall Study|Death|2
2950102|NCT01307267|10154530|P6|Overall Study|Death|26
2950103|NCT01307267|10154531|P5|Overall Study|Death|1
2950104|NCT01307267|10154532|P4|Overall Study|Death|3
2950105|NCT01307267|10154533|P3|Overall Study|Death|5
2950106|NCT01307267|10154534|P2|Overall Study|Death|3
2950107|NCT01307267|10154535|P1|Overall Study|Death|4
2950108|NCT01307111|10155126|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
2950109|NCT01307111|10155127|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
2950110|NCT01307111|10155126|P2|IUD Insertion|Lost to Follow-up|0
2950111|NCT01307111|10155127|P1|IUD Insertion|Lost to Follow-up|2
2950112|NCT01307046|10155150|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
2950113|NCT01307046|10155151|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
2950114|NCT01307046|10155150|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
2950115|NCT01307046|10155151|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
2950116|NCT01307046|10155150|P2|Overall Study|Withdrawal by Subject|1
2950117|NCT01307046|10155151|P1|Overall Study|Withdrawal by Subject|1
2950118|NCT01307046|10155150|P2|Overall Study|Physician Decision|0
2950119|NCT01307046|10155151|P1|Overall Study|Physician Decision|2
2950120|NCT01307046|10155150|P2|Overall Study|Lack of Efficacy|2
2950121|NCT01307046|10155151|P1|Overall Study|Lack of Efficacy|0
2950122|NCT01307046|10155150|P2|Overall Study|Adverse Event|3
2950123|NCT01307046|10155151|P1|Overall Study|Adverse Event|3
2950124|NCT01307033|10155163|P4|44-week Open-label Extension|Death|1
2950125|NCT01307033|10155164|P3|44-week Open-label Extension|Death|0
2950126|NCT01307033|10155165|P2|44-week Open-label Extension|Death|0
2950127|NCT01307033|10155166|P1|44-week Open-label Extension|Death|0
2950128|NCT01307033|10155163|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
2950129|NCT01307033|10155164|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
2950130|NCT01307033|10155165|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
2950131|NCT01307033|10155166|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
2950132|NCT01307033|10155163|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
2950133|NCT01307033|10155164|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2950134|NCT01307033|10155165|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2950135|NCT01307033|10155166|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2950216|NCT01306942|10155280|P4|Phase II|Death|1
2950136|NCT01307033|10155163|P4|44-week Open-label Extension|Physician Decision|0
2950137|NCT01307033|10155164|P3|44-week Open-label Extension|Physician Decision|1
2950138|NCT01307033|10155165|P2|44-week Open-label Extension|Physician Decision|0
2950139|NCT01307033|10155166|P1|44-week Open-label Extension|Physician Decision|0
2950140|NCT01307033|10155163|P4|44-week Open-label Extension|Withdrawal by Subject|1
2950141|NCT01307033|10155164|P3|44-week Open-label Extension|Withdrawal by Subject|2
2950142|NCT01307033|10155165|P2|44-week Open-label Extension|Withdrawal by Subject|0
2950143|NCT01307033|10155166|P1|44-week Open-label Extension|Withdrawal by Subject|0
2950144|NCT01307033|10155163|P4|44-week Open-label Extension|Adverse Event|1
2950145|NCT01307033|10155164|P3|44-week Open-label Extension|Adverse Event|2
2950146|NCT01307033|10155165|P2|44-week Open-label Extension|Adverse Event|0
2950147|NCT01307033|10155166|P1|44-week Open-label Extension|Adverse Event|0
2950148|NCT01307033|10155163|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
2950149|NCT01307033|10155164|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
2950150|NCT01307033|10155165|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
2950151|NCT01307033|10155166|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
2950152|NCT01307033|10155163|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2950153|NCT01307033|10155164|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2950154|NCT01307033|10155165|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
2950155|NCT01307033|10155166|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2950156|NCT01307033|10155163|P4|8-week Double-blind Period|Lack of Efficacy|0
2950157|NCT01307033|10155164|P3|8-week Double-blind Period|Lack of Efficacy|0
2950158|NCT01307033|10155165|P2|8-week Double-blind Period|Lack of Efficacy|0
2950159|NCT01307033|10155166|P1|8-week Double-blind Period|Lack of Efficacy|1
2950160|NCT01307033|10155163|P4|8-week Double-blind Period|Withdrawal by Subject|0
2950161|NCT01307033|10155164|P3|8-week Double-blind Period|Withdrawal by Subject|0
2950162|NCT01307033|10155165|P2|8-week Double-blind Period|Withdrawal by Subject|1
2950163|NCT01307033|10155166|P1|8-week Double-blind Period|Withdrawal by Subject|4
2950164|NCT01307033|10155163|P4|8-week Double-blind Period|Adverse Event|0
2950165|NCT01307033|10155164|P3|8-week Double-blind Period|Adverse Event|0
2950166|NCT01307033|10155165|P2|8-week Double-blind Period|Adverse Event|0
2950167|NCT01307033|10155166|P1|8-week Double-blind Period|Adverse Event|2
2950168|NCT01307020|10155188|P10|Overall Study|Electronic data capture failure|0
2950169|NCT01307020|10155189|P9|Overall Study|Electronic data capture failure|0
2950170|NCT01307020|10155190|P8|Overall Study|Electronic data capture failure|0
2950171|NCT01307020|10155191|P7|Overall Study|Electronic data capture failure|0
2950172|NCT01307020|10155192|P6|Overall Study|Electronic data capture failure|0
2950173|NCT01307020|10155193|P5|Overall Study|Electronic data capture failure|0
2950174|NCT01307020|10155194|P4|Overall Study|Electronic data capture failure|0
2950175|NCT01307020|10155195|P3|Overall Study|Electronic data capture failure|0
2950176|NCT01307020|10155196|P2|Overall Study|Electronic data capture failure|1
2950177|NCT01307020|10155197|P1|Overall Study|Electronic data capture failure|0
2950178|NCT01307020|10155188|P10|Overall Study|Lost to Follow-up|0
2950179|NCT01307020|10155189|P9|Overall Study|Lost to Follow-up|0
2950180|NCT01307020|10155190|P8|Overall Study|Lost to Follow-up|0
2950181|NCT01307020|10155191|P7|Overall Study|Lost to Follow-up|1
2950182|NCT01307020|10155192|P6|Overall Study|Lost to Follow-up|0
2950183|NCT01307020|10155193|P5|Overall Study|Lost to Follow-up|0
2950184|NCT01307020|10155194|P4|Overall Study|Lost to Follow-up|1
2950185|NCT01307020|10155195|P3|Overall Study|Lost to Follow-up|1
2950186|NCT01307020|10155196|P2|Overall Study|Lost to Follow-up|0
2950187|NCT01307020|10155197|P1|Overall Study|Lost to Follow-up|0
2950188|NCT01306968|10155252|P4|Overall Study|Withdrew over privacy concerns|1
2950189|NCT01306968|10155253|P3|Overall Study|Withdrew over privacy concerns|0
2950190|NCT01306968|10155254|P2|Overall Study|Withdrew over privacy concerns|0
2950191|NCT01306968|10155255|P1|Overall Study|Withdrew over privacy concerns|0
2950192|NCT01306968|10155252|P4|Overall Study|Withdrew - time commitment|2
2950193|NCT01306968|10155253|P3|Overall Study|Withdrew - time commitment|0
2950194|NCT01306968|10155254|P2|Overall Study|Withdrew - time commitment|0
2950195|NCT01306968|10155255|P1|Overall Study|Withdrew - time commitment|0
2950196|NCT01306968|10155252|P4|Overall Study|Relocated and left active duty|1
2950197|NCT01306968|10155253|P3|Overall Study|Relocated and left active duty|1
2950198|NCT01306968|10155254|P2|Overall Study|Relocated and left active duty|1
2950199|NCT01306968|10155255|P1|Overall Study|Relocated and left active duty|0
2950200|NCT01306968|10155252|P4|Overall Study|Physician Decision|0
2950201|NCT01306968|10155253|P3|Overall Study|Physician Decision|0
2950202|NCT01306968|10155254|P2|Overall Study|Physician Decision|1
2950203|NCT01306968|10155255|P1|Overall Study|Physician Decision|0
2950204|NCT01306968|10155252|P4|Overall Study|Lost to Follow-up|0
2950205|NCT01306968|10155253|P3|Overall Study|Lost to Follow-up|0
2950206|NCT01306968|10155254|P2|Overall Study|Lost to Follow-up|1
2950207|NCT01306968|10155255|P1|Overall Study|Lost to Follow-up|1
2950208|NCT01306942|10155280|P4|Phase II|Protocol Violation|1
2950209|NCT01306942|10155281|P3|Phase II|Protocol Violation|0
2950210|NCT01306942|10155282|P2|Phase II|Protocol Violation|0
2950211|NCT01306942|10155283|P1|Phase II|Protocol Violation|0
2950212|NCT01306942|10155280|P4|Phase II|Not finished treatment|1
2950213|NCT01306942|10155281|P3|Phase II|Not finished treatment|0
2950214|NCT01306942|10155282|P2|Phase II|Not finished treatment|0
2950215|NCT01306942|10155283|P1|Phase II|Not finished treatment|0
2950217|NCT01306942|10155281|P3|Phase II|Death|0
2950218|NCT01306942|10155282|P2|Phase II|Death|0
2950219|NCT01306942|10155283|P1|Phase II|Death|0
2950220|NCT01306942|10155280|P4|Phase II|Withdrawal by Subject|2
2950221|NCT01306942|10155281|P3|Phase II|Withdrawal by Subject|0
2950222|NCT01306942|10155282|P2|Phase II|Withdrawal by Subject|0
2950223|NCT01306942|10155283|P1|Phase II|Withdrawal by Subject|0
2950224|NCT01306942|10155280|P4|Phase II|Physician Decision|5
2950225|NCT01306942|10155281|P3|Phase II|Physician Decision|0
2950226|NCT01306942|10155282|P2|Phase II|Physician Decision|0
2950227|NCT01306942|10155283|P1|Phase II|Physician Decision|2
2950228|NCT01306942|10155280|P4|Phase II|Adverse Event|6
2950229|NCT01306942|10155281|P3|Phase II|Adverse Event|0
2950230|NCT01306942|10155282|P2|Phase II|Adverse Event|0
2950231|NCT01306942|10155283|P1|Phase II|Adverse Event|0
2950232|NCT01306942|10155280|P4|Phase I|Physician Decision|0
2950233|NCT01306942|10155281|P3|Phase I|Physician Decision|0
2950234|NCT01306942|10155282|P2|Phase I|Physician Decision|1
2950235|NCT01306942|10155283|P1|Phase I|Physician Decision|3
2950236|NCT01306942|10155280|P4|Phase I|Adverse Event|0
2950237|NCT01306942|10155281|P3|Phase I|Adverse Event|0
2950238|NCT01306942|10155282|P2|Phase I|Adverse Event|2
2950239|NCT01306942|10155283|P1|Phase I|Adverse Event|2
2950240|NCT01306890|10155315|P1|Overall Study|No discontinuation documentation|41
2950241|NCT01306890|10155315|P1|Overall Study|Study Termination|3
2950242|NCT01306890|10155315|P1|Overall Study|Unspecified reasons|104
2950243|NCT01306890|10155315|P1|Overall Study|Withdrawal by Subject|88
2950244|NCT01306890|10155315|P1|Overall Study|Lost to Follow-up|58
2950245|NCT01306890|10155315|P1|Overall Study|Death|1223
2950246|NCT01306890|10155315|P1|Overall Study|Adverse Event|2
2950247|NCT01306877|10155322|P2|Overall Study|Physician Decision|1
2950248|NCT01306877|10155323|P1|Overall Study|Physician Decision|0
2950249|NCT01306877|10155322|P2|Overall Study|Lost to Follow-up|3
2950250|NCT01306877|10155323|P1|Overall Study|Lost to Follow-up|3
2950251|NCT01306656|10155343|P2|Overall Study|Lost to Follow-up|0
2950252|NCT01306656|10155344|P1|Overall Study|Lost to Follow-up|1
2950253|NCT01306643|10155356|P1|Overall Study|Other: Change in Eligibility Status|1
2950254|NCT01306643|10155356|P1|Overall Study|Disease Progression|7
2950255|NCT01306643|10155356|P1|Overall Study|Adverse Event|5
2950256|NCT01306617|10155368|P3|Overall Study|Non-compliance|0
2950257|NCT01306617|10155369|P2|Overall Study|Non-compliance|1
2950258|NCT01306617|10155370|P1|Overall Study|Non-compliance|0
2950259|NCT01306617|10155368|P3|Overall Study|Virologic Failure|5
2950260|NCT01306617|10155369|P2|Overall Study|Virologic Failure|0
2950261|NCT01306617|10155370|P1|Overall Study|Virologic Failure|0
2950262|NCT01306617|10155368|P3|Overall Study|Adverse Event|0
2950263|NCT01306617|10155369|P2|Overall Study|Adverse Event|0
2950264|NCT01306617|10155370|P1|Overall Study|Adverse Event|1
2950265|NCT01306305|10155413|P2|Overall Study|Withdrew consent|0
2950266|NCT01306305|10155414|P1|Overall Study|Withdrew consent|1
2950267|NCT01306305|10155413|P2|Overall Study|Lost to Follow-up|0
2950268|NCT01306305|10155414|P1|Overall Study|Lost to Follow-up|1
2950269|NCT01306253|10155451|P2|Overall Study|Lost to Follow-up|1
2950270|NCT01306253|10155452|P1|Overall Study|Lost to Follow-up|1
2950271|NCT01306214|10155469|P3|Overall Study|Not treated|1
2950272|NCT01306214|10155470|P2|Overall Study|Not treated|1
2950273|NCT01306214|10155471|P1|Overall Study|Not treated|1
2950274|NCT01306214|10155469|P3|Overall Study|Withdrawal by Subject|16
2950275|NCT01306214|10155470|P2|Overall Study|Withdrawal by Subject|22
2950276|NCT01306214|10155471|P1|Overall Study|Withdrawal by Subject|24
2950277|NCT01306214|10155469|P3|Overall Study|Lost to Follow-up|4
2950278|NCT01306214|10155470|P2|Overall Study|Lost to Follow-up|5
2950279|NCT01306214|10155471|P1|Overall Study|Lost to Follow-up|3
2950280|NCT01306214|10155469|P3|Overall Study|Death|1
2950281|NCT01306214|10155470|P2|Overall Study|Death|0
2950282|NCT01306214|10155471|P1|Overall Study|Death|0
2950283|NCT01306201|10155488|P1|Overall Study|Files unreadable|3
2950284|NCT01306201|10155488|P1|Overall Study|Files could not be processed|3
2950285|NCT01306201|10155488|P1|Overall Study|Arrhythmia|4
2950286|NCT01306162|10155510|P4|Washout 1|Non-compliance to protocol|0
2950287|NCT01306162|10155511|P3|Washout 1|Non-compliance to protocol|0
2950288|NCT01306162|10155512|P2|Washout 1|Non-compliance to protocol|1
2950289|NCT01306162|10155513|P1|Washout 1|Non-compliance to protocol|0
2950290|NCT01306162|10155510|P4|Period 1|Adverse Event|1
2950291|NCT01306162|10155511|P3|Period 1|Adverse Event|0
2950292|NCT01306162|10155512|P2|Period 1|Adverse Event|0
2950293|NCT01306162|10155513|P1|Period 1|Adverse Event|0
2950294|NCT01306058|10155541|P1|Overall Study|Enrolled but did not get treatment|1
2950295|NCT01306058|10155541|P1|Overall Study|Death|1
2950296|NCT01306032|10155568|P6|Disease Progression/Crossover|other/symptomatic progression|0
2950297|NCT01306032|10155569|P5|Disease Progression/Crossover|other/symptomatic progression|0
2950298|NCT01306032|10155570|P4|Disease Progression/Crossover|other/symptomatic progression|2
2950299|NCT01306032|10155571|P3|Disease Progression/Crossover|other/symptomatic progression|0
2950300|NCT01306032|10155572|P2|Disease Progression/Crossover|other/symptomatic progression|2
2950301|NCT01306032|10155573|P1|Disease Progression/Crossover|other/symptomatic progression|0
2950302|NCT01306032|10155568|P6|Disease Progression/Crossover|Withdrawal by Subject|0
2950303|NCT01306032|10155569|P5|Disease Progression/Crossover|Withdrawal by Subject|0
2950304|NCT01306032|10155570|P4|Disease Progression/Crossover|Withdrawal by Subject|1
2950305|NCT01306032|10155571|P3|Disease Progression/Crossover|Withdrawal by Subject|0
2950394|NCT01304706|10155919|P1|Overall Study|Withdrawal by Subject|3
2950306|NCT01306032|10155572|P2|Disease Progression/Crossover|Withdrawal by Subject|0
2950307|NCT01306032|10155573|P1|Disease Progression/Crossover|Withdrawal by Subject|0
2950308|NCT01306032|10155568|P6|First Intervention|Progressive disease|0
2950309|NCT01306032|10155569|P5|First Intervention|Progressive disease|2
2950310|NCT01306032|10155570|P4|First Intervention|Progressive disease|0
2950311|NCT01306032|10155571|P3|First Intervention|Progressive disease|0
2950312|NCT01306032|10155572|P2|First Intervention|Progressive disease|0
2950313|NCT01306032|10155573|P1|First Intervention|Progressive disease|0
2950314|NCT01306032|10155568|P6|First Intervention|Ineligible|1
2950315|NCT01306032|10155569|P5|First Intervention|Ineligible|0
2950316|NCT01306032|10155570|P4|First Intervention|Ineligible|0
2950317|NCT01306032|10155571|P3|First Intervention|Ineligible|0
2950318|NCT01306032|10155572|P2|First Intervention|Ineligible|0
2950319|NCT01306032|10155573|P1|First Intervention|Ineligible|0
2950320|NCT01306032|10155568|P6|First Intervention|Death|0
2950321|NCT01306032|10155569|P5|First Intervention|Death|0
2950322|NCT01306032|10155570|P4|First Intervention|Death|0
2950323|NCT01306032|10155571|P3|First Intervention|Death|1
2950324|NCT01306032|10155572|P2|First Intervention|Death|0
2950325|NCT01306032|10155573|P1|First Intervention|Death|0
2950326|NCT01306032|10155568|P6|First Intervention|Withdrawal by Subject|0
2950327|NCT01306032|10155569|P5|First Intervention|Withdrawal by Subject|0
2950328|NCT01306032|10155570|P4|First Intervention|Withdrawal by Subject|1
2950329|NCT01306032|10155571|P3|First Intervention|Withdrawal by Subject|0
2950330|NCT01306032|10155572|P2|First Intervention|Withdrawal by Subject|2
2950331|NCT01306032|10155573|P1|First Intervention|Withdrawal by Subject|0
2950332|NCT01306032|10155568|P6|First Intervention|Adverse Event|1
2950333|NCT01306032|10155569|P5|First Intervention|Adverse Event|0
2950334|NCT01306032|10155570|P4|First Intervention|Adverse Event|0
2950335|NCT01306032|10155571|P3|First Intervention|Adverse Event|1
2950336|NCT01306032|10155572|P2|First Intervention|Adverse Event|0
2950337|NCT01306032|10155573|P1|First Intervention|Adverse Event|1
2950338|NCT01305941|10155625|P1|Overall Study|Death|1
2950339|NCT01305941|10155625|P1|Overall Study|Withdrawal by Subject|1
2950340|NCT01305941|10155625|P1|Overall Study|Clinical decline|2
2950341|NCT01305941|10155625|P1|Overall Study|Adverse Event|6
2950342|NCT01305577|10155665|P3|Overall Study|Protocol Deviation|1
2950343|NCT01305577|10155666|P2|Overall Study|Protocol Deviation|1
2950344|NCT01305577|10155667|P1|Overall Study|Protocol Deviation|0
2950345|NCT01305577|10155665|P3|Overall Study|Lost to Follow-up|2
2950346|NCT01305577|10155666|P2|Overall Study|Lost to Follow-up|3
2950347|NCT01305577|10155667|P1|Overall Study|Lost to Follow-up|4
2950348|NCT01305577|10155665|P3|Overall Study|Withdrawal by Subject|6
2950349|NCT01305577|10155666|P2|Overall Study|Withdrawal by Subject|5
2950350|NCT01305577|10155667|P1|Overall Study|Withdrawal by Subject|7
2950351|NCT01305577|10155665|P3|Overall Study|Adverse Event|1
2950352|NCT01305577|10155666|P2|Overall Study|Adverse Event|2
2950353|NCT01305577|10155667|P1|Overall Study|Adverse Event|2
2950354|NCT01305564|10155696|P1|Overall Study|Physician Decision|3
2950355|NCT01305564|10155696|P1|Overall Study|Withdrawal by Subject|1
2950356|NCT01305564|10155696|P1|Overall Study|Lost to Follow-up|12
2950357|NCT01305564|10155696|P1|Overall Study|Death|21
2950358|NCT01305408|10155723|P2|Overall Study|Other|0
2950359|NCT01305408|10155724|P1|Overall Study|Other|1
2950360|NCT01305408|10155723|P2|Overall Study|Noncompliance with study procedures|1
2950361|NCT01305408|10155724|P1|Overall Study|Noncompliance with study procedures|0
2950362|NCT01305408|10155723|P2|Overall Study|Noncompliance with study medication|1
2950363|NCT01305408|10155724|P1|Overall Study|Noncompliance with study medication|0
2950364|NCT01305408|10155723|P2|Overall Study|Lost to Follow-up|3
2950365|NCT01305408|10155724|P1|Overall Study|Lost to Follow-up|5
2950366|NCT01305408|10155723|P2|Overall Study|Protocol Violation|6
2950367|NCT01305408|10155724|P1|Overall Study|Protocol Violation|4
2950368|NCT01305408|10155723|P2|Overall Study|Withdrawal by Subject|9
2950369|NCT01305408|10155724|P1|Overall Study|Withdrawal by Subject|9
2950370|NCT01305408|10155723|P2|Overall Study|Lack of Efficacy|4
2950371|NCT01305408|10155724|P1|Overall Study|Lack of Efficacy|3
2950372|NCT01305408|10155723|P2|Overall Study|Adverse Event|7
2950373|NCT01305408|10155724|P1|Overall Study|Adverse Event|10
2950374|NCT01305239|10155817|P1|Overall Study|Exemestane taken prior to inclusion only|1
2950375|NCT01305239|10155817|P1|Overall Study|Adverse Event|22
2950376|NCT01305200|10155847|P3|Overall Study|Death|0
2950377|NCT01305200|10155848|P2|Overall Study|Death|2
2950378|NCT01305200|10155849|P1|Overall Study|Death|0
2950379|NCT01305200|10155847|P3|Overall Study|Ineligible|1
2950380|NCT01305200|10155848|P2|Overall Study|Ineligible|2
2950381|NCT01305200|10155849|P1|Overall Study|Ineligible|1
2950382|NCT01305200|10155847|P3|Overall Study|Withdrawal by Subject|1
2950383|NCT01305200|10155848|P2|Overall Study|Withdrawal by Subject|21
2950384|NCT01305200|10155849|P1|Overall Study|Withdrawal by Subject|24
2950385|NCT01305200|10155847|P3|Overall Study|Physician Decision|1
2950386|NCT01305200|10155848|P2|Overall Study|Physician Decision|6
2950387|NCT01305200|10155849|P1|Overall Study|Physician Decision|4
2950388|NCT01305044|10155879|P2|Overall Study|Withdrawal by Subject|6
2950389|NCT01305044|10155880|P1|Overall Study|Withdrawal by Subject|3
2950390|NCT01304940|10155912|P2|Overall Study|not meet symptom severity requirement|0
2950391|NCT01304940|10155913|P1|Overall Study|not meet symptom severity requirement|3
2950392|NCT01304706|10155919|P1|Overall Study|Discontinued due to failed drug admin.|1
2950393|NCT01304706|10155919|P1|Overall Study|Lost to Follow-up|7
2950395|NCT01304706|10155919|P1|Overall Study|Death|3
2950396|NCT01304706|10155919|P1|Overall Study|Lack of Efficacy|1
2950397|NCT01304706|10155919|P1|Overall Study|Adverse Event|2
2950398|NCT01304693|10155928|P5|Overall Study|Decision Unrelated to an Adverse Event|0
2950399|NCT01304693|10155929|P4|Overall Study|Decision Unrelated to an Adverse Event|1
2950400|NCT01304693|10155930|P3|Overall Study|Decision Unrelated to an Adverse Event|1
2950401|NCT01304693|10155931|P2|Overall Study|Decision Unrelated to an Adverse Event|0
2950402|NCT01304693|10155932|P1|Overall Study|Decision Unrelated to an Adverse Event|0
2950403|NCT01304693|10155928|P5|Overall Study|Adverse Event|1
2950404|NCT01304693|10155929|P4|Overall Study|Adverse Event|0
2950405|NCT01304693|10155930|P3|Overall Study|Adverse Event|0
2950406|NCT01304693|10155931|P2|Overall Study|Adverse Event|0
2950407|NCT01304693|10155932|P1|Overall Study|Adverse Event|0
2950408|NCT01304498|10155979|P2|Overall Study|Lost to Follow-up|1
2950409|NCT01304498|10155980|P1|Overall Study|Lost to Follow-up|2
2950410|NCT01304498|10155979|P2|Overall Study|Protocol Violation|0
2950411|NCT01304498|10155980|P1|Overall Study|Protocol Violation|1
2950412|NCT01304498|10155979|P2|Overall Study|Withdrawal by Subject|3
2950413|NCT01304498|10155980|P1|Overall Study|Withdrawal by Subject|2
2950414|NCT01304498|10155979|P2|Overall Study|Adverse Event|1
2950415|NCT01304498|10155980|P1|Overall Study|Adverse Event|1
2950416|NCT01304329|10156000|P6|Third Intervention (3 Days)|Adverse Event|0
2950417|NCT01304329|10156001|P5|Third Intervention (3 Days)|Adverse Event|0
2950418|NCT01304329|10156002|P4|Third Intervention (3 Days)|Adverse Event|0
2950419|NCT01304329|10156003|P3|Third Intervention (3 Days)|Adverse Event|0
2950420|NCT01304329|10156004|P2|Third Intervention (3 Days)|Adverse Event|1
2950421|NCT01304329|10156005|P1|Third Intervention (3 Days)|Adverse Event|0
2950422|NCT01304147|10156139|P2|Second Intervention (7days)|Withdrawal by Subject|1
2950423|NCT01304147|10156140|P1|Second Intervention (7days)|Withdrawal by Subject|1
2950424|NCT01303965|10156171|P2|Overall Study|Disease Progression|6
2950425|NCT01303965|10156172|P1|Overall Study|Disease Progression|1
2950426|NCT01303965|10156171|P2|Overall Study|Withdrawal by Subject|0
2950427|NCT01303965|10156172|P1|Overall Study|Withdrawal by Subject|1
2950428|NCT01303965|10156171|P2|Overall Study|Death|3
2950429|NCT01303965|10156172|P1|Overall Study|Death|0
2950430|NCT01303965|10156171|P2|Overall Study|Adverse Event|1
2950431|NCT01303965|10156172|P1|Overall Study|Adverse Event|1
2950432|NCT01303861|10156200|P4|Overall Study|Pregnancy|0
2950433|NCT01303861|10156201|P3|Overall Study|Pregnancy|0
2950434|NCT01303861|10156202|P2|Overall Study|Pregnancy|0
2950435|NCT01303861|10156203|P1|Overall Study|Pregnancy|1
2950436|NCT01303861|10156200|P4|Overall Study|Adverse Event|5
2950437|NCT01303861|10156201|P3|Overall Study|Adverse Event|0
2950438|NCT01303861|10156202|P2|Overall Study|Adverse Event|1
2950439|NCT01303861|10156203|P1|Overall Study|Adverse Event|4
2950440|NCT01303861|10156200|P4|Overall Study|Withdrawal by Subject|23
2950441|NCT01303861|10156201|P3|Overall Study|Withdrawal by Subject|8
2950442|NCT01303861|10156202|P2|Overall Study|Withdrawal by Subject|8
2950443|NCT01303861|10156203|P1|Overall Study|Withdrawal by Subject|16
2950444|NCT01303861|10156200|P4|Overall Study|Lack of Efficacy|0
2950445|NCT01303861|10156201|P3|Overall Study|Lack of Efficacy|1
2950446|NCT01303861|10156202|P2|Overall Study|Lack of Efficacy|2
2950447|NCT01303861|10156203|P1|Overall Study|Lack of Efficacy|3
2950448|NCT01303861|10156200|P4|Overall Study|Lost to Follow-up|31
2950449|NCT01303861|10156201|P3|Overall Study|Lost to Follow-up|27
2950450|NCT01303861|10156202|P2|Overall Study|Lost to Follow-up|14
2950451|NCT01303861|10156203|P1|Overall Study|Lost to Follow-up|34
2950452|NCT01303627|10156262|P2|Overall Study|the failure while performing URS|1
2950453|NCT01303627|10156263|P1|Overall Study|the failure while performing URS|0
2950454|NCT01303510|10156271|P2|Overall Study|Lost to Follow-up|0
2950455|NCT01303510|10156272|P1|Overall Study|Lost to Follow-up|1
2950456|NCT01303445|10156286|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
2950457|NCT01303445|10156287|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
2950458|NCT01303445|10156286|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
2950459|NCT01303445|10156287|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
2950460|NCT01303445|10156286|P2|Washout (14 Days)|Lost to Follow-up|2
2950461|NCT01303445|10156287|P1|Washout (14 Days)|Lost to Follow-up|0
2950462|NCT01303445|10156286|P2|Washout (14 Days)|Protocol Violation|0
2950463|NCT01303445|10156287|P1|Washout (14 Days)|Protocol Violation|1
2950464|NCT01303445|10156286|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
2950465|NCT01303445|10156287|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
2950466|NCT01303445|10156286|P2|Second Intervention (7 Days)|Adverse Event|2
2950467|NCT01303445|10156287|P1|Second Intervention (7 Days)|Adverse Event|0
2950468|NCT01303445|10156286|P2|First Intervention (7 Days)|Withdrawal by Subject|0
2950469|NCT01303445|10156287|P1|First Intervention (7 Days)|Withdrawal by Subject|1
2950470|NCT01303419|10156317|P1|Overall Study|Did not meet all I/E after screening|31
2950471|NCT01303419|10156317|P1|Overall Study|Did not complete both imaging methods|5
2950472|NCT01303419|10156317|P1|Overall Study|Discontinuation of study|60
2950473|NCT01303380|10156336|P1|Overall Study|Lack of compliance to study procedures|1
2950474|NCT01303159|10156395|P1|Overall Study|Study Termination|7
2950475|NCT01303159|10156395|P1|Overall Study|Death|16
2950476|NCT01302964|10156413|P2|Overall Study|Adverse Event|0
2950477|NCT01302964|10156414|P1|Overall Study|Adverse Event|1
2950478|NCT01302938|10156424|P2|Overall Study|Adverse Event|0
2950479|NCT01302938|10156425|P1|Overall Study|Adverse Event|1
2950480|NCT01302938|10156424|P2|Overall Study|Withdrawal by Subject|0
2950481|NCT01302938|10156425|P1|Overall Study|Withdrawal by Subject|1
2950482|NCT01302899|10156470|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
2950483|NCT01302899|10156471|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
2950484|NCT01302899|10156470|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
2950485|NCT01302899|10156471|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
2950486|NCT01302834|10156535|P2|Overall Study|HIV positive|3
2950487|NCT01302834|10156536|P1|Overall Study|HIV positive|1
2950488|NCT01302834|10156535|P2|Overall Study|Protocol Violation|23
2950489|NCT01302834|10156536|P1|Overall Study|Protocol Violation|17
2950490|NCT01302691|10156596|P2|Overall Study|Protocol Violation|0
2950491|NCT01302691|10156597|P1|Overall Study|Protocol Violation|1
2950492|NCT01302691|10156596|P2|Overall Study|Physician Decision|1
2950493|NCT01302691|10156597|P1|Overall Study|Physician Decision|0
2950494|NCT01302691|10156596|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
2950495|NCT01302691|10156597|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
2950496|NCT01302691|10156596|P2|Overall Study|Lost to Follow-up|0
2950497|NCT01302691|10156597|P1|Overall Study|Lost to Follow-up|1
2950498|NCT01302691|10156596|P2|Overall Study|Death|1
2950499|NCT01302691|10156597|P1|Overall Study|Death|0
2950500|NCT01302691|10156596|P2|Overall Study|Adverse Event|0
2950501|NCT01302691|10156597|P1|Overall Study|Adverse Event|2
2950502|NCT01302548|10156617|P2|Overall Study|Lost to Follow-up|1
2950503|NCT01302548|10156618|P1|Overall Study|Lost to Follow-up|2
2950504|NCT01302418|10156668|P1|Overall Study|Non-evaluable|9
2950505|NCT01302418|10156668|P1|Overall Study|Protocol Violation|9
2950506|NCT01302392|10156674|P2|Overall Study|Withdrawal by Subject|1
2950507|NCT01302392|10156675|P1|Overall Study|Withdrawal by Subject|6
2950508|NCT01302392|10156674|P2|Overall Study|Lost to Follow-up|0
2950509|NCT01302392|10156675|P1|Overall Study|Lost to Follow-up|1
2950510|NCT01302366|10156695|P1|Overall Study|patient choice or noncompliance|5
2950511|NCT01302119|10156703|P2|Overall Study|Non-specific|1
2950512|NCT01302119|10156704|P1|Overall Study|Non-specific|4
2950513|NCT01302119|10156703|P2|Overall Study|Non-compliance|2
2950514|NCT01302119|10156704|P1|Overall Study|Non-compliance|4
2950515|NCT01302119|10156703|P2|Overall Study|Adverse Event|1
2950516|NCT01302119|10156704|P1|Overall Study|Adverse Event|2
2950517|NCT01302119|10156703|P2|Overall Study|Lost to Follow-up|4
2950518|NCT01302119|10156704|P1|Overall Study|Lost to Follow-up|10
2950519|NCT01302119|10156703|P2|Overall Study|Withdrawal by Subject|20
2950520|NCT01302119|10156704|P1|Overall Study|Withdrawal by Subject|30
2950521|NCT01302067|10156719|P3|Overall Study|Adverse Event|45
2950522|NCT01302067|10156720|P2|Overall Study|Adverse Event|14
2950523|NCT01302067|10156721|P1|Overall Study|Adverse Event|27
2950524|NCT01302067|10156719|P3|Overall Study|Protocol Violation|8
2950525|NCT01302067|10156720|P2|Overall Study|Protocol Violation|0
2950526|NCT01302067|10156721|P1|Overall Study|Protocol Violation|11
2950527|NCT01302067|10156719|P3|Overall Study|Other|3
2950528|NCT01302067|10156720|P2|Overall Study|Other|1
2950529|NCT01302067|10156721|P1|Overall Study|Other|1
2950530|NCT01302067|10156719|P3|Overall Study|Withdrawal by Subject|10
2950531|NCT01302067|10156720|P2|Overall Study|Withdrawal by Subject|6
2950532|NCT01302067|10156721|P1|Overall Study|Withdrawal by Subject|13
2950533|NCT01302067|10156719|P3|Overall Study|Lost to Follow-up|15
2950534|NCT01302067|10156720|P2|Overall Study|Lost to Follow-up|4
2950535|NCT01302067|10156721|P1|Overall Study|Lost to Follow-up|9
2950536|NCT01302067|10156719|P3|Overall Study|Lack of Efficacy|2
2950537|NCT01302067|10156720|P2|Overall Study|Lack of Efficacy|4
2950538|NCT01302067|10156721|P1|Overall Study|Lack of Efficacy|8
2950539|NCT01302067|10156719|P3|Overall Study|Physician Decision|14
2950540|NCT01302067|10156720|P2|Overall Study|Physician Decision|5
2950541|NCT01302067|10156721|P1|Overall Study|Physician Decision|9
2950542|NCT01302067|10156719|P3|Overall Study|Death|1
2950543|NCT01302067|10156720|P2|Overall Study|Death|0
2950544|NCT01302067|10156721|P1|Overall Study|Death|0
2950545|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Other|9
2950546|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Other|4
2950547|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Other|0
2950548|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
2950549|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2950550|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2950551|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Adverse Event|10
2950552|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Adverse Event|10
2950553|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Adverse Event|0
2950554|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Protocol Violation|6
2950555|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Protocol Violation|3
2950556|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Protocol Violation|0
2950557|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
2950558|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
2950559|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
2950560|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
2950561|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
2950562|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
2950563|NCT01302054|10156792|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
2950564|NCT01302054|10156793|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
2950565|NCT01302054|10156794|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
2950566|NCT01302054|10156792|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2950567|NCT01302054|10156793|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2950568|NCT01302054|10156794|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
2950569|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Other|0
2950570|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Other|0
2950571|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Other|7
2950572|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2950573|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2950574|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
2950575|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2950576|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2950577|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
2950578|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2950579|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2950580|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
2950581|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2950582|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2950583|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
2950584|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2950585|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2950586|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
2950587|NCT01302054|10156792|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2950588|NCT01302054|10156793|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2950589|NCT01302054|10156794|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
2950590|NCT01302041|10156821|P1|Overall Study|Other-Miscellaneous Reason|2
2950591|NCT01302041|10156821|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
2950592|NCT01302041|10156821|P1|Overall Study|Withdrawal by Subject|4
2950593|NCT01302041|10156821|P1|Overall Study|Death|5
2950594|NCT01301950|10156863|P2|Overall Study|Surgery was cancelled by patient|1
2950595|NCT01301950|10156864|P1|Overall Study|Surgery was cancelled by patient|0
2950596|NCT01301833|10156882|P4|Overall Study|Personal matter|0
2950597|NCT01301833|10156883|P3|Overall Study|Personal matter|0
2950598|NCT01301833|10156884|P2|Overall Study|Personal matter|0
2950599|NCT01301833|10156885|P1|Overall Study|Personal matter|1
2950600|NCT01301833|10156882|P4|Overall Study|Withdrawal by Subject|2
2950601|NCT01301833|10156883|P3|Overall Study|Withdrawal by Subject|1
2950602|NCT01301833|10156884|P2|Overall Study|Withdrawal by Subject|1
2950603|NCT01301833|10156885|P1|Overall Study|Withdrawal by Subject|3
2950604|NCT01301833|10156882|P4|Overall Study|Physician Decision|0
2950605|NCT01301833|10156883|P3|Overall Study|Physician Decision|1
2950606|NCT01301833|10156884|P2|Overall Study|Physician Decision|1
2950607|NCT01301833|10156885|P1|Overall Study|Physician Decision|3
2950608|NCT01301833|10156882|P4|Overall Study|Lack of Efficacy|0
2950609|NCT01301833|10156883|P3|Overall Study|Lack of Efficacy|0
2950610|NCT01301833|10156884|P2|Overall Study|Lack of Efficacy|1
2950611|NCT01301833|10156885|P1|Overall Study|Lack of Efficacy|1
2950612|NCT01301833|10156882|P4|Overall Study|Adverse Event|5
2950613|NCT01301833|10156883|P3|Overall Study|Adverse Event|5
2950614|NCT01301833|10156884|P2|Overall Study|Adverse Event|5
2950615|NCT01301833|10156885|P1|Overall Study|Adverse Event|7
2950616|NCT01301729|10156923|P1|Overall Study|Violated Selection Criteria|1
2950617|NCT01301729|10156923|P1|Overall Study|Participant did not Return for Treatment|1
2950618|NCT01301729|10156923|P1|Overall Study|Withdrawal by Subject|2
2950619|NCT01301625|10156934|P1|Overall Study|Lost to Follow-up|1
2950620|NCT01301625|10156934|P1|Overall Study|Expected|8
2950621|NCT01301625|10156934|P1|Overall Study|Not Due|21
2950622|NCT01301625|10156934|P1|Overall Study|Death|5
2950623|NCT01301508|10157006|P2|Overall Study|Lost to Follow-up|1
2950624|NCT01301508|10157007|P1|Overall Study|Lost to Follow-up|0
2950625|NCT01301508|10157006|P2|Overall Study|Withdrawal by Subject|2
2950626|NCT01301508|10157007|P1|Overall Study|Withdrawal by Subject|1
2950627|NCT01301456|10157037|P12|Stage 2|Adverse Event|0
2950628|NCT01301456|10157038|P11|Stage 2|Adverse Event|1
2950629|NCT01301456|10157039|P10|Stage 2|Adverse Event|0
2950630|NCT01301456|10157040|P9|Stage 2|Adverse Event|0
2950631|NCT01301456|10157041|P8|Stage 2|Adverse Event|0
2950632|NCT01301456|10157042|P7|Stage 2|Adverse Event|0
2950633|NCT01301456|10157043|P6|Stage 2|Adverse Event|0
2950634|NCT01301456|10157044|P5|Stage 2|Adverse Event|0
2950635|NCT01301456|10157045|P4|Stage 2|Adverse Event|0
2950636|NCT01301456|10157046|P3|Stage 2|Adverse Event|0
2950637|NCT01301456|10157047|P2|Stage 2|Adverse Event|0
2950638|NCT01301456|10157048|P1|Stage 2|Adverse Event|0
2950639|NCT01301456|10157037|P12|Stage 1|Randomized but not treated|0
2950640|NCT01301456|10157038|P11|Stage 1|Randomized but not treated|0
2950641|NCT01301456|10157039|P10|Stage 1|Randomized but not treated|0
2950642|NCT01301456|10157040|P9|Stage 1|Randomized but not treated|0
2950643|NCT01301456|10157041|P8|Stage 1|Randomized but not treated|0
2950644|NCT01301456|10157042|P7|Stage 1|Randomized but not treated|1
2950645|NCT01301456|10157043|P6|Stage 1|Randomized but not treated|0
2950646|NCT01301456|10157044|P5|Stage 1|Randomized but not treated|0
2950647|NCT01301456|10157045|P4|Stage 1|Randomized but not treated|0
2950648|NCT01301456|10157046|P3|Stage 1|Randomized but not treated|0
2950649|NCT01301456|10157047|P2|Stage 1|Randomized but not treated|0
2950650|NCT01301456|10157048|P1|Stage 1|Randomized but not treated|0
2950651|NCT01301456|10157037|P12|Stage 1|Withdrawal by Subject|0
2950652|NCT01301456|10157038|P11|Stage 1|Withdrawal by Subject|0
2950653|NCT01301456|10157039|P10|Stage 1|Withdrawal by Subject|0
2950654|NCT01301456|10157040|P9|Stage 1|Withdrawal by Subject|0
2950655|NCT01301456|10157041|P8|Stage 1|Withdrawal by Subject|0
2950656|NCT01301456|10157042|P7|Stage 1|Withdrawal by Subject|0
2950657|NCT01301456|10157043|P6|Stage 1|Withdrawal by Subject|0
2950658|NCT01301456|10157044|P5|Stage 1|Withdrawal by Subject|1
2950659|NCT01301456|10157045|P4|Stage 1|Withdrawal by Subject|0
2950660|NCT01301456|10157046|P3|Stage 1|Withdrawal by Subject|1
2950661|NCT01301456|10157047|P2|Stage 1|Withdrawal by Subject|0
2950662|NCT01301456|10157048|P1|Stage 1|Withdrawal by Subject|0
2950663|NCT01301391|10157274|P1|Overall Study|Sponsor's decision|8
2950664|NCT01301391|10157274|P1|Overall Study|Physician Decision|2
2950665|NCT01301391|10157274|P1|Overall Study|Lost to Follow-up|3
2950666|NCT01301391|10157274|P1|Overall Study|Death|13
2950667|NCT01301274|10157286|P2|Overall Study|Physician Decision|1
2950668|NCT01301274|10157287|P1|Overall Study|Physician Decision|2
2950669|NCT01301092|10157302|P3|Overall Study|Lost to Follow-up|1
2950670|NCT01301092|10157303|P2|Overall Study|Lost to Follow-up|0
2950671|NCT01301092|10157304|P1|Overall Study|Lost to Follow-up|0
2950672|NCT01301079|10157321|P2|Overall Study|Lost to Follow-up|2
2950673|NCT01301079|10157322|P1|Overall Study|Lost to Follow-up|2
2950674|NCT01301066|10157400|P2|Overall Study|Other|0
2950675|NCT01301066|10157401|P1|Overall Study|Other|2
2950676|NCT01301066|10157400|P2|Overall Study|Physician Decision|1
2950677|NCT01301066|10157401|P1|Overall Study|Physician Decision|0
2950678|NCT01301066|10157400|P2|Overall Study|Sponsor Decision|1
2950679|NCT01301066|10157401|P1|Overall Study|Sponsor Decision|2
2950680|NCT01301066|10157400|P2|Overall Study|Adverse Event|6
2950681|NCT01301066|10157401|P1|Overall Study|Adverse Event|6
2950682|NCT01301066|10157400|P2|Overall Study|Withdrawal by Subject|9
2950683|NCT01301066|10157401|P1|Overall Study|Withdrawal by Subject|4
2950684|NCT01301066|10157400|P2|Overall Study|Protocol Violation|7
2950685|NCT01301066|10157401|P1|Overall Study|Protocol Violation|8
2950686|NCT01301066|10157400|P2|Overall Study|Lost to Follow-up|11
2950687|NCT01301066|10157401|P1|Overall Study|Lost to Follow-up|5
2950688|NCT01301027|10157409|P2|Overall Study|Volume Overload|0
2950689|NCT01301027|10157410|P1|Overall Study|Volume Overload|3
2950690|NCT01301027|10157409|P2|Overall Study|Transplant|2
2950691|NCT01301027|10157410|P1|Overall Study|Transplant|0
2950692|NCT01301027|10157409|P2|Overall Study|Fracture|3
2950693|NCT01301027|10157410|P1|Overall Study|Fracture|1
2950694|NCT01301027|10157409|P2|Overall Study|Adverse Event|2
2950695|NCT01301027|10157410|P1|Overall Study|Adverse Event|0
2950696|NCT01301027|10157409|P2|Overall Study|Withdrawal by Subject|3
2950697|NCT01301027|10157410|P1|Overall Study|Withdrawal by Subject|2
2950698|NCT01301027|10157409|P2|Overall Study|Physician Decision|0
2950699|NCT01301027|10157410|P1|Overall Study|Physician Decision|2
2950700|NCT01301001|10157422|P2|Second Intervention|Withdrawal by Subject|0
2950701|NCT01301001|10157423|P1|Second Intervention|Withdrawal by Subject|2
2950702|NCT01301001|10157422|P2|Second Intervention|Adverse Event|0
2950703|NCT01301001|10157423|P1|Second Intervention|Adverse Event|2
2950704|NCT01301001|10157422|P2|First Intervention|Protocol Violation|1
2950705|NCT01301001|10157423|P1|First Intervention|Protocol Violation|0
2950706|NCT01301001|10157422|P2|First Intervention|Adverse Event|0
2950707|NCT01301001|10157423|P1|First Intervention|Adverse Event|5
2950708|NCT01301001|10157422|P2|First Intervention|Withdrawal by Subject|4
2950709|NCT01301001|10157423|P1|First Intervention|Withdrawal by Subject|1
2950710|NCT01301001|10157422|P2|First Intervention|Lost to Follow-up|4
2950711|NCT01301001|10157423|P1|First Intervention|Lost to Follow-up|4
2950712|NCT01300923|10157446|P2|Overall Study|Physician Decision|2
2950713|NCT01300923|10157447|P1|Overall Study|Physician Decision|0
2950714|NCT01300819|10157460|P2|Overall Study|Follow up call was not done|0
2950715|NCT01300819|10157461|P1|Overall Study|Follow up call was not done|1
2950716|NCT01300819|10157460|P2|Overall Study|Safety follow up not done by mistake|1
2950717|NCT01300819|10157461|P1|Overall Study|Safety follow up not done by mistake|0
2950718|NCT01300819|10157460|P2|Overall Study|Administrative reason|1
2950719|NCT01300819|10157461|P1|Overall Study|Administrative reason|0
2950720|NCT01300819|10157460|P2|Overall Study|Refusal to down titrate study drug|1
2950721|NCT01300819|10157461|P1|Overall Study|Refusal to down titrate study drug|0
2950722|NCT01300819|10157460|P2|Overall Study|Patient was 1 month late for Visit 10|1
2950723|NCT01300819|10157461|P1|Overall Study|Patient was 1 month late for Visit 10|0
2950724|NCT01300819|10157460|P2|Overall Study|Withdrawal by Subject|12
2950725|NCT01300819|10157461|P1|Overall Study|Withdrawal by Subject|10
2950726|NCT01300819|10157460|P2|Overall Study|Lack of Efficacy|1
2950727|NCT01300819|10157461|P1|Overall Study|Lack of Efficacy|2
2950728|NCT01300819|10157460|P2|Overall Study|Adverse Event|27
2950729|NCT01300819|10157461|P1|Overall Study|Adverse Event|9
2950730|NCT01300767|10157489|P1|Overall Study|Unacceptable fit|1
2950731|NCT01300767|10157489|P1|Overall Study|Biomicroscopy|1
2950732|NCT01300767|10157489|P1|Overall Study|Discomfort|2
2950733|NCT01300741|10157517|P1|Overall Study|Discomfort|1
2950734|NCT01300741|10157517|P1|Overall Study|Lost to Follow-up|1
2950735|NCT01300741|10157517|P1|Overall Study|Lens deposits|1
2950736|NCT01300728|10157547|P2|Overall Study|Physician Decision|0
2950737|NCT01300728|10157548|P1|Overall Study|Physician Decision|1
2950738|NCT01300728|10157547|P2|Overall Study|Withdrawal by Subject|1
2950739|NCT01300728|10157548|P1|Overall Study|Withdrawal by Subject|1
2950740|NCT01300650|10157562|P1|Overall Study|Adverse Event|1
2950741|NCT01300572|10157578|P1|Overall Study|HAMA + post dosimetry|1
2950742|NCT01300546|10157602|P2|Overall Study|Adverse Event|1
2950743|NCT01300546|10157603|P1|Overall Study|Adverse Event|0
2950744|NCT01300546|10157602|P2|Overall Study|Lack of Efficacy|3
2950745|NCT01300546|10157603|P1|Overall Study|Lack of Efficacy|0
2950746|NCT01300546|10157602|P2|Overall Study|Lost to Follow-up|2
2950747|NCT01300546|10157603|P1|Overall Study|Lost to Follow-up|0
2950748|NCT01300546|10157602|P2|Overall Study|Withdrawal by Subject|0
2950749|NCT01300546|10157603|P1|Overall Study|Withdrawal by Subject|1
2950750|NCT01300455|10157633|P2|Washout|Withdrawal by Subject|0
2950751|NCT01300455|10157634|P1|Washout|Withdrawal by Subject|1
2950752|NCT01300351|10157654|P2|Overall Study|Withdrawal by Subject|10
2950753|NCT01300351|10157655|P1|Overall Study|Withdrawal by Subject|7
2950754|NCT01300351|10157654|P2|Overall Study|Adverse Event|4
2950755|NCT01300351|10157655|P1|Overall Study|Adverse Event|0
2950756|NCT01300351|10157654|P2|Overall Study|Lost to Follow-up|1
2950757|NCT01300351|10157655|P1|Overall Study|Lost to Follow-up|0
2950758|NCT01300351|10157654|P2|Overall Study|Ongoing treatment at data cut-off|23
2950759|NCT01300351|10157655|P1|Overall Study|Ongoing treatment at data cut-off|27
2950760|NCT01300351|10157654|P2|Overall Study|Did not receive treatment|0
2950761|NCT01300351|10157655|P1|Overall Study|Did not receive treatment|2
2950762|NCT01300338|10157671|P2|Overall Study|Lost to Follow-up|0
2950763|NCT01300338|10157672|P1|Overall Study|Lost to Follow-up|5
2950764|NCT01300286|10157680|P1|Overall Study|did not get dosed|1
2950765|NCT01300260|10157690|P2|Period 2 of Study: Second Intervention|Adverse Event|1
2950766|NCT01300260|10157691|P1|Period 2 of Study: Second Intervention|Adverse Event|0
2950767|NCT01300260|10157690|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
2950768|NCT01300260|10157691|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
2950769|NCT01300260|10157690|P2|Period 1 of Study: First Intervention|Adverse Event|1
2950770|NCT01300260|10157691|P1|Period 1 of Study: First Intervention|Adverse Event|0
2950771|NCT01300247|10157723|P2|Overall Study|Non-Compliance|1
2950772|NCT01300247|10157724|P1|Overall Study|Non-Compliance|0
2950773|NCT01300247|10157723|P2|Overall Study|Withdrawal by Subject|0
2950774|NCT01300247|10157724|P1|Overall Study|Withdrawal by Subject|1
2950775|NCT01300247|10157723|P2|Overall Study|Lost to Follow-up|0
2950776|NCT01300247|10157724|P1|Overall Study|Lost to Follow-up|2
2950777|NCT01300247|10157723|P2|Overall Study|Death|1
2950778|NCT01300247|10157724|P1|Overall Study|Death|1
2950779|NCT01300234|10157756|P2|Overall Study|Participant refused return to hospital|0
2950780|NCT01300234|10157757|P1|Overall Study|Participant refused return to hospital|1
2950781|NCT01300234|10157756|P2|Overall Study|Participant stopped medication|1
2950782|NCT01300234|10157757|P1|Overall Study|Participant stopped medication|1
2950783|NCT01300234|10157756|P2|Overall Study|Participant reached stopping critera|0
2950784|NCT01300234|10157757|P1|Overall Study|Participant reached stopping critera|2
2950785|NCT01300234|10157756|P2|Overall Study|Pregnancy|1
2950786|NCT01300234|10157757|P1|Overall Study|Pregnancy|2
2950787|NCT01300234|10157756|P2|Overall Study|Lost to Follow-up|12
2950788|NCT01300234|10157757|P1|Overall Study|Lost to Follow-up|14
2950789|NCT01300234|10157756|P2|Overall Study|Withdrawal by Subject|9
2950790|NCT01300234|10157757|P1|Overall Study|Withdrawal by Subject|5
2950791|NCT01300234|10157756|P2|Overall Study|Protocol Violation|3
2950792|NCT01300234|10157757|P1|Overall Study|Protocol Violation|2
2950793|NCT01300234|10157756|P2|Overall Study|Adverse Event|1
2950794|NCT01300234|10157757|P1|Overall Study|Adverse Event|1
2950795|NCT01300052|10157793|P2|Overall Study|Protocol Violation|1
2950796|NCT01300052|10157794|P1|Overall Study|Protocol Violation|1
2950797|NCT01300052|10157793|P2|Overall Study|Withdrawal by Subject|2
2950798|NCT01300052|10157794|P1|Overall Study|Withdrawal by Subject|2
2950799|NCT01300052|10157793|P2|Overall Study|Adverse Event|0
2950800|NCT01300052|10157794|P1|Overall Study|Adverse Event|3
2950801|NCT01299961|10157812|P1|Overall Study|Lost to Follow-up|1
2950802|NCT01299961|10157812|P1|Overall Study|Lack of Efficacy|2
2950803|NCT01299961|10157812|P1|Overall Study|Adverse Event|3
2950804|NCT01299909|10157821|P3|Overall Study|Lost to Follow-up|17
2950805|NCT01299909|10157822|P2|Overall Study|Lost to Follow-up|18
2950806|NCT01299909|10157823|P1|Overall Study|Lost to Follow-up|22
2950807|NCT01299896|10157838|P2|Overall Study|Lost to Follow-up|11
2950808|NCT01299896|10157839|P1|Overall Study|Lost to Follow-up|0
2950809|NCT01299896|10157838|P2|Overall Study|Withdrawal by Subject|7
2950810|NCT01299896|10157839|P1|Overall Study|Withdrawal by Subject|1
2950811|NCT01299805|10157847|P2|Overall Study|Adverse Event|0
2950812|NCT01299805|10157848|P1|Overall Study|Adverse Event|2
2950813|NCT01299766|10157878|P2|Overall Study|Withdrawal by Subject|19
2950814|NCT01299766|10157879|P1|Overall Study|Withdrawal by Subject|29
2950815|NCT01299766|10157878|P2|Overall Study|Death|4
2950816|NCT01299766|10157879|P1|Overall Study|Death|5
2950817|NCT01299727|10157890|P3|Overall Study|Completed the Treatment Period|3
2950818|NCT01299727|10157891|P2|Overall Study|Completed the Treatment Period|4
2950819|NCT01299727|10157892|P1|Overall Study|Completed the Treatment Period|3
2950820|NCT01299727|10157890|P3|Overall Study|Adverse Event|1
2950821|NCT01299727|10157891|P2|Overall Study|Adverse Event|0
2950822|NCT01299727|10157892|P1|Overall Study|Adverse Event|0
2950823|NCT01299727|10157890|P3|Overall Study|Withdrawal by Subject|0
2950824|NCT01299727|10157891|P2|Overall Study|Withdrawal by Subject|0
2950825|NCT01299727|10157892|P1|Overall Study|Withdrawal by Subject|1
2950826|NCT01299584|10157986|P1|Overall Study|Protocol Violation|9
2950827|NCT01299571|10157993|P1|Overall Study|Protocol Violation|107
2950828|NCT01299480|10158004|P5|Overall Study|Started, but not vaccinated|0
2950829|NCT01299480|10158005|P4|Overall Study|Started, but not vaccinated|1
2950830|NCT01299480|10158006|P3|Overall Study|Started, but not vaccinated|1
2950831|NCT01299480|10158007|P2|Overall Study|Started, but not vaccinated|0
2950832|NCT01299480|10158008|P1|Overall Study|Started, but not vaccinated|0
2950833|NCT01299480|10158004|P5|Overall Study|Other|3
2950834|NCT01299480|10158005|P4|Overall Study|Other|0
2950835|NCT01299480|10158006|P3|Overall Study|Other|3
2950836|NCT01299480|10158007|P2|Overall Study|Other|2
2950837|NCT01299480|10158008|P1|Overall Study|Other|3
2950838|NCT01299480|10158004|P5|Overall Study|Lost to Follow-up|2
2950839|NCT01299480|10158005|P4|Overall Study|Lost to Follow-up|1
2950840|NCT01299480|10158006|P3|Overall Study|Lost to Follow-up|2
2950841|NCT01299480|10158007|P2|Overall Study|Lost to Follow-up|1
2950842|NCT01299480|10158008|P1|Overall Study|Lost to Follow-up|3
2950843|NCT01299480|10158004|P5|Overall Study|Physician Decision|0
2950844|NCT01299480|10158005|P4|Overall Study|Physician Decision|2
2950845|NCT01299480|10158006|P3|Overall Study|Physician Decision|0
2950846|NCT01299480|10158007|P2|Overall Study|Physician Decision|1
2950847|NCT01299480|10158008|P1|Overall Study|Physician Decision|1
2950848|NCT01299480|10158004|P5|Overall Study|Withdrawal due to pregnancy|0
2950849|NCT01299480|10158005|P4|Overall Study|Withdrawal due to pregnancy|0
2950850|NCT01299480|10158006|P3|Overall Study|Withdrawal due to pregnancy|1
2950851|NCT01299480|10158007|P2|Overall Study|Withdrawal due to pregnancy|1
2950852|NCT01299480|10158008|P1|Overall Study|Withdrawal due to pregnancy|0
2950853|NCT01299480|10158004|P5|Overall Study|Adverse Event|0
2950854|NCT01299480|10158005|P4|Overall Study|Adverse Event|4
2950855|NCT01299480|10158006|P3|Overall Study|Adverse Event|5
2950856|NCT01299480|10158007|P2|Overall Study|Adverse Event|4
2950857|NCT01299480|10158008|P1|Overall Study|Adverse Event|6
2950858|NCT01299480|10158004|P5|Overall Study|Withdrawal by Subject|4
2950859|NCT01299480|10158005|P4|Overall Study|Withdrawal by Subject|3
2950860|NCT01299480|10158006|P3|Overall Study|Withdrawal by Subject|7
2950861|NCT01299480|10158007|P2|Overall Study|Withdrawal by Subject|4
2950862|NCT01299480|10158008|P1|Overall Study|Withdrawal by Subject|3
2950863|NCT01299480|10158004|P5|Overall Study|Protocol Violation|1
2950864|NCT01299480|10158005|P4|Overall Study|Protocol Violation|1
2950865|NCT01299480|10158006|P3|Overall Study|Protocol Violation|8
2950866|NCT01299480|10158007|P2|Overall Study|Protocol Violation|5
2950867|NCT01299480|10158008|P1|Overall Study|Protocol Violation|7
2950868|NCT01299480|10158004|P5|Overall Study|No longer willing to participate|10
2950869|NCT01299480|10158005|P4|Overall Study|No longer willing to participate|13
2950870|NCT01299480|10158006|P3|Overall Study|No longer willing to participate|14
2950871|NCT01299480|10158007|P2|Overall Study|No longer willing to participate|17
2950872|NCT01299480|10158008|P1|Overall Study|No longer willing to participate|19
2950873|NCT01299389|10158210|P4|Post-observational|Other|6
2950874|NCT01299389|10158211|P3|Post-observational|Other|12
2950875|NCT01299389|10158212|P2|Post-observational|Other|0
2950876|NCT01299389|10158213|P1|Post-observational|Other|0
2950877|NCT01299389|10158210|P4|Double-blind|fail to meet “study population” criteria|0
2950878|NCT01299389|10158211|P3|Double-blind|fail to meet “study population” criteria|0
2950879|NCT01299389|10158212|P2|Double-blind|fail to meet “study population” criteria|1
2950880|NCT01299389|10158213|P1|Double-blind|fail to meet “study population” criteria|0
2950881|NCT01299389|10158210|P4|Double-blind|Other|0
2950882|NCT01299389|10158211|P3|Double-blind|Other|0
2950883|NCT01299389|10158212|P2|Double-blind|Other|1
2950884|NCT01299389|10158213|P1|Double-blind|Other|1
2950885|NCT01299389|10158210|P4|Double-blind|Withdrawal by Subject|0
2950886|NCT01299389|10158211|P3|Double-blind|Withdrawal by Subject|0
2950887|NCT01299389|10158212|P2|Double-blind|Withdrawal by Subject|13
2950888|NCT01299389|10158213|P1|Double-blind|Withdrawal by Subject|16
2950889|NCT01299389|10158210|P4|Double-blind|Lost to Follow-up|0
2950890|NCT01299389|10158211|P3|Double-blind|Lost to Follow-up|0
2950891|NCT01299389|10158212|P2|Double-blind|Lost to Follow-up|1
2950892|NCT01299389|10158213|P1|Double-blind|Lost to Follow-up|2
2950893|NCT01299389|10158210|P4|Double-blind|Lack of Efficacy|0
2950894|NCT01299389|10158211|P3|Double-blind|Lack of Efficacy|0
2950895|NCT01299389|10158212|P2|Double-blind|Lack of Efficacy|21
2950896|NCT01299389|10158213|P1|Double-blind|Lack of Efficacy|45
2950897|NCT01299389|10158210|P4|Double-blind|Adverse Event|0
2950898|NCT01299389|10158211|P3|Double-blind|Adverse Event|0
2950899|NCT01299389|10158212|P2|Double-blind|Adverse Event|27
2950900|NCT01299389|10158213|P1|Double-blind|Adverse Event|45
2950901|NCT01299376|10158235|P2|Extension (Weeks 9 to 52)|Physician Decision|0
2950902|NCT01299376|10158236|P1|Extension (Weeks 9 to 52)|Physician Decision|1
2950903|NCT01299376|10158235|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
2950904|NCT01299376|10158236|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
2950905|NCT01299376|10158235|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
2950906|NCT01299376|10158236|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
2950907|NCT01299376|10158235|P2|Extension (Weeks 9 to 52)|Adverse Event|3
2950908|NCT01299376|10158236|P1|Extension (Weeks 9 to 52)|Adverse Event|2
2950909|NCT01299376|10158235|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
2950910|NCT01299376|10158236|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
2950911|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2950912|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2950913|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
2950914|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
2950915|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
2950916|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
2950917|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
2950918|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
2950919|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
2950920|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
2950921|NCT01299376|10158235|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
2950922|NCT01299376|10158236|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
2950923|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
2950924|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
2950925|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
2950926|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
2950927|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Physician Decision|1
2950928|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Physician Decision|2
2950929|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Physician Decision|0
2950930|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Physician Decision|0
2950931|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
2950932|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
2950933|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2950934|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2950935|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2950936|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2950937|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2950938|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2950939|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
2950940|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
2950941|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
2950942|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
2950943|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Adverse Event|9
2950944|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Adverse Event|8
2950945|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Adverse Event|0
2950946|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Adverse Event|0
2950947|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
2950948|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
2950949|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2950950|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2950951|NCT01299272|10158279|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
2950952|NCT01299272|10158280|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
2950953|NCT01299272|10158281|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2950954|NCT01299272|10158282|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2950955|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Physician Decision|0
2950956|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Physician Decision|0
2950957|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Physician Decision|3
2950958|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Physician Decision|0
2950959|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2950960|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2950961|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
2950962|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2950963|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2950964|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2950965|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
2950966|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2950967|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2950968|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2950969|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
2950970|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2950971|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
2950972|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
2950973|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
2950974|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
2950975|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2950976|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2950977|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
2950978|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2950979|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Adverse Event|0
2950980|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Adverse Event|0
2950981|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Adverse Event|42
2950982|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Adverse Event|0
2950983|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
2950984|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
2950985|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
2950986|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
2950987|NCT01299272|10158279|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2950988|NCT01299272|10158280|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2950989|NCT01299272|10158281|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
2950990|NCT01299272|10158282|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2950991|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Physician Decision|0
2950992|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Physician Decision|0
2950993|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Physician Decision|0
2950994|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Physician Decision|5
2950995|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
2950996|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
2950997|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
2950998|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
2950999|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Sponsor Decision|0
2951000|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Sponsor Decision|0
2951001|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Sponsor Decision|0
2951002|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Sponsor Decision|13
2951003|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
2951004|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
2951005|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
2951006|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
2951007|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Protocol Violation|0
2951008|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Protocol Violation|0
2951009|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Protocol Violation|0
2951010|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Protocol Violation|36
2951011|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
2951012|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
2951013|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
2951014|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
2951015|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Adverse Event|0
2951016|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Adverse Event|0
2951017|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Adverse Event|0
2951018|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Adverse Event|140
2951019|NCT01299272|10158279|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2951020|NCT01299272|10158280|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2951021|NCT01299272|10158281|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2951022|NCT01299272|10158282|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
2951023|NCT01299116|10158337|P3|Overall Study|Lost to Follow-up|11
2951024|NCT01299116|10158338|P2|Overall Study|Lost to Follow-up|9
2951025|NCT01299116|10158339|P1|Overall Study|Lost to Follow-up|65
2951026|NCT01299038|10158384|P2|Overall Study|Withdrawal by Subject|0
2951027|NCT01299038|10158385|P1|Overall Study|Withdrawal by Subject|1
2951028|NCT01299025|10158393|P2|Overall Study|Lost to Follow-up|0
2951029|NCT01299025|10158394|P1|Overall Study|Lost to Follow-up|1
2951030|NCT01299025|10158393|P2|Overall Study|Withdrawal by Subject|1
2951031|NCT01299025|10158394|P1|Overall Study|Withdrawal by Subject|2
2951032|NCT01298778|10158419|P2|Overall Study|not meet inclusion/exclusion criteria|1
2951033|NCT01298778|10158420|P1|Overall Study|not meet inclusion/exclusion criteria|0
2951034|NCT01298778|10158419|P2|Overall Study|Protocol Violation|1
2951035|NCT01298778|10158420|P1|Overall Study|Protocol Violation|0
2951036|NCT01298778|10158419|P2|Overall Study|Withdrawal by Subject|1
2951037|NCT01298778|10158420|P1|Overall Study|Withdrawal by Subject|0
2951038|NCT01298778|10158419|P2|Overall Study|Incorrect use of VAS|0
2951039|NCT01298778|10158420|P1|Overall Study|Incorrect use of VAS|1
2951040|NCT01298778|10158419|P2|Overall Study|Lost to Follow-up|3
2951041|NCT01298778|10158420|P1|Overall Study|Lost to Follow-up|2
2951042|NCT01298765|10158440|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
2951043|NCT01298765|10158440|P1|Long-Term Treatment Period|Physician Decision|1
2951044|NCT01298765|10158440|P1|Long-Term Treatment Period|Withdrawal by Subject|19
2951045|NCT01298765|10158440|P1|Long-Term Treatment Period|Lost to Follow-up|8
2951046|NCT01298765|10158440|P1|Long-Term Treatment Period|Lack of Efficacy|6
2951047|NCT01298765|10158440|P1|Long-Term Treatment Period|Adverse Event|19
2951048|NCT01298765|10158440|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
2951049|NCT01298765|10158440|P1|Titration Period|Withdrawal by Subject|10
2951050|NCT01298765|10158440|P1|Titration Period|Physician Decision|1
2951051|NCT01298765|10158440|P1|Titration Period|Lost to Follow-up|9
2951052|NCT01298765|10158440|P1|Titration Period|Lack of Efficacy|21
2951053|NCT01298765|10158440|P1|Titration Period|Death|1
2951054|NCT01298765|10158440|P1|Titration Period|Adverse Event|26
2951055|NCT01298700|10158450|P2|Overall Study|Did not Receive Study Drug|5
2951056|NCT01298700|10158451|P1|Overall Study|Did not Receive Study Drug|3
2951057|NCT01298700|10158450|P2|Overall Study|Other Miscellaneous Reasons|15
2951058|NCT01298700|10158451|P1|Overall Study|Other Miscellaneous Reasons|16
2951059|NCT01298700|10158450|P2|Overall Study|Protocol Violation|4
2951060|NCT01298700|10158451|P1|Overall Study|Protocol Violation|6
2951061|NCT01298700|10158450|P2|Overall Study|Withdrawal by Subject|9
2951062|NCT01298700|10158451|P1|Overall Study|Withdrawal by Subject|12
2951063|NCT01298700|10158450|P2|Overall Study|Lost to Follow-up|2
2951064|NCT01298700|10158451|P1|Overall Study|Lost to Follow-up|5
2951065|NCT01298700|10158450|P2|Overall Study|Lack of Efficacy|14
2951066|NCT01298700|10158451|P1|Overall Study|Lack of Efficacy|9
2951067|NCT01298700|10158450|P2|Overall Study|Adverse Event|51
2951068|NCT01298700|10158451|P1|Overall Study|Adverse Event|50
2951069|NCT01298661|10158462|P3|Overall Study|Withdrawal by Subject|2
2951070|NCT01298661|10158463|P2|Overall Study|Withdrawal by Subject|0
2951071|NCT01298661|10158464|P1|Overall Study|Withdrawal by Subject|2
2951072|NCT01298648|10158542|P1|Overall Study|Lost to Follow-up|21
2951073|NCT01298648|10158542|P1|Overall Study|Withdrawal by Subject|2
2951074|NCT01298596|10158553|P2|Overall Study|Referred for further management|15
2951075|NCT01298596|10158554|P1|Overall Study|Referred for further management|16
2951076|NCT01298596|10158553|P2|Overall Study|Lost to Follow-up|14
2951077|NCT01298596|10158554|P1|Overall Study|Lost to Follow-up|6
2951078|NCT01298596|10158553|P2|Overall Study|Death|3
2951079|NCT01298596|10158554|P1|Overall Study|Death|5
2951080|NCT01298596|10158553|P2|Overall Study|Withdrawal by Subject|1
2951081|NCT01298596|10158554|P1|Overall Study|Withdrawal by Subject|1
2951082|NCT01298570|10158564|P2|Overall Study|Ineligibility|1
2951083|NCT01298570|10158565|P1|Overall Study|Ineligibility|0
2951084|NCT01298570|10158564|P2|Overall Study|Death|1
2951085|NCT01298570|10158565|P1|Overall Study|Death|0
2951086|NCT01298570|10158564|P2|Overall Study|Symptomatic progression/deterioration|2
2951087|NCT01298570|10158565|P1|Overall Study|Symptomatic progression/deterioration|3
2951088|NCT01298570|10158564|P2|Overall Study|Surgery|1
2951089|NCT01298570|10158565|P1|Overall Study|Surgery|2
2951090|NCT01298570|10158564|P2|Overall Study|Other complicating disease|1
2951091|NCT01298570|10158565|P1|Overall Study|Other complicating disease|2
2951092|NCT01298570|10158564|P2|Overall Study|Physician Decision|2
2951093|NCT01298570|10158565|P1|Overall Study|Physician Decision|4
2951094|NCT01298570|10158564|P2|Overall Study|Treatment delay > 4 weeks|5
2951095|NCT01298570|10158565|P1|Overall Study|Treatment delay > 4 weeks|4
2951096|NCT01298570|10158564|P2|Overall Study|Withdrawal by Subject|6
2951097|NCT01298570|10158565|P1|Overall Study|Withdrawal by Subject|21
2951098|NCT01298570|10158564|P2|Overall Study|Adverse Event|2
2951099|NCT01298570|10158565|P1|Overall Study|Adverse Event|20
2951100|NCT01298570|10158564|P2|Overall Study|Disease progression, relapse during acti|40
2951101|NCT01298570|10158565|P1|Overall Study|Disease progression, relapse during acti|64
2951102|NCT01298531|10158592|P2|Overall Study|Other|1
2951103|NCT01298531|10158593|P1|Overall Study|Other|2
2951104|NCT01298531|10158592|P2|Overall Study|Does not meet entrance criteria|1
2951105|NCT01298531|10158593|P1|Overall Study|Does not meet entrance criteria|0
2951106|NCT01298531|10158592|P2|Overall Study|Adverse Event|3
2951107|NCT01298531|10158593|P1|Overall Study|Adverse Event|4
2951108|NCT01298531|10158592|P2|Overall Study|Protocol Violation|1
2951109|NCT01298531|10158593|P1|Overall Study|Protocol Violation|1
2951110|NCT01298531|10158592|P2|Overall Study|Lost to Follow-up|0
2951111|NCT01298531|10158593|P1|Overall Study|Lost to Follow-up|2
2951112|NCT01298531|10158592|P2|Overall Study|Lack of Efficacy|1
2951113|NCT01298531|10158593|P1|Overall Study|Lack of Efficacy|0
2951114|NCT01298518|10158722|P3|Overall Study|Withdrawal by Subject|1
2951115|NCT01298518|10158723|P2|Overall Study|Withdrawal by Subject|0
2951116|NCT01298518|10158724|P1|Overall Study|Withdrawal by Subject|0
2951117|NCT01298492|10158776|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
2951118|NCT01298492|10158776|P1|Overall Study|Adverse Event(Related to Study Drug)|8
2951119|NCT01298492|10158776|P1|Overall Study|Protocol Violation|2
2951120|NCT01298492|10158776|P1|Overall Study|Withdrawn Due to Pregnancy|1
2951121|NCT01298492|10158776|P1|Overall Study|Other (Unspecified)|7
2951122|NCT01298492|10158776|P1|Overall Study|Withdrawal by Subject|47
2951123|NCT01298492|10158776|P1|Overall Study|Lost to Follow-up|12
2951124|NCT01298492|10158776|P1|Overall Study|Insufficient Clinical Response|22
2951125|NCT01298492|10158776|P1|Overall Study|Death|2
2951126|NCT01298362|10158784|P2|Overall Study|Did not provide 12month BMD measurements|43
2951127|NCT01298362|10158785|P1|Overall Study|Did not provide 12month BMD measurements|38
2951128|NCT01298323|10158805|P2|Overall Study|Eligibility criteria not fulfilled|1
2951129|NCT01298323|10158806|P1|Overall Study|Eligibility criteria not fulfilled|0
2951130|NCT01298323|10158805|P2|Overall Study|Ongoing|55
2951131|NCT01298323|10158806|P1|Overall Study|Ongoing|55
2951132|NCT01298323|10158805|P2|Overall Study|Other|9
2951133|NCT01298323|10158806|P1|Overall Study|Other|10
2951134|NCT01298323|10158805|P2|Overall Study|Protocol Violation|0
2951135|NCT01298323|10158806|P1|Overall Study|Protocol Violation|1
2951136|NCT01298323|10158805|P2|Overall Study|Withdrawal by Subject|3
2951137|NCT01298323|10158806|P1|Overall Study|Withdrawal by Subject|6
2951138|NCT01298323|10158805|P2|Overall Study|Lost to Follow-up|0
2951139|NCT01298323|10158806|P1|Overall Study|Lost to Follow-up|1
2951140|NCT01298323|10158805|P2|Overall Study|Death|16
2951141|NCT01298323|10158806|P1|Overall Study|Death|11
2951142|NCT01298323|10158805|P2|Overall Study|Adverse Event|4
2951143|NCT01298323|10158806|P1|Overall Study|Adverse Event|2
2951144|NCT01298193|10158829|P1|Efficacy Phase (Second Cycle)|Death|1
2951145|NCT01298193|10158829|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
2951146|NCT01298193|10158829|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
2951147|NCT01298193|10158829|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
2951148|NCT01298141|10158851|P1|Overall Study|Not treated|4
2951149|NCT01298141|10158851|P1|Overall Study|Death|6
2951150|NCT01298141|10158851|P1|Overall Study|Lost to Follow-up|1
2951151|NCT01298141|10158851|P1|Overall Study|Other|5
2951152|NCT01298141|10158851|P1|Overall Study|Termination of Study by the Investigator|5
2951153|NCT01298141|10158851|P1|Overall Study|Withdrawal by Subject|6
2951154|NCT01298141|10158851|P1|Overall Study|Refusal of Required Study Procedures|1
2951155|NCT01298141|10158851|P1|Overall Study|Adverse Event|3
2951156|NCT01297920|10158926|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
2951157|NCT01297920|10158927|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
2951158|NCT01297920|10158928|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
2951159|NCT01297920|10158926|P3|Overall Study|Inadequate Control of IOP|17
2951160|NCT01297920|10158927|P2|Overall Study|Inadequate Control of IOP|9
2951161|NCT01297920|10158928|P1|Overall Study|Inadequate Control of IOP|7
2951162|NCT01297920|10158926|P3|Overall Study|Protocol Violation|0
2951163|NCT01297920|10158927|P2|Overall Study|Protocol Violation|3
2951164|NCT01297920|10158928|P1|Overall Study|Protocol Violation|1
2951165|NCT01297920|10158926|P3|Overall Study|Noncompliance|0
2951166|NCT01297920|10158927|P2|Overall Study|Noncompliance|0
2951167|NCT01297920|10158928|P1|Overall Study|Noncompliance|1
2951168|NCT01297920|10158926|P3|Overall Study|Patient Decision Unrelated to AE|2
2951169|NCT01297920|10158927|P2|Overall Study|Patient Decision Unrelated to AE|5
2951170|NCT01297920|10158928|P1|Overall Study|Patient Decision Unrelated to AE|6
2951171|NCT01297920|10158926|P3|Overall Study|Adverse Event|38
2951172|NCT01297920|10158927|P2|Overall Study|Adverse Event|10
2951173|NCT01297920|10158928|P1|Overall Study|Adverse Event|42
2951174|NCT01297517|10158972|P3|Overall Study|Inadequate Control of IOP|2
2951175|NCT01297517|10158973|P2|Overall Study|Inadequate Control of IOP|1
2951176|NCT01297517|10158974|P1|Overall Study|Inadequate Control of IOP|1
2951177|NCT01297517|10158972|P3|Overall Study|Protocol Violation|1
2951178|NCT01297517|10158973|P2|Overall Study|Protocol Violation|1
2951179|NCT01297517|10158974|P1|Overall Study|Protocol Violation|1
2951180|NCT01297517|10158972|P3|Overall Study|Noncompliance|0
2951181|NCT01297517|10158973|P2|Overall Study|Noncompliance|0
2951182|NCT01297517|10158974|P1|Overall Study|Noncompliance|1
2951183|NCT01297517|10158972|P3|Overall Study|Patient Decision Unrelated to AE|7
2951184|NCT01297517|10158973|P2|Overall Study|Patient Decision Unrelated to AE|3
2951185|NCT01297517|10158974|P1|Overall Study|Patient Decision Unrelated to AE|2
2951186|NCT01297517|10158972|P3|Overall Study|Lost to Follow-up|1
2951187|NCT01297517|10158973|P2|Overall Study|Lost to Follow-up|0
2951188|NCT01297517|10158974|P1|Overall Study|Lost to Follow-up|1
2951189|NCT01297517|10158972|P3|Overall Study|Adverse Event|16
2951190|NCT01297517|10158973|P2|Overall Study|Adverse Event|7
2951191|NCT01297517|10158974|P1|Overall Study|Adverse Event|21
2951192|NCT01297504|10158982|P1|Overall Study|Protocol Violation|3
2951193|NCT01297504|10158982|P1|Overall Study|Site Closure|3
2951194|NCT01297504|10158982|P1|Overall Study|Withdrawal by Subject|9
2951195|NCT01297504|10158982|P1|Overall Study|Lost to Follow-up|43
2951196|NCT01297504|10158982|P1|Overall Study|Death|3
2951197|NCT01297504|10158982|P1|Overall Study|No Study Visits|4
2951198|NCT01297504|10158982|P1|Overall Study|Received Palivizumab in Previous Season|1
2951199|NCT01297504|10158982|P1|Overall Study|Invalid Consent|1
2951200|NCT01297491|10158996|P2|Overall Study|Death|1
2951201|NCT01297491|10158997|P1|Overall Study|Death|2
2951202|NCT01297491|10158996|P2|Overall Study|Patient/Guardian decision|4
2951203|NCT01297491|10158997|P1|Overall Study|Patient/Guardian decision|3
2951204|NCT01297491|10158996|P2|Overall Study|Progressive disease|20
2951205|NCT01297491|10158997|P1|Overall Study|Progressive disease|11
2951206|NCT01297491|10158996|P2|Overall Study|Physician Decision|2
2951207|NCT01297491|10158997|P1|Overall Study|Physician Decision|3
2951208|NCT01297491|10158996|P2|Overall Study|Adverse Event|6
2951209|NCT01297491|10158997|P1|Overall Study|Adverse Event|11
2951210|NCT01297465|10159015|P2|Overall Study|Intention to Freeze all Embryos|1
2951211|NCT01297465|10159016|P1|Overall Study|Intention to Freeze all Embryos|0
2951212|NCT01297465|10159015|P2|Overall Study|All Embryos Discarded|1
2951213|NCT01297465|10159016|P1|Overall Study|All Embryos Discarded|0
2951214|NCT01297465|10159015|P2|Overall Study|No Fertilization|4
2951215|NCT01297465|10159016|P1|Overall Study|No Fertilization|6
2951216|NCT01297465|10159015|P2|Overall Study|Poor oocyte quality|1
2951217|NCT01297465|10159016|P1|Overall Study|Poor oocyte quality|0
2951218|NCT01297465|10159015|P2|Overall Study|No Oocytes Retrieved|1
2951219|NCT01297465|10159016|P1|Overall Study|No Oocytes Retrieved|1
2951220|NCT01297465|10159015|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
2951221|NCT01297465|10159016|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
2951222|NCT01297465|10159015|P2|Overall Study|Lack of Ovarian Response|1
2951223|NCT01297465|10159016|P1|Overall Study|Lack of Ovarian Response|1
2951224|NCT01297322|10159069|P2|Overall Study|Protocol Violation|3
2951225|NCT01297322|10159070|P1|Overall Study|Protocol Violation|0
2951226|NCT01297322|10159069|P2|Overall Study|Withdrawal by Subject|1
2951227|NCT01297322|10159070|P1|Overall Study|Withdrawal by Subject|0
2951228|NCT01297322|10159069|P2|Overall Study|Lost to Follow-up|0
2951229|NCT01297322|10159070|P1|Overall Study|Lost to Follow-up|1
2951230|NCT01297309|10159089|P1|Overall Study|Participant not entering extensionperiod|1
2951231|NCT01297309|10159089|P1|Overall Study|Death|1
2951232|NCT01297309|10159089|P1|Overall Study|Investigator Decision|2
2951233|NCT01297309|10159089|P1|Overall Study|Adverse Event|1
2951234|NCT01297309|10159089|P1|Overall Study|Withdrawal by Subject|5
2951235|NCT01297309|10159089|P1|Overall Study|Screen failure|2
2951236|NCT01297309|10159089|P1|Overall Study|Eligibility failure|2
2951237|NCT01297270|10159114|P3|Overall Study|Not treated|0
2951238|NCT01297270|10159115|P2|Overall Study|Not treated|1
2951239|NCT01297270|10159116|P1|Overall Study|Not treated|0
2951240|NCT01297270|10159114|P3|Overall Study|Other reason not defined above|1
2951241|NCT01297270|10159115|P2|Overall Study|Other reason not defined above|3
2951242|NCT01297270|10159116|P1|Overall Study|Other reason not defined above|3
2951243|NCT01297270|10159114|P3|Overall Study|Withdrawal by Subject|7
2951244|NCT01297270|10159115|P2|Overall Study|Withdrawal by Subject|15
2951245|NCT01297270|10159116|P1|Overall Study|Withdrawal by Subject|7
2951246|NCT01297270|10159114|P3|Overall Study|Protocol Violation|0
2951247|NCT01297270|10159115|P2|Overall Study|Protocol Violation|2
2951248|NCT01297270|10159116|P1|Overall Study|Protocol Violation|0
2951249|NCT01297270|10159114|P3|Overall Study|Lost to Follow-up|1
2951250|NCT01297270|10159115|P2|Overall Study|Lost to Follow-up|2
2951251|NCT01297270|10159116|P1|Overall Study|Lost to Follow-up|1
2951252|NCT01297270|10159114|P3|Overall Study|Lack of Efficacy|15
2951253|NCT01297270|10159115|P2|Overall Study|Lack of Efficacy|17
2951254|NCT01297270|10159116|P1|Overall Study|Lack of Efficacy|15
2951255|NCT01297270|10159114|P3|Overall Study|Adverse Event|5
2951256|NCT01297270|10159115|P2|Overall Study|Adverse Event|32
2951257|NCT01297270|10159116|P1|Overall Study|Adverse Event|19
2951258|NCT01297062|10159165|P7|Overall Study|Subject Decision|2
2951259|NCT01297062|10159166|P6|Overall Study|Subject Decision|1
2951260|NCT01297062|10159167|P5|Overall Study|Subject Decision|1
2951261|NCT01297062|10159168|P4|Overall Study|Subject Decision|1
2951262|NCT01297062|10159169|P3|Overall Study|Subject Decision|0
2951263|NCT01297062|10159170|P2|Overall Study|Subject Decision|1
2951264|NCT01297062|10159171|P1|Overall Study|Subject Decision|1
2951265|NCT01297062|10159165|P7|Overall Study|Protocol Violation|0
2951266|NCT01297062|10159166|P6|Overall Study|Protocol Violation|0
2951267|NCT01297062|10159167|P5|Overall Study|Protocol Violation|1
2951268|NCT01297062|10159168|P4|Overall Study|Protocol Violation|0
2951269|NCT01297062|10159169|P3|Overall Study|Protocol Violation|0
2951270|NCT01297062|10159170|P2|Overall Study|Protocol Violation|0
2951271|NCT01297062|10159171|P1|Overall Study|Protocol Violation|0
2951272|NCT01297062|10159165|P7|Overall Study|Physician Decision|6
2951273|NCT01297062|10159166|P6|Overall Study|Physician Decision|0
2951274|NCT01297062|10159167|P5|Overall Study|Physician Decision|0
2951275|NCT01297062|10159168|P4|Overall Study|Physician Decision|0
2951276|NCT01297062|10159169|P3|Overall Study|Physician Decision|1
2951277|NCT01297062|10159170|P2|Overall Study|Physician Decision|0
2951278|NCT01297062|10159171|P1|Overall Study|Physician Decision|1
2951279|NCT01297062|10159165|P7|Overall Study|Adverse Event|0
2951280|NCT01297062|10159166|P6|Overall Study|Adverse Event|0
2951281|NCT01297062|10159167|P5|Overall Study|Adverse Event|0
2951282|NCT01297062|10159168|P4|Overall Study|Adverse Event|0
2951283|NCT01297062|10159169|P3|Overall Study|Adverse Event|1
2951284|NCT01297062|10159170|P2|Overall Study|Adverse Event|0
2951285|NCT01297062|10159171|P1|Overall Study|Adverse Event|2
2951286|NCT01296698|10159233|P2|Overall Study|Study Terminated by Sponsor|12
2951287|NCT01296698|10159234|P1|Overall Study|Study Terminated by Sponsor|209
2951288|NCT01296698|10159233|P2|Overall Study|Difficulty Contacting Subject|0
2951289|NCT01296698|10159234|P1|Overall Study|Difficulty Contacting Subject|2
2951290|NCT01296698|10159233|P2|Overall Study|Withdrawal by Subject|0
2951291|NCT01296698|10159234|P1|Overall Study|Withdrawal by Subject|12
2951292|NCT01296698|10159233|P2|Overall Study|Lost to Follow-up|1
2951293|NCT01296698|10159234|P1|Overall Study|Lost to Follow-up|19
2951294|NCT01296698|10159233|P2|Overall Study|Death|0
2951295|NCT01296698|10159234|P1|Overall Study|Death|1
2951296|NCT01296698|10159233|P2|Overall Study|Adverse Event|0
2951297|NCT01296698|10159234|P1|Overall Study|Adverse Event|1
2951298|NCT01296672|10159288|P2|Overall Study|Lost to Follow-up|18
2951299|NCT01296672|10159289|P1|Overall Study|Lost to Follow-up|73
2951300|NCT01296568|10159310|P1|Continued Access Phase|Disease Progression|1
2951301|NCT01296568|10159310|P1|Continued Access Phase|Withdrawal by Subject|1
2951302|NCT01296568|10159310|P1|Continued Access Phase|Lost to Follow-up|1
2951303|NCT01296412|10159326|P2|Overall Study|Withdrawal by Subject|13
2951304|NCT01296412|10159327|P1|Overall Study|Withdrawal by Subject|10
2951305|NCT01296412|10159326|P2|Overall Study|Pregnancy|1
2951306|NCT01296412|10159327|P1|Overall Study|Pregnancy|0
2951307|NCT01296412|10159326|P2|Overall Study|Physician Decision|3
2951308|NCT01296412|10159327|P1|Overall Study|Physician Decision|1
2951309|NCT01296412|10159326|P2|Overall Study|Other reason not specified|15
2951310|NCT01296412|10159327|P1|Overall Study|Other reason not specified|20
2951311|NCT01296412|10159326|P2|Overall Study|Non-compliance with study drug|2
2951312|NCT01296412|10159327|P1|Overall Study|Non-compliance with study drug|1
2951313|NCT01296412|10159326|P2|Overall Study|Lost to Follow-up|7
2951314|NCT01296412|10159327|P1|Overall Study|Lost to Follow-up|10
2951315|NCT01296412|10159326|P2|Overall Study|Lack of Efficacy|0
2951316|NCT01296412|10159327|P1|Overall Study|Lack of Efficacy|1
2951317|NCT01296412|10159326|P2|Overall Study|Adverse Event|29
2951318|NCT01296412|10159327|P1|Overall Study|Adverse Event|8
2951319|NCT01296347|10159350|P2|12 Month Follow up|Withdrawal by Subject|1
2951320|NCT01296347|10159351|P1|12 Month Follow up|Withdrawal by Subject|0
2951321|NCT01296347|10159350|P2|12 Month Follow up|Death|1
2951322|NCT01296347|10159351|P1|12 Month Follow up|Death|1
2951323|NCT01296347|10159350|P2|12 Month Follow up|Lost to Follow-up|1
2951324|NCT01296347|10159351|P1|12 Month Follow up|Lost to Follow-up|3
2951325|NCT01296347|10159350|P2|6 Month Follow up|Lost to Follow-up|1
2951326|NCT01296347|10159351|P1|6 Month Follow up|Lost to Follow-up|0
2951327|NCT01296347|10159350|P2|6 Month Follow up|Death|1
2951328|NCT01296347|10159351|P1|6 Month Follow up|Death|2
2951329|NCT01296347|10159350|P2|3 Month Follow up|Lost to Follow-up|1
2951330|NCT01296347|10159351|P1|3 Month Follow up|Lost to Follow-up|0
2951331|NCT01296347|10159350|P2|3 Month Follow up|Death|0
2951332|NCT01296347|10159351|P1|3 Month Follow up|Death|1
2951333|NCT01296347|10159350|P2|6 Week Follow up|Death|1
2951334|NCT01296347|10159351|P1|6 Week Follow up|Death|0
2951335|NCT01296347|10159350|P2|Allocation|not received infusion|0
2951336|NCT01296347|10159351|P1|Allocation|not received infusion|1
2951337|NCT01296347|10159350|P2|Allocation|Lack of Efficacy|2
2951338|NCT01296347|10159351|P1|Allocation|Lack of Efficacy|1
2951339|NCT01296347|10159350|P2|Allocation|Withdrawal by Subject|2
2951340|NCT01296347|10159351|P1|Allocation|Withdrawal by Subject|1
2951341|NCT01296152|10159376|P1|Overall Study|Unwilling to adhere to study requirement|1
2951342|NCT01296035|10159403|P1|Overall Study|Withdrawal by Subject|1
2951343|NCT01295905|10159410|P2|Overall Study|Met exclusion criteria|0
2951344|NCT01295905|10159411|P1|Overall Study|Met exclusion criteria|1
2951345|NCT01295905|10159410|P2|Overall Study|Did not meet inclusion criteria|0
2951346|NCT01295905|10159411|P1|Overall Study|Did not meet inclusion criteria|1
2951347|NCT01295827|10159455|P15|Overall Study|Other|0
2951348|NCT01295827|10159456|P14|Overall Study|Other|0
2951349|NCT01295827|10159457|P13|Overall Study|Other|0
2951350|NCT01295827|10159458|P12|Overall Study|Other|0
2951351|NCT01295827|10159459|P11|Overall Study|Other|2
2951352|NCT01295827|10159460|P10|Overall Study|Other|0
2951353|NCT01295827|10159461|P9|Overall Study|Other|1
2951354|NCT01295827|10159462|P8|Overall Study|Other|1
2951355|NCT01295827|10159463|P7|Overall Study|Other|1
2951356|NCT01295827|10159464|P6|Overall Study|Other|0
2951357|NCT01295827|10159465|P5|Overall Study|Other|0
2951358|NCT01295827|10159466|P4|Overall Study|Other|0
2951359|NCT01295827|10159467|P3|Overall Study|Other|0
2951360|NCT01295827|10159468|P2|Overall Study|Other|0
2951361|NCT01295827|10159469|P1|Overall Study|Other|0
2951362|NCT01295827|10159455|P15|Overall Study|Withdrawal by Subject|0
2951363|NCT01295827|10159456|P14|Overall Study|Withdrawal by Subject|0
2951364|NCT01295827|10159457|P13|Overall Study|Withdrawal by Subject|0
2951365|NCT01295827|10159458|P12|Overall Study|Withdrawal by Subject|13
2951366|NCT01295827|10159459|P11|Overall Study|Withdrawal by Subject|18
2951367|NCT01295827|10159460|P10|Overall Study|Withdrawal by Subject|2
2951368|NCT01295827|10159461|P9|Overall Study|Withdrawal by Subject|11
2951369|NCT01295827|10159462|P8|Overall Study|Withdrawal by Subject|35
2951370|NCT01295827|10159463|P7|Overall Study|Withdrawal by Subject|13
2951371|NCT01295827|10159464|P6|Overall Study|Withdrawal by Subject|1
2951372|NCT01295827|10159465|P5|Overall Study|Withdrawal by Subject|0
2951373|NCT01295827|10159466|P4|Overall Study|Withdrawal by Subject|0
2951374|NCT01295827|10159467|P3|Overall Study|Withdrawal by Subject|2
2951375|NCT01295827|10159468|P2|Overall Study|Withdrawal by Subject|0
2951376|NCT01295827|10159469|P1|Overall Study|Withdrawal by Subject|1
2951377|NCT01295827|10159455|P15|Overall Study|Screen Failure|0
2951378|NCT01295827|10159456|P14|Overall Study|Screen Failure|0
2951379|NCT01295827|10159457|P13|Overall Study|Screen Failure|0
2951380|NCT01295827|10159458|P12|Overall Study|Screen Failure|0
2951381|NCT01295827|10159459|P11|Overall Study|Screen Failure|1
2951382|NCT01295827|10159460|P10|Overall Study|Screen Failure|0
2951383|NCT01295827|10159461|P9|Overall Study|Screen Failure|2
2951384|NCT01295827|10159462|P8|Overall Study|Screen Failure|2
2951385|NCT01295827|10159463|P7|Overall Study|Screen Failure|2
2951386|NCT01295827|10159464|P6|Overall Study|Screen Failure|0
2951387|NCT01295827|10159465|P5|Overall Study|Screen Failure|0
2951388|NCT01295827|10159466|P4|Overall Study|Screen Failure|0
2951389|NCT01295827|10159467|P3|Overall Study|Screen Failure|0
2951390|NCT01295827|10159468|P2|Overall Study|Screen Failure|0
2951391|NCT01295827|10159469|P1|Overall Study|Screen Failure|0
2951392|NCT01295827|10159455|P15|Overall Study|Progressive Disease|0
2951393|NCT01295827|10159456|P14|Overall Study|Progressive Disease|0
2951394|NCT01295827|10159457|P13|Overall Study|Progressive Disease|0
2951395|NCT01295827|10159458|P12|Overall Study|Progressive Disease|136
2951396|NCT01295827|10159459|P11|Overall Study|Progressive Disease|175
2951397|NCT01295827|10159460|P10|Overall Study|Progressive Disease|40
2951398|NCT01295827|10159461|P9|Overall Study|Progressive Disease|85
2951399|NCT01295827|10159462|P8|Overall Study|Progressive Disease|144
2951400|NCT01295827|10159463|P7|Overall Study|Progressive Disease|87
2951401|NCT01295827|10159464|P6|Overall Study|Progressive Disease|1
2951402|NCT01295827|10159465|P5|Overall Study|Progressive Disease|0
2951403|NCT01295827|10159466|P4|Overall Study|Progressive Disease|2
2951404|NCT01295827|10159467|P3|Overall Study|Progressive Disease|5
2951405|NCT01295827|10159468|P2|Overall Study|Progressive Disease|1
2951406|NCT01295827|10159469|P1|Overall Study|Progressive Disease|2
2951407|NCT01295827|10159455|P15|Overall Study|Not Reported|0
2951408|NCT01295827|10159456|P14|Overall Study|Not Reported|0
2951409|NCT01295827|10159457|P13|Overall Study|Not Reported|0
2951410|NCT01295827|10159458|P12|Overall Study|Not Reported|13
2951411|NCT01295827|10159459|P11|Overall Study|Not Reported|23
2951412|NCT01295827|10159460|P10|Overall Study|Not Reported|2
2951413|NCT01295827|10159461|P9|Overall Study|Not Reported|41
2951414|NCT01295827|10159462|P8|Overall Study|Not Reported|58
2951415|NCT01295827|10159463|P7|Overall Study|Not Reported|24
2951416|NCT01295827|10159464|P6|Overall Study|Not Reported|0
2951417|NCT01295827|10159465|P5|Overall Study|Not Reported|0
2951418|NCT01295827|10159466|P4|Overall Study|Not Reported|1
2951419|NCT01295827|10159467|P3|Overall Study|Not Reported|0
2951420|NCT01295827|10159468|P2|Overall Study|Not Reported|0
2951421|NCT01295827|10159469|P1|Overall Study|Not Reported|0
2951422|NCT01295827|10159455|P15|Overall Study|Lost to Follow-up|0
2951423|NCT01295827|10159456|P14|Overall Study|Lost to Follow-up|0
2951424|NCT01295827|10159457|P13|Overall Study|Lost to Follow-up|0
2951425|NCT01295827|10159458|P12|Overall Study|Lost to Follow-up|3
2951426|NCT01295827|10159459|P11|Overall Study|Lost to Follow-up|7
2951427|NCT01295827|10159460|P10|Overall Study|Lost to Follow-up|4
2951428|NCT01295827|10159461|P9|Overall Study|Lost to Follow-up|7
2951429|NCT01295827|10159462|P8|Overall Study|Lost to Follow-up|8
2951430|NCT01295827|10159463|P7|Overall Study|Lost to Follow-up|4
2951431|NCT01295827|10159464|P6|Overall Study|Lost to Follow-up|0
2951432|NCT01295827|10159465|P5|Overall Study|Lost to Follow-up|1
2951433|NCT01295827|10159466|P4|Overall Study|Lost to Follow-up|0
2951434|NCT01295827|10159467|P3|Overall Study|Lost to Follow-up|3
2951435|NCT01295827|10159468|P2|Overall Study|Lost to Follow-up|0
2951436|NCT01295827|10159469|P1|Overall Study|Lost to Follow-up|0
2951437|NCT01295827|10159455|P15|Overall Study|Adverse Event|0
2951438|NCT01295827|10159456|P14|Overall Study|Adverse Event|0
2951439|NCT01295827|10159457|P13|Overall Study|Adverse Event|0
2951440|NCT01295827|10159458|P12|Overall Study|Adverse Event|21
2951441|NCT01295827|10159459|P11|Overall Study|Adverse Event|50
2951442|NCT01295827|10159460|P10|Overall Study|Adverse Event|7
2951443|NCT01295827|10159461|P9|Overall Study|Adverse Event|22
2951444|NCT01295827|10159462|P8|Overall Study|Adverse Event|49
2951445|NCT01295827|10159463|P7|Overall Study|Adverse Event|15
2951446|NCT01295827|10159464|P6|Overall Study|Adverse Event|4
2951447|NCT01295827|10159465|P5|Overall Study|Adverse Event|1
2951448|NCT01295827|10159466|P4|Overall Study|Adverse Event|1
2951449|NCT01295827|10159467|P3|Overall Study|Adverse Event|2
2951450|NCT01295827|10159468|P2|Overall Study|Adverse Event|2
2951451|NCT01295827|10159469|P1|Overall Study|Adverse Event|1
2951452|NCT01295814|10159842|P2|Overall Study|Withdrawal by Subject|0
2951453|NCT01295814|10159843|P1|Overall Study|Withdrawal by Subject|2
2951454|NCT01295814|10159842|P2|Overall Study|Lack of Efficacy|2
2951455|NCT01295814|10159843|P1|Overall Study|Lack of Efficacy|0
2951456|NCT01295671|10159923|P3|Overall Study|Withdrawal by Subject|0
2951457|NCT01295671|10159924|P2|Overall Study|Withdrawal by Subject|1
2951458|NCT01295671|10159925|P1|Overall Study|Withdrawal by Subject|3
2951459|NCT01295671|10159923|P3|Overall Study|Lost to Follow-up|3
2951460|NCT01295671|10159924|P2|Overall Study|Lost to Follow-up|6
2951461|NCT01295671|10159925|P1|Overall Study|Lost to Follow-up|4
2951462|NCT01295320|10159971|P1|Overall Study|Unable to travel|1
2951463|NCT01295320|10159971|P1|Overall Study|Subject was bedridden|1
2951464|NCT01295320|10159971|P1|Overall Study|Withdrawal by Subject|2
2951465|NCT01295320|10159971|P1|Overall Study|Lost to Follow-up|4
2951466|NCT01295320|10159971|P1|Overall Study|Adverse Event|2
2951467|NCT01295281|10159988|P2|First Intervention (7 Days)|Death|1
2951468|NCT01295281|10159989|P1|First Intervention (7 Days)|Death|0
2951469|NCT01295034|10160027|P2|Overall Study|Lost to Follow-up|5
2951470|NCT01295034|10160028|P1|Overall Study|Lost to Follow-up|5
2951471|NCT01294917|10160036|P1|Overall Study|Inconvenience|1
2951472|NCT01294917|10160036|P1|Overall Study|Relocation|5
2951473|NCT01294800|10160046|P4|Overall Study|Did Not Meet Protocol Eligibility|0
2951474|NCT01294800|10160047|P3|Overall Study|Did Not Meet Protocol Eligibility|1
2951475|NCT01294800|10160048|P2|Overall Study|Did Not Meet Protocol Eligibility|1
2951476|NCT01294800|10160049|P1|Overall Study|Did Not Meet Protocol Eligibility|2
2951477|NCT01294800|10160046|P4|Overall Study|Non-compliance With Protocol|0
2951478|NCT01294800|10160047|P3|Overall Study|Non-compliance With Protocol|1
2951479|NCT01294800|10160048|P2|Overall Study|Non-compliance With Protocol|1
2951480|NCT01294800|10160049|P1|Overall Study|Non-compliance With Protocol|0
2951481|NCT01294800|10160046|P4|Overall Study|Lost to Follow-up|0
2951482|NCT01294800|10160047|P3|Overall Study|Lost to Follow-up|1
2951483|NCT01294800|10160048|P2|Overall Study|Lost to Follow-up|0
2951484|NCT01294800|10160049|P1|Overall Study|Lost to Follow-up|0
2951485|NCT01294800|10160046|P4|Overall Study|Subject Withdrew Consent|11
2951486|NCT01294800|10160047|P3|Overall Study|Subject Withdrew Consent|2
2951487|NCT01294800|10160048|P2|Overall Study|Subject Withdrew Consent|2
2951488|NCT01294800|10160049|P1|Overall Study|Subject Withdrew Consent|2
2951489|NCT01294800|10160046|P4|Overall Study|Adverse Event|5
2951490|NCT01294800|10160047|P3|Overall Study|Adverse Event|12
2951491|NCT01294800|10160048|P2|Overall Study|Adverse Event|6
2951492|NCT01294800|10160049|P1|Overall Study|Adverse Event|7
2951493|NCT01294787|10160075|P6|Period 3|Adverse Event|0
2951494|NCT01294787|10160076|P5|Period 3|Adverse Event|1
2951495|NCT01294787|10160077|P4|Period 3|Adverse Event|0
2951496|NCT01294787|10160078|P3|Period 3|Adverse Event|0
2951497|NCT01294787|10160079|P2|Period 3|Adverse Event|0
2951498|NCT01294787|10160080|P1|Period 3|Adverse Event|0
2951499|NCT01294787|10160075|P6|Period 2|No longer needs study drug|0
2951500|NCT01294787|10160076|P5|Period 2|No longer needs study drug|0
2951501|NCT01294787|10160077|P4|Period 2|No longer needs study drug|1
2951502|NCT01294787|10160078|P3|Period 2|No longer needs study drug|0
2951503|NCT01294787|10160079|P2|Period 2|No longer needs study drug|0
2951504|NCT01294787|10160080|P1|Period 2|No longer needs study drug|0
2951505|NCT01294787|10160075|P6|Period 2|Adverse Event|0
2951506|NCT01294787|10160076|P5|Period 2|Adverse Event|0
2951507|NCT01294787|10160077|P4|Period 2|Adverse Event|1
2951508|NCT01294787|10160078|P3|Period 2|Adverse Event|0
2951509|NCT01294787|10160079|P2|Period 2|Adverse Event|3
2951510|NCT01294787|10160080|P1|Period 2|Adverse Event|0
2951511|NCT01294787|10160075|P6|Period 1|Administrative problem|1
2951512|NCT01294787|10160076|P5|Period 1|Administrative problem|0
2951513|NCT01294787|10160077|P4|Period 1|Administrative problem|0
2951514|NCT01294787|10160078|P3|Period 1|Administrative problem|1
2951515|NCT01294787|10160079|P2|Period 1|Administrative problem|0
2951516|NCT01294787|10160080|P1|Period 1|Administrative problem|0
2951517|NCT01294787|10160075|P6|Period 1|Withdrawal by Subject|1
2951518|NCT01294787|10160076|P5|Period 1|Withdrawal by Subject|1
2951519|NCT01294787|10160077|P4|Period 1|Withdrawal by Subject|1
2951520|NCT01294787|10160078|P3|Period 1|Withdrawal by Subject|0
2951521|NCT01294787|10160079|P2|Period 1|Withdrawal by Subject|0
2951522|NCT01294787|10160080|P1|Period 1|Withdrawal by Subject|0
2951523|NCT01294787|10160075|P6|Period 1|Adverse Event|0
2951524|NCT01294787|10160076|P5|Period 1|Adverse Event|1
2951525|NCT01294787|10160077|P4|Period 1|Adverse Event|0
2951526|NCT01294787|10160078|P3|Period 1|Adverse Event|0
2951527|NCT01294787|10160079|P2|Period 1|Adverse Event|0
2951528|NCT01294787|10160080|P1|Period 1|Adverse Event|0
2951529|NCT01294696|10160171|P1|Overall Study|Site closure|52
2951530|NCT01294696|10160171|P1|Overall Study|Missing BPI Response|7
2951531|NCT01294696|10160171|P1|Overall Study|Protocol Violation|8
2951532|NCT01294696|10160171|P1|Overall Study|Screening failures|7
2951533|NCT01294683|10160185|P2|Post Crossover (Period III)|Withdrawal by Subject|2
2951534|NCT01294683|10160186|P1|Post Crossover (Period III)|Withdrawal by Subject|3
2951535|NCT01294683|10160185|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
2951536|NCT01294683|10160186|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
2951537|NCT01294683|10160185|P2|Post Crossover (Period III)|Lost to Follow-up|3
2951538|NCT01294683|10160186|P1|Post Crossover (Period III)|Lost to Follow-up|1
2951539|NCT01294683|10160185|P2|Post Crossover (Period III)|Adverse Event|6
2951540|NCT01294683|10160186|P1|Post Crossover (Period III)|Adverse Event|6
2951541|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
2951542|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
2951543|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Technical Problems|1
2951544|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Technical Problems|0
2951545|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
2951546|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
2951547|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Protocol Violation|5
2951548|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Protocol Violation|5
2951549|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Physician Decision|0
2951550|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Physician Decision|1
2951551|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2951552|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2951553|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
2951554|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
2951555|NCT01294683|10160185|P2|Precrossover (Periods I/II)|Adverse Event|52
2951556|NCT01294683|10160186|P1|Precrossover (Periods I/II)|Adverse Event|49
2951557|NCT01294644|10160239|P3|Overall Study|Miscellaneous Reason|4
2951558|NCT01294644|10160240|P2|Overall Study|Miscellaneous Reason|1
2951559|NCT01294644|10160241|P1|Overall Study|Miscellaneous Reason|2
2951560|NCT01294644|10160239|P3|Overall Study|Lost to Follow-up|5
2951561|NCT01294644|10160240|P2|Overall Study|Lost to Follow-up|2
2951562|NCT01294644|10160241|P1|Overall Study|Lost to Follow-up|3
2951563|NCT01294644|10160239|P3|Overall Study|Withdrawal by Subject|4
2951564|NCT01294644|10160240|P2|Overall Study|Withdrawal by Subject|7
2951565|NCT01294644|10160241|P1|Overall Study|Withdrawal by Subject|3
2951566|NCT01294644|10160239|P3|Overall Study|Adverse Event|1
2951567|NCT01294644|10160240|P2|Overall Study|Adverse Event|0
2951568|NCT01294644|10160241|P1|Overall Study|Adverse Event|2
2951569|NCT01294592|10160272|P2|Overall Study|Withdrawal by Subject|28
2951570|NCT01294592|10160273|P1|Overall Study|Withdrawal by Subject|28
2951571|NCT01294592|10160272|P2|Overall Study|Physician Decision|11
2951572|NCT01294592|10160273|P1|Overall Study|Physician Decision|6
2951573|NCT01294592|10160272|P2|Overall Study|Lost to Follow-up|9
2951574|NCT01294592|10160273|P1|Overall Study|Lost to Follow-up|7
2951575|NCT01294592|10160272|P2|Overall Study|Protocol Violation|7
2951576|NCT01294592|10160273|P1|Overall Study|Protocol Violation|1
2951577|NCT01294592|10160272|P2|Overall Study|Lack of Efficacy|5
2951578|NCT01294592|10160273|P1|Overall Study|Lack of Efficacy|7
2951579|NCT01294592|10160272|P2|Overall Study|Adverse Event|13
2951580|NCT01294592|10160273|P1|Overall Study|Adverse Event|28
2951581|NCT01294579|10160301|P1|Overall Study|Withdrawal by Subject|5
2951582|NCT01294579|10160301|P1|Overall Study|Physician Decision|3
2951583|NCT01294579|10160301|P1|Overall Study|Lost to Follow-up|1
2951584|NCT01294579|10160301|P1|Overall Study|Study closed/terminated|3
2951585|NCT01294579|10160301|P1|Overall Study|Adverse Event|11
2951586|NCT01294579|10160301|P1|Overall Study|Disease progression|12
2951587|NCT01294553|10160311|P1|Overall Study|Protocol Violation|268
2951588|NCT01294553|10160311|P1|Overall Study|Duplicated Participants|1
2951589|NCT01294514|10160317|P1|Overall Study|Excluded due to Arrhythmia|1
2951590|NCT01294462|10160327|P2|Overall Study|Withdrawal by Subject|63
2951591|NCT01294462|10160328|P1|Overall Study|Withdrawal by Subject|65
2951592|NCT01294462|10160327|P2|Overall Study|Lost to Follow-up|0
2951593|NCT01294462|10160328|P1|Overall Study|Lost to Follow-up|1
2951594|NCT01294449|10160342|P2|Overall Study|Withdrawal by Subject|3
2951595|NCT01294449|10160343|P1|Overall Study|Withdrawal by Subject|1
2951596|NCT01294449|10160342|P2|Overall Study|Death|12
2951597|NCT01294449|10160343|P1|Overall Study|Death|11
2951598|NCT01294436|10160351|P2|Overall Study|poor/non-compliance|5
2951599|NCT01294436|10160352|P1|Overall Study|poor/non-compliance|2
2951600|NCT01294436|10160351|P2|Overall Study|subject no longer meets study criteria|20
2951601|NCT01294436|10160352|P1|Overall Study|subject no longer meets study criteria|5
2951602|NCT01294436|10160351|P2|Overall Study|Withdrawal by Subject|28
2951603|NCT01294436|10160352|P1|Overall Study|Withdrawal by Subject|11
2951604|NCT01294436|10160351|P2|Overall Study|Adverse Event|17
2951605|NCT01294436|10160352|P1|Overall Study|Adverse Event|10
2951606|NCT01294423|10160387|P3|Overall Study|poor/non-compliance|1
2951607|NCT01294423|10160388|P2|Overall Study|poor/non-compliance|0
2951608|NCT01294423|10160389|P1|Overall Study|poor/non-compliance|1
2951609|NCT01294423|10160387|P3|Overall Study|subject no longer meets study criteria|2
2951610|NCT01294423|10160388|P2|Overall Study|subject no longer meets study criteria|5
2951611|NCT01294423|10160389|P1|Overall Study|subject no longer meets study criteria|2
2951612|NCT01294423|10160387|P3|Overall Study|Withdrawal by Subject|2
2951613|NCT01294423|10160388|P2|Overall Study|Withdrawal by Subject|2
2951614|NCT01294423|10160389|P1|Overall Study|Withdrawal by Subject|1
2951615|NCT01294423|10160387|P3|Overall Study|Adverse Event|3
2951616|NCT01294423|10160388|P2|Overall Study|Adverse Event|2
2951617|NCT01294423|10160389|P1|Overall Study|Adverse Event|1
2951618|NCT01294397|10160403|P1|Overall Study|Administrative Decision|1
2951619|NCT01294397|10160403|P1|Overall Study|Withdrawal by Subject|1
2951620|NCT01294371|10160447|P1|Overall Study|Other|14
2951621|NCT01294371|10160447|P1|Overall Study|Administrative Reason|1
2951622|NCT01294371|10160447|P1|Overall Study|Lost to Follow-up|6
2951623|NCT01294371|10160447|P1|Overall Study|Withdrawal by Subject|12
2951624|NCT01294371|10160447|P1|Overall Study|Adverse Event|1
2951625|NCT01294358|10160455|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
2951626|NCT01294358|10160456|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2951627|NCT01294358|10160457|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2951628|NCT01294358|10160458|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2951629|NCT01294358|10160459|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2951630|NCT01294358|10160455|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2951631|NCT01294358|10160456|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
2951632|NCT01294358|10160457|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2951633|NCT01294358|10160458|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2951634|NCT01294358|10160459|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2951635|NCT01294358|10160455|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2951636|NCT01294358|10160456|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2951637|NCT01294358|10160457|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
2951638|NCT01294358|10160458|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2951639|NCT01294358|10160459|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2951640|NCT01294358|10160455|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2951641|NCT01294358|10160456|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2951642|NCT01294358|10160457|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2951643|NCT01294358|10160458|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
2951644|NCT01294358|10160459|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2951645|NCT01294150|10160587|P2|Overall Study|Physician Decision|2
2951646|NCT01294150|10160588|P1|Overall Study|Physician Decision|2
2951647|NCT01294046|10160617|P1|Overall Study|Stimulation response inadqequate|1
2951648|NCT01294046|10160617|P1|Overall Study|Eligibility criteria expanded|1
2951649|NCT01294046|10160617|P1|Overall Study|Infection and surgical explant|1
2951650|NCT01293968|10160632|P2|Overall Study|non-cooperation|3
2951651|NCT01293968|10160633|P1|Overall Study|non-cooperation|3
2951652|NCT01293695|10160653|P2|Overall Study|Lost to Follow-up|6
2951653|NCT01293695|10160654|P1|Overall Study|Lost to Follow-up|8
2951654|NCT01293695|10160653|P2|Overall Study|Withdrawal by Subject|1
2951655|NCT01293695|10160654|P1|Overall Study|Withdrawal by Subject|7
2951656|NCT01293539|10160673|P1|Overall Study|Physician Decision|1
2951657|NCT01293240|10160677|P1|Overall Study|Noncompliance|2
2951658|NCT01293123|10160694|P2|Overall Study|Lost to Follow-up|1
2951659|NCT01293123|10160695|P1|Overall Study|Lost to Follow-up|0
2951660|NCT01293084|10160709|P1|Overall Study|Withdrawal by Subject|2
2951661|NCT01293084|10160709|P1|Overall Study|Physician Decision|3
2951662|NCT01293032|10160721|P4|Treatment|Disease Progression, relapse|0
2951663|NCT01293032|10160722|P3|Treatment|Disease Progression, relapse|0
2951664|NCT01293032|10160723|P2|Treatment|Disease Progression, relapse|1
2951665|NCT01293032|10160724|P1|Treatment|Disease Progression, relapse|0
2951666|NCT01293032|10160721|P4|Treatment|Withdrawal by Subject|0
2951667|NCT01293032|10160722|P3|Treatment|Withdrawal by Subject|0
2951668|NCT01293032|10160723|P2|Treatment|Withdrawal by Subject|4
2951669|NCT01293032|10160724|P1|Treatment|Withdrawal by Subject|2
2951670|NCT01293032|10160721|P4|Treatment|Adverse Event|1
2951671|NCT01293032|10160722|P3|Treatment|Adverse Event|1
2951672|NCT01293032|10160723|P2|Treatment|Adverse Event|0
2951673|NCT01293032|10160724|P1|Treatment|Adverse Event|0
2951674|NCT01293032|10160721|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2951675|NCT01293032|10160722|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
2951676|NCT01293032|10160723|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2951677|NCT01293032|10160724|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2951678|NCT01293006|10160735|P4|Period 2|Lost to Follow-up|0
2951679|NCT01293006|10160736|P3|Period 2|Lost to Follow-up|0
2951680|NCT01293006|10160737|P2|Period 2|Lost to Follow-up|0
2951681|NCT01293006|10160738|P1|Period 2|Lost to Follow-up|1
2951682|NCT01292928|10160759|P1|Overall Study|Physician Decision|2
2951683|NCT01292928|10160759|P1|Overall Study|Lost to Follow-up|6
2951684|NCT01292928|10160759|P1|Overall Study|Withdrawal by Subject|8
2951685|NCT01292928|10160759|P1|Overall Study|Death|8
2951686|NCT01292876|10160776|P1|Overall Study|Physician Decision|4
2951687|NCT01292837|10160782|P1|Overall Study|Further treatment determined|1
2951688|NCT01292837|10160782|P1|Overall Study|Adverse Event|1
2951689|NCT01292603|10160819|P6|Overall Survival Status|Death|10
2951690|NCT01292603|10160820|P5|Overall Survival Status|Death|16
2951691|NCT01292603|10160821|P4|Overall Survival Status|Death|1
2951692|NCT01292603|10160822|P3|Overall Survival Status|Death|3
2951693|NCT01292603|10160823|P2|Overall Survival Status|Death|1
2951694|NCT01292603|10160824|P1|Overall Survival Status|Death|3
2951695|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Adverse Event|2
2951696|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Adverse Event|2
2951697|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Adverse Event|0
2951698|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Adverse Event|0
2951699|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Adverse Event|0
2951700|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Adverse Event|0
2951701|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
2951702|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
2951703|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
2951704|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
2951705|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
2951706|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
2951707|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Physician Decision|0
2951708|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Physician Decision|2
2951709|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Physician Decision|0
2951710|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Physician Decision|0
2951711|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Physician Decision|0
2951712|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Physician Decision|0
2951713|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Protocol Violation|0
2951714|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Protocol Violation|2
2951715|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Protocol Violation|0
2951716|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Protocol Violation|0
2951717|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Protocol Violation|0
2951718|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Protocol Violation|0
2951719|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
2951720|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2951721|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2951722|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2951723|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2951724|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2951725|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Noncompliance|0
2951726|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Noncompliance|1
2951727|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Noncompliance|0
2951728|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Noncompliance|0
2951729|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Noncompliance|0
2951730|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Noncompliance|0
2951731|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Disease Progression|5
2951732|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Disease Progression|5
2951733|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Disease Progression|0
2951734|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Disease Progression|0
2951735|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Disease Progression|0
2951736|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Disease Progression|0
2951737|NCT01292603|10160819|P6|Part 2: Regular Follow-Up|Death|3
2951738|NCT01292603|10160820|P5|Part 2: Regular Follow-Up|Death|6
2951739|NCT01292603|10160821|P4|Part 2: Regular Follow-Up|Death|0
2951740|NCT01292603|10160822|P3|Part 2: Regular Follow-Up|Death|0
2951741|NCT01292603|10160823|P2|Part 2: Regular Follow-Up|Death|0
2951742|NCT01292603|10160824|P1|Part 2: Regular Follow-Up|Death|0
2951743|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
2951744|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2951745|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2951746|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2951747|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2951748|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2951749|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
2951750|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
2951751|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
2951752|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
2951753|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
2951754|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
2951755|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Adverse Event|9
2951756|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Adverse Event|7
2951757|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Adverse Event|0
2951758|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Adverse Event|0
2951759|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Adverse Event|0
2951760|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Adverse Event|0
2951761|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2951762|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2951763|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2951764|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2951765|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2951766|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2951767|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Physician Decision|0
2951768|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Physician Decision|2
2951769|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Physician Decision|0
2951770|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Physician Decision|0
2951771|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Physician Decision|0
2951772|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Physician Decision|0
2951773|NCT01292603|10160819|P6|Part 2: Dose Confirmation Period|Death|0
2951774|NCT01292603|10160820|P5|Part 2: Dose Confirmation Period|Death|1
2951775|NCT01292603|10160821|P4|Part 2: Dose Confirmation Period|Death|0
2951776|NCT01292603|10160822|P3|Part 2: Dose Confirmation Period|Death|0
2951777|NCT01292603|10160823|P2|Part 2: Dose Confirmation Period|Death|0
2951778|NCT01292603|10160824|P1|Part 2: Dose Confirmation Period|Death|0
2951779|NCT01292603|10160819|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
2951780|NCT01292603|10160820|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
2951781|NCT01292603|10160821|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
2951782|NCT01292603|10160822|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
2951783|NCT01292603|10160823|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
2951784|NCT01292603|10160824|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
2951785|NCT01292603|10160819|P6|Part 1: Regular Follow-Up Period|Death|0
2951786|NCT01292603|10160820|P5|Part 1: Regular Follow-Up Period|Death|0
2951787|NCT01292603|10160821|P4|Part 1: Regular Follow-Up Period|Death|1
2951788|NCT01292603|10160822|P3|Part 1: Regular Follow-Up Period|Death|3
2951789|NCT01292603|10160823|P2|Part 1: Regular Follow-Up Period|Death|1
2951790|NCT01292603|10160824|P1|Part 1: Regular Follow-Up Period|Death|3
2951791|NCT01292603|10160819|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2951792|NCT01292603|10160820|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2951793|NCT01292603|10160821|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
2951794|NCT01292603|10160822|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2951795|NCT01292603|10160823|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2951796|NCT01292603|10160824|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2951797|NCT01292603|10160819|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2951798|NCT01292603|10160820|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2951799|NCT01292603|10160821|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
2951800|NCT01292603|10160822|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2951801|NCT01292603|10160823|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2951802|NCT01292603|10160824|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2951803|NCT01292603|10160819|P6|Part 1: Pilot Dose Selection Period|Death|0
2951804|NCT01292603|10160820|P5|Part 1: Pilot Dose Selection Period|Death|0
2951805|NCT01292603|10160821|P4|Part 1: Pilot Dose Selection Period|Death|1
2951806|NCT01292603|10160822|P3|Part 1: Pilot Dose Selection Period|Death|0
2951807|NCT01292603|10160823|P2|Part 1: Pilot Dose Selection Period|Death|0
2951808|NCT01292603|10160824|P1|Part 1: Pilot Dose Selection Period|Death|0
2951809|NCT01292603|10160819|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
2951810|NCT01292603|10160820|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
2951811|NCT01292603|10160821|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
2951812|NCT01292603|10160822|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
2951813|NCT01292603|10160823|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
2951814|NCT01292603|10160824|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
2951815|NCT01292486|10160877|P1|Overall Study|Physician Decision|1
2951816|NCT01292486|10160877|P1|Overall Study|Adverse Event|1
2951817|NCT01292486|10160877|P1|Overall Study|Did not meet screening criteria|2
2951818|NCT01292486|10160877|P1|Overall Study|Protocol Violation|2
2951819|NCT01292473|10160891|P4|Overall Study|Disease Progression|6
2951820|NCT01292473|10160892|P3|Overall Study|Disease Progression|3
2951821|NCT01292473|10160893|P2|Overall Study|Disease Progression|1
2951822|NCT01292473|10160894|P1|Overall Study|Disease Progression|0
2951823|NCT01292473|10160891|P4|Overall Study|Physician Decision|0
2951824|NCT01292473|10160892|P3|Overall Study|Physician Decision|0
2951825|NCT01292473|10160893|P2|Overall Study|Physician Decision|1
2951826|NCT01292473|10160894|P1|Overall Study|Physician Decision|0
2951827|NCT01292473|10160891|P4|Overall Study|Withdrawal by Subject|3
2951828|NCT01292473|10160892|P3|Overall Study|Withdrawal by Subject|3
2951829|NCT01292473|10160893|P2|Overall Study|Withdrawal by Subject|4
2951830|NCT01292473|10160894|P1|Overall Study|Withdrawal by Subject|3
2951831|NCT01292473|10160891|P4|Overall Study|Lost to Follow-up|2
2951832|NCT01292473|10160892|P3|Overall Study|Lost to Follow-up|2
2951833|NCT01292473|10160893|P2|Overall Study|Lost to Follow-up|1
2951834|NCT01292473|10160894|P1|Overall Study|Lost to Follow-up|1
2951835|NCT01292473|10160891|P4|Overall Study|Adverse Event|1
2951836|NCT01292473|10160892|P3|Overall Study|Adverse Event|1
2951837|NCT01292473|10160893|P2|Overall Study|Adverse Event|0
2951838|NCT01292473|10160894|P1|Overall Study|Adverse Event|1
2951839|NCT01292239|10160953|P2|Overall Study|Withdrawal by Subject|6
2951840|NCT01292239|10160954|P1|Overall Study|Withdrawal by Subject|3
2951841|NCT01292239|10160953|P2|Overall Study|Other|1
2951842|NCT01292239|10160954|P1|Overall Study|Other|1
2951843|NCT01292226|10160975|P1|Overall Study|Other|2
2951844|NCT01292226|10160975|P1|Overall Study|Withdrawal by Subject|1
2951845|NCT01292226|10160975|P1|Overall Study|Protocol Violation|3
2951846|NCT01292226|10160975|P1|Overall Study|Graft loss|1
2951847|NCT01292226|10160975|P1|Overall Study|Death|1
2951848|NCT01292226|10160975|P1|Overall Study|Adverse Event|5
2951849|NCT01292187|10161008|P2|Overall Study|All other reasons|3
2951850|NCT01292187|10161009|P1|Overall Study|All other reasons|1
2951851|NCT01292187|10161008|P2|Overall Study|Withdrawal by Subject|5
2951852|NCT01292187|10161009|P1|Overall Study|Withdrawal by Subject|6
2951853|NCT01292187|10161008|P2|Overall Study|Adverse Event|5
2951854|NCT01292187|10161009|P1|Overall Study|Adverse Event|10
2951855|NCT01292057|10161044|P2|Overall Study|Lost to Follow-up|1
2951856|NCT01292057|10161045|P1|Overall Study|Lost to Follow-up|1
2951857|NCT01292057|10161044|P2|Overall Study|Protocol Violation|1
2951858|NCT01292057|10161045|P1|Overall Study|Protocol Violation|1
2951859|NCT01291277|10161117|P2|Overall Study|Lost to Follow-up|1
2951860|NCT01291277|10161118|P1|Overall Study|Lost to Follow-up|3
2951861|NCT01291277|10161117|P2|Overall Study|Death|2
2951862|NCT01291277|10161118|P1|Overall Study|Death|2
2951863|NCT01291225|10161130|P2|Overall Study|Lost to Follow-up|39
2951864|NCT01291225|10161131|P1|Overall Study|Lost to Follow-up|85
2951865|NCT01291173|10161145|P4|Overall Study|Excluded therapy|0
2951866|NCT01291173|10161146|P3|Overall Study|Excluded therapy|1
2951867|NCT01291173|10161147|P2|Overall Study|Excluded therapy|0
2951868|NCT01291173|10161148|P1|Overall Study|Excluded therapy|0
2951869|NCT01291173|10161145|P4|Overall Study|Subject was unblinded|0
2951870|NCT01291173|10161146|P3|Overall Study|Subject was unblinded|1
2951871|NCT01291173|10161147|P2|Overall Study|Subject was unblinded|0
2951872|NCT01291173|10161148|P1|Overall Study|Subject was unblinded|0
2951873|NCT01291173|10161145|P4|Overall Study|Lack of compliance|1
2951874|NCT01291173|10161146|P3|Overall Study|Lack of compliance|0
2951875|NCT01291173|10161147|P2|Overall Study|Lack of compliance|0
2951876|NCT01291173|10161148|P1|Overall Study|Lack of compliance|0
2951877|NCT01291173|10161145|P4|Overall Study|Unable to meet visit schedule|0
2951878|NCT01291173|10161146|P3|Overall Study|Unable to meet visit schedule|1
2951879|NCT01291173|10161147|P2|Overall Study|Unable to meet visit schedule|0
2951880|NCT01291173|10161148|P1|Overall Study|Unable to meet visit schedule|0
2951881|NCT01291173|10161145|P4|Overall Study|Lost to Follow-up|2
2951882|NCT01291173|10161146|P3|Overall Study|Lost to Follow-up|3
2951883|NCT01291173|10161147|P2|Overall Study|Lost to Follow-up|6
2951884|NCT01291173|10161148|P1|Overall Study|Lost to Follow-up|4
2951885|NCT01291173|10161145|P4|Overall Study|Withdrawal by Subject|2
2951886|NCT01291173|10161146|P3|Overall Study|Withdrawal by Subject|4
2951887|NCT01291173|10161147|P2|Overall Study|Withdrawal by Subject|4
2951888|NCT01291173|10161148|P1|Overall Study|Withdrawal by Subject|6
2951889|NCT01291173|10161145|P4|Overall Study|Protocol Violation|5
2951890|NCT01291173|10161146|P3|Overall Study|Protocol Violation|2
2951891|NCT01291173|10161147|P2|Overall Study|Protocol Violation|2
2951892|NCT01291173|10161148|P1|Overall Study|Protocol Violation|7
2951893|NCT01291173|10161145|P4|Overall Study|Adverse Event|3
2951894|NCT01291173|10161146|P3|Overall Study|Adverse Event|1
2951895|NCT01291173|10161147|P2|Overall Study|Adverse Event|3
2951896|NCT01291173|10161148|P1|Overall Study|Adverse Event|0
2951897|NCT01291017|10161257|P1|Overall Study|Withdrawal by Subject|3
2951898|NCT01291017|10161257|P1|Overall Study|Lost to Follow-up|2
2951899|NCT01290887|10161290|P2|Overall Study|Other|6
2951900|NCT01290887|10161291|P1|Overall Study|Other|3
2951901|NCT01290887|10161290|P2|Overall Study|Sponsor closure of study|476
2951902|NCT01290887|10161291|P1|Overall Study|Sponsor closure of study|420
2951903|NCT01290887|10161290|P2|Overall Study|Non-compliance to study medications|0
2951904|NCT01290887|10161291|P1|Overall Study|Non-compliance to study medications|1
2951905|NCT01290887|10161290|P2|Overall Study|Non-compliance to study procedures|1
2951906|NCT01290887|10161291|P1|Overall Study|Non-compliance to study procedures|0
2951907|NCT01290887|10161290|P2|Overall Study|Lost to Follow-up|4
2951908|NCT01290887|10161291|P1|Overall Study|Lost to Follow-up|4
2951909|NCT01290887|10161290|P2|Overall Study|Protocol Violation|1
2951910|NCT01290887|10161291|P1|Overall Study|Protocol Violation|2
2951911|NCT01290887|10161290|P2|Overall Study|Withdrawal by Subject|32
2951912|NCT01290887|10161291|P1|Overall Study|Withdrawal by Subject|26
2951913|NCT01290887|10161290|P2|Overall Study|Lack of Efficacy|5
2951914|NCT01290887|10161291|P1|Overall Study|Lack of Efficacy|4
2951915|NCT01290887|10161290|P2|Overall Study|Adverse Event|11
2951916|NCT01290887|10161291|P1|Overall Study|Adverse Event|6
2951917|NCT01290822|10161352|P1|Overall Study|Physician Decision|10
2951918|NCT01290822|10161352|P1|Overall Study|Withdrawal by Subject|1
2951919|NCT01290796|10161361|P1|Overall Study|Withdrawal by Sponsor|1
2951920|NCT01290796|10161361|P1|Overall Study|Secondary Surgical Intervention|2
2951921|NCT01290796|10161361|P1|Overall Study|Physician Decision|2
2951922|NCT01290796|10161361|P1|Overall Study|Withdrawal by Subject|4
2951923|NCT01290796|10161361|P1|Overall Study|Lost to Follow-up|21
2951924|NCT01290757|10161377|P2|Overall Study|Other|1
2951925|NCT01290757|10161378|P1|Overall Study|Other|0
2951926|NCT01290757|10161377|P2|Overall Study|Protocol Violation|1
2951927|NCT01290757|10161378|P1|Overall Study|Protocol Violation|1
2951928|NCT01290757|10161377|P2|Overall Study|Adverse Event|0
2951929|NCT01290757|10161378|P1|Overall Study|Adverse Event|1
2951930|NCT01290731|10161394|P1|Overall Study|Withdrawal by Subject|1
2951931|NCT01290718|10161406|P1|Overall Study|Early termination of the study|4
2951932|NCT01290679|10161415|P2|Overall Study|Subject Entered Another Trial|5
2951933|NCT01290679|10161416|P1|Overall Study|Subject Entered Another Trial|0
2951934|NCT01290679|10161415|P2|Overall Study|Withdrawal by Subject|5
2951935|NCT01290679|10161416|P1|Overall Study|Withdrawal by Subject|6
2951936|NCT01290679|10161415|P2|Overall Study|Protocol Violation|1
2951937|NCT01290679|10161416|P1|Overall Study|Protocol Violation|0
2951938|NCT01290679|10161415|P2|Overall Study|Lost to Follow-up|10
2951939|NCT01290679|10161416|P1|Overall Study|Lost to Follow-up|8
2951940|NCT01290679|10161415|P2|Overall Study|Adverse Event|0
2951941|NCT01290679|10161416|P1|Overall Study|Adverse Event|2
2951942|NCT01290666|10161485|P1|Overall Study|Early Termination of Study|4
2951943|NCT01290666|10161485|P1|Overall Study|Withdrawal by Subject|23
2951944|NCT01290666|10161485|P1|Overall Study|Lost to Follow-up|11
2951945|NCT01290601|10161538|P4|Overall Study|Protocol Violation|0
2951946|NCT01290601|10161539|P3|Overall Study|Protocol Violation|0
2951947|NCT01290601|10161540|P2|Overall Study|Protocol Violation|0
2951948|NCT01290601|10161541|P1|Overall Study|Protocol Violation|1
2951949|NCT01290601|10161538|P4|Overall Study|Other|0
2951950|NCT01290601|10161539|P3|Overall Study|Other|0
2951951|NCT01290601|10161540|P2|Overall Study|Other|0
2951952|NCT01290601|10161541|P1|Overall Study|Other|1
2951953|NCT01290601|10161538|P4|Overall Study|Lost to Follow-up|0
2951954|NCT01290601|10161539|P3|Overall Study|Lost to Follow-up|0
2951955|NCT01290601|10161540|P2|Overall Study|Lost to Follow-up|2
2951956|NCT01290601|10161541|P1|Overall Study|Lost to Follow-up|7
2951957|NCT01290601|10161538|P4|Overall Study|Lack of Efficacy|0
2951958|NCT01290601|10161539|P3|Overall Study|Lack of Efficacy|0
2951959|NCT01290601|10161540|P2|Overall Study|Lack of Efficacy|1
2951960|NCT01290601|10161541|P1|Overall Study|Lack of Efficacy|2
2951961|NCT01290601|10161538|P4|Overall Study|Adverse Event|0
2951962|NCT01290601|10161539|P3|Overall Study|Adverse Event|0
2951963|NCT01290601|10161540|P2|Overall Study|Adverse Event|2
2951964|NCT01290601|10161541|P1|Overall Study|Adverse Event|0
2951965|NCT01290523|10161562|P1|Overall Study|Death|3
2951966|NCT01290341|10161601|P2|Overall Study|Negative baseline culture and others|11
2951967|NCT01290341|10161602|P1|Overall Study|Negative baseline culture and others|44
2951968|NCT01290341|10161601|P2|Overall Study|Withdrawal by Subject|5
2951969|NCT01290341|10161602|P1|Overall Study|Withdrawal by Subject|19
2951970|NCT01290341|10161601|P2|Overall Study|Lost to Follow-up|10
2951971|NCT01290341|10161602|P1|Overall Study|Lost to Follow-up|21
2951972|NCT01290341|10161601|P2|Overall Study|Adverse Event|0
2951973|NCT01290341|10161602|P1|Overall Study|Adverse Event|1
2951974|NCT01290341|10161601|P2|Overall Study|Protocol Violation|3
2951975|NCT01290341|10161602|P1|Overall Study|Protocol Violation|7
2951976|NCT01290315|10161614|P4|Overall Study|Withdrawal by Subject|0
2951977|NCT01290315|10161615|P3|Overall Study|Withdrawal by Subject|0
2951978|NCT01290315|10161616|P2|Overall Study|Withdrawal by Subject|1
2951979|NCT01290315|10161617|P1|Overall Study|Withdrawal by Subject|1
2951980|NCT01290315|10161614|P4|Overall Study|Lost to Follow-up|0
2951981|NCT01290315|10161615|P3|Overall Study|Lost to Follow-up|0
2951982|NCT01290315|10161616|P2|Overall Study|Lost to Follow-up|1
2951983|NCT01290315|10161617|P1|Overall Study|Lost to Follow-up|0
2951984|NCT01290315|10161614|P4|Overall Study|Selection criteria/compliance|2
2951985|NCT01290315|10161615|P3|Overall Study|Selection criteria/compliance|0
2951986|NCT01290315|10161616|P2|Overall Study|Selection criteria/compliance|1
2951987|NCT01290315|10161617|P1|Overall Study|Selection criteria/compliance|2
2951988|NCT01290315|10161614|P4|Overall Study|Adverse Event|3
2951989|NCT01290315|10161615|P3|Overall Study|Adverse Event|0
2951990|NCT01290315|10161616|P2|Overall Study|Adverse Event|0
2951991|NCT01290315|10161617|P1|Overall Study|Adverse Event|0
2951992|NCT01290263|10161639|P5|Overall Study|Participant Non-Compliance|1
2951993|NCT01290263|10161640|P4|Overall Study|Participant Non-Compliance|1
2951994|NCT01290263|10161641|P3|Overall Study|Participant Non-Compliance|0
2951995|NCT01290263|10161642|P2|Overall Study|Participant Non-Compliance|0
2951996|NCT01290263|10161643|P1|Overall Study|Participant Non-Compliance|0
2951997|NCT01290263|10161639|P5|Overall Study|Withdrawal by Subject|2
2951998|NCT01290263|10161640|P4|Overall Study|Withdrawal by Subject|1
2951999|NCT01290263|10161641|P3|Overall Study|Withdrawal by Subject|0
2952000|NCT01290263|10161642|P2|Overall Study|Withdrawal by Subject|1
2952001|NCT01290263|10161643|P1|Overall Study|Withdrawal by Subject|3
2952002|NCT01290263|10161639|P5|Overall Study|Lack of Efficacy|33
2952003|NCT01290263|10161640|P4|Overall Study|Lack of Efficacy|24
2952004|NCT01290263|10161641|P3|Overall Study|Lack of Efficacy|7
2952005|NCT01290263|10161642|P2|Overall Study|Lack of Efficacy|2
2952006|NCT01290263|10161643|P1|Overall Study|Lack of Efficacy|8
2952007|NCT01290263|10161639|P5|Overall Study|Adverse Event|1
2952008|NCT01290263|10161640|P4|Overall Study|Adverse Event|1
2952009|NCT01290263|10161641|P3|Overall Study|Adverse Event|0
2952010|NCT01290263|10161642|P2|Overall Study|Adverse Event|0
2952011|NCT01290263|10161643|P1|Overall Study|Adverse Event|0
2952012|NCT01290224|10161670|P1|Overall Study|Refused Further Treatment|4
2952013|NCT01290224|10161670|P1|Overall Study|Adverse Event|1
2952014|NCT01290094|10161681|P1|Overall Study|Lost to Follow-up|5
2952015|NCT01290094|10161681|P1|Overall Study|Withdrawal by Subject|1
2952016|NCT01290068|10161694|P2|Overall Study|Other|1
2952017|NCT01290068|10161695|P1|Overall Study|Other|3
2952018|NCT01290068|10161694|P2|Overall Study|Withdrawal by subject prior to implant|2
2952019|NCT01290068|10161695|P1|Overall Study|Withdrawal by subject prior to implant|0
2952020|NCT01290068|10161694|P2|Overall Study|Lost to Follow-up|0
2952021|NCT01290068|10161695|P1|Overall Study|Lost to Follow-up|3
2952022|NCT01290068|10161694|P2|Overall Study|Adverse Event|3
2952023|NCT01290068|10161695|P1|Overall Study|Adverse Event|1
2952024|NCT01290029|10161707|P1|Overall Study|Other|2
2952025|NCT01289990|10161733|P13|Overall Study|Not treated|0
2952026|NCT01289990|10161734|P12|Overall Study|Not treated|2
2952027|NCT01289990|10161735|P11|Overall Study|Not treated|1
2952028|NCT01289990|10161736|P10|Overall Study|Not treated|0
2952029|NCT01289990|10161737|P9|Overall Study|Not treated|1
2952030|NCT01289990|10161738|P8|Overall Study|Not treated|0
2952031|NCT01289990|10161739|P7|Overall Study|Not treated|1
2952032|NCT01289990|10161740|P6|Overall Study|Not treated|0
2952033|NCT01289990|10161741|P5|Overall Study|Not treated|0
2952034|NCT01289990|10161742|P4|Overall Study|Not treated|0
2952035|NCT01289990|10161743|P3|Overall Study|Not treated|0
2952036|NCT01289990|10161744|P2|Overall Study|Not treated|0
2952037|NCT01289990|10161745|P1|Overall Study|Not treated|0
2952038|NCT01289990|10161733|P13|Overall Study|did not continue in extension|56
2952039|NCT01289990|10161734|P12|Overall Study|did not continue in extension|34
2952040|NCT01289990|10161735|P11|Overall Study|did not continue in extension|45
2952041|NCT01289990|10161736|P10|Overall Study|did not continue in extension|48
2952042|NCT01289990|10161737|P9|Overall Study|did not continue in extension|44
2952043|NCT01289990|10161738|P8|Overall Study|did not continue in extension|36
2952044|NCT01289990|10161739|P7|Overall Study|did not continue in extension|54
2952045|NCT01289990|10161740|P6|Overall Study|did not continue in extension|50
2952046|NCT01289990|10161741|P5|Overall Study|did not continue in extension|48
2952047|NCT01289990|10161742|P4|Overall Study|did not continue in extension|51
2952048|NCT01289990|10161743|P3|Overall Study|did not continue in extension|51
2952049|NCT01289990|10161744|P2|Overall Study|did not continue in extension|45
2952050|NCT01289990|10161745|P1|Overall Study|did not continue in extension|41
2952051|NCT01289990|10161733|P13|Overall Study|discontinued in preceding trial|24
2952052|NCT01289990|10161734|P12|Overall Study|discontinued in preceding trial|17
2952053|NCT01289990|10161735|P11|Overall Study|discontinued in preceding trial|17
2952054|NCT01289990|10161736|P10|Overall Study|discontinued in preceding trial|21
2952055|NCT01289990|10161737|P9|Overall Study|discontinued in preceding trial|17
2952056|NCT01289990|10161738|P8|Overall Study|discontinued in preceding trial|8
2952057|NCT01289990|10161739|P7|Overall Study|discontinued in preceding trial|18
2952058|NCT01289990|10161740|P6|Overall Study|discontinued in preceding trial|12
2952059|NCT01289990|10161741|P5|Overall Study|discontinued in preceding trial|11
2952060|NCT01289990|10161742|P4|Overall Study|discontinued in preceding trial|17
2952061|NCT01289990|10161743|P3|Overall Study|discontinued in preceding trial|41
2952062|NCT01289990|10161744|P2|Overall Study|discontinued in preceding trial|20
2952063|NCT01289990|10161745|P1|Overall Study|discontinued in preceding trial|18
2952064|NCT01289990|10161733|P13|Overall Study|Withdrawal by Subject|16
2952065|NCT01289990|10161734|P12|Overall Study|Withdrawal by Subject|13
2952066|NCT01289990|10161735|P11|Overall Study|Withdrawal by Subject|11
2952067|NCT01289990|10161736|P10|Overall Study|Withdrawal by Subject|13
2952068|NCT01289990|10161737|P9|Overall Study|Withdrawal by Subject|12
2952069|NCT01289990|10161738|P8|Overall Study|Withdrawal by Subject|9
2952070|NCT01289990|10161739|P7|Overall Study|Withdrawal by Subject|13
2952071|NCT01289990|10161740|P6|Overall Study|Withdrawal by Subject|7
2952072|NCT01289990|10161741|P5|Overall Study|Withdrawal by Subject|8
2952073|NCT01289990|10161742|P4|Overall Study|Withdrawal by Subject|13
2952074|NCT01289990|10161743|P3|Overall Study|Withdrawal by Subject|12
2952075|NCT01289990|10161744|P2|Overall Study|Withdrawal by Subject|14
2952076|NCT01289990|10161745|P1|Overall Study|Withdrawal by Subject|15
2952077|NCT01289990|10161733|P13|Overall Study|Lost to Follow-up|2
2952078|NCT01289990|10161734|P12|Overall Study|Lost to Follow-up|1
2952079|NCT01289990|10161735|P11|Overall Study|Lost to Follow-up|2
2952080|NCT01289990|10161736|P10|Overall Study|Lost to Follow-up|4
2952081|NCT01289990|10161737|P9|Overall Study|Lost to Follow-up|1
2952082|NCT01289990|10161738|P8|Overall Study|Lost to Follow-up|2
2952083|NCT01289990|10161739|P7|Overall Study|Lost to Follow-up|2
2952084|NCT01289990|10161740|P6|Overall Study|Lost to Follow-up|4
2952085|NCT01289990|10161741|P5|Overall Study|Lost to Follow-up|3
2952086|NCT01289990|10161742|P4|Overall Study|Lost to Follow-up|5
2952087|NCT01289990|10161743|P3|Overall Study|Lost to Follow-up|5
2952088|NCT01289990|10161744|P2|Overall Study|Lost to Follow-up|2
2952089|NCT01289990|10161745|P1|Overall Study|Lost to Follow-up|3
2952090|NCT01289990|10161733|P13|Overall Study|Death|0
2952091|NCT01289990|10161734|P12|Overall Study|Death|1
2952092|NCT01289990|10161735|P11|Overall Study|Death|0
2952093|NCT01289990|10161736|P10|Overall Study|Death|0
2952094|NCT01289990|10161737|P9|Overall Study|Death|0
2952095|NCT01289990|10161738|P8|Overall Study|Death|0
2952096|NCT01289990|10161739|P7|Overall Study|Death|0
2952097|NCT01289990|10161740|P6|Overall Study|Death|1
2952098|NCT01289990|10161741|P5|Overall Study|Death|2
2952099|NCT01289990|10161742|P4|Overall Study|Death|1
2952100|NCT01289990|10161743|P3|Overall Study|Death|0
2952101|NCT01289990|10161744|P2|Overall Study|Death|0
2952102|NCT01289990|10161745|P1|Overall Study|Death|0
2952191|NCT01289119|10162246|P1|Overall Study|Adverse Event|2
2952103|NCT01289847|10161962|P1|Overall Study|Patient could not comply with visits|1
2952104|NCT01289821|10161971|P1|Survival Follow-up Period|Clinical endpoint reached|16
2952105|NCT01289821|10161971|P1|Survival Follow-up Period|Lost to Follow-up|1
2952106|NCT01289821|10161971|P1|Survival Follow-up Period|Protocol Violation|1
2952107|NCT01289821|10161971|P1|Safety Follow-up Period|Unspecified reason|1
2952108|NCT01289821|10161971|P1|Safety Follow-up Period|Protocol Violation|3
2952109|NCT01289821|10161971|P1|Safety Follow-up Period|Withdrawal by Subject|1
2952110|NCT01289821|10161971|P1|Treatment Period|Therapeutic procedure required|1
2952111|NCT01289821|10161971|P1|Treatment Period|Clinical Progression|2
2952112|NCT01289821|10161971|P1|Treatment Period|Radiological Progression|43
2952113|NCT01289821|10161971|P1|Treatment Period|Adverse Event|4
2952114|NCT01289821|10161971|P1|Treatment Period|Physician Decision|3
2952115|NCT01289821|10161971|P1|Treatment Period|Withdrawal by Subject|1
2952116|NCT01289782|10161982|P2|Overall Study|Reason not specified|2
2952117|NCT01289782|10161983|P1|Overall Study|Reason not specified|1
2952118|NCT01289782|10161982|P2|Overall Study|Sponsor's Decision|0
2952119|NCT01289782|10161983|P1|Overall Study|Sponsor's Decision|1
2952120|NCT01289782|10161982|P2|Overall Study|Withdrawal by Subject|2
2952121|NCT01289782|10161983|P1|Overall Study|Withdrawal by Subject|8
2952122|NCT01289782|10161982|P2|Overall Study|Protocol Violation|1
2952123|NCT01289782|10161983|P1|Overall Study|Protocol Violation|1
2952124|NCT01289782|10161982|P2|Overall Study|Lost to Follow-up|7
2952125|NCT01289782|10161983|P1|Overall Study|Lost to Follow-up|14
2952126|NCT01289678|10162052|P1|Overall Study|Physician Decision|6
2952127|NCT01289639|10162059|P3|Overall Study|Lost to Follow-up|0
2952128|NCT01289639|10162060|P2|Overall Study|Lost to Follow-up|0
2952129|NCT01289639|10162061|P1|Overall Study|Lost to Follow-up|1
2952130|NCT01289574|10162087|P3|Overall Study|Subject wanted alternate treatment|0
2952131|NCT01289574|10162088|P2|Overall Study|Subject wanted alternate treatment|1
2952132|NCT01289574|10162089|P1|Overall Study|Subject wanted alternate treatment|0
2952133|NCT01289574|10162087|P3|Overall Study|Adverse Event|0
2952134|NCT01289574|10162088|P2|Overall Study|Adverse Event|1
2952135|NCT01289574|10162089|P1|Overall Study|Adverse Event|0
2952136|NCT01289574|10162087|P3|Overall Study|Withdrawal by Subject|1
2952137|NCT01289574|10162088|P2|Overall Study|Withdrawal by Subject|1
2952138|NCT01289574|10162089|P1|Overall Study|Withdrawal by Subject|1
2952139|NCT01289574|10162087|P3|Overall Study|Lost to Follow-up|1
2952140|NCT01289574|10162088|P2|Overall Study|Lost to Follow-up|0
2952141|NCT01289574|10162089|P1|Overall Study|Lost to Follow-up|2
2952142|NCT01289574|10162087|P3|Overall Study|Lack of Efficacy|1
2952143|NCT01289574|10162088|P2|Overall Study|Lack of Efficacy|0
2952144|NCT01289574|10162089|P1|Overall Study|Lack of Efficacy|4
2952145|NCT01289418|10162183|P1|Day 29 Survey|participants did not complete the survey|2185
2952146|NCT01289418|10162183|P1|Day 29 Survey|email address invalid|283
2952147|NCT01289418|10162183|P1|Day 8 Survey|participants did not complete the survey|1935
2952148|NCT01289418|10162183|P1|Day 8 Survey|email address invalid|283
2952149|NCT01289210|10162231|P1|Overall Study|Adverse Event|1
2952150|NCT01289119|10162241|P6|Overall Study|Other|0
2952151|NCT01289119|10162242|P5|Overall Study|Other|0
2952152|NCT01289119|10162243|P4|Overall Study|Other|0
2952153|NCT01289119|10162244|P3|Overall Study|Other|1
2952154|NCT01289119|10162245|P2|Overall Study|Other|0
2952155|NCT01289119|10162246|P1|Overall Study|Other|1
2952156|NCT01289119|10162241|P6|Overall Study|Lack of Efficacy|1
2952157|NCT01289119|10162242|P5|Overall Study|Lack of Efficacy|1
2952158|NCT01289119|10162243|P4|Overall Study|Lack of Efficacy|1
2952159|NCT01289119|10162244|P3|Overall Study|Lack of Efficacy|1
2952160|NCT01289119|10162245|P2|Overall Study|Lack of Efficacy|1
2952161|NCT01289119|10162246|P1|Overall Study|Lack of Efficacy|0
2952162|NCT01289119|10162241|P6|Overall Study|Pregnancy|0
2952163|NCT01289119|10162242|P5|Overall Study|Pregnancy|0
2952164|NCT01289119|10162243|P4|Overall Study|Pregnancy|0
2952165|NCT01289119|10162244|P3|Overall Study|Pregnancy|0
2952166|NCT01289119|10162245|P2|Overall Study|Pregnancy|1
2952167|NCT01289119|10162246|P1|Overall Study|Pregnancy|0
2952168|NCT01289119|10162241|P6|Overall Study|Withdrawal by Subject|1
2952169|NCT01289119|10162242|P5|Overall Study|Withdrawal by Subject|1
2952170|NCT01289119|10162243|P4|Overall Study|Withdrawal by Subject|3
2952171|NCT01289119|10162244|P3|Overall Study|Withdrawal by Subject|4
2952172|NCT01289119|10162245|P2|Overall Study|Withdrawal by Subject|2
2952173|NCT01289119|10162246|P1|Overall Study|Withdrawal by Subject|4
2952174|NCT01289119|10162241|P6|Overall Study|Lost to Follow-up|1
2952175|NCT01289119|10162242|P5|Overall Study|Lost to Follow-up|0
2952176|NCT01289119|10162243|P4|Overall Study|Lost to Follow-up|0
2952177|NCT01289119|10162244|P3|Overall Study|Lost to Follow-up|0
2952178|NCT01289119|10162245|P2|Overall Study|Lost to Follow-up|3
2952179|NCT01289119|10162246|P1|Overall Study|Lost to Follow-up|0
2952180|NCT01289119|10162241|P6|Overall Study|Major Protocol Deviation|1
2952181|NCT01289119|10162242|P5|Overall Study|Major Protocol Deviation|2
2952182|NCT01289119|10162243|P4|Overall Study|Major Protocol Deviation|0
2952183|NCT01289119|10162244|P3|Overall Study|Major Protocol Deviation|3
2952184|NCT01289119|10162245|P2|Overall Study|Major Protocol Deviation|1
2952185|NCT01289119|10162246|P1|Overall Study|Major Protocol Deviation|2
2952186|NCT01289119|10162241|P6|Overall Study|Adverse Event|0
2952187|NCT01289119|10162242|P5|Overall Study|Adverse Event|1
2952188|NCT01289119|10162243|P4|Overall Study|Adverse Event|2
2952189|NCT01289119|10162244|P3|Overall Study|Adverse Event|0
2952190|NCT01289119|10162245|P2|Overall Study|Adverse Event|1
2952192|NCT01289041|10162367|P1|Overall Study|Death|1
2952193|NCT01289041|10162367|P1|Overall Study|Withdrawal by Subject|3
2952194|NCT01289041|10162367|P1|Overall Study|Progressive Disease|41
2952195|NCT01289041|10162367|P1|Overall Study|Physician Decision|1
2952196|NCT01289041|10162367|P1|Overall Study|Adverse Event|24
2952197|NCT01289028|10162379|P1|Overall Study|Missing reason for discon|1
2952198|NCT01289028|10162379|P1|Overall Study|Abnormal Lab Value|1
2952199|NCT01289028|10162379|P1|Overall Study|New Cancer Therapy|2
2952200|NCT01289028|10162379|P1|Overall Study|Lost to Follow-up|2
2952201|NCT01289028|10162379|P1|Overall Study|No longer required|2
2952202|NCT01289028|10162379|P1|Overall Study|Lack of Efficacy|2
2952203|NCT01289028|10162379|P1|Overall Study|Death|4
2952204|NCT01289028|10162379|P1|Overall Study|Withdrawal by Subject|6
2952205|NCT01289028|10162379|P1|Overall Study|Adverse Event|14
2952206|NCT01289028|10162379|P1|Overall Study|Progressive Disease|49
2952207|NCT01289015|10162393|P2|Overall Study|Negative baseline culture and others|20
2952208|NCT01289015|10162394|P1|Overall Study|Negative baseline culture and others|33
2952209|NCT01289015|10162393|P2|Overall Study|Disease progression|0
2952210|NCT01289015|10162394|P1|Overall Study|Disease progression|1
2952211|NCT01289015|10162393|P2|Overall Study|Withdrawal by Subject|8
2952212|NCT01289015|10162394|P1|Overall Study|Withdrawal by Subject|17
2952213|NCT01289015|10162393|P2|Overall Study|Lost to Follow-up|17
2952214|NCT01289015|10162394|P1|Overall Study|Lost to Follow-up|33
2952215|NCT01289015|10162393|P2|Overall Study|Adverse Event|0
2952216|NCT01289015|10162394|P1|Overall Study|Adverse Event|3
2952217|NCT01289015|10162393|P2|Overall Study|Protocol Violation|9
2952218|NCT01289015|10162394|P1|Overall Study|Protocol Violation|12
2952219|NCT01288989|10162407|P5|Overall Study|Withdrawal by Subject|3
2952220|NCT01288989|10162408|P4|Overall Study|Withdrawal by Subject|0
2952221|NCT01288989|10162409|P3|Overall Study|Withdrawal by Subject|0
2952222|NCT01288989|10162410|P2|Overall Study|Withdrawal by Subject|0
2952223|NCT01288989|10162411|P1|Overall Study|Withdrawal by Subject|0
2952224|NCT01288989|10162407|P5|Overall Study|Physician Decision|1
2952225|NCT01288989|10162408|P4|Overall Study|Physician Decision|0
2952226|NCT01288989|10162409|P3|Overall Study|Physician Decision|0
2952227|NCT01288989|10162410|P2|Overall Study|Physician Decision|0
2952228|NCT01288989|10162411|P1|Overall Study|Physician Decision|0
2952229|NCT01288989|10162407|P5|Overall Study|Adverse Event|2
2952230|NCT01288989|10162408|P4|Overall Study|Adverse Event|0
2952231|NCT01288989|10162409|P3|Overall Study|Adverse Event|0
2952232|NCT01288989|10162410|P2|Overall Study|Adverse Event|0
2952233|NCT01288989|10162411|P1|Overall Study|Adverse Event|0
2952234|NCT01288989|10162407|P5|Overall Study|Dose limiting toxicity|0
2952235|NCT01288989|10162408|P4|Overall Study|Dose limiting toxicity|0
2952236|NCT01288989|10162409|P3|Overall Study|Dose limiting toxicity|0
2952237|NCT01288989|10162410|P2|Overall Study|Dose limiting toxicity|0
2952238|NCT01288989|10162411|P1|Overall Study|Dose limiting toxicity|1
2952239|NCT01288989|10162407|P5|Overall Study|Death|0
2952240|NCT01288989|10162408|P4|Overall Study|Death|1
2952241|NCT01288989|10162409|P3|Overall Study|Death|0
2952242|NCT01288989|10162410|P2|Overall Study|Death|0
2952243|NCT01288989|10162411|P1|Overall Study|Death|0
2952244|NCT01288976|10162472|P3|Overall Study|Data unavailable|7
2952245|NCT01288976|10162473|P2|Overall Study|Data unavailable|9
2952246|NCT01288976|10162474|P1|Overall Study|Data unavailable|22
2952247|NCT01288976|10162472|P3|Overall Study|Death|4
2952248|NCT01288976|10162473|P2|Overall Study|Death|6
2952249|NCT01288976|10162474|P1|Overall Study|Death|98
2952250|NCT01288976|10162472|P3|Overall Study|Withdrawal by Subject|9
2952251|NCT01288976|10162473|P2|Overall Study|Withdrawal by Subject|12
2952252|NCT01288976|10162474|P1|Overall Study|Withdrawal by Subject|58
2952253|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
2952254|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
2952255|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
2952256|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
2952257|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
2952258|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
2952259|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
2952260|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
2952261|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
2952262|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
2952263|NCT01288911|10162503|P2|Open-label Period (All Enzalutamide)|Death|1
2952264|NCT01288911|10162504|P1|Open-label Period (All Enzalutamide)|Death|0
2952265|NCT01288911|10162503|P2|Double-blind Period|Randomized but never received study drug|2
2952266|NCT01288911|10162504|P1|Double-blind Period|Randomized but never received study drug|1
2952267|NCT01288911|10162503|P2|Double-blind Period|Miscellaneous Reason|42
2952268|NCT01288911|10162504|P1|Double-blind Period|Miscellaneous Reason|29
2952269|NCT01288911|10162503|P2|Double-blind Period|Withdrawal by Subject|26
2952270|NCT01288911|10162504|P1|Double-blind Period|Withdrawal by Subject|25
2952271|NCT01288911|10162503|P2|Double-blind Period|Protocol Violation|0
2952272|NCT01288911|10162504|P1|Double-blind Period|Protocol Violation|1
2952273|NCT01288911|10162503|P2|Double-blind Period|Progressive Disease|103
2952274|NCT01288911|10162504|P1|Double-blind Period|Progressive Disease|75
2952275|NCT01288911|10162503|P2|Double-blind Period|Lost to Follow-up|2
2952276|NCT01288911|10162504|P1|Double-blind Period|Lost to Follow-up|0
2952277|NCT01288911|10162503|P2|Double-blind Period|Death|7
2952278|NCT01288911|10162504|P1|Double-blind Period|Death|11
2952279|NCT01288729|10162614|P2|Overall Study|Withdrawal by Subject|0
2952280|NCT01288729|10162615|P1|Overall Study|Withdrawal by Subject|1
2952281|NCT01288612|10162624|P3|Overall Study|Unable to intubate|0
2952282|NCT01288612|10162625|P2|Overall Study|Unable to intubate|3
2952283|NCT01288612|10162626|P1|Overall Study|Unable to intubate|0
2952284|NCT01288612|10162624|P3|Overall Study|Declined|62
2952285|NCT01288612|10162625|P2|Overall Study|Declined|63
2952286|NCT01288612|10162626|P1|Overall Study|Declined|78
2952287|NCT01288612|10162624|P3|Overall Study|Unable to contact|20
2952288|NCT01288612|10162625|P2|Overall Study|Unable to contact|16
2952289|NCT01288612|10162626|P1|Overall Study|Unable to contact|11
2952290|NCT01288469|10162675|P3|Overall Study|Exclusion criteria finally met|0
2952291|NCT01288469|10162676|P2|Overall Study|Exclusion criteria finally met|0
2952292|NCT01288469|10162677|P1|Overall Study|Exclusion criteria finally met|1
2952293|NCT01288469|10162675|P3|Overall Study|Consent withdrawn by subject|1
2952294|NCT01288469|10162676|P2|Overall Study|Consent withdrawn by subject|1
2952295|NCT01288469|10162677|P1|Overall Study|Consent withdrawn by subject|1
2952296|NCT01288469|10162675|P3|Overall Study|Participant Moved|0
2952297|NCT01288469|10162676|P2|Overall Study|Participant Moved|0
2952298|NCT01288469|10162677|P1|Overall Study|Participant Moved|1
2952299|NCT01288469|10162675|P3|Overall Study|Poor compliance to protocol|0
2952300|NCT01288469|10162676|P2|Overall Study|Poor compliance to protocol|1
2952301|NCT01288469|10162677|P1|Overall Study|Poor compliance to protocol|0
2952302|NCT01288469|10162675|P3|Overall Study|Adverse Event|1
2952303|NCT01288469|10162676|P2|Overall Study|Adverse Event|1
2952304|NCT01288469|10162677|P1|Overall Study|Adverse Event|4
2952305|NCT01288443|10162709|P6|Overall Study|Other than above|0
2952306|NCT01288443|10162710|P5|Overall Study|Other than above|1
2952307|NCT01288443|10162711|P4|Overall Study|Other than above|2
2952308|NCT01288443|10162712|P3|Overall Study|Other than above|0
2952309|NCT01288443|10162713|P2|Overall Study|Other than above|0
2952310|NCT01288443|10162714|P1|Overall Study|Other than above|0
2952311|NCT01288443|10162709|P6|Overall Study|Study drug auto-injector administration|1
2952312|NCT01288443|10162710|P5|Overall Study|Study drug auto-injector administration|1
2952313|NCT01288443|10162711|P4|Overall Study|Study drug auto-injector administration|0
2952314|NCT01288443|10162712|P3|Overall Study|Study drug auto-injector administration|0
2952315|NCT01288443|10162713|P2|Overall Study|Study drug auto-injector administration|0
2952316|NCT01288443|10162714|P1|Overall Study|Study drug auto-injector administration|0
2952317|NCT01288443|10162709|P6|Overall Study|Lost to Follow-up|0
2952318|NCT01288443|10162710|P5|Overall Study|Lost to Follow-up|0
2952319|NCT01288443|10162711|P4|Overall Study|Lost to Follow-up|0
2952320|NCT01288443|10162712|P3|Overall Study|Lost to Follow-up|0
2952321|NCT01288443|10162713|P2|Overall Study|Lost to Follow-up|1
2952322|NCT01288443|10162714|P1|Overall Study|Lost to Follow-up|0
2952323|NCT01288443|10162709|P6|Overall Study|Consent withdrawn by Participant|1
2952324|NCT01288443|10162710|P5|Overall Study|Consent withdrawn by Participant|0
2952325|NCT01288443|10162711|P4|Overall Study|Consent withdrawn by Participant|0
2952326|NCT01288443|10162712|P3|Overall Study|Consent withdrawn by Participant|0
2952327|NCT01288443|10162713|P2|Overall Study|Consent withdrawn by Participant|0
2952328|NCT01288443|10162714|P1|Overall Study|Consent withdrawn by Participant|0
2952329|NCT01288443|10162709|P6|Overall Study|Participant Moved|1
2952330|NCT01288443|10162710|P5|Overall Study|Participant Moved|2
2952331|NCT01288443|10162711|P4|Overall Study|Participant Moved|1
2952332|NCT01288443|10162712|P3|Overall Study|Participant Moved|0
2952333|NCT01288443|10162713|P2|Overall Study|Participant Moved|0
2952334|NCT01288443|10162714|P1|Overall Study|Participant Moved|0
2952335|NCT01288443|10162709|P6|Overall Study|Poor compliance to protocol|1
2952336|NCT01288443|10162710|P5|Overall Study|Poor compliance to protocol|0
2952337|NCT01288443|10162711|P4|Overall Study|Poor compliance to protocol|0
2952338|NCT01288443|10162712|P3|Overall Study|Poor compliance to protocol|0
2952339|NCT01288443|10162713|P2|Overall Study|Poor compliance to protocol|0
2952340|NCT01288443|10162714|P1|Overall Study|Poor compliance to protocol|0
2952341|NCT01288443|10162709|P6|Overall Study|Adverse Event|1
2952342|NCT01288443|10162710|P5|Overall Study|Adverse Event|3
2952343|NCT01288443|10162711|P4|Overall Study|Adverse Event|1
2952344|NCT01288443|10162712|P3|Overall Study|Adverse Event|1
2952345|NCT01288443|10162713|P2|Overall Study|Adverse Event|0
2952346|NCT01288443|10162714|P1|Overall Study|Adverse Event|0
2952347|NCT01288287|10162764|P1|Overall Study|Unknown Status|7
2952348|NCT01288287|10162764|P1|Overall Study|Unknown Reason|1
2952349|NCT01288287|10162764|P1|Overall Study|Other Reason|13
2952350|NCT01288287|10162764|P1|Overall Study|Lack of Efficacy|13
2952351|NCT01288287|10162764|P1|Overall Study|Withdrawal by Subject|4
2952352|NCT01288287|10162764|P1|Overall Study|Lost to Follow-up|8
2952353|NCT01288209|10162779|P2|Overall Study|Other|0
2952354|NCT01288209|10162780|P1|Overall Study|Other|1
2952355|NCT01288209|10162779|P2|Overall Study|Withdrawal by Subject|3
2952356|NCT01288209|10162780|P1|Overall Study|Withdrawal by Subject|1
2952357|NCT01288079|10162810|P4|Overall Study|Other or Study Termination|8
2952358|NCT01288079|10162811|P3|Overall Study|Other or Study Termination|14
2952359|NCT01288079|10162812|P2|Overall Study|Other or Study Termination|15
2952360|NCT01288079|10162813|P1|Overall Study|Other or Study Termination|11
2952361|NCT01288079|10162810|P4|Overall Study|Lost to Follow-up|0
2952362|NCT01288079|10162811|P3|Overall Study|Lost to Follow-up|1
2952363|NCT01288079|10162812|P2|Overall Study|Lost to Follow-up|1
2952364|NCT01288079|10162813|P1|Overall Study|Lost to Follow-up|1
2952365|NCT01288079|10162810|P4|Overall Study|Study-Specific Withdrawal Criteria|0
2952366|NCT01288079|10162811|P3|Overall Study|Study-Specific Withdrawal Criteria|0
2952367|NCT01288079|10162812|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2952368|NCT01288079|10162813|P1|Overall Study|Study-Specific Withdrawal Criteria|1
2952369|NCT01288079|10162810|P4|Overall Study|Lack of Efficacy|2
2952370|NCT01288079|10162811|P3|Overall Study|Lack of Efficacy|0
2952371|NCT01288079|10162812|P2|Overall Study|Lack of Efficacy|2
2952372|NCT01288079|10162813|P1|Overall Study|Lack of Efficacy|2
2952373|NCT01288079|10162810|P4|Overall Study|Condition under Investigation Worsened|1
2952374|NCT01288079|10162811|P3|Overall Study|Condition under Investigation Worsened|0
2952375|NCT01288079|10162812|P2|Overall Study|Condition under Investigation Worsened|0
2952376|NCT01288079|10162813|P1|Overall Study|Condition under Investigation Worsened|0
2952377|NCT01288079|10162810|P4|Overall Study|Severe Non-Compliance to Protocol|3
2952378|NCT01288079|10162811|P3|Overall Study|Severe Non-Compliance to Protocol|1
2952379|NCT01288079|10162812|P2|Overall Study|Severe Non-Compliance to Protocol|3
2952380|NCT01288079|10162813|P1|Overall Study|Severe Non-Compliance to Protocol|1
2952381|NCT01288079|10162810|P4|Overall Study|Adverse Event|3
2952382|NCT01288079|10162811|P3|Overall Study|Adverse Event|2
2952383|NCT01288079|10162812|P2|Overall Study|Adverse Event|1
2952384|NCT01288079|10162813|P1|Overall Study|Adverse Event|2
2952385|NCT01288079|10162810|P4|Overall Study|Withdrawal by Subject|0
2952386|NCT01288079|10162811|P3|Overall Study|Withdrawal by Subject|1
2952387|NCT01288079|10162812|P2|Overall Study|Withdrawal by Subject|4
2952388|NCT01288079|10162813|P1|Overall Study|Withdrawal by Subject|2
2952389|NCT01288053|10162823|P1|Overall Study|Death|1
2952390|NCT01287897|10162841|P4|Overall Study|Other|0
2952391|NCT01287897|10162842|P3|Overall Study|Other|1
2952392|NCT01287897|10162843|P2|Overall Study|Other|0
2952393|NCT01287897|10162844|P1|Overall Study|Other|1
2952394|NCT01287897|10162841|P4|Overall Study|Not meeting entrance criteria|0
2952395|NCT01287897|10162842|P3|Overall Study|Not meeting entrance criteria|0
2952396|NCT01287897|10162843|P2|Overall Study|Not meeting entrance criteria|1
2952397|NCT01287897|10162844|P1|Overall Study|Not meeting entrance criteria|1
2952398|NCT01287897|10162841|P4|Overall Study|Not consented properly|0
2952399|NCT01287897|10162842|P3|Overall Study|Not consented properly|0
2952400|NCT01287897|10162843|P2|Overall Study|Not consented properly|1
2952401|NCT01287897|10162844|P1|Overall Study|Not consented properly|0
2952402|NCT01287897|10162841|P4|Overall Study|Withdrawal by Subject|2
2952403|NCT01287897|10162842|P3|Overall Study|Withdrawal by Subject|3
2952404|NCT01287897|10162843|P2|Overall Study|Withdrawal by Subject|5
2952405|NCT01287897|10162844|P1|Overall Study|Withdrawal by Subject|1
2952406|NCT01287897|10162841|P4|Overall Study|Lost to Follow-up|0
2952407|NCT01287897|10162842|P3|Overall Study|Lost to Follow-up|2
2952408|NCT01287897|10162843|P2|Overall Study|Lost to Follow-up|0
2952409|NCT01287897|10162844|P1|Overall Study|Lost to Follow-up|0
2952410|NCT01287897|10162841|P4|Overall Study|Protocol Violation|1
2952411|NCT01287897|10162842|P3|Overall Study|Protocol Violation|0
2952412|NCT01287897|10162843|P2|Overall Study|Protocol Violation|1
2952413|NCT01287897|10162844|P1|Overall Study|Protocol Violation|1
2952414|NCT01287897|10162841|P4|Overall Study|Lack of Efficacy|0
2952415|NCT01287897|10162842|P3|Overall Study|Lack of Efficacy|0
2952416|NCT01287897|10162843|P2|Overall Study|Lack of Efficacy|0
2952417|NCT01287897|10162844|P1|Overall Study|Lack of Efficacy|2
2952418|NCT01287897|10162841|P4|Overall Study|Adverse Event|4
2952419|NCT01287897|10162842|P3|Overall Study|Adverse Event|6
2952420|NCT01287897|10162843|P2|Overall Study|Adverse Event|3
2952421|NCT01287897|10162844|P1|Overall Study|Adverse Event|5
2952422|NCT01287832|10162895|P2|Overall Study|Death|1
2952423|NCT01287832|10162896|P1|Overall Study|Death|0
2952424|NCT01287832|10162895|P2|Overall Study|Adverse Event|0
2952425|NCT01287832|10162896|P1|Overall Study|Adverse Event|1
2952426|NCT01287754|10162904|P2|Overall Study|Protocol Violation|3
2952427|NCT01287754|10162905|P1|Overall Study|Protocol Violation|0
2952428|NCT01287754|10162904|P2|Overall Study|Lost to Follow-up|6
2952429|NCT01287754|10162905|P1|Overall Study|Lost to Follow-up|1
2952430|NCT01287754|10162904|P2|Overall Study|Death|12
2952431|NCT01287754|10162905|P1|Overall Study|Death|2
2952432|NCT01287741|10162917|P2|Overall Study|Reason not specified|9
2952433|NCT01287741|10162918|P1|Overall Study|Reason not specified|23
2952434|NCT01287741|10162917|P2|Overall Study|Progressive disease|166
2952435|NCT01287741|10162918|P1|Overall Study|Progressive disease|190
2952436|NCT01287741|10162917|P2|Overall Study|Study terminated by Sponsor|315
2952437|NCT01287741|10162918|P1|Overall Study|Study terminated by Sponsor|307
2952438|NCT01287741|10162917|P2|Overall Study|Adverse Event|6
2952439|NCT01287741|10162918|P1|Overall Study|Adverse Event|4
2952440|NCT01287741|10162917|P2|Overall Study|Death|44
2952441|NCT01287741|10162918|P1|Overall Study|Death|32
2952442|NCT01287741|10162917|P2|Overall Study|Lost to Follow-up|8
2952443|NCT01287741|10162918|P1|Overall Study|Lost to Follow-up|10
2952444|NCT01287741|10162917|P2|Overall Study|Non-compliance|6
2952445|NCT01287741|10162918|P1|Overall Study|Non-compliance|8
2952446|NCT01287741|10162917|P2|Overall Study|Physician Decision|23
2952447|NCT01287741|10162918|P1|Overall Study|Physician Decision|15
2952448|NCT01287741|10162917|P2|Overall Study|Protocol Violation|0
2952449|NCT01287741|10162918|P1|Overall Study|Protocol Violation|2
2952450|NCT01287741|10162917|P2|Overall Study|Withdrawal by Subject|38
2952451|NCT01287741|10162918|P1|Overall Study|Withdrawal by Subject|35
2952452|NCT01287611|10162954|P2|Overall Study|Exclusion due to expanded Kerr incision|3
2952453|NCT01287611|10162955|P1|Overall Study|Exclusion due to expanded Kerr incision|4
2952454|NCT01287611|10162954|P2|Overall Study|Lost to Follow-up|16
2952455|NCT01287611|10162955|P1|Overall Study|Lost to Follow-up|29
2952456|NCT01287520|10162972|P9|Overall Study|Withdrawal by Subject|1
2952457|NCT01287520|10162973|P8|Overall Study|Withdrawal by Subject|0
2952458|NCT01287520|10162974|P7|Overall Study|Withdrawal by Subject|0
2952459|NCT01287520|10162975|P6|Overall Study|Withdrawal by Subject|1
2952460|NCT01287520|10162976|P5|Overall Study|Withdrawal by Subject|0
2952461|NCT01287520|10162977|P4|Overall Study|Withdrawal by Subject|0
2952462|NCT01287520|10162978|P3|Overall Study|Withdrawal by Subject|0
2952463|NCT01287520|10162979|P2|Overall Study|Withdrawal by Subject|0
2952464|NCT01287520|10162980|P1|Overall Study|Withdrawal by Subject|0
2952465|NCT01287520|10162972|P9|Overall Study|Progressive disease|4
2952466|NCT01287520|10162973|P8|Overall Study|Progressive disease|2
2952467|NCT01287520|10162974|P7|Overall Study|Progressive disease|2
2952468|NCT01287520|10162975|P6|Overall Study|Progressive disease|0
2952469|NCT01287520|10162976|P5|Overall Study|Progressive disease|1
2952470|NCT01287520|10162977|P4|Overall Study|Progressive disease|6
2952471|NCT01287520|10162978|P3|Overall Study|Progressive disease|1
2952472|NCT01287520|10162979|P2|Overall Study|Progressive disease|4
2952473|NCT01287520|10162980|P1|Overall Study|Progressive disease|0
2952474|NCT01287520|10162972|P9|Overall Study|Physician Decision|0
2952475|NCT01287520|10162973|P8|Overall Study|Physician Decision|1
2952476|NCT01287520|10162974|P7|Overall Study|Physician Decision|0
2952477|NCT01287520|10162975|P6|Overall Study|Physician Decision|1
2952478|NCT01287520|10162976|P5|Overall Study|Physician Decision|1
2952479|NCT01287520|10162977|P4|Overall Study|Physician Decision|0
2952480|NCT01287520|10162978|P3|Overall Study|Physician Decision|2
2952481|NCT01287520|10162979|P2|Overall Study|Physician Decision|1
2952482|NCT01287520|10162980|P1|Overall Study|Physician Decision|1
2952483|NCT01287520|10162972|P9|Overall Study|Adverse Event|0
2952484|NCT01287520|10162973|P8|Overall Study|Adverse Event|2
2952485|NCT01287520|10162974|P7|Overall Study|Adverse Event|0
2952486|NCT01287520|10162975|P6|Overall Study|Adverse Event|2
2952487|NCT01287520|10162976|P5|Overall Study|Adverse Event|1
2952488|NCT01287520|10162977|P4|Overall Study|Adverse Event|1
2952489|NCT01287520|10162978|P3|Overall Study|Adverse Event|2
2952490|NCT01287520|10162979|P2|Overall Study|Adverse Event|2
2952491|NCT01287520|10162980|P1|Overall Study|Adverse Event|2
2952492|NCT01287416|10163044|P2|6 Month Follow-up|Lost to Follow-up|2
2952493|NCT01287416|10163045|P1|6 Month Follow-up|Lost to Follow-up|3
2952494|NCT01287416|10163044|P2|Pre-post Training|Lost to Follow-up|1
2952495|NCT01287416|10163045|P1|Pre-post Training|Lost to Follow-up|5
2952496|NCT01287416|10163044|P2|Pre-post Training|Withdrawal by Subject|24
2952497|NCT01287416|10163045|P1|Pre-post Training|Withdrawal by Subject|17
2952498|NCT01287403|10163081|P1|1st Intervention (1 Day)|Adverse Event|1
2952499|NCT01287364|10163113|P2|Overall Study|Other Reason|2
2952500|NCT01287364|10163114|P1|Overall Study|Other Reason|4
2952501|NCT01287364|10163113|P2|Overall Study|Protocol Violation|5
2952502|NCT01287364|10163114|P1|Overall Study|Protocol Violation|5
2952503|NCT01287364|10163113|P2|Overall Study|Adverse Event|3
2952504|NCT01287364|10163114|P1|Overall Study|Adverse Event|0
2952505|NCT01287221|10163136|P2|Overall Study|Withdrawal by Subject|1
2952506|NCT01287221|10163137|P1|Overall Study|Withdrawal by Subject|0
2952507|NCT01287221|10163136|P2|Overall Study|Adverse Event|3
2952508|NCT01287221|10163137|P1|Overall Study|Adverse Event|3
2952509|NCT01287221|10163136|P2|Overall Study|Lack of Perceived Benefit|1
2952510|NCT01287221|10163137|P1|Overall Study|Lack of Perceived Benefit|1
2952511|NCT01287195|10163172|P1|Overall Study|Withdrawal by Subject|2
2952512|NCT01287117|10163187|P4|Overall Study|Disease Progression|5
2952513|NCT01287117|10163188|P3|Overall Study|Disease Progression|6
2952514|NCT01287117|10163189|P2|Overall Study|Disease Progression|5
2952515|NCT01287117|10163190|P1|Overall Study|Disease Progression|10
2952516|NCT01287117|10163187|P4|Overall Study|Patient/Legal Guardian's Decision|5
2952517|NCT01287117|10163188|P3|Overall Study|Patient/Legal Guardian's Decision|8
2952518|NCT01287117|10163189|P2|Overall Study|Patient/Legal Guardian's Decision|6
2952519|NCT01287117|10163190|P1|Overall Study|Patient/Legal Guardian's Decision|2
2952520|NCT01287117|10163187|P4|Overall Study|Physician Decision|1
2952521|NCT01287117|10163188|P3|Overall Study|Physician Decision|1
2952522|NCT01287117|10163189|P2|Overall Study|Physician Decision|1
2952523|NCT01287117|10163190|P1|Overall Study|Physician Decision|0
2952524|NCT01287117|10163187|P4|Overall Study|Lost to Follow-up|0
2952525|NCT01287117|10163188|P3|Overall Study|Lost to Follow-up|0
2952526|NCT01287117|10163189|P2|Overall Study|Lost to Follow-up|1
2952527|NCT01287117|10163190|P1|Overall Study|Lost to Follow-up|1
2952528|NCT01287117|10163187|P4|Overall Study|Adverse Event|1
2952529|NCT01287117|10163188|P3|Overall Study|Adverse Event|1
2952530|NCT01287117|10163189|P2|Overall Study|Adverse Event|1
2952531|NCT01287117|10163190|P1|Overall Study|Adverse Event|2
2952532|NCT01287104|10163240|P4|Overall Study|NK cells did not meet release criteria|0
2952533|NCT01287104|10163241|P3|Overall Study|NK cells did not meet release criteria|0
2952534|NCT01287104|10163242|P2|Overall Study|NK cells did not meet release criteria|1
2952535|NCT01287104|10163243|P1|Overall Study|NK cells did not meet release criteria|0
2952536|NCT01287104|10163240|P4|Overall Study|Low donor chimerism|0
2952537|NCT01287104|10163241|P3|Overall Study|Low donor chimerism|0
2952538|NCT01287104|10163242|P2|Overall Study|Low donor chimerism|1
2952539|NCT01287104|10163243|P1|Overall Study|Low donor chimerism|0
2952540|NCT01287104|10163240|P4|Overall Study|Developed GVHD or complications of BMT|0
2952541|NCT01287104|10163241|P3|Overall Study|Developed GVHD or complications of BMT|4
2952542|NCT01287104|10163242|P2|Overall Study|Developed GVHD or complications of BMT|1
2952543|NCT01287104|10163243|P1|Overall Study|Developed GVHD or complications of BMT|0
2952544|NCT01287104|10163240|P4|Overall Study|Donor anaphylaxis|1
2952545|NCT01287104|10163241|P3|Overall Study|Donor anaphylaxis|0
2952546|NCT01287104|10163242|P2|Overall Study|Donor anaphylaxis|1
2952547|NCT01287104|10163243|P1|Overall Study|Donor anaphylaxis|0
2952548|NCT01287104|10163240|P4|Overall Study|Patient developed progressive disease|2
2952549|NCT01287104|10163241|P3|Overall Study|Patient developed progressive disease|3
2952550|NCT01287104|10163242|P2|Overall Study|Patient developed progressive disease|1
2952551|NCT01287104|10163243|P1|Overall Study|Patient developed progressive disease|1
2952552|NCT01287065|10163276|P6|Treatment Period 1|Withdrawal by Subject|1
2952553|NCT01287065|10163277|P5|Treatment Period 1|Withdrawal by Subject|0
2952554|NCT01287065|10163278|P4|Treatment Period 1|Withdrawal by Subject|0
2952555|NCT01287065|10163279|P3|Treatment Period 1|Withdrawal by Subject|0
2952556|NCT01287065|10163280|P2|Treatment Period 1|Withdrawal by Subject|0
2952557|NCT01287065|10163281|P1|Treatment Period 1|Withdrawal by Subject|0
2952558|NCT01287065|10163276|P6|Treatment Period 1|Adverse Event|0
2952559|NCT01287065|10163277|P5|Treatment Period 1|Adverse Event|1
2952560|NCT01287065|10163278|P4|Treatment Period 1|Adverse Event|0
2952561|NCT01287065|10163279|P3|Treatment Period 1|Adverse Event|0
2952562|NCT01287065|10163280|P2|Treatment Period 1|Adverse Event|0
2952563|NCT01287065|10163281|P1|Treatment Period 1|Adverse Event|0
2952564|NCT01287039|10163300|P2|Overall Study|Lost to Follow-up|2
2952565|NCT01287039|10163301|P1|Overall Study|Lost to Follow-up|3
2952566|NCT01287039|10163300|P2|Overall Study|Withdrawal by Subject|11
2952567|NCT01287039|10163301|P1|Overall Study|Withdrawal by Subject|14
2952568|NCT01287039|10163300|P2|Overall Study|Adverse Event|4
2952569|NCT01287039|10163301|P1|Overall Study|Adverse Event|7
2952570|NCT01287039|10163300|P2|Overall Study|Change of residence|0
2952571|NCT01287039|10163301|P1|Overall Study|Change of residence|1
2952572|NCT01287039|10163300|P2|Overall Study|Death|0
2952573|NCT01287039|10163301|P1|Overall Study|Death|1
2952574|NCT01287039|10163300|P2|Overall Study|Problem with travel|1
2952575|NCT01287039|10163301|P1|Overall Study|Problem with travel|0
2952576|NCT01287039|10163300|P2|Overall Study|Noncompliance with study medication|1
2952577|NCT01287039|10163301|P1|Overall Study|Noncompliance with study medication|0
2952578|NCT01287039|10163300|P2|Overall Study|Excluded medication taken|0
2952579|NCT01287039|10163301|P1|Overall Study|Excluded medication taken|1
2952580|NCT01287039|10163300|P2|Overall Study|Protocol Violation|3
2952581|NCT01287039|10163301|P1|Overall Study|Protocol Violation|2
2952582|NCT01287039|10163300|P2|Overall Study|Elective surgery|1
2952583|NCT01287039|10163301|P1|Overall Study|Elective surgery|0
2952584|NCT01287039|10163300|P2|Overall Study|Change of location/residence|3
2952585|NCT01287039|10163301|P1|Overall Study|Change of location/residence|0
2952586|NCT01287039|10163300|P2|Overall Study|Noncompliance with study procedures|1
2952587|NCT01287039|10163301|P1|Overall Study|Noncompliance with study procedures|0
2952588|NCT01287013|10163334|P3|Overall Study|Non-evaluable|21
2952589|NCT01287013|10163335|P2|Overall Study|Non-evaluable|5
2952590|NCT01287013|10163336|P1|Overall Study|Non-evaluable|3
2952591|NCT01286987|10163366|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
2952592|NCT01286987|10163367|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
2952593|NCT01286987|10163368|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
2952594|NCT01286987|10163369|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
2952595|NCT01286987|10163370|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
2952596|NCT01286987|10163371|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
2952597|NCT01286987|10163372|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
2952598|NCT01286987|10163373|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
2952599|NCT01286987|10163374|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
2952600|NCT01286987|10163375|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
2952601|NCT01286987|10163376|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
2952602|NCT01286987|10163377|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
2952603|NCT01286987|10163378|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
2952604|NCT01286987|10163379|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
2952605|NCT01286987|10163380|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
2952606|NCT01286987|10163366|P15|Part 2: Dose Expansion|Clinical Progression|0
2952607|NCT01286987|10163367|P14|Part 2: Dose Expansion|Clinical Progression|2
2952608|NCT01286987|10163368|P13|Part 2: Dose Expansion|Clinical Progression|0
2952609|NCT01286987|10163369|P12|Part 2: Dose Expansion|Clinical Progression|2
2952610|NCT01286987|10163370|P11|Part 2: Dose Expansion|Clinical Progression|2
2952611|NCT01286987|10163371|P10|Part 2: Dose Expansion|Clinical Progression|0
2952612|NCT01286987|10163372|P9|Part 2: Dose Expansion|Clinical Progression|0
2952613|NCT01286987|10163373|P8|Part 2: Dose Expansion|Clinical Progression|0
2952614|NCT01286987|10163374|P7|Part 2: Dose Expansion|Clinical Progression|0
2952615|NCT01286987|10163375|P6|Part 2: Dose Expansion|Clinical Progression|0
2952616|NCT01286987|10163376|P5|Part 2: Dose Expansion|Clinical Progression|0
2952617|NCT01286987|10163377|P4|Part 2: Dose Expansion|Clinical Progression|0
2952618|NCT01286987|10163378|P3|Part 2: Dose Expansion|Clinical Progression|0
2952619|NCT01286987|10163379|P2|Part 2: Dose Expansion|Clinical Progression|0
2952620|NCT01286987|10163380|P1|Part 2: Dose Expansion|Clinical Progression|0
2952621|NCT01286987|10163366|P15|Part 2: Dose Expansion|Progressive Disease|2
2952622|NCT01286987|10163367|P14|Part 2: Dose Expansion|Progressive Disease|19
2952623|NCT01286987|10163368|P13|Part 2: Dose Expansion|Progressive Disease|11
2952624|NCT01286987|10163369|P12|Part 2: Dose Expansion|Progressive Disease|7
2952625|NCT01286987|10163370|P11|Part 2: Dose Expansion|Progressive Disease|6
2952626|NCT01286987|10163371|P10|Part 2: Dose Expansion|Progressive Disease|11
2952627|NCT01286987|10163372|P9|Part 2: Dose Expansion|Progressive Disease|0
2952628|NCT01286987|10163373|P8|Part 2: Dose Expansion|Progressive Disease|0
2952629|NCT01286987|10163374|P7|Part 2: Dose Expansion|Progressive Disease|0
2952630|NCT01286987|10163375|P6|Part 2: Dose Expansion|Progressive Disease|0
2952631|NCT01286987|10163376|P5|Part 2: Dose Expansion|Progressive Disease|0
2952632|NCT01286987|10163377|P4|Part 2: Dose Expansion|Progressive Disease|0
2952633|NCT01286987|10163378|P3|Part 2: Dose Expansion|Progressive Disease|0
2952634|NCT01286987|10163379|P2|Part 2: Dose Expansion|Progressive Disease|0
2952635|NCT01286987|10163380|P1|Part 2: Dose Expansion|Progressive Disease|0
2952636|NCT01286987|10163366|P15|Part 2: Dose Expansion|Other|0
2952637|NCT01286987|10163367|P14|Part 2: Dose Expansion|Other|1
2952638|NCT01286987|10163368|P13|Part 2: Dose Expansion|Other|0
2952639|NCT01286987|10163369|P12|Part 2: Dose Expansion|Other|0
2952640|NCT01286987|10163370|P11|Part 2: Dose Expansion|Other|0
2952641|NCT01286987|10163371|P10|Part 2: Dose Expansion|Other|0
2952642|NCT01286987|10163372|P9|Part 2: Dose Expansion|Other|0
2952643|NCT01286987|10163373|P8|Part 2: Dose Expansion|Other|0
2952644|NCT01286987|10163374|P7|Part 2: Dose Expansion|Other|0
2952645|NCT01286987|10163375|P6|Part 2: Dose Expansion|Other|0
2952646|NCT01286987|10163376|P5|Part 2: Dose Expansion|Other|0
2952647|NCT01286987|10163377|P4|Part 2: Dose Expansion|Other|0
2952648|NCT01286987|10163378|P3|Part 2: Dose Expansion|Other|0
2952649|NCT01286987|10163379|P2|Part 2: Dose Expansion|Other|0
2952650|NCT01286987|10163380|P1|Part 2: Dose Expansion|Other|0
2952651|NCT01286987|10163366|P15|Part 2: Dose Expansion|Physician Decision|0
2952652|NCT01286987|10163367|P14|Part 2: Dose Expansion|Physician Decision|1
2952653|NCT01286987|10163368|P13|Part 2: Dose Expansion|Physician Decision|0
2952654|NCT01286987|10163369|P12|Part 2: Dose Expansion|Physician Decision|1
2952655|NCT01286987|10163370|P11|Part 2: Dose Expansion|Physician Decision|1
2952656|NCT01286987|10163371|P10|Part 2: Dose Expansion|Physician Decision|0
2952657|NCT01286987|10163372|P9|Part 2: Dose Expansion|Physician Decision|0
2952658|NCT01286987|10163373|P8|Part 2: Dose Expansion|Physician Decision|0
2952659|NCT01286987|10163374|P7|Part 2: Dose Expansion|Physician Decision|0
2952660|NCT01286987|10163375|P6|Part 2: Dose Expansion|Physician Decision|0
2952661|NCT01286987|10163376|P5|Part 2: Dose Expansion|Physician Decision|0
2952662|NCT01286987|10163377|P4|Part 2: Dose Expansion|Physician Decision|0
2952663|NCT01286987|10163378|P3|Part 2: Dose Expansion|Physician Decision|0
2952664|NCT01286987|10163379|P2|Part 2: Dose Expansion|Physician Decision|0
2952665|NCT01286987|10163380|P1|Part 2: Dose Expansion|Physician Decision|0
2952666|NCT01286987|10163366|P15|Part 2: Dose Expansion|Death|0
2952667|NCT01286987|10163367|P14|Part 2: Dose Expansion|Death|1
2952668|NCT01286987|10163368|P13|Part 2: Dose Expansion|Death|1
2952669|NCT01286987|10163369|P12|Part 2: Dose Expansion|Death|0
2952670|NCT01286987|10163370|P11|Part 2: Dose Expansion|Death|0
2952671|NCT01286987|10163371|P10|Part 2: Dose Expansion|Death|0
2952672|NCT01286987|10163372|P9|Part 2: Dose Expansion|Death|0
2952673|NCT01286987|10163373|P8|Part 2: Dose Expansion|Death|0
2952674|NCT01286987|10163374|P7|Part 2: Dose Expansion|Death|0
2952675|NCT01286987|10163375|P6|Part 2: Dose Expansion|Death|0
2952676|NCT01286987|10163376|P5|Part 2: Dose Expansion|Death|0
2952677|NCT01286987|10163377|P4|Part 2: Dose Expansion|Death|0
2952678|NCT01286987|10163378|P3|Part 2: Dose Expansion|Death|0
2952679|NCT01286987|10163379|P2|Part 2: Dose Expansion|Death|0
2952680|NCT01286987|10163380|P1|Part 2: Dose Expansion|Death|0
2952681|NCT01286987|10163366|P15|Part 1: Dose Escalation|Physician Decision|0
2952682|NCT01286987|10163367|P14|Part 1: Dose Escalation|Physician Decision|0
2952683|NCT01286987|10163368|P13|Part 1: Dose Escalation|Physician Decision|0
2952684|NCT01286987|10163369|P12|Part 1: Dose Escalation|Physician Decision|0
2952685|NCT01286987|10163370|P11|Part 1: Dose Escalation|Physician Decision|0
2952686|NCT01286987|10163371|P10|Part 1: Dose Escalation|Physician Decision|0
2952687|NCT01286987|10163372|P9|Part 1: Dose Escalation|Physician Decision|0
2952688|NCT01286987|10163373|P8|Part 1: Dose Escalation|Physician Decision|0
2952689|NCT01286987|10163374|P7|Part 1: Dose Escalation|Physician Decision|0
2952690|NCT01286987|10163375|P6|Part 1: Dose Escalation|Physician Decision|0
2952691|NCT01286987|10163376|P5|Part 1: Dose Escalation|Physician Decision|1
2952692|NCT01286987|10163377|P4|Part 1: Dose Escalation|Physician Decision|0
2952693|NCT01286987|10163378|P3|Part 1: Dose Escalation|Physician Decision|0
2952694|NCT01286987|10163379|P2|Part 1: Dose Escalation|Physician Decision|0
2952695|NCT01286987|10163380|P1|Part 1: Dose Escalation|Physician Decision|0
2952696|NCT01286987|10163366|P15|Part 1: Dose Escalation|Progressive Disease|0
2952697|NCT01286987|10163367|P14|Part 1: Dose Escalation|Progressive Disease|0
2952698|NCT01286987|10163368|P13|Part 1: Dose Escalation|Progressive Disease|0
2952699|NCT01286987|10163369|P12|Part 1: Dose Escalation|Progressive Disease|0
2952700|NCT01286987|10163370|P11|Part 1: Dose Escalation|Progressive Disease|0
2952701|NCT01286987|10163371|P10|Part 1: Dose Escalation|Progressive Disease|0
2952702|NCT01286987|10163372|P9|Part 1: Dose Escalation|Progressive Disease|5
2952703|NCT01286987|10163373|P8|Part 1: Dose Escalation|Progressive Disease|3
2952704|NCT01286987|10163374|P7|Part 1: Dose Escalation|Progressive Disease|5
2952705|NCT01286987|10163375|P6|Part 1: Dose Escalation|Progressive Disease|5
2952706|NCT01286987|10163376|P5|Part 1: Dose Escalation|Progressive Disease|1
2952707|NCT01286987|10163377|P4|Part 1: Dose Escalation|Progressive Disease|2
2952708|NCT01286987|10163378|P3|Part 1: Dose Escalation|Progressive Disease|3
2952709|NCT01286987|10163379|P2|Part 1: Dose Escalation|Progressive Disease|2
2952710|NCT01286987|10163380|P1|Part 1: Dose Escalation|Progressive Disease|2
2952711|NCT01286987|10163366|P15|Part 1: Dose Escalation|Clinical Progression|0
2952712|NCT01286987|10163367|P14|Part 1: Dose Escalation|Clinical Progression|0
2952713|NCT01286987|10163368|P13|Part 1: Dose Escalation|Clinical Progression|0
2952714|NCT01286987|10163369|P12|Part 1: Dose Escalation|Clinical Progression|0
2952715|NCT01286987|10163370|P11|Part 1: Dose Escalation|Clinical Progression|0
2952716|NCT01286987|10163371|P10|Part 1: Dose Escalation|Clinical Progression|0
2952717|NCT01286987|10163372|P9|Part 1: Dose Escalation|Clinical Progression|1
2952718|NCT01286987|10163373|P8|Part 1: Dose Escalation|Clinical Progression|2
2952719|NCT01286987|10163374|P7|Part 1: Dose Escalation|Clinical Progression|0
2952720|NCT01286987|10163375|P6|Part 1: Dose Escalation|Clinical Progression|1
2952721|NCT01286987|10163376|P5|Part 1: Dose Escalation|Clinical Progression|1
2952722|NCT01286987|10163377|P4|Part 1: Dose Escalation|Clinical Progression|1
2952723|NCT01286987|10163378|P3|Part 1: Dose Escalation|Clinical Progression|0
2952724|NCT01286987|10163379|P2|Part 1: Dose Escalation|Clinical Progression|1
2952725|NCT01286987|10163380|P1|Part 1: Dose Escalation|Clinical Progression|1
2952726|NCT01286779|10163561|P1|Overall Study|Discontinued by sponsor|1
2952727|NCT01286779|10163561|P1|Overall Study|Participant moved to another country|1
2952728|NCT01286779|10163561|P1|Overall Study|Participant had scheduled surgery|1
2952729|NCT01286779|10163561|P1|Overall Study|Physician Decision|2
2952730|NCT01286779|10163561|P1|Overall Study|Protocol Violation|5
2952731|NCT01286779|10163561|P1|Overall Study|Withdrawal by Subject|9
2952732|NCT01286753|10163613|P2|Overall Study|Participant to Receive Radiotherapy|0
2952733|NCT01286753|10163614|P1|Overall Study|Participant to Receive Radiotherapy|1
2952734|NCT01286753|10163613|P2|Overall Study|Discontinued to Join Extension Study|4
2952735|NCT01286753|10163614|P1|Overall Study|Discontinued to Join Extension Study|6
2952736|NCT01286753|10163613|P2|Overall Study|Withdrawal of Consent|2
2952737|NCT01286753|10163614|P1|Overall Study|Withdrawal of Consent|0
2952738|NCT01286753|10163613|P2|Overall Study|Refused Treatment|0
2952739|NCT01286753|10163614|P1|Overall Study|Refused Treatment|1
2952740|NCT01286753|10163613|P2|Overall Study|Progression|13
2952741|NCT01286753|10163614|P1|Overall Study|Progression|11
2952742|NCT01286753|10163613|P2|Overall Study|Adverse Event|6
2952743|NCT01286753|10163614|P1|Overall Study|Adverse Event|7
2952744|NCT01286740|10163632|P1|Overall Study|Protocol Violation|1
2952745|NCT01286740|10163632|P1|Overall Study|Enrolled but not treated|1
2952746|NCT01286558|10163650|P2|Overall Study|Withdrawal by Subject|1
2952747|NCT01286558|10163651|P1|Overall Study|Withdrawal by Subject|0
2952748|NCT01286558|10163650|P2|Overall Study|Adverse Event|1
2952749|NCT01286558|10163651|P1|Overall Study|Adverse Event|1
2952750|NCT01286480|10163687|P2|Overall Study|Withdrawal by Subject|3
2952751|NCT01286480|10163688|P1|Overall Study|Withdrawal by Subject|5
2952752|NCT01286311|10163795|P2|Overall Study|Physician did not want outreach sent|0
2952753|NCT01286311|10163796|P1|Overall Study|Physician did not want outreach sent|14
2952754|NCT01286272|10163812|P2|Overall Study|Ineligible after beginning treatment|3
2952755|NCT01286272|10163813|P1|Overall Study|Ineligible after beginning treatment|1
2952756|NCT01286207|10163826|P3|Overall Study|Other|13
2952757|NCT01286207|10163827|P2|Overall Study|Other|47
2952758|NCT01286207|10163828|P1|Overall Study|Other|37
2952759|NCT01286207|10163826|P3|Overall Study|Lack of Response|8
2952760|NCT01286207|10163827|P2|Overall Study|Lack of Response|38
2952761|NCT01286207|10163828|P1|Overall Study|Lack of Response|92
2952762|NCT01286207|10163826|P3|Overall Study|Withdrawal by Subject|41
2952763|NCT01286207|10163827|P2|Overall Study|Withdrawal by Subject|79
2952764|NCT01286207|10163828|P1|Overall Study|Withdrawal by Subject|93
2952765|NCT01286207|10163826|P3|Overall Study|Lost to Follow-up|20
2952766|NCT01286207|10163827|P2|Overall Study|Lost to Follow-up|43
2952767|NCT01286207|10163828|P1|Overall Study|Lost to Follow-up|49
2952768|NCT01286207|10163826|P3|Overall Study|Adverse Event|8
2952769|NCT01286207|10163827|P2|Overall Study|Adverse Event|41
2952770|NCT01286207|10163828|P1|Overall Study|Adverse Event|27
2952771|NCT01286168|10163848|P1|Overall Study|Surgical Drains Fell Out at Home|2
2952772|NCT01286168|10163848|P1|Overall Study|Withdrawal by Subject|1
2952773|NCT01286129|10163862|P2|Overall Study|Could not comply with study requirements|4
2952774|NCT01286129|10163863|P1|Overall Study|Could not comply with study requirements|4
2952775|NCT01286129|10163862|P2|Overall Study|Withdrawal by Subject|1
2952776|NCT01286129|10163863|P1|Overall Study|Withdrawal by Subject|4
2952777|NCT01286077|10163873|P2|Overall Study|refill medication not received in time|0
2952778|NCT01286077|10163874|P1|Overall Study|refill medication not received in time|1
2952779|NCT01286077|10163873|P2|Overall Study|Progression of disease|1
2952780|NCT01286077|10163874|P1|Overall Study|Progression of disease|0
2952781|NCT01286077|10163873|P2|Overall Study|Patient's decision to stop treatment|0
2952782|NCT01286077|10163874|P1|Overall Study|Patient's decision to stop treatment|3
2952783|NCT01286077|10163873|P2|Overall Study|The subject starts with alternative MMY|3
2952784|NCT01286077|10163874|P1|Overall Study|The subject starts with alternative MMY|0
2952785|NCT01286077|10163873|P2|Overall Study|Non-compliance|0
2952786|NCT01286077|10163874|P1|Overall Study|Non-compliance|1
2952787|NCT01286077|10163873|P2|Overall Study|Intercurrent illness|0
2952788|NCT01286077|10163874|P1|Overall Study|Intercurrent illness|1
2952789|NCT01286077|10163873|P2|Overall Study|Withdrawal by Subject|2
2952790|NCT01286077|10163874|P1|Overall Study|Withdrawal by Subject|0
2952791|NCT01286077|10163873|P2|Overall Study|Protocol Violation|1
2952792|NCT01286077|10163874|P1|Overall Study|Protocol Violation|1
2952793|NCT01286077|10163873|P2|Overall Study|Death|0
2952794|NCT01286077|10163874|P1|Overall Study|Death|1
2952795|NCT01286077|10163873|P2|Overall Study|Adverse Event|0
2952796|NCT01286077|10163874|P1|Overall Study|Adverse Event|2
2952797|NCT01286012|10163910|P2|Overall Study|peritoneal dialysis, randomized in error|3
2952798|NCT01286012|10163911|P1|Overall Study|peritoneal dialysis, randomized in error|1
2952799|NCT01286012|10163910|P2|Overall Study|Physician Decision|0
2952800|NCT01286012|10163911|P1|Overall Study|Physician Decision|2
2952801|NCT01286012|10163910|P2|Overall Study|Withdrawal by Subject|4
2952802|NCT01286012|10163911|P1|Overall Study|Withdrawal by Subject|4
2952803|NCT01286012|10163910|P2|Overall Study|Protocol Violation|1
2952804|NCT01286012|10163911|P1|Overall Study|Protocol Violation|1
2952805|NCT01286012|10163910|P2|Overall Study|Death|3
2952806|NCT01286012|10163911|P1|Overall Study|Death|2
2952807|NCT01286012|10163910|P2|Overall Study|Adverse Event|3
2952808|NCT01286012|10163911|P1|Overall Study|Adverse Event|3
2952809|NCT01285960|10163925|P1|Overall Study|2 subjects received less 10 sonications|2
2952810|NCT01285960|10163925|P1|Overall Study|Lost to Follow-up|2
2952811|NCT01285960|10163925|P1|Overall Study|Withdrawal by Subject|2
2952812|NCT01285908|10163938|P3|Baseline Measurement|unable to tolerate procedure|0
2952813|NCT01285908|10163939|P2|Baseline Measurement|unable to tolerate procedure|0
2952814|NCT01285908|10163940|P1|Baseline Measurement|unable to tolerate procedure|1
2952815|NCT01285908|10163938|P3|Baseline Measurement|History of stroke, exclusion criteria|0
2952816|NCT01285908|10163939|P2|Baseline Measurement|History of stroke, exclusion criteria|0
2952817|NCT01285908|10163940|P1|Baseline Measurement|History of stroke, exclusion criteria|1
2952818|NCT01285908|10163938|P3|Baseline Measurement|unable to insert catheter|0
2952819|NCT01285908|10163939|P2|Baseline Measurement|unable to insert catheter|0
2952820|NCT01285908|10163940|P1|Baseline Measurement|unable to insert catheter|1
2952821|NCT01285609|10164034|P2|Treated With Blinded Therapy|Worsening of general condition|1
2952822|NCT01285609|10164035|P1|Treated With Blinded Therapy|Worsening of general condition|0
2952823|NCT01285609|10164034|P2|Treated With Blinded Therapy|PI decision to discontinue|1
2952824|NCT01285609|10164035|P1|Treated With Blinded Therapy|PI decision to discontinue|0
2952825|NCT01285609|10164034|P2|Treated With Blinded Therapy|Investigator's assessment|0
2952826|NCT01285609|10164035|P1|Treated With Blinded Therapy|Investigator's assessment|1
2952827|NCT01285609|10164034|P2|Treated With Blinded Therapy|Participant hospitalized|0
2952828|NCT01285609|10164035|P1|Treated With Blinded Therapy|Participant hospitalized|1
2952829|NCT01285609|10164034|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
2952830|NCT01285609|10164035|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
2952831|NCT01285609|10164034|P2|Treated With Blinded Therapy|Participant refused participation|0
2952832|NCT01285609|10164035|P1|Treated With Blinded Therapy|Participant refused participation|1
2952833|NCT01285609|10164034|P2|Treated With Blinded Therapy|Physician and Patient decision|3
2952834|NCT01285609|10164035|P1|Treated With Blinded Therapy|Physician and Patient decision|1
2952835|NCT01285609|10164034|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
2952836|NCT01285609|10164035|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
2952837|NCT01285609|10164034|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
2952838|NCT01285609|10164035|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
2952839|NCT01285609|10164034|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
2952840|NCT01285609|10164035|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
2952841|NCT01285609|10164034|P2|Treated With Blinded Therapy|Not Reported|2
2952842|NCT01285609|10164035|P1|Treated With Blinded Therapy|Not Reported|0
2952843|NCT01285609|10164034|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
2952844|NCT01285609|10164035|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
2952845|NCT01285609|10164034|P2|Treated With Blinded Therapy|Death|3
2952846|NCT01285609|10164035|P1|Treated With Blinded Therapy|Death|11
2952847|NCT01285609|10164034|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
2952848|NCT01285609|10164035|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
2952849|NCT01285609|10164034|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
2952850|NCT01285609|10164035|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
2952851|NCT01285609|10164034|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
2952852|NCT01285609|10164035|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
2952853|NCT01285609|10164034|P2|Treated With Blinded Therapy|Progressive Disease|305
2952854|NCT01285609|10164035|P1|Treated With Blinded Therapy|Progressive Disease|223
2952855|NCT01285609|10164034|P2|Randomized|Randomized but not Treated|4
2952856|NCT01285609|10164035|P1|Randomized|Randomized but not Treated|4
2952857|NCT01285609|10164034|P2|Randomized|Undisclosed Reasons|0
2952858|NCT01285609|10164035|P1|Randomized|Undisclosed Reasons|1
2952859|NCT01285609|10164034|P2|Randomized|Subject No Longer Met Study Criteria|1
2952860|NCT01285609|10164035|P1|Randomized|Subject No Longer Met Study Criteria|1
2952861|NCT01285609|10164034|P2|Randomized|Withdrawal by Subject|11
2952862|NCT01285609|10164035|P1|Randomized|Withdrawal by Subject|8
2952863|NCT01285609|10164034|P2|Randomized|Death|7
2952864|NCT01285609|10164035|P1|Randomized|Death|5
2952865|NCT01285609|10164034|P2|Randomized|Study Drug Toxicity|14
2952866|NCT01285609|10164035|P1|Randomized|Study Drug Toxicity|13
2952867|NCT01285609|10164034|P2|Randomized|Adverse Event Unrelated to Study Drug|18
2952868|NCT01285609|10164035|P1|Randomized|Adverse Event Unrelated to Study Drug|18
2952869|NCT01285609|10164034|P2|Randomized|Progressive Disease|61
2952870|NCT01285609|10164035|P1|Randomized|Progressive Disease|41
2952871|NCT01285518|10164053|P8|Overall Study|Lost to Follow-up|0
2952872|NCT01285518|10164054|P7|Overall Study|Lost to Follow-up|0
2952873|NCT01285518|10164055|P6|Overall Study|Lost to Follow-up|1
2952874|NCT01285518|10164056|P5|Overall Study|Lost to Follow-up|0
2952875|NCT01285518|10164057|P4|Overall Study|Lost to Follow-up|0
2952876|NCT01285518|10164058|P3|Overall Study|Lost to Follow-up|0
2952877|NCT01285518|10164059|P2|Overall Study|Lost to Follow-up|0
2952878|NCT01285518|10164060|P1|Overall Study|Lost to Follow-up|0
2952879|NCT01285492|10164320|P2|Overall Study|Death|0
2952880|NCT01285492|10164321|P1|Overall Study|Death|1
2952881|NCT01285492|10164320|P2|Overall Study|Withdrawal by Subject|1
2952882|NCT01285492|10164321|P1|Overall Study|Withdrawal by Subject|2
2952883|NCT01285492|10164320|P2|Overall Study|Protocol Violation|0
2952884|NCT01285492|10164321|P1|Overall Study|Protocol Violation|3
2952885|NCT01285492|10164320|P2|Overall Study|Adverse Event|0
2952886|NCT01285492|10164321|P1|Overall Study|Adverse Event|11
2952887|NCT01285401|10164353|P2|Overall Study|Prematurely withdrawn from the study|29
2952888|NCT01285401|10164354|P1|Overall Study|Prematurely withdrawn from the study|17
2952889|NCT01285349|10164395|P3|Overall Study|Lost to Follow-up|27
2952890|NCT01285349|10164396|P2|Overall Study|Lost to Follow-up|20
2952891|NCT01285349|10164397|P1|Overall Study|Lost to Follow-up|27
2952892|NCT01285323|10164410|P2|Overall Study|Other|3
2952893|NCT01285323|10164411|P1|Overall Study|Other|1
2952894|NCT01285323|10164410|P2|Overall Study|Lost to Follow-up|1
2952895|NCT01285323|10164411|P1|Overall Study|Lost to Follow-up|1
2952896|NCT01285323|10164410|P2|Overall Study|Non-compliance with study procedures|3
2952897|NCT01285323|10164411|P1|Overall Study|Non-compliance with study procedures|2
2952898|NCT01285323|10164410|P2|Overall Study|Protocol Violation|2
2952899|NCT01285323|10164411|P1|Overall Study|Protocol Violation|1
2952900|NCT01285323|10164410|P2|Overall Study|Withdrawal by Subject|11
2952901|NCT01285323|10164411|P1|Overall Study|Withdrawal by Subject|15
2952902|NCT01285323|10164410|P2|Overall Study|Lack of Efficacy|2
2952903|NCT01285323|10164411|P1|Overall Study|Lack of Efficacy|4
2952904|NCT01285323|10164410|P2|Overall Study|Adverse Event|8
2952905|NCT01285323|10164411|P1|Overall Study|Adverse Event|9
2952906|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2952907|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2952908|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2952909|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2952910|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2952911|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Other|0
2952912|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Other|0
2952913|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Other|0
2952914|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Other|1
2952915|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Other|0
2952916|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
2952917|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
2952918|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
2952919|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
2952920|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
2952921|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2952922|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2952923|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2952924|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
2952925|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2952926|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2952927|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
2952928|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
2952929|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
2952930|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2952931|NCT01285310|10164446|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2952932|NCT01285310|10164447|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2952933|NCT01285310|10164448|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
2952934|NCT01285310|10164449|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2952935|NCT01285310|10164450|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2952936|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
2952937|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
2952938|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
2952939|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
2952940|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
2952941|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2952942|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2952943|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2952944|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2952945|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2952946|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2952947|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2952948|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
2952949|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2952950|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2952951|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2952952|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2952953|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
2952954|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2952955|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
2952956|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2952957|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2952958|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
2952959|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
2952960|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
2952961|NCT01285310|10164446|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2952962|NCT01285310|10164447|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2952963|NCT01285310|10164448|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
2952964|NCT01285310|10164449|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
2952965|NCT01285310|10164450|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
2952966|NCT01284959|10164715|P3|Overall Study|Adverse Event|1
2952967|NCT01284959|10164716|P2|Overall Study|Adverse Event|0
2952968|NCT01284959|10164717|P1|Overall Study|Adverse Event|0
2952969|NCT01284959|10164715|P3|Overall Study|Withdrawal by Subject|0
2952970|NCT01284959|10164716|P2|Overall Study|Withdrawal by Subject|0
2952971|NCT01284959|10164717|P1|Overall Study|Withdrawal by Subject|1
2952972|NCT01284634|10164747|P4|Overall Study|Adverse Event|1
2952973|NCT01284634|10164748|P3|Overall Study|Adverse Event|2
2952974|NCT01284634|10164749|P2|Overall Study|Adverse Event|0
2952975|NCT01284634|10164750|P1|Overall Study|Adverse Event|1
2952976|NCT01284621|10164780|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2952977|NCT01284621|10164781|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
2952978|NCT01284621|10164782|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2952979|NCT01284621|10164783|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2952980|NCT01284621|10164784|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2952981|NCT01284621|10164785|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2952982|NCT01284491|10164853|P1|Overall Study|Study termination|13
2952983|NCT01284361|10164863|P1|Overall Study|Lost to Follow-up|2
2952984|NCT01284361|10164863|P1|Overall Study|Adverse Event|1
2952985|NCT01284361|10164863|P1|Overall Study|Protocol Violation|5
2952986|NCT01284361|10164863|P1|Overall Study|Withdrawal by Subject|1
2952987|NCT01284140|10164959|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
2952988|NCT01284140|10164960|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
2952989|NCT01284140|10164959|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2952990|NCT01284140|10164960|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2952991|NCT01284127|10164974|P1|Overall Study|Physician Decision|1
2952992|NCT01284127|10164974|P1|Overall Study|Withdrawal by Subject|4
2952993|NCT01284127|10164974|P1|Overall Study|Adverse Event|2
2952994|NCT01284114|10164983|P1|Overall Study|dizziness|1
2952995|NCT01284114|10164983|P1|Overall Study|Symptomatic hypotension|1
2952996|NCT01284114|10164983|P1|Overall Study|From the results of ALLTITUDE study|1
2952997|NCT01284114|10164983|P1|Overall Study|viral infection|1
2952998|NCT01284062|10164995|P4|Overall Study|Site Closed|0
2952999|NCT01284062|10164996|P3|Overall Study|Site Closed|1
2953000|NCT01284062|10164997|P2|Overall Study|Site Closed|0
2953001|NCT01284062|10164998|P1|Overall Study|Site Closed|0
2953002|NCT01284062|10164995|P4|Overall Study|Other|1
2953003|NCT01284062|10164996|P3|Overall Study|Other|0
2953004|NCT01284062|10164997|P2|Overall Study|Other|0
2953005|NCT01284062|10164998|P1|Overall Study|Other|0
2953006|NCT01284062|10164995|P4|Overall Study|Withdrawal by Subject|5
2953007|NCT01284062|10164996|P3|Overall Study|Withdrawal by Subject|2
2953008|NCT01284062|10164997|P2|Overall Study|Withdrawal by Subject|1
2953009|NCT01284062|10164998|P1|Overall Study|Withdrawal by Subject|3
2953010|NCT01284062|10164995|P4|Overall Study|Protocol Violation|2
2953011|NCT01284062|10164996|P3|Overall Study|Protocol Violation|0
2953012|NCT01284062|10164997|P2|Overall Study|Protocol Violation|0
2953013|NCT01284062|10164998|P1|Overall Study|Protocol Violation|1
2953014|NCT01284062|10164995|P4|Overall Study|Medication error without adverse event|0
2953015|NCT01284062|10164996|P3|Overall Study|Medication error without adverse event|1
2953016|NCT01284062|10164997|P2|Overall Study|Medication error without adverse event|0
2953017|NCT01284062|10164998|P1|Overall Study|Medication error without adverse event|0
2953018|NCT01284062|10164995|P4|Overall Study|Lack of Efficacy|1
2953019|NCT01284062|10164996|P3|Overall Study|Lack of Efficacy|2
2953020|NCT01284062|10164997|P2|Overall Study|Lack of Efficacy|2
2953021|NCT01284062|10164998|P1|Overall Study|Lack of Efficacy|3
2953022|NCT01284062|10164995|P4|Overall Study|Adverse Event|5
2953023|NCT01284062|10164996|P3|Overall Study|Adverse Event|0
2953024|NCT01284062|10164997|P2|Overall Study|Adverse Event|5
2953025|NCT01284062|10164998|P1|Overall Study|Adverse Event|4
2953026|NCT01283971|10165072|P2|Overall Study|Administrative reasons|1
2953027|NCT01283971|10165073|P1|Overall Study|Administrative reasons|1
2953028|NCT01283971|10165072|P2|Overall Study|Failure to return|1
2953029|NCT01283971|10165073|P1|Overall Study|Failure to return|0
2953030|NCT01283971|10165072|P2|Overall Study|Refused treatment|1
2953031|NCT01283971|10165073|P1|Overall Study|Refused treatment|3
2953032|NCT01283971|10165072|P2|Overall Study|Protocol Violation|1
2953033|NCT01283971|10165073|P1|Overall Study|Protocol Violation|5
2953034|NCT01283971|10165072|P2|Overall Study|Insufficient therapeutic responses|3
2953035|NCT01283971|10165073|P1|Overall Study|Insufficient therapeutic responses|3
2953036|NCT01283971|10165072|P2|Overall Study|Adverse Event|5
2953037|NCT01283971|10165073|P1|Overall Study|Adverse Event|3
2953038|NCT01283581|10165120|P3|Overall Study|"Early termination"|1
2953039|NCT01283581|10165121|P2|Overall Study|"Early termination"|0
2953040|NCT01283581|10165122|P1|Overall Study|"Early termination"|0
2953041|NCT01283581|10165120|P3|Overall Study|Investigator unblinded|1
2953042|NCT01283581|10165121|P2|Overall Study|Investigator unblinded|0
2953043|NCT01283581|10165122|P1|Overall Study|Investigator unblinded|0
2953044|NCT01283581|10165120|P3|Overall Study|Noncompliance|0
2953045|NCT01283581|10165121|P2|Overall Study|Noncompliance|0
2953046|NCT01283581|10165122|P1|Overall Study|Noncompliance|1
2953047|NCT01283581|10165120|P3|Overall Study|Protocol Violation|2
2953048|NCT01283581|10165121|P2|Overall Study|Protocol Violation|1
2953049|NCT01283581|10165122|P1|Overall Study|Protocol Violation|0
2953050|NCT01283581|10165120|P3|Overall Study|Physician Decision|2
2953051|NCT01283581|10165121|P2|Overall Study|Physician Decision|1
2953052|NCT01283581|10165122|P1|Overall Study|Physician Decision|0
2953053|NCT01283581|10165120|P3|Overall Study|Adverse Event|4
2953054|NCT01283581|10165121|P2|Overall Study|Adverse Event|1
2953055|NCT01283581|10165122|P1|Overall Study|Adverse Event|1
2953056|NCT01283581|10165120|P3|Overall Study|Withdrawal by Subject|2
2953057|NCT01283581|10165121|P2|Overall Study|Withdrawal by Subject|5
2953058|NCT01283581|10165122|P1|Overall Study|Withdrawal by Subject|2
2953059|NCT01283581|10165120|P3|Overall Study|Lost to Follow-up|8
2953060|NCT01283581|10165121|P2|Overall Study|Lost to Follow-up|6
2953061|NCT01283581|10165122|P1|Overall Study|Lost to Follow-up|8
2953062|NCT01283542|10165192|P1|Extension Phase|Administrative problems|1
2953063|NCT01283542|10165192|P1|Extension Phase|Adverse Event|1
2953064|NCT01283542|10165192|P1|Extension Phase|Physician Decision|1
2953065|NCT01283542|10165192|P1|Main Phase|abnormal laboratory values|5
2953066|NCT01283542|10165192|P1|Main Phase|Uncontrolled diabetes mellitus|1
2953067|NCT01283542|10165192|P1|Main Phase|Acute or progressive vision loss|1
2953068|NCT01283516|10165257|P9|Overall Study|Lost to Follow-up|1
2953069|NCT01283516|10165258|P8|Overall Study|Lost to Follow-up|0
2953070|NCT01283516|10165259|P7|Overall Study|Lost to Follow-up|0
2953071|NCT01283516|10165260|P6|Overall Study|Lost to Follow-up|0
2953072|NCT01283516|10165261|P5|Overall Study|Lost to Follow-up|0
2953073|NCT01283516|10165262|P4|Overall Study|Lost to Follow-up|0
2953074|NCT01283516|10165263|P3|Overall Study|Lost to Follow-up|0
2953075|NCT01283516|10165264|P2|Overall Study|Lost to Follow-up|0
2953076|NCT01283516|10165265|P1|Overall Study|Lost to Follow-up|0
2953077|NCT01283516|10165257|P9|Overall Study|Administrative problems|39
2953078|NCT01283516|10165258|P8|Overall Study|Administrative problems|1
2953079|NCT01283516|10165259|P7|Overall Study|Administrative problems|1
2953080|NCT01283516|10165260|P6|Overall Study|Administrative problems|1
2953081|NCT01283516|10165261|P5|Overall Study|Administrative problems|0
2953082|NCT01283516|10165262|P4|Overall Study|Administrative problems|0
2953083|NCT01283516|10165263|P3|Overall Study|Administrative problems|0
2953084|NCT01283516|10165264|P2|Overall Study|Administrative problems|0
2953085|NCT01283516|10165265|P1|Overall Study|Administrative problems|0
2953086|NCT01283516|10165257|P9|Overall Study|Withdrawal by Subject|36
2953087|NCT01283516|10165258|P8|Overall Study|Withdrawal by Subject|0
2953088|NCT01283516|10165259|P7|Overall Study|Withdrawal by Subject|1
2953089|NCT01283516|10165260|P6|Overall Study|Withdrawal by Subject|0
2953090|NCT01283516|10165261|P5|Overall Study|Withdrawal by Subject|1
2953091|NCT01283516|10165262|P4|Overall Study|Withdrawal by Subject|0
2953092|NCT01283516|10165263|P3|Overall Study|Withdrawal by Subject|0
2953093|NCT01283516|10165264|P2|Overall Study|Withdrawal by Subject|0
2953094|NCT01283516|10165265|P1|Overall Study|Withdrawal by Subject|0
2953095|NCT01283516|10165257|P9|Overall Study|Disease Progression|139
2953096|NCT01283516|10165258|P8|Overall Study|Disease Progression|3
2953097|NCT01283516|10165259|P7|Overall Study|Disease Progression|6
2953098|NCT01283516|10165260|P6|Overall Study|Disease Progression|8
2953099|NCT01283516|10165261|P5|Overall Study|Disease Progression|13
2953100|NCT01283516|10165262|P4|Overall Study|Disease Progression|3
2953101|NCT01283516|10165263|P3|Overall Study|Disease Progression|3
2953102|NCT01283516|10165264|P2|Overall Study|Disease Progression|2
2953103|NCT01283516|10165265|P1|Overall Study|Disease Progression|2
2953104|NCT01283516|10165257|P9|Overall Study|Death|12
2953105|NCT01283516|10165258|P8|Overall Study|Death|1
2953106|NCT01283516|10165259|P7|Overall Study|Death|0
2953107|NCT01283516|10165260|P6|Overall Study|Death|1
2953108|NCT01283516|10165261|P5|Overall Study|Death|0
2953109|NCT01283516|10165262|P4|Overall Study|Death|0
2953110|NCT01283516|10165263|P3|Overall Study|Death|0
2953111|NCT01283516|10165264|P2|Overall Study|Death|0
2953112|NCT01283516|10165265|P1|Overall Study|Death|0
2953113|NCT01283516|10165257|P9|Overall Study|Adverse Event|28
2953114|NCT01283516|10165258|P8|Overall Study|Adverse Event|0
2953115|NCT01283516|10165259|P7|Overall Study|Adverse Event|2
2953116|NCT01283516|10165260|P6|Overall Study|Adverse Event|0
2953117|NCT01283516|10165261|P5|Overall Study|Adverse Event|0
2953118|NCT01283516|10165262|P4|Overall Study|Adverse Event|0
2953119|NCT01283516|10165263|P3|Overall Study|Adverse Event|0
2953120|NCT01283516|10165264|P2|Overall Study|Adverse Event|0
2953121|NCT01283516|10165265|P1|Overall Study|Adverse Event|0
2953122|NCT01283464|10165387|P2|Overall Study|Physician Decision|0
2953123|NCT01283464|10165388|P1|Overall Study|Physician Decision|1
2953124|NCT01283464|10165387|P2|Overall Study|Withdrawal by Subject|0
2953125|NCT01283464|10165388|P1|Overall Study|Withdrawal by Subject|1
2953126|NCT01283464|10165387|P2|Overall Study|Lost to Follow-up|1
2953127|NCT01283464|10165388|P1|Overall Study|Lost to Follow-up|0
2953128|NCT01283386|10165396|P2|Overall Study|Protocol Violation|1
2953129|NCT01283386|10165397|P1|Overall Study|Protocol Violation|0
2953130|NCT01283386|10165396|P2|Overall Study|Reason not specified|0
2953131|NCT01283386|10165397|P1|Overall Study|Reason not specified|1
2953132|NCT01283386|10165396|P2|Overall Study|Progression of underlying disease|7
2953133|NCT01283386|10165397|P1|Overall Study|Progression of underlying disease|2
2953134|NCT01283386|10165396|P2|Overall Study|Relapse of underlying disease|3
2953135|NCT01283386|10165397|P1|Overall Study|Relapse of underlying disease|1
2953136|NCT01283386|10165396|P2|Overall Study|Withdrawal by Subject|1
2953137|NCT01283386|10165397|P1|Overall Study|Withdrawal by Subject|2
2953138|NCT01283386|10165396|P2|Overall Study|Death|0
2953139|NCT01283386|10165397|P1|Overall Study|Death|2
2953140|NCT01283334|10165421|P1|Overall Study|Physician Decision|1
2953141|NCT01283334|10165421|P1|Overall Study|Adverse Event|4
2953142|NCT01283334|10165421|P1|Overall Study|Inability to Swallow Everolimus Pills|1
2953143|NCT01283334|10165421|P1|Overall Study|Withdrawal by Subject|1
2953144|NCT01283282|10165444|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
2953145|NCT01283282|10165445|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
2953146|NCT01283282|10165444|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
2953147|NCT01283282|10165445|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
2953148|NCT01283282|10165444|P2|First Intervention (6 Weeks)|Physician Decision|1
2953149|NCT01283282|10165445|P1|First Intervention (6 Weeks)|Physician Decision|0
2953150|NCT01283152|10165465|P2|Overall Study|Refused HESA|0
2953151|NCT01283152|10165466|P1|Overall Study|Refused HESA|1
2953152|NCT01283152|10165465|P2|Overall Study|Discharged prior to 24 hr assessment|0
2953153|NCT01283152|10165466|P1|Overall Study|Discharged prior to 24 hr assessment|1
2953154|NCT01283139|10165480|P4|Overall Study|Participant randomized in error|0
2953155|NCT01283139|10165481|P3|Overall Study|Participant randomized in error|1
2953156|NCT01283139|10165482|P2|Overall Study|Participant randomized in error|0
2953157|NCT01283139|10165483|P1|Overall Study|Participant randomized in error|0
2953158|NCT01283139|10165480|P4|Overall Study|Missed follow-up visit|2
2953159|NCT01283139|10165481|P3|Overall Study|Missed follow-up visit|2
2953160|NCT01283139|10165482|P2|Overall Study|Missed follow-up visit|1
2953161|NCT01283139|10165483|P1|Overall Study|Missed follow-up visit|0
2953162|NCT01283139|10165480|P4|Overall Study|Pregnancy|0
2953163|NCT01283139|10165481|P3|Overall Study|Pregnancy|1
2953164|NCT01283139|10165482|P2|Overall Study|Pregnancy|1
2953165|NCT01283139|10165483|P1|Overall Study|Pregnancy|0
2953166|NCT01283139|10165480|P4|Overall Study|Participant's refusal to continue|1
2953167|NCT01283139|10165481|P3|Overall Study|Participant's refusal to continue|1
2953168|NCT01283139|10165482|P2|Overall Study|Participant's refusal to continue|3
2953169|NCT01283139|10165483|P1|Overall Study|Participant's refusal to continue|0
2953170|NCT01283139|10165480|P4|Overall Study|Early termination due to AE/SAE|0
2953171|NCT01283139|10165481|P3|Overall Study|Early termination due to AE/SAE|0
2953172|NCT01283139|10165482|P2|Overall Study|Early termination due to AE/SAE|1
2953173|NCT01283139|10165483|P1|Overall Study|Early termination due to AE/SAE|1
2953174|NCT01283139|10165480|P4|Overall Study|Lack of Efficacy|1
2953175|NCT01283139|10165481|P3|Overall Study|Lack of Efficacy|2
2953176|NCT01283139|10165482|P2|Overall Study|Lack of Efficacy|2
2953177|NCT01283139|10165483|P1|Overall Study|Lack of Efficacy|1
2953178|NCT01283139|10165480|P4|Overall Study|Death|2
2953179|NCT01283139|10165481|P3|Overall Study|Death|2
2953180|NCT01283139|10165482|P2|Overall Study|Death|0
2953181|NCT01283139|10165483|P1|Overall Study|Death|2
2953182|NCT01283139|10165480|P4|Overall Study|Withdrawal by Subject|8
2953183|NCT01283139|10165481|P3|Overall Study|Withdrawal by Subject|6
2953184|NCT01283139|10165482|P2|Overall Study|Withdrawal by Subject|8
2953185|NCT01283139|10165483|P1|Overall Study|Withdrawal by Subject|8
2953186|NCT01283139|10165480|P4|Overall Study|Lost to Follow-up|1
2953187|NCT01283139|10165481|P3|Overall Study|Lost to Follow-up|3
2953188|NCT01283139|10165482|P2|Overall Study|Lost to Follow-up|2
2953189|NCT01283139|10165483|P1|Overall Study|Lost to Follow-up|5
2953190|NCT01283035|10165525|P1|Overall Study|Subject later found ineligible|1
2953191|NCT01282866|10165540|P1|Overall Study|Adverse Event|1
2953192|NCT01282814|10165548|P2|Washout of 7 Days|Withdrawal by Subject|0
2953193|NCT01282814|10165549|P1|Washout of 7 Days|Withdrawal by Subject|2
2953194|NCT01282814|10165548|P2|First Intervention|Emesis During Dosing Interval|3
2953195|NCT01282814|10165549|P1|First Intervention|Emesis During Dosing Interval|0
2953196|NCT01282801|10165561|P2|Second Intervention|Emesis During Critical Breakfast|1
2953197|NCT01282801|10165562|P1|Second Intervention|Emesis During Critical Breakfast|0
2953198|NCT01282476|10165586|P1|Overall Study|Death|11
2953199|NCT01282463|10165595|P3|Overall Study|Physician Decision|0
2953200|NCT01282463|10165596|P2|Overall Study|Physician Decision|0
2953201|NCT01282463|10165597|P1|Overall Study|Physician Decision|1
2953202|NCT01282463|10165595|P3|Overall Study|Protocol Violation|1
2953203|NCT01282463|10165596|P2|Overall Study|Protocol Violation|0
2953204|NCT01282463|10165597|P1|Overall Study|Protocol Violation|0
2953205|NCT01282463|10165595|P3|Overall Study|"Never Treated PD"|0
2953206|NCT01282463|10165596|P2|Overall Study|"Never Treated PD"|1
2953207|NCT01282463|10165597|P1|Overall Study|"Never Treated PD"|0
2953208|NCT01282463|10165595|P3|Overall Study|"Never Treated Death"|0
2953209|NCT01282463|10165596|P2|Overall Study|"Never Treated Death"|1
2953210|NCT01282463|10165597|P1|Overall Study|"Never Treated Death"|0
2953211|NCT01282463|10165595|P3|Overall Study|Withdrawal by Subject|3
2953212|NCT01282463|10165596|P2|Overall Study|Withdrawal by Subject|2
2953213|NCT01282463|10165597|P1|Overall Study|Withdrawal by Subject|6
2953214|NCT01282463|10165595|P3|Overall Study|Lost to Follow-up|0
2953215|NCT01282463|10165596|P2|Overall Study|Lost to Follow-up|0
2953216|NCT01282463|10165597|P1|Overall Study|Lost to Follow-up|1
2953217|NCT01282424|10165635|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
2953218|NCT01282424|10165635|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
2953219|NCT01282424|10165635|P1|Long-term Follow-up Period (5 Years)|Death|40
2953220|NCT01282424|10165635|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
2953221|NCT01282424|10165635|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
2953222|NCT01282424|10165635|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
2953223|NCT01282424|10165635|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
2953224|NCT01282424|10165635|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
2953225|NCT01282372|10165652|P1|Overall Study|Adverse Event|12
2953226|NCT01282372|10165652|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
2953227|NCT01282372|10165652|P1|Overall Study|Presence of AE, Regression of Symptoms|1
2953228|NCT01282372|10165652|P1|Overall Study|Presence of AE, Lack of Efficacy|1
2953229|NCT01282372|10165652|P1|Overall Study|Death|1
2953230|NCT01282372|10165652|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
2953231|NCT01282372|10165652|P1|Overall Study|Withdrawal by Subject|11
2953232|NCT01282372|10165652|P1|Overall Study|Lost to Follow-up|23
2953233|NCT01282372|10165652|P1|Overall Study|Lack of Efficacy / Exacerbation|25
2953234|NCT01282294|10165680|P1|Overall Study|Physician Decision|1
2953235|NCT01282294|10165680|P1|Overall Study|Patient non-compliance|2
2953236|NCT01282294|10165680|P1|Overall Study|Adverse Event|1
2953237|NCT01282294|10165680|P1|Overall Study|Screening failure|1
2953238|NCT01282294|10165680|P1|Overall Study|Lost to Follow-up|14
2953239|NCT01282229|10165709|P1|Overall Study|Protocol Violation|2
2953240|NCT01282216|10165741|P4|Overall Study|Death|0
2953241|NCT01282216|10165742|P3|Overall Study|Death|2
2953242|NCT01282216|10165743|P2|Overall Study|Death|0
2953243|NCT01282216|10165744|P1|Overall Study|Death|0
2953244|NCT01282216|10165741|P4|Overall Study|Relapse|6
2953245|NCT01282216|10165742|P3|Overall Study|Relapse|17
2953246|NCT01282216|10165743|P2|Overall Study|Relapse|0
2953247|NCT01282216|10165744|P1|Overall Study|Relapse|0
2953248|NCT01282216|10165741|P4|Overall Study|Physician Decision|0
2953249|NCT01282216|10165742|P3|Overall Study|Physician Decision|11
2953250|NCT01282216|10165743|P2|Overall Study|Physician Decision|0
2953251|NCT01282216|10165744|P1|Overall Study|Physician Decision|0
2953252|NCT01282216|10165741|P4|Overall Study|Graft failure|2
2953253|NCT01282216|10165742|P3|Overall Study|Graft failure|3
2953254|NCT01282216|10165743|P2|Overall Study|Graft failure|0
2953255|NCT01282216|10165744|P1|Overall Study|Graft failure|0
2953256|NCT01282203|10165754|P1|Overall Study|Adverse Event|1
2953257|NCT01282164|10165776|P2|Overall Study|Lack of hypoglycemia during ITT|0
2953258|NCT01282164|10165777|P1|Overall Study|Lack of hypoglycemia during ITT|1
2953259|NCT01281969|10165830|P3|Overall Study|not randomized, child consent not given|2
2953260|NCT01281969|10165831|P2|Overall Study|not randomized, child consent not given|0
2953261|NCT01281969|10165832|P1|Overall Study|not randomized, child consent not given|0
2953262|NCT01281969|10165830|P3|Overall Study|AE during LP prior to IVIG admin|3
2953263|NCT01281969|10165831|P2|Overall Study|AE during LP prior to IVIG admin|0
2953264|NCT01281969|10165832|P1|Overall Study|AE during LP prior to IVIG admin|1
2953265|NCT01281969|10165830|P3|Overall Study|not randomized didn't meet criteria|7
2953266|NCT01281969|10165831|P2|Overall Study|not randomized didn't meet criteria|0
2953267|NCT01281969|10165832|P1|Overall Study|not randomized didn't meet criteria|0
2953268|NCT01281956|10165844|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
2953269|NCT01281956|10165845|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
2953270|NCT01281917|10165876|P1|Overall Study|Withdrawal by Subject|1
2953271|NCT01281865|10165888|P2|Overall Study|Lack of Efficacy|0
2953272|NCT01281865|10165889|P1|Overall Study|Lack of Efficacy|1
2953273|NCT01281865|10165888|P2|Overall Study|Withdrawal by Subject|0
2953274|NCT01281865|10165889|P1|Overall Study|Withdrawal by Subject|1
2953275|NCT01281865|10165888|P2|Overall Study|Adverse Event|1
2953276|NCT01281865|10165889|P1|Overall Study|Adverse Event|1
2953277|NCT01281839|10165897|P2|Overall Study|Reason not specified|1
2953278|NCT01281839|10165898|P1|Overall Study|Reason not specified|0
2953279|NCT01281839|10165897|P2|Overall Study|Withdrawal by Subject|10
2953280|NCT01281839|10165898|P1|Overall Study|Withdrawal by Subject|4
2953281|NCT01281839|10165897|P2|Overall Study|Lost to Follow-up|3
2953282|NCT01281839|10165898|P1|Overall Study|Lost to Follow-up|6
2953283|NCT01281644|10165959|P1|Overall Study|Withdrawal by Subject|2
2953284|NCT01281644|10165959|P1|Overall Study|Lost to Follow-up|3
2953285|NCT01281306|10166000|P7|Overall Study|Randomized in error|0
2953286|NCT01281306|10166001|P6|Overall Study|Randomized in error|0
2953287|NCT01281306|10166002|P5|Overall Study|Randomized in error|0
2953288|NCT01281306|10166003|P4|Overall Study|Randomized in error|1
2953289|NCT01281306|10166004|P3|Overall Study|Randomized in error|0
2953290|NCT01281306|10166005|P2|Overall Study|Randomized in error|0
2953291|NCT01281306|10166006|P1|Overall Study|Randomized in error|1
2953292|NCT01281306|10166000|P7|Overall Study|Adverse Event|3
2953293|NCT01281306|10166001|P6|Overall Study|Adverse Event|3
2953294|NCT01281306|10166002|P5|Overall Study|Adverse Event|5
2953295|NCT01281306|10166003|P4|Overall Study|Adverse Event|3
2953296|NCT01281306|10166004|P3|Overall Study|Adverse Event|2
2953297|NCT01281306|10166005|P2|Overall Study|Adverse Event|2
2953298|NCT01281306|10166006|P1|Overall Study|Adverse Event|3
2953299|NCT01281306|10166000|P7|Overall Study|Death|0
2953300|NCT01281306|10166001|P6|Overall Study|Death|0
2953301|NCT01281306|10166002|P5|Overall Study|Death|0
2953302|NCT01281306|10166003|P4|Overall Study|Death|0
2953303|NCT01281306|10166004|P3|Overall Study|Death|0
2953304|NCT01281306|10166005|P2|Overall Study|Death|0
2953305|NCT01281306|10166006|P1|Overall Study|Death|1
2953306|NCT01281306|10166000|P7|Overall Study|Lost to Follow-up|1
2953307|NCT01281306|10166001|P6|Overall Study|Lost to Follow-up|0
2953308|NCT01281306|10166002|P5|Overall Study|Lost to Follow-up|0
2953309|NCT01281306|10166003|P4|Overall Study|Lost to Follow-up|2
2953310|NCT01281306|10166004|P3|Overall Study|Lost to Follow-up|0
2953311|NCT01281306|10166005|P2|Overall Study|Lost to Follow-up|0
2953312|NCT01281306|10166006|P1|Overall Study|Lost to Follow-up|1
2953313|NCT01281306|10166000|P7|Overall Study|Condition no longer requires study drug|1
2953314|NCT01281306|10166001|P6|Overall Study|Condition no longer requires study drug|1
2953315|NCT01281306|10166002|P5|Overall Study|Condition no longer requires study drug|0
2953316|NCT01281306|10166003|P4|Overall Study|Condition no longer requires study drug|0
2953317|NCT01281306|10166004|P3|Overall Study|Condition no longer requires study drug|0
2953318|NCT01281306|10166005|P2|Overall Study|Condition no longer requires study drug|0
2953319|NCT01281306|10166006|P1|Overall Study|Condition no longer requires study drug|1
2953320|NCT01281306|10166000|P7|Overall Study|Protocol deviation|0
2953321|NCT01281306|10166001|P6|Overall Study|Protocol deviation|0
2953322|NCT01281306|10166002|P5|Overall Study|Protocol deviation|1
2953323|NCT01281306|10166003|P4|Overall Study|Protocol deviation|1
2953324|NCT01281306|10166004|P3|Overall Study|Protocol deviation|1
2953325|NCT01281306|10166005|P2|Overall Study|Protocol deviation|1
2953326|NCT01281306|10166006|P1|Overall Study|Protocol deviation|0
2953327|NCT01281306|10166000|P7|Overall Study|Withdrawal by Subject|1
2953328|NCT01281306|10166001|P6|Overall Study|Withdrawal by Subject|3
2953329|NCT01281306|10166002|P5|Overall Study|Withdrawal by Subject|1
2953330|NCT01281306|10166003|P4|Overall Study|Withdrawal by Subject|4
2953331|NCT01281306|10166004|P3|Overall Study|Withdrawal by Subject|2
2953332|NCT01281306|10166005|P2|Overall Study|Withdrawal by Subject|0
2953333|NCT01281306|10166006|P1|Overall Study|Withdrawal by Subject|1
2953334|NCT01281306|10166000|P7|Overall Study|Lack of Efficacy|1
2953335|NCT01281306|10166001|P6|Overall Study|Lack of Efficacy|0
2953336|NCT01281306|10166002|P5|Overall Study|Lack of Efficacy|2
2953337|NCT01281306|10166003|P4|Overall Study|Lack of Efficacy|0
2953338|NCT01281306|10166004|P3|Overall Study|Lack of Efficacy|3
2953339|NCT01281306|10166005|P2|Overall Study|Lack of Efficacy|1
2953340|NCT01281306|10166006|P1|Overall Study|Lack of Efficacy|0
2953341|NCT01281202|10166122|P2|Overall Study|Incarceration|3
2953342|NCT01281202|10166123|P1|Overall Study|Incarceration|0
2953343|NCT01281202|10166122|P2|Overall Study|Lost to Follow-up|13
2953344|NCT01281202|10166123|P1|Overall Study|Lost to Follow-up|11
2953345|NCT01281202|10166122|P2|Overall Study|Administrative|8
2953346|NCT01281202|10166123|P1|Overall Study|Administrative|2
2953347|NCT01281202|10166122|P2|Overall Study|Protocol Violation|10
2953348|NCT01281202|10166123|P1|Overall Study|Protocol Violation|11
2953349|NCT01281202|10166122|P2|Overall Study|Withdrawal by Subject|2
2953350|NCT01281202|10166123|P1|Overall Study|Withdrawal by Subject|2
2953351|NCT01281202|10166122|P2|Overall Study|Adverse Event|0
2953352|NCT01281202|10166123|P1|Overall Study|Adverse Event|2
2953353|NCT01281124|10166131|P1|Overall Study|Death|1
2953354|NCT01280981|10166146|P1|Overall Study|Study site closure|1
2953355|NCT01280981|10166146|P1|Overall Study|Elective surgery|2
2953356|NCT01280981|10166146|P1|Overall Study|Withdrawal of consent|3
2953357|NCT01280981|10166146|P1|Overall Study|Non-compliance with protocol|3
2953358|NCT01280981|10166146|P1|Overall Study|Failed to return|45
2953359|NCT01280981|10166146|P1|Overall Study|Irregular or discontinued menses|3
2953360|NCT01280981|10166146|P1|Overall Study|Adverse Event|6
2953361|NCT01280981|10166146|P1|Overall Study|Lost to Follow-up|3
2953362|NCT01280981|10166146|P1|Overall Study|Lack of Efficacy|13
2953363|NCT01280981|10166146|P1|Overall Study|Protocol Violation|2
2953364|NCT01280981|10166146|P1|Overall Study|Withdrawal by Subject|11
2953365|NCT01280968|10166157|P2|Overall Study|Unable to Smoke in Supine Position|0
2953366|NCT01280968|10166158|P1|Overall Study|Unable to Smoke in Supine Position|1
2953367|NCT01280968|10166157|P2|Overall Study|Pre-existing Neurological Condition|0
2953368|NCT01280968|10166158|P1|Overall Study|Pre-existing Neurological Condition|1
2953369|NCT01280968|10166157|P2|Overall Study|Scheduling Conflicts|1
2953370|NCT01280968|10166158|P1|Overall Study|Scheduling Conflicts|1
2953371|NCT01280968|10166157|P2|Overall Study|Adverse Event|0
2953372|NCT01280968|10166158|P1|Overall Study|Adverse Event|1
2953373|NCT01280968|10166157|P2|Overall Study|Anxiety|0
2953374|NCT01280968|10166158|P1|Overall Study|Anxiety|2
2953375|NCT01280968|10166157|P2|Overall Study|Commuting Problems|0
2953376|NCT01280968|10166158|P1|Overall Study|Commuting Problems|2
2953377|NCT01280968|10166157|P2|Overall Study|Unable to Follow Experimental Protocol|0
2953378|NCT01280968|10166158|P1|Overall Study|Unable to Follow Experimental Protocol|2
2953379|NCT01280968|10166157|P2|Overall Study|Lost to Follow-up|2
2953380|NCT01280968|10166158|P1|Overall Study|Lost to Follow-up|8
2953381|NCT01280955|10166174|P1|Overall Study|Withdrawal by Subject|1
2953382|NCT01280955|10166174|P1|Overall Study|Death|2
2953383|NCT01280903|10166218|P2|Overall Study|Lost to Follow-up|16
2953384|NCT01280903|10166219|P1|Overall Study|Lost to Follow-up|23
2953385|NCT01280721|10166283|P1|Overall Study|No tolerability for the lowest dose|2
2953386|NCT01280721|10166283|P1|Overall Study|eGFR under the withdrawal criteria|7
2953387|NCT01280721|10166283|P1|Overall Study|Withdrawal by Subject|6
2953388|NCT01280721|10166283|P1|Overall Study|Physician Decision|3
2953389|NCT01280721|10166283|P1|Overall Study|Adverse Event|4
2953390|NCT01280656|10166347|P3|Overall Study|Other|7
2953391|NCT01280656|10166348|P2|Overall Study|Other|7
2953392|NCT01280656|10166349|P1|Overall Study|Other|1
2953393|NCT01280656|10166347|P3|Overall Study|Treatment shortening (RGT)|5
2953394|NCT01280656|10166348|P2|Overall Study|Treatment shortening (RGT)|4
2953395|NCT01280656|10166349|P1|Overall Study|Treatment shortening (RGT)|0
2953396|NCT01280656|10166347|P3|Overall Study|Lack of Efficacy|38
2953397|NCT01280656|10166348|P2|Overall Study|Lack of Efficacy|22
2953398|NCT01280656|10166349|P1|Overall Study|Lack of Efficacy|1
2953399|NCT01280656|10166347|P3|Overall Study|Adverse Event|13
2953400|NCT01280656|10166348|P2|Overall Study|Adverse Event|14
2953401|NCT01280656|10166349|P1|Overall Study|Adverse Event|1
2953402|NCT01280591|10166416|P4|Overall Study|Does not meet exclusion #27 criteria|1
2953403|NCT01280591|10166417|P3|Overall Study|Does not meet exclusion #27 criteria|0
2953404|NCT01280591|10166418|P2|Overall Study|Does not meet exclusion #27 criteria|0
2953405|NCT01280591|10166419|P1|Overall Study|Does not meet exclusion #27 criteria|0
2953406|NCT01280591|10166416|P4|Overall Study|Withdrawal by Subject|2
2953407|NCT01280591|10166417|P3|Overall Study|Withdrawal by Subject|0
2953408|NCT01280591|10166418|P2|Overall Study|Withdrawal by Subject|0
2953409|NCT01280591|10166419|P1|Overall Study|Withdrawal by Subject|0
2953410|NCT01280357|10166557|P1|Overall Study|IInsufficient data/No data supplied|12
2953411|NCT01280357|10166557|P1|Overall Study|Excluded no internal monitoring|14
2953412|NCT01280266|10166566|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
2953413|NCT01280266|10166567|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
2953414|NCT01280266|10166566|P2|First Intervention (Week 1-4)|Adverse Event|0
2953415|NCT01280266|10166567|P1|First Intervention (Week 1-4)|Adverse Event|1
2953416|NCT01279954|10166658|P2|Overall Study|Lack of Efficacy|4
2953417|NCT01279954|10166659|P1|Overall Study|Lack of Efficacy|3
2953418|NCT01279850|10166670|P1|Overall Study|No Visit After Treatment|34
2953419|NCT01279850|10166670|P1|Overall Study|No Drug Administration Information|7
2953420|NCT01279850|10166670|P1|Overall Study|Protocol Violation|50
2953421|NCT01279681|10166686|P2|Overall Study|Other Reason|2
2953422|NCT01279681|10166687|P1|Overall Study|Other Reason|0
2953423|NCT01279681|10166686|P2|Overall Study|Physician Decision|0
2953424|NCT01279681|10166687|P1|Overall Study|Physician Decision|1
2953425|NCT01279681|10166686|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
2953426|NCT01279681|10166687|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
2953427|NCT01279681|10166686|P2|Overall Study|Death|1
2953428|NCT01279681|10166687|P1|Overall Study|Death|0
2953429|NCT01279681|10166686|P2|Overall Study|Adverse Event|3
2953430|NCT01279681|10166687|P1|Overall Study|Adverse Event|2
2953431|NCT01279681|10166686|P2|Overall Study|Withdrawal by Subject|4
2953432|NCT01279681|10166687|P1|Overall Study|Withdrawal by Subject|3
2953433|NCT01279681|10166686|P2|Overall Study|Disease Progression|6
2953434|NCT01279681|10166687|P1|Overall Study|Disease Progression|9
2953435|NCT01279616|10166699|P1|Overall Study|no signs of sickle cell disease|2
2953436|NCT01279616|10166699|P1|Overall Study|donor could not be located|5
2953437|NCT01279486|10166712|P1|Overall Study|Lost to Follow-up|1
2953438|NCT01279447|10166718|P2|Overall Study|Lost to Follow-up|1
2953439|NCT01279447|10166719|P1|Overall Study|Lost to Follow-up|3
2953440|NCT01279343|10166727|P2|Overall Study|Did not receive treatment|6
2953441|NCT01279343|10166728|P1|Overall Study|Did not receive treatment|2
2953442|NCT01279200|10166773|P2|Overall Study|Adverse Event|0
2953443|NCT01279200|10166774|P1|Overall Study|Adverse Event|1
2953444|NCT01279200|10166773|P2|Overall Study|Lost to Follow-up|1
2953445|NCT01279200|10166774|P1|Overall Study|Lost to Follow-up|0
2953446|NCT01279200|10166773|P2|Overall Study|ultrasound screening failure|1
2953447|NCT01279200|10166774|P1|Overall Study|ultrasound screening failure|0
2953448|NCT01279200|10166773|P2|Overall Study|Inconvenience of ultrasound visit|1
2953449|NCT01279200|10166774|P1|Overall Study|Inconvenience of ultrasound visit|0
2953450|NCT01279200|10166773|P2|Overall Study|Patient withdrawal due to high cost|1
2953451|NCT01279200|10166774|P1|Overall Study|Patient withdrawal due to high cost|0
2953452|NCT01279200|10166773|P2|Overall Study|Withdrawal by Subject|3
2953453|NCT01279200|10166774|P1|Overall Study|Withdrawal by Subject|1
2953454|NCT01279070|10166812|P2|Overall Study|Acute exacerbation|1
2953455|NCT01279070|10166813|P1|Overall Study|Acute exacerbation|3
2953456|NCT01279070|10166812|P2|Overall Study|Withdrawal by Subject|3
2953457|NCT01279070|10166813|P1|Overall Study|Withdrawal by Subject|2
2953458|NCT01279044|10166832|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
2953459|NCT01279044|10166833|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
2953460|NCT01279044|10166834|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
2953461|NCT01279044|10166832|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2953462|NCT01279044|10166833|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
2953463|NCT01279044|10166834|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2953464|NCT01279044|10166832|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
2953465|NCT01279044|10166833|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
2953466|NCT01279044|10166834|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
2953467|NCT01278862|10166910|P2|Overall Study|Lost to Follow-up|1
2953468|NCT01278862|10166911|P1|Overall Study|Lost to Follow-up|1
2953469|NCT01278797|10166919|P2|Period 1|Protocol Violation|0
2953470|NCT01278797|10166920|P1|Period 1|Protocol Violation|1
2953471|NCT01278797|10166919|P2|Period 1|Adverse Event|1
2953472|NCT01278797|10166920|P1|Period 1|Adverse Event|0
2953473|NCT01278745|10166932|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
2953474|NCT01278745|10166933|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
2953475|NCT01278745|10166934|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
2953476|NCT01278745|10166935|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
2953477|NCT01278745|10166932|P4|Overall Study|Ineligible|61
2953478|NCT01278745|10166933|P3|Overall Study|Ineligible|42
2953479|NCT01278745|10166934|P2|Overall Study|Ineligible|0
2953480|NCT01278745|10166935|P1|Overall Study|Ineligible|0
2953481|NCT01278745|10166932|P4|Overall Study|Sponsor Decision|6
2953482|NCT01278745|10166933|P3|Overall Study|Sponsor Decision|62
2953483|NCT01278745|10166934|P2|Overall Study|Sponsor Decision|0
2953484|NCT01278745|10166935|P1|Overall Study|Sponsor Decision|1
2953485|NCT01278745|10166932|P4|Overall Study|Withdrawal by Subject|1
2953486|NCT01278745|10166933|P3|Overall Study|Withdrawal by Subject|5
2953487|NCT01278745|10166934|P2|Overall Study|Withdrawal by Subject|1
2953488|NCT01278745|10166935|P1|Overall Study|Withdrawal by Subject|1
2953489|NCT01278745|10166932|P4|Overall Study|Physician Decision|9
2953490|NCT01278745|10166933|P3|Overall Study|Physician Decision|0
2953491|NCT01278745|10166934|P2|Overall Study|Physician Decision|0
2953492|NCT01278745|10166935|P1|Overall Study|Physician Decision|1
2953493|NCT01278745|10166932|P4|Overall Study|Death|0
2953494|NCT01278745|10166933|P3|Overall Study|Death|7
2953495|NCT01278745|10166934|P2|Overall Study|Death|5
2953496|NCT01278745|10166935|P1|Overall Study|Death|2
2953497|NCT01278615|10166967|P1|Overall Study|Withdrawal by Subject|2
2953498|NCT01278407|10166993|P5|Extension Phase|Other|3
2953499|NCT01278407|10166994|P4|Extension Phase|Other|1
2953500|NCT01278407|10166995|P3|Extension Phase|Other|0
2953501|NCT01278407|10166996|P2|Extension Phase|Other|0
2953502|NCT01278407|10166997|P1|Extension Phase|Other|0
2953503|NCT01278407|10166993|P5|Extension Phase|Participant's Choice|11
2953504|NCT01278407|10166994|P4|Extension Phase|Participant's Choice|4
2953505|NCT01278407|10166995|P3|Extension Phase|Participant's Choice|0
2953506|NCT01278407|10166996|P2|Extension Phase|Participant's Choice|0
2953507|NCT01278407|10166997|P1|Extension Phase|Participant's Choice|0
2953508|NCT01278407|10166993|P5|Extension Phase|Adverse Event|16
2953509|NCT01278407|10166994|P4|Extension Phase|Adverse Event|7
2953510|NCT01278407|10166995|P3|Extension Phase|Adverse Event|0
2953511|NCT01278407|10166996|P2|Extension Phase|Adverse Event|0
2953512|NCT01278407|10166997|P1|Extension Phase|Adverse Event|0
2953513|NCT01278407|10166993|P5|Confirmatory Phase|Other|0
2953514|NCT01278407|10166994|P4|Confirmatory Phase|Other|0
2953515|NCT01278407|10166995|P3|Confirmatory Phase|Other|2
2953516|NCT01278407|10166996|P2|Confirmatory Phase|Other|1
2953517|NCT01278407|10166997|P1|Confirmatory Phase|Other|1
2953518|NCT01278407|10166993|P5|Confirmatory Phase|Participant's Choice|0
2953519|NCT01278407|10166994|P4|Confirmatory Phase|Participant's Choice|0
2953520|NCT01278407|10166995|P3|Confirmatory Phase|Participant's Choice|3
2953521|NCT01278407|10166996|P2|Confirmatory Phase|Participant's Choice|5
2953522|NCT01278407|10166997|P1|Confirmatory Phase|Participant's Choice|3
2953523|NCT01278407|10166993|P5|Confirmatory Phase|Adverse Event|0
2953524|NCT01278407|10166994|P4|Confirmatory Phase|Adverse Event|0
2953525|NCT01278407|10166995|P3|Confirmatory Phase|Adverse Event|1
2953526|NCT01278407|10166996|P2|Confirmatory Phase|Adverse Event|10
2953527|NCT01278407|10166997|P1|Confirmatory Phase|Adverse Event|5
2953528|NCT01278394|10167010|P1|Overall Study|Lost to Follow-up|1
2953529|NCT01278342|10167023|P3|Overall Study|Other|0
2953530|NCT01278342|10167024|P2|Overall Study|Other|0
2953531|NCT01278342|10167025|P1|Overall Study|Other|1
2953532|NCT01278342|10167023|P3|Overall Study|Administrative problems|0
2953533|NCT01278342|10167024|P2|Overall Study|Administrative problems|0
2953534|NCT01278342|10167025|P1|Overall Study|Administrative problems|2
2953535|NCT01278342|10167023|P3|Overall Study|Lost to Follow-up|0
2953536|NCT01278342|10167024|P2|Overall Study|Lost to Follow-up|0
2953537|NCT01278342|10167025|P1|Overall Study|Lost to Follow-up|1
2953538|NCT01278342|10167023|P3|Overall Study|Physician Decision|0
2953539|NCT01278342|10167024|P2|Overall Study|Physician Decision|1
2953540|NCT01278342|10167025|P1|Overall Study|Physician Decision|0
2953541|NCT01278173|10167045|P1|Overall Study|Withdrawal by Subject|1
2953542|NCT01278173|10167045|P1|Overall Study|Protocol Violation|1
2953543|NCT01278173|10167045|P1|Overall Study|Administrative or other reason|4
2953544|NCT01278173|10167045|P1|Overall Study|Adverse Event|8
2953545|NCT01278173|10167045|P1|Overall Study|Lack of Efficacy|13
2953546|NCT01278160|10167052|P2|Overall Study|Unclassified|2
2953547|NCT01278160|10167053|P1|Overall Study|Unclassified|1
2953548|NCT01278160|10167052|P2|Overall Study|Withdrawal by Subject|2
2953549|NCT01278160|10167053|P1|Overall Study|Withdrawal by Subject|3
2953550|NCT01278160|10167052|P2|Overall Study|Lost to Follow-up|1
2953551|NCT01278160|10167053|P1|Overall Study|Lost to Follow-up|0
2953552|NCT01278160|10167052|P2|Overall Study|Adverse Event|1
2953553|NCT01278160|10167053|P1|Overall Study|Adverse Event|1
2953554|NCT01278030|10167069|P2|Overall Study|Withdrawal by Subject|4
2953555|NCT01278030|10167070|P1|Overall Study|Withdrawal by Subject|8
2953556|NCT01277887|10167078|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
2953557|NCT01277887|10167079|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
2953558|NCT01277887|10167078|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
2953559|NCT01277887|10167079|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
2953560|NCT01277887|10167078|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
2953561|NCT01277887|10167079|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
2953562|NCT01277861|10167091|P2|Overall Study|Physician Decision|2
2953563|NCT01277861|10167092|P1|Overall Study|Physician Decision|2
2953564|NCT01277822|10167104|P2|Overall Study|Participant moved|0
2953565|NCT01277822|10167105|P1|Overall Study|Participant moved|1
2953566|NCT01277822|10167104|P2|Overall Study|Contraindicated medication used|1
2953567|NCT01277822|10167105|P1|Overall Study|Contraindicated medication used|2
2953568|NCT01277822|10167104|P2|Overall Study|Lost to Follow-up|1
2953569|NCT01277822|10167105|P1|Overall Study|Lost to Follow-up|2
2953570|NCT01277822|10167104|P2|Overall Study|Protocol Violation|0
2953571|NCT01277822|10167105|P1|Overall Study|Protocol Violation|1
2953572|NCT01277822|10167104|P2|Overall Study|Physician Decision|1
2953573|NCT01277822|10167105|P1|Overall Study|Physician Decision|1
2953574|NCT01277822|10167104|P2|Overall Study|Withdrawal by Subject|7
2953575|NCT01277822|10167105|P1|Overall Study|Withdrawal by Subject|6
2953576|NCT01277822|10167104|P2|Overall Study|Adverse Event|1
2953577|NCT01277822|10167105|P1|Overall Study|Adverse Event|2
2953578|NCT01277757|10167141|P1|Overall Study|Withdrawal by Subject|1
2953579|NCT01277757|10167141|P1|Overall Study|Disease Progression|1
2953580|NCT01277744|10167148|P1|Overall Study|Physician Decision|2
2953581|NCT01277718|10167153|P2|Period 2 - Second Intervention|Physician Decision|2
2953582|NCT01277718|10167154|P1|Period 2 - Second Intervention|Physician Decision|0
2953583|NCT01277718|10167153|P2|Period 2 - Second Intervention|Protocol Violation|1
2953584|NCT01277718|10167154|P1|Period 2 - Second Intervention|Protocol Violation|0
2953585|NCT01277666|10167168|P3|Overall Study|Death|1
2953586|NCT01277666|10167169|P2|Overall Study|Death|0
2953587|NCT01277666|10167170|P1|Overall Study|Death|0
2953588|NCT01277666|10167168|P3|Overall Study|Withdrawal by Subject|6
2953589|NCT01277666|10167169|P2|Overall Study|Withdrawal by Subject|8
2953590|NCT01277666|10167170|P1|Overall Study|Withdrawal by Subject|7
2953591|NCT01277666|10167168|P3|Overall Study|Lost to Follow-up|2
2953592|NCT01277666|10167169|P2|Overall Study|Lost to Follow-up|1
2953593|NCT01277666|10167170|P1|Overall Study|Lost to Follow-up|1
2953594|NCT01277666|10167168|P3|Overall Study|Protocol Defined Stopping criteria|6
2953595|NCT01277666|10167169|P2|Overall Study|Protocol Defined Stopping criteria|2
2953596|NCT01277666|10167170|P1|Overall Study|Protocol Defined Stopping criteria|1
2953597|NCT01277666|10167168|P3|Overall Study|Protocol Violation|2
2953598|NCT01277666|10167169|P2|Overall Study|Protocol Violation|3
2953599|NCT01277666|10167170|P1|Overall Study|Protocol Violation|2
2953600|NCT01277666|10167168|P3|Overall Study|Lack of Efficacy|12
2953601|NCT01277666|10167169|P2|Overall Study|Lack of Efficacy|20
2953602|NCT01277666|10167170|P1|Overall Study|Lack of Efficacy|8
2953603|NCT01277666|10167168|P3|Overall Study|Adverse Event|20
2953604|NCT01277666|10167169|P2|Overall Study|Adverse Event|25
2953605|NCT01277666|10167170|P1|Overall Study|Adverse Event|26
2953606|NCT01277601|10167203|P4|Overall Study|Subject Terminated from Study by Sponsor|2
2953607|NCT01277601|10167204|P3|Overall Study|Subject Terminated from Study by Sponsor|0
2953608|NCT01277601|10167205|P2|Overall Study|Subject Terminated from Study by Sponsor|1
2953609|NCT01277601|10167206|P1|Overall Study|Subject Terminated from Study by Sponsor|0
2953610|NCT01277601|10167203|P4|Overall Study|Protocol Violation|0
2953611|NCT01277601|10167204|P3|Overall Study|Protocol Violation|5
2953612|NCT01277601|10167205|P2|Overall Study|Protocol Violation|2
2953613|NCT01277601|10167206|P1|Overall Study|Protocol Violation|0
2953614|NCT01277601|10167203|P4|Overall Study|Subject Never Dosed with Study Drug|1
2953615|NCT01277601|10167204|P3|Overall Study|Subject Never Dosed with Study Drug|3
2953616|NCT01277601|10167205|P2|Overall Study|Subject Never Dosed with Study Drug|2
2953617|NCT01277601|10167206|P1|Overall Study|Subject Never Dosed with Study Drug|1
2953618|NCT01277601|10167203|P4|Overall Study|Noncompliance with Study Drug|0
2953619|NCT01277601|10167204|P3|Overall Study|Noncompliance with Study Drug|2
2953620|NCT01277601|10167205|P2|Overall Study|Noncompliance with Study Drug|3
2953621|NCT01277601|10167206|P1|Overall Study|Noncompliance with Study Drug|1
2953622|NCT01277601|10167203|P4|Overall Study|Pregnancy|1
2953623|NCT01277601|10167204|P3|Overall Study|Pregnancy|4
2953624|NCT01277601|10167205|P2|Overall Study|Pregnancy|2
2953625|NCT01277601|10167206|P1|Overall Study|Pregnancy|2
2953626|NCT01277601|10167203|P4|Overall Study|Physician Decision|6
2953627|NCT01277601|10167204|P3|Overall Study|Physician Decision|1
2953628|NCT01277601|10167205|P2|Overall Study|Physician Decision|5
2953629|NCT01277601|10167206|P1|Overall Study|Physician Decision|3
2953630|NCT01277601|10167203|P4|Overall Study|Lost to Follow-up|2
2953631|NCT01277601|10167204|P3|Overall Study|Lost to Follow-up|4
2953632|NCT01277601|10167205|P2|Overall Study|Lost to Follow-up|9
2953633|NCT01277601|10167206|P1|Overall Study|Lost to Follow-up|7
2953634|NCT01277601|10167203|P4|Overall Study|Withdrawal by Subject|17
2953635|NCT01277601|10167204|P3|Overall Study|Withdrawal by Subject|8
2953636|NCT01277601|10167205|P2|Overall Study|Withdrawal by Subject|21
2953637|NCT01277601|10167206|P1|Overall Study|Withdrawal by Subject|18
2953638|NCT01277601|10167203|P4|Overall Study|Adverse Event|7
2953639|NCT01277601|10167204|P3|Overall Study|Adverse Event|0
2953640|NCT01277601|10167205|P2|Overall Study|Adverse Event|3
2953641|NCT01277601|10167206|P1|Overall Study|Adverse Event|5
2953642|NCT01277549|10167297|P2|Overall Study|Physician Decision|1
2953643|NCT01277549|10167298|P1|Overall Study|Physician Decision|2
2953644|NCT01277549|10167297|P2|Overall Study|Protocol Violation|1
2953645|NCT01277549|10167298|P1|Overall Study|Protocol Violation|10
2953646|NCT01277549|10167297|P2|Overall Study|Withdrawal by Subject|3
2953647|NCT01277549|10167298|P1|Overall Study|Withdrawal by Subject|1
2953648|NCT01277549|10167297|P2|Overall Study|Failed to meet eligibility criteria|9
2953649|NCT01277549|10167298|P1|Overall Study|Failed to meet eligibility criteria|13
2953650|NCT01277523|10167315|P3|Overall Study|Other Reason not Defined|0
2953651|NCT01277523|10167316|P2|Overall Study|Other Reason not Defined|1
2953652|NCT01277523|10167317|P1|Overall Study|Other Reason not Defined|0
2953653|NCT01277523|10167315|P3|Overall Study|Protocol Violation|0
2953654|NCT01277523|10167316|P2|Overall Study|Protocol Violation|0
2953655|NCT01277523|10167317|P1|Overall Study|Protocol Violation|2
2953656|NCT01277523|10167315|P3|Overall Study|Adverse Event|0
2953657|NCT01277523|10167316|P2|Overall Study|Adverse Event|0
2953658|NCT01277523|10167317|P1|Overall Study|Adverse Event|1
2953659|NCT01277510|10167369|P2|Open-label Phase|Never received investigational product|0
2953660|NCT01277510|10167370|P1|Open-label Phase|Never received investigational product|2
2953661|NCT01277510|10167369|P2|Open-label Phase|Protocol-specified criteria|0
2953662|NCT01277510|10167370|P1|Open-label Phase|Protocol-specified criteria|1
2953663|NCT01277510|10167369|P2|Open-label Phase|Administrative decision|3
2953664|NCT01277510|10167370|P1|Open-label Phase|Administrative decision|4
2953665|NCT01277510|10167369|P2|Double-blind Phase|Other|1
2953666|NCT01277510|10167370|P1|Double-blind Phase|Other|1
2953667|NCT01277510|10167369|P2|Double-blind Phase|Protocol-specified criteria|6
2953668|NCT01277510|10167370|P1|Double-blind Phase|Protocol-specified criteria|2
2953669|NCT01277510|10167369|P2|Double-blind Phase|Death|1
2953670|NCT01277510|10167370|P1|Double-blind Phase|Death|0
2953671|NCT01277510|10167369|P2|Double-blind Phase|Administrative decision|9
2953672|NCT01277510|10167370|P1|Double-blind Phase|Administrative decision|7
2953673|NCT01277510|10167369|P2|Double-blind Phase|Withdrawal by Subject|0
2953674|NCT01277510|10167370|P1|Double-blind Phase|Withdrawal by Subject|2
2953675|NCT01277510|10167369|P2|Double-blind Phase|Adverse Event|0
2953676|NCT01277510|10167370|P1|Double-blind Phase|Adverse Event|1
2953677|NCT01277510|10167369|P2|Double-blind Phase|Non-compliance|1
2953678|NCT01277510|10167370|P1|Double-blind Phase|Non-compliance|0
2953679|NCT01277302|10167404|P3|8-Month Alternate Dose Regimen Period|Relocation|1
2953680|NCT01277302|10167405|P2|8-Month Alternate Dose Regimen Period|Relocation|0
2953681|NCT01277302|10167406|P1|8-Month Alternate Dose Regimen Period|Relocation|1
2953682|NCT01277302|10167404|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
2953683|NCT01277302|10167405|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
2953684|NCT01277302|10167406|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
2953685|NCT01277302|10167404|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
2953686|NCT01277302|10167405|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
2953687|NCT01277302|10167406|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
2953688|NCT01277302|10167404|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
2953689|NCT01277302|10167405|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2953690|NCT01277302|10167406|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2953691|NCT01277302|10167404|P3|8-Month Alternate Dose Regimen Period|Death|0
2953692|NCT01277302|10167405|P2|8-Month Alternate Dose Regimen Period|Death|1
2953693|NCT01277302|10167406|P1|8-Month Alternate Dose Regimen Period|Death|0
2953694|NCT01277302|10167404|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
2953695|NCT01277302|10167405|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
2953696|NCT01277302|10167406|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
2953697|NCT01277302|10167404|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
2953698|NCT01277302|10167405|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2953699|NCT01277302|10167406|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2953700|NCT01277302|10167404|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
2953701|NCT01277302|10167405|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
2953702|NCT01277302|10167406|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
2953703|NCT01277302|10167404|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
2953704|NCT01277302|10167405|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2953705|NCT01277302|10167406|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2953706|NCT01277211|10167438|P2|Overall Study|Discontinued prior to treatment|13
2953707|NCT01277211|10167439|P1|Overall Study|Discontinued prior to treatment|24
2953708|NCT01277211|10167438|P2|Overall Study|Pregnancy wish|2
2953709|NCT01277211|10167439|P1|Overall Study|Pregnancy wish|0
2953710|NCT01277211|10167438|P2|Overall Study|Administrative|0
2953711|NCT01277211|10167439|P1|Overall Study|Administrative|3
2953712|NCT01277211|10167438|P2|Overall Study|Did not meet protocol eligibility|0
2953713|NCT01277211|10167439|P1|Overall Study|Did not meet protocol eligibility|1
2953714|NCT01277211|10167438|P2|Overall Study|Non-compliance with protocol|4
2953715|NCT01277211|10167439|P1|Overall Study|Non-compliance with protocol|13
2953716|NCT01277211|10167438|P2|Overall Study|Withdrew Consent|9
2953717|NCT01277211|10167439|P1|Overall Study|Withdrew Consent|9
2953718|NCT01277211|10167438|P2|Overall Study|Did not wish to continue|0
2953719|NCT01277211|10167439|P1|Overall Study|Did not wish to continue|17
2953720|NCT01277211|10167438|P2|Overall Study|Lost to Follow-up|9
2953721|NCT01277211|10167439|P1|Overall Study|Lost to Follow-up|14
2953722|NCT01277211|10167438|P2|Overall Study|Pregnancy|4
2953723|NCT01277211|10167439|P1|Overall Study|Pregnancy|9
2953724|NCT01277211|10167438|P2|Overall Study|Adverse Event|22
2953725|NCT01277211|10167439|P1|Overall Study|Adverse Event|60
2953726|NCT01277042|10167491|P2|Overall Study|Withdrawal by Subject|0
2953727|NCT01277042|10167492|P1|Overall Study|Withdrawal by Subject|2
2953728|NCT01277042|10167491|P2|Overall Study|Lost to Follow-up|2
2953729|NCT01277042|10167492|P1|Overall Study|Lost to Follow-up|2
2953730|NCT01277042|10167491|P2|Overall Study|Adverse Event|3
2953731|NCT01277042|10167492|P1|Overall Study|Adverse Event|4
2953732|NCT01276847|10167517|P3|Overall Study|Withdrawal by Subject|0
2953733|NCT01276847|10167518|P2|Overall Study|Withdrawal by Subject|0
2953734|NCT01276847|10167519|P1|Overall Study|Withdrawal by Subject|1
2953735|NCT01276821|10167529|P2|Overall Study|Protocol Violation|1
2953736|NCT01276821|10167530|P1|Overall Study|Protocol Violation|0
2953737|NCT01276756|10167550|P2|Overall Study|Adverse Event|2
2953738|NCT01276756|10167551|P1|Overall Study|Adverse Event|3
2953739|NCT01276756|10167550|P2|Overall Study|Lost to Follow-up|0
2953740|NCT01276756|10167551|P1|Overall Study|Lost to Follow-up|2
2953741|NCT01276639|10167596|P5|Week 16 to 52|Other|3
2953742|NCT01276639|10167597|P4|Week 16 to 52|Other|1
2953743|NCT01276639|10167598|P3|Week 16 to 52|Other|0
2953744|NCT01276639|10167599|P2|Week 16 to 52|Other|12
2953745|NCT01276639|10167600|P1|Week 16 to 52|Other|10
2953746|NCT01276639|10167596|P5|Week 16 to 52|Withdrawal by Subject|1
2953747|NCT01276639|10167597|P4|Week 16 to 52|Withdrawal by Subject|0
2953748|NCT01276639|10167598|P3|Week 16 to 52|Withdrawal by Subject|0
2953749|NCT01276639|10167599|P2|Week 16 to 52|Withdrawal by Subject|4
2953750|NCT01276639|10167600|P1|Week 16 to 52|Withdrawal by Subject|4
2953751|NCT01276639|10167596|P5|Week 16 to 52|Lost to Follow-up|1
2953752|NCT01276639|10167597|P4|Week 16 to 52|Lost to Follow-up|0
2953753|NCT01276639|10167598|P3|Week 16 to 52|Lost to Follow-up|0
2953754|NCT01276639|10167599|P2|Week 16 to 52|Lost to Follow-up|1
2953755|NCT01276639|10167600|P1|Week 16 to 52|Lost to Follow-up|3
2953756|NCT01276639|10167596|P5|Week 16 to 52|Lack of Efficacy|13
2953757|NCT01276639|10167597|P4|Week 16 to 52|Lack of Efficacy|14
2953758|NCT01276639|10167598|P3|Week 16 to 52|Lack of Efficacy|0
2953759|NCT01276639|10167599|P2|Week 16 to 52|Lack of Efficacy|71
2953760|NCT01276639|10167600|P1|Week 16 to 52|Lack of Efficacy|99
2953761|NCT01276639|10167596|P5|Week 16 to 52|Adverse Event|3
2953762|NCT01276639|10167597|P4|Week 16 to 52|Adverse Event|1
2953763|NCT01276639|10167598|P3|Week 16 to 52|Adverse Event|0
2953764|NCT01276639|10167599|P2|Week 16 to 52|Adverse Event|13
2953765|NCT01276639|10167600|P1|Week 16 to 52|Adverse Event|10
2953766|NCT01276639|10167596|P5|Week 16 to 52|Death|0
2953767|NCT01276639|10167597|P4|Week 16 to 52|Death|0
2953768|NCT01276639|10167598|P3|Week 16 to 52|Death|0
2953769|NCT01276639|10167599|P2|Week 16 to 52|Death|0
2953770|NCT01276639|10167600|P1|Week 16 to 52|Death|1
2953771|NCT01276639|10167596|P5|Week 0 to 16|Randomized, But Not Treated|0
2953772|NCT01276639|10167597|P4|Week 0 to 16|Randomized, But Not Treated|0
2953773|NCT01276639|10167598|P3|Week 0 to 16|Randomized, But Not Treated|0
2953774|NCT01276639|10167599|P2|Week 0 to 16|Randomized, But Not Treated|1
2953775|NCT01276639|10167600|P1|Week 0 to 16|Randomized, But Not Treated|0
2953776|NCT01276639|10167596|P5|Week 0 to 16|Other|0
2953777|NCT01276639|10167597|P4|Week 0 to 16|Other|0
2953778|NCT01276639|10167598|P3|Week 0 to 16|Other|2
2953779|NCT01276639|10167599|P2|Week 0 to 16|Other|7
2953780|NCT01276639|10167600|P1|Week 0 to 16|Other|7
2953781|NCT01276639|10167596|P5|Week 0 to 16|Withdrawal by Subject|0
2953782|NCT01276639|10167597|P4|Week 0 to 16|Withdrawal by Subject|0
2953783|NCT01276639|10167598|P3|Week 0 to 16|Withdrawal by Subject|4
2953784|NCT01276639|10167599|P2|Week 0 to 16|Withdrawal by Subject|5
2953785|NCT01276639|10167600|P1|Week 0 to 16|Withdrawal by Subject|8
2953786|NCT01276639|10167596|P5|Week 0 to 16|Lost to Follow-up|0
2953787|NCT01276639|10167597|P4|Week 0 to 16|Lost to Follow-up|0
2953788|NCT01276639|10167598|P3|Week 0 to 16|Lost to Follow-up|3
2953789|NCT01276639|10167599|P2|Week 0 to 16|Lost to Follow-up|5
2953790|NCT01276639|10167600|P1|Week 0 to 16|Lost to Follow-up|3
2953791|NCT01276639|10167596|P5|Week 0 to 16|Lack of Efficacy|0
2953792|NCT01276639|10167597|P4|Week 0 to 16|Lack of Efficacy|0
2953793|NCT01276639|10167598|P3|Week 0 to 16|Lack of Efficacy|25
2953794|NCT01276639|10167599|P2|Week 0 to 16|Lack of Efficacy|15
2953795|NCT01276639|10167600|P1|Week 0 to 16|Lack of Efficacy|20
2953796|NCT01276639|10167596|P5|Week 0 to 16|Adverse Event|0
2953797|NCT01276639|10167597|P4|Week 0 to 16|Adverse Event|0
2953798|NCT01276639|10167598|P3|Week 0 to 16|Adverse Event|11
2953799|NCT01276639|10167599|P2|Week 0 to 16|Adverse Event|8
2953800|NCT01276639|10167600|P1|Week 0 to 16|Adverse Event|11
2953801|NCT01276639|10167596|P5|Week 0 to 16|Death|0
2953802|NCT01276639|10167597|P4|Week 0 to 16|Death|0
2953803|NCT01276639|10167598|P3|Week 0 to 16|Death|0
2953804|NCT01276639|10167599|P2|Week 0 to 16|Death|0
2953805|NCT01276639|10167600|P1|Week 0 to 16|Death|1
2953806|NCT01276509|10167805|P4|Overall Study|Other|0
2953807|NCT01276509|10167806|P3|Overall Study|Other|0
2953808|NCT01276509|10167807|P2|Overall Study|Other|1
2953809|NCT01276509|10167808|P1|Overall Study|Other|0
2953810|NCT01276509|10167805|P4|Overall Study|Withdrawal by Subject|0
2953811|NCT01276509|10167806|P3|Overall Study|Withdrawal by Subject|0
2953812|NCT01276509|10167807|P2|Overall Study|Withdrawal by Subject|2
2953813|NCT01276509|10167808|P1|Overall Study|Withdrawal by Subject|1
2953814|NCT01276509|10167805|P4|Overall Study|Pregnancy|0
2953815|NCT01276509|10167806|P3|Overall Study|Pregnancy|0
2953816|NCT01276509|10167807|P2|Overall Study|Pregnancy|0
2953817|NCT01276509|10167808|P1|Overall Study|Pregnancy|1
2953818|NCT01276509|10167805|P4|Overall Study|Lack of Efficacy|2
2953819|NCT01276509|10167806|P3|Overall Study|Lack of Efficacy|1
2953820|NCT01276509|10167807|P2|Overall Study|Lack of Efficacy|1
2953821|NCT01276509|10167808|P1|Overall Study|Lack of Efficacy|2
2953822|NCT01276509|10167805|P4|Overall Study|Adverse Event|3
2953823|NCT01276509|10167806|P3|Overall Study|Adverse Event|4
2953824|NCT01276509|10167807|P2|Overall Study|Adverse Event|8
2953825|NCT01276509|10167808|P1|Overall Study|Adverse Event|9
2953826|NCT01276457|10167861|P2|Extension Study|Lack of Efficacy|1
2953827|NCT01276457|10167862|P1|Extension Study|Lack of Efficacy|3
2953828|NCT01276457|10167861|P2|Extension Study|Death|1
2953829|NCT01276457|10167862|P1|Extension Study|Death|0
2953830|NCT01276457|10167861|P2|Extension Study|Lost to Follow-up|0
2953831|NCT01276457|10167862|P1|Extension Study|Lost to Follow-up|3
2953832|NCT01276457|10167861|P2|Core Study|Lack of Efficacy|12
2953833|NCT01276457|10167862|P1|Core Study|Lack of Efficacy|3
2953834|NCT01276457|10167861|P2|Core Study|Death|2
2953835|NCT01276457|10167862|P1|Core Study|Death|2
2953836|NCT01276457|10167861|P2|Core Study|Administrative problems|1
2953837|NCT01276457|10167862|P1|Core Study|Administrative problems|1
2953838|NCT01276457|10167861|P2|Core Study|Lost to Follow-up|2
2953839|NCT01276457|10167862|P1|Core Study|Lost to Follow-up|1
2953840|NCT01276457|10167861|P2|Core Study|Adverse Event|3
2953841|NCT01276457|10167862|P1|Core Study|Adverse Event|6
2953842|NCT01276353|10167876|P2|Extension|Prohibited concomitant medications|1
2953843|NCT01276353|10167877|P1|Extension|Prohibited concomitant medications|0
2953844|NCT01276353|10167876|P2|Extension|Physician Decision|0
2953845|NCT01276353|10167877|P1|Extension|Physician Decision|1
2953846|NCT01276353|10167876|P2|Extension|Withdrawal of study drug 4 days in a row|1
2953847|NCT01276353|10167877|P1|Extension|Withdrawal of study drug 4 days in a row|3
2953848|NCT01276353|10167876|P2|Extension|Withdrawal by Subject|2
2953849|NCT01276353|10167877|P1|Extension|Withdrawal by Subject|1
2953850|NCT01276353|10167876|P2|Extension|Adverse Event|5
2953851|NCT01276353|10167877|P1|Extension|Adverse Event|2
2953852|NCT01276353|10167876|P2|Double-blind|Withdrawal by Subject|0
2953853|NCT01276353|10167877|P1|Double-blind|Withdrawal by Subject|1
2953854|NCT01276353|10167876|P2|Double-blind|Adverse Event|0
2953855|NCT01276353|10167877|P1|Double-blind|Adverse Event|2
2953856|NCT01276327|10167889|P2|Overall Study|Withdrawal by Subject|0
2953857|NCT01276327|10167890|P1|Overall Study|Withdrawal by Subject|1
2953858|NCT01276327|10167889|P2|Overall Study|Adverse Event|3
2953859|NCT01276327|10167890|P1|Overall Study|Adverse Event|1
2953860|NCT01276288|10167957|P4|Overall Study|not treated|0
2953861|NCT01276288|10167958|P3|Overall Study|not treated|0
2953862|NCT01276288|10167959|P2|Overall Study|not treated|0
2953863|NCT01276288|10167960|P1|Overall Study|not treated|1
2953864|NCT01276288|10167957|P4|Overall Study|Adverse Event|0
2953865|NCT01276288|10167958|P3|Overall Study|Adverse Event|0
2953866|NCT01276288|10167959|P2|Overall Study|Adverse Event|1
2953867|NCT01276288|10167960|P1|Overall Study|Adverse Event|1
2953868|NCT01276223|10168087|P3|Overall Study|Protocol Violation|0
2953869|NCT01276223|10168088|P2|Overall Study|Protocol Violation|0
2953870|NCT01276223|10168089|P1|Overall Study|Protocol Violation|1
2953871|NCT01276223|10168087|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
2953872|NCT01276223|10168088|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
2953873|NCT01276223|10168089|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
2953874|NCT01276223|10168087|P3|Overall Study|Other|1
2953875|NCT01276223|10168088|P2|Overall Study|Other|0
2953876|NCT01276223|10168089|P1|Overall Study|Other|0
2953877|NCT01276223|10168087|P3|Overall Study|Lost to Follow-up|1
2953878|NCT01276223|10168088|P2|Overall Study|Lost to Follow-up|0
2953879|NCT01276223|10168089|P1|Overall Study|Lost to Follow-up|0
2953880|NCT01276223|10168087|P3|Overall Study|Adverse Event|1
2953881|NCT01276223|10168088|P2|Overall Study|Adverse Event|4
2953882|NCT01276223|10168089|P1|Overall Study|Adverse Event|7
2953883|NCT01276106|10168130|P4|Overall Study|Insufficient therapeutic effects|0
2953884|NCT01276106|10168131|P3|Overall Study|Insufficient therapeutic effects|2
2953885|NCT01276106|10168132|P2|Overall Study|Insufficient therapeutic effects|0
2953886|NCT01276106|10168133|P1|Overall Study|Insufficient therapeutic effects|0
2953887|NCT01276106|10168130|P4|Overall Study|Protocol Violation|2
2953888|NCT01276106|10168131|P3|Overall Study|Protocol Violation|0
2953889|NCT01276106|10168132|P2|Overall Study|Protocol Violation|1
2953890|NCT01276106|10168133|P1|Overall Study|Protocol Violation|1
2953891|NCT01276106|10168130|P4|Overall Study|Physician Decision|1
2953892|NCT01276106|10168131|P3|Overall Study|Physician Decision|1
2953893|NCT01276106|10168132|P2|Overall Study|Physician Decision|0
2953894|NCT01276106|10168133|P1|Overall Study|Physician Decision|0
2953895|NCT01276106|10168130|P4|Overall Study|Lost to Follow-up|0
2953896|NCT01276106|10168131|P3|Overall Study|Lost to Follow-up|1
2953897|NCT01276106|10168132|P2|Overall Study|Lost to Follow-up|1
2953898|NCT01276106|10168133|P1|Overall Study|Lost to Follow-up|2
2953899|NCT01276106|10168130|P4|Overall Study|Lack of Efficacy|1
2953900|NCT01276106|10168131|P3|Overall Study|Lack of Efficacy|0
2953901|NCT01276106|10168132|P2|Overall Study|Lack of Efficacy|1
2953902|NCT01276106|10168133|P1|Overall Study|Lack of Efficacy|0
2953903|NCT01276106|10168130|P4|Overall Study|Withdrawal by Subject|6
2953904|NCT01276106|10168131|P3|Overall Study|Withdrawal by Subject|1
2953905|NCT01276106|10168132|P2|Overall Study|Withdrawal by Subject|3
2953906|NCT01276106|10168133|P1|Overall Study|Withdrawal by Subject|6
2953907|NCT01276106|10168130|P4|Overall Study|Adverse Event|3
2953908|NCT01276106|10168131|P3|Overall Study|Adverse Event|11
2953909|NCT01276106|10168132|P2|Overall Study|Adverse Event|3
2953910|NCT01276106|10168133|P1|Overall Study|Adverse Event|3
2953911|NCT01276054|10168145|P2|Overall Study|No one to oversee trial after P.I. left|2
2953912|NCT01276054|10168146|P1|Overall Study|No one to oversee trial after P.I. left|2
2953913|NCT01275833|10168154|P2|Overall Study|Study terminated|1
2953914|NCT01275833|10168155|P1|Overall Study|Study terminated|1
2953915|NCT01275755|10168163|P2|Run-out Placebo Period|Lost to Follow-up|0
2953916|NCT01275755|10168164|P1|Run-out Placebo Period|Lost to Follow-up|1
2953917|NCT01275755|10168163|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2953918|NCT01275755|10168164|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2953919|NCT01275755|10168163|P2|Double-blind Treatment Period|Lost to Follow-up|1
2953920|NCT01275755|10168164|P1|Double-blind Treatment Period|Lost to Follow-up|1
2953921|NCT01275755|10168163|P2|Double-blind Treatment Period|Adverse Event|2
2953922|NCT01275755|10168164|P1|Double-blind Treatment Period|Adverse Event|0
2953923|NCT01275625|10168178|P1|Overall Study|Other|1
2953924|NCT01275625|10168178|P1|Overall Study|Adverse Event|4
2953925|NCT01275625|10168178|P1|Overall Study|Protocol Violation|1
2953926|NCT01275625|10168178|P1|Overall Study|Withdrawal by Subject|3
2953927|NCT01275625|10168178|P1|Overall Study|Lost to Follow-up|1
2953928|NCT01275625|10168178|P1|Overall Study|Lack of Efficacy|2
2953929|NCT01275625|10168178|P1|Overall Study|Death|1
2953930|NCT01275430|10168196|P1|Overall Study|Inability to achieve maximum p-wave|1
2953931|NCT01275430|10168196|P1|Overall Study|Device Malfunction|1
2953932|NCT01275430|10168196|P1|Overall Study|No Contrast Injection|6
2953933|NCT01275430|10168196|P1|Overall Study|Adverse Event|1
2953934|NCT01275339|10168261|P4|Overall Study|Withdrawal by Subject|0
2953935|NCT01275339|10168262|P3|Overall Study|Withdrawal by Subject|1
2953936|NCT01275339|10168263|P2|Overall Study|Withdrawal by Subject|0
2953937|NCT01275339|10168264|P1|Overall Study|Withdrawal by Subject|0
2953938|NCT01275339|10168261|P4|Overall Study|Referred for surgery for AS symptoms|0
2953939|NCT01275339|10168262|P3|Overall Study|Referred for surgery for AS symptoms|0
2953940|NCT01275339|10168263|P2|Overall Study|Referred for surgery for AS symptoms|0
2953941|NCT01275339|10168264|P1|Overall Study|Referred for surgery for AS symptoms|1
2953942|NCT01275196|10168285|P2|Overall Study|Suboptimal response/treatment failure|6
2953943|NCT01275196|10168286|P1|Overall Study|Suboptimal response/treatment failure|5
2953944|NCT01275196|10168285|P2|Overall Study|Protocol Violation|0
2953945|NCT01275196|10168286|P1|Overall Study|Protocol Violation|1
2953946|NCT01275196|10168285|P2|Overall Study|Disease Progression|5
2953947|NCT01275196|10168286|P1|Overall Study|Disease Progression|6
2953948|NCT01275196|10168285|P2|Overall Study|Lost to Follow-up|0
2953949|NCT01275196|10168286|P1|Overall Study|Lost to Follow-up|1
2953950|NCT01275196|10168285|P2|Overall Study|Withdrawal by Subject|5
2953951|NCT01275196|10168286|P1|Overall Study|Withdrawal by Subject|4
2953952|NCT01275196|10168285|P2|Overall Study|Adverse Event|5
2953953|NCT01275196|10168286|P1|Overall Study|Adverse Event|3
2953954|NCT01275170|10168333|P8|Part 1: Period 1|Equipment malfunction before study drug|0
2953955|NCT01275170|10168334|P7|Part 1: Period 1|Equipment malfunction before study drug|0
2953956|NCT01275170|10168335|P6|Part 1: Period 1|Equipment malfunction before study drug|0
2953957|NCT01275170|10168336|P5|Part 1: Period 1|Equipment malfunction before study drug|0
2953958|NCT01275170|10168337|P4|Part 1: Period 1|Equipment malfunction before study drug|0
2953959|NCT01275170|10168338|P3|Part 1: Period 1|Equipment malfunction before study drug|0
2953960|NCT01275170|10168339|P2|Part 1: Period 1|Equipment malfunction before study drug|0
2953961|NCT01275170|10168340|P1|Part 1: Period 1|Equipment malfunction before study drug|1
2953962|NCT01275144|10168558|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
2953963|NCT01275144|10168559|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
2953964|NCT01275131|10168617|P4|Period 2 (Crossover)|Withdrawal by Subject|2
2953965|NCT01275131|10168618|P3|Period 2 (Crossover)|Withdrawal by Subject|1
2953966|NCT01275131|10168619|P2|Period 2 (Crossover)|Withdrawal by Subject|0
2953967|NCT01275131|10168620|P1|Period 2 (Crossover)|Withdrawal by Subject|1
2953968|NCT01275131|10168617|P4|Period 2 (Crossover)|Adverse Event|0
2953969|NCT01275131|10168618|P3|Period 2 (Crossover)|Adverse Event|0
2953970|NCT01275131|10168619|P2|Period 2 (Crossover)|Adverse Event|1
2953971|NCT01275131|10168620|P1|Period 2 (Crossover)|Adverse Event|0
2953972|NCT01275131|10168617|P4|Period 1|Physician Decision|0
2953973|NCT01275131|10168618|P3|Period 1|Physician Decision|0
2953974|NCT01275131|10168619|P2|Period 1|Physician Decision|0
2953975|NCT01275131|10168620|P1|Period 1|Physician Decision|1
2953976|NCT01275131|10168617|P4|Period 1|Withdrawal by Subject|2
2953977|NCT01275131|10168618|P3|Period 1|Withdrawal by Subject|3
2953978|NCT01275131|10168619|P2|Period 1|Withdrawal by Subject|0
2953979|NCT01275131|10168620|P1|Period 1|Withdrawal by Subject|1
2953980|NCT01275066|10168663|P3|Overall Study|Not Diagnosed w/ Disease|0
2953981|NCT01275066|10168664|P2|Overall Study|Not Diagnosed w/ Disease|0
2953982|NCT01275066|10168665|P1|Overall Study|Not Diagnosed w/ Disease|1
2953983|NCT01275066|10168663|P3|Overall Study|Withdrawal by Subject|1
2953984|NCT01275066|10168664|P2|Overall Study|Withdrawal by Subject|0
2953985|NCT01275066|10168665|P1|Overall Study|Withdrawal by Subject|0
2953986|NCT01274715|10168698|P1|Overall Study|After consent, met exclusion criteria.|1
2953987|NCT01274715|10168698|P1|Overall Study|After consent, met exclusion criteria.|1
2953988|NCT01274715|10168698|P1|Overall Study|After consent, met exclusion criteria.|1
2953989|NCT01274715|10168698|P1|Overall Study|Lost to Follow-up|1
2953990|NCT01274637|10168705|P2|Overall Study|Lost to Follow-up|1
2953991|NCT01274637|10168706|P1|Overall Study|Lost to Follow-up|0
2953992|NCT01274637|10168705|P2|Overall Study|Withdrawal by Subject|1
2953993|NCT01274637|10168706|P1|Overall Study|Withdrawal by Subject|0
2953994|NCT01274559|10168745|P2|Overall Study|Withdrawal by Subject|13
2953995|NCT01274559|10168746|P1|Overall Study|Withdrawal by Subject|25
2953996|NCT01274559|10168745|P2|Overall Study|Study Terminated by Sponsor|87
2953997|NCT01274559|10168746|P1|Overall Study|Study Terminated by Sponsor|79
2953998|NCT01274559|10168745|P2|Overall Study|Protocol Violation|23
2953999|NCT01274559|10168746|P1|Overall Study|Protocol Violation|28
2954000|NCT01274559|10168745|P2|Overall Study|Physician Decision|1
2954001|NCT01274559|10168746|P1|Overall Study|Physician Decision|2
2954002|NCT01274559|10168745|P2|Overall Study|Non-compliance with Study Drug|4
2954003|NCT01274559|10168746|P1|Overall Study|Non-compliance with Study Drug|2
2954004|NCT01274559|10168745|P2|Overall Study|Lost to Follow-up|3
2954005|NCT01274559|10168746|P1|Overall Study|Lost to Follow-up|3
2954006|NCT01274559|10168745|P2|Overall Study|Death|1
2954007|NCT01274559|10168746|P1|Overall Study|Death|1
2954008|NCT01274559|10168745|P2|Overall Study|Adverse Event|13
2954009|NCT01274559|10168746|P1|Overall Study|Adverse Event|57
2954010|NCT01274533|10168796|P1|Overall Study|Disease progression|2
2954011|NCT01274533|10168796|P1|Overall Study|Non-compliance|1
2954012|NCT01274533|10168796|P1|Overall Study|Withdrawal by Subject|1
2954013|NCT01274429|10168801|P1|Overall Study|Study closed do to lack of funding|5
2954014|NCT01274182|10168809|P3|Overall Study|Death|1
2954015|NCT01274182|10168810|P2|Overall Study|Death|0
2954016|NCT01274182|10168811|P1|Overall Study|Death|1
2954017|NCT01274182|10168809|P3|Overall Study|Protocol Violation|0
2954018|NCT01274182|10168810|P2|Overall Study|Protocol Violation|2
2954019|NCT01274182|10168811|P1|Overall Study|Protocol Violation|3
2954020|NCT01274182|10168809|P3|Overall Study|Lost to Follow-up|1
2954021|NCT01274182|10168810|P2|Overall Study|Lost to Follow-up|3
2954022|NCT01274182|10168811|P1|Overall Study|Lost to Follow-up|2
2954023|NCT01274182|10168809|P3|Overall Study|Withdrawal by Subject|3
2954024|NCT01274182|10168810|P2|Overall Study|Withdrawal by Subject|5
2954025|NCT01274182|10168811|P1|Overall Study|Withdrawal by Subject|5
2954026|NCT01274182|10168809|P3|Overall Study|Adverse Event|3
2954027|NCT01274182|10168810|P2|Overall Study|Adverse Event|5
2954028|NCT01274182|10168811|P1|Overall Study|Adverse Event|4
2954029|NCT01274182|10168809|P3|Overall Study|Unsatisfactory therapeutic effect|4
2954030|NCT01274182|10168810|P2|Overall Study|Unsatisfactory therapeutic effect|3
2954031|NCT01274182|10168811|P1|Overall Study|Unsatisfactory therapeutic effect|6
2954032|NCT01273883|10168852|P2|Second Intervention|Lack of Efficacy|0
2954033|NCT01273883|10168853|P1|Second Intervention|Lack of Efficacy|1
2954034|NCT01273883|10168852|P2|Second Intervention|Lost to Follow-up|1
2954035|NCT01273883|10168853|P1|Second Intervention|Lost to Follow-up|1
2954036|NCT01273883|10168852|P2|First Intervention|Adverse Event|1
2954037|NCT01273883|10168853|P1|First Intervention|Adverse Event|2
2954038|NCT01273818|10168879|P3|Overall Study|Physician Decision|9
2954039|NCT01273818|10168880|P2|Overall Study|Physician Decision|2
2954040|NCT01273818|10168881|P1|Overall Study|Physician Decision|13
2954041|NCT01273805|10168891|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
2954042|NCT01273805|10168892|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
2954043|NCT01273623|10168923|P1|Overall Study|did not meet IVUS criteria|29
2954044|NCT01273597|10168930|P1|Overall Study|Reason Not Reported|1
2954045|NCT01273597|10168930|P1|Overall Study|Underwent Kidney Transplantation|2
2954046|NCT01273597|10168930|P1|Overall Study|Adverse Event|5
2954047|NCT01273519|10168945|P3|Overall Study|Other|1
2954048|NCT01273519|10168946|P2|Overall Study|Other|1
2954049|NCT01273519|10168947|P1|Overall Study|Other|6
2954050|NCT01273519|10168945|P3|Overall Study|Lack of Efficacy|4
2954051|NCT01273519|10168946|P2|Overall Study|Lack of Efficacy|3
2954052|NCT01273519|10168947|P1|Overall Study|Lack of Efficacy|8
2954053|NCT01273519|10168945|P3|Overall Study|Lost to Follow-up|3
2954054|NCT01273519|10168946|P2|Overall Study|Lost to Follow-up|1
2954055|NCT01273519|10168947|P1|Overall Study|Lost to Follow-up|2
2954056|NCT01273519|10168945|P3|Overall Study|Adverse Event|0
2954057|NCT01273519|10168946|P2|Overall Study|Adverse Event|0
2954058|NCT01273519|10168947|P1|Overall Study|Adverse Event|3
2954059|NCT01273181|10168984|P4|Phase 2, Dose 2|Death during treatment|1
2954060|NCT01273181|10168985|P3|Phase 2, Dose 2|Death during treatment|0
2954061|NCT01273181|10168986|P2|Phase 2, Dose 2|Death during treatment|0
2954062|NCT01273181|10168987|P1|Phase 2, Dose 2|Death during treatment|0
2954063|NCT01273181|10168984|P4|Phase 2, Dose 1|Study termination|0
2954064|NCT01273181|10168985|P3|Phase 2, Dose 1|Study termination|1
2954065|NCT01273181|10168986|P2|Phase 2, Dose 1|Study termination|0
2954066|NCT01273181|10168987|P1|Phase 2, Dose 1|Study termination|0
2954067|NCT01273181|10168984|P4|Phase I, Dose 2|Death during treatment|0
2954068|NCT01273181|10168985|P3|Phase I, Dose 2|Death during treatment|0
2954069|NCT01273181|10168986|P2|Phase I, Dose 2|Death during treatment|1
2954070|NCT01273181|10168987|P1|Phase I, Dose 2|Death during treatment|0
2954071|NCT01273181|10168984|P4|Phase I, Dose 1|Study termination|0
2954072|NCT01273181|10168985|P3|Phase I, Dose 1|Study termination|0
2954073|NCT01273181|10168986|P2|Phase I, Dose 1|Study termination|0
2954074|NCT01273181|10168987|P1|Phase I, Dose 1|Study termination|1
2954075|NCT01273155|10169005|P7|Overall Study|Withdrew during C1/refused further trmt|0
2954076|NCT01273155|10169006|P6|Overall Study|Withdrew during C1/refused further trmt|1
2954077|NCT01273155|10169007|P5|Overall Study|Withdrew during C1/refused further trmt|1
2954078|NCT01273155|10169008|P4|Overall Study|Withdrew during C1/refused further trmt|0
2954079|NCT01273155|10169009|P3|Overall Study|Withdrew during C1/refused further trmt|1
2954080|NCT01273155|10169010|P2|Overall Study|Withdrew during C1/refused further trmt|0
2954081|NCT01273155|10169011|P1|Overall Study|Withdrew during C1/refused further trmt|0
2954082|NCT01273155|10169005|P7|Overall Study|Died during Cycle 1|2
2954083|NCT01273155|10169006|P6|Overall Study|Died during Cycle 1|2
2954084|NCT01273155|10169007|P5|Overall Study|Died during Cycle 1|0
2954085|NCT01273155|10169008|P4|Overall Study|Died during Cycle 1|1
2954086|NCT01273155|10169009|P3|Overall Study|Died during Cycle 1|1
2954087|NCT01273155|10169010|P2|Overall Study|Died during Cycle 1|0
2954088|NCT01273155|10169011|P1|Overall Study|Died during Cycle 1|0
2954089|NCT01273155|10169005|P7|Overall Study|Off study prior to C1/due to toxicity|1
2954090|NCT01273155|10169006|P6|Overall Study|Off study prior to C1/due to toxicity|0
2954091|NCT01273155|10169007|P5|Overall Study|Off study prior to C1/due to toxicity|0
2954092|NCT01273155|10169008|P4|Overall Study|Off study prior to C1/due to toxicity|0
2954093|NCT01273155|10169009|P3|Overall Study|Off study prior to C1/due to toxicity|2
2954094|NCT01273155|10169010|P2|Overall Study|Off study prior to C1/due to toxicity|0
2954095|NCT01273155|10169011|P1|Overall Study|Off study prior to C1/due to toxicity|0
2954096|NCT01273155|10169005|P7|Overall Study|Change in liver function/no longer eval.|0
2954097|NCT01273155|10169006|P6|Overall Study|Change in liver function/no longer eval.|0
2954098|NCT01273155|10169007|P5|Overall Study|Change in liver function/no longer eval.|1
2954099|NCT01273155|10169008|P4|Overall Study|Change in liver function/no longer eval.|0
2954100|NCT01273155|10169009|P3|Overall Study|Change in liver function/no longer eval.|0
2954101|NCT01273155|10169010|P2|Overall Study|Change in liver function/no longer eval.|1
2954102|NCT01273155|10169011|P1|Overall Study|Change in liver function/no longer eval.|0
2954103|NCT01273155|10169005|P7|Overall Study|Off study trmt prior to end of C1/PD|3
2954104|NCT01273155|10169006|P6|Overall Study|Off study trmt prior to end of C1/PD|2
2954105|NCT01273155|10169007|P5|Overall Study|Off study trmt prior to end of C1/PD|0
2954106|NCT01273155|10169008|P4|Overall Study|Off study trmt prior to end of C1/PD|0
2954107|NCT01273155|10169009|P3|Overall Study|Off study trmt prior to end of C1/PD|8
2954108|NCT01273155|10169010|P2|Overall Study|Off study trmt prior to end of C1/PD|3
2954109|NCT01273155|10169011|P1|Overall Study|Off study trmt prior to end of C1/PD|2
2954110|NCT01273064|10169088|P5|Overall Study|Physician Decision|1
2954111|NCT01273064|10169089|P4|Overall Study|Physician Decision|0
2954112|NCT01273064|10169090|P3|Overall Study|Physician Decision|0
2954113|NCT01273064|10169091|P2|Overall Study|Physician Decision|0
2954114|NCT01273064|10169092|P1|Overall Study|Physician Decision|0
2954115|NCT01273064|10169088|P5|Overall Study|Lost to Follow-up|0
2954116|NCT01273064|10169089|P4|Overall Study|Lost to Follow-up|0
2954117|NCT01273064|10169090|P3|Overall Study|Lost to Follow-up|0
2954118|NCT01273064|10169091|P2|Overall Study|Lost to Follow-up|0
2954119|NCT01273064|10169092|P1|Overall Study|Lost to Follow-up|1
2954120|NCT01273064|10169088|P5|Overall Study|Study Termination|8
2954121|NCT01273064|10169089|P4|Overall Study|Study Termination|16
2954122|NCT01273064|10169090|P3|Overall Study|Study Termination|26
2954123|NCT01273064|10169091|P2|Overall Study|Study Termination|27
2954124|NCT01273064|10169092|P1|Overall Study|Study Termination|13
2954125|NCT01273064|10169088|P5|Overall Study|Withdrawal by Subject|0
2954126|NCT01273064|10169089|P4|Overall Study|Withdrawal by Subject|2
2954127|NCT01273064|10169090|P3|Overall Study|Withdrawal by Subject|2
2954128|NCT01273064|10169091|P2|Overall Study|Withdrawal by Subject|2
2954129|NCT01273064|10169092|P1|Overall Study|Withdrawal by Subject|4
2954130|NCT01273064|10169088|P5|Overall Study|Adverse Event|1
2954131|NCT01273064|10169089|P4|Overall Study|Adverse Event|2
2954132|NCT01273064|10169090|P3|Overall Study|Adverse Event|3
2954133|NCT01273064|10169091|P2|Overall Study|Adverse Event|1
2954134|NCT01273064|10169092|P1|Overall Study|Adverse Event|5
2954135|NCT01273038|10169111|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2954136|NCT01273038|10169112|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2954137|NCT01273038|10169111|P2|Second Intervention (14 Days)|Adverse Event|1
2954138|NCT01273038|10169112|P1|Second Intervention (14 Days)|Adverse Event|0
2954139|NCT01272947|10169135|P2|Overall Study|Abnormal Laboratory Value|2
2954140|NCT01272947|10169136|P1|Overall Study|Abnormal Laboratory Value|2
2954141|NCT01272934|10169146|P2|Overall Study|Abnormal Laboratory Value|1
2954142|NCT01272934|10169147|P1|Overall Study|Abnormal Laboratory Value|0
2954143|NCT01272934|10169146|P2|Overall Study|Adverse Event|1
2954144|NCT01272934|10169147|P1|Overall Study|Adverse Event|0
2954145|NCT01272921|10169157|P2|Overall Study|Protocol Violation|1
2954146|NCT01272921|10169158|P1|Overall Study|Protocol Violation|2
2954147|NCT01272908|10169166|P1|Re-Treatment Period|Withdrawal by Subject|1
2954148|NCT01272908|10169166|P1|Re-Treatment Period|Lack of Efficacy|3
2954149|NCT01272908|10169166|P1|Re-Treatment Period|Adverse Event|2
2954150|NCT01272908|10169166|P1|Initial Treatment Period|Withdrawal by Subject|1
2954151|NCT01272908|10169166|P1|Initial Treatment Period|Protocol Violation|1
2954152|NCT01272908|10169166|P1|Initial Treatment Period|Lack of Efficacy|5
2954153|NCT01272908|10169166|P1|Initial Treatment Period|Adverse Event|1
2954154|NCT01272869|10169206|P2|Period 2 (14 Days)|Adverse Event|0
2954155|NCT01272869|10169207|P1|Period 2 (14 Days)|Adverse Event|1
2954156|NCT01272804|10169234|P6|Overall Study|Adverse Event|1
2954157|NCT01272804|10169235|P5|Overall Study|Adverse Event|2
2954158|NCT01272804|10169236|P4|Overall Study|Adverse Event|0
2954159|NCT01272804|10169237|P3|Overall Study|Adverse Event|0
2954160|NCT01272804|10169238|P2|Overall Study|Adverse Event|0
2954161|NCT01272804|10169239|P1|Overall Study|Adverse Event|1
2954162|NCT01272661|10169397|P3|Overall Study|lost to followup/case closed/ no birth|72
2954163|NCT01272661|10169398|P2|Overall Study|lost to followup/case closed/ no birth|209
2954164|NCT01272661|10169399|P1|Overall Study|lost to followup/case closed/ no birth|126
2954165|NCT01272635|10169424|P4|Overall Study|Lost to Follow-up|23
2954166|NCT01272635|10169425|P3|Overall Study|Lost to Follow-up|31
2954167|NCT01272635|10169426|P2|Overall Study|Lost to Follow-up|20
2954168|NCT01272635|10169427|P1|Overall Study|Lost to Follow-up|31
2954169|NCT01272232|10169511|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
2954170|NCT01272232|10169512|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2954171|NCT01272232|10169513|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2954172|NCT01272232|10169511|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
2954173|NCT01272232|10169512|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
2954174|NCT01272232|10169513|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
2954175|NCT01272232|10169511|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2954176|NCT01272232|10169512|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
2954177|NCT01272232|10169513|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2954178|NCT01272232|10169511|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2954179|NCT01272232|10169512|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2954180|NCT01272232|10169513|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
2954181|NCT01272232|10169511|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
2954182|NCT01272232|10169512|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2954183|NCT01272232|10169513|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2954184|NCT01272232|10169511|P3|Weeks 0-56|Unclassified|12
2954185|NCT01272232|10169512|P2|Weeks 0-56|Unclassified|7
2954186|NCT01272232|10169513|P1|Weeks 0-56|Unclassified|16
2954187|NCT01272232|10169511|P3|Weeks 0-56|Withdrawal criteria|37
2954188|NCT01272232|10169512|P2|Weeks 0-56|Withdrawal criteria|14
2954189|NCT01272232|10169513|P1|Weeks 0-56|Withdrawal criteria|32
2954190|NCT01272232|10169511|P3|Weeks 0-56|Protocol Violation|13
2954191|NCT01272232|10169512|P2|Weeks 0-56|Protocol Violation|8
2954192|NCT01272232|10169513|P1|Weeks 0-56|Protocol Violation|12
2954193|NCT01272232|10169511|P3|Weeks 0-56|Lack of Efficacy|3
2954194|NCT01272232|10169512|P2|Weeks 0-56|Lack of Efficacy|0
2954195|NCT01272232|10169513|P1|Weeks 0-56|Lack of Efficacy|0
2954196|NCT01272232|10169511|P3|Weeks 0-56|Adverse Event|7
2954197|NCT01272232|10169512|P2|Weeks 0-56|Adverse Event|18
2954198|NCT01272232|10169513|P1|Weeks 0-56|Adverse Event|39
2954199|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Unclassified|51
2954200|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Unclassified|61
2954201|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Unclassified|0
2954202|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Unclassified|0
2954203|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Unclassified|0
2954204|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Unclassified|0
2954205|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Missing reason|0
2954206|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Missing reason|1
2954207|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Missing reason|0
2954208|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Missing reason|0
2954209|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Missing reason|0
2954210|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Missing reason|0
2954211|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
2954212|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
2954213|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2954214|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2954215|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2954216|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2954217|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
2954218|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
2954219|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
2954220|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
2954221|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
2954222|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
2954223|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
2954224|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
2954225|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2954226|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2954227|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2954228|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2954229|NCT01272219|10169558|P6|Main + Extension Period: Week 0-172|Adverse Event|43
2954230|NCT01272219|10169559|P5|Main + Extension Period: Week 0-172|Adverse Event|191
2954231|NCT01272219|10169560|P4|Main + Extension Period: Week 0-172|Adverse Event|0
2954232|NCT01272219|10169561|P3|Main + Extension Period: Week 0-172|Adverse Event|0
2954233|NCT01272219|10169562|P2|Main + Extension Period: Week 0-172|Adverse Event|0
2954234|NCT01272219|10169563|P1|Main + Extension Period: Week 0-172|Adverse Event|0
2954235|NCT01272219|10169558|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2954236|NCT01272219|10169559|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2954237|NCT01272219|10169560|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2954238|NCT01272219|10169561|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2954239|NCT01272219|10169562|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
2954240|NCT01272219|10169563|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2954241|NCT01272219|10169558|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2954242|NCT01272219|10169559|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2954243|NCT01272219|10169560|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
2954244|NCT01272219|10169561|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
2954245|NCT01272219|10169562|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
2954246|NCT01272219|10169563|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2954247|NCT01272219|10169558|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2954248|NCT01272219|10169559|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2954249|NCT01272219|10169560|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
2954250|NCT01272219|10169561|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2954251|NCT01272219|10169562|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
2954252|NCT01272219|10169563|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2954253|NCT01272219|10169558|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2954254|NCT01272219|10169559|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2954255|NCT01272219|10169560|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
2954256|NCT01272219|10169561|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2954257|NCT01272219|10169562|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2954258|NCT01272219|10169563|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2954259|NCT01272219|10169558|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2954260|NCT01272219|10169559|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2954261|NCT01272219|10169560|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
2954262|NCT01272219|10169561|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2954263|NCT01272219|10169562|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2954264|NCT01272219|10169563|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2954265|NCT01272219|10169558|P6|Main Period: Week 0 to Week 56|Unclassified|34
2954266|NCT01272219|10169559|P5|Main Period: Week 0 to Week 56|Unclassified|42
2954267|NCT01272219|10169560|P4|Main Period: Week 0 to Week 56|Unclassified|29
2954268|NCT01272219|10169561|P3|Main Period: Week 0 to Week 56|Unclassified|0
2954269|NCT01272219|10169562|P2|Main Period: Week 0 to Week 56|Unclassified|0
2954270|NCT01272219|10169563|P1|Main Period: Week 0 to Week 56|Unclassified|36
2954271|NCT01272219|10169558|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
2954272|NCT01272219|10169559|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
2954273|NCT01272219|10169560|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
2954274|NCT01272219|10169561|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2954275|NCT01272219|10169562|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2954276|NCT01272219|10169563|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
2954277|NCT01272219|10169558|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
2954278|NCT01272219|10169559|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
2954279|NCT01272219|10169560|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
2954280|NCT01272219|10169561|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
2954281|NCT01272219|10169562|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
2954282|NCT01272219|10169563|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
2954283|NCT01272219|10169558|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
2954284|NCT01272219|10169559|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
2954285|NCT01272219|10169560|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
2954286|NCT01272219|10169561|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2954287|NCT01272219|10169562|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2954288|NCT01272219|10169563|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
2954289|NCT01272219|10169558|P6|Main Period: Week 0 to Week 56|Adverse Event|29
2954290|NCT01272219|10169559|P5|Main Period: Week 0 to Week 56|Adverse Event|152
2954291|NCT01272219|10169560|P4|Main Period: Week 0 to Week 56|Adverse Event|16
2954292|NCT01272219|10169561|P3|Main Period: Week 0 to Week 56|Adverse Event|0
2954293|NCT01272219|10169562|P2|Main Period: Week 0 to Week 56|Adverse Event|0
2954294|NCT01272219|10169563|P1|Main Period: Week 0 to Week 56|Adverse Event|86
2954295|NCT01272193|10169597|P2|Overall Study|Unclassified|7
2954296|NCT01272193|10169598|P1|Overall Study|Unclassified|8
2954297|NCT01272193|10169597|P2|Overall Study|Withdrawal Criteria|1
2954298|NCT01272193|10169598|P1|Overall Study|Withdrawal Criteria|1
2954299|NCT01272193|10169597|P2|Overall Study|Lack of Efficacy|3
2954300|NCT01272193|10169598|P1|Overall Study|Lack of Efficacy|0
2954301|NCT01272193|10169597|P2|Overall Study|Adverse Event|1
2954302|NCT01272193|10169598|P1|Overall Study|Adverse Event|1
2954303|NCT01272180|10169618|P4|Overall Study|Protocol Violation|1
2954304|NCT01272180|10169619|P3|Overall Study|Protocol Violation|0
2954305|NCT01272180|10169620|P2|Overall Study|Protocol Violation|1
2954306|NCT01272180|10169621|P1|Overall Study|Protocol Violation|0
2954307|NCT01272180|10169618|P4|Overall Study|Inappropriate enrollment|1
2954308|NCT01272180|10169619|P3|Overall Study|Inappropriate enrollment|1
2954309|NCT01272180|10169620|P2|Overall Study|Inappropriate enrollment|0
2954310|NCT01272180|10169621|P1|Overall Study|Inappropriate enrollment|0
2954311|NCT01272180|10169618|P4|Overall Study|Lost to Follow-up|10
2954312|NCT01272180|10169619|P3|Overall Study|Lost to Follow-up|8
2954313|NCT01272180|10169620|P2|Overall Study|Lost to Follow-up|14
2954314|NCT01272180|10169621|P1|Overall Study|Lost to Follow-up|15
2954315|NCT01272180|10169618|P4|Overall Study|Withdrawal by Subject|2
2954316|NCT01272180|10169619|P3|Overall Study|Withdrawal by Subject|3
2954317|NCT01272180|10169620|P2|Overall Study|Withdrawal by Subject|6
2954318|NCT01272180|10169621|P1|Overall Study|Withdrawal by Subject|2
2954319|NCT01272180|10169618|P4|Overall Study|Adverse Event|0
2954320|NCT01272180|10169619|P3|Overall Study|Adverse Event|1
2954321|NCT01272180|10169620|P2|Overall Study|Adverse Event|0
2954322|NCT01272180|10169621|P1|Overall Study|Adverse Event|0
2954323|NCT01272011|10169670|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
2954324|NCT01272011|10169671|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
2954325|NCT01272011|10169672|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
2954326|NCT01271933|10169708|P3|Double-Blind Phase|Participant request-personal reason|0
2954327|NCT01271933|10169709|P2|Double-Blind Phase|Participant request-personal reason|1
2954328|NCT01271933|10169710|P1|Double-Blind Phase|Participant request-personal reason|0
2954329|NCT01271933|10169708|P3|Double-Blind Phase|Adverse Event|0
2954330|NCT01271933|10169709|P2|Double-Blind Phase|Adverse Event|3
2954331|NCT01271933|10169710|P1|Double-Blind Phase|Adverse Event|0
2954332|NCT01271933|10169708|P3|Double-Blind Phase|Withdrawal by Subject|1
2954333|NCT01271933|10169709|P2|Double-Blind Phase|Withdrawal by Subject|6
2954334|NCT01271933|10169710|P1|Double-Blind Phase|Withdrawal by Subject|0
2954335|NCT01271933|10169708|P3|Double-Blind Phase|Lost to Follow-up|1
2954336|NCT01271933|10169709|P2|Double-Blind Phase|Lost to Follow-up|1
2954337|NCT01271933|10169710|P1|Double-Blind Phase|Lost to Follow-up|0
2954338|NCT01271933|10169708|P3|Double-Blind Phase|Lack of Efficacy|9
2954339|NCT01271933|10169709|P2|Double-Blind Phase|Lack of Efficacy|6
2954340|NCT01271933|10169710|P1|Double-Blind Phase|Lack of Efficacy|0
2954341|NCT01271933|10169708|P3|Double-Blind Phase|Randomized but not treated|1
2954342|NCT01271933|10169709|P2|Double-Blind Phase|Randomized but not treated|0
2954343|NCT01271933|10169710|P1|Double-Blind Phase|Randomized but not treated|0
2954344|NCT01271933|10169708|P3|Single-Blind Phase|(Participant request-personal reason)|0
2954345|NCT01271933|10169709|P2|Single-Blind Phase|(Participant request-personal reason)|0
2954346|NCT01271933|10169710|P1|Single-Blind Phase|(Participant request-personal reason)|1
2954347|NCT01271933|10169708|P3|Single-Blind Phase|(Protocol non-compliance)|0
2954348|NCT01271933|10169709|P2|Single-Blind Phase|(Protocol non-compliance)|0
2954349|NCT01271933|10169710|P1|Single-Blind Phase|(Protocol non-compliance)|2
2954350|NCT01271933|10169708|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
2954351|NCT01271933|10169709|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
2954352|NCT01271933|10169710|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
2954353|NCT01271933|10169708|P3|Single-Blind Phase|Adverse Event|0
2954354|NCT01271933|10169709|P2|Single-Blind Phase|Adverse Event|0
2954355|NCT01271933|10169710|P1|Single-Blind Phase|Adverse Event|52
2954356|NCT01271933|10169708|P3|Single-Blind Phase|Protocol Violation|0
2954357|NCT01271933|10169709|P2|Single-Blind Phase|Protocol Violation|0
2954358|NCT01271933|10169710|P1|Single-Blind Phase|Protocol Violation|3
2954359|NCT01271933|10169708|P3|Single-Blind Phase|Withdrawal by Subject|0
2954360|NCT01271933|10169709|P2|Single-Blind Phase|Withdrawal by Subject|0
2954361|NCT01271933|10169710|P1|Single-Blind Phase|Withdrawal by Subject|15
2954362|NCT01271933|10169708|P3|Single-Blind Phase|Lost to Follow-up|0
2954363|NCT01271933|10169709|P2|Single-Blind Phase|Lost to Follow-up|0
2954364|NCT01271933|10169710|P1|Single-Blind Phase|Lost to Follow-up|10
2954365|NCT01271933|10169708|P3|Single-Blind Phase|Lack of Efficacy|0
2954366|NCT01271933|10169709|P2|Single-Blind Phase|Lack of Efficacy|0
2954367|NCT01271933|10169710|P1|Single-Blind Phase|Lack of Efficacy|37
2954368|NCT01271803|10169853|P3|Overall Study|Lost to Follow-up|0
2954369|NCT01271803|10169854|P2|Overall Study|Lost to Follow-up|0
2954370|NCT01271803|10169855|P1|Overall Study|Lost to Follow-up|1
2954371|NCT01271803|10169853|P3|Overall Study|Withdrawal by Subject|0
2954372|NCT01271803|10169854|P2|Overall Study|Withdrawal by Subject|5
2954373|NCT01271803|10169855|P1|Overall Study|Withdrawal by Subject|1
2954374|NCT01271803|10169853|P3|Overall Study|Death|0
2954375|NCT01271803|10169854|P2|Overall Study|Death|34
2954376|NCT01271803|10169855|P1|Overall Study|Death|53
2954377|NCT01271803|10169853|P3|Overall Study|Progressive disease|2
2954378|NCT01271803|10169854|P2|Overall Study|Progressive disease|0
2954379|NCT01271803|10169855|P1|Overall Study|Progressive disease|0
2954380|NCT01271725|10170017|P2|Part B|Withdrawal by Subject|6
2954381|NCT01271725|10170018|P1|Part B|Withdrawal by Subject|0
2954382|NCT01271725|10170017|P2|Part B|Protocol Violation|1
2954383|NCT01271725|10170018|P1|Part B|Protocol Violation|0
2954384|NCT01271725|10170017|P2|Part B|Other Adverse Event|1
2954385|NCT01271725|10170018|P1|Part B|Other Adverse Event|0
2954386|NCT01271725|10170017|P2|Part B|Clinical signs/symptoms of progression|2
2954387|NCT01271725|10170018|P1|Part B|Clinical signs/symptoms of progression|0
2954388|NCT01271725|10170017|P2|Part B|Other than specified|2
2954389|NCT01271725|10170018|P1|Part B|Other than specified|0
2954390|NCT01271725|10170017|P2|Part A|Protocol Violation|0
2954391|NCT01271725|10170018|P1|Part A|Protocol Violation|1
2954392|NCT01271725|10170017|P2|Part A|Other than specified|0
2954393|NCT01271725|10170018|P1|Part A|Other than specified|3
2954394|NCT01271725|10170017|P2|Part A|Withdrawal by Subject|0
2954395|NCT01271725|10170018|P1|Part A|Withdrawal by Subject|12
2954396|NCT01271725|10170017|P2|Part A|Lost to Follow-up|0
2954397|NCT01271725|10170018|P1|Part A|Lost to Follow-up|1
2954398|NCT01271725|10170017|P2|Part A|Other Adverse Event|0
2954399|NCT01271725|10170018|P1|Part A|Other Adverse Event|8
2954400|NCT01271725|10170017|P2|Part A|Clinical signs/symptoms of progression|0
2954401|NCT01271725|10170018|P1|Part A|Clinical signs/symptoms of progression|2
2954402|NCT01271725|10170017|P2|Part A|Progressive disease according to RECIST|0
2954403|NCT01271725|10170018|P1|Part A|Progressive disease according to RECIST|8
2954404|NCT01271712|10170047|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
2954405|NCT01271712|10170048|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
2954406|NCT01271712|10170047|P2|Safety Follow-up|Progressive disease|0
2954407|NCT01271712|10170048|P1|Safety Follow-up|Progressive disease|1
2954408|NCT01271712|10170047|P2|Safety Follow-up|No follow-up|1
2954409|NCT01271712|10170048|P1|Safety Follow-up|No follow-up|1
2954410|NCT01271712|10170047|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
2954411|NCT01271712|10170048|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
2954412|NCT01271712|10170047|P2|Safety Follow-up|Protocol Violation|1
2954413|NCT01271712|10170048|P1|Safety Follow-up|Protocol Violation|1
2954414|NCT01271712|10170047|P2|Safety Follow-up|Withdrawal by Subject|2
2954415|NCT01271712|10170048|P1|Safety Follow-up|Withdrawal by Subject|4
2954416|NCT01271712|10170047|P2|Safety Follow-up|Death|7
2954417|NCT01271712|10170048|P1|Safety Follow-up|Death|11
2954418|NCT01271712|10170047|P2|Open Label Treatment|Switching to other therapy|1
2954419|NCT01271712|10170048|P1|Open Label Treatment|Switching to other therapy|2
2954420|NCT01271712|10170047|P2|Open Label Treatment|Protocol Violation|1
2954421|NCT01271712|10170048|P1|Open Label Treatment|Protocol Violation|0
2954422|NCT01271712|10170047|P2|Open Label Treatment|Non-compliance with study drug|0
2954423|NCT01271712|10170048|P1|Open Label Treatment|Non-compliance with study drug|1
2954424|NCT01271712|10170047|P2|Open Label Treatment|transferred to rollover study|0
2954425|NCT01271712|10170048|P1|Open Label Treatment|transferred to rollover study|1
2954426|NCT01271712|10170047|P2|Open Label Treatment|Progressive disease|32
2954427|NCT01271712|10170048|P1|Open Label Treatment|Progressive disease|59
2954428|NCT01271712|10170047|P2|Open Label Treatment|Adverse Event|8
2954429|NCT01271712|10170048|P1|Open Label Treatment|Adverse Event|14
2954430|NCT01271712|10170047|P2|Open Label Treatment|Physician Decision|0
2954431|NCT01271712|10170048|P1|Open Label Treatment|Physician Decision|2
2954432|NCT01271712|10170047|P2|Open Label Treatment|Withdrawal by Subject|11
2954433|NCT01271712|10170048|P1|Open Label Treatment|Withdrawal by Subject|6
2954434|NCT01271712|10170047|P2|Open Label Treatment|Death|5
2954435|NCT01271712|10170048|P1|Open Label Treatment|Death|6
2954436|NCT01271712|10170047|P2|Double Blind Treatment|receive no study drug|0
2954437|NCT01271712|10170048|P1|Double Blind Treatment|receive no study drug|1
2954438|NCT01271712|10170047|P2|Double Blind Treatment|Non compliance with study drug|0
2954439|NCT01271712|10170048|P1|Double Blind Treatment|Non compliance with study drug|2
2954440|NCT01271712|10170047|P2|Double Blind Treatment|Withdrawal by Subject|1
2954441|NCT01271712|10170048|P1|Double Blind Treatment|Withdrawal by Subject|4
2954442|NCT01271712|10170047|P2|Double Blind Treatment|Progressive disease|3
2954443|NCT01271712|10170048|P1|Double Blind Treatment|Progressive disease|23
2954444|NCT01271712|10170047|P2|Double Blind Treatment|Adverse Event|4
2954445|NCT01271712|10170048|P1|Double Blind Treatment|Adverse Event|9
2954446|NCT01271712|10170047|P2|Double Blind Treatment|Lack of Efficacy|0
2954447|NCT01271712|10170048|P1|Double Blind Treatment|Lack of Efficacy|1
2954448|NCT01271712|10170047|P2|Double Blind Treatment|Death|0
2954449|NCT01271712|10170048|P1|Double Blind Treatment|Death|2
2954450|NCT01271010|10170144|P1|Overall Study|Disease progression|27
2954451|NCT01271010|10170144|P1|Overall Study|Withdrawal by Subject|18
2954452|NCT01271010|10170144|P1|Overall Study|Progression and relapse of disease|1
2954453|NCT01271010|10170144|P1|Overall Study|Death|2
2954454|NCT01271010|10170144|P1|Overall Study|Protocol Violation|1
2954455|NCT01271010|10170144|P1|Overall Study|Start of new CLL therapy|1
2954456|NCT01271010|10170144|P1|Overall Study|Reason not specified|11
2954457|NCT01270971|10170159|P2|Overall Study|Non-specific|3
2954458|NCT01270971|10170160|P1|Overall Study|Non-specific|7
2954459|NCT01270971|10170159|P2|Overall Study|Non compliance|2
2954460|NCT01270971|10170160|P1|Overall Study|Non compliance|2
2954461|NCT01270971|10170159|P2|Overall Study|Adverse Event|2
2954462|NCT01270971|10170160|P1|Overall Study|Adverse Event|1
2954463|NCT01270971|10170159|P2|Overall Study|Lost to Follow-up|5
2954464|NCT01270971|10170160|P1|Overall Study|Lost to Follow-up|18
2954465|NCT01270971|10170159|P2|Overall Study|Withdrawal by Subject|11
2954466|NCT01270971|10170160|P1|Overall Study|Withdrawal by Subject|24
2954467|NCT01270958|10170172|P1|Overall Study|Did not meet inclusion criteria for age|2
2954468|NCT01270958|10170172|P1|Overall Study|Lost to Follow-up|2
2954469|NCT01270880|10170201|P1|Overall Study|Never rec'd treatment, but registered.|1
2954470|NCT01270841|10170231|P4|Overall Study|Enrolled in error|0
2954471|NCT01270841|10170232|P3|Overall Study|Enrolled in error|0
2954472|NCT01270841|10170233|P2|Overall Study|Enrolled in error|1
2954473|NCT01270841|10170234|P1|Overall Study|Enrolled in error|0
2954474|NCT01270841|10170231|P4|Overall Study|Protocol Violation|0
2954475|NCT01270841|10170232|P3|Overall Study|Protocol Violation|0
2954476|NCT01270841|10170233|P2|Overall Study|Protocol Violation|5
2954477|NCT01270841|10170234|P1|Overall Study|Protocol Violation|1
2954478|NCT01270841|10170231|P4|Overall Study|Did not qualify|5
2954479|NCT01270841|10170232|P3|Overall Study|Did not qualify|4
2954480|NCT01270841|10170233|P2|Overall Study|Did not qualify|3
2954481|NCT01270841|10170234|P1|Overall Study|Did not qualify|6
2954482|NCT01270841|10170231|P4|Overall Study|Physician Decision|0
2954483|NCT01270841|10170232|P3|Overall Study|Physician Decision|0
2954484|NCT01270841|10170233|P2|Overall Study|Physician Decision|1
2954485|NCT01270841|10170234|P1|Overall Study|Physician Decision|0
2954486|NCT01270841|10170231|P4|Overall Study|Lost to Follow-up|2
2954487|NCT01270841|10170232|P3|Overall Study|Lost to Follow-up|4
2954488|NCT01270841|10170233|P2|Overall Study|Lost to Follow-up|1
2954489|NCT01270841|10170234|P1|Overall Study|Lost to Follow-up|3
2954490|NCT01270841|10170231|P4|Overall Study|Withdrawal by Subject|3
2954491|NCT01270841|10170232|P3|Overall Study|Withdrawal by Subject|3
2954492|NCT01270841|10170233|P2|Overall Study|Withdrawal by Subject|2
2954493|NCT01270841|10170234|P1|Overall Study|Withdrawal by Subject|3
2954494|NCT01270841|10170231|P4|Overall Study|Adverse Event|3
2954495|NCT01270841|10170232|P3|Overall Study|Adverse Event|0
2954496|NCT01270841|10170233|P2|Overall Study|Adverse Event|1
2954497|NCT01270841|10170234|P1|Overall Study|Adverse Event|0
2954498|NCT01270828|10170258|P3|Double Blind Phase|Adverse event related to study drug|0
2954499|NCT01270828|10170259|P2|Double Blind Phase|Adverse event related to study drug|7
2954500|NCT01270828|10170260|P1|Double Blind Phase|Adverse event related to study drug|5
2954501|NCT01270828|10170258|P3|Double Blind Phase|Adverse event not related to study drug|0
2954502|NCT01270828|10170259|P2|Double Blind Phase|Adverse event not related to study drug|1
2954503|NCT01270828|10170260|P1|Double Blind Phase|Adverse event not related to study drug|1
2954504|NCT01270828|10170258|P3|Double Blind Phase|Lack of Efficacy|0
2954505|NCT01270828|10170259|P2|Double Blind Phase|Lack of Efficacy|11
2954506|NCT01270828|10170260|P1|Double Blind Phase|Lack of Efficacy|2
2954507|NCT01270828|10170258|P3|Double Blind Phase|Lost to Follow-up|0
2954508|NCT01270828|10170259|P2|Double Blind Phase|Lost to Follow-up|2
2954509|NCT01270828|10170260|P1|Double Blind Phase|Lost to Follow-up|1
2954510|NCT01270828|10170258|P3|Double Blind Phase|Withdrawal by Subject|0
2954511|NCT01270828|10170259|P2|Double Blind Phase|Withdrawal by Subject|15
2954512|NCT01270828|10170260|P1|Double Blind Phase|Withdrawal by Subject|6
2954513|NCT01270828|10170258|P3|Double Blind Phase|Reason Unspecified|0
2954514|NCT01270828|10170259|P2|Double Blind Phase|Reason Unspecified|4
2954515|NCT01270828|10170260|P1|Double Blind Phase|Reason Unspecified|7
2954516|NCT01270828|10170258|P3|Double Blind Phase|Protocol and GCP non-compliance|0
2954517|NCT01270828|10170259|P2|Double Blind Phase|Protocol and GCP non-compliance|3
2954518|NCT01270828|10170260|P1|Double Blind Phase|Protocol and GCP non-compliance|4
2954519|NCT01270828|10170258|P3|Double Blind Phase|Protocol Violation|0
2954520|NCT01270828|10170259|P2|Double Blind Phase|Protocol Violation|1
2954521|NCT01270828|10170260|P1|Double Blind Phase|Protocol Violation|0
2954522|NCT01270828|10170258|P3|Double Blind Phase|Death|0
2954523|NCT01270828|10170259|P2|Double Blind Phase|Death|1
2954524|NCT01270828|10170260|P1|Double Blind Phase|Death|0
2954525|NCT01270828|10170258|P3|Pregabalin CR SB|Protocol Violation|8
2954526|NCT01270828|10170259|P2|Pregabalin CR SB|Protocol Violation|0
2954527|NCT01270828|10170260|P1|Pregabalin CR SB|Protocol Violation|0
2954528|NCT01270828|10170258|P3|Pregabalin CR SB|Unrelated AE|8
2954529|NCT01270828|10170259|P2|Pregabalin CR SB|Unrelated AE|0
2954530|NCT01270828|10170260|P1|Pregabalin CR SB|Unrelated AE|0
2954531|NCT01270828|10170258|P3|Pregabalin CR SB|Lost to Follow-up|10
2954532|NCT01270828|10170259|P2|Pregabalin CR SB|Lost to Follow-up|0
2954533|NCT01270828|10170260|P1|Pregabalin CR SB|Lost to Follow-up|0
2954534|NCT01270828|10170258|P3|Pregabalin CR SB|Withdrawal by Subject|29
2954535|NCT01270828|10170259|P2|Pregabalin CR SB|Withdrawal by Subject|0
2954536|NCT01270828|10170260|P1|Pregabalin CR SB|Withdrawal by Subject|0
2954537|NCT01270828|10170258|P3|Pregabalin CR SB|Lack of Efficacy|32
2954538|NCT01270828|10170259|P2|Pregabalin CR SB|Lack of Efficacy|0
2954539|NCT01270828|10170260|P1|Pregabalin CR SB|Lack of Efficacy|0
2954540|NCT01270828|10170258|P3|Pregabalin CR SB|Related adverse event|46
2954541|NCT01270828|10170259|P2|Pregabalin CR SB|Related adverse event|0
2954542|NCT01270828|10170260|P1|Pregabalin CR SB|Related adverse event|0
2954543|NCT01270828|10170258|P3|Pregabalin CR SB|Enrolled but not treated|5
2954544|NCT01270828|10170259|P2|Pregabalin CR SB|Enrolled but not treated|0
2954545|NCT01270828|10170260|P1|Pregabalin CR SB|Enrolled but not treated|0
2954546|NCT01270828|10170258|P3|Pregabalin CR SB|Reason Unspecified|8
2954547|NCT01270828|10170259|P2|Pregabalin CR SB|Reason Unspecified|0
2954548|NCT01270828|10170260|P1|Pregabalin CR SB|Reason Unspecified|0
2954549|NCT01270802|10170302|P2|Overall Study|Lost to Follow-up|1
2954550|NCT01270802|10170303|P1|Overall Study|Lost to Follow-up|0
2954551|NCT01270802|10170302|P2|Overall Study|Adverse Event|0
2954552|NCT01270802|10170303|P1|Overall Study|Adverse Event|1
2954553|NCT01270802|10170302|P2|Overall Study|Withdrawal by Subject|0
2954554|NCT01270802|10170303|P1|Overall Study|Withdrawal by Subject|1
2954555|NCT01270620|10170450|P2|Overall Study|Withdrawal by Subject|3
2954556|NCT01270620|10170451|P1|Overall Study|Withdrawal by Subject|1
2954557|NCT01270503|10170546|P1|Overall Study|Lost to Follow-up|1
2954558|NCT01270464|10170554|P3|Overall Study|Other|3
2954559|NCT01270464|10170555|P2|Overall Study|Other|1
2954560|NCT01270464|10170556|P1|Overall Study|Other|1
2954561|NCT01270464|10170554|P3|Overall Study|Lost to Follow-up|1
2954562|NCT01270464|10170555|P2|Overall Study|Lost to Follow-up|3
2954563|NCT01270464|10170556|P1|Overall Study|Lost to Follow-up|2
2954564|NCT01270464|10170554|P3|Overall Study|Withdrawal by Subject|4
2954565|NCT01270464|10170555|P2|Overall Study|Withdrawal by Subject|1
2954566|NCT01270464|10170556|P1|Overall Study|Withdrawal by Subject|2
2954567|NCT01270464|10170554|P3|Overall Study|Adverse Event|7
2954568|NCT01270464|10170555|P2|Overall Study|Adverse Event|1
2954569|NCT01270464|10170556|P1|Overall Study|Adverse Event|9
2954570|NCT01270464|10170554|P3|Overall Study|Lack of Efficacy|1
2954571|NCT01270464|10170555|P2|Overall Study|Lack of Efficacy|3
2954572|NCT01270464|10170556|P1|Overall Study|Lack of Efficacy|2
2954573|NCT01270464|10170554|P3|Overall Study|Protocol Violation|2
2954574|NCT01270464|10170555|P2|Overall Study|Protocol Violation|3
2954575|NCT01270464|10170556|P1|Overall Study|Protocol Violation|4
2954576|NCT01270256|10170605|P2|Overall Study|Withdrawal by Subject|0
2954577|NCT01270256|10170606|P1|Overall Study|Withdrawal by Subject|1
2954578|NCT01270139|10170615|P3|Overall Study|Lost to Follow-up|2
2954579|NCT01270139|10170616|P2|Overall Study|Lost to Follow-up|9
2954580|NCT01270139|10170617|P1|Overall Study|Lost to Follow-up|10
2954581|NCT01270139|10170615|P3|Overall Study|Adverse Event|18
2954582|NCT01270139|10170616|P2|Overall Study|Adverse Event|17
2954583|NCT01270139|10170617|P1|Overall Study|Adverse Event|8
2954584|NCT01269918|10170686|P2|Overall Study|Did not receive study drug|3
2954585|NCT01269918|10170687|P1|Overall Study|Did not receive study drug|0
2954586|NCT01269346|10170762|P1|Extension Phase|Started a prohibited con med|1
2954587|NCT01269346|10170762|P1|Extension Phase|Clinical progression|1
2954588|NCT01269346|10170762|P1|Extension Phase|Physician decision or participant choice|9
2954589|NCT01269346|10170762|P1|Extension Phase|Disease progression|22
2954590|NCT01269346|10170762|P1|Extension Phase|Withdrawal by Subject|4
2954591|NCT01269346|10170762|P1|Extension Phase|Adverse Event|6
2954592|NCT01269346|10170762|P1|Treatment Phase|Other|2
2954593|NCT01269346|10170762|P1|Treatment Phase|Withdrawal by Subject|1
2954594|NCT01269346|10170762|P1|Treatment Phase|Adverse Event|3
2954595|NCT01269346|10170762|P1|Treatment Phase|Disease progression|3
2954596|NCT01269125|10170773|P3|Overall Study|Lost to Follow-up|0
2954597|NCT01269125|10170774|P2|Overall Study|Lost to Follow-up|0
2954598|NCT01269125|10170775|P1|Overall Study|Lost to Follow-up|4
2954599|NCT01269125|10170773|P3|Overall Study|Adverse Event|0
2954600|NCT01269125|10170774|P2|Overall Study|Adverse Event|5
2954601|NCT01269125|10170775|P1|Overall Study|Adverse Event|3
2954602|NCT01268891|10170834|P2|Overall Study|Administrative or other reason(s)|0
2954603|NCT01268891|10170835|P1|Overall Study|Administrative or other reason(s)|1
2954604|NCT01268891|10170834|P2|Overall Study|Withdrawal of Consent|1
2954605|NCT01268891|10170835|P1|Overall Study|Withdrawal of Consent|3
2954606|NCT01268891|10170834|P2|Overall Study|Lack of Efficacy|0
2954607|NCT01268891|10170835|P1|Overall Study|Lack of Efficacy|1
2954608|NCT01268891|10170834|P2|Overall Study|Adverse Event|7
2954609|NCT01268891|10170835|P1|Overall Study|Adverse Event|3
2954610|NCT01268566|10170861|P1|Overall Study|Death|30
2954611|NCT01268566|10170861|P1|Overall Study|Withdrawal by Subject|12
2954612|NCT01268566|10170861|P1|Overall Study|Lost to Follow-up|1
2954613|NCT01268514|10170888|P1|Overall Study|Withdrawal by Surgeon|5
2954614|NCT01268514|10170888|P1|Overall Study|Withdrawal by Subject|3
2954615|NCT01268514|10170888|P1|Overall Study|Lost to Follow-up|5
2954616|NCT01268514|10170888|P1|Overall Study|Death|8
2954617|NCT01268514|10170888|P1|Overall Study|Adverse Event|20
2954618|NCT01268501|10170897|P1|Overall Study|Handling Difficulties|2
2954619|NCT01268501|10170897|P1|Overall Study|Unacceptable Subjective Vision|3
2954620|NCT01268501|10170897|P1|Overall Study|Withdrawal by Subject|3
2954621|NCT01268501|10170897|P1|Overall Study|Lost to Follow-up|1
2954622|NCT01268488|10170901|P1|Overall Study|Physician Decision|2
2954623|NCT01268488|10170901|P1|Overall Study|Adverse Event|3
2954624|NCT01268306|10170908|P1|Overall Study|Lost to Follow-up|1
2954625|NCT01268293|10170912|P1|Overall Study|Subject choice|1
2954626|NCT01268293|10170912|P1|Overall Study|Adverse Event|1
2954627|NCT01268293|10170912|P1|Overall Study|Disease progression|7
2954628|NCT01268267|10170917|P1|Overall Study|Protocol Violation|1
2954629|NCT01268150|10170938|P1|Extension Phase|Other|6
2954630|NCT01268150|10170938|P1|Extension Phase|Disease progression|18
2954631|NCT01268150|10170938|P1|Extension Phase|Adverse Event|3
2954632|NCT01268150|10170938|P1|Treatment Phase|Other|4
2954633|NCT01268150|10170938|P1|Treatment Phase|Withdrawal by Subject|3
2954634|NCT01268150|10170938|P1|Treatment Phase|Adverse Event|3
2954635|NCT01268150|10170938|P1|Treatment Phase|Progression of disease|18
2954636|NCT01268098|10170957|P2|Overall Study|Adverse Event|0
2954637|NCT01268098|10170958|P1|Overall Study|Adverse Event|1
2954638|NCT01268046|10170970|P4|Overall Study|Lost to Follow-up|0
2954639|NCT01268046|10170971|P3|Overall Study|Lost to Follow-up|1
2954640|NCT01268046|10170972|P2|Overall Study|Lost to Follow-up|0
2954641|NCT01268046|10170973|P1|Overall Study|Lost to Follow-up|0
2954642|NCT01268046|10170970|P4|Overall Study|Withdrawal by Subject|1
2954643|NCT01268046|10170971|P3|Overall Study|Withdrawal by Subject|0
2954644|NCT01268046|10170972|P2|Overall Study|Withdrawal by Subject|0
2954645|NCT01268046|10170973|P1|Overall Study|Withdrawal by Subject|1
2954646|NCT01267994|10170983|P1|Overall Study|Adverse Event|2
2954647|NCT01267955|10170988|P1|Stage 2 (6 Months)|Protocol Violation|1
2954648|NCT01267955|10170988|P1|Stage 2 (6 Months)|Death|5
2954649|NCT01267955|10170988|P1|Stage 1 (6 Months)|Death|3
2954650|NCT01267825|10171025|P2|Overall Study|study terminated. no data collected.|0
2954651|NCT01267825|10171026|P1|Overall Study|study terminated. no data collected.|1
2954652|NCT01267266|10171101|P2|Lead-in Phase|Withdrawal by Subject|0
2954653|NCT01267266|10171102|P1|Lead-in Phase|Withdrawal by Subject|1
2954654|NCT01267266|10171101|P2|Lead-in Phase|Adverse Event|0
2954655|NCT01267266|10171102|P1|Lead-in Phase|Adverse Event|2
2954656|NCT01267266|10171101|P2|Lead-in Phase|Lack of Efficacy|0
2954657|NCT01267266|10171102|P1|Lead-in Phase|Lack of Efficacy|20
2954658|NCT01267266|10171101|P2|Enrollment Phase|Withdrawal by Subject|0
2954659|NCT01267266|10171102|P1|Enrollment Phase|Withdrawal by Subject|2
2954660|NCT01267253|10171115|P1|Overall Study|Inevaluable-never received study treatme|2
2954661|NCT01267253|10171115|P1|Overall Study|Ineligible - required test not done|1
2954662|NCT01267201|10171154|P6|Second Intervention Period|Withdrawal by Subject|0
2954663|NCT01267201|10171155|P5|Second Intervention Period|Withdrawal by Subject|0
2954664|NCT01267201|10171156|P4|Second Intervention Period|Withdrawal by Subject|0
2954665|NCT01267201|10171157|P3|Second Intervention Period|Withdrawal by Subject|0
2954666|NCT01267201|10171158|P2|Second Intervention Period|Withdrawal by Subject|1
2954667|NCT01267201|10171159|P1|Second Intervention Period|Withdrawal by Subject|0
2954668|NCT01267201|10171154|P6|First Intervention Period|Withdrawal by Subject|0
2954669|NCT01267201|10171155|P5|First Intervention Period|Withdrawal by Subject|0
2954670|NCT01267201|10171156|P4|First Intervention Period|Withdrawal by Subject|0
2954671|NCT01267201|10171157|P3|First Intervention Period|Withdrawal by Subject|0
2954672|NCT01267201|10171158|P2|First Intervention Period|Withdrawal by Subject|0
2954673|NCT01267201|10171159|P1|First Intervention Period|Withdrawal by Subject|1
2954674|NCT01267175|10171176|P1|Overall Study|Lost to Follow-up|1
2954675|NCT01267175|10171176|P1|Overall Study|Withdrawal by Subject|1
2954676|NCT01266993|10171248|P2|Booster Phase (Month 69)|Withdrawal by Subject|1
2954677|NCT01266993|10171249|P1|Booster Phase (Month 69)|Withdrawal by Subject|0
2954678|NCT01266993|10171248|P2|Booster Phase (Month 69)|Lost to Follow-up|1
2954679|NCT01266993|10171249|P1|Booster Phase (Month 69)|Lost to Follow-up|5
2954680|NCT01266967|10171319|P2|Overall Study|Withdrawal by Subject|3
2954681|NCT01266967|10171320|P1|Overall Study|Withdrawal by Subject|3
2954682|NCT01266967|10171319|P2|Overall Study|Physician Decision|1
2954683|NCT01266967|10171320|P1|Overall Study|Physician Decision|0
2954684|NCT01266967|10171319|P2|Overall Study|Lost to Follow-up|1
2954685|NCT01266967|10171320|P1|Overall Study|Lost to Follow-up|2
2954686|NCT01266967|10171319|P2|Overall Study|Study Closed/Terminated|17
2954687|NCT01266967|10171320|P1|Overall Study|Study Closed/Terminated|15
2954688|NCT01266967|10171319|P2|Overall Study|Death|61
2954689|NCT01266967|10171320|P1|Overall Study|Death|69
2954690|NCT01266876|10171372|P5|Overall Study|Adverse Event|0
2954691|NCT01266876|10171373|P4|Overall Study|Adverse Event|1
2954692|NCT01266876|10171374|P3|Overall Study|Adverse Event|0
2954693|NCT01266876|10171375|P2|Overall Study|Adverse Event|0
2954694|NCT01266876|10171376|P1|Overall Study|Adverse Event|0
2954695|NCT01266850|10171483|P5|Overall Study|Site Closure|0
2954696|NCT01266850|10171484|P4|Overall Study|Site Closure|1
2954697|NCT01266850|10171485|P3|Overall Study|Site Closure|1
2954698|NCT01266850|10171486|P2|Overall Study|Site Closure|1
2954699|NCT01266850|10171487|P1|Overall Study|Site Closure|0
2954700|NCT01266850|10171483|P5|Overall Study|Adverse Event|1
2954701|NCT01266850|10171484|P4|Overall Study|Adverse Event|0
2954702|NCT01266850|10171485|P3|Overall Study|Adverse Event|0
2954703|NCT01266850|10171486|P2|Overall Study|Adverse Event|0
2954704|NCT01266850|10171487|P1|Overall Study|Adverse Event|0
2954705|NCT01266850|10171483|P5|Overall Study|Protocol Violation|2
2954706|NCT01266850|10171484|P4|Overall Study|Protocol Violation|1
2954707|NCT01266850|10171485|P3|Overall Study|Protocol Violation|0
2954708|NCT01266850|10171486|P2|Overall Study|Protocol Violation|1
2954709|NCT01266850|10171487|P1|Overall Study|Protocol Violation|0
2954710|NCT01266850|10171483|P5|Overall Study|Physician Decision|3
2954711|NCT01266850|10171484|P4|Overall Study|Physician Decision|4
2954712|NCT01266850|10171485|P3|Overall Study|Physician Decision|4
2954713|NCT01266850|10171486|P2|Overall Study|Physician Decision|6
2954714|NCT01266850|10171487|P1|Overall Study|Physician Decision|3
2954715|NCT01266850|10171483|P5|Overall Study|Withdrawal by Subject|12
2954716|NCT01266850|10171484|P4|Overall Study|Withdrawal by Subject|9
2954717|NCT01266850|10171485|P3|Overall Study|Withdrawal by Subject|6
2954718|NCT01266850|10171486|P2|Overall Study|Withdrawal by Subject|9
2954719|NCT01266850|10171487|P1|Overall Study|Withdrawal by Subject|8
2954720|NCT01266850|10171483|P5|Overall Study|Lost to Follow-up|12
2954721|NCT01266850|10171484|P4|Overall Study|Lost to Follow-up|13
2954722|NCT01266850|10171485|P3|Overall Study|Lost to Follow-up|13
2954723|NCT01266850|10171486|P2|Overall Study|Lost to Follow-up|19
2954724|NCT01266850|10171487|P1|Overall Study|Lost to Follow-up|19
2954725|NCT01266824|10171541|P2|Overall Study|Study terminated prior to completion|3
2954726|NCT01266824|10171542|P1|Overall Study|Study terminated prior to completion|2
2954727|NCT01266603|10171554|P1|Overall Study|Failed screening; MAGE-A3 negative|26
2954728|NCT01266603|10171554|P1|Overall Study|Withdrawal by Subject|1
2954729|NCT01266603|10171554|P1|Overall Study|Lack of Efficacy|14
2954730|NCT01266603|10171554|P1|Overall Study|Adverse Event|1
2954731|NCT01266590|10171560|P1|Overall Study|Physician Decision|1
2954732|NCT01266590|10171560|P1|Overall Study|Withdrawal by Subject|1
2954733|NCT01266590|10171560|P1|Overall Study|Lost to Follow-up|1
2954734|NCT01266590|10171560|P1|Overall Study|Adverse Event|3
2954735|NCT01266317|10171580|P1|Overall Study|Withdrawal by Subject|2
2954736|NCT01266291|10171585|P1|Overall Study|Adverse Event|1
2954737|NCT01266265|10171592|P2|Overall Study|Clinical worsening|1
2954738|NCT01266265|10171593|P1|Overall Study|Clinical worsening|1
2954739|NCT01266265|10171592|P2|Overall Study|Site closed early|3
2954740|NCT01266265|10171593|P1|Overall Study|Site closed early|4
2954741|NCT01266265|10171592|P2|Overall Study|Lung transplant|5
2954742|NCT01266265|10171593|P1|Overall Study|Lung transplant|6
2954743|NCT01266265|10171592|P2|Overall Study|Non-compliance|5
2954744|NCT01266265|10171593|P1|Overall Study|Non-compliance|8
2954745|NCT01266265|10171592|P2|Overall Study|Enrolled in another clinical study|26
2954746|NCT01266265|10171593|P1|Overall Study|Enrolled in another clinical study|15
2954747|NCT01266265|10171592|P2|Overall Study|Stopped/changed PAH medication(s)|9
2954748|NCT01266265|10171593|P1|Overall Study|Stopped/changed PAH medication(s)|16
2954749|NCT01266265|10171592|P2|Overall Study|Transferred care to another provider|28
2954750|NCT01266265|10171593|P1|Overall Study|Transferred care to another provider|22
2954751|NCT01266265|10171592|P2|Overall Study|Respiratory-related adverse event|1
2954752|NCT01266265|10171593|P1|Overall Study|Respiratory-related adverse event|2
2954753|NCT01266265|10171592|P2|Overall Study|Withdrawal by Subject|11
2954754|NCT01266265|10171593|P1|Overall Study|Withdrawal by Subject|13
2954755|NCT01266265|10171592|P2|Overall Study|Lost to Follow-up|28
2954756|NCT01266265|10171593|P1|Overall Study|Lost to Follow-up|23
2954757|NCT01266265|10171592|P2|Overall Study|Death|73
2954758|NCT01266265|10171593|P1|Overall Study|Death|95
2954759|NCT01266161|10171601|P2|Overall Study|Vomited within 4 hours of dosing|0
2954760|NCT01266161|10171602|P1|Overall Study|Vomited within 4 hours of dosing|3
2954761|NCT01266161|10171601|P2|Overall Study|Lack of Efficacy|1
2954762|NCT01266161|10171602|P1|Overall Study|Lack of Efficacy|0
2954763|NCT01266161|10171601|P2|Overall Study|Ineligible|0
2954764|NCT01266161|10171602|P1|Overall Study|Ineligible|1
2954765|NCT01266148|10171634|P2|Overall Study|missing mGFR value + AE|0
2954766|NCT01266148|10171635|P1|Overall Study|missing mGFR value + AE|1
2954767|NCT01266148|10171634|P2|Overall Study|Death|3
2954768|NCT01266148|10171635|P1|Overall Study|Death|2
2954769|NCT01266148|10171634|P2|Overall Study|2 2R rejections|0
2954770|NCT01266148|10171635|P1|Overall Study|2 2R rejections|1
2954771|NCT01266148|10171634|P2|Overall Study|Ongoing rejection|0
2954772|NCT01266148|10171635|P1|Overall Study|Ongoing rejection|1
2954773|NCT01266148|10171634|P2|Overall Study|Adverse Event|0
2954774|NCT01266148|10171635|P1|Overall Study|Adverse Event|2
2954775|NCT01266122|10171663|P2|Overall Study|Lost to Follow-up|6
2954776|NCT01266122|10171664|P1|Overall Study|Lost to Follow-up|6
2954777|NCT01266070|10171672|P1|Overall Study|Protocol Violation|1
2954778|NCT01266070|10171672|P1|Overall Study|Adverse Event|3
2954779|NCT01266031|10171680|P3|Overall Study|Not treated|2
2954780|NCT01266031|10171681|P2|Overall Study|Not treated|3
2954781|NCT01266031|10171682|P1|Overall Study|Not treated|0
2954782|NCT01266018|10171709|P2|Overall Study|Progressive disease|1
2954783|NCT01266018|10171710|P1|Overall Study|Progressive disease|0
2954784|NCT01266018|10171709|P2|Overall Study|Physician Decision|0
2954785|NCT01266018|10171710|P1|Overall Study|Physician Decision|1
2954786|NCT01265992|10171721|P1|Overall Study|Did not receive treatment|1
2954787|NCT01265992|10171721|P1|Overall Study|Stopped treatment|3
2954788|NCT01265992|10171721|P1|Overall Study|Administrative reasons|2
2954789|NCT01265992|10171721|P1|Overall Study|Adverse Event|1
2954790|NCT01265992|10171721|P1|Overall Study|Withdrawal by Subject|1
2954791|NCT01265992|10171721|P1|Overall Study|Lost to Follow-up|1
2954792|NCT01265953|10171749|P2|Overall Study|Non compliance|3
2954793|NCT01265953|10171750|P1|Overall Study|Non compliance|5
2954794|NCT01265875|10171762|P1|Overall Study|Uncooperative/unreliable|1
2954795|NCT01265823|10171770|P1|Overall Study|Participant Request|1
2954796|NCT01265823|10171770|P1|Overall Study|Protocol Violation|1
2954797|NCT01265823|10171770|P1|Overall Study|Failure to Return|4
2954798|NCT01265823|10171770|P1|Overall Study|Unsatisfactory Response Efficacy|1
2954799|NCT01265797|10171799|P2|Open Label Month|Lost to Follow-up|1
2954800|NCT01265797|10171800|P1|Open Label Month|Lost to Follow-up|0
2954801|NCT01265797|10171799|P2|Blinded Month|Diary data incomplete|1
2954802|NCT01265797|10171800|P1|Blinded Month|Diary data incomplete|0
2954803|NCT01265797|10171799|P2|Blinded Month|Adverse Event|0
2954804|NCT01265797|10171800|P1|Blinded Month|Adverse Event|2
2954805|NCT01265797|10171799|P2|Blinded Month|Protocol Violation|1
2954806|NCT01265797|10171800|P1|Blinded Month|Protocol Violation|2
2954807|NCT01265797|10171799|P2|Blinded Month|Lost to Follow-up|0
2954808|NCT01265797|10171800|P1|Blinded Month|Lost to Follow-up|1
2954809|NCT01265797|10171799|P2|Blinded Month|Lack of Efficacy|0
2954810|NCT01265797|10171800|P1|Blinded Month|Lack of Efficacy|5
2954811|NCT01265797|10171799|P2|Run-in Month|1st seizure during run-in month|1
2954812|NCT01265797|10171800|P1|Run-in Month|1st seizure during run-in month|0
2954813|NCT01265797|10171799|P2|Run-in Month|Withdrawal by Subject|4
2954814|NCT01265797|10171800|P1|Run-in Month|Withdrawal by Subject|0
2954815|NCT01265784|10171831|P3|Overall Study|Incorrectly Randomized|1
2954816|NCT01265784|10171832|P2|Overall Study|Incorrectly Randomized|0
2954817|NCT01265784|10171833|P1|Overall Study|Incorrectly Randomized|0
2954818|NCT01265784|10171831|P3|Overall Study|Protocol Violation|0
2954819|NCT01265784|10171832|P2|Overall Study|Protocol Violation|0
2954820|NCT01265784|10171833|P1|Overall Study|Protocol Violation|2
2954821|NCT01265784|10171831|P3|Overall Study|Death|0
2954822|NCT01265784|10171832|P2|Overall Study|Death|0
2954823|NCT01265784|10171833|P1|Overall Study|Death|3
2954824|NCT01265784|10171831|P3|Overall Study|Adverse Event|0
2954825|NCT01265784|10171832|P2|Overall Study|Adverse Event|0
2954826|NCT01265784|10171833|P1|Overall Study|Adverse Event|1
2954827|NCT01265784|10171831|P3|Overall Study|Physician Decision|1
2954828|NCT01265784|10171832|P2|Overall Study|Physician Decision|0
2954829|NCT01265784|10171833|P1|Overall Study|Physician Decision|1
2954830|NCT01265784|10171831|P3|Overall Study|Withdrawal by Subject|0
2954831|NCT01265784|10171832|P2|Overall Study|Withdrawal by Subject|5
2954832|NCT01265784|10171833|P1|Overall Study|Withdrawal by Subject|0
2954833|NCT01265784|10171831|P3|Overall Study|Lost to Follow-up|2
2954834|NCT01265784|10171832|P2|Overall Study|Lost to Follow-up|3
2954835|NCT01265784|10171833|P1|Overall Study|Lost to Follow-up|5
2954836|NCT01265719|10171901|P2|Overall Study|Adverse Event|0
2954837|NCT01265719|10171902|P1|Overall Study|Adverse Event|2
2954838|NCT01265719|10171901|P2|Overall Study|Lost to Follow-up|7
2954839|NCT01265719|10171902|P1|Overall Study|Lost to Follow-up|2
2954840|NCT01265719|10171901|P2|Overall Study|Withdrawal by Subject|3
2954841|NCT01265719|10171902|P1|Overall Study|Withdrawal by Subject|8
2954842|NCT01265719|10171901|P2|Overall Study|Other reasons|0
2954843|NCT01265719|10171902|P1|Overall Study|Other reasons|2
2954844|NCT01265719|10171901|P2|Overall Study|Does not meet entrance criteria|3
2954845|NCT01265719|10171902|P1|Overall Study|Does not meet entrance criteria|0
2954846|NCT01265615|10171953|P4|Overall Study|Protocol Violation|3
2954847|NCT01265615|10171954|P3|Overall Study|Protocol Violation|4
2954848|NCT01265615|10171955|P2|Overall Study|Protocol Violation|2
2954849|NCT01265615|10171956|P1|Overall Study|Protocol Violation|2
2954850|NCT01265563|10172007|P5|Overall Study|Withdrawal by Subject|2
2954851|NCT01265563|10172008|P4|Overall Study|Withdrawal by Subject|0
2954852|NCT01265563|10172009|P3|Overall Study|Withdrawal by Subject|1
2954853|NCT01265563|10172010|P2|Overall Study|Withdrawal by Subject|1
2954854|NCT01265563|10172011|P1|Overall Study|Withdrawal by Subject|0
2954855|NCT01265550|10172037|P4|Pre Randomization|Functional heartburn|99
2954856|NCT01265550|10172038|P3|Pre Randomization|Functional heartburn|0
2954857|NCT01265550|10172039|P2|Pre Randomization|Functional heartburn|0
2954858|NCT01265550|10172040|P1|Pre Randomization|Functional heartburn|0
2954859|NCT01265550|10172037|P4|Pre Randomization|Non-GERD organic disorders|23
2954860|NCT01265550|10172038|P3|Pre Randomization|Non-GERD organic disorders|0
2954861|NCT01265550|10172039|P2|Pre Randomization|Non-GERD organic disorders|0
2954862|NCT01265550|10172040|P1|Pre Randomization|Non-GERD organic disorders|0
2954863|NCT01265550|10172037|P4|Pre Randomization|GERD, PPI-Responsive|42
2954864|NCT01265550|10172038|P3|Pre Randomization|GERD, PPI-Responsive|0
2954865|NCT01265550|10172039|P2|Pre Randomization|GERD, PPI-Responsive|0
2954866|NCT01265550|10172040|P1|Pre Randomization|GERD, PPI-Responsive|0
2954867|NCT01265550|10172037|P4|Pre Randomization|Technical Exclusions|54
2954868|NCT01265550|10172038|P3|Pre Randomization|Technical Exclusions|0
2954869|NCT01265550|10172039|P2|Pre Randomization|Technical Exclusions|0
2954870|NCT01265550|10172040|P1|Pre Randomization|Technical Exclusions|0
2954871|NCT01265550|10172037|P4|Pre Randomization|Withdrawal by Subject|70
2954872|NCT01265550|10172038|P3|Pre Randomization|Withdrawal by Subject|0
2954873|NCT01265550|10172039|P2|Pre Randomization|Withdrawal by Subject|0
2954874|NCT01265550|10172040|P1|Pre Randomization|Withdrawal by Subject|0
2954875|NCT01265537|10172132|P2|Overall Study|Physician Decision|1
2954876|NCT01265537|10172133|P1|Overall Study|Physician Decision|0
2954877|NCT01265537|10172132|P2|Overall Study|Adverse Event|1
2954878|NCT01265537|10172133|P1|Overall Study|Adverse Event|2
2954879|NCT01265511|10172184|P2|Overall Study|Met stopping rules|2
2954880|NCT01265511|10172185|P1|Overall Study|Met stopping rules|0
2954881|NCT01265511|10172184|P2|Overall Study|Lack of Efficacy|1
2954882|NCT01265511|10172185|P1|Overall Study|Lack of Efficacy|2
2954883|NCT01265498|10172199|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
2954884|NCT01265498|10172200|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
2954885|NCT01265420|10172336|P1|Overall Study|Lost to Follow-up|1
2954886|NCT01265394|10172340|P1|Overall Study|Subjects withdrawn|37
2954887|NCT01265056|10172347|P2|Follow up|Lost to Follow-up|3
2954888|NCT01265056|10172348|P1|Follow up|Lost to Follow-up|7
2954889|NCT01265056|10172347|P2|Initial Study Period|Withdrawal by Subject|1
2954890|NCT01265056|10172348|P1|Initial Study Period|Withdrawal by Subject|1
2954891|NCT01265056|10172347|P2|Initial Study Period|Withdrawal by Subject|1
2954892|NCT01265056|10172348|P1|Initial Study Period|Withdrawal by Subject|1
2954893|NCT01264939|10172379|P2|Overall Study|Disease Progression|11
2954894|NCT01264939|10172380|P1|Overall Study|Disease Progression|8
2954895|NCT01264939|10172379|P2|Overall Study|Patient/Guardian Decision|10
2954896|NCT01264939|10172380|P1|Overall Study|Patient/Guardian Decision|8
2954897|NCT01264939|10172379|P2|Overall Study|Physician Decision|1
2954898|NCT01264939|10172380|P1|Overall Study|Physician Decision|1
2954899|NCT01264939|10172379|P2|Overall Study|Lost to Follow-up|3
2954900|NCT01264939|10172380|P1|Overall Study|Lost to Follow-up|0
2954901|NCT01264939|10172379|P2|Overall Study|Adverse Event|3
2954902|NCT01264939|10172380|P1|Overall Study|Adverse Event|1
2954903|NCT01264887|10172406|P1|Overall Study|Other|2
2954904|NCT01264887|10172406|P1|Overall Study|Sponsor Decision Administrative Reasons|2
2954905|NCT01264887|10172406|P1|Overall Study|Withdrawal by Subject|6
2954906|NCT01264887|10172406|P1|Overall Study|Physician Decision|4
2954907|NCT01264887|10172406|P1|Overall Study|Lack of Efficacy|5
2954908|NCT01264887|10172406|P1|Overall Study|Death|7
2954909|NCT01264887|10172406|P1|Overall Study|Adverse Event|5
2954910|NCT01264835|10172417|P1|Overall Study|Lost to Follow-up|1
2954911|NCT01264770|10172427|P6|Overall Study|Adverse Event|1
2954912|NCT01264770|10172428|P5|Overall Study|Adverse Event|2
2954913|NCT01264770|10172429|P4|Overall Study|Adverse Event|0
2954914|NCT01264770|10172430|P3|Overall Study|Adverse Event|8
2954915|NCT01264770|10172431|P2|Overall Study|Adverse Event|7
2954916|NCT01264770|10172432|P1|Overall Study|Adverse Event|7
2954917|NCT01264770|10172427|P6|Overall Study|Lost to Follow-up|0
2954918|NCT01264770|10172428|P5|Overall Study|Lost to Follow-up|0
2954919|NCT01264770|10172429|P4|Overall Study|Lost to Follow-up|1
2954920|NCT01264770|10172430|P3|Overall Study|Lost to Follow-up|1
2954921|NCT01264770|10172431|P2|Overall Study|Lost to Follow-up|0
2954922|NCT01264770|10172432|P1|Overall Study|Lost to Follow-up|0
2954923|NCT01264770|10172427|P6|Overall Study|Dev. of study specific discont. criteria|1
2954924|NCT01264770|10172428|P5|Overall Study|Dev. of study specific discont. criteria|1
2954925|NCT01264770|10172429|P4|Overall Study|Dev. of study specific discont. criteria|0
2954926|NCT01264770|10172430|P3|Overall Study|Dev. of study specific discont. criteria|0
2954927|NCT01264770|10172431|P2|Overall Study|Dev. of study specific discont. criteria|0
2954928|NCT01264770|10172432|P1|Overall Study|Dev. of study specific discont. criteria|2
2954929|NCT01264770|10172427|P6|Overall Study|Lack of therapeutic response|0
2954930|NCT01264770|10172428|P5|Overall Study|Lack of therapeutic response|1
2954931|NCT01264770|10172429|P4|Overall Study|Lack of therapeutic response|1
2954932|NCT01264770|10172430|P3|Overall Study|Lack of therapeutic response|2
2954933|NCT01264770|10172431|P2|Overall Study|Lack of therapeutic response|0
2954934|NCT01264770|10172432|P1|Overall Study|Lack of therapeutic response|1
2954935|NCT01264770|10172427|P6|Overall Study|Severe non-compliance to protocol|0
2954936|NCT01264770|10172428|P5|Overall Study|Severe non-compliance to protocol|0
2954937|NCT01264770|10172429|P4|Overall Study|Severe non-compliance to protocol|1
2954938|NCT01264770|10172430|P3|Overall Study|Severe non-compliance to protocol|1
2954939|NCT01264770|10172431|P2|Overall Study|Severe non-compliance to protocol|0
2954940|NCT01264770|10172432|P1|Overall Study|Severe non-compliance to protocol|0
2954941|NCT01264770|10172427|P6|Overall Study|e.g., change in circumstances|4
2954942|NCT01264770|10172428|P5|Overall Study|e.g., change in circumstances|4
2954943|NCT01264770|10172429|P4|Overall Study|e.g., change in circumstances|3
2954944|NCT01264770|10172430|P3|Overall Study|e.g., change in circumstances|3
2954945|NCT01264770|10172431|P2|Overall Study|e.g., change in circumstances|3
2954946|NCT01264770|10172432|P1|Overall Study|e.g., change in circumstances|8
2954947|NCT01264770|10172427|P6|Overall Study|Not reported|0
2954948|NCT01264770|10172428|P5|Overall Study|Not reported|0
2954949|NCT01264770|10172429|P4|Overall Study|Not reported|0
2954950|NCT01264770|10172430|P3|Overall Study|Not reported|1
2954951|NCT01264770|10172431|P2|Overall Study|Not reported|0
2954952|NCT01264770|10172432|P1|Overall Study|Not reported|0
2954953|NCT01264718|10172518|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
2954954|NCT01264718|10172519|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
2954955|NCT01264718|10172518|P2|Overall Study|Withdrawal by Subject|15
2954956|NCT01264718|10172519|P1|Overall Study|Withdrawal by Subject|9
2954957|NCT01264718|10172518|P2|Overall Study|Lost to Follow-up|2
2954958|NCT01264718|10172519|P1|Overall Study|Lost to Follow-up|3
2954959|NCT01264679|10172531|P1|Overall Study|Withdrawal by Subject|1
2954960|NCT01264679|10172531|P1|Overall Study|Sponsor's Suspension of Dosing|2
2954961|NCT01264679|10172531|P1|Overall Study|Physician Decision|1
2954962|NCT01264679|10172531|P1|Overall Study|Participation in Another Clinical Trial|1
2954963|NCT01264419|10172565|P1|Overall Study|Lost to Follow-up|3
2954964|NCT01264380|10172570|P3|Period C|Adverse Event|1
2954965|NCT01264380|10172571|P2|Period C|Adverse Event|0
2954966|NCT01264380|10172572|P1|Period C|Adverse Event|0
2954967|NCT01264380|10172570|P3|Period C|Withdrawal by Subject|1
2954968|NCT01264380|10172571|P2|Period C|Withdrawal by Subject|0
2954969|NCT01264380|10172572|P1|Period C|Withdrawal by Subject|0
2954970|NCT01264380|10172570|P3|Period C|Follow-up for survival status|6
2954971|NCT01264380|10172571|P2|Period C|Follow-up for survival status|0
2954972|NCT01264380|10172572|P1|Period C|Follow-up for survival status|0
2954973|NCT01264380|10172570|P3|Period C|Death|2
2954974|NCT01264380|10172571|P2|Period C|Death|0
2954975|NCT01264380|10172572|P1|Period C|Death|0
2954976|NCT01264380|10172570|P3|Period C|Disease Progression|4
2954977|NCT01264380|10172571|P2|Period C|Disease Progression|0
2954978|NCT01264380|10172572|P1|Period C|Disease Progression|0
2954979|NCT01264081|10172593|P1|Started Treatment|Not complete cycle 1 due to death|1
2954980|NCT01264081|10172593|P1|Started Treatment|Withdrawal by Subject|1
2954981|NCT01264081|10172593|P1|Participants Screened|Screening failures|30
2954982|NCT01264016|10172598|P1|Overall Study|Felt faint at sight of blood|1
2954983|NCT01264016|10172598|P1|Overall Study|Withdrawal by Subject|1
2954984|NCT01263925|10172613|P2|Overall Study|Withdrawal/ Not specified|1
2954985|NCT01263925|10172614|P1|Overall Study|Withdrawal/ Not specified|0
2954986|NCT01263925|10172613|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
2954987|NCT01263925|10172614|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
2954988|NCT01263925|10172613|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2954989|NCT01263925|10172614|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2954990|NCT01263925|10172613|P2|Overall Study|AE/ Withdrawal|4
2954991|NCT01263925|10172614|P1|Overall Study|AE/ Withdrawal|1
2954992|NCT01263925|10172613|P2|Overall Study|AE/ Unsatisfactory Compliance|2
2954993|NCT01263925|10172614|P1|Overall Study|AE/ Unsatisfactory Compliance|2
2954994|NCT01263925|10172613|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2954995|NCT01263925|10172614|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2954996|NCT01263925|10172613|P2|Overall Study|Lost to Follow-up|1
2954997|NCT01263925|10172614|P1|Overall Study|Lost to Follow-up|3
2954998|NCT01263925|10172613|P2|Overall Study|Other|4
2954999|NCT01263925|10172614|P1|Overall Study|Other|4
2955000|NCT01263925|10172613|P2|Overall Study|Withdrawal by Subject|8
2955001|NCT01263925|10172614|P1|Overall Study|Withdrawal by Subject|6
2955002|NCT01263925|10172613|P2|Overall Study|Unsatisfactory Compliance of Subject|5
2955160|NCT01263483|10173305|P3|Overall Study|Adverse Event|3
2955003|NCT01263925|10172614|P1|Overall Study|Unsatisfactory Compliance of Subject|8
2955004|NCT01263925|10172613|P2|Overall Study|Adverse Event|22
2955005|NCT01263925|10172614|P1|Overall Study|Adverse Event|23
2955006|NCT01263925|10172613|P2|Overall Study|Lack of Efficacy|1
2955007|NCT01263925|10172614|P1|Overall Study|Lack of Efficacy|0
2955008|NCT01263925|10172613|P2|Overall Study|Protocol Violation|0
2955009|NCT01263925|10172614|P1|Overall Study|Protocol Violation|1
2955010|NCT01263873|10172648|P2|Overall Study|One provider unable to complete numbers|1
2955011|NCT01263873|10172649|P1|Overall Study|One provider unable to complete numbers|1
2955012|NCT01263782|10172663|P4|Overall Study|Inevaluable|0
2955013|NCT01263782|10172664|P3|Overall Study|Inevaluable|1
2955014|NCT01263782|10172665|P2|Overall Study|Inevaluable|0
2955015|NCT01263782|10172666|P1|Overall Study|Inevaluable|0
2955016|NCT01263782|10172663|P4|Overall Study|Too early|0
2955017|NCT01263782|10172664|P3|Overall Study|Too early|1
2955018|NCT01263782|10172665|P2|Overall Study|Too early|0
2955019|NCT01263782|10172666|P1|Overall Study|Too early|0
2955020|NCT01263782|10172663|P4|Overall Study|Progressive disease|1
2955021|NCT01263782|10172664|P3|Overall Study|Progressive disease|0
2955022|NCT01263782|10172665|P2|Overall Study|Progressive disease|0
2955023|NCT01263782|10172666|P1|Overall Study|Progressive disease|0
2955024|NCT01263782|10172663|P4|Overall Study|Death|0
2955025|NCT01263782|10172664|P3|Overall Study|Death|1
2955026|NCT01263782|10172665|P2|Overall Study|Death|0
2955027|NCT01263782|10172666|P1|Overall Study|Death|0
2955028|NCT01263704|10172711|P1|Overall Study|Principal Investigator (PI) decision|1
2955029|NCT01263704|10172711|P1|Overall Study|Colon metastases|1
2955030|NCT01263704|10172711|P1|Overall Study|Lost to Follow-up|1
2955031|NCT01263704|10172711|P1|Overall Study|Eligibility criteria not fulfilled|1
2955032|NCT01263704|10172711|P1|Overall Study|Patient withdrew consent|2
2955033|NCT01263704|10172711|P1|Overall Study|Death|2
2955034|NCT01263704|10172711|P1|Overall Study|Adverse Event|3
2955035|NCT01263704|10172711|P1|Overall Study|Progressive disease|18
2955036|NCT01263691|10172726|P6|Overall Study|Adverse Event|0
2955037|NCT01263691|10172727|P5|Overall Study|Adverse Event|0
2955038|NCT01263691|10172728|P4|Overall Study|Adverse Event|0
2955039|NCT01263691|10172729|P3|Overall Study|Adverse Event|0
2955040|NCT01263691|10172730|P2|Overall Study|Adverse Event|0
2955041|NCT01263691|10172731|P1|Overall Study|Adverse Event|1
2955042|NCT01263691|10172726|P6|Overall Study|Withdrawal by Subject|0
2955043|NCT01263691|10172727|P5|Overall Study|Withdrawal by Subject|0
2955044|NCT01263691|10172728|P4|Overall Study|Withdrawal by Subject|0
2955045|NCT01263691|10172729|P3|Overall Study|Withdrawal by Subject|0
2955046|NCT01263691|10172730|P2|Overall Study|Withdrawal by Subject|0
2955047|NCT01263691|10172731|P1|Overall Study|Withdrawal by Subject|1
2955048|NCT01263691|10172726|P6|Overall Study|Lost to Follow-up|0
2955049|NCT01263691|10172727|P5|Overall Study|Lost to Follow-up|0
2955050|NCT01263691|10172728|P4|Overall Study|Lost to Follow-up|1
2955051|NCT01263691|10172729|P3|Overall Study|Lost to Follow-up|1
2955052|NCT01263691|10172730|P2|Overall Study|Lost to Follow-up|0
2955053|NCT01263691|10172731|P1|Overall Study|Lost to Follow-up|1
2955054|NCT01263665|10172841|P1|Overall Study|Surgical Bypass|2
2955055|NCT01263665|10172841|P1|Overall Study|Amputation above the ankle|1
2955056|NCT01263665|10172841|P1|Overall Study|Death|2
2955057|NCT01263665|10172841|P1|Overall Study|Lost to Follow-up|3
2955058|NCT01263665|10172841|P1|Overall Study|Withdrew Consent|1
2955059|NCT01263639|10172848|P2|Overall Study|Exclusion =Admission greater than 7 days|9
2955060|NCT01263639|10172849|P1|Overall Study|Exclusion =Admission greater than 7 days|7
2955061|NCT01263639|10172848|P2|Overall Study|Lost to Follow-up|70
2955062|NCT01263639|10172849|P1|Overall Study|Lost to Follow-up|66
2955063|NCT01263561|10172857|P2|Overall Study|Death|2
2955064|NCT01263561|10172858|P1|Overall Study|Death|1
2955065|NCT01263509|10172870|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
2955066|NCT01263509|10172871|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2955067|NCT01263509|10172872|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2955068|NCT01263509|10172873|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2955069|NCT01263509|10172870|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
2955070|NCT01263509|10172871|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
2955071|NCT01263509|10172872|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
2955072|NCT01263509|10172873|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
2955073|NCT01263509|10172870|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2955074|NCT01263509|10172871|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2955075|NCT01263509|10172872|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2955076|NCT01263509|10172873|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2955077|NCT01263509|10172870|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
2955078|NCT01263509|10172871|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
2955079|NCT01263509|10172872|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
2955080|NCT01263509|10172873|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
2955081|NCT01263509|10172870|P4|Entered - Long-Term Extension Study|Adverse Event|1
2955082|NCT01263509|10172871|P3|Entered - Long-Term Extension Study|Adverse Event|4
2955083|NCT01263509|10172872|P2|Entered - Long-Term Extension Study|Adverse Event|5
2955084|NCT01263509|10172873|P1|Entered - Long-Term Extension Study|Adverse Event|5
2955085|NCT01263496|10173002|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
2955086|NCT01263496|10173003|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
2955087|NCT01263496|10173004|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
2955088|NCT01263496|10173005|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
2955089|NCT01263496|10173006|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
2955090|NCT01263496|10173007|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
2955091|NCT01263496|10173008|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
2955092|NCT01263496|10173009|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
2955093|NCT01263496|10173010|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
2955094|NCT01263496|10173002|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
2955095|NCT01263496|10173003|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
2955096|NCT01263496|10173004|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
2955097|NCT01263496|10173005|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
2955098|NCT01263496|10173006|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
2955099|NCT01263496|10173007|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
2955100|NCT01263496|10173008|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
2955101|NCT01263496|10173009|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
2955102|NCT01263496|10173010|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
2955103|NCT01263496|10173002|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2955104|NCT01263496|10173003|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2955105|NCT01263496|10173004|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2955106|NCT01263496|10173005|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2955107|NCT01263496|10173006|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
2955108|NCT01263496|10173007|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2955109|NCT01263496|10173008|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2955110|NCT01263496|10173009|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2955111|NCT01263496|10173010|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2955112|NCT01263496|10173002|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955113|NCT01263496|10173003|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955114|NCT01263496|10173004|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955115|NCT01263496|10173005|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955116|NCT01263496|10173006|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955117|NCT01263496|10173007|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955118|NCT01263496|10173008|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955119|NCT01263496|10173009|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
2955120|NCT01263496|10173010|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
2955121|NCT01263496|10173002|P9|Entered - Long-Term Extension Study|Adverse Event|1
2955122|NCT01263496|10173003|P8|Entered - Long-Term Extension Study|Adverse Event|0
2955123|NCT01263496|10173004|P7|Entered - Long-Term Extension Study|Adverse Event|0
2955124|NCT01263496|10173005|P6|Entered - Long-Term Extension Study|Adverse Event|0
2955125|NCT01263496|10173006|P5|Entered - Long-Term Extension Study|Adverse Event|1
2955126|NCT01263496|10173007|P4|Entered - Long-Term Extension Study|Adverse Event|3
2955127|NCT01263496|10173008|P3|Entered - Long-Term Extension Study|Adverse Event|6
2955128|NCT01263496|10173009|P2|Entered - Long-Term Extension Study|Adverse Event|5
2955129|NCT01263496|10173010|P1|Entered - Long-Term Extension Study|Adverse Event|0
2955130|NCT01263496|10173002|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
2955131|NCT01263496|10173003|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
2955132|NCT01263496|10173004|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
2955133|NCT01263496|10173005|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
2955134|NCT01263496|10173006|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
2955135|NCT01263496|10173007|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
2955136|NCT01263496|10173008|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
2955137|NCT01263496|10173009|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2955138|NCT01263496|10173010|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
2955139|NCT01263496|10173002|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955140|NCT01263496|10173003|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955141|NCT01263496|10173004|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955142|NCT01263496|10173005|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955143|NCT01263496|10173006|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955144|NCT01263496|10173007|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955145|NCT01263496|10173008|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955146|NCT01263496|10173009|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
2955147|NCT01263496|10173010|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
2955148|NCT01263483|10173305|P3|Overall Study|Participant Unavailability|1
2955149|NCT01263483|10173306|P2|Overall Study|Participant Unavailability|1
2955150|NCT01263483|10173307|P1|Overall Study|Participant Unavailability|0
2955151|NCT01263483|10173305|P3|Overall Study|Protocol Violation|1
2955152|NCT01263483|10173306|P2|Overall Study|Protocol Violation|1
2955153|NCT01263483|10173307|P1|Overall Study|Protocol Violation|0
2955154|NCT01263483|10173305|P3|Overall Study|Lack of Efficacy|0
2955155|NCT01263483|10173306|P2|Overall Study|Lack of Efficacy|0
2955156|NCT01263483|10173307|P1|Overall Study|Lack of Efficacy|2
2955157|NCT01263483|10173305|P3|Overall Study|Withdrawal by Subject|0
2955158|NCT01263483|10173306|P2|Overall Study|Withdrawal by Subject|0
2955159|NCT01263483|10173307|P1|Overall Study|Withdrawal by Subject|1
2955161|NCT01263483|10173306|P2|Overall Study|Adverse Event|0
2955162|NCT01263483|10173307|P1|Overall Study|Adverse Event|4
2955163|NCT01263470|10173369|P6|Overall Study|Study Drug Non-compliance|0
2955164|NCT01263470|10173370|P5|Overall Study|Study Drug Non-compliance|1
2955165|NCT01263470|10173371|P4|Overall Study|Study Drug Non-compliance|0
2955166|NCT01263470|10173372|P3|Overall Study|Study Drug Non-compliance|0
2955167|NCT01263470|10173373|P2|Overall Study|Study Drug Non-compliance|0
2955168|NCT01263470|10173374|P1|Overall Study|Study Drug Non-compliance|0
2955169|NCT01263470|10173369|P6|Overall Study|Participant Unavailability|0
2955170|NCT01263470|10173370|P5|Overall Study|Participant Unavailability|0
2955171|NCT01263470|10173371|P4|Overall Study|Participant Unavailability|0
2955172|NCT01263470|10173372|P3|Overall Study|Participant Unavailability|0
2955173|NCT01263470|10173373|P2|Overall Study|Participant Unavailability|1
2955174|NCT01263470|10173374|P1|Overall Study|Participant Unavailability|0
2955175|NCT01263470|10173369|P6|Overall Study|Lack of Efficacy|0
2955176|NCT01263470|10173370|P5|Overall Study|Lack of Efficacy|0
2955177|NCT01263470|10173371|P4|Overall Study|Lack of Efficacy|0
2955178|NCT01263470|10173372|P3|Overall Study|Lack of Efficacy|2
2955179|NCT01263470|10173373|P2|Overall Study|Lack of Efficacy|0
2955180|NCT01263470|10173374|P1|Overall Study|Lack of Efficacy|0
2955181|NCT01263470|10173369|P6|Overall Study|Withdrawal by Subject|2
2955182|NCT01263470|10173370|P5|Overall Study|Withdrawal by Subject|0
2955183|NCT01263470|10173371|P4|Overall Study|Withdrawal by Subject|2
2955184|NCT01263470|10173372|P3|Overall Study|Withdrawal by Subject|1
2955185|NCT01263470|10173373|P2|Overall Study|Withdrawal by Subject|1
2955186|NCT01263470|10173374|P1|Overall Study|Withdrawal by Subject|0
2955187|NCT01263470|10173369|P6|Overall Study|Protocol Violation|1
2955188|NCT01263470|10173370|P5|Overall Study|Protocol Violation|0
2955189|NCT01263470|10173371|P4|Overall Study|Protocol Violation|0
2955190|NCT01263470|10173372|P3|Overall Study|Protocol Violation|0
2955191|NCT01263470|10173373|P2|Overall Study|Protocol Violation|1
2955192|NCT01263470|10173374|P1|Overall Study|Protocol Violation|0
2955193|NCT01263470|10173369|P6|Overall Study|Adverse Event|2
2955194|NCT01263470|10173370|P5|Overall Study|Adverse Event|2
2955195|NCT01263470|10173371|P4|Overall Study|Adverse Event|1
2955196|NCT01263470|10173372|P3|Overall Study|Adverse Event|1
2955197|NCT01263470|10173373|P2|Overall Study|Adverse Event|2
2955198|NCT01263470|10173374|P1|Overall Study|Adverse Event|2
2955199|NCT01263444|10173484|P1|Overall Study|Protocol Violation|1
2955200|NCT01263444|10173484|P1|Overall Study|Withdrawal by Subject|1
2955201|NCT01263444|10173484|P1|Overall Study|Adverse Event|8
2955202|NCT01263223|10173621|P2|7-day Follow-up|Lost to Follow-up|0
2955203|NCT01263223|10173622|P1|7-day Follow-up|Lost to Follow-up|1
2955204|NCT01263223|10173621|P2|7-day Follow-up|Withdrawal by Subject|1
2955205|NCT01263223|10173622|P1|7-day Follow-up|Withdrawal by Subject|0
2955206|NCT01263223|10173621|P2|Period 2|Withdrawal by Subject|1
2955207|NCT01263223|10173622|P1|Period 2|Withdrawal by Subject|0
2955208|NCT01263197|10173645|P6|Third Intervention (Period 3)|Adverse Event|0
2955209|NCT01263197|10173646|P5|Third Intervention (Period 3)|Adverse Event|0
2955210|NCT01263197|10173647|P4|Third Intervention (Period 3)|Adverse Event|0
2955211|NCT01263197|10173648|P3|Third Intervention (Period 3)|Adverse Event|0
2955212|NCT01263197|10173649|P2|Third Intervention (Period 3)|Adverse Event|1
2955213|NCT01263197|10173650|P1|Third Intervention (Period 3)|Adverse Event|0
2955214|NCT01263197|10173645|P6|Washout Period 2|Protocol Violation|0
2955215|NCT01263197|10173646|P5|Washout Period 2|Protocol Violation|0
2955216|NCT01263197|10173647|P4|Washout Period 2|Protocol Violation|1
2955217|NCT01263197|10173648|P3|Washout Period 2|Protocol Violation|0
2955218|NCT01263197|10173649|P2|Washout Period 2|Protocol Violation|0
2955219|NCT01263197|10173650|P1|Washout Period 2|Protocol Violation|0
2955220|NCT01263197|10173645|P6|Washout Period 2|Physician Decision|1
2955221|NCT01263197|10173646|P5|Washout Period 2|Physician Decision|0
2955222|NCT01263197|10173647|P4|Washout Period 2|Physician Decision|0
2955223|NCT01263197|10173648|P3|Washout Period 2|Physician Decision|0
2955224|NCT01263197|10173649|P2|Washout Period 2|Physician Decision|0
2955225|NCT01263197|10173650|P1|Washout Period 2|Physician Decision|0
2955226|NCT01263197|10173645|P6|Washout Period 1|Protocol Violation|0
2955227|NCT01263197|10173646|P5|Washout Period 1|Protocol Violation|1
2955228|NCT01263197|10173647|P4|Washout Period 1|Protocol Violation|0
2955229|NCT01263197|10173648|P3|Washout Period 1|Protocol Violation|0
2955230|NCT01263197|10173649|P2|Washout Period 1|Protocol Violation|0
2955231|NCT01263197|10173650|P1|Washout Period 1|Protocol Violation|0
2955232|NCT01263197|10173645|P6|First Intervention (Period 1)|Adverse Event|1
2955233|NCT01263197|10173646|P5|First Intervention (Period 1)|Adverse Event|0
2955234|NCT01263197|10173647|P4|First Intervention (Period 1)|Adverse Event|0
2955235|NCT01263197|10173648|P3|First Intervention (Period 1)|Adverse Event|0
2955236|NCT01263197|10173649|P2|First Intervention (Period 1)|Adverse Event|0
2955237|NCT01263197|10173650|P1|First Intervention (Period 1)|Adverse Event|0
2955238|NCT01263119|10173693|P1|Period 2|Adverse Event|2
2955239|NCT01263119|10173693|P1|Period 1|Protocol Violation|2
2955240|NCT01263106|10173714|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
2955241|NCT01263106|10173715|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
2955242|NCT01263093|10173730|P2|Period 2|Adverse Event|0
2955243|NCT01263093|10173731|P1|Period 2|Adverse Event|1
2955244|NCT01263093|10173730|P2|Washout|Physician Decision|0
2955245|NCT01263093|10173731|P1|Washout|Physician Decision|1
2955246|NCT01263054|10173748|P2|Overall Study|Other|1
2955247|NCT01263054|10173749|P1|Overall Study|Other|0
2955248|NCT01263054|10173748|P2|Overall Study|Qualification Violation|0
2955249|NCT01263054|10173749|P1|Overall Study|Qualification Violation|1
2955250|NCT01263054|10173748|P2|Overall Study|Withdrawal by Subject|3
2955251|NCT01263054|10173749|P1|Overall Study|Withdrawal by Subject|1
2955252|NCT01263054|10173748|P2|Overall Study|Lost to Follow-up|2
2955253|NCT01263054|10173749|P1|Overall Study|Lost to Follow-up|2
2955254|NCT01263054|10173748|P2|Overall Study|Death|0
2955255|NCT01263054|10173749|P1|Overall Study|Death|1
2955256|NCT01263028|10173767|P1|Overall Study|Study terminated due to low enrollment.|4
2955257|NCT01263028|10173767|P1|Overall Study|Adverse Event|1
2955258|NCT01263028|10173767|P1|Overall Study|Withdrawal by Subject|1
2955259|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
2955260|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
2955261|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
2955262|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
2955263|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2955264|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2955265|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
2955266|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
2955267|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
2955268|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
2955269|NCT01263015|10173777|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
2955270|NCT01263015|10173778|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
2955271|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
2955272|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
2955273|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
2955274|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
2955275|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
2955276|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
2955277|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
2955278|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
2955279|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
2955280|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
2955281|NCT01263015|10173777|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
2955282|NCT01263015|10173778|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
2955283|NCT01262989|10173804|P2|Period 2|Intercurrent disease|1
2955284|NCT01262989|10173805|P1|Period 2|Intercurrent disease|0
2955285|NCT01262989|10173804|P2|Period 1|Positive answer for exclusion criteria|1
2955286|NCT01262989|10173805|P1|Period 1|Positive answer for exclusion criteria|0
2955287|NCT01262989|10173804|P2|Period 1|Intercurrent disease|1
2955288|NCT01262989|10173805|P1|Period 1|Intercurrent disease|0
2955289|NCT01262989|10173804|P2|Period 1|Lost to Follow-up|1
2955290|NCT01262989|10173805|P1|Period 1|Lost to Follow-up|1
2955291|NCT01262976|10173821|P6|Up to Year 3|Other|0
2955292|NCT01262976|10173822|P5|Up to Year 3|Other|0
2955293|NCT01262976|10173823|P4|Up to Year 3|Other|0
2955294|NCT01262976|10173824|P3|Up to Year 3|Other|0
2955295|NCT01262976|10173825|P2|Up to Year 3|Other|0
2955296|NCT01262976|10173826|P1|Up to Year 3|Other|3
2955297|NCT01262976|10173821|P6|Up to Year 3|Subjects with unknown completion status|0
2955298|NCT01262976|10173822|P5|Up to Year 3|Subjects with unknown completion status|0
2955299|NCT01262976|10173823|P4|Up to Year 3|Subjects with unknown completion status|0
2955300|NCT01262976|10173824|P3|Up to Year 3|Subjects with unknown completion status|1
2955301|NCT01262976|10173825|P2|Up to Year 3|Subjects with unknown completion status|0
2955302|NCT01262976|10173826|P1|Up to Year 3|Subjects with unknown completion status|0
2955303|NCT01262976|10173821|P6|Up to Year 3|Lost to Follow-up|3
2955304|NCT01262976|10173822|P5|Up to Year 3|Lost to Follow-up|1
2955305|NCT01262976|10173823|P4|Up to Year 3|Lost to Follow-up|3
2955306|NCT01262976|10173824|P3|Up to Year 3|Lost to Follow-up|4
2955307|NCT01262976|10173825|P2|Up to Year 3|Lost to Follow-up|2
2955308|NCT01262976|10173826|P1|Up to Year 3|Lost to Follow-up|2
2955309|NCT01262976|10173821|P6|Up to Year 3|Migrated/moved from study area|1
2955310|NCT01262976|10173822|P5|Up to Year 3|Migrated/moved from study area|1
2955311|NCT01262976|10173823|P4|Up to Year 3|Migrated/moved from study area|2
2955312|NCT01262976|10173824|P3|Up to Year 3|Migrated/moved from study area|0
2955313|NCT01262976|10173825|P2|Up to Year 3|Migrated/moved from study area|0
2955314|NCT01262976|10173826|P1|Up to Year 3|Migrated/moved from study area|0
2955315|NCT01262976|10173821|P6|Up to Year 3|Withdrawal by Subject|0
2955316|NCT01262976|10173822|P5|Up to Year 3|Withdrawal by Subject|0
2955317|NCT01262976|10173823|P4|Up to Year 3|Withdrawal by Subject|0
2955318|NCT01262976|10173824|P3|Up to Year 3|Withdrawal by Subject|0
2955319|NCT01262976|10173825|P2|Up to Year 3|Withdrawal by Subject|0
2955320|NCT01262976|10173826|P1|Up to Year 3|Withdrawal by Subject|1
2955321|NCT01262976|10173821|P6|Up to Year 3|Serious Adverse Event|0
2955322|NCT01262976|10173822|P5|Up to Year 3|Serious Adverse Event|0
2955323|NCT01262976|10173823|P4|Up to Year 3|Serious Adverse Event|0
2955324|NCT01262976|10173824|P3|Up to Year 3|Serious Adverse Event|2
2955325|NCT01262976|10173825|P2|Up to Year 3|Serious Adverse Event|0
2955326|NCT01262976|10173826|P1|Up to Year 3|Serious Adverse Event|0
2955327|NCT01262976|10173821|P6|Up to Year 2|Other|0
2955328|NCT01262976|10173822|P5|Up to Year 2|Other|0
2955329|NCT01262976|10173823|P4|Up to Year 2|Other|0
2955330|NCT01262976|10173824|P3|Up to Year 2|Other|0
2955331|NCT01262976|10173825|P2|Up to Year 2|Other|0
2955332|NCT01262976|10173826|P1|Up to Year 2|Other|3
2955333|NCT01262976|10173821|P6|Up to Year 2|Subjects with unknown completion status|0
2955334|NCT01262976|10173822|P5|Up to Year 2|Subjects with unknown completion status|0
2955335|NCT01262976|10173823|P4|Up to Year 2|Subjects with unknown completion status|0
2955336|NCT01262976|10173824|P3|Up to Year 2|Subjects with unknown completion status|1
2955337|NCT01262976|10173825|P2|Up to Year 2|Subjects with unknown completion status|0
2955338|NCT01262976|10173826|P1|Up to Year 2|Subjects with unknown completion status|0
2955339|NCT01262976|10173821|P6|Up to Year 2|Lost to Follow-up|3
2955340|NCT01262976|10173822|P5|Up to Year 2|Lost to Follow-up|3
2955341|NCT01262976|10173823|P4|Up to Year 2|Lost to Follow-up|2
2955342|NCT01262976|10173824|P3|Up to Year 2|Lost to Follow-up|2
2955343|NCT01262976|10173825|P2|Up to Year 2|Lost to Follow-up|1
2955344|NCT01262976|10173826|P1|Up to Year 2|Lost to Follow-up|1
2955345|NCT01262976|10173821|P6|Up to Year 2|Migrated/moved from study area|2
2955346|NCT01262976|10173822|P5|Up to Year 2|Migrated/moved from study area|1
2955347|NCT01262976|10173823|P4|Up to Year 2|Migrated/moved from study area|2
2955348|NCT01262976|10173824|P3|Up to Year 2|Migrated/moved from study area|0
2955349|NCT01262976|10173825|P2|Up to Year 2|Migrated/moved from study area|0
2955350|NCT01262976|10173826|P1|Up to Year 2|Migrated/moved from study area|0
2955351|NCT01262976|10173821|P6|Up to Year 2|Withdrawal by Subject|0
2955352|NCT01262976|10173822|P5|Up to Year 2|Withdrawal by Subject|0
2955353|NCT01262976|10173823|P4|Up to Year 2|Withdrawal by Subject|0
2955354|NCT01262976|10173824|P3|Up to Year 2|Withdrawal by Subject|0
2955355|NCT01262976|10173825|P2|Up to Year 2|Withdrawal by Subject|0
2955356|NCT01262976|10173826|P1|Up to Year 2|Withdrawal by Subject|1
2955357|NCT01262976|10173821|P6|Up to Year 2|Serious Adverse Event|0
2955358|NCT01262976|10173822|P5|Up to Year 2|Serious Adverse Event|0
2955359|NCT01262976|10173823|P4|Up to Year 2|Serious Adverse Event|0
2955360|NCT01262976|10173824|P3|Up to Year 2|Serious Adverse Event|2
2955361|NCT01262976|10173825|P2|Up to Year 2|Serious Adverse Event|0
2955362|NCT01262976|10173826|P1|Up to Year 2|Serious Adverse Event|0
2955363|NCT01262976|10173821|P6|Up to Year 1|Subjects with unknown completion status|1
2955364|NCT01262976|10173822|P5|Up to Year 1|Subjects with unknown completion status|0
2955365|NCT01262976|10173823|P4|Up to Year 1|Subjects with unknown completion status|0
2955366|NCT01262976|10173824|P3|Up to Year 1|Subjects with unknown completion status|1
2955367|NCT01262976|10173825|P2|Up to Year 1|Subjects with unknown completion status|0
2955368|NCT01262976|10173826|P1|Up to Year 1|Subjects with unknown completion status|0
2955369|NCT01262976|10173821|P6|Up to Year 1|Other|1
2955370|NCT01262976|10173822|P5|Up to Year 1|Other|2
2955371|NCT01262976|10173823|P4|Up to Year 1|Other|0
2955372|NCT01262976|10173824|P3|Up to Year 1|Other|0
2955373|NCT01262976|10173825|P2|Up to Year 1|Other|1
2955374|NCT01262976|10173826|P1|Up to Year 1|Other|3
2955375|NCT01262976|10173821|P6|Up to Year 1|Lost to Follow-up|5
2955376|NCT01262976|10173822|P5|Up to Year 1|Lost to Follow-up|6
2955377|NCT01262976|10173823|P4|Up to Year 1|Lost to Follow-up|1
2955378|NCT01262976|10173824|P3|Up to Year 1|Lost to Follow-up|0
2955379|NCT01262976|10173825|P2|Up to Year 1|Lost to Follow-up|0
2955380|NCT01262976|10173826|P1|Up to Year 1|Lost to Follow-up|4
2955381|NCT01262976|10173821|P6|Up to Year 1|Migrated/moved from study area|2
2955382|NCT01262976|10173822|P5|Up to Year 1|Migrated/moved from study area|3
2955383|NCT01262976|10173823|P4|Up to Year 1|Migrated/moved from study area|3
2955384|NCT01262976|10173824|P3|Up to Year 1|Migrated/moved from study area|0
2955385|NCT01262976|10173825|P2|Up to Year 1|Migrated/moved from study area|0
2955386|NCT01262976|10173826|P1|Up to Year 1|Migrated/moved from study area|1
2955387|NCT01262976|10173821|P6|Up to Year 1|Withdrawal by Subject|0
2955388|NCT01262976|10173822|P5|Up to Year 1|Withdrawal by Subject|0
2955389|NCT01262976|10173823|P4|Up to Year 1|Withdrawal by Subject|0
2955390|NCT01262976|10173824|P3|Up to Year 1|Withdrawal by Subject|0
2955391|NCT01262976|10173825|P2|Up to Year 1|Withdrawal by Subject|0
2955392|NCT01262976|10173826|P1|Up to Year 1|Withdrawal by Subject|1
2955393|NCT01262976|10173821|P6|Up to Year 1|Serious Adverse Event|0
2955394|NCT01262976|10173822|P5|Up to Year 1|Serious Adverse Event|0
2955395|NCT01262976|10173823|P4|Up to Year 1|Serious Adverse Event|0
2955396|NCT01262976|10173824|P3|Up to Year 1|Serious Adverse Event|2
2955397|NCT01262976|10173825|P2|Up to Year 1|Serious Adverse Event|0
2955398|NCT01262976|10173826|P1|Up to Year 1|Serious Adverse Event|0
2955399|NCT01262976|10173821|P6|Up to Month 7|Other|0
2955400|NCT01262976|10173822|P5|Up to Month 7|Other|0
2955401|NCT01262976|10173823|P4|Up to Month 7|Other|0
2955402|NCT01262976|10173824|P3|Up to Month 7|Other|2
2955403|NCT01262976|10173825|P2|Up to Month 7|Other|0
2955404|NCT01262976|10173826|P1|Up to Month 7|Other|3
2955405|NCT01262976|10173821|P6|Up to Month 7|Lost to Follow-up|3
2955406|NCT01262976|10173822|P5|Up to Month 7|Lost to Follow-up|1
2955407|NCT01262976|10173823|P4|Up to Month 7|Lost to Follow-up|3
2955408|NCT01262976|10173824|P3|Up to Month 7|Lost to Follow-up|1
2955409|NCT01262976|10173825|P2|Up to Month 7|Lost to Follow-up|0
2955410|NCT01262976|10173826|P1|Up to Month 7|Lost to Follow-up|1
2955411|NCT01262976|10173821|P6|Up to Month 7|Migrated/moved from study area|1
2955412|NCT01262976|10173822|P5|Up to Month 7|Migrated/moved from study area|1
2955413|NCT01262976|10173823|P4|Up to Month 7|Migrated/moved from study area|3
2955414|NCT01262976|10173824|P3|Up to Month 7|Migrated/moved from study area|1
2955415|NCT01262976|10173825|P2|Up to Month 7|Migrated/moved from study area|0
2955416|NCT01262976|10173826|P1|Up to Month 7|Migrated/moved from study area|0
2955417|NCT01262976|10173821|P6|Up to Month 7|Withdrawal by Subject|0
2955418|NCT01262976|10173822|P5|Up to Month 7|Withdrawal by Subject|0
2955419|NCT01262976|10173823|P4|Up to Month 7|Withdrawal by Subject|0
2955420|NCT01262976|10173824|P3|Up to Month 7|Withdrawal by Subject|0
2955421|NCT01262976|10173825|P2|Up to Month 7|Withdrawal by Subject|0
2955422|NCT01262976|10173826|P1|Up to Month 7|Withdrawal by Subject|1
2955423|NCT01262976|10173821|P6|Up to Month 7|Serious Adverse Event|0
2955424|NCT01262976|10173822|P5|Up to Month 7|Serious Adverse Event|0
2955425|NCT01262976|10173823|P4|Up to Month 7|Serious Adverse Event|0
2955426|NCT01262976|10173824|P3|Up to Month 7|Serious Adverse Event|2
2955427|NCT01262976|10173825|P2|Up to Month 7|Serious Adverse Event|0
2955428|NCT01262976|10173826|P1|Up to Month 7|Serious Adverse Event|0
2955429|NCT01262976|10173821|P6|Up to Month 2|Other|2
2955430|NCT01262976|10173822|P5|Up to Month 2|Other|0
2955431|NCT01262976|10173823|P4|Up to Month 2|Other|1
2955432|NCT01262976|10173824|P3|Up to Month 2|Other|0
2955433|NCT01262976|10173825|P2|Up to Month 2|Other|0
2955434|NCT01262976|10173826|P1|Up to Month 2|Other|1
2955435|NCT01262976|10173821|P6|Up to Month 2|Lost to Follow-up|1
2955436|NCT01262976|10173822|P5|Up to Month 2|Lost to Follow-up|1
2955437|NCT01262976|10173823|P4|Up to Month 2|Lost to Follow-up|1
2955438|NCT01262976|10173824|P3|Up to Month 2|Lost to Follow-up|0
2955439|NCT01262976|10173825|P2|Up to Month 2|Lost to Follow-up|0
2955440|NCT01262976|10173826|P1|Up to Month 2|Lost to Follow-up|1
2955441|NCT01262976|10173821|P6|Up to Month 2|Migrated/moved from study area|1
2955442|NCT01262976|10173822|P5|Up to Month 2|Migrated/moved from study area|1
2955443|NCT01262976|10173823|P4|Up to Month 2|Migrated/moved from study area|0
2955444|NCT01262976|10173824|P3|Up to Month 2|Migrated/moved from study area|0
2955445|NCT01262976|10173825|P2|Up to Month 2|Migrated/moved from study area|1
2955446|NCT01262976|10173826|P1|Up to Month 2|Migrated/moved from study area|0
2955447|NCT01262976|10173821|P6|Up to Month 2|Withdrawal by Subject|0
2955448|NCT01262976|10173822|P5|Up to Month 2|Withdrawal by Subject|0
2955449|NCT01262976|10173823|P4|Up to Month 2|Withdrawal by Subject|0
2955450|NCT01262976|10173824|P3|Up to Month 2|Withdrawal by Subject|0
2955451|NCT01262976|10173825|P2|Up to Month 2|Withdrawal by Subject|0
2955452|NCT01262976|10173826|P1|Up to Month 2|Withdrawal by Subject|1
2955453|NCT01262976|10173821|P6|Up to Month 2|Serious Adverse Event|0
2955454|NCT01262976|10173822|P5|Up to Month 2|Serious Adverse Event|0
2955455|NCT01262976|10173823|P4|Up to Month 2|Serious Adverse Event|0
2955456|NCT01262976|10173824|P3|Up to Month 2|Serious Adverse Event|1
2955457|NCT01262976|10173825|P2|Up to Month 2|Serious Adverse Event|0
2955458|NCT01262976|10173826|P1|Up to Month 2|Serious Adverse Event|0
2955459|NCT01262898|10173982|P4|Overall Study|Withdrawal by Subject|0
2955460|NCT01262898|10173983|P3|Overall Study|Withdrawal by Subject|0
2955461|NCT01262898|10173984|P2|Overall Study|Withdrawal by Subject|1
2955462|NCT01262898|10173985|P1|Overall Study|Withdrawal by Subject|1
2955463|NCT01262898|10173982|P4|Overall Study|Lost to Follow-up|0
2955464|NCT01262898|10173983|P3|Overall Study|Lost to Follow-up|0
2955465|NCT01262898|10173984|P2|Overall Study|Lost to Follow-up|0
2955466|NCT01262898|10173985|P1|Overall Study|Lost to Follow-up|1
2955467|NCT01262898|10173982|P4|Overall Study|Protocol Violation|0
2955468|NCT01262898|10173983|P3|Overall Study|Protocol Violation|0
2955469|NCT01262898|10173984|P2|Overall Study|Protocol Violation|1
2955470|NCT01262898|10173985|P1|Overall Study|Protocol Violation|1
2955471|NCT01262872|10174113|P8|Step 2|Migrated/moved from study area|3
2955472|NCT01262872|10174114|P7|Step 2|Migrated/moved from study area|2
2955473|NCT01262872|10174115|P6|Step 2|Migrated/moved from study area|6
2955474|NCT01262872|10174116|P5|Step 2|Migrated/moved from study area|2
2955475|NCT01262872|10174117|P4|Step 2|Migrated/moved from study area|3
2955476|NCT01262872|10174118|P3|Step 2|Migrated/moved from study area|4
2955477|NCT01262872|10174119|P2|Step 2|Migrated/moved from study area|0
2955478|NCT01262872|10174120|P1|Step 2|Migrated/moved from study area|0
2955479|NCT01262872|10174113|P8|Step 2|Withdrawal by Subject|1
2955480|NCT01262872|10174114|P7|Step 2|Withdrawal by Subject|2
2955481|NCT01262872|10174115|P6|Step 2|Withdrawal by Subject|1
2955482|NCT01262872|10174116|P5|Step 2|Withdrawal by Subject|3
2955483|NCT01262872|10174117|P4|Step 2|Withdrawal by Subject|6
2955484|NCT01262872|10174118|P3|Step 2|Withdrawal by Subject|4
2955485|NCT01262872|10174119|P2|Step 2|Withdrawal by Subject|0
2955486|NCT01262872|10174120|P1|Step 2|Withdrawal by Subject|0
2955487|NCT01262872|10174113|P8|Step 2|Protocol Violation|1
2955488|NCT01262872|10174114|P7|Step 2|Protocol Violation|3
2955489|NCT01262872|10174115|P6|Step 2|Protocol Violation|0
2955490|NCT01262872|10174116|P5|Step 2|Protocol Violation|0
2955491|NCT01262872|10174117|P4|Step 2|Protocol Violation|0
2955492|NCT01262872|10174118|P3|Step 2|Protocol Violation|1
2955493|NCT01262872|10174119|P2|Step 2|Protocol Violation|0
2955494|NCT01262872|10174120|P1|Step 2|Protocol Violation|0
2955495|NCT01262872|10174113|P8|Step 2|Death|1
2955496|NCT01262872|10174114|P7|Step 2|Death|2
2955497|NCT01262872|10174115|P6|Step 2|Death|2
2955498|NCT01262872|10174116|P5|Step 2|Death|0
2955499|NCT01262872|10174117|P4|Step 2|Death|1
2955500|NCT01262872|10174118|P3|Step 2|Death|0
2955501|NCT01262872|10174119|P2|Step 2|Death|0
2955502|NCT01262872|10174120|P1|Step 2|Death|0
2955503|NCT01262820|10174394|P1|Overall Study|Drug held for 21+ days|1
2955504|NCT01262820|10174394|P1|Overall Study|Lack of Efficacy|9
2955505|NCT01262820|10174394|P1|Overall Study|Adverse Event|5
2955506|NCT01262677|10174408|P3|Overall Study|Adverse Event (AE) related to study drug|3
2955507|NCT01262677|10174409|P2|Overall Study|Adverse Event (AE) related to study drug|8
2955508|NCT01262677|10174410|P1|Overall Study|Adverse Event (AE) related to study drug|3
2955509|NCT01262677|10174408|P3|Overall Study|Protocol Violation|1
2955510|NCT01262677|10174409|P2|Overall Study|Protocol Violation|1
2955511|NCT01262677|10174410|P1|Overall Study|Protocol Violation|0
2955512|NCT01262677|10174408|P3|Overall Study|Reason not provided|3
2955513|NCT01262677|10174409|P2|Overall Study|Reason not provided|1
2955514|NCT01262677|10174410|P1|Overall Study|Reason not provided|2
2955515|NCT01262677|10174408|P3|Overall Study|No longer willing to participate|2
2955516|NCT01262677|10174409|P2|Overall Study|No longer willing to participate|3
2955517|NCT01262677|10174410|P1|Overall Study|No longer willing to participate|3
2955518|NCT01262677|10174408|P3|Overall Study|Lost to Follow-up|2
2955519|NCT01262677|10174409|P2|Overall Study|Lost to Follow-up|0
2955520|NCT01262677|10174410|P1|Overall Study|Lost to Follow-up|1
2955521|NCT01262677|10174408|P3|Overall Study|Insufficient clinical response|1
2955522|NCT01262677|10174409|P2|Overall Study|Insufficient clinical response|0
2955523|NCT01262677|10174410|P1|Overall Study|Insufficient clinical response|0
2955524|NCT01262677|10174408|P3|Overall Study|Does not meet entrance criteria|0
2955525|NCT01262677|10174409|P2|Overall Study|Does not meet entrance criteria|2
2955526|NCT01262677|10174410|P1|Overall Study|Does not meet entrance criteria|0
2955527|NCT01262651|10174501|P2|Overall Study|Met Withdrawal Criteria|0
2955528|NCT01262651|10174502|P1|Overall Study|Met Withdrawal Criteria|1
2955529|NCT01262651|10174501|P2|Overall Study|Withdrawal by Investigator|2
2955530|NCT01262651|10174502|P1|Overall Study|Withdrawal by Investigator|2
2955531|NCT01262651|10174501|P2|Overall Study|Withdrawal by Subject|11
2955532|NCT01262651|10174502|P1|Overall Study|Withdrawal by Subject|15
2955533|NCT01262651|10174501|P2|Overall Study|Adverse Event|35
2955534|NCT01262651|10174502|P1|Overall Study|Adverse Event|40
2955535|NCT01262573|10174543|P2|Overall Study|Withdrawal by Subject|1
2955536|NCT01262573|10174544|P1|Overall Study|Withdrawal by Subject|0
2955537|NCT01262560|10174555|P3|Overall Study|Protocol Violation|2
2955538|NCT01262560|10174556|P2|Overall Study|Protocol Violation|1
2955539|NCT01262560|10174557|P1|Overall Study|Protocol Violation|0
2955540|NCT01262456|10174606|P3|1-Month Open-Label Extension Period|Other Reason|0
2955541|NCT01262456|10174607|P2|1-Month Open-Label Extension Period|Other Reason|1
2955542|NCT01262456|10174608|P1|1-Month Open-Label Extension Period|Other Reason|0
2955543|NCT01262456|10174606|P3|1-Month Open-Label Extension Period|Protocol Violation|2
2955544|NCT01262456|10174607|P2|1-Month Open-Label Extension Period|Protocol Violation|0
2955545|NCT01262456|10174608|P1|1-Month Open-Label Extension Period|Protocol Violation|1
2955546|NCT01262456|10174606|P3|1-Month Open-Label Extension Period|Adverse Event|2
2955547|NCT01262456|10174607|P2|1-Month Open-Label Extension Period|Adverse Event|0
2955548|NCT01262456|10174608|P1|1-Month Open-Label Extension Period|Adverse Event|2
2955549|NCT01262456|10174606|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
2955550|NCT01262456|10174607|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
2955551|NCT01262456|10174608|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
2955552|NCT01262456|10174606|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2955553|NCT01262456|10174607|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2955554|NCT01262456|10174608|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2955555|NCT01262456|10174606|P3|3-Month Double-Blind Period|Protocol Violation|6
2955556|NCT01262456|10174607|P2|3-Month Double-Blind Period|Protocol Violation|6
2955557|NCT01262456|10174608|P1|3-Month Double-Blind Period|Protocol Violation|3
2955558|NCT01262456|10174606|P3|3-Month Double-Blind Period|Adverse Event|8
2955559|NCT01262456|10174607|P2|3-Month Double-Blind Period|Adverse Event|4
2955560|NCT01262456|10174608|P1|3-Month Double-Blind Period|Adverse Event|6
2955561|NCT01262456|10174606|P3|3-Month Double-Blind Period|Lost to Follow-up|3
2955562|NCT01262456|10174607|P2|3-Month Double-Blind Period|Lost to Follow-up|5
2955563|NCT01262456|10174608|P1|3-Month Double-Blind Period|Lost to Follow-up|4
2955564|NCT01262456|10174606|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
2955565|NCT01262456|10174607|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
2955566|NCT01262456|10174608|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
2955567|NCT01262365|10174652|P3|Overall Study|Patient unavailable|1
2955568|NCT01262365|10174653|P2|Overall Study|Patient unavailable|0
2955569|NCT01262365|10174654|P1|Overall Study|Patient unavailable|0
2955570|NCT01262365|10174652|P3|Overall Study|Cannot tolerate the protocol|0
2955571|NCT01262365|10174653|P2|Overall Study|Cannot tolerate the protocol|1
2955572|NCT01262365|10174654|P1|Overall Study|Cannot tolerate the protocol|0
2955573|NCT01262365|10174652|P3|Overall Study|Toxicity related to study drug|0
2955574|NCT01262365|10174653|P2|Overall Study|Toxicity related to study drug|1
2955575|NCT01262365|10174654|P1|Overall Study|Toxicity related to study drug|0
2955576|NCT01262365|10174652|P3|Overall Study|Patient pregnant|1
2955577|NCT01262365|10174653|P2|Overall Study|Patient pregnant|0
2955578|NCT01262365|10174654|P1|Overall Study|Patient pregnant|1
2955579|NCT01262365|10174652|P3|Overall Study|Suspected pregnancy|0
2955580|NCT01262365|10174653|P2|Overall Study|Suspected pregnancy|0
2955581|NCT01262365|10174654|P1|Overall Study|Suspected pregnancy|1
2955582|NCT01262365|10174652|P3|Overall Study|Non-compliance|2
2955583|NCT01262365|10174653|P2|Overall Study|Non-compliance|0
2955584|NCT01262365|10174654|P1|Overall Study|Non-compliance|1
2955585|NCT01262365|10174652|P3|Overall Study|Randomization error|2
2955586|NCT01262365|10174653|P2|Overall Study|Randomization error|0
2955587|NCT01262365|10174654|P1|Overall Study|Randomization error|1
2955588|NCT01262365|10174652|P3|Overall Study|sponsor decision|0
2955589|NCT01262365|10174653|P2|Overall Study|sponsor decision|1
2955590|NCT01262365|10174654|P1|Overall Study|sponsor decision|1
2955591|NCT01262365|10174652|P3|Overall Study|Adverse Event|11
2955592|NCT01262365|10174653|P2|Overall Study|Adverse Event|16
2955593|NCT01262365|10174654|P1|Overall Study|Adverse Event|26
2955594|NCT01262365|10174652|P3|Overall Study|Death|1
2955595|NCT01262365|10174653|P2|Overall Study|Death|2
2955596|NCT01262365|10174654|P1|Overall Study|Death|1
2955597|NCT01262365|10174652|P3|Overall Study|Withdrawal by Subject|22
2955598|NCT01262365|10174653|P2|Overall Study|Withdrawal by Subject|22
2955599|NCT01262365|10174654|P1|Overall Study|Withdrawal by Subject|17
2955600|NCT01262365|10174652|P3|Overall Study|Lost to Follow-up|6
2955601|NCT01262365|10174653|P2|Overall Study|Lost to Follow-up|7
2955602|NCT01262365|10174654|P1|Overall Study|Lost to Follow-up|3
2955603|NCT01262365|10174652|P3|Overall Study|Protocol Violation|1
2955604|NCT01262365|10174653|P2|Overall Study|Protocol Violation|1
2955605|NCT01262365|10174654|P1|Overall Study|Protocol Violation|3
2955606|NCT01262365|10174652|P3|Overall Study|Lack of Efficacy|47
2955607|NCT01262365|10174653|P2|Overall Study|Lack of Efficacy|30
2955608|NCT01262365|10174654|P1|Overall Study|Lack of Efficacy|35
2955609|NCT01262352|10174679|P2|Washout|Extended Washout|1
2955610|NCT01262352|10174680|P1|Washout|Extended Washout|0
2955611|NCT01262352|10174679|P2|Washout|Adverse Event|1
2955612|NCT01262352|10174680|P1|Washout|Adverse Event|1
2955613|NCT01262352|10174679|P2|Period 1|Illness after randomization|0
2955614|NCT01262352|10174680|P1|Period 1|Illness after randomization|1
2955615|NCT01262287|10174698|P2|Overall Study|Lost to Follow-up|1
2955616|NCT01262287|10174699|P1|Overall Study|Lost to Follow-up|2
2955617|NCT01262092|10174760|P2|Gabapentin Taper|noncompliance - missed medications|0
2955618|NCT01262092|10174761|P1|Gabapentin Taper|noncompliance - missed medications|1
2955619|NCT01262092|10174760|P2|Buprenorphine Taper|noncompliance - missed medication|1
2955620|NCT01262092|10174761|P1|Buprenorphine Taper|noncompliance - missed medication|1
2955621|NCT01262092|10174760|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
2955622|NCT01262092|10174761|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
2955623|NCT01262092|10174760|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
2955624|NCT01262092|10174761|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
2955625|NCT01262027|10174767|P1|Overall Study|Protocol Violation|1
2955626|NCT01262027|10174767|P1|Overall Study|Withdrawal by Subject|3
2955627|NCT01262027|10174767|P1|Overall Study|Adverse Event|1
2955628|NCT01261975|10174772|P1|Overall Study|Surgical complication|1
2955629|NCT01261793|10174794|P3|Overall Study|Patient unable to start IV line|1
2955630|NCT01261793|10174795|P2|Overall Study|Patient unable to start IV line|0
2955631|NCT01261793|10174796|P1|Overall Study|Patient unable to start IV line|0
2955632|NCT01261793|10174794|P3|Overall Study|Randomization error|0
2955633|NCT01261793|10174795|P2|Overall Study|Randomization error|1
2955634|NCT01261793|10174796|P1|Overall Study|Randomization error|0
2955635|NCT01261793|10174794|P3|Overall Study|Patient withdrew after cardiology visit|0
2955636|NCT01261793|10174795|P2|Overall Study|Patient withdrew after cardiology visit|1
2955637|NCT01261793|10174796|P1|Overall Study|Patient withdrew after cardiology visit|0
2955638|NCT01261793|10174794|P3|Overall Study|Lack of efficacy & patient not available|0
2955639|NCT01261793|10174795|P2|Overall Study|Lack of efficacy & patient not available|1
2955640|NCT01261793|10174796|P1|Overall Study|Lack of efficacy & patient not available|0
2955641|NCT01261793|10174794|P3|Overall Study|Outside the study area|1
2955642|NCT01261793|10174795|P2|Overall Study|Outside the study area|2
2955643|NCT01261793|10174796|P1|Overall Study|Outside the study area|0
2955644|NCT01261793|10174794|P3|Overall Study|Patient pregnant|0
2955645|NCT01261793|10174795|P2|Overall Study|Patient pregnant|0
2955646|NCT01261793|10174796|P1|Overall Study|Patient pregnant|1
2955647|NCT01261793|10174794|P3|Overall Study|Patient non-compliance|1
2955648|NCT01261793|10174795|P2|Overall Study|Patient non-compliance|0
2955649|NCT01261793|10174796|P1|Overall Study|Patient non-compliance|1
2955650|NCT01261793|10174794|P3|Overall Study|Suspected pregnancy|0
2955651|NCT01261793|10174795|P2|Overall Study|Suspected pregnancy|1
2955652|NCT01261793|10174796|P1|Overall Study|Suspected pregnancy|1
2955653|NCT01261793|10174794|P3|Overall Study|Patient non-availability|1
2955654|NCT01261793|10174795|P2|Overall Study|Patient non-availability|1
2955655|NCT01261793|10174796|P1|Overall Study|Patient non-availability|1
2955656|NCT01261793|10174794|P3|Overall Study|Adverse Event|19
2955657|NCT01261793|10174795|P2|Overall Study|Adverse Event|24
2955658|NCT01261793|10174796|P1|Overall Study|Adverse Event|9
2955659|NCT01261793|10174794|P3|Overall Study|Death|0
2955660|NCT01261793|10174795|P2|Overall Study|Death|1
2955661|NCT01261793|10174796|P1|Overall Study|Death|3
2955662|NCT01261793|10174794|P3|Overall Study|Withdrawal by Subject|14
2955663|NCT01261793|10174795|P2|Overall Study|Withdrawal by Subject|14
2955664|NCT01261793|10174796|P1|Overall Study|Withdrawal by Subject|12
2955665|NCT01261793|10174794|P3|Overall Study|Lost to Follow-up|7
2955666|NCT01261793|10174795|P2|Overall Study|Lost to Follow-up|3
2955667|NCT01261793|10174796|P1|Overall Study|Lost to Follow-up|10
2955668|NCT01261793|10174794|P3|Overall Study|Protocol Violation|6
2955669|NCT01261793|10174795|P2|Overall Study|Protocol Violation|5
2955670|NCT01261793|10174796|P1|Overall Study|Protocol Violation|3
2955671|NCT01261793|10174794|P3|Overall Study|Lack of Efficacy|32
2955672|NCT01261793|10174795|P2|Overall Study|Lack of Efficacy|37
2955673|NCT01261793|10174796|P1|Overall Study|Lack of Efficacy|44
2955674|NCT01261780|10174821|P2|Overall Study|Event not related to subject|2
2955675|NCT01261780|10174822|P1|Overall Study|Event not related to subject|1
2955676|NCT01261780|10174821|P2|Overall Study|Withdrawal by Subject|0
2955677|NCT01261780|10174822|P1|Overall Study|Withdrawal by Subject|1
2955678|NCT01261624|10174832|P2|Week 13 to Week 24|Insufficient Response|1
2955679|NCT01261624|10174833|P1|Week 13 to Week 24|Insufficient Response|0
2955680|NCT01261624|10174832|P2|Week 0 to Week 12|Insufficient Response|2
2955681|NCT01261624|10174833|P1|Week 0 to Week 12|Insufficient Response|0
2955682|NCT01261624|10174832|P2|Week 0 to Week 12|Disease Progression|1
2955683|NCT01261624|10174833|P1|Week 0 to Week 12|Disease Progression|1
2955684|NCT01261611|10174853|P3|Treatment Cycle 5|Lost to Follow-up|0
2955685|NCT01261611|10174854|P2|Treatment Cycle 5|Lost to Follow-up|0
2955686|NCT01261611|10174855|P1|Treatment Cycle 5|Lost to Follow-up|1
2955687|NCT01261611|10174853|P3|Treatment Cycle 5|Adverse Event|0
2955688|NCT01261611|10174854|P2|Treatment Cycle 5|Adverse Event|0
2955689|NCT01261611|10174855|P1|Treatment Cycle 5|Adverse Event|1
2955690|NCT01261611|10174853|P3|Treatment Cycle 5|Withdrawal by Subject|0
2955691|NCT01261611|10174854|P2|Treatment Cycle 5|Withdrawal by Subject|0
2955692|NCT01261611|10174855|P1|Treatment Cycle 5|Withdrawal by Subject|1
2955693|NCT01261611|10174853|P3|Treatment Cycle 4|Not otherwise specified|0
2955694|NCT01261611|10174854|P2|Treatment Cycle 4|Not otherwise specified|0
2955695|NCT01261611|10174855|P1|Treatment Cycle 4|Not otherwise specified|3
2955696|NCT01261611|10174853|P3|Treatment Cycle 4|Lost to Follow-up|0
2955697|NCT01261611|10174854|P2|Treatment Cycle 4|Lost to Follow-up|0
2955698|NCT01261611|10174855|P1|Treatment Cycle 4|Lost to Follow-up|2
2955699|NCT01261611|10174853|P3|Treatment Cycle 4|Adverse Event|0
2955700|NCT01261611|10174854|P2|Treatment Cycle 4|Adverse Event|0
2955701|NCT01261611|10174855|P1|Treatment Cycle 4|Adverse Event|1
2955702|NCT01261611|10174853|P3|Treatment Cycle 4|Withdrawal by Subject|0
2955703|NCT01261611|10174854|P2|Treatment Cycle 4|Withdrawal by Subject|0
2955704|NCT01261611|10174855|P1|Treatment Cycle 4|Withdrawal by Subject|3
2955705|NCT01261611|10174853|P3|Treatment Cycle 4|Completed study|0
2955706|NCT01261611|10174854|P2|Treatment Cycle 4|Completed study|0
2955707|NCT01261611|10174855|P1|Treatment Cycle 4|Completed study|87
2955708|NCT01261611|10174853|P3|Treatment Cycle 3|Lost to Follow-up|0
2955709|NCT01261611|10174854|P2|Treatment Cycle 3|Lost to Follow-up|0
2955710|NCT01261611|10174855|P1|Treatment Cycle 3|Lost to Follow-up|1
2955711|NCT01261611|10174853|P3|Treatment Cycle 3|Adverse Event|0
2955712|NCT01261611|10174854|P2|Treatment Cycle 3|Adverse Event|0
2955713|NCT01261611|10174855|P1|Treatment Cycle 3|Adverse Event|1
2955714|NCT01261611|10174853|P3|Treatment Cycle 3|Withdrawal by Subject|0
2955715|NCT01261611|10174854|P2|Treatment Cycle 3|Withdrawal by Subject|0
2955716|NCT01261611|10174855|P1|Treatment Cycle 3|Withdrawal by Subject|4
2955717|NCT01261611|10174853|P3|Treatment Cycle 3|Completed study|0
2955718|NCT01261611|10174854|P2|Treatment Cycle 3|Completed study|0
2955719|NCT01261611|10174855|P1|Treatment Cycle 3|Completed study|24
2955720|NCT01261611|10174853|P3|Treatment Cycle 2|Not otherwise specified|0
2955721|NCT01261611|10174854|P2|Treatment Cycle 2|Not otherwise specified|0
2955722|NCT01261611|10174855|P1|Treatment Cycle 2|Not otherwise specified|2
2955723|NCT01261611|10174853|P3|Treatment Cycle 2|Protocol Violation|0
2955724|NCT01261611|10174854|P2|Treatment Cycle 2|Protocol Violation|0
2955725|NCT01261611|10174855|P1|Treatment Cycle 2|Protocol Violation|2
2955726|NCT01261611|10174853|P3|Treatment Cycle 2|Adverse Event|0
2955727|NCT01261611|10174854|P2|Treatment Cycle 2|Adverse Event|0
2955728|NCT01261611|10174855|P1|Treatment Cycle 2|Adverse Event|1
2955729|NCT01261611|10174853|P3|Treatment Cycle 2|Withdrawal by Subject|0
2955730|NCT01261611|10174854|P2|Treatment Cycle 2|Withdrawal by Subject|0
2955731|NCT01261611|10174855|P1|Treatment Cycle 2|Withdrawal by Subject|4
2955732|NCT01261611|10174853|P3|Treatment Cycle 2|Completed study|0
2955733|NCT01261611|10174854|P2|Treatment Cycle 2|Completed study|0
2955734|NCT01261611|10174855|P1|Treatment Cycle 2|Completed study|4
2955735|NCT01261611|10174853|P3|Treatment Cycle 1|Protocol Violation|2
2955736|NCT01261611|10174854|P2|Treatment Cycle 1|Protocol Violation|0
2955737|NCT01261611|10174855|P1|Treatment Cycle 1|Protocol Violation|0
2955738|NCT01261611|10174853|P3|Treatment Cycle 1|Adverse Event|0
2955739|NCT01261611|10174854|P2|Treatment Cycle 1|Adverse Event|1
2955740|NCT01261611|10174855|P1|Treatment Cycle 1|Adverse Event|0
2955741|NCT01261611|10174853|P3|Treatment Cycle 1|Lost to Follow-up|0
2955742|NCT01261611|10174854|P2|Treatment Cycle 1|Lost to Follow-up|0
2955743|NCT01261611|10174855|P1|Treatment Cycle 1|Lost to Follow-up|1
2955744|NCT01261611|10174853|P3|Treatment Cycle 1|Withdrawal by Subject|0
2955745|NCT01261611|10174854|P2|Treatment Cycle 1|Withdrawal by Subject|2
2955746|NCT01261611|10174855|P1|Treatment Cycle 1|Withdrawal by Subject|3
2955747|NCT01261390|10174919|P4|Overall Study|Lost to Follow-up|6
2955748|NCT01261390|10174920|P3|Overall Study|Lost to Follow-up|5
2955749|NCT01261390|10174921|P2|Overall Study|Lost to Follow-up|6
2955750|NCT01261390|10174922|P1|Overall Study|Lost to Follow-up|1
2955751|NCT01261390|10174919|P4|Overall Study|Loss of Interest in the Study|0
2955752|NCT01261390|10174920|P3|Overall Study|Loss of Interest in the Study|0
2955753|NCT01261390|10174921|P2|Overall Study|Loss of Interest in the Study|1
2955754|NCT01261390|10174922|P1|Overall Study|Loss of Interest in the Study|3
2955755|NCT01261390|10174919|P4|Overall Study|Relocation|0
2955756|NCT01261390|10174920|P3|Overall Study|Relocation|0
2955757|NCT01261390|10174921|P2|Overall Study|Relocation|1
2955758|NCT01261390|10174922|P1|Overall Study|Relocation|0
2955759|NCT01261390|10174919|P4|Overall Study|Dissatisfaction with Treatment|2
2955760|NCT01261390|10174920|P3|Overall Study|Dissatisfaction with Treatment|1
2955761|NCT01261390|10174921|P2|Overall Study|Dissatisfaction with Treatment|1
2955762|NCT01261390|10174922|P1|Overall Study|Dissatisfaction with Treatment|2
2955763|NCT01261390|10174919|P4|Overall Study|Significant Concurrent Illness|0
2955764|NCT01261390|10174920|P3|Overall Study|Significant Concurrent Illness|1
2955765|NCT01261390|10174921|P2|Overall Study|Significant Concurrent Illness|0
2955766|NCT01261390|10174922|P1|Overall Study|Significant Concurrent Illness|1
2955767|NCT01261325|10175087|P3|Overall Study|AE, serious fatal|2
2955768|NCT01261325|10175088|P2|Overall Study|AE, serious fatal|0
2955769|NCT01261325|10175089|P1|Overall Study|AE, serious fatal|0
2955770|NCT01261325|10175087|P3|Overall Study|Lost to Follow-up|3
2955771|NCT01261325|10175088|P2|Overall Study|Lost to Follow-up|1
2955772|NCT01261325|10175089|P1|Overall Study|Lost to Follow-up|0
2955773|NCT01261325|10175087|P3|Overall Study|Protocol Violation|1
2955774|NCT01261325|10175088|P2|Overall Study|Protocol Violation|3
2955775|NCT01261325|10175089|P1|Overall Study|Protocol Violation|0
2955776|NCT01261325|10175087|P3|Overall Study|Randomized in Error|1
2955777|NCT01261325|10175088|P2|Overall Study|Randomized in Error|0
2955778|NCT01261325|10175089|P1|Overall Study|Randomized in Error|0
2955779|NCT01261325|10175087|P3|Overall Study|Screen Failure|0
2955780|NCT01261325|10175088|P2|Overall Study|Screen Failure|0
2955781|NCT01261325|10175089|P1|Overall Study|Screen Failure|1
2955782|NCT01261325|10175087|P3|Overall Study|Erroneously Randomized|0
2955783|NCT01261325|10175088|P2|Overall Study|Erroneously Randomized|0
2955784|NCT01261325|10175089|P1|Overall Study|Erroneously Randomized|1
2955785|NCT01261325|10175087|P3|Overall Study|Patient Randomized by Mistake|0
2955786|NCT01261325|10175088|P2|Overall Study|Patient Randomized by Mistake|1
2955787|NCT01261325|10175089|P1|Overall Study|Patient Randomized by Mistake|0
2955788|NCT01261325|10175087|P3|Overall Study|Non Compliance|0
2955789|NCT01261325|10175088|P2|Overall Study|Non Compliance|0
2955790|NCT01261325|10175089|P1|Overall Study|Non Compliance|2
2955791|NCT01261325|10175087|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2955792|NCT01261325|10175088|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2955793|NCT01261325|10175089|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2955794|NCT01261325|10175087|P3|Overall Study|AE, non-serious non-fatal|13
2955795|NCT01261325|10175088|P2|Overall Study|AE, non-serious non-fatal|15
2955796|NCT01261325|10175089|P1|Overall Study|AE, non-serious non-fatal|9
2955797|NCT01261325|10175087|P3|Overall Study|SAE, non-fatal|1
2955798|NCT01261325|10175088|P2|Overall Study|SAE, non-fatal|5
2955799|NCT01261325|10175089|P1|Overall Study|SAE, non-fatal|1
2955800|NCT01261325|10175087|P3|Overall Study|Withdrawal by Subject|4
2955801|NCT01261325|10175088|P2|Overall Study|Withdrawal by Subject|2
2955802|NCT01261325|10175089|P1|Overall Study|Withdrawal by Subject|2
2955803|NCT01261325|10175087|P3|Overall Study|Lack of Efficacy|0
2955804|NCT01261325|10175088|P2|Overall Study|Lack of Efficacy|1
2955805|NCT01261325|10175089|P1|Overall Study|Lack of Efficacy|1
2955806|NCT01261247|10175121|P1|Overall Study|Ineligible|2
2955807|NCT01261000|10175134|P1|Overall Study|Screen failure|1
2955808|NCT01260948|10175140|P2|Second Intervention|Emesis|1
2955809|NCT01260948|10175141|P1|Second Intervention|Emesis|0
2955810|NCT01260948|10175140|P2|Washout of 28 Days|Withdrawal by Subject|3
2955811|NCT01260948|10175141|P1|Washout of 28 Days|Withdrawal by Subject|1
2955812|NCT01260922|10175151|P2|Second Intervention|Emesis|2
2955813|NCT01260922|10175152|P1|Second Intervention|Emesis|0
2955814|NCT01260922|10175151|P2|Washout of 28 Days|Withdrawal by Subject|2
2955815|NCT01260922|10175152|P1|Washout of 28 Days|Withdrawal by Subject|4
2955816|NCT01260922|10175151|P2|First Intervention|Withdrawal by Subject|1
2955817|NCT01260922|10175152|P1|First Intervention|Withdrawal by Subject|0
2955818|NCT01260896|10175162|P2|First Intervention|Withdrawn Due to Emesis|0
2955819|NCT01260896|10175163|P1|First Intervention|Withdrawn Due to Emesis|2
2955820|NCT01260701|10175221|P1|Overall Study|Did not begin protocol therapy|1
2955821|NCT01260701|10175221|P1|Overall Study|Ineligible|4
2955822|NCT01260701|10175221|P1|Overall Study|Under review|1
2955823|NCT01260701|10175221|P1|Overall Study|Not protocol specified|3
2955824|NCT01260701|10175221|P1|Overall Study|Death|2
2955825|NCT01260701|10175221|P1|Overall Study|Progression|53
2955826|NCT01260701|10175221|P1|Overall Study|Withdrawal by Subject|2
2955827|NCT01260701|10175221|P1|Overall Study|Adverse Event|9
2955828|NCT01260584|10175302|P4|Period 2|Withdrawal by Subject|0
2955829|NCT01260584|10175303|P3|Period 2|Withdrawal by Subject|0
2955830|NCT01260584|10175304|P2|Period 2|Withdrawal by Subject|1
2955831|NCT01260584|10175305|P1|Period 2|Withdrawal by Subject|0
2955832|NCT01260584|10175302|P4|Period 2|Adverse Event|0
2955833|NCT01260584|10175303|P3|Period 2|Adverse Event|2
2955834|NCT01260584|10175304|P2|Period 2|Adverse Event|0
2955835|NCT01260584|10175305|P1|Period 2|Adverse Event|1
2955836|NCT01260584|10175302|P4|Period 2|Protocol Violation|1
2955837|NCT01260584|10175303|P3|Period 2|Protocol Violation|3
2955838|NCT01260584|10175304|P2|Period 2|Protocol Violation|2
2955839|NCT01260584|10175305|P1|Period 2|Protocol Violation|0
2955840|NCT01260584|10175302|P4|Period 1|Adverse Event|0
2955841|NCT01260584|10175303|P3|Period 1|Adverse Event|1
2955842|NCT01260584|10175304|P2|Period 1|Adverse Event|0
2955843|NCT01260584|10175305|P1|Period 1|Adverse Event|0
2955844|NCT01260584|10175302|P4|Period 1|Protocol Violation|1
2955845|NCT01260584|10175303|P3|Period 1|Protocol Violation|1
2955846|NCT01260584|10175304|P2|Period 1|Protocol Violation|0
2955847|NCT01260584|10175305|P1|Period 1|Protocol Violation|0
2955848|NCT01260467|10175348|P1|Overall Study|Withdrawal by Subject|2
2955849|NCT01260350|10175380|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955850|NCT01260350|10175381|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955851|NCT01260350|10175382|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955852|NCT01260350|10175383|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955853|NCT01260350|10175384|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955854|NCT01260350|10175385|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955855|NCT01260350|10175386|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955856|NCT01260350|10175387|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955857|NCT01260350|10175388|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955858|NCT01260350|10175389|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955859|NCT01260350|10175390|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955860|NCT01260350|10175391|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955861|NCT01260350|10175392|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955862|NCT01260350|10175393|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
2955863|NCT01260350|10175394|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955864|NCT01260350|10175395|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955865|NCT01260350|10175396|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955866|NCT01260350|10175397|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955867|NCT01260350|10175398|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955868|NCT01260350|10175399|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955869|NCT01260350|10175400|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955870|NCT01260350|10175401|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
2955871|NCT01260350|10175380|P22|Overall Study|Lack of Efficacy|0
2955872|NCT01260350|10175381|P21|Overall Study|Lack of Efficacy|3
2955873|NCT01260350|10175382|P20|Overall Study|Lack of Efficacy|0
2955874|NCT01260350|10175383|P19|Overall Study|Lack of Efficacy|0
2955875|NCT01260350|10175384|P18|Overall Study|Lack of Efficacy|1
2955876|NCT01260350|10175385|P17|Overall Study|Lack of Efficacy|0
2955877|NCT01260350|10175386|P16|Overall Study|Lack of Efficacy|0
2955878|NCT01260350|10175387|P15|Overall Study|Lack of Efficacy|0
2955879|NCT01260350|10175388|P14|Overall Study|Lack of Efficacy|0
2955880|NCT01260350|10175389|P13|Overall Study|Lack of Efficacy|0
2955881|NCT01260350|10175390|P12|Overall Study|Lack of Efficacy|0
2955882|NCT01260350|10175391|P11|Overall Study|Lack of Efficacy|0
2955883|NCT01260350|10175392|P10|Overall Study|Lack of Efficacy|0
2955884|NCT01260350|10175393|P9|Overall Study|Lack of Efficacy|0
2955885|NCT01260350|10175394|P8|Overall Study|Lack of Efficacy|0
2955886|NCT01260350|10175395|P7|Overall Study|Lack of Efficacy|0
2955887|NCT01260350|10175396|P6|Overall Study|Lack of Efficacy|0
2955888|NCT01260350|10175397|P5|Overall Study|Lack of Efficacy|0
2955889|NCT01260350|10175398|P4|Overall Study|Lack of Efficacy|0
2955890|NCT01260350|10175399|P3|Overall Study|Lack of Efficacy|0
2955891|NCT01260350|10175400|P2|Overall Study|Lack of Efficacy|0
2955892|NCT01260350|10175401|P1|Overall Study|Lack of Efficacy|0
2955893|NCT01260311|10175608|P1|Overall Study|Fesoterodine Started Before Enrollment|1
2955894|NCT01260311|10175608|P1|Overall Study|Medication Stopped|1
2955895|NCT01260311|10175608|P1|Overall Study|Gone to Province|2
2955896|NCT01260311|10175608|P1|Overall Study|Financial Constraints|77
2955897|NCT01260311|10175608|P1|Overall Study|Withdrawal by Subject|6
2955898|NCT01260311|10175608|P1|Overall Study|Lost to Follow-up|25
2955899|NCT01260311|10175608|P1|Overall Study|Lack of Efficacy|4
2955900|NCT01260311|10175608|P1|Overall Study|Adverse Event|11
2955901|NCT01260194|10175639|P1|Overall Study|Withdrawal of Consent|1
2955902|NCT01260181|10175651|P1|Overall Study|Decision of Investigator|1
2955903|NCT01260142|10175666|P6|Treatment Period 1|Withdrawal by Subject|1
2955904|NCT01260142|10175667|P5|Treatment Period 1|Withdrawal by Subject|0
2955905|NCT01260142|10175668|P4|Treatment Period 1|Withdrawal by Subject|0
2955906|NCT01260142|10175669|P3|Treatment Period 1|Withdrawal by Subject|0
2955907|NCT01260142|10175670|P2|Treatment Period 1|Withdrawal by Subject|0
2955908|NCT01260142|10175671|P1|Treatment Period 1|Withdrawal by Subject|0
2955909|NCT01260142|10175666|P6|Treatment Period 1|Unexplained elevated sys. BP|0
2955910|NCT01260142|10175667|P5|Treatment Period 1|Unexplained elevated sys. BP|1
2955911|NCT01260142|10175668|P4|Treatment Period 1|Unexplained elevated sys. BP|0
2955912|NCT01260142|10175669|P3|Treatment Period 1|Unexplained elevated sys. BP|0
2955913|NCT01260142|10175670|P2|Treatment Period 1|Unexplained elevated sys. BP|0
2955914|NCT01260142|10175671|P1|Treatment Period 1|Unexplained elevated sys. BP|0
2955915|NCT01260142|10175666|P6|Treatment Period 1|Study on hold|2
2955916|NCT01260142|10175667|P5|Treatment Period 1|Study on hold|1
2955917|NCT01260142|10175668|P4|Treatment Period 1|Study on hold|0
2955918|NCT01260142|10175669|P3|Treatment Period 1|Study on hold|0
2955919|NCT01260142|10175670|P2|Treatment Period 1|Study on hold|1
2955920|NCT01260142|10175671|P1|Treatment Period 1|Study on hold|1
2955921|NCT01259869|10175721|P1|Overall Study|Duplicated registration|1
2955922|NCT01259856|10175727|P2|Overall Study|Unknown/missing|2
2955923|NCT01259856|10175728|P1|Overall Study|Unknown/missing|2
2955924|NCT01259856|10175727|P2|Overall Study|Transfer to another study|1
2955925|NCT01259856|10175728|P1|Overall Study|Transfer to another study|0
2955926|NCT01259856|10175727|P2|Overall Study|Patient developed other disease|1
2955927|NCT01259856|10175728|P1|Overall Study|Patient developed other disease|0
2955928|NCT01259856|10175727|P2|Overall Study|Study closure by sponsor|41
2955929|NCT01259856|10175728|P1|Overall Study|Study closure by sponsor|40
2955930|NCT01259856|10175727|P2|Overall Study|Treatment never started|6
2955931|NCT01259856|10175728|P1|Overall Study|Treatment never started|0
2955932|NCT01259856|10175727|P2|Overall Study|Withdrawal by Subject|10
2955933|NCT01259856|10175728|P1|Overall Study|Withdrawal by Subject|9
2955934|NCT01259856|10175727|P2|Overall Study|Physician Decision|1
2955935|NCT01259856|10175728|P1|Overall Study|Physician Decision|2
2955936|NCT01259856|10175727|P2|Overall Study|Lost to Follow-up|1
2955937|NCT01259856|10175728|P1|Overall Study|Lost to Follow-up|1
2955938|NCT01259856|10175727|P2|Overall Study|Lack of Efficacy|1
2955939|NCT01259856|10175728|P1|Overall Study|Lack of Efficacy|3
2955940|NCT01259856|10175727|P2|Overall Study|Death|1
2955941|NCT01259856|10175728|P1|Overall Study|Death|0
2955942|NCT01259856|10175727|P2|Overall Study|Adverse Event|9
2955943|NCT01259856|10175728|P1|Overall Study|Adverse Event|12
2955944|NCT01259726|10175752|P4|Overall Study|Lost to Follow-up|3
2955945|NCT01259726|10175753|P3|Overall Study|Lost to Follow-up|1
2955946|NCT01259726|10175754|P2|Overall Study|Lost to Follow-up|1
2955947|NCT01259726|10175755|P1|Overall Study|Lost to Follow-up|1
2955948|NCT01259726|10175752|P4|Overall Study|Withdrawal by Subject|1
2955949|NCT01259726|10175753|P3|Overall Study|Withdrawal by Subject|2
2955950|NCT01259726|10175754|P2|Overall Study|Withdrawal by Subject|3
2955951|NCT01259726|10175755|P1|Overall Study|Withdrawal by Subject|1
2955952|NCT01259726|10175752|P4|Overall Study|Physician Decision|1
2955953|NCT01259726|10175753|P3|Overall Study|Physician Decision|1
2955954|NCT01259726|10175754|P2|Overall Study|Physician Decision|0
2955955|NCT01259726|10175755|P1|Overall Study|Physician Decision|2
2955956|NCT01259726|10175752|P4|Overall Study|Death|0
2955957|NCT01259726|10175753|P3|Overall Study|Death|0
2955958|NCT01259726|10175754|P2|Overall Study|Death|0
2955959|NCT01259726|10175755|P1|Overall Study|Death|1
2955960|NCT01259713|10175787|P2|Overall Study|Subject Withdrew Consent|7
2955961|NCT01259713|10175788|P1|Overall Study|Subject Withdrew Consent|12
2955962|NCT01259713|10175787|P2|Overall Study|Protocol Violation|4
2955963|NCT01259713|10175788|P1|Overall Study|Protocol Violation|5
2955964|NCT01259713|10175787|P2|Overall Study|Lack of Efficacy|0
2955965|NCT01259713|10175788|P1|Overall Study|Lack of Efficacy|2
2955966|NCT01259713|10175787|P2|Overall Study|Investigators Discretion|6
2955967|NCT01259713|10175788|P1|Overall Study|Investigators Discretion|14
2955968|NCT01259713|10175787|P2|Overall Study|Death Not Related to IFI|1
2955969|NCT01259713|10175788|P1|Overall Study|Death Not Related to IFI|8
2955970|NCT01259713|10175787|P2|Overall Study|Adverse Event|23
2955971|NCT01259713|10175788|P1|Overall Study|Adverse Event|54
2955972|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
2955973|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
2955974|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
2955975|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
2955976|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2955977|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
2955978|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2955979|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2955980|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2955981|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
2955982|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
2955983|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2955984|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
2955985|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
2955986|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
2955987|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
2955988|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2955989|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2955990|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2955991|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
2955992|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
2955993|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
2955994|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
2955995|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
2955996|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2955997|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
2955998|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2955999|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2956000|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
2956001|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2956002|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2956003|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2956004|NCT01259492|10175835|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2956005|NCT01259492|10175836|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
2956006|NCT01259492|10175837|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
2956007|NCT01259492|10175838|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2956008|NCT01259492|10175835|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2956009|NCT01259492|10175836|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
2956010|NCT01259492|10175837|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
2956011|NCT01259492|10175838|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2956012|NCT01259492|10175835|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2956013|NCT01259492|10175836|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
2956014|NCT01259492|10175837|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2956015|NCT01259492|10175838|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2956016|NCT01259492|10175835|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
2956017|NCT01259492|10175836|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
2956018|NCT01259492|10175837|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
2956019|NCT01259492|10175838|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
2956020|NCT01259492|10175835|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2956021|NCT01259492|10175836|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2956022|NCT01259492|10175837|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2956023|NCT01259492|10175838|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2956024|NCT01259492|10175835|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
2956025|NCT01259492|10175836|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
2956026|NCT01259492|10175837|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
2956027|NCT01259492|10175838|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
2956028|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Protocol Violation|1
2956029|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Protocol Violation|3
2956030|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Protocol Violation|6
2956031|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Protocol Violation|5
2956032|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Administrative Problems|2
2956033|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Administrative Problems|1
2956034|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Administrative Problems|1
2956035|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Administrative Problems|0
2956036|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
2956037|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
2956038|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
2956039|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
2956040|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
2956041|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
2956042|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
2956043|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
2956044|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
2956045|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
2956046|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
2956047|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
2956048|NCT01259492|10175835|P4|Period 1 (9 Weeks)|Adverse Event|3
2956049|NCT01259492|10175836|P3|Period 1 (9 Weeks)|Adverse Event|26
2956050|NCT01259492|10175837|P2|Period 1 (9 Weeks)|Adverse Event|18
2956051|NCT01259492|10175838|P1|Period 1 (9 Weeks)|Adverse Event|13
2956052|NCT01259466|10175887|P2|Overall Study|Withdrawal by Subject|9
2956053|NCT01259466|10175888|P1|Overall Study|Withdrawal by Subject|1
2956054|NCT01259401|10175926|P2|4-month Follow-up|Lost to Follow-up|1
2956055|NCT01259401|10175927|P1|4-month Follow-up|Lost to Follow-up|0
2956056|NCT01259401|10175926|P2|4-month Follow-up|Death|1
2956057|NCT01259401|10175927|P1|4-month Follow-up|Death|0
2956058|NCT01259388|10175937|P2|Overall Study|Physician Decision|0
2956059|NCT01259388|10175938|P1|Overall Study|Physician Decision|1
2956060|NCT01259388|10175937|P2|Overall Study|Withdrawal by Subject|1
2956061|NCT01259388|10175938|P1|Overall Study|Withdrawal by Subject|1
2956062|NCT01259388|10175937|P2|Overall Study|Adverse Event|0
2956063|NCT01259388|10175938|P1|Overall Study|Adverse Event|3
2956064|NCT01259375|10175948|P1|Overall Study|Adverse Event|1
2956065|NCT01259297|10175965|P8|Double Blind Randomized Period|Other reasons|1
2956066|NCT01259297|10175966|P7|Double Blind Randomized Period|Other reasons|3
2956067|NCT01259297|10175967|P6|Double Blind Randomized Period|Other reasons|2
2956068|NCT01259297|10175968|P5|Double Blind Randomized Period|Other reasons|1
2956069|NCT01259297|10175969|P4|Double Blind Randomized Period|Other reasons|0
2956070|NCT01259297|10175970|P3|Double Blind Randomized Period|Other reasons|0
2956071|NCT01259297|10175971|P2|Double Blind Randomized Period|Other reasons|1
2956072|NCT01259297|10175972|P1|Double Blind Randomized Period|Other reasons|0
2956073|NCT01259297|10175965|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2956074|NCT01259297|10175966|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2956075|NCT01259297|10175967|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2956076|NCT01259297|10175968|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2956077|NCT01259297|10175969|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2956078|NCT01259297|10175970|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
2956079|NCT01259297|10175971|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2956080|NCT01259297|10175972|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2956081|NCT01259297|10175965|P8|Double Blind Randomized Period|Death|1
2956082|NCT01259297|10175966|P7|Double Blind Randomized Period|Death|2
2956083|NCT01259297|10175967|P6|Double Blind Randomized Period|Death|5
2956084|NCT01259297|10175968|P5|Double Blind Randomized Period|Death|1
2956085|NCT01259297|10175969|P4|Double Blind Randomized Period|Death|2
2956086|NCT01259297|10175970|P3|Double Blind Randomized Period|Death|1
2956087|NCT01259297|10175971|P2|Double Blind Randomized Period|Death|1
2956088|NCT01259297|10175972|P1|Double Blind Randomized Period|Death|1
2956089|NCT01259284|10176003|P3|Overall Study|Study Termination|0
2956090|NCT01259284|10176004|P2|Overall Study|Study Termination|0
2956091|NCT01259284|10176005|P1|Overall Study|Study Termination|2
2956092|NCT01259245|10176015|P2|Overall Study|Death|2
2956093|NCT01259245|10176016|P1|Overall Study|Death|1
2956094|NCT01259245|10176015|P2|Overall Study|Withdrawal by Subject|24
2956095|NCT01259245|10176016|P1|Overall Study|Withdrawal by Subject|27
2956096|NCT01259115|10176040|P2|Period 2|Adverse Event|0
2956097|NCT01259115|10176041|P1|Period 2|Adverse Event|1
2956098|NCT01259115|10176040|P2|Period 1|Lost to Follow-up|1
2956099|NCT01259115|10176041|P1|Period 1|Lost to Follow-up|0
2956100|NCT01259115|10176040|P2|Period 1|Protocol Violation|0
2956101|NCT01259115|10176041|P1|Period 1|Protocol Violation|2
2956102|NCT01259115|10176040|P2|Period 1|Adverse Event|0
2956103|NCT01259115|10176041|P1|Period 1|Adverse Event|1
2956104|NCT01259102|10176077|P5|Overall Study|Other|1
2956105|NCT01259102|10176078|P4|Overall Study|Other|1
2956106|NCT01259102|10176079|P3|Overall Study|Other|1
2956107|NCT01259102|10176080|P2|Overall Study|Other|0
2956108|NCT01259102|10176081|P1|Overall Study|Other|0
2956109|NCT01259102|10176077|P5|Overall Study|Adverse Event|0
2956110|NCT01259102|10176078|P4|Overall Study|Adverse Event|1
2956111|NCT01259102|10176079|P3|Overall Study|Adverse Event|1
2956112|NCT01259102|10176080|P2|Overall Study|Adverse Event|0
2956113|NCT01259102|10176081|P1|Overall Study|Adverse Event|1
2956114|NCT01259089|10176138|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
2956115|NCT01259089|10176139|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
2956116|NCT01259089|10176140|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
2956117|NCT01259089|10176141|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
2956118|NCT01259089|10176142|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
2956119|NCT01259089|10176143|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
2956120|NCT01259089|10176138|P6|Survival Follow up for Two Years|Lost to Follow-up|2
2956121|NCT01259089|10176139|P5|Survival Follow up for Two Years|Lost to Follow-up|0
2956122|NCT01259089|10176140|P4|Survival Follow up for Two Years|Lost to Follow-up|0
2956123|NCT01259089|10176141|P3|Survival Follow up for Two Years|Lost to Follow-up|0
2956124|NCT01259089|10176142|P2|Survival Follow up for Two Years|Lost to Follow-up|0
2956125|NCT01259089|10176143|P1|Survival Follow up for Two Years|Lost to Follow-up|0
2956126|NCT01259089|10176138|P6|Survival Follow up for Two Years|Death|13
2956127|NCT01259089|10176139|P5|Survival Follow up for Two Years|Death|6
2956128|NCT01259089|10176140|P4|Survival Follow up for Two Years|Death|3
2956129|NCT01259089|10176141|P3|Survival Follow up for Two Years|Death|2
2956130|NCT01259089|10176142|P2|Survival Follow up for Two Years|Death|2
2956131|NCT01259089|10176143|P1|Survival Follow up for Two Years|Death|3
2956132|NCT01259089|10176138|P6|Continued Treatment After 8 Weeks|Progressive disease|0
2956133|NCT01259089|10176139|P5|Continued Treatment After 8 Weeks|Progressive disease|0
2956134|NCT01259089|10176140|P4|Continued Treatment After 8 Weeks|Progressive disease|1
2956135|NCT01259089|10176141|P3|Continued Treatment After 8 Weeks|Progressive disease|1
2956136|NCT01259089|10176142|P2|Continued Treatment After 8 Weeks|Progressive disease|1
2956137|NCT01259089|10176143|P1|Continued Treatment After 8 Weeks|Progressive disease|1
2956138|NCT01259089|10176138|P6|Continued Treatment After 8 Weeks|Adverse Event|1
2956139|NCT01259089|10176139|P5|Continued Treatment After 8 Weeks|Adverse Event|2
2956140|NCT01259089|10176140|P4|Continued Treatment After 8 Weeks|Adverse Event|0
2956141|NCT01259089|10176141|P3|Continued Treatment After 8 Weeks|Adverse Event|0
2956142|NCT01259089|10176142|P2|Continued Treatment After 8 Weeks|Adverse Event|0
2956143|NCT01259089|10176143|P1|Continued Treatment After 8 Weeks|Adverse Event|0
2956144|NCT01259089|10176138|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2956145|NCT01259089|10176139|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2956146|NCT01259089|10176140|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2956147|NCT01259089|10176141|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2956148|NCT01259089|10176142|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2956149|NCT01259089|10176143|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
2956150|NCT01259089|10176138|P6|Confirmed Response at 8 Weeks|Progressive disease|7
2956151|NCT01259089|10176139|P5|Confirmed Response at 8 Weeks|Progressive disease|3
2956152|NCT01259089|10176140|P4|Confirmed Response at 8 Weeks|Progressive disease|1
2956153|NCT01259089|10176141|P3|Confirmed Response at 8 Weeks|Progressive disease|1
2956154|NCT01259089|10176142|P2|Confirmed Response at 8 Weeks|Progressive disease|0
2956155|NCT01259089|10176143|P1|Confirmed Response at 8 Weeks|Progressive disease|0
2956156|NCT01259089|10176138|P6|Confirmed Response at 8 Weeks|Adverse Event|2
2956157|NCT01259089|10176139|P5|Confirmed Response at 8 Weeks|Adverse Event|1
2956158|NCT01259089|10176140|P4|Confirmed Response at 8 Weeks|Adverse Event|0
2956159|NCT01259089|10176141|P3|Confirmed Response at 8 Weeks|Adverse Event|0
2956160|NCT01259089|10176142|P2|Confirmed Response at 8 Weeks|Adverse Event|0
2956161|NCT01259089|10176143|P1|Confirmed Response at 8 Weeks|Adverse Event|0
2956162|NCT01259089|10176138|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
2956163|NCT01259089|10176139|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2956164|NCT01259089|10176140|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2956165|NCT01259089|10176141|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2956166|NCT01259089|10176142|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2956167|NCT01259089|10176143|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2956168|NCT01259089|10176138|P6|Reached First Response at 4 Weeks|Adverse Event|1
2956169|NCT01259089|10176139|P5|Reached First Response at 4 Weeks|Adverse Event|0
2956170|NCT01259089|10176140|P4|Reached First Response at 4 Weeks|Adverse Event|0
2956171|NCT01259089|10176141|P3|Reached First Response at 4 Weeks|Adverse Event|0
2956172|NCT01259089|10176142|P2|Reached First Response at 4 Weeks|Adverse Event|0
2956173|NCT01259089|10176143|P1|Reached First Response at 4 Weeks|Adverse Event|0
2956174|NCT01259089|10176138|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
2956175|NCT01259089|10176139|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
2956176|NCT01259089|10176140|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
2956177|NCT01259089|10176141|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
2956178|NCT01259089|10176142|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
2956179|NCT01259089|10176143|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
2956180|NCT01259024|10176171|P1|Overall Study|Physician Decision|1
2956181|NCT01258998|10176191|P1|Overall Study|Ineligible|1
2956182|NCT01258803|10176245|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
2956183|NCT01258803|10176246|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
2956184|NCT01258803|10176247|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
2956185|NCT01258803|10176248|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
2956186|NCT01258803|10176249|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
2956187|NCT01258803|10176250|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
2956188|NCT01258803|10176245|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2956189|NCT01258803|10176246|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2956190|NCT01258803|10176247|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2956191|NCT01258803|10176248|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2956192|NCT01258803|10176249|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
2956193|NCT01258803|10176250|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2956194|NCT01258803|10176245|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
2956195|NCT01258803|10176246|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
2956196|NCT01258803|10176247|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
2956197|NCT01258803|10176248|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
2956198|NCT01258803|10176249|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
2956199|NCT01258803|10176250|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
2956200|NCT01258738|10176287|P2|Open-label Period|Withdrawn due to pregnancy|1
2956201|NCT01258738|10176288|P1|Open-label Period|Withdrawn due to pregnancy|1
2956202|NCT01258738|10176287|P2|Open-label Period|Other Reasons|1
2956203|NCT01258738|10176288|P1|Open-label Period|Other Reasons|0
2956204|NCT01258738|10176287|P2|Open-label Period|Adverse Event|5
2956205|NCT01258738|10176288|P1|Open-label Period|Adverse Event|4
2956206|NCT01258738|10176287|P2|Open-label Period|Protocol Violation|2
2956207|NCT01258738|10176288|P1|Open-label Period|Protocol Violation|2
2956208|NCT01258738|10176287|P2|Open-label Period|Withdrawal by Subject|6
2956209|NCT01258738|10176288|P1|Open-label Period|Withdrawal by Subject|5
2956210|NCT01258738|10176287|P2|Open-label Period|Lost to Follow-up|2
2956211|NCT01258738|10176288|P1|Open-label Period|Lost to Follow-up|0
2956212|NCT01258738|10176287|P2|Open-label Period|Insufficient clinical response|3
2956213|NCT01258738|10176288|P1|Open-label Period|Insufficient clinical response|5
2956214|NCT01258738|10176287|P2|Open-label Period|Did not meet inclusion criteria|1
2956215|NCT01258738|10176288|P1|Open-label Period|Did not meet inclusion criteria|0
2956216|NCT01258738|10176287|P2|Double-blind Period|Adverse Event|1
2956217|NCT01258738|10176288|P1|Double-blind Period|Adverse Event|3
2956218|NCT01258738|10176287|P2|Double-blind Period|Protocol Violation|1
2956219|NCT01258738|10176288|P1|Double-blind Period|Protocol Violation|1
2956220|NCT01258738|10176287|P2|Double-blind Period|Withdrawal by Subject|2
2956221|NCT01258738|10176288|P1|Double-blind Period|Withdrawal by Subject|2
2956222|NCT01258738|10176287|P2|Double-blind Period|Did not meet inclusion criteria|3
2956223|NCT01258738|10176288|P1|Double-blind Period|Did not meet inclusion criteria|3
2956224|NCT01258660|10176426|P2|Overall Study|Invalid for primary analysis data set|6
2956225|NCT01258660|10176427|P1|Overall Study|Invalid for primary analysis data set|4
2956226|NCT01258660|10176426|P2|Overall Study|Protocol Violation|1
2956227|NCT01258660|10176427|P1|Overall Study|Protocol Violation|0
2956228|NCT01258660|10176426|P2|Overall Study|due to relocation|0
2956229|NCT01258660|10176427|P1|Overall Study|due to relocation|2
2956230|NCT01258660|10176426|P2|Overall Study|Withdrawal by Subject|0
2956231|NCT01258660|10176427|P1|Overall Study|Withdrawal by Subject|3
2956232|NCT01258660|10176426|P2|Overall Study|Adverse Event|4
2956233|NCT01258660|10176427|P1|Overall Study|Adverse Event|2
2956234|NCT01258608|10176446|P2|Overall Study|Withdrawal by Subject|5
2956235|NCT01258608|10176447|P1|Overall Study|Withdrawal by Subject|6
2956236|NCT01258608|10176446|P2|Overall Study|Adverse Event|10
2956237|NCT01258608|10176447|P1|Overall Study|Adverse Event|6
2956238|NCT01258608|10176446|P2|Overall Study|Lack of Efficacy|1
2956239|NCT01258608|10176447|P1|Overall Study|Lack of Efficacy|0
2956240|NCT01258608|10176446|P2|Overall Study|Lack of compliance|0
2956241|NCT01258608|10176447|P1|Overall Study|Lack of compliance|1
2956242|NCT01258608|10176446|P2|Overall Study|Lost to Follow-up|1
2956243|NCT01258608|10176447|P1|Overall Study|Lost to Follow-up|0
2956244|NCT01258608|10176446|P2|Overall Study|Physician Decision|1
2956245|NCT01258608|10176447|P1|Overall Study|Physician Decision|6
2956246|NCT01258608|10176446|P2|Overall Study|Sponsor decision|1
2956247|NCT01258608|10176447|P1|Overall Study|Sponsor decision|0
2956248|NCT01258608|10176446|P2|Overall Study|Clinical progression|0
2956249|NCT01258608|10176447|P1|Overall Study|Clinical progression|1
2956250|NCT01258608|10176446|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
2956251|NCT01258608|10176447|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
2956252|NCT01258595|10176495|P2|Overall Study|Withdrawal by Subject|1
2956253|NCT01258595|10176496|P1|Overall Study|Withdrawal by Subject|0
2956254|NCT01258595|10176495|P2|Overall Study|Lost to Follow-up|0
2956255|NCT01258595|10176496|P1|Overall Study|Lost to Follow-up|1
2956256|NCT01258348|10176593|P5|Overall Study|Withdrawal by Subject|0
2956257|NCT01258348|10176594|P4|Overall Study|Withdrawal by Subject|0
2956258|NCT01258348|10176595|P3|Overall Study|Withdrawal by Subject|0
2956259|NCT01258348|10176596|P2|Overall Study|Withdrawal by Subject|1
2956260|NCT01258348|10176597|P1|Overall Study|Withdrawal by Subject|0
2956261|NCT01258348|10176593|P5|Overall Study|Physician Decision|0
2956262|NCT01258348|10176594|P4|Overall Study|Physician Decision|2
2956263|NCT01258348|10176595|P3|Overall Study|Physician Decision|0
2956264|NCT01258348|10176596|P2|Overall Study|Physician Decision|0
2956265|NCT01258348|10176597|P1|Overall Study|Physician Decision|0
2956266|NCT01258348|10176593|P5|Overall Study|Progressive Disease|2
2956267|NCT01258348|10176594|P4|Overall Study|Progressive Disease|2
2956268|NCT01258348|10176595|P3|Overall Study|Progressive Disease|0
2956269|NCT01258348|10176596|P2|Overall Study|Progressive Disease|3
2956270|NCT01258348|10176597|P1|Overall Study|Progressive Disease|0
2956271|NCT01258348|10176593|P5|Overall Study|Adverse Event|4
2956272|NCT01258348|10176594|P4|Overall Study|Adverse Event|2
2956273|NCT01258348|10176595|P3|Overall Study|Adverse Event|3
2956274|NCT01258348|10176596|P2|Overall Study|Adverse Event|1
2956275|NCT01258348|10176597|P1|Overall Study|Adverse Event|1
2956276|NCT01258101|10176654|P4|Overall Study|Other reason|8
2956277|NCT01258101|10176655|P3|Overall Study|Other reason|1
2956278|NCT01258101|10176656|P2|Overall Study|Other reason|8
2956279|NCT01258101|10176657|P1|Overall Study|Other reason|7
2956280|NCT01258101|10176654|P4|Overall Study|PCR positive at week 24|1
2956281|NCT01258101|10176655|P3|Overall Study|PCR positive at week 24|0
2956282|NCT01258101|10176656|P2|Overall Study|PCR positive at week 24|0
2956283|NCT01258101|10176657|P1|Overall Study|PCR positive at week 24|0
2956284|NCT01258101|10176654|P4|Overall Study|Lost to Follow-up|6
2956285|NCT01258101|10176655|P3|Overall Study|Lost to Follow-up|0
2956286|NCT01258101|10176656|P2|Overall Study|Lost to Follow-up|5
2956287|NCT01258101|10176657|P1|Overall Study|Lost to Follow-up|5
2956288|NCT01258101|10176654|P4|Overall Study|Patient´s compliance|2
2956289|NCT01258101|10176655|P3|Overall Study|Patient´s compliance|1
2956290|NCT01258101|10176656|P2|Overall Study|Patient´s compliance|3
2956291|NCT01258101|10176657|P1|Overall Study|Patient´s compliance|4
2956292|NCT01258101|10176654|P4|Overall Study|Patient is not able to attend visits|6
2956293|NCT01258101|10176655|P3|Overall Study|Patient is not able to attend visits|7
2956294|NCT01258101|10176656|P2|Overall Study|Patient is not able to attend visits|9
2956295|NCT01258101|10176657|P1|Overall Study|Patient is not able to attend visits|8
2956296|NCT01258101|10176654|P4|Overall Study|Informed consent has been withdrawn|1
2956297|NCT01258101|10176655|P3|Overall Study|Informed consent has been withdrawn|1
2956298|NCT01258101|10176656|P2|Overall Study|Informed consent has been withdrawn|2
2956299|NCT01258101|10176657|P1|Overall Study|Informed consent has been withdrawn|2
2956300|NCT01258101|10176654|P4|Overall Study|Extra exclusion criterion amended|1
2956301|NCT01258101|10176655|P3|Overall Study|Extra exclusion criterion amended|1
2956302|NCT01258101|10176656|P2|Overall Study|Extra exclusion criterion amended|1
2956303|NCT01258101|10176657|P1|Overall Study|Extra exclusion criterion amended|2
2956304|NCT01258101|10176654|P4|Overall Study|Adverse Event|0
2956305|NCT01258101|10176655|P3|Overall Study|Adverse Event|0
2956306|NCT01258101|10176656|P2|Overall Study|Adverse Event|6
2956307|NCT01258101|10176657|P1|Overall Study|Adverse Event|5
2956308|NCT01257737|10176787|P2|Overall Study|Withdrew from study|1
2956309|NCT01257737|10176788|P1|Overall Study|Withdrew from study|0
2956310|NCT01257737|10176787|P2|Overall Study|Relocation out of the country|1
2956311|NCT01257737|10176788|P1|Overall Study|Relocation out of the country|0
2956312|NCT01257737|10176787|P2|Overall Study|Liver transplant|0
2956313|NCT01257737|10176788|P1|Overall Study|Liver transplant|1
2956314|NCT01257737|10176787|P2|Overall Study|Lost to Follow-up|2
2956315|NCT01257737|10176788|P1|Overall Study|Lost to Follow-up|1
2956316|NCT01257698|10176808|P2|Overall Study|Protocol Violation|0
2956317|NCT01257698|10176809|P1|Overall Study|Protocol Violation|4
2956318|NCT01257581|10176818|P3|Overall Study|Death|4
2956319|NCT01257581|10176819|P2|Overall Study|Death|2
2956320|NCT01257581|10176820|P1|Overall Study|Death|2
2956321|NCT01257581|10176818|P3|Overall Study|Early Termination|2
2956322|NCT01257581|10176819|P2|Overall Study|Early Termination|1
2956323|NCT01257581|10176820|P1|Overall Study|Early Termination|3
2956324|NCT01257568|10176858|P1|Overall Study|Component Revision|24
2956325|NCT01257568|10176858|P1|Overall Study|Terminated|1
2956326|NCT01257568|10176858|P1|Overall Study|Withdrawal by Subject|6
2956327|NCT01257568|10176858|P1|Overall Study|Lost to Follow-up|2
2956328|NCT01257542|10176872|P2|Overall Study|Withdrawal by Subject|2
2956329|NCT01257542|10176873|P1|Overall Study|Withdrawal by Subject|0
2956330|NCT01257542|10176872|P2|Overall Study|Protocol Violation|5
2956331|NCT01257542|10176873|P1|Overall Study|Protocol Violation|3
2956332|NCT01257503|10176893|P2|Overall Study|strep culture positive at enrollment|0
2956333|NCT01257503|10176894|P1|Overall Study|strep culture positive at enrollment|1
2956334|NCT01257503|10176893|P2|Overall Study|Over 5 years old at enrollment|1
2956335|NCT01257503|10176894|P1|Overall Study|Over 5 years old at enrollment|0
2956336|NCT01257503|10176893|P2|Overall Study|Lost to Follow-up|10
2956337|NCT01257503|10176894|P1|Overall Study|Lost to Follow-up|7
2956338|NCT01257425|10176923|P2|Overall Study|Death|0
2956339|NCT01257425|10176924|P1|Overall Study|Death|1
2956340|NCT01257425|10176923|P2|Overall Study|Withdrawal by Subject|1
2956341|NCT01257425|10176924|P1|Overall Study|Withdrawal by Subject|0
2956342|NCT01257425|10176923|P2|Overall Study|Protocol Violation|1
2956343|NCT01257425|10176924|P1|Overall Study|Protocol Violation|1
2956344|NCT01257425|10176923|P2|Overall Study|Adverse Event|1
2956345|NCT01257425|10176924|P1|Overall Study|Adverse Event|1
2956346|NCT01257425|10176923|P2|Overall Study|Lack of Efficacy|3
2956347|NCT01257425|10176924|P1|Overall Study|Lack of Efficacy|3
2956348|NCT01257230|10176966|P3|Overall Study|Other reason not defined above|3
2956349|NCT01257230|10176967|P2|Overall Study|Other reason not defined above|5
2956350|NCT01257230|10176968|P1|Overall Study|Other reason not defined above|1
2956351|NCT01257230|10176966|P3|Overall Study|Withdrawal by Subject|1
2956352|NCT01257230|10176967|P2|Overall Study|Withdrawal by Subject|4
2956353|NCT01257230|10176968|P1|Overall Study|Withdrawal by Subject|0
2956354|NCT01257230|10176966|P3|Overall Study|Protocol Violation|1
2956355|NCT01257230|10176967|P2|Overall Study|Protocol Violation|0
2956356|NCT01257230|10176968|P1|Overall Study|Protocol Violation|3
2956357|NCT01257230|10176966|P3|Overall Study|Lack of Efficacy|0
2956358|NCT01257230|10176967|P2|Overall Study|Lack of Efficacy|1
2956359|NCT01257230|10176968|P1|Overall Study|Lack of Efficacy|0
2956360|NCT01257230|10176966|P3|Overall Study|Adverse Event|0
2956361|NCT01257230|10176967|P2|Overall Study|Adverse Event|0
2956362|NCT01257230|10176968|P1|Overall Study|Adverse Event|2
2956363|NCT01257230|10176966|P3|Overall Study|Not Treated|1
2956364|NCT01257230|10176967|P2|Overall Study|Not Treated|0
2956365|NCT01257230|10176968|P1|Overall Study|Not Treated|0
2956366|NCT01257204|10177045|P3|Follow-up Period (up to Week 48)|Other|5
2956367|NCT01257204|10177046|P2|Follow-up Period (up to Week 48)|Other|0
2956368|NCT01257204|10177047|P1|Follow-up Period (up to Week 48)|Other|0
2956369|NCT01257204|10177045|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2956370|NCT01257204|10177046|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2956371|NCT01257204|10177047|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
2956372|NCT01257204|10177045|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
2956373|NCT01257204|10177046|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
2956374|NCT01257204|10177047|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
2956375|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2956376|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2956377|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
2956378|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
2956379|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2956380|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2956381|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
2956382|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
2956383|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
2956384|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2956385|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
2956386|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2956387|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Adverse Event|2
2956388|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Adverse Event|1
2956389|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Adverse Event|3
2956390|NCT01257204|10177045|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
2956391|NCT01257204|10177046|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
2956392|NCT01257204|10177047|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
2956393|NCT01256879|10177142|P1|Overall Study|Withdrawal by Subject|1
2956394|NCT01256788|10177168|P3|Overall Study|Lost to Follow-up|3
2956395|NCT01256788|10177169|P2|Overall Study|Lost to Follow-up|8
2956396|NCT01256788|10177170|P1|Overall Study|Lost to Follow-up|5
2956397|NCT01256684|10177181|P3|Overall Study|Entry criteria not met/non-compliance|6
2956398|NCT01256684|10177182|P2|Overall Study|Entry criteria not met/non-compliance|7
2956399|NCT01256684|10177183|P1|Overall Study|Entry criteria not met/non-compliance|4
2956400|NCT01256684|10177181|P3|Overall Study|Lack of Efficacy|1
2956401|NCT01256684|10177182|P2|Overall Study|Lack of Efficacy|1
2956402|NCT01256684|10177183|P1|Overall Study|Lack of Efficacy|0
2956403|NCT01256684|10177181|P3|Overall Study|Physician Decision|0
2956404|NCT01256684|10177182|P2|Overall Study|Physician Decision|1
2956405|NCT01256684|10177183|P1|Overall Study|Physician Decision|0
2956406|NCT01256684|10177181|P3|Overall Study|Withdrawal by Subject|2
2956407|NCT01256684|10177182|P2|Overall Study|Withdrawal by Subject|0
2956408|NCT01256684|10177183|P1|Overall Study|Withdrawal by Subject|4
2956409|NCT01256684|10177181|P3|Overall Study|Adverse Event|2
2956410|NCT01256684|10177182|P2|Overall Study|Adverse Event|4
2956411|NCT01256684|10177183|P1|Overall Study|Adverse Event|1
2956412|NCT01256671|10177215|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
2956413|NCT01256671|10177215|P1|Overall Study|Lack of Efficacy|4
2956414|NCT01256671|10177215|P1|Overall Study|Physician Decision|3
2956415|NCT01256671|10177215|P1|Overall Study|Withdrawal by Subject|31
2956416|NCT01256671|10177215|P1|Overall Study|Lost to Follow-up|16
2956417|NCT01256671|10177215|P1|Overall Study|Adverse Event|29
2956418|NCT01256658|10177228|P2|Period 1|Death|44
2956419|NCT01256658|10177229|P1|Period 1|Death|48
2956420|NCT01256658|10177228|P2|Period 1|Withdrawal by Subject|43
2956421|NCT01256658|10177229|P1|Period 1|Withdrawal by Subject|35
2956422|NCT01256658|10177228|P2|Period 1|Lost to Follow-up|661
2956423|NCT01256658|10177229|P1|Period 1|Lost to Follow-up|837
2956424|NCT01256593|10177279|P1|Overall Study|No Visit After Treatment|186
2956425|NCT01256593|10177279|P1|Overall Study|No Drug Administration Information|2
2956426|NCT01256593|10177279|P1|Overall Study|Protocol Violation|26
2956427|NCT01256567|10177293|P1|Overall Study|Withdrawal by Subject|1
2956428|NCT01256502|10177303|P1|Overall Study|Protocol deviation|1
2956429|NCT01256502|10177303|P1|Overall Study|Personal reasons|5
2956430|NCT01256502|10177303|P1|Overall Study|Had scaffold removed|4
2956431|NCT01256476|10177315|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
2956432|NCT01256476|10177316|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
2956433|NCT01256476|10177315|P2|Overall Study|Subject non-compliance|1
2956434|NCT01256476|10177316|P1|Overall Study|Subject non-compliance|0
2956435|NCT01256476|10177315|P2|Overall Study|Physician Decision|1
2956436|NCT01256476|10177316|P1|Overall Study|Physician Decision|0
2956437|NCT01256476|10177315|P2|Overall Study|Persistent ALT or AST elevation|0
2956438|NCT01256476|10177316|P1|Overall Study|Persistent ALT or AST elevation|1
2956439|NCT01256476|10177315|P2|Overall Study|Lost to Follow-up|2
2956440|NCT01256476|10177316|P1|Overall Study|Lost to Follow-up|1
2956441|NCT01256476|10177315|P2|Overall Study|Withdrawal by Subject|1
2956442|NCT01256476|10177316|P1|Overall Study|Withdrawal by Subject|2
2956443|NCT01256476|10177315|P2|Overall Study|Adverse Event|1
2956444|NCT01256476|10177316|P1|Overall Study|Adverse Event|2
2956445|NCT01256450|10177324|P3|Double-blind Treatment|Other|12
2956446|NCT01256450|10177325|P2|Double-blind Treatment|Other|9
2956447|NCT01256450|10177326|P1|Double-blind Treatment|Other|0
2956448|NCT01256450|10177324|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
2956449|NCT01256450|10177325|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
2956450|NCT01256450|10177326|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
2956451|NCT01256450|10177324|P3|Double-blind Treatment|Non-compliance|4
2956452|NCT01256450|10177325|P2|Double-blind Treatment|Non-compliance|5
2956453|NCT01256450|10177326|P1|Double-blind Treatment|Non-compliance|0
2956454|NCT01256450|10177324|P3|Double-blind Treatment|Lack of analgesic effect|6
2956455|NCT01256450|10177325|P2|Double-blind Treatment|Lack of analgesic effect|5
2956456|NCT01256450|10177326|P1|Double-blind Treatment|Lack of analgesic effect|0
2956457|NCT01256450|10177324|P3|Double-blind Treatment|Withdrawal by Subject|1
2956458|NCT01256450|10177325|P2|Double-blind Treatment|Withdrawal by Subject|0
2956459|NCT01256450|10177326|P1|Double-blind Treatment|Withdrawal by Subject|0
2956460|NCT01256450|10177324|P3|Double-blind Treatment|Lost to Follow-up|7
2956461|NCT01256450|10177325|P2|Double-blind Treatment|Lost to Follow-up|1
2956462|NCT01256450|10177326|P1|Double-blind Treatment|Lost to Follow-up|0
2956463|NCT01256450|10177324|P3|Double-blind Treatment|Adverse Event|6
2956464|NCT01256450|10177325|P2|Double-blind Treatment|Adverse Event|8
2956465|NCT01256450|10177326|P1|Double-blind Treatment|Adverse Event|0
2956466|NCT01256450|10177324|P3|Open-label Titration|Other|0
2956467|NCT01256450|10177325|P2|Open-label Titration|Other|0
2956468|NCT01256450|10177326|P1|Open-label Titration|Other|13
2956469|NCT01256450|10177324|P3|Open-label Titration|Screen failure|0
2956470|NCT01256450|10177325|P2|Open-label Titration|Screen failure|0
2956471|NCT01256450|10177326|P1|Open-label Titration|Screen failure|1
2956472|NCT01256450|10177324|P3|Open-label Titration|Non-compliance|0
2956473|NCT01256450|10177325|P2|Open-label Titration|Non-compliance|0
2956474|NCT01256450|10177326|P1|Open-label Titration|Non-compliance|9
2956475|NCT01256450|10177324|P3|Open-label Titration|Lack of analgesic effect|0
2956476|NCT01256450|10177325|P2|Open-label Titration|Lack of analgesic effect|0
2956477|NCT01256450|10177326|P1|Open-label Titration|Lack of analgesic effect|30
2956478|NCT01256450|10177324|P3|Open-label Titration|Lost to Follow-up|0
2956479|NCT01256450|10177325|P2|Open-label Titration|Lost to Follow-up|0
2956480|NCT01256450|10177326|P1|Open-label Titration|Lost to Follow-up|7
2956481|NCT01256450|10177324|P3|Open-label Titration|Adverse Event|0
2956482|NCT01256450|10177325|P2|Open-label Titration|Adverse Event|0
2956483|NCT01256450|10177326|P1|Open-label Titration|Adverse Event|39
2956484|NCT01256411|10177384|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2956485|NCT01256411|10177385|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2956486|NCT01256411|10177386|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2956487|NCT01256411|10177387|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2956488|NCT01256411|10177388|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2956489|NCT01256411|10177389|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2956490|NCT01256411|10177384|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
2956491|NCT01256411|10177385|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
2956492|NCT01256411|10177386|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2956493|NCT01256411|10177387|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2956494|NCT01256411|10177388|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2956495|NCT01256411|10177389|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2956496|NCT01256411|10177384|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2956497|NCT01256411|10177385|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
2956498|NCT01256411|10177386|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2956499|NCT01256411|10177387|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2956500|NCT01256411|10177388|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2956501|NCT01256411|10177389|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2956502|NCT01256411|10177384|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
2956503|NCT01256411|10177385|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
2956504|NCT01256411|10177386|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
2956505|NCT01256411|10177387|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
2956506|NCT01256411|10177388|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
2956507|NCT01256411|10177389|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
2956508|NCT01256411|10177384|P6|Extension by Mono or Combination Therapy|Adverse Event|1
2956509|NCT01256411|10177385|P5|Extension by Mono or Combination Therapy|Adverse Event|6
2956510|NCT01256411|10177386|P4|Extension by Mono or Combination Therapy|Adverse Event|0
2956511|NCT01256411|10177387|P3|Extension by Mono or Combination Therapy|Adverse Event|0
2956512|NCT01256411|10177388|P2|Extension by Mono or Combination Therapy|Adverse Event|0
2956513|NCT01256411|10177389|P1|Extension by Mono or Combination Therapy|Adverse Event|0
2956514|NCT01256411|10177384|P6|Extension by Maximum Treatment|Adverse Event|0
2956515|NCT01256411|10177385|P5|Extension by Maximum Treatment|Adverse Event|0
2956516|NCT01256411|10177386|P4|Extension by Maximum Treatment|Adverse Event|0
2956517|NCT01256411|10177387|P3|Extension by Maximum Treatment|Adverse Event|1
2956518|NCT01256411|10177388|P2|Extension by Maximum Treatment|Adverse Event|2
2956519|NCT01256411|10177389|P1|Extension by Maximum Treatment|Adverse Event|4
2956520|NCT01256411|10177384|P6|Extension by Maximum Treatment|Lack of Efficacy|0
2956521|NCT01256411|10177385|P5|Extension by Maximum Treatment|Lack of Efficacy|0
2956522|NCT01256411|10177386|P4|Extension by Maximum Treatment|Lack of Efficacy|0
2956523|NCT01256411|10177387|P3|Extension by Maximum Treatment|Lack of Efficacy|1
2956524|NCT01256411|10177388|P2|Extension by Maximum Treatment|Lack of Efficacy|0
2956525|NCT01256411|10177389|P1|Extension by Maximum Treatment|Lack of Efficacy|1
2956526|NCT01256411|10177384|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
2956527|NCT01256411|10177385|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
2956528|NCT01256411|10177386|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
2956529|NCT01256411|10177387|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
2956530|NCT01256411|10177388|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
2956531|NCT01256411|10177389|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
2956532|NCT01256411|10177384|P6|Extension by Maximum Treatment|Lost to Follow-up|0
2956533|NCT01256411|10177385|P5|Extension by Maximum Treatment|Lost to Follow-up|0
2956534|NCT01256411|10177386|P4|Extension by Maximum Treatment|Lost to Follow-up|0
2956535|NCT01256411|10177387|P3|Extension by Maximum Treatment|Lost to Follow-up|0
2956536|NCT01256411|10177388|P2|Extension by Maximum Treatment|Lost to Follow-up|2
2956537|NCT01256411|10177389|P1|Extension by Maximum Treatment|Lost to Follow-up|1
2956538|NCT01256411|10177384|P6|Extension by Maximum Treatment|Protocol deviation|0
2956539|NCT01256411|10177385|P5|Extension by Maximum Treatment|Protocol deviation|0
2956540|NCT01256411|10177386|P4|Extension by Maximum Treatment|Protocol deviation|0
2956541|NCT01256411|10177387|P3|Extension by Maximum Treatment|Protocol deviation|1
2956542|NCT01256411|10177388|P2|Extension by Maximum Treatment|Protocol deviation|0
2956543|NCT01256411|10177389|P1|Extension by Maximum Treatment|Protocol deviation|0
2956544|NCT01256398|10177413|P1|Overall Study|Withdrawal by Subject|1
2956545|NCT01256385|10177419|P2|Overall Study|Withdrawal by Subject|2
2956546|NCT01256385|10177420|P1|Overall Study|Withdrawal by Subject|2
2956547|NCT01256385|10177419|P2|Overall Study|Physician Decision|1
2956548|NCT01256385|10177420|P1|Overall Study|Physician Decision|1
2956549|NCT01256294|10177440|P2|Overall Study|Protocol deviation|1
2956550|NCT01256294|10177441|P1|Overall Study|Protocol deviation|2
2956551|NCT01256294|10177440|P2|Overall Study|Withdrawal by Subject|1
2956552|NCT01256294|10177441|P1|Overall Study|Withdrawal by Subject|1
2956553|NCT01256294|10177440|P2|Overall Study|Adverse Event|0
2956554|NCT01256294|10177441|P1|Overall Study|Adverse Event|1
2956555|NCT01256190|10177463|P2|Overall Study|Lost to Follow-up|0
2956556|NCT01256190|10177464|P1|Overall Study|Lost to Follow-up|2
2956557|NCT01256177|10177480|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
2956558|NCT01256177|10177481|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
2956559|NCT01256177|10177480|P2|Overall Study|Lack of Efficacy|2
2956560|NCT01256177|10177481|P1|Overall Study|Lack of Efficacy|11
2956561|NCT01256177|10177480|P2|Overall Study|Condition under Investigation Worsened|0
2956562|NCT01256177|10177481|P1|Overall Study|Condition under Investigation Worsened|1
2956563|NCT01256177|10177480|P2|Overall Study|Severe Non-Compliance to Protocol|2
2956564|NCT01256177|10177481|P1|Overall Study|Severe Non-Compliance to Protocol|4
2956565|NCT01256177|10177480|P2|Overall Study|Adverse Event|9
2956566|NCT01256177|10177481|P1|Overall Study|Adverse Event|8
2956567|NCT01256177|10177480|P2|Overall Study|Lost to Follow-up|2
2956568|NCT01256177|10177481|P1|Overall Study|Lost to Follow-up|2
2956569|NCT01256177|10177480|P2|Overall Study|Withdrawal by Subject|22
2956570|NCT01256177|10177481|P1|Overall Study|Withdrawal by Subject|23
2956571|NCT01256060|10177537|P4|Overall Study|Lost to Follow-up|0
2956572|NCT01256060|10177538|P3|Overall Study|Lost to Follow-up|0
2956573|NCT01256060|10177539|P2|Overall Study|Lost to Follow-up|1
2956574|NCT01256060|10177540|P1|Overall Study|Lost to Follow-up|0
2956575|NCT01256008|10177559|P3|Overall Study|Withdrawal by Subject|10
2956576|NCT01256008|10177560|P2|Overall Study|Withdrawal by Subject|3
2956577|NCT01256008|10177561|P1|Overall Study|Withdrawal by Subject|2
2956578|NCT01256008|10177559|P3|Overall Study|Lost to Follow-up|11
2956579|NCT01256008|10177560|P2|Overall Study|Lost to Follow-up|4
2956580|NCT01256008|10177561|P1|Overall Study|Lost to Follow-up|6
2956581|NCT01255904|10177583|P2|Overall Study|Physician Decision|4
2956582|NCT01255904|10177584|P1|Overall Study|Physician Decision|1
2956583|NCT01255787|10177594|P4|Overall Study|Noncompliance with Study Drug|0
2956584|NCT01255787|10177595|P3|Overall Study|Noncompliance with Study Drug|0
2956585|NCT01255787|10177596|P2|Overall Study|Noncompliance with Study Drug|1
2956586|NCT01255787|10177597|P1|Overall Study|Noncompliance with Study Drug|3
2956587|NCT01255787|10177594|P4|Overall Study|Lack of Efficacy|2
2956588|NCT01255787|10177595|P3|Overall Study|Lack of Efficacy|2
2956589|NCT01255787|10177596|P2|Overall Study|Lack of Efficacy|2
2956590|NCT01255787|10177597|P1|Overall Study|Lack of Efficacy|2
2956591|NCT01255787|10177594|P4|Overall Study|Pregnancy|1
2956592|NCT01255787|10177595|P3|Overall Study|Pregnancy|0
2956593|NCT01255787|10177596|P2|Overall Study|Pregnancy|0
2956594|NCT01255787|10177597|P1|Overall Study|Pregnancy|0
2956595|NCT01255787|10177594|P4|Overall Study|Withdrawal of Consent|4
2956596|NCT01255787|10177595|P3|Overall Study|Withdrawal of Consent|3
2956597|NCT01255787|10177596|P2|Overall Study|Withdrawal of Consent|9
2956598|NCT01255787|10177597|P1|Overall Study|Withdrawal of Consent|3
2956599|NCT01255787|10177594|P4|Overall Study|Lost to Follow-up|2
2956600|NCT01255787|10177595|P3|Overall Study|Lost to Follow-up|4
2956601|NCT01255787|10177596|P2|Overall Study|Lost to Follow-up|2
2956602|NCT01255787|10177597|P1|Overall Study|Lost to Follow-up|1
2956603|NCT01255787|10177594|P4|Overall Study|Major Protocol Deviation|4
2956604|NCT01255787|10177595|P3|Overall Study|Major Protocol Deviation|0
2956605|NCT01255787|10177596|P2|Overall Study|Major Protocol Deviation|1
2956606|NCT01255787|10177597|P1|Overall Study|Major Protocol Deviation|1
2956607|NCT01255787|10177594|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2956608|NCT01255787|10177595|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2956609|NCT01255787|10177596|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
2956610|NCT01255787|10177597|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2956611|NCT01255761|10177625|P2|Overall Study|Other Reasons|18
2956612|NCT01255761|10177626|P1|Overall Study|Other Reasons|37
2956613|NCT01255761|10177625|P2|Overall Study|Withdrawal by Subject|27
2956614|NCT01255761|10177626|P1|Overall Study|Withdrawal by Subject|11
2956615|NCT01255761|10177625|P2|Overall Study|Lost to Follow-up|8
2956616|NCT01255761|10177626|P1|Overall Study|Lost to Follow-up|10
2956617|NCT01255761|10177625|P2|Overall Study|Protocol Violation|5
2956618|NCT01255761|10177626|P1|Overall Study|Protocol Violation|9
2956619|NCT01255761|10177625|P2|Overall Study|Lack of Efficacy|74
2956620|NCT01255761|10177626|P1|Overall Study|Lack of Efficacy|86
2956621|NCT01255761|10177625|P2|Overall Study|Adverse Event|43
2956622|NCT01255761|10177626|P1|Overall Study|Adverse Event|29
2956623|NCT01255722|10177711|P3|Overall Study|beta-blocker contraindicated|0
2956624|NCT01255722|10177712|P2|Overall Study|beta-blocker contraindicated|0
2956625|NCT01255722|10177713|P1|Overall Study|beta-blocker contraindicated|2
2956626|NCT01255722|10177711|P3|Overall Study|asymptomatic patient|0
2956627|NCT01255722|10177712|P2|Overall Study|asymptomatic patient|0
2956628|NCT01255722|10177713|P1|Overall Study|asymptomatic patient|1
2956629|NCT01255722|10177711|P3|Overall Study|Adverse Event|1
2956630|NCT01255722|10177712|P2|Overall Study|Adverse Event|1
2956631|NCT01255722|10177713|P1|Overall Study|Adverse Event|0
2956632|NCT01255631|10177738|P2|Overall Study|poor enrollment, no data analyzed|6
2956633|NCT01255631|10177739|P1|Overall Study|poor enrollment, no data analyzed|9
2956634|NCT01255592|10177757|P2|Overall Study|Other|1
2956635|NCT01255592|10177758|P1|Overall Study|Other|0
2956636|NCT01255592|10177757|P2|Overall Study|Withdrawal by Subject|0
2956637|NCT01255592|10177758|P1|Overall Study|Withdrawal by Subject|1
2956638|NCT01255592|10177757|P2|Overall Study|Adverse Event|0
2956639|NCT01255592|10177758|P1|Overall Study|Adverse Event|5
2956640|NCT01255436|10177821|P2|Overall Study|Death, stroke, or MI|3
2956641|NCT01255436|10177822|P1|Overall Study|Death, stroke, or MI|4
2956642|NCT01255436|10177821|P2|Overall Study|Lost to Follow-up|191
2956643|NCT01255436|10177822|P1|Overall Study|Lost to Follow-up|178
2956644|NCT01255423|10177836|P2|Overall Study|Use of prohibited medications|1
2956645|NCT01255423|10177837|P1|Overall Study|Use of prohibited medications|0
2956646|NCT01255423|10177836|P2|Overall Study|Abnormal Laboratory value|2
2956647|NCT01255423|10177837|P1|Overall Study|Abnormal Laboratory value|3
2956648|NCT01255306|10177853|P2|Overall Study|Physician Decision|1
2956649|NCT01255306|10177854|P1|Overall Study|Physician Decision|1
2956650|NCT01255163|10177865|P2|Overall Study|AstraZeneca stopped support of the study|3
2956651|NCT01255163|10177866|P1|Overall Study|AstraZeneca stopped support of the study|1
2956652|NCT01255163|10177865|P2|Overall Study|Adverse Event|2
2956653|NCT01255163|10177866|P1|Overall Study|Adverse Event|0
2956654|NCT01255163|10177865|P2|Overall Study|Lost to Follow-up|0
2956655|NCT01255163|10177866|P1|Overall Study|Lost to Follow-up|2
2956656|NCT01255163|10177865|P2|Overall Study|Withdrawal by Subject|0
2956657|NCT01255163|10177866|P1|Overall Study|Withdrawal by Subject|1
2956658|NCT01254890|10177895|P2|Overall Study|Disease Progression|5
2956659|NCT01254890|10177896|P1|Overall Study|Disease Progression|0
2956660|NCT01254890|10177895|P2|Overall Study|Withdrawal by Subject|2
2956661|NCT01254890|10177896|P1|Overall Study|Withdrawal by Subject|1
2956662|NCT01254890|10177895|P2|Overall Study|Ineligible|3
2956663|NCT01254890|10177896|P1|Overall Study|Ineligible|0
2956664|NCT01254747|10177958|P4|Overall Study|Discomfort|0
2956665|NCT01254747|10177959|P3|Overall Study|Discomfort|0
2956666|NCT01254747|10177960|P2|Overall Study|Discomfort|4
2956667|NCT01254747|10177961|P1|Overall Study|Discomfort|0
2956668|NCT01254747|10177958|P4|Overall Study|Biomicroscopy|0
2956669|NCT01254747|10177959|P3|Overall Study|Biomicroscopy|1
2956670|NCT01254747|10177960|P2|Overall Study|Biomicroscopy|0
2956671|NCT01254747|10177961|P1|Overall Study|Biomicroscopy|0
2956672|NCT01254747|10177958|P4|Overall Study|Lost to Follow-up|0
2956673|NCT01254747|10177959|P3|Overall Study|Lost to Follow-up|1
2956674|NCT01254747|10177960|P2|Overall Study|Lost to Follow-up|0
2956675|NCT01254747|10177961|P1|Overall Study|Lost to Follow-up|0
2956676|NCT01254747|10177958|P4|Overall Study|Symptoms and problems|0
2956677|NCT01254747|10177959|P3|Overall Study|Symptoms and problems|1
2956678|NCT01254747|10177960|P2|Overall Study|Symptoms and problems|2
2956679|NCT01254747|10177961|P1|Overall Study|Symptoms and problems|0
2956680|NCT01254747|10177958|P4|Overall Study|Difficult removal handling|0
2956681|NCT01254747|10177959|P3|Overall Study|Difficult removal handling|1
2956682|NCT01254747|10177960|P2|Overall Study|Difficult removal handling|0
2956683|NCT01254747|10177961|P1|Overall Study|Difficult removal handling|0
2956684|NCT01254747|10177958|P4|Overall Study|Unacceptable subjective vision|2
2956685|NCT01254747|10177959|P3|Overall Study|Unacceptable subjective vision|0
2956686|NCT01254747|10177960|P2|Overall Study|Unacceptable subjective vision|0
2956687|NCT01254747|10177961|P1|Overall Study|Unacceptable subjective vision|0
2956688|NCT01254721|10178001|P2|Overall Study|Wrongly randomization|1
2956689|NCT01254721|10178002|P1|Overall Study|Wrongly randomization|0
2956690|NCT01254721|10178001|P2|Overall Study|Withdrawal by Subject|11
2956691|NCT01254721|10178002|P1|Overall Study|Withdrawal by Subject|8
2956692|NCT01254721|10178001|P2|Overall Study|Adverse Event|3
2956693|NCT01254721|10178002|P1|Overall Study|Adverse Event|2
2956694|NCT01254721|10178001|P2|Overall Study|technical problum|0
2956695|NCT01254721|10178002|P1|Overall Study|technical problum|1
2956696|NCT01254721|10178001|P2|Overall Study|Death|1
2956697|NCT01254721|10178002|P1|Overall Study|Death|0
2956698|NCT01254721|10178001|P2|Overall Study|Lack of Efficacy|2
2956699|NCT01254721|10178002|P1|Overall Study|Lack of Efficacy|4
2956700|NCT01254721|10178001|P2|Overall Study|Lost to Follow-up|4
2956701|NCT01254721|10178002|P1|Overall Study|Lost to Follow-up|0
2956702|NCT01254669|10178012|P2|Overall Study|called to clinic during intervention|1
2956703|NCT01254669|10178013|P1|Overall Study|called to clinic during intervention|1
2956704|NCT01254669|10178012|P2|Overall Study|time constraint|2
2956705|NCT01254669|10178013|P1|Overall Study|time constraint|2
2956706|NCT01254669|10178012|P2|Overall Study|Withdrawal by Subject|1
2956707|NCT01254669|10178013|P1|Overall Study|Withdrawal by Subject|0
2956708|NCT01254656|10178024|P3|Overall Study|Death|0
2956709|NCT01254656|10178025|P2|Overall Study|Death|1
2956710|NCT01254656|10178026|P1|Overall Study|Death|0
2956711|NCT01254656|10178024|P3|Overall Study|Adverse Event|0
2956712|NCT01254656|10178025|P2|Overall Study|Adverse Event|1
2956713|NCT01254656|10178026|P1|Overall Study|Adverse Event|1
2956714|NCT01254656|10178024|P3|Overall Study|Pregnancy|2
2956715|NCT01254656|10178025|P2|Overall Study|Pregnancy|0
2956716|NCT01254656|10178026|P1|Overall Study|Pregnancy|0
2956717|NCT01254656|10178024|P3|Overall Study|Withdrawal by Subject|1
2956718|NCT01254656|10178025|P2|Overall Study|Withdrawal by Subject|2
2956719|NCT01254656|10178026|P1|Overall Study|Withdrawal by Subject|2
2956720|NCT01254656|10178024|P3|Overall Study|Lost to Follow-up|2
2956721|NCT01254656|10178025|P2|Overall Study|Lost to Follow-up|0
2956722|NCT01254656|10178026|P1|Overall Study|Lost to Follow-up|1
2956723|NCT01254656|10178024|P3|Overall Study|Lack of Efficacy|0
2956724|NCT01254656|10178025|P2|Overall Study|Lack of Efficacy|0
2956725|NCT01254656|10178026|P1|Overall Study|Lack of Efficacy|3
2956726|NCT01254656|10178024|P3|Overall Study|Discontinued due to termination of study|13
2956727|NCT01254656|10178025|P2|Overall Study|Discontinued due to termination of study|39
2956728|NCT01254656|10178026|P1|Overall Study|Discontinued due to termination of study|40
2956729|NCT01254643|10178052|P1|Overall Study|Withdrawal by Subject|1
2956730|NCT01254630|10178064|P4|Overall Study|Status not recorded|0
2956731|NCT01254630|10178065|P3|Overall Study|Status not recorded|1
2956732|NCT01254630|10178066|P2|Overall Study|Status not recorded|0
2956733|NCT01254630|10178067|P1|Overall Study|Status not recorded|0
2956734|NCT01254630|10178064|P4|Overall Study|Study terminated by sponsor|1010
2956735|NCT01254630|10178065|P3|Overall Study|Study terminated by sponsor|0
2956736|NCT01254630|10178066|P2|Overall Study|Study terminated by sponsor|994
2956737|NCT01254630|10178067|P1|Overall Study|Study terminated by sponsor|0
2956738|NCT01254630|10178064|P4|Overall Study|Withdrawal by Subject|89
2956739|NCT01254630|10178065|P3|Overall Study|Withdrawal by Subject|188
2956740|NCT01254630|10178066|P2|Overall Study|Withdrawal by Subject|94
2956741|NCT01254630|10178067|P1|Overall Study|Withdrawal by Subject|201
2956742|NCT01254630|10178064|P4|Overall Study|Physician Decision|7
2956743|NCT01254630|10178065|P3|Overall Study|Physician Decision|16
2956744|NCT01254630|10178066|P2|Overall Study|Physician Decision|8
2956745|NCT01254630|10178067|P1|Overall Study|Physician Decision|24
2956746|NCT01254630|10178064|P4|Overall Study|Lost to Follow-up|32
2956747|NCT01254630|10178065|P3|Overall Study|Lost to Follow-up|89
2956748|NCT01254630|10178066|P2|Overall Study|Lost to Follow-up|26
2956749|NCT01254630|10178067|P1|Overall Study|Lost to Follow-up|80
2956750|NCT01254630|10178064|P4|Overall Study|Death|139
2956751|NCT01254630|10178065|P3|Overall Study|Death|478
2956752|NCT01254630|10178066|P2|Overall Study|Death|151
2956753|NCT01254630|10178067|P1|Overall Study|Death|461
2956754|NCT01254630|10178064|P4|Overall Study|Adverse Event|8
2956755|NCT01254630|10178065|P3|Overall Study|Adverse Event|40
2956756|NCT01254630|10178066|P2|Overall Study|Adverse Event|15
2956757|NCT01254630|10178067|P1|Overall Study|Adverse Event|36
2956758|NCT01254604|10178087|P2|Overall Study|Adverse Event|2
2956759|NCT01254604|10178088|P1|Overall Study|Adverse Event|3
2956760|NCT01254604|10178087|P2|Overall Study|Withdrawal by Subject|4
2956761|NCT01254604|10178088|P1|Overall Study|Withdrawal by Subject|2
2956762|NCT01254604|10178087|P2|Overall Study|Protocol Violation|2
2956763|NCT01254604|10178088|P1|Overall Study|Protocol Violation|2
2956764|NCT01254604|10178087|P2|Overall Study|Lost to Follow-up|1
2956765|NCT01254604|10178088|P1|Overall Study|Lost to Follow-up|1
2956766|NCT01254565|10178106|P6|Overall Study|Other|0
2956767|NCT01254565|10178107|P5|Overall Study|Other|0
2956768|NCT01254565|10178108|P4|Overall Study|Other|1
2956769|NCT01254565|10178109|P3|Overall Study|Other|0
2956770|NCT01254565|10178110|P2|Overall Study|Other|0
2956771|NCT01254565|10178111|P1|Overall Study|Other|0
2956772|NCT01254565|10178106|P6|Overall Study|Did not Receive Treatment|4
2956773|NCT01254565|10178107|P5|Overall Study|Did not Receive Treatment|3
2956774|NCT01254565|10178108|P4|Overall Study|Did not Receive Treatment|0
2956775|NCT01254565|10178109|P3|Overall Study|Did not Receive Treatment|0
2956776|NCT01254565|10178110|P2|Overall Study|Did not Receive Treatment|1
2956777|NCT01254565|10178111|P1|Overall Study|Did not Receive Treatment|1
2956778|NCT01254565|10178106|P6|Overall Study|Non-compliance to Study Procedures|0
2956779|NCT01254565|10178107|P5|Overall Study|Non-compliance to Study Procedures|1
2956780|NCT01254565|10178108|P4|Overall Study|Non-compliance to Study Procedures|0
2956781|NCT01254565|10178109|P3|Overall Study|Non-compliance to Study Procedures|0
2956782|NCT01254565|10178110|P2|Overall Study|Non-compliance to Study Procedures|0
2956783|NCT01254565|10178111|P1|Overall Study|Non-compliance to Study Procedures|0
2956784|NCT01254422|10178171|P2|Overall Study|Lost to Follow-up|0
2956785|NCT01254422|10178172|P1|Overall Study|Lost to Follow-up|1
2956786|NCT01254422|10178171|P2|Overall Study|Serious adverse event|1
2956787|NCT01254422|10178172|P1|Overall Study|Serious adverse event|0
2956788|NCT01254422|10178171|P2|Overall Study|Adverse Event|0
2956789|NCT01254422|10178172|P1|Overall Study|Adverse Event|1
2956790|NCT01254422|10178171|P2|Overall Study|Protocol Violation|0
2956791|NCT01254422|10178172|P1|Overall Study|Protocol Violation|1
2956792|NCT01254409|10178200|P4|Overall Study|Adverse Event|0
2956793|NCT01254409|10178201|P3|Overall Study|Adverse Event|0
2956794|NCT01254409|10178202|P2|Overall Study|Adverse Event|1
2956795|NCT01254409|10178203|P1|Overall Study|Adverse Event|0
2956796|NCT01254344|10178272|P2|Overall Study|Withdrawal by Subject|6
2956797|NCT01254344|10178273|P1|Overall Study|Withdrawal by Subject|3
2956798|NCT01254344|10178272|P2|Overall Study|Protocol Violation|4
2956799|NCT01254344|10178273|P1|Overall Study|Protocol Violation|1
2956800|NCT01254344|10178272|P2|Overall Study|Physician Decision|4
2956801|NCT01254344|10178273|P1|Overall Study|Physician Decision|7
2956802|NCT01254344|10178272|P2|Overall Study|Adverse Event|5
2956803|NCT01254344|10178273|P1|Overall Study|Adverse Event|2
2956804|NCT01254331|10178281|P1|Extension Phase|Lost to Follow-up|3
2956805|NCT01254331|10178281|P1|Extension Phase|Lack of Efficacy|1
2956806|NCT01254331|10178281|P1|Initial Phase|Pregnancy|1
2956807|NCT01254331|10178281|P1|Initial Phase|Withdrawal by Subject|1
2956808|NCT01254331|10178281|P1|Initial Phase|Adverse Event|3
2956809|NCT01254318|10178299|P1|Overall Study|Death|47
2956810|NCT01254318|10178299|P1|Overall Study|Lost to Follow-up|5
2956811|NCT01254305|10178308|P3|Overall Study|Other Reasons|2
2956812|NCT01254305|10178309|P2|Overall Study|Other Reasons|0
2956813|NCT01254305|10178310|P1|Overall Study|Other Reasons|0
2956814|NCT01254305|10178308|P3|Overall Study|Lost to Follow-up|5
2956815|NCT01254305|10178309|P2|Overall Study|Lost to Follow-up|6
2956816|NCT01254305|10178310|P1|Overall Study|Lost to Follow-up|10
2956817|NCT01254305|10178308|P3|Overall Study|Withdrawal by Subject|4
2956818|NCT01254305|10178309|P2|Overall Study|Withdrawal by Subject|2
2956819|NCT01254305|10178310|P1|Overall Study|Withdrawal by Subject|4
2956820|NCT01254305|10178308|P3|Overall Study|Protocol Violation|3
2956821|NCT01254305|10178309|P2|Overall Study|Protocol Violation|7
2956822|NCT01254305|10178310|P1|Overall Study|Protocol Violation|1
2956823|NCT01254305|10178308|P3|Overall Study|Lack of Efficacy|1
2956824|NCT01254305|10178309|P2|Overall Study|Lack of Efficacy|0
2956825|NCT01254305|10178310|P1|Overall Study|Lack of Efficacy|1
2956826|NCT01254305|10178308|P3|Overall Study|Adverse Event|2
2956827|NCT01254305|10178309|P2|Overall Study|Adverse Event|3
2956828|NCT01254305|10178310|P1|Overall Study|Adverse Event|6
2956829|NCT01254292|10178326|P2|LCS12 Extension Phase|Lost to Follow-up|0
2956830|NCT01254292|10178327|P1|LCS12 Extension Phase|Lost to Follow-up|1
2956831|NCT01254292|10178326|P2|LCS12 Extension Phase|Pregnancy|0
2956832|NCT01254292|10178327|P1|LCS12 Extension Phase|Pregnancy|2
2956833|NCT01254292|10178326|P2|LCS12 Extension Phase|Other unknown|0
2956834|NCT01254292|10178327|P1|LCS12 Extension Phase|Other unknown|4
2956835|NCT01254292|10178326|P2|LCS12 Extension Phase|Withdrawal by Subject|0
2956836|NCT01254292|10178327|P1|LCS12 Extension Phase|Withdrawal by Subject|7
2956837|NCT01254292|10178326|P2|LCS12 Extension Phase|Adverse Event|0
2956838|NCT01254292|10178327|P1|LCS12 Extension Phase|Adverse Event|9
2956839|NCT01254292|10178326|P2|LCS12 Extension Phase|Wish for pregnancy|0
2956840|NCT01254292|10178327|P1|LCS12 Extension Phase|Wish for pregnancy|14
2956841|NCT01254292|10178326|P2|Comparative Phase|Wish for pregnancy|6
2956842|NCT01254292|10178327|P1|Comparative Phase|Wish for pregnancy|4
2956843|NCT01254292|10178326|P2|Comparative Phase|Protocol Violation|2
2956844|NCT01254292|10178327|P1|Comparative Phase|Protocol Violation|1
2956845|NCT01254292|10178326|P2|Comparative Phase|Withdrawal by Subject|21
2956846|NCT01254292|10178327|P1|Comparative Phase|Withdrawal by Subject|20
2956847|NCT01254292|10178326|P2|Comparative Phase|Pregnancy|6
2956848|NCT01254292|10178327|P1|Comparative Phase|Pregnancy|2
2956849|NCT01254292|10178326|P2|Comparative Phase|Lost to Follow-up|21
2956850|NCT01254292|10178327|P1|Comparative Phase|Lost to Follow-up|3
2956851|NCT01254292|10178326|P2|Comparative Phase|Adverse Event|25
2956852|NCT01254292|10178327|P1|Comparative Phase|Adverse Event|25
2956853|NCT01254188|10178404|P1|Overall Study|per investigator discretion|20
2956854|NCT01254188|10178404|P1|Overall Study|Adverse Event|43
2956855|NCT01254188|10178404|P1|Overall Study|Withdrawal by Subject|7
2956856|NCT01254188|10178404|P1|Overall Study|Lost to Follow-up|5
2956857|NCT01254188|10178404|P1|Overall Study|Death|4
2956858|NCT01254188|10178404|P1|Overall Study|Pregnancy|2
2956859|NCT01254188|10178404|P1|Overall Study|Protocol Violation|6
2956860|NCT01254188|10178404|P1|Overall Study|Disease Progression|6
2956861|NCT01254045|10178415|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2956862|NCT01254045|10178416|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2956863|NCT01254045|10178417|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2956864|NCT01254045|10178418|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2956865|NCT01254045|10178419|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2956866|NCT01254045|10178420|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
2956867|NCT01254019|10178433|P2|Overall Study|Withdrawal by Subject|2
2956868|NCT01254019|10178434|P1|Overall Study|Withdrawal by Subject|0
2956869|NCT01254019|10178433|P2|Overall Study|Protocol Violation|0
2956870|NCT01254019|10178434|P1|Overall Study|Protocol Violation|1
2956871|NCT01254019|10178433|P2|Overall Study|Adverse Event|2
2956872|NCT01254019|10178434|P1|Overall Study|Adverse Event|0
2956873|NCT01253811|10178528|P1|Overall Study|Withdrawal criteria|1
2956874|NCT01253577|10178559|P1|Overall Study|Lost to Follow-up|3
2956875|NCT01253564|10178567|P1|Overall Study|Serious Adverse Event|1
2956876|NCT01253564|10178567|P1|Overall Study|Withdrawal by Subject|1
2956877|NCT01253564|10178567|P1|Overall Study|Disease Progression|22
2956878|NCT01253447|10178616|P1|Overall Study|Adverse Event|2
2956879|NCT01253421|10178626|P5|Drug+Scanning Visit|Physician Decision|1
2956880|NCT01253421|10178627|P4|Drug+Scanning Visit|Physician Decision|0
2956881|NCT01253421|10178628|P3|Drug+Scanning Visit|Physician Decision|0
2956882|NCT01253421|10178629|P2|Drug+Scanning Visit|Physician Decision|0
2956883|NCT01253421|10178630|P1|Drug+Scanning Visit|Physician Decision|0
2956884|NCT01253421|10178626|P5|Assessment and Scheduling|Physician Decision|0
2956885|NCT01253421|10178627|P4|Assessment and Scheduling|Physician Decision|0
2956886|NCT01253421|10178628|P3|Assessment and Scheduling|Physician Decision|0
2956887|NCT01253421|10178629|P2|Assessment and Scheduling|Physician Decision|0
2956888|NCT01253421|10178630|P1|Assessment and Scheduling|Physician Decision|1
2956889|NCT01253421|10178626|P5|Assessment and Scheduling|Withdrawal by Subject|0
2956890|NCT01253421|10178627|P4|Assessment and Scheduling|Withdrawal by Subject|0
2956891|NCT01253421|10178628|P3|Assessment and Scheduling|Withdrawal by Subject|0
2956892|NCT01253421|10178629|P2|Assessment and Scheduling|Withdrawal by Subject|0
2956893|NCT01253421|10178630|P1|Assessment and Scheduling|Withdrawal by Subject|7
2956894|NCT01253421|10178626|P5|Assessment and Scheduling|Lost to Follow-up|0
2956895|NCT01253421|10178627|P4|Assessment and Scheduling|Lost to Follow-up|0
2956896|NCT01253421|10178628|P3|Assessment and Scheduling|Lost to Follow-up|0
2956897|NCT01253421|10178629|P2|Assessment and Scheduling|Lost to Follow-up|0
2956898|NCT01253421|10178630|P1|Assessment and Scheduling|Lost to Follow-up|17
2956899|NCT01253421|10178626|P5|Assessment and Scheduling|Found to be Ineligible|0
2956900|NCT01253421|10178627|P4|Assessment and Scheduling|Found to be Ineligible|0
2956901|NCT01253421|10178628|P3|Assessment and Scheduling|Found to be Ineligible|0
2956902|NCT01253421|10178629|P2|Assessment and Scheduling|Found to be Ineligible|0
2956903|NCT01253421|10178630|P1|Assessment and Scheduling|Found to be Ineligible|74
2956904|NCT01253408|10178679|P3|Overall Study|Adverse Event|0
2956905|NCT01253408|10178680|P2|Overall Study|Adverse Event|1
2956906|NCT01253408|10178681|P1|Overall Study|Adverse Event|0
2956907|NCT01253369|10178704|P1|Overall Study|Not Evaluable|3
2956908|NCT01253369|10178704|P1|Overall Study|Progressive disease|23
2956909|NCT01253369|10178704|P1|Overall Study|Death|1
2956910|NCT01253369|10178704|P1|Overall Study|Withdrawal by Subject|2
2956911|NCT01253369|10178704|P1|Overall Study|Adverse Event|4
2956912|NCT01253317|10178734|P1|Overall Study|Adverse Event|2
2956913|NCT01253304|10178746|P4|Overall Study|Adverse Event|1
2956914|NCT01253304|10178747|P3|Overall Study|Adverse Event|0
2956915|NCT01253304|10178748|P2|Overall Study|Adverse Event|0
2956916|NCT01253304|10178749|P1|Overall Study|Adverse Event|0
2956917|NCT01253291|10178788|P5|Overall Study|Physician Decision|2
2956918|NCT01253291|10178789|P4|Overall Study|Physician Decision|0
2956919|NCT01253291|10178790|P3|Overall Study|Physician Decision|0
2956920|NCT01253291|10178791|P2|Overall Study|Physician Decision|0
2956921|NCT01253291|10178792|P1|Overall Study|Physician Decision|2
2956922|NCT01253291|10178788|P5|Overall Study|Lack of Efficacy|0
2956923|NCT01253291|10178789|P4|Overall Study|Lack of Efficacy|0
2956924|NCT01253291|10178790|P3|Overall Study|Lack of Efficacy|0
2956925|NCT01253291|10178791|P2|Overall Study|Lack of Efficacy|0
2956926|NCT01253291|10178792|P1|Overall Study|Lack of Efficacy|1
2956927|NCT01253291|10178788|P5|Overall Study|Adverse Event|0
2956928|NCT01253291|10178789|P4|Overall Study|Adverse Event|0
2956929|NCT01253291|10178790|P3|Overall Study|Adverse Event|0
2956930|NCT01253291|10178791|P2|Overall Study|Adverse Event|1
2956931|NCT01253291|10178792|P1|Overall Study|Adverse Event|0
2956932|NCT01253291|10178788|P5|Overall Study|Withdrawal by Subject|0
2956933|NCT01253291|10178789|P4|Overall Study|Withdrawal by Subject|0
2956934|NCT01253291|10178790|P3|Overall Study|Withdrawal by Subject|0
2956935|NCT01253291|10178791|P2|Overall Study|Withdrawal by Subject|1
2956936|NCT01253291|10178792|P1|Overall Study|Withdrawal by Subject|1
2956937|NCT01253265|10178816|P5|Overall Study|Withdrawal by Subject|1
2956938|NCT01253265|10178817|P4|Overall Study|Withdrawal by Subject|0
2956939|NCT01253265|10178818|P3|Overall Study|Withdrawal by Subject|0
2956940|NCT01253265|10178819|P2|Overall Study|Withdrawal by Subject|0
2956941|NCT01253265|10178820|P1|Overall Study|Withdrawal by Subject|0
2956942|NCT01253265|10178816|P5|Overall Study|Met Predefined Discontinuation Criteria|0
2956943|NCT01253265|10178817|P4|Overall Study|Met Predefined Discontinuation Criteria|0
2956944|NCT01253265|10178818|P3|Overall Study|Met Predefined Discontinuation Criteria|0
2956945|NCT01253265|10178819|P2|Overall Study|Met Predefined Discontinuation Criteria|0
2956946|NCT01253265|10178820|P1|Overall Study|Met Predefined Discontinuation Criteria|1
2956947|NCT01253226|10178869|P5|Overall Study|Withdrawal by Subject|0
2956948|NCT01253226|10178870|P4|Overall Study|Withdrawal by Subject|1
2956949|NCT01253226|10178871|P3|Overall Study|Withdrawal by Subject|0
2956950|NCT01253226|10178872|P2|Overall Study|Withdrawal by Subject|0
2956951|NCT01253226|10178873|P1|Overall Study|Withdrawal by Subject|0
2956952|NCT01253226|10178869|P5|Overall Study|Physician Decision|2
2956953|NCT01253226|10178870|P4|Overall Study|Physician Decision|0
2956954|NCT01253226|10178871|P3|Overall Study|Physician Decision|0
2956955|NCT01253226|10178872|P2|Overall Study|Physician Decision|0
2956956|NCT01253226|10178873|P1|Overall Study|Physician Decision|0
2956957|NCT01253226|10178869|P5|Overall Study|Death|0
2956958|NCT01253226|10178870|P4|Overall Study|Death|0
2956959|NCT01253226|10178871|P3|Overall Study|Death|0
2956960|NCT01253226|10178872|P2|Overall Study|Death|1
2956961|NCT01253226|10178873|P1|Overall Study|Death|0
2956962|NCT01253226|10178869|P5|Overall Study|Adverse Event|0
2956963|NCT01253226|10178870|P4|Overall Study|Adverse Event|0
2956964|NCT01253226|10178871|P3|Overall Study|Adverse Event|1
2956965|NCT01253226|10178872|P2|Overall Study|Adverse Event|0
2956966|NCT01253226|10178873|P1|Overall Study|Adverse Event|0
2956967|NCT01253200|10178933|P5|Overall Study|Attempts|0
2956968|NCT01253200|10178934|P4|Overall Study|Attempts|2
2956969|NCT01253200|10178935|P3|Overall Study|Attempts|1
2956970|NCT01253200|10178936|P2|Overall Study|Attempts|4
2956971|NCT01253200|10178937|P1|Overall Study|Attempts|6
2956972|NCT01253200|10178933|P5|Overall Study|intents|0
2956973|NCT01253200|10178934|P4|Overall Study|intents|3
2956974|NCT01253200|10178935|P3|Overall Study|intents|1
2956975|NCT01253200|10178936|P2|Overall Study|intents|10
2956976|NCT01253200|10178937|P1|Overall Study|intents|10
2956977|NCT01253200|10178933|P5|Overall Study|Protocol Violation|5
2956978|NCT01253200|10178934|P4|Overall Study|Protocol Violation|0
2956979|NCT01253200|10178935|P3|Overall Study|Protocol Violation|0
2956980|NCT01253200|10178936|P2|Overall Study|Protocol Violation|4
2956981|NCT01253200|10178937|P1|Overall Study|Protocol Violation|1
2956982|NCT01253200|10178933|P5|Overall Study|Withdrawal by Subject|0
2956983|NCT01253200|10178934|P4|Overall Study|Withdrawal by Subject|0
2956984|NCT01253200|10178935|P3|Overall Study|Withdrawal by Subject|0
2956985|NCT01253200|10178936|P2|Overall Study|Withdrawal by Subject|0
2956986|NCT01253200|10178937|P1|Overall Study|Withdrawal by Subject|2
2956987|NCT01253200|10178933|P5|Overall Study|Lost to Follow-up|0
2956988|NCT01253200|10178934|P4|Overall Study|Lost to Follow-up|0
2956989|NCT01253200|10178935|P3|Overall Study|Lost to Follow-up|0
2956990|NCT01253200|10178936|P2|Overall Study|Lost to Follow-up|1
2956991|NCT01253200|10178937|P1|Overall Study|Lost to Follow-up|1
2956992|NCT01253200|10178933|P5|Overall Study|Death|0
2956993|NCT01253200|10178934|P4|Overall Study|Death|0
2956994|NCT01253200|10178935|P3|Overall Study|Death|0
2956995|NCT01253200|10178936|P2|Overall Study|Death|0
2956996|NCT01253200|10178937|P1|Overall Study|Death|1
2956997|NCT01253187|10178952|P6|Period 3|non-compliance|0
2956998|NCT01253187|10178953|P5|Period 3|non-compliance|1
2956999|NCT01253187|10178954|P4|Period 3|non-compliance|0
2957000|NCT01253187|10178955|P3|Period 3|non-compliance|0
2957001|NCT01253187|10178956|P2|Period 3|non-compliance|0
2957002|NCT01253187|10178957|P1|Period 3|non-compliance|0
2957003|NCT01253187|10178952|P6|Period 3|difficulty with blood sampling|0
2957004|NCT01253187|10178953|P5|Period 3|difficulty with blood sampling|0
2957005|NCT01253187|10178954|P4|Period 3|difficulty with blood sampling|0
2957006|NCT01253187|10178955|P3|Period 3|difficulty with blood sampling|0
2957007|NCT01253187|10178956|P2|Period 3|difficulty with blood sampling|1
2957008|NCT01253187|10178957|P1|Period 3|difficulty with blood sampling|0
2957009|NCT01253187|10178952|P6|Period 3|Pregnancy|0
2957010|NCT01253187|10178953|P5|Period 3|Pregnancy|0
2957011|NCT01253187|10178954|P4|Period 3|Pregnancy|0
2957012|NCT01253187|10178955|P3|Period 3|Pregnancy|0
2957013|NCT01253187|10178956|P2|Period 3|Pregnancy|0
2957014|NCT01253187|10178957|P1|Period 3|Pregnancy|1
2957015|NCT01253187|10178952|P6|Period 2|Withdrawal by Subject|0
2957016|NCT01253187|10178953|P5|Period 2|Withdrawal by Subject|1
2957017|NCT01253187|10178954|P4|Period 2|Withdrawal by Subject|0
2957018|NCT01253187|10178955|P3|Period 2|Withdrawal by Subject|0
2957019|NCT01253187|10178956|P2|Period 2|Withdrawal by Subject|0
2957020|NCT01253187|10178957|P1|Period 2|Withdrawal by Subject|0
2957021|NCT01253174|10178986|P6|Period 3|Pregnancy|0
2957022|NCT01253174|10178987|P5|Period 3|Pregnancy|0
2957023|NCT01253174|10178988|P4|Period 3|Pregnancy|0
2957024|NCT01253174|10178989|P3|Period 3|Pregnancy|1
2957025|NCT01253174|10178990|P2|Period 3|Pregnancy|0
2957026|NCT01253174|10178991|P1|Period 3|Pregnancy|0
2957027|NCT01253174|10178986|P6|Period 3|Withdrawal by Subject|0
2957028|NCT01253174|10178987|P5|Period 3|Withdrawal by Subject|1
2957029|NCT01253174|10178988|P4|Period 3|Withdrawal by Subject|0
2957030|NCT01253174|10178989|P3|Period 3|Withdrawal by Subject|0
2957031|NCT01253174|10178990|P2|Period 3|Withdrawal by Subject|1
2957032|NCT01253174|10178991|P1|Period 3|Withdrawal by Subject|0
2957033|NCT01253174|10178986|P6|Period 2|Adverse Event|0
2957034|NCT01253174|10178987|P5|Period 2|Adverse Event|0
2957035|NCT01253174|10178988|P4|Period 2|Adverse Event|0
2957036|NCT01253174|10178989|P3|Period 2|Adverse Event|1
2957037|NCT01253174|10178990|P2|Period 2|Adverse Event|0
2957038|NCT01253174|10178991|P1|Period 2|Adverse Event|0
2957039|NCT01253174|10178986|P6|Period 1|Randomized but not treated|0
2957040|NCT01253174|10178987|P5|Period 1|Randomized but not treated|1
2957041|NCT01253174|10178988|P4|Period 1|Randomized but not treated|0
2957042|NCT01253174|10178989|P3|Period 1|Randomized but not treated|1
2957043|NCT01253174|10178990|P2|Period 1|Randomized but not treated|1
2957044|NCT01253174|10178991|P1|Period 1|Randomized but not treated|0
2957045|NCT01253135|10179026|P1|Amended Protocol|Non-compliance|1
2957046|NCT01253135|10179026|P1|Original Protocol|Protocol Amendment|15
2957047|NCT01253044|10179045|P2|Overall Study|Lost to Follow-up|29
2957048|NCT01253044|10179046|P1|Overall Study|Lost to Follow-up|38
2957049|NCT01253018|10179056|P2|Overall Study|Withdrawal by Subject|1
2957050|NCT01253018|10179057|P1|Overall Study|Withdrawal by Subject|1
2957051|NCT01253018|10179056|P2|Overall Study|Robot Repair Issues|0
2957052|NCT01253018|10179057|P1|Overall Study|Robot Repair Issues|2
2957053|NCT01253018|10179056|P2|Overall Study|Lost to Follow-up|1
2957054|NCT01253018|10179057|P1|Overall Study|Lost to Follow-up|1
2957055|NCT01252966|10179071|P2|Overall Study|Withdrawal by Subject|3
2957056|NCT01252966|10179072|P1|Overall Study|Withdrawal by Subject|7
2957057|NCT01252966|10179071|P2|Overall Study|Lost to Follow-up|10
2957058|NCT01252966|10179072|P1|Overall Study|Lost to Follow-up|16
2957059|NCT01252953|10179088|P2|Overall Study|Lost to Follow-up|21
2957060|NCT01252953|10179089|P1|Overall Study|Lost to Follow-up|22
2957061|NCT01252953|10179088|P2|Overall Study|Withdrawal by Subject|17
2957062|NCT01252953|10179089|P1|Overall Study|Withdrawal by Subject|16
2957063|NCT01252940|10179103|P2|Extension Phase|Withdrawal by Subject|1
2957064|NCT01252940|10179104|P1|Extension Phase|Withdrawal by Subject|1
2957065|NCT01252940|10179103|P2|Extension Phase|Subject Non-compliance|0
2957066|NCT01252940|10179104|P1|Extension Phase|Subject Non-compliance|1
2957067|NCT01252940|10179103|P2|Extension Phase|Physician Decision|1
2957068|NCT01252940|10179104|P1|Extension Phase|Physician Decision|0
2957069|NCT01252940|10179103|P2|Extension Phase|Lost to Follow-up|0
2957070|NCT01252940|10179104|P1|Extension Phase|Lost to Follow-up|5
2957071|NCT01252940|10179103|P2|Extension Phase|Lack of Efficacy|0
2957072|NCT01252940|10179104|P1|Extension Phase|Lack of Efficacy|1
2957073|NCT01252940|10179103|P2|Extension Phase|Adverse Event|1
2957074|NCT01252940|10179104|P1|Extension Phase|Adverse Event|2
2957075|NCT01252940|10179103|P2|Main Study Phase|Subject Non-compliance|1
2957076|NCT01252940|10179104|P1|Main Study Phase|Subject Non-compliance|1
2957077|NCT01252940|10179103|P2|Main Study Phase|Withdrawal by Subject|5
2957078|NCT01252940|10179104|P1|Main Study Phase|Withdrawal by Subject|6
2957079|NCT01252940|10179103|P2|Main Study Phase|Protocol Violation|2
2957080|NCT01252940|10179104|P1|Main Study Phase|Protocol Violation|4
2957081|NCT01252940|10179103|P2|Main Study Phase|Physician Decision|0
2957082|NCT01252940|10179104|P1|Main Study Phase|Physician Decision|1
2957083|NCT01252940|10179103|P2|Main Study Phase|Lost to Follow-up|1
2957084|NCT01252940|10179104|P1|Main Study Phase|Lost to Follow-up|6
2957085|NCT01252940|10179103|P2|Main Study Phase|Lack of Efficacy|0
2957086|NCT01252940|10179104|P1|Main Study Phase|Lack of Efficacy|1
2957087|NCT01252940|10179103|P2|Main Study Phase|Adverse Event|1
2957088|NCT01252940|10179104|P1|Main Study Phase|Adverse Event|3
2957089|NCT01252940|10179103|P2|Main Study Phase|Randomized but not treated|2
2957090|NCT01252940|10179104|P1|Main Study Phase|Randomized but not treated|4
2957091|NCT01252810|10179135|P2|Overall Study|Various reasons|0
2957092|NCT01252810|10179136|P1|Overall Study|Various reasons|8
2957093|NCT01252810|10179135|P2|Overall Study|Physician Decision|1
2957094|NCT01252810|10179136|P1|Overall Study|Physician Decision|2
2957095|NCT01252810|10179135|P2|Overall Study|Lost to Follow-up|1
2957096|NCT01252810|10179136|P1|Overall Study|Lost to Follow-up|0
2957097|NCT01252810|10179135|P2|Overall Study|Withdrawal by Subject|1
2957098|NCT01252810|10179136|P1|Overall Study|Withdrawal by Subject|4
2957099|NCT01252667|10179171|P6|Overall Study|Transplant aborted post-conditioning|1
2957100|NCT01252667|10179172|P5|Overall Study|Transplant aborted post-conditioning|0
2957101|NCT01252667|10179173|P4|Overall Study|Transplant aborted post-conditioning|0
2957102|NCT01252667|10179174|P3|Overall Study|Transplant aborted post-conditioning|0
2957103|NCT01252667|10179175|P2|Overall Study|Transplant aborted post-conditioning|0
2957104|NCT01252667|10179176|P1|Overall Study|Transplant aborted post-conditioning|0
2957105|NCT01252563|10179238|P1|Overall Study|No drug administration|6
2957106|NCT01252563|10179238|P1|Overall Study|No visit after first day of treatment|194
2957107|NCT01252563|10179238|P1|Overall Study|Lost to Follow-up|161
2957108|NCT01252563|10179238|P1|Overall Study|Centralized Registration Deviation|30
2957109|NCT01252563|10179238|P1|Overall Study|Contract Deviation|41
2957110|NCT01252355|10179278|P3|Overall Study|Other Than Above|7
2957111|NCT01252355|10179279|P2|Overall Study|Other Than Above|7
2957112|NCT01252355|10179280|P1|Overall Study|Other Than Above|8
2957113|NCT01252355|10179278|P3|Overall Study|Randomized but not Treated|0
2957114|NCT01252355|10179279|P2|Overall Study|Randomized but not Treated|0
2957115|NCT01252355|10179280|P1|Overall Study|Randomized but not Treated|2
2957116|NCT01252355|10179278|P3|Overall Study|Sponsor Early Termination of Study|146
2957117|NCT01252355|10179279|P2|Overall Study|Sponsor Early Termination of Study|149
2957118|NCT01252355|10179280|P1|Overall Study|Sponsor Early Termination of Study|149
2957119|NCT01252355|10179278|P3|Overall Study|Progressive Disease|0
2957120|NCT01252355|10179279|P2|Overall Study|Progressive Disease|0
2957121|NCT01252355|10179280|P1|Overall Study|Progressive Disease|2
2957122|NCT01252355|10179278|P3|Overall Study|Poor Compliance to Protocol|1
2957123|NCT01252355|10179279|P2|Overall Study|Poor Compliance to Protocol|1
2957124|NCT01252355|10179280|P1|Overall Study|Poor Compliance to Protocol|1
2957125|NCT01252355|10179278|P3|Overall Study|Lost to Follow-up|1
2957126|NCT01252355|10179279|P2|Overall Study|Lost to Follow-up|0
2957127|NCT01252355|10179280|P1|Overall Study|Lost to Follow-up|0
2957128|NCT01252355|10179278|P3|Overall Study|Lack of Efficacy|2
2957129|NCT01252355|10179279|P2|Overall Study|Lack of Efficacy|4
2957130|NCT01252355|10179280|P1|Overall Study|Lack of Efficacy|6
2957131|NCT01252355|10179278|P3|Overall Study|Adverse Event|22
2957132|NCT01252355|10179279|P2|Overall Study|Adverse Event|17
2957133|NCT01252355|10179280|P1|Overall Study|Adverse Event|9
2957134|NCT01252290|10179318|P1|Overall Study|Withdrawal by Subject|1
2957135|NCT01252251|10179334|P1|Overall Study|Withdrawal by Subject|1
2957136|NCT01252238|10179346|P3|Overall Study|Sponsor terminated study|4
2957137|NCT01252238|10179347|P2|Overall Study|Sponsor terminated study|4
2957138|NCT01252238|10179348|P1|Overall Study|Sponsor terminated study|4
2957139|NCT01252186|10179365|P3|Overall Study|Other - Miscellaneous Reasons|7
2957140|NCT01252186|10179366|P2|Overall Study|Other - Miscellaneous Reasons|5
2957141|NCT01252186|10179367|P1|Overall Study|Other - Miscellaneous Reasons|5
2957142|NCT01252186|10179365|P3|Overall Study|Lost to Follow-up|11
2957143|NCT01252186|10179366|P2|Overall Study|Lost to Follow-up|10
2957144|NCT01252186|10179367|P1|Overall Study|Lost to Follow-up|10
2957145|NCT01252186|10179365|P3|Overall Study|Sponsor Request|0
2957146|NCT01252186|10179366|P2|Overall Study|Sponsor Request|1
2957147|NCT01252186|10179367|P1|Overall Study|Sponsor Request|2
2957148|NCT01252186|10179365|P3|Overall Study|Pregnancy|0
2957149|NCT01252186|10179366|P2|Overall Study|Pregnancy|2
2957150|NCT01252186|10179367|P1|Overall Study|Pregnancy|2
2957151|NCT01252186|10179365|P3|Overall Study|Protocol Violation|1
2957152|NCT01252186|10179366|P2|Overall Study|Protocol Violation|0
2957153|NCT01252186|10179367|P1|Overall Study|Protocol Violation|0
2957154|NCT01252186|10179365|P3|Overall Study|Non-compliance|4
2957155|NCT01252186|10179366|P2|Overall Study|Non-compliance|3
2957156|NCT01252186|10179367|P1|Overall Study|Non-compliance|0
2957157|NCT01252186|10179365|P3|Overall Study|Physician Decision|1
2957158|NCT01252186|10179366|P2|Overall Study|Physician Decision|0
2957159|NCT01252186|10179367|P1|Overall Study|Physician Decision|0
2957160|NCT01252186|10179365|P3|Overall Study|Withdrawal by Subject|2
2957161|NCT01252186|10179366|P2|Overall Study|Withdrawal by Subject|5
2957162|NCT01252186|10179367|P1|Overall Study|Withdrawal by Subject|2
2957163|NCT01252186|10179365|P3|Overall Study|Adverse Event|8
2957164|NCT01252186|10179366|P2|Overall Study|Adverse Event|6
2957165|NCT01252186|10179367|P1|Overall Study|Adverse Event|9
2957166|NCT01252134|10179440|P6|Period 1, 8 Hours|Personal Reasons|0
2957167|NCT01252134|10179441|P5|Period 1, 8 Hours|Personal Reasons|0
2957168|NCT01252134|10179442|P4|Period 1, 8 Hours|Personal Reasons|0
2957169|NCT01252134|10179443|P3|Period 1, 8 Hours|Personal Reasons|1
2957170|NCT01252134|10179444|P2|Period 1, 8 Hours|Personal Reasons|1
2957171|NCT01252134|10179445|P1|Period 1, 8 Hours|Personal Reasons|0
2957172|NCT01252095|10179464|P2|Overall Study|Disease progression|0
2957173|NCT01252095|10179465|P1|Overall Study|Disease progression|1
2957174|NCT01251965|10179486|P3|Overall Study|Death|11
2957175|NCT01251965|10179487|P2|Overall Study|Death|0
2957176|NCT01251965|10179488|P1|Overall Study|Death|0
2957177|NCT01251965|10179486|P3|Overall Study|Participant/physician decision|0
2957178|NCT01251965|10179487|P2|Overall Study|Participant/physician decision|2
2957179|NCT01251965|10179488|P1|Overall Study|Participant/physician decision|1
2957180|NCT01251952|10179500|P1|Overall Study|Adverse Event|1
2957181|NCT01251861|10179506|P2|Overall Study|Potential interaction of drugs|1
2957182|NCT01251861|10179507|P1|Overall Study|Potential interaction of drugs|0
2957183|NCT01251861|10179506|P2|Overall Study|Never started therapy|1
2957184|NCT01251861|10179507|P1|Overall Study|Never started therapy|4
2957185|NCT01251861|10179506|P2|Overall Study|Other|0
2957186|NCT01251861|10179507|P1|Overall Study|Other|1
2957187|NCT01251861|10179506|P2|Overall Study|Continued treatment beyond 18 cycles|0
2957188|NCT01251861|10179507|P1|Overall Study|Continued treatment beyond 18 cycles|1
2957189|NCT01251861|10179506|P2|Overall Study|Physician Decision|0
2957190|NCT01251861|10179507|P1|Overall Study|Physician Decision|1
2957191|NCT01251861|10179506|P2|Overall Study|Other complicating disease|1
2957192|NCT01251861|10179507|P1|Overall Study|Other complicating disease|0
2957193|NCT01251861|10179506|P2|Overall Study|Alternative therapy|0
2957194|NCT01251861|10179507|P1|Overall Study|Alternative therapy|1
2957195|NCT01251861|10179506|P2|Overall Study|Withdrawal by Subject|2
2957196|NCT01251861|10179507|P1|Overall Study|Withdrawal by Subject|2
2957197|NCT01251861|10179506|P2|Overall Study|Adverse Event|17
2957198|NCT01251861|10179507|P1|Overall Study|Adverse Event|2
2957199|NCT01251861|10179506|P2|Overall Study|Disease progression|6
2957200|NCT01251861|10179507|P1|Overall Study|Disease progression|6
2957201|NCT01251770|10179535|P2|Overall Study|Protocol Violation|7
2957202|NCT01251770|10179536|P1|Overall Study|Protocol Violation|13
2957203|NCT01251744|10179580|P2|Overall Study|Lost to Follow-up|0
2957204|NCT01251744|10179581|P1|Overall Study|Lost to Follow-up|1
2957205|NCT01251653|10179639|P9|Overall Study|Other reason not mentioned above|0
2957206|NCT01251653|10179640|P8|Overall Study|Other reason not mentioned above|2
2957207|NCT01251653|10179641|P7|Overall Study|Other reason not mentioned above|0
2957208|NCT01251653|10179642|P6|Overall Study|Other reason not mentioned above|0
2957209|NCT01251653|10179643|P5|Overall Study|Other reason not mentioned above|0
2957210|NCT01251653|10179644|P4|Overall Study|Other reason not mentioned above|0
2957211|NCT01251653|10179645|P3|Overall Study|Other reason not mentioned above|0
2957212|NCT01251653|10179646|P2|Overall Study|Other reason not mentioned above|0
2957213|NCT01251653|10179647|P1|Overall Study|Other reason not mentioned above|0
2957214|NCT01251653|10179639|P9|Overall Study|Withdrawal by Subject|0
2957215|NCT01251653|10179640|P8|Overall Study|Withdrawal by Subject|1
2957216|NCT01251653|10179641|P7|Overall Study|Withdrawal by Subject|0
2957217|NCT01251653|10179642|P6|Overall Study|Withdrawal by Subject|1
2957218|NCT01251653|10179643|P5|Overall Study|Withdrawal by Subject|1
2957219|NCT01251653|10179644|P4|Overall Study|Withdrawal by Subject|0
2957220|NCT01251653|10179645|P3|Overall Study|Withdrawal by Subject|1
2957221|NCT01251653|10179646|P2|Overall Study|Withdrawal by Subject|0
2957222|NCT01251653|10179647|P1|Overall Study|Withdrawal by Subject|1
2957223|NCT01251653|10179639|P9|Overall Study|Adverse Event|1
2957224|NCT01251653|10179640|P8|Overall Study|Adverse Event|2
2957225|NCT01251653|10179641|P7|Overall Study|Adverse Event|2
2957226|NCT01251653|10179642|P6|Overall Study|Adverse Event|0
2957227|NCT01251653|10179643|P5|Overall Study|Adverse Event|1
2957228|NCT01251653|10179644|P4|Overall Study|Adverse Event|1
2957229|NCT01251653|10179645|P3|Overall Study|Adverse Event|2
2957230|NCT01251653|10179646|P2|Overall Study|Adverse Event|0
2957231|NCT01251653|10179647|P1|Overall Study|Adverse Event|1
2957232|NCT01251653|10179639|P9|Overall Study|Dose-limiting toxicity|0
2957233|NCT01251653|10179640|P8|Overall Study|Dose-limiting toxicity|0
2957234|NCT01251653|10179641|P7|Overall Study|Dose-limiting toxicity|2
2957235|NCT01251653|10179642|P6|Overall Study|Dose-limiting toxicity|0
2957236|NCT01251653|10179643|P5|Overall Study|Dose-limiting toxicity|0
2957237|NCT01251653|10179644|P4|Overall Study|Dose-limiting toxicity|1
2957238|NCT01251653|10179645|P3|Overall Study|Dose-limiting toxicity|1
2957239|NCT01251653|10179646|P2|Overall Study|Dose-limiting toxicity|1
2957240|NCT01251653|10179647|P1|Overall Study|Dose-limiting toxicity|0
2957241|NCT01251653|10179639|P9|Overall Study|Progressive Disease|5
2957242|NCT01251653|10179640|P8|Overall Study|Progressive Disease|7
2957243|NCT01251653|10179641|P7|Overall Study|Progressive Disease|14
2957244|NCT01251653|10179642|P6|Overall Study|Progressive Disease|17
2957245|NCT01251653|10179643|P5|Overall Study|Progressive Disease|0
2957246|NCT01251653|10179644|P4|Overall Study|Progressive Disease|4
2957247|NCT01251653|10179645|P3|Overall Study|Progressive Disease|16
2957248|NCT01251653|10179646|P2|Overall Study|Progressive Disease|7
2957249|NCT01251653|10179647|P1|Overall Study|Progressive Disease|1
2957250|NCT01251614|10179775|P3|Overall Study|Lost to Follow-up|0
2957251|NCT01251614|10179776|P2|Overall Study|Lost to Follow-up|1
2957252|NCT01251614|10179777|P1|Overall Study|Lost to Follow-up|0
2957253|NCT01251614|10179775|P3|Overall Study|Withdrawal by Subject|1
2957254|NCT01251614|10179776|P2|Overall Study|Withdrawal by Subject|2
2957255|NCT01251614|10179777|P1|Overall Study|Withdrawal by Subject|0
2957256|NCT01251614|10179775|P3|Overall Study|Loss of Disease Control|0
2957257|NCT01251614|10179776|P2|Overall Study|Loss of Disease Control|1
2957258|NCT01251614|10179777|P1|Overall Study|Loss of Disease Control|0
2957259|NCT01251614|10179775|P3|Overall Study|Pregnancy|2
2957260|NCT01251614|10179776|P2|Overall Study|Pregnancy|0
2957261|NCT01251614|10179777|P1|Overall Study|Pregnancy|0
2957262|NCT01251614|10179775|P3|Overall Study|Clearing of Psoriatic Lesions|0
2957263|NCT01251614|10179776|P2|Overall Study|Clearing of Psoriatic Lesions|0
2957264|NCT01251614|10179777|P1|Overall Study|Clearing of Psoriatic Lesions|1
2957265|NCT01251614|10179775|P3|Overall Study|Lack of Efficacy|4
2957266|NCT01251614|10179776|P2|Overall Study|Lack of Efficacy|9
2957267|NCT01251614|10179777|P1|Overall Study|Lack of Efficacy|1
2957268|NCT01251614|10179775|P3|Overall Study|Adverse Event|1
2957269|NCT01251614|10179776|P2|Overall Study|Adverse Event|0
2957270|NCT01251614|10179777|P1|Overall Study|Adverse Event|1
2957271|NCT01251380|10179975|P1|Overall Study|Lost to Follow-up|2
2957272|NCT01251380|10179975|P1|Overall Study|Adverse Event|1
2957273|NCT01251380|10179975|P1|Overall Study|Lack of Efficacy|1
2957274|NCT01251380|10179975|P1|Overall Study|Withdrawal by Subject|6
2957275|NCT01251380|10179975|P1|Overall Study|Other (Not otherwise specified)|12
2957276|NCT01251367|10179999|P1|Overall Study|End of Study Visit Performed in Error|1
2957277|NCT01251367|10179999|P1|Overall Study|Subject had Personal or Medical Issues|4
2957278|NCT01251367|10179999|P1|Overall Study|No Study Drug Available|1
2957279|NCT01251367|10179999|P1|Overall Study|Subject Required Alternative Treatment|7
2957280|NCT01251367|10179999|P1|Overall Study|Lost to Follow-up|5
2957281|NCT01251367|10179999|P1|Overall Study|Withdrawal by Subject|36
2957282|NCT01251367|10179999|P1|Overall Study|Adverse Event|19
2957283|NCT01251367|10179999|P1|Overall Study|Lack of Efficacy|2
2957284|NCT01251367|10179999|P1|Overall Study|Protocol Violation|1
2957285|NCT01251354|10180034|P1|Overall Study|Disease Progression|4
2957286|NCT01251354|10180034|P1|Overall Study|Investigator's Decision|1
2957287|NCT01251354|10180034|P1|Overall Study|Adverse Event|1
2957288|NCT01251276|10180077|P2|Overall Study|Lost to Follow-up|1
2957289|NCT01251276|10180078|P1|Overall Study|Lost to Follow-up|0
2957290|NCT01251276|10180077|P2|Overall Study|Protocol Violation|0
2957291|NCT01251276|10180078|P1|Overall Study|Protocol Violation|1
2957292|NCT01251146|10180096|P2|Overall Study|Lost to Follow-up|10
2957293|NCT01251146|10180097|P1|Overall Study|Lost to Follow-up|3
2957294|NCT01251120|10180119|P2|Overall Study|Lack of Efficacy|1
2957295|NCT01251120|10180120|P1|Overall Study|Lack of Efficacy|0
2957296|NCT01250925|10180200|P3|Overall Study|Adverse Event|1
2957297|NCT01250925|10180201|P2|Overall Study|Adverse Event|0
2957298|NCT01250925|10180202|P1|Overall Study|Adverse Event|0
2957299|NCT01250925|10180200|P3|Overall Study|Physician Decision|1
2957300|NCT01250925|10180201|P2|Overall Study|Physician Decision|2
2957301|NCT01250925|10180202|P1|Overall Study|Physician Decision|0
2957302|NCT01250925|10180200|P3|Overall Study|Protocol Violation|0
2957303|NCT01250925|10180201|P2|Overall Study|Protocol Violation|0
2957304|NCT01250925|10180202|P1|Overall Study|Protocol Violation|2
2957305|NCT01250925|10180200|P3|Overall Study|Withdrawal by Subject|0
2957306|NCT01250925|10180201|P2|Overall Study|Withdrawal by Subject|0
2957307|NCT01250925|10180202|P1|Overall Study|Withdrawal by Subject|2
2957308|NCT01250925|10180200|P3|Overall Study|Lost to Follow-up|0
2957309|NCT01250925|10180201|P2|Overall Study|Lost to Follow-up|1
2957310|NCT01250925|10180202|P1|Overall Study|Lost to Follow-up|1
2957311|NCT01250873|10180247|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
2957312|NCT01250873|10180247|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
2957313|NCT01250769|10180279|P4|Overall Study|Adverse Event|0
2957314|NCT01250769|10180280|P3|Overall Study|Adverse Event|1
2957315|NCT01250769|10180281|P2|Overall Study|Adverse Event|0
2957316|NCT01250769|10180282|P1|Overall Study|Adverse Event|0
2957317|NCT01250769|10180279|P4|Overall Study|Withdrawal by Subject|0
2957318|NCT01250769|10180280|P3|Overall Study|Withdrawal by Subject|1
2957319|NCT01250769|10180281|P2|Overall Study|Withdrawal by Subject|1
2957320|NCT01250769|10180282|P1|Overall Study|Withdrawal by Subject|0
2957321|NCT01250756|10180314|P2|After Toddler Dose|Adverse Event|1
2957322|NCT01250756|10180315|P1|After Toddler Dose|Adverse Event|0
2957323|NCT01250756|10180314|P2|Toddler Dose|Adverse Event|1
2957324|NCT01250756|10180315|P1|Toddler Dose|Adverse Event|0
2957325|NCT01250756|10180314|P2|After Infant Series|Other|1
2957326|NCT01250756|10180315|P1|After Infant Series|Other|2
2957327|NCT01250756|10180314|P2|After Infant Series|Withdrawal by Subject|1
2957328|NCT01250756|10180315|P1|After Infant Series|Withdrawal by Subject|4
2957329|NCT01250756|10180314|P2|After Infant Series|Adverse Event|2
2957330|NCT01250756|10180315|P1|After Infant Series|Adverse Event|5
2957331|NCT01250756|10180314|P2|Infant Series|Other|0
2957332|NCT01250756|10180315|P1|Infant Series|Other|22
2957333|NCT01250756|10180314|P2|Infant Series|Randomized, Not Vaccinated|2
2957334|NCT01250756|10180315|P1|Infant Series|Randomized, Not Vaccinated|2
2957335|NCT01250756|10180314|P2|Infant Series|Withdrawal by Subject|5
2957336|NCT01250756|10180315|P1|Infant Series|Withdrawal by Subject|4
2957337|NCT01250509|10180432|P2|Overall Study|Lost to Follow-up|2
2957338|NCT01250509|10180433|P1|Overall Study|Lost to Follow-up|5
2957339|NCT01250418|10180447|P2|Overall Study|monitor data failure|1
2957340|NCT01250418|10180448|P1|Overall Study|monitor data failure|1
2957341|NCT01250379|10180456|P2|Overall Study|Participant noncompliance|0
2957342|NCT01250379|10180457|P1|Overall Study|Participant noncompliance|2
2957343|NCT01250379|10180456|P2|Overall Study|Other|4
2957344|NCT01250379|10180457|P1|Overall Study|Other|0
2957345|NCT01250379|10180456|P2|Overall Study|Adverse Event|4
2957346|NCT01250379|10180457|P1|Overall Study|Adverse Event|5
2957347|NCT01250379|10180456|P2|Overall Study|Lost to Follow-up|6
2957348|NCT01250379|10180457|P1|Overall Study|Lost to Follow-up|9
2957349|NCT01250379|10180456|P2|Overall Study|Protocol Violation|8
2957350|NCT01250379|10180457|P1|Overall Study|Protocol Violation|2
2957351|NCT01250379|10180456|P2|Overall Study|Physician Decision|3
2957352|NCT01250379|10180457|P1|Overall Study|Physician Decision|11
2957353|NCT01250379|10180456|P2|Overall Study|Withdrawal by Subject|20
2957354|NCT01250379|10180457|P1|Overall Study|Withdrawal by Subject|32
2957355|NCT01250379|10180456|P2|Overall Study|Death|148
2957356|NCT01250379|10180457|P1|Overall Study|Death|141
2957357|NCT01250171|10180562|P3|Overall Study|Administrative reasons|0
2957358|NCT01250171|10180563|P2|Overall Study|Administrative reasons|0
2957359|NCT01250171|10180564|P1|Overall Study|Administrative reasons|1
2957360|NCT01250145|10180595|P2|Overall Study|Withdrawal by Subject|4
2957361|NCT01250145|10180596|P1|Overall Study|Withdrawal by Subject|0
2957362|NCT01250145|10180595|P2|Overall Study|Adverse Event|1
2957363|NCT01250145|10180596|P1|Overall Study|Adverse Event|2
2957364|NCT01250119|10180616|P2|Treatment Phase|Unknown reason|4
2957365|NCT01250119|10180617|P1|Treatment Phase|Unknown reason|0
2957366|NCT01250119|10180616|P2|Treatment Phase|Adverse Event|2
2957367|NCT01250119|10180617|P1|Treatment Phase|Adverse Event|0
2957368|NCT01250119|10180616|P2|Treatment Phase|Withdrawal by Subject|1
2957369|NCT01250119|10180617|P1|Treatment Phase|Withdrawal by Subject|0
2957370|NCT01250119|10180616|P2|Treatment Phase|Death|2
2957371|NCT01250119|10180617|P1|Treatment Phase|Death|0
2957372|NCT01250119|10180616|P2|Treatment Phase|Progressive Disease|32
2957373|NCT01250119|10180617|P1|Treatment Phase|Progressive Disease|0
2957374|NCT01250119|10180616|P2|Diagnostic Phase|Participants Not Tested|0
2957375|NCT01250119|10180617|P1|Diagnostic Phase|Participants Not Tested|44
2957376|NCT01250119|10180616|P2|Diagnostic Phase|Failed to Produce a Test Results|0
2957377|NCT01250119|10180617|P1|Diagnostic Phase|Failed to Produce a Test Results|69
2957378|NCT01250054|10180632|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
2957379|NCT01250054|10180633|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
2957380|NCT01250002|10180641|P2|Overall Study|Change to open surgical procedure|3
2957381|NCT01250002|10180642|P1|Overall Study|Change to open surgical procedure|4
2957382|NCT01249833|10180707|P2|Overall Study|Lost to Follow-up|1
2957383|NCT01249833|10180708|P1|Overall Study|Lost to Follow-up|0
2957384|NCT01249664|10180722|P2|Overall Study|Adverse Event|0
2957385|NCT01249664|10180723|P1|Overall Study|Adverse Event|1
2957386|NCT01249664|10180722|P2|Overall Study|Withdrawal by Subject|0
2957387|NCT01249664|10180723|P1|Overall Study|Withdrawal by Subject|5
2957388|NCT01249651|10180773|P1|Overall Study|Sponsor Decision|1
2957389|NCT01249651|10180773|P1|Overall Study|Protocol Violation|1
2957390|NCT01249651|10180773|P1|Overall Study|Adverse Event|1
2957391|NCT01249651|10180773|P1|Overall Study|Withdrawal by Subject|4
2957392|NCT01249417|10180802|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
2957393|NCT01249417|10180803|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
2957394|NCT01249417|10180804|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
2957395|NCT01249417|10180802|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
2957396|NCT01249417|10180803|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
2957397|NCT01249417|10180804|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
2957398|NCT01249417|10180802|P3|Treatment Phase - ITT Population|Adverse Event|1
2957399|NCT01249417|10180803|P2|Treatment Phase - ITT Population|Adverse Event|0
2957400|NCT01249417|10180804|P1|Treatment Phase - ITT Population|Adverse Event|0
2957401|NCT01249417|10180802|P3|Treatment Phase - ITT Population|Other|1
2957402|NCT01249417|10180803|P2|Treatment Phase - ITT Population|Other|0
2957403|NCT01249417|10180804|P1|Treatment Phase - ITT Population|Other|0
2957404|NCT01249417|10180802|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
2957405|NCT01249417|10180803|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
2957406|NCT01249417|10180804|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
2957407|NCT01249417|10180802|P3|Randomised Population|Study treatment not received|2
2957408|NCT01249417|10180803|P2|Randomised Population|Study treatment not received|0
2957409|NCT01249417|10180804|P1|Randomised Population|Study treatment not received|0
2957410|NCT01249404|10180821|P3|Overall Study|Non compliance to visit schedule|0
2957411|NCT01249404|10180822|P2|Overall Study|Non compliance to visit schedule|1
2957412|NCT01249404|10180823|P1|Overall Study|Non compliance to visit schedule|0
2957413|NCT01249404|10180821|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
2957414|NCT01249404|10180822|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
2957415|NCT01249404|10180823|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
2957416|NCT01249404|10180821|P3|Overall Study|Withdrawal by Subject|0
2957417|NCT01249404|10180822|P2|Overall Study|Withdrawal by Subject|2
2957418|NCT01249404|10180823|P1|Overall Study|Withdrawal by Subject|2
2957419|NCT01249404|10180821|P3|Overall Study|Adverse Event|2
2957420|NCT01249404|10180822|P2|Overall Study|Adverse Event|2
2957421|NCT01249404|10180823|P1|Overall Study|Adverse Event|2
2957422|NCT01249404|10180821|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
2957423|NCT01249404|10180822|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
2957424|NCT01249404|10180823|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
2957425|NCT01249404|10180821|P3|Overall Study|Study treatment not received|2
2957426|NCT01249404|10180822|P2|Overall Study|Study treatment not received|1
2957427|NCT01249404|10180823|P1|Overall Study|Study treatment not received|0
2957428|NCT01249365|10180900|P1|Overall Study|Lost to Follow-up|1
2957429|NCT01249274|10180908|P2|Overall Study|Received inpatient substance treatment|2
2957430|NCT01249274|10180909|P1|Overall Study|Received inpatient substance treatment|1
2957431|NCT01249274|10180908|P2|Overall Study|Lost to Follow-up|4
2957432|NCT01249274|10180909|P1|Overall Study|Lost to Follow-up|3
2957433|NCT01249261|10180935|P2|Overall Study|Withdrawal by Subject|0
2957434|NCT01249261|10180936|P1|Overall Study|Withdrawal by Subject|1
2957435|NCT01249157|10180964|P1|Overall Study|Withdrawal by Subject|1
2957436|NCT01249131|10180968|P6|Washout Period of 10 Days|Adverse Event|0
2957437|NCT01249131|10180969|P5|Washout Period of 10 Days|Adverse Event|1
2957438|NCT01249131|10180970|P4|Washout Period of 10 Days|Adverse Event|0
2957439|NCT01249131|10180971|P3|Washout Period of 10 Days|Adverse Event|0
2957440|NCT01249131|10180972|P2|Washout Period of 10 Days|Adverse Event|0
2957441|NCT01249131|10180973|P1|Washout Period of 10 Days|Adverse Event|0
2957442|NCT01249118|10180993|P3|First Washout Period|Physician Decision|0
2957443|NCT01249118|10180994|P2|First Washout Period|Physician Decision|1
2957444|NCT01249118|10180995|P1|First Washout Period|Physician Decision|0
2957445|NCT01249092|10181029|P1|Overall Study|Unable to tolerate expected SE -nausea|1
2957446|NCT01249092|10181029|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
2957447|NCT01248962|10181106|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
2957448|NCT01248962|10181107|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
2957449|NCT01248962|10181106|P2|Overall Study|Complete Response after 3 Cycles|1
2957450|NCT01248962|10181107|P1|Overall Study|Complete Response after 3 Cycles|0
2957451|NCT01248962|10181106|P2|Overall Study|Complete Response after 4 Cycles|0
2957452|NCT01248962|10181107|P1|Overall Study|Complete Response after 4 Cycles|1
2957453|NCT01248962|10181106|P2|Overall Study|Adverse Event|1
2957454|NCT01248962|10181107|P1|Overall Study|Adverse Event|2
2957455|NCT01248962|10181106|P2|Overall Study|Withdrawal by Subject|1
2957456|NCT01248962|10181107|P1|Overall Study|Withdrawal by Subject|1
2957457|NCT01248949|10181123|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2957458|NCT01248949|10181124|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2957459|NCT01248949|10181125|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
2957460|NCT01248949|10181126|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2957461|NCT01248949|10181127|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2957462|NCT01248949|10181123|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
2957463|NCT01248949|10181124|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
2957464|NCT01248949|10181125|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
2957465|NCT01248949|10181126|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
2957466|NCT01248949|10181127|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
2957467|NCT01248949|10181123|P5|Overall Study|Pi Decision Due To Declining Status|0
2957468|NCT01248949|10181124|P4|Overall Study|Pi Decision Due To Declining Status|0
2957469|NCT01248949|10181125|P3|Overall Study|Pi Decision Due To Declining Status|1
2957470|NCT01248949|10181126|P2|Overall Study|Pi Decision Due To Declining Status|0
2957471|NCT01248949|10181127|P1|Overall Study|Pi Decision Due To Declining Status|0
2957472|NCT01248949|10181123|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
2957473|NCT01248949|10181124|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
2957474|NCT01248949|10181125|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
2957475|NCT01248949|10181126|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
2957476|NCT01248949|10181127|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
2957477|NCT01248949|10181123|P5|Overall Study|Participant Went To Hospice|0
2957478|NCT01248949|10181124|P4|Overall Study|Participant Went To Hospice|0
2957479|NCT01248949|10181125|P3|Overall Study|Participant Went To Hospice|1
2957480|NCT01248949|10181126|P2|Overall Study|Participant Went To Hospice|0
2957481|NCT01248949|10181127|P1|Overall Study|Participant Went To Hospice|0
2957482|NCT01248949|10181123|P5|Overall Study|Entered Hospice And Refused Follow Up|1
2957483|NCT01248949|10181124|P4|Overall Study|Entered Hospice And Refused Follow Up|0
2957484|NCT01248949|10181125|P3|Overall Study|Entered Hospice And Refused Follow Up|0
2957485|NCT01248949|10181126|P2|Overall Study|Entered Hospice And Refused Follow Up|0
2957486|NCT01248949|10181127|P1|Overall Study|Entered Hospice And Refused Follow Up|0
2957487|NCT01248949|10181123|P5|Overall Study|Palliative Radiation To Brain Metastases|0
2957488|NCT01248949|10181124|P4|Overall Study|Palliative Radiation To Brain Metastases|0
2957489|NCT01248949|10181125|P3|Overall Study|Palliative Radiation To Brain Metastases|0
2957490|NCT01248949|10181126|P2|Overall Study|Palliative Radiation To Brain Metastases|0
2957491|NCT01248949|10181127|P1|Overall Study|Palliative Radiation To Brain Metastases|1
2957492|NCT01248949|10181123|P5|Overall Study|Alternative Therapy.|0
2957493|NCT01248949|10181124|P4|Overall Study|Alternative Therapy.|0
2957494|NCT01248949|10181125|P3|Overall Study|Alternative Therapy.|0
2957495|NCT01248949|10181126|P2|Overall Study|Alternative Therapy.|0
2957496|NCT01248949|10181127|P1|Overall Study|Alternative Therapy.|1
2957497|NCT01248949|10181123|P5|Overall Study|Alternative Therapy|0
2957498|NCT01248949|10181124|P4|Overall Study|Alternative Therapy|0
2957499|NCT01248949|10181125|P3|Overall Study|Alternative Therapy|0
2957500|NCT01248949|10181126|P2|Overall Study|Alternative Therapy|0
2957501|NCT01248949|10181127|P1|Overall Study|Alternative Therapy|1
2957502|NCT01248949|10181123|P5|Overall Study|Death|2
2957503|NCT01248949|10181124|P4|Overall Study|Death|6
2957504|NCT01248949|10181125|P3|Overall Study|Death|21
2957505|NCT01248949|10181126|P2|Overall Study|Death|7
2957506|NCT01248949|10181127|P1|Overall Study|Death|22
2957507|NCT01248949|10181123|P5|Overall Study|Withdrawal by Subject|1
2957508|NCT01248949|10181124|P4|Overall Study|Withdrawal by Subject|3
2957509|NCT01248949|10181125|P3|Overall Study|Withdrawal by Subject|11
2957510|NCT01248949|10181126|P2|Overall Study|Withdrawal by Subject|3
2957511|NCT01248949|10181127|P1|Overall Study|Withdrawal by Subject|5
2957512|NCT01248949|10181123|P5|Overall Study|Lost to Follow-up|0
2957513|NCT01248949|10181124|P4|Overall Study|Lost to Follow-up|1
2957514|NCT01248949|10181125|P3|Overall Study|Lost to Follow-up|2
2957515|NCT01248949|10181126|P2|Overall Study|Lost to Follow-up|2
2957516|NCT01248949|10181127|P1|Overall Study|Lost to Follow-up|2
2957517|NCT01248936|10181239|P1|Overall Study|Other reason|3
2957518|NCT01248936|10181239|P1|Overall Study|Refused Treatment|1
2957519|NCT01248936|10181239|P1|Overall Study|Lost to Follow-up|7
2957520|NCT01248936|10181239|P1|Overall Study|Adverse Event|8
2957521|NCT01248936|10181239|P1|Overall Study|Withdrawal of Consent|20
2957522|NCT01248936|10181239|P1|Overall Study|Death|26
2957523|NCT01248936|10181239|P1|Overall Study|Progression of Disease|50
2957524|NCT01248936|10181239|P1|Overall Study|Sponsor Decision|259
2957525|NCT01248884|10181252|P3|Overall Study|Adverse Event|0
2957526|NCT01248884|10181253|P2|Overall Study|Adverse Event|0
2957527|NCT01248884|10181254|P1|Overall Study|Adverse Event|1
2957528|NCT01248884|10181252|P3|Overall Study|Withdrawal by Subject|1
2957529|NCT01248884|10181253|P2|Overall Study|Withdrawal by Subject|3
2957530|NCT01248884|10181254|P1|Overall Study|Withdrawal by Subject|1
2957531|NCT01248793|10181312|P2|Overall Study|Withdrawal by Subject|3
2957532|NCT01248793|10181313|P1|Overall Study|Withdrawal by Subject|3
2957533|NCT01248793|10181312|P2|Overall Study|Protocol Violation|1
2957534|NCT01248793|10181313|P1|Overall Study|Protocol Violation|0
2957535|NCT01248793|10181312|P2|Overall Study|Adverse Event|1
2957536|NCT01248793|10181313|P1|Overall Study|Adverse Event|1
2957537|NCT01248793|10181312|P2|Overall Study|Lost to Follow-up|1
2957538|NCT01248793|10181313|P1|Overall Study|Lost to Follow-up|0
2957539|NCT01248780|10181327|P2|Overall Study|Not treated|1
2957540|NCT01248780|10181328|P1|Overall Study|Not treated|0
2957541|NCT01248780|10181327|P2|Overall Study|Withdrawal by Subject|4
2957542|NCT01248780|10181328|P1|Overall Study|Withdrawal by Subject|4
2957543|NCT01248780|10181327|P2|Overall Study|Protocol Violation|1
2957544|NCT01248780|10181328|P1|Overall Study|Protocol Violation|1
2957545|NCT01248780|10181327|P2|Overall Study|Adverse Event|7
2957546|NCT01248780|10181328|P1|Overall Study|Adverse Event|2
2957547|NCT01248780|10181327|P2|Overall Study|Death|1
2957548|NCT01248780|10181328|P1|Overall Study|Death|0
2957549|NCT01248780|10181327|P2|Overall Study|Lost to Follow-up|1
2957550|NCT01248780|10181328|P1|Overall Study|Lost to Follow-up|0
2957551|NCT01248780|10181327|P2|Overall Study|Lack of Efficacy|0
2957552|NCT01248780|10181328|P1|Overall Study|Lack of Efficacy|2
2957553|NCT01248728|10181342|P2|Overall Study|Lack of Efficacy|0
2957554|NCT01248728|10181343|P1|Overall Study|Lack of Efficacy|1
2957555|NCT01248728|10181342|P2|Overall Study|Withdrawal by Subject|1
2957556|NCT01248728|10181343|P1|Overall Study|Withdrawal by Subject|2
2957557|NCT01248728|10181342|P2|Overall Study|Adverse Event|1
2957558|NCT01248728|10181343|P1|Overall Study|Adverse Event|1
2957559|NCT01248715|10181359|P2|Overall Study|Not influenza positive|510
2957560|NCT01248715|10181360|P1|Overall Study|Not influenza positive|501
2957561|NCT01248468|10181381|P3|Overall Study|Withdrawal by Subject|0
2957562|NCT01248468|10181382|P2|Overall Study|Withdrawal by Subject|2
2957563|NCT01248468|10181383|P1|Overall Study|Withdrawal by Subject|4
2957564|NCT01248468|10181381|P3|Overall Study|Pregnancy|0
2957565|NCT01248468|10181382|P2|Overall Study|Pregnancy|0
2957566|NCT01248468|10181383|P1|Overall Study|Pregnancy|1
2957567|NCT01248468|10181381|P3|Overall Study|Lost to Follow-up|4
2957568|NCT01248468|10181382|P2|Overall Study|Lost to Follow-up|12
2957569|NCT01248468|10181383|P1|Overall Study|Lost to Follow-up|9
2957570|NCT01248468|10181381|P3|Overall Study|Administrative problem|0
2957571|NCT01248468|10181382|P2|Overall Study|Administrative problem|0
2957572|NCT01248468|10181383|P1|Overall Study|Administrative problem|1
2957573|NCT01248455|10181400|P1|Overall Study|switched to alternate treatment|1
2957574|NCT01248364|10181445|P4|Overall Study|Adverse Event|0
2957575|NCT01248364|10181446|P3|Overall Study|Adverse Event|0
2957576|NCT01248364|10181447|P2|Overall Study|Adverse Event|1
2957577|NCT01248364|10181448|P1|Overall Study|Adverse Event|0
2957578|NCT01248130|10181511|P2|Overall Study|Ineligible|0
2957579|NCT01248130|10181512|P1|Overall Study|Ineligible|1
2957580|NCT01248130|10181511|P2|Overall Study|Protocol Violation|0
2957581|NCT01248130|10181512|P1|Overall Study|Protocol Violation|1
2957582|NCT01248065|10181522|P2|Overall Study|Other|5
2957583|NCT01248065|10181523|P1|Overall Study|Other|3
2957584|NCT01248065|10181522|P2|Overall Study|Third treatment failure event|1
2957585|NCT01248065|10181523|P1|Overall Study|Third treatment failure event|3
2957586|NCT01248065|10181522|P2|Overall Study|Adverse Event|0
2957587|NCT01248065|10181523|P1|Overall Study|Adverse Event|3
2957588|NCT01248065|10181522|P2|Overall Study|Withdrawal by Subject|11
2957589|NCT01248065|10181523|P1|Overall Study|Withdrawal by Subject|14
2957590|NCT01248065|10181522|P2|Overall Study|Lost to Follow-up|5
2957591|NCT01248065|10181523|P1|Overall Study|Lost to Follow-up|3
2957592|NCT01248013|10181533|P1|Overall Study|Withdrawal by Subject|14
2957593|NCT01247922|10181548|P1|Overall Study|Disease progression|4
2957594|NCT01247350|10181646|P5|Overall Study|Entry criteria not met|1
2957595|NCT01247350|10181647|P4|Overall Study|Entry criteria not met|0
2957596|NCT01247350|10181648|P3|Overall Study|Entry criteria not met|0
2957597|NCT01247350|10181649|P2|Overall Study|Entry criteria not met|0
2957598|NCT01247350|10181650|P1|Overall Study|Entry criteria not met|0
2957599|NCT01247350|10181646|P5|Overall Study|Withdrawal by Subject|0
2957600|NCT01247350|10181647|P4|Overall Study|Withdrawal by Subject|1
2957601|NCT01247350|10181648|P3|Overall Study|Withdrawal by Subject|0
2957602|NCT01247350|10181649|P2|Overall Study|Withdrawal by Subject|0
2957603|NCT01247350|10181650|P1|Overall Study|Withdrawal by Subject|0
2957604|NCT01247350|10181646|P5|Overall Study|Adverse Event|0
2957605|NCT01247350|10181647|P4|Overall Study|Adverse Event|0
2957606|NCT01247350|10181648|P3|Overall Study|Adverse Event|1
2957607|NCT01247350|10181649|P2|Overall Study|Adverse Event|0
2957608|NCT01247350|10181650|P1|Overall Study|Adverse Event|0
2957609|NCT01247324|10181708|P2|Overall Study|Lost to Follow-up|1
2957610|NCT01247324|10181709|P1|Overall Study|Lost to Follow-up|1
2957611|NCT01247324|10181708|P2|Overall Study|Adverse Event|13
2957612|NCT01247324|10181709|P1|Overall Study|Adverse Event|25
2957613|NCT01247324|10181708|P2|Overall Study|Consent withdrawn by participant|8
2957614|NCT01247324|10181709|P1|Overall Study|Consent withdrawn by participant|13
2957615|NCT01247324|10181708|P2|Overall Study|Reason not specified|8
2957616|NCT01247324|10181709|P1|Overall Study|Reason not specified|11
2957617|NCT01247324|10181708|P2|Overall Study|Protocol Violation|2
2957618|NCT01247324|10181709|P1|Overall Study|Protocol Violation|1
2957619|NCT01247324|10181708|P2|Overall Study|Pregnancy|3
2957620|NCT01247324|10181709|P1|Overall Study|Pregnancy|2
2957621|NCT01247324|10181708|P2|Overall Study|Non-compliance|0
2957622|NCT01247324|10181709|P1|Overall Study|Non-compliance|2
2957623|NCT01247324|10181708|P2|Overall Study|Lack of Efficacy|8
2957624|NCT01247324|10181709|P1|Overall Study|Lack of Efficacy|12
2957625|NCT01247324|10181708|P2|Overall Study|Non-compliance with study drug|0
2957626|NCT01247324|10181709|P1|Overall Study|Non-compliance with study drug|3
2957627|NCT01247324|10181708|P2|Overall Study|Physician Decision|1
2957628|NCT01247324|10181709|P1|Overall Study|Physician Decision|0
2957629|NCT01247324|10181708|P2|Overall Study|Death|0
2957630|NCT01247324|10181709|P1|Overall Study|Death|1
2957631|NCT01247090|10181802|P3|Overall Study|Withdrawal by Subject|0
2957632|NCT01247090|10181803|P2|Overall Study|Withdrawal by Subject|1
2957633|NCT01247090|10181804|P1|Overall Study|Withdrawal by Subject|0
2957634|NCT01247090|10181802|P3|Overall Study|Physician Decision|0
2957635|NCT01247090|10181803|P2|Overall Study|Physician Decision|0
2957636|NCT01247090|10181804|P1|Overall Study|Physician Decision|1
2957637|NCT01246999|10181833|P4|Overall Study|Withdrawal by Subject|2
2957638|NCT01246999|10181834|P3|Overall Study|Withdrawal by Subject|0
2957639|NCT01246999|10181835|P2|Overall Study|Withdrawal by Subject|0
2957640|NCT01246999|10181836|P1|Overall Study|Withdrawal by Subject|0
2957641|NCT01246999|10181833|P4|Overall Study|Lost to Follow-up|0
2957642|NCT01246999|10181834|P3|Overall Study|Lost to Follow-up|0
2957643|NCT01246999|10181835|P2|Overall Study|Lost to Follow-up|1
2957644|NCT01246999|10181836|P1|Overall Study|Lost to Follow-up|0
2957645|NCT01246973|10181871|P2|Overall Study|Withdrawal by Subject|13
2957646|NCT01246973|10181872|P1|Overall Study|Withdrawal by Subject|7
2957647|NCT01246973|10181871|P2|Overall Study|Adverse Event|9
2957648|NCT01246973|10181872|P1|Overall Study|Adverse Event|16
2957649|NCT01246973|10181871|P2|Overall Study|Other|25
2957650|NCT01246973|10181872|P1|Overall Study|Other|38
2957651|NCT01246960|10181882|P2|Overall Study|Withdrawal (by participant or physician)|3
2957652|NCT01246960|10181883|P1|Overall Study|Withdrawal (by participant or physician)|3
2957653|NCT01246960|10181882|P2|Overall Study|Lost to Follow-up|1
2957654|NCT01246960|10181883|P1|Overall Study|Lost to Follow-up|3
2957655|NCT01246206|10181995|P1|Overall Study|Patient did not receive study regiments.|1
2957656|NCT01246011|10182073|P3|Overall Study|Withdrawal by Subject|1
2957657|NCT01246011|10182074|P2|Overall Study|Withdrawal by Subject|0
2957658|NCT01246011|10182075|P1|Overall Study|Withdrawal by Subject|0
2957659|NCT01246011|10182073|P3|Overall Study|If needed warfarin clinically, withdrawn|3
2957660|NCT01246011|10182074|P2|Overall Study|If needed warfarin clinically, withdrawn|0
2957661|NCT01246011|10182075|P1|Overall Study|If needed warfarin clinically, withdrawn|0
2957662|NCT01245764|10182103|P4|Study Phase A|Lost to Follow-up|0
2957663|NCT01245764|10182104|P3|Study Phase A|Lost to Follow-up|5
2957664|NCT01245764|10182105|P2|Study Phase A|Lost to Follow-up|0
2957665|NCT01245764|10182106|P1|Study Phase A|Lost to Follow-up|0
2957666|NCT01245764|10182103|P4|Study Phase A|Protocol Violation|2
2957667|NCT01245764|10182104|P3|Study Phase A|Protocol Violation|2
2957668|NCT01245764|10182105|P2|Study Phase A|Protocol Violation|3
2957669|NCT01245764|10182106|P1|Study Phase A|Protocol Violation|6
2957670|NCT01245764|10182103|P4|Study Phase A|Other|1
2957671|NCT01245764|10182104|P3|Study Phase A|Other|3
2957672|NCT01245764|10182105|P2|Study Phase A|Other|2
2957673|NCT01245764|10182106|P1|Study Phase A|Other|3
2957674|NCT01245751|10182144|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2957675|NCT01245751|10182145|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2957676|NCT01245751|10182146|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
2957677|NCT01245751|10182147|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2957678|NCT01245751|10182144|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
2957679|NCT01245751|10182145|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2957680|NCT01245751|10182146|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2957681|NCT01245751|10182147|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2957682|NCT01245751|10182144|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2957683|NCT01245751|10182145|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2957684|NCT01245751|10182146|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
2957685|NCT01245751|10182147|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
2957686|NCT01245673|10182196|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
2957687|NCT01245387|10182264|P1|Overall Study|Missing discontinuation status|369
2957688|NCT01245387|10182264|P1|Overall Study|Other|131
2957689|NCT01245387|10182264|P1|Overall Study|Death|3
2957690|NCT01245387|10182264|P1|Overall Study|Adverse Event|9
2957691|NCT01245387|10182264|P1|Overall Study|Lack of Efficacy|195
2957692|NCT01245387|10182264|P1|Overall Study|Lost to Follow-up|106
2957693|NCT01245374|10182313|P1|Overall Study|Withdrawal by Subject|3
2957694|NCT01245374|10182313|P1|Overall Study|Protocol Violation|1
2957695|NCT01245283|10182336|P3|Overall Study|Lost to Follow-up|11
2957696|NCT01245283|10182337|P2|Overall Study|Lost to Follow-up|11
2957697|NCT01245283|10182338|P1|Overall Study|Lost to Follow-up|14
2957698|NCT01245140|10182383|P2|Overall Study|Refused Treatment/Did Not Coopera|1
2957699|NCT01245140|10182384|P1|Overall Study|Refused Treatment/Did Not Coopera|0
2957700|NCT01245140|10182383|P2|Overall Study|Withdrawal by Subject|1
2957701|NCT01245140|10182384|P1|Overall Study|Withdrawal by Subject|0
2957702|NCT01245140|10182383|P2|Overall Study|Protocol Violation|1
2957703|NCT01245140|10182384|P1|Overall Study|Protocol Violation|0
2957704|NCT01245140|10182383|P2|Overall Study|Lack of Efficacy|4
2957705|NCT01245140|10182384|P1|Overall Study|Lack of Efficacy|2
2957706|NCT01245140|10182383|P2|Overall Study|Adverse Event|3
2957707|NCT01245140|10182384|P1|Overall Study|Adverse Event|1
2957708|NCT01245101|10182440|P2|Period 3 (Treatment)|Withdrawal by Subject|0
2957709|NCT01245101|10182441|P1|Period 3 (Treatment)|Withdrawal by Subject|1
2957710|NCT01245101|10182440|P2|Period 2 (Washout)|Withdrawal by Subject|0
2957711|NCT01245101|10182441|P1|Period 2 (Washout)|Withdrawal by Subject|1
2957712|NCT01245101|10182440|P2|Period 1 (Treatment)|Withdrawal by Subject|0
2957713|NCT01245101|10182441|P1|Period 1 (Treatment)|Withdrawal by Subject|2
2957714|NCT01245062|10182451|P3|Cross-over Phase|Study closed/ terminated|11
2957715|NCT01245062|10182452|P2|Cross-over Phase|Study closed/ terminated|0
2957716|NCT01245062|10182453|P1|Cross-over Phase|Study closed/ terminated|0
2957717|NCT01245062|10182451|P3|Cross-over Phase|Withdrew Consent|4
2957718|NCT01245062|10182452|P2|Cross-over Phase|Withdrew Consent|0
2957719|NCT01245062|10182453|P1|Cross-over Phase|Withdrew Consent|0
2957720|NCT01245062|10182451|P3|Cross-over Phase|Physician Decision|1
2957721|NCT01245062|10182452|P2|Cross-over Phase|Physician Decision|0
2957722|NCT01245062|10182453|P1|Cross-over Phase|Physician Decision|0
2957723|NCT01245062|10182451|P3|Cross-over Phase|Lost to Follow-up|1
2957724|NCT01245062|10182452|P2|Cross-over Phase|Lost to Follow-up|0
2957725|NCT01245062|10182453|P1|Cross-over Phase|Lost to Follow-up|0
2957726|NCT01245062|10182451|P3|Randomization and Crossover Phase|Study closed/ terminated|0
2957727|NCT01245062|10182452|P2|Randomization and Crossover Phase|Study closed/ terminated|14
2957728|NCT01245062|10182453|P1|Randomization and Crossover Phase|Study closed/ terminated|23
2957729|NCT01245062|10182451|P3|Randomization and Crossover Phase|Withdrew Consent|0
2957730|NCT01245062|10182452|P2|Randomization and Crossover Phase|Withdrew Consent|11
2957731|NCT01245062|10182453|P1|Randomization and Crossover Phase|Withdrew Consent|12
2957732|NCT01245062|10182451|P3|Randomization and Crossover Phase|Physician Decision|0
2957733|NCT01245062|10182452|P2|Randomization and Crossover Phase|Physician Decision|4
2957734|NCT01245062|10182453|P1|Randomization and Crossover Phase|Physician Decision|2
2957735|NCT01245062|10182451|P3|Randomization and Crossover Phase|Lost to Follow-up|0
2957736|NCT01245062|10182452|P2|Randomization and Crossover Phase|Lost to Follow-up|2
2957737|NCT01245062|10182453|P1|Randomization and Crossover Phase|Lost to Follow-up|4
2957738|NCT01245049|10182491|P2|Overall Study|Lost to Follow-up|2
2957739|NCT01245049|10182492|P1|Overall Study|Lost to Follow-up|1
2957740|NCT01245049|10182491|P2|Overall Study|Withdrawal by Subject|1
2957741|NCT01245049|10182492|P1|Overall Study|Withdrawal by Subject|0
2957742|NCT01245049|10182491|P2|Overall Study|Migrated/moved from study area|1
2957743|NCT01245049|10182492|P1|Overall Study|Migrated/moved from study area|0
2957744|NCT01244984|10182545|P3|Overall Study|Withdrawal by Subject|2
2957745|NCT01244984|10182546|P2|Overall Study|Withdrawal by Subject|2
2957746|NCT01244984|10182547|P1|Overall Study|Withdrawal by Subject|1
2957747|NCT01244984|10182545|P3|Overall Study|Protocol Defined Stopping Criteria|0
2957748|NCT01244984|10182546|P2|Overall Study|Protocol Defined Stopping Criteria|1
2957749|NCT01244984|10182547|P1|Overall Study|Protocol Defined Stopping Criteria|1
2957750|NCT01244984|10182545|P3|Overall Study|Protocol Violation|0
2957751|NCT01244984|10182546|P2|Overall Study|Protocol Violation|0
2957752|NCT01244984|10182547|P1|Overall Study|Protocol Violation|1
2957753|NCT01244984|10182545|P3|Overall Study|Adverse Event|2
2957754|NCT01244984|10182546|P2|Overall Study|Adverse Event|11
2957755|NCT01244984|10182547|P1|Overall Study|Adverse Event|2
2957756|NCT01244906|10182621|P1|Overall Study|Progression of disease post treatment|6
2957757|NCT01244906|10182621|P1|Overall Study|Death|2
2957758|NCT01244893|10182630|P2|1-Week Follow Up|Lost to Follow-up|0
2957759|NCT01244893|10182631|P1|1-Week Follow Up|Lost to Follow-up|1
2957760|NCT01244893|10182630|P2|Baseline|Protocol Violation|1
2957761|NCT01244893|10182631|P1|Baseline|Protocol Violation|0
2957762|NCT01244828|10182643|P1|Overall Study|Other reason (not specified)|1
2957763|NCT01244828|10182643|P1|Overall Study|Lost to Follow-up|2
2957764|NCT01244828|10182643|P1|Overall Study|Lack of Efficacy|7
2957765|NCT01244828|10182643|P1|Overall Study|Withdrawal by Subject|31
2957766|NCT01244828|10182643|P1|Overall Study|Adverse Event|37
2957767|NCT01244815|10182659|P4|Overall Study|Did Not Meet Protocol Eligibility|0
2957768|NCT01244815|10182660|P3|Overall Study|Did Not Meet Protocol Eligibility|0
2957769|NCT01244815|10182661|P2|Overall Study|Did Not Meet Protocol Eligibility|1
2957770|NCT01244815|10182662|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2957771|NCT01244815|10182659|P4|Overall Study|Protocol Violation|1
2957772|NCT01244815|10182660|P3|Overall Study|Protocol Violation|3
2957773|NCT01244815|10182661|P2|Overall Study|Protocol Violation|4
2957774|NCT01244815|10182662|P1|Overall Study|Protocol Violation|7
2957775|NCT01244815|10182659|P4|Overall Study|Withdrawal by Subject|3
2957776|NCT01244815|10182660|P3|Overall Study|Withdrawal by Subject|0
2957777|NCT01244815|10182661|P2|Overall Study|Withdrawal by Subject|2
2957778|NCT01244815|10182662|P1|Overall Study|Withdrawal by Subject|0
2957779|NCT01244815|10182659|P4|Overall Study|Lost to Follow-up|2
2957780|NCT01244815|10182660|P3|Overall Study|Lost to Follow-up|3
2957781|NCT01244815|10182661|P2|Overall Study|Lost to Follow-up|2
2957782|NCT01244815|10182662|P1|Overall Study|Lost to Follow-up|3
2957783|NCT01244815|10182659|P4|Overall Study|Treatment Failure|1
2957784|NCT01244815|10182660|P3|Overall Study|Treatment Failure|0
2957785|NCT01244815|10182661|P2|Overall Study|Treatment Failure|0
2957786|NCT01244815|10182662|P1|Overall Study|Treatment Failure|0
2957787|NCT01244815|10182659|P4|Overall Study|Adverse Event|5
2957788|NCT01244815|10182660|P3|Overall Study|Adverse Event|5
2957789|NCT01244815|10182661|P2|Overall Study|Adverse Event|7
2957790|NCT01244815|10182662|P1|Overall Study|Adverse Event|4
2957791|NCT01244815|10182659|P4|Overall Study|Not Treated|0
2957792|NCT01244815|10182660|P3|Overall Study|Not Treated|0
2957793|NCT01244815|10182661|P2|Overall Study|Not Treated|1
2957794|NCT01244815|10182662|P1|Overall Study|Not Treated|0
2957795|NCT01244620|10182749|P4|Overall Study|Study terminated|4
2957796|NCT01244620|10182750|P3|Overall Study|Study terminated|4
2957797|NCT01244620|10182751|P2|Overall Study|Study terminated|4
2957798|NCT01244620|10182752|P1|Overall Study|Study terminated|4
2957799|NCT01244516|10182811|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
2957800|NCT01244516|10182812|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2957801|NCT01244516|10182813|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2957802|NCT01244516|10182811|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2957803|NCT01244516|10182812|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
2957804|NCT01244516|10182813|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2957805|NCT01244516|10182811|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2957806|NCT01244516|10182812|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
2957807|NCT01244516|10182813|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2957808|NCT01244516|10182811|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2957809|NCT01244516|10182812|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2957810|NCT01244516|10182813|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
2957811|NCT01244516|10182811|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
2957812|NCT01244516|10182812|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2957813|NCT01244516|10182813|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2957814|NCT01244516|10182811|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2957815|NCT01244516|10182812|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
2957816|NCT01244516|10182813|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2957817|NCT01244516|10182811|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
2957818|NCT01244516|10182812|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
2957819|NCT01244516|10182813|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
2957820|NCT01244490|10182834|P3|Overall Study|Other|1
2957821|NCT01244490|10182835|P2|Overall Study|Other|0
2957822|NCT01244490|10182836|P1|Overall Study|Other|0
2957823|NCT01244490|10182834|P3|Overall Study|Lost to Follow-up|3
2957824|NCT01244490|10182835|P2|Overall Study|Lost to Follow-up|6
2957825|NCT01244490|10182836|P1|Overall Study|Lost to Follow-up|0
2957826|NCT01244490|10182834|P3|Overall Study|Adverse Event|5
2957827|NCT01244490|10182835|P2|Overall Study|Adverse Event|9
2957828|NCT01244490|10182836|P1|Overall Study|Adverse Event|1
2957829|NCT01244490|10182834|P3|Overall Study|Withdrawal by Subject|9
2957830|NCT01244490|10182835|P2|Overall Study|Withdrawal by Subject|4
2957831|NCT01244490|10182836|P1|Overall Study|Withdrawal by Subject|4
2957832|NCT01244490|10182834|P3|Overall Study|Lack of Efficacy|5
2957833|NCT01244490|10182835|P2|Overall Study|Lack of Efficacy|5
2957834|NCT01244490|10182836|P1|Overall Study|Lack of Efficacy|14
2957835|NCT01244425|10182913|P2|Overall Study|Adverse Event|1
2957836|NCT01244425|10182914|P1|Overall Study|Adverse Event|1
2957837|NCT01244425|10182913|P2|Overall Study|Withdrawal by Subject|2
2957838|NCT01244425|10182914|P1|Overall Study|Withdrawal by Subject|2
2957839|NCT01244126|10182946|P3|Overall Study|Protocol Violation|9
2957840|NCT01244126|10182947|P2|Overall Study|Protocol Violation|3
2957841|NCT01244126|10182948|P1|Overall Study|Protocol Violation|3
2957842|NCT01244061|10182961|P2|Overall Study|Randomized but not treated|2
2957843|NCT01244061|10182962|P1|Overall Study|Randomized but not treated|2
2957844|NCT01244061|10182961|P2|Overall Study|Adverse Event|2
2957845|NCT01244061|10182962|P1|Overall Study|Adverse Event|5
2957846|NCT01244061|10182961|P2|Overall Study|Protocol Violation|1
2957847|NCT01244061|10182962|P1|Overall Study|Protocol Violation|1
2957848|NCT01244061|10182961|P2|Overall Study|Other|19
2957849|NCT01244061|10182962|P1|Overall Study|Other|8
2957850|NCT01244061|10182961|P2|Overall Study|Withdrawal by Subject|46
2957851|NCT01244061|10182962|P1|Overall Study|Withdrawal by Subject|29
2957852|NCT01244061|10182961|P2|Overall Study|Lost to Follow-up|30
2957853|NCT01244061|10182962|P1|Overall Study|Lost to Follow-up|34
2957854|NCT01244061|10182961|P2|Overall Study|Lack of Efficacy|3
2957855|NCT01244061|10182962|P1|Overall Study|Lack of Efficacy|1
2957856|NCT01244061|10182961|P2|Overall Study|Did not meet entrance criteria|0
2957857|NCT01244061|10182962|P1|Overall Study|Did not meet entrance criteria|1
2957858|NCT01244061|10182961|P2|Overall Study|Death|0
2957859|NCT01244061|10182962|P1|Overall Study|Death|1
2957860|NCT01244035|10182974|P6|Part 1: Period 3|Protocol Deviation|0
2957861|NCT01244035|10182975|P5|Part 1: Period 3|Protocol Deviation|0
2957862|NCT01244035|10182976|P4|Part 1: Period 3|Protocol Deviation|0
2957863|NCT01244035|10182977|P3|Part 1: Period 3|Protocol Deviation|0
2957864|NCT01244035|10182978|P2|Part 1: Period 3|Protocol Deviation|1
2957865|NCT01244035|10182979|P1|Part 1: Period 3|Protocol Deviation|0
2957866|NCT01244035|10182974|P6|Part 1: Period 3|Withdrawal by Subject|0
2957867|NCT01244035|10182975|P5|Part 1: Period 3|Withdrawal by Subject|1
2957868|NCT01244035|10182976|P4|Part 1: Period 3|Withdrawal by Subject|0
2957869|NCT01244035|10182977|P3|Part 1: Period 3|Withdrawal by Subject|0
2957870|NCT01244035|10182978|P2|Part 1: Period 3|Withdrawal by Subject|0
2957871|NCT01244035|10182979|P1|Part 1: Period 3|Withdrawal by Subject|0
2957872|NCT01244035|10182974|P6|Part 1: Period 3|Adverse Event|1
2957873|NCT01244035|10182975|P5|Part 1: Period 3|Adverse Event|0
2957874|NCT01244035|10182976|P4|Part 1: Period 3|Adverse Event|0
2957875|NCT01244035|10182977|P3|Part 1: Period 3|Adverse Event|0
2957876|NCT01244035|10182978|P2|Part 1: Period 3|Adverse Event|0
2957877|NCT01244035|10182979|P1|Part 1: Period 3|Adverse Event|0
2957878|NCT01244035|10182974|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
2957879|NCT01244035|10182975|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
2957880|NCT01244035|10182976|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
2957881|NCT01244035|10182977|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
2957882|NCT01244035|10182978|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
2957883|NCT01244035|10182979|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
2957884|NCT01244035|10182974|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
2957885|NCT01244035|10182975|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
2957886|NCT01244035|10182976|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
2957887|NCT01244035|10182977|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
2957888|NCT01244035|10182978|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
2957889|NCT01244035|10182979|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
2957890|NCT01244035|10182974|P6|Part 1: Period 1|Withdrawal by Subject|0
2957891|NCT01244035|10182975|P5|Part 1: Period 1|Withdrawal by Subject|0
2957892|NCT01244035|10182976|P4|Part 1: Period 1|Withdrawal by Subject|0
2957893|NCT01244035|10182977|P3|Part 1: Period 1|Withdrawal by Subject|0
2957894|NCT01244035|10182978|P2|Part 1: Period 1|Withdrawal by Subject|2
2957895|NCT01244035|10182979|P1|Part 1: Period 1|Withdrawal by Subject|0
2957896|NCT01244035|10182974|P6|Part 1: Period 1|Adverse Event|1
2957897|NCT01244035|10182975|P5|Part 1: Period 1|Adverse Event|0
2957898|NCT01244035|10182976|P4|Part 1: Period 1|Adverse Event|0
2957899|NCT01244035|10182977|P3|Part 1: Period 1|Adverse Event|0
2957900|NCT01244035|10182978|P2|Part 1: Period 1|Adverse Event|0
2957901|NCT01244035|10182979|P1|Part 1: Period 1|Adverse Event|0
2957902|NCT01243944|10183020|P2|Overall Study|Non-compliance with study treatment|0
2957903|NCT01243944|10183021|P1|Overall Study|Non-compliance with study treatment|1
2957904|NCT01243944|10183020|P2|Overall Study|Death|3
2957905|NCT01243944|10183021|P1|Overall Study|Death|2
2957906|NCT01243944|10183020|P2|Overall Study|Participant decision|15
2957907|NCT01243944|10183021|P1|Overall Study|Participant decision|10
2957908|NCT01243944|10183020|P2|Overall Study|Protocol deviation|1
2957909|NCT01243944|10183021|P1|Overall Study|Protocol deviation|1
2957910|NCT01243944|10183020|P2|Overall Study|Disease progression|11
2957911|NCT01243944|10183021|P1|Overall Study|Disease progression|12
2957912|NCT01243944|10183020|P2|Overall Study|Physician Decision|7
2957913|NCT01243944|10183021|P1|Overall Study|Physician Decision|2
2957914|NCT01243944|10183020|P2|Overall Study|Lost to Follow-up|1
2957915|NCT01243944|10183021|P1|Overall Study|Lost to Follow-up|2
2957916|NCT01243944|10183020|P2|Overall Study|Adverse Event|13
2957917|NCT01243944|10183021|P1|Overall Study|Adverse Event|15
2957918|NCT01243892|10183049|P2|Overall Study|Did not meet eligibility criteria|0
2957919|NCT01243892|10183050|P1|Overall Study|Did not meet eligibility criteria|2
2957920|NCT01243775|10183060|P1|Overall Study|Withdrawal by Subject|2
2957921|NCT01243762|10183074|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2957922|NCT01243762|10183075|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2957923|NCT01243762|10183076|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2957924|NCT01243762|10183077|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2957925|NCT01243762|10183078|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2957926|NCT01243762|10183079|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2957927|NCT01243762|10183080|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2957928|NCT01243762|10183074|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2957929|NCT01243762|10183075|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2957930|NCT01243762|10183076|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2957931|NCT01243762|10183077|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2957932|NCT01243762|10183078|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2957933|NCT01243762|10183079|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2957934|NCT01243762|10183080|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2957935|NCT01243762|10183074|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2957936|NCT01243762|10183075|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2957937|NCT01243762|10183076|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
2957938|NCT01243762|10183077|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2957939|NCT01243762|10183078|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2957940|NCT01243762|10183079|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2957941|NCT01243762|10183080|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2957942|NCT01243762|10183074|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
2957943|NCT01243762|10183075|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2957944|NCT01243762|10183076|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2957945|NCT01243762|10183077|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2957946|NCT01243762|10183078|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2957947|NCT01243762|10183079|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
2957948|NCT01243762|10183080|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2957949|NCT01243762|10183074|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957950|NCT01243762|10183075|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957951|NCT01243762|10183076|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957952|NCT01243762|10183077|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957953|NCT01243762|10183078|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957954|NCT01243762|10183079|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
2957955|NCT01243762|10183080|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2957956|NCT01243762|10183074|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
2957957|NCT01243762|10183075|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2957958|NCT01243762|10183076|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2957959|NCT01243762|10183077|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2957960|NCT01243762|10183078|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2957961|NCT01243762|10183079|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2957962|NCT01243762|10183080|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2957963|NCT01243762|10183074|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2957964|NCT01243762|10183075|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2957965|NCT01243762|10183076|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2957966|NCT01243762|10183077|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2957967|NCT01243762|10183078|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2957968|NCT01243762|10183079|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2957969|NCT01243762|10183080|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2957970|NCT01243762|10183074|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2957971|NCT01243762|10183075|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2957972|NCT01243762|10183076|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2957973|NCT01243762|10183077|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2957974|NCT01243762|10183078|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2957975|NCT01243762|10183079|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
2957976|NCT01243762|10183080|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2957977|NCT01243671|10183099|P1|Overall Study|Other|1
2957978|NCT01243671|10183099|P1|Overall Study|Anti-adalimumab antibody positive|1
2957979|NCT01243671|10183099|P1|Overall Study|Adverse Event|3
2957980|NCT01243424|10183178|P2|Discontinuation From Treatment|Other than listed above|211
2957981|NCT01243424|10183179|P1|Discontinuation From Treatment|Other than listed above|230
2957982|NCT01243424|10183178|P2|Discontinuation From Treatment|Withdrawal by Subject|328
2957983|NCT01243424|10183179|P1|Discontinuation From Treatment|Withdrawal by Subject|309
2957984|NCT01243424|10183178|P2|Discontinuation From Treatment|Lost to Follow-up|28
2957985|NCT01243424|10183179|P1|Discontinuation From Treatment|Lost to Follow-up|24
2957986|NCT01243424|10183178|P2|Discontinuation From Treatment|Protocol Violation|47
2957987|NCT01243424|10183179|P1|Discontinuation From Treatment|Protocol Violation|46
2957988|NCT01243424|10183178|P2|Discontinuation From Treatment|Lack of Efficacy|41
2957989|NCT01243424|10183179|P1|Discontinuation From Treatment|Lack of Efficacy|61
2957990|NCT01243424|10183178|P2|Discontinuation From Treatment|Adverse Event|523
2957991|NCT01243424|10183179|P1|Discontinuation From Treatment|Adverse Event|457
2957992|NCT01243424|10183178|P2|Discontinuation From Treatment|Not treated|4
2957993|NCT01243424|10183179|P1|Discontinuation From Treatment|Not treated|5
2957994|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|Not treated|4
2957995|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|Not treated|5
2957996|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
2957997|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
2957998|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|35
2957999|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|38
2958000|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
2958001|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
2958002|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
2958003|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
2958004|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
2958005|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
2958006|NCT01243424|10183178|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
2958007|NCT01243424|10183179|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
2958008|NCT01243411|10183221|P1|Overall Study|Other|8
2958009|NCT01243411|10183221|P1|Overall Study|Adverse Event|5
2958010|NCT01243411|10183221|P1|Overall Study|Lost to Follow-up|10
2958011|NCT01243411|10183221|P1|Overall Study|Withdrawal by Subject|18
2958012|NCT01243268|10183332|P1|Overall Study|Duplicate subject|2
2958013|NCT01243268|10183332|P1|Overall Study|Deviation with contract date|7
2958014|NCT01243268|10183332|P1|Overall Study|Protocol Violation|51
2958015|NCT01243268|10183332|P1|Overall Study|Lost to Follow-up|4
2958016|NCT01243242|10183342|P2|Overall Study|non compliance|0
2958017|NCT01243242|10183343|P1|Overall Study|non compliance|1
2958018|NCT01243242|10183342|P2|Overall Study|sponsor decision|1
2958019|NCT01243242|10183343|P1|Overall Study|sponsor decision|0
2958020|NCT01243242|10183342|P2|Overall Study|Physician Decision|1
2958021|NCT01243242|10183343|P1|Overall Study|Physician Decision|0
2958022|NCT01243242|10183342|P2|Overall Study|Withdrawal by Subject|1
2958023|NCT01243242|10183343|P1|Overall Study|Withdrawal by Subject|1
2958024|NCT01243242|10183342|P2|Overall Study|Adverse Event|1
2958025|NCT01243242|10183343|P1|Overall Study|Adverse Event|1
2958026|NCT01243177|10183357|P2|Overall Study|Other Reason|12
2958027|NCT01243177|10183358|P1|Overall Study|Other Reason|11
2958028|NCT01243177|10183357|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2958029|NCT01243177|10183358|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2958030|NCT01243177|10183357|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
2958031|NCT01243177|10183358|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
2958032|NCT01243177|10183357|P2|Overall Study|AE, non-serious non-fatal|58
2958033|NCT01243177|10183358|P1|Overall Study|AE, non-serious non-fatal|40
2958034|NCT01243177|10183357|P2|Overall Study|SAE, non-fatal|9
2958035|NCT01243177|10183358|P1|Overall Study|SAE, non-fatal|7
2958036|NCT01243177|10183357|P2|Overall Study|AE, serious fatal|1
2958037|NCT01243177|10183358|P1|Overall Study|AE, serious fatal|0
2958038|NCT01243177|10183357|P2|Overall Study|Withdrawal by Subject|38
2958039|NCT01243177|10183358|P1|Overall Study|Withdrawal by Subject|46
2958040|NCT01243177|10183357|P2|Overall Study|Lost to Follow-up|18
2958041|NCT01243177|10183358|P1|Overall Study|Lost to Follow-up|15
2958042|NCT01243177|10183357|P2|Overall Study|Protocol Violation|10
2958043|NCT01243177|10183358|P1|Overall Study|Protocol Violation|11
2958044|NCT01243177|10183357|P2|Overall Study|Lack of Efficacy|31
2958045|NCT01243177|10183358|P1|Overall Study|Lack of Efficacy|47
2958046|NCT01243151|10183379|P5|Overall Study|Randomized but not treated|0
2958047|NCT01243151|10183380|P4|Overall Study|Randomized but not treated|1
2958048|NCT01243151|10183381|P3|Overall Study|Randomized but not treated|0
2958049|NCT01243151|10183382|P2|Overall Study|Randomized but not treated|0
2958050|NCT01243151|10183383|P1|Overall Study|Randomized but not treated|0
2958051|NCT01243151|10183379|P5|Overall Study|Other|0
2958052|NCT01243151|10183380|P4|Overall Study|Other|1
2958053|NCT01243151|10183381|P3|Overall Study|Other|0
2958054|NCT01243151|10183382|P2|Overall Study|Other|0
2958055|NCT01243151|10183383|P1|Overall Study|Other|0
2958056|NCT01243151|10183379|P5|Overall Study|Protocol Violation|0
2958057|NCT01243151|10183380|P4|Overall Study|Protocol Violation|0
2958058|NCT01243151|10183381|P3|Overall Study|Protocol Violation|1
2958059|NCT01243151|10183382|P2|Overall Study|Protocol Violation|0
2958060|NCT01243151|10183383|P1|Overall Study|Protocol Violation|0
2958061|NCT01243151|10183379|P5|Overall Study|Adverse Event|0
2958062|NCT01243151|10183380|P4|Overall Study|Adverse Event|0
2958063|NCT01243151|10183381|P3|Overall Study|Adverse Event|0
2958064|NCT01243151|10183382|P2|Overall Study|Adverse Event|1
2958065|NCT01243151|10183383|P1|Overall Study|Adverse Event|0
2958066|NCT01242813|10183627|P1|Overall Study|Lost to Follow-up|2
2958067|NCT01242748|10183649|P2|Overall Study|Miscellaneous reasons|3
2958068|NCT01242748|10183650|P1|Overall Study|Miscellaneous reasons|8
2958069|NCT01242748|10183649|P2|Overall Study|Withdrawal by Subject|2
2958070|NCT01242748|10183650|P1|Overall Study|Withdrawal by Subject|10
2958071|NCT01242748|10183649|P2|Overall Study|Protocol Violation|0
2958072|NCT01242748|10183650|P1|Overall Study|Protocol Violation|1
2958073|NCT01242748|10183649|P2|Overall Study|Physician Decision|2
2958074|NCT01242748|10183650|P1|Overall Study|Physician Decision|3
2958075|NCT01242748|10183649|P2|Overall Study|Lost to Follow-up|2
2958076|NCT01242748|10183650|P1|Overall Study|Lost to Follow-up|6
2958077|NCT01242748|10183649|P2|Overall Study|Adverse Event|5
2958078|NCT01242748|10183650|P1|Overall Study|Adverse Event|10
2958079|NCT01242514|10183690|P3|Overall Study|Adverse Event|19
2958080|NCT01242514|10183691|P2|Overall Study|Adverse Event|18
2958081|NCT01242514|10183692|P1|Overall Study|Adverse Event|129
2958082|NCT01242514|10183690|P3|Overall Study|Lost to Follow-up|4
2958083|NCT01242514|10183691|P2|Overall Study|Lost to Follow-up|5
2958084|NCT01242514|10183692|P1|Overall Study|Lost to Follow-up|14
2958085|NCT01242514|10183690|P3|Overall Study|Dev. of study specific discont. criteria|5
2958086|NCT01242514|10183691|P2|Overall Study|Dev. of study specific discont. criteria|3
2958087|NCT01242514|10183692|P1|Overall Study|Dev. of study specific discont. criteria|21
2958088|NCT01242514|10183690|P3|Overall Study|Lack of therapeutic response|10
2958089|NCT01242514|10183691|P2|Overall Study|Lack of therapeutic response|16
2958090|NCT01242514|10183692|P1|Overall Study|Lack of therapeutic response|99
2958091|NCT01242514|10183690|P3|Overall Study|Severe non-compliance to protocol|1
2958092|NCT01242514|10183691|P2|Overall Study|Severe non-compliance to protocol|2
2958093|NCT01242514|10183692|P1|Overall Study|Severe non-compliance to protocol|5
2958094|NCT01242514|10183690|P3|Overall Study|Subject decision|2
2958095|NCT01242514|10183691|P2|Overall Study|Subject decision|8
2958096|NCT01242514|10183692|P1|Overall Study|Subject decision|33
2958097|NCT01242514|10183690|P3|Overall Study|e.g., project closure|171
2958098|NCT01242514|10183691|P2|Overall Study|e.g., project closure|305
2958099|NCT01242514|10183692|P1|Overall Study|e.g., project closure|1042
2958100|NCT01242371|10183711|P2|Overall Study|Protocol Violation|3
2958101|NCT01242371|10183712|P1|Overall Study|Protocol Violation|0
2958102|NCT01242371|10183711|P2|Overall Study|Withdrawal by Subject|2
2958103|NCT01242371|10183712|P1|Overall Study|Withdrawal by Subject|2
2958104|NCT01242176|10183718|P2|Washout Period of 7 Days|Non-compliant with protocol|0
2958105|NCT01242176|10183719|P1|Washout Period of 7 Days|Non-compliant with protocol|1
2958106|NCT01242176|10183718|P2|Washout Period of 7 Days|Adverse Event|2
2958107|NCT01242176|10183719|P1|Washout Period of 7 Days|Adverse Event|0
2958108|NCT01242111|10183729|P1|Overall Study|Did not consent to MOR-100 follow-up|1
2958109|NCT01242111|10183729|P1|Overall Study|Withdrawal by Subject|1
2958110|NCT01242111|10183729|P1|Overall Study|Adverse Event|1
2958111|NCT01242085|10183741|P3|Overall Study|medically unable to have surgery|0
2958112|NCT01242085|10183742|P2|Overall Study|medically unable to have surgery|5
2958113|NCT01242085|10183743|P1|Overall Study|medically unable to have surgery|4
2958114|NCT01242085|10183741|P3|Overall Study|Withdrawal by Subject|0
2958115|NCT01242085|10183742|P2|Overall Study|Withdrawal by Subject|2
2958116|NCT01242085|10183743|P1|Overall Study|Withdrawal by Subject|4
2958117|NCT01242020|10183753|P2|Overall Study|Failed screening|0
2958118|NCT01242020|10183754|P1|Overall Study|Failed screening|1
2958119|NCT01242020|10183753|P2|Overall Study|Withdrawal by Subject|0
2958120|NCT01242020|10183754|P1|Overall Study|Withdrawal by Subject|2
2958121|NCT01241760|10183784|P2|Overall Study|Other|1
2958122|NCT01241760|10183785|P1|Overall Study|Other|1
2958123|NCT01241760|10183784|P2|Overall Study|Switch To Commercially Available Medicat|4
2958124|NCT01241760|10183785|P1|Overall Study|Switch To Commercially Available Medicat|1
2958125|NCT01241760|10183784|P2|Overall Study|Withdrawal by Subject|13
2958126|NCT01241760|10183785|P1|Overall Study|Withdrawal by Subject|13
2958127|NCT01241760|10183784|P2|Overall Study|Lost to Follow-up|22
2958128|NCT01241760|10183785|P1|Overall Study|Lost to Follow-up|18
2958129|NCT01241760|10183784|P2|Overall Study|Adverse Event|0
2958130|NCT01241760|10183785|P1|Overall Study|Adverse Event|1
2958131|NCT01241604|10183804|P3|Screening Period|Screen Failure|0
2958132|NCT01241604|10183805|P2|Screening Period|Screen Failure|0
2958133|NCT01241604|10183806|P1|Screening Period|Screen Failure|3
2958134|NCT01241591|10183851|P4|Overall Study|Adverse Event|4
2958135|NCT01241591|10183852|P3|Overall Study|Adverse Event|12
2958136|NCT01241591|10183853|P2|Overall Study|Adverse Event|11
2958137|NCT01241591|10183854|P1|Overall Study|Adverse Event|3
2958138|NCT01241591|10183851|P4|Overall Study|Other|1
2958139|NCT01241591|10183852|P3|Overall Study|Other|0
2958140|NCT01241591|10183853|P2|Overall Study|Other|1
2958141|NCT01241591|10183854|P1|Overall Study|Other|0
2958142|NCT01241591|10183851|P4|Overall Study|Withdrawal by Subject|2
2958143|NCT01241591|10183852|P3|Overall Study|Withdrawal by Subject|2
2958144|NCT01241591|10183853|P2|Overall Study|Withdrawal by Subject|4
2958145|NCT01241591|10183854|P1|Overall Study|Withdrawal by Subject|6
2958146|NCT01241591|10183851|P4|Overall Study|Screen Failure|0
2958147|NCT01241591|10183852|P3|Overall Study|Screen Failure|1
2958148|NCT01241591|10183853|P2|Overall Study|Screen Failure|2
2958149|NCT01241591|10183854|P1|Overall Study|Screen Failure|3
2958150|NCT01241591|10183851|P4|Overall Study|Lost to Follow-up|2
2958151|NCT01241591|10183852|P3|Overall Study|Lost to Follow-up|2
2958152|NCT01241591|10183853|P2|Overall Study|Lost to Follow-up|2
2958153|NCT01241591|10183854|P1|Overall Study|Lost to Follow-up|1
2958154|NCT01241591|10183851|P4|Overall Study|Protocol Violation|0
2958155|NCT01241591|10183852|P3|Overall Study|Protocol Violation|3
2958156|NCT01241591|10183853|P2|Overall Study|Protocol Violation|2
2958157|NCT01241591|10183854|P1|Overall Study|Protocol Violation|5
2958158|NCT01241591|10183851|P4|Overall Study|Lack of Efficacy|3
2958159|NCT01241591|10183852|P3|Overall Study|Lack of Efficacy|2
2958160|NCT01241591|10183853|P2|Overall Study|Lack of Efficacy|2
2958161|NCT01241591|10183854|P1|Overall Study|Lack of Efficacy|5
2958162|NCT01241552|10184057|P4|Overall Study|Lost to Follow-up|16
2958163|NCT01241552|10184058|P3|Overall Study|Lost to Follow-up|15
2958164|NCT01241552|10184059|P2|Overall Study|Lost to Follow-up|11
2958165|NCT01241552|10184060|P1|Overall Study|Lost to Follow-up|2
2958166|NCT01241552|10184057|P4|Overall Study|Physician Decision|3
2958167|NCT01241552|10184058|P3|Overall Study|Physician Decision|2
2958168|NCT01241552|10184059|P2|Overall Study|Physician Decision|4
2958169|NCT01241552|10184060|P1|Overall Study|Physician Decision|2
2958170|NCT01241552|10184057|P4|Overall Study|Withdrawal by Subject|15
2958171|NCT01241552|10184058|P3|Overall Study|Withdrawal by Subject|14
2958172|NCT01241552|10184059|P2|Overall Study|Withdrawal by Subject|15
2958173|NCT01241552|10184060|P1|Overall Study|Withdrawal by Subject|7
2958174|NCT01241552|10184057|P4|Overall Study|Protocol Violation|1
2958175|NCT01241552|10184058|P3|Overall Study|Protocol Violation|6
2958176|NCT01241552|10184059|P2|Overall Study|Protocol Violation|2
2958177|NCT01241552|10184060|P1|Overall Study|Protocol Violation|0
2958178|NCT01241552|10184057|P4|Overall Study|Progressive Disease|2
2958179|NCT01241552|10184058|P3|Overall Study|Progressive Disease|1
2958180|NCT01241552|10184059|P2|Overall Study|Progressive Disease|0
2958181|NCT01241552|10184060|P1|Overall Study|Progressive Disease|0
2958182|NCT01241552|10184057|P4|Overall Study|Technical Problems|2
2958183|NCT01241552|10184058|P3|Overall Study|Technical Problems|2
2958184|NCT01241552|10184059|P2|Overall Study|Technical Problems|0
2958185|NCT01241552|10184060|P1|Overall Study|Technical Problems|2
2958186|NCT01241552|10184057|P4|Overall Study|Adverse Event|0
2958187|NCT01241552|10184058|P3|Overall Study|Adverse Event|0
2958188|NCT01241552|10184059|P2|Overall Study|Adverse Event|1
2958189|NCT01241552|10184060|P1|Overall Study|Adverse Event|1
2958190|NCT01241552|10184057|P4|Overall Study|Death|25
2958191|NCT01241552|10184058|P3|Overall Study|Death|20
2958192|NCT01241552|10184059|P2|Overall Study|Death|30
2958193|NCT01241552|10184060|P1|Overall Study|Death|26
2958194|NCT01241552|10184057|P4|Overall Study|Lack of Efficacy|0
2958195|NCT01241552|10184058|P3|Overall Study|Lack of Efficacy|0
2958196|NCT01241552|10184059|P2|Overall Study|Lack of Efficacy|0
2958197|NCT01241552|10184060|P1|Overall Study|Lack of Efficacy|1
2958198|NCT01241461|10184155|P2|Overall Study|Progressive Disease|6
2958199|NCT01241461|10184156|P1|Overall Study|Progressive Disease|3
2958200|NCT01241448|10184176|P4|Overall Study|Excluded due to data integrity issues|2
2958201|NCT01241448|10184177|P3|Overall Study|Excluded due to data integrity issues|2
2958202|NCT01241448|10184178|P2|Overall Study|Excluded due to data integrity issues|2
2958203|NCT01241448|10184179|P1|Overall Study|Excluded due to data integrity issues|3
2958204|NCT01241448|10184176|P4|Overall Study|Withdrawal by Subject|6
2958205|NCT01241448|10184177|P3|Overall Study|Withdrawal by Subject|3
2958206|NCT01241448|10184178|P2|Overall Study|Withdrawal by Subject|5
2958207|NCT01241448|10184179|P1|Overall Study|Withdrawal by Subject|4
2958208|NCT01241448|10184176|P4|Overall Study|Sponsor Decision|6
2958209|NCT01241448|10184177|P3|Overall Study|Sponsor Decision|12
2958210|NCT01241448|10184178|P2|Overall Study|Sponsor Decision|14
2958211|NCT01241448|10184179|P1|Overall Study|Sponsor Decision|17
2958212|NCT01241448|10184176|P4|Overall Study|Protocol Violation|6
2958213|NCT01241448|10184177|P3|Overall Study|Protocol Violation|3
2958214|NCT01241448|10184178|P2|Overall Study|Protocol Violation|5
2958215|NCT01241448|10184179|P1|Overall Study|Protocol Violation|10
2958216|NCT01241448|10184176|P4|Overall Study|Physician Decision|0
2958217|NCT01241448|10184177|P3|Overall Study|Physician Decision|0
2958218|NCT01241448|10184178|P2|Overall Study|Physician Decision|2
2958219|NCT01241448|10184179|P1|Overall Study|Physician Decision|0
2958220|NCT01241448|10184176|P4|Overall Study|Lost to Follow-up|1
2958221|NCT01241448|10184177|P3|Overall Study|Lost to Follow-up|1
2958222|NCT01241448|10184178|P2|Overall Study|Lost to Follow-up|1
2958223|NCT01241448|10184179|P1|Overall Study|Lost to Follow-up|2
2958224|NCT01241448|10184176|P4|Overall Study|Adverse Event|2
2958225|NCT01241448|10184177|P3|Overall Study|Adverse Event|2
2958226|NCT01241448|10184178|P2|Overall Study|Adverse Event|0
2958227|NCT01241448|10184179|P1|Overall Study|Adverse Event|1
2958228|NCT01241318|10184270|P2|Overall Study|Woman: Stillborn infant|146
2958229|NCT01241318|10184271|P1|Overall Study|Woman: Stillborn infant|129
2958230|NCT01241318|10184270|P2|Overall Study|Withdrew/LTF after delivery|38
2958231|NCT01241318|10184271|P1|Overall Study|Withdrew/LTF after delivery|60
2958232|NCT01241318|10184270|P2|Overall Study|Death|4
2958233|NCT01241318|10184271|P1|Overall Study|Death|2
2958234|NCT01241318|10184270|P2|Overall Study|Lost to Follow-up|455
2958235|NCT01241318|10184271|P1|Overall Study|Lost to Follow-up|740
2958236|NCT01241318|10184270|P2|Overall Study|Withdrawal by Subject|46
2958237|NCT01241318|10184271|P1|Overall Study|Withdrawal by Subject|175
2958238|NCT01241318|10184270|P2|Overall Study|Woman: miscarriage/abortion|38
2958239|NCT01241318|10184271|P1|Overall Study|Woman: miscarriage/abortion|46
2958240|NCT01241318|10184270|P2|Overall Study|Woman: false pregnancies|15
2958241|NCT01241318|10184271|P1|Overall Study|Woman: false pregnancies|27
2958242|NCT01241292|10184284|P2|Overall Study|Participant Discontinued Treatment|2
2958243|NCT01241292|10184285|P1|Overall Study|Participant Discontinued Treatment|0
2958244|NCT01241292|10184284|P2|Overall Study|Study Drug Toxicity|1
2958245|NCT01241292|10184285|P1|Overall Study|Study Drug Toxicity|0
2958246|NCT01241292|10184284|P2|Overall Study|Disease Progression|0
2958247|NCT01241292|10184285|P1|Overall Study|Disease Progression|2
2958248|NCT01241292|10184284|P2|Overall Study|Administrative Reason by Sponsor|0
2958249|NCT01241292|10184285|P1|Overall Study|Administrative Reason by Sponsor|1
2958250|NCT01241279|10184309|P2|Overall Study|Lost to Follow-up|1
2958251|NCT01241279|10184310|P1|Overall Study|Lost to Follow-up|0
2958252|NCT01241240|10184320|P2|Overall Study|Personal Reasons|1
2958253|NCT01241240|10184321|P1|Overall Study|Personal Reasons|1
2958254|NCT01241240|10184320|P2|Overall Study|Lost to Follow-up|4
2958255|NCT01241240|10184321|P1|Overall Study|Lost to Follow-up|2
2958256|NCT01241240|10184320|P2|Overall Study|Adverse Event|4
2958257|NCT01241240|10184321|P1|Overall Study|Adverse Event|5
2958258|NCT01240915|10184339|P9|Overall Study|Insufficient Clinical Response|3
2958259|NCT01240915|10184340|P8|Overall Study|Insufficient Clinical Response|0
2958260|NCT01240915|10184341|P7|Overall Study|Insufficient Clinical Response|6
2958261|NCT01240915|10184342|P6|Overall Study|Insufficient Clinical Response|3
2958262|NCT01240915|10184343|P5|Overall Study|Insufficient Clinical Response|1
2958263|NCT01240915|10184344|P4|Overall Study|Insufficient Clinical Response|0
2958264|NCT01240915|10184345|P3|Overall Study|Insufficient Clinical Response|0
2958265|NCT01240915|10184346|P2|Overall Study|Insufficient Clinical Response|0
2958266|NCT01240915|10184347|P1|Overall Study|Insufficient Clinical Response|0
2958267|NCT01240915|10184339|P9|Overall Study|Other|0
2958268|NCT01240915|10184340|P8|Overall Study|Other|0
2958269|NCT01240915|10184341|P7|Overall Study|Other|0
2958270|NCT01240915|10184342|P6|Overall Study|Other|0
2958271|NCT01240915|10184343|P5|Overall Study|Other|2
2958272|NCT01240915|10184344|P4|Overall Study|Other|0
2958273|NCT01240915|10184345|P3|Overall Study|Other|0
2958274|NCT01240915|10184346|P2|Overall Study|Other|0
2958275|NCT01240915|10184347|P1|Overall Study|Other|0
2958276|NCT01240915|10184339|P9|Overall Study|Withdrawal by Subject|3
2958277|NCT01240915|10184340|P8|Overall Study|Withdrawal by Subject|3
2958278|NCT01240915|10184341|P7|Overall Study|Withdrawal by Subject|2
2958279|NCT01240915|10184342|P6|Overall Study|Withdrawal by Subject|4
2958280|NCT01240915|10184343|P5|Overall Study|Withdrawal by Subject|0
2958281|NCT01240915|10184344|P4|Overall Study|Withdrawal by Subject|2
2958282|NCT01240915|10184345|P3|Overall Study|Withdrawal by Subject|0
2958283|NCT01240915|10184346|P2|Overall Study|Withdrawal by Subject|1
2958284|NCT01240915|10184347|P1|Overall Study|Withdrawal by Subject|2
2958285|NCT01240915|10184339|P9|Overall Study|Lost to Follow-up|1
2958286|NCT01240915|10184340|P8|Overall Study|Lost to Follow-up|1
2958287|NCT01240915|10184341|P7|Overall Study|Lost to Follow-up|0
2958288|NCT01240915|10184342|P6|Overall Study|Lost to Follow-up|1
2958289|NCT01240915|10184343|P5|Overall Study|Lost to Follow-up|1
2958290|NCT01240915|10184344|P4|Overall Study|Lost to Follow-up|0
2958291|NCT01240915|10184345|P3|Overall Study|Lost to Follow-up|0
2958292|NCT01240915|10184346|P2|Overall Study|Lost to Follow-up|0
2958293|NCT01240915|10184347|P1|Overall Study|Lost to Follow-up|0
2958294|NCT01240915|10184339|P9|Overall Study|Adverse Event|1
2958295|NCT01240915|10184340|P8|Overall Study|Adverse Event|0
2958296|NCT01240915|10184341|P7|Overall Study|Adverse Event|0
2958297|NCT01240915|10184342|P6|Overall Study|Adverse Event|2
2958298|NCT01240915|10184343|P5|Overall Study|Adverse Event|0
2958299|NCT01240915|10184344|P4|Overall Study|Adverse Event|1
2958300|NCT01240915|10184345|P3|Overall Study|Adverse Event|0
2958301|NCT01240915|10184346|P2|Overall Study|Adverse Event|0
2958302|NCT01240915|10184347|P1|Overall Study|Adverse Event|0
2958303|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2958304|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
2958305|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2958306|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Other|5
2958307|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Other|1
2958308|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Other|0
2958309|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2958310|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2958311|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
2958312|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
2958313|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
2958314|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2958315|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
2958316|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2958317|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2958318|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
2958319|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
2958320|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2958321|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2958322|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2958323|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2958324|NCT01240863|10184621|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
2958325|NCT01240863|10184622|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
2958326|NCT01240863|10184623|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2958327|NCT01240863|10184621|P3|Open-label Titration Period|Other|0
2958328|NCT01240863|10184622|P2|Open-label Titration Period|Other|0
2958329|NCT01240863|10184623|P1|Open-label Titration Period|Other|7
2958330|NCT01240863|10184621|P3|Open-label Titration Period|Dropped out prior to dosing|0
2958331|NCT01240863|10184622|P2|Open-label Titration Period|Dropped out prior to dosing|0
2958332|NCT01240863|10184623|P1|Open-label Titration Period|Dropped out prior to dosing|2
2958333|NCT01240863|10184621|P3|Open-label Titration Period|Noncompliance to study procedures|0
2958334|NCT01240863|10184622|P2|Open-label Titration Period|Noncompliance to study procedures|0
2958335|NCT01240863|10184623|P1|Open-label Titration Period|Noncompliance to study procedures|3
2958336|NCT01240863|10184621|P3|Open-label Titration Period|Noncompliance to study drug admin|0
2958337|NCT01240863|10184622|P2|Open-label Titration Period|Noncompliance to study drug admin|0
2958338|NCT01240863|10184623|P1|Open-label Titration Period|Noncompliance to study drug admin|3
2958339|NCT01240863|10184621|P3|Open-label Titration Period|Protocol Violation|0
2958340|NCT01240863|10184622|P2|Open-label Titration Period|Protocol Violation|0
2958341|NCT01240863|10184623|P1|Open-label Titration Period|Protocol Violation|7
2958342|NCT01240863|10184621|P3|Open-label Titration Period|Withdrawal by Subject|0
2958343|NCT01240863|10184622|P2|Open-label Titration Period|Withdrawal by Subject|0
2958344|NCT01240863|10184623|P1|Open-label Titration Period|Withdrawal by Subject|9
2958345|NCT01240863|10184621|P3|Open-label Titration Period|Lack of Efficacy|0
2958346|NCT01240863|10184622|P2|Open-label Titration Period|Lack of Efficacy|0
2958347|NCT01240863|10184623|P1|Open-label Titration Period|Lack of Efficacy|19
2958348|NCT01240863|10184621|P3|Open-label Titration Period|Adverse Event|0
2958349|NCT01240863|10184622|P2|Open-label Titration Period|Adverse Event|0
2958350|NCT01240863|10184623|P1|Open-label Titration Period|Adverse Event|47
2958351|NCT01240811|10184685|P3|Overall Study|Withdrawal by Subject|1
2958352|NCT01240811|10184686|P2|Overall Study|Withdrawal by Subject|0
2958353|NCT01240811|10184687|P1|Overall Study|Withdrawal by Subject|0
2958354|NCT01240811|10184685|P3|Overall Study|Physician Decision|0
2958355|NCT01240811|10184686|P2|Overall Study|Physician Decision|1
2958356|NCT01240811|10184687|P1|Overall Study|Physician Decision|0
2958357|NCT01240785|10184703|P2|Overall Study|Protocol Violation|3
2958358|NCT01240785|10184704|P1|Overall Study|Protocol Violation|0
2958359|NCT01240785|10184703|P2|Overall Study|Lost to Follow-up|0
2958360|NCT01240785|10184704|P1|Overall Study|Lost to Follow-up|1
2958361|NCT01240746|10184735|P3|Overall Study|Withdrawal by Subject|59
2958362|NCT01240746|10184736|P2|Overall Study|Withdrawal by Subject|13
2958363|NCT01240746|10184737|P1|Overall Study|Withdrawal by Subject|10
2958364|NCT01240746|10184735|P3|Overall Study|Protocol Violation|72
2958365|NCT01240746|10184736|P2|Overall Study|Protocol Violation|15
2958366|NCT01240746|10184737|P1|Overall Study|Protocol Violation|24
2958367|NCT01240746|10184735|P3|Overall Study|Lost to Follow-up|102
2958368|NCT01240746|10184736|P2|Overall Study|Lost to Follow-up|20
2958369|NCT01240746|10184737|P1|Overall Study|Lost to Follow-up|23
2958370|NCT01240746|10184735|P3|Overall Study|Adverse Event|10
2958371|NCT01240746|10184736|P2|Overall Study|Adverse Event|0
2958372|NCT01240746|10184737|P1|Overall Study|Adverse Event|2
2958373|NCT01240590|10184792|P5|Phase II|Refused further treatment|1
2958374|NCT01240590|10184793|P4|Phase II|Refused further treatment|2
2958375|NCT01240590|10184794|P3|Phase II|Refused further treatment|0
2958376|NCT01240590|10184795|P2|Phase II|Refused further treatment|0
2958377|NCT01240590|10184796|P1|Phase II|Refused further treatment|0
2958378|NCT01240590|10184792|P5|Phase I|Refused further treatment|0
2958379|NCT01240590|10184793|P4|Phase I|Refused further treatment|0
2958380|NCT01240590|10184794|P3|Phase I|Refused further treatment|3
2958381|NCT01240590|10184795|P2|Phase I|Refused further treatment|0
2958382|NCT01240590|10184796|P1|Phase I|Refused further treatment|0
2958383|NCT01240551|10184824|P2|Overall Study|Lost to Follow-up|1
2958384|NCT01240551|10184825|P1|Overall Study|Lost to Follow-up|1
2958385|NCT01240551|10184824|P2|Overall Study|Refused further treatment|2
2958386|NCT01240551|10184825|P1|Overall Study|Refused further treatment|3
2958387|NCT01240382|10184835|P2|Overall Study|Fear of adverse events|1
2958388|NCT01240382|10184836|P1|Overall Study|Fear of adverse events|0
2958389|NCT01240382|10184835|P2|Overall Study|Lack of Efficacy|2
2958390|NCT01240382|10184836|P1|Overall Study|Lack of Efficacy|0
2958391|NCT01240382|10184835|P2|Overall Study|Adverse Event|1
2958392|NCT01240382|10184836|P1|Overall Study|Adverse Event|2
2958393|NCT01240356|10184846|P2|Overall Study|MRI contraindication|0
2958394|NCT01240356|10184847|P1|Overall Study|MRI contraindication|1
2958395|NCT01240356|10184846|P2|Overall Study|Withdrawal by Subject|0
2958396|NCT01240356|10184847|P1|Overall Study|Withdrawal by Subject|2
2958397|NCT01240200|10184870|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
2958398|NCT01240200|10184871|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
2958399|NCT01240135|10184889|P2|Period Two, 14 Days of Wear|Adverse Event|1
2958400|NCT01240135|10184890|P1|Period Two, 14 Days of Wear|Adverse Event|0
2958401|NCT01240135|10184889|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2958402|NCT01240135|10184890|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2958403|NCT01239992|10184907|P1|Overall Study|Withdrawal by Subject|2
2958404|NCT01239797|10184916|P2|Treated Participants|Poor/Non-compliance|1
2958405|NCT01239797|10184917|P1|Treated Participants|Poor/Non-compliance|0
2958406|NCT01239797|10184916|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
2958407|NCT01239797|10184917|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
2958408|NCT01239797|10184916|P2|Treated Participants|Death|1
2958409|NCT01239797|10184917|P1|Treated Participants|Death|1
2958410|NCT01239797|10184916|P2|Treated Participants|Non-specified|11
2958411|NCT01239797|10184917|P1|Treated Participants|Non-specified|1
2958412|NCT01239797|10184916|P2|Treated Participants|Withdrawal by Subject|23
2958413|NCT01239797|10184917|P1|Treated Participants|Withdrawal by Subject|27
2958414|NCT01239797|10184916|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
2958415|NCT01239797|10184917|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
2958416|NCT01239797|10184916|P2|Treated Participants|Study Drug Toxicity|44
2958417|NCT01239797|10184917|P1|Treated Participants|Study Drug Toxicity|30
2958418|NCT01239797|10184916|P2|Treated Participants|Disease Progression|161
2958419|NCT01239797|10184917|P1|Treated Participants|Disease Progression|153
2958420|NCT01239745|10184925|P1|Overall Study|Adverse Event|1
2958421|NCT01239745|10184925|P1|Overall Study|Study terminated by sponsor|45
2958422|NCT01239732|10184936|P1|Overall Study|Other|19
2958423|NCT01239732|10184936|P1|Overall Study|Treatment failure|2
2958424|NCT01239732|10184936|P1|Overall Study|Investigator's decision|4
2958425|NCT01239732|10184936|P1|Overall Study|Study termination by sponsor|2
2958426|NCT01239732|10184936|P1|Overall Study|Participant non compliance|5
2958427|NCT01239732|10184936|P1|Overall Study|Protocol Violation|3
2958428|NCT01239732|10184936|P1|Overall Study|Adverse Event|6
2958429|NCT01239732|10184936|P1|Overall Study|Withdrawal by Subject|87
2958430|NCT01239732|10184936|P1|Overall Study|Death|226
2958431|NCT01239732|10184936|P1|Overall Study|Termination of study per protocol|667
2958432|NCT01239680|10184949|P2|Overall Study|Withdrawal by Subject|0
2958433|NCT01239680|10184950|P1|Overall Study|Withdrawal by Subject|2
2958434|NCT01239472|10184975|P2|Overall Study|Lack of Efficacy|1
2958435|NCT01239472|10184976|P1|Overall Study|Lack of Efficacy|0
2958436|NCT01239472|10184975|P2|Overall Study|Adverse Event|1
2958437|NCT01239472|10184976|P1|Overall Study|Adverse Event|0
2958438|NCT01239472|10184975|P2|Overall Study|Withdrawal by Subject|1
2958439|NCT01239472|10184976|P1|Overall Study|Withdrawal by Subject|5
2958440|NCT01239394|10184984|P1|Overall Study|Adverse Event|1
2958441|NCT01239381|10184991|P1|Overall Study|Withdrawal by Subject|1
2958442|NCT01239381|10184991|P1|Overall Study|Protocol Violation|1
2958443|NCT01239368|10185011|P10|Overall Study|Death|0
2958444|NCT01239368|10185012|P9|Overall Study|Death|0
2958445|NCT01239368|10185013|P8|Overall Study|Death|0
2958446|NCT01239368|10185014|P7|Overall Study|Death|1
2958447|NCT01239368|10185015|P6|Overall Study|Death|0
2958448|NCT01239368|10185016|P5|Overall Study|Death|0
2958449|NCT01239368|10185017|P4|Overall Study|Death|0
2958450|NCT01239368|10185018|P3|Overall Study|Death|0
2958451|NCT01239368|10185019|P2|Overall Study|Death|0
2958452|NCT01239368|10185020|P1|Overall Study|Death|0
2958453|NCT01239368|10185011|P10|Overall Study|Refused further treatment|1
2958454|NCT01239368|10185012|P9|Overall Study|Refused further treatment|0
2958455|NCT01239368|10185013|P8|Overall Study|Refused further treatment|0
2958456|NCT01239368|10185014|P7|Overall Study|Refused further treatment|0
2958457|NCT01239368|10185015|P6|Overall Study|Refused further treatment|0
2958458|NCT01239368|10185016|P5|Overall Study|Refused further treatment|0
2958459|NCT01239368|10185017|P4|Overall Study|Refused further treatment|0
2958460|NCT01239368|10185018|P3|Overall Study|Refused further treatment|0
2958461|NCT01239368|10185019|P2|Overall Study|Refused further treatment|0
2958462|NCT01239368|10185020|P1|Overall Study|Refused further treatment|0
2958463|NCT01239368|10185011|P10|Overall Study|Disease progression on study|2
2958464|NCT01239368|10185012|P9|Overall Study|Disease progression on study|0
2958465|NCT01239368|10185013|P8|Overall Study|Disease progression on study|0
2958466|NCT01239368|10185014|P7|Overall Study|Disease progression on study|5
2958467|NCT01239368|10185015|P6|Overall Study|Disease progression on study|2
2958468|NCT01239368|10185016|P5|Overall Study|Disease progression on study|4
2958469|NCT01239368|10185017|P4|Overall Study|Disease progression on study|1
2958470|NCT01239368|10185018|P3|Overall Study|Disease progression on study|1
2958471|NCT01239368|10185019|P2|Overall Study|Disease progression on study|1
2958472|NCT01239368|10185020|P1|Overall Study|Disease progression on study|1
2958473|NCT01239368|10185011|P10|Overall Study|Principal investigator discretion|1
2958474|NCT01239368|10185012|P9|Overall Study|Principal investigator discretion|0
2958475|NCT01239368|10185013|P8|Overall Study|Principal investigator discretion|0
2958476|NCT01239368|10185014|P7|Overall Study|Principal investigator discretion|0
2958477|NCT01239368|10185015|P6|Overall Study|Principal investigator discretion|2
2958478|NCT01239368|10185016|P5|Overall Study|Principal investigator discretion|1
2958479|NCT01239368|10185017|P4|Overall Study|Principal investigator discretion|0
2958480|NCT01239368|10185018|P3|Overall Study|Principal investigator discretion|0
2958481|NCT01239368|10185019|P2|Overall Study|Principal investigator discretion|0
2958482|NCT01239368|10185020|P1|Overall Study|Principal investigator discretion|1
2958483|NCT01239342|10185072|P2|Overall Study|Reason Unknown|1
2958484|NCT01239342|10185073|P1|Overall Study|Reason Unknown|1
2958485|NCT01239342|10185072|P2|Overall Study|Withdrawal by Subject|5
2958486|NCT01239342|10185073|P1|Overall Study|Withdrawal by Subject|1
2958487|NCT01239342|10185072|P2|Overall Study|Adverse Event|0
2958488|NCT01239342|10185073|P1|Overall Study|Adverse Event|1
2958489|NCT01239316|10185089|P1|Overall Study|Adverse Event|1
2958490|NCT01239316|10185089|P1|Overall Study|Progression/Relapse|11
2958491|NCT01239121|10185104|P3|Overall Study|Withdrawal by Subject|0
2958492|NCT01239121|10185105|P2|Overall Study|Withdrawal by Subject|4
2958493|NCT01239121|10185106|P1|Overall Study|Withdrawal by Subject|2
2958494|NCT01239043|10185128|P2|Overall Study|Protocol Violation|1
2958495|NCT01239043|10185129|P1|Overall Study|Protocol Violation|2
2958496|NCT01238991|10185157|P10|Overall Study|Admission to a nursing home|0
2958497|NCT01238991|10185158|P9|Overall Study|Admission to a nursing home|0
2958498|NCT01238991|10185159|P8|Overall Study|Admission to a nursing home|0
2958499|NCT01238991|10185160|P7|Overall Study|Admission to a nursing home|0
2958500|NCT01238991|10185161|P6|Overall Study|Admission to a nursing home|0
2958501|NCT01238991|10185162|P5|Overall Study|Admission to a nursing home|0
2958502|NCT01238991|10185163|P4|Overall Study|Admission to a nursing home|0
2958503|NCT01238991|10185164|P3|Overall Study|Admission to a nursing home|1
2958504|NCT01238991|10185165|P2|Overall Study|Admission to a nursing home|0
2958505|NCT01238991|10185166|P1|Overall Study|Admission to a nursing home|1
2958506|NCT01238991|10185157|P10|Overall Study|Caregiver's request|0
2958507|NCT01238991|10185158|P9|Overall Study|Caregiver's request|1
2958508|NCT01238991|10185159|P8|Overall Study|Caregiver's request|0
2958509|NCT01238991|10185160|P7|Overall Study|Caregiver's request|0
2958510|NCT01238991|10185161|P6|Overall Study|Caregiver's request|0
2958511|NCT01238991|10185162|P5|Overall Study|Caregiver's request|0
2958512|NCT01238991|10185163|P4|Overall Study|Caregiver's request|0
2958513|NCT01238991|10185164|P3|Overall Study|Caregiver's request|0
2958514|NCT01238991|10185165|P2|Overall Study|Caregiver's request|0
2958515|NCT01238991|10185166|P1|Overall Study|Caregiver's request|0
2958516|NCT01238991|10185157|P10|Overall Study|Study Terminated by Sponsor|2
2958517|NCT01238991|10185158|P9|Overall Study|Study Terminated by Sponsor|2
2958518|NCT01238991|10185159|P8|Overall Study|Study Terminated by Sponsor|4
2958519|NCT01238991|10185160|P7|Overall Study|Study Terminated by Sponsor|7
2958520|NCT01238991|10185161|P6|Overall Study|Study Terminated by Sponsor|0
2958521|NCT01238991|10185162|P5|Overall Study|Study Terminated by Sponsor|1
2958522|NCT01238991|10185163|P4|Overall Study|Study Terminated by Sponsor|0
2958523|NCT01238991|10185164|P3|Overall Study|Study Terminated by Sponsor|0
2958524|NCT01238991|10185165|P2|Overall Study|Study Terminated by Sponsor|0
2958525|NCT01238991|10185166|P1|Overall Study|Study Terminated by Sponsor|0
2958526|NCT01238991|10185157|P10|Overall Study|Withdrawal by Subject|0
2958527|NCT01238991|10185158|P9|Overall Study|Withdrawal by Subject|0
2958528|NCT01238991|10185159|P8|Overall Study|Withdrawal by Subject|0
2958529|NCT01238991|10185160|P7|Overall Study|Withdrawal by Subject|0
2958530|NCT01238991|10185161|P6|Overall Study|Withdrawal by Subject|0
2958531|NCT01238991|10185162|P5|Overall Study|Withdrawal by Subject|0
2958532|NCT01238991|10185163|P4|Overall Study|Withdrawal by Subject|0
2958533|NCT01238991|10185164|P3|Overall Study|Withdrawal by Subject|1
2958534|NCT01238991|10185165|P2|Overall Study|Withdrawal by Subject|0
2958535|NCT01238991|10185166|P1|Overall Study|Withdrawal by Subject|0
2958536|NCT01238991|10185157|P10|Overall Study|Lack of Efficacy|0
2958537|NCT01238991|10185158|P9|Overall Study|Lack of Efficacy|1
2958538|NCT01238991|10185159|P8|Overall Study|Lack of Efficacy|0
2958539|NCT01238991|10185160|P7|Overall Study|Lack of Efficacy|0
2958540|NCT01238991|10185161|P6|Overall Study|Lack of Efficacy|0
2958541|NCT01238991|10185162|P5|Overall Study|Lack of Efficacy|0
2958542|NCT01238991|10185163|P4|Overall Study|Lack of Efficacy|0
2958543|NCT01238991|10185164|P3|Overall Study|Lack of Efficacy|1
2958544|NCT01238991|10185165|P2|Overall Study|Lack of Efficacy|0
2958545|NCT01238991|10185166|P1|Overall Study|Lack of Efficacy|0
2958546|NCT01238991|10185157|P10|Overall Study|Death|0
2958547|NCT01238991|10185158|P9|Overall Study|Death|0
2958548|NCT01238991|10185159|P8|Overall Study|Death|0
2958549|NCT01238991|10185160|P7|Overall Study|Death|0
2958550|NCT01238991|10185161|P6|Overall Study|Death|0
2958551|NCT01238991|10185162|P5|Overall Study|Death|0
2958552|NCT01238991|10185163|P4|Overall Study|Death|1
2958553|NCT01238991|10185164|P3|Overall Study|Death|0
2958554|NCT01238991|10185165|P2|Overall Study|Death|0
2958555|NCT01238991|10185166|P1|Overall Study|Death|0
2958556|NCT01238991|10185157|P10|Overall Study|Adverse Event|0
2958557|NCT01238991|10185158|P9|Overall Study|Adverse Event|0
2958558|NCT01238991|10185159|P8|Overall Study|Adverse Event|1
2958559|NCT01238991|10185160|P7|Overall Study|Adverse Event|1
2958560|NCT01238991|10185161|P6|Overall Study|Adverse Event|0
2958561|NCT01238991|10185162|P5|Overall Study|Adverse Event|1
2958562|NCT01238991|10185163|P4|Overall Study|Adverse Event|1
2958563|NCT01238991|10185164|P3|Overall Study|Adverse Event|3
2958564|NCT01238991|10185165|P2|Overall Study|Adverse Event|0
2958565|NCT01238991|10185166|P1|Overall Study|Adverse Event|1
2958566|NCT01238900|10185253|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
2958567|NCT01238900|10185253|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
2958568|NCT01238861|10185267|P6|Overall Study|Withdrawal by Subject|9
2958569|NCT01238861|10185268|P5|Overall Study|Withdrawal by Subject|10
2958570|NCT01238861|10185269|P4|Overall Study|Withdrawal by Subject|8
2958571|NCT01238861|10185270|P3|Overall Study|Withdrawal by Subject|4
2958572|NCT01238861|10185271|P2|Overall Study|Withdrawal by Subject|5
2958573|NCT01238861|10185272|P1|Overall Study|Withdrawal by Subject|6
2958574|NCT01238861|10185267|P6|Overall Study|Adverse Event|0
2958575|NCT01238861|10185268|P5|Overall Study|Adverse Event|0
2958576|NCT01238861|10185269|P4|Overall Study|Adverse Event|0
2958577|NCT01238861|10185270|P3|Overall Study|Adverse Event|0
2958578|NCT01238861|10185271|P2|Overall Study|Adverse Event|1
2958579|NCT01238861|10185272|P1|Overall Study|Adverse Event|0
2958580|NCT01238861|10185267|P6|Overall Study|Lack of compliance|1
2958581|NCT01238861|10185268|P5|Overall Study|Lack of compliance|0
2958582|NCT01238861|10185269|P4|Overall Study|Lack of compliance|0
2958583|NCT01238861|10185270|P3|Overall Study|Lack of compliance|0
2958584|NCT01238861|10185271|P2|Overall Study|Lack of compliance|0
2958585|NCT01238861|10185272|P1|Overall Study|Lack of compliance|0
2958586|NCT01238861|10185267|P6|Overall Study|Serious adverse event|1
2958587|NCT01238861|10185268|P5|Overall Study|Serious adverse event|0
2958588|NCT01238861|10185269|P4|Overall Study|Serious adverse event|0
2958589|NCT01238861|10185270|P3|Overall Study|Serious adverse event|0
2958590|NCT01238861|10185271|P2|Overall Study|Serious adverse event|0
2958591|NCT01238861|10185272|P1|Overall Study|Serious adverse event|0
2958592|NCT01238861|10185267|P6|Overall Study|Unable to continue visits|1
2958593|NCT01238861|10185268|P5|Overall Study|Unable to continue visits|0
2958594|NCT01238861|10185269|P4|Overall Study|Unable to continue visits|1
2958595|NCT01238861|10185270|P3|Overall Study|Unable to continue visits|0
2958596|NCT01238861|10185271|P2|Overall Study|Unable to continue visits|0
2958597|NCT01238861|10185272|P1|Overall Study|Unable to continue visits|0
2958598|NCT01238861|10185267|P6|Overall Study|Personal problems|0
2958599|NCT01238861|10185268|P5|Overall Study|Personal problems|0
2958600|NCT01238861|10185269|P4|Overall Study|Personal problems|1
2958601|NCT01238861|10185270|P3|Overall Study|Personal problems|0
2958602|NCT01238861|10185271|P2|Overall Study|Personal problems|0
2958603|NCT01238861|10185272|P1|Overall Study|Personal problems|0
2958604|NCT01238861|10185267|P6|Overall Study|Strongyloides stercoralis antibodies +|0
2958605|NCT01238861|10185268|P5|Overall Study|Strongyloides stercoralis antibodies +|0
2958606|NCT01238861|10185269|P4|Overall Study|Strongyloides stercoralis antibodies +|1
2958607|NCT01238861|10185270|P3|Overall Study|Strongyloides stercoralis antibodies +|0
2958608|NCT01238861|10185271|P2|Overall Study|Strongyloides stercoralis antibodies +|0
2958609|NCT01238861|10185272|P1|Overall Study|Strongyloides stercoralis antibodies +|0
2958610|NCT01238861|10185267|P6|Overall Study|Subject moved out of state/area|0
2958611|NCT01238861|10185268|P5|Overall Study|Subject moved out of state/area|0
2958612|NCT01238861|10185269|P4|Overall Study|Subject moved out of state/area|1
2958613|NCT01238861|10185270|P3|Overall Study|Subject moved out of state/area|1
2958614|NCT01238861|10185271|P2|Overall Study|Subject moved out of state/area|0
2958615|NCT01238861|10185272|P1|Overall Study|Subject moved out of state/area|0
2958616|NCT01238861|10185267|P6|Overall Study|Subject traveled to Argentina by 1 year|0
2958617|NCT01238861|10185268|P5|Overall Study|Subject traveled to Argentina by 1 year|0
2958618|NCT01238861|10185269|P4|Overall Study|Subject traveled to Argentina by 1 year|0
2958619|NCT01238861|10185270|P3|Overall Study|Subject traveled to Argentina by 1 year|1
2958620|NCT01238861|10185271|P2|Overall Study|Subject traveled to Argentina by 1 year|0
2958621|NCT01238861|10185272|P1|Overall Study|Subject traveled to Argentina by 1 year|0
2958622|NCT01238861|10185267|P6|Overall Study|Incorrect enrollment/randomization|0
2958623|NCT01238861|10185268|P5|Overall Study|Incorrect enrollment/randomization|1
2958624|NCT01238861|10185269|P4|Overall Study|Incorrect enrollment/randomization|0
2958625|NCT01238861|10185270|P3|Overall Study|Incorrect enrollment/randomization|1
2958626|NCT01238861|10185271|P2|Overall Study|Incorrect enrollment/randomization|0
2958627|NCT01238861|10185272|P1|Overall Study|Incorrect enrollment/randomization|0
2958628|NCT01238861|10185267|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
2958629|NCT01238861|10185268|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
2958630|NCT01238861|10185269|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
2958631|NCT01238861|10185270|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
2958632|NCT01238861|10185271|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
2958633|NCT01238861|10185272|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
2958634|NCT01238861|10185267|P6|Overall Study|Unplanned surgery|0
2958635|NCT01238861|10185268|P5|Overall Study|Unplanned surgery|0
2958636|NCT01238861|10185269|P4|Overall Study|Unplanned surgery|0
2958637|NCT01238861|10185270|P3|Overall Study|Unplanned surgery|0
2958638|NCT01238861|10185271|P2|Overall Study|Unplanned surgery|0
2958639|NCT01238861|10185272|P1|Overall Study|Unplanned surgery|1
2958640|NCT01238861|10185267|P6|Overall Study|Lost to Follow-up|2
2958641|NCT01238861|10185268|P5|Overall Study|Lost to Follow-up|1
2958642|NCT01238861|10185269|P4|Overall Study|Lost to Follow-up|1
2958643|NCT01238861|10185270|P3|Overall Study|Lost to Follow-up|3
2958644|NCT01238861|10185271|P2|Overall Study|Lost to Follow-up|2
2958645|NCT01238861|10185272|P1|Overall Study|Lost to Follow-up|4
2958646|NCT01238848|10185352|P2|Overall Study|Physician Decision|5
2958647|NCT01238848|10185353|P1|Overall Study|Physician Decision|13
2958648|NCT01238822|10185361|P1|Overall Study|COULD NOT SWALLOW PILLS|3
2958649|NCT01238588|10185388|P1|Overall Study|Physician Decision|2
2958650|NCT01238588|10185388|P1|Overall Study|Withdrawal by Subject|1
2958651|NCT01238575|10185401|P2|Overall Study|Adverse Event|0
2958652|NCT01238575|10185402|P1|Overall Study|Adverse Event|2
2958653|NCT01238575|10185401|P2|Overall Study|Lack of Efficacy|4
2958654|NCT01238575|10185402|P1|Overall Study|Lack of Efficacy|2
2958655|NCT01238211|10185486|P1|Overall Study|Investigator/Patient Decision|3
2958656|NCT01238211|10185486|P1|Overall Study|Non-protocol treatment|4
2958657|NCT01238211|10185486|P1|Overall Study|Withdrawal by Subject|7
2958658|NCT01238211|10185486|P1|Overall Study|Relapse/Progression|2
2958659|NCT01238211|10185486|P1|Overall Study|Death|4
2958660|NCT01238211|10185486|P1|Overall Study|Adverse Event|7
2958661|NCT01238211|10185486|P1|Overall Study|Continues active treatment|31
2958662|NCT01238172|10185492|P2|Overall Study|Ineligible: based on Central Path Review|19
2958663|NCT01238172|10185493|P1|Overall Study|Ineligible: based on Central Path Review|9
2958664|NCT01238172|10185492|P2|Overall Study|Ineligible: based on Eligibility Review|5
2958665|NCT01238172|10185493|P1|Overall Study|Ineligible: based on Eligibility Review|2
2958666|NCT01237951|10185505|P1|Overall Study|Death|1
2958667|NCT01237899|10185523|P11|Washout Period of at Least 7 Days|Adverse Event|0
2958668|NCT01237899|10185524|P10|Washout Period of at Least 7 Days|Adverse Event|0
2958669|NCT01237899|10185525|P9|Washout Period of at Least 7 Days|Adverse Event|0
2958670|NCT01237899|10185526|P8|Washout Period of at Least 7 Days|Adverse Event|0
2958671|NCT01237899|10185527|P7|Washout Period of at Least 7 Days|Adverse Event|0
2958672|NCT01237899|10185528|P6|Washout Period of at Least 7 Days|Adverse Event|0
2958673|NCT01237899|10185529|P5|Washout Period of at Least 7 Days|Adverse Event|0
2958674|NCT01237899|10185530|P4|Washout Period of at Least 7 Days|Adverse Event|0
2958675|NCT01237899|10185531|P3|Washout Period of at Least 7 Days|Adverse Event|1
2958676|NCT01237899|10185532|P2|Washout Period of at Least 7 Days|Adverse Event|0
2958677|NCT01237899|10185533|P1|Washout Period of at Least 7 Days|Adverse Event|0
2958678|NCT01237678|10185613|P3|Phase II|Randomized but were not treated|3
2958679|NCT01237678|10185614|P2|Phase II|Randomized but were not treated|4
2958680|NCT01237678|10185615|P1|Phase II|Randomized but were not treated|0
2958681|NCT01237678|10185613|P3|Phase II|Sponsor Decision/Study Closed|7
2958682|NCT01237678|10185614|P2|Phase II|Sponsor Decision/Study Closed|18
2958683|NCT01237678|10185615|P1|Phase II|Sponsor Decision/Study Closed|0
2958684|NCT01237678|10185613|P3|Phase II|Completed Cycles 4-6|21
2958685|NCT01237678|10185614|P2|Phase II|Completed Cycles 4-6|11
2958686|NCT01237678|10185615|P1|Phase II|Completed Cycles 4-6|0
2958687|NCT01237678|10185613|P3|Phase II|Withdrawal by Subject|5
2958688|NCT01237678|10185614|P2|Phase II|Withdrawal by Subject|1
2958689|NCT01237678|10185615|P1|Phase II|Withdrawal by Subject|0
2958690|NCT01237678|10185613|P3|Phase II|Lack of Efficacy|3
2958691|NCT01237678|10185614|P2|Phase II|Lack of Efficacy|25
2958692|NCT01237678|10185615|P1|Phase II|Lack of Efficacy|0
2958693|NCT01237678|10185613|P3|Phase II|Death|2
2958694|NCT01237678|10185614|P2|Phase II|Death|0
2958695|NCT01237678|10185615|P1|Phase II|Death|0
2958696|NCT01237678|10185613|P3|Phase II|Adverse Event|9
2958697|NCT01237678|10185614|P2|Phase II|Adverse Event|39
2958698|NCT01237678|10185615|P1|Phase II|Adverse Event|0
2958699|NCT01237678|10185613|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2958700|NCT01237678|10185614|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2958701|NCT01237678|10185615|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
2958702|NCT01237678|10185613|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2958703|NCT01237678|10185614|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2958704|NCT01237678|10185615|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
2958705|NCT01237678|10185613|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2958706|NCT01237678|10185614|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2958707|NCT01237678|10185615|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
2958708|NCT01237678|10185613|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2958709|NCT01237678|10185614|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2958710|NCT01237678|10185615|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
2958711|NCT01237587|10185660|P2|Taper Phase|Withdrawal by Subject|1
2958712|NCT01237587|10185661|P1|Taper Phase|Withdrawal by Subject|0
2958713|NCT01237587|10185660|P2|Taper Phase|Sponsor Decision|0
2958714|NCT01237587|10185661|P1|Taper Phase|Sponsor Decision|1
2958715|NCT01237587|10185660|P2|Taper Phase|Parent/Guardian Decision|2
2958716|NCT01237587|10185661|P1|Taper Phase|Parent/Guardian Decision|0
2958717|NCT01237587|10185660|P2|Taper Phase|Lack of Efficacy|5
2958718|NCT01237587|10185661|P1|Taper Phase|Lack of Efficacy|2
2958719|NCT01237587|10185660|P2|Taper Phase|Protocol Violation|0
2958720|NCT01237587|10185661|P1|Taper Phase|Protocol Violation|2
2958721|NCT01237587|10185660|P2|Taper Phase|Adverse Event|2
2958722|NCT01237587|10185661|P1|Taper Phase|Adverse Event|0
2958723|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
2958724|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
2958725|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
2958726|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
2958727|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
2958728|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
2958729|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
2958730|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
2958731|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
2958732|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
2958733|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
2958734|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
2958735|NCT01237587|10185660|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
2958736|NCT01237587|10185661|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
2958737|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
2958738|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
2958739|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
2958740|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
2958741|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
2958742|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
2958743|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
2958744|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
2958745|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
2958746|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
2958747|NCT01237587|10185660|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
2958748|NCT01237587|10185661|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
2958749|NCT01237340|10185713|P1|Overall Study|Early termination of the trial|36
2958750|NCT01237340|10185713|P1|Overall Study|Withdrawal by Subject|1
2958751|NCT01237340|10185713|P1|Overall Study|Adverse Event|3
2958752|NCT01237327|10185727|P2|Overall Study|Lost to Follow-up|0
2958753|NCT01237327|10185728|P1|Overall Study|Lost to Follow-up|3
2958754|NCT01237327|10185727|P2|Overall Study|Withdrawal by Subject|3
2958755|NCT01237327|10185728|P1|Overall Study|Withdrawal by Subject|1
2958756|NCT01237327|10185727|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
2958757|NCT01237327|10185728|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
2958758|NCT01237327|10185727|P2|Overall Study|Progression of Disease: Extension Study|13
2958759|NCT01237327|10185728|P1|Overall Study|Progression of Disease: Extension Study|15
2958760|NCT01237327|10185727|P2|Overall Study|Progression of Disease: Core Study|22
2958761|NCT01237327|10185728|P1|Overall Study|Progression of Disease: Core Study|18
2958762|NCT01237327|10185727|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
2958763|NCT01237327|10185728|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
2958764|NCT01237327|10185727|P2|Overall Study|Protocol Violation: Core Study|0
2958765|NCT01237327|10185728|P1|Overall Study|Protocol Violation: Core Study|1
2958766|NCT01237223|10185763|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2958767|NCT01237223|10185764|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2958768|NCT01237223|10185765|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
2958769|NCT01237223|10185766|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2958770|NCT01237223|10185767|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2958771|NCT01237223|10185768|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
2958772|NCT01237223|10185763|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
2958773|NCT01237223|10185764|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2958774|NCT01237223|10185765|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2958775|NCT01237223|10185766|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2958776|NCT01237223|10185767|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2958777|NCT01237223|10185768|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2958778|NCT01237223|10185763|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2958779|NCT01237223|10185764|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2958780|NCT01237223|10185765|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
2958781|NCT01237223|10185766|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2958782|NCT01237223|10185767|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2958783|NCT01237223|10185768|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2958784|NCT01237223|10185763|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2958785|NCT01237223|10185764|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
2958786|NCT01237223|10185765|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2958787|NCT01237223|10185766|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
2958788|NCT01237223|10185767|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
2958789|NCT01237223|10185768|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
2958790|NCT01237223|10185763|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
2958791|NCT01237223|10185764|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2958792|NCT01237223|10185765|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2958793|NCT01237223|10185766|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
2958794|NCT01237223|10185767|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
2958795|NCT01237223|10185768|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
2958796|NCT01237223|10185763|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2958797|NCT01237223|10185764|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2958798|NCT01237223|10185765|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2958799|NCT01237223|10185766|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2958800|NCT01237223|10185767|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2958801|NCT01237223|10185768|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
2958802|NCT01237223|10185763|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2958803|NCT01237223|10185764|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2958804|NCT01237223|10185765|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2958805|NCT01237223|10185766|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2958806|NCT01237223|10185767|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2958807|NCT01237223|10185768|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
2958808|NCT01237223|10185763|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2958809|NCT01237223|10185764|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2958810|NCT01237223|10185765|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2958811|NCT01237223|10185766|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2958812|NCT01237223|10185767|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2958813|NCT01237223|10185768|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
2958814|NCT01237223|10185763|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2958815|NCT01237223|10185764|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2958816|NCT01237223|10185765|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2958817|NCT01237223|10185766|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2958818|NCT01237223|10185767|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2958819|NCT01237223|10185768|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
2958820|NCT01237223|10185763|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2958821|NCT01237223|10185764|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2958822|NCT01237223|10185765|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2958823|NCT01237223|10185766|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2958824|NCT01237223|10185767|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2958825|NCT01237223|10185768|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
2958826|NCT01237054|10185827|P1|Overall Study|imaging 10C0096|1
2958827|NCT01236755|10185896|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
2958828|NCT01236755|10185896|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
2958829|NCT01236755|10185896|P1|Spectacles Wearing Phase|Lost to Follow-up|9
2958830|NCT01236755|10185896|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
2958831|NCT01236534|10185919|P2|Overall Study|Adverse Event|0
2958832|NCT01236534|10185920|P1|Overall Study|Adverse Event|3
2958833|NCT01236365|10185938|P2|Overall Study|Dropped at Randomization due to high LFT|0
2958834|NCT01236365|10185939|P1|Overall Study|Dropped at Randomization due to high LFT|1
2958835|NCT01236365|10185938|P2|Overall Study|Moved Out of State|0
2958836|NCT01236365|10185939|P1|Overall Study|Moved Out of State|1
2958837|NCT01236365|10185938|P2|Overall Study|Lost to Follow-up|2
2958838|NCT01236365|10185939|P1|Overall Study|Lost to Follow-up|0
2958839|NCT01236339|10185963|P2|Overall Study|Termination of study by sponsor|13
2958840|NCT01236339|10185964|P1|Overall Study|Termination of study by sponsor|11
2958841|NCT01235793|10185993|P1|Overall Study|Death|6
2958842|NCT01236573|10186009|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
2958843|NCT01236573|10186010|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958844|NCT01236573|10186011|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958845|NCT01236573|10186012|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958846|NCT01236573|10186013|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958847|NCT01236573|10186014|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958848|NCT01236573|10186015|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958849|NCT01236573|10186016|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958850|NCT01236573|10186017|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958851|NCT01236573|10186018|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958852|NCT01236573|10186019|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2958853|NCT01236573|10186009|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958854|NCT01236573|10186010|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958855|NCT01236573|10186011|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
2958856|NCT01236573|10186012|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958857|NCT01236573|10186013|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958858|NCT01236573|10186014|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958859|NCT01236573|10186015|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958860|NCT01236573|10186016|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958861|NCT01236573|10186017|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958862|NCT01236573|10186018|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958863|NCT01236573|10186019|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2958864|NCT01236573|10186009|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958865|NCT01236573|10186010|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2958866|NCT01236573|10186011|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2958867|NCT01236573|10186012|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958868|NCT01236573|10186013|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2958869|NCT01236573|10186014|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958870|NCT01236573|10186015|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958871|NCT01236573|10186016|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958872|NCT01236573|10186017|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958873|NCT01236573|10186018|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958874|NCT01236573|10186019|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2958875|NCT01236521|10186057|P2|Overall Study|Lost to Follow-up|7
2958876|NCT01236521|10186058|P1|Overall Study|Lost to Follow-up|7
2958877|NCT01236521|10186057|P2|Overall Study|Death|1
2958878|NCT01236521|10186058|P1|Overall Study|Death|2
2958879|NCT01236521|10186057|P2|Overall Study|Withdrawal by Subject|17
2958880|NCT01236521|10186058|P1|Overall Study|Withdrawal by Subject|12
2958881|NCT01236352|10186109|P11|Overall Study|Patient transferred to IST|6
2958882|NCT01236352|10186110|P10|Overall Study|Patient transferred to IST|2
2958883|NCT01236352|10186111|P9|Overall Study|Patient transferred to IST|0
2958884|NCT01236352|10186112|P8|Overall Study|Patient transferred to IST|0
2958885|NCT01236352|10186113|P7|Overall Study|Patient transferred to IST|0
2958886|NCT01236352|10186114|P6|Overall Study|Patient transferred to IST|0
2958887|NCT01236352|10186115|P5|Overall Study|Patient transferred to IST|0
2958888|NCT01236352|10186116|P4|Overall Study|Patient transferred to IST|0
2958889|NCT01236352|10186117|P3|Overall Study|Patient transferred to IST|0
2958890|NCT01236352|10186118|P2|Overall Study|Patient transferred to IST|0
2958891|NCT01236352|10186119|P1|Overall Study|Patient transferred to IST|0
2958892|NCT01236352|10186109|P11|Overall Study|Lack of response to drug|1
2958893|NCT01236352|10186110|P10|Overall Study|Lack of response to drug|1
2958894|NCT01236352|10186111|P9|Overall Study|Lack of response to drug|0
2958895|NCT01236352|10186112|P8|Overall Study|Lack of response to drug|0
2958896|NCT01236352|10186113|P7|Overall Study|Lack of response to drug|0
2958897|NCT01236352|10186114|P6|Overall Study|Lack of response to drug|0
2958898|NCT01236352|10186115|P5|Overall Study|Lack of response to drug|0
2958899|NCT01236352|10186116|P4|Overall Study|Lack of response to drug|0
2958900|NCT01236352|10186117|P3|Overall Study|Lack of response to drug|0
2958901|NCT01236352|10186118|P2|Overall Study|Lack of response to drug|0
2958902|NCT01236352|10186119|P1|Overall Study|Lack of response to drug|0
2958903|NCT01236352|10186109|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
2958904|NCT01236352|10186110|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
2958905|NCT01236352|10186111|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
2958906|NCT01236352|10186112|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
2958907|NCT01236352|10186113|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
2958908|NCT01236352|10186114|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
2958909|NCT01236352|10186115|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
2958910|NCT01236352|10186116|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
2958911|NCT01236352|10186117|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
2958912|NCT01236352|10186118|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
2958913|NCT01236352|10186119|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
2958914|NCT01236352|10186109|P11|Overall Study|Patient moving to allogeneic transplant|0
2958915|NCT01236352|10186110|P10|Overall Study|Patient moving to allogeneic transplant|0
2958916|NCT01236352|10186111|P9|Overall Study|Patient moving to allogeneic transplant|0
2958917|NCT01236352|10186112|P8|Overall Study|Patient moving to allogeneic transplant|0
2958918|NCT01236352|10186113|P7|Overall Study|Patient moving to allogeneic transplant|1
2958919|NCT01236352|10186114|P6|Overall Study|Patient moving to allogeneic transplant|0
2958920|NCT01236352|10186115|P5|Overall Study|Patient moving to allogeneic transplant|0
2958921|NCT01236352|10186116|P4|Overall Study|Patient moving to allogeneic transplant|0
2958922|NCT01236352|10186117|P3|Overall Study|Patient moving to allogeneic transplant|0
2958923|NCT01236352|10186118|P2|Overall Study|Patient moving to allogeneic transplant|0
2958924|NCT01236352|10186119|P1|Overall Study|Patient moving to allogeneic transplant|0
2958925|NCT01236352|10186109|P11|Overall Study|Subject to receive drug via EAP|0
2958926|NCT01236352|10186110|P10|Overall Study|Subject to receive drug via EAP|4
2958927|NCT01236352|10186111|P9|Overall Study|Subject to receive drug via EAP|0
2958928|NCT01236352|10186112|P8|Overall Study|Subject to receive drug via EAP|2
2958929|NCT01236352|10186113|P7|Overall Study|Subject to receive drug via EAP|0
2958930|NCT01236352|10186114|P6|Overall Study|Subject to receive drug via EAP|0
2958931|NCT01236352|10186115|P5|Overall Study|Subject to receive drug via EAP|0
2958932|NCT01236352|10186116|P4|Overall Study|Subject to receive drug via EAP|0
2958933|NCT01236352|10186117|P3|Overall Study|Subject to receive drug via EAP|1
2958934|NCT01236352|10186118|P2|Overall Study|Subject to receive drug via EAP|1
2958935|NCT01236352|10186119|P1|Overall Study|Subject to receive drug via EAP|1
2958936|NCT01236352|10186109|P11|Overall Study|Subject request to discontinue treatment|4
2958937|NCT01236352|10186110|P10|Overall Study|Subject request to discontinue treatment|1
2958938|NCT01236352|10186111|P9|Overall Study|Subject request to discontinue treatment|0
2958939|NCT01236352|10186112|P8|Overall Study|Subject request to discontinue treatment|0
2958940|NCT01236352|10186113|P7|Overall Study|Subject request to discontinue treatment|0
2958941|NCT01236352|10186114|P6|Overall Study|Subject request to discontinue treatment|1
2958942|NCT01236352|10186115|P5|Overall Study|Subject request to discontinue treatment|0
2958943|NCT01236352|10186116|P4|Overall Study|Subject request to discontinue treatment|1
2958944|NCT01236352|10186117|P3|Overall Study|Subject request to discontinue treatment|1
2958945|NCT01236352|10186118|P2|Overall Study|Subject request to discontinue treatment|0
2958946|NCT01236352|10186119|P1|Overall Study|Subject request to discontinue treatment|0
2958947|NCT01236352|10186109|P11|Overall Study|Maximum clinical benefit|2
2958948|NCT01236352|10186110|P10|Overall Study|Maximum clinical benefit|4
2958949|NCT01236352|10186111|P9|Overall Study|Maximum clinical benefit|1
2958950|NCT01236352|10186112|P8|Overall Study|Maximum clinical benefit|1
2958951|NCT01236352|10186113|P7|Overall Study|Maximum clinical benefit|3
2958952|NCT01236352|10186114|P6|Overall Study|Maximum clinical benefit|0
2958953|NCT01236352|10186115|P5|Overall Study|Maximum clinical benefit|2
2958954|NCT01236352|10186116|P4|Overall Study|Maximum clinical benefit|0
2958955|NCT01236352|10186117|P3|Overall Study|Maximum clinical benefit|1
2958956|NCT01236352|10186118|P2|Overall Study|Maximum clinical benefit|1
2958957|NCT01236352|10186119|P1|Overall Study|Maximum clinical benefit|1
2958958|NCT01236352|10186109|P11|Overall Study|Poor/Non-compliance|0
2958959|NCT01236352|10186110|P10|Overall Study|Poor/Non-compliance|0
2958960|NCT01236352|10186111|P9|Overall Study|Poor/Non-compliance|0
2958961|NCT01236352|10186112|P8|Overall Study|Poor/Non-compliance|0
2958962|NCT01236352|10186113|P7|Overall Study|Poor/Non-compliance|0
2958963|NCT01236352|10186114|P6|Overall Study|Poor/Non-compliance|0
2958964|NCT01236352|10186115|P5|Overall Study|Poor/Non-compliance|0
2958965|NCT01236352|10186116|P4|Overall Study|Poor/Non-compliance|0
2958966|NCT01236352|10186117|P3|Overall Study|Poor/Non-compliance|0
2958967|NCT01236352|10186118|P2|Overall Study|Poor/Non-compliance|0
2958968|NCT01236352|10186119|P1|Overall Study|Poor/Non-compliance|1
2958969|NCT01236352|10186109|P11|Overall Study|Disease progression|2
2958970|NCT01236352|10186110|P10|Overall Study|Disease progression|2
2958971|NCT01236352|10186111|P9|Overall Study|Disease progression|2
2958972|NCT01236352|10186112|P8|Overall Study|Disease progression|3
2958973|NCT01236352|10186113|P7|Overall Study|Disease progression|1
2958974|NCT01236352|10186114|P6|Overall Study|Disease progression|2
2958975|NCT01236352|10186115|P5|Overall Study|Disease progression|2
2958976|NCT01236352|10186116|P4|Overall Study|Disease progression|2
2958977|NCT01236352|10186117|P3|Overall Study|Disease progression|1
2958978|NCT01236352|10186118|P2|Overall Study|Disease progression|2
2958979|NCT01236352|10186119|P1|Overall Study|Disease progression|1
2958980|NCT01236352|10186109|P11|Overall Study|Study drug toxicity|2
2958981|NCT01236352|10186110|P10|Overall Study|Study drug toxicity|2
2958982|NCT01236352|10186111|P9|Overall Study|Study drug toxicity|0
2958983|NCT01236352|10186112|P8|Overall Study|Study drug toxicity|0
2958984|NCT01236352|10186113|P7|Overall Study|Study drug toxicity|1
2958985|NCT01236352|10186114|P6|Overall Study|Study drug toxicity|1
2958986|NCT01236352|10186115|P5|Overall Study|Study drug toxicity|0
2958987|NCT01236352|10186116|P4|Overall Study|Study drug toxicity|0
2958988|NCT01236352|10186117|P3|Overall Study|Study drug toxicity|0
2958989|NCT01236352|10186118|P2|Overall Study|Study drug toxicity|0
2958990|NCT01236352|10186119|P1|Overall Study|Study drug toxicity|0
2958991|NCT01236352|10186109|P11|Overall Study|Adverse Event|1
2958992|NCT01236352|10186110|P10|Overall Study|Adverse Event|4
2958993|NCT01236352|10186111|P9|Overall Study|Adverse Event|0
2958994|NCT01236352|10186112|P8|Overall Study|Adverse Event|0
2958995|NCT01236352|10186113|P7|Overall Study|Adverse Event|2
2958996|NCT01236352|10186114|P6|Overall Study|Adverse Event|0
2958997|NCT01236352|10186115|P5|Overall Study|Adverse Event|0
2958998|NCT01236352|10186116|P4|Overall Study|Adverse Event|0
2958999|NCT01236352|10186117|P3|Overall Study|Adverse Event|0
2959000|NCT01236352|10186118|P2|Overall Study|Adverse Event|0
2959001|NCT01236352|10186119|P1|Overall Study|Adverse Event|0
2959002|NCT01236352|10186109|P11|Overall Study|Withdrawal by Subject|1
2959003|NCT01236352|10186110|P10|Overall Study|Withdrawal by Subject|2
2959004|NCT01236352|10186111|P9|Overall Study|Withdrawal by Subject|0
2959005|NCT01236352|10186112|P8|Overall Study|Withdrawal by Subject|0
2959006|NCT01236352|10186113|P7|Overall Study|Withdrawal by Subject|0
2959007|NCT01236352|10186114|P6|Overall Study|Withdrawal by Subject|0
2959008|NCT01236352|10186115|P5|Overall Study|Withdrawal by Subject|0
2959009|NCT01236352|10186116|P4|Overall Study|Withdrawal by Subject|0
2959010|NCT01236352|10186117|P3|Overall Study|Withdrawal by Subject|0
2959011|NCT01236352|10186118|P2|Overall Study|Withdrawal by Subject|0
2959012|NCT01236352|10186119|P1|Overall Study|Withdrawal by Subject|0
2959013|NCT01236352|10186109|P11|Overall Study|Death|0
2959014|NCT01236352|10186110|P10|Overall Study|Death|0
2959015|NCT01236352|10186111|P9|Overall Study|Death|0
2959016|NCT01236352|10186112|P8|Overall Study|Death|1
2959017|NCT01236352|10186113|P7|Overall Study|Death|0
2959018|NCT01236352|10186114|P6|Overall Study|Death|0
2959019|NCT01236352|10186115|P5|Overall Study|Death|0
2959020|NCT01236352|10186116|P4|Overall Study|Death|0
2959021|NCT01236352|10186117|P3|Overall Study|Death|0
2959022|NCT01236352|10186118|P2|Overall Study|Death|0
2959023|NCT01236352|10186119|P1|Overall Study|Death|0
2959024|NCT01236118|10186337|P3|Overall Study|Withdrawal by Subject|1
2959025|NCT01236118|10186338|P2|Overall Study|Withdrawal by Subject|0
2959026|NCT01236118|10186339|P1|Overall Study|Withdrawal by Subject|0
2959027|NCT01236118|10186337|P3|Overall Study|Physician Decision|0
2959028|NCT01236118|10186338|P2|Overall Study|Physician Decision|1
2959029|NCT01236118|10186339|P1|Overall Study|Physician Decision|0
2959030|NCT01236118|10186337|P3|Overall Study|Adverse Event|2
2959031|NCT01236118|10186338|P2|Overall Study|Adverse Event|0
2959032|NCT01236118|10186339|P1|Overall Study|Adverse Event|2
2959033|NCT01236001|10186540|P2|Overall Study|Planned Visit After End of Study|1
2959034|NCT01236001|10186541|P1|Overall Study|Planned Visit After End of Study|0
2959035|NCT01236001|10186540|P2|Overall Study|Incompliance|0
2959036|NCT01236001|10186541|P1|Overall Study|Incompliance|1
2959037|NCT01236001|10186540|P2|Overall Study|Lost to Follow-up|1
2959038|NCT01236001|10186541|P1|Overall Study|Lost to Follow-up|6
2959039|NCT01236001|10186540|P2|Overall Study|Lack of Efficacy|6
2959040|NCT01236001|10186541|P1|Overall Study|Lack of Efficacy|6
2959041|NCT01236001|10186540|P2|Overall Study|Adverse Event|14
2959042|NCT01236001|10186541|P1|Overall Study|Adverse Event|5
2959043|NCT01235975|10186573|P2|Overall Study|Lost to Follow-up|3
2959044|NCT01235975|10186574|P1|Overall Study|Lost to Follow-up|7
2959045|NCT01235975|10186573|P2|Overall Study|Migrated/moved from study area|1
2959046|NCT01235975|10186574|P1|Overall Study|Migrated/moved from study area|2
2959047|NCT01235975|10186573|P2|Overall Study|Withdrawal by Subject|2
2959048|NCT01235975|10186574|P1|Overall Study|Withdrawal by Subject|8
2959049|NCT01235975|10186573|P2|Overall Study|Serious Adverse Event|1
2959050|NCT01235975|10186574|P1|Overall Study|Serious Adverse Event|0
2959051|NCT01235949|10186624|P18|Booster Phase|Lost to Follow-up|1
2959052|NCT01235949|10186625|P17|Booster Phase|Lost to Follow-up|0
2959053|NCT01235949|10186626|P16|Booster Phase|Lost to Follow-up|0
2959054|NCT01235949|10186627|P15|Booster Phase|Lost to Follow-up|0
2959055|NCT01235949|10186628|P14|Booster Phase|Lost to Follow-up|0
2959056|NCT01235949|10186629|P13|Booster Phase|Lost to Follow-up|0
2959057|NCT01235949|10186630|P12|Booster Phase|Lost to Follow-up|1
2959058|NCT01235949|10186631|P11|Booster Phase|Lost to Follow-up|1
2959059|NCT01235949|10186632|P10|Booster Phase|Lost to Follow-up|1
2959060|NCT01235949|10186633|P9|Booster Phase|Lost to Follow-up|1
2959061|NCT01235949|10186634|P8|Booster Phase|Lost to Follow-up|0
2959062|NCT01235949|10186635|P7|Booster Phase|Lost to Follow-up|0
2959063|NCT01235949|10186636|P6|Booster Phase|Lost to Follow-up|0
2959064|NCT01235949|10186637|P5|Booster Phase|Lost to Follow-up|0
2959065|NCT01235949|10186638|P4|Booster Phase|Lost to Follow-up|0
2959066|NCT01235949|10186639|P3|Booster Phase|Lost to Follow-up|0
2959067|NCT01235949|10186640|P2|Booster Phase|Lost to Follow-up|0
2959068|NCT01235949|10186641|P1|Booster Phase|Lost to Follow-up|0
2959069|NCT01235949|10186624|P18|Booster Phase|Withdrawal by Subject|0
2959070|NCT01235949|10186625|P17|Booster Phase|Withdrawal by Subject|0
2959071|NCT01235949|10186626|P16|Booster Phase|Withdrawal by Subject|0
2959072|NCT01235949|10186627|P15|Booster Phase|Withdrawal by Subject|2
2959073|NCT01235949|10186628|P14|Booster Phase|Withdrawal by Subject|0
2959074|NCT01235949|10186629|P13|Booster Phase|Withdrawal by Subject|2
2959075|NCT01235949|10186630|P12|Booster Phase|Withdrawal by Subject|1
2959076|NCT01235949|10186631|P11|Booster Phase|Withdrawal by Subject|1
2959077|NCT01235949|10186632|P10|Booster Phase|Withdrawal by Subject|0
2959078|NCT01235949|10186633|P9|Booster Phase|Withdrawal by Subject|1
2959079|NCT01235949|10186634|P8|Booster Phase|Withdrawal by Subject|1
2959080|NCT01235949|10186635|P7|Booster Phase|Withdrawal by Subject|0
2959081|NCT01235949|10186636|P6|Booster Phase|Withdrawal by Subject|0
2959082|NCT01235949|10186637|P5|Booster Phase|Withdrawal by Subject|0
2959083|NCT01235949|10186638|P4|Booster Phase|Withdrawal by Subject|0
2959084|NCT01235949|10186639|P3|Booster Phase|Withdrawal by Subject|0
2959085|NCT01235949|10186640|P2|Booster Phase|Withdrawal by Subject|0
2959086|NCT01235949|10186641|P1|Booster Phase|Withdrawal by Subject|0
2959087|NCT01235949|10186624|P18|Booster Phase|Adverse Event|0
2959088|NCT01235949|10186625|P17|Booster Phase|Adverse Event|0
2959089|NCT01235949|10186626|P16|Booster Phase|Adverse Event|1
2959090|NCT01235949|10186627|P15|Booster Phase|Adverse Event|0
2959091|NCT01235949|10186628|P14|Booster Phase|Adverse Event|0
2959092|NCT01235949|10186629|P13|Booster Phase|Adverse Event|0
2959093|NCT01235949|10186630|P12|Booster Phase|Adverse Event|0
2959094|NCT01235949|10186631|P11|Booster Phase|Adverse Event|0
2959095|NCT01235949|10186632|P10|Booster Phase|Adverse Event|0
2959096|NCT01235949|10186633|P9|Booster Phase|Adverse Event|0
2959097|NCT01235949|10186634|P8|Booster Phase|Adverse Event|0
2959098|NCT01235949|10186635|P7|Booster Phase|Adverse Event|0
2959099|NCT01235949|10186636|P6|Booster Phase|Adverse Event|0
2959100|NCT01235949|10186637|P5|Booster Phase|Adverse Event|0
2959101|NCT01235949|10186638|P4|Booster Phase|Adverse Event|0
2959102|NCT01235949|10186639|P3|Booster Phase|Adverse Event|0
2959103|NCT01235949|10186640|P2|Booster Phase|Adverse Event|0
2959104|NCT01235949|10186641|P1|Booster Phase|Adverse Event|0
2959105|NCT01235949|10186624|P18|Booster Phase|Migrated/moved from study area|1
2959106|NCT01235949|10186625|P17|Booster Phase|Migrated/moved from study area|0
2959107|NCT01235949|10186626|P16|Booster Phase|Migrated/moved from study area|0
2959108|NCT01235949|10186627|P15|Booster Phase|Migrated/moved from study area|0
2959109|NCT01235949|10186628|P14|Booster Phase|Migrated/moved from study area|0
2959110|NCT01235949|10186629|P13|Booster Phase|Migrated/moved from study area|1
2959111|NCT01235949|10186630|P12|Booster Phase|Migrated/moved from study area|1
2959112|NCT01235949|10186631|P11|Booster Phase|Migrated/moved from study area|0
2959113|NCT01235949|10186632|P10|Booster Phase|Migrated/moved from study area|0
2959114|NCT01235949|10186633|P9|Booster Phase|Migrated/moved from study area|0
2959115|NCT01235949|10186634|P8|Booster Phase|Migrated/moved from study area|0
2959116|NCT01235949|10186635|P7|Booster Phase|Migrated/moved from study area|0
2959117|NCT01235949|10186636|P6|Booster Phase|Migrated/moved from study area|0
2959118|NCT01235949|10186637|P5|Booster Phase|Migrated/moved from study area|0
2959119|NCT01235949|10186638|P4|Booster Phase|Migrated/moved from study area|0
2959120|NCT01235949|10186639|P3|Booster Phase|Migrated/moved from study area|0
2959121|NCT01235949|10186640|P2|Booster Phase|Migrated/moved from study area|0
2959122|NCT01235949|10186641|P1|Booster Phase|Migrated/moved from study area|0
2959123|NCT01235949|10186624|P18|Primary Phase|Lost to Follow-up|0
2959124|NCT01235949|10186625|P17|Primary Phase|Lost to Follow-up|0
2959125|NCT01235949|10186626|P16|Primary Phase|Lost to Follow-up|0
2959126|NCT01235949|10186627|P15|Primary Phase|Lost to Follow-up|0
2959127|NCT01235949|10186628|P14|Primary Phase|Lost to Follow-up|0
2959128|NCT01235949|10186629|P13|Primary Phase|Lost to Follow-up|0
2959129|NCT01235949|10186630|P12|Primary Phase|Lost to Follow-up|0
2959130|NCT01235949|10186631|P11|Primary Phase|Lost to Follow-up|0
2959131|NCT01235949|10186632|P10|Primary Phase|Lost to Follow-up|0
2959132|NCT01235949|10186633|P9|Primary Phase|Lost to Follow-up|0
2959133|NCT01235949|10186634|P8|Primary Phase|Lost to Follow-up|0
2959134|NCT01235949|10186635|P7|Primary Phase|Lost to Follow-up|0
2959135|NCT01235949|10186636|P6|Primary Phase|Lost to Follow-up|2
2959136|NCT01235949|10186637|P5|Primary Phase|Lost to Follow-up|0
2959137|NCT01235949|10186638|P4|Primary Phase|Lost to Follow-up|1
2959138|NCT01235949|10186639|P3|Primary Phase|Lost to Follow-up|1
2959139|NCT01235949|10186640|P2|Primary Phase|Lost to Follow-up|0
2959140|NCT01235949|10186641|P1|Primary Phase|Lost to Follow-up|0
2959141|NCT01235949|10186624|P18|Primary Phase|Withdrawal by Subject|0
2959142|NCT01235949|10186625|P17|Primary Phase|Withdrawal by Subject|0
2959143|NCT01235949|10186626|P16|Primary Phase|Withdrawal by Subject|0
2959144|NCT01235949|10186627|P15|Primary Phase|Withdrawal by Subject|0
2959145|NCT01235949|10186628|P14|Primary Phase|Withdrawal by Subject|0
2959146|NCT01235949|10186629|P13|Primary Phase|Withdrawal by Subject|0
2959147|NCT01235949|10186630|P12|Primary Phase|Withdrawal by Subject|0
2959148|NCT01235949|10186631|P11|Primary Phase|Withdrawal by Subject|0
2959149|NCT01235949|10186632|P10|Primary Phase|Withdrawal by Subject|0
2959150|NCT01235949|10186633|P9|Primary Phase|Withdrawal by Subject|0
2959151|NCT01235949|10186634|P8|Primary Phase|Withdrawal by Subject|0
2959152|NCT01235949|10186635|P7|Primary Phase|Withdrawal by Subject|0
2959153|NCT01235949|10186636|P6|Primary Phase|Withdrawal by Subject|3
2959154|NCT01235949|10186637|P5|Primary Phase|Withdrawal by Subject|0
2959155|NCT01235949|10186638|P4|Primary Phase|Withdrawal by Subject|0
2959156|NCT01235949|10186639|P3|Primary Phase|Withdrawal by Subject|2
2959157|NCT01235949|10186640|P2|Primary Phase|Withdrawal by Subject|2
2959158|NCT01235949|10186641|P1|Primary Phase|Withdrawal by Subject|3
2959159|NCT01235949|10186624|P18|Primary Phase|Adverse Event|0
2959160|NCT01235949|10186625|P17|Primary Phase|Adverse Event|0
2959161|NCT01235949|10186626|P16|Primary Phase|Adverse Event|0
2959162|NCT01235949|10186627|P15|Primary Phase|Adverse Event|0
2959163|NCT01235949|10186628|P14|Primary Phase|Adverse Event|0
2959164|NCT01235949|10186629|P13|Primary Phase|Adverse Event|0
2959165|NCT01235949|10186630|P12|Primary Phase|Adverse Event|0
2959166|NCT01235949|10186631|P11|Primary Phase|Adverse Event|0
2959167|NCT01235949|10186632|P10|Primary Phase|Adverse Event|0
2959168|NCT01235949|10186633|P9|Primary Phase|Adverse Event|0
2959169|NCT01235949|10186634|P8|Primary Phase|Adverse Event|0
2959170|NCT01235949|10186635|P7|Primary Phase|Adverse Event|0
2959171|NCT01235949|10186636|P6|Primary Phase|Adverse Event|0
2959172|NCT01235949|10186637|P5|Primary Phase|Adverse Event|0
2959173|NCT01235949|10186638|P4|Primary Phase|Adverse Event|1
2959174|NCT01235949|10186639|P3|Primary Phase|Adverse Event|0
2959175|NCT01235949|10186640|P2|Primary Phase|Adverse Event|0
2959176|NCT01235949|10186641|P1|Primary Phase|Adverse Event|0
2959177|NCT01235949|10186624|P18|Primary Phase|Migrated/moved from study area|0
2959178|NCT01235949|10186625|P17|Primary Phase|Migrated/moved from study area|0
2959179|NCT01235949|10186626|P16|Primary Phase|Migrated/moved from study area|0
2959180|NCT01235949|10186627|P15|Primary Phase|Migrated/moved from study area|0
2959181|NCT01235949|10186628|P14|Primary Phase|Migrated/moved from study area|0
2959182|NCT01235949|10186629|P13|Primary Phase|Migrated/moved from study area|0
2959183|NCT01235949|10186630|P12|Primary Phase|Migrated/moved from study area|0
2959184|NCT01235949|10186631|P11|Primary Phase|Migrated/moved from study area|0
2959185|NCT01235949|10186632|P10|Primary Phase|Migrated/moved from study area|0
2959186|NCT01235949|10186633|P9|Primary Phase|Migrated/moved from study area|0
2959187|NCT01235949|10186634|P8|Primary Phase|Migrated/moved from study area|0
2959188|NCT01235949|10186635|P7|Primary Phase|Migrated/moved from study area|0
2959189|NCT01235949|10186636|P6|Primary Phase|Migrated/moved from study area|2
2959190|NCT01235949|10186637|P5|Primary Phase|Migrated/moved from study area|1
2959191|NCT01235949|10186638|P4|Primary Phase|Migrated/moved from study area|0
2959192|NCT01235949|10186639|P3|Primary Phase|Migrated/moved from study area|0
2959193|NCT01235949|10186640|P2|Primary Phase|Migrated/moved from study area|1
2959194|NCT01235949|10186641|P1|Primary Phase|Migrated/moved from study area|1
2959195|NCT01235741|10186891|P3|Follow-Up Post Treatment up to Month 6|Other|0
2959196|NCT01235741|10186892|P2|Follow-Up Post Treatment up to Month 6|Other|1
2959197|NCT01235741|10186893|P1|Follow-Up Post Treatment up to Month 6|Other|0
2959198|NCT01235741|10186891|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
2959199|NCT01235741|10186892|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
2959200|NCT01235741|10186893|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
2959201|NCT01235741|10186891|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
2959202|NCT01235741|10186892|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
2959203|NCT01235741|10186893|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
2959204|NCT01235741|10186891|P3|Randomized to Treatment|Sponsor terminated study|34
2959205|NCT01235741|10186892|P2|Randomized to Treatment|Sponsor terminated study|35
2959206|NCT01235741|10186893|P1|Randomized to Treatment|Sponsor terminated study|0
2959207|NCT01235741|10186891|P3|Randomized to Treatment|Adverse Event|1
2959208|NCT01235741|10186892|P2|Randomized to Treatment|Adverse Event|1
2959209|NCT01235741|10186893|P1|Randomized to Treatment|Adverse Event|0
2959210|NCT01235741|10186891|P3|Randomized to Treatment|Withdrawal by Subject|1
2959211|NCT01235741|10186892|P2|Randomized to Treatment|Withdrawal by Subject|0
2959212|NCT01235741|10186893|P1|Randomized to Treatment|Withdrawal by Subject|0
2959213|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2959214|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2959215|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
2959216|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2959217|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2959218|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
2959219|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2959220|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2959221|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
2959222|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2959223|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2959224|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
2959225|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2959226|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2959227|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
2959228|NCT01235741|10186891|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2959229|NCT01235741|10186892|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2959230|NCT01235741|10186893|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
2959231|NCT01235728|10186920|P8|Overall Study|Protocol Violation|0
2959232|NCT01235728|10186921|P7|Overall Study|Protocol Violation|0
2959233|NCT01235728|10186922|P6|Overall Study|Protocol Violation|0
2959234|NCT01235728|10186923|P5|Overall Study|Protocol Violation|0
2959235|NCT01235728|10186924|P4|Overall Study|Protocol Violation|1
2959236|NCT01235728|10186925|P3|Overall Study|Protocol Violation|0
2959237|NCT01235728|10186926|P2|Overall Study|Protocol Violation|0
2959238|NCT01235728|10186927|P1|Overall Study|Protocol Violation|0
2959239|NCT01235715|10186937|P2|Overall Study|Physician Decision|2
2959240|NCT01235715|10186938|P1|Overall Study|Physician Decision|0
2959241|NCT01235689|10186978|P2|Overall Study|Miscellaneous|5
2959242|NCT01235689|10186979|P1|Overall Study|Miscellaneous|1
2959243|NCT01235689|10186978|P2|Overall Study|Lost to Follow-up|2
2959244|NCT01235689|10186979|P1|Overall Study|Lost to Follow-up|1
2959245|NCT01235689|10186978|P2|Overall Study|Withdrawal by Subject|4
2959246|NCT01235689|10186979|P1|Overall Study|Withdrawal by Subject|3
2959247|NCT01235689|10186978|P2|Overall Study|Lack of Efficacy|5
2959248|NCT01235689|10186979|P1|Overall Study|Lack of Efficacy|12
2959249|NCT01235689|10186978|P2|Overall Study|Adverse Event|16
2959250|NCT01235689|10186979|P1|Overall Study|Adverse Event|12
2959251|NCT01235598|10187051|P2|Overall Study|Withdrawal by Subject|0
2959252|NCT01235598|10187052|P1|Overall Study|Withdrawal by Subject|1
2959253|NCT01235598|10187051|P2|Overall Study|Lack of Efficacy|1
2959254|NCT01235598|10187052|P1|Overall Study|Lack of Efficacy|0
2959255|NCT01235598|10187051|P2|Overall Study|Adverse Event|3
2959256|NCT01235598|10187052|P1|Overall Study|Adverse Event|0
2959257|NCT01235546|10187097|P2|Overall Study|Protocol Violation|1
2959258|NCT01235546|10187098|P1|Overall Study|Protocol Violation|1
2959259|NCT01235546|10187097|P2|Overall Study|Staff error, medication not administered|0
2959260|NCT01235546|10187098|P1|Overall Study|Staff error, medication not administered|1
2959261|NCT01235507|10187122|P1|Overall Study|Withdrawal by Subject|1
2959262|NCT01235507|10187122|P1|Overall Study|Adverse Event|1
2959263|NCT01235442|10187136|P2|Overall Study|Other unspecified|2
2959264|NCT01235442|10187137|P1|Overall Study|Other unspecified|1
2959265|NCT01235442|10187136|P2|Overall Study|Administrative decision|2
2959266|NCT01235442|10187137|P1|Overall Study|Administrative decision|1
2959267|NCT01235442|10187136|P2|Overall Study|Noncompliance|2
2959268|NCT01235442|10187137|P1|Overall Study|Noncompliance|1
2959269|NCT01235442|10187136|P2|Overall Study|Lack of Efficacy|3
2959270|NCT01235442|10187137|P1|Overall Study|Lack of Efficacy|1
2959271|NCT01235442|10187136|P2|Overall Study|Withdrawal by Subject|9
2959272|NCT01235442|10187137|P1|Overall Study|Withdrawal by Subject|15
2959273|NCT01235442|10187136|P2|Overall Study|Adverse Event|6
2959274|NCT01235442|10187137|P1|Overall Study|Adverse Event|4
2959275|NCT01235442|10187136|P2|Overall Study|Protocol Violation|3
2959276|NCT01235442|10187137|P1|Overall Study|Protocol Violation|3
2959277|NCT01235442|10187136|P2|Overall Study|Ineligibility determined|4
2959278|NCT01235442|10187137|P1|Overall Study|Ineligibility determined|5
2959279|NCT01235442|10187136|P2|Overall Study|Pregnancy|1
2959280|NCT01235442|10187137|P1|Overall Study|Pregnancy|1
2959281|NCT01235442|10187136|P2|Overall Study|Death|2
2959282|NCT01235442|10187137|P1|Overall Study|Death|0
2959283|NCT01235442|10187136|P2|Overall Study|Lost to Follow-up|10
2959284|NCT01235442|10187137|P1|Overall Study|Lost to Follow-up|12
2959370|NCT01234337|10187494|P1|Overall Study|Randomized but not treated|6
2959285|NCT01235403|10187155|P1|Overall Study|Other reasons for premature termination|4
2959286|NCT01235403|10187155|P1|Overall Study|Lack of Efficacy|2
2959287|NCT01235403|10187155|P1|Overall Study|Withdrawal by Subject|4
2959288|NCT01235403|10187155|P1|Overall Study|Lost to Follow-up|2
2959289|NCT01235403|10187155|P1|Overall Study|Adverse Event|14
2959290|NCT01235351|10187172|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
2959291|NCT01235351|10187173|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
2959292|NCT01235338|10187185|P2|Overall Study|Prohibited meds|0
2959293|NCT01235338|10187186|P1|Overall Study|Prohibited meds|1
2959294|NCT01235338|10187185|P2|Overall Study|Positive drug screen|1
2959295|NCT01235338|10187186|P1|Overall Study|Positive drug screen|0
2959296|NCT01235338|10187185|P2|Overall Study|Exclusion criteria violations|1
2959297|NCT01235338|10187186|P1|Overall Study|Exclusion criteria violations|1
2959298|NCT01235338|10187185|P2|Overall Study|Withdrawal by Subject|0
2959299|NCT01235338|10187186|P1|Overall Study|Withdrawal by Subject|5
2959300|NCT01235338|10187185|P2|Overall Study|Protocol Violation|1
2959301|NCT01235338|10187186|P1|Overall Study|Protocol Violation|1
2959302|NCT01235338|10187185|P2|Overall Study|Adverse Event|2
2959303|NCT01235338|10187186|P1|Overall Study|Adverse Event|3
2959304|NCT01235234|10187231|P3|Overall Study|Adverse Event|1
2959305|NCT01235234|10187232|P2|Overall Study|Adverse Event|2
2959306|NCT01235234|10187233|P1|Overall Study|Adverse Event|2
2959307|NCT01234883|10187281|P2|Overall Study|Inclusion/exclusion failure|0
2959308|NCT01234883|10187282|P1|Overall Study|Inclusion/exclusion failure|1
2959309|NCT01234883|10187281|P2|Overall Study|Technical difficulties with IV infusion|1
2959310|NCT01234883|10187282|P1|Overall Study|Technical difficulties with IV infusion|0
2959311|NCT01234883|10187281|P2|Overall Study|Parent/guardian withdrew consent|2
2959312|NCT01234883|10187282|P1|Overall Study|Parent/guardian withdrew consent|1
2959313|NCT01234883|10187281|P2|Overall Study|Early treatment release|10
2959314|NCT01234883|10187282|P1|Overall Study|Early treatment release|8
2959315|NCT01234675|10187329|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
2959316|NCT01234675|10187330|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
2959317|NCT01234675|10187329|P2|First Intervention (6 Weeks)|Adverse Event|1
2959318|NCT01234675|10187330|P1|First Intervention (6 Weeks)|Adverse Event|0
2959319|NCT01234649|10187362|P2|Overall Study|Lack of Efficacy|3
2959320|NCT01234649|10187363|P1|Overall Study|Lack of Efficacy|0
2959321|NCT01234649|10187362|P2|Overall Study|Allergic reaction|0
2959322|NCT01234649|10187363|P1|Overall Study|Allergic reaction|1
2959323|NCT01234649|10187362|P2|Overall Study|intolerant to side effects|3
2959324|NCT01234649|10187363|P1|Overall Study|intolerant to side effects|4
2959325|NCT01234649|10187362|P2|Overall Study|Pregnancy|6
2959326|NCT01234649|10187363|P1|Overall Study|Pregnancy|6
2959327|NCT01234649|10187362|P2|Overall Study|Withdrawal by Subject|26
2959328|NCT01234649|10187363|P1|Overall Study|Withdrawal by Subject|32
2959329|NCT01234467|10187411|P1|Overall Study|Other complicating disease (stroke)|1
2959330|NCT01234467|10187411|P1|Overall Study|Physician Decision|1
2959331|NCT01234467|10187411|P1|Overall Study|Clinical deterioration|1
2959332|NCT01234467|10187411|P1|Overall Study|Disease Progression|2
2959333|NCT01234467|10187411|P1|Overall Study|Withdrawal by Subject|2
2959334|NCT01234467|10187411|P1|Overall Study|Death|2
2959335|NCT01234467|10187411|P1|Overall Study|Adverse Event|3
2959336|NCT01234402|10187423|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
2959337|NCT01234402|10187424|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
2959338|NCT01234402|10187425|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
2959339|NCT01234402|10187423|P3|Overall Study|Never treated: Withdrawal By Subject|0
2959340|NCT01234402|10187424|P2|Overall Study|Never treated: Withdrawal By Subject|1
2959341|NCT01234402|10187425|P1|Overall Study|Never treated: Withdrawal By Subject|0
2959342|NCT01234402|10187423|P3|Overall Study|Never treated: Death|1
2959343|NCT01234402|10187424|P2|Overall Study|Never treated: Death|0
2959344|NCT01234402|10187425|P1|Overall Study|Never treated: Death|0
2959345|NCT01234402|10187423|P3|Overall Study|Withdrawal by Subject|4
2959346|NCT01234402|10187424|P2|Overall Study|Withdrawal by Subject|3
2959347|NCT01234402|10187425|P1|Overall Study|Withdrawal by Subject|1
2959348|NCT01234402|10187423|P3|Overall Study|Lost to Follow-up|3
2959349|NCT01234402|10187424|P2|Overall Study|Lost to Follow-up|1
2959350|NCT01234402|10187425|P1|Overall Study|Lost to Follow-up|0
2959351|NCT01234350|10187466|P2|Overall Study|Covers a diverse set of reasons|92
2959352|NCT01234350|10187467|P1|Overall Study|Covers a diverse set of reasons|234
2959353|NCT01234350|10187466|P2|Overall Study|Lost to Follow-up|47
2959354|NCT01234350|10187467|P1|Overall Study|Lost to Follow-up|115
2959355|NCT01234350|10187466|P2|Overall Study|Withdrawal by Subject|36
2959356|NCT01234350|10187467|P1|Overall Study|Withdrawal by Subject|61
2959357|NCT01234350|10187466|P2|Overall Study|Adverse Event|92
2959358|NCT01234350|10187467|P1|Overall Study|Adverse Event|277
2959359|NCT01234337|10187493|P2|Overall Study|Switch to commercial drug|1
2959360|NCT01234337|10187494|P1|Overall Study|Switch to commercial drug|0
2959361|NCT01234337|10187493|P2|Overall Study|Death|1
2959362|NCT01234337|10187494|P1|Overall Study|Death|0
2959363|NCT01234337|10187493|P2|Overall Study|Withdrawal by Subject|9
2959364|NCT01234337|10187494|P1|Overall Study|Withdrawal by Subject|11
2959365|NCT01234337|10187493|P2|Overall Study|Protocol Violation|3
2959366|NCT01234337|10187494|P1|Overall Study|Protocol Violation|2
2959367|NCT01234337|10187493|P2|Overall Study|Lost to Follow-up|1
2959368|NCT01234337|10187494|P1|Overall Study|Lost to Follow-up|0
2959369|NCT01234337|10187493|P2|Overall Study|Randomized but not treated|4
2959371|NCT01234337|10187493|P2|Overall Study|Non-compliant with study medication|2
2959372|NCT01234337|10187494|P1|Overall Study|Non-compliant with study medication|3
2959373|NCT01234337|10187493|P2|Overall Study|Investi. decision not protocol driven|6
2959374|NCT01234337|10187494|P1|Overall Study|Investi. decision not protocol driven|5
2959375|NCT01234337|10187493|P2|Overall Study|Disease progression/recurrence/relapse|223
2959376|NCT01234337|10187494|P1|Overall Study|Disease progression/recurrence/relapse|181
2959377|NCT01234337|10187493|P2|Overall Study|Adverse Event|21
2959378|NCT01234337|10187494|P1|Overall Study|Adverse Event|58
2959379|NCT01233999|10187554|P1|Overall Study|Lost to Follow-up|1
2959380|NCT01233999|10187554|P1|Overall Study|Withdrawal by Subject|1
2959381|NCT01233869|10187573|P4|Extended Treatment Period (46 Months)|Adverse Event|1
2959382|NCT01233869|10187574|P3|Extended Treatment Period (46 Months)|Adverse Event|0
2959383|NCT01233869|10187575|P2|Extended Treatment Period (46 Months)|Adverse Event|0
2959384|NCT01233869|10187576|P1|Extended Treatment Period (46 Months)|Adverse Event|1
2959385|NCT01233869|10187573|P4|Extended Treatment Period (46 Months)|Other|3
2959386|NCT01233869|10187574|P3|Extended Treatment Period (46 Months)|Other|0
2959387|NCT01233869|10187575|P2|Extended Treatment Period (46 Months)|Other|0
2959388|NCT01233869|10187576|P1|Extended Treatment Period (46 Months)|Other|3
2959389|NCT01233869|10187573|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
2959390|NCT01233869|10187574|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
2959391|NCT01233869|10187575|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
2959392|NCT01233869|10187576|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
2959393|NCT01233869|10187573|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
2959394|NCT01233869|10187574|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2959395|NCT01233869|10187575|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2959396|NCT01233869|10187576|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2959397|NCT01233869|10187573|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
2959398|NCT01233869|10187574|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
2959399|NCT01233869|10187575|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
2959400|NCT01233869|10187576|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
2959401|NCT01233869|10187573|P4|Initial Treatment Period (24 Months)|Adverse Event|3
2959402|NCT01233869|10187574|P3|Initial Treatment Period (24 Months)|Adverse Event|0
2959403|NCT01233869|10187575|P2|Initial Treatment Period (24 Months)|Adverse Event|17
2959404|NCT01233869|10187576|P1|Initial Treatment Period (24 Months)|Adverse Event|9
2959405|NCT01233869|10187573|P4|Initial Treatment Period (24 Months)|Death|0
2959406|NCT01233869|10187574|P3|Initial Treatment Period (24 Months)|Death|0
2959407|NCT01233869|10187575|P2|Initial Treatment Period (24 Months)|Death|0
2959408|NCT01233869|10187576|P1|Initial Treatment Period (24 Months)|Death|1
2959409|NCT01233817|10187662|P1|Overall Study|Withdrawal by Subject|2
2959410|NCT01233817|10187662|P1|Overall Study|Lost to Follow-up|1
2959411|NCT01233687|10187709|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
2959412|NCT01233687|10187709|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
2959413|NCT01233687|10187709|P1|Phase II AMG 102 + Erlotinib|Death|1
2959414|NCT01233609|10187719|P2|Overall Study|Withdrawal by Subject|0
2959415|NCT01233609|10187720|P1|Overall Study|Withdrawal by Subject|3
2959416|NCT01233609|10187719|P2|Overall Study|Adverse Event|1
2959417|NCT01233609|10187720|P1|Overall Study|Adverse Event|2
2959418|NCT01233609|10187719|P2|Overall Study|Lost to Follow-up|1
2959419|NCT01233609|10187720|P1|Overall Study|Lost to Follow-up|3
2959420|NCT01233609|10187719|P2|Overall Study|Death|0
2959421|NCT01233609|10187720|P1|Overall Study|Death|1
2959422|NCT01233284|10187744|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
2959423|NCT01233284|10187745|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
2959424|NCT01233284|10187746|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
2959425|NCT01233284|10187747|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
2959426|NCT01233284|10187748|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
2959427|NCT01233284|10187744|P5|Period 4 (4 Weeks)|Adverse Event|0
2959428|NCT01233284|10187745|P4|Period 4 (4 Weeks)|Adverse Event|0
2959429|NCT01233284|10187746|P3|Period 4 (4 Weeks)|Adverse Event|0
2959430|NCT01233284|10187747|P2|Period 4 (4 Weeks)|Adverse Event|1
2959431|NCT01233284|10187748|P1|Period 4 (4 Weeks)|Adverse Event|0
2959432|NCT01233284|10187744|P5|Period 3 (4 Weeks)|Other|0
2959433|NCT01233284|10187745|P4|Period 3 (4 Weeks)|Other|1
2959434|NCT01233284|10187746|P3|Period 3 (4 Weeks)|Other|0
2959435|NCT01233284|10187747|P2|Period 3 (4 Weeks)|Other|0
2959436|NCT01233284|10187748|P1|Period 3 (4 Weeks)|Other|0
2959437|NCT01233284|10187744|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
2959438|NCT01233284|10187745|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
2959439|NCT01233284|10187746|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
2959440|NCT01233284|10187747|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
2959441|NCT01233284|10187748|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
2959442|NCT01233284|10187744|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
2959443|NCT01233284|10187745|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
2959444|NCT01233284|10187746|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
2959445|NCT01233284|10187747|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
2959446|NCT01233284|10187748|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
2959447|NCT01233284|10187744|P5|Period 1 (4 Weeks)|Other|0
2959448|NCT01233284|10187745|P4|Period 1 (4 Weeks)|Other|0
2959449|NCT01233284|10187746|P3|Period 1 (4 Weeks)|Other|1
2959450|NCT01233284|10187747|P2|Period 1 (4 Weeks)|Other|0
2959451|NCT01233284|10187748|P1|Period 1 (4 Weeks)|Other|0
2959452|NCT01233284|10187744|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
2959453|NCT01233284|10187745|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
2959454|NCT01233284|10187746|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
2959455|NCT01233284|10187747|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
2959456|NCT01233284|10187748|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
2959457|NCT01233284|10187744|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
2959458|NCT01233284|10187745|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
2959459|NCT01233284|10187746|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
2959460|NCT01233284|10187747|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
2959461|NCT01233284|10187748|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
2959462|NCT01233258|10187829|P6|First Intervention (6 Months)|Non-compliance with study medication|0
2959463|NCT01233258|10187830|P5|First Intervention (6 Months)|Non-compliance with study medication|0
2959464|NCT01233258|10187831|P4|First Intervention (6 Months)|Non-compliance with study medication|0
2959465|NCT01233258|10187832|P3|First Intervention (6 Months)|Non-compliance with study medication|0
2959466|NCT01233258|10187833|P2|First Intervention (6 Months)|Non-compliance with study medication|0
2959467|NCT01233258|10187834|P1|First Intervention (6 Months)|Non-compliance with study medication|1
2959468|NCT01233258|10187829|P6|First Intervention (6 Months)|Protocol Violation|0
2959469|NCT01233258|10187830|P5|First Intervention (6 Months)|Protocol Violation|0
2959470|NCT01233258|10187831|P4|First Intervention (6 Months)|Protocol Violation|0
2959471|NCT01233258|10187832|P3|First Intervention (6 Months)|Protocol Violation|1
2959472|NCT01233258|10187833|P2|First Intervention (6 Months)|Protocol Violation|0
2959473|NCT01233258|10187834|P1|First Intervention (6 Months)|Protocol Violation|0
2959474|NCT01233258|10187829|P6|First Intervention (6 Months)|Withdrawal by Subject|1
2959475|NCT01233258|10187830|P5|First Intervention (6 Months)|Withdrawal by Subject|0
2959476|NCT01233258|10187831|P4|First Intervention (6 Months)|Withdrawal by Subject|1
2959477|NCT01233258|10187832|P3|First Intervention (6 Months)|Withdrawal by Subject|0
2959478|NCT01233258|10187833|P2|First Intervention (6 Months)|Withdrawal by Subject|0
2959479|NCT01233258|10187834|P1|First Intervention (6 Months)|Withdrawal by Subject|0
2959480|NCT01233232|10187854|P3|Overall Study|Voluntary Discontinuation by Subject|0
2959481|NCT01233232|10187855|P2|Overall Study|Voluntary Discontinuation by Subject|0
2959482|NCT01233232|10187856|P1|Overall Study|Voluntary Discontinuation by Subject|1
2959483|NCT01233076|10187909|P2|Period 2, One Week|Lost to Follow-up|0
2959484|NCT01233076|10187910|P1|Period 2, One Week|Lost to Follow-up|1
2959485|NCT01233050|10187918|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
2959486|NCT01233050|10187919|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
2959487|NCT01232894|10187971|P2|Overall Study|Physician Decision|1
2959488|NCT01232894|10187972|P1|Overall Study|Physician Decision|2
2959489|NCT01232894|10187971|P2|Overall Study|Withdrawal by Subject|5
2959490|NCT01232894|10187972|P1|Overall Study|Withdrawal by Subject|8
2959491|NCT01232894|10187971|P2|Overall Study|Protocol Violation|1
2959492|NCT01232894|10187972|P1|Overall Study|Protocol Violation|1
2959493|NCT01232894|10187971|P2|Overall Study|Death|0
2959494|NCT01232894|10187972|P1|Overall Study|Death|1
2959495|NCT01232894|10187971|P2|Overall Study|Lost to Follow-up|1
2959496|NCT01232894|10187972|P1|Overall Study|Lost to Follow-up|0
2959497|NCT01232868|10187980|P2|Overall Study|Lost to Follow-up|4
2959498|NCT01232868|10187981|P1|Overall Study|Lost to Follow-up|2
2959499|NCT01232790|10187995|P2|Second Crossover|Withdrawal by Subject|2
2959500|NCT01232790|10187996|P1|Second Crossover|Withdrawal by Subject|1
2959501|NCT01232790|10187995|P2|First Crossover|Withdrawal by Subject|0
2959502|NCT01232790|10187996|P1|First Crossover|Withdrawal by Subject|1
2959503|NCT01232790|10187995|P2|Initial Assessment|Withdrawal by Subject|1
2959504|NCT01232790|10187996|P1|Initial Assessment|Withdrawal by Subject|0
2959505|NCT01232790|10187995|P2|Randomization|Physician Decision|1
2959506|NCT01232790|10187996|P1|Randomization|Physician Decision|0
2959507|NCT01232790|10187995|P2|Randomization|Protocol Violation|1
2959508|NCT01232790|10187996|P1|Randomization|Protocol Violation|0
2959509|NCT01232790|10187995|P2|Randomization|Withdrawal by Subject|0
2959510|NCT01232790|10187996|P1|Randomization|Withdrawal by Subject|2
2959511|NCT01232738|10188050|P1|Overall Study|Adverse Event|5
2959512|NCT01232738|10188050|P1|Overall Study|Withdrawal by Subject|2
2959513|NCT01232738|10188050|P1|Overall Study|Lost to Follow-up|1
2959514|NCT01232738|10188050|P1|Overall Study|Physician Decision|2
2959515|NCT01232738|10188050|P1|Overall Study|Death|3
2959516|NCT01232569|10188066|P4|Double-blind Treatment Period|Death|0
2959517|NCT01232569|10188067|P3|Double-blind Treatment Period|Death|0
2959518|NCT01232569|10188068|P2|Double-blind Treatment Period|Death|0
2959519|NCT01232569|10188069|P1|Double-blind Treatment Period|Death|2
2959520|NCT01232569|10188066|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2959521|NCT01232569|10188067|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2959522|NCT01232569|10188068|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
2959523|NCT01232569|10188069|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
2959524|NCT01232569|10188066|P4|Double-blind Treatment Period|Physician Decision|0
2959525|NCT01232569|10188067|P3|Double-blind Treatment Period|Physician Decision|0
2959526|NCT01232569|10188068|P2|Double-blind Treatment Period|Physician Decision|0
2959527|NCT01232569|10188069|P1|Double-blind Treatment Period|Physician Decision|1
2959528|NCT01232569|10188066|P4|Double-blind Treatment Period|Lack of Efficacy|0
2959529|NCT01232569|10188067|P3|Double-blind Treatment Period|Lack of Efficacy|0
2959530|NCT01232569|10188068|P2|Double-blind Treatment Period|Lack of Efficacy|2
2959531|NCT01232569|10188069|P1|Double-blind Treatment Period|Lack of Efficacy|1
2959532|NCT01232569|10188066|P4|Double-blind Treatment Period|Lost to Follow-up|0
2959533|NCT01232569|10188067|P3|Double-blind Treatment Period|Lost to Follow-up|0
2959534|NCT01232569|10188068|P2|Double-blind Treatment Period|Lost to Follow-up|0
2959535|NCT01232569|10188069|P1|Double-blind Treatment Period|Lost to Follow-up|4
2959536|NCT01232569|10188066|P4|Double-blind Treatment Period|Escape|0
2959537|NCT01232569|10188067|P3|Double-blind Treatment Period|Escape|0
2959538|NCT01232569|10188068|P2|Double-blind Treatment Period|Escape|2
2959539|NCT01232569|10188069|P1|Double-blind Treatment Period|Escape|2
2959540|NCT01232569|10188066|P4|Double-blind Treatment Period|Withdrawal by Subject|0
2959541|NCT01232569|10188067|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2959542|NCT01232569|10188068|P2|Double-blind Treatment Period|Withdrawal by Subject|2
2959543|NCT01232569|10188069|P1|Double-blind Treatment Period|Withdrawal by Subject|9
2959544|NCT01232556|10188112|P2|Overall Study|Other|4
2959545|NCT01232556|10188113|P1|Overall Study|Other|6
2959546|NCT01232556|10188112|P2|Overall Study|Terminated by Sponsor|51
2959547|NCT01232556|10188113|P1|Overall Study|Terminated by Sponsor|35
2959548|NCT01232556|10188112|P2|Overall Study|Lost to Follow-up|2
2959549|NCT01232556|10188113|P1|Overall Study|Lost to Follow-up|0
2959550|NCT01232556|10188112|P2|Overall Study|Death|97
2959551|NCT01232556|10188113|P1|Overall Study|Death|97
2959552|NCT01232556|10188112|P2|Overall Study|Withdrawal by Subject|17
2959553|NCT01232556|10188113|P1|Overall Study|Withdrawal by Subject|21
2959554|NCT01232491|10188172|P2|Overall Study|Other|18
2959555|NCT01232491|10188173|P1|Overall Study|Other|21
2959556|NCT01232491|10188172|P2|Overall Study|Withdrawal Criteria|21
2959557|NCT01232491|10188173|P1|Overall Study|Withdrawal Criteria|12
2959558|NCT01232491|10188172|P2|Overall Study|Protocol Violation|11
2959559|NCT01232491|10188173|P1|Overall Study|Protocol Violation|13
2959560|NCT01232491|10188172|P2|Overall Study|Lack of Efficacy|5
2959561|NCT01232491|10188173|P1|Overall Study|Lack of Efficacy|1
2959562|NCT01232491|10188172|P2|Overall Study|Adverse Event|8
2959563|NCT01232491|10188173|P1|Overall Study|Adverse Event|13
2959564|NCT01232452|10188202|P2|Overall Study|Protocol Violation|1
2959565|NCT01232452|10188203|P1|Overall Study|Protocol Violation|0
2959566|NCT01232452|10188202|P2|Overall Study|Sponsor Decision|1
2959567|NCT01232452|10188203|P1|Overall Study|Sponsor Decision|3
2959568|NCT01232452|10188202|P2|Overall Study|Protocol entry criterion not met|2
2959569|NCT01232452|10188203|P1|Overall Study|Protocol entry criterion not met|0
2959570|NCT01232452|10188202|P2|Overall Study|Physician Decision|12
2959571|NCT01232452|10188203|P1|Overall Study|Physician Decision|8
2959572|NCT01232452|10188202|P2|Overall Study|Withdrawal by Subject|8
2959573|NCT01232452|10188203|P1|Overall Study|Withdrawal by Subject|11
2959574|NCT01232452|10188202|P2|Overall Study|Adverse Event|15
2959575|NCT01232452|10188203|P1|Overall Study|Adverse Event|17
2959576|NCT01232296|10188229|P2|Overall Study|Death|6
2959577|NCT01232296|10188230|P1|Overall Study|Death|1
2959578|NCT01232296|10188229|P2|Overall Study|Subject/guardian decision|2
2959579|NCT01232296|10188230|P1|Overall Study|Subject/guardian decision|10
2959580|NCT01232296|10188229|P2|Overall Study|Technical problems|0
2959581|NCT01232296|10188230|P1|Overall Study|Technical problems|3
2959582|NCT01232296|10188229|P2|Overall Study|Study terminated by sponsor|1
2959583|NCT01232296|10188230|P1|Overall Study|Study terminated by sponsor|0
2959584|NCT01232296|10188229|P2|Overall Study|Progressive disease|61
2959585|NCT01232296|10188230|P1|Overall Study|Progressive disease|43
2959586|NCT01232296|10188229|P2|Overall Study|Physician Decision|1
2959587|NCT01232296|10188230|P1|Overall Study|Physician Decision|1
2959588|NCT01232296|10188229|P2|Overall Study|Adverse Event|12
2959589|NCT01232296|10188230|P1|Overall Study|Adverse Event|24
2959590|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
2959591|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
2959592|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959593|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959594|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959595|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959596|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959597|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959598|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959599|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2959600|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959601|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
2959602|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959603|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959604|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959605|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959606|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959607|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959608|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959609|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2959610|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959611|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
2959612|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959613|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959614|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959615|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959616|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959617|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959618|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959619|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
2959620|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
2959621|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
2959622|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959623|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959624|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959625|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959626|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959627|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959628|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959629|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2959630|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
2959631|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
2959632|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959633|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959634|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959635|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959636|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959637|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959638|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959639|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2959640|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
2959641|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
2959642|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959643|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959644|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959645|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959646|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959647|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959648|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959649|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2959650|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
2959651|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
2959652|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959653|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959654|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959655|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959656|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959657|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959658|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959659|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2959660|NCT01232283|10188247|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
2959661|NCT01232283|10188248|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
2959662|NCT01232283|10188249|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959663|NCT01232283|10188250|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959664|NCT01232283|10188251|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959665|NCT01232283|10188252|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959666|NCT01232283|10188253|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959667|NCT01232283|10188254|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959668|NCT01232283|10188255|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959669|NCT01232283|10188256|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2959670|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959671|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959672|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959673|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959674|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
2959675|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959676|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959677|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959678|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959679|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2959680|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959681|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959682|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
2959683|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959684|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959685|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959686|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959687|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959688|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959689|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2959690|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959691|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959692|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2959693|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2959694|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959695|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
2959696|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959697|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959698|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959699|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2959700|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959701|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959702|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959703|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959704|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959705|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
2959706|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959707|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959708|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959709|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2959710|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959711|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959712|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
2959713|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2959714|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2959715|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2959716|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959717|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959718|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959719|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2959720|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959721|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959722|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
2959723|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
2959724|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959725|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
2959726|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959727|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959728|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959729|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2959730|NCT01232283|10188247|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959731|NCT01232283|10188248|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959732|NCT01232283|10188249|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2959733|NCT01232283|10188250|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959734|NCT01232283|10188251|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2959735|NCT01232283|10188252|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
2959736|NCT01232283|10188253|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959737|NCT01232283|10188254|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959738|NCT01232283|10188255|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959739|NCT01232283|10188256|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2959740|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Other|0
2959741|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Other|0
2959742|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Other|0
2959743|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Other|0
2959744|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Other|0
2959745|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Other|0
2959746|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Other|0
2959747|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Other|2
2959748|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Other|0
2959749|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Other|0
2959750|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959751|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959752|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959753|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959754|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959755|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959756|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
2960080|NCT01230827|10189086|P1|Overall Study|Lack of Efficacy|14
2959757|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
2959758|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959759|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2959760|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959761|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959762|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959763|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959764|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959765|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959766|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
2959767|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
2959768|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959769|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2959770|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959771|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959772|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959773|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959774|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959775|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959776|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959777|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
2959778|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959779|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2959780|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959781|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959782|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959783|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959784|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959785|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959786|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
2959787|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
2959788|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959789|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2959790|NCT01232283|10188247|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959791|NCT01232283|10188248|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959792|NCT01232283|10188249|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959793|NCT01232283|10188250|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959794|NCT01232283|10188251|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959795|NCT01232283|10188252|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959796|NCT01232283|10188253|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
2959797|NCT01232283|10188254|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
2959798|NCT01232283|10188255|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959799|NCT01232283|10188256|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
2959800|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959801|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959802|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959803|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959804|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959805|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959806|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959807|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
2959808|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
2959809|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
2959810|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959811|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959812|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959813|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959814|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959815|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959816|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959817|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2959818|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
2959819|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
2959820|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959821|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959822|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959823|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959824|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959825|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959826|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959827|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2959828|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2959829|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2960081|NCT01230827|10189083|P4|Overall Study|Withdrawal by Subject|2
2959830|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959831|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959832|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959833|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959834|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959835|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959836|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959837|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2959838|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
2959839|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
2959840|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959841|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959842|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959843|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959844|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959845|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959846|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959847|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959848|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2959849|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
2959850|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959851|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959852|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959853|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959854|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959855|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959856|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959857|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2959858|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
2959859|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
2959860|NCT01232283|10188247|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959861|NCT01232283|10188248|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959862|NCT01232283|10188249|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959863|NCT01232283|10188250|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959864|NCT01232283|10188251|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959865|NCT01232283|10188252|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959866|NCT01232283|10188253|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959867|NCT01232283|10188254|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2959868|NCT01232283|10188255|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
2959869|NCT01232283|10188256|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
2959870|NCT01232127|10188297|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
2959871|NCT01232127|10188298|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
2959872|NCT01232127|10188299|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
2959873|NCT01231984|10188323|P4|Study Period 2|Did not continue to meet I/E Criteria|1
2959874|NCT01231984|10188324|P3|Study Period 2|Did not continue to meet I/E Criteria|0
2959875|NCT01231984|10188325|P2|Study Period 2|Did not continue to meet I/E Criteria|1
2959876|NCT01231984|10188326|P1|Study Period 2|Did not continue to meet I/E Criteria|1
2959877|NCT01231984|10188323|P4|Study Period 2|Lost to Follow-up|3
2959878|NCT01231984|10188324|P3|Study Period 2|Lost to Follow-up|0
2959879|NCT01231984|10188325|P2|Study Period 2|Lost to Follow-up|0
2959880|NCT01231984|10188326|P1|Study Period 2|Lost to Follow-up|1
2959881|NCT01231984|10188323|P4|Study Period 2|Withdrawal by Subject|0
2959882|NCT01231984|10188324|P3|Study Period 2|Withdrawal by Subject|0
2959883|NCT01231984|10188325|P2|Study Period 2|Withdrawal by Subject|1
2959884|NCT01231984|10188326|P1|Study Period 2|Withdrawal by Subject|1
2959885|NCT01231984|10188323|P4|Study Period 1|Other|1
2959886|NCT01231984|10188324|P3|Study Period 1|Other|0
2959887|NCT01231984|10188325|P2|Study Period 1|Other|0
2959888|NCT01231984|10188326|P1|Study Period 1|Other|0
2959889|NCT01231984|10188323|P4|Study Period 1|Adverse Event|0
2959890|NCT01231984|10188324|P3|Study Period 1|Adverse Event|0
2959891|NCT01231984|10188325|P2|Study Period 1|Adverse Event|0
2959892|NCT01231984|10188326|P1|Study Period 1|Adverse Event|1
2959893|NCT01231984|10188323|P4|Study Period 1|Protocol Violation|3
2959894|NCT01231984|10188324|P3|Study Period 1|Protocol Violation|2
2959895|NCT01231984|10188325|P2|Study Period 1|Protocol Violation|4
2959896|NCT01231984|10188326|P1|Study Period 1|Protocol Violation|3
2959897|NCT01231984|10188323|P4|Study Period 1|Non-compliance with study requirements|1
2959898|NCT01231984|10188324|P3|Study Period 1|Non-compliance with study requirements|2
2959899|NCT01231984|10188325|P2|Study Period 1|Non-compliance with study requirements|0
2959900|NCT01231984|10188326|P1|Study Period 1|Non-compliance with study requirements|5
2959901|NCT01231984|10188323|P4|Study Period 1|Screen Failure|1
2959902|NCT01231984|10188324|P3|Study Period 1|Screen Failure|0
2959903|NCT01231984|10188325|P2|Study Period 1|Screen Failure|0
2959904|NCT01231984|10188326|P1|Study Period 1|Screen Failure|0
2959905|NCT01231984|10188323|P4|Study Period 1|Did not continue to meet I/E Criteria|2
2959906|NCT01231984|10188324|P3|Study Period 1|Did not continue to meet I/E Criteria|2
2959907|NCT01231984|10188325|P2|Study Period 1|Did not continue to meet I/E Criteria|2
2959908|NCT01231984|10188326|P1|Study Period 1|Did not continue to meet I/E Criteria|2
2959909|NCT01231984|10188323|P4|Study Period 1|Lost to Follow-up|0
2959910|NCT01231984|10188324|P3|Study Period 1|Lost to Follow-up|1
2959911|NCT01231984|10188325|P2|Study Period 1|Lost to Follow-up|1
2959912|NCT01231984|10188326|P1|Study Period 1|Lost to Follow-up|1
2959913|NCT01231984|10188323|P4|Study Period 1|Withdrawal by Subject|1
2959914|NCT01231984|10188324|P3|Study Period 1|Withdrawal by Subject|0
2959915|NCT01231984|10188325|P2|Study Period 1|Withdrawal by Subject|0
2959916|NCT01231984|10188326|P1|Study Period 1|Withdrawal by Subject|0
2959917|NCT01231620|10188395|P3|Overall Study|Lost to Follow-up|9
2959918|NCT01231620|10188396|P2|Overall Study|Lost to Follow-up|4
2959919|NCT01231620|10188397|P1|Overall Study|Lost to Follow-up|3
2959920|NCT01231620|10188395|P3|Overall Study|Withdrawal by Subject|8
2959921|NCT01231620|10188396|P2|Overall Study|Withdrawal by Subject|6
2959922|NCT01231620|10188397|P1|Overall Study|Withdrawal by Subject|6
2959923|NCT01231620|10188395|P3|Overall Study|Adverse Event|1
2959924|NCT01231620|10188396|P2|Overall Study|Adverse Event|2
2959925|NCT01231620|10188397|P1|Overall Study|Adverse Event|2
2959926|NCT01231620|10188395|P3|Overall Study|Death|11
2959927|NCT01231620|10188396|P2|Overall Study|Death|14
2959928|NCT01231620|10188397|P1|Overall Study|Death|12
2959929|NCT01231620|10188395|P3|Overall Study|Physician Decision|10
2959930|NCT01231620|10188396|P2|Overall Study|Physician Decision|5
2959931|NCT01231620|10188397|P1|Overall Study|Physician Decision|3
2959932|NCT01231607|10188503|P5|Overall Study|Withdrawal by Subject|9
2959933|NCT01231607|10188504|P4|Overall Study|Withdrawal by Subject|17
2959934|NCT01231607|10188505|P3|Overall Study|Withdrawal by Subject|14
2959935|NCT01231607|10188506|P2|Overall Study|Withdrawal by Subject|9
2959936|NCT01231607|10188507|P1|Overall Study|Withdrawal by Subject|9
2959937|NCT01231607|10188503|P5|Overall Study|Protocol Violation|2
2959938|NCT01231607|10188504|P4|Overall Study|Protocol Violation|2
2959939|NCT01231607|10188505|P3|Overall Study|Protocol Violation|0
2959940|NCT01231607|10188506|P2|Overall Study|Protocol Violation|2
2959941|NCT01231607|10188507|P1|Overall Study|Protocol Violation|3
2959942|NCT01231607|10188503|P5|Overall Study|Physician Decision|4
2959943|NCT01231607|10188504|P4|Overall Study|Physician Decision|5
2959944|NCT01231607|10188505|P3|Overall Study|Physician Decision|3
2959945|NCT01231607|10188506|P2|Overall Study|Physician Decision|4
2959946|NCT01231607|10188507|P1|Overall Study|Physician Decision|4
2959947|NCT01231607|10188503|P5|Overall Study|Lost to Follow-up|4
2959948|NCT01231607|10188504|P4|Overall Study|Lost to Follow-up|10
2959949|NCT01231607|10188505|P3|Overall Study|Lost to Follow-up|10
2959950|NCT01231607|10188506|P2|Overall Study|Lost to Follow-up|11
2959951|NCT01231607|10188507|P1|Overall Study|Lost to Follow-up|13
2959952|NCT01231607|10188503|P5|Overall Study|Adverse Event|5
2959953|NCT01231607|10188504|P4|Overall Study|Adverse Event|4
2959954|NCT01231607|10188505|P3|Overall Study|Adverse Event|4
2959955|NCT01231607|10188506|P2|Overall Study|Adverse Event|8
2959956|NCT01231607|10188507|P1|Overall Study|Adverse Event|0
2959957|NCT01231581|10188599|P2|Overall Study|Ongoing|0
2959958|NCT01231581|10188600|P1|Overall Study|Ongoing|1
2959959|NCT01231581|10188599|P2|Overall Study|Death|64
2959960|NCT01231581|10188600|P1|Overall Study|Death|65
2959961|NCT01231581|10188599|P2|Overall Study|Study Closed/Terminated|5
2959962|NCT01231581|10188600|P1|Overall Study|Study Closed/Terminated|6
2959963|NCT01231581|10188599|P2|Overall Study|Withdrawal by Subject|9
2959964|NCT01231581|10188600|P1|Overall Study|Withdrawal by Subject|6
2959965|NCT01231581|10188599|P2|Overall Study|Lost to Follow-up|2
2959966|NCT01231581|10188600|P1|Overall Study|Lost to Follow-up|2
2959967|NCT01231555|10188621|P3|Overall Study|Withdrawal by Subject|0
2959968|NCT01231555|10188622|P2|Overall Study|Withdrawal by Subject|2
2959969|NCT01231555|10188623|P1|Overall Study|Withdrawal by Subject|0
2959970|NCT01231555|10188621|P3|Overall Study|Study terminated|8
2959971|NCT01231555|10188622|P2|Overall Study|Study terminated|5
2959972|NCT01231555|10188623|P1|Overall Study|Study terminated|8
2959973|NCT01231516|10188654|P2|Open-label Phase|Ongoing at the time of analysis|23
2959974|NCT01231516|10188655|P1|Open-label Phase|Ongoing at the time of analysis|282
2959975|NCT01231516|10188654|P2|Open-label Phase|Withdrawal by Subject|0
2959976|NCT01231516|10188655|P1|Open-label Phase|Withdrawal by Subject|1
2959977|NCT01231516|10188654|P2|Open-label Phase|Lost to Follow-up|0
2959978|NCT01231516|10188655|P1|Open-label Phase|Lost to Follow-up|3
2959979|NCT01231516|10188654|P2|Open-label Phase|Protocol Violation|0
2959980|NCT01231516|10188655|P1|Open-label Phase|Protocol Violation|2
2959981|NCT01231516|10188654|P2|Open-label Phase|Lack of Efficacy|3
2959982|NCT01231516|10188655|P1|Open-label Phase|Lack of Efficacy|7
2959983|NCT01231516|10188654|P2|48 Week Double-blind Phase|Site Closed|1
2959984|NCT01231516|10188655|P1|48 Week Double-blind Phase|Site Closed|3
2959985|NCT01231516|10188654|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
2959986|NCT01231516|10188655|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
2959987|NCT01231516|10188654|P2|48 Week Double-blind Phase|Physician Decision|1
2959988|NCT01231516|10188655|P1|48 Week Double-blind Phase|Physician Decision|1
2959989|NCT01231516|10188654|P2|48 Week Double-blind Phase|Lost to Follow-up|10
2959990|NCT01231516|10188655|P1|48 Week Double-blind Phase|Lost to Follow-up|5
2959991|NCT01231516|10188654|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
2959992|NCT01231516|10188655|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
2959993|NCT01231516|10188654|P2|48 Week Double-blind Phase|Protocol Violation|6
2959994|NCT01231516|10188655|P1|48 Week Double-blind Phase|Protocol Violation|9
2959995|NCT01231516|10188654|P2|48 Week Double-blind Phase|Lack of Efficacy|42
2959996|NCT01231516|10188655|P1|48 Week Double-blind Phase|Lack of Efficacy|20
2959997|NCT01231516|10188654|P2|48 Week Double-blind Phase|Adverse Event|11
2959998|NCT01231516|10188655|P1|48 Week Double-blind Phase|Adverse Event|4
2959999|NCT01231503|10188685|P8|Overall Study|Protocol Violation|0
2960000|NCT01231503|10188686|P7|Overall Study|Protocol Violation|0
2960001|NCT01231503|10188687|P6|Overall Study|Protocol Violation|0
2960002|NCT01231503|10188688|P5|Overall Study|Protocol Violation|0
2960003|NCT01231503|10188689|P4|Overall Study|Protocol Violation|1
2960004|NCT01231503|10188690|P3|Overall Study|Protocol Violation|0
2960005|NCT01231503|10188691|P2|Overall Study|Protocol Violation|0
2960006|NCT01231503|10188692|P1|Overall Study|Protocol Violation|0
2960007|NCT01231503|10188685|P8|Overall Study|Lost to Follow-up|6
2960008|NCT01231503|10188686|P7|Overall Study|Lost to Follow-up|6
2960009|NCT01231503|10188687|P6|Overall Study|Lost to Follow-up|9
2960010|NCT01231503|10188688|P5|Overall Study|Lost to Follow-up|7
2960011|NCT01231503|10188689|P4|Overall Study|Lost to Follow-up|5
2960012|NCT01231503|10188690|P3|Overall Study|Lost to Follow-up|8
2960013|NCT01231503|10188691|P2|Overall Study|Lost to Follow-up|10
2960014|NCT01231503|10188692|P1|Overall Study|Lost to Follow-up|8
2960015|NCT01231503|10188685|P8|Overall Study|Withdrawal by Subject|2
2960016|NCT01231503|10188686|P7|Overall Study|Withdrawal by Subject|1
2960017|NCT01231503|10188687|P6|Overall Study|Withdrawal by Subject|5
2960018|NCT01231503|10188688|P5|Overall Study|Withdrawal by Subject|3
2960019|NCT01231503|10188689|P4|Overall Study|Withdrawal by Subject|1
2960020|NCT01231503|10188690|P3|Overall Study|Withdrawal by Subject|3
2960021|NCT01231503|10188691|P2|Overall Study|Withdrawal by Subject|3
2960022|NCT01231503|10188692|P1|Overall Study|Withdrawal by Subject|6
2960023|NCT01231503|10188685|P8|Overall Study|Adverse event, serious fatal|0
2960024|NCT01231503|10188686|P7|Overall Study|Adverse event, serious fatal|0
2960025|NCT01231503|10188687|P6|Overall Study|Adverse event, serious fatal|1
2960026|NCT01231503|10188688|P5|Overall Study|Adverse event, serious fatal|0
2960027|NCT01231503|10188689|P4|Overall Study|Adverse event, serious fatal|1
2960028|NCT01231503|10188690|P3|Overall Study|Adverse event, serious fatal|1
2960029|NCT01231503|10188691|P2|Overall Study|Adverse event, serious fatal|0
2960030|NCT01231503|10188692|P1|Overall Study|Adverse event, serious fatal|0
2960031|NCT01231503|10188685|P8|Overall Study|Adverse Event|0
2960032|NCT01231503|10188686|P7|Overall Study|Adverse Event|0
2960033|NCT01231503|10188687|P6|Overall Study|Adverse Event|1
2960034|NCT01231503|10188688|P5|Overall Study|Adverse Event|0
2960035|NCT01231503|10188689|P4|Overall Study|Adverse Event|0
2960036|NCT01231503|10188690|P3|Overall Study|Adverse Event|0
2960037|NCT01231503|10188691|P2|Overall Study|Adverse Event|0
2960038|NCT01231503|10188692|P1|Overall Study|Adverse Event|0
2960039|NCT01231464|10188932|P2|Overall Study|Withdrawal by Subject|2
2960040|NCT01231464|10188933|P1|Overall Study|Withdrawal by Subject|3
2960041|NCT01231464|10188932|P2|Overall Study|Lost to Follow-up|2
2960042|NCT01231464|10188933|P1|Overall Study|Lost to Follow-up|1
2960043|NCT01231464|10188932|P2|Overall Study|Protocol Violation|2
2960044|NCT01231464|10188933|P1|Overall Study|Protocol Violation|1
2960045|NCT01231464|10188932|P2|Overall Study|Adverse Event|1
2960046|NCT01231464|10188933|P1|Overall Study|Adverse Event|0
2960047|NCT01231373|10188982|P4|Overall Study|Withdrew Consent|0
2960048|NCT01231373|10188983|P3|Overall Study|Withdrew Consent|0
2960049|NCT01231373|10188984|P2|Overall Study|Withdrew Consent|0
2960050|NCT01231373|10188985|P1|Overall Study|Withdrew Consent|1
2960051|NCT01231373|10188982|P4|Overall Study|Lost to Follow-up|1
2960052|NCT01231373|10188983|P3|Overall Study|Lost to Follow-up|0
2960053|NCT01231373|10188984|P2|Overall Study|Lost to Follow-up|0
2960054|NCT01231373|10188985|P1|Overall Study|Lost to Follow-up|0
2960055|NCT01231373|10188982|P4|Overall Study|Withdrew consent prior to randomization|0
2960056|NCT01231373|10188983|P3|Overall Study|Withdrew consent prior to randomization|0
2960057|NCT01231373|10188984|P2|Overall Study|Withdrew consent prior to randomization|1
2960058|NCT01231373|10188985|P1|Overall Study|Withdrew consent prior to randomization|2
2960059|NCT01231321|10189024|P1|Overall Study|Lack of Efficacy|2
2960060|NCT01231321|10189024|P1|Overall Study|Adverse Event|3
2960061|NCT01230892|10189072|P2|Overall Study|Lost to Follow-up|0
2960062|NCT01230892|10189073|P1|Overall Study|Lost to Follow-up|2
2960063|NCT01230892|10189072|P2|Overall Study|Withdrawal by Subject|1
2960064|NCT01230892|10189073|P1|Overall Study|Withdrawal by Subject|1
2960065|NCT01230827|10189083|P4|Overall Study|Study terminated by Sponsor|63
2960066|NCT01230827|10189084|P3|Overall Study|Study terminated by Sponsor|56
2960067|NCT01230827|10189085|P2|Overall Study|Study terminated by Sponsor|2
2960068|NCT01230827|10189086|P1|Overall Study|Study terminated by Sponsor|0
2960069|NCT01230827|10189083|P4|Overall Study|Recovery|0
2960070|NCT01230827|10189084|P3|Overall Study|Recovery|0
2960071|NCT01230827|10189085|P2|Overall Study|Recovery|6
2960072|NCT01230827|10189086|P1|Overall Study|Recovery|0
2960073|NCT01230827|10189083|P4|Overall Study|Adverse Event|7
2960074|NCT01230827|10189084|P3|Overall Study|Adverse Event|3
2960075|NCT01230827|10189085|P2|Overall Study|Adverse Event|2
2960076|NCT01230827|10189086|P1|Overall Study|Adverse Event|4
2960077|NCT01230827|10189083|P4|Overall Study|Lack of Efficacy|3
2960078|NCT01230827|10189084|P3|Overall Study|Lack of Efficacy|2
2960079|NCT01230827|10189085|P2|Overall Study|Lack of Efficacy|1
2960082|NCT01230827|10189084|P3|Overall Study|Withdrawal by Subject|3
2960083|NCT01230827|10189085|P2|Overall Study|Withdrawal by Subject|0
2960084|NCT01230827|10189086|P1|Overall Study|Withdrawal by Subject|1
2960085|NCT01230827|10189083|P4|Overall Study|Lost to Follow-up|3
2960086|NCT01230827|10189084|P3|Overall Study|Lost to Follow-up|1
2960087|NCT01230827|10189085|P2|Overall Study|Lost to Follow-up|0
2960088|NCT01230827|10189086|P1|Overall Study|Lost to Follow-up|0
2960089|NCT01230814|10189102|P2|Overall Study|Discontinued (not due to adverse event)|1
2960090|NCT01230814|10189103|P1|Overall Study|Discontinued (not due to adverse event)|2
2960091|NCT01230814|10189102|P2|Overall Study|Lost to Follow-up|3
2960092|NCT01230814|10189103|P1|Overall Study|Lost to Follow-up|11
2960093|NCT01230788|10189153|P1|Overall Study|Prescribed exclusion drug|1
2960094|NCT01230749|10189165|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
2960095|NCT01230749|10189166|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
2960096|NCT01230749|10189167|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
2960097|NCT01230749|10189168|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
2960098|NCT01230749|10189165|P4|Overall Study|Withdrawal by Subject|0
2960099|NCT01230749|10189166|P3|Overall Study|Withdrawal by Subject|0
2960100|NCT01230749|10189167|P2|Overall Study|Withdrawal by Subject|1
2960101|NCT01230749|10189168|P1|Overall Study|Withdrawal by Subject|0
2960102|NCT01230749|10189165|P4|Overall Study|Physician Decision|0
2960103|NCT01230749|10189166|P3|Overall Study|Physician Decision|1
2960104|NCT01230749|10189167|P2|Overall Study|Physician Decision|0
2960105|NCT01230749|10189168|P1|Overall Study|Physician Decision|0
2960106|NCT01230749|10189165|P4|Overall Study|Adverse Event|1
2960107|NCT01230749|10189166|P3|Overall Study|Adverse Event|0
2960108|NCT01230749|10189167|P2|Overall Study|Adverse Event|0
2960109|NCT01230749|10189168|P1|Overall Study|Adverse Event|0
2960110|NCT01230710|10189203|P1|Overall Study|Withdrawal of Consent|1
2960111|NCT01230710|10189203|P1|Overall Study|Death|4
2960112|NCT01230710|10189203|P1|Overall Study|Lost to Follow-up|3
2960113|NCT01230710|10189203|P1|Overall Study|Disease Progression|41
2960114|NCT01230554|10189227|P1|Overall Study|Inability to maintain visit schedule|1
2960115|NCT01230554|10189227|P1|Overall Study|Lost to Follow-up|2
2960116|NCT01230489|10189250|P1|Overall Study|Treatment modality changed|1
2960117|NCT01230489|10189250|P1|Overall Study|Adverse Event|2
2960118|NCT01230489|10189250|P1|Overall Study|Death|2
2960119|NCT01230307|10189285|P2|Overall Study|LVAD Placement|2
2960120|NCT01230307|10189286|P1|Overall Study|LVAD Placement|0
2960121|NCT01230060|10189306|P1|Overall Study|Withdrawal by Subject|1
2960122|NCT01229735|10189379|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2960123|NCT01229735|10189380|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2960124|NCT01229735|10189379|P2|Overall Study|AE, non-serious non-fatal|17
2960125|NCT01229735|10189380|P1|Overall Study|AE, non-serious non-fatal|13
2960126|NCT01229735|10189379|P2|Overall Study|SAE, non-fatal|4
2960127|NCT01229735|10189380|P1|Overall Study|SAE, non-fatal|0
2960128|NCT01229735|10189379|P2|Overall Study|Other Reason|10
2960129|NCT01229735|10189380|P1|Overall Study|Other Reason|13
2960130|NCT01229735|10189379|P2|Overall Study|Withdrawal by Subject|17
2960131|NCT01229735|10189380|P1|Overall Study|Withdrawal by Subject|18
2960132|NCT01229735|10189379|P2|Overall Study|Lost to Follow-up|2
2960133|NCT01229735|10189380|P1|Overall Study|Lost to Follow-up|0
2960134|NCT01229735|10189379|P2|Overall Study|Protocol Violation|8
2960135|NCT01229735|10189380|P1|Overall Study|Protocol Violation|13
2960136|NCT01229735|10189379|P2|Overall Study|Lack of Efficacy|8
2960137|NCT01229735|10189380|P1|Overall Study|Lack of Efficacy|8
2960138|NCT01229449|10189437|P5|Overall Study|Physician Decision|0
2960139|NCT01229449|10189438|P4|Overall Study|Physician Decision|0
2960140|NCT01229449|10189439|P3|Overall Study|Physician Decision|1
2960141|NCT01229449|10189440|P2|Overall Study|Physician Decision|0
2960142|NCT01229449|10189441|P1|Overall Study|Physician Decision|0
2960143|NCT01229449|10189437|P5|Overall Study|Lost to Follow-up|0
2960144|NCT01229449|10189438|P4|Overall Study|Lost to Follow-up|0
2960145|NCT01229449|10189439|P3|Overall Study|Lost to Follow-up|1
2960146|NCT01229449|10189440|P2|Overall Study|Lost to Follow-up|1
2960147|NCT01229449|10189441|P1|Overall Study|Lost to Follow-up|1
2960148|NCT01229449|10189437|P5|Overall Study|Withdrawal by Subject|1
2960149|NCT01229449|10189438|P4|Overall Study|Withdrawal by Subject|1
2960150|NCT01229449|10189439|P3|Overall Study|Withdrawal by Subject|0
2960151|NCT01229449|10189440|P2|Overall Study|Withdrawal by Subject|3
2960152|NCT01229449|10189441|P1|Overall Study|Withdrawal by Subject|0
2960153|NCT01229436|10189498|P1|Overall Study|Lost to Follow-up|3
2960154|NCT01229436|10189498|P1|Overall Study|Withdrawal by Subject|2
2960155|NCT01229397|10189560|P2|Overall Study|Migrated/moved from study area|0
2960156|NCT01229397|10189561|P1|Overall Study|Migrated/moved from study area|1
2960157|NCT01229397|10189560|P2|Overall Study|Lost to Follow-up|6
2960158|NCT01229397|10189561|P1|Overall Study|Lost to Follow-up|7
2960159|NCT01229397|10189560|P2|Overall Study|Withdrawal by Subject|3
2960160|NCT01229397|10189561|P1|Overall Study|Withdrawal by Subject|3
2960161|NCT01229371|10189579|P4|Overall Study|Withdrawal by Subject|0
2960162|NCT01229371|10189580|P3|Overall Study|Withdrawal by Subject|0
2960163|NCT01229371|10189581|P2|Overall Study|Withdrawal by Subject|1
2960164|NCT01229371|10189582|P1|Overall Study|Withdrawal by Subject|0
2960165|NCT01229267|10189609|P5|Overall Study|Lost to Follow-up|22
2960166|NCT01229267|10189610|P4|Overall Study|Lost to Follow-up|3
2960167|NCT01229267|10189611|P3|Overall Study|Lost to Follow-up|8
2960168|NCT01229267|10189612|P2|Overall Study|Lost to Follow-up|5
2960169|NCT01229267|10189613|P1|Overall Study|Lost to Follow-up|6
2960170|NCT01229267|10189609|P5|Overall Study|Physician Decision|25
2960171|NCT01229267|10189610|P4|Overall Study|Physician Decision|3
2960172|NCT01229267|10189611|P3|Overall Study|Physician Decision|8
2960173|NCT01229267|10189612|P2|Overall Study|Physician Decision|11
2960174|NCT01229267|10189613|P1|Overall Study|Physician Decision|8
2960175|NCT01229267|10189609|P5|Overall Study|Progressive disease|1
2960176|NCT01229267|10189610|P4|Overall Study|Progressive disease|0
2960177|NCT01229267|10189611|P3|Overall Study|Progressive disease|0
2960178|NCT01229267|10189612|P2|Overall Study|Progressive disease|0
2960179|NCT01229267|10189613|P1|Overall Study|Progressive disease|0
2960180|NCT01229267|10189609|P5|Overall Study|Protocol Violation|0
2960181|NCT01229267|10189610|P4|Overall Study|Protocol Violation|0
2960182|NCT01229267|10189611|P3|Overall Study|Protocol Violation|0
2960183|NCT01229267|10189612|P2|Overall Study|Protocol Violation|1
2960184|NCT01229267|10189613|P1|Overall Study|Protocol Violation|0
2960185|NCT01229267|10189609|P5|Overall Study|Withdrawal by Subject|59
2960186|NCT01229267|10189610|P4|Overall Study|Withdrawal by Subject|14
2960187|NCT01229267|10189611|P3|Overall Study|Withdrawal by Subject|32
2960188|NCT01229267|10189612|P2|Overall Study|Withdrawal by Subject|22
2960189|NCT01229267|10189613|P1|Overall Study|Withdrawal by Subject|23
2960190|NCT01229267|10189609|P5|Overall Study|Death|103
2960191|NCT01229267|10189610|P4|Overall Study|Death|13
2960192|NCT01229267|10189611|P3|Overall Study|Death|35
2960193|NCT01229267|10189612|P2|Overall Study|Death|37
2960194|NCT01229267|10189613|P1|Overall Study|Death|40
2960195|NCT01229267|10189609|P5|Overall Study|Adverse Event|10
2960196|NCT01229267|10189610|P4|Overall Study|Adverse Event|2
2960197|NCT01229267|10189611|P3|Overall Study|Adverse Event|3
2960198|NCT01229267|10189612|P2|Overall Study|Adverse Event|6
2960199|NCT01229267|10189613|P1|Overall Study|Adverse Event|4
2960200|NCT01229254|10189632|P3|Overall Study|Non-compliance with Study Drug|1
2960201|NCT01229254|10189633|P2|Overall Study|Non-compliance with Study Drug|1
2960202|NCT01229254|10189634|P1|Overall Study|Non-compliance with Study Drug|0
2960203|NCT01229254|10189632|P3|Overall Study|Withdrawal by Subject|1
2960204|NCT01229254|10189633|P2|Overall Study|Withdrawal by Subject|0
2960205|NCT01229254|10189634|P1|Overall Study|Withdrawal by Subject|1
2960206|NCT01229254|10189632|P3|Overall Study|Protocol Violation|5
2960207|NCT01229254|10189633|P2|Overall Study|Protocol Violation|6
2960208|NCT01229254|10189634|P1|Overall Study|Protocol Violation|4
2960209|NCT01229254|10189632|P3|Overall Study|Physician Decision|0
2960210|NCT01229254|10189633|P2|Overall Study|Physician Decision|3
2960211|NCT01229254|10189634|P1|Overall Study|Physician Decision|0
2960212|NCT01229254|10189632|P3|Overall Study|Lost to Follow-up|1
2960213|NCT01229254|10189633|P2|Overall Study|Lost to Follow-up|0
2960214|NCT01229254|10189634|P1|Overall Study|Lost to Follow-up|3
2960215|NCT01229254|10189632|P3|Overall Study|Adverse Event|3
2960216|NCT01229254|10189633|P2|Overall Study|Adverse Event|5
2960217|NCT01229254|10189634|P1|Overall Study|Adverse Event|4
2960218|NCT01229254|10189632|P3|Overall Study|Not Continuing Into Safety Extension|1
2960219|NCT01229254|10189633|P2|Overall Study|Not Continuing Into Safety Extension|1
2960220|NCT01229254|10189634|P1|Overall Study|Not Continuing Into Safety Extension|3
2960221|NCT01229176|10189672|P8|Overall Study|Lost to Follow-up|2
2960222|NCT01229176|10189673|P7|Overall Study|Lost to Follow-up|0
2960223|NCT01229176|10189674|P6|Overall Study|Lost to Follow-up|1
2960224|NCT01229176|10189675|P5|Overall Study|Lost to Follow-up|1
2960225|NCT01229176|10189676|P4|Overall Study|Lost to Follow-up|0
2960226|NCT01229176|10189677|P3|Overall Study|Lost to Follow-up|0
2960227|NCT01229176|10189678|P2|Overall Study|Lost to Follow-up|3
2960228|NCT01229176|10189679|P1|Overall Study|Lost to Follow-up|0
2960229|NCT01229176|10189672|P8|Overall Study|Withdrawal by Subject|1
2960230|NCT01229176|10189673|P7|Overall Study|Withdrawal by Subject|0
2960231|NCT01229176|10189674|P6|Overall Study|Withdrawal by Subject|1
2960232|NCT01229176|10189675|P5|Overall Study|Withdrawal by Subject|1
2960233|NCT01229176|10189676|P4|Overall Study|Withdrawal by Subject|1
2960234|NCT01229176|10189677|P3|Overall Study|Withdrawal by Subject|0
2960235|NCT01229176|10189678|P2|Overall Study|Withdrawal by Subject|0
2960236|NCT01229176|10189679|P1|Overall Study|Withdrawal by Subject|0
2960237|NCT01229150|10189733|P4|Overall Study|Toxicity|0
2960238|NCT01229150|10189734|P3|Overall Study|Toxicity|0
2960239|NCT01229150|10189735|P2|Overall Study|Toxicity|2
2960240|NCT01229150|10189736|P1|Overall Study|Toxicity|2
2960241|NCT01229111|10189793|P1|Overall Study|Death|1
2960242|NCT01228747|10189842|P2|Overall Study|Other Reason|5
2960243|NCT01228747|10189843|P1|Overall Study|Other Reason|2
2960244|NCT01228747|10189842|P2|Overall Study|Withdrawal by Subject|1
2960245|NCT01228747|10189843|P1|Overall Study|Withdrawal by Subject|5
2960246|NCT01228747|10189842|P2|Overall Study|Lost to Follow-up|3
2960247|NCT01228747|10189843|P1|Overall Study|Lost to Follow-up|4
2960248|NCT01228747|10189842|P2|Overall Study|Protocol Violation|5
2960249|NCT01228747|10189843|P1|Overall Study|Protocol Violation|6
2960250|NCT01228747|10189842|P2|Overall Study|Lack of Efficacy|27
2960251|NCT01228747|10189843|P1|Overall Study|Lack of Efficacy|40
2960252|NCT01228747|10189842|P2|Overall Study|Adverse Event|4
2960253|NCT01228747|10189843|P1|Overall Study|Adverse Event|8
2960254|NCT01228734|10189859|P2|Overall Study|Randomized, but not treated|4
2960255|NCT01228734|10189860|P1|Overall Study|Randomized, but not treated|0
2960256|NCT01228591|10189874|P2|Baseline|Lack of Efficacy|2
2960257|NCT01228591|10189875|P1|Baseline|Lack of Efficacy|1
2960258|NCT01228318|10189904|P2|Overall Study|Incarcerated|0
2960259|NCT01228318|10189905|P1|Overall Study|Incarcerated|1
2960260|NCT01228318|10189904|P2|Overall Study|Moved|2
2960261|NCT01228318|10189905|P1|Overall Study|Moved|0
2960262|NCT01228318|10189904|P2|Overall Study|Unable to contact|5
2960263|NCT01228318|10189905|P1|Overall Study|Unable to contact|2
2960264|NCT01228318|10189904|P2|Overall Study|Clinic no show to receive intervention|0
2960265|NCT01228318|10189905|P1|Overall Study|Clinic no show to receive intervention|1
2960266|NCT01228175|10189921|P2|Overall Study|Physician Decision|1
2960267|NCT01228175|10189922|P1|Overall Study|Physician Decision|1
2960268|NCT01228175|10189921|P2|Overall Study|Withdrawal by Subject|2
2960269|NCT01228175|10189922|P1|Overall Study|Withdrawal by Subject|1
2960270|NCT01228175|10189921|P2|Overall Study|Lost to Follow-up|50
2960271|NCT01228175|10189922|P1|Overall Study|Lost to Follow-up|64
2960272|NCT01228071|10189964|P1|Overall Study|Withdrawal by Subject|1
2960273|NCT01228071|10189964|P1|Overall Study|Protocol Violation|1
2960274|NCT01228019|10189970|P1|Overall Study|Violation of Entry Criterion|9
2960275|NCT01228019|10189970|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
2960276|NCT01228019|10189970|P1|Overall Study|Missing pre-treatment data|72
2960277|NCT01228019|10189970|P1|Overall Study|Duplicate enrollment|1
2960278|NCT01228019|10189970|P1|Overall Study|Dose Violation|70
2960279|NCT01227967|10190036|P2|Overall Study|Taking Additional Antiviral Drug|0
2960280|NCT01227967|10190037|P1|Overall Study|Taking Additional Antiviral Drug|1
2960281|NCT01227967|10190036|P2|Overall Study|Never Started Treatment|4
2960282|NCT01227967|10190037|P1|Overall Study|Never Started Treatment|0
2960283|NCT01227967|10190036|P2|Overall Study|Physician Decision|1
2960284|NCT01227967|10190037|P1|Overall Study|Physician Decision|0
2960285|NCT01227967|10190036|P2|Overall Study|Withdrawal by Subject|3
2960286|NCT01227967|10190037|P1|Overall Study|Withdrawal by Subject|4
2960287|NCT01227967|10190036|P2|Overall Study|Lost to Follow-up|3
2960288|NCT01227967|10190037|P1|Overall Study|Lost to Follow-up|8
2960289|NCT01227967|10190036|P2|Overall Study|Death|1
2960290|NCT01227967|10190037|P1|Overall Study|Death|0
2960291|NCT01227967|10190036|P2|Overall Study|Protocol Violation|1
2960292|NCT01227967|10190037|P1|Overall Study|Protocol Violation|3
2960293|NCT01227954|10190071|P1|Overall Study|No protocol treatment|7
2960294|NCT01227954|10190071|P1|Overall Study|Protocol Violation|6
2960295|NCT01227928|10190085|P2|Overall Study|Death|12
2960296|NCT01227928|10190086|P1|Overall Study|Death|14
2960297|NCT01227928|10190085|P2|Overall Study|Withdrawal by Subject|3
2960298|NCT01227928|10190086|P1|Overall Study|Withdrawal by Subject|4
2960299|NCT01227928|10190085|P2|Overall Study|Lost to Follow-up|2
2960300|NCT01227928|10190086|P1|Overall Study|Lost to Follow-up|4
2960301|NCT01227902|10190124|P4|Overall Study|Withdrawal by Subject|3
2960302|NCT01227902|10190125|P3|Overall Study|Withdrawal by Subject|4
2960303|NCT01227902|10190126|P2|Overall Study|Withdrawal by Subject|2
2960304|NCT01227902|10190127|P1|Overall Study|Withdrawal by Subject|4
2960305|NCT01227902|10190124|P4|Overall Study|Physician Decision|0
2960306|NCT01227902|10190125|P3|Overall Study|Physician Decision|1
2960307|NCT01227902|10190126|P2|Overall Study|Physician Decision|1
2960308|NCT01227902|10190127|P1|Overall Study|Physician Decision|0
2960309|NCT01227902|10190124|P4|Overall Study|Lost to Follow-up|2
2960310|NCT01227902|10190125|P3|Overall Study|Lost to Follow-up|1
2960311|NCT01227902|10190126|P2|Overall Study|Lost to Follow-up|0
2960312|NCT01227902|10190127|P1|Overall Study|Lost to Follow-up|0
2960313|NCT01227902|10190124|P4|Overall Study|Protocol Violation|0
2960314|NCT01227902|10190125|P3|Overall Study|Protocol Violation|0
2960315|NCT01227902|10190126|P2|Overall Study|Protocol Violation|0
2960316|NCT01227902|10190127|P1|Overall Study|Protocol Violation|1
2960317|NCT01227902|10190124|P4|Overall Study|Lack of Efficacy|1
2960318|NCT01227902|10190125|P3|Overall Study|Lack of Efficacy|2
2960319|NCT01227902|10190126|P2|Overall Study|Lack of Efficacy|2
2960320|NCT01227902|10190127|P1|Overall Study|Lack of Efficacy|1
2960321|NCT01227902|10190124|P4|Overall Study|Adverse Event|4
2960322|NCT01227902|10190125|P3|Overall Study|Adverse Event|11
2960323|NCT01227902|10190126|P2|Overall Study|Adverse Event|8
2960324|NCT01227902|10190127|P1|Overall Study|Adverse Event|12
2960325|NCT01227889|10190220|P2|Crossover Phase|Withdrawal by Subject|1
2960326|NCT01227889|10190221|P1|Crossover Phase|Withdrawal by Subject|0
2960327|NCT01227889|10190220|P2|Crossover Phase|Study Terminated By Sponsor|1
2960328|NCT01227889|10190221|P1|Crossover Phase|Study Terminated By Sponsor|0
2960329|NCT01227889|10190220|P2|Crossover Phase|Progressive Disease|31
2960330|NCT01227889|10190221|P1|Crossover Phase|Progressive Disease|0
2960331|NCT01227889|10190220|P2|Crossover Phase|Physician Decision|3
2960332|NCT01227889|10190221|P1|Crossover Phase|Physician Decision|0
2960333|NCT01227889|10190220|P2|Crossover Phase|Adverse Event|1
2960334|NCT01227889|10190221|P1|Crossover Phase|Adverse Event|0
2960335|NCT01227889|10190220|P2|Randomized Phase (RP)|Withdrawal by Subject|3
2960336|NCT01227889|10190221|P1|Randomized Phase (RP)|Withdrawal by Subject|15
2960337|NCT01227889|10190220|P2|Randomized Phase (RP)|Missing|3
2960338|NCT01227889|10190221|P1|Randomized Phase (RP)|Missing|1
2960339|NCT01227889|10190220|P2|Randomized Phase (RP)|Study terminated by sponsor|0
2960340|NCT01227889|10190221|P1|Randomized Phase (RP)|Study terminated by sponsor|10
2960341|NCT01227889|10190220|P2|Randomized Phase (RP)|Progressive Disease|52
2960342|NCT01227889|10190221|P1|Randomized Phase (RP)|Progressive Disease|135
2960343|NCT01227889|10190220|P2|Randomized Phase (RP)|Physician Decision|5
2960344|NCT01227889|10190221|P1|Randomized Phase (RP)|Physician Decision|13
2960345|NCT01227889|10190220|P2|Randomized Phase (RP)|Adverse Event|0
2960346|NCT01227889|10190221|P1|Randomized Phase (RP)|Adverse Event|13
2960347|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
2960348|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
2960349|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
2960350|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
2960351|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2960352|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2960353|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
2960354|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2960355|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2960356|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
2960357|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2960358|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2960359|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
2960360|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2960361|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2960362|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
2960363|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2960364|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2960365|NCT01227824|10190248|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
2960366|NCT01227824|10190249|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
2960367|NCT01227824|10190250|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
2960368|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2960369|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2960370|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
2960371|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
2960372|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
2960373|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
2960374|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
2960375|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
2960376|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
2960377|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
2960378|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
2960379|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
2960380|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
2960381|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
2960382|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
2960383|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
2960384|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
2960385|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
2960386|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
2960387|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
2960388|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
2960389|NCT01227824|10190248|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
2960390|NCT01227824|10190249|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
2960391|NCT01227824|10190250|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
2960392|NCT01227707|10190345|P1|Overall Study|Death|1
2960393|NCT01227707|10190345|P1|Overall Study|Medical decision|6
2960394|NCT01227707|10190345|P1|Overall Study|Patient non-compliance|3
2960395|NCT01227707|10190345|P1|Overall Study|Withdrawal by Subject|1
2960396|NCT01227707|10190345|P1|Overall Study|Progression of disease|3
2960397|NCT01227707|10190345|P1|Overall Study|Adverse Event|10
2960398|NCT01227668|10190372|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
2960399|NCT01227668|10190373|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
2960400|NCT01227668|10190372|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
2960401|NCT01227668|10190373|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
2960402|NCT01227668|10190372|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
2960403|NCT01227668|10190373|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
2960404|NCT01227668|10190372|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
2960405|NCT01227668|10190373|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
2960406|NCT01227668|10190372|P2|Phase 2 (Randomization Phase)|Adverse Event|1
2960407|NCT01227668|10190373|P1|Phase 2 (Randomization Phase)|Adverse Event|0
2960408|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
2960409|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
2960410|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
2960411|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
2960412|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
2960413|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
2960414|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
2960415|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
2960416|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
2960417|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
2960418|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
2960419|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
2960420|NCT01227668|10190372|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
2960421|NCT01227668|10190373|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
2960422|NCT01227629|10190419|P10|Overall Study|Other|1
2960423|NCT01227629|10190420|P9|Overall Study|Other|2
2960424|NCT01227629|10190421|P8|Overall Study|Other|0
2960425|NCT01227629|10190422|P7|Overall Study|Other|0
2960426|NCT01227629|10190423|P6|Overall Study|Other|0
2960427|NCT01227629|10190424|P5|Overall Study|Other|0
2960428|NCT01227629|10190425|P4|Overall Study|Other|1
2960429|NCT01227629|10190426|P3|Overall Study|Other|0
2960430|NCT01227629|10190427|P2|Overall Study|Other|0
2960431|NCT01227629|10190428|P1|Overall Study|Other|0
2960432|NCT01227629|10190419|P10|Overall Study|Withdrawal by Subject|1
2960433|NCT01227629|10190420|P9|Overall Study|Withdrawal by Subject|0
2960434|NCT01227629|10190421|P8|Overall Study|Withdrawal by Subject|0
2960435|NCT01227629|10190422|P7|Overall Study|Withdrawal by Subject|2
2960436|NCT01227629|10190423|P6|Overall Study|Withdrawal by Subject|0
2960437|NCT01227629|10190424|P5|Overall Study|Withdrawal by Subject|0
2960438|NCT01227629|10190425|P4|Overall Study|Withdrawal by Subject|0
2960439|NCT01227629|10190426|P3|Overall Study|Withdrawal by Subject|0
2960440|NCT01227629|10190427|P2|Overall Study|Withdrawal by Subject|0
2960441|NCT01227629|10190428|P1|Overall Study|Withdrawal by Subject|0
2960442|NCT01227629|10190419|P10|Overall Study|Lost to Follow-up|0
2960443|NCT01227629|10190420|P9|Overall Study|Lost to Follow-up|0
2960444|NCT01227629|10190421|P8|Overall Study|Lost to Follow-up|0
2960445|NCT01227629|10190422|P7|Overall Study|Lost to Follow-up|0
2960446|NCT01227629|10190423|P6|Overall Study|Lost to Follow-up|0
2960447|NCT01227629|10190424|P5|Overall Study|Lost to Follow-up|1
2960448|NCT01227629|10190425|P4|Overall Study|Lost to Follow-up|0
2960449|NCT01227629|10190426|P3|Overall Study|Lost to Follow-up|0
2960450|NCT01227629|10190427|P2|Overall Study|Lost to Follow-up|0
2960451|NCT01227629|10190428|P1|Overall Study|Lost to Follow-up|0
2960452|NCT01227629|10190419|P10|Overall Study|Protocol Violation|0
2960453|NCT01227629|10190420|P9|Overall Study|Protocol Violation|0
2960454|NCT01227629|10190421|P8|Overall Study|Protocol Violation|0
2960455|NCT01227629|10190422|P7|Overall Study|Protocol Violation|0
2960456|NCT01227629|10190423|P6|Overall Study|Protocol Violation|0
2960457|NCT01227629|10190424|P5|Overall Study|Protocol Violation|0
2960458|NCT01227629|10190425|P4|Overall Study|Protocol Violation|1
2960459|NCT01227629|10190426|P3|Overall Study|Protocol Violation|0
2960460|NCT01227629|10190427|P2|Overall Study|Protocol Violation|0
2960461|NCT01227629|10190428|P1|Overall Study|Protocol Violation|0
2960462|NCT01227629|10190419|P10|Overall Study|Adverse Event|0
2960463|NCT01227629|10190420|P9|Overall Study|Adverse Event|4
2960464|NCT01227629|10190421|P8|Overall Study|Adverse Event|6
2960465|NCT01227629|10190422|P7|Overall Study|Adverse Event|6
2960466|NCT01227629|10190423|P6|Overall Study|Adverse Event|1
2960467|NCT01227629|10190424|P5|Overall Study|Adverse Event|1
2960468|NCT01227629|10190425|P4|Overall Study|Adverse Event|6
2960469|NCT01227629|10190426|P3|Overall Study|Adverse Event|1
2960470|NCT01227629|10190427|P2|Overall Study|Adverse Event|2
2960471|NCT01227629|10190428|P1|Overall Study|Adverse Event|2
2960472|NCT01227577|10190677|P1|Overall Study|Adverse Event|17
2960473|NCT01227577|10190677|P1|Overall Study|Lack of Efficacy|5
2960474|NCT01227577|10190677|P1|Overall Study|Withdrawal by Subject|4
2960475|NCT01227577|10190677|P1|Overall Study|Lost to Follow-up|1
2960476|NCT01227577|10190677|P1|Overall Study|Administrative problems|2
2960477|NCT01227577|10190677|P1|Overall Study|Death|3
2960478|NCT01227577|10190677|P1|Overall Study|Protocol deviation|3
2960479|NCT01227564|10190692|P3|Overall Study|Participant moved to another town|1
2960480|NCT01227564|10190693|P2|Overall Study|Participant moved to another town|0
2960481|NCT01227564|10190694|P1|Overall Study|Participant moved to another town|0
2960482|NCT01227564|10190692|P3|Overall Study|No Longer Willing to Participate|5
2960483|NCT01227564|10190693|P2|Overall Study|No Longer Willing to Participate|2
2960484|NCT01227564|10190694|P1|Overall Study|No Longer Willing to Participate|4
2960485|NCT01227512|10190832|P2|Overall Study|Participant met withdrawal criteria|1
2960486|NCT01227512|10190833|P1|Overall Study|Participant met withdrawal criteria|0
2960487|NCT01227512|10190832|P2|Overall Study|Withdrawal by Subject|0
2960488|NCT01227512|10190833|P1|Overall Study|Withdrawal by Subject|3
2960489|NCT01227512|10190832|P2|Overall Study|Adverse Event|3
2960490|NCT01227512|10190833|P1|Overall Study|Adverse Event|4
2960491|NCT01227512|10190832|P2|Overall Study|Physician Decision|6
2960492|NCT01227512|10190833|P1|Overall Study|Physician Decision|6
2960493|NCT01227421|10190867|P3|Overall Study|Randomized in error|0
2960494|NCT01227421|10190868|P2|Overall Study|Randomized in error|1
2960495|NCT01227421|10190869|P1|Overall Study|Randomized in error|1
2960496|NCT01227421|10190867|P3|Overall Study|Protocol Violation|2
2960497|NCT01227421|10190868|P2|Overall Study|Protocol Violation|1
2960498|NCT01227421|10190869|P1|Overall Study|Protocol Violation|1
2960499|NCT01227421|10190867|P3|Overall Study|Withdrawal by Subject|1
2960500|NCT01227421|10190868|P2|Overall Study|Withdrawal by Subject|2
2960501|NCT01227421|10190869|P1|Overall Study|Withdrawal by Subject|1
2960502|NCT01227421|10190867|P3|Overall Study|Adverse Event|2
2960503|NCT01227421|10190868|P2|Overall Study|Adverse Event|7
2960504|NCT01227421|10190869|P1|Overall Study|Adverse Event|2
2960505|NCT01227421|10190867|P3|Overall Study|Lost to Follow-up|5
2960506|NCT01227421|10190868|P2|Overall Study|Lost to Follow-up|7
2960507|NCT01227421|10190869|P1|Overall Study|Lost to Follow-up|6
2960508|NCT01227395|10190921|P2|Overall Study|Protocol Violation|1
2960509|NCT01227395|10190922|P1|Overall Study|Protocol Violation|0
2960510|NCT01227278|10190962|P2|Overall Study|Other|2
2960511|NCT01227278|10190963|P1|Overall Study|Other|1
2960512|NCT01227278|10190962|P2|Overall Study|Death|2
2960513|NCT01227278|10190963|P1|Overall Study|Death|0
2960514|NCT01227278|10190962|P2|Overall Study|Withdrawal by Subject|4
2960515|NCT01227278|10190963|P1|Overall Study|Withdrawal by Subject|4
2960516|NCT01227265|10190990|P3|Overall Study|Adverse Event|5
2960517|NCT01227265|10190991|P2|Overall Study|Adverse Event|10
2960518|NCT01227265|10190992|P1|Overall Study|Adverse Event|6
2960519|NCT01227265|10190990|P3|Overall Study|Lost to Follow-up|3
2960520|NCT01227265|10190991|P2|Overall Study|Lost to Follow-up|0
2960521|NCT01227265|10190992|P1|Overall Study|Lost to Follow-up|2
2960522|NCT01227265|10190990|P3|Overall Study|Withdrawal by Subject|3
2960523|NCT01227265|10190991|P2|Overall Study|Withdrawal by Subject|7
2960524|NCT01227265|10190992|P1|Overall Study|Withdrawal by Subject|7
2960525|NCT01227265|10190990|P3|Overall Study|Protocol Violation|0
2960526|NCT01227265|10190991|P2|Overall Study|Protocol Violation|1
2960527|NCT01227265|10190992|P1|Overall Study|Protocol Violation|2
2960528|NCT01227265|10190990|P3|Overall Study|Did Not Meet Protocol Eligibility|1
2960529|NCT01227265|10190991|P2|Overall Study|Did Not Meet Protocol Eligibility|0
2960530|NCT01227265|10190992|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2960531|NCT01227265|10190990|P3|Overall Study|Administrative|2
2960532|NCT01227265|10190991|P2|Overall Study|Administrative|0
2960533|NCT01227265|10190992|P1|Overall Study|Administrative|1
2960534|NCT01227265|10190990|P3|Overall Study|Did Not Receive Treatment|0
2960535|NCT01227265|10190991|P2|Overall Study|Did Not Receive Treatment|2
2960536|NCT01227265|10190992|P1|Overall Study|Did Not Receive Treatment|1
2960537|NCT01227252|10191022|P4|Overall Study|Withdrawal by Subject|0
2960538|NCT01227252|10191023|P3|Overall Study|Withdrawal by Subject|0
2960539|NCT01227252|10191024|P2|Overall Study|Withdrawal by Subject|1
2960540|NCT01227252|10191025|P1|Overall Study|Withdrawal by Subject|0
2960541|NCT01227252|10191022|P4|Overall Study|Lost to Follow-up|0
2960542|NCT01227252|10191023|P3|Overall Study|Lost to Follow-up|0
2960543|NCT01227252|10191024|P2|Overall Study|Lost to Follow-up|1
2960544|NCT01227252|10191025|P1|Overall Study|Lost to Follow-up|0
2960545|NCT01227252|10191022|P4|Overall Study|Sponsor Decision|0
2960546|NCT01227252|10191023|P3|Overall Study|Sponsor Decision|0
2960547|NCT01227252|10191024|P2|Overall Study|Sponsor Decision|1
2960548|NCT01227252|10191025|P1|Overall Study|Sponsor Decision|0
2960549|NCT01227044|10191067|P2|Overall Study|Discontinued Intervention|2
2960550|NCT01227044|10191068|P1|Overall Study|Discontinued Intervention|1
2960551|NCT01227044|10191067|P2|Overall Study|Lost to Follow-up|7
2960552|NCT01227044|10191068|P1|Overall Study|Lost to Follow-up|5
2960553|NCT01227018|10191076|P1|Overall Study|Withdrew after beginning treatment|4
2960554|NCT01227018|10191076|P1|Overall Study|Toxicity|2
2960555|NCT01227018|10191076|P1|Overall Study|Disease progression|9
2960556|NCT01226745|10191112|P6|Overall Study|Other|1
2960557|NCT01226745|10191113|P5|Overall Study|Other|3
2960558|NCT01226745|10191114|P4|Overall Study|Other|4
2960559|NCT01226745|10191115|P3|Overall Study|Other|8
2960560|NCT01226745|10191116|P2|Overall Study|Other|7
2960561|NCT01226745|10191117|P1|Overall Study|Other|6
2960562|NCT01226745|10191112|P6|Overall Study|Death|1
2960563|NCT01226745|10191113|P5|Overall Study|Death|0
2960564|NCT01226745|10191114|P4|Overall Study|Death|0
2960565|NCT01226745|10191115|P3|Overall Study|Death|0
2960566|NCT01226745|10191116|P2|Overall Study|Death|0
2960567|NCT01226745|10191117|P1|Overall Study|Death|1
2960568|NCT01226745|10191112|P6|Overall Study|Lost to Follow-up|2
2960569|NCT01226745|10191113|P5|Overall Study|Lost to Follow-up|1
2960570|NCT01226745|10191114|P4|Overall Study|Lost to Follow-up|1
2960571|NCT01226745|10191115|P3|Overall Study|Lost to Follow-up|6
2960572|NCT01226745|10191116|P2|Overall Study|Lost to Follow-up|6
2960573|NCT01226745|10191117|P1|Overall Study|Lost to Follow-up|2
2960574|NCT01226745|10191112|P6|Overall Study|Did not complete schedule of assessments|1
2960575|NCT01226745|10191113|P5|Overall Study|Did not complete schedule of assessments|0
2960576|NCT01226745|10191114|P4|Overall Study|Did not complete schedule of assessments|0
2960577|NCT01226745|10191115|P3|Overall Study|Did not complete schedule of assessments|6
2960578|NCT01226745|10191116|P2|Overall Study|Did not complete schedule of assessments|3
2960579|NCT01226745|10191117|P1|Overall Study|Did not complete schedule of assessments|8
2960580|NCT01226511|10191313|P2|Taper Period|Parent/Caregiver Decision|1
2960581|NCT01226511|10191314|P1|Taper Period|Parent/Caregiver Decision|1
2960582|NCT01226511|10191313|P2|Taper Period|Protocol Violation|0
2960583|NCT01226511|10191314|P1|Taper Period|Protocol Violation|1
2960584|NCT01226511|10191313|P2|Taper Period|Lost to Follow-up|2
2960585|NCT01226511|10191314|P1|Taper Period|Lost to Follow-up|2
2960586|NCT01226511|10191313|P2|Taper Period|Adverse Event|0
2960587|NCT01226511|10191314|P1|Taper Period|Adverse Event|1
2960588|NCT01226511|10191313|P2|Extension Treatment Period|Sponsor Decision|1
2960589|NCT01226511|10191314|P1|Extension Treatment Period|Sponsor Decision|1
2960590|NCT01226511|10191313|P2|Extension Treatment Period|Parent/Caregiver Decision|8
2960591|NCT01226511|10191314|P1|Extension Treatment Period|Parent/Caregiver Decision|8
2960592|NCT01226511|10191313|P2|Extension Treatment Period|Withdrawal by Subject|3
2960593|NCT01226511|10191314|P1|Extension Treatment Period|Withdrawal by Subject|1
2960594|NCT01226511|10191313|P2|Extension Treatment Period|Protocol Violation|2
2960595|NCT01226511|10191314|P1|Extension Treatment Period|Protocol Violation|2
2960596|NCT01226511|10191313|P2|Extension Treatment Period|Lost to Follow-up|3
2960597|NCT01226511|10191314|P1|Extension Treatment Period|Lost to Follow-up|4
2960598|NCT01226511|10191313|P2|Extension Treatment Period|Lack of Efficacy|2
2960599|NCT01226511|10191314|P1|Extension Treatment Period|Lack of Efficacy|3
2960600|NCT01226511|10191313|P2|Extension Treatment Period|Adverse Event|8
2960601|NCT01226511|10191314|P1|Extension Treatment Period|Adverse Event|8
2960602|NCT01226511|10191313|P2|Acute Treatment Period|Withdrawal by Subject|6
2960603|NCT01226511|10191314|P1|Acute Treatment Period|Withdrawal by Subject|10
2960604|NCT01226511|10191313|P2|Acute Treatment Period|Protocol Violation|5
2960605|NCT01226511|10191314|P1|Acute Treatment Period|Protocol Violation|5
2960606|NCT01226511|10191313|P2|Acute Treatment Period|Parent/caregiver decision|7
2960607|NCT01226511|10191314|P1|Acute Treatment Period|Parent/caregiver decision|5
2960608|NCT01226511|10191313|P2|Acute Treatment Period|Lost to Follow-up|6
2960609|NCT01226511|10191314|P1|Acute Treatment Period|Lost to Follow-up|3
2960610|NCT01226511|10191313|P2|Acute Treatment Period|Lack of Efficacy|1
2960611|NCT01226511|10191314|P1|Acute Treatment Period|Lack of Efficacy|2
2960612|NCT01226511|10191313|P2|Acute Treatment Period|Adverse Event|6
2960613|NCT01226511|10191314|P1|Acute Treatment Period|Adverse Event|7
2960614|NCT01226459|10191414|P2|Overall Study|Pregnancy|0
2960615|NCT01226459|10191415|P1|Overall Study|Pregnancy|1
2960616|NCT01226459|10191414|P2|Overall Study|Lost to Follow-up|8
2960617|NCT01226459|10191415|P1|Overall Study|Lost to Follow-up|4
2960618|NCT01226459|10191414|P2|Overall Study|Withdrawal by Subject|13
2960619|NCT01226459|10191415|P1|Overall Study|Withdrawal by Subject|10
2960620|NCT01226459|10191414|P2|Overall Study|Protocol Violation|3
2960621|NCT01226459|10191415|P1|Overall Study|Protocol Violation|4
2960622|NCT01226459|10191414|P2|Overall Study|Adverse Event|8
2960623|NCT01226459|10191415|P1|Overall Study|Adverse Event|2
2960624|NCT01226121|10191433|P3|Overall Study|Lost to Follow-up|1
2960625|NCT01226121|10191434|P2|Overall Study|Lost to Follow-up|0
2960626|NCT01226121|10191435|P1|Overall Study|Lost to Follow-up|2
2960627|NCT01226095|10191446|P1|Overall Study|Poor compliance|1
2960628|NCT01226043|10191471|P4|30-week Observational Phase|Physician Decision|2
2960629|NCT01226043|10191472|P3|30-week Observational Phase|Physician Decision|2
2960630|NCT01226043|10191473|P2|30-week Observational Phase|Physician Decision|0
2960631|NCT01226043|10191474|P1|30-week Observational Phase|Physician Decision|0
2960632|NCT01226043|10191471|P4|30-week Observational Phase|Withdrawal by Subject|7
2960633|NCT01226043|10191472|P3|30-week Observational Phase|Withdrawal by Subject|1
2960634|NCT01226043|10191473|P2|30-week Observational Phase|Withdrawal by Subject|0
2960635|NCT01226043|10191474|P1|30-week Observational Phase|Withdrawal by Subject|0
2960636|NCT01226043|10191471|P4|30-week Observational Phase|Lost to Follow-up|2
2960637|NCT01226043|10191472|P3|30-week Observational Phase|Lost to Follow-up|2
2960638|NCT01226043|10191473|P2|30-week Observational Phase|Lost to Follow-up|0
2960639|NCT01226043|10191474|P1|30-week Observational Phase|Lost to Follow-up|0
2960640|NCT01226043|10191471|P4|30-week Observational Phase|Protocol Violation|1
2960641|NCT01226043|10191472|P3|30-week Observational Phase|Protocol Violation|0
2960642|NCT01226043|10191473|P2|30-week Observational Phase|Protocol Violation|0
2960643|NCT01226043|10191474|P1|30-week Observational Phase|Protocol Violation|0
2960644|NCT01226043|10191471|P4|30-week Observational Phase|Adverse Event|1
2960645|NCT01226043|10191472|P3|30-week Observational Phase|Adverse Event|1
2960646|NCT01226043|10191473|P2|30-week Observational Phase|Adverse Event|0
2960647|NCT01226043|10191474|P1|30-week Observational Phase|Adverse Event|0
2960648|NCT01226043|10191471|P4|6-week Re-randomization Phase|completed in error|1
2960649|NCT01226043|10191472|P3|6-week Re-randomization Phase|completed in error|0
2960650|NCT01226043|10191473|P2|6-week Re-randomization Phase|completed in error|0
2960651|NCT01226043|10191474|P1|6-week Re-randomization Phase|completed in error|0
2960652|NCT01226043|10191471|P4|6-week Re-randomization Phase|Physician Decision|2
2960653|NCT01226043|10191472|P3|6-week Re-randomization Phase|Physician Decision|3
2960654|NCT01226043|10191473|P2|6-week Re-randomization Phase|Physician Decision|0
2960655|NCT01226043|10191474|P1|6-week Re-randomization Phase|Physician Decision|0
2960656|NCT01226043|10191471|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
2960657|NCT01226043|10191472|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
2960658|NCT01226043|10191473|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
2960659|NCT01226043|10191474|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
2960660|NCT01226043|10191471|P4|6-week Re-randomization Phase|Lost to Follow-up|3
2960661|NCT01226043|10191472|P3|6-week Re-randomization Phase|Lost to Follow-up|1
2960662|NCT01226043|10191473|P2|6-week Re-randomization Phase|Lost to Follow-up|0
2960663|NCT01226043|10191474|P1|6-week Re-randomization Phase|Lost to Follow-up|0
2960664|NCT01226043|10191471|P4|6-week Re-randomization Phase|Protocol Violation|1
2960665|NCT01226043|10191472|P3|6-week Re-randomization Phase|Protocol Violation|1
2960666|NCT01226043|10191473|P2|6-week Re-randomization Phase|Protocol Violation|0
2960667|NCT01226043|10191474|P1|6-week Re-randomization Phase|Protocol Violation|0
2960668|NCT01226043|10191471|P4|6-week Re-randomization Phase|Adverse Event|1
2960669|NCT01226043|10191472|P3|6-week Re-randomization Phase|Adverse Event|1
2960670|NCT01226043|10191473|P2|6-week Re-randomization Phase|Adverse Event|0
2960671|NCT01226043|10191474|P1|6-week Re-randomization Phase|Adverse Event|0
2960672|NCT01226043|10191471|P4|4-week Crossover Phase - Period 2|Physician Decision|0
2960673|NCT01226043|10191472|P3|4-week Crossover Phase - Period 2|Physician Decision|0
2960674|NCT01226043|10191473|P2|4-week Crossover Phase - Period 2|Physician Decision|5
2960761|NCT01225731|10191750|P10|Part 3|Physician Decision|0
2960675|NCT01226043|10191474|P1|4-week Crossover Phase - Period 2|Physician Decision|4
2960676|NCT01226043|10191471|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2960677|NCT01226043|10191472|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2960678|NCT01226043|10191473|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
2960679|NCT01226043|10191474|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2960680|NCT01226043|10191471|P4|4-week Crossover Phase - Period 1|Physician Decision|0
2960681|NCT01226043|10191472|P3|4-week Crossover Phase - Period 1|Physician Decision|0
2960682|NCT01226043|10191473|P2|4-week Crossover Phase - Period 1|Physician Decision|6
2960683|NCT01226043|10191474|P1|4-week Crossover Phase - Period 1|Physician Decision|0
2960684|NCT01226043|10191471|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2960685|NCT01226043|10191472|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2960686|NCT01226043|10191473|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2960687|NCT01226043|10191474|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
2960688|NCT01226043|10191471|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2960689|NCT01226043|10191472|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2960690|NCT01226043|10191473|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
2960691|NCT01226043|10191474|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2960692|NCT01226043|10191471|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
2960693|NCT01226043|10191472|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
2960694|NCT01226043|10191473|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
2960695|NCT01226043|10191474|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
2960696|NCT01225991|10191512|P1|Overall Study|Withdrawal by Subject|6
2960697|NCT01225952|10191523|P3|Overall Study|Surgical complications|0
2960698|NCT01225952|10191524|P2|Overall Study|Surgical complications|0
2960699|NCT01225952|10191525|P1|Overall Study|Surgical complications|1
2960700|NCT01225952|10191523|P3|Overall Study|Withdrawal by Subject|5
2960701|NCT01225952|10191524|P2|Overall Study|Withdrawal by Subject|4
2960702|NCT01225952|10191525|P1|Overall Study|Withdrawal by Subject|4
2960703|NCT01225952|10191523|P3|Overall Study|Study Eye Explanted|1
2960704|NCT01225952|10191524|P2|Overall Study|Study Eye Explanted|0
2960705|NCT01225952|10191525|P1|Overall Study|Study Eye Explanted|0
2960706|NCT01225952|10191523|P3|Overall Study|Lost to Follow-up|0
2960707|NCT01225952|10191524|P2|Overall Study|Lost to Follow-up|0
2960708|NCT01225952|10191525|P1|Overall Study|Lost to Follow-up|1
2960709|NCT01225887|10191617|P1|Overall Study|Ineligible:inadequate pathology|2
2960710|NCT01225887|10191617|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
2960711|NCT01225887|10191617|P1|Overall Study|Ineligible:required test not done|2
2960712|NCT01225835|10191627|P2|Overall Study|Other|1
2960713|NCT01225835|10191628|P1|Overall Study|Other|1
2960714|NCT01225835|10191627|P2|Overall Study|Adverse Event|1
2960715|NCT01225835|10191628|P1|Overall Study|Adverse Event|2
2960716|NCT01225835|10191627|P2|Overall Study|Did not meet hCG criterion|0
2960717|NCT01225835|10191628|P1|Overall Study|Did not meet hCG criterion|2
2960718|NCT01225835|10191627|P2|Overall Study|Completed protocol|1
2960719|NCT01225835|10191628|P1|Overall Study|Completed protocol|2
2960720|NCT01225822|10191676|P5|Overall Study|Other|7
2960721|NCT01225822|10191677|P4|Overall Study|Other|10
2960722|NCT01225822|10191678|P3|Overall Study|Other|7
2960723|NCT01225822|10191679|P2|Overall Study|Other|10
2960724|NCT01225822|10191680|P1|Overall Study|Other|13
2960725|NCT01225822|10191676|P5|Overall Study|Withdrawal by Subject|6
2960726|NCT01225822|10191677|P4|Overall Study|Withdrawal by Subject|11
2960727|NCT01225822|10191678|P3|Overall Study|Withdrawal by Subject|7
2960728|NCT01225822|10191679|P2|Overall Study|Withdrawal by Subject|7
2960729|NCT01225822|10191680|P1|Overall Study|Withdrawal by Subject|6
2960730|NCT01225822|10191676|P5|Overall Study|Lost to Follow-up|0
2960731|NCT01225822|10191677|P4|Overall Study|Lost to Follow-up|1
2960732|NCT01225822|10191678|P3|Overall Study|Lost to Follow-up|0
2960733|NCT01225822|10191679|P2|Overall Study|Lost to Follow-up|0
2960734|NCT01225822|10191680|P1|Overall Study|Lost to Follow-up|0
2960735|NCT01225822|10191676|P5|Overall Study|Protocol Violation|4
2960736|NCT01225822|10191677|P4|Overall Study|Protocol Violation|7
2960737|NCT01225822|10191678|P3|Overall Study|Protocol Violation|6
2960738|NCT01225822|10191679|P2|Overall Study|Protocol Violation|8
2960739|NCT01225822|10191680|P1|Overall Study|Protocol Violation|6
2960740|NCT01225822|10191676|P5|Overall Study|Adverse Event|14
2960741|NCT01225822|10191677|P4|Overall Study|Adverse Event|23
2960742|NCT01225822|10191678|P3|Overall Study|Adverse Event|18
2960743|NCT01225822|10191679|P2|Overall Study|Adverse Event|31
2960744|NCT01225822|10191680|P1|Overall Study|Adverse Event|13
2960745|NCT01225731|10191747|P13|Part 3|Withdrawal by Subject|4
2960746|NCT01225731|10191748|P12|Part 3|Withdrawal by Subject|6
2960747|NCT01225731|10191749|P11|Part 3|Withdrawal by Subject|4
2960748|NCT01225731|10191750|P10|Part 3|Withdrawal by Subject|0
2960749|NCT01225731|10191751|P9|Part 3|Withdrawal by Subject|0
2960750|NCT01225731|10191752|P8|Part 3|Withdrawal by Subject|0
2960751|NCT01225731|10191753|P7|Part 3|Withdrawal by Subject|0
2960752|NCT01225731|10191754|P6|Part 3|Withdrawal by Subject|0
2960753|NCT01225731|10191755|P5|Part 3|Withdrawal by Subject|0
2960754|NCT01225731|10191756|P4|Part 3|Withdrawal by Subject|0
2960755|NCT01225731|10191757|P3|Part 3|Withdrawal by Subject|0
2960756|NCT01225731|10191758|P2|Part 3|Withdrawal by Subject|0
2960757|NCT01225731|10191759|P1|Part 3|Withdrawal by Subject|0
2960758|NCT01225731|10191747|P13|Part 3|Physician Decision|2
2960759|NCT01225731|10191748|P12|Part 3|Physician Decision|1
2960760|NCT01225731|10191749|P11|Part 3|Physician Decision|0
2960762|NCT01225731|10191751|P9|Part 3|Physician Decision|0
2960763|NCT01225731|10191752|P8|Part 3|Physician Decision|0
2960764|NCT01225731|10191753|P7|Part 3|Physician Decision|0
2960765|NCT01225731|10191754|P6|Part 3|Physician Decision|0
2960766|NCT01225731|10191755|P5|Part 3|Physician Decision|0
2960767|NCT01225731|10191756|P4|Part 3|Physician Decision|0
2960768|NCT01225731|10191757|P3|Part 3|Physician Decision|0
2960769|NCT01225731|10191758|P2|Part 3|Physician Decision|0
2960770|NCT01225731|10191759|P1|Part 3|Physician Decision|0
2960771|NCT01225731|10191747|P13|Part 3|Lost to Follow-up|1
2960772|NCT01225731|10191748|P12|Part 3|Lost to Follow-up|2
2960773|NCT01225731|10191749|P11|Part 3|Lost to Follow-up|1
2960774|NCT01225731|10191750|P10|Part 3|Lost to Follow-up|0
2960775|NCT01225731|10191751|P9|Part 3|Lost to Follow-up|0
2960776|NCT01225731|10191752|P8|Part 3|Lost to Follow-up|0
2960777|NCT01225731|10191753|P7|Part 3|Lost to Follow-up|0
2960778|NCT01225731|10191754|P6|Part 3|Lost to Follow-up|0
2960779|NCT01225731|10191755|P5|Part 3|Lost to Follow-up|0
2960780|NCT01225731|10191756|P4|Part 3|Lost to Follow-up|0
2960781|NCT01225731|10191757|P3|Part 3|Lost to Follow-up|0
2960782|NCT01225731|10191758|P2|Part 3|Lost to Follow-up|0
2960783|NCT01225731|10191759|P1|Part 3|Lost to Follow-up|0
2960784|NCT01225731|10191747|P13|Part 3|Adverse Event|0
2960785|NCT01225731|10191748|P12|Part 3|Adverse Event|1
2960786|NCT01225731|10191749|P11|Part 3|Adverse Event|1
2960787|NCT01225731|10191750|P10|Part 3|Adverse Event|0
2960788|NCT01225731|10191751|P9|Part 3|Adverse Event|0
2960789|NCT01225731|10191752|P8|Part 3|Adverse Event|0
2960790|NCT01225731|10191753|P7|Part 3|Adverse Event|0
2960791|NCT01225731|10191754|P6|Part 3|Adverse Event|0
2960792|NCT01225731|10191755|P5|Part 3|Adverse Event|0
2960793|NCT01225731|10191756|P4|Part 3|Adverse Event|0
2960794|NCT01225731|10191757|P3|Part 3|Adverse Event|0
2960795|NCT01225731|10191758|P2|Part 3|Adverse Event|0
2960796|NCT01225731|10191759|P1|Part 3|Adverse Event|0
2960797|NCT01225731|10191747|P13|Part 2|Withdrawal by Subject|0
2960798|NCT01225731|10191748|P12|Part 2|Withdrawal by Subject|0
2960799|NCT01225731|10191749|P11|Part 2|Withdrawal by Subject|0
2960800|NCT01225731|10191750|P10|Part 2|Withdrawal by Subject|0
2960801|NCT01225731|10191751|P9|Part 2|Withdrawal by Subject|1
2960802|NCT01225731|10191752|P8|Part 2|Withdrawal by Subject|4
2960803|NCT01225731|10191753|P7|Part 2|Withdrawal by Subject|3
2960804|NCT01225731|10191754|P6|Part 2|Withdrawal by Subject|1
2960805|NCT01225731|10191755|P5|Part 2|Withdrawal by Subject|0
2960806|NCT01225731|10191756|P4|Part 2|Withdrawal by Subject|0
2960807|NCT01225731|10191757|P3|Part 2|Withdrawal by Subject|0
2960808|NCT01225731|10191758|P2|Part 2|Withdrawal by Subject|0
2960809|NCT01225731|10191759|P1|Part 2|Withdrawal by Subject|0
2960810|NCT01225731|10191747|P13|Part 2|Physician Decision|0
2960811|NCT01225731|10191748|P12|Part 2|Physician Decision|0
2960812|NCT01225731|10191749|P11|Part 2|Physician Decision|0
2960813|NCT01225731|10191750|P10|Part 2|Physician Decision|0
2960814|NCT01225731|10191751|P9|Part 2|Physician Decision|2
2960815|NCT01225731|10191752|P8|Part 2|Physician Decision|2
2960816|NCT01225731|10191753|P7|Part 2|Physician Decision|0
2960817|NCT01225731|10191754|P6|Part 2|Physician Decision|0
2960818|NCT01225731|10191755|P5|Part 2|Physician Decision|0
2960819|NCT01225731|10191756|P4|Part 2|Physician Decision|0
2960820|NCT01225731|10191757|P3|Part 2|Physician Decision|0
2960821|NCT01225731|10191758|P2|Part 2|Physician Decision|0
2960822|NCT01225731|10191759|P1|Part 2|Physician Decision|0
2960823|NCT01225731|10191747|P13|Part 2|Lost to Follow-up|0
2960824|NCT01225731|10191748|P12|Part 2|Lost to Follow-up|0
2960825|NCT01225731|10191749|P11|Part 2|Lost to Follow-up|0
2960826|NCT01225731|10191750|P10|Part 2|Lost to Follow-up|0
2960827|NCT01225731|10191751|P9|Part 2|Lost to Follow-up|1
2960828|NCT01225731|10191752|P8|Part 2|Lost to Follow-up|3
2960829|NCT01225731|10191753|P7|Part 2|Lost to Follow-up|0
2960830|NCT01225731|10191754|P6|Part 2|Lost to Follow-up|0
2960831|NCT01225731|10191755|P5|Part 2|Lost to Follow-up|0
2960832|NCT01225731|10191756|P4|Part 2|Lost to Follow-up|0
2960833|NCT01225731|10191757|P3|Part 2|Lost to Follow-up|0
2960834|NCT01225731|10191758|P2|Part 2|Lost to Follow-up|0
2960835|NCT01225731|10191759|P1|Part 2|Lost to Follow-up|0
2960836|NCT01225731|10191747|P13|Part 2|Pregnancy|0
2960837|NCT01225731|10191748|P12|Part 2|Pregnancy|0
2960838|NCT01225731|10191749|P11|Part 2|Pregnancy|0
2960839|NCT01225731|10191750|P10|Part 2|Pregnancy|0
2960840|NCT01225731|10191751|P9|Part 2|Pregnancy|1
2960841|NCT01225731|10191752|P8|Part 2|Pregnancy|0
2960842|NCT01225731|10191753|P7|Part 2|Pregnancy|1
2960843|NCT01225731|10191754|P6|Part 2|Pregnancy|0
2960844|NCT01225731|10191755|P5|Part 2|Pregnancy|0
2960845|NCT01225731|10191756|P4|Part 2|Pregnancy|0
2960846|NCT01225731|10191757|P3|Part 2|Pregnancy|0
2960847|NCT01225731|10191758|P2|Part 2|Pregnancy|0
2960848|NCT01225731|10191759|P1|Part 2|Pregnancy|0
2960849|NCT01225731|10191747|P13|Part 2|Lack of Efficacy|0
2960850|NCT01225731|10191748|P12|Part 2|Lack of Efficacy|0
2960851|NCT01225731|10191749|P11|Part 2|Lack of Efficacy|0
2960852|NCT01225731|10191750|P10|Part 2|Lack of Efficacy|0
2960853|NCT01225731|10191751|P9|Part 2|Lack of Efficacy|3
2960854|NCT01225731|10191752|P8|Part 2|Lack of Efficacy|12
2960855|NCT01225731|10191753|P7|Part 2|Lack of Efficacy|0
2960856|NCT01225731|10191754|P6|Part 2|Lack of Efficacy|1
2960857|NCT01225731|10191755|P5|Part 2|Lack of Efficacy|0
2960858|NCT01225731|10191756|P4|Part 2|Lack of Efficacy|0
2960859|NCT01225731|10191757|P3|Part 2|Lack of Efficacy|0
2962260|NCT01214655|10197269|P1|Part C|Death|0
2960860|NCT01225731|10191758|P2|Part 2|Lack of Efficacy|0
2960861|NCT01225731|10191759|P1|Part 2|Lack of Efficacy|0
2960862|NCT01225731|10191747|P13|Part 2|Adverse Event|0
2960863|NCT01225731|10191748|P12|Part 2|Adverse Event|0
2960864|NCT01225731|10191749|P11|Part 2|Adverse Event|0
2960865|NCT01225731|10191750|P10|Part 2|Adverse Event|0
2960866|NCT01225731|10191751|P9|Part 2|Adverse Event|2
2960867|NCT01225731|10191752|P8|Part 2|Adverse Event|4
2960868|NCT01225731|10191753|P7|Part 2|Adverse Event|4
2960869|NCT01225731|10191754|P6|Part 2|Adverse Event|0
2960870|NCT01225731|10191755|P5|Part 2|Adverse Event|0
2960871|NCT01225731|10191756|P4|Part 2|Adverse Event|0
2960872|NCT01225731|10191757|P3|Part 2|Adverse Event|0
2960873|NCT01225731|10191758|P2|Part 2|Adverse Event|0
2960874|NCT01225731|10191759|P1|Part 2|Adverse Event|0
2960875|NCT01225731|10191747|P13|Part 2|Protocol Violation|0
2960876|NCT01225731|10191748|P12|Part 2|Protocol Violation|0
2960877|NCT01225731|10191749|P11|Part 2|Protocol Violation|0
2960878|NCT01225731|10191750|P10|Part 2|Protocol Violation|0
2960879|NCT01225731|10191751|P9|Part 2|Protocol Violation|1
2960880|NCT01225731|10191752|P8|Part 2|Protocol Violation|0
2960881|NCT01225731|10191753|P7|Part 2|Protocol Violation|0
2960882|NCT01225731|10191754|P6|Part 2|Protocol Violation|1
2960883|NCT01225731|10191755|P5|Part 2|Protocol Violation|0
2960884|NCT01225731|10191756|P4|Part 2|Protocol Violation|0
2960885|NCT01225731|10191757|P3|Part 2|Protocol Violation|0
2960886|NCT01225731|10191758|P2|Part 2|Protocol Violation|0
2960887|NCT01225731|10191759|P1|Part 2|Protocol Violation|0
2960888|NCT01225731|10191747|P13|Part 1|Protocol Violation|0
2960889|NCT01225731|10191748|P12|Part 1|Protocol Violation|0
2960890|NCT01225731|10191749|P11|Part 1|Protocol Violation|0
2960891|NCT01225731|10191750|P10|Part 1|Protocol Violation|0
2960892|NCT01225731|10191751|P9|Part 1|Protocol Violation|0
2960893|NCT01225731|10191752|P8|Part 1|Protocol Violation|0
2960894|NCT01225731|10191753|P7|Part 1|Protocol Violation|0
2960895|NCT01225731|10191754|P6|Part 1|Protocol Violation|0
2960896|NCT01225731|10191755|P5|Part 1|Protocol Violation|0
2960897|NCT01225731|10191756|P4|Part 1|Protocol Violation|1
2960898|NCT01225731|10191757|P3|Part 1|Protocol Violation|0
2960899|NCT01225731|10191758|P2|Part 1|Protocol Violation|0
2960900|NCT01225731|10191759|P1|Part 1|Protocol Violation|0
2960901|NCT01225731|10191747|P13|Part 1|Withdrawal by Subject|0
2960902|NCT01225731|10191748|P12|Part 1|Withdrawal by Subject|0
2960903|NCT01225731|10191749|P11|Part 1|Withdrawal by Subject|0
2960904|NCT01225731|10191750|P10|Part 1|Withdrawal by Subject|0
2960905|NCT01225731|10191751|P9|Part 1|Withdrawal by Subject|0
2960906|NCT01225731|10191752|P8|Part 1|Withdrawal by Subject|0
2960907|NCT01225731|10191753|P7|Part 1|Withdrawal by Subject|0
2960908|NCT01225731|10191754|P6|Part 1|Withdrawal by Subject|0
2960909|NCT01225731|10191755|P5|Part 1|Withdrawal by Subject|4
2960910|NCT01225731|10191756|P4|Part 1|Withdrawal by Subject|0
2960911|NCT01225731|10191757|P3|Part 1|Withdrawal by Subject|0
2960912|NCT01225731|10191758|P2|Part 1|Withdrawal by Subject|3
2960913|NCT01225731|10191759|P1|Part 1|Withdrawal by Subject|0
2960914|NCT01225731|10191747|P13|Part 1|Adverse Event|0
2960915|NCT01225731|10191748|P12|Part 1|Adverse Event|0
2960916|NCT01225731|10191749|P11|Part 1|Adverse Event|0
2960917|NCT01225731|10191750|P10|Part 1|Adverse Event|0
2960918|NCT01225731|10191751|P9|Part 1|Adverse Event|0
2960919|NCT01225731|10191752|P8|Part 1|Adverse Event|0
2960920|NCT01225731|10191753|P7|Part 1|Adverse Event|0
2960921|NCT01225731|10191754|P6|Part 1|Adverse Event|0
2960922|NCT01225731|10191755|P5|Part 1|Adverse Event|1
2960923|NCT01225731|10191756|P4|Part 1|Adverse Event|1
2960924|NCT01225731|10191757|P3|Part 1|Adverse Event|1
2960925|NCT01225731|10191758|P2|Part 1|Adverse Event|2
2960926|NCT01225731|10191759|P1|Part 1|Adverse Event|1
2960927|NCT01225731|10191747|P13|Part 1|Did not meet eligibility criteria|0
2960928|NCT01225731|10191748|P12|Part 1|Did not meet eligibility criteria|0
2960929|NCT01225731|10191749|P11|Part 1|Did not meet eligibility criteria|0
2960930|NCT01225731|10191750|P10|Part 1|Did not meet eligibility criteria|0
2960931|NCT01225731|10191751|P9|Part 1|Did not meet eligibility criteria|0
2960932|NCT01225731|10191752|P8|Part 1|Did not meet eligibility criteria|0
2960933|NCT01225731|10191753|P7|Part 1|Did not meet eligibility criteria|0
2960934|NCT01225731|10191754|P6|Part 1|Did not meet eligibility criteria|0
2960935|NCT01225731|10191755|P5|Part 1|Did not meet eligibility criteria|1
2960936|NCT01225731|10191756|P4|Part 1|Did not meet eligibility criteria|0
2960937|NCT01225731|10191757|P3|Part 1|Did not meet eligibility criteria|0
2960938|NCT01225731|10191758|P2|Part 1|Did not meet eligibility criteria|0
2960939|NCT01225731|10191759|P1|Part 1|Did not meet eligibility criteria|1
2960940|NCT01225562|10191854|P3|Overall Study|Lost to Follow-up|1
2960941|NCT01225562|10191855|P2|Overall Study|Lost to Follow-up|6
2960942|NCT01225562|10191856|P1|Overall Study|Lost to Follow-up|3
2960943|NCT01225562|10191854|P3|Overall Study|Withdrawal by Subject|52
2960944|NCT01225562|10191855|P2|Overall Study|Withdrawal by Subject|50
2960945|NCT01225562|10191856|P1|Overall Study|Withdrawal by Subject|52
2960946|NCT01225549|10191873|P10|Period 6 - Washout|Disallowed medication|0
2960947|NCT01225549|10191874|P9|Period 6 - Washout|Disallowed medication|0
2960948|NCT01225549|10191875|P8|Period 6 - Washout|Disallowed medication|0
2960949|NCT01225549|10191876|P7|Period 6 - Washout|Disallowed medication|0
2960950|NCT01225549|10191877|P6|Period 6 - Washout|Disallowed medication|0
2960951|NCT01225549|10191878|P5|Period 6 - Washout|Disallowed medication|0
2960952|NCT01225549|10191879|P4|Period 6 - Washout|Disallowed medication|1
2960953|NCT01225549|10191880|P3|Period 6 - Washout|Disallowed medication|0
2960954|NCT01225549|10191881|P2|Period 6 - Washout|Disallowed medication|0
2960955|NCT01225549|10191882|P1|Period 6 - Washout|Disallowed medication|0
2960956|NCT01225549|10191873|P10|Period 4 - Washout|Disallowed medication|0
2960957|NCT01225549|10191874|P9|Period 4 - Washout|Disallowed medication|0
2960958|NCT01225549|10191875|P8|Period 4 - Washout|Disallowed medication|0
2960959|NCT01225549|10191876|P7|Period 4 - Washout|Disallowed medication|0
2960960|NCT01225549|10191877|P6|Period 4 - Washout|Disallowed medication|0
2960961|NCT01225549|10191878|P5|Period 4 - Washout|Disallowed medication|0
2960962|NCT01225549|10191879|P4|Period 4 - Washout|Disallowed medication|0
2960963|NCT01225549|10191880|P3|Period 4 - Washout|Disallowed medication|0
2960964|NCT01225549|10191881|P2|Period 4 - Washout|Disallowed medication|1
2960965|NCT01225549|10191882|P1|Period 4 - Washout|Disallowed medication|0
2960966|NCT01225211|10191965|P10|Overall Study|Other|1
2960967|NCT01225211|10191966|P9|Overall Study|Other|0
2960968|NCT01225211|10191967|P8|Overall Study|Other|0
2960969|NCT01225211|10191968|P7|Overall Study|Other|0
2960970|NCT01225211|10191969|P6|Overall Study|Other|0
2960971|NCT01225211|10191970|P5|Overall Study|Other|0
2960972|NCT01225211|10191971|P4|Overall Study|Other|0
2960973|NCT01225211|10191972|P3|Overall Study|Other|0
2960974|NCT01225211|10191973|P2|Overall Study|Other|0
2960975|NCT01225211|10191974|P1|Overall Study|Other|0
2960976|NCT01225211|10191965|P10|Overall Study|Withdrawal by Subject|3
2960977|NCT01225211|10191966|P9|Overall Study|Withdrawal by Subject|1
2960978|NCT01225211|10191967|P8|Overall Study|Withdrawal by Subject|0
2960979|NCT01225211|10191968|P7|Overall Study|Withdrawal by Subject|1
2960980|NCT01225211|10191969|P6|Overall Study|Withdrawal by Subject|0
2960981|NCT01225211|10191970|P5|Overall Study|Withdrawal by Subject|0
2960982|NCT01225211|10191971|P4|Overall Study|Withdrawal by Subject|0
2960983|NCT01225211|10191972|P3|Overall Study|Withdrawal by Subject|0
2960984|NCT01225211|10191973|P2|Overall Study|Withdrawal by Subject|0
2960985|NCT01225211|10191974|P1|Overall Study|Withdrawal by Subject|0
2960986|NCT01225211|10191965|P10|Overall Study|Adverse Event|1
2960987|NCT01225211|10191966|P9|Overall Study|Adverse Event|0
2960988|NCT01225211|10191967|P8|Overall Study|Adverse Event|0
2960989|NCT01225211|10191968|P7|Overall Study|Adverse Event|0
2960990|NCT01225211|10191969|P6|Overall Study|Adverse Event|0
2960991|NCT01225211|10191970|P5|Overall Study|Adverse Event|0
2960992|NCT01225211|10191971|P4|Overall Study|Adverse Event|0
2960993|NCT01225211|10191972|P3|Overall Study|Adverse Event|1
2960994|NCT01225211|10191973|P2|Overall Study|Adverse Event|0
2960995|NCT01225211|10191974|P1|Overall Study|Adverse Event|0
2960996|NCT01225172|10192077|P2|Overall Study|Withdrawal by Subject|0
2960997|NCT01225172|10192078|P1|Overall Study|Withdrawal by Subject|1
2960998|NCT01225172|10192077|P2|Overall Study|Subject no longer meets study criteria|0
2960999|NCT01225172|10192078|P1|Overall Study|Subject no longer meets study criteria|1
2961000|NCT01225172|10192077|P2|Overall Study|Subject request to discontinue treatment|1
2961001|NCT01225172|10192078|P1|Overall Study|Subject request to discontinue treatment|3
2961002|NCT01225172|10192077|P2|Overall Study|Subject decision to stop|0
2961003|NCT01225172|10192078|P1|Overall Study|Subject decision to stop|1
2961004|NCT01225159|10192100|P2|Overall Study|Change operation|0
2961005|NCT01225159|10192101|P1|Overall Study|Change operation|1
2961006|NCT01225146|10192111|P2|Overall Study|Sponsor discontinued making 2mg drug|2
2961007|NCT01225146|10192112|P1|Overall Study|Sponsor discontinued making 2mg drug|0
2961008|NCT01224925|10192180|P2|Overall Study|Lost to Follow-up|2
2961009|NCT01224925|10192181|P1|Overall Study|Lost to Follow-up|3
2961010|NCT01224821|10192189|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
2961011|NCT01224821|10192189|P1|Long-Term Follow-Up|Death|2
2961012|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
2961013|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
2961014|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2961015|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
2961016|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
2961017|NCT01224821|10192189|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
2961018|NCT01224782|10192208|P1|Overall Study|Transplantation|1
2961019|NCT01224782|10192208|P1|Overall Study|Deterioration|1
2961020|NCT01224782|10192208|P1|Overall Study|Financial Reasons|1
2961021|NCT01224782|10192208|P1|Overall Study|Change of Treatment|1
2961022|NCT01224782|10192208|P1|Overall Study|Start of Dialysis|3
2961023|NCT01224782|10192208|P1|Overall Study|Other|4
2961024|NCT01224782|10192208|P1|Overall Study|Noncompliance|10
2961025|NCT01224782|10192208|P1|Overall Study|Adverse Reaction|11
2961026|NCT01224782|10192208|P1|Overall Study|Adverse Event|12
2961027|NCT01224782|10192208|P1|Overall Study|Improvement|13
2961028|NCT01224782|10192208|P1|Overall Study|Death|14
2961029|NCT01224782|10192208|P1|Overall Study|Withdrawal by Subject|16
2961030|NCT01224782|10192208|P1|Overall Study|Lost to Follow-up|177
2961031|NCT01224639|10192234|P8|Overall Study|Adverse Event|1
2961032|NCT01224639|10192235|P7|Overall Study|Adverse Event|0
2961033|NCT01224639|10192236|P6|Overall Study|Adverse Event|0
2961034|NCT01224639|10192237|P5|Overall Study|Adverse Event|0
2961035|NCT01224639|10192238|P4|Overall Study|Adverse Event|0
2961036|NCT01224639|10192239|P3|Overall Study|Adverse Event|0
2961037|NCT01224639|10192240|P2|Overall Study|Adverse Event|0
2961038|NCT01224639|10192241|P1|Overall Study|Adverse Event|0
2961039|NCT01224639|10192234|P8|Overall Study|Withdrawal by Subject|1
2961040|NCT01224639|10192235|P7|Overall Study|Withdrawal by Subject|1
2961041|NCT01224639|10192236|P6|Overall Study|Withdrawal by Subject|0
2961042|NCT01224639|10192237|P5|Overall Study|Withdrawal by Subject|2
2961043|NCT01224639|10192238|P4|Overall Study|Withdrawal by Subject|0
2961044|NCT01224639|10192239|P3|Overall Study|Withdrawal by Subject|0
2961045|NCT01224639|10192240|P2|Overall Study|Withdrawal by Subject|0
2961046|NCT01224639|10192241|P1|Overall Study|Withdrawal by Subject|0
2961047|NCT01224431|10192359|P2|Overall Study|no video record|1
2961048|NCT01224431|10192360|P1|Overall Study|no video record|0
2961049|NCT01224431|10192359|P2|Overall Study|not randomized|4
2961050|NCT01224431|10192360|P1|Overall Study|not randomized|0
2961051|NCT01224171|10192381|P2|Overall Study|Lost to Follow-up|3
2961052|NCT01224171|10192382|P1|Overall Study|Lost to Follow-up|0
2961053|NCT01224171|10192381|P2|Overall Study|Withdrawal of Consent|4
2961054|NCT01224171|10192382|P1|Overall Study|Withdrawal of Consent|2
2961055|NCT01224171|10192381|P2|Overall Study|Lack of Efficacy|1
2961056|NCT01224171|10192382|P1|Overall Study|Lack of Efficacy|5
2961057|NCT01224171|10192381|P2|Overall Study|Protocol Violation|1
2961058|NCT01224171|10192382|P1|Overall Study|Protocol Violation|0
2961059|NCT01224171|10192381|P2|Overall Study|Adverse Event|4
2961060|NCT01224171|10192382|P1|Overall Study|Adverse Event|8
2961061|NCT01224158|10192404|P2|Overall Study|Withdrawal by Subject|0
2961062|NCT01224158|10192405|P1|Overall Study|Withdrawal by Subject|1
2961063|NCT01223937|10192441|P2|Overall Study|Other|1
2961064|NCT01223937|10192442|P1|Overall Study|Other|4
2961065|NCT01223937|10192441|P2|Overall Study|Protocol Violation|7
2961066|NCT01223937|10192442|P1|Overall Study|Protocol Violation|8
2961067|NCT01223937|10192441|P2|Overall Study|Adverse Event|4
2961068|NCT01223937|10192442|P1|Overall Study|Adverse Event|1
2961069|NCT01223937|10192441|P2|Overall Study|Lost to Follow-up|4
2961070|NCT01223937|10192442|P1|Overall Study|Lost to Follow-up|1
2961071|NCT01223937|10192441|P2|Overall Study|Withdrawal by Subject|2
2961072|NCT01223937|10192442|P1|Overall Study|Withdrawal by Subject|3
2961073|NCT01223404|10192488|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
2961074|NCT01223404|10192489|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
2961075|NCT01223404|10192490|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
2961076|NCT01223404|10192491|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
2961077|NCT01223404|10192492|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
2961078|NCT01223404|10192493|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
2961079|NCT01223404|10192488|P6|Second Intervention (1 Day)|Adverse Event|0
2961080|NCT01223404|10192489|P5|Second Intervention (1 Day)|Adverse Event|0
2961081|NCT01223404|10192490|P4|Second Intervention (1 Day)|Adverse Event|0
2961082|NCT01223404|10192491|P3|Second Intervention (1 Day)|Adverse Event|0
2961083|NCT01223404|10192492|P2|Second Intervention (1 Day)|Adverse Event|0
2961084|NCT01223404|10192493|P1|Second Intervention (1 Day)|Adverse Event|1
2961085|NCT01223404|10192488|P6|First Intervention (1 Day)|Adverse Event|0
2961086|NCT01223404|10192489|P5|First Intervention (1 Day)|Adverse Event|0
2961087|NCT01223404|10192490|P4|First Intervention (1 Day)|Adverse Event|1
2961088|NCT01223404|10192491|P3|First Intervention (1 Day)|Adverse Event|0
2961089|NCT01223404|10192492|P2|First Intervention (1 Day)|Adverse Event|0
2961090|NCT01223404|10192493|P1|First Intervention (1 Day)|Adverse Event|0
2961091|NCT01223365|10192557|P1|Open-label Treatment Period|Physician Decision|2
2961092|NCT01223365|10192557|P1|Open-label Treatment Period|Starting physical therapy|1
2961093|NCT01223365|10192557|P1|Open-label Treatment Period|"Out of window"|1
2961094|NCT01223365|10192557|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
2961095|NCT01223365|10192557|P1|Open-label Treatment Period|Moved out of area|2
2961096|NCT01223365|10192557|P1|Open-label Treatment Period|Noncompliance with study procedures|6
2961097|NCT01223365|10192557|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
2961098|NCT01223365|10192557|P1|Open-label Treatment Period|Lost to Follow-up|7
2961099|NCT01223365|10192557|P1|Open-label Treatment Period|Protocol Violation|15
2961100|NCT01223365|10192557|P1|Open-label Treatment Period|Withdrawal by Subject|19
2961101|NCT01223365|10192557|P1|Open-label Treatment Period|Lack of Efficacy|2
2961102|NCT01223365|10192557|P1|Open-label Treatment Period|Adverse Event|39
2961103|NCT01223365|10192557|P1|Open-label Titration Period|Starting physical therapy|1
2961104|NCT01223365|10192557|P1|Open-label Titration Period|Noncompliance with study procedures|2
2961105|NCT01223365|10192557|P1|Open-label Titration Period|Noncompliance with study drug admin|1
2961106|NCT01223365|10192557|P1|Open-label Titration Period|Lost to Follow-up|2
2961107|NCT01223365|10192557|P1|Open-label Titration Period|Protocol Violation|1
2961108|NCT01223365|10192557|P1|Open-label Titration Period|Withdrawal by Subject|5
2961109|NCT01223365|10192557|P1|Open-label Titration Period|Lack of Efficacy|3
2961110|NCT01223365|10192557|P1|Open-label Titration Period|Adverse Event|23
2961111|NCT01223365|10192557|P1|Open-label Titration Period|Enrolled but not treated|1
2961112|NCT01223235|10192621|P1|Overall Study|Withdrawal by Subject|1
2961113|NCT01223196|10192629|P2|Overall Study|Withdrawal by Subject|0
2961114|NCT01223196|10192630|P1|Overall Study|Withdrawal by Subject|1
2961115|NCT01223196|10192629|P2|Overall Study|Physician Decision|0
2961116|NCT01223196|10192630|P1|Overall Study|Physician Decision|1
2961117|NCT01223196|10192629|P2|Overall Study|Lost to Follow-up|0
2961118|NCT01223196|10192630|P1|Overall Study|Lost to Follow-up|2
2961119|NCT01223183|10192642|P2|Washout Period (5-24 Days)|Physician Decision|0
2961120|NCT01223183|10192643|P1|Washout Period (5-24 Days)|Physician Decision|1
2961121|NCT01223183|10192642|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
2961122|NCT01223183|10192643|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
2961123|NCT01223183|10192642|P2|Imaging Day 1|Physician Decision|1
2961124|NCT01223183|10192643|P1|Imaging Day 1|Physician Decision|0
2961125|NCT01223027|10192653|P2|Overall Study|Study terminated by sponsor|8
2961126|NCT01223027|10192654|P1|Overall Study|Study terminated by sponsor|2
2961127|NCT01223027|10192653|P2|Overall Study|New therapy for study indication|8
2961128|NCT01223027|10192654|P1|Overall Study|New therapy for study indication|17
2961129|NCT01223027|10192653|P2|Overall Study|Subject/guardian decicion|16
2961130|NCT01223027|10192654|P1|Overall Study|Subject/guardian decicion|18
2961131|NCT01223027|10192653|P2|Overall Study|Protocol Violation|1
2961132|NCT01223027|10192654|P1|Overall Study|Protocol Violation|2
2961133|NCT01223027|10192653|P2|Overall Study|Progressive Disease|183
2961134|NCT01223027|10192654|P1|Overall Study|Progressive Disease|167
2961135|NCT01223027|10192653|P2|Overall Study|Physician Decision|8
2961136|NCT01223027|10192654|P1|Overall Study|Physician Decision|4
2961137|NCT01223027|10192653|P2|Overall Study|Lost to Follow-up|1
2961138|NCT01223027|10192654|P1|Overall Study|Lost to Follow-up|2
2961139|NCT01223027|10192653|P2|Overall Study|Death|42
2961140|NCT01223027|10192654|P1|Overall Study|Death|42
2961141|NCT01223027|10192653|P2|Overall Study|Adverse Event|10
2961142|NCT01223027|10192654|P1|Overall Study|Adverse Event|20
2961143|NCT01222715|10192716|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
2961144|NCT01222715|10192717|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
2961145|NCT01222715|10192716|P2|Overall Study|Ineligible|1
2961146|NCT01222715|10192717|P1|Overall Study|Ineligible|0
2961147|NCT01222715|10192716|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
2961148|NCT01222715|10192717|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
2961149|NCT01222715|10192716|P2|Overall Study|Refusal of further protocol therapy|4
2961150|NCT01222715|10192717|P1|Overall Study|Refusal of further protocol therapy|0
2961151|NCT01222715|10192716|P2|Overall Study|Physician Decision|2
2961152|NCT01222715|10192717|P1|Overall Study|Physician Decision|12
2961153|NCT01222715|10192716|P2|Overall Study|Lack of Efficacy|14
2961154|NCT01222715|10192717|P1|Overall Study|Lack of Efficacy|22
2961155|NCT01222715|10192716|P2|Overall Study|Death|1
2961156|NCT01222715|10192717|P1|Overall Study|Death|0
2961157|NCT01222715|10192716|P2|Overall Study|Adverse Event|4
2961158|NCT01222715|10192717|P1|Overall Study|Adverse Event|0
2961159|NCT01222533|10192756|P1|Overall Study|Other|4
2961160|NCT01222533|10192756|P1|Overall Study|Withdrawal by Subject|5
2961161|NCT01222533|10192756|P1|Overall Study|Adverse Event|5
2961162|NCT01222520|10192895|P2|Double-blind Period|Study medication stolen|0
2961163|NCT01222520|10192896|P1|Double-blind Period|Study medication stolen|1
2961164|NCT01222520|10192895|P2|Double-blind Period|Lack of Efficacy|1
2961165|NCT01222520|10192896|P1|Double-blind Period|Lack of Efficacy|0
2961166|NCT01222520|10192895|P2|Double-blind Period|Adverse Event|1
2961167|NCT01222520|10192896|P1|Double-blind Period|Adverse Event|0
2961168|NCT01222520|10192895|P2|Open-label run-in Period|Number of patients fulfilled|3
2961169|NCT01222520|10192896|P1|Open-label run-in Period|Number of patients fulfilled|0
2961170|NCT01222520|10192895|P2|Open-label run-in Period|Blood pressure criteria not met|18
2961171|NCT01222520|10192896|P1|Open-label run-in Period|Blood pressure criteria not met|0
2961172|NCT01222520|10192895|P2|Open-label run-in Period|Withdrawal by Subject|2
2961173|NCT01222520|10192896|P1|Open-label run-in Period|Withdrawal by Subject|0
2961174|NCT01222507|10192914|P1|Overall Study|Withdrawal by Subject|1
2961175|NCT01222507|10192914|P1|Overall Study|Physician Decision|1
2961176|NCT01222416|10192942|P2|Overall Study|Death|0
2961177|NCT01222416|10192943|P1|Overall Study|Death|1
2961178|NCT01222416|10192942|P2|Overall Study|missed view/scan|0
2961179|NCT01222416|10192943|P1|Overall Study|missed view/scan|1
2961180|NCT01222416|10192942|P2|Overall Study|scheduling|0
2961181|NCT01222416|10192943|P1|Overall Study|scheduling|6
2961182|NCT01222416|10192942|P2|Overall Study|Withdrawal by Subject|0
2961183|NCT01222416|10192943|P1|Overall Study|Withdrawal by Subject|5
2961184|NCT01222416|10192942|P2|Overall Study|Adverse Event|0
2961185|NCT01222416|10192943|P1|Overall Study|Adverse Event|4
2961186|NCT01222416|10192942|P2|Overall Study|ineligible;metastasis|0
2961187|NCT01222416|10192943|P1|Overall Study|ineligible;metastasis|3
2961188|NCT01222403|10192953|P2|Overall Study|Inappropriate enrollment|2
2961189|NCT01222403|10192954|P1|Overall Study|Inappropriate enrollment|0
2961190|NCT01222247|10192998|P2|Overall Study|Lost to Follow-up|2
2961191|NCT01222247|10192999|P1|Overall Study|Lost to Follow-up|2
2961192|NCT01222104|10193135|P1|Overall Study|Death|10
2961193|NCT01222104|10193135|P1|Overall Study|Lost to Follow-up|37
2961194|NCT01222078|10193158|P1|Overall Study|Early termination of the study|1
2961195|NCT01221948|10193192|P1|Overall Study|Protocol Violation|4
2961196|NCT01221948|10193192|P1|Overall Study|Death|1
2961197|NCT01221948|10193192|P1|Overall Study|not disclosed|2
2961198|NCT01221948|10193192|P1|Overall Study|Withdrawal by Subject|2
2961199|NCT01221948|10193192|P1|Overall Study|Physician Decision|5
2961200|NCT01221753|10193211|P1|Overall Study|Adverse Event|1
2961201|NCT01221727|10193218|P2|Overall Study|Withdrawal by Subject|1
2961202|NCT01221727|10193219|P1|Overall Study|Withdrawal by Subject|1
2961203|NCT01221727|10193218|P2|Overall Study|Physician Decision|0
2961204|NCT01221727|10193219|P1|Overall Study|Physician Decision|2
2961205|NCT01221623|10193240|P2|Overall Study|Other|2
2961206|NCT01221623|10193241|P1|Overall Study|Other|5
2961207|NCT01221623|10193240|P2|Overall Study|Death|0
2961208|NCT01221623|10193241|P1|Overall Study|Death|1
2961209|NCT01221623|10193240|P2|Overall Study|Adverse Event|3
2961210|NCT01221623|10193241|P1|Overall Study|Adverse Event|6
2961211|NCT01221623|10193240|P2|Overall Study|Lost to Follow-up|1
2961212|NCT01221623|10193241|P1|Overall Study|Lost to Follow-up|7
2961213|NCT01221623|10193240|P2|Overall Study|Withdrawal by Subject|8
2961214|NCT01221623|10193241|P1|Overall Study|Withdrawal by Subject|19
2961215|NCT01221597|10193265|P2|Overall Study|Death|0
2961216|NCT01221597|10193266|P1|Overall Study|Death|2
2961217|NCT01221597|10193265|P2|Overall Study|Other|4
2961218|NCT01221597|10193266|P1|Overall Study|Other|3
2961219|NCT01221597|10193265|P2|Overall Study|Protocol Violation|0
2961220|NCT01221597|10193266|P1|Overall Study|Protocol Violation|1
2961221|NCT01221597|10193265|P2|Overall Study|Lost to Follow-up|5
2961222|NCT01221597|10193266|P1|Overall Study|Lost to Follow-up|6
2961223|NCT01221597|10193265|P2|Overall Study|Withdrawal by Subject|6
2961224|NCT01221597|10193266|P1|Overall Study|Withdrawal by Subject|20
2961225|NCT01221597|10193265|P2|Overall Study|Adverse Event|1
2961226|NCT01221597|10193266|P1|Overall Study|Adverse Event|4
2961227|NCT01221363|10193323|P2|Overall Study|Withdrawal by Subject|5
2961228|NCT01221363|10193324|P1|Overall Study|Withdrawal by Subject|11
2961229|NCT01221363|10193323|P2|Overall Study|Pregnancy|0
2961230|NCT01221363|10193324|P1|Overall Study|Pregnancy|1
2961231|NCT01221350|10193334|P2|Overall Study|Withdrawal by Subject|2
2961232|NCT01221350|10193335|P1|Overall Study|Withdrawal by Subject|4
2961233|NCT01221350|10193334|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
2961234|NCT01221350|10193335|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
2961235|NCT01221350|10193334|P2|Overall Study|Discontinued intervention (GERD)|0
2961236|NCT01221350|10193335|P1|Overall Study|Discontinued intervention (GERD)|1
2961237|NCT01221285|10193394|P1|Overall Study|Withdrawal by Subject|1
2961238|NCT01221272|10193403|P2|Period 2|Adverse Event|2
2961239|NCT01221272|10193404|P1|Period 2|Adverse Event|0
2961240|NCT01221272|10193403|P2|Period 1|Significant Dosing Noncompliance|1
2961241|NCT01221272|10193404|P1|Period 1|Significant Dosing Noncompliance|0
2961242|NCT01221272|10193403|P2|Period 1|Consent Withdrawal|1
2961243|NCT01221272|10193404|P1|Period 1|Consent Withdrawal|0
2961244|NCT01221272|10193403|P2|Period 1|Adverse Event|0
2961245|NCT01221272|10193404|P1|Period 1|Adverse Event|2
2961246|NCT01221233|10193421|P2|Overall Study|Withdrawal by Subject|1
2961247|NCT01221233|10193422|P1|Overall Study|Withdrawal by Subject|3
2961248|NCT01221181|10193428|P1|Overall Study|Lost to Follow-up|1
2961249|NCT01221090|10193436|P4|Overall Study|Withdrawal by Subject|2
2961250|NCT01221090|10193437|P3|Overall Study|Withdrawal by Subject|27
2961251|NCT01221090|10193438|P2|Overall Study|Withdrawal by Subject|22
2961252|NCT01221090|10193439|P1|Overall Study|Withdrawal by Subject|0
2961253|NCT01221090|10193436|P4|Overall Study|Non-Compliant or Unable to Contact|20
2961254|NCT01221090|10193437|P3|Overall Study|Non-Compliant or Unable to Contact|15
2961255|NCT01221090|10193438|P2|Overall Study|Non-Compliant or Unable to Contact|12
2961256|NCT01221090|10193439|P1|Overall Study|Non-Compliant or Unable to Contact|15
2961257|NCT01220999|10193470|P5|Overall Study|Progressive disease|0
2961258|NCT01220999|10193471|P4|Overall Study|Progressive disease|0
2961259|NCT01220999|10193472|P3|Overall Study|Progressive disease|1
2961260|NCT01220999|10193473|P2|Overall Study|Progressive disease|0
2961261|NCT01220999|10193474|P1|Overall Study|Progressive disease|0
2961262|NCT01220609|10193595|P1|Overall Study|Ineligible-Never treated|1
2961263|NCT01220609|10193595|P1|Overall Study|Ineligible- Wrong cell type|1
2961264|NCT01220609|10193595|P1|Overall Study|Ineligible-Wrong primary cancer site|1
2961265|NCT01220557|10193609|P2|Overall Study|attended less than 6 lessons|2
2961266|NCT01220557|10193610|P1|Overall Study|attended less than 6 lessons|1
2961267|NCT01220557|10193609|P2|Overall Study|Lost to Follow-up|3
2961268|NCT01220557|10193610|P1|Overall Study|Lost to Follow-up|5
2961269|NCT01220414|10193643|P4|Overall Study|Withdrawal by Subject|1
2961270|NCT01220414|10193644|P3|Overall Study|Withdrawal by Subject|0
2961271|NCT01220414|10193645|P2|Overall Study|Withdrawal by Subject|0
2961272|NCT01220414|10193646|P1|Overall Study|Withdrawal by Subject|1
2961273|NCT01220401|10193653|P1|Overall Study|Protocol Violation|1
2961274|NCT01220401|10193653|P1|Overall Study|Withdrawal by Subject|2
2961275|NCT01220297|10193662|P1|Overall Study|Lost to Follow-up|1
2961276|NCT01220297|10193662|P1|Overall Study|Death|2
2961277|NCT01220180|10193679|P1|Overall Study|Randomized but not treated|1
2961278|NCT01220180|10193679|P1|Overall Study|Death|1
2961279|NCT01220180|10193679|P1|Overall Study|Lack of Efficacy|22
2961280|NCT01220180|10193679|P1|Overall Study|Adverse Event|35
2961281|NCT01220180|10193679|P1|Overall Study|Other|72
2961282|NCT01220180|10193679|P1|Overall Study|Lost to Follow-up|76
2961283|NCT01220128|10193709|P7|Overall Study|Consent withdrawn by subject|0
2961284|NCT01220128|10193710|P6|Overall Study|Consent withdrawn by subject|0
2961285|NCT01220128|10193711|P5|Overall Study|Consent withdrawn by subject|0
2961286|NCT01220128|10193712|P4|Overall Study|Consent withdrawn by subject|0
2961287|NCT01220128|10193713|P3|Overall Study|Consent withdrawn by subject|0
2961288|NCT01220128|10193714|P2|Overall Study|Consent withdrawn by subject|0
2961289|NCT01220128|10193715|P1|Overall Study|Consent withdrawn by subject|1
2961290|NCT01220128|10193709|P7|Overall Study|Other|0
2961291|NCT01220128|10193710|P6|Overall Study|Other|0
2961292|NCT01220128|10193711|P5|Overall Study|Other|0
2961293|NCT01220128|10193712|P4|Overall Study|Other|0
2961294|NCT01220128|10193713|P3|Overall Study|Other|1
2961295|NCT01220128|10193714|P2|Overall Study|Other|0
2961296|NCT01220128|10193715|P1|Overall Study|Other|0
2961297|NCT01220128|10193709|P7|Overall Study|Adverse event, non-fatal|3
2961298|NCT01220128|10193710|P6|Overall Study|Adverse event, non-fatal|0
2961299|NCT01220128|10193711|P5|Overall Study|Adverse event, non-fatal|0
2961300|NCT01220128|10193712|P4|Overall Study|Adverse event, non-fatal|0
2961301|NCT01220128|10193713|P3|Overall Study|Adverse event, non-fatal|0
2961302|NCT01220128|10193714|P2|Overall Study|Adverse event, non-fatal|0
2961303|NCT01220128|10193715|P1|Overall Study|Adverse event, non-fatal|1
2961304|NCT01220128|10193709|P7|Overall Study|Adverse event, serious fatal|1
2961305|NCT01220128|10193710|P6|Overall Study|Adverse event, serious fatal|0
2961306|NCT01220128|10193711|P5|Overall Study|Adverse event, serious fatal|0
2961307|NCT01220128|10193712|P4|Overall Study|Adverse event, serious fatal|0
2961308|NCT01220128|10193713|P3|Overall Study|Adverse event, serious fatal|0
2961309|NCT01220128|10193714|P2|Overall Study|Adverse event, serious fatal|0
2961310|NCT01220128|10193715|P1|Overall Study|Adverse event, serious fatal|2
2961311|NCT01220128|10193709|P7|Overall Study|Sponsor study termination|1
2961312|NCT01220128|10193710|P6|Overall Study|Sponsor study termination|0
2961313|NCT01220128|10193711|P5|Overall Study|Sponsor study termination|0
2961314|NCT01220128|10193712|P4|Overall Study|Sponsor study termination|0
2961315|NCT01220128|10193713|P3|Overall Study|Sponsor study termination|0
2961316|NCT01220128|10193714|P2|Overall Study|Sponsor study termination|1
2961317|NCT01220128|10193715|P1|Overall Study|Sponsor study termination|0
2961318|NCT01220128|10193709|P7|Overall Study|Progressive disease|0
2961319|NCT01220128|10193710|P6|Overall Study|Progressive disease|0
2961320|NCT01220128|10193711|P5|Overall Study|Progressive disease|0
2961321|NCT01220128|10193712|P4|Overall Study|Progressive disease|0
2961322|NCT01220128|10193713|P3|Overall Study|Progressive disease|2
2961323|NCT01220128|10193714|P2|Overall Study|Progressive disease|0
2961324|NCT01220128|10193715|P1|Overall Study|Progressive disease|0
2961325|NCT01219985|10193920|P1|Overall Study|Physician Decision|20
2961326|NCT01219959|10193928|P2|Overall Study|Other|0
2961327|NCT01219959|10193929|P1|Overall Study|Other|1
2961328|NCT01219959|10193928|P2|Overall Study|Renal Transplantation|3
2961329|NCT01219959|10193929|P1|Overall Study|Renal Transplantation|0
2961330|NCT01219959|10193928|P2|Overall Study|Withdrawal by Subject|2
2961331|NCT01219959|10193929|P1|Overall Study|Withdrawal by Subject|0
2961332|NCT01219959|10193928|P2|Overall Study|Physician Decision|4
2961333|NCT01219959|10193929|P1|Overall Study|Physician Decision|0
2961334|NCT01219959|10193928|P2|Overall Study|Adverse Event|14
2961335|NCT01219959|10193929|P1|Overall Study|Adverse Event|6
2961336|NCT01219933|10193977|P1|Overall Study|Lack of Efficacy|1
2961337|NCT01219933|10193977|P1|Overall Study|Protocol Violation|8
2961338|NCT01219933|10193977|P1|Overall Study|Withdrawal by Subject|5
2961339|NCT01219933|10193977|P1|Overall Study|GC free|1
2961340|NCT01219933|10193977|P1|Overall Study|Lost to Follow-up|3
2961341|NCT01219933|10193977|P1|Overall Study|No LDA maintained|7
2961342|NCT01219933|10193977|P1|Overall Study|No LDA reached|5
2961343|NCT01219933|10193977|P1|Overall Study|Adverse Event|8
2961344|NCT01218867|10194187|P11|Overall Study|Death during treatment|0
2961345|NCT01218867|10194188|P10|Overall Study|Death during treatment|0
2961346|NCT01218867|10194189|P9|Overall Study|Death during treatment|0
2961347|NCT01218867|10194190|P8|Overall Study|Death during treatment|0
2961348|NCT01218867|10194191|P7|Overall Study|Death during treatment|1
2961349|NCT01218867|10194192|P6|Overall Study|Death during treatment|0
2961350|NCT01218867|10194193|P5|Overall Study|Death during treatment|0
2961351|NCT01218867|10194194|P4|Overall Study|Death during treatment|0
2961352|NCT01218867|10194195|P3|Overall Study|Death during treatment|0
2961353|NCT01218867|10194196|P2|Overall Study|Death during treatment|0
2961354|NCT01218867|10194197|P1|Overall Study|Death during treatment|0
2961355|NCT01218802|10194245|P2|Overall Study|Incarcerated|0
2961356|NCT01218802|10194246|P1|Overall Study|Incarcerated|2
2961357|NCT01218802|10194245|P2|Overall Study|Adverse Event|2
2961358|NCT01218802|10194246|P1|Overall Study|Adverse Event|0
2961359|NCT01218802|10194245|P2|Overall Study|Withdrawal by Subject|10
2961360|NCT01218802|10194246|P1|Overall Study|Withdrawal by Subject|3
2961361|NCT01218802|10194245|P2|Overall Study|Lost to Follow-up|6
2961362|NCT01218802|10194246|P1|Overall Study|Lost to Follow-up|5
2961363|NCT01218659|10194256|P3|12-Month OLE|Declined to participate in the OLE|4
2961364|NCT01218659|10194257|P2|12-Month OLE|Declined to participate in the OLE|0
2961365|NCT01218659|10194258|P1|12-Month OLE|Declined to participate in the OLE|0
2961366|NCT01218659|10194256|P3|12-Month OLE|Lack of Efficacy|1
2961367|NCT01218659|10194257|P2|12-Month OLE|Lack of Efficacy|0
2961368|NCT01218659|10194258|P1|12-Month OLE|Lack of Efficacy|0
2961369|NCT01218659|10194256|P3|12-Month OLE|Pregnancy|1
2961370|NCT01218659|10194257|P2|12-Month OLE|Pregnancy|0
2961371|NCT01218659|10194258|P1|12-Month OLE|Pregnancy|0
2961372|NCT01218659|10194256|P3|12-Month OLE|Lost to Follow-up|1
2961373|NCT01218659|10194257|P2|12-Month OLE|Lost to Follow-up|0
2961374|NCT01218659|10194258|P1|12-Month OLE|Lost to Follow-up|0
2961375|NCT01218659|10194256|P3|12-Month OLE|Physician Decision|1
2961376|NCT01218659|10194257|P2|12-Month OLE|Physician Decision|0
2961377|NCT01218659|10194258|P1|12-Month OLE|Physician Decision|0
2961378|NCT01218659|10194256|P3|12-Month OLE|Withdrawal by Subject|2
2961379|NCT01218659|10194257|P2|12-Month OLE|Withdrawal by Subject|0
2961380|NCT01218659|10194258|P1|12-Month OLE|Withdrawal by Subject|0
2961381|NCT01218659|10194256|P3|18-Month Randomized Period|Did not receive study drug|0
2961382|NCT01218659|10194257|P2|18-Month Randomized Period|Did not receive study drug|3
2961383|NCT01218659|10194258|P1|18-Month Randomized Period|Did not receive study drug|0
2961384|NCT01218659|10194256|P3|18-Month Randomized Period|Withdrawal by Subject|0
2961385|NCT01218659|10194257|P2|18-Month Randomized Period|Withdrawal by Subject|3
2961386|NCT01218659|10194258|P1|18-Month Randomized Period|Withdrawal by Subject|2
2961387|NCT01218646|10194273|P4|Overall Study|Protocol Violation|1
2961388|NCT01218646|10194274|P3|Overall Study|Protocol Violation|1
2961389|NCT01218646|10194275|P2|Overall Study|Protocol Violation|0
2961390|NCT01218646|10194276|P1|Overall Study|Protocol Violation|0
2961391|NCT01218646|10194273|P4|Overall Study|Lost to Follow-up|0
2961392|NCT01218646|10194274|P3|Overall Study|Lost to Follow-up|0
2961393|NCT01218646|10194275|P2|Overall Study|Lost to Follow-up|0
2961394|NCT01218646|10194276|P1|Overall Study|Lost to Follow-up|1
2961395|NCT01218646|10194273|P4|Overall Study|Adverse Event|0
2961396|NCT01218646|10194274|P3|Overall Study|Adverse Event|1
2961397|NCT01218646|10194275|P2|Overall Study|Adverse Event|0
2961398|NCT01218646|10194276|P1|Overall Study|Adverse Event|0
2961399|NCT01218594|10194314|P1|Overall Study|Physician Decision|6
2961400|NCT01218594|10194314|P1|Overall Study|Adverse Event|2
2961401|NCT01218594|10194314|P1|Overall Study|Withdrawal by Subject|3
2961402|NCT01218594|10194314|P1|Overall Study|Death|1
2961403|NCT01218477|10194322|P4|Overall Study|Maximum clinical benefit|0
2961404|NCT01218477|10194323|P3|Overall Study|Maximum clinical benefit|0
2961405|NCT01218477|10194324|P2|Overall Study|Maximum clinical benefit|2
2961406|NCT01218477|10194325|P1|Overall Study|Maximum clinical benefit|0
2961407|NCT01218477|10194322|P4|Overall Study|Administrative reason by sponsor|0
2961408|NCT01218477|10194323|P3|Overall Study|Administrative reason by sponsor|1
2961409|NCT01218477|10194324|P2|Overall Study|Administrative reason by sponsor|0
2961410|NCT01218477|10194325|P1|Overall Study|Administrative reason by sponsor|0
2961411|NCT01218477|10194322|P4|Overall Study|Prepared for cell transplantation|0
2961412|NCT01218477|10194323|P3|Overall Study|Prepared for cell transplantation|1
2961413|NCT01218477|10194324|P2|Overall Study|Prepared for cell transplantation|1
2961414|NCT01218477|10194325|P1|Overall Study|Prepared for cell transplantation|0
2961415|NCT01218477|10194322|P4|Overall Study|Withdrawal by Subject|0
2961416|NCT01218477|10194323|P3|Overall Study|Withdrawal by Subject|1
2961417|NCT01218477|10194324|P2|Overall Study|Withdrawal by Subject|0
2961418|NCT01218477|10194325|P1|Overall Study|Withdrawal by Subject|0
2961419|NCT01218477|10194322|P4|Overall Study|No longer meets study criteria|0
2961420|NCT01218477|10194323|P3|Overall Study|No longer meets study criteria|0
2961421|NCT01218477|10194324|P2|Overall Study|No longer meets study criteria|0
2961422|NCT01218477|10194325|P1|Overall Study|No longer meets study criteria|1
2961423|NCT01218477|10194322|P4|Overall Study|Study drug toxicity|0
2961424|NCT01218477|10194323|P3|Overall Study|Study drug toxicity|5
2961425|NCT01218477|10194324|P2|Overall Study|Study drug toxicity|2
2961426|NCT01218477|10194325|P1|Overall Study|Study drug toxicity|0
2961427|NCT01218477|10194322|P4|Overall Study|Disease progression|2
2961428|NCT01218477|10194323|P3|Overall Study|Disease progression|6
2961429|NCT01218477|10194324|P2|Overall Study|Disease progression|3
2961430|NCT01218477|10194325|P1|Overall Study|Disease progression|2
2961431|NCT01218438|10194342|P1|Epoch 4|Withdrawal by Subject|2
2961432|NCT01218438|10194342|P1|Epoch 4|Physician Decision|1
2961433|NCT01218438|10194342|P1|Epoch 3|Adverse Event|1
2961434|NCT01218438|10194342|P1|Epoch 3|Withdrawal by Subject|3
2961435|NCT01218438|10194342|P1|Epoch 1|Adverse Event|1
2961436|NCT01218438|10194342|P1|Epoch 1|Physician Decision|2
2961437|NCT01218308|10194508|P2|Overall Study|Other|21
2961438|NCT01218308|10194509|P1|Overall Study|Other|14
2961439|NCT01218308|10194508|P2|Overall Study|Lost to Follow-up|31
2961440|NCT01218308|10194509|P1|Overall Study|Lost to Follow-up|27
2961441|NCT01218308|10194508|P2|Overall Study|Withdrawal by Subject|64
2961442|NCT01218308|10194509|P1|Overall Study|Withdrawal by Subject|61
2961443|NCT01218308|10194508|P2|Overall Study|Protocol Violation|2
2961444|NCT01218308|10194509|P1|Overall Study|Protocol Violation|0
2961445|NCT01218308|10194508|P2|Overall Study|Adverse Event|2
2961446|NCT01218308|10194509|P1|Overall Study|Adverse Event|1
2961447|NCT01218243|10194553|P2|Overall Study|Protocol Violation|10
2961448|NCT01218243|10194554|P1|Overall Study|Protocol Violation|5
2961449|NCT01218243|10194553|P2|Overall Study|Lost to Follow-up|3
2961450|NCT01218243|10194554|P1|Overall Study|Lost to Follow-up|3
2961451|NCT01218243|10194553|P2|Overall Study|Lack of Efficacy|1
2961452|NCT01218243|10194554|P1|Overall Study|Lack of Efficacy|1
2961453|NCT01218204|10194570|P4|Part B Pooled Treatment Arm|Protocol Violation|1
2961454|NCT01218204|10194571|P3|Part B Pooled Treatment Arm|Protocol Violation|0
2961455|NCT01218204|10194572|P2|Part B Pooled Treatment Arm|Protocol Violation|0
2961456|NCT01218204|10194573|P1|Part B Pooled Treatment Arm|Protocol Violation|0
2961457|NCT01218204|10194570|P4|Part B Pooled Treatment Arm|Adverse Event|2
2961458|NCT01218204|10194571|P3|Part B Pooled Treatment Arm|Adverse Event|0
2961459|NCT01218204|10194572|P2|Part B Pooled Treatment Arm|Adverse Event|0
2961460|NCT01218204|10194573|P1|Part B Pooled Treatment Arm|Adverse Event|0
2961461|NCT01218204|10194570|P4|Part B Run-in|Withdrawal by Subject|0
2961462|NCT01218204|10194571|P3|Part B Run-in|Withdrawal by Subject|3
2961463|NCT01218204|10194572|P2|Part B Run-in|Withdrawal by Subject|0
2961464|NCT01218204|10194573|P1|Part B Run-in|Withdrawal by Subject|0
2961465|NCT01218204|10194570|P4|Part B Run-in|Protocol Violation|0
2961466|NCT01218204|10194571|P3|Part B Run-in|Protocol Violation|2
2961467|NCT01218204|10194572|P2|Part B Run-in|Protocol Violation|0
2961468|NCT01218204|10194573|P1|Part B Run-in|Protocol Violation|0
2961469|NCT01218204|10194570|P4|Part B Run-in|Adverse Event|0
2961470|NCT01218204|10194571|P3|Part B Run-in|Adverse Event|1
2961471|NCT01218204|10194572|P2|Part B Run-in|Adverse Event|0
2961472|NCT01218204|10194573|P1|Part B Run-in|Adverse Event|0
2961473|NCT01218204|10194570|P4|Part B Washout|Did not meet continuation criteria|0
2961474|NCT01218204|10194571|P3|Part B Washout|Did not meet continuation criteria|0
2961475|NCT01218204|10194572|P2|Part B Washout|Did not meet continuation criteria|112
2961476|NCT01218204|10194573|P1|Part B Washout|Did not meet continuation criteria|0
2961477|NCT01218204|10194570|P4|Part B Washout|Reached defined stopping criteria|0
2961478|NCT01218204|10194571|P3|Part B Washout|Reached defined stopping criteria|0
2961479|NCT01218204|10194572|P2|Part B Washout|Reached defined stopping criteria|2
2961480|NCT01218204|10194573|P1|Part B Washout|Reached defined stopping criteria|0
2961481|NCT01218204|10194570|P4|Part B Washout|Withdrawal by Subject|0
2961482|NCT01218204|10194571|P3|Part B Washout|Withdrawal by Subject|0
2961483|NCT01218204|10194572|P2|Part B Washout|Withdrawal by Subject|14
2961484|NCT01218204|10194573|P1|Part B Washout|Withdrawal by Subject|0
2961485|NCT01218204|10194570|P4|Part B Washout|Physician Decision|0
2961486|NCT01218204|10194571|P3|Part B Washout|Physician Decision|0
2961487|NCT01218204|10194572|P2|Part B Washout|Physician Decision|14
2961488|NCT01218204|10194573|P1|Part B Washout|Physician Decision|0
2961489|NCT01218204|10194570|P4|Part B Washout|Lost to Follow-up|0
2961490|NCT01218204|10194571|P3|Part B Washout|Lost to Follow-up|0
2961491|NCT01218204|10194572|P2|Part B Washout|Lost to Follow-up|2
2961492|NCT01218204|10194573|P1|Part B Washout|Lost to Follow-up|0
2961493|NCT01218204|10194570|P4|Part B Washout|Adverse Event|0
2961494|NCT01218204|10194571|P3|Part B Washout|Adverse Event|0
2961495|NCT01218204|10194572|P2|Part B Washout|Adverse Event|1
2961496|NCT01218204|10194573|P1|Part B Washout|Adverse Event|0
2961497|NCT01218126|10194837|P4|Overall Study|Withdrawal by Subject|6
2961498|NCT01218126|10194838|P3|Overall Study|Withdrawal by Subject|4
2961499|NCT01218126|10194839|P2|Overall Study|Withdrawal by Subject|5
2961500|NCT01218126|10194840|P1|Overall Study|Withdrawal by Subject|2
2961501|NCT01218126|10194837|P4|Overall Study|Physician Decision|2
2961502|NCT01218126|10194838|P3|Overall Study|Physician Decision|4
2961503|NCT01218126|10194839|P2|Overall Study|Physician Decision|2
2961504|NCT01218126|10194840|P1|Overall Study|Physician Decision|1
2961505|NCT01218126|10194837|P4|Overall Study|Lost to Follow-up|2
2961506|NCT01218126|10194838|P3|Overall Study|Lost to Follow-up|0
2961507|NCT01218126|10194839|P2|Overall Study|Lost to Follow-up|0
2961508|NCT01218126|10194840|P1|Overall Study|Lost to Follow-up|0
2961509|NCT01218126|10194837|P4|Overall Study|Protocol-defined stopping criteria|0
2961510|NCT01218126|10194838|P3|Overall Study|Protocol-defined stopping criteria|0
2961511|NCT01218126|10194839|P2|Overall Study|Protocol-defined stopping criteria|1
2961512|NCT01218126|10194840|P1|Overall Study|Protocol-defined stopping criteria|1
2961513|NCT01218126|10194837|P4|Overall Study|Protocol Violation|3
2961514|NCT01218126|10194838|P3|Overall Study|Protocol Violation|2
2961515|NCT01218126|10194839|P2|Overall Study|Protocol Violation|2
2961516|NCT01218126|10194840|P1|Overall Study|Protocol Violation|5
2961517|NCT01218126|10194837|P4|Overall Study|Lack of Efficacy|6
2961518|NCT01218126|10194838|P3|Overall Study|Lack of Efficacy|2
2961519|NCT01218126|10194839|P2|Overall Study|Lack of Efficacy|2
2961520|NCT01218126|10194840|P1|Overall Study|Lack of Efficacy|7
2961521|NCT01218126|10194837|P4|Overall Study|Adverse Event|16
2961522|NCT01218126|10194838|P3|Overall Study|Adverse Event|12
2961523|NCT01218126|10194839|P2|Overall Study|Adverse Event|10
2961524|NCT01218126|10194840|P1|Overall Study|Adverse Event|8
2961525|NCT01218113|10194881|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
2961526|NCT01218113|10194882|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
2961527|NCT01218113|10194883|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
2961528|NCT01218113|10194881|P3|Overall Study|Lost to Follow-up|4
2961529|NCT01218113|10194882|P2|Overall Study|Lost to Follow-up|1
2961530|NCT01218113|10194883|P1|Overall Study|Lost to Follow-up|4
2961531|NCT01218113|10194881|P3|Overall Study|Withdrawal by Subject|1
2961532|NCT01218113|10194882|P2|Overall Study|Withdrawal by Subject|0
2961533|NCT01218113|10194883|P1|Overall Study|Withdrawal by Subject|1
2961534|NCT01218100|10195064|P4|Overall Study|Other Reason|4
2961535|NCT01218100|10195065|P3|Overall Study|Other Reason|6
2961536|NCT01218100|10195066|P2|Overall Study|Other Reason|2
2961537|NCT01218100|10195067|P1|Overall Study|Other Reason|2
2961538|NCT01218100|10195064|P4|Overall Study|Lost to Follow-up|1
2961539|NCT01218100|10195065|P3|Overall Study|Lost to Follow-up|2
2961540|NCT01218100|10195066|P2|Overall Study|Lost to Follow-up|8
2961541|NCT01218100|10195067|P1|Overall Study|Lost to Follow-up|3
2961542|NCT01218100|10195064|P4|Overall Study|Withdrawal by Subject|7
2961543|NCT01218100|10195065|P3|Overall Study|Withdrawal by Subject|6
2961544|NCT01218100|10195066|P2|Overall Study|Withdrawal by Subject|2
2961545|NCT01218100|10195067|P1|Overall Study|Withdrawal by Subject|5
2961546|NCT01218100|10195064|P4|Overall Study|Protocol Violation|1
2961547|NCT01218100|10195065|P3|Overall Study|Protocol Violation|1
2961548|NCT01218100|10195066|P2|Overall Study|Protocol Violation|0
2961549|NCT01218100|10195067|P1|Overall Study|Protocol Violation|0
2961550|NCT01218100|10195064|P4|Overall Study|Lack of Efficacy|12
2961551|NCT01218100|10195065|P3|Overall Study|Lack of Efficacy|5
2961552|NCT01218100|10195066|P2|Overall Study|Lack of Efficacy|6
2961553|NCT01218100|10195067|P1|Overall Study|Lack of Efficacy|9
2961554|NCT01218100|10195064|P4|Overall Study|Adverse Event|7
2961555|NCT01218100|10195065|P3|Overall Study|Adverse Event|6
2961556|NCT01218100|10195066|P2|Overall Study|Adverse Event|6
2961557|NCT01218100|10195067|P1|Overall Study|Adverse Event|4
2961558|NCT01218100|10195064|P4|Overall Study|Did not meet InclusionExclusion criteria|2
2961559|NCT01218100|10195065|P3|Overall Study|Did not meet InclusionExclusion criteria|1
2961560|NCT01218100|10195066|P2|Overall Study|Did not meet InclusionExclusion criteria|1
2961561|NCT01218100|10195067|P1|Overall Study|Did not meet InclusionExclusion criteria|1
2961562|NCT01218087|10195083|P2|Overall Study|Transferred|5
2961563|NCT01218087|10195084|P1|Overall Study|Transferred|8
2961564|NCT01218087|10195083|P2|Overall Study|Withdrawal by Subject|0
2961565|NCT01218087|10195084|P1|Overall Study|Withdrawal by Subject|5
2961566|NCT01218087|10195083|P2|Overall Study|Death|1
2961567|NCT01218087|10195084|P1|Overall Study|Death|2
2961568|NCT01218009|10195106|P2|Overall Study|Sponsor terminated study|163
2961569|NCT01218009|10195107|P1|Overall Study|Sponsor terminated study|161
2961570|NCT01218009|10195106|P2|Overall Study|Withdrawal by Subject|1
2961571|NCT01218009|10195107|P1|Overall Study|Withdrawal by Subject|3
2961572|NCT01218009|10195106|P2|Overall Study|Protocol Violation|1
2961573|NCT01218009|10195107|P1|Overall Study|Protocol Violation|2
2961574|NCT01217957|10195130|P5|Phase 2|Withdrawal by Patient|1
2961575|NCT01217957|10195131|P4|Phase 2|Withdrawal by Patient|0
2961576|NCT01217957|10195132|P3|Phase 2|Withdrawal by Patient|0
2961577|NCT01217957|10195133|P2|Phase 2|Withdrawal by Patient|0
2961578|NCT01217957|10195134|P1|Phase 2|Withdrawal by Patient|0
2961579|NCT01217957|10195130|P5|Phase 1|Withdrawal by Patient|0
2961580|NCT01217957|10195131|P4|Phase 1|Withdrawal by Patient|1
2961581|NCT01217957|10195132|P3|Phase 1|Withdrawal by Patient|1
2961582|NCT01217957|10195133|P2|Phase 1|Withdrawal by Patient|0
2961583|NCT01217957|10195134|P1|Phase 1|Withdrawal by Patient|1
2961584|NCT01217944|10195193|P3|Overall Study|Lack of Efficacy|0
2961585|NCT01217944|10195194|P2|Overall Study|Lack of Efficacy|0
2961586|NCT01217944|10195195|P1|Overall Study|Lack of Efficacy|1
2961587|NCT01217944|10195193|P3|Overall Study|Withdrawal by Subject|0
2961588|NCT01217944|10195194|P2|Overall Study|Withdrawal by Subject|2
2961589|NCT01217944|10195195|P1|Overall Study|Withdrawal by Subject|1
2961590|NCT01217944|10195193|P3|Overall Study|Lost to Follow-up|0
2961591|NCT01217944|10195194|P2|Overall Study|Lost to Follow-up|1
2961592|NCT01217944|10195195|P1|Overall Study|Lost to Follow-up|3
2961593|NCT01217944|10195193|P3|Overall Study|Protocol Violation|0
2961594|NCT01217944|10195194|P2|Overall Study|Protocol Violation|1
2961595|NCT01217944|10195195|P1|Overall Study|Protocol Violation|1
2961596|NCT01217892|10195238|P4|Overall Study|Poor/Non-Compliance|0
2961597|NCT01217892|10195239|P3|Overall Study|Poor/Non-Compliance|1
2961598|NCT01217892|10195240|P2|Overall Study|Poor/Non-Compliance|0
2961599|NCT01217892|10195241|P1|Overall Study|Poor/Non-Compliance|0
2961600|NCT01217892|10195238|P4|Overall Study|Incorrect enrollment|0
2961601|NCT01217892|10195239|P3|Overall Study|Incorrect enrollment|1
2961602|NCT01217892|10195240|P2|Overall Study|Incorrect enrollment|1
2961603|NCT01217892|10195241|P1|Overall Study|Incorrect enrollment|0
2961604|NCT01217892|10195238|P4|Overall Study|Subject no longer meets study criteria|8
2961605|NCT01217892|10195239|P3|Overall Study|Subject no longer meets study criteria|4
2961606|NCT01217892|10195240|P2|Overall Study|Subject no longer meets study criteria|2
2961607|NCT01217892|10195241|P1|Overall Study|Subject no longer meets study criteria|5
2961608|NCT01217892|10195238|P4|Overall Study|Lab value|0
2961609|NCT01217892|10195239|P3|Overall Study|Lab value|1
2961610|NCT01217892|10195240|P2|Overall Study|Lab value|0
2961611|NCT01217892|10195241|P1|Overall Study|Lab value|1
2961612|NCT01217892|10195238|P4|Overall Study|Withdrawal by Subject|0
2961613|NCT01217892|10195239|P3|Overall Study|Withdrawal by Subject|1
2961614|NCT01217892|10195240|P2|Overall Study|Withdrawal by Subject|2
2961615|NCT01217892|10195241|P1|Overall Study|Withdrawal by Subject|0
2961616|NCT01217892|10195238|P4|Overall Study|Adverse Event|0
2961617|NCT01217892|10195239|P3|Overall Study|Adverse Event|1
2961618|NCT01217892|10195240|P2|Overall Study|Adverse Event|1
2961619|NCT01217892|10195241|P1|Overall Study|Adverse Event|1
2961620|NCT01217814|10195304|P3|Overall Study|Lack of Efficacy|1
2961621|NCT01217814|10195305|P2|Overall Study|Lack of Efficacy|0
2961622|NCT01217814|10195306|P1|Overall Study|Lack of Efficacy|0
2961623|NCT01217814|10195304|P3|Overall Study|Adverse Event|0
2961624|NCT01217814|10195305|P2|Overall Study|Adverse Event|1
2961625|NCT01217814|10195306|P1|Overall Study|Adverse Event|1
2961626|NCT01217801|10195332|P2|Period 1|Withdrawal by Subject|1
2961627|NCT01217801|10195333|P1|Period 1|Withdrawal by Subject|0
2961628|NCT01217801|10195332|P2|Period 1|Protocol Violation|1
2961629|NCT01217801|10195333|P1|Period 1|Protocol Violation|1
2961630|NCT01217606|10195362|P2|9-Month Masked Extension|Lack of Efficacy|0
2961631|NCT01217606|10195363|P1|9-Month Masked Extension|Lack of Efficacy|2
2961632|NCT01217606|10195362|P2|9-Month Masked Extension|Pregnancy|0
2961633|NCT01217606|10195363|P1|9-Month Masked Extension|Pregnancy|1
2961634|NCT01217606|10195362|P2|9-Month Masked Extension|Lost to Follow-up|0
2961635|NCT01217606|10195363|P1|9-Month Masked Extension|Lost to Follow-up|1
2961636|NCT01217606|10195362|P2|9-Month Masked Extension|Personal Reasons|1
2961637|NCT01217606|10195363|P1|9-Month Masked Extension|Personal Reasons|2
2961638|NCT01217606|10195362|P2|9-Month Masked Extension|Other Reasons|4
2961639|NCT01217606|10195363|P1|9-Month Masked Extension|Other Reasons|4
2961640|NCT01217606|10195362|P2|9-Month Masked Extension|Adverse Event|6
2961641|NCT01217606|10195363|P1|9-Month Masked Extension|Adverse Event|3
2961642|NCT01217606|10195362|P2|Initial Treatment Phase|Adverse Event|6
2961643|NCT01217606|10195363|P1|Initial Treatment Phase|Adverse Event|10
2961644|NCT01217606|10195362|P2|Initial Treatment Phase|Lack of Efficacy|0
2961645|NCT01217606|10195363|P1|Initial Treatment Phase|Lack of Efficacy|1
2961646|NCT01217606|10195362|P2|Initial Treatment Phase|Personal Reasons|2
2961647|NCT01217606|10195363|P1|Initial Treatment Phase|Personal Reasons|0
2961648|NCT01217606|10195362|P2|Initial Treatment Phase|Protocol Violation|2
2961649|NCT01217606|10195363|P1|Initial Treatment Phase|Protocol Violation|3
2961650|NCT01217606|10195362|P2|Initial Treatment Phase|Other Reasons|2
2961651|NCT01217606|10195363|P1|Initial Treatment Phase|Other Reasons|0
2961652|NCT01217476|10195394|P2|Overall Study|Other|0
2961653|NCT01217476|10195395|P1|Overall Study|Other|2
2961654|NCT01217476|10195394|P2|Overall Study|Protocol Deviation|0
2961655|NCT01217476|10195395|P1|Overall Study|Protocol Deviation|1
2961656|NCT01217476|10195394|P2|Overall Study|Surgery on the Target Limb|2
2961657|NCT01217476|10195395|P1|Overall Study|Surgery on the Target Limb|0
2961658|NCT01217476|10195394|P2|Overall Study|Withdrawal by Subject|3
2961659|NCT01217476|10195395|P1|Overall Study|Withdrawal by Subject|3
2961660|NCT01217476|10195394|P2|Overall Study|Physician Decision|1
2961661|NCT01217476|10195395|P1|Overall Study|Physician Decision|0
2961662|NCT01217476|10195394|P2|Overall Study|Adverse Event|1
2961663|NCT01217476|10195395|P1|Overall Study|Adverse Event|6
2961664|NCT01217463|10195405|P2|Overall Study|Other|1
2961665|NCT01217463|10195406|P1|Overall Study|Other|1
2961666|NCT01217463|10195405|P2|Overall Study|Patient Non-compliant|0
2961667|NCT01217463|10195406|P1|Overall Study|Patient Non-compliant|1
2961668|NCT01217463|10195405|P2|Overall Study|Surgery on the Target Limb|1
2961669|NCT01217463|10195406|P1|Overall Study|Surgery on the Target Limb|0
2961670|NCT01217463|10195405|P2|Overall Study|Withdrawal by Subject|0
2961671|NCT01217463|10195406|P1|Overall Study|Withdrawal by Subject|3
2961672|NCT01217463|10195405|P2|Overall Study|Physician Decision|1
2961673|NCT01217463|10195406|P1|Overall Study|Physician Decision|0
2961674|NCT01217463|10195405|P2|Overall Study|Adverse Event|5
2961675|NCT01217463|10195406|P1|Overall Study|Adverse Event|8
2961676|NCT01217437|10195416|P2|Overall Study|Ineligible|1
2961677|NCT01217437|10195417|P1|Overall Study|Ineligible|1
2961678|NCT01217437|10195416|P2|Overall Study|Withdrawal by Subject|2
2961679|NCT01217437|10195417|P1|Overall Study|Withdrawal by Subject|0
2961680|NCT01217437|10195416|P2|Overall Study|Physician Decision|5
2961681|NCT01217437|10195417|P1|Overall Study|Physician Decision|8
2961682|NCT01217437|10195416|P2|Overall Study|Lack of Efficacy|25
2961683|NCT01217437|10195417|P1|Overall Study|Lack of Efficacy|29
2961684|NCT01217437|10195416|P2|Overall Study|Death|0
2961685|NCT01217437|10195417|P1|Overall Study|Death|5
2961686|NCT01217437|10195416|P2|Overall Study|Adverse Event|8
2961687|NCT01217437|10195417|P1|Overall Study|Adverse Event|0
2961688|NCT01217385|10195438|P1|Overall Study|Normal Breast TOI not available|10
2961689|NCT01217385|10195438|P1|Overall Study|Central Path not Available|1
2961690|NCT01217385|10195438|P1|Overall Study|DOSI not performed/not eval|12
2961691|NCT01217385|10195438|P1|Overall Study|Withdrawal by Subject|3
2961692|NCT01217307|10195450|P2|Overall Study|Withdrawal by Subject|1
2961693|NCT01217307|10195451|P1|Overall Study|Withdrawal by Subject|0
2961694|NCT01217229|10195457|P1|Overall Study|Disease progression not confirmed|2
2961695|NCT01217229|10195457|P1|Overall Study|Protocol Violation|1
2961696|NCT01217229|10195457|P1|Overall Study|Disease progression, Cheson criteria|14
2961697|NCT01217229|10195457|P1|Overall Study|Disease progression, deterioration|2
2961698|NCT01217229|10195457|P1|Overall Study|Adverse Event|1
2961699|NCT01217112|10195469|P5|Overall Study|Physician Decision|1
2961700|NCT01217112|10195470|P4|Overall Study|Physician Decision|0
2961701|NCT01217112|10195471|P3|Overall Study|Physician Decision|0
2961702|NCT01217112|10195472|P2|Overall Study|Physician Decision|0
2961703|NCT01217112|10195473|P1|Overall Study|Physician Decision|0
2961704|NCT01217112|10195469|P5|Overall Study|Withdrawal by Subject|0
2961705|NCT01217112|10195470|P4|Overall Study|Withdrawal by Subject|0
2961706|NCT01217112|10195471|P3|Overall Study|Withdrawal by Subject|1
2961707|NCT01217112|10195472|P2|Overall Study|Withdrawal by Subject|0
2961708|NCT01217112|10195473|P1|Overall Study|Withdrawal by Subject|0
2961709|NCT01217112|10195469|P5|Overall Study|Adverse Event|0
2961710|NCT01217112|10195470|P4|Overall Study|Adverse Event|2
2961711|NCT01217112|10195471|P3|Overall Study|Adverse Event|0
2961712|NCT01217112|10195472|P2|Overall Study|Adverse Event|2
2961713|NCT01217112|10195473|P1|Overall Study|Adverse Event|0
2961714|NCT01217073|10195706|P8|Extension Period|Withdrawal by Subject|8
2961715|NCT01217073|10195707|P7|Extension Period|Withdrawal by Subject|30
2961716|NCT01217073|10195708|P6|Extension Period|Withdrawal by Subject|0
2961717|NCT01217073|10195709|P5|Extension Period|Withdrawal by Subject|0
2961718|NCT01217073|10195710|P4|Extension Period|Withdrawal by Subject|0
2961719|NCT01217073|10195711|P3|Extension Period|Withdrawal by Subject|0
2961720|NCT01217073|10195712|P2|Extension Period|Withdrawal by Subject|0
2961721|NCT01217073|10195713|P1|Extension Period|Withdrawal by Subject|0
2961722|NCT01217073|10195706|P8|Extension Period|Site discontinued study participation|2
2961723|NCT01217073|10195707|P7|Extension Period|Site discontinued study participation|7
2961724|NCT01217073|10195708|P6|Extension Period|Site discontinued study participation|0
2961725|NCT01217073|10195709|P5|Extension Period|Site discontinued study participation|0
2961726|NCT01217073|10195710|P4|Extension Period|Site discontinued study participation|0
2961727|NCT01217073|10195711|P3|Extension Period|Site discontinued study participation|0
2961728|NCT01217073|10195712|P2|Extension Period|Site discontinued study participation|0
2961729|NCT01217073|10195713|P1|Extension Period|Site discontinued study participation|0
2961730|NCT01217073|10195706|P8|Extension Period|Protocol Violation|1
2961731|NCT01217073|10195707|P7|Extension Period|Protocol Violation|2
2961732|NCT01217073|10195708|P6|Extension Period|Protocol Violation|0
2961733|NCT01217073|10195709|P5|Extension Period|Protocol Violation|0
2961734|NCT01217073|10195710|P4|Extension Period|Protocol Violation|0
2961735|NCT01217073|10195711|P3|Extension Period|Protocol Violation|0
2961736|NCT01217073|10195712|P2|Extension Period|Protocol Violation|0
2961737|NCT01217073|10195713|P1|Extension Period|Protocol Violation|0
2961738|NCT01217073|10195706|P8|Extension Period|Physician Decision|1
2961739|NCT01217073|10195707|P7|Extension Period|Physician Decision|4
2961740|NCT01217073|10195708|P6|Extension Period|Physician Decision|0
2961741|NCT01217073|10195709|P5|Extension Period|Physician Decision|0
2961742|NCT01217073|10195710|P4|Extension Period|Physician Decision|0
2961743|NCT01217073|10195711|P3|Extension Period|Physician Decision|0
2961744|NCT01217073|10195712|P2|Extension Period|Physician Decision|0
2961745|NCT01217073|10195713|P1|Extension Period|Physician Decision|0
2961746|NCT01217073|10195706|P8|Extension Period|Non-compliance with study drug|1
2961747|NCT01217073|10195707|P7|Extension Period|Non-compliance with study drug|0
2961748|NCT01217073|10195708|P6|Extension Period|Non-compliance with study drug|0
2961749|NCT01217073|10195709|P5|Extension Period|Non-compliance with study drug|0
2961750|NCT01217073|10195710|P4|Extension Period|Non-compliance with study drug|0
2961751|NCT01217073|10195711|P3|Extension Period|Non-compliance with study drug|0
2961752|NCT01217073|10195712|P2|Extension Period|Non-compliance with study drug|0
2961753|NCT01217073|10195713|P1|Extension Period|Non-compliance with study drug|0
2961754|NCT01217073|10195706|P8|Extension Period|Lost to Follow-up|1
2961755|NCT01217073|10195707|P7|Extension Period|Lost to Follow-up|9
2961756|NCT01217073|10195708|P6|Extension Period|Lost to Follow-up|0
2961757|NCT01217073|10195709|P5|Extension Period|Lost to Follow-up|0
2961758|NCT01217073|10195710|P4|Extension Period|Lost to Follow-up|0
2961759|NCT01217073|10195711|P3|Extension Period|Lost to Follow-up|0
2961760|NCT01217073|10195712|P2|Extension Period|Lost to Follow-up|0
2961761|NCT01217073|10195713|P1|Extension Period|Lost to Follow-up|0
2961762|NCT01217073|10195706|P8|Extension Period|Lack of Efficacy|0
2961763|NCT01217073|10195707|P7|Extension Period|Lack of Efficacy|3
2961764|NCT01217073|10195708|P6|Extension Period|Lack of Efficacy|0
2961765|NCT01217073|10195709|P5|Extension Period|Lack of Efficacy|0
2961766|NCT01217073|10195710|P4|Extension Period|Lack of Efficacy|0
2961767|NCT01217073|10195711|P3|Extension Period|Lack of Efficacy|0
2961768|NCT01217073|10195712|P2|Extension Period|Lack of Efficacy|0
2961769|NCT01217073|10195713|P1|Extension Period|Lack of Efficacy|0
2961770|NCT01217073|10195706|P8|Extension Period|Excluded medication|0
2961771|NCT01217073|10195707|P7|Extension Period|Excluded medication|2
2961772|NCT01217073|10195708|P6|Extension Period|Excluded medication|0
2961773|NCT01217073|10195709|P5|Extension Period|Excluded medication|0
2961774|NCT01217073|10195710|P4|Extension Period|Excluded medication|0
2961775|NCT01217073|10195711|P3|Extension Period|Excluded medication|0
2961776|NCT01217073|10195712|P2|Extension Period|Excluded medication|0
2961777|NCT01217073|10195713|P1|Extension Period|Excluded medication|0
2961778|NCT01217073|10195706|P8|Extension Period|Death|0
2961779|NCT01217073|10195707|P7|Extension Period|Death|1
2961780|NCT01217073|10195708|P6|Extension Period|Death|0
2961781|NCT01217073|10195709|P5|Extension Period|Death|0
2961782|NCT01217073|10195710|P4|Extension Period|Death|0
2961783|NCT01217073|10195711|P3|Extension Period|Death|0
2961784|NCT01217073|10195712|P2|Extension Period|Death|0
2961785|NCT01217073|10195713|P1|Extension Period|Death|0
2961786|NCT01217073|10195706|P8|Extension Period|Creatinine/eGFR|1
2961787|NCT01217073|10195707|P7|Extension Period|Creatinine/eGFR|11
2961788|NCT01217073|10195708|P6|Extension Period|Creatinine/eGFR|0
2961789|NCT01217073|10195709|P5|Extension Period|Creatinine/eGFR|0
2961790|NCT01217073|10195710|P4|Extension Period|Creatinine/eGFR|0
2961791|NCT01217073|10195711|P3|Extension Period|Creatinine/eGFR|0
2961792|NCT01217073|10195712|P2|Extension Period|Creatinine/eGFR|0
2961793|NCT01217073|10195713|P1|Extension Period|Creatinine/eGFR|0
2961794|NCT01217073|10195706|P8|Extension Period|Contraindication to study medication|0
2961795|NCT01217073|10195707|P7|Extension Period|Contraindication to study medication|1
2961796|NCT01217073|10195708|P6|Extension Period|Contraindication to study medication|0
2961797|NCT01217073|10195709|P5|Extension Period|Contraindication to study medication|0
2961798|NCT01217073|10195710|P4|Extension Period|Contraindication to study medication|0
2961799|NCT01217073|10195711|P3|Extension Period|Contraindication to study medication|0
2961800|NCT01217073|10195712|P2|Extension Period|Contraindication to study medication|0
2961801|NCT01217073|10195713|P1|Extension Period|Contraindication to study medication|0
2961802|NCT01217073|10195706|P8|Extension Period|ALT/AST|0
2961803|NCT01217073|10195707|P7|Extension Period|ALT/AST|2
2961804|NCT01217073|10195708|P6|Extension Period|ALT/AST|0
2961805|NCT01217073|10195709|P5|Extension Period|ALT/AST|0
2961806|NCT01217073|10195710|P4|Extension Period|ALT/AST|0
2961807|NCT01217073|10195711|P3|Extension Period|ALT/AST|0
2961808|NCT01217073|10195712|P2|Extension Period|ALT/AST|0
2961809|NCT01217073|10195713|P1|Extension Period|ALT/AST|0
2961810|NCT01217073|10195706|P8|Extension Period|Adverse Event|5
2961811|NCT01217073|10195707|P7|Extension Period|Adverse Event|19
2961812|NCT01217073|10195708|P6|Extension Period|Adverse Event|0
2961813|NCT01217073|10195709|P5|Extension Period|Adverse Event|0
2961814|NCT01217073|10195710|P4|Extension Period|Adverse Event|0
2961815|NCT01217073|10195711|P3|Extension Period|Adverse Event|0
2961816|NCT01217073|10195712|P2|Extension Period|Adverse Event|0
2961817|NCT01217073|10195713|P1|Extension Period|Adverse Event|0
2961818|NCT01217073|10195706|P8|Base Period|Withdrawal by Subject|0
2961819|NCT01217073|10195707|P7|Base Period|Withdrawal by Subject|0
2961820|NCT01217073|10195708|P6|Base Period|Withdrawal by Subject|5
2961821|NCT01217073|10195709|P5|Base Period|Withdrawal by Subject|5
2961822|NCT01217073|10195710|P4|Base Period|Withdrawal by Subject|1
2961823|NCT01217073|10195711|P3|Base Period|Withdrawal by Subject|5
2961824|NCT01217073|10195712|P2|Base Period|Withdrawal by Subject|5
2961825|NCT01217073|10195713|P1|Base Period|Withdrawal by Subject|4
2961826|NCT01217073|10195706|P8|Base Period|Protocol Violation|0
2961827|NCT01217073|10195707|P7|Base Period|Protocol Violation|0
2961828|NCT01217073|10195708|P6|Base Period|Protocol Violation|2
2961829|NCT01217073|10195709|P5|Base Period|Protocol Violation|1
2961830|NCT01217073|10195710|P4|Base Period|Protocol Violation|0
2961831|NCT01217073|10195711|P3|Base Period|Protocol Violation|0
2961832|NCT01217073|10195712|P2|Base Period|Protocol Violation|0
2961833|NCT01217073|10195713|P1|Base Period|Protocol Violation|1
2961834|NCT01217073|10195706|P8|Base Period|Physician Decision|0
2961835|NCT01217073|10195707|P7|Base Period|Physician Decision|0
2961836|NCT01217073|10195708|P6|Base Period|Physician Decision|0
2961837|NCT01217073|10195709|P5|Base Period|Physician Decision|1
2961838|NCT01217073|10195710|P4|Base Period|Physician Decision|0
2961839|NCT01217073|10195711|P3|Base Period|Physician Decision|0
2961840|NCT01217073|10195712|P2|Base Period|Physician Decision|0
2961841|NCT01217073|10195713|P1|Base Period|Physician Decision|0
2961842|NCT01217073|10195706|P8|Base Period|Lost to Follow-up|0
2961843|NCT01217073|10195707|P7|Base Period|Lost to Follow-up|0
2961844|NCT01217073|10195708|P6|Base Period|Lost to Follow-up|0
2961845|NCT01217073|10195709|P5|Base Period|Lost to Follow-up|3
2961846|NCT01217073|10195710|P4|Base Period|Lost to Follow-up|1
2961847|NCT01217073|10195711|P3|Base Period|Lost to Follow-up|1
2961848|NCT01217073|10195712|P2|Base Period|Lost to Follow-up|0
2961849|NCT01217073|10195713|P1|Base Period|Lost to Follow-up|0
2961850|NCT01217073|10195706|P8|Base Period|Lack of Efficacy|0
2961851|NCT01217073|10195707|P7|Base Period|Lack of Efficacy|0
2961852|NCT01217073|10195708|P6|Base Period|Lack of Efficacy|1
2961853|NCT01217073|10195709|P5|Base Period|Lack of Efficacy|0
2961854|NCT01217073|10195710|P4|Base Period|Lack of Efficacy|0
2961855|NCT01217073|10195711|P3|Base Period|Lack of Efficacy|0
2961856|NCT01217073|10195712|P2|Base Period|Lack of Efficacy|0
2961857|NCT01217073|10195713|P1|Base Period|Lack of Efficacy|0
2961858|NCT01217073|10195706|P8|Base Period|Excluded medication|0
2961859|NCT01217073|10195707|P7|Base Period|Excluded medication|0
2961860|NCT01217073|10195708|P6|Base Period|Excluded medication|0
2961861|NCT01217073|10195709|P5|Base Period|Excluded medication|1
2961862|NCT01217073|10195710|P4|Base Period|Excluded medication|0
2961863|NCT01217073|10195711|P3|Base Period|Excluded medication|0
2961864|NCT01217073|10195712|P2|Base Period|Excluded medication|0
2961865|NCT01217073|10195713|P1|Base Period|Excluded medication|0
2961866|NCT01217073|10195706|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
2961867|NCT01217073|10195707|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
2961868|NCT01217073|10195708|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
2961869|NCT01217073|10195709|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
2961870|NCT01217073|10195710|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
2961871|NCT01217073|10195711|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
2961872|NCT01217073|10195712|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
2961873|NCT01217073|10195713|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
2961874|NCT01217073|10195706|P8|Base Period|Adverse Event|0
2961875|NCT01217073|10195707|P7|Base Period|Adverse Event|0
2961876|NCT01217073|10195708|P6|Base Period|Adverse Event|1
2961877|NCT01217073|10195709|P5|Base Period|Adverse Event|4
2961878|NCT01217073|10195710|P4|Base Period|Adverse Event|0
2961879|NCT01217073|10195711|P3|Base Period|Adverse Event|1
2961880|NCT01217073|10195712|P2|Base Period|Adverse Event|0
2961881|NCT01217073|10195713|P1|Base Period|Adverse Event|1
2961882|NCT01216332|10195904|P2|Overall Study|Withdrawal by Subject|0
2961883|NCT01216332|10195905|P1|Overall Study|Withdrawal by Subject|4
2961884|NCT01216319|10195923|P1|Overall Study|Unanticipated chemo for breast cancer|2
2961885|NCT01216319|10195923|P1|Overall Study|Lost to Follow-up|2
2961886|NCT01216176|10195940|P3|Overall Study|Physician Decision|1
2961887|NCT01216176|10195941|P2|Overall Study|Physician Decision|0
2961888|NCT01216176|10195942|P1|Overall Study|Physician Decision|0
2961889|NCT01216176|10195940|P3|Overall Study|Adverse Event|0
2961890|NCT01216176|10195941|P2|Overall Study|Adverse Event|8
2961891|NCT01216176|10195942|P1|Overall Study|Adverse Event|0
2961892|NCT01216163|10195965|P3|Overall Study|Withdrawal by Subject|0
2961893|NCT01216163|10195966|P2|Overall Study|Withdrawal by Subject|1
2961894|NCT01216163|10195967|P1|Overall Study|Withdrawal by Subject|1
2961895|NCT01216072|10196019|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
2961896|NCT01216072|10196020|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
2961897|NCT01216072|10196019|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
2961898|NCT01216072|10196020|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
2961899|NCT01216072|10196019|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
2961900|NCT01216072|10196020|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
2961901|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
2961902|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
2961903|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
2961904|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
2961905|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
2961906|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
2961907|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
2961908|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
2961909|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
2961910|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
2961911|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
2961912|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
2961913|NCT01216072|10196019|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
2961914|NCT01216072|10196020|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
2961915|NCT01215981|10196048|P2|Overall Study|Withdrawal by Subject|0
2961916|NCT01215981|10196049|P1|Overall Study|Withdrawal by Subject|1
2961917|NCT01215981|10196048|P2|Overall Study|Protocol Violation|0
2961918|NCT01215981|10196049|P1|Overall Study|Protocol Violation|1
2961919|NCT01215981|10196048|P2|Overall Study|Physician Decision|1
2961920|NCT01215981|10196049|P1|Overall Study|Physician Decision|0
2961921|NCT01215968|10196059|P2|Overall Study|Not received study drug|1
2961922|NCT01215968|10196060|P1|Overall Study|Not received study drug|0
2961923|NCT01215968|10196059|P2|Overall Study|Protocol Violation|4
2961924|NCT01215968|10196060|P1|Overall Study|Protocol Violation|2
2961925|NCT01215968|10196059|P2|Overall Study|Adverse Event|2
2961926|NCT01215968|10196060|P1|Overall Study|Adverse Event|0
2961927|NCT01215955|10196080|P4|Overall Study|Quality Issues|2
2961928|NCT01215955|10196081|P3|Overall Study|Quality Issues|3
2961929|NCT01215955|10196082|P2|Overall Study|Quality Issues|0
2961930|NCT01215955|10196083|P1|Overall Study|Quality Issues|0
2961931|NCT01215955|10196080|P4|Overall Study|Withdrawal by Subject|9
2961932|NCT01215955|10196081|P3|Overall Study|Withdrawal by Subject|13
2961933|NCT01215955|10196082|P2|Overall Study|Withdrawal by Subject|15
2961934|NCT01215955|10196083|P1|Overall Study|Withdrawal by Subject|14
2961935|NCT01215955|10196080|P4|Overall Study|Sponsor Decision|1
2961936|NCT01215955|10196081|P3|Overall Study|Sponsor Decision|0
2961937|NCT01215955|10196082|P2|Overall Study|Sponsor Decision|2
2961938|NCT01215955|10196083|P1|Overall Study|Sponsor Decision|1
2961939|NCT01215955|10196080|P4|Overall Study|Protocol Violation|8
2961940|NCT01215955|10196081|P3|Overall Study|Protocol Violation|8
2961941|NCT01215955|10196082|P2|Overall Study|Protocol Violation|13
2961942|NCT01215955|10196083|P1|Overall Study|Protocol Violation|17
2961943|NCT01215955|10196080|P4|Overall Study|Physician Decision|11
2961944|NCT01215955|10196081|P3|Overall Study|Physician Decision|8
2961945|NCT01215955|10196082|P2|Overall Study|Physician Decision|10
2961946|NCT01215955|10196083|P1|Overall Study|Physician Decision|4
2961947|NCT01215955|10196080|P4|Overall Study|Lost to Follow-up|9
2961948|NCT01215955|10196081|P3|Overall Study|Lost to Follow-up|8
2961949|NCT01215955|10196082|P2|Overall Study|Lost to Follow-up|4
2961950|NCT01215955|10196083|P1|Overall Study|Lost to Follow-up|4
2961951|NCT01215955|10196080|P4|Overall Study|Lack of Efficacy|0
2961952|NCT01215955|10196081|P3|Overall Study|Lack of Efficacy|1
2961953|NCT01215955|10196082|P2|Overall Study|Lack of Efficacy|2
2961954|NCT01215955|10196083|P1|Overall Study|Lack of Efficacy|1
2961955|NCT01215955|10196080|P4|Overall Study|Entry Criteria Not Met|7
2961956|NCT01215955|10196081|P3|Overall Study|Entry Criteria Not Met|4
2961957|NCT01215955|10196082|P2|Overall Study|Entry Criteria Not Met|3
2961958|NCT01215955|10196083|P1|Overall Study|Entry Criteria Not Met|1
2961959|NCT01215955|10196080|P4|Overall Study|Death|3
2961960|NCT01215955|10196081|P3|Overall Study|Death|1
2961961|NCT01215955|10196082|P2|Overall Study|Death|0
2961962|NCT01215955|10196083|P1|Overall Study|Death|2
2961963|NCT01215955|10196080|P4|Overall Study|Adverse Event|3
2961964|NCT01215955|10196081|P3|Overall Study|Adverse Event|2
2961965|NCT01215955|10196082|P2|Overall Study|Adverse Event|4
2961966|NCT01215955|10196083|P1|Overall Study|Adverse Event|1
2961967|NCT01215942|10196151|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
2961968|NCT01215942|10196152|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
2961969|NCT01215942|10196151|P2|Post-Treatment Follow-Up Period|Physician Decision|2
2961970|NCT01215942|10196152|P1|Post-Treatment Follow-Up Period|Physician Decision|1
2961971|NCT01215942|10196151|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
2961972|NCT01215942|10196152|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
2961973|NCT01215942|10196151|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2961974|NCT01215942|10196152|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2961975|NCT01215942|10196151|P2|Post-Treatment Follow-Up Period|Death|1
2961976|NCT01215942|10196152|P1|Post-Treatment Follow-Up Period|Death|0
2961977|NCT01215942|10196151|P2|Treatment Period|Sponsor Decision|530
2961978|NCT01215942|10196152|P1|Treatment Period|Sponsor Decision|349
2961979|NCT01215942|10196151|P2|Treatment Period|Protocol Violation|1
2961980|NCT01215942|10196152|P1|Treatment Period|Protocol Violation|0
2961981|NCT01215942|10196151|P2|Treatment Period|Physician Decision|5
2961982|NCT01215942|10196152|P1|Treatment Period|Physician Decision|5
2961983|NCT01215942|10196151|P2|Treatment Period|Withdrawal by Subject|40
2961984|NCT01215942|10196152|P1|Treatment Period|Withdrawal by Subject|17
2961985|NCT01215942|10196151|P2|Treatment Period|Lost to Follow-up|4
2961986|NCT01215942|10196152|P1|Treatment Period|Lost to Follow-up|3
2961987|NCT01215942|10196151|P2|Treatment Period|Lack of Efficacy|62
2961988|NCT01215942|10196152|P1|Treatment Period|Lack of Efficacy|23
2961989|NCT01215942|10196151|P2|Treatment Period|Death|4
2961990|NCT01215942|10196152|P1|Treatment Period|Death|2
2961991|NCT01215942|10196151|P2|Treatment Period|Adverse Event|26
2961992|NCT01215942|10196152|P1|Treatment Period|Adverse Event|15
2961993|NCT01215916|10196285|P9|Overall Study|Physician Decision|0
2961994|NCT01215916|10196286|P8|Overall Study|Physician Decision|0
2961995|NCT01215916|10196287|P7|Overall Study|Physician Decision|0
2961996|NCT01215916|10196288|P6|Overall Study|Physician Decision|0
2961997|NCT01215916|10196289|P5|Overall Study|Physician Decision|0
2961998|NCT01215916|10196290|P4|Overall Study|Physician Decision|1
2961999|NCT01215916|10196291|P3|Overall Study|Physician Decision|1
2962000|NCT01215916|10196292|P2|Overall Study|Physician Decision|0
2962001|NCT01215916|10196293|P1|Overall Study|Physician Decision|0
2962002|NCT01215916|10196285|P9|Overall Study|Death|1
2962003|NCT01215916|10196286|P8|Overall Study|Death|0
2962004|NCT01215916|10196287|P7|Overall Study|Death|0
2962005|NCT01215916|10196288|P6|Overall Study|Death|0
2962006|NCT01215916|10196289|P5|Overall Study|Death|1
2962007|NCT01215916|10196290|P4|Overall Study|Death|0
2962008|NCT01215916|10196291|P3|Overall Study|Death|0
2962009|NCT01215916|10196292|P2|Overall Study|Death|1
2962010|NCT01215916|10196293|P1|Overall Study|Death|0
2962011|NCT01215916|10196285|P9|Overall Study|Withdrawal by Subject|0
2962012|NCT01215916|10196286|P8|Overall Study|Withdrawal by Subject|0
2962013|NCT01215916|10196287|P7|Overall Study|Withdrawal by Subject|1
2962014|NCT01215916|10196288|P6|Overall Study|Withdrawal by Subject|0
2962015|NCT01215916|10196289|P5|Overall Study|Withdrawal by Subject|0
2962016|NCT01215916|10196290|P4|Overall Study|Withdrawal by Subject|2
2962017|NCT01215916|10196291|P3|Overall Study|Withdrawal by Subject|1
2962018|NCT01215916|10196292|P2|Overall Study|Withdrawal by Subject|1
2962019|NCT01215916|10196293|P1|Overall Study|Withdrawal by Subject|0
2962020|NCT01215916|10196285|P9|Overall Study|Adverse Event|0
2962021|NCT01215916|10196286|P8|Overall Study|Adverse Event|0
2962022|NCT01215916|10196287|P7|Overall Study|Adverse Event|3
2962023|NCT01215916|10196288|P6|Overall Study|Adverse Event|0
2962024|NCT01215916|10196289|P5|Overall Study|Adverse Event|0
2962025|NCT01215916|10196290|P4|Overall Study|Adverse Event|1
2962026|NCT01215916|10196291|P3|Overall Study|Adverse Event|0
2962027|NCT01215916|10196292|P2|Overall Study|Adverse Event|1
2962028|NCT01215916|10196293|P1|Overall Study|Adverse Event|1
2962029|NCT01215916|10196285|P9|Overall Study|Progressive Disease|1
2962030|NCT01215916|10196286|P8|Overall Study|Progressive Disease|3
2962031|NCT01215916|10196287|P7|Overall Study|Progressive Disease|5
2962032|NCT01215916|10196288|P6|Overall Study|Progressive Disease|4
2962033|NCT01215916|10196289|P5|Overall Study|Progressive Disease|5
2962034|NCT01215916|10196290|P4|Overall Study|Progressive Disease|2
2962035|NCT01215916|10196291|P3|Overall Study|Progressive Disease|1
2962036|NCT01215916|10196292|P2|Overall Study|Progressive Disease|2
2962037|NCT01215916|10196293|P1|Overall Study|Progressive Disease|0
2962038|NCT01215851|10196327|P6|Follow up Period|Lost to Follow-up|1
2962039|NCT01215851|10196328|P5|Follow up Period|Lost to Follow-up|0
2962040|NCT01215851|10196329|P4|Follow up Period|Lost to Follow-up|0
2962041|NCT01215851|10196330|P3|Follow up Period|Lost to Follow-up|0
2962042|NCT01215851|10196331|P2|Follow up Period|Lost to Follow-up|0
2962043|NCT01215851|10196332|P1|Follow up Period|Lost to Follow-up|0
2962044|NCT01215851|10196327|P6|Treatment Period|Adverse Event|1
2962045|NCT01215851|10196328|P5|Treatment Period|Adverse Event|0
2962046|NCT01215851|10196329|P4|Treatment Period|Adverse Event|3
2962047|NCT01215851|10196330|P3|Treatment Period|Adverse Event|1
2962048|NCT01215851|10196331|P2|Treatment Period|Adverse Event|1
2962049|NCT01215851|10196332|P1|Treatment Period|Adverse Event|1
2962050|NCT01215734|10196391|P2|Overall Study|Death|1
2962051|NCT01215734|10196392|P1|Overall Study|Death|0
2962052|NCT01215721|10196400|P1|Overall Study|Adverse Event|2
2962053|NCT01215513|10196532|P1|Overall Study|Miscellaneous reasons (CS42A)|2
2962054|NCT01215513|10196532|P1|Overall Study|Withdrawal by subject (CS42A)|5
2962055|NCT01215513|10196532|P1|Overall Study|Physician decision (CS42A)|6
2962056|NCT01215513|10196532|P1|Overall Study|Adverse event (CS42A)|2
2962057|NCT01215513|10196532|P1|Overall Study|Not enrolled from CS42 to CS42A|21
2962058|NCT01215513|10196532|P1|Overall Study|Not completed CS42|9
2962059|NCT01215435|10196541|P2|Overall Study|Unclassified|5
2962060|NCT01215435|10196542|P1|Overall Study|Unclassified|5
2962061|NCT01215435|10196541|P2|Overall Study|Lost to Follow-up|0
2962062|NCT01215435|10196542|P1|Overall Study|Lost to Follow-up|3
2962063|NCT01215435|10196541|P2|Overall Study|Withdrawal Criteria|11
2962064|NCT01215435|10196542|P1|Overall Study|Withdrawal Criteria|8
2962065|NCT01215435|10196541|P2|Overall Study|Protocol Violation|0
2962066|NCT01215435|10196542|P1|Overall Study|Protocol Violation|2
2962067|NCT01215435|10196541|P2|Overall Study|Adverse Event|0
2962068|NCT01215435|10196542|P1|Overall Study|Adverse Event|1
2962069|NCT01215422|10196556|P4|Overall Study|Did not complete all intubations|0
2962070|NCT01215422|10196557|P3|Overall Study|Did not complete all intubations|0
2962071|NCT01215422|10196558|P2|Overall Study|Did not complete all intubations|0
2962072|NCT01215422|10196559|P1|Overall Study|Did not complete all intubations|7
2962073|NCT01215422|10196556|P4|Overall Study|Failed intubations|8
2962074|NCT01215422|10196557|P3|Overall Study|Failed intubations|3
2962075|NCT01215422|10196558|P2|Overall Study|Failed intubations|0
2962076|NCT01215422|10196559|P1|Overall Study|Failed intubations|0
2962077|NCT01215422|10196556|P4|Overall Study|Relocation|0
2962078|NCT01215422|10196557|P3|Overall Study|Relocation|0
2962079|NCT01215422|10196558|P2|Overall Study|Relocation|0
2962080|NCT01215422|10196559|P1|Overall Study|Relocation|1
2962081|NCT01215357|10196581|P1|Overall Study|Protocol Violation|9
2962082|NCT01215357|10196581|P1|Overall Study|Withdrawal by Subject|3
2962083|NCT01215253|10196707|P2|Overall Study|Other|12
2962084|NCT01215253|10196708|P1|Overall Study|Other|14
2962085|NCT01215253|10196707|P2|Overall Study|Lost to Follow-up|4
2962086|NCT01215253|10196708|P1|Overall Study|Lost to Follow-up|6
2962087|NCT01215253|10196707|P2|Overall Study|Physician Decision|12
2962088|NCT01215253|10196708|P1|Overall Study|Physician Decision|9
2962089|NCT01215253|10196707|P2|Overall Study|Withdrawal by Subject|35
2962090|NCT01215253|10196708|P1|Overall Study|Withdrawal by Subject|57
2962091|NCT01215227|10196761|P6|Overall Study|Randomized but not treated|1
2962092|NCT01215227|10196762|P5|Overall Study|Randomized but not treated|0
2962093|NCT01215227|10196763|P4|Overall Study|Randomized but not treated|1
2962094|NCT01215227|10196764|P3|Overall Study|Randomized but not treated|1
2962095|NCT01215227|10196765|P2|Overall Study|Randomized but not treated|0
2962096|NCT01215227|10196766|P1|Overall Study|Randomized but not treated|0
2962097|NCT01215227|10196761|P6|Overall Study|Missing Status|0
2962098|NCT01215227|10196762|P5|Overall Study|Missing Status|0
2962099|NCT01215227|10196763|P4|Overall Study|Missing Status|0
2962100|NCT01215227|10196764|P3|Overall Study|Missing Status|0
2962101|NCT01215227|10196765|P2|Overall Study|Missing Status|1
2962102|NCT01215227|10196766|P1|Overall Study|Missing Status|0
2962103|NCT01215227|10196761|P6|Overall Study|Administrative|40
2962104|NCT01215227|10196762|P5|Overall Study|Administrative|28
2962105|NCT01215227|10196763|P4|Overall Study|Administrative|24
2962106|NCT01215227|10196764|P3|Overall Study|Administrative|42
2962107|NCT01215227|10196765|P2|Overall Study|Administrative|73
2962108|NCT01215227|10196766|P1|Overall Study|Administrative|83
2962109|NCT01215227|10196761|P6|Overall Study|Non-Compliance With Protocol|0
2962110|NCT01215227|10196762|P5|Overall Study|Non-Compliance With Protocol|0
2962111|NCT01215227|10196763|P4|Overall Study|Non-Compliance With Protocol|0
2962112|NCT01215227|10196764|P3|Overall Study|Non-Compliance With Protocol|1
2962113|NCT01215227|10196765|P2|Overall Study|Non-Compliance With Protocol|6
2962114|NCT01215227|10196766|P1|Overall Study|Non-Compliance With Protocol|2
2962115|NCT01215227|10196761|P6|Overall Study|Subject Withdrew Consent|8
2962116|NCT01215227|10196762|P5|Overall Study|Subject Withdrew Consent|11
2962117|NCT01215227|10196763|P4|Overall Study|Subject Withdrew Consent|10
2962118|NCT01215227|10196764|P3|Overall Study|Subject Withdrew Consent|7
2962119|NCT01215227|10196765|P2|Overall Study|Subject Withdrew Consent|20
2962120|NCT01215227|10196766|P1|Overall Study|Subject Withdrew Consent|16
2962121|NCT01215227|10196761|P6|Overall Study|Lost to Follow-up|2
2962122|NCT01215227|10196762|P5|Overall Study|Lost to Follow-up|1
2962123|NCT01215227|10196763|P4|Overall Study|Lost to Follow-up|1
2962124|NCT01215227|10196764|P3|Overall Study|Lost to Follow-up|1
2962125|NCT01215227|10196765|P2|Overall Study|Lost to Follow-up|4
2962126|NCT01215227|10196766|P1|Overall Study|Lost to Follow-up|1
2962127|NCT01215227|10196761|P6|Overall Study|Treatment Failure|1
2962128|NCT01215227|10196762|P5|Overall Study|Treatment Failure|1
2962129|NCT01215227|10196763|P4|Overall Study|Treatment Failure|5
2962130|NCT01215227|10196764|P3|Overall Study|Treatment Failure|1
2962131|NCT01215227|10196765|P2|Overall Study|Treatment Failure|4
2962132|NCT01215227|10196766|P1|Overall Study|Treatment Failure|8
2962133|NCT01215227|10196761|P6|Overall Study|Adverse Event|6
2962134|NCT01215227|10196762|P5|Overall Study|Adverse Event|7
2962135|NCT01215227|10196763|P4|Overall Study|Adverse Event|8
2962136|NCT01215227|10196764|P3|Overall Study|Adverse Event|4
2962137|NCT01215227|10196765|P2|Overall Study|Adverse Event|11
2962138|NCT01215227|10196766|P1|Overall Study|Adverse Event|11
2962139|NCT01215188|10196813|P3|Overall Study|Withdrawal by Subject|31
2962140|NCT01215188|10196814|P2|Overall Study|Withdrawal by Subject|34
2962141|NCT01215188|10196815|P1|Overall Study|Withdrawal by Subject|32
2962142|NCT01215188|10196813|P3|Overall Study|Protocol Violation|1
2962143|NCT01215188|10196814|P2|Overall Study|Protocol Violation|1
2962144|NCT01215188|10196815|P1|Overall Study|Protocol Violation|1
2962145|NCT01215188|10196813|P3|Overall Study|Lack of Efficacy|1
2962146|NCT01215188|10196814|P2|Overall Study|Lack of Efficacy|0
2962147|NCT01215188|10196815|P1|Overall Study|Lack of Efficacy|0
2962148|NCT01215188|10196813|P3|Overall Study|Physician Decision|0
2962149|NCT01215188|10196814|P2|Overall Study|Physician Decision|1
2962150|NCT01215188|10196815|P1|Overall Study|Physician Decision|2
2962151|NCT01215188|10196813|P3|Overall Study|Adverse Event|3
2962152|NCT01215188|10196814|P2|Overall Study|Adverse Event|1
2962153|NCT01215188|10196815|P1|Overall Study|Adverse Event|1
2962154|NCT01215188|10196813|P3|Overall Study|Lost to Follow-up|16
2962155|NCT01215188|10196814|P2|Overall Study|Lost to Follow-up|22
2962156|NCT01215188|10196815|P1|Overall Study|Lost to Follow-up|22
2962157|NCT01215175|10196867|P5|Overall Study|Lost to Follow-up|0
2962158|NCT01215175|10196868|P4|Overall Study|Lost to Follow-up|1
2962159|NCT01215175|10196869|P3|Overall Study|Lost to Follow-up|0
2962160|NCT01215175|10196870|P2|Overall Study|Lost to Follow-up|1
2962161|NCT01215175|10196871|P1|Overall Study|Lost to Follow-up|0
2962162|NCT01215097|10196988|P2|Overall Study|patient's private reason|1
2962163|NCT01215097|10196989|P1|Overall Study|patient's private reason|1
2962164|NCT01215097|10196988|P2|Overall Study|patient's refusal to come|2
2962165|NCT01215097|10196989|P1|Overall Study|patient's refusal to come|2
2962166|NCT01215097|10196988|P2|Overall Study|Lack of Efficacy|3
2962167|NCT01215097|10196989|P1|Overall Study|Lack of Efficacy|0
2962168|NCT01215097|10196988|P2|Overall Study|Withdrawal by Subject|3
2962169|NCT01215097|10196989|P1|Overall Study|Withdrawal by Subject|6
2962170|NCT01215097|10196988|P2|Overall Study|Lost to Follow-up|0
2962171|NCT01215097|10196989|P1|Overall Study|Lost to Follow-up|2
2962172|NCT01215097|10196988|P2|Overall Study|Protocol Violation|2
2962173|NCT01215097|10196989|P1|Overall Study|Protocol Violation|0
2962174|NCT01215097|10196988|P2|Overall Study|Adverse Event|3
2962175|NCT01215097|10196989|P1|Overall Study|Adverse Event|1
2962176|NCT01215032|10197021|P1|Overall Study|Lack of Efficacy|17
2962177|NCT01215032|10197021|P1|Overall Study|Adverse Event|3
2962178|NCT01214915|10197046|P1|Overall Study|Lack of Efficacy|3
2962179|NCT01214915|10197046|P1|Overall Study|Adverse Event|8
2962180|NCT01214850|10197057|P3|Overall Study|Unable to classify|1
2962181|NCT01214850|10197058|P2|Overall Study|Unable to classify|1
2962182|NCT01214850|10197059|P1|Overall Study|Unable to classify|2
2962183|NCT01214850|10197057|P3|Overall Study|Administrative reason|0
2962184|NCT01214850|10197058|P2|Overall Study|Administrative reason|0
2962185|NCT01214850|10197059|P1|Overall Study|Administrative reason|1
2962186|NCT01214850|10197057|P3|Overall Study|Inappropriate enrollment|0
2962187|NCT01214850|10197058|P2|Overall Study|Inappropriate enrollment|1
2962188|NCT01214850|10197059|P1|Overall Study|Inappropriate enrollment|2
2962189|NCT01214850|10197057|P3|Overall Study|Adverse event or death|3
2962190|NCT01214850|10197058|P2|Overall Study|Adverse event or death|8
2962191|NCT01214850|10197059|P1|Overall Study|Adverse event or death|11
2962192|NCT01214850|10197057|P3|Overall Study|Protocol Violation|6
2962193|NCT01214850|10197058|P2|Overall Study|Protocol Violation|5
2962194|NCT01214850|10197059|P1|Overall Study|Protocol Violation|5
2962195|NCT01214850|10197057|P3|Overall Study|Lost to Follow-up|123
2962196|NCT01214850|10197058|P2|Overall Study|Lost to Follow-up|98
2962197|NCT01214850|10197059|P1|Overall Study|Lost to Follow-up|124
2962198|NCT01214850|10197057|P3|Overall Study|Withdrawal by Subject|28
2962199|NCT01214850|10197058|P2|Overall Study|Withdrawal by Subject|31
2962200|NCT01214850|10197059|P1|Overall Study|Withdrawal by Subject|38
2962201|NCT01214837|10197143|P3|Overall Study|Unable to Classify|0
2962202|NCT01214837|10197144|P2|Overall Study|Unable to Classify|3
2962203|NCT01214837|10197145|P1|Overall Study|Unable to Classify|1
2962204|NCT01214837|10197143|P3|Overall Study|Protocol Violation|5
2962205|NCT01214837|10197144|P2|Overall Study|Protocol Violation|1
2962206|NCT01214837|10197145|P1|Overall Study|Protocol Violation|3
2962207|NCT01214837|10197143|P3|Overall Study|Administrative Reason|4
2962208|NCT01214837|10197144|P2|Overall Study|Administrative Reason|6
2962209|NCT01214837|10197145|P1|Overall Study|Administrative Reason|2
2962210|NCT01214837|10197143|P3|Overall Study|Inappropriate Enrolment|2
2962211|NCT01214837|10197144|P2|Overall Study|Inappropriate Enrolment|1
2962212|NCT01214837|10197145|P1|Overall Study|Inappropriate Enrolment|0
2962213|NCT01214837|10197143|P3|Overall Study|Lost to Follow-up|21
2962214|NCT01214837|10197144|P2|Overall Study|Lost to Follow-up|15
2962215|NCT01214837|10197145|P1|Overall Study|Lost to Follow-up|20
2962216|NCT01214837|10197143|P3|Overall Study|Withdrawal by Subject|28
2962217|NCT01214837|10197144|P2|Overall Study|Withdrawal by Subject|36
2962218|NCT01214837|10197145|P1|Overall Study|Withdrawal by Subject|27
2962219|NCT01214837|10197143|P3|Overall Study|Adverse Event|1
2962220|NCT01214837|10197144|P2|Overall Study|Adverse Event|2
2962221|NCT01214837|10197145|P1|Overall Study|Adverse Event|1
2962222|NCT01214837|10197143|P3|Overall Study|Death|1
2962223|NCT01214837|10197144|P2|Overall Study|Death|0
2962224|NCT01214837|10197145|P1|Overall Study|Death|0
2962225|NCT01214720|10197201|P2|Overall Study|Lost to Follow-up|2
2962226|NCT01214720|10197202|P1|Overall Study|Lost to Follow-up|6
2962227|NCT01214720|10197201|P2|Overall Study|Alive and in follow-up|48
2962228|NCT01214720|10197202|P1|Overall Study|Alive and in follow-up|45
2962229|NCT01214720|10197201|P2|Overall Study|Alive and still on treatment|18
2962230|NCT01214720|10197202|P1|Overall Study|Alive and still on treatment|34
2962231|NCT01214668|10197225|P6|Overall Study|Withdrawal by Subject|0
2962232|NCT01214668|10197226|P5|Overall Study|Withdrawal by Subject|1
2962233|NCT01214668|10197227|P4|Overall Study|Withdrawal by Subject|0
2962234|NCT01214668|10197228|P3|Overall Study|Withdrawal by Subject|0
2962235|NCT01214668|10197229|P2|Overall Study|Withdrawal by Subject|0
2962236|NCT01214668|10197230|P1|Overall Study|Withdrawal by Subject|0
2962237|NCT01214668|10197225|P6|Overall Study|Progressive Disease|5
2962238|NCT01214668|10197226|P5|Overall Study|Progressive Disease|4
2962239|NCT01214668|10197227|P4|Overall Study|Progressive Disease|4
2962240|NCT01214668|10197228|P3|Overall Study|Progressive Disease|5
2962241|NCT01214668|10197229|P2|Overall Study|Progressive Disease|2
2962242|NCT01214668|10197230|P1|Overall Study|Progressive Disease|4
2962243|NCT01214668|10197225|P6|Overall Study|Death|0
2962244|NCT01214668|10197226|P5|Overall Study|Death|0
2962245|NCT01214668|10197227|P4|Overall Study|Death|0
2962246|NCT01214668|10197228|P3|Overall Study|Death|1
2962247|NCT01214668|10197229|P2|Overall Study|Death|0
2962248|NCT01214668|10197230|P1|Overall Study|Death|0
2962249|NCT01214668|10197225|P6|Overall Study|Adverse Event|1
2962250|NCT01214668|10197226|P5|Overall Study|Adverse Event|1
2962251|NCT01214668|10197227|P4|Overall Study|Adverse Event|2
2962252|NCT01214668|10197228|P3|Overall Study|Adverse Event|0
2962253|NCT01214668|10197229|P2|Overall Study|Adverse Event|1
2962254|NCT01214668|10197230|P1|Overall Study|Adverse Event|0
2962255|NCT01214655|10197267|P3|Part C|Physician Decision|1
2962256|NCT01214655|10197268|P2|Part C|Physician Decision|0
2962257|NCT01214655|10197269|P1|Part C|Physician Decision|0
2962258|NCT01214655|10197267|P3|Part C|Death|1
2962259|NCT01214655|10197268|P2|Part C|Death|0
2962261|NCT01214655|10197267|P3|Part C|Progressive Disease|5
2962262|NCT01214655|10197268|P2|Part C|Progressive Disease|0
2962263|NCT01214655|10197269|P1|Part C|Progressive Disease|0
2962264|NCT01214655|10197267|P3|Part B|Withdrawal by Subject|0
2962265|NCT01214655|10197268|P2|Part B|Withdrawal by Subject|2
2962266|NCT01214655|10197269|P1|Part B|Withdrawal by Subject|0
2962267|NCT01214655|10197267|P3|Part B|Death|0
2962268|NCT01214655|10197268|P2|Part B|Death|1
2962269|NCT01214655|10197269|P1|Part B|Death|0
2962270|NCT01214655|10197267|P3|Part B|Progressive disease|0
2962271|NCT01214655|10197268|P2|Part B|Progressive disease|10
2962272|NCT01214655|10197269|P1|Part B|Progressive disease|0
2962273|NCT01214655|10197267|P3|Part A|Physician Decision|0
2962274|NCT01214655|10197268|P2|Part A|Physician Decision|0
2962275|NCT01214655|10197269|P1|Part A|Physician Decision|1
2962276|NCT01214655|10197267|P3|Part A|Progressive Disease|0
2962277|NCT01214655|10197268|P2|Part A|Progressive Disease|0
2962278|NCT01214655|10197269|P1|Part A|Progressive Disease|7
2962279|NCT01214642|10197342|P12|Overall Study|Physician Decision|2
2962280|NCT01214642|10197343|P11|Overall Study|Physician Decision|0
2962281|NCT01214642|10197344|P10|Overall Study|Physician Decision|0
2962282|NCT01214642|10197345|P9|Overall Study|Physician Decision|0
2962283|NCT01214642|10197346|P8|Overall Study|Physician Decision|0
2962284|NCT01214642|10197347|P7|Overall Study|Physician Decision|0
2962285|NCT01214642|10197348|P6|Overall Study|Physician Decision|0
2962286|NCT01214642|10197349|P5|Overall Study|Physician Decision|1
2962287|NCT01214642|10197350|P4|Overall Study|Physician Decision|1
2962288|NCT01214642|10197351|P3|Overall Study|Physician Decision|1
2962289|NCT01214642|10197352|P2|Overall Study|Physician Decision|0
2962290|NCT01214642|10197353|P1|Overall Study|Physician Decision|0
2962291|NCT01214642|10197342|P12|Overall Study|Withdrawal by Subject|0
2962292|NCT01214642|10197343|P11|Overall Study|Withdrawal by Subject|1
2962293|NCT01214642|10197344|P10|Overall Study|Withdrawal by Subject|1
2962294|NCT01214642|10197345|P9|Overall Study|Withdrawal by Subject|3
2962295|NCT01214642|10197346|P8|Overall Study|Withdrawal by Subject|0
2962296|NCT01214642|10197347|P7|Overall Study|Withdrawal by Subject|0
2962297|NCT01214642|10197348|P6|Overall Study|Withdrawal by Subject|0
2962298|NCT01214642|10197349|P5|Overall Study|Withdrawal by Subject|0
2962299|NCT01214642|10197350|P4|Overall Study|Withdrawal by Subject|0
2962300|NCT01214642|10197351|P3|Overall Study|Withdrawal by Subject|1
2962301|NCT01214642|10197352|P2|Overall Study|Withdrawal by Subject|0
2962302|NCT01214642|10197353|P1|Overall Study|Withdrawal by Subject|0
2962303|NCT01214642|10197342|P12|Overall Study|Death|0
2962304|NCT01214642|10197343|P11|Overall Study|Death|1
2962305|NCT01214642|10197344|P10|Overall Study|Death|0
2962306|NCT01214642|10197345|P9|Overall Study|Death|0
2962307|NCT01214642|10197346|P8|Overall Study|Death|0
2962308|NCT01214642|10197347|P7|Overall Study|Death|0
2962309|NCT01214642|10197348|P6|Overall Study|Death|0
2962310|NCT01214642|10197349|P5|Overall Study|Death|0
2962311|NCT01214642|10197350|P4|Overall Study|Death|0
2962312|NCT01214642|10197351|P3|Overall Study|Death|1
2962313|NCT01214642|10197352|P2|Overall Study|Death|0
2962314|NCT01214642|10197353|P1|Overall Study|Death|0
2962315|NCT01214642|10197342|P12|Overall Study|Adverse Event|0
2962316|NCT01214642|10197343|P11|Overall Study|Adverse Event|1
2962317|NCT01214642|10197344|P10|Overall Study|Adverse Event|1
2962318|NCT01214642|10197345|P9|Overall Study|Adverse Event|0
2962319|NCT01214642|10197346|P8|Overall Study|Adverse Event|0
2962320|NCT01214642|10197347|P7|Overall Study|Adverse Event|1
2962321|NCT01214642|10197348|P6|Overall Study|Adverse Event|0
2962322|NCT01214642|10197349|P5|Overall Study|Adverse Event|0
2962323|NCT01214642|10197350|P4|Overall Study|Adverse Event|0
2962324|NCT01214642|10197351|P3|Overall Study|Adverse Event|0
2962325|NCT01214642|10197352|P2|Overall Study|Adverse Event|1
2962326|NCT01214642|10197353|P1|Overall Study|Adverse Event|0
2962327|NCT01214642|10197342|P12|Overall Study|Progressive Disease|4
2962328|NCT01214642|10197343|P11|Overall Study|Progressive Disease|1
2962329|NCT01214642|10197344|P10|Overall Study|Progressive Disease|2
2962330|NCT01214642|10197345|P9|Overall Study|Progressive Disease|10
2962331|NCT01214642|10197346|P8|Overall Study|Progressive Disease|3
2962332|NCT01214642|10197347|P7|Overall Study|Progressive Disease|5
2962333|NCT01214642|10197348|P6|Overall Study|Progressive Disease|3
2962334|NCT01214642|10197349|P5|Overall Study|Progressive Disease|5
2962335|NCT01214642|10197350|P4|Overall Study|Progressive Disease|5
2962336|NCT01214642|10197351|P3|Overall Study|Progressive Disease|3
2962337|NCT01214642|10197352|P2|Overall Study|Progressive Disease|2
2962338|NCT01214642|10197353|P1|Overall Study|Progressive Disease|3
2962339|NCT01214629|10197433|P11|Overall Study|Withdrawal by Subject|0
2962340|NCT01214629|10197434|P10|Overall Study|Withdrawal by Subject|1
2962341|NCT01214629|10197435|P9|Overall Study|Withdrawal by Subject|0
2962342|NCT01214629|10197436|P8|Overall Study|Withdrawal by Subject|0
2962343|NCT01214629|10197437|P7|Overall Study|Withdrawal by Subject|0
2962344|NCT01214629|10197438|P6|Overall Study|Withdrawal by Subject|0
2962345|NCT01214629|10197439|P5|Overall Study|Withdrawal by Subject|0
2962346|NCT01214629|10197440|P4|Overall Study|Withdrawal by Subject|0
2962347|NCT01214629|10197441|P3|Overall Study|Withdrawal by Subject|0
2962348|NCT01214629|10197442|P2|Overall Study|Withdrawal by Subject|0
2962349|NCT01214629|10197443|P1|Overall Study|Withdrawal by Subject|0
2962350|NCT01214629|10197433|P11|Overall Study|Physician Decision|1
2962351|NCT01214629|10197434|P10|Overall Study|Physician Decision|0
2962352|NCT01214629|10197435|P9|Overall Study|Physician Decision|0
2962353|NCT01214629|10197436|P8|Overall Study|Physician Decision|0
2962354|NCT01214629|10197437|P7|Overall Study|Physician Decision|0
2962355|NCT01214629|10197438|P6|Overall Study|Physician Decision|0
2962356|NCT01214629|10197439|P5|Overall Study|Physician Decision|0
2962357|NCT01214629|10197440|P4|Overall Study|Physician Decision|0
2962358|NCT01214629|10197441|P3|Overall Study|Physician Decision|0
2962359|NCT01214629|10197442|P2|Overall Study|Physician Decision|0
2962360|NCT01214629|10197443|P1|Overall Study|Physician Decision|0
2962361|NCT01214629|10197433|P11|Overall Study|Adverse Event|0
2962362|NCT01214629|10197434|P10|Overall Study|Adverse Event|1
2962363|NCT01214629|10197435|P9|Overall Study|Adverse Event|0
2962364|NCT01214629|10197436|P8|Overall Study|Adverse Event|0
2962365|NCT01214629|10197437|P7|Overall Study|Adverse Event|0
2962366|NCT01214629|10197438|P6|Overall Study|Adverse Event|1
2962367|NCT01214629|10197439|P5|Overall Study|Adverse Event|0
2962368|NCT01214629|10197440|P4|Overall Study|Adverse Event|1
2962369|NCT01214629|10197441|P3|Overall Study|Adverse Event|0
2962370|NCT01214629|10197442|P2|Overall Study|Adverse Event|0
2962371|NCT01214629|10197443|P1|Overall Study|Adverse Event|0
2962372|NCT01214629|10197433|P11|Overall Study|Progressive Disease|1
2962373|NCT01214629|10197434|P10|Overall Study|Progressive Disease|5
2962374|NCT01214629|10197435|P9|Overall Study|Progressive Disease|1
2962375|NCT01214629|10197436|P8|Overall Study|Progressive Disease|1
2962376|NCT01214629|10197437|P7|Overall Study|Progressive Disease|1
2962377|NCT01214629|10197438|P6|Overall Study|Progressive Disease|3
2962378|NCT01214629|10197439|P5|Overall Study|Progressive Disease|2
2962379|NCT01214629|10197440|P4|Overall Study|Progressive Disease|1
2962380|NCT01214629|10197441|P3|Overall Study|Progressive Disease|0
2962381|NCT01214629|10197442|P2|Overall Study|Progressive Disease|1
2962382|NCT01214629|10197443|P1|Overall Study|Progressive Disease|1
2962383|NCT01214616|10197508|P4|Overall Study|Withdrawal by Subject|1
2962384|NCT01214616|10197509|P3|Overall Study|Withdrawal by Subject|0
2962385|NCT01214616|10197510|P2|Overall Study|Withdrawal by Subject|0
2962386|NCT01214616|10197511|P1|Overall Study|Withdrawal by Subject|1
2962387|NCT01214616|10197508|P4|Overall Study|Other adverse events|1
2962388|NCT01214616|10197509|P3|Overall Study|Other adverse events|1
2962389|NCT01214616|10197510|P2|Overall Study|Other adverse events|1
2962390|NCT01214616|10197511|P1|Overall Study|Other adverse events|0
2962391|NCT01214616|10197508|P4|Overall Study|Dose limiting toxicity|0
2962392|NCT01214616|10197509|P3|Overall Study|Dose limiting toxicity|0
2962393|NCT01214616|10197510|P2|Overall Study|Dose limiting toxicity|2
2962394|NCT01214616|10197511|P1|Overall Study|Dose limiting toxicity|0
2962395|NCT01214616|10197508|P4|Overall Study|Progressive disease|4
2962396|NCT01214616|10197509|P3|Overall Study|Progressive disease|2
2962397|NCT01214616|10197510|P2|Overall Study|Progressive disease|2
2962398|NCT01214616|10197511|P1|Overall Study|Progressive disease|2
2962399|NCT01214603|10197548|P3|Overall Study|Progressive Disease|3
2962400|NCT01214603|10197549|P2|Overall Study|Progressive Disease|1
2962401|NCT01214603|10197550|P1|Overall Study|Progressive Disease|4
2962402|NCT01214603|10197548|P3|Overall Study|Death|0
2962403|NCT01214603|10197549|P2|Overall Study|Death|0
2962404|NCT01214603|10197550|P1|Overall Study|Death|1
2962405|NCT01214603|10197548|P3|Overall Study|Adverse Event|1
2962406|NCT01214603|10197549|P2|Overall Study|Adverse Event|0
2962407|NCT01214603|10197550|P1|Overall Study|Adverse Event|0
2962408|NCT01214434|10197573|P2|Overall Study|Site error|0
2962409|NCT01214434|10197574|P1|Overall Study|Site error|1
2962410|NCT01214434|10197573|P2|Overall Study|Lost to Follow-up|2
2962411|NCT01214434|10197574|P1|Overall Study|Lost to Follow-up|2
2962412|NCT01214434|10197573|P2|Overall Study|Withdrawal by Subject|0
2962413|NCT01214434|10197574|P1|Overall Study|Withdrawal by Subject|1
2962414|NCT01214395|10197590|P1|Overall Study|All patients had infection|5
2962415|NCT01214252|10197608|P1|Overall Study|Not eligible per protocol|82
2962416|NCT01214239|10197616|P2|Overall Study|patient's private reason|1
2962417|NCT01214239|10197617|P1|Overall Study|patient's private reason|1
2962418|NCT01214239|10197616|P2|Overall Study|Lack of Efficacy|2
2962419|NCT01214239|10197617|P1|Overall Study|Lack of Efficacy|1
2962420|NCT01214239|10197616|P2|Overall Study|Withdrawal by Subject|9
2962421|NCT01214239|10197617|P1|Overall Study|Withdrawal by Subject|4
2962422|NCT01214239|10197616|P2|Overall Study|Lost to Follow-up|1
2962423|NCT01214239|10197617|P1|Overall Study|Lost to Follow-up|1
2962424|NCT01214239|10197616|P2|Overall Study|Protocol Violation|1
2962425|NCT01214239|10197617|P1|Overall Study|Protocol Violation|2
2962426|NCT01214239|10197616|P2|Overall Study|Adverse Event|4
2962427|NCT01214239|10197617|P1|Overall Study|Adverse Event|3
2962428|NCT01214200|10197649|P1|Overall Study|Withdrawal by Subject|2
2962429|NCT01214200|10197649|P1|Overall Study|Did not meet inclusion/exclusion|9
2962430|NCT01214187|10197663|P2|Overall Study|Withdrawal by Subject|3
2962431|NCT01214187|10197664|P1|Overall Study|Withdrawal by Subject|0
2962432|NCT01214187|10197663|P2|Overall Study|Death|1
2962433|NCT01214187|10197664|P1|Overall Study|Death|1
2962434|NCT01214187|10197663|P2|Overall Study|Adverse Event|2
2962435|NCT01214187|10197664|P1|Overall Study|Adverse Event|6
2962436|NCT01214174|10197681|P3|Overall Study|Withdrawal by Subject|1
2962437|NCT01214174|10197682|P2|Overall Study|Withdrawal by Subject|0
2962438|NCT01214174|10197683|P1|Overall Study|Withdrawal by Subject|0
2962439|NCT01214044|10197833|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
2962440|NCT01214044|10197833|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
2962441|NCT01214044|10197833|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
2962442|NCT01214044|10197833|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
2962443|NCT01214044|10197833|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
2962444|NCT01214044|10197833|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
2962445|NCT01213966|10197847|P4|Overall Study|Protocol Violation|1
2962446|NCT01213966|10197848|P3|Overall Study|Protocol Violation|3
2962447|NCT01213966|10197849|P2|Overall Study|Protocol Violation|0
2962448|NCT01213966|10197850|P1|Overall Study|Protocol Violation|1
2962449|NCT01213836|10197862|P2|Period 1, First Intervention|Withdrawal by Subject|1
2962450|NCT01213836|10197863|P1|Period 1, First Intervention|Withdrawal by Subject|1
2962451|NCT01213836|10197862|P2|Period 1, First Intervention|Protocol Violation|1
2962452|NCT01213836|10197863|P1|Period 1, First Intervention|Protocol Violation|0
2962453|NCT01213836|10197862|P2|Period 1, First Intervention|Adverse Event|1
2962454|NCT01213836|10197863|P1|Period 1, First Intervention|Adverse Event|2
2962455|NCT01213472|10197948|P1|Overall Study|Physician Decision|1
2962456|NCT01213472|10197948|P1|Overall Study|Withdrawal by Subject|1
2962457|NCT01213472|10197948|P1|Overall Study|Recurrence/Progressive disease|25
2962458|NCT01213264|10197997|P3|Overall Study|Lost to Follow-up|6
2962459|NCT01213264|10197998|P2|Overall Study|Lost to Follow-up|2
2962460|NCT01213264|10197999|P1|Overall Study|Lost to Follow-up|1
2962461|NCT01213264|10197997|P3|Overall Study|Adverse Event|0
2962462|NCT01213264|10197998|P2|Overall Study|Adverse Event|0
2962463|NCT01213264|10197999|P1|Overall Study|Adverse Event|1
2962464|NCT01213251|10198019|P3|Overall Study|Missed 18-Month Follow-up|1
2962465|NCT01213251|10198020|P2|Overall Study|Missed 18-Month Follow-up|0
2962466|NCT01213251|10198021|P1|Overall Study|Missed 18-Month Follow-up|0
2962467|NCT01213251|10198019|P3|Overall Study|Protocol Violation|0
2962468|NCT01213251|10198020|P2|Overall Study|Protocol Violation|1
2962469|NCT01213251|10198021|P1|Overall Study|Protocol Violation|1
2962470|NCT01213251|10198019|P3|Overall Study|Exit|8
2962471|NCT01213251|10198020|P2|Overall Study|Exit|2
2962472|NCT01213251|10198021|P1|Overall Study|Exit|3
2962473|NCT01213251|10198019|P3|Overall Study|Death|2
2962474|NCT01213251|10198020|P2|Overall Study|Death|1
2962475|NCT01213251|10198021|P1|Overall Study|Death|2
2962476|NCT01213173|10198048|P2|Overall Study|Incorrect Enrollment|3
2962477|NCT01213173|10198049|P1|Overall Study|Incorrect Enrollment|1
2962478|NCT01213173|10198048|P2|Overall Study|Withdrawal by Subject|5
2962479|NCT01213173|10198049|P1|Overall Study|Withdrawal by Subject|5
2962480|NCT01213173|10198048|P2|Overall Study|Adverse Event|8
2962481|NCT01213173|10198049|P1|Overall Study|Adverse Event|4
2962482|NCT01213173|10198048|P2|Overall Study|Protocol Violation|0
2962483|NCT01213173|10198049|P1|Overall Study|Protocol Violation|2
2962484|NCT01213082|10198082|P3|Overall Study|Physician Decision|1
2962485|NCT01213082|10198083|P2|Overall Study|Physician Decision|0
2962486|NCT01213082|10198084|P1|Overall Study|Physician Decision|0
2962487|NCT01213082|10198082|P3|Overall Study|Lost to Follow-up|4
2962488|NCT01213082|10198083|P2|Overall Study|Lost to Follow-up|7
2962489|NCT01213082|10198084|P1|Overall Study|Lost to Follow-up|6
2962490|NCT01212991|10198126|P3|Open-label|Other|3
2962491|NCT01212991|10198127|P2|Open-label|Other|0
2962492|NCT01212991|10198128|P1|Open-label|Other|0
2962493|NCT01212991|10198126|P3|Open-label|Sponsor decision|53
2962494|NCT01212991|10198127|P2|Open-label|Sponsor decision|0
2962495|NCT01212991|10198128|P1|Open-label|Sponsor decision|0
2962496|NCT01212991|10198126|P3|Open-label|Withdrawal by Subject|7
2962497|NCT01212991|10198127|P2|Open-label|Withdrawal by Subject|0
2962498|NCT01212991|10198128|P1|Open-label|Withdrawal by Subject|0
2962499|NCT01212991|10198126|P3|Open-label|Lost to Follow-up|5
2962500|NCT01212991|10198127|P2|Open-label|Lost to Follow-up|0
2962501|NCT01212991|10198128|P1|Open-label|Lost to Follow-up|0
2962502|NCT01212991|10198126|P3|Open-label|Death|166
2962503|NCT01212991|10198127|P2|Open-label|Death|0
2962504|NCT01212991|10198128|P1|Open-label|Death|0
2962505|NCT01212991|10198126|P3|Double-blind|Sponsor decision|0
2962506|NCT01212991|10198127|P2|Double-blind|Sponsor decision|38
2962507|NCT01212991|10198128|P1|Double-blind|Sponsor decision|142
2962508|NCT01212991|10198126|P3|Double-blind|Other|0
2962509|NCT01212991|10198127|P2|Double-blind|Other|0
2962510|NCT01212991|10198128|P1|Double-blind|Other|7
2962511|NCT01212991|10198126|P3|Double-blind|Withdrawal by Subject|0
2962512|NCT01212991|10198127|P2|Double-blind|Withdrawal by Subject|19
2962513|NCT01212991|10198128|P1|Double-blind|Withdrawal by Subject|16
2962514|NCT01212991|10198126|P3|Double-blind|Death|0
2962515|NCT01212991|10198127|P2|Double-blind|Death|550
2962516|NCT01212991|10198128|P1|Double-blind|Death|699
2962517|NCT01212991|10198126|P3|Double-blind|Lost to Follow-up|0
2962518|NCT01212991|10198127|P2|Double-blind|Lost to Follow-up|4
2962519|NCT01212991|10198128|P1|Double-blind|Lost to Follow-up|8
2962520|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Death|0
2962521|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Death|1
2962522|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Death|0
2962523|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Death|0
2962524|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Death|0
2962525|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Death|0
2962526|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Death|0
2962527|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Death|0
2962528|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Death|0
2962529|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962530|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2962531|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962532|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962533|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962534|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962535|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2962536|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2962537|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2962538|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962539|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962540|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962541|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962542|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962543|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962544|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
2962545|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962546|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2962547|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
2962548|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
2962549|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
2962550|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
2962551|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
2962552|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
2962553|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
2962554|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
2962555|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
2962556|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962557|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962558|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962559|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962560|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962561|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962562|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
2962563|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962564|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
2962565|NCT01212770|10198200|P9|Long-term Safety Phase (Year 5)|Missing|0
2962566|NCT01212770|10198201|P8|Long-term Safety Phase (Year 5)|Missing|0
2962567|NCT01212770|10198202|P7|Long-term Safety Phase (Year 5)|Missing|0
2962568|NCT01212770|10198203|P6|Long-term Safety Phase (Year 5)|Missing|0
2962569|NCT01212770|10198204|P5|Long-term Safety Phase (Year 5)|Missing|0
2962570|NCT01212770|10198205|P4|Long-term Safety Phase (Year 5)|Missing|0
2962571|NCT01212770|10198206|P3|Long-term Safety Phase (Year 5)|Missing|1
2962572|NCT01212770|10198207|P2|Long-term Safety Phase (Year 5)|Missing|0
2962573|NCT01212770|10198208|P1|Long-term Safety Phase (Year 5)|Missing|0
2962574|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
2962575|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962576|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962577|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962578|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962579|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962580|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962581|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
2962582|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
2962583|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962584|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962585|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962586|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962587|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962588|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962589|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2962590|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962591|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2962592|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962593|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962594|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962595|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962596|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962597|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962598|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
2962599|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
2962600|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2962601|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962602|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2962603|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962604|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962605|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962606|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962607|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2962608|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2962609|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2962610|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962611|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
2962612|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962613|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962614|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962615|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962616|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
2962617|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2962618|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2962619|NCT01212770|10198200|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
2962620|NCT01212770|10198201|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
2962621|NCT01212770|10198202|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
2962622|NCT01212770|10198203|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
2962623|NCT01212770|10198204|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
2962624|NCT01212770|10198205|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
2962625|NCT01212770|10198206|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
2962626|NCT01212770|10198207|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
2962627|NCT01212770|10198208|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
2962628|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
2962629|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
2962630|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
2962631|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
2962632|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
2962633|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
2962634|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
2962635|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
2962636|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
2962637|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962638|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
2962639|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962640|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962641|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962642|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962643|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962644|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962645|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
2962646|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962647|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962648|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962649|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962650|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962651|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962652|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962653|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2962654|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2962655|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2962656|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2962657|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2962658|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2962659|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2962660|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2962661|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2962662|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
2962663|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2962664|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2962665|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2962666|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2962667|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2962668|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2962669|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2962670|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2962671|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
2962672|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2962673|NCT01212770|10198200|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
2962674|NCT01212770|10198201|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
2962675|NCT01212770|10198202|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
2962676|NCT01212770|10198203|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
2962677|NCT01212770|10198204|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
2962678|NCT01212770|10198205|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
2962679|NCT01212770|10198206|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
2962680|NCT01212770|10198207|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
2962681|NCT01212770|10198208|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
2962682|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
2962683|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962684|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962685|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962686|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962687|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962688|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
2962689|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
2962690|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
2962691|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2962692|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2962693|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2962694|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2962695|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2962696|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2962697|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2962698|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
2962699|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2962700|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2962701|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2962702|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2962703|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2962704|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2962705|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2962706|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2962707|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
2962708|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2962709|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962710|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962711|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962712|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962713|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962714|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962715|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962716|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
2962717|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2962718|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2962719|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2962720|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2962721|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2962722|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2962723|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2962724|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2962725|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2962726|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2962727|NCT01212770|10198200|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
2962728|NCT01212770|10198201|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
2962729|NCT01212770|10198202|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
2962730|NCT01212770|10198203|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
2962731|NCT01212770|10198204|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
2962732|NCT01212770|10198205|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
2962733|NCT01212770|10198206|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
2962734|NCT01212770|10198207|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
2962735|NCT01212770|10198208|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
2962736|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962737|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962738|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962739|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962740|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962741|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2962742|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2962743|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962744|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2962745|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962746|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962747|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962748|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962749|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962750|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
2962751|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962752|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962753|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2962754|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962755|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962756|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962757|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962758|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962759|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962760|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
2962761|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962762|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2962763|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2962764|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2962765|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2962766|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2962767|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2962768|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2962769|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2962770|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
2962771|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2962772|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2962773|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2962774|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2962775|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
2962776|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
2962777|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
2962778|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
2962779|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
2962780|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2962781|NCT01212770|10198200|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2962782|NCT01212770|10198201|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2962783|NCT01212770|10198202|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
2962784|NCT01212770|10198203|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2962785|NCT01212770|10198204|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2962786|NCT01212770|10198205|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2962787|NCT01212770|10198206|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2962788|NCT01212770|10198207|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
2962789|NCT01212770|10198208|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2962790|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962791|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962792|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962793|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962794|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962795|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2962796|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
2962797|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
2962798|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
2962799|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962800|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962801|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962802|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962803|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962804|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962805|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2962806|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962807|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2962808|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962809|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962810|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962811|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962812|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962813|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962814|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
2962815|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2962816|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2962817|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962818|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962819|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962820|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962821|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962822|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2962823|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2962824|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2962825|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2962826|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962827|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962828|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962829|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962830|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962831|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2962832|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
2962833|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
2962834|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2962835|NCT01212770|10198200|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962836|NCT01212770|10198201|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962837|NCT01212770|10198202|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962838|NCT01212770|10198203|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962839|NCT01212770|10198204|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962840|NCT01212770|10198205|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2962841|NCT01212770|10198206|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
2962842|NCT01212770|10198207|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2962843|NCT01212770|10198208|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2962844|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962845|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962846|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962847|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962848|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962849|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962850|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2962851|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2962852|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2962853|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962854|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962855|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962856|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962857|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962858|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962859|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962860|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
2962861|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2962862|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2962863|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2962864|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2962865|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2962866|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2962867|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2962868|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2962869|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2962870|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2962871|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962872|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
2962873|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962874|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962875|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962876|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962877|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
2962878|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
2962879|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
2962880|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2962881|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2962882|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2962883|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2962884|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2962885|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2962886|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2962887|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2962888|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2962889|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962890|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
2962891|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962892|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962893|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962894|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962895|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962896|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962897|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2962898|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Death|1
2962899|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Death|0
2962900|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Death|0
2962901|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Death|0
2962902|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Death|0
2962903|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Death|0
2962904|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Death|1
2962905|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Death|0
2962906|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Death|0
2962907|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
2962908|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
2962909|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2962910|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2962911|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2962912|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2962913|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
2962914|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
2962915|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2962916|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2962917|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2962918|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2962919|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2962920|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2962921|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2962922|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2962923|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2962924|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2962925|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
2962926|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
2962927|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
2962928|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
2962929|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
2962930|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
2962931|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
2962932|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
2962933|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
2962934|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
2962935|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962936|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962937|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962938|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962939|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962940|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962941|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
2962942|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2962943|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
2962944|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962945|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962946|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962947|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962948|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962949|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
2962950|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962951|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2962952|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962953|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962954|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962955|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962956|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962957|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962958|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962959|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
2962960|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2962961|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
2962962|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962963|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962964|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962965|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962966|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962967|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962968|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962969|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2962970|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2962971|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2962972|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2962973|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2962974|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2962975|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2962976|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2962977|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
2962978|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2962979|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962980|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962981|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962982|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962983|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962984|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962985|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
2962986|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962987|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2962988|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
2962989|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
2962990|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2962991|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2962992|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2962993|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2962994|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
2962995|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
2962996|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2962997|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
2962998|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
2962999|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
2963000|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
2963001|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
2963002|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
2963003|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
2963004|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
2963005|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
2963006|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963007|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963008|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963009|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963010|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963011|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963012|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
2963013|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963014|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2963015|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
2963016|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
2963017|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2963018|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2963019|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2963020|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2963021|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
2963022|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
2963023|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2963024|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963025|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2963026|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963027|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963028|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963029|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963030|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
2963031|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2963032|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2963033|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
2963034|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
2963035|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
2963036|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
2963037|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
2963038|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
2963039|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
2963040|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
2963041|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
2963042|NCT01212757|10198405|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
2963043|NCT01212757|10198406|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963044|NCT01212757|10198407|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963045|NCT01212757|10198408|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963046|NCT01212757|10198409|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963047|NCT01212757|10198410|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963048|NCT01212757|10198411|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963049|NCT01212757|10198412|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963050|NCT01212757|10198413|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2963051|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963052|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963053|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963054|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963055|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963056|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963057|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
2963058|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
2963059|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
2963060|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963061|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963062|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963063|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963064|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2963065|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963066|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963067|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2963068|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2963069|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2963070|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2963071|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2963072|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2963073|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
2963074|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2963075|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
2963076|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2963077|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2963078|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963079|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963080|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963081|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963082|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963083|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963084|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
2963085|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963086|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2963087|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2963088|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2963089|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2963090|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
2963091|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2963092|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
2963093|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
2963094|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
2963095|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2963096|NCT01212757|10198405|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2963097|NCT01212757|10198406|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2963098|NCT01212757|10198407|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2963099|NCT01212757|10198408|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2963100|NCT01212757|10198409|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2963101|NCT01212757|10198410|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
2963102|NCT01212757|10198411|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
2963103|NCT01212757|10198412|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2963104|NCT01212757|10198413|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2963105|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963106|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963107|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963108|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963109|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963110|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963111|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
2963112|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
2963113|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
2963114|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963115|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963116|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963117|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963118|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963119|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963120|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2963121|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2963122|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2963123|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963124|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963125|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963126|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963127|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963128|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2963129|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2963130|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2963131|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2963132|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963133|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963134|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963135|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963136|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963137|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963138|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2963139|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2963140|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
2963141|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963142|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963143|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963144|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963145|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963146|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2963147|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2963148|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
2963149|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
2963150|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963151|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963152|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963153|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963154|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963155|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2963156|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2963157|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2963158|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2963159|NCT01212757|10198405|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963160|NCT01212757|10198406|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963161|NCT01212757|10198407|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963162|NCT01212757|10198408|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963163|NCT01212757|10198409|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963164|NCT01212757|10198410|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2963165|NCT01212757|10198411|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2963166|NCT01212757|10198412|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2963167|NCT01212757|10198413|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2963168|NCT01212744|10198597|P1|Overall Study|Withdrawal by Subject|1
2963169|NCT01212588|10198616|P2|Overall Study|Protocol Violation|1
2963170|NCT01212588|10198617|P1|Overall Study|Protocol Violation|1
2963171|NCT01212588|10198616|P2|Overall Study|Physician Decision|1
2963172|NCT01212588|10198617|P1|Overall Study|Physician Decision|0
2963173|NCT01212185|10198702|P2|Overall Study|Protocol Violation|1
2963174|NCT01212185|10198703|P1|Overall Study|Protocol Violation|2
2963175|NCT01212159|10198722|P2|Overall Study|Withdrawal by Subject|12
2963176|NCT01212159|10198723|P1|Overall Study|Withdrawal by Subject|12
2963177|NCT01212094|10198822|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
2963178|NCT01212094|10198823|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
2963179|NCT01212094|10198824|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
2963180|NCT01212094|10198822|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
2963181|NCT01212094|10198823|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2963182|NCT01212094|10198824|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2963183|NCT01212094|10198822|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
2963184|NCT01212094|10198823|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
2963185|NCT01212094|10198824|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
2963186|NCT01212094|10198822|P3|Year 1: Baseline Monitoring|Started on DMT|0
2963187|NCT01212094|10198823|P2|Year 1: Baseline Monitoring|Started on DMT|0
2963188|NCT01212094|10198824|P1|Year 1: Baseline Monitoring|Started on DMT|2
2963189|NCT01212094|10198822|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2963190|NCT01212094|10198823|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2963191|NCT01212094|10198824|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
2963192|NCT01212094|10198822|P3|Year 1: Baseline Monitoring|Study terminated|0
2963193|NCT01212094|10198823|P2|Year 1: Baseline Monitoring|Study terminated|0
2963194|NCT01212094|10198824|P1|Year 1: Baseline Monitoring|Study terminated|7
2963195|NCT01211769|10198883|P4|Overall Study|Adverse Event|1
2963196|NCT01211769|10198884|P3|Overall Study|Adverse Event|1
2963197|NCT01211769|10198885|P2|Overall Study|Adverse Event|1
2963198|NCT01211769|10198886|P1|Overall Study|Adverse Event|0
2963199|NCT01211769|10198883|P4|Overall Study|Physician Decision|1
2963200|NCT01211769|10198884|P3|Overall Study|Physician Decision|2
2963201|NCT01211769|10198885|P2|Overall Study|Physician Decision|0
2963202|NCT01211769|10198886|P1|Overall Study|Physician Decision|2
2963203|NCT01211769|10198883|P4|Overall Study|Lost to Follow-up|9
2963204|NCT01211769|10198884|P3|Overall Study|Lost to Follow-up|5
2963205|NCT01211769|10198885|P2|Overall Study|Lost to Follow-up|9
2963206|NCT01211769|10198886|P1|Overall Study|Lost to Follow-up|7
2963207|NCT01211665|10198941|P2|Overall Study|Death|0
2963208|NCT01211665|10198942|P1|Overall Study|Death|1
2963209|NCT01211665|10198941|P2|Overall Study|Withdrawal by Subject|0
2963210|NCT01211665|10198942|P1|Overall Study|Withdrawal by Subject|1
2963211|NCT01211613|10198969|P3|Overall Study|Withdrawal by Subject|0
2963212|NCT01211613|10198970|P2|Overall Study|Withdrawal by Subject|0
2963213|NCT01211613|10198971|P1|Overall Study|Withdrawal by Subject|1
2963214|NCT01211613|10198969|P3|Overall Study|Lost to Follow-up|2
2963215|NCT01211613|10198970|P2|Overall Study|Lost to Follow-up|2
2963216|NCT01211613|10198971|P1|Overall Study|Lost to Follow-up|2
2963217|NCT01211535|10199017|P2|Overall Study|Adverse Event|1
2963218|NCT01211535|10199018|P1|Overall Study|Adverse Event|0
2963219|NCT01211522|10199027|P3|Overall Study|Withdrawal by Subject|5
2963220|NCT01211522|10199028|P2|Overall Study|Withdrawal by Subject|7
2963221|NCT01211522|10199029|P1|Overall Study|Withdrawal by Subject|3
2963222|NCT01211288|10199079|P2|Overall Study|Lost to Follow-up|1
2963223|NCT01211288|10199080|P1|Overall Study|Lost to Follow-up|1
2963224|NCT01211197|10199096|P6|Washout Period 2 (7 Days)|Adverse Event|0
2963225|NCT01211197|10199097|P5|Washout Period 2 (7 Days)|Adverse Event|0
2963226|NCT01211197|10199098|P4|Washout Period 2 (7 Days)|Adverse Event|0
2963227|NCT01211197|10199099|P3|Washout Period 2 (7 Days)|Adverse Event|0
2963228|NCT01211197|10199100|P2|Washout Period 2 (7 Days)|Adverse Event|0
2963229|NCT01211197|10199101|P1|Washout Period 2 (7 Days)|Adverse Event|1
2963230|NCT01211197|10199096|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2963231|NCT01211197|10199097|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2963232|NCT01211197|10199098|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2963233|NCT01211197|10199099|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2963234|NCT01211197|10199100|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2963235|NCT01211197|10199101|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2963236|NCT01211184|10199148|P3|Overall Study|Withdrawal by Subject|1
2963237|NCT01211184|10199149|P2|Overall Study|Withdrawal by Subject|2
2963238|NCT01211184|10199150|P1|Overall Study|Withdrawal by Subject|0
2963239|NCT01211145|10199165|P4|Overall Study|Patient decision|2
2963240|NCT01211145|10199166|P3|Overall Study|Patient decision|0
2963241|NCT01211145|10199167|P2|Overall Study|Patient decision|1
2963242|NCT01211145|10199168|P1|Overall Study|Patient decision|2
2963243|NCT01211145|10199165|P4|Overall Study|Eligibility criteria not fulfilled|15
2963244|NCT01211145|10199166|P3|Overall Study|Eligibility criteria not fulfilled|10
2963245|NCT01211145|10199167|P2|Overall Study|Eligibility criteria not fulfilled|12
2963246|NCT01211145|10199168|P1|Overall Study|Eligibility criteria not fulfilled|16
2963247|NCT01211145|10199165|P4|Overall Study|Severe noncompliance to protocol|0
2963248|NCT01211145|10199166|P3|Overall Study|Severe noncompliance to protocol|0
2963249|NCT01211145|10199167|P2|Overall Study|Severe noncompliance to protocol|0
2963250|NCT01211145|10199168|P1|Overall Study|Severe noncompliance to protocol|1
2963251|NCT01211145|10199165|P4|Overall Study|Study-specific withdrawal criteria|0
2963252|NCT01211145|10199166|P3|Overall Study|Study-specific withdrawal criteria|0
2963253|NCT01211145|10199167|P2|Overall Study|Study-specific withdrawal criteria|0
2963254|NCT01211145|10199168|P1|Overall Study|Study-specific withdrawal criteria|1
2963255|NCT01211145|10199165|P4|Overall Study|Lost to Follow-up|2
2963256|NCT01211145|10199166|P3|Overall Study|Lost to Follow-up|1
2963257|NCT01211145|10199167|P2|Overall Study|Lost to Follow-up|2
2963258|NCT01211145|10199168|P1|Overall Study|Lost to Follow-up|3
2963259|NCT01211145|10199165|P4|Overall Study|Reason not specified|1
2963260|NCT01211145|10199166|P3|Overall Study|Reason not specified|2
2963261|NCT01211145|10199167|P2|Overall Study|Reason not specified|2
2963262|NCT01211145|10199168|P1|Overall Study|Reason not specified|3
2963263|NCT01210807|10199222|P2|Overall Study|Not implanted bilaterally|1
2963264|NCT01210807|10199223|P1|Overall Study|Not implanted bilaterally|2
2963265|NCT01210807|10199222|P2|Overall Study|Lost to Follow-up|2
2963266|NCT01210807|10199223|P1|Overall Study|Lost to Follow-up|1
2963267|NCT01210690|10199238|P1|Overall Study|Patient could not take glucose|1
2963268|NCT01210690|10199238|P1|Overall Study|Patient refused to swallow|1
2963269|NCT01210690|10199238|P1|Overall Study|Withdrawal by Subject|1
2963270|NCT01210690|10199238|P1|Overall Study|Disease Remission|1
2963271|NCT01210690|10199238|P1|Overall Study|Lost to Follow-up|3
2963272|NCT01210690|10199238|P1|Overall Study|Lack of Efficacy|12
2963273|NCT01210690|10199238|P1|Overall Study|Adverse Event|7
2963357|NCT01210352|10199489|P5|Overall Study|Adverse Event|0
2963274|NCT01210664|10199251|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
2963275|NCT01210664|10199252|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2963276|NCT01210664|10199253|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2963277|NCT01210664|10199254|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2963278|NCT01210664|10199251|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2963279|NCT01210664|10199252|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
2963280|NCT01210664|10199253|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2963281|NCT01210664|10199254|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2963282|NCT01210664|10199251|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2963283|NCT01210664|10199252|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
2963284|NCT01210664|10199253|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2963285|NCT01210664|10199254|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2963286|NCT01210651|10199282|P2|Overall Study|Injury outside study|0
2963287|NCT01210651|10199283|P1|Overall Study|Injury outside study|2
2963288|NCT01210651|10199282|P2|Overall Study|Withdrawal by Subject|1
2963289|NCT01210651|10199283|P1|Overall Study|Withdrawal by Subject|1
2963290|NCT01210651|10199282|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
2963291|NCT01210651|10199283|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
2963292|NCT01210651|10199282|P2|Overall Study|schedule conflicts|5
2963293|NCT01210651|10199283|P1|Overall Study|schedule conflicts|1
2963294|NCT01210651|10199282|P2|Overall Study|Lost to Follow-up|1
2963295|NCT01210651|10199283|P1|Overall Study|Lost to Follow-up|1
2963296|NCT01210495|10199403|P4|Overall Study|Other unspecified|0
2963297|NCT01210495|10199404|P3|Overall Study|Other unspecified|6
2963298|NCT01210495|10199405|P2|Overall Study|Other unspecified|0
2963299|NCT01210495|10199406|P1|Overall Study|Other unspecified|0
2963300|NCT01210495|10199403|P4|Overall Study|Lost to Follow-up|1
2963301|NCT01210495|10199404|P3|Overall Study|Lost to Follow-up|1
2963302|NCT01210495|10199405|P2|Overall Study|Lost to Follow-up|0
2963303|NCT01210495|10199406|P1|Overall Study|Lost to Follow-up|0
2963304|NCT01210495|10199403|P4|Overall Study|Study Terminated by Sponsor|11
2963305|NCT01210495|10199404|P3|Overall Study|Study Terminated by Sponsor|4
2963306|NCT01210495|10199405|P2|Overall Study|Study Terminated by Sponsor|0
2963307|NCT01210495|10199406|P1|Overall Study|Study Terminated by Sponsor|0
2963308|NCT01210495|10199403|P4|Overall Study|Death|54
2963309|NCT01210495|10199404|P3|Overall Study|Death|112
2963310|NCT01210495|10199405|P2|Overall Study|Death|7
2963311|NCT01210495|10199406|P1|Overall Study|Death|14
2963312|NCT01210495|10199403|P4|Overall Study|Participant Refused Further Follow-Up|2
2963313|NCT01210495|10199404|P3|Overall Study|Participant Refused Further Follow-Up|11
2963314|NCT01210495|10199405|P2|Overall Study|Participant Refused Further Follow-Up|0
2963315|NCT01210495|10199406|P1|Overall Study|Participant Refused Further Follow-Up|1
2963316|NCT01210443|10199468|P1|Overall Study|Study terminated by sponsor|2
2963317|NCT01210352|10199485|P9|Overall Study|Patient Discharged Early|0
2963318|NCT01210352|10199486|P8|Overall Study|Patient Discharged Early|0
2963319|NCT01210352|10199487|P7|Overall Study|Patient Discharged Early|0
2963320|NCT01210352|10199488|P6|Overall Study|Patient Discharged Early|0
2963321|NCT01210352|10199489|P5|Overall Study|Patient Discharged Early|0
2963322|NCT01210352|10199490|P4|Overall Study|Patient Discharged Early|0
2963323|NCT01210352|10199491|P3|Overall Study|Patient Discharged Early|1
2963324|NCT01210352|10199492|P2|Overall Study|Patient Discharged Early|0
2963325|NCT01210352|10199493|P1|Overall Study|Patient Discharged Early|0
2963326|NCT01210352|10199485|P9|Overall Study|Withdrawal by Subject|1
2963327|NCT01210352|10199486|P8|Overall Study|Withdrawal by Subject|0
2963328|NCT01210352|10199487|P7|Overall Study|Withdrawal by Subject|1
2963329|NCT01210352|10199488|P6|Overall Study|Withdrawal by Subject|0
2963330|NCT01210352|10199489|P5|Overall Study|Withdrawal by Subject|0
2963331|NCT01210352|10199490|P4|Overall Study|Withdrawal by Subject|0
2963332|NCT01210352|10199491|P3|Overall Study|Withdrawal by Subject|1
2963333|NCT01210352|10199492|P2|Overall Study|Withdrawal by Subject|0
2963334|NCT01210352|10199493|P1|Overall Study|Withdrawal by Subject|0
2963335|NCT01210352|10199485|P9|Overall Study|Physician Decision|2
2963336|NCT01210352|10199486|P8|Overall Study|Physician Decision|1
2963337|NCT01210352|10199487|P7|Overall Study|Physician Decision|0
2963338|NCT01210352|10199488|P6|Overall Study|Physician Decision|0
2963339|NCT01210352|10199489|P5|Overall Study|Physician Decision|0
2963340|NCT01210352|10199490|P4|Overall Study|Physician Decision|0
2963341|NCT01210352|10199491|P3|Overall Study|Physician Decision|0
2963342|NCT01210352|10199492|P2|Overall Study|Physician Decision|0
2963343|NCT01210352|10199493|P1|Overall Study|Physician Decision|0
2963344|NCT01210352|10199485|P9|Overall Study|Lack of Efficacy|0
2963345|NCT01210352|10199486|P8|Overall Study|Lack of Efficacy|0
2963346|NCT01210352|10199487|P7|Overall Study|Lack of Efficacy|1
2963347|NCT01210352|10199488|P6|Overall Study|Lack of Efficacy|0
2963348|NCT01210352|10199489|P5|Overall Study|Lack of Efficacy|0
2963349|NCT01210352|10199490|P4|Overall Study|Lack of Efficacy|0
2963350|NCT01210352|10199491|P3|Overall Study|Lack of Efficacy|0
2963351|NCT01210352|10199492|P2|Overall Study|Lack of Efficacy|0
2963352|NCT01210352|10199493|P1|Overall Study|Lack of Efficacy|0
2963353|NCT01210352|10199485|P9|Overall Study|Adverse Event|1
2963354|NCT01210352|10199486|P8|Overall Study|Adverse Event|2
2963355|NCT01210352|10199487|P7|Overall Study|Adverse Event|0
2963356|NCT01210352|10199488|P6|Overall Study|Adverse Event|0
2963358|NCT01210352|10199490|P4|Overall Study|Adverse Event|0
2963359|NCT01210352|10199491|P3|Overall Study|Adverse Event|0
2963360|NCT01210352|10199492|P2|Overall Study|Adverse Event|0
2963361|NCT01210352|10199493|P1|Overall Study|Adverse Event|0
2963362|NCT01210222|10199684|P1|Overall Study|Never treated|1
2963363|NCT01210222|10199684|P1|Overall Study|Ineligible|2
2963364|NCT01210144|10199720|P2|Overall Study|No transfer|0
2963365|NCT01210144|10199721|P1|Overall Study|No transfer|1
2963366|NCT01210144|10199720|P2|Overall Study|No fertilization|0
2963367|NCT01210144|10199721|P1|Overall Study|No fertilization|1
2963368|NCT01210144|10199720|P2|Overall Study|Lack of ovarian response|0
2963369|NCT01210144|10199721|P1|Overall Study|Lack of ovarian response|1
2963370|NCT01210118|10199743|P2|Overall Study|Spontaneous abortion|3
2963371|NCT01210118|10199744|P1|Overall Study|Spontaneous abortion|1
2963372|NCT01210118|10199743|P2|Overall Study|Protocol Violation|1
2963373|NCT01210118|10199744|P1|Overall Study|Protocol Violation|1
2963374|NCT01210118|10199743|P2|Overall Study|Lost to Follow-up|1
2963375|NCT01210118|10199744|P1|Overall Study|Lost to Follow-up|1
2963376|NCT01210001|10199768|P3|Overall Study|Other reason not defined above|1
2963377|NCT01210001|10199769|P2|Overall Study|Other reason not defined above|2
2963378|NCT01210001|10199770|P1|Overall Study|Other reason not defined above|2
2963379|NCT01210001|10199768|P3|Overall Study|Patient refusal to continue,not due toAE|1
2963380|NCT01210001|10199769|P2|Overall Study|Patient refusal to continue,not due toAE|2
2963381|NCT01210001|10199770|P1|Overall Study|Patient refusal to continue,not due toAE|6
2963382|NCT01210001|10199768|P3|Overall Study|Lost to Follow-up|2
2963383|NCT01210001|10199769|P2|Overall Study|Lost to Follow-up|3
2963384|NCT01210001|10199770|P1|Overall Study|Lost to Follow-up|4
2963385|NCT01210001|10199768|P3|Overall Study|Non compliant with protocol|3
2963386|NCT01210001|10199769|P2|Overall Study|Non compliant with protocol|2
2963387|NCT01210001|10199770|P1|Overall Study|Non compliant with protocol|2
2963388|NCT01210001|10199768|P3|Overall Study|Adverse Event|5
2963389|NCT01210001|10199769|P2|Overall Study|Adverse Event|2
2963390|NCT01210001|10199770|P1|Overall Study|Adverse Event|4
2963391|NCT01210001|10199768|P3|Overall Study|Not treated|0
2963392|NCT01210001|10199769|P2|Overall Study|Not treated|0
2963393|NCT01210001|10199770|P1|Overall Study|Not treated|1
2963394|NCT01209949|10199790|P1|Overall Study|Lost to Follow-up|3
2963395|NCT01209832|10199796|P1|Period 2|Sponsor Decision|1
2963396|NCT01209832|10199796|P1|Period 1|Sponsor Decision and was not dosed|1
2963397|NCT01209780|10199815|P5|Overall Study|Inappropriate enrollment|1
2963398|NCT01209780|10199816|P4|Overall Study|Inappropriate enrollment|0
2963399|NCT01209780|10199817|P3|Overall Study|Inappropriate enrollment|0
2963400|NCT01209780|10199818|P2|Overall Study|Inappropriate enrollment|2
2963401|NCT01209780|10199819|P1|Overall Study|Inappropriate enrollment|0
2963402|NCT01209780|10199815|P5|Overall Study|Protocol Violation|0
2963403|NCT01209780|10199816|P4|Overall Study|Protocol Violation|0
2963404|NCT01209780|10199817|P3|Overall Study|Protocol Violation|0
2963405|NCT01209780|10199818|P2|Overall Study|Protocol Violation|1
2963406|NCT01209780|10199819|P1|Overall Study|Protocol Violation|0
2963407|NCT01209780|10199815|P5|Overall Study|Lost to Follow-up|4
2963408|NCT01209780|10199816|P4|Overall Study|Lost to Follow-up|9
2963409|NCT01209780|10199817|P3|Overall Study|Lost to Follow-up|3
2963410|NCT01209780|10199818|P2|Overall Study|Lost to Follow-up|12
2963411|NCT01209780|10199819|P1|Overall Study|Lost to Follow-up|17
2963412|NCT01209780|10199815|P5|Overall Study|Withdrawal by Subject|0
2963413|NCT01209780|10199816|P4|Overall Study|Withdrawal by Subject|1
2963414|NCT01209780|10199817|P3|Overall Study|Withdrawal by Subject|1
2963415|NCT01209780|10199818|P2|Overall Study|Withdrawal by Subject|2
2963416|NCT01209780|10199819|P1|Overall Study|Withdrawal by Subject|9
2963417|NCT01209780|10199815|P5|Overall Study|Adverse Event|0
2963418|NCT01209780|10199816|P4|Overall Study|Adverse Event|0
2963419|NCT01209780|10199817|P3|Overall Study|Adverse Event|0
2963420|NCT01209780|10199818|P2|Overall Study|Adverse Event|1
2963421|NCT01209780|10199819|P1|Overall Study|Adverse Event|0
2963422|NCT01209767|10199845|P1|Overall Study|Lost to Follow-up|3
2963423|NCT01209767|10199845|P1|Overall Study|Withdrawal by Subject|1
2963424|NCT01209689|10199914|P2|Overall Study|Sponsor's Decision to Stop the Study|17
2963425|NCT01209689|10199915|P1|Overall Study|Sponsor's Decision to Stop the Study|68
2963426|NCT01209689|10199914|P2|Overall Study|Failure to Return|0
2963427|NCT01209689|10199915|P1|Overall Study|Failure to Return|3
2963428|NCT01209689|10199914|P2|Overall Study|Violation of Selection Criteria at Entry|0
2963429|NCT01209689|10199915|P1|Overall Study|Violation of Selection Criteria at Entry|1
2963430|NCT01209689|10199914|P2|Overall Study|Adverse Event|0
2963431|NCT01209689|10199915|P1|Overall Study|Adverse Event|4
2963432|NCT01209689|10199914|P2|Overall Study|Refused Treatment|3
2963433|NCT01209689|10199915|P1|Overall Study|Refused Treatment|8
2963434|NCT01209689|10199914|P2|Overall Study|Insufficient Therapeutic Response|2
2963435|NCT01209689|10199915|P1|Overall Study|Insufficient Therapeutic Response|7
2963436|NCT01209624|10199921|P1|Overall Study|Other|4
2963437|NCT01209624|10199921|P1|Overall Study|Lost to Follow-up|290
2963438|NCT01209624|10199921|P1|Overall Study|Lack of Efficacy|17
2963439|NCT01209624|10199921|P1|Overall Study|Adverse Event|13
2963440|NCT01209624|10199921|P1|Overall Study|Death|2
2963441|NCT01209598|10199954|P2|Overall Study|Withdrawal by Subject|0
2963442|NCT01209598|10199955|P1|Overall Study|Withdrawal by Subject|1
2963443|NCT01209520|10199963|P1|Overall Study|Withdrawal by Subject|3
2963444|NCT01209325|10199973|P1|Overall Study|Incarceration|2
2963445|NCT01209325|10199973|P1|Overall Study|Refusal prior to therapy|1
2963446|NCT01209325|10199973|P1|Overall Study|Protocol Violation|4
2963447|NCT01209325|10199973|P1|Overall Study|Refusal after starting therapy|8
2963448|NCT01209325|10199973|P1|Overall Study|Relocated|3
2963449|NCT01209325|10199973|P1|Overall Study|Adverse Event|1
2963450|NCT01209325|10199973|P1|Overall Study|Lost to Follow-up|24
2963451|NCT01209286|10200028|P3|Overall Study|Other|0
2963452|NCT01209286|10200029|P2|Overall Study|Other|1
2963453|NCT01209286|10200030|P1|Overall Study|Other|0
2963454|NCT01209286|10200028|P3|Overall Study|Physician Decision|0
2963455|NCT01209286|10200029|P2|Overall Study|Physician Decision|2
2963456|NCT01209286|10200030|P1|Overall Study|Physician Decision|0
2963457|NCT01209286|10200028|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
2963458|NCT01209286|10200029|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
2963459|NCT01209286|10200030|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
2963460|NCT01209286|10200028|P3|Overall Study|Hematological Relapse After Remission|1
2963461|NCT01209286|10200029|P2|Overall Study|Hematological Relapse After Remission|1
2963462|NCT01209286|10200030|P1|Overall Study|Hematological Relapse After Remission|0
2963463|NCT01209286|10200028|P3|Overall Study|Adverse Event|1
2963464|NCT01209286|10200029|P2|Overall Study|Adverse Event|3
2963465|NCT01209286|10200030|P1|Overall Study|Adverse Event|4
2963466|NCT01209143|10200139|P2|Overall Study|Disease progression|16
2963467|NCT01209143|10200140|P1|Overall Study|Disease progression|11
2963468|NCT01209143|10200139|P2|Overall Study|Withdrawal by Subject|1
2963469|NCT01209143|10200140|P1|Overall Study|Withdrawal by Subject|2
2963470|NCT01209143|10200139|P2|Overall Study|Lost to Follow-up|0
2963471|NCT01209143|10200140|P1|Overall Study|Lost to Follow-up|1
2963472|NCT01209143|10200139|P2|Overall Study|Physician Decision|1
2963473|NCT01209143|10200140|P1|Overall Study|Physician Decision|3
2963474|NCT01209143|10200139|P2|Overall Study|Death|1
2963475|NCT01209143|10200140|P1|Overall Study|Death|0
2963476|NCT01209143|10200139|P2|Overall Study|Adverse Event|1
2963477|NCT01209143|10200140|P1|Overall Study|Adverse Event|2
2963478|NCT01209078|10200150|P2|Overall Study|Withdrawal by Subject|1
2963479|NCT01209078|10200151|P1|Overall Study|Withdrawal by Subject|2
2963480|NCT01209078|10200150|P2|Overall Study|Physician Decision|2
2963481|NCT01209078|10200151|P1|Overall Study|Physician Decision|5
2963482|NCT01209078|10200150|P2|Overall Study|Lost to Follow-up|0
2963483|NCT01209078|10200151|P1|Overall Study|Lost to Follow-up|4
2963484|NCT01209078|10200150|P2|Overall Study|Adverse Event|0
2963485|NCT01209078|10200151|P1|Overall Study|Adverse Event|5
2963486|NCT01208961|10200226|P2|High-Fat Period III|Protocol Violation|0
2963487|NCT01208961|10200227|P1|High-Fat Period III|Protocol Violation|1
2963488|NCT01208870|10200249|P2|Overall Study|Lost to Follow-up|8
2963489|NCT01208870|10200250|P1|Overall Study|Lost to Follow-up|2
2963490|NCT01208415|10200266|P1|Overall Study|Still be eligible for follow-up|33
2963491|NCT01208415|10200266|P1|Overall Study|Device not placed|1
2963492|NCT01208415|10200266|P1|Overall Study|Withdrawal by Subject|3
2963493|NCT01208415|10200266|P1|Overall Study|Lost to Follow-up|2
2963494|NCT01208415|10200266|P1|Overall Study|Death|1
2963495|NCT01208402|10200272|P2|Overall Study|Withdrawal by Subject|0
2963496|NCT01208402|10200273|P1|Overall Study|Withdrawal by Subject|1
2963497|NCT01208337|10200289|P1|Overall Study|Death|3
2963498|NCT01208233|10200303|P6|Overall Study|Withdrawal by Subject|2
2963499|NCT01208233|10200304|P5|Overall Study|Withdrawal by Subject|4
2963500|NCT01208233|10200305|P4|Overall Study|Withdrawal by Subject|1
2963501|NCT01208233|10200306|P3|Overall Study|Withdrawal by Subject|1
2963502|NCT01208233|10200307|P2|Overall Study|Withdrawal by Subject|0
2963503|NCT01208233|10200308|P1|Overall Study|Withdrawal by Subject|1
2963504|NCT01208233|10200303|P6|Overall Study|Other|1
2963505|NCT01208233|10200304|P5|Overall Study|Other|0
2963506|NCT01208233|10200305|P4|Overall Study|Other|0
2963507|NCT01208233|10200306|P3|Overall Study|Other|0
2963508|NCT01208233|10200307|P2|Overall Study|Other|1
2963509|NCT01208233|10200308|P1|Overall Study|Other|2
2963510|NCT01208233|10200303|P6|Overall Study|Protocol Violation|0
2963511|NCT01208233|10200304|P5|Overall Study|Protocol Violation|3
2963512|NCT01208233|10200305|P4|Overall Study|Protocol Violation|0
2963513|NCT01208233|10200306|P3|Overall Study|Protocol Violation|0
2963514|NCT01208233|10200307|P2|Overall Study|Protocol Violation|0
2963515|NCT01208233|10200308|P1|Overall Study|Protocol Violation|0
2963516|NCT01208233|10200303|P6|Overall Study|Study terminated by sponsor|7
2963517|NCT01208233|10200304|P5|Overall Study|Study terminated by sponsor|10
2963518|NCT01208233|10200305|P4|Overall Study|Study terminated by sponsor|0
2963519|NCT01208233|10200306|P3|Overall Study|Study terminated by sponsor|0
2963520|NCT01208233|10200307|P2|Overall Study|Study terminated by sponsor|0
2963521|NCT01208233|10200308|P1|Overall Study|Study terminated by sponsor|0
2963522|NCT01208233|10200303|P6|Overall Study|Medication error without adverse event|1
2963523|NCT01208233|10200304|P5|Overall Study|Medication error without adverse event|0
2963524|NCT01208233|10200305|P4|Overall Study|Medication error without adverse event|0
2963525|NCT01208233|10200306|P3|Overall Study|Medication error without adverse event|0
2963526|NCT01208233|10200307|P2|Overall Study|Medication error without adverse event|0
2963527|NCT01208233|10200308|P1|Overall Study|Medication error without adverse event|0
2963528|NCT01208233|10200303|P6|Overall Study|Did not meet entrance criteria|0
2963529|NCT01208233|10200304|P5|Overall Study|Did not meet entrance criteria|1
2963530|NCT01208233|10200305|P4|Overall Study|Did not meet entrance criteria|0
2963531|NCT01208233|10200306|P3|Overall Study|Did not meet entrance criteria|1
2963532|NCT01208233|10200307|P2|Overall Study|Did not meet entrance criteria|1
2963533|NCT01208233|10200308|P1|Overall Study|Did not meet entrance criteria|2
2963534|NCT01208233|10200303|P6|Overall Study|Death|5
2963535|NCT01208233|10200304|P5|Overall Study|Death|3
2963536|NCT01208233|10200305|P4|Overall Study|Death|0
2963537|NCT01208233|10200306|P3|Overall Study|Death|0
2963538|NCT01208233|10200307|P2|Overall Study|Death|0
2963539|NCT01208233|10200308|P1|Overall Study|Death|0
2963540|NCT01208233|10200303|P6|Overall Study|Adverse Event|5
2963541|NCT01208233|10200304|P5|Overall Study|Adverse Event|3
2963542|NCT01208233|10200305|P4|Overall Study|Adverse Event|0
2963543|NCT01208233|10200306|P3|Overall Study|Adverse Event|2
2963544|NCT01208233|10200307|P2|Overall Study|Adverse Event|1
2963545|NCT01208233|10200308|P1|Overall Study|Adverse Event|0
2963546|NCT01208207|10200433|P7|Part II|Technical Problems|0
2963547|NCT01208207|10200434|P6|Part II|Technical Problems|1
2963548|NCT01208207|10200435|P5|Part II|Technical Problems|0
2963549|NCT01208207|10200436|P4|Part II|Technical Problems|1
2963550|NCT01208207|10200437|P3|Part II|Technical Problems|0
2963551|NCT01208207|10200438|P2|Part II|Technical Problems|0
2963552|NCT01208207|10200439|P1|Part II|Technical Problems|0
2963553|NCT01208207|10200433|P7|Part II|Protocol Violation|0
2963554|NCT01208207|10200434|P6|Part II|Protocol Violation|0
2963555|NCT01208207|10200435|P5|Part II|Protocol Violation|0
2963556|NCT01208207|10200436|P4|Part II|Protocol Violation|1
2963557|NCT01208207|10200437|P3|Part II|Protocol Violation|0
2963558|NCT01208207|10200438|P2|Part II|Protocol Violation|0
2963559|NCT01208207|10200439|P1|Part II|Protocol Violation|0
2963560|NCT01208207|10200433|P7|Part II|Physician Decision|0
2963561|NCT01208207|10200434|P6|Part II|Physician Decision|2
2963562|NCT01208207|10200435|P5|Part II|Physician Decision|0
2963563|NCT01208207|10200436|P4|Part II|Physician Decision|1
2963564|NCT01208207|10200437|P3|Part II|Physician Decision|0
2963565|NCT01208207|10200438|P2|Part II|Physician Decision|0
2963566|NCT01208207|10200439|P1|Part II|Physician Decision|0
2963567|NCT01208207|10200433|P7|Part II|Non-Compliance With Study Drug|0
2963568|NCT01208207|10200434|P6|Part II|Non-Compliance With Study Drug|1
2963569|NCT01208207|10200435|P5|Part II|Non-Compliance With Study Drug|1
2963570|NCT01208207|10200436|P4|Part II|Non-Compliance With Study Drug|4
2963571|NCT01208207|10200437|P3|Part II|Non-Compliance With Study Drug|0
2963572|NCT01208207|10200438|P2|Part II|Non-Compliance With Study Drug|0
2963573|NCT01208207|10200439|P1|Part II|Non-Compliance With Study Drug|0
2963574|NCT01208207|10200433|P7|Part II|Lost to Follow-up|1
2963575|NCT01208207|10200434|P6|Part II|Lost to Follow-up|2
2963576|NCT01208207|10200435|P5|Part II|Lost to Follow-up|0
2963577|NCT01208207|10200436|P4|Part II|Lost to Follow-up|4
2963578|NCT01208207|10200437|P3|Part II|Lost to Follow-up|0
2963579|NCT01208207|10200438|P2|Part II|Lost to Follow-up|0
2963580|NCT01208207|10200439|P1|Part II|Lost to Follow-up|0
2963581|NCT01208207|10200433|P7|Part II|Lack of Efficacy|3
2963582|NCT01208207|10200434|P6|Part II|Lack of Efficacy|3
2963583|NCT01208207|10200435|P5|Part II|Lack of Efficacy|4
2963584|NCT01208207|10200436|P4|Part II|Lack of Efficacy|6
2963585|NCT01208207|10200437|P3|Part II|Lack of Efficacy|0
2963586|NCT01208207|10200438|P2|Part II|Lack of Efficacy|0
2963587|NCT01208207|10200439|P1|Part II|Lack of Efficacy|0
2963588|NCT01208207|10200433|P7|Part II|Adverse Event|2
2963589|NCT01208207|10200434|P6|Part II|Adverse Event|4
2963590|NCT01208207|10200435|P5|Part II|Adverse Event|9
2963591|NCT01208207|10200436|P4|Part II|Adverse Event|5
2963592|NCT01208207|10200437|P3|Part II|Adverse Event|0
2963593|NCT01208207|10200438|P2|Part II|Adverse Event|0
2963594|NCT01208207|10200439|P1|Part II|Adverse Event|0
2963595|NCT01208207|10200433|P7|Part II|Withdrawal by Subject|5
2963596|NCT01208207|10200434|P6|Part II|Withdrawal by Subject|3
2963597|NCT01208207|10200435|P5|Part II|Withdrawal by Subject|9
2963598|NCT01208207|10200436|P4|Part II|Withdrawal by Subject|10
2963599|NCT01208207|10200437|P3|Part II|Withdrawal by Subject|0
2963600|NCT01208207|10200438|P2|Part II|Withdrawal by Subject|0
2963601|NCT01208207|10200439|P1|Part II|Withdrawal by Subject|0
2963602|NCT01208207|10200433|P7|Part I|Withdrawal by Subject|0
2963603|NCT01208207|10200434|P6|Part I|Withdrawal by Subject|0
2963604|NCT01208207|10200435|P5|Part I|Withdrawal by Subject|0
2963605|NCT01208207|10200436|P4|Part I|Withdrawal by Subject|0
2963606|NCT01208207|10200437|P3|Part I|Withdrawal by Subject|4
2963607|NCT01208207|10200438|P2|Part I|Withdrawal by Subject|4
2963608|NCT01208207|10200439|P1|Part I|Withdrawal by Subject|14
2963609|NCT01208207|10200433|P7|Part I|Protocol Violation|0
2963610|NCT01208207|10200434|P6|Part I|Protocol Violation|0
2963611|NCT01208207|10200435|P5|Part I|Protocol Violation|0
2963612|NCT01208207|10200436|P4|Part I|Protocol Violation|0
2963613|NCT01208207|10200437|P3|Part I|Protocol Violation|2
2963614|NCT01208207|10200438|P2|Part I|Protocol Violation|0
2963615|NCT01208207|10200439|P1|Part I|Protocol Violation|8
2963616|NCT01208207|10200433|P7|Part I|Progressive Disease|0
2963617|NCT01208207|10200434|P6|Part I|Progressive Disease|0
2963618|NCT01208207|10200435|P5|Part I|Progressive Disease|0
2963619|NCT01208207|10200436|P4|Part I|Progressive Disease|0
2963620|NCT01208207|10200437|P3|Part I|Progressive Disease|0
2963621|NCT01208207|10200438|P2|Part I|Progressive Disease|0
2963622|NCT01208207|10200439|P1|Part I|Progressive Disease|1
2963623|NCT01208207|10200433|P7|Part I|Physician Decision|0
2963624|NCT01208207|10200434|P6|Part I|Physician Decision|0
2963625|NCT01208207|10200435|P5|Part I|Physician Decision|0
2963626|NCT01208207|10200436|P4|Part I|Physician Decision|0
2963627|NCT01208207|10200437|P3|Part I|Physician Decision|0
2963628|NCT01208207|10200438|P2|Part I|Physician Decision|1
2963629|NCT01208207|10200439|P1|Part I|Physician Decision|0
2963630|NCT01208207|10200433|P7|Part I|Non-Compliance With Study Drug|0
2963631|NCT01208207|10200434|P6|Part I|Non-Compliance With Study Drug|0
2963632|NCT01208207|10200435|P5|Part I|Non-Compliance With Study Drug|0
2963633|NCT01208207|10200436|P4|Part I|Non-Compliance With Study Drug|0
2963634|NCT01208207|10200437|P3|Part I|Non-Compliance With Study Drug|1
2963635|NCT01208207|10200438|P2|Part I|Non-Compliance With Study Drug|0
2963636|NCT01208207|10200439|P1|Part I|Non-Compliance With Study Drug|1
2963637|NCT01208207|10200433|P7|Part I|Lost to Follow-up|0
2963638|NCT01208207|10200434|P6|Part I|Lost to Follow-up|0
2963639|NCT01208207|10200435|P5|Part I|Lost to Follow-up|0
2963640|NCT01208207|10200436|P4|Part I|Lost to Follow-up|0
2963641|NCT01208207|10200437|P3|Part I|Lost to Follow-up|0
2963642|NCT01208207|10200438|P2|Part I|Lost to Follow-up|1
2963643|NCT01208207|10200439|P1|Part I|Lost to Follow-up|6
2963644|NCT01208207|10200433|P7|Part I|Lack of Efficacy|0
2963645|NCT01208207|10200434|P6|Part I|Lack of Efficacy|0
2963646|NCT01208207|10200435|P5|Part I|Lack of Efficacy|0
2963647|NCT01208207|10200436|P4|Part I|Lack of Efficacy|0
2963648|NCT01208207|10200437|P3|Part I|Lack of Efficacy|2
2963649|NCT01208207|10200438|P2|Part I|Lack of Efficacy|3
2963650|NCT01208207|10200439|P1|Part I|Lack of Efficacy|21
2963651|NCT01208207|10200433|P7|Part I|Adverse Event|0
2963652|NCT01208207|10200434|P6|Part I|Adverse Event|0
2963653|NCT01208207|10200435|P5|Part I|Adverse Event|0
2963654|NCT01208207|10200436|P4|Part I|Adverse Event|0
2963655|NCT01208207|10200437|P3|Part I|Adverse Event|6
2963656|NCT01208207|10200438|P2|Part I|Adverse Event|2
2963657|NCT01208207|10200439|P1|Part I|Adverse Event|19
2963658|NCT01208181|10200466|P5|Part 2|Lack of Efficacy|0
2963659|NCT01208181|10200467|P4|Part 2|Lack of Efficacy|7
2963660|NCT01208181|10200468|P3|Part 2|Lack of Efficacy|5
2963661|NCT01208181|10200469|P2|Part 2|Lack of Efficacy|0
2963662|NCT01208181|10200470|P1|Part 2|Lack of Efficacy|0
2963663|NCT01208181|10200466|P5|Part 2|Lost to Follow-up|0
2963664|NCT01208181|10200467|P4|Part 2|Lost to Follow-up|2
2963665|NCT01208181|10200468|P3|Part 2|Lost to Follow-up|1
2963666|NCT01208181|10200469|P2|Part 2|Lost to Follow-up|0
2963667|NCT01208181|10200470|P1|Part 2|Lost to Follow-up|0
2963668|NCT01208181|10200466|P5|Part 2|Non-compliance with study drug|0
2963669|NCT01208181|10200467|P4|Part 2|Non-compliance with study drug|1
2963670|NCT01208181|10200468|P3|Part 2|Non-compliance with study drug|1
2963671|NCT01208181|10200469|P2|Part 2|Non-compliance with study drug|0
2963672|NCT01208181|10200470|P1|Part 2|Non-compliance with study drug|0
2963673|NCT01208181|10200466|P5|Part 2|Physician Decision|0
2963674|NCT01208181|10200467|P4|Part 2|Physician Decision|2
2963675|NCT01208181|10200468|P3|Part 2|Physician Decision|1
2963676|NCT01208181|10200469|P2|Part 2|Physician Decision|0
2963677|NCT01208181|10200470|P1|Part 2|Physician Decision|0
2963678|NCT01208181|10200466|P5|Part 2|Protocol Violation|0
2963679|NCT01208181|10200467|P4|Part 2|Protocol Violation|0
2963680|NCT01208181|10200468|P3|Part 2|Protocol Violation|1
2963681|NCT01208181|10200469|P2|Part 2|Protocol Violation|0
2963682|NCT01208181|10200470|P1|Part 2|Protocol Violation|0
2963683|NCT01208181|10200466|P5|Part 2|Withdrawal by Subject|0
2963684|NCT01208181|10200467|P4|Part 2|Withdrawal by Subject|1
2963685|NCT01208181|10200468|P3|Part 2|Withdrawal by Subject|1
2963686|NCT01208181|10200469|P2|Part 2|Withdrawal by Subject|0
2963687|NCT01208181|10200470|P1|Part 2|Withdrawal by Subject|0
2963688|NCT01208181|10200466|P5|Part 2|Adverse Event|0
2963689|NCT01208181|10200467|P4|Part 2|Adverse Event|7
2963690|NCT01208181|10200468|P3|Part 2|Adverse Event|6
2963691|NCT01208181|10200469|P2|Part 2|Adverse Event|0
2963692|NCT01208181|10200470|P1|Part 2|Adverse Event|0
2963693|NCT01208181|10200466|P5|Part 1|Adverse Event|4
2963694|NCT01208181|10200467|P4|Part 1|Adverse Event|0
2963695|NCT01208181|10200468|P3|Part 1|Adverse Event|0
2963696|NCT01208181|10200469|P2|Part 1|Adverse Event|24
2963697|NCT01208181|10200470|P1|Part 1|Adverse Event|26
2963698|NCT01208181|10200466|P5|Part 1|Lack of Efficacy|17
2963699|NCT01208181|10200467|P4|Part 1|Lack of Efficacy|0
2963700|NCT01208181|10200468|P3|Part 1|Lack of Efficacy|0
2963701|NCT01208181|10200469|P2|Part 1|Lack of Efficacy|12
2963702|NCT01208181|10200470|P1|Part 1|Lack of Efficacy|37
2963703|NCT01208181|10200466|P5|Part 1|Lost to Follow-up|1
2963704|NCT01208181|10200467|P4|Part 1|Lost to Follow-up|0
2963705|NCT01208181|10200468|P3|Part 1|Lost to Follow-up|0
2963706|NCT01208181|10200469|P2|Part 1|Lost to Follow-up|3
2963707|NCT01208181|10200470|P1|Part 1|Lost to Follow-up|5
2963708|NCT01208181|10200466|P5|Part 1|Non-compliance with study drug|0
2963709|NCT01208181|10200467|P4|Part 1|Non-compliance with study drug|0
2963710|NCT01208181|10200468|P3|Part 1|Non-compliance with study drug|0
2963711|NCT01208181|10200469|P2|Part 1|Non-compliance with study drug|1
2963712|NCT01208181|10200470|P1|Part 1|Non-compliance with study drug|1
2963713|NCT01208181|10200466|P5|Part 1|Physician Decision|0
2963714|NCT01208181|10200467|P4|Part 1|Physician Decision|0
2963715|NCT01208181|10200468|P3|Part 1|Physician Decision|0
2963716|NCT01208181|10200469|P2|Part 1|Physician Decision|0
2963717|NCT01208181|10200470|P1|Part 1|Physician Decision|4
2963718|NCT01208181|10200466|P5|Part 1|Protocol Violation|0
2963719|NCT01208181|10200467|P4|Part 1|Protocol Violation|0
2963720|NCT01208181|10200468|P3|Part 1|Protocol Violation|0
2963721|NCT01208181|10200469|P2|Part 1|Protocol Violation|5
2963722|NCT01208181|10200470|P1|Part 1|Protocol Violation|10
2963723|NCT01208181|10200466|P5|Part 1|Technical problem|0
2963724|NCT01208181|10200467|P4|Part 1|Technical problem|0
2963725|NCT01208181|10200468|P3|Part 1|Technical problem|0
2963726|NCT01208181|10200469|P2|Part 1|Technical problem|0
2963727|NCT01208181|10200470|P1|Part 1|Technical problem|5
2963728|NCT01208181|10200466|P5|Part 1|Withdrawal by Subject|0
2963729|NCT01208181|10200467|P4|Part 1|Withdrawal by Subject|0
2963730|NCT01208181|10200468|P3|Part 1|Withdrawal by Subject|0
2963731|NCT01208181|10200469|P2|Part 1|Withdrawal by Subject|10
2963732|NCT01208181|10200470|P1|Part 1|Withdrawal by Subject|11
2963733|NCT01208103|10200499|P1|Overall Study|Withdrawal by Subject|1
2963734|NCT01208103|10200499|P1|Overall Study|Adverse Event|1
2963735|NCT01208038|10200507|P1|Overall Study|Withdrawal by Subject|1
2963736|NCT01207687|10200563|P1|Overall Study|Withdrawal by Subject|1
2963737|NCT01207687|10200563|P1|Overall Study|Adverse Event|1
2963738|NCT01207596|10200601|P1|Overall Study|Withdrawal by Subject|1
2963739|NCT01207596|10200601|P1|Overall Study|Adverse Event|3
2963740|NCT01207596|10200601|P1|Overall Study|Lack of Efficacy|1
2963741|NCT01207596|10200601|P1|Overall Study|Physician Decision|4
2963742|NCT01207583|10200614|P3|Overall Study|Lost to Follow-up|0
2963743|NCT01207583|10200615|P2|Overall Study|Lost to Follow-up|2
2963744|NCT01207583|10200616|P1|Overall Study|Lost to Follow-up|0
2963745|NCT01207583|10200614|P3|Overall Study|Participant failed to return|0
2963746|NCT01207583|10200615|P2|Overall Study|Participant failed to return|0
2963747|NCT01207583|10200616|P1|Overall Study|Participant failed to return|1
2963748|NCT01207583|10200614|P3|Overall Study|Withdrawal by Subject|1
2963749|NCT01207583|10200615|P2|Overall Study|Withdrawal by Subject|3
2963750|NCT01207583|10200616|P1|Overall Study|Withdrawal by Subject|0
2963751|NCT01207492|10200669|P1|Overall Study|Toxicity|1
2963752|NCT01207492|10200669|P1|Overall Study|Progressive disease|3
2963753|NCT01207492|10200669|P1|Overall Study|Physician Decision|1
2963754|NCT01207492|10200669|P1|Overall Study|Withdrawal by Subject|9
2963755|NCT01207492|10200669|P1|Overall Study|Still on study|1
2963756|NCT01207453|10200684|P2|2nd Intervention|Lost to Follow-up|0
2963757|NCT01207453|10200685|P1|2nd Intervention|Lost to Follow-up|1
2963758|NCT01207453|10200684|P2|2nd Intervention|Adverse Event|2
2963759|NCT01207453|10200685|P1|2nd Intervention|Adverse Event|1
2963760|NCT01207453|10200684|P2|Washout|Lost to Follow-up|0
2963761|NCT01207453|10200685|P1|Washout|Lost to Follow-up|1
2963762|NCT01207453|10200684|P2|Washout|Adverse Event|0
2963763|NCT01207453|10200685|P1|Washout|Adverse Event|1
2963764|NCT01207453|10200684|P2|First Intervention|Adverse Event|1
2963765|NCT01207453|10200685|P1|First Intervention|Adverse Event|2
2963766|NCT01207440|10200711|P7|Overall Study|Reason Not Specified|0
2963767|NCT01207440|10200712|P6|Overall Study|Reason Not Specified|3
2963768|NCT01207440|10200713|P5|Overall Study|Reason Not Specified|4
2963769|NCT01207440|10200714|P4|Overall Study|Reason Not Specified|0
2963770|NCT01207440|10200715|P3|Overall Study|Reason Not Specified|7
2963771|NCT01207440|10200716|P2|Overall Study|Reason Not Specified|10
2963772|NCT01207440|10200717|P1|Overall Study|Reason Not Specified|10
2963773|NCT01207440|10200711|P7|Overall Study|Withdrawal by Subject|0
2963774|NCT01207440|10200712|P6|Overall Study|Withdrawal by Subject|2
2963775|NCT01207440|10200713|P5|Overall Study|Withdrawal by Subject|2
2963776|NCT01207440|10200714|P4|Overall Study|Withdrawal by Subject|3
2963777|NCT01207440|10200715|P3|Overall Study|Withdrawal by Subject|5
2963778|NCT01207440|10200716|P2|Overall Study|Withdrawal by Subject|4
2963779|NCT01207440|10200717|P1|Overall Study|Withdrawal by Subject|29
2963780|NCT01207440|10200711|P7|Overall Study|Site Terminated by Sponsor|2
2963781|NCT01207440|10200712|P6|Overall Study|Site Terminated by Sponsor|0
2963782|NCT01207440|10200713|P5|Overall Study|Site Terminated by Sponsor|3
2963783|NCT01207440|10200714|P4|Overall Study|Site Terminated by Sponsor|2
2963784|NCT01207440|10200715|P3|Overall Study|Site Terminated by Sponsor|12
2963785|NCT01207440|10200716|P2|Overall Study|Site Terminated by Sponsor|19
2963786|NCT01207440|10200717|P1|Overall Study|Site Terminated by Sponsor|69
2963787|NCT01207440|10200711|P7|Overall Study|Protocol Violation|0
2963788|NCT01207440|10200712|P6|Overall Study|Protocol Violation|0
2963789|NCT01207440|10200713|P5|Overall Study|Protocol Violation|0
2963790|NCT01207440|10200714|P4|Overall Study|Protocol Violation|0
2963791|NCT01207440|10200715|P3|Overall Study|Protocol Violation|0
2963792|NCT01207440|10200716|P2|Overall Study|Protocol Violation|0
2963793|NCT01207440|10200717|P1|Overall Study|Protocol Violation|2
2963794|NCT01207440|10200711|P7|Overall Study|Progressive Disease|0
2963795|NCT01207440|10200712|P6|Overall Study|Progressive Disease|27
2963796|NCT01207440|10200713|P5|Overall Study|Progressive Disease|23
2963797|NCT01207440|10200714|P4|Overall Study|Progressive Disease|7
2963798|NCT01207440|10200715|P3|Overall Study|Progressive Disease|19
2963799|NCT01207440|10200716|P2|Overall Study|Progressive Disease|10
2963800|NCT01207440|10200717|P1|Overall Study|Progressive Disease|19
2963801|NCT01207440|10200711|P7|Overall Study|Physician Decision|0
2963802|NCT01207440|10200712|P6|Overall Study|Physician Decision|0
2963803|NCT01207440|10200713|P5|Overall Study|Physician Decision|1
2963804|NCT01207440|10200714|P4|Overall Study|Physician Decision|0
2963805|NCT01207440|10200715|P3|Overall Study|Physician Decision|5
2963806|NCT01207440|10200716|P2|Overall Study|Physician Decision|5
2963807|NCT01207440|10200717|P1|Overall Study|Physician Decision|6
2963808|NCT01207440|10200711|P7|Overall Study|Non-compliance with Study Drug|0
2963809|NCT01207440|10200712|P6|Overall Study|Non-compliance with Study Drug|0
2963810|NCT01207440|10200713|P5|Overall Study|Non-compliance with Study Drug|0
2963811|NCT01207440|10200714|P4|Overall Study|Non-compliance with Study Drug|0
2963812|NCT01207440|10200715|P3|Overall Study|Non-compliance with Study Drug|1
2963813|NCT01207440|10200716|P2|Overall Study|Non-compliance with Study Drug|0
2963814|NCT01207440|10200717|P1|Overall Study|Non-compliance with Study Drug|3
2963815|NCT01207440|10200711|P7|Overall Study|Lost to Follow-up|0
2963816|NCT01207440|10200712|P6|Overall Study|Lost to Follow-up|0
2963817|NCT01207440|10200713|P5|Overall Study|Lost to Follow-up|0
2963818|NCT01207440|10200714|P4|Overall Study|Lost to Follow-up|1
2963819|NCT01207440|10200715|P3|Overall Study|Lost to Follow-up|2
2963820|NCT01207440|10200716|P2|Overall Study|Lost to Follow-up|0
2963821|NCT01207440|10200717|P1|Overall Study|Lost to Follow-up|0
2963822|NCT01207440|10200711|P7|Overall Study|Lack of Efficacy|0
2963823|NCT01207440|10200712|P6|Overall Study|Lack of Efficacy|3
2963824|NCT01207440|10200713|P5|Overall Study|Lack of Efficacy|2
2963825|NCT01207440|10200714|P4|Overall Study|Lack of Efficacy|1
2963826|NCT01207440|10200715|P3|Overall Study|Lack of Efficacy|5
2963827|NCT01207440|10200716|P2|Overall Study|Lack of Efficacy|2
2963828|NCT01207440|10200717|P1|Overall Study|Lack of Efficacy|13
2963829|NCT01207440|10200711|P7|Overall Study|Death|1
2963830|NCT01207440|10200712|P6|Overall Study|Death|5
2963831|NCT01207440|10200713|P5|Overall Study|Death|7
2963832|NCT01207440|10200714|P4|Overall Study|Death|2
2963833|NCT01207440|10200715|P3|Overall Study|Death|2
2963834|NCT01207440|10200716|P2|Overall Study|Death|3
2963835|NCT01207440|10200717|P1|Overall Study|Death|6
2963836|NCT01207440|10200711|P7|Overall Study|Adverse Event|2
2963837|NCT01207440|10200712|P6|Overall Study|Adverse Event|6
2963838|NCT01207440|10200713|P5|Overall Study|Adverse Event|6
2963839|NCT01207440|10200714|P4|Overall Study|Adverse Event|2
2963840|NCT01207440|10200715|P3|Overall Study|Adverse Event|7
2963841|NCT01207440|10200716|P2|Overall Study|Adverse Event|11
2963842|NCT01207440|10200717|P1|Overall Study|Adverse Event|46
2963843|NCT01207427|10200784|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2963844|NCT01207427|10200785|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2963845|NCT01207427|10200786|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2963846|NCT01207427|10200784|P3|Double-blind Treatment Period|Protocol Violation|1
2963847|NCT01207427|10200785|P2|Double-blind Treatment Period|Protocol Violation|1
2963848|NCT01207427|10200786|P1|Double-blind Treatment Period|Protocol Violation|2
2963849|NCT01207427|10200784|P3|Double-blind Treatment Period|Lost to Follow-up|1
2963850|NCT01207427|10200785|P2|Double-blind Treatment Period|Lost to Follow-up|0
2963851|NCT01207427|10200786|P1|Double-blind Treatment Period|Lost to Follow-up|0
2963852|NCT01207427|10200784|P3|Double-blind Treatment Period|Adverse Event|0
2963853|NCT01207427|10200785|P2|Double-blind Treatment Period|Adverse Event|1
2963854|NCT01207427|10200786|P1|Double-blind Treatment Period|Adverse Event|0
2963855|NCT01207414|10200796|P2|Overall Study|Randomized in error|0
2963856|NCT01207414|10200797|P1|Overall Study|Randomized in error|1
2963857|NCT01207414|10200796|P2|Overall Study|Protocol deviation|9
2963858|NCT01207414|10200797|P1|Overall Study|Protocol deviation|12
2963859|NCT01207414|10200796|P2|Overall Study|Administrative problems|1
2963860|NCT01207414|10200797|P1|Overall Study|Administrative problems|1
2963861|NCT01207414|10200796|P2|Overall Study|Lost to Follow-up|17
2963862|NCT01207414|10200797|P1|Overall Study|Lost to Follow-up|15
2963863|NCT01207414|10200796|P2|Overall Study|Patient withdrew consent|11
2963864|NCT01207414|10200797|P1|Overall Study|Patient withdrew consent|14
2963865|NCT01207414|10200796|P2|Overall Study|Unsatisfactory therapeutic effect|4
2963866|NCT01207414|10200797|P1|Overall Study|Unsatisfactory therapeutic effect|5
2963867|NCT01207414|10200796|P2|Overall Study|Abnormal test procedure results|1
2963868|NCT01207414|10200797|P1|Overall Study|Abnormal test procedure results|0
2963869|NCT01207414|10200796|P2|Overall Study|Adverse Event|39
2963870|NCT01207414|10200797|P1|Overall Study|Adverse Event|25
2963871|NCT01207388|10200822|P1|Overall Study|Withdrawal by Subject|1
2963872|NCT01207388|10200822|P1|Overall Study|Death|67
2963873|NCT01207219|10200847|P3|Overall Study|Lost to Follow-up|6
2963874|NCT01207219|10200848|P2|Overall Study|Lost to Follow-up|8
2963875|NCT01207219|10200849|P1|Overall Study|Lost to Follow-up|6
2963876|NCT01207219|10200847|P3|Overall Study|changed diagnosis during study period|1
2963877|NCT01207219|10200848|P2|Overall Study|changed diagnosis during study period|3
2963878|NCT01207219|10200849|P1|Overall Study|changed diagnosis during study period|5
2963879|NCT01207102|10200869|P1|Overall Study|Withdrawal by Treating Physician|1
2963880|NCT01207102|10200869|P1|Overall Study|progression|2
2963881|NCT01207102|10200869|P1|Overall Study|Adverse Event|2
2963882|NCT01207102|10200869|P1|Overall Study|Withdrawal by Subject|5
2963883|NCT01206816|10200881|P7|Overall Study|other than stated above|1
2963884|NCT01206816|10200882|P6|Overall Study|other than stated above|0
2963885|NCT01206816|10200883|P5|Overall Study|other than stated above|0
2963886|NCT01206816|10200884|P4|Overall Study|other than stated above|0
2963887|NCT01206816|10200885|P3|Overall Study|other than stated above|1
2963888|NCT01206816|10200886|P2|Overall Study|other than stated above|0
2963889|NCT01206816|10200887|P1|Overall Study|other than stated above|0
2963890|NCT01206816|10200881|P7|Overall Study|Other AE|2
2963891|NCT01206816|10200882|P6|Overall Study|Other AE|3
2963892|NCT01206816|10200883|P5|Overall Study|Other AE|0
2963893|NCT01206816|10200884|P4|Overall Study|Other AE|0
2963894|NCT01206816|10200885|P3|Overall Study|Other AE|4
2963895|NCT01206816|10200886|P2|Overall Study|Other AE|0
2963896|NCT01206816|10200887|P1|Overall Study|Other AE|0
2963897|NCT01206816|10200881|P7|Overall Study|Progressive disease|3
2963898|NCT01206816|10200882|P6|Overall Study|Progressive disease|16
2963899|NCT01206816|10200883|P5|Overall Study|Progressive disease|3
2963900|NCT01206816|10200884|P4|Overall Study|Progressive disease|3
2963901|NCT01206816|10200885|P3|Overall Study|Progressive disease|13
2963902|NCT01206816|10200886|P2|Overall Study|Progressive disease|3
2963903|NCT01206816|10200887|P1|Overall Study|Progressive disease|3
2963904|NCT01206816|10200881|P7|Overall Study|Withdrawal by Subject|0
2963905|NCT01206816|10200882|P6|Overall Study|Withdrawal by Subject|0
2963906|NCT01206816|10200883|P5|Overall Study|Withdrawal by Subject|0
2963907|NCT01206816|10200884|P4|Overall Study|Withdrawal by Subject|0
2963908|NCT01206816|10200885|P3|Overall Study|Withdrawal by Subject|1
2963909|NCT01206816|10200886|P2|Overall Study|Withdrawal by Subject|0
2963910|NCT01206816|10200887|P1|Overall Study|Withdrawal by Subject|0
2963911|NCT01206816|10200881|P7|Overall Study|Protocol Violation|0
2963912|NCT01206816|10200882|P6|Overall Study|Protocol Violation|0
2963913|NCT01206816|10200883|P5|Overall Study|Protocol Violation|0
2963914|NCT01206816|10200884|P4|Overall Study|Protocol Violation|0
2963915|NCT01206816|10200885|P3|Overall Study|Protocol Violation|1
2963916|NCT01206816|10200886|P2|Overall Study|Protocol Violation|0
2963917|NCT01206816|10200887|P1|Overall Study|Protocol Violation|0
2963918|NCT01206777|10200933|P1|Overall Study|Adverse Event|1
2963919|NCT01206777|10200933|P1|Overall Study|Death|1
2963920|NCT01206764|10200939|P1|Overall Study|Protocol deviation|3
2963921|NCT01206764|10200939|P1|Overall Study|Disease progression|88
2963922|NCT01206764|10200939|P1|Overall Study|New cancer therapy|2
2963923|NCT01206764|10200939|P1|Overall Study|Death|11
2963924|NCT01206764|10200939|P1|Overall Study|Lost to Follow-up|6
2963925|NCT01206764|10200939|P1|Overall Study|Patient withdrew consent|5
2963926|NCT01206764|10200939|P1|Overall Study|Abnormal test procedure result|1
2963927|NCT01206764|10200939|P1|Overall Study|Abnormal laboratory value|2
2963928|NCT01206764|10200939|P1|Overall Study|Adverse Event|20
2963929|NCT01206582|10200997|P2|Overall Study|Discontinued intervention before week 8|2
2963930|NCT01206582|10200998|P1|Overall Study|Discontinued intervention before week 8|1
2963931|NCT01206582|10200997|P2|Overall Study|Withdrew prior to study|0
2963932|NCT01206582|10200998|P1|Overall Study|Withdrew prior to study|1
2963933|NCT01206517|10201030|P6|Overall Study|Withdrawal by Subject|0
2963934|NCT01206517|10201031|P5|Overall Study|Withdrawal by Subject|1
2963935|NCT01206517|10201032|P4|Overall Study|Withdrawal by Subject|0
2963936|NCT01206517|10201033|P3|Overall Study|Withdrawal by Subject|2
2963937|NCT01206517|10201034|P2|Overall Study|Withdrawal by Subject|0
2963938|NCT01206517|10201035|P1|Overall Study|Withdrawal by Subject|0
2963939|NCT01206439|10201115|P1|Overall Study|subject did not meet inclusion criteria|1
2963940|NCT01206322|10201138|P4|Overall Study|Adverse Event|1
2963941|NCT01206322|10201139|P3|Overall Study|Adverse Event|0
2963942|NCT01206322|10201140|P2|Overall Study|Adverse Event|0
2963943|NCT01206322|10201141|P1|Overall Study|Adverse Event|0
2963944|NCT01206140|10201157|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
2963945|NCT01206140|10201158|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
2963946|NCT01206101|10201170|P2|Overall Study|Unclassified|0
2963947|NCT01206101|10201171|P1|Overall Study|Unclassified|1
2963948|NCT01206101|10201170|P2|Overall Study|Physician Decision|1
2963949|NCT01206101|10201171|P1|Overall Study|Physician Decision|0
2963950|NCT01206101|10201170|P2|Overall Study|Adverse Event|0
2963951|NCT01206101|10201171|P1|Overall Study|Adverse Event|1
2963952|NCT01205776|10201212|P2|Overall Study|Withdrawal by Subject|34
2963953|NCT01205776|10201213|P1|Overall Study|Withdrawal by Subject|11
2963954|NCT01205776|10201212|P2|Overall Study|Lost to Follow-up|61
2963955|NCT01205776|10201213|P1|Overall Study|Lost to Follow-up|53
2963956|NCT01205685|10201401|P1|Overall Study|Withdrawal by Subject|1
2963957|NCT01205685|10201401|P1|Overall Study|Disease Progression|10
2963958|NCT01205581|10201421|P6|Overall Study|Withdrawal by Subject|0
2963959|NCT01205581|10201422|P5|Overall Study|Withdrawal by Subject|0
2963960|NCT01205581|10201423|P4|Overall Study|Withdrawal by Subject|0
2963961|NCT01205581|10201424|P3|Overall Study|Withdrawal by Subject|0
2963962|NCT01205581|10201425|P2|Overall Study|Withdrawal by Subject|0
2963963|NCT01205581|10201426|P1|Overall Study|Withdrawal by Subject|1
2963964|NCT01205529|10201496|P1|Overall Study|No longer met criteria|30
2963965|NCT01205529|10201496|P1|Overall Study|Unstable post op|15
2963966|NCT01205529|10201496|P1|Overall Study|Physician Decision|4
2963967|NCT01205529|10201496|P1|Overall Study|Withdrawal by Subject|2
2963968|NCT01205529|10201496|P1|Overall Study|Procedure Cancelled|4
2963969|NCT01205451|10201519|P2|Overall Study|Withdrawal by Subject|9
2963970|NCT01205451|10201520|P1|Overall Study|Withdrawal by Subject|5
2963971|NCT01205451|10201519|P2|Overall Study|Lost to Follow-up|1
2963972|NCT01205451|10201520|P1|Overall Study|Lost to Follow-up|1
2963973|NCT01205438|10201565|P3|Overall Study|Sponsor Decision|1
2963974|NCT01205438|10201566|P2|Overall Study|Sponsor Decision|1
2963975|NCT01205438|10201567|P1|Overall Study|Sponsor Decision|0
2963976|NCT01205438|10201565|P3|Overall Study|Protocol Violation|4
2963977|NCT01205438|10201566|P2|Overall Study|Protocol Violation|7
2963978|NCT01205438|10201567|P1|Overall Study|Protocol Violation|2
2963979|NCT01205438|10201565|P3|Overall Study|Physician Decision|2
2963980|NCT01205438|10201566|P2|Overall Study|Physician Decision|3
2963981|NCT01205438|10201567|P1|Overall Study|Physician Decision|0
2963982|NCT01205438|10201565|P3|Overall Study|Withdrawal by Subject|19
2963983|NCT01205438|10201566|P2|Overall Study|Withdrawal by Subject|25
2963984|NCT01205438|10201567|P1|Overall Study|Withdrawal by Subject|19
2963985|NCT01205438|10201565|P3|Overall Study|Lost to Follow-up|8
2963986|NCT01205438|10201566|P2|Overall Study|Lost to Follow-up|7
2963987|NCT01205438|10201567|P1|Overall Study|Lost to Follow-up|6
2963988|NCT01205438|10201565|P3|Overall Study|Lack of Efficacy|14
2963989|NCT01205438|10201566|P2|Overall Study|Lack of Efficacy|11
2963990|NCT01205438|10201567|P1|Overall Study|Lack of Efficacy|14
2963991|NCT01205438|10201565|P3|Overall Study|Entry Criteria Not Met|13
2963992|NCT01205438|10201566|P2|Overall Study|Entry Criteria Not Met|15
2963993|NCT01205438|10201567|P1|Overall Study|Entry Criteria Not Met|16
2963994|NCT01205438|10201565|P3|Overall Study|Death|3
2963995|NCT01205438|10201566|P2|Overall Study|Death|1
2963996|NCT01205438|10201567|P1|Overall Study|Death|1
2963997|NCT01205438|10201565|P3|Overall Study|Adverse Event|24
2963998|NCT01205438|10201566|P2|Overall Study|Adverse Event|17
2963999|NCT01205438|10201567|P1|Overall Study|Adverse Event|19
2964000|NCT01205269|10201623|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
2964001|NCT01205269|10201624|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
2964002|NCT01205269|10201625|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
2964003|NCT01205269|10201626|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
2964004|NCT01205269|10201627|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
2964005|NCT01205269|10201628|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
2964006|NCT01205230|10201668|P2|Overall Study|Physician Decision|0
2964007|NCT01205230|10201669|P1|Overall Study|Physician Decision|1
2964008|NCT01205230|10201668|P2|Overall Study|Adverse Event|0
2964009|NCT01205230|10201669|P1|Overall Study|Adverse Event|4
2964010|NCT01205165|10201712|P1|Overall Study|Lost to Follow-up|2
2964011|NCT01205152|10201725|P1|Overall Study|Death|1
2964012|NCT01205126|10201738|P2|Maintenance Phase|Withdrawal by Subject|11
2964013|NCT01205126|10201739|P1|Maintenance Phase|Withdrawal by Subject|8
2964014|NCT01205126|10201738|P2|Maintenance Phase|Lost to Follow-up|5
2964015|NCT01205126|10201739|P1|Maintenance Phase|Lost to Follow-up|5
2964016|NCT01205126|10201738|P2|Maintenance Phase|Other|8
2964017|NCT01205126|10201739|P1|Maintenance Phase|Other|11
2964018|NCT01205126|10201738|P2|Maintenance Phase|Prohibited drugs used|0
2964019|NCT01205126|10201739|P1|Maintenance Phase|Prohibited drugs used|1
2964020|NCT01205126|10201738|P2|Maintenance Phase|More than the maximum dosage required|5
2964021|NCT01205126|10201739|P1|Maintenance Phase|More than the maximum dosage required|5
2964022|NCT01205126|10201738|P2|Maintenance Phase|Death|4
2964023|NCT01205126|10201739|P1|Maintenance Phase|Death|4
2964024|NCT01205126|10201738|P2|Maintenance Phase|Adverse Event|7
2964025|NCT01205126|10201739|P1|Maintenance Phase|Adverse Event|3
2964026|NCT01205126|10201738|P2|Between Titration & Maintenance Phase|Other|4
2964027|NCT01205126|10201739|P1|Between Titration & Maintenance Phase|Other|0
2964028|NCT01205126|10201738|P2|Titration Phase|Other|6
2964029|NCT01205126|10201739|P1|Titration Phase|Other|8
2964030|NCT01205126|10201738|P2|Titration Phase|More than maximum dosage required|3
2964031|NCT01205126|10201739|P1|Titration Phase|More than maximum dosage required|2
2964032|NCT01205126|10201738|P2|Titration Phase|No stable titration dose|0
2964033|NCT01205126|10201739|P1|Titration Phase|No stable titration dose|1
2964034|NCT01205126|10201738|P2|Titration Phase|Lost to Follow-up|2
2964035|NCT01205126|10201739|P1|Titration Phase|Lost to Follow-up|2
2964036|NCT01205126|10201738|P2|Titration Phase|Withdrawal by Subject|5
2964037|NCT01205126|10201739|P1|Titration Phase|Withdrawal by Subject|5
2964038|NCT01205126|10201738|P2|Titration Phase|Adverse Event|3
2964039|NCT01205126|10201739|P1|Titration Phase|Adverse Event|5
2964040|NCT01205035|10201757|P2|Overall Study|Physician Decision|0
2964041|NCT01205035|10201758|P1|Overall Study|Physician Decision|1
2964042|NCT01205035|10201757|P2|Overall Study|Withdrawal by Subject|0
2964043|NCT01205035|10201758|P1|Overall Study|Withdrawal by Subject|1
2964044|NCT01204918|10201775|P3|Overall Study|Withdrawal by Subject|5
2964045|NCT01204918|10201776|P2|Overall Study|Withdrawal by Subject|10
2964046|NCT01204918|10201777|P1|Overall Study|Withdrawal by Subject|4
2964047|NCT01204775|10201820|P2|Overall Study|Withdrawal by Subject|0
2964048|NCT01204775|10201821|P1|Overall Study|Withdrawal by Subject|1
2964049|NCT01204775|10201820|P2|Overall Study|Poor/non-compliance|1
2964050|NCT01204775|10201821|P1|Overall Study|Poor/non-compliance|0
2964051|NCT01204710|10201846|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
2964052|NCT01204710|10201847|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
2964053|NCT01204710|10201846|P2|Optional Olaratumab Monotherapy|Physician Decision|1
2964054|NCT01204710|10201847|P1|Optional Olaratumab Monotherapy|Physician Decision|0
2964055|NCT01204710|10201846|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
2964056|NCT01204710|10201847|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
2964057|NCT01204710|10201846|P2|Randomization Treatment|Moved and Followed for Survival|1
2964058|NCT01204710|10201847|P1|Randomization Treatment|Moved and Followed for Survival|0
2964059|NCT01204710|10201846|P2|Randomization Treatment|Worsening of General condition|1
2964060|NCT01204710|10201847|P1|Randomization Treatment|Worsening of General condition|0
2964061|NCT01204710|10201846|P2|Randomization Treatment|Sponsor Decision|1
2964062|NCT01204710|10201847|P1|Randomization Treatment|Sponsor Decision|0
2964063|NCT01204710|10201846|P2|Randomization Treatment|Adverse Event|2
2964064|NCT01204710|10201847|P1|Randomization Treatment|Adverse Event|4
2964065|NCT01204710|10201846|P2|Randomization Treatment|Entry criteria not met|1
2964066|NCT01204710|10201847|P1|Randomization Treatment|Entry criteria not met|0
2964067|NCT01204710|10201846|P2|Randomization Treatment|Physician Decision|2
2964068|NCT01204710|10201847|P1|Randomization Treatment|Physician Decision|3
2964069|NCT01204710|10201846|P2|Randomization Treatment|Withdrawal by Subject|5
2964070|NCT01204710|10201847|P1|Randomization Treatment|Withdrawal by Subject|6
2964071|NCT01204710|10201846|P2|Randomization Treatment|Lost to Follow-up|0
2964072|NCT01204710|10201847|P1|Randomization Treatment|Lost to Follow-up|1
2964073|NCT01204697|10201883|P2|Overall Study|Randomized, but not treated|1
2964074|NCT01204697|10201884|P1|Overall Study|Randomized, but not treated|0
2964075|NCT01204697|10201883|P2|Overall Study|Withdrawal by Subject|4
2964076|NCT01204697|10201884|P1|Overall Study|Withdrawal by Subject|2
2964077|NCT01204697|10201883|P2|Overall Study|Lost to Follow-up|4
2964078|NCT01204697|10201884|P1|Overall Study|Lost to Follow-up|3
2964079|NCT01204697|10201883|P2|Overall Study|Death|27
2964080|NCT01204697|10201884|P1|Overall Study|Death|26
2964081|NCT01204671|10201905|P5|Overall Study|Physician Decision|0
2964082|NCT01204671|10201906|P4|Overall Study|Physician Decision|1
2964083|NCT01204671|10201907|P3|Overall Study|Physician Decision|0
2964084|NCT01204671|10201908|P2|Overall Study|Physician Decision|0
2964085|NCT01204671|10201909|P1|Overall Study|Physician Decision|0
2964086|NCT01204671|10201905|P5|Overall Study|Unknown Completion Status|0
2964087|NCT01204671|10201906|P4|Overall Study|Unknown Completion Status|0
2964088|NCT01204671|10201907|P3|Overall Study|Unknown Completion Status|0
2964089|NCT01204671|10201908|P2|Overall Study|Unknown Completion Status|1
2964090|NCT01204671|10201909|P1|Overall Study|Unknown Completion Status|1
2964091|NCT01204671|10201905|P5|Overall Study|Lost to Follow-up|0
2964092|NCT01204671|10201906|P4|Overall Study|Lost to Follow-up|4
2964093|NCT01204671|10201907|P3|Overall Study|Lost to Follow-up|6
2964094|NCT01204671|10201908|P2|Overall Study|Lost to Follow-up|8
2964095|NCT01204671|10201909|P1|Overall Study|Lost to Follow-up|7
2964096|NCT01204671|10201905|P5|Overall Study|Withdrawal by Subject|3
2964097|NCT01204671|10201906|P4|Overall Study|Withdrawal by Subject|5
2964098|NCT01204671|10201907|P3|Overall Study|Withdrawal by Subject|4
2964099|NCT01204671|10201908|P2|Overall Study|Withdrawal by Subject|3
2964100|NCT01204671|10201909|P1|Overall Study|Withdrawal by Subject|2
2964101|NCT01204671|10201905|P5|Overall Study|Adverse Event|1
2964102|NCT01204671|10201906|P4|Overall Study|Adverse Event|3
2964103|NCT01204671|10201907|P3|Overall Study|Adverse Event|3
2964104|NCT01204671|10201908|P2|Overall Study|Adverse Event|3
2964105|NCT01204671|10201909|P1|Overall Study|Adverse Event|4
2964106|NCT01204658|10201971|P4|Primary Phase|Adverse Event|0
2964107|NCT01204658|10201972|P3|Primary Phase|Adverse Event|1
2964108|NCT01204658|10201973|P2|Primary Phase|Adverse Event|0
2964109|NCT01204658|10201974|P1|Primary Phase|Adverse Event|0
2964110|NCT01204398|10202092|P1|Overall Study|Adverse Event|1
2964111|NCT01204294|10202109|P7|Overall Study|Other (house moving)|0
2964112|NCT01204294|10202110|P6|Overall Study|Other (house moving)|0
2964113|NCT01204294|10202111|P5|Overall Study|Other (house moving)|0
2964114|NCT01204294|10202112|P4|Overall Study|Other (house moving)|0
2964115|NCT01204294|10202113|P3|Overall Study|Other (house moving)|1
2964116|NCT01204294|10202114|P2|Overall Study|Other (house moving)|0
2964117|NCT01204294|10202115|P1|Overall Study|Other (house moving)|0
2964118|NCT01204294|10202109|P7|Overall Study|Lack of Efficacy|0
2964119|NCT01204294|10202110|P6|Overall Study|Lack of Efficacy|0
2964120|NCT01204294|10202111|P5|Overall Study|Lack of Efficacy|0
2964121|NCT01204294|10202112|P4|Overall Study|Lack of Efficacy|2
2964122|NCT01204294|10202113|P3|Overall Study|Lack of Efficacy|0
2964123|NCT01204294|10202114|P2|Overall Study|Lack of Efficacy|0
2964124|NCT01204294|10202115|P1|Overall Study|Lack of Efficacy|0
2964125|NCT01204294|10202109|P7|Overall Study|Withdrawal by Subject|2
2964126|NCT01204294|10202110|P6|Overall Study|Withdrawal by Subject|1
2964127|NCT01204294|10202111|P5|Overall Study|Withdrawal by Subject|1
2964128|NCT01204294|10202112|P4|Overall Study|Withdrawal by Subject|1
2964129|NCT01204294|10202113|P3|Overall Study|Withdrawal by Subject|2
2964130|NCT01204294|10202114|P2|Overall Study|Withdrawal by Subject|2
2964131|NCT01204294|10202115|P1|Overall Study|Withdrawal by Subject|0
2964132|NCT01204294|10202109|P7|Overall Study|Protocol Violation|0
2964133|NCT01204294|10202110|P6|Overall Study|Protocol Violation|0
2964134|NCT01204294|10202111|P5|Overall Study|Protocol Violation|0
2964135|NCT01204294|10202112|P4|Overall Study|Protocol Violation|1
2964136|NCT01204294|10202113|P3|Overall Study|Protocol Violation|2
2964137|NCT01204294|10202114|P2|Overall Study|Protocol Violation|0
2964138|NCT01204294|10202115|P1|Overall Study|Protocol Violation|1
2964139|NCT01204294|10202109|P7|Overall Study|Adverse Event|0
2964140|NCT01204294|10202110|P6|Overall Study|Adverse Event|4
2964141|NCT01204294|10202111|P5|Overall Study|Adverse Event|1
2964142|NCT01204294|10202112|P4|Overall Study|Adverse Event|7
2964143|NCT01204294|10202113|P3|Overall Study|Adverse Event|0
2964144|NCT01204294|10202114|P2|Overall Study|Adverse Event|6
2964145|NCT01204294|10202115|P1|Overall Study|Adverse Event|2
2964146|NCT01203956|10202149|P2|Second Two-week Period|Non-compliant: no evaluable results|6
2964147|NCT01203956|10202150|P1|Second Two-week Period|Non-compliant: no evaluable results|5
2964148|NCT01203930|10202159|P2|Overall Study|Adverse Event|5
2964149|NCT01203930|10202160|P1|Overall Study|Adverse Event|17
2964150|NCT01203930|10202159|P2|Overall Study|Poor tolerance of study drug|1
2964151|NCT01203930|10202160|P1|Overall Study|Poor tolerance of study drug|0
2964152|NCT01203930|10202159|P2|Overall Study|Study Terminated by Sponsor|12
2964153|NCT01203930|10202160|P1|Overall Study|Study Terminated by Sponsor|0
2964154|NCT01203930|10202159|P2|Overall Study|Investigator Request|8
2964155|NCT01203930|10202160|P1|Overall Study|Investigator Request|0
2964156|NCT01203930|10202159|P2|Overall Study|Withdrew Consent|10
2964157|NCT01203930|10202160|P1|Overall Study|Withdrew Consent|1
2964158|NCT01203930|10202159|P2|Overall Study|Death|1
2964159|NCT01203930|10202160|P1|Overall Study|Death|3
2964160|NCT01203930|10202159|P2|Overall Study|Disease Progression|4
2964161|NCT01203930|10202160|P1|Overall Study|Disease Progression|0
2964162|NCT01203917|10202182|P1|Overall Study|Due to EGFR M+I patient|1
2964163|NCT01203917|10202182|P1|Overall Study|Due to objective disease progression|1
2964164|NCT01203917|10202182|P1|Overall Study|Withdrawal by Subject|3
2964165|NCT01203917|10202182|P1|Overall Study|Lost to Follow-up|2
2964166|NCT01203917|10202182|P1|Overall Study|Death|29
2964167|NCT01203878|10202195|P3|Overall Study|Adverse Event|2
2964168|NCT01203878|10202196|P2|Overall Study|Adverse Event|0
2964169|NCT01203878|10202197|P1|Overall Study|Adverse Event|0
2964170|NCT01203878|10202195|P3|Overall Study|Withdrawal by Subject|1
2964171|NCT01203878|10202196|P2|Overall Study|Withdrawal by Subject|0
2964172|NCT01203878|10202197|P1|Overall Study|Withdrawal by Subject|0
2964173|NCT01203852|10202208|P1|Washout 2 Weeks|Physician Decision|46
2964174|NCT01203852|10202208|P1|Metoprolol 8 Weeks|Physician Decision|470
2964175|NCT01203787|10202226|P2|Overall Study|Adverse Event|15
2964176|NCT01203787|10202227|P1|Overall Study|Adverse Event|11
2964177|NCT01203787|10202226|P2|Overall Study|Lost to Follow-up|0
2964178|NCT01203787|10202227|P1|Overall Study|Lost to Follow-up|2
2964179|NCT01203787|10202226|P2|Overall Study|Withdrawal by Subject|2
2964180|NCT01203787|10202227|P1|Overall Study|Withdrawal by Subject|6
2964181|NCT01203787|10202226|P2|Overall Study|Death|10
2964182|NCT01203787|10202227|P1|Overall Study|Death|12
2964183|NCT01203098|10202298|P3|Overall Study|Withdrawal by Subject|3
2964184|NCT01203098|10202299|P2|Overall Study|Withdrawal by Subject|1
2964185|NCT01203098|10202300|P1|Overall Study|Withdrawal by Subject|1
2964186|NCT01203098|10202298|P3|Overall Study|Physician Decision|0
2964187|NCT01203098|10202299|P2|Overall Study|Physician Decision|2
2964188|NCT01203098|10202300|P1|Overall Study|Physician Decision|2
2964189|NCT01203098|10202298|P3|Overall Study|Lost to Follow-up|1
2964190|NCT01203098|10202299|P2|Overall Study|Lost to Follow-up|0
2964191|NCT01203098|10202300|P1|Overall Study|Lost to Follow-up|0
2964192|NCT01203098|10202298|P3|Overall Study|Adverse Event|7
2964193|NCT01203098|10202299|P2|Overall Study|Adverse Event|1
2964194|NCT01203098|10202300|P1|Overall Study|Adverse Event|3
2964195|NCT01203072|10202316|P5|Overall Study|Withdrawal by Subject|3
2964196|NCT01203072|10202317|P4|Overall Study|Withdrawal by Subject|2
2964197|NCT01203072|10202318|P3|Overall Study|Withdrawal by Subject|1
2964198|NCT01203072|10202319|P2|Overall Study|Withdrawal by Subject|2
2964199|NCT01203072|10202320|P1|Overall Study|Withdrawal by Subject|2
2964200|NCT01203072|10202316|P5|Overall Study|Protocol Violation|1
2964201|NCT01203072|10202317|P4|Overall Study|Protocol Violation|0
2964202|NCT01203072|10202318|P3|Overall Study|Protocol Violation|0
2964203|NCT01203072|10202319|P2|Overall Study|Protocol Violation|0
2964204|NCT01203072|10202320|P1|Overall Study|Protocol Violation|2
2964205|NCT01203072|10202316|P5|Overall Study|Lost to Follow-up|0
2964206|NCT01203072|10202317|P4|Overall Study|Lost to Follow-up|0
2964207|NCT01203072|10202318|P3|Overall Study|Lost to Follow-up|0
2964208|NCT01203072|10202319|P2|Overall Study|Lost to Follow-up|1
2964209|NCT01203072|10202320|P1|Overall Study|Lost to Follow-up|0
2964210|NCT01203072|10202316|P5|Overall Study|Lack of Efficacy|0
2964211|NCT01203072|10202317|P4|Overall Study|Lack of Efficacy|0
2964212|NCT01203072|10202318|P3|Overall Study|Lack of Efficacy|0
2964213|NCT01203072|10202319|P2|Overall Study|Lack of Efficacy|0
2964214|NCT01203072|10202320|P1|Overall Study|Lack of Efficacy|1
2964215|NCT01203072|10202316|P5|Overall Study|Adverse Event|2
2964216|NCT01203072|10202317|P4|Overall Study|Adverse Event|4
2964217|NCT01203072|10202318|P3|Overall Study|Adverse Event|2
2964218|NCT01203072|10202319|P2|Overall Study|Adverse Event|3
2964219|NCT01203072|10202320|P1|Overall Study|Adverse Event|5
2964220|NCT01202955|10202355|P2|Period 1: 10 Days|Withdrawal by Subject|2
2964221|NCT01202955|10202356|P1|Period 1: 10 Days|Withdrawal by Subject|0
2964222|NCT01202903|10202368|P2|Overall Study|Withdrawal by Subject|4
2964223|NCT01202903|10202369|P1|Overall Study|Withdrawal by Subject|4
2964224|NCT01202903|10202368|P2|Overall Study|Adverse Event|3
2964225|NCT01202903|10202369|P1|Overall Study|Adverse Event|3
2964226|NCT01202903|10202368|P2|Overall Study|Lack of Efficacy|3
2964227|NCT01202903|10202369|P1|Overall Study|Lack of Efficacy|1
2964228|NCT01202903|10202368|P2|Overall Study|Lost to Follow-up|1
2964229|NCT01202903|10202369|P1|Overall Study|Lost to Follow-up|1
2964230|NCT01202903|10202368|P2|Overall Study|Death|0
2964231|NCT01202903|10202369|P1|Overall Study|Death|1
2964232|NCT01202903|10202368|P2|Overall Study|Protocol Violation|1
2964233|NCT01202903|10202369|P1|Overall Study|Protocol Violation|0
2964234|NCT01202903|10202368|P2|Overall Study|Administrative Probelms|4
2964235|NCT01202903|10202369|P1|Overall Study|Administrative Probelms|1
2964236|NCT01202877|10202396|P3|Overall Study|Death|1
2964237|NCT01202877|10202397|P2|Overall Study|Death|0
2964238|NCT01202877|10202398|P1|Overall Study|Death|0
2964239|NCT01202877|10202396|P3|Overall Study|Withdrawal by Subject|1
2964240|NCT01202877|10202397|P2|Overall Study|Withdrawal by Subject|0
2964241|NCT01202877|10202398|P1|Overall Study|Withdrawal by Subject|0
2964242|NCT01202877|10202396|P3|Overall Study|Adverse Event|2
2964243|NCT01202877|10202397|P2|Overall Study|Adverse Event|0
2964244|NCT01202877|10202398|P1|Overall Study|Adverse Event|0
2964245|NCT01202877|10202396|P3|Overall Study|Disease Progression|2
2964246|NCT01202877|10202397|P2|Overall Study|Disease Progression|1
2964247|NCT01202877|10202398|P1|Overall Study|Disease Progression|0
2964248|NCT01202773|10202412|P3|Overall Study|Sponsor Decision|23
2964249|NCT01202773|10202413|P2|Overall Study|Sponsor Decision|20
2964250|NCT01202773|10202414|P1|Overall Study|Sponsor Decision|19
2964251|NCT01202773|10202412|P3|Overall Study|Protocol Violation|10
2964252|NCT01202773|10202413|P2|Overall Study|Protocol Violation|6
2964253|NCT01202773|10202414|P1|Overall Study|Protocol Violation|11
2964254|NCT01202773|10202412|P3|Overall Study|Physician Decision|0
2964255|NCT01202773|10202413|P2|Overall Study|Physician Decision|0
2964256|NCT01202773|10202414|P1|Overall Study|Physician Decision|2
2964257|NCT01202773|10202412|P3|Overall Study|Withdrawal by Subject|5
2964258|NCT01202773|10202413|P2|Overall Study|Withdrawal by Subject|6
2964259|NCT01202773|10202414|P1|Overall Study|Withdrawal by Subject|13
2964260|NCT01202773|10202412|P3|Overall Study|Lost to Follow-up|2
2964261|NCT01202773|10202413|P2|Overall Study|Lost to Follow-up|2
2964262|NCT01202773|10202414|P1|Overall Study|Lost to Follow-up|1
2964263|NCT01202773|10202412|P3|Overall Study|Entry Criteria Not Met|1
2964264|NCT01202773|10202413|P2|Overall Study|Entry Criteria Not Met|0
2964265|NCT01202773|10202414|P1|Overall Study|Entry Criteria Not Met|2
2964266|NCT01202773|10202412|P3|Overall Study|Lack of Efficacy|9
2964267|NCT01202773|10202413|P2|Overall Study|Lack of Efficacy|4
2964268|NCT01202773|10202414|P1|Overall Study|Lack of Efficacy|5
2964269|NCT01202773|10202412|P3|Overall Study|Adverse Event|5
2964270|NCT01202773|10202413|P2|Overall Study|Adverse Event|5
2964271|NCT01202773|10202414|P1|Overall Study|Adverse Event|4
2964272|NCT01202760|10202491|P3|Overall Study|Sponsor Decision|0
2964273|NCT01202760|10202492|P2|Overall Study|Sponsor Decision|4
2964274|NCT01202760|10202493|P1|Overall Study|Sponsor Decision|4
2964275|NCT01202760|10202491|P3|Overall Study|Protocol Violation|2
2964276|NCT01202760|10202492|P2|Overall Study|Protocol Violation|5
2964277|NCT01202760|10202493|P1|Overall Study|Protocol Violation|7
2964278|NCT01202760|10202491|P3|Overall Study|Physician Decision|0
2964279|NCT01202760|10202492|P2|Overall Study|Physician Decision|1
2964280|NCT01202760|10202493|P1|Overall Study|Physician Decision|0
2964281|NCT01202760|10202491|P3|Overall Study|Withdrawal by Subject|14
2964282|NCT01202760|10202492|P2|Overall Study|Withdrawal by Subject|18
2964283|NCT01202760|10202493|P1|Overall Study|Withdrawal by Subject|17
2964284|NCT01202760|10202491|P3|Overall Study|Parent / Caregiver Decision|0
2964285|NCT01202760|10202492|P2|Overall Study|Parent / Caregiver Decision|1
2964286|NCT01202760|10202493|P1|Overall Study|Parent / Caregiver Decision|0
2964287|NCT01202760|10202491|P3|Overall Study|Lost to Follow-up|1
2964288|NCT01202760|10202492|P2|Overall Study|Lost to Follow-up|2
2964289|NCT01202760|10202493|P1|Overall Study|Lost to Follow-up|0
2964290|NCT01202760|10202491|P3|Overall Study|Lack of Efficacy|7
2964291|NCT01202760|10202492|P2|Overall Study|Lack of Efficacy|8
2964292|NCT01202760|10202493|P1|Overall Study|Lack of Efficacy|6
2964293|NCT01202760|10202491|P3|Overall Study|Death|0
2964294|NCT01202760|10202492|P2|Overall Study|Death|1
2964295|NCT01202760|10202493|P1|Overall Study|Death|2
2964296|NCT01202760|10202491|P3|Overall Study|Adverse Event|10
2964297|NCT01202760|10202492|P2|Overall Study|Adverse Event|9
2964298|NCT01202760|10202493|P1|Overall Study|Adverse Event|11
2964299|NCT01202760|10202491|P3|Overall Study|Entry Criteria Not Met|1
2964300|NCT01202760|10202492|P2|Overall Study|Entry Criteria Not Met|3
2964301|NCT01202760|10202493|P1|Overall Study|Entry Criteria Not Met|0
2964302|NCT01202747|10202561|P1|Overall Study|Withdrawal by Subject|1
2964303|NCT01202591|10202614|P6|Overall Study|Objective Disease Progression|0
2964304|NCT01202591|10202615|P5|Overall Study|Objective Disease Progression|2
2964305|NCT01202591|10202616|P4|Overall Study|Objective Disease Progression|0
2964306|NCT01202591|10202617|P3|Overall Study|Objective Disease Progression|0
2964307|NCT01202591|10202618|P2|Overall Study|Objective Disease Progression|0
2964308|NCT01202591|10202619|P1|Overall Study|Objective Disease Progression|0
2964309|NCT01202591|10202614|P6|Overall Study|Withdrawal by Subject|1
2964310|NCT01202591|10202615|P5|Overall Study|Withdrawal by Subject|2
2964311|NCT01202591|10202616|P4|Overall Study|Withdrawal by Subject|0
2964312|NCT01202591|10202617|P3|Overall Study|Withdrawal by Subject|0
2964313|NCT01202591|10202618|P2|Overall Study|Withdrawal by Subject|0
2964314|NCT01202591|10202619|P1|Overall Study|Withdrawal by Subject|0
2964315|NCT01202591|10202614|P6|Overall Study|Other reason as per investigator|3
2964316|NCT01202591|10202615|P5|Overall Study|Other reason as per investigator|1
2964317|NCT01202591|10202616|P4|Overall Study|Other reason as per investigator|3
2964318|NCT01202591|10202617|P3|Overall Study|Other reason as per investigator|7
2964319|NCT01202591|10202618|P2|Overall Study|Other reason as per investigator|4
2964320|NCT01202591|10202619|P1|Overall Study|Other reason as per investigator|3
2964321|NCT01202591|10202614|P6|Overall Study|Adverse Event|0
2964322|NCT01202591|10202615|P5|Overall Study|Adverse Event|0
2964323|NCT01202591|10202616|P4|Overall Study|Adverse Event|4
2964324|NCT01202591|10202617|P3|Overall Study|Adverse Event|4
2964325|NCT01202591|10202618|P2|Overall Study|Adverse Event|1
2964326|NCT01202591|10202619|P1|Overall Study|Adverse Event|2
2964327|NCT01202409|10202663|P1|Overall Study|Ineligible - KRAS mutants|7
2964328|NCT01202409|10202663|P1|Overall Study|Adverse Event|1
2964329|NCT01202279|10202670|P2|Overall Study|study compliance|2
2964330|NCT01202279|10202671|P1|Overall Study|study compliance|5
2964331|NCT01202279|10202670|P2|Overall Study|Protocol Violation|1
2964332|NCT01202279|10202671|P1|Overall Study|Protocol Violation|1
2964333|NCT01202279|10202670|P2|Overall Study|Lost to Follow-up|7
2964334|NCT01202279|10202671|P1|Overall Study|Lost to Follow-up|10
2964335|NCT01202279|10202670|P2|Overall Study|Physician Decision|1
2964336|NCT01202279|10202671|P1|Overall Study|Physician Decision|0
2964337|NCT01202279|10202670|P2|Overall Study|Withdrawal by Subject|10
2964338|NCT01202279|10202671|P1|Overall Study|Withdrawal by Subject|13
2964339|NCT01202279|10202670|P2|Overall Study|Adverse Event|6
2964340|NCT01202279|10202671|P1|Overall Study|Adverse Event|8
2964341|NCT01202227|10202723|P1|Overall Study|Lack of Efficacy|1
2964342|NCT01202227|10202723|P1|Overall Study|Withdrawal by Subject|2
2964343|NCT01202227|10202723|P1|Overall Study|Adverse Event|16
2964344|NCT01202188|10202747|P5|Overall Study|Abnormal test procedure result (s)|0
2964345|NCT01202188|10202748|P4|Overall Study|Abnormal test procedure result (s)|0
2964346|NCT01202188|10202749|P3|Overall Study|Abnormal test procedure result (s)|2
2964347|NCT01202188|10202750|P2|Overall Study|Abnormal test procedure result (s)|0
2964348|NCT01202188|10202751|P1|Overall Study|Abnormal test procedure result (s)|0
2964349|NCT01202188|10202747|P5|Overall Study|Death|0
2964350|NCT01202188|10202748|P4|Overall Study|Death|1
2964351|NCT01202188|10202749|P3|Overall Study|Death|1
2964352|NCT01202188|10202750|P2|Overall Study|Death|1
2964353|NCT01202188|10202751|P1|Overall Study|Death|1
2964354|NCT01202188|10202747|P5|Overall Study|Lost to Follow-up|1
2964355|NCT01202188|10202748|P4|Overall Study|Lost to Follow-up|4
2964356|NCT01202188|10202749|P3|Overall Study|Lost to Follow-up|0
2964357|NCT01202188|10202750|P2|Overall Study|Lost to Follow-up|1
2964358|NCT01202188|10202751|P1|Overall Study|Lost to Follow-up|1
2964359|NCT01202188|10202747|P5|Overall Study|Unsatisfactory therapeutic effect|8
2964360|NCT01202188|10202748|P4|Overall Study|Unsatisfactory therapeutic effect|5
2964361|NCT01202188|10202749|P3|Overall Study|Unsatisfactory therapeutic effect|2
2964362|NCT01202188|10202750|P2|Overall Study|Unsatisfactory therapeutic effect|8
2964363|NCT01202188|10202751|P1|Overall Study|Unsatisfactory therapeutic effect|2
2964364|NCT01202188|10202747|P5|Overall Study|Administrative problems|2
2964365|NCT01202188|10202748|P4|Overall Study|Administrative problems|1
2964366|NCT01202188|10202749|P3|Overall Study|Administrative problems|1
2964367|NCT01202188|10202750|P2|Overall Study|Administrative problems|2
2964368|NCT01202188|10202751|P1|Overall Study|Administrative problems|3
2964369|NCT01202188|10202747|P5|Overall Study|Adverse Event|10
2964370|NCT01202188|10202748|P4|Overall Study|Adverse Event|10
2964371|NCT01202188|10202749|P3|Overall Study|Adverse Event|13
2964372|NCT01202188|10202750|P2|Overall Study|Adverse Event|23
2964373|NCT01202188|10202751|P1|Overall Study|Adverse Event|5
2964374|NCT01202188|10202747|P5|Overall Study|Subject withdrew consent|13
2964375|NCT01202188|10202748|P4|Overall Study|Subject withdrew consent|11
2964376|NCT01202188|10202749|P3|Overall Study|Subject withdrew consent|22
2964377|NCT01202188|10202750|P2|Overall Study|Subject withdrew consent|13
2964378|NCT01202188|10202751|P1|Overall Study|Subject withdrew consent|12
2964379|NCT01202188|10202747|P5|Overall Study|Protocol deviation|11
2964380|NCT01202188|10202748|P4|Overall Study|Protocol deviation|10
2964381|NCT01202188|10202749|P3|Overall Study|Protocol deviation|12
2964382|NCT01202188|10202750|P2|Overall Study|Protocol deviation|8
2964383|NCT01202188|10202751|P1|Overall Study|Protocol deviation|14
2964384|NCT01202175|10202859|P1|Overall Study|Adverse Event|2
2964385|NCT01202175|10202859|P1|Overall Study|Withdrawal by Subject|1
2964386|NCT01202175|10202859|P1|Overall Study|Lost to Follow-up|2
2964387|NCT01201967|10202927|P2|Overall Study|Lost to Follow-up|5
2964388|NCT01201967|10202928|P1|Overall Study|Lost to Follow-up|6
2964389|NCT01201915|10202953|P3|Overall Study|Target Lesion Progression|0
2964390|NCT01201915|10202954|P2|Overall Study|Target Lesion Progression|3
2964391|NCT01201915|10202955|P1|Overall Study|Target Lesion Progression|0
2964392|NCT01201915|10202953|P3|Overall Study|Subject Decision|5
2964393|NCT01201915|10202954|P2|Overall Study|Subject Decision|3
2964394|NCT01201915|10202955|P1|Overall Study|Subject Decision|3
2964395|NCT01201915|10202953|P3|Overall Study|Physician Decision|0
2964396|NCT01201915|10202954|P2|Overall Study|Physician Decision|0
2964397|NCT01201915|10202955|P1|Overall Study|Physician Decision|3
2964398|NCT01201915|10202953|P3|Overall Study|Lost to Follow-up|0
2964399|NCT01201915|10202954|P2|Overall Study|Lost to Follow-up|4
2964400|NCT01201915|10202955|P1|Overall Study|Lost to Follow-up|0
2964401|NCT01201915|10202953|P3|Overall Study|Adverse Event|1
2964402|NCT01201915|10202954|P2|Overall Study|Adverse Event|1
2964403|NCT01201915|10202955|P1|Overall Study|Adverse Event|2
2964404|NCT01201811|10202966|P1|Overall Study|Physician Decision|1
2964405|NCT01201811|10202966|P1|Overall Study|Treatment Failure|2
2964406|NCT01201811|10202966|P1|Overall Study|Death|4
2964407|NCT01201811|10202966|P1|Overall Study|Withdrawal by Subject|3
2964408|NCT01201811|10202966|P1|Overall Study|Disease progression|3
2964409|NCT01201811|10202966|P1|Overall Study|Adverse Event|6
2964410|NCT01201798|10202988|P2|Overall Study|Treatment Failure|8
2964411|NCT01201798|10202989|P1|Overall Study|Treatment Failure|1
2964412|NCT01201798|10202988|P2|Overall Study|Protocol Violation|1
2964413|NCT01201798|10202989|P1|Overall Study|Protocol Violation|1
2964414|NCT01201798|10202988|P2|Overall Study|Noncompliance|0
2964415|NCT01201798|10202989|P1|Overall Study|Noncompliance|1
2964416|NCT01201798|10202988|P2|Overall Study|Decision Unrelated to an Adverse Event|1
2964417|NCT01201798|10202989|P1|Overall Study|Decision Unrelated to an Adverse Event|1
2964418|NCT01201798|10202988|P2|Overall Study|Lost to Follow-up|5
2964419|NCT01201798|10202989|P1|Overall Study|Lost to Follow-up|3
2964420|NCT01201798|10202988|P2|Overall Study|Adverse Event|0
2964421|NCT01201798|10202989|P1|Overall Study|Adverse Event|2
2964422|NCT01201785|10203013|P1|Overall Study|Lost to Follow-up|16
2964423|NCT01201759|10203030|P2|Visit 4 Crossover|Lost to Follow-up|1
2964424|NCT01201759|10203031|P1|Visit 4 Crossover|Lost to Follow-up|0
2964425|NCT01201759|10203030|P2|Visit 3 - Washout|Lost to Follow-up|0
2964426|NCT01201759|10203031|P1|Visit 3 - Washout|Lost to Follow-up|1
2964427|NCT01201759|10203030|P2|Visit 3 - Washout|Adverse Event|3
2964428|NCT01201759|10203031|P1|Visit 3 - Washout|Adverse Event|0
2964429|NCT01201759|10203030|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
2964430|NCT01201759|10203031|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
2964431|NCT01201356|10203060|P1|Overall Study|Protocol Violation|12
2964432|NCT01201356|10203060|P1|Overall Study|Death|16
2964433|NCT01201356|10203060|P1|Overall Study|administrative problems|74
2964434|NCT01201356|10203060|P1|Overall Study|Lost to Follow-up|50
2964435|NCT01201356|10203060|P1|Overall Study|Withdrawal by Subject|144
2964436|NCT01201356|10203060|P1|Overall Study|Condition no longer requires study drug|12
2964437|NCT01201356|10203060|P1|Overall Study|Unsatisfactory therapeutic effect|112
2964438|NCT01201356|10203060|P1|Overall Study|Abnormal test procedure result(s)|3
2964439|NCT01201356|10203060|P1|Overall Study|Abnormal laboratory value(s)|51
2964440|NCT01201356|10203060|P1|Overall Study|Adverse Event|170
2964441|NCT01201343|10203074|P1|Overall Study|Randomized, not treated|3
2964442|NCT01201343|10203074|P1|Overall Study|Participant wrongly included in trial|1
2964443|NCT01201343|10203074|P1|Overall Study|Lack of Efficacy|2
2964444|NCT01201343|10203074|P1|Overall Study|Lost to Follow-up|2
2964445|NCT01201343|10203074|P1|Overall Study|Withdrawal by Subject|5
2964446|NCT01201343|10203074|P1|Overall Study|Adverse Event|6
2964447|NCT01201317|10203088|P3|Overall Study|Safety, possible history of tuberculosis|1
2964448|NCT01201317|10203089|P2|Overall Study|Safety, possible history of tuberculosis|0
2964449|NCT01201317|10203090|P1|Overall Study|Safety, possible history of tuberculosis|0
2964450|NCT01201317|10203088|P3|Overall Study|Lack of Efficacy|0
2964451|NCT01201317|10203089|P2|Overall Study|Lack of Efficacy|0
2964452|NCT01201317|10203090|P1|Overall Study|Lack of Efficacy|1
2964453|NCT01201317|10203088|P3|Overall Study|Decrease in renal function|0
2964454|NCT01201317|10203089|P2|Overall Study|Decrease in renal function|1
2964455|NCT01201317|10203090|P1|Overall Study|Decrease in renal function|0
2964456|NCT01201317|10203088|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
2964457|NCT01201317|10203089|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
2964458|NCT01201317|10203090|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
2964459|NCT01201317|10203088|P3|Overall Study|Study-specific withdrawal criteria|1
2964460|NCT01201317|10203089|P2|Overall Study|Study-specific withdrawal criteria|0
2964461|NCT01201317|10203090|P1|Overall Study|Study-specific withdrawal criteria|0
2964462|NCT01201317|10203088|P3|Overall Study|Death|0
2964463|NCT01201317|10203089|P2|Overall Study|Death|1
2964464|NCT01201317|10203090|P1|Overall Study|Death|0
2964465|NCT01201317|10203088|P3|Overall Study|Protocol Violation|1
2964466|NCT01201317|10203089|P2|Overall Study|Protocol Violation|1
2964467|NCT01201317|10203090|P1|Overall Study|Protocol Violation|0
2964468|NCT01201317|10203088|P3|Overall Study|Screen failure|0
2964469|NCT01201317|10203089|P2|Overall Study|Screen failure|1
2964470|NCT01201317|10203090|P1|Overall Study|Screen failure|1
2964471|NCT01201317|10203088|P3|Overall Study|Adverse Event|2
2964472|NCT01201317|10203089|P2|Overall Study|Adverse Event|2
2964473|NCT01201317|10203090|P1|Overall Study|Adverse Event|2
2964474|NCT01201317|10203088|P3|Overall Study|Withdrawal by Subject|3
2964475|NCT01201317|10203089|P2|Overall Study|Withdrawal by Subject|0
2964476|NCT01201317|10203090|P1|Overall Study|Withdrawal by Subject|5
2964477|NCT01201265|10203110|P1|Overall Study|Disease Progression|4
2964478|NCT01201265|10203110|P1|Overall Study|Withdrawal by Subject|7
2964479|NCT01201265|10203110|P1|Overall Study|Lost to Follow-up|10
2964480|NCT01201265|10203110|P1|Overall Study|Insufficient Therapeutic Response|3
2964481|NCT01201265|10203110|P1|Overall Study|Death|14
2964482|NCT01200992|10203157|P2|Overall Study|Randomized but not treated|0
2964483|NCT01200992|10203158|P1|Overall Study|Randomized but not treated|2
2964484|NCT01200992|10203157|P2|Overall Study|Study terminated early|41
2964485|NCT01200992|10203158|P1|Overall Study|Study terminated early|35
2964486|NCT01200810|10203172|P2|Overall Study|Sponsor stopped making study drug|3
2964487|NCT01200810|10203173|P1|Overall Study|Sponsor stopped making study drug|3
2964488|NCT01200810|10203172|P2|Overall Study|Withdrawal by Subject|2
2964489|NCT01200810|10203173|P1|Overall Study|Withdrawal by Subject|1
2964490|NCT01200810|10203172|P2|Overall Study|Physician Decision|0
2964491|NCT01200810|10203173|P1|Overall Study|Physician Decision|1
2964492|NCT01200797|10203193|P1|Overall Study|Disease Progression|13
2964493|NCT01200797|10203193|P1|Overall Study|Adverse Event|4
2964494|NCT01200797|10203193|P1|Overall Study|symptomatic deterioration|2
2964495|NCT01200758|10203203|P4|Stage 2|Death|5
2964496|NCT01200758|10203204|P3|Stage 2|Death|3
2964497|NCT01200758|10203205|P2|Stage 2|Death|0
2964498|NCT01200758|10203206|P1|Stage 2|Death|0
2964499|NCT01200758|10203203|P4|Stage 2|Protocol Violation|4
2964500|NCT01200758|10203204|P3|Stage 2|Protocol Violation|1
2964501|NCT01200758|10203205|P2|Stage 2|Protocol Violation|0
2964502|NCT01200758|10203206|P1|Stage 2|Protocol Violation|0
2964503|NCT01200758|10203203|P4|Stage 2|Lost to Follow-up|1
2964504|NCT01200758|10203204|P3|Stage 2|Lost to Follow-up|3
2964505|NCT01200758|10203205|P2|Stage 2|Lost to Follow-up|0
2964506|NCT01200758|10203206|P1|Stage 2|Lost to Follow-up|0
2964507|NCT01200758|10203203|P4|Stage 2|Withdrawal by Subject|1
2964508|NCT01200758|10203204|P3|Stage 2|Withdrawal by Subject|4
2964509|NCT01200758|10203205|P2|Stage 2|Withdrawal by Subject|0
2964510|NCT01200758|10203206|P1|Stage 2|Withdrawal by Subject|0
2964511|NCT01200758|10203203|P4|Stage 2|Adverse Event|9
2964512|NCT01200758|10203204|P3|Stage 2|Adverse Event|5
2964513|NCT01200758|10203205|P2|Stage 2|Adverse Event|0
2964514|NCT01200758|10203206|P1|Stage 2|Adverse Event|0
2964515|NCT01200758|10203203|P4|Stage 2|Physician Decision|7
2964516|NCT01200758|10203204|P3|Stage 2|Physician Decision|5
2964517|NCT01200758|10203205|P2|Stage 2|Physician Decision|0
2964518|NCT01200758|10203206|P1|Stage 2|Physician Decision|0
2964519|NCT01200758|10203203|P4|Stage 2|Lack of Efficacy|2
2964520|NCT01200758|10203204|P3|Stage 2|Lack of Efficacy|4
2964521|NCT01200758|10203205|P2|Stage 2|Lack of Efficacy|0
2964522|NCT01200758|10203206|P1|Stage 2|Lack of Efficacy|0
2964523|NCT01200758|10203203|P4|Stage 2|Disease Progression|21
2964524|NCT01200758|10203204|P3|Stage 2|Disease Progression|16
2964525|NCT01200758|10203205|P2|Stage 2|Disease Progression|0
2964526|NCT01200758|10203206|P1|Stage 2|Disease Progression|0
2964527|NCT01200758|10203203|P4|Stage I|Disease Progression|0
2964528|NCT01200758|10203204|P3|Stage I|Disease Progression|0
2964529|NCT01200758|10203205|P2|Stage I|Disease Progression|7
2964530|NCT01200758|10203206|P1|Stage I|Disease Progression|9
2964531|NCT01200758|10203203|P4|Stage I|Withdrawal by Subject|0
2964532|NCT01200758|10203204|P3|Stage I|Withdrawal by Subject|0
2964533|NCT01200758|10203205|P2|Stage I|Withdrawal by Subject|2
2964534|NCT01200758|10203206|P1|Stage I|Withdrawal by Subject|1
2964535|NCT01200758|10203203|P4|Stage I|Adverse Event|0
2964536|NCT01200758|10203204|P3|Stage I|Adverse Event|0
2964537|NCT01200758|10203205|P2|Stage I|Adverse Event|5
2964538|NCT01200758|10203206|P1|Stage I|Adverse Event|5
2964539|NCT01200758|10203203|P4|Stage I|Lack of Efficacy|0
2964540|NCT01200758|10203204|P3|Stage I|Lack of Efficacy|0
2964541|NCT01200758|10203205|P2|Stage I|Lack of Efficacy|1
2964542|NCT01200758|10203206|P1|Stage I|Lack of Efficacy|2
2964543|NCT01200758|10203203|P4|Stage I|Physician Decision|0
2964544|NCT01200758|10203204|P3|Stage I|Physician Decision|0
2964545|NCT01200758|10203205|P2|Stage I|Physician Decision|1
2964546|NCT01200758|10203206|P1|Stage I|Physician Decision|1
2964547|NCT01200758|10203203|P4|Stage I|Death|0
2964548|NCT01200758|10203204|P3|Stage I|Death|0
2964549|NCT01200758|10203205|P2|Stage I|Death|1
2964550|NCT01200758|10203206|P1|Stage I|Death|0
2964551|NCT01200589|10203279|P2|Overall Study|Study terminated|172
2964552|NCT01200589|10203280|P1|Overall Study|Study terminated|170
2964553|NCT01200589|10203279|P2|Overall Study|Lost to Follow-up|4
2964554|NCT01200589|10203280|P1|Overall Study|Lost to Follow-up|5
2964555|NCT01200589|10203279|P2|Overall Study|Physician Decision|2
2964556|NCT01200589|10203280|P1|Overall Study|Physician Decision|2
2964557|NCT01200589|10203279|P2|Overall Study|Withdrawal by Subject|11
2964558|NCT01200589|10203280|P1|Overall Study|Withdrawal by Subject|13
2964559|NCT01200524|10203307|P3|Overall Study|Non availability of study nurse|1
2964560|NCT01200524|10203308|P2|Overall Study|Non availability of study nurse|0
2964561|NCT01200524|10203309|P1|Overall Study|Non availability of study nurse|0
2964562|NCT01200524|10203307|P3|Overall Study|Adverse Event|0
2964563|NCT01200524|10203308|P2|Overall Study|Adverse Event|0
2964564|NCT01200524|10203309|P1|Overall Study|Adverse Event|1
2964565|NCT01200524|10203307|P3|Overall Study|Withdrawal by Subject|3
2964566|NCT01200524|10203308|P2|Overall Study|Withdrawal by Subject|1
2964567|NCT01200524|10203309|P1|Overall Study|Withdrawal by Subject|1
2964568|NCT01200511|10203329|P1|Overall Study|Adverse Event|1
2964569|NCT01200511|10203329|P1|Overall Study|Withdrawal by Subject|1
2964570|NCT01200511|10203329|P1|Overall Study|Lost to Follow-up|3
2964571|NCT01200485|10203341|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2964572|NCT01200485|10203342|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2964573|NCT01200485|10203343|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
2964574|NCT01200485|10203341|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2964575|NCT01200485|10203342|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2964576|NCT01200485|10203343|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
2964577|NCT01200394|10203377|P2|Overall Study|Other|1
2964578|NCT01200394|10203378|P1|Overall Study|Other|0
2964579|NCT01200394|10203377|P2|Overall Study|Withdrawal by Subject|5
2964580|NCT01200394|10203378|P1|Overall Study|Withdrawal by Subject|0
2964581|NCT01200394|10203377|P2|Overall Study|Protocol Violation|3
2964582|NCT01200394|10203378|P1|Overall Study|Protocol Violation|0
2964583|NCT01200394|10203377|P2|Overall Study|Did Not Meet Entrance Criteria|4
2964584|NCT01200394|10203378|P1|Overall Study|Did Not Meet Entrance Criteria|1
2964585|NCT01200394|10203377|P2|Overall Study|Lost to Follow-up|1
2964586|NCT01200394|10203378|P1|Overall Study|Lost to Follow-up|0
2964587|NCT01200394|10203377|P2|Overall Study|Death|0
2964588|NCT01200394|10203378|P1|Overall Study|Death|1
2964589|NCT01200394|10203377|P2|Overall Study|Adverse Event|14
2964590|NCT01200394|10203378|P1|Overall Study|Adverse Event|0
2964591|NCT01200368|10203416|P3|Toddler Dose|Adverse Event|1
2964592|NCT01200368|10203417|P2|Toddler Dose|Adverse Event|3
2964593|NCT01200368|10203418|P1|Toddler Dose|Adverse Event|0
2964594|NCT01200368|10203416|P3|After Infant Series|Other|2
2964595|NCT01200368|10203417|P2|After Infant Series|Other|2
2964596|NCT01200368|10203418|P1|After Infant Series|Other|1
2964597|NCT01200368|10203416|P3|After Infant Series|Lost to Follow-up|0
2964598|NCT01200368|10203417|P2|After Infant Series|Lost to Follow-up|0
2964599|NCT01200368|10203418|P1|After Infant Series|Lost to Follow-up|1
2964600|NCT01200368|10203416|P3|After Infant Series|Withdrawal by Subject|4
2964601|NCT01200368|10203417|P2|After Infant Series|Withdrawal by Subject|8
2964602|NCT01200368|10203418|P1|After Infant Series|Withdrawal by Subject|10
2964603|NCT01200368|10203416|P3|After Infant Series|Adverse Event|3
2964604|NCT01200368|10203417|P2|After Infant Series|Adverse Event|6
2964605|NCT01200368|10203418|P1|After Infant Series|Adverse Event|6
2964606|NCT01200368|10203416|P3|Infant Series|Other|0
2964607|NCT01200368|10203417|P2|Infant Series|Other|0
2964608|NCT01200368|10203418|P1|Infant Series|Other|1
2964609|NCT01200368|10203416|P3|Infant Series|Randomized, not vaccinated|1
2964610|NCT01200368|10203417|P2|Infant Series|Randomized, not vaccinated|1
2964611|NCT01200368|10203418|P1|Infant Series|Randomized, not vaccinated|0
2964612|NCT01200368|10203416|P3|Infant Series|Did not meet entrance criteria|0
2964613|NCT01200368|10203417|P2|Infant Series|Did not meet entrance criteria|1
2964614|NCT01200368|10203418|P1|Infant Series|Did not meet entrance criteria|0
2964615|NCT01200368|10203416|P3|Infant Series|Withdrawal by Subject|2
2964616|NCT01200368|10203417|P2|Infant Series|Withdrawal by Subject|2
2964617|NCT01200368|10203418|P1|Infant Series|Withdrawal by Subject|0
2964618|NCT01200368|10203416|P3|Infant Series|Adverse Event|3
2964619|NCT01200368|10203417|P2|Infant Series|Adverse Event|2
2964620|NCT01200368|10203418|P1|Infant Series|Adverse Event|2
2964621|NCT01200355|10203484|P2|Overall Study|Death|2
2964622|NCT01200355|10203485|P1|Overall Study|Death|7
2964623|NCT01200342|10203499|P1|Overall Study|Disease Progression|1
2964624|NCT01200329|10203504|P1|Overall Study|Progressive disease|1
2964625|NCT01200329|10203504|P1|Overall Study|Lack of financial coverage|2
2964626|NCT01200290|10203509|P1|Post-Treatment Follow-Up Period|Death|2
2964627|NCT01200290|10203509|P1|Treatment Period|Adverse Event|1
2964628|NCT01200238|10203522|P2|Overall Study|Withdrawal by Subject|1
2964629|NCT01200238|10203523|P1|Overall Study|Withdrawal by Subject|0
2964630|NCT01200238|10203522|P2|Overall Study|Progressive Disease|8
2964631|NCT01200238|10203523|P1|Overall Study|Progressive Disease|5
2964632|NCT01200238|10203522|P2|Overall Study|Adverse Event|1
2964633|NCT01200238|10203523|P1|Overall Study|Adverse Event|2
2964634|NCT01200069|10203547|P2|Overall Study|Withdrawal by Subject|1
2964635|NCT01200069|10203548|P1|Overall Study|Withdrawal by Subject|0
2964636|NCT01199939|10203644|P1|Overall Study|Reached a virologic endpoint|4
2964637|NCT01199939|10203644|P1|Overall Study|Lost to Follow-up|2
2964638|NCT01199939|10203644|P1|Overall Study|Protocol Violation|3
2964639|NCT01199939|10203644|P1|Overall Study|Adverse Event|4
2964640|NCT01199861|10203676|P2|Overall Study|Adverse Event|0
2964641|NCT01199861|10203677|P1|Overall Study|Adverse Event|1
2964642|NCT01199861|10203676|P2|Overall Study|Administrative problems|0
2964643|NCT01199861|10203677|P1|Overall Study|Administrative problems|1
2964644|NCT01199822|10203698|P3|Overall Study|Investigator discontinued therapy|0
2964645|NCT01199822|10203699|P2|Overall Study|Investigator discontinued therapy|1
2964646|NCT01199822|10203700|P1|Overall Study|Investigator discontinued therapy|0
2964647|NCT01199731|10203749|P3|Overall Study|Withdrawal by Subject|0
2964648|NCT01199731|10203750|P2|Overall Study|Withdrawal by Subject|0
2964649|NCT01199731|10203751|P1|Overall Study|Withdrawal by Subject|2
2964650|NCT01199731|10203749|P3|Overall Study|Physician Decision|1
2964651|NCT01199731|10203750|P2|Overall Study|Physician Decision|1
2964652|NCT01199731|10203751|P1|Overall Study|Physician Decision|0
2964653|NCT01199731|10203749|P3|Overall Study|Lost to Follow-up|2
2964654|NCT01199731|10203750|P2|Overall Study|Lost to Follow-up|0
2964655|NCT01199731|10203751|P1|Overall Study|Lost to Follow-up|0
2964656|NCT01199731|10203749|P3|Overall Study|Study closed/terminated|7
2964657|NCT01199731|10203750|P2|Overall Study|Study closed/terminated|9
2964658|NCT01199731|10203751|P1|Overall Study|Study closed/terminated|7
2964659|NCT01199731|10203749|P3|Overall Study|Adverse Event|0
2964660|NCT01199731|10203750|P2|Overall Study|Adverse Event|1
2964661|NCT01199731|10203751|P1|Overall Study|Adverse Event|0
2964662|NCT01199705|10203789|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
2964663|NCT01199601|10203821|P2|Overall Study|Insecurity prevented staff interviewing.|9
2964664|NCT01199601|10203822|P1|Overall Study|Insecurity prevented staff interviewing.|7
2964665|NCT01199601|10203821|P2|Overall Study|Withdrawal by Subject|3
2964666|NCT01199601|10203822|P1|Overall Study|Withdrawal by Subject|15
2964667|NCT01199601|10203821|P2|Overall Study|Lost to Follow-up|66
2964668|NCT01199601|10203822|P1|Overall Study|Lost to Follow-up|47
2964669|NCT01199575|10203832|P1|Overall Study|Withdrawal by Subject|5
2964670|NCT01199471|10203837|P1|Overall Study|Physician Decision|1
2964671|NCT01199471|10203837|P1|Overall Study|Withdrawal by Subject|1
2964672|NCT01199471|10203837|P1|Overall Study|Protocol Violation|4
2964673|NCT01199263|10203848|P2|Overall Study|Never Treated|0
2964674|NCT01199263|10203849|P1|Overall Study|Never Treated|6
2964675|NCT01199263|10203848|P2|Overall Study|Ineligible|2
2964676|NCT01199263|10203849|P1|Overall Study|Ineligible|0
2964677|NCT01199042|10203886|P1|At Home (3 Months)|Lost to Follow-up|1
2964678|NCT01199042|10203886|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
2964679|NCT01199016|10203895|P1|Overall Study|Lost to Follow-up|25
2964680|NCT01199016|10203895|P1|Overall Study|Withdrawal by Subject|21
2964681|NCT01199016|10203895|P1|Overall Study|Other|13
2964682|NCT01199016|10203895|P1|Overall Study|Protocol Violation|9
2964683|NCT01199016|10203895|P1|Overall Study|Entrance criteria|5
2964684|NCT01199016|10203895|P1|Overall Study|No longer meets eligibility criteria|4
2964685|NCT01198977|10203904|P2|Overall Study|Lost to Follow-up|0
2964686|NCT01198977|10203905|P1|Overall Study|Lost to Follow-up|1
2964687|NCT01198873|10203917|P2|Overall Study|Other than above|2
2964688|NCT01198873|10203918|P1|Overall Study|Other than above|4
2964689|NCT01198873|10203917|P2|Overall Study|Study closure|23
2964690|NCT01198873|10203918|P1|Overall Study|Study closure|29
2964691|NCT01198873|10203917|P2|Overall Study|Adverse Event|7
2964692|NCT01198873|10203918|P1|Overall Study|Adverse Event|4
2964693|NCT01198795|10203932|P1|Overall Study|Other Reason|4
2964694|NCT01198795|10203932|P1|Overall Study|Protocol Violation|2
2964695|NCT01198795|10203932|P1|Overall Study|Lack of Efficacy|5
2964696|NCT01198795|10203932|P1|Overall Study|Adverse Event|9
2964697|NCT01198795|10203932|P1|Overall Study|Lost to Follow-up|15
2964698|NCT01198795|10203932|P1|Overall Study|Withdrawal by Subject|17
2964699|NCT01198795|10203932|P1|Overall Study|Did not meet InclusionExclusion criteria|30
2964700|NCT01198756|10203949|P4|Overall Study|Lost to Follow-up|18
2964701|NCT01198756|10203950|P3|Overall Study|Lost to Follow-up|23
2964702|NCT01198756|10203951|P2|Overall Study|Lost to Follow-up|36
2964703|NCT01198756|10203952|P1|Overall Study|Lost to Follow-up|29
2964704|NCT01198756|10203949|P4|Overall Study|Withdrawal by Subject|5
2964705|NCT01198756|10203950|P3|Overall Study|Withdrawal by Subject|7
2964706|NCT01198756|10203951|P2|Overall Study|Withdrawal by Subject|4
2964707|NCT01198756|10203952|P1|Overall Study|Withdrawal by Subject|9
2964708|NCT01198756|10203949|P4|Overall Study|Protocol Violation|2
2964709|NCT01198756|10203950|P3|Overall Study|Protocol Violation|0
2964710|NCT01198756|10203951|P2|Overall Study|Protocol Violation|0
2964711|NCT01198756|10203952|P1|Overall Study|Protocol Violation|0
2964712|NCT01198756|10203949|P4|Overall Study|Adverse Event|1
2964713|NCT01198756|10203950|P3|Overall Study|Adverse Event|0
2964714|NCT01198756|10203951|P2|Overall Study|Adverse Event|0
2964715|NCT01198756|10203952|P1|Overall Study|Adverse Event|0
2964716|NCT01198600|10204063|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2964717|NCT01198600|10204064|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
2964718|NCT01198600|10204065|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2964719|NCT01198600|10204066|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2964720|NCT01198600|10204063|P4|Phase 2: 56 Days of Wear|Relocation|0
2964721|NCT01198600|10204064|P3|Phase 2: 56 Days of Wear|Relocation|2
2964722|NCT01198600|10204065|P2|Phase 2: 56 Days of Wear|Relocation|0
2964723|NCT01198600|10204066|P1|Phase 2: 56 Days of Wear|Relocation|0
2964724|NCT01198600|10204063|P4|Phase 2: 56 Days of Wear|Inconvenience|0
2964725|NCT01198600|10204064|P3|Phase 2: 56 Days of Wear|Inconvenience|2
2964726|NCT01198600|10204065|P2|Phase 2: 56 Days of Wear|Inconvenience|0
2964727|NCT01198600|10204066|P1|Phase 2: 56 Days of Wear|Inconvenience|0
2964728|NCT01198600|10204063|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2964729|NCT01198600|10204064|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2964730|NCT01198600|10204065|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
2964731|NCT01198600|10204066|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2964732|NCT01198600|10204063|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2964733|NCT01198600|10204064|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2964734|NCT01198600|10204065|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
2964735|NCT01198600|10204066|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2964736|NCT01198600|10204063|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2964737|NCT01198600|10204064|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2964738|NCT01198600|10204065|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2964739|NCT01198600|10204066|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
2964740|NCT01198600|10204063|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2964741|NCT01198600|10204064|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2964742|NCT01198600|10204065|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2964743|NCT01198600|10204066|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
2964744|NCT01198587|10204092|P4|Overall Study|Lost to Follow-up|0
2964745|NCT01198587|10204093|P3|Overall Study|Lost to Follow-up|9
2964746|NCT01198587|10204094|P2|Overall Study|Lost to Follow-up|0
2964747|NCT01198587|10204095|P1|Overall Study|Lost to Follow-up|8
2964748|NCT01198574|10204117|P4|Overall Study|Resigned from schools|4
2964749|NCT01198574|10204118|P3|Overall Study|Resigned from schools|1
2964750|NCT01198574|10204119|P2|Overall Study|Resigned from schools|1
2964751|NCT01198574|10204120|P1|Overall Study|Resigned from schools|4
2964752|NCT01198548|10204138|P1|Overall Study|Administrative Decision|1
2964753|NCT01198548|10204138|P1|Overall Study|Disease Progression|9
2964754|NCT01198509|10204153|P6|Overall Study|Withdrawal by Subject|0
2964755|NCT01198509|10204154|P5|Overall Study|Withdrawal by Subject|0
2964756|NCT01198509|10204155|P4|Overall Study|Withdrawal by Subject|0
2964757|NCT01198509|10204156|P3|Overall Study|Withdrawal by Subject|0
2964758|NCT01198509|10204157|P2|Overall Study|Withdrawal by Subject|0
2964759|NCT01198509|10204158|P1|Overall Study|Withdrawal by Subject|1
2964760|NCT01198470|10204175|P1|Overall Study|Adverse Event|2
2964761|NCT01198275|10204241|P2|Overall Study|spontaneous return to sinus rhythm|2
2964762|NCT01198275|10204242|P1|Overall Study|spontaneous return to sinus rhythm|4
2964763|NCT01198275|10204241|P2|Overall Study|Adverse Event|3
2964764|NCT01198275|10204242|P1|Overall Study|Adverse Event|2
2964765|NCT01198145|10204265|P2|Overall Study|Withdrawal by Subject|1
2964766|NCT01198145|10204266|P1|Overall Study|Withdrawal by Subject|1
2964767|NCT01198132|10204288|P2|Overall Study|Protocol Violation|0
2964768|NCT01198132|10204289|P1|Overall Study|Protocol Violation|1
2964769|NCT01198132|10204288|P2|Overall Study|Adverse Event|1
2964770|NCT01198132|10204289|P1|Overall Study|Adverse Event|0
2964771|NCT01198132|10204288|P2|Overall Study|Abnormal/clinically significant biologic|1
2964772|NCT01198132|10204289|P1|Overall Study|Abnormal/clinically significant biologic|1
2964773|NCT01198132|10204288|P2|Overall Study|Sign/symptoms of underlying disease|1
2964774|NCT01198132|10204289|P1|Overall Study|Sign/symptoms of underlying disease|2
2964775|NCT01198132|10204288|P2|Overall Study|Lack of Efficacy|3
2964776|NCT01198132|10204289|P1|Overall Study|Lack of Efficacy|2
2964777|NCT01198132|10204288|P2|Overall Study|Other Unspecified|6
2964778|NCT01198132|10204289|P1|Overall Study|Other Unspecified|3
2964779|NCT01198132|10204288|P2|Overall Study|Physician Decision|4
2964780|NCT01198132|10204289|P1|Overall Study|Physician Decision|5
2964781|NCT01198132|10204288|P2|Overall Study|Withdrawal by Subject|5
2964782|NCT01198132|10204289|P1|Overall Study|Withdrawal by Subject|4
2964783|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
2964784|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
2964785|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
2964786|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2964787|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
2964788|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2964789|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2964790|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
2964791|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2964792|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2964793|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2964794|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
2964795|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2964796|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2964797|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
2964798|NCT01198002|10204316|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
2964799|NCT01198002|10204317|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
2964800|NCT01198002|10204318|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
2964801|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
2964802|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
2964803|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
2964804|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2964805|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2964806|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
2964807|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2964808|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2964809|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
2964810|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
2964811|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
2964812|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
2964813|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2964814|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
2964815|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2964816|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2964817|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2964818|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
2964819|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
2964820|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
2964821|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
2964822|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Death|1
2964823|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Death|0
2964824|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Death|2
2964825|NCT01198002|10204316|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2964826|NCT01198002|10204317|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2964827|NCT01198002|10204318|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
2964828|NCT01197911|10204433|P3|Overall Study|Adverse Event|1
2964829|NCT01197911|10204434|P2|Overall Study|Adverse Event|0
2964830|NCT01197911|10204435|P1|Overall Study|Adverse Event|0
2964831|NCT01197794|10204550|P7|Overall Study|Other|4
2964832|NCT01197794|10204551|P6|Overall Study|Other|2
2964833|NCT01197794|10204552|P5|Overall Study|Other|2
2964834|NCT01197794|10204553|P4|Overall Study|Other|0
2964835|NCT01197794|10204554|P3|Overall Study|Other|3
2964836|NCT01197794|10204555|P2|Overall Study|Other|1
2964837|NCT01197794|10204556|P1|Overall Study|Other|1
2964838|NCT01197794|10204550|P7|Overall Study|Lost to Follow-up|0
2964839|NCT01197794|10204551|P6|Overall Study|Lost to Follow-up|1
2964840|NCT01197794|10204552|P5|Overall Study|Lost to Follow-up|0
2964841|NCT01197794|10204553|P4|Overall Study|Lost to Follow-up|1
2964842|NCT01197794|10204554|P3|Overall Study|Lost to Follow-up|0
2964843|NCT01197794|10204555|P2|Overall Study|Lost to Follow-up|1
2964844|NCT01197794|10204556|P1|Overall Study|Lost to Follow-up|1
2964845|NCT01197794|10204550|P7|Overall Study|Withdrawal by Subject|6
2964846|NCT01197794|10204551|P6|Overall Study|Withdrawal by Subject|5
2964847|NCT01197794|10204552|P5|Overall Study|Withdrawal by Subject|1
2964848|NCT01197794|10204553|P4|Overall Study|Withdrawal by Subject|1
2964849|NCT01197794|10204554|P3|Overall Study|Withdrawal by Subject|4
2964850|NCT01197794|10204555|P2|Overall Study|Withdrawal by Subject|3
2964851|NCT01197794|10204556|P1|Overall Study|Withdrawal by Subject|3
2964852|NCT01197794|10204550|P7|Overall Study|Eligibility criteria not fulfilled|6
2964853|NCT01197794|10204551|P6|Overall Study|Eligibility criteria not fulfilled|9
2964854|NCT01197794|10204552|P5|Overall Study|Eligibility criteria not fulfilled|5
2964855|NCT01197794|10204553|P4|Overall Study|Eligibility criteria not fulfilled|5
2964856|NCT01197794|10204554|P3|Overall Study|Eligibility criteria not fulfilled|2
2964857|NCT01197794|10204555|P2|Overall Study|Eligibility criteria not fulfilled|8
2964858|NCT01197794|10204556|P1|Overall Study|Eligibility criteria not fulfilled|5
2964859|NCT01197794|10204550|P7|Overall Study|Development of study withdrawal criteria|1
2964860|NCT01197794|10204551|P6|Overall Study|Development of study withdrawal criteria|0
2964861|NCT01197794|10204552|P5|Overall Study|Development of study withdrawal criteria|0
2964862|NCT01197794|10204553|P4|Overall Study|Development of study withdrawal criteria|1
2964863|NCT01197794|10204554|P3|Overall Study|Development of study withdrawal criteria|0
2964864|NCT01197794|10204555|P2|Overall Study|Development of study withdrawal criteria|0
2964865|NCT01197794|10204556|P1|Overall Study|Development of study withdrawal criteria|3
2964866|NCT01197794|10204550|P7|Overall Study|Protocol Violation|1
2964867|NCT01197794|10204551|P6|Overall Study|Protocol Violation|0
2964868|NCT01197794|10204552|P5|Overall Study|Protocol Violation|2
2964869|NCT01197794|10204553|P4|Overall Study|Protocol Violation|0
2964870|NCT01197794|10204554|P3|Overall Study|Protocol Violation|0
2964871|NCT01197794|10204555|P2|Overall Study|Protocol Violation|0
2964872|NCT01197794|10204556|P1|Overall Study|Protocol Violation|0
2964873|NCT01197794|10204550|P7|Overall Study|Adverse Event|3
2964874|NCT01197794|10204551|P6|Overall Study|Adverse Event|2
2964875|NCT01197794|10204552|P5|Overall Study|Adverse Event|4
2964876|NCT01197794|10204553|P4|Overall Study|Adverse Event|4
2964877|NCT01197794|10204554|P3|Overall Study|Adverse Event|4
2964878|NCT01197794|10204555|P2|Overall Study|Adverse Event|2
2964879|NCT01197794|10204556|P1|Overall Study|Adverse Event|3
2964880|NCT01197755|10204638|P3|Overall Study|eg, change in circumstances|2
2964881|NCT01197755|10204639|P2|Overall Study|eg, change in circumstances|3
2964882|NCT01197755|10204640|P1|Overall Study|eg, change in circumstances|7
2964883|NCT01197755|10204638|P3|Overall Study|Lost to Follow-up|1
2964884|NCT01197755|10204639|P2|Overall Study|Lost to Follow-up|0
2964885|NCT01197755|10204640|P1|Overall Study|Lost to Follow-up|0
2964886|NCT01197755|10204638|P3|Overall Study|Withdrawal by Subject|0
2964887|NCT01197755|10204639|P2|Overall Study|Withdrawal by Subject|0
2964888|NCT01197755|10204640|P1|Overall Study|Withdrawal by Subject|1
2964889|NCT01197755|10204638|P3|Overall Study|Severe non-compliance to the protocol|2
2964890|NCT01197755|10204639|P2|Overall Study|Severe non-compliance to the protocol|1
2964891|NCT01197755|10204640|P1|Overall Study|Severe non-compliance to the protocol|2
2964892|NCT01197755|10204638|P3|Overall Study|Lack of therapeutic response|4
2964893|NCT01197755|10204639|P2|Overall Study|Lack of therapeutic response|7
2964894|NCT01197755|10204640|P1|Overall Study|Lack of therapeutic response|0
2964895|NCT01197755|10204638|P3|Overall Study|Entered the long-term extension study|35
2964896|NCT01197755|10204639|P2|Overall Study|Entered the long-term extension study|21
2964897|NCT01197755|10204640|P1|Overall Study|Entered the long-term extension study|18
2964898|NCT01197755|10204638|P3|Overall Study|Study-specific discontinuation criteria|0
2964899|NCT01197755|10204639|P2|Overall Study|Study-specific discontinuation criteria|1
2964900|NCT01197755|10204640|P1|Overall Study|Study-specific discontinuation criteria|2
2964901|NCT01197755|10204638|P3|Overall Study|Adverse Event|10
2964902|NCT01197755|10204639|P2|Overall Study|Adverse Event|10
2964903|NCT01197755|10204640|P1|Overall Study|Adverse Event|8
2964904|NCT01197560|10204712|P2|Overall Study|Missing|1
2964905|NCT01197560|10204713|P1|Overall Study|Missing|0
2964906|NCT01197560|10204712|P2|Overall Study|Miscellaneous|3
2964907|NCT01197560|10204713|P1|Overall Study|Miscellaneous|4
2964908|NCT01197560|10204712|P2|Overall Study|Disease progression|35
2964909|NCT01197560|10204713|P1|Overall Study|Disease progression|40
2964910|NCT01197560|10204712|P2|Overall Study|Withdrawal by Subject|1
2964911|NCT01197560|10204713|P1|Overall Study|Withdrawal by Subject|1
2964912|NCT01197560|10204712|P2|Overall Study|Death|5
2964913|NCT01197560|10204713|P1|Overall Study|Death|3
2964914|NCT01197560|10204712|P2|Overall Study|Adverse Event|8
2964915|NCT01197560|10204713|P1|Overall Study|Adverse Event|6
2964916|NCT01197534|10204760|P3|Overall Study|Adverse Event|24
2964917|NCT01197534|10204761|P2|Overall Study|Adverse Event|36
2964918|NCT01197534|10204762|P1|Overall Study|Adverse Event|35
2964919|NCT01197534|10204760|P3|Overall Study|Lost to Follow-up|2
2964920|NCT01197534|10204761|P2|Overall Study|Lost to Follow-up|4
2964921|NCT01197534|10204762|P1|Overall Study|Lost to Follow-up|1
2964922|NCT01197534|10204760|P3|Overall Study|Dev. of study specific discont. criteria|2
2964923|NCT01197534|10204761|P2|Overall Study|Dev. of study specific discont. criteria|6
2964924|NCT01197534|10204762|P1|Overall Study|Dev. of study specific discont. criteria|13
2964925|NCT01197534|10204760|P3|Overall Study|Lack of therapeutic response|9
2964926|NCT01197534|10204761|P2|Overall Study|Lack of therapeutic response|4
2964927|NCT01197534|10204762|P1|Overall Study|Lack of therapeutic response|9
2964928|NCT01197534|10204760|P3|Overall Study|Severe non-compliance to protocol|1
2964929|NCT01197534|10204761|P2|Overall Study|Severe non-compliance to protocol|4
2964930|NCT01197534|10204762|P1|Overall Study|Severe non-compliance to protocol|3
2964931|NCT01197534|10204760|P3|Overall Study|Enrolment in long term extension|119
2964932|NCT01197534|10204761|P2|Overall Study|Enrolment in long term extension|66
2964933|NCT01197534|10204762|P1|Overall Study|Enrolment in long term extension|57
2964934|NCT01197534|10204760|P3|Overall Study|Not reported|16
2964935|NCT01197534|10204761|P2|Overall Study|Not reported|10
2964936|NCT01197534|10204762|P1|Overall Study|Not reported|16
2964937|NCT01197521|10204806|P3|Overall Study|Adverse Event|24
2964938|NCT01197521|10204807|P2|Overall Study|Adverse Event|28
2964939|NCT01197521|10204808|P1|Overall Study|Adverse Event|25
2964940|NCT01197521|10204806|P3|Overall Study|Lost to Follow-up|2
2964941|NCT01197521|10204807|P2|Overall Study|Lost to Follow-up|2
2964942|NCT01197521|10204808|P1|Overall Study|Lost to Follow-up|3
2964943|NCT01197521|10204806|P3|Overall Study|Dev. of study specific discont. criteria|2
2964944|NCT01197521|10204807|P2|Overall Study|Dev. of study specific discont. criteria|16
2964945|NCT01197521|10204808|P1|Overall Study|Dev. of study specific discont. criteria|6
2964946|NCT01197521|10204806|P3|Overall Study|Lack of therapeutic response|4
2964947|NCT01197521|10204807|P2|Overall Study|Lack of therapeutic response|3
2964948|NCT01197521|10204808|P1|Overall Study|Lack of therapeutic response|2
2964949|NCT01197521|10204806|P3|Overall Study|Severe non-compliance to protocol|3
2964950|NCT01197521|10204807|P2|Overall Study|Severe non-compliance to protocol|3
2964951|NCT01197521|10204808|P1|Overall Study|Severe non-compliance to protocol|1
2964952|NCT01197521|10204806|P3|Overall Study|Enrolment in long term extension|87
2964953|NCT01197521|10204807|P2|Overall Study|Enrolment in long term extension|36
2964954|NCT01197521|10204808|P1|Overall Study|Enrolment in long term extension|42
2964955|NCT01197521|10204806|P3|Overall Study|Not reported|21
2964956|NCT01197521|10204807|P2|Overall Study|Not reported|25
2964957|NCT01197521|10204808|P1|Overall Study|Not reported|24
2964958|NCT01197508|10204853|P4|Overall Study|Other|2
2964959|NCT01197508|10204854|P3|Overall Study|Other|2
2964960|NCT01197508|10204855|P2|Overall Study|Other|3
2964961|NCT01197508|10204856|P1|Overall Study|Other|2
2964962|NCT01197508|10204853|P4|Overall Study|Lost to Follow-up|0
2964963|NCT01197508|10204854|P3|Overall Study|Lost to Follow-up|2
2964964|NCT01197508|10204855|P2|Overall Study|Lost to Follow-up|1
2964965|NCT01197508|10204856|P1|Overall Study|Lost to Follow-up|1
2964966|NCT01197508|10204853|P4|Overall Study|Study-specific withdrawal criteria|2
2964967|NCT01197508|10204854|P3|Overall Study|Study-specific withdrawal criteria|1
2964968|NCT01197508|10204855|P2|Overall Study|Study-specific withdrawal criteria|0
2964969|NCT01197508|10204856|P1|Overall Study|Study-specific withdrawal criteria|0
2964970|NCT01197508|10204853|P4|Overall Study|Lack of Efficacy|1
2964971|NCT01197508|10204854|P3|Overall Study|Lack of Efficacy|2
2964972|NCT01197508|10204855|P2|Overall Study|Lack of Efficacy|2
2964973|NCT01197508|10204856|P1|Overall Study|Lack of Efficacy|1
2964974|NCT01197508|10204853|P4|Overall Study|Condition under investigation worsened|1
2964975|NCT01197508|10204854|P3|Overall Study|Condition under investigation worsened|1
2964976|NCT01197508|10204855|P2|Overall Study|Condition under investigation worsened|1
2964977|NCT01197508|10204856|P1|Overall Study|Condition under investigation worsened|1
2964978|NCT01197508|10204853|P4|Overall Study|Severe non-compliance to protocol|3
2964979|NCT01197508|10204854|P3|Overall Study|Severe non-compliance to protocol|1
2964980|NCT01197508|10204855|P2|Overall Study|Severe non-compliance to protocol|3
2964981|NCT01197508|10204856|P1|Overall Study|Severe non-compliance to protocol|0
2964982|NCT01197508|10204853|P4|Overall Study|Adverse Event|3
2964983|NCT01197508|10204854|P3|Overall Study|Adverse Event|23
2964984|NCT01197508|10204855|P2|Overall Study|Adverse Event|13
2964985|NCT01197508|10204856|P1|Overall Study|Adverse Event|10
2964986|NCT01197508|10204853|P4|Overall Study|Eligiblity criteria not fulfilled|0
2964987|NCT01197508|10204854|P3|Overall Study|Eligiblity criteria not fulfilled|2
2964988|NCT01197508|10204855|P2|Overall Study|Eligiblity criteria not fulfilled|0
2964989|NCT01197508|10204856|P1|Overall Study|Eligiblity criteria not fulfilled|0
2964990|NCT01197508|10204853|P4|Overall Study|Withdrawal by Subject|4
2964991|NCT01197508|10204854|P3|Overall Study|Withdrawal by Subject|15
2964992|NCT01197508|10204855|P2|Overall Study|Withdrawal by Subject|7
2964993|NCT01197508|10204856|P1|Overall Study|Withdrawal by Subject|8
2964994|NCT01197417|10204977|P2|Overall Study|No 25-hour magnesium level|2
2964995|NCT01197417|10204978|P1|Overall Study|No 25-hour magnesium level|0
2964996|NCT01197417|10204977|P2|Overall Study|Found to be ineligible|5
2964997|NCT01197417|10204978|P1|Overall Study|Found to be ineligible|2
2964998|NCT01197417|10204977|P2|Overall Study|Hypotension|2
2964999|NCT01197417|10204978|P1|Overall Study|Hypotension|1
2965000|NCT01197417|10204977|P2|Overall Study|Not consented in time to receive drug|1
2965001|NCT01197417|10204978|P1|Overall Study|Not consented in time to receive drug|0
2965002|NCT01197417|10204977|P2|Overall Study|Subject transferred to intensive care|1
2965003|NCT01197417|10204978|P1|Overall Study|Subject transferred to intensive care|0
2965004|NCT01197417|10204977|P2|Overall Study|Site miscommunication|1
2965005|NCT01197417|10204978|P1|Overall Study|Site miscommunication|0
2965006|NCT01197417|10204977|P2|Overall Study|Withdrawal by Subject|4
2965007|NCT01197417|10204978|P1|Overall Study|Withdrawal by Subject|2
2965008|NCT01197417|10204977|P2|Overall Study|Physician Decision|2
2965009|NCT01197417|10204978|P1|Overall Study|Physician Decision|3
2965010|NCT01197378|10204996|P1|Overall Study|Other|2
2965011|NCT01197378|10204996|P1|Overall Study|Physician Decision|1
2965012|NCT01197378|10204996|P1|Overall Study|Withdrawal by Subject|1
2965013|NCT01197378|10204996|P1|Overall Study|Adverse Event|3
2965014|NCT01197300|10205015|P2|Overall Study|Protocol Violation|1
2965015|NCT01197300|10205016|P1|Overall Study|Protocol Violation|0
2965016|NCT01197300|10205015|P2|Overall Study|Lost to Follow-up|1
2965017|NCT01197300|10205016|P1|Overall Study|Lost to Follow-up|0
2965018|NCT01196988|10205048|P4|Overall Study|Other|0
2965019|NCT01196988|10205049|P3|Overall Study|Other|0
2965020|NCT01196988|10205050|P2|Overall Study|Other|0
2965021|NCT01196988|10205051|P1|Overall Study|Other|2
2965022|NCT01196988|10205048|P4|Overall Study|Lost to Follow-up|1
2965023|NCT01196988|10205049|P3|Overall Study|Lost to Follow-up|21
2965024|NCT01196988|10205050|P2|Overall Study|Lost to Follow-up|29
2965025|NCT01196988|10205051|P1|Overall Study|Lost to Follow-up|16
2965026|NCT01196988|10205048|P4|Overall Study|Withdrawal by Subject|0
2965027|NCT01196988|10205049|P3|Overall Study|Withdrawal by Subject|4
2965028|NCT01196988|10205050|P2|Overall Study|Withdrawal by Subject|1
2965029|NCT01196988|10205051|P1|Overall Study|Withdrawal by Subject|5
2965030|NCT01196988|10205048|P4|Overall Study|Adverse Event|0
2965031|NCT01196988|10205049|P3|Overall Study|Adverse Event|0
2965032|NCT01196988|10205050|P2|Overall Study|Adverse Event|2
2965033|NCT01196988|10205051|P1|Overall Study|Adverse Event|1
2965034|NCT01196975|10205145|P5|Overall Study|Lost to Follow-up|11
2965035|NCT01196975|10205146|P4|Overall Study|Lost to Follow-up|5
2965036|NCT01196975|10205147|P3|Overall Study|Lost to Follow-up|5
2965037|NCT01196975|10205148|P2|Overall Study|Lost to Follow-up|6
2965038|NCT01196975|10205149|P1|Overall Study|Lost to Follow-up|11
2965039|NCT01196975|10205145|P5|Overall Study|Withdrawal by Subject|0
2965040|NCT01196975|10205146|P4|Overall Study|Withdrawal by Subject|1
2965041|NCT01196975|10205147|P3|Overall Study|Withdrawal by Subject|0
2965042|NCT01196975|10205148|P2|Overall Study|Withdrawal by Subject|1
2965043|NCT01196975|10205149|P1|Overall Study|Withdrawal by Subject|2
2965044|NCT01196975|10205145|P5|Overall Study|Adverse Event|2
2965045|NCT01196975|10205146|P4|Overall Study|Adverse Event|0
2965046|NCT01196975|10205147|P3|Overall Study|Adverse Event|0
2965047|NCT01196975|10205148|P2|Overall Study|Adverse Event|2
2965048|NCT01196975|10205149|P1|Overall Study|Adverse Event|2
2965049|NCT01196741|10205433|P2|Overall Study|Protocol Violation|1
2965050|NCT01196741|10205434|P1|Overall Study|Protocol Violation|2
2965051|NCT01196741|10205433|P2|Overall Study|Other|2
2965052|NCT01196741|10205434|P1|Overall Study|Other|3
2965053|NCT01196741|10205433|P2|Overall Study|Other reason|3
2965054|NCT01196741|10205434|P1|Overall Study|Other reason|3
2965055|NCT01196741|10205433|P2|Overall Study|Withdrawal by Subject|0
2965056|NCT01196741|10205434|P1|Overall Study|Withdrawal by Subject|3
2965057|NCT01196741|10205433|P2|Overall Study|Dose limiting Adverse Event|1
2965058|NCT01196741|10205434|P1|Overall Study|Dose limiting Adverse Event|2
2965059|NCT01196741|10205433|P2|Overall Study|Serious Adverse Event|1
2965060|NCT01196741|10205434|P1|Overall Study|Serious Adverse Event|3
2965061|NCT01196741|10205433|P2|Overall Study|Adverse Event|6
2965062|NCT01196741|10205434|P1|Overall Study|Adverse Event|10
2965063|NCT01196741|10205433|P2|Overall Study|Disease progression|14
2965064|NCT01196741|10205434|P1|Overall Study|Disease progression|34
2965065|NCT01196429|10205464|P2|Overall Study|Refused – Never Treated|0
2965066|NCT01196429|10205465|P1|Overall Study|Refused – Never Treated|1
2965067|NCT01196429|10205464|P2|Overall Study|Ineligible - wrong cell type|0
2965068|NCT01196429|10205465|P1|Overall Study|Ineligible - wrong cell type|1
2965069|NCT01196429|10205464|P2|Overall Study|Ineligible - inadequate pathology|0
2965070|NCT01196429|10205465|P1|Overall Study|Ineligible - inadequate pathology|1
2965071|NCT01196416|10205481|P1|Overall Study|Withdrawal by Subject|2
2965072|NCT01196104|10205539|P2|Overall Study|Various|1
2965073|NCT01196104|10205540|P1|Overall Study|Various|0
2965074|NCT01196104|10205539|P2|Overall Study|Withdrawal by Subject|3
2965075|NCT01196104|10205540|P1|Overall Study|Withdrawal by Subject|3
2965076|NCT01196104|10205539|P2|Overall Study|Physician Decision|1
2965077|NCT01196104|10205540|P1|Overall Study|Physician Decision|0
2965078|NCT01196104|10205539|P2|Overall Study|Lost to Follow-up|0
2965079|NCT01196104|10205540|P1|Overall Study|Lost to Follow-up|1
2965080|NCT01196091|10205583|P3|Overall Study|Randomized, No Study Drug Received|1
2965081|NCT01196091|10205584|P2|Overall Study|Randomized, No Study Drug Received|0
2965082|NCT01196091|10205585|P1|Overall Study|Randomized, No Study Drug Received|1
2965083|NCT01196091|10205583|P3|Overall Study|Excluded Site|8
2965084|NCT01196091|10205584|P2|Overall Study|Excluded Site|11
2965085|NCT01196091|10205585|P1|Overall Study|Excluded Site|5
2965086|NCT01196091|10205583|P3|Overall Study|Sponsor Decision|4
2965087|NCT01196091|10205584|P2|Overall Study|Sponsor Decision|5
2965088|NCT01196091|10205585|P1|Overall Study|Sponsor Decision|6
2965089|NCT01196091|10205583|P3|Overall Study|Protocol Violation|3
2965090|NCT01196091|10205584|P2|Overall Study|Protocol Violation|3
2965091|NCT01196091|10205585|P1|Overall Study|Protocol Violation|1
2965092|NCT01196091|10205583|P3|Overall Study|Physician Decision|4
2965093|NCT01196091|10205584|P2|Overall Study|Physician Decision|3
2965094|NCT01196091|10205585|P1|Overall Study|Physician Decision|3
2965095|NCT01196091|10205583|P3|Overall Study|Withdrawal by Subject|22
2965096|NCT01196091|10205584|P2|Overall Study|Withdrawal by Subject|19
2965097|NCT01196091|10205585|P1|Overall Study|Withdrawal by Subject|16
2965098|NCT01196091|10205583|P3|Overall Study|Parent/Caregiver Decision|1
2965099|NCT01196091|10205584|P2|Overall Study|Parent/Caregiver Decision|0
2965100|NCT01196091|10205585|P1|Overall Study|Parent/Caregiver Decision|0
2965101|NCT01196091|10205583|P3|Overall Study|Lost to Follow-up|6
2965102|NCT01196091|10205584|P2|Overall Study|Lost to Follow-up|5
2965103|NCT01196091|10205585|P1|Overall Study|Lost to Follow-up|5
2965104|NCT01196091|10205583|P3|Overall Study|Lack of Efficacy|17
2965105|NCT01196091|10205584|P2|Overall Study|Lack of Efficacy|12
2965106|NCT01196091|10205585|P1|Overall Study|Lack of Efficacy|15
2965107|NCT01196091|10205583|P3|Overall Study|Entry Criteria Not Met|10
2965108|NCT01196091|10205584|P2|Overall Study|Entry Criteria Not Met|11
2965109|NCT01196091|10205585|P1|Overall Study|Entry Criteria Not Met|11
2965110|NCT01196091|10205583|P3|Overall Study|Death|2
2965111|NCT01196091|10205584|P2|Overall Study|Death|2
2965112|NCT01196091|10205585|P1|Overall Study|Death|3
2965113|NCT01196091|10205583|P3|Overall Study|Adverse Event|26
2965114|NCT01196091|10205584|P2|Overall Study|Adverse Event|27
2965115|NCT01196091|10205585|P1|Overall Study|Adverse Event|22
2965116|NCT01196078|10205637|P2|Overall Study|Death|4
2965117|NCT01196078|10205638|P1|Overall Study|Death|6
2965118|NCT01196078|10205637|P2|Overall Study|Lost to Follow-up|0
2965119|NCT01196078|10205638|P1|Overall Study|Lost to Follow-up|1
2965120|NCT01196078|10205637|P2|Overall Study|Lack of Efficacy|23
2965121|NCT01196078|10205638|P1|Overall Study|Lack of Efficacy|17
2965122|NCT01196078|10205637|P2|Overall Study|Protocol Violation|1
2965123|NCT01196078|10205638|P1|Overall Study|Protocol Violation|2
2965124|NCT01196078|10205637|P2|Overall Study|Adverse Event|4
2965125|NCT01196078|10205638|P1|Overall Study|Adverse Event|4
2965126|NCT01196078|10205637|P2|Overall Study|Withdrawal by Subject|5
2965127|NCT01196078|10205638|P1|Overall Study|Withdrawal by Subject|3
2965128|NCT01196052|10205666|P1|Overall Study|Withdrawal by Subject|6
2965129|NCT01196052|10205666|P1|Overall Study|Reason not Specified|5
2965130|NCT01196052|10205666|P1|Overall Study|Noncompliance to Protocol Requirements|2
2965131|NCT01196052|10205666|P1|Overall Study|Lost to Follow-up|1
2965132|NCT01196052|10205666|P1|Overall Study|Adverse Event|9
2965133|NCT01196026|10205683|P6|Overall Study|Other|0
2965134|NCT01196026|10205684|P5|Overall Study|Other|0
2965135|NCT01196026|10205685|P4|Overall Study|Other|0
2965136|NCT01196026|10205686|P3|Overall Study|Other|0
2965137|NCT01196026|10205687|P2|Overall Study|Other|1
2965138|NCT01196026|10205688|P1|Overall Study|Other|0
2965139|NCT01196026|10205683|P6|Overall Study|Lost to Follow-up|0
2965140|NCT01196026|10205684|P5|Overall Study|Lost to Follow-up|1
2965141|NCT01196026|10205685|P4|Overall Study|Lost to Follow-up|0
2965142|NCT01196026|10205686|P3|Overall Study|Lost to Follow-up|0
2965143|NCT01196026|10205687|P2|Overall Study|Lost to Follow-up|3
2965144|NCT01196026|10205688|P1|Overall Study|Lost to Follow-up|0
2965145|NCT01196026|10205683|P6|Overall Study|Withdrawal by Subject|0
2965146|NCT01196026|10205684|P5|Overall Study|Withdrawal by Subject|0
2965147|NCT01196026|10205685|P4|Overall Study|Withdrawal by Subject|0
2965148|NCT01196026|10205686|P3|Overall Study|Withdrawal by Subject|0
2965149|NCT01196026|10205687|P2|Overall Study|Withdrawal by Subject|4
2965150|NCT01196026|10205688|P1|Overall Study|Withdrawal by Subject|1
2965151|NCT01195948|10205922|P3|Overall Study|Lost to Follow-up|2
2965152|NCT01195948|10205923|P2|Overall Study|Lost to Follow-up|1
2965153|NCT01195948|10205924|P1|Overall Study|Lost to Follow-up|0
2965154|NCT01195844|10205977|P1|Overall Study|Fecal sample not collected|40
2965155|NCT01195831|10205994|P2|Overall Study|Protocol Violation|2
2965156|NCT01195831|10205995|P1|Overall Study|Protocol Violation|0
2965157|NCT01195831|10205994|P2|Overall Study|Adverse Event|2
2965158|NCT01195831|10205995|P1|Overall Study|Adverse Event|4
2965159|NCT01195831|10205994|P2|Overall Study|Withdrawal by Subject|2
2965160|NCT01195831|10205995|P1|Overall Study|Withdrawal by Subject|2
2965161|NCT01195831|10205994|P2|Overall Study|Lost to Follow-up|4
2965162|NCT01195831|10205995|P1|Overall Study|Lost to Follow-up|2
2965163|NCT01195675|10206235|P1|Overall Study|Withdrawal by Subject|2
2965164|NCT01195675|10206235|P1|Overall Study|Adverse Event|1
2965165|NCT01195662|10206268|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2965166|NCT01195662|10206269|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2965167|NCT01195662|10206270|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
2965168|NCT01195662|10206268|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
2965169|NCT01195662|10206269|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
2965170|NCT01195662|10206270|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
2965171|NCT01195662|10206268|P3|Double Blind Treatment Period|Missing disposition information|1
2965172|NCT01195662|10206269|P2|Double Blind Treatment Period|Missing disposition information|1
2965173|NCT01195662|10206270|P1|Double Blind Treatment Period|Missing disposition information|0
2965174|NCT01195662|10206268|P3|Double Blind Treatment Period|Non-specified|0
2965175|NCT01195662|10206269|P2|Double Blind Treatment Period|Non-specified|0
2965176|NCT01195662|10206270|P1|Double Blind Treatment Period|Non-specified|3
2965177|NCT01195662|10206268|P3|Double Blind Treatment Period|Lack of Efficacy|0
2965178|NCT01195662|10206269|P2|Double Blind Treatment Period|Lack of Efficacy|0
2965179|NCT01195662|10206270|P1|Double Blind Treatment Period|Lack of Efficacy|2
2965180|NCT01195662|10206268|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
2965181|NCT01195662|10206269|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
2965182|NCT01195662|10206270|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
2965183|NCT01195662|10206268|P3|Double Blind Treatment Period|Requested discontinue treatment|1
2965184|NCT01195662|10206269|P2|Double Blind Treatment Period|Requested discontinue treatment|0
2965185|NCT01195662|10206270|P1|Double Blind Treatment Period|Requested discontinue treatment|1
2965186|NCT01195662|10206268|P3|Double Blind Treatment Period|Administrative reason|1
2965187|NCT01195662|10206269|P2|Double Blind Treatment Period|Administrative reason|1
2965188|NCT01195662|10206270|P1|Double Blind Treatment Period|Administrative reason|2
2965189|NCT01195662|10206268|P3|Double Blind Treatment Period|Lost to Follow-up|3
2965190|NCT01195662|10206269|P2|Double Blind Treatment Period|Lost to Follow-up|2
2965191|NCT01195662|10206270|P1|Double Blind Treatment Period|Lost to Follow-up|3
2965192|NCT01195662|10206268|P3|Double Blind Treatment Period|Withdrawal by Subject|4
2965193|NCT01195662|10206269|P2|Double Blind Treatment Period|Withdrawal by Subject|4
2965194|NCT01195662|10206270|P1|Double Blind Treatment Period|Withdrawal by Subject|6
2965195|NCT01195662|10206268|P3|Double Blind Treatment Period|Adverse Event|2
2965196|NCT01195662|10206269|P2|Double Blind Treatment Period|Adverse Event|1
2965197|NCT01195662|10206270|P1|Double Blind Treatment Period|Adverse Event|4
2965198|NCT01195636|10206300|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2965199|NCT01195636|10206301|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2965200|NCT01195636|10206300|P2|Second Intervention (3 Weeks)|Adverse Event|1
2965201|NCT01195636|10206301|P1|Second Intervention (3 Weeks)|Adverse Event|1
2965202|NCT01195636|10206300|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
2965203|NCT01195636|10206301|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
2965204|NCT01195636|10206300|P2|Washout Period (2 Weeks)|Adverse Event|1
2965205|NCT01195636|10206301|P1|Washout Period (2 Weeks)|Adverse Event|1
2965206|NCT01195636|10206300|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
2965207|NCT01195636|10206301|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
2965208|NCT01195636|10206300|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
2965209|NCT01195636|10206301|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
2965210|NCT01195636|10206300|P2|First Intervention (3 Weeks)|Protocol Violation|0
2965211|NCT01195636|10206301|P1|First Intervention (3 Weeks)|Protocol Violation|1
2965212|NCT01195636|10206300|P2|First Intervention (3 Weeks)|Adverse Event|3
2965213|NCT01195636|10206301|P1|First Intervention (3 Weeks)|Adverse Event|2
2965214|NCT01195623|10206327|P2|Overall Study|Lost to Follow-up|37
2965215|NCT01195623|10206328|P1|Overall Study|Lost to Follow-up|35
2965216|NCT01195545|10206357|P1|Overall Study|Protocol Violation|4
2965217|NCT01195415|10206369|P1|Overall Study|No repeat biopsy due to progression|2
2965218|NCT01195363|10206378|P2|Overall Study|incarceration|0
2965219|NCT01195363|10206379|P1|Overall Study|incarceration|1
2965220|NCT01195363|10206378|P2|Overall Study|Lack of Efficacy|4
2965221|NCT01195363|10206379|P1|Overall Study|Lack of Efficacy|0
2965222|NCT01195363|10206378|P2|Overall Study|Adverse Event|1
2965223|NCT01195363|10206379|P1|Overall Study|Adverse Event|3
2965224|NCT01195363|10206378|P2|Overall Study|Lost to Follow-up|4
2965225|NCT01195363|10206379|P1|Overall Study|Lost to Follow-up|7
2965226|NCT01195272|10206385|P1|Overall Study|Lack of Efficacy|3
2965227|NCT01195272|10206385|P1|Overall Study|Adverse Event|1
2965228|NCT01195103|10206414|P3|Overall Study|Withdrawal by Subject|0
2965229|NCT01195103|10206415|P2|Overall Study|Withdrawal by Subject|0
2965230|NCT01195103|10206416|P1|Overall Study|Withdrawal by Subject|1
2965231|NCT01195090|10206426|P2|Overall Study|Protocol Violation|4
2965232|NCT01195090|10206427|P1|Overall Study|Protocol Violation|3
2965233|NCT01195090|10206426|P2|Overall Study|Lost to Follow-up|2
2965234|NCT01195090|10206427|P1|Overall Study|Lost to Follow-up|2
2965235|NCT01195090|10206426|P2|Overall Study|Adverse Event|2
2965236|NCT01195090|10206427|P1|Overall Study|Adverse Event|1
2965237|NCT01194999|10206496|P1|Overall Study|Lost to Follow-up|17
2965238|NCT01194973|10206500|P1|26 Week Treatment Period|Pregnancy|1
2965239|NCT01194973|10206500|P1|26 Week Treatment Period|Lack of Efficacy|1
2965240|NCT01194973|10206500|P1|26 Week Treatment Period|Adverse Event|1
2965241|NCT01194973|10206500|P1|Screening Period|Screen Failure|3
2965242|NCT01194869|10206520|P1|Overall Study|Toxicity|2
2965243|NCT01194869|10206520|P1|Overall Study|Disease Progression|2
2965244|NCT01194830|10206551|P2|Overall Study|Other Reason|8
2965245|NCT01194830|10206552|P1|Overall Study|Other Reason|12
2965246|NCT01194830|10206551|P2|Overall Study|Non-compliance issues|4
2965247|NCT01194830|10206552|P1|Overall Study|Non-compliance issues|4
2965248|NCT01194830|10206551|P2|Overall Study|Lack of Efficacy|1
2965249|NCT01194830|10206552|P1|Overall Study|Lack of Efficacy|1
2965250|NCT01194830|10206551|P2|Overall Study|Withdrawal by Subject|1
2965251|NCT01194830|10206552|P1|Overall Study|Withdrawal by Subject|2
2965252|NCT01194830|10206551|P2|Overall Study|Lost to Follow-up|7
2965253|NCT01194830|10206552|P1|Overall Study|Lost to Follow-up|9
2965254|NCT01194830|10206551|P2|Overall Study|Protocol Violation|4
2965255|NCT01194830|10206552|P1|Overall Study|Protocol Violation|5
2965256|NCT01194830|10206551|P2|Overall Study|Adverse Event|2
2965257|NCT01194830|10206552|P1|Overall Study|Adverse Event|3
2965258|NCT01194804|10206574|P1|Overall Study|Withdrawal by Subject|1
2965259|NCT01194570|10206596|P2|Overall Study|Lost to Follow-up|4
2965260|NCT01194570|10206597|P1|Overall Study|Lost to Follow-up|1
2965261|NCT01194570|10206596|P2|Overall Study|Pregnancy|1
2965262|NCT01194570|10206597|P1|Overall Study|Pregnancy|1
2965263|NCT01194570|10206596|P2|Overall Study|Withdrawal by Subject|22
2965264|NCT01194570|10206597|P1|Overall Study|Withdrawal by Subject|21
2965265|NCT01194570|10206596|P2|Overall Study|Lack of Efficacy|21
2965266|NCT01194570|10206597|P1|Overall Study|Lack of Efficacy|27
2965267|NCT01194570|10206596|P2|Overall Study|Non-compliance|2
2965268|NCT01194570|10206597|P1|Overall Study|Non-compliance|2
2965269|NCT01194570|10206596|P2|Overall Study|Adverse Event|18
2965270|NCT01194570|10206597|P1|Overall Study|Adverse Event|12
2965271|NCT01194570|10206596|P2|Overall Study|Non-compliance with study drug|2
2965272|NCT01194570|10206597|P1|Overall Study|Non-compliance with study drug|2
2965273|NCT01194570|10206596|P2|Overall Study|Protocol Violation|2
2965274|NCT01194570|10206597|P1|Overall Study|Protocol Violation|0
2965275|NCT01194570|10206596|P2|Overall Study|Reason not specified|20
2965276|NCT01194570|10206597|P1|Overall Study|Reason not specified|13
2965277|NCT01194570|10206596|P2|Overall Study|Physician Decision|6
2965278|NCT01194570|10206597|P1|Overall Study|Physician Decision|2
2965279|NCT01194570|10206596|P2|Overall Study|Ongoing at CCOD|387
2965280|NCT01194570|10206597|P1|Overall Study|Ongoing at CCOD|162
2965281|NCT01194570|10206596|P2|Overall Study|Death|3
2965282|NCT01194570|10206597|P1|Overall Study|Death|1
2965283|NCT01194531|10206617|P2|Overall Study|Physician Decision|2
2965284|NCT01194531|10206618|P1|Overall Study|Physician Decision|0
2965285|NCT01194531|10206617|P2|Overall Study|Protocol Violation|1
2965286|NCT01194531|10206618|P1|Overall Study|Protocol Violation|4
2965287|NCT01194531|10206617|P2|Overall Study|Withdrawal by Subject|0
2965288|NCT01194531|10206618|P1|Overall Study|Withdrawal by Subject|1
2965289|NCT01194440|10206672|P1|6-months (2nd Dose)|Change in therapy|4
2965290|NCT01194440|10206672|P1|Baseline (First Dose)|Adverse Event|1
2965291|NCT01194440|10206672|P1|Baseline (First Dose)|Change in therapy|1
2965292|NCT01194440|10206672|P1|Baseline (First Dose)|Lack of Efficacy|1
2965293|NCT01194440|10206672|P1|Baseline (First Dose)|Reason not specified|4
2965294|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Death|2
2965295|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Death|0
2965296|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Death|2
2965297|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Death|1
2965298|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2965299|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2965300|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2965301|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2965302|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Adverse Event|12
2965303|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Adverse Event|2
2965304|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Adverse Event|21
2965305|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Adverse Event|35
2965306|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Protocol Violation|1
2965307|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Protocol Violation|0
2965308|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Protocol Violation|0
2965309|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Protocol Violation|0
2965310|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Other|0
2965311|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Other|0
2965312|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Other|1
2965313|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Other|2
2965314|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Pregnancy|1
2965315|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Pregnancy|1
2965316|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Pregnancy|3
2965317|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Pregnancy|1
2965318|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2965319|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2965320|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
2965321|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
2965322|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
2965323|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
2965324|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
2965325|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
2965326|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
2965327|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
2965328|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
2965329|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
2965330|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
2965331|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
2965332|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
2965333|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
2965334|NCT01194414|10206685|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
2965335|NCT01194414|10206686|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
2965336|NCT01194414|10206687|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
2965337|NCT01194414|10206688|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
2965338|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Death|0
2965339|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Death|0
2965340|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Death|1
2965341|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Death|0
2965342|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2965343|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2965344|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
2965345|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
2965346|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Adverse Event|0
2965347|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Adverse Event|0
2965348|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Adverse Event|40
2965349|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Adverse Event|28
2965350|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Other|0
2965351|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Other|0
2965352|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Other|1
2965353|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Other|0
2965354|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
2965355|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
2965356|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
2965357|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
2965358|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Pregnancy|0
2965359|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Pregnancy|0
2965360|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Pregnancy|2
2965361|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Pregnancy|2
2965362|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2965363|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2965364|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
2965365|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2965366|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Protocol Violation|0
2965367|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Protocol Violation|0
2965368|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Protocol Violation|3
2965369|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Protocol Violation|5
2965370|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2965371|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2965372|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
2965373|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
2965374|NCT01194414|10206685|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2965375|NCT01194414|10206686|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2965376|NCT01194414|10206687|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
2965377|NCT01194414|10206688|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
2965378|NCT01194258|10206759|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
2965379|NCT01194258|10206760|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
2965380|NCT01194258|10206761|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
2965381|NCT01194258|10206762|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
2965382|NCT01194258|10206763|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
2965383|NCT01194258|10206759|P5|Period 2 (12 Weeks)|Adverse Event|0
2965384|NCT01194258|10206760|P4|Period 2 (12 Weeks)|Adverse Event|0
2965385|NCT01194258|10206761|P3|Period 2 (12 Weeks)|Adverse Event|0
2965386|NCT01194258|10206762|P2|Period 2 (12 Weeks)|Adverse Event|1
2965387|NCT01194258|10206763|P1|Period 2 (12 Weeks)|Adverse Event|0
2965388|NCT01194258|10206759|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
2965389|NCT01194258|10206760|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
2965390|NCT01194258|10206761|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
2965391|NCT01194258|10206762|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
2965392|NCT01194258|10206763|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
2965393|NCT01194258|10206759|P5|Period 1 (12 Weeks)|Death|1
2965394|NCT01194258|10206760|P4|Period 1 (12 Weeks)|Death|0
2965395|NCT01194258|10206761|P3|Period 1 (12 Weeks)|Death|0
2965396|NCT01194258|10206762|P2|Period 1 (12 Weeks)|Death|0
2965397|NCT01194258|10206763|P1|Period 1 (12 Weeks)|Death|0
2965398|NCT01194258|10206759|P5|Titration Period|Titration failure|0
2965399|NCT01194258|10206760|P4|Titration Period|Titration failure|0
2965400|NCT01194258|10206761|P3|Titration Period|Titration failure|0
2965401|NCT01194258|10206762|P2|Titration Period|Titration failure|0
2965402|NCT01194258|10206763|P1|Titration Period|Titration failure|3
2965403|NCT01194258|10206759|P5|Titration Period|Lost to Follow-up|0
2965404|NCT01194258|10206760|P4|Titration Period|Lost to Follow-up|0
2965405|NCT01194258|10206761|P3|Titration Period|Lost to Follow-up|0
2965406|NCT01194258|10206762|P2|Titration Period|Lost to Follow-up|0
2965407|NCT01194258|10206763|P1|Titration Period|Lost to Follow-up|2
2965408|NCT01194258|10206759|P5|Titration Period|Withdrawal by Subject|0
2965409|NCT01194258|10206760|P4|Titration Period|Withdrawal by Subject|0
2965410|NCT01194258|10206761|P3|Titration Period|Withdrawal by Subject|0
2965411|NCT01194258|10206762|P2|Titration Period|Withdrawal by Subject|0
2965412|NCT01194258|10206763|P1|Titration Period|Withdrawal by Subject|6
2965413|NCT01194245|10206787|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2965414|NCT01194245|10206788|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2965415|NCT01194245|10206789|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2965416|NCT01194245|10206790|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2965417|NCT01194245|10206791|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2965418|NCT01194245|10206787|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
2965419|NCT01194245|10206788|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2965420|NCT01194245|10206789|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2965421|NCT01194245|10206790|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2965422|NCT01194245|10206791|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2965423|NCT01194245|10206787|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2965424|NCT01194245|10206788|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2965425|NCT01194245|10206789|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2965426|NCT01194245|10206790|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2965427|NCT01194245|10206791|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
2965428|NCT01194245|10206787|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
2965429|NCT01194245|10206788|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
2965430|NCT01194245|10206789|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
2965431|NCT01194245|10206790|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
2965432|NCT01194245|10206791|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
2965433|NCT01194245|10206787|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
2965434|NCT01194245|10206788|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
2965435|NCT01194245|10206789|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
2965436|NCT01194245|10206790|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
2965437|NCT01194245|10206791|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
2965438|NCT01194245|10206787|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2965439|NCT01194245|10206788|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2965440|NCT01194245|10206789|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2965441|NCT01194245|10206790|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2965442|NCT01194245|10206791|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
2965443|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
2965444|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
2965445|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965446|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965447|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965448|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965449|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965450|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965451|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965452|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2965453|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965454|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
2965455|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965456|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965457|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965458|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965459|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965460|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965461|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965462|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2965463|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
2965464|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
2965465|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965466|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965467|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965468|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965469|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965470|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965471|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965472|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2965473|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Death|1
2965474|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Death|1
2965475|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Death|0
2965476|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Death|0
2965477|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Death|0
2965478|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Death|0
2965479|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Death|0
2965480|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Death|0
2965481|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Death|0
2965482|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Death|0
2965483|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
2965484|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
2965485|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965486|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965487|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965488|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965489|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965490|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965491|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965492|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2965493|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
2965494|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
2965495|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965496|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965497|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965498|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965499|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965500|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965501|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965502|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2965503|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
2965504|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
2965505|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965506|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965811|NCT01193920|10206903|P4|Overall Study|Withdrawal by Subject|1
2965507|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965508|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965509|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965510|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965511|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965512|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2965513|NCT01194219|10206812|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
2965514|NCT01194219|10206813|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
2965515|NCT01194219|10206814|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965516|NCT01194219|10206815|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965517|NCT01194219|10206816|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965518|NCT01194219|10206817|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965519|NCT01194219|10206818|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965520|NCT01194219|10206819|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965521|NCT01194219|10206820|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965522|NCT01194219|10206821|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2965523|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965524|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965525|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965526|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
2965527|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965528|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965529|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965530|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965531|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965532|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2965533|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965534|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965535|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
2965536|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965537|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965538|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965539|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965540|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965541|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965542|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2965543|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965544|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965545|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965546|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
2965547|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
2965548|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
2965549|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965550|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965551|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965552|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2965553|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965554|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965555|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
2965556|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
2965557|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965558|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
2965559|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965560|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965561|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965562|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2965563|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965564|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965565|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965566|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
2965567|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965568|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
2965569|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965570|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965571|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965572|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2965573|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965574|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965575|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
2965576|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
2965577|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2965578|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2965579|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965580|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965581|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965582|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2965583|NCT01194219|10206812|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965584|NCT01194219|10206813|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965585|NCT01194219|10206814|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
2965586|NCT01194219|10206815|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
2965587|NCT01194219|10206816|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
2965588|NCT01194219|10206817|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965589|NCT01194219|10206818|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965590|NCT01194219|10206819|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965591|NCT01194219|10206820|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965592|NCT01194219|10206821|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2965593|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Other|0
2965594|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Other|0
2965595|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Other|0
2965596|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Other|0
2965597|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Other|0
2965598|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Other|0
2965599|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Other|1
2965600|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Other|2
2965601|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Other|0
2965602|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Other|0
2965603|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
2965604|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
2965605|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
2965606|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
2965607|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
2965608|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
2965609|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
2965610|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
2965611|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
2965612|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
2965613|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965614|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965615|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965616|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965617|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965618|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965619|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965620|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
2965621|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965622|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2965623|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965624|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965625|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965626|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965627|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965628|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965629|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
2965630|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
2965631|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965632|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2965633|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965634|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965635|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965636|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965637|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965638|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965639|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
2965640|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
2965641|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965642|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2965643|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965644|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965645|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965646|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965647|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965648|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965649|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
2965650|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
2965651|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965652|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2965653|NCT01194219|10206812|P10|Maintenance Phase Weeks16-32|Adverse Event|0
2965654|NCT01194219|10206813|P9|Maintenance Phase Weeks16-32|Adverse Event|0
2965655|NCT01194219|10206814|P8|Maintenance Phase Weeks16-32|Adverse Event|0
2965656|NCT01194219|10206815|P7|Maintenance Phase Weeks16-32|Adverse Event|0
2965657|NCT01194219|10206816|P6|Maintenance Phase Weeks16-32|Adverse Event|0
2965658|NCT01194219|10206817|P5|Maintenance Phase Weeks16-32|Adverse Event|0
2965659|NCT01194219|10206818|P4|Maintenance Phase Weeks16-32|Adverse Event|9
2965660|NCT01194219|10206819|P3|Maintenance Phase Weeks16-32|Adverse Event|8
2965661|NCT01194219|10206820|P2|Maintenance Phase Weeks16-32|Adverse Event|0
2965662|NCT01194219|10206821|P1|Maintenance Phase Weeks16-32|Adverse Event|0
2965663|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965664|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965665|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965666|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965667|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965668|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965669|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965670|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2965671|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2965672|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2965673|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965674|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965675|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965676|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965677|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965678|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965679|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965680|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2965681|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
2965682|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
2965683|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965684|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965685|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965686|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965687|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965688|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965689|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965690|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2965691|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
2965692|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
2965693|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
2965694|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
2965695|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
2965696|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
2965697|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
2965698|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
2965699|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
2965700|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
2965701|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
2965702|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
2965703|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965704|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965705|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965706|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965707|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965708|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965709|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965710|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2965711|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
2965712|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
2965713|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965714|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965715|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965716|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965717|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965718|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965719|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965720|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965721|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2965722|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
2965723|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965724|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965725|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965726|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965727|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965728|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965729|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965730|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2965731|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
2965732|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
2965733|NCT01194219|10206812|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965734|NCT01194219|10206813|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965735|NCT01194219|10206814|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965736|NCT01194219|10206815|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965737|NCT01194219|10206816|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965738|NCT01194219|10206817|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965739|NCT01194219|10206818|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965740|NCT01194219|10206819|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2965741|NCT01194219|10206820|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
2965742|NCT01194219|10206821|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
2965743|NCT01194154|10206855|P2|Overall Study|Did not receive study medication|4
2965744|NCT01194154|10206856|P1|Overall Study|Did not receive study medication|2
2965745|NCT01194154|10206855|P2|Overall Study|Other|0
2965746|NCT01194154|10206856|P1|Overall Study|Other|4
2965747|NCT01194154|10206855|P2|Overall Study|Treatment with prohibited medication|5
2965748|NCT01194154|10206856|P1|Overall Study|Treatment with prohibited medication|4
2965749|NCT01194154|10206855|P2|Overall Study|Skipping of CERA treatment at two visits|0
2965750|NCT01194154|10206856|P1|Overall Study|Skipping of CERA treatment at two visits|3
2965751|NCT01194154|10206855|P2|Overall Study|Hemoglobin increase|3
2965752|NCT01194154|10206856|P1|Overall Study|Hemoglobin increase|12
2965753|NCT01194154|10206855|P2|Overall Study|Hemoglobin decrease|1
2965754|NCT01194154|10206856|P1|Overall Study|Hemoglobin decrease|0
2965755|NCT01194154|10206855|P2|Overall Study|Blood pressure increase|3
2965756|NCT01194154|10206856|P1|Overall Study|Blood pressure increase|5
2965757|NCT01194154|10206855|P2|Overall Study|Withdrawal by Subject|6
2965758|NCT01194154|10206856|P1|Overall Study|Withdrawal by Subject|5
2965759|NCT01194154|10206855|P2|Overall Study|Protocol Violation|1
2965760|NCT01194154|10206856|P1|Overall Study|Protocol Violation|0
2965761|NCT01194154|10206855|P2|Overall Study|Lost to Follow-up|3
2965762|NCT01194154|10206856|P1|Overall Study|Lost to Follow-up|2
2965763|NCT01194154|10206855|P2|Overall Study|Adverse Event|7
2965764|NCT01194154|10206856|P1|Overall Study|Adverse Event|12
2965765|NCT01193920|10206897|P10|Overall Study|Unable to classify|0
2965766|NCT01193920|10206898|P9|Overall Study|Unable to classify|0
2965767|NCT01193920|10206899|P8|Overall Study|Unable to classify|1
2965768|NCT01193920|10206900|P7|Overall Study|Unable to classify|0
2965769|NCT01193920|10206901|P6|Overall Study|Unable to classify|0
2965770|NCT01193920|10206902|P5|Overall Study|Unable to classify|0
2965771|NCT01193920|10206903|P4|Overall Study|Unable to classify|1
2965772|NCT01193920|10206904|P3|Overall Study|Unable to classify|0
2965773|NCT01193920|10206905|P2|Overall Study|Unable to classify|0
2965774|NCT01193920|10206906|P1|Overall Study|Unable to classify|0
2965775|NCT01193920|10206897|P10|Overall Study|Death|4
2965776|NCT01193920|10206898|P9|Overall Study|Death|2
2965777|NCT01193920|10206899|P8|Overall Study|Death|3
2965778|NCT01193920|10206900|P7|Overall Study|Death|2
2965779|NCT01193920|10206901|P6|Overall Study|Death|0
2965780|NCT01193920|10206902|P5|Overall Study|Death|0
2965781|NCT01193920|10206903|P4|Overall Study|Death|1
2965782|NCT01193920|10206904|P3|Overall Study|Death|0
2965783|NCT01193920|10206905|P2|Overall Study|Death|0
2965784|NCT01193920|10206906|P1|Overall Study|Death|0
2965785|NCT01193920|10206897|P10|Overall Study|Protocol Violation|0
2965786|NCT01193920|10206898|P9|Overall Study|Protocol Violation|0
2965787|NCT01193920|10206899|P8|Overall Study|Protocol Violation|0
2965788|NCT01193920|10206900|P7|Overall Study|Protocol Violation|0
2965789|NCT01193920|10206901|P6|Overall Study|Protocol Violation|0
2965790|NCT01193920|10206902|P5|Overall Study|Protocol Violation|0
2965791|NCT01193920|10206903|P4|Overall Study|Protocol Violation|0
2965792|NCT01193920|10206904|P3|Overall Study|Protocol Violation|0
2965793|NCT01193920|10206905|P2|Overall Study|Protocol Violation|0
2965794|NCT01193920|10206906|P1|Overall Study|Protocol Violation|1
2965795|NCT01193920|10206897|P10|Overall Study|Lost to Follow-up|3
2965796|NCT01193920|10206898|P9|Overall Study|Lost to Follow-up|2
2965797|NCT01193920|10206899|P8|Overall Study|Lost to Follow-up|0
2965798|NCT01193920|10206900|P7|Overall Study|Lost to Follow-up|1
2965799|NCT01193920|10206901|P6|Overall Study|Lost to Follow-up|3
2965800|NCT01193920|10206902|P5|Overall Study|Lost to Follow-up|3
2965801|NCT01193920|10206903|P4|Overall Study|Lost to Follow-up|1
2965802|NCT01193920|10206904|P3|Overall Study|Lost to Follow-up|1
2965803|NCT01193920|10206905|P2|Overall Study|Lost to Follow-up|0
2965804|NCT01193920|10206906|P1|Overall Study|Lost to Follow-up|1
2965805|NCT01193920|10206897|P10|Overall Study|Withdrawal by Subject|0
2965806|NCT01193920|10206898|P9|Overall Study|Withdrawal by Subject|1
2965807|NCT01193920|10206899|P8|Overall Study|Withdrawal by Subject|0
2965808|NCT01193920|10206900|P7|Overall Study|Withdrawal by Subject|3
2965809|NCT01193920|10206901|P6|Overall Study|Withdrawal by Subject|1
2965810|NCT01193920|10206902|P5|Overall Study|Withdrawal by Subject|3
2965812|NCT01193920|10206904|P3|Overall Study|Withdrawal by Subject|5
2965813|NCT01193920|10206905|P2|Overall Study|Withdrawal by Subject|0
2965814|NCT01193920|10206906|P1|Overall Study|Withdrawal by Subject|1
2965815|NCT01193842|10207002|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
2965816|NCT01193842|10207003|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
2965817|NCT01193842|10207004|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2965818|NCT01193842|10207005|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2965819|NCT01193842|10207006|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2965820|NCT01193842|10207002|P5|Phase II: Randomized Groups|Ineligible|1
2965821|NCT01193842|10207003|P4|Phase II: Randomized Groups|Ineligible|0
2965822|NCT01193842|10207004|P3|Phase II: Randomized Groups|Ineligible|0
2965823|NCT01193842|10207005|P2|Phase II: Randomized Groups|Ineligible|0
2965824|NCT01193842|10207006|P1|Phase II: Randomized Groups|Ineligible|0
2965825|NCT01193842|10207002|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
2965826|NCT01193842|10207003|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
2965827|NCT01193842|10207004|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
2965828|NCT01193842|10207005|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
2965829|NCT01193842|10207006|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
2965830|NCT01193842|10207002|P5|Phase II: Randomized Groups|Adverse Event|3
2965831|NCT01193842|10207003|P4|Phase II: Randomized Groups|Adverse Event|5
2965832|NCT01193842|10207004|P3|Phase II: Randomized Groups|Adverse Event|0
2965833|NCT01193842|10207005|P2|Phase II: Randomized Groups|Adverse Event|0
2965834|NCT01193842|10207006|P1|Phase II: Randomized Groups|Adverse Event|0
2965835|NCT01193842|10207002|P5|Phase II: Randomized Groups|Death|1
2965836|NCT01193842|10207003|P4|Phase II: Randomized Groups|Death|1
2965837|NCT01193842|10207004|P3|Phase II: Randomized Groups|Death|0
2965838|NCT01193842|10207005|P2|Phase II: Randomized Groups|Death|0
2965839|NCT01193842|10207006|P1|Phase II: Randomized Groups|Death|0
2965840|NCT01193842|10207002|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2965841|NCT01193842|10207003|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2965842|NCT01193842|10207004|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
2965843|NCT01193842|10207005|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2965844|NCT01193842|10207006|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2965845|NCT01193842|10207002|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2965846|NCT01193842|10207003|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2965847|NCT01193842|10207004|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2965848|NCT01193842|10207005|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2965849|NCT01193842|10207006|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
2965850|NCT01193842|10207002|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2965851|NCT01193842|10207003|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2965852|NCT01193842|10207004|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2965853|NCT01193842|10207005|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
2965854|NCT01193842|10207006|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2965855|NCT01193686|10207041|P2|Overall Study|Removed by Investigators; unable to matc|0
2965856|NCT01193686|10207042|P1|Overall Study|Removed by Investigators; unable to matc|3
2965857|NCT01193686|10207041|P2|Overall Study|Withdrawal by Subject|1
2965858|NCT01193686|10207042|P1|Overall Study|Withdrawal by Subject|4
2965859|NCT01193660|10207059|P3|Overall Study|Physician Decision|1
2965860|NCT01193660|10207060|P2|Overall Study|Physician Decision|0
2965861|NCT01193660|10207061|P1|Overall Study|Physician Decision|1
2965862|NCT01193660|10207059|P3|Overall Study|Death|0
2965863|NCT01193660|10207060|P2|Overall Study|Death|0
2965864|NCT01193660|10207061|P1|Overall Study|Death|1
2965865|NCT01193660|10207059|P3|Overall Study|Withdrawal by Subject|1
2965866|NCT01193660|10207060|P2|Overall Study|Withdrawal by Subject|3
2965867|NCT01193660|10207061|P1|Overall Study|Withdrawal by Subject|2
2965868|NCT01193608|10207105|P6|Overall Study|Adverse Event|0
2965869|NCT01193608|10207106|P5|Overall Study|Adverse Event|1
2965870|NCT01193608|10207107|P4|Overall Study|Adverse Event|0
2965871|NCT01193608|10207108|P3|Overall Study|Adverse Event|0
2965872|NCT01193608|10207109|P2|Overall Study|Adverse Event|0
2965873|NCT01193608|10207110|P1|Overall Study|Adverse Event|0
2965874|NCT01193608|10207105|P6|Overall Study|Lost to Follow-up|2
2965875|NCT01193608|10207106|P5|Overall Study|Lost to Follow-up|1
2965876|NCT01193608|10207107|P4|Overall Study|Lost to Follow-up|0
2965877|NCT01193608|10207108|P3|Overall Study|Lost to Follow-up|0
2965878|NCT01193608|10207109|P2|Overall Study|Lost to Follow-up|0
2965879|NCT01193608|10207110|P1|Overall Study|Lost to Follow-up|0
2965880|NCT01193608|10207105|P6|Overall Study|Withdrawal by Subject|0
2965881|NCT01193608|10207106|P5|Overall Study|Withdrawal by Subject|3
2965882|NCT01193608|10207107|P4|Overall Study|Withdrawal by Subject|3
2965883|NCT01193608|10207108|P3|Overall Study|Withdrawal by Subject|2
2965884|NCT01193608|10207109|P2|Overall Study|Withdrawal by Subject|1
2965885|NCT01193608|10207110|P1|Overall Study|Withdrawal by Subject|0
2965886|NCT01193608|10207105|P6|Overall Study|Other|0
2965887|NCT01193608|10207106|P5|Overall Study|Other|0
2965888|NCT01193608|10207107|P4|Overall Study|Other|0
2965889|NCT01193608|10207108|P3|Overall Study|Other|0
2965890|NCT01193608|10207109|P2|Overall Study|Other|1
2965891|NCT01193608|10207110|P1|Overall Study|Other|0
2965892|NCT01193582|10207347|P4|12 Month Follow-up|Withdrawal by Subject|11
2965893|NCT01193582|10207348|P3|12 Month Follow-up|Withdrawal by Subject|3
2965894|NCT01193582|10207349|P2|12 Month Follow-up|Withdrawal by Subject|0
2965895|NCT01193582|10207350|P1|12 Month Follow-up|Withdrawal by Subject|6
2965896|NCT01193582|10207347|P4|12 Month Follow-up|Death|0
2965897|NCT01193582|10207348|P3|12 Month Follow-up|Death|1
2965898|NCT01193582|10207349|P2|12 Month Follow-up|Death|0
2965899|NCT01193582|10207350|P1|12 Month Follow-up|Death|0
2965900|NCT01193582|10207347|P4|Vaccination Series|Withdrawal by Subject|3
2965901|NCT01193582|10207348|P3|Vaccination Series|Withdrawal by Subject|8
2965902|NCT01193582|10207349|P2|Vaccination Series|Withdrawal by Subject|13
2965903|NCT01193582|10207350|P1|Vaccination Series|Withdrawal by Subject|11
2965904|NCT01193556|10207380|P2|Overall Study|Study termination|25
2965905|NCT01193556|10207381|P1|Overall Study|Study termination|26
2965906|NCT01193530|10207391|P2|Overall Study|Non-Compliance|1
2965907|NCT01193530|10207392|P1|Overall Study|Non-Compliance|0
2965908|NCT01193530|10207391|P2|Overall Study|Returned home - out of state|1
2965909|NCT01193530|10207392|P1|Overall Study|Returned home - out of state|0
2965910|NCT01193530|10207391|P2|Overall Study|Lost Light Box|1
2965911|NCT01193530|10207392|P1|Overall Study|Lost Light Box|0
2965912|NCT01193530|10207391|P2|Overall Study|Began Contraindicated Therapy|0
2965913|NCT01193530|10207392|P1|Overall Study|Began Contraindicated Therapy|1
2965914|NCT01193530|10207391|P2|Overall Study|Withdrawal by Subject|2
2965915|NCT01193530|10207392|P1|Overall Study|Withdrawal by Subject|2
2965916|NCT01193517|10207401|P3|Overall Study|Early Progression|0
2965917|NCT01193517|10207402|P2|Overall Study|Early Progression|0
2965918|NCT01193517|10207403|P1|Overall Study|Early Progression|1
2965919|NCT01193348|10207412|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
2965920|NCT01193348|10207412|P1|Extension Treatment Period|Physician Decision|1
2965921|NCT01193348|10207412|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
2965922|NCT01193348|10207412|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
2965923|NCT01193348|10207412|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
2965924|NCT01193348|10207412|P1|Screening Period|Screen Failure|5
2965925|NCT01193335|10207432|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2965926|NCT01193335|10207433|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2965927|NCT01193335|10207432|P2|2-Year Follow-up|No Longer Willing to Participate|6
2965928|NCT01193335|10207433|P1|2-Year Follow-up|No Longer Willing to Participate|5
2965929|NCT01193335|10207432|P2|1-Year Follow-up|Lost to Follow-up|0
2965930|NCT01193335|10207433|P1|1-Year Follow-up|Lost to Follow-up|4
2965931|NCT01193335|10207432|P2|1-Year Follow-up|No Longer Willing to Participate|9
2965932|NCT01193335|10207433|P1|1-Year Follow-up|No Longer Willing to Participate|7
2965933|NCT01193335|10207432|P2|After Infant Series|No Longer Met Eligibility Criteria|1
2965934|NCT01193335|10207433|P1|After Infant Series|No Longer Met Eligibility Criteria|0
2965935|NCT01193335|10207432|P2|After Infant Series|Lost to Follow-up|2
2965936|NCT01193335|10207433|P1|After Infant Series|Lost to Follow-up|1
2965937|NCT01193283|10207528|P1|Overall Study|Death|1
2965938|NCT01193257|10207534|P2|Overall Study|Unblinded due to futility|251
2965939|NCT01193257|10207535|P1|Overall Study|Unblinded due to futility|135
2965940|NCT01193257|10207534|P2|Overall Study|Lost to Follow-up|3
2965941|NCT01193257|10207535|P1|Overall Study|Lost to Follow-up|2
2965942|NCT01193257|10207534|P2|Overall Study|Withdrawal by Subject|86
2965943|NCT01193257|10207535|P1|Overall Study|Withdrawal by Subject|26
2965944|NCT01193257|10207534|P2|Overall Study|Study termination by sponsor|3
2965945|NCT01193257|10207535|P1|Overall Study|Study termination by sponsor|0
2965946|NCT01193257|10207534|P2|Overall Study|Death|391
2965947|NCT01193257|10207535|P1|Overall Study|Death|202
2965948|NCT01193244|10207585|P2|Overall Study|Lost to Follow-up|15
2965949|NCT01193244|10207586|P1|Overall Study|Lost to Follow-up|6
2965950|NCT01193244|10207585|P2|Overall Study|Other|278
2965951|NCT01193244|10207586|P1|Overall Study|Other|303
2965952|NCT01193244|10207585|P2|Overall Study|Withdrawal by Subject|97
2965953|NCT01193244|10207586|P1|Overall Study|Withdrawal by Subject|79
2965954|NCT01193218|10207641|P8|12-52 Weeks|Other reason than above|0
2965955|NCT01193218|10207642|P7|12-52 Weeks|Other reason than above|0
2965956|NCT01193218|10207643|P6|12-52 Weeks|Other reason than above|0
2965957|NCT01193218|10207644|P5|12-52 Weeks|Other reason than above|1
2965958|NCT01193218|10207645|P4|12-52 Weeks|Other reason than above|1
2965959|NCT01193218|10207646|P3|12-52 Weeks|Other reason than above|0
2965960|NCT01193218|10207647|P2|12-52 Weeks|Other reason than above|0
2965961|NCT01193218|10207648|P1|12-52 Weeks|Other reason than above|1
2965962|NCT01193218|10207641|P8|12-52 Weeks|Withdrawal by Subject|2
2965963|NCT01193218|10207642|P7|12-52 Weeks|Withdrawal by Subject|1
2965964|NCT01193218|10207643|P6|12-52 Weeks|Withdrawal by Subject|2
2965965|NCT01193218|10207644|P5|12-52 Weeks|Withdrawal by Subject|0
2965966|NCT01193218|10207645|P4|12-52 Weeks|Withdrawal by Subject|0
2965967|NCT01193218|10207646|P3|12-52 Weeks|Withdrawal by Subject|3
2965968|NCT01193218|10207647|P2|12-52 Weeks|Withdrawal by Subject|0
2965969|NCT01193218|10207648|P1|12-52 Weeks|Withdrawal by Subject|3
2965970|NCT01193218|10207641|P8|12-52 Weeks|Lack of Efficacy|0
2965971|NCT01193218|10207642|P7|12-52 Weeks|Lack of Efficacy|1
2965972|NCT01193218|10207643|P6|12-52 Weeks|Lack of Efficacy|0
2965973|NCT01193218|10207644|P5|12-52 Weeks|Lack of Efficacy|0
2965974|NCT01193218|10207645|P4|12-52 Weeks|Lack of Efficacy|0
2965975|NCT01193218|10207646|P3|12-52 Weeks|Lack of Efficacy|0
2965976|NCT01193218|10207647|P2|12-52 Weeks|Lack of Efficacy|0
2965977|NCT01193218|10207648|P1|12-52 Weeks|Lack of Efficacy|0
2965978|NCT01193218|10207641|P8|12-52 Weeks|Adverse Event|2
2965979|NCT01193218|10207642|P7|12-52 Weeks|Adverse Event|1
2965980|NCT01193218|10207643|P6|12-52 Weeks|Adverse Event|3
2965981|NCT01193218|10207644|P5|12-52 Weeks|Adverse Event|3
2965982|NCT01193218|10207645|P4|12-52 Weeks|Adverse Event|2
2965983|NCT01193218|10207646|P3|12-52 Weeks|Adverse Event|1
2965984|NCT01193218|10207647|P2|12-52 Weeks|Adverse Event|0
2965985|NCT01193218|10207648|P1|12-52 Weeks|Adverse Event|1
2965986|NCT01193218|10207641|P8|0-12 Weeks|Withdrawal by Subject|0
2965987|NCT01193218|10207642|P7|0-12 Weeks|Withdrawal by Subject|1
2965988|NCT01193218|10207643|P6|0-12 Weeks|Withdrawal by Subject|0
2965989|NCT01193218|10207644|P5|0-12 Weeks|Withdrawal by Subject|0
2965990|NCT01193218|10207645|P4|0-12 Weeks|Withdrawal by Subject|0
2965991|NCT01193218|10207646|P3|0-12 Weeks|Withdrawal by Subject|2
2965992|NCT01193218|10207647|P2|0-12 Weeks|Withdrawal by Subject|0
2965993|NCT01193218|10207648|P1|0-12 Weeks|Withdrawal by Subject|3
2965994|NCT01193218|10207641|P8|0-12 Weeks|Protocol Violation|0
2965995|NCT01193218|10207642|P7|0-12 Weeks|Protocol Violation|0
2965996|NCT01193218|10207643|P6|0-12 Weeks|Protocol Violation|1
2965997|NCT01193218|10207644|P5|0-12 Weeks|Protocol Violation|1
2965998|NCT01193218|10207645|P4|0-12 Weeks|Protocol Violation|0
2965999|NCT01193218|10207646|P3|0-12 Weeks|Protocol Violation|0
2966000|NCT01193218|10207647|P2|0-12 Weeks|Protocol Violation|0
2966001|NCT01193218|10207648|P1|0-12 Weeks|Protocol Violation|0
2966002|NCT01193218|10207641|P8|0-12 Weeks|Adverse Event|0
2966003|NCT01193218|10207642|P7|0-12 Weeks|Adverse Event|2
2966004|NCT01193218|10207643|P6|0-12 Weeks|Adverse Event|2
2966005|NCT01193218|10207644|P5|0-12 Weeks|Adverse Event|0
2966006|NCT01193218|10207645|P4|0-12 Weeks|Adverse Event|0
2966007|NCT01193218|10207646|P3|0-12 Weeks|Adverse Event|1
2966008|NCT01193218|10207647|P2|0-12 Weeks|Adverse Event|0
2966009|NCT01193218|10207648|P1|0-12 Weeks|Adverse Event|6
2966010|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
2966011|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
2966012|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
2966013|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
2966014|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
2966015|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
2966016|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Pregnancy|0
2966017|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Pregnancy|1
2966018|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
2966019|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
2966020|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Death|0
2966021|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Death|2
2966022|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Adverse Event|3
2966023|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Adverse Event|12
2966024|NCT01193153|10207679|P2|Double Blind Relapse Prevention Period|Other|3
2966025|NCT01193153|10207680|P1|Double Blind Relapse Prevention Period|Other|2
2966026|NCT01193153|10207679|P2|Open-label Stabilization Period|Other|0
2966027|NCT01193153|10207680|P1|Open-label Stabilization Period|Other|8
2966028|NCT01193153|10207679|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
2966029|NCT01193153|10207680|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
2966030|NCT01193153|10207679|P2|Open-label Stabilization Period|Withdrawal by Subject|0
2966031|NCT01193153|10207680|P1|Open-label Stabilization Period|Withdrawal by Subject|29
2966032|NCT01193153|10207679|P2|Open-label Stabilization Period|Lack of Efficacy|0
2966033|NCT01193153|10207680|P1|Open-label Stabilization Period|Lack of Efficacy|5
2966034|NCT01193153|10207679|P2|Open-label Stabilization Period|Lost to Follow-up|0
2966035|NCT01193153|10207680|P1|Open-label Stabilization Period|Lost to Follow-up|10
2966036|NCT01193153|10207679|P2|Open-label Stabilization Period|Death|0
2966037|NCT01193153|10207680|P1|Open-label Stabilization Period|Death|2
2966038|NCT01193153|10207679|P2|Open-label Stabilization Period|Adverse Event|0
2966039|NCT01193153|10207680|P1|Open-label Stabilization Period|Adverse Event|9
2966040|NCT01193153|10207679|P2|Open-label Lead in Period|Lack of Efficacy|0
2966041|NCT01193153|10207680|P1|Open-label Lead in Period|Lack of Efficacy|26
2966042|NCT01193153|10207679|P2|Open-label Lead in Period|Death|0
2966043|NCT01193153|10207680|P1|Open-label Lead in Period|Death|1
2966044|NCT01193153|10207679|P2|Open-label Lead in Period|Adverse Event|0
2966045|NCT01193153|10207680|P1|Open-label Lead in Period|Adverse Event|41
2966046|NCT01193153|10207679|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
2966047|NCT01193153|10207680|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
2966048|NCT01193153|10207679|P2|Open-label Lead in Period|Other|0
2966049|NCT01193153|10207680|P1|Open-label Lead in Period|Other|14
2966050|NCT01193153|10207679|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
2966051|NCT01193153|10207680|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
2966052|NCT01193153|10207679|P2|Open-label Lead in Period|Withdrawal by Subject|0
2966053|NCT01193153|10207680|P1|Open-label Lead in Period|Withdrawal by Subject|69
2966054|NCT01193153|10207679|P2|Open-label Lead in Period|Pregnancy|0
2966055|NCT01193153|10207680|P1|Open-label Lead in Period|Pregnancy|1
2966056|NCT01193153|10207679|P2|Open-label Lead in Period|Lost to Follow-up|0
2966057|NCT01193153|10207680|P1|Open-label Lead in Period|Lost to Follow-up|32
2966058|NCT01193127|10207715|P4|Treated|Withdrawal by Subject|1
2966059|NCT01193127|10207716|P3|Treated|Withdrawal by Subject|0
2966060|NCT01193127|10207717|P2|Treated|Withdrawal by Subject|0
2966061|NCT01193127|10207718|P1|Treated|Withdrawal by Subject|0
2966062|NCT01193127|10207715|P4|Randomized|Surgery Cancelled|1
2966063|NCT01193127|10207716|P3|Randomized|Surgery Cancelled|0
2966064|NCT01193127|10207717|P2|Randomized|Surgery Cancelled|0
2966065|NCT01193127|10207718|P1|Randomized|Surgery Cancelled|0
2966066|NCT01193101|10208043|P4|Overall Study|Abnormal test procedure results|0
2966067|NCT01193101|10208044|P3|Overall Study|Abnormal test procedure results|0
2966068|NCT01193101|10208045|P2|Overall Study|Abnormal test procedure results|1
2966069|NCT01193101|10208046|P1|Overall Study|Abnormal test procedure results|0
2966070|NCT01193101|10208043|P4|Overall Study|Administrative problems|0
2966071|NCT01193101|10208044|P3|Overall Study|Administrative problems|1
2966072|NCT01193101|10208045|P2|Overall Study|Administrative problems|0
2966073|NCT01193101|10208046|P1|Overall Study|Administrative problems|0
2966074|NCT01193101|10208043|P4|Overall Study|Withdrawal by Subject|1
2966075|NCT01193101|10208044|P3|Overall Study|Withdrawal by Subject|1
2966076|NCT01193101|10208045|P2|Overall Study|Withdrawal by Subject|4
2966077|NCT01193101|10208046|P1|Overall Study|Withdrawal by Subject|2
2966078|NCT01193101|10208043|P4|Overall Study|Lack of Efficacy|8
2966079|NCT01193101|10208044|P3|Overall Study|Lack of Efficacy|0
2966080|NCT01193101|10208045|P2|Overall Study|Lack of Efficacy|1
2966081|NCT01193101|10208046|P1|Overall Study|Lack of Efficacy|3
2966082|NCT01193101|10208043|P4|Overall Study|Adverse Event|3
2966083|NCT01193101|10208044|P3|Overall Study|Adverse Event|1
2966084|NCT01193101|10208045|P2|Overall Study|Adverse Event|1
2966085|NCT01193101|10208046|P1|Overall Study|Adverse Event|0
2966086|NCT01192815|10208163|P1|Overall Study|Lack of Efficacy|1
2966087|NCT01192815|10208163|P1|Overall Study|Withdrawal by Subject|1
2966088|NCT01192776|10208178|P4|Overall Study|Lost to Follow-up|5
2966089|NCT01192776|10208179|P3|Overall Study|Lost to Follow-up|3
2966090|NCT01192776|10208180|P2|Overall Study|Lost to Follow-up|6
2966091|NCT01192776|10208181|P1|Overall Study|Lost to Follow-up|3
2966092|NCT01192776|10208178|P4|Overall Study|Death|15
2966093|NCT01192776|10208179|P3|Overall Study|Death|18
2966094|NCT01192776|10208180|P2|Overall Study|Death|15
2966095|NCT01192776|10208181|P1|Overall Study|Death|8
2966096|NCT01192516|10208259|P3|Overall Study|Unable to follow Actiwatch instructions|0
2966097|NCT01192516|10208260|P2|Overall Study|Unable to follow Actiwatch instructions|2
2966098|NCT01192516|10208261|P1|Overall Study|Unable to follow Actiwatch instructions|4
2966099|NCT01192516|10208259|P3|Overall Study|started new treatment|0
2966100|NCT01192516|10208260|P2|Overall Study|started new treatment|1
2966101|NCT01192516|10208261|P1|Overall Study|started new treatment|5
2966102|NCT01192516|10208259|P3|Overall Study|Withdrawal by Subject|1
2966103|NCT01192516|10208260|P2|Overall Study|Withdrawal by Subject|4
2966104|NCT01192516|10208261|P1|Overall Study|Withdrawal by Subject|4
2966105|NCT01192516|10208259|P3|Overall Study|Lost to Follow-up|7
2966106|NCT01192516|10208260|P2|Overall Study|Lost to Follow-up|10
2966107|NCT01192516|10208261|P1|Overall Study|Lost to Follow-up|7
2966108|NCT01192412|10208295|P2|Overall Study|Withdrawal by Subject|1
2966109|NCT01192412|10208296|P1|Overall Study|Withdrawal by Subject|2
2966110|NCT01192412|10208295|P2|Overall Study|Lost to Follow-up|1
2966111|NCT01192412|10208296|P1|Overall Study|Lost to Follow-up|2
2966112|NCT01192399|10208304|P1|Overall Study|Lack of Efficacy|2
2966113|NCT01192347|10208314|P1|Overall Study|Patient did not show up for visits|1
2966114|NCT01192347|10208314|P1|Overall Study|Patient not visiting hospital regularly|1
2966115|NCT01192347|10208314|P1|Overall Study|Patient seen in different hospital|1
2966116|NCT01192347|10208314|P1|Overall Study|Suspected serious adverse drug reaction|1
2966117|NCT01192347|10208314|P1|Overall Study|Adverse Event|1
2966118|NCT01192347|10208314|P1|Overall Study|Withdrawal by Subject|1
2966119|NCT01192347|10208314|P1|Overall Study|Lost to Follow-up|3
2966120|NCT01192347|10208314|P1|Overall Study|Death|3
2966121|NCT01192295|10208337|P2|Overall Study|Administrative|6
2966122|NCT01192295|10208338|P1|Overall Study|Administrative|4
2966123|NCT01192295|10208337|P2|Overall Study|Lack of Efficacy|5
2966124|NCT01192295|10208338|P1|Overall Study|Lack of Efficacy|0
2966125|NCT01192295|10208337|P2|Overall Study|Lost to Follow-up|1
2966126|NCT01192295|10208338|P1|Overall Study|Lost to Follow-up|0
2966127|NCT01192295|10208337|P2|Overall Study|Withdrawal by Subject|4
2966128|NCT01192295|10208338|P1|Overall Study|Withdrawal by Subject|3
2966129|NCT01192295|10208337|P2|Overall Study|Adverse Event|7
2966130|NCT01192295|10208338|P1|Overall Study|Adverse Event|3
2966131|NCT01192204|10208376|P2|Overall Study|could not keep recall appointments|0
2966132|NCT01192204|10208377|P1|Overall Study|could not keep recall appointments|1
2966133|NCT01192191|10208389|P2|Overall Study|Withdrawal by Subject|6
2966134|NCT01192191|10208390|P1|Overall Study|Withdrawal by Subject|1
2966135|NCT01192191|10208389|P2|Overall Study|Lost to Follow-up|1
2966136|NCT01192191|10208390|P1|Overall Study|Lost to Follow-up|0
2966137|NCT01192191|10208389|P2|Overall Study|Participants Reached Stopping Criteria|2
2966138|NCT01192191|10208390|P1|Overall Study|Participants Reached Stopping Criteria|3
2966139|NCT01192191|10208389|P2|Overall Study|Adverse Event|12
2966140|NCT01192191|10208390|P1|Overall Study|Adverse Event|7
2966141|NCT01192178|10208416|P2|Overall Study|Lack of Efficacy|2
2966142|NCT01192178|10208417|P1|Overall Study|Lack of Efficacy|1
2966143|NCT01192178|10208416|P2|Overall Study|Adverse Event|1
2966144|NCT01192178|10208417|P1|Overall Study|Adverse Event|2
2966145|NCT01192178|10208416|P2|Overall Study|Lost to Follow-up|3
2966146|NCT01192178|10208417|P1|Overall Study|Lost to Follow-up|3
2966147|NCT01192178|10208416|P2|Overall Study|Physician Decision|4
2966148|NCT01192178|10208417|P1|Overall Study|Physician Decision|2
2966149|NCT01192178|10208416|P2|Overall Study|Protocol Violation|3
2966150|NCT01192178|10208417|P1|Overall Study|Protocol Violation|10
2966151|NCT01192178|10208416|P2|Overall Study|Withdrawal by Subject|10
2966152|NCT01192178|10208417|P1|Overall Study|Withdrawal by Subject|6
2966153|NCT01192152|10208437|P2|Period 3|family emergency|0
2966154|NCT01192152|10208438|P1|Period 3|family emergency|1
2966155|NCT01192152|10208437|P2|Period 1|left prematurely (while on treatment B)|1
2966156|NCT01192152|10208438|P1|Period 1|left prematurely (while on treatment B)|0
2966157|NCT01192126|10208609|P2|First Intervention (1 Week)|Lost to Follow-up|1
2966158|NCT01192126|10208610|P1|First Intervention (1 Week)|Lost to Follow-up|1
2966159|NCT01192126|10208609|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
2966160|NCT01192126|10208610|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
2966161|NCT01192100|10208618|P6|Overall Study|Protocol Violation|0
2966162|NCT01192100|10208619|P5|Overall Study|Protocol Violation|0
2966163|NCT01192100|10208620|P4|Overall Study|Protocol Violation|1
2966164|NCT01192100|10208621|P3|Overall Study|Protocol Violation|0
2966165|NCT01192100|10208622|P2|Overall Study|Protocol Violation|0
2966166|NCT01192100|10208623|P1|Overall Study|Protocol Violation|0
2966167|NCT01192100|10208618|P6|Overall Study|Withdrawal by Subject|0
2966168|NCT01192100|10208619|P5|Overall Study|Withdrawal by Subject|1
2966169|NCT01192100|10208620|P4|Overall Study|Withdrawal by Subject|0
2966170|NCT01192100|10208621|P3|Overall Study|Withdrawal by Subject|0
2966171|NCT01192100|10208622|P2|Overall Study|Withdrawal by Subject|0
2966172|NCT01192100|10208623|P1|Overall Study|Withdrawal by Subject|0
2966173|NCT01192022|10208643|P5|Overall Study|Parents did not allow all follow up|0
2966174|NCT01192022|10208644|P4|Overall Study|Parents did not allow all follow up|1
2966175|NCT01192022|10208645|P3|Overall Study|Parents did not allow all follow up|0
2966176|NCT01192022|10208646|P2|Overall Study|Parents did not allow all follow up|0
2966177|NCT01192022|10208647|P1|Overall Study|Parents did not allow all follow up|0
2966178|NCT01192022|10208643|P5|Overall Study|Patient needed surgery|0
2966179|NCT01192022|10208644|P4|Overall Study|Patient needed surgery|0
2966180|NCT01192022|10208645|P3|Overall Study|Patient needed surgery|0
2966181|NCT01192022|10208646|P2|Overall Study|Patient needed surgery|1
2966182|NCT01192022|10208647|P1|Overall Study|Patient needed surgery|0
2966183|NCT01192022|10208643|P5|Overall Study|Patient too sick from chemotherapy|0
2966184|NCT01192022|10208644|P4|Overall Study|Patient too sick from chemotherapy|0
2966185|NCT01192022|10208645|P3|Overall Study|Patient too sick from chemotherapy|0
2966186|NCT01192022|10208646|P2|Overall Study|Patient too sick from chemotherapy|1
2966187|NCT01192022|10208647|P1|Overall Study|Patient too sick from chemotherapy|0
2966188|NCT01192022|10208643|P5|Overall Study|Physician withdrew-patient hardship|0
2966189|NCT01192022|10208644|P4|Overall Study|Physician withdrew-patient hardship|0
2966190|NCT01192022|10208645|P3|Overall Study|Physician withdrew-patient hardship|0
2966191|NCT01192022|10208646|P2|Overall Study|Physician withdrew-patient hardship|0
2966192|NCT01192022|10208647|P1|Overall Study|Physician withdrew-patient hardship|1
2966193|NCT01192022|10208643|P5|Overall Study|Fatal Adverse Event|1
2966194|NCT01192022|10208644|P4|Overall Study|Fatal Adverse Event|0
2966195|NCT01192022|10208645|P3|Overall Study|Fatal Adverse Event|0
2966196|NCT01192022|10208646|P2|Overall Study|Fatal Adverse Event|6
2966197|NCT01192022|10208647|P1|Overall Study|Fatal Adverse Event|4
2966198|NCT01192022|10208643|P5|Overall Study|Adverse Event|0
2966199|NCT01192022|10208644|P4|Overall Study|Adverse Event|0
2966200|NCT01192022|10208645|P3|Overall Study|Adverse Event|0
2966201|NCT01192022|10208646|P2|Overall Study|Adverse Event|0
2966202|NCT01192022|10208647|P1|Overall Study|Adverse Event|1
2966203|NCT01192022|10208643|P5|Overall Study|Lost to Follow-up|0
2966204|NCT01192022|10208644|P4|Overall Study|Lost to Follow-up|1
2966205|NCT01192022|10208645|P3|Overall Study|Lost to Follow-up|1
2966206|NCT01192022|10208646|P2|Overall Study|Lost to Follow-up|2
2966207|NCT01192022|10208647|P1|Overall Study|Lost to Follow-up|4
2966208|NCT01192022|10208643|P5|Overall Study|Withdrawal of Consent|0
2966209|NCT01192022|10208644|P4|Overall Study|Withdrawal of Consent|0
2966210|NCT01192022|10208645|P3|Overall Study|Withdrawal of Consent|0
2966211|NCT01192022|10208646|P2|Overall Study|Withdrawal of Consent|1
2966212|NCT01192022|10208647|P1|Overall Study|Withdrawal of Consent|3
2966213|NCT01191944|10208670|P2|Overall Study|Other|3
2966214|NCT01191944|10208671|P1|Overall Study|Other|1
2966215|NCT01191944|10208670|P2|Overall Study|Withdrawal by Subject|2
2966216|NCT01191944|10208671|P1|Overall Study|Withdrawal by Subject|4
2966217|NCT01191944|10208670|P2|Overall Study|Protocol Violation|2
2966218|NCT01191944|10208671|P1|Overall Study|Protocol Violation|1
2966219|NCT01191944|10208670|P2|Overall Study|Adverse Event|12
2966220|NCT01191944|10208671|P1|Overall Study|Adverse Event|11
2966221|NCT01191840|10208717|P2|Overall Study|Withdrawal by Subject|0
2966222|NCT01191840|10208718|P1|Overall Study|Withdrawal by Subject|2
2966223|NCT01191840|10208717|P2|Overall Study|lab error speciation - non Staph infecti|1
2966224|NCT01191840|10208718|P1|Overall Study|lab error speciation - non Staph infecti|0
2966225|NCT01191840|10208717|P2|Overall Study|IRB approval lapse|2
2966226|NCT01191840|10208718|P1|Overall Study|IRB approval lapse|0
2966227|NCT01191840|10208717|P2|Overall Study|ineligible at enrollment|0
2966228|NCT01191840|10208718|P1|Overall Study|ineligible at enrollment|1
2966229|NCT01191840|10208717|P2|Overall Study|Non Staph Infection|3
2966230|NCT01191840|10208718|P1|Overall Study|Non Staph Infection|4
2966231|NCT01191840|10208717|P2|Overall Study|Lost to Follow-up|6
2966232|NCT01191840|10208718|P1|Overall Study|Lost to Follow-up|4
2966233|NCT01191840|10208717|P2|Overall Study|Subject discontinued treatment|2
2966234|NCT01191840|10208718|P1|Overall Study|Subject discontinued treatment|1
2966235|NCT01191840|10208717|P2|Overall Study|withdrew consent|1
2966236|NCT01191840|10208718|P1|Overall Study|withdrew consent|2
2966237|NCT01191801|10208743|P2|Overall Study|Not Provided|27
2966238|NCT01191801|10208744|P1|Overall Study|Not Provided|45
2966239|NCT01191801|10208743|P2|Overall Study|Withdrawal by Subject|4
2966240|NCT01191801|10208744|P1|Overall Study|Withdrawal by Subject|1
2966241|NCT01191801|10208743|P2|Overall Study|Physician Decision|24
2966242|NCT01191801|10208744|P1|Overall Study|Physician Decision|47
2966243|NCT01191801|10208743|P2|Overall Study|Protocol Violation|4
2966244|NCT01191801|10208744|P1|Overall Study|Protocol Violation|2
2966245|NCT01191801|10208743|P2|Overall Study|Adverse Event|8
2966246|NCT01191801|10208744|P1|Overall Study|Adverse Event|9
2966247|NCT01191801|10208743|P2|Overall Study|Lack of Efficacy|258
2966248|NCT01191801|10208744|P1|Overall Study|Lack of Efficacy|176
2966249|NCT01191801|10208743|P2|Overall Study|Death|12
2966250|NCT01191801|10208744|P1|Overall Study|Death|36
2966251|NCT01191788|10208764|P2|Overall Study|Lost to Follow-up|22
2966252|NCT01191788|10208765|P1|Overall Study|Lost to Follow-up|21
2966253|NCT01191762|10208775|P2|Overall Study|Adverse Event|0
2966254|NCT01191762|10208776|P1|Overall Study|Adverse Event|1
2966255|NCT01191268|10208934|P3|Overall Study|Sponsor Decision|0
2966256|NCT01191268|10208935|P2|Overall Study|Sponsor Decision|2
2966257|NCT01191268|10208936|P1|Overall Study|Sponsor Decision|0
2966258|NCT01191268|10208934|P3|Overall Study|Protocol Violation|1
2966259|NCT01191268|10208935|P2|Overall Study|Protocol Violation|0
2966260|NCT01191268|10208936|P1|Overall Study|Protocol Violation|1
2966261|NCT01191268|10208934|P3|Overall Study|Death|3
2966262|NCT01191268|10208935|P2|Overall Study|Death|1
2966263|NCT01191268|10208936|P1|Overall Study|Death|0
2966264|NCT01191268|10208934|P3|Overall Study|Entry Criteria Not Met|1
2966265|NCT01191268|10208935|P2|Overall Study|Entry Criteria Not Met|1
2966266|NCT01191268|10208936|P1|Overall Study|Entry Criteria Not Met|3
2966267|NCT01191268|10208934|P3|Overall Study|Lost to Follow-up|9
2966268|NCT01191268|10208935|P2|Overall Study|Lost to Follow-up|5
2966269|NCT01191268|10208936|P1|Overall Study|Lost to Follow-up|8
2966270|NCT01191268|10208934|P3|Overall Study|Physician Decision|9
2966271|NCT01191268|10208935|P2|Overall Study|Physician Decision|8
2966272|NCT01191268|10208936|P1|Overall Study|Physician Decision|6
2966273|NCT01191268|10208934|P3|Overall Study|Adverse Event|8
2966274|NCT01191268|10208935|P2|Overall Study|Adverse Event|13
2966275|NCT01191268|10208936|P1|Overall Study|Adverse Event|21
2966276|NCT01191268|10208934|P3|Overall Study|Withdrawal by Subject|21
2966277|NCT01191268|10208935|P2|Overall Study|Withdrawal by Subject|25
2966278|NCT01191268|10208936|P1|Overall Study|Withdrawal by Subject|19
2966279|NCT01191190|10209077|P1|Overall Study|Withdrawal by Subject|1
2966280|NCT01191086|10209090|P1|Overall Study|Other|1
2966281|NCT01191086|10209090|P1|Overall Study|Discontinuation criterion met|1
2966282|NCT01191086|10209090|P1|Overall Study|Withdrawal by Subject|24
2966283|NCT01191086|10209090|P1|Overall Study|Physician Decision|2
2966284|NCT01191086|10209090|P1|Overall Study|Lost to Follow-up|4
2966285|NCT01191086|10209090|P1|Overall Study|Lack of Efficacy|10
2966286|NCT01191086|10209090|P1|Overall Study|Adverse Event|20
2966287|NCT01191008|10209094|P1|Overall Study|Lost to Follow-up|8
2966288|NCT01191008|10209094|P1|Overall Study|Protocol Violation|7
2966289|NCT01190891|10209102|P2|Overall Study|Withdrawal by Subject|0
2966290|NCT01190891|10209103|P1|Overall Study|Withdrawal by Subject|5
2966291|NCT01190891|10209102|P2|Overall Study|Protocol Violation|0
2966292|NCT01190891|10209103|P1|Overall Study|Protocol Violation|1
2966293|NCT01190865|10209128|P1|Overall Study|Non-compliance|2
2966294|NCT01190865|10209128|P1|Overall Study|Withdrawal by Subject|1
2966295|NCT01190839|10209135|P2|Overall Study|Randomized but not treated|4
2966296|NCT01190839|10209136|P1|Overall Study|Randomized but not treated|2
2966297|NCT01190839|10209135|P2|Overall Study|Undefined|31
2966298|NCT01190839|10209136|P1|Overall Study|Undefined|35
2966299|NCT01190839|10209135|P2|Overall Study|Trial stopped by Sponsor|68
2966300|NCT01190839|10209136|P1|Overall Study|Trial stopped by Sponsor|71
2966301|NCT01190839|10209135|P2|Overall Study|Death|0
2966302|NCT01190839|10209136|P1|Overall Study|Death|1
2966303|NCT01190839|10209135|P2|Overall Study|Lost to Follow-up|1
2966304|NCT01190839|10209136|P1|Overall Study|Lost to Follow-up|7
2966305|NCT01190839|10209135|P2|Overall Study|Protocol Violation|2
2966306|NCT01190839|10209136|P1|Overall Study|Protocol Violation|2
2966307|NCT01190839|10209135|P2|Overall Study|Adverse Event|41
2966308|NCT01190839|10209136|P1|Overall Study|Adverse Event|32
2966309|NCT01190813|10209150|P2|Overall Study|Adverse Event|1
2966310|NCT01190813|10209151|P1|Overall Study|Adverse Event|0
2966311|NCT01190813|10209150|P2|Overall Study|Refused study treatment after randomized|0
2966312|NCT01190813|10209151|P1|Overall Study|Refused study treatment after randomized|1
2966313|NCT01190813|10209150|P2|Overall Study|Withdrawal by Subject|1
2966314|NCT01190813|10209151|P1|Overall Study|Withdrawal by Subject|2
2966315|NCT01190813|10209150|P2|Overall Study|Lost to Follow-up|2
2966316|NCT01190813|10209151|P1|Overall Study|Lost to Follow-up|1
2966317|NCT01190514|10209272|P4|Third Intervention (Period 3)|Adverse Event|0
2966318|NCT01190514|10209273|P3|Third Intervention (Period 3)|Adverse Event|0
2966319|NCT01190514|10209274|P2|Third Intervention (Period 3)|Adverse Event|0
2966320|NCT01190514|10209275|P1|Third Intervention (Period 3)|Adverse Event|1
2966321|NCT01190514|10209272|P4|First Intervention (Period 1)|Adverse Event|0
2966322|NCT01190514|10209273|P3|First Intervention (Period 1)|Adverse Event|0
2966323|NCT01190514|10209274|P2|First Intervention (Period 1)|Adverse Event|0
2966324|NCT01190514|10209275|P1|First Intervention (Period 1)|Adverse Event|1
2966325|NCT01190449|10209320|P2|Overall Study|Ineligible|4
2966326|NCT01190449|10209321|P1|Overall Study|Ineligible|0
2966327|NCT01190436|10209329|P1|Overall Study|Other|4
2966328|NCT01190436|10209329|P1|Overall Study|Lost to Follow-up|35
2966329|NCT01190410|10209345|P2|Overall Study|PI discretion|2
2966330|NCT01190410|10209346|P1|Overall Study|PI discretion|0
2966331|NCT01190410|10209345|P2|Overall Study|Administrative decision|0
2966332|NCT01190410|10209346|P1|Overall Study|Administrative decision|1
2966333|NCT01190410|10209345|P2|Overall Study|Withdrawal by Subject|2
2966334|NCT01190410|10209346|P1|Overall Study|Withdrawal by Subject|0
2966335|NCT01190410|10209345|P2|Overall Study|Lack of Efficacy|2
2966336|NCT01190410|10209346|P1|Overall Study|Lack of Efficacy|0
2966337|NCT01190410|10209345|P2|Overall Study|Adverse Event|3
2966338|NCT01190410|10209346|P1|Overall Study|Adverse Event|0
2966339|NCT01190267|10209374|P2|Overall Study|Protocol Violation|1
2966340|NCT01190267|10209375|P1|Overall Study|Protocol Violation|8
2966341|NCT01190267|10209374|P2|Overall Study|Withdrawal by Subject|1
2966342|NCT01190267|10209375|P1|Overall Study|Withdrawal by Subject|13
2966343|NCT01190267|10209374|P2|Overall Study|Lost to Follow-up|0
2966344|NCT01190267|10209375|P1|Overall Study|Lost to Follow-up|2
2966345|NCT01190267|10209374|P2|Overall Study|Treatment Failure|2
2966346|NCT01190267|10209375|P1|Overall Study|Treatment Failure|8
2966347|NCT01190267|10209374|P2|Overall Study|Adverse Event|0
2966348|NCT01190267|10209375|P1|Overall Study|Adverse Event|10
2966349|NCT01190254|10209386|P3|Overall Study|Did not meet protocol eligibility|0
2966350|NCT01190254|10209387|P2|Overall Study|Did not meet protocol eligibility|0
2966351|NCT01190254|10209388|P1|Overall Study|Did not meet protocol eligibility|1
2966352|NCT01190254|10209386|P3|Overall Study|Protocol Violation|2
2966353|NCT01190254|10209387|P2|Overall Study|Protocol Violation|0
2966354|NCT01190254|10209388|P1|Overall Study|Protocol Violation|2
2966355|NCT01190254|10209386|P3|Overall Study|Withdrawal by Subject|7
2966356|NCT01190254|10209387|P2|Overall Study|Withdrawal by Subject|5
2966357|NCT01190254|10209388|P1|Overall Study|Withdrawal by Subject|4
2966358|NCT01190254|10209386|P3|Overall Study|Lost to Follow-up|0
2966359|NCT01190254|10209387|P2|Overall Study|Lost to Follow-up|2
2966360|NCT01190254|10209388|P1|Overall Study|Lost to Follow-up|4
2966361|NCT01190254|10209386|P3|Overall Study|Lack of Efficacy|5
2966362|NCT01190254|10209387|P2|Overall Study|Lack of Efficacy|4
2966363|NCT01190254|10209388|P1|Overall Study|Lack of Efficacy|7
2966364|NCT01190254|10209386|P3|Overall Study|Adverse Event|8
2966365|NCT01190254|10209387|P2|Overall Study|Adverse Event|6
2966366|NCT01190254|10209388|P1|Overall Study|Adverse Event|3
2966367|NCT01190228|10209453|P3|Overall Study|Withdrawal by Subject|0
2966368|NCT01190228|10209454|P2|Overall Study|Withdrawal by Subject|0
2966369|NCT01190228|10209455|P1|Overall Study|Withdrawal by Subject|1
2966370|NCT01190228|10209453|P3|Overall Study|Protocol Violation|0
2966371|NCT01190228|10209454|P2|Overall Study|Protocol Violation|0
2966372|NCT01190228|10209455|P1|Overall Study|Protocol Violation|4
2966373|NCT01190215|10209478|P2|Up to Month 6|Lost to Follow-up|0
2966374|NCT01190215|10209479|P1|Up to Month 6|Lost to Follow-up|2
2966375|NCT01190189|10209547|P1|Overall Study|Migrated/moved from study area|1
2966376|NCT01190189|10209547|P1|Overall Study|Withdrawal by Subject|1
2966377|NCT01190189|10209547|P1|Overall Study|Lost to Follow-up|4
2966378|NCT01190176|10209554|P1|Overall Study|Lost to Follow-up|1
2966379|NCT01190176|10209554|P1|Overall Study|Withdrawal by Subject|1
2966380|NCT01190150|10209575|P2|Washout|Difficulty in adherence|1
2966381|NCT01190150|10209576|P1|Washout|Difficulty in adherence|0
2966382|NCT01190150|10209575|P2|Washout|Withdrawal by Subject|1
2966383|NCT01190150|10209576|P1|Washout|Withdrawal by Subject|0
2966384|NCT01190150|10209575|P2|First Treatment|Withdrawal by Subject|0
2966385|NCT01190150|10209576|P1|First Treatment|Withdrawal by Subject|1
2966386|NCT01190124|10209603|P3|Overall Study|Lost to Follow-up|0
2966387|NCT01190124|10209604|P2|Overall Study|Lost to Follow-up|0
2966388|NCT01190124|10209605|P1|Overall Study|Lost to Follow-up|2
2966389|NCT01190124|10209603|P3|Overall Study|Therapeutic Failure|1
2966390|NCT01190124|10209604|P2|Overall Study|Therapeutic Failure|0
2966391|NCT01190124|10209605|P1|Overall Study|Therapeutic Failure|12
2966392|NCT01190124|10209603|P3|Overall Study|Death|0
2966393|NCT01190124|10209604|P2|Overall Study|Death|0
2966394|NCT01190124|10209605|P1|Overall Study|Death|3
2966395|NCT01190098|10209643|P2|Overall Study|Other|1
2966396|NCT01190098|10209644|P1|Overall Study|Other|0
2966397|NCT01190098|10209643|P2|Overall Study|Lack of transportation|0
2966398|NCT01190098|10209644|P1|Overall Study|Lack of transportation|1
2966399|NCT01190098|10209643|P2|Overall Study|Patient coomorbidity|1
2966400|NCT01190098|10209644|P1|Overall Study|Patient coomorbidity|0
2966401|NCT01190098|10209643|P2|Overall Study|Adverse Event|0
2966402|NCT01190098|10209644|P1|Overall Study|Adverse Event|2
2966403|NCT01190020|10209685|P2|Overall Study|Withdrawal by Subject|0
2966404|NCT01190020|10209686|P1|Overall Study|Withdrawal by Subject|3
2966405|NCT01190020|10209685|P2|Overall Study|Lost to Follow-up|0
2966406|NCT01190020|10209686|P1|Overall Study|Lost to Follow-up|2
2966407|NCT01190020|10209685|P2|Overall Study|Adverse Event|0
2966408|NCT01190020|10209686|P1|Overall Study|Adverse Event|2
2966409|NCT01190007|10209698|P1|Overall Study|Participant was arrested|1
2966410|NCT01190007|10209698|P1|Overall Study|Difficulty of visit for complications|1
2966411|NCT01190007|10209698|P1|Overall Study|Adverse Event|8
2966412|NCT01190007|10209698|P1|Overall Study|Withdrawal by Subject|4
2966413|NCT01189890|10209715|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
2966414|NCT01189890|10209716|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
2966415|NCT01189890|10209715|P2|Overall Study|Physician Decision|4
2966416|NCT01189890|10209716|P1|Overall Study|Physician Decision|5
2966417|NCT01189890|10209715|P2|Overall Study|Non Compliance|1
2966418|NCT01189890|10209716|P1|Overall Study|Non Compliance|0
2966419|NCT01189890|10209715|P2|Overall Study|Withdrawal by Subject|11
2966420|NCT01189890|10209716|P1|Overall Study|Withdrawal by Subject|15
2966421|NCT01189890|10209715|P2|Overall Study|Protocol Violation|5
2966422|NCT01189890|10209716|P1|Overall Study|Protocol Violation|1
2966423|NCT01189890|10209715|P2|Overall Study|Lost to Follow-up|7
2966424|NCT01189890|10209716|P1|Overall Study|Lost to Follow-up|1
2966425|NCT01189890|10209715|P2|Overall Study|Lack of Efficacy|2
2966426|NCT01189890|10209716|P1|Overall Study|Lack of Efficacy|7
2966427|NCT01189890|10209715|P2|Overall Study|Adverse Event|4
2966428|NCT01189890|10209716|P1|Overall Study|Adverse Event|3
2966429|NCT01189812|10209738|P2|Overall Study|Moved out of State|2
2966430|NCT01189812|10209739|P1|Overall Study|Moved out of State|1
2966431|NCT01189812|10209738|P2|Overall Study|Out of Window|3
2966432|NCT01189812|10209739|P1|Overall Study|Out of Window|4
2966433|NCT01189812|10209738|P2|Overall Study|Adverse Event|0
2966434|NCT01189812|10209739|P1|Overall Study|Adverse Event|1
2966435|NCT01189812|10209738|P2|Overall Study|Withdrawal by Subject|3
2966436|NCT01189812|10209739|P1|Overall Study|Withdrawal by Subject|2
2966437|NCT01189604|10209823|P7|Overall Study|Withdrawal by Subject|0
2966438|NCT01189604|10209824|P6|Overall Study|Withdrawal by Subject|0
2966439|NCT01189604|10209825|P5|Overall Study|Withdrawal by Subject|0
2966440|NCT01189604|10209826|P4|Overall Study|Withdrawal by Subject|0
2966441|NCT01189604|10209827|P3|Overall Study|Withdrawal by Subject|0
2966442|NCT01189604|10209828|P2|Overall Study|Withdrawal by Subject|0
2966443|NCT01189604|10209829|P1|Overall Study|Withdrawal by Subject|1
2966444|NCT01189604|10209823|P7|Overall Study|Adverse Event|1
2966445|NCT01189604|10209824|P6|Overall Study|Adverse Event|0
2966446|NCT01189604|10209825|P5|Overall Study|Adverse Event|2
2966447|NCT01189604|10209826|P4|Overall Study|Adverse Event|0
2966448|NCT01189604|10209827|P3|Overall Study|Adverse Event|0
2966449|NCT01189604|10209828|P2|Overall Study|Adverse Event|1
2966450|NCT01189604|10209829|P1|Overall Study|Adverse Event|0
2966451|NCT01189604|10209823|P7|Overall Study|Impossible to visit|0
2966452|NCT01189604|10209824|P6|Overall Study|Impossible to visit|1
2966453|NCT01189604|10209825|P5|Overall Study|Impossible to visit|0
2966454|NCT01189604|10209826|P4|Overall Study|Impossible to visit|0
2966455|NCT01189604|10209827|P3|Overall Study|Impossible to visit|0
2966456|NCT01189604|10209828|P2|Overall Study|Impossible to visit|0
2966457|NCT01189604|10209829|P1|Overall Study|Impossible to visit|0
2966458|NCT01189500|10209873|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
2966459|NCT01189500|10209873|P1|Period 1: TAMOX Alone|Adverse Event|1
2966460|NCT01189487|10209934|P1|Overall Study|Adverse Event|1
2966461|NCT01189487|10209934|P1|Overall Study|Lack of Efficacy|2
2966462|NCT01189461|10209942|P1|Overall Study|Other|8
2966463|NCT01189461|10209942|P1|Overall Study|Did not meet entrance criteria|3
2966464|NCT01189461|10209942|P1|Overall Study|Adverse Event|2
2966465|NCT01189461|10209942|P1|Overall Study|Protocol Violation|1
2966466|NCT01189461|10209942|P1|Overall Study|Withdrawal by Subject|6
2966467|NCT01189461|10209942|P1|Overall Study|Lost to Follow-up|1
2966468|NCT01189461|10209942|P1|Overall Study|Lack of Efficacy|13
2966469|NCT01189435|10209949|P1|Overall Study|Physician Decision|1
2966470|NCT01189435|10209949|P1|Overall Study|Withdrawal by Subject|1
2966471|NCT01189266|10210029|P3|Overall Study|No treatment|1
2966472|NCT01189266|10210030|P2|Overall Study|No treatment|0
2966473|NCT01189266|10210031|P1|Overall Study|No treatment|0
2966474|NCT01189266|10210029|P3|Overall Study|Patient refuses further therapy|7
2966475|NCT01189266|10210030|P2|Overall Study|Patient refuses further therapy|0
2966476|NCT01189266|10210031|P1|Overall Study|Patient refuses further therapy|1
2966477|NCT01189266|10210029|P3|Overall Study|Withdrawal by Subject|1
2966478|NCT01189266|10210030|P2|Overall Study|Withdrawal by Subject|0
2966479|NCT01189266|10210031|P1|Overall Study|Withdrawal by Subject|0
2966480|NCT01189266|10210029|P3|Overall Study|Protocol Violation|1
2966481|NCT01189266|10210030|P2|Overall Study|Protocol Violation|1
2966482|NCT01189266|10210031|P1|Overall Study|Protocol Violation|0
2966483|NCT01189266|10210029|P3|Overall Study|Physician Decision|1
2966484|NCT01189266|10210030|P2|Overall Study|Physician Decision|0
2966485|NCT01189266|10210031|P1|Overall Study|Physician Decision|0
2966486|NCT01189266|10210029|P3|Overall Study|Lack of Efficacy|44
2966487|NCT01189266|10210030|P2|Overall Study|Lack of Efficacy|5
2966488|NCT01189266|10210031|P1|Overall Study|Lack of Efficacy|4
2966489|NCT01189266|10210029|P3|Overall Study|Death|5
2966490|NCT01189266|10210030|P2|Overall Study|Death|0
2966491|NCT01189266|10210031|P1|Overall Study|Death|0
2966492|NCT01189266|10210029|P3|Overall Study|Adverse Event|5
2966493|NCT01189266|10210030|P2|Overall Study|Adverse Event|0
2966494|NCT01189266|10210031|P1|Overall Study|Adverse Event|1
2966495|NCT01189227|10210072|P2|Overall Study|Study terminated due to low accrual|3
2966496|NCT01189227|10210073|P1|Overall Study|Study terminated due to low accrual|6
2966497|NCT01189201|10210079|P1|Overall Study|Adverse Event|1
2966498|NCT01189032|10210182|P3|Overall Study|Protocol Violation|1
2966499|NCT01189032|10210183|P2|Overall Study|Protocol Violation|1
2966500|NCT01189032|10210184|P1|Overall Study|Protocol Violation|1
2966501|NCT01189032|10210182|P3|Overall Study|Withdrawal by Subject|1
2966502|NCT01189032|10210183|P2|Overall Study|Withdrawal by Subject|0
2966503|NCT01189032|10210184|P1|Overall Study|Withdrawal by Subject|1
2966504|NCT01189032|10210182|P3|Overall Study|Lack of Efficacy|0
2966505|NCT01189032|10210183|P2|Overall Study|Lack of Efficacy|3
2966506|NCT01189032|10210184|P1|Overall Study|Lack of Efficacy|2
2966507|NCT01189032|10210182|P3|Overall Study|Adverse Event|4
2966508|NCT01189032|10210183|P2|Overall Study|Adverse Event|3
2966509|NCT01189032|10210184|P1|Overall Study|Adverse Event|1
2966510|NCT01188967|10210194|P2|Overall Study|Lost to Follow-up|2
2966511|NCT01188967|10210195|P1|Overall Study|Lost to Follow-up|3
2966512|NCT01188967|10210194|P2|Overall Study|Physician Decision|1
2966513|NCT01188967|10210195|P1|Overall Study|Physician Decision|1
2966514|NCT01188967|10210194|P2|Overall Study|Withdrawal by Subject|1
2966515|NCT01188967|10210195|P1|Overall Study|Withdrawal by Subject|1
2966516|NCT01188811|10210248|P2|Overall Study|Adverse Event|0
2966517|NCT01188811|10210249|P1|Overall Study|Adverse Event|6
2966518|NCT01188811|10210248|P2|Overall Study|Withdrawal by Subject|2
2966519|NCT01188811|10210249|P1|Overall Study|Withdrawal by Subject|0
2966520|NCT01188798|10210261|P2|Overall Study|Protocol closure|1
2966521|NCT01188798|10210262|P1|Overall Study|Protocol closure|1
2966522|NCT01188798|10210261|P2|Overall Study|Required additional transplant|1
2966523|NCT01188798|10210262|P1|Overall Study|Required additional transplant|1
2966524|NCT01188798|10210261|P2|Overall Study|Death|1
2966525|NCT01188798|10210262|P1|Overall Study|Death|0
2966526|NCT01188772|10210274|P4|Overall Study|Withdrawal by Subject|0
2966527|NCT01188772|10210275|P3|Overall Study|Withdrawal by Subject|2
2966528|NCT01188772|10210276|P2|Overall Study|Withdrawal by Subject|0
2966529|NCT01188772|10210277|P1|Overall Study|Withdrawal by Subject|0
2966530|NCT01188772|10210274|P4|Overall Study|Virologic Failure|0
2966531|NCT01188772|10210275|P3|Overall Study|Virologic Failure|0
2966532|NCT01188772|10210276|P2|Overall Study|Virologic Failure|0
2966533|NCT01188772|10210277|P1|Overall Study|Virologic Failure|1
2966534|NCT01188772|10210274|P4|Overall Study|Treatment Failure|0
2966535|NCT01188772|10210275|P3|Overall Study|Treatment Failure|1
2966536|NCT01188772|10210276|P2|Overall Study|Treatment Failure|0
2966537|NCT01188772|10210277|P1|Overall Study|Treatment Failure|0
2966538|NCT01188772|10210274|P4|Overall Study|Terminated by Sponsor|0
2966539|NCT01188772|10210275|P3|Overall Study|Terminated by Sponsor|1
2966540|NCT01188772|10210276|P2|Overall Study|Terminated by Sponsor|0
2966541|NCT01188772|10210277|P1|Overall Study|Terminated by Sponsor|0
2966542|NCT01188772|10210274|P4|Overall Study|Physician Decision|0
2966543|NCT01188772|10210275|P3|Overall Study|Physician Decision|1
2966544|NCT01188772|10210276|P2|Overall Study|Physician Decision|0
2966545|NCT01188772|10210277|P1|Overall Study|Physician Decision|0
2966546|NCT01188772|10210274|P4|Overall Study|Non-responder|0
2966547|NCT01188772|10210275|P3|Overall Study|Non-responder|3
2966548|NCT01188772|10210276|P2|Overall Study|Non-responder|0
2966549|NCT01188772|10210277|P1|Overall Study|Non-responder|0
2966550|NCT01188772|10210274|P4|Overall Study|Lost to Follow-up|1
2966551|NCT01188772|10210275|P3|Overall Study|Lost to Follow-up|1
2966552|NCT01188772|10210276|P2|Overall Study|Lost to Follow-up|1
2966553|NCT01188772|10210277|P1|Overall Study|Lost to Follow-up|4
2966554|NCT01188772|10210274|P4|Overall Study|Adverse Event|0
2966555|NCT01188772|10210275|P3|Overall Study|Adverse Event|2
2966556|NCT01188772|10210276|P2|Overall Study|Adverse Event|1
2966557|NCT01188772|10210277|P1|Overall Study|Adverse Event|0
2966558|NCT01188772|10210274|P4|Overall Study|Randomized but Not Treated|0
2966559|NCT01188772|10210275|P3|Overall Study|Randomized but Not Treated|0
2966560|NCT01188772|10210276|P2|Overall Study|Randomized but Not Treated|1
2966561|NCT01188772|10210277|P1|Overall Study|Randomized but Not Treated|0
2966562|NCT01188681|10210349|P4|Overall Study|Withdrawal by Subject|1
2966563|NCT01188681|10210350|P3|Overall Study|Withdrawal by Subject|0
2966564|NCT01188681|10210351|P2|Overall Study|Withdrawal by Subject|0
2966565|NCT01188681|10210352|P1|Overall Study|Withdrawal by Subject|0
2966566|NCT01188681|10210349|P4|Overall Study|bladder cancer|0
2966567|NCT01188681|10210350|P3|Overall Study|bladder cancer|1
2966568|NCT01188681|10210351|P2|Overall Study|bladder cancer|0
2966569|NCT01188681|10210352|P1|Overall Study|bladder cancer|0
2966570|NCT01188668|10210366|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
2966571|NCT01188668|10210366|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
2966572|NCT01188668|10210366|P1|Period 1: ARIP Alone|Protocol Violation|2
2966573|NCT01188655|10210399|P1|Overall Study|Other|11
2966574|NCT01188655|10210399|P1|Overall Study|Lost to Follow-up|1
2966575|NCT01188655|10210399|P1|Overall Study|Lack of Efficacy|1
2966576|NCT01188564|10210443|P2|Double-blind Phase|randomized not treated|0
2966577|NCT01188564|10210444|P1|Double-blind Phase|randomized not treated|1
2966578|NCT01188551|10210456|P4|Overall Study|Pharmacy issues|0
2966579|NCT01188551|10210457|P3|Overall Study|Pharmacy issues|0
2966580|NCT01188551|10210458|P2|Overall Study|Pharmacy issues|0
2966581|NCT01188551|10210459|P1|Overall Study|Pharmacy issues|1
2966582|NCT01188538|10210475|P2|Overall Study|Lost to Follow-up|1
2966583|NCT01188538|10210476|P1|Overall Study|Lost to Follow-up|0
2966584|NCT01188343|10210572|P3|Overall Study|Withdrawal by Subject|0
2966585|NCT01188343|10210573|P2|Overall Study|Withdrawal by Subject|24
2966586|NCT01188343|10210574|P1|Overall Study|Withdrawal by Subject|1
2966587|NCT01188343|10210572|P3|Overall Study|Not vaccinated|1
2966588|NCT01188343|10210573|P2|Overall Study|Not vaccinated|2
2966589|NCT01188343|10210574|P1|Overall Study|Not vaccinated|0
2966590|NCT01188226|10210600|P1|Overall Study|Withdrawal by Subject|4
2966591|NCT01187953|10210646|P2|Overall Study|Withdrawal by Subject|3
2966592|NCT01187953|10210647|P1|Overall Study|Withdrawal by Subject|3
2966593|NCT01187953|10210646|P2|Overall Study|Lost to Follow-up|3
2966594|NCT01187953|10210647|P1|Overall Study|Lost to Follow-up|0
2966595|NCT01187953|10210646|P2|Overall Study|Adverse Event|2
2966596|NCT01187953|10210647|P1|Overall Study|Adverse Event|1
2966597|NCT01187953|10210646|P2|Overall Study|Death|13
2966598|NCT01187953|10210647|P1|Overall Study|Death|11
2966599|NCT01187901|10210661|P2|Overall Study|Pregnancy|2
2966600|NCT01187901|10210662|P1|Overall Study|Pregnancy|0
2966601|NCT01187901|10210661|P2|Overall Study|No Endpoint due to Early Study Halt|3
2966602|NCT01187901|10210662|P1|Overall Study|No Endpoint due to Early Study Halt|2
2966603|NCT01187901|10210661|P2|Overall Study|Adverse Event|0
2966604|NCT01187901|10210662|P1|Overall Study|Adverse Event|3
2966605|NCT01187901|10210661|P2|Overall Study|Suspected Allergic Reaction|1
2966606|NCT01187901|10210662|P1|Overall Study|Suspected Allergic Reaction|1
2966607|NCT01187901|10210661|P2|Overall Study|Unrelated Health Reasons|2
2966608|NCT01187901|10210662|P1|Overall Study|Unrelated Health Reasons|1
2966609|NCT01187901|10210661|P2|Overall Study|Lost to Follow-up|2
2966610|NCT01187901|10210662|P1|Overall Study|Lost to Follow-up|1
2966611|NCT01187901|10210661|P2|Overall Study|Protocol Violation|0
2966612|NCT01187901|10210662|P1|Overall Study|Protocol Violation|1
2966613|NCT01187550|10210703|P2|Overall Study|Randomized but not treated|0
2966614|NCT01187550|10210704|P1|Overall Study|Randomized but not treated|8
2966615|NCT01187550|10210703|P2|Overall Study|Other|0
2966616|NCT01187550|10210704|P1|Overall Study|Other|3
2966617|NCT01187550|10210703|P2|Overall Study|Protocol Violation|1
2966618|NCT01187550|10210704|P1|Overall Study|Protocol Violation|3
2966619|NCT01187446|10210860|P2|Overall Study|Patient started non-protocol therapy|1
2966620|NCT01187446|10210861|P1|Overall Study|Patient started non-protocol therapy|0
2966621|NCT01187433|10210877|P2|Overall Study|Withdrawal by Subject|2
2966622|NCT01187433|10210878|P1|Overall Study|Withdrawal by Subject|5
2966623|NCT01187433|10210877|P2|Overall Study|Protocol Violation|2
2966624|NCT01187433|10210878|P1|Overall Study|Protocol Violation|6
2966625|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2966626|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2966627|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2966628|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2966629|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2966630|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
2966631|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
2966632|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2966633|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2966634|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2966635|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
2966636|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
2966637|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2966638|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
2966639|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2966640|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2966641|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2966642|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2966643|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2966644|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2966645|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2966646|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2966647|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2966648|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2966649|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2966650|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
2966651|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
2966652|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2966653|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
2966654|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2966655|NCT01187407|10210908|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
2966656|NCT01187407|10210909|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
2966657|NCT01187407|10210910|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
2966658|NCT01187407|10210911|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2966659|NCT01187407|10210912|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2966660|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2966661|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2966662|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2966663|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2966664|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
2966665|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2966666|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2966667|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2966668|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2966669|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
2966670|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2966671|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2966672|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2966673|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2966674|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
2966675|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2966676|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2966677|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2966678|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2966679|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2966680|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2966681|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2966682|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2966683|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2966684|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
2966685|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2966686|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2966687|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2966688|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2966689|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
2966690|NCT01187407|10210908|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2966691|NCT01187407|10210909|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2966692|NCT01187407|10210910|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2966693|NCT01187407|10210911|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2966694|NCT01187407|10210912|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
2966695|NCT01187043|10211025|P5|Overall Study|Unable to make scheduled visits|1
2966696|NCT01187043|10211026|P4|Overall Study|Unable to make scheduled visits|0
2966697|NCT01187043|10211027|P3|Overall Study|Unable to make scheduled visits|4
2966698|NCT01187043|10211028|P2|Overall Study|Unable to make scheduled visits|0
2966699|NCT01187043|10211029|P1|Overall Study|Unable to make scheduled visits|1
2966700|NCT01187043|10211025|P5|Overall Study|Adverse Event|1
2966701|NCT01187043|10211026|P4|Overall Study|Adverse Event|0
2966702|NCT01187043|10211027|P3|Overall Study|Adverse Event|0
2966703|NCT01187043|10211028|P2|Overall Study|Adverse Event|0
2966704|NCT01187043|10211029|P1|Overall Study|Adverse Event|0
2966705|NCT01186939|10211055|P1|Overall Study|Transformation to AML|1
2966706|NCT01186939|10211055|P1|Overall Study|Bone marrow transplant|1
2966707|NCT01186939|10211055|P1|Overall Study|Myocardial infarction|1
2966708|NCT01186939|10211055|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
2966709|NCT01186939|10211055|P1|Overall Study|Started additional treatment|1
2966710|NCT01186939|10211055|P1|Overall Study|Sponsor decision|4
2966711|NCT01186939|10211055|P1|Overall Study|Program closed|5
2966712|NCT01186939|10211055|P1|Overall Study|No longer receiving clinical benefit|17
2966713|NCT01186939|10211055|P1|Overall Study|Withdrawal by Subject|2
2966714|NCT01186939|10211055|P1|Overall Study|Death|7
2966715|NCT01186848|10211059|P1|Overall Study|Adverse Event|2
2966716|NCT01186848|10211059|P1|Overall Study|Withdrawal by Subject|2
2966717|NCT01186848|10211059|P1|Overall Study|Lost to Follow-up|4
2966718|NCT01186809|10211065|P1|Overall Study|Death|30
2966719|NCT01186796|10211071|P2|Overall Study|Protocol Violation|1
2966720|NCT01186796|10211072|P1|Overall Study|Protocol Violation|0
2966721|NCT01186796|10211071|P2|Overall Study|Withdrawal by Subject|1
2966722|NCT01186796|10211072|P1|Overall Study|Withdrawal by Subject|1
2966723|NCT01186796|10211071|P2|Overall Study|Adverse Event|0
2966724|NCT01186796|10211072|P1|Overall Study|Adverse Event|3
2966725|NCT01186770|10211090|P4|Overall Study|Other than specified|2
2966726|NCT01186770|10211091|P3|Overall Study|Other than specified|1
2966727|NCT01186770|10211092|P2|Overall Study|Other than specified|1
2966728|NCT01186770|10211093|P1|Overall Study|Other than specified|0
2966729|NCT01186770|10211090|P4|Overall Study|Insufficient response to treatment|7
2966730|NCT01186770|10211091|P3|Overall Study|Insufficient response to treatment|5
2966731|NCT01186770|10211092|P2|Overall Study|Insufficient response to treatment|8
2966732|NCT01186770|10211093|P1|Overall Study|Insufficient response to treatment|7
2966733|NCT01186770|10211090|P4|Overall Study|Lost to Follow-up|9
2966734|NCT01186770|10211091|P3|Overall Study|Lost to Follow-up|14
2966735|NCT01186770|10211092|P2|Overall Study|Lost to Follow-up|6
2966736|NCT01186770|10211093|P1|Overall Study|Lost to Follow-up|10
2966737|NCT01186770|10211090|P4|Overall Study|Withdrawal by Subject|17
2966738|NCT01186770|10211091|P3|Overall Study|Withdrawal by Subject|11
2966739|NCT01186770|10211092|P2|Overall Study|Withdrawal by Subject|13
2966740|NCT01186770|10211093|P1|Overall Study|Withdrawal by Subject|15
2966741|NCT01186770|10211090|P4|Overall Study|Adverse Event|9
2966742|NCT01186770|10211091|P3|Overall Study|Adverse Event|7
2966743|NCT01186770|10211092|P2|Overall Study|Adverse Event|9
2966744|NCT01186770|10211093|P1|Overall Study|Adverse Event|2
2966745|NCT01186770|10211090|P4|Overall Study|Protocol Violation|14
2966746|NCT01186770|10211091|P3|Overall Study|Protocol Violation|12
2966747|NCT01186770|10211092|P2|Overall Study|Protocol Violation|9
2966748|NCT01186770|10211093|P1|Overall Study|Protocol Violation|7
2966749|NCT01186770|10211090|P4|Overall Study|Ineligibility|0
2966750|NCT01186770|10211091|P3|Overall Study|Ineligibility|2
2966751|NCT01186770|10211092|P2|Overall Study|Ineligibility|0
2966752|NCT01186770|10211093|P1|Overall Study|Ineligibility|0
2966753|NCT01186744|10211117|P6|Overall Study|Death|0
2966754|NCT01186744|10211118|P5|Overall Study|Death|0
2966755|NCT01186744|10211119|P4|Overall Study|Death|0
2966756|NCT01186744|10211120|P3|Overall Study|Death|0
2966757|NCT01186744|10211121|P2|Overall Study|Death|0
2966758|NCT01186744|10211122|P1|Overall Study|Death|1
2966759|NCT01186744|10211117|P6|Overall Study|Adverse Event|4
2966760|NCT01186744|10211118|P5|Overall Study|Adverse Event|1
2966761|NCT01186744|10211119|P4|Overall Study|Adverse Event|0
2966762|NCT01186744|10211120|P3|Overall Study|Adverse Event|1
2966763|NCT01186744|10211121|P2|Overall Study|Adverse Event|14
2966764|NCT01186744|10211122|P1|Overall Study|Adverse Event|10
2966765|NCT01186744|10211117|P6|Overall Study|Other|5
2966766|NCT01186744|10211118|P5|Overall Study|Other|1
2966767|NCT01186744|10211119|P4|Overall Study|Other|2
2966768|NCT01186744|10211120|P3|Overall Study|Other|1
2966769|NCT01186744|10211121|P2|Overall Study|Other|10
2966770|NCT01186744|10211122|P1|Overall Study|Other|9
2966771|NCT01186744|10211117|P6|Overall Study|Study terminated by Sponsor|0
2966772|NCT01186744|10211118|P5|Overall Study|Study terminated by Sponsor|0
2966773|NCT01186744|10211119|P4|Overall Study|Study terminated by Sponsor|0
2966774|NCT01186744|10211120|P3|Overall Study|Study terminated by Sponsor|0
2966775|NCT01186744|10211121|P2|Overall Study|Study terminated by Sponsor|0
2966776|NCT01186744|10211122|P1|Overall Study|Study terminated by Sponsor|1
2966777|NCT01186744|10211117|P6|Overall Study|Withdrawal by Subject|6
2966778|NCT01186744|10211118|P5|Overall Study|Withdrawal by Subject|0
2966779|NCT01186744|10211119|P4|Overall Study|Withdrawal by Subject|5
2966780|NCT01186744|10211120|P3|Overall Study|Withdrawal by Subject|2
2966781|NCT01186744|10211121|P2|Overall Study|Withdrawal by Subject|10
2966782|NCT01186744|10211122|P1|Overall Study|Withdrawal by Subject|14
2966783|NCT01186744|10211117|P6|Overall Study|Screen failure|0
2966784|NCT01186744|10211118|P5|Overall Study|Screen failure|0
2966785|NCT01186744|10211119|P4|Overall Study|Screen failure|1
2966786|NCT01186744|10211120|P3|Overall Study|Screen failure|0
2966787|NCT01186744|10211121|P2|Overall Study|Screen failure|1
2966788|NCT01186744|10211122|P1|Overall Study|Screen failure|1
2966789|NCT01186744|10211117|P6|Overall Study|Lost to Follow-up|4
2966790|NCT01186744|10211118|P5|Overall Study|Lost to Follow-up|1
2966791|NCT01186744|10211119|P4|Overall Study|Lost to Follow-up|1
2966792|NCT01186744|10211120|P3|Overall Study|Lost to Follow-up|2
2966793|NCT01186744|10211121|P2|Overall Study|Lost to Follow-up|16
2966794|NCT01186744|10211122|P1|Overall Study|Lost to Follow-up|15
2966795|NCT01186744|10211117|P6|Overall Study|Protocol Violation|2
2966796|NCT01186744|10211118|P5|Overall Study|Protocol Violation|1
2966797|NCT01186744|10211119|P4|Overall Study|Protocol Violation|1
2966798|NCT01186744|10211120|P3|Overall Study|Protocol Violation|0
2966799|NCT01186744|10211121|P2|Overall Study|Protocol Violation|2
2966800|NCT01186744|10211122|P1|Overall Study|Protocol Violation|1
2966801|NCT01186744|10211117|P6|Overall Study|Lack of Efficacy|5
2966802|NCT01186744|10211118|P5|Overall Study|Lack of Efficacy|2
2966803|NCT01186744|10211119|P4|Overall Study|Lack of Efficacy|2
2966804|NCT01186744|10211120|P3|Overall Study|Lack of Efficacy|0
2966805|NCT01186744|10211121|P2|Overall Study|Lack of Efficacy|99
2966806|NCT01186744|10211122|P1|Overall Study|Lack of Efficacy|156
2966807|NCT01186692|10211542|P1|Overall Study|Adverse Event|2
2966808|NCT01186692|10211542|P1|Overall Study|Futher testing contraindicated implant|19
2966809|NCT01186692|10211542|P1|Overall Study|Not Catheterized|11
2966810|NCT01186458|10211569|P1|Overall Study|Adverse Event|1
2966811|NCT01186419|10211578|P2|Overall Study|Other|1
2966812|NCT01186419|10211579|P1|Overall Study|Other|1
2966813|NCT01186419|10211578|P2|Overall Study|Physician Decision|3
2966814|NCT01186419|10211579|P1|Overall Study|Physician Decision|0
2966815|NCT01186419|10211578|P2|Overall Study|Adverse Event|2
2966816|NCT01186419|10211579|P1|Overall Study|Adverse Event|1
2966817|NCT01186419|10211578|P2|Overall Study|Withdrawal by Subject|3
2966818|NCT01186419|10211579|P1|Overall Study|Withdrawal by Subject|5
2966819|NCT01186328|10211593|P3|Overall Study|Death|0
2966820|NCT01186328|10211594|P2|Overall Study|Death|0
2966821|NCT01186328|10211595|P1|Overall Study|Death|1
2966822|NCT01185964|10211625|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
2966823|NCT01185964|10211626|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2966824|NCT01185964|10211627|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2966825|NCT01185964|10211628|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2966826|NCT01185964|10211625|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
2966827|NCT01185964|10211626|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2966828|NCT01185964|10211627|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2966829|NCT01185964|10211628|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2966830|NCT01185964|10211625|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
2966831|NCT01185964|10211626|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2966832|NCT01185964|10211627|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2966833|NCT01185964|10211628|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2966834|NCT01185964|10211625|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2966835|NCT01185964|10211626|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2966836|NCT01185964|10211627|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2966837|NCT01185964|10211628|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2966838|NCT01185964|10211625|P4|Phase 1b and Phase 2|Adverse Event|0
2966839|NCT01185964|10211626|P3|Phase 1b and Phase 2|Adverse Event|2
2966840|NCT01185964|10211627|P2|Phase 1b and Phase 2|Adverse Event|0
2966841|NCT01185964|10211628|P1|Phase 1b and Phase 2|Adverse Event|1
2966842|NCT01185964|10211625|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2966843|NCT01185964|10211626|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
2966844|NCT01185964|10211627|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2966845|NCT01185964|10211628|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2966846|NCT01185964|10211625|P4|Phase 1b and Phase 2|Other Therapy Started|0
2966847|NCT01185964|10211626|P3|Phase 1b and Phase 2|Other Therapy Started|3
2966848|NCT01185964|10211627|P2|Phase 1b and Phase 2|Other Therapy Started|3
2966849|NCT01185964|10211628|P1|Phase 1b and Phase 2|Other Therapy Started|0
2966850|NCT01185964|10211625|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
2966851|NCT01185964|10211626|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
2966852|NCT01185964|10211627|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
2966853|NCT01185964|10211628|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
2966854|NCT01185834|10211654|P1|Overall Study|Early exit - Site error|2
2966855|NCT01185834|10211654|P1|Overall Study|Time/Job Conflict|2
2966856|NCT01185834|10211654|P1|Overall Study|Biomicroscopy|4
2966857|NCT01185834|10211654|P1|Overall Study|Discomfort|4
2966858|NCT01185834|10211654|P1|Overall Study|Lost to Follow-up|2
2966859|NCT01185821|10211664|P5|Overall Study|Administrative problems|2
2966860|NCT01185821|10211665|P4|Overall Study|Administrative problems|1
2966861|NCT01185821|10211666|P3|Overall Study|Administrative problems|1
2966862|NCT01185821|10211667|P2|Overall Study|Administrative problems|0
2966863|NCT01185821|10211668|P1|Overall Study|Administrative problems|0
2966864|NCT01185821|10211664|P5|Overall Study|Lost to Follow-up|2
2966865|NCT01185821|10211665|P4|Overall Study|Lost to Follow-up|1
2966866|NCT01185821|10211666|P3|Overall Study|Lost to Follow-up|2
2966867|NCT01185821|10211667|P2|Overall Study|Lost to Follow-up|1
2966868|NCT01185821|10211668|P1|Overall Study|Lost to Follow-up|1
2966869|NCT01185821|10211664|P5|Overall Study|Withdrawal by Subject|3
2966870|NCT01185821|10211665|P4|Overall Study|Withdrawal by Subject|1
2966871|NCT01185821|10211666|P3|Overall Study|Withdrawal by Subject|2
2966872|NCT01185821|10211667|P2|Overall Study|Withdrawal by Subject|2
2966873|NCT01185821|10211668|P1|Overall Study|Withdrawal by Subject|3
2966874|NCT01185821|10211664|P5|Overall Study|Lack of Efficacy|9
2966875|NCT01185821|10211665|P4|Overall Study|Lack of Efficacy|0
2966876|NCT01185821|10211666|P3|Overall Study|Lack of Efficacy|3
2966877|NCT01185821|10211667|P2|Overall Study|Lack of Efficacy|0
2966878|NCT01185821|10211668|P1|Overall Study|Lack of Efficacy|0
2966879|NCT01185821|10211664|P5|Overall Study|Adverse Event|5
2966880|NCT01185821|10211665|P4|Overall Study|Adverse Event|2
2966881|NCT01185821|10211666|P3|Overall Study|Adverse Event|1
2966882|NCT01185821|10211667|P2|Overall Study|Adverse Event|3
2966883|NCT01185821|10211668|P1|Overall Study|Adverse Event|2
2966884|NCT01185821|10211664|P5|Overall Study|Condition no longer required study drug|1
2966885|NCT01185821|10211665|P4|Overall Study|Condition no longer required study drug|0
2966886|NCT01185821|10211666|P3|Overall Study|Condition no longer required study drug|0
2966887|NCT01185821|10211667|P2|Overall Study|Condition no longer required study drug|0
2966888|NCT01185821|10211668|P1|Overall Study|Condition no longer required study drug|0
2966889|NCT01185821|10211664|P5|Overall Study|Death|0
2966890|NCT01185821|10211665|P4|Overall Study|Death|0
2966891|NCT01185821|10211666|P3|Overall Study|Death|0
2966892|NCT01185821|10211667|P2|Overall Study|Death|1
2966893|NCT01185821|10211668|P1|Overall Study|Death|0
2966894|NCT01185821|10211664|P5|Overall Study|Abnormal test procedure result|1
2966895|NCT01185821|10211665|P4|Overall Study|Abnormal test procedure result|0
2966896|NCT01185821|10211666|P3|Overall Study|Abnormal test procedure result|0
2966897|NCT01185821|10211667|P2|Overall Study|Abnormal test procedure result|0
2966898|NCT01185821|10211668|P1|Overall Study|Abnormal test procedure result|0
2966899|NCT01185821|10211664|P5|Overall Study|Protocol Violation|1
2966900|NCT01185821|10211665|P4|Overall Study|Protocol Violation|1
2966901|NCT01185821|10211666|P3|Overall Study|Protocol Violation|0
2966902|NCT01185821|10211667|P2|Overall Study|Protocol Violation|0
2966903|NCT01185821|10211668|P1|Overall Study|Protocol Violation|0
2966904|NCT01185821|10211664|P5|Overall Study|Abnormal laboratory value(s)|0
2966905|NCT01185821|10211665|P4|Overall Study|Abnormal laboratory value(s)|0
2966906|NCT01185821|10211666|P3|Overall Study|Abnormal laboratory value(s)|1
2966907|NCT01185821|10211667|P2|Overall Study|Abnormal laboratory value(s)|2
2966908|NCT01185821|10211668|P1|Overall Study|Abnormal laboratory value(s)|1
2966909|NCT01185782|10211719|P2|Overall Study|Randomized but not treated|4
2966910|NCT01185782|10211720|P1|Overall Study|Randomized but not treated|0
2966911|NCT01185782|10211719|P2|Overall Study|Other|5
2966912|NCT01185782|10211720|P1|Overall Study|Other|2
2966913|NCT01185782|10211719|P2|Overall Study|Poor Response to Treatment|1
2966914|NCT01185782|10211720|P1|Overall Study|Poor Response to Treatment|3
2966915|NCT01185782|10211719|P2|Overall Study|Protocol Violation|0
2966916|NCT01185782|10211720|P1|Overall Study|Protocol Violation|1
2966917|NCT01185782|10211719|P2|Overall Study|Adverse Event|1
2966918|NCT01185782|10211720|P1|Overall Study|Adverse Event|0
2966919|NCT01185704|10211748|P2|Overall Study|Ectopic pregnancy|1
2966920|NCT01185704|10211749|P1|Overall Study|Ectopic pregnancy|0
2966921|NCT01185704|10211748|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
2966922|NCT01185704|10211749|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
2966923|NCT01185704|10211748|P2|Overall Study|Lack of ovarian response|1
2966924|NCT01185704|10211749|P1|Overall Study|Lack of ovarian response|5
2966925|NCT01185704|10211748|P2|Overall Study|Randomized but not treated|3
2966926|NCT01185704|10211749|P1|Overall Study|Randomized but not treated|3
2966927|NCT01185639|10211783|P1|Overall Study|Progressed and didn't receive therapy|2
2966928|NCT01185600|10211793|P2|Overall Study|Hold by DSMB|2
2966929|NCT01185600|10211794|P1|Overall Study|Hold by DSMB|1
2966930|NCT01185600|10211793|P2|Overall Study|Withdrawal by Subject|1
2966931|NCT01185600|10211794|P1|Overall Study|Withdrawal by Subject|1
2966932|NCT01185600|10211793|P2|Overall Study|Physician Decision|35
2966933|NCT01185600|10211794|P1|Overall Study|Physician Decision|29
2966934|NCT01185600|10211793|P2|Overall Study|Lost to Follow-up|5
2966935|NCT01185600|10211794|P1|Overall Study|Lost to Follow-up|0
2966936|NCT01185600|10211793|P2|Overall Study|Death|1
2966937|NCT01185600|10211794|P1|Overall Study|Death|0
2966938|NCT01185600|10211793|P2|Overall Study|Adverse Event|1
2966939|NCT01185600|10211794|P1|Overall Study|Adverse Event|1
2966940|NCT01185561|10211816|P2|Overall Study|Withdrawal by Subject|8
2966941|NCT01185561|10211817|P1|Overall Study|Withdrawal by Subject|2
2966942|NCT01185561|10211816|P2|Overall Study|Lost to Follow-up|4
2966943|NCT01185561|10211817|P1|Overall Study|Lost to Follow-up|0
2966944|NCT01185548|10211829|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
2966945|NCT01185522|10211842|P1|Overall Study|Other reasons|12
2966946|NCT01185522|10211842|P1|Overall Study|Poor tolerance|39
2966947|NCT01185522|10211842|P1|Overall Study|Withdrawal by Subject|10
2966948|NCT01185522|10211842|P1|Overall Study|Lost to Follow-up|19
2966949|NCT01185522|10211842|P1|Overall Study|Lack of Efficacy|28
2966950|NCT01185509|10211868|P2|Overall Study|Intercurrent Illness|1
2966951|NCT01185509|10211869|P1|Overall Study|Intercurrent Illness|0
2966952|NCT01185509|10211868|P2|Overall Study|Death|1
2966953|NCT01185509|10211869|P1|Overall Study|Death|0
2966954|NCT01185509|10211868|P2|Overall Study|Withdrawal by Subject|1
2966955|NCT01185509|10211869|P1|Overall Study|Withdrawal by Subject|0
2966956|NCT01185509|10211868|P2|Overall Study|Physician Decision|2
2966957|NCT01185509|10211869|P1|Overall Study|Physician Decision|2
2966958|NCT01185509|10211868|P2|Overall Study|Progression/Relapse|15
2966959|NCT01185509|10211869|P1|Overall Study|Progression/Relapse|9
2966960|NCT01185353|10211885|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
2966961|NCT01185353|10211886|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
2966962|NCT01185353|10211887|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
2966963|NCT01185353|10211888|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
2966964|NCT01185353|10211889|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
2966965|NCT01185353|10211890|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
2966966|NCT01185353|10211891|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
2966967|NCT01185353|10211892|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
2966968|NCT01185353|10211893|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
2966969|NCT01185353|10211894|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
2966970|NCT01185353|10211885|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2966971|NCT01185353|10211886|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
2966972|NCT01185353|10211887|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2966973|NCT01185353|10211888|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966974|NCT01185353|10211889|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966975|NCT01185353|10211890|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966976|NCT01185353|10211891|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966977|NCT01185353|10211892|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966978|NCT01185353|10211893|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966979|NCT01185353|10211894|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2966980|NCT01185353|10211885|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966981|NCT01185353|10211886|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
2966982|NCT01185353|10211887|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
2966983|NCT01185353|10211888|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966984|NCT01185353|10211889|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966985|NCT01185353|10211890|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966986|NCT01185353|10211891|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966987|NCT01185353|10211892|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966988|NCT01185353|10211893|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966989|NCT01185353|10211894|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2966990|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Reason missing|0
2966991|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Reason missing|1
2966992|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Reason missing|0
2966993|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Reason missing|0
2966994|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Reason missing|0
2966995|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Reason missing|0
2966996|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Reason missing|0
2966997|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Reason missing|0
2966998|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Reason missing|0
2966999|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Reason missing|0
2967000|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
2967001|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
2967002|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
2967003|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
2967004|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
2967005|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
2967006|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
2967007|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
2967008|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
2967009|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
2967010|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
2967011|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967012|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967013|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967014|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967015|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967016|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967017|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967018|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967019|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2967020|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Death|1
2967021|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Death|0
2967022|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Death|0
2967023|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Death|0
2967024|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Death|0
2967025|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Death|0
2967026|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Death|0
2967027|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Death|0
2967028|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Death|0
2967029|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Death|0
2967030|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967031|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
2967032|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967033|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967034|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967035|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967036|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967037|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967038|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967039|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2967040|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2967041|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2967042|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
2967043|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967044|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967045|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967046|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967047|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967048|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967049|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2967050|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2967051|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2967052|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
2967053|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967054|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967055|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967056|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967057|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967058|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967059|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2967060|NCT01185353|10211885|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
2967061|NCT01185353|10211886|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
2967062|NCT01185353|10211887|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
2967063|NCT01185353|10211888|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
2967064|NCT01185353|10211889|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
2967065|NCT01185353|10211890|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
2967066|NCT01185353|10211891|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
2967067|NCT01185353|10211892|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
2967068|NCT01185353|10211893|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
2967069|NCT01185353|10211894|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
2967070|NCT01185353|10211885|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967071|NCT01185353|10211886|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967072|NCT01185353|10211887|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967073|NCT01185353|10211888|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
2967074|NCT01185353|10211889|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967075|NCT01185353|10211890|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967076|NCT01185353|10211891|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967077|NCT01185353|10211892|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967078|NCT01185353|10211893|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967079|NCT01185353|10211894|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2967080|NCT01185353|10211885|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967081|NCT01185353|10211886|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967082|NCT01185353|10211887|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967083|NCT01185353|10211888|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
2967084|NCT01185353|10211889|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
2967085|NCT01185353|10211890|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967086|NCT01185353|10211891|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
2967087|NCT01185353|10211892|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
2967088|NCT01185353|10211893|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967089|NCT01185353|10211894|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2967090|NCT01185353|10211885|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967091|NCT01185353|10211886|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967092|NCT01185353|10211887|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967093|NCT01185353|10211888|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2967094|NCT01185353|10211889|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967095|NCT01185353|10211890|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967096|NCT01185353|10211891|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2967097|NCT01185353|10211892|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967098|NCT01185353|10211893|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967099|NCT01185353|10211894|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2967100|NCT01185353|10211885|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967101|NCT01185353|10211886|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967102|NCT01185353|10211887|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967103|NCT01185353|10211888|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967104|NCT01185353|10211889|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967105|NCT01185353|10211890|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967106|NCT01185353|10211891|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2967107|NCT01185353|10211892|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967108|NCT01185353|10211893|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2967109|NCT01185353|10211894|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2967110|NCT01185353|10211885|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
2967111|NCT01185353|10211886|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
2967112|NCT01185353|10211887|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
2967113|NCT01185353|10211888|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
2967114|NCT01185353|10211889|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
2967115|NCT01185353|10211890|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
2967116|NCT01185353|10211891|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
2967117|NCT01185353|10211892|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
2967118|NCT01185353|10211893|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
2967119|NCT01185353|10211894|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
2967120|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967121|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967122|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967123|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967124|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967125|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
2967126|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967127|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967128|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2967129|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
2967130|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967131|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967132|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967133|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967134|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967135|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
2967136|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967137|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967138|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967139|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
2967140|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
2967141|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
2967142|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
2967143|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
2967144|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
2967145|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
2967146|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
2967147|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
2967148|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
2967149|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
2967150|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967151|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967152|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967153|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967154|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967155|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
2967156|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967157|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967158|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2967159|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
2967160|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967161|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967162|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967163|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967164|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967165|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
2967166|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967167|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967168|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967169|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2967170|NCT01185353|10211885|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
2967171|NCT01185353|10211886|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
2967172|NCT01185353|10211887|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
2967173|NCT01185353|10211888|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
2967174|NCT01185353|10211889|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
2967175|NCT01185353|10211890|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
2967176|NCT01185353|10211891|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
2967177|NCT01185353|10211892|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
2967178|NCT01185353|10211893|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
2967179|NCT01185353|10211894|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
2967180|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2967181|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
2967182|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2967183|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2967184|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2967185|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2967186|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2967187|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2967188|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2967189|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
2967190|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2967191|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2967192|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2967193|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2967194|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2967195|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2967196|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
2967197|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2967198|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
2967199|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2967200|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2967201|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
2967202|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2967203|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2967204|NCT01185340|10212055|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2967205|NCT01185340|10212056|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
2967206|NCT01185340|10212057|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2967207|NCT01185340|10212058|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2967208|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2967209|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2967210|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2967211|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
2967212|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2967213|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2967214|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2967215|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
2967216|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2967217|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2967218|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2967219|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
2967220|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2967221|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2967222|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2967223|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2967224|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2967225|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2967226|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2967227|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
2967228|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2967229|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2967230|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2967231|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
2967232|NCT01185340|10212055|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2967233|NCT01185340|10212056|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2967234|NCT01185340|10212057|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2967235|NCT01185340|10212058|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
2967236|NCT01185301|10212110|P4|Overall Study|Other Reason|2
2967237|NCT01185301|10212111|P3|Overall Study|Other Reason|2
2967238|NCT01185301|10212112|P2|Overall Study|Other Reason|2
2967239|NCT01185301|10212113|P1|Overall Study|Other Reason|3
2967240|NCT01185301|10212110|P4|Overall Study|Lost to Follow-up|1
2967241|NCT01185301|10212111|P3|Overall Study|Lost to Follow-up|0
2967242|NCT01185301|10212112|P2|Overall Study|Lost to Follow-up|0
2967243|NCT01185301|10212113|P1|Overall Study|Lost to Follow-up|2
2967244|NCT01185301|10212110|P4|Overall Study|Withdrawal by Subject|3
2967245|NCT01185301|10212111|P3|Overall Study|Withdrawal by Subject|2
2967246|NCT01185301|10212112|P2|Overall Study|Withdrawal by Subject|5
2967247|NCT01185301|10212113|P1|Overall Study|Withdrawal by Subject|7
2967248|NCT01185301|10212110|P4|Overall Study|Adverse Event|3
2967249|NCT01185301|10212111|P3|Overall Study|Adverse Event|2
2967250|NCT01185301|10212112|P2|Overall Study|Adverse Event|0
2967251|NCT01185301|10212113|P1|Overall Study|Adverse Event|3
2967252|NCT01185288|10212173|P2|Overall Study|Noncompliance|1
2967253|NCT01185288|10212174|P1|Overall Study|Noncompliance|0
2967254|NCT01185288|10212173|P2|Overall Study|Did not meet inclusion criteria|0
2967255|NCT01185288|10212174|P1|Overall Study|Did not meet inclusion criteria|1
2967256|NCT01185288|10212173|P2|Overall Study|Investigator discretion|0
2967257|NCT01185288|10212174|P1|Overall Study|Investigator discretion|1
2967258|NCT01185288|10212173|P2|Overall Study|Lack of Efficacy|0
2967259|NCT01185288|10212174|P1|Overall Study|Lack of Efficacy|2
2967260|NCT01185288|10212173|P2|Overall Study|Lost to Follow-up|5
2967261|NCT01185288|10212174|P1|Overall Study|Lost to Follow-up|2
2967262|NCT01185288|10212173|P2|Overall Study|Withdrawal by Subject|4
2967263|NCT01185288|10212174|P1|Overall Study|Withdrawal by Subject|6
2967264|NCT01185288|10212173|P2|Overall Study|Adverse Event|6
2967265|NCT01185288|10212174|P1|Overall Study|Adverse Event|7
2967266|NCT01185249|10212192|P1|Overall Study|Patients discharged or change in status|42
2967267|NCT01185080|10212200|P3|Overall Study|Personal reasons|1
2967268|NCT01185080|10212201|P2|Overall Study|Personal reasons|0
2967269|NCT01185080|10212202|P1|Overall Study|Personal reasons|0
2967270|NCT01185080|10212200|P3|Overall Study|Adverse Event|0
2967271|NCT01185080|10212201|P2|Overall Study|Adverse Event|1
2967272|NCT01185080|10212202|P1|Overall Study|Adverse Event|1
2967273|NCT01184989|10212254|P1|Overall Study|Withdrawal by Subject|1
2967274|NCT01184989|10212254|P1|Overall Study|Adverse Event|11
2967275|NCT01184872|10212274|P2|Overall Study|Protocol deviation|0
2967276|NCT01184872|10212275|P1|Overall Study|Protocol deviation|1
2967277|NCT01184872|10212274|P2|Overall Study|Administrative problems|1
2967278|NCT01184872|10212275|P1|Overall Study|Administrative problems|1
2967279|NCT01184872|10212274|P2|Overall Study|Lost to Follow-up|1
2967280|NCT01184872|10212275|P1|Overall Study|Lost to Follow-up|0
2967281|NCT01184872|10212274|P2|Overall Study|Withdrawal by Subject|0
2967282|NCT01184872|10212275|P1|Overall Study|Withdrawal by Subject|2
2967283|NCT01184872|10212274|P2|Overall Study|Unsatisfactory therapeutic effect|2
2967284|NCT01184872|10212275|P1|Overall Study|Unsatisfactory therapeutic effect|3
2967285|NCT01184872|10212274|P2|Overall Study|Adverse Event|4
2967286|NCT01184872|10212275|P1|Overall Study|Adverse Event|3
2967287|NCT01184859|10212294|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
2967288|NCT01184859|10212295|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
2967289|NCT01184859|10212296|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
2967290|NCT01184859|10212297|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
2967291|NCT01184859|10212298|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
2967292|NCT01184859|10212294|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
2967293|NCT01184859|10212295|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2967294|NCT01184859|10212296|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2967295|NCT01184859|10212297|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2967296|NCT01184859|10212298|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2967297|NCT01184859|10212294|P5|Period 1: Single Dose|Adverse Event|1
2967298|NCT01184859|10212295|P4|Period 1: Single Dose|Adverse Event|0
2967299|NCT01184859|10212296|P3|Period 1: Single Dose|Adverse Event|0
2967300|NCT01184859|10212297|P2|Period 1: Single Dose|Adverse Event|0
2967301|NCT01184859|10212298|P1|Period 1: Single Dose|Adverse Event|0
2967302|NCT01184859|10212294|P5|Period 1: Single Dose|Protocol Violation|0
2967303|NCT01184859|10212295|P4|Period 1: Single Dose|Protocol Violation|0
2967304|NCT01184859|10212296|P3|Period 1: Single Dose|Protocol Violation|0
2967305|NCT01184859|10212297|P2|Period 1: Single Dose|Protocol Violation|1
2967306|NCT01184859|10212298|P1|Period 1: Single Dose|Protocol Violation|0
2967307|NCT01184859|10212294|P5|Period 1: Single Dose|Insufficient urine production|0
2967308|NCT01184859|10212295|P4|Period 1: Single Dose|Insufficient urine production|0
2967309|NCT01184859|10212296|P3|Period 1: Single Dose|Insufficient urine production|0
2967310|NCT01184859|10212297|P2|Period 1: Single Dose|Insufficient urine production|1
2967311|NCT01184859|10212298|P1|Period 1: Single Dose|Insufficient urine production|0
2967312|NCT01184846|10212390|P1|Overall Study|Insufficient response|1
2967313|NCT01184846|10212390|P1|Overall Study|Adverse Event|2
2967314|NCT01184508|10212423|P2|Overall Study|Randomized, Not Treated|1
2967315|NCT01184508|10212424|P1|Overall Study|Randomized, Not Treated|0
2967316|NCT01184508|10212423|P2|Overall Study|Withdrawal by Subject|3
2967317|NCT01184508|10212424|P1|Overall Study|Withdrawal by Subject|1
2967318|NCT01184508|10212423|P2|Overall Study|Sponsor Decision|2
2967319|NCT01184508|10212424|P1|Overall Study|Sponsor Decision|5
2967320|NCT01184508|10212423|P2|Overall Study|Protocol Violation|1
2967321|NCT01184508|10212424|P1|Overall Study|Protocol Violation|3
2967322|NCT01184508|10212423|P2|Overall Study|Physician Decision|0
2967323|NCT01184508|10212424|P1|Overall Study|Physician Decision|1
2967324|NCT01184508|10212423|P2|Overall Study|Lost to Follow-up|1
2967325|NCT01184508|10212424|P1|Overall Study|Lost to Follow-up|1
2967326|NCT01184508|10212423|P2|Overall Study|Lack of Efficacy|1
2967327|NCT01184508|10212424|P1|Overall Study|Lack of Efficacy|1
2967328|NCT01184508|10212423|P2|Overall Study|Adverse Event|6
2967329|NCT01184508|10212424|P1|Overall Study|Adverse Event|4
2967330|NCT01184326|10212484|P3|Overall Study|Disease Progression|12
2967331|NCT01184326|10212485|P2|Overall Study|Disease Progression|3
2967332|NCT01184326|10212486|P1|Overall Study|Disease Progression|1
2967333|NCT01184326|10212484|P3|Overall Study|Physician Decision|0
2967334|NCT01184326|10212485|P2|Overall Study|Physician Decision|1
2967335|NCT01184326|10212486|P1|Overall Study|Physician Decision|1
2967336|NCT01184326|10212484|P3|Overall Study|Withdrawal by Subject|1
2967337|NCT01184326|10212485|P2|Overall Study|Withdrawal by Subject|0
2967338|NCT01184326|10212486|P1|Overall Study|Withdrawal by Subject|0
2967339|NCT01184326|10212484|P3|Overall Study|Death|1
2967340|NCT01184326|10212485|P2|Overall Study|Death|0
2967341|NCT01184326|10212486|P1|Overall Study|Death|0
2967342|NCT01184326|10212484|P3|Overall Study|Adverse Event|0
2967343|NCT01184326|10212485|P2|Overall Study|Adverse Event|2
2967344|NCT01184326|10212486|P1|Overall Study|Adverse Event|1
2967345|NCT01184118|10212500|P1|Overall Study|Withdrawal by Subject|5
2967346|NCT01184118|10212500|P1|Overall Study|Exclusionary medical condition|2
2967347|NCT01184118|10212500|P1|Overall Study|FEV1 <60% predicted|2
2967348|NCT01184118|10212500|P1|Overall Study|No physiologic confirmation of asthma|8
2967349|NCT01184118|10212500|P1|Overall Study|Only asthma step 1 - screen fail|1
2967350|NCT01184079|10212508|P2|Overall Study|Lost to Follow-up|2
2967351|NCT01184079|10212509|P1|Overall Study|Lost to Follow-up|14
2967352|NCT01184053|10212519|P1|Overall Study|progression while on treatment|3
2967353|NCT01183975|10212535|P1|Overall Study|Lost to Follow-up|73
2967354|NCT01183884|10212552|P1|Overall Study|Other|4
2967355|NCT01183884|10212552|P1|Overall Study|Not Treated|1
2967356|NCT01183884|10212552|P1|Overall Study|Other Complicating Disease|3
2967357|NCT01183884|10212552|P1|Overall Study|Withdrawal by Subject|1
2967358|NCT01183884|10212552|P1|Overall Study|Adverse Event|3
2967359|NCT01183884|10212552|P1|Overall Study|Progressive Disease|26
2967360|NCT01183858|10212560|P2|Overall Study|Lost to Follow-up|1
2967361|NCT01183858|10212561|P1|Overall Study|Lost to Follow-up|1
2967362|NCT01183858|10212560|P2|Overall Study|Death related to Progressive Disease|5
2967363|NCT01183858|10212561|P1|Overall Study|Death related to Progressive Disease|4
2967364|NCT01183858|10212560|P2|Overall Study|Progressive Disease|115
2967365|NCT01183858|10212561|P1|Overall Study|Progressive Disease|112
2967366|NCT01183858|10212560|P2|Overall Study|Administrative/Other|6
2967367|NCT01183858|10212561|P1|Overall Study|Administrative/Other|6
2967368|NCT01183858|10212560|P2|Overall Study|Protocol Violation|0
2967369|NCT01183858|10212561|P1|Overall Study|Protocol Violation|1
2967370|NCT01183858|10212560|P2|Overall Study|Discontinued Smoking|1
2967371|NCT01183858|10212561|P1|Overall Study|Discontinued Smoking|3
2967372|NCT01183858|10212560|P2|Overall Study|Withdrew Consent|4
2967373|NCT01183858|10212561|P1|Overall Study|Withdrew Consent|4
2967374|NCT01183858|10212560|P2|Overall Study|Refused Treatment|4
2967375|NCT01183858|10212561|P1|Overall Study|Refused Treatment|1
2967376|NCT01183858|10212560|P2|Overall Study|Insufficient Therapeutic Response|0
2967377|NCT01183858|10212561|P1|Overall Study|Insufficient Therapeutic Response|2
2967378|NCT01183858|10212560|P2|Overall Study|Investigator's Decision|3
2967379|NCT01183858|10212561|P1|Overall Study|Investigator's Decision|0
2967380|NCT01183858|10212560|P2|Overall Study|Adverse Event|11
2967381|NCT01183858|10212561|P1|Overall Study|Adverse Event|14
2967382|NCT01183858|10212560|P2|Overall Study|Death not related to Progressive Disease|6
2967383|NCT01183858|10212561|P1|Overall Study|Death not related to Progressive Disease|5
2967384|NCT01183780|10212583|P2|Overall Study|Lost to Follow-up|11
2967385|NCT01183780|10212584|P1|Overall Study|Lost to Follow-up|6
2967386|NCT01183780|10212583|P2|Overall Study|Withdrawal by Subject|14
2967387|NCT01183780|10212584|P1|Overall Study|Withdrawal by Subject|25
2967388|NCT01183468|10212717|P4|Overall Study|Withdrawal by Subject|0
2967389|NCT01183468|10212718|P3|Overall Study|Withdrawal by Subject|0
2967390|NCT01183468|10212719|P2|Overall Study|Withdrawal by Subject|1
2967391|NCT01183468|10212720|P1|Overall Study|Withdrawal by Subject|0
2967392|NCT01183468|10212717|P4|Overall Study|Physician Decision|0
2967393|NCT01183468|10212718|P3|Overall Study|Physician Decision|0
2967394|NCT01183468|10212719|P2|Overall Study|Physician Decision|0
2967395|NCT01183468|10212720|P1|Overall Study|Physician Decision|1
2967396|NCT01183468|10212717|P4|Overall Study|Lost to Follow-up|0
2967397|NCT01183468|10212718|P3|Overall Study|Lost to Follow-up|0
2967398|NCT01183468|10212719|P2|Overall Study|Lost to Follow-up|1
2967399|NCT01183468|10212720|P1|Overall Study|Lost to Follow-up|2
2967400|NCT01183390|10212742|P2|First Intervention|Adverse Event|1
2967401|NCT01183390|10212743|P1|First Intervention|Adverse Event|0
2967402|NCT01183260|10212776|P2|Overall Study|Death|0
2967403|NCT01183260|10212777|P1|Overall Study|Death|1
2967404|NCT01183260|10212776|P2|Overall Study|Revised within 30 days|1
2967405|NCT01183260|10212777|P1|Overall Study|Revised within 30 days|0
2967406|NCT01183260|10212776|P2|Overall Study|Withdrawal by Subject|1
2967407|NCT01183260|10212777|P1|Overall Study|Withdrawal by Subject|1
2967408|NCT01183260|10212776|P2|Overall Study|Intraop screen failure|0
2967409|NCT01183260|10212777|P1|Overall Study|Intraop screen failure|2
2967410|NCT01183234|10212787|P2|First Intervention|Adverse Event|0
2967411|NCT01183234|10212788|P1|First Intervention|Adverse Event|1
2967412|NCT01183143|10212880|P1|Overall Study|Subjects enrolled, but not treated|11
2967413|NCT01183143|10212880|P1|Overall Study|Subject Questionnaires not returned|5
2967414|NCT01183143|10212880|P1|Overall Study|Withdrawal by Subject|19
2967415|NCT01183143|10212880|P1|Overall Study|Protocol Violation|115
2967416|NCT01183104|10212896|P2|Overall Study|Did not receive study drug|9
2967417|NCT01183104|10212897|P1|Overall Study|Did not receive study drug|5
2967418|NCT01183104|10212896|P2|Overall Study|Nonparticipation in Extension Study|50
2967419|NCT01183104|10212897|P1|Overall Study|Nonparticipation in Extension Study|39
2967420|NCT01183104|10212896|P2|Overall Study|Withdrawal by Subject|11
2967421|NCT01183104|10212897|P1|Overall Study|Withdrawal by Subject|6
2967422|NCT01183104|10212896|P2|Overall Study|Physician Decision|8
2967423|NCT01183104|10212897|P1|Overall Study|Physician Decision|5
2967424|NCT01183104|10212896|P2|Overall Study|Lost to Follow-up|7
2967425|NCT01183104|10212897|P1|Overall Study|Lost to Follow-up|14
2967426|NCT01183104|10212896|P2|Overall Study|Death|1
2967427|NCT01183104|10212897|P1|Overall Study|Death|0
2967428|NCT01183104|10212896|P2|Overall Study|Adverse Event|6
2967429|NCT01183104|10212897|P1|Overall Study|Adverse Event|8
2967430|NCT01183065|10212913|P1|Overall Study|Patient no longer fits eligibility crite|1
2967431|NCT01183013|10212924|P7|Overall Study|Reasons other than stated above|13
2967432|NCT01183013|10212925|P6|Overall Study|Reasons other than stated above|15
2967433|NCT01183013|10212926|P5|Overall Study|Reasons other than stated above|12
2967434|NCT01183013|10212927|P4|Overall Study|Reasons other than stated above|12
2967435|NCT01183013|10212928|P3|Overall Study|Reasons other than stated above|17
2967436|NCT01183013|10212929|P2|Overall Study|Reasons other than stated above|11
2967437|NCT01183013|10212930|P1|Overall Study|Reasons other than stated above|15
2967438|NCT01183013|10212924|P7|Overall Study|Withdrawal by Subject|10
2967439|NCT01183013|10212925|P6|Overall Study|Withdrawal by Subject|9
2967440|NCT01183013|10212926|P5|Overall Study|Withdrawal by Subject|7
2967441|NCT01183013|10212927|P4|Overall Study|Withdrawal by Subject|8
2967442|NCT01183013|10212928|P3|Overall Study|Withdrawal by Subject|10
2967443|NCT01183013|10212929|P2|Overall Study|Withdrawal by Subject|13
2967444|NCT01183013|10212930|P1|Overall Study|Withdrawal by Subject|9
2967445|NCT01183013|10212924|P7|Overall Study|Lost to Follow-up|5
2967446|NCT01183013|10212925|P6|Overall Study|Lost to Follow-up|6
2967447|NCT01183013|10212926|P5|Overall Study|Lost to Follow-up|2
2967448|NCT01183013|10212927|P4|Overall Study|Lost to Follow-up|3
2967449|NCT01183013|10212928|P3|Overall Study|Lost to Follow-up|4
2967450|NCT01183013|10212929|P2|Overall Study|Lost to Follow-up|3
2967451|NCT01183013|10212930|P1|Overall Study|Lost to Follow-up|7
2967452|NCT01183013|10212924|P7|Overall Study|Protocol Violation|3
2967453|NCT01183013|10212925|P6|Overall Study|Protocol Violation|3
2967454|NCT01183013|10212926|P5|Overall Study|Protocol Violation|4
2967455|NCT01183013|10212927|P4|Overall Study|Protocol Violation|0
2967456|NCT01183013|10212928|P3|Overall Study|Protocol Violation|4
2967457|NCT01183013|10212929|P2|Overall Study|Protocol Violation|2
2967458|NCT01183013|10212930|P1|Overall Study|Protocol Violation|5
2967459|NCT01183013|10212924|P7|Overall Study|Lack of Efficacy|0
2967460|NCT01183013|10212925|P6|Overall Study|Lack of Efficacy|2
2967461|NCT01183013|10212926|P5|Overall Study|Lack of Efficacy|1
2967462|NCT01183013|10212927|P4|Overall Study|Lack of Efficacy|2
2967463|NCT01183013|10212928|P3|Overall Study|Lack of Efficacy|1
2967464|NCT01183013|10212929|P2|Overall Study|Lack of Efficacy|2
2967465|NCT01183013|10212930|P1|Overall Study|Lack of Efficacy|3
2967466|NCT01183013|10212924|P7|Overall Study|Adverse Event|6
2967467|NCT01183013|10212925|P6|Overall Study|Adverse Event|10
2967468|NCT01183013|10212926|P5|Overall Study|Adverse Event|10
2967469|NCT01183013|10212927|P4|Overall Study|Adverse Event|5
2967470|NCT01183013|10212928|P3|Overall Study|Adverse Event|5
2967471|NCT01183013|10212929|P2|Overall Study|Adverse Event|8
2967472|NCT01183013|10212930|P1|Overall Study|Adverse Event|6
2967473|NCT01182441|10213097|P2|Overall Study|Physician Decision|1
2967474|NCT01182441|10213098|P1|Overall Study|Physician Decision|1
2967475|NCT01182441|10213097|P2|Overall Study|Adverse Event|0
2967476|NCT01182441|10213098|P1|Overall Study|Adverse Event|2
2967477|NCT01182441|10213097|P2|Overall Study|Implant Not Attempted|0
2967478|NCT01182441|10213098|P1|Overall Study|Implant Not Attempted|4
2967479|NCT01182441|10213097|P2|Overall Study|Withdrawal by Subject|13
2967480|NCT01182441|10213098|P1|Overall Study|Withdrawal by Subject|6
2967481|NCT01182441|10213097|P2|Overall Study|Lost to Follow-up|8
2967482|NCT01182441|10213098|P1|Overall Study|Lost to Follow-up|5
2967483|NCT01182441|10213097|P2|Overall Study|Implant Attempt Unsuccessful|0
2967484|NCT01182441|10213098|P1|Overall Study|Implant Attempt Unsuccessful|13
2967485|NCT01182441|10213097|P2|Overall Study|Death|25
2967486|NCT01182441|10213098|P1|Overall Study|Death|37
2967487|NCT01182441|10213097|P2|Overall Study|Patient Still in Follow-up|72
2967488|NCT01182441|10213098|P1|Overall Study|Patient Still in Follow-up|152
2967489|NCT01182428|10213109|P2|Overall Study|Withdrawal by Subject|0
2967490|NCT01182428|10213110|P1|Overall Study|Withdrawal by Subject|1
2967491|NCT01182428|10213109|P2|Overall Study|Lost to Follow-up|1
2967492|NCT01182428|10213110|P1|Overall Study|Lost to Follow-up|9
2967493|NCT01182428|10213109|P2|Overall Study|Physician Decision|0
2967494|NCT01182428|10213110|P1|Overall Study|Physician Decision|1
2967495|NCT01182415|10213174|P1|Overall Study|Lost to Follow-up|1
2967496|NCT01182350|10213190|P5|Overall Study|Unevaluable for Biopsy|3
2967497|NCT01182350|10213191|P4|Overall Study|Unevaluable for Biopsy|0
2967498|NCT01182350|10213192|P3|Overall Study|Unevaluable for Biopsy|0
2967499|NCT01182350|10213193|P2|Overall Study|Unevaluable for Biopsy|0
2967500|NCT01182350|10213194|P1|Overall Study|Unevaluable for Biopsy|0
2967501|NCT01182350|10213190|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
2967502|NCT01182350|10213191|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
2967503|NCT01182350|10213192|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
2967504|NCT01182350|10213193|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
2967505|NCT01182350|10213194|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
2967506|NCT01182350|10213190|P5|Overall Study|Alternative Therapy|0
2967507|NCT01182350|10213191|P4|Overall Study|Alternative Therapy|0
2967508|NCT01182350|10213192|P3|Overall Study|Alternative Therapy|1
2967509|NCT01182350|10213193|P2|Overall Study|Alternative Therapy|0
2967510|NCT01182350|10213194|P1|Overall Study|Alternative Therapy|2
2967511|NCT01182350|10213190|P5|Overall Study|Withdrawal by Subject|0
2967512|NCT01182350|10213191|P4|Overall Study|Withdrawal by Subject|1
2967513|NCT01182350|10213192|P3|Overall Study|Withdrawal by Subject|0
2967514|NCT01182350|10213193|P2|Overall Study|Withdrawal by Subject|1
2967515|NCT01182350|10213194|P1|Overall Study|Withdrawal by Subject|3
2967516|NCT01182350|10213190|P5|Overall Study|Death|0
2967517|NCT01182350|10213191|P4|Overall Study|Death|0
2967518|NCT01182350|10213192|P3|Overall Study|Death|1
2967519|NCT01182350|10213193|P2|Overall Study|Death|1
2967520|NCT01182350|10213194|P1|Overall Study|Death|0
2967521|NCT01182350|10213190|P5|Overall Study|Disease Progression|0
2967522|NCT01182350|10213191|P4|Overall Study|Disease Progression|1
2967523|NCT01182350|10213192|P3|Overall Study|Disease Progression|0
2967524|NCT01182350|10213193|P2|Overall Study|Disease Progression|12
2967525|NCT01182350|10213194|P1|Overall Study|Disease Progression|15
2967526|NCT01182350|10213190|P5|Overall Study|Adverse Event|0
2967527|NCT01182350|10213191|P4|Overall Study|Adverse Event|0
2967528|NCT01182350|10213192|P3|Overall Study|Adverse Event|0
2967529|NCT01182350|10213193|P2|Overall Study|Adverse Event|0
2967530|NCT01182350|10213194|P1|Overall Study|Adverse Event|5
2967531|NCT01182337|10213216|P2|Overall Study|Lost to Follow-up|1
2967532|NCT01182337|10213217|P1|Overall Study|Lost to Follow-up|0
2967533|NCT01182337|10213216|P2|Overall Study|Withdrawal by Subject|1
2967534|NCT01182337|10213217|P1|Overall Study|Withdrawal by Subject|3
2967535|NCT01182298|10213235|P1|Overall Study|Withdrawal by Subject|2
2967536|NCT01182298|10213235|P1|Overall Study|Lack of Efficacy|4
2967537|NCT01182285|10213239|P3|Third Intervention Week 11-52|Other|2
2967538|NCT01182285|10213240|P2|Third Intervention Week 11-52|Other|0
2967539|NCT01182285|10213241|P1|Third Intervention Week 11-52|Other|0
2967540|NCT01182285|10213239|P3|Third Intervention Week 11-52|Disease Progression|6
2967541|NCT01182285|10213240|P2|Third Intervention Week 11-52|Disease Progression|0
2967542|NCT01182285|10213241|P1|Third Intervention Week 11-52|Disease Progression|0
2967543|NCT01182285|10213239|P3|First Intervention Week 1-10|Non-compliance|0
2967544|NCT01182285|10213240|P2|First Intervention Week 1-10|Non-compliance|0
2967545|NCT01182285|10213241|P1|First Intervention Week 1-10|Non-compliance|1
2967546|NCT01182285|10213239|P3|First Intervention Week 1-10|Adverse Event|0
2967547|NCT01182285|10213240|P2|First Intervention Week 1-10|Adverse Event|0
2967548|NCT01182285|10213241|P1|First Intervention Week 1-10|Adverse Event|1
2967549|NCT01182285|10213239|P3|First Intervention Week 1-10|Disease progression|0
2967550|NCT01182285|10213240|P2|First Intervention Week 1-10|Disease progression|0
2967551|NCT01182285|10213241|P1|First Intervention Week 1-10|Disease progression|1
2967552|NCT01182207|10213251|P2|Second Intervention|Emeses within 1 hour of dosing|0
2967553|NCT01182207|10213252|P1|Second Intervention|Emeses within 1 hour of dosing|1
2967554|NCT01182207|10213251|P2|First Intervention|Positive Hepatitis Results|1
2967555|NCT01182207|10213252|P1|First Intervention|Positive Hepatitis Results|0
2967556|NCT01182194|10213270|P2|Washout of 28 Days|Withdrawal by Subject|0
2967557|NCT01182194|10213271|P1|Washout of 28 Days|Withdrawal by Subject|1
2967558|NCT01182181|10213289|P2|Washout of 21 Days|Withdrawal by Subject|1
2967559|NCT01182181|10213290|P1|Washout of 21 Days|Withdrawal by Subject|0
2967560|NCT01182181|10213289|P2|First Intervention|Adverse Event|0
2967561|NCT01182181|10213290|P1|First Intervention|Adverse Event|1
2967562|NCT01181986|10213315|P3|Phase 2|Medical condition|0
2967563|NCT01181986|10213316|P2|Phase 2|Medical condition|1
2967564|NCT01181986|10213317|P1|Phase 2|Medical condition|0
2967565|NCT01181986|10213315|P3|Phase 2|Adverse Event|0
2967566|NCT01181986|10213316|P2|Phase 2|Adverse Event|3
2967567|NCT01181986|10213317|P1|Phase 2|Adverse Event|0
2967568|NCT01181986|10213315|P3|Phase 1|Protocol Violation|0
2967569|NCT01181986|10213316|P2|Phase 1|Protocol Violation|0
2967570|NCT01181986|10213317|P1|Phase 1|Protocol Violation|1
2967571|NCT01181986|10213315|P3|Phase 1|Adverse Event|1
2967572|NCT01181986|10213316|P2|Phase 1|Adverse Event|0
2967573|NCT01181986|10213317|P1|Phase 1|Adverse Event|0
2967574|NCT01181986|10213315|P3|Phase 1|Lost to Follow-up|1
2967575|NCT01181986|10213316|P2|Phase 1|Lost to Follow-up|1
2967576|NCT01181986|10213317|P1|Phase 1|Lost to Follow-up|0
2967577|NCT01181921|10213338|P1|Overall Study|Lost to Follow-up|1
2967578|NCT01181895|10213345|P3|Overall Study|Withdrawal by Subject|5
2967579|NCT01181895|10213346|P2|Overall Study|Withdrawal by Subject|0
2967580|NCT01181895|10213347|P1|Overall Study|Withdrawal by Subject|3
2967581|NCT01181895|10213345|P3|Overall Study|Investigator Discretion|1
2967582|NCT01181895|10213346|P2|Overall Study|Investigator Discretion|2
2967583|NCT01181895|10213347|P1|Overall Study|Investigator Discretion|1
2967584|NCT01181895|10213345|P3|Overall Study|Lost to Follow-up|2
2967585|NCT01181895|10213346|P2|Overall Study|Lost to Follow-up|1
2967586|NCT01181895|10213347|P1|Overall Study|Lost to Follow-up|0
2967587|NCT01181895|10213345|P3|Overall Study|Protocol Violation|0
2967588|NCT01181895|10213346|P2|Overall Study|Protocol Violation|1
2967589|NCT01181895|10213347|P1|Overall Study|Protocol Violation|2
2967590|NCT01181895|10213345|P3|Overall Study|Lack of Efficacy|9
2967591|NCT01181895|10213346|P2|Overall Study|Lack of Efficacy|9
2967592|NCT01181895|10213347|P1|Overall Study|Lack of Efficacy|8
2967593|NCT01181895|10213345|P3|Overall Study|Adverse Event|1
2967594|NCT01181895|10213346|P2|Overall Study|Adverse Event|1
2967595|NCT01181895|10213347|P1|Overall Study|Adverse Event|3
2967596|NCT01181778|10213405|P1|Overall Study|Physician Decision|48
2967597|NCT01181726|10213413|P2|First Intervention|Adverse Event|0
2967598|NCT01181726|10213414|P1|First Intervention|Adverse Event|1
2967599|NCT01181609|10213494|P1|Overall Study|Death|50
2967600|NCT01181609|10213494|P1|Overall Study|Lost to Follow-up|1
2967601|NCT01181609|10213494|P1|Overall Study|Withdrawal by Subject|1
2967602|NCT01181609|10213494|P1|Overall Study|Adverse Event|1
2967603|NCT01181531|10213512|P2|Overall Study|Adverse Event|1
2967604|NCT01181531|10213513|P1|Overall Study|Adverse Event|0
2967605|NCT01181531|10213512|P2|Overall Study|Death|12
2967606|NCT01181531|10213513|P1|Overall Study|Death|9
2967607|NCT01181531|10213512|P2|Overall Study|Protocol Violation|6
2967608|NCT01181531|10213513|P1|Overall Study|Protocol Violation|6
2967609|NCT01181531|10213512|P2|Overall Study|Withdrawal by Subject|7
2967610|NCT01181531|10213513|P1|Overall Study|Withdrawal by Subject|8
2967611|NCT01181531|10213512|P2|Overall Study|Pregnancy|1
2967612|NCT01181531|10213513|P1|Overall Study|Pregnancy|0
2967613|NCT01181531|10213512|P2|Overall Study|Protocol Specified Criteria|8
2967614|NCT01181531|10213513|P1|Overall Study|Protocol Specified Criteria|15
2967615|NCT01181531|10213512|P2|Overall Study|Ineligibility determined|2
2967616|NCT01181531|10213513|P1|Overall Study|Ineligibility determined|1
2967617|NCT01181531|10213512|P2|Overall Study|Noncompliance|2
2967618|NCT01181531|10213513|P1|Overall Study|Noncompliance|2
2967619|NCT01181531|10213512|P2|Overall Study|Physician Decision|1
2967620|NCT01181531|10213513|P1|Overall Study|Physician Decision|3
2967621|NCT01181531|10213512|P2|Overall Study|Partial consent by subject withdrawn|1
2967622|NCT01181531|10213513|P1|Overall Study|Partial consent by subject withdrawn|0
2967623|NCT01181531|10213512|P2|Overall Study|Other|12
2967624|NCT01181531|10213513|P1|Overall Study|Other|17
2967625|NCT01181271|10213655|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
2967626|NCT01181271|10213655|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
2967627|NCT01181271|10213655|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
2967628|NCT01181271|10213655|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
2967629|NCT01181167|10213679|P2|Overall Study|Withdrawal by Subject|8
2967630|NCT01181167|10213680|P1|Overall Study|Withdrawal by Subject|6
2967631|NCT01181167|10213679|P2|Overall Study|Protocol Violation|0
2967632|NCT01181167|10213680|P1|Overall Study|Protocol Violation|3
2967633|NCT01181167|10213679|P2|Overall Study|Physician Decision|3
2967634|NCT01181167|10213680|P1|Overall Study|Physician Decision|2
2967635|NCT01181167|10213679|P2|Overall Study|Lost to Follow-up|0
2967636|NCT01181167|10213680|P1|Overall Study|Lost to Follow-up|1
2967637|NCT01181167|10213679|P2|Overall Study|Adverse Event|21
2967638|NCT01181167|10213680|P1|Overall Study|Adverse Event|11
2967639|NCT01181141|10213690|P2|Overall Study|Withdrawal by Subject|1
2967640|NCT01181141|10213691|P1|Overall Study|Withdrawal by Subject|3
2967641|NCT01181141|10213690|P2|Overall Study|Protocol Violation|1
2967642|NCT01181141|10213691|P1|Overall Study|Protocol Violation|3
2967643|NCT01181141|10213690|P2|Overall Study|Physician Decision|0
2967644|NCT01181141|10213691|P1|Overall Study|Physician Decision|2
2967645|NCT01181141|10213690|P2|Overall Study|Lost to Follow-up|1
2967646|NCT01181141|10213691|P1|Overall Study|Lost to Follow-up|1
2967647|NCT01181141|10213690|P2|Overall Study|Lack of Efficacy|0
2967648|NCT01181141|10213691|P1|Overall Study|Lack of Efficacy|1
2967649|NCT01181141|10213690|P2|Overall Study|Adverse Event|1
2967650|NCT01181141|10213691|P1|Overall Study|Adverse Event|2
2967651|NCT01181128|10213700|P3|Overall Study|Other|1
2967652|NCT01181128|10213701|P2|Overall Study|Other|1
2967653|NCT01181128|10213702|P1|Overall Study|Other|1
2967654|NCT01181128|10213700|P3|Overall Study|Adverse Event|0
2967655|NCT01181128|10213701|P2|Overall Study|Adverse Event|2
2967656|NCT01181128|10213702|P1|Overall Study|Adverse Event|0
2967657|NCT01181128|10213700|P3|Overall Study|Physician Decision|0
2967658|NCT01181128|10213701|P2|Overall Study|Physician Decision|0
2967659|NCT01181128|10213702|P1|Overall Study|Physician Decision|2
2967660|NCT01181128|10213700|P3|Overall Study|Death|0
2967661|NCT01181128|10213701|P2|Overall Study|Death|0
2967662|NCT01181128|10213702|P1|Overall Study|Death|1
2967663|NCT01181128|10213700|P3|Overall Study|Withdrawal by Subject|0
2967664|NCT01181128|10213701|P2|Overall Study|Withdrawal by Subject|2
2967665|NCT01181128|10213702|P1|Overall Study|Withdrawal by Subject|2
2967666|NCT01181102|10213790|P2|Overall Study|Withdrawal by Subject|12
2967667|NCT01181102|10213791|P1|Overall Study|Withdrawal by Subject|10
2967668|NCT01181102|10213790|P2|Overall Study|Protocol Violation|6
2967669|NCT01181102|10213791|P1|Overall Study|Protocol Violation|5
2967670|NCT01181102|10213790|P2|Overall Study|Physician Decision|1
2967671|NCT01181102|10213791|P1|Overall Study|Physician Decision|3
2967672|NCT01181102|10213790|P2|Overall Study|Lost to Follow-up|0
2967673|NCT01181102|10213791|P1|Overall Study|Lost to Follow-up|2
2967674|NCT01181102|10213790|P2|Overall Study|Lack of Efficacy|1
2967675|NCT01181102|10213791|P1|Overall Study|Lack of Efficacy|3
2967676|NCT01181102|10213790|P2|Overall Study|Adverse Event|26
2967677|NCT01181102|10213791|P1|Overall Study|Adverse Event|28
2967678|NCT01181011|10213835|P1|Overall Study|Lost to Follow-up|1
2967679|NCT01181011|10213835|P1|Overall Study|Adverse Event|2
2967680|NCT01180998|10213885|P3|Overall Study|Poor lens handling|2
2967681|NCT01180998|10213886|P2|Overall Study|Poor lens handling|0
2967682|NCT01180998|10213887|P1|Overall Study|Poor lens handling|0
2967683|NCT01180998|10213885|P3|Overall Study|Poor comfort|4
2967684|NCT01180998|10213886|P2|Overall Study|Poor comfort|0
2967685|NCT01180998|10213887|P1|Overall Study|Poor comfort|3
2967686|NCT01180998|10213885|P3|Overall Study|Withdrawal by Subject|1
2967687|NCT01180998|10213886|P2|Overall Study|Withdrawal by Subject|0
2967688|NCT01180998|10213887|P1|Overall Study|Withdrawal by Subject|0
2967689|NCT01180998|10213885|P3|Overall Study|Protocol Violation|0
2967690|NCT01180998|10213886|P2|Overall Study|Protocol Violation|2
2967691|NCT01180998|10213887|P1|Overall Study|Protocol Violation|1
2967692|NCT01180998|10213885|P3|Overall Study|Lost to Follow-up|1
2967693|NCT01180998|10213886|P2|Overall Study|Lost to Follow-up|0
2967694|NCT01180998|10213887|P1|Overall Study|Lost to Follow-up|0
2967695|NCT01180998|10213885|P3|Overall Study|Poor Vision|2
2967696|NCT01180998|10213886|P2|Overall Study|Poor Vision|2
2967697|NCT01180998|10213887|P1|Overall Study|Poor Vision|0
2967698|NCT01180985|10213901|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
2967699|NCT01180985|10213902|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
2967700|NCT01180790|10213941|P7|Overall Study|Severe coronary atherosclerosis (death)|0
2967701|NCT01180790|10213942|P6|Overall Study|Severe coronary atherosclerosis (death)|0
2967702|NCT01180790|10213943|P5|Overall Study|Severe coronary atherosclerosis (death)|0
2967703|NCT01180790|10213944|P4|Overall Study|Severe coronary atherosclerosis (death)|0
2967704|NCT01180790|10213945|P3|Overall Study|Severe coronary atherosclerosis (death)|1
2967705|NCT01180790|10213946|P2|Overall Study|Severe coronary atherosclerosis (death)|0
2967706|NCT01180790|10213947|P1|Overall Study|Severe coronary atherosclerosis (death)|0
2967707|NCT01180790|10213941|P7|Overall Study|compliance|0
2967708|NCT01180790|10213942|P6|Overall Study|compliance|0
2967709|NCT01180790|10213943|P5|Overall Study|compliance|0
2967710|NCT01180790|10213944|P4|Overall Study|compliance|0
2967711|NCT01180790|10213945|P3|Overall Study|compliance|0
2967712|NCT01180790|10213946|P2|Overall Study|compliance|1
2967713|NCT01180790|10213947|P1|Overall Study|compliance|0
2967714|NCT01180790|10213941|P7|Overall Study|Lack of Efficacy|0
2967715|NCT01180790|10213942|P6|Overall Study|Lack of Efficacy|3
2967716|NCT01180790|10213943|P5|Overall Study|Lack of Efficacy|1
2967717|NCT01180790|10213944|P4|Overall Study|Lack of Efficacy|6
2967718|NCT01180790|10213945|P3|Overall Study|Lack of Efficacy|5
2967719|NCT01180790|10213946|P2|Overall Study|Lack of Efficacy|2
2967720|NCT01180790|10213947|P1|Overall Study|Lack of Efficacy|1
2967721|NCT01180790|10213941|P7|Overall Study|Physician Decision|0
2967722|NCT01180790|10213942|P6|Overall Study|Physician Decision|0
2967723|NCT01180790|10213943|P5|Overall Study|Physician Decision|0
2967724|NCT01180790|10213944|P4|Overall Study|Physician Decision|1
2967725|NCT01180790|10213945|P3|Overall Study|Physician Decision|0
2967726|NCT01180790|10213946|P2|Overall Study|Physician Decision|0
2967727|NCT01180790|10213947|P1|Overall Study|Physician Decision|1
2967728|NCT01180790|10213941|P7|Overall Study|Lost to Follow-up|1
2967729|NCT01180790|10213942|P6|Overall Study|Lost to Follow-up|0
2967730|NCT01180790|10213943|P5|Overall Study|Lost to Follow-up|1
2967731|NCT01180790|10213944|P4|Overall Study|Lost to Follow-up|2
2967732|NCT01180790|10213945|P3|Overall Study|Lost to Follow-up|0
2967733|NCT01180790|10213946|P2|Overall Study|Lost to Follow-up|1
2967734|NCT01180790|10213947|P1|Overall Study|Lost to Follow-up|3
2967735|NCT01180790|10213941|P7|Overall Study|Withdrawal by Subject|0
2967736|NCT01180790|10213942|P6|Overall Study|Withdrawal by Subject|1
2967737|NCT01180790|10213943|P5|Overall Study|Withdrawal by Subject|2
2967738|NCT01180790|10213944|P4|Overall Study|Withdrawal by Subject|0
2967739|NCT01180790|10213945|P3|Overall Study|Withdrawal by Subject|5
2967740|NCT01180790|10213946|P2|Overall Study|Withdrawal by Subject|0
2967741|NCT01180790|10213947|P1|Overall Study|Withdrawal by Subject|3
2967742|NCT01180790|10213941|P7|Overall Study|Adverse Event|0
2967743|NCT01180790|10213942|P6|Overall Study|Adverse Event|3
2967744|NCT01180790|10213943|P5|Overall Study|Adverse Event|1
2967745|NCT01180790|10213944|P4|Overall Study|Adverse Event|0
2967746|NCT01180790|10213945|P3|Overall Study|Adverse Event|2
2967747|NCT01180790|10213946|P2|Overall Study|Adverse Event|1
2967748|NCT01180790|10213947|P1|Overall Study|Adverse Event|1
2967749|NCT01180777|10214012|P1|Overall Study|Adverse Event|1
2967750|NCT01180777|10214012|P1|Overall Study|Lost to Follow-up|1
2967751|NCT01180777|10214012|P1|Overall Study|Poor lens fit|4
2967752|NCT01180777|10214012|P1|Overall Study|Protocol Violation|6
2967753|NCT01180660|10214026|P2|Overall Study|Changed to open surgery|0
2967754|NCT01180660|10214027|P1|Overall Study|Changed to open surgery|1
2967755|NCT01180647|10214037|P2|Overall Study|Lost to Follow-up|6
2967756|NCT01180647|10214038|P1|Overall Study|Lost to Follow-up|5
2967757|NCT01180400|10214073|P2|Overall Study|Other|1
2967758|NCT01180400|10214074|P1|Overall Study|Other|0
2967759|NCT01180400|10214073|P2|Overall Study|Lost to Follow-up|3
2967760|NCT01180400|10214074|P1|Overall Study|Lost to Follow-up|2
2967849|NCT01179516|10214297|P3|Overall Study|Noncompliance with Study Drug|1
2967761|NCT01180400|10214073|P2|Overall Study|Study-specific withdrawal criteria|2
2967762|NCT01180400|10214074|P1|Overall Study|Study-specific withdrawal criteria|1
2967763|NCT01180400|10214073|P2|Overall Study|Lack of Efficacy|0
2967764|NCT01180400|10214074|P1|Overall Study|Lack of Efficacy|2
2967765|NCT01180400|10214073|P2|Overall Study|Condition under investigation worsened|1
2967766|NCT01180400|10214074|P1|Overall Study|Condition under investigation worsened|2
2967767|NCT01180400|10214073|P2|Overall Study|Severe non-compliance to protocol|2
2967768|NCT01180400|10214074|P1|Overall Study|Severe non-compliance to protocol|1
2967769|NCT01180400|10214073|P2|Overall Study|Adverse Event|10
2967770|NCT01180400|10214074|P1|Overall Study|Adverse Event|12
2967771|NCT01180400|10214073|P2|Overall Study|Eligibility criteria not fulfilled|2
2967772|NCT01180400|10214074|P1|Overall Study|Eligibility criteria not fulfilled|0
2967773|NCT01180400|10214073|P2|Overall Study|Withdrawal by Subject|6
2967774|NCT01180400|10214074|P1|Overall Study|Withdrawal by Subject|5
2967775|NCT01180296|10214122|P2|Overall Study|Protocol Violation|2
2967776|NCT01180296|10214123|P1|Overall Study|Protocol Violation|1
2967777|NCT01180244|10214133|P2|Overall Study|Lost to Follow-up|0
2967778|NCT01180244|10214134|P1|Overall Study|Lost to Follow-up|1
2967779|NCT01180244|10214133|P2|Overall Study|Protocol Violation|0
2967780|NCT01180244|10214134|P1|Overall Study|Protocol Violation|1
2967781|NCT01180244|10214133|P2|Overall Study|Withdrawal by Subject|1
2967782|NCT01180244|10214134|P1|Overall Study|Withdrawal by Subject|0
2967783|NCT01180244|10214133|P2|Overall Study|Adverse Event|0
2967784|NCT01180244|10214134|P1|Overall Study|Adverse Event|1
2967785|NCT01180244|10214133|P2|Overall Study|Physician Decision|0
2967786|NCT01180244|10214134|P1|Overall Study|Physician Decision|3
2967787|NCT01180244|10214133|P2|Overall Study|Lack of Efficacy|7
2967788|NCT01180244|10214134|P1|Overall Study|Lack of Efficacy|0
2967789|NCT01180049|10214179|P2|Overall Study|Death|35
2967790|NCT01180049|10214180|P1|Overall Study|Death|36
2967791|NCT01180049|10214179|P2|Overall Study|Lost to Follow-up|6
2967792|NCT01180049|10214180|P1|Overall Study|Lost to Follow-up|8
2967793|NCT01180049|10214179|P2|Overall Study|Other|7
2967794|NCT01180049|10214180|P1|Overall Study|Other|9
2967795|NCT01179919|10214217|P1|Overall Study|Adverse Event|1
2967796|NCT01179919|10214217|P1|Overall Study|Protocol Violation|1
2967797|NCT01179737|10214226|P4|Extension|The study was terminated|0
2967798|NCT01179737|10214227|P3|Extension|The study was terminated|0
2967799|NCT01179737|10214228|P2|Extension|The study was terminated|0
2967800|NCT01179737|10214229|P1|Extension|The study was terminated|3
2967801|NCT01179737|10214226|P4|Cohort 1 & Cohort 2 Expansion|Death|0
2967802|NCT01179737|10214227|P3|Cohort 1 & Cohort 2 Expansion|Death|0
2967803|NCT01179737|10214228|P2|Cohort 1 & Cohort 2 Expansion|Death|0
2967804|NCT01179737|10214229|P1|Cohort 1 & Cohort 2 Expansion|Death|1
2967805|NCT01179737|10214226|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2967806|NCT01179737|10214227|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2967807|NCT01179737|10214228|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
2967808|NCT01179737|10214229|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2967809|NCT01179737|10214226|P4|Cohort 1 & Cohort 2|Death|0
2967810|NCT01179737|10214227|P3|Cohort 1 & Cohort 2|Death|1
2967811|NCT01179737|10214228|P2|Cohort 1 & Cohort 2|Death|0
2967812|NCT01179737|10214229|P1|Cohort 1 & Cohort 2|Death|0
2967813|NCT01179737|10214226|P4|Cohort 1 & Cohort 2|Administrative problems|4
2967814|NCT01179737|10214227|P3|Cohort 1 & Cohort 2|Administrative problems|2
2967815|NCT01179737|10214228|P2|Cohort 1 & Cohort 2|Administrative problems|0
2967816|NCT01179737|10214229|P1|Cohort 1 & Cohort 2|Administrative problems|0
2967817|NCT01179737|10214226|P4|Cohort 1 & Cohort 2|Withdrew consent|0
2967818|NCT01179737|10214227|P3|Cohort 1 & Cohort 2|Withdrew consent|0
2967819|NCT01179737|10214228|P2|Cohort 1 & Cohort 2|Withdrew consent|0
2967820|NCT01179737|10214229|P1|Cohort 1 & Cohort 2|Withdrew consent|2
2967821|NCT01179737|10214226|P4|Cohort 1 & Cohort 2|Adverse Event|0
2967822|NCT01179737|10214227|P3|Cohort 1 & Cohort 2|Adverse Event|1
2967823|NCT01179737|10214228|P2|Cohort 1 & Cohort 2|Adverse Event|1
2967824|NCT01179737|10214229|P1|Cohort 1 & Cohort 2|Adverse Event|3
2967825|NCT01179672|10214240|P2|Overall Study|Physician Decision|1
2967826|NCT01179672|10214241|P1|Overall Study|Physician Decision|1
2967827|NCT01179672|10214240|P2|Overall Study|Protocol Violation|2
2967828|NCT01179672|10214241|P1|Overall Study|Protocol Violation|2
2967829|NCT01179672|10214240|P2|Overall Study|Lost to Follow-up|1
2967830|NCT01179672|10214241|P1|Overall Study|Lost to Follow-up|0
2967831|NCT01179672|10214240|P2|Overall Study|Entry Criteria Not Met|2
2967832|NCT01179672|10214241|P1|Overall Study|Entry Criteria Not Met|0
2967833|NCT01179672|10214240|P2|Overall Study|Withdrawal by Subject|12
2967834|NCT01179672|10214241|P1|Overall Study|Withdrawal by Subject|10
2967835|NCT01179672|10214240|P2|Overall Study|Adverse Event|8
2967836|NCT01179672|10214241|P1|Overall Study|Adverse Event|17
2967837|NCT01179516|10214297|P3|Overall Study|Other|2
2967838|NCT01179516|10214298|P2|Overall Study|Other|0
2967839|NCT01179516|10214299|P1|Overall Study|Other|2
2967840|NCT01179516|10214297|P3|Overall Study|Lost to Follow-up|3
2967841|NCT01179516|10214298|P2|Overall Study|Lost to Follow-up|7
2967842|NCT01179516|10214299|P1|Overall Study|Lost to Follow-up|7
2967843|NCT01179516|10214297|P3|Overall Study|Withdrawal of Consent|10
2967844|NCT01179516|10214298|P2|Overall Study|Withdrawal of Consent|6
2967845|NCT01179516|10214299|P1|Overall Study|Withdrawal of Consent|2
2967846|NCT01179516|10214297|P3|Overall Study|Protocol Deviations|3
2967847|NCT01179516|10214298|P2|Overall Study|Protocol Deviations|3
2967848|NCT01179516|10214299|P1|Overall Study|Protocol Deviations|4
2967850|NCT01179516|10214298|P2|Overall Study|Noncompliance with Study Drug|0
2967851|NCT01179516|10214299|P1|Overall Study|Noncompliance with Study Drug|2
2967852|NCT01179516|10214297|P3|Overall Study|Lack of Efficacy|0
2967853|NCT01179516|10214298|P2|Overall Study|Lack of Efficacy|2
2967854|NCT01179516|10214299|P1|Overall Study|Lack of Efficacy|4
2967855|NCT01179516|10214297|P3|Overall Study|Pretreatment Event or Adverse Event|12
2967856|NCT01179516|10214298|P2|Overall Study|Pretreatment Event or Adverse Event|8
2967857|NCT01179516|10214299|P1|Overall Study|Pretreatment Event or Adverse Event|6
2967858|NCT01179477|10214343|P1|Overall Study|Did not complete final visit|27
2967859|NCT01179477|10214343|P1|Overall Study|Non-death withdrawal|438
2967860|NCT01179477|10214343|P1|Overall Study|Unsuccessful implant|80
2967861|NCT01179477|10214343|P1|Overall Study|Death|542
2967862|NCT01179399|10214348|P1|Overall Study|Withdrawal by Subject|1
2967863|NCT01179399|10214348|P1|Overall Study|Lack of Efficacy|30
2967864|NCT01179399|10214348|P1|Overall Study|Adverse Event|1
2967865|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Other|4
2967866|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Other|7
2967867|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Protocol Violation|0
2967868|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Protocol Violation|1
2967869|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2967870|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2967871|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
2967872|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
2967873|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
2967874|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
2967875|NCT01179347|10214354|P2|Open-label Period (12 Weeks)|Adverse Event|9
2967876|NCT01179347|10214355|P1|Open-label Period (12 Weeks)|Adverse Event|5
2967877|NCT01179347|10214354|P2|Double-blind Period (12 Weeks)|Other|4
2967878|NCT01179347|10214355|P1|Double-blind Period (12 Weeks)|Other|2
2967879|NCT01179347|10214354|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
2967880|NCT01179347|10214355|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
2967881|NCT01179347|10214354|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
2967882|NCT01179347|10214355|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
2967883|NCT01179347|10214354|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
2967884|NCT01179347|10214355|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
2967885|NCT01179347|10214354|P2|Double-blind Period (12 Weeks)|Adverse Event|6
2967886|NCT01179347|10214355|P1|Double-blind Period (12 Weeks)|Adverse Event|2
2967887|NCT01179334|10214377|P2|Long-term Extension (LTE) Period|Adverse Event|4
2967888|NCT01179334|10214378|P1|Long-term Extension (LTE) Period|Adverse Event|2
2967889|NCT01179334|10214377|P2|Long-term Extension (LTE) Period|Death|0
2967890|NCT01179334|10214378|P1|Long-term Extension (LTE) Period|Death|3
2967891|NCT01179334|10214377|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
2967892|NCT01179334|10214378|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
2967893|NCT01179334|10214377|P2|Treatment Period|Adverse Event|0
2967894|NCT01179334|10214378|P1|Treatment Period|Adverse Event|1
2967895|NCT01179191|10214433|P1|Maintenance Phase (8 Weeks)|Other|66
2967896|NCT01179191|10214433|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
2967897|NCT01179191|10214433|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
2967898|NCT01179191|10214433|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
2967899|NCT01179191|10214433|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
2967900|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Other|62
2967901|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
2967902|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
2967903|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
2967904|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
2967905|NCT01179191|10214433|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
2967906|NCT01179048|10214465|P2|Overall Study|Alive|142
2967907|NCT01179048|10214466|P1|Overall Study|Alive|127
2967908|NCT01179048|10214465|P2|Overall Study|Lost to Follow-up|9
2967909|NCT01179048|10214466|P1|Overall Study|Lost to Follow-up|8
2967910|NCT01179048|10214465|P2|Overall Study|Withdrawn - does not allow contact|8
2967911|NCT01179048|10214466|P1|Overall Study|Withdrawn - does not allow contact|4
2967912|NCT01178853|10214493|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
2967913|NCT01178853|10214494|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
2967914|NCT01178853|10214493|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
2967915|NCT01178853|10214494|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
2967916|NCT01178853|10214493|P2|Period 3 (Warfarin Titration)|Adverse Event|0
2967917|NCT01178853|10214494|P1|Period 3 (Warfarin Titration)|Adverse Event|1
2967918|NCT01178853|10214493|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
2967919|NCT01178853|10214494|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
2967920|NCT01178853|10214493|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
2967921|NCT01178853|10214494|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
2967922|NCT01178762|10214534|P1|Overall Study|Lost to Follow-up|15
2967923|NCT01178671|10214540|P2|Overall Study|Physician Decision|6
2967924|NCT01178671|10214541|P1|Overall Study|Physician Decision|4
2967925|NCT01178671|10214540|P2|Overall Study|Lost to Follow-up|1
2967926|NCT01178671|10214541|P1|Overall Study|Lost to Follow-up|3
2967927|NCT01178671|10214540|P2|Overall Study|Lack of Efficacy|1
2967928|NCT01178671|10214541|P1|Overall Study|Lack of Efficacy|0
2967929|NCT01178671|10214540|P2|Overall Study|Protocol Violation|1
2967930|NCT01178671|10214541|P1|Overall Study|Protocol Violation|1
2967931|NCT01178671|10214540|P2|Overall Study|Adverse Event|6
2967932|NCT01178671|10214541|P1|Overall Study|Adverse Event|4
2967933|NCT01178385|10214589|P2|Overall Study|Withdrawal by Subject|0
2967934|NCT01178385|10214590|P1|Overall Study|Withdrawal by Subject|2
2967935|NCT01178294|10214659|P1|Overall Study|Completion status could not be verified|1
2967936|NCT01178294|10214659|P1|Overall Study|Subject status is terminal|1
2967937|NCT01178294|10214659|P1|Overall Study|Development of inhibitors to OBI-1|1
2967938|NCT01178294|10214659|P1|Overall Study|Death|1
2967939|NCT01178294|10214659|P1|Overall Study|Lack of Efficacy|1
2967940|NCT01178294|10214659|P1|Overall Study|Lost to Follow-up|2
2967941|NCT01178294|10214659|P1|Overall Study|Adverse Event|4
2967942|NCT01178138|10214939|P1|Overall Study|Physician Decision|8
2967943|NCT01178138|10214939|P1|Overall Study|Withdrawal by Subject|7
2967944|NCT01178138|10214939|P1|Overall Study|Lost to Follow-up|8
2967945|NCT01178125|10214960|P1|Overall Study|Investigator Decision|5
2967946|NCT01178125|10214960|P1|Overall Study|Protocol Violation|17
2967947|NCT01178125|10214960|P1|Overall Study|Sponsor Decision|28
2967948|NCT01178125|10214960|P1|Overall Study|Other Reason|39
2967949|NCT01178125|10214960|P1|Overall Study|Pregnancy|55
2967950|NCT01178125|10214960|P1|Overall Study|Noncompliance|184
2967951|NCT01178125|10214960|P1|Overall Study|Withdrawal by Subject|209
2967952|NCT01178125|10214960|P1|Overall Study|Adverse Event|244
2967953|NCT01178125|10214960|P1|Overall Study|Lost to Follow-up|397
2967954|NCT01178099|10214991|P2|Overall Study|Physician Decision|1
2967955|NCT01178099|10214992|P1|Overall Study|Physician Decision|0
2967956|NCT01178086|10215032|P1|Overall Study|Excluded from EAS|20
2967957|NCT01178086|10215032|P1|Overall Study|Other unspecified|89
2967958|NCT01178086|10215032|P1|Overall Study|Death|59
2967959|NCT01178086|10215032|P1|Overall Study|Switch to other CLL therapy|113
2967960|NCT01178086|10215032|P1|Overall Study|Physician Decision|44
2967961|NCT01178086|10215032|P1|Overall Study|Participant refusal|7
2967962|NCT01178073|10215059|P3|Overall Study|Missing Completion Status|0
2967963|NCT01178073|10215060|P2|Overall Study|Missing Completion Status|0
2967964|NCT01178073|10215061|P1|Overall Study|Missing Completion Status|1
2967965|NCT01178073|10215059|P3|Overall Study|Withdrawal by Subject|8
2967966|NCT01178073|10215060|P2|Overall Study|Withdrawal by Subject|6
2967967|NCT01178073|10215061|P1|Overall Study|Withdrawal by Subject|10
2967968|NCT01178073|10215059|P3|Overall Study|Physician Decision|10
2967969|NCT01178073|10215060|P2|Overall Study|Physician Decision|10
2967970|NCT01178073|10215061|P1|Overall Study|Physician Decision|14
2967971|NCT01178073|10215059|P3|Overall Study|Lost to Follow-up|3
2967972|NCT01178073|10215060|P2|Overall Study|Lost to Follow-up|0
2967973|NCT01178073|10215061|P1|Overall Study|Lost to Follow-up|2
2967974|NCT01178073|10215059|P3|Overall Study|Protocol Violation|1
2967975|NCT01178073|10215060|P2|Overall Study|Protocol Violation|1
2967976|NCT01178073|10215061|P1|Overall Study|Protocol Violation|1
2967977|NCT01178073|10215059|P3|Overall Study|Adverse Event|24
2967978|NCT01178073|10215060|P2|Overall Study|Adverse Event|27
2967979|NCT01178073|10215061|P1|Overall Study|Adverse Event|34
2967980|NCT01177969|10215092|P2|Overall Study|Withdrawal by Subject|2
2967981|NCT01177969|10215093|P1|Overall Study|Withdrawal by Subject|1
2967982|NCT01177969|10215092|P2|Overall Study|Protocol Violation|1
2967983|NCT01177969|10215093|P1|Overall Study|Protocol Violation|2
2967984|NCT01177943|10215116|P2|First Intervention|Withdrawal by Subject|0
2967985|NCT01177943|10215117|P1|First Intervention|Withdrawal by Subject|2
2967986|NCT01177813|10215130|P5|Overall Study|Other reason not defined above|2
2967987|NCT01177813|10215131|P4|Overall Study|Other reason not defined above|3
2967988|NCT01177813|10215132|P3|Overall Study|Other reason not defined above|2
2967989|NCT01177813|10215133|P2|Overall Study|Other reason not defined above|2
2967990|NCT01177813|10215134|P1|Overall Study|Other reason not defined above|5
2967991|NCT01177813|10215130|P5|Overall Study|Withdrawal by Subject|3
2967992|NCT01177813|10215131|P4|Overall Study|Withdrawal by Subject|5
2967993|NCT01177813|10215132|P3|Overall Study|Withdrawal by Subject|6
2967994|NCT01177813|10215133|P2|Overall Study|Withdrawal by Subject|7
2967995|NCT01177813|10215134|P1|Overall Study|Withdrawal by Subject|12
2967996|NCT01177813|10215130|P5|Overall Study|Lost to Follow-up|0
2967997|NCT01177813|10215131|P4|Overall Study|Lost to Follow-up|3
2967998|NCT01177813|10215132|P3|Overall Study|Lost to Follow-up|6
2967999|NCT01177813|10215133|P2|Overall Study|Lost to Follow-up|5
2968000|NCT01177813|10215134|P1|Overall Study|Lost to Follow-up|12
2968001|NCT01177813|10215130|P5|Overall Study|Protocol Violation|1
2968002|NCT01177813|10215131|P4|Overall Study|Protocol Violation|0
2968003|NCT01177813|10215132|P3|Overall Study|Protocol Violation|2
2968004|NCT01177813|10215133|P2|Overall Study|Protocol Violation|2
2968005|NCT01177813|10215134|P1|Overall Study|Protocol Violation|3
2968006|NCT01177813|10215130|P5|Overall Study|Lack of Efficacy|0
2968007|NCT01177813|10215131|P4|Overall Study|Lack of Efficacy|0
2968008|NCT01177813|10215132|P3|Overall Study|Lack of Efficacy|0
2968009|NCT01177813|10215133|P2|Overall Study|Lack of Efficacy|0
2968010|NCT01177813|10215134|P1|Overall Study|Lack of Efficacy|1
2968011|NCT01177813|10215130|P5|Overall Study|Adverse Event|3
2968012|NCT01177813|10215131|P4|Overall Study|Adverse Event|6
2968013|NCT01177813|10215132|P3|Overall Study|Adverse Event|4
2968014|NCT01177813|10215133|P2|Overall Study|Adverse Event|2
2968015|NCT01177813|10215134|P1|Overall Study|Adverse Event|8
2968016|NCT01177800|10215163|P2|Overall Study|Withdrawal of informed consent|1
2968017|NCT01177800|10215164|P1|Overall Study|Withdrawal of informed consent|0
2968018|NCT01177800|10215163|P2|Overall Study|Physician Decision|0
2968019|NCT01177800|10215164|P1|Overall Study|Physician Decision|1
2968020|NCT01177800|10215163|P2|Overall Study|Protocol Violation|1
2968021|NCT01177800|10215164|P1|Overall Study|Protocol Violation|0
2968022|NCT01177800|10215163|P2|Overall Study|Adverse Event|3
2968023|NCT01177800|10215164|P1|Overall Study|Adverse Event|9
2968024|NCT01177722|10215186|P4|Overall Study|Withdrawal by Subject|6
2968025|NCT01177722|10215187|P3|Overall Study|Withdrawal by Subject|4
2968026|NCT01177722|10215188|P2|Overall Study|Withdrawal by Subject|6
2968027|NCT01177722|10215189|P1|Overall Study|Withdrawal by Subject|10
2968028|NCT01177722|10215186|P4|Overall Study|Lost to Follow-up|1
2968029|NCT01177722|10215187|P3|Overall Study|Lost to Follow-up|3
2968030|NCT01177722|10215188|P2|Overall Study|Lost to Follow-up|4
2968031|NCT01177722|10215189|P1|Overall Study|Lost to Follow-up|3
2968032|NCT01177722|10215186|P4|Overall Study|Protocol Violation|0
2968033|NCT01177722|10215187|P3|Overall Study|Protocol Violation|1
2968034|NCT01177722|10215188|P2|Overall Study|Protocol Violation|0
2968035|NCT01177722|10215189|P1|Overall Study|Protocol Violation|0
2968036|NCT01177722|10215186|P4|Overall Study|Serious Adverse Event|0
2968037|NCT01177722|10215187|P3|Overall Study|Serious Adverse Event|1
2968038|NCT01177722|10215188|P2|Overall Study|Serious Adverse Event|0
2968039|NCT01177722|10215189|P1|Overall Study|Serious Adverse Event|0
2968040|NCT01177670|10215221|P1|Overall Study|Withdrawal by Subject|4
2968041|NCT01177670|10215221|P1|Overall Study|Physician Decision|50
2968042|NCT01177670|10215221|P1|Overall Study|Study Terminated|115
2968043|NCT01177553|10215228|P2|Overall Study|babies not yet 6 months of age|0
2968044|NCT01177553|10215229|P1|Overall Study|babies not yet 6 months of age|1
2968045|NCT01177410|10215238|P3|Overall Study|Lost to Follow-up|0
2968046|NCT01177410|10215239|P2|Overall Study|Lost to Follow-up|1
2968047|NCT01177410|10215240|P1|Overall Study|Lost to Follow-up|0
2968048|NCT01177410|10215238|P3|Overall Study|Withdrawal by Subject|3
2968049|NCT01177410|10215239|P2|Overall Study|Withdrawal by Subject|4
2968050|NCT01177410|10215240|P1|Overall Study|Withdrawal by Subject|1
2968051|NCT01177410|10215238|P3|Overall Study|Adverse Event|2
2968052|NCT01177410|10215239|P2|Overall Study|Adverse Event|2
2968053|NCT01177410|10215240|P1|Overall Study|Adverse Event|0
2968054|NCT01177384|10215253|P2|Overall Study|Withdrawal by Subject|12
2968055|NCT01177384|10215254|P1|Overall Study|Withdrawal by Subject|5
2968056|NCT01177384|10215253|P2|Overall Study|Protocol Violation|2
2968057|NCT01177384|10215254|P1|Overall Study|Protocol Violation|0
2968058|NCT01177384|10215253|P2|Overall Study|Physician Decision|3
2968059|NCT01177384|10215254|P1|Overall Study|Physician Decision|0
2968060|NCT01177384|10215253|P2|Overall Study|Lost to Follow-up|4
2968061|NCT01177384|10215254|P1|Overall Study|Lost to Follow-up|3
2968062|NCT01177384|10215253|P2|Overall Study|Lack of Efficacy|1
2968063|NCT01177384|10215254|P1|Overall Study|Lack of Efficacy|0
2968064|NCT01177384|10215253|P2|Overall Study|Adverse Event|4
2968065|NCT01177384|10215254|P1|Overall Study|Adverse Event|6
2968066|NCT01177293|10215266|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
2968067|NCT01177293|10215267|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
2968068|NCT01177228|10215285|P4|Overall Study|Withdrawal by Subject|0
2968069|NCT01177228|10215286|P3|Overall Study|Withdrawal by Subject|0
2968070|NCT01177228|10215287|P2|Overall Study|Withdrawal by Subject|1
2968071|NCT01177228|10215288|P1|Overall Study|Withdrawal by Subject|0
2968072|NCT01177228|10215285|P4|Overall Study|Worsening disease activity|0
2968073|NCT01177228|10215286|P3|Overall Study|Worsening disease activity|0
2968074|NCT01177228|10215287|P2|Overall Study|Worsening disease activity|0
2968075|NCT01177228|10215288|P1|Overall Study|Worsening disease activity|1
2968076|NCT01177228|10215285|P4|Overall Study|Positive tuberculosis test|0
2968077|NCT01177228|10215286|P3|Overall Study|Positive tuberculosis test|0
2968078|NCT01177228|10215287|P2|Overall Study|Positive tuberculosis test|1
2968079|NCT01177228|10215288|P1|Overall Study|Positive tuberculosis test|0
2968080|NCT01177137|10215342|P3|Overall Study|Withdrawal by Subject|2
2968081|NCT01177137|10215343|P2|Overall Study|Withdrawal by Subject|10
2968082|NCT01177137|10215344|P1|Overall Study|Withdrawal by Subject|10
2968083|NCT01177059|10215428|P1|Overall Study|Lost to Follow-up|18
2968084|NCT01177059|10215428|P1|Overall Study|Withdrew consent|2
2968085|NCT01177059|10215428|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
2968086|NCT01177007|10215434|P1|Overall Study|Change in treatment modality|21
2968087|NCT01177007|10215434|P1|Overall Study|Required additional Y90 treatment|6
2968088|NCT01177007|10215434|P1|Overall Study|Entered hospice care|5
2968089|NCT01177007|10215434|P1|Overall Study|Death|4
2968090|NCT01177007|10215434|P1|Overall Study|Lost to Follow-up|2
2968091|NCT01176968|10215448|P2|Overall Study|Reason not defined|3
2968092|NCT01176968|10215449|P1|Overall Study|Reason not defined|5
2968093|NCT01176968|10215448|P2|Overall Study|Study terminated by sponsor|1
2968094|NCT01176968|10215449|P1|Overall Study|Study terminated by sponsor|0
2968095|NCT01176968|10215448|P2|Overall Study|Did Not Meet Entrance Criteria|0
2968096|NCT01176968|10215449|P1|Overall Study|Did Not Meet Entrance Criteria|1
2968097|NCT01176968|10215448|P2|Overall Study|Protocol Violation|1
2968098|NCT01176968|10215449|P1|Overall Study|Protocol Violation|2
2968099|NCT01176968|10215448|P2|Overall Study|Withdrawal by Subject|48
2968100|NCT01176968|10215449|P1|Overall Study|Withdrawal by Subject|48
2968101|NCT01176968|10215448|P2|Overall Study|Lost to Follow-up|14
2968102|NCT01176968|10215449|P1|Overall Study|Lost to Follow-up|16
2968103|NCT01176968|10215448|P2|Overall Study|Lack of Efficacy|1
2968104|NCT01176968|10215449|P1|Overall Study|Lack of Efficacy|0
2968105|NCT01176968|10215448|P2|Overall Study|Death|3
2968106|NCT01176968|10215449|P1|Overall Study|Death|2
2968107|NCT01176968|10215448|P2|Overall Study|Adverse Event|11
2968108|NCT01176968|10215449|P1|Overall Study|Adverse Event|10
2968109|NCT01176773|10215500|P1|Overall Study|Withdrew consent|1
2968110|NCT01176773|10215500|P1|Overall Study|Screen Failure|2
2968111|NCT01176565|10215524|P2|Overall Study|Not Analyzed (any other reason)|2
2968112|NCT01176565|10215525|P1|Overall Study|Not Analyzed (any other reason)|1
2968113|NCT01176565|10215524|P2|Overall Study|Withdrawal by Subject|1
2968114|NCT01176565|10215525|P1|Overall Study|Withdrawal by Subject|7
2968115|NCT01176565|10215524|P2|Overall Study|Lost to Follow-up|16
2968116|NCT01176565|10215525|P1|Overall Study|Lost to Follow-up|12
2968117|NCT01176513|10215543|P1|Overall Study|Withdrew subjects prior to dosing|3
2968118|NCT01176292|10215571|P2|Overall Study|Has not scheduled one-year visit yet|2
2968119|NCT01176292|10215572|P1|Overall Study|Has not scheduled one-year visit yet|2
2968120|NCT01176292|10215571|P2|Overall Study|Physician Decision|2
2968121|NCT01176292|10215572|P1|Overall Study|Physician Decision|0
2968122|NCT01176292|10215571|P2|Overall Study|Adverse Event|1
2968123|NCT01176292|10215572|P1|Overall Study|Adverse Event|1
2968124|NCT01176292|10215571|P2|Overall Study|Lost to Follow-up|4
2968125|NCT01176292|10215572|P1|Overall Study|Lost to Follow-up|2
2968126|NCT01176266|10215590|P1|Overall Study|Withdrawal by Subject|3
2968127|NCT01176266|10215590|P1|Overall Study|Death|6
2968128|NCT01176240|10215614|P2|Study 306B|withdrew prior to dosing|1
2968129|NCT01176240|10215615|P1|Study 306B|withdrew prior to dosing|2
2968130|NCT01176240|10215614|P2|Study 306B|Lost to Follow-up|1
2968131|NCT01176240|10215615|P1|Study 306B|Lost to Follow-up|0
2968132|NCT01176240|10215614|P2|Study 306B|Supine Hypertension|2
2968133|NCT01176240|10215615|P1|Study 306B|Supine Hypertension|1
2968134|NCT01176240|10215614|P2|Study 306B|Physician Decision|1
2968135|NCT01176240|10215615|P1|Study 306B|Physician Decision|2
2968136|NCT01176240|10215614|P2|Study 306B|Withdrawal by Subject|1
2968137|NCT01176240|10215615|P1|Study 306B|Withdrawal by Subject|4
2968138|NCT01176240|10215614|P2|Study 306B|Protocol Violation|3
2968139|NCT01176240|10215615|P1|Study 306B|Protocol Violation|2
2968140|NCT01176240|10215614|P2|Study 306B|Adverse Event|5
2968141|NCT01176240|10215615|P1|Study 306B|Adverse Event|10
2968142|NCT01176240|10215614|P2|Study 306B|Lack of Efficacy|3
2968143|NCT01176240|10215615|P1|Study 306B|Lack of Efficacy|5
2968144|NCT01176240|10215614|P2|Study 306A|Stop due to diverse problems|0
2968145|NCT01176240|10215615|P1|Study 306A|Stop due to diverse problems|1
2968146|NCT01176240|10215614|P2|Study 306A|Withdrawal by Subject|1
2968147|NCT01176240|10215615|P1|Study 306A|Withdrawal by Subject|0
2968148|NCT01176240|10215614|P2|Study 306A|Protocol Violation|1
2968149|NCT01176240|10215615|P1|Study 306A|Protocol Violation|0
2968150|NCT01176240|10215614|P2|Study 306A|Lack of Efficacy|1
2968151|NCT01176240|10215615|P1|Study 306A|Lack of Efficacy|2
2968152|NCT01176058|10215641|P2|Overall Study|Withdrawal by Subject|0
2968153|NCT01176058|10215642|P1|Overall Study|Withdrawal by Subject|1
2968154|NCT01176058|10215641|P2|Overall Study|Insufficient mycological response|1
2968155|NCT01176058|10215642|P1|Overall Study|Insufficient mycological response|0
2968156|NCT01176058|10215641|P2|Overall Study|Insufficient clinical response|2
2968157|NCT01176058|10215642|P1|Overall Study|Insufficient clinical response|2
2968158|NCT01176058|10215641|P2|Overall Study|Adverse Event|0
2968159|NCT01176058|10215642|P1|Overall Study|Adverse Event|1
2968160|NCT01176032|10215666|P2|Overall Study|Other|0
2968161|NCT01176032|10215667|P1|Overall Study|Other|1
2968162|NCT01176032|10215666|P2|Overall Study|Informed consent withdrawn|0
2968163|NCT01176032|10215667|P1|Overall Study|Informed consent withdrawn|3
2968164|NCT01176032|10215666|P2|Overall Study|Protocol Violation|0
2968165|NCT01176032|10215667|P1|Overall Study|Protocol Violation|1
2968166|NCT01176032|10215666|P2|Overall Study|Unsatisfactory therapeutic effect|1
2968167|NCT01176032|10215667|P1|Overall Study|Unsatisfactory therapeutic effect|0
2968168|NCT01176032|10215666|P2|Overall Study|Adverse Event|0
2968169|NCT01176032|10215667|P1|Overall Study|Adverse Event|1
2968170|NCT01175824|10215791|P2|Overall Study|Entry Criteria Not Met|4
2968171|NCT01175824|10215792|P1|Overall Study|Entry Criteria Not Met|6
2968172|NCT01175824|10215791|P2|Overall Study|Sponsor Decision|0
2968173|NCT01175824|10215792|P1|Overall Study|Sponsor Decision|1
2968174|NCT01175824|10215791|P2|Overall Study|Withdrawal by Subject|7
2968175|NCT01175824|10215792|P1|Overall Study|Withdrawal by Subject|3
2968176|NCT01175824|10215791|P2|Overall Study|Protocol Violation|5
2968177|NCT01175824|10215792|P1|Overall Study|Protocol Violation|2
2968178|NCT01175824|10215791|P2|Overall Study|Physician Decision|4
2968179|NCT01175824|10215792|P1|Overall Study|Physician Decision|0
2968180|NCT01175824|10215791|P2|Overall Study|Lost to Follow-up|1
2968181|NCT01175824|10215792|P1|Overall Study|Lost to Follow-up|0
2968182|NCT01175824|10215791|P2|Overall Study|Lack of Efficacy|0
2968183|NCT01175824|10215792|P1|Overall Study|Lack of Efficacy|2
2968184|NCT01175824|10215791|P2|Overall Study|Adverse Event|1
2968185|NCT01175824|10215792|P1|Overall Study|Adverse Event|2
2968186|NCT01175811|10215826|P2|Overall Study|Withdrawal by Subject|7
2968187|NCT01175811|10215827|P1|Overall Study|Withdrawal by Subject|6
2968188|NCT01175811|10215826|P2|Overall Study|Protocol Violation|2
2968189|NCT01175811|10215827|P1|Overall Study|Protocol Violation|1
2968190|NCT01175811|10215826|P2|Overall Study|Physician Decision|1
2968191|NCT01175811|10215827|P1|Overall Study|Physician Decision|1
2968192|NCT01175811|10215826|P2|Overall Study|Lost to Follow-up|2
2968193|NCT01175811|10215827|P1|Overall Study|Lost to Follow-up|3
2968194|NCT01175811|10215826|P2|Overall Study|Lack of Efficacy|0
2968195|NCT01175811|10215827|P1|Overall Study|Lack of Efficacy|1
2968196|NCT01175811|10215826|P2|Overall Study|Entry criteria not met|1
2968197|NCT01175811|10215827|P1|Overall Study|Entry criteria not met|3
2968198|NCT01175811|10215826|P2|Overall Study|Adverse Event|1
2968199|NCT01175811|10215827|P1|Overall Study|Adverse Event|1
2968200|NCT01175707|10215862|P2|Overall Study|Adverse Event|6
2968201|NCT01175707|10215863|P1|Overall Study|Adverse Event|4
2968202|NCT01175668|10215899|P2|Overall Study|Withdrawal by Subject|0
2968203|NCT01175668|10215900|P1|Overall Study|Withdrawal by Subject|2
2968204|NCT01175590|10215910|P2|Overall Study|Protocol Violation|1
2968205|NCT01175590|10215911|P1|Overall Study|Protocol Violation|0
2968206|NCT01175590|10215910|P2|Overall Study|Herpes Simplex Dermatitis|0
2968207|NCT01175590|10215911|P1|Overall Study|Herpes Simplex Dermatitis|1
2968208|NCT01175590|10215910|P2|Overall Study|Treated not as randomized|2
2968209|NCT01175590|10215911|P1|Overall Study|Treated not as randomized|3
2968210|NCT01175590|10215910|P2|Overall Study|Residual Bacterial Conjunctivitis|0
2968211|NCT01175590|10215911|P1|Overall Study|Residual Bacterial Conjunctivitis|1
2968212|NCT01175590|10215910|P2|Overall Study|Lack of Efficacy|1
2968213|NCT01175590|10215911|P1|Overall Study|Lack of Efficacy|1
2968214|NCT01175590|10215910|P2|Overall Study|Physician Decision|4
2968215|NCT01175590|10215911|P1|Overall Study|Physician Decision|1
2968216|NCT01175590|10215910|P2|Overall Study|Adverse Event|0
2968217|NCT01175590|10215911|P1|Overall Study|Adverse Event|4
2968218|NCT01175590|10215910|P2|Overall Study|Withdrawal by Subject|2
2968219|NCT01175590|10215911|P1|Overall Study|Withdrawal by Subject|0
2968220|NCT01175590|10215910|P2|Overall Study|Lost to Follow-up|0
2968221|NCT01175590|10215911|P1|Overall Study|Lost to Follow-up|1
2968222|NCT01175473|10215945|P2|Overall Study|Adverse Event|2
2968223|NCT01175473|10215946|P1|Overall Study|Adverse Event|2
2968224|NCT01175382|10215987|P3|Overall Study|Unable to tolerate study meds|1
2968225|NCT01175382|10215988|P2|Overall Study|Unable to tolerate study meds|1
2968226|NCT01175382|10215989|P1|Overall Study|Unable to tolerate study meds|0
2968227|NCT01175382|10215987|P3|Overall Study|Unwilling to follow protocol|0
2968228|NCT01175382|10215988|P2|Overall Study|Unwilling to follow protocol|1
2968229|NCT01175382|10215989|P1|Overall Study|Unwilling to follow protocol|0
2968230|NCT01175382|10215987|P3|Overall Study|Unable/unwilling to attend visits|2
2968231|NCT01175382|10215988|P2|Overall Study|Unable/unwilling to attend visits|1
2968232|NCT01175382|10215989|P1|Overall Study|Unable/unwilling to attend visits|3
2968233|NCT01175382|10215987|P3|Overall Study|No longer having problem|1
2968234|NCT01175382|10215988|P2|Overall Study|No longer having problem|0
2968235|NCT01175382|10215989|P1|Overall Study|No longer having problem|1
2968236|NCT01175382|10215987|P3|Overall Study|Withdrawal by Subject|1
2968237|NCT01175382|10215988|P2|Overall Study|Withdrawal by Subject|0
2968238|NCT01175382|10215989|P1|Overall Study|Withdrawal by Subject|0
2968239|NCT01175382|10215987|P3|Overall Study|Physician Decision|0
2968240|NCT01175382|10215988|P2|Overall Study|Physician Decision|1
2968241|NCT01175382|10215989|P1|Overall Study|Physician Decision|0
2968242|NCT01175382|10215987|P3|Overall Study|Lost to Follow-up|1
2968243|NCT01175382|10215988|P2|Overall Study|Lost to Follow-up|3
2968244|NCT01175382|10215989|P1|Overall Study|Lost to Follow-up|4
2968245|NCT01175356|10216075|P1|Overall Study|Initiation other tx prior to completion|9
2968246|NCT01175356|10216075|P1|Overall Study|Inadequate stem cell for transplant|1
2968247|NCT01175356|10216075|P1|Overall Study|On other COG study w/tumor tx intent|7
2968248|NCT01175356|10216075|P1|Overall Study|Pts MIBG non-avid after enrollment|2
2968249|NCT01175356|10216075|P1|Overall Study|Refusal by patient/parent/guardian|6
2968250|NCT01175356|10216075|P1|Overall Study|Treatment Slot Not Available|18
2968251|NCT01175356|10216075|P1|Overall Study|Ineligible|1
2968252|NCT01175356|10216075|P1|Overall Study|Physician Decision|23
2968253|NCT01175356|10216075|P1|Overall Study|Lost to Follow-up|1
2968254|NCT01175356|10216075|P1|Overall Study|Lack of Efficacy|12
2968255|NCT01175356|10216075|P1|Overall Study|Death|1
2968256|NCT01175213|10216115|P2|Safety Follow-up|Adverse Event|0
2968257|NCT01175213|10216116|P1|Safety Follow-up|Adverse Event|1
2968258|NCT01175213|10216115|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
2968259|NCT01175213|10216116|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
2968260|NCT01175213|10216115|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
2968261|NCT01175213|10216116|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
2968262|NCT01175213|10216115|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
2968263|NCT01175213|10216116|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
2968264|NCT01175213|10216115|P2|IGSC, 10%/rHuPH20|Death|0
2968265|NCT01175213|10216116|P1|IGSC, 10%/rHuPH20|Death|1
2968266|NCT01175213|10216115|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
2968267|NCT01175213|10216116|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
2968268|NCT01175135|10216173|P4|Overall Study|Randomized But Not Treated|0
2968269|NCT01175135|10216174|P3|Overall Study|Randomized But Not Treated|1
2968270|NCT01175135|10216175|P2|Overall Study|Randomized But Not Treated|0
2968271|NCT01175135|10216176|P1|Overall Study|Randomized But Not Treated|0
2968272|NCT01175135|10216173|P4|Overall Study|Other|0
2968273|NCT01175135|10216174|P3|Overall Study|Other|3
2968274|NCT01175135|10216175|P2|Overall Study|Other|1
2968275|NCT01175135|10216176|P1|Overall Study|Other|3
2968276|NCT01175135|10216173|P4|Overall Study|Withdrawal by Subject|5
2968277|NCT01175135|10216174|P3|Overall Study|Withdrawal by Subject|5
2968278|NCT01175135|10216175|P2|Overall Study|Withdrawal by Subject|8
2968279|NCT01175135|10216176|P1|Overall Study|Withdrawal by Subject|4
2968280|NCT01175135|10216173|P4|Overall Study|Protocol Violation|0
2968281|NCT01175135|10216174|P3|Overall Study|Protocol Violation|0
2968282|NCT01175135|10216175|P2|Overall Study|Protocol Violation|1
2968283|NCT01175135|10216176|P1|Overall Study|Protocol Violation|1
2968284|NCT01175135|10216173|P4|Overall Study|Lost to Follow-up|0
2968285|NCT01175135|10216174|P3|Overall Study|Lost to Follow-up|0
2968286|NCT01175135|10216175|P2|Overall Study|Lost to Follow-up|2
2968287|NCT01175135|10216176|P1|Overall Study|Lost to Follow-up|1
2968288|NCT01175135|10216173|P4|Overall Study|Lack of Efficacy|5
2968289|NCT01175135|10216174|P3|Overall Study|Lack of Efficacy|0
2968290|NCT01175135|10216175|P2|Overall Study|Lack of Efficacy|5
2968291|NCT01175135|10216176|P1|Overall Study|Lack of Efficacy|4
2968292|NCT01175135|10216173|P4|Overall Study|Death|0
2968293|NCT01175135|10216174|P3|Overall Study|Death|0
2968294|NCT01175135|10216175|P2|Overall Study|Death|0
2968295|NCT01175135|10216176|P1|Overall Study|Death|1
2968296|NCT01175135|10216173|P4|Overall Study|Adverse Event|4
2968297|NCT01175135|10216174|P3|Overall Study|Adverse Event|3
2968298|NCT01175135|10216175|P2|Overall Study|Adverse Event|5
2968299|NCT01175135|10216176|P1|Overall Study|Adverse Event|2
2968300|NCT01175083|10216264|P6|Booster Epoch|Withdrawal by Subject|0
2968301|NCT01175083|10216265|P5|Booster Epoch|Withdrawal by Subject|0
2968302|NCT01175083|10216266|P4|Booster Epoch|Withdrawal by Subject|1
2968303|NCT01175083|10216267|P3|Booster Epoch|Withdrawal by Subject|0
2968304|NCT01175083|10216268|P2|Booster Epoch|Withdrawal by Subject|0
2968305|NCT01175083|10216269|P1|Booster Epoch|Withdrawal by Subject|0
2968306|NCT01175083|10216264|P6|Booster Epoch|Death|0
2968307|NCT01175083|10216265|P5|Booster Epoch|Death|0
2968308|NCT01175083|10216266|P4|Booster Epoch|Death|0
2968309|NCT01175083|10216267|P3|Booster Epoch|Death|1
2968310|NCT01175083|10216268|P2|Booster Epoch|Death|0
2968311|NCT01175083|10216269|P1|Booster Epoch|Death|0
2968312|NCT01175083|10216264|P6|Primary Epoch|Lost to Follow-up|1
2968313|NCT01175083|10216265|P5|Primary Epoch|Lost to Follow-up|0
2968314|NCT01175083|10216266|P4|Primary Epoch|Lost to Follow-up|0
2968315|NCT01175083|10216267|P3|Primary Epoch|Lost to Follow-up|0
2968316|NCT01175083|10216268|P2|Primary Epoch|Lost to Follow-up|0
2968317|NCT01175083|10216269|P1|Primary Epoch|Lost to Follow-up|0
2968318|NCT01175083|10216264|P6|Primary Epoch|Withdrawal by Subject|2
2968319|NCT01175083|10216265|P5|Primary Epoch|Withdrawal by Subject|0
2968320|NCT01175083|10216266|P4|Primary Epoch|Withdrawal by Subject|0
2968321|NCT01175083|10216267|P3|Primary Epoch|Withdrawal by Subject|0
2968322|NCT01175083|10216268|P2|Primary Epoch|Withdrawal by Subject|0
2968323|NCT01175083|10216269|P1|Primary Epoch|Withdrawal by Subject|0
2968324|NCT01175018|10216361|P2|Overall Study|Adverse Event|1
2968325|NCT01175018|10216362|P1|Overall Study|Adverse Event|3
2968326|NCT01174563|10216449|P1|Overall Study|Sponsor's decision|1
2968327|NCT01174563|10216449|P1|Overall Study|Rash Adverse Event|1
2968328|NCT01174563|10216449|P1|Overall Study|Participant Withdrew Consent|3
2968329|NCT01174563|10216449|P1|Overall Study|Investigator's Discretion|5
2968330|NCT01174563|10216449|P1|Overall Study|Death|5
2968331|NCT01174563|10216449|P1|Overall Study|Progressive Disease|45
2968332|NCT01174550|10216457|P2|Overall Study|Withdrawal by Subject|289
2968333|NCT01174550|10216458|P1|Overall Study|Withdrawal by Subject|543
2968334|NCT01174550|10216457|P2|Overall Study|Lost to Follow-up|510
2968335|NCT01174550|10216458|P1|Overall Study|Lost to Follow-up|652
2968336|NCT01174550|10216457|P2|Overall Study|Death|74
2968337|NCT01174550|10216458|P1|Overall Study|Death|75
2968338|NCT01174459|10216486|P1|Overall Study|case report form (CRF) not collected|5
2968339|NCT01174446|10216491|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2968340|NCT01174446|10216492|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2968341|NCT01174446|10216493|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
2968342|NCT01174446|10216494|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2968343|NCT01174446|10216491|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2968344|NCT01174446|10216492|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2968345|NCT01174446|10216493|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2968346|NCT01174446|10216494|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
2968347|NCT01174446|10216491|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2968348|NCT01174446|10216492|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
2968349|NCT01174446|10216493|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2968350|NCT01174446|10216494|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2968351|NCT01174446|10216491|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2968352|NCT01174446|10216492|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
2968353|NCT01174446|10216493|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2968354|NCT01174446|10216494|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2968355|NCT01174368|10216681|P1|Overall Study|Withdrawal by Subject|1
2968356|NCT01174342|10216687|P1|Overall Study|Conversion to cesarean section|4
2968357|NCT01174264|10216694|P3|Steady-state Pharmacokinetics|Not evaluable|2
2968358|NCT01174264|10216695|P2|Steady-state Pharmacokinetics|Not evaluable|0
2968359|NCT01174264|10216696|P1|Steady-state Pharmacokinetics|Not evaluable|6
2968360|NCT01174264|10216694|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
2968361|NCT01174264|10216695|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
2968362|NCT01174264|10216696|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
2968363|NCT01174264|10216694|P3|Single Dose Pharmacokinetics|Early progressive disease|1
2968364|NCT01174264|10216695|P2|Single Dose Pharmacokinetics|Early progressive disease|0
2968365|NCT01174264|10216696|P1|Single Dose Pharmacokinetics|Early progressive disease|1
2968366|NCT01174238|10216728|P1|Overall Study|Lost to Follow-up|2
2968367|NCT01174186|10216739|P2|Overall Study|Withdrawal by Subject|2
2968368|NCT01174186|10216740|P1|Overall Study|Withdrawal by Subject|0
2968369|NCT01174186|10216739|P2|Overall Study|Lost to Follow-up|1
2968370|NCT01174186|10216740|P1|Overall Study|Lost to Follow-up|0
2968371|NCT01174173|10216747|P1|Overall Study|drug-drug interaction|1
2968372|NCT01174160|10216758|P2|Overall Study|Withdrawal by Subject|0
2968373|NCT01174160|10216759|P1|Overall Study|Withdrawal by Subject|1
2968374|NCT01174160|10216758|P2|Overall Study|Protocol Violation|6
2968375|NCT01174160|10216759|P1|Overall Study|Protocol Violation|4
2968376|NCT01174160|10216758|P2|Overall Study|Physician Decision|0
2968377|NCT01174160|10216759|P1|Overall Study|Physician Decision|1
2968378|NCT01174160|10216758|P2|Overall Study|Lost to Follow-up|0
2968379|NCT01174160|10216759|P1|Overall Study|Lost to Follow-up|1
2968380|NCT01174160|10216758|P2|Overall Study|Adverse Event|0
2968381|NCT01174160|10216759|P1|Overall Study|Adverse Event|1
2968382|NCT01174043|10216774|P1|Overall Study|Withdrawal by Subject|2
2968383|NCT01174043|10216774|P1|Overall Study|Death|1
2968384|NCT01174043|10216774|P1|Overall Study|Adverse Event|3
2968385|NCT01174043|10216774|P1|Overall Study|Disease progression|5
2968386|NCT01174004|10216813|P2|Overall Study|Physician Decision|0
2968387|NCT01174004|10216814|P1|Overall Study|Physician Decision|1
2968388|NCT01174004|10216813|P2|Overall Study|Protocol Violation|1
2968389|NCT01174004|10216814|P1|Overall Study|Protocol Violation|0
2968390|NCT01174004|10216813|P2|Overall Study|At Discretion of Sponsor|2
2968391|NCT01174004|10216814|P1|Overall Study|At Discretion of Sponsor|2
2968392|NCT01174004|10216813|P2|Overall Study|Withdrawal by Subject|3
2968393|NCT01174004|10216814|P1|Overall Study|Withdrawal by Subject|2
2968394|NCT01174004|10216813|P2|Overall Study|Adverse Event|10
2968395|NCT01174004|10216814|P1|Overall Study|Adverse Event|2
2968396|NCT01173718|10216845|P1|Overall Study|Abandonment of study graft|27
2968397|NCT01173718|10216845|P1|Overall Study|Death|17
2968398|NCT01173679|10216854|P1|Overall Study|Death|1
2968399|NCT01173653|10216862|P2|Overall Study|Pts unwilling to provide follow-up|41
2968400|NCT01173653|10216863|P1|Overall Study|Pts unwilling to provide follow-up|53
2968401|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
2968402|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2968403|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2968404|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2968405|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2968406|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2968407|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
2968408|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
2968409|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2968410|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2968411|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2968412|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
2968413|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2968414|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
2968415|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2968416|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2968417|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2968418|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2968419|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2968420|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2968421|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2968422|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2968423|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2968424|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2968425|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2968426|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
2968427|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2968428|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
2968429|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
2968430|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2968431|NCT01173601|10216873|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
2968432|NCT01173601|10216874|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
2968433|NCT01173601|10216875|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
2968434|NCT01173601|10216876|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
2968435|NCT01173601|10216877|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2968436|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2968437|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2968438|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2968439|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2968440|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
2968885|NCT01172808|10217511|P4|Overall Study|Lost to Follow-up|3
2968441|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2968442|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2968443|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2968444|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2968445|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
2968446|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2968447|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2968448|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2968449|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2968450|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
2968451|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2968452|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2968453|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2968454|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2968455|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
2968456|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2968457|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2968458|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2968459|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2968460|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
2968461|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2968462|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2968463|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2968464|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2968465|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
2968466|NCT01173601|10216873|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2968467|NCT01173601|10216874|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2968468|NCT01173601|10216875|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2968469|NCT01173601|10216876|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2968470|NCT01173601|10216877|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
2968471|NCT01173523|10216954|P2|Overall Study|Other|3
2968472|NCT01173523|10216955|P1|Overall Study|Other|2
2968473|NCT01173523|10216954|P2|Overall Study|Progressive Disease|8
2968474|NCT01173523|10216955|P1|Overall Study|Progressive Disease|10
2968475|NCT01173523|10216954|P2|Overall Study|Clinical Progression|1
2968476|NCT01173523|10216955|P1|Overall Study|Clinical Progression|1
2968477|NCT01173471|10216971|P4|Overall Study|Reason given as Other|0
2968478|NCT01173471|10216972|P3|Overall Study|Reason given as Other|1
2968479|NCT01173471|10216973|P2|Overall Study|Reason given as Other|0
2968480|NCT01173471|10216974|P1|Overall Study|Reason given as Other|0
2968481|NCT01173471|10216971|P4|Overall Study|Lost to Follow-up|0
2968482|NCT01173471|10216972|P3|Overall Study|Lost to Follow-up|1
2968483|NCT01173471|10216973|P2|Overall Study|Lost to Follow-up|0
2968484|NCT01173471|10216974|P1|Overall Study|Lost to Follow-up|0
2968485|NCT01173471|10216971|P4|Overall Study|Condition under investigation worsened|0
2968486|NCT01173471|10216972|P3|Overall Study|Condition under investigation worsened|0
2968487|NCT01173471|10216973|P2|Overall Study|Condition under investigation worsened|0
2968488|NCT01173471|10216974|P1|Overall Study|Condition under investigation worsened|2
2968489|NCT01173471|10216971|P4|Overall Study|Eligibility criteria not fulfilled|1
2968490|NCT01173471|10216972|P3|Overall Study|Eligibility criteria not fulfilled|1
2968491|NCT01173471|10216973|P2|Overall Study|Eligibility criteria not fulfilled|0
2968492|NCT01173471|10216974|P1|Overall Study|Eligibility criteria not fulfilled|0
2968493|NCT01173120|10217114|P1|Overall Study|Switch-Difficulty With Device|12
2968494|NCT01173120|10217114|P1|Overall Study|Switch-Participant Decision|12
2968495|NCT01173120|10217114|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
2968496|NCT01173120|10217114|P1|Overall Study|Participant Decision|2
2968497|NCT01173120|10217114|P1|Overall Study|Lost to Follow-up|1
2968498|NCT01173120|10217114|P1|Overall Study|Lack of Efficacy|2
2968499|NCT01173055|10217132|P2|Period 2 - Day 64 to 112|Adverse Event|1
2968500|NCT01173055|10217133|P1|Period 2 - Day 64 to 112|Adverse Event|0
2968501|NCT01173055|10217132|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2968502|NCT01173055|10217133|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2968503|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
2968504|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968505|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968506|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968507|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968508|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968509|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968510|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968511|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2968512|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968513|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968514|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968515|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968516|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968517|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968518|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
2968519|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968520|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2968521|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
2968522|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
2968523|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
2968524|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
2968525|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
2968526|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
2968527|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
2968528|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
2968529|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
2968530|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968531|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
2968532|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968533|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968534|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968535|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968536|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
2968537|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
2968538|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2968539|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968540|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2968541|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968542|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968543|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968544|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968545|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968546|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2968547|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2968548|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968549|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968550|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968551|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968552|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968553|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968554|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
2968555|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968556|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2968557|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2968558|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2968559|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968560|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968561|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968562|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968563|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2968564|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968565|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2968566|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968567|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
2968568|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968569|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968570|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968571|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968572|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968573|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968574|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2968575|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2968576|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968577|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968578|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968579|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968580|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968581|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2968582|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968583|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2968584|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2968585|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2968586|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2968587|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2968588|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2968589|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2968590|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2968591|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2968592|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2968593|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
2968594|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
2968595|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2968596|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2968597|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2968598|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2968599|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2968600|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2968601|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2968602|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968603|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
2968604|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968605|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968606|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968607|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968608|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
2968609|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
2968610|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2968611|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968612|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968613|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968614|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968615|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968616|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968617|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
2968618|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968619|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2968620|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968621|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968622|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968623|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968624|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968625|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968626|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968627|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
2968628|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2968629|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Death|0
2968630|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Death|1
2968631|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Death|0
2968632|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Death|0
2968633|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Death|0
2968634|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Death|0
2968635|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Death|0
2968636|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Death|0
2968637|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Death|0
2968638|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
2968639|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
2968640|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2968641|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2968642|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2968643|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2968644|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
2968645|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
2968646|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2968647|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2968648|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2968649|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2968650|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2968651|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2968652|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2968653|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2968654|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
2968655|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2968656|NCT01172938|10217184|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
2968657|NCT01172938|10217185|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968658|NCT01172938|10217186|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968659|NCT01172938|10217187|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968660|NCT01172938|10217188|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968661|NCT01172938|10217189|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968662|NCT01172938|10217190|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968663|NCT01172938|10217191|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968664|NCT01172938|10217192|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2968665|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968666|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968667|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968668|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968669|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968670|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968671|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968672|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
2968673|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
2968674|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
2968675|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968676|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968677|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968678|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968679|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968680|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968681|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
2968682|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2968683|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968684|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
2968685|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968686|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968687|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968688|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968689|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2968690|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2968691|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2968692|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
2968693|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
2968694|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
2968695|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
2968696|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
2968697|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
2968698|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
2968699|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
2968700|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
2968701|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
2968702|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
2968703|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2968704|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2968705|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2968706|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2968707|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
2968708|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
2968709|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2968710|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968711|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968712|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968713|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968714|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968715|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968716|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
2968717|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968718|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2968719|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968720|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
2968721|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968722|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968723|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968724|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968725|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
2968726|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
2968727|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2968728|NCT01172938|10217184|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2968729|NCT01172938|10217185|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
2968730|NCT01172938|10217186|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2968731|NCT01172938|10217187|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2968732|NCT01172938|10217188|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2968886|NCT01172808|10217512|P3|Overall Study|Lost to Follow-up|1
2968733|NCT01172938|10217189|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2968734|NCT01172938|10217190|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2968735|NCT01172938|10217191|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
2968736|NCT01172938|10217192|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2968737|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Other|0
2968738|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Other|0
2968739|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Other|1
2968740|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Other|1
2968741|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Other|0
2968742|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Other|0
2968743|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Other|0
2968744|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Other|0
2968745|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Other|0
2968746|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968747|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968748|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968749|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968750|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968751|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2968752|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2968753|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2968754|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2968755|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2968756|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2968757|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2968758|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
2968759|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2968760|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2968761|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2968762|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
2968763|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2968764|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968765|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968766|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968767|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968768|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968769|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968770|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
2968771|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968772|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2968773|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2968774|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2968775|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2968776|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2968777|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
2968778|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2968779|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
2968780|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
2968781|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2968782|NCT01172938|10217184|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2968783|NCT01172938|10217185|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2968784|NCT01172938|10217186|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2968785|NCT01172938|10217187|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2968786|NCT01172938|10217188|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2968787|NCT01172938|10217189|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2968788|NCT01172938|10217190|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
2968789|NCT01172938|10217191|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2968790|NCT01172938|10217192|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2968791|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Other|0
2968792|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Other|0
2968793|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Other|0
2968794|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Other|0
2968795|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Other|0
2968796|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Other|0
2968797|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Other|1
2968798|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Other|2
2968799|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Other|0
2968800|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968801|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968802|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968803|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968804|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968805|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968806|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968807|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2968808|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
2968809|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Death|0
2968810|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Death|0
2968811|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Death|0
2968812|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Death|0
2968813|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Death|0
2968814|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Death|0
2968815|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Death|0
2968816|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Death|1
2968817|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Death|0
2968818|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968819|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968820|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968821|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968822|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968823|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2968824|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2968825|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2968826|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
2968827|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968828|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968829|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968830|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968831|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968832|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968833|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
2968834|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2968835|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2968836|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968837|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968838|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968839|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968840|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968841|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2968842|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2968843|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2968844|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2968845|NCT01172938|10217184|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968846|NCT01172938|10217185|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968847|NCT01172938|10217186|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968848|NCT01172938|10217187|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968849|NCT01172938|10217188|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968850|NCT01172938|10217189|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2968851|NCT01172938|10217190|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
2968852|NCT01172938|10217191|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
2968853|NCT01172938|10217192|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
2968854|NCT01172873|10217378|P2|Overall Study|Withdrawal by Subject|2
2968855|NCT01172873|10217379|P1|Overall Study|Withdrawal by Subject|3
2968856|NCT01172847|10217389|P1|Overall Study|Withdrawal by Subject|3
2968857|NCT01172821|10217418|P4|Overall Study|Other|3
2968858|NCT01172821|10217419|P3|Overall Study|Other|5
2968859|NCT01172821|10217420|P2|Overall Study|Other|4
2968860|NCT01172821|10217421|P1|Overall Study|Other|3
2968861|NCT01172821|10217418|P4|Overall Study|Withdrawal by Subject|3
2968862|NCT01172821|10217419|P3|Overall Study|Withdrawal by Subject|3
2968863|NCT01172821|10217420|P2|Overall Study|Withdrawal by Subject|3
2968864|NCT01172821|10217421|P1|Overall Study|Withdrawal by Subject|2
2968865|NCT01172821|10217418|P4|Overall Study|Lost to Follow-up|2
2968866|NCT01172821|10217419|P3|Overall Study|Lost to Follow-up|2
2968867|NCT01172821|10217420|P2|Overall Study|Lost to Follow-up|1
2968868|NCT01172821|10217421|P1|Overall Study|Lost to Follow-up|4
2968869|NCT01172821|10217418|P4|Overall Study|Protocol Violation|2
2968870|NCT01172821|10217419|P3|Overall Study|Protocol Violation|1
2968871|NCT01172821|10217420|P2|Overall Study|Protocol Violation|2
2968872|NCT01172821|10217421|P1|Overall Study|Protocol Violation|0
2968873|NCT01172821|10217418|P4|Overall Study|Adverse Event|7
2968874|NCT01172821|10217419|P3|Overall Study|Adverse Event|2
2968875|NCT01172821|10217420|P2|Overall Study|Adverse Event|2
2968876|NCT01172821|10217421|P1|Overall Study|Adverse Event|5
2968877|NCT01172808|10217511|P4|Overall Study|Other|7
2968878|NCT01172808|10217512|P3|Overall Study|Other|9
2968879|NCT01172808|10217513|P2|Overall Study|Other|5
2968880|NCT01172808|10217514|P1|Overall Study|Other|6
2968881|NCT01172808|10217511|P4|Overall Study|Withdrawal by Subject|2
2968882|NCT01172808|10217512|P3|Overall Study|Withdrawal by Subject|3
2968883|NCT01172808|10217513|P2|Overall Study|Withdrawal by Subject|1
2968884|NCT01172808|10217514|P1|Overall Study|Withdrawal by Subject|4
2968887|NCT01172808|10217513|P2|Overall Study|Lost to Follow-up|1
2968888|NCT01172808|10217514|P1|Overall Study|Lost to Follow-up|0
2968889|NCT01172808|10217511|P4|Overall Study|Protocol Violation|0
2968890|NCT01172808|10217512|P3|Overall Study|Protocol Violation|2
2968891|NCT01172808|10217513|P2|Overall Study|Protocol Violation|2
2968892|NCT01172808|10217514|P1|Overall Study|Protocol Violation|2
2968893|NCT01172808|10217511|P4|Overall Study|Lack of Efficacy|0
2968894|NCT01172808|10217512|P3|Overall Study|Lack of Efficacy|0
2968895|NCT01172808|10217513|P2|Overall Study|Lack of Efficacy|0
2968896|NCT01172808|10217514|P1|Overall Study|Lack of Efficacy|1
2968897|NCT01172808|10217511|P4|Overall Study|Adverse Event|3
2968898|NCT01172808|10217512|P3|Overall Study|Adverse Event|8
2968899|NCT01172808|10217513|P2|Overall Study|Adverse Event|4
2968900|NCT01172808|10217514|P1|Overall Study|Adverse Event|8
2968901|NCT01172639|10217605|P5|Overall Study|Withdrawal by Subject|0
2968902|NCT01172639|10217606|P4|Overall Study|Withdrawal by Subject|5
2968903|NCT01172639|10217607|P3|Overall Study|Withdrawal by Subject|5
2968904|NCT01172639|10217608|P2|Overall Study|Withdrawal by Subject|3
2968905|NCT01172639|10217609|P1|Overall Study|Withdrawal by Subject|3
2968906|NCT01172639|10217605|P5|Overall Study|Lost to Follow-up|6
2968907|NCT01172639|10217606|P4|Overall Study|Lost to Follow-up|6
2968908|NCT01172639|10217607|P3|Overall Study|Lost to Follow-up|11
2968909|NCT01172639|10217608|P2|Overall Study|Lost to Follow-up|7
2968910|NCT01172639|10217609|P1|Overall Study|Lost to Follow-up|9
2968911|NCT01172639|10217605|P5|Overall Study|Death|0
2968912|NCT01172639|10217606|P4|Overall Study|Death|0
2968913|NCT01172639|10217607|P3|Overall Study|Death|0
2968914|NCT01172639|10217608|P2|Overall Study|Death|1
2968915|NCT01172639|10217609|P1|Overall Study|Death|1
2968916|NCT01172535|10217684|P1|Overall Study|Unwilling to adhere to study requirement|1
2968917|NCT01172535|10217684|P1|Overall Study|Ineligible at study entry|1
2968918|NCT01172535|10217684|P1|Overall Study|Lost to Follow-up|1
2968919|NCT01172535|10217684|P1|Overall Study|Withdrawal by Subject|2
2968920|NCT01172535|10217684|P1|Overall Study|Death|3
2968921|NCT01172288|10217737|P2|Overall Study|Protocol Violation|1
2968922|NCT01172288|10217738|P1|Overall Study|Protocol Violation|0
2968923|NCT01172288|10217737|P2|Overall Study|Adverse Event|0
2968924|NCT01172288|10217738|P1|Overall Study|Adverse Event|1
2968925|NCT01172275|10217754|P2|Overall Study|Protocol Violation|0
2968926|NCT01172275|10217755|P1|Overall Study|Protocol Violation|1
2968927|NCT01172275|10217754|P2|Overall Study|Lost to Follow-up|0
2968928|NCT01172275|10217755|P1|Overall Study|Lost to Follow-up|1
2968929|NCT01171989|10217813|P3|Overall Study|Lost to Follow-up|1
2968930|NCT01171989|10217814|P2|Overall Study|Lost to Follow-up|0
2968931|NCT01171989|10217815|P1|Overall Study|Lost to Follow-up|0
2968932|NCT01171976|10217889|P3|Overall Study|Adverse Event|5
2968933|NCT01171976|10217890|P2|Overall Study|Adverse Event|2
2968934|NCT01171976|10217891|P1|Overall Study|Adverse Event|6
2968935|NCT01171976|10217889|P3|Overall Study|Abnormal test result|0
2968936|NCT01171976|10217890|P2|Overall Study|Abnormal test result|0
2968937|NCT01171976|10217891|P1|Overall Study|Abnormal test result|1
2968938|NCT01171976|10217889|P3|Overall Study|Withdrawal by Subject|6
2968939|NCT01171976|10217890|P2|Overall Study|Withdrawal by Subject|5
2968940|NCT01171976|10217891|P1|Overall Study|Withdrawal by Subject|1
2968941|NCT01171976|10217889|P3|Overall Study|Lost to Follow-up|2
2968942|NCT01171976|10217890|P2|Overall Study|Lost to Follow-up|0
2968943|NCT01171976|10217891|P1|Overall Study|Lost to Follow-up|4
2968944|NCT01171976|10217889|P3|Overall Study|Death|1
2968945|NCT01171976|10217890|P2|Overall Study|Death|4
2968946|NCT01171976|10217891|P1|Overall Study|Death|2
2968947|NCT01171976|10217889|P3|Overall Study|Protocol Violation|1
2968948|NCT01171976|10217890|P2|Overall Study|Protocol Violation|0
2968949|NCT01171976|10217891|P1|Overall Study|Protocol Violation|0
2968950|NCT01171963|10217928|P2|Overall Study|Withdrawal by Subject|129
2968951|NCT01171963|10217929|P1|Overall Study|Withdrawal by Subject|114
2968952|NCT01171963|10217928|P2|Overall Study|Other - diarrhoea|0
2968953|NCT01171963|10217929|P1|Overall Study|Other - diarrhoea|1
2968954|NCT01171963|10217928|P2|Overall Study|Lost to Follow-up|24
2968955|NCT01171963|10217929|P1|Overall Study|Lost to Follow-up|23
2968956|NCT01171963|10217928|P2|Overall Study|Adverse Event|15
2968957|NCT01171963|10217929|P1|Overall Study|Adverse Event|10
2968958|NCT01171898|10217998|P4|Overall Study|Other|2
2968959|NCT01171898|10217999|P3|Overall Study|Other|0
2968960|NCT01171898|10218000|P2|Overall Study|Other|5
2968961|NCT01171898|10218001|P1|Overall Study|Other|1
2968962|NCT01171898|10217998|P4|Overall Study|Ongoing|0
2968963|NCT01171898|10217999|P3|Overall Study|Ongoing|3
2968964|NCT01171898|10218000|P2|Overall Study|Ongoing|9
2968965|NCT01171898|10218001|P1|Overall Study|Ongoing|1
2968966|NCT01171898|10217998|P4|Overall Study|Terminated by Sponsor|0
2968967|NCT01171898|10217999|P3|Overall Study|Terminated by Sponsor|0
2968968|NCT01171898|10218000|P2|Overall Study|Terminated by Sponsor|0
2968969|NCT01171898|10218001|P1|Overall Study|Terminated by Sponsor|1
2968970|NCT01171898|10217998|P4|Overall Study|Withdrawal by Subject|3
2968971|NCT01171898|10217999|P3|Overall Study|Withdrawal by Subject|6
2968972|NCT01171898|10218000|P2|Overall Study|Withdrawal by Subject|4
2968973|NCT01171898|10218001|P1|Overall Study|Withdrawal by Subject|1
2968974|NCT01171898|10217998|P4|Overall Study|Lost to Follow-up|1
2968975|NCT01171898|10217999|P3|Overall Study|Lost to Follow-up|1
2968976|NCT01171898|10218000|P2|Overall Study|Lost to Follow-up|1
2968977|NCT01171898|10218001|P1|Overall Study|Lost to Follow-up|0
2968978|NCT01171898|10217998|P4|Overall Study|Death|0
2968979|NCT01171898|10217999|P3|Overall Study|Death|2
2968980|NCT01171898|10218000|P2|Overall Study|Death|0
2968981|NCT01171898|10218001|P1|Overall Study|Death|0
2968982|NCT01171820|10218025|P2|Overall Study|1-Year Missed Visit|1
2968983|NCT01171820|10218026|P1|Overall Study|1-Year Missed Visit|1
2968984|NCT01171820|10218025|P2|Overall Study|Physician Decision|1
2968985|NCT01171820|10218026|P1|Overall Study|Physician Decision|0
2968986|NCT01171820|10218025|P2|Overall Study|Withdrawal by Subject|0
2968987|NCT01171820|10218026|P1|Overall Study|Withdrawal by Subject|2
2968988|NCT01171820|10218025|P2|Overall Study|Lost to Follow-up|1
2968989|NCT01171820|10218026|P1|Overall Study|Lost to Follow-up|0
2968990|NCT01171820|10218025|P2|Overall Study|Death|3
2968991|NCT01171820|10218026|P1|Overall Study|Death|3
2968992|NCT01171677|10218104|P2|Overall Study|completed <70% IntenSati classes|0
2968993|NCT01171677|10218105|P1|Overall Study|completed <70% IntenSati classes|5
2968994|NCT01171677|10218104|P2|Overall Study|Adverse Event|0
2968995|NCT01171677|10218105|P1|Overall Study|Adverse Event|1
2968996|NCT01171677|10218104|P2|Overall Study|Withdrawal by Subject|3
2968997|NCT01171677|10218105|P1|Overall Study|Withdrawal by Subject|0
2968998|NCT01171625|10218137|P1|Overall Study|Consented but did not receive device|25
2968999|NCT01171625|10218137|P1|Overall Study|Other|1
2969000|NCT01171625|10218137|P1|Overall Study|Patient received valve-in-valve|3
2969001|NCT01171625|10218137|P1|Overall Study|Lost to Follow-up|5
2969002|NCT01171625|10218137|P1|Overall Study|Explanted|10
2969003|NCT01171625|10218137|P1|Overall Study|Withdrawal by Subject|31
2969004|NCT01171625|10218137|P1|Overall Study|Death|38
2969005|NCT01171625|10218137|P1|Overall Study|On-Protocol|67
2969006|NCT01171612|10218170|P1|Overall Study|Lost to Follow-up|51
2969007|NCT01171534|10218180|P2|Overall Study|screen failure|1
2969008|NCT01171534|10218181|P1|Overall Study|screen failure|0
2969009|NCT01171534|10218180|P2|Overall Study|Lost to Follow-up|2
2969010|NCT01171534|10218181|P1|Overall Study|Lost to Follow-up|0
2969011|NCT01171521|10218193|P1|Overall Study|screen failure|1
2969012|NCT01171521|10218193|P1|Overall Study|Lost to Follow-up|5
2969013|NCT01171183|10218200|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
2969014|NCT01171183|10218201|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
2969015|NCT01171183|10218200|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
2969016|NCT01171183|10218201|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
2969017|NCT01171183|10218200|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2969018|NCT01171183|10218201|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2969019|NCT01171183|10218200|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
2969020|NCT01171183|10218201|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
2969021|NCT01171183|10218200|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
2969022|NCT01171183|10218201|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
2969023|NCT01171183|10218200|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2969024|NCT01171183|10218201|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2969025|NCT01170962|10218222|P3|Follow up Period|Others|3
2969026|NCT01170962|10218223|P2|Follow up Period|Others|7
2969027|NCT01170962|10218224|P1|Follow up Period|Others|10
2969028|NCT01170962|10218222|P3|Follow up Period|Death|0
2969029|NCT01170962|10218223|P2|Follow up Period|Death|2
2969030|NCT01170962|10218224|P1|Follow up Period|Death|2
2969031|NCT01170962|10218222|P3|Follow up Period|Lost to Follow-up|1
2969032|NCT01170962|10218223|P2|Follow up Period|Lost to Follow-up|8
2969033|NCT01170962|10218224|P1|Follow up Period|Lost to Follow-up|13
2969034|NCT01170962|10218222|P3|Follow up Period|Withdrawal by Subject|2
2969035|NCT01170962|10218223|P2|Follow up Period|Withdrawal by Subject|10
2969036|NCT01170962|10218224|P1|Follow up Period|Withdrawal by Subject|14
2969037|NCT01170962|10218222|P3|Treatment Period|Completed 24 Week treatment period only|0
2969038|NCT01170962|10218223|P2|Treatment Period|Completed 24 Week treatment period only|2
2969039|NCT01170962|10218224|P1|Treatment Period|Completed 24 Week treatment period only|10
2969040|NCT01170962|10218222|P3|Treatment Period|Request to discontinue treatment|1
2969041|NCT01170962|10218223|P2|Treatment Period|Request to discontinue treatment|3
2969042|NCT01170962|10218224|P1|Treatment Period|Request to discontinue treatment|7
2969043|NCT01170962|10218222|P3|Treatment Period|Participant no longer meets criteria|0
2969044|NCT01170962|10218223|P2|Treatment Period|Participant no longer meets criteria|1
2969045|NCT01170962|10218224|P1|Treatment Period|Participant no longer meets criteria|0
2969046|NCT01170962|10218222|P3|Treatment Period|Lost to Follow-up|1
2969047|NCT01170962|10218223|P2|Treatment Period|Lost to Follow-up|1
2969048|NCT01170962|10218224|P1|Treatment Period|Lost to Follow-up|1
2969049|NCT01170962|10218222|P3|Treatment Period|Withdrawal by Subject|0
2969050|NCT01170962|10218223|P2|Treatment Period|Withdrawal by Subject|1
2969051|NCT01170962|10218224|P1|Treatment Period|Withdrawal by Subject|2
2969052|NCT01170962|10218222|P3|Treatment Period|Adverse Event|3
2969053|NCT01170962|10218223|P2|Treatment Period|Adverse Event|12
2969054|NCT01170962|10218224|P1|Treatment Period|Adverse Event|11
2969055|NCT01170962|10218222|P3|Treatment Period|Lack of Efficacy|7
2969056|NCT01170962|10218223|P2|Treatment Period|Lack of Efficacy|91
2969057|NCT01170962|10218224|P1|Treatment Period|Lack of Efficacy|96
2969058|NCT01170663|10218319|P2|Overall Study|Withdrawal of consent without follow-up|11
2969059|NCT01170663|10218320|P1|Overall Study|Withdrawal of consent without follow-up|11
2969060|NCT01170663|10218319|P2|Overall Study|Lost to Follow-up|9
2969061|NCT01170663|10218320|P1|Overall Study|Lost to Follow-up|3
2969062|NCT01170598|10218348|P1|Overall Study|Refused|1
2969063|NCT01170598|10218348|P1|Overall Study|Lost to Follow-up|1
2969064|NCT01170598|10218348|P1|Overall Study|Death|3
2969065|NCT01170598|10218348|P1|Overall Study|Withdrawal by Subject|1
2969066|NCT01170364|10218411|P2|Overall Study|Protocol Violation|1
2969067|NCT01170364|10218412|P1|Overall Study|Protocol Violation|4
2969068|NCT01170273|10218420|P2|Overall Study|Adverse Event|1
2969069|NCT01170273|10218421|P1|Overall Study|Adverse Event|0
2969070|NCT01170273|10218420|P2|Overall Study|Death|0
2969071|NCT01170273|10218421|P1|Overall Study|Death|1
2969072|NCT01170273|10218420|P2|Overall Study|Protocol Violation|0
2969073|NCT01170273|10218421|P1|Overall Study|Protocol Violation|1
2969074|NCT01170273|10218420|P2|Overall Study|Lost to Follow-up|8
2969075|NCT01170273|10218421|P1|Overall Study|Lost to Follow-up|6
2969076|NCT01170221|10218438|P2|Overall Study|Randomized but not treated|0
2969077|NCT01170221|10218439|P1|Overall Study|Randomized but not treated|1
2969078|NCT01170221|10218438|P2|Overall Study|Subject completed only screening and LFU|0
2969079|NCT01170221|10218439|P1|Overall Study|Subject completed only screening and LFU|1
2969080|NCT01170221|10218438|P2|Overall Study|Withdrawal by Subject|7
2969081|NCT01170221|10218439|P1|Overall Study|Withdrawal by Subject|9
2969082|NCT01170221|10218438|P2|Overall Study|Lost to Follow-up|21
2969083|NCT01170221|10218439|P1|Overall Study|Lost to Follow-up|22
2969084|NCT01170208|10218462|P3|Overall Study|Protocol Violation|1
2969085|NCT01170208|10218463|P2|Overall Study|Protocol Violation|0
2969086|NCT01170208|10218464|P1|Overall Study|Protocol Violation|1
2969087|NCT01170208|10218462|P3|Overall Study|Withdrawal by Subject|1
2969088|NCT01170208|10218463|P2|Overall Study|Withdrawal by Subject|0
2969089|NCT01170208|10218464|P1|Overall Study|Withdrawal by Subject|5
2969090|NCT01170091|10218492|P1|Overall Study|Treatment duration is less than 4 weeks|21
2969091|NCT01170091|10218492|P1|Overall Study|Missing efficacy evaluation|3
2969092|NCT01170065|10218502|P3|Overall Study|Ongoing after planned observation time|10
2969093|NCT01170065|10218503|P2|Overall Study|Ongoing after planned observation time|26
2969094|NCT01170065|10218504|P1|Overall Study|Ongoing after planned observation time|5
2969095|NCT01170065|10218502|P3|Overall Study|Reason other than specified|3
2969096|NCT01170065|10218503|P2|Overall Study|Reason other than specified|8
2969097|NCT01170065|10218504|P1|Overall Study|Reason other than specified|3
2969098|NCT01170065|10218502|P3|Overall Study|Consent withdrawn, not due to AE|2
2969099|NCT01170065|10218503|P2|Overall Study|Consent withdrawn, not due to AE|4
2969100|NCT01170065|10218504|P1|Overall Study|Consent withdrawn, not due to AE|2
2969101|NCT01170065|10218502|P3|Overall Study|Lost to Follow-up|1
2969102|NCT01170065|10218503|P2|Overall Study|Lost to Follow-up|4
2969103|NCT01170065|10218504|P1|Overall Study|Lost to Follow-up|1
2969104|NCT01170065|10218502|P3|Overall Study|Adverse Event|10
2969105|NCT01170065|10218503|P2|Overall Study|Adverse Event|50
2969106|NCT01170065|10218504|P1|Overall Study|Adverse Event|17
2969107|NCT01170039|10218535|P2|Overall Study|Lack of funding, drug not available|3
2969108|NCT01170039|10218536|P1|Overall Study|Lack of funding, drug not available|3
2969109|NCT01170039|10218535|P2|Overall Study|Withdrawal by Subject|3
2969110|NCT01170039|10218536|P1|Overall Study|Withdrawal by Subject|5
2969111|NCT01169987|10218548|P1|Overall Study|Other|4
2969112|NCT01169987|10218548|P1|Overall Study|Lost to Follow-up|24
2969113|NCT01169987|10218548|P1|Overall Study|Withdrawal by Subject|3
2969114|NCT01169779|10218614|P2|Overall Study|Familial and personal reasons|3
2969115|NCT01169779|10218615|P1|Overall Study|Familial and personal reasons|3
2969116|NCT01169779|10218614|P2|Overall Study|Withdrawal by Subject|2
2969117|NCT01169779|10218615|P1|Overall Study|Withdrawal by Subject|3
2969118|NCT01169779|10218614|P2|Overall Study|Protocol Violation|1
2969119|NCT01169779|10218615|P1|Overall Study|Protocol Violation|1
2969120|NCT01169779|10218614|P2|Overall Study|Lack of Efficacy|0
2969121|NCT01169779|10218615|P1|Overall Study|Lack of Efficacy|1
2969122|NCT01169779|10218614|P2|Overall Study|Adverse Event|11
2969123|NCT01169779|10218615|P1|Overall Study|Adverse Event|3
2969124|NCT01169701|10218650|P2|Overall Study|Sponsor decision|1
2969125|NCT01169701|10218651|P1|Overall Study|Sponsor decision|0
2969126|NCT01169701|10218650|P2|Overall Study|Serious adverse event|1
2969127|NCT01169701|10218651|P1|Overall Study|Serious adverse event|0
2969128|NCT01169701|10218650|P2|Overall Study|Administrative problems|1
2969129|NCT01169701|10218651|P1|Overall Study|Administrative problems|0
2969130|NCT01169701|10218650|P2|Overall Study|Death|1
2969131|NCT01169701|10218651|P1|Overall Study|Death|0
2969132|NCT01169701|10218650|P2|Overall Study|Exclusion criteria|0
2969133|NCT01169701|10218651|P1|Overall Study|Exclusion criteria|2
2969134|NCT01169701|10218650|P2|Overall Study|Adverse Event|2
2969135|NCT01169701|10218651|P1|Overall Study|Adverse Event|1
2969136|NCT01169701|10218650|P2|Overall Study|Withdrawal by Subject|3
2969137|NCT01169701|10218651|P1|Overall Study|Withdrawal by Subject|1
2969138|NCT01169701|10218650|P2|Overall Study|Lost to Follow-up|1
2969139|NCT01169701|10218651|P1|Overall Study|Lost to Follow-up|1
2969140|NCT01169675|10218688|P5|Overall Study|Other Reason Not Defined Above|1
2969141|NCT01169675|10218689|P4|Overall Study|Other Reason Not Defined Above|1
2969142|NCT01169675|10218690|P3|Overall Study|Other Reason Not Defined Above|0
2969143|NCT01169675|10218691|P2|Overall Study|Other Reason Not Defined Above|0
2969144|NCT01169675|10218692|P1|Overall Study|Other Reason Not Defined Above|0
2969145|NCT01169675|10218688|P5|Overall Study|Withdrawal by Subject|2
2969146|NCT01169675|10218689|P4|Overall Study|Withdrawal by Subject|1
2969147|NCT01169675|10218690|P3|Overall Study|Withdrawal by Subject|0
2969148|NCT01169675|10218691|P2|Overall Study|Withdrawal by Subject|0
2969149|NCT01169675|10218692|P1|Overall Study|Withdrawal by Subject|1
2969150|NCT01169675|10218688|P5|Overall Study|Adverse Event|0
2969151|NCT01169675|10218689|P4|Overall Study|Adverse Event|0
2969152|NCT01169675|10218690|P3|Overall Study|Adverse Event|2
2969153|NCT01169675|10218691|P2|Overall Study|Adverse Event|1
2969154|NCT01169675|10218692|P1|Overall Study|Adverse Event|5
2969155|NCT01169675|10218688|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
2969156|NCT01169675|10218689|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
2969157|NCT01169675|10218690|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
2969158|NCT01169675|10218691|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
2969159|NCT01169675|10218692|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
2969160|NCT01169675|10218688|P5|Overall Study|Progressive disease|1
2969161|NCT01169675|10218689|P4|Overall Study|Progressive disease|15
2969162|NCT01169675|10218690|P3|Overall Study|Progressive disease|5
2969163|NCT01169675|10218691|P2|Overall Study|Progressive disease|2
2969164|NCT01169675|10218692|P1|Overall Study|Progressive disease|13
2969165|NCT01169649|10218729|P1|Overall Study|Patient Not Treated|3
2969166|NCT01169558|10218741|P1|Overall Study|Partial response|2
2969167|NCT01169558|10218741|P1|Overall Study|Protocol Violation|2
2969168|NCT01169558|10218741|P1|Overall Study|Non-compliance|2
2969169|NCT01169558|10218741|P1|Overall Study|Need for Surgery|4
2969170|NCT01169558|10218741|P1|Overall Study|Lost to Follow-up|4
2969171|NCT01169558|10218741|P1|Overall Study|Stable Disease|4
2969172|NCT01169558|10218741|P1|Overall Study|Medical Decision|7
2969173|NCT01169558|10218741|P1|Overall Study|Withdrawal of Consent|8
2969174|NCT01169558|10218741|P1|Overall Study|Adverse Event|25
2969175|NCT01169558|10218741|P1|Overall Study|Disease progression|98
2969176|NCT01169493|10218766|P6|Period 3 (6 Months)|Physician Decision|0
2969177|NCT01169493|10218767|P5|Period 3 (6 Months)|Physician Decision|0
2969178|NCT01169493|10218768|P4|Period 3 (6 Months)|Physician Decision|0
2969179|NCT01169493|10218769|P3|Period 3 (6 Months)|Physician Decision|1
2969180|NCT01169493|10218770|P2|Period 3 (6 Months)|Physician Decision|1
2969181|NCT01169493|10218771|P1|Period 3 (6 Months)|Physician Decision|0
2969182|NCT01169493|10218766|P6|Period 3 (6 Months)|Adverse Event|0
2969183|NCT01169493|10218767|P5|Period 3 (6 Months)|Adverse Event|0
2969184|NCT01169493|10218768|P4|Period 3 (6 Months)|Adverse Event|0
2969185|NCT01169493|10218769|P3|Period 3 (6 Months)|Adverse Event|0
2969186|NCT01169493|10218770|P2|Period 3 (6 Months)|Adverse Event|1
2969187|NCT01169493|10218771|P1|Period 3 (6 Months)|Adverse Event|0
2969188|NCT01169493|10218766|P6|Period 1 (6 Months)|Withdrawal by Subject|3
2969189|NCT01169493|10218767|P5|Period 1 (6 Months)|Withdrawal by Subject|0
2969190|NCT01169493|10218768|P4|Period 1 (6 Months)|Withdrawal by Subject|0
2969191|NCT01169493|10218769|P3|Period 1 (6 Months)|Withdrawal by Subject|2
2969192|NCT01169493|10218770|P2|Period 1 (6 Months)|Withdrawal by Subject|1
2969193|NCT01169493|10218771|P1|Period 1 (6 Months)|Withdrawal by Subject|0
2969194|NCT01169350|10218817|P1|Overall Study|Lost to Follow-up|2
2969195|NCT01169350|10218817|P1|Overall Study|Physician Decision|3
2969196|NCT01169103|10218947|P2|Overall Study|Withdrawal by Subject|1
2969197|NCT01169103|10218948|P1|Overall Study|Withdrawal by Subject|3
2969198|NCT01169103|10218947|P2|Overall Study|Lost to Follow-up|3
2969199|NCT01169103|10218948|P1|Overall Study|Lost to Follow-up|3
2969200|NCT01169038|10218975|P1|Overall Study|Required antibiotic administration|1
2969201|NCT01169038|10218975|P1|Overall Study|Adverse Event|5
2969202|NCT01169038|10218975|P1|Overall Study|Death|1
2969203|NCT01168999|10218983|P4|Overall Study|Lost to Follow-up|0
2969204|NCT01168999|10218984|P3|Overall Study|Lost to Follow-up|0
2969205|NCT01168999|10218985|P2|Overall Study|Lost to Follow-up|1
2969206|NCT01168999|10218986|P1|Overall Study|Lost to Follow-up|2
2969207|NCT01168973|10219052|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
2969208|NCT01168973|10219053|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
2969209|NCT01168973|10219052|P2|Overall Study|Sponsor Decision|1
2969210|NCT01168973|10219053|P1|Overall Study|Sponsor Decision|2
2969211|NCT01168973|10219052|P2|Overall Study|Physician Decision|19
2969212|NCT01168973|10219053|P1|Overall Study|Physician Decision|37
2969213|NCT01168973|10219052|P2|Overall Study|Death|45
2969214|NCT01168973|10219053|P1|Overall Study|Death|42
2969215|NCT01168973|10219052|P2|Overall Study|Withdrawal by Subject|53
2969216|NCT01168973|10219053|P1|Overall Study|Withdrawal by Subject|90
2969217|NCT01168973|10219052|P2|Overall Study|Adverse Event|55
2969218|NCT01168973|10219053|P1|Overall Study|Adverse Event|94
2969219|NCT01168973|10219052|P2|Overall Study|Progressive Disease|429
2969220|NCT01168973|10219053|P1|Overall Study|Progressive Disease|341
2969221|NCT01168856|10219128|P2|Overall Study|Protocol Violation|6
2969222|NCT01168856|10219129|P1|Overall Study|Protocol Violation|4
2969223|NCT01168856|10219128|P2|Overall Study|Other|291
2969224|NCT01168856|10219129|P1|Overall Study|Other|1
2969225|NCT01168856|10219128|P2|Overall Study|Death|2
2969226|NCT01168856|10219129|P1|Overall Study|Death|0
2969227|NCT01168856|10219128|P2|Overall Study|Participant received anti-HCV treatment|0
2969228|NCT01168856|10219129|P1|Overall Study|Participant received anti-HCV treatment|1
2969229|NCT01168856|10219128|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
2969230|NCT01168856|10219129|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
2969231|NCT01168856|10219128|P2|Overall Study|Physician Decision|1
2969232|NCT01168856|10219129|P1|Overall Study|Physician Decision|2
2969233|NCT01168856|10219128|P2|Overall Study|Withdrawal by Subject|8
2969234|NCT01168856|10219129|P1|Overall Study|Withdrawal by Subject|6
2969235|NCT01168856|10219128|P2|Overall Study|Lost to Follow-up|34
2969236|NCT01168856|10219129|P1|Overall Study|Lost to Follow-up|4
2969237|NCT01168596|10219227|P2|Overall Study|Withdrawal by Subject|1
2969238|NCT01168596|10219228|P1|Overall Study|Withdrawal by Subject|3
2969239|NCT01168427|10219272|P1|Overall Study|Patient exited prior to implant|1
2969240|NCT01168401|10219288|P11|Overall Study|Withdrawal by Subject|0
2969241|NCT01168401|10219289|P10|Overall Study|Withdrawal by Subject|0
2969242|NCT01168401|10219290|P9|Overall Study|Withdrawal by Subject|0
2969243|NCT01168401|10219291|P8|Overall Study|Withdrawal by Subject|0
2969244|NCT01168401|10219292|P7|Overall Study|Withdrawal by Subject|0
2969245|NCT01168401|10219293|P6|Overall Study|Withdrawal by Subject|0
2969246|NCT01168401|10219294|P5|Overall Study|Withdrawal by Subject|0
2969247|NCT01168401|10219295|P4|Overall Study|Withdrawal by Subject|1
2969248|NCT01168401|10219296|P3|Overall Study|Withdrawal by Subject|0
2969249|NCT01168401|10219297|P2|Overall Study|Withdrawal by Subject|0
2969250|NCT01168401|10219298|P1|Overall Study|Withdrawal by Subject|0
2969251|NCT01168401|10219288|P11|Overall Study|Lost to Follow-up|0
2969252|NCT01168401|10219289|P10|Overall Study|Lost to Follow-up|0
2969253|NCT01168401|10219290|P9|Overall Study|Lost to Follow-up|0
2969254|NCT01168401|10219291|P8|Overall Study|Lost to Follow-up|0
2969255|NCT01168401|10219292|P7|Overall Study|Lost to Follow-up|0
2969256|NCT01168401|10219293|P6|Overall Study|Lost to Follow-up|0
2969257|NCT01168401|10219294|P5|Overall Study|Lost to Follow-up|0
2969258|NCT01168401|10219295|P4|Overall Study|Lost to Follow-up|1
2969259|NCT01168401|10219296|P3|Overall Study|Lost to Follow-up|2
2969260|NCT01168401|10219297|P2|Overall Study|Lost to Follow-up|1
2969261|NCT01168401|10219298|P1|Overall Study|Lost to Follow-up|1
2969262|NCT01168349|10219531|P1|Overall Study|Protocol Violation|76
2969263|NCT01168349|10219531|P1|Overall Study|Other|22
2969264|NCT01168349|10219531|P1|Overall Study|Kidney transplantation|3
2969265|NCT01168349|10219531|P1|Overall Study|Withdrawal by Subject|9
2969266|NCT01168349|10219531|P1|Overall Study|Lost to Follow-up|34
2969267|NCT01168349|10219531|P1|Overall Study|Death|157
2969268|NCT01168232|10219637|P1|Overall Study|Ineligible-Inadequate pathology|1
2969269|NCT01168232|10219637|P1|Overall Study|Ineligible- Wrong cell type|6
2969270|NCT01168232|10219637|P1|Overall Study|Ineligible-Second primary cancer site|1
2969271|NCT01168219|10219644|P1|Overall Study|ineligible due to CML|2
2969272|NCT01168219|10219644|P1|Overall Study|withdrew before transplant|1
2969273|NCT01168219|10219644|P1|Overall Study|off study before starting treatment|2
2969274|NCT01167907|10219667|P2|Overall Study|saphenous catheter dislodged before comp|1
2969275|NCT01167907|10219668|P1|Overall Study|saphenous catheter dislodged before comp|1
2969276|NCT01167907|10219667|P2|Overall Study|Protocol Violation|0
2969277|NCT01167907|10219668|P1|Overall Study|Protocol Violation|1
2969278|NCT01167881|10219686|P2|Overall Study|Other not defined above|55
2969279|NCT01167881|10219687|P1|Overall Study|Other not defined above|31
2969280|NCT01167881|10219686|P2|Overall Study|Not treated|0
2969281|NCT01167881|10219687|P1|Overall Study|Not treated|4
2969282|NCT01167881|10219686|P2|Overall Study|Patient refusal to cont., not due to AE|40
2969283|NCT01167881|10219687|P1|Overall Study|Patient refusal to cont., not due to AE|45
2969284|NCT01167881|10219686|P2|Overall Study|Lost to Follow-up|20
2969285|NCT01167881|10219687|P1|Overall Study|Lost to Follow-up|19
2969286|NCT01167881|10219686|P2|Overall Study|Non compliant with protocol|18
2969287|NCT01167881|10219687|P1|Overall Study|Non compliant with protocol|9
2969288|NCT01167881|10219686|P2|Overall Study|Lack of Efficacy|7
2969289|NCT01167881|10219687|P1|Overall Study|Lack of Efficacy|4
2969290|NCT01167881|10219686|P2|Overall Study|Adverse Event|51
2969291|NCT01167881|10219687|P1|Overall Study|Adverse Event|47
2969292|NCT01167634|10219741|P4|Overall Study|Withdrawal by Subject|0
2969293|NCT01167634|10219742|P3|Overall Study|Withdrawal by Subject|0
2969294|NCT01167634|10219743|P2|Overall Study|Withdrawal by Subject|1
2969295|NCT01167634|10219744|P1|Overall Study|Withdrawal by Subject|1
2969296|NCT01167634|10219741|P4|Overall Study|Lost to Follow-up|4
2969297|NCT01167634|10219742|P3|Overall Study|Lost to Follow-up|3
2969298|NCT01167634|10219743|P2|Overall Study|Lost to Follow-up|3
2969299|NCT01167634|10219744|P1|Overall Study|Lost to Follow-up|1
2969300|NCT01167582|10219765|P2|Overall Study|Lost to Follow-up|1
2969301|NCT01167582|10219766|P1|Overall Study|Lost to Follow-up|0
2969302|NCT01167426|10219806|P1|Overall Study|Sponsor Decision|1
2969303|NCT01167426|10219806|P1|Overall Study|Withdrawal by Subject|2
2969304|NCT01167426|10219806|P1|Overall Study|Protocol Violation|1
2969305|NCT01167426|10219806|P1|Overall Study|Lost to Follow-up|6
2969306|NCT01167257|10219814|P2|Overall Study|Withdrew consent|1
2969307|NCT01167257|10219815|P1|Overall Study|Withdrew consent|1
2969308|NCT01167257|10219814|P2|Overall Study|Lost to Follow-up|2
2969309|NCT01167257|10219815|P1|Overall Study|Lost to Follow-up|2
2969310|NCT01167192|10219837|P1|Overall Study|Insurance denial|1
2969311|NCT01167192|10219837|P1|Overall Study|Withdrawal by Subject|1
2969312|NCT01167192|10219837|P1|Overall Study|Death|1
2969313|NCT01167192|10219837|P1|Overall Study|Adverse Event|1
2969314|NCT01167179|10219854|P2|Overall Study|diverse|5
2969315|NCT01167179|10219855|P1|Overall Study|diverse|6
2969316|NCT01167179|10219854|P2|Overall Study|Withdrawal by Subject|2
2969317|NCT01167179|10219855|P1|Overall Study|Withdrawal by Subject|1
2969318|NCT01167179|10219854|P2|Overall Study|Death|10
2969319|NCT01167179|10219855|P1|Overall Study|Death|4
2969320|NCT01167179|10219854|P2|Overall Study|disease recurrence|4
2969321|NCT01167179|10219855|P1|Overall Study|disease recurrence|4
2969322|NCT01167153|10219865|P2|Overall Study|Subject initiation withdrawal, Other|8
2969323|NCT01167153|10219866|P1|Overall Study|Subject initiation withdrawal, Other|5
2969324|NCT01167153|10219865|P2|Overall Study|Withdrawal consent|1
2969325|NCT01167153|10219866|P1|Overall Study|Withdrawal consent|1
2969326|NCT01167153|10219865|P2|Overall Study|Investigator initiation withdrawal,Other|1
2969327|NCT01167153|10219866|P1|Overall Study|Investigator initiation withdrawal,Other|1
2969328|NCT01167153|10219865|P2|Overall Study|Non-compliance to concomitant medication|2
2969329|NCT01167153|10219866|P1|Overall Study|Non-compliance to concomitant medication|0
2969330|NCT01167153|10219865|P2|Overall Study|Lost to Follow-up|9
2969331|NCT01167153|10219866|P1|Overall Study|Lost to Follow-up|7
2969332|NCT01167153|10219865|P2|Overall Study|Hypotension|0
2969333|NCT01167153|10219866|P1|Overall Study|Hypotension|1
2969334|NCT01167153|10219865|P2|Overall Study|AE including clinical laboratory AE|8
2969335|NCT01167153|10219866|P1|Overall Study|AE including clinical laboratory AE|2
2969336|NCT01167153|10219865|P2|Overall Study|Non-effective therapy|4
2969337|NCT01167153|10219866|P1|Overall Study|Non-effective therapy|1
2969338|NCT01167140|10219884|P1|Overall Study|Withdrawal by Subject|1
2969339|NCT01167023|10219892|P3|Overall Study|Withdrawal by Subject|1
2969340|NCT01167023|10219893|P2|Overall Study|Withdrawal by Subject|0
2969341|NCT01167023|10219894|P1|Overall Study|Withdrawal by Subject|0
2969342|NCT01167023|10219892|P3|Overall Study|Sponsor Decision|0
2969343|NCT01167023|10219893|P2|Overall Study|Sponsor Decision|1
2969344|NCT01167023|10219894|P1|Overall Study|Sponsor Decision|0
2969345|NCT01167023|10219892|P3|Overall Study|Screen Failure|0
2969346|NCT01167023|10219893|P2|Overall Study|Screen Failure|1
2969347|NCT01167023|10219894|P1|Overall Study|Screen Failure|0
2969348|NCT01167023|10219892|P3|Overall Study|Lost to Follow-up|1
2969349|NCT01167023|10219893|P2|Overall Study|Lost to Follow-up|1
2969350|NCT01167023|10219894|P1|Overall Study|Lost to Follow-up|0
2969351|NCT01166958|10219934|P2|Overall Study|Withdrawal by Subject|0
2969352|NCT01166958|10219935|P1|Overall Study|Withdrawal by Subject|1
2969353|NCT01166945|10219951|P2|Day 30|Lost to Follow-up|3
2969354|NCT01166945|10219952|P1|Day 30|Lost to Follow-up|4
2969355|NCT01166945|10219951|P2|Day 15|NonCompliance/Lost to Follow Up|1
2969356|NCT01166945|10219952|P1|Day 15|NonCompliance/Lost to Follow Up|2
2969357|NCT01166945|10219951|P2|Day 10|NonCompliance/Lost to Follow Up|2
2969358|NCT01166945|10219952|P1|Day 10|NonCompliance/Lost to Follow Up|3
2969359|NCT01166945|10219951|P2|Randomized|diagnosed with Group A strep|4
2969360|NCT01166945|10219952|P1|Randomized|diagnosed with Group A strep|4
2969361|NCT01166763|10219960|P1|Overall Study|Withdrawal by Subject|3
2969362|NCT01166750|10219968|P2|Overall Study|Lost to Follow-up|0
2969363|NCT01166750|10219969|P1|Overall Study|Lost to Follow-up|1
2969364|NCT01166659|10219986|P1|Overall Study|Study Closed at Site|1
2969365|NCT01166659|10219986|P1|Overall Study|Lost to Follow-up|1
2969366|NCT01166659|10219986|P1|Overall Study|Death|1
2969367|NCT01166659|10219986|P1|Overall Study|Investigator Decision|2
2969368|NCT01166659|10219986|P1|Overall Study|Subject Decision|8
2969369|NCT01166646|10219995|P2|Overall Study|Adverse Event|0
2969370|NCT01166646|10219996|P1|Overall Study|Adverse Event|1
2969371|NCT01166646|10219995|P2|Overall Study|Protocol Violation|1
2969372|NCT01166646|10219996|P1|Overall Study|Protocol Violation|0
2969373|NCT01166568|10220015|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2969374|NCT01166568|10220016|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2969375|NCT01166568|10220017|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
2969376|NCT01166568|10220015|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
2969377|NCT01166568|10220016|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2969378|NCT01166568|10220017|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
2969379|NCT01166568|10220015|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
2969380|NCT01166568|10220016|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
2969381|NCT01166568|10220017|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
2969382|NCT01166438|10220030|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
2969383|NCT01166438|10220031|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
2969384|NCT01166438|10220030|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
2969385|NCT01166438|10220031|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
2969386|NCT01166438|10220030|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
2969387|NCT01166438|10220031|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
2969388|NCT01166438|10220030|P2|Double-blind Phase: 1st 6 Months|Not treated|1
2969389|NCT01166438|10220031|P1|Double-blind Phase: 1st 6 Months|Not treated|1
2969390|NCT01166438|10220030|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
2969391|NCT01166438|10220031|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
2969392|NCT01166438|10220030|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
2969393|NCT01166438|10220031|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
2969394|NCT01166282|10220080|P3|Open-label Period|Irregular Compliance|1
2969395|NCT01166282|10220081|P2|Open-label Period|Irregular Compliance|0
2969396|NCT01166282|10220082|P1|Open-label Period|Irregular Compliance|0
2969397|NCT01166282|10220080|P3|Open-label Period|Remission|4
2969398|NCT01166282|10220081|P2|Open-label Period|Remission|0
2969399|NCT01166282|10220082|P1|Open-label Period|Remission|0
2969400|NCT01166282|10220080|P3|Open-label Period|Lack of Efficacy|2
2969401|NCT01166282|10220081|P2|Open-label Period|Lack of Efficacy|0
2969402|NCT01166282|10220082|P1|Open-label Period|Lack of Efficacy|0
2969403|NCT01166282|10220080|P3|Open-label Period|Withdrawal by Subject|4
2969404|NCT01166282|10220081|P2|Open-label Period|Withdrawal by Subject|0
2969405|NCT01166282|10220082|P1|Open-label Period|Withdrawal by Subject|0
2969406|NCT01166282|10220080|P3|Open-label Period|Adverse Event|6
2969407|NCT01166282|10220081|P2|Open-label Period|Adverse Event|0
2969408|NCT01166282|10220082|P1|Open-label Period|Adverse Event|0
2969409|NCT01166178|10220121|P2|Overall Study|Study was terminated|8
2969410|NCT01166178|10220122|P1|Overall Study|Study was terminated|20
2969411|NCT01166178|10220121|P2|Overall Study|Withdrawal by Subject|0
2969412|NCT01166178|10220122|P1|Overall Study|Withdrawal by Subject|1
2969413|NCT01165996|10220161|P1|Overall Study|Physician Decision|1
2969414|NCT01165996|10220161|P1|Overall Study|Death|1
2969415|NCT01165684|10220232|P2|Overall Study|Unclassified|22
2969416|NCT01165684|10220233|P1|Overall Study|Unclassified|16
2969417|NCT01165684|10220232|P2|Overall Study|Withdrawal Criteria|13
2969418|NCT01165684|10220233|P1|Overall Study|Withdrawal Criteria|2
2969419|NCT01165684|10220232|P2|Overall Study|Protocol Violation|15
2969420|NCT01165684|10220233|P1|Overall Study|Protocol Violation|7
2969421|NCT01165684|10220232|P2|Overall Study|Lack of Efficacy|1
2969422|NCT01165684|10220233|P1|Overall Study|Lack of Efficacy|2
2969423|NCT01165684|10220232|P2|Overall Study|Adverse Event|1
2969424|NCT01165684|10220233|P1|Overall Study|Adverse Event|1
2969425|NCT01165554|10220267|P1|Overall Study|Withdrawal by Subject|23
2969426|NCT01165424|10220290|P1|Overall Study|Participant moved (relocated)|1
2969427|NCT01165424|10220290|P1|Overall Study|Did not meet entry criteria|1
2969428|NCT01165424|10220290|P1|Overall Study|Laboratory adverse experiences|1
2969429|NCT01165424|10220290|P1|Overall Study|Clinical adverse experiences|1
2969430|NCT01165320|10220297|P3|Overall Study|Reason unknown|0
2969431|NCT01165320|10220298|P2|Overall Study|Reason unknown|1
2969432|NCT01165320|10220299|P1|Overall Study|Reason unknown|0
2969433|NCT01165320|10220297|P3|Overall Study|Lack of Efficacy|0
2969434|NCT01165320|10220298|P2|Overall Study|Lack of Efficacy|2
2969435|NCT01165320|10220299|P1|Overall Study|Lack of Efficacy|0
2969436|NCT01165320|10220297|P3|Overall Study|Laboratory adverse experience|0
2969437|NCT01165320|10220298|P2|Overall Study|Laboratory adverse experience|0
2969438|NCT01165320|10220299|P1|Overall Study|Laboratory adverse experience|1
2969439|NCT01165320|10220297|P3|Overall Study|Clinical adverse experience|0
2969440|NCT01165320|10220298|P2|Overall Study|Clinical adverse experience|1
2969441|NCT01165320|10220299|P1|Overall Study|Clinical adverse experience|2
2969442|NCT01165307|10220309|P2|Overall Study|Subject not available for contact|0
2969443|NCT01165307|10220310|P1|Overall Study|Subject not available for contact|1
2969444|NCT01165307|10220309|P2|Overall Study|Withdrawal by Subject|0
2969445|NCT01165307|10220310|P1|Overall Study|Withdrawal by Subject|2
2969446|NCT01165307|10220309|P2|Overall Study|Lost to Follow-up|3
2969447|NCT01165307|10220310|P1|Overall Study|Lost to Follow-up|11
2969448|NCT01165281|10220340|P2|Overall Study|Other|0
2969449|NCT01165281|10220341|P1|Overall Study|Other|6
2969450|NCT01165281|10220340|P2|Overall Study|Progressive Disease|14
2969451|NCT01165281|10220341|P1|Overall Study|Progressive Disease|10
2969452|NCT01165281|10220340|P2|Overall Study|Noncompliance with Study Drug|4
2969453|NCT01165281|10220341|P1|Overall Study|Noncompliance with Study Drug|1
2969454|NCT01165281|10220340|P2|Overall Study|Withdrawal by Subject|7
2969455|NCT01165281|10220341|P1|Overall Study|Withdrawal by Subject|8
2969456|NCT01165281|10220340|P2|Overall Study|Protocol Violation|5
2969457|NCT01165281|10220341|P1|Overall Study|Protocol Violation|6
2969458|NCT01165281|10220340|P2|Overall Study|Physician Decision|1
2969459|NCT01165281|10220341|P1|Overall Study|Physician Decision|8
2969460|NCT01165281|10220340|P2|Overall Study|Lost to Follow-up|1
2969461|NCT01165281|10220341|P1|Overall Study|Lost to Follow-up|0
2969462|NCT01165281|10220340|P2|Overall Study|Lack of Efficacy|1
2969463|NCT01165281|10220341|P1|Overall Study|Lack of Efficacy|4
2969464|NCT01165281|10220340|P2|Overall Study|Death|4
2969465|NCT01165281|10220341|P1|Overall Study|Death|3
2969466|NCT01165281|10220340|P2|Overall Study|Adverse Event|14
2969467|NCT01165281|10220341|P1|Overall Study|Adverse Event|12
2969468|NCT01165242|10220362|P3|Overall Study|Lost to Follow-up|10
2969469|NCT01165242|10220363|P2|Overall Study|Lost to Follow-up|7
2969470|NCT01165242|10220364|P1|Overall Study|Lost to Follow-up|9
2969471|NCT01165242|10220362|P3|Overall Study|Extended Holiday|1
2969472|NCT01165242|10220363|P2|Overall Study|Extended Holiday|0
2969473|NCT01165242|10220364|P1|Overall Study|Extended Holiday|0
2969474|NCT01165242|10220362|P3|Overall Study|Withdrawal by Subject|2
2969475|NCT01165242|10220363|P2|Overall Study|Withdrawal by Subject|2
2969476|NCT01165242|10220364|P1|Overall Study|Withdrawal by Subject|0
2969477|NCT01165242|10220362|P3|Overall Study|Visit 2 Declined by Subject|1
2969478|NCT01165242|10220363|P2|Overall Study|Visit 2 Declined by Subject|0
2969479|NCT01165242|10220364|P1|Overall Study|Visit 2 Declined by Subject|0
2969480|NCT01165242|10220362|P3|Overall Study|Incarcerated Subjects|0
2969481|NCT01165242|10220363|P2|Overall Study|Incarcerated Subjects|1
2969482|NCT01165242|10220364|P1|Overall Study|Incarcerated Subjects|0
2969483|NCT01165242|10220362|P3|Overall Study|Unreachable Subjects|0
2969484|NCT01165242|10220363|P2|Overall Study|Unreachable Subjects|0
2969485|NCT01165242|10220364|P1|Overall Study|Unreachable Subjects|1
2969486|NCT01165229|10220398|P2|Overall Study|Unknown completion status|1
2969487|NCT01165229|10220399|P1|Overall Study|Unknown completion status|0
2969488|NCT01165229|10220398|P2|Overall Study|No reason from the subject|102
2969489|NCT01165229|10220399|P1|Overall Study|No reason from the subject|108
2969490|NCT01165229|10220398|P2|Overall Study|Suspected HZ Episode|2
2969491|NCT01165229|10220399|P1|Overall Study|Suspected HZ Episode|2
2969492|NCT01165229|10220398|P2|Overall Study|Lost to Follow-up|133
2969493|NCT01165229|10220399|P1|Overall Study|Lost to Follow-up|123
2969494|NCT01165229|10220398|P2|Overall Study|Migrated/moved from study area|46
2969495|NCT01165229|10220399|P1|Overall Study|Migrated/moved from study area|51
2969496|NCT01165229|10220398|P2|Overall Study|Withdrawal by Subject|396
2969497|NCT01165229|10220399|P1|Overall Study|Withdrawal by Subject|387
2969498|NCT01165229|10220398|P2|Overall Study|Protocol Violation|8
2969499|NCT01165229|10220399|P1|Overall Study|Protocol Violation|6
2969500|NCT01165229|10220398|P2|Overall Study|Non-Serious Adverse Event|15
2969501|NCT01165229|10220399|P1|Overall Study|Non-Serious Adverse Event|47
2969502|NCT01165229|10220398|P2|Overall Study|Serious Adverse Event|487
2969503|NCT01165229|10220399|P1|Overall Study|Serious Adverse Event|456
2969504|NCT01165216|10220533|P2|Overall Study|Disease progression|3
2969505|NCT01165216|10220534|P1|Overall Study|Disease progression|1
2969506|NCT01165216|10220533|P2|Overall Study|Withdrawal by Subject|1
2969507|NCT01165216|10220534|P1|Overall Study|Withdrawal by Subject|1
2969508|NCT01165216|10220533|P2|Overall Study|Adverse Event|3
2969509|NCT01165216|10220534|P1|Overall Study|Adverse Event|6
2969510|NCT01165203|10220556|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
2969511|NCT01165203|10220557|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
2969512|NCT01165203|10220556|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
2969513|NCT01165203|10220557|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
2969514|NCT01165203|10220556|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
2969515|NCT01165203|10220557|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
2969516|NCT01165203|10220556|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2969517|NCT01165203|10220557|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2969518|NCT01165203|10220556|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
2969519|NCT01165203|10220557|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
2969520|NCT01165203|10220556|P2|Active Phase|Lost to Follow-up|0
2969521|NCT01165203|10220557|P1|Active Phase|Lost to Follow-up|2
2969522|NCT01165203|10220556|P2|Active Phase|Migrated/moved from study area|1
2969523|NCT01165203|10220557|P1|Active Phase|Migrated/moved from study area|0
2969524|NCT01165203|10220556|P2|Active Phase|Withdrawal by Subject|1
2969525|NCT01165203|10220557|P1|Active Phase|Withdrawal by Subject|2
2969526|NCT01165203|10220556|P2|Active Phase|Serious Adverse Event|0
2969527|NCT01165203|10220557|P1|Active Phase|Serious Adverse Event|1
2969528|NCT01165177|10220647|P2|Overall Study|Migrated/ moved from study area|43
2969529|NCT01165177|10220648|P1|Overall Study|Migrated/ moved from study area|48
2969530|NCT01165177|10220647|P2|Overall Study|Lost to Follow-up|194
2969531|NCT01165177|10220648|P1|Overall Study|Lost to Follow-up|183
2969532|NCT01165177|10220647|P2|Overall Study|Suspected HZ episode|2
2969533|NCT01165177|10220648|P1|Overall Study|Suspected HZ episode|0
2969534|NCT01165177|10220647|P2|Overall Study|Other unspecified reasons|35
2969535|NCT01165177|10220648|P1|Overall Study|Other unspecified reasons|47
2969536|NCT01165177|10220647|P2|Overall Study|Non-serious adverse event|18
2969537|NCT01165177|10220648|P1|Overall Study|Non-serious adverse event|30
2969538|NCT01165177|10220647|P2|Overall Study|Protocol Violation|21
2969539|NCT01165177|10220648|P1|Overall Study|Protocol Violation|19
2969540|NCT01165177|10220647|P2|Overall Study|Withdrawal by Subject|354
2969541|NCT01165177|10220648|P1|Overall Study|Withdrawal by Subject|368
2969542|NCT01165177|10220647|P2|Overall Study|Serious Adverse Event|235
2969543|NCT01165177|10220648|P1|Overall Study|Serious Adverse Event|227
2969544|NCT01165138|10220777|P4|Overall Study|Withdrawal by Subject|3
2969545|NCT01165138|10220778|P3|Overall Study|Withdrawal by Subject|6
2969546|NCT01165138|10220779|P2|Overall Study|Withdrawal by Subject|6
2969547|NCT01165138|10220780|P1|Overall Study|Withdrawal by Subject|0
2969548|NCT01165138|10220777|P4|Overall Study|Physician Decision|6
2969549|NCT01165138|10220778|P3|Overall Study|Physician Decision|7
2969550|NCT01165138|10220779|P2|Overall Study|Physician Decision|6
2969551|NCT01165138|10220780|P1|Overall Study|Physician Decision|0
2969552|NCT01165138|10220777|P4|Overall Study|Lost to Follow-up|2
2969553|NCT01165138|10220778|P3|Overall Study|Lost to Follow-up|1
2969554|NCT01165138|10220779|P2|Overall Study|Lost to Follow-up|0
2969555|NCT01165138|10220780|P1|Overall Study|Lost to Follow-up|0
2969556|NCT01165138|10220777|P4|Overall Study|Protocol Violation|2
2969557|NCT01165138|10220778|P3|Overall Study|Protocol Violation|0
2969558|NCT01165138|10220779|P2|Overall Study|Protocol Violation|7
2969559|NCT01165138|10220780|P1|Overall Study|Protocol Violation|0
2969560|NCT01165138|10220777|P4|Overall Study|Lack of Efficacy|7
2969561|NCT01165138|10220778|P3|Overall Study|Lack of Efficacy|6
2969562|NCT01165138|10220779|P2|Overall Study|Lack of Efficacy|32
2969563|NCT01165138|10220780|P1|Overall Study|Lack of Efficacy|0
2969564|NCT01165138|10220777|P4|Overall Study|Adverse Event|2
2969565|NCT01165138|10220778|P3|Overall Study|Adverse Event|0
2969566|NCT01165138|10220779|P2|Overall Study|Adverse Event|1
2969567|NCT01165138|10220780|P1|Overall Study|Adverse Event|0
2969568|NCT01165021|10220850|P1|Overall Study|Death|1
2969569|NCT01164956|10220858|P3|Overall Study|Side Effects|1
2969570|NCT01164956|10220859|P2|Overall Study|Side Effects|0
2969571|NCT01164956|10220860|P1|Overall Study|Side Effects|1
2969572|NCT01164891|10220868|P1|Overall Study|Adverse Event|1
2969573|NCT01164891|10220868|P1|Overall Study|Disease Progression|5
2969574|NCT01164865|10220888|P2|Overall Study|Lost to Follow-up|1
2969575|NCT01164865|10220889|P1|Overall Study|Lost to Follow-up|2
2969576|NCT01164722|10220899|P2|Overall Study|enrolled on other study, concomitant med|3
2969577|NCT01164722|10220900|P1|Overall Study|enrolled on other study, concomitant med|1
2969578|NCT01164722|10220899|P2|Overall Study|met protocol criteria for non-treatment|1
2969579|NCT01164722|10220900|P1|Overall Study|met protocol criteria for non-treatment|11
2969580|NCT01164722|10220899|P2|Overall Study|Lost to Follow-up|6
2969581|NCT01164722|10220900|P1|Overall Study|Lost to Follow-up|3
2969582|NCT01164722|10220899|P2|Overall Study|Withdrawal by Subject|4
2969583|NCT01164722|10220900|P1|Overall Study|Withdrawal by Subject|3
2969584|NCT01164722|10220899|P2|Overall Study|Adverse Event|1
2969585|NCT01164722|10220900|P1|Overall Study|Adverse Event|0
2969586|NCT01164579|10220930|P3|Overall Study|Reason not specified|0
2969587|NCT01164579|10220931|P2|Overall Study|Reason not specified|0
2969588|NCT01164579|10220932|P1|Overall Study|Reason not specified|1
2969589|NCT01164579|10220930|P3|Overall Study|Adverse Event|5
2969590|NCT01164579|10220931|P2|Overall Study|Adverse Event|2
2969591|NCT01164579|10220932|P1|Overall Study|Adverse Event|4
2969592|NCT01164579|10220930|P3|Overall Study|Protocol Violation|2
2969593|NCT01164579|10220931|P2|Overall Study|Protocol Violation|1
2969594|NCT01164579|10220932|P1|Overall Study|Protocol Violation|0
2969595|NCT01164579|10220930|P3|Overall Study|Withdrawal by Subject|3
2969596|NCT01164579|10220931|P2|Overall Study|Withdrawal by Subject|5
2969597|NCT01164579|10220932|P1|Overall Study|Withdrawal by Subject|2
2969598|NCT01164579|10220930|P3|Overall Study|Lost to Follow-up|0
2969599|NCT01164579|10220931|P2|Overall Study|Lost to Follow-up|1
2969600|NCT01164579|10220932|P1|Overall Study|Lost to Follow-up|1
2969601|NCT01164579|10220930|P3|Overall Study|Lack of Efficacy|6
2969602|NCT01164579|10220931|P2|Overall Study|Lack of Efficacy|0
2969603|NCT01164579|10220932|P1|Overall Study|Lack of Efficacy|0
2969604|NCT01164501|10221012|P3|Overall Study|Other reason not defined above|4
2969605|NCT01164501|10221013|P2|Overall Study|Other reason not defined above|1
2969606|NCT01164501|10221014|P1|Overall Study|Other reason not defined above|9
2969607|NCT01164501|10221012|P3|Overall Study|Patient refusal to continue,not due toAE|8
2969608|NCT01164501|10221013|P2|Overall Study|Patient refusal to continue,not due toAE|4
2969609|NCT01164501|10221014|P1|Overall Study|Patient refusal to continue,not due toAE|10
2969610|NCT01164501|10221012|P3|Overall Study|Lost to Follow-up|3
2969611|NCT01164501|10221013|P2|Overall Study|Lost to Follow-up|0
2969612|NCT01164501|10221014|P1|Overall Study|Lost to Follow-up|3
2969613|NCT01164501|10221012|P3|Overall Study|Non compliant with protocol|4
2969614|NCT01164501|10221013|P2|Overall Study|Non compliant with protocol|1
2969615|NCT01164501|10221014|P1|Overall Study|Non compliant with protocol|1
2969616|NCT01164501|10221012|P3|Overall Study|Lack of Efficacy|1
2969617|NCT01164501|10221013|P2|Overall Study|Lack of Efficacy|0
2969618|NCT01164501|10221014|P1|Overall Study|Lack of Efficacy|0
2969619|NCT01164501|10221012|P3|Overall Study|Adverse Event|21
2969620|NCT01164501|10221013|P2|Overall Study|Adverse Event|4
2969621|NCT01164501|10221014|P1|Overall Study|Adverse Event|18
2969622|NCT01164501|10221012|P3|Overall Study|Not treated|1
2969623|NCT01164501|10221013|P2|Overall Study|Not treated|0
2969624|NCT01164501|10221014|P1|Overall Study|Not treated|2
2969625|NCT01164475|10221031|P2|Overall Study|Protocol Violation|0
2969626|NCT01164475|10221032|P1|Overall Study|Protocol Violation|1
2969627|NCT01164475|10221031|P2|Overall Study|Progressive disease|1
2969628|NCT01164475|10221032|P1|Overall Study|Progressive disease|0
2969629|NCT01164475|10221031|P2|Overall Study|Other|1
2969630|NCT01164475|10221032|P1|Overall Study|Other|0
2969631|NCT01164475|10221031|P2|Overall Study|Lack of Efficacy|0
2969632|NCT01164475|10221032|P1|Overall Study|Lack of Efficacy|1
2969633|NCT01164007|10221086|P1|Overall Study|Medical Decision|3
2969634|NCT01164007|10221086|P1|Overall Study|Withdrawal by Subject|1
2969635|NCT01164007|10221086|P1|Overall Study|Protocol Violation|1
2969636|NCT01164007|10221086|P1|Overall Study|Progression of Disease|30
2969637|NCT01164007|10221086|P1|Overall Study|Adverse Event|5
2969638|NCT01163916|10221112|P3|Overall Study|Other|16
2969639|NCT01163916|10221113|P2|Overall Study|Other|4
2969640|NCT01163916|10221114|P1|Overall Study|Other|24
2969641|NCT01163916|10221112|P3|Overall Study|Lack of Efficacy|1
2969642|NCT01163916|10221113|P2|Overall Study|Lack of Efficacy|0
2969643|NCT01163916|10221114|P1|Overall Study|Lack of Efficacy|2
2969644|NCT01163916|10221112|P3|Overall Study|Adverse Event|1
2969645|NCT01163916|10221113|P2|Overall Study|Adverse Event|0
2969646|NCT01163916|10221114|P1|Overall Study|Adverse Event|2
2969647|NCT01163916|10221112|P3|Overall Study|Withdrawal by Subject|2
2969648|NCT01163916|10221113|P2|Overall Study|Withdrawal by Subject|0
2969649|NCT01163916|10221114|P1|Overall Study|Withdrawal by Subject|2
2969650|NCT01163851|10221152|P2|Overall Study|Enrolled but not treated|0
2969651|NCT01163851|10221153|P1|Overall Study|Enrolled but not treated|1
2969652|NCT01163851|10221152|P2|Overall Study|Site Closure|1
2969653|NCT01163851|10221153|P1|Overall Study|Site Closure|0
2969654|NCT01163786|10221231|P1|Completed Follow up (Visit 9 and 10)|Other|1
2969655|NCT01163786|10221231|P1|Treatment With Bortezomib|Adverse Event|2
2969656|NCT01163786|10221231|P1|Treatment With Bortezomib|Withdrawal by Subject|1
2969657|NCT01163747|10221254|P2|Overall Study|Refused Treatment|4
2969658|NCT01163747|10221255|P1|Overall Study|Refused Treatment|6
2969659|NCT01163747|10221254|P2|Overall Study|Protocol Violation|1
2969660|NCT01163747|10221255|P1|Overall Study|Protocol Violation|0
2969661|NCT01163747|10221254|P2|Overall Study|Insufficient Therapeutic Response|1
2969662|NCT01163747|10221255|P1|Overall Study|Insufficient Therapeutic Response|0
2969663|NCT01163747|10221254|P2|Overall Study|Adverse Event|5
2969664|NCT01163747|10221255|P1|Overall Study|Adverse Event|0
2969665|NCT01163721|10221275|P2|Overall Study|Physician Decision|1
2969666|NCT01163721|10221276|P1|Overall Study|Physician Decision|0
2969667|NCT01163721|10221275|P2|Overall Study|Lost to Follow-up|1
2969668|NCT01163721|10221276|P1|Overall Study|Lost to Follow-up|0
2969669|NCT01163721|10221275|P2|Overall Study|Withdrawal by Subject|4
2969670|NCT01163721|10221276|P1|Overall Study|Withdrawal by Subject|3
2969671|NCT01163721|10221275|P2|Overall Study|Adverse Event|6
2969672|NCT01163721|10221276|P1|Overall Study|Adverse Event|5
2969673|NCT01163617|10221295|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969674|NCT01163617|10221296|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969675|NCT01163617|10221297|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969676|NCT01163617|10221298|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969677|NCT01163617|10221299|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969678|NCT01163617|10221300|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
2969679|NCT01163617|10221301|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969680|NCT01163617|10221302|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2969681|NCT01163617|10221295|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969682|NCT01163617|10221296|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969683|NCT01163617|10221297|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969684|NCT01163617|10221298|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969685|NCT01163617|10221299|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969686|NCT01163617|10221300|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969687|NCT01163617|10221301|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
2969688|NCT01163617|10221302|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2969689|NCT01163617|10221295|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969690|NCT01163617|10221296|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969691|NCT01163617|10221297|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969692|NCT01163617|10221298|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969693|NCT01163617|10221299|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969694|NCT01163617|10221300|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969695|NCT01163617|10221301|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
2969696|NCT01163617|10221302|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2969697|NCT01163474|10221331|P1|Overall Study|Lost to Follow-up|3
2969698|NCT01163474|10221331|P1|Overall Study|Tech barriers to videoteleconference vis|12
2969699|NCT01163474|10221331|P1|Overall Study|Withdrawal by Subject|1
2969700|NCT01163318|10221343|P1|Overall Study|Multiple Reasons Per Participant|224
2969701|NCT01163318|10221343|P1|Overall Study|Participants Without Case Report Form|7
2969702|NCT01163318|10221343|P1|Overall Study|History/comorbidity of malignant tumor|3
2969703|NCT01163318|10221343|P1|Overall Study|Did Not Continue Use of Adalimumab|26
2969704|NCT01163318|10221343|P1|Overall Study|Off-Label Use of Adalimumab|8
2969705|NCT01163292|10221352|P2|Overall Study|No further visits|7
2969706|NCT01163292|10221353|P1|Overall Study|No further visits|5
2969707|NCT01163292|10221352|P2|Overall Study|Economic reasons|0
2969708|NCT01163292|10221353|P1|Overall Study|Economic reasons|6
2969709|NCT01163292|10221352|P2|Overall Study|Refusal to receive adalimumab|0
2969710|NCT01163292|10221353|P1|Overall Study|Refusal to receive adalimumab|7
2969711|NCT01163292|10221352|P2|Overall Study|Sufficient response to adalimumab|0
2969712|NCT01163292|10221353|P1|Overall Study|Sufficient response to adalimumab|8
2969713|NCT01163292|10221352|P2|Overall Study|Initiation of biological therapy|15
2969714|NCT01163292|10221353|P1|Overall Study|Initiation of biological therapy|0
2969715|NCT01163292|10221352|P2|Overall Study|Adverse Event|0
2969716|NCT01163292|10221353|P1|Overall Study|Adverse Event|6
2969717|NCT01163292|10221352|P2|Overall Study|Lack of Efficacy|0
2969718|NCT01163292|10221353|P1|Overall Study|Lack of Efficacy|9
2969719|NCT01163279|10221369|P2|Overall Study|Withdrawal by Subject|0
2969720|NCT01163279|10221370|P1|Overall Study|Withdrawal by Subject|2
2969721|NCT01163266|10221399|P3|Overall Study|Other|2
2969722|NCT01163266|10221400|P2|Overall Study|Other|1
2969723|NCT01163266|10221401|P1|Overall Study|Other|1
2969724|NCT01163266|10221399|P3|Overall Study|Lost to Follow-up|10
2969725|NCT01163266|10221400|P2|Overall Study|Lost to Follow-up|7
2969726|NCT01163266|10221401|P1|Overall Study|Lost to Follow-up|7
2969727|NCT01163266|10221399|P3|Overall Study|Withdrawal of Consent|3
2969728|NCT01163266|10221400|P2|Overall Study|Withdrawal of Consent|7
2969729|NCT01163266|10221401|P1|Overall Study|Withdrawal of Consent|5
2969730|NCT01163266|10221399|P3|Overall Study|Protocol Deviations|5
2969731|NCT01163266|10221400|P2|Overall Study|Protocol Deviations|2
2969732|NCT01163266|10221401|P1|Overall Study|Protocol Deviations|2
2969733|NCT01163266|10221399|P3|Overall Study|Noncompliance with Study Drug|0
2969734|NCT01163266|10221400|P2|Overall Study|Noncompliance with Study Drug|2
2969735|NCT01163266|10221401|P1|Overall Study|Noncompliance with Study Drug|0
2969736|NCT01163266|10221399|P3|Overall Study|Lack of Efficacy|1
2969737|NCT01163266|10221400|P2|Overall Study|Lack of Efficacy|3
2969738|NCT01163266|10221401|P1|Overall Study|Lack of Efficacy|1
2969739|NCT01163266|10221399|P3|Overall Study|Pretreatment Event or Adverse Event|7
2969740|NCT01163266|10221400|P2|Overall Study|Pretreatment Event or Adverse Event|9
2969741|NCT01163266|10221401|P1|Overall Study|Pretreatment Event or Adverse Event|2
2969742|NCT01163253|10221426|P2|Overall Study|Other Unspecified|34
2969743|NCT01163253|10221427|P1|Overall Study|Other Unspecified|170
2969744|NCT01163253|10221426|P2|Overall Study|Ongoing|4
2969745|NCT01163253|10221427|P1|Overall Study|Ongoing|13
2969746|NCT01163253|10221426|P2|Overall Study|Death|5
2969747|NCT01163253|10221427|P1|Overall Study|Death|17
2969748|NCT01163253|10221426|P2|Overall Study|Adverse Event|78
2969749|NCT01163253|10221427|P1|Overall Study|Adverse Event|300
2969750|NCT01163253|10221426|P2|Overall Study|Insufficient Clinical Response|29
2969751|NCT01163253|10221427|P1|Overall Study|Insufficient Clinical Response|423
2969752|NCT01163253|10221426|P2|Overall Study|Lost to Follow-up|23
2969753|NCT01163253|10221427|P1|Overall Study|Lost to Follow-up|125
2969754|NCT01163253|10221426|P2|Overall Study|Medication Error|0
2969755|NCT01163253|10221427|P1|Overall Study|Medication Error|1
2969756|NCT01163253|10221426|P2|Overall Study|Withdrawal by Subject|50
2969757|NCT01163253|10221427|P1|Overall Study|Withdrawal by Subject|199
2969758|NCT01163253|10221426|P2|Overall Study|Protocol Violation|12
2969759|NCT01163253|10221427|P1|Overall Study|Protocol Violation|43
2969760|NCT01163253|10221426|P2|Overall Study|Study Terminated by Sponsor|349
2969761|NCT01163253|10221427|P1|Overall Study|Study Terminated by Sponsor|978
2969762|NCT01163253|10221426|P2|Overall Study|Withdrawn Due to Pregnancy|2
2969763|NCT01163253|10221427|P1|Overall Study|Withdrawn Due to Pregnancy|12
2969764|NCT01163149|10221615|P3|Extension Treatment Period|Noncompliance|1
2969765|NCT01163149|10221616|P2|Extension Treatment Period|Noncompliance|0
2969766|NCT01163149|10221617|P1|Extension Treatment Period|Noncompliance|0
2969767|NCT01163149|10221615|P3|Extension Treatment Period|Adverse Event|0
2969768|NCT01163149|10221616|P2|Extension Treatment Period|Adverse Event|1
2969769|NCT01163149|10221617|P1|Extension Treatment Period|Adverse Event|0
2969770|NCT01163149|10221615|P3|Extension Treatment Period|Withdrawal by Subject|1
2969771|NCT01163149|10221616|P2|Extension Treatment Period|Withdrawal by Subject|0
2969772|NCT01163149|10221617|P1|Extension Treatment Period|Withdrawal by Subject|2
2969773|NCT01163032|10221726|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
2969774|NCT01163032|10221727|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2969775|NCT01163032|10221728|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2969776|NCT01163032|10221726|P3|Open Label Extension Phase|Study Termination|7
2969777|NCT01163032|10221727|P2|Open Label Extension Phase|Study Termination|0
2969778|NCT01163032|10221728|P1|Open Label Extension Phase|Study Termination|0
2969779|NCT01163032|10221726|P3|Open Label Extension Phase|Protocol Violation|1
2969780|NCT01163032|10221727|P2|Open Label Extension Phase|Protocol Violation|0
2969781|NCT01163032|10221728|P1|Open Label Extension Phase|Protocol Violation|0
2969782|NCT01163032|10221726|P3|Open Label Extension Phase|Withdrawal by Subject|3
2969783|NCT01163032|10221727|P2|Open Label Extension Phase|Withdrawal by Subject|0
2969784|NCT01163032|10221728|P1|Open Label Extension Phase|Withdrawal by Subject|0
2969785|NCT01163032|10221726|P3|Open Label Extension Phase|Adverse Event|3
2969786|NCT01163032|10221727|P2|Open Label Extension Phase|Adverse Event|0
2969787|NCT01163032|10221728|P1|Open Label Extension Phase|Adverse Event|0
2969788|NCT01163032|10221726|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2969789|NCT01163032|10221727|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
2969790|NCT01163032|10221728|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2969791|NCT01163032|10221726|P3|Randomization Phase|Various*|0
2969792|NCT01163032|10221727|P2|Randomization Phase|Various*|4
2969793|NCT01163032|10221728|P1|Randomization Phase|Various*|5
2969794|NCT01163032|10221726|P3|Randomization Phase|Protocol Violation|0
2969795|NCT01163032|10221727|P2|Randomization Phase|Protocol Violation|1
2969796|NCT01163032|10221728|P1|Randomization Phase|Protocol Violation|0
2969797|NCT01163032|10221726|P3|Randomization Phase|Adverse Event|0
2969798|NCT01163032|10221727|P2|Randomization Phase|Adverse Event|3
2969799|NCT01163032|10221728|P1|Randomization Phase|Adverse Event|3
2969800|NCT01163032|10221726|P3|Randomization Phase|Withdrawal by Subject|0
2969801|NCT01163032|10221727|P2|Randomization Phase|Withdrawal by Subject|3
2969802|NCT01163032|10221728|P1|Randomization Phase|Withdrawal by Subject|2
2969803|NCT01162863|10221761|P3|Overall Study|Adverse Event|0
2969804|NCT01162863|10221762|P2|Overall Study|Adverse Event|1
2969805|NCT01162863|10221763|P1|Overall Study|Adverse Event|0
2969806|NCT01162863|10221761|P3|Overall Study|Lack of Efficacy|0
2969807|NCT01162863|10221762|P2|Overall Study|Lack of Efficacy|0
2969808|NCT01162863|10221763|P1|Overall Study|Lack of Efficacy|1
2969809|NCT01162499|10221793|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
2969810|NCT01162499|10221794|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
2969811|NCT01162486|10221819|P5|Overall Study|Pregnancy|0
2969812|NCT01162486|10221820|P4|Overall Study|Pregnancy|1
2969813|NCT01162486|10221821|P3|Overall Study|Pregnancy|0
2969814|NCT01162486|10221822|P2|Overall Study|Pregnancy|0
2969815|NCT01162486|10221823|P1|Overall Study|Pregnancy|0
2969816|NCT01162486|10221819|P5|Overall Study|elevated LFTs|0
2969817|NCT01162486|10221820|P4|Overall Study|elevated LFTs|0
2969818|NCT01162486|10221821|P3|Overall Study|elevated LFTs|1
2969819|NCT01162486|10221822|P2|Overall Study|elevated LFTs|0
2969820|NCT01162486|10221823|P1|Overall Study|elevated LFTs|0
2969821|NCT01162486|10221819|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
2969822|NCT01162486|10221820|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
2969823|NCT01162486|10221821|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
2969824|NCT01162486|10221822|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
2969825|NCT01162486|10221823|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
2969826|NCT01162486|10221819|P5|Overall Study|low ANC|0
2969827|NCT01162486|10221820|P4|Overall Study|low ANC|0
2969828|NCT01162486|10221821|P3|Overall Study|low ANC|0
2969829|NCT01162486|10221822|P2|Overall Study|low ANC|0
2969830|NCT01162486|10221823|P1|Overall Study|low ANC|1
2969831|NCT01162473|10221856|P2|Overall Study|Withdrawal by Subject|4
2969832|NCT01162473|10221857|P1|Overall Study|Withdrawal by Subject|0
2969833|NCT01162473|10221856|P2|Overall Study|Adverse Event|1
2969834|NCT01162473|10221857|P1|Overall Study|Adverse Event|2
2969835|NCT01162421|10221865|P2|Overall Study|Other|3
2969836|NCT01162421|10221866|P1|Overall Study|Other|2
2969837|NCT01162421|10221865|P2|Overall Study|Lack of Efficacy|2
2969838|NCT01162421|10221866|P1|Overall Study|Lack of Efficacy|2
2969839|NCT01162421|10221865|P2|Overall Study|Lost to Follow-up|2
2969840|NCT01162421|10221866|P1|Overall Study|Lost to Follow-up|0
2969841|NCT01162421|10221865|P2|Overall Study|Adverse Event|5
2969842|NCT01162421|10221866|P1|Overall Study|Adverse Event|2
2969843|NCT01162421|10221865|P2|Overall Study|Did not receive study drug|1
2969844|NCT01162421|10221866|P1|Overall Study|Did not receive study drug|2
2969845|NCT01162343|10221949|P1|Overall Study|Refused psychiatrist assessment|12
2969846|NCT01162343|10221949|P1|Overall Study|Left ED prior to psychiatrist assessment|80
2969847|NCT01162304|10221964|P1|Overall Study|Beck scale to high|11
2969848|NCT01162135|10221978|P1|Overall Study|Ineligible|1
2969849|NCT01162135|10221978|P1|Overall Study|Severe back pain|1
2969850|NCT01162135|10221978|P1|Overall Study|Withdrawal by Subject|1
2969851|NCT01162122|10221984|P2|Overall Study|Missing primary reason|0
2969852|NCT01162122|10221985|P1|Overall Study|Missing primary reason|1
2969853|NCT01162122|10221984|P2|Overall Study|Unable to classify|7
2969854|NCT01162122|10221985|P1|Overall Study|Unable to classify|3
2969855|NCT01162122|10221984|P2|Overall Study|Administrative reason|1
2969856|NCT01162122|10221985|P1|Overall Study|Administrative reason|1
2969857|NCT01162122|10221984|P2|Overall Study|Inappropriate enrollment|4
2969858|NCT01162122|10221985|P1|Overall Study|Inappropriate enrollment|5
2969859|NCT01162122|10221984|P2|Overall Study|Protocol Violation|2
2969860|NCT01162122|10221985|P1|Overall Study|Protocol Violation|2
2969861|NCT01162122|10221984|P2|Overall Study|Death|46
2969862|NCT01162122|10221985|P1|Overall Study|Death|51
2969863|NCT01162122|10221984|P2|Overall Study|Adverse Event|2
2969864|NCT01162122|10221985|P1|Overall Study|Adverse Event|3
2969865|NCT01162122|10221984|P2|Overall Study|Lost to Follow-up|91
2969866|NCT01162122|10221985|P1|Overall Study|Lost to Follow-up|73
2969867|NCT01162122|10221984|P2|Overall Study|Withdrawal by Subject|43
2969868|NCT01162122|10221985|P1|Overall Study|Withdrawal by Subject|52
2969869|NCT01161628|10222091|P1|Overall Study|Lack of Efficacy|2
2969870|NCT01161628|10222091|P1|Overall Study|Death|6
2969871|NCT01161537|10222114|P1|Part B|Withdrawal by Subject|2
2969872|NCT01161524|10222132|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
2969873|NCT01161524|10222133|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2969874|NCT01161524|10222134|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2969875|NCT01161524|10222132|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
2969876|NCT01161524|10222133|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2969877|NCT01161524|10222134|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2969878|NCT01161524|10222132|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
2969879|NCT01161524|10222133|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2969880|NCT01161524|10222134|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2969881|NCT01161524|10222132|P3|Extension Phase (Approximately 83 Weeks)|Other|6
2969882|NCT01161524|10222133|P2|Extension Phase (Approximately 83 Weeks)|Other|0
2969883|NCT01161524|10222134|P1|Extension Phase (Approximately 83 Weeks)|Other|0
2969884|NCT01161524|10222132|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
2969885|NCT01161524|10222133|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2969886|NCT01161524|10222134|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2969887|NCT01161524|10222132|P3|Core Study (23 Weeks)|Subject Choice|0
2969888|NCT01161524|10222133|P2|Core Study (23 Weeks)|Subject Choice|2
2969889|NCT01161524|10222134|P1|Core Study (23 Weeks)|Subject Choice|3
2969890|NCT01161524|10222132|P3|Core Study (23 Weeks)|Lost to Follow-up|0
2969891|NCT01161524|10222133|P2|Core Study (23 Weeks)|Lost to Follow-up|2
2969892|NCT01161524|10222134|P1|Core Study (23 Weeks)|Lost to Follow-up|1
2969893|NCT01161524|10222132|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
2969894|NCT01161524|10222133|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
2969895|NCT01161524|10222134|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
2969896|NCT01161524|10222132|P3|Core Study (23 Weeks)|Other|0
2969897|NCT01161524|10222133|P2|Core Study (23 Weeks)|Other|0
2969898|NCT01161524|10222134|P1|Core Study (23 Weeks)|Other|1
2969899|NCT01161524|10222132|P3|Core Study (23 Weeks)|Adverse Event|0
2969900|NCT01161524|10222133|P2|Core Study (23 Weeks)|Adverse Event|0
2969901|NCT01161524|10222134|P1|Core Study (23 Weeks)|Adverse Event|3
2969902|NCT01161498|10222173|P2|Overall Study|Disease Progression|1
2969903|NCT01161498|10222174|P1|Overall Study|Disease Progression|0
2969904|NCT01161472|10222198|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2969905|NCT01161472|10222199|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2969906|NCT01161472|10222200|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2969907|NCT01161472|10222201|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
2969908|NCT01161446|10222257|P2|Overall Study|Withdrawal by Subject|1
2969909|NCT01161446|10222258|P1|Overall Study|Withdrawal by Subject|0
2969910|NCT01161446|10222257|P2|Overall Study|Lost to Follow-up|14
2969911|NCT01161446|10222258|P1|Overall Study|Lost to Follow-up|18
2969912|NCT01161407|10222284|P2|Overall Study|Protocol Violation|1
2969913|NCT01161407|10222285|P1|Overall Study|Protocol Violation|3
2969914|NCT01161173|10222340|P1|Overall Study|Reasons Not Specified|23
2969915|NCT01161173|10222340|P1|Overall Study|End of Study|2
2969916|NCT01161173|10222340|P1|Overall Study|Death|194
2969917|NCT01161173|10222340|P1|Overall Study|Unacceptable Toxicity|21
2969918|NCT01161173|10222340|P1|Overall Study|Withdrawal of Consent|5
2969919|NCT01161173|10222340|P1|Overall Study|Progressive Disease|82
2969920|NCT01161173|10222340|P1|Overall Study|Lost to Follow-up|7
2969921|NCT01161173|10222340|P1|Overall Study|Protocol Violation|13
2969922|NCT01160822|10222467|P7|Overall Study|Protocol deviation|0
2969923|NCT01160822|10222468|P6|Overall Study|Protocol deviation|0
2969924|NCT01160822|10222469|P5|Overall Study|Protocol deviation|2
2969925|NCT01160822|10222470|P4|Overall Study|Protocol deviation|0
2969926|NCT01160822|10222471|P3|Overall Study|Protocol deviation|0
2969927|NCT01160822|10222472|P2|Overall Study|Protocol deviation|0
2969928|NCT01160822|10222473|P1|Overall Study|Protocol deviation|0
2969929|NCT01160822|10222467|P7|Overall Study|Administrative problems|0
2969930|NCT01160822|10222468|P6|Overall Study|Administrative problems|0
2969931|NCT01160822|10222469|P5|Overall Study|Administrative problems|1
2969932|NCT01160822|10222470|P4|Overall Study|Administrative problems|0
2969933|NCT01160822|10222471|P3|Overall Study|Administrative problems|0
2969934|NCT01160822|10222472|P2|Overall Study|Administrative problems|0
2969935|NCT01160822|10222473|P1|Overall Study|Administrative problems|0
2969936|NCT01160822|10222467|P7|Overall Study|Lost to Follow-up|0
2969937|NCT01160822|10222468|P6|Overall Study|Lost to Follow-up|0
2969938|NCT01160822|10222469|P5|Overall Study|Lost to Follow-up|1
2969939|NCT01160822|10222470|P4|Overall Study|Lost to Follow-up|0
2969940|NCT01160822|10222471|P3|Overall Study|Lost to Follow-up|0
2969941|NCT01160822|10222472|P2|Overall Study|Lost to Follow-up|0
2969942|NCT01160822|10222473|P1|Overall Study|Lost to Follow-up|0
2969943|NCT01160822|10222467|P7|Overall Study|Withdrawal by Subject|1
2969944|NCT01160822|10222468|P6|Overall Study|Withdrawal by Subject|0
2969945|NCT01160822|10222469|P5|Overall Study|Withdrawal by Subject|0
2969946|NCT01160822|10222470|P4|Overall Study|Withdrawal by Subject|0
2969947|NCT01160822|10222471|P3|Overall Study|Withdrawal by Subject|0
2969948|NCT01160822|10222472|P2|Overall Study|Withdrawal by Subject|0
2969949|NCT01160822|10222473|P1|Overall Study|Withdrawal by Subject|0
2969950|NCT01160822|10222467|P7|Overall Study|Unsatisfactory therapeutic effect|3
2969951|NCT01160822|10222468|P6|Overall Study|Unsatisfactory therapeutic effect|5
2969952|NCT01160822|10222469|P5|Overall Study|Unsatisfactory therapeutic effect|4
2969953|NCT01160822|10222470|P4|Overall Study|Unsatisfactory therapeutic effect|0
2969954|NCT01160822|10222471|P3|Overall Study|Unsatisfactory therapeutic effect|0
2969955|NCT01160822|10222472|P2|Overall Study|Unsatisfactory therapeutic effect|0
2969956|NCT01160822|10222473|P1|Overall Study|Unsatisfactory therapeutic effect|0
2969957|NCT01160822|10222467|P7|Overall Study|Adverse Event|5
2969958|NCT01160822|10222468|P6|Overall Study|Adverse Event|2
2969959|NCT01160822|10222469|P5|Overall Study|Adverse Event|1
2969960|NCT01160822|10222470|P4|Overall Study|Adverse Event|0
2969961|NCT01160822|10222471|P3|Overall Study|Adverse Event|0
2969962|NCT01160822|10222472|P2|Overall Study|Adverse Event|0
2969963|NCT01160822|10222473|P1|Overall Study|Adverse Event|0
2969964|NCT01160770|10222562|P1|Overall Study|Other Reasons|1
2969965|NCT01160770|10222562|P1|Overall Study|Lack of Efficacy|15
2969966|NCT01160770|10222562|P1|Overall Study|Death|9
2969967|NCT01160770|10222562|P1|Overall Study|Study termination or sponsor request|1
2969968|NCT01160770|10222562|P1|Overall Study|Lost to Follow-up|7
2969969|NCT01160770|10222562|P1|Overall Study|Physician Decision|1
2969970|NCT01160770|10222562|P1|Overall Study|Subject/parent/caregiver request|33
2969971|NCT01160770|10222562|P1|Overall Study|Protocol Violation|2
2969972|NCT01160770|10222562|P1|Overall Study|Adverse Event|10
2969973|NCT01160744|10222575|P4|Overall Study|Not meet inclusion/exclusion criteria|0
2969974|NCT01160744|10222576|P3|Overall Study|Not meet inclusion/exclusion criteria|1
2969975|NCT01160744|10222577|P2|Overall Study|Not meet inclusion/exclusion criteria|0
2969976|NCT01160744|10222578|P1|Overall Study|Not meet inclusion/exclusion criteria|0
2969977|NCT01160744|10222575|P4|Overall Study|Withdrawal by Subject|4
2969978|NCT01160744|10222576|P3|Overall Study|Withdrawal by Subject|6
2969979|NCT01160744|10222577|P2|Overall Study|Withdrawal by Subject|5
2969980|NCT01160744|10222578|P1|Overall Study|Withdrawal by Subject|11
2969981|NCT01160640|10222614|P2|Overall Study|Withdrawal by Subject|3
2969982|NCT01160640|10222615|P1|Overall Study|Withdrawal by Subject|0
2969983|NCT01160640|10222614|P2|Overall Study|Incarceration|0
2969984|NCT01160640|10222615|P1|Overall Study|Incarceration|1
2969985|NCT01160640|10222614|P2|Overall Study|Physician Decision|3
2969986|NCT01160640|10222615|P1|Overall Study|Physician Decision|3
2969987|NCT01160614|10222631|P2|Overall Study|Withdrawal by Subject|2
2969988|NCT01160614|10222632|P1|Overall Study|Withdrawal by Subject|0
2969989|NCT01160484|10222680|P1|Overall Study|inclusion/exclusion criteria failure|1
2969990|NCT01160484|10222680|P1|Overall Study|Withdrawal by Subject|2
2969991|NCT01160484|10222680|P1|Overall Study|Adverse Event|6
2969992|NCT01160484|10222680|P1|Overall Study|Lack of Efficacy|9
2969993|NCT01160354|10222733|P3|Overall Study|Death|1
2969994|NCT01160354|10222734|P2|Overall Study|Death|1
2969995|NCT01160354|10222735|P1|Overall Study|Death|0
2969996|NCT01160289|10222754|P6|Post-Randomization Period|Sponsor Decision|0
2969997|NCT01160289|10222755|P5|Post-Randomization Period|Sponsor Decision|0
2969998|NCT01160289|10222756|P4|Post-Randomization Period|Sponsor Decision|0
2969999|NCT01160289|10222757|P3|Post-Randomization Period|Sponsor Decision|0
2970000|NCT01160289|10222758|P2|Post-Randomization Period|Sponsor Decision|1
2970001|NCT01160289|10222759|P1|Post-Randomization Period|Sponsor Decision|0
2970002|NCT01160289|10222754|P6|Post-Randomization Period|Entry Criteria Not Met|0
2970003|NCT01160289|10222755|P5|Post-Randomization Period|Entry Criteria Not Met|0
2970004|NCT01160289|10222756|P4|Post-Randomization Period|Entry Criteria Not Met|2
2970005|NCT01160289|10222757|P3|Post-Randomization Period|Entry Criteria Not Met|2
2970006|NCT01160289|10222758|P2|Post-Randomization Period|Entry Criteria Not Met|2
2970007|NCT01160289|10222759|P1|Post-Randomization Period|Entry Criteria Not Met|0
2970008|NCT01160289|10222754|P6|Post-Randomization Period|Withdrawal by Subject|7
2970009|NCT01160289|10222755|P5|Post-Randomization Period|Withdrawal by Subject|5
2970010|NCT01160289|10222756|P4|Post-Randomization Period|Withdrawal by Subject|8
2970011|NCT01160289|10222757|P3|Post-Randomization Period|Withdrawal by Subject|13
2970012|NCT01160289|10222758|P2|Post-Randomization Period|Withdrawal by Subject|5
2970013|NCT01160289|10222759|P1|Post-Randomization Period|Withdrawal by Subject|0
2970014|NCT01160289|10222754|P6|Post-Randomization Period|Protocol Violation|3
2970015|NCT01160289|10222755|P5|Post-Randomization Period|Protocol Violation|1
2970016|NCT01160289|10222756|P4|Post-Randomization Period|Protocol Violation|0
2970017|NCT01160289|10222757|P3|Post-Randomization Period|Protocol Violation|2
2970018|NCT01160289|10222758|P2|Post-Randomization Period|Protocol Violation|4
2970019|NCT01160289|10222759|P1|Post-Randomization Period|Protocol Violation|0
2970020|NCT01160289|10222754|P6|Post-Randomization Period|Physician Decision|0
2970021|NCT01160289|10222755|P5|Post-Randomization Period|Physician Decision|0
2970022|NCT01160289|10222756|P4|Post-Randomization Period|Physician Decision|0
2970023|NCT01160289|10222757|P3|Post-Randomization Period|Physician Decision|1
2970024|NCT01160289|10222758|P2|Post-Randomization Period|Physician Decision|0
2970025|NCT01160289|10222759|P1|Post-Randomization Period|Physician Decision|0
2970026|NCT01160289|10222754|P6|Post-Randomization Period|Lost to Follow-up|4
2970027|NCT01160289|10222755|P5|Post-Randomization Period|Lost to Follow-up|3
2970028|NCT01160289|10222756|P4|Post-Randomization Period|Lost to Follow-up|5
2970029|NCT01160289|10222757|P3|Post-Randomization Period|Lost to Follow-up|2
2970030|NCT01160289|10222758|P2|Post-Randomization Period|Lost to Follow-up|3
2970031|NCT01160289|10222759|P1|Post-Randomization Period|Lost to Follow-up|0
2970032|NCT01160289|10222754|P6|Post-Randomization Period|Lack of Efficacy|0
2970033|NCT01160289|10222755|P5|Post-Randomization Period|Lack of Efficacy|0
2970034|NCT01160289|10222756|P4|Post-Randomization Period|Lack of Efficacy|3
2970035|NCT01160289|10222757|P3|Post-Randomization Period|Lack of Efficacy|0
2970036|NCT01160289|10222758|P2|Post-Randomization Period|Lack of Efficacy|1
2970037|NCT01160289|10222759|P1|Post-Randomization Period|Lack of Efficacy|0
2970038|NCT01160289|10222754|P6|Post-Randomization Period|Death|0
2970039|NCT01160289|10222755|P5|Post-Randomization Period|Death|0
2970040|NCT01160289|10222756|P4|Post-Randomization Period|Death|1
2970041|NCT01160289|10222757|P3|Post-Randomization Period|Death|0
2970042|NCT01160289|10222758|P2|Post-Randomization Period|Death|0
2970043|NCT01160289|10222759|P1|Post-Randomization Period|Death|0
2970044|NCT01160289|10222754|P6|Post-Randomization Period|Adverse Event|0
2970045|NCT01160289|10222755|P5|Post-Randomization Period|Adverse Event|0
2970046|NCT01160289|10222756|P4|Post-Randomization Period|Adverse Event|2
2970047|NCT01160289|10222757|P3|Post-Randomization Period|Adverse Event|4
2970048|NCT01160289|10222758|P2|Post-Randomization Period|Adverse Event|4
2970049|NCT01160289|10222759|P1|Post-Randomization Period|Adverse Event|0
2970050|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2970051|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2970052|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2970053|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2970054|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2970055|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
2970056|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2970057|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2970058|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2970059|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2970060|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2970061|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
2970062|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
2970063|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
2970064|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
2970065|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
2970066|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
2970067|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
2970068|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
2970069|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
2970070|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
2970071|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
2970072|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
2970073|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
2970074|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2970075|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2970076|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2970077|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2970078|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2970079|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
2970080|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2970081|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2970082|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2970083|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2970084|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2970085|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
2970086|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2970087|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2970088|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2970089|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2970090|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2970091|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
2970092|NCT01160289|10222754|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
2970093|NCT01160289|10222755|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
2970094|NCT01160289|10222756|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
2970095|NCT01160289|10222757|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
2970096|NCT01160289|10222758|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
2970097|NCT01160289|10222759|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
2970098|NCT01160211|10222848|P3|Overall Study|Lost to Follow-up|5
2970099|NCT01160211|10222849|P2|Overall Study|Lost to Follow-up|7
2970100|NCT01160211|10222850|P1|Overall Study|Lost to Follow-up|4
2970101|NCT01160211|10222848|P3|Overall Study|Physician Decision|0
2970102|NCT01160211|10222849|P2|Overall Study|Physician Decision|0
2970103|NCT01160211|10222850|P1|Overall Study|Physician Decision|2
2970104|NCT01160211|10222848|P3|Overall Study|Withdrawal by Subject|3
2970105|NCT01160211|10222849|P2|Overall Study|Withdrawal by Subject|5
2970106|NCT01160211|10222850|P1|Overall Study|Withdrawal by Subject|3
2970107|NCT01160211|10222848|P3|Overall Study|ongoing|79
2970108|NCT01160211|10222849|P2|Overall Study|ongoing|75
2970109|NCT01160211|10222850|P1|Overall Study|ongoing|90
2970110|NCT01160198|10222883|P3|Overall Study|Participant lost drug; withdrew consent|1
2970111|NCT01160198|10222884|P2|Overall Study|Participant lost drug; withdrew consent|0
2970112|NCT01160198|10222885|P1|Overall Study|Participant lost drug; withdrew consent|0
2970113|NCT01160198|10222883|P3|Overall Study|Lost to Follow-up|0
2970114|NCT01160198|10222884|P2|Overall Study|Lost to Follow-up|1
2970115|NCT01160198|10222885|P1|Overall Study|Lost to Follow-up|0
2970116|NCT01160198|10222883|P3|Overall Study|Adverse Event|0
2970117|NCT01160198|10222884|P2|Overall Study|Adverse Event|1
2970118|NCT01160198|10222885|P1|Overall Study|Adverse Event|0
2970119|NCT01160198|10222883|P3|Overall Study|Withdrawal by Subject|0
2970120|NCT01160198|10222884|P2|Overall Study|Withdrawal by Subject|1
2970121|NCT01160198|10222885|P1|Overall Study|Withdrawal by Subject|2
2970122|NCT01159938|10222907|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
2970123|NCT01159938|10222908|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
2970124|NCT01159938|10222909|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
2970125|NCT01159938|10222910|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
2970126|NCT01159938|10222911|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
2970127|NCT01159912|10222974|P3|Overall Study|Withdrawal by Subject|3
2970128|NCT01159912|10222975|P2|Overall Study|Withdrawal by Subject|3
2970129|NCT01159912|10222976|P1|Overall Study|Withdrawal by Subject|10
2970130|NCT01159912|10222974|P3|Overall Study|Physician Decision|3
2970131|NCT01159912|10222975|P2|Overall Study|Physician Decision|0
2970132|NCT01159912|10222976|P1|Overall Study|Physician Decision|0
2970133|NCT01159912|10222974|P3|Overall Study|Lost to Follow-up|0
2970134|NCT01159912|10222975|P2|Overall Study|Lost to Follow-up|0
2970135|NCT01159912|10222976|P1|Overall Study|Lost to Follow-up|4
2970136|NCT01159912|10222974|P3|Overall Study|Protocol Violation|3
2970137|NCT01159912|10222975|P2|Overall Study|Protocol Violation|2
2970138|NCT01159912|10222976|P1|Overall Study|Protocol Violation|1
2970139|NCT01159912|10222974|P3|Overall Study|Lack of Efficacy|14
2970140|NCT01159912|10222975|P2|Overall Study|Lack of Efficacy|15
2970141|NCT01159912|10222976|P1|Overall Study|Lack of Efficacy|23
2970142|NCT01159912|10222974|P3|Overall Study|Adverse Event|3
2970143|NCT01159912|10222975|P2|Overall Study|Adverse Event|2
2970144|NCT01159912|10222976|P1|Overall Study|Adverse Event|2
2970145|NCT01159769|10222999|P1|Overall Study|Adverse Event|1
2970146|NCT01159691|10223019|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
2970147|NCT01159691|10223019|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
2970148|NCT01159691|10223019|P1|Overall Study|Disc. Neupro other & unknown reasons|7
2970149|NCT01159691|10223019|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
2970150|NCT01159691|10223019|P1|Overall Study|Discontinued Neupro due to other reasons|1
2970151|NCT01159691|10223019|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
2970152|NCT01159691|10223019|P1|Overall Study|Unknown reasons|1
2970153|NCT01159691|10223019|P1|Overall Study|Lost to Follow-up|2
2970154|NCT01159665|10223032|P6|Overall Study|Withdrawal by Subject|0
2970155|NCT01159665|10223033|P5|Overall Study|Withdrawal by Subject|0
2970156|NCT01159665|10223034|P4|Overall Study|Withdrawal by Subject|0
2970157|NCT01159665|10223035|P3|Overall Study|Withdrawal by Subject|0
2970158|NCT01159665|10223036|P2|Overall Study|Withdrawal by Subject|1
2970159|NCT01159665|10223037|P1|Overall Study|Withdrawal by Subject|0
2970160|NCT01159600|10223065|P8|Overall Study|Other reason not defined above|3
2970161|NCT01159600|10223066|P7|Overall Study|Other reason not defined above|3
2970162|NCT01159600|10223067|P6|Overall Study|Other reason not defined above|7
2970163|NCT01159600|10223068|P5|Overall Study|Other reason not defined above|5
2970164|NCT01159600|10223069|P4|Overall Study|Other reason not defined above|2
2970165|NCT01159600|10223070|P3|Overall Study|Other reason not defined above|4
2970166|NCT01159600|10223071|P2|Overall Study|Other reason not defined above|0
2970167|NCT01159600|10223072|P1|Overall Study|Other reason not defined above|3
2970168|NCT01159600|10223065|P8|Overall Study|Patient refusal to continue,not due toAE|5
2970169|NCT01159600|10223066|P7|Overall Study|Patient refusal to continue,not due toAE|2
2970170|NCT01159600|10223067|P6|Overall Study|Patient refusal to continue,not due toAE|4
2970171|NCT01159600|10223068|P5|Overall Study|Patient refusal to continue,not due toAE|4
2970172|NCT01159600|10223069|P4|Overall Study|Patient refusal to continue,not due toAE|5
2970173|NCT01159600|10223070|P3|Overall Study|Patient refusal to continue,not due toAE|4
2970174|NCT01159600|10223071|P2|Overall Study|Patient refusal to continue,not due toAE|2
2970175|NCT01159600|10223072|P1|Overall Study|Patient refusal to continue,not due toAE|7
2970176|NCT01159600|10223065|P8|Overall Study|Lost to Follow-up|2
2970177|NCT01159600|10223066|P7|Overall Study|Lost to Follow-up|3
2970178|NCT01159600|10223067|P6|Overall Study|Lost to Follow-up|0
2970179|NCT01159600|10223068|P5|Overall Study|Lost to Follow-up|3
2970180|NCT01159600|10223069|P4|Overall Study|Lost to Follow-up|3
2970181|NCT01159600|10223070|P3|Overall Study|Lost to Follow-up|4
2970182|NCT01159600|10223071|P2|Overall Study|Lost to Follow-up|3
2970183|NCT01159600|10223072|P1|Overall Study|Lost to Follow-up|2
2970184|NCT01159600|10223065|P8|Overall Study|Non compliant with protocol|0
2970185|NCT01159600|10223066|P7|Overall Study|Non compliant with protocol|2
2970186|NCT01159600|10223067|P6|Overall Study|Non compliant with protocol|0
2970187|NCT01159600|10223068|P5|Overall Study|Non compliant with protocol|2
2970188|NCT01159600|10223069|P4|Overall Study|Non compliant with protocol|0
2970189|NCT01159600|10223070|P3|Overall Study|Non compliant with protocol|0
2970190|NCT01159600|10223071|P2|Overall Study|Non compliant with protocol|1
2970191|NCT01159600|10223072|P1|Overall Study|Non compliant with protocol|2
2970192|NCT01159600|10223065|P8|Overall Study|Lack of Efficacy|1
2970193|NCT01159600|10223066|P7|Overall Study|Lack of Efficacy|0
2970194|NCT01159600|10223067|P6|Overall Study|Lack of Efficacy|0
2970195|NCT01159600|10223068|P5|Overall Study|Lack of Efficacy|2
2970196|NCT01159600|10223069|P4|Overall Study|Lack of Efficacy|0
2970197|NCT01159600|10223070|P3|Overall Study|Lack of Efficacy|0
2970198|NCT01159600|10223071|P2|Overall Study|Lack of Efficacy|0
2970199|NCT01159600|10223072|P1|Overall Study|Lack of Efficacy|0
2970200|NCT01159600|10223065|P8|Overall Study|Adverse Event|5
2970201|NCT01159600|10223066|P7|Overall Study|Adverse Event|7
2970202|NCT01159600|10223067|P6|Overall Study|Adverse Event|6
2970203|NCT01159600|10223068|P5|Overall Study|Adverse Event|8
2970204|NCT01159600|10223069|P4|Overall Study|Adverse Event|1
2970205|NCT01159600|10223070|P3|Overall Study|Adverse Event|5
2970206|NCT01159600|10223071|P2|Overall Study|Adverse Event|2
2970207|NCT01159600|10223072|P1|Overall Study|Adverse Event|7
2970208|NCT01159600|10223065|P8|Overall Study|Not treated|2
2970209|NCT01159600|10223066|P7|Overall Study|Not treated|2
2970210|NCT01159600|10223067|P6|Overall Study|Not treated|1
2970211|NCT01159600|10223068|P5|Overall Study|Not treated|0
2970212|NCT01159600|10223069|P4|Overall Study|Not treated|0
2970213|NCT01159600|10223070|P3|Overall Study|Not treated|1
2970214|NCT01159600|10223071|P2|Overall Study|Not treated|0
2970215|NCT01159600|10223072|P1|Overall Study|Not treated|0
2970216|NCT01159574|10223114|P1|Follow Up Phase|still being followed for overall surviva|18
2970217|NCT01159574|10223114|P1|Follow Up Phase|Lost to Follow-up|2
2970218|NCT01159574|10223114|P1|Treatment Phase|still on treatment|2
2970219|NCT01159574|10223114|P1|Treatment Phase|Withdrawal by Subject|7
2970220|NCT01159574|10223114|P1|Treatment Phase|Physician Decision|2
2970221|NCT01159574|10223114|P1|Treatment Phase|Death|6
2970222|NCT01159574|10223114|P1|Treatment Phase|Adverse Event|3
2970223|NCT01159574|10223114|P1|Treatment Phase|non-evaluable/not included in analysis|1
2970224|NCT01159431|10223135|P2|Overall Study|Lack of Efficacy|3
2970225|NCT01159431|10223136|P1|Overall Study|Lack of Efficacy|0
2970226|NCT01159431|10223135|P2|Overall Study|non-compliance|1
2970227|NCT01159431|10223136|P1|Overall Study|non-compliance|1
2970228|NCT01159431|10223135|P2|Overall Study|Adverse Event|2
2970229|NCT01159431|10223136|P1|Overall Study|Adverse Event|1
2970230|NCT01159171|10223189|P1|Overall Study|Death|1
2970231|NCT01159171|10223189|P1|Overall Study|Medical Decision|4
2970232|NCT01159171|10223189|P1|Overall Study|Need for Surgery|5
2970233|NCT01159171|10223189|P1|Overall Study|Protocol Violation|1
2970234|NCT01159171|10223189|P1|Overall Study|Progression of Disease|28
2970235|NCT01159171|10223189|P1|Overall Study|Adverse Event|11
2970236|NCT01158924|10223270|P2|Overall Study|Lost to Follow-up|1
2970237|NCT01158924|10223271|P1|Overall Study|Lost to Follow-up|0
2970238|NCT01158924|10223270|P2|Overall Study|Withdrawal by Subject|2
2970239|NCT01158924|10223271|P1|Overall Study|Withdrawal by Subject|1
2970240|NCT01158534|10223376|P1|Overall Study|Other|1
2970241|NCT01158534|10223376|P1|Overall Study|Death|1
2970242|NCT01158534|10223376|P1|Overall Study|Withdrawal by Subject|1
2970243|NCT01158404|10223401|P8|Overall Study|Progressive Disease|0
2970244|NCT01158404|10223402|P7|Overall Study|Progressive Disease|1
2970245|NCT01158404|10223403|P6|Overall Study|Progressive Disease|0
2970246|NCT01158404|10223404|P5|Overall Study|Progressive Disease|0
2970247|NCT01158404|10223405|P4|Overall Study|Progressive Disease|0
2970248|NCT01158404|10223406|P3|Overall Study|Progressive Disease|0
2970249|NCT01158404|10223407|P2|Overall Study|Progressive Disease|0
2970250|NCT01158404|10223408|P1|Overall Study|Progressive Disease|0
2970251|NCT01158404|10223401|P8|Overall Study|Physician Decision|1
2970252|NCT01158404|10223402|P7|Overall Study|Physician Decision|0
2970253|NCT01158404|10223403|P6|Overall Study|Physician Decision|0
2970254|NCT01158404|10223404|P5|Overall Study|Physician Decision|0
2970255|NCT01158404|10223405|P4|Overall Study|Physician Decision|0
2970256|NCT01158404|10223406|P3|Overall Study|Physician Decision|0
2970257|NCT01158404|10223407|P2|Overall Study|Physician Decision|0
2970258|NCT01158404|10223408|P1|Overall Study|Physician Decision|0
2970259|NCT01158404|10223401|P8|Overall Study|Withdrawal by Subject|1
2970260|NCT01158404|10223402|P7|Overall Study|Withdrawal by Subject|0
2970261|NCT01158404|10223403|P6|Overall Study|Withdrawal by Subject|1
2970262|NCT01158404|10223404|P5|Overall Study|Withdrawal by Subject|3
2970263|NCT01158404|10223405|P4|Overall Study|Withdrawal by Subject|0
2970264|NCT01158404|10223406|P3|Overall Study|Withdrawal by Subject|0
2970265|NCT01158404|10223407|P2|Overall Study|Withdrawal by Subject|1
2970266|NCT01158404|10223408|P1|Overall Study|Withdrawal by Subject|0
2970267|NCT01158378|10223450|P2|Overall Study|Withdrawal by Subject|0
2970268|NCT01158378|10223451|P1|Overall Study|Withdrawal by Subject|4
2970269|NCT01158378|10223450|P2|Overall Study|Lost to Follow-up|4
2970270|NCT01158378|10223451|P1|Overall Study|Lost to Follow-up|2
2970271|NCT01158378|10223450|P2|Overall Study|Death|5
2970272|NCT01158378|10223451|P1|Overall Study|Death|4
2970273|NCT01158261|10223463|P1|Overall Study|Withdrawal by Subject|1
2970274|NCT01158261|10223463|P1|Overall Study|Death|7
2970275|NCT01158261|10223463|P1|Overall Study|Lost to Follow-up|9
2970276|NCT01158222|10223467|P1|Overall Study|Not eligible for intermediate phase|17
2970277|NCT01158118|10223479|P2|Overall Study|Death|1
2970278|NCT01158118|10223480|P1|Overall Study|Death|0
2970279|NCT01158118|10223479|P2|Overall Study|Suffered stroke prior to transplant|1
2970280|NCT01158118|10223480|P1|Overall Study|Suffered stroke prior to transplant|0
2970281|NCT01158118|10223479|P2|Overall Study|Donor match was a screen failure|1
2970282|NCT01158118|10223480|P1|Overall Study|Donor match was a screen failure|0
2970283|NCT01158118|10223479|P2|Overall Study|Screen failure|0
2970284|NCT01158118|10223480|P1|Overall Study|Screen failure|1
2970285|NCT01157897|10223500|P4|Overall Study|Relocated|0
2970286|NCT01157897|10223501|P3|Overall Study|Relocated|0
2970287|NCT01157897|10223502|P2|Overall Study|Relocated|2
2970288|NCT01157897|10223503|P1|Overall Study|Relocated|0
2970289|NCT01157897|10223500|P4|Overall Study|Lost to Follow-up|1
2970290|NCT01157897|10223501|P3|Overall Study|Lost to Follow-up|0
2970291|NCT01157897|10223502|P2|Overall Study|Lost to Follow-up|0
2970292|NCT01157897|10223503|P1|Overall Study|Lost to Follow-up|2
2970293|NCT01157845|10223528|P1|Overall Study|Device malfunction|1
2970294|NCT01157845|10223528|P1|Overall Study|Study was ended|1
2970295|NCT01157845|10223528|P1|Overall Study|Protocol Violation|13
2970296|NCT01157845|10223528|P1|Overall Study|Physician Decision|3
2970297|NCT01157845|10223528|P1|Overall Study|Withdrawal by Subject|12
2970298|NCT01157845|10223528|P1|Overall Study|Lost to Follow-up|5
2970299|NCT01157676|10223535|P2|Surgery|underwent robotic cystectomy|0
2970300|NCT01157676|10223536|P1|Surgery|underwent robotic cystectomy|1
2970301|NCT01157676|10223535|P2|Surgery|converted to open procedure|5
2970302|NCT01157676|10223536|P1|Surgery|converted to open procedure|0
2970303|NCT01157676|10223535|P2|Surgery|underwent open cystectomy|4
2970304|NCT01157676|10223536|P1|Surgery|underwent open cystectomy|0
2970305|NCT01157676|10223535|P2|Randomization|Physician Decision|0
2970306|NCT01157676|10223536|P1|Randomization|Physician Decision|1
2970307|NCT01157676|10223535|P2|Randomization|Withdrawal by Subject|13
2970308|NCT01157676|10223536|P1|Randomization|Withdrawal by Subject|17
2970309|NCT01157676|10223535|P2|Randomization|unresectable|3
2970310|NCT01157676|10223536|P1|Randomization|unresectable|2
2970311|NCT01157676|10223535|P2|Randomization|Death|1
2970312|NCT01157676|10223536|P1|Randomization|Death|1
2970313|NCT01157377|10223611|P7|Overall Study|Other Miscellaneous Reasons|1
2970314|NCT01157377|10223612|P6|Overall Study|Other Miscellaneous Reasons|1
2970315|NCT01157377|10223613|P5|Overall Study|Other Miscellaneous Reasons|1
2970316|NCT01157377|10223614|P4|Overall Study|Other Miscellaneous Reasons|0
2970317|NCT01157377|10223615|P3|Overall Study|Other Miscellaneous Reasons|0
2970318|NCT01157377|10223616|P2|Overall Study|Other Miscellaneous Reasons|2
2970319|NCT01157377|10223617|P1|Overall Study|Other Miscellaneous Reasons|0
2970320|NCT01157377|10223611|P7|Overall Study|Lack of Efficacy|1
2970321|NCT01157377|10223612|P6|Overall Study|Lack of Efficacy|0
2970322|NCT01157377|10223613|P5|Overall Study|Lack of Efficacy|0
2970323|NCT01157377|10223614|P4|Overall Study|Lack of Efficacy|0
2970324|NCT01157377|10223615|P3|Overall Study|Lack of Efficacy|0
2970325|NCT01157377|10223616|P2|Overall Study|Lack of Efficacy|0
2970326|NCT01157377|10223617|P1|Overall Study|Lack of Efficacy|0
2970327|NCT01157377|10223611|P7|Overall Study|Protocol Violation|0
2970328|NCT01157377|10223612|P6|Overall Study|Protocol Violation|1
2970329|NCT01157377|10223613|P5|Overall Study|Protocol Violation|0
2970330|NCT01157377|10223614|P4|Overall Study|Protocol Violation|0
2970331|NCT01157377|10223615|P3|Overall Study|Protocol Violation|0
2970332|NCT01157377|10223616|P2|Overall Study|Protocol Violation|0
2970333|NCT01157377|10223617|P1|Overall Study|Protocol Violation|0
2970334|NCT01157377|10223611|P7|Overall Study|Personal Reasons|0
2970335|NCT01157377|10223612|P6|Overall Study|Personal Reasons|0
2970336|NCT01157377|10223613|P5|Overall Study|Personal Reasons|0
2970337|NCT01157377|10223614|P4|Overall Study|Personal Reasons|1
2970338|NCT01157377|10223615|P3|Overall Study|Personal Reasons|0
2970339|NCT01157377|10223616|P2|Overall Study|Personal Reasons|1
2970340|NCT01157377|10223617|P1|Overall Study|Personal Reasons|2
2970341|NCT01157377|10223611|P7|Overall Study|Lost to Follow-up|0
2970342|NCT01157377|10223612|P6|Overall Study|Lost to Follow-up|1
2970343|NCT01157377|10223613|P5|Overall Study|Lost to Follow-up|1
2970344|NCT01157377|10223614|P4|Overall Study|Lost to Follow-up|0
2970345|NCT01157377|10223615|P3|Overall Study|Lost to Follow-up|1
2970346|NCT01157377|10223616|P2|Overall Study|Lost to Follow-up|0
2970347|NCT01157377|10223617|P1|Overall Study|Lost to Follow-up|0
2970348|NCT01157364|10223639|P6|Overall Study|Adverse Event|0
2970349|NCT01157364|10223640|P5|Overall Study|Adverse Event|1
2970350|NCT01157364|10223641|P4|Overall Study|Adverse Event|0
2970351|NCT01157364|10223642|P3|Overall Study|Adverse Event|1
2970352|NCT01157364|10223643|P2|Overall Study|Adverse Event|1
2970353|NCT01157364|10223644|P1|Overall Study|Adverse Event|0
2970354|NCT01157364|10223639|P6|Overall Study|Lack of Efficacy|0
2970355|NCT01157364|10223640|P5|Overall Study|Lack of Efficacy|0
2970356|NCT01157364|10223641|P4|Overall Study|Lack of Efficacy|1
2970357|NCT01157364|10223642|P3|Overall Study|Lack of Efficacy|0
2970358|NCT01157364|10223643|P2|Overall Study|Lack of Efficacy|0
2970359|NCT01157364|10223644|P1|Overall Study|Lack of Efficacy|0
2970360|NCT01157364|10223639|P6|Overall Study|Lost to Follow-up|0
2970361|NCT01157364|10223640|P5|Overall Study|Lost to Follow-up|0
2970362|NCT01157364|10223641|P4|Overall Study|Lost to Follow-up|0
2970363|NCT01157364|10223642|P3|Overall Study|Lost to Follow-up|1
2970364|NCT01157364|10223643|P2|Overall Study|Lost to Follow-up|0
2970365|NCT01157364|10223644|P1|Overall Study|Lost to Follow-up|1
2970366|NCT01157364|10223639|P6|Overall Study|Personal Reasons|1
2970367|NCT01157364|10223640|P5|Overall Study|Personal Reasons|1
2970368|NCT01157364|10223641|P4|Overall Study|Personal Reasons|0
2970369|NCT01157364|10223642|P3|Overall Study|Personal Reasons|0
2970370|NCT01157364|10223643|P2|Overall Study|Personal Reasons|2
2970371|NCT01157364|10223644|P1|Overall Study|Personal Reasons|0
2970372|NCT01157364|10223639|P6|Overall Study|Other Reasons|0
2970373|NCT01157364|10223640|P5|Overall Study|Other Reasons|0
2970374|NCT01157364|10223641|P4|Overall Study|Other Reasons|1
2970375|NCT01157364|10223642|P3|Overall Study|Other Reasons|2
2970376|NCT01157364|10223643|P2|Overall Study|Other Reasons|1
2970377|NCT01157364|10223644|P1|Overall Study|Other Reasons|1
2970378|NCT01157351|10223678|P2|Overall Study|Randomized but not Treated|2
2970379|NCT01157351|10223679|P1|Overall Study|Randomized but not Treated|4
2970380|NCT01157351|10223678|P2|Overall Study|Noncompliance with Study Drug|3
2970381|NCT01157351|10223679|P1|Overall Study|Noncompliance with Study Drug|0
2970382|NCT01157351|10223678|P2|Overall Study|Other|36
2970383|NCT01157351|10223679|P1|Overall Study|Other|32
2970384|NCT01157351|10223678|P2|Overall Study|Protocol Violation|1
2970385|NCT01157351|10223679|P1|Overall Study|Protocol Violation|0
2970386|NCT01157351|10223678|P2|Overall Study|Physician Decision|4
2970387|NCT01157351|10223679|P1|Overall Study|Physician Decision|5
2970388|NCT01157351|10223678|P2|Overall Study|Withdrawal by Subject|27
2970389|NCT01157351|10223679|P1|Overall Study|Withdrawal by Subject|37
2970390|NCT01157351|10223678|P2|Overall Study|Lost to Follow-up|55
2970391|NCT01157351|10223679|P1|Overall Study|Lost to Follow-up|53
2970392|NCT01157351|10223678|P2|Overall Study|Death|0
2970393|NCT01157351|10223679|P1|Overall Study|Death|1
2970394|NCT01157351|10223678|P2|Overall Study|Adverse Event|4
2970395|NCT01157351|10223679|P1|Overall Study|Adverse Event|5
2970396|NCT01157234|10223697|P2|Overall Study|Withdrawal by Subject|0
2970397|NCT01157234|10223698|P1|Overall Study|Withdrawal by Subject|1
2970398|NCT01157182|10223730|P2|Washout of 28 Days|Adverse Event|0
2970399|NCT01157182|10223731|P1|Washout of 28 Days|Adverse Event|2
2970400|NCT01157169|10223779|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
2970401|NCT01157169|10223780|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
2970402|NCT01157169|10223779|P2|First Intervention|Emesis Within 4 hrs of Administration|2
2970403|NCT01157169|10223780|P1|First Intervention|Emesis Within 4 hrs of Administration|4
2970404|NCT01157117|10223799|P3|Overall Study|Unknown (Pending Final Form Submission)|13
2970405|NCT01157117|10223800|P2|Overall Study|Unknown (Pending Final Form Submission)|5
2970406|NCT01157117|10223801|P1|Overall Study|Unknown (Pending Final Form Submission)|4
2970407|NCT01157117|10223799|P3|Overall Study|Lost to Follow-up|1
2970408|NCT01157117|10223800|P2|Overall Study|Lost to Follow-up|0
2970409|NCT01157117|10223801|P1|Overall Study|Lost to Follow-up|0
2970410|NCT01157117|10223799|P3|Overall Study|Lack of Efficacy|0
2970411|NCT01157117|10223800|P2|Overall Study|Lack of Efficacy|1
2970412|NCT01157117|10223801|P1|Overall Study|Lack of Efficacy|1
2970413|NCT01157117|10223799|P3|Overall Study|Withdrawal by Subject|1
2970414|NCT01157117|10223800|P2|Overall Study|Withdrawal by Subject|1
2970415|NCT01157117|10223801|P1|Overall Study|Withdrawal by Subject|4
2970416|NCT01157117|10223799|P3|Overall Study|Dosing Symptoms|0
2970417|NCT01157117|10223800|P2|Overall Study|Dosing Symptoms|4
2970418|NCT01157117|10223801|P1|Overall Study|Dosing Symptoms|0
2970419|NCT01157078|10223842|P2|Overall Study|Other|4
2970420|NCT01157078|10223843|P1|Overall Study|Other|2
2970421|NCT01157078|10223842|P2|Overall Study|Lost to Follow-up|5
2970422|NCT01157078|10223843|P1|Overall Study|Lost to Follow-up|7
2970423|NCT01157078|10223842|P2|Overall Study|Study-specific withdrawal criteria|2
2970424|NCT01157078|10223843|P1|Overall Study|Study-specific withdrawal criteria|2
2970425|NCT01157078|10223842|P2|Overall Study|Lack of Efficacy|0
2970426|NCT01157078|10223843|P1|Overall Study|Lack of Efficacy|2
2970427|NCT01157078|10223842|P2|Overall Study|Condition under investigation worsened|1
2970428|NCT01157078|10223843|P1|Overall Study|Condition under investigation worsened|0
2970429|NCT01157078|10223842|P2|Overall Study|Severe non-compliance to protocol|4
2970430|NCT01157078|10223843|P1|Overall Study|Severe non-compliance to protocol|2
2970431|NCT01157078|10223842|P2|Overall Study|Adverse Event|6
2970432|NCT01157078|10223843|P1|Overall Study|Adverse Event|6
2970433|NCT01157078|10223842|P2|Overall Study|Eligibility criteria not fulfilled|0
2970434|NCT01157078|10223843|P1|Overall Study|Eligibility criteria not fulfilled|2
2970435|NCT01157078|10223842|P2|Overall Study|Withdrawal by Subject|14
2970436|NCT01157078|10223843|P1|Overall Study|Withdrawal by Subject|12
2970437|NCT01157065|10223893|P2|Overall Study|Death|1
2970438|NCT01157065|10223894|P1|Overall Study|Death|0
2970439|NCT01156844|10223915|P4|Overall Study|Protocol deviation|0
2970440|NCT01156844|10223916|P3|Overall Study|Protocol deviation|0
2970441|NCT01156844|10223917|P2|Overall Study|Protocol deviation|0
2970442|NCT01156844|10223918|P1|Overall Study|Protocol deviation|2
2970443|NCT01156844|10223915|P4|Overall Study|Administrative problems|1
2970444|NCT01156844|10223916|P3|Overall Study|Administrative problems|0
2970445|NCT01156844|10223917|P2|Overall Study|Administrative problems|1
2970446|NCT01156844|10223918|P1|Overall Study|Administrative problems|0
2970447|NCT01156844|10223915|P4|Overall Study|Lost to Follow-up|0
2970448|NCT01156844|10223916|P3|Overall Study|Lost to Follow-up|1
2970449|NCT01156844|10223917|P2|Overall Study|Lost to Follow-up|0
2970450|NCT01156844|10223918|P1|Overall Study|Lost to Follow-up|0
2970451|NCT01156844|10223915|P4|Overall Study|Withdrawal by Subject|2
2970452|NCT01156844|10223916|P3|Overall Study|Withdrawal by Subject|2
2970453|NCT01156844|10223917|P2|Overall Study|Withdrawal by Subject|0
2970454|NCT01156844|10223918|P1|Overall Study|Withdrawal by Subject|0
2970455|NCT01156844|10223915|P4|Overall Study|Abnormal test procedure result(s)|2
2970456|NCT01156844|10223916|P3|Overall Study|Abnormal test procedure result(s)|2
2970457|NCT01156844|10223917|P2|Overall Study|Abnormal test procedure result(s)|1
2970458|NCT01156844|10223918|P1|Overall Study|Abnormal test procedure result(s)|0
2970459|NCT01156844|10223915|P4|Overall Study|Adverse Event|1
2970460|NCT01156844|10223916|P3|Overall Study|Adverse Event|1
2970461|NCT01156844|10223917|P2|Overall Study|Adverse Event|0
2970462|NCT01156844|10223918|P1|Overall Study|Adverse Event|0
2970463|NCT01156792|10223952|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
2970464|NCT01156792|10223952|P1|Overall Study|Withdrawal by Subject|9
2970465|NCT01156792|10223952|P1|Overall Study|Physician Decision|3
2970466|NCT01156792|10223952|P1|Overall Study|Lost to Follow-up|3
2970467|NCT01156792|10223952|P1|Overall Study|Protocol Violation|6
2970468|NCT01156792|10223952|P1|Overall Study|Lack of Efficacy|36
2970469|NCT01156792|10223952|P1|Overall Study|Adverse Event|1
2970470|NCT01156714|10224020|P3|Overall Study|Withdrawal by Subject|3
2970471|NCT01156714|10224021|P2|Overall Study|Withdrawal by Subject|4
2970472|NCT01156714|10224022|P1|Overall Study|Withdrawal by Subject|9
2970473|NCT01156675|10224085|P3|Overall Study|No data|2
2970474|NCT01156675|10224086|P2|Overall Study|No data|22
2970475|NCT01156675|10224087|P1|Overall Study|No data|29
2970476|NCT01156675|10224085|P3|Overall Study|Death|0
2970477|NCT01156675|10224086|P2|Overall Study|Death|3
2970478|NCT01156675|10224087|P1|Overall Study|Death|5
2970479|NCT01156532|10224145|P1|Overall Study|Lost to Follow-up|1
2970480|NCT01156532|10224145|P1|Overall Study|Family Reasons|1
2970481|NCT01156480|10224157|P2|Overall Study|change in diagnosis|1
2970482|NCT01156480|10224158|P1|Overall Study|change in diagnosis|0
2970483|NCT01156376|10224187|P3|Overall Study|Withdrawal by Subject|3
2970484|NCT01156376|10224188|P2|Overall Study|Withdrawal by Subject|0
2970485|NCT01156376|10224189|P1|Overall Study|Withdrawal by Subject|0
2970486|NCT01156376|10224187|P3|Overall Study|Adverse Event|1
2970487|NCT01156376|10224188|P2|Overall Study|Adverse Event|0
2970488|NCT01156376|10224189|P1|Overall Study|Adverse Event|1
2970489|NCT01156363|10224410|P1|Overall Study|Other|6
2970490|NCT01156363|10224410|P1|Overall Study|Refused Treatment|4
2970491|NCT01156363|10224410|P1|Overall Study|Failure to Return|1
2970492|NCT01156363|10224410|P1|Overall Study|Insufficient Therapeutic Response|5
2970493|NCT01156363|10224410|P1|Overall Study|Adverse Event|6
2970494|NCT01156311|10224432|P4|6-month Add-on Therapy Period|Other|2
2970495|NCT01156311|10224433|P3|6-month Add-on Therapy Period|Other|1
2970496|NCT01156311|10224434|P2|6-month Add-on Therapy Period|Other|0
2970497|NCT01156311|10224435|P1|6-month Add-on Therapy Period|Other|0
2970498|NCT01156311|10224432|P4|6-month Add-on Therapy Period|Physician Decision|0
2970499|NCT01156311|10224433|P3|6-month Add-on Therapy Period|Physician Decision|1
2970500|NCT01156311|10224434|P2|6-month Add-on Therapy Period|Physician Decision|0
2970501|NCT01156311|10224435|P1|6-month Add-on Therapy Period|Physician Decision|0
2970502|NCT01156311|10224432|P4|6-month Add-on Therapy Period|Disease Activity|2
2970503|NCT01156311|10224433|P3|6-month Add-on Therapy Period|Disease Activity|1
2970504|NCT01156311|10224434|P2|6-month Add-on Therapy Period|Disease Activity|0
2970505|NCT01156311|10224435|P1|6-month Add-on Therapy Period|Disease Activity|0
2970506|NCT01156311|10224432|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
2970507|NCT01156311|10224433|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
2970508|NCT01156311|10224434|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
2970509|NCT01156311|10224435|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
2970510|NCT01156311|10224432|P4|6-month Add-on Therapy Period|Adverse Event|6
2970511|NCT01156311|10224433|P3|6-month Add-on Therapy Period|Adverse Event|7
2970512|NCT01156311|10224434|P2|6-month Add-on Therapy Period|Adverse Event|0
2970513|NCT01156311|10224435|P1|6-month Add-on Therapy Period|Adverse Event|0
2970514|NCT01156311|10224432|P4|2-Month Monotherapy Period|Other|0
2970515|NCT01156311|10224433|P3|2-Month Monotherapy Period|Other|0
2970516|NCT01156311|10224434|P2|2-Month Monotherapy Period|Other|0
2970517|NCT01156311|10224435|P1|2-Month Monotherapy Period|Other|1
2970518|NCT01156311|10224432|P4|2-Month Monotherapy Period|Physician Decision|0
2970519|NCT01156311|10224433|P3|2-Month Monotherapy Period|Physician Decision|0
2970520|NCT01156311|10224434|P2|2-Month Monotherapy Period|Physician Decision|1
2970521|NCT01156311|10224435|P1|2-Month Monotherapy Period|Physician Decision|0
2970522|NCT01156311|10224432|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
2970523|NCT01156311|10224433|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
2970524|NCT01156311|10224434|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
2970525|NCT01156311|10224435|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
2970526|NCT01156142|10224459|P2|Overall Study|Ineligible|1
2970527|NCT01156142|10224460|P1|Overall Study|Ineligible|0
2970528|NCT01156142|10224459|P2|Overall Study|Withdrawal by Subject|6
2970529|NCT01156142|10224460|P1|Overall Study|Withdrawal by Subject|8
2970530|NCT01156116|10224478|P2|Overall Study|CPAP intolerance|0
2970531|NCT01156116|10224479|P1|Overall Study|CPAP intolerance|2
2970532|NCT01156116|10224478|P2|Overall Study|Withdrawal by Subject|1
2970533|NCT01156116|10224479|P1|Overall Study|Withdrawal by Subject|3
2970534|NCT01156051|10224493|P2|Overall Study|patient not compliant with protocol|1
2970535|NCT01156051|10224494|P1|Overall Study|patient not compliant with protocol|0
2970536|NCT01156051|10224493|P2|Overall Study|Lost to Follow-up|0
2970537|NCT01156051|10224494|P1|Overall Study|Lost to Follow-up|1
2970538|NCT01156012|10224508|P2|Overall Study|Non respect of one of inclusion criteria|1
2970539|NCT01156012|10224509|P1|Overall Study|Non respect of one of inclusion criteria|2
2970540|NCT01156012|10224508|P2|Overall Study|use of commercial drug instead of study|1
2970541|NCT01156012|10224509|P1|Overall Study|use of commercial drug instead of study|0
2970542|NCT01156012|10224508|P2|Overall Study|Withdrawal by Subject|0
2970543|NCT01156012|10224509|P1|Overall Study|Withdrawal by Subject|1
2970544|NCT01156012|10224508|P2|Overall Study|Lost to Follow-up|0
2970545|NCT01156012|10224509|P1|Overall Study|Lost to Follow-up|1
2970546|NCT01156012|10224508|P2|Overall Study|Adverse Event|1
2970547|NCT01156012|10224509|P1|Overall Study|Adverse Event|3
2970548|NCT01155869|10224526|P2|Overall Study|Lost to Follow-up|1
2970549|NCT01155869|10224527|P1|Overall Study|Lost to Follow-up|3
2970550|NCT01155726|10224636|P4|Period 1, 3 Days (Masked)|Inconvenience|0
2970551|NCT01155726|10224637|P3|Period 1, 3 Days (Masked)|Inconvenience|2
2970552|NCT01155726|10224638|P2|Period 1, 3 Days (Masked)|Inconvenience|0
2970553|NCT01155726|10224639|P1|Period 1, 3 Days (Masked)|Inconvenience|1
2970554|NCT01155661|10224661|P1|Overall Study|Sponsor Decision|13
2970555|NCT01155661|10224661|P1|Overall Study|Withdrawal by Subject|73
2970556|NCT01155661|10224661|P1|Overall Study|Protocol Violation|35
2970557|NCT01155661|10224661|P1|Overall Study|Physician Decision|3
2970558|NCT01155661|10224661|P1|Overall Study|Lost to Follow-up|22
2970559|NCT01155661|10224661|P1|Overall Study|Lack of Efficacy|32
2970560|NCT01155661|10224661|P1|Overall Study|Death|1
2970561|NCT01155661|10224661|P1|Overall Study|Adverse Event|101
2970562|NCT01155570|10224687|P1|Overall Study|Other Reasons|23
2970563|NCT01155570|10224687|P1|Overall Study|Participant's Economic Reasons + Other|1
2970564|NCT01155570|10224687|P1|Overall Study|Adverse Event + Other Reasons|7
2970565|NCT01155570|10224687|P1|Overall Study|Adverse Event + Lack of Efficacy|2
2970566|NCT01155570|10224687|P1|Overall Study|No Hospital Visits|7
2970567|NCT01155570|10224687|P1|Overall Study|Participant's Economic Reasons|17
2970568|NCT01155570|10224687|P1|Overall Study|Lack of Efficacy|46
2970569|NCT01155570|10224687|P1|Overall Study|Adverse Event|39
2970570|NCT01155531|10224721|P4|Overall Study|Withdrawal by Subject|0
2970571|NCT01155531|10224722|P3|Overall Study|Withdrawal by Subject|1
2970572|NCT01155531|10224723|P2|Overall Study|Withdrawal by Subject|0
2970573|NCT01155531|10224724|P1|Overall Study|Withdrawal by Subject|1
2970574|NCT01155531|10224721|P4|Overall Study|Lost to Follow-up|1
2970575|NCT01155531|10224722|P3|Overall Study|Lost to Follow-up|0
2970576|NCT01155531|10224723|P2|Overall Study|Lost to Follow-up|0
2970577|NCT01155531|10224724|P1|Overall Study|Lost to Follow-up|0
2970578|NCT01155531|10224721|P4|Overall Study|Adverse Event|0
2970579|NCT01155531|10224722|P3|Overall Study|Adverse Event|1
2970580|NCT01155531|10224723|P2|Overall Study|Adverse Event|0
2970581|NCT01155531|10224724|P1|Overall Study|Adverse Event|0
2970582|NCT01155479|10224772|P5|Part II|Non-Compliance with Protocol|0
2970583|NCT01155479|10224773|P4|Part II|Non-Compliance with Protocol|2
2970584|NCT01155479|10224774|P3|Part II|Non-Compliance with Protocol|0
2970585|NCT01155479|10224775|P2|Part II|Non-Compliance with Protocol|1
2970586|NCT01155479|10224776|P1|Part II|Non-Compliance with Protocol|0
2970587|NCT01155479|10224772|P5|Part II|Treatment Failure|1
2970588|NCT01155479|10224773|P4|Part II|Treatment Failure|0
2970589|NCT01155479|10224774|P3|Part II|Treatment Failure|2
2970590|NCT01155479|10224775|P2|Part II|Treatment Failure|1
2970591|NCT01155479|10224776|P1|Part II|Treatment Failure|0
2970592|NCT01155479|10224772|P5|Part II|Lost to Follow-up|1
2970593|NCT01155479|10224773|P4|Part II|Lost to Follow-up|0
2970594|NCT01155479|10224774|P3|Part II|Lost to Follow-up|0
2970595|NCT01155479|10224775|P2|Part II|Lost to Follow-up|0
2970596|NCT01155479|10224776|P1|Part II|Lost to Follow-up|1
2970597|NCT01155479|10224772|P5|Part II|Withdrawal by Subject|3
2970598|NCT01155479|10224773|P4|Part II|Withdrawal by Subject|7
2970599|NCT01155479|10224774|P3|Part II|Withdrawal by Subject|12
2970600|NCT01155479|10224775|P2|Part II|Withdrawal by Subject|4
2970601|NCT01155479|10224776|P1|Part II|Withdrawal by Subject|8
2970602|NCT01155479|10224772|P5|Part II|Administrative|46
2970603|NCT01155479|10224773|P4|Part II|Administrative|38
2970604|NCT01155479|10224774|P3|Part II|Administrative|36
2970605|NCT01155479|10224775|P2|Part II|Administrative|49
2970606|NCT01155479|10224776|P1|Part II|Administrative|43
2970607|NCT01155479|10224772|P5|Part II|Adverse Event|4
2970608|NCT01155479|10224773|P4|Part II|Adverse Event|3
2970609|NCT01155479|10224774|P3|Part II|Adverse Event|8
2970610|NCT01155479|10224775|P2|Part II|Adverse Event|6
2970611|NCT01155479|10224776|P1|Part II|Adverse Event|7
2970612|NCT01155479|10224772|P5|Part I|Non-Compliance with Protocol|2
2970613|NCT01155479|10224773|P4|Part I|Non-Compliance with Protocol|3
2970614|NCT01155479|10224774|P3|Part I|Non-Compliance with Protocol|3
2970615|NCT01155479|10224775|P2|Part I|Non-Compliance with Protocol|1
2970616|NCT01155479|10224776|P1|Part I|Non-Compliance with Protocol|2
2970617|NCT01155479|10224772|P5|Part I|Did Not Receive Treatment|1
2970618|NCT01155479|10224773|P4|Part I|Did Not Receive Treatment|6
2970619|NCT01155479|10224774|P3|Part I|Did Not Receive Treatment|2
2970620|NCT01155479|10224775|P2|Part I|Did Not Receive Treatment|2
2970621|NCT01155479|10224776|P1|Part I|Did Not Receive Treatment|4
2970622|NCT01155479|10224772|P5|Part I|Treatment Failure|2
2970623|NCT01155479|10224773|P4|Part I|Treatment Failure|1
2970624|NCT01155479|10224774|P3|Part I|Treatment Failure|3
2970625|NCT01155479|10224775|P2|Part I|Treatment Failure|0
2970626|NCT01155479|10224776|P1|Part I|Treatment Failure|3
2970627|NCT01155479|10224772|P5|Part I|Lost to Follow-up|0
2970628|NCT01155479|10224773|P4|Part I|Lost to Follow-up|1
2970629|NCT01155479|10224774|P3|Part I|Lost to Follow-up|1
2970630|NCT01155479|10224775|P2|Part I|Lost to Follow-up|0
2970631|NCT01155479|10224776|P1|Part I|Lost to Follow-up|0
2970632|NCT01155479|10224772|P5|Part I|Withdrawal by Subject|9
2970633|NCT01155479|10224773|P4|Part I|Withdrawal by Subject|8
2970634|NCT01155479|10224774|P3|Part I|Withdrawal by Subject|8
2970635|NCT01155479|10224775|P2|Part I|Withdrawal by Subject|13
2970636|NCT01155479|10224776|P1|Part I|Withdrawal by Subject|11
2970637|NCT01155479|10224772|P5|Part I|Did Not Meet Protocol Eligibility|3
2970638|NCT01155479|10224773|P4|Part I|Did Not Meet Protocol Eligibility|1
2970639|NCT01155479|10224774|P3|Part I|Did Not Meet Protocol Eligibility|2
2970640|NCT01155479|10224775|P2|Part I|Did Not Meet Protocol Eligibility|1
2970641|NCT01155479|10224776|P1|Part I|Did Not Meet Protocol Eligibility|3
2970642|NCT01155479|10224772|P5|Part I|Administrative|0
2970643|NCT01155479|10224773|P4|Part I|Administrative|0
2970644|NCT01155479|10224774|P3|Part I|Administrative|2
2970645|NCT01155479|10224775|P2|Part I|Administrative|2
2970646|NCT01155479|10224776|P1|Part I|Administrative|2
2970647|NCT01155479|10224772|P5|Part I|Adverse Event|6
2970648|NCT01155479|10224773|P4|Part I|Adverse Event|7
2970649|NCT01155479|10224774|P3|Part I|Adverse Event|18
2970650|NCT01155479|10224775|P2|Part I|Adverse Event|8
2970651|NCT01155479|10224776|P1|Part I|Adverse Event|13
2970652|NCT01155466|10224828|P5|Overall Study|Randomized not treated|2
2970653|NCT01155466|10224829|P4|Overall Study|Randomized not treated|0
2970654|NCT01155466|10224830|P3|Overall Study|Randomized not treated|3
2970655|NCT01155466|10224831|P2|Overall Study|Randomized not treated|2
2970656|NCT01155466|10224832|P1|Overall Study|Randomized not treated|2
2970657|NCT01155466|10224828|P5|Overall Study|Administrative|0
2970658|NCT01155466|10224829|P4|Overall Study|Administrative|0
2970659|NCT01155466|10224830|P3|Overall Study|Administrative|0
2970660|NCT01155466|10224831|P2|Overall Study|Administrative|3
2970661|NCT01155466|10224832|P1|Overall Study|Administrative|0
2970662|NCT01155466|10224828|P5|Overall Study|Protocol Violation|1
2970663|NCT01155466|10224829|P4|Overall Study|Protocol Violation|0
2970664|NCT01155466|10224830|P3|Overall Study|Protocol Violation|2
2970665|NCT01155466|10224831|P2|Overall Study|Protocol Violation|0
2970666|NCT01155466|10224832|P1|Overall Study|Protocol Violation|0
2970667|NCT01155466|10224828|P5|Overall Study|Withdrawal by Subject|4
2970668|NCT01155466|10224829|P4|Overall Study|Withdrawal by Subject|4
2970669|NCT01155466|10224830|P3|Overall Study|Withdrawal by Subject|9
2970670|NCT01155466|10224831|P2|Overall Study|Withdrawal by Subject|5
2970671|NCT01155466|10224832|P1|Overall Study|Withdrawal by Subject|7
2970672|NCT01155466|10224828|P5|Overall Study|Lost to Follow-up|2
2970673|NCT01155466|10224829|P4|Overall Study|Lost to Follow-up|0
2970674|NCT01155466|10224830|P3|Overall Study|Lost to Follow-up|0
2970675|NCT01155466|10224831|P2|Overall Study|Lost to Follow-up|0
2970676|NCT01155466|10224832|P1|Overall Study|Lost to Follow-up|0
2970677|NCT01155466|10224828|P5|Overall Study|Adverse Event|18
2970678|NCT01155466|10224829|P4|Overall Study|Adverse Event|17
2970679|NCT01155466|10224830|P3|Overall Study|Adverse Event|6
2970680|NCT01155466|10224831|P2|Overall Study|Adverse Event|15
2970681|NCT01155466|10224832|P1|Overall Study|Adverse Event|13
2970682|NCT01155388|10224886|P2|Overall Study|Adverse Event|0
2970683|NCT01155388|10224887|P1|Overall Study|Adverse Event|1
2970684|NCT01155375|10224897|P2|Overall Study|Adverse Event|0
2970685|NCT01155375|10224898|P1|Overall Study|Adverse Event|1
2970686|NCT01155323|10224917|P2|Second Intervention|Lost to Follow-up|1
2970687|NCT01155323|10224918|P1|Second Intervention|Lost to Follow-up|1
2970688|NCT01155323|10224917|P2|First Intervention|exclusion criteria|1
2970689|NCT01155323|10224918|P1|First Intervention|exclusion criteria|1
2970690|NCT01155284|10224936|P2|Overall Study|Adverse Event|0
2970691|NCT01155284|10224937|P1|Overall Study|Adverse Event|1
2970692|NCT01155284|10224936|P2|Overall Study|Physician Decision|0
2970693|NCT01155284|10224937|P1|Overall Study|Physician Decision|1
2970694|NCT01155284|10224936|P2|Overall Study|Lost to Follow-up|2
2970695|NCT01155284|10224937|P1|Overall Study|Lost to Follow-up|1
2970696|NCT01155284|10224936|P2|Overall Study|Withdrawal by Subject|3
2970697|NCT01155284|10224937|P1|Overall Study|Withdrawal by Subject|4
2970698|NCT01155219|10224947|P2|Overall Study|non-medical reason|2
2970699|NCT01155219|10224948|P1|Overall Study|non-medical reason|1
2970700|NCT01155219|10224947|P2|Overall Study|Adverse Event|1
2970701|NCT01155219|10224948|P1|Overall Study|Adverse Event|3
2970702|NCT01155167|10224997|P2|Overall Study|Access site changed to femoral artery|0
2970703|NCT01155167|10224998|P1|Overall Study|Access site changed to femoral artery|1
2970704|NCT01155167|10224997|P2|Overall Study|Insufficient ultrasound data|0
2970705|NCT01155167|10224998|P1|Overall Study|Insufficient ultrasound data|2
2970706|NCT01155141|10225021|P1|Overall Study|Screen Failure|1
2970707|NCT01155141|10225021|P1|Overall Study|Withdrawal by Subject|1
2970708|NCT01155063|10225033|P1|Overall Study|Study terminated by sponsor|87
2970709|NCT01155063|10225033|P1|Overall Study|Withdrawal by Subject|1
2970710|NCT01155063|10225033|P1|Overall Study|Adverse Event|1
2970711|NCT01155024|10225043|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
2970712|NCT01155024|10225044|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
2970713|NCT01155024|10225043|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
2970714|NCT01155024|10225044|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
2970715|NCT01155024|10225043|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
2970716|NCT01155024|10225044|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
2970717|NCT01155011|10225054|P2|6 to 12 Months|Death|5
2970718|NCT01155011|10225055|P1|6 to 12 Months|Death|1
2970719|NCT01155011|10225054|P2|6 to 12 Months|Withdrawal by Subject|5
2970720|NCT01155011|10225055|P1|6 to 12 Months|Withdrawal by Subject|8
2970721|NCT01155011|10225054|P2|Baseline to 6 Months|Death|1
2970722|NCT01155011|10225055|P1|Baseline to 6 Months|Death|0
2970723|NCT01155011|10225054|P2|Baseline to 6 Months|investigator decision, moved|5
2970724|NCT01155011|10225055|P1|Baseline to 6 Months|investigator decision, moved|4
2970725|NCT01155011|10225054|P2|Baseline to 6 Months|Withdrawal by Subject|19
2970726|NCT01155011|10225055|P1|Baseline to 6 Months|Withdrawal by Subject|18
2970727|NCT01154816|10225096|P12|Overall Study|Adverse Event|0
2970728|NCT01154816|10225097|P11|Overall Study|Adverse Event|0
2970729|NCT01154816|10225098|P10|Overall Study|Adverse Event|0
2970730|NCT01154816|10225099|P9|Overall Study|Adverse Event|0
2970731|NCT01154816|10225100|P8|Overall Study|Adverse Event|1
2970732|NCT01154816|10225101|P7|Overall Study|Adverse Event|1
2970733|NCT01154816|10225102|P6|Overall Study|Adverse Event|0
2970734|NCT01154816|10225103|P5|Overall Study|Adverse Event|0
2970735|NCT01154816|10225104|P4|Overall Study|Adverse Event|0
2970736|NCT01154816|10225105|P3|Overall Study|Adverse Event|0
2970737|NCT01154816|10225106|P2|Overall Study|Adverse Event|2
2970738|NCT01154816|10225107|P1|Overall Study|Adverse Event|5
2970739|NCT01154816|10225096|P12|Overall Study|Physician Decision|1
2970740|NCT01154816|10225097|P11|Overall Study|Physician Decision|1
2970741|NCT01154816|10225098|P10|Overall Study|Physician Decision|1
2970742|NCT01154816|10225099|P9|Overall Study|Physician Decision|0
2970743|NCT01154816|10225100|P8|Overall Study|Physician Decision|0
2970744|NCT01154816|10225101|P7|Overall Study|Physician Decision|0
2970745|NCT01154816|10225102|P6|Overall Study|Physician Decision|0
2970746|NCT01154816|10225103|P5|Overall Study|Physician Decision|2
2970747|NCT01154816|10225104|P4|Overall Study|Physician Decision|0
2970748|NCT01154816|10225105|P3|Overall Study|Physician Decision|1
2970749|NCT01154816|10225106|P2|Overall Study|Physician Decision|0
2970750|NCT01154816|10225107|P1|Overall Study|Physician Decision|1
2970751|NCT01154816|10225096|P12|Overall Study|Progressive Disease|3
2970752|NCT01154816|10225097|P11|Overall Study|Progressive Disease|10
2970753|NCT01154816|10225098|P10|Overall Study|Progressive Disease|6
2970754|NCT01154816|10225099|P9|Overall Study|Progressive Disease|8
2970755|NCT01154816|10225100|P8|Overall Study|Progressive Disease|6
2970756|NCT01154816|10225101|P7|Overall Study|Progressive Disease|5
2970757|NCT01154816|10225102|P6|Overall Study|Progressive Disease|8
2970758|NCT01154816|10225103|P5|Overall Study|Progressive Disease|8
2970759|NCT01154816|10225104|P4|Overall Study|Progressive Disease|9
2970760|NCT01154816|10225105|P3|Overall Study|Progressive Disease|9
2970761|NCT01154816|10225106|P2|Overall Study|Progressive Disease|8
2970762|NCT01154816|10225107|P1|Overall Study|Progressive Disease|13
2970763|NCT01154816|10225096|P12|Overall Study|Withdrawal by Subject|0
2970764|NCT01154816|10225097|P11|Overall Study|Withdrawal by Subject|0
2970765|NCT01154816|10225098|P10|Overall Study|Withdrawal by Subject|3
2970766|NCT01154816|10225099|P9|Overall Study|Withdrawal by Subject|1
2970767|NCT01154816|10225100|P8|Overall Study|Withdrawal by Subject|0
2970768|NCT01154816|10225101|P7|Overall Study|Withdrawal by Subject|0
2970769|NCT01154816|10225102|P6|Overall Study|Withdrawal by Subject|0
2970770|NCT01154816|10225103|P5|Overall Study|Withdrawal by Subject|0
2970771|NCT01154816|10225104|P4|Overall Study|Withdrawal by Subject|1
2970772|NCT01154816|10225105|P3|Overall Study|Withdrawal by Subject|0
2970773|NCT01154816|10225106|P2|Overall Study|Withdrawal by Subject|0
2970774|NCT01154816|10225107|P1|Overall Study|Withdrawal by Subject|1
2970775|NCT01154673|10225184|P2|Overall Study|moved out of province|0
2970776|NCT01154673|10225185|P1|Overall Study|moved out of province|1
2970777|NCT01154673|10225184|P2|Overall Study|Lost to Follow-up|0
2970778|NCT01154673|10225185|P1|Overall Study|Lost to Follow-up|1
2970779|NCT01154452|10225240|P4|Phase II|Adverse Event|4
2970780|NCT01154452|10225241|P3|Phase II|Adverse Event|4
2970781|NCT01154452|10225242|P2|Phase II|Adverse Event|0
2970782|NCT01154452|10225243|P1|Phase II|Adverse Event|0
2970783|NCT01154452|10225240|P4|Phase II|Withdrawal by Subject|2
2970784|NCT01154452|10225241|P3|Phase II|Withdrawal by Subject|1
2970785|NCT01154452|10225242|P2|Phase II|Withdrawal by Subject|0
2970786|NCT01154452|10225243|P1|Phase II|Withdrawal by Subject|0
2970787|NCT01154452|10225240|P4|Phase Ib|Adverse Event|0
2970788|NCT01154452|10225241|P3|Phase Ib|Adverse Event|0
2970789|NCT01154452|10225242|P2|Phase Ib|Adverse Event|1
2970790|NCT01154452|10225243|P1|Phase Ib|Adverse Event|2
2970791|NCT01154452|10225240|P4|Phase Ib|Not Treated|0
2970792|NCT01154452|10225241|P3|Phase Ib|Not Treated|0
2970793|NCT01154452|10225242|P2|Phase Ib|Not Treated|0
2970794|NCT01154452|10225243|P1|Phase Ib|Not Treated|1
2970795|NCT01154296|10225275|P2|6-month Follow-up|Declined by Study Coordinator|4
2970796|NCT01154296|10225276|P1|6-month Follow-up|Declined by Study Coordinator|5
2970797|NCT01154296|10225275|P2|6-month Follow-up|Death|2
2970798|NCT01154296|10225276|P1|6-month Follow-up|Death|3
2970799|NCT01154296|10225275|P2|6-month Follow-up|Withdrew consent|15
2970800|NCT01154296|10225276|P1|6-month Follow-up|Withdrew consent|14
2970801|NCT01154296|10225275|P2|6-month Follow-up|Incarcerated|32
2970802|NCT01154296|10225276|P1|6-month Follow-up|Incarcerated|37
2970803|NCT01154296|10225275|P2|6-month Follow-up|Lost contact|275
2970804|NCT01154296|10225276|P1|6-month Follow-up|Lost contact|269
2970805|NCT01154296|10225275|P2|Randomization and Intervention|Left clinic early|0
2970806|NCT01154296|10225276|P1|Randomization and Intervention|Left clinic early|2
2970807|NCT01154296|10225275|P2|Randomization and Intervention|Left before test|1
2970808|NCT01154296|10225276|P1|Randomization and Intervention|Left before test|0
2970809|NCT01154296|10225275|P2|Randomization and Intervention|Did not return|0
2970810|NCT01154296|10225276|P1|Randomization and Intervention|Did not return|1
2970811|NCT01154296|10225275|P2|Randomization and Intervention|Declined by staff|0
2970812|NCT01154296|10225276|P1|Randomization and Intervention|Declined by staff|1
2970813|NCT01154296|10225275|P2|Randomization and Intervention|Decided to decline|1
2970814|NCT01154296|10225276|P1|Randomization and Intervention|Decided to decline|1
2970815|NCT01154283|10225294|P2|7-12 Weeks|Withdrawal by Subject|1
2970816|NCT01154283|10225295|P1|7-12 Weeks|Withdrawal by Subject|0
2970817|NCT01154283|10225294|P2|7-12 Weeks|Death|0
2970818|NCT01154283|10225295|P1|7-12 Weeks|Death|1
2970819|NCT01154283|10225294|P2|0-6 Weeks|Death|1
2970820|NCT01154283|10225295|P1|0-6 Weeks|Death|0
2970821|NCT01154283|10225294|P2|0-6 Weeks|Withdrawal by Subject|2
2970822|NCT01154283|10225295|P1|0-6 Weeks|Withdrawal by Subject|7
2970823|NCT01154231|10225307|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
2970824|NCT01154231|10225307|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
2970825|NCT01154218|10225313|P4|Fourth Intervention Period|Withdrawal by Subject|0
2970826|NCT01154218|10225314|P3|Fourth Intervention Period|Withdrawal by Subject|0
2970827|NCT01154218|10225315|P2|Fourth Intervention Period|Withdrawal by Subject|0
2970828|NCT01154218|10225316|P1|Fourth Intervention Period|Withdrawal by Subject|1
2970829|NCT01154218|10225313|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2970830|NCT01154218|10225314|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2970831|NCT01154218|10225315|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2970832|NCT01154218|10225316|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2970833|NCT01154218|10225313|P4|Third Intervention Period|Adverse Event|0
2970834|NCT01154218|10225314|P3|Third Intervention Period|Adverse Event|0
2970835|NCT01154218|10225315|P2|Third Intervention Period|Adverse Event|1
2970836|NCT01154218|10225316|P1|Third Intervention Period|Adverse Event|0
2970837|NCT01154166|10225390|P2|Overall Study|Poor Compliance|0
2970838|NCT01154166|10225391|P1|Overall Study|Poor Compliance|1
2970839|NCT01154166|10225390|P2|Overall Study|Disease Progression|0
2970840|NCT01154166|10225391|P1|Overall Study|Disease Progression|1
2970841|NCT01154166|10225390|P2|Overall Study|Lack of Efficacy|0
2970842|NCT01154166|10225391|P1|Overall Study|Lack of Efficacy|3
2970843|NCT01154166|10225390|P2|Overall Study|Withdrawal by Subject|1
2970844|NCT01154166|10225391|P1|Overall Study|Withdrawal by Subject|10
2970845|NCT01154166|10225390|P2|Overall Study|Protocol Violation|1
2970846|NCT01154166|10225391|P1|Overall Study|Protocol Violation|4
2970847|NCT01154166|10225390|P2|Overall Study|Lost to Follow-up|1
2970848|NCT01154166|10225391|P1|Overall Study|Lost to Follow-up|1
2970849|NCT01154166|10225390|P2|Overall Study|Adverse Event|9
2970850|NCT01154166|10225391|P1|Overall Study|Adverse Event|14
2970851|NCT01154153|10225423|P2|Overall Study|Withdrew consent|0
2970852|NCT01154153|10225424|P1|Overall Study|Withdrew consent|1
2970853|NCT01154153|10225423|P2|Overall Study|Unable to use labs|3
2970854|NCT01154153|10225424|P1|Overall Study|Unable to use labs|2
2970855|NCT01154153|10225423|P2|Overall Study|Poor compliance to protocol|0
2970856|NCT01154153|10225424|P1|Overall Study|Poor compliance to protocol|2
2970857|NCT01154140|10225442|P2|Overall Study|Randomized but not treated|2
2970858|NCT01154140|10225443|P1|Overall Study|Randomized but not treated|1
2970859|NCT01154140|10225442|P2|Overall Study|Other|1
2970860|NCT01154140|10225443|P1|Overall Study|Other|3
2970861|NCT01154140|10225442|P2|Overall Study|Withdrawal by Subject|13
2970862|NCT01154140|10225443|P1|Overall Study|Withdrawal by Subject|12
2970863|NCT01154140|10225442|P2|Overall Study|Lost to Follow-up|5
2970864|NCT01154140|10225443|P1|Overall Study|Lost to Follow-up|4
2970865|NCT01154140|10225442|P2|Overall Study|Death|81
2970866|NCT01154140|10225443|P1|Overall Study|Death|71
2970867|NCT01154127|10225496|P2|Period 2 (21 Days)|Protocol Deviation|1
2970868|NCT01154127|10225497|P1|Period 2 (21 Days)|Protocol Deviation|0
2970869|NCT01154127|10225496|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
2970870|NCT01154127|10225497|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
2970871|NCT01154127|10225496|P2|Washout (14 - 28 Days)|Adverse Event|0
2970872|NCT01154127|10225497|P1|Washout (14 - 28 Days)|Adverse Event|2
2970873|NCT01154127|10225496|P2|Period 1 (21 Days)|Withdrawal by Subject|2
2970874|NCT01154127|10225497|P1|Period 1 (21 Days)|Withdrawal by Subject|0
2970875|NCT01154127|10225496|P2|Period 1 (21 Days)|Adverse Event|4
2970876|NCT01154127|10225497|P1|Period 1 (21 Days)|Adverse Event|3
2970877|NCT01154101|10225524|P5|Overall Study|Withdrawal by Subject|1
2970878|NCT01154101|10225525|P4|Overall Study|Withdrawal by Subject|0
2970879|NCT01154101|10225526|P3|Overall Study|Withdrawal by Subject|2
2970880|NCT01154101|10225527|P2|Overall Study|Withdrawal by Subject|1
2970881|NCT01154101|10225528|P1|Overall Study|Withdrawal by Subject|0
2970882|NCT01154101|10225524|P5|Overall Study|Lost to Follow-up|0
2970883|NCT01154101|10225525|P4|Overall Study|Lost to Follow-up|1
2970884|NCT01154101|10225526|P3|Overall Study|Lost to Follow-up|0
2970885|NCT01154101|10225527|P2|Overall Study|Lost to Follow-up|1
2970886|NCT01154101|10225528|P1|Overall Study|Lost to Follow-up|0
2970887|NCT01154101|10225524|P5|Overall Study|Adverse Event|0
2970888|NCT01154101|10225525|P4|Overall Study|Adverse Event|1
2970889|NCT01154101|10225526|P3|Overall Study|Adverse Event|1
2970890|NCT01154101|10225527|P2|Overall Study|Adverse Event|2
2970891|NCT01154101|10225528|P1|Overall Study|Adverse Event|0
2970892|NCT01154088|10225583|P3|Overall Study|Lost to Follow-up|7
2970893|NCT01154088|10225584|P2|Overall Study|Lost to Follow-up|6
2970894|NCT01154088|10225585|P1|Overall Study|Lost to Follow-up|4
2970895|NCT01154036|10225625|P8|Phase II|Withdrawal by Subject|4
2970896|NCT01154036|10225626|P7|Phase II|Withdrawal by Subject|5
2970897|NCT01154036|10225627|P6|Phase II|Withdrawal by Subject|2
2970898|NCT01154036|10225628|P5|Phase II|Withdrawal by Subject|4
2970899|NCT01154036|10225629|P4|Phase II|Withdrawal by Subject|0
2970900|NCT01154036|10225630|P3|Phase II|Withdrawal by Subject|0
2970901|NCT01154036|10225631|P2|Phase II|Withdrawal by Subject|0
2970902|NCT01154036|10225632|P1|Phase II|Withdrawal by Subject|0
2970903|NCT01154036|10225625|P8|Phase II|Protocol Violation|0
2970904|NCT01154036|10225626|P7|Phase II|Protocol Violation|0
2970905|NCT01154036|10225627|P6|Phase II|Protocol Violation|2
2970906|NCT01154036|10225628|P5|Phase II|Protocol Violation|1
2970907|NCT01154036|10225629|P4|Phase II|Protocol Violation|0
2970908|NCT01154036|10225630|P3|Phase II|Protocol Violation|0
2970909|NCT01154036|10225631|P2|Phase II|Protocol Violation|0
2970910|NCT01154036|10225632|P1|Phase II|Protocol Violation|0
2970911|NCT01154036|10225625|P8|Phase II|Lost to Follow-up|1
2970912|NCT01154036|10225626|P7|Phase II|Lost to Follow-up|2
2970913|NCT01154036|10225627|P6|Phase II|Lost to Follow-up|0
2970914|NCT01154036|10225628|P5|Phase II|Lost to Follow-up|2
2970915|NCT01154036|10225629|P4|Phase II|Lost to Follow-up|1
2970916|NCT01154036|10225630|P3|Phase II|Lost to Follow-up|0
2970917|NCT01154036|10225631|P2|Phase II|Lost to Follow-up|0
2970918|NCT01154036|10225632|P1|Phase II|Lost to Follow-up|0
2970919|NCT01154036|10225625|P8|Phase II|Physician Decision|0
2970920|NCT01154036|10225626|P7|Phase II|Physician Decision|1
2970921|NCT01154036|10225627|P6|Phase II|Physician Decision|0
2970922|NCT01154036|10225628|P5|Phase II|Physician Decision|0
2970923|NCT01154036|10225629|P4|Phase II|Physician Decision|0
2970924|NCT01154036|10225630|P3|Phase II|Physician Decision|0
2970925|NCT01154036|10225631|P2|Phase II|Physician Decision|0
2970926|NCT01154036|10225632|P1|Phase II|Physician Decision|0
2970927|NCT01154036|10225625|P8|Phase II|Adverse Event|1
2970928|NCT01154036|10225626|P7|Phase II|Adverse Event|1
2970929|NCT01154036|10225627|P6|Phase II|Adverse Event|1
2970930|NCT01154036|10225628|P5|Phase II|Adverse Event|1
2970931|NCT01154036|10225629|P4|Phase II|Adverse Event|0
2970932|NCT01154036|10225630|P3|Phase II|Adverse Event|0
2970933|NCT01154036|10225631|P2|Phase II|Adverse Event|0
2970934|NCT01154036|10225632|P1|Phase II|Adverse Event|0
2970935|NCT01154036|10225625|P8|Phase I|Adverse Event|0
2970936|NCT01154036|10225626|P7|Phase I|Adverse Event|0
2970937|NCT01154036|10225627|P6|Phase I|Adverse Event|0
2970938|NCT01154036|10225628|P5|Phase I|Adverse Event|0
2970939|NCT01154036|10225629|P4|Phase I|Adverse Event|0
2970940|NCT01154036|10225630|P3|Phase I|Adverse Event|12
2970941|NCT01154036|10225631|P2|Phase I|Adverse Event|11
2970942|NCT01154036|10225632|P1|Phase I|Adverse Event|1
2970943|NCT01154036|10225625|P8|Phase I|Withdrawal by Subject|0
2970944|NCT01154036|10225626|P7|Phase I|Withdrawal by Subject|0
2970945|NCT01154036|10225627|P6|Phase I|Withdrawal by Subject|0
2970946|NCT01154036|10225628|P5|Phase I|Withdrawal by Subject|0
2970947|NCT01154036|10225629|P4|Phase I|Withdrawal by Subject|0
2970948|NCT01154036|10225630|P3|Phase I|Withdrawal by Subject|29
2970949|NCT01154036|10225631|P2|Phase I|Withdrawal by Subject|10
2970950|NCT01154036|10225632|P1|Phase I|Withdrawal by Subject|2
2970951|NCT01154036|10225625|P8|Phase I|Protocol Violation|0
2970952|NCT01154036|10225626|P7|Phase I|Protocol Violation|0
2970953|NCT01154036|10225627|P6|Phase I|Protocol Violation|0
2970954|NCT01154036|10225628|P5|Phase I|Protocol Violation|0
2970955|NCT01154036|10225629|P4|Phase I|Protocol Violation|0
2970956|NCT01154036|10225630|P3|Phase I|Protocol Violation|9
2970957|NCT01154036|10225631|P2|Phase I|Protocol Violation|3
2970958|NCT01154036|10225632|P1|Phase I|Protocol Violation|0
2970959|NCT01154036|10225625|P8|Phase I|Lost to Follow-up|0
2970960|NCT01154036|10225626|P7|Phase I|Lost to Follow-up|0
2970961|NCT01154036|10225627|P6|Phase I|Lost to Follow-up|0
2970962|NCT01154036|10225628|P5|Phase I|Lost to Follow-up|0
2970963|NCT01154036|10225629|P4|Phase I|Lost to Follow-up|0
2970964|NCT01154036|10225630|P3|Phase I|Lost to Follow-up|6
2970965|NCT01154036|10225631|P2|Phase I|Lost to Follow-up|3
2970966|NCT01154036|10225632|P1|Phase I|Lost to Follow-up|0
2970967|NCT01154036|10225625|P8|Phase I|Physician Decision|0
2970968|NCT01154036|10225626|P7|Phase I|Physician Decision|0
2970969|NCT01154036|10225627|P6|Phase I|Physician Decision|0
2970970|NCT01154036|10225628|P5|Phase I|Physician Decision|0
2970971|NCT01154036|10225629|P4|Phase I|Physician Decision|0
2970972|NCT01154036|10225630|P3|Phase I|Physician Decision|0
2970973|NCT01154036|10225631|P2|Phase I|Physician Decision|1
2970974|NCT01154036|10225632|P1|Phase I|Physician Decision|0
2970975|NCT01154010|10225756|P2|Overall Study|Lost to Follow-up|1
2970976|NCT01154010|10225757|P1|Overall Study|Lost to Follow-up|0
2970977|NCT01153984|10225763|P1|Overall Study|Adverse Event|1
2970978|NCT01153984|10225763|P1|Overall Study|Withdrawal by Subject|1
2970979|NCT01153971|10225774|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
2970980|NCT01153971|10225774|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
2970981|NCT01153971|10225774|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
2970982|NCT01153971|10225774|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
2970983|NCT01153971|10225774|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
2970984|NCT01153971|10225774|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
2970985|NCT01153971|10225774|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
2970986|NCT01153958|10225797|P2|Overall Study|Study Terminated|32
2970987|NCT01153958|10225798|P1|Overall Study|Study Terminated|36
2970988|NCT01153893|10225816|P2|Overall Study|Adverse Event|0
2970989|NCT01153893|10225817|P1|Overall Study|Adverse Event|1
2970990|NCT01153841|10225843|P2|Overall Study|Lost to Follow-up|0
2970991|NCT01153841|10225844|P1|Overall Study|Lost to Follow-up|2
2970992|NCT01153841|10225843|P2|Overall Study|Protocol Violation|0
2970993|NCT01153841|10225844|P1|Overall Study|Protocol Violation|2
2970994|NCT01153841|10225843|P2|Overall Study|Withdrawal by Subject|0
2970995|NCT01153841|10225844|P1|Overall Study|Withdrawal by Subject|1
2970996|NCT01153841|10225843|P2|Overall Study|Adverse Event|0
2970997|NCT01153841|10225844|P1|Overall Study|Adverse Event|1
2970998|NCT01153815|10225860|P2|Overall Study|Withdrawal by Subject|4
2970999|NCT01153815|10225861|P1|Overall Study|Withdrawal by Subject|6
2971000|NCT01153815|10225860|P2|Overall Study|Adverse Event|1
2971001|NCT01153815|10225861|P1|Overall Study|Adverse Event|3
2971002|NCT01153763|10225883|P1|Overall Study|Withdrawal by Subject|2
2971003|NCT01153763|10225883|P1|Overall Study|Physician Decision|2
2971004|NCT01153763|10225883|P1|Overall Study|Lost to Follow-up|1
2971005|NCT01153763|10225883|P1|Overall Study|Study Closed|16
2971006|NCT01153724|10225899|P1|Treatment Period 2|Other reason not defined above|1
2971007|NCT01153724|10225899|P1|Treatment Period 2|Adverse Event|1
2971008|NCT01153724|10225899|P1|Treatment Period 1|Withdrawal by Subject|1
2971009|NCT01153698|10225939|P1|Overall Study|Not treated with Pradaxa|5
2971010|NCT01153698|10225939|P1|Overall Study|Other|2
2971011|NCT01153698|10225939|P1|Overall Study|Switch to other anticoagulants|4
2971012|NCT01153698|10225939|P1|Overall Study|Withdrawal by Subject|2
2971013|NCT01153698|10225939|P1|Overall Study|Lost to Follow-up|4
2971014|NCT01153698|10225939|P1|Overall Study|Adverse Event|12
2971015|NCT01153633|10225990|P2|Overall Study|Therapeutic failure|3
2971016|NCT01153633|10225991|P1|Overall Study|Therapeutic failure|3
2971017|NCT01153633|10225990|P2|Overall Study|Protocol Violation|1
2971018|NCT01153633|10225991|P1|Overall Study|Protocol Violation|1
2971019|NCT01153516|10226028|P2|Overall Study|Both subjects refused surgery|0
2971020|NCT01153516|10226029|P1|Overall Study|Both subjects refused surgery|2
2971021|NCT01153425|10226054|P2|Overall Study|Withdrawal by Subject|3
2971022|NCT01153425|10226055|P1|Overall Study|Withdrawal by Subject|3
2971023|NCT01153347|10226067|P4|Overall Study|Death|0
2971024|NCT01153347|10226068|P3|Overall Study|Death|0
2971025|NCT01153347|10226069|P2|Overall Study|Death|0
2971026|NCT01153347|10226070|P1|Overall Study|Death|1
2971027|NCT01153347|10226067|P4|Overall Study|Other|0
2971028|NCT01153347|10226068|P3|Overall Study|Other|4
2971029|NCT01153347|10226069|P2|Overall Study|Other|5
2971030|NCT01153347|10226070|P1|Overall Study|Other|5
2971031|NCT01153347|10226067|P4|Overall Study|Lost to Follow-up|8
2971032|NCT01153347|10226068|P3|Overall Study|Lost to Follow-up|11
2971033|NCT01153347|10226069|P2|Overall Study|Lost to Follow-up|9
2971034|NCT01153347|10226070|P1|Overall Study|Lost to Follow-up|4
2971035|NCT01153347|10226067|P4|Overall Study|Study-specific withdrawal criteria|2
2971036|NCT01153347|10226068|P3|Overall Study|Study-specific withdrawal criteria|1
2971037|NCT01153347|10226069|P2|Overall Study|Study-specific withdrawal criteria|3
2971038|NCT01153347|10226070|P1|Overall Study|Study-specific withdrawal criteria|4
2971039|NCT01153347|10226067|P4|Overall Study|Lack of Efficacy|4
2971040|NCT01153347|10226068|P3|Overall Study|Lack of Efficacy|0
2971041|NCT01153347|10226069|P2|Overall Study|Lack of Efficacy|2
2971042|NCT01153347|10226070|P1|Overall Study|Lack of Efficacy|2
2971043|NCT01153347|10226067|P4|Overall Study|Condition under investigation worsened|0
2971044|NCT01153347|10226068|P3|Overall Study|Condition under investigation worsened|0
2971045|NCT01153347|10226069|P2|Overall Study|Condition under investigation worsened|1
2971046|NCT01153347|10226070|P1|Overall Study|Condition under investigation worsened|1
2971047|NCT01153347|10226067|P4|Overall Study|Severe non-compliance to protocol|3
2971048|NCT01153347|10226068|P3|Overall Study|Severe non-compliance to protocol|4
2971049|NCT01153347|10226069|P2|Overall Study|Severe non-compliance to protocol|7
2971050|NCT01153347|10226070|P1|Overall Study|Severe non-compliance to protocol|6
2971051|NCT01153347|10226067|P4|Overall Study|Adverse Event|7
2971052|NCT01153347|10226068|P3|Overall Study|Adverse Event|21
2971053|NCT01153347|10226069|P2|Overall Study|Adverse Event|9
2971054|NCT01153347|10226070|P1|Overall Study|Adverse Event|3
2971055|NCT01153347|10226067|P4|Overall Study|Eligibility criteria not fulfilled|1
2971056|NCT01153347|10226068|P3|Overall Study|Eligibility criteria not fulfilled|2
2971057|NCT01153347|10226069|P2|Overall Study|Eligibility criteria not fulfilled|1
2971058|NCT01153347|10226070|P1|Overall Study|Eligibility criteria not fulfilled|0
2971059|NCT01153347|10226067|P4|Overall Study|Withdrawal by Subject|7
2971060|NCT01153347|10226068|P3|Overall Study|Withdrawal by Subject|7
2971061|NCT01153347|10226069|P2|Overall Study|Withdrawal by Subject|7
2971062|NCT01153347|10226070|P1|Overall Study|Withdrawal by Subject|7
2971063|NCT01153321|10226170|P2|Overall Study|Adverse Event|1
2971064|NCT01153321|10226171|P1|Overall Study|Adverse Event|1
2971065|NCT01153321|10226170|P2|Overall Study|Withdrawal by Subject|1
2971066|NCT01153321|10226171|P1|Overall Study|Withdrawal by Subject|0
2971067|NCT01153321|10226170|P2|Overall Study|Development of study withdrawal criteria|1
2971068|NCT01153321|10226171|P1|Overall Study|Development of study withdrawal criteria|0
2971069|NCT01153269|10226283|P1|Overall Study|Antiretroviral therapy break|1
2971070|NCT01153269|10226283|P1|Overall Study|Withdrawal by Subject|1
2971071|NCT01153009|10226346|P4|Overall Study|Other|2
2971072|NCT01153009|10226347|P3|Overall Study|Other|3
2971073|NCT01153009|10226348|P2|Overall Study|Other|1
2971074|NCT01153009|10226349|P1|Overall Study|Other|1
2971075|NCT01153009|10226346|P4|Overall Study|Lost to Follow-up|15
2971076|NCT01153009|10226347|P3|Overall Study|Lost to Follow-up|11
2971077|NCT01153009|10226348|P2|Overall Study|Lost to Follow-up|8
2971078|NCT01153009|10226349|P1|Overall Study|Lost to Follow-up|8
2971079|NCT01153009|10226346|P4|Overall Study|Withdrawal of Consent|6
2971080|NCT01153009|10226347|P3|Overall Study|Withdrawal of Consent|4
2971081|NCT01153009|10226348|P2|Overall Study|Withdrawal of Consent|5
2971082|NCT01153009|10226349|P1|Overall Study|Withdrawal of Consent|5
2971083|NCT01153009|10226346|P4|Overall Study|Protocol Deviations|2
2971084|NCT01153009|10226347|P3|Overall Study|Protocol Deviations|3
2971085|NCT01153009|10226348|P2|Overall Study|Protocol Deviations|3
2971086|NCT01153009|10226349|P1|Overall Study|Protocol Deviations|4
2971087|NCT01153009|10226346|P4|Overall Study|Noncompliance with Study Medication|1
2971088|NCT01153009|10226347|P3|Overall Study|Noncompliance with Study Medication|4
2971089|NCT01153009|10226348|P2|Overall Study|Noncompliance with Study Medication|3
2971090|NCT01153009|10226349|P1|Overall Study|Noncompliance with Study Medication|1
2971091|NCT01153009|10226346|P4|Overall Study|Lack of Efficacy|1
2971092|NCT01153009|10226347|P3|Overall Study|Lack of Efficacy|2
2971093|NCT01153009|10226348|P2|Overall Study|Lack of Efficacy|0
2971094|NCT01153009|10226349|P1|Overall Study|Lack of Efficacy|9
2971095|NCT01153009|10226346|P4|Overall Study|Adverse Event|10
2971096|NCT01153009|10226347|P3|Overall Study|Adverse Event|14
2971097|NCT01153009|10226348|P2|Overall Study|Adverse Event|14
2971098|NCT01153009|10226349|P1|Overall Study|Adverse Event|4
2971099|NCT01152996|10226379|P1|Overall Study|Elevated liver enzymes|1
2971100|NCT01152996|10226379|P1|Overall Study|Protocol Violation|22
2971101|NCT01152996|10226379|P1|Overall Study|Other|36
2971102|NCT01152996|10226379|P1|Overall Study|Noncompliance|41
2971103|NCT01152996|10226379|P1|Overall Study|Lack of Efficacy|68
2971104|NCT01152996|10226379|P1|Overall Study|Lost to Follow-up|112
2971105|NCT01152996|10226379|P1|Overall Study|Adverse Event|115
2971106|NCT01152996|10226379|P1|Overall Study|Withdrawal by Subject|142
2971107|NCT01152814|10226392|P1|Overall Study|Lost to Follow-up|2
2971108|NCT01152788|10226401|P2|Overall Study|No treatment|1
2971109|NCT01152788|10226402|P1|Overall Study|No treatment|0
2971110|NCT01152788|10226401|P2|Overall Study|Withdrawal by Subject|3
2971111|NCT01152788|10226402|P1|Overall Study|Withdrawal by Subject|0
2971112|NCT01152580|10226439|P2|Overall Study|Withdrawal by Subject|1
2971113|NCT01152580|10226440|P1|Overall Study|Withdrawal by Subject|0
2971114|NCT01152554|10226462|P2|Overall Study|Death|1
2971115|NCT01152554|10226463|P1|Overall Study|Death|1
2971116|NCT01152554|10226462|P2|Overall Study|Other|8
2971117|NCT01152554|10226463|P1|Overall Study|Other|28
2971118|NCT01152554|10226462|P2|Overall Study|Lost to Follow-up|32
2971119|NCT01152554|10226463|P1|Overall Study|Lost to Follow-up|87
2971120|NCT01152554|10226462|P2|Overall Study|Study-specific withdrawal criteria|8
2971121|NCT01152554|10226463|P1|Overall Study|Study-specific withdrawal criteria|17
2971122|NCT01152554|10226462|P2|Overall Study|Lack of Efficacy|3
2971123|NCT01152554|10226463|P1|Overall Study|Lack of Efficacy|20
2971124|NCT01152554|10226462|P2|Overall Study|Condition under investigation worsened|2
2971125|NCT01152554|10226463|P1|Overall Study|Condition under investigation worsened|5
2971126|NCT01152554|10226462|P2|Overall Study|Severe non-compliance to protocol|14
2971127|NCT01152554|10226463|P1|Overall Study|Severe non-compliance to protocol|36
2971128|NCT01152554|10226462|P2|Overall Study|Adverse Event|14
2971129|NCT01152554|10226463|P1|Overall Study|Adverse Event|67
2971130|NCT01152554|10226462|P2|Overall Study|Eligiblity criteria not fulfilled|1
2971131|NCT01152554|10226463|P1|Overall Study|Eligiblity criteria not fulfilled|0
2971132|NCT01152554|10226462|P2|Overall Study|Withdrawal by Subject|28
2971133|NCT01152554|10226463|P1|Overall Study|Withdrawal by Subject|73
2971134|NCT01152450|10226502|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
2971135|NCT01152450|10226503|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
2971136|NCT01152450|10226504|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
2971137|NCT01152450|10226505|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
2971138|NCT01152450|10226506|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
2971139|NCT01152450|10226507|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
2971140|NCT01152450|10226502|P6|Period 1 (4 Weeks)|Protocol Violation|0
2971141|NCT01152450|10226503|P5|Period 1 (4 Weeks)|Protocol Violation|1
2971142|NCT01152450|10226504|P4|Period 1 (4 Weeks)|Protocol Violation|0
2971143|NCT01152450|10226505|P3|Period 1 (4 Weeks)|Protocol Violation|0
2971144|NCT01152450|10226506|P2|Period 1 (4 Weeks)|Protocol Violation|0
2971145|NCT01152450|10226507|P1|Period 1 (4 Weeks)|Protocol Violation|0
2971146|NCT01152450|10226502|P6|Period 1 (4 Weeks)|Adverse Event|1
2971147|NCT01152450|10226503|P5|Period 1 (4 Weeks)|Adverse Event|1
2971148|NCT01152450|10226504|P4|Period 1 (4 Weeks)|Adverse Event|0
2971149|NCT01152450|10226505|P3|Period 1 (4 Weeks)|Adverse Event|0
2971150|NCT01152450|10226506|P2|Period 1 (4 Weeks)|Adverse Event|0
2971151|NCT01152450|10226507|P1|Period 1 (4 Weeks)|Adverse Event|0
2971152|NCT01152437|10226578|P3|Overall Study|Refusal to continue taking trial medicat|2
2971153|NCT01152437|10226579|P2|Overall Study|Refusal to continue taking trial medicat|0
2971154|NCT01152437|10226580|P1|Overall Study|Refusal to continue taking trial medicat|1
2971155|NCT01152437|10226578|P3|Overall Study|Progressive disease|32
2971156|NCT01152437|10226579|P2|Overall Study|Progressive disease|13
2971157|NCT01152437|10226580|P1|Overall Study|Progressive disease|27
2971158|NCT01152437|10226578|P3|Overall Study|Not treated|2
2971159|NCT01152437|10226579|P2|Overall Study|Not treated|1
2971160|NCT01152437|10226580|P1|Overall Study|Not treated|0
2971161|NCT01152437|10226578|P3|Overall Study|Other Adverse Event|7
2971162|NCT01152437|10226579|P2|Overall Study|Other Adverse Event|1
2971163|NCT01152437|10226580|P1|Overall Study|Other Adverse Event|8
2971164|NCT01152385|10226600|P4|Overall Study|Other|3
2971165|NCT01152385|10226601|P3|Overall Study|Other|2
2971166|NCT01152385|10226602|P2|Overall Study|Other|3
2971167|NCT01152385|10226603|P1|Overall Study|Other|4
2971168|NCT01152385|10226600|P4|Overall Study|Study-specific withdrawal criteria|0
2971169|NCT01152385|10226601|P3|Overall Study|Study-specific withdrawal criteria|2
2971170|NCT01152385|10226602|P2|Overall Study|Study-specific withdrawal criteria|1
2971171|NCT01152385|10226603|P1|Overall Study|Study-specific withdrawal criteria|1
2971172|NCT01152385|10226600|P4|Overall Study|Adverse Event|0
2971173|NCT01152385|10226601|P3|Overall Study|Adverse Event|0
2971174|NCT01152385|10226602|P2|Overall Study|Adverse Event|1
2971175|NCT01152385|10226603|P1|Overall Study|Adverse Event|1
2971176|NCT01152385|10226600|P4|Overall Study|Protocol Violation|1
2971177|NCT01152385|10226601|P3|Overall Study|Protocol Violation|0
2971178|NCT01152385|10226602|P2|Overall Study|Protocol Violation|0
2971179|NCT01152385|10226603|P1|Overall Study|Protocol Violation|0
2971180|NCT01152385|10226600|P4|Overall Study|Withdrawal by Subject|1
2971181|NCT01152385|10226601|P3|Overall Study|Withdrawal by Subject|1
2971182|NCT01152385|10226602|P2|Overall Study|Withdrawal by Subject|1
2971183|NCT01152385|10226603|P1|Overall Study|Withdrawal by Subject|3
2971184|NCT01152190|10226674|P2|Overall Study|Withdrawal by Subject|3
2971185|NCT01152190|10226675|P1|Overall Study|Withdrawal by Subject|1
2971186|NCT01152190|10226674|P2|Overall Study|Protocol Violation|1
2971187|NCT01152190|10226675|P1|Overall Study|Protocol Violation|1
2971188|NCT01152190|10226674|P2|Overall Study|Death|0
2971189|NCT01152190|10226675|P1|Overall Study|Death|1
2971190|NCT01152190|10226674|P2|Overall Study|Adverse Event|4
2971191|NCT01152190|10226675|P1|Overall Study|Adverse Event|2
2971192|NCT01152021|10226698|P2|Overall Study|No access to study drug in Pharmacy|1
2971193|NCT01152021|10226699|P1|Overall Study|No access to study drug in Pharmacy|0
2971194|NCT01152021|10226698|P2|Overall Study|Physician Decision|1
2971195|NCT01152021|10226699|P1|Overall Study|Physician Decision|1
2971196|NCT01152021|10226698|P2|Overall Study|Study drug had expired|0
2971197|NCT01152021|10226699|P1|Overall Study|Study drug had expired|1
2971198|NCT01152021|10226698|P2|Overall Study|Adverse Event|4
2971199|NCT01152021|10226699|P1|Overall Study|Adverse Event|4
2971200|NCT01151618|10226743|P1|Overall Study|Withdrawal by Subject|7
2971201|NCT01151618|10226743|P1|Overall Study|Adverse Event|2
2971202|NCT01151579|10226751|P2|Overall Study|Not meet inclusion criteria|4
2971203|NCT01151579|10226752|P1|Overall Study|Not meet inclusion criteria|6
2971204|NCT01151579|10226751|P2|Overall Study|Withdrawal by Subject|2
2971205|NCT01151579|10226752|P1|Overall Study|Withdrawal by Subject|3
2971206|NCT01151579|10226751|P2|Overall Study|Physician Decision|1
2971207|NCT01151579|10226752|P1|Overall Study|Physician Decision|3
2971208|NCT01151540|10226766|P1|Overall Study|Withdrawal by Subject|7
2971209|NCT01151540|10226766|P1|Overall Study|Adverse event, non-fatal|4
2971210|NCT01151540|10226766|P1|Overall Study|Other|2
2971211|NCT01151423|10226815|P2|Overall Study|Participated in other clinical trial|0
2971212|NCT01151423|10226816|P1|Overall Study|Participated in other clinical trial|1
2971213|NCT01151423|10226815|P2|Overall Study|Diagnosed as non-TTP patient|1
2971214|NCT01151423|10226816|P1|Overall Study|Diagnosed as non-TTP patient|0
2971215|NCT01151423|10226815|P2|Overall Study|Lost to Follow-up|0
2971216|NCT01151423|10226816|P1|Overall Study|Lost to Follow-up|1
2971217|NCT01151423|10226815|P2|Overall Study|Withdrawal by Subject|3
2971218|NCT01151423|10226816|P1|Overall Study|Withdrawal by Subject|1
2971219|NCT01151423|10226815|P2|Overall Study|Adverse Event|0
2971220|NCT01151423|10226816|P1|Overall Study|Adverse Event|3
2971221|NCT01151423|10226815|P2|Overall Study|Death|1
2971222|NCT01151423|10226816|P1|Overall Study|Death|0
2971223|NCT01151423|10226815|P2|Overall Study|Pregnancy|1
2971224|NCT01151423|10226816|P1|Overall Study|Pregnancy|0
2971225|NCT01151423|10226815|P2|Overall Study|Physician Decision|1
2971226|NCT01151423|10226816|P1|Overall Study|Physician Decision|1
2971227|NCT01151423|10226815|P2|Overall Study|Protocol Violation|1
2971228|NCT01151423|10226816|P1|Overall Study|Protocol Violation|0
2971229|NCT01151423|10226815|P2|Overall Study|Study terminated by Sponsor|10
2971230|NCT01151423|10226816|P1|Overall Study|Study terminated by Sponsor|9
2971231|NCT01151410|10226864|P2|Overall Study|Abnormal laboratory value(s)|1
2971232|NCT01151410|10226865|P1|Overall Study|Abnormal laboratory value(s)|0
2971233|NCT01151410|10226864|P2|Overall Study|Unsatisfactory therapeutic effect|1
2971234|NCT01151410|10226865|P1|Overall Study|Unsatisfactory therapeutic effect|1
2971235|NCT01151410|10226864|P2|Overall Study|Administrative problems|1
2971236|NCT01151410|10226865|P1|Overall Study|Administrative problems|1
2971237|NCT01151410|10226864|P2|Overall Study|Protocol deviation|1
2971238|NCT01151410|10226865|P1|Overall Study|Protocol deviation|2
2971239|NCT01151410|10226864|P2|Overall Study|Adverse Event|2
2971240|NCT01151410|10226865|P1|Overall Study|Adverse Event|1
2971241|NCT01151410|10226864|P2|Overall Study|Lost to Follow-up|4
2971242|NCT01151410|10226865|P1|Overall Study|Lost to Follow-up|3
2971243|NCT01151410|10226864|P2|Overall Study|Withdrawal by Subject|5
2971244|NCT01151410|10226865|P1|Overall Study|Withdrawal by Subject|3
2971245|NCT01151345|10226909|P2|First Intervention Period|Protocol Violation|1
2971246|NCT01151345|10226910|P1|First Intervention Period|Protocol Violation|0
2971247|NCT01151280|10226924|P1|Overall Study|Lack of Efficacy|3
2971248|NCT01151280|10226924|P1|Overall Study|Adverse Event|1
2971249|NCT01151215|10226937|P3|Overall Study|Safety as judged by the investigator|1
2971250|NCT01151215|10226938|P2|Overall Study|Safety as judged by the investigator|0
2971251|NCT01151215|10226939|P1|Overall Study|Safety as judged by the investigator|0
2971252|NCT01151215|10226937|P3|Overall Study|Disease progression|1
2971253|NCT01151215|10226938|P2|Overall Study|Disease progression|1
2971254|NCT01151215|10226939|P1|Overall Study|Disease progression|0
2971255|NCT01151215|10226937|P3|Overall Study|Withdrawal by Subject|2
2971256|NCT01151215|10226938|P2|Overall Study|Withdrawal by Subject|1
2971257|NCT01151215|10226939|P1|Overall Study|Withdrawal by Subject|3
2971258|NCT01151215|10226937|P3|Overall Study|Lost to Follow-up|3
2971259|NCT01151215|10226938|P2|Overall Study|Lost to Follow-up|0
2971260|NCT01151215|10226939|P1|Overall Study|Lost to Follow-up|0
2971261|NCT01151215|10226937|P3|Overall Study|Death|11
2971262|NCT01151215|10226938|P2|Overall Study|Death|20
2971263|NCT01151215|10226939|P1|Overall Study|Death|16
2971264|NCT01151215|10226937|P3|Overall Study|Worsening of condition under study|1
2971265|NCT01151215|10226938|P2|Overall Study|Worsening of condition under study|1
2971266|NCT01151215|10226939|P1|Overall Study|Worsening of condition under study|1
2971267|NCT01151137|10226977|P2|Overall Study|Lost to Follow-up|1
2971268|NCT01151137|10226978|P1|Overall Study|Lost to Follow-up|1
2971269|NCT01151137|10226977|P2|Overall Study|Death|27
2971270|NCT01151137|10226978|P1|Overall Study|Death|15
2971271|NCT01151098|10226996|P1|Overall Study|Miscellaneous|13
2971272|NCT01151098|10226996|P1|Overall Study|Protocol Violation|1
2971273|NCT01151098|10226996|P1|Overall Study|Lack of Efficacy|15
2971274|NCT01151098|10226996|P1|Overall Study|Lost to Follow-up|6
2971275|NCT01151098|10226996|P1|Overall Study|Adverse Event|82
2971276|NCT01151085|10227000|P1|Overall Study|Protocol Violation|25
2971277|NCT01151085|10227000|P1|Overall Study|Lost to Follow-up|31
2971278|NCT01151020|10227031|P1|Overall Study|Still be eligible for follow-up|79
2971279|NCT01151020|10227031|P1|Overall Study|Patients did not receive the device|2
2971280|NCT01151020|10227031|P1|Overall Study|Withdrawal by Subject|12
2971281|NCT01151020|10227031|P1|Overall Study|Lost to Follow-up|1
2971282|NCT01151020|10227031|P1|Overall Study|Conversion to open repair|1
2971283|NCT01151020|10227031|P1|Overall Study|Death|15
2971284|NCT01150474|10227110|P2|Overall Study|Surgery Changed|0
2971285|NCT01150474|10227111|P1|Overall Study|Surgery Changed|1
2971286|NCT01150474|10227110|P2|Overall Study|Drug not administered|0
2971287|NCT01150474|10227111|P1|Overall Study|Drug not administered|1
2971288|NCT01150474|10227110|P2|Overall Study|Drug did not arrive in time|0
2971289|NCT01150474|10227111|P1|Overall Study|Drug did not arrive in time|1
2971290|NCT01150474|10227110|P2|Overall Study|Rectotomy|0
2971291|NCT01150474|10227111|P1|Overall Study|Rectotomy|1
2971292|NCT01150474|10227110|P2|Overall Study|Multiple Studies|1
2971293|NCT01150474|10227111|P1|Overall Study|Multiple Studies|0
2971294|NCT01150474|10227110|P2|Overall Study|Cancer found|0
2971295|NCT01150474|10227111|P1|Overall Study|Cancer found|1
2971296|NCT01150474|10227110|P2|Overall Study|Withdrawal by Subject|2
2971297|NCT01150474|10227111|P1|Overall Study|Withdrawal by Subject|5
2971298|NCT01150357|10227156|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2971299|NCT01150357|10227157|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2971300|NCT01150357|10227158|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
2971301|NCT01150357|10227156|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2971302|NCT01150357|10227157|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2971303|NCT01150357|10227158|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
2971304|NCT01150357|10227156|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
2971305|NCT01150357|10227157|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2971306|NCT01150357|10227158|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2971307|NCT01150357|10227156|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
2971308|NCT01150357|10227157|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
2971309|NCT01150357|10227158|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
2971310|NCT01150357|10227156|P3|Dose Response Phase (Phase 1)|Adverse Event|1
2971311|NCT01150357|10227157|P2|Dose Response Phase (Phase 1)|Adverse Event|0
2971312|NCT01150357|10227158|P1|Dose Response Phase (Phase 1)|Adverse Event|0
2971313|NCT01150357|10227156|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2971314|NCT01150357|10227157|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2971315|NCT01150357|10227158|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
2971316|NCT01150357|10227156|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
2971317|NCT01150357|10227157|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
2971318|NCT01150357|10227158|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
2971319|NCT01150123|10227238|P18|Overall Study|Lost to Follow-up|0
2971320|NCT01150123|10227239|P17|Overall Study|Lost to Follow-up|0
2971321|NCT01150123|10227240|P16|Overall Study|Lost to Follow-up|0
2971322|NCT01150123|10227241|P15|Overall Study|Lost to Follow-up|0
2971323|NCT01150123|10227242|P14|Overall Study|Lost to Follow-up|0
2971324|NCT01150123|10227243|P13|Overall Study|Lost to Follow-up|2
2971325|NCT01150123|10227244|P12|Overall Study|Lost to Follow-up|1
2971326|NCT01150123|10227245|P11|Overall Study|Lost to Follow-up|1
2971327|NCT01150123|10227246|P10|Overall Study|Lost to Follow-up|1
2971328|NCT01150123|10227247|P9|Overall Study|Lost to Follow-up|3
2971329|NCT01150123|10227248|P8|Overall Study|Lost to Follow-up|0
2971330|NCT01150123|10227249|P7|Overall Study|Lost to Follow-up|0
2971331|NCT01150123|10227250|P6|Overall Study|Lost to Follow-up|5
2971332|NCT01150123|10227251|P5|Overall Study|Lost to Follow-up|2
2971333|NCT01150123|10227252|P4|Overall Study|Lost to Follow-up|2
2971334|NCT01150123|10227253|P3|Overall Study|Lost to Follow-up|2
2971335|NCT01150123|10227254|P2|Overall Study|Lost to Follow-up|1
2971336|NCT01150123|10227255|P1|Overall Study|Lost to Follow-up|2
2971337|NCT01150123|10227238|P18|Overall Study|Withdrawal by Subject|1
2971338|NCT01150123|10227239|P17|Overall Study|Withdrawal by Subject|0
2971339|NCT01150123|10227240|P16|Overall Study|Withdrawal by Subject|1
2971340|NCT01150123|10227241|P15|Overall Study|Withdrawal by Subject|0
2971341|NCT01150123|10227242|P14|Overall Study|Withdrawal by Subject|0
2971342|NCT01150123|10227243|P13|Overall Study|Withdrawal by Subject|1
2971343|NCT01150123|10227244|P12|Overall Study|Withdrawal by Subject|0
2971344|NCT01150123|10227245|P11|Overall Study|Withdrawal by Subject|1
2971345|NCT01150123|10227246|P10|Overall Study|Withdrawal by Subject|0
2971346|NCT01150123|10227247|P9|Overall Study|Withdrawal by Subject|2
2971347|NCT01150123|10227248|P8|Overall Study|Withdrawal by Subject|3
2971348|NCT01150123|10227249|P7|Overall Study|Withdrawal by Subject|0
2971349|NCT01150123|10227250|P6|Overall Study|Withdrawal by Subject|1
2971350|NCT01150123|10227251|P5|Overall Study|Withdrawal by Subject|1
2971351|NCT01150123|10227252|P4|Overall Study|Withdrawal by Subject|1
2971352|NCT01150123|10227253|P3|Overall Study|Withdrawal by Subject|2
2971353|NCT01150123|10227254|P2|Overall Study|Withdrawal by Subject|1
2971354|NCT01150123|10227255|P1|Overall Study|Withdrawal by Subject|1
2971355|NCT01150097|10227431|P3|Months 24 to 48 Post-transplantation|Death|0
2971356|NCT01150097|10227432|P2|Months 24 to 48 Post-transplantation|Death|0
2971357|NCT01150097|10227433|P1|Months 24 to 48 Post-transplantation|Death|2
2971358|NCT01150097|10227431|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2971359|NCT01150097|10227432|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2971360|NCT01150097|10227433|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
2971361|NCT01150097|10227431|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
2971362|NCT01150097|10227432|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
2971363|NCT01150097|10227433|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
2971364|NCT01150097|10227431|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2971365|NCT01150097|10227432|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
2971366|NCT01150097|10227433|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2971367|NCT01150097|10227431|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
2971368|NCT01150097|10227432|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2971369|NCT01150097|10227433|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2971370|NCT01150097|10227431|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
2971371|NCT01150097|10227432|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
2971372|NCT01150097|10227433|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
2971373|NCT01150097|10227431|P3|Months 24 to 36 Post-transplantation|Death|0
2971374|NCT01150097|10227432|P2|Months 24 to 36 Post-transplantation|Death|0
2971375|NCT01150097|10227433|P1|Months 24 to 36 Post-transplantation|Death|2
2971376|NCT01149863|10227477|P1|Overall Study|Missing data or Not receiveing studydrug|3
2971377|NCT01149655|10227554|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
2971378|NCT01149655|10227555|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
2971379|NCT01149655|10227556|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
2971380|NCT01149655|10227557|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
2971381|NCT01149655|10227554|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2971382|NCT01149655|10227555|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2971383|NCT01149655|10227556|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2971384|NCT01149655|10227557|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2971385|NCT01149655|10227554|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2971386|NCT01149655|10227555|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2971387|NCT01149655|10227556|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2971388|NCT01149655|10227557|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2971389|NCT01149655|10227554|P4|Period 3-DB Maintenance Phase|Physician Decision|0
2971390|NCT01149655|10227555|P3|Period 3-DB Maintenance Phase|Physician Decision|1
2971391|NCT01149655|10227556|P2|Period 3-DB Maintenance Phase|Physician Decision|0
2971392|NCT01149655|10227557|P1|Period 3-DB Maintenance Phase|Physician Decision|0
2971393|NCT01149655|10227554|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
2971394|NCT01149655|10227555|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
2971395|NCT01149655|10227556|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2971396|NCT01149655|10227557|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2971397|NCT01149655|10227554|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2971398|NCT01149655|10227555|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2971399|NCT01149655|10227556|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
2971400|NCT01149655|10227557|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2971401|NCT01149655|10227554|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
2971402|NCT01149655|10227555|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
2971403|NCT01149655|10227556|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
2971404|NCT01149655|10227557|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
2971405|NCT01149655|10227554|P4|Period 2-Stabilization Phase|Physician Decision|0
2971406|NCT01149655|10227555|P3|Period 2-Stabilization Phase|Physician Decision|0
2971407|NCT01149655|10227556|P2|Period 2-Stabilization Phase|Physician Decision|3
2971408|NCT01149655|10227557|P1|Period 2-Stabilization Phase|Physician Decision|0
2971409|NCT01149655|10227554|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2971410|NCT01149655|10227555|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2971411|NCT01149655|10227556|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
2971412|NCT01149655|10227557|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2971413|NCT01149655|10227554|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2971414|NCT01149655|10227555|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2971415|NCT01149655|10227556|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
2971416|NCT01149655|10227557|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2971417|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2971418|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2971419|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2971420|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
2971421|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
2971422|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
2971423|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
2971424|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
2971425|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Physician Decision|0
2971426|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Physician Decision|0
2971427|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Physician Decision|0
2971428|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Physician Decision|2
2971429|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2971430|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2971431|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2971432|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2971433|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2971434|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2971435|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2971436|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
2971437|NCT01149655|10227554|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
2971438|NCT01149655|10227555|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
2971439|NCT01149655|10227556|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
2971440|NCT01149655|10227557|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
2971441|NCT01149538|10227600|P2|Overall Study|Withdrawal by Subject|3
2971442|NCT01149538|10227601|P1|Overall Study|Withdrawal by Subject|5
2971443|NCT01149538|10227600|P2|Overall Study|Lost to Follow-up|1
2971444|NCT01149538|10227601|P1|Overall Study|Lost to Follow-up|0
2971445|NCT01149486|10227622|P2|First Intervention|Adverse Event|1
2971446|NCT01149486|10227623|P1|First Intervention|Adverse Event|0
2971447|NCT01149473|10227647|P2|Washout of 7 Days|Withdrawal by Subject|1
2971448|NCT01149473|10227648|P1|Washout of 7 Days|Withdrawal by Subject|1
2971449|NCT01149473|10227647|P2|First Intervention|Adverse Event|1
2971450|NCT01149473|10227648|P1|First Intervention|Adverse Event|1
2971451|NCT01149460|10227666|P2|Overall Study|Withdrawal by Subject|2
2971452|NCT01149460|10227667|P1|Overall Study|Withdrawal by Subject|0
2971453|NCT01149421|10227700|P3|Overall Study|Protocol Violation|6
2971454|NCT01149421|10227701|P2|Overall Study|Protocol Violation|2
2971455|NCT01149421|10227702|P1|Overall Study|Protocol Violation|2
2971456|NCT01149421|10227700|P3|Overall Study|Entry Criteria Not Met|2
2971457|NCT01149421|10227701|P2|Overall Study|Entry Criteria Not Met|1
2971458|NCT01149421|10227702|P1|Overall Study|Entry Criteria Not Met|1
2971459|NCT01149421|10227700|P3|Overall Study|Physician Decision|6
2971460|NCT01149421|10227701|P2|Overall Study|Physician Decision|3
2971461|NCT01149421|10227702|P1|Overall Study|Physician Decision|5
2971462|NCT01149421|10227700|P3|Overall Study|Lost to Follow-up|5
2971463|NCT01149421|10227701|P2|Overall Study|Lost to Follow-up|4
2971464|NCT01149421|10227702|P1|Overall Study|Lost to Follow-up|2
2971465|NCT01149421|10227700|P3|Overall Study|Sponsor Decision|1
2971466|NCT01149421|10227701|P2|Overall Study|Sponsor Decision|1
2971467|NCT01149421|10227702|P1|Overall Study|Sponsor Decision|0
2971468|NCT01149421|10227700|P3|Overall Study|Withdrawal by Subject|13
2971469|NCT01149421|10227701|P2|Overall Study|Withdrawal by Subject|12
2971470|NCT01149421|10227702|P1|Overall Study|Withdrawal by Subject|20
2971471|NCT01149421|10227700|P3|Overall Study|Adverse Event|11
2971472|NCT01149421|10227701|P2|Overall Study|Adverse Event|6
2971473|NCT01149421|10227702|P1|Overall Study|Adverse Event|22
2971474|NCT01149369|10227783|P2|Overall Study|Adverse Event|3
2971475|NCT01149369|10227784|P1|Overall Study|Adverse Event|6
2971476|NCT01149343|10227952|P4|Overall Study|Recurrence / Progressive disease|0
2971477|NCT01149343|10227953|P3|Overall Study|Recurrence / Progressive disease|1
2971478|NCT01149343|10227954|P2|Overall Study|Recurrence / Progressive disease|0
2971479|NCT01149343|10227955|P1|Overall Study|Recurrence / Progressive disease|0
2971480|NCT01149343|10227952|P4|Overall Study|Sponsor study termination|2
2971481|NCT01149343|10227953|P3|Overall Study|Sponsor study termination|0
2971482|NCT01149343|10227954|P2|Overall Study|Sponsor study termination|0
2971483|NCT01149343|10227955|P1|Overall Study|Sponsor study termination|0
2971484|NCT01149343|10227952|P4|Overall Study|Other|14
2971485|NCT01149343|10227953|P3|Overall Study|Other|2
2971486|NCT01149343|10227954|P2|Overall Study|Other|10
2971487|NCT01149343|10227955|P1|Overall Study|Other|8
2971488|NCT01149343|10227952|P4|Overall Study|Lost to Follow-up|1
2971489|NCT01149343|10227953|P3|Overall Study|Lost to Follow-up|0
2971490|NCT01149343|10227954|P2|Overall Study|Lost to Follow-up|0
2971491|NCT01149343|10227955|P1|Overall Study|Lost to Follow-up|1
2971492|NCT01149343|10227952|P4|Overall Study|Death|18
2971493|NCT01149343|10227953|P3|Overall Study|Death|18
2971494|NCT01149343|10227954|P2|Overall Study|Death|13
2971495|NCT01149343|10227955|P1|Overall Study|Death|10
2971496|NCT01149343|10227952|P4|Overall Study|Withdrawal by Subject|5
2971497|NCT01149343|10227953|P3|Overall Study|Withdrawal by Subject|1
2971498|NCT01149343|10227954|P2|Overall Study|Withdrawal by Subject|1
2971499|NCT01149343|10227955|P1|Overall Study|Withdrawal by Subject|1
2971500|NCT01149148|10228040|P2|Overall Study|Death|0
2971501|NCT01149148|10228041|P1|Overall Study|Death|1
2971502|NCT01149148|10228040|P2|Overall Study|Lost to Follow-up|2
2971503|NCT01149148|10228041|P1|Overall Study|Lost to Follow-up|1
2971504|NCT01149096|10228051|P2|Overall Study|Lost to Follow-up|1
2971505|NCT01149096|10228052|P1|Overall Study|Lost to Follow-up|0
2971506|NCT01149057|10228076|P1|Overall Study|Other|6
2971507|NCT01149057|10228076|P1|Overall Study|High Parathyroid Hormone Value|1
2971508|NCT01149057|10228076|P1|Overall Study|Lost to Follow-up|1
2971509|NCT01149057|10228076|P1|Overall Study|Participant Non-Compliance|2
2971510|NCT01149057|10228076|P1|Overall Study|B Cell Depletion|4
2971511|NCT01149057|10228076|P1|Overall Study|Positive Hepatitis B Core Antibody|5
2971512|NCT01149057|10228076|P1|Overall Study|Withdrawal by Subject|9
2971513|NCT01149057|10228076|P1|Overall Study|Adverse Event|13
2971514|NCT01149057|10228076|P1|Overall Study|Lack of Efficacy|16
2971515|NCT01148979|10228103|P2|Overall Study|Lost to Follow-up|1
2971516|NCT01148979|10228104|P1|Overall Study|Lost to Follow-up|0
2971517|NCT01148862|10228122|P2|Second Intervention|Withdrawal by Subject|2
2971518|NCT01148862|10228123|P1|Second Intervention|Withdrawal by Subject|0
2971519|NCT01148810|10228155|P2|Overall Study|Protocol Violation|0
2971520|NCT01148810|10228156|P1|Overall Study|Protocol Violation|1
2971521|NCT01148810|10228155|P2|Overall Study|Withdrawal by Subject|2
2971522|NCT01148810|10228156|P1|Overall Study|Withdrawal by Subject|0
2971523|NCT01148810|10228155|P2|Overall Study|Lack of Efficacy|1
2971524|NCT01148810|10228156|P1|Overall Study|Lack of Efficacy|0
2971525|NCT01148810|10228155|P2|Overall Study|Adverse Event|2
2971526|NCT01148810|10228156|P1|Overall Study|Adverse Event|0
2971527|NCT01148771|10228183|P2|Washout Period|Withdrawal by Subject|1
2971528|NCT01148771|10228184|P1|Washout Period|Withdrawal by Subject|0
2971529|NCT01148693|10228204|P2|Overall Study|Attempts for cannulation were failed|10
2971530|NCT01148693|10228205|P1|Overall Study|Attempts for cannulation were failed|13
2971531|NCT01148537|10228225|P3|Overall Study|Adverse Event|1
2971532|NCT01148537|10228226|P2|Overall Study|Adverse Event|0
2971533|NCT01148537|10228227|P1|Overall Study|Adverse Event|2
2971534|NCT01148537|10228225|P3|Overall Study|Withdrawal by Subject|2
2971535|NCT01148537|10228226|P2|Overall Study|Withdrawal by Subject|0
2971536|NCT01148537|10228227|P1|Overall Study|Withdrawal by Subject|1
2971537|NCT01148511|10228313|P3|Randomized|Other|1
2971538|NCT01148511|10228314|P2|Randomized|Other|1
2971539|NCT01148511|10228315|P1|Randomized|Other|0
2971540|NCT01148511|10228313|P3|Randomized|Consent withdrawal|3
2971541|NCT01148511|10228314|P2|Randomized|Consent withdrawal|5
2971542|NCT01148511|10228315|P1|Randomized|Consent withdrawal|0
2971543|NCT01148511|10228313|P3|Randomized|Lost to Follow-up|1
2971544|NCT01148511|10228314|P2|Randomized|Lost to Follow-up|1
2971545|NCT01148511|10228315|P1|Randomized|Lost to Follow-up|0
2971546|NCT01148511|10228313|P3|Randomized|Protocol Violation|1
2971547|NCT01148511|10228314|P2|Randomized|Protocol Violation|2
2971548|NCT01148511|10228315|P1|Randomized|Protocol Violation|0
2971549|NCT01148511|10228313|P3|Randomized|Adverse Event|0
2971550|NCT01148511|10228314|P2|Randomized|Adverse Event|1
2971551|NCT01148511|10228315|P1|Randomized|Adverse Event|0
2971552|NCT01148511|10228313|P3|Exposed to Study Drug|Lost to Follow-up|0
2971553|NCT01148511|10228314|P2|Exposed to Study Drug|Lost to Follow-up|0
2971554|NCT01148511|10228315|P1|Exposed to Study Drug|Lost to Follow-up|4
2971555|NCT01148511|10228313|P3|Exposed to Study Drug|Protocol Violation|0
2971556|NCT01148511|10228314|P2|Exposed to Study Drug|Protocol Violation|0
2971557|NCT01148511|10228315|P1|Exposed to Study Drug|Protocol Violation|2
2971558|NCT01148459|10228336|P2|Overall Study|Failure to comply with study procedures|1
2971559|NCT01148459|10228337|P1|Overall Study|Failure to comply with study procedures|0
2971560|NCT01148459|10228336|P2|Overall Study|Refusal|0
2971561|NCT01148459|10228337|P1|Overall Study|Refusal|1
2971562|NCT01148459|10228336|P2|Overall Study|Lost to Follow-up|0
2971563|NCT01148459|10228337|P1|Overall Study|Lost to Follow-up|2
2971564|NCT01148459|10228336|P2|Overall Study|Migrated/moved from study area|6
2971565|NCT01148459|10228337|P1|Overall Study|Migrated/moved from study area|3
2971566|NCT01148459|10228336|P2|Overall Study|Withdrawal by Subject|0
2971567|NCT01148459|10228337|P1|Overall Study|Withdrawal by Subject|1
2971568|NCT01148459|10228336|P2|Overall Study|Serious Adverse Event|4
2971569|NCT01148459|10228337|P1|Overall Study|Serious Adverse Event|5
2971570|NCT01148225|10228385|P1|Overall Study|Other|185
2971571|NCT01148017|10228436|P4|Overall Study|Unable to classify|0
2971572|NCT01148017|10228437|P3|Overall Study|Unable to classify|0
2971573|NCT01148017|10228438|P2|Overall Study|Unable to classify|1
2971574|NCT01148017|10228439|P1|Overall Study|Unable to classify|3
2971575|NCT01148017|10228436|P4|Overall Study|Administrative reason|0
2971576|NCT01148017|10228437|P3|Overall Study|Administrative reason|0
2971577|NCT01148017|10228438|P2|Overall Study|Administrative reason|9
2971578|NCT01148017|10228439|P1|Overall Study|Administrative reason|22
2971579|NCT01148017|10228436|P4|Overall Study|Inappropriate enrollment|0
2971580|NCT01148017|10228437|P3|Overall Study|Inappropriate enrollment|0
2971581|NCT01148017|10228438|P2|Overall Study|Inappropriate enrollment|0
2971582|NCT01148017|10228439|P1|Overall Study|Inappropriate enrollment|1
2971583|NCT01148017|10228436|P4|Overall Study|Lost to Follow-up|0
2971584|NCT01148017|10228437|P3|Overall Study|Lost to Follow-up|0
2971585|NCT01148017|10228438|P2|Overall Study|Lost to Follow-up|10
2971586|NCT01148017|10228439|P1|Overall Study|Lost to Follow-up|23
2971587|NCT01148017|10228436|P4|Overall Study|Withdrawal by Subject|0
2971588|NCT01148017|10228437|P3|Overall Study|Withdrawal by Subject|0
2971589|NCT01148017|10228438|P2|Overall Study|Withdrawal by Subject|14
2971590|NCT01148017|10228439|P1|Overall Study|Withdrawal by Subject|31
2971591|NCT01147926|10228478|P2|Overall Study|Colonoscopy result|1
2971592|NCT01147926|10228479|P1|Overall Study|Colonoscopy result|0
2971593|NCT01147926|10228478|P2|Overall Study|Went on holiday|1
2971594|NCT01147926|10228479|P1|Overall Study|Went on holiday|0
2971595|NCT01147926|10228478|P2|Overall Study|Too busy, no time for study|0
2971596|NCT01147926|10228479|P1|Overall Study|Too busy, no time for study|1
2971597|NCT01147926|10228478|P2|Overall Study|Lack of Efficacy|0
2971598|NCT01147926|10228479|P1|Overall Study|Lack of Efficacy|1
2971599|NCT01147926|10228478|P2|Overall Study|Sponsor's Decision|1
2971600|NCT01147926|10228479|P1|Overall Study|Sponsor's Decision|0
2971601|NCT01147926|10228478|P2|Overall Study|Lost to Follow-up|2
2971602|NCT01147926|10228479|P1|Overall Study|Lost to Follow-up|0
2971603|NCT01147926|10228478|P2|Overall Study|Selection criteria not met|1
2971604|NCT01147926|10228479|P1|Overall Study|Selection criteria not met|3
2971605|NCT01147926|10228478|P2|Overall Study|Principal investigator left hospital|3
2971606|NCT01147926|10228479|P1|Overall Study|Principal investigator left hospital|1
2971607|NCT01147926|10228478|P2|Overall Study|Subject Non-Compliant|4
2971608|NCT01147926|10228479|P1|Overall Study|Subject Non-Compliant|5
2971609|NCT01147926|10228478|P2|Overall Study|Adverse Event|6
2971610|NCT01147926|10228479|P1|Overall Study|Adverse Event|7
2971611|NCT01147926|10228478|P2|Overall Study|Subject Withdrew Consent|10
2971612|NCT01147926|10228479|P1|Overall Study|Subject Withdrew Consent|9
2971613|NCT01147900|10228514|P3|At Year 10|Lost to Follow-up|0
2971614|NCT01147900|10228515|P2|At Year 10|Lost to Follow-up|1
2971615|NCT01147900|10228516|P1|At Year 10|Lost to Follow-up|0
2971616|NCT01147874|10228575|P1|Overall Study|Withdrawal by Subject|24
2971617|NCT01147874|10228575|P1|Overall Study|Sponsor's Decision|2
2971618|NCT01147874|10228575|P1|Overall Study|Protocol Violation|5
2971619|NCT01147874|10228575|P1|Overall Study|Other|5
2971620|NCT01147874|10228575|P1|Overall Study|Lost to Follow-up|25
2971621|NCT01147874|10228575|P1|Overall Study|Investigator’s Request|1
2971622|NCT01147874|10228575|P1|Overall Study|Adverse Event|5
2971623|NCT01147848|10228583|P3|Randomized Phase|Withdrawal by Subject|9
2971624|NCT01147848|10228584|P2|Randomized Phase|Withdrawal by Subject|7
2971625|NCT01147848|10228585|P1|Randomized Phase|Withdrawal by Subject|0
2971626|NCT01147848|10228583|P3|Randomized Phase|Physician Decision|1
2971627|NCT01147848|10228584|P2|Randomized Phase|Physician Decision|0
2971628|NCT01147848|10228585|P1|Randomized Phase|Physician Decision|0
2971629|NCT01147848|10228583|P3|Randomized Phase|Lost to Follow-up|7
2971630|NCT01147848|10228584|P2|Randomized Phase|Lost to Follow-up|5
2971631|NCT01147848|10228585|P1|Randomized Phase|Lost to Follow-up|0
2971632|NCT01147848|10228583|P3|Randomized Phase|Protocol Violation|10
2971633|NCT01147848|10228584|P2|Randomized Phase|Protocol Violation|7
2971634|NCT01147848|10228585|P1|Randomized Phase|Protocol Violation|0
2971635|NCT01147848|10228583|P3|Randomized Phase|Lack of Efficacy|11
2971636|NCT01147848|10228584|P2|Randomized Phase|Lack of Efficacy|20
2971637|NCT01147848|10228585|P1|Randomized Phase|Lack of Efficacy|0
2971638|NCT01147848|10228583|P3|Randomized Phase|Adverse Event|8
2971639|NCT01147848|10228584|P2|Randomized Phase|Adverse Event|6
2971640|NCT01147848|10228585|P1|Randomized Phase|Adverse Event|0
2971641|NCT01147848|10228583|P3|Run-in Period|Run-in Failure|0
2971642|NCT01147848|10228584|P2|Run-in Period|Run-in Failure|0
2971643|NCT01147848|10228585|P1|Run-in Period|Run-in Failure|135
2971644|NCT01147848|10228583|P3|Run-in Period|Screen Failure|0
2971645|NCT01147848|10228584|P2|Run-in Period|Screen Failure|0
2971646|NCT01147848|10228585|P1|Run-in Period|Screen Failure|623
2971647|NCT01147822|10228617|P2|Overall Study|Not Completed/Ongoing|102
2971648|NCT01147822|10228618|P1|Overall Study|Not Completed/Ongoing|111
2971649|NCT01147822|10228617|P2|Overall Study|Withdrawal by Subject|13
2971650|NCT01147822|10228618|P1|Overall Study|Withdrawal by Subject|8
2971651|NCT01147822|10228617|P2|Overall Study|Physician Decision|2
2971652|NCT01147822|10228618|P1|Overall Study|Physician Decision|0
2971653|NCT01147822|10228617|P2|Overall Study|Lost to Follow-up|2
2971654|NCT01147822|10228618|P1|Overall Study|Lost to Follow-up|3
2971655|NCT01147822|10228617|P2|Overall Study|Protocol Violation|1
2971656|NCT01147822|10228618|P1|Overall Study|Protocol Violation|0
2971657|NCT01147822|10228617|P2|Overall Study|Death|59
2971658|NCT01147822|10228618|P1|Overall Study|Death|66
2971659|NCT01147809|10228638|P6|Phase II (168 Days)|Ongoing|0
2971660|NCT01147809|10228639|P5|Phase II (168 Days)|Ongoing|1
2971661|NCT01147809|10228640|P4|Phase II (168 Days)|Ongoing|0
2971662|NCT01147809|10228641|P3|Phase II (168 Days)|Ongoing|0
2971663|NCT01147809|10228642|P2|Phase II (168 Days)|Ongoing|0
2971664|NCT01147809|10228643|P1|Phase II (168 Days)|Ongoing|0
2971665|NCT01147809|10228638|P6|Phase II (168 Days)|Withdrawal by Subject|15
2971666|NCT01147809|10228639|P5|Phase II (168 Days)|Withdrawal by Subject|7
2971667|NCT01147809|10228640|P4|Phase II (168 Days)|Withdrawal by Subject|0
2971668|NCT01147809|10228641|P3|Phase II (168 Days)|Withdrawal by Subject|0
2971669|NCT01147809|10228642|P2|Phase II (168 Days)|Withdrawal by Subject|0
2971670|NCT01147809|10228643|P1|Phase II (168 Days)|Withdrawal by Subject|0
2971671|NCT01147809|10228638|P6|Phase II (168 Days)|Physician Decision|11
2971672|NCT01147809|10228639|P5|Phase II (168 Days)|Physician Decision|5
2971673|NCT01147809|10228640|P4|Phase II (168 Days)|Physician Decision|0
2971674|NCT01147809|10228641|P3|Phase II (168 Days)|Physician Decision|0
2971675|NCT01147809|10228642|P2|Phase II (168 Days)|Physician Decision|0
2971676|NCT01147809|10228643|P1|Phase II (168 Days)|Physician Decision|0
2971677|NCT01147809|10228638|P6|Phase II (168 Days)|Protocol Violation|1
2971678|NCT01147809|10228639|P5|Phase II (168 Days)|Protocol Violation|0
2971679|NCT01147809|10228640|P4|Phase II (168 Days)|Protocol Violation|0
2971680|NCT01147809|10228641|P3|Phase II (168 Days)|Protocol Violation|0
2971681|NCT01147809|10228642|P2|Phase II (168 Days)|Protocol Violation|0
2971682|NCT01147809|10228643|P1|Phase II (168 Days)|Protocol Violation|0
2971683|NCT01147809|10228638|P6|Phase II (168 Days)|Adverse Event|6
2971684|NCT01147809|10228639|P5|Phase II (168 Days)|Adverse Event|3
2971685|NCT01147809|10228640|P4|Phase II (168 Days)|Adverse Event|0
2971686|NCT01147809|10228641|P3|Phase II (168 Days)|Adverse Event|0
2971687|NCT01147809|10228642|P2|Phase II (168 Days)|Adverse Event|0
2971688|NCT01147809|10228643|P1|Phase II (168 Days)|Adverse Event|0
2971689|NCT01147809|10228638|P6|Phase I (168 Days)|Withdrawal by Subject|0
2971690|NCT01147809|10228639|P5|Phase I (168 Days)|Withdrawal by Subject|0
2971691|NCT01147809|10228640|P4|Phase I (168 Days)|Withdrawal by Subject|3
2971692|NCT01147809|10228641|P3|Phase I (168 Days)|Withdrawal by Subject|0
2971693|NCT01147809|10228642|P2|Phase I (168 Days)|Withdrawal by Subject|0
2971694|NCT01147809|10228643|P1|Phase I (168 Days)|Withdrawal by Subject|0
2971695|NCT01147809|10228638|P6|Phase I (168 Days)|Physician Decision|0
2971696|NCT01147809|10228639|P5|Phase I (168 Days)|Physician Decision|0
2971697|NCT01147809|10228640|P4|Phase I (168 Days)|Physician Decision|0
2971698|NCT01147809|10228641|P3|Phase I (168 Days)|Physician Decision|2
2971699|NCT01147809|10228642|P2|Phase I (168 Days)|Physician Decision|1
2971700|NCT01147809|10228643|P1|Phase I (168 Days)|Physician Decision|0
2971701|NCT01147809|10228638|P6|Phase I (168 Days)|Lost to Follow-up|0
2971702|NCT01147809|10228639|P5|Phase I (168 Days)|Lost to Follow-up|0
2971703|NCT01147809|10228640|P4|Phase I (168 Days)|Lost to Follow-up|1
2971704|NCT01147809|10228641|P3|Phase I (168 Days)|Lost to Follow-up|0
2971705|NCT01147809|10228642|P2|Phase I (168 Days)|Lost to Follow-up|0
2971706|NCT01147809|10228643|P1|Phase I (168 Days)|Lost to Follow-up|1
2971707|NCT01147809|10228638|P6|Phase I (168 Days)|Adverse Event|0
2971708|NCT01147809|10228639|P5|Phase I (168 Days)|Adverse Event|0
2971709|NCT01147809|10228640|P4|Phase I (168 Days)|Adverse Event|1
2971710|NCT01147809|10228641|P3|Phase I (168 Days)|Adverse Event|0
2971711|NCT01147809|10228642|P2|Phase I (168 Days)|Adverse Event|0
2971712|NCT01147809|10228643|P1|Phase I (168 Days)|Adverse Event|0
2971713|NCT01147744|10228764|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
2971714|NCT01147744|10228765|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
2971715|NCT01147744|10228766|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
2971716|NCT01147744|10228767|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
2971717|NCT01147744|10228768|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
2971718|NCT01147744|10228769|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
2971719|NCT01147744|10228770|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2971720|NCT01147744|10228764|P7|Overall Study|Sponsor decision to amend protocol|6
2971721|NCT01147744|10228765|P6|Overall Study|Sponsor decision to amend protocol|2
2971722|NCT01147744|10228766|P5|Overall Study|Sponsor decision to amend protocol|7
2971723|NCT01147744|10228767|P4|Overall Study|Sponsor decision to amend protocol|5
2971724|NCT01147744|10228768|P3|Overall Study|Sponsor decision to amend protocol|2
2971725|NCT01147744|10228769|P2|Overall Study|Sponsor decision to amend protocol|4
2971726|NCT01147744|10228770|P1|Overall Study|Sponsor decision to amend protocol|7
2971727|NCT01147744|10228764|P7|Overall Study|Lost to Follow-up|0
2971728|NCT01147744|10228765|P6|Overall Study|Lost to Follow-up|0
2971729|NCT01147744|10228766|P5|Overall Study|Lost to Follow-up|0
2971730|NCT01147744|10228767|P4|Overall Study|Lost to Follow-up|0
2971731|NCT01147744|10228768|P3|Overall Study|Lost to Follow-up|0
2971732|NCT01147744|10228769|P2|Overall Study|Lost to Follow-up|1
2971733|NCT01147744|10228770|P1|Overall Study|Lost to Follow-up|0
2971734|NCT01147744|10228764|P7|Overall Study|Withdrawal by Subject|2
2971735|NCT01147744|10228765|P6|Overall Study|Withdrawal by Subject|5
2971736|NCT01147744|10228766|P5|Overall Study|Withdrawal by Subject|2
2971737|NCT01147744|10228767|P4|Overall Study|Withdrawal by Subject|2
2971738|NCT01147744|10228768|P3|Overall Study|Withdrawal by Subject|2
2971739|NCT01147744|10228769|P2|Overall Study|Withdrawal by Subject|4
2971740|NCT01147744|10228770|P1|Overall Study|Withdrawal by Subject|8
2971741|NCT01147744|10228764|P7|Overall Study|Adverse Event|2
2971742|NCT01147744|10228765|P6|Overall Study|Adverse Event|1
2971743|NCT01147744|10228766|P5|Overall Study|Adverse Event|2
2971744|NCT01147744|10228767|P4|Overall Study|Adverse Event|0
2971745|NCT01147744|10228768|P3|Overall Study|Adverse Event|3
2971746|NCT01147744|10228769|P2|Overall Study|Adverse Event|2
2971747|NCT01147744|10228770|P1|Overall Study|Adverse Event|1
2971748|NCT01147744|10228764|P7|Overall Study|Lack of Efficacy|7
2971749|NCT01147744|10228765|P6|Overall Study|Lack of Efficacy|8
2971750|NCT01147744|10228766|P5|Overall Study|Lack of Efficacy|13
2971751|NCT01147744|10228767|P4|Overall Study|Lack of Efficacy|11
2971752|NCT01147744|10228768|P3|Overall Study|Lack of Efficacy|9
2971753|NCT01147744|10228769|P2|Overall Study|Lack of Efficacy|11
2971754|NCT01147744|10228770|P1|Overall Study|Lack of Efficacy|11
2971755|NCT01147744|10228764|P7|Overall Study|Physician Decision|1
2971756|NCT01147744|10228765|P6|Overall Study|Physician Decision|0
2971757|NCT01147744|10228766|P5|Overall Study|Physician Decision|0
2971758|NCT01147744|10228767|P4|Overall Study|Physician Decision|0
2971759|NCT01147744|10228768|P3|Overall Study|Physician Decision|1
2971760|NCT01147744|10228769|P2|Overall Study|Physician Decision|1
2971761|NCT01147744|10228770|P1|Overall Study|Physician Decision|0
2971762|NCT01147744|10228764|P7|Overall Study|Protocol Violation|1
2971763|NCT01147744|10228765|P6|Overall Study|Protocol Violation|3
2971764|NCT01147744|10228766|P5|Overall Study|Protocol Violation|1
2971765|NCT01147744|10228767|P4|Overall Study|Protocol Violation|0
2971766|NCT01147744|10228768|P3|Overall Study|Protocol Violation|1
2971767|NCT01147744|10228769|P2|Overall Study|Protocol Violation|0
2971768|NCT01147744|10228770|P1|Overall Study|Protocol Violation|1
2971769|NCT01147653|10228865|P2|Year 2|Withdrawal by Subject|3
2971770|NCT01147653|10228866|P1|Year 2|Withdrawal by Subject|2
2971771|NCT01147640|10228927|P2|Overall Study|Didn't meet eligibility criteria|0
2971772|NCT01147640|10228928|P1|Overall Study|Didn't meet eligibility criteria|1
2971773|NCT01147640|10228927|P2|Overall Study|Lost to Follow-up|1
2971774|NCT01147640|10228928|P1|Overall Study|Lost to Follow-up|0
2971775|NCT01147640|10228927|P2|Overall Study|Withdrawal by Subject|0
2971776|NCT01147640|10228928|P1|Overall Study|Withdrawal by Subject|1
2971777|NCT01147640|10228927|P2|Overall Study|Physician Decision|0
2971778|NCT01147640|10228928|P1|Overall Study|Physician Decision|1
2971779|NCT01147640|10228927|P2|Overall Study|Adverse Event|0
2971780|NCT01147640|10228928|P1|Overall Study|Adverse Event|2
2971781|NCT01147497|10228960|P2|Overall Study|failed insertion|0
2971782|NCT01147497|10228961|P1|Overall Study|failed insertion|2
2971783|NCT01147471|10228981|P2|6 Month Follow Up|Lost to Follow-up|2
2971784|NCT01147471|10228982|P1|6 Month Follow Up|Lost to Follow-up|4
2971785|NCT01147471|10228981|P2|3 Month Follow Up|Physician Decision|1
2971786|NCT01147471|10228982|P1|3 Month Follow Up|Physician Decision|0
2971787|NCT01147471|10228981|P2|3 Month Follow Up|Lost to Follow-up|1
2971788|NCT01147471|10228982|P1|3 Month Follow Up|Lost to Follow-up|1
2971789|NCT01147471|10228981|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
2971790|NCT01147471|10228982|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
2971791|NCT01147471|10228981|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
2971792|NCT01147471|10228982|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
2971793|NCT01147471|10228981|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
2971794|NCT01147471|10228982|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
2971795|NCT01147458|10228996|P4|Second Intervention|Other|0
2971796|NCT01147458|10228997|P3|Second Intervention|Other|1
2971797|NCT01147458|10228998|P2|Second Intervention|Other|0
2971798|NCT01147458|10228999|P1|Second Intervention|Other|0
2971799|NCT01147458|10228996|P4|Second Intervention|Adverse Event|1
2971800|NCT01147458|10228997|P3|Second Intervention|Adverse Event|1
2971801|NCT01147458|10228998|P2|Second Intervention|Adverse Event|0
2971802|NCT01147458|10228999|P1|Second Intervention|Adverse Event|2
2971803|NCT01147458|10228996|P4|Second Intervention|Withdrawal by Subject|0
2971804|NCT01147458|10228997|P3|Second Intervention|Withdrawal by Subject|0
2971805|NCT01147458|10228998|P2|Second Intervention|Withdrawal by Subject|1
2971806|NCT01147458|10228999|P1|Second Intervention|Withdrawal by Subject|0
2971807|NCT01147458|10228996|P4|Second Intervention|Protocol Violation|0
2971808|NCT01147458|10228997|P3|Second Intervention|Protocol Violation|1
2971809|NCT01147458|10228998|P2|Second Intervention|Protocol Violation|1
2971810|NCT01147458|10228999|P1|Second Intervention|Protocol Violation|0
2971811|NCT01147458|10228996|P4|Second Intervention|Study terminated by sponsor|3
2971812|NCT01147458|10228997|P3|Second Intervention|Study terminated by sponsor|5
2971813|NCT01147458|10228998|P2|Second Intervention|Study terminated by sponsor|5
2971814|NCT01147458|10228999|P1|Second Intervention|Study terminated by sponsor|7
2971815|NCT01147458|10228996|P4|First Intervention|Other|0
2971816|NCT01147458|10228997|P3|First Intervention|Other|0
2971817|NCT01147458|10228998|P2|First Intervention|Other|2
2971818|NCT01147458|10228999|P1|First Intervention|Other|1
2971819|NCT01147458|10228996|P4|First Intervention|Adverse Event|3
2971820|NCT01147458|10228997|P3|First Intervention|Adverse Event|2
2971821|NCT01147458|10228998|P2|First Intervention|Adverse Event|3
2971822|NCT01147458|10228999|P1|First Intervention|Adverse Event|0
2971823|NCT01147458|10228996|P4|First Intervention|Withdrawal by Subject|0
2971824|NCT01147458|10228997|P3|First Intervention|Withdrawal by Subject|1
2971825|NCT01147458|10228998|P2|First Intervention|Withdrawal by Subject|0
2971826|NCT01147458|10228999|P1|First Intervention|Withdrawal by Subject|3
2971827|NCT01147458|10228996|P4|First Intervention|Protocol Violation|3
2971828|NCT01147458|10228997|P3|First Intervention|Protocol Violation|2
2971829|NCT01147458|10228998|P2|First Intervention|Protocol Violation|3
2971830|NCT01147458|10228999|P1|First Intervention|Protocol Violation|2
2971831|NCT01147458|10228996|P4|First Intervention|Study terminated by sponsor|8
2971832|NCT01147458|10228997|P3|First Intervention|Study terminated by sponsor|7
2971833|NCT01147458|10228998|P2|First Intervention|Study terminated by sponsor|8
2971834|NCT01147458|10228999|P1|First Intervention|Study terminated by sponsor|8
2971835|NCT01147393|10229078|P1|Dose Level -1|Dose Limited Toxicity|1
2971836|NCT01147393|10229078|P1|Dose Level 1|Dose limiting Toxicity|2
2971837|NCT01147341|10229099|P2|Open Label Period|Subject moved|0
2971838|NCT01147341|10229100|P1|Open Label Period|Subject moved|1
2971839|NCT01147341|10229099|P2|Open Label Period|Lack of Efficacy|0
2971840|NCT01147341|10229100|P1|Open Label Period|Lack of Efficacy|3
2971841|NCT01147341|10229099|P2|Double Blind Period|Withdrawal by Subject|1
2971842|NCT01147341|10229100|P1|Double Blind Period|Withdrawal by Subject|0
2971843|NCT01147341|10229099|P2|Double Blind Period|Lack of Efficacy|1
2971844|NCT01147341|10229100|P1|Double Blind Period|Lack of Efficacy|1
2971845|NCT01147250|10229163|P2|Overall Study|Other than specified|1
2971846|NCT01147250|10229164|P1|Overall Study|Other than specified|0
2971847|NCT01147250|10229163|P2|Overall Study|Site termination by sponsor|5
2971848|NCT01147250|10229164|P1|Overall Study|Site termination by sponsor|13
2971849|NCT01147250|10229163|P2|Overall Study|Withdrawal by Subject|88
2971850|NCT01147250|10229164|P1|Overall Study|Withdrawal by Subject|83
2971851|NCT01147250|10229163|P2|Overall Study|Lost to Follow-up|11
2971852|NCT01147250|10229164|P1|Overall Study|Lost to Follow-up|14
2971853|NCT01147172|10229176|P1|Overall Study|Lost to Follow-up|2
2971854|NCT01147172|10229176|P1|Overall Study|Withdrawal by Subject|2
2971855|NCT01147068|10229194|P7|Subjects That Completed Safety Follow-up|Ineligible|0
2971856|NCT01147068|10229195|P6|Subjects That Completed Safety Follow-up|Ineligible|0
2971857|NCT01147068|10229196|P5|Subjects That Completed Safety Follow-up|Ineligible|0
2971858|NCT01147068|10229197|P4|Subjects That Completed Safety Follow-up|Ineligible|0
2971859|NCT01147068|10229198|P3|Subjects That Completed Safety Follow-up|Ineligible|0
2971860|NCT01147068|10229199|P2|Subjects That Completed Safety Follow-up|Ineligible|1
2971861|NCT01147068|10229200|P1|Subjects That Completed Safety Follow-up|Ineligible|0
2971862|NCT01147068|10229194|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971863|NCT01147068|10229195|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971864|NCT01147068|10229196|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971865|NCT01147068|10229197|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
2971866|NCT01147068|10229198|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971867|NCT01147068|10229199|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971868|NCT01147068|10229200|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2971869|NCT01147068|10229194|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2971870|NCT01147068|10229195|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2971871|NCT01147068|10229196|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2971872|NCT01147068|10229197|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2971873|NCT01147068|10229198|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2971874|NCT01147068|10229199|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2971875|NCT01147068|10229200|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2971876|NCT01147068|10229194|P7|Subjects That Received 2nd Dose|Other|0
2971877|NCT01147068|10229195|P6|Subjects That Received 2nd Dose|Other|0
2971878|NCT01147068|10229196|P5|Subjects That Received 2nd Dose|Other|1
2971879|NCT01147068|10229197|P4|Subjects That Received 2nd Dose|Other|0
2971880|NCT01147068|10229198|P3|Subjects That Received 2nd Dose|Other|3
2971881|NCT01147068|10229199|P2|Subjects That Received 2nd Dose|Other|3
2971882|NCT01147068|10229200|P1|Subjects That Received 2nd Dose|Other|0
2971883|NCT01147068|10229194|P7|Subjects That Received 2nd Dose|Did not complete the study|0
2971884|NCT01147068|10229195|P6|Subjects That Received 2nd Dose|Did not complete the study|1
2971885|NCT01147068|10229196|P5|Subjects That Received 2nd Dose|Did not complete the study|0
2971886|NCT01147068|10229197|P4|Subjects That Received 2nd Dose|Did not complete the study|0
2971887|NCT01147068|10229198|P3|Subjects That Received 2nd Dose|Did not complete the study|0
2971888|NCT01147068|10229199|P2|Subjects That Received 2nd Dose|Did not complete the study|1
2971889|NCT01147068|10229200|P1|Subjects That Received 2nd Dose|Did not complete the study|0
2971890|NCT01147068|10229194|P7|Subjects That Received 2nd Dose|Ineligible|0
2971891|NCT01147068|10229195|P6|Subjects That Received 2nd Dose|Ineligible|0
2971892|NCT01147068|10229196|P5|Subjects That Received 2nd Dose|Ineligible|0
2971893|NCT01147068|10229197|P4|Subjects That Received 2nd Dose|Ineligible|0
2971894|NCT01147068|10229198|P3|Subjects That Received 2nd Dose|Ineligible|0
2971895|NCT01147068|10229199|P2|Subjects That Received 2nd Dose|Ineligible|1
2971896|NCT01147068|10229200|P1|Subjects That Received 2nd Dose|Ineligible|0
2971897|NCT01147068|10229194|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
2971898|NCT01147068|10229195|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
2971899|NCT01147068|10229196|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
2971900|NCT01147068|10229197|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
2971901|NCT01147068|10229198|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
2971902|NCT01147068|10229199|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
2971903|NCT01147068|10229200|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
2971904|NCT01147055|10229230|P2|First Intervention Period|Lost to Follow-up|0
2971905|NCT01147055|10229231|P1|First Intervention Period|Lost to Follow-up|1
2971906|NCT01146951|10229273|P2|Overall Study|Adverse Event|1
2971907|NCT01146951|10229274|P1|Overall Study|Adverse Event|4
2971908|NCT01146912|10229295|P8|Overall Study|Duplicate patient|0
2971909|NCT01146912|10229296|P7|Overall Study|Duplicate patient|0
2971910|NCT01146912|10229297|P6|Overall Study|Duplicate patient|0
2971911|NCT01146912|10229298|P5|Overall Study|Duplicate patient|0
2971912|NCT01146912|10229299|P4|Overall Study|Duplicate patient|0
2971913|NCT01146912|10229300|P3|Overall Study|Duplicate patient|1
2971914|NCT01146912|10229301|P2|Overall Study|Duplicate patient|0
2971915|NCT01146912|10229302|P1|Overall Study|Duplicate patient|0
2971916|NCT01146912|10229295|P8|Overall Study|< 14 weeks gestational age|0
2971917|NCT01146912|10229296|P7|Overall Study|< 14 weeks gestational age|0
2971918|NCT01146912|10229297|P6|Overall Study|< 14 weeks gestational age|0
2971919|NCT01146912|10229298|P5|Overall Study|< 14 weeks gestational age|0
2971920|NCT01146912|10229299|P4|Overall Study|< 14 weeks gestational age|2
2971921|NCT01146912|10229300|P3|Overall Study|< 14 weeks gestational age|3
2971922|NCT01146912|10229301|P2|Overall Study|< 14 weeks gestational age|0
2971923|NCT01146912|10229302|P1|Overall Study|< 14 weeks gestational age|0
2971924|NCT01146912|10229295|P8|Overall Study|Already received influenza vaccination|0
2971925|NCT01146912|10229296|P7|Overall Study|Already received influenza vaccination|56
2971926|NCT01146912|10229297|P6|Overall Study|Already received influenza vaccination|61
2971927|NCT01146912|10229298|P5|Overall Study|Already received influenza vaccination|41
2971928|NCT01146912|10229299|P4|Overall Study|Already received influenza vaccination|15
2971929|NCT01146912|10229300|P3|Overall Study|Already received influenza vaccination|13
2971930|NCT01146912|10229301|P2|Overall Study|Already received influenza vaccination|822
2971931|NCT01146912|10229302|P1|Overall Study|Already received influenza vaccination|817
2971932|NCT01146873|10229324|P2|Overall Study|Transfer out|6
2971933|NCT01146873|10229325|P1|Overall Study|Transfer out|0
2971934|NCT01146860|10229341|P2|Overall Study|Withdrawal by Subject|1
2971935|NCT01146860|10229342|P1|Overall Study|Withdrawal by Subject|0
2971936|NCT01146782|10229393|P1|Primary Endpoint Cohort|Physician Decision|1
2971937|NCT01146782|10229393|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
2971938|NCT01146782|10229393|P1|Safety Cohort|TST <4 hrs|14
2971939|NCT01146782|10229393|P1|Safety Cohort|Control AHI <5|4
2971940|NCT01146782|10229393|P1|Safety Cohort|Withdrawal by Subject|4
2971941|NCT01146782|10229393|P1|Safety Cohort|Screen Failure|61
2971942|NCT01146782|10229393|P1|Screening Cohort|Withdrawal by Subject|29
2971943|NCT01146782|10229393|P1|Screening Cohort|Physician Decision|1
2971944|NCT01146782|10229393|P1|Screening Cohort|Lost to Follow-up|4
2971945|NCT01146782|10229393|P1|Screening Cohort|Screen Failure|187
2971946|NCT01146665|10229411|P2|Overall Study|Withdrawal by Subject|16
2971947|NCT01146665|10229412|P1|Overall Study|Withdrawal by Subject|10
2971948|NCT01146613|10229444|P2|Overall Study|Outpatient detox|0
2971949|NCT01146613|10229445|P1|Overall Study|Outpatient detox|1
2971950|NCT01146613|10229444|P2|Overall Study|schedule conflict|0
2971951|NCT01146613|10229445|P1|Overall Study|schedule conflict|1
2971952|NCT01146613|10229444|P2|Overall Study|Withdrawal by Subject|3
2971953|NCT01146613|10229445|P1|Overall Study|Withdrawal by Subject|0
2971954|NCT01146613|10229444|P2|Overall Study|Physician Decision|0
2971955|NCT01146613|10229445|P1|Overall Study|Physician Decision|1
2971956|NCT01146613|10229444|P2|Overall Study|Death|0
2971957|NCT01146613|10229445|P1|Overall Study|Death|1
2971958|NCT01146613|10229444|P2|Overall Study|Lack of Efficacy|1
2971959|NCT01146613|10229445|P1|Overall Study|Lack of Efficacy|0
2971960|NCT01146613|10229444|P2|Overall Study|Lost to Follow-up|8
2971961|NCT01146613|10229445|P1|Overall Study|Lost to Follow-up|3
2971962|NCT01146288|10229555|P2|First Intervention(1 Day)|Adverse Event|1
2971963|NCT01146288|10229556|P1|First Intervention(1 Day)|Adverse Event|0
2971964|NCT01146054|10229570|P1|Overall Study|Lost to Follow-up|1
2971965|NCT01146054|10229570|P1|Overall Study|Other illness precluded treatment|2
2971966|NCT01146054|10229570|P1|Overall Study|Rapid tumor progression|2
2971967|NCT01146054|10229570|P1|Overall Study|Did not meet dose constraints for SBRT|5
2971968|NCT01145898|10229580|P2|3-year Treatment|medication change by treating physician|16
2971969|NCT01145898|10229581|P1|3-year Treatment|medication change by treating physician|3
2971970|NCT01145885|10229612|P1|Overall Study|Progressive Disease|7
2971971|NCT01145755|10229647|P3|Overall Study|Positive urine ethanol|0
2971972|NCT01145755|10229648|P2|Overall Study|Positive urine ethanol|1
2971973|NCT01145755|10229649|P1|Overall Study|Positive urine ethanol|0
2971974|NCT01145755|10229647|P3|Overall Study|Withdrawal by Subject|1
2971975|NCT01145755|10229648|P2|Overall Study|Withdrawal by Subject|0
2971976|NCT01145755|10229649|P1|Overall Study|Withdrawal by Subject|0
2971977|NCT01145755|10229647|P3|Overall Study|Patient could not swollow medication|1
2971978|NCT01145755|10229648|P2|Overall Study|Patient could not swollow medication|0
2971979|NCT01145755|10229649|P1|Overall Study|Patient could not swollow medication|0
2971980|NCT01145755|10229647|P3|Overall Study|Lack of Efficacy|0
2971981|NCT01145755|10229648|P2|Overall Study|Lack of Efficacy|1
2971982|NCT01145755|10229649|P1|Overall Study|Lack of Efficacy|0
2971983|NCT01145755|10229647|P3|Overall Study|Study Closure|17
2971984|NCT01145755|10229648|P2|Overall Study|Study Closure|14
2971985|NCT01145755|10229649|P1|Overall Study|Study Closure|14
2971986|NCT01145755|10229647|P3|Overall Study|Protocol Violation|1
2971987|NCT01145755|10229648|P2|Overall Study|Protocol Violation|3
2971988|NCT01145755|10229649|P1|Overall Study|Protocol Violation|0
2971989|NCT01145755|10229647|P3|Overall Study|Lost to Follow-up|1
2971990|NCT01145755|10229648|P2|Overall Study|Lost to Follow-up|3
2971991|NCT01145755|10229649|P1|Overall Study|Lost to Follow-up|2
2971992|NCT01145755|10229647|P3|Overall Study|Withdrawal by Subject|2
2971993|NCT01145755|10229648|P2|Overall Study|Withdrawal by Subject|2
2971994|NCT01145755|10229649|P1|Overall Study|Withdrawal by Subject|2
2971995|NCT01145755|10229647|P3|Overall Study|Adverse Event|2
2971996|NCT01145755|10229648|P2|Overall Study|Adverse Event|4
2971997|NCT01145755|10229649|P1|Overall Study|Adverse Event|2
2971998|NCT01145625|10229676|P2|Overall Study|Pregnancy|1
2971999|NCT01145625|10229677|P1|Overall Study|Pregnancy|0
2972000|NCT01145625|10229676|P2|Overall Study|Withdrawal by Subject|16
2972001|NCT01145625|10229677|P1|Overall Study|Withdrawal by Subject|7
2972002|NCT01145625|10229676|P2|Overall Study|Protocol Violation|1
2972003|NCT01145625|10229677|P1|Overall Study|Protocol Violation|3
2972004|NCT01145625|10229676|P2|Overall Study|Adverse Event|4
2972005|NCT01145625|10229677|P1|Overall Study|Adverse Event|6
2972006|NCT01145625|10229676|P2|Overall Study|Lost to Follow-up|9
2972007|NCT01145625|10229677|P1|Overall Study|Lost to Follow-up|8
2972008|NCT01145560|10229690|P3|Overall Study|Withdrawal of therapy|1
2972009|NCT01145560|10229691|P2|Overall Study|Withdrawal of therapy|0
2972010|NCT01145560|10229692|P1|Overall Study|Withdrawal of therapy|0
2972011|NCT01145560|10229690|P3|Overall Study|False insurance information|0
2972012|NCT01145560|10229691|P2|Overall Study|False insurance information|1
2972013|NCT01145560|10229692|P1|Overall Study|False insurance information|0
2972014|NCT01145560|10229690|P3|Overall Study|Accidental unblinding of study treatment|0
2972015|NCT01145560|10229691|P2|Overall Study|Accidental unblinding of study treatment|1
2972016|NCT01145560|10229692|P1|Overall Study|Accidental unblinding of study treatment|0
2972017|NCT01145560|10229690|P3|Overall Study|No study drug by 24h after organ failure|0
2972018|NCT01145560|10229691|P2|Overall Study|No study drug by 24h after organ failure|0
2972019|NCT01145560|10229692|P1|Overall Study|No study drug by 24h after organ failure|1
2972020|NCT01145560|10229690|P3|Overall Study|Lost to Follow-up|1
2972021|NCT01145560|10229691|P2|Overall Study|Lost to Follow-up|1
2972022|NCT01145560|10229692|P1|Overall Study|Lost to Follow-up|1
2972023|NCT01145560|10229690|P3|Overall Study|Withdrawal by Subject|0
2972024|NCT01145560|10229691|P2|Overall Study|Withdrawal by Subject|1
2972025|NCT01145560|10229692|P1|Overall Study|Withdrawal by Subject|2
2972026|NCT01145508|10229718|P2|Overall Study|Never started treatment|1
2972027|NCT01145508|10229719|P1|Overall Study|Never started treatment|1
2972028|NCT01145508|10229718|P2|Overall Study|Physician Decision|1
2972029|NCT01145508|10229719|P1|Overall Study|Physician Decision|2
2972030|NCT01145508|10229718|P2|Overall Study|Death|0
2972031|NCT01145508|10229719|P1|Overall Study|Death|1
2972032|NCT01145508|10229718|P2|Overall Study|Adverse Event|0
2972033|NCT01145508|10229719|P1|Overall Study|Adverse Event|1
2972034|NCT01145495|10229725|P1|Overall Study|Disease progression after respone|1
2972035|NCT01145495|10229725|P1|Overall Study|Withdrawal by Subject|5
2972036|NCT01145495|10229725|P1|Overall Study|Adverse Event|6
2972037|NCT01145482|10229731|P2|First Intervention (1 Day)|Withdrawal by Subject|1
2972038|NCT01145482|10229732|P1|First Intervention (1 Day)|Withdrawal by Subject|0
2972039|NCT01145417|10229742|P2|Overall Study|Other|0
2972040|NCT01145417|10229743|P1|Overall Study|Other|1
2972041|NCT01145417|10229742|P2|Overall Study|Study terminated by sponsor|43
2972042|NCT01145417|10229743|P1|Overall Study|Study terminated by sponsor|35
2972043|NCT01145417|10229742|P2|Overall Study|Adverse Event|1
2972044|NCT01145417|10229743|P1|Overall Study|Adverse Event|0
2972045|NCT01145417|10229742|P2|Overall Study|Pregnancy|0
2972046|NCT01145417|10229743|P1|Overall Study|Pregnancy|1
2972047|NCT01145417|10229742|P2|Overall Study|Withdrawal by Subject|2
2972048|NCT01145417|10229743|P1|Overall Study|Withdrawal by Subject|1
2972049|NCT01145417|10229742|P2|Overall Study|Lost to Follow-up|1
2972050|NCT01145417|10229743|P1|Overall Study|Lost to Follow-up|2
2972051|NCT01145417|10229742|P2|Overall Study|Death|0
2972052|NCT01145417|10229743|P1|Overall Study|Death|1
2972053|NCT01145352|10229776|P1|Overall Study|Syringe formulation was used|1
2972054|NCT01145352|10229776|P1|Overall Study|Treated before marketing approval|4
2972055|NCT01145352|10229776|P1|Overall Study|Found to have been registered twice|6
2972056|NCT01145222|10229788|P4|Overall Study|Poor bowel preparation|1
2972057|NCT01145222|10229789|P3|Overall Study|Poor bowel preparation|0
2972058|NCT01145222|10229790|P2|Overall Study|Poor bowel preparation|0
2972059|NCT01145222|10229791|P1|Overall Study|Poor bowel preparation|0
2972060|NCT01145222|10229788|P4|Overall Study|Procedure not done (no anesthesiologist)|0
2972061|NCT01145222|10229789|P3|Overall Study|Procedure not done (no anesthesiologist)|1
2972062|NCT01145222|10229790|P2|Overall Study|Procedure not done (no anesthesiologist)|0
2972063|NCT01145222|10229791|P1|Overall Study|Procedure not done (no anesthesiologist)|0
2972064|NCT01145066|10229838|P3|Overall Study|Low platelet count|0
2972065|NCT01145066|10229839|P2|Overall Study|Low platelet count|1
2972066|NCT01145066|10229840|P1|Overall Study|Low platelet count|0
2972067|NCT01145066|10229838|P3|Overall Study|Abdominal discomfort|0
2972068|NCT01145066|10229839|P2|Overall Study|Abdominal discomfort|1
2972069|NCT01145066|10229840|P1|Overall Study|Abdominal discomfort|0
2972070|NCT01145066|10229838|P3|Overall Study|problems swallowing capsule|0
2972071|NCT01145066|10229839|P2|Overall Study|problems swallowing capsule|0
2972072|NCT01145066|10229840|P1|Overall Study|problems swallowing capsule|1
2972073|NCT01145066|10229838|P3|Overall Study|To start new med|0
2972074|NCT01145066|10229839|P2|Overall Study|To start new med|0
2972075|NCT01145066|10229840|P1|Overall Study|To start new med|1
2972076|NCT01145066|10229838|P3|Overall Study|Withdrawal by Subject|2
2972077|NCT01145066|10229839|P2|Overall Study|Withdrawal by Subject|0
2972078|NCT01145066|10229840|P1|Overall Study|Withdrawal by Subject|0
2972079|NCT01145066|10229838|P3|Overall Study|Non-related surgery|1
2972080|NCT01145066|10229839|P2|Overall Study|Non-related surgery|0
2972081|NCT01145066|10229840|P1|Overall Study|Non-related surgery|0
2972082|NCT01145066|10229838|P3|Overall Study|To resume NSAIDs|1
2972083|NCT01145066|10229839|P2|Overall Study|To resume NSAIDs|2
2972084|NCT01145066|10229840|P1|Overall Study|To resume NSAIDs|2
2972085|NCT01145053|10229908|P1|Overall Study|Other|18
2972086|NCT01145053|10229908|P1|Overall Study|Withdrawal by Subject|25
2972087|NCT01145053|10229908|P1|Overall Study|Lost to Follow-up|28
2972088|NCT01145053|10229908|P1|Overall Study|Adverse Event|22
2972089|NCT01144715|10229960|P2|Overall Study|Adverse Event|1
2972090|NCT01144715|10229961|P1|Overall Study|Adverse Event|0
2972091|NCT01144715|10229960|P2|Overall Study|Withdrawal by Subject|1
2972092|NCT01144715|10229961|P1|Overall Study|Withdrawal by Subject|2
2972093|NCT01144715|10229960|P2|Overall Study|Lost to Follow-up|1
2972094|NCT01144715|10229961|P1|Overall Study|Lost to Follow-up|2
2972095|NCT01144663|10229977|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
2972096|NCT01144663|10229978|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
2972097|NCT01144663|10229979|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
2972098|NCT01144663|10229980|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
2972099|NCT01144663|10229977|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
2972100|NCT01144663|10229978|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2972101|NCT01144663|10229979|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
2972102|NCT01144663|10229980|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2972103|NCT01144663|10229977|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2972104|NCT01144663|10229978|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2972105|NCT01144663|10229979|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2972106|NCT01144663|10229980|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2972107|NCT01144663|10229977|P4|Booster Vaccination Phase|Lost to Follow-up|0
2972108|NCT01144663|10229978|P3|Booster Vaccination Phase|Lost to Follow-up|3
2972109|NCT01144663|10229979|P2|Booster Vaccination Phase|Lost to Follow-up|1
2972110|NCT01144663|10229980|P1|Booster Vaccination Phase|Lost to Follow-up|2
2972111|NCT01144663|10229977|P4|Booster Vaccination Phase|Migrated/moved from study area|0
2972112|NCT01144663|10229978|P3|Booster Vaccination Phase|Migrated/moved from study area|1
2972113|NCT01144663|10229979|P2|Booster Vaccination Phase|Migrated/moved from study area|1
2972114|NCT01144663|10229980|P1|Booster Vaccination Phase|Migrated/moved from study area|1
2972115|NCT01144663|10229977|P4|Booster Vaccination Phase|Withdrawal by Subject|1
2972116|NCT01144663|10229978|P3|Booster Vaccination Phase|Withdrawal by Subject|1
2972117|NCT01144663|10229979|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2972118|NCT01144663|10229980|P1|Booster Vaccination Phase|Withdrawal by Subject|0
2972119|NCT01144663|10229977|P4|Primary Vaccination Phase|Other|2
2972120|NCT01144663|10229978|P3|Primary Vaccination Phase|Other|0
2972121|NCT01144663|10229979|P2|Primary Vaccination Phase|Other|1
2972122|NCT01144663|10229980|P1|Primary Vaccination Phase|Other|0
2972123|NCT01144663|10229977|P4|Primary Vaccination Phase|Lost to Follow-up|2
2972124|NCT01144663|10229978|P3|Primary Vaccination Phase|Lost to Follow-up|1
2972125|NCT01144663|10229979|P2|Primary Vaccination Phase|Lost to Follow-up|0
2972126|NCT01144663|10229980|P1|Primary Vaccination Phase|Lost to Follow-up|2
2972127|NCT01144663|10229977|P4|Primary Vaccination Phase|Migrated/moved from study area|3
2972128|NCT01144663|10229978|P3|Primary Vaccination Phase|Migrated/moved from study area|2
2972129|NCT01144663|10229979|P2|Primary Vaccination Phase|Migrated/moved from study area|1
2972130|NCT01144663|10229980|P1|Primary Vaccination Phase|Migrated/moved from study area|4
2972131|NCT01144663|10229977|P4|Primary Vaccination Phase|Withdrawal by Subject|10
2972132|NCT01144663|10229978|P3|Primary Vaccination Phase|Withdrawal by Subject|3
2972133|NCT01144663|10229979|P2|Primary Vaccination Phase|Withdrawal by Subject|5
2972134|NCT01144663|10229980|P1|Primary Vaccination Phase|Withdrawal by Subject|9
2972135|NCT01144663|10229977|P4|Primary Vaccination Phase|Protocol Violation|0
2972136|NCT01144663|10229978|P3|Primary Vaccination Phase|Protocol Violation|1
2972137|NCT01144663|10229979|P2|Primary Vaccination Phase|Protocol Violation|0
2972138|NCT01144663|10229980|P1|Primary Vaccination Phase|Protocol Violation|2
2972139|NCT01144663|10229977|P4|Primary Vaccination Phase|Adverse Event|1
2972140|NCT01144663|10229978|P3|Primary Vaccination Phase|Adverse Event|0
2972141|NCT01144663|10229979|P2|Primary Vaccination Phase|Adverse Event|0
2972142|NCT01144663|10229980|P1|Primary Vaccination Phase|Adverse Event|1
2972143|NCT01144663|10229977|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
2972144|NCT01144663|10229978|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
2972145|NCT01144663|10229979|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
2972146|NCT01144663|10229980|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
2972147|NCT01144416|10230318|P2|Intervention Period|Other|5
2972148|NCT01144416|10230319|P1|Intervention Period|Other|7
2972149|NCT01144416|10230318|P2|Intervention Period|No/too few/bad quality embryos|3
2972150|NCT01144416|10230319|P1|Intervention Period|No/too few/bad quality embryos|3
2972151|NCT01144416|10230318|P2|Intervention Period|No or abnormal fertilization|10
2972152|NCT01144416|10230319|P1|Intervention Period|No or abnormal fertilization|25
2972153|NCT01144416|10230318|P2|Intervention Period|No/too few/bad oocytes|5
2972154|NCT01144416|10230319|P1|Intervention Period|No/too few/bad oocytes|7
2972155|NCT01144416|10230318|P2|Intervention Period|Too high ovarian response|2
2972156|NCT01144416|10230319|P1|Intervention Period|Too high ovarian response|4
2972157|NCT01144416|10230318|P2|Intervention Period|Risk of OHSS|1
2972158|NCT01144416|10230319|P1|Intervention Period|Risk of OHSS|0
2972159|NCT01144416|10230318|P2|Intervention Period|Insufficient ovarian response|17
2972160|NCT01144416|10230319|P1|Intervention Period|Insufficient ovarian response|11
2972161|NCT01144416|10230318|P2|Intervention Period|Adverse Event|6
2972162|NCT01144416|10230319|P1|Intervention Period|Adverse Event|5
2972163|NCT01144403|10230335|P1|Overall Study|Adverse Event|1
2972164|NCT01144403|10230335|P1|Overall Study|Death|1
2972165|NCT01144403|10230335|P1|Overall Study|Lost to Follow-up|3
2972166|NCT01144377|10230347|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2972167|NCT01144377|10230348|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2972168|NCT01144377|10230349|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2972169|NCT01144377|10230350|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2972170|NCT01144377|10230351|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
2972171|NCT01144377|10230347|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
2972172|NCT01144377|10230348|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2972173|NCT01144377|10230349|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2972174|NCT01144377|10230350|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2972175|NCT01144377|10230351|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2972176|NCT01144377|10230347|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2972177|NCT01144377|10230348|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2972178|NCT01144377|10230349|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2972179|NCT01144377|10230350|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2972180|NCT01144377|10230351|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2972181|NCT01144377|10230347|P5|52 Week Treatment Period|Sponsor Decision|1
2972182|NCT01144377|10230348|P4|52 Week Treatment Period|Sponsor Decision|0
2972183|NCT01144377|10230349|P3|52 Week Treatment Period|Sponsor Decision|0
2972184|NCT01144377|10230350|P2|52 Week Treatment Period|Sponsor Decision|0
2972185|NCT01144377|10230351|P1|52 Week Treatment Period|Sponsor Decision|0
2972186|NCT01144377|10230347|P5|52 Week Treatment Period|Withdrawal by Subject|0
2972187|NCT01144377|10230348|P4|52 Week Treatment Period|Withdrawal by Subject|1
2972188|NCT01144377|10230349|P3|52 Week Treatment Period|Withdrawal by Subject|1
2972189|NCT01144377|10230350|P2|52 Week Treatment Period|Withdrawal by Subject|1
2972190|NCT01144377|10230351|P1|52 Week Treatment Period|Withdrawal by Subject|4
2972191|NCT01144377|10230347|P5|52 Week Treatment Period|Lost to Follow-up|0
2972192|NCT01144377|10230348|P4|52 Week Treatment Period|Lost to Follow-up|0
2972193|NCT01144377|10230349|P3|52 Week Treatment Period|Lost to Follow-up|0
2972194|NCT01144377|10230350|P2|52 Week Treatment Period|Lost to Follow-up|0
2972195|NCT01144377|10230351|P1|52 Week Treatment Period|Lost to Follow-up|1
2972196|NCT01144377|10230347|P5|52 Week Treatment Period|Protocol Violation|1
2972197|NCT01144377|10230348|P4|52 Week Treatment Period|Protocol Violation|0
2972198|NCT01144377|10230349|P3|52 Week Treatment Period|Protocol Violation|0
2972199|NCT01144377|10230350|P2|52 Week Treatment Period|Protocol Violation|0
2972200|NCT01144377|10230351|P1|52 Week Treatment Period|Protocol Violation|0
2972201|NCT01144377|10230347|P5|52 Week Treatment Period|Entry Criteria Not Met|0
2972202|NCT01144377|10230348|P4|52 Week Treatment Period|Entry Criteria Not Met|1
2972203|NCT01144377|10230349|P3|52 Week Treatment Period|Entry Criteria Not Met|1
2972204|NCT01144377|10230350|P2|52 Week Treatment Period|Entry Criteria Not Met|0
2972205|NCT01144377|10230351|P1|52 Week Treatment Period|Entry Criteria Not Met|0
2972206|NCT01144377|10230347|P5|52 Week Treatment Period|Adverse Event|1
2972207|NCT01144377|10230348|P4|52 Week Treatment Period|Adverse Event|2
2972208|NCT01144377|10230349|P3|52 Week Treatment Period|Adverse Event|3
2972209|NCT01144377|10230350|P2|52 Week Treatment Period|Adverse Event|0
2972210|NCT01144377|10230351|P1|52 Week Treatment Period|Adverse Event|0
2972211|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Physician Decision|1
2972212|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Physician Decision|0
2972213|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Physician Decision|0
2972214|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Relapse|5
2972215|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Relapse|5
2972216|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Relapse|0
2972217|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
2972218|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
2972219|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
2972220|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2972221|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2972222|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
2972223|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Death|0
2972224|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Death|2
2972225|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Death|0
2972226|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Adverse Event|1
2972227|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Adverse Event|3
2972228|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Adverse Event|0
2972229|NCT01144364|10230400|P3|Follow-Up/Maintenance Phase|Disease progression|29
2972230|NCT01144364|10230401|P2|Follow-Up/Maintenance Phase|Disease progression|23
2972231|NCT01144364|10230402|P1|Follow-Up/Maintenance Phase|Disease progression|0
2972232|NCT01144364|10230400|P3|Induction Phase|Protocol Violation|0
2972233|NCT01144364|10230401|P2|Induction Phase|Protocol Violation|0
2972234|NCT01144364|10230402|P1|Induction Phase|Protocol Violation|1
2972235|NCT01144364|10230400|P3|Induction Phase|Secondary neoplasia|0
2972236|NCT01144364|10230401|P2|Induction Phase|Secondary neoplasia|0
2972237|NCT01144364|10230402|P1|Induction Phase|Secondary neoplasia|1
2972238|NCT01144364|10230400|P3|Induction Phase|Stable disease|0
2972239|NCT01144364|10230401|P2|Induction Phase|Stable disease|0
2972240|NCT01144364|10230402|P1|Induction Phase|Stable disease|2
2972241|NCT01144364|10230400|P3|Induction Phase|Physician Decision|0
2972242|NCT01144364|10230401|P2|Induction Phase|Physician Decision|0
2972243|NCT01144364|10230402|P1|Induction Phase|Physician Decision|1
2972244|NCT01144364|10230400|P3|Induction Phase|Lost to Follow-up|0
2972245|NCT01144364|10230401|P2|Induction Phase|Lost to Follow-up|0
2972246|NCT01144364|10230402|P1|Induction Phase|Lost to Follow-up|2
2972247|NCT01144364|10230400|P3|Induction Phase|Withdrawal by Subject|0
2972248|NCT01144364|10230401|P2|Induction Phase|Withdrawal by Subject|0
2972249|NCT01144364|10230402|P1|Induction Phase|Withdrawal by Subject|1
2972250|NCT01144364|10230400|P3|Induction Phase|Death|0
2972251|NCT01144364|10230401|P2|Induction Phase|Death|0
2972252|NCT01144364|10230402|P1|Induction Phase|Death|1
2972253|NCT01144364|10230400|P3|Induction Phase|Adverse Event|0
2972254|NCT01144364|10230401|P2|Induction Phase|Adverse Event|0
2972255|NCT01144364|10230402|P1|Induction Phase|Adverse Event|9
2972256|NCT01144364|10230400|P3|Induction Phase|Disease progression|0
2972257|NCT01144364|10230401|P2|Induction Phase|Disease progression|0
2972258|NCT01144364|10230402|P1|Induction Phase|Disease progression|14
2972259|NCT01144299|10230451|P2|Overall Study|Withdrawal by Subject|0
2972260|NCT01144299|10230452|P1|Overall Study|Withdrawal by Subject|1
2972261|NCT01144299|10230451|P2|Overall Study|Lost to Follow-up|0
2972262|NCT01144299|10230452|P1|Overall Study|Lost to Follow-up|1
2972263|NCT01144182|10230497|P2|Overall Study|Lost to Follow-up|9
2972264|NCT01144182|10230498|P1|Overall Study|Lost to Follow-up|9
2972265|NCT01144182|10230497|P2|Overall Study|Withdrawal by Subject|6
2972266|NCT01144182|10230498|P1|Overall Study|Withdrawal by Subject|3
2972267|NCT01144182|10230497|P2|Overall Study|Death|6
2972268|NCT01144182|10230498|P1|Overall Study|Death|5
2972269|NCT01144052|10230558|P2|Overall Study|Withdrawal by Subject|1
2972270|NCT01144052|10230559|P1|Overall Study|Withdrawal by Subject|1
2972271|NCT01143896|10230590|P2|Overall Study|Death|3
2972272|NCT01143896|10230591|P1|Overall Study|Death|6
2972273|NCT01143896|10230590|P2|Overall Study|Withdrawal by Subject|5
2972274|NCT01143896|10230591|P1|Overall Study|Withdrawal by Subject|13
2972275|NCT01143896|10230590|P2|Overall Study|Lost to Follow-up|13
2972276|NCT01143896|10230591|P1|Overall Study|Lost to Follow-up|18
2972277|NCT01143896|10230590|P2|Overall Study|Did not complete Baseline Interview|4
2972278|NCT01143896|10230591|P1|Overall Study|Did not complete Baseline Interview|5
2972279|NCT01143714|10230703|P2|Overall Study|wound size increased|0
2972280|NCT01143714|10230704|P1|Overall Study|wound size increased|1
2972281|NCT01143714|10230703|P2|Overall Study|wound closed = deemed healed|0
2972282|NCT01143714|10230704|P1|Overall Study|wound closed = deemed healed|1
2972283|NCT01143714|10230703|P2|Overall Study|Subject non-compliance|1
2972284|NCT01143714|10230704|P1|Overall Study|Subject non-compliance|0
2972285|NCT01143714|10230703|P2|Overall Study|Withdrawal by Subject|0
2972286|NCT01143714|10230704|P1|Overall Study|Withdrawal by Subject|1
2972287|NCT01143714|10230703|P2|Overall Study|Adverse Event|2
2972288|NCT01143714|10230704|P1|Overall Study|Adverse Event|4
2972289|NCT01143402|10230809|P3|Overall Study|Not Treated|1
2972290|NCT01143402|10230810|P2|Overall Study|Not Treated|0
2972291|NCT01143402|10230811|P1|Overall Study|Not Treated|0
2972292|NCT01143402|10230809|P3|Overall Study|Rapid clinical decline|0
2972293|NCT01143402|10230810|P2|Overall Study|Rapid clinical decline|1
2972294|NCT01143402|10230811|P1|Overall Study|Rapid clinical decline|1
2972295|NCT01143389|10230822|P2|Overall Study|Lost to Follow-up|25
2972296|NCT01143389|10230823|P1|Overall Study|Lost to Follow-up|26
2972297|NCT01143337|10230837|P3|Overall Study|Other reason|5
2972298|NCT01143337|10230838|P2|Overall Study|Other reason|0
2972299|NCT01143337|10230839|P1|Overall Study|Other reason|0
2972300|NCT01143337|10230837|P3|Overall Study|Withdrawal by Subject|1
2972301|NCT01143337|10230838|P2|Overall Study|Withdrawal by Subject|0
2972302|NCT01143337|10230839|P1|Overall Study|Withdrawal by Subject|0
2972303|NCT01143337|10230837|P3|Overall Study|Protocol Violation|0
2972304|NCT01143337|10230838|P2|Overall Study|Protocol Violation|0
2972305|NCT01143337|10230839|P1|Overall Study|Protocol Violation|1
2972306|NCT01143337|10230837|P3|Overall Study|Lack of Efficacy|1
2972307|NCT01143337|10230838|P2|Overall Study|Lack of Efficacy|2
2972308|NCT01143337|10230839|P1|Overall Study|Lack of Efficacy|6
2972309|NCT01143337|10230837|P3|Overall Study|Adverse Event|5
2972310|NCT01143337|10230838|P2|Overall Study|Adverse Event|9
2972311|NCT01143337|10230839|P1|Overall Study|Adverse Event|3
2972312|NCT01143324|10230853|P1|Overall Study|Explant of the device|4
2972313|NCT01143324|10230853|P1|Overall Study|Withdrawal by Subject|4
2972314|NCT01143324|10230853|P1|Overall Study|Lost to Follow-up|11
2972315|NCT01143259|10230892|P2|Overall Study|Screen Failure|9
2972316|NCT01143259|10230893|P1|Overall Study|Screen Failure|7
2972317|NCT01143259|10230892|P2|Overall Study|Protocol Violation|9
2972318|NCT01143259|10230893|P1|Overall Study|Protocol Violation|13
2972319|NCT01143259|10230892|P2|Overall Study|Withdrawal by Subject|2
2972320|NCT01143259|10230893|P1|Overall Study|Withdrawal by Subject|3
2972321|NCT01143207|10230901|P1|Overall Study|Lost to Follow-up|2
2972322|NCT01143090|10230921|P1|Overall Study|Administrative|1
2972323|NCT01143090|10230921|P1|Overall Study|Failure to meet eligibility criteria|1
2972324|NCT01143090|10230921|P1|Overall Study|Non-compliance with study drug|1
2972325|NCT01143090|10230921|P1|Overall Study|Withdrawal by Subject|18
2972326|NCT01143090|10230921|P1|Overall Study|Protocol Violation|2
2972327|NCT01143090|10230921|P1|Overall Study|Lost to Follow-up|9
2972328|NCT01143090|10230921|P1|Overall Study|Adverse Event|17
2972329|NCT01143090|10230921|P1|Overall Study|Lack of Efficacy|2
2972330|NCT01143077|10230928|P3|Overall Study|Principal Investigator Decision|1
2972331|NCT01143077|10230929|P2|Overall Study|Principal Investigator Decision|0
2972332|NCT01143077|10230930|P1|Overall Study|Principal Investigator Decision|2
2972333|NCT01143077|10230928|P3|Overall Study|Administrative|0
2972334|NCT01143077|10230929|P2|Overall Study|Administrative|0
2972335|NCT01143077|10230930|P1|Overall Study|Administrative|1
2972336|NCT01143077|10230928|P3|Overall Study|Non-compliance with study drug|1
2972337|NCT01143077|10230929|P2|Overall Study|Non-compliance with study drug|1
2972338|NCT01143077|10230930|P1|Overall Study|Non-compliance with study drug|0
2972339|NCT01143077|10230928|P3|Overall Study|Withdrawal by Subject|3
2972340|NCT01143077|10230929|P2|Overall Study|Withdrawal by Subject|3
2972341|NCT01143077|10230930|P1|Overall Study|Withdrawal by Subject|4
2972342|NCT01143077|10230928|P3|Overall Study|Protocol Violation|0
2972343|NCT01143077|10230929|P2|Overall Study|Protocol Violation|0
2972344|NCT01143077|10230930|P1|Overall Study|Protocol Violation|2
2972345|NCT01143077|10230928|P3|Overall Study|Lost to Follow-up|4
2972346|NCT01143077|10230929|P2|Overall Study|Lost to Follow-up|3
2972347|NCT01143077|10230930|P1|Overall Study|Lost to Follow-up|2
2972348|NCT01143077|10230928|P3|Overall Study|Adverse Event|5
2972349|NCT01143077|10230929|P2|Overall Study|Adverse Event|6
2972350|NCT01143077|10230930|P1|Overall Study|Adverse Event|5
2972351|NCT01143077|10230928|P3|Overall Study|Lack of Efficacy|1
2972352|NCT01143077|10230929|P2|Overall Study|Lack of Efficacy|2
2972353|NCT01143077|10230930|P1|Overall Study|Lack of Efficacy|0
2972354|NCT01143051|10230947|P6|3-14 Day Washout|Withdrawal by Subject|1
2972355|NCT01143051|10230948|P5|3-14 Day Washout|Withdrawal by Subject|0
2972356|NCT01143051|10230949|P4|3-14 Day Washout|Withdrawal by Subject|0
2972357|NCT01143051|10230950|P3|3-14 Day Washout|Withdrawal by Subject|0
2972358|NCT01143051|10230951|P2|3-14 Day Washout|Withdrawal by Subject|0
2972359|NCT01143051|10230952|P1|3-14 Day Washout|Withdrawal by Subject|0
2972360|NCT01143051|10230947|P6|3-14 Day Washout|Withdrawal by Subject|0
2972361|NCT01143051|10230948|P5|3-14 Day Washout|Withdrawal by Subject|0
2972362|NCT01143051|10230949|P4|3-14 Day Washout|Withdrawal by Subject|0
2972363|NCT01143051|10230950|P3|3-14 Day Washout|Withdrawal by Subject|1
2972364|NCT01143051|10230951|P2|3-14 Day Washout|Withdrawal by Subject|0
2972365|NCT01143051|10230952|P1|3-14 Day Washout|Withdrawal by Subject|0
2972366|NCT01143038|10231001|P1|Overall Study|Death|1
2972367|NCT01143038|10231001|P1|Overall Study|Protocol Deviation|1
2972368|NCT01143038|10231001|P1|Overall Study|Lost to Follow-up|2
2972369|NCT01143038|10231001|P1|Overall Study|Adverse Event|3
2972370|NCT01143038|10231001|P1|Overall Study|Requirement for alternative therapy|5
2972371|NCT01143038|10231001|P1|Overall Study|Withdrawal by Subject|4
2972372|NCT01142908|10231015|P2|Overall Study|Withdrawal by Subject|0
2972373|NCT01142908|10231016|P1|Overall Study|Withdrawal by Subject|3
2972374|NCT01142908|10231015|P2|Overall Study|Excluded - did not meet criteria|5
2972375|NCT01142908|10231016|P1|Overall Study|Excluded - did not meet criteria|9
2972376|NCT01142908|10231015|P2|Overall Study|Death|4
2972377|NCT01142908|10231016|P1|Overall Study|Death|1
2972378|NCT01142908|10231015|P2|Overall Study|Lost to Follow-up|13
2972379|NCT01142908|10231016|P1|Overall Study|Lost to Follow-up|19
2972380|NCT01142791|10231062|P2|Overall Study|Received only 1 sonication|6
2972381|NCT01142791|10231063|P1|Overall Study|Received only 1 sonication|0
2972382|NCT01142791|10231062|P2|Overall Study|Withdrawal by Subject|0
2972383|NCT01142791|10231063|P1|Overall Study|Withdrawal by Subject|5
2972384|NCT01142791|10231062|P2|Overall Study|Lost to Follow-up|0
2972385|NCT01142791|10231063|P1|Overall Study|Lost to Follow-up|1
2972386|NCT01142791|10231062|P2|Overall Study|Alternative Treatment|0
2972387|NCT01142791|10231063|P1|Overall Study|Alternative Treatment|1
2972388|NCT01142726|10231070|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2972389|NCT01142726|10231071|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
2972390|NCT01142726|10231072|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2972391|NCT01142726|10231070|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
2972392|NCT01142726|10231071|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2972393|NCT01142726|10231072|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2972394|NCT01142726|10231070|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2972395|NCT01142726|10231071|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2972396|NCT01142726|10231072|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2972397|NCT01142726|10231070|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
2972398|NCT01142726|10231071|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2972399|NCT01142726|10231072|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2972400|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
2972401|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
2972402|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
2972403|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
2972404|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
2972405|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
2972406|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2972407|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2972408|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
2972409|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2972410|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2972411|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
2972412|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2972413|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
2972414|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2972415|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
2972416|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2972417|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2972418|NCT01142726|10231070|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
2972419|NCT01142726|10231071|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2972420|NCT01142726|10231072|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2972421|NCT01142726|10231070|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
2972422|NCT01142726|10231071|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
2972423|NCT01142726|10231072|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
2972424|NCT01142726|10231070|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2972425|NCT01142726|10231071|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2972426|NCT01142726|10231072|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
2972427|NCT01142726|10231070|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2972428|NCT01142726|10231071|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
2972429|NCT01142726|10231072|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2972430|NCT01142726|10231070|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
2972431|NCT01142726|10231071|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
2972432|NCT01142726|10231072|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
2972433|NCT01142726|10231070|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2972434|NCT01142726|10231071|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
2972435|NCT01142726|10231072|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2972436|NCT01142661|10231135|P1|Overall Study|Physician Decision|1
2972437|NCT01142661|10231135|P1|Overall Study|Withdrawal by Subject|1
2972438|NCT01142661|10231135|P1|Overall Study|Adverse Event|2
2972439|NCT01142596|10231142|P2|Overall Study|Other reason (not specified)|4
2972440|NCT01142596|10231143|P1|Overall Study|Other reason (not specified)|5
2972441|NCT01142596|10231142|P2|Overall Study|Lost to Follow-up|3
2972442|NCT01142596|10231143|P1|Overall Study|Lost to Follow-up|2
2972443|NCT01142596|10231142|P2|Overall Study|Lack of Efficacy|9
2972444|NCT01142596|10231143|P1|Overall Study|Lack of Efficacy|5
2972445|NCT01142596|10231142|P2|Overall Study|Adverse Event|35
2972446|NCT01142596|10231143|P1|Overall Study|Adverse Event|8
2972447|NCT01142596|10231142|P2|Overall Study|Withdrawal by Subject|35
2972448|NCT01142596|10231143|P1|Overall Study|Withdrawal by Subject|9
2972449|NCT01142466|10231195|P2|Overall Study|Withdrawal by Subject|1
2972450|NCT01142466|10231196|P1|Overall Study|Withdrawal by Subject|1
2972451|NCT01142466|10231195|P2|Overall Study|Adverse Event|1
2972452|NCT01142466|10231196|P1|Overall Study|Adverse Event|2
2972453|NCT01142388|10231216|P2|Overall Study|Never started therapy|3
2972454|NCT01142388|10231217|P1|Overall Study|Never started therapy|7
2972455|NCT01142388|10231216|P2|Overall Study|Other|1
2972456|NCT01142388|10231217|P1|Overall Study|Other|1
2972457|NCT01142388|10231216|P2|Overall Study|Other complications|2
2972458|NCT01142388|10231217|P1|Overall Study|Other complications|0
2972459|NCT01142388|10231216|P2|Overall Study|Alternative therapy|0
2972460|NCT01142388|10231217|P1|Overall Study|Alternative therapy|1
2972461|NCT01142388|10231216|P2|Overall Study|Withdrawal by Subject|3
2972462|NCT01142388|10231217|P1|Overall Study|Withdrawal by Subject|5
2972463|NCT01142388|10231216|P2|Overall Study|Death|2
2972464|NCT01142388|10231217|P1|Overall Study|Death|3
2972465|NCT01142388|10231216|P2|Overall Study|Adverse Event|5
2972466|NCT01142388|10231217|P1|Overall Study|Adverse Event|9
2972467|NCT01142388|10231216|P2|Overall Study|Lack of Efficacy|31
2972468|NCT01142388|10231217|P1|Overall Study|Lack of Efficacy|21
2972469|NCT01142336|10231229|P2|Overall Study|Lost to Follow-up|1
2972470|NCT01142336|10231230|P1|Overall Study|Lost to Follow-up|0
2972471|NCT01142336|10231229|P2|Overall Study|Adverse Event|1
2972472|NCT01142336|10231230|P1|Overall Study|Adverse Event|1
2972473|NCT01142232|10231267|P5|Overall Study|Noncompliance|2
2972474|NCT01142232|10231268|P4|Overall Study|Noncompliance|0
2972475|NCT01142232|10231269|P3|Overall Study|Noncompliance|0
2972476|NCT01142232|10231270|P2|Overall Study|Noncompliance|0
2972477|NCT01142232|10231271|P1|Overall Study|Noncompliance|0
2972478|NCT01142232|10231267|P5|Overall Study|Off Trt for other complicating disease|1
2972479|NCT01142232|10231268|P4|Overall Study|Off Trt for other complicating disease|0
2972480|NCT01142232|10231269|P3|Overall Study|Off Trt for other complicating disease|0
2972481|NCT01142232|10231270|P2|Overall Study|Off Trt for other complicating disease|0
2972482|NCT01142232|10231271|P1|Overall Study|Off Trt for other complicating disease|0
2972483|NCT01142232|10231267|P5|Overall Study|Alternative Therapy|1
2972484|NCT01142232|10231268|P4|Overall Study|Alternative Therapy|0
2972485|NCT01142232|10231269|P3|Overall Study|Alternative Therapy|1
2972486|NCT01142232|10231270|P2|Overall Study|Alternative Therapy|1
2972487|NCT01142232|10231271|P1|Overall Study|Alternative Therapy|0
2972488|NCT01142232|10231267|P5|Overall Study|Physician Decision|10
2972489|NCT01142232|10231268|P4|Overall Study|Physician Decision|2
2972490|NCT01142232|10231269|P3|Overall Study|Physician Decision|0
2972491|NCT01142232|10231270|P2|Overall Study|Physician Decision|1
2972492|NCT01142232|10231271|P1|Overall Study|Physician Decision|0
2972493|NCT01142232|10231267|P5|Overall Study|Withdrawal by Subject|3
2972494|NCT01142232|10231268|P4|Overall Study|Withdrawal by Subject|1
2972495|NCT01142232|10231269|P3|Overall Study|Withdrawal by Subject|0
2972496|NCT01142232|10231270|P2|Overall Study|Withdrawal by Subject|0
2972497|NCT01142232|10231271|P1|Overall Study|Withdrawal by Subject|0
2972498|NCT01142232|10231267|P5|Overall Study|Disease Progression|12
2972499|NCT01142232|10231268|P4|Overall Study|Disease Progression|2
2972500|NCT01142232|10231269|P3|Overall Study|Disease Progression|1
2972501|NCT01142232|10231270|P2|Overall Study|Disease Progression|0
2972502|NCT01142232|10231271|P1|Overall Study|Disease Progression|2
2972503|NCT01142232|10231267|P5|Overall Study|Death|1
2972504|NCT01142232|10231268|P4|Overall Study|Death|0
2972505|NCT01142232|10231269|P3|Overall Study|Death|0
2972506|NCT01142232|10231270|P2|Overall Study|Death|0
2972507|NCT01142232|10231271|P1|Overall Study|Death|0
2972508|NCT01142232|10231267|P5|Overall Study|Adverse Event|4
2972509|NCT01142232|10231268|P4|Overall Study|Adverse Event|0
2972510|NCT01142232|10231269|P3|Overall Study|Adverse Event|1
2972511|NCT01142232|10231270|P2|Overall Study|Adverse Event|2
2972512|NCT01142232|10231271|P1|Overall Study|Adverse Event|1
2972513|NCT01142193|10231286|P2|Overall Study|Other|2
2972514|NCT01142193|10231287|P1|Overall Study|Other|1
2972515|NCT01142193|10231286|P2|Overall Study|Protocol Discontinuation Criterion Met|0
2972516|NCT01142193|10231287|P1|Overall Study|Protocol Discontinuation Criterion Met|1
2972517|NCT01142193|10231286|P2|Overall Study|Withdrawal by Subject|3
2972518|NCT01142193|10231287|P1|Overall Study|Withdrawal by Subject|4
2972519|NCT01142193|10231286|P2|Overall Study|Physician Decision|1
2972520|NCT01142193|10231287|P1|Overall Study|Physician Decision|1
2972521|NCT01142193|10231286|P2|Overall Study|Lack of Efficacy|1
2972522|NCT01142193|10231287|P1|Overall Study|Lack of Efficacy|2
2972523|NCT01142193|10231286|P2|Overall Study|Adverse Event|4
2972524|NCT01142193|10231287|P1|Overall Study|Adverse Event|12
2972525|NCT01142128|10231315|P1|Overall Study|Withdrawal by Subject|2
2972526|NCT01142128|10231315|P1|Overall Study|Lost to Follow-up|1
2972527|NCT01142128|10231315|P1|Overall Study|Physician Decision|1
2972528|NCT01142115|10231325|P2|First Intervention|Adverse Event|0
2972529|NCT01142115|10231326|P1|First Intervention|Adverse Event|1
2972530|NCT01142115|10231325|P2|First Intervention|Lack of Efficacy|1
2972531|NCT01142115|10231326|P1|First Intervention|Lack of Efficacy|1
2972532|NCT01142089|10231343|P2|Overall Study|Patient required rescue medication|17
2972533|NCT01142089|10231344|P1|Overall Study|Patient required rescue medication|8
2972534|NCT01142089|10231343|P2|Overall Study|Noncompliance with study procedures|1
2972535|NCT01142089|10231344|P1|Overall Study|Noncompliance with study procedures|2
2972536|NCT01142089|10231343|P2|Overall Study|Use of prohibited medications|1
2972537|NCT01142089|10231344|P1|Overall Study|Use of prohibited medications|0
2972538|NCT01142089|10231343|P2|Overall Study|Withdrawal by Subject|2
2972539|NCT01142089|10231344|P1|Overall Study|Withdrawal by Subject|1
2972540|NCT01142089|10231343|P2|Overall Study|Physician Decision|0
2972541|NCT01142089|10231344|P1|Overall Study|Physician Decision|1
2972542|NCT01141712|10231375|P1|Overall Study|Disease progression|3
2972543|NCT01141660|10231396|P2|Overall Study|Physician Decision|12
2972544|NCT01141660|10231397|P1|Overall Study|Physician Decision|0
2972545|NCT01141283|10231465|P1|Overall Study|Lack of Efficacy|10
2972546|NCT01141283|10231465|P1|Overall Study|Administrative|4
2972547|NCT01141283|10231465|P1|Overall Study|Withdrawal by Subject|14
2972548|NCT01141283|10231465|P1|Overall Study|Lost to Follow-up|4
2972549|NCT01141283|10231465|P1|Overall Study|Adverse Event|56
2972550|NCT01141205|10231471|P2|Overall Study|Withdrawal by Subject|1
2972551|NCT01141205|10231472|P1|Overall Study|Withdrawal by Subject|1
2972552|NCT01141205|10231471|P2|Overall Study|Lost to Follow-up|0
2972553|NCT01141205|10231472|P1|Overall Study|Lost to Follow-up|1
2972554|NCT01141205|10231471|P2|Overall Study|Physician Decision|1
2972555|NCT01141205|10231472|P1|Overall Study|Physician Decision|1
2972556|NCT01140906|10231499|P4|Overall Study|Administrative or other reason|2
2972557|NCT01140906|10231500|P3|Overall Study|Administrative or other reason|3
2972558|NCT01140906|10231501|P2|Overall Study|Administrative or other reason|5
2972559|NCT01140906|10231502|P1|Overall Study|Administrative or other reason|0
2972560|NCT01140906|10231499|P4|Overall Study|Lost to Follow-up|2
2972561|NCT01140906|10231500|P3|Overall Study|Lost to Follow-up|0
2972562|NCT01140906|10231501|P2|Overall Study|Lost to Follow-up|1
2972563|NCT01140906|10231502|P1|Overall Study|Lost to Follow-up|1
2972564|NCT01140906|10231499|P4|Overall Study|Withdrawal of consent|2
2972565|NCT01140906|10231500|P3|Overall Study|Withdrawal of consent|2
2972566|NCT01140906|10231501|P2|Overall Study|Withdrawal of consent|6
2972567|NCT01140906|10231502|P1|Overall Study|Withdrawal of consent|6
2972568|NCT01140906|10231499|P4|Overall Study|Protocol Violation|1
2972569|NCT01140906|10231500|P3|Overall Study|Protocol Violation|2
2972570|NCT01140906|10231501|P2|Overall Study|Protocol Violation|3
2972571|NCT01140906|10231502|P1|Overall Study|Protocol Violation|5
2972572|NCT01140906|10231499|P4|Overall Study|Non-compliance|1
2972573|NCT01140906|10231500|P3|Overall Study|Non-compliance|0
2972574|NCT01140906|10231501|P2|Overall Study|Non-compliance|1
2972575|NCT01140906|10231502|P1|Overall Study|Non-compliance|0
2972576|NCT01140906|10231499|P4|Overall Study|Lack of Efficacy|1
2972577|NCT01140906|10231500|P3|Overall Study|Lack of Efficacy|2
2972578|NCT01140906|10231501|P2|Overall Study|Lack of Efficacy|8
2972579|NCT01140906|10231502|P1|Overall Study|Lack of Efficacy|6
2972580|NCT01140906|10231499|P4|Overall Study|Adverse Event|7
2972581|NCT01140906|10231500|P3|Overall Study|Adverse Event|17
2972582|NCT01140906|10231501|P2|Overall Study|Adverse Event|10
2972583|NCT01140906|10231502|P1|Overall Study|Adverse Event|7
2972584|NCT01140880|10231542|P2|Overall Study|Protocol Violation|30
2972585|NCT01140880|10231543|P1|Overall Study|Protocol Violation|0
2972586|NCT01140880|10231542|P2|Overall Study|Lost to Follow-up|10
2972587|NCT01140880|10231543|P1|Overall Study|Lost to Follow-up|8
2972588|NCT01140880|10231542|P2|Overall Study|Withdrawal by Subject|3
2972589|NCT01140880|10231543|P1|Overall Study|Withdrawal by Subject|6
2972590|NCT01140880|10231542|P2|Overall Study|Death|1
2972591|NCT01140880|10231543|P1|Overall Study|Death|0
2972592|NCT01140867|10231555|P1|Overall Study|Medication Noncompliance|2
2972593|NCT01140867|10231555|P1|Overall Study|Uncooperative patient|2
2972594|NCT01140867|10231555|P1|Overall Study|Protocol Violation|1
2972595|NCT01140867|10231555|P1|Overall Study|Withdrawal by Subject|1
2972596|NCT01140867|10231555|P1|Overall Study|Lost to Follow-up|2
2972597|NCT01140867|10231555|P1|Overall Study|Lack of Efficacy|3
2972598|NCT01140867|10231555|P1|Overall Study|Adverse Event|22
2972599|NCT01140646|10231595|P1|Overall Study|Refused Further Treatment|5
2972600|NCT01140646|10231595|P1|Overall Study|Adverse Event|4
2972601|NCT01140568|10231603|P1|Overall Study|Screen Fail|4
2972602|NCT01140568|10231603|P1|Overall Study|Withdrawal by Subject|1
2972603|NCT01140568|10231603|P1|Overall Study|disease progression|31
2972604|NCT01140503|10231608|P1|Overall Study|Withdrawal by Subject|1
2972605|NCT01140477|10231616|P2|Overall Study|Subject explanted|1
2972606|NCT01140477|10231617|P1|Overall Study|Subject explanted|0
2972607|NCT01140477|10231616|P2|Overall Study|Death|1
2972608|NCT01140477|10231617|P1|Overall Study|Death|1
2972609|NCT01140477|10231616|P2|Overall Study|Surgical complication preventing implant|0
2972610|NCT01140477|10231617|P1|Overall Study|Surgical complication preventing implant|2
2972611|NCT01140477|10231616|P2|Overall Study|Withdrawal by Subject|4
2972612|NCT01140477|10231617|P1|Overall Study|Withdrawal by Subject|1
2972613|NCT01140477|10231616|P2|Overall Study|Lost to Follow-up|0
2972614|NCT01140477|10231617|P1|Overall Study|Lost to Follow-up|4
2972615|NCT01140347|10231632|P2|Overall Study|Withdrawal by Subject|8
2972616|NCT01140347|10231633|P1|Overall Study|Withdrawal by Subject|13
2972617|NCT01140347|10231632|P2|Overall Study|Lost to Follow-up|6
2972618|NCT01140347|10231633|P1|Overall Study|Lost to Follow-up|5
2972619|NCT01140061|10231686|P10|Extension|Laboratory Adverse Event|1
2972620|NCT01140061|10231687|P9|Extension|Laboratory Adverse Event|0
2972621|NCT01140061|10231688|P8|Extension|Laboratory Adverse Event|0
2972622|NCT01140061|10231689|P7|Extension|Laboratory Adverse Event|0
2972623|NCT01140061|10231690|P6|Extension|Laboratory Adverse Event|0
2972624|NCT01140061|10231691|P5|Extension|Laboratory Adverse Event|0
2972625|NCT01140061|10231692|P4|Extension|Laboratory Adverse Event|0
2972626|NCT01140061|10231693|P3|Extension|Laboratory Adverse Event|0
2972627|NCT01140061|10231694|P2|Extension|Laboratory Adverse Event|0
2972628|NCT01140061|10231695|P1|Extension|Laboratory Adverse Event|0
2972629|NCT01140061|10231686|P10|Part I|Adverse Event|0
2972630|NCT01140061|10231687|P9|Part I|Adverse Event|0
2972631|NCT01140061|10231688|P8|Part I|Adverse Event|0
2972632|NCT01140061|10231689|P7|Part I|Adverse Event|0
2972633|NCT01140061|10231690|P6|Part I|Adverse Event|0
2972634|NCT01140061|10231691|P5|Part I|Adverse Event|0
2972635|NCT01140061|10231692|P4|Part I|Adverse Event|0
2972636|NCT01140061|10231693|P3|Part I|Adverse Event|0
2972637|NCT01140061|10231694|P2|Part I|Adverse Event|0
2972638|NCT01140061|10231695|P1|Part I|Adverse Event|1
2972639|NCT01140048|10231722|P1|Overall Study|Lost to Follow-up|31
2972640|NCT01140048|10231722|P1|Overall Study|Withdrawal by Subject|13
2972641|NCT01140048|10231722|P1|Overall Study|Physician Decision|1
2972642|NCT01139775|10231762|P3|Overall Study|Physician Decision|2
2972643|NCT01139775|10231763|P2|Overall Study|Physician Decision|2
2972644|NCT01139775|10231764|P1|Overall Study|Physician Decision|0
2972645|NCT01139775|10231762|P3|Overall Study|Withdrawal by Subject|2
2972646|NCT01139775|10231763|P2|Overall Study|Withdrawal by Subject|0
2972647|NCT01139775|10231764|P1|Overall Study|Withdrawal by Subject|1
2972648|NCT01139775|10231762|P3|Overall Study|Protocol Violation|0
2972649|NCT01139775|10231763|P2|Overall Study|Protocol Violation|5
2972650|NCT01139775|10231764|P1|Overall Study|Protocol Violation|0
2972651|NCT01139775|10231762|P3|Overall Study|Adverse Event|2
2972652|NCT01139775|10231763|P2|Overall Study|Adverse Event|6
2972653|NCT01139775|10231764|P1|Overall Study|Adverse Event|0
2972654|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
2972655|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
2972656|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
2972657|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
2972658|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
2972659|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
2972660|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
2972661|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
2972662|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
2972663|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
2972664|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
2972665|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
2972666|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
2972667|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
2972668|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
2972669|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
2972670|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
2972671|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
2972672|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
2972673|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
2972674|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
2972675|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Death|1
2972676|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Death|1
2972677|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Death|0
2972678|NCT01139762|10231796|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
2972679|NCT01139762|10231797|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
2972680|NCT01139762|10231798|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
2972681|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2972682|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2972683|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
2972684|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
2972685|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
2972686|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
2972687|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Physician Decision|0
2972688|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Physician Decision|0
2972689|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Physician Decision|12
2972690|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2972691|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2972692|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
2972693|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Adverse Event|0
2972694|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Adverse Event|0
2972695|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Adverse Event|1
2972696|NCT01139762|10231796|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2972697|NCT01139762|10231797|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2972698|NCT01139762|10231798|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
2972699|NCT01139658|10231833|P2|Overall Study|Other|75
2972700|NCT01139658|10231834|P1|Overall Study|Other|28
2972701|NCT01139658|10231833|P2|Overall Study|No documentation of treatment|0
2972702|NCT01139658|10231834|P1|Overall Study|No documentation of treatment|1
2972703|NCT01139658|10231833|P2|Overall Study|Withdrawal by Subject|4
2972704|NCT01139658|10231834|P1|Overall Study|Withdrawal by Subject|2
2972705|NCT01139658|10231833|P2|Overall Study|Lack of Efficacy|7
2972706|NCT01139658|10231834|P1|Overall Study|Lack of Efficacy|15
2972707|NCT01139658|10231833|P2|Overall Study|Adverse Event|27
2972708|NCT01139658|10231834|P1|Overall Study|Adverse Event|10
2972709|NCT01139580|10231872|P2|Overall Study|Participant Randomization in Error|1
2972710|NCT01139580|10231873|P1|Overall Study|Participant Randomization in Error|0
2972711|NCT01139580|10231872|P2|Overall Study|Beginning Study Exclusion Treatment|1
2972712|NCT01139580|10231873|P1|Overall Study|Beginning Study Exclusion Treatment|0
2972713|NCT01139580|10231872|P2|Overall Study|Misrandomized|0
2972714|NCT01139580|10231873|P1|Overall Study|Misrandomized|1
2972715|NCT01139580|10231872|P2|Overall Study|Did Not Meet Exclusion Criteria|0
2972716|NCT01139580|10231873|P1|Overall Study|Did Not Meet Exclusion Criteria|1
2972717|NCT01139580|10231872|P2|Overall Study|Used Excluded Medicine After Enrollment|0
2972718|NCT01139580|10231873|P1|Overall Study|Used Excluded Medicine After Enrollment|1
2972719|NCT01139580|10231872|P2|Overall Study|Withdrawal by Subject|9
2972720|NCT01139580|10231873|P1|Overall Study|Withdrawal by Subject|6
2972721|NCT01139580|10231872|P2|Overall Study|Lack of Efficacy|2
2972722|NCT01139580|10231873|P1|Overall Study|Lack of Efficacy|0
2972723|NCT01139580|10231872|P2|Overall Study|Lost to Follow-up|1
2972724|NCT01139580|10231873|P1|Overall Study|Lost to Follow-up|9
2972725|NCT01139580|10231872|P2|Overall Study|Adverse Event|4
2972726|NCT01139580|10231873|P1|Overall Study|Adverse Event|5
2972727|NCT01139450|10231921|P3|Overall Study|Adverse Event|3
2972728|NCT01139450|10231922|P2|Overall Study|Adverse Event|2
2972729|NCT01139450|10231923|P1|Overall Study|Adverse Event|2
2972730|NCT01139450|10231921|P3|Overall Study|Administrative|1
2972731|NCT01139450|10231922|P2|Overall Study|Administrative|0
2972732|NCT01139450|10231923|P1|Overall Study|Administrative|0
2972733|NCT01139450|10231921|P3|Overall Study|Lost to Follow-up|11
2972734|NCT01139450|10231922|P2|Overall Study|Lost to Follow-up|7
2972735|NCT01139450|10231923|P1|Overall Study|Lost to Follow-up|9
2972736|NCT01139450|10231921|P3|Overall Study|Protocol Violation|2
2972737|NCT01139450|10231922|P2|Overall Study|Protocol Violation|5
2972738|NCT01139450|10231923|P1|Overall Study|Protocol Violation|6
2972739|NCT01139450|10231921|P3|Overall Study|Lack of Efficacy|8
2972740|NCT01139450|10231922|P2|Overall Study|Lack of Efficacy|1
2972741|NCT01139450|10231923|P1|Overall Study|Lack of Efficacy|3
2972742|NCT01139450|10231921|P3|Overall Study|Withdrawal by Subject|13
2972743|NCT01139450|10231922|P2|Overall Study|Withdrawal by Subject|10
2972744|NCT01139450|10231923|P1|Overall Study|Withdrawal by Subject|7
2972745|NCT01139164|10231975|P3|Overall Study|Withdrawn prior to study start|0
2972746|NCT01139164|10231976|P2|Overall Study|Withdrawn prior to study start|2
2972747|NCT01139164|10231977|P1|Overall Study|Withdrawn prior to study start|0
2972748|NCT01139125|10231991|P1|Overall Study|Withdrawal by Subject|1
2972749|NCT01139047|10231995|P1|Overall Study|Withdrawal by Subject|1
2972750|NCT01139021|10232010|P6|Overall Study|Withdrawal by Subject|0
2972751|NCT01139021|10232011|P5|Overall Study|Withdrawal by Subject|4
2972752|NCT01139021|10232012|P4|Overall Study|Withdrawal by Subject|1
2972753|NCT01139021|10232013|P3|Overall Study|Withdrawal by Subject|0
2972754|NCT01139021|10232014|P2|Overall Study|Withdrawal by Subject|0
2972755|NCT01139021|10232015|P1|Overall Study|Withdrawal by Subject|0
2972756|NCT01139021|10232010|P6|Overall Study|Protocol Violation|0
2972757|NCT01139021|10232011|P5|Overall Study|Protocol Violation|2
2972758|NCT01139021|10232012|P4|Overall Study|Protocol Violation|0
2972759|NCT01139021|10232013|P3|Overall Study|Protocol Violation|0
2972760|NCT01139021|10232014|P2|Overall Study|Protocol Violation|0
2972761|NCT01139021|10232015|P1|Overall Study|Protocol Violation|1
2972762|NCT01139021|10232010|P6|Overall Study|Lost to Follow-up|0
2972763|NCT01139021|10232011|P5|Overall Study|Lost to Follow-up|2
2972764|NCT01139021|10232012|P4|Overall Study|Lost to Follow-up|0
2972765|NCT01139021|10232013|P3|Overall Study|Lost to Follow-up|0
2972766|NCT01139021|10232014|P2|Overall Study|Lost to Follow-up|0
2972767|NCT01139021|10232015|P1|Overall Study|Lost to Follow-up|0
2972768|NCT01139021|10232010|P6|Overall Study|Adverse Event|0
2972769|NCT01139021|10232011|P5|Overall Study|Adverse Event|1
2972770|NCT01139021|10232012|P4|Overall Study|Adverse Event|0
2972771|NCT01139021|10232013|P3|Overall Study|Adverse Event|0
2972772|NCT01139021|10232014|P2|Overall Study|Adverse Event|0
2972773|NCT01139021|10232015|P1|Overall Study|Adverse Event|0
2972774|NCT01139008|10232051|P1|Overall Study|Non-compliant, lost product|1
2972775|NCT01139008|10232051|P1|Overall Study|Withdrawal by Subject|5
2972776|NCT01138826|10232098|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
2972777|NCT01138826|10232099|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
2972778|NCT01138826|10232100|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
2972779|NCT01138826|10232101|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
2972780|NCT01138826|10232102|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
2972781|NCT01138826|10232103|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
2972782|NCT01138657|10232140|P2|Overall Study|Miscellaneous Reasons|4
2972783|NCT01138657|10232141|P1|Overall Study|Miscellaneous Reasons|3
2972784|NCT01138657|10232140|P2|Overall Study|Lost to Follow-up|3
2972785|NCT01138657|10232141|P1|Overall Study|Lost to Follow-up|0
2972786|NCT01138657|10232140|P2|Overall Study|Lack of Efficacy|1
2972787|NCT01138657|10232141|P1|Overall Study|Lack of Efficacy|2
2972788|NCT01138657|10232140|P2|Overall Study|Adverse Event|10
2972789|NCT01138657|10232141|P1|Overall Study|Adverse Event|3
2972790|NCT01138501|10232204|P1|Overall Study|Withdrawal by Subject|3
2972791|NCT01138501|10232204|P1|Overall Study|Protocol Violation|2
2972792|NCT01138150|10232248|P2|Overall Study|Physician Decision|0
2972793|NCT01138150|10232249|P1|Overall Study|Physician Decision|1
2972794|NCT01138150|10232248|P2|Overall Study|blood unable to be processed|1
2972795|NCT01138150|10232249|P1|Overall Study|blood unable to be processed|0
2972796|NCT01138111|10232330|P1|Overall Study|Lost to Follow-up|2
2972797|NCT01138111|10232330|P1|Overall Study|Death|1
2972798|NCT01138111|10232330|P1|Overall Study|Adverse Event|1
2972799|NCT01138111|10232330|P1|Overall Study|Withdrawal by Subject|5
2972800|NCT01138046|10232384|P1|Overall Study|Withdrawal due to death|6
2972801|NCT01138007|10232404|P3|Overall Study|Withdrawal by Subject|15
2972802|NCT01138007|10232405|P2|Overall Study|Withdrawal by Subject|6
2972803|NCT01138007|10232406|P1|Overall Study|Withdrawal by Subject|5
2972804|NCT01138007|10232404|P3|Overall Study|Physician Decision|3
2972805|NCT01138007|10232405|P2|Overall Study|Physician Decision|5
2972806|NCT01138007|10232406|P1|Overall Study|Physician Decision|0
2972807|NCT01138007|10232404|P3|Overall Study|Lost to Follow-up|5
2972808|NCT01138007|10232405|P2|Overall Study|Lost to Follow-up|3
2972809|NCT01138007|10232406|P1|Overall Study|Lost to Follow-up|3
2972810|NCT01138007|10232404|P3|Overall Study|Protocol-Defined Stopping Criteria|8
2972811|NCT01138007|10232405|P2|Overall Study|Protocol-Defined Stopping Criteria|1
2972812|NCT01138007|10232406|P1|Overall Study|Protocol-Defined Stopping Criteria|6
2972813|NCT01138007|10232404|P3|Overall Study|Protocol Violation|2
2972814|NCT01138007|10232405|P2|Overall Study|Protocol Violation|3
2972815|NCT01138007|10232406|P1|Overall Study|Protocol Violation|2
2972816|NCT01138007|10232404|P3|Overall Study|Lack of Efficacy|6
2972817|NCT01138007|10232405|P2|Overall Study|Lack of Efficacy|0
2972818|NCT01138007|10232406|P1|Overall Study|Lack of Efficacy|2
2972819|NCT01138007|10232404|P3|Overall Study|Adverse Event|9
2972820|NCT01138007|10232405|P2|Overall Study|Adverse Event|12
2972821|NCT01138007|10232406|P1|Overall Study|Adverse Event|4
2972822|NCT01137812|10232513|P2|Overall Study|Other|27
2972823|NCT01137812|10232514|P1|Overall Study|Other|19
2972824|NCT01137812|10232513|P2|Overall Study|Patient met glycemic withdrawal criteria|85
2972825|NCT01137812|10232514|P1|Overall Study|Patient met glycemic withdrawal criteria|40
2972826|NCT01137812|10232513|P2|Overall Study|Death|0
2972827|NCT01137812|10232514|P1|Overall Study|Death|2
2972828|NCT01137812|10232513|P2|Overall Study|Withdrawal by Subject|13
2972829|NCT01137812|10232514|P1|Overall Study|Withdrawal by Subject|5
2972830|NCT01137812|10232513|P2|Overall Study|Protocol Violation|4
2972831|NCT01137812|10232514|P1|Overall Study|Protocol Violation|5
2972832|NCT01137812|10232513|P2|Overall Study|Physician Decision|17
2972833|NCT01137812|10232514|P1|Overall Study|Physician Decision|25
2972834|NCT01137812|10232513|P2|Overall Study|Lost to Follow-up|8
2972835|NCT01137812|10232514|P1|Overall Study|Lost to Follow-up|6
2972836|NCT01137812|10232513|P2|Overall Study|Adverse Event|14
2972837|NCT01137812|10232514|P1|Overall Study|Adverse Event|21
2972838|NCT01137786|10232534|P2|Overall Study|Withdrawal by Subject|1
2972839|NCT01137786|10232535|P1|Overall Study|Withdrawal by Subject|1
2972840|NCT01137786|10232534|P2|Overall Study|Lost to Follow-up|2
2972841|NCT01137786|10232535|P1|Overall Study|Lost to Follow-up|0
2972842|NCT01137773|10232545|P2|Overall Study|Lost to Follow-up|0
2972843|NCT01137773|10232546|P1|Overall Study|Lost to Follow-up|6
2972844|NCT01137773|10232545|P2|Overall Study|Death|3
2972845|NCT01137773|10232546|P1|Overall Study|Death|3
2972846|NCT01137682|10232557|P3|Overall Study|Did not receive treatment in extension|1
2972847|NCT01137682|10232558|P2|Overall Study|Did not receive treatment in extension|0
2972848|NCT01137682|10232559|P1|Overall Study|Did not receive treatment in extension|0
2972849|NCT01137682|10232557|P3|Overall Study|Did not enter extension|2
2972850|NCT01137682|10232558|P2|Overall Study|Did not enter extension|3
2972851|NCT01137682|10232559|P1|Overall Study|Did not enter extension|2
2972852|NCT01137682|10232557|P3|Overall Study|Protocol Violation-Extension|0
2972853|NCT01137682|10232558|P2|Overall Study|Protocol Violation-Extension|1
2972854|NCT01137682|10232559|P1|Overall Study|Protocol Violation-Extension|2
2972855|NCT01137682|10232557|P3|Overall Study|Death-Extension|0
2972856|NCT01137682|10232558|P2|Overall Study|Death-Extension|0
2972857|NCT01137682|10232559|P1|Overall Study|Death-Extension|2
2972858|NCT01137682|10232557|P3|Overall Study|Administrative problems-Extension|0
2972859|NCT01137682|10232558|P2|Overall Study|Administrative problems-Extension|2
2972860|NCT01137682|10232559|P1|Overall Study|Administrative problems-Extension|0
2972861|NCT01137682|10232557|P3|Overall Study|Lost to Follow Up-Extension|0
2972862|NCT01137682|10232558|P2|Overall Study|Lost to Follow Up-Extension|1
2972863|NCT01137682|10232559|P1|Overall Study|Lost to Follow Up-Extension|0
2972864|NCT01137682|10232557|P3|Overall Study|Withdrawal by Subject-Extension|8
2972865|NCT01137682|10232558|P2|Overall Study|Withdrawal by Subject-Extension|8
2972866|NCT01137682|10232559|P1|Overall Study|Withdrawal by Subject-Extension|6
2972867|NCT01137682|10232557|P3|Overall Study|Lack of Efficacy-Extension|13
2972868|NCT01137682|10232558|P2|Overall Study|Lack of Efficacy-Extension|9
2972869|NCT01137682|10232559|P1|Overall Study|Lack of Efficacy-Extension|15
2972870|NCT01137682|10232557|P3|Overall Study|Adverse Event-Extension|7
2972871|NCT01137682|10232558|P2|Overall Study|Adverse Event-Extension|8
2972872|NCT01137682|10232559|P1|Overall Study|Adverse Event-Extension|4
2972873|NCT01137682|10232557|P3|Overall Study|Protocol Violation-CORE|1
2972874|NCT01137682|10232558|P2|Overall Study|Protocol Violation-CORE|1
2972875|NCT01137682|10232559|P1|Overall Study|Protocol Violation-CORE|0
2972876|NCT01137682|10232557|P3|Overall Study|Administrative problems-CORE|0
2972877|NCT01137682|10232558|P2|Overall Study|Administrative problems-CORE|1
2972878|NCT01137682|10232559|P1|Overall Study|Administrative problems-CORE|2
2972879|NCT01137682|10232557|P3|Overall Study|Withdrawal by Subject-CORE|2
2972880|NCT01137682|10232558|P2|Overall Study|Withdrawal by Subject-CORE|2
2972881|NCT01137682|10232559|P1|Overall Study|Withdrawal by Subject-CORE|2
2972882|NCT01137682|10232557|P3|Overall Study|Adverse Event-CORE|0
2972883|NCT01137682|10232558|P2|Overall Study|Adverse Event-CORE|4
2972884|NCT01137682|10232559|P1|Overall Study|Adverse Event-CORE|2
2972885|NCT01137604|10232609|P4|Overall Study|Clinical Decline|1
2972886|NCT01137604|10232610|P3|Overall Study|Clinical Decline|1
2972887|NCT01137604|10232611|P2|Overall Study|Clinical Decline|0
2972888|NCT01137604|10232612|P1|Overall Study|Clinical Decline|0
2972889|NCT01137604|10232609|P4|Overall Study|Participant's Decision|0
2972890|NCT01137604|10232610|P3|Overall Study|Participant's Decision|0
2972891|NCT01137604|10232611|P2|Overall Study|Participant's Decision|0
2972892|NCT01137604|10232612|P1|Overall Study|Participant's Decision|1
2972893|NCT01137604|10232609|P4|Overall Study|Clinical Progression|0
2972894|NCT01137604|10232610|P3|Overall Study|Clinical Progression|1
2972895|NCT01137604|10232611|P2|Overall Study|Clinical Progression|2
2972896|NCT01137604|10232612|P1|Overall Study|Clinical Progression|0
2972897|NCT01137604|10232609|P4|Overall Study|Withdrawal by Subject|1
2972898|NCT01137604|10232610|P3|Overall Study|Withdrawal by Subject|2
2972899|NCT01137604|10232611|P2|Overall Study|Withdrawal by Subject|2
2972900|NCT01137604|10232612|P1|Overall Study|Withdrawal by Subject|0
2972901|NCT01137604|10232609|P4|Overall Study|Adverse Event|9
2972902|NCT01137604|10232610|P3|Overall Study|Adverse Event|9
2972903|NCT01137604|10232611|P2|Overall Study|Adverse Event|6
2972904|NCT01137604|10232612|P1|Overall Study|Adverse Event|1
2972905|NCT01137578|10232646|P3|Overall Study|Other|6
2972906|NCT01137578|10232647|P2|Overall Study|Other|2
2972907|NCT01137578|10232648|P1|Overall Study|Other|12
2972908|NCT01137578|10232646|P3|Overall Study|Withdrawal by Subject|0
2972909|NCT01137578|10232647|P2|Overall Study|Withdrawal by Subject|0
2972910|NCT01137578|10232648|P1|Overall Study|Withdrawal by Subject|1
2972911|NCT01137578|10232646|P3|Overall Study|Participant requested to Discontinue|0
2972912|NCT01137578|10232647|P2|Overall Study|Participant requested to Discontinue|0
2972913|NCT01137578|10232648|P1|Overall Study|Participant requested to Discontinue|3
2972914|NCT01137474|10232697|P4|Overall Study|Administrative reason by sponsor|0
2972915|NCT01137474|10232698|P3|Overall Study|Administrative reason by sponsor|0
2972916|NCT01137474|10232699|P2|Overall Study|Administrative reason by sponsor|1
2972917|NCT01137474|10232700|P1|Overall Study|Administrative reason by sponsor|0
2972918|NCT01137474|10232697|P4|Overall Study|Pregnancy|0
2972919|NCT01137474|10232698|P3|Overall Study|Pregnancy|0
2972920|NCT01137474|10232699|P2|Overall Study|Pregnancy|1
2972921|NCT01137474|10232700|P1|Overall Study|Pregnancy|0
2972922|NCT01137474|10232697|P4|Overall Study|Other|0
2972923|NCT01137474|10232698|P3|Overall Study|Other|0
2972924|NCT01137474|10232699|P2|Overall Study|Other|1
2972925|NCT01137474|10232700|P1|Overall Study|Other|3
2972926|NCT01137474|10232697|P4|Overall Study|Lack of Efficacy|2
2972927|NCT01137474|10232698|P3|Overall Study|Lack of Efficacy|0
2972928|NCT01137474|10232699|P2|Overall Study|Lack of Efficacy|0
2972929|NCT01137474|10232700|P1|Overall Study|Lack of Efficacy|0
2972930|NCT01137474|10232697|P4|Overall Study|Lost to Follow-up|2
2972931|NCT01137474|10232698|P3|Overall Study|Lost to Follow-up|0
2972932|NCT01137474|10232699|P2|Overall Study|Lost to Follow-up|1
2972933|NCT01137474|10232700|P1|Overall Study|Lost to Follow-up|5
2972934|NCT01137474|10232697|P4|Overall Study|No longer met study criteria|5
2972935|NCT01137474|10232698|P3|Overall Study|No longer met study criteria|0
2972936|NCT01137474|10232699|P2|Overall Study|No longer met study criteria|1
2972937|NCT01137474|10232700|P1|Overall Study|No longer met study criteria|6
2972938|NCT01137474|10232697|P4|Overall Study|Withdrawal by Subject|9
2972939|NCT01137474|10232698|P3|Overall Study|Withdrawal by Subject|6
2972940|NCT01137474|10232699|P2|Overall Study|Withdrawal by Subject|2
2972941|NCT01137474|10232700|P1|Overall Study|Withdrawal by Subject|7
2972942|NCT01137474|10232697|P4|Overall Study|Adverse Event|3
2972943|NCT01137474|10232698|P3|Overall Study|Adverse Event|1
2972944|NCT01137474|10232699|P2|Overall Study|Adverse Event|5
2972945|NCT01137474|10232700|P1|Overall Study|Adverse Event|3
2972946|NCT01137435|10232718|P1|Overall Study|Off label usage|4
2972947|NCT01137435|10232718|P1|Overall Study|Lost to Follow-up|24
2972948|NCT01137292|10232745|P1|Overall Study|Other|7
2972949|NCT01137292|10232745|P1|Overall Study|Lost to Follow-up|1
2972950|NCT01137292|10232745|P1|Overall Study|Lack of Efficacy|13
2972951|NCT01137292|10232745|P1|Overall Study|Adverse Event|3
2972952|NCT01137292|10232745|P1|Overall Study|Death|30
2972953|NCT01137110|10232754|P2|Overall Study|Protocol Violation|0
2972954|NCT01137110|10232755|P1|Overall Study|Protocol Violation|1
2972955|NCT01137071|10232761|P1|Overall Study|Wrongly Included|1
2972956|NCT01137071|10232761|P1|Overall Study|Withdrawal by Subject|2
2972957|NCT01137071|10232761|P1|Overall Study|Disease Progression|11
2972958|NCT01136967|10232917|P2|Overall Study|Diagnosis of Second Primary Cancer|1
2972959|NCT01136967|10232918|P1|Overall Study|Diagnosis of Second Primary Cancer|0
2972960|NCT01136967|10232917|P2|Overall Study|Increase in Lesion Size|2
2972961|NCT01136967|10232918|P1|Overall Study|Increase in Lesion Size|0
2972962|NCT01136967|10232917|P2|Overall Study|Investigator's Choice|1
2972963|NCT01136967|10232918|P1|Overall Study|Investigator's Choice|1
2972964|NCT01136967|10232917|P2|Overall Study|Non-compliance|0
2972965|NCT01136967|10232918|P1|Overall Study|Non-compliance|1
2972966|NCT01136967|10232917|P2|Overall Study|Radiation|0
2972967|NCT01136967|10232918|P1|Overall Study|Radiation|1
2972968|NCT01136967|10232917|P2|Overall Study|Clinical Progression|5
2972969|NCT01136967|10232918|P1|Overall Study|Clinical Progression|3
2972970|NCT01136967|10232917|P2|Overall Study|Withdrawal by Subject|2
2972971|NCT01136967|10232918|P1|Overall Study|Withdrawal by Subject|1
2972972|NCT01136967|10232917|P2|Overall Study|Lost to Follow-up|1
2972973|NCT01136967|10232918|P1|Overall Study|Lost to Follow-up|0
2972974|NCT01136967|10232917|P2|Overall Study|Participant Choice|3
2972975|NCT01136967|10232918|P1|Overall Study|Participant Choice|8
2972976|NCT01136967|10232917|P2|Overall Study|Adverse Event|12
2972977|NCT01136967|10232918|P1|Overall Study|Adverse Event|9
2972978|NCT01136954|10232940|P2|Overall Study|Other|3
2972979|NCT01136954|10232941|P1|Overall Study|Other|1
2972980|NCT01136954|10232940|P2|Overall Study|Physician Decision|1
2972981|NCT01136954|10232941|P1|Overall Study|Physician Decision|0
2972982|NCT01136954|10232940|P2|Overall Study|Lack of Efficacy|13
2972983|NCT01136954|10232941|P1|Overall Study|Lack of Efficacy|14
2972984|NCT01136954|10232940|P2|Overall Study|Withdrawal by Subject|2
2972985|NCT01136954|10232941|P1|Overall Study|Withdrawal by Subject|6
2972986|NCT01136954|10232940|P2|Overall Study|Adverse Event|2
2972987|NCT01136954|10232941|P1|Overall Study|Adverse Event|3
2972988|NCT01136915|10232955|P2|Overall Study|Exclusion criterion met|1
2972989|NCT01136915|10232956|P1|Overall Study|Exclusion criterion met|0
2972990|NCT01136915|10232955|P2|Overall Study|Lost to Follow-up|0
2972991|NCT01136915|10232956|P1|Overall Study|Lost to Follow-up|2
2972992|NCT01136876|10232966|P2|Overall Study|Physician Decision|5
2972993|NCT01136876|10232967|P1|Overall Study|Physician Decision|3
2972994|NCT01136876|10232966|P2|Overall Study|Lost to Follow-up|1
2972995|NCT01136876|10232967|P1|Overall Study|Lost to Follow-up|0
2972996|NCT01136785|10232996|P2|Overall Study|Protocol Violation|1
2972997|NCT01136785|10232997|P1|Overall Study|Protocol Violation|2
2972998|NCT01136772|10233012|P2|Overall Study|Did not follow up after first injection|2
2972999|NCT01136772|10233013|P1|Overall Study|Did not follow up after first injection|2
2973000|NCT01136772|10233012|P2|Overall Study|Did not receive injection|7
2973001|NCT01136772|10233013|P1|Overall Study|Did not receive injection|10
2973002|NCT01136772|10233012|P2|Overall Study|Withdrawal by Subject|36
2973003|NCT01136772|10233013|P1|Overall Study|Withdrawal by Subject|33
2973004|NCT01136772|10233012|P2|Overall Study|Administrative|12
2973005|NCT01136772|10233013|P1|Overall Study|Administrative|14
2973006|NCT01136772|10233012|P2|Overall Study|Lack of Efficacy|39
2973007|NCT01136772|10233013|P1|Overall Study|Lack of Efficacy|42
2973008|NCT01136772|10233012|P2|Overall Study|Adverse Event|14
2973009|NCT01136772|10233013|P1|Overall Study|Adverse Event|15
2973010|NCT01136746|10233023|P2|Overall Study|Death|0
2973011|NCT01136746|10233024|P1|Overall Study|Death|1
2973012|NCT01136746|10233023|P2|Overall Study|Protocol Violation|1
2973013|NCT01136746|10233024|P1|Overall Study|Protocol Violation|2
2973014|NCT01136746|10233023|P2|Overall Study|Lost to Follow-up|2
2973015|NCT01136746|10233024|P1|Overall Study|Lost to Follow-up|0
2973016|NCT01136733|10233091|P7|Phase 2|Other|6
2973017|NCT01136733|10233092|P6|Phase 2|Other|7
2973018|NCT01136733|10233093|P5|Phase 2|Other|6
2973019|NCT01136733|10233094|P4|Phase 2|Other|0
2973020|NCT01136733|10233095|P3|Phase 2|Other|0
2973021|NCT01136733|10233096|P2|Phase 2|Other|0
2973022|NCT01136733|10233097|P1|Phase 2|Other|0
2973023|NCT01136733|10233091|P7|Phase 2|Administrative-Withdrew Consent|0
2973024|NCT01136733|10233092|P6|Phase 2|Administrative-Withdrew Consent|0
2973025|NCT01136733|10233093|P5|Phase 2|Administrative-Withdrew Consent|1
2973026|NCT01136733|10233094|P4|Phase 2|Administrative-Withdrew Consent|0
2973027|NCT01136733|10233095|P3|Phase 2|Administrative-Withdrew Consent|0
2973028|NCT01136733|10233096|P2|Phase 2|Administrative-Withdrew Consent|0
2973029|NCT01136733|10233097|P1|Phase 2|Administrative-Withdrew Consent|0
2973030|NCT01136733|10233091|P7|Phase 2|Participant Choice|1
2973031|NCT01136733|10233092|P6|Phase 2|Participant Choice|0
2973032|NCT01136733|10233093|P5|Phase 2|Participant Choice|3
2973033|NCT01136733|10233094|P4|Phase 2|Participant Choice|0
2973034|NCT01136733|10233095|P3|Phase 2|Participant Choice|0
2973035|NCT01136733|10233096|P2|Phase 2|Participant Choice|0
2973036|NCT01136733|10233097|P1|Phase 2|Participant Choice|0
2973037|NCT01136733|10233091|P7|Phase 2|Adverse Event|5
2973038|NCT01136733|10233092|P6|Phase 2|Adverse Event|13
2973039|NCT01136733|10233093|P5|Phase 2|Adverse Event|11
2973040|NCT01136733|10233094|P4|Phase 2|Adverse Event|0
2973041|NCT01136733|10233095|P3|Phase 2|Adverse Event|0
2973042|NCT01136733|10233096|P2|Phase 2|Adverse Event|0
2973043|NCT01136733|10233097|P1|Phase 2|Adverse Event|0
2973044|NCT01136733|10233091|P7|Phase 2|Disease Progression|38
2973045|NCT01136733|10233092|P6|Phase 2|Disease Progression|32
2973046|NCT01136733|10233093|P5|Phase 2|Disease Progression|30
2973047|NCT01136733|10233094|P4|Phase 2|Disease Progression|0
2973048|NCT01136733|10233095|P3|Phase 2|Disease Progression|0
2973049|NCT01136733|10233096|P2|Phase 2|Disease Progression|0
2973050|NCT01136733|10233097|P1|Phase 2|Disease Progression|0
2973051|NCT01136733|10233091|P7|Phase 1b|Clinical Progression|0
2973052|NCT01136733|10233092|P6|Phase 1b|Clinical Progression|0
2973053|NCT01136733|10233093|P5|Phase 1b|Clinical Progression|0
2973054|NCT01136733|10233094|P4|Phase 1b|Clinical Progression|0
2973055|NCT01136733|10233095|P3|Phase 1b|Clinical Progression|0
2973056|NCT01136733|10233096|P2|Phase 1b|Clinical Progression|1
2973057|NCT01136733|10233097|P1|Phase 1b|Clinical Progression|1
2973058|NCT01136733|10233091|P7|Phase 1b|Administrative-Withdrew Consent|0
2973059|NCT01136733|10233092|P6|Phase 1b|Administrative-Withdrew Consent|0
2973060|NCT01136733|10233093|P5|Phase 1b|Administrative-Withdrew Consent|0
2973061|NCT01136733|10233094|P4|Phase 1b|Administrative-Withdrew Consent|0
2973062|NCT01136733|10233095|P3|Phase 1b|Administrative-Withdrew Consent|0
2973063|NCT01136733|10233096|P2|Phase 1b|Administrative-Withdrew Consent|1
2973064|NCT01136733|10233097|P1|Phase 1b|Administrative-Withdrew Consent|0
2973065|NCT01136733|10233091|P7|Phase 1b|Participant Choice|0
2973066|NCT01136733|10233092|P6|Phase 1b|Participant Choice|0
2973067|NCT01136733|10233093|P5|Phase 1b|Participant Choice|0
2973068|NCT01136733|10233094|P4|Phase 1b|Participant Choice|0
2973069|NCT01136733|10233095|P3|Phase 1b|Participant Choice|1
2973070|NCT01136733|10233096|P2|Phase 1b|Participant Choice|0
2973071|NCT01136733|10233097|P1|Phase 1b|Participant Choice|0
2973072|NCT01136733|10233091|P7|Phase 1b|Adverse Event|0
2973073|NCT01136733|10233092|P6|Phase 1b|Adverse Event|0
2973074|NCT01136733|10233093|P5|Phase 1b|Adverse Event|0
2973075|NCT01136733|10233094|P4|Phase 1b|Adverse Event|0
2973076|NCT01136733|10233095|P3|Phase 1b|Adverse Event|1
2973077|NCT01136733|10233096|P2|Phase 1b|Adverse Event|3
2973078|NCT01136733|10233097|P1|Phase 1b|Adverse Event|0
2973079|NCT01136655|10233180|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
2973080|NCT01136655|10233180|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
2973081|NCT01136655|10233180|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
2973082|NCT01136655|10233180|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
2973083|NCT01136408|10233213|P3|Overall Study|Protocol Violation|1
2973084|NCT01136408|10233214|P2|Overall Study|Protocol Violation|1
2973085|NCT01136408|10233215|P1|Overall Study|Protocol Violation|1
2973086|NCT01136408|10233213|P3|Overall Study|Adverse Event|4
2973087|NCT01136408|10233214|P2|Overall Study|Adverse Event|8
2973088|NCT01136408|10233215|P1|Overall Study|Adverse Event|4
2973089|NCT01136382|10233272|P2|Overall Study|Withdrawal by Subject|1
2973090|NCT01136382|10233273|P1|Overall Study|Withdrawal by Subject|4
2973091|NCT01136382|10233272|P2|Overall Study|Severe Non-Compliance to Protocol|2
2973092|NCT01136382|10233273|P1|Overall Study|Severe Non-Compliance to Protocol|0
2973093|NCT01136382|10233272|P2|Overall Study|Study-Specific Withdrawal Criteria|25
2973094|NCT01136382|10233273|P1|Overall Study|Study-Specific Withdrawal Criteria|48
2973095|NCT01136382|10233272|P2|Overall Study|Other|3
2973096|NCT01136382|10233273|P1|Overall Study|Other|8
2973097|NCT01136356|10233299|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
2973098|NCT01136356|10233300|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
2973099|NCT01136356|10233299|P2|First 18-day Withdrawal|Physician Decision|0
2973100|NCT01136356|10233300|P1|First 18-day Withdrawal|Physician Decision|1
2973101|NCT01136356|10233299|P2|First 18-day Withdrawal|Withdrawal by Subject|0
2973102|NCT01136356|10233300|P1|First 18-day Withdrawal|Withdrawal by Subject|3
2973103|NCT01136291|10233311|P2|Overall Study|Lost to Follow-up|1
2973104|NCT01136291|10233312|P1|Overall Study|Lost to Follow-up|1
2973105|NCT01136174|10233331|P4|Overall Study|Adverse Event|4
2973106|NCT01136174|10233332|P3|Overall Study|Adverse Event|0
2973107|NCT01136174|10233333|P2|Overall Study|Adverse Event|0
2973108|NCT01136174|10233334|P1|Overall Study|Adverse Event|0
2973109|NCT01135992|10233414|P1|Overall Study|Unclassified|7
2973110|NCT01135992|10233414|P1|Overall Study|Withdrawal criteria|10
2973111|NCT01135992|10233414|P1|Overall Study|Protocol Violation|2
2973112|NCT01135992|10233414|P1|Overall Study|Lack of Efficacy|1
2973113|NCT01135992|10233414|P1|Overall Study|Adverse Event|1
2973114|NCT01135914|10233426|P3|Overall Study|Adverse Event|2
2973115|NCT01135914|10233427|P2|Overall Study|Adverse Event|1
2973116|NCT01135914|10233428|P1|Overall Study|Adverse Event|0
2973117|NCT01135914|10233426|P3|Overall Study|Lack of Efficacy|10
2973118|NCT01135914|10233427|P2|Overall Study|Lack of Efficacy|1
2973119|NCT01135914|10233428|P1|Overall Study|Lack of Efficacy|2
2973120|NCT01135914|10233426|P3|Overall Study|Protocol Violation|3
2973121|NCT01135914|10233427|P2|Overall Study|Protocol Violation|0
2973122|NCT01135914|10233428|P1|Overall Study|Protocol Violation|0
2973123|NCT01135914|10233426|P3|Overall Study|Lost to Follow-up|1
2973124|NCT01135914|10233427|P2|Overall Study|Lost to Follow-up|0
2973125|NCT01135914|10233428|P1|Overall Study|Lost to Follow-up|1
2973126|NCT01135914|10233426|P3|Overall Study|Withdrawal by Subject|6
2973127|NCT01135914|10233427|P2|Overall Study|Withdrawal by Subject|3
2973128|NCT01135914|10233428|P1|Overall Study|Withdrawal by Subject|1
2973129|NCT01135524|10233461|P1|Overall Study|Lack of Efficacy|8
2973130|NCT01135524|10233461|P1|Overall Study|Administrative|151
2973131|NCT01135524|10233461|P1|Overall Study|Lost to Follow-up|3
2973132|NCT01135524|10233461|P1|Overall Study|Adverse Event|20
2973133|NCT01135524|10233461|P1|Overall Study|Withdrawal by Subject|14
2973134|NCT01135511|10233474|P9|Overall Study|Withdrawal by Subject|1
2973135|NCT01135511|10233475|P8|Overall Study|Withdrawal by Subject|0
2973136|NCT01135511|10233476|P7|Overall Study|Withdrawal by Subject|1
2973137|NCT01135511|10233477|P6|Overall Study|Withdrawal by Subject|0
2973138|NCT01135511|10233478|P5|Overall Study|Withdrawal by Subject|0
2973139|NCT01135511|10233479|P4|Overall Study|Withdrawal by Subject|0
2973140|NCT01135511|10233480|P3|Overall Study|Withdrawal by Subject|0
2973141|NCT01135511|10233481|P2|Overall Study|Withdrawal by Subject|0
2973142|NCT01135511|10233482|P1|Overall Study|Withdrawal by Subject|0
2973143|NCT01135511|10233474|P9|Overall Study|noncompliance with study drug taken|0
2973144|NCT01135511|10233475|P8|Overall Study|noncompliance with study drug taken|0
2973145|NCT01135511|10233476|P7|Overall Study|noncompliance with study drug taken|0
2973146|NCT01135511|10233477|P6|Overall Study|noncompliance with study drug taken|0
2973147|NCT01135511|10233478|P5|Overall Study|noncompliance with study drug taken|1
2973148|NCT01135511|10233479|P4|Overall Study|noncompliance with study drug taken|0
2973149|NCT01135511|10233480|P3|Overall Study|noncompliance with study drug taken|0
2973150|NCT01135511|10233481|P2|Overall Study|noncompliance with study drug taken|0
2973151|NCT01135511|10233482|P1|Overall Study|noncompliance with study drug taken|0
2973152|NCT01135511|10233474|P9|Overall Study|could not visit the clinic|0
2973153|NCT01135511|10233475|P8|Overall Study|could not visit the clinic|0
2973154|NCT01135511|10233476|P7|Overall Study|could not visit the clinic|0
2973155|NCT01135511|10233477|P6|Overall Study|could not visit the clinic|0
2973156|NCT01135511|10233478|P5|Overall Study|could not visit the clinic|0
2973157|NCT01135511|10233479|P4|Overall Study|could not visit the clinic|0
2973158|NCT01135511|10233480|P3|Overall Study|could not visit the clinic|2
2973159|NCT01135511|10233481|P2|Overall Study|could not visit the clinic|1
2973160|NCT01135511|10233482|P1|Overall Study|could not visit the clinic|0
2973161|NCT01135511|10233474|P9|Overall Study|Pregnancy|0
2973162|NCT01135511|10233475|P8|Overall Study|Pregnancy|0
2973163|NCT01135511|10233476|P7|Overall Study|Pregnancy|0
2973164|NCT01135511|10233477|P6|Overall Study|Pregnancy|0
2973165|NCT01135511|10233478|P5|Overall Study|Pregnancy|0
2973166|NCT01135511|10233479|P4|Overall Study|Pregnancy|1
2973167|NCT01135511|10233480|P3|Overall Study|Pregnancy|0
2973168|NCT01135511|10233481|P2|Overall Study|Pregnancy|0
2973169|NCT01135511|10233482|P1|Overall Study|Pregnancy|0
2973170|NCT01135511|10233474|P9|Overall Study|Protocol Violation|0
2973171|NCT01135511|10233475|P8|Overall Study|Protocol Violation|0
2973172|NCT01135511|10233476|P7|Overall Study|Protocol Violation|0
2973173|NCT01135511|10233477|P6|Overall Study|Protocol Violation|0
2973174|NCT01135511|10233478|P5|Overall Study|Protocol Violation|0
2973175|NCT01135511|10233479|P4|Overall Study|Protocol Violation|0
2973176|NCT01135511|10233480|P3|Overall Study|Protocol Violation|3
2973177|NCT01135511|10233481|P2|Overall Study|Protocol Violation|0
2973178|NCT01135511|10233482|P1|Overall Study|Protocol Violation|0
2973179|NCT01135511|10233474|P9|Overall Study|Lack of Efficacy|0
2973180|NCT01135511|10233475|P8|Overall Study|Lack of Efficacy|0
2973181|NCT01135511|10233476|P7|Overall Study|Lack of Efficacy|0
2973182|NCT01135511|10233477|P6|Overall Study|Lack of Efficacy|0
2973183|NCT01135511|10233478|P5|Overall Study|Lack of Efficacy|0
2973184|NCT01135511|10233479|P4|Overall Study|Lack of Efficacy|2
2973185|NCT01135511|10233480|P3|Overall Study|Lack of Efficacy|1
2973186|NCT01135511|10233481|P2|Overall Study|Lack of Efficacy|1
2973187|NCT01135511|10233482|P1|Overall Study|Lack of Efficacy|0
2973188|NCT01135511|10233474|P9|Overall Study|Adverse Event|0
2973189|NCT01135511|10233475|P8|Overall Study|Adverse Event|1
2973190|NCT01135511|10233476|P7|Overall Study|Adverse Event|0
2973191|NCT01135511|10233477|P6|Overall Study|Adverse Event|1
2973192|NCT01135511|10233478|P5|Overall Study|Adverse Event|0
2973193|NCT01135511|10233479|P4|Overall Study|Adverse Event|0
2973194|NCT01135511|10233480|P3|Overall Study|Adverse Event|2
2973195|NCT01135511|10233481|P2|Overall Study|Adverse Event|1
2973196|NCT01135511|10233482|P1|Overall Study|Adverse Event|0
2973197|NCT01135498|10233764|P1|Overall Study|Ongoing at time of analysis|2
2973198|NCT01135498|10233764|P1|Overall Study|Death|1
2973199|NCT01135498|10233764|P1|Overall Study|Withdrawal by Subject|4
2973200|NCT01135498|10233764|P1|Overall Study|Investigator judgement|25
2973201|NCT01135498|10233764|P1|Overall Study|Progressive disease|38
2973202|NCT01135498|10233764|P1|Overall Study|Adverse Event|20
2973203|NCT01135134|10233943|P2|Overall Study|Did not meet protocol eligibility|0
2973204|NCT01135134|10233944|P1|Overall Study|Did not meet protocol eligibility|1
2973205|NCT01135134|10233943|P2|Overall Study|Adverse Event|1
2973206|NCT01135134|10233944|P1|Overall Study|Adverse Event|1
2973207|NCT01135017|10233967|P2|Overall Study|Other than above|4
2973208|NCT01135017|10233968|P1|Overall Study|Other than above|3
2973209|NCT01135017|10233967|P2|Overall Study|Adverse Event|8
2973210|NCT01135017|10233968|P1|Overall Study|Adverse Event|3
2973211|NCT01134939|10234006|P8|Overall Study|Termination page not available|0
2973212|NCT01134939|10234007|P7|Overall Study|Termination page not available|7
2973213|NCT01134939|10234008|P6|Overall Study|Termination page not available|3
2973214|NCT01134939|10234009|P5|Overall Study|Termination page not available|0
2973215|NCT01134939|10234010|P4|Overall Study|Termination page not available|8
2973216|NCT01134939|10234011|P3|Overall Study|Termination page not available|5
2973217|NCT01134939|10234012|P2|Overall Study|Termination page not available|6
2973218|NCT01134939|10234013|P1|Overall Study|Termination page not available|4
2973219|NCT01134939|10234006|P8|Overall Study|Death|0
2973220|NCT01134939|10234007|P7|Overall Study|Death|0
2973221|NCT01134939|10234008|P6|Overall Study|Death|0
2973222|NCT01134939|10234009|P5|Overall Study|Death|0
2973223|NCT01134939|10234010|P4|Overall Study|Death|0
2973224|NCT01134939|10234011|P3|Overall Study|Death|0
2973225|NCT01134939|10234012|P2|Overall Study|Death|1
2973226|NCT01134939|10234013|P1|Overall Study|Death|0
2973227|NCT01134939|10234006|P8|Overall Study|Lost to Follow-up|0
2973228|NCT01134939|10234007|P7|Overall Study|Lost to Follow-up|0
2973229|NCT01134939|10234008|P6|Overall Study|Lost to Follow-up|1
2973230|NCT01134939|10234009|P5|Overall Study|Lost to Follow-up|2
2973231|NCT01134939|10234010|P4|Overall Study|Lost to Follow-up|1
2973232|NCT01134939|10234011|P3|Overall Study|Lost to Follow-up|0
2973233|NCT01134939|10234012|P2|Overall Study|Lost to Follow-up|3
2973234|NCT01134939|10234013|P1|Overall Study|Lost to Follow-up|2
2973235|NCT01134939|10234006|P8|Overall Study|Lack of Efficacy|0
2973236|NCT01134939|10234007|P7|Overall Study|Lack of Efficacy|1
2973237|NCT01134939|10234008|P6|Overall Study|Lack of Efficacy|0
2973238|NCT01134939|10234009|P5|Overall Study|Lack of Efficacy|3
2973239|NCT01134939|10234010|P4|Overall Study|Lack of Efficacy|0
2973240|NCT01134939|10234011|P3|Overall Study|Lack of Efficacy|1
2973241|NCT01134939|10234012|P2|Overall Study|Lack of Efficacy|5
2973242|NCT01134939|10234013|P1|Overall Study|Lack of Efficacy|2
2973243|NCT01134939|10234006|P8|Overall Study|Adverse Event|0
2973244|NCT01134939|10234007|P7|Overall Study|Adverse Event|1
2973245|NCT01134939|10234008|P6|Overall Study|Adverse Event|5
2973246|NCT01134939|10234009|P5|Overall Study|Adverse Event|5
2973247|NCT01134939|10234010|P4|Overall Study|Adverse Event|5
2973248|NCT01134939|10234011|P3|Overall Study|Adverse Event|4
2973249|NCT01134939|10234012|P2|Overall Study|Adverse Event|3
2973250|NCT01134939|10234013|P1|Overall Study|Adverse Event|9
2973251|NCT01134783|10234151|P2|Overall Study|Lost to Follow-up|20
2973252|NCT01134783|10234152|P1|Overall Study|Lost to Follow-up|5
2973253|NCT01134783|10234151|P2|Overall Study|Withdrawal by Subject|9
2973254|NCT01134783|10234152|P1|Overall Study|Withdrawal by Subject|15
2973255|NCT01134783|10234151|P2|Overall Study|Pregnancy|8
2973256|NCT01134783|10234152|P1|Overall Study|Pregnancy|16
2973257|NCT01134731|10234171|P3|Overall Study|Lost to Follow-up|3
2973258|NCT01134731|10234172|P2|Overall Study|Lost to Follow-up|4
2973259|NCT01134731|10234173|P1|Overall Study|Lost to Follow-up|5
2973260|NCT01134731|10234171|P3|Overall Study|Withdrawal by Subject|1
2973261|NCT01134731|10234172|P2|Overall Study|Withdrawal by Subject|3
2973262|NCT01134731|10234173|P1|Overall Study|Withdrawal by Subject|3
2973263|NCT01134731|10234171|P3|Overall Study|Lack of Efficacy|1
2973264|NCT01134731|10234172|P2|Overall Study|Lack of Efficacy|0
2973265|NCT01134731|10234173|P1|Overall Study|Lack of Efficacy|0
2973266|NCT01134731|10234171|P3|Overall Study|Physician Decision|2
2973267|NCT01134731|10234172|P2|Overall Study|Physician Decision|2
2973268|NCT01134731|10234173|P1|Overall Study|Physician Decision|2
2973269|NCT01134731|10234171|P3|Overall Study|Adverse Event|1
2973270|NCT01134731|10234172|P2|Overall Study|Adverse Event|2
2973271|NCT01134731|10234173|P1|Overall Study|Adverse Event|3
2973272|NCT01134705|10234186|P2|Overall Study|Other|6
2973273|NCT01134705|10234187|P1|Overall Study|Other|1
2973274|NCT01134705|10234186|P2|Overall Study|Protocol Violation|1
2973275|NCT01134705|10234187|P1|Overall Study|Protocol Violation|1
2973276|NCT01134705|10234186|P2|Overall Study|Lost to Follow-up|2
2973277|NCT01134705|10234187|P1|Overall Study|Lost to Follow-up|5
2973278|NCT01134705|10234186|P2|Overall Study|Pregnancy|0
2973279|NCT01134705|10234187|P1|Overall Study|Pregnancy|1
2973280|NCT01134705|10234186|P2|Overall Study|Withdrawal by Subject|6
2973281|NCT01134705|10234187|P1|Overall Study|Withdrawal by Subject|6
2973282|NCT01134705|10234186|P2|Overall Study|Adverse Event|7
2973283|NCT01134705|10234187|P1|Overall Study|Adverse Event|1
2973284|NCT01134627|10234199|P2|Overall Study|Other|14
2973285|NCT01134627|10234200|P1|Overall Study|Other|11
2973286|NCT01134627|10234199|P2|Overall Study|Planning to become pregnant/pregnancy|0
2973287|NCT01134627|10234200|P1|Overall Study|Planning to become pregnant/pregnancy|1
2973288|NCT01134627|10234199|P2|Overall Study|Withdrawal by Subject|3
2973289|NCT01134627|10234200|P1|Overall Study|Withdrawal by Subject|4
2973290|NCT01134627|10234199|P2|Overall Study|Lack of Efficacy|12
2973291|NCT01134627|10234200|P1|Overall Study|Lack of Efficacy|2
2973292|NCT01134627|10234199|P2|Overall Study|Protocol Violation|5
2973293|NCT01134627|10234200|P1|Overall Study|Protocol Violation|3
2973294|NCT01134627|10234199|P2|Overall Study|Lost to Follow-up|2
2973295|NCT01134627|10234200|P1|Overall Study|Lost to Follow-up|1
2973296|NCT01134627|10234199|P2|Overall Study|Adverse Event|31
2973297|NCT01134627|10234200|P1|Overall Study|Adverse Event|47
2973298|NCT01134614|10234230|P2|Overall Study|Patient in hospice care|1
2973299|NCT01134614|10234231|P1|Overall Study|Patient in hospice care|0
2973300|NCT01134614|10234230|P2|Overall Study|Symptomatic deterioration|1
2973301|NCT01134614|10234231|P1|Overall Study|Symptomatic deterioration|0
2973302|NCT01134614|10234230|P2|Overall Study|Pt received tx not allowed on study|1
2973303|NCT01134614|10234231|P1|Overall Study|Pt received tx not allowed on study|0
2973304|NCT01134614|10234230|P2|Overall Study|Never started treatment|1
2973305|NCT01134614|10234231|P1|Overall Study|Never started treatment|4
2973306|NCT01134614|10234230|P2|Overall Study|Physician's decision|1
2973307|NCT01134614|10234231|P1|Overall Study|Physician's decision|0
2973308|NCT01134614|10234230|P2|Overall Study|Complicating disease|1
2973309|NCT01134614|10234231|P1|Overall Study|Complicating disease|2
2973310|NCT01134614|10234230|P2|Overall Study|Alternative therapy|0
2973311|NCT01134614|10234231|P1|Overall Study|Alternative therapy|2
2973312|NCT01134614|10234230|P2|Overall Study|Withdrawal by Subject|2
2973313|NCT01134614|10234231|P1|Overall Study|Withdrawal by Subject|3
2973314|NCT01134614|10234230|P2|Overall Study|Death|8
2973315|NCT01134614|10234231|P1|Overall Study|Death|5
2973316|NCT01134614|10234230|P2|Overall Study|Adverse Event|39
2973317|NCT01134614|10234231|P1|Overall Study|Adverse Event|26
2973318|NCT01134614|10234230|P2|Overall Study|Progressive disease|54
2973319|NCT01134614|10234231|P1|Overall Study|Progressive disease|60
2973320|NCT01134614|10234230|P2|Overall Study|Still on treatment as of March 2013|13
2973321|NCT01134614|10234231|P1|Overall Study|Still on treatment as of March 2013|21
2973322|NCT01134562|10234259|P5|Overall Study|Adverse Event|0
2973323|NCT01134562|10234260|P4|Overall Study|Adverse Event|0
2973324|NCT01134562|10234261|P3|Overall Study|Adverse Event|0
2973325|NCT01134562|10234262|P2|Overall Study|Adverse Event|1
2973326|NCT01134562|10234263|P1|Overall Study|Adverse Event|0
2973327|NCT01134393|10234435|P1|Overall Study|Other|6
2973328|NCT01134393|10234435|P1|Overall Study|Withdrawal by Subject|11
2973329|NCT01134393|10234435|P1|Overall Study|Lost to Follow-up|3
2973330|NCT01134393|10234435|P1|Overall Study|Protocol Violation|12
2973331|NCT01134393|10234435|P1|Overall Study|Lack of Efficacy|2
2973332|NCT01134393|10234435|P1|Overall Study|Adverse Event|18
2973333|NCT01134315|10234556|P2|Overall Study|Other Reason|17
2973334|NCT01134315|10234557|P1|Overall Study|Other Reason|8
2973335|NCT01134315|10234556|P2|Overall Study|Adverse Event|2
2973336|NCT01134315|10234557|P1|Overall Study|Adverse Event|1
2973337|NCT01134263|10234595|P5|Overall Study|Enrolled, but not treated|0
2973338|NCT01134263|10234596|P4|Overall Study|Enrolled, but not treated|1
2973339|NCT01134263|10234597|P3|Overall Study|Enrolled, but not treated|0
2973340|NCT01134263|10234598|P2|Overall Study|Enrolled, but not treated|1
2973341|NCT01134263|10234599|P1|Overall Study|Enrolled, but not treated|1
2973342|NCT01134263|10234595|P5|Overall Study|Withdrawal by Subject|5
2973343|NCT01134263|10234596|P4|Overall Study|Withdrawal by Subject|7
2973344|NCT01134263|10234597|P3|Overall Study|Withdrawal by Subject|16
2973345|NCT01134263|10234598|P2|Overall Study|Withdrawal by Subject|6
2973346|NCT01134263|10234599|P1|Overall Study|Withdrawal by Subject|8
2973347|NCT01134263|10234595|P5|Overall Study|Lost to Follow-up|1
2973348|NCT01134263|10234596|P4|Overall Study|Lost to Follow-up|3
2973349|NCT01134263|10234597|P3|Overall Study|Lost to Follow-up|5
2973350|NCT01134263|10234598|P2|Overall Study|Lost to Follow-up|3
2973351|NCT01134263|10234599|P1|Overall Study|Lost to Follow-up|4
2973352|NCT01134263|10234595|P5|Overall Study|Protocol Violation|2
2973353|NCT01134263|10234596|P4|Overall Study|Protocol Violation|4
2973354|NCT01134263|10234597|P3|Overall Study|Protocol Violation|2
2973355|NCT01134263|10234598|P2|Overall Study|Protocol Violation|7
2973356|NCT01134263|10234599|P1|Overall Study|Protocol Violation|8
2973357|NCT01134263|10234595|P5|Overall Study|Other adverse event|0
2973358|NCT01134263|10234596|P4|Overall Study|Other adverse event|3
2973359|NCT01134263|10234597|P3|Overall Study|Other adverse event|5
2973360|NCT01134263|10234598|P2|Overall Study|Other adverse event|2
2973361|NCT01134263|10234599|P1|Overall Study|Other adverse event|1
2973362|NCT01134263|10234595|P5|Overall Study|Serious adverse event|1
2973363|NCT01134263|10234596|P4|Overall Study|Serious adverse event|1
2973364|NCT01134263|10234597|P3|Overall Study|Serious adverse event|1
2973365|NCT01134263|10234598|P2|Overall Study|Serious adverse event|1
2973366|NCT01134263|10234599|P1|Overall Study|Serious adverse event|2
2973367|NCT01134107|10234632|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
2973368|NCT01134107|10234633|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
2973369|NCT01134107|10234632|P2|Period 2-Second Treatment Intervention|Physician Decision|0
2973370|NCT01134107|10234633|P1|Period 2-Second Treatment Intervention|Physician Decision|1
2973371|NCT01134107|10234632|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
2973372|NCT01134107|10234633|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
2973373|NCT01134107|10234632|P2|Period 1-First Treatment Intervention|Physician Decision|0
2973374|NCT01134107|10234633|P1|Period 1-First Treatment Intervention|Physician Decision|1
2973375|NCT01134107|10234632|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
2973376|NCT01134107|10234633|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
2973377|NCT01134107|10234632|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2973378|NCT01134107|10234633|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2973379|NCT01134107|10234632|P2|Period 1-First Treatment Intervention|Adverse Event|0
2973380|NCT01134107|10234633|P1|Period 1-First Treatment Intervention|Adverse Event|1
2973381|NCT01134055|10234680|P7|Overall Study|Physician Decision|1
2973382|NCT01134055|10234681|P6|Overall Study|Physician Decision|0
2973383|NCT01134055|10234682|P5|Overall Study|Physician Decision|0
2973384|NCT01134055|10234683|P4|Overall Study|Physician Decision|0
2973385|NCT01134055|10234684|P3|Overall Study|Physician Decision|0
2973386|NCT01134055|10234685|P2|Overall Study|Physician Decision|0
2973387|NCT01134055|10234686|P1|Overall Study|Physician Decision|0
2973388|NCT01134055|10234680|P7|Overall Study|Protocol Violation|0
2973389|NCT01134055|10234681|P6|Overall Study|Protocol Violation|0
2973390|NCT01134055|10234682|P5|Overall Study|Protocol Violation|1
2973391|NCT01134055|10234683|P4|Overall Study|Protocol Violation|1
2973392|NCT01134055|10234684|P3|Overall Study|Protocol Violation|0
2973393|NCT01134055|10234685|P2|Overall Study|Protocol Violation|0
2973394|NCT01134055|10234686|P1|Overall Study|Protocol Violation|0
2973395|NCT01134055|10234680|P7|Overall Study|Withdrawal by Subject|8
2973396|NCT01134055|10234681|P6|Overall Study|Withdrawal by Subject|0
2973397|NCT01134055|10234682|P5|Overall Study|Withdrawal by Subject|0
2973398|NCT01134055|10234683|P4|Overall Study|Withdrawal by Subject|2
2973399|NCT01134055|10234684|P3|Overall Study|Withdrawal by Subject|1
2973400|NCT01134055|10234685|P2|Overall Study|Withdrawal by Subject|3
2973401|NCT01134055|10234686|P1|Overall Study|Withdrawal by Subject|3
2973402|NCT01134055|10234680|P7|Overall Study|Lost to Follow-up|0
2973403|NCT01134055|10234681|P6|Overall Study|Lost to Follow-up|0
2973404|NCT01134055|10234682|P5|Overall Study|Lost to Follow-up|0
2973405|NCT01134055|10234683|P4|Overall Study|Lost to Follow-up|1
2973406|NCT01134055|10234684|P3|Overall Study|Lost to Follow-up|0
2973407|NCT01134055|10234685|P2|Overall Study|Lost to Follow-up|1
2973408|NCT01134055|10234686|P1|Overall Study|Lost to Follow-up|0
2973409|NCT01134055|10234680|P7|Overall Study|Adverse Event|2
2973410|NCT01134055|10234681|P6|Overall Study|Adverse Event|7
2973411|NCT01134055|10234682|P5|Overall Study|Adverse Event|5
2973412|NCT01134055|10234683|P4|Overall Study|Adverse Event|2
2973413|NCT01134055|10234684|P3|Overall Study|Adverse Event|2
2973414|NCT01134055|10234685|P2|Overall Study|Adverse Event|2
2973415|NCT01134055|10234686|P1|Overall Study|Adverse Event|5
2973416|NCT01134042|10234820|P3|Overall Study|Withdrawal by Subject|7
2973417|NCT01134042|10234821|P2|Overall Study|Withdrawal by Subject|4
2973418|NCT01134042|10234822|P1|Overall Study|Withdrawal by Subject|13
2973419|NCT01134042|10234820|P3|Overall Study|Physician Decision|1
2973420|NCT01134042|10234821|P2|Overall Study|Physician Decision|8
2973421|NCT01134042|10234822|P1|Overall Study|Physician Decision|4
2973422|NCT01134042|10234820|P3|Overall Study|Lost to Follow-up|1
2973423|NCT01134042|10234821|P2|Overall Study|Lost to Follow-up|0
2973424|NCT01134042|10234822|P1|Overall Study|Lost to Follow-up|2
2973425|NCT01134042|10234820|P3|Overall Study|Protocol Violation|5
2973426|NCT01134042|10234821|P2|Overall Study|Protocol Violation|3
2973427|NCT01134042|10234822|P1|Overall Study|Protocol Violation|5
2973428|NCT01134042|10234820|P3|Overall Study|Lack of Efficacy|18
2973429|NCT01134042|10234821|P2|Overall Study|Lack of Efficacy|6
2973430|NCT01134042|10234822|P1|Overall Study|Lack of Efficacy|21
2973431|NCT01134042|10234820|P3|Overall Study|Adverse Event|2
2973432|NCT01134042|10234821|P2|Overall Study|Adverse Event|7
2973433|NCT01134042|10234822|P1|Overall Study|Adverse Event|3
2973434|NCT01133977|10234898|P5|Overall Study|Withdrawal by Subject|1
2973435|NCT01133977|10234899|P4|Overall Study|Withdrawal by Subject|5
2973436|NCT01133977|10234900|P3|Overall Study|Withdrawal by Subject|0
2973437|NCT01133977|10234901|P2|Overall Study|Withdrawal by Subject|0
2973438|NCT01133977|10234902|P1|Overall Study|Withdrawal by Subject|0
2973439|NCT01133977|10234898|P5|Overall Study|Lost to Follow-up|1
2973440|NCT01133977|10234899|P4|Overall Study|Lost to Follow-up|2
2973441|NCT01133977|10234900|P3|Overall Study|Lost to Follow-up|0
2973442|NCT01133977|10234901|P2|Overall Study|Lost to Follow-up|0
2973443|NCT01133977|10234902|P1|Overall Study|Lost to Follow-up|0
2973444|NCT01133977|10234898|P5|Overall Study|Started a New Line of Therapy|33
2973445|NCT01133977|10234899|P4|Overall Study|Started a New Line of Therapy|25
2973446|NCT01133977|10234900|P3|Overall Study|Started a New Line of Therapy|4
2973447|NCT01133977|10234901|P2|Overall Study|Started a New Line of Therapy|6
2973448|NCT01133977|10234902|P1|Overall Study|Started a New Line of Therapy|2
2973449|NCT01133977|10234898|P5|Overall Study|Death|3
2973450|NCT01133977|10234899|P4|Overall Study|Death|7
2973451|NCT01133977|10234900|P3|Overall Study|Death|1
2973452|NCT01133977|10234901|P2|Overall Study|Death|1
2973453|NCT01133977|10234902|P1|Overall Study|Death|1
2973454|NCT01133977|10234898|P5|Overall Study|Adverse Event|0
2973455|NCT01133977|10234899|P4|Overall Study|Adverse Event|0
2973456|NCT01133977|10234900|P3|Overall Study|Adverse Event|1
2973457|NCT01133977|10234901|P2|Overall Study|Adverse Event|0
2973458|NCT01133977|10234902|P1|Overall Study|Adverse Event|0
2973459|NCT01133847|10234929|P3|Follow-Up Phase|Lost to Follow-up|7
2973460|NCT01133847|10234930|P2|Follow-Up Phase|Lost to Follow-up|3
2973461|NCT01133847|10234931|P1|Follow-Up Phase|Lost to Follow-up|1
2973462|NCT01133847|10234929|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
2973463|NCT01133847|10234930|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
2973464|NCT01133847|10234931|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
2973465|NCT01133821|10234971|P2|Overall Study|Refused participation|3
2973466|NCT01133821|10234972|P1|Overall Study|Refused participation|1
2973467|NCT01133821|10234971|P2|Overall Study|Protocol Violation|1
2973468|NCT01133821|10234972|P1|Overall Study|Protocol Violation|0
2973469|NCT01133821|10234971|P2|Overall Study|preferred other treatment|1
2973470|NCT01133821|10234972|P1|Overall Study|preferred other treatment|1
2973471|NCT01133821|10234971|P2|Overall Study|Withdrawal by Subject|3
2973472|NCT01133821|10234972|P1|Overall Study|Withdrawal by Subject|8
2973473|NCT01133821|10234971|P2|Overall Study|Lost to Follow-up|11
2973474|NCT01133821|10234972|P1|Overall Study|Lost to Follow-up|8
2973475|NCT01133756|10234983|P3|Overall Study|Progression of Disease|1
2973476|NCT01133756|10234984|P2|Overall Study|Progression of Disease|0
2973477|NCT01133756|10234985|P1|Overall Study|Progression of Disease|0
2973478|NCT01133756|10234983|P3|Overall Study|Withdrawal by Subject|0
2973479|NCT01133756|10234984|P2|Overall Study|Withdrawal by Subject|1
2973480|NCT01133756|10234985|P1|Overall Study|Withdrawal by Subject|0
2973481|NCT01133756|10234983|P3|Overall Study|Investigator Decision|0
2973482|NCT01133756|10234984|P2|Overall Study|Investigator Decision|0
2973483|NCT01133756|10234985|P1|Overall Study|Investigator Decision|1
2973484|NCT01133756|10234983|P3|Overall Study|Adverse Event|1
2973485|NCT01133756|10234984|P2|Overall Study|Adverse Event|2
2973486|NCT01133756|10234985|P1|Overall Study|Adverse Event|1
2973487|NCT01133704|10235001|P2|Overall Study|Study Closure|0
2973488|NCT01133704|10235002|P1|Overall Study|Study Closure|1
2973489|NCT01133704|10235001|P2|Overall Study|Patient refused to continue|0
2973490|NCT01133704|10235002|P1|Overall Study|Patient refused to continue|4
2973491|NCT01133704|10235001|P2|Overall Study|Death|26
2973492|NCT01133704|10235002|P1|Overall Study|Death|44
2973493|NCT01133678|10235012|P2|Overall Study|Death|1
2973494|NCT01133678|10235013|P1|Overall Study|Death|1
2973495|NCT01133665|10235019|P1|Overall Study|Physician Decision|2
2973496|NCT01133626|10235079|P3|Overall Study|Other|0
2973497|NCT01133626|10235080|P2|Overall Study|Other|2
2973498|NCT01133626|10235081|P1|Overall Study|Other|0
2973499|NCT01133626|10235079|P3|Overall Study|Withdrawal by Subject|2
2973500|NCT01133626|10235080|P2|Overall Study|Withdrawal by Subject|2
2973501|NCT01133626|10235081|P1|Overall Study|Withdrawal by Subject|1
2973502|NCT01133626|10235079|P3|Overall Study|Adverse Event|0
2973503|NCT01133626|10235080|P2|Overall Study|Adverse Event|1
2973504|NCT01133626|10235081|P1|Overall Study|Adverse Event|0
2973505|NCT01133522|10235099|P10|Overall Study|Physician Decision|0
2973506|NCT01133522|10235100|P9|Overall Study|Physician Decision|0
2973507|NCT01133522|10235101|P8|Overall Study|Physician Decision|0
2973508|NCT01133522|10235102|P7|Overall Study|Physician Decision|0
2973509|NCT01133522|10235103|P6|Overall Study|Physician Decision|0
2973510|NCT01133522|10235104|P5|Overall Study|Physician Decision|1
2973511|NCT01133522|10235105|P4|Overall Study|Physician Decision|0
2973512|NCT01133522|10235106|P3|Overall Study|Physician Decision|0
2973513|NCT01133522|10235107|P2|Overall Study|Physician Decision|0
2973514|NCT01133522|10235108|P1|Overall Study|Physician Decision|0
2973515|NCT01133522|10235099|P10|Overall Study|Withdrawal by Subject|0
2973516|NCT01133522|10235100|P9|Overall Study|Withdrawal by Subject|0
2973517|NCT01133522|10235101|P8|Overall Study|Withdrawal by Subject|0
2973518|NCT01133522|10235102|P7|Overall Study|Withdrawal by Subject|0
2973519|NCT01133522|10235103|P6|Overall Study|Withdrawal by Subject|0
2973520|NCT01133522|10235104|P5|Overall Study|Withdrawal by Subject|0
2973521|NCT01133522|10235105|P4|Overall Study|Withdrawal by Subject|1
2973522|NCT01133522|10235106|P3|Overall Study|Withdrawal by Subject|0
2973523|NCT01133522|10235107|P2|Overall Study|Withdrawal by Subject|1
2973524|NCT01133522|10235108|P1|Overall Study|Withdrawal by Subject|0
2973525|NCT01133418|10235176|P2|Overall Study|Lost to Follow-up|6
2973526|NCT01133418|10235177|P1|Overall Study|Lost to Follow-up|5
2973527|NCT01133405|10235199|P10|Period 2|Physician Decision|0
2973528|NCT01133405|10235200|P9|Period 2|Physician Decision|0
2973529|NCT01133405|10235201|P8|Period 2|Physician Decision|0
2973530|NCT01133405|10235202|P7|Period 2|Physician Decision|0
2973531|NCT01133405|10235203|P6|Period 2|Physician Decision|1
2973532|NCT01133405|10235204|P5|Period 2|Physician Decision|0
2973533|NCT01133405|10235205|P4|Period 2|Physician Decision|0
2973534|NCT01133405|10235206|P3|Period 2|Physician Decision|0
2973535|NCT01133405|10235207|P2|Period 2|Physician Decision|0
2973536|NCT01133405|10235208|P1|Period 2|Physician Decision|0
2973537|NCT01133405|10235199|P10|Period 2|Entry Criteria Not Met|0
2973538|NCT01133405|10235200|P9|Period 2|Entry Criteria Not Met|0
2973539|NCT01133405|10235201|P8|Period 2|Entry Criteria Not Met|0
2973540|NCT01133405|10235202|P7|Period 2|Entry Criteria Not Met|0
2973541|NCT01133405|10235203|P6|Period 2|Entry Criteria Not Met|0
2973542|NCT01133405|10235204|P5|Period 2|Entry Criteria Not Met|0
2973543|NCT01133405|10235205|P4|Period 2|Entry Criteria Not Met|0
2973544|NCT01133405|10235206|P3|Period 2|Entry Criteria Not Met|0
2973545|NCT01133405|10235207|P2|Period 2|Entry Criteria Not Met|1
2973546|NCT01133405|10235208|P1|Period 2|Entry Criteria Not Met|0
2973547|NCT01133405|10235199|P10|Period 2|Withdrawal by Subject|0
2973548|NCT01133405|10235200|P9|Period 2|Withdrawal by Subject|0
2973549|NCT01133405|10235201|P8|Period 2|Withdrawal by Subject|0
2973550|NCT01133405|10235202|P7|Period 2|Withdrawal by Subject|0
2973551|NCT01133405|10235203|P6|Period 2|Withdrawal by Subject|1
2973552|NCT01133405|10235204|P5|Period 2|Withdrawal by Subject|0
2973553|NCT01133405|10235205|P4|Period 2|Withdrawal by Subject|1
2973554|NCT01133405|10235206|P3|Period 2|Withdrawal by Subject|0
2973555|NCT01133405|10235207|P2|Period 2|Withdrawal by Subject|0
2973556|NCT01133405|10235208|P1|Period 2|Withdrawal by Subject|0
2973557|NCT01133405|10235199|P10|Period 2|Adverse Event|0
2973558|NCT01133405|10235200|P9|Period 2|Adverse Event|0
2973559|NCT01133405|10235201|P8|Period 2|Adverse Event|0
2973560|NCT01133405|10235202|P7|Period 2|Adverse Event|0
2973561|NCT01133405|10235203|P6|Period 2|Adverse Event|0
2973562|NCT01133405|10235204|P5|Period 2|Adverse Event|0
2973563|NCT01133405|10235205|P4|Period 2|Adverse Event|0
2973564|NCT01133405|10235206|P3|Period 2|Adverse Event|1
2973565|NCT01133405|10235207|P2|Period 2|Adverse Event|0
2973566|NCT01133405|10235208|P1|Period 2|Adverse Event|0
2973567|NCT01133405|10235199|P10|Period 1|Received drug only in period 3|0
2973568|NCT01133405|10235200|P9|Period 1|Received drug only in period 3|0
2973569|NCT01133405|10235201|P8|Period 1|Received drug only in period 3|0
2973570|NCT01133405|10235202|P7|Period 1|Received drug only in period 3|0
2973571|NCT01133405|10235203|P6|Period 1|Received drug only in period 3|0
2973572|NCT01133405|10235204|P5|Period 1|Received drug only in period 3|0
2973573|NCT01133405|10235205|P4|Period 1|Received drug only in period 3|0
2973574|NCT01133405|10235206|P3|Period 1|Received drug only in period 3|1
2973575|NCT01133405|10235207|P2|Period 1|Received drug only in period 3|1
2973576|NCT01133405|10235208|P1|Period 1|Received drug only in period 3|0
2973577|NCT01133405|10235199|P10|Period 1|Received drug only in period 2|0
2973578|NCT01133405|10235200|P9|Period 1|Received drug only in period 2|0
2973579|NCT01133405|10235201|P8|Period 1|Received drug only in period 2|0
2973580|NCT01133405|10235202|P7|Period 1|Received drug only in period 2|0
2973581|NCT01133405|10235203|P6|Period 1|Received drug only in period 2|1
2973582|NCT01133405|10235204|P5|Period 1|Received drug only in period 2|0
2973583|NCT01133405|10235205|P4|Period 1|Received drug only in period 2|2
2973584|NCT01133405|10235206|P3|Period 1|Received drug only in period 2|0
2973585|NCT01133405|10235207|P2|Period 1|Received drug only in period 2|1
2973586|NCT01133405|10235208|P1|Period 1|Received drug only in period 2|0
2973587|NCT01133405|10235199|P10|Period 1|Discontinued after randomization|0
2973588|NCT01133405|10235200|P9|Period 1|Discontinued after randomization|0
2973589|NCT01133405|10235201|P8|Period 1|Discontinued after randomization|0
2973590|NCT01133405|10235202|P7|Period 1|Discontinued after randomization|1
2973591|NCT01133405|10235203|P6|Period 1|Discontinued after randomization|0
2973592|NCT01133405|10235204|P5|Period 1|Discontinued after randomization|0
2973593|NCT01133405|10235205|P4|Period 1|Discontinued after randomization|0
2973594|NCT01133405|10235206|P3|Period 1|Discontinued after randomization|0
2973595|NCT01133405|10235207|P2|Period 1|Discontinued after randomization|0
2973596|NCT01133405|10235208|P1|Period 1|Discontinued after randomization|1
2973597|NCT01133405|10235199|P10|Period 1|Physician Decision|0
2973598|NCT01133405|10235200|P9|Period 1|Physician Decision|0
2973599|NCT01133405|10235201|P8|Period 1|Physician Decision|0
2973600|NCT01133405|10235202|P7|Period 1|Physician Decision|0
2973601|NCT01133405|10235203|P6|Period 1|Physician Decision|0
2973602|NCT01133405|10235204|P5|Period 1|Physician Decision|0
2973603|NCT01133405|10235205|P4|Period 1|Physician Decision|1
2973604|NCT01133405|10235206|P3|Period 1|Physician Decision|0
2973605|NCT01133405|10235207|P2|Period 1|Physician Decision|0
2973606|NCT01133405|10235208|P1|Period 1|Physician Decision|0
2973607|NCT01133405|10235199|P10|Period 1|Withdrawal by Subject|0
2973608|NCT01133405|10235200|P9|Period 1|Withdrawal by Subject|0
2973609|NCT01133405|10235201|P8|Period 1|Withdrawal by Subject|0
2973610|NCT01133405|10235202|P7|Period 1|Withdrawal by Subject|0
2973611|NCT01133405|10235203|P6|Period 1|Withdrawal by Subject|1
2973612|NCT01133405|10235204|P5|Period 1|Withdrawal by Subject|0
2973613|NCT01133405|10235205|P4|Period 1|Withdrawal by Subject|1
2973614|NCT01133405|10235206|P3|Period 1|Withdrawal by Subject|0
2973615|NCT01133405|10235207|P2|Period 1|Withdrawal by Subject|1
2973616|NCT01133405|10235208|P1|Period 1|Withdrawal by Subject|0
2973617|NCT01133392|10235259|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
2973618|NCT01133392|10235260|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
2973619|NCT01133392|10235259|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
2973620|NCT01133392|10235260|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
2973621|NCT01133379|10235277|P3|Overall Study|Lost to Follow-up|1
2973622|NCT01133379|10235278|P2|Overall Study|Lost to Follow-up|1
2973623|NCT01133379|10235279|P1|Overall Study|Lost to Follow-up|1
2973624|NCT01133379|10235277|P3|Overall Study|Withdrawal by Subject|1
2973625|NCT01133379|10235278|P2|Overall Study|Withdrawal by Subject|1
2973626|NCT01133379|10235279|P1|Overall Study|Withdrawal by Subject|0
2973627|NCT01133288|10235332|P1|Intervention Allocation|study terminated|2
2973628|NCT01133288|10235332|P1|Eligibility Assessment|met exclusion criteria|5
2973629|NCT01133275|10235337|P1|Overall Study|Cerebrovascular accident (CVA)|1
2973630|NCT01133275|10235337|P1|Overall Study|Withdrawal by Subject|1
2973631|NCT01133171|10235345|P3|Overall Study|Withdrawal by Subject|0
2973632|NCT01133171|10235346|P2|Overall Study|Withdrawal by Subject|2
2973633|NCT01133171|10235347|P1|Overall Study|Withdrawal by Subject|1
2973634|NCT01133067|10235363|P1|Overall Study|Lost to Follow-up|3
2973635|NCT01133067|10235363|P1|Overall Study|Death|136
2973636|NCT01132820|10235423|P1|Overall Study|Inadequate data|1
2973637|NCT01132820|10235423|P1|Overall Study|Never treated|1
2973638|NCT01132820|10235423|P1|Overall Study|Ineligible:Inadequate pathology|1
2973639|NCT01132820|10235423|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
2973640|NCT01132820|10235423|P1|Overall Study|Ineligible: wrong cell type|1
2973641|NCT01132755|10235432|P1|Overall Study|Withdrawal by Subject|4
2973642|NCT01132755|10235432|P1|Overall Study|Protocol Violation|15
2973643|NCT01132755|10235432|P1|Overall Study|Procedure not done due to medical reason|23
2973644|NCT01132664|10235461|P5|BM Cohort|Withdrawal by Subject|1
2973645|NCT01132664|10235462|P4|BM Cohort|Withdrawal by Subject|0
2973646|NCT01132664|10235463|P3|BM Cohort|Withdrawal by Subject|0
2973647|NCT01132664|10235464|P2|BM Cohort|Withdrawal by Subject|0
2973648|NCT01132664|10235465|P1|BM Cohort|Withdrawal by Subject|0
2973649|NCT01132664|10235461|P5|BM Cohort|Adverse Event|1
2973650|NCT01132664|10235462|P4|BM Cohort|Adverse Event|0
2973651|NCT01132664|10235463|P3|BM Cohort|Adverse Event|0
2973652|NCT01132664|10235464|P2|BM Cohort|Adverse Event|0
2973653|NCT01132664|10235465|P1|BM Cohort|Adverse Event|0
2973654|NCT01132664|10235461|P5|BM Cohort|Disease progression|4
2973655|NCT01132664|10235462|P4|BM Cohort|Disease progression|3
2973656|NCT01132664|10235463|P3|BM Cohort|Disease progression|0
2973657|NCT01132664|10235464|P2|BM Cohort|Disease progression|0
2973658|NCT01132664|10235465|P1|BM Cohort|Disease progression|0
2973659|NCT01132664|10235461|P5|Phase ll|Disease progression|0
2973660|NCT01132664|10235462|P4|Phase ll|Disease progression|0
2973661|NCT01132664|10235463|P3|Phase ll|Disease progression|35
2973662|NCT01132664|10235464|P2|Phase ll|Disease progression|0
2973663|NCT01132664|10235465|P1|Phase ll|Disease progression|0
2973664|NCT01132664|10235461|P5|Phase ll|Withdrawal by Subject|0
2973665|NCT01132664|10235462|P4|Phase ll|Withdrawal by Subject|0
2973666|NCT01132664|10235463|P3|Phase ll|Withdrawal by Subject|3
2973667|NCT01132664|10235464|P2|Phase ll|Withdrawal by Subject|0
2973668|NCT01132664|10235465|P1|Phase ll|Withdrawal by Subject|0
2973669|NCT01132664|10235461|P5|Phase ll|Adverse Event|0
2973670|NCT01132664|10235462|P4|Phase ll|Adverse Event|0
2973671|NCT01132664|10235463|P3|Phase ll|Adverse Event|10
2973672|NCT01132664|10235464|P2|Phase ll|Adverse Event|0
2973673|NCT01132664|10235465|P1|Phase ll|Adverse Event|0
2973674|NCT01132664|10235461|P5|Phase ll|Death|0
2973675|NCT01132664|10235462|P4|Phase ll|Death|0
2973676|NCT01132664|10235463|P3|Phase ll|Death|2
2973677|NCT01132664|10235464|P2|Phase ll|Death|0
2973678|NCT01132664|10235465|P1|Phase ll|Death|0
2973679|NCT01132664|10235461|P5|Phase lb|Disease Progression|0
2973680|NCT01132664|10235462|P4|Phase lb|Disease Progression|0
2973681|NCT01132664|10235463|P3|Phase lb|Disease Progression|0
2973682|NCT01132664|10235464|P2|Phase lb|Disease Progression|9
2973683|NCT01132664|10235465|P1|Phase lb|Disease Progression|4
2973684|NCT01132664|10235461|P5|Phase lb|Withdrawal by Subject|0
2973685|NCT01132664|10235462|P4|Phase lb|Withdrawal by Subject|0
2973686|NCT01132664|10235463|P3|Phase lb|Withdrawal by Subject|0
2973687|NCT01132664|10235464|P2|Phase lb|Withdrawal by Subject|2
2973688|NCT01132664|10235465|P1|Phase lb|Withdrawal by Subject|1
2973689|NCT01132664|10235461|P5|Phase lb|Adverse Event|0
2973690|NCT01132664|10235462|P4|Phase lb|Adverse Event|0
2973691|NCT01132664|10235463|P3|Phase lb|Adverse Event|0
2973692|NCT01132664|10235464|P2|Phase lb|Adverse Event|1
2973693|NCT01132664|10235465|P1|Phase lb|Adverse Event|0
2973694|NCT01132651|10235499|P2|Overall Study|Lost to Follow-up|1
2973695|NCT01132651|10235500|P1|Overall Study|Lost to Follow-up|1
2973696|NCT01132612|10235511|P3|Overall Study|Lack of Efficacy|73
2973697|NCT01132612|10235512|P2|Overall Study|Lack of Efficacy|22
2973698|NCT01132612|10235513|P1|Overall Study|Lack of Efficacy|23
2973699|NCT01132612|10235511|P3|Overall Study|Administrative problems|52
2973700|NCT01132612|10235512|P2|Overall Study|Administrative problems|1
2973701|NCT01132612|10235513|P1|Overall Study|Administrative problems|5
2973702|NCT01132612|10235511|P3|Overall Study|Withdrawal by Subject|19
2973703|NCT01132612|10235512|P2|Overall Study|Withdrawal by Subject|8
2973704|NCT01132612|10235513|P1|Overall Study|Withdrawal by Subject|5
2973705|NCT01132612|10235511|P3|Overall Study|Adverse Event|15
2973706|NCT01132612|10235512|P2|Overall Study|Adverse Event|2
2973707|NCT01132612|10235513|P1|Overall Study|Adverse Event|5
2973708|NCT01132612|10235511|P3|Overall Study|Lost to Follow-up|7
2973709|NCT01132612|10235512|P2|Overall Study|Lost to Follow-up|2
2973710|NCT01132612|10235513|P1|Overall Study|Lost to Follow-up|2
2973711|NCT01132612|10235511|P3|Overall Study|Protocol deviation|3
2973712|NCT01132612|10235512|P2|Overall Study|Protocol deviation|0
2973713|NCT01132612|10235513|P1|Overall Study|Protocol deviation|0
2973714|NCT01132612|10235511|P3|Overall Study|Death|1
2973715|NCT01132612|10235512|P2|Overall Study|Death|0
2973716|NCT01132612|10235513|P1|Overall Study|Death|0
2973717|NCT01132547|10235529|P2|Overall Study|Death|0
2973718|NCT01132547|10235530|P1|Overall Study|Death|1
2973719|NCT01132547|10235529|P2|Overall Study|Withdrawal by Subject|1
2973720|NCT01132547|10235530|P1|Overall Study|Withdrawal by Subject|3
2973721|NCT01132495|10235600|P4|Overall Study|Various reasons|12
2973722|NCT01132495|10235601|P3|Overall Study|Various reasons|20
2973723|NCT01132495|10235602|P2|Overall Study|Various reasons|38
2973724|NCT01132495|10235603|P1|Overall Study|Various reasons|40
2973725|NCT01132482|10235616|P2|Overall Study|Adverse Event|0
2973726|NCT01132482|10235617|P1|Overall Study|Adverse Event|1
2973727|NCT01132326|10235640|P1|Overall Study|Subject Unable to Come To Visits|1
2973728|NCT01132326|10235640|P1|Overall Study|Death|5
2973729|NCT01132326|10235640|P1|Overall Study|Caregiver Withdrew Consent|1
2973730|NCT01132326|10235640|P1|Overall Study|Pregnancy|1
2973731|NCT01132326|10235640|P1|Overall Study|Declining Health|1
2973732|NCT01132326|10235640|P1|Overall Study|Study Termination|80
2973733|NCT01132326|10235640|P1|Overall Study|Physician Decision|10
2973734|NCT01132326|10235640|P1|Overall Study|Withdrawal by Subject|40
2973735|NCT01132326|10235640|P1|Overall Study|Lost to Follow-up|16
2973736|NCT01132326|10235640|P1|Overall Study|Protocol Violation|1
2973737|NCT01132326|10235640|P1|Overall Study|Adverse Event|37
2973738|NCT01132326|10235640|P1|Overall Study|Lack of Efficacy|25
2973739|NCT01132313|10235656|P12|Overall Study|Other reason not defined above|0
2973740|NCT01132313|10235657|P11|Overall Study|Other reason not defined above|0
2973741|NCT01132313|10235658|P10|Overall Study|Other reason not defined above|0
2973742|NCT01132313|10235659|P9|Overall Study|Other reason not defined above|0
2973743|NCT01132313|10235660|P8|Overall Study|Other reason not defined above|1
2973744|NCT01132313|10235661|P7|Overall Study|Other reason not defined above|0
2973745|NCT01132313|10235662|P6|Overall Study|Other reason not defined above|0
2973746|NCT01132313|10235663|P5|Overall Study|Other reason not defined above|0
2973747|NCT01132313|10235664|P4|Overall Study|Other reason not defined above|0
2973748|NCT01132313|10235665|P3|Overall Study|Other reason not defined above|0
2973749|NCT01132313|10235666|P2|Overall Study|Other reason not defined above|0
2973750|NCT01132313|10235667|P1|Overall Study|Other reason not defined above|0
2973751|NCT01132313|10235656|P12|Overall Study|Lack of antiviral response|0
2973752|NCT01132313|10235657|P11|Overall Study|Lack of antiviral response|1
2973753|NCT01132313|10235658|P10|Overall Study|Lack of antiviral response|0
2973754|NCT01132313|10235659|P9|Overall Study|Lack of antiviral response|0
2973755|NCT01132313|10235660|P8|Overall Study|Lack of antiviral response|0
2973756|NCT01132313|10235661|P7|Overall Study|Lack of antiviral response|21
2973757|NCT01132313|10235662|P6|Overall Study|Lack of antiviral response|18
2973758|NCT01132313|10235663|P5|Overall Study|Lack of antiviral response|18
2973759|NCT01132313|10235664|P4|Overall Study|Lack of antiviral response|18
2973760|NCT01132313|10235665|P3|Overall Study|Lack of antiviral response|12
2973761|NCT01132313|10235666|P2|Overall Study|Lack of antiviral response|0
2973762|NCT01132313|10235667|P1|Overall Study|Lack of antiviral response|0
2973763|NCT01132313|10235656|P12|Overall Study|Withdrawal by Subject|0
2973764|NCT01132313|10235657|P11|Overall Study|Withdrawal by Subject|0
2973765|NCT01132313|10235658|P10|Overall Study|Withdrawal by Subject|2
2973766|NCT01132313|10235659|P9|Overall Study|Withdrawal by Subject|0
2973767|NCT01132313|10235660|P8|Overall Study|Withdrawal by Subject|0
2973768|NCT01132313|10235661|P7|Overall Study|Withdrawal by Subject|1
2973769|NCT01132313|10235662|P6|Overall Study|Withdrawal by Subject|0
2973770|NCT01132313|10235663|P5|Overall Study|Withdrawal by Subject|6
2973771|NCT01132313|10235664|P4|Overall Study|Withdrawal by Subject|3
2973772|NCT01132313|10235665|P3|Overall Study|Withdrawal by Subject|3
2973773|NCT01132313|10235666|P2|Overall Study|Withdrawal by Subject|0
2973774|NCT01132313|10235667|P1|Overall Study|Withdrawal by Subject|0
2973775|NCT01132313|10235656|P12|Overall Study|Lost to Follow-up|0
2973776|NCT01132313|10235657|P11|Overall Study|Lost to Follow-up|0
2973777|NCT01132313|10235658|P10|Overall Study|Lost to Follow-up|0
2973778|NCT01132313|10235659|P9|Overall Study|Lost to Follow-up|0
2973779|NCT01132313|10235660|P8|Overall Study|Lost to Follow-up|1
2973780|NCT01132313|10235661|P7|Overall Study|Lost to Follow-up|0
2973781|NCT01132313|10235662|P6|Overall Study|Lost to Follow-up|0
2973782|NCT01132313|10235663|P5|Overall Study|Lost to Follow-up|0
2973783|NCT01132313|10235664|P4|Overall Study|Lost to Follow-up|0
2973784|NCT01132313|10235665|P3|Overall Study|Lost to Follow-up|1
2973785|NCT01132313|10235666|P2|Overall Study|Lost to Follow-up|0
2973786|NCT01132313|10235667|P1|Overall Study|Lost to Follow-up|0
2973787|NCT01132313|10235656|P12|Overall Study|Protocol Violation|0
2973788|NCT01132313|10235657|P11|Overall Study|Protocol Violation|0
2973789|NCT01132313|10235658|P10|Overall Study|Protocol Violation|0
2973790|NCT01132313|10235659|P9|Overall Study|Protocol Violation|0
2973791|NCT01132313|10235660|P8|Overall Study|Protocol Violation|0
2973792|NCT01132313|10235661|P7|Overall Study|Protocol Violation|0
2973793|NCT01132313|10235662|P6|Overall Study|Protocol Violation|0
2973794|NCT01132313|10235663|P5|Overall Study|Protocol Violation|0
2973795|NCT01132313|10235664|P4|Overall Study|Protocol Violation|1
2973796|NCT01132313|10235665|P3|Overall Study|Protocol Violation|0
2973797|NCT01132313|10235666|P2|Overall Study|Protocol Violation|0
2973798|NCT01132313|10235667|P1|Overall Study|Protocol Violation|0
2973799|NCT01132313|10235656|P12|Overall Study|Adverse Event|0
2973800|NCT01132313|10235657|P11|Overall Study|Adverse Event|0
2973801|NCT01132313|10235658|P10|Overall Study|Adverse Event|2
2973802|NCT01132313|10235659|P9|Overall Study|Adverse Event|7
2973803|NCT01132313|10235660|P8|Overall Study|Adverse Event|3
2973804|NCT01132313|10235661|P7|Overall Study|Adverse Event|5
2973805|NCT01132313|10235662|P6|Overall Study|Adverse Event|6
2973806|NCT01132313|10235663|P5|Overall Study|Adverse Event|19
2973807|NCT01132313|10235664|P4|Overall Study|Adverse Event|10
2973808|NCT01132313|10235665|P3|Overall Study|Adverse Event|4
2973809|NCT01132313|10235666|P2|Overall Study|Adverse Event|0
2973810|NCT01132313|10235667|P1|Overall Study|Adverse Event|0
2973811|NCT01132313|10235656|P12|Overall Study|Not treated|0
2973812|NCT01132313|10235657|P11|Overall Study|Not treated|0
2973813|NCT01132313|10235658|P10|Overall Study|Not treated|0
2973814|NCT01132313|10235659|P9|Overall Study|Not treated|0
2973815|NCT01132313|10235660|P8|Overall Study|Not treated|0
2973816|NCT01132313|10235661|P7|Overall Study|Not treated|3
2973817|NCT01132313|10235662|P6|Overall Study|Not treated|1
2973818|NCT01132313|10235663|P5|Overall Study|Not treated|2
2973819|NCT01132313|10235664|P4|Overall Study|Not treated|0
2973820|NCT01132313|10235665|P3|Overall Study|Not treated|0
2973821|NCT01132313|10235666|P2|Overall Study|Not treated|0
2973822|NCT01132313|10235667|P1|Overall Study|Not treated|2
2973823|NCT01132313|10235656|P12|Overall Study|Lack of Efficacy|0
2973824|NCT01132313|10235657|P11|Overall Study|Lack of Efficacy|0
2973825|NCT01132313|10235658|P10|Overall Study|Lack of Efficacy|16
2973826|NCT01132313|10235659|P9|Overall Study|Lack of Efficacy|14
2973827|NCT01132313|10235660|P8|Overall Study|Lack of Efficacy|3
2973828|NCT01132313|10235661|P7|Overall Study|Lack of Efficacy|0
2973829|NCT01132313|10235662|P6|Overall Study|Lack of Efficacy|0
2973830|NCT01132313|10235663|P5|Overall Study|Lack of Efficacy|0
2973831|NCT01132313|10235664|P4|Overall Study|Lack of Efficacy|0
2973832|NCT01132313|10235665|P3|Overall Study|Lack of Efficacy|0
2973833|NCT01132313|10235666|P2|Overall Study|Lack of Efficacy|0
2973834|NCT01132313|10235667|P1|Overall Study|Lack of Efficacy|1
2973835|NCT01132118|10235747|P2|Second Intervention (8 Weeks)|Adverse Event|1
2973836|NCT01132118|10235748|P1|Second Intervention (8 Weeks)|Adverse Event|0
2973837|NCT01132118|10235747|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
2973838|NCT01132118|10235748|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2973839|NCT01132118|10235747|P2|First Intervention (8 Weeks)|Adverse Event|0
2973840|NCT01132118|10235748|P1|First Intervention (8 Weeks)|Adverse Event|1
2973841|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
2973842|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2973843|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2973844|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
2973845|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
2973846|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
2973847|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
2973848|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
2973849|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
2973850|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
2973851|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
2973852|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
2973853|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
2973854|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
2973855|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
2973856|NCT01131676|10235778|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
2973857|NCT01131676|10235779|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
2973858|NCT01131676|10235780|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
2973859|NCT01131676|10235778|P3|Discontinuation From Treatment|Adverse Event|273
2973860|NCT01131676|10235779|P2|Discontinuation From Treatment|Adverse Event|267
2973861|NCT01131676|10235780|P1|Discontinuation From Treatment|Adverse Event|303
2973862|NCT01131676|10235778|P3|Discontinuation From Treatment|Other than those specified|125
2973863|NCT01131676|10235779|P2|Discontinuation From Treatment|Other than those specified|142
2973864|NCT01131676|10235780|P1|Discontinuation From Treatment|Other than those specified|162
2973865|NCT01131676|10235778|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
2973866|NCT01131676|10235779|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
2973867|NCT01131676|10235780|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
2973868|NCT01131676|10235778|P3|Discontinuation From Treatment|Lost to Follow-up|6
2973869|NCT01131676|10235779|P2|Discontinuation From Treatment|Lost to Follow-up|9
2973870|NCT01131676|10235780|P1|Discontinuation From Treatment|Lost to Follow-up|15
2973871|NCT01131676|10235778|P3|Discontinuation From Treatment|Non compliant with protocol|12
2973872|NCT01131676|10235779|P2|Discontinuation From Treatment|Non compliant with protocol|15
2973873|NCT01131676|10235780|P1|Discontinuation From Treatment|Non compliant with protocol|15
2973874|NCT01131676|10235778|P3|Discontinuation From Treatment|Lack of Efficacy|0
2973875|NCT01131676|10235779|P2|Discontinuation From Treatment|Lack of Efficacy|1
2973876|NCT01131676|10235780|P1|Discontinuation From Treatment|Lack of Efficacy|11
2973877|NCT01131676|10235778|P3|Discontinuation From Treatment|Not treated|2
2973878|NCT01131676|10235779|P2|Discontinuation From Treatment|Not treated|2
2973879|NCT01131676|10235780|P1|Discontinuation From Treatment|Not treated|4
2973880|NCT01131676|10235778|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
2973881|NCT01131676|10235779|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
2973882|NCT01131676|10235780|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
2973883|NCT01131585|10235815|P2|Overall Study|Study termination|32
2973884|NCT01131585|10235816|P1|Overall Study|Study termination|78
2973885|NCT01131585|10235815|P2|Overall Study|Administrative problems|1
2973886|NCT01131585|10235816|P1|Overall Study|Administrative problems|1
2973887|NCT01131585|10235815|P2|Overall Study|Lost to Follow-up|1
2973888|NCT01131585|10235816|P1|Overall Study|Lost to Follow-up|0
2973889|NCT01131585|10235815|P2|Overall Study|Withdrawal by Subject|3
2973890|NCT01131585|10235816|P1|Overall Study|Withdrawal by Subject|3
2973891|NCT01131585|10235815|P2|Overall Study|Protocol Violation|1
2973892|NCT01131585|10235816|P1|Overall Study|Protocol Violation|2
2973893|NCT01131585|10235815|P2|Overall Study|Unsatisfactory therapeutic effect|3
2973894|NCT01131585|10235816|P1|Overall Study|Unsatisfactory therapeutic effect|0
2973895|NCT01131585|10235815|P2|Overall Study|Abnormal laboratory value|0
2973896|NCT01131585|10235816|P1|Overall Study|Abnormal laboratory value|1
2973897|NCT01131585|10235815|P2|Overall Study|Adverse Event|2
2973898|NCT01131585|10235816|P1|Overall Study|Adverse Event|0
2973899|NCT01131520|10235824|P2|Overall Study|Subject changed history after enrollment|1
2973900|NCT01131520|10235825|P1|Overall Study|Subject changed history after enrollment|0
2973901|NCT01131520|10235824|P2|Overall Study|Counselor not available|3
2973902|NCT01131520|10235825|P1|Overall Study|Counselor not available|0
2973903|NCT01131520|10235824|P2|Overall Study|Computer problem|0
2973904|NCT01131520|10235825|P1|Overall Study|Computer problem|1
2973905|NCT01131507|10235847|P1|Overall Study|Withdrawal by Subject|1
2973906|NCT01131507|10235847|P1|Overall Study|Lost to Follow-up|1
2973907|NCT01131507|10235847|P1|Overall Study|Adverse Event|1
2973908|NCT01131494|10235852|P1|Overall Study|Withdrawal by Subject|2
2973909|NCT01131455|10235862|P3|Overall Study|Death of PI|0
2973910|NCT01131455|10235863|P2|Overall Study|Death of PI|4
2973911|NCT01131455|10235864|P1|Overall Study|Death of PI|6
2973912|NCT01131312|10235875|P3|Overall Study|Lost to Follow-up|351
2973913|NCT01131312|10235876|P2|Overall Study|Lost to Follow-up|229
2973914|NCT01131312|10235877|P1|Overall Study|Lost to Follow-up|425
2973915|NCT01131299|10235888|P2|Overall Study|Withdrawal by Subject|7
2973916|NCT01131299|10235889|P1|Overall Study|Withdrawal by Subject|4
2973917|NCT01131260|10235902|P2|Overall Study|Ineligible|2
2973918|NCT01131260|10235903|P1|Overall Study|Ineligible|0
2973919|NCT01131260|10235902|P2|Overall Study|Staff error|1
2973920|NCT01131260|10235903|P1|Overall Study|Staff error|2
2973921|NCT01131260|10235902|P2|Overall Study|Technical problems|6
2973922|NCT01131260|10235903|P1|Overall Study|Technical problems|7
2973923|NCT01131260|10235902|P2|Overall Study|Physician Decision|24
2973924|NCT01131260|10235903|P1|Overall Study|Physician Decision|22
2973925|NCT01131260|10235902|P2|Overall Study|Declined to continue participation|13
2973926|NCT01131260|10235903|P1|Overall Study|Declined to continue participation|8
2973927|NCT01131260|10235902|P2|Overall Study|Randomization error|1
2973928|NCT01131260|10235903|P1|Overall Study|Randomization error|5
2973929|NCT01131182|10235951|P2|Overall Study|Other Reason|0
2973930|NCT01131182|10235952|P1|Overall Study|Other Reason|1
2973931|NCT01131182|10235951|P2|Overall Study|Lost to Follow-up|15
2973932|NCT01131182|10235952|P1|Overall Study|Lost to Follow-up|14
2973933|NCT01131182|10235951|P2|Overall Study|Withdrawal by Subject|1
2973934|NCT01131182|10235952|P1|Overall Study|Withdrawal by Subject|1
2973935|NCT01131130|10235960|P1|Period 3- Crossover|+ Slit lamp finding|1
2973936|NCT01131130|10235960|P1|Period 1 - Baseline|Pregnancy|1
2973937|NCT01131104|10235973|P1|Overall Study|No Information on Index Date of Onset|1
2973938|NCT01131104|10235973|P1|Overall Study|Information Not Available|5
2973939|NCT01131104|10235973|P1|Overall Study|Physician Decision|4
2973940|NCT01131104|10235973|P1|Overall Study|Withdrawal by Subject|3
2973941|NCT01131078|10235980|P3|Overall Study|Other|0
2973942|NCT01131078|10235981|P2|Overall Study|Other|1
2973943|NCT01131078|10235982|P1|Overall Study|Other|0
2973944|NCT01131078|10235980|P3|Overall Study|Death|2
2973945|NCT01131078|10235981|P2|Overall Study|Death|0
2973946|NCT01131078|10235982|P1|Overall Study|Death|4
2973947|NCT01131078|10235980|P3|Overall Study|Physician Decision|8
2973948|NCT01131078|10235981|P2|Overall Study|Physician Decision|6
2973949|NCT01131078|10235982|P1|Overall Study|Physician Decision|10
2973950|NCT01131078|10235980|P3|Overall Study|Non-compliance|0
2973951|NCT01131078|10235981|P2|Overall Study|Non-compliance|0
2973952|NCT01131078|10235982|P1|Overall Study|Non-compliance|3
2973953|NCT01131078|10235980|P3|Overall Study|Withdrawal by Subject|3
2973954|NCT01131078|10235981|P2|Overall Study|Withdrawal by Subject|4
2973955|NCT01131078|10235982|P1|Overall Study|Withdrawal by Subject|2
2973956|NCT01131078|10235980|P3|Overall Study|Lost to Follow-up|1
2973957|NCT01131078|10235981|P2|Overall Study|Lost to Follow-up|1
2973958|NCT01131078|10235982|P1|Overall Study|Lost to Follow-up|1
2973959|NCT01131078|10235980|P3|Overall Study|Protocol Violation|0
2973960|NCT01131078|10235981|P2|Overall Study|Protocol Violation|0
2973961|NCT01131078|10235982|P1|Overall Study|Protocol Violation|1
2973962|NCT01131078|10235980|P3|Overall Study|Progressive Disease|71
2973963|NCT01131078|10235981|P2|Overall Study|Progressive Disease|77
2973964|NCT01131078|10235982|P1|Overall Study|Progressive Disease|58
2973965|NCT01131078|10235980|P3|Overall Study|Adverse Event|17
2973966|NCT01131078|10235981|P2|Overall Study|Adverse Event|12
2973967|NCT01131078|10235982|P1|Overall Study|Adverse Event|22
2973968|NCT01130974|10236069|P2|Overall Study|Ineligibility criteria|2
2973969|NCT01130974|10236070|P1|Overall Study|Ineligibility criteria|5
2973970|NCT01130974|10236069|P2|Overall Study|Withdrawal by Subject|1
2973971|NCT01130974|10236070|P1|Overall Study|Withdrawal by Subject|0
2973972|NCT01130974|10236069|P2|Overall Study|Protocol Violation|10
2973973|NCT01130974|10236070|P1|Overall Study|Protocol Violation|10
2973974|NCT01130883|10236096|P1|Overall Study|Adverse Event|3
2973975|NCT01130883|10236096|P1|Overall Study|Reason Unknown|1
2973976|NCT01130883|10236096|P1|Overall Study|Patient Noncompliance|6
2973977|NCT01130831|10236153|P1|Overall Study|Information was missing|3
2973978|NCT01130831|10236153|P1|Overall Study|Death|4
2973979|NCT01130831|10236153|P1|Overall Study|Withdrawal by Subject|7
2973980|NCT01130597|10236192|P1|Overall Study|Protocol Violation|1
2973981|NCT01130597|10236192|P1|Overall Study|Death|1
2973982|NCT01130597|10236192|P1|Overall Study|Adverse Event|4
2973983|NCT01130597|10236192|P1|Overall Study|Protocol-specified (High K+)|1
2973984|NCT01130532|10236217|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
2973985|NCT01130532|10236218|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2973986|NCT01130532|10236219|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2973987|NCT01130532|10236220|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2973988|NCT01130532|10236217|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
2973989|NCT01130532|10236218|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
2973990|NCT01130532|10236219|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
2973991|NCT01130532|10236220|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
2973992|NCT01130532|10236217|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
2973993|NCT01130532|10236218|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2973994|NCT01130532|10236219|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2973995|NCT01130532|10236220|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2973996|NCT01130532|10236217|P4|Period IV (Weeks 13-16)|Adverse Event|1
2973997|NCT01130532|10236218|P3|Period IV (Weeks 13-16)|Adverse Event|0
2973998|NCT01130532|10236219|P2|Period IV (Weeks 13-16)|Adverse Event|0
2973999|NCT01130532|10236220|P1|Period IV (Weeks 13-16)|Adverse Event|0
2974000|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
2974001|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
2974002|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
2974003|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
2974004|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Sponsor Decision|0
2974005|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Sponsor Decision|2
2974006|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Sponsor Decision|4
2974007|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Sponsor Decision|3
2974008|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Protocol Violation|0
2974009|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Protocol Violation|1
2974010|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Protocol Violation|0
2974011|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Protocol Violation|0
2974012|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
2974013|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
2974014|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
2974015|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
2974016|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
2974017|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
2974018|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
2974019|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
2974020|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
2974021|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2974022|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
2974023|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2974024|NCT01130532|10236217|P4|Period III (Weeks 0-12)|Adverse Event|0
2974025|NCT01130532|10236218|P3|Period III (Weeks 0-12)|Adverse Event|2
2974026|NCT01130532|10236219|P2|Period III (Weeks 0-12)|Adverse Event|3
2974027|NCT01130532|10236220|P1|Period III (Weeks 0-12)|Adverse Event|3
2974028|NCT01130493|10236265|P3|Part 2: OLE|Withdrawal by Subject|4
2974029|NCT01130493|10236266|P2|Part 2: OLE|Withdrawal by Subject|1
2974030|NCT01130493|10236267|P1|Part 2: OLE|Withdrawal by Subject|0
2974031|NCT01130493|10236265|P3|Part 2: OLE|Adverse Event|1
2974032|NCT01130493|10236266|P2|Part 2: OLE|Adverse Event|2
2974033|NCT01130493|10236267|P1|Part 2: OLE|Adverse Event|0
2974034|NCT01130493|10236265|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
2974035|NCT01130493|10236266|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2974036|NCT01130493|10236267|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2974037|NCT01130493|10236265|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
2974038|NCT01130493|10236266|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2974039|NCT01130493|10236267|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2974040|NCT01130493|10236265|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
2974041|NCT01130493|10236266|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2974042|NCT01130493|10236267|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2974043|NCT01130493|10236265|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
2974044|NCT01130493|10236266|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2974045|NCT01130493|10236267|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2974046|NCT01130493|10236265|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2974047|NCT01130493|10236266|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
2974048|NCT01130493|10236267|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2974049|NCT01130493|10236265|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2974050|NCT01130493|10236266|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
2974051|NCT01130493|10236267|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2974052|NCT01130493|10236265|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2974053|NCT01130493|10236266|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
2974054|NCT01130493|10236267|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2974055|NCT01130493|10236265|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2974056|NCT01130493|10236266|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2974057|NCT01130493|10236267|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
2974058|NCT01130493|10236265|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2974059|NCT01130493|10236266|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2974060|NCT01130493|10236267|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
2974061|NCT01130493|10236265|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2974062|NCT01130493|10236266|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2974063|NCT01130493|10236267|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
2974064|NCT01130493|10236265|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
2974065|NCT01130493|10236266|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
2974066|NCT01130493|10236267|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
2974067|NCT01130493|10236265|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
2974068|NCT01130493|10236266|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
2974069|NCT01130493|10236267|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
2974070|NCT01130337|10236284|P1|Overall Study|Surgical resection (R2)|1
2974071|NCT01130337|10236284|P1|Overall Study|Toxicity, AE/intercurrent disease|7
2974072|NCT01130337|10236284|P1|Overall Study|Disease progression|1
2974073|NCT01130337|10236284|P1|Overall Study|Death|1
2974074|NCT01130337|10236284|P1|Overall Study|Principal investigator decision|1
2974075|NCT01130337|10236284|P1|Overall Study|Withdrawal by Subject|3
2974076|NCT01130272|10236296|P5|Overall Study|Study arm discontinued|0
2974077|NCT01130272|10236297|P4|Overall Study|Study arm discontinued|0
2974078|NCT01130272|10236298|P3|Overall Study|Study arm discontinued|0
2974079|NCT01130272|10236299|P2|Overall Study|Study arm discontinued|0
2974080|NCT01130272|10236300|P1|Overall Study|Study arm discontinued|38
2974081|NCT01130272|10236296|P5|Overall Study|Sponsor decision|16
2974082|NCT01130272|10236297|P4|Overall Study|Sponsor decision|13
2974083|NCT01130272|10236298|P3|Overall Study|Sponsor decision|16
2974084|NCT01130272|10236299|P2|Overall Study|Sponsor decision|15
2974085|NCT01130272|10236300|P1|Overall Study|Sponsor decision|6
2974086|NCT01130272|10236296|P5|Overall Study|Physician Decision|2
2974087|NCT01130272|10236297|P4|Overall Study|Physician Decision|1
2974088|NCT01130272|10236298|P3|Overall Study|Physician Decision|0
2974089|NCT01130272|10236299|P2|Overall Study|Physician Decision|1
2974090|NCT01130272|10236300|P1|Overall Study|Physician Decision|1
2974091|NCT01130272|10236296|P5|Overall Study|Withdrawal by Subject|8
2974092|NCT01130272|10236297|P4|Overall Study|Withdrawal by Subject|9
2974093|NCT01130272|10236298|P3|Overall Study|Withdrawal by Subject|10
2974094|NCT01130272|10236299|P2|Overall Study|Withdrawal by Subject|11
2974095|NCT01130272|10236300|P1|Overall Study|Withdrawal by Subject|4
2974096|NCT01130272|10236296|P5|Overall Study|Lost to Follow-up|6
2974097|NCT01130272|10236297|P4|Overall Study|Lost to Follow-up|7
2974098|NCT01130272|10236298|P3|Overall Study|Lost to Follow-up|4
2974099|NCT01130272|10236299|P2|Overall Study|Lost to Follow-up|3
2974100|NCT01130272|10236300|P1|Overall Study|Lost to Follow-up|4
2974101|NCT01130272|10236296|P5|Overall Study|Protocol Violation|5
2974102|NCT01130272|10236297|P4|Overall Study|Protocol Violation|5
2974103|NCT01130272|10236298|P3|Overall Study|Protocol Violation|3
2974104|NCT01130272|10236299|P2|Overall Study|Protocol Violation|0
2974105|NCT01130272|10236300|P1|Overall Study|Protocol Violation|0
2974106|NCT01130272|10236296|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2974107|NCT01130272|10236297|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
2974108|NCT01130272|10236298|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2974109|NCT01130272|10236299|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2974110|NCT01130272|10236300|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2974111|NCT01130272|10236296|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
2974112|NCT01130272|10236297|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2974113|NCT01130272|10236298|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2974114|NCT01130272|10236299|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2974115|NCT01130272|10236300|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2974116|NCT01130272|10236296|P5|Overall Study|Rescue medications due to diarrhea|6
2974117|NCT01130272|10236297|P4|Overall Study|Rescue medications due to diarrhea|8
2974118|NCT01130272|10236298|P3|Overall Study|Rescue medications due to diarrhea|8
2974119|NCT01130272|10236299|P2|Overall Study|Rescue medications due to diarrhea|5
2974120|NCT01130272|10236300|P1|Overall Study|Rescue medications due to diarrhea|3
2974121|NCT01130272|10236296|P5|Overall Study|IVRS-confirmed constipation|0
2974122|NCT01130272|10236297|P4|Overall Study|IVRS-confirmed constipation|2
2974123|NCT01130272|10236298|P3|Overall Study|IVRS-confirmed constipation|1
2974124|NCT01130272|10236299|P2|Overall Study|IVRS-confirmed constipation|1
2974125|NCT01130272|10236300|P1|Overall Study|IVRS-confirmed constipation|0
2974126|NCT01130272|10236296|P5|Overall Study|Adverse Event|7
2974127|NCT01130272|10236297|P4|Overall Study|Adverse Event|22
2974128|NCT01130272|10236298|P3|Overall Study|Adverse Event|6
2974129|NCT01130272|10236299|P2|Overall Study|Adverse Event|5
2974130|NCT01130272|10236300|P1|Overall Study|Adverse Event|2
2974131|NCT01130168|10236337|P6|Period 1|Adverse Event|0
2974132|NCT01130168|10236338|P5|Period 1|Adverse Event|0
2974133|NCT01130168|10236339|P4|Period 1|Adverse Event|1
2974134|NCT01130168|10236340|P3|Period 1|Adverse Event|0
2974135|NCT01130168|10236341|P2|Period 1|Adverse Event|0
2974136|NCT01130168|10236342|P1|Period 1|Adverse Event|0
2974137|NCT01130168|10236337|P6|Period 1|Discontinued For Other Reason|0
2974138|NCT01130168|10236338|P5|Period 1|Discontinued For Other Reason|0
2974139|NCT01130168|10236339|P4|Period 1|Discontinued For Other Reason|1
2974140|NCT01130168|10236340|P3|Period 1|Discontinued For Other Reason|1
2974141|NCT01130168|10236341|P2|Period 1|Discontinued For Other Reason|0
2974142|NCT01130168|10236342|P1|Period 1|Discontinued For Other Reason|0
2974143|NCT01130168|10236337|P6|Period 1|Withdrawal by Subject|0
2974144|NCT01130168|10236338|P5|Period 1|Withdrawal by Subject|0
2974145|NCT01130168|10236339|P4|Period 1|Withdrawal by Subject|1
2974146|NCT01130168|10236340|P3|Period 1|Withdrawal by Subject|0
2974147|NCT01130168|10236341|P2|Period 1|Withdrawal by Subject|1
2974148|NCT01130168|10236342|P1|Period 1|Withdrawal by Subject|0
2974149|NCT01130103|10236379|P2|Maintenance Treatment|Withdrawal by Subject|0
2974150|NCT01130103|10236380|P1|Maintenance Treatment|Withdrawal by Subject|1
2974151|NCT01130103|10236379|P2|Maintenance Treatment|Lost to Follow-up|1
2974152|NCT01130103|10236380|P1|Maintenance Treatment|Lost to Follow-up|1
2974153|NCT01130103|10236379|P2|Maintenance Treatment|Lack of Efficacy|1
2974154|NCT01130103|10236380|P1|Maintenance Treatment|Lack of Efficacy|0
2974155|NCT01130103|10236379|P2|Randomized Treatment|Withdrawal by Subject|2
2974156|NCT01130103|10236380|P1|Randomized Treatment|Withdrawal by Subject|1
2974157|NCT01130103|10236379|P2|Randomized Treatment|Protocol Violation|2
2974158|NCT01130103|10236380|P1|Randomized Treatment|Protocol Violation|3
2974159|NCT01130103|10236379|P2|Randomized Treatment|Lost to Follow-up|0
2974160|NCT01130103|10236380|P1|Randomized Treatment|Lost to Follow-up|1
2974161|NCT01130103|10236379|P2|Randomized Treatment|Adverse Event|1
2974162|NCT01130103|10236380|P1|Randomized Treatment|Adverse Event|1
2974163|NCT01130051|10236394|P2|Washout Period of 14 Days|Protocol Violation|1
2974164|NCT01130051|10236395|P1|Washout Period of 14 Days|Protocol Violation|1
2974165|NCT01130051|10236394|P2|Washout Period of 14 Days|Withdrawal by Subject|1
2974166|NCT01130051|10236395|P1|Washout Period of 14 Days|Withdrawal by Subject|0
2974167|NCT01129960|10236409|P4|Overall Study|Pregnancy|0
2974168|NCT01129960|10236410|P3|Overall Study|Pregnancy|0
2974169|NCT01129960|10236411|P2|Overall Study|Pregnancy|0
2974170|NCT01129960|10236412|P1|Overall Study|Pregnancy|1
2974171|NCT01129960|10236409|P4|Overall Study|Physician Decision|0
2974172|NCT01129960|10236410|P3|Overall Study|Physician Decision|0
2974173|NCT01129960|10236411|P2|Overall Study|Physician Decision|0
2974174|NCT01129960|10236412|P1|Overall Study|Physician Decision|1
2974175|NCT01129960|10236409|P4|Overall Study|Discontinuation of the study by Sponsor|0
2974176|NCT01129960|10236410|P3|Overall Study|Discontinuation of the study by Sponsor|0
2974177|NCT01129960|10236411|P2|Overall Study|Discontinuation of the study by Sponsor|1
2974178|NCT01129960|10236412|P1|Overall Study|Discontinuation of the study by Sponsor|0
2974179|NCT01129960|10236409|P4|Overall Study|Lost to Follow-up|3
2974180|NCT01129960|10236410|P3|Overall Study|Lost to Follow-up|3
2974181|NCT01129960|10236411|P2|Overall Study|Lost to Follow-up|2
2974182|NCT01129960|10236412|P1|Overall Study|Lost to Follow-up|0
2974183|NCT01129960|10236409|P4|Overall Study|Protocol Violation|0
2974184|NCT01129960|10236410|P3|Overall Study|Protocol Violation|3
2974185|NCT01129960|10236411|P2|Overall Study|Protocol Violation|2
2974186|NCT01129960|10236412|P1|Overall Study|Protocol Violation|1
2974187|NCT01129960|10236409|P4|Overall Study|Adverse Event|7
2974188|NCT01129960|10236410|P3|Overall Study|Adverse Event|16
2974189|NCT01129960|10236411|P2|Overall Study|Adverse Event|16
2974190|NCT01129960|10236412|P1|Overall Study|Adverse Event|23
2974191|NCT01129960|10236409|P4|Overall Study|Lack of Efficacy|1
2974192|NCT01129960|10236410|P3|Overall Study|Lack of Efficacy|1
2974193|NCT01129960|10236411|P2|Overall Study|Lack of Efficacy|1
2974194|NCT01129960|10236412|P1|Overall Study|Lack of Efficacy|1
2974195|NCT01129960|10236409|P4|Overall Study|Withdrawal by Subject|2
2974196|NCT01129960|10236410|P3|Overall Study|Withdrawal by Subject|3
2974197|NCT01129960|10236411|P2|Overall Study|Withdrawal by Subject|0
2974198|NCT01129960|10236412|P1|Overall Study|Withdrawal by Subject|3
2974199|NCT01129921|10236424|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
2974200|NCT01129921|10236425|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
2974201|NCT01129921|10236424|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
2974202|NCT01129921|10236425|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
2974203|NCT01129921|10236424|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
2974204|NCT01129921|10236425|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
2974205|NCT01129921|10236424|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
2974206|NCT01129921|10236425|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
2974207|NCT01129882|10236435|P1|Overall Study|Withdrawal by Subject|160
2974208|NCT01129882|10236435|P1|Overall Study|Trial Termination by Sponsor|6
2974209|NCT01129882|10236435|P1|Overall Study|Withdrawal Criteria Met|19
2974210|NCT01129882|10236435|P1|Overall Study|Protocol Deviation|3
2974211|NCT01129882|10236435|P1|Overall Study|Physician Decision|27
2974212|NCT01129882|10236435|P1|Overall Study|Lost to Follow-up|13
2974213|NCT01129882|10236435|P1|Overall Study|Lack of Efficacy|5
2974214|NCT01129882|10236435|P1|Overall Study|Death|6
2974215|NCT01129882|10236435|P1|Overall Study|Adverse Event|39
2974216|NCT01129622|10236454|P1|Overall Study|Withdrawal by Subject|2
2974217|NCT01129583|10236465|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
2974218|NCT01129583|10236466|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
2974219|NCT01129583|10236465|P2|Overall Study|Lost to Follow-up|1
2974220|NCT01129583|10236466|P1|Overall Study|Lost to Follow-up|1
2974221|NCT01129583|10236465|P2|Overall Study|Death|0
2974222|NCT01129583|10236466|P1|Overall Study|Death|1
2974223|NCT01129557|10236479|P3|Overall Study|Novartis terminated study early|2
2974224|NCT01129557|10236480|P2|Overall Study|Novartis terminated study early|3
2974225|NCT01129557|10236481|P1|Overall Study|Novartis terminated study early|3
2974226|NCT01129557|10236479|P3|Overall Study|Adverse Event|2
2974227|NCT01129557|10236480|P2|Overall Study|Adverse Event|2
2974228|NCT01129557|10236481|P1|Overall Study|Adverse Event|1
2974229|NCT01129336|10236594|P2|Overall Study|Death|4
2974230|NCT01129336|10236595|P1|Overall Study|Death|0
2974231|NCT01129336|10236594|P2|Overall Study|Missing Study Completion Status|3
2974232|NCT01129336|10236595|P1|Overall Study|Missing Study Completion Status|2
2974233|NCT01129336|10236594|P2|Overall Study|Adverse Event|1
2974234|NCT01129336|10236595|P1|Overall Study|Adverse Event|0
2974235|NCT01129336|10236594|P2|Overall Study|Withdrawal by Subject|4
2974236|NCT01129336|10236595|P1|Overall Study|Withdrawal by Subject|7
2974237|NCT01129336|10236594|P2|Overall Study|Lost to Follow-up|0
2974238|NCT01129336|10236595|P1|Overall Study|Lost to Follow-up|1
2974239|NCT01129336|10236594|P2|Overall Study|Disease Progression|4
2974240|NCT01129336|10236595|P1|Overall Study|Disease Progression|1
2974241|NCT01129336|10236594|P2|Overall Study|Protocol Violation|0
2974242|NCT01129336|10236595|P1|Overall Study|Protocol Violation|1
2974243|NCT01129284|10236610|P3|Overall Study|Adverse Event|1
2974244|NCT01129284|10236611|P2|Overall Study|Adverse Event|0
2974245|NCT01129284|10236612|P1|Overall Study|Adverse Event|2
2974246|NCT01129128|10236660|P3|Overall Study|Physician Decision|0
2974247|NCT01129128|10236661|P2|Overall Study|Physician Decision|0
2974248|NCT01129128|10236662|P1|Overall Study|Physician Decision|1
2974249|NCT01129128|10236660|P3|Overall Study|Withdrawal by Subject|3
2974250|NCT01129128|10236661|P2|Overall Study|Withdrawal by Subject|1
2974251|NCT01129128|10236662|P1|Overall Study|Withdrawal by Subject|0
2974252|NCT01129128|10236660|P3|Overall Study|Protocol Violation|0
2974253|NCT01129128|10236661|P2|Overall Study|Protocol Violation|1
2974254|NCT01129128|10236662|P1|Overall Study|Protocol Violation|0
2974255|NCT01129128|10236660|P3|Overall Study|Lost to Follow-up|1
2974256|NCT01129128|10236661|P2|Overall Study|Lost to Follow-up|2
2974257|NCT01129128|10236662|P1|Overall Study|Lost to Follow-up|2
2974258|NCT01129115|10236686|P4|Overall Study|Protocol Violation|2
2974259|NCT01129115|10236687|P3|Overall Study|Protocol Violation|2
2974260|NCT01129115|10236688|P2|Overall Study|Protocol Violation|2
2974261|NCT01129115|10236689|P1|Overall Study|Protocol Violation|0
2974262|NCT01129115|10236686|P4|Overall Study|Withdrawal by Subject|4
2974263|NCT01129115|10236687|P3|Overall Study|Withdrawal by Subject|1
2974264|NCT01129115|10236688|P2|Overall Study|Withdrawal by Subject|3
2974265|NCT01129115|10236689|P1|Overall Study|Withdrawal by Subject|1
2974266|NCT01129115|10236686|P4|Overall Study|Adverse Event|3
2974267|NCT01129115|10236687|P3|Overall Study|Adverse Event|3
2974268|NCT01129115|10236688|P2|Overall Study|Adverse Event|2
2974269|NCT01129115|10236689|P1|Overall Study|Adverse Event|1
2974270|NCT01129102|10236726|P3|Overall Study|Lost to Follow-up|0
2974271|NCT01129102|10236727|P2|Overall Study|Lost to Follow-up|0
2974272|NCT01129102|10236728|P1|Overall Study|Lost to Follow-up|2
2974273|NCT01129102|10236726|P3|Overall Study|Adverse Event|1
2974274|NCT01129102|10236727|P2|Overall Study|Adverse Event|2
2974275|NCT01129102|10236728|P1|Overall Study|Adverse Event|2
2974276|NCT01129102|10236726|P3|Overall Study|Pregnancy|1
2974277|NCT01129102|10236727|P2|Overall Study|Pregnancy|0
2974278|NCT01129102|10236728|P1|Overall Study|Pregnancy|0
2974279|NCT01129102|10236726|P3|Overall Study|Protocol Violation|1
2974280|NCT01129102|10236727|P2|Overall Study|Protocol Violation|1
2974281|NCT01129102|10236728|P1|Overall Study|Protocol Violation|0
2974282|NCT01129102|10236726|P3|Overall Study|Withdrawal by Subject|3
2974283|NCT01129102|10236727|P2|Overall Study|Withdrawal by Subject|0
2974284|NCT01129102|10236728|P1|Overall Study|Withdrawal by Subject|2
2974285|NCT01129102|10236726|P3|Overall Study|No study drug treatment|1
2974286|NCT01129102|10236727|P2|Overall Study|No study drug treatment|3
2974287|NCT01129102|10236728|P1|Overall Study|No study drug treatment|2
2974288|NCT01129011|10236739|P2|Overall Study|misc|4
2974289|NCT01129011|10236740|P1|Overall Study|misc|7
2974290|NCT01129011|10236739|P2|Overall Study|Duodenal Ulcer|8
2974291|NCT01129011|10236740|P1|Overall Study|Duodenal Ulcer|2
2974292|NCT01129011|10236739|P2|Overall Study|Lost to Follow-up|7
2974293|NCT01129011|10236740|P1|Overall Study|Lost to Follow-up|6
2974294|NCT01129011|10236739|P2|Overall Study|Withdrawal by Subject|8
2974295|NCT01129011|10236740|P1|Overall Study|Withdrawal by Subject|24
2974296|NCT01129011|10236739|P2|Overall Study|Adverse Event|30
2974297|NCT01129011|10236740|P1|Overall Study|Adverse Event|20
2974298|NCT01128959|10236795|P1|Treatment Period|Withdrawal by Subject|1
2974299|NCT01128959|10236795|P1|Treatment Period|Adverse Event|3
2974300|NCT01128959|10236795|P1|Lead in Period|Adverse Event|3
2974301|NCT01128946|10236801|P4|Period III|Protocol Violation|0
2974302|NCT01128946|10236802|P3|Period III|Protocol Violation|0
2974303|NCT01128946|10236803|P2|Period III|Protocol Violation|0
2974304|NCT01128946|10236804|P1|Period III|Protocol Violation|1
2974305|NCT01128946|10236801|P4|Period II|Withdrawal by Subject|1
2974306|NCT01128946|10236802|P3|Period II|Withdrawal by Subject|0
2974307|NCT01128946|10236803|P2|Period II|Withdrawal by Subject|0
2974308|NCT01128946|10236804|P1|Period II|Withdrawal by Subject|0
2974309|NCT01128946|10236801|P4|Period II|Protocol Violation|0
2974310|NCT01128946|10236802|P3|Period II|Protocol Violation|0
2974311|NCT01128946|10236803|P2|Period II|Protocol Violation|1
2974312|NCT01128946|10236804|P1|Period II|Protocol Violation|0
2974313|NCT01128946|10236801|P4|Period I|Withdrawal by Subject|1
2974314|NCT01128946|10236802|P3|Period I|Withdrawal by Subject|1
2974315|NCT01128946|10236803|P2|Period I|Withdrawal by Subject|0
2974316|NCT01128946|10236804|P1|Period I|Withdrawal by Subject|0
2974317|NCT01128946|10236801|P4|Period I|Protocol Violation|0
2974318|NCT01128946|10236802|P3|Period I|Protocol Violation|0
2974319|NCT01128946|10236803|P2|Period I|Protocol Violation|1
2974320|NCT01128946|10236804|P1|Period I|Protocol Violation|0
2974321|NCT01128894|10236822|P2|Overall Study|Conflicting HbA1c Results at Screening|0
2974322|NCT01128894|10236823|P1|Overall Study|Conflicting HbA1c Results at Screening|1
2974323|NCT01128894|10236822|P2|Overall Study|Physician Decision|1
2974324|NCT01128894|10236823|P1|Overall Study|Physician Decision|2
2974325|NCT01128894|10236822|P2|Overall Study|Withdrawal by Subject|12
2974326|NCT01128894|10236823|P1|Overall Study|Withdrawal by Subject|10
2974327|NCT01128894|10236822|P2|Overall Study|Lost to Follow-up|8
2974328|NCT01128894|10236823|P1|Overall Study|Lost to Follow-up|8
2974329|NCT01128894|10236822|P2|Overall Study|Noncompliance|5
2974330|NCT01128894|10236823|P1|Overall Study|Noncompliance|4
2974331|NCT01128894|10236822|P2|Overall Study|Protocol Violation|1
2974332|NCT01128894|10236823|P1|Overall Study|Protocol Violation|2
2974333|NCT01128894|10236822|P2|Overall Study|Adverse Event|41
2974334|NCT01128894|10236823|P1|Overall Study|Adverse Event|31
2974335|NCT01128842|10236841|P1|Overall Study|Disease Progression|6
2974336|NCT01128842|10236841|P1|Overall Study|Adverse Event|1
2974337|NCT01128738|10236858|P2|Second TP|Withdrawal by Subject|2
2974338|NCT01128738|10236859|P1|Second TP|Withdrawal by Subject|0
2974339|NCT01128738|10236858|P2|Second TP|Lost to Follow-up|1
2974340|NCT01128738|10236859|P1|Second TP|Lost to Follow-up|0
2974341|NCT01128738|10236858|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
2974342|NCT01128738|10236859|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
2974343|NCT01128738|10236858|P2|First Treatment Phase (TP)|Lost to Follow-up|0
2974344|NCT01128738|10236859|P1|First Treatment Phase (TP)|Lost to Follow-up|1
2974345|NCT01128621|10236984|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
2974346|NCT01128621|10236985|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
2974347|NCT01128595|10237106|P4|Treatment Period 3|Withdrawal by Subject|0
2974348|NCT01128595|10237107|P3|Treatment Period 3|Withdrawal by Subject|0
2974349|NCT01128595|10237108|P2|Treatment Period 3|Withdrawal by Subject|1
2974350|NCT01128595|10237109|P1|Treatment Period 3|Withdrawal by Subject|0
2974351|NCT01128569|10237139|P6|Treatment Period 2|Withdrawal by Subject|0
2974352|NCT01128569|10237140|P5|Treatment Period 2|Withdrawal by Subject|0
2974353|NCT01128569|10237141|P4|Treatment Period 2|Withdrawal by Subject|0
2974354|NCT01128569|10237142|P3|Treatment Period 2|Withdrawal by Subject|0
2974355|NCT01128569|10237143|P2|Treatment Period 2|Withdrawal by Subject|1
2974356|NCT01128569|10237144|P1|Treatment Period 2|Withdrawal by Subject|0
2974357|NCT01128569|10237139|P6|Washout Period 1|Adverse Event|0
2974358|NCT01128569|10237140|P5|Washout Period 1|Adverse Event|0
2974359|NCT01128569|10237141|P4|Washout Period 1|Adverse Event|0
2974360|NCT01128569|10237142|P3|Washout Period 1|Adverse Event|1
2974361|NCT01128569|10237143|P2|Washout Period 1|Adverse Event|0
2974362|NCT01128569|10237144|P1|Washout Period 1|Adverse Event|0
2974363|NCT01128543|10237161|P1|Overall Study|Protocol Violation|1
2974364|NCT01128543|10237161|P1|Overall Study|Withdrawal by Subject|3
2974365|NCT01128413|10237187|P2|Overall Study|Pt made DNR|0
2974366|NCT01128413|10237188|P1|Overall Study|Pt made DNR|1
2974367|NCT01128413|10237187|P2|Overall Study|NICOM Monitor Problems|1
2974368|NCT01128413|10237188|P1|Overall Study|NICOM Monitor Problems|2
2974369|NCT01128413|10237187|P2|Overall Study|Withdrawal by Subject|0
2974370|NCT01128413|10237188|P1|Overall Study|Withdrawal by Subject|1
2974371|NCT01128400|10237197|P3|Overall Study|Excluded due to sinus problems|0
2974372|NCT01128400|10237198|P2|Overall Study|Excluded due to sinus problems|1
2974373|NCT01128400|10237199|P1|Overall Study|Excluded due to sinus problems|0
2974374|NCT01128400|10237197|P3|Overall Study|were not invited to participate on taste|15
2974375|NCT01128400|10237198|P2|Overall Study|were not invited to participate on taste|0
2974376|NCT01128400|10237199|P1|Overall Study|were not invited to participate on taste|0
2974377|NCT01128400|10237197|P3|Overall Study|Screening failure|0
2974378|NCT01128400|10237198|P2|Overall Study|Screening failure|0
2974379|NCT01128400|10237199|P1|Overall Study|Screening failure|1
2974380|NCT01128400|10237197|P3|Overall Study|Lost to Follow-up|1
2974381|NCT01128400|10237198|P2|Overall Study|Lost to Follow-up|0
2974382|NCT01128400|10237199|P1|Overall Study|Lost to Follow-up|1
2974383|NCT01128387|10237212|P2|Overall Study|Physician Decision|1
2974384|NCT01128387|10237213|P1|Overall Study|Physician Decision|0
2974385|NCT01128361|10237223|P2|Overall Study|Withdrawal by Subject|2
2974386|NCT01128361|10237224|P1|Overall Study|Withdrawal by Subject|5
2974387|NCT01128361|10237223|P2|Overall Study|Lost to Follow-up|1
2974388|NCT01128361|10237224|P1|Overall Study|Lost to Follow-up|0
2974389|NCT01128296|10237236|P6|Overall Study|Withdrawal by Subject|2
2974390|NCT01128296|10237237|P5|Overall Study|Withdrawal by Subject|0
2974391|NCT01128296|10237238|P4|Overall Study|Withdrawal by Subject|0
2974392|NCT01128296|10237239|P3|Overall Study|Withdrawal by Subject|0
2974393|NCT01128296|10237240|P2|Overall Study|Withdrawal by Subject|0
2974394|NCT01128296|10237241|P1|Overall Study|Withdrawal by Subject|0
2974395|NCT01128296|10237236|P6|Overall Study|Physician Decision|3
2974396|NCT01128296|10237237|P5|Overall Study|Physician Decision|0
2974397|NCT01128296|10237238|P4|Overall Study|Physician Decision|0
2974398|NCT01128296|10237239|P3|Overall Study|Physician Decision|0
2974399|NCT01128296|10237240|P2|Overall Study|Physician Decision|0
2974400|NCT01128296|10237241|P1|Overall Study|Physician Decision|0
2974401|NCT01128244|10237272|P1|Overall Study|Scheduling conflict|2
2974402|NCT01128244|10237272|P1|Overall Study|Adverse Event|1
2974403|NCT01128179|10237313|P2|Overall Study|Protocol Violation|0
2974404|NCT01128179|10237314|P1|Overall Study|Protocol Violation|1
2974405|NCT01128179|10237313|P2|Overall Study|Death|0
2974406|NCT01128179|10237314|P1|Overall Study|Death|1
2974407|NCT01128153|10237334|P2|Overall Study|Developed discontinuation criteria|1
2974408|NCT01128153|10237335|P1|Overall Study|Developed discontinuation criteria|1
2974409|NCT01128153|10237334|P2|Overall Study|Protocol Violation|0
2974410|NCT01128153|10237335|P1|Overall Study|Protocol Violation|2
2974411|NCT01128153|10237334|P2|Overall Study|Incorrect enrolment to study|1
2974412|NCT01128153|10237335|P1|Overall Study|Incorrect enrolment to study|2
2974413|NCT01128153|10237334|P2|Overall Study|Withdrawal by Subject|3
2974414|NCT01128153|10237335|P1|Overall Study|Withdrawal by Subject|2
2974415|NCT01128153|10237334|P2|Overall Study|Condition under investigation worsened|7
2974416|NCT01128153|10237335|P1|Overall Study|Condition under investigation worsened|8
2974417|NCT01128153|10237334|P2|Overall Study|Adverse Event|3
2974418|NCT01128153|10237335|P1|Overall Study|Adverse Event|1
2974419|NCT01128114|10237351|P1|Overall Study|Screening Failed|2
2974420|NCT01128114|10237351|P1|Overall Study|Treatment Withdrawn|6
2974421|NCT01127763|10237368|P1|Overall Study|Physician Decision|2
2974422|NCT01127763|10237368|P1|Overall Study|Withdrawal by Subject|1
2974423|NCT01127763|10237368|P1|Overall Study|Adverse Event|2
2974424|NCT01127646|10237413|P2|Overall Study|Protocol Violation|1
2974425|NCT01127646|10237414|P1|Overall Study|Protocol Violation|0
2974426|NCT01127646|10237413|P2|Overall Study|Entry Criteria Not Met|0
2974427|NCT01127646|10237414|P1|Overall Study|Entry Criteria Not Met|1
2974428|NCT01127633|10237448|P2|Overall Study|Not treated|0
2974429|NCT01127633|10237449|P1|Overall Study|Not treated|1
2974430|NCT01127633|10237448|P2|Overall Study|Abnormal Lab/ECG Result|1
2974431|NCT01127633|10237449|P1|Overall Study|Abnormal Lab/ECG Result|0
2974432|NCT01127633|10237448|P2|Overall Study|Protocol Violation|16
2974433|NCT01127633|10237449|P1|Overall Study|Protocol Violation|8
2974434|NCT01127633|10237448|P2|Overall Study|Sponsor Decision|195
2974435|NCT01127633|10237449|P1|Overall Study|Sponsor Decision|163
2974436|NCT01127633|10237448|P2|Overall Study|Withdrawal by Subject|72
2974437|NCT01127633|10237449|P1|Overall Study|Withdrawal by Subject|57
2974438|NCT01127633|10237448|P2|Overall Study|Physician Decision|45
2974439|NCT01127633|10237449|P1|Overall Study|Physician Decision|60
2974440|NCT01127633|10237448|P2|Overall Study|Parent/Caregiver Decision|228
2974441|NCT01127633|10237449|P1|Overall Study|Parent/Caregiver Decision|246
2974442|NCT01127633|10237448|P2|Overall Study|Lost to Follow-up|0
2974443|NCT01127633|10237449|P1|Overall Study|Lost to Follow-up|4
2974444|NCT01127633|10237448|P2|Overall Study|Death|43
2974445|NCT01127633|10237449|P1|Overall Study|Death|40
2974446|NCT01127633|10237448|P2|Overall Study|Adverse Event|73
2974447|NCT01127633|10237449|P1|Overall Study|Adverse Event|74
2974448|NCT01127607|10237481|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
2974449|NCT01127607|10237482|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
2974450|NCT01127607|10237481|P2|Phase II (Between Subjects)|Lost to Follow-up|2
2974451|NCT01127607|10237482|P1|Phase II (Between Subjects)|Lost to Follow-up|0
2974452|NCT01127256|10237659|P2|Overall Study|Protocol Violation|0
2974453|NCT01127256|10237660|P1|Overall Study|Protocol Violation|1
2974454|NCT01127256|10237659|P2|Overall Study|Withdrawal by Subject|9
2974455|NCT01127256|10237660|P1|Overall Study|Withdrawal by Subject|5
2974456|NCT01127256|10237659|P2|Overall Study|Lost to Follow-up|17
2974457|NCT01127256|10237660|P1|Overall Study|Lost to Follow-up|16
2974458|NCT01127256|10237659|P2|Overall Study|Lack of Efficacy|0
2974459|NCT01127256|10237660|P1|Overall Study|Lack of Efficacy|4
2974460|NCT01127256|10237659|P2|Overall Study|Adverse Event|13
2974461|NCT01127256|10237660|P1|Overall Study|Adverse Event|13
2974462|NCT01127165|10237672|P2|Overall Study|Protocol Violation|1
2974463|NCT01127165|10237673|P1|Overall Study|Protocol Violation|0
2974464|NCT01127165|10237672|P2|Overall Study|Withdrawal by Subject|3
2974465|NCT01127165|10237673|P1|Overall Study|Withdrawal by Subject|1
2974466|NCT01127165|10237672|P2|Overall Study|Lost to Follow-up|5
2974467|NCT01127165|10237673|P1|Overall Study|Lost to Follow-up|3
2974468|NCT01127165|10237672|P2|Overall Study|Lack of Efficacy|8
2974469|NCT01127165|10237673|P1|Overall Study|Lack of Efficacy|10
2974470|NCT01127165|10237672|P2|Overall Study|Adverse Event|2
2974471|NCT01127165|10237673|P1|Overall Study|Adverse Event|2
2974472|NCT01127139|10237685|P1|Overall Study|Reason not specified|1
2974473|NCT01127139|10237685|P1|Overall Study|Lack of Efficacy|4
2974474|NCT01127139|10237685|P1|Overall Study|Incompliance|12
2974475|NCT01127139|10237685|P1|Overall Study|Adverse Event|40
2974476|NCT01127061|10237713|P2|Overall Study|Physician Decision|3
2974477|NCT01127061|10237714|P1|Overall Study|Physician Decision|3
2974478|NCT01127061|10237713|P2|Overall Study|Lost to Follow-up|10
2974479|NCT01127061|10237714|P1|Overall Study|Lost to Follow-up|7
2974480|NCT01126879|10237751|P2|Overall Study|Physician Decision|0
2974481|NCT01126879|10237752|P1|Overall Study|Physician Decision|1
2974482|NCT01126879|10237751|P2|Overall Study|Adverse Event|1
2974483|NCT01126879|10237752|P1|Overall Study|Adverse Event|0
2974484|NCT01126879|10237751|P2|Overall Study|Withdrawal by Subject|0
2974485|NCT01126879|10237752|P1|Overall Study|Withdrawal by Subject|1
2974486|NCT01126879|10237751|P2|Overall Study|Progressive Disease|1
2974487|NCT01126879|10237752|P1|Overall Study|Progressive Disease|3
2974488|NCT01126619|10237799|P1|Overall Study|Non-compliance|1
2974489|NCT01126619|10237799|P1|Overall Study|Withdrawal by Subject|9
2974490|NCT01126619|10237799|P1|Overall Study|Serious adverse event|1
2974491|NCT01126619|10237799|P1|Overall Study|Investigator decision|4
2974492|NCT01126619|10237799|P1|Overall Study|Not eligible for the study|2
2974493|NCT01126580|10237827|P3|Overall Study|Treatment Non-compliance|3
2974494|NCT01126580|10237828|P2|Overall Study|Treatment Non-compliance|2
2974495|NCT01126580|10237829|P1|Overall Study|Treatment Non-compliance|0
2974496|NCT01126580|10237827|P3|Overall Study|Lost to Follow-up|9
2974497|NCT01126580|10237828|P2|Overall Study|Lost to Follow-up|13
2974498|NCT01126580|10237829|P1|Overall Study|Lost to Follow-up|15
2974499|NCT01126580|10237827|P3|Overall Study|Protocol Violation|2
2974500|NCT01126580|10237828|P2|Overall Study|Protocol Violation|1
2974501|NCT01126580|10237829|P1|Overall Study|Protocol Violation|0
2974502|NCT01126580|10237827|P3|Overall Study|Lack of Efficacy|4
2974503|NCT01126580|10237828|P2|Overall Study|Lack of Efficacy|3
2974504|NCT01126580|10237829|P1|Overall Study|Lack of Efficacy|2
2974505|NCT01126580|10237827|P3|Overall Study|Entry Criteria Not Met|2
2974506|NCT01126580|10237828|P2|Overall Study|Entry Criteria Not Met|1
2974507|NCT01126580|10237829|P1|Overall Study|Entry Criteria Not Met|1
2974508|NCT01126580|10237827|P3|Overall Study|Physician Decision|2
2974509|NCT01126580|10237828|P2|Overall Study|Physician Decision|1
2974510|NCT01126580|10237829|P1|Overall Study|Physician Decision|1
2974511|NCT01126580|10237827|P3|Overall Study|Sponsor Decision|7
2974512|NCT01126580|10237828|P2|Overall Study|Sponsor Decision|4
2974513|NCT01126580|10237829|P1|Overall Study|Sponsor Decision|5
2974514|NCT01126580|10237827|P3|Overall Study|Withdrawal by Subject|14
2974515|NCT01126580|10237828|P2|Overall Study|Withdrawal by Subject|19
2974516|NCT01126580|10237829|P1|Overall Study|Withdrawal by Subject|11
2974517|NCT01126580|10237827|P3|Overall Study|Adverse Event|12
2974518|NCT01126580|10237828|P2|Overall Study|Adverse Event|8
2974519|NCT01126580|10237829|P1|Overall Study|Adverse Event|14
2974520|NCT01126541|10237924|P3|Overall Study|Administrative reason or other|2
2974521|NCT01126541|10237925|P2|Overall Study|Administrative reason or other|1
2974522|NCT01126541|10237926|P1|Overall Study|Administrative reason or other|1
2974523|NCT01126541|10237924|P3|Overall Study|Protocol Violation|1
2974524|NCT01126541|10237925|P2|Overall Study|Protocol Violation|0
2974525|NCT01126541|10237926|P1|Overall Study|Protocol Violation|0
2974526|NCT01126541|10237924|P3|Overall Study|Withdrawal by Subject|6
2974527|NCT01126541|10237925|P2|Overall Study|Withdrawal by Subject|5
2974528|NCT01126541|10237926|P1|Overall Study|Withdrawal by Subject|2
2974529|NCT01126541|10237924|P3|Overall Study|Lost to Follow-up|2
2974530|NCT01126541|10237925|P2|Overall Study|Lost to Follow-up|2
2974531|NCT01126541|10237926|P1|Overall Study|Lost to Follow-up|1
2974532|NCT01126541|10237924|P3|Overall Study|Lack of Efficacy|11
2974533|NCT01126541|10237925|P2|Overall Study|Lack of Efficacy|1
2974534|NCT01126541|10237926|P1|Overall Study|Lack of Efficacy|6
2974535|NCT01126541|10237924|P3|Overall Study|Death|0
2974536|NCT01126541|10237925|P2|Overall Study|Death|1
2974537|NCT01126541|10237926|P1|Overall Study|Death|0
2974538|NCT01126541|10237924|P3|Overall Study|Adverse Event|4
2974539|NCT01126541|10237925|P2|Overall Study|Adverse Event|2
2974540|NCT01126541|10237926|P1|Overall Study|Adverse Event|0
2974541|NCT01126437|10238010|P3|Overall Study|Other reason not specified|178
2974542|NCT01126437|10238011|P2|Overall Study|Other reason not specified|176
2974543|NCT01126437|10238012|P1|Overall Study|Other reason not specified|210
2974544|NCT01126437|10238010|P3|Overall Study|Withdrawal by Subject|319
2974545|NCT01126437|10238011|P2|Overall Study|Withdrawal by Subject|335
2974546|NCT01126437|10238012|P1|Overall Study|Withdrawal by Subject|331
2974547|NCT01126437|10238010|P3|Overall Study|Lost to Follow-up|55
2974548|NCT01126437|10238011|P2|Overall Study|Lost to Follow-up|63
2974549|NCT01126437|10238012|P1|Overall Study|Lost to Follow-up|52
2974550|NCT01126437|10238010|P3|Overall Study|Protocol Violation|41
2974551|NCT01126437|10238011|P2|Overall Study|Protocol Violation|66
2974552|NCT01126437|10238012|P1|Overall Study|Protocol Violation|64
2974553|NCT01126437|10238010|P3|Overall Study|Lack of Efficacy|59
2974554|NCT01126437|10238011|P2|Overall Study|Lack of Efficacy|60
2974555|NCT01126437|10238012|P1|Overall Study|Lack of Efficacy|65
2974556|NCT01126437|10238010|P3|Overall Study|Adverse Event|635
2974557|NCT01126437|10238011|P2|Overall Study|Adverse Event|606
2974558|NCT01126437|10238012|P1|Overall Study|Adverse Event|602
2974559|NCT01126437|10238010|P3|Overall Study|Sites with data irregularities/fraud|7
2974560|NCT01126437|10238011|P2|Overall Study|Sites with data irregularities/fraud|6
2974561|NCT01126437|10238012|P1|Overall Study|Sites with data irregularities/fraud|6
2974562|NCT01126437|10238010|P3|Overall Study|Not treated|19
2974563|NCT01126437|10238011|P2|Overall Study|Not treated|18
2974564|NCT01126437|10238012|P1|Overall Study|Not treated|11
2974565|NCT01126424|10238050|P6|Overall Study|Withdrawal by Subject|0
2974566|NCT01126424|10238051|P5|Overall Study|Withdrawal by Subject|1
2974567|NCT01126424|10238052|P4|Overall Study|Withdrawal by Subject|3
2974568|NCT01126424|10238053|P3|Overall Study|Withdrawal by Subject|1
2974569|NCT01126424|10238054|P2|Overall Study|Withdrawal by Subject|0
2974570|NCT01126424|10238055|P1|Overall Study|Withdrawal by Subject|0
2974571|NCT01126424|10238050|P6|Overall Study|Adverse Event|0
2974572|NCT01126424|10238051|P5|Overall Study|Adverse Event|1
2974573|NCT01126424|10238052|P4|Overall Study|Adverse Event|0
2974574|NCT01126424|10238053|P3|Overall Study|Adverse Event|0
2974575|NCT01126424|10238054|P2|Overall Study|Adverse Event|0
2974576|NCT01126424|10238055|P1|Overall Study|Adverse Event|0
2974577|NCT01126359|10238078|P2|First Intervention (20-minutes)|Physician Decision|1
2974578|NCT01126359|10238079|P1|First Intervention (20-minutes)|Physician Decision|0
2974579|NCT01126268|10238091|P1|Overall Study|Adverse Event|1
2974580|NCT01126060|10238130|P2|Overall Study|Protocol Violation|2
2974581|NCT01126060|10238131|P1|Overall Study|Protocol Violation|0
2974582|NCT01125930|10238139|P2|Overall Study|Lost to Follow-up|2
2974583|NCT01125930|10238140|P1|Overall Study|Lost to Follow-up|0
2974584|NCT01125930|10238139|P2|Overall Study|Protocol Violation|1
2974585|NCT01125930|10238140|P1|Overall Study|Protocol Violation|0
2974586|NCT01125930|10238139|P2|Overall Study|Withdrawal by Subject|6
2974587|NCT01125930|10238140|P1|Overall Study|Withdrawal by Subject|1
2974588|NCT01125930|10238139|P2|Overall Study|Adverse Event|1
2974589|NCT01125930|10238140|P1|Overall Study|Adverse Event|0
2974590|NCT01125917|10238294|P1|Overall Study|Lack of Efficacy|19
2974591|NCT01125917|10238294|P1|Overall Study|Administrative|223
2974592|NCT01125917|10238294|P1|Overall Study|Withdrawal by Subject|31
2974593|NCT01125917|10238294|P1|Overall Study|Lost to Follow-up|23
2974594|NCT01125917|10238294|P1|Overall Study|Adverse Event|43
2974595|NCT01125813|10238298|P1|Overall Study|Screen Failures|4
2974596|NCT01125813|10238298|P1|Overall Study|Withdrawal by Subject|1
2974597|NCT01125813|10238298|P1|Overall Study|Death|1
2974598|NCT01125800|10238308|P5|Phase II|Disease progression|8
2974599|NCT01125800|10238309|P4|Phase II|Disease progression|1
2974600|NCT01125800|10238310|P3|Phase II|Disease progression|0
2974601|NCT01125800|10238311|P2|Phase II|Disease progression|0
2974602|NCT01125800|10238312|P1|Phase II|Disease progression|0
2974603|NCT01125800|10238308|P5|Phase II|Adverse Event|2
2974604|NCT01125800|10238309|P4|Phase II|Adverse Event|0
2974605|NCT01125800|10238310|P3|Phase II|Adverse Event|0
2974606|NCT01125800|10238311|P2|Phase II|Adverse Event|0
2974607|NCT01125800|10238312|P1|Phase II|Adverse Event|0
2974608|NCT01125800|10238308|P5|Phase II|Protocol Violation|1
2974609|NCT01125800|10238309|P4|Phase II|Protocol Violation|0
2974610|NCT01125800|10238310|P3|Phase II|Protocol Violation|0
2974611|NCT01125800|10238311|P2|Phase II|Protocol Violation|0
2974612|NCT01125800|10238312|P1|Phase II|Protocol Violation|0
2974613|NCT01125800|10238308|P5|Phase I|Disease progression|0
2974614|NCT01125800|10238309|P4|Phase I|Disease progression|3
2974615|NCT01125800|10238310|P3|Phase I|Disease progression|1
2974616|NCT01125800|10238311|P2|Phase I|Disease progression|4
2974617|NCT01125800|10238312|P1|Phase I|Disease progression|5
2974618|NCT01125800|10238308|P5|Phase I|Withdrawal by Subject|0
2974619|NCT01125800|10238309|P4|Phase I|Withdrawal by Subject|0
2974620|NCT01125800|10238310|P3|Phase I|Withdrawal by Subject|1
2974621|NCT01125800|10238311|P2|Phase I|Withdrawal by Subject|0
2974622|NCT01125800|10238312|P1|Phase I|Withdrawal by Subject|0
2974623|NCT01125800|10238308|P5|Phase I|Administrative problems|0
2974624|NCT01125800|10238309|P4|Phase I|Administrative problems|0
2974625|NCT01125800|10238310|P3|Phase I|Administrative problems|0
2974626|NCT01125800|10238311|P2|Phase I|Administrative problems|0
2974627|NCT01125800|10238312|P1|Phase I|Administrative problems|1
2974628|NCT01125800|10238308|P5|Phase I|Adverse Event|0
2974629|NCT01125800|10238309|P4|Phase I|Adverse Event|7
2974630|NCT01125800|10238310|P3|Phase I|Adverse Event|1
2974631|NCT01125800|10238311|P2|Phase I|Adverse Event|2
2974632|NCT01125800|10238312|P1|Phase I|Adverse Event|2
2974633|NCT01125800|10238308|P5|Phase I|Protocol Violation|0
2974634|NCT01125800|10238309|P4|Phase I|Protocol Violation|1
2974635|NCT01125800|10238310|P3|Phase I|Protocol Violation|1
2974636|NCT01125800|10238311|P2|Phase I|Protocol Violation|3
2974637|NCT01125800|10238312|P1|Phase I|Protocol Violation|0
2974638|NCT01125748|10238378|P2|Overall Study|Patient Decision to Withdraw|4
2974639|NCT01125748|10238379|P1|Overall Study|Patient Decision to Withdraw|2
2974640|NCT01125748|10238378|P2|Overall Study|Physician Decision|7
2974641|NCT01125748|10238379|P1|Overall Study|Physician Decision|8
2974642|NCT01125748|10238378|P2|Overall Study|Lost to Follow-up|1
2974643|NCT01125748|10238379|P1|Overall Study|Lost to Follow-up|0
2974644|NCT01125748|10238378|P2|Overall Study|Adverse Event|2
2974645|NCT01125748|10238379|P1|Overall Study|Adverse Event|0
2974646|NCT01125722|10238389|P2|Overall Study|Lost to Follow-up|0
2974647|NCT01125722|10238390|P1|Overall Study|Lost to Follow-up|1
2974648|NCT01125722|10238389|P2|Overall Study|Withdrawal by Subject|1
2974649|NCT01125722|10238390|P1|Overall Study|Withdrawal by Subject|2
2974650|NCT01125566|10238437|P3|Patients Who Switched From AV to TV|Other than listed above|4
2974651|NCT01125566|10238438|P2|Patients Who Switched From AV to TV|Other than listed above|0
2974652|NCT01125566|10238439|P1|Patients Who Switched From AV to TV|Other than listed above|0
2974653|NCT01125566|10238437|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
2974654|NCT01125566|10238438|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2974655|NCT01125566|10238439|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2974656|NCT01125566|10238437|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
2974657|NCT01125566|10238438|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2974658|NCT01125566|10238439|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2974659|NCT01125566|10238437|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
2974660|NCT01125566|10238438|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2974661|NCT01125566|10238439|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2974662|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
2974663|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2974664|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2974665|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
2974666|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
2974667|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
2974668|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Not treated|0
2974669|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Not treated|0
2974670|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Not treated|2
2974671|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
2974672|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
2974673|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
2974674|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2974675|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
2974676|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2974677|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
2974678|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
2974679|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
2974680|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
2974681|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2974682|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2974683|NCT01125566|10238437|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
2974684|NCT01125566|10238438|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
2974685|NCT01125566|10238439|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
2974686|NCT01125514|10238452|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
2974687|NCT01125514|10238452|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
2974688|NCT01125514|10238452|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
2974689|NCT01125514|10238452|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
2974690|NCT01125514|10238452|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
2974691|NCT01125514|10238452|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
2974692|NCT01125189|10238552|P3|Follow up Period|Other reasons|5
2974693|NCT01125189|10238553|P2|Follow up Period|Other reasons|4
2974694|NCT01125189|10238554|P1|Follow up Period|Other reasons|4
2974695|NCT01125189|10238552|P3|Follow up Period|Lost to Follow-up|6
2974696|NCT01125189|10238553|P2|Follow up Period|Lost to Follow-up|9
2974697|NCT01125189|10238554|P1|Follow up Period|Lost to Follow-up|12
2974698|NCT01125189|10238552|P3|Follow up Period|Death|0
2974699|NCT01125189|10238553|P2|Follow up Period|Death|0
2974700|NCT01125189|10238554|P1|Follow up Period|Death|1
2974701|NCT01125189|10238552|P3|Follow up Period|Withdrawal by Subject|5
2974702|NCT01125189|10238553|P2|Follow up Period|Withdrawal by Subject|2
2974703|NCT01125189|10238554|P1|Follow up Period|Withdrawal by Subject|3
2974704|NCT01125189|10238552|P3|Treatment Period|Completed 24 week treatment period only|2
2974705|NCT01125189|10238553|P2|Treatment Period|Completed 24 week treatment period only|1
2974706|NCT01125189|10238554|P1|Treatment Period|Completed 24 week treatment period only|2
2974707|NCT01125189|10238552|P3|Treatment Period|Other reasons|0
2974708|NCT01125189|10238553|P2|Treatment Period|Other reasons|1
2974709|NCT01125189|10238554|P1|Treatment Period|Other reasons|1
2974710|NCT01125189|10238552|P3|Treatment Period|Participants requested to discontinue|4
2974711|NCT01125189|10238553|P2|Treatment Period|Participants requested to discontinue|3
2974712|NCT01125189|10238554|P1|Treatment Period|Participants requested to discontinue|1
2974713|NCT01125189|10238552|P3|Treatment Period|Poor compliance/noncompliance|0
2974714|NCT01125189|10238553|P2|Treatment Period|Poor compliance/noncompliance|1
2974715|NCT01125189|10238554|P1|Treatment Period|Poor compliance/noncompliance|0
2974716|NCT01125189|10238552|P3|Treatment Period|Lost to Follow-up|1
2974717|NCT01125189|10238553|P2|Treatment Period|Lost to Follow-up|2
2974718|NCT01125189|10238554|P1|Treatment Period|Lost to Follow-up|1
2974719|NCT01125189|10238552|P3|Treatment Period|Death|0
2974720|NCT01125189|10238553|P2|Treatment Period|Death|0
2974721|NCT01125189|10238554|P1|Treatment Period|Death|1
2974722|NCT01125189|10238552|P3|Treatment Period|Withdrawal by Subject|1
2974723|NCT01125189|10238553|P2|Treatment Period|Withdrawal by Subject|1
2974724|NCT01125189|10238554|P1|Treatment Period|Withdrawal by Subject|3
2974725|NCT01125189|10238552|P3|Treatment Period|Adverse Event|8
2974726|NCT01125189|10238553|P2|Treatment Period|Adverse Event|8
2974727|NCT01125189|10238554|P1|Treatment Period|Adverse Event|7
2974728|NCT01125189|10238552|P3|Treatment Period|Lack of Efficacy|25
2974729|NCT01125189|10238553|P2|Treatment Period|Lack of Efficacy|18
2974730|NCT01125189|10238554|P1|Treatment Period|Lack of Efficacy|15
2974731|NCT01124916|10238623|P2|Overall Study|Lost to Follow-up|2
2974732|NCT01124916|10238624|P1|Overall Study|Lost to Follow-up|3
2974733|NCT01124864|10238638|P6|Overall Study|Protocol Violation|0
2974734|NCT01124864|10238639|P5|Overall Study|Protocol Violation|1
2974735|NCT01124864|10238640|P4|Overall Study|Protocol Violation|0
2974736|NCT01124864|10238641|P3|Overall Study|Protocol Violation|0
2974737|NCT01124864|10238642|P2|Overall Study|Protocol Violation|0
2974738|NCT01124864|10238643|P1|Overall Study|Protocol Violation|1
2974739|NCT01124864|10238638|P6|Overall Study|Lost to Follow-up|0
2974740|NCT01124864|10238639|P5|Overall Study|Lost to Follow-up|0
2974741|NCT01124864|10238640|P4|Overall Study|Lost to Follow-up|1
2974742|NCT01124864|10238641|P3|Overall Study|Lost to Follow-up|0
2974743|NCT01124864|10238642|P2|Overall Study|Lost to Follow-up|1
2974744|NCT01124864|10238643|P1|Overall Study|Lost to Follow-up|1
2974745|NCT01124864|10238638|P6|Overall Study|Withdrawal by Subject|1
2974746|NCT01124864|10238639|P5|Overall Study|Withdrawal by Subject|2
2974747|NCT01124864|10238640|P4|Overall Study|Withdrawal by Subject|0
2974748|NCT01124864|10238641|P3|Overall Study|Withdrawal by Subject|4
2974749|NCT01124864|10238642|P2|Overall Study|Withdrawal by Subject|3
2974750|NCT01124864|10238643|P1|Overall Study|Withdrawal by Subject|2
2974751|NCT01124864|10238638|P6|Overall Study|Death|0
2974752|NCT01124864|10238639|P5|Overall Study|Death|1
2974753|NCT01124864|10238640|P4|Overall Study|Death|2
2974754|NCT01124864|10238641|P3|Overall Study|Death|6
2974755|NCT01124864|10238642|P2|Overall Study|Death|9
2974756|NCT01124864|10238643|P1|Overall Study|Death|6
2974757|NCT01124864|10238638|P6|Overall Study|Follow up phase competed as per protocol|2
2974758|NCT01124864|10238639|P5|Overall Study|Follow up phase competed as per protocol|26
2974759|NCT01124864|10238640|P4|Overall Study|Follow up phase competed as per protocol|18
2974760|NCT01124864|10238641|P3|Overall Study|Follow up phase competed as per protocol|24
2974761|NCT01124864|10238642|P2|Overall Study|Follow up phase competed as per protocol|22
2974762|NCT01124864|10238643|P1|Overall Study|Follow up phase competed as per protocol|18
2974763|NCT01124838|10238677|P2|Overall Study|Lost to Follow-up|0
2974764|NCT01124838|10238678|P1|Overall Study|Lost to Follow-up|2
2974765|NCT01124838|10238677|P2|Overall Study|Withdrawal by Subject|2
2974766|NCT01124838|10238678|P1|Overall Study|Withdrawal by Subject|3
2974767|NCT01124838|10238677|P2|Overall Study|Lack of Efficacy|0
2974768|NCT01124838|10238678|P1|Overall Study|Lack of Efficacy|2
2974769|NCT01124838|10238677|P2|Overall Study|Adverse Event|11
2974770|NCT01124838|10238678|P1|Overall Study|Adverse Event|7
2974771|NCT01124838|10238677|P2|Overall Study|Miscellaneous|2
2974772|NCT01124838|10238678|P1|Overall Study|Miscellaneous|4
2974773|NCT01124734|10238745|P1|Overall Study|Elected for alternative treatment|2
2974774|NCT01124734|10238745|P1|Overall Study|Withdrawal by Subject|1
2974775|NCT01124734|10238745|P1|Overall Study|Adverse Event|1
2974776|NCT01124734|10238745|P1|Overall Study|Disease progression|13
2974777|NCT01124643|10238756|P1|Overall Study|Death|1
2974778|NCT01124617|10238770|P2|Overall Study|Other|1
2974779|NCT01124617|10238771|P1|Overall Study|Other|2
2974780|NCT01124617|10238770|P2|Overall Study|Withdrawal by Subject|1
2974781|NCT01124617|10238771|P1|Overall Study|Withdrawal by Subject|9
2974782|NCT01124617|10238770|P2|Overall Study|Protocol Violation|1
2974783|NCT01124617|10238771|P1|Overall Study|Protocol Violation|1
2974784|NCT01124617|10238770|P2|Overall Study|Lack of Efficacy|1
2974785|NCT01124617|10238771|P1|Overall Study|Lack of Efficacy|2
2974786|NCT01124617|10238770|P2|Overall Study|Adverse Event|2
2974787|NCT01124617|10238771|P1|Overall Study|Adverse Event|5
2974788|NCT01124604|10238803|P2|Overall Study|Disease Progression|1
2974789|NCT01124604|10238804|P1|Overall Study|Disease Progression|0
2974790|NCT01124604|10238803|P2|Overall Study|Withdrawal by Subject|0
2974791|NCT01124604|10238804|P1|Overall Study|Withdrawal by Subject|4
2974792|NCT01124604|10238803|P2|Overall Study|Lack of Efficacy|0
2974793|NCT01124604|10238804|P1|Overall Study|Lack of Efficacy|1
2974794|NCT01124604|10238803|P2|Overall Study|Adverse Event|1
2974795|NCT01124604|10238804|P1|Overall Study|Adverse Event|10
2974796|NCT01124448|10238843|P2|Overall Study|Protocol Violation|0
2974797|NCT01124448|10238844|P1|Overall Study|Protocol Violation|2
2974798|NCT01124448|10238843|P2|Overall Study|Lost to Follow-up|3
2974799|NCT01124448|10238844|P1|Overall Study|Lost to Follow-up|0
2974800|NCT01124422|10238852|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
2974801|NCT01124422|10238853|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2974802|NCT01124422|10238854|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2974803|NCT01124422|10238852|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
2974804|NCT01124422|10238853|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
2974805|NCT01124422|10238854|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
2974806|NCT01124422|10238852|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
2974807|NCT01124422|10238853|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
2974808|NCT01124422|10238854|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
2974809|NCT01124422|10238852|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
2974810|NCT01124422|10238853|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2974811|NCT01124422|10238854|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2974812|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
2974813|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
2974814|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
2974815|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2974816|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2974817|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
2974818|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2974819|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2974820|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
2974821|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Physician Decision|0
2974822|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Physician Decision|0
2974823|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Physician Decision|4
2974824|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Adverse Event|0
2974825|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Adverse Event|0
2974826|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Adverse Event|7
2974827|NCT01124422|10238852|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2974828|NCT01124422|10238853|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2974829|NCT01124422|10238854|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
2974830|NCT01124292|10238924|P3|Overall Study|piercing track closed|1
2974831|NCT01124292|10238925|P2|Overall Study|piercing track closed|2
2974832|NCT01124292|10238926|P1|Overall Study|piercing track closed|0
2974833|NCT01124292|10238924|P3|Overall Study|medical issue unrelated to the study|2
2974834|NCT01124292|10238925|P2|Overall Study|medical issue unrelated to the study|0
2974835|NCT01124292|10238926|P1|Overall Study|medical issue unrelated to the study|0
2974836|NCT01124292|10238924|P3|Overall Study|Withdrawal by Subject|2
2974837|NCT01124292|10238925|P2|Overall Study|Withdrawal by Subject|6
2974838|NCT01124292|10238926|P1|Overall Study|Withdrawal by Subject|0
2974839|NCT01124292|10238924|P3|Overall Study|Physician Decision|2
2974840|NCT01124292|10238925|P2|Overall Study|Physician Decision|3
2974841|NCT01124292|10238926|P1|Overall Study|Physician Decision|0
2974842|NCT01124292|10238924|P3|Overall Study|Lost to Follow-up|3
2974843|NCT01124292|10238925|P2|Overall Study|Lost to Follow-up|4
2974844|NCT01124292|10238926|P1|Overall Study|Lost to Follow-up|2
2974845|NCT01124175|10238997|P2|Washout of 7 Days|Withdrawal by Subject|2
2974846|NCT01124175|10238998|P1|Washout of 7 Days|Withdrawal by Subject|0
2974847|NCT01124162|10239016|P2|Washout of 7 Days|Withdrawal by Subject|0
2974848|NCT01124162|10239017|P1|Washout of 7 Days|Withdrawal by Subject|1
2974849|NCT01124162|10239016|P2|First Intervention|Adverse Event|0
2974850|NCT01124162|10239017|P1|First Intervention|Adverse Event|2
2974851|NCT01124149|10239033|P1|Maintenance Phase|Non-compliance|1
2974852|NCT01124149|10239033|P1|Maintenance Phase|Coordinator error|1
2974853|NCT01124149|10239033|P1|Maintenance Phase|Protocol Violation|5
2974854|NCT01124149|10239033|P1|Maintenance Phase|Withdrawal by Subject|10
2974855|NCT01124149|10239033|P1|Maintenance Phase|Lost to Follow-up|15
2974856|NCT01124149|10239033|P1|Maintenance Phase|Adverse Event|24
2974857|NCT01124149|10239033|P1|Maintenance Phase|Lack of Efficacy|40
2974858|NCT01124149|10239033|P1|Acute Phase|Sponsor decision|1
2974859|NCT01124149|10239033|P1|Acute Phase|Travelling to another country|1
2974860|NCT01124149|10239033|P1|Acute Phase|Low hemoglobin|1
2974861|NCT01124149|10239033|P1|Acute Phase|Non-compliance|1
2974862|NCT01124149|10239033|P1|Acute Phase|UC symptoms not ameliorated|1
2974863|NCT01124149|10239033|P1|Acute Phase|Sponsor request|1
2974864|NCT01124149|10239033|P1|Acute Phase|Prolonged antibiotic therapy|1
2974865|NCT01124149|10239033|P1|Acute Phase|Lost to Follow-up|2
2974866|NCT01124149|10239033|P1|Acute Phase|Protocol Violation|14
2974867|NCT01124149|10239033|P1|Acute Phase|Lack of Efficacy|17
2974868|NCT01124149|10239033|P1|Acute Phase|Adverse Event|21
2974869|NCT01124149|10239033|P1|Acute Phase|Withdrawal by Subject|22
2974870|NCT01124097|10239053|P4|Overall Study|Physician Decision|0
2974871|NCT01124097|10239054|P3|Overall Study|Physician Decision|0
2974872|NCT01124097|10239055|P2|Overall Study|Physician Decision|1
2974873|NCT01124097|10239056|P1|Overall Study|Physician Decision|2
2974874|NCT01124097|10239053|P4|Overall Study|Protocol Violation|1
2974875|NCT01124097|10239054|P3|Overall Study|Protocol Violation|2
2974876|NCT01124097|10239055|P2|Overall Study|Protocol Violation|0
2974877|NCT01124097|10239056|P1|Overall Study|Protocol Violation|2
2974878|NCT01124097|10239053|P4|Overall Study|Adverse Event|7
2974879|NCT01124097|10239054|P3|Overall Study|Adverse Event|15
2974880|NCT01124097|10239055|P2|Overall Study|Adverse Event|15
2974881|NCT01124097|10239056|P1|Overall Study|Adverse Event|24
2974882|NCT01124097|10239053|P4|Overall Study|Lack of Efficacy|3
2974883|NCT01124097|10239054|P3|Overall Study|Lack of Efficacy|1
2974884|NCT01124097|10239055|P2|Overall Study|Lack of Efficacy|3
2974885|NCT01124097|10239056|P1|Overall Study|Lack of Efficacy|2
2974886|NCT01124097|10239053|P4|Overall Study|Withdrawal by Subject|3
2974887|NCT01124097|10239054|P3|Overall Study|Withdrawal by Subject|2
2974888|NCT01124097|10239055|P2|Overall Study|Withdrawal by Subject|3
2974889|NCT01124097|10239056|P1|Overall Study|Withdrawal by Subject|4
2974890|NCT01124045|10239068|P2|Overall Study|Physician Decision|2
2974891|NCT01124045|10239069|P1|Overall Study|Physician Decision|0
2974892|NCT01124045|10239068|P2|Overall Study|Lost to Follow-up|1
2974893|NCT01124045|10239069|P1|Overall Study|Lost to Follow-up|0
2974894|NCT01124006|10239102|P3|Overall Study|Other|1
2974895|NCT01124006|10239103|P2|Overall Study|Other|0
2974896|NCT01124006|10239104|P1|Overall Study|Other|0
2974897|NCT01124006|10239102|P3|Overall Study|Lost to Follow-up|1
2974898|NCT01124006|10239103|P2|Overall Study|Lost to Follow-up|0
2974899|NCT01124006|10239104|P1|Overall Study|Lost to Follow-up|1
2974900|NCT01124006|10239102|P3|Overall Study|Withdrawal by Subject|0
2974901|NCT01124006|10239103|P2|Overall Study|Withdrawal by Subject|2
2974902|NCT01124006|10239104|P1|Overall Study|Withdrawal by Subject|2
2974903|NCT01123980|10239132|P2|Overall Study|Unclassified|7
2974904|NCT01123980|10239133|P1|Overall Study|Unclassified|6
2974905|NCT01123980|10239132|P2|Overall Study|Withdrawal by Subject|3
2974906|NCT01123980|10239133|P1|Overall Study|Withdrawal by Subject|5
2974907|NCT01123980|10239132|P2|Overall Study|Protocol Violation|6
2974908|NCT01123980|10239133|P1|Overall Study|Protocol Violation|6
2974909|NCT01123980|10239132|P2|Overall Study|Lost to Follow-up|6
2974910|NCT01123980|10239133|P1|Overall Study|Lost to Follow-up|0
2974911|NCT01123980|10239132|P2|Overall Study|Physician Decision|1
2974912|NCT01123980|10239133|P1|Overall Study|Physician Decision|0
2974913|NCT01123980|10239132|P2|Overall Study|Lack of Efficacy|0
2974914|NCT01123980|10239133|P1|Overall Study|Lack of Efficacy|1
2974915|NCT01123980|10239132|P2|Overall Study|Adverse Event|1
2974916|NCT01123980|10239133|P1|Overall Study|Adverse Event|1
2974917|NCT01123941|10239153|P2|Overall Study|Lost to Follow-up|1
2974918|NCT01123941|10239154|P1|Overall Study|Lost to Follow-up|2
2974919|NCT01123889|10239189|P2|Overall Study|Lost to Follow-up|1
2974920|NCT01123889|10239190|P1|Overall Study|Lost to Follow-up|3
2974921|NCT01123850|10239200|P1|Overall Study|Slow enrollment|45
2974922|NCT01123655|10239207|P3|Overall Study|began prohibitive drug|1
2974923|NCT01123655|10239208|P2|Overall Study|began prohibitive drug|0
2974924|NCT01123655|10239209|P1|Overall Study|began prohibitive drug|0
2974925|NCT01123655|10239207|P3|Overall Study|new illness|0
2974926|NCT01123655|10239208|P2|Overall Study|new illness|1
2974927|NCT01123655|10239209|P1|Overall Study|new illness|0
2974928|NCT01123655|10239207|P3|Overall Study|Medication for RA had to be changed|0
2974929|NCT01123655|10239208|P2|Overall Study|Medication for RA had to be changed|0
2974930|NCT01123655|10239209|P1|Overall Study|Medication for RA had to be changed|1
2974931|NCT01123642|10239281|P1|Overall Study|ineligible at baseline assessment|36
2974932|NCT01123642|10239281|P1|Overall Study|Withdrawal by Subject|9
2974933|NCT01123642|10239281|P1|Overall Study|Lost to Follow-up|23
2974934|NCT01123395|10239297|P2|Washout Period of 14 Days|Withdrawal by Subject|1
2974935|NCT01123395|10239298|P1|Washout Period of 14 Days|Withdrawal by Subject|0
2974936|NCT01123382|10239310|P2|Overall Study|Lost to Follow-up|2
2974937|NCT01123382|10239311|P1|Overall Study|Lost to Follow-up|1
2974938|NCT01123382|10239310|P2|Overall Study|Withdrawal by Subject|4
2974939|NCT01123382|10239311|P1|Overall Study|Withdrawal by Subject|1
2974940|NCT01123356|10239333|P1|Overall Study|Withdrawal by Subject|1
2974941|NCT01123356|10239333|P1|Overall Study|Lack of Efficacy|4
2974942|NCT01123356|10239333|P1|Overall Study|Adverse Event|2
2974943|NCT01123200|10239341|P1|Overall Study|Withdrawal by Subject|1
2974944|NCT01123161|10239348|P2|Overall Study|Withdrawal by Subject|0
2974945|NCT01123161|10239349|P1|Overall Study|Withdrawal by Subject|1
2974946|NCT01123161|10239348|P2|Overall Study|Lost to Follow-up|0
2974947|NCT01123161|10239349|P1|Overall Study|Lost to Follow-up|1
2974948|NCT01123148|10239367|P1|Overall Study|Didn't meet milestone criteria|1
2974949|NCT01123148|10239367|P1|Overall Study|Coughing caused unacceptable EEG quality|1
2974950|NCT01123083|10239373|P2|Overall Study|Participant/legal representative request|3
2974951|NCT01123083|10239374|P1|Overall Study|Participant/legal representative request|7
2974952|NCT01123083|10239373|P2|Overall Study|Withdrew for another reason not covered|1
2974953|NCT01123083|10239374|P1|Overall Study|Withdrew for another reason not covered|0
2974954|NCT01123083|10239373|P2|Overall Study|Adverse Event|0
2974955|NCT01123083|10239374|P1|Overall Study|Adverse Event|1
2974956|NCT01123083|10239373|P2|Overall Study|Lost to Follow-up|6
2974957|NCT01123083|10239374|P1|Overall Study|Lost to Follow-up|2
2974958|NCT01123083|10239373|P2|Overall Study|Administrative reasons|4
2974959|NCT01123083|10239374|P1|Overall Study|Administrative reasons|0
2974960|NCT01123083|10239373|P2|Overall Study|Investigator recommendation|1
2974961|NCT01123083|10239374|P1|Overall Study|Investigator recommendation|1
2974962|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
2974963|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
2974964|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
2974965|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
2974966|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
2974967|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
2974968|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
2974969|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
2974970|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
2974971|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
2974972|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
2974973|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
2974974|NCT01122927|10239398|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
2974975|NCT01122927|10239399|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
2974976|NCT01122927|10239398|P2|Period 1 - Conversion Phase|Protocol Deviation|0
2974977|NCT01122927|10239399|P1|Period 1 - Conversion Phase|Protocol Deviation|1
2974978|NCT01122927|10239398|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
2974979|NCT01122927|10239399|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
2974980|NCT01122927|10239398|P2|Period 1 - Conversion Phase|Physician Decision|0
2974981|NCT01122927|10239399|P1|Period 1 - Conversion Phase|Physician Decision|2
2974982|NCT01122927|10239398|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2974983|NCT01122927|10239399|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2974984|NCT01122927|10239398|P2|Period 1 - Conversion Phase|Adverse Event|0
2974985|NCT01122927|10239399|P1|Period 1 - Conversion Phase|Adverse Event|3
2974986|NCT01122862|10239451|P3|Period 2|Adverse Event|1
2974987|NCT01122862|10239452|P2|Period 2|Adverse Event|0
2974988|NCT01122862|10239453|P1|Period 2|Adverse Event|0
2974989|NCT01122862|10239451|P3|Period 1|Protocol Violation|0
2974990|NCT01122862|10239452|P2|Period 1|Protocol Violation|1
2974991|NCT01122862|10239453|P1|Period 1|Protocol Violation|0
2974992|NCT01122680|10239559|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
2974993|NCT01122680|10239560|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
2974994|NCT01122680|10239561|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
2974995|NCT01122680|10239562|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
2974996|NCT01122680|10239559|P4|Period 3 (4 Weeks)|Adverse Event|0
2974997|NCT01122680|10239560|P3|Period 3 (4 Weeks)|Adverse Event|0
2974998|NCT01122680|10239561|P2|Period 3 (4 Weeks)|Adverse Event|0
2974999|NCT01122680|10239562|P1|Period 3 (4 Weeks)|Adverse Event|1
2975000|NCT01122680|10239559|P4|Period 2 (4 Weeks)|Other|0
2975001|NCT01122680|10239560|P3|Period 2 (4 Weeks)|Other|0
2975002|NCT01122680|10239561|P2|Period 2 (4 Weeks)|Other|0
2975003|NCT01122680|10239562|P1|Period 2 (4 Weeks)|Other|1
2975004|NCT01122680|10239559|P4|Period 2 (4 Weeks)|Protocol Violation|1
2975005|NCT01122680|10239560|P3|Period 2 (4 Weeks)|Protocol Violation|0
2975006|NCT01122680|10239561|P2|Period 2 (4 Weeks)|Protocol Violation|0
2975007|NCT01122680|10239562|P1|Period 2 (4 Weeks)|Protocol Violation|0
2975008|NCT01122680|10239559|P4|Period 1 (4 Weeks)|Other|0
2975009|NCT01122680|10239560|P3|Period 1 (4 Weeks)|Other|0
2975010|NCT01122680|10239561|P2|Period 1 (4 Weeks)|Other|1
2975011|NCT01122680|10239562|P1|Period 1 (4 Weeks)|Other|1
2975012|NCT01122680|10239559|P4|Period 1 (4 Weeks)|Protocol Violation|0
2975013|NCT01122680|10239560|P3|Period 1 (4 Weeks)|Protocol Violation|0
2975014|NCT01122680|10239561|P2|Period 1 (4 Weeks)|Protocol Violation|0
2975015|NCT01122680|10239562|P1|Period 1 (4 Weeks)|Protocol Violation|1
2975016|NCT01122680|10239559|P4|Period 1 (4 Weeks)|Adverse Event|0
2975017|NCT01122680|10239560|P3|Period 1 (4 Weeks)|Adverse Event|0
2975018|NCT01122680|10239561|P2|Period 1 (4 Weeks)|Adverse Event|0
2975019|NCT01122680|10239562|P1|Period 1 (4 Weeks)|Adverse Event|1
2975020|NCT01122576|10239627|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
2975021|NCT01122576|10239628|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
2975022|NCT01122576|10239629|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
2975023|NCT01122576|10239627|P3|Post-Cataract Surgery|Central Macular Edema|1
2975024|NCT01122576|10239628|P2|Post-Cataract Surgery|Central Macular Edema|0
2975025|NCT01122576|10239629|P1|Post-Cataract Surgery|Central Macular Edema|0
2975026|NCT01122576|10239627|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
2975027|NCT01122576|10239628|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
2975028|NCT01122576|10239629|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
2975029|NCT01122394|10239810|P2|Overall Study|Adverse Event|1
2975030|NCT01122394|10239811|P1|Overall Study|Adverse Event|0
2975031|NCT01122394|10239810|P2|Overall Study|Lost to Follow-up|2
2975032|NCT01122394|10239811|P1|Overall Study|Lost to Follow-up|2
2975033|NCT01122394|10239810|P2|Overall Study|Withdrawal by Subject|1
2975034|NCT01122394|10239811|P1|Overall Study|Withdrawal by Subject|1
2975035|NCT01122381|10239827|P2|Overall Study|study terminated early|1
2975036|NCT01122381|10239828|P1|Overall Study|study terminated early|0
2975037|NCT01122264|10239837|P3|Overall Study|Lack of Efficacy|1
2975038|NCT01122264|10239838|P2|Overall Study|Lack of Efficacy|1
2975039|NCT01122264|10239839|P1|Overall Study|Lack of Efficacy|3
2975040|NCT01122264|10239837|P3|Overall Study|Physician Decision|1
2975041|NCT01122264|10239838|P2|Overall Study|Physician Decision|1
2975042|NCT01122264|10239839|P1|Overall Study|Physician Decision|3
2975043|NCT01122264|10239837|P3|Overall Study|Withdrawal by Subject|16
2975044|NCT01122264|10239838|P2|Overall Study|Withdrawal by Subject|6
2975045|NCT01122264|10239839|P1|Overall Study|Withdrawal by Subject|6
2975046|NCT01122264|10239837|P3|Overall Study|Protocol Violation|9
2975047|NCT01122264|10239838|P2|Overall Study|Protocol Violation|7
2975048|NCT01122264|10239839|P1|Overall Study|Protocol Violation|7
2975049|NCT01122264|10239837|P3|Overall Study|Entry Criteria Not Met|0
2975050|NCT01122264|10239838|P2|Overall Study|Entry Criteria Not Met|0
2975051|NCT01122264|10239839|P1|Overall Study|Entry Criteria Not Met|1
2975052|NCT01122264|10239837|P3|Overall Study|Lost to Follow-up|13
2975053|NCT01122264|10239838|P2|Overall Study|Lost to Follow-up|9
2975054|NCT01122264|10239839|P1|Overall Study|Lost to Follow-up|5
2975055|NCT01122264|10239837|P3|Overall Study|Death|0
2975056|NCT01122264|10239838|P2|Overall Study|Death|0
2975057|NCT01122264|10239839|P1|Overall Study|Death|1
2975058|NCT01122264|10239837|P3|Overall Study|Adverse Event|7
2975059|NCT01122264|10239838|P2|Overall Study|Adverse Event|5
2975060|NCT01122264|10239839|P1|Overall Study|Adverse Event|6
2975061|NCT01122173|10239949|P1|Overall Study|Left study for other reasons|3
2975062|NCT01122173|10239949|P1|Overall Study|Withdrawal by Subject|3
2975063|NCT01122173|10239949|P1|Overall Study|Lost to Follow-up|3
2975064|NCT01121991|10240172|P1|Overall Study|No Fertilization|1
2975065|NCT01121991|10240172|P1|Overall Study|No Oocytes Retrieved|3
2975066|NCT01121991|10240172|P1|Overall Study|Lack of Ovarian Response|2
2975067|NCT01121926|10240197|P2|Washout Period|Positive pregnancy test|1
2975068|NCT01121926|10240198|P1|Washout Period|Positive pregnancy test|0
2975069|NCT01121926|10240197|P2|Washout Period|Adverse Event|1
2975070|NCT01121926|10240198|P1|Washout Period|Adverse Event|0
2975071|NCT01121926|10240197|P2|First Intervention Period|Adverse Event|0
2975072|NCT01121926|10240198|P1|First Intervention Period|Adverse Event|1
2975073|NCT01121913|10240216|P4|Third Washout Period|Adverse Event|0
2975074|NCT01121913|10240217|P3|Third Washout Period|Adverse Event|0
2975075|NCT01121913|10240218|P2|Third Washout Period|Adverse Event|0
2975076|NCT01121913|10240219|P1|Third Washout Period|Adverse Event|1
2975077|NCT01121913|10240216|P4|Second Washout Period|Withdrawal by Subject|0
2975078|NCT01121913|10240217|P3|Second Washout Period|Withdrawal by Subject|1
2975079|NCT01121913|10240218|P2|Second Washout Period|Withdrawal by Subject|0
2975080|NCT01121913|10240219|P1|Second Washout Period|Withdrawal by Subject|0
2975081|NCT01121913|10240216|P4|Second Intervention Period|Adverse Event|0
2975082|NCT01121913|10240217|P3|Second Intervention Period|Adverse Event|1
2975083|NCT01121913|10240218|P2|Second Intervention Period|Adverse Event|0
2975084|NCT01121913|10240219|P1|Second Intervention Period|Adverse Event|0
2975085|NCT01121913|10240216|P4|First Washout Period|Withdrawal by Subject|0
2975086|NCT01121913|10240217|P3|First Washout Period|Withdrawal by Subject|0
2975087|NCT01121913|10240218|P2|First Washout Period|Withdrawal by Subject|0
2975088|NCT01121913|10240219|P1|First Washout Period|Withdrawal by Subject|1
2975089|NCT01121913|10240216|P4|First Intervention Period|Adverse Event|0
2975090|NCT01121913|10240217|P3|First Intervention Period|Adverse Event|1
2975091|NCT01121913|10240218|P2|First Intervention Period|Adverse Event|0
2975092|NCT01121913|10240219|P1|First Intervention Period|Adverse Event|0
2975093|NCT01121900|10240249|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2975094|NCT01121900|10240250|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2975095|NCT01121900|10240249|P2|First Intervention Period|Adverse Event|1
2975096|NCT01121900|10240250|P1|First Intervention Period|Adverse Event|1
2975097|NCT01121757|10240270|P2|Combination|Disease Progression|0
2975098|NCT01121757|10240271|P1|Combination|Disease Progression|2
2975099|NCT01121757|10240270|P2|Combination|Physician Decision|1
2975100|NCT01121757|10240271|P1|Combination|Physician Decision|0
2975101|NCT01121757|10240270|P2|First Drug|Disease Progression|2
2975102|NCT01121757|10240271|P1|First Drug|Disease Progression|0
2975103|NCT01121757|10240270|P2|First Drug|Death|0
2975104|NCT01121757|10240271|P1|First Drug|Death|1
2975105|NCT01121666|10240287|P2|Overall Study|Protocol Violation|10
2975106|NCT01121666|10240288|P1|Overall Study|Protocol Violation|29
2975107|NCT01121575|10240344|P6|Overall Study|Death|1
2975108|NCT01121575|10240345|P5|Overall Study|Death|7
2975109|NCT01121575|10240346|P4|Overall Study|Death|1
2975110|NCT01121575|10240347|P3|Overall Study|Death|0
2975111|NCT01121575|10240348|P2|Overall Study|Death|0
2975112|NCT01121575|10240349|P1|Overall Study|Death|6
2975113|NCT01121575|10240344|P6|Overall Study|Unspecified Reasons|10
2975114|NCT01121575|10240345|P5|Overall Study|Unspecified Reasons|13
2975115|NCT01121575|10240346|P4|Overall Study|Unspecified Reasons|5
2975116|NCT01121575|10240347|P3|Overall Study|Unspecified Reasons|7
2975117|NCT01121575|10240348|P2|Overall Study|Unspecified Reasons|6
2975118|NCT01121575|10240349|P1|Overall Study|Unspecified Reasons|8
2975119|NCT01121575|10240344|P6|Overall Study|Participant Refused Further Follow-Up|1
2975120|NCT01121575|10240345|P5|Overall Study|Participant Refused Further Follow-Up|5
2975121|NCT01121575|10240346|P4|Overall Study|Participant Refused Further Follow-Up|0
2975122|NCT01121575|10240347|P3|Overall Study|Participant Refused Further Follow-Up|0
2975123|NCT01121575|10240348|P2|Overall Study|Participant Refused Further Follow-Up|0
2975124|NCT01121575|10240349|P1|Overall Study|Participant Refused Further Follow-Up|0
2975125|NCT01121562|10240473|P1|Overall Study|Met study discontinuation criteria|1
2975126|NCT01121562|10240473|P1|Overall Study|Sponsor Decision|1
2975127|NCT01121562|10240473|P1|Overall Study|Adverse Event|1
2975128|NCT01121562|10240473|P1|Overall Study|Withdrawal by Subject|1
2975129|NCT01121562|10240473|P1|Overall Study|Objective progression or relapse|8
2975130|NCT01121549|10240482|P1|Overall Study|Other|58
2975131|NCT01121549|10240482|P1|Overall Study|Withdrawal by Subject|16
2975132|NCT01121549|10240482|P1|Overall Study|Protocol Violation|33
2975133|NCT01121549|10240482|P1|Overall Study|Pregnancy|1
2975134|NCT01121549|10240482|P1|Overall Study|Study terminated by sponsor|197
2975135|NCT01121549|10240482|P1|Overall Study|Did not meet entrance criteria|9
2975136|NCT01121549|10240482|P1|Overall Study|Lost to Follow-up|12
2975137|NCT01121549|10240482|P1|Overall Study|Lack of Efficacy|11
2975138|NCT01121549|10240482|P1|Overall Study|Adverse Event|10
2975139|NCT01121536|10240493|P1|Overall Study|Other|118
2975140|NCT01121536|10240493|P1|Overall Study|Lost to Follow-up|39
2975141|NCT01121536|10240493|P1|Overall Study|Noncompliance with study procedures|9
2975142|NCT01121536|10240493|P1|Overall Study|Noncompliance with study medication|12
2975143|NCT01121536|10240493|P1|Overall Study|Protocol Violation|20
2975144|NCT01121536|10240493|P1|Overall Study|Withdrawal by Subject|65
2975145|NCT01121536|10240493|P1|Overall Study|Lack of Efficacy|35
2975146|NCT01121536|10240493|P1|Overall Study|Adverse Event|63
2975147|NCT01121484|10240514|P2|Overall Study|Randomized, not treated|4
2975148|NCT01121484|10240515|P1|Overall Study|Randomized, not treated|1
2975149|NCT01121484|10240514|P2|Overall Study|Other|3
2975150|NCT01121484|10240515|P1|Overall Study|Other|3
2975151|NCT01121484|10240514|P2|Overall Study|Discontinuation of study by sponsor|1
2975152|NCT01121484|10240515|P1|Overall Study|Discontinuation of study by sponsor|0
2975153|NCT01121484|10240514|P2|Overall Study|Withdrawal by Subject|7
2975154|NCT01121484|10240515|P1|Overall Study|Withdrawal by Subject|8
2975155|NCT01121484|10240514|P2|Overall Study|Protocol Violation|0
2975156|NCT01121484|10240515|P1|Overall Study|Protocol Violation|1
2975157|NCT01121484|10240514|P2|Overall Study|Physician Decision|3
2975158|NCT01121484|10240515|P1|Overall Study|Physician Decision|0
2975159|NCT01121484|10240514|P2|Overall Study|Lost to Follow-up|9
2975160|NCT01121484|10240515|P1|Overall Study|Lost to Follow-up|5
2975161|NCT01121484|10240514|P2|Overall Study|Lack of Efficacy|11
2975162|NCT01121484|10240515|P1|Overall Study|Lack of Efficacy|3
2975163|NCT01121484|10240514|P2|Overall Study|Adverse Event|5
2975164|NCT01121484|10240515|P1|Overall Study|Adverse Event|12
2975165|NCT01121406|10240533|P2|Overall Study|Not treated|0
2975166|NCT01121406|10240534|P1|Overall Study|Not treated|1
2975167|NCT01121406|10240533|P2|Overall Study|Reason other than specified above|6
2975168|NCT01121406|10240534|P1|Overall Study|Reason other than specified above|2
2975169|NCT01121406|10240533|P2|Overall Study|Refused continuation of study med.|2
2975170|NCT01121406|10240534|P1|Overall Study|Refused continuation of study med.|1
2975171|NCT01121406|10240533|P2|Overall Study|Lost to Follow-up|1
2975172|NCT01121406|10240534|P1|Overall Study|Lost to Follow-up|0
2975173|NCT01121406|10240533|P2|Overall Study|Non−compliant with protocol|2
2975174|NCT01121406|10240534|P1|Overall Study|Non−compliant with protocol|0
2975175|NCT01121406|10240533|P2|Overall Study|Other AE|10
2975176|NCT01121406|10240534|P1|Overall Study|Other AE|3
2975177|NCT01121406|10240533|P2|Overall Study|Wors. or AE of underlying cancer disease|6
2975178|NCT01121406|10240534|P1|Overall Study|Wors. or AE of underlying cancer disease|4
2975179|NCT01121406|10240533|P2|Overall Study|Progressive disease RECIST|28
2975180|NCT01121406|10240534|P1|Overall Study|Progressive disease RECIST|44
2975181|NCT01121393|10240584|P2|Overall Study|Other than listed|0
2975182|NCT01121393|10240585|P1|Overall Study|Other than listed|6
2975183|NCT01121393|10240584|P2|Overall Study|Not treated|9
2975184|NCT01121393|10240585|P1|Overall Study|Not treated|3
2975185|NCT01121393|10240584|P2|Overall Study|Refused cont. medication|7
2975186|NCT01121393|10240585|P1|Overall Study|Refused cont. medication|7
2975187|NCT01121393|10240584|P2|Overall Study|Lost to Follow-up|0
2975188|NCT01121393|10240585|P1|Overall Study|Lost to Follow-up|1
2975189|NCT01121393|10240584|P2|Overall Study|Non-compliant with protocol|3
2975190|NCT01121393|10240585|P1|Overall Study|Non-compliant with protocol|0
2975191|NCT01121393|10240584|P2|Overall Study|Other Adverse events|45
2975192|NCT01121393|10240585|P1|Overall Study|Other Adverse events|24
2975193|NCT01121393|10240584|P2|Overall Study|Progressive disease|20
2975194|NCT01121393|10240585|P1|Overall Study|Progressive disease|201
2975195|NCT01121263|10240630|P2|Overall Study|Withdrawal by Subject|1
2975196|NCT01121263|10240631|P1|Overall Study|Withdrawal by Subject|0
2975197|NCT01121263|10240630|P2|Overall Study|Lost to Follow-up|12
2975198|NCT01121263|10240631|P1|Overall Study|Lost to Follow-up|22
2975199|NCT01121263|10240630|P2|Overall Study|Death|2
2975200|NCT01121263|10240631|P1|Overall Study|Death|3
2975201|NCT01121185|10240722|P2|Overall Study|Not transplanted|0
2975202|NCT01121185|10240723|P1|Overall Study|Not transplanted|1
2975203|NCT01121185|10240722|P2|Overall Study|Not infused|1
2975204|NCT01121185|10240723|P1|Overall Study|Not infused|0
2975205|NCT01121146|10240757|P2|Overall Study|Lost to Follow-up|16
2975206|NCT01121146|10240758|P1|Overall Study|Lost to Follow-up|7
2975207|NCT01121146|10240757|P2|Overall Study|Adverse Event|11
2975208|NCT01121146|10240758|P1|Overall Study|Adverse Event|2
2975209|NCT01121146|10240757|P2|Overall Study|Death|15
2975210|NCT01121146|10240758|P1|Overall Study|Death|17
2975211|NCT01120899|10240779|P1|Overall Study|Withdrawal by Subject|3
2975212|NCT01120782|10240807|P1|Overall Study|Test article shipping error|11
2975213|NCT01120756|10240813|P2|Overall Study|Withdrawal by Subject|1
2975214|NCT01120756|10240814|P1|Overall Study|Withdrawal by Subject|1
2975215|NCT01120717|10240824|P2|Overall Study|Abnormal Test Procedure Result(s)|0
2975216|NCT01120717|10240825|P1|Overall Study|Abnormal Test Procedure Result(s)|1
2975217|NCT01120717|10240824|P2|Overall Study|Death|1
2975218|NCT01120717|10240825|P1|Overall Study|Death|3
2975219|NCT01120717|10240824|P2|Overall Study|Lost to Follow-up|3
2975220|NCT01120717|10240825|P1|Overall Study|Lost to Follow-up|2
2975221|NCT01120717|10240824|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
2975222|NCT01120717|10240825|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
2975223|NCT01120717|10240824|P2|Overall Study|Protocol Deviation|5
2975224|NCT01120717|10240825|P1|Overall Study|Protocol Deviation|2
2975225|NCT01120717|10240824|P2|Overall Study|Adverse Event|6
2975226|NCT01120717|10240825|P1|Overall Study|Adverse Event|10
2975227|NCT01120717|10240824|P2|Overall Study|Withdrawal by Subject|6
2975228|NCT01120717|10240825|P1|Overall Study|Withdrawal by Subject|11
2975229|NCT01120691|10240931|P3|Overall Study|Abnormal laboratory value(s)|4
2975230|NCT01120691|10240932|P2|Overall Study|Abnormal laboratory value(s)|3
2975231|NCT01120691|10240933|P1|Overall Study|Abnormal laboratory value(s)|1
2975232|NCT01120691|10240931|P3|Overall Study|Patient's inability to use the device|0
2975233|NCT01120691|10240932|P2|Overall Study|Patient's inability to use the device|1
2975234|NCT01120691|10240933|P1|Overall Study|Patient's inability to use the device|3
2975235|NCT01120691|10240931|P3|Overall Study|Abnormal test procedure result(s)|1
2975236|NCT01120691|10240932|P2|Overall Study|Abnormal test procedure result(s)|2
2975237|NCT01120691|10240933|P1|Overall Study|Abnormal test procedure result(s)|3
2975238|NCT01120691|10240931|P3|Overall Study|Lost to Follow-up|4
2975239|NCT01120691|10240932|P2|Overall Study|Lost to Follow-up|6
2975240|NCT01120691|10240933|P1|Overall Study|Lost to Follow-up|5
2975241|NCT01120691|10240931|P3|Overall Study|Protocol deviation|12
2975242|NCT01120691|10240932|P2|Overall Study|Protocol deviation|12
2975243|NCT01120691|10240933|P1|Overall Study|Protocol deviation|13
2975244|NCT01120691|10240931|P3|Overall Study|Administrative problems|9
2975245|NCT01120691|10240932|P2|Overall Study|Administrative problems|8
2975246|NCT01120691|10240933|P1|Overall Study|Administrative problems|15
2975247|NCT01120691|10240931|P3|Overall Study|Unsatisfactory therapeutic effect|38
2975248|NCT01120691|10240932|P2|Overall Study|Unsatisfactory therapeutic effect|32
2975249|NCT01120691|10240933|P1|Overall Study|Unsatisfactory therapeutic effect|18
2975250|NCT01120691|10240931|P3|Overall Study|Death|24
2975251|NCT01120691|10240932|P2|Overall Study|Death|22
2975252|NCT01120691|10240933|P1|Overall Study|Death|21
2975253|NCT01120691|10240931|P3|Overall Study|Subject withdrew consent|44
2975254|NCT01120691|10240932|P2|Overall Study|Subject withdrew consent|50
2975255|NCT01120691|10240933|P1|Overall Study|Subject withdrew consent|33
2975256|NCT01120691|10240931|P3|Overall Study|Adverse Event|47
2975257|NCT01120691|10240932|P2|Overall Study|Adverse Event|67
2975258|NCT01120691|10240933|P1|Overall Study|Adverse Event|59
2975259|NCT01120626|10241030|P2|Overall Study|Withdrawal by Subject|0
2975260|NCT01120626|10241031|P1|Overall Study|Withdrawal by Subject|1
2975261|NCT01120600|10241041|P2|Overall Study|Withdrawal by Subject|11
2975262|NCT01120600|10241042|P1|Overall Study|Withdrawal by Subject|10
2975263|NCT01120600|10241041|P2|Overall Study|Protocol Violation|4
2975264|NCT01120600|10241042|P1|Overall Study|Protocol Violation|0
2975265|NCT01120600|10241041|P2|Overall Study|Physician Decision|3
2975266|NCT01120600|10241042|P1|Overall Study|Physician Decision|1
2975267|NCT01120600|10241041|P2|Overall Study|Lost to Follow-up|3
2975268|NCT01120600|10241042|P1|Overall Study|Lost to Follow-up|1
2975269|NCT01120600|10241041|P2|Overall Study|Excessive Bone Loss|4
2975270|NCT01120600|10241042|P1|Overall Study|Excessive Bone Loss|0
2975271|NCT01120600|10241041|P2|Overall Study|Adverse Event|7
2975272|NCT01120600|10241042|P1|Overall Study|Adverse Event|7
2975273|NCT01120379|10241097|P1|Four Year Timepoint|Any other reason for early termination|217
2975274|NCT01120379|10241097|P1|Four Year Timepoint|Physician Decision|5
2975275|NCT01120379|10241097|P1|Four Year Timepoint|Death|131
2975276|NCT01120379|10241097|P1|Four Year Timepoint|Lost to Follow-up|10
2975277|NCT01120379|10241097|P1|Four Year Timepoint|Withdrawal by Subject|5
2975278|NCT01120379|10241097|P1|Three Year Timepoint|Any other reason for early termination|17
2975279|NCT01120379|10241097|P1|Three Year Timepoint|Physician Decision|9
2975280|NCT01120379|10241097|P1|Three Year Timepoint|Death|120
2975281|NCT01120379|10241097|P1|Three Year Timepoint|Lost to Follow-up|43
2975282|NCT01120379|10241097|P1|Three Year Timepoint|Withdrawal by Subject|25
2975283|NCT01120379|10241097|P1|Two Year Timepoint|Any other reason for early termination|4
2975284|NCT01120379|10241097|P1|Two Year Timepoint|Physician Decision|12
2975285|NCT01120379|10241097|P1|Two Year Timepoint|Death|123
2975286|NCT01120379|10241097|P1|Two Year Timepoint|Lost to Follow-up|87
2975287|NCT01120379|10241097|P1|Two Year Timepoint|Withdrawal by Subject|11
2975288|NCT01120379|10241097|P1|One Year Timepoint|Any other reason for early termination|5
2975289|NCT01120379|10241097|P1|One Year Timepoint|Physician Decision|9
2975290|NCT01120379|10241097|P1|One Year Timepoint|Death|108
2975291|NCT01120379|10241097|P1|One Year Timepoint|Lost to Follow-up|115
2975292|NCT01120379|10241097|P1|One Year Timepoint|Withdrawal by Subject|41
2975293|NCT01120275|10241133|P1|Overall Study|Not specific|1
2975294|NCT01120275|10241133|P1|Overall Study|Refusal|1
2975295|NCT01120275|10241133|P1|Overall Study|Withdrawal by Subject|1
2975296|NCT01120275|10241133|P1|Overall Study|Ineligible|3
2975297|NCT01120275|10241133|P1|Overall Study|Progression|27
2975298|NCT01120275|10241133|P1|Overall Study|Adverse Event|3
2975299|NCT01120210|10241200|P2|MAIN INFUSION|Withdrawal by Subject|1
2975300|NCT01120210|10241201|P1|MAIN INFUSION|Withdrawal by Subject|0
2975301|NCT01120210|10241200|P2|MAIN INFUSION|Adverse Event|0
2975302|NCT01120210|10241201|P1|MAIN INFUSION|Adverse Event|1
2975303|NCT01120184|10241251|P3|Overall Study|Death|169
2975304|NCT01120184|10241252|P2|Overall Study|Death|176
2975305|NCT01120184|10241253|P1|Overall Study|Death|170
2975306|NCT01120184|10241251|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
2975307|NCT01120184|10241252|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
2975308|NCT01120184|10241253|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
2975309|NCT01120184|10241251|P3|Overall Study|Sponsor Decision to Terminate Study|143
2975310|NCT01120184|10241252|P2|Overall Study|Sponsor Decision to Terminate Study|144
2975311|NCT01120184|10241253|P1|Overall Study|Sponsor Decision to Terminate Study|133
2975312|NCT01120184|10241251|P3|Overall Study|Reason not Specified|12
2975313|NCT01120184|10241252|P2|Overall Study|Reason not Specified|3
2975314|NCT01120184|10241253|P1|Overall Study|Reason not Specified|8
2975315|NCT01120184|10241251|P3|Overall Study|Physician Decision|3
2975316|NCT01120184|10241252|P2|Overall Study|Physician Decision|1
2975317|NCT01120184|10241253|P1|Overall Study|Physician Decision|9
2975318|NCT01120184|10241251|P3|Overall Study|Lost to Follow-up|11
2975319|NCT01120184|10241252|P2|Overall Study|Lost to Follow-up|13
2975320|NCT01120184|10241253|P1|Overall Study|Lost to Follow-up|13
2975321|NCT01120184|10241251|P3|Overall Study|Adverse Event|0
2975322|NCT01120184|10241252|P2|Overall Study|Adverse Event|1
2975323|NCT01120184|10241253|P1|Overall Study|Adverse Event|0
2975324|NCT01120093|10241375|P5|Treatment Period 5|Adverse Event|0
2975325|NCT01120093|10241376|P4|Treatment Period 5|Adverse Event|1
2975326|NCT01120093|10241377|P3|Treatment Period 5|Adverse Event|0
2975327|NCT01120093|10241378|P2|Treatment Period 5|Adverse Event|1
2975328|NCT01120093|10241379|P1|Treatment Period 5|Adverse Event|0
2975329|NCT01120093|10241375|P5|Treatment Period 4|Adverse Event|0
2975330|NCT01120093|10241376|P4|Treatment Period 4|Adverse Event|0
2975331|NCT01120093|10241377|P3|Treatment Period 4|Adverse Event|0
2975332|NCT01120093|10241378|P2|Treatment Period 4|Adverse Event|0
2975333|NCT01120093|10241379|P1|Treatment Period 4|Adverse Event|1
2975334|NCT01120093|10241375|P5|Treatment Period 3|Withdrawal by Subject|0
2975335|NCT01120093|10241376|P4|Treatment Period 3|Withdrawal by Subject|0
2975336|NCT01120093|10241377|P3|Treatment Period 3|Withdrawal by Subject|1
2975337|NCT01120093|10241378|P2|Treatment Period 3|Withdrawal by Subject|0
2975338|NCT01120093|10241379|P1|Treatment Period 3|Withdrawal by Subject|0
2975339|NCT01120093|10241375|P5|Treatment Period 3|Adverse Event|1
2975340|NCT01120093|10241376|P4|Treatment Period 3|Adverse Event|0
2975341|NCT01120093|10241377|P3|Treatment Period 3|Adverse Event|0
2975342|NCT01120093|10241378|P2|Treatment Period 3|Adverse Event|0
2975343|NCT01120093|10241379|P1|Treatment Period 3|Adverse Event|0
2975344|NCT01120093|10241375|P5|Treatment Period 3|Lack of Efficacy|0
2975345|NCT01120093|10241376|P4|Treatment Period 3|Lack of Efficacy|1
2975346|NCT01120093|10241377|P3|Treatment Period 3|Lack of Efficacy|0
2975347|NCT01120093|10241378|P2|Treatment Period 3|Lack of Efficacy|0
2975348|NCT01120093|10241379|P1|Treatment Period 3|Lack of Efficacy|0
2975349|NCT01120093|10241375|P5|Treatment Period 2|Withdrawal by Subject|1
2975350|NCT01120093|10241376|P4|Treatment Period 2|Withdrawal by Subject|0
2975351|NCT01120093|10241377|P3|Treatment Period 2|Withdrawal by Subject|0
2975352|NCT01120093|10241378|P2|Treatment Period 2|Withdrawal by Subject|0
2975353|NCT01120093|10241379|P1|Treatment Period 2|Withdrawal by Subject|0
2975354|NCT01120093|10241375|P5|Treatment Period 2|Adverse Event|0
2975355|NCT01120093|10241376|P4|Treatment Period 2|Adverse Event|1
2975356|NCT01120093|10241377|P3|Treatment Period 2|Adverse Event|0
2975357|NCT01120093|10241378|P2|Treatment Period 2|Adverse Event|0
2975358|NCT01120093|10241379|P1|Treatment Period 2|Adverse Event|0
2975359|NCT01120093|10241375|P5|Treatment Period 1|Withdrawal by Subject|0
2975360|NCT01120093|10241376|P4|Treatment Period 1|Withdrawal by Subject|0
2975361|NCT01120093|10241377|P3|Treatment Period 1|Withdrawal by Subject|0
2975362|NCT01120093|10241378|P2|Treatment Period 1|Withdrawal by Subject|1
2975363|NCT01120093|10241379|P1|Treatment Period 1|Withdrawal by Subject|0
2975364|NCT01120093|10241375|P5|Treatment Period 1|Adverse Event|1
2975365|NCT01120093|10241376|P4|Treatment Period 1|Adverse Event|0
2975366|NCT01120093|10241377|P3|Treatment Period 1|Adverse Event|1
2975367|NCT01120093|10241378|P2|Treatment Period 1|Adverse Event|0
2975368|NCT01120093|10241379|P1|Treatment Period 1|Adverse Event|0
2975369|NCT01120067|10241408|P2|Overall Study|fail to engage >3 sessions|0
2975370|NCT01120067|10241409|P1|Overall Study|fail to engage >3 sessions|2
2975371|NCT01120067|10241408|P2|Overall Study|Lost to Follow-up|1
2975372|NCT01120067|10241409|P1|Overall Study|Lost to Follow-up|3
2975373|NCT01120028|10241419|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2975374|NCT01120028|10241420|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2975375|NCT01120028|10241421|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
2975376|NCT01120028|10241422|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
2975377|NCT01120028|10241419|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2975378|NCT01120028|10241420|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2975379|NCT01120028|10241421|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
2975380|NCT01120028|10241422|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2975381|NCT01119963|10241446|P2|Overall Study|Lost to Follow-up|1
2975382|NCT01119963|10241447|P1|Overall Study|Lost to Follow-up|1
2975383|NCT01119950|10241457|P1|Overall Study|Death|1
2975384|NCT01119950|10241457|P1|Overall Study|Abnormal lab value|1
2975385|NCT01119950|10241457|P1|Overall Study|Administrative|2
2975386|NCT01119950|10241457|P1|Overall Study|Lost to Follow-up|4
2975387|NCT01119950|10241457|P1|Overall Study|Protocol Violation|5
2975388|NCT01119950|10241457|P1|Overall Study|Withdrawal by Subject|9
2975389|NCT01119950|10241457|P1|Overall Study|Adverse Event|25
2975390|NCT01119937|10241704|P2|Overall Study|Withdrawal by Subject|1
2975391|NCT01119937|10241705|P1|Overall Study|Withdrawal by Subject|2
2975392|NCT01119937|10241704|P2|Overall Study|Unsatisfactory therapeutic effect|0
2975393|NCT01119937|10241705|P1|Overall Study|Unsatisfactory therapeutic effect|3
2975394|NCT01119937|10241704|P2|Overall Study|Protocol deviation|1
2975395|NCT01119937|10241705|P1|Overall Study|Protocol deviation|3
2975396|NCT01119937|10241704|P2|Overall Study|Adverse Event|5
2975397|NCT01119937|10241705|P1|Overall Study|Adverse Event|11
2975398|NCT01119898|10241733|P2|Overall Study|Randomized in error did not participate|0
2975399|NCT01119898|10241734|P1|Overall Study|Randomized in error did not participate|1
2975400|NCT01119898|10241733|P2|Overall Study|Medical procedure|0
2975401|NCT01119898|10241734|P1|Overall Study|Medical procedure|1
2975402|NCT01119898|10241733|P2|Overall Study|Protocol Violation|1
2975403|NCT01119898|10241734|P1|Overall Study|Protocol Violation|1
2975404|NCT01119898|10241733|P2|Overall Study|Lack of Efficacy|2
2975405|NCT01119898|10241734|P1|Overall Study|Lack of Efficacy|0
2975406|NCT01119898|10241733|P2|Overall Study|Withdrawal by Subject|4
2975407|NCT01119898|10241734|P1|Overall Study|Withdrawal by Subject|1
2975408|NCT01119898|10241733|P2|Overall Study|Adverse Event|5
2975409|NCT01119898|10241734|P1|Overall Study|Adverse Event|4
2975410|NCT01119859|10241760|P2|Overall Study|Failure to return|0
2975411|NCT01119859|10241761|P1|Overall Study|Failure to return|3
2975412|NCT01119859|10241760|P2|Overall Study|Refused treatment|6
2975413|NCT01119859|10241761|P1|Overall Study|Refused treatment|3
2975414|NCT01119859|10241760|P2|Overall Study|Insufficient therapeutic response|14
2975415|NCT01119859|10241761|P1|Overall Study|Insufficient therapeutic response|7
2975416|NCT01119859|10241760|P2|Overall Study|Death|0
2975417|NCT01119859|10241761|P1|Overall Study|Death|2
2975418|NCT01119859|10241760|P2|Overall Study|Adverse Event|10
2975419|NCT01119859|10241761|P1|Overall Study|Adverse Event|9
2975420|NCT01119846|10241780|P3|Overall Study|Withdrawal by Subject|4
2975421|NCT01119846|10241781|P2|Overall Study|Withdrawal by Subject|0
2975422|NCT01119846|10241782|P1|Overall Study|Withdrawal by Subject|0
2975423|NCT01119846|10241780|P3|Overall Study|Protocol Violation|1
2975424|NCT01119846|10241781|P2|Overall Study|Protocol Violation|0
2975425|NCT01119846|10241782|P1|Overall Study|Protocol Violation|0
2975426|NCT01119846|10241780|P3|Overall Study|Physician Decision|0
2975427|NCT01119846|10241781|P2|Overall Study|Physician Decision|0
2975428|NCT01119846|10241782|P1|Overall Study|Physician Decision|1
2975429|NCT01119846|10241780|P3|Overall Study|Adverse Event|6
2975430|NCT01119846|10241781|P2|Overall Study|Adverse Event|0
2975431|NCT01119846|10241782|P1|Overall Study|Adverse Event|1
2975432|NCT01119768|10241996|P2|Treatment Period|Lack of Efficacy|25
2975433|NCT01119768|10241997|P1|Treatment Period|Lack of Efficacy|18
2975434|NCT01119703|10242053|P2|Overall Study|Adverse Event|1
2975435|NCT01119703|10242054|P1|Overall Study|Adverse Event|0
2975436|NCT01119625|10242068|P2|Overall Study|Other|1
2975437|NCT01119625|10242069|P1|Overall Study|Other|0
2975438|NCT01119625|10242068|P2|Overall Study|Withdrawal by Subject|1
2975439|NCT01119625|10242069|P1|Overall Study|Withdrawal by Subject|2
2975440|NCT01119625|10242068|P2|Overall Study|Lost to Follow-up|2
2975441|NCT01119625|10242069|P1|Overall Study|Lost to Follow-up|1
2975442|NCT01119508|10242109|P1|Overall Study|Died before tumor response evaluation|1
2975443|NCT01119508|10242109|P1|Overall Study|Withdrawal by Subject|2
2975444|NCT01119508|10242109|P1|Overall Study|Adverse Event|56
2975445|NCT01119443|10242189|P2|Crossover Period 1 (5 Days)|Adverse Event|1
2975446|NCT01119443|10242190|P1|Crossover Period 1 (5 Days)|Adverse Event|0
2975447|NCT01119287|10242233|P6|Overall Study|Patient Decision, not related to AE|0
2975448|NCT01119287|10242234|P5|Overall Study|Patient Decision, not related to AE|1
2975449|NCT01119287|10242235|P4|Overall Study|Patient Decision, not related to AE|2
2975450|NCT01119287|10242236|P3|Overall Study|Patient Decision, not related to AE|2
2975451|NCT01119287|10242237|P2|Overall Study|Patient Decision, not related to AE|0
2975452|NCT01119287|10242238|P1|Overall Study|Patient Decision, not related to AE|0
2975453|NCT01119248|10242251|P1|Overall Study|Physician Decision|5
2975454|NCT01119131|10242301|P3|Overall Study|Physician Decision|1
2975455|NCT01119131|10242302|P2|Overall Study|Physician Decision|0
2975456|NCT01119131|10242303|P1|Overall Study|Physician Decision|0
2975457|NCT01119131|10242301|P3|Overall Study|Non-Compliance|4
2975458|NCT01119131|10242302|P2|Overall Study|Non-Compliance|0
2975459|NCT01119131|10242303|P1|Overall Study|Non-Compliance|1
2975460|NCT01119131|10242301|P3|Overall Study|Adverse Event|1
2975461|NCT01119131|10242302|P2|Overall Study|Adverse Event|1
2975462|NCT01119131|10242303|P1|Overall Study|Adverse Event|1
2975463|NCT01119118|10242332|P1|Overall Study|Adverse Event|1
2975464|NCT01119001|10242344|P1|Overall Study|Withdrawal by Subject|2
2975465|NCT01118975|10242388|P2|Overall Study|Adverse Event|1
2975466|NCT01118975|10242389|P1|Overall Study|Adverse Event|0
2975467|NCT01118962|10242395|P1|Overall Study|Non-compliance with Medicinal Product|1
2975468|NCT01118962|10242395|P1|Overall Study|Pregnancy|1
2975469|NCT01118962|10242395|P1|Overall Study|Withdrawal by Subject|4
2975470|NCT01118962|10242395|P1|Overall Study|Protocol Violation|1
2975471|NCT01118962|10242395|P1|Overall Study|Lack of Efficacy|1
2975472|NCT01118962|10242395|P1|Overall Study|Adverse Event|2
2975473|NCT01118949|10242400|P1|Overall Study|Withdrawal by Subject|4
2975474|NCT01118949|10242400|P1|Overall Study|Adverse Event|5
2975475|NCT01118780|10242430|P2|Overall Study|Withdrawal by Subject|8
2975476|NCT01118780|10242431|P1|Overall Study|Withdrawal by Subject|13
2975477|NCT01118780|10242430|P2|Overall Study|Protocol Violation|6
2975478|NCT01118780|10242431|P1|Overall Study|Protocol Violation|3
2975479|NCT01118780|10242430|P2|Overall Study|Physician Decision|0
2975480|NCT01118780|10242431|P1|Overall Study|Physician Decision|2
2975481|NCT01118780|10242430|P2|Overall Study|Lack of Efficacy|6
2975482|NCT01118780|10242431|P1|Overall Study|Lack of Efficacy|2
2975483|NCT01118780|10242430|P2|Overall Study|Death|0
2975484|NCT01118780|10242431|P1|Overall Study|Death|1
2975485|NCT01118780|10242430|P2|Overall Study|Adverse Event|15
2975486|NCT01118780|10242431|P1|Overall Study|Adverse Event|15
2975487|NCT01118728|10242489|P1|Overall Study|Lost to Follow-up|4
2975488|NCT01118728|10242489|P1|Overall Study|Withdrawal by Subject|3
2975489|NCT01118728|10242489|P1|Overall Study|Sponsor's decision to discontinue study|172
2975490|NCT01118728|10242489|P1|Overall Study|Lack of Efficacy|27
2975491|NCT01118728|10242489|P1|Overall Study|Adverse Event|17
2975492|NCT01118663|10242496|P2|Overall Study|Withdrawal by Subject|1
2975493|NCT01118663|10242497|P1|Overall Study|Withdrawal by Subject|0
2975494|NCT01118663|10242496|P2|Overall Study|Adverse Event|1
2975495|NCT01118663|10242497|P1|Overall Study|Adverse Event|2
2975496|NCT01118455|10242520|P2|Baseline [Visits 1 & 2]|Adverse Event|0
2975497|NCT01118455|10242521|P1|Baseline [Visits 1 & 2]|Adverse Event|1
2975498|NCT01118377|10242549|P1|Overall Study|Failure to Return|3
2975499|NCT01118377|10242549|P1|Overall Study|Death|38
2975500|NCT01118377|10242549|P1|Overall Study|Did Not Receive Study Medication|1
2975501|NCT01118351|10242555|P1|Overall Study|Withdrawal by Subject|1
2975502|NCT01118351|10242555|P1|Overall Study|Adverse Event|3
2975503|NCT01118325|10242566|P3|Overall Study|Adverse Event|1
2975504|NCT01118325|10242567|P2|Overall Study|Adverse Event|0
2975505|NCT01118325|10242568|P1|Overall Study|Adverse Event|1
2975506|NCT01118312|10242614|P2|Overall Study|Withdrawal by Subject|3
2975507|NCT01118312|10242615|P1|Overall Study|Withdrawal by Subject|1
2975508|NCT01118312|10242614|P2|Overall Study|Lost to Follow-up|32
2975509|NCT01118312|10242615|P1|Overall Study|Lost to Follow-up|33
2975510|NCT01118299|10242625|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
2975511|NCT01118299|10242626|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
2975512|NCT01118299|10242625|P2|Overall Study|Lost to Follow-up|1
2975513|NCT01118299|10242626|P1|Overall Study|Lost to Follow-up|2
2975514|NCT01118299|10242625|P2|Overall Study|Withdrawal by Subject|8
2975515|NCT01118299|10242626|P1|Overall Study|Withdrawal by Subject|8
2975516|NCT01118299|10242625|P2|Overall Study|Death|5
2975517|NCT01118299|10242626|P1|Overall Study|Death|7
2975518|NCT01118143|10242823|P2|Overall Study|Withdrawal by Subject|5
2975519|NCT01118143|10242824|P1|Overall Study|Withdrawal by Subject|2
2975520|NCT01118117|10242834|P2|Overall Study|Missed 12 Month Visit|0
2975521|NCT01118117|10242835|P1|Overall Study|Missed 12 Month Visit|7
2975522|NCT01118117|10242834|P2|Overall Study|Lost to Follow-up|0
2975523|NCT01118117|10242835|P1|Overall Study|Lost to Follow-up|6
2975524|NCT01118117|10242834|P2|Overall Study|Death|0
2975525|NCT01118117|10242835|P1|Overall Study|Death|8
2975526|NCT01118052|10242867|P1|Overall Study|Never treated|2
2975527|NCT01117987|10242890|P2|Overall Study|Administrative problems|22
2975528|NCT01117987|10242891|P1|Overall Study|Administrative problems|25
2975529|NCT01117987|10242890|P2|Overall Study|Adverse Event|26
2975530|NCT01117987|10242891|P1|Overall Study|Adverse Event|19
2975531|NCT01117987|10242890|P2|Overall Study|Withdrawal by Subject|10
2975532|NCT01117987|10242891|P1|Overall Study|Withdrawal by Subject|5
2975533|NCT01117987|10242890|P2|Overall Study|Death|10
2975534|NCT01117987|10242891|P1|Overall Study|Death|5
2975535|NCT01117987|10242890|P2|Overall Study|Lack of Efficacy|4
2975536|NCT01117987|10242891|P1|Overall Study|Lack of Efficacy|3
2975537|NCT01117987|10242890|P2|Overall Study|Abnormal test procedure result|0
2975538|NCT01117987|10242891|P1|Overall Study|Abnormal test procedure result|2
2975539|NCT01117987|10242890|P2|Overall Study|Lost to Follow-up|1
2975540|NCT01117987|10242891|P1|Overall Study|Lost to Follow-up|1
2975541|NCT01117987|10242890|P2|Overall Study|Subject no longer requires study drug|0
2975542|NCT01117987|10242891|P1|Overall Study|Subject no longer requires study drug|1
2975543|NCT01117987|10242890|P2|Overall Study|Protocol deviation|1
2975544|NCT01117987|10242891|P1|Overall Study|Protocol deviation|0
2975545|NCT01117870|10242912|P2|Overall Study|Inability to place needle|0
2975546|NCT01117870|10242913|P1|Overall Study|Inability to place needle|1
2975547|NCT01117857|10242927|P1|Overall Study|Physician Decision|1
2975548|NCT01117857|10242927|P1|Overall Study|Withdrawal by Subject|4
2975549|NCT01117857|10242927|P1|Overall Study|Lost to Follow-up|4
2975550|NCT01117766|10242935|P2|Second Intervention|Withdrawal by Subject|1
2975551|NCT01117766|10242936|P1|Second Intervention|Withdrawal by Subject|0
2975552|NCT01117766|10242935|P2|Second Intervention|Adverse Event|2
2975553|NCT01117766|10242936|P1|Second Intervention|Adverse Event|0
2975554|NCT01117766|10242935|P2|Second Intervention|Other|2
2975555|NCT01117766|10242936|P1|Second Intervention|Other|1
2975556|NCT01117766|10242935|P2|Second Intervention|Lost to Follow-up|0
2975557|NCT01117766|10242936|P1|Second Intervention|Lost to Follow-up|1
2975558|NCT01117766|10242935|P2|Washout Period|Protocol Violation|2
2975559|NCT01117766|10242936|P1|Washout Period|Protocol Violation|0
2975560|NCT01117766|10242935|P2|First Intervention|Protocol Violation|0
2975561|NCT01117766|10242936|P1|First Intervention|Protocol Violation|1
2975562|NCT01117766|10242935|P2|First Intervention|Adverse Event|1
2975563|NCT01117766|10242936|P1|First Intervention|Adverse Event|0
2975564|NCT01117623|10242973|P8|Overall Study|Invest. text: completed all planned txs|0
2975565|NCT01117623|10242974|P7|Overall Study|Invest. text: completed all planned txs|0
2975566|NCT01117623|10242975|P6|Overall Study|Invest. text: completed all planned txs|1
2975567|NCT01117623|10242976|P5|Overall Study|Invest. text: completed all planned txs|0
2975568|NCT01117623|10242977|P4|Overall Study|Invest. text: completed all planned txs|0
2975569|NCT01117623|10242978|P3|Overall Study|Invest. text: completed all planned txs|0
2975570|NCT01117623|10242979|P2|Overall Study|Invest. text: completed all planned txs|0
2975571|NCT01117623|10242980|P1|Overall Study|Invest. text: completed all planned txs|0
2975572|NCT01117623|10242973|P8|Overall Study|Non-compliance with study medication|1
2975573|NCT01117623|10242974|P7|Overall Study|Non-compliance with study medication|0
2975574|NCT01117623|10242975|P6|Overall Study|Non-compliance with study medication|0
2975575|NCT01117623|10242976|P5|Overall Study|Non-compliance with study medication|0
2975576|NCT01117623|10242977|P4|Overall Study|Non-compliance with study medication|0
2975577|NCT01117623|10242978|P3|Overall Study|Non-compliance with study medication|0
2975578|NCT01117623|10242979|P2|Overall Study|Non-compliance with study medication|0
2975579|NCT01117623|10242980|P1|Overall Study|Non-compliance with study medication|0
2975580|NCT01117623|10242973|P8|Overall Study|Withdrawal by Subject|1
2975581|NCT01117623|10242974|P7|Overall Study|Withdrawal by Subject|1
2975582|NCT01117623|10242975|P6|Overall Study|Withdrawal by Subject|1
2975583|NCT01117623|10242976|P5|Overall Study|Withdrawal by Subject|0
2975584|NCT01117623|10242977|P4|Overall Study|Withdrawal by Subject|0
2975585|NCT01117623|10242978|P3|Overall Study|Withdrawal by Subject|2
2975586|NCT01117623|10242979|P2|Overall Study|Withdrawal by Subject|0
2975587|NCT01117623|10242980|P1|Overall Study|Withdrawal by Subject|0
2975588|NCT01117623|10242973|P8|Overall Study|Disease progression, recurrence, relapse|22
2975589|NCT01117623|10242974|P7|Overall Study|Disease progression, recurrence, relapse|5
2975590|NCT01117623|10242975|P6|Overall Study|Disease progression, recurrence, relapse|14
2975591|NCT01117623|10242976|P5|Overall Study|Disease progression, recurrence, relapse|8
2975592|NCT01117623|10242977|P4|Overall Study|Disease progression, recurrence, relapse|6
2975593|NCT01117623|10242978|P3|Overall Study|Disease progression, recurrence, relapse|5
2975594|NCT01117623|10242979|P2|Overall Study|Disease progression, recurrence, relapse|6
2975595|NCT01117623|10242980|P1|Overall Study|Disease progression, recurrence, relapse|3
2975596|NCT01117623|10242973|P8|Overall Study|Adverse Event|2
2975597|NCT01117623|10242974|P7|Overall Study|Adverse Event|0
2975598|NCT01117623|10242975|P6|Overall Study|Adverse Event|0
2975599|NCT01117623|10242976|P5|Overall Study|Adverse Event|2
2975600|NCT01117623|10242977|P4|Overall Study|Adverse Event|0
2975601|NCT01117623|10242978|P3|Overall Study|Adverse Event|4
2975602|NCT01117623|10242979|P2|Overall Study|Adverse Event|2
2975603|NCT01117623|10242980|P1|Overall Study|Adverse Event|0
2975604|NCT01117480|10243132|P1|Overall Study|Did Not Start Adalimumab Therapy|20
2975605|NCT01117480|10243132|P1|Overall Study|Protocol Violation|8
2975606|NCT01117454|10243140|P2|Overall Study|Pregnancy|1
2975607|NCT01117454|10243141|P1|Overall Study|Pregnancy|0
2975608|NCT01117428|10243153|P6|Overall Study|Progressive disease|17
2975609|NCT01117428|10243154|P5|Overall Study|Progressive disease|16
2975610|NCT01117428|10243155|P4|Overall Study|Progressive disease|12
2975611|NCT01117428|10243156|P3|Overall Study|Progressive disease|10
2975612|NCT01117428|10243157|P2|Overall Study|Progressive disease|27
2975613|NCT01117428|10243158|P1|Overall Study|Progressive disease|15
2975614|NCT01117428|10243153|P6|Overall Study|Withdrawal by Subject|0
2975615|NCT01117428|10243154|P5|Overall Study|Withdrawal by Subject|0
2975616|NCT01117428|10243155|P4|Overall Study|Withdrawal by Subject|0
2975617|NCT01117428|10243156|P3|Overall Study|Withdrawal by Subject|1
2975618|NCT01117428|10243157|P2|Overall Study|Withdrawal by Subject|0
2975619|NCT01117428|10243158|P1|Overall Study|Withdrawal by Subject|0
2975620|NCT01117428|10243153|P6|Overall Study|Physician Decision|0
2975621|NCT01117428|10243154|P5|Overall Study|Physician Decision|0
2975622|NCT01117428|10243155|P4|Overall Study|Physician Decision|0
2975623|NCT01117428|10243156|P3|Overall Study|Physician Decision|0
2975624|NCT01117428|10243157|P2|Overall Study|Physician Decision|1
2975625|NCT01117428|10243158|P1|Overall Study|Physician Decision|0
2975626|NCT01117428|10243153|P6|Overall Study|Death|1
2975627|NCT01117428|10243154|P5|Overall Study|Death|0
2975628|NCT01117428|10243155|P4|Overall Study|Death|0
2975629|NCT01117428|10243156|P3|Overall Study|Death|2
2975630|NCT01117428|10243157|P2|Overall Study|Death|1
2975631|NCT01117428|10243158|P1|Overall Study|Death|0
2975632|NCT01117428|10243153|P6|Overall Study|Adverse Event|2
2975633|NCT01117428|10243154|P5|Overall Study|Adverse Event|1
2975634|NCT01117428|10243155|P4|Overall Study|Adverse Event|0
2975635|NCT01117428|10243156|P3|Overall Study|Adverse Event|0
2975636|NCT01117428|10243157|P2|Overall Study|Adverse Event|0
2975637|NCT01117428|10243158|P1|Overall Study|Adverse Event|4
2975638|NCT01117428|10243153|P6|Overall Study|Lack of Efficacy|0
2975639|NCT01117428|10243154|P5|Overall Study|Lack of Efficacy|0
2975640|NCT01117428|10243155|P4|Overall Study|Lack of Efficacy|0
2975641|NCT01117428|10243156|P3|Overall Study|Lack of Efficacy|0
2975642|NCT01117428|10243157|P2|Overall Study|Lack of Efficacy|0
2975643|NCT01117428|10243158|P1|Overall Study|Lack of Efficacy|1
2975644|NCT01117350|10243192|P2|Extension Period|Prohibited medication|1
2975645|NCT01117350|10243193|P1|Extension Period|Prohibited medication|0
2975646|NCT01117350|10243192|P2|Extension Period|Inclusion criteria not respected|1
2975647|NCT01117350|10243193|P1|Extension Period|Inclusion criteria not respected|0
2975648|NCT01117350|10243192|P2|Extension Period|Lack of Efficacy|2
2975649|NCT01117350|10243193|P1|Extension Period|Lack of Efficacy|0
2975650|NCT01117350|10243192|P2|Extension Period|Withdrawal by Subject|3
2975651|NCT01117350|10243193|P1|Extension Period|Withdrawal by Subject|0
2975652|NCT01117350|10243192|P2|Extension Period|Lost to Follow-up|2
2975653|NCT01117350|10243193|P1|Extension Period|Lost to Follow-up|0
2975654|NCT01117350|10243192|P2|Extension Period|Protocol Violation|2
2975655|NCT01117350|10243193|P1|Extension Period|Protocol Violation|0
2975656|NCT01117350|10243192|P2|Extension Period|Adverse Event|2
2975657|NCT01117350|10243193|P1|Extension Period|Adverse Event|0
2975658|NCT01117350|10243192|P2|Extension Period|Not included in extension, not treated|50
2975659|NCT01117350|10243193|P1|Extension Period|Not included in extension, not treated|0
2975660|NCT01117350|10243192|P2|Comparative Period|Move to another city/country|1
2975661|NCT01117350|10243193|P1|Comparative Period|Move to another city/country|2
2975662|NCT01117350|10243192|P2|Comparative Period|Physician Decision|1
2975663|NCT01117350|10243193|P1|Comparative Period|Physician Decision|0
2975664|NCT01117350|10243192|P2|Comparative Period|Lack of Efficacy|0
2975665|NCT01117350|10243193|P1|Comparative Period|Lack of Efficacy|1
2975666|NCT01117350|10243192|P2|Comparative Period|Protocol Violation|12
2975667|NCT01117350|10243193|P1|Comparative Period|Protocol Violation|8
2975668|NCT01117350|10243192|P2|Comparative Period|Withdrawal by Subject|13
2975669|NCT01117350|10243193|P1|Comparative Period|Withdrawal by Subject|9
2975670|NCT01117350|10243192|P2|Comparative Period|Lost to Follow-up|7
2975671|NCT01117350|10243193|P1|Comparative Period|Lost to Follow-up|11
2975672|NCT01117350|10243192|P2|Comparative Period|Adverse Event|33
2975673|NCT01117350|10243193|P1|Comparative Period|Adverse Event|6
2975674|NCT01117350|10243192|P2|Comparative Period|Not Treated|8
2975675|NCT01117350|10243193|P1|Comparative Period|Not Treated|5
2975676|NCT01117337|10243225|P2|Overall Study|Lost to Follow-up|0
2975677|NCT01117337|10243226|P1|Overall Study|Lost to Follow-up|4
2975678|NCT01117181|10243247|P2|Overall Study|Withdrawal by Subject|2
2975679|NCT01117181|10243248|P1|Overall Study|Withdrawal by Subject|0
2975680|NCT01117181|10243247|P2|Overall Study|Lost to Follow-up|0
2975681|NCT01117181|10243248|P1|Overall Study|Lost to Follow-up|1
2975682|NCT01117051|10243281|P2|Overall Study|Convenience issue|0
2975683|NCT01117051|10243282|P1|Overall Study|Convenience issue|1
2975684|NCT01117051|10243281|P2|Overall Study|Randomized by mistake|1
2975685|NCT01117051|10243282|P1|Overall Study|Randomized by mistake|0
2975686|NCT01117051|10243281|P2|Overall Study|Surgical procedure|1
2975687|NCT01117051|10243282|P1|Overall Study|Surgical procedure|0
2975688|NCT01117051|10243281|P2|Overall Study|Sponsor's decision|1
2975689|NCT01117051|10243282|P1|Overall Study|Sponsor's decision|3
2975690|NCT01117051|10243281|P2|Overall Study|Did not meet in-/exclusion criteria|1
2975691|NCT01117051|10243282|P1|Overall Study|Did not meet in-/exclusion criteria|0
2975692|NCT01117051|10243281|P2|Overall Study|Lost to Follow-up|1
2975693|NCT01117051|10243282|P1|Overall Study|Lost to Follow-up|0
2975694|NCT01117051|10243281|P2|Overall Study|Adverse Event|3
2975695|NCT01117051|10243282|P1|Overall Study|Adverse Event|4
2975696|NCT01117051|10243281|P2|Overall Study|Withdrawal by Subject|3
2975697|NCT01117051|10243282|P1|Overall Study|Withdrawal by Subject|5
2975698|NCT01117012|10243292|P2|Overall Study|Undefined|3
2975699|NCT01117012|10243293|P1|Overall Study|Undefined|4
2975700|NCT01117012|10243292|P2|Overall Study|Withdrawal by Subject|0
2975701|NCT01117012|10243293|P1|Overall Study|Withdrawal by Subject|3
2975702|NCT01117012|10243292|P2|Overall Study|Death|1
2975703|NCT01117012|10243293|P1|Overall Study|Death|1
2975704|NCT01117012|10243292|P2|Overall Study|Adverse Event|1
2975705|NCT01117012|10243293|P1|Overall Study|Adverse Event|0
2975706|NCT01116882|10243467|P2|12-month|Withdrawal by Subject|8
2975707|NCT01116882|10243468|P1|12-month|Withdrawal by Subject|5
2975708|NCT01116882|10243467|P2|12-month|Other Reasons|49
2975709|NCT01116882|10243468|P1|12-month|Other Reasons|151
2975710|NCT01116882|10243467|P2|12-month|Lost to Follow-up|42
2975711|NCT01116882|10243468|P1|12-month|Lost to Follow-up|111
2975712|NCT01116882|10243467|P2|30-day|Other Reasons|6
2975713|NCT01116882|10243468|P1|30-day|Other Reasons|16
2975714|NCT01116882|10243467|P2|30-day|Withdrawal by Subject|4
2975715|NCT01116882|10243468|P1|30-day|Withdrawal by Subject|2
2975716|NCT01116882|10243467|P2|30-day|Lost to Follow-up|21
2975717|NCT01116882|10243468|P1|30-day|Lost to Follow-up|50
2975718|NCT01116687|10243506|P1|Overall Study|Withdrawal by Subject|4
2975719|NCT01116544|10243520|P2|Overall Study|Withdrawal by Subject|1
2975720|NCT01116544|10243521|P1|Overall Study|Withdrawal by Subject|1
2975721|NCT01116544|10243520|P2|Overall Study|Protocol Violation|0
2975722|NCT01116544|10243521|P1|Overall Study|Protocol Violation|1
2975723|NCT01116427|10243547|P2|Extension Phase|Not using appropriate birth control|0
2975724|NCT01116427|10243548|P1|Extension Phase|Not using appropriate birth control|1
2975725|NCT01116427|10243547|P2|Extension Phase|Withdrawal by Subject|1
2975726|NCT01116427|10243548|P1|Extension Phase|Withdrawal by Subject|5
2975727|NCT01116427|10243547|P2|Extension Phase|Lost to Follow-up|0
2975728|NCT01116427|10243548|P1|Extension Phase|Lost to Follow-up|2
2975729|NCT01116427|10243547|P2|Extension Phase|Adverse Event|1
2975730|NCT01116427|10243548|P1|Extension Phase|Adverse Event|1
2975731|NCT01116427|10243547|P2|Core Phase|Worsening Multiple Sclerosis|0
2975732|NCT01116427|10243548|P1|Core Phase|Worsening Multiple Sclerosis|1
2975733|NCT01116427|10243547|P2|Core Phase|Withdrawal by Subject|0
2975734|NCT01116427|10243548|P1|Core Phase|Withdrawal by Subject|3
2975735|NCT01116427|10243547|P2|Core Phase|Lost to Follow-up|0
2975736|NCT01116427|10243548|P1|Core Phase|Lost to Follow-up|1
2975737|NCT01116427|10243547|P2|Core Phase|Adverse Event|1
2975738|NCT01116427|10243548|P1|Core Phase|Adverse Event|0
2975739|NCT01116232|10243589|P1|Overall Study|Progressive diease|4
2975740|NCT01115998|10243703|P2|Overall Study|Lost to Follow-up|6
2975741|NCT01115998|10243704|P1|Overall Study|Lost to Follow-up|6
2975742|NCT01115933|10243714|P1|Overall Study|Did not receive XIENCE PRIME SV|1
2975743|NCT01115855|10243811|P2|Overall Study|Other|6
2975744|NCT01115855|10243812|P1|Overall Study|Other|8
2975745|NCT01115855|10243811|P2|Overall Study|Withdrawal by Subject|5
2975746|NCT01115855|10243812|P1|Overall Study|Withdrawal by Subject|5
2975747|NCT01115855|10243811|P2|Overall Study|Protocol Violation|1
2975748|NCT01115855|10243812|P1|Overall Study|Protocol Violation|0
2975749|NCT01115855|10243811|P2|Overall Study|Lab Abnormality|1
2975750|NCT01115855|10243812|P1|Overall Study|Lab Abnormality|1
2975751|NCT01115855|10243811|P2|Overall Study|Death|5
2975752|NCT01115855|10243812|P1|Overall Study|Death|6
2975753|NCT01115855|10243811|P2|Overall Study|Adverse Event|18
2975754|NCT01115855|10243812|P1|Overall Study|Adverse Event|16
2975755|NCT01115803|10243867|P7|Overall Study|Progressive Disease during Cycle1|1
2975756|NCT01115803|10243868|P6|Overall Study|Progressive Disease during Cycle1|0
2975757|NCT01115803|10243869|P5|Overall Study|Progressive Disease during Cycle1|0
2975758|NCT01115803|10243870|P4|Overall Study|Progressive Disease during Cycle1|0
2975759|NCT01115803|10243871|P3|Overall Study|Progressive Disease during Cycle1|0
2975760|NCT01115803|10243872|P2|Overall Study|Progressive Disease during Cycle1|0
2975761|NCT01115803|10243873|P1|Overall Study|Progressive Disease during Cycle1|0
2975762|NCT01115803|10243867|P7|Overall Study|Lost to Follow-up|0
2975763|NCT01115803|10243868|P6|Overall Study|Lost to Follow-up|0
2975764|NCT01115803|10243869|P5|Overall Study|Lost to Follow-up|0
2975765|NCT01115803|10243870|P4|Overall Study|Lost to Follow-up|0
2975766|NCT01115803|10243871|P3|Overall Study|Lost to Follow-up|1
2975767|NCT01115803|10243872|P2|Overall Study|Lost to Follow-up|0
2975768|NCT01115803|10243873|P1|Overall Study|Lost to Follow-up|0
2975769|NCT01115803|10243867|P7|Overall Study|Withdrawal by Subject|1
2975770|NCT01115803|10243868|P6|Overall Study|Withdrawal by Subject|0
2975771|NCT01115803|10243869|P5|Overall Study|Withdrawal by Subject|0
2975772|NCT01115803|10243870|P4|Overall Study|Withdrawal by Subject|0
2975773|NCT01115803|10243871|P3|Overall Study|Withdrawal by Subject|0
2975774|NCT01115803|10243872|P2|Overall Study|Withdrawal by Subject|0
2975775|NCT01115803|10243873|P1|Overall Study|Withdrawal by Subject|0
2975776|NCT01115738|10243936|P3|Overall Study|Withdrawal by Subject|9
2975777|NCT01115738|10243937|P2|Overall Study|Withdrawal by Subject|6
2975778|NCT01115738|10243938|P1|Overall Study|Withdrawal by Subject|6
2975779|NCT01115738|10243936|P3|Overall Study|Physician Decision|17
2975780|NCT01115738|10243937|P2|Overall Study|Physician Decision|15
2975781|NCT01115738|10243938|P1|Overall Study|Physician Decision|18
2975782|NCT01115738|10243936|P3|Overall Study|Lost to Follow-up|1
2975783|NCT01115738|10243937|P2|Overall Study|Lost to Follow-up|0
2975784|NCT01115738|10243938|P1|Overall Study|Lost to Follow-up|0
2975785|NCT01115738|10243936|P3|Overall Study|Death|0
2975786|NCT01115738|10243937|P2|Overall Study|Death|0
2975787|NCT01115738|10243938|P1|Overall Study|Death|1
2975788|NCT01115569|10244136|P2|Maintenance Phase|Administrative|1
2975789|NCT01115569|10244137|P1|Maintenance Phase|Administrative|0
2975790|NCT01115569|10244136|P2|Maintenance Phase|Non-Compliance with Study Drug|48
2975791|NCT01115569|10244137|P1|Maintenance Phase|Non-Compliance with Study Drug|0
2975792|NCT01115569|10244136|P2|Maintenance Phase|Withdrawal by Subject|27
2975793|NCT01115569|10244137|P1|Maintenance Phase|Withdrawal by Subject|0
2975794|NCT01115569|10244136|P2|Maintenance Phase|Protocol Violation|9
2975795|NCT01115569|10244137|P1|Maintenance Phase|Protocol Violation|0
2975796|NCT01115569|10244136|P2|Maintenance Phase|Physician Decision|3
2975797|NCT01115569|10244137|P1|Maintenance Phase|Physician Decision|0
2975798|NCT01115569|10244136|P2|Maintenance Phase|Lost to Follow-up|8
2975799|NCT01115569|10244137|P1|Maintenance Phase|Lost to Follow-up|0
2975800|NCT01115569|10244136|P2|Maintenance Phase|Adverse Event|43
2975801|NCT01115569|10244137|P1|Maintenance Phase|Adverse Event|0
2975802|NCT01115569|10244136|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
2975803|NCT01115569|10244137|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
2975804|NCT01115569|10244136|P2|Conversion/Titration Phase|Withdrawal by Subject|0
2975805|NCT01115569|10244137|P1|Conversion/Titration Phase|Withdrawal by Subject|26
2975806|NCT01115569|10244136|P2|Conversion/Titration Phase|Protocol Violation|0
2975807|NCT01115569|10244137|P1|Conversion/Titration Phase|Protocol Violation|68
2975808|NCT01115569|10244136|P2|Conversion/Titration Phase|Physician Decision|0
2975809|NCT01115569|10244137|P1|Conversion/Titration Phase|Physician Decision|5
2975810|NCT01115569|10244136|P2|Conversion/Titration Phase|Lost to Follow-up|0
2975811|NCT01115569|10244137|P1|Conversion/Titration Phase|Lost to Follow-up|3
2975812|NCT01115569|10244136|P2|Conversion/Titration Phase|Adverse Event|0
2975813|NCT01115569|10244137|P1|Conversion/Titration Phase|Adverse Event|59
2975814|NCT01115491|10244166|P1|Overall Study|Physician Decision|1
2975815|NCT01115491|10244166|P1|Overall Study|Withdrawal by Subject|1
2975816|NCT01115491|10244166|P1|Overall Study|Lost to Follow-up|3
2975817|NCT01115491|10244166|P1|Overall Study|Adverse Event|3
2975818|NCT01115491|10244166|P1|Overall Study|Death|22
2975819|NCT01114880|10244384|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
2975820|NCT01114880|10244385|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
2975821|NCT01114880|10244384|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
2975822|NCT01114880|10244385|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
2975823|NCT01114880|10244384|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
2975824|NCT01114880|10244385|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
2975825|NCT01114880|10244384|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
2975826|NCT01114880|10244385|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
2975827|NCT01114880|10244384|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
2975828|NCT01114880|10244385|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
2975829|NCT01114880|10244384|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
2975830|NCT01114880|10244385|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
2975831|NCT01114828|10244437|P2|Overall Study|Withdrawal by Subject|1
2975832|NCT01114828|10244438|P1|Overall Study|Withdrawal by Subject|0
2975833|NCT01114828|10244437|P2|Overall Study|Protocol Violation|0
2975834|NCT01114828|10244438|P1|Overall Study|Protocol Violation|2
2975835|NCT01114828|10244437|P2|Overall Study|Lack of Efficacy|2
2975836|NCT01114828|10244438|P1|Overall Study|Lack of Efficacy|0
2975837|NCT01114828|10244437|P2|Overall Study|Adverse Event|1
2975838|NCT01114828|10244438|P1|Overall Study|Adverse Event|1
2975839|NCT01114737|10244448|P2|Open-Label Treatment Period|Difficult Personal Events|0
2975840|NCT01114737|10244449|P1|Open-Label Treatment Period|Difficult Personal Events|1
2975841|NCT01114737|10244448|P2|Open-Label Treatment Period|Lost to Follow-up|1
2975842|NCT01114737|10244449|P1|Open-Label Treatment Period|Lost to Follow-up|3
2975843|NCT01114737|10244448|P2|Open-Label Treatment Period|Withdrawal by Subject|1
2975844|NCT01114737|10244449|P1|Open-Label Treatment Period|Withdrawal by Subject|1
2975845|NCT01114737|10244448|P2|Randomized Treatment Period|Pregnancy|0
2975846|NCT01114737|10244449|P1|Randomized Treatment Period|Pregnancy|1
2975847|NCT01114737|10244448|P2|Randomized Treatment Period|Lost to Follow-up|1
2975848|NCT01114737|10244449|P1|Randomized Treatment Period|Lost to Follow-up|1
2975849|NCT01114737|10244448|P2|Randomized Treatment Period|Withdrawal by Subject|0
2975850|NCT01114737|10244449|P1|Randomized Treatment Period|Withdrawal by Subject|1
2975851|NCT01114724|10244497|P1|Overall Study|Withdrawal by Subject|1
2975852|NCT01114724|10244497|P1|Overall Study|Lost to Follow-up|1
2975853|NCT01114724|10244497|P1|Overall Study|Death|8
2975854|NCT01114672|10244517|P2|Overall Study|transplanted|0
2975855|NCT01114672|10244518|P1|Overall Study|transplanted|1
2975856|NCT01114672|10244517|P2|Overall Study|Lost to Follow-up|0
2975857|NCT01114672|10244518|P1|Overall Study|Lost to Follow-up|1
2975858|NCT01114672|10244517|P2|Overall Study|Withdrawal by Subject|1
2975859|NCT01114672|10244518|P1|Overall Study|Withdrawal by Subject|2
2975860|NCT01114672|10244517|P2|Overall Study|Death|1
2975861|NCT01114672|10244518|P1|Overall Study|Death|0
2975862|NCT01114646|10244526|P2|Overall Study|Withdrawal by Subject|2
2975863|NCT01114646|10244527|P1|Overall Study|Withdrawal by Subject|3
2975864|NCT01114529|10244587|P3|Completed Study Phase at Month 24|Missing|0
2975865|NCT01114529|10244588|P2|Completed Study Phase at Month 24|Missing|0
2975866|NCT01114529|10244589|P1|Completed Study Phase at Month 24|Missing|2
2975867|NCT01114529|10244587|P3|Completed Study Phase at Month 24|Other|0
2975868|NCT01114529|10244588|P2|Completed Study Phase at Month 24|Other|0
2975869|NCT01114529|10244589|P1|Completed Study Phase at Month 24|Other|2
2975870|NCT01114529|10244587|P3|Completed Study Phase at Month 24|Death|4
2975871|NCT01114529|10244588|P2|Completed Study Phase at Month 24|Death|5
2975872|NCT01114529|10244589|P1|Completed Study Phase at Month 24|Death|8
2975873|NCT01114529|10244587|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
2975874|NCT01114529|10244588|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
2975875|NCT01114529|10244589|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
2975876|NCT01114529|10244587|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
2975877|NCT01114529|10244588|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
2975878|NCT01114529|10244589|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
2975879|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Missing|0
2975880|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Missing|0
2975881|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Missing|2
2975882|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Protocol Violation|2
2975883|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Protocol Violation|5
2975884|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Protocol Violation|0
2975885|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Graft loss|0
2975886|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Graft loss|2
2975887|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Graft loss|0
2975888|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Death|2
2975889|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Death|1
2975890|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Death|2
2975891|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Administrative problems|2
2975892|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Administrative problems|1
2975893|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Administrative problems|2
2975894|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
2975895|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
2975896|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
2975897|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
2975898|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
2975899|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
2975900|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
2975901|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
2975902|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
2975903|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
2975904|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
2975905|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
2975906|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
2975907|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
2975908|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
2975909|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
2975910|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
2975911|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
2975912|NCT01114529|10244587|P3|Completed Study Medication at Month 24|Adverse Event|17
2975913|NCT01114529|10244588|P2|Completed Study Medication at Month 24|Adverse Event|18
2975914|NCT01114529|10244589|P1|Completed Study Medication at Month 24|Adverse Event|87
2975915|NCT01114516|10244608|P2|Overall Study|Lost to Follow-up|1
2975916|NCT01114516|10244609|P1|Overall Study|Lost to Follow-up|2
2975917|NCT01114438|10244644|P1|Overall Study|Withdrawal by Subject|2
2975918|NCT01114438|10244644|P1|Overall Study|Physician Decision|1
2975919|NCT01114438|10244644|P1|Overall Study|concomitant medication|1
2975920|NCT01114438|10244644|P1|Overall Study|Adverse Event|10
2975921|NCT01114373|10244654|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
2975922|NCT01114373|10244655|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
2975923|NCT01114373|10244654|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
2975924|NCT01114373|10244655|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
2975925|NCT01114373|10244654|P2|Intervention 1 (4 Weeks)|Incarceration|0
2975926|NCT01114373|10244655|P1|Intervention 1 (4 Weeks)|Incarceration|1
2975927|NCT01114373|10244654|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
2975928|NCT01114373|10244655|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
2975929|NCT01114360|10244687|P2|Intervention 1 (4 Weeks)|Physician Decision|1
2975930|NCT01114360|10244688|P1|Intervention 1 (4 Weeks)|Physician Decision|0
2975931|NCT01114217|10244739|P2|Overall Study|Other-Withdrawal by Subject|1
2975932|NCT01114217|10244740|P1|Overall Study|Other-Withdrawal by Subject|1
2975933|NCT01114217|10244739|P2|Overall Study|Other-Lost to Follow-up|0
2975934|NCT01114217|10244740|P1|Overall Study|Other-Lost to Follow-up|1
2975935|NCT01114217|10244739|P2|Overall Study|Other-Site Stopped Communicating|0
2975936|NCT01114217|10244740|P1|Overall Study|Other-Site Stopped Communicating|2
2975937|NCT01114217|10244739|P2|Overall Study|Other-Study Withdrawn|1
2975938|NCT01114217|10244740|P1|Overall Study|Other-Study Withdrawn|1
2975939|NCT01114217|10244739|P2|Overall Study|Other-Study Termination|1
2975940|NCT01114217|10244740|P1|Overall Study|Other-Study Termination|0
2975941|NCT01114217|10244739|P2|Overall Study|Other-Sponsor Decision|12
2975942|NCT01114217|10244740|P1|Overall Study|Other-Sponsor Decision|10
2975943|NCT01114217|10244739|P2|Overall Study|Other-Physician Decision|1
2975944|NCT01114217|10244740|P1|Overall Study|Other-Physician Decision|1
2975945|NCT01114217|10244739|P2|Overall Study|Other-Non Compliance|0
2975946|NCT01114217|10244740|P1|Overall Study|Other-Non Compliance|2
2975947|NCT01114217|10244739|P2|Overall Study|Other-Lack of Efficacy|0
2975948|NCT01114217|10244740|P1|Overall Study|Other-Lack of Efficacy|1
2975949|NCT01114217|10244739|P2|Overall Study|Other-Protocol Violation|3
2975950|NCT01114217|10244740|P1|Overall Study|Other-Protocol Violation|1
2975951|NCT01114217|10244739|P2|Overall Study|Other-Pregnancy|4
2975952|NCT01114217|10244740|P1|Overall Study|Other-Pregnancy|2
2975953|NCT01114217|10244739|P2|Overall Study|Other-Procedure|1
2975954|NCT01114217|10244740|P1|Overall Study|Other-Procedure|1
2975955|NCT01114217|10244739|P2|Overall Study|Other-Early termination|10
2975956|NCT01114217|10244740|P1|Overall Study|Other-Early termination|6
2975957|NCT01114217|10244739|P2|Overall Study|Other-Clerical Error|0
2975958|NCT01114217|10244740|P1|Overall Study|Other-Clerical Error|3
2975959|NCT01114217|10244739|P2|Overall Study|Withdrawal by Subject|28
2975960|NCT01114217|10244740|P1|Overall Study|Withdrawal by Subject|21
2975961|NCT01114217|10244739|P2|Overall Study|Lost to Follow-up|33
2975962|NCT01114217|10244740|P1|Overall Study|Lost to Follow-up|17
2975963|NCT01114217|10244739|P2|Overall Study|Adverse Event|3
2975964|NCT01114217|10244740|P1|Overall Study|Adverse Event|5
2975965|NCT01114204|10244752|P2|Overall Study|Other-Protocol Violation|0
2975966|NCT01114204|10244753|P1|Overall Study|Other-Protocol Violation|1
2975967|NCT01114204|10244752|P2|Overall Study|Other-Participant request|0
2975968|NCT01114204|10244753|P1|Overall Study|Other-Participant request|2
2975969|NCT01114204|10244752|P2|Overall Study|Other-Medical monitor request|0
2975970|NCT01114204|10244753|P1|Overall Study|Other-Medical monitor request|1
2975971|NCT01114204|10244752|P2|Overall Study|Other-Personal reasons|0
2975972|NCT01114204|10244753|P1|Overall Study|Other-Personal reasons|2
2975973|NCT01114204|10244752|P2|Overall Study|Death|0
2975974|NCT01114204|10244753|P1|Overall Study|Death|1
2975975|NCT01114204|10244752|P2|Overall Study|Withdrawal by Subject|6
2975976|NCT01114204|10244753|P1|Overall Study|Withdrawal by Subject|10
2975977|NCT01114204|10244752|P2|Overall Study|Lost to Follow-up|0
2975978|NCT01114204|10244753|P1|Overall Study|Lost to Follow-up|1
2975979|NCT01114204|10244752|P2|Overall Study|Adverse Event|2
2975980|NCT01114204|10244753|P1|Overall Study|Adverse Event|3
2975981|NCT01114139|10244771|P2|Overall Study|Other-Withdrew prior to receiving dose|3
2975982|NCT01114139|10244772|P1|Overall Study|Other-Withdrew prior to receiving dose|1
2975983|NCT01114139|10244771|P2|Overall Study|Other-Physician changed treatment|0
2975984|NCT01114139|10244772|P1|Overall Study|Other-Physician changed treatment|1
2975985|NCT01114139|10244771|P2|Overall Study|Other-Participant went on hospice|1
2975986|NCT01114139|10244772|P1|Overall Study|Other-Participant went on hospice|0
2975987|NCT01114139|10244771|P2|Overall Study|Other-Participant falsified records|1
2975988|NCT01114139|10244772|P1|Overall Study|Other-Participant falsified records|0
2975989|NCT01114139|10244771|P2|Overall Study|Other-Out of window for study drug dose|0
2975990|NCT01114139|10244772|P1|Overall Study|Other-Out of window for study drug dose|1
2975991|NCT01114139|10244771|P2|Overall Study|Other-Protocol Violation|0
2975992|NCT01114139|10244772|P1|Overall Study|Other-Protocol Violation|1
2975993|NCT01114139|10244771|P2|Overall Study|Other-Missed 1 visit|0
2975994|NCT01114139|10244772|P1|Overall Study|Other-Missed 1 visit|1
2975995|NCT01114139|10244771|P2|Overall Study|Withdrawal by Subject|6
2975996|NCT01114139|10244772|P1|Overall Study|Withdrawal by Subject|17
2975997|NCT01114139|10244771|P2|Overall Study|Lost to Follow-up|3
2975998|NCT01114139|10244772|P1|Overall Study|Lost to Follow-up|15
2975999|NCT01114139|10244771|P2|Overall Study|Adverse Event|2
2976000|NCT01114139|10244772|P1|Overall Study|Adverse Event|3
2976001|NCT01113931|10244801|P2|Overall Study|Withdrawal by Subject|0
2976002|NCT01113931|10244802|P1|Overall Study|Withdrawal by Subject|3
2976003|NCT01113931|10244801|P2|Overall Study|Various|4
2976004|NCT01113931|10244802|P1|Overall Study|Various|2
2976005|NCT01113931|10244801|P2|Overall Study|Lost to Follow-up|9
2976006|NCT01113931|10244802|P1|Overall Study|Lost to Follow-up|12
2976007|NCT01113931|10244801|P2|Overall Study|Physician Decision|2
2976008|NCT01113931|10244802|P1|Overall Study|Physician Decision|0
2976009|NCT01113931|10244801|P2|Overall Study|Adverse Event|2
2976010|NCT01113931|10244802|P1|Overall Study|Adverse Event|2
2976011|NCT01113892|10244816|P2|Overall Study|Graft no longer evaluable|9
2976012|NCT01113892|10244817|P1|Overall Study|Graft no longer evaluable|9
2976013|NCT01113892|10244816|P2|Overall Study|Death|4
2976014|NCT01113892|10244817|P1|Overall Study|Death|2
2976015|NCT01113892|10244816|P2|Overall Study|Withdrawal by Subject|1
2976016|NCT01113892|10244817|P1|Overall Study|Withdrawal by Subject|1
2976017|NCT01113892|10244816|P2|Overall Study|Lost to Follow-up|2
2976018|NCT01113892|10244817|P1|Overall Study|Lost to Follow-up|2
2976019|NCT01113879|10244845|P2|Period 1: Block 1|Withdrawal by Subject|0
2976020|NCT01113879|10244846|P1|Period 1: Block 1|Withdrawal by Subject|2
2976021|NCT01113801|10244858|P4|Overall Study|Clinical Endpoint (ESRD)|5
2976022|NCT01113801|10244859|P3|Overall Study|Clinical Endpoint (ESRD)|2
2976023|NCT01113801|10244860|P2|Overall Study|Clinical Endpoint (ESRD)|4
2976024|NCT01113801|10244861|P1|Overall Study|Clinical Endpoint (ESRD)|7
2976025|NCT01113801|10244858|P4|Overall Study|Sponsor Decision|15
2976026|NCT01113801|10244859|P3|Overall Study|Sponsor Decision|20
2976027|NCT01113801|10244860|P2|Overall Study|Sponsor Decision|21
2976028|NCT01113801|10244861|P1|Overall Study|Sponsor Decision|15
2976029|NCT01113801|10244858|P4|Overall Study|Physician Decision|3
2976030|NCT01113801|10244859|P3|Overall Study|Physician Decision|3
2976031|NCT01113801|10244860|P2|Overall Study|Physician Decision|2
2976032|NCT01113801|10244861|P1|Overall Study|Physician Decision|2
2976033|NCT01113801|10244858|P4|Overall Study|Withdrawal by Subject|8
2976034|NCT01113801|10244859|P3|Overall Study|Withdrawal by Subject|7
2976035|NCT01113801|10244860|P2|Overall Study|Withdrawal by Subject|7
2976036|NCT01113801|10244861|P1|Overall Study|Withdrawal by Subject|9
2976037|NCT01113801|10244858|P4|Overall Study|Protocol Violation|0
2976038|NCT01113801|10244859|P3|Overall Study|Protocol Violation|0
2976039|NCT01113801|10244860|P2|Overall Study|Protocol Violation|1
2976040|NCT01113801|10244861|P1|Overall Study|Protocol Violation|0
2976041|NCT01113801|10244858|P4|Overall Study|Death|4
2976042|NCT01113801|10244859|P3|Overall Study|Death|3
2976043|NCT01113801|10244860|P2|Overall Study|Death|5
2976044|NCT01113801|10244861|P1|Overall Study|Death|4
2976045|NCT01113801|10244858|P4|Overall Study|Adverse Event|6
2976046|NCT01113801|10244859|P3|Overall Study|Adverse Event|2
2976047|NCT01113801|10244860|P2|Overall Study|Adverse Event|0
2976048|NCT01113801|10244861|P1|Overall Study|Adverse Event|4
2976049|NCT01113749|10244889|P2|Overall Study|Lost to Follow-up|2
2976050|NCT01113749|10244890|P1|Overall Study|Lost to Follow-up|1
2976051|NCT01113710|10244913|P1|Overall Study|Subject Did Not Receive Neupro|3
2976052|NCT01113710|10244913|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
2976053|NCT01113710|10244913|P1|Overall Study|Lack of Patient's Compliance/Other|1
2976054|NCT01113710|10244913|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
2976055|NCT01113710|10244913|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
2976056|NCT01113710|10244913|P1|Overall Study|Compliance/Efficacy/AE/Other|1
2976057|NCT01113710|10244913|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
2976058|NCT01113710|10244913|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
2976059|NCT01113710|10244913|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
2976060|NCT01113710|10244913|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
2976061|NCT01113710|10244913|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
2976062|NCT01113710|10244913|P1|Overall Study|Lack of Efficacy/Adverse Event|3
2976063|NCT01113710|10244913|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
2976064|NCT01113710|10244913|P1|Overall Study|Lack of Efficacy/Other|4
2976065|NCT01113710|10244913|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
2976066|NCT01113710|10244913|P1|Overall Study|Adverse Event/Other|5
2976067|NCT01113710|10244913|P1|Overall Study|Other|7
2976068|NCT01113710|10244913|P1|Overall Study|Lack of Patient's Compliance|8
2976069|NCT01113710|10244913|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
2976070|NCT01113710|10244913|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
2976071|NCT01113710|10244913|P1|Overall Study|Lost to Follow-up|20
2976072|NCT01113710|10244913|P1|Overall Study|Withdrawal by Subject|28
2976073|NCT01113710|10244913|P1|Overall Study|No Information Available|40
2976074|NCT01113710|10244913|P1|Overall Study|Lack of Efficacy|41
2976075|NCT01113710|10244913|P1|Overall Study|Adverse Event|64
2976076|NCT01113580|10244941|P2|Overall Study|Protocol Violation|0
2976077|NCT01113580|10244942|P1|Overall Study|Protocol Violation|1
2976078|NCT01113541|10244956|P1|Overall Study|Adverse Event|4
2976079|NCT01113541|10244956|P1|Overall Study|Study Terminated by Sponsor|7
2976080|NCT01113541|10244956|P1|Overall Study|Protocol Violation|1
2976081|NCT01113541|10244956|P1|Overall Study|Withdrawal by Subject|1
2976082|NCT01113463|10244989|P1|Overall Study|Physician Decision|5
2976083|NCT01112982|10245019|P1|Overall Study|exceeded weight limit to complete MRI|1
2976084|NCT01112982|10245019|P1|Overall Study|Withdrawal by Subject|1
2976085|NCT01112917|10245031|P2|Overall Study|Unable to Convert Filter|0
2976086|NCT01112917|10245032|P1|Overall Study|Unable to Convert Filter|3
2976087|NCT01112917|10245031|P2|Overall Study|Withdrawal by Subject|3
2976088|NCT01112917|10245032|P1|Overall Study|Withdrawal by Subject|1
2976089|NCT01112917|10245031|P2|Overall Study|Lost to Follow-up|1
2976090|NCT01112917|10245032|P1|Overall Study|Lost to Follow-up|1
2976091|NCT01112917|10245031|P2|Overall Study|Death|11
2976092|NCT01112917|10245032|P1|Overall Study|Death|2
2976093|NCT01112579|10245136|P2|Overall Study|Death|2
2976094|NCT01112579|10245137|P1|Overall Study|Death|0
2976095|NCT01112579|10245136|P2|Overall Study|Missed Visit|1
2976096|NCT01112579|10245137|P1|Overall Study|Missed Visit|1
2976097|NCT01112514|10245147|P1|Overall Study|Lost to Follow-up|1
2976098|NCT01112267|10245203|P2|Overall Study|Participants not receive any study drug|2
2976099|NCT01112267|10245204|P1|Overall Study|Participants not receive any study drug|1
2976100|NCT01112267|10245203|P2|Overall Study|Participants not compliant|2
2976101|NCT01112267|10245204|P1|Overall Study|Participants not compliant|1
2976102|NCT01112267|10245203|P2|Overall Study|Protocol Violation|3
2976103|NCT01112267|10245204|P1|Overall Study|Protocol Violation|5
2976104|NCT01112267|10245203|P2|Overall Study|Withdrawal by Subject|5
2976105|NCT01112267|10245204|P1|Overall Study|Withdrawal by Subject|3
2976106|NCT01112267|10245203|P2|Overall Study|Adverse Event|6
2976107|NCT01112267|10245204|P1|Overall Study|Adverse Event|24
2976108|NCT01112059|10245237|P2|Overall Study|Withdrawal by Subject|0
2976109|NCT01112059|10245238|P1|Overall Study|Withdrawal by Subject|1
2976110|NCT01111851|10245252|P2|Overall Study|All planned PET scans were not obtained.|0
2976111|NCT01111851|10245253|P1|Overall Study|All planned PET scans were not obtained.|2
2976112|NCT01111838|10245265|P1|Overall Study|Other Complicating Disease|1
2976113|NCT01111838|10245265|P1|Overall Study|Clinical deterioration|1
2976114|NCT01111838|10245265|P1|Overall Study|Not Treated|3
2976115|NCT01111838|10245265|P1|Overall Study|Patient Ineligible|2
2976116|NCT01111825|10245273|P4|Overall Study|Discontinuation by Sponsor|20
2976117|NCT01111825|10245274|P3|Overall Study|Discontinuation by Sponsor|0
2976118|NCT01111825|10245275|P2|Overall Study|Discontinuation by Sponsor|0
2976119|NCT01111825|10245276|P1|Overall Study|Discontinuation by Sponsor|0
2976120|NCT01111825|10245273|P4|Overall Study|Disease Progression|0
2976121|NCT01111825|10245274|P3|Overall Study|Disease Progression|0
2976122|NCT01111825|10245275|P2|Overall Study|Disease Progression|0
2976123|NCT01111825|10245276|P1|Overall Study|Disease Progression|1
2976124|NCT01111825|10245273|P4|Overall Study|Adverse Event|0
2976125|NCT01111825|10245274|P3|Overall Study|Adverse Event|4
2976126|NCT01111825|10245275|P2|Overall Study|Adverse Event|1
2976127|NCT01111825|10245276|P1|Overall Study|Adverse Event|2
2976128|NCT01111825|10245273|P4|Overall Study|Lost to Follow-up|1
2976129|NCT01111825|10245274|P3|Overall Study|Lost to Follow-up|3
2976130|NCT01111825|10245275|P2|Overall Study|Lost to Follow-up|0
2976131|NCT01111825|10245276|P1|Overall Study|Lost to Follow-up|0
2976132|NCT01111825|10245273|P4|Overall Study|Withdrawal by Subject|0
2976133|NCT01111825|10245274|P3|Overall Study|Withdrawal by Subject|1
2976134|NCT01111825|10245275|P2|Overall Study|Withdrawal by Subject|0
2976135|NCT01111825|10245276|P1|Overall Study|Withdrawal by Subject|0
2976136|NCT01111604|10245298|P3|Overall Study|Met Exclusion Criteria|0
2976137|NCT01111604|10245299|P2|Overall Study|Met Exclusion Criteria|0
2976138|NCT01111604|10245300|P1|Overall Study|Met Exclusion Criteria|2
2976139|NCT01111604|10245298|P3|Overall Study|Death|0
2976140|NCT01111604|10245299|P2|Overall Study|Death|0
2976141|NCT01111604|10245300|P1|Overall Study|Death|1
2976142|NCT01111604|10245298|P3|Overall Study|Withdrawal by Subject|0
2976143|NCT01111604|10245299|P2|Overall Study|Withdrawal by Subject|0
2976144|NCT01111604|10245300|P1|Overall Study|Withdrawal by Subject|2
2976145|NCT01111604|10245298|P3|Overall Study|Withdrew Consent|2
2976146|NCT01111604|10245299|P2|Overall Study|Withdrew Consent|0
2976147|NCT01111604|10245300|P1|Overall Study|Withdrew Consent|3
2976148|NCT01111604|10245298|P3|Overall Study|Lost to Follow-up|1
2976149|NCT01111604|10245299|P2|Overall Study|Lost to Follow-up|0
2976150|NCT01111604|10245300|P1|Overall Study|Lost to Follow-up|0
2976151|NCT01111526|10245338|P3|Overall Study|GVHD Disease Progression|2
2976152|NCT01111526|10245339|P2|Overall Study|GVHD Disease Progression|1
2976153|NCT01111526|10245340|P1|Overall Study|GVHD Disease Progression|0
2976154|NCT01111461|10245352|P1|Overall Study|Other|6
2976155|NCT01111461|10245352|P1|Overall Study|Withdrawal by Subject|1
2976156|NCT01111461|10245352|P1|Overall Study|Lost to Follow-up|1
2976157|NCT01111461|10245352|P1|Overall Study|Participant choice|11
2976158|NCT01111461|10245352|P1|Overall Study|Adverse Event|32
2976159|NCT01111292|10245532|P2|Treatment|Physician Decision|1
2976160|NCT01111292|10245533|P1|Treatment|Physician Decision|1
2976161|NCT01111240|10245539|P1|Overall Study|Other|312
2976162|NCT01111240|10245539|P1|Overall Study|Lack of Efficacy and Adverse Event|19
2976163|NCT01111240|10245539|P1|Overall Study|Lack of Efficacy|545
2976164|NCT01111240|10245539|P1|Overall Study|Adverse Event|190
2976165|NCT01111149|10245569|P3|Overall Study|Withdrawal by Subject|2
2976166|NCT01111149|10245570|P2|Overall Study|Withdrawal by Subject|0
2976167|NCT01111149|10245571|P1|Overall Study|Withdrawal by Subject|1
2976168|NCT01111149|10245569|P3|Overall Study|Protocol Violation|2
2976169|NCT01111149|10245570|P2|Overall Study|Protocol Violation|1
2976170|NCT01111149|10245571|P1|Overall Study|Protocol Violation|1
2976171|NCT01111123|10245647|P2|Maintenance Phase|Lost to Follow-up|2
2976172|NCT01111123|10245648|P1|Maintenance Phase|Lost to Follow-up|0
2976173|NCT01111123|10245647|P2|Open- Label Phase|Failed to be clear or almost cleared|0
2976174|NCT01111123|10245648|P1|Open- Label Phase|Failed to be clear or almost cleared|14
2976175|NCT01111019|10245694|P1|Overall Study|Other|1
2976176|NCT01111019|10245694|P1|Overall Study|Withdrew Prematurely|2
2976177|NCT01110915|10245726|P2|Overall Study|Withdrawal by Subject|1
2976178|NCT01110915|10245727|P1|Overall Study|Withdrawal by Subject|7
2976179|NCT01110915|10245726|P2|Overall Study|Lost to Follow-up|0
2976180|NCT01110915|10245727|P1|Overall Study|Lost to Follow-up|1
2976181|NCT01110915|10245726|P2|Overall Study|Death|1
2976182|NCT01110915|10245727|P1|Overall Study|Death|2
2976183|NCT01110707|10245744|P2|Overall Study|Protocol Violation|3
2976184|NCT01110707|10245745|P1|Overall Study|Protocol Violation|0
2976185|NCT01110408|10245833|P2|Overall Study|Protocol Violation|0
2976186|NCT01110408|10245834|P1|Overall Study|Protocol Violation|1
2976187|NCT01110382|10245854|P2|Overall Study|Protocol Violation|1
2976188|NCT01110382|10245855|P1|Overall Study|Protocol Violation|0
2976189|NCT01110382|10245854|P2|Overall Study|Withdrawal by Subject|1
2976190|NCT01110382|10245855|P1|Overall Study|Withdrawal by Subject|0
2976191|NCT01110330|10245876|P3|Overall Study|Other|1
2976192|NCT01110330|10245877|P2|Overall Study|Other|1
2976193|NCT01110330|10245878|P1|Overall Study|Other|1
2976194|NCT01110330|10245876|P3|Overall Study|Withdrawal by Subject|2
2976195|NCT01110330|10245877|P2|Overall Study|Withdrawal by Subject|6
2976196|NCT01110330|10245878|P1|Overall Study|Withdrawal by Subject|0
2976197|NCT01110330|10245876|P3|Overall Study|Protocol Violation|4
2976198|NCT01110330|10245877|P2|Overall Study|Protocol Violation|0
2976199|NCT01110330|10245878|P1|Overall Study|Protocol Violation|2
2976200|NCT01110330|10245876|P3|Overall Study|Physician Decision|0
2976201|NCT01110330|10245877|P2|Overall Study|Physician Decision|1
2976202|NCT01110330|10245878|P1|Overall Study|Physician Decision|0
2976203|NCT01110330|10245876|P3|Overall Study|Lost to Follow-up|15
2976204|NCT01110330|10245877|P2|Overall Study|Lost to Follow-up|10
2976205|NCT01110330|10245878|P1|Overall Study|Lost to Follow-up|9
2976206|NCT01110330|10245876|P3|Overall Study|Lack of Efficacy|1
2976207|NCT01110330|10245877|P2|Overall Study|Lack of Efficacy|1
2976208|NCT01110330|10245878|P1|Overall Study|Lack of Efficacy|3
2976209|NCT01110330|10245876|P3|Overall Study|Adverse Event|3
2976210|NCT01110330|10245877|P2|Overall Study|Adverse Event|4
2976211|NCT01110330|10245878|P1|Overall Study|Adverse Event|0
2976212|NCT01110239|10245906|P4|7.5 Min Ischemia|Withdrawal by Subject|0
2976213|NCT01110239|10245907|P3|7.5 Min Ischemia|Withdrawal by Subject|1
2976214|NCT01110239|10245908|P2|7.5 Min Ischemia|Withdrawal by Subject|0
2976215|NCT01110239|10245909|P1|7.5 Min Ischemia|Withdrawal by Subject|0
2976216|NCT01110239|10245906|P4|Sham Preconditioning|Withdrawal by Subject|0
2976217|NCT01110239|10245907|P3|Sham Preconditioning|Withdrawal by Subject|1
2976218|NCT01110239|10245908|P2|Sham Preconditioning|Withdrawal by Subject|0
2976219|NCT01110239|10245909|P1|Sham Preconditioning|Withdrawal by Subject|0
2976220|NCT01110200|10245925|P2|Overall Study|Lost to Follow-up|7
2976221|NCT01110200|10245926|P1|Overall Study|Lost to Follow-up|10
2976222|NCT01110200|10245925|P2|Overall Study|Physician Decision|17
2976223|NCT01110200|10245926|P1|Overall Study|Physician Decision|13
2976224|NCT01110200|10245925|P2|Overall Study|Protocol Violation|12
2976225|NCT01110200|10245926|P1|Overall Study|Protocol Violation|14
2976226|NCT01110200|10245925|P2|Overall Study|Lack of Efficacy|25
2976227|NCT01110200|10245926|P1|Overall Study|Lack of Efficacy|16
2976228|NCT01110200|10245925|P2|Overall Study|Withdrawal by Subject|32
2976229|NCT01110200|10245926|P1|Overall Study|Withdrawal by Subject|25
2976230|NCT01110200|10245925|P2|Overall Study|Adverse Event|28
2976231|NCT01110200|10245926|P1|Overall Study|Adverse Event|28
2976232|NCT01110005|10245962|P2|Overall Study|Withdrawal by Subject|1
2976233|NCT01110005|10245963|P1|Overall Study|Withdrawal by Subject|0
2976234|NCT01110005|10245962|P2|Overall Study|missing consent|2
2976235|NCT01110005|10245963|P1|Overall Study|missing consent|3
2976236|NCT01110005|10245962|P2|Overall Study|ineligible|2
2976237|NCT01110005|10245963|P1|Overall Study|ineligible|1
2976238|NCT01109992|10245975|P2|Overall Study|Movement during rest scan.|1
2976239|NCT01109992|10245976|P1|Overall Study|Movement during rest scan.|0
2976240|NCT01109992|10245975|P2|Overall Study|Withdrawal by Subject|1
2976241|NCT01109992|10245976|P1|Overall Study|Withdrawal by Subject|0
2976242|NCT01109979|10245990|P2|Overall Study|Withdrawal by Subject|1
2976243|NCT01109979|10245991|P1|Overall Study|Withdrawal by Subject|0
2976244|NCT01109979|10245990|P2|Overall Study|Physician Decision|0
2976245|NCT01109979|10245991|P1|Overall Study|Physician Decision|2
2976246|NCT01109849|10245999|P5|Adaptive Randomization: Weight Recovery|moved away|0
2976247|NCT01109849|10246000|P4|Adaptive Randomization: Weight Recovery|moved away|2
2976248|NCT01109849|10246001|P3|Adaptive Randomization: Weight Recovery|moved away|0
2976249|NCT01109849|10246002|P2|Adaptive Randomization: Weight Recovery|moved away|0
2976250|NCT01109849|10246003|P1|Adaptive Randomization: Weight Recovery|moved away|0
2976251|NCT01109849|10245999|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2976252|NCT01109849|10246000|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2976253|NCT01109849|10246001|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2976254|NCT01109849|10246002|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2976255|NCT01109849|10246003|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2976256|NCT01109849|10245999|P5|Initial Randomization: ADHD Treatment|move away|0
2976257|NCT01109849|10246000|P4|Initial Randomization: ADHD Treatment|move away|0
2976258|NCT01109849|10246001|P3|Initial Randomization: ADHD Treatment|move away|0
2976259|NCT01109849|10246002|P2|Initial Randomization: ADHD Treatment|move away|7
2976260|NCT01109849|10246003|P1|Initial Randomization: ADHD Treatment|move away|2
2976261|NCT01109849|10245999|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2976262|NCT01109849|10246000|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2976263|NCT01109849|10246001|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2976264|NCT01109849|10246002|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
2976265|NCT01109849|10246003|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
2976266|NCT01109849|10245999|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
2976267|NCT01109849|10246000|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
2976268|NCT01109849|10246001|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
2976269|NCT01109849|10246002|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
2976270|NCT01109849|10246003|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
2976271|NCT01109849|10245999|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2976272|NCT01109849|10246000|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2976273|NCT01109849|10246001|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2976274|NCT01109849|10246002|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
2976275|NCT01109849|10246003|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
2976276|NCT01109524|10246072|P1|Overall Study|Other|5
2976277|NCT01109524|10246072|P1|Overall Study|Participant requested to end treatment|4
2976278|NCT01109524|10246072|P1|Overall Study|No longer meets criteria|2
2976279|NCT01109524|10246072|P1|Overall Study|Death|2
2976280|NCT01109524|10246072|P1|Overall Study|Maximum clinical benefit|3
2976281|NCT01109524|10246072|P1|Overall Study|Withdrawal by Subject|2
2976282|NCT01109524|10246072|P1|Overall Study|Adverse Event|4
2976283|NCT01109524|10246072|P1|Overall Study|Study Drug toxicity|6
2976284|NCT01109524|10246072|P1|Overall Study|Disease Progression|29
2976285|NCT01109316|10246094|P6|Study Period 3|Withdrawal by Subject|0
2976286|NCT01109316|10246095|P5|Study Period 3|Withdrawal by Subject|1
2976287|NCT01109316|10246096|P4|Study Period 3|Withdrawal by Subject|0
2976288|NCT01109316|10246097|P3|Study Period 3|Withdrawal by Subject|0
2976289|NCT01109316|10246098|P2|Study Period 3|Withdrawal by Subject|0
2976290|NCT01109316|10246099|P1|Study Period 3|Withdrawal by Subject|1
2976291|NCT01109316|10246094|P6|Study Period 3|Lost to Follow-up|0
2976292|NCT01109316|10246095|P5|Study Period 3|Lost to Follow-up|1
2976293|NCT01109316|10246096|P4|Study Period 3|Lost to Follow-up|0
2976294|NCT01109316|10246097|P3|Study Period 3|Lost to Follow-up|0
2976295|NCT01109316|10246098|P2|Study Period 3|Lost to Follow-up|0
2976296|NCT01109316|10246099|P1|Study Period 3|Lost to Follow-up|0
2976297|NCT01109316|10246094|P6|Study Period 2|Withdrawal by Subject|1
2976298|NCT01109316|10246095|P5|Study Period 2|Withdrawal by Subject|0
2976299|NCT01109316|10246096|P4|Study Period 2|Withdrawal by Subject|0
2976300|NCT01109316|10246097|P3|Study Period 2|Withdrawal by Subject|1
2976301|NCT01109316|10246098|P2|Study Period 2|Withdrawal by Subject|0
2976302|NCT01109316|10246099|P1|Study Period 2|Withdrawal by Subject|0
2976303|NCT01109316|10246094|P6|Study Period 2|Protocol Violation|0
2976304|NCT01109316|10246095|P5|Study Period 2|Protocol Violation|0
2976305|NCT01109316|10246096|P4|Study Period 2|Protocol Violation|0
2976306|NCT01109316|10246097|P3|Study Period 2|Protocol Violation|0
2976307|NCT01109316|10246098|P2|Study Period 2|Protocol Violation|0
2976308|NCT01109316|10246099|P1|Study Period 2|Protocol Violation|1
2976309|NCT01109316|10246094|P6|Study Period 2|Physician Decision|0
2976310|NCT01109316|10246095|P5|Study Period 2|Physician Decision|0
2976311|NCT01109316|10246096|P4|Study Period 2|Physician Decision|1
2976312|NCT01109316|10246097|P3|Study Period 2|Physician Decision|0
2976313|NCT01109316|10246098|P2|Study Period 2|Physician Decision|0
2976314|NCT01109316|10246099|P1|Study Period 2|Physician Decision|0
2976315|NCT01109316|10246094|P6|Study Period 2|Entry Criteria Not Met|0
2976316|NCT01109316|10246095|P5|Study Period 2|Entry Criteria Not Met|0
2976317|NCT01109316|10246096|P4|Study Period 2|Entry Criteria Not Met|0
2976318|NCT01109316|10246097|P3|Study Period 2|Entry Criteria Not Met|0
2976319|NCT01109316|10246098|P2|Study Period 2|Entry Criteria Not Met|1
2976320|NCT01109316|10246099|P1|Study Period 2|Entry Criteria Not Met|0
2976321|NCT01109316|10246094|P6|Study Period 1|Sponsor Decision|2
2976322|NCT01109316|10246095|P5|Study Period 1|Sponsor Decision|0
2976323|NCT01109316|10246096|P4|Study Period 1|Sponsor Decision|0
2976324|NCT01109316|10246097|P3|Study Period 1|Sponsor Decision|0
2976325|NCT01109316|10246098|P2|Study Period 1|Sponsor Decision|0
2976326|NCT01109316|10246099|P1|Study Period 1|Sponsor Decision|0
2976327|NCT01109316|10246094|P6|Study Period 1|Withdrawal by Subject|0
2976328|NCT01109316|10246095|P5|Study Period 1|Withdrawal by Subject|2
2976329|NCT01109316|10246096|P4|Study Period 1|Withdrawal by Subject|0
2976330|NCT01109316|10246097|P3|Study Period 1|Withdrawal by Subject|1
2976331|NCT01109316|10246098|P2|Study Period 1|Withdrawal by Subject|0
2976332|NCT01109316|10246099|P1|Study Period 1|Withdrawal by Subject|0
2976333|NCT01109316|10246094|P6|Study Period 1|Lost to Follow-up|0
2976334|NCT01109316|10246095|P5|Study Period 1|Lost to Follow-up|0
2976335|NCT01109316|10246096|P4|Study Period 1|Lost to Follow-up|1
2976336|NCT01109316|10246097|P3|Study Period 1|Lost to Follow-up|1
2976337|NCT01109316|10246098|P2|Study Period 1|Lost to Follow-up|0
2976338|NCT01109316|10246099|P1|Study Period 1|Lost to Follow-up|0
2976339|NCT01109316|10246094|P6|Study Period 1|Adverse Event|0
2976340|NCT01109316|10246095|P5|Study Period 1|Adverse Event|0
2976341|NCT01109316|10246096|P4|Study Period 1|Adverse Event|0
2976342|NCT01109316|10246097|P3|Study Period 1|Adverse Event|1
2976343|NCT01109316|10246098|P2|Study Period 1|Adverse Event|0
2976344|NCT01109316|10246099|P1|Study Period 1|Adverse Event|0
2976345|NCT01109173|10246147|P4|Overall Study|Not Specifiied|14
2976346|NCT01109173|10246148|P3|Overall Study|Not Specifiied|9
2976347|NCT01109173|10246149|P2|Overall Study|Not Specifiied|4
2976348|NCT01109173|10246150|P1|Overall Study|Not Specifiied|5
2976349|NCT01109173|10246147|P4|Overall Study|Patient Did Not Use Study Medication|7
2976350|NCT01109173|10246148|P3|Overall Study|Patient Did Not Use Study Medication|11
2976351|NCT01109173|10246149|P2|Overall Study|Patient Did Not Use Study Medication|26
2976352|NCT01109173|10246150|P1|Overall Study|Patient Did Not Use Study Medication|34
2976353|NCT01109173|10246147|P4|Overall Study|Protocol Violation|2
2976354|NCT01109173|10246148|P3|Overall Study|Protocol Violation|1
2976355|NCT01109173|10246149|P2|Overall Study|Protocol Violation|5
2976356|NCT01109173|10246150|P1|Overall Study|Protocol Violation|4
2976357|NCT01109173|10246147|P4|Overall Study|Treatment Failure|64
2976358|NCT01109173|10246148|P3|Overall Study|Treatment Failure|69
2976359|NCT01109173|10246149|P2|Overall Study|Treatment Failure|32
2976360|NCT01109173|10246150|P1|Overall Study|Treatment Failure|25
2976361|NCT01109173|10246147|P4|Overall Study|Noncompliance|0
2976362|NCT01109173|10246148|P3|Overall Study|Noncompliance|0
2976363|NCT01109173|10246149|P2|Overall Study|Noncompliance|1
2976364|NCT01109173|10246150|P1|Overall Study|Noncompliance|0
2976365|NCT01109173|10246147|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2976366|NCT01109173|10246148|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
2976367|NCT01109173|10246149|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2976368|NCT01109173|10246150|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
2976369|NCT01109173|10246147|P4|Overall Study|Lost to Follow-up|0
2976370|NCT01109173|10246148|P3|Overall Study|Lost to Follow-up|0
2976371|NCT01109173|10246149|P2|Overall Study|Lost to Follow-up|1
2976372|NCT01109173|10246150|P1|Overall Study|Lost to Follow-up|0
2976373|NCT01109173|10246147|P4|Overall Study|Adverse Event|6
2976374|NCT01109173|10246148|P3|Overall Study|Adverse Event|9
2976375|NCT01109173|10246149|P2|Overall Study|Adverse Event|17
2976376|NCT01109173|10246150|P1|Overall Study|Adverse Event|15
2976377|NCT01108809|10246263|P1|Overall Study|Lost to Follow-up|1
2976378|NCT01108809|10246263|P1|Overall Study|Adverse Event|3
2976379|NCT01108796|10246280|P2|Overall Study|Lost to Follow-up|6
2976380|NCT01108796|10246281|P1|Overall Study|Lost to Follow-up|7
2976381|NCT01108796|10246280|P2|Overall Study|Adverse Event|1
2976382|NCT01108796|10246281|P1|Overall Study|Adverse Event|0
2976383|NCT01108731|10246324|P2|Overall Study|Adverse Event|3
2976384|NCT01108731|10246325|P1|Overall Study|Adverse Event|3
2976385|NCT01108731|10246324|P2|Overall Study|Withdrawal by Subject|1
2976386|NCT01108731|10246325|P1|Overall Study|Withdrawal by Subject|1
2976387|NCT01108718|10246337|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
2976388|NCT01108718|10246338|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
2976389|NCT01108523|10246343|P1|Overall Study|Protocol Violation|4
2976390|NCT01108510|10246350|P2|Overall Study|Death|1
2976391|NCT01108510|10246351|P1|Overall Study|Death|1
2976392|NCT01108510|10246350|P2|Overall Study|Pregnancy|3
2976393|NCT01108510|10246351|P1|Overall Study|Pregnancy|0
2976394|NCT01108510|10246350|P2|Overall Study|Lack of Efficacy|0
2976395|NCT01108510|10246351|P1|Overall Study|Lack of Efficacy|3
2976396|NCT01108510|10246350|P2|Overall Study|Participant Noncompliance|7
2976397|NCT01108510|10246351|P1|Overall Study|Participant Noncompliance|5
2976398|NCT01108510|10246350|P2|Overall Study|Investigator’s Discretion|10
2976399|NCT01108510|10246351|P1|Overall Study|Investigator’s Discretion|12
2976400|NCT01108510|10246350|P2|Overall Study|Withdrew Consent|15
2976401|NCT01108510|10246351|P1|Overall Study|Withdrew Consent|21
2976402|NCT01108510|10246350|P2|Overall Study|Lost to Follow-up|17
2976403|NCT01108510|10246351|P1|Overall Study|Lost to Follow-up|20
2976404|NCT01108510|10246350|P2|Overall Study|Adverse Event|19
2976405|NCT01108510|10246351|P1|Overall Study|Adverse Event|26
2976406|NCT01108510|10246350|P2|Overall Study|Joined Another Gilead-sponsored Study|195
2976407|NCT01108510|10246351|P1|Overall Study|Joined Another Gilead-sponsored Study|186
2976408|NCT01108510|10246350|P2|Overall Study|Randomized but Not Treated|1
2976409|NCT01108510|10246351|P1|Overall Study|Randomized but Not Treated|5
2976410|NCT01108458|10246371|P1|Overall Study|Withdrawal by Subject|1
2976411|NCT01108341|10246423|P1|Overall Study|Other|1
2976412|NCT01108341|10246423|P1|Overall Study|Lost to Follow-up|1
2976413|NCT01108341|10246423|P1|Overall Study|Withdrawal by Subject|1
2976414|NCT01108341|10246423|P1|Overall Study|Death|2
2976415|NCT01108263|10246430|P2|Overall Study|Adverse Event|1
2976416|NCT01108263|10246431|P1|Overall Study|Adverse Event|0
2976417|NCT01108237|10246441|P2|Overall Study|Did not meet criteria for analysis|0
2976418|NCT01108237|10246442|P1|Overall Study|Did not meet criteria for analysis|7
2976419|NCT01108237|10246441|P2|Overall Study|No alignment data|17
2976420|NCT01108237|10246442|P1|Overall Study|No alignment data|2
2976421|NCT01108185|10246448|P1|Overall Study|Lost to Follow-up|12
2976422|NCT01108185|10246448|P1|Overall Study|Non-compliance|15
2976423|NCT01108094|10246465|P4|Overall Study|Withdrawal by Subject|0
2976424|NCT01108094|10246466|P3|Overall Study|Withdrawal by Subject|0
2976425|NCT01108094|10246467|P2|Overall Study|Withdrawal by Subject|0
2976426|NCT01108094|10246468|P1|Overall Study|Withdrawal by Subject|1
2976427|NCT01108094|10246465|P4|Overall Study|Adverse Event|0
2976428|NCT01108094|10246466|P3|Overall Study|Adverse Event|0
2976429|NCT01108094|10246467|P2|Overall Study|Adverse Event|0
2976430|NCT01108094|10246468|P1|Overall Study|Adverse Event|2
2976431|NCT01108068|10246512|P2|Overall Study|5 not started, 1 stop due to side effect|0
2976432|NCT01108068|10246513|P1|Overall Study|5 not started, 1 stop due to side effect|6
2976433|NCT01108055|10246520|P1|Overall Study|Not evaluable- didn't complete treatment|4
2976434|NCT01108055|10246520|P1|Overall Study|Ineligible|11
2976435|NCT01107925|10246558|P6|Period 2|Withdrawal by Subject|1
2976436|NCT01107925|10246559|P5|Period 2|Withdrawal by Subject|0
2976437|NCT01107925|10246560|P4|Period 2|Withdrawal by Subject|0
2976438|NCT01107925|10246561|P3|Period 2|Withdrawal by Subject|0
2976439|NCT01107925|10246562|P2|Period 2|Withdrawal by Subject|1
2976440|NCT01107925|10246563|P1|Period 2|Withdrawal by Subject|0
2976441|NCT01107925|10246558|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2976442|NCT01107925|10246559|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2976443|NCT01107925|10246560|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2976444|NCT01107925|10246561|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2976445|NCT01107925|10246562|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2976446|NCT01107925|10246563|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2976447|NCT01107912|10246601|P6|Period 3|Withdrawal by Subject|0
2976448|NCT01107912|10246602|P5|Period 3|Withdrawal by Subject|0
2976449|NCT01107912|10246603|P4|Period 3|Withdrawal by Subject|1
2976450|NCT01107912|10246604|P3|Period 3|Withdrawal by Subject|0
2976451|NCT01107912|10246605|P2|Period 3|Withdrawal by Subject|0
2976452|NCT01107912|10246606|P1|Period 3|Withdrawal by Subject|0
2976453|NCT01107912|10246601|P6|Period 3|Adverse Event|0
2976454|NCT01107912|10246602|P5|Period 3|Adverse Event|0
2976455|NCT01107912|10246603|P4|Period 3|Adverse Event|0
2976456|NCT01107912|10246604|P3|Period 3|Adverse Event|1
2976457|NCT01107912|10246605|P2|Period 3|Adverse Event|1
2976458|NCT01107912|10246606|P1|Period 3|Adverse Event|0
2976459|NCT01107912|10246601|P6|Period 2|Physician Decision|0
2976460|NCT01107912|10246602|P5|Period 2|Physician Decision|0
2976461|NCT01107912|10246603|P4|Period 2|Physician Decision|0
2976462|NCT01107912|10246604|P3|Period 2|Physician Decision|1
2976463|NCT01107912|10246605|P2|Period 2|Physician Decision|0
2976464|NCT01107912|10246606|P1|Period 2|Physician Decision|0
2976465|NCT01107912|10246601|P6|Period 1|Withdrawal by Subject|0
2976466|NCT01107912|10246602|P5|Period 1|Withdrawal by Subject|0
2976467|NCT01107912|10246603|P4|Period 1|Withdrawal by Subject|0
2976468|NCT01107912|10246604|P3|Period 1|Withdrawal by Subject|0
2976469|NCT01107912|10246605|P2|Period 1|Withdrawal by Subject|0
2976470|NCT01107912|10246606|P1|Period 1|Withdrawal by Subject|1
2976471|NCT01107912|10246601|P6|Period 1|Physician Decision|0
2976472|NCT01107912|10246602|P5|Period 1|Physician Decision|1
2976473|NCT01107912|10246603|P4|Period 1|Physician Decision|0
2976474|NCT01107912|10246604|P3|Period 1|Physician Decision|0
2976475|NCT01107912|10246605|P2|Period 1|Physician Decision|0
2976476|NCT01107912|10246606|P1|Period 1|Physician Decision|0
2976477|NCT01107912|10246601|P6|Period 1|Adverse Event|0
2976478|NCT01107912|10246602|P5|Period 1|Adverse Event|2
2976479|NCT01107912|10246603|P4|Period 1|Adverse Event|0
2976480|NCT01107912|10246604|P3|Period 1|Adverse Event|0
2976481|NCT01107912|10246605|P2|Period 1|Adverse Event|0
2976482|NCT01107912|10246606|P1|Period 1|Adverse Event|0
2976483|NCT01107899|10246643|P3|Overall Study|Withdrawal by Subject|1
2976484|NCT01107899|10246644|P2|Overall Study|Withdrawal by Subject|0
2976485|NCT01107899|10246645|P1|Overall Study|Withdrawal by Subject|0
2976486|NCT01107899|10246643|P3|Overall Study|Physician Decision|3
2976487|NCT01107899|10246644|P2|Overall Study|Physician Decision|0
2976488|NCT01107899|10246645|P1|Overall Study|Physician Decision|5
2976489|NCT01107886|10246691|P2|Overall Study|Administrative withdrawal of consent|5
2976490|NCT01107886|10246692|P1|Overall Study|Administrative withdrawal of consent|7
2976491|NCT01107886|10246691|P2|Overall Study|Withdrawal by Subject|196
2976492|NCT01107886|10246692|P1|Overall Study|Withdrawal by Subject|180
2976493|NCT01107886|10246691|P2|Overall Study|Lost to Follow-up|13
2976494|NCT01107886|10246692|P1|Overall Study|Lost to Follow-up|15
2976495|NCT01107743|10246725|P1|Overall Study|Protocol Violation|46
2976496|NCT01107535|10246839|P1|Overall Study|Death|5
2976497|NCT01107457|10246852|P6|Part B and C|Clinical Relapse|4
2976498|NCT01107457|10246853|P5|Part B and C|Clinical Relapse|0
2976499|NCT01107457|10246854|P4|Part B and C|Clinical Relapse|0
2976500|NCT01107457|10246855|P3|Part B and C|Clinical Relapse|0
2976501|NCT01107457|10246856|P2|Part B and C|Clinical Relapse|0
2976502|NCT01107457|10246857|P1|Part B and C|Clinical Relapse|0
2976503|NCT01107457|10246852|P6|Part B and C|Withdrawal by Subject|16
2976504|NCT01107457|10246853|P5|Part B and C|Withdrawal by Subject|0
2976505|NCT01107457|10246854|P4|Part B and C|Withdrawal by Subject|0
2976506|NCT01107457|10246855|P3|Part B and C|Withdrawal by Subject|0
2976507|NCT01107457|10246856|P2|Part B and C|Withdrawal by Subject|0
2976508|NCT01107457|10246857|P1|Part B and C|Withdrawal by Subject|0
2976509|NCT01107457|10246852|P6|Part B and C|Sponsor Decision|66
2976510|NCT01107457|10246853|P5|Part B and C|Sponsor Decision|0
2976511|NCT01107457|10246854|P4|Part B and C|Sponsor Decision|0
2976512|NCT01107457|10246855|P3|Part B and C|Sponsor Decision|0
2976513|NCT01107457|10246856|P2|Part B and C|Sponsor Decision|0
2976514|NCT01107457|10246857|P1|Part B and C|Sponsor Decision|0
2976515|NCT01107457|10246852|P6|Part B and C|Protocol Violation|1
2976516|NCT01107457|10246853|P5|Part B and C|Protocol Violation|0
2976517|NCT01107457|10246854|P4|Part B and C|Protocol Violation|0
2976518|NCT01107457|10246855|P3|Part B and C|Protocol Violation|0
2976519|NCT01107457|10246856|P2|Part B and C|Protocol Violation|0
2976520|NCT01107457|10246857|P1|Part B and C|Protocol Violation|0
2976521|NCT01107457|10246852|P6|Part B and C|Lost to Follow-up|10
2976522|NCT01107457|10246853|P5|Part B and C|Lost to Follow-up|0
2976523|NCT01107457|10246854|P4|Part B and C|Lost to Follow-up|0
2976524|NCT01107457|10246855|P3|Part B and C|Lost to Follow-up|0
2976525|NCT01107457|10246856|P2|Part B and C|Lost to Follow-up|0
2976526|NCT01107457|10246857|P1|Part B and C|Lost to Follow-up|0
2976527|NCT01107457|10246852|P6|Part B and C|Lack of Efficacy|7
2976528|NCT01107457|10246853|P5|Part B and C|Lack of Efficacy|0
2976529|NCT01107457|10246854|P4|Part B and C|Lack of Efficacy|0
2976530|NCT01107457|10246855|P3|Part B and C|Lack of Efficacy|0
2976531|NCT01107457|10246856|P2|Part B and C|Lack of Efficacy|0
2976532|NCT01107457|10246857|P1|Part B and C|Lack of Efficacy|0
2976533|NCT01107457|10246852|P6|Part B and C|Physician Decision|3
2976534|NCT01107457|10246853|P5|Part B and C|Physician Decision|0
2976535|NCT01107457|10246854|P4|Part B and C|Physician Decision|0
2976536|NCT01107457|10246855|P3|Part B and C|Physician Decision|0
2976537|NCT01107457|10246856|P2|Part B and C|Physician Decision|0
2976538|NCT01107457|10246857|P1|Part B and C|Physician Decision|0
2976539|NCT01107457|10246852|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
2976540|NCT01107457|10246853|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2976541|NCT01107457|10246854|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2976542|NCT01107457|10246855|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2976543|NCT01107457|10246856|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2976544|NCT01107457|10246857|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2976545|NCT01107457|10246852|P6|Part B and C|Adverse Event|12
2976546|NCT01107457|10246853|P5|Part B and C|Adverse Event|0
2976547|NCT01107457|10246854|P4|Part B and C|Adverse Event|0
2976548|NCT01107457|10246855|P3|Part B and C|Adverse Event|0
2976549|NCT01107457|10246856|P2|Part B and C|Adverse Event|0
2976550|NCT01107457|10246857|P1|Part B and C|Adverse Event|0
2976551|NCT01107457|10246852|P6|Part A|Protocol Violation|0
2976552|NCT01107457|10246853|P5|Part A|Protocol Violation|0
2976553|NCT01107457|10246854|P4|Part A|Protocol Violation|0
2976554|NCT01107457|10246855|P3|Part A|Protocol Violation|0
2976555|NCT01107457|10246856|P2|Part A|Protocol Violation|1
2976556|NCT01107457|10246857|P1|Part A|Protocol Violation|0
2976557|NCT01107457|10246852|P6|Part A|Lack of Efficacy|0
2976558|NCT01107457|10246853|P5|Part A|Lack of Efficacy|0
2976559|NCT01107457|10246854|P4|Part A|Lack of Efficacy|0
2976560|NCT01107457|10246855|P3|Part A|Lack of Efficacy|0
2976561|NCT01107457|10246856|P2|Part A|Lack of Efficacy|0
2976562|NCT01107457|10246857|P1|Part A|Lack of Efficacy|1
2976563|NCT01107457|10246852|P6|Part A|Lost to Follow-up|0
2976564|NCT01107457|10246853|P5|Part A|Lost to Follow-up|0
2976565|NCT01107457|10246854|P4|Part A|Lost to Follow-up|0
2976566|NCT01107457|10246855|P3|Part A|Lost to Follow-up|0
2976567|NCT01107457|10246856|P2|Part A|Lost to Follow-up|1
2976568|NCT01107457|10246857|P1|Part A|Lost to Follow-up|0
2976569|NCT01107457|10246852|P6|Part A|Withdrawal by Subject|0
2976570|NCT01107457|10246853|P5|Part A|Withdrawal by Subject|1
2976571|NCT01107457|10246854|P4|Part A|Withdrawal by Subject|3
2976572|NCT01107457|10246855|P3|Part A|Withdrawal by Subject|0
2976573|NCT01107457|10246856|P2|Part A|Withdrawal by Subject|3
2976574|NCT01107457|10246857|P1|Part A|Withdrawal by Subject|3
2976575|NCT01107457|10246852|P6|Part A|Adverse Event|0
2976576|NCT01107457|10246853|P5|Part A|Adverse Event|0
2976577|NCT01107457|10246854|P4|Part A|Adverse Event|0
2976578|NCT01107457|10246855|P3|Part A|Adverse Event|1
2976579|NCT01107457|10246856|P2|Part A|Adverse Event|2
2976580|NCT01107457|10246857|P1|Part A|Adverse Event|1
2976581|NCT01107444|10246985|P2|Overall Study|Protocol Entry Criteria Not Met|1
2976582|NCT01107444|10246986|P1|Overall Study|Protocol Entry Criteria Not Met|0
2976583|NCT01107444|10246985|P2|Overall Study|Withdrawal by Subject|12
2976584|NCT01107444|10246986|P1|Overall Study|Withdrawal by Subject|8
2976585|NCT01107418|10247020|P1|Overall Study|Entered Extension Study|1
2976586|NCT01107418|10247020|P1|Overall Study|Started Other Therapy|1
2976587|NCT01107418|10247020|P1|Overall Study|Study Closing|1
2976588|NCT01107418|10247020|P1|Overall Study|Withdrawal by Subject|1
2976589|NCT01107418|10247020|P1|Overall Study|Adverse Event|3
2976590|NCT01107418|10247020|P1|Overall Study|Disease Progression|45
2976591|NCT01107405|10247093|P5|Overall Study|Protocol Violation|0
2976592|NCT01107405|10247094|P4|Overall Study|Protocol Violation|1
2976593|NCT01107405|10247095|P3|Overall Study|Protocol Violation|1
2976594|NCT01107405|10247096|P2|Overall Study|Protocol Violation|0
2976595|NCT01107405|10247097|P1|Overall Study|Protocol Violation|0
2976596|NCT01107405|10247093|P5|Overall Study|Withdrawal by Subject|1
2976597|NCT01107405|10247094|P4|Overall Study|Withdrawal by Subject|2
2976598|NCT01107405|10247095|P3|Overall Study|Withdrawal by Subject|1
2976599|NCT01107405|10247096|P2|Overall Study|Withdrawal by Subject|0
2976600|NCT01107405|10247097|P1|Overall Study|Withdrawal by Subject|1
2976601|NCT01107405|10247093|P5|Overall Study|Adverse Event|2
2976602|NCT01107405|10247094|P4|Overall Study|Adverse Event|0
2976603|NCT01107405|10247095|P3|Overall Study|Adverse Event|0
2976604|NCT01107405|10247096|P2|Overall Study|Adverse Event|1
2976605|NCT01107405|10247097|P1|Overall Study|Adverse Event|1
2976606|NCT01107392|10247136|P2|Overall Study|Administrative decision|0
2976607|NCT01107392|10247137|P1|Overall Study|Administrative decision|1
2976608|NCT01107392|10247136|P2|Overall Study|Personal Reasons|3
2976609|NCT01107392|10247137|P1|Overall Study|Personal Reasons|2
2976610|NCT01107392|10247136|P2|Overall Study|Adverse Event|0
2976611|NCT01107392|10247137|P1|Overall Study|Adverse Event|2
2976612|NCT01107379|10247149|P1|Overall Study|Lost to Follow-up|3
2976613|NCT01107379|10247149|P1|Overall Study|Withdrawal by Subject|18
2976614|NCT01107353|10247160|P2|Overall Study|Positive Drug Screen|0
2976615|NCT01107353|10247161|P1|Overall Study|Positive Drug Screen|1
2976616|NCT01107197|10247169|P2|Overall Study|Withdrawal by Subject|5
2976617|NCT01107197|10247170|P1|Overall Study|Withdrawal by Subject|3
2976618|NCT01107197|10247169|P2|Overall Study|Lost to Follow-up|8
2976619|NCT01107197|10247170|P1|Overall Study|Lost to Follow-up|5
2976620|NCT01107197|10247169|P2|Overall Study|Death|10
2976621|NCT01107197|10247170|P1|Overall Study|Death|12
2976622|NCT01106976|10247205|P1|Overall Study|Lost to Follow-up|8
2976623|NCT01106911|10247219|P1|Overall Study|deemed ineligible after screening|3
2976624|NCT01106911|10247219|P1|Overall Study|Physician Decision|2
2976625|NCT01106898|10247223|P1|Overall Study|Adverse Event|6
2976626|NCT01106846|10247268|P2|Overall Study|Change in surgical procedure|1
2976627|NCT01106846|10247269|P1|Overall Study|Change in surgical procedure|0
2976628|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2976629|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2976630|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2976631|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Other|4
2976632|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Other|3
2976633|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Other|8
2976634|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2976635|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2976636|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2976637|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2976638|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2976639|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2976640|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
2976641|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
2976642|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
2976643|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2976644|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2976645|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2976646|NCT01106690|10247319|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
2976647|NCT01106690|10247320|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2976648|NCT01106690|10247321|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2976649|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Other|6
2976650|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Other|2
2976651|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Other|10
2976652|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2976653|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2976654|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2976655|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2976656|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2976657|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2976658|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2976659|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2976660|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2976661|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2976662|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2976663|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
2976664|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
2976665|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2976666|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2976667|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2976668|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Protocol Violation|0
2976669|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Protocol Violation|1
2976900|NCT01106352|10247612|P2|Overall Study|Home hospice since July 2013|0
2976670|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
2976671|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
2976672|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
2976673|NCT01106690|10247319|P3|Core Period: Baseline to Week 26|Adverse Event|4
2976674|NCT01106690|10247320|P2|Core Period: Baseline to Week 26|Adverse Event|1
2976675|NCT01106690|10247321|P1|Core Period: Baseline to Week 26|Adverse Event|6
2976676|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Other|5
2976677|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Other|8
2976678|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Other|5
2976679|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Other|6
2976680|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2976681|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2976682|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2976683|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2976684|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2976685|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
2976686|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2976687|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2976688|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2976689|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2976690|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
2976691|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2976692|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
2976693|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2976694|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
2976695|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
2976696|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
2976697|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
2976698|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
2976699|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
2976700|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2976701|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2976702|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2976703|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2976704|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
2976705|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2976706|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2976707|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
2976708|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Death|1
2976709|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Death|0
2976710|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Death|0
2976711|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Death|0
2976712|NCT01106677|10247357|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
2976713|NCT01106677|10247358|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
2976714|NCT01106677|10247359|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2976715|NCT01106677|10247360|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2976716|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Pregnancy|0
2976717|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Pregnancy|0
2976718|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Pregnancy|1
2976719|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Pregnancy|0
2976720|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Other|23
2976721|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Other|8
2976722|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Other|14
2976723|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Other|8
2976724|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Product quality complaint|0
2976725|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Product quality complaint|1
2976726|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Product quality complaint|1
2976727|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Product quality complaint|0
2976728|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2976729|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
2976730|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
2976731|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2976732|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2976733|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2976734|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2976735|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2976736|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2976737|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2976738|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2976739|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2976740|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2976741|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2976742|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2976743|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
2976744|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Protocol Violation|3
2976745|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2976746|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Protocol Violation|1
2976747|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Protocol Violation|0
2976748|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Physician Decision|1
2976749|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Physician Decision|3
2976750|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Physician Decision|1
2976751|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Physician Decision|2
2976752|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
2976753|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
2976754|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
2976755|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
2976756|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
2976757|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
2976758|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
2976759|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
2976760|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Death|0
2976761|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Death|1
2976762|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Death|0
2976763|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Death|0
2976764|NCT01106677|10247357|P4|Core Period: Baseline to Week 26|Adverse Event|8
2976765|NCT01106677|10247358|P3|Core Period: Baseline to Week 26|Adverse Event|6
2976766|NCT01106677|10247359|P2|Core Period: Baseline to Week 26|Adverse Event|18
2976767|NCT01106677|10247360|P1|Core Period: Baseline to Week 26|Adverse Event|7
2976768|NCT01106651|10247423|P3|Overall Study|Death|0
2976769|NCT01106651|10247424|P2|Overall Study|Death|3
2976770|NCT01106651|10247425|P1|Overall Study|Death|0
2976771|NCT01106651|10247423|P3|Overall Study|Other|21
2976772|NCT01106651|10247424|P2|Overall Study|Other|31
2976773|NCT01106651|10247425|P1|Overall Study|Other|34
2976774|NCT01106651|10247423|P3|Overall Study|Noncompliance with study drug|2
2976775|NCT01106651|10247424|P2|Overall Study|Noncompliance with study drug|0
2976776|NCT01106651|10247425|P1|Overall Study|Noncompliance with study drug|1
2976777|NCT01106651|10247423|P3|Overall Study|Withdrawal by Subject|4
2976778|NCT01106651|10247424|P2|Overall Study|Withdrawal by Subject|7
2976779|NCT01106651|10247425|P1|Overall Study|Withdrawal by Subject|14
2976780|NCT01106651|10247423|P3|Overall Study|Protocol Violation|1
2976781|NCT01106651|10247424|P2|Overall Study|Protocol Violation|2
2976782|NCT01106651|10247425|P1|Overall Study|Protocol Violation|1
2976783|NCT01106651|10247423|P3|Overall Study|Physician Decision|1
2976784|NCT01106651|10247424|P2|Overall Study|Physician Decision|3
2976785|NCT01106651|10247425|P1|Overall Study|Physician Decision|4
2976786|NCT01106651|10247423|P3|Overall Study|Lost to Follow-up|6
2976787|NCT01106651|10247424|P2|Overall Study|Lost to Follow-up|2
2976788|NCT01106651|10247425|P1|Overall Study|Lost to Follow-up|8
2976789|NCT01106651|10247423|P3|Overall Study|Adverse Event|23
2976790|NCT01106651|10247424|P2|Overall Study|Adverse Event|9
2976791|NCT01106651|10247425|P1|Overall Study|Adverse Event|17
2976792|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Other|4
2976793|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Other|5
2976794|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Other|5
2976795|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2976796|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2976797|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2976798|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
2976799|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
2976800|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
2976801|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2976802|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2976803|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
2976804|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2976805|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2976806|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
2976807|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
2976808|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
2976809|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
2976810|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2976811|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
2976812|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2976813|NCT01106625|10247478|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
2976814|NCT01106625|10247479|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
2976815|NCT01106625|10247480|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
2976816|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Other|4
2976817|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Other|7
2976818|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Other|8
2976819|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2976820|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2976821|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2976822|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2976823|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2976824|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
2976825|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2976826|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2976827|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
2976828|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
2976829|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2976830|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2976831|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Protocol Violation|3
2976832|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Protocol Violation|1
2976833|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Protocol Violation|2
2976834|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Physician Decision|0
2976835|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Physician Decision|0
2976836|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Physician Decision|1
2976837|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
2976838|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
2976839|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
2976840|NCT01106625|10247478|P3|Core Period: Baseline to Week 26|Adverse Event|8
2976841|NCT01106625|10247479|P2|Core Period: Baseline to Week 26|Adverse Event|8
2976842|NCT01106625|10247480|P1|Core Period: Baseline to Week 26|Adverse Event|6
2976843|NCT01106586|10247511|P2|Overall Study|Participant Transferred to Another Study|197
2976844|NCT01106586|10247512|P1|Overall Study|Participant Transferred to Another Study|212
2976845|NCT01106586|10247511|P2|Overall Study|Protocol Violation|0
2976846|NCT01106586|10247512|P1|Overall Study|Protocol Violation|1
2976847|NCT01106586|10247511|P2|Overall Study|Participant Noncompliance|10
2976848|NCT01106586|10247512|P1|Overall Study|Participant Noncompliance|12
2976849|NCT01106586|10247511|P2|Overall Study|Lost to Follow-up|20
2976850|NCT01106586|10247512|P1|Overall Study|Lost to Follow-up|24
2976851|NCT01106586|10247511|P2|Overall Study|Withdrew Consent|30
2976852|NCT01106586|10247512|P1|Overall Study|Withdrew Consent|18
2976853|NCT01106586|10247511|P2|Overall Study|Investigator's Discretion|8
2976854|NCT01106586|10247512|P1|Overall Study|Investigator's Discretion|5
2976855|NCT01106586|10247511|P2|Overall Study|Lack of Efficacy|0
2976856|NCT01106586|10247512|P1|Overall Study|Lack of Efficacy|1
2976857|NCT01106586|10247511|P2|Overall Study|Pregnancy|2
2976858|NCT01106586|10247512|P1|Overall Study|Pregnancy|2
2976859|NCT01106586|10247511|P2|Overall Study|Death|3
2976860|NCT01106586|10247512|P1|Overall Study|Death|1
2976861|NCT01106586|10247511|P2|Overall Study|Adverse Event|15
2976862|NCT01106586|10247512|P1|Overall Study|Adverse Event|9
2976863|NCT01106534|10247530|P1|Overall Study|Physician Decision|1
2976864|NCT01106534|10247530|P1|Overall Study|Death|16
2976865|NCT01106534|10247530|P1|Overall Study|Lost to Follow-up|2
2976866|NCT01106534|10247530|P1|Overall Study|Withdrawal by Subject|18
2976867|NCT01106430|10247562|P2|Overall Study|Withdrawal by Subject|4
2976868|NCT01106430|10247563|P1|Overall Study|Withdrawal by Subject|8
2976869|NCT01106430|10247562|P2|Overall Study|Protocol Violation|2
2976870|NCT01106430|10247563|P1|Overall Study|Protocol Violation|7
2976871|NCT01106430|10247562|P2|Overall Study|Previous Use Of Marijuana|0
2976872|NCT01106430|10247563|P1|Overall Study|Previous Use Of Marijuana|1
2976873|NCT01106430|10247562|P2|Overall Study|Hard Time Swallowing The Pills|0
2976874|NCT01106430|10247563|P1|Overall Study|Hard Time Swallowing The Pills|1
2976875|NCT01106430|10247562|P2|Overall Study|Noncompliance|1
2976876|NCT01106430|10247563|P1|Overall Study|Noncompliance|0
2976877|NCT01106430|10247562|P2|Overall Study|Refused To Take Medication|1
2976878|NCT01106430|10247563|P1|Overall Study|Refused To Take Medication|0
2976879|NCT01106430|10247562|P2|Overall Study|Moved Out Of State|1
2976880|NCT01106430|10247563|P1|Overall Study|Moved Out Of State|0
2976881|NCT01106430|10247562|P2|Overall Study|Early Termination Requested By Sponsor|0
2976882|NCT01106430|10247563|P1|Overall Study|Early Termination Requested By Sponsor|1
2976883|NCT01106430|10247562|P2|Overall Study|Lost to Follow-up|1
2976884|NCT01106430|10247563|P1|Overall Study|Lost to Follow-up|5
2976885|NCT01106430|10247562|P2|Overall Study|Lack of Efficacy|13
2976886|NCT01106430|10247563|P1|Overall Study|Lack of Efficacy|2
2976887|NCT01106430|10247562|P2|Overall Study|Adverse Event|10
2976888|NCT01106430|10247563|P1|Overall Study|Adverse Event|8
2976889|NCT01106404|10247585|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
2976890|NCT01106404|10247586|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
2976891|NCT01106404|10247585|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
2976892|NCT01106404|10247586|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
2976893|NCT01106404|10247585|P2|Period I (First 6 Weeks)|Physician Decision|0
2976894|NCT01106404|10247586|P1|Period I (First 6 Weeks)|Physician Decision|1
2976895|NCT01106404|10247585|P2|Period I (First 6 Weeks)|Adverse Event|0
2976896|NCT01106404|10247586|P1|Period I (First 6 Weeks)|Adverse Event|2
2976897|NCT01106352|10247609|P5|Overall Study|Home hospice since July 2013|0
2976898|NCT01106352|10247610|P4|Overall Study|Home hospice since July 2013|1
2976899|NCT01106352|10247611|P3|Overall Study|Home hospice since July 2013|0
2976901|NCT01106352|10247613|P1|Overall Study|Home hospice since July 2013|0
2976902|NCT01106352|10247609|P5|Overall Study|Subject entered hospice|0
2976903|NCT01106352|10247610|P4|Overall Study|Subject entered hospice|1
2976904|NCT01106352|10247611|P3|Overall Study|Subject entered hospice|0
2976905|NCT01106352|10247612|P2|Overall Study|Subject entered hospice|0
2976906|NCT01106352|10247613|P1|Overall Study|Subject entered hospice|0
2976907|NCT01106352|10247609|P5|Overall Study|Went on hospice|0
2976908|NCT01106352|10247610|P4|Overall Study|Went on hospice|1
2976909|NCT01106352|10247611|P3|Overall Study|Went on hospice|0
2976910|NCT01106352|10247612|P2|Overall Study|Went on hospice|0
2976911|NCT01106352|10247613|P1|Overall Study|Went on hospice|0
2976912|NCT01106352|10247609|P5|Overall Study|Withdrawal by Subject|2
2976913|NCT01106352|10247610|P4|Overall Study|Withdrawal by Subject|3
2976914|NCT01106352|10247611|P3|Overall Study|Withdrawal by Subject|0
2976915|NCT01106352|10247612|P2|Overall Study|Withdrawal by Subject|0
2976916|NCT01106352|10247613|P1|Overall Study|Withdrawal by Subject|0
2976917|NCT01106352|10247609|P5|Overall Study|Disease progression|0
2976918|NCT01106352|10247610|P4|Overall Study|Disease progression|1
2976919|NCT01106352|10247611|P3|Overall Study|Disease progression|0
2976920|NCT01106352|10247612|P2|Overall Study|Disease progression|0
2976921|NCT01106352|10247613|P1|Overall Study|Disease progression|0
2976922|NCT01106352|10247609|P5|Overall Study|Death|1
2976923|NCT01106352|10247610|P4|Overall Study|Death|3
2976924|NCT01106352|10247611|P3|Overall Study|Death|1
2976925|NCT01106352|10247612|P2|Overall Study|Death|0
2976926|NCT01106352|10247613|P1|Overall Study|Death|0
2976927|NCT01106352|10247609|P5|Overall Study|Lost to Follow-up|1
2976928|NCT01106352|10247610|P4|Overall Study|Lost to Follow-up|0
2976929|NCT01106352|10247611|P3|Overall Study|Lost to Follow-up|0
2976930|NCT01106352|10247612|P2|Overall Study|Lost to Follow-up|0
2976931|NCT01106352|10247613|P1|Overall Study|Lost to Follow-up|0
2976932|NCT01106352|10247609|P5|Overall Study|Too ill to come in for the visit|0
2976933|NCT01106352|10247610|P4|Overall Study|Too ill to come in for the visit|0
2976934|NCT01106352|10247611|P3|Overall Study|Too ill to come in for the visit|1
2976935|NCT01106352|10247612|P2|Overall Study|Too ill to come in for the visit|0
2976936|NCT01106352|10247613|P1|Overall Study|Too ill to come in for the visit|0
2976937|NCT01106352|10247609|P5|Overall Study|Sponsor Decision|0
2976938|NCT01106352|10247610|P4|Overall Study|Sponsor Decision|0
2976939|NCT01106352|10247611|P3|Overall Study|Sponsor Decision|0
2976940|NCT01106352|10247612|P2|Overall Study|Sponsor Decision|0
2976941|NCT01106352|10247613|P1|Overall Study|Sponsor Decision|1
2976942|NCT01106352|10247609|P5|Overall Study|Subjects untreated|4
2976943|NCT01106352|10247610|P4|Overall Study|Subjects untreated|3
2976944|NCT01106352|10247611|P3|Overall Study|Subjects untreated|0
2976945|NCT01106352|10247612|P2|Overall Study|Subjects untreated|0
2976946|NCT01106352|10247613|P1|Overall Study|Subjects untreated|0
2976947|NCT01106287|10247709|P4|Overall Study|Adverse Event|0
2976948|NCT01106287|10247710|P3|Overall Study|Adverse Event|0
2976949|NCT01106287|10247711|P2|Overall Study|Adverse Event|0
2976950|NCT01106287|10247712|P1|Overall Study|Adverse Event|1
2976951|NCT01106248|10247732|P1|Overall Study|Administrative|2
2976952|NCT01106248|10247732|P1|Overall Study|Adverse Event|1
2976953|NCT01106157|10247740|P2|Overall Study|Withdrawal by Subject|0
2976954|NCT01106157|10247741|P1|Overall Study|Withdrawal by Subject|1
2976955|NCT01106092|10247769|P4|Overall Study|Withdrawal by Subject|1
2976956|NCT01106092|10247770|P3|Overall Study|Withdrawal by Subject|0
2976957|NCT01106092|10247771|P2|Overall Study|Withdrawal by Subject|0
2976958|NCT01106092|10247772|P1|Overall Study|Withdrawal by Subject|0
2976959|NCT01106027|10247855|P1|Overall Study|Lost graft early, discontinued|1
2976960|NCT01106014|10247861|P2|Overall Study|Lost to Follow-up|3
2976961|NCT01106014|10247862|P1|Overall Study|Lost to Follow-up|2
2976962|NCT01106014|10247861|P2|Overall Study|Administrative reason|6
2976963|NCT01106014|10247862|P1|Overall Study|Administrative reason|7
2976964|NCT01106014|10247861|P2|Overall Study|Withdrawal by Subject|37
2976965|NCT01106014|10247862|P1|Overall Study|Withdrawal by Subject|43
2976966|NCT01106014|10247861|P2|Overall Study|Adverse Event|42
2976967|NCT01106014|10247862|P1|Overall Study|Adverse Event|78
2976968|NCT01106014|10247861|P2|Overall Study|Morbidity or Mortality primary endpoint|242
2976969|NCT01106014|10247862|P1|Overall Study|Morbidity or Mortality primary endpoint|155
2976970|NCT01105975|10247882|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2976971|NCT01105975|10247883|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2976972|NCT01105975|10247884|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2976973|NCT01105975|10247885|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2976974|NCT01105975|10247886|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2976975|NCT01105975|10247887|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2976976|NCT01105975|10247888|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2976977|NCT01105975|10247889|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2976978|NCT01105975|10247890|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2976979|NCT01105975|10247891|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2976980|NCT01105975|10247882|P10|Overall Study|Protocol Violation|2
2976981|NCT01105975|10247883|P9|Overall Study|Protocol Violation|2
2976982|NCT01105975|10247884|P8|Overall Study|Protocol Violation|1
2976983|NCT01105975|10247885|P7|Overall Study|Protocol Violation|1
2976984|NCT01105975|10247886|P6|Overall Study|Protocol Violation|1
2976985|NCT01105975|10247887|P5|Overall Study|Protocol Violation|1
2976986|NCT01105975|10247888|P4|Overall Study|Protocol Violation|0
2976987|NCT01105975|10247889|P3|Overall Study|Protocol Violation|2
2976988|NCT01105975|10247890|P2|Overall Study|Protocol Violation|2
2976989|NCT01105975|10247891|P1|Overall Study|Protocol Violation|0
2976990|NCT01105975|10247882|P10|Overall Study|Physician Decision|0
2976991|NCT01105975|10247883|P9|Overall Study|Physician Decision|0
2976992|NCT01105975|10247884|P8|Overall Study|Physician Decision|0
2976993|NCT01105975|10247885|P7|Overall Study|Physician Decision|2
2976994|NCT01105975|10247886|P6|Overall Study|Physician Decision|0
2976995|NCT01105975|10247887|P5|Overall Study|Physician Decision|0
2976996|NCT01105975|10247888|P4|Overall Study|Physician Decision|0
2976997|NCT01105975|10247889|P3|Overall Study|Physician Decision|0
2976998|NCT01105975|10247890|P2|Overall Study|Physician Decision|0
2976999|NCT01105975|10247891|P1|Overall Study|Physician Decision|0
2977000|NCT01105975|10247882|P10|Overall Study|Lost to Follow-up|0
2977001|NCT01105975|10247883|P9|Overall Study|Lost to Follow-up|1
2977002|NCT01105975|10247884|P8|Overall Study|Lost to Follow-up|0
2977003|NCT01105975|10247885|P7|Overall Study|Lost to Follow-up|0
2977004|NCT01105975|10247886|P6|Overall Study|Lost to Follow-up|0
2977005|NCT01105975|10247887|P5|Overall Study|Lost to Follow-up|1
2977006|NCT01105975|10247888|P4|Overall Study|Lost to Follow-up|1
2977007|NCT01105975|10247889|P3|Overall Study|Lost to Follow-up|0
2977008|NCT01105975|10247890|P2|Overall Study|Lost to Follow-up|0
2977009|NCT01105975|10247891|P1|Overall Study|Lost to Follow-up|1
2977010|NCT01105975|10247882|P10|Overall Study|Withdrawal by Subject|3
2977011|NCT01105975|10247883|P9|Overall Study|Withdrawal by Subject|0
2977012|NCT01105975|10247884|P8|Overall Study|Withdrawal by Subject|1
2977013|NCT01105975|10247885|P7|Overall Study|Withdrawal by Subject|2
2977014|NCT01105975|10247886|P6|Overall Study|Withdrawal by Subject|1
2977015|NCT01105975|10247887|P5|Overall Study|Withdrawal by Subject|4
2977016|NCT01105975|10247888|P4|Overall Study|Withdrawal by Subject|0
2977017|NCT01105975|10247889|P3|Overall Study|Withdrawal by Subject|2
2977018|NCT01105975|10247890|P2|Overall Study|Withdrawal by Subject|2
2977019|NCT01105975|10247891|P1|Overall Study|Withdrawal by Subject|2
2977020|NCT01105975|10247882|P10|Overall Study|Adverse Event|4
2977021|NCT01105975|10247883|P9|Overall Study|Adverse Event|1
2977022|NCT01105975|10247884|P8|Overall Study|Adverse Event|4
2977023|NCT01105975|10247885|P7|Overall Study|Adverse Event|2
2977024|NCT01105975|10247886|P6|Overall Study|Adverse Event|1
2977025|NCT01105975|10247887|P5|Overall Study|Adverse Event|0
2977026|NCT01105975|10247888|P4|Overall Study|Adverse Event|1
2977027|NCT01105975|10247889|P3|Overall Study|Adverse Event|5
2977028|NCT01105975|10247890|P2|Overall Study|Adverse Event|1
2977029|NCT01105975|10247891|P1|Overall Study|Adverse Event|2
2977030|NCT01105936|10248039|P4|Period 3|Protocol Violation|0
2977031|NCT01105936|10248040|P3|Period 3|Protocol Violation|0
2977032|NCT01105936|10248041|P2|Period 3|Protocol Violation|2
2977033|NCT01105936|10248042|P1|Period 3|Protocol Violation|0
2977034|NCT01105936|10248039|P4|Period 2|Adverse Event|0
2977035|NCT01105936|10248040|P3|Period 2|Adverse Event|0
2977036|NCT01105936|10248041|P2|Period 2|Adverse Event|0
2977037|NCT01105936|10248042|P1|Period 2|Adverse Event|1
2977038|NCT01105936|10248039|P4|Period 1|Adverse Event|1
2977039|NCT01105936|10248040|P3|Period 1|Adverse Event|0
2977040|NCT01105936|10248041|P2|Period 1|Adverse Event|0
2977041|NCT01105936|10248042|P1|Period 1|Adverse Event|0
2977042|NCT01105767|10248071|P3|Overall Study|Lost to Follow-up|1184
2977043|NCT01105767|10248072|P2|Overall Study|Lost to Follow-up|1614
2977044|NCT01105767|10248073|P1|Overall Study|Lost to Follow-up|1160
2977045|NCT01105533|10248125|P9|Overall Study|Physician Decision|0
2977046|NCT01105533|10248126|P8|Overall Study|Physician Decision|1
2977047|NCT01105533|10248127|P7|Overall Study|Physician Decision|0
2977048|NCT01105533|10248128|P6|Overall Study|Physician Decision|0
2977049|NCT01105533|10248129|P5|Overall Study|Physician Decision|0
2977050|NCT01105533|10248130|P4|Overall Study|Physician Decision|0
2977051|NCT01105533|10248131|P3|Overall Study|Physician Decision|0
2977052|NCT01105533|10248132|P2|Overall Study|Physician Decision|0
2977053|NCT01105533|10248133|P1|Overall Study|Physician Decision|0
2977054|NCT01105533|10248125|P9|Overall Study|Other|2
2977055|NCT01105533|10248126|P8|Overall Study|Other|1
2977056|NCT01105533|10248127|P7|Overall Study|Other|3
2977057|NCT01105533|10248128|P6|Overall Study|Other|0
2977058|NCT01105533|10248129|P5|Overall Study|Other|1
2977059|NCT01105533|10248130|P4|Overall Study|Other|0
2977060|NCT01105533|10248131|P3|Overall Study|Other|0
2977061|NCT01105533|10248132|P2|Overall Study|Other|0
2977062|NCT01105533|10248133|P1|Overall Study|Other|0
2977063|NCT01105533|10248125|P9|Overall Study|Adverse Event|1
2977064|NCT01105533|10248126|P8|Overall Study|Adverse Event|0
2977065|NCT01105533|10248127|P7|Overall Study|Adverse Event|2
2977066|NCT01105533|10248128|P6|Overall Study|Adverse Event|2
2977067|NCT01105533|10248129|P5|Overall Study|Adverse Event|1
2977068|NCT01105533|10248130|P4|Overall Study|Adverse Event|0
2977069|NCT01105533|10248131|P3|Overall Study|Adverse Event|0
2977070|NCT01105533|10248132|P2|Overall Study|Adverse Event|0
2977071|NCT01105533|10248133|P1|Overall Study|Adverse Event|0
2977072|NCT01105533|10248125|P9|Overall Study|Lack of Efficacy|9
2977073|NCT01105533|10248126|P8|Overall Study|Lack of Efficacy|2
2977074|NCT01105533|10248127|P7|Overall Study|Lack of Efficacy|3
2977075|NCT01105533|10248128|P6|Overall Study|Lack of Efficacy|5
2977076|NCT01105533|10248129|P5|Overall Study|Lack of Efficacy|4
2977077|NCT01105533|10248130|P4|Overall Study|Lack of Efficacy|3
2977078|NCT01105533|10248131|P3|Overall Study|Lack of Efficacy|3
2977079|NCT01105533|10248132|P2|Overall Study|Lack of Efficacy|1
2977080|NCT01105533|10248133|P1|Overall Study|Lack of Efficacy|1
2977081|NCT01105533|10248125|P9|Overall Study|Death|0
2977082|NCT01105533|10248126|P8|Overall Study|Death|0
2977083|NCT01105533|10248127|P7|Overall Study|Death|0
2977084|NCT01105533|10248128|P6|Overall Study|Death|0
2977085|NCT01105533|10248129|P5|Overall Study|Death|1
2977086|NCT01105533|10248130|P4|Overall Study|Death|0
2977087|NCT01105533|10248131|P3|Overall Study|Death|0
2977088|NCT01105533|10248132|P2|Overall Study|Death|0
2977089|NCT01105533|10248133|P1|Overall Study|Death|0
2977090|NCT01105377|10248223|P2|Overall Study|Withdrawal by Subject|1
2977091|NCT01105377|10248224|P1|Overall Study|Withdrawal by Subject|0
2977092|NCT01105130|10248272|P3|Overall Study|Multiple Reasons|2
2977093|NCT01105130|10248273|P2|Overall Study|Multiple Reasons|0
2977094|NCT01105130|10248274|P1|Overall Study|Multiple Reasons|3
2977095|NCT01105130|10248272|P3|Overall Study|Toxicity|2
2977096|NCT01105130|10248273|P2|Overall Study|Toxicity|3
2977097|NCT01105130|10248274|P1|Overall Study|Toxicity|1
2977098|NCT01105130|10248272|P3|Overall Study|Never Started|4
2977099|NCT01105130|10248273|P2|Overall Study|Never Started|2
2977100|NCT01105130|10248274|P1|Overall Study|Never Started|2
2977101|NCT01105130|10248272|P3|Overall Study|Withdrawal by Subject|2
2977102|NCT01105130|10248273|P2|Overall Study|Withdrawal by Subject|6
2977103|NCT01105130|10248274|P1|Overall Study|Withdrawal by Subject|4
2977104|NCT01105091|10248304|P2|Overall Study|Death|0
2977105|NCT01105091|10248305|P1|Overall Study|Death|2
2977106|NCT01105065|10248329|P1|Overall Study|Technical Problems|1
2977107|NCT01105065|10248329|P1|Overall Study|Adverse Event|5
2977108|NCT01104870|10248338|P3|Overall Study|Withdrawal by Subject|1
2977109|NCT01104870|10248339|P2|Overall Study|Withdrawal by Subject|0
2977110|NCT01104870|10248340|P1|Overall Study|Withdrawal by Subject|0
2977111|NCT01104870|10248338|P3|Overall Study|Death|1
2977112|NCT01104870|10248339|P2|Overall Study|Death|0
2977113|NCT01104870|10248340|P1|Overall Study|Death|0
2977114|NCT01104870|10248338|P3|Overall Study|Adverse Event|0
2977115|NCT01104870|10248339|P2|Overall Study|Adverse Event|1
2977116|NCT01104870|10248340|P1|Overall Study|Adverse Event|1
2977117|NCT01104792|10248369|P1|Overall Study|Did Not Meet Eligibility Criteria|133
2977118|NCT01104792|10248369|P1|Overall Study|Reasons Not Specified|27
2977119|NCT01104792|10248369|P1|Overall Study|Lost to Follow-up|43
2977120|NCT01104792|10248369|P1|Overall Study|Withdrawal of Consent|179
2977121|NCT01104792|10248369|P1|Overall Study|Protocol Violation|45
2977122|NCT01104792|10248369|P1|Overall Study|Insufficient Therapeutic Response|22
2977123|NCT01104792|10248369|P1|Overall Study|Adverse Event|77
2977124|NCT01104779|10248377|P3|Overall Study|Withdrawal by Subject|32
2977125|NCT01104779|10248378|P2|Overall Study|Withdrawal by Subject|25
2977126|NCT01104779|10248379|P1|Overall Study|Withdrawal by Subject|16
2977127|NCT01104779|10248377|P3|Overall Study|Lost to Follow-up|1
2977128|NCT01104779|10248378|P2|Overall Study|Lost to Follow-up|0
2977129|NCT01104779|10248379|P1|Overall Study|Lost to Follow-up|2
2977130|NCT01104779|10248377|P3|Overall Study|Other reasons|0
2977131|NCT01104779|10248378|P2|Overall Study|Other reasons|1
2977132|NCT01104779|10248379|P1|Overall Study|Other reasons|0
2977133|NCT01104779|10248377|P3|Overall Study|Did not meet inc/exc criteria|1
2977134|NCT01104779|10248378|P2|Overall Study|Did not meet inc/exc criteria|1
2977135|NCT01104779|10248379|P1|Overall Study|Did not meet inc/exc criteria|1
2977136|NCT01104779|10248377|P3|Overall Study|Adverse Event|13
2977137|NCT01104779|10248378|P2|Overall Study|Adverse Event|14
2977138|NCT01104779|10248379|P1|Overall Study|Adverse Event|13
2977139|NCT01104779|10248377|P3|Overall Study|Lack of Efficacy|13
2977140|NCT01104779|10248378|P2|Overall Study|Lack of Efficacy|12
2977141|NCT01104779|10248379|P1|Overall Study|Lack of Efficacy|26
2977142|NCT01104779|10248377|P3|Overall Study|Protocol Violation|2
2977143|NCT01104779|10248378|P2|Overall Study|Protocol Violation|2
2977144|NCT01104779|10248379|P1|Overall Study|Protocol Violation|1
2977145|NCT01104766|10248394|P4|Overall Study|Lost to Follow-up|1
2977146|NCT01104766|10248395|P3|Overall Study|Lost to Follow-up|1
2977147|NCT01104766|10248396|P2|Overall Study|Lost to Follow-up|2
2977148|NCT01104766|10248397|P1|Overall Study|Lost to Follow-up|1
2977149|NCT01104766|10248394|P4|Overall Study|Withdrawal by Subject|15
2977150|NCT01104766|10248395|P3|Overall Study|Withdrawal by Subject|25
2977151|NCT01104766|10248396|P2|Overall Study|Withdrawal by Subject|19
2977152|NCT01104766|10248397|P1|Overall Study|Withdrawal by Subject|17
2977153|NCT01104766|10248394|P4|Overall Study|Protocol Violation|0
2977154|NCT01104766|10248395|P3|Overall Study|Protocol Violation|0
2977155|NCT01104766|10248396|P2|Overall Study|Protocol Violation|0
2977156|NCT01104766|10248397|P1|Overall Study|Protocol Violation|2
2977157|NCT01104766|10248394|P4|Overall Study|Lack of Efficacy|8
2977158|NCT01104766|10248395|P3|Overall Study|Lack of Efficacy|14
2977159|NCT01104766|10248396|P2|Overall Study|Lack of Efficacy|15
2977160|NCT01104766|10248397|P1|Overall Study|Lack of Efficacy|20
2977161|NCT01104766|10248394|P4|Overall Study|Adverse Event|14
2977162|NCT01104766|10248395|P3|Overall Study|Adverse Event|20
2977163|NCT01104766|10248396|P2|Overall Study|Adverse Event|15
2977164|NCT01104766|10248397|P1|Overall Study|Adverse Event|17
2977165|NCT01104766|10248394|P4|Overall Study|Did not meet inc/exc criteria|0
2977166|NCT01104766|10248395|P3|Overall Study|Did not meet inc/exc criteria|0
2977167|NCT01104766|10248396|P2|Overall Study|Did not meet inc/exc criteria|0
2977168|NCT01104766|10248397|P1|Overall Study|Did not meet inc/exc criteria|1
2977169|NCT01104701|10248415|P4|Overall Study|Physician Decision|0
2977170|NCT01104701|10248416|P3|Overall Study|Physician Decision|0
2977171|NCT01104701|10248417|P2|Overall Study|Physician Decision|2
2977172|NCT01104701|10248418|P1|Overall Study|Physician Decision|0
2977173|NCT01104701|10248415|P4|Overall Study|Adverse Event|1
2977174|NCT01104701|10248416|P3|Overall Study|Adverse Event|0
2977175|NCT01104701|10248417|P2|Overall Study|Adverse Event|0
2977176|NCT01104701|10248418|P1|Overall Study|Adverse Event|0
2977177|NCT01104701|10248415|P4|Overall Study|Withdrawal by Subject|1
2977178|NCT01104701|10248416|P3|Overall Study|Withdrawal by Subject|2
2977179|NCT01104701|10248417|P2|Overall Study|Withdrawal by Subject|1
2977180|NCT01104701|10248418|P1|Overall Study|Withdrawal by Subject|0
2977181|NCT01104662|10248480|P8|Overall Study|Randomized but not treated|0
2977182|NCT01104662|10248481|P7|Overall Study|Randomized but not treated|0
2977183|NCT01104662|10248482|P6|Overall Study|Randomized but not treated|1
2977184|NCT01104662|10248483|P5|Overall Study|Randomized but not treated|0
2977185|NCT01104662|10248484|P4|Overall Study|Randomized but not treated|0
2977186|NCT01104662|10248485|P3|Overall Study|Randomized but not treated|1
2977187|NCT01104662|10248486|P2|Overall Study|Randomized but not treated|4
2977188|NCT01104662|10248487|P1|Overall Study|Randomized but not treated|3
2977189|NCT01104662|10248480|P8|Overall Study|Reason not specified|0
2977190|NCT01104662|10248481|P7|Overall Study|Reason not specified|0
2977191|NCT01104662|10248482|P6|Overall Study|Reason not specified|1
2977192|NCT01104662|10248483|P5|Overall Study|Reason not specified|0
2977193|NCT01104662|10248484|P4|Overall Study|Reason not specified|0
2977194|NCT01104662|10248485|P3|Overall Study|Reason not specified|0
2977195|NCT01104662|10248486|P2|Overall Study|Reason not specified|3
2977196|NCT01104662|10248487|P1|Overall Study|Reason not specified|3
2977197|NCT01104662|10248480|P8|Overall Study|Participant left investigator’s care|0
2977198|NCT01104662|10248481|P7|Overall Study|Participant left investigator’s care|0
2977199|NCT01104662|10248482|P6|Overall Study|Participant left investigator’s care|0
2977200|NCT01104662|10248483|P5|Overall Study|Participant left investigator’s care|0
2977201|NCT01104662|10248484|P4|Overall Study|Participant left investigator’s care|0
2977202|NCT01104662|10248485|P3|Overall Study|Participant left investigator’s care|0
2977203|NCT01104662|10248486|P2|Overall Study|Participant left investigator’s care|1
2977204|NCT01104662|10248487|P1|Overall Study|Participant left investigator’s care|1
2977205|NCT01104662|10248480|P8|Overall Study|Clinical Failure|0
2977206|NCT01104662|10248481|P7|Overall Study|Clinical Failure|0
2977207|NCT01104662|10248482|P6|Overall Study|Clinical Failure|1
2977208|NCT01104662|10248483|P5|Overall Study|Clinical Failure|0
2977209|NCT01104662|10248484|P4|Overall Study|Clinical Failure|0
2977210|NCT01104662|10248485|P3|Overall Study|Clinical Failure|0
2977211|NCT01104662|10248486|P2|Overall Study|Clinical Failure|0
2977212|NCT01104662|10248487|P1|Overall Study|Clinical Failure|1
2977213|NCT01104662|10248480|P8|Overall Study|Adverse Event|0
2977214|NCT01104662|10248481|P7|Overall Study|Adverse Event|0
2977215|NCT01104662|10248482|P6|Overall Study|Adverse Event|1
2977216|NCT01104662|10248483|P5|Overall Study|Adverse Event|1
2977217|NCT01104662|10248484|P4|Overall Study|Adverse Event|1
2977218|NCT01104662|10248485|P3|Overall Study|Adverse Event|0
2977219|NCT01104662|10248486|P2|Overall Study|Adverse Event|2
2977220|NCT01104662|10248487|P1|Overall Study|Adverse Event|2
2977221|NCT01104636|10248513|P1|Overall Study|Ongoing|21
2977222|NCT01104636|10248513|P1|Overall Study|Adverse Event|40
2977223|NCT01104636|10248513|P1|Overall Study|Pregnancy|2
2977224|NCT01104636|10248513|P1|Overall Study|Study terminated by sponsor|1
2977225|NCT01104636|10248513|P1|Overall Study|Other|43
2977226|NCT01104636|10248513|P1|Overall Study|Withdrawal by Subject|4
2977227|NCT01104636|10248513|P1|Overall Study|Lost to Follow-up|24
2977228|NCT01104636|10248513|P1|Overall Study|Lack of Efficacy|43
2977229|NCT01104584|10248518|P1|Overall Study|Study prematurely discontinued|2
2977230|NCT01104584|10248518|P1|Overall Study|Study drug never administered|21
2977231|NCT01104558|10248588|P1|Overall Study|Missing of genetic analysis results|1
2977232|NCT01104558|10248588|P1|Overall Study|Missing of primary efficacy assessment|10
2977233|NCT01104558|10248588|P1|Overall Study|Protocol Violation|6
2977234|NCT01104545|10248632|P3|Overall Study|Adverse Event|2
2977235|NCT01104545|10248633|P2|Overall Study|Adverse Event|1
2977236|NCT01104545|10248634|P1|Overall Study|Adverse Event|0
2977237|NCT01104493|10248791|P2|Overall Study|Lost to Follow-up|2
2977238|NCT01104493|10248792|P1|Overall Study|Lost to Follow-up|0
2977239|NCT01104415|10248810|P2|Extension Period|Heart surgery/feeling miserable|1
2977240|NCT01104415|10248811|P1|Extension Period|Heart surgery/feeling miserable|0
2977241|NCT01104415|10248810|P2|Extension Period|Transition to Study LX1606.302|4
2977242|NCT01104415|10248811|P1|Extension Period|Transition to Study LX1606.302|0
2977243|NCT01104415|10248810|P2|Extension Period|Physician Decision|1
2977244|NCT01104415|10248811|P1|Extension Period|Physician Decision|0
2977245|NCT01104415|10248810|P2|Extension Period|Death|1
2977246|NCT01104415|10248811|P1|Extension Period|Death|0
2977247|NCT01104415|10248810|P2|Extension Period|Progressive disease|4
2977248|NCT01104415|10248811|P1|Extension Period|Progressive disease|0
2977249|NCT01104415|10248810|P2|Core Phase|Consent withdrawn by subjects|0
2977250|NCT01104415|10248811|P1|Core Phase|Consent withdrawn by subjects|1
2977251|NCT01104376|10248855|P1|Overall Study|Consented but excluded after labs|13
2977252|NCT01104376|10248855|P1|Overall Study|Withdrawal by Subject|15
2977253|NCT01104311|10248861|P2|Overall Study|Adverse Event|2
2977254|NCT01104311|10248862|P1|Overall Study|Adverse Event|1
2977255|NCT01104311|10248861|P2|Overall Study|low compliance|1
2977256|NCT01104311|10248862|P1|Overall Study|low compliance|1
2977257|NCT01104311|10248861|P2|Overall Study|Physician Decision|2
2977258|NCT01104311|10248862|P1|Overall Study|Physician Decision|2
2977259|NCT01104311|10248861|P2|Overall Study|Protocol Violation|1
2977260|NCT01104311|10248862|P1|Overall Study|Protocol Violation|0
2977261|NCT01104311|10248861|P2|Overall Study|Withdrawal by Subject|6
2977262|NCT01104311|10248862|P1|Overall Study|Withdrawal by Subject|6
2977263|NCT01104246|10248889|P1|Overall Study|did not meet inclusion criteria|4
2977264|NCT01104246|10248889|P1|Overall Study|Withdrawal by Subject|1
2977265|NCT01104155|10248904|P2|Overall Study|Other|4
2977266|NCT01104155|10248905|P1|Overall Study|Other|3
2977267|NCT01104155|10248904|P2|Overall Study|Withdrawal of consent|1
2977268|NCT01104155|10248905|P1|Overall Study|Withdrawal of consent|1
2977269|NCT01104155|10248904|P2|Overall Study|Participant choice|5
2977270|NCT01104155|10248905|P1|Overall Study|Participant choice|6
2977271|NCT01104155|10248904|P2|Overall Study|Adverse Event|8
2977272|NCT01104155|10248905|P1|Overall Study|Adverse Event|15
2977273|NCT01103960|10248948|P2|Overall Study|Other|0
2977274|NCT01103960|10248949|P1|Overall Study|Other|1
2977275|NCT01103960|10248948|P2|Overall Study|Withdrawal by Subject|1
2977276|NCT01103960|10248949|P1|Overall Study|Withdrawal by Subject|2
2977277|NCT01103960|10248948|P2|Overall Study|Adverse Event|1
2977278|NCT01103960|10248949|P1|Overall Study|Adverse Event|2
2977279|NCT01103778|10248984|P1|Overall Study|Screen failure|1
2977280|NCT01103778|10248984|P1|Overall Study|Proteinuria improved prior to enrollment|1
2977281|NCT01103778|10248984|P1|Overall Study|Lost to Follow-up|1
2977282|NCT01103713|10248991|P1|Overall Study|Other|1
2977283|NCT01103713|10248991|P1|Overall Study|Study terminated by sponsor|2
2977284|NCT01103713|10248991|P1|Overall Study|Withdrawal by Subject|8
2977285|NCT01103713|10248991|P1|Overall Study|Lost to Follow-up|2
2977286|NCT01103479|10249041|P3|Overall Study|Saw non-study physician|0
2977287|NCT01103479|10249042|P2|Overall Study|Saw non-study physician|0
2977288|NCT01103479|10249043|P1|Overall Study|Saw non-study physician|2
2977289|NCT01103479|10249041|P3|Overall Study|Active cancer|0
2977290|NCT01103479|10249042|P2|Overall Study|Active cancer|0
2977291|NCT01103479|10249043|P1|Overall Study|Active cancer|1
2977292|NCT01103479|10249041|P3|Overall Study|Family history of CRC|2
2977293|NCT01103479|10249042|P2|Overall Study|Family history of CRC|0
2977294|NCT01103479|10249043|P1|Overall Study|Family history of CRC|1
2977295|NCT01103479|10249041|P3|Overall Study|Up to date with CRC screening|12
2977296|NCT01103479|10249042|P2|Overall Study|Up to date with CRC screening|9
2977297|NCT01103479|10249043|P1|Overall Study|Up to date with CRC screening|1
2977298|NCT01103466|10249056|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
2977299|NCT01103466|10249057|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
2977300|NCT01103466|10249058|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
2977301|NCT01103466|10249056|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2977302|NCT01103466|10249057|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2977303|NCT01103466|10249058|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
2977304|NCT01103466|10249056|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
2977305|NCT01103466|10249057|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
2977306|NCT01103466|10249058|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
2977307|NCT01103466|10249056|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2977308|NCT01103466|10249057|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2977309|NCT01103466|10249058|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
2977310|NCT01103466|10249056|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
2977311|NCT01103466|10249057|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
2977312|NCT01103466|10249058|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
2977313|NCT01103466|10249056|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
2977314|NCT01103466|10249057|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
2977315|NCT01103466|10249058|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
2977316|NCT01103362|10249148|P1|Overall Study|study terminated|596
2977317|NCT01103323|10249154|P2|Switched From Placebo to Regorafenib|Adverse Event|1
2977318|NCT01103323|10249155|P1|Switched From Placebo to Regorafenib|Adverse Event|0
2977319|NCT01103323|10249154|P2|Without/Before Drug Switch|Switch to Regorafenib|4
2977320|NCT01103323|10249155|P1|Without/Before Drug Switch|Switch to Regorafenib|0
2977321|NCT01103323|10249154|P2|Without/Before Drug Switch|did not receive study treatment|2
2977322|NCT01103323|10249155|P1|Without/Before Drug Switch|did not receive study treatment|5
2977323|NCT01103323|10249154|P2|Without/Before Drug Switch|Physician Decision|0
2977324|NCT01103323|10249155|P1|Without/Before Drug Switch|Physician Decision|2
2977325|NCT01103323|10249154|P2|Without/Before Drug Switch|Protocol Violation|0
2977326|NCT01103323|10249155|P1|Without/Before Drug Switch|Protocol Violation|2
2977327|NCT01103323|10249154|P2|Without/Before Drug Switch|Withdrawal by Subject|5
2977328|NCT01103323|10249155|P1|Without/Before Drug Switch|Withdrawal by Subject|17
2977329|NCT01103323|10249154|P2|Without/Before Drug Switch|Adverse Event|7
2977330|NCT01103323|10249155|P1|Without/Before Drug Switch|Adverse Event|50
2977331|NCT01103284|10249172|P2|Overall Study|Missing CRF entries for study completion|2
2977332|NCT01103284|10249173|P1|Overall Study|Missing CRF entries for study completion|0
2977333|NCT01103284|10249172|P2|Overall Study|Not described|1
2977334|NCT01103284|10249173|P1|Overall Study|Not described|2
2977335|NCT01103284|10249172|P2|Overall Study|Termination by the Sponsor|1
2977336|NCT01103284|10249173|P1|Overall Study|Termination by the Sponsor|0
2977337|NCT01103284|10249172|P2|Overall Study|Dermal Hypersensitivity|1
2977338|NCT01103284|10249173|P1|Overall Study|Dermal Hypersensitivity|0
2977339|NCT01103284|10249172|P2|Overall Study|Withdrawal by Subject|18
2977340|NCT01103284|10249173|P1|Overall Study|Withdrawal by Subject|14
2977341|NCT01103284|10249172|P2|Overall Study|Adverse Event|5
2977342|NCT01103284|10249173|P1|Overall Study|Adverse Event|0
2977343|NCT01103284|10249172|P2|Overall Study|Protocol Violation|5
2977344|NCT01103284|10249173|P1|Overall Study|Protocol Violation|12
2977345|NCT01103284|10249172|P2|Overall Study|Pregnancy|1
2977346|NCT01103284|10249173|P1|Overall Study|Pregnancy|3
2977347|NCT01103284|10249172|P2|Overall Study|Lost to Follow-up|10
2977348|NCT01103284|10249173|P1|Overall Study|Lost to Follow-up|9
2977349|NCT01103284|10249172|P2|Overall Study|Death|0
2977350|NCT01103284|10249173|P1|Overall Study|Death|2
2977351|NCT01103245|10249201|P4|Overall Study|Physician Decision|0
2977352|NCT01103245|10249202|P3|Overall Study|Physician Decision|0
2977353|NCT01103245|10249203|P2|Overall Study|Physician Decision|0
2977354|NCT01103245|10249204|P1|Overall Study|Physician Decision|1
2977355|NCT01103245|10249201|P4|Overall Study|Adverse Event|0
2977356|NCT01103245|10249202|P3|Overall Study|Adverse Event|1
2977357|NCT01103245|10249203|P2|Overall Study|Adverse Event|2
2977358|NCT01103245|10249204|P1|Overall Study|Adverse Event|0
2977359|NCT01103245|10249201|P4|Overall Study|Inadequate IV access|0
2977360|NCT01103245|10249202|P3|Overall Study|Inadequate IV access|0
2977361|NCT01103245|10249203|P2|Overall Study|Inadequate IV access|0
2977362|NCT01103245|10249204|P1|Overall Study|Inadequate IV access|1
2977363|NCT01103245|10249201|P4|Overall Study|Withdrawal by Subject|0
2977364|NCT01103245|10249202|P3|Overall Study|Withdrawal by Subject|3
2977365|NCT01103245|10249203|P2|Overall Study|Withdrawal by Subject|0
2977366|NCT01103245|10249204|P1|Overall Study|Withdrawal by Subject|1
2977367|NCT01103232|10249220|P2|Overall Study|Protocol Violation|1
2977368|NCT01103232|10249221|P1|Overall Study|Protocol Violation|0
2977369|NCT01103232|10249220|P2|Overall Study|Withdrawal by Subject|1
2977370|NCT01103232|10249221|P1|Overall Study|Withdrawal by Subject|1
2977371|NCT01103180|10249229|P2|Overall Study|Protocol Violation|1
2977372|NCT01103180|10249230|P1|Overall Study|Protocol Violation|0
2977373|NCT01103180|10249229|P2|Overall Study|Physician Decision|0
2977374|NCT01103180|10249230|P1|Overall Study|Physician Decision|1
2977375|NCT01103180|10249229|P2|Overall Study|Lost to Follow-up|7
2977376|NCT01103180|10249230|P1|Overall Study|Lost to Follow-up|13
2977377|NCT01103180|10249229|P2|Overall Study|Withdrawal by Subject|13
2977378|NCT01103180|10249230|P1|Overall Study|Withdrawal by Subject|8
2977379|NCT01103141|10249240|P2|Overall Study|Lost to Follow-up|1
2977380|NCT01103141|10249241|P1|Overall Study|Lost to Follow-up|2
2977381|NCT01103141|10249240|P2|Overall Study|Death|1
2977382|NCT01103141|10249241|P1|Overall Study|Death|0
2977383|NCT01103063|10249249|P2|Overall Study|Death|1
2977384|NCT01103063|10249250|P1|Overall Study|Death|3
2977385|NCT01103063|10249249|P2|Overall Study|Study terminated by Sponsor|342
2977386|NCT01103063|10249250|P1|Overall Study|Study terminated by Sponsor|326
2977387|NCT01103063|10249249|P2|Overall Study|Protocol Violation|0
2977388|NCT01103063|10249250|P1|Overall Study|Protocol Violation|1
2977389|NCT01103063|10249249|P2|Overall Study|Other|11
2977390|NCT01103063|10249250|P1|Overall Study|Other|16
2977391|NCT01103063|10249249|P2|Overall Study|Withdrawal by Subject|15
2977392|NCT01103063|10249250|P1|Overall Study|Withdrawal by Subject|60
2977393|NCT01103063|10249249|P2|Overall Study|Lost to Follow-up|51
2977394|NCT01103063|10249250|P1|Overall Study|Lost to Follow-up|68
2977395|NCT01103063|10249249|P2|Overall Study|Adverse Event|1
2977396|NCT01103063|10249250|P1|Overall Study|Adverse Event|3
2977397|NCT01102972|10249318|P2|Overall Study|Withdrawal by Subject|6
2977398|NCT01102972|10249319|P1|Overall Study|Withdrawal by Subject|6
2977399|NCT01102972|10249318|P2|Overall Study|Investigator Discretion|0
2977400|NCT01102972|10249319|P1|Overall Study|Investigator Discretion|2
2977401|NCT01102972|10249318|P2|Overall Study|Lost to Follow-up|5
2977402|NCT01102972|10249319|P1|Overall Study|Lost to Follow-up|10
2977403|NCT01102972|10249318|P2|Overall Study|Protocol Violation|0
2977404|NCT01102972|10249319|P1|Overall Study|Protocol Violation|1
2977405|NCT01102972|10249318|P2|Overall Study|Lack of Efficacy|1
2977406|NCT01102972|10249319|P1|Overall Study|Lack of Efficacy|2
2977407|NCT01102972|10249318|P2|Overall Study|Adverse Event|2
2977408|NCT01102972|10249319|P1|Overall Study|Adverse Event|8
2977409|NCT01102803|10249383|P2|Post to Follow-Up|Lost to Follow-up|3
2977410|NCT01102803|10249384|P1|Post to Follow-Up|Lost to Follow-up|1
2977411|NCT01102803|10249383|P2|Baseline to Post-Treatment|Lost to Follow-up|0
2977412|NCT01102803|10249384|P1|Baseline to Post-Treatment|Lost to Follow-up|3
2977413|NCT01102777|10249398|P2|Overall Study|Lost to Follow-up|10
2977414|NCT01102777|10249399|P1|Overall Study|Lost to Follow-up|7
2977415|NCT01102777|10249398|P2|Overall Study|Death|6
2977416|NCT01102777|10249399|P1|Overall Study|Death|2
2977417|NCT01102491|10249458|P2|Overall Study|Protocol Violation|12
2977418|NCT01102491|10249459|P1|Overall Study|Protocol Violation|11
2977419|NCT01102374|10249478|P2|Overall Study|Lost to Follow-up|6
2977420|NCT01102374|10249479|P1|Overall Study|Lost to Follow-up|7
2977421|NCT01102374|10249478|P2|Overall Study|Death|13
2977422|NCT01102374|10249479|P1|Overall Study|Death|9
2977423|NCT01102257|10249528|P2|Overall Study|Adverse Event|0
2977424|NCT01102257|10249529|P1|Overall Study|Adverse Event|1
2977425|NCT01102257|10249528|P2|Overall Study|Adverse Event|0
2977426|NCT01102257|10249529|P1|Overall Study|Adverse Event|1
2977427|NCT01102140|10249546|P2|Overall Study|Investigator terminated study|2
2977428|NCT01102140|10249547|P1|Overall Study|Investigator terminated study|2
2977429|NCT01102140|10249546|P2|Overall Study|Lost to Follow-up|0
2977430|NCT01102140|10249547|P1|Overall Study|Lost to Follow-up|1
2977431|NCT01101841|10249602|P2|Overall Study|Eligibility Criteria|2
2977432|NCT01101841|10249603|P1|Overall Study|Eligibility Criteria|1
2977433|NCT01101841|10249602|P2|Overall Study|Suicidality Tracking Scale|1
2977434|NCT01101841|10249603|P1|Overall Study|Suicidality Tracking Scale|3
2977435|NCT01101841|10249602|P2|Overall Study|Other|1
2977436|NCT01101841|10249603|P1|Overall Study|Other|0
2977437|NCT01101841|10249602|P2|Overall Study|Lack of Efficacy|2
2977438|NCT01101841|10249603|P1|Overall Study|Lack of Efficacy|0
2977439|NCT01101841|10249602|P2|Overall Study|Physician Decision|2
2977440|NCT01101841|10249603|P1|Overall Study|Physician Decision|0
2977441|NCT01101841|10249602|P2|Overall Study|Protocol Violation|1
2977442|NCT01101841|10249603|P1|Overall Study|Protocol Violation|1
2977443|NCT01101841|10249602|P2|Overall Study|Withdrawal by Subject|40
2977444|NCT01101841|10249603|P1|Overall Study|Withdrawal by Subject|21
2977445|NCT01101841|10249602|P2|Overall Study|Lost to Follow-up|3
2977446|NCT01101841|10249603|P1|Overall Study|Lost to Follow-up|9
2977447|NCT01101841|10249602|P2|Overall Study|Adverse Event|15
2977448|NCT01101841|10249603|P1|Overall Study|Adverse Event|15
2977449|NCT01101542|10249641|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
2977450|NCT01101542|10249641|P1|Year 6 Surveillance Period|Pregnancy|1
2977451|NCT01101542|10249641|P1|Year 6 Surveillance Period|Lost to Follow-up|986
2977452|NCT01101542|10249641|P1|Year 5 Surveillance Period|Pregnancy|1
2977453|NCT01101542|10249641|P1|Year 5 Surveillance Period|Lost to Follow-up|140
2977454|NCT01101542|10249641|P1|Year 4 Surveillance Period|Other|287
2977455|NCT01101542|10249641|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
2977456|NCT01101542|10249641|P1|Year 3 Surveillance Period|Lost to Follow-up|7
2977457|NCT01101477|10249657|P3|Overall Study|Protocol Violation|1
2977458|NCT01101477|10249658|P2|Overall Study|Protocol Violation|3
2977459|NCT01101477|10249659|P1|Overall Study|Protocol Violation|5
2977460|NCT01101321|10249680|P2|Period 1|Adverse Event|3
2977461|NCT01101321|10249681|P1|Period 1|Adverse Event|3
2977462|NCT01101321|10249680|P2|Period 1|Withdrawal by Subject|1
2977463|NCT01101321|10249681|P1|Period 1|Withdrawal by Subject|1
2977464|NCT01101308|10249691|P2|Period 1|Positive for cotinine|0
2977465|NCT01101308|10249692|P1|Period 1|Positive for cotinine|1
2977466|NCT01101308|10249691|P2|Period 1|Adverse Event|1
2977467|NCT01101308|10249692|P1|Period 1|Adverse Event|2
2977468|NCT01101191|10249703|P2|Period 1|Adverse Event|2
2977469|NCT01101191|10249704|P1|Period 1|Adverse Event|1
2977470|NCT01101191|10249703|P2|Period 1|Withdrawal by Subject|0
2977471|NCT01101191|10249704|P1|Period 1|Withdrawal by Subject|1
2977472|NCT01101178|10249715|P2|Period 2|Withdrawal by Subject|1
2977473|NCT01101178|10249716|P1|Period 2|Withdrawal by Subject|0
2977474|NCT01101178|10249715|P2|Period 1|Adverse Event|1
2977475|NCT01101178|10249716|P1|Period 1|Adverse Event|2
2977476|NCT01101178|10249715|P2|Period 1|Positive drug screen|1
2977477|NCT01101178|10249716|P1|Period 1|Positive drug screen|1
2977478|NCT01101178|10249715|P2|Period 1|Withdrawal by Subject|2
2977479|NCT01101178|10249716|P1|Period 1|Withdrawal by Subject|1
2977480|NCT01101165|10249727|P2|Period 2|Adverse Event|0
2977481|NCT01101165|10249728|P1|Period 2|Adverse Event|1
2977482|NCT01101165|10249727|P2|Period 2|Withdrawal by Subject|1
2977483|NCT01101165|10249728|P1|Period 2|Withdrawal by Subject|3
2977484|NCT01101165|10249727|P2|Period 1|Lost to Follow-up|0
2977485|NCT01101165|10249728|P1|Period 1|Lost to Follow-up|1
2977486|NCT01101165|10249727|P2|Period 1|Positive Drug Screen|1
2977487|NCT01101165|10249728|P1|Period 1|Positive Drug Screen|0
2977488|NCT01101165|10249727|P2|Period 1|Withdrawal by Subject|2
2977489|NCT01101165|10249728|P1|Period 1|Withdrawal by Subject|0
2977490|NCT01101165|10249727|P2|Period 1|Adverse Event|2
2977491|NCT01101165|10249728|P1|Period 1|Adverse Event|1
2977492|NCT01101061|10249749|P6|Overall Study|Adverse Event|0
2977493|NCT01101061|10249750|P5|Overall Study|Adverse Event|0
2977494|NCT01101061|10249751|P4|Overall Study|Adverse Event|0
2977495|NCT01101061|10249752|P3|Overall Study|Adverse Event|1
2977496|NCT01101061|10249753|P2|Overall Study|Adverse Event|0
2977497|NCT01101061|10249754|P1|Overall Study|Adverse Event|0
2977498|NCT01101035|10249834|P2|Overall Study|Reason not Specified|363
2977499|NCT01101035|10249835|P1|Overall Study|Reason not Specified|333
2977500|NCT01101035|10249834|P2|Overall Study|Voluntary Withdrawal|587
2977501|NCT01101035|10249835|P1|Overall Study|Voluntary Withdrawal|595
2977502|NCT01101035|10249834|P2|Overall Study|Lost to Follow-up|223
2977503|NCT01101035|10249835|P1|Overall Study|Lost to Follow-up|226
2977504|NCT01101035|10249834|P2|Overall Study|Major Protocol Deviation|46
2977505|NCT01101035|10249835|P1|Overall Study|Major Protocol Deviation|52
2977506|NCT01101035|10249834|P2|Overall Study|Adverse Event|172
2977507|NCT01101035|10249835|P1|Overall Study|Adverse Event|191
2977508|NCT01101022|10249855|P2|Overall Study|Vacation|1
2977509|NCT01101022|10249856|P1|Overall Study|Vacation|0
2977510|NCT01101022|10249855|P2|Overall Study|Work schedule|1
2977511|NCT01101022|10249856|P1|Overall Study|Work schedule|1
2977512|NCT01101022|10249855|P2|Overall Study|Non-compliance|0
2977513|NCT01101022|10249856|P1|Overall Study|Non-compliance|1
2977514|NCT01101022|10249855|P2|Overall Study|Sponsor decision|1
2977515|NCT01101022|10249856|P1|Overall Study|Sponsor decision|1
2977516|NCT01101022|10249855|P2|Overall Study|Lack of Efficacy|7
2977517|NCT01101022|10249856|P1|Overall Study|Lack of Efficacy|0
2977518|NCT01101022|10249855|P2|Overall Study|Lost to Follow-up|4
2977519|NCT01101022|10249856|P1|Overall Study|Lost to Follow-up|1
2977520|NCT01101022|10249855|P2|Overall Study|Withdrawal by Subject|8
2977521|NCT01101022|10249856|P1|Overall Study|Withdrawal by Subject|3
2977522|NCT01101022|10249855|P2|Overall Study|Protocol Violation|3
2977523|NCT01101022|10249856|P1|Overall Study|Protocol Violation|4
2977524|NCT01101022|10249855|P2|Overall Study|Adverse Event|2
2977525|NCT01101022|10249856|P1|Overall Study|Adverse Event|6
2977526|NCT01100944|10249890|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2977527|NCT01100944|10249891|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
2977528|NCT01100944|10249892|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2977529|NCT01100944|10249890|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2977530|NCT01100944|10249891|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2977531|NCT01100944|10249892|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
2977532|NCT01100944|10249890|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2977533|NCT01100944|10249891|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2977534|NCT01100944|10249892|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
2977535|NCT01100944|10249890|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2977536|NCT01100944|10249891|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2977537|NCT01100944|10249892|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
2977538|NCT01100853|10249950|P2|Overall Study|Withdrawal by Subject|4
2977539|NCT01100853|10249951|P1|Overall Study|Withdrawal by Subject|6
2977540|NCT01100853|10249950|P2|Overall Study|Received <4 study injections|13
2977541|NCT01100853|10249951|P1|Overall Study|Received <4 study injections|10
2977542|NCT01100853|10249950|P2|Overall Study|Lost to Follow-up|6
2977543|NCT01100853|10249951|P1|Overall Study|Lost to Follow-up|11
2977544|NCT01100658|10249997|P1|Overall Study|Withdrawal by Subject|1
2977545|NCT01100567|10250029|P2|Overall Study|Deemed ineligible after consent|1
2977546|NCT01100567|10250030|P1|Overall Study|Deemed ineligible after consent|0
2977547|NCT01100567|10250029|P2|Overall Study|Physician Decision|1
2977548|NCT01100567|10250030|P1|Overall Study|Physician Decision|0
2977549|NCT01100567|10250029|P2|Overall Study|Lost to Follow-up|2
2977550|NCT01100567|10250030|P1|Overall Study|Lost to Follow-up|1
2977551|NCT01100567|10250029|P2|Overall Study|Early Hospital Discharge|4
2977552|NCT01100567|10250030|P1|Overall Study|Early Hospital Discharge|6
2977553|NCT01100567|10250029|P2|Overall Study|Withdrawal by Subject|8
2977554|NCT01100567|10250030|P1|Overall Study|Withdrawal by Subject|5
2977555|NCT01100528|10250038|P1|Overall Study|Withdrawal by Subject|2
2977556|NCT01100528|10250038|P1|Overall Study|Death|1
2977557|NCT01100502|10250046|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
2977558|NCT01100502|10250047|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
2977559|NCT01100502|10250046|P2|Long-Term Follow-up|Lost to Follow-up|2
2977560|NCT01100502|10250047|P1|Long-Term Follow-up|Lost to Follow-up|5
2977561|NCT01100502|10250046|P2|Long-Term Follow-up|Withdrawal by Subject|8
2977562|NCT01100502|10250047|P1|Long-Term Follow-up|Withdrawal by Subject|10
2977563|NCT01100502|10250046|P2|Treatment Period|Progressive Disease|69
2977564|NCT01100502|10250047|P1|Treatment Period|Progressive Disease|24
2977565|NCT01100502|10250046|P2|Treatment Period|Withdrawal by Subject|4
2977566|NCT01100502|10250047|P1|Treatment Period|Withdrawal by Subject|9
2977567|NCT01100502|10250046|P2|Treatment Period|Adverse Event|10
2977568|NCT01100502|10250047|P1|Treatment Period|Adverse Event|54
2977569|NCT01100437|10250057|P3|Maintenance|Sponsor termination of study|1
2977570|NCT01100437|10250058|P2|Maintenance|Sponsor termination of study|0
2977571|NCT01100437|10250059|P1|Maintenance|Sponsor termination of study|0
2977572|NCT01100437|10250057|P3|Maintenance|Withdrawal by Subject|1
2977573|NCT01100437|10250058|P2|Maintenance|Withdrawal by Subject|0
2977574|NCT01100437|10250059|P1|Maintenance|Withdrawal by Subject|0
2977575|NCT01100437|10250057|P3|Titration/Stabilization|Sponsor canceled study|1
2977576|NCT01100437|10250058|P2|Titration/Stabilization|Sponsor canceled study|0
2977577|NCT01100437|10250059|P1|Titration/Stabilization|Sponsor canceled study|0
2977578|NCT01100437|10250057|P3|Titration/Stabilization|Non-compliance|1
2977579|NCT01100437|10250058|P2|Titration/Stabilization|Non-compliance|0
2977580|NCT01100437|10250059|P1|Titration/Stabilization|Non-compliance|0
2977581|NCT01100437|10250057|P3|Titration/Stabilization|Adverse Event|4
2977582|NCT01100437|10250058|P2|Titration/Stabilization|Adverse Event|0
2977583|NCT01100437|10250059|P1|Titration/Stabilization|Adverse Event|0
2977584|NCT01100320|10250096|P2|Period 2|Withdrawal by Subject|1
2977585|NCT01100320|10250097|P1|Period 2|Withdrawal by Subject|1
2977586|NCT01100320|10250096|P2|Period 1|Adverse Event|2
2977587|NCT01100320|10250097|P1|Period 1|Adverse Event|2
2977588|NCT01100320|10250096|P2|Period 1|Positive Drug Screen|1
2977589|NCT01100320|10250097|P1|Period 1|Positive Drug Screen|1
2977590|NCT01100320|10250096|P2|Period 1|Withdrawal by Subject|4
2977591|NCT01100320|10250097|P1|Period 1|Withdrawal by Subject|2
2977592|NCT01100307|10250109|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
2977593|NCT01100307|10250110|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
2977594|NCT01100307|10250109|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
2977595|NCT01100307|10250110|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
2977596|NCT01100307|10250109|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
2977597|NCT01100307|10250110|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
2977598|NCT01100307|10250109|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
2977599|NCT01100307|10250110|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
2977600|NCT01100307|10250109|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
2977601|NCT01100307|10250110|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
2977602|NCT01100307|10250109|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2977603|NCT01100307|10250110|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2977604|NCT01100086|10250179|P2|Period 1|Withdrawal by Subject|0
2977605|NCT01100086|10250180|P1|Period 1|Withdrawal by Subject|1
2977606|NCT01100073|10250190|P1|Overall Study|Missing|5
2977607|NCT01100073|10250190|P1|Overall Study|Other|8
2977608|NCT01100073|10250190|P1|Overall Study|Insufficient tolerability +patients wish|8
2977609|NCT01100073|10250190|P1|Overall Study|Lack of effect + patient's wish|2
2977610|NCT01100073|10250190|P1|Overall Study|Lost to Follow-up|39
2977611|NCT01100073|10250190|P1|Overall Study|Withdrawal by Subject|13
2977612|NCT01100073|10250190|P1|Overall Study|Insufficient Tolerability|21
2977613|NCT01100073|10250190|P1|Overall Study|Lack of Efficacy|4
2977614|NCT01100034|10250205|P1|Overall Study|Site closed due to non-responsiveness|1
2977615|NCT01100034|10250205|P1|Overall Study|Participants moved to another hospital|4
2977616|NCT01100034|10250205|P1|Overall Study|Participated in another clinical trial|1
2977617|NCT01100034|10250205|P1|Overall Study|Sponsor decision|21
2977618|NCT01100034|10250205|P1|Overall Study|Withdrawal by Subject|4
2977619|NCT01100034|10250205|P1|Overall Study|Withdrawal of parent/guardian consent|1
2977620|NCT01100034|10250205|P1|Overall Study|Lost to Follow-up|11
2977621|NCT01099917|10250243|P1|Overall Study|Not Treated|24
2977622|NCT01099917|10250243|P1|Overall Study|Adverse Event|3
2977623|NCT01099709|10250305|P2|Period 1|Adverse Event|0
2977624|NCT01099709|10250306|P1|Period 1|Adverse Event|1
2977625|NCT01099709|10250305|P2|Period 1|Positive cotinine test|1
2977626|NCT01099709|10250306|P1|Period 1|Positive cotinine test|0
2977627|NCT01099709|10250305|P2|Period 1|Withdrawal by Subject|1
2977628|NCT01099709|10250306|P1|Period 1|Withdrawal by Subject|0
2977629|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|Adverse Event|0
2977630|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|Adverse Event|1
2977631|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|Adverse Event|0
2977632|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
2977633|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
2977634|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
2977635|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2977636|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2977637|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2977638|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
2977639|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2977640|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2977641|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2977642|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2977643|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2977644|NCT01099579|10250332|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
2977645|NCT01099579|10250333|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
2977646|NCT01099579|10250334|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
2977647|NCT01099579|10250332|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2977648|NCT01099579|10250333|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
2977649|NCT01099579|10250334|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2977650|NCT01099579|10250332|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2977651|NCT01099579|10250333|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
2977652|NCT01099579|10250334|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2977653|NCT01099579|10250332|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
2977654|NCT01099579|10250333|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2977655|NCT01099579|10250334|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2977656|NCT01099579|10250332|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
2977657|NCT01099579|10250333|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
2977658|NCT01099579|10250334|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
2977659|NCT01099397|10250443|P1|Overall Study|Withdrawal by Subject|5
2977660|NCT01099397|10250443|P1|Overall Study|Protocol Violation|4
2977661|NCT01099397|10250443|P1|Overall Study|Lost to Follow-up|4
2977662|NCT01099267|10250470|P1|MDS-003 Study|Secondary Malign Disease|1
2977663|NCT01099267|10250470|P1|MDS-003 Study|Loss of Response|1
2977664|NCT01099267|10250470|P1|MDS-003 Study|Non-Compliance|2
2977665|NCT01099267|10250470|P1|MDS-003 Study|Investigator Decision|2
2977666|NCT01099267|10250470|P1|MDS-003 Study|Disease Progression|7
2977667|NCT01099267|10250470|P1|MDS-003 Study|Study Closed by Sponsor|2
2977668|NCT01099267|10250470|P1|MDS-003 Study|Death|11
2977669|NCT01099267|10250470|P1|MDS-003 Study|Lost to Follow-up|1
2977670|NCT01099267|10250470|P1|MDS-003 Study|Withdrawal by Subject|8
2977671|NCT01099267|10250470|P1|MDS-003 Study|Lack of Efficacy|52
2977672|NCT01099267|10250470|P1|MDS-003 Study|Adverse Event|37
2977673|NCT01099215|10250480|P2|Overall Study|Adverse Event|1
2977674|NCT01099215|10250481|P1|Overall Study|Adverse Event|0
2977675|NCT01099215|10250480|P2|Overall Study|Withdrawal by Subject|0
2977676|NCT01099215|10250481|P1|Overall Study|Withdrawal by Subject|1
2977677|NCT01098851|10250551|P2|Overall Study|Equipment failure|0
2977678|NCT01098851|10250552|P1|Overall Study|Equipment failure|1
2977679|NCT01098812|10250563|P3|Overall Study|Lost to Follow-up|0
2977680|NCT01098812|10250564|P2|Overall Study|Lost to Follow-up|1
2977681|NCT01098812|10250565|P1|Overall Study|Lost to Follow-up|0
2977682|NCT01098812|10250563|P3|Overall Study|Death|1
2977683|NCT01098812|10250564|P2|Overall Study|Death|0
2977684|NCT01098812|10250565|P1|Overall Study|Death|2
2977685|NCT01098539|10250641|P2|Overall Study|Physician Decision|3
2977686|NCT01098539|10250642|P1|Overall Study|Physician Decision|5
2977687|NCT01098539|10250641|P2|Overall Study|Withdrawal by Subject|26
2977688|NCT01098539|10250642|P1|Overall Study|Withdrawal by Subject|12
2977689|NCT01098539|10250641|P2|Overall Study|Lost to Follow-up|4
2977690|NCT01098539|10250642|P1|Overall Study|Lost to Follow-up|4
2977691|NCT01098539|10250641|P2|Overall Study|Noncompliance|5
2977692|NCT01098539|10250642|P1|Overall Study|Noncompliance|3
2977693|NCT01098539|10250641|P2|Overall Study|Protocol Violation|4
2977694|NCT01098539|10250642|P1|Overall Study|Protocol Violation|1
2977695|NCT01098539|10250641|P2|Overall Study|Adverse Event|26
2977696|NCT01098539|10250642|P1|Overall Study|Adverse Event|26
2977697|NCT01098487|10250693|P1|Overall Study|Physician Decision|1
2977698|NCT01098487|10250693|P1|Overall Study|Lost to Follow-up|3
2977699|NCT01098487|10250693|P1|Overall Study|Withdrawal by Subject|7
2977700|NCT01098487|10250693|P1|Overall Study|Lack of Efficacy|11
2977701|NCT01098487|10250693|P1|Overall Study|Adverse Event|22
2977702|NCT01098474|10250711|P6|Follow Up Phase|Lost to Follow-up|0
2977703|NCT01098474|10250712|P5|Follow Up Phase|Lost to Follow-up|1
2977704|NCT01098474|10250713|P4|Follow Up Phase|Lost to Follow-up|0
2977705|NCT01098474|10250714|P3|Follow Up Phase|Lost to Follow-up|0
2977706|NCT01098474|10250715|P2|Follow Up Phase|Lost to Follow-up|0
2977707|NCT01098474|10250716|P1|Follow Up Phase|Lost to Follow-up|0
2977708|NCT01098474|10250711|P6|Follow Up Phase|Withdrawal by Subject|1
2977709|NCT01098474|10250712|P5|Follow Up Phase|Withdrawal by Subject|0
2977710|NCT01098474|10250713|P4|Follow Up Phase|Withdrawal by Subject|2
2977711|NCT01098474|10250714|P3|Follow Up Phase|Withdrawal by Subject|0
2977712|NCT01098474|10250715|P2|Follow Up Phase|Withdrawal by Subject|0
2977713|NCT01098474|10250716|P1|Follow Up Phase|Withdrawal by Subject|0
2977714|NCT01098474|10250711|P6|Follow Up Phase|Other|4
2977715|NCT01098474|10250712|P5|Follow Up Phase|Other|0
2977716|NCT01098474|10250713|P4|Follow Up Phase|Other|0
2977717|NCT01098474|10250714|P3|Follow Up Phase|Other|0
2977718|NCT01098474|10250715|P2|Follow Up Phase|Other|0
2977719|NCT01098474|10250716|P1|Follow Up Phase|Other|0
2977720|NCT01098474|10250711|P6|Follow Up Phase|Travelled out of study area|0
2977721|NCT01098474|10250712|P5|Follow Up Phase|Travelled out of study area|1
2977722|NCT01098474|10250713|P4|Follow Up Phase|Travelled out of study area|0
2977723|NCT01098474|10250714|P3|Follow Up Phase|Travelled out of study area|0
2977724|NCT01098474|10250715|P2|Follow Up Phase|Travelled out of study area|0
2977725|NCT01098474|10250716|P1|Follow Up Phase|Travelled out of study area|0
2977726|NCT01098474|10250711|P6|Active Phase|Lost to Follow-up|0
2977727|NCT01098474|10250712|P5|Active Phase|Lost to Follow-up|0
2977728|NCT01098474|10250713|P4|Active Phase|Lost to Follow-up|0
2977729|NCT01098474|10250714|P3|Active Phase|Lost to Follow-up|0
2977730|NCT01098474|10250715|P2|Active Phase|Lost to Follow-up|0
2977731|NCT01098474|10250716|P1|Active Phase|Lost to Follow-up|1
2977732|NCT01098474|10250711|P6|Active Phase|Withdrawal by Subject|0
2977733|NCT01098474|10250712|P5|Active Phase|Withdrawal by Subject|0
2977734|NCT01098474|10250713|P4|Active Phase|Withdrawal by Subject|0
2977735|NCT01098474|10250714|P3|Active Phase|Withdrawal by Subject|2
2977736|NCT01098474|10250715|P2|Active Phase|Withdrawal by Subject|1
2977737|NCT01098474|10250716|P1|Active Phase|Withdrawal by Subject|1
2977738|NCT01098474|10250711|P6|Active Phase|Other|0
2977739|NCT01098474|10250712|P5|Active Phase|Other|0
2977740|NCT01098474|10250713|P4|Active Phase|Other|0
2977741|NCT01098474|10250714|P3|Active Phase|Other|3
2977742|NCT01098474|10250715|P2|Active Phase|Other|0
2977743|NCT01098474|10250716|P1|Active Phase|Other|0
2977744|NCT01098461|10250950|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2977745|NCT01098461|10250951|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2977746|NCT01098461|10250952|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2977747|NCT01098461|10250953|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2977748|NCT01098461|10250950|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2977749|NCT01098461|10250951|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2977750|NCT01098461|10250952|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
2977751|NCT01098461|10250953|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2977752|NCT01098461|10250950|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2977753|NCT01098461|10250951|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2977754|NCT01098461|10250952|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
2977755|NCT01098461|10250953|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2977756|NCT01098461|10250950|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2977757|NCT01098461|10250951|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2977758|NCT01098461|10250952|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
2977759|NCT01098461|10250953|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2977760|NCT01098461|10250950|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2977761|NCT01098461|10250951|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2977762|NCT01098461|10250952|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
2977763|NCT01098461|10250953|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
2977764|NCT01098461|10250950|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
2977765|NCT01098461|10250951|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2977766|NCT01098461|10250952|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
2977767|NCT01098461|10250953|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2977768|NCT01098461|10250950|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2977769|NCT01098461|10250951|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2977770|NCT01098461|10250952|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
2977771|NCT01098461|10250953|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
2977772|NCT01098305|10251013|P2|Overall Study|Lost to Follow-up|33
2977773|NCT01098305|10251014|P1|Overall Study|Lost to Follow-up|31
2977774|NCT01098266|10251024|P2|Overall Study|Withdrawal by Subject|5
2977775|NCT01098266|10251025|P1|Overall Study|Withdrawal by Subject|3
2977776|NCT01098266|10251024|P2|Overall Study|Death|2
2977777|NCT01098266|10251025|P1|Overall Study|Death|3
2977778|NCT01098266|10251024|P2|Overall Study|Physician Decision|0
2977779|NCT01098266|10251025|P1|Overall Study|Physician Decision|1
2977780|NCT01098240|10251054|P3|Double-Blind Phase|Adverse Event|3
2977781|NCT01098240|10251055|P2|Double-Blind Phase|Adverse Event|3
2977782|NCT01098240|10251056|P1|Double-Blind Phase|Adverse Event|0
2977783|NCT01098240|10251054|P3|Double-Blind Phase|Withdrawal by Subject|3
2977784|NCT01098240|10251055|P2|Double-Blind Phase|Withdrawal by Subject|1
2977785|NCT01098240|10251056|P1|Double-Blind Phase|Withdrawal by Subject|0
2977786|NCT01098240|10251054|P3|Double-Blind Phase|Insufficient Clinical Response|2
2977787|NCT01098240|10251055|P2|Double-Blind Phase|Insufficient Clinical Response|1
2977788|NCT01098240|10251056|P1|Double-Blind Phase|Insufficient Clinical Response|0
2977789|NCT01098240|10251054|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2977790|NCT01098240|10251055|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
2977791|NCT01098240|10251056|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2977792|NCT01098240|10251054|P3|Double-Blind Phase|Other|2
2977793|NCT01098240|10251055|P2|Double-Blind Phase|Other|2
2977794|NCT01098240|10251056|P1|Double-Blind Phase|Other|0
2977795|NCT01098240|10251054|P3|Double-Blind Phase|Lost to Follow-up|0
2977796|NCT01098240|10251055|P2|Double-Blind Phase|Lost to Follow-up|2
2977797|NCT01098240|10251056|P1|Double-Blind Phase|Lost to Follow-up|0
2977798|NCT01098240|10251054|P3|Double-Blind Phase|Protocol Violation|4
2977799|NCT01098240|10251055|P2|Double-Blind Phase|Protocol Violation|2
2977800|NCT01098240|10251056|P1|Double-Blind Phase|Protocol Violation|0
2977801|NCT01098240|10251054|P3|Double-Blind Phase|Study Terminated by Sponsor|8
2977802|NCT01098240|10251055|P2|Double-Blind Phase|Study Terminated by Sponsor|5
2977803|NCT01098240|10251056|P1|Double-Blind Phase|Study Terminated by Sponsor|0
2977804|NCT01098240|10251054|P3|Open-Label Phase|Adverse Event|0
2977805|NCT01098240|10251055|P2|Open-Label Phase|Adverse Event|0
2977806|NCT01098240|10251056|P1|Open-Label Phase|Adverse Event|12
2977807|NCT01098240|10251054|P3|Open-Label Phase|Withdrawal by Subject|0
2977808|NCT01098240|10251055|P2|Open-Label Phase|Withdrawal by Subject|0
2977809|NCT01098240|10251056|P1|Open-Label Phase|Withdrawal by Subject|9
2977810|NCT01098240|10251054|P3|Open-Label Phase|Pregnancy|0
2977811|NCT01098240|10251055|P2|Open-Label Phase|Pregnancy|0
2977812|NCT01098240|10251056|P1|Open-Label Phase|Pregnancy|1
2977813|NCT01098240|10251054|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
2977814|NCT01098240|10251055|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
2977815|NCT01098240|10251056|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
2977816|NCT01098240|10251054|P3|Open-Label Phase|Other|0
2977817|NCT01098240|10251055|P2|Open-Label Phase|Other|0
2977818|NCT01098240|10251056|P1|Open-Label Phase|Other|19
2977819|NCT01098240|10251054|P3|Open-Label Phase|Lost to Follow-up|0
2977820|NCT01098240|10251055|P2|Open-Label Phase|Lost to Follow-up|0
2977821|NCT01098240|10251056|P1|Open-Label Phase|Lost to Follow-up|13
2977822|NCT01098240|10251054|P3|Open-Label Phase|Protocol Violation|0
2977823|NCT01098240|10251055|P2|Open-Label Phase|Protocol Violation|0
2977824|NCT01098240|10251056|P1|Open-Label Phase|Protocol Violation|4
2977825|NCT01098240|10251054|P3|Open-Label Phase|Study Terminated by Sponsor|0
2977826|NCT01098240|10251055|P2|Open-Label Phase|Study Terminated by Sponsor|0
2977827|NCT01098240|10251056|P1|Open-Label Phase|Study Terminated by Sponsor|27
2977828|NCT01098162|10251086|P1|Overall Study|Reason Unknown|26
2977829|NCT01098162|10251086|P1|Overall Study|Other Reason|1
2977830|NCT01098162|10251086|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
2977831|NCT01098162|10251086|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
2977832|NCT01098162|10251086|P1|Overall Study|Adverse Event & Lost to Follow-up|2
2977833|NCT01098162|10251086|P1|Overall Study|Adverse Event & Wish of Patient|13
2977834|NCT01098162|10251086|P1|Overall Study|Adverse Event & Lack of Efficacy|6
2977835|NCT01098162|10251086|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
2977836|NCT01098162|10251086|P1|Overall Study|Lost to Follow-up|9
2977837|NCT01098162|10251086|P1|Overall Study|Wish of Patient|7
2977838|NCT01098162|10251086|P1|Overall Study|Lack of Efficacy|4
2977839|NCT01098162|10251086|P1|Overall Study|Adverse Event|37
2977840|NCT01098110|10251098|P3|Overall Study|Untreated|0
2977841|NCT01098110|10251099|P2|Overall Study|Untreated|1
2977842|NCT01098110|10251100|P1|Overall Study|Untreated|1
2977843|NCT01098110|10251098|P3|Overall Study|Other|5
2977844|NCT01098110|10251099|P2|Overall Study|Other|7
2977845|NCT01098110|10251100|P1|Overall Study|Other|4
2977846|NCT01098110|10251098|P3|Overall Study|Lack of Efficacy|27
2977847|NCT01098110|10251099|P2|Overall Study|Lack of Efficacy|9
2977848|NCT01098110|10251100|P1|Overall Study|Lack of Efficacy|13
2977849|NCT01098110|10251098|P3|Overall Study|Adverse Event|43
2977850|NCT01098110|10251099|P2|Overall Study|Adverse Event|32
2977851|NCT01098110|10251100|P1|Overall Study|Adverse Event|30
2977852|NCT01098110|10251098|P3|Overall Study|Withdrawal by Subject|19
2977853|NCT01098110|10251099|P2|Overall Study|Withdrawal by Subject|24
2977854|NCT01098110|10251100|P1|Overall Study|Withdrawal by Subject|14
2977855|NCT01098097|10251141|P1|Overall Study|No reason reported|31
2977856|NCT01098097|10251141|P1|Overall Study|Status unknown|16
2977857|NCT01098097|10251141|P1|Overall Study|Lost to Follow-up|18
2977858|NCT01098097|10251141|P1|Overall Study|Adverse Event|17
2977859|NCT01098071|10251150|P1|Overall Study|Lost to Follow-up|13
2977860|NCT01098071|10251150|P1|Overall Study|Surgery (adenoidectomy)|2
2977861|NCT01098032|10251163|P2|Overall Study|Withdrawal by Subject|1
2977862|NCT01098032|10251164|P1|Overall Study|Withdrawal by Subject|1
2977863|NCT01097863|10251281|P3|Overall Study|Did not return for final visit|1
2977864|NCT01097863|10251282|P2|Overall Study|Did not return for final visit|0
2977865|NCT01097863|10251283|P1|Overall Study|Did not return for final visit|0
2977866|NCT01097863|10251281|P3|Overall Study|Discomfort|1
2977867|NCT01097863|10251282|P2|Overall Study|Discomfort|0
2977868|NCT01097863|10251283|P1|Overall Study|Discomfort|1
2977869|NCT01097707|10251307|P5|Overall Study|Reason unknown|1
2977870|NCT01097707|10251308|P4|Overall Study|Reason unknown|0
2977871|NCT01097707|10251309|P3|Overall Study|Reason unknown|0
2977872|NCT01097707|10251310|P2|Overall Study|Reason unknown|0
2977873|NCT01097707|10251311|P1|Overall Study|Reason unknown|0
2977874|NCT01097707|10251307|P5|Overall Study|Withdrawal by Subject|3
2977875|NCT01097707|10251308|P4|Overall Study|Withdrawal by Subject|4
2977876|NCT01097707|10251309|P3|Overall Study|Withdrawal by Subject|1
2977877|NCT01097707|10251310|P2|Overall Study|Withdrawal by Subject|6
2977878|NCT01097707|10251311|P1|Overall Study|Withdrawal by Subject|3
2977879|NCT01097707|10251307|P5|Overall Study|Sponsor Decision|36
2977880|NCT01097707|10251308|P4|Overall Study|Sponsor Decision|35
2977881|NCT01097707|10251309|P3|Overall Study|Sponsor Decision|34
2977882|NCT01097707|10251310|P2|Overall Study|Sponsor Decision|31
2977883|NCT01097707|10251311|P1|Overall Study|Sponsor Decision|31
2977884|NCT01097707|10251307|P5|Overall Study|Protocol Violation|2
2977885|NCT01097707|10251308|P4|Overall Study|Protocol Violation|2
2977886|NCT01097707|10251309|P3|Overall Study|Protocol Violation|3
2977887|NCT01097707|10251310|P2|Overall Study|Protocol Violation|2
2977888|NCT01097707|10251311|P1|Overall Study|Protocol Violation|2
2977889|NCT01097707|10251307|P5|Overall Study|Lost to Follow-up|3
2977890|NCT01097707|10251308|P4|Overall Study|Lost to Follow-up|0
2977891|NCT01097707|10251309|P3|Overall Study|Lost to Follow-up|2
2977892|NCT01097707|10251310|P2|Overall Study|Lost to Follow-up|1
2977893|NCT01097707|10251311|P1|Overall Study|Lost to Follow-up|1
2977894|NCT01097707|10251307|P5|Overall Study|Lack of Efficacy|0
2977895|NCT01097707|10251308|P4|Overall Study|Lack of Efficacy|1
2977896|NCT01097707|10251309|P3|Overall Study|Lack of Efficacy|0
2977897|NCT01097707|10251310|P2|Overall Study|Lack of Efficacy|0
2977898|NCT01097707|10251311|P1|Overall Study|Lack of Efficacy|1
2977899|NCT01097707|10251307|P5|Overall Study|Entry Criteria Not Met|1
2977900|NCT01097707|10251308|P4|Overall Study|Entry Criteria Not Met|0
2977901|NCT01097707|10251309|P3|Overall Study|Entry Criteria Not Met|1
2977902|NCT01097707|10251310|P2|Overall Study|Entry Criteria Not Met|1
2977903|NCT01097707|10251311|P1|Overall Study|Entry Criteria Not Met|2
2977904|NCT01097707|10251307|P5|Overall Study|Adverse Event|3
2977905|NCT01097707|10251308|P4|Overall Study|Adverse Event|1
2977906|NCT01097707|10251309|P3|Overall Study|Adverse Event|3
2977907|NCT01097707|10251310|P2|Overall Study|Adverse Event|2
2977908|NCT01097707|10251311|P1|Overall Study|Adverse Event|4
2977909|NCT01097707|10251307|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2977910|NCT01097707|10251308|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2977911|NCT01097707|10251309|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2977912|NCT01097707|10251310|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2977913|NCT01097707|10251311|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2977914|NCT01097694|10251360|P2|Overall Study|Withdrawal by Subject|1
2977915|NCT01097694|10251361|P1|Overall Study|Withdrawal by Subject|3
2977916|NCT01097694|10251360|P2|Overall Study|Lost to Follow-up|3
2977917|NCT01097694|10251361|P1|Overall Study|Lost to Follow-up|0
2977918|NCT01097694|10251360|P2|Overall Study|Adverse Event|0
2977919|NCT01097694|10251361|P1|Overall Study|Adverse Event|5
2977920|NCT01097668|10251423|P2|Overall Study|Lost to Follow-up|0
2977921|NCT01097668|10251424|P1|Overall Study|Lost to Follow-up|1
2977922|NCT01097668|10251423|P2|Overall Study|Withdrawal by Subject|2
2977923|NCT01097668|10251424|P1|Overall Study|Withdrawal by Subject|1
2977924|NCT01097655|10251434|P1|Overall Study|Did Not Meet Inclusion Criteria|8
2977925|NCT01097655|10251434|P1|Overall Study|Subject Documented Twice|1
2977926|NCT01097655|10251434|P1|Overall Study|Withdrawal by Subject|1
2977927|NCT01097629|10251444|P8|DB RO Phase|Lost to Follow-up|0
2977928|NCT01097629|10251445|P7|DB RO Phase|Lost to Follow-up|2
2977929|NCT01097629|10251446|P6|DB RO Phase|Lost to Follow-up|0
2977930|NCT01097629|10251447|P5|DB RO Phase|Lost to Follow-up|0
2977931|NCT01097629|10251448|P4|DB RO Phase|Lost to Follow-up|0
2977932|NCT01097629|10251449|P3|DB RO Phase|Lost to Follow-up|0
2977933|NCT01097629|10251450|P2|DB RO Phase|Lost to Follow-up|0
2977934|NCT01097629|10251451|P1|DB RO Phase|Lost to Follow-up|0
2977935|NCT01097629|10251444|P8|DB RO Phase|Protocol Violation|0
2977936|NCT01097629|10251445|P7|DB RO Phase|Protocol Violation|1
2977937|NCT01097629|10251446|P6|DB RO Phase|Protocol Violation|1
2977938|NCT01097629|10251447|P5|DB RO Phase|Protocol Violation|0
2977939|NCT01097629|10251448|P4|DB RO Phase|Protocol Violation|1
2977940|NCT01097629|10251449|P3|DB RO Phase|Protocol Violation|0
2977941|NCT01097629|10251450|P2|DB RO Phase|Protocol Violation|0
2977942|NCT01097629|10251451|P1|DB RO Phase|Protocol Violation|0
2977943|NCT01097629|10251444|P8|DB RO Phase|Withdrawal by Subject|1
2977944|NCT01097629|10251445|P7|DB RO Phase|Withdrawal by Subject|0
2977945|NCT01097629|10251446|P6|DB RO Phase|Withdrawal by Subject|0
2977946|NCT01097629|10251447|P5|DB RO Phase|Withdrawal by Subject|0
2977947|NCT01097629|10251448|P4|DB RO Phase|Withdrawal by Subject|0
2977948|NCT01097629|10251449|P3|DB RO Phase|Withdrawal by Subject|0
2977949|NCT01097629|10251450|P2|DB RO Phase|Withdrawal by Subject|0
2977950|NCT01097629|10251451|P1|DB RO Phase|Withdrawal by Subject|0
2977951|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2977952|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2977953|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2977954|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2977955|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2977956|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
2977957|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
2977958|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2977959|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977960|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977961|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977962|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977963|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977964|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2977965|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
2977966|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
2977967|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2977968|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2977969|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2977970|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2977971|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2977972|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
2977973|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
2977974|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2977975|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2977976|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2977977|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2977978|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2977979|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2977980|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2977981|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
2977982|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
2977983|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2977984|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2977985|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2977986|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2977987|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2977988|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
2977989|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
2977990|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2977991|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2977992|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2977993|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2977994|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2977995|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2977996|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
2977997|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
2977998|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2977999|NCT01097629|10251444|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978000|NCT01097629|10251445|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978001|NCT01097629|10251446|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978002|NCT01097629|10251447|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978003|NCT01097629|10251448|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978004|NCT01097629|10251449|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
2978005|NCT01097629|10251450|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
2978006|NCT01097629|10251451|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
2978007|NCT01097616|10251502|P8|DB RO Phase|Not Treated in RO|0
2978008|NCT01097616|10251503|P7|DB RO Phase|Not Treated in RO|0
2978009|NCT01097616|10251504|P6|DB RO Phase|Not Treated in RO|1
2978010|NCT01097616|10251505|P5|DB RO Phase|Not Treated in RO|0
2978011|NCT01097616|10251506|P4|DB RO Phase|Not Treated in RO|0
2978012|NCT01097616|10251507|P3|DB RO Phase|Not Treated in RO|0
2978013|NCT01097616|10251508|P2|DB RO Phase|Not Treated in RO|0
2978014|NCT01097616|10251509|P1|DB RO Phase|Not Treated in RO|0
2978015|NCT01097616|10251502|P8|DB RO Phase|Lost to Follow-up|1
2978016|NCT01097616|10251503|P7|DB RO Phase|Lost to Follow-up|0
2978017|NCT01097616|10251504|P6|DB RO Phase|Lost to Follow-up|0
2978018|NCT01097616|10251505|P5|DB RO Phase|Lost to Follow-up|1
2978019|NCT01097616|10251506|P4|DB RO Phase|Lost to Follow-up|1
2978020|NCT01097616|10251507|P3|DB RO Phase|Lost to Follow-up|0
2978021|NCT01097616|10251508|P2|DB RO Phase|Lost to Follow-up|0
2978022|NCT01097616|10251509|P1|DB RO Phase|Lost to Follow-up|0
2978023|NCT01097616|10251502|P8|DB RO Phase|Withdrawal by Subject|0
2978024|NCT01097616|10251503|P7|DB RO Phase|Withdrawal by Subject|0
2978025|NCT01097616|10251504|P6|DB RO Phase|Withdrawal by Subject|1
2978026|NCT01097616|10251505|P5|DB RO Phase|Withdrawal by Subject|0
2978027|NCT01097616|10251506|P4|DB RO Phase|Withdrawal by Subject|0
2978028|NCT01097616|10251507|P3|DB RO Phase|Withdrawal by Subject|0
2978029|NCT01097616|10251508|P2|DB RO Phase|Withdrawal by Subject|0
2978030|NCT01097616|10251509|P1|DB RO Phase|Withdrawal by Subject|0
2978031|NCT01097616|10251502|P8|DB RO Phase|Adverse Event|0
2978032|NCT01097616|10251503|P7|DB RO Phase|Adverse Event|1
2978033|NCT01097616|10251504|P6|DB RO Phase|Adverse Event|0
2978034|NCT01097616|10251505|P5|DB RO Phase|Adverse Event|0
2978035|NCT01097616|10251506|P4|DB RO Phase|Adverse Event|0
2978036|NCT01097616|10251507|P3|DB RO Phase|Adverse Event|0
2978037|NCT01097616|10251508|P2|DB RO Phase|Adverse Event|0
2978038|NCT01097616|10251509|P1|DB RO Phase|Adverse Event|0
2978039|NCT01097616|10251502|P8|Optional DB EXT Phase|Physician Decision|0
2978040|NCT01097616|10251503|P7|Optional DB EXT Phase|Physician Decision|0
2978041|NCT01097616|10251504|P6|Optional DB EXT Phase|Physician Decision|0
2978042|NCT01097616|10251505|P5|Optional DB EXT Phase|Physician Decision|0
2978043|NCT01097616|10251506|P4|Optional DB EXT Phase|Physician Decision|0
2978044|NCT01097616|10251507|P3|Optional DB EXT Phase|Physician Decision|0
2978045|NCT01097616|10251508|P2|Optional DB EXT Phase|Physician Decision|0
2978046|NCT01097616|10251509|P1|Optional DB EXT Phase|Physician Decision|1
2978047|NCT01097616|10251502|P8|Optional DB EXT Phase|Lack of Efficacy|0
2978048|NCT01097616|10251503|P7|Optional DB EXT Phase|Lack of Efficacy|0
2978049|NCT01097616|10251504|P6|Optional DB EXT Phase|Lack of Efficacy|0
2978050|NCT01097616|10251505|P5|Optional DB EXT Phase|Lack of Efficacy|0
2978051|NCT01097616|10251506|P4|Optional DB EXT Phase|Lack of Efficacy|0
2978052|NCT01097616|10251507|P3|Optional DB EXT Phase|Lack of Efficacy|1
2978053|NCT01097616|10251508|P2|Optional DB EXT Phase|Lack of Efficacy|1
2978054|NCT01097616|10251509|P1|Optional DB EXT Phase|Lack of Efficacy|1
2978055|NCT01097616|10251502|P8|Optional DB EXT Phase|Lost to Follow-up|0
2978056|NCT01097616|10251503|P7|Optional DB EXT Phase|Lost to Follow-up|0
2978057|NCT01097616|10251504|P6|Optional DB EXT Phase|Lost to Follow-up|0
2978058|NCT01097616|10251505|P5|Optional DB EXT Phase|Lost to Follow-up|0
2978059|NCT01097616|10251506|P4|Optional DB EXT Phase|Lost to Follow-up|0
2978060|NCT01097616|10251507|P3|Optional DB EXT Phase|Lost to Follow-up|1
2978061|NCT01097616|10251508|P2|Optional DB EXT Phase|Lost to Follow-up|5
2978062|NCT01097616|10251509|P1|Optional DB EXT Phase|Lost to Follow-up|1
2978063|NCT01097616|10251502|P8|Optional DB EXT Phase|Protocol Violation|0
2978064|NCT01097616|10251503|P7|Optional DB EXT Phase|Protocol Violation|0
2978065|NCT01097616|10251504|P6|Optional DB EXT Phase|Protocol Violation|0
2978066|NCT01097616|10251505|P5|Optional DB EXT Phase|Protocol Violation|0
2978067|NCT01097616|10251506|P4|Optional DB EXT Phase|Protocol Violation|0
2978068|NCT01097616|10251507|P3|Optional DB EXT Phase|Protocol Violation|3
2978069|NCT01097616|10251508|P2|Optional DB EXT Phase|Protocol Violation|2
2978070|NCT01097616|10251509|P1|Optional DB EXT Phase|Protocol Violation|0
2978071|NCT01097616|10251502|P8|Optional DB EXT Phase|Withdrawal by Subject|0
2978072|NCT01097616|10251503|P7|Optional DB EXT Phase|Withdrawal by Subject|0
2978073|NCT01097616|10251504|P6|Optional DB EXT Phase|Withdrawal by Subject|0
2978074|NCT01097616|10251505|P5|Optional DB EXT Phase|Withdrawal by Subject|0
2978075|NCT01097616|10251506|P4|Optional DB EXT Phase|Withdrawal by Subject|0
2978076|NCT01097616|10251507|P3|Optional DB EXT Phase|Withdrawal by Subject|3
2978077|NCT01097616|10251508|P2|Optional DB EXT Phase|Withdrawal by Subject|6
2978078|NCT01097616|10251509|P1|Optional DB EXT Phase|Withdrawal by Subject|12
2978079|NCT01097616|10251502|P8|Optional DB EXT Phase|Adverse Event|0
2978080|NCT01097616|10251503|P7|Optional DB EXT Phase|Adverse Event|0
2978081|NCT01097616|10251504|P6|Optional DB EXT Phase|Adverse Event|0
2978082|NCT01097616|10251505|P5|Optional DB EXT Phase|Adverse Event|0
2978083|NCT01097616|10251506|P4|Optional DB EXT Phase|Adverse Event|0
2978084|NCT01097616|10251507|P3|Optional DB EXT Phase|Adverse Event|2
2978085|NCT01097616|10251508|P2|Optional DB EXT Phase|Adverse Event|7
2978086|NCT01097616|10251509|P1|Optional DB EXT Phase|Adverse Event|0
2978087|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978088|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978089|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978090|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978091|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978092|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2978093|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978094|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2978095|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978096|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978097|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978098|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978099|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978100|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2978101|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
2978102|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
2978103|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978104|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978105|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978106|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978107|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978108|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2978109|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2978110|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2978111|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2978112|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2978113|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2978114|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2978115|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2978116|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
2978117|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2978118|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
2978119|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978120|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978121|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978122|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978123|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978124|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2978125|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2978126|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2978127|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2978128|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2978129|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2978130|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2978131|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2978132|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
2978133|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
2978134|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2978135|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2978136|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2978137|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2978138|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2978139|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2978140|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
2978141|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2978142|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
2978143|NCT01097616|10251502|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978144|NCT01097616|10251503|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978145|NCT01097616|10251504|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978146|NCT01097616|10251505|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978147|NCT01097616|10251506|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2978148|NCT01097616|10251507|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
2978149|NCT01097616|10251508|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
2978150|NCT01097616|10251509|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
2978151|NCT01097421|10251584|P1|Overall Study|Withdrawal by Subject|3
2978152|NCT01097421|10251584|P1|Overall Study|Lost to Follow-up|1
2978153|NCT01097421|10251584|P1|Overall Study|Protocol Violation|2
2978154|NCT01097421|10251584|P1|Overall Study|Adverse Event|8
2978155|NCT01097330|10251603|P2|Overall Study|Study terminated early|5
2978156|NCT01097330|10251604|P1|Overall Study|Study terminated early|7
2978157|NCT01097057|10251621|P1|Overall Study|Physician Decision|3
2978158|NCT01097044|10251630|P2|Overall Study|Withdrawal by Sponsor|1
2978159|NCT01097044|10251631|P1|Overall Study|Withdrawal by Sponsor|0
2978160|NCT01097044|10251630|P2|Overall Study|Lost to Follow-up|0
2978161|NCT01097044|10251631|P1|Overall Study|Lost to Follow-up|1
2978162|NCT01097044|10251630|P2|Overall Study|Withdrawal by Subject|4
2978163|NCT01097044|10251631|P1|Overall Study|Withdrawal by Subject|4
2978164|NCT01097005|10251649|P1|Overall Study|Discontinuance by complication|50
2978165|NCT01097005|10251649|P1|Overall Study|Adverse Event|14
2978166|NCT01097005|10251649|P1|Overall Study|Deviation from exclusion criteria|37
2978167|NCT01097005|10251649|P1|Overall Study|No examination data available|244
2978168|NCT01097005|10251649|P1|Overall Study|Poor medication compliance|1
2978169|NCT01097005|10251649|P1|Overall Study|Subjects cannot visit the hospital|1
2978170|NCT01097005|10251649|P1|Overall Study|Case Report Form not collected|18
2978171|NCT01096849|10251695|P3|Overall Study|Lost to Follow-up|1
2978172|NCT01096849|10251696|P2|Overall Study|Lost to Follow-up|3
2978173|NCT01096849|10251697|P1|Overall Study|Lost to Follow-up|1
2978174|NCT01096849|10251695|P3|Overall Study|Administrative Reasons|2
2978175|NCT01096849|10251696|P2|Overall Study|Administrative Reasons|1
2978176|NCT01096849|10251697|P1|Overall Study|Administrative Reasons|0
2978177|NCT01096849|10251695|P3|Overall Study|Investigator or Medical Monitor Decision|0
2978178|NCT01096849|10251696|P2|Overall Study|Investigator or Medical Monitor Decision|1
2978179|NCT01096849|10251697|P1|Overall Study|Investigator or Medical Monitor Decision|0
2978180|NCT01096849|10251695|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
2978181|NCT01096849|10251696|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
2978182|NCT01096849|10251697|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
2978183|NCT01096849|10251695|P3|Overall Study|Lack of Efficacy|0
2978184|NCT01096849|10251696|P2|Overall Study|Lack of Efficacy|2
2978185|NCT01096849|10251697|P1|Overall Study|Lack of Efficacy|0
2978186|NCT01096849|10251695|P3|Overall Study|Consent Withdrawn|2
2978187|NCT01096849|10251696|P2|Overall Study|Consent Withdrawn|4
2978188|NCT01096849|10251697|P1|Overall Study|Consent Withdrawn|1
2978189|NCT01096784|10251773|P2|Overall Study|Other Unspecified|1
2978190|NCT01096784|10251774|P1|Overall Study|Other Unspecified|0
2978191|NCT01096784|10251773|P2|Overall Study|Administrative Decision|1
2978192|NCT01096784|10251774|P1|Overall Study|Administrative Decision|0
2978193|NCT01096784|10251773|P2|Overall Study|Protocol Deviation|2
2978194|NCT01096784|10251774|P1|Overall Study|Protocol Deviation|2
2978195|NCT01096784|10251773|P2|Overall Study|Adverse Event|9
2978196|NCT01096784|10251774|P1|Overall Study|Adverse Event|11
2978197|NCT01096784|10251773|P2|Overall Study|Withdrawal by Subject|1
2978198|NCT01096784|10251774|P1|Overall Study|Withdrawal by Subject|2
2978199|NCT01096667|10251879|P5|Overall Study|Not treated|0
2978200|NCT01096667|10251880|P4|Overall Study|Not treated|0
2978201|NCT01096667|10251881|P3|Overall Study|Not treated|0
2978202|NCT01096667|10251882|P2|Overall Study|Not treated|0
2978203|NCT01096667|10251883|P1|Overall Study|Not treated|1
2978204|NCT01096667|10251879|P5|Overall Study|Protocol Violation|0
2978205|NCT01096667|10251880|P4|Overall Study|Protocol Violation|1
2978206|NCT01096667|10251881|P3|Overall Study|Protocol Violation|0
2978207|NCT01096667|10251882|P2|Overall Study|Protocol Violation|0
2978208|NCT01096667|10251883|P1|Overall Study|Protocol Violation|0
2978209|NCT01096667|10251879|P5|Overall Study|Reason not available|0
2978210|NCT01096667|10251880|P4|Overall Study|Reason not available|1
2978211|NCT01096667|10251881|P3|Overall Study|Reason not available|1
2978212|NCT01096667|10251882|P2|Overall Study|Reason not available|1
2978213|NCT01096667|10251883|P1|Overall Study|Reason not available|0
2978214|NCT01096667|10251879|P5|Overall Study|Withdrawal by Subject|0
2978215|NCT01096667|10251880|P4|Overall Study|Withdrawal by Subject|1
2978216|NCT01096667|10251881|P3|Overall Study|Withdrawal by Subject|0
2978217|NCT01096667|10251882|P2|Overall Study|Withdrawal by Subject|0
2978218|NCT01096667|10251883|P1|Overall Study|Withdrawal by Subject|1
2978219|NCT01096667|10251879|P5|Overall Study|Lost to Follow-up|0
2978220|NCT01096667|10251880|P4|Overall Study|Lost to Follow-up|0
2978221|NCT01096667|10251881|P3|Overall Study|Lost to Follow-up|1
2978222|NCT01096667|10251882|P2|Overall Study|Lost to Follow-up|1
2978223|NCT01096667|10251883|P1|Overall Study|Lost to Follow-up|1
2978224|NCT01096589|10252025|P4|Overall Study|found treatment exhausting|1
2978225|NCT01096589|10252026|P3|Overall Study|found treatment exhausting|0
2978226|NCT01096589|10252027|P2|Overall Study|found treatment exhausting|0
2978227|NCT01096589|10252028|P1|Overall Study|found treatment exhausting|0
2978228|NCT01096589|10252025|P4|Overall Study|Compliance with protocol|0
2978229|NCT01096589|10252026|P3|Overall Study|Compliance with protocol|1
2978230|NCT01096589|10252027|P2|Overall Study|Compliance with protocol|0
2978231|NCT01096589|10252028|P1|Overall Study|Compliance with protocol|0
2978232|NCT01096589|10252025|P4|Overall Study|Withdrawal by Subject|1
2978233|NCT01096589|10252026|P3|Overall Study|Withdrawal by Subject|1
2978234|NCT01096589|10252027|P2|Overall Study|Withdrawal by Subject|1
2978235|NCT01096589|10252028|P1|Overall Study|Withdrawal by Subject|2
2978236|NCT01096589|10252025|P4|Overall Study|Adverse Event|1
2978237|NCT01096589|10252026|P3|Overall Study|Adverse Event|2
2978238|NCT01096589|10252027|P2|Overall Study|Adverse Event|1
2978239|NCT01096589|10252028|P1|Overall Study|Adverse Event|2
2978240|NCT01096550|10252044|P2|Overall Study|Lost to Follow-up|9
2978241|NCT01096550|10252045|P1|Overall Study|Lost to Follow-up|12
2978242|NCT01096550|10252044|P2|Overall Study|non-African American participant|6
2978243|NCT01096550|10252045|P1|Overall Study|non-African American participant|13
2978244|NCT01096550|10252044|P2|Overall Study|Withdrawal by Subject|1
2978245|NCT01096550|10252045|P1|Overall Study|Withdrawal by Subject|0
2978246|NCT01096550|10252044|P2|Overall Study|clinic readmission|1
2978247|NCT01096550|10252045|P1|Overall Study|clinic readmission|1
2978248|NCT01096550|10252044|P2|Overall Study|non-regular treatment track at clinic|1
2978249|NCT01096550|10252045|P1|Overall Study|non-regular treatment track at clinic|1
2978250|NCT01096550|10252044|P2|Overall Study|discontinued site|11
2978251|NCT01096550|10252045|P1|Overall Study|discontinued site|10
2978252|NCT01096446|10252053|P2|Overall Study|Protocol Violation|0
2978253|NCT01096446|10252054|P1|Overall Study|Protocol Violation|2
2978254|NCT01096446|10252053|P2|Overall Study|Death|0
2978255|NCT01096446|10252054|P1|Overall Study|Death|1
2978256|NCT01096342|10252059|P1|Overall Study|Protocol Violation|1
2978257|NCT01096316|10252067|P2|Overall Study|Lost to Follow-up|9
2978258|NCT01096316|10252068|P1|Overall Study|Lost to Follow-up|15
2978259|NCT01096186|10252078|P1|Overall Study|Noncompliance with study drug|1
2978260|NCT01096186|10252078|P1|Overall Study|Physician Decision|1
2978261|NCT01096186|10252078|P1|Overall Study|Withdrawal by Subject|22
2978262|NCT01096186|10252078|P1|Overall Study|Lost to Follow-up|2
2978263|NCT01096186|10252078|P1|Overall Study|Lack of Efficacy|4
2978264|NCT01096186|10252078|P1|Overall Study|Death|4
2978265|NCT01096186|10252078|P1|Overall Study|Adverse Event|16
2978266|NCT01096160|10252094|P10|Overall Study|Met stopping criteria per protocol|0
2978267|NCT01096160|10252095|P9|Overall Study|Met stopping criteria per protocol|2
2978268|NCT01096160|10252096|P8|Overall Study|Met stopping criteria per protocol|0
2978269|NCT01096160|10252097|P7|Overall Study|Met stopping criteria per protocol|2
2978270|NCT01096160|10252098|P6|Overall Study|Met stopping criteria per protocol|0
2978271|NCT01096160|10252099|P5|Overall Study|Met stopping criteria per protocol|1
2978272|NCT01096160|10252100|P4|Overall Study|Met stopping criteria per protocol|0
2978273|NCT01096160|10252101|P3|Overall Study|Met stopping criteria per protocol|0
2978274|NCT01096160|10252102|P2|Overall Study|Met stopping criteria per protocol|0
2978275|NCT01096160|10252103|P1|Overall Study|Met stopping criteria per protocol|0
2978276|NCT01096160|10252094|P10|Overall Study|Adverse Event|1
2978277|NCT01096160|10252095|P9|Overall Study|Adverse Event|0
2978278|NCT01096160|10252096|P8|Overall Study|Adverse Event|0
2978279|NCT01096160|10252097|P7|Overall Study|Adverse Event|0
2978280|NCT01096160|10252098|P6|Overall Study|Adverse Event|0
2978281|NCT01096160|10252099|P5|Overall Study|Adverse Event|0
2978282|NCT01096160|10252100|P4|Overall Study|Adverse Event|0
2978283|NCT01096160|10252101|P3|Overall Study|Adverse Event|1
2978284|NCT01096160|10252102|P2|Overall Study|Adverse Event|0
2978285|NCT01096160|10252103|P1|Overall Study|Adverse Event|0
2978286|NCT01096056|10252161|P2|Overall Study|Lost to Follow-up|1
2978287|NCT01096056|10252162|P1|Overall Study|Lost to Follow-up|0
2978288|NCT01096017|10252194|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
2978289|NCT01096017|10252195|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
2978290|NCT01095978|10252223|P1|Overall Study|Adverse Event|1
2978291|NCT01095978|10252223|P1|Overall Study|Did not take Klacid SR|2
2978292|NCT01095835|10252257|P3|Overall Study|Protocol Violation|0
2978293|NCT01095835|10252258|P2|Overall Study|Protocol Violation|2
2978294|NCT01095835|10252259|P1|Overall Study|Protocol Violation|1
2978295|NCT01095835|10252257|P3|Overall Study|Non study compliance|1
2978296|NCT01095835|10252258|P2|Overall Study|Non study compliance|0
2978297|NCT01095835|10252259|P1|Overall Study|Non study compliance|0
2978298|NCT01095835|10252257|P3|Overall Study|Withdrawal by Subject|0
2978299|NCT01095835|10252258|P2|Overall Study|Withdrawal by Subject|3
2978300|NCT01095835|10252259|P1|Overall Study|Withdrawal by Subject|1
2978301|NCT01095835|10252257|P3|Overall Study|Physician Decision|1
2978302|NCT01095835|10252258|P2|Overall Study|Physician Decision|0
2978303|NCT01095835|10252259|P1|Overall Study|Physician Decision|0
2978304|NCT01095835|10252257|P3|Overall Study|Lack of Efficacy|0
2978305|NCT01095835|10252258|P2|Overall Study|Lack of Efficacy|1
2978306|NCT01095835|10252259|P1|Overall Study|Lack of Efficacy|0
2978307|NCT01095835|10252257|P3|Overall Study|Adverse Event|6
2978308|NCT01095835|10252258|P2|Overall Study|Adverse Event|6
2978309|NCT01095835|10252259|P1|Overall Study|Adverse Event|8
2978310|NCT01095796|10252297|P2|Overall Study|Participant Transferred to Another Study|200
2978311|NCT01095796|10252298|P1|Overall Study|Participant Transferred to Another Study|215
2978312|NCT01095796|10252297|P2|Overall Study|Protocol Violation|0
2978313|NCT01095796|10252298|P1|Overall Study|Protocol Violation|1
2978314|NCT01095796|10252297|P2|Overall Study|Participant Noncompliance|10
2978315|NCT01095796|10252298|P1|Overall Study|Participant Noncompliance|5
2978316|NCT01095796|10252297|P2|Overall Study|Lost to Follow-up|29
2978317|NCT01095796|10252298|P1|Overall Study|Lost to Follow-up|27
2978318|NCT01095796|10252297|P2|Overall Study|Withdrew Consent|22
2978319|NCT01095796|10252298|P1|Overall Study|Withdrew Consent|16
2978320|NCT01095796|10252297|P2|Overall Study|Investigator's Discretion|2
2978321|NCT01095796|10252298|P1|Overall Study|Investigator's Discretion|7
2978322|NCT01095796|10252297|P2|Overall Study|Lack of Efficacy|3
2978323|NCT01095796|10252298|P1|Overall Study|Lack of Efficacy|5
2978324|NCT01095796|10252297|P2|Overall Study|Pregnancy|0
2978325|NCT01095796|10252298|P1|Overall Study|Pregnancy|2
2978326|NCT01095796|10252297|P2|Overall Study|Death|2
2978327|NCT01095796|10252298|P1|Overall Study|Death|3
2978328|NCT01095796|10252297|P2|Overall Study|Adverse Event|19
2978329|NCT01095796|10252298|P1|Overall Study|Adverse Event|9
2978330|NCT01095796|10252297|P2|Overall Study|Randomized but Not Treated|2
2978331|NCT01095796|10252298|P1|Overall Study|Randomized but Not Treated|5
2978332|NCT01095666|10252328|P3|Overall Study|Non-compliance, not met criteria etc.|2
2978333|NCT01095666|10252329|P2|Overall Study|Non-compliance, not met criteria etc.|2
2978334|NCT01095666|10252330|P1|Overall Study|Non-compliance, not met criteria etc.|7
2978335|NCT01095666|10252328|P3|Overall Study|Withdrawal by Subject|1
2978336|NCT01095666|10252329|P2|Overall Study|Withdrawal by Subject|6
2978337|NCT01095666|10252330|P1|Overall Study|Withdrawal by Subject|6
2978338|NCT01095666|10252328|P3|Overall Study|Lost to Follow-up|0
2978339|NCT01095666|10252329|P2|Overall Study|Lost to Follow-up|2
2978340|NCT01095666|10252330|P1|Overall Study|Lost to Follow-up|2
2978341|NCT01095666|10252328|P3|Overall Study|Adverse Event|3
2978342|NCT01095666|10252329|P2|Overall Study|Adverse Event|1
2978343|NCT01095666|10252330|P1|Overall Study|Adverse Event|2
2978344|NCT01095666|10252328|P3|Overall Study|Lack of Efficacy|1
2978345|NCT01095666|10252329|P2|Overall Study|Lack of Efficacy|0
2978346|NCT01095666|10252330|P1|Overall Study|Lack of Efficacy|0
2978347|NCT01095653|10252353|P3|Overall Study|non-compliance, not met criteria, etc.|5
2978348|NCT01095653|10252354|P2|Overall Study|non-compliance, not met criteria, etc.|6
2978349|NCT01095653|10252355|P1|Overall Study|non-compliance, not met criteria, etc.|10
2978350|NCT01095653|10252353|P3|Overall Study|Withdrawal by Subject|3
2978351|NCT01095653|10252354|P2|Overall Study|Withdrawal by Subject|5
2978352|NCT01095653|10252355|P1|Overall Study|Withdrawal by Subject|4
2978353|NCT01095653|10252353|P3|Overall Study|Lost to Follow-up|4
2978354|NCT01095653|10252354|P2|Overall Study|Lost to Follow-up|0
2978355|NCT01095653|10252355|P1|Overall Study|Lost to Follow-up|1
2978356|NCT01095653|10252353|P3|Overall Study|Adverse Event|4
2978357|NCT01095653|10252354|P2|Overall Study|Adverse Event|4
2978358|NCT01095653|10252355|P1|Overall Study|Adverse Event|1
2978359|NCT01095653|10252353|P3|Overall Study|Lack of Efficacy|0
2978360|NCT01095653|10252354|P2|Overall Study|Lack of Efficacy|0
2978361|NCT01095653|10252355|P1|Overall Study|Lack of Efficacy|3
2978362|NCT01095250|10252413|P4|Overall Study|Withdrawal by Subject|0
2978363|NCT01095250|10252414|P3|Overall Study|Withdrawal by Subject|1
2978364|NCT01095250|10252415|P2|Overall Study|Withdrawal by Subject|0
2978365|NCT01095250|10252416|P1|Overall Study|Withdrawal by Subject|0
2978366|NCT01095250|10252413|P4|Overall Study|administrative reasons|5
2978367|NCT01095250|10252414|P3|Overall Study|administrative reasons|7
2978368|NCT01095250|10252415|P2|Overall Study|administrative reasons|10
2978369|NCT01095250|10252416|P1|Overall Study|administrative reasons|8
2978370|NCT01095094|10252446|P1|Overall Study|Physician Decision|1
2978371|NCT01095094|10252446|P1|Overall Study|Death|1
2978372|NCT01095094|10252446|P1|Overall Study|Withdrawal by Subject|1
2978373|NCT01094886|10252468|P1|Overall Study|Withdrawal by Subject|5
2978374|NCT01094886|10252468|P1|Overall Study|Adverse Event|2
2978375|NCT01094808|10252478|P3|Overall Study|Withdrawal by Subject|0
2978376|NCT01094808|10252479|P2|Overall Study|Withdrawal by Subject|1
2978377|NCT01094808|10252480|P1|Overall Study|Withdrawal by Subject|1
2978378|NCT01094782|10252521|P6|Overall Study|Noncompliance With Study Schedule|0
2978379|NCT01094782|10252522|P5|Overall Study|Noncompliance With Study Schedule|0
2978380|NCT01094782|10252523|P4|Overall Study|Noncompliance With Study Schedule|1
2978381|NCT01094782|10252524|P3|Overall Study|Noncompliance With Study Schedule|0
2978382|NCT01094782|10252525|P2|Overall Study|Noncompliance With Study Schedule|0
2978383|NCT01094782|10252526|P1|Overall Study|Noncompliance With Study Schedule|0
2978384|NCT01094782|10252521|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
2978385|NCT01094782|10252522|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
2978386|NCT01094782|10252523|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
2978387|NCT01094782|10252524|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
2978388|NCT01094782|10252525|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
2978389|NCT01094782|10252526|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
2978390|NCT01094782|10252521|P6|Overall Study|Recent Interventional Injection|1
2978391|NCT01094782|10252522|P5|Overall Study|Recent Interventional Injection|0
2978392|NCT01094782|10252523|P4|Overall Study|Recent Interventional Injection|0
2978393|NCT01094782|10252524|P3|Overall Study|Recent Interventional Injection|0
2978394|NCT01094782|10252525|P2|Overall Study|Recent Interventional Injection|0
2978395|NCT01094782|10252526|P1|Overall Study|Recent Interventional Injection|0
2978396|NCT01094782|10252521|P6|Overall Study|Wrong Pain Condition|1
2978397|NCT01094782|10252522|P5|Overall Study|Wrong Pain Condition|1
2978398|NCT01094782|10252523|P4|Overall Study|Wrong Pain Condition|2
2978399|NCT01094782|10252524|P3|Overall Study|Wrong Pain Condition|0
2978400|NCT01094782|10252525|P2|Overall Study|Wrong Pain Condition|0
2978401|NCT01094782|10252526|P1|Overall Study|Wrong Pain Condition|0
2978402|NCT01094782|10252521|P6|Overall Study|Hypertension|0
2978403|NCT01094782|10252522|P5|Overall Study|Hypertension|0
2978404|NCT01094782|10252523|P4|Overall Study|Hypertension|0
2978405|NCT01094782|10252524|P3|Overall Study|Hypertension|1
2978406|NCT01094782|10252525|P2|Overall Study|Hypertension|0
2978407|NCT01094782|10252526|P1|Overall Study|Hypertension|0
2978408|NCT01094782|10252521|P6|Overall Study|Healthy Subject Had Pain|0
2978409|NCT01094782|10252522|P5|Overall Study|Healthy Subject Had Pain|0
2978410|NCT01094782|10252523|P4|Overall Study|Healthy Subject Had Pain|0
2978411|NCT01094782|10252524|P3|Overall Study|Healthy Subject Had Pain|0
2978412|NCT01094782|10252525|P2|Overall Study|Healthy Subject Had Pain|1
2978413|NCT01094782|10252526|P1|Overall Study|Healthy Subject Had Pain|0
2978414|NCT01094782|10252521|P6|Overall Study|Unable to Complete Questionnaires|0
2978415|NCT01094782|10252522|P5|Overall Study|Unable to Complete Questionnaires|0
2978416|NCT01094782|10252523|P4|Overall Study|Unable to Complete Questionnaires|0
2978417|NCT01094782|10252524|P3|Overall Study|Unable to Complete Questionnaires|0
2978418|NCT01094782|10252525|P2|Overall Study|Unable to Complete Questionnaires|1
2978419|NCT01094782|10252526|P1|Overall Study|Unable to Complete Questionnaires|0
2978420|NCT01094782|10252521|P6|Overall Study|Sensory Deficit at Site of QST|0
2978421|NCT01094782|10252522|P5|Overall Study|Sensory Deficit at Site of QST|0
2978422|NCT01094782|10252523|P4|Overall Study|Sensory Deficit at Site of QST|0
2978423|NCT01094782|10252524|P3|Overall Study|Sensory Deficit at Site of QST|0
2978424|NCT01094782|10252525|P2|Overall Study|Sensory Deficit at Site of QST|1
2978425|NCT01094782|10252526|P1|Overall Study|Sensory Deficit at Site of QST|0
2978426|NCT01094782|10252521|P6|Overall Study|Positive Drug Screen|2
2978427|NCT01094782|10252522|P5|Overall Study|Positive Drug Screen|3
2978428|NCT01094782|10252523|P4|Overall Study|Positive Drug Screen|1
2978429|NCT01094782|10252524|P3|Overall Study|Positive Drug Screen|1
2978430|NCT01094782|10252525|P2|Overall Study|Positive Drug Screen|2
2978431|NCT01094782|10252526|P1|Overall Study|Positive Drug Screen|2
2978432|NCT01094782|10252521|P6|Overall Study|Lost to Follow-up|4
2978433|NCT01094782|10252522|P5|Overall Study|Lost to Follow-up|1
2978434|NCT01094782|10252523|P4|Overall Study|Lost to Follow-up|2
2978435|NCT01094782|10252524|P3|Overall Study|Lost to Follow-up|0
2978436|NCT01094782|10252525|P2|Overall Study|Lost to Follow-up|0
2978437|NCT01094782|10252526|P1|Overall Study|Lost to Follow-up|1
2978438|NCT01094782|10252521|P6|Overall Study|Withdrawal by Subject|0
2978439|NCT01094782|10252522|P5|Overall Study|Withdrawal by Subject|5
2978440|NCT01094782|10252523|P4|Overall Study|Withdrawal by Subject|5
2978441|NCT01094782|10252524|P3|Overall Study|Withdrawal by Subject|1
2978442|NCT01094782|10252525|P2|Overall Study|Withdrawal by Subject|5
2978443|NCT01094782|10252526|P1|Overall Study|Withdrawal by Subject|5
2978444|NCT01094743|10252570|P1|Period 1|Unsatisfactory comfort at lens fitting|2
2978445|NCT01094730|10252587|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
2978446|NCT01094730|10252588|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
2978447|NCT01094730|10252587|P2|Period 2 (14 Days)|Adverse Event|1
2978448|NCT01094730|10252588|P1|Period 2 (14 Days)|Adverse Event|0
2978449|NCT01094730|10252587|P2|Period 2 (14 Days)|No time for the follow-up visit|0
2978450|NCT01094730|10252588|P1|Period 2 (14 Days)|No time for the follow-up visit|1
2978451|NCT01094730|10252587|P2|Period 2 (14 Days)|Protocol Violation|0
2978452|NCT01094730|10252588|P1|Period 2 (14 Days)|Protocol Violation|2
2978453|NCT01094730|10252587|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
2978454|NCT01094730|10252588|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
2978455|NCT01094730|10252587|P2|Period 1 (14 Days)|No time for the follow-up visit|0
2978456|NCT01094730|10252588|P1|Period 1 (14 Days)|No time for the follow-up visit|1
2978457|NCT01094730|10252587|P2|Period 1 (14 Days)|Withdrawal by Subject|1
2978458|NCT01094730|10252588|P1|Period 1 (14 Days)|Withdrawal by Subject|0
2978459|NCT01094730|10252587|P2|Period 1 (14 Days)|Lost to Follow-up|1
2978460|NCT01094730|10252588|P1|Period 1 (14 Days)|Lost to Follow-up|0
2978461|NCT01094301|10252724|P1|Implant Stage|No return of pain|4
2978462|NCT01094301|10252724|P1|Implant Stage|Withdrawal by Subject|2
2978463|NCT01094301|10252724|P1|Implant Stage|Protocol Violation|1
2978464|NCT01094301|10252724|P1|Implant Stage|Adverse Event|1
2978465|NCT01094301|10252724|P1|Trial Stage|Withdrawal by Subject|1
2978466|NCT01094288|10252754|P8|Overall Study|Ongoing Participants|0
2978467|NCT01094288|10252755|P7|Overall Study|Ongoing Participants|0
2978468|NCT01094288|10252756|P6|Overall Study|Ongoing Participants|0
2978469|NCT01094288|10252757|P5|Overall Study|Ongoing Participants|0
2978470|NCT01094288|10252758|P4|Overall Study|Ongoing Participants|0
2978471|NCT01094288|10252759|P3|Overall Study|Ongoing Participants|0
2978472|NCT01094288|10252760|P2|Overall Study|Ongoing Participants|3
2978473|NCT01094288|10252761|P1|Overall Study|Ongoing Participants|0
2978474|NCT01094288|10252754|P8|Overall Study|Reason not Specified|0
2978475|NCT01094288|10252755|P7|Overall Study|Reason not Specified|0
2978476|NCT01094288|10252756|P6|Overall Study|Reason not Specified|0
2978477|NCT01094288|10252757|P5|Overall Study|Reason not Specified|0
2978478|NCT01094288|10252758|P4|Overall Study|Reason not Specified|1
2978479|NCT01094288|10252759|P3|Overall Study|Reason not Specified|0
2978480|NCT01094288|10252760|P2|Overall Study|Reason not Specified|3
2978481|NCT01094288|10252761|P1|Overall Study|Reason not Specified|2
2978482|NCT01094288|10252754|P8|Overall Study|Initiation of Alternative Therapy|0
2978483|NCT01094288|10252755|P7|Overall Study|Initiation of Alternative Therapy|0
2978484|NCT01094288|10252756|P6|Overall Study|Initiation of Alternative Therapy|0
2978485|NCT01094288|10252757|P5|Overall Study|Initiation of Alternative Therapy|0
2978486|NCT01094288|10252758|P4|Overall Study|Initiation of Alternative Therapy|0
2978487|NCT01094288|10252759|P3|Overall Study|Initiation of Alternative Therapy|1
2978488|NCT01094288|10252760|P2|Overall Study|Initiation of Alternative Therapy|0
2978489|NCT01094288|10252761|P1|Overall Study|Initiation of Alternative Therapy|0
2978490|NCT01094288|10252754|P8|Overall Study|Withdrawal by Subject|2
2978491|NCT01094288|10252755|P7|Overall Study|Withdrawal by Subject|0
2978492|NCT01094288|10252756|P6|Overall Study|Withdrawal by Subject|0
2978493|NCT01094288|10252757|P5|Overall Study|Withdrawal by Subject|0
2978494|NCT01094288|10252758|P4|Overall Study|Withdrawal by Subject|0
2978495|NCT01094288|10252759|P3|Overall Study|Withdrawal by Subject|2
2978496|NCT01094288|10252760|P2|Overall Study|Withdrawal by Subject|1
2978497|NCT01094288|10252761|P1|Overall Study|Withdrawal by Subject|0
2978498|NCT01094288|10252754|P8|Overall Study|Adverse Event|0
2978499|NCT01094288|10252755|P7|Overall Study|Adverse Event|0
2978500|NCT01094288|10252756|P6|Overall Study|Adverse Event|0
2978501|NCT01094288|10252757|P5|Overall Study|Adverse Event|0
2978502|NCT01094288|10252758|P4|Overall Study|Adverse Event|1
2978503|NCT01094288|10252759|P3|Overall Study|Adverse Event|1
2978504|NCT01094288|10252760|P2|Overall Study|Adverse Event|3
2978505|NCT01094288|10252761|P1|Overall Study|Adverse Event|0
2978506|NCT01094184|10252873|P2|Overall Study|Death|11
2978507|NCT01094184|10252874|P1|Overall Study|Death|35
2978508|NCT01094171|10253108|P1|Overall Study|Other|1
2978509|NCT01094171|10253108|P1|Overall Study|Migration from the study area|3
2978510|NCT01094171|10253108|P1|Overall Study|Informed consent withdrawal|4
2978511|NCT01094171|10253108|P1|Overall Study|Lost to Follow-up|2
2978512|NCT01094119|10253117|P2|Overall Study|Lack of Efficacy|4
2978513|NCT01094119|10253118|P1|Overall Study|Lack of Efficacy|2
2978514|NCT01093885|10253130|P1|Overall Study|Lost to Follow-up|1
2978515|NCT01093885|10253130|P1|Overall Study|Adverse Event|4
2978516|NCT01093846|10253138|P3|Overall Study|Administrative Problems|15
2978517|NCT01093846|10253139|P2|Overall Study|Administrative Problems|17
2978518|NCT01093846|10253140|P1|Overall Study|Administrative Problems|18
2978519|NCT01093846|10253138|P3|Overall Study|Condition no longer required study drug|1
2978520|NCT01093846|10253139|P2|Overall Study|Condition no longer required study drug|1
2978521|NCT01093846|10253140|P1|Overall Study|Condition no longer required study drug|1
2978522|NCT01093846|10253138|P3|Overall Study|Lack of Efficacy|4
2978523|NCT01093846|10253139|P2|Overall Study|Lack of Efficacy|0
2978524|NCT01093846|10253140|P1|Overall Study|Lack of Efficacy|0
2978525|NCT01093846|10253138|P3|Overall Study|Adverse Event|1
2978526|NCT01093846|10253139|P2|Overall Study|Adverse Event|0
2978527|NCT01093846|10253140|P1|Overall Study|Adverse Event|0
2978528|NCT01093755|10253165|P2|Overall Study|Withdrawal by Subject|4
2978529|NCT01093755|10253166|P1|Overall Study|Withdrawal by Subject|3
2978530|NCT01093625|10253206|P2|1-Year Visit|Lost to Follow-up|3
2978531|NCT01093625|10253207|P1|1-Year Visit|Lost to Follow-up|5
2978532|NCT01093625|10253206|P2|6-Month Visit|Lost to Follow-up|2
2978533|NCT01093625|10253207|P1|6-Month Visit|Lost to Follow-up|2
2978534|NCT01093625|10253206|P2|6-Month Visit|Withdrawal by Subject|7
2978535|NCT01093625|10253207|P1|6-Month Visit|Withdrawal by Subject|6
2978536|NCT01093625|10253206|P2|3-Month Visit|Lost to Follow-up|0
2978537|NCT01093625|10253207|P1|3-Month Visit|Lost to Follow-up|2
2978538|NCT01093625|10253206|P2|1-Month Visit|Lost to Follow-up|0
2978539|NCT01093625|10253207|P1|1-Month Visit|Lost to Follow-up|2
2978540|NCT01093625|10253206|P2|2-Week Visit|Withdrawal by Subject|0
2978541|NCT01093625|10253207|P1|2-Week Visit|Withdrawal by Subject|1
2978542|NCT01093625|10253206|P2|Baseline and Dispensed|Withdrawal by Subject|0
2978543|NCT01093625|10253207|P1|Baseline and Dispensed|Withdrawal by Subject|2
2978544|NCT01093599|10253227|P2|Overall Study|Lost to Follow-up|46
2978545|NCT01093599|10253228|P1|Overall Study|Lost to Follow-up|32
2978546|NCT01093586|10253234|P1|Overall Study|Failed to engraft|3
2978547|NCT01093573|10253255|P3|Overall Study|Insurance Denied|1
2978548|NCT01093573|10253256|P2|Overall Study|Insurance Denied|0
2978549|NCT01093573|10253257|P1|Overall Study|Insurance Denied|0
2978550|NCT01093573|10253255|P3|Overall Study|Physician Decision|1
2978551|NCT01093573|10253256|P2|Overall Study|Physician Decision|0
2978552|NCT01093573|10253257|P1|Overall Study|Physician Decision|0
2978553|NCT01093534|10253274|P3|Overall Study|Other|4
2978554|NCT01093534|10253275|P2|Overall Study|Other|3
2978555|NCT01093534|10253276|P1|Overall Study|Other|1
2978556|NCT01093534|10253274|P3|Overall Study|Withdrawal by Subject|2
2978557|NCT01093534|10253275|P2|Overall Study|Withdrawal by Subject|7
2978558|NCT01093534|10253276|P1|Overall Study|Withdrawal by Subject|5
2978559|NCT01093534|10253274|P3|Overall Study|Lack of Efficacy|1
2978560|NCT01093534|10253275|P2|Overall Study|Lack of Efficacy|1
2978561|NCT01093534|10253276|P1|Overall Study|Lack of Efficacy|2
2978562|NCT01093534|10253274|P3|Overall Study|Adverse Event|2
2978563|NCT01093534|10253275|P2|Overall Study|Adverse Event|5
2978564|NCT01093534|10253276|P1|Overall Study|Adverse Event|2
2978565|NCT01093222|10253424|P1|Overall Study|Not protocol specified|1
2978566|NCT01093222|10253424|P1|Overall Study|Death|2
2978567|NCT01093222|10253424|P1|Overall Study|Progression/relapse|24
2978568|NCT01093222|10253424|P1|Overall Study|Adverse Event|7
2978569|NCT01093222|10253424|P1|Overall Study|Ineligible|6
2978570|NCT01092832|10253500|P2|Overall Study|Other|0
2978571|NCT01092832|10253501|P1|Overall Study|Other|1
2978572|NCT01092780|10253513|P4|Washout Period 2|Adverse Event|0
2978573|NCT01092780|10253514|P3|Washout Period 2|Adverse Event|1
2978574|NCT01092780|10253515|P2|Washout Period 2|Adverse Event|1
2978575|NCT01092780|10253516|P1|Washout Period 2|Adverse Event|0
2978576|NCT01092780|10253513|P4|Washout Period 1|Noncompliance with nCPAP|0
2978577|NCT01092780|10253514|P3|Washout Period 1|Noncompliance with nCPAP|0
2978578|NCT01092780|10253515|P2|Washout Period 1|Noncompliance with nCPAP|0
2978579|NCT01092780|10253516|P1|Washout Period 1|Noncompliance with nCPAP|1
2978580|NCT01092780|10253513|P4|Washout Period 1|Adverse Event|0
2978581|NCT01092780|10253514|P3|Washout Period 1|Adverse Event|0
2978582|NCT01092780|10253515|P2|Washout Period 1|Adverse Event|1
2978583|NCT01092780|10253516|P1|Washout Period 1|Adverse Event|0
2978584|NCT01092728|10253552|P2|Overall Study|Prohibited Concomitant Medications|0
2978585|NCT01092728|10253553|P1|Overall Study|Prohibited Concomitant Medications|1
2978586|NCT01092728|10253552|P2|Overall Study|Disease Progression|13
2978587|NCT01092728|10253553|P1|Overall Study|Disease Progression|1
2978588|NCT01092728|10253552|P2|Overall Study|Adverse Event|1
2978589|NCT01092728|10253553|P1|Overall Study|Adverse Event|0
2978590|NCT01092728|10253552|P2|Overall Study|Withdrawal by Subject|0
2978591|NCT01092728|10253553|P1|Overall Study|Withdrawal by Subject|2
2978592|NCT01092702|10253561|P1|Overall Study|Lost to Follow-up|2
2978593|NCT01092702|10253561|P1|Overall Study|Withdrawal by Subject|7
2978594|NCT01092663|10253578|P2|Overall Study|Protocol Violation|1
2978595|NCT01092663|10253579|P1|Overall Study|Protocol Violation|0
2978596|NCT01092663|10253578|P2|Overall Study|Adverse Event|1
2978597|NCT01092663|10253579|P1|Overall Study|Adverse Event|1
2978598|NCT01092663|10253578|P2|Overall Study|High fasting triglyceride|0
2978599|NCT01092663|10253579|P1|Overall Study|High fasting triglyceride|2
2978600|NCT01092663|10253578|P2|Overall Study|Glucose >300mg/dL|0
2978601|NCT01092663|10253579|P1|Overall Study|Glucose >300mg/dL|1
2978602|NCT01092663|10253578|P2|Overall Study|Withdrawal by Subject|2
2978603|NCT01092663|10253579|P1|Overall Study|Withdrawal by Subject|3
2978604|NCT01092637|10253627|P2|Overall Study|Death|49
2978605|NCT01092637|10253628|P1|Overall Study|Death|47
2978606|NCT01092546|10253643|P1|Overall Study|Subjects withdrawn prior to dosing|4
2978607|NCT01092507|10253650|P2|Overall Study|Withdrawal by Subject|0
2978608|NCT01092507|10253651|P1|Overall Study|Withdrawal by Subject|2
2978609|NCT01092416|10253686|P1|12-Month Follow-up|Data collected after close of 1Y window|2
2978610|NCT01092416|10253686|P1|12-Month Follow-up|Missed 1-year follow-up|1
2978611|NCT01092416|10253686|P1|12-Month Follow-up|Withdrawal by Subject|2
2978612|NCT01092416|10253686|P1|12-Month Follow-up|Lost to Follow-up|4
2978613|NCT01092416|10253686|P1|12-Month Follow-up|Death|16
2978614|NCT01092416|10253686|P1|30-Day Follow-up|Data collected after close of 30D window|5
2978615|NCT01092416|10253686|P1|30-Day Follow-up|Missed 30-day follow-up|3
2978616|NCT01092416|10253686|P1|30-Day Follow-up|Death|2
2978617|NCT01092416|10253686|P1|Enrollment|Atherectomy device not inserted|3
2978618|NCT01091974|10253736|P4|Overall Study|side-effects|2
2978619|NCT01091974|10253737|P3|Overall Study|side-effects|0
2978620|NCT01091974|10253738|P2|Overall Study|side-effects|1
2978621|NCT01091974|10253739|P1|Overall Study|side-effects|1
2978622|NCT01091974|10253736|P4|Overall Study|Withdrawal by Subject|2
2978623|NCT01091974|10253737|P3|Overall Study|Withdrawal by Subject|2
2978624|NCT01091974|10253738|P2|Overall Study|Withdrawal by Subject|3
2978625|NCT01091974|10253739|P1|Overall Study|Withdrawal by Subject|1
2978626|NCT01091974|10253736|P4|Overall Study|resumed sleep medication|2
2978627|NCT01091974|10253737|P3|Overall Study|resumed sleep medication|1
2978628|NCT01091974|10253738|P2|Overall Study|resumed sleep medication|0
2978629|NCT01091974|10253739|P1|Overall Study|resumed sleep medication|0
2978630|NCT01091974|10253736|P4|Overall Study|Did not start intervention|1
2978631|NCT01091974|10253737|P3|Overall Study|Did not start intervention|3
2978632|NCT01091974|10253738|P2|Overall Study|Did not start intervention|1
2978633|NCT01091974|10253739|P1|Overall Study|Did not start intervention|3
2978634|NCT01091675|10253774|P1|Overall Study|Lack of Efficacy|27
2978635|NCT01091675|10253774|P1|Overall Study|Adverse Event|7
2978636|NCT01091662|10253780|P2|Overall Study|unable to swallow capsule|1
2978637|NCT01091662|10253781|P1|Overall Study|unable to swallow capsule|0
2978638|NCT01091662|10253780|P2|Overall Study|Protocol Violation|2
2978639|NCT01091662|10253781|P1|Overall Study|Protocol Violation|0
2978640|NCT01091662|10253780|P2|Overall Study|Pregnancy|1
2978641|NCT01091662|10253781|P1|Overall Study|Pregnancy|0
2978642|NCT01091662|10253780|P2|Overall Study|Lost to Follow-up|1
2978643|NCT01091662|10253781|P1|Overall Study|Lost to Follow-up|0
2978644|NCT01091662|10253780|P2|Overall Study|met exclusion criteria|0
2978645|NCT01091662|10253781|P1|Overall Study|met exclusion criteria|1
2978646|NCT01091662|10253780|P2|Overall Study|met exit criteria|13
2978647|NCT01091662|10253781|P1|Overall Study|met exit criteria|7
2978648|NCT01091662|10253780|P2|Overall Study|Withdrawal by Subject|6
2978649|NCT01091662|10253781|P1|Overall Study|Withdrawal by Subject|7
2978650|NCT01091662|10253780|P2|Overall Study|Physician Decision|1
2978651|NCT01091662|10253781|P1|Overall Study|Physician Decision|1
2978652|NCT01091662|10253780|P2|Overall Study|Adverse Event|9
2978653|NCT01091662|10253781|P1|Overall Study|Adverse Event|1
2978654|NCT01091519|10253819|P2|Overall Study|Randomized not treated|4
2978655|NCT01091519|10253820|P1|Overall Study|Randomized not treated|4
2978656|NCT01091519|10253819|P2|Overall Study|Other|8
2978657|NCT01091519|10253820|P1|Overall Study|Other|6
2978658|NCT01091519|10253819|P2|Overall Study|Withdrawal by Subject|2
2978659|NCT01091519|10253820|P1|Overall Study|Withdrawal by Subject|2
2978660|NCT01091519|10253819|P2|Overall Study|Lost to Follow-up|24
2978661|NCT01091519|10253820|P1|Overall Study|Lost to Follow-up|14
2978662|NCT01091519|10253819|P2|Overall Study|Lack of Efficacy|19
2978663|NCT01091519|10253820|P1|Overall Study|Lack of Efficacy|16
2978664|NCT01091519|10253819|P2|Overall Study|Death|0
2978665|NCT01091519|10253820|P1|Overall Study|Death|1
2978666|NCT01091519|10253819|P2|Overall Study|Adverse Event|16
2978667|NCT01091519|10253820|P1|Overall Study|Adverse Event|12
2978668|NCT01091454|10253832|P1|Overall Study|Ineligible|1
2978669|NCT01091428|10253845|P4|Phase 2|Physician Decision|0
2978670|NCT01091428|10253846|P3|Phase 2|Physician Decision|2
2978671|NCT01091428|10253847|P2|Phase 2|Physician Decision|0
2978672|NCT01091428|10253848|P1|Phase 2|Physician Decision|0
2978673|NCT01091428|10253845|P4|Phase 2|Reason not specified|3
2978674|NCT01091428|10253846|P3|Phase 2|Reason not specified|4
2978675|NCT01091428|10253847|P2|Phase 2|Reason not specified|0
2978676|NCT01091428|10253848|P1|Phase 2|Reason not specified|0
2978677|NCT01091428|10253845|P4|Phase 2|Unsatisfactory Therapeutic Response|1
2978678|NCT01091428|10253846|P3|Phase 2|Unsatisfactory Therapeutic Response|1
2978679|NCT01091428|10253847|P2|Phase 2|Unsatisfactory Therapeutic Response|0
2978680|NCT01091428|10253848|P1|Phase 2|Unsatisfactory Therapeutic Response|0
2978681|NCT01091428|10253845|P4|Phase 2|Withdrawal by Subject|8
2978682|NCT01091428|10253846|P3|Phase 2|Withdrawal by Subject|9
2978683|NCT01091428|10253847|P2|Phase 2|Withdrawal by Subject|0
2978684|NCT01091428|10253848|P1|Phase 2|Withdrawal by Subject|0
2978685|NCT01091428|10253845|P4|Phase 2|Adverse Event|5
2978686|NCT01091428|10253846|P3|Phase 2|Adverse Event|12
2978687|NCT01091428|10253847|P2|Phase 2|Adverse Event|0
2978688|NCT01091428|10253848|P1|Phase 2|Adverse Event|0
2978689|NCT01091428|10253845|P4|Phase 2|Symptomatic Deterioration|6
2978690|NCT01091428|10253846|P3|Phase 2|Symptomatic Deterioration|1
2978691|NCT01091428|10253847|P2|Phase 2|Symptomatic Deterioration|0
2978692|NCT01091428|10253848|P1|Phase 2|Symptomatic Deterioration|0
2978693|NCT01091428|10253845|P4|Phase 2|Progressive Disease|46
2978694|NCT01091428|10253846|P3|Phase 2|Progressive Disease|44
2978695|NCT01091428|10253847|P2|Phase 2|Progressive Disease|0
2978696|NCT01091428|10253848|P1|Phase 2|Progressive Disease|0
2978697|NCT01091428|10253845|P4|Phase 1|Single-Patient IND|0
2978698|NCT01091428|10253846|P3|Phase 1|Single-Patient IND|0
2978699|NCT01091428|10253847|P2|Phase 1|Single-Patient IND|0
2978700|NCT01091428|10253848|P1|Phase 1|Single-Patient IND|2
2978701|NCT01091428|10253845|P4|Phase 1|Reason not specified|0
2978702|NCT01091428|10253846|P3|Phase 1|Reason not specified|0
2978703|NCT01091428|10253847|P2|Phase 1|Reason not specified|1
2978704|NCT01091428|10253848|P1|Phase 1|Reason not specified|0
2978705|NCT01091428|10253845|P4|Phase 1|Withdrawal by Subject|0
2978706|NCT01091428|10253846|P3|Phase 1|Withdrawal by Subject|0
2978707|NCT01091428|10253847|P2|Phase 1|Withdrawal by Subject|0
2978708|NCT01091428|10253848|P1|Phase 1|Withdrawal by Subject|7
2978709|NCT01091428|10253845|P4|Phase 1|Adverse Event|0
2978710|NCT01091428|10253846|P3|Phase 1|Adverse Event|0
2978711|NCT01091428|10253847|P2|Phase 1|Adverse Event|0
2978712|NCT01091428|10253848|P1|Phase 1|Adverse Event|2
2978713|NCT01091428|10253845|P4|Phase 1|Symptomatic Deterioration|0
2978714|NCT01091428|10253846|P3|Phase 1|Symptomatic Deterioration|0
2978715|NCT01091428|10253847|P2|Phase 1|Symptomatic Deterioration|2
2978716|NCT01091428|10253848|P1|Phase 1|Symptomatic Deterioration|3
2978717|NCT01091428|10253845|P4|Phase 1|Progressive Disease|0
2978718|NCT01091428|10253846|P3|Phase 1|Progressive Disease|0
2978719|NCT01091428|10253847|P2|Phase 1|Progressive Disease|8
2978720|NCT01091428|10253848|P1|Phase 1|Progressive Disease|24
2978721|NCT01091363|10253951|P2|Overall Study|Lost to Follow-up|2
2978722|NCT01091363|10253952|P1|Overall Study|Lost to Follow-up|2
2978723|NCT01091363|10253951|P2|Overall Study|Withdrawal by Subject|15
2978724|NCT01091363|10253952|P1|Overall Study|Withdrawal by Subject|11
2978725|NCT01091259|10253962|P1|Overall Study|Lack of Efficacy|2
2978726|NCT01091259|10253962|P1|Overall Study|Adverse Event|3
2978727|NCT01091246|10253973|P3|Overall Study|Subject not dosed|1
2978728|NCT01091246|10253974|P2|Overall Study|Subject not dosed|0
2978729|NCT01091246|10253975|P1|Overall Study|Subject not dosed|2
2978730|NCT01091246|10253973|P3|Overall Study|Withdrawal by Subject|4
2978731|NCT01091246|10253974|P2|Overall Study|Withdrawal by Subject|5
2978732|NCT01091246|10253975|P1|Overall Study|Withdrawal by Subject|9
2978733|NCT01091246|10253973|P3|Overall Study|Adverse Event|1
2978734|NCT01091246|10253974|P2|Overall Study|Adverse Event|0
2978735|NCT01091246|10253975|P1|Overall Study|Adverse Event|1
2978736|NCT01091246|10253973|P3|Overall Study|Lost to Follow-up|7
2978737|NCT01091246|10253974|P2|Overall Study|Lost to Follow-up|11
2978738|NCT01091246|10253975|P1|Overall Study|Lost to Follow-up|23
2978739|NCT01091168|10254051|P2|Overall Study|Physician, patient's decision, other|37
2978740|NCT01091168|10254052|P1|Overall Study|Physician, patient's decision, other|27
2978741|NCT01091168|10254051|P2|Overall Study|Lost to Follow-up|1
2978742|NCT01091168|10254052|P1|Overall Study|Lost to Follow-up|0
2978743|NCT01091168|10254051|P2|Overall Study|Adverse Event|24
2978744|NCT01091168|10254052|P1|Overall Study|Adverse Event|21
2978745|NCT01091168|10254051|P2|Overall Study|Progressive disease|234
2978746|NCT01091168|10254052|P1|Overall Study|Progressive disease|250
2978747|NCT01091103|10254127|P1|Overall Study|Progressive Disease|3
2978748|NCT01091103|10254127|P1|Overall Study|Adverse Event|1
2978749|NCT01090973|10254147|P1|Overall Study|Disease progression|1
2978750|NCT01090765|10254163|P6|Overall Study|Vasovagal reaction with first infusion|0
2978751|NCT01090765|10254164|P5|Overall Study|Vasovagal reaction with first infusion|1
2978752|NCT01090765|10254165|P4|Overall Study|Vasovagal reaction with first infusion|0
2978753|NCT01090765|10254166|P3|Overall Study|Vasovagal reaction with first infusion|0
2978754|NCT01090765|10254167|P2|Overall Study|Vasovagal reaction with first infusion|0
2978755|NCT01090765|10254168|P1|Overall Study|Vasovagal reaction with first infusion|0
2978756|NCT01090765|10254163|P6|Overall Study|Developed a DVT, needed anticoagulation|0
2978757|NCT01090765|10254164|P5|Overall Study|Developed a DVT, needed anticoagulation|0
2978758|NCT01090765|10254165|P4|Overall Study|Developed a DVT, needed anticoagulation|1
2978759|NCT01090765|10254166|P3|Overall Study|Developed a DVT, needed anticoagulation|0
2978760|NCT01090765|10254167|P2|Overall Study|Developed a DVT, needed anticoagulation|0
2978761|NCT01090765|10254168|P1|Overall Study|Developed a DVT, needed anticoagulation|0
2978762|NCT01090765|10254163|P6|Overall Study|Patient withdrew consent|1
2978763|NCT01090765|10254164|P5|Overall Study|Patient withdrew consent|1
2978764|NCT01090765|10254165|P4|Overall Study|Patient withdrew consent|0
2978765|NCT01090765|10254166|P3|Overall Study|Patient withdrew consent|0
2978766|NCT01090765|10254167|P2|Overall Study|Patient withdrew consent|0
2978767|NCT01090765|10254168|P1|Overall Study|Patient withdrew consent|0
2978768|NCT01090739|10254214|P1|36 Month Follow-up|Visit still pending|17
2978769|NCT01090739|10254214|P1|36 Month Follow-up|Withdrawal by Subject|6
2978770|NCT01090739|10254214|P1|24 Month Follow-up|Death|1
2978771|NCT01090739|10254214|P1|24 Month Follow-up|Lost to Follow-up|1
2978772|NCT01090739|10254214|P1|24 Month Follow-up|Withdrawal by Subject|7
2978773|NCT01090739|10254214|P1|12 Month Follow-up|Death|1
2978774|NCT01090739|10254214|P1|12 Month Follow-up|Physician Decision|1
2978775|NCT01090739|10254214|P1|12 Month Follow-up|Lost to Follow-up|1
2978776|NCT01090739|10254214|P1|12 Month Follow-up|Withdrawal by Subject|2
2978777|NCT01090739|10254214|P1|Enrollment|Adverse Event|1
2978778|NCT01090739|10254214|P1|Enrollment|Study implant limit reached|2
2978779|NCT01090739|10254214|P1|Enrollment|Sponsor termination of site|4
2978780|NCT01090739|10254214|P1|Enrollment|Physician Decision|5
2978781|NCT01090739|10254214|P1|Enrollment|Lost to Follow-up|5
2978782|NCT01090739|10254214|P1|Enrollment|Protocol Violation|14
2978783|NCT01090739|10254214|P1|Enrollment|Withdrawal by Subject|24
2978784|NCT01090492|10254239|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978785|NCT01090492|10254240|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
2978786|NCT01090492|10254241|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978787|NCT01090492|10254242|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978788|NCT01090492|10254243|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978789|NCT01090492|10254244|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978790|NCT01090492|10254245|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978791|NCT01090492|10254246|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2978792|NCT01090492|10254239|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
2978793|NCT01090492|10254240|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
2978794|NCT01090492|10254241|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
2978795|NCT01090492|10254242|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
2978796|NCT01090492|10254243|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
2978797|NCT01090492|10254244|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
2978798|NCT01090492|10254245|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
2978799|NCT01090492|10254246|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
2978800|NCT01090492|10254239|P8|Second Intervention Period (4 Weeks)|Other|0
2978801|NCT01090492|10254240|P7|Second Intervention Period (4 Weeks)|Other|0
2978802|NCT01090492|10254241|P6|Second Intervention Period (4 Weeks)|Other|0
2978803|NCT01090492|10254242|P5|Second Intervention Period (4 Weeks)|Other|0
2978804|NCT01090492|10254243|P4|Second Intervention Period (4 Weeks)|Other|0
2978805|NCT01090492|10254244|P3|Second Intervention Period (4 Weeks)|Other|1
2978806|NCT01090492|10254245|P2|Second Intervention Period (4 Weeks)|Other|1
2978807|NCT01090492|10254246|P1|Second Intervention Period (4 Weeks)|Other|0
2978808|NCT01090492|10254239|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
2978809|NCT01090492|10254240|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
2978810|NCT01090492|10254241|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
2978811|NCT01090492|10254242|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
2978812|NCT01090492|10254243|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
2978813|NCT01090492|10254244|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
2978814|NCT01090492|10254245|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
2978815|NCT01090492|10254246|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
2978816|NCT01090492|10254239|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
2978817|NCT01090492|10254240|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
2978818|NCT01090492|10254241|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
2978819|NCT01090492|10254242|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
2978820|NCT01090492|10254243|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
2978821|NCT01090492|10254244|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
2978822|NCT01090492|10254245|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
2978823|NCT01090492|10254246|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
2978824|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Adverse Event|5
2978825|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Adverse Event|0
2978826|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Adverse Event|2
2978827|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Adverse Event|1
2978828|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Adverse Event|3
2978829|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Adverse Event|0
2978830|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Adverse Event|2
2978831|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Adverse Event|0
2978832|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Pregnancy|0
2978833|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Pregnancy|0
2978834|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Pregnancy|0
2978835|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Pregnancy|1
2978836|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Pregnancy|0
2978837|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Pregnancy|0
2978838|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Pregnancy|0
2978839|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Pregnancy|0
2978840|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Other|0
2978841|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Other|0
2978842|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Other|0
2978843|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Other|2
2978844|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Other|1
2978845|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Other|1
2978846|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Other|0
2978847|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Other|0
2978848|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978849|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978850|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978851|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978852|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978853|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
2978854|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978855|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2978856|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
2978857|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978858|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978859|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978860|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978861|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978862|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
2978863|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2978864|NCT01090492|10254239|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
2978865|NCT01090492|10254240|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
2978866|NCT01090492|10254241|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
2978867|NCT01090492|10254242|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
2978868|NCT01090492|10254243|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
2978869|NCT01090492|10254244|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
2978870|NCT01090492|10254245|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
2978871|NCT01090492|10254246|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
2978872|NCT01090453|10254314|P2|Overall Study|Eligibility Criteria|1
2978873|NCT01090453|10254315|P1|Overall Study|Eligibility Criteria|0
2978874|NCT01090453|10254314|P2|Overall Study|Other|4
2978875|NCT01090453|10254315|P1|Overall Study|Other|2
2978876|NCT01090453|10254314|P2|Overall Study|Protocol Violation|0
2978877|NCT01090453|10254315|P1|Overall Study|Protocol Violation|2
2978878|NCT01090453|10254314|P2|Overall Study|Non serious AEs|0
2978879|NCT01090453|10254315|P1|Overall Study|Non serious AEs|1
2978880|NCT01090453|10254314|P2|Overall Study|Lost to Follow-up|7
2978881|NCT01090453|10254315|P1|Overall Study|Lost to Follow-up|7
2978882|NCT01090453|10254314|P2|Overall Study|Withdrawal by Subject|2
2978883|NCT01090453|10254315|P1|Overall Study|Withdrawal by Subject|1
2978884|NCT01090427|10254366|P7|After Controlled Period|Adverse Event|0
2978885|NCT01090427|10254367|P6|After Controlled Period|Adverse Event|1
2978886|NCT01090427|10254368|P5|After Controlled Period|Adverse Event|0
2978887|NCT01090427|10254369|P4|After Controlled Period|Adverse Event|2
2978888|NCT01090427|10254370|P3|After Controlled Period|Adverse Event|0
2978889|NCT01090427|10254371|P2|After Controlled Period|Adverse Event|0
2978890|NCT01090427|10254372|P1|After Controlled Period|Adverse Event|0
2978891|NCT01090427|10254366|P7|After Controlled Period|Lack of Efficacy|2
2978892|NCT01090427|10254367|P6|After Controlled Period|Lack of Efficacy|3
2978893|NCT01090427|10254368|P5|After Controlled Period|Lack of Efficacy|0
2978894|NCT01090427|10254369|P4|After Controlled Period|Lack of Efficacy|0
2978895|NCT01090427|10254370|P3|After Controlled Period|Lack of Efficacy|0
2978896|NCT01090427|10254371|P2|After Controlled Period|Lack of Efficacy|0
2978897|NCT01090427|10254372|P1|After Controlled Period|Lack of Efficacy|0
2978898|NCT01090427|10254366|P7|After Controlled Period|Death|0
2978899|NCT01090427|10254367|P6|After Controlled Period|Death|1
2978900|NCT01090427|10254368|P5|After Controlled Period|Death|0
2978901|NCT01090427|10254369|P4|After Controlled Period|Death|0
2978902|NCT01090427|10254370|P3|After Controlled Period|Death|0
2978903|NCT01090427|10254371|P2|After Controlled Period|Death|0
2978904|NCT01090427|10254372|P1|After Controlled Period|Death|0
2978905|NCT01090414|10254409|P4|Study 101-99|Participant Request|0
2978906|NCT01090414|10254410|P3|Study 101-99|Participant Request|0
2978907|NCT01090414|10254411|P2|Study 101-99|Participant Request|1
2978908|NCT01090414|10254412|P1|Study 101-99|Participant Request|3
2978909|NCT01090414|10254409|P4|Study 101-99|Withdrew Consent|1
2978910|NCT01090414|10254410|P3|Study 101-99|Withdrew Consent|3
2978911|NCT01090414|10254411|P2|Study 101-99|Withdrew Consent|2
2978912|NCT01090414|10254412|P1|Study 101-99|Withdrew Consent|0
2978913|NCT01090414|10254409|P4|Study 101-99|Other (Unknown Reasons)|0
2978914|NCT01090414|10254410|P3|Study 101-99|Other (Unknown Reasons)|0
2978915|NCT01090414|10254411|P2|Study 101-99|Other (Unknown Reasons)|3
2978916|NCT01090414|10254412|P1|Study 101-99|Other (Unknown Reasons)|3
2978917|NCT01090414|10254409|P4|Study 101-99|Sponsor Discontinued Study|0
2978918|NCT01090414|10254410|P3|Study 101-99|Sponsor Discontinued Study|5
2978919|NCT01090414|10254411|P2|Study 101-99|Sponsor Discontinued Study|7
2978920|NCT01090414|10254412|P1|Study 101-99|Sponsor Discontinued Study|0
2978921|NCT01090414|10254409|P4|Study 101-99|Death|0
2978922|NCT01090414|10254410|P3|Study 101-99|Death|1
2978923|NCT01090414|10254411|P2|Study 101-99|Death|8
2978924|NCT01090414|10254412|P1|Study 101-99|Death|3
2978925|NCT01090414|10254409|P4|Study 101-99|Investigator Request|0
2978926|NCT01090414|10254410|P3|Study 101-99|Investigator Request|4
2978927|NCT01090414|10254411|P2|Study 101-99|Investigator Request|11
2978928|NCT01090414|10254412|P1|Study 101-99|Investigator Request|1
2978929|NCT01090414|10254409|P4|Study 101-99|Adverse Event|0
2978930|NCT01090414|10254410|P3|Study 101-99|Adverse Event|18
2978931|NCT01090414|10254411|P2|Study 101-99|Adverse Event|28
2978932|NCT01090414|10254412|P1|Study 101-99|Adverse Event|10
2978933|NCT01090414|10254409|P4|Study 101-99|Progressive Disease|4
2978934|NCT01090414|10254410|P3|Study 101-99|Progressive Disease|10
2978935|NCT01090414|10254411|P2|Study 101-99|Progressive Disease|48
2978936|NCT01090414|10254412|P1|Study 101-99|Progressive Disease|28
2978937|NCT01090323|10254479|P2|Overall Study|Stopped end of extension 1#|1
2978938|NCT01090323|10254480|P1|Overall Study|Stopped end of extension 1#|3
2978939|NCT01090323|10254479|P2|Overall Study|Stopped end of core|0
2978940|NCT01090323|10254480|P1|Overall Study|Stopped end of core|7
2978941|NCT01090323|10254479|P2|Overall Study|Death|2
2978942|NCT01090323|10254480|P1|Overall Study|Death|1
2978943|NCT01090323|10254479|P2|Overall Study|Administrative problems|4
2978944|NCT01090323|10254480|P1|Overall Study|Administrative problems|6
2978945|NCT01090323|10254479|P2|Overall Study|Lost to Follow-up|6
2978946|NCT01090323|10254480|P1|Overall Study|Lost to Follow-up|11
2978947|NCT01090323|10254479|P2|Overall Study|Withdrew consent|11
2978948|NCT01090323|10254480|P1|Overall Study|Withdrew consent|33
2978949|NCT01090323|10254479|P2|Overall Study|Protocol Violation|1
2978950|NCT01090323|10254480|P1|Overall Study|Protocol Violation|2
2978951|NCT01090323|10254479|P2|Overall Study|Condition no longer requires drug|4
2978952|NCT01090323|10254480|P1|Overall Study|Condition no longer requires drug|5
2978953|NCT01090323|10254479|P2|Overall Study|Unsatisfactory therapeutic effect|2
2978954|NCT01090323|10254480|P1|Overall Study|Unsatisfactory therapeutic effect|4
2978955|NCT01090323|10254479|P2|Overall Study|Abnormal Test Procedure Results|0
2978956|NCT01090323|10254480|P1|Overall Study|Abnormal Test Procedure Results|2
2978957|NCT01090323|10254479|P2|Overall Study|Abnormal Lab Values|1
2978958|NCT01090323|10254480|P1|Overall Study|Abnormal Lab Values|3
2978959|NCT01090323|10254479|P2|Overall Study|Adverse Event|2
2978960|NCT01090323|10254480|P1|Overall Study|Adverse Event|12
2978961|NCT01090310|10254492|P4|Extension Study|Subject withdrew consent|0
2978962|NCT01090310|10254493|P3|Extension Study|Subject withdrew consent|0
2978963|NCT01090310|10254494|P2|Extension Study|Subject withdrew consent|1
2978964|NCT01090310|10254495|P1|Extension Study|Subject withdrew consent|0
2978965|NCT01090310|10254492|P4|Extension Study|Unsatisfactory therapeutic effect|1
2978966|NCT01090310|10254493|P3|Extension Study|Unsatisfactory therapeutic effect|1
2978967|NCT01090310|10254494|P2|Extension Study|Unsatisfactory therapeutic effect|0
2978968|NCT01090310|10254495|P1|Extension Study|Unsatisfactory therapeutic effect|1
2978969|NCT01090310|10254492|P4|Extension Study|Adverse Event|1
2978970|NCT01090310|10254493|P3|Extension Study|Adverse Event|0
2978971|NCT01090310|10254494|P2|Extension Study|Adverse Event|0
2978972|NCT01090310|10254495|P1|Extension Study|Adverse Event|0
2978973|NCT01090310|10254492|P4|Extension Study|Aministrative problems|18
2978974|NCT01090310|10254493|P3|Extension Study|Aministrative problems|14
2978975|NCT01090310|10254494|P2|Extension Study|Aministrative problems|15
2978976|NCT01090310|10254495|P1|Extension Study|Aministrative problems|13
2978977|NCT01090310|10254492|P4|Core Study|Protocol deviation|1
2978978|NCT01090310|10254493|P3|Core Study|Protocol deviation|0
2978979|NCT01090310|10254494|P2|Core Study|Protocol deviation|0
2978980|NCT01090310|10254495|P1|Core Study|Protocol deviation|1
2978981|NCT01090310|10254492|P4|Core Study|Administrative reasons|4
2978982|NCT01090310|10254493|P3|Core Study|Administrative reasons|4
2978983|NCT01090310|10254494|P2|Core Study|Administrative reasons|6
2978984|NCT01090310|10254495|P1|Core Study|Administrative reasons|5
2978985|NCT01090310|10254492|P4|Core Study|Abnormal test procedure result|0
2978986|NCT01090310|10254493|P3|Core Study|Abnormal test procedure result|1
2978987|NCT01090310|10254494|P2|Core Study|Abnormal test procedure result|0
2978988|NCT01090310|10254495|P1|Core Study|Abnormal test procedure result|0
2978989|NCT01090310|10254492|P4|Core Study|Subject withdrew consent|1
2978990|NCT01090310|10254493|P3|Core Study|Subject withdrew consent|1
2978991|NCT01090310|10254494|P2|Core Study|Subject withdrew consent|3
2978992|NCT01090310|10254495|P1|Core Study|Subject withdrew consent|0
2978993|NCT01090310|10254492|P4|Core Study|Adverse Event|1
2978994|NCT01090310|10254493|P3|Core Study|Adverse Event|1
2978995|NCT01090310|10254494|P2|Core Study|Adverse Event|2
2978996|NCT01090310|10254495|P1|Core Study|Adverse Event|2
2978997|NCT01090102|10254534|P2|Second 12 Weeks|Withdrawal by Subject|1
2978998|NCT01090102|10254535|P1|Second 12 Weeks|Withdrawal by Subject|0
2978999|NCT01090102|10254534|P2|First 12 Weeks|Death|1
2979000|NCT01090102|10254535|P1|First 12 Weeks|Death|1
2979001|NCT01090102|10254534|P2|First 12 Weeks|Adverse Event|0
2979002|NCT01090102|10254535|P1|First 12 Weeks|Adverse Event|2
2979003|NCT01090102|10254534|P2|First 12 Weeks|Withdrawal by Subject|1
2979004|NCT01090102|10254535|P1|First 12 Weeks|Withdrawal by Subject|1
2979005|NCT01090076|10254545|P2|Overall Study|Withdrawal by Subject|1
2979006|NCT01090076|10254546|P1|Overall Study|Withdrawal by Subject|0
2979007|NCT01090076|10254545|P2|Overall Study|Death|1
2979008|NCT01090076|10254546|P1|Overall Study|Death|1
2979009|NCT01090063|10254556|P1|Treatment|Withdrawal by Subject|4
2979010|NCT01090063|10254556|P1|Screen|Screen Failed|4
2979011|NCT01090050|10254572|P2|Overall Study|Physician Decision|1
2979012|NCT01090050|10254573|P1|Overall Study|Physician Decision|0
2979013|NCT01090050|10254572|P2|Overall Study|Lack of Efficacy|5
2979014|NCT01090050|10254573|P1|Overall Study|Lack of Efficacy|1
2979015|NCT01090050|10254572|P2|Overall Study|Lost to Follow-up|1
2979016|NCT01090050|10254573|P1|Overall Study|Lost to Follow-up|0
2979017|NCT01090011|10254593|P1|Overall Study|Other reason not defined above|5
2979018|NCT01090011|10254593|P1|Overall Study|Refusal to start/continue medication|5
2979019|NCT01090011|10254593|P1|Overall Study|Protocol Violation|1
2979020|NCT01090011|10254593|P1|Overall Study|Adverse Event|32
2979021|NCT01090011|10254593|P1|Overall Study|Progressive disease|128
2979022|NCT01089647|10254686|P2|Overall Study|Adverse Event|1
2979023|NCT01089647|10254687|P1|Overall Study|Adverse Event|0
2979024|NCT01089647|10254686|P2|Overall Study|Withdrawal by Subject|1
2979025|NCT01089647|10254687|P1|Overall Study|Withdrawal by Subject|2
2979026|NCT01089647|10254686|P2|Overall Study|Lost to Follow-up|2
2979027|NCT01089647|10254687|P1|Overall Study|Lost to Follow-up|2
2979028|NCT01089608|10254695|P2|Overall Study|Lost to Follow-up|2
2979029|NCT01089608|10254696|P1|Overall Study|Lost to Follow-up|0
2979030|NCT01089608|10254695|P2|Overall Study|Adverse Event|4
2979031|NCT01089608|10254696|P1|Overall Study|Adverse Event|0
2979032|NCT01089582|10254713|P1|Overall Study|Withdrawal by Subject|1
2979033|NCT01089582|10254713|P1|Overall Study|Other|4
2979034|NCT01089582|10254713|P1|Overall Study|Lost to Follow-up|8
2979035|NCT01089582|10254713|P1|Overall Study|Adverse Event|15
2979036|NCT01089582|10254713|P1|Overall Study|Death|2
2979037|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
2979038|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
2979039|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2979040|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
2979041|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2979042|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2979043|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
2979044|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
2979045|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
2979046|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
2979047|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
2979048|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
2979049|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
2979050|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
2979051|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
2979052|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
2979053|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
2979054|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
2979055|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2979056|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2979057|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2979058|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
2979059|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2979060|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2979061|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2979062|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
2979063|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
2979064|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2979065|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2979066|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2979067|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2979068|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2979069|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2979070|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2979071|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2979072|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2979073|NCT01089556|10254756|P6|Study Period III (Weeks 9-16)|Adverse Event|3
2979074|NCT01089556|10254757|P5|Study Period III (Weeks 9-16)|Adverse Event|4
2979075|NCT01089556|10254758|P4|Study Period III (Weeks 9-16)|Adverse Event|2
2979076|NCT01089556|10254759|P3|Study Period III (Weeks 9-16)|Adverse Event|4
2979077|NCT01089556|10254760|P2|Study Period III (Weeks 9-16)|Adverse Event|0
2979078|NCT01089556|10254761|P1|Study Period III (Weeks 9-16)|Adverse Event|0
2979079|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
2979080|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
2979081|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
2979082|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
2979083|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
2979084|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
2979085|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2979086|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2979087|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2979088|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2979089|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
2979090|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
2979091|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
2979092|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
2979093|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
2979094|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
2979095|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
2979096|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
2979097|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Physician Decision|0
2979098|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Physician Decision|0
2979099|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Physician Decision|0
2979100|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Physician Decision|0
2979101|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Physician Decision|0
2979102|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Physician Decision|4
2979103|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2979104|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2979105|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2979106|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2979107|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
2979108|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2979109|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2979110|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2979111|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2979112|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2979113|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
2979114|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
2979115|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2979116|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2979117|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2979118|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2979119|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
2979120|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
2979121|NCT01089556|10254756|P6|Study Period II (Weeks 1-8)|Adverse Event|0
2979122|NCT01089556|10254757|P5|Study Period II (Weeks 1-8)|Adverse Event|0
2979123|NCT01089556|10254758|P4|Study Period II (Weeks 1-8)|Adverse Event|0
2979124|NCT01089556|10254759|P3|Study Period II (Weeks 1-8)|Adverse Event|0
2979125|NCT01089556|10254760|P2|Study Period II (Weeks 1-8)|Adverse Event|39
2979126|NCT01089556|10254761|P1|Study Period II (Weeks 1-8)|Adverse Event|35
2979127|NCT01089543|10254835|P4|Overall Study|Adverse Event|0
2979128|NCT01089543|10254836|P3|Overall Study|Adverse Event|0
2979129|NCT01089543|10254837|P2|Overall Study|Adverse Event|1
2979130|NCT01089543|10254838|P1|Overall Study|Adverse Event|0
2979131|NCT01089543|10254835|P4|Overall Study|Physician Decision|1
2979132|NCT01089543|10254836|P3|Overall Study|Physician Decision|0
2979133|NCT01089543|10254837|P2|Overall Study|Physician Decision|0
2979134|NCT01089543|10254838|P1|Overall Study|Physician Decision|1
2979135|NCT01089543|10254835|P4|Overall Study|Withdrawal by Subject|1
2979136|NCT01089543|10254836|P3|Overall Study|Withdrawal by Subject|3
2979137|NCT01089543|10254837|P2|Overall Study|Withdrawal by Subject|3
2979138|NCT01089543|10254838|P1|Overall Study|Withdrawal by Subject|2
2979139|NCT01089504|10254873|P2|Overall Study|Withdrawal by Subject|0
2979140|NCT01089504|10254874|P1|Overall Study|Withdrawal by Subject|2
2979141|NCT01089504|10254873|P2|Overall Study|Lost to Follow-up|1
2979142|NCT01089504|10254874|P1|Overall Study|Lost to Follow-up|1
2979143|NCT01089413|10254887|P1|Overall Study|Other|71
2979144|NCT01089413|10254887|P1|Overall Study|Metastasectomy|13
2979145|NCT01089413|10254887|P1|Overall Study|Death|10
2979146|NCT01089413|10254887|P1|Overall Study|Unacceptable Toxicity|12
2979147|NCT01089413|10254887|P1|Overall Study|Participant Withdrew Consent|1
2979148|NCT01089413|10254887|P1|Overall Study|Progressive Disease|93
2979149|NCT01089413|10254887|P1|Overall Study|Lost to Follow-up|1
2979150|NCT01089361|10254906|P2|Overall Study|Death|0
2979151|NCT01089361|10254907|P1|Overall Study|Death|1
2979152|NCT01089127|10254956|P6|Overall Study|Protocol deviation|0
2979153|NCT01089127|10254957|P5|Overall Study|Protocol deviation|1
2979154|NCT01089127|10254958|P4|Overall Study|Protocol deviation|0
2979155|NCT01089127|10254959|P3|Overall Study|Protocol deviation|0
2979156|NCT01089127|10254960|P2|Overall Study|Protocol deviation|1
2979157|NCT01089127|10254961|P1|Overall Study|Protocol deviation|0
2979158|NCT01089127|10254956|P6|Overall Study|Lost to Follow-up|0
2979159|NCT01089127|10254957|P5|Overall Study|Lost to Follow-up|1
2979160|NCT01089127|10254958|P4|Overall Study|Lost to Follow-up|0
2979161|NCT01089127|10254959|P3|Overall Study|Lost to Follow-up|0
2979162|NCT01089127|10254960|P2|Overall Study|Lost to Follow-up|1
2979163|NCT01089127|10254961|P1|Overall Study|Lost to Follow-up|1
2979164|NCT01089127|10254956|P6|Overall Study|Abnormal test procedure result(s)|0
2979165|NCT01089127|10254957|P5|Overall Study|Abnormal test procedure result(s)|0
2979166|NCT01089127|10254958|P4|Overall Study|Abnormal test procedure result(s)|0
2979167|NCT01089127|10254959|P3|Overall Study|Abnormal test procedure result(s)|0
2979168|NCT01089127|10254960|P2|Overall Study|Abnormal test procedure result(s)|1
2979169|NCT01089127|10254961|P1|Overall Study|Abnormal test procedure result(s)|2
2979170|NCT01089127|10254956|P6|Overall Study|Subject withdrew consent|2
2979171|NCT01089127|10254957|P5|Overall Study|Subject withdrew consent|0
2979172|NCT01089127|10254958|P4|Overall Study|Subject withdrew consent|1
2979173|NCT01089127|10254959|P3|Overall Study|Subject withdrew consent|1
2979174|NCT01089127|10254960|P2|Overall Study|Subject withdrew consent|1
2979175|NCT01089127|10254961|P1|Overall Study|Subject withdrew consent|0
2979176|NCT01089127|10254956|P6|Overall Study|Adverse Event|1
2979177|NCT01089127|10254957|P5|Overall Study|Adverse Event|0
2979178|NCT01089127|10254958|P4|Overall Study|Adverse Event|0
2979179|NCT01089127|10254959|P3|Overall Study|Adverse Event|1
2979180|NCT01089127|10254960|P2|Overall Study|Adverse Event|1
2979181|NCT01089127|10254961|P1|Overall Study|Adverse Event|5
2979182|NCT01089023|10255015|P1|Overall Study|Lack of Efficacy|1
2979183|NCT01089023|10255015|P1|Overall Study|Protocol Violation|1
2979184|NCT01089023|10255015|P1|Overall Study|Withdrawal by Subject|1
2979185|NCT01089023|10255015|P1|Overall Study|Adverse Event|1
2979186|NCT01089023|10255015|P1|Overall Study|Lost to Follow-up|3
2979187|NCT01088997|10255029|P2|Overall Study|Excluded prior to receiving drug|1
2979188|NCT01088997|10255030|P1|Overall Study|Excluded prior to receiving drug|1
2979189|NCT01088997|10255029|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
2979190|NCT01088997|10255030|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
2979191|NCT01088997|10255029|P2|Overall Study|Physician Decision|1
2979192|NCT01088997|10255030|P1|Overall Study|Physician Decision|1
2979193|NCT01088984|10255041|P2|Phase 2|Other|1
2979194|NCT01088984|10255042|P1|Phase 2|Other|0
2979195|NCT01088984|10255041|P2|Phase 2|DIsease Progression|25
2979196|NCT01088984|10255042|P1|Phase 2|DIsease Progression|0
2979197|NCT01088984|10255041|P2|Phase 2|Withdrawal by Subject|1
2979198|NCT01088984|10255042|P1|Phase 2|Withdrawal by Subject|0
2979199|NCT01088984|10255041|P2|Phase 2|Death|5
2979200|NCT01088984|10255042|P1|Phase 2|Death|0
2979201|NCT01088984|10255041|P2|Phase 1|Other|1
2979202|NCT01088984|10255042|P1|Phase 1|Other|1
2979203|NCT01088984|10255041|P2|Phase 1|Disease Progression|4
2979204|NCT01088984|10255042|P1|Phase 1|Disease Progression|2
2979205|NCT01088984|10255041|P2|Phase 1|Death|1
2979206|NCT01088984|10255042|P1|Phase 1|Death|2
2979207|NCT01088529|10255112|P2|Overall Study|Did not receive study treatment|1
2979208|NCT01088529|10255113|P1|Overall Study|Did not receive study treatment|0
2979209|NCT01088503|10255126|P3|Overall Study|Death|7
2979210|NCT01088503|10255127|P2|Overall Study|Death|358
2979211|NCT01088503|10255128|P1|Overall Study|Death|64
2979212|NCT01088503|10255126|P3|Overall Study|Withdrawal by Subject|10
2979213|NCT01088503|10255127|P2|Overall Study|Withdrawal by Subject|327
2979214|NCT01088503|10255128|P1|Overall Study|Withdrawal by Subject|118
2979215|NCT01088438|10255206|P2|Overall Study|Lost to Follow-up|30
2979216|NCT01088438|10255207|P1|Overall Study|Lost to Follow-up|18
2979217|NCT01088438|10255206|P2|Overall Study|Withdrawal by Subject|6
2979218|NCT01088438|10255207|P1|Overall Study|Withdrawal by Subject|11
2979219|NCT01088412|10255220|P3|Overall Study|Study Summary Not Completed|22
2979220|NCT01088412|10255221|P2|Overall Study|Study Summary Not Completed|64
2979221|NCT01088412|10255222|P1|Overall Study|Study Summary Not Completed|4360
2979222|NCT01088412|10255220|P3|Overall Study|Lost to Follow-up|11
2979223|NCT01088412|10255221|P2|Overall Study|Lost to Follow-up|130
2979224|NCT01088412|10255222|P1|Overall Study|Lost to Follow-up|3052
2979225|NCT01088412|10255220|P3|Overall Study|Third Party Required to Change Brand|0
2979226|NCT01088412|10255221|P2|Overall Study|Third Party Required to Change Brand|0
2979227|NCT01088412|10255222|P1|Overall Study|Third Party Required to Change Brand|487
2979228|NCT01088412|10255220|P3|Overall Study|Sponsor Decision|23
2979229|NCT01088412|10255221|P2|Overall Study|Sponsor Decision|79
2979230|NCT01088412|10255222|P1|Overall Study|Sponsor Decision|4467
2979231|NCT01088412|10255220|P3|Overall Study|Physician Decision|4
2979232|NCT01088412|10255221|P2|Overall Study|Physician Decision|8
2979233|NCT01088412|10255222|P1|Overall Study|Physician Decision|1041
2979234|NCT01088412|10255220|P3|Overall Study|Participant Moved|2
2979235|NCT01088412|10255221|P2|Overall Study|Participant Moved|21
2979236|NCT01088412|10255222|P1|Overall Study|Participant Moved|601
2979237|NCT01088412|10255220|P3|Overall Study|Received Another GH Product|0
2979238|NCT01088412|10255221|P2|Overall Study|Received Another GH Product|0
2979239|NCT01088412|10255222|P1|Overall Study|Received Another GH Product|79
2979240|NCT01088412|10255220|P3|Overall Study|Withdrawal by Subject|1
2979241|NCT01088412|10255221|P2|Overall Study|Withdrawal by Subject|25
2979242|NCT01088412|10255222|P1|Overall Study|Withdrawal by Subject|1761
2979243|NCT01088412|10255220|P3|Overall Study|Other Reason per Case Report Form|9
2979244|NCT01088412|10255221|P2|Overall Study|Other Reason per Case Report Form|103
2979245|NCT01088412|10255222|P1|Overall Study|Other Reason per Case Report Form|2089
2979246|NCT01088412|10255220|P3|Overall Study|Death|0
2979247|NCT01088412|10255221|P2|Overall Study|Death|6
2979248|NCT01088412|10255222|P1|Overall Study|Death|42
2979249|NCT01088412|10255220|P3|Overall Study|Adverse Event|0
2979250|NCT01088412|10255221|P2|Overall Study|Adverse Event|0
2979251|NCT01088412|10255222|P1|Overall Study|Adverse Event|38
2979252|NCT01088399|10255241|P3|Overall Study|Study summary visit not completed|80
2979253|NCT01088399|10255242|P2|Overall Study|Study summary visit not completed|283
2979254|NCT01088399|10255243|P1|Overall Study|Study summary visit not completed|2398
2979255|NCT01088399|10255241|P3|Overall Study|Enrollment criteria not met|70
2979256|NCT01088399|10255242|P2|Overall Study|Enrollment criteria not met|119
2979257|NCT01088399|10255243|P1|Overall Study|Enrollment criteria not met|48
2979258|NCT01088399|10255241|P3|Overall Study|Protocol Violation|0
2979259|NCT01088399|10255242|P2|Overall Study|Protocol Violation|1
2979260|NCT01088399|10255243|P1|Overall Study|Protocol Violation|10
2979261|NCT01088399|10255241|P3|Overall Study|Sponsor decision|7
2979262|NCT01088399|10255242|P2|Overall Study|Sponsor decision|298
2979263|NCT01088399|10255243|P1|Overall Study|Sponsor decision|1573
2979264|NCT01088399|10255241|P3|Overall Study|Change to or start of somatropin therapy|12
2979265|NCT01088399|10255242|P2|Overall Study|Change to or start of somatropin therapy|17
2979266|NCT01088399|10255243|P1|Overall Study|Change to or start of somatropin therapy|234
2979267|NCT01088399|10255241|P3|Overall Study|Withdrawal by Subject|33
2979268|NCT01088399|10255242|P2|Overall Study|Withdrawal by Subject|195
2979269|NCT01088399|10255243|P1|Overall Study|Withdrawal by Subject|544
2979270|NCT01088399|10255241|P3|Overall Study|Physician Decision|16
2979271|NCT01088399|10255242|P2|Overall Study|Physician Decision|88
2979272|NCT01088399|10255243|P1|Overall Study|Physician Decision|531
2979273|NCT01088399|10255241|P3|Overall Study|Lost to Follow-up|58
2979274|NCT01088399|10255242|P2|Overall Study|Lost to Follow-up|278
2979275|NCT01088399|10255243|P1|Overall Study|Lost to Follow-up|1070
2979276|NCT01088399|10255241|P3|Overall Study|Lack of Efficacy|5
2979277|NCT01088399|10255242|P2|Overall Study|Lack of Efficacy|7
2979278|NCT01088399|10255243|P1|Overall Study|Lack of Efficacy|298
2979279|NCT01088399|10255241|P3|Overall Study|Death|0
2979280|NCT01088399|10255242|P2|Overall Study|Death|45
2979281|NCT01088399|10255243|P1|Overall Study|Death|204
2979282|NCT01088399|10255241|P3|Overall Study|Adverse Event|0
2979283|NCT01088399|10255242|P2|Overall Study|Adverse Event|16
2979284|NCT01088399|10255243|P1|Overall Study|Adverse Event|211
2979285|NCT01088243|10255272|P2|Overall Study|Adverse Event|0
2979286|NCT01088243|10255273|P1|Overall Study|Adverse Event|1
2979287|NCT01087970|10255314|P1|Overall Study|Protocol Violation|2
2979288|NCT01087957|10255326|P2|Overall Study|Physician Decision|9
2979289|NCT01087957|10255327|P1|Overall Study|Physician Decision|5
2979290|NCT01087957|10255326|P2|Overall Study|Withdrawal by Subject|15
2979291|NCT01087957|10255327|P1|Overall Study|Withdrawal by Subject|18
2979292|NCT01087957|10255326|P2|Overall Study|Protocol Violation|25
2979293|NCT01087957|10255327|P1|Overall Study|Protocol Violation|13
2979294|NCT01087957|10255326|P2|Overall Study|Lost to Follow-up|4
2979295|NCT01087957|10255327|P1|Overall Study|Lost to Follow-up|3
2979296|NCT01087957|10255326|P2|Overall Study|Death|2
2979297|NCT01087957|10255327|P1|Overall Study|Death|2
2979298|NCT01087944|10255353|P2|Period 2 (Week 4-6)|Adverse Event|2
2979299|NCT01087944|10255354|P1|Period 2 (Week 4-6)|Adverse Event|0
2979300|NCT01087944|10255353|P2|Period 1 (Week 1-3)|Adverse Event|0
2979301|NCT01087944|10255354|P1|Period 1 (Week 1-3)|Adverse Event|1
2979302|NCT01087905|10255434|P8|Overall Study|Withdrawal by Subject|5
2979303|NCT01087905|10255435|P7|Overall Study|Withdrawal by Subject|3
2979304|NCT01087905|10255436|P6|Overall Study|Withdrawal by Subject|3
2979305|NCT01087905|10255437|P5|Overall Study|Withdrawal by Subject|4
2979306|NCT01087905|10255438|P4|Overall Study|Withdrawal by Subject|5
2979307|NCT01087905|10255439|P3|Overall Study|Withdrawal by Subject|4
2979308|NCT01087905|10255440|P2|Overall Study|Withdrawal by Subject|4
2979309|NCT01087905|10255441|P1|Overall Study|Withdrawal by Subject|5
2979310|NCT01087905|10255434|P8|Overall Study|Lost to Follow-up|24
2979311|NCT01087905|10255435|P7|Overall Study|Lost to Follow-up|20
2979312|NCT01087905|10255436|P6|Overall Study|Lost to Follow-up|25
2979313|NCT01087905|10255437|P5|Overall Study|Lost to Follow-up|27
2979314|NCT01087905|10255438|P4|Overall Study|Lost to Follow-up|31
2979315|NCT01087905|10255439|P3|Overall Study|Lost to Follow-up|18
2979316|NCT01087905|10255440|P2|Overall Study|Lost to Follow-up|28
2979317|NCT01087905|10255441|P1|Overall Study|Lost to Follow-up|24
2979318|NCT01087814|10255463|P2|Second Intervention (5 Days)|Physician Decision|0
2979319|NCT01087814|10255464|P1|Second Intervention (5 Days)|Physician Decision|1
2979320|NCT01087814|10255463|P2|First Intervention (5 Days)|Withdrawal by Subject|1
2979321|NCT01087814|10255464|P1|First Intervention (5 Days)|Withdrawal by Subject|3
2979322|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Personal reasons|1
2979323|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Personal reasons|0
2979324|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Personal reasons|0
2979325|NCT01087788|10255482|P3|Open-Label Period (OL-P)|No participation in study extension|1
2979326|NCT01087788|10255483|P2|Open-Label Period (OL-P)|No participation in study extension|0
2979327|NCT01087788|10255484|P1|Open-Label Period (OL-P)|No participation in study extension|0
2979328|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Principal investigator decision|2
2979329|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Principal investigator decision|1
2979330|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Principal investigator decision|0
2979331|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Sponsor request|0
2979332|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Sponsor request|0
2979333|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Sponsor request|1
2979334|NCT01087788|10255482|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
2979335|NCT01087788|10255483|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
2979336|NCT01087788|10255484|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
2979337|NCT01087788|10255482|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2979338|NCT01087788|10255483|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
2979339|NCT01087788|10255484|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2979340|NCT01087788|10255482|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2979341|NCT01087788|10255483|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2979342|NCT01087788|10255484|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
2979343|NCT01087788|10255482|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
2979344|NCT01087788|10255483|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
2979345|NCT01087788|10255484|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
2979346|NCT01087788|10255482|P3|Open-Label Period (OL-P)|AE, serious fatal|1
2979347|NCT01087788|10255483|P2|Open-Label Period (OL-P)|AE, serious fatal|0
2979348|NCT01087788|10255484|P1|Open-Label Period (OL-P)|AE, serious fatal|2
2979349|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
2979350|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
2979351|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
2979352|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
2979353|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
2979354|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
2979355|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Protocol Violation|0
2979356|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Protocol Violation|1
2979357|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Protocol Violation|2
2979358|NCT01087788|10255482|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
2979359|NCT01087788|10255483|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
2979360|NCT01087788|10255484|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
2979361|NCT01087788|10255482|P3|24-weeks Dose-blind Period|Patient moved|1
2979362|NCT01087788|10255483|P2|24-weeks Dose-blind Period|Patient moved|0
2979363|NCT01087788|10255484|P1|24-weeks Dose-blind Period|Patient moved|0
2979364|NCT01087788|10255482|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2979365|NCT01087788|10255483|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2979366|NCT01087788|10255484|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
2979367|NCT01087788|10255482|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2979368|NCT01087788|10255483|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2979369|NCT01087788|10255484|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
2979370|NCT01087788|10255482|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
2979371|NCT01087788|10255483|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
2979372|NCT01087788|10255484|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
2979373|NCT01087788|10255482|P3|24-weeks Dose-blind Period|AE, serious fatal|0
2979374|NCT01087788|10255483|P2|24-weeks Dose-blind Period|AE, serious fatal|1
2979375|NCT01087788|10255484|P1|24-weeks Dose-blind Period|AE, serious fatal|0
2979376|NCT01087788|10255482|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
2979377|NCT01087788|10255483|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
2979378|NCT01087788|10255484|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
2979379|NCT01087788|10255482|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
2979380|NCT01087788|10255483|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
2979381|NCT01087788|10255484|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
2979382|NCT01087788|10255482|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
2979383|NCT01087788|10255483|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
2979384|NCT01087788|10255484|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
2979385|NCT01087788|10255482|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
2979386|NCT01087788|10255483|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2979387|NCT01087788|10255484|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2979388|NCT01087788|10255482|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
2979389|NCT01087788|10255483|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
2979390|NCT01087788|10255484|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
2979391|NCT01087788|10255482|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2979392|NCT01087788|10255483|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
2979393|NCT01087788|10255484|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2979394|NCT01087788|10255482|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2979395|NCT01087788|10255483|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2979396|NCT01087788|10255484|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
2979397|NCT01087788|10255482|P3|24-weeks Double-blind Period|AE, unknown type|1
2979398|NCT01087788|10255483|P2|24-weeks Double-blind Period|AE, unknown type|0
2979399|NCT01087788|10255484|P1|24-weeks Double-blind Period|AE, unknown type|0
2979400|NCT01087788|10255482|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2979401|NCT01087788|10255483|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
2979402|NCT01087788|10255484|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2979403|NCT01087788|10255482|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
2979404|NCT01087788|10255483|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
2979405|NCT01087788|10255484|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
2979406|NCT01087788|10255482|P3|24-weeks Double-blind Period|AE, serious fatal|1
2979407|NCT01087788|10255483|P2|24-weeks Double-blind Period|AE, serious fatal|1
2979408|NCT01087788|10255484|P1|24-weeks Double-blind Period|AE, serious fatal|0
2979409|NCT01087788|10255482|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
2979410|NCT01087788|10255483|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
2979411|NCT01087788|10255484|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
2979412|NCT01087788|10255482|P3|24-weeks Double-blind Period|Lost to Follow-up|1
2979413|NCT01087788|10255483|P2|24-weeks Double-blind Period|Lost to Follow-up|1
2979414|NCT01087788|10255484|P1|24-weeks Double-blind Period|Lost to Follow-up|4
2979415|NCT01087788|10255482|P3|24-weeks Double-blind Period|Protocol Violation|0
2979416|NCT01087788|10255483|P2|24-weeks Double-blind Period|Protocol Violation|1
2979417|NCT01087788|10255484|P1|24-weeks Double-blind Period|Protocol Violation|0
2979418|NCT01087788|10255482|P3|24-weeks Double-blind Period|Lack of Efficacy|1
2979419|NCT01087788|10255483|P2|24-weeks Double-blind Period|Lack of Efficacy|0
2979420|NCT01087788|10255484|P1|24-weeks Double-blind Period|Lack of Efficacy|2
2979421|NCT01087775|10255511|P1|Overall Study|failed inclusion criteria|2
2979422|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
2979423|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
2979424|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2979425|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2979426|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2979427|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
2979428|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
2979429|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2979430|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2979431|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2979432|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
2979433|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
2979434|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2979435|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2979436|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2979437|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|Other|4
2979438|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|Other|2
2979439|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|Other|0
2979440|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|Other|0
2979441|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|Other|0
2979442|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
2979443|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
2979444|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2979445|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2979446|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2979447|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
2979448|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
2979449|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2979450|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2979451|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2979452|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2979453|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2979454|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2979455|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2979456|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2979457|NCT01087762|10255519|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
2979458|NCT01087762|10255520|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
2979459|NCT01087762|10255521|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2979460|NCT01087762|10255522|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2979461|NCT01087762|10255523|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2979462|NCT01087762|10255519|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2979463|NCT01087762|10255520|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2979464|NCT01087762|10255521|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
2979465|NCT01087762|10255522|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2979466|NCT01087762|10255523|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2979467|NCT01087762|10255519|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2979468|NCT01087762|10255520|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2979469|NCT01087762|10255521|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2979470|NCT01087762|10255522|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
2979471|NCT01087762|10255523|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2979472|NCT01087762|10255519|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2979473|NCT01087762|10255520|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2979474|NCT01087762|10255521|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2979475|NCT01087762|10255522|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
2979476|NCT01087762|10255523|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2979477|NCT01087762|10255519|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2979478|NCT01087762|10255520|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2979479|NCT01087762|10255521|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
2979480|NCT01087762|10255522|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2979481|NCT01087762|10255523|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
2979482|NCT01087762|10255519|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2979483|NCT01087762|10255520|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2979484|NCT01087762|10255521|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
2979485|NCT01087762|10255522|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2979486|NCT01087762|10255523|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
2979487|NCT01087736|10255571|P2|Overall Study|Withdrawal by Subject|1
2979488|NCT01087736|10255572|P1|Overall Study|Withdrawal by Subject|0
2979489|NCT01087736|10255571|P2|Overall Study|Death|1
2979490|NCT01087736|10255572|P1|Overall Study|Death|0
2979491|NCT01087736|10255571|P2|Overall Study|Lost to Follow-up|0
2979492|NCT01087736|10255572|P1|Overall Study|Lost to Follow-up|1
2979493|NCT01087723|10255582|P2|Overall Study|Reason Not Specified|2
2979494|NCT01087723|10255583|P1|Overall Study|Reason Not Specified|1
2979495|NCT01087723|10255582|P2|Overall Study|Lost to Follow-up|4
2979496|NCT01087723|10255583|P1|Overall Study|Lost to Follow-up|1
2979497|NCT01087723|10255582|P2|Overall Study|Physician Decision|0
2979498|NCT01087723|10255583|P1|Overall Study|Physician Decision|2
2979499|NCT01087723|10255582|P2|Overall Study|Withdrawal by Subject|13
2979500|NCT01087723|10255583|P1|Overall Study|Withdrawal by Subject|10
2979501|NCT01087723|10255582|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
2979502|NCT01087723|10255583|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
2979503|NCT01087528|10255624|P1|Overall Study|Incomplete CE procedure|6
2979504|NCT01087528|10255624|P1|Overall Study|Withdrawal by Subject|1
2979505|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
2979506|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
2979507|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
2979508|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
2979509|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
2979510|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
2979511|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
2979512|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
2979513|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
2979514|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
2979515|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
2979516|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
2979517|NCT01087502|10255630|P2|Up to Final Analysis (Week 52)|Adverse Event|10
2979518|NCT01087502|10255631|P1|Up to Final Analysis (Week 52)|Adverse Event|17
2979519|NCT01087502|10255630|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
2979520|NCT01087502|10255631|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
2979521|NCT01087502|10255630|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
2979522|NCT01087502|10255631|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
2979523|NCT01087502|10255630|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2979524|NCT01087502|10255631|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2979525|NCT01087502|10255630|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
2979526|NCT01087502|10255631|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
2979527|NCT01087502|10255630|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
2979528|NCT01087502|10255631|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
2979529|NCT01087489|10255650|P2|Overall Study|unable to survey by telephone|1
2979530|NCT01087489|10255651|P1|Overall Study|unable to survey by telephone|0
2979531|NCT01087489|10255650|P2|Overall Study|Death|1
2979532|NCT01087489|10255651|P1|Overall Study|Death|0
2979533|NCT01087489|10255650|P2|Overall Study|enrolled in another VA study|1
2979534|NCT01087489|10255651|P1|Overall Study|enrolled in another VA study|0
2979535|NCT01086969|10255664|P3|Overall Study|Withdrawal by Subject|0
2979536|NCT01086969|10255665|P2|Overall Study|Withdrawal by Subject|2
2979537|NCT01086969|10255666|P1|Overall Study|Withdrawal by Subject|1
2979538|NCT01086423|10255776|P3|Overall Study|Lost to Follow-up|1
2979539|NCT01086423|10255777|P2|Overall Study|Lost to Follow-up|0
2979540|NCT01086423|10255778|P1|Overall Study|Lost to Follow-up|0
2979541|NCT01086423|10255776|P3|Overall Study|Withdrawal by Subject|3
2979542|NCT01086423|10255777|P2|Overall Study|Withdrawal by Subject|1
2979543|NCT01086423|10255778|P1|Overall Study|Withdrawal by Subject|5
2979544|NCT01086423|10255776|P3|Overall Study|Adverse event, non-fatal|0
2979545|NCT01086423|10255777|P2|Overall Study|Adverse event, non-fatal|1
2979546|NCT01086423|10255778|P1|Overall Study|Adverse event, non-fatal|2
2979547|NCT01086423|10255776|P3|Overall Study|Adverse event, fatal|0
2979548|NCT01086423|10255777|P2|Overall Study|Adverse event, fatal|1
2979549|NCT01086423|10255778|P1|Overall Study|Adverse event, fatal|1
2979550|NCT01086423|10255776|P3|Overall Study|Migrated/moved from study area|4
2979551|NCT01086423|10255777|P2|Overall Study|Migrated/moved from study area|0
2979552|NCT01086423|10255778|P1|Overall Study|Migrated/moved from study area|2
2979553|NCT01086423|10255776|P3|Overall Study|Protocol Violation|1
2979554|NCT01086423|10255777|P2|Overall Study|Protocol Violation|0
2979555|NCT01086423|10255778|P1|Overall Study|Protocol Violation|0
2979556|NCT01086410|10255823|P4|Overall Study|Lost to Follow-up|0
2979557|NCT01086410|10255824|P3|Overall Study|Lost to Follow-up|1
2979558|NCT01086410|10255825|P2|Overall Study|Lost to Follow-up|0
2979559|NCT01086410|10255826|P1|Overall Study|Lost to Follow-up|0
2979560|NCT01086410|10255823|P4|Overall Study|Protocol Violation|0
2979561|NCT01086410|10255824|P3|Overall Study|Protocol Violation|0
2979562|NCT01086410|10255825|P2|Overall Study|Protocol Violation|1
2979563|NCT01086410|10255826|P1|Overall Study|Protocol Violation|1
2979564|NCT01086410|10255823|P4|Overall Study|Lack of Efficacy|0
2979565|NCT01086410|10255824|P3|Overall Study|Lack of Efficacy|0
2979566|NCT01086410|10255825|P2|Overall Study|Lack of Efficacy|1
2979567|NCT01086410|10255826|P1|Overall Study|Lack of Efficacy|1
2979568|NCT01086410|10255823|P4|Overall Study|Adverse Event|2
2979569|NCT01086410|10255824|P3|Overall Study|Adverse Event|0
2979570|NCT01086410|10255825|P2|Overall Study|Adverse Event|0
2979571|NCT01086410|10255826|P1|Overall Study|Adverse Event|1
2979572|NCT01086384|10255922|P3|Treatment Period|Received Treatment in Error|0
2979573|NCT01086384|10255923|P2|Treatment Period|Received Treatment in Error|1
2979574|NCT01086384|10255924|P1|Treatment Period|Received Treatment in Error|0
2979575|NCT01086384|10255922|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
2979576|NCT01086384|10255923|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
2979577|NCT01086384|10255924|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
2979578|NCT01086384|10255922|P3|Treatment Period|Study Closed/Terminated|8
2979579|NCT01086384|10255923|P2|Treatment Period|Study Closed/Terminated|7
2979580|NCT01086384|10255924|P1|Treatment Period|Study Closed/Terminated|0
2979581|NCT01086384|10255922|P3|Treatment Period|Physician Decision|6
2979582|NCT01086384|10255923|P2|Treatment Period|Physician Decision|9
2979583|NCT01086384|10255924|P1|Treatment Period|Physician Decision|0
2979584|NCT01086384|10255922|P3|Treatment Period|Lost to Follow-up|9
2979585|NCT01086384|10255923|P2|Treatment Period|Lost to Follow-up|11
2979586|NCT01086384|10255924|P1|Treatment Period|Lost to Follow-up|0
2979587|NCT01086384|10255922|P3|Treatment Period|Adverse Event|15
2979588|NCT01086384|10255923|P2|Treatment Period|Adverse Event|19
2979589|NCT01086384|10255924|P1|Treatment Period|Adverse Event|0
2979590|NCT01086384|10255922|P3|Treatment Period|Lack of Efficacy|13
2979591|NCT01086384|10255923|P2|Treatment Period|Lack of Efficacy|22
2979592|NCT01086384|10255924|P1|Treatment Period|Lack of Efficacy|0
2979593|NCT01086384|10255922|P3|Treatment Period|Protocol Violation|17
2979594|NCT01086384|10255923|P2|Treatment Period|Protocol Violation|26
2979595|NCT01086384|10255924|P1|Treatment Period|Protocol Violation|0
2979596|NCT01086384|10255922|P3|Treatment Period|Withdrawal by Subject|55
2979597|NCT01086384|10255923|P2|Treatment Period|Withdrawal by Subject|53
2979598|NCT01086384|10255924|P1|Treatment Period|Withdrawal by Subject|0
2979599|NCT01086384|10255922|P3|2-week Run-in Period|Randomized in Error|0
2979600|NCT01086384|10255923|P2|2-week Run-in Period|Randomized in Error|0
2979601|NCT01086384|10255924|P1|2-week Run-in Period|Randomized in Error|1
2979602|NCT01086384|10255922|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2979603|NCT01086384|10255923|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2979604|NCT01086384|10255924|P1|2-week Run-in Period|Continuation Criteria Not Met|92
2979605|NCT01086384|10255922|P3|2-week Run-in Period|Study Closed/Terminated|0
2979606|NCT01086384|10255923|P2|2-week Run-in Period|Study Closed/Terminated|0
2979607|NCT01086384|10255924|P1|2-week Run-in Period|Study Closed/Terminated|42
2979608|NCT01086384|10255922|P3|2-week Run-in Period|Withdrawal by Subject|0
2979609|NCT01086384|10255923|P2|2-week Run-in Period|Withdrawal by Subject|0
2979610|NCT01086384|10255924|P1|2-week Run-in Period|Withdrawal by Subject|19
2979611|NCT01086384|10255922|P3|2-week Run-in Period|Physician Decision|0
2979612|NCT01086384|10255923|P2|2-week Run-in Period|Physician Decision|0
2979613|NCT01086384|10255924|P1|2-week Run-in Period|Physician Decision|6
2979614|NCT01086384|10255922|P3|2-week Run-in Period|Lost to Follow-up|0
2979615|NCT01086384|10255923|P2|2-week Run-in Period|Lost to Follow-up|0
2979616|NCT01086384|10255924|P1|2-week Run-in Period|Lost to Follow-up|1
2979617|NCT01086384|10255922|P3|2-week Run-in Period|Protocol Violation|0
2979618|NCT01086384|10255923|P2|2-week Run-in Period|Protocol Violation|0
2979619|NCT01086384|10255924|P1|2-week Run-in Period|Protocol Violation|1
2979620|NCT01086384|10255922|P3|2-week Run-in Period|Adverse Event|0
2979621|NCT01086384|10255923|P2|2-week Run-in Period|Adverse Event|0
2979622|NCT01086384|10255924|P1|2-week Run-in Period|Adverse Event|1
2979623|NCT01086358|10255934|P2|Second Intervention|Lost to Follow-up|4
2979624|NCT01086358|10255935|P1|Second Intervention|Lost to Follow-up|4
2979625|NCT01086358|10255934|P2|First Intervention|Withdrawal by Subject|1
2979626|NCT01086358|10255935|P1|First Intervention|Withdrawal by Subject|0
2979627|NCT01086358|10255934|P2|First Intervention|Lost to Follow-up|4
2979628|NCT01086358|10255935|P1|First Intervention|Lost to Follow-up|9
2979629|NCT01086215|10256005|P4|Overall Study|Lost to Follow-up|2
2979630|NCT01086215|10256006|P3|Overall Study|Lost to Follow-up|18
2979631|NCT01086215|10256007|P2|Overall Study|Lost to Follow-up|39
2979632|NCT01086215|10256008|P1|Overall Study|Lost to Follow-up|22
2979633|NCT01086215|10256005|P4|Overall Study|Death|1
2979634|NCT01086215|10256006|P3|Overall Study|Death|8
2979635|NCT01086215|10256007|P2|Overall Study|Death|8
2979636|NCT01086215|10256008|P1|Overall Study|Death|14
2979637|NCT01086033|10256026|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
2979638|NCT01086033|10256026|P1|Overall Study|AE and Other Reason|1
2979639|NCT01086033|10256026|P1|Overall Study|AE and Lost to Follow-up|1
2979640|NCT01086033|10256026|P1|Overall Study|Death|1
2979641|NCT01086033|10256026|P1|Overall Study|AE and Lack of Efficacy|4
2979642|NCT01086033|10256026|P1|Overall Study|Withdrew consent and Other Reason|4
2979643|NCT01086033|10256026|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
2979644|NCT01086033|10256026|P1|Overall Study|AE and Withdrew Consent|5
2979645|NCT01086033|10256026|P1|Overall Study|Other|13
2979646|NCT01086033|10256026|P1|Overall Study|Other|14
2979647|NCT01086033|10256026|P1|Overall Study|Withdrawal by Subject|41
2979648|NCT01086033|10256026|P1|Overall Study|Adverse Event|42
2979649|NCT01086033|10256026|P1|Overall Study|Lost to Follow-up|86
2979650|NCT01086033|10256026|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
2979651|NCT01085812|10256092|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
2979652|NCT01085812|10256093|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
2979653|NCT01085812|10256092|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
2979654|NCT01085812|10256093|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
2979655|NCT01085812|10256092|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
2979656|NCT01085812|10256093|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
2979657|NCT01085812|10256092|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
2979658|NCT01085812|10256093|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
2979659|NCT01085812|10256092|P2|Double-blind Intent-to-treat Population|Adverse Event|8
2979660|NCT01085812|10256093|P1|Double-blind Intent-to-treat Population|Adverse Event|3
2979661|NCT01085812|10256092|P2|Double-Blind Period|Other Reasons|2
2979662|NCT01085812|10256093|P1|Double-Blind Period|Other Reasons|0
2979663|NCT01085812|10256092|P2|Double-Blind Period|Lost to Follow-up|17
2979664|NCT01085812|10256093|P1|Double-Blind Period|Lost to Follow-up|5
2979665|NCT01085812|10256092|P2|Double-Blind Period|Withdrawal by Subject|24
2979666|NCT01085812|10256093|P1|Double-Blind Period|Withdrawal by Subject|11
2979667|NCT01085812|10256092|P2|Double-Blind Period|Protocol Violation|7
2979668|NCT01085812|10256093|P1|Double-Blind Period|Protocol Violation|2
2979669|NCT01085812|10256092|P2|Double-Blind Period|Adverse Event|8
2979670|NCT01085812|10256093|P1|Double-Blind Period|Adverse Event|3
2979671|NCT01085812|10256092|P2|Open-Label Period|Lost to Follow-up|42
2979672|NCT01085812|10256093|P1|Open-Label Period|Lost to Follow-up|0
2979673|NCT01085812|10256092|P2|Open-Label Period|Withdrawal by Subject|53
2979674|NCT01085812|10256093|P1|Open-Label Period|Withdrawal by Subject|0
2979675|NCT01085812|10256092|P2|Open-Label Period|Protocol Violation|39
2979676|NCT01085812|10256093|P1|Open-Label Period|Protocol Violation|0
2979677|NCT01085812|10256092|P2|Open-Label Period|Lack of Efficacy|26
2979678|NCT01085812|10256093|P1|Open-Label Period|Lack of Efficacy|0
2979679|NCT01085812|10256092|P2|Open-Label Period|Adverse Event|80
2979680|NCT01085812|10256093|P1|Open-Label Period|Adverse Event|0
2979681|NCT01085734|10256140|P2|Overall Study|Withdrawal by Subject|1
2979682|NCT01085734|10256141|P1|Overall Study|Withdrawal by Subject|0
2979683|NCT01085734|10256140|P2|Overall Study|Lost to Follow-up|1
2979684|NCT01085734|10256141|P1|Overall Study|Lost to Follow-up|0
2979685|NCT01085734|10256140|P2|Overall Study|Death|0
2979686|NCT01085734|10256141|P1|Overall Study|Death|1
2979687|NCT01085734|10256140|P2|Overall Study|Adverse Event|2
2979688|NCT01085734|10256141|P1|Overall Study|Adverse Event|0
2979689|NCT01085682|10256153|P2|Overall Study|Withdrawal by Subject|25
2979690|NCT01085682|10256154|P1|Overall Study|Withdrawal by Subject|25
2979691|NCT01085630|10256171|P2|Overall Study|Ineligible|0
2979692|NCT01085630|10256172|P1|Overall Study|Ineligible|3
2979693|NCT01085630|10256171|P2|Overall Study|Insufficient data|0
2979694|NCT01085630|10256172|P1|Overall Study|Insufficient data|1
2979695|NCT01085591|10256185|P3|Overall Study|Not Properly Consented|0
2979696|NCT01085591|10256186|P2|Overall Study|Not Properly Consented|0
2979697|NCT01085591|10256187|P1|Overall Study|Not Properly Consented|1
2979698|NCT01085591|10256185|P3|Overall Study|Other|0
2979699|NCT01085591|10256186|P2|Overall Study|Other|1
2979700|NCT01085591|10256187|P1|Overall Study|Other|0
2979701|NCT01085591|10256185|P3|Overall Study|Protocol Violation|1
2979702|NCT01085591|10256186|P2|Overall Study|Protocol Violation|1
2979703|NCT01085591|10256187|P1|Overall Study|Protocol Violation|1
2979704|NCT01085591|10256185|P3|Overall Study|Lost to Follow-up|1
2979705|NCT01085591|10256186|P2|Overall Study|Lost to Follow-up|1
2979706|NCT01085591|10256187|P1|Overall Study|Lost to Follow-up|0
2979707|NCT01085591|10256185|P3|Overall Study|Withdrawal by Subject|1
2979708|NCT01085591|10256186|P2|Overall Study|Withdrawal by Subject|2
2979709|NCT01085591|10256187|P1|Overall Study|Withdrawal by Subject|0
2979710|NCT01085591|10256185|P3|Overall Study|Physician Decision|1
2979711|NCT01085591|10256186|P2|Overall Study|Physician Decision|0
2979712|NCT01085591|10256187|P1|Overall Study|Physician Decision|1
2979713|NCT01085591|10256185|P3|Overall Study|Adverse Event|3
2979714|NCT01085591|10256186|P2|Overall Study|Adverse Event|1
2979715|NCT01085591|10256187|P1|Overall Study|Adverse Event|0
2979716|NCT01085357|10256238|P2|Overall Study|Lost to Follow-up|0
2979717|NCT01085357|10256239|P1|Overall Study|Lost to Follow-up|2
2979718|NCT01085357|10256238|P2|Overall Study|Death|1
2979719|NCT01085357|10256239|P1|Overall Study|Death|11
2979720|NCT01085357|10256238|P2|Overall Study|Investigator Decision|1
2979721|NCT01085357|10256239|P1|Overall Study|Investigator Decision|1
2979722|NCT01085357|10256238|P2|Overall Study|Subject Decision|3
2979723|NCT01085357|10256239|P1|Overall Study|Subject Decision|4
2979724|NCT01085357|10256238|P2|Overall Study|Adverse Event|1
2979725|NCT01085357|10256239|P1|Overall Study|Adverse Event|1
2979726|NCT01085214|10256312|P1|Overall Study|Alternate treatment required|1
2979727|NCT01085201|10256324|P5|Overall Study|Fond ineligible after consent|0
2979728|NCT01085201|10256325|P4|Overall Study|Fond ineligible after consent|0
2979729|NCT01085201|10256326|P3|Overall Study|Fond ineligible after consent|1
2979730|NCT01085201|10256327|P2|Overall Study|Fond ineligible after consent|1
2979731|NCT01085201|10256328|P1|Overall Study|Fond ineligible after consent|0
2979732|NCT01085201|10256324|P5|Overall Study|Unknown- no study drug|0
2979733|NCT01085201|10256325|P4|Overall Study|Unknown- no study drug|0
2979734|NCT01085201|10256326|P3|Overall Study|Unknown- no study drug|0
2979735|NCT01085201|10256327|P2|Overall Study|Unknown- no study drug|0
2979736|NCT01085201|10256328|P1|Overall Study|Unknown- no study drug|2
2979737|NCT01085201|10256324|P5|Overall Study|Scheduling conflict|0
2979738|NCT01085201|10256325|P4|Overall Study|Scheduling conflict|0
2979739|NCT01085201|10256326|P3|Overall Study|Scheduling conflict|1
2979740|NCT01085201|10256327|P2|Overall Study|Scheduling conflict|0
2979741|NCT01085201|10256328|P1|Overall Study|Scheduling conflict|1
2979742|NCT01085136|10256350|P3|Part B|Other reason not defined above|3
2979743|NCT01085136|10256351|P2|Part B|Other reason not defined above|6
2979744|NCT01085136|10256352|P1|Part B|Other reason not defined above|0
2979745|NCT01085136|10256350|P3|Part B|Not treated|8
2979746|NCT01085136|10256351|P2|Part B|Not treated|4
2979747|NCT01085136|10256352|P1|Part B|Not treated|0
2979748|NCT01085136|10256350|P3|Part B|Refusal to continue trial medication|7
2979749|NCT01085136|10256351|P2|Part B|Refusal to continue trial medication|12
2979750|NCT01085136|10256352|P1|Part B|Refusal to continue trial medication|0
2979751|NCT01085136|10256350|P3|Part B|Other AE|8
2979752|NCT01085136|10256351|P2|Part B|Other AE|29
2979753|NCT01085136|10256352|P1|Part B|Other AE|0
2979754|NCT01085136|10256350|P3|Part A|Other reason not defined above|0
2979755|NCT01085136|10256351|P2|Part A|Other reason not defined above|0
2979756|NCT01085136|10256352|P1|Part A|Other reason not defined above|30
2979757|NCT01085136|10256350|P3|Part A|Refusal to continue trial medication|0
2979758|NCT01085136|10256351|P2|Part A|Refusal to continue trial medication|0
2979759|NCT01085136|10256352|P1|Part A|Refusal to continue trial medication|64
2979760|NCT01085136|10256350|P3|Part A|Lost to Follow-up|0
2979761|NCT01085136|10256351|P2|Part A|Lost to Follow-up|0
2979762|NCT01085136|10256352|P1|Part A|Lost to Follow-up|3
2979763|NCT01085136|10256350|P3|Part A|Protocol Violation|0
2979764|NCT01085136|10256351|P2|Part A|Protocol Violation|0
2979765|NCT01085136|10256352|P1|Part A|Protocol Violation|3
2979766|NCT01085136|10256350|P3|Part A|Other Adverse event|0
2979767|NCT01085136|10256351|P2|Part A|Other Adverse event|0
2979768|NCT01085136|10256352|P1|Part A|Other Adverse event|223
2979769|NCT01085045|10256368|P1|Part B|Adverse Event|6
2979770|NCT01085045|10256368|P1|Part B|Lost to Follow-up|1
2979771|NCT01085045|10256368|P1|Part B|Protocol Specified Criteria|6
2979772|NCT01085045|10256368|P1|Part B|Withdrawal by Subject|2
2979773|NCT01085045|10256368|P1|Part A|Protocol Specified Criteria|7
2979774|NCT01085045|10256368|P1|Part A|Protocol Violation|1
2979775|NCT01085045|10256368|P1|Part A|Adverse Event|6
2979776|NCT01085045|10256368|P1|Part A|Withdrawal by Subject|4
2979777|NCT01084772|10256479|P2|2 Years|Study Termination|2
2979778|NCT01084772|10256480|P1|2 Years|Study Termination|3
2979779|NCT01084772|10256479|P2|2 Years|Lost to Follow-up|2
2979780|NCT01084772|10256480|P1|2 Years|Lost to Follow-up|5
2979781|NCT01084772|10256479|P2|2 Years|Withdrawal by Subject|0
2979782|NCT01084772|10256480|P1|2 Years|Withdrawal by Subject|1
2979783|NCT01084772|10256479|P2|1 Year|Study Termination|7
2979784|NCT01084772|10256480|P1|1 Year|Study Termination|0
2979785|NCT01084772|10256479|P2|1 Year|Lost to Follow-up|0
2979786|NCT01084772|10256480|P1|1 Year|Lost to Follow-up|3
2979787|NCT01084772|10256479|P2|1 Year|Withdrawal by Subject|1
2979788|NCT01084772|10256480|P1|1 Year|Withdrawal by Subject|0
2979789|NCT01084772|10256479|P2|3 Months|Study Termination|2
2979790|NCT01084772|10256480|P1|3 Months|Study Termination|2
2979791|NCT01084772|10256479|P2|3 Months|Death|0
2979792|NCT01084772|10256480|P1|3 Months|Death|1
2979793|NCT01084772|10256479|P2|Baseline|Withdrawal by Subject|6
2979794|NCT01084772|10256480|P1|Baseline|Withdrawal by Subject|7
2979795|NCT01084707|10256516|P1|Overall Study|Withdrawal by Subject|6
2979796|NCT01084694|10256552|P2|Overall Study|eligibility not maintained|7
2979797|NCT01084694|10256553|P1|Overall Study|eligibility not maintained|2
2979798|NCT01084694|10256552|P2|Overall Study|Death|12
2979799|NCT01084694|10256553|P1|Overall Study|Death|2
2979800|NCT01084694|10256552|P2|Overall Study|Withdrawal by Subject|1
2979801|NCT01084694|10256553|P1|Overall Study|Withdrawal by Subject|2
2979802|NCT01084668|10256569|P1|Overall Study|Non-compliance|1
2979803|NCT01084668|10256569|P1|Overall Study|Pregnancy|1
2979804|NCT01084668|10256569|P1|Overall Study|Withdrawal by Subject|2
2979805|NCT01084668|10256569|P1|Overall Study|Lack of Efficacy|5
2979806|NCT01084655|10256581|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
2979807|NCT01084655|10256582|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
2979808|NCT01084655|10256583|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
2979809|NCT01084655|10256581|P3|Overall Study|Symptomatic deterioration|2
2979810|NCT01084655|10256582|P2|Overall Study|Symptomatic deterioration|0
2979811|NCT01084655|10256583|P1|Overall Study|Symptomatic deterioration|0
2979812|NCT01084655|10256581|P3|Overall Study|Other|2
2979813|NCT01084655|10256582|P2|Overall Study|Other|3
2979814|NCT01084655|10256583|P1|Overall Study|Other|0
2979815|NCT01084655|10256581|P3|Overall Study|Adverse Event|2
2979816|NCT01084655|10256582|P2|Overall Study|Adverse Event|1
2979817|NCT01084655|10256583|P1|Overall Study|Adverse Event|2
2979818|NCT01084655|10256581|P3|Overall Study|Withdrawal by Subject|4
2979819|NCT01084655|10256582|P2|Overall Study|Withdrawal by Subject|0
2979820|NCT01084655|10256583|P1|Overall Study|Withdrawal by Subject|1
2979821|NCT01084655|10256581|P3|Overall Study|Radiographic disease progression|8
2979822|NCT01084655|10256582|P2|Overall Study|Radiographic disease progression|2
2979823|NCT01084655|10256583|P1|Overall Study|Radiographic disease progression|3
2979824|NCT01084603|10256618|P1|Washout Period 4|Adverse Event|1
2979825|NCT01084603|10256618|P1|Oral Nicotine 1|Withdrawal by Subject|1
2979826|NCT01084603|10256618|P1|Nicorette® Gum|Withdrawal by Subject|1
2979827|NCT01084603|10256618|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
2979828|NCT01084603|10256618|P1|Baseline|Withdrawal by Subject|2
2979829|NCT01084551|10256654|P3|Overall Study|Physician Decision|0
2979830|NCT01084551|10256655|P2|Overall Study|Physician Decision|0
2979831|NCT01084551|10256656|P1|Overall Study|Physician Decision|1
2979832|NCT01084551|10256654|P3|Overall Study|Lost to Follow-up|3
2979833|NCT01084551|10256655|P2|Overall Study|Lost to Follow-up|0
2979834|NCT01084551|10256656|P1|Overall Study|Lost to Follow-up|0
2979835|NCT01084551|10256654|P3|Overall Study|Protocol Violation|0
2979836|NCT01084551|10256655|P2|Overall Study|Protocol Violation|4
2979837|NCT01084551|10256656|P1|Overall Study|Protocol Violation|2
2979838|NCT01084551|10256654|P3|Overall Study|Withdrawal by Subject|0
2979839|NCT01084551|10256655|P2|Overall Study|Withdrawal by Subject|1
2979840|NCT01084551|10256656|P1|Overall Study|Withdrawal by Subject|2
2979841|NCT01084551|10256654|P3|Overall Study|Lack of Efficacy|1
2979842|NCT01084551|10256655|P2|Overall Study|Lack of Efficacy|0
2979843|NCT01084551|10256656|P1|Overall Study|Lack of Efficacy|2
2979844|NCT01084551|10256654|P3|Overall Study|Adverse Event|4
2979845|NCT01084551|10256655|P2|Overall Study|Adverse Event|9
2979846|NCT01084551|10256656|P1|Overall Study|Adverse Event|2
2979847|NCT01084538|10256694|P1|Overall Study|Reason unknown|8
2979848|NCT01084538|10256694|P1|Overall Study|Over-suppression of parathyroid gland|2
2979849|NCT01084538|10256694|P1|Overall Study|Change of residence|2
2979850|NCT01084538|10256694|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
2979851|NCT01084538|10256694|P1|Overall Study|Hyperphosphatemia|2
2979852|NCT01084538|10256694|P1|Overall Study|Patient noncompliance|2
2979853|NCT01084538|10256694|P1|Overall Study|Lack of effectiveness|2
2979854|NCT01084538|10256694|P1|Overall Study|Serious Adverse Event|3
2979855|NCT01084538|10256694|P1|Overall Study|Kidney transplant|6
2979856|NCT01084538|10256694|P1|Overall Study|Adverse Event|9
2979857|NCT01084538|10256694|P1|Overall Study|Drug not available|30
2979858|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979859|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
2979860|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979861|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979862|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979863|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979864|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979865|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979866|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979867|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979868|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979869|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979870|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979871|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2979872|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
2979873|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
2979874|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979875|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979876|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979877|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979878|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979879|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979880|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979881|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979882|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979883|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979884|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979885|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2979886|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
2979887|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
2979888|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979889|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979890|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979891|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979892|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979893|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979894|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979895|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979896|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979897|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979898|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979899|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2979900|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979901|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
2979902|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979903|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979904|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979905|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979906|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979907|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979908|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979909|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979910|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979911|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979912|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979913|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2979914|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
2979915|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
2979916|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979917|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979918|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979919|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979920|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979921|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979922|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979923|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979924|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979925|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979926|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979927|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2979928|NCT01084252|10256828|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
2979929|NCT01084252|10256829|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
2979930|NCT01084252|10256830|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979931|NCT01084252|10256831|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979932|NCT01084252|10256832|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979933|NCT01084252|10256833|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979934|NCT01084252|10256834|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979935|NCT01084252|10256835|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979936|NCT01084252|10256836|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979937|NCT01084252|10256837|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979938|NCT01084252|10256838|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979939|NCT01084252|10256839|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979940|NCT01084252|10256840|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979941|NCT01084252|10256841|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2979942|NCT01084252|10256828|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979943|NCT01084252|10256829|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979944|NCT01084252|10256830|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2979945|NCT01084252|10256831|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2979946|NCT01084252|10256832|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
2979947|NCT01084252|10256833|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
2979948|NCT01084252|10256834|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979949|NCT01084252|10256835|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979950|NCT01084252|10256836|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979951|NCT01084252|10256837|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979952|NCT01084252|10256838|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979953|NCT01084252|10256839|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979954|NCT01084252|10256840|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979955|NCT01084252|10256841|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2979956|NCT01084252|10256828|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979957|NCT01084252|10256829|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979958|NCT01084252|10256830|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
2979959|NCT01084252|10256831|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
2979960|NCT01084252|10256832|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979961|NCT01084252|10256833|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
2979962|NCT01084252|10256834|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979963|NCT01084252|10256835|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979964|NCT01084252|10256836|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979965|NCT01084252|10256837|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979966|NCT01084252|10256838|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979967|NCT01084252|10256839|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979968|NCT01084252|10256840|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979969|NCT01084252|10256841|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2979970|NCT01084252|10256828|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979971|NCT01084252|10256829|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979972|NCT01084252|10256830|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
2979973|NCT01084252|10256831|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
2979974|NCT01084252|10256832|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
2979975|NCT01084252|10256833|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
2979976|NCT01084252|10256834|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979977|NCT01084252|10256835|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979978|NCT01084252|10256836|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979979|NCT01084252|10256837|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979980|NCT01084252|10256838|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979981|NCT01084252|10256839|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979982|NCT01084252|10256840|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979983|NCT01084252|10256841|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2979984|NCT01084252|10256828|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979985|NCT01084252|10256829|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979986|NCT01084252|10256830|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
2979987|NCT01084252|10256831|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2979988|NCT01084252|10256832|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2979989|NCT01084252|10256833|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979990|NCT01084252|10256834|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979991|NCT01084252|10256835|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979992|NCT01084252|10256836|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979993|NCT01084252|10256837|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979994|NCT01084252|10256838|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979995|NCT01084252|10256839|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979996|NCT01084252|10256840|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979997|NCT01084252|10256841|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2979998|NCT01084252|10256828|P14|Phase 1 (120 Weeks)|Other than specified above|0
2979999|NCT01084252|10256829|P13|Phase 1 (120 Weeks)|Other than specified above|0
2980000|NCT01084252|10256830|P12|Phase 1 (120 Weeks)|Other than specified above|0
2980001|NCT01084252|10256831|P11|Phase 1 (120 Weeks)|Other than specified above|0
2980002|NCT01084252|10256832|P10|Phase 1 (120 Weeks)|Other than specified above|0
2980003|NCT01084252|10256833|P9|Phase 1 (120 Weeks)|Other than specified above|0
2980004|NCT01084252|10256834|P8|Phase 1 (120 Weeks)|Other than specified above|1
2980005|NCT01084252|10256835|P7|Phase 1 (120 Weeks)|Other than specified above|1
2980006|NCT01084252|10256836|P6|Phase 1 (120 Weeks)|Other than specified above|0
2980007|NCT01084252|10256837|P5|Phase 1 (120 Weeks)|Other than specified above|1
2980008|NCT01084252|10256838|P4|Phase 1 (120 Weeks)|Other than specified above|3
2980009|NCT01084252|10256839|P3|Phase 1 (120 Weeks)|Other than specified above|0
2980010|NCT01084252|10256840|P2|Phase 1 (120 Weeks)|Other than specified above|1
2980011|NCT01084252|10256841|P1|Phase 1 (120 Weeks)|Other than specified above|1
2980012|NCT01084252|10256828|P14|Phase 1 (120 Weeks)|Progressive disease|0
2980013|NCT01084252|10256829|P13|Phase 1 (120 Weeks)|Progressive disease|0
2980014|NCT01084252|10256830|P12|Phase 1 (120 Weeks)|Progressive disease|0
2980015|NCT01084252|10256831|P11|Phase 1 (120 Weeks)|Progressive disease|0
2980016|NCT01084252|10256832|P10|Phase 1 (120 Weeks)|Progressive disease|0
2980017|NCT01084252|10256833|P9|Phase 1 (120 Weeks)|Progressive disease|0
2980018|NCT01084252|10256834|P8|Phase 1 (120 Weeks)|Progressive disease|6
2980019|NCT01084252|10256835|P7|Phase 1 (120 Weeks)|Progressive disease|5
2980020|NCT01084252|10256836|P6|Phase 1 (120 Weeks)|Progressive disease|6
2980021|NCT01084252|10256837|P5|Phase 1 (120 Weeks)|Progressive disease|16
2980022|NCT01084252|10256838|P4|Phase 1 (120 Weeks)|Progressive disease|22
2980023|NCT01084252|10256839|P3|Phase 1 (120 Weeks)|Progressive disease|2
2980024|NCT01084252|10256840|P2|Phase 1 (120 Weeks)|Progressive disease|5
2980025|NCT01084252|10256841|P1|Phase 1 (120 Weeks)|Progressive disease|15
2980026|NCT01084252|10256828|P14|Phase 1 (120 Weeks)|Adverse Event|0
2980027|NCT01084252|10256829|P13|Phase 1 (120 Weeks)|Adverse Event|0
2980028|NCT01084252|10256830|P12|Phase 1 (120 Weeks)|Adverse Event|0
2980029|NCT01084252|10256831|P11|Phase 1 (120 Weeks)|Adverse Event|0
2980030|NCT01084252|10256832|P10|Phase 1 (120 Weeks)|Adverse Event|0
2980031|NCT01084252|10256833|P9|Phase 1 (120 Weeks)|Adverse Event|0
2980032|NCT01084252|10256834|P8|Phase 1 (120 Weeks)|Adverse Event|0
2980033|NCT01084252|10256835|P7|Phase 1 (120 Weeks)|Adverse Event|1
2980034|NCT01084252|10256836|P6|Phase 1 (120 Weeks)|Adverse Event|0
2980035|NCT01084252|10256837|P5|Phase 1 (120 Weeks)|Adverse Event|1
2980036|NCT01084252|10256838|P4|Phase 1 (120 Weeks)|Adverse Event|1
2980037|NCT01084252|10256839|P3|Phase 1 (120 Weeks)|Adverse Event|1
2980038|NCT01084252|10256840|P2|Phase 1 (120 Weeks)|Adverse Event|0
2980039|NCT01084252|10256841|P1|Phase 1 (120 Weeks)|Adverse Event|0
2980040|NCT01084239|10257025|P2|28-Day Follow-up|Lost to Follow-up|9
2980041|NCT01084239|10257026|P1|28-Day Follow-up|Lost to Follow-up|4
2980042|NCT01084174|10257044|P2|Overall Study|Participant noncompliance|1
2980043|NCT01084174|10257045|P1|Overall Study|Participant noncompliance|0
2980044|NCT01084174|10257044|P2|Overall Study|Anaphylaxis|1
2980045|NCT01084174|10257045|P1|Overall Study|Anaphylaxis|0
2980046|NCT01084174|10257044|P2|Overall Study|Eosinophilic esophagitis|1
2980047|NCT01084174|10257045|P1|Overall Study|Eosinophilic esophagitis|0
2980048|NCT01084174|10257044|P2|Overall Study|gastrointestinal symptoms|1
2980049|NCT01084174|10257045|P1|Overall Study|gastrointestinal symptoms|1
2980050|NCT01084135|10257078|P2|20 Week|Physician Decision|1
2980051|NCT01084135|10257079|P1|20 Week|Physician Decision|0
2980052|NCT01084083|10257089|P1|Overall Study|Never started assigned therapy|1
2980053|NCT01084083|10257089|P1|Overall Study|Other|2
2980054|NCT01084083|10257089|P1|Overall Study|Complicating disease|1
2980055|NCT01084083|10257089|P1|Overall Study|Withdrawal by Subject|2
2980056|NCT01084083|10257089|P1|Overall Study|Death|1
2980057|NCT01084083|10257089|P1|Overall Study|Adverse Event|5
2980058|NCT01084005|10257097|P2|Overall Study|Withdrawal by Subject|1
2980059|NCT01084005|10257098|P1|Overall Study|Withdrawal by Subject|1
2980060|NCT01084005|10257097|P2|Overall Study|Protocol Violation|7
2980061|NCT01084005|10257098|P1|Overall Study|Protocol Violation|3
2980062|NCT01084005|10257097|P2|Overall Study|Adverse Event|8
2980063|NCT01084005|10257098|P1|Overall Study|Adverse Event|1
2980064|NCT01083810|10257179|P3|Overall Study|Virologic failure|0
2980065|NCT01083810|10257180|P2|Overall Study|Virologic failure|8
2980066|NCT01083810|10257181|P1|Overall Study|Virologic failure|1
2980067|NCT01083810|10257179|P3|Overall Study|Therapy break|2
2980068|NCT01083810|10257180|P2|Overall Study|Therapy break|2
2980069|NCT01083810|10257181|P1|Overall Study|Therapy break|1
2980070|NCT01083810|10257179|P3|Overall Study|Participation in study|0
2980071|NCT01083810|10257180|P2|Overall Study|Participation in study|0
2980072|NCT01083810|10257181|P1|Overall Study|Participation in study|1
2980073|NCT01083810|10257179|P3|Overall Study|Co-morbidities|0
2980074|NCT01083810|10257180|P2|Overall Study|Co-morbidities|0
2980075|NCT01083810|10257181|P1|Overall Study|Co-morbidities|1
2980076|NCT01083810|10257179|P3|Overall Study|Death|3
2980077|NCT01083810|10257180|P2|Overall Study|Death|2
2980078|NCT01083810|10257181|P1|Overall Study|Death|2
2980079|NCT01083810|10257179|P3|Overall Study|Simplification|0
2980080|NCT01083810|10257180|P2|Overall Study|Simplification|1
2980081|NCT01083810|10257181|P1|Overall Study|Simplification|4
2980082|NCT01083810|10257179|P3|Overall Study|Non-compliance|2
2980083|NCT01083810|10257180|P2|Overall Study|Non-compliance|7
2980084|NCT01083810|10257181|P1|Overall Study|Non-compliance|4
2980085|NCT01083810|10257179|P3|Overall Study|Reason not reported|1
2980086|NCT01083810|10257180|P2|Overall Study|Reason not reported|1
2980087|NCT01083810|10257181|P1|Overall Study|Reason not reported|6
2980088|NCT01083810|10257179|P3|Overall Study|Withdrawal by Subject|4
2980089|NCT01083810|10257180|P2|Overall Study|Withdrawal by Subject|2
2980090|NCT01083810|10257181|P1|Overall Study|Withdrawal by Subject|7
2980091|NCT01083810|10257179|P3|Overall Study|Adverse Event|4
2980092|NCT01083810|10257180|P2|Overall Study|Adverse Event|11
2980093|NCT01083810|10257181|P1|Overall Study|Adverse Event|15
2980094|NCT01083810|10257179|P3|Overall Study|Lost to Follow-up|4
2980095|NCT01083810|10257180|P2|Overall Study|Lost to Follow-up|11
2980096|NCT01083810|10257181|P1|Overall Study|Lost to Follow-up|23
2980097|NCT01083771|10257202|P1|Overall Study|Withdrawal by Subject|3
2980098|NCT01083771|10257202|P1|Overall Study|non-compliant|2
2980099|NCT01083693|10257303|P3|Overall Study|Reason unknown|1
2980100|NCT01083693|10257304|P2|Overall Study|Reason unknown|0
2980101|NCT01083693|10257305|P1|Overall Study|Reason unknown|0
2980102|NCT01083693|10257303|P3|Overall Study|Withdrawal by Subject|2
2980103|NCT01083693|10257304|P2|Overall Study|Withdrawal by Subject|0
2980104|NCT01083693|10257305|P1|Overall Study|Withdrawal by Subject|3
2980105|NCT01083693|10257303|P3|Overall Study|Other medical condition/surgery|0
2980106|NCT01083693|10257304|P2|Overall Study|Other medical condition/surgery|1
2980107|NCT01083693|10257305|P1|Overall Study|Other medical condition/surgery|1
2980108|NCT01083693|10257303|P3|Overall Study|Complete remission|0
2980109|NCT01083693|10257304|P2|Overall Study|Complete remission|1
2980110|NCT01083693|10257305|P1|Overall Study|Complete remission|0
2980111|NCT01083693|10257303|P3|Overall Study|Patient Moved|0
2980112|NCT01083693|10257304|P2|Overall Study|Patient Moved|1
2980113|NCT01083693|10257305|P1|Overall Study|Patient Moved|0
2980114|NCT01083693|10257303|P3|Overall Study|Lack of effectiveness|2
2980115|NCT01083693|10257304|P2|Overall Study|Lack of effectiveness|2
2980116|NCT01083693|10257305|P1|Overall Study|Lack of effectiveness|13
2980117|NCT01083693|10257303|P3|Overall Study|Lost to Follow-up|2
2980118|NCT01083693|10257304|P2|Overall Study|Lost to Follow-up|0
2980119|NCT01083693|10257305|P1|Overall Study|Lost to Follow-up|2
2980120|NCT01083693|10257303|P3|Overall Study|Adverse Event|0
2980121|NCT01083693|10257304|P2|Overall Study|Adverse Event|1
2980122|NCT01083693|10257305|P1|Overall Study|Adverse Event|1
2980123|NCT01083680|10257340|P1|Overall Study|Withdrawal by Subject|1086
2980124|NCT01083680|10257340|P1|Overall Study|Lost to Follow-up|2758
2980125|NCT01083641|10257363|P1|Overall Study|Withdrawal by Subject|2
2980126|NCT01083602|10257383|P1|Overall Study|Lack of Efficacy|36
2980127|NCT01083602|10257383|P1|Overall Study|Withdrawal by Subject|5
2980128|NCT01083602|10257383|P1|Overall Study|Death|1
2980129|NCT01083602|10257383|P1|Overall Study|New Cancer Therapy|2
2980130|NCT01083602|10257383|P1|Overall Study|Adverse Event|11
2980131|NCT01083576|10257394|P2|Overall Study|Treatment Failure|1
2980132|NCT01083576|10257395|P1|Overall Study|Treatment Failure|6
2980133|NCT01083485|10257425|P2|Overall Study|Other|0
2980134|NCT01083485|10257426|P1|Overall Study|Other|1
2980135|NCT01083485|10257425|P2|Overall Study|Withdrawal by Subject|2
2980136|NCT01083485|10257426|P1|Overall Study|Withdrawal by Subject|5
2980137|NCT01083485|10257425|P2|Overall Study|Protocol Violation|0
2980138|NCT01083485|10257426|P1|Overall Study|Protocol Violation|1
2980139|NCT01083485|10257425|P2|Overall Study|Adverse Event|1
2980140|NCT01083485|10257426|P1|Overall Study|Adverse Event|0
2980141|NCT01083316|10257458|P1|Overall Study|Withdrawal by Subject|1
2980142|NCT01083316|10257458|P1|Overall Study|Adverse Event|2
2980143|NCT01083186|10257470|P1|Overall Study|Non-compliance to Study Treatment|1
2980144|NCT01083186|10257470|P1|Overall Study|Administrative Reasons|2
2980145|NCT01083186|10257470|P1|Overall Study|Hemodialysis Initiation|28
2980146|NCT01083186|10257470|P1|Overall Study|Lack of Efficacy|2
2980147|NCT01083186|10257470|P1|Overall Study|Adverse Event|3
2980148|NCT01083186|10257470|P1|Overall Study|Death|3
2980149|NCT01083186|10257470|P1|Overall Study|Consent Withdrawal|7
2980150|NCT01083186|10257470|P1|Overall Study|Lost to Follow-up|48
2980151|NCT01083173|10257511|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
2980152|NCT01083173|10257512|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
2980153|NCT01083173|10257511|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
2980154|NCT01083173|10257512|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
2980155|NCT01083173|10257511|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
2980156|NCT01083173|10257512|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
2980157|NCT01083173|10257511|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
2980158|NCT01083173|10257512|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
2980159|NCT01083173|10257511|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
2980160|NCT01083173|10257512|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
2980161|NCT01083173|10257511|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2980162|NCT01083173|10257512|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2980163|NCT01083173|10257511|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
2980164|NCT01083173|10257512|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
2980165|NCT01083173|10257511|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
2980166|NCT01083173|10257512|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
2980167|NCT01083173|10257511|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
2980168|NCT01083173|10257512|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
2980169|NCT01083173|10257511|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
2980170|NCT01083173|10257512|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
2980171|NCT01083173|10257511|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2980172|NCT01083173|10257512|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2980173|NCT01083160|10257530|P1|Overall Study|Adverse Event|1
2980174|NCT01083121|10257537|P1|Overall Study|Use of Humira outside the approved label|81
2980175|NCT01082965|10257547|P2|Overall Study|Other|1
2980176|NCT01082965|10257548|P1|Overall Study|Other|1
2980177|NCT01082965|10257547|P2|Overall Study|Protocol Violation|1
2980178|NCT01082965|10257548|P1|Overall Study|Protocol Violation|0
2980179|NCT01082874|10257585|P4|Overall Study|Withdrawal by Subject|3
2980180|NCT01082874|10257586|P3|Overall Study|Withdrawal by Subject|5
2980181|NCT01082874|10257587|P2|Overall Study|Withdrawal by Subject|2
2980182|NCT01082874|10257588|P1|Overall Study|Withdrawal by Subject|1
2980183|NCT01082874|10257585|P4|Overall Study|Lost to Follow-up|10
2980184|NCT01082874|10257586|P3|Overall Study|Lost to Follow-up|6
2980185|NCT01082874|10257587|P2|Overall Study|Lost to Follow-up|10
2980186|NCT01082874|10257588|P1|Overall Study|Lost to Follow-up|10
2980187|NCT01082640|10257601|P3|Overall Study|Other|3
2980188|NCT01082640|10257602|P2|Overall Study|Other|1
2980189|NCT01082640|10257603|P1|Overall Study|Other|2
2980190|NCT01082640|10257601|P3|Overall Study|Lost to Follow-up|0
2980191|NCT01082640|10257602|P2|Overall Study|Lost to Follow-up|3
2980192|NCT01082640|10257603|P1|Overall Study|Lost to Follow-up|0
2980193|NCT01082640|10257601|P3|Overall Study|Major protocol deviation|0
2980194|NCT01082640|10257602|P2|Overall Study|Major protocol deviation|3
2980195|NCT01082640|10257603|P1|Overall Study|Major protocol deviation|3
2980196|NCT01082640|10257601|P3|Overall Study|Withdrawal by Subject|2
2980197|NCT01082640|10257602|P2|Overall Study|Withdrawal by Subject|3
2980198|NCT01082640|10257603|P1|Overall Study|Withdrawal by Subject|3
2980199|NCT01082640|10257601|P3|Overall Study|Adverse Event|3
2980200|NCT01082640|10257602|P2|Overall Study|Adverse Event|5
2980201|NCT01082640|10257603|P1|Overall Study|Adverse Event|9
2980202|NCT01082614|10257625|P2|Overall Study|Physician Decision|0
2980203|NCT01082614|10257626|P1|Overall Study|Physician Decision|2
2980204|NCT01082614|10257625|P2|Overall Study|Equipment Malfunction|1
2980205|NCT01082614|10257626|P1|Overall Study|Equipment Malfunction|0
2980206|NCT01082614|10257625|P2|Overall Study|Adverse Event|4
2980207|NCT01082614|10257626|P1|Overall Study|Adverse Event|1
2980208|NCT01082367|10257697|P2|Follow-up (F-U) Period|Adverse Event|1
2980209|NCT01082367|10257698|P1|Follow-up (F-U) Period|Adverse Event|0
2980210|NCT01082367|10257697|P2|Follow-up (F-U) Period|Abnormal lab values|0
2980211|NCT01082367|10257698|P1|Follow-up (F-U) Period|Abnormal lab values|1
2980212|NCT01082367|10257697|P2|Follow-up (F-U) Period|Administrative problems|0
2980213|NCT01082367|10257698|P1|Follow-up (F-U) Period|Administrative problems|1
2980214|NCT01082367|10257697|P2|Double-blind Period|Adverse Event|1
2980215|NCT01082367|10257698|P1|Double-blind Period|Adverse Event|0
2980216|NCT01082367|10257697|P2|Double-blind Period|Lack of Efficacy|11
2980217|NCT01082367|10257698|P1|Double-blind Period|Lack of Efficacy|5
2980218|NCT01082367|10257697|P2|Double-blind Period|Administrative problems|1
2980219|NCT01082367|10257698|P1|Double-blind Period|Administrative problems|0
2980220|NCT01082328|10257712|P1|Overall Study|Adverse Event|1
2980221|NCT01082211|10257721|P1|Overall Study|No protocol treatment received|3
2980222|NCT01082211|10257721|P1|Overall Study|Protocol Violation|4
2980223|NCT01082081|10257748|P3|Overall Study|Other Reason|0
2980224|NCT01082081|10257749|P2|Overall Study|Other Reason|1
2980225|NCT01082081|10257750|P1|Overall Study|Other Reason|0
2980226|NCT01082081|10257748|P3|Overall Study|Withdrawal by Subject|1
2980227|NCT01082081|10257749|P2|Overall Study|Withdrawal by Subject|0
2980228|NCT01082081|10257750|P1|Overall Study|Withdrawal by Subject|0
2980229|NCT01082081|10257748|P3|Overall Study|Lost to Follow-up|1
2980230|NCT01082081|10257749|P2|Overall Study|Lost to Follow-up|0
2980231|NCT01082081|10257750|P1|Overall Study|Lost to Follow-up|0
2980232|NCT01081951|10257802|P2|Overall Study|Lost to Follow-up|1
2980233|NCT01081951|10257803|P1|Overall Study|Lost to Follow-up|0
2980234|NCT01081951|10257802|P2|Overall Study|Allocated treatment but did not take it|1
2980235|NCT01081951|10257803|P1|Overall Study|Allocated treatment but did not take it|0
2980236|NCT01081951|10257802|P2|Overall Study|Withdrawal by Subject|6
2980237|NCT01081951|10257803|P1|Overall Study|Withdrawal by Subject|2
2980238|NCT01081951|10257802|P2|Overall Study|Death|47
2980239|NCT01081951|10257803|P1|Overall Study|Death|54
2980240|NCT01081912|10257813|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
2980241|NCT01081912|10257814|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
2980242|NCT01081912|10257815|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
2980243|NCT01081912|10257813|P3|Maintenance Treatment|Non-Compliance|7
2980244|NCT01081912|10257814|P2|Maintenance Treatment|Non-Compliance|4
2980245|NCT01081912|10257815|P1|Maintenance Treatment|Non-Compliance|0
2980246|NCT01081912|10257813|P3|Maintenance Treatment|Withdrawal by Subject|5
2980247|NCT01081912|10257814|P2|Maintenance Treatment|Withdrawal by Subject|5
2980248|NCT01081912|10257815|P1|Maintenance Treatment|Withdrawal by Subject|0
2980249|NCT01081912|10257813|P3|Maintenance Treatment|Protocol Violation|2
2980250|NCT01081912|10257814|P2|Maintenance Treatment|Protocol Violation|1
2980251|NCT01081912|10257815|P1|Maintenance Treatment|Protocol Violation|0
2980252|NCT01081912|10257813|P3|Maintenance Treatment|Physician Decision|1
2980253|NCT01081912|10257814|P2|Maintenance Treatment|Physician Decision|0
2980254|NCT01081912|10257815|P1|Maintenance Treatment|Physician Decision|0
2980255|NCT01081912|10257813|P3|Maintenance Treatment|Lost to Follow-up|0
2980256|NCT01081912|10257814|P2|Maintenance Treatment|Lost to Follow-up|1
2980257|NCT01081912|10257815|P1|Maintenance Treatment|Lost to Follow-up|0
2980258|NCT01081912|10257813|P3|Maintenance Treatment|Lack of Efficacy|64
2980259|NCT01081912|10257814|P2|Maintenance Treatment|Lack of Efficacy|14
2980260|NCT01081912|10257815|P1|Maintenance Treatment|Lack of Efficacy|0
2980261|NCT01081912|10257813|P3|Maintenance Treatment|Adverse Event|12
2980262|NCT01081912|10257814|P2|Maintenance Treatment|Adverse Event|2
2980263|NCT01081912|10257815|P1|Maintenance Treatment|Adverse Event|0
2980264|NCT01081912|10257813|P3|Conversion/Titration|Non-Compliance|0
2980265|NCT01081912|10257814|P2|Conversion/Titration|Non-Compliance|0
2980266|NCT01081912|10257815|P1|Conversion/Titration|Non-Compliance|47
2980267|NCT01081912|10257813|P3|Conversion/Titration|Withdrawal by Subject|0
2980268|NCT01081912|10257814|P2|Conversion/Titration|Withdrawal by Subject|0
2980269|NCT01081912|10257815|P1|Conversion/Titration|Withdrawal by Subject|23
2980270|NCT01081912|10257813|P3|Conversion/Titration|Protocol Violation|0
2980271|NCT01081912|10257814|P2|Conversion/Titration|Protocol Violation|0
2980272|NCT01081912|10257815|P1|Conversion/Titration|Protocol Violation|67
2980273|NCT01081912|10257813|P3|Conversion/Titration|Physician Decision|0
2980274|NCT01081912|10257814|P2|Conversion/Titration|Physician Decision|0
2980275|NCT01081912|10257815|P1|Conversion/Titration|Physician Decision|2
2980276|NCT01081912|10257813|P3|Conversion/Titration|Lost to Follow-up|0
2980277|NCT01081912|10257814|P2|Conversion/Titration|Lost to Follow-up|0
2980278|NCT01081912|10257815|P1|Conversion/Titration|Lost to Follow-up|5
2980279|NCT01081912|10257813|P3|Conversion/Titration|Lack of Efficacy|0
2980280|NCT01081912|10257814|P2|Conversion/Titration|Lack of Efficacy|0
2980281|NCT01081912|10257815|P1|Conversion/Titration|Lack of Efficacy|17
2980282|NCT01081912|10257813|P3|Conversion/Titration|Adverse Event|0
2980283|NCT01081912|10257814|P2|Conversion/Titration|Adverse Event|0
2980284|NCT01081912|10257815|P1|Conversion/Titration|Adverse Event|47
2980285|NCT01081886|10257824|P2|Overall Study|Study termination|13
2980286|NCT01081886|10257825|P1|Overall Study|Study termination|11
2980287|NCT01081873|10257833|P1|Overall Study|Other|47
2980288|NCT01081873|10257833|P1|Overall Study|Progression of prostate cancer|13
2980289|NCT01081873|10257833|P1|Overall Study|Lost to Follow-up|142
2980290|NCT01081873|10257833|P1|Overall Study|Withdrawal by Subject|10
2980291|NCT01081873|10257833|P1|Overall Study|Death|86
2980292|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
2980293|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
2980294|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
2980295|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
2980296|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
2980297|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2980298|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2980299|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2980300|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
2980301|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
2980302|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Other|0
2980303|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Other|0
2980304|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Other|4
2980305|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Other|5
2980306|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Other|4
2980307|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2980308|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2980309|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2980310|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2980311|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2980312|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2980313|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2980314|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2980315|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2980316|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2980317|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2980318|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2980319|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2980320|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2980321|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2980322|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
2980323|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
2980324|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2980325|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2980326|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
2980327|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2980328|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2980329|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2980330|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2980331|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2980332|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Death|0
2980333|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Death|0
2980334|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Death|0
2980335|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Death|0
2980336|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Death|1
2980337|NCT01081834|10257905|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
2980338|NCT01081834|10257906|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
2980339|NCT01081834|10257907|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
2980340|NCT01081834|10257908|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
2980341|NCT01081834|10257909|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2980342|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2980343|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2980344|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2980345|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2980346|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
2980347|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Other|0
2980348|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Other|1
2980349|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Other|3
2980350|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Other|4
2980351|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Other|4
2980352|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2980353|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2980354|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2980355|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2980356|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2980357|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2980358|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2980359|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2980360|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
2980361|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2980362|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2980363|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2980364|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2980365|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2980366|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2980367|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Protocol Violation|2
2980368|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Protocol Violation|0
2980369|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2980370|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Protocol Violation|4
2980371|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Protocol Violation|0
2980372|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
2980373|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
2980374|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
2980375|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
2980376|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
2980377|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Death|0
2980378|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Death|0
2980379|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Death|0
2980380|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Death|0
2980381|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Death|1
2980382|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Adverse Event|1
2980383|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Adverse Event|1
2980384|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Adverse Event|3
2980385|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Adverse Event|5
2980386|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Adverse Event|2
2980387|NCT01081834|10257905|P5|Core Period: Baseline to Week 26|Pregnancy|0
2980388|NCT01081834|10257906|P4|Core Period: Baseline to Week 26|Pregnancy|0
2980389|NCT01081834|10257907|P3|Core Period: Baseline to Week 26|Pregnancy|0
2980390|NCT01081834|10257908|P2|Core Period: Baseline to Week 26|Pregnancy|0
2980391|NCT01081834|10257909|P1|Core Period: Baseline to Week 26|Pregnancy|1
2980392|NCT01081795|10257970|P3|Overall Study|Other|0
2980393|NCT01081795|10257971|P2|Overall Study|Other|2
2980394|NCT01081795|10257972|P1|Overall Study|Other|1
2980395|NCT01081795|10257970|P3|Overall Study|Using drug with restricted days of use|2
2980396|NCT01081795|10257971|P2|Overall Study|Using drug with restricted days of use|3
2980397|NCT01081795|10257972|P1|Overall Study|Using drug with restricted days of use|2
2980398|NCT01081795|10257970|P3|Overall Study|Use of a prohibited concomitant drug|1
2980399|NCT01081795|10257971|P2|Overall Study|Use of a prohibited concomitant drug|1
2980400|NCT01081795|10257972|P1|Overall Study|Use of a prohibited concomitant drug|1
2980401|NCT01081795|10257970|P3|Overall Study|Ineligible for participation|0
2980402|NCT01081795|10257971|P2|Overall Study|Ineligible for participation|0
2980403|NCT01081795|10257972|P1|Overall Study|Ineligible for participation|1
2980404|NCT01081795|10257970|P3|Overall Study|Revocation of informed consent|0
2980405|NCT01081795|10257971|P2|Overall Study|Revocation of informed consent|0
2980406|NCT01081795|10257972|P1|Overall Study|Revocation of informed consent|2
2980407|NCT01081795|10257970|P3|Overall Study|Subject’s schedule|2
2980408|NCT01081795|10257971|P2|Overall Study|Subject’s schedule|1
2980409|NCT01081795|10257972|P1|Overall Study|Subject’s schedule|1
2980410|NCT01081795|10257970|P3|Overall Study|Lack of Efficacy|19
2980411|NCT01081795|10257971|P2|Overall Study|Lack of Efficacy|5
2980412|NCT01081795|10257972|P1|Overall Study|Lack of Efficacy|7
2980413|NCT01081795|10257970|P3|Overall Study|Adverse Event|6
2980414|NCT01081795|10257971|P2|Overall Study|Adverse Event|23
2980415|NCT01081795|10257972|P1|Overall Study|Adverse Event|18
2980416|NCT01081769|10258009|P2|CORE Intent-To-Treat|Patient Moved|2
2980417|NCT01081769|10258010|P1|CORE Intent-To-Treat|Patient Moved|2
2980418|NCT01081769|10258009|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
2980419|NCT01081769|10258010|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
2980420|NCT01081769|10258009|P2|CORE Intent-To-Treat|Ineligibility|4
2980421|NCT01081769|10258010|P1|CORE Intent-To-Treat|Ineligibility|3
2980422|NCT01081769|10258009|P2|CORE Intent-To-Treat|Other|1
2980423|NCT01081769|10258010|P1|CORE Intent-To-Treat|Other|0
2980424|NCT01081769|10258009|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
2980425|NCT01081769|10258010|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
2980426|NCT01081769|10258009|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
2980427|NCT01081769|10258010|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
2980428|NCT01081769|10258009|P2|CORE Intent-To-Treat|Pregnancy|0
2980429|NCT01081769|10258010|P1|CORE Intent-To-Treat|Pregnancy|1
2980430|NCT01081769|10258009|P2|CORE Intent-To-Treat|Lost to Follow-up|5
2980431|NCT01081769|10258010|P1|CORE Intent-To-Treat|Lost to Follow-up|4
2980432|NCT01081769|10258009|P2|CORE Intent-To-Treat|Lack of Efficacy|6
2980433|NCT01081769|10258010|P1|CORE Intent-To-Treat|Lack of Efficacy|2
2980434|NCT01081769|10258009|P2|CORE Intent-To-Treat|Death|1
2980435|NCT01081769|10258010|P1|CORE Intent-To-Treat|Death|1
2980436|NCT01081769|10258009|P2|CORE Intent-To-Treat|Adverse Event|11
2980437|NCT01081769|10258010|P1|CORE Intent-To-Treat|Adverse Event|14
2980438|NCT01081769|10258009|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
2980439|NCT01081769|10258010|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
2980440|NCT01081769|10258009|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
2980441|NCT01081769|10258010|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
2980442|NCT01081769|10258009|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2980443|NCT01081769|10258010|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2980444|NCT01081769|10258009|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
2980445|NCT01081769|10258010|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
2980446|NCT01081678|10258048|P4|Overall Study|Other|0
2980447|NCT01081678|10258049|P3|Overall Study|Other|0
2980448|NCT01081678|10258050|P2|Overall Study|Other|1
2980449|NCT01081678|10258051|P1|Overall Study|Other|0
2980450|NCT01081678|10258048|P4|Overall Study|Death|6
2980451|NCT01081678|10258049|P3|Overall Study|Death|2
2980452|NCT01081678|10258050|P2|Overall Study|Death|2
2980453|NCT01081678|10258051|P1|Overall Study|Death|2
2980454|NCT01081678|10258048|P4|Overall Study|Lost to Follow-up|3
2980455|NCT01081678|10258049|P3|Overall Study|Lost to Follow-up|4
2980456|NCT01081678|10258050|P2|Overall Study|Lost to Follow-up|1
2980457|NCT01081678|10258051|P1|Overall Study|Lost to Follow-up|4
2980458|NCT01081678|10258048|P4|Overall Study|Administrative Decision|1
2980459|NCT01081678|10258049|P3|Overall Study|Administrative Decision|0
2980460|NCT01081678|10258050|P2|Overall Study|Administrative Decision|0
2980461|NCT01081678|10258051|P1|Overall Study|Administrative Decision|1
2980462|NCT01081678|10258048|P4|Overall Study|Withdrawal by Subject|14
2980463|NCT01081678|10258049|P3|Overall Study|Withdrawal by Subject|17
2980464|NCT01081678|10258050|P2|Overall Study|Withdrawal by Subject|7
2980465|NCT01081678|10258051|P1|Overall Study|Withdrawal by Subject|15
2980466|NCT01081678|10258048|P4|Overall Study|Adverse Event|2
2980467|NCT01081678|10258049|P3|Overall Study|Adverse Event|2
2980468|NCT01081678|10258050|P2|Overall Study|Adverse Event|1
2980469|NCT01081678|10258051|P1|Overall Study|Adverse Event|2
2980470|NCT01081678|10258048|P4|Overall Study|Noncompliance|2
2980471|NCT01081678|10258049|P3|Overall Study|Noncompliance|5
2980472|NCT01081678|10258050|P2|Overall Study|Noncompliance|4
2980473|NCT01081678|10258051|P1|Overall Study|Noncompliance|3
2980474|NCT01081678|10258048|P4|Overall Study|Ineligibility Determined|1
2980475|NCT01081678|10258049|P3|Overall Study|Ineligibility Determined|1
2980476|NCT01081678|10258050|P2|Overall Study|Ineligibility Determined|0
2980477|NCT01081678|10258051|P1|Overall Study|Ineligibility Determined|0
2980478|NCT01081665|10258081|P1|Overall Study|Lack of Efficacy|1
2980479|NCT01081665|10258081|P1|Overall Study|Adverse Event|1
2980480|NCT01081665|10258081|P1|Overall Study|Change in renal replacement therapy|2
2980481|NCT01081665|10258081|P1|Overall Study|Regulation of iPTH|5
2980482|NCT01081665|10258081|P1|Overall Study|Change of dialysis unit|10
2980483|NCT01081665|10258081|P1|Overall Study|Withdrawal by Subject|17
2980484|NCT01081665|10258081|P1|Overall Study|Lost to Follow-up|18
2980485|NCT01081665|10258081|P1|Overall Study|Death|41
2980486|NCT01081626|10258093|P2|Overall Study|Other|30
2980487|NCT01081626|10258094|P1|Overall Study|Other|33
2980488|NCT01081626|10258093|P2|Overall Study|Lost to Follow-up|1
2980489|NCT01081626|10258094|P1|Overall Study|Lost to Follow-up|0
2980490|NCT01081626|10258093|P2|Overall Study|Overstimulation|1
2980491|NCT01081626|10258094|P1|Overall Study|Overstimulation|0
2980492|NCT01081626|10258093|P2|Overall Study|Low antral follicle count|0
2980493|NCT01081626|10258094|P1|Overall Study|Low antral follicle count|1
2980494|NCT01081626|10258093|P2|Overall Study|Missing Estradiol|28
2980495|NCT01081626|10258094|P1|Overall Study|Missing Estradiol|25
2980496|NCT01081626|10258093|P2|Overall Study|Dosing error|1
2980497|NCT01081626|10258094|P1|Overall Study|Dosing error|1
2980498|NCT01081301|10258120|P1|Overall Study|Lost to Follow-up|4
2980499|NCT01081301|10258120|P1|Overall Study|Patient too ill|2
2980500|NCT01081301|10258120|P1|Overall Study|Too busy|5
2980501|NCT01081301|10258120|P1|Overall Study|Bereaved|3
2980502|NCT01081249|10258195|P2|Overall Study|Diagnosed with Bipolar Disorder|1
2980503|NCT01081249|10258196|P1|Overall Study|Diagnosed with Bipolar Disorder|0
2980504|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
2980505|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
2980506|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
2980507|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
2980508|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
2980509|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
2980510|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
2980511|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
2980512|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
2980513|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
2980514|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
2980515|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
2980516|NCT01081145|10258202|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
2980517|NCT01081145|10258203|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
2980518|NCT01081145|10258202|P2|Open-Label Phase|Protocol Violation|0
2980519|NCT01081145|10258203|P1|Open-Label Phase|Protocol Violation|4
2980520|NCT01081145|10258202|P2|Open-Label Phase|Lost to Follow-up|0
2980521|NCT01081145|10258203|P1|Open-Label Phase|Lost to Follow-up|11
2980522|NCT01081145|10258202|P2|Open-Label Phase|Other|0
2980523|NCT01081145|10258203|P1|Open-Label Phase|Other|12
2980524|NCT01081145|10258202|P2|Open-Label Phase|Withdrawal by Subject|0
2980525|NCT01081145|10258203|P1|Open-Label Phase|Withdrawal by Subject|41
2980526|NCT01081145|10258202|P2|Open-Label Phase|Adverse Event|0
2980527|NCT01081145|10258203|P1|Open-Label Phase|Adverse Event|42
2980528|NCT01081145|10258202|P2|Open-Label Phase|Response criteria not met|0
2980529|NCT01081145|10258203|P1|Open-Label Phase|Response criteria not met|46
2980530|NCT01081145|10258202|P2|Open-Label Phase|Lack of Efficacy|0
2980531|NCT01081145|10258203|P1|Open-Label Phase|Lack of Efficacy|56
2980532|NCT01081132|10258231|P2|Overall Study|Protocol Violation|1
2980533|NCT01081132|10258232|P1|Overall Study|Protocol Violation|3
2980534|NCT01081132|10258231|P2|Overall Study|Declined Taper Phase|1
2980535|NCT01081132|10258232|P1|Overall Study|Declined Taper Phase|0
2980536|NCT01081132|10258231|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
2980537|NCT01081132|10258232|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
2980538|NCT01081132|10258231|P2|Overall Study|Stopped Taking Meds|0
2980539|NCT01081132|10258232|P1|Overall Study|Stopped Taking Meds|2
2980540|NCT01081132|10258231|P2|Overall Study|Missed Visits|1
2980541|NCT01081132|10258232|P1|Overall Study|Missed Visits|1
2980542|NCT01081132|10258231|P2|Overall Study|Lack Of Compliance|1
2980543|NCT01081132|10258232|P1|Overall Study|Lack Of Compliance|0
2980544|NCT01081132|10258231|P2|Overall Study|Non Compliance|2
2980545|NCT01081132|10258232|P1|Overall Study|Non Compliance|4
2980546|NCT01081132|10258231|P2|Overall Study|Adverse Event|9
2980547|NCT01081132|10258232|P1|Overall Study|Adverse Event|3
2980548|NCT01081132|10258231|P2|Overall Study|Lost to Follow-up|11
2980549|NCT01081132|10258232|P1|Overall Study|Lost to Follow-up|4
2980550|NCT01081132|10258231|P2|Overall Study|Withdrawal by Subject|16
2980551|NCT01081132|10258232|P1|Overall Study|Withdrawal by Subject|13
2980552|NCT01081132|10258231|P2|Overall Study|Lack of Efficacy|9
2980553|NCT01081132|10258232|P1|Overall Study|Lack of Efficacy|25
2980554|NCT01080807|10258316|P2|Overall Study|Moved away without notifying center|0
2980555|NCT01080807|10258317|P1|Overall Study|Moved away without notifying center|1
2980556|NCT01080807|10258316|P2|Overall Study|Switched to first shift|0
2980557|NCT01080807|10258317|P1|Overall Study|Switched to first shift|1
2980558|NCT01080807|10258316|P2|Overall Study|Work schedule and travel|1
2980559|NCT01080807|10258317|P1|Overall Study|Work schedule and travel|0
2980560|NCT01080807|10258316|P2|Overall Study|Work schedule changing|1
2980561|NCT01080807|10258317|P1|Overall Study|Work schedule changing|1
2980562|NCT01080807|10258316|P2|Overall Study|Stopped working consistent night shifts|1
2980563|NCT01080807|10258317|P1|Overall Study|Stopped working consistent night shifts|0
2980564|NCT01080807|10258316|P2|Overall Study|Laid off or terminated from job|2
2980565|NCT01080807|10258317|P1|Overall Study|Laid off or terminated from job|1
2980566|NCT01080807|10258316|P2|Overall Study|Began working day shift|2
2980567|NCT01080807|10258317|P1|Overall Study|Began working day shift|0
2980568|NCT01080807|10258316|P2|Overall Study|Noncompliance to study procedures|1
2980569|NCT01080807|10258317|P1|Overall Study|Noncompliance to study procedures|1
2980570|NCT01080807|10258316|P2|Overall Study|Noncompliance with drug administration|1
2980571|NCT01080807|10258317|P1|Overall Study|Noncompliance with drug administration|1
2980572|NCT01080807|10258316|P2|Overall Study|Lost to Follow-up|4
2980573|NCT01080807|10258317|P1|Overall Study|Lost to Follow-up|6
2980574|NCT01080807|10258316|P2|Overall Study|Protocol Violation|6
2980575|NCT01080807|10258317|P1|Overall Study|Protocol Violation|7
2980576|NCT01080807|10258316|P2|Overall Study|Withdrawal by Subject|2
2980577|NCT01080807|10258317|P1|Overall Study|Withdrawal by Subject|7
2980578|NCT01080807|10258316|P2|Overall Study|Lack of Efficacy|1
2980579|NCT01080807|10258317|P1|Overall Study|Lack of Efficacy|0
2980580|NCT01080807|10258316|P2|Overall Study|Adverse Event|1
2980581|NCT01080807|10258317|P1|Overall Study|Adverse Event|9
2980582|NCT01080768|10258426|P2|Overall Study|Protocol Deviation|1
2980583|NCT01080768|10258427|P1|Overall Study|Protocol Deviation|2
2980584|NCT01080716|10258437|P4|Part 1|Physician Decision|0
2980585|NCT01080716|10258438|P3|Part 1|Physician Decision|0
2980586|NCT01080716|10258439|P2|Part 1|Physician Decision|0
2980587|NCT01080716|10258440|P1|Part 1|Physician Decision|1
2980588|NCT01080625|10258479|P3|Overall Study|Physician Decision|1
2980589|NCT01080625|10258480|P2|Overall Study|Physician Decision|2
2980590|NCT01080625|10258481|P1|Overall Study|Physician Decision|0
2980591|NCT01080391|10258491|P2|Overall Study|Randomized but not treated|4
2980592|NCT01080391|10258492|P1|Overall Study|Randomized but not treated|7
2980593|NCT01080326|10258510|P1|Overall Study|Surgeon decision|1
2980594|NCT01080326|10258510|P1|Overall Study|Patient deterioration prior to procedure|3
2980595|NCT01080300|10258516|P2|Overall Study|Reasons not specified|6
2980596|NCT01080300|10258517|P1|Overall Study|Reasons not specified|4
2980597|NCT01080300|10258516|P2|Overall Study|Withdrawal by Subject|28
2980598|NCT01080300|10258517|P1|Overall Study|Withdrawal by Subject|12
2980599|NCT01080300|10258516|P2|Overall Study|Death|1
2980600|NCT01080300|10258517|P1|Overall Study|Death|0
2980601|NCT01080300|10258516|P2|Overall Study|Lost to Follow-up|6
2980602|NCT01080300|10258517|P1|Overall Study|Lost to Follow-up|10
2980603|NCT01080300|10258516|P2|Overall Study|Protocol Violation|13
2980604|NCT01080300|10258517|P1|Overall Study|Protocol Violation|7
2980605|NCT01080300|10258516|P2|Overall Study|Lack of Efficacy|15
2980606|NCT01080300|10258517|P1|Overall Study|Lack of Efficacy|12
2980607|NCT01080300|10258516|P2|Overall Study|Adverse Event|35
2980608|NCT01080300|10258517|P1|Overall Study|Adverse Event|49
2980609|NCT01080131|10258622|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
2980610|NCT01080131|10258623|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
2980611|NCT01080131|10258622|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
2980612|NCT01080131|10258623|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
2980613|NCT01080131|10258622|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
2980614|NCT01080131|10258623|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
2980615|NCT01080131|10258622|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
2980616|NCT01080131|10258623|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
2980617|NCT01080131|10258622|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
2980618|NCT01080131|10258623|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
2980619|NCT01080131|10258622|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
2980620|NCT01080131|10258623|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
2980621|NCT01080131|10258622|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
2980622|NCT01080131|10258623|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
2980623|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
2980624|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
2980625|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Death|0
2980626|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Death|1
2980627|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Administrative problems|1
2980628|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Administrative problems|0
2980629|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
2980630|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
2980631|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
2980632|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
2980633|NCT01080131|10258622|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2980634|NCT01080131|10258623|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2980635|NCT01079988|10258718|P5|Overall Study|Other|1
2980636|NCT01079988|10258719|P4|Overall Study|Other|2
2980637|NCT01079988|10258720|P3|Overall Study|Other|0
2980638|NCT01079988|10258721|P2|Overall Study|Other|0
2980639|NCT01079988|10258722|P1|Overall Study|Other|0
2980640|NCT01079988|10258718|P5|Overall Study|Lack of Efficacy|0
2980641|NCT01079988|10258719|P4|Overall Study|Lack of Efficacy|0
2980642|NCT01079988|10258720|P3|Overall Study|Lack of Efficacy|0
2980643|NCT01079988|10258721|P2|Overall Study|Lack of Efficacy|0
2980644|NCT01079988|10258722|P1|Overall Study|Lack of Efficacy|1
2980645|NCT01079988|10258718|P5|Overall Study|Lost to Follow-up|0
2980646|NCT01079988|10258719|P4|Overall Study|Lost to Follow-up|1
2980647|NCT01079988|10258720|P3|Overall Study|Lost to Follow-up|0
2980648|NCT01079988|10258721|P2|Overall Study|Lost to Follow-up|0
2980649|NCT01079988|10258722|P1|Overall Study|Lost to Follow-up|0
2980650|NCT01079962|10258741|P2|Overall Study|Due to arrhythmia/bradycardia|1
2980651|NCT01079962|10258742|P1|Overall Study|Due to arrhythmia/bradycardia|1
2980652|NCT01079962|10258741|P2|Overall Study|Participant not returning for next visit|0
2980653|NCT01079962|10258742|P1|Overall Study|Participant not returning for next visit|1
2980654|NCT01079962|10258741|P2|Overall Study|Inclusion/exclusion criteria|3
2980655|NCT01079962|10258742|P1|Overall Study|Inclusion/exclusion criteria|1
2980656|NCT01079962|10258741|P2|Overall Study|No blood pressure (BP) control|0
2980657|NCT01079962|10258742|P1|Overall Study|No blood pressure (BP) control|3
2980658|NCT01079962|10258741|P2|Overall Study|Protocol Violation|2
2980659|NCT01079962|10258742|P1|Overall Study|Protocol Violation|2
2980660|NCT01079962|10258741|P2|Overall Study|Withdrawal by Subject|7
2980661|NCT01079962|10258742|P1|Overall Study|Withdrawal by Subject|5
2980662|NCT01079962|10258741|P2|Overall Study|Adverse Event|2
2980663|NCT01079962|10258742|P1|Overall Study|Adverse Event|2
2980664|NCT01079949|10258770|P2|Overall Study|Randomized but not treated|0
2980665|NCT01079949|10258771|P1|Overall Study|Randomized but not treated|1
2980666|NCT01079949|10258770|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
2980667|NCT01079949|10258771|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
2980668|NCT01079949|10258770|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
2980669|NCT01079949|10258771|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
2980670|NCT01079949|10258770|P2|Overall Study|Withdrawal before r-hCG administration|3
2980671|NCT01079949|10258771|P1|Overall Study|Withdrawal before r-hCG administration|2
2980672|NCT01079936|10258817|P5|Phase II|Insurance Issue|1
2980673|NCT01079936|10258818|P4|Phase II|Insurance Issue|0
2980674|NCT01079936|10258819|P3|Phase II|Insurance Issue|0
2980675|NCT01079936|10258820|P2|Phase II|Insurance Issue|0
2980676|NCT01079936|10258821|P1|Phase II|Insurance Issue|0
2980677|NCT01079936|10258817|P5|Phase II|Adverse Event|0
2980678|NCT01079936|10258818|P4|Phase II|Adverse Event|0
2980679|NCT01079936|10258819|P3|Phase II|Adverse Event|1
2980680|NCT01079936|10258820|P2|Phase II|Adverse Event|0
2980681|NCT01079936|10258821|P1|Phase II|Adverse Event|0
2980682|NCT01079936|10258817|P5|Phase I: MTD|No Stem Cell Transplantation|0
2980683|NCT01079936|10258818|P4|Phase I: MTD|No Stem Cell Transplantation|0
2980684|NCT01079936|10258819|P3|Phase I: MTD|No Stem Cell Transplantation|0
2980685|NCT01079936|10258820|P2|Phase I: MTD|No Stem Cell Transplantation|0
2980686|NCT01079936|10258821|P1|Phase I: MTD|No Stem Cell Transplantation|2
2980687|NCT01079936|10258817|P5|Phase I: MTD|First Remission Status|0
2980688|NCT01079936|10258818|P4|Phase I: MTD|First Remission Status|0
2980689|NCT01079936|10258819|P3|Phase I: MTD|First Remission Status|0
2980690|NCT01079936|10258820|P2|Phase I: MTD|First Remission Status|0
2980691|NCT01079936|10258821|P1|Phase I: MTD|First Remission Status|2
2980692|NCT01079832|10258840|P1|Overall Study|Withdrawal by Subject|1
2980693|NCT01079806|10258850|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2980694|NCT01079806|10258851|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2980695|NCT01079806|10258850|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
2980696|NCT01079806|10258851|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
2980697|NCT01079806|10258850|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
2980698|NCT01079806|10258851|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
2980699|NCT01079806|10258850|P2|Day 1 to Week 96|Removal by Medical Monitor|1
2980700|NCT01079806|10258851|P1|Day 1 to Week 96|Removal by Medical Monitor|0
2980701|NCT01079806|10258850|P2|Day 1 to Week 96|Subject request to stop study treatment|0
2980702|NCT01079806|10258851|P1|Day 1 to Week 96|Subject request to stop study treatment|1
2980703|NCT01079806|10258850|P2|Day 1 to Week 96|Lost to Follow-up|0
2980704|NCT01079806|10258851|P1|Day 1 to Week 96|Lost to Follow-up|1
2980705|NCT01079806|10258850|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
2980706|NCT01079806|10258851|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
2980707|NCT01079806|10258850|P2|Day 1 to Week 96|Pregnancy|1
2980708|NCT01079806|10258851|P1|Day 1 to Week 96|Pregnancy|0
2980709|NCT01079806|10258850|P2|Day 1 to Week 96|Withdrawal by Subject|2
2980710|NCT01079806|10258851|P1|Day 1 to Week 96|Withdrawal by Subject|3
2980711|NCT01079806|10258850|P2|Day 1 to Week 96|Adverse Event|3
2980712|NCT01079806|10258851|P1|Day 1 to Week 96|Adverse Event|0
2980713|NCT01079741|10258886|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
2980714|NCT01079741|10258887|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2980715|NCT01079741|10258888|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2980716|NCT01079741|10258889|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2980717|NCT01079741|10258890|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2980718|NCT01079741|10258886|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2980719|NCT01079741|10258887|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2980720|NCT01079741|10258888|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2980721|NCT01079741|10258889|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
2980722|NCT01079741|10258890|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2980723|NCT01079234|10258938|P4|Extension: Week 27 to 52|Unclassified|7
2980724|NCT01079234|10258939|P3|Extension: Week 27 to 52|Unclassified|4
2980725|NCT01079234|10258940|P2|Extension: Week 27 to 52|Unclassified|0
2980726|NCT01079234|10258941|P1|Extension: Week 27 to 52|Unclassified|0
2980727|NCT01079234|10258938|P4|Extension: Week 27 to 52|Withdrawal criteria|2
2980728|NCT01079234|10258939|P3|Extension: Week 27 to 52|Withdrawal criteria|4
2980729|NCT01079234|10258940|P2|Extension: Week 27 to 52|Withdrawal criteria|0
2980730|NCT01079234|10258941|P1|Extension: Week 27 to 52|Withdrawal criteria|0
2980731|NCT01079234|10258938|P4|Extension: Week 27 to 52|Protocol Violation|5
2980732|NCT01079234|10258939|P3|Extension: Week 27 to 52|Protocol Violation|2
2980733|NCT01079234|10258940|P2|Extension: Week 27 to 52|Protocol Violation|0
2980734|NCT01079234|10258941|P1|Extension: Week 27 to 52|Protocol Violation|0
2980735|NCT01079234|10258938|P4|Extension: Week 27 to 52|Lack of Efficacy|2
2980736|NCT01079234|10258939|P3|Extension: Week 27 to 52|Lack of Efficacy|0
2980737|NCT01079234|10258940|P2|Extension: Week 27 to 52|Lack of Efficacy|0
2980738|NCT01079234|10258941|P1|Extension: Week 27 to 52|Lack of Efficacy|0
2980739|NCT01079234|10258938|P4|Extension: Week 27 to 52|Adverse Event|0
2980740|NCT01079234|10258939|P3|Extension: Week 27 to 52|Adverse Event|1
2980741|NCT01079234|10258940|P2|Extension: Week 27 to 52|Adverse Event|0
2980742|NCT01079234|10258941|P1|Extension: Week 27 to 52|Adverse Event|0
2980743|NCT01079234|10258938|P4|Main: Week 0 to 26|Unclassified|0
2980744|NCT01079234|10258939|P3|Main: Week 0 to 26|Unclassified|4
2980745|NCT01079234|10258940|P2|Main: Week 0 to 26|Unclassified|13
2980746|NCT01079234|10258941|P1|Main: Week 0 to 26|Unclassified|7
2980747|NCT01079234|10258938|P4|Main: Week 0 to 26|Withdrawal criteria|0
2980748|NCT01079234|10258939|P3|Main: Week 0 to 26|Withdrawal criteria|2
2980749|NCT01079234|10258940|P2|Main: Week 0 to 26|Withdrawal criteria|6
2980750|NCT01079234|10258941|P1|Main: Week 0 to 26|Withdrawal criteria|6
2980751|NCT01079234|10258938|P4|Main: Week 0 to 26|Protocol Violation|0
2980752|NCT01079234|10258939|P3|Main: Week 0 to 26|Protocol Violation|4
2980753|NCT01079234|10258940|P2|Main: Week 0 to 26|Protocol Violation|2
2980754|NCT01079234|10258941|P1|Main: Week 0 to 26|Protocol Violation|6
2980755|NCT01079234|10258938|P4|Main: Week 0 to 26|Lack of Efficacy|0
2980756|NCT01079234|10258939|P3|Main: Week 0 to 26|Lack of Efficacy|1
2980757|NCT01079234|10258940|P2|Main: Week 0 to 26|Lack of Efficacy|1
2980758|NCT01079234|10258941|P1|Main: Week 0 to 26|Lack of Efficacy|2
2980759|NCT01079234|10258938|P4|Main: Week 0 to 26|Adverse Event|0
2980760|NCT01079234|10258939|P3|Main: Week 0 to 26|Adverse Event|1
2980761|NCT01079234|10258940|P2|Main: Week 0 to 26|Adverse Event|4
2980762|NCT01079234|10258941|P1|Main: Week 0 to 26|Adverse Event|5
2980763|NCT01079195|10258959|P1|Overall Study|Non-compliance|2
2980764|NCT01079195|10258959|P1|Overall Study|No Follow-up Documentation Available|4
2980765|NCT01079195|10258959|P1|Overall Study|Improved Status of Participant|4
2980766|NCT01079195|10258959|P1|Overall Study|Physician Decision|4
2980767|NCT01079195|10258959|P1|Overall Study|Lack of Effectiveness|12
2980768|NCT01079195|10258959|P1|Overall Study|Financial Reasons|15
2980769|NCT01079195|10258959|P1|Overall Study|Withdrawal by Subject|18
2980770|NCT01079195|10258959|P1|Overall Study|Reason Unknown|39
2980771|NCT01079195|10258959|P1|Overall Study|Adverse Event|157
2980772|NCT01079195|10258959|P1|Overall Study|No Documentation Available|437
2980773|NCT01079195|10258959|P1|Overall Study|No Documentation of Tarka Therapy|739
2980774|NCT01079182|10258965|P1|Overall Study|Reasons not Evaluated|271
2980775|NCT01079182|10258965|P1|Overall Study|ADR and Lack of Effectiveness|39
2980776|NCT01079182|10258965|P1|Overall Study|Lack of Efficacy|514
2980777|NCT01079182|10258965|P1|Overall Study|Adverse Drug Reaction (ADR)|261
2980778|NCT01079182|10258965|P1|Overall Study|Lost to Follow-up|1634
2980779|NCT01079130|10259073|P6|Overall Study|Lost to Follow-up|0
2980780|NCT01079130|10259074|P5|Overall Study|Lost to Follow-up|1
2980781|NCT01079130|10259075|P4|Overall Study|Lost to Follow-up|0
2980782|NCT01079130|10259076|P3|Overall Study|Lost to Follow-up|0
2980783|NCT01079130|10259077|P2|Overall Study|Lost to Follow-up|0
2980784|NCT01079130|10259078|P1|Overall Study|Lost to Follow-up|0
2980785|NCT01079130|10259073|P6|Overall Study|Unsatisfactory therapeutic effect|0
2980786|NCT01079130|10259074|P5|Overall Study|Unsatisfactory therapeutic effect|0
2980787|NCT01079130|10259075|P4|Overall Study|Unsatisfactory therapeutic effect|2
2980788|NCT01079130|10259076|P3|Overall Study|Unsatisfactory therapeutic effect|0
2980789|NCT01079130|10259077|P2|Overall Study|Unsatisfactory therapeutic effect|0
2980790|NCT01079130|10259078|P1|Overall Study|Unsatisfactory therapeutic effect|0
2980791|NCT01079130|10259073|P6|Overall Study|Abnormal test procedure result(s)|0
2980792|NCT01079130|10259074|P5|Overall Study|Abnormal test procedure result(s)|1
2980793|NCT01079130|10259075|P4|Overall Study|Abnormal test procedure result(s)|0
2980794|NCT01079130|10259076|P3|Overall Study|Abnormal test procedure result(s)|0
2980795|NCT01079130|10259077|P2|Overall Study|Abnormal test procedure result(s)|0
2980796|NCT01079130|10259078|P1|Overall Study|Abnormal test procedure result(s)|0
2980797|NCT01079130|10259073|P6|Overall Study|Protocol deviation|0
2980798|NCT01079130|10259074|P5|Overall Study|Protocol deviation|0
2980799|NCT01079130|10259075|P4|Overall Study|Protocol deviation|2
2980800|NCT01079130|10259076|P3|Overall Study|Protocol deviation|1
2980801|NCT01079130|10259077|P2|Overall Study|Protocol deviation|2
2980802|NCT01079130|10259078|P1|Overall Study|Protocol deviation|0
2980803|NCT01079130|10259073|P6|Overall Study|Withdrawal by Subject|3
2980804|NCT01079130|10259074|P5|Overall Study|Withdrawal by Subject|1
2980805|NCT01079130|10259075|P4|Overall Study|Withdrawal by Subject|0
2980806|NCT01079130|10259076|P3|Overall Study|Withdrawal by Subject|0
2980807|NCT01079130|10259077|P2|Overall Study|Withdrawal by Subject|1
2980808|NCT01079130|10259078|P1|Overall Study|Withdrawal by Subject|0
2980809|NCT01079130|10259073|P6|Overall Study|Administrative problems|1
2980810|NCT01079130|10259074|P5|Overall Study|Administrative problems|0
2980811|NCT01079130|10259075|P4|Overall Study|Administrative problems|0
2980812|NCT01079130|10259076|P3|Overall Study|Administrative problems|0
2980813|NCT01079130|10259077|P2|Overall Study|Administrative problems|3
2980814|NCT01079130|10259078|P1|Overall Study|Administrative problems|1
2980815|NCT01079130|10259073|P6|Overall Study|Adverse Event|1
2980816|NCT01079130|10259074|P5|Overall Study|Adverse Event|5
2980817|NCT01079130|10259075|P4|Overall Study|Adverse Event|1
2980818|NCT01079130|10259076|P3|Overall Study|Adverse Event|0
2980819|NCT01079130|10259077|P2|Overall Study|Adverse Event|1
2980820|NCT01079130|10259078|P1|Overall Study|Adverse Event|1
2980821|NCT01078974|10259098|P1|Overall Study|Adverse Event|3
2980822|NCT01078922|10259103|P1|Overall Study|Adverse Event|1
2980823|NCT01078805|10259144|P1|Overall Study|Didn't take study drug|82
2980824|NCT01078805|10259144|P1|Overall Study|Other|173
2980825|NCT01078805|10259144|P1|Overall Study|Withdrawal by Subject|739
2980826|NCT01078805|10259144|P1|Overall Study|Sponsor decision|46
2980827|NCT01078805|10259144|P1|Overall Study|Serious adverse event|26
2980828|NCT01078805|10259144|P1|Overall Study|Physician Decision|169
2980829|NCT01078805|10259144|P1|Overall Study|Lost to Follow-up|676
2980830|NCT01078805|10259144|P1|Overall Study|Death|134
2980831|NCT01078805|10259144|P1|Overall Study|Clinically significant abnormal lab|5
2980832|NCT01078675|10259171|P2|Overall Study|Adverse Event|0
2980833|NCT01078675|10259172|P1|Overall Study|Adverse Event|3
2980834|NCT01078675|10259171|P2|Overall Study|Provided in CRF for specific reasons|3
2980835|NCT01078675|10259172|P1|Overall Study|Provided in CRF for specific reasons|2
2980836|NCT01078675|10259171|P2|Overall Study|Protocol Violation|0
2980837|NCT01078675|10259172|P1|Overall Study|Protocol Violation|56
2980838|NCT01078675|10259171|P2|Overall Study|Withdrawal by Subject|3
2980839|NCT01078675|10259172|P1|Overall Study|Withdrawal by Subject|7
2980840|NCT01078662|10259194|P5|Overall Study|Lost to Follow-up|0
2980841|NCT01078662|10259195|P4|Overall Study|Lost to Follow-up|0
2980842|NCT01078662|10259196|P3|Overall Study|Lost to Follow-up|0
2980843|NCT01078662|10259197|P2|Overall Study|Lost to Follow-up|0
2980844|NCT01078662|10259198|P1|Overall Study|Lost to Follow-up|1
2980845|NCT01078662|10259194|P5|Overall Study|Protocol Violation|0
2980846|NCT01078662|10259195|P4|Overall Study|Protocol Violation|0
2980847|NCT01078662|10259196|P3|Overall Study|Protocol Violation|0
2980848|NCT01078662|10259197|P2|Overall Study|Protocol Violation|1
2980849|NCT01078662|10259198|P1|Overall Study|Protocol Violation|0
2980850|NCT01078662|10259194|P5|Overall Study|Withdrawal by Subject|0
2980851|NCT01078662|10259195|P4|Overall Study|Withdrawal by Subject|0
2980852|NCT01078662|10259196|P3|Overall Study|Withdrawal by Subject|1
2980853|NCT01078662|10259197|P2|Overall Study|Withdrawal by Subject|11
2980854|NCT01078662|10259198|P1|Overall Study|Withdrawal by Subject|4
2980855|NCT01078662|10259194|P5|Overall Study|Patients reached data cut-off|3
2980856|NCT01078662|10259195|P4|Overall Study|Patients reached data cut-off|2
2980857|NCT01078662|10259196|P3|Overall Study|Patients reached data cut-off|2
2980858|NCT01078662|10259197|P2|Overall Study|Patients reached data cut-off|53
2980859|NCT01078662|10259198|P1|Overall Study|Patients reached data cut-off|12
2980860|NCT01078662|10259194|P5|Overall Study|Death|8
2980861|NCT01078662|10259195|P4|Overall Study|Death|5
2980862|NCT01078662|10259196|P3|Overall Study|Death|18
2980863|NCT01078662|10259197|P2|Overall Study|Death|103
2980864|NCT01078662|10259198|P1|Overall Study|Death|41
2980865|NCT01078623|10259237|P20|Treatment Period 4|Withdrawal by Subject|0
2980866|NCT01078623|10259238|P19|Treatment Period 4|Withdrawal by Subject|0
2980867|NCT01078623|10259239|P18|Treatment Period 4|Withdrawal by Subject|0
2980868|NCT01078623|10259240|P17|Treatment Period 4|Withdrawal by Subject|0
2980869|NCT01078623|10259241|P16|Treatment Period 4|Withdrawal by Subject|1
2980870|NCT01078623|10259242|P15|Treatment Period 4|Withdrawal by Subject|0
2980871|NCT01078623|10259243|P14|Treatment Period 4|Withdrawal by Subject|0
2980872|NCT01078623|10259244|P13|Treatment Period 4|Withdrawal by Subject|0
2980873|NCT01078623|10259245|P12|Treatment Period 4|Withdrawal by Subject|0
2980874|NCT01078623|10259246|P11|Treatment Period 4|Withdrawal by Subject|0
2980875|NCT01078623|10259247|P10|Treatment Period 4|Withdrawal by Subject|0
2980876|NCT01078623|10259248|P9|Treatment Period 4|Withdrawal by Subject|0
2980877|NCT01078623|10259249|P8|Treatment Period 4|Withdrawal by Subject|0
2980878|NCT01078623|10259250|P7|Treatment Period 4|Withdrawal by Subject|0
2980879|NCT01078623|10259251|P6|Treatment Period 4|Withdrawal by Subject|0
2980880|NCT01078623|10259252|P5|Treatment Period 4|Withdrawal by Subject|0
2980881|NCT01078623|10259253|P4|Treatment Period 4|Withdrawal by Subject|0
2980882|NCT01078623|10259254|P3|Treatment Period 4|Withdrawal by Subject|0
2980883|NCT01078623|10259255|P2|Treatment Period 4|Withdrawal by Subject|0
2980884|NCT01078623|10259256|P1|Treatment Period 4|Withdrawal by Subject|0
2980885|NCT01078623|10259237|P20|Treatment Period 4|Adverse Event|0
2980886|NCT01078623|10259238|P19|Treatment Period 4|Adverse Event|0
2980887|NCT01078623|10259239|P18|Treatment Period 4|Adverse Event|0
2980888|NCT01078623|10259240|P17|Treatment Period 4|Adverse Event|0
2980889|NCT01078623|10259241|P16|Treatment Period 4|Adverse Event|0
2980890|NCT01078623|10259242|P15|Treatment Period 4|Adverse Event|0
2980891|NCT01078623|10259243|P14|Treatment Period 4|Adverse Event|0
2980892|NCT01078623|10259244|P13|Treatment Period 4|Adverse Event|0
2980893|NCT01078623|10259245|P12|Treatment Period 4|Adverse Event|0
2980894|NCT01078623|10259246|P11|Treatment Period 4|Adverse Event|0
2980895|NCT01078623|10259247|P10|Treatment Period 4|Adverse Event|0
2980896|NCT01078623|10259248|P9|Treatment Period 4|Adverse Event|0
2980897|NCT01078623|10259249|P8|Treatment Period 4|Adverse Event|0
2980898|NCT01078623|10259250|P7|Treatment Period 4|Adverse Event|0
2980899|NCT01078623|10259251|P6|Treatment Period 4|Adverse Event|0
2980900|NCT01078623|10259252|P5|Treatment Period 4|Adverse Event|0
2980901|NCT01078623|10259253|P4|Treatment Period 4|Adverse Event|0
2980902|NCT01078623|10259254|P3|Treatment Period 4|Adverse Event|1
2980903|NCT01078623|10259255|P2|Treatment Period 4|Adverse Event|0
2980904|NCT01078623|10259256|P1|Treatment Period 4|Adverse Event|0
2980905|NCT01078623|10259237|P20|Treatment Period 3|Adverse Event|0
2980906|NCT01078623|10259238|P19|Treatment Period 3|Adverse Event|0
2980907|NCT01078623|10259239|P18|Treatment Period 3|Adverse Event|0
2980908|NCT01078623|10259240|P17|Treatment Period 3|Adverse Event|0
2980909|NCT01078623|10259241|P16|Treatment Period 3|Adverse Event|0
2980910|NCT01078623|10259242|P15|Treatment Period 3|Adverse Event|0
2980911|NCT01078623|10259243|P14|Treatment Period 3|Adverse Event|1
2980912|NCT01078623|10259244|P13|Treatment Period 3|Adverse Event|0
2980913|NCT01078623|10259245|P12|Treatment Period 3|Adverse Event|0
2980914|NCT01078623|10259246|P11|Treatment Period 3|Adverse Event|0
2980915|NCT01078623|10259247|P10|Treatment Period 3|Adverse Event|0
2980916|NCT01078623|10259248|P9|Treatment Period 3|Adverse Event|0
2980917|NCT01078623|10259249|P8|Treatment Period 3|Adverse Event|0
2980918|NCT01078623|10259250|P7|Treatment Period 3|Adverse Event|0
2980919|NCT01078623|10259251|P6|Treatment Period 3|Adverse Event|0
2980920|NCT01078623|10259252|P5|Treatment Period 3|Adverse Event|1
2980921|NCT01078623|10259253|P4|Treatment Period 3|Adverse Event|0
2980922|NCT01078623|10259254|P3|Treatment Period 3|Adverse Event|0
2980923|NCT01078623|10259255|P2|Treatment Period 3|Adverse Event|0
2980924|NCT01078623|10259256|P1|Treatment Period 3|Adverse Event|0
2980925|NCT01078623|10259237|P20|Treatment Period 2|Withdrawal by Subject|0
2980926|NCT01078623|10259238|P19|Treatment Period 2|Withdrawal by Subject|0
2980927|NCT01078623|10259239|P18|Treatment Period 2|Withdrawal by Subject|0
2980928|NCT01078623|10259240|P17|Treatment Period 2|Withdrawal by Subject|0
2980929|NCT01078623|10259241|P16|Treatment Period 2|Withdrawal by Subject|0
2980930|NCT01078623|10259242|P15|Treatment Period 2|Withdrawal by Subject|0
2980931|NCT01078623|10259243|P14|Treatment Period 2|Withdrawal by Subject|0
2980932|NCT01078623|10259244|P13|Treatment Period 2|Withdrawal by Subject|0
2980933|NCT01078623|10259245|P12|Treatment Period 2|Withdrawal by Subject|0
2980934|NCT01078623|10259246|P11|Treatment Period 2|Withdrawal by Subject|0
2980935|NCT01078623|10259247|P10|Treatment Period 2|Withdrawal by Subject|0
2980936|NCT01078623|10259248|P9|Treatment Period 2|Withdrawal by Subject|0
2980937|NCT01078623|10259249|P8|Treatment Period 2|Withdrawal by Subject|0
2980938|NCT01078623|10259250|P7|Treatment Period 2|Withdrawal by Subject|0
2980939|NCT01078623|10259251|P6|Treatment Period 2|Withdrawal by Subject|1
2980940|NCT01078623|10259252|P5|Treatment Period 2|Withdrawal by Subject|0
2980941|NCT01078623|10259253|P4|Treatment Period 2|Withdrawal by Subject|0
2980942|NCT01078623|10259254|P3|Treatment Period 2|Withdrawal by Subject|0
2980943|NCT01078623|10259255|P2|Treatment Period 2|Withdrawal by Subject|0
2980944|NCT01078623|10259256|P1|Treatment Period 2|Withdrawal by Subject|0
2980945|NCT01078623|10259237|P20|Treatment Period 2|Adverse Event|0
2980946|NCT01078623|10259238|P19|Treatment Period 2|Adverse Event|1
2980947|NCT01078623|10259239|P18|Treatment Period 2|Adverse Event|0
2980948|NCT01078623|10259240|P17|Treatment Period 2|Adverse Event|0
2980949|NCT01078623|10259241|P16|Treatment Period 2|Adverse Event|0
2980950|NCT01078623|10259242|P15|Treatment Period 2|Adverse Event|0
2980951|NCT01078623|10259243|P14|Treatment Period 2|Adverse Event|0
2980952|NCT01078623|10259244|P13|Treatment Period 2|Adverse Event|0
2980953|NCT01078623|10259245|P12|Treatment Period 2|Adverse Event|0
2980954|NCT01078623|10259246|P11|Treatment Period 2|Adverse Event|0
2980955|NCT01078623|10259247|P10|Treatment Period 2|Adverse Event|0
2980956|NCT01078623|10259248|P9|Treatment Period 2|Adverse Event|0
2980957|NCT01078623|10259249|P8|Treatment Period 2|Adverse Event|0
2980958|NCT01078623|10259250|P7|Treatment Period 2|Adverse Event|1
2980959|NCT01078623|10259251|P6|Treatment Period 2|Adverse Event|0
2980960|NCT01078623|10259252|P5|Treatment Period 2|Adverse Event|0
2980961|NCT01078623|10259253|P4|Treatment Period 2|Adverse Event|0
2980962|NCT01078623|10259254|P3|Treatment Period 2|Adverse Event|0
2980963|NCT01078623|10259255|P2|Treatment Period 2|Adverse Event|0
2980964|NCT01078623|10259256|P1|Treatment Period 2|Adverse Event|0
2980965|NCT01078623|10259237|P20|Treatment Period 1|Protocol Violation|0
2980966|NCT01078623|10259238|P19|Treatment Period 1|Protocol Violation|0
2980967|NCT01078623|10259239|P18|Treatment Period 1|Protocol Violation|0
2980968|NCT01078623|10259240|P17|Treatment Period 1|Protocol Violation|0
2980969|NCT01078623|10259241|P16|Treatment Period 1|Protocol Violation|0
2980970|NCT01078623|10259242|P15|Treatment Period 1|Protocol Violation|0
2980971|NCT01078623|10259243|P14|Treatment Period 1|Protocol Violation|0
2980972|NCT01078623|10259244|P13|Treatment Period 1|Protocol Violation|0
2980973|NCT01078623|10259245|P12|Treatment Period 1|Protocol Violation|0
2980974|NCT01078623|10259246|P11|Treatment Period 1|Protocol Violation|0
2980975|NCT01078623|10259247|P10|Treatment Period 1|Protocol Violation|0
2980976|NCT01078623|10259248|P9|Treatment Period 1|Protocol Violation|0
2980977|NCT01078623|10259249|P8|Treatment Period 1|Protocol Violation|0
2980978|NCT01078623|10259250|P7|Treatment Period 1|Protocol Violation|0
2980979|NCT01078623|10259251|P6|Treatment Period 1|Protocol Violation|1
2980980|NCT01078623|10259252|P5|Treatment Period 1|Protocol Violation|0
2980981|NCT01078623|10259253|P4|Treatment Period 1|Protocol Violation|0
2980982|NCT01078623|10259254|P3|Treatment Period 1|Protocol Violation|0
2980983|NCT01078623|10259255|P2|Treatment Period 1|Protocol Violation|0
2980984|NCT01078623|10259256|P1|Treatment Period 1|Protocol Violation|0
2980985|NCT01078623|10259237|P20|Treatment Period 1|Withdrawal by Subject|0
2980986|NCT01078623|10259238|P19|Treatment Period 1|Withdrawal by Subject|0
2980987|NCT01078623|10259239|P18|Treatment Period 1|Withdrawal by Subject|0
2980988|NCT01078623|10259240|P17|Treatment Period 1|Withdrawal by Subject|0
2980989|NCT01078623|10259241|P16|Treatment Period 1|Withdrawal by Subject|0
2980990|NCT01078623|10259242|P15|Treatment Period 1|Withdrawal by Subject|0
2980991|NCT01078623|10259243|P14|Treatment Period 1|Withdrawal by Subject|0
2980992|NCT01078623|10259244|P13|Treatment Period 1|Withdrawal by Subject|0
2980993|NCT01078623|10259245|P12|Treatment Period 1|Withdrawal by Subject|0
2980994|NCT01078623|10259246|P11|Treatment Period 1|Withdrawal by Subject|1
2980995|NCT01078623|10259247|P10|Treatment Period 1|Withdrawal by Subject|0
2980996|NCT01078623|10259248|P9|Treatment Period 1|Withdrawal by Subject|0
2980997|NCT01078623|10259249|P8|Treatment Period 1|Withdrawal by Subject|1
2980998|NCT01078623|10259250|P7|Treatment Period 1|Withdrawal by Subject|0
2980999|NCT01078623|10259251|P6|Treatment Period 1|Withdrawal by Subject|0
2981000|NCT01078623|10259252|P5|Treatment Period 1|Withdrawal by Subject|0
2981001|NCT01078623|10259253|P4|Treatment Period 1|Withdrawal by Subject|0
2981002|NCT01078623|10259254|P3|Treatment Period 1|Withdrawal by Subject|0
2981003|NCT01078623|10259255|P2|Treatment Period 1|Withdrawal by Subject|0
2981004|NCT01078623|10259256|P1|Treatment Period 1|Withdrawal by Subject|0
2981005|NCT01078623|10259237|P20|Treatment Period 1|Adverse Event|0
2981006|NCT01078623|10259238|P19|Treatment Period 1|Adverse Event|0
2981007|NCT01078623|10259239|P18|Treatment Period 1|Adverse Event|0
2981008|NCT01078623|10259240|P17|Treatment Period 1|Adverse Event|0
2981009|NCT01078623|10259241|P16|Treatment Period 1|Adverse Event|0
2981010|NCT01078623|10259242|P15|Treatment Period 1|Adverse Event|0
2981011|NCT01078623|10259243|P14|Treatment Period 1|Adverse Event|0
2981012|NCT01078623|10259244|P13|Treatment Period 1|Adverse Event|0
2981013|NCT01078623|10259245|P12|Treatment Period 1|Adverse Event|0
2981014|NCT01078623|10259246|P11|Treatment Period 1|Adverse Event|0
2981015|NCT01078623|10259247|P10|Treatment Period 1|Adverse Event|1
2981016|NCT01078623|10259248|P9|Treatment Period 1|Adverse Event|1
2981017|NCT01078623|10259249|P8|Treatment Period 1|Adverse Event|0
2981018|NCT01078623|10259250|P7|Treatment Period 1|Adverse Event|1
2981019|NCT01078623|10259251|P6|Treatment Period 1|Adverse Event|0
2981020|NCT01078623|10259252|P5|Treatment Period 1|Adverse Event|0
2981021|NCT01078623|10259253|P4|Treatment Period 1|Adverse Event|0
2981022|NCT01078623|10259254|P3|Treatment Period 1|Adverse Event|1
2981023|NCT01078623|10259255|P2|Treatment Period 1|Adverse Event|1
2981024|NCT01078623|10259256|P1|Treatment Period 1|Adverse Event|1
2981025|NCT01078584|10259278|P1|Overall Study|Multiple Reasons|2
2981026|NCT01078584|10259278|P1|Overall Study|Serious Adverse Event|27
2981027|NCT01078584|10259278|P1|Overall Study|Protocol Violation|75
2981028|NCT01078584|10259278|P1|Overall Study|Lack of Efficacy|98
2981029|NCT01078584|10259278|P1|Overall Study|Physician Discontinued Patient|12
2981030|NCT01078584|10259278|P1|Overall Study|Physician Switched Medication|26
2981031|NCT01078584|10259278|P1|Overall Study|Blood Pressure Controlled|49
2981032|NCT01078584|10259278|P1|Overall Study|Non-compliance|67
2981033|NCT01078584|10259278|P1|Overall Study|Physician Withdrew from Study|90
2981034|NCT01078584|10259278|P1|Overall Study|Withdrawal of Consent|244
2981035|NCT01078584|10259278|P1|Overall Study|Non-serious Adverse Event|577
2981036|NCT01078584|10259278|P1|Overall Study|Lost to Follow-up|670
2981037|NCT01078584|10259278|P1|Overall Study|Final Status Unknown|1073
2981038|NCT01078571|10259359|P1|Overall Study|Protocol Violation|2
2981039|NCT01078571|10259359|P1|Overall Study|Lost to Follow-up|8
2981040|NCT01078571|10259359|P1|Overall Study|Withdrawal by Subject|12
2981041|NCT01078571|10259359|P1|Overall Study|Reason not reported|21
2981042|NCT01078571|10259359|P1|Overall Study|Lack of effectiveness|36
2981043|NCT01078571|10259359|P1|Overall Study|Adverse Event|36
2981044|NCT01078545|10259410|P1|Overall Study|Participant moved to another physician|1
2981045|NCT01078545|10259410|P1|Overall Study|Death|3
2981046|NCT01078545|10259410|P1|Overall Study|Withdrawal by Subject|3
2981047|NCT01078545|10259410|P1|Overall Study|Physician Decision|6
2981048|NCT01078545|10259410|P1|Overall Study|Lost to Follow-up|13
2981049|NCT01078454|10259420|P2|Overall Study|Death|1
2981050|NCT01078454|10259421|P1|Overall Study|Death|0
2981051|NCT01078454|10259420|P2|Overall Study|Adverse Event|1
2981052|NCT01078454|10259421|P1|Overall Study|Adverse Event|1
2981053|NCT01078441|10259427|P1|Overall Study|Withdrawal by Subject|1
2981054|NCT01078389|10259467|P2|Overall Study|Other|2
2981055|NCT01078389|10259468|P1|Overall Study|Other|9
2981056|NCT01078389|10259467|P2|Overall Study|Voluntary Withdrawal|36
2981057|NCT01078389|10259468|P1|Overall Study|Voluntary Withdrawal|20
2981058|NCT01078389|10259467|P2|Overall Study|Lost to Follow-up|23
2981059|NCT01078389|10259468|P1|Overall Study|Lost to Follow-up|23
2981060|NCT01078389|10259467|P2|Overall Study|Major Protocol Deviation|0
2981061|NCT01078389|10259468|P1|Overall Study|Major Protocol Deviation|2
2981062|NCT01078389|10259467|P2|Overall Study|Adverse Event|6
2981063|NCT01078389|10259468|P1|Overall Study|Adverse Event|10
2981064|NCT01078298|10259629|P2|Overall Study|Other|32
2981065|NCT01078298|10259630|P1|Overall Study|Other|24
2981066|NCT01078298|10259629|P2|Overall Study|Did not meet entrance criteria|1
2981067|NCT01078298|10259630|P1|Overall Study|Did not meet entrance criteria|0
2981068|NCT01078298|10259629|P2|Overall Study|Death|0
2981069|NCT01078298|10259630|P1|Overall Study|Death|2
2981070|NCT01078298|10259629|P2|Overall Study|Adverse Event|5
2981071|NCT01078298|10259630|P1|Overall Study|Adverse Event|6
2981072|NCT01078298|10259629|P2|Overall Study|Protocol Violation|6
2981073|NCT01078298|10259630|P1|Overall Study|Protocol Violation|6
2981074|NCT01078298|10259629|P2|Overall Study|Withdrawal by Subject|33
2981075|NCT01078298|10259630|P1|Overall Study|Withdrawal by Subject|31
2981076|NCT01078298|10259629|P2|Overall Study|Lost to Follow-up|13
2981077|NCT01078298|10259630|P1|Overall Study|Lost to Follow-up|12
2981078|NCT01078168|10259740|P2|Overall Study|Physician Decision|1
2981079|NCT01078168|10259741|P1|Overall Study|Physician Decision|0
2981080|NCT01078155|10259747|P1|Overall Study|Lost to Follow-up|15
2981081|NCT01078155|10259747|P1|Overall Study|Participant's Decision|6
2981082|NCT01078155|10259747|P1|Overall Study|Lack of Efficacy|16
2981083|NCT01078155|10259747|P1|Overall Study|Adverse Event|7
2981084|NCT01078116|10259763|P1|Overall Study|Case report form not completed|3
2981085|NCT01078116|10259763|P1|Overall Study|Lack of effectiveness|15
2981086|NCT01078116|10259763|P1|Overall Study|Withdrawal by Subject|8
2981087|NCT01078116|10259763|P1|Overall Study|Adverse Event|5
2981088|NCT01078116|10259763|P1|Overall Study|Lost to Follow-up|17
2981089|NCT01078090|10259771|P1|Overall Study|Other|523
2981090|NCT01078090|10259771|P1|Overall Study|ADR and lack of efficacy|61
2981091|NCT01078090|10259771|P1|Overall Study|Lack of Efficacy|1193
2981092|NCT01078090|10259771|P1|Overall Study|Adverse drug reaction (ADR)|453
2981093|NCT01078090|10259771|P1|Overall Study|Lost to Follow-up|2363
2981094|NCT01077960|10259865|P1|Overall Study|Reason unspecified|1
2981095|NCT01077960|10259865|P1|Overall Study|Subject decision|1
2981096|NCT01077960|10259865|P1|Overall Study|Lost to Follow-up|5
2981097|NCT01077960|10259865|P1|Overall Study|Protocol Violation|3
2981098|NCT01077960|10259865|P1|Overall Study|Adverse Event|6
2981099|NCT01077804|10260115|P1|Overall Study|Other|18
2981100|NCT01077804|10260115|P1|Overall Study|Refused to continue|79
2981101|NCT01077804|10260115|P1|Overall Study|Unreachable|102
2981102|NCT01077739|10260124|P2|Overall Study|Other|2
2981103|NCT01077739|10260125|P1|Overall Study|Other|2
2981104|NCT01077739|10260124|P2|Overall Study|Unacceptable toxicity|2
2981105|NCT01077739|10260125|P1|Overall Study|Unacceptable toxicity|1
2981106|NCT01077739|10260124|P2|Overall Study|Death|3
2981107|NCT01077739|10260125|P1|Overall Study|Death|0
2981108|NCT01077739|10260124|P2|Overall Study|Withdrawal by Subject|0
2981109|NCT01077739|10260125|P1|Overall Study|Withdrawal by Subject|1
2981110|NCT01077739|10260124|P2|Overall Study|Premature withdrawal|3
2981111|NCT01077739|10260125|P1|Overall Study|Premature withdrawal|1
2981112|NCT01077713|10260139|P2|Overall Study|Other|2
2981113|NCT01077713|10260140|P1|Overall Study|Other|4
2981114|NCT01077713|10260139|P2|Overall Study|Adverse Event|1
2981115|NCT01077713|10260140|P1|Overall Study|Adverse Event|2
2981116|NCT01077713|10260139|P2|Overall Study|Lost to Follow-up|1
2981117|NCT01077713|10260140|P1|Overall Study|Lost to Follow-up|1
2981118|NCT01077713|10260139|P2|Overall Study|Death|29
2981119|NCT01077713|10260140|P1|Overall Study|Death|28
2981120|NCT01077713|10260139|P2|Overall Study|Progressive Disease (PD)|1
2981121|NCT01077713|10260140|P1|Overall Study|Progressive Disease (PD)|0
2981122|NCT01077713|10260139|P2|Overall Study|Withdrawal by Subject|2
2981123|NCT01077713|10260140|P1|Overall Study|Withdrawal by Subject|1
2981124|NCT01077622|10260164|P1|Overall Study|Withdrawal by Subject|1
2981125|NCT01077622|10260164|P1|Overall Study|Physician Decision|2
2981126|NCT01077544|10260284|P2|Overall Study|Disease Progression|1
2981127|NCT01077544|10260285|P1|Overall Study|Disease Progression|0
2981128|NCT01077544|10260284|P2|Overall Study|Adverse Event|1
2981129|NCT01077544|10260285|P1|Overall Study|Adverse Event|0
2981130|NCT01077544|10260284|P2|Overall Study|New Cancer Therapy|3
2981131|NCT01077544|10260285|P1|Overall Study|New Cancer Therapy|3
2981132|NCT01077518|10260313|P3|Optional Ofa Phase|Withdrawal by Subject|3
2981133|NCT01077518|10260314|P2|Optional Ofa Phase|Withdrawal by Subject|0
2981134|NCT01077518|10260315|P1|Optional Ofa Phase|Withdrawal by Subject|0
2981135|NCT01077518|10260313|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
2981136|NCT01077518|10260314|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
2981137|NCT01077518|10260315|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
2981138|NCT01077518|10260313|P3|Optional Ofa Phase|Physician Decision|1
2981139|NCT01077518|10260314|P2|Optional Ofa Phase|Physician Decision|0
2981140|NCT01077518|10260315|P1|Optional Ofa Phase|Physician Decision|0
2981141|NCT01077518|10260313|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
2981142|NCT01077518|10260314|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
2981143|NCT01077518|10260315|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
2981144|NCT01077518|10260313|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
2981145|NCT01077518|10260314|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
2981146|NCT01077518|10260315|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
2981147|NCT01077518|10260313|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
2981148|NCT01077518|10260314|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
2981149|NCT01077518|10260315|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
2981150|NCT01077518|10260313|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
2981151|NCT01077518|10260314|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
2981152|NCT01077518|10260315|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
2981153|NCT01077375|10260388|P2|Overall Study|Other Reason|1
2981154|NCT01077375|10260389|P1|Overall Study|Other Reason|0
2981155|NCT01077375|10260388|P2|Overall Study|Lost to Follow-up|5
2981156|NCT01077375|10260389|P1|Overall Study|Lost to Follow-up|2
2981157|NCT01077375|10260388|P2|Overall Study|Withdrawal by Subject|6
2981158|NCT01077375|10260389|P1|Overall Study|Withdrawal by Subject|0
2981159|NCT01077375|10260388|P2|Overall Study|Lack of Efficacy|8
2981160|NCT01077375|10260389|P1|Overall Study|Lack of Efficacy|6
2981161|NCT01077375|10260388|P2|Overall Study|Adverse Event|15
2981162|NCT01077375|10260389|P1|Overall Study|Adverse Event|2
2981163|NCT01077362|10260400|P3|Overall Study|Other|2
2981164|NCT01077362|10260401|P2|Overall Study|Other|1
2981165|NCT01077362|10260402|P1|Overall Study|Other|0
2981166|NCT01077362|10260400|P3|Overall Study|Withdrawal by Subject|5
2981167|NCT01077362|10260401|P2|Overall Study|Withdrawal by Subject|3
2981168|NCT01077362|10260402|P1|Overall Study|Withdrawal by Subject|5
2981169|NCT01077362|10260400|P3|Overall Study|Adverse Event|4
2981170|NCT01077362|10260401|P2|Overall Study|Adverse Event|7
2981171|NCT01077362|10260402|P1|Overall Study|Adverse Event|12
2981172|NCT01077362|10260400|P3|Overall Study|Lost to Follow-up|3
2981173|NCT01077362|10260401|P2|Overall Study|Lost to Follow-up|0
2981174|NCT01077362|10260402|P1|Overall Study|Lost to Follow-up|1
2981175|NCT01077362|10260400|P3|Overall Study|Lack of Efficacy|10
2981176|NCT01077362|10260401|P2|Overall Study|Lack of Efficacy|8
2981177|NCT01077362|10260402|P1|Overall Study|Lack of Efficacy|13
2981178|NCT01077323|10260438|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
2981179|NCT01077323|10260439|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
2981180|NCT01077323|10260440|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
2981181|NCT01077323|10260438|P3|Overall Study|Dispensing of drug in baseline period|256446
2981182|NCT01077323|10260439|P2|Overall Study|Dispensing of drug in baseline period|120229
2981183|NCT01077323|10260440|P1|Overall Study|Dispensing of drug in baseline period|0
2981184|NCT01077323|10260438|P3|Overall Study|<9 months enroll before drug dispensed|11655523
2981185|NCT01077323|10260439|P2|Overall Study|<9 months enroll before drug dispensed|263954
2981186|NCT01077323|10260440|P1|Overall Study|<9 months enroll before drug dispensed|11226
2981187|NCT01077284|10260483|P3|Overall Study|Other|1
2981188|NCT01077284|10260484|P2|Overall Study|Other|0
2981189|NCT01077284|10260485|P1|Overall Study|Other|0
2981190|NCT01077284|10260483|P3|Overall Study|Withdrawal by Subject|1
2981191|NCT01077284|10260484|P2|Overall Study|Withdrawal by Subject|3
2981192|NCT01077284|10260485|P1|Overall Study|Withdrawal by Subject|2
2981193|NCT01077284|10260483|P3|Overall Study|Lost to Follow-up|0
2981194|NCT01077284|10260484|P2|Overall Study|Lost to Follow-up|2
2981195|NCT01077284|10260485|P1|Overall Study|Lost to Follow-up|1
2981196|NCT01077284|10260483|P3|Overall Study|Adverse Event|1
2981197|NCT01077284|10260484|P2|Overall Study|Adverse Event|0
2981198|NCT01077284|10260485|P1|Overall Study|Adverse Event|2
2981199|NCT01077271|10260506|P1|Overall Study|Mother unconvinced of the necessity|1
2981200|NCT01077271|10260506|P1|Overall Study|End of RSV season nearly reached|1
2981201|NCT01077271|10260506|P1|Overall Study|Parents thought too many injections|2
2981202|NCT01077271|10260506|P1|Overall Study|Changed doctors|2
2981203|NCT01077271|10260506|P1|Overall Study|Quota used up (insurance reimb issue)|2
2981204|NCT01077271|10260506|P1|Overall Study|Noncompliance|2
2981205|NCT01077271|10260506|P1|Overall Study|Screen failure, did not take palivizumab|4
2981206|NCT01077271|10260506|P1|Overall Study|Parental desire|8
2981207|NCT01077258|10260544|P1|Overall Study|Other reasons|260
2981208|NCT01077258|10260544|P1|Overall Study|Clinical remission|37
2981209|NCT01077258|10260544|P1|Overall Study|Lack of Efficacy|663
2981210|NCT01077258|10260544|P1|Overall Study|Adverse drug reaction|218
2981211|NCT01077258|10260544|P1|Overall Study|Lost to Follow-up|1390
2981212|NCT01077193|10260580|P1|Overall Study|Study Terminated by Sponsor|40
2981213|NCT01077193|10260580|P1|Overall Study|Lack of Efficacy|1
2981214|NCT01077193|10260580|P1|Overall Study|Withdrawal by Subject|2
2981215|NCT01077193|10260580|P1|Overall Study|Lost to Follow-up|1
2981216|NCT01077154|10260586|P2|Overall Study|Protocol Deviation|0
2981217|NCT01077154|10260587|P1|Overall Study|Protocol Deviation|1
2981218|NCT01077154|10260586|P2|Overall Study|Administrative Decision|6
2981219|NCT01077154|10260587|P1|Overall Study|Administrative Decision|1
2981220|NCT01077154|10260586|P2|Overall Study|Adverse Event|9
2981221|NCT01077154|10260587|P1|Overall Study|Adverse Event|9
2981222|NCT01077154|10260586|P2|Overall Study|Other|11
2981223|NCT01077154|10260587|P1|Overall Study|Other|14
2981224|NCT01077154|10260586|P2|Overall Study|Ineligibility Determined|14
2981225|NCT01077154|10260587|P1|Overall Study|Ineligibility Determined|10
2981226|NCT01077154|10260586|P2|Overall Study|Disease Progression|20
2981227|NCT01077154|10260587|P1|Overall Study|Disease Progression|18
2981228|NCT01077154|10260586|P2|Overall Study|Noncompliance|20
2981229|NCT01077154|10260587|P1|Overall Study|Noncompliance|22
2981230|NCT01077154|10260586|P2|Overall Study|Lost to Follow-up|35
2981231|NCT01077154|10260587|P1|Overall Study|Lost to Follow-up|43
2981232|NCT01077154|10260586|P2|Overall Study|Death|214
2981233|NCT01077154|10260587|P1|Overall Study|Death|215
2981234|NCT01077154|10260586|P2|Overall Study|Withdrawal by Subject|385
2981235|NCT01077154|10260587|P1|Overall Study|Withdrawal by Subject|369
2981236|NCT01077154|10260586|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
2981237|NCT01077154|10260587|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
2981238|NCT01077128|10260601|P1|Overall Study|Other|54
2981239|NCT01077128|10260601|P1|Overall Study|Lack of efficacy/disease exacerbation|1
2981240|NCT01077128|10260601|P1|Overall Study|Adverse event and disease exacerbation|1
2981241|NCT01077128|10260601|P1|Overall Study|Adverse event and consent withdrawal|1
2981242|NCT01077128|10260601|P1|Overall Study|Disease exacerbation|1
2981243|NCT01077128|10260601|P1|Overall Study|Lack of Efficacy|1
2981244|NCT01077128|10260601|P1|Overall Study|Adverse Event|8
2981245|NCT01077076|10260659|P6|Third Intervention|Death in the participant's family|1
2981246|NCT01077076|10260660|P5|Third Intervention|Death in the participant's family|0
2981247|NCT01077076|10260661|P4|Third Intervention|Death in the participant's family|0
2981248|NCT01077076|10260662|P3|Third Intervention|Death in the participant's family|0
2981249|NCT01077076|10260663|P2|Third Intervention|Death in the participant's family|0
2981250|NCT01077076|10260664|P1|Third Intervention|Death in the participant's family|0
2981251|NCT01077076|10260659|P6|First Intervention|Withdrawal by Subject|0
2981252|NCT01077076|10260660|P5|First Intervention|Withdrawal by Subject|0
2981253|NCT01077076|10260661|P4|First Intervention|Withdrawal by Subject|0
2981254|NCT01077076|10260662|P3|First Intervention|Withdrawal by Subject|0
2981255|NCT01077076|10260663|P2|First Intervention|Withdrawal by Subject|0
2981256|NCT01077076|10260664|P1|First Intervention|Withdrawal by Subject|1
2981257|NCT01077063|10260674|P2|Overall Study|Withdrawal by Subject|2
2981258|NCT01077063|10260675|P1|Overall Study|Withdrawal by Subject|0
2981259|NCT01077063|10260674|P2|Overall Study|Death|1
2981260|NCT01077063|10260675|P1|Overall Study|Death|1
2981261|NCT01077063|10260674|P2|Overall Study|Adverse Event|0
2981262|NCT01077063|10260675|P1|Overall Study|Adverse Event|3
2981263|NCT01077050|10260681|P1|Overall Study|Screen failure|8
2981264|NCT01077050|10260681|P1|Overall Study|Subjects signed ICF could not be located|1
2981265|NCT01077024|10260687|P2|Overall Study|Other|4
2981266|NCT01077024|10260688|P1|Overall Study|Other|4
2981267|NCT01077024|10260687|P2|Overall Study|Incarcerated|8
2981268|NCT01077024|10260688|P1|Overall Study|Incarcerated|7
2981269|NCT01077024|10260687|P2|Overall Study|Withdrawal by Subject|2
2981270|NCT01077024|10260688|P1|Overall Study|Withdrawal by Subject|0
2981271|NCT01077024|10260687|P2|Overall Study|Lost to Follow-up|14
2981272|NCT01077024|10260688|P1|Overall Study|Lost to Follow-up|20
2981273|NCT01076959|10260727|P1|Overall Study|Other|119
2981274|NCT01076959|10260727|P1|Overall Study|Lost to Follow-up|241
2981275|NCT01076959|10260727|P1|Overall Study|Non-compliance|274
2981276|NCT01076959|10260727|P1|Overall Study|Lack of Efficacy|849
2981277|NCT01076959|10260727|P1|Overall Study|Adverse Event|767
2981278|NCT01076647|10260763|P2|Overall Study|Unclassified|12
2981279|NCT01076647|10260764|P1|Overall Study|Unclassified|12
2981280|NCT01076647|10260763|P2|Overall Study|Withdrawal criteria|2
2981281|NCT01076647|10260764|P1|Overall Study|Withdrawal criteria|2
2981282|NCT01076647|10260763|P2|Overall Study|Protocol Violation|9
2981283|NCT01076647|10260764|P1|Overall Study|Protocol Violation|7
2981284|NCT01076647|10260763|P2|Overall Study|Lack of Efficacy|1
2981285|NCT01076647|10260764|P1|Overall Study|Lack of Efficacy|0
2981286|NCT01076647|10260763|P2|Overall Study|Adverse Event|1
2981287|NCT01076647|10260764|P1|Overall Study|Adverse Event|4
2981288|NCT01076543|10260778|P6|Overall Study|Withdrawal by Subject|0
2981289|NCT01076543|10260779|P5|Overall Study|Withdrawal by Subject|0
2981290|NCT01076543|10260780|P4|Overall Study|Withdrawal by Subject|0
2981291|NCT01076543|10260781|P3|Overall Study|Withdrawal by Subject|0
2981292|NCT01076543|10260782|P2|Overall Study|Withdrawal by Subject|0
2981293|NCT01076543|10260783|P1|Overall Study|Withdrawal by Subject|2
2981294|NCT01076400|10260844|P3|Overall Study|Progressive Disease|0
2981295|NCT01076400|10260845|P2|Overall Study|Progressive Disease|0
2981296|NCT01076400|10260846|P1|Overall Study|Progressive Disease|5
2981297|NCT01076400|10260844|P3|Overall Study|Adverse Event|0
2981298|NCT01076400|10260845|P2|Overall Study|Adverse Event|0
2981299|NCT01076400|10260846|P1|Overall Study|Adverse Event|2
2981300|NCT01076361|10260852|P1|Overall Study|22 leads were excluded from analysis|21
2981301|NCT01076335|10260860|P1|Overall Study|Withdrawal without treatment|1
2981302|NCT01076335|10260860|P1|Overall Study|Withdrawal by Subject|3
2981303|NCT01076205|10260912|P1|Overall Study|Lost to Follow-up|3151
2981304|NCT01076205|10260912|P1|Overall Study|Unknown Reason|71
2981305|NCT01076205|10260912|P1|Overall Study|Other Reason|1075
2981306|NCT01076205|10260912|P1|Overall Study|Lack of Effectiveness|1423
2981307|NCT01076205|10260912|P1|Overall Study|Adverse Drug Reaction|299
2981308|NCT01076192|10260965|P1|Overall Study|Other|197
2981309|NCT01076179|10260980|P1|Overall Study|Withdrawal by Subject|1
2981310|NCT01076166|10261003|P1|Overall Study|Symptoms improved/resolved|6
2981311|NCT01076166|10261003|P1|Overall Study|Adverse Event|3
2981312|NCT01076153|10261010|P1|Overall Study|Adverse Event|1
2981313|NCT01076153|10261010|P1|Overall Study|Symptoms improved/resolved|10
2981314|NCT01076088|10261024|P6|Overall Study|Other protocol specified criteria|1
2981315|NCT01076088|10261025|P5|Overall Study|Other protocol specified criteria|0
2981316|NCT01076088|10261026|P4|Overall Study|Other protocol specified criteria|0
2981317|NCT01076088|10261027|P3|Overall Study|Other protocol specified criteria|0
2981318|NCT01076088|10261028|P2|Overall Study|Other protocol specified criteria|0
2981319|NCT01076088|10261029|P1|Overall Study|Other protocol specified criteria|0
2981320|NCT01076088|10261024|P6|Overall Study|Withdrawal by Subject|17
2981321|NCT01076088|10261025|P5|Overall Study|Withdrawal by Subject|11
2981322|NCT01076088|10261026|P4|Overall Study|Withdrawal by Subject|10
2981323|NCT01076088|10261027|P3|Overall Study|Withdrawal by Subject|14
2981324|NCT01076088|10261028|P2|Overall Study|Withdrawal by Subject|8
2981325|NCT01076088|10261029|P1|Overall Study|Withdrawal by Subject|8
2981326|NCT01076088|10261024|P6|Overall Study|Physician Decision|0
2981327|NCT01076088|10261025|P5|Overall Study|Physician Decision|1
2981328|NCT01076088|10261026|P4|Overall Study|Physician Decision|1
2981329|NCT01076088|10261027|P3|Overall Study|Physician Decision|0
2981330|NCT01076088|10261028|P2|Overall Study|Physician Decision|3
2981331|NCT01076088|10261029|P1|Overall Study|Physician Decision|1
2981332|NCT01076088|10261024|P6|Overall Study|Non-compliance with study drug|0
2981333|NCT01076088|10261025|P5|Overall Study|Non-compliance with study drug|0
2981334|NCT01076088|10261026|P4|Overall Study|Non-compliance with study drug|1
2981335|NCT01076088|10261027|P3|Overall Study|Non-compliance with study drug|0
2981336|NCT01076088|10261028|P2|Overall Study|Non-compliance with study drug|0
2981337|NCT01076088|10261029|P1|Overall Study|Non-compliance with study drug|0
2981338|NCT01076088|10261024|P6|Overall Study|Lost to Follow-up|2
2981339|NCT01076088|10261025|P5|Overall Study|Lost to Follow-up|1
2981340|NCT01076088|10261026|P4|Overall Study|Lost to Follow-up|1
2981341|NCT01076088|10261027|P3|Overall Study|Lost to Follow-up|0
2981342|NCT01076088|10261028|P2|Overall Study|Lost to Follow-up|1
2981343|NCT01076088|10261029|P1|Overall Study|Lost to Follow-up|1
2981344|NCT01076088|10261024|P6|Overall Study|Adverse Event|3
2981345|NCT01076088|10261025|P5|Overall Study|Adverse Event|3
2981346|NCT01076088|10261026|P4|Overall Study|Adverse Event|2
2981347|NCT01076088|10261027|P3|Overall Study|Adverse Event|3
2981348|NCT01076088|10261028|P2|Overall Study|Adverse Event|6
2981349|NCT01076088|10261029|P1|Overall Study|Adverse Event|1
2981350|NCT01076075|10261057|P2|Overall Study|Withdrawal by Subject|19
2981351|NCT01076075|10261058|P1|Overall Study|Withdrawal by Subject|8
2981352|NCT01076075|10261057|P2|Overall Study|Protocol Violation|1
2981353|NCT01076075|10261058|P1|Overall Study|Protocol Violation|0
2981354|NCT01076075|10261057|P2|Overall Study|other|9
2981355|NCT01076075|10261058|P1|Overall Study|other|19
2981356|NCT01076075|10261057|P2|Overall Study|Lost to Follow-up|5
2981357|NCT01076075|10261058|P1|Overall Study|Lost to Follow-up|6
2981358|NCT01076075|10261057|P2|Overall Study|Lack of Efficacy|4
2981359|NCT01076075|10261058|P1|Overall Study|Lack of Efficacy|5
2981360|NCT01076075|10261057|P2|Overall Study|Adverse Event|9
2981361|NCT01076075|10261058|P1|Overall Study|Adverse Event|3
2981362|NCT01076036|10261072|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
2981363|NCT01075984|10261082|P5|Follow-up Phase|Treatment failure|4
2981364|NCT01075984|10261083|P4|Follow-up Phase|Treatment failure|0
2981365|NCT01075984|10261084|P3|Follow-up Phase|Treatment failure|0
2981366|NCT01075984|10261085|P2|Follow-up Phase|Treatment failure|0
2981367|NCT01075984|10261086|P1|Follow-up Phase|Treatment failure|0
2981368|NCT01075984|10261082|P5|Follow-up Phase|Progression of disease|2
2981369|NCT01075984|10261083|P4|Follow-up Phase|Progression of disease|0
2981370|NCT01075984|10261084|P3|Follow-up Phase|Progression of disease|0
2981371|NCT01075984|10261085|P2|Follow-up Phase|Progression of disease|0
2981372|NCT01075984|10261086|P1|Follow-up Phase|Progression of disease|0
2981373|NCT01075984|10261082|P5|Follow-up Phase|Withdrawal by Subject|10
2981374|NCT01075984|10261083|P4|Follow-up Phase|Withdrawal by Subject|0
2981375|NCT01075984|10261084|P3|Follow-up Phase|Withdrawal by Subject|0
2981376|NCT01075984|10261085|P2|Follow-up Phase|Withdrawal by Subject|0
2981377|NCT01075984|10261086|P1|Follow-up Phase|Withdrawal by Subject|0
2981378|NCT01075984|10261082|P5|Follow-up Phase|Administrative|1
2981379|NCT01075984|10261083|P4|Follow-up Phase|Administrative|0
2981380|NCT01075984|10261084|P3|Follow-up Phase|Administrative|0
2981381|NCT01075984|10261085|P2|Follow-up Phase|Administrative|0
2981382|NCT01075984|10261086|P1|Follow-up Phase|Administrative|0
2981383|NCT01075984|10261082|P5|Follow-up Phase|Adverse Event|27
2981384|NCT01075984|10261083|P4|Follow-up Phase|Adverse Event|2
2981385|NCT01075984|10261084|P3|Follow-up Phase|Adverse Event|0
2981386|NCT01075984|10261085|P2|Follow-up Phase|Adverse Event|0
2981387|NCT01075984|10261086|P1|Follow-up Phase|Adverse Event|0
2981388|NCT01075984|10261082|P5|Follow-up Phase|Protocol Violation|3
2981389|NCT01075984|10261083|P4|Follow-up Phase|Protocol Violation|0
2981390|NCT01075984|10261084|P3|Follow-up Phase|Protocol Violation|1
2981391|NCT01075984|10261085|P2|Follow-up Phase|Protocol Violation|0
2981392|NCT01075984|10261086|P1|Follow-up Phase|Protocol Violation|0
2981393|NCT01075984|10261082|P5|Treatment Phase|Progression of disease|2
2981394|NCT01075984|10261083|P4|Treatment Phase|Progression of disease|0
2981395|NCT01075984|10261084|P3|Treatment Phase|Progression of disease|0
2981396|NCT01075984|10261085|P2|Treatment Phase|Progression of disease|0
2981397|NCT01075984|10261086|P1|Treatment Phase|Progression of disease|0
2981398|NCT01075984|10261082|P5|Treatment Phase|Treatment Failure|5
2981399|NCT01075984|10261083|P4|Treatment Phase|Treatment Failure|0
2981400|NCT01075984|10261084|P3|Treatment Phase|Treatment Failure|1
2981401|NCT01075984|10261085|P2|Treatment Phase|Treatment Failure|0
2981402|NCT01075984|10261086|P1|Treatment Phase|Treatment Failure|0
2981403|NCT01075984|10261082|P5|Treatment Phase|Withdrawal by Subject|15
2981404|NCT01075984|10261083|P4|Treatment Phase|Withdrawal by Subject|0
2981405|NCT01075984|10261084|P3|Treatment Phase|Withdrawal by Subject|2
2981406|NCT01075984|10261085|P2|Treatment Phase|Withdrawal by Subject|0
2981407|NCT01075984|10261086|P1|Treatment Phase|Withdrawal by Subject|0
2981408|NCT01075984|10261082|P5|Treatment Phase|Protocol Violation|3
2981409|NCT01075984|10261083|P4|Treatment Phase|Protocol Violation|0
2981410|NCT01075984|10261084|P3|Treatment Phase|Protocol Violation|1
2981411|NCT01075984|10261085|P2|Treatment Phase|Protocol Violation|0
2981412|NCT01075984|10261086|P1|Treatment Phase|Protocol Violation|0
2981413|NCT01075984|10261082|P5|Treatment Phase|Adverse Event|35
2981414|NCT01075984|10261083|P4|Treatment Phase|Adverse Event|7
2981415|NCT01075984|10261084|P3|Treatment Phase|Adverse Event|3
2981416|NCT01075984|10261085|P2|Treatment Phase|Adverse Event|1
2981417|NCT01075984|10261086|P1|Treatment Phase|Adverse Event|0
2981418|NCT01075958|10261144|P1|Overall Study|Blood sample could not be obtained|44
2981419|NCT01075815|10261160|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
2981420|NCT01075815|10261161|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
2981421|NCT01075815|10261160|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2981422|NCT01075815|10261161|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2981423|NCT01075815|10261160|P2|Overall Study|Withdrawal before r-hCG administration|1
2981424|NCT01075815|10261161|P1|Overall Study|Withdrawal before r-hCG administration|6
2981425|NCT01075763|10261199|P2|Overall Study|Withdrawal by Subject|2
2981426|NCT01075763|10261200|P1|Overall Study|Withdrawal by Subject|2
2981427|NCT01075763|10261199|P2|Overall Study|Lack of Efficacy|1
2981428|NCT01075763|10261200|P1|Overall Study|Lack of Efficacy|0
2981429|NCT01075763|10261199|P2|Overall Study|Lost to Follow-up|1
2981430|NCT01075763|10261200|P1|Overall Study|Lost to Follow-up|2
2981431|NCT01075685|10261224|P2|Overall Study|Lost to Follow-up|220
2981432|NCT01075685|10261225|P1|Overall Study|Lost to Follow-up|563
2981433|NCT01075685|10261224|P2|Overall Study|Withdrawal by Subject|5
2981434|NCT01075685|10261225|P1|Overall Study|Withdrawal by Subject|20
2981435|NCT01075685|10261224|P2|Overall Study|Protocol Violation|1
2981436|NCT01075685|10261225|P1|Overall Study|Protocol Violation|9
2981437|NCT01075646|10261241|P4|Overall Study|Lost to Follow-up|2
2981438|NCT01075646|10261242|P3|Overall Study|Lost to Follow-up|1
2981439|NCT01075646|10261243|P2|Overall Study|Lost to Follow-up|3
2981440|NCT01075646|10261244|P1|Overall Study|Lost to Follow-up|4
2981441|NCT01075412|10261276|P2|Overall Study|Withdrawal by Subject|1
2981442|NCT01075412|10261277|P1|Overall Study|Withdrawal by Subject|0
2981443|NCT01075321|10261302|P4|Overall Study|Ineligible (miscalculated lab value)|1
2981444|NCT01075321|10261303|P3|Overall Study|Ineligible (miscalculated lab value)|0
2981445|NCT01075321|10261304|P2|Overall Study|Ineligible (miscalculated lab value)|0
2981446|NCT01075321|10261305|P1|Overall Study|Ineligible (miscalculated lab value)|0
2981447|NCT01075321|10261302|P4|Overall Study|Treatment Incomplete due to progression|0
2981448|NCT01075321|10261303|P3|Overall Study|Treatment Incomplete due to progression|0
2981449|NCT01075321|10261304|P2|Overall Study|Treatment Incomplete due to progression|0
2981450|NCT01075321|10261305|P1|Overall Study|Treatment Incomplete due to progression|1
2981451|NCT01075321|10261302|P4|Overall Study|Protocol Violation|0
2981452|NCT01075321|10261303|P3|Overall Study|Protocol Violation|1
2981453|NCT01075321|10261304|P2|Overall Study|Protocol Violation|0
2981454|NCT01075321|10261305|P1|Overall Study|Protocol Violation|0
2981455|NCT01075321|10261302|P4|Overall Study|Withdrawal by Subject|1
2981456|NCT01075321|10261303|P3|Overall Study|Withdrawal by Subject|1
2981457|NCT01075321|10261304|P2|Overall Study|Withdrawal by Subject|0
2981458|NCT01075321|10261305|P1|Overall Study|Withdrawal by Subject|0
2981459|NCT01075282|10261323|P3|Overall Study|Death|2
2981460|NCT01075282|10261324|P2|Overall Study|Death|1
2981461|NCT01075282|10261325|P1|Overall Study|Death|0
2981462|NCT01075282|10261323|P3|Overall Study|Protocol Violation|1
2981463|NCT01075282|10261324|P2|Overall Study|Protocol Violation|2
2981464|NCT01075282|10261325|P1|Overall Study|Protocol Violation|0
2981465|NCT01075282|10261323|P3|Overall Study|Treatment Non-compliance|2
2981466|NCT01075282|10261324|P2|Overall Study|Treatment Non-compliance|2
2981467|NCT01075282|10261325|P1|Overall Study|Treatment Non-compliance|1
2981468|NCT01075282|10261323|P3|Overall Study|Lack of Efficacy|0
2981469|NCT01075282|10261324|P2|Overall Study|Lack of Efficacy|1
2981470|NCT01075282|10261325|P1|Overall Study|Lack of Efficacy|1
2981471|NCT01075282|10261323|P3|Overall Study|Physician Decision|3
2981472|NCT01075282|10261324|P2|Overall Study|Physician Decision|3
2981473|NCT01075282|10261325|P1|Overall Study|Physician Decision|3
2981474|NCT01075282|10261323|P3|Overall Study|Lost to Follow-up|3
2981475|NCT01075282|10261324|P2|Overall Study|Lost to Follow-up|3
2981476|NCT01075282|10261325|P1|Overall Study|Lost to Follow-up|3
2981477|NCT01075282|10261323|P3|Overall Study|Entry Criteria Not Met|0
2981478|NCT01075282|10261324|P2|Overall Study|Entry Criteria Not Met|2
2981479|NCT01075282|10261325|P1|Overall Study|Entry Criteria Not Met|3
2981480|NCT01075282|10261323|P3|Overall Study|Adverse Event|5
2981481|NCT01075282|10261324|P2|Overall Study|Adverse Event|8
2981482|NCT01075282|10261325|P1|Overall Study|Adverse Event|9
2981483|NCT01075282|10261323|P3|Overall Study|Withdrawal by Subject|11
2981484|NCT01075282|10261324|P2|Overall Study|Withdrawal by Subject|7
2981485|NCT01075282|10261325|P1|Overall Study|Withdrawal by Subject|11
2981486|NCT01075256|10261408|P3|Overall Study|Withdrawal by Subject|0
2981487|NCT01075256|10261409|P2|Overall Study|Withdrawal by Subject|0
2981488|NCT01075256|10261410|P1|Overall Study|Withdrawal by Subject|1
2981489|NCT01075243|10261442|P3|Overall Study|Withdrawal by Subject|0
2981490|NCT01075243|10261443|P2|Overall Study|Withdrawal by Subject|1
2981491|NCT01075243|10261444|P1|Overall Study|Withdrawal by Subject|1
2981492|NCT01075243|10261442|P3|Overall Study|Lost to Follow-up|0
2981493|NCT01075243|10261443|P2|Overall Study|Lost to Follow-up|2
2981494|NCT01075243|10261444|P1|Overall Study|Lost to Follow-up|5
2981495|NCT01075217|10261496|P2|Overall Study|Physician Decision|0
2981496|NCT01075217|10261497|P1|Overall Study|Physician Decision|1
2981497|NCT01075217|10261496|P2|Overall Study|Adverse Event|1
2981498|NCT01075217|10261497|P1|Overall Study|Adverse Event|1
2981499|NCT01075191|10261530|P1|Overall Study|Unknown Reasons|1
2981500|NCT01075191|10261530|P1|Overall Study|Patient's Wish|2
2981501|NCT01075191|10261530|P1|Overall Study|Therapy Break|3
2981502|NCT01075191|10261530|P1|Overall Study|Noncompliance|3
2981503|NCT01075191|10261530|P1|Overall Study|Adverse Event|4
2981504|NCT01075191|10261530|P1|Overall Study|Co-morbidities|1
2981505|NCT01075191|10261530|P1|Overall Study|Intensification|3
2981506|NCT01075191|10261530|P1|Overall Study|Death|1
2981507|NCT01075178|10261541|P2|Subject Chart Review|matched partner excluded (reasons above)|3
2981508|NCT01075178|10261542|P1|Subject Chart Review|matched partner excluded (reasons above)|6
2981509|NCT01075178|10261541|P2|Subject Chart Review|no data collected due to site closure|4
2981510|NCT01075178|10261542|P1|Subject Chart Review|no data collected due to site closure|3
2981511|NCT01075178|10261541|P2|Subject Chart Review|died before chart review period|2
2981512|NCT01075178|10261542|P1|Subject Chart Review|died before chart review period|0
2981513|NCT01075178|10261541|P2|Subject Matching|eligible but not matched|403
2981514|NCT01075178|10261542|P1|Subject Matching|eligible but not matched|130
2981515|NCT01075152|10261556|P2|Overall Study|Withdrawal by Subject|0
2981516|NCT01075152|10261557|P1|Overall Study|Withdrawal by Subject|1
2981517|NCT01075100|10261583|P2|Overall Study|Other|1
2981518|NCT01075100|10261584|P1|Overall Study|Other|3
2981519|NCT01075100|10261583|P2|Overall Study|Disease Progression|29
2981520|NCT01075100|10261584|P1|Overall Study|Disease Progression|25
2981521|NCT01075100|10261583|P2|Overall Study|Investigator Request|1
2981522|NCT01075100|10261584|P1|Overall Study|Investigator Request|2
2981523|NCT01075100|10261583|P2|Overall Study|Patient Request|4
2981524|NCT01075100|10261584|P1|Overall Study|Patient Request|4
2981525|NCT01075100|10261583|P2|Overall Study|Adverse Event|18
2981526|NCT01075100|10261584|P1|Overall Study|Adverse Event|15
2981527|NCT01075074|10261614|P3|Overall Study|Surgeon changed to open incisional case|2
2981528|NCT01075074|10261615|P2|Overall Study|Surgeon changed to open incisional case|2
2981529|NCT01075074|10261616|P1|Overall Study|Surgeon changed to open incisional case|1
2981530|NCT01074944|10261633|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
2981531|NCT01074944|10261634|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2981532|NCT01074944|10261635|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2981533|NCT01074944|10261636|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2981534|NCT01074944|10261637|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2981535|NCT01074944|10261633|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
2981536|NCT01074944|10261634|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
2981537|NCT01074944|10261635|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
2981538|NCT01074944|10261636|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
2981539|NCT01074944|10261637|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
2981540|NCT01074944|10261633|P5|Long Term Treatment|Withdrawal by Subject|0
2981541|NCT01074944|10261634|P4|Long Term Treatment|Withdrawal by Subject|2
2981542|NCT01074944|10261635|P3|Long Term Treatment|Withdrawal by Subject|0
2981543|NCT01074944|10261636|P2|Long Term Treatment|Withdrawal by Subject|0
2981544|NCT01074944|10261637|P1|Long Term Treatment|Withdrawal by Subject|0
2981545|NCT01074944|10261633|P5|Long Term Treatment|Entered in Period, But Not Treated|0
2981546|NCT01074944|10261634|P4|Long Term Treatment|Entered in Period, But Not Treated|1
2981547|NCT01074944|10261635|P3|Long Term Treatment|Entered in Period, But Not Treated|0
2981548|NCT01074944|10261636|P2|Long Term Treatment|Entered in Period, But Not Treated|0
2981549|NCT01074944|10261637|P1|Long Term Treatment|Entered in Period, But Not Treated|0
2981550|NCT01074944|10261633|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2981551|NCT01074944|10261634|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
2981552|NCT01074944|10261635|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2981553|NCT01074944|10261636|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2981554|NCT01074944|10261637|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2981555|NCT01074944|10261633|P5|Long Term Treatment|Lost to Follow-up|0
2981556|NCT01074944|10261634|P4|Long Term Treatment|Lost to Follow-up|2
2981557|NCT01074944|10261635|P3|Long Term Treatment|Lost to Follow-up|0
2981558|NCT01074944|10261636|P2|Long Term Treatment|Lost to Follow-up|0
2981559|NCT01074944|10261637|P1|Long Term Treatment|Lost to Follow-up|0
2981560|NCT01074944|10261633|P5|Long Term Treatment|Adverse Event|0
2981561|NCT01074944|10261634|P4|Long Term Treatment|Adverse Event|3
2981562|NCT01074944|10261635|P3|Long Term Treatment|Adverse Event|0
2981563|NCT01074944|10261636|P2|Long Term Treatment|Adverse Event|0
2981564|NCT01074944|10261637|P1|Long Term Treatment|Adverse Event|0
2981565|NCT01074944|10261633|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2981566|NCT01074944|10261634|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2981567|NCT01074944|10261635|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2981568|NCT01074944|10261636|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2981569|NCT01074944|10261637|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2981570|NCT01074944|10261633|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2981571|NCT01074944|10261634|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2981572|NCT01074944|10261635|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2981573|NCT01074944|10261636|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
2981574|NCT01074944|10261637|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2981575|NCT01074944|10261633|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2981576|NCT01074944|10261634|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2981577|NCT01074944|10261635|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2981578|NCT01074944|10261636|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2981579|NCT01074944|10261637|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2981580|NCT01074944|10261633|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2981581|NCT01074944|10261634|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2981582|NCT01074944|10261635|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
2981583|NCT01074944|10261636|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
2981584|NCT01074944|10261637|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2981585|NCT01074944|10261633|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2981586|NCT01074944|10261634|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2981587|NCT01074944|10261635|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
2981588|NCT01074944|10261636|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
2981589|NCT01074944|10261637|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2981590|NCT01074944|10261633|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2981591|NCT01074944|10261634|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2981760|NCT01073618|10262199|P1|Overall Study|Death|208
2981592|NCT01074944|10261635|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2981593|NCT01074944|10261636|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2981594|NCT01074944|10261637|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
2981595|NCT01074944|10261633|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2981596|NCT01074944|10261634|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2981597|NCT01074944|10261635|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2981598|NCT01074944|10261636|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2981599|NCT01074944|10261637|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
2981600|NCT01074944|10261633|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2981601|NCT01074944|10261634|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2981602|NCT01074944|10261635|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2981603|NCT01074944|10261636|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2981604|NCT01074944|10261637|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
2981605|NCT01074944|10261633|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2981606|NCT01074944|10261634|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2981607|NCT01074944|10261635|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2981608|NCT01074944|10261636|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2981609|NCT01074944|10261637|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
2981610|NCT01074931|10261691|P1|Overall Study|Death|5
2981611|NCT01074931|10261691|P1|Overall Study|Economic reasons|1
2981612|NCT01074658|10261703|P1|Overall Study|No implant attempted|19
2981613|NCT01074554|10261711|P2|Overall Study|Lost to Follow-up|1
2981614|NCT01074554|10261712|P1|Overall Study|Lost to Follow-up|0
2981615|NCT01074554|10261711|P2|Overall Study|Adverse Event|3
2981616|NCT01074554|10261712|P1|Overall Study|Adverse Event|3
2981617|NCT01074502|10261722|P1|Overall Study|Withdrawal by Subject|1
2981618|NCT01074450|10261746|P2|Second Intervention|Physician Decision|1
2981619|NCT01074450|10261747|P1|Second Intervention|Physician Decision|0
2981620|NCT01074450|10261746|P2|Second Intervention|Protocol Violation|0
2981621|NCT01074450|10261747|P1|Second Intervention|Protocol Violation|1
2981622|NCT01074450|10261746|P2|First Intervention|Emesis in Dosing Interval|2
2981623|NCT01074450|10261747|P1|First Intervention|Emesis in Dosing Interval|0
2981624|NCT01074307|10261776|P2|Overall Study|Protocol Violation|5
2981625|NCT01074307|10261777|P1|Overall Study|Protocol Violation|8
2981626|NCT01074307|10261776|P2|Overall Study|Exclusion criterion|1
2981627|NCT01074307|10261777|P1|Overall Study|Exclusion criterion|0
2981628|NCT01074307|10261776|P2|Overall Study|No primary endpoint evaluation|6
2981629|NCT01074307|10261777|P1|Overall Study|No primary endpoint evaluation|14
2981630|NCT01074268|10261799|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
2981631|NCT01074268|10261800|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
2981632|NCT01074268|10261799|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2981633|NCT01074268|10261800|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2981634|NCT01074268|10261799|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
2981635|NCT01074268|10261800|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
2981636|NCT01074268|10261799|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2981637|NCT01074268|10261800|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2981638|NCT01074268|10261799|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
2981639|NCT01074268|10261800|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
2981640|NCT01074268|10261799|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
2981641|NCT01074268|10261800|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
2981642|NCT01074268|10261799|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
2981643|NCT01074268|10261800|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
2981644|NCT01074268|10261799|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
2981645|NCT01074268|10261800|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
2981646|NCT01074268|10261799|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
2981647|NCT01074268|10261800|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
2981648|NCT01074255|10261826|P1|Overall Study|Did not receive EMEND|2
2981649|NCT01074242|10261830|P1|Overall Study|Duplicate Case Report Form|5
2981650|NCT01074242|10261830|P1|Overall Study|Violation of vaccine dose or dosage|351
2981651|NCT01074242|10261830|P1|Overall Study|Case report unclear|6
2981652|NCT01074242|10261830|P1|Overall Study|Lost to Follow-up|1
2981653|NCT01074242|10261830|P1|Overall Study|Case report before date of contract|40
2981654|NCT01074229|10261838|P3|Overall Study|Change to open surgical procedure|4
2981655|NCT01074229|10261839|P2|Overall Study|Change to open surgical procedure|3
2981656|NCT01074229|10261840|P1|Overall Study|Change to open surgical procedure|1
2981657|NCT01074229|10261838|P3|Overall Study|Lost to Follow-up|0
2981658|NCT01074229|10261839|P2|Overall Study|Lost to Follow-up|0
2981659|NCT01074229|10261840|P1|Overall Study|Lost to Follow-up|1
2981660|NCT01074216|10261851|P1|Overall Study|Not Treated|12
2981661|NCT01074216|10261851|P1|Overall Study|Physician Decision|1
2981662|NCT01074047|10261915|P2|Extension Phase|Death|0
2981663|NCT01074047|10261916|P1|Extension Phase|Death|5
2981664|NCT01074047|10261915|P2|Extension Phase|Withdrawal by Subject|0
2981665|NCT01074047|10261916|P1|Extension Phase|Withdrawal by Subject|2
2981666|NCT01074047|10261915|P2|Extension Phase|Disease Progression|0
2981667|NCT01074047|10261916|P1|Extension Phase|Disease Progression|9
2981668|NCT01074047|10261915|P2|Extension Phase|Adverse Event|0
2981669|NCT01074047|10261916|P1|Extension Phase|Adverse Event|5
2981670|NCT01074047|10261915|P2|Extension Phase|Physician Decision|0
2981671|NCT01074047|10261916|P1|Extension Phase|Physician Decision|1
2981672|NCT01074047|10261915|P2|Survival Follow-Up Phase|Alive at study closure|3
2981673|NCT01074047|10261916|P1|Survival Follow-Up Phase|Alive at study closure|1
2981674|NCT01074047|10261915|P2|Survival Follow-Up Phase|Death|124
2981675|NCT01074047|10261916|P1|Survival Follow-Up Phase|Death|116
2981676|NCT01074047|10261915|P2|Survival Follow-Up Phase|Lost to Follow-up|1
2981677|NCT01074047|10261916|P1|Survival Follow-Up Phase|Lost to Follow-up|2
2981678|NCT01074047|10261915|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
2981679|NCT01074047|10261916|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
2981680|NCT01074047|10261915|P2|Treatment Phase|Miscellaneous|39
2981681|NCT01074047|10261916|P1|Treatment Phase|Miscellaneous|32
2981682|NCT01074047|10261915|P2|Treatment Phase|Protocol Violation|1
2981683|NCT01074047|10261916|P1|Treatment Phase|Protocol Violation|0
2981684|NCT01074047|10261915|P2|Treatment Phase|Lost to Follow-up|1
2981685|NCT01074047|10261916|P1|Treatment Phase|Lost to Follow-up|0
2981686|NCT01074047|10261915|P2|Treatment Phase|Death|58
2981687|NCT01074047|10261916|P1|Treatment Phase|Death|53
2981688|NCT01074047|10261915|P2|Treatment Phase|Withdrawal by Subject|48
2981689|NCT01074047|10261916|P1|Treatment Phase|Withdrawal by Subject|27
2981690|NCT01074047|10261915|P2|Treatment Phase|Disease Progression|21
2981691|NCT01074047|10261916|P1|Treatment Phase|Disease Progression|16
2981692|NCT01074047|10261915|P2|Treatment Phase|Adverse Event|66
2981693|NCT01074047|10261916|P1|Treatment Phase|Adverse Event|89
2981694|NCT01074008|10262004|P9|Overall Study|Lost to Follow-up|4
2981695|NCT01074008|10262005|P8|Overall Study|Lost to Follow-up|0
2981696|NCT01074008|10262006|P7|Overall Study|Lost to Follow-up|1
2981697|NCT01074008|10262007|P6|Overall Study|Lost to Follow-up|0
2981698|NCT01074008|10262008|P5|Overall Study|Lost to Follow-up|1
2981699|NCT01074008|10262009|P4|Overall Study|Lost to Follow-up|1
2981700|NCT01074008|10262010|P3|Overall Study|Lost to Follow-up|1
2981701|NCT01074008|10262011|P2|Overall Study|Lost to Follow-up|1
2981702|NCT01074008|10262012|P1|Overall Study|Lost to Follow-up|0
2981703|NCT01074008|10262004|P9|Overall Study|Withdrawal by Subject|0
2981704|NCT01074008|10262005|P8|Overall Study|Withdrawal by Subject|0
2981705|NCT01074008|10262006|P7|Overall Study|Withdrawal by Subject|0
2981706|NCT01074008|10262007|P6|Overall Study|Withdrawal by Subject|0
2981707|NCT01074008|10262008|P5|Overall Study|Withdrawal by Subject|1
2981708|NCT01074008|10262009|P4|Overall Study|Withdrawal by Subject|0
2981709|NCT01074008|10262010|P3|Overall Study|Withdrawal by Subject|1
2981710|NCT01074008|10262011|P2|Overall Study|Withdrawal by Subject|1
2981711|NCT01074008|10262012|P1|Overall Study|Withdrawal by Subject|1
2981712|NCT01074008|10262004|P9|Overall Study|Adverse Event|0
2981713|NCT01074008|10262005|P8|Overall Study|Adverse Event|0
2981714|NCT01074008|10262006|P7|Overall Study|Adverse Event|0
2981715|NCT01074008|10262007|P6|Overall Study|Adverse Event|0
2981716|NCT01074008|10262008|P5|Overall Study|Adverse Event|0
2981717|NCT01074008|10262009|P4|Overall Study|Adverse Event|0
2981718|NCT01074008|10262010|P3|Overall Study|Adverse Event|0
2981719|NCT01074008|10262011|P2|Overall Study|Adverse Event|1
2981720|NCT01074008|10262012|P1|Overall Study|Adverse Event|0
2981721|NCT01073943|10262122|P2|Overall Study|Could not tolerate prep|0
2981722|NCT01073943|10262123|P1|Overall Study|Could not tolerate prep|1
2981723|NCT01073943|10262122|P2|Overall Study|Unable to return for follow-up|1
2981724|NCT01073943|10262123|P1|Overall Study|Unable to return for follow-up|0
2981725|NCT01073943|10262122|P2|Overall Study|Subject forgot|1
2981726|NCT01073943|10262123|P1|Overall Study|Subject forgot|0
2981727|NCT01073943|10262122|P2|Overall Study|Power outage; colonoscopy not done|0
2981728|NCT01073943|10262123|P1|Overall Study|Power outage; colonoscopy not done|1
2981729|NCT01073943|10262122|P2|Overall Study|Lost to Follow-up|2
2981730|NCT01073943|10262123|P1|Overall Study|Lost to Follow-up|0
2981731|NCT01073943|10262122|P2|Overall Study|Adverse Event|1
2981732|NCT01073943|10262123|P1|Overall Study|Adverse Event|1
2981733|NCT01073943|10262122|P2|Overall Study|Protocol Violation|1
2981734|NCT01073943|10262123|P1|Overall Study|Protocol Violation|2
2981735|NCT01073943|10262122|P2|Overall Study|Withdrawal by Subject|2
2981736|NCT01073943|10262123|P1|Overall Study|Withdrawal by Subject|8
2981737|NCT01073930|10262149|P2|Overall Study|Inadequate prep; unable to do procedure|1
2981738|NCT01073930|10262150|P1|Overall Study|Inadequate prep; unable to do procedure|0
2981739|NCT01073930|10262149|P2|Overall Study|Noncompliance with study drug|1
2981740|NCT01073930|10262150|P1|Overall Study|Noncompliance with study drug|0
2981741|NCT01073930|10262149|P2|Overall Study|Adverse Event|1
2981742|NCT01073930|10262150|P1|Overall Study|Adverse Event|0
2981743|NCT01073930|10262149|P2|Overall Study|Lost to Follow-up|1
2981744|NCT01073930|10262150|P1|Overall Study|Lost to Follow-up|0
2981745|NCT01073930|10262149|P2|Overall Study|Withdrawal by Subject|2
2981746|NCT01073930|10262150|P1|Overall Study|Withdrawal by Subject|3
2981747|NCT01073865|10262174|P2|Overall Study|Withdrawal by Subject|5
2981748|NCT01073865|10262175|P1|Overall Study|Withdrawal by Subject|5
2981749|NCT01073865|10262174|P2|Overall Study|Death|2
2981750|NCT01073865|10262175|P1|Overall Study|Death|3
2981751|NCT01073865|10262174|P2|Overall Study|Lost to Follow-up|1
2981752|NCT01073865|10262175|P1|Overall Study|Lost to Follow-up|1
2981753|NCT01073865|10262174|P2|Overall Study|Reasons other than below|31
2981754|NCT01073865|10262175|P1|Overall Study|Reasons other than below|19
2981755|NCT01073631|10262194|P1|Overall Study|Other|63
2981756|NCT01073631|10262194|P1|Overall Study|Adverse Event|24
2981757|NCT01073631|10262194|P1|Overall Study|Death|82
2981758|NCT01073618|10262199|P1|Overall Study|Other|80
2981759|NCT01073618|10262199|P1|Overall Study|Adverse Event|19
2981761|NCT01073605|10262207|P3|Overall Study|Randomized But Not Treated|1
2981762|NCT01073605|10262208|P2|Overall Study|Randomized But Not Treated|1
2981763|NCT01073605|10262209|P1|Overall Study|Randomized But Not Treated|0
2981764|NCT01073605|10262207|P3|Overall Study|Withdrawal by Subject|22
2981765|NCT01073605|10262208|P2|Overall Study|Withdrawal by Subject|39
2981766|NCT01073605|10262209|P1|Overall Study|Withdrawal by Subject|31
2981767|NCT01073605|10262207|P3|Overall Study|Other|29
2981768|NCT01073605|10262208|P2|Overall Study|Other|21
2981769|NCT01073605|10262209|P1|Overall Study|Other|25
2981770|NCT01073605|10262207|P3|Overall Study|Lost to Follow-up|9
2981771|NCT01073605|10262208|P2|Overall Study|Lost to Follow-up|4
2981772|NCT01073605|10262209|P1|Overall Study|Lost to Follow-up|3
2981773|NCT01073605|10262207|P3|Overall Study|Adverse Event|0
2981774|NCT01073605|10262208|P2|Overall Study|Adverse Event|1
2981775|NCT01073605|10262209|P1|Overall Study|Adverse Event|2
2981776|NCT01073605|10262207|P3|Overall Study|Ongoing at Cutoff Date|0
2981777|NCT01073605|10262208|P2|Overall Study|Ongoing at Cutoff Date|1
2981778|NCT01073605|10262209|P1|Overall Study|Ongoing at Cutoff Date|1
2981779|NCT01073566|10262255|P2|Period 2 (6 Weeks)|Adverse Event|0
2981780|NCT01073566|10262256|P1|Period 2 (6 Weeks)|Adverse Event|1
2981781|NCT01073462|10262268|P1|Overall Study|Lost to Follow-up|7
2981782|NCT01073462|10262268|P1|Overall Study|Serious adverse event|2
2981783|NCT01073462|10262268|P1|Overall Study|Low parathyroid hormone levels|8
2981784|NCT01073462|10262268|P1|Overall Study|Kidney transplant|10
2981785|NCT01073462|10262268|P1|Overall Study|Death|14
2981786|NCT01073293|10262287|P2|Overall Study|Withdrawal by Subject|10
2981787|NCT01073293|10262288|P1|Overall Study|Withdrawal by Subject|5
2981788|NCT01073293|10262287|P2|Overall Study|Lost to Follow-up|1
2981789|NCT01073293|10262288|P1|Overall Study|Lost to Follow-up|0
2981790|NCT01073267|10262310|P1|Overall Study|Disease Progression|3
2981791|NCT01073163|10262314|P1|Overall Study|Early termination|1
2981792|NCT01073163|10262314|P1|Overall Study|Disease Progression|1
2981793|NCT01073163|10262314|P1|Overall Study|Adverse Event|1
2981794|NCT01072929|10262337|P3|Overall Study|Other|0
2981795|NCT01072929|10262338|P2|Overall Study|Other|3
2981796|NCT01072929|10262339|P1|Overall Study|Other|0
2981797|NCT01072929|10262337|P3|Overall Study|Noncompliance with study procedures|1
2981798|NCT01072929|10262338|P2|Overall Study|Noncompliance with study procedures|0
2981799|NCT01072929|10262339|P1|Overall Study|Noncompliance with study procedures|1
2981800|NCT01072929|10262337|P3|Overall Study|Noncompliance with study medication|0
2981801|NCT01072929|10262338|P2|Overall Study|Noncompliance with study medication|3
2981802|NCT01072929|10262339|P1|Overall Study|Noncompliance with study medication|0
2981803|NCT01072929|10262337|P3|Overall Study|Lost to Follow-up|1
2981804|NCT01072929|10262338|P2|Overall Study|Lost to Follow-up|4
2981805|NCT01072929|10262339|P1|Overall Study|Lost to Follow-up|8
2981806|NCT01072929|10262337|P3|Overall Study|Protocol Violation|2
2981807|NCT01072929|10262338|P2|Overall Study|Protocol Violation|11
2981808|NCT01072929|10262339|P1|Overall Study|Protocol Violation|13
2981809|NCT01072929|10262337|P3|Overall Study|Withdrawal by Subject|3
2981810|NCT01072929|10262338|P2|Overall Study|Withdrawal by Subject|15
2981811|NCT01072929|10262339|P1|Overall Study|Withdrawal by Subject|7
2981812|NCT01072929|10262337|P3|Overall Study|Lack of Efficacy|0
2981813|NCT01072929|10262338|P2|Overall Study|Lack of Efficacy|4
2981814|NCT01072929|10262339|P1|Overall Study|Lack of Efficacy|7
2981815|NCT01072929|10262337|P3|Overall Study|Adverse Event|2
2981816|NCT01072929|10262338|P2|Overall Study|Adverse Event|11
2981817|NCT01072929|10262339|P1|Overall Study|Adverse Event|8
2981818|NCT01072877|10262418|P5|Overall Study|Lost to Follow-up|0
2981819|NCT01072877|10262419|P4|Overall Study|Lost to Follow-up|2
2981820|NCT01072877|10262420|P3|Overall Study|Lost to Follow-up|0
2981821|NCT01072877|10262421|P2|Overall Study|Lost to Follow-up|1
2981822|NCT01072877|10262422|P1|Overall Study|Lost to Follow-up|1
2981823|NCT01072630|10262501|P3|Overall Study|Other|1
2981824|NCT01072630|10262502|P2|Overall Study|Other|2
2981825|NCT01072630|10262503|P1|Overall Study|Other|3
2981826|NCT01072630|10262501|P3|Overall Study|Noncompliance with study procedures|1
2981827|NCT01072630|10262502|P2|Overall Study|Noncompliance with study procedures|2
2981828|NCT01072630|10262503|P1|Overall Study|Noncompliance with study procedures|1
2981829|NCT01072630|10262501|P3|Overall Study|Noncompliance with study medication|1
2981830|NCT01072630|10262502|P2|Overall Study|Noncompliance with study medication|1
2981831|NCT01072630|10262503|P1|Overall Study|Noncompliance with study medication|1
2981832|NCT01072630|10262501|P3|Overall Study|Lost to Follow-up|1
2981833|NCT01072630|10262502|P2|Overall Study|Lost to Follow-up|11
2981834|NCT01072630|10262503|P1|Overall Study|Lost to Follow-up|11
2981835|NCT01072630|10262501|P3|Overall Study|Protocol Violation|4
2981836|NCT01072630|10262502|P2|Overall Study|Protocol Violation|8
2981837|NCT01072630|10262503|P1|Overall Study|Protocol Violation|10
2981838|NCT01072630|10262501|P3|Overall Study|Withdrawal by Subject|2
2981839|NCT01072630|10262502|P2|Overall Study|Withdrawal by Subject|7
2981840|NCT01072630|10262503|P1|Overall Study|Withdrawal by Subject|8
2981841|NCT01072630|10262501|P3|Overall Study|Lack of Efficacy|1
2981842|NCT01072630|10262502|P2|Overall Study|Lack of Efficacy|10
2981843|NCT01072630|10262503|P1|Overall Study|Lack of Efficacy|10
2981844|NCT01072630|10262501|P3|Overall Study|Adverse Event|2
2981845|NCT01072630|10262502|P2|Overall Study|Adverse Event|19
2981846|NCT01072630|10262503|P1|Overall Study|Adverse Event|11
2981847|NCT01072539|10262584|P1|Overall Study|Protocol Violation|2
2981848|NCT01072539|10262584|P1|Overall Study|Treated prior to the Site Initiation|1
2981849|NCT01072500|10262608|P2|Overall Study|Withdrawal by Subject|10
2981850|NCT01072500|10262609|P1|Overall Study|Withdrawal by Subject|17
2981851|NCT01072500|10262608|P2|Overall Study|Lost to Follow-up|2
2981852|NCT01072500|10262609|P1|Overall Study|Lost to Follow-up|5
2981853|NCT01072500|10262608|P2|Overall Study|Death|2
2981854|NCT01072500|10262609|P1|Overall Study|Death|2
2981855|NCT01072448|10262619|P2|Overall Study|Death|2
2981856|NCT01072448|10262620|P1|Overall Study|Death|0
2981857|NCT01072448|10262619|P2|Overall Study|Abnormal laboratory value(s)|1
2981858|NCT01072448|10262620|P1|Overall Study|Abnormal laboratory value(s)|0
2981859|NCT01072448|10262619|P2|Overall Study|Lost to Follow-up|1
2981860|NCT01072448|10262620|P1|Overall Study|Lost to Follow-up|1
2981861|NCT01072448|10262619|P2|Overall Study|Unsatisfactory therapeutic effect|3
2981862|NCT01072448|10262620|P1|Overall Study|Unsatisfactory therapeutic effect|1
2981863|NCT01072448|10262619|P2|Overall Study|Abnormal test procedure result(s)|0
2981864|NCT01072448|10262620|P1|Overall Study|Abnormal test procedure result(s)|1
2981865|NCT01072448|10262619|P2|Overall Study|Protocol deviation|4
2981866|NCT01072448|10262620|P1|Overall Study|Protocol deviation|3
2981867|NCT01072448|10262619|P2|Overall Study|Subject withdrew consent|9
2981868|NCT01072448|10262620|P1|Overall Study|Subject withdrew consent|4
2981869|NCT01072448|10262619|P2|Overall Study|Adverse Event|10
2981870|NCT01072448|10262620|P1|Overall Study|Adverse Event|9
2981871|NCT01072396|10262634|P2|Period Two|Lost to Follow-up|0
2981872|NCT01072396|10262635|P1|Period Two|Lost to Follow-up|1
2981873|NCT01072396|10262634|P2|Period Two|Adverse Event|3
2981874|NCT01072396|10262635|P1|Period Two|Adverse Event|0
2981875|NCT01072396|10262634|P2|Washout Period|Missing termination information|1
2981876|NCT01072396|10262635|P1|Washout Period|Missing termination information|0
2981877|NCT01072396|10262634|P2|Period One|Withdrawal by Subject|0
2981878|NCT01072396|10262635|P1|Period One|Withdrawal by Subject|2
2981879|NCT01072396|10262634|P2|Period One|Protocol Violation|1
2981880|NCT01072396|10262635|P1|Period One|Protocol Violation|2
2981881|NCT01072396|10262634|P2|Period One|Adverse Event|1
2981882|NCT01072396|10262635|P1|Period One|Adverse Event|1
2981883|NCT01072357|10262647|P2|Overall Study|Lost to Follow-up|1
2981884|NCT01072357|10262648|P1|Overall Study|Lost to Follow-up|0
2981885|NCT01072344|10262658|P2|Overall Study|Lost to Follow-up|4
2981886|NCT01072344|10262659|P1|Overall Study|Lost to Follow-up|3
2981887|NCT01072344|10262658|P2|Overall Study|Protocol Violation|2
2981888|NCT01072344|10262659|P1|Overall Study|Protocol Violation|1
2981889|NCT01072344|10262658|P2|Overall Study|Relasped-reached end point|12
2981890|NCT01072344|10262659|P1|Overall Study|Relasped-reached end point|7
2981891|NCT01072201|10262697|P2|Overall Study|Lost to Follow-up|1
2981892|NCT01072201|10262698|P1|Overall Study|Lost to Follow-up|0
2981893|NCT01072175|10262731|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981894|NCT01072175|10262732|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
2981895|NCT01072175|10262733|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
2981896|NCT01072175|10262734|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981897|NCT01072175|10262735|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981898|NCT01072175|10262736|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981899|NCT01072175|10262737|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981900|NCT01072175|10262738|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981901|NCT01072175|10262739|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981902|NCT01072175|10262740|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981903|NCT01072175|10262741|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981904|NCT01072175|10262742|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981905|NCT01072175|10262743|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
2981906|NCT01072175|10262731|P13|Part D (HPMC Capsules)|Study closed/terminated|9
2981907|NCT01072175|10262732|P12|Part D (HPMC Capsules)|Study closed/terminated|10
2981908|NCT01072175|10262733|P11|Part D (HPMC Capsules)|Study closed/terminated|1
2981909|NCT01072175|10262734|P10|Part D (HPMC Capsules)|Study closed/terminated|2
2981910|NCT01072175|10262735|P9|Part D (HPMC Capsules)|Study closed/terminated|0
2981911|NCT01072175|10262736|P8|Part D (HPMC Capsules)|Study closed/terminated|0
2981912|NCT01072175|10262737|P7|Part D (HPMC Capsules)|Study closed/terminated|0
2981913|NCT01072175|10262738|P6|Part D (HPMC Capsules)|Study closed/terminated|0
2981914|NCT01072175|10262739|P5|Part D (HPMC Capsules)|Study closed/terminated|0
2981915|NCT01072175|10262740|P4|Part D (HPMC Capsules)|Study closed/terminated|0
2981916|NCT01072175|10262741|P3|Part D (HPMC Capsules)|Study closed/terminated|0
2981917|NCT01072175|10262742|P2|Part D (HPMC Capsules)|Study closed/terminated|0
2981918|NCT01072175|10262743|P1|Part D (HPMC Capsules)|Study closed/terminated|0
2981919|NCT01072175|10262731|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
2981920|NCT01072175|10262732|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
2981921|NCT01072175|10262733|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
2981922|NCT01072175|10262734|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
2981923|NCT01072175|10262735|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
2981924|NCT01072175|10262736|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
2981925|NCT01072175|10262737|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
2981926|NCT01072175|10262738|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
2981927|NCT01072175|10262739|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
2981928|NCT01072175|10262740|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
2981929|NCT01072175|10262741|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
2981930|NCT01072175|10262742|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
2981931|NCT01072175|10262743|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
2981932|NCT01072175|10262731|P13|Part D (HPMC Capsules)|Physician Decision|1
2981933|NCT01072175|10262732|P12|Part D (HPMC Capsules)|Physician Decision|1
2981934|NCT01072175|10262733|P11|Part D (HPMC Capsules)|Physician Decision|1
2981935|NCT01072175|10262734|P10|Part D (HPMC Capsules)|Physician Decision|0
2981936|NCT01072175|10262735|P9|Part D (HPMC Capsules)|Physician Decision|0
2981937|NCT01072175|10262736|P8|Part D (HPMC Capsules)|Physician Decision|0
2981938|NCT01072175|10262737|P7|Part D (HPMC Capsules)|Physician Decision|0
2981939|NCT01072175|10262738|P6|Part D (HPMC Capsules)|Physician Decision|0
2981940|NCT01072175|10262739|P5|Part D (HPMC Capsules)|Physician Decision|0
2981941|NCT01072175|10262740|P4|Part D (HPMC Capsules)|Physician Decision|0
2981942|NCT01072175|10262741|P3|Part D (HPMC Capsules)|Physician Decision|0
2981943|NCT01072175|10262742|P2|Part D (HPMC Capsules)|Physician Decision|0
2981944|NCT01072175|10262743|P1|Part D (HPMC Capsules)|Physician Decision|0
2981945|NCT01072175|10262731|P13|Part D (HPMC Capsules)|Death|26
2981946|NCT01072175|10262732|P12|Part D (HPMC Capsules)|Death|28
2981947|NCT01072175|10262733|P11|Part D (HPMC Capsules)|Death|12
2981948|NCT01072175|10262734|P10|Part D (HPMC Capsules)|Death|10
2981949|NCT01072175|10262735|P9|Part D (HPMC Capsules)|Death|0
2981950|NCT01072175|10262736|P8|Part D (HPMC Capsules)|Death|0
2981951|NCT01072175|10262737|P7|Part D (HPMC Capsules)|Death|0
2981952|NCT01072175|10262738|P6|Part D (HPMC Capsules)|Death|0
2981953|NCT01072175|10262739|P5|Part D (HPMC Capsules)|Death|0
2981954|NCT01072175|10262740|P4|Part D (HPMC Capsules)|Death|0
2981955|NCT01072175|10262741|P3|Part D (HPMC Capsules)|Death|0
2981956|NCT01072175|10262742|P2|Part D (HPMC Capsules)|Death|0
2981957|NCT01072175|10262743|P1|Part D (HPMC Capsules)|Death|0
2981958|NCT01072175|10262731|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981959|NCT01072175|10262732|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981960|NCT01072175|10262733|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981961|NCT01072175|10262734|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981962|NCT01072175|10262735|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
2981963|NCT01072175|10262736|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981964|NCT01072175|10262737|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981965|NCT01072175|10262738|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981966|NCT01072175|10262739|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981967|NCT01072175|10262740|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981968|NCT01072175|10262741|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981969|NCT01072175|10262742|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981970|NCT01072175|10262743|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2981971|NCT01072175|10262731|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981972|NCT01072175|10262732|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981973|NCT01072175|10262733|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981974|NCT01072175|10262734|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981975|NCT01072175|10262735|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
2981976|NCT01072175|10262736|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981977|NCT01072175|10262737|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981978|NCT01072175|10262738|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981979|NCT01072175|10262739|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981980|NCT01072175|10262740|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981981|NCT01072175|10262741|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981982|NCT01072175|10262742|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981983|NCT01072175|10262743|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2981984|NCT01072175|10262731|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981985|NCT01072175|10262732|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981986|NCT01072175|10262733|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981987|NCT01072175|10262734|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981988|NCT01072175|10262735|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
2981989|NCT01072175|10262736|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981990|NCT01072175|10262737|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981991|NCT01072175|10262738|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981992|NCT01072175|10262739|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981993|NCT01072175|10262740|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981994|NCT01072175|10262741|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981995|NCT01072175|10262742|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981996|NCT01072175|10262743|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2981997|NCT01072175|10262731|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
2981998|NCT01072175|10262732|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
2981999|NCT01072175|10262733|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
2982000|NCT01072175|10262734|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
2982001|NCT01072175|10262735|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
2982002|NCT01072175|10262736|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
2982003|NCT01072175|10262737|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
2982004|NCT01072175|10262738|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
2982005|NCT01072175|10262739|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
2982006|NCT01072175|10262740|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
2982007|NCT01072175|10262741|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
2982008|NCT01072175|10262742|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
2982009|NCT01072175|10262743|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
2982010|NCT01072175|10262731|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982011|NCT01072175|10262732|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982012|NCT01072175|10262733|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982013|NCT01072175|10262734|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982014|NCT01072175|10262735|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982015|NCT01072175|10262736|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982016|NCT01072175|10262737|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
2982017|NCT01072175|10262738|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
2982018|NCT01072175|10262739|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982019|NCT01072175|10262740|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982020|NCT01072175|10262741|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982021|NCT01072175|10262742|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982022|NCT01072175|10262743|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2982023|NCT01072175|10262731|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982024|NCT01072175|10262732|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982025|NCT01072175|10262733|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982026|NCT01072175|10262734|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982027|NCT01072175|10262735|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982028|NCT01072175|10262736|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
2982029|NCT01072175|10262737|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
2982030|NCT01072175|10262738|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
2982031|NCT01072175|10262739|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982032|NCT01072175|10262740|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982033|NCT01072175|10262741|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982034|NCT01072175|10262742|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982035|NCT01072175|10262743|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2982036|NCT01072175|10262731|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982037|NCT01072175|10262732|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982038|NCT01072175|10262733|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982039|NCT01072175|10262734|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982040|NCT01072175|10262735|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982041|NCT01072175|10262736|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2982042|NCT01072175|10262737|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2982043|NCT01072175|10262738|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982044|NCT01072175|10262739|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982045|NCT01072175|10262740|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982046|NCT01072175|10262741|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982047|NCT01072175|10262742|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982048|NCT01072175|10262743|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2982049|NCT01072175|10262731|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982050|NCT01072175|10262732|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982051|NCT01072175|10262733|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982052|NCT01072175|10262734|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982053|NCT01072175|10262735|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982054|NCT01072175|10262736|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
2982055|NCT01072175|10262737|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
2982056|NCT01072175|10262738|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
2982057|NCT01072175|10262739|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982058|NCT01072175|10262740|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982059|NCT01072175|10262741|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982060|NCT01072175|10262742|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982061|NCT01072175|10262743|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
2982062|NCT01072175|10262731|P13|Part C (Phase II: Randomized Phase)|Death|0
2982063|NCT01072175|10262732|P12|Part C (Phase II: Randomized Phase)|Death|0
2982064|NCT01072175|10262733|P11|Part C (Phase II: Randomized Phase)|Death|0
2982065|NCT01072175|10262734|P10|Part C (Phase II: Randomized Phase)|Death|0
2982066|NCT01072175|10262735|P9|Part C (Phase II: Randomized Phase)|Death|0
2982067|NCT01072175|10262736|P8|Part C (Phase II: Randomized Phase)|Death|39
2982068|NCT01072175|10262737|P7|Part C (Phase II: Randomized Phase)|Death|34
2982069|NCT01072175|10262738|P6|Part C (Phase II: Randomized Phase)|Death|44
2982070|NCT01072175|10262739|P5|Part C (Phase II: Randomized Phase)|Death|0
2982071|NCT01072175|10262740|P4|Part C (Phase II: Randomized Phase)|Death|0
2982072|NCT01072175|10262741|P3|Part C (Phase II: Randomized Phase)|Death|0
2982073|NCT01072175|10262742|P2|Part C (Phase II: Randomized Phase)|Death|0
2982074|NCT01072175|10262743|P1|Part C (Phase II: Randomized Phase)|Death|0
2982075|NCT01072175|10262731|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982076|NCT01072175|10262732|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982077|NCT01072175|10262733|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982078|NCT01072175|10262734|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982079|NCT01072175|10262735|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982080|NCT01072175|10262736|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982081|NCT01072175|10262737|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982082|NCT01072175|10262738|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982083|NCT01072175|10262739|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
2982084|NCT01072175|10262740|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
2982085|NCT01072175|10262741|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982086|NCT01072175|10262742|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
2982087|NCT01072175|10262743|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2982088|NCT01072175|10262731|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982089|NCT01072175|10262732|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982090|NCT01072175|10262733|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982091|NCT01072175|10262734|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982092|NCT01072175|10262735|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982093|NCT01072175|10262736|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982094|NCT01072175|10262737|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982095|NCT01072175|10262738|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982096|NCT01072175|10262739|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
2982097|NCT01072175|10262740|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
2982098|NCT01072175|10262741|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
2982099|NCT01072175|10262742|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982100|NCT01072175|10262743|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2982101|NCT01072175|10262731|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982102|NCT01072175|10262732|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982103|NCT01072175|10262733|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982104|NCT01072175|10262734|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982105|NCT01072175|10262735|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982106|NCT01072175|10262736|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982107|NCT01072175|10262737|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982108|NCT01072175|10262738|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982109|NCT01072175|10262739|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
2982110|NCT01072175|10262740|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2982111|NCT01072175|10262741|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982112|NCT01072175|10262742|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2982113|NCT01072175|10262743|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2982114|NCT01072175|10262731|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982115|NCT01072175|10262732|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982116|NCT01072175|10262733|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982117|NCT01072175|10262734|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982118|NCT01072175|10262735|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982119|NCT01072175|10262736|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982120|NCT01072175|10262737|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982121|NCT01072175|10262738|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982122|NCT01072175|10262739|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
2982123|NCT01072175|10262740|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982124|NCT01072175|10262741|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
2982125|NCT01072175|10262742|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982126|NCT01072175|10262743|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
2982127|NCT01072175|10262731|P13|Part B (Dose Escalation and Expansion)|Death|0
2982128|NCT01072175|10262732|P12|Part B (Dose Escalation and Expansion)|Death|0
2982129|NCT01072175|10262733|P11|Part B (Dose Escalation and Expansion)|Death|0
2982130|NCT01072175|10262734|P10|Part B (Dose Escalation and Expansion)|Death|0
2982131|NCT01072175|10262735|P9|Part B (Dose Escalation and Expansion)|Death|0
2982132|NCT01072175|10262736|P8|Part B (Dose Escalation and Expansion)|Death|0
2982133|NCT01072175|10262737|P7|Part B (Dose Escalation and Expansion)|Death|0
2982134|NCT01072175|10262738|P6|Part B (Dose Escalation and Expansion)|Death|0
2982135|NCT01072175|10262739|P5|Part B (Dose Escalation and Expansion)|Death|68
2982136|NCT01072175|10262740|P4|Part B (Dose Escalation and Expansion)|Death|21
2982137|NCT01072175|10262741|P3|Part B (Dose Escalation and Expansion)|Death|18
2982138|NCT01072175|10262742|P2|Part B (Dose Escalation and Expansion)|Death|4
2982139|NCT01072175|10262743|P1|Part B (Dose Escalation and Expansion)|Death|0
2982140|NCT01072175|10262731|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982141|NCT01072175|10262732|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982142|NCT01072175|10262733|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982143|NCT01072175|10262734|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982144|NCT01072175|10262735|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982145|NCT01072175|10262736|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982146|NCT01072175|10262737|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982147|NCT01072175|10262738|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982148|NCT01072175|10262739|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982149|NCT01072175|10262740|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982150|NCT01072175|10262741|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982151|NCT01072175|10262742|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2982152|NCT01072175|10262743|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
2982153|NCT01072175|10262731|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
2982154|NCT01072175|10262732|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
2982155|NCT01072175|10262733|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
2982156|NCT01072175|10262734|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
2982157|NCT01072175|10262735|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
2982158|NCT01072175|10262736|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
2982159|NCT01072175|10262737|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
2982160|NCT01072175|10262738|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
2982161|NCT01072175|10262739|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
2982162|NCT01072175|10262740|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
2982163|NCT01072175|10262741|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
2982164|NCT01072175|10262742|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
2982165|NCT01072175|10262743|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
2982166|NCT01072175|10262731|P13|Part A (Drug-Drug Interaction)|Death|0
2982167|NCT01072175|10262732|P12|Part A (Drug-Drug Interaction)|Death|0
2982168|NCT01072175|10262733|P11|Part A (Drug-Drug Interaction)|Death|0
2982169|NCT01072175|10262734|P10|Part A (Drug-Drug Interaction)|Death|0
2982170|NCT01072175|10262735|P9|Part A (Drug-Drug Interaction)|Death|0
2982171|NCT01072175|10262736|P8|Part A (Drug-Drug Interaction)|Death|0
2982172|NCT01072175|10262737|P7|Part A (Drug-Drug Interaction)|Death|0
2982173|NCT01072175|10262738|P6|Part A (Drug-Drug Interaction)|Death|0
2982174|NCT01072175|10262739|P5|Part A (Drug-Drug Interaction)|Death|0
2982175|NCT01072175|10262740|P4|Part A (Drug-Drug Interaction)|Death|0
2982176|NCT01072175|10262741|P3|Part A (Drug-Drug Interaction)|Death|0
2982177|NCT01072175|10262742|P2|Part A (Drug-Drug Interaction)|Death|0
2982178|NCT01072175|10262743|P1|Part A (Drug-Drug Interaction)|Death|1
2982179|NCT01072149|10262952|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982180|NCT01072149|10262953|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982181|NCT01072149|10262954|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982182|NCT01072149|10262955|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982183|NCT01072149|10262956|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2982184|NCT01072149|10262957|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982185|NCT01072149|10262958|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982186|NCT01072149|10262959|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982187|NCT01072149|10262960|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982188|NCT01072149|10262961|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982189|NCT01072149|10262962|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982190|NCT01072149|10262963|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982191|NCT01072149|10262964|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982192|NCT01072149|10262965|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982193|NCT01072149|10262966|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982194|NCT01072149|10262967|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2982195|NCT01072149|10262968|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982196|NCT01072149|10262969|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2982197|NCT01072149|10262952|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982198|NCT01072149|10262953|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982199|NCT01072149|10262954|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982200|NCT01072149|10262955|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982201|NCT01072149|10262956|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982202|NCT01072149|10262957|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
2982203|NCT01072149|10262958|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982204|NCT01072149|10262959|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982205|NCT01072149|10262960|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982206|NCT01072149|10262961|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982207|NCT01072149|10262962|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982208|NCT01072149|10262963|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982209|NCT01072149|10262964|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982210|NCT01072149|10262965|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982211|NCT01072149|10262966|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982212|NCT01072149|10262967|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982213|NCT01072149|10262968|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982214|NCT01072149|10262969|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
2982215|NCT01072149|10262952|P18|Washout Period 2 (14 Days)|Adverse Event|0
2982216|NCT01072149|10262953|P17|Washout Period 2 (14 Days)|Adverse Event|0
2982217|NCT01072149|10262954|P16|Washout Period 2 (14 Days)|Adverse Event|1
2982218|NCT01072149|10262955|P15|Washout Period 2 (14 Days)|Adverse Event|0
2982219|NCT01072149|10262956|P14|Washout Period 2 (14 Days)|Adverse Event|0
2982220|NCT01072149|10262957|P13|Washout Period 2 (14 Days)|Adverse Event|0
2982221|NCT01072149|10262958|P12|Washout Period 2 (14 Days)|Adverse Event|0
2982222|NCT01072149|10262959|P11|Washout Period 2 (14 Days)|Adverse Event|0
2982223|NCT01072149|10262960|P10|Washout Period 2 (14 Days)|Adverse Event|0
2982224|NCT01072149|10262961|P9|Washout Period 2 (14 Days)|Adverse Event|0
2982225|NCT01072149|10262962|P8|Washout Period 2 (14 Days)|Adverse Event|0
2982226|NCT01072149|10262963|P7|Washout Period 2 (14 Days)|Adverse Event|0
2982227|NCT01072149|10262964|P6|Washout Period 2 (14 Days)|Adverse Event|0
2982228|NCT01072149|10262965|P5|Washout Period 2 (14 Days)|Adverse Event|0
2982229|NCT01072149|10262966|P4|Washout Period 2 (14 Days)|Adverse Event|0
2982230|NCT01072149|10262967|P3|Washout Period 2 (14 Days)|Adverse Event|0
2982231|NCT01072149|10262968|P2|Washout Period 2 (14 Days)|Adverse Event|0
2982232|NCT01072149|10262969|P1|Washout Period 2 (14 Days)|Adverse Event|0
2982233|NCT01072149|10262952|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982234|NCT01072149|10262953|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982235|NCT01072149|10262954|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
2982236|NCT01072149|10262955|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982237|NCT01072149|10262956|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982238|NCT01072149|10262957|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982239|NCT01072149|10262958|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982240|NCT01072149|10262959|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982241|NCT01072149|10262960|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982242|NCT01072149|10262961|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982243|NCT01072149|10262962|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982244|NCT01072149|10262963|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982245|NCT01072149|10262964|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982246|NCT01072149|10262965|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982247|NCT01072149|10262966|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982248|NCT01072149|10262967|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982249|NCT01072149|10262968|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982250|NCT01072149|10262969|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2982251|NCT01072149|10262952|P18|Washout Period 2 (14 Days)|Physician Decision|0
2982252|NCT01072149|10262953|P17|Washout Period 2 (14 Days)|Physician Decision|0
2982253|NCT01072149|10262954|P16|Washout Period 2 (14 Days)|Physician Decision|0
2982254|NCT01072149|10262955|P15|Washout Period 2 (14 Days)|Physician Decision|0
2982255|NCT01072149|10262956|P14|Washout Period 2 (14 Days)|Physician Decision|0
2982256|NCT01072149|10262957|P13|Washout Period 2 (14 Days)|Physician Decision|0
2982257|NCT01072149|10262958|P12|Washout Period 2 (14 Days)|Physician Decision|0
2982258|NCT01072149|10262959|P11|Washout Period 2 (14 Days)|Physician Decision|0
2982259|NCT01072149|10262960|P10|Washout Period 2 (14 Days)|Physician Decision|0
2982260|NCT01072149|10262961|P9|Washout Period 2 (14 Days)|Physician Decision|0
2982261|NCT01072149|10262962|P8|Washout Period 2 (14 Days)|Physician Decision|0
2982262|NCT01072149|10262963|P7|Washout Period 2 (14 Days)|Physician Decision|0
2982263|NCT01072149|10262964|P6|Washout Period 2 (14 Days)|Physician Decision|0
2982264|NCT01072149|10262965|P5|Washout Period 2 (14 Days)|Physician Decision|0
2982265|NCT01072149|10262966|P4|Washout Period 2 (14 Days)|Physician Decision|0
2982266|NCT01072149|10262967|P3|Washout Period 2 (14 Days)|Physician Decision|0
2982267|NCT01072149|10262968|P2|Washout Period 2 (14 Days)|Physician Decision|0
2982268|NCT01072149|10262969|P1|Washout Period 2 (14 Days)|Physician Decision|1
2982269|NCT01072149|10262952|P18|Treatment Period 2 (28 Days)|Physician Decision|0
2982270|NCT01072149|10262953|P17|Treatment Period 2 (28 Days)|Physician Decision|0
2982271|NCT01072149|10262954|P16|Treatment Period 2 (28 Days)|Physician Decision|0
2982272|NCT01072149|10262955|P15|Treatment Period 2 (28 Days)|Physician Decision|0
2982273|NCT01072149|10262956|P14|Treatment Period 2 (28 Days)|Physician Decision|0
2982274|NCT01072149|10262957|P13|Treatment Period 2 (28 Days)|Physician Decision|0
2982275|NCT01072149|10262958|P12|Treatment Period 2 (28 Days)|Physician Decision|0
2982276|NCT01072149|10262959|P11|Treatment Period 2 (28 Days)|Physician Decision|0
2982277|NCT01072149|10262960|P10|Treatment Period 2 (28 Days)|Physician Decision|0
2982278|NCT01072149|10262961|P9|Treatment Period 2 (28 Days)|Physician Decision|0
2982279|NCT01072149|10262962|P8|Treatment Period 2 (28 Days)|Physician Decision|1
2982280|NCT01072149|10262963|P7|Treatment Period 2 (28 Days)|Physician Decision|0
2982281|NCT01072149|10262964|P6|Treatment Period 2 (28 Days)|Physician Decision|0
2982282|NCT01072149|10262965|P5|Treatment Period 2 (28 Days)|Physician Decision|0
2982283|NCT01072149|10262966|P4|Treatment Period 2 (28 Days)|Physician Decision|0
2982284|NCT01072149|10262967|P3|Treatment Period 2 (28 Days)|Physician Decision|0
2982285|NCT01072149|10262968|P2|Treatment Period 2 (28 Days)|Physician Decision|0
2982286|NCT01072149|10262969|P1|Treatment Period 2 (28 Days)|Physician Decision|0
2982287|NCT01072149|10262952|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982288|NCT01072149|10262953|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982289|NCT01072149|10262954|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982290|NCT01072149|10262955|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982291|NCT01072149|10262956|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982292|NCT01072149|10262957|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982293|NCT01072149|10262958|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982294|NCT01072149|10262959|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982295|NCT01072149|10262960|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982296|NCT01072149|10262961|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982297|NCT01072149|10262962|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982298|NCT01072149|10262963|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982299|NCT01072149|10262964|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982300|NCT01072149|10262965|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982301|NCT01072149|10262966|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982302|NCT01072149|10262967|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2982303|NCT01072149|10262968|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982304|NCT01072149|10262969|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2982305|NCT01072149|10262952|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982306|NCT01072149|10262953|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982307|NCT01072149|10262954|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982308|NCT01072149|10262955|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982309|NCT01072149|10262956|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982310|NCT01072149|10262957|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982311|NCT01072149|10262958|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982312|NCT01072149|10262959|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982313|NCT01072149|10262960|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982314|NCT01072149|10262961|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982315|NCT01072149|10262962|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982316|NCT01072149|10262963|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982317|NCT01072149|10262964|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982318|NCT01072149|10262965|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982319|NCT01072149|10262966|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982320|NCT01072149|10262967|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982321|NCT01072149|10262968|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
2982322|NCT01072149|10262969|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2982323|NCT01072149|10262952|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982324|NCT01072149|10262953|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982325|NCT01072149|10262954|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982326|NCT01072149|10262955|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982327|NCT01072149|10262956|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982328|NCT01072149|10262957|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982329|NCT01072149|10262958|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982330|NCT01072149|10262959|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
2982331|NCT01072149|10262960|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982332|NCT01072149|10262961|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982333|NCT01072149|10262962|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982334|NCT01072149|10262963|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982335|NCT01072149|10262964|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982336|NCT01072149|10262965|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982337|NCT01072149|10262966|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982338|NCT01072149|10262967|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982339|NCT01072149|10262968|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982340|NCT01072149|10262969|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2982341|NCT01072149|10262952|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
2982342|NCT01072149|10262953|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
2982343|NCT01072149|10262954|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
2982344|NCT01072149|10262955|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
2982345|NCT01072149|10262956|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
2982346|NCT01072149|10262957|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
2982347|NCT01072149|10262958|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
2982348|NCT01072149|10262959|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
2982349|NCT01072149|10262960|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
2982350|NCT01072149|10262961|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
2982351|NCT01072149|10262962|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
2982352|NCT01072149|10262963|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
2982353|NCT01072149|10262964|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
2982354|NCT01072149|10262965|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
2982355|NCT01072149|10262966|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
2982356|NCT01072149|10262967|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
2982357|NCT01072149|10262968|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
2982358|NCT01072149|10262969|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
2982359|NCT01072149|10262952|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982360|NCT01072149|10262953|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982361|NCT01072149|10262954|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982362|NCT01072149|10262955|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982363|NCT01072149|10262956|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982364|NCT01072149|10262957|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982365|NCT01072149|10262958|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982366|NCT01072149|10262959|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982367|NCT01072149|10262960|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982368|NCT01072149|10262961|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982369|NCT01072149|10262962|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982370|NCT01072149|10262963|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982371|NCT01072149|10262964|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982372|NCT01072149|10262965|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982373|NCT01072149|10262966|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982374|NCT01072149|10262967|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2982375|NCT01072149|10262968|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982376|NCT01072149|10262969|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2982377|NCT01071954|10263058|P1|Overall Study|Protocol Specified Criteria|1
2982378|NCT01071954|10263058|P1|Overall Study|Administrative Decision|5
2982379|NCT01071954|10263058|P1|Overall Study|Requirement for Alternative Therapy|5
2982380|NCT01071954|10263058|P1|Overall Study|Withdrawal by Subject|11
2982381|NCT01071954|10263058|P1|Overall Study|Adverse Event|1
2982382|NCT01071954|10263058|P1|Overall Study|Noncompliance|4
2982383|NCT01071915|10263067|P1|Overall Study|Miscellaneous Reasons|2
2982384|NCT01071915|10263067|P1|Overall Study|Withdrawal by Subject|2
2982385|NCT01071915|10263067|P1|Overall Study|Physician Decision|2
2982386|NCT01071915|10263067|P1|Overall Study|Adverse Event|3
2982387|NCT01071798|10263077|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
2982388|NCT01071798|10263077|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
2982389|NCT01071798|10263077|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
2982390|NCT01071798|10263077|P1|Subpopulation Who Received Two Cycles|Remission|1
2982391|NCT01071798|10263077|P1|Participants Who Received One Cycle|Severe concomitant disease|2
2982392|NCT01071798|10263077|P1|Participants Who Received One Cycle|Change of therapy|6
2982393|NCT01071798|10263077|P1|Participants Who Received One Cycle|Death|5
2982394|NCT01071798|10263077|P1|Participants Who Received One Cycle|Patient requirement|20
2982395|NCT01071798|10263077|P1|Participants Who Received One Cycle|Lack of tolerability|14
2982396|NCT01071798|10263077|P1|Participants Who Received One Cycle|Lack of Efficacy|18
2982397|NCT01071512|10263107|P1|Overall Study|positive anti-JC virus antibody test|2
2982398|NCT01071512|10263107|P1|Overall Study|Development of antibodies to drug|2
2982399|NCT01071512|10263107|P1|Overall Study|Adverse Event|1
2982400|NCT01071395|10263117|P2|Overall Study|Adverse Event|1
2982401|NCT01071395|10263118|P1|Overall Study|Adverse Event|3
2982402|NCT01071395|10263117|P2|Overall Study|Withdrawal by Subject|1
2982403|NCT01071395|10263118|P1|Overall Study|Withdrawal by Subject|2
2982404|NCT01071317|10263137|P2|Overall Study|Lost to Follow-up|2
2982405|NCT01071317|10263138|P1|Overall Study|Lost to Follow-up|2
2982406|NCT01071278|10263150|P1|Overall Study|Completion Status Unknown|459
2982407|NCT01071278|10263150|P1|Overall Study|Premature Discontinuation|254
2982408|NCT01071252|10263161|P5|Overall Study|Death|1
2982409|NCT01071252|10263162|P4|Overall Study|Death|0
2982410|NCT01071252|10263163|P3|Overall Study|Death|0
2982411|NCT01071252|10263164|P2|Overall Study|Death|0
2982412|NCT01071252|10263165|P1|Overall Study|Death|0
2982413|NCT01071252|10263161|P5|Overall Study|Adverse Event|0
2982414|NCT01071252|10263162|P4|Overall Study|Adverse Event|1
2982415|NCT01071252|10263163|P3|Overall Study|Adverse Event|0
2982416|NCT01071252|10263164|P2|Overall Study|Adverse Event|1
2982417|NCT01071252|10263165|P1|Overall Study|Adverse Event|1
2982418|NCT01071252|10263161|P5|Overall Study|Lost to Follow-up|0
2982419|NCT01071252|10263162|P4|Overall Study|Lost to Follow-up|2
2982420|NCT01071252|10263163|P3|Overall Study|Lost to Follow-up|1
2982421|NCT01071252|10263164|P2|Overall Study|Lost to Follow-up|0
2982422|NCT01071252|10263165|P1|Overall Study|Lost to Follow-up|1
2982423|NCT01071252|10263161|P5|Overall Study|administrative problems|1
2982424|NCT01071252|10263162|P4|Overall Study|administrative problems|2
2982425|NCT01071252|10263163|P3|Overall Study|administrative problems|0
2982426|NCT01071252|10263164|P2|Overall Study|administrative problems|1
2982427|NCT01071252|10263165|P1|Overall Study|administrative problems|1
2982428|NCT01071252|10263161|P5|Overall Study|Withdrawal by Subject|3
2982429|NCT01071252|10263162|P4|Overall Study|Withdrawal by Subject|2
2982430|NCT01071252|10263163|P3|Overall Study|Withdrawal by Subject|1
2982431|NCT01071252|10263164|P2|Overall Study|Withdrawal by Subject|2
2982432|NCT01071252|10263165|P1|Overall Study|Withdrawal by Subject|8
2982433|NCT01071252|10263161|P5|Overall Study|unsatisfactory therapeutic effect|6
2982434|NCT01071252|10263162|P4|Overall Study|unsatisfactory therapeutic effect|0
2982435|NCT01071252|10263163|P3|Overall Study|unsatisfactory therapeutic effect|2
2982436|NCT01071252|10263164|P2|Overall Study|unsatisfactory therapeutic effect|6
2982437|NCT01071252|10263165|P1|Overall Study|unsatisfactory therapeutic effect|4
2982438|NCT01071200|10263193|P2|Overall Study|No viable embryos|1
2982439|NCT01071200|10263194|P1|Overall Study|No viable embryos|0
2982440|NCT01071200|10263193|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
2982441|NCT01071200|10263194|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
2982442|NCT01071200|10263193|P2|Overall Study|No oocytes retrieved|1
2982443|NCT01071200|10263194|P1|Overall Study|No oocytes retrieved|1
2982444|NCT01071200|10263193|P2|Overall Study|No fertilization|0
2982445|NCT01071200|10263194|P1|Overall Study|No fertilization|4
2982446|NCT01071200|10263193|P2|Overall Study|Lack of ovarian response|1
2982447|NCT01071200|10263194|P1|Overall Study|Lack of ovarian response|1
2982448|NCT01071096|10263226|P2|First Intervention (90 Days)|Lost to Follow-up|0
2982449|NCT01071096|10263227|P1|First Intervention (90 Days)|Lost to Follow-up|1
2982450|NCT01071083|10263251|P5|Overall Study|Subject Refused to Continue|0
2982451|NCT01071083|10263252|P4|Overall Study|Subject Refused to Continue|0
2982452|NCT01071083|10263253|P3|Overall Study|Subject Refused to Continue|0
2982453|NCT01071083|10263254|P2|Overall Study|Subject Refused to Continue|0
2982454|NCT01071083|10263255|P1|Overall Study|Subject Refused to Continue|1
2982455|NCT01071083|10263251|P5|Overall Study|Did Not Want Per Protocol Treatment|1
2982456|NCT01071083|10263252|P4|Overall Study|Did Not Want Per Protocol Treatment|0
2982457|NCT01071083|10263253|P3|Overall Study|Did Not Want Per Protocol Treatment|1
2982458|NCT01071083|10263254|P2|Overall Study|Did Not Want Per Protocol Treatment|0
2982459|NCT01071083|10263255|P1|Overall Study|Did Not Want Per Protocol Treatment|0
2982460|NCT01071083|10263251|P5|Overall Study|Did Not Meet Eligibility Criteria|1
2982461|NCT01071083|10263252|P4|Overall Study|Did Not Meet Eligibility Criteria|1
2982462|NCT01071083|10263253|P3|Overall Study|Did Not Meet Eligibility Criteria|1
2982463|NCT01071083|10263254|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2982464|NCT01071083|10263255|P1|Overall Study|Did Not Meet Eligibility Criteria|0
2982465|NCT01071083|10263251|P5|Overall Study|Images Not Usable (Motion)|0
2982466|NCT01071083|10263252|P4|Overall Study|Images Not Usable (Motion)|0
2982467|NCT01071083|10263253|P3|Overall Study|Images Not Usable (Motion)|0
2982468|NCT01071083|10263254|P2|Overall Study|Images Not Usable (Motion)|1
2982469|NCT01071083|10263255|P1|Overall Study|Images Not Usable (Motion)|0
2982470|NCT01071083|10263251|P5|Overall Study|Subject Moved|0
2982471|NCT01071083|10263252|P4|Overall Study|Subject Moved|0
2982472|NCT01071083|10263253|P3|Overall Study|Subject Moved|0
2982473|NCT01071083|10263254|P2|Overall Study|Subject Moved|1
2982474|NCT01071083|10263255|P1|Overall Study|Subject Moved|0
2982475|NCT01071083|10263251|P5|Overall Study|Early Rescue|1
2982476|NCT01071083|10263252|P4|Overall Study|Early Rescue|0
2982477|NCT01071083|10263253|P3|Overall Study|Early Rescue|0
2982478|NCT01071083|10263254|P2|Overall Study|Early Rescue|0
2982479|NCT01071083|10263255|P1|Overall Study|Early Rescue|1
2982480|NCT01071083|10263251|P5|Overall Study|Physician Decision|1
2982481|NCT01071083|10263252|P4|Overall Study|Physician Decision|1
2982482|NCT01071083|10263253|P3|Overall Study|Physician Decision|0
2982483|NCT01071083|10263254|P2|Overall Study|Physician Decision|0
2982484|NCT01071083|10263255|P1|Overall Study|Physician Decision|1
2982485|NCT01071083|10263251|P5|Overall Study|Withdrawal by Subject|3
2982486|NCT01071083|10263252|P4|Overall Study|Withdrawal by Subject|0
2982487|NCT01071083|10263253|P3|Overall Study|Withdrawal by Subject|2
2982488|NCT01071083|10263254|P2|Overall Study|Withdrawal by Subject|0
2982489|NCT01071083|10263255|P1|Overall Study|Withdrawal by Subject|3
2982490|NCT01071083|10263251|P5|Overall Study|Adverse Event|1
2982491|NCT01071083|10263252|P4|Overall Study|Adverse Event|0
2982492|NCT01071083|10263253|P3|Overall Study|Adverse Event|1
2982493|NCT01071083|10263254|P2|Overall Study|Adverse Event|0
2982494|NCT01071083|10263255|P1|Overall Study|Adverse Event|1
2982495|NCT01071070|10263274|P2|Overall Study|Hypercalcemia|0
2982496|NCT01071070|10263275|P1|Overall Study|Hypercalcemia|1
2982497|NCT01071070|10263274|P2|Overall Study|Missed 3 consecutive doses of study drug|0
2982498|NCT01071070|10263275|P1|Overall Study|Missed 3 consecutive doses of study drug|2
2982499|NCT01071070|10263274|P2|Overall Study|Withdrawal by Subject|0
2982500|NCT01071070|10263275|P1|Overall Study|Withdrawal by Subject|1
2982501|NCT01071070|10263274|P2|Overall Study|Adverse Event|3
2982502|NCT01071070|10263275|P1|Overall Study|Adverse Event|0
2982503|NCT01070979|10263321|P3|Overall Study|No study drug taken|0
2982504|NCT01070979|10263322|P2|Overall Study|No study drug taken|1
2982505|NCT01070979|10263323|P1|Overall Study|No study drug taken|0
2982506|NCT01070979|10263321|P3|Overall Study|Withdrawal by Subject|1
2982507|NCT01070979|10263322|P2|Overall Study|Withdrawal by Subject|1
2982508|NCT01070979|10263323|P1|Overall Study|Withdrawal by Subject|3
2982509|NCT01070979|10263321|P3|Overall Study|Surgery, moving, personal, abn. labs|2
2982510|NCT01070979|10263322|P2|Overall Study|Surgery, moving, personal, abn. labs|4
2982511|NCT01070979|10263323|P1|Overall Study|Surgery, moving, personal, abn. labs|4
2982512|NCT01070979|10263321|P3|Overall Study|Protocol Violation|6
2982513|NCT01070979|10263322|P2|Overall Study|Protocol Violation|2
2982514|NCT01070979|10263323|P1|Overall Study|Protocol Violation|0
2982515|NCT01070979|10263321|P3|Overall Study|Lost to Follow-up|1
2982516|NCT01070979|10263322|P2|Overall Study|Lost to Follow-up|1
2982517|NCT01070979|10263323|P1|Overall Study|Lost to Follow-up|2
2982518|NCT01070979|10263321|P3|Overall Study|Adverse Event|3
2982519|NCT01070979|10263322|P2|Overall Study|Adverse Event|3
2982520|NCT01070979|10263323|P1|Overall Study|Adverse Event|2
2982521|NCT01070966|10263349|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
2982522|NCT01070966|10263349|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
2982523|NCT01070966|10263349|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
2982524|NCT01070966|10263349|P1|Participants for Safety Evaluation|TMT given before date of contract|3
2982525|NCT01070966|10263349|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
2982526|NCT01070966|10263349|P1|Participants for Safety Evaluation|Duplicate Participants|4
2982527|NCT01070966|10263349|P1|Participants for Safety Evaluation|Off-label use|9
2982528|NCT01070966|10263349|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
2982529|NCT01070953|10263360|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
2982530|NCT01070953|10263360|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
2982531|NCT01070953|10263360|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
2982532|NCT01070953|10263360|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
2982533|NCT01070953|10263360|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
2982534|NCT01070953|10263360|P1|Participants for Safety Evaluation|Uncontracted participants|4
2982535|NCT01070953|10263360|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
2982536|NCT01070953|10263360|P1|Participants for Safety Evaluation|Duplicated participants|22
2982537|NCT01070953|10263360|P1|Participants for Safety Evaluation|Off-label use|283
2982538|NCT01070953|10263360|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
2982539|NCT01070888|10263373|P2|Washout (14 Days)|Physician Decision|0
2982540|NCT01070888|10263374|P1|Washout (14 Days)|Physician Decision|1
2982541|NCT01070888|10263373|P2|First Intervention (14 Days)|Lost to Follow-up|1
2982542|NCT01070888|10263374|P1|First Intervention (14 Days)|Lost to Follow-up|0
2982543|NCT01070888|10263373|P2|First Intervention (14 Days)|Adverse Event|1
2982544|NCT01070888|10263374|P1|First Intervention (14 Days)|Adverse Event|0
2982545|NCT01070784|10263399|P2|Overall Study|Adverse Event|9
2982546|NCT01070784|10263400|P1|Overall Study|Adverse Event|14
2982547|NCT01070784|10263399|P2|Overall Study|Withdrawal by Subject|9
2982548|NCT01070784|10263400|P1|Overall Study|Withdrawal by Subject|6
2982549|NCT01070771|10263488|P1|Overall Study|Protocol Violation|1
2982550|NCT01070771|10263488|P1|Overall Study|Adverse Event|2
2982551|NCT01070550|10263508|P6|Overall Study|Withdrawal by Subject|0
2982552|NCT01070550|10263509|P5|Overall Study|Withdrawal by Subject|0
2982553|NCT01070550|10263510|P4|Overall Study|Withdrawal by Subject|0
2982554|NCT01070550|10263511|P3|Overall Study|Withdrawal by Subject|3
2982555|NCT01070550|10263512|P2|Overall Study|Withdrawal by Subject|0
2982556|NCT01070550|10263513|P1|Overall Study|Withdrawal by Subject|35
2982557|NCT01070550|10263508|P6|Overall Study|Other|0
2982558|NCT01070550|10263509|P5|Overall Study|Other|0
2982559|NCT01070550|10263510|P4|Overall Study|Other|1
2982560|NCT01070550|10263511|P3|Overall Study|Other|0
2982561|NCT01070550|10263512|P2|Overall Study|Other|0
2982562|NCT01070550|10263513|P1|Overall Study|Other|5
2982563|NCT01070550|10263508|P6|Overall Study|Treatment was stopped early|0
2982564|NCT01070550|10263509|P5|Overall Study|Treatment was stopped early|0
2982565|NCT01070550|10263510|P4|Overall Study|Treatment was stopped early|0
2982566|NCT01070550|10263511|P3|Overall Study|Treatment was stopped early|0
2982567|NCT01070550|10263512|P2|Overall Study|Treatment was stopped early|0
2982568|NCT01070550|10263513|P1|Overall Study|Treatment was stopped early|7
2982569|NCT01070550|10263508|P6|Overall Study|Treatment unavailable|0
2982570|NCT01070550|10263509|P5|Overall Study|Treatment unavailable|0
2982571|NCT01070550|10263510|P4|Overall Study|Treatment unavailable|0
2982572|NCT01070550|10263511|P3|Overall Study|Treatment unavailable|0
2982573|NCT01070550|10263512|P2|Overall Study|Treatment unavailable|0
2982574|NCT01070550|10263513|P1|Overall Study|Treatment unavailable|1
2982575|NCT01070550|10263508|P6|Overall Study|Treatment stopped|0
2982576|NCT01070550|10263509|P5|Overall Study|Treatment stopped|0
2982577|NCT01070550|10263510|P4|Overall Study|Treatment stopped|0
2982578|NCT01070550|10263511|P3|Overall Study|Treatment stopped|0
2982579|NCT01070550|10263512|P2|Overall Study|Treatment stopped|0
2982580|NCT01070550|10263513|P1|Overall Study|Treatment stopped|3
2982581|NCT01070550|10263508|P6|Overall Study|Treatment restarted|0
2982582|NCT01070550|10263509|P5|Overall Study|Treatment restarted|0
2982583|NCT01070550|10263510|P4|Overall Study|Treatment restarted|0
2982584|NCT01070550|10263511|P3|Overall Study|Treatment restarted|0
2982585|NCT01070550|10263512|P2|Overall Study|Treatment restarted|1
2982586|NCT01070550|10263513|P1|Overall Study|Treatment restarted|0
2982587|NCT01070550|10263508|P6|Overall Study|Treatment not started|0
2982588|NCT01070550|10263509|P5|Overall Study|Treatment not started|0
2982589|NCT01070550|10263510|P4|Overall Study|Treatment not started|0
2982590|NCT01070550|10263511|P3|Overall Study|Treatment not started|4
2982591|NCT01070550|10263512|P2|Overall Study|Treatment not started|2
2982592|NCT01070550|10263513|P1|Overall Study|Treatment not started|14
2982593|NCT01070550|10263508|P6|Overall Study|Treatment interrupted|0
2982594|NCT01070550|10263509|P5|Overall Study|Treatment interrupted|0
2982595|NCT01070550|10263510|P4|Overall Study|Treatment interrupted|1
2982596|NCT01070550|10263511|P3|Overall Study|Treatment interrupted|1
2982597|NCT01070550|10263512|P2|Overall Study|Treatment interrupted|0
2982598|NCT01070550|10263513|P1|Overall Study|Treatment interrupted|7
2982599|NCT01070550|10263508|P6|Overall Study|Treatment duration shortened|0
2982600|NCT01070550|10263509|P5|Overall Study|Treatment duration shortened|0
2982601|NCT01070550|10263510|P4|Overall Study|Treatment duration shortened|0
2982602|NCT01070550|10263511|P3|Overall Study|Treatment duration shortened|0
2982603|NCT01070550|10263512|P2|Overall Study|Treatment duration shortened|0
2982604|NCT01070550|10263513|P1|Overall Study|Treatment duration shortened|1
2982605|NCT01070550|10263508|P6|Overall Study|Sponsor decision|0
2982606|NCT01070550|10263509|P5|Overall Study|Sponsor decision|0
2982607|NCT01070550|10263510|P4|Overall Study|Sponsor decision|0
2982608|NCT01070550|10263511|P3|Overall Study|Sponsor decision|0
2982609|NCT01070550|10263512|P2|Overall Study|Sponsor decision|0
2982610|NCT01070550|10263513|P1|Overall Study|Sponsor decision|1
2982611|NCT01070550|10263508|P6|Overall Study|Screen failure|0
2982612|NCT01070550|10263509|P5|Overall Study|Screen failure|0
2982613|NCT01070550|10263510|P4|Overall Study|Screen failure|0
2982614|NCT01070550|10263511|P3|Overall Study|Screen failure|0
2982615|NCT01070550|10263512|P2|Overall Study|Screen failure|0
2982616|NCT01070550|10263513|P1|Overall Study|Screen failure|1
2982617|NCT01070550|10263508|P6|Overall Study|Result not available|0
2982618|NCT01070550|10263509|P5|Overall Study|Result not available|0
2982619|NCT01070550|10263510|P4|Overall Study|Result not available|0
2982620|NCT01070550|10263511|P3|Overall Study|Result not available|3
2982621|NCT01070550|10263512|P2|Overall Study|Result not available|1
2982622|NCT01070550|10263513|P1|Overall Study|Result not available|3
2982623|NCT01070550|10263508|P6|Overall Study|Relapse|0
2982624|NCT01070550|10263509|P5|Overall Study|Relapse|0
2982625|NCT01070550|10263510|P4|Overall Study|Relapse|4
2982626|NCT01070550|10263511|P3|Overall Study|Relapse|14
2982627|NCT01070550|10263512|P2|Overall Study|Relapse|5
2982628|NCT01070550|10263513|P1|Overall Study|Relapse|44
2982629|NCT01070550|10263508|P6|Overall Study|Protocol Violation|0
2982630|NCT01070550|10263509|P5|Overall Study|Protocol Violation|0
2982631|NCT01070550|10263510|P4|Overall Study|Protocol Violation|1
2982632|NCT01070550|10263511|P3|Overall Study|Protocol Violation|1
2982633|NCT01070550|10263512|P2|Overall Study|Protocol Violation|1
2982634|NCT01070550|10263513|P1|Overall Study|Protocol Violation|15
2982635|NCT01070550|10263508|P6|Overall Study|Not categorized|1
2982636|NCT01070550|10263509|P5|Overall Study|Not categorized|0
2982637|NCT01070550|10263510|P4|Overall Study|Not categorized|1
2982638|NCT01070550|10263511|P3|Overall Study|Not categorized|6
2982639|NCT01070550|10263512|P2|Overall Study|Not categorized|2
2982640|NCT01070550|10263513|P1|Overall Study|Not categorized|33
2982641|NCT01070550|10263508|P6|Overall Study|Non-responders|2
2982642|NCT01070550|10263509|P5|Overall Study|Non-responders|0
2982643|NCT01070550|10263510|P4|Overall Study|Non-responders|20
2982644|NCT01070550|10263511|P3|Overall Study|Non-responders|21
2982645|NCT01070550|10263512|P2|Overall Study|Non-responders|4
2982646|NCT01070550|10263513|P1|Overall Study|Non-responders|493
2982647|NCT01070550|10263508|P6|Overall Study|New treatment started|0
2982648|NCT01070550|10263509|P5|Overall Study|New treatment started|0
2982649|NCT01070550|10263510|P4|Overall Study|New treatment started|2
2982650|NCT01070550|10263511|P3|Overall Study|New treatment started|0
2982651|NCT01070550|10263512|P2|Overall Study|New treatment started|1
2982652|NCT01070550|10263513|P1|Overall Study|New treatment started|3
2982653|NCT01070550|10263508|P6|Overall Study|Miscellaneous|0
2982654|NCT01070550|10263509|P5|Overall Study|Miscellaneous|0
2982655|NCT01070550|10263510|P4|Overall Study|Miscellaneous|1
2982656|NCT01070550|10263511|P3|Overall Study|Miscellaneous|3
2982657|NCT01070550|10263512|P2|Overall Study|Miscellaneous|2
2982658|NCT01070550|10263513|P1|Overall Study|Miscellaneous|12
2982659|NCT01070550|10263508|P6|Overall Study|Lack of Efficacy|1
2982660|NCT01070550|10263509|P5|Overall Study|Lack of Efficacy|0
2982661|NCT01070550|10263510|P4|Overall Study|Lack of Efficacy|5
2982662|NCT01070550|10263511|P3|Overall Study|Lack of Efficacy|5
2982663|NCT01070550|10263512|P2|Overall Study|Lack of Efficacy|1
2982664|NCT01070550|10263513|P1|Overall Study|Lack of Efficacy|65
2982665|NCT01070550|10263508|P6|Overall Study|Lab test not done|1
2982666|NCT01070550|10263509|P5|Overall Study|Lab test not done|0
2982667|NCT01070550|10263510|P4|Overall Study|Lab test not done|1
2982668|NCT01070550|10263511|P3|Overall Study|Lab test not done|4
2982669|NCT01070550|10263512|P2|Overall Study|Lab test not done|3
2982670|NCT01070550|10263513|P1|Overall Study|Lab test not done|22
2982671|NCT01070550|10263508|P6|Overall Study|Incomplete treatment|0
2982672|NCT01070550|10263509|P5|Overall Study|Incomplete treatment|0
2982673|NCT01070550|10263510|P4|Overall Study|Incomplete treatment|0
2982674|NCT01070550|10263511|P3|Overall Study|Incomplete treatment|0
2982675|NCT01070550|10263512|P2|Overall Study|Incomplete treatment|0
2982676|NCT01070550|10263513|P1|Overall Study|Incomplete treatment|2
2982677|NCT01070550|10263508|P6|Overall Study|Failed to return|2
2982678|NCT01070550|10263509|P5|Overall Study|Failed to return|1
2982679|NCT01070550|10263510|P4|Overall Study|Failed to return|40
2982680|NCT01070550|10263511|P3|Overall Study|Failed to return|144
2982681|NCT01070550|10263512|P2|Overall Study|Failed to return|33
2982682|NCT01070550|10263513|P1|Overall Study|Failed to return|450
2982683|NCT01070550|10263508|P6|Overall Study|Early termination|0
2982684|NCT01070550|10263509|P5|Overall Study|Early termination|0
2982685|NCT01070550|10263510|P4|Overall Study|Early termination|0
2982686|NCT01070550|10263511|P3|Overall Study|Early termination|0
2982687|NCT01070550|10263512|P2|Overall Study|Early termination|0
2982688|NCT01070550|10263513|P1|Overall Study|Early termination|3
2982689|NCT01070550|10263508|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
2982690|NCT01070550|10263509|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
2982691|NCT01070550|10263510|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
2982692|NCT01070550|10263511|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
2982693|NCT01070550|10263512|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2982694|NCT01070550|10263513|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
2982695|NCT01070550|10263508|P6|Overall Study|Death|0
2982696|NCT01070550|10263509|P5|Overall Study|Death|0
2982697|NCT01070550|10263510|P4|Overall Study|Death|0
2982698|NCT01070550|10263511|P3|Overall Study|Death|3
2982699|NCT01070550|10263512|P2|Overall Study|Death|4
2982700|NCT01070550|10263513|P1|Overall Study|Death|20
2982701|NCT01070550|10263508|P6|Overall Study|Adverse Event|0
2982702|NCT01070550|10263509|P5|Overall Study|Adverse Event|0
2982703|NCT01070550|10263510|P4|Overall Study|Adverse Event|0
2982704|NCT01070550|10263511|P3|Overall Study|Adverse Event|3
2982705|NCT01070550|10263512|P2|Overall Study|Adverse Event|1
2982706|NCT01070550|10263513|P1|Overall Study|Adverse Event|43
2982707|NCT01070394|10263653|P1|Overall Study|Withdrawal by Subject|1
2982708|NCT01070394|10263653|P1|Overall Study|Adverse Event|6
2982709|NCT01070381|10263664|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
2982710|NCT01070381|10263665|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
2982711|NCT01070381|10263664|P2|Period 2, 1 Week of Wear|Handling|1
2982712|NCT01070381|10263665|P1|Period 2, 1 Week of Wear|Handling|0
2982713|NCT01070329|10263673|P2|Overall Study|Sponsor Decision|1
2982714|NCT01070329|10263674|P1|Overall Study|Sponsor Decision|0
2982715|NCT01070329|10263673|P2|Overall Study|Entry Criteria Not Met|0
2982716|NCT01070329|10263674|P1|Overall Study|Entry Criteria Not Met|1
2982717|NCT01070329|10263673|P2|Overall Study|Physician Decision|1
2982718|NCT01070329|10263674|P1|Overall Study|Physician Decision|2
2982719|NCT01070329|10263673|P2|Overall Study|Lack of Efficacy|6
2982720|NCT01070329|10263674|P1|Overall Study|Lack of Efficacy|2
2982721|NCT01070329|10263673|P2|Overall Study|Protocol Violation|8
2982722|NCT01070329|10263674|P1|Overall Study|Protocol Violation|3
2982723|NCT01070329|10263673|P2|Overall Study|Withdrawal by Subject|11
2982724|NCT01070329|10263674|P1|Overall Study|Withdrawal by Subject|9
2982725|NCT01070329|10263673|P2|Overall Study|Lost to Follow-up|12
2982726|NCT01070329|10263674|P1|Overall Study|Lost to Follow-up|22
2982727|NCT01070329|10263673|P2|Overall Study|Adverse Event|10
2982728|NCT01070329|10263674|P1|Overall Study|Adverse Event|13
2982729|NCT01070316|10263706|P1|Extension Phase|Withdrawal by Subject|1
2982730|NCT01070316|10263706|P1|Extension Phase|Lack of Efficacy|3
2982731|NCT01070303|10263713|P1|Overall Study|Other|18
2982732|NCT01070303|10263713|P1|Overall Study|Administrative Reason|1
2982733|NCT01070303|10263713|P1|Overall Study|Lack of Efficacy|2
2982734|NCT01070303|10263713|P1|Overall Study|Protocol Violation|0
2982735|NCT01070303|10263713|P1|Overall Study|Lost to Follow-up|9
2982736|NCT01070303|10263713|P1|Overall Study|Withdrawal by Subject|20
2982737|NCT01070303|10263713|P1|Overall Study|Adverse Event|39
2982738|NCT01070043|10263808|P3|Double-Blind Treatment|Adverse Event|2
2982739|NCT01070043|10263809|P2|Double-Blind Treatment|Adverse Event|0
2982740|NCT01070043|10263810|P1|Double-Blind Treatment|Adverse Event|0
2982741|NCT01070043|10263808|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
2982742|NCT01070043|10263809|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
2982743|NCT01070043|10263810|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
2982744|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Removal|0
2982745|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Removal|1
2982746|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Physician Decision|2
2982747|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Physician Decision|0
2982748|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
2982749|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
2982750|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
2982751|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
2982752|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
2982753|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
2982754|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
2982755|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
2982756|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Protocol Violation|1
2982757|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Protocol Violation|0
2982758|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
2982759|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
2982760|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
2982761|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
2982762|NCT01069939|10263826|P2|Randomised and Included in the Analyses|Adverse Event|22
2982763|NCT01069939|10263827|P1|Randomised and Included in the Analyses|Adverse Event|17
2982764|NCT01069900|10263853|P2|Overall Study|Insufficient Therapeutic effect|0
2982765|NCT01069900|10263854|P1|Overall Study|Insufficient Therapeutic effect|1
2982766|NCT01069900|10263853|P2|Overall Study|Protocol Violation|1
2982767|NCT01069900|10263854|P1|Overall Study|Protocol Violation|4
2982768|NCT01069900|10263853|P2|Overall Study|Withdrawal by Subject|1
2982769|NCT01069900|10263854|P1|Overall Study|Withdrawal by Subject|6
2982770|NCT01069900|10263853|P2|Overall Study|Lost to Follow-up|1
2982771|NCT01069900|10263854|P1|Overall Study|Lost to Follow-up|7
2982772|NCT01069900|10263853|P2|Overall Study|Technical problems|1
2982773|NCT01069900|10263854|P1|Overall Study|Technical problems|0
2982774|NCT01069861|10263898|P1|Overall Study|Did not meet entrance criteria|1
2982775|NCT01069861|10263898|P1|Overall Study|Adverse Event|1
2982776|NCT01069861|10263898|P1|Overall Study|Death|1
2982777|NCT01069627|10263911|P1|Overall Study|Protocol Violation|1
2982778|NCT01069627|10263911|P1|Overall Study|Adverse Event|12
2982779|NCT01069627|10263911|P1|Overall Study|Disease progression|7
2982780|NCT01069523|10263961|P2|Overall Study|Withdrawal by Subject|7
2982781|NCT01069523|10263962|P1|Overall Study|Withdrawal by Subject|4
2982782|NCT01069484|10263985|P2|Overall Study|Illness mother or child|1
2982783|NCT01069484|10263986|P1|Overall Study|Illness mother or child|3
2982784|NCT01069484|10263985|P2|Overall Study|No specific reason|2
2982785|NCT01069484|10263986|P1|Overall Study|No specific reason|8
2982786|NCT01069484|10263985|P2|Overall Study|Death-in-near-family|0
2982787|NCT01069484|10263986|P1|Overall Study|Death-in-near-family|1
2982788|NCT01069419|10263994|P1|Overall Study|Missing termination information|13
2982789|NCT01069419|10263994|P1|Overall Study|Other Reason|43
2982790|NCT01069419|10263994|P1|Overall Study|Withdrawal by Subject|34
2982791|NCT01069419|10263994|P1|Overall Study|Remission of disease|11
2982792|NCT01069419|10263994|P1|Overall Study|Lost to Follow-up|49
2982793|NCT01069419|10263994|P1|Overall Study|Lack of Efficacy|332
2982794|NCT01069419|10263994|P1|Overall Study|Adverse Event|233
2982795|NCT01069341|10264023|P1|Overall Study|Lost to Follow-up|1
2982796|NCT01069289|10264065|P2|Overall Study|Due to deteriorating health condition|0
2982797|NCT01069289|10264066|P1|Overall Study|Due to deteriorating health condition|1
2982798|NCT01069289|10264065|P2|Overall Study|Severe non-compliance to protocol|2
2982799|NCT01069289|10264066|P1|Overall Study|Severe non-compliance to protocol|3
2982800|NCT01069289|10264065|P2|Overall Study|Eligibility criteria not fulfilled|0
2982801|NCT01069289|10264066|P1|Overall Study|Eligibility criteria not fulfilled|2
2982802|NCT01069289|10264065|P2|Overall Study|Adverse Event|28
2982803|NCT01069289|10264066|P1|Overall Study|Adverse Event|21
2982804|NCT01069289|10264065|P2|Overall Study|Withdrawal by Subject|26
2982805|NCT01069289|10264066|P1|Overall Study|Withdrawal by Subject|15
2982806|NCT01069172|10264115|P2|Overall Study|Withdrawal by Subject|0
2982807|NCT01069172|10264116|P1|Overall Study|Withdrawal by Subject|1
2982808|NCT01069120|10264126|P1|Overall Study|Study prematurely terminated|27
2982809|NCT01068912|10264163|P3|Overall Study|other underlying illness|3
2982810|NCT01068912|10264164|P2|Overall Study|other underlying illness|3
2982811|NCT01068912|10264165|P1|Overall Study|other underlying illness|0
2982812|NCT01068912|10264163|P3|Overall Study|aggravation influenza|1
2982813|NCT01068912|10264164|P2|Overall Study|aggravation influenza|1
2982814|NCT01068912|10264165|P1|Overall Study|aggravation influenza|1
2982815|NCT01068912|10264163|P3|Overall Study|Protocol Violation|0
2982816|NCT01068912|10264164|P2|Overall Study|Protocol Violation|2
2982817|NCT01068912|10264165|P1|Overall Study|Protocol Violation|0
2982818|NCT01068912|10264163|P3|Overall Study|Lost to Follow-up|3
2982819|NCT01068912|10264164|P2|Overall Study|Lost to Follow-up|7
2982820|NCT01068912|10264165|P1|Overall Study|Lost to Follow-up|3
2982821|NCT01068912|10264163|P3|Overall Study|Withdrawal by Subject|6
2982822|NCT01068912|10264164|P2|Overall Study|Withdrawal by Subject|6
2982823|NCT01068912|10264165|P1|Overall Study|Withdrawal by Subject|5
2982824|NCT01068912|10264163|P3|Overall Study|Adverse Event|2
2982825|NCT01068912|10264164|P2|Overall Study|Adverse Event|3
2982826|NCT01068912|10264165|P1|Overall Study|Adverse Event|2
2982827|NCT01068860|10264183|P10|Overall Study|Lost to Follow-up|0
2982828|NCT01068860|10264184|P9|Overall Study|Lost to Follow-up|0
2982829|NCT01068860|10264185|P8|Overall Study|Lost to Follow-up|0
2982830|NCT01068860|10264186|P7|Overall Study|Lost to Follow-up|0
2982831|NCT01068860|10264187|P6|Overall Study|Lost to Follow-up|0
2982832|NCT01068860|10264188|P5|Overall Study|Lost to Follow-up|0
2982833|NCT01068860|10264189|P4|Overall Study|Lost to Follow-up|0
2982834|NCT01068860|10264190|P3|Overall Study|Lost to Follow-up|0
2982835|NCT01068860|10264191|P2|Overall Study|Lost to Follow-up|1
2982836|NCT01068860|10264192|P1|Overall Study|Lost to Follow-up|0
2982837|NCT01068860|10264183|P10|Overall Study|Administrative problems; misrandomized|1
2982838|NCT01068860|10264184|P9|Overall Study|Administrative problems; misrandomized|0
2982839|NCT01068860|10264185|P8|Overall Study|Administrative problems; misrandomized|0
2982840|NCT01068860|10264186|P7|Overall Study|Administrative problems; misrandomized|0
2982841|NCT01068860|10264187|P6|Overall Study|Administrative problems; misrandomized|0
2982842|NCT01068860|10264188|P5|Overall Study|Administrative problems; misrandomized|0
2982843|NCT01068860|10264189|P4|Overall Study|Administrative problems; misrandomized|1
2982844|NCT01068860|10264190|P3|Overall Study|Administrative problems; misrandomized|0
2982845|NCT01068860|10264191|P2|Overall Study|Administrative problems; misrandomized|0
2982846|NCT01068860|10264192|P1|Overall Study|Administrative problems; misrandomized|0
2982847|NCT01068860|10264183|P10|Overall Study|Withdrawal by Subject|3
2982848|NCT01068860|10264184|P9|Overall Study|Withdrawal by Subject|0
2982849|NCT01068860|10264185|P8|Overall Study|Withdrawal by Subject|0
2982850|NCT01068860|10264186|P7|Overall Study|Withdrawal by Subject|0
2982851|NCT01068860|10264187|P6|Overall Study|Withdrawal by Subject|2
2982852|NCT01068860|10264188|P5|Overall Study|Withdrawal by Subject|0
2982853|NCT01068860|10264189|P4|Overall Study|Withdrawal by Subject|0
2982854|NCT01068860|10264190|P3|Overall Study|Withdrawal by Subject|0
2982855|NCT01068860|10264191|P2|Overall Study|Withdrawal by Subject|0
2982856|NCT01068860|10264192|P1|Overall Study|Withdrawal by Subject|0
2982857|NCT01068769|10264375|P1|Overall Study|Ineligible|1
2982858|NCT01068743|10264380|P4|Period 3|Adverse Event|0
2982859|NCT01068743|10264381|P3|Period 3|Adverse Event|0
2982860|NCT01068743|10264382|P2|Period 3|Adverse Event|1
2982861|NCT01068743|10264383|P1|Period 3|Adverse Event|0
2982862|NCT01068730|10264457|P4|Period 4|Family emergency|0
2982863|NCT01068730|10264458|P3|Period 4|Family emergency|0
2982864|NCT01068730|10264459|P2|Period 4|Family emergency|1
2982865|NCT01068730|10264460|P1|Period 4|Family emergency|0
2982866|NCT01068730|10264457|P4|Period 3|Personal reason|0
2982867|NCT01068730|10264458|P3|Period 3|Personal reason|0
2982868|NCT01068730|10264459|P2|Period 3|Personal reason|0
2982869|NCT01068730|10264460|P1|Period 3|Personal reason|1
2982870|NCT01068717|10264514|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2982871|NCT01068717|10264515|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2982872|NCT01068717|10264516|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2982873|NCT01068717|10264517|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
2982874|NCT01068678|10264573|P2|Overall Study|Unclassified|15
2982875|NCT01068678|10264574|P1|Overall Study|Unclassified|18
2982876|NCT01068678|10264573|P2|Overall Study|Withdrawal criteria|6
2982877|NCT01068678|10264574|P1|Overall Study|Withdrawal criteria|12
2982878|NCT01068678|10264573|P2|Overall Study|Protocol Violation|1
2982879|NCT01068678|10264574|P1|Overall Study|Protocol Violation|5
2982880|NCT01068678|10264573|P2|Overall Study|Lack of Efficacy|2
2982881|NCT01068678|10264574|P1|Overall Study|Lack of Efficacy|3
2982882|NCT01068665|10264584|P2|Overall Study|Other|12
2982883|NCT01068665|10264585|P1|Overall Study|Other|17
2982884|NCT01068665|10264584|P2|Overall Study|Withdrawal Criteria|9
2982885|NCT01068665|10264585|P1|Overall Study|Withdrawal Criteria|3
2982886|NCT01068665|10264584|P2|Overall Study|Protocol Violation|2
2982887|NCT01068665|10264585|P1|Overall Study|Protocol Violation|5
2982888|NCT01068665|10264584|P2|Overall Study|Lack of Efficacy|2
2982889|NCT01068665|10264585|P1|Overall Study|Lack of Efficacy|0
2982890|NCT01068665|10264584|P2|Overall Study|Adverse Event|4
2982891|NCT01068665|10264585|P1|Overall Study|Adverse Event|5
2982892|NCT01068652|10264595|P2|Overall Study|Unclassified|4
2982893|NCT01068652|10264596|P1|Overall Study|Unclassified|7
2982894|NCT01068652|10264595|P2|Overall Study|Patient was not eligible|0
2982895|NCT01068652|10264596|P1|Overall Study|Patient was not eligible|1
2982896|NCT01068652|10264595|P2|Overall Study|Withdrawal criteria|2
2982897|NCT01068652|10264596|P1|Overall Study|Withdrawal criteria|1
2982898|NCT01068652|10264595|P2|Overall Study|Protocol Violation|6
2982899|NCT01068652|10264596|P1|Overall Study|Protocol Violation|3
2982900|NCT01068652|10264595|P2|Overall Study|Lost to Follow-up|1
2982901|NCT01068652|10264596|P1|Overall Study|Lost to Follow-up|2
2982902|NCT01068652|10264595|P2|Overall Study|Lack of Efficacy|2
2982903|NCT01068652|10264596|P1|Overall Study|Lack of Efficacy|0
2982904|NCT01068652|10264595|P2|Overall Study|Adverse Event|0
2982905|NCT01068652|10264596|P1|Overall Study|Adverse Event|4
2982906|NCT01068626|10264636|P2|Overall Study|Withdrawal by Subject|2
2982907|NCT01068626|10264637|P1|Overall Study|Withdrawal by Subject|0
2982908|NCT01068626|10264636|P2|Overall Study|Adverse Event|0
2982909|NCT01068626|10264637|P1|Overall Study|Adverse Event|3
2982910|NCT01068600|10264655|P2|Overall Study|Administrative problems|1
2982911|NCT01068600|10264656|P1|Overall Study|Administrative problems|0
2982912|NCT01068600|10264655|P2|Overall Study|Unsatisfactory therapeutic effect|4
2982913|NCT01068600|10264656|P1|Overall Study|Unsatisfactory therapeutic effect|0
2982914|NCT01068600|10264655|P2|Overall Study|Protocol deviation|1
2982915|NCT01068600|10264656|P1|Overall Study|Protocol deviation|1
2982916|NCT01068600|10264655|P2|Overall Study|Lost to Follow-up|2
2982917|NCT01068600|10264656|P1|Overall Study|Lost to Follow-up|1
2982918|NCT01068600|10264655|P2|Overall Study|Abnormal laboratory value(s)|0
2982919|NCT01068600|10264656|P1|Overall Study|Abnormal laboratory value(s)|1
2982920|NCT01068600|10264655|P2|Overall Study|Adverse Event|3
2982921|NCT01068600|10264656|P1|Overall Study|Adverse Event|3
2982922|NCT01068600|10264655|P2|Overall Study|Withdrawal by Subject|6
2982923|NCT01068600|10264656|P1|Overall Study|Withdrawal by Subject|5
2982924|NCT01068509|10264678|P3|Overall Study|Reason Not Specified|0
2982925|NCT01068509|10264679|P2|Overall Study|Reason Not Specified|1
2982926|NCT01068509|10264680|P1|Overall Study|Reason Not Specified|0
2982927|NCT01068509|10264678|P3|Overall Study|Withdrew Consent|2
2982928|NCT01068509|10264679|P2|Overall Study|Withdrew Consent|1
2982929|NCT01068509|10264680|P1|Overall Study|Withdrew Consent|0
2982930|NCT01068509|10264678|P3|Overall Study|Lost to Follow-up|0
2982931|NCT01068509|10264679|P2|Overall Study|Lost to Follow-up|0
2982932|NCT01068509|10264680|P1|Overall Study|Lost to Follow-up|1
2982933|NCT01068509|10264678|P3|Overall Study|Disease Progression|18
2982934|NCT01068509|10264679|P2|Overall Study|Disease Progression|20
2982935|NCT01068509|10264680|P1|Overall Study|Disease Progression|5
2982936|NCT01068509|10264678|P3|Overall Study|Death|1
2982937|NCT01068509|10264679|P2|Overall Study|Death|0
2982938|NCT01068509|10264680|P1|Overall Study|Death|0
2982939|NCT01068418|10264693|P1|Overall Study|Physician Decision|12
2982940|NCT01068262|10264702|P4|Overall Study|Withdrawal by Subject|0
2982941|NCT01068262|10264703|P3|Overall Study|Withdrawal by Subject|0
2982942|NCT01068262|10264704|P2|Overall Study|Withdrawal by Subject|1
2982943|NCT01068262|10264705|P1|Overall Study|Withdrawal by Subject|0
2982944|NCT01068262|10264702|P4|Overall Study|Protocol Violation|0
2982945|NCT01068262|10264703|P3|Overall Study|Protocol Violation|0
2982946|NCT01068262|10264704|P2|Overall Study|Protocol Violation|0
2982947|NCT01068262|10264705|P1|Overall Study|Protocol Violation|1
2982948|NCT01068262|10264702|P4|Overall Study|Adverse Event|0
2982949|NCT01068262|10264703|P3|Overall Study|Adverse Event|1
2982950|NCT01068262|10264704|P2|Overall Study|Adverse Event|0
2982951|NCT01068262|10264705|P1|Overall Study|Adverse Event|2
2982952|NCT01068158|10264735|P2|Overall Study|Protocol Violation|2
2982953|NCT01068158|10264736|P1|Overall Study|Protocol Violation|0
2982954|NCT01068158|10264735|P2|Overall Study|Lost to Follow-up|0
2982955|NCT01068158|10264736|P1|Overall Study|Lost to Follow-up|7
2982956|NCT01068158|10264735|P2|Overall Study|Withdrawal by Subject|2
2982957|NCT01068158|10264736|P1|Overall Study|Withdrawal by Subject|1
2982958|NCT01067976|10264748|P1|Overall Study|Study prematurely discontinued|2
2982959|NCT01067976|10264748|P1|Overall Study|Study drug never administered|20
2982960|NCT01067846|10264809|P2|Overall Study|participation in other tx study|0
2982961|NCT01067846|10264810|P1|Overall Study|participation in other tx study|1
2982962|NCT01067846|10264809|P2|Overall Study|Withdrawal by Subject|0
2982963|NCT01067846|10264810|P1|Overall Study|Withdrawal by Subject|1
2982964|NCT01067846|10264809|P2|Overall Study|Lost to Follow-up|19
2982965|NCT01067846|10264810|P1|Overall Study|Lost to Follow-up|17
2982966|NCT01067521|10264880|P2|Open-Label Period|Lost to Follow-up|20
2982967|NCT01067521|10264881|P1|Open-Label Period|Lost to Follow-up|21
2982968|NCT01067521|10264880|P2|Open-Label Period|Teva requested subject to be withdrawn|2
2982969|NCT01067521|10264881|P1|Open-Label Period|Teva requested subject to be withdrawn|5
2982970|NCT01067521|10264880|P2|Open-Label Period|Pregnancy|8
2982971|NCT01067521|10264881|P1|Open-Label Period|Pregnancy|14
2982972|NCT01067521|10264880|P2|Open-Label Period|Protocol Violation|0
2982973|NCT01067521|10264881|P1|Open-Label Period|Protocol Violation|3
2982974|NCT01067521|10264880|P2|Open-Label Period|Non-compliance with study drug|0
2982975|NCT01067521|10264881|P1|Open-Label Period|Non-compliance with study drug|5
2982976|NCT01067521|10264880|P2|Open-Label Period|Physician Decision|11
2982977|NCT01067521|10264881|P1|Open-Label Period|Physician Decision|13
2982978|NCT01067521|10264880|P2|Open-Label Period|Withdrawal by Subject|88
2982979|NCT01067521|10264881|P1|Open-Label Period|Withdrawal by Subject|160
2982980|NCT01067521|10264880|P2|Open-Label Period|Adverse Event|28
2982981|NCT01067521|10264881|P1|Open-Label Period|Adverse Event|30
2982982|NCT01067521|10264880|P2|Open-Label Period|Death|1
2982983|NCT01067521|10264881|P1|Open-Label Period|Death|3
2982984|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
2982985|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
2982986|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
2982987|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
2982988|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
2982989|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
2982990|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
2982991|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
2982992|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
2982993|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
2982994|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
2982995|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
2982996|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
2982997|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
2982998|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
2982999|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
2983000|NCT01067521|10264880|P2|Double-Blind Placebo-Controlled Period|Death|1
2983001|NCT01067521|10264881|P1|Double-Blind Placebo-Controlled Period|Death|0
2983002|NCT01067508|10264907|P2|Overall Study|Withdrawal by Subject|1
2983003|NCT01067508|10264908|P1|Overall Study|Withdrawal by Subject|0
2983004|NCT01067508|10264907|P2|Overall Study|Physician Decision|1
2983005|NCT01067508|10264908|P1|Overall Study|Physician Decision|0
2983006|NCT01067469|10264916|P2|Overall Study|Disease Progression|1
2983007|NCT01067469|10264917|P1|Overall Study|Disease Progression|0
2983008|NCT01067469|10264916|P2|Overall Study|Withdrawal by Subject|1
2983009|NCT01067469|10264917|P1|Overall Study|Withdrawal by Subject|0
2983010|NCT01067352|10264949|P3|Overall Study|Physician Decision|0
2983011|NCT01067352|10264950|P2|Overall Study|Physician Decision|1
2983012|NCT01067352|10264951|P1|Overall Study|Physician Decision|0
2983013|NCT01067352|10264949|P3|Overall Study|Withdrawal by Subject|1
2983014|NCT01067352|10264950|P2|Overall Study|Withdrawal by Subject|2
2983015|NCT01067352|10264951|P1|Overall Study|Withdrawal by Subject|1
2983016|NCT01067339|10264967|P2|Overall Study|Withdrawal by Subject|5
2983017|NCT01067339|10264968|P1|Overall Study|Withdrawal by Subject|6
2983018|NCT01067326|10264978|P2|Overall Study|Early Study Termination|1
2983019|NCT01067326|10264979|P1|Overall Study|Early Study Termination|1
2983020|NCT01067326|10264978|P2|Overall Study|Withdrawal by Subject|0
2983021|NCT01067326|10264979|P1|Overall Study|Withdrawal by Subject|1
2983022|NCT01067326|10264978|P2|Overall Study|Adverse Event|2
2983023|NCT01067326|10264979|P1|Overall Study|Adverse Event|0
2983024|NCT01067144|10264993|P2|Follow-up|Death|1
2983025|NCT01067144|10264994|P1|Follow-up|Death|0
2983026|NCT01067144|10264993|P2|Follow-up|Surgery cancelled|1
2983027|NCT01067144|10264994|P1|Follow-up|Surgery cancelled|0
2983028|NCT01067144|10264993|P2|Follow-up|Withdrawal by Subject|14
2983029|NCT01067144|10264994|P1|Follow-up|Withdrawal by Subject|18
2983030|NCT01067144|10264993|P2|Follow-up|Censored owing to second surgery|28
2983031|NCT01067144|10264994|P1|Follow-up|Censored owing to second surgery|19
2983032|NCT01067144|10264993|P2|Follow-up|Lost to Follow-up|12
2983033|NCT01067144|10264994|P1|Follow-up|Lost to Follow-up|22
2983034|NCT01067144|10264993|P2|Treatment|Did not receive allocated intervention|7
2983035|NCT01067144|10264994|P1|Treatment|Did not receive allocated intervention|4
2983036|NCT01067105|10265010|P1|Overall Study|Other|31
2983037|NCT01067105|10265010|P1|Overall Study|Physician Decision|6
2983038|NCT01067105|10265010|P1|Overall Study|Lost to Follow-up|6
2983039|NCT01067105|10265010|P1|Overall Study|Withdrawal by Subject|36
2983040|NCT01067105|10265010|P1|Overall Study|Protocol Violation|48
2983041|NCT01067105|10265010|P1|Overall Study|Adverse Event|14
2983042|NCT01066936|10265027|P1|Overall Study|Withdrawal by Subject|4
2983043|NCT01066936|10265027|P1|Overall Study|Lost to Follow-up|3
2983044|NCT01066936|10265027|P1|Overall Study|Device revised/removed|1
2983045|NCT01066936|10265027|P1|Overall Study|Death|2
2983046|NCT01066923|10265063|P4|Overall Study|Withdrawal by Subject|8
2983047|NCT01066923|10265064|P3|Overall Study|Withdrawal by Subject|8
2983048|NCT01066923|10265065|P2|Overall Study|Withdrawal by Subject|3
2983049|NCT01066923|10265066|P1|Overall Study|Withdrawal by Subject|3
2983050|NCT01066897|10265090|P2|Overall Study|stopped study after developing the flu.|0
2983051|NCT01066897|10265091|P1|Overall Study|stopped study after developing the flu.|1
2983052|NCT01066897|10265090|P2|Overall Study|Withdrawal by Subject|0
2983053|NCT01066897|10265091|P1|Overall Study|Withdrawal by Subject|1
2983054|NCT01066871|10265105|P4|Overall Study|Other|2
2983055|NCT01066871|10265106|P3|Overall Study|Other|1
2983056|NCT01066871|10265107|P2|Overall Study|Other|2
2983057|NCT01066871|10265108|P1|Overall Study|Other|0
2983058|NCT01066871|10265105|P4|Overall Study|Withdrawal by Subject|0
2983059|NCT01066871|10265106|P3|Overall Study|Withdrawal by Subject|0
2983060|NCT01066871|10265107|P2|Overall Study|Withdrawal by Subject|1
2983061|NCT01066871|10265108|P1|Overall Study|Withdrawal by Subject|3
2983062|NCT01066871|10265105|P4|Overall Study|Lack of Efficacy|1
2983063|NCT01066871|10265106|P3|Overall Study|Lack of Efficacy|0
2983064|NCT01066871|10265107|P2|Overall Study|Lack of Efficacy|0
2983065|NCT01066871|10265108|P1|Overall Study|Lack of Efficacy|0
2983066|NCT01066871|10265105|P4|Overall Study|Protocol Violation|2
2983067|NCT01066871|10265106|P3|Overall Study|Protocol Violation|3
2983068|NCT01066871|10265107|P2|Overall Study|Protocol Violation|0
2983069|NCT01066871|10265108|P1|Overall Study|Protocol Violation|1
2983070|NCT01066871|10265105|P4|Overall Study|Lost to Follow-up|0
2983071|NCT01066871|10265106|P3|Overall Study|Lost to Follow-up|2
2983072|NCT01066871|10265107|P2|Overall Study|Lost to Follow-up|2
2983073|NCT01066871|10265108|P1|Overall Study|Lost to Follow-up|0
2983074|NCT01066819|10265172|P6|Overall Study|Other|0
2983075|NCT01066819|10265173|P5|Overall Study|Other|0
2983076|NCT01066819|10265174|P4|Overall Study|Other|0
2983077|NCT01066819|10265175|P3|Overall Study|Other|1
2983078|NCT01066819|10265176|P2|Overall Study|Other|1
2983079|NCT01066819|10265177|P1|Overall Study|Other|5
2983080|NCT01066819|10265172|P6|Overall Study|Treatment stopped|0
2983081|NCT01066819|10265173|P5|Overall Study|Treatment stopped|0
2983082|NCT01066819|10265174|P4|Overall Study|Treatment stopped|1
2983083|NCT01066819|10265175|P3|Overall Study|Treatment stopped|2
2983084|NCT01066819|10265176|P2|Overall Study|Treatment stopped|1
2983085|NCT01066819|10265177|P1|Overall Study|Treatment stopped|12
2983086|NCT01066819|10265172|P6|Overall Study|Treatment never started|2
2983087|NCT01066819|10265173|P5|Overall Study|Treatment never started|2
2983088|NCT01066819|10265174|P4|Overall Study|Treatment never started|3
2983089|NCT01066819|10265175|P3|Overall Study|Treatment never started|19
2983090|NCT01066819|10265176|P2|Overall Study|Treatment never started|19
2983091|NCT01066819|10265177|P1|Overall Study|Treatment never started|85
2983092|NCT01066819|10265172|P6|Overall Study|Spontaneous cure|0
2983093|NCT01066819|10265173|P5|Overall Study|Spontaneous cure|0
2983094|NCT01066819|10265174|P4|Overall Study|Spontaneous cure|0
2983095|NCT01066819|10265175|P3|Overall Study|Spontaneous cure|0
2983096|NCT01066819|10265176|P2|Overall Study|Spontaneous cure|0
2983097|NCT01066819|10265177|P1|Overall Study|Spontaneous cure|1
2983098|NCT01066819|10265172|P6|Overall Study|Screen failure|0
2983099|NCT01066819|10265173|P5|Overall Study|Screen failure|0
2983100|NCT01066819|10265174|P4|Overall Study|Screen failure|0
2983101|NCT01066819|10265175|P3|Overall Study|Screen failure|0
2983102|NCT01066819|10265176|P2|Overall Study|Screen failure|0
2983103|NCT01066819|10265177|P1|Overall Study|Screen failure|1
2983104|NCT01066819|10265172|P6|Overall Study|Results not available|0
2983105|NCT01066819|10265173|P5|Overall Study|Results not available|0
2983106|NCT01066819|10265174|P4|Overall Study|Results not available|0
2983107|NCT01066819|10265175|P3|Overall Study|Results not available|0
2983108|NCT01066819|10265176|P2|Overall Study|Results not available|0
2983109|NCT01066819|10265177|P1|Overall Study|Results not available|1
2983110|NCT01066819|10265172|P6|Overall Study|Relapse|0
2983111|NCT01066819|10265173|P5|Overall Study|Relapse|0
2983112|NCT01066819|10265174|P4|Overall Study|Relapse|0
2983113|NCT01066819|10265175|P3|Overall Study|Relapse|3
2983114|NCT01066819|10265176|P2|Overall Study|Relapse|4
2983115|NCT01066819|10265177|P1|Overall Study|Relapse|16
2983116|NCT01066819|10265172|P6|Overall Study|Not categorised|0
2983117|NCT01066819|10265173|P5|Overall Study|Not categorised|0
2983118|NCT01066819|10265174|P4|Overall Study|Not categorised|1
2983119|NCT01066819|10265175|P3|Overall Study|Not categorised|6
2983120|NCT01066819|10265176|P2|Overall Study|Not categorised|2
2983121|NCT01066819|10265177|P1|Overall Study|Not categorised|9
2983122|NCT01066819|10265172|P6|Overall Study|Non responders|1
2983123|NCT01066819|10265173|P5|Overall Study|Non responders|0
2983124|NCT01066819|10265174|P4|Overall Study|Non responders|2
2983125|NCT01066819|10265175|P3|Overall Study|Non responders|7
2983126|NCT01066819|10265176|P2|Overall Study|Non responders|2
2983127|NCT01066819|10265177|P1|Overall Study|Non responders|123
2983128|NCT01066819|10265172|P6|Overall Study|Miscellaneous|0
2983129|NCT01066819|10265173|P5|Overall Study|Miscellaneous|0
2983130|NCT01066819|10265174|P4|Overall Study|Miscellaneous|1
2983131|NCT01066819|10265175|P3|Overall Study|Miscellaneous|18
2983132|NCT01066819|10265176|P2|Overall Study|Miscellaneous|10
2983133|NCT01066819|10265177|P1|Overall Study|Miscellaneous|28
2983134|NCT01066819|10265172|P6|Overall Study|Lab test not done|0
2983135|NCT01066819|10265173|P5|Overall Study|Lab test not done|0
2983136|NCT01066819|10265174|P4|Overall Study|Lab test not done|1
2983137|NCT01066819|10265175|P3|Overall Study|Lab test not done|2
2983138|NCT01066819|10265176|P2|Overall Study|Lab test not done|0
2983139|NCT01066819|10265177|P1|Overall Study|Lab test not done|9
2983140|NCT01066819|10265172|P6|Overall Study|Failed to return|3
2983141|NCT01066819|10265173|P5|Overall Study|Failed to return|2
2983142|NCT01066819|10265174|P4|Overall Study|Failed to return|7
2983143|NCT01066819|10265175|P3|Overall Study|Failed to return|68
2983144|NCT01066819|10265176|P2|Overall Study|Failed to return|107
2983145|NCT01066819|10265177|P1|Overall Study|Failed to return|298
2983146|NCT01066819|10265172|P6|Overall Study|Early termination|0
2983147|NCT01066819|10265173|P5|Overall Study|Early termination|0
2983148|NCT01066819|10265174|P4|Overall Study|Early termination|0
2983149|NCT01066819|10265175|P3|Overall Study|Early termination|0
2983150|NCT01066819|10265176|P2|Overall Study|Early termination|0
2983151|NCT01066819|10265177|P1|Overall Study|Early termination|2
2983152|NCT01066819|10265172|P6|Overall Study|Not met inclusion/exclusion criteria|0
2983153|NCT01066819|10265173|P5|Overall Study|Not met inclusion/exclusion criteria|0
2983154|NCT01066819|10265174|P4|Overall Study|Not met inclusion/exclusion criteria|0
2983155|NCT01066819|10265175|P3|Overall Study|Not met inclusion/exclusion criteria|0
2983156|NCT01066819|10265176|P2|Overall Study|Not met inclusion/exclusion criteria|0
2983157|NCT01066819|10265177|P1|Overall Study|Not met inclusion/exclusion criteria|1
2983158|NCT01066819|10265172|P6|Overall Study|Administrative|0
2983159|NCT01066819|10265173|P5|Overall Study|Administrative|0
2983160|NCT01066819|10265174|P4|Overall Study|Administrative|0
2983161|NCT01066819|10265175|P3|Overall Study|Administrative|2
2983162|NCT01066819|10265176|P2|Overall Study|Administrative|4
2983163|NCT01066819|10265177|P1|Overall Study|Administrative|6
2983164|NCT01066819|10265172|P6|Overall Study|Withdrawal by Subject|0
2983165|NCT01066819|10265173|P5|Overall Study|Withdrawal by Subject|0
2983166|NCT01066819|10265174|P4|Overall Study|Withdrawal by Subject|0
2983167|NCT01066819|10265175|P3|Overall Study|Withdrawal by Subject|6
2983168|NCT01066819|10265176|P2|Overall Study|Withdrawal by Subject|11
2983169|NCT01066819|10265177|P1|Overall Study|Withdrawal by Subject|29
2983170|NCT01066819|10265172|P6|Overall Study|Protocol Violation|0
2983171|NCT01066819|10265173|P5|Overall Study|Protocol Violation|0
2983172|NCT01066819|10265174|P4|Overall Study|Protocol Violation|0
2983173|NCT01066819|10265175|P3|Overall Study|Protocol Violation|0
2983174|NCT01066819|10265176|P2|Overall Study|Protocol Violation|6
2983175|NCT01066819|10265177|P1|Overall Study|Protocol Violation|12
2983176|NCT01066819|10265172|P6|Overall Study|Physician Decision|0
2983177|NCT01066819|10265173|P5|Overall Study|Physician Decision|0
2983178|NCT01066819|10265174|P4|Overall Study|Physician Decision|0
2983179|NCT01066819|10265175|P3|Overall Study|Physician Decision|3
2983180|NCT01066819|10265176|P2|Overall Study|Physician Decision|2
2983181|NCT01066819|10265177|P1|Overall Study|Physician Decision|6
2983182|NCT01066819|10265172|P6|Overall Study|Lack of Efficacy|0
2983183|NCT01066819|10265173|P5|Overall Study|Lack of Efficacy|0
2983184|NCT01066819|10265174|P4|Overall Study|Lack of Efficacy|1
2983185|NCT01066819|10265175|P3|Overall Study|Lack of Efficacy|2
2983186|NCT01066819|10265176|P2|Overall Study|Lack of Efficacy|1
2983187|NCT01066819|10265177|P1|Overall Study|Lack of Efficacy|22
2983188|NCT01066819|10265172|P6|Overall Study|Death|0
2983189|NCT01066819|10265173|P5|Overall Study|Death|0
2983190|NCT01066819|10265174|P4|Overall Study|Death|0
2983191|NCT01066819|10265175|P3|Overall Study|Death|1
2983192|NCT01066819|10265176|P2|Overall Study|Death|0
2983193|NCT01066819|10265177|P1|Overall Study|Death|5
2983194|NCT01066819|10265172|P6|Overall Study|Adverse Event|0
2983195|NCT01066819|10265173|P5|Overall Study|Adverse Event|0
2983196|NCT01066819|10265174|P4|Overall Study|Adverse Event|0
2983197|NCT01066819|10265175|P3|Overall Study|Adverse Event|6
2983198|NCT01066819|10265176|P2|Overall Study|Adverse Event|1
2983199|NCT01066819|10265177|P1|Overall Study|Adverse Event|18
2983200|NCT01066793|10265318|P6|Overall Study|Treatment Stopped|0
2983201|NCT01066793|10265319|P5|Overall Study|Treatment Stopped|0
2983202|NCT01066793|10265320|P4|Overall Study|Treatment Stopped|1
2983203|NCT01066793|10265321|P3|Overall Study|Treatment Stopped|0
2983204|NCT01066793|10265322|P2|Overall Study|Treatment Stopped|1
2983205|NCT01066793|10265323|P1|Overall Study|Treatment Stopped|2
2983206|NCT01066793|10265318|P6|Overall Study|Treatment Never Started|0
2983207|NCT01066793|10265319|P5|Overall Study|Treatment Never Started|0
2983208|NCT01066793|10265320|P4|Overall Study|Treatment Never Started|1
2983209|NCT01066793|10265321|P3|Overall Study|Treatment Never Started|4
2983210|NCT01066793|10265322|P2|Overall Study|Treatment Never Started|5
2983211|NCT01066793|10265323|P1|Overall Study|Treatment Never Started|18
2983212|NCT01066793|10265318|P6|Overall Study|Treatment Interrupted|0
2983213|NCT01066793|10265319|P5|Overall Study|Treatment Interrupted|0
2983214|NCT01066793|10265320|P4|Overall Study|Treatment Interrupted|0
2983215|NCT01066793|10265321|P3|Overall Study|Treatment Interrupted|0
2983216|NCT01066793|10265322|P2|Overall Study|Treatment Interrupted|1
2983217|NCT01066793|10265323|P1|Overall Study|Treatment Interrupted|1
2983218|NCT01066793|10265318|P6|Overall Study|Result Not Available|0
2983219|NCT01066793|10265319|P5|Overall Study|Result Not Available|0
2983220|NCT01066793|10265320|P4|Overall Study|Result Not Available|0
2983221|NCT01066793|10265321|P3|Overall Study|Result Not Available|0
2983222|NCT01066793|10265322|P2|Overall Study|Result Not Available|0
2983223|NCT01066793|10265323|P1|Overall Study|Result Not Available|1
2983224|NCT01066793|10265318|P6|Overall Study|Relapse|0
2983225|NCT01066793|10265319|P5|Overall Study|Relapse|0
2983226|NCT01066793|10265320|P4|Overall Study|Relapse|3
2983227|NCT01066793|10265321|P3|Overall Study|Relapse|2
2983228|NCT01066793|10265322|P2|Overall Study|Relapse|8
2983229|NCT01066793|10265323|P1|Overall Study|Relapse|20
2983230|NCT01066793|10265318|P6|Overall Study|Other|0
2983231|NCT01066793|10265319|P5|Overall Study|Other|0
2983232|NCT01066793|10265320|P4|Overall Study|Other|2
2983233|NCT01066793|10265321|P3|Overall Study|Other|6
2983234|NCT01066793|10265322|P2|Overall Study|Other|5
2983235|NCT01066793|10265323|P1|Overall Study|Other|15
2983236|NCT01066793|10265318|P6|Overall Study|Non-responders|0
2983237|NCT01066793|10265319|P5|Overall Study|Non-responders|0
2983238|NCT01066793|10265320|P4|Overall Study|Non-responders|25
2983239|NCT01066793|10265321|P3|Overall Study|Non-responders|11
2983240|NCT01066793|10265322|P2|Overall Study|Non-responders|5
2983241|NCT01066793|10265323|P1|Overall Study|Non-responders|104
2983242|NCT01066793|10265318|P6|Overall Study|Miscellaneous|0
2983243|NCT01066793|10265319|P5|Overall Study|Miscellaneous|0
2983244|NCT01066793|10265320|P4|Overall Study|Miscellaneous|0
2983245|NCT01066793|10265321|P3|Overall Study|Miscellaneous|6
2983246|NCT01066793|10265322|P2|Overall Study|Miscellaneous|5
2983247|NCT01066793|10265323|P1|Overall Study|Miscellaneous|4
2983248|NCT01066793|10265318|P6|Overall Study|Lab test not done|0
2983249|NCT01066793|10265319|P5|Overall Study|Lab test not done|0
2983250|NCT01066793|10265320|P4|Overall Study|Lab test not done|1
2983251|NCT01066793|10265321|P3|Overall Study|Lab test not done|0
2983252|NCT01066793|10265322|P2|Overall Study|Lab test not done|0
2983253|NCT01066793|10265323|P1|Overall Study|Lab test not done|7
2983254|NCT01066793|10265318|P6|Overall Study|Early Termination|0
2983255|NCT01066793|10265319|P5|Overall Study|Early Termination|0
2983256|NCT01066793|10265320|P4|Overall Study|Early Termination|0
2983257|NCT01066793|10265321|P3|Overall Study|Early Termination|0
2983258|NCT01066793|10265322|P2|Overall Study|Early Termination|0
2983259|NCT01066793|10265323|P1|Overall Study|Early Termination|3
2983260|NCT01066793|10265318|P6|Overall Study|Withdrawal by Subject|0
2983261|NCT01066793|10265319|P5|Overall Study|Withdrawal by Subject|0
2983262|NCT01066793|10265320|P4|Overall Study|Withdrawal by Subject|0
2983263|NCT01066793|10265321|P3|Overall Study|Withdrawal by Subject|1
2983264|NCT01066793|10265322|P2|Overall Study|Withdrawal by Subject|4
2983265|NCT01066793|10265323|P1|Overall Study|Withdrawal by Subject|7
2983266|NCT01066793|10265318|P6|Overall Study|Protocol Violation|0
2983267|NCT01066793|10265319|P5|Overall Study|Protocol Violation|0
2983268|NCT01066793|10265320|P4|Overall Study|Protocol Violation|0
2983269|NCT01066793|10265321|P3|Overall Study|Protocol Violation|2
2983270|NCT01066793|10265322|P2|Overall Study|Protocol Violation|2
2983271|NCT01066793|10265323|P1|Overall Study|Protocol Violation|3
2983272|NCT01066793|10265318|P6|Overall Study|Physician Decision|0
2983273|NCT01066793|10265319|P5|Overall Study|Physician Decision|0
2983274|NCT01066793|10265320|P4|Overall Study|Physician Decision|0
2983275|NCT01066793|10265321|P3|Overall Study|Physician Decision|0
2983276|NCT01066793|10265322|P2|Overall Study|Physician Decision|0
2983277|NCT01066793|10265323|P1|Overall Study|Physician Decision|3
2983278|NCT01066793|10265318|P6|Overall Study|Lost to Follow-up|1
2983279|NCT01066793|10265319|P5|Overall Study|Lost to Follow-up|0
2983280|NCT01066793|10265320|P4|Overall Study|Lost to Follow-up|16
2983281|NCT01066793|10265321|P3|Overall Study|Lost to Follow-up|82
2983282|NCT01066793|10265322|P2|Overall Study|Lost to Follow-up|39
2983283|NCT01066793|10265323|P1|Overall Study|Lost to Follow-up|180
2983284|NCT01066793|10265318|P6|Overall Study|Lack of Efficacy|0
2983285|NCT01066793|10265319|P5|Overall Study|Lack of Efficacy|0
2983286|NCT01066793|10265320|P4|Overall Study|Lack of Efficacy|0
2983287|NCT01066793|10265321|P3|Overall Study|Lack of Efficacy|0
2983288|NCT01066793|10265322|P2|Overall Study|Lack of Efficacy|1
2983289|NCT01066793|10265323|P1|Overall Study|Lack of Efficacy|2
2983290|NCT01066793|10265318|P6|Overall Study|Death|0
2983291|NCT01066793|10265319|P5|Overall Study|Death|0
2983292|NCT01066793|10265320|P4|Overall Study|Death|0
2983293|NCT01066793|10265321|P3|Overall Study|Death|1
2983294|NCT01066793|10265322|P2|Overall Study|Death|1
2983295|NCT01066793|10265323|P1|Overall Study|Death|4
2983296|NCT01066780|10265463|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2983297|NCT01066780|10265464|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2983298|NCT01066585|10265483|P2|Overall Study|Withdrawal by Subject|3
2983299|NCT01066585|10265484|P1|Overall Study|Withdrawal by Subject|0
2983300|NCT01066585|10265483|P2|Overall Study|Protocol Violation|0
2983301|NCT01066585|10265484|P1|Overall Study|Protocol Violation|1
2983302|NCT01066546|10265496|P1|Overall Study|Study terminated by sponsor|5
2983303|NCT01066156|10265526|P1|Overall Study|Withdrawal by Subject|1
2983304|NCT01066156|10265526|P1|Overall Study|Lost to Follow-up|7
2983305|NCT01066156|10265526|P1|Overall Study|ineligible|2
2983306|NCT01066143|10265530|P1|Overall Study|ineligible for the study|8
2983307|NCT01066104|10265536|P2|Overall Study|Protocol Violation|0
2983308|NCT01066104|10265537|P1|Overall Study|Protocol Violation|1
2983309|NCT01066104|10265536|P2|Overall Study|Adverse Event|1
2983310|NCT01066104|10265537|P1|Overall Study|Adverse Event|1
2983311|NCT01066052|10265547|P2|Overall Study|Enrolled But Not Treated|0
2983312|NCT01066052|10265548|P1|Overall Study|Enrolled But Not Treated|3
2983313|NCT01066039|10265559|P1|Overall Study|Drug/Dose Adjustment Required|1
2983314|NCT01066039|10265559|P1|Overall Study|Failure to Control Blood Pressure|1
2983315|NCT01066039|10265559|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
2983316|NCT01066039|10265559|P1|Overall Study|Additional Antihypertensive Required|4
2983317|NCT01066039|10265559|P1|Overall Study|Dropout due to Insulin Administration|1
2983318|NCT01066039|10265559|P1|Overall Study|Investigator’s Request|1
2983319|NCT01066039|10265559|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
2983320|NCT01066039|10265559|P1|Overall Study|Protocol Violation|2
2983321|NCT01066039|10265559|P1|Overall Study|Withdrawal by Subject|17
2983322|NCT01066039|10265559|P1|Overall Study|Adverse Event|6
2983323|NCT01066000|10265572|P1|Overall Study|Adverse Event|1
2983324|NCT01066000|10265572|P1|Overall Study|Withdrawal by Subject|1
2983325|NCT01066000|10265572|P1|Overall Study|Death|3
2983326|NCT01066000|10265572|P1|Overall Study|Protocol Violation|4
2983327|NCT01065844|10265583|P1|Overall Study|Adverse Event|5
2983328|NCT01065818|10265587|P1|Overall Study|Not a candidate for surgery|1
2983329|NCT01065818|10265587|P1|Overall Study|Withdrawal by Subject|1
2983330|NCT01065779|10265591|P1|Overall Study|Inclusion Criteria Violation|7
2983331|NCT01065779|10265591|P1|Overall Study|Failed to Follow-up|10
2983332|NCT01065779|10265591|P1|Overall Study|Not Administered With Study Drug|17
2983333|NCT01065779|10265591|P1|Overall Study|Non-enrollment Period Administration|10
2983334|NCT01065779|10265591|P1|Overall Study|Investigation Before Contract Date|37
2983335|NCT01065779|10265591|P1|Overall Study|Duplicate Investigation|1
2983336|NCT01065766|10265602|P1|Overall Study|Violated dosage/administration|25
2983337|NCT01065766|10265602|P1|Overall Study|Contraindication to administration|6
2983338|NCT01065766|10265602|P1|Overall Study|Assessed before the contracted date|1
2983339|NCT01065597|10265621|P1|Overall Study|Adverse Event|1
2983340|NCT01065454|10265668|P4|Follow up|study ongoing|41
2983341|NCT01065454|10265669|P3|Follow up|study ongoing|15
2983342|NCT01065454|10265670|P2|Follow up|study ongoing|22
2983343|NCT01065454|10265671|P1|Follow up|study ongoing|37
2983344|NCT01065454|10265668|P4|Follow up|Withdrawal by Subject|0
2983345|NCT01065454|10265669|P3|Follow up|Withdrawal by Subject|1
2983346|NCT01065454|10265670|P2|Follow up|Withdrawal by Subject|1
2983347|NCT01065454|10265671|P1|Follow up|Withdrawal by Subject|1
2983348|NCT01065454|10265668|P4|Follow up|Progressive disease|1
2983349|NCT01065454|10265669|P3|Follow up|Progressive disease|0
2983350|NCT01065454|10265670|P2|Follow up|Progressive disease|0
2983351|NCT01065454|10265671|P1|Follow up|Progressive disease|0
2983352|NCT01065454|10265668|P4|Follow up|Lost to Follow-up|1
2983353|NCT01065454|10265669|P3|Follow up|Lost to Follow-up|0
2983354|NCT01065454|10265670|P2|Follow up|Lost to Follow-up|0
2983355|NCT01065454|10265671|P1|Follow up|Lost to Follow-up|0
2983356|NCT01065454|10265668|P4|Follow up|Death|0
2983357|NCT01065454|10265669|P3|Follow up|Death|1
2983358|NCT01065454|10265670|P2|Follow up|Death|1
2983359|NCT01065454|10265671|P1|Follow up|Death|0
2983360|NCT01065454|10265668|P4|Follow up|Adverse Event|1
2983361|NCT01065454|10265669|P3|Follow up|Adverse Event|0
2983362|NCT01065454|10265670|P2|Follow up|Adverse Event|0
2983363|NCT01065454|10265671|P1|Follow up|Adverse Event|1
2983364|NCT01065454|10265668|P4|Treatment|Withdrawal by Subject|3
2983365|NCT01065454|10265669|P3|Treatment|Withdrawal by Subject|2
2983366|NCT01065454|10265670|P2|Treatment|Withdrawal by Subject|1
2983367|NCT01065454|10265671|P1|Treatment|Withdrawal by Subject|3
2983368|NCT01065454|10265668|P4|Treatment|Protocol Violation|0
2983369|NCT01065454|10265669|P3|Treatment|Protocol Violation|1
2983370|NCT01065454|10265670|P2|Treatment|Protocol Violation|0
2983371|NCT01065454|10265671|P1|Treatment|Protocol Violation|1
2983372|NCT01065454|10265668|P4|Treatment|Protocol Decision|2
2983373|NCT01065454|10265669|P3|Treatment|Protocol Decision|3
2983374|NCT01065454|10265670|P2|Treatment|Protocol Decision|0
2983375|NCT01065454|10265671|P1|Treatment|Protocol Decision|0
2983376|NCT01065454|10265668|P4|Treatment|Non-compliance|1
2983377|NCT01065454|10265669|P3|Treatment|Non-compliance|0
2983378|NCT01065454|10265670|P2|Treatment|Non-compliance|0
2983379|NCT01065454|10265671|P1|Treatment|Non-compliance|1
2983380|NCT01065454|10265668|P4|Treatment|Death|0
2983381|NCT01065454|10265669|P3|Treatment|Death|0
2983382|NCT01065454|10265670|P2|Treatment|Death|0
2983383|NCT01065454|10265671|P1|Treatment|Death|1
2983384|NCT01065454|10265668|P4|Treatment|Adverse Event|6
2983385|NCT01065454|10265669|P3|Treatment|Adverse Event|3
2983386|NCT01065454|10265670|P2|Treatment|Adverse Event|4
2983387|NCT01065454|10265671|P1|Treatment|Adverse Event|7
2983388|NCT01065350|10265794|P2|Overall Study|Received incorrect drug allocation|1
2983389|NCT01065350|10265795|P1|Overall Study|Received incorrect drug allocation|0
2983390|NCT01064947|10265856|P1|Overall Study|negative culture|41
2983391|NCT01064856|10265897|P4|Open-label (OL) Period|Other|7
2983392|NCT01064856|10265898|P3|Open-label (OL) Period|Other|7
2983393|NCT01064856|10265899|P2|Open-label (OL) Period|Other|0
2983394|NCT01064856|10265900|P1|Open-label (OL) Period|Other|0
2983395|NCT01064856|10265897|P4|Open-label (OL) Period|Lost to Follow-up|1
2983396|NCT01064856|10265898|P3|Open-label (OL) Period|Lost to Follow-up|2
2983397|NCT01064856|10265899|P2|Open-label (OL) Period|Lost to Follow-up|0
2983398|NCT01064856|10265900|P1|Open-label (OL) Period|Lost to Follow-up|0
2983399|NCT01064856|10265897|P4|Open-label (OL) Period|Consent withdrawn by participant|6
2983400|NCT01064856|10265898|P3|Open-label (OL) Period|Consent withdrawn by participant|5
2983401|NCT01064856|10265899|P2|Open-label (OL) Period|Consent withdrawn by participant|0
2983402|NCT01064856|10265900|P1|Open-label (OL) Period|Consent withdrawn by participant|0
2983403|NCT01064856|10265897|P4|Open-label (OL) Period|Adverse Event|6
2983404|NCT01064856|10265898|P3|Open-label (OL) Period|Adverse Event|12
2983405|NCT01064856|10265899|P2|Open-label (OL) Period|Adverse Event|0
2983406|NCT01064856|10265900|P1|Open-label (OL) Period|Adverse Event|0
2983407|NCT01064856|10265897|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
2983408|NCT01064856|10265898|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
2983409|NCT01064856|10265899|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
2983410|NCT01064856|10265900|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
2983411|NCT01064856|10265897|P4|Double-blind (DB) Period|Adverse Event|0
2983412|NCT01064856|10265898|P3|Double-blind (DB) Period|Adverse Event|0
2983413|NCT01064856|10265899|P2|Double-blind (DB) Period|Adverse Event|0
2983414|NCT01064856|10265900|P1|Double-blind (DB) Period|Adverse Event|1
2983415|NCT01064817|10265944|P2|Study Completion|Withdrawal by Subject|0
2983416|NCT01064817|10265945|P1|Study Completion|Withdrawal by Subject|1
2983417|NCT01064817|10265944|P2|Study Completion|Physician Decision|0
2983418|NCT01064817|10265945|P1|Study Completion|Physician Decision|1
2983419|NCT01064739|10265957|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
2983420|NCT01064687|10266028|P4|Overall Study|Treatment Noncompliance|0
2983421|NCT01064687|10266029|P3|Overall Study|Treatment Noncompliance|1
2983422|NCT01064687|10266030|P2|Overall Study|Treatment Noncompliance|1
2983423|NCT01064687|10266031|P1|Overall Study|Treatment Noncompliance|1
2983424|NCT01064687|10266028|P4|Overall Study|Withdrawal by Subject|5
2983425|NCT01064687|10266029|P3|Overall Study|Withdrawal by Subject|12
2983426|NCT01064687|10266030|P2|Overall Study|Withdrawal by Subject|7
2983427|NCT01064687|10266031|P1|Overall Study|Withdrawal by Subject|9
2983428|NCT01064687|10266028|P4|Overall Study|Sponsor Decision|0
2983429|NCT01064687|10266029|P3|Overall Study|Sponsor Decision|3
2983430|NCT01064687|10266030|P2|Overall Study|Sponsor Decision|0
2983431|NCT01064687|10266031|P1|Overall Study|Sponsor Decision|0
2983432|NCT01064687|10266028|P4|Overall Study|Protocol Violation|1
2983433|NCT01064687|10266029|P3|Overall Study|Protocol Violation|0
2983434|NCT01064687|10266030|P2|Overall Study|Protocol Violation|1
2983435|NCT01064687|10266031|P1|Overall Study|Protocol Violation|1
2983436|NCT01064687|10266028|P4|Overall Study|Physician Decision|0
2983437|NCT01064687|10266029|P3|Overall Study|Physician Decision|0
2983438|NCT01064687|10266030|P2|Overall Study|Physician Decision|2
2983439|NCT01064687|10266031|P1|Overall Study|Physician Decision|2
2983440|NCT01064687|10266028|P4|Overall Study|Lost to Follow-up|5
2983441|NCT01064687|10266029|P3|Overall Study|Lost to Follow-up|13
2983442|NCT01064687|10266030|P2|Overall Study|Lost to Follow-up|10
2983443|NCT01064687|10266031|P1|Overall Study|Lost to Follow-up|7
2983444|NCT01064687|10266028|P4|Overall Study|Lack of Efficacy|3
2983445|NCT01064687|10266029|P3|Overall Study|Lack of Efficacy|2
2983446|NCT01064687|10266030|P2|Overall Study|Lack of Efficacy|0
2983447|NCT01064687|10266031|P1|Overall Study|Lack of Efficacy|1
2983448|NCT01064687|10266028|P4|Overall Study|Entry Criteria Not Met|0
2983449|NCT01064687|10266029|P3|Overall Study|Entry Criteria Not Met|0
2983450|NCT01064687|10266030|P2|Overall Study|Entry Criteria Not Met|0
2983451|NCT01064687|10266031|P1|Overall Study|Entry Criteria Not Met|3
2983452|NCT01064687|10266028|P4|Overall Study|Death|0
2983453|NCT01064687|10266029|P3|Overall Study|Death|0
2983454|NCT01064687|10266030|P2|Overall Study|Death|1
2983455|NCT01064687|10266031|P1|Overall Study|Death|1
2983456|NCT01064687|10266028|P4|Overall Study|Adverse Event|3
2983457|NCT01064687|10266029|P3|Overall Study|Adverse Event|10
2983458|NCT01064687|10266030|P2|Overall Study|Adverse Event|4
2983459|NCT01064687|10266031|P1|Overall Study|Adverse Event|9
2983460|NCT01064648|10266211|P4|Phase II|Under Review|0
2983461|NCT01064648|10266212|P3|Phase II|Under Review|2
2983462|NCT01064648|10266213|P2|Phase II|Under Review|0
2983463|NCT01064648|10266214|P1|Phase II|Under Review|0
2983464|NCT01064648|10266211|P4|Phase II|Non-protocol specified|3
2983465|NCT01064648|10266212|P3|Phase II|Non-protocol specified|5
2983466|NCT01064648|10266213|P2|Phase II|Non-protocol specified|0
2983467|NCT01064648|10266214|P1|Phase II|Non-protocol specified|0
2983468|NCT01064648|10266211|P4|Phase II|Progression|27
2983469|NCT01064648|10266212|P3|Phase II|Progression|21
2983470|NCT01064648|10266213|P2|Phase II|Progression|0
2983471|NCT01064648|10266214|P1|Phase II|Progression|0
2983472|NCT01064648|10266211|P4|Phase II|Withdrawal by Subject|5
2983473|NCT01064648|10266212|P3|Phase II|Withdrawal by Subject|2
2983474|NCT01064648|10266213|P2|Phase II|Withdrawal by Subject|0
2983475|NCT01064648|10266214|P1|Phase II|Withdrawal by Subject|0
2983476|NCT01064648|10266211|P4|Phase II|Death|5
2983477|NCT01064648|10266212|P3|Phase II|Death|4
2983478|NCT01064648|10266213|P2|Phase II|Death|0
2983479|NCT01064648|10266214|P1|Phase II|Death|0
2983480|NCT01064648|10266211|P4|Phase II|Adverse Event|8
2983481|NCT01064648|10266212|P3|Phase II|Adverse Event|15
2983482|NCT01064648|10266213|P2|Phase II|Adverse Event|0
2983483|NCT01064648|10266214|P1|Phase II|Adverse Event|0
2983484|NCT01064648|10266211|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2983485|NCT01064648|10266212|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2983486|NCT01064648|10266213|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
2983487|NCT01064648|10266214|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2983488|NCT01064648|10266211|P4|Phase I Cohort 2: Dose Level 2|Progression|0
2983489|NCT01064648|10266212|P3|Phase I Cohort 2: Dose Level 2|Progression|0
2983490|NCT01064648|10266213|P2|Phase I Cohort 2: Dose Level 2|Progression|5
2983491|NCT01064648|10266214|P1|Phase I Cohort 2: Dose Level 2|Progression|0
2983492|NCT01064648|10266211|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2983493|NCT01064648|10266212|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2983494|NCT01064648|10266213|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
2983495|NCT01064648|10266214|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2983496|NCT01064648|10266211|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2983497|NCT01064648|10266212|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2983498|NCT01064648|10266213|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
2983499|NCT01064648|10266214|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2983500|NCT01064648|10266211|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2983501|NCT01064648|10266212|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2983502|NCT01064648|10266213|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2983503|NCT01064648|10266214|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
2983504|NCT01064648|10266211|P4|Phase I Cohort1: Dose Level 1|Progression|0
2983505|NCT01064648|10266212|P3|Phase I Cohort1: Dose Level 1|Progression|0
2983506|NCT01064648|10266213|P2|Phase I Cohort1: Dose Level 1|Progression|0
2983507|NCT01064648|10266214|P1|Phase I Cohort1: Dose Level 1|Progression|5
2983508|NCT01064622|10266240|P2|Randomized Phase II|Protocol Violation|1
2983509|NCT01064622|10266241|P1|Randomized Phase II|Protocol Violation|0
2983510|NCT01064622|10266240|P2|Randomized Phase II|Withdrawal by Subject|2
2983511|NCT01064622|10266241|P1|Randomized Phase II|Withdrawal by Subject|2
2983512|NCT01064531|10266264|P2|Overall Study|Death|1
2983513|NCT01064531|10266265|P1|Overall Study|Death|0
2983514|NCT01064531|10266264|P2|Overall Study|Revision due to dislocation|1
2983515|NCT01064531|10266265|P1|Overall Study|Revision due to dislocation|0
2983516|NCT01064531|10266264|P2|Overall Study|Revision due to femoral stem loosening|0
2983517|NCT01064531|10266265|P1|Overall Study|Revision due to femoral stem loosening|1
2983518|NCT01064531|10266264|P2|Overall Study|Withdrawal by Subject|2
2983519|NCT01064531|10266265|P1|Overall Study|Withdrawal by Subject|2
2983520|NCT01064531|10266264|P2|Overall Study|Physician Decision|1
2983521|NCT01064531|10266265|P1|Overall Study|Physician Decision|0
2983522|NCT01064531|10266264|P2|Overall Study|Lost to Follow-up|2
2983523|NCT01064531|10266265|P1|Overall Study|Lost to Follow-up|0
2983524|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Other|1
2983525|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Other|2
2983526|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Other|5
2983527|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
2983528|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2983529|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
2983530|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2983531|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2983532|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2983533|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2983534|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2983535|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2983536|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
2983537|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
2983538|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
2983539|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2983540|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2983541|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2983542|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Death|0
2983543|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Death|1
2983544|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Death|0
2983545|NCT01064414|10266312|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
2983546|NCT01064414|10266313|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2983547|NCT01064414|10266314|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
2983548|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Other|2
2983549|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Other|7
2983550|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Other|4
2983551|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2983552|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2983553|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2983554|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2983555|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2983556|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2983557|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Protocol Violation|1
2983558|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Protocol Violation|0
2983559|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Protocol Violation|1
2983560|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Death|0
2983561|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Death|1
2983562|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Death|0
2983563|NCT01064414|10266312|P3|Core Period: Baseline to Week 26|Adverse Event|2
2983564|NCT01064414|10266313|P2|Core Period: Baseline to Week 26|Adverse Event|4
2983565|NCT01064414|10266314|P1|Core Period: Baseline to Week 26|Adverse Event|4
2983566|NCT01064401|10266333|P2|Overall Study|Other|1
2983567|NCT01064401|10266334|P1|Overall Study|Other|2
2983568|NCT01064401|10266333|P2|Overall Study|Site Closure|5
2983569|NCT01064401|10266334|P1|Overall Study|Site Closure|4
2983570|NCT01064401|10266333|P2|Overall Study|Noncompliance|8
2983571|NCT01064401|10266334|P1|Overall Study|Noncompliance|7
2983572|NCT01064401|10266333|P2|Overall Study|Pregnancy|7
2983573|NCT01064401|10266334|P1|Overall Study|Pregnancy|4
2983574|NCT01064401|10266333|P2|Overall Study|Death|0
2983575|NCT01064401|10266334|P1|Overall Study|Death|4
2983576|NCT01064401|10266333|P2|Overall Study|Investigator Decision|6
2983577|NCT01064401|10266334|P1|Overall Study|Investigator Decision|4
2983578|NCT01064401|10266333|P2|Overall Study|Consent Withdrawn|80
2983579|NCT01064401|10266334|P1|Overall Study|Consent Withdrawn|98
2983580|NCT01064401|10266333|P2|Overall Study|Lost to Follow-up|9
2983581|NCT01064401|10266334|P1|Overall Study|Lost to Follow-up|12
2983582|NCT01064401|10266333|P2|Overall Study|Lack of Efficacy|23
2983583|NCT01064401|10266334|P1|Overall Study|Lack of Efficacy|46
2983584|NCT01064401|10266333|P2|Overall Study|Adverse Event|56
2983585|NCT01064401|10266334|P1|Overall Study|Adverse Event|47
2983586|NCT01064310|10266383|P3|Open Label Pazopinib|Physician Decision|20
2983587|NCT01064310|10266384|P2|Open Label Pazopinib|Physician Decision|0
2983588|NCT01064310|10266385|P1|Open Label Pazopinib|Physician Decision|0
2983589|NCT01064310|10266383|P3|Open Label Pazopinib|Lack of Efficacy|51
2983590|NCT01064310|10266384|P2|Open Label Pazopinib|Lack of Efficacy|0
2983591|NCT01064310|10266385|P1|Open Label Pazopinib|Lack of Efficacy|0
2983592|NCT01064310|10266383|P3|Open Label Pazopinib|Adverse Event|12
2983593|NCT01064310|10266384|P2|Open Label Pazopinib|Adverse Event|0
2983594|NCT01064310|10266385|P1|Open Label Pazopinib|Adverse Event|0
2983595|NCT01064310|10266383|P3|Open Label Pazopinib|Withdrawal by Subject|1
2983596|NCT01064310|10266384|P2|Open Label Pazopinib|Withdrawal by Subject|0
2983597|NCT01064310|10266385|P1|Open Label Pazopinib|Withdrawal by Subject|0
2983598|NCT01064310|10266383|P3|Period 2|Lack of Efficacy|0
2983599|NCT01064310|10266384|P2|Period 2|Lack of Efficacy|4
2983600|NCT01064310|10266385|P1|Period 2|Lack of Efficacy|1
2983601|NCT01064310|10266383|P3|Period 2|Entered Open-label Period|0
2983602|NCT01064310|10266384|P2|Period 2|Entered Open-label Period|0
2983603|NCT01064310|10266385|P1|Period 2|Entered Open-label Period|1
2983604|NCT01064310|10266383|P3|Period 2|Physician Decision|0
2983605|NCT01064310|10266384|P2|Period 2|Physician Decision|1
2983606|NCT01064310|10266385|P1|Period 2|Physician Decision|0
2983607|NCT01064310|10266383|P3|Period 2|Adverse Event|0
2983608|NCT01064310|10266384|P2|Period 2|Adverse Event|1
2983609|NCT01064310|10266385|P1|Period 2|Adverse Event|2
2983610|NCT01064310|10266383|P3|Period 1|Entered Open-label Period|0
2983611|NCT01064310|10266384|P2|Period 1|Entered Open-label Period|1
2983612|NCT01064310|10266385|P1|Period 1|Entered Open-label Period|1
2983613|NCT01064310|10266383|P3|Period 1|Lack of Efficacy|0
2983614|NCT01064310|10266384|P2|Period 1|Lack of Efficacy|5
2983615|NCT01064310|10266385|P1|Period 1|Lack of Efficacy|3
2983616|NCT01064310|10266383|P3|Period 1|Withdrawal by Subject|0
2983617|NCT01064310|10266384|P2|Period 1|Withdrawal by Subject|2
2983618|NCT01064310|10266385|P1|Period 1|Withdrawal by Subject|2
2983619|NCT01064310|10266383|P3|Period 1|Physician Decision|0
2983620|NCT01064310|10266384|P2|Period 1|Physician Decision|0
2983621|NCT01064310|10266385|P1|Period 1|Physician Decision|1
2983622|NCT01064310|10266383|P3|Period 1|Adverse Event|0
2983623|NCT01064310|10266384|P2|Period 1|Adverse Event|10
2983624|NCT01064310|10266385|P1|Period 1|Adverse Event|7
2983625|NCT01064297|10266415|P3|Overall Study|Lost to Follow-up|133
2983626|NCT01064297|10266416|P2|Overall Study|Lost to Follow-up|48
2983627|NCT01064297|10266417|P1|Overall Study|Lost to Follow-up|791
2983628|NCT01064167|10266486|P2|Overall Study|Protocol Violation|15
2983629|NCT01064167|10266487|P1|Overall Study|Protocol Violation|14
2983630|NCT01063972|10266502|P2|Overall Study|Incarcerated|1
2983631|NCT01063972|10266503|P1|Overall Study|Incarcerated|2
2983632|NCT01063972|10266502|P2|Overall Study|Death|11
2983633|NCT01063972|10266503|P1|Overall Study|Death|12
2983634|NCT01063881|10266553|P3|Overall Study|Reason for not completed not specified|0
2983635|NCT01063881|10266554|P2|Overall Study|Reason for not completed not specified|1
2983636|NCT01063881|10266555|P1|Overall Study|Reason for not completed not specified|5
2983637|NCT01063881|10266553|P3|Overall Study|Withdrawal by Subject|0
2983638|NCT01063881|10266554|P2|Overall Study|Withdrawal by Subject|1
2983639|NCT01063881|10266555|P1|Overall Study|Withdrawal by Subject|25
2983640|NCT01063881|10266553|P3|Overall Study|Lost to Follow-up|1
2983641|NCT01063881|10266554|P2|Overall Study|Lost to Follow-up|7
2983642|NCT01063881|10266555|P1|Overall Study|Lost to Follow-up|13
2983643|NCT01063881|10266553|P3|Overall Study|Adverse Event|0
2983644|NCT01063881|10266554|P2|Overall Study|Adverse Event|2
2983645|NCT01063881|10266555|P1|Overall Study|Adverse Event|12
2983646|NCT01063868|10266579|P2|Overall Study|Study Terminated By Sponsor|4
2983647|NCT01063868|10266580|P1|Overall Study|Study Terminated By Sponsor|23
2983648|NCT01063868|10266579|P2|Overall Study|Withdrawal by Subject|1
2983649|NCT01063868|10266580|P1|Overall Study|Withdrawal by Subject|3
2983650|NCT01063868|10266579|P2|Overall Study|Adverse Event|7
2983651|NCT01063868|10266580|P1|Overall Study|Adverse Event|9
2983652|NCT01063855|10266588|P2|Overall Study|Reason not specified|11
2983653|NCT01063855|10266589|P1|Overall Study|Reason not specified|13
2983654|NCT01063855|10266588|P2|Overall Study|Withdrawal by Subject|8
2983655|NCT01063855|10266589|P1|Overall Study|Withdrawal by Subject|11
2983656|NCT01063855|10266588|P2|Overall Study|Lack of Efficacy|1
2983657|NCT01063855|10266589|P1|Overall Study|Lack of Efficacy|0
2983658|NCT01063855|10266588|P2|Overall Study|Pregnancy|0
2983659|NCT01063855|10266589|P1|Overall Study|Pregnancy|1
2983660|NCT01063855|10266588|P2|Overall Study|Lost to Follow-up|4
2983661|NCT01063855|10266589|P1|Overall Study|Lost to Follow-up|8
2983662|NCT01063855|10266588|P2|Overall Study|Death|1
2983663|NCT01063855|10266589|P1|Overall Study|Death|0
2983664|NCT01063855|10266588|P2|Overall Study|Adverse Event|4
2983665|NCT01063855|10266589|P1|Overall Study|Adverse Event|4
2983666|NCT01063764|10266636|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
2983667|NCT01063764|10266636|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
2983668|NCT01063764|10266636|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
2983669|NCT01063764|10266636|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
2983670|NCT01063764|10266636|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
2983671|NCT01063764|10266636|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
2983672|NCT01063764|10266636|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
2983673|NCT01063595|10266655|P2|First Intervention|Reason not Specified|1
2983674|NCT01063595|10266656|P1|First Intervention|Reason not Specified|0
2983675|NCT01063595|10266655|P2|First Intervention|Withdrawal by Subject|0
2983676|NCT01063595|10266656|P1|First Intervention|Withdrawal by Subject|1
2983677|NCT01063595|10266655|P2|First Intervention|Adverse Event|4
2983678|NCT01063595|10266656|P1|First Intervention|Adverse Event|1
2983679|NCT01063595|10266655|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
2983680|NCT01063595|10266656|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
2983681|NCT01063595|10266655|P2|Enrolled in Study and Randomized|Adverse Event|1
2983682|NCT01063595|10266656|P1|Enrolled in Study and Randomized|Adverse Event|0
2983683|NCT01063595|10266655|P2|Enrolled in Study and Randomized|Reason not Specified|0
2983684|NCT01063595|10266656|P1|Enrolled in Study and Randomized|Reason not Specified|1
2983685|NCT01063517|10266668|P2|Overall Study|Death|48
2983686|NCT01063517|10266669|P1|Overall Study|Death|33
2983687|NCT01063517|10266668|P2|Overall Study|Withdrawal by Subject|2
2983688|NCT01063517|10266669|P1|Overall Study|Withdrawal by Subject|1
2983689|NCT01063517|10266668|P2|Overall Study|Lost to Follow-up|3
2983690|NCT01063517|10266669|P1|Overall Study|Lost to Follow-up|4
2983691|NCT01063517|10266668|P2|Overall Study|Study reached data cut-off|7
2983692|NCT01063517|10266669|P1|Overall Study|Study reached data cut-off|19
2983693|NCT01063517|10266668|P2|Overall Study|Consent withdrawal|0
2983694|NCT01063517|10266669|P1|Overall Study|Consent withdrawal|1
2983695|NCT01063348|10266709|P2|Overall Study|Lost to Follow-up|10
2983696|NCT01063348|10266710|P1|Overall Study|Lost to Follow-up|3
2983697|NCT01063283|10266720|P3|Cycle 1|Technical failure in data collection|0
2983698|NCT01063283|10266721|P2|Cycle 1|Technical failure in data collection|0
2983699|NCT01063283|10266722|P1|Cycle 1|Technical failure in data collection|1
2983700|NCT01063283|10266720|P3|Cycle 1|Adverse Event|0
2983701|NCT01063283|10266721|P2|Cycle 1|Adverse Event|0
2983702|NCT01063283|10266722|P1|Cycle 1|Adverse Event|2
2983703|NCT01063153|10266736|P2|Overall Study|Physician Decision|4
2983704|NCT01063153|10266737|P1|Overall Study|Physician Decision|0
2983705|NCT01063153|10266736|P2|Overall Study|Withdrawal by Subject|1
2983706|NCT01063153|10266737|P1|Overall Study|Withdrawal by Subject|0
2983707|NCT01063153|10266736|P2|Overall Study|Lost to Follow-up|7
2983708|NCT01063153|10266737|P1|Overall Study|Lost to Follow-up|0
2983709|NCT01063153|10266736|P2|Overall Study|Found Ineligible During Screening|0
2983710|NCT01063153|10266737|P1|Overall Study|Found Ineligible During Screening|2
2983711|NCT01063062|10266768|P2|Overall Study|Miscellaneous reason|1
2983712|NCT01063062|10266769|P1|Overall Study|Miscellaneous reason|0
2983713|NCT01063062|10266768|P2|Overall Study|Lost to Follow-up|2
2983714|NCT01063062|10266769|P1|Overall Study|Lost to Follow-up|0
2983715|NCT01063062|10266768|P2|Overall Study|Investigator's request|0
2983716|NCT01063062|10266769|P1|Overall Study|Investigator's request|1
2983717|NCT01063062|10266768|P2|Overall Study|Protocol Violation|4
2983718|NCT01063062|10266769|P1|Overall Study|Protocol Violation|5
2983719|NCT01063062|10266768|P2|Overall Study|Adverse Event|4
2983720|NCT01063062|10266769|P1|Overall Study|Adverse Event|2
2983721|NCT01063062|10266768|P2|Overall Study|Patient withdrew consent|1
2983722|NCT01063062|10266769|P1|Overall Study|Patient withdrew consent|0
2983723|NCT01063036|10266823|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
2983724|NCT01063036|10266823|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
2983725|NCT01063036|10266823|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
2983726|NCT01063036|10266823|P1|Participants Treated With Study Drug|Pregnancy|1
2983727|NCT01063036|10266823|P1|Participants Treated With Study Drug|Lost to Follow-up|1
2983728|NCT01063036|10266823|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
2983729|NCT01063036|10266823|P1|Participants Treated With Study Drug|Protocol Violation|1
2983730|NCT01063036|10266823|P1|Participants Treated With Study Drug|Adverse Event|1
2983731|NCT01062971|10266839|P2|Overall Study|Lost to Follow-up|4
2983732|NCT01062971|10266840|P1|Overall Study|Lost to Follow-up|3
2983733|NCT01062971|10266839|P2|Overall Study|Protocol Violation|3
2983734|NCT01062971|10266840|P1|Overall Study|Protocol Violation|1
2983735|NCT01062841|10266879|P2|Overall Study|Withdrawal by Study|0
2983736|NCT01062841|10266880|P1|Overall Study|Withdrawal by Study|3
2983737|NCT01062841|10266879|P2|Overall Study|Withdrawal by Subject|0
2983738|NCT01062841|10266880|P1|Overall Study|Withdrawal by Subject|2
2983739|NCT01062841|10266879|P2|Overall Study|Death|5
2983740|NCT01062841|10266880|P1|Overall Study|Death|3
2983741|NCT01062841|10266879|P2|Overall Study|Indwelling Device Removed|48
2983742|NCT01062841|10266880|P1|Overall Study|Indwelling Device Removed|41
2983743|NCT01062763|10266910|P2|Overall Study|Adverse Event|4
2983744|NCT01062763|10266911|P1|Overall Study|Adverse Event|3
2983745|NCT01062425|10266937|P2|Overall Study|Protocol Violation|6
2983746|NCT01062425|10266938|P1|Overall Study|Protocol Violation|3
2983747|NCT01062399|10266955|P5|Overall Study|Protocol Violation|4
2983748|NCT01062399|10266956|P4|Overall Study|Protocol Violation|6
2983749|NCT01062399|10266957|P3|Overall Study|Protocol Violation|0
2983750|NCT01062399|10266958|P2|Overall Study|Protocol Violation|1
2983751|NCT01062399|10266959|P1|Overall Study|Protocol Violation|0
2983752|NCT01062256|10267003|P3|Overall Study|Administrative|0
2983753|NCT01062256|10267004|P2|Overall Study|Administrative|2
2983754|NCT01062256|10267005|P1|Overall Study|Administrative|0
2983755|NCT01062256|10267003|P3|Overall Study|Ineligible|3
2983756|NCT01062256|10267004|P2|Overall Study|Ineligible|4
2983757|NCT01062256|10267005|P1|Overall Study|Ineligible|1
2983758|NCT01062256|10267003|P3|Overall Study|Withdrawal by Subject|1
2983759|NCT01062256|10267004|P2|Overall Study|Withdrawal by Subject|1
2983760|NCT01062256|10267005|P1|Overall Study|Withdrawal by Subject|1
2983761|NCT01062256|10267003|P3|Overall Study|Adverse Event|0
2983762|NCT01062256|10267004|P2|Overall Study|Adverse Event|0
2983763|NCT01062256|10267005|P1|Overall Study|Adverse Event|1
2983764|NCT01062113|10267039|P3|Overall Study|Withdrawal by Subject|0
2983765|NCT01062113|10267040|P2|Overall Study|Withdrawal by Subject|0
2983766|NCT01062113|10267041|P1|Overall Study|Withdrawal by Subject|1
2983767|NCT01062113|10267039|P3|Overall Study|Lack of Efficacy|31
2983768|NCT01062113|10267040|P2|Overall Study|Lack of Efficacy|22
2983769|NCT01062113|10267041|P1|Overall Study|Lack of Efficacy|38
2983770|NCT01062113|10267039|P3|Overall Study|Adverse Event|0
2983771|NCT01062113|10267040|P2|Overall Study|Adverse Event|0
2983772|NCT01062113|10267041|P1|Overall Study|Adverse Event|1
2983773|NCT01062061|10267059|P1|Overall Study|Failed to meet inclusion criteria|2
2983774|NCT01062061|10267059|P1|Overall Study|Outside chief indications|10
2983775|NCT01062061|10267059|P1|Overall Study|Investigated before study start|13
2983776|NCT01062061|10267059|P1|Overall Study|Enrolled more than once|2
2983777|NCT01061866|10267098|P1|Overall Study|Adverse Event|2
2983778|NCT01061775|10267102|P1|Overall Study|Lost to Follow-up|1
2983779|NCT01061775|10267102|P1|Overall Study|Physician Decision|2
2983780|NCT01061736|10267119|P10|Overall Study|Other than specified above|21
2983781|NCT01061736|10267120|P9|Overall Study|Other than specified above|15
2983782|NCT01061736|10267121|P8|Overall Study|Other than specified above|18
2983783|NCT01061736|10267122|P7|Overall Study|Other than specified above|0
2983784|NCT01061736|10267123|P6|Overall Study|Other than specified above|0
2983785|NCT01061736|10267124|P5|Overall Study|Other than specified above|1
2983786|NCT01061736|10267125|P4|Overall Study|Other than specified above|0
2983787|NCT01061736|10267126|P3|Overall Study|Other than specified above|2
2983788|NCT01061736|10267127|P2|Overall Study|Other than specified above|1
2983789|NCT01061736|10267128|P1|Overall Study|Other than specified above|0
2983790|NCT01061736|10267119|P10|Overall Study|Not treated|0
2983791|NCT01061736|10267120|P9|Overall Study|Not treated|1
2983792|NCT01061736|10267121|P8|Overall Study|Not treated|2
2983793|NCT01061736|10267122|P7|Overall Study|Not treated|0
2983794|NCT01061736|10267123|P6|Overall Study|Not treated|0
2983795|NCT01061736|10267124|P5|Overall Study|Not treated|1
2983796|NCT01061736|10267125|P4|Overall Study|Not treated|0
2983797|NCT01061736|10267126|P3|Overall Study|Not treated|0
2983798|NCT01061736|10267127|P2|Overall Study|Not treated|0
2983799|NCT01061736|10267128|P1|Overall Study|Not treated|0
2983800|NCT01061736|10267119|P10|Overall Study|Poor compliance to protocol|9
2983801|NCT01061736|10267120|P9|Overall Study|Poor compliance to protocol|5
2983802|NCT01061736|10267121|P8|Overall Study|Poor compliance to protocol|2
2983803|NCT01061736|10267122|P7|Overall Study|Poor compliance to protocol|0
2983804|NCT01061736|10267123|P6|Overall Study|Poor compliance to protocol|0
2983805|NCT01061736|10267124|P5|Overall Study|Poor compliance to protocol|0
2983806|NCT01061736|10267125|P4|Overall Study|Poor compliance to protocol|0
2983807|NCT01061736|10267126|P3|Overall Study|Poor compliance to protocol|0
2983808|NCT01061736|10267127|P2|Overall Study|Poor compliance to protocol|0
2983809|NCT01061736|10267128|P1|Overall Study|Poor compliance to protocol|0
2983810|NCT01061736|10267119|P10|Overall Study|Lack of Efficacy|10
2983811|NCT01061736|10267120|P9|Overall Study|Lack of Efficacy|9
2983812|NCT01061736|10267121|P8|Overall Study|Lack of Efficacy|9
2983813|NCT01061736|10267122|P7|Overall Study|Lack of Efficacy|1
2983814|NCT01061736|10267123|P6|Overall Study|Lack of Efficacy|2
2983815|NCT01061736|10267124|P5|Overall Study|Lack of Efficacy|1
2983816|NCT01061736|10267125|P4|Overall Study|Lack of Efficacy|1
2983817|NCT01061736|10267126|P3|Overall Study|Lack of Efficacy|1
2983818|NCT01061736|10267127|P2|Overall Study|Lack of Efficacy|2
2983819|NCT01061736|10267128|P1|Overall Study|Lack of Efficacy|0
2983820|NCT01061736|10267119|P10|Overall Study|Adverse Event|34
2983821|NCT01061736|10267120|P9|Overall Study|Adverse Event|67
2983822|NCT01061736|10267121|P8|Overall Study|Adverse Event|63
2983823|NCT01061736|10267122|P7|Overall Study|Adverse Event|4
2983824|NCT01061736|10267123|P6|Overall Study|Adverse Event|1
2983825|NCT01061736|10267124|P5|Overall Study|Adverse Event|4
2983826|NCT01061736|10267125|P4|Overall Study|Adverse Event|2
2983827|NCT01061736|10267126|P3|Overall Study|Adverse Event|3
2983828|NCT01061736|10267127|P2|Overall Study|Adverse Event|1
2983829|NCT01061736|10267128|P1|Overall Study|Adverse Event|13
2983830|NCT01061736|10267119|P10|Overall Study|Dose regimen not selected|0
2983831|NCT01061736|10267120|P9|Overall Study|Dose regimen not selected|0
2983832|NCT01061736|10267121|P8|Overall Study|Dose regimen not selected|0
2983833|NCT01061736|10267122|P7|Overall Study|Dose regimen not selected|79
2983834|NCT01061736|10267123|P6|Overall Study|Dose regimen not selected|0
2983835|NCT01061736|10267124|P5|Overall Study|Dose regimen not selected|0
2983836|NCT01061736|10267125|P4|Overall Study|Dose regimen not selected|0
2983837|NCT01061736|10267126|P3|Overall Study|Dose regimen not selected|0
2983838|NCT01061736|10267127|P2|Overall Study|Dose regimen not selected|0
2983839|NCT01061736|10267128|P1|Overall Study|Dose regimen not selected|0
2983840|NCT01061723|10267167|P6|Overall Study|Other than specified above|1
2983841|NCT01061723|10267168|P5|Overall Study|Other than specified above|0
2983842|NCT01061723|10267169|P4|Overall Study|Other than specified above|1
2983843|NCT01061723|10267170|P3|Overall Study|Other than specified above|1
2983844|NCT01061723|10267171|P2|Overall Study|Other than specified above|1
2983845|NCT01061723|10267172|P1|Overall Study|Other than specified above|2
2983846|NCT01061723|10267167|P6|Overall Study|Randomized but not treated|1
2983847|NCT01061723|10267168|P5|Overall Study|Randomized but not treated|0
2983848|NCT01061723|10267169|P4|Overall Study|Randomized but not treated|0
2983849|NCT01061723|10267170|P3|Overall Study|Randomized but not treated|0
2983850|NCT01061723|10267171|P2|Overall Study|Randomized but not treated|0
2983851|NCT01061723|10267172|P1|Overall Study|Randomized but not treated|0
2983852|NCT01061723|10267167|P6|Overall Study|Lack of Efficacy|1
2983853|NCT01061723|10267168|P5|Overall Study|Lack of Efficacy|1
2983854|NCT01061723|10267169|P4|Overall Study|Lack of Efficacy|2
2983855|NCT01061723|10267170|P3|Overall Study|Lack of Efficacy|4
2983856|NCT01061723|10267171|P2|Overall Study|Lack of Efficacy|3
2983857|NCT01061723|10267172|P1|Overall Study|Lack of Efficacy|2
2983858|NCT01061723|10267167|P6|Overall Study|Adverse Event|6
2983859|NCT01061723|10267168|P5|Overall Study|Adverse Event|2
2983860|NCT01061723|10267169|P4|Overall Study|Adverse Event|5
2983861|NCT01061723|10267170|P3|Overall Study|Adverse Event|5
2983862|NCT01061723|10267171|P2|Overall Study|Adverse Event|2
2983863|NCT01061723|10267172|P1|Overall Study|Adverse Event|0
2983864|NCT01061710|10267252|P1|Overall Study|Protocol Violation|14
2983865|NCT01061671|10267262|P2|Overall Study|Death|30
2983866|NCT01061671|10267263|P1|Overall Study|Death|28
2983867|NCT01061671|10267262|P2|Overall Study|Lost to Follow-up|5
2983868|NCT01061671|10267263|P1|Overall Study|Lost to Follow-up|3
2983869|NCT01061671|10267262|P2|Overall Study|Withdrawal by Subject|20
2983870|NCT01061671|10267263|P1|Overall Study|Withdrawal by Subject|16
2983871|NCT01061606|10267275|P1|Overall Study|alternative therapy|2
2983872|NCT01061606|10267275|P1|Overall Study|Disease Progression|4
2983873|NCT01061606|10267275|P1|Overall Study|Death|1
2983874|NCT01061606|10267275|P1|Overall Study|Adverse Event|1
2983875|NCT01061567|10267284|P1|Overall Study|Other reason than stated above|3
2983876|NCT01061567|10267284|P1|Overall Study|Withdrawal by Subject|11
2983877|NCT01061567|10267284|P1|Overall Study|Protocol Violation|1
2983878|NCT01061567|10267284|P1|Overall Study|Lost to Follow-up|24
2983879|NCT01061567|10267284|P1|Overall Study|Lack of Efficacy|3
2983880|NCT01061567|10267284|P1|Overall Study|Death|2
2983881|NCT01061567|10267284|P1|Overall Study|Adverse Event|32
2983882|NCT01061385|10267308|P2|Overall Study|subject decision not related to AE|1
2983883|NCT01061385|10267309|P1|Overall Study|subject decision not related to AE|0
2983884|NCT01061385|10267308|P2|Overall Study|Lost to Follow-up|0
2983885|NCT01061385|10267309|P1|Overall Study|Lost to Follow-up|1
2983886|NCT01061359|10267317|P1|Overall Study|Secondary neoplasm|11
2983887|NCT01061359|10267317|P1|Overall Study|Relapse|187
2983888|NCT01061359|10267317|P1|Overall Study|Lost to Follow-up|1072
2983889|NCT01061359|10267317|P1|Overall Study|Death|32
2983890|NCT01061333|10267323|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
2983891|NCT01061333|10267324|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
2983892|NCT01061177|10267362|P1|Overall Study|Death|4
2983893|NCT01061177|10267362|P1|Overall Study|Administratie problems|4
2983894|NCT01061177|10267362|P1|Overall Study|Abnormal test procedure results|4
2983895|NCT01061177|10267362|P1|Overall Study|Abnormal laboratory values|6
2983896|NCT01061177|10267362|P1|Overall Study|New cancer therapy|9
2983897|NCT01061177|10267362|P1|Overall Study|Lost to Follow-up|9
2983898|NCT01061177|10267362|P1|Overall Study|Protocol Violation|11
2983899|NCT01061177|10267362|P1|Overall Study|Disease progression|17
2983900|NCT01061177|10267362|P1|Overall Study|Withdrawal by Subject|27
2983901|NCT01061177|10267362|P1|Overall Study|Adverse Event|117
2983902|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
2983903|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
2983904|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
2983905|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
2983906|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
2983907|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
2983908|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
2983909|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
2983910|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
2983911|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
2983912|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
2983913|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
2983914|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
2983915|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
2983916|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
2983917|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
2983918|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
2983919|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
2983920|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
2983921|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
2983922|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
2983923|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
2983924|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
2983925|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
2983926|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2983927|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2983928|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2983929|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
2983930|NCT01061151|10267385|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
2983931|NCT01061151|10267386|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
2983932|NCT01061151|10267387|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2983933|NCT01061151|10267388|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2983934|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
2983935|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
2983936|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
2983937|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
2983938|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
2983939|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
2983940|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
2983941|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
2983942|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
2983943|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
2983944|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
2983945|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
2983946|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
2983947|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
2983948|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
2983949|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
2983950|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
2983951|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
2983952|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
2983953|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
2983954|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
2983955|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
2983956|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
2983957|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
2983958|NCT01061151|10267385|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
2983959|NCT01061151|10267386|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2983960|NCT01061151|10267387|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2983961|NCT01061151|10267388|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
2983962|NCT01061008|10267447|P2|Overall Study|Adverse Event|1
2983963|NCT01061008|10267448|P1|Overall Study|Adverse Event|0
2983964|NCT01061008|10267447|P2|Overall Study|Unable to exercise following surgery|0
2983965|NCT01061008|10267448|P1|Overall Study|Unable to exercise following surgery|1
2983966|NCT01061008|10267447|P2|Overall Study|Withdrawal by Subject|3
2983967|NCT01061008|10267448|P1|Overall Study|Withdrawal by Subject|1
2983968|NCT01061008|10267447|P2|Overall Study|Death|0
2983969|NCT01061008|10267448|P1|Overall Study|Death|1
2983970|NCT01061008|10267447|P2|Overall Study|Badiocephalic fistula failed|2
2983971|NCT01061008|10267448|P1|Overall Study|Badiocephalic fistula failed|3
2983972|NCT01060670|10267456|P2|Run In|screen failure|238
2983973|NCT01060670|10267457|P1|Run In|screen failure|0
2983974|NCT01060553|10267492|P2|Overall Study|Lack of Efficacy|0
2983975|NCT01060553|10267493|P1|Overall Study|Lack of Efficacy|1
2983976|NCT01060553|10267492|P2|Overall Study|Withdrawal by Subject|5
2983977|NCT01060553|10267493|P1|Overall Study|Withdrawal by Subject|5
2983978|NCT01060553|10267492|P2|Overall Study|Lost to Follow-up|5
2983979|NCT01060553|10267493|P1|Overall Study|Lost to Follow-up|3
2983980|NCT01060540|10267500|P2|Overall Study|Physician Decision|1
2983981|NCT01060540|10267501|P1|Overall Study|Physician Decision|0
2983982|NCT01060540|10267500|P2|Overall Study|Death|1
2983983|NCT01060540|10267501|P1|Overall Study|Death|2
2983984|NCT01060540|10267500|P2|Overall Study|Lost to Follow-up|43
2983985|NCT01060540|10267501|P1|Overall Study|Lost to Follow-up|52
2983986|NCT01060540|10267500|P2|Overall Study|Withdrawal by Subject|20
2983987|NCT01060540|10267501|P1|Overall Study|Withdrawal by Subject|10
2983988|NCT01060384|10267515|P5|Overall Study|Intercurrent illness|1
2983989|NCT01060384|10267516|P4|Overall Study|Intercurrent illness|0
2983990|NCT01060384|10267517|P3|Overall Study|Intercurrent illness|0
2983991|NCT01060384|10267518|P2|Overall Study|Intercurrent illness|0
2983992|NCT01060384|10267519|P1|Overall Study|Intercurrent illness|0
2983993|NCT01060384|10267515|P5|Overall Study|Death|1
2983994|NCT01060384|10267516|P4|Overall Study|Death|0
2983995|NCT01060384|10267517|P3|Overall Study|Death|0
2983996|NCT01060384|10267518|P2|Overall Study|Death|0
2983997|NCT01060384|10267519|P1|Overall Study|Death|0
2983998|NCT01060384|10267515|P5|Overall Study|Withdrawal by Subject|0
2983999|NCT01060384|10267516|P4|Overall Study|Withdrawal by Subject|0
2984000|NCT01060384|10267517|P3|Overall Study|Withdrawal by Subject|0
2984001|NCT01060384|10267518|P2|Overall Study|Withdrawal by Subject|1
2984002|NCT01060384|10267519|P1|Overall Study|Withdrawal by Subject|0
2984003|NCT01060150|10267538|P1|Overall Study|Enrolled, but not treated|2
2984004|NCT01060150|10267538|P1|Overall Study|Withdrawal by Subject|8
2984005|NCT01060150|10267538|P1|Overall Study|Protocol Violation|6
2984006|NCT01060150|10267538|P1|Overall Study|Lost to Follow-up|1
2984007|NCT01060150|10267538|P1|Overall Study|Adverse Event|6
2984008|NCT01060124|10267553|P1|Overall Study|Withdrawal by Subject|7
2984009|NCT01060124|10267553|P1|Overall Study|Adverse Event|14
2984010|NCT01060124|10267553|P1|Overall Study|Other|16
2984011|NCT01060111|10267564|P3|Overall Study|Other|4
2984012|NCT01060111|10267565|P2|Overall Study|Other|3
2984013|NCT01060111|10267566|P1|Overall Study|Other|2
2984014|NCT01060111|10267564|P3|Overall Study|Participants' non-cooperation|0
2984015|NCT01060111|10267565|P2|Overall Study|Participants' non-cooperation|0
2984016|NCT01060111|10267566|P1|Overall Study|Participants' non-cooperation|1
2984017|NCT01060111|10267564|P3|Overall Study|Adverse event and insufficient effect|0
2984018|NCT01060111|10267565|P2|Overall Study|Adverse event and insufficient effect|1
2984019|NCT01060111|10267566|P1|Overall Study|Adverse event and insufficient effect|0
2984020|NCT01060111|10267564|P3|Overall Study|Participants' non-cooperation|6
2984021|NCT01060111|10267565|P2|Overall Study|Participants' non-cooperation|6
2984022|NCT01060111|10267566|P1|Overall Study|Participants' non-cooperation|8
2984023|NCT01060111|10267564|P3|Overall Study|Participants' evasion for hospital visit|2
2984024|NCT01060111|10267565|P2|Overall Study|Participants' evasion for hospital visit|3
2984025|NCT01060111|10267566|P1|Overall Study|Participants' evasion for hospital visit|0
2984026|NCT01060111|10267564|P3|Overall Study|Inappropriate participant|5
2984027|NCT01060111|10267565|P2|Overall Study|Inappropriate participant|4
2984028|NCT01060111|10267566|P1|Overall Study|Inappropriate participant|5
2984029|NCT01060111|10267564|P3|Overall Study|Lack of Efficacy|0
2984030|NCT01060111|10267565|P2|Overall Study|Lack of Efficacy|1
2984031|NCT01060111|10267566|P1|Overall Study|Lack of Efficacy|2
2984032|NCT01060111|10267564|P3|Overall Study|Adverse Event|18
2984033|NCT01060111|10267565|P2|Overall Study|Adverse Event|5
2984034|NCT01060111|10267566|P1|Overall Study|Adverse Event|9
2984035|NCT01060072|10267598|P2|Overall Study|Excluded Medications|1
2984036|NCT01060072|10267599|P1|Overall Study|Excluded Medications|0
2984037|NCT01060072|10267598|P2|Overall Study|Acute cholecystitis|0
2984038|NCT01060072|10267599|P1|Overall Study|Acute cholecystitis|1
2984039|NCT01060072|10267598|P2|Overall Study|Protocol Violation|1
2984040|NCT01060072|10267599|P1|Overall Study|Protocol Violation|0
2984041|NCT01060072|10267598|P2|Overall Study|Physician Decision|2
2984042|NCT01060072|10267599|P1|Overall Study|Physician Decision|0
2984043|NCT01060072|10267598|P2|Overall Study|Adverse Event|1
2984044|NCT01060072|10267599|P1|Overall Study|Adverse Event|1
2984045|NCT01060059|10267615|P2|Overall Study|lack of compliance|2
2984046|NCT01060059|10267616|P1|Overall Study|lack of compliance|5
2984047|NCT01060059|10267615|P2|Overall Study|lack of glycemic control|1
2984048|NCT01060059|10267616|P1|Overall Study|lack of glycemic control|2
2984049|NCT01060059|10267615|P2|Overall Study|Withdrawal by Subject|23
2984050|NCT01060059|10267616|P1|Overall Study|Withdrawal by Subject|35
2984051|NCT01060059|10267615|P2|Overall Study|entry criteria not met|3
2984052|NCT01060059|10267616|P1|Overall Study|entry criteria not met|4
2984053|NCT01060059|10267615|P2|Overall Study|Lost to Follow-up|34
2984054|NCT01060059|10267616|P1|Overall Study|Lost to Follow-up|18
2984055|NCT01060059|10267615|P2|Overall Study|Death|3
2984056|NCT01060059|10267616|P1|Overall Study|Death|2
2984057|NCT01060059|10267615|P2|Overall Study|Adverse Event|1
2984058|NCT01060059|10267616|P1|Overall Study|Adverse Event|1
2984059|NCT01060007|10267674|P1|Overall Study|Inevaluable for response at surgery|3
2984060|NCT01060007|10267674|P1|Overall Study|Withdrawal by Subject|1
2984061|NCT01059903|10267742|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
2984062|NCT01059903|10267743|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
2984063|NCT01059864|10267786|P3|Double-Blind Treatment Phase|Adverse Event|3
2984064|NCT01059864|10267787|P2|Double-Blind Treatment Phase|Adverse Event|3
2984065|NCT01059864|10267788|P1|Double-Blind Treatment Phase|Adverse Event|0
2984066|NCT01059864|10267786|P3|Open-Label Run-In Phase|Protocol Violation|0
2984067|NCT01059864|10267787|P2|Open-Label Run-In Phase|Protocol Violation|0
2984068|NCT01059864|10267788|P1|Open-Label Run-In Phase|Protocol Violation|2
2984069|NCT01059864|10267786|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
2984070|NCT01059864|10267787|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
2984071|NCT01059864|10267788|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
2984072|NCT01059864|10267786|P3|Open-Label Run-In Phase|Lost to Follow-up|0
2984073|NCT01059864|10267787|P2|Open-Label Run-In Phase|Lost to Follow-up|0
2984074|NCT01059864|10267788|P1|Open-Label Run-In Phase|Lost to Follow-up|2
2984075|NCT01059864|10267786|P3|Open-Label Run-In Phase|Lack of Efficacy|0
2984076|NCT01059864|10267787|P2|Open-Label Run-In Phase|Lack of Efficacy|0
2984077|NCT01059864|10267788|P1|Open-Label Run-In Phase|Lack of Efficacy|1
2984078|NCT01059864|10267786|P3|Open-Label Run-In Phase|Adverse Event|0
2984079|NCT01059864|10267787|P2|Open-Label Run-In Phase|Adverse Event|0
2984080|NCT01059864|10267788|P1|Open-Label Run-In Phase|Adverse Event|7
2984081|NCT01059825|10267862|P7|Treatment Period|Adverse event not related to study drug|0
2984082|NCT01059825|10267863|P6|Treatment Period|Adverse event not related to study drug|1
2984083|NCT01059825|10267864|P5|Treatment Period|Adverse event not related to study drug|1
2984084|NCT01059825|10267865|P4|Treatment Period|Adverse event not related to study drug|1
2984085|NCT01059825|10267866|P3|Treatment Period|Adverse event not related to study drug|2
2984086|NCT01059825|10267867|P2|Treatment Period|Adverse event not related to study drug|1
2984087|NCT01059825|10267868|P1|Treatment Period|Adverse event not related to study drug|0
2984088|NCT01059825|10267862|P7|Treatment Period|Insufficient clinical response|0
2984089|NCT01059825|10267863|P6|Treatment Period|Insufficient clinical response|0
2984090|NCT01059825|10267864|P5|Treatment Period|Insufficient clinical response|0
2984091|NCT01059825|10267865|P4|Treatment Period|Insufficient clinical response|0
2984092|NCT01059825|10267866|P3|Treatment Period|Insufficient clinical response|0
2984093|NCT01059825|10267867|P2|Treatment Period|Insufficient clinical response|0
2984094|NCT01059825|10267868|P1|Treatment Period|Insufficient clinical response|3
2984095|NCT01059825|10267862|P7|Treatment Period|Adverse event related to study drug|0
2984096|NCT01059825|10267863|P6|Treatment Period|Adverse event related to study drug|0
2984097|NCT01059825|10267864|P5|Treatment Period|Adverse event related to study drug|0
2984098|NCT01059825|10267865|P4|Treatment Period|Adverse event related to study drug|1
2984099|NCT01059825|10267866|P3|Treatment Period|Adverse event related to study drug|1
2984100|NCT01059825|10267867|P2|Treatment Period|Adverse event related to study drug|0
2984101|NCT01059825|10267868|P1|Treatment Period|Adverse event related to study drug|1
2984102|NCT01059825|10267862|P7|Treatment Period|Protocol Violation|0
2984103|NCT01059825|10267863|P6|Treatment Period|Protocol Violation|1
2984104|NCT01059825|10267864|P5|Treatment Period|Protocol Violation|1
2984105|NCT01059825|10267865|P4|Treatment Period|Protocol Violation|1
2984106|NCT01059825|10267866|P3|Treatment Period|Protocol Violation|1
2984107|NCT01059825|10267867|P2|Treatment Period|Protocol Violation|0
2984108|NCT01059825|10267868|P1|Treatment Period|Protocol Violation|0
2984109|NCT01059825|10267862|P7|Treatment Period|Other reason not specified|0
2984110|NCT01059825|10267863|P6|Treatment Period|Other reason not specified|0
2984111|NCT01059825|10267864|P5|Treatment Period|Other reason not specified|0
2984112|NCT01059825|10267865|P4|Treatment Period|Other reason not specified|2
2984113|NCT01059825|10267866|P3|Treatment Period|Other reason not specified|1
2984114|NCT01059825|10267867|P2|Treatment Period|Other reason not specified|2
2984115|NCT01059825|10267868|P1|Treatment Period|Other reason not specified|1
2984116|NCT01059825|10267862|P7|Treatment Period|Withdrawal by Subject|0
2984117|NCT01059825|10267863|P6|Treatment Period|Withdrawal by Subject|1
2984118|NCT01059825|10267864|P5|Treatment Period|Withdrawal by Subject|4
2984119|NCT01059825|10267865|P4|Treatment Period|Withdrawal by Subject|5
2984120|NCT01059825|10267866|P3|Treatment Period|Withdrawal by Subject|1
2984121|NCT01059825|10267867|P2|Treatment Period|Withdrawal by Subject|0
2984122|NCT01059825|10267868|P1|Treatment Period|Withdrawal by Subject|3
2984123|NCT01059825|10267862|P7|Treatment Period|Lost to Follow-up|0
2984124|NCT01059825|10267863|P6|Treatment Period|Lost to Follow-up|0
2984125|NCT01059825|10267864|P5|Treatment Period|Lost to Follow-up|2
2984126|NCT01059825|10267865|P4|Treatment Period|Lost to Follow-up|1
2984127|NCT01059825|10267866|P3|Treatment Period|Lost to Follow-up|0
2984128|NCT01059825|10267867|P2|Treatment Period|Lost to Follow-up|1
2984129|NCT01059825|10267868|P1|Treatment Period|Lost to Follow-up|2
2984130|NCT01059825|10267862|P7|Enrolled, Run-in Period|Protocol Violation|5
2984131|NCT01059825|10267863|P6|Enrolled, Run-in Period|Protocol Violation|0
2984132|NCT01059825|10267864|P5|Enrolled, Run-in Period|Protocol Violation|0
2984133|NCT01059825|10267865|P4|Enrolled, Run-in Period|Protocol Violation|0
2984134|NCT01059825|10267866|P3|Enrolled, Run-in Period|Protocol Violation|0
2984135|NCT01059825|10267867|P2|Enrolled, Run-in Period|Protocol Violation|0
2984136|NCT01059825|10267868|P1|Enrolled, Run-in Period|Protocol Violation|0
2984137|NCT01059825|10267862|P7|Enrolled, Run-in Period|Other reason not specified|7
2984138|NCT01059825|10267863|P6|Enrolled, Run-in Period|Other reason not specified|0
2984139|NCT01059825|10267864|P5|Enrolled, Run-in Period|Other reason not specified|0
2984140|NCT01059825|10267865|P4|Enrolled, Run-in Period|Other reason not specified|0
2984141|NCT01059825|10267866|P3|Enrolled, Run-in Period|Other reason not specified|0
2984142|NCT01059825|10267867|P2|Enrolled, Run-in Period|Other reason not specified|0
2984143|NCT01059825|10267868|P1|Enrolled, Run-in Period|Other reason not specified|0
2984144|NCT01059825|10267862|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
2984145|NCT01059825|10267863|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
2984146|NCT01059825|10267864|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
2984147|NCT01059825|10267865|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
2984148|NCT01059825|10267866|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
2984149|NCT01059825|10267867|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
2984150|NCT01059825|10267868|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
2984151|NCT01059825|10267862|P7|Enrolled, Run-in Period|Lost to Follow-up|5
2984152|NCT01059825|10267863|P6|Enrolled, Run-in Period|Lost to Follow-up|0
2984153|NCT01059825|10267864|P5|Enrolled, Run-in Period|Lost to Follow-up|0
2984154|NCT01059825|10267865|P4|Enrolled, Run-in Period|Lost to Follow-up|0
2984155|NCT01059825|10267866|P3|Enrolled, Run-in Period|Lost to Follow-up|0
2984156|NCT01059825|10267867|P2|Enrolled, Run-in Period|Lost to Follow-up|0
2984157|NCT01059825|10267868|P1|Enrolled, Run-in Period|Lost to Follow-up|0
2984158|NCT01059825|10267862|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
2984159|NCT01059825|10267863|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984160|NCT01059825|10267864|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984161|NCT01059825|10267865|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984162|NCT01059825|10267866|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984163|NCT01059825|10267867|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984164|NCT01059825|10267868|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
2984165|NCT01059825|10267862|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
2984166|NCT01059825|10267863|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984167|NCT01059825|10267864|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984168|NCT01059825|10267865|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984169|NCT01059825|10267866|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984170|NCT01059825|10267867|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984171|NCT01059825|10267868|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
2984172|NCT01059812|10268055|P2|Overall Study|Unclassified|4
2984173|NCT01059812|10268056|P1|Overall Study|Unclassified|14
2984174|NCT01059812|10268055|P2|Overall Study|Withdrawal Criteria|4
2984175|NCT01059812|10268056|P1|Overall Study|Withdrawal Criteria|9
2984176|NCT01059812|10268055|P2|Overall Study|Protocol Violation|1
2984177|NCT01059812|10268056|P1|Overall Study|Protocol Violation|3
2984178|NCT01059812|10268055|P2|Overall Study|Lack of Efficacy|2
2984179|NCT01059812|10268056|P1|Overall Study|Lack of Efficacy|2
2984180|NCT01059812|10268055|P2|Overall Study|Adverse Event|5
2984181|NCT01059812|10268056|P1|Overall Study|Adverse Event|9
2984182|NCT01059799|10268072|P2|Overall Study|Other|3
2984183|NCT01059799|10268073|P1|Overall Study|Other|12
2984184|NCT01059799|10268072|P2|Overall Study|Withdrawal criteria|2
2984185|NCT01059799|10268073|P1|Overall Study|Withdrawal criteria|13
2984186|NCT01059799|10268072|P2|Overall Study|Protocol Violation|2
2984187|NCT01059799|10268073|P1|Overall Study|Protocol Violation|3
2984188|NCT01059799|10268072|P2|Overall Study|Lack of Efficacy|0
2984189|NCT01059799|10268073|P1|Overall Study|Lack of Efficacy|1
2984190|NCT01059799|10268072|P2|Overall Study|Adverse Event|3
2984191|NCT01059799|10268073|P1|Overall Study|Adverse Event|2
2984192|NCT01059773|10268087|P2|Overall Study|Other|3
2984193|NCT01059773|10268088|P1|Overall Study|Other|1
2984194|NCT01059773|10268087|P2|Overall Study|Ineligible follow TB screening criteria|1
2984195|NCT01059773|10268088|P1|Overall Study|Ineligible follow TB screening criteria|0
2984196|NCT01059773|10268087|P2|Overall Study|Malignancy including squamous cell skin|1
2984197|NCT01059773|10268088|P1|Overall Study|Malignancy including squamous cell skin|0
2984198|NCT01059773|10268087|P2|Overall Study|Death|1
2984199|NCT01059773|10268088|P1|Overall Study|Death|0
2984200|NCT01059773|10268087|P2|Overall Study|Lack of Efficacy|3
2984201|NCT01059773|10268088|P1|Overall Study|Lack of Efficacy|3
2984202|NCT01059773|10268087|P2|Overall Study|Physician Decision|4
2984203|NCT01059773|10268088|P1|Overall Study|Physician Decision|5
2984204|NCT01059773|10268087|P2|Overall Study|Protocol Violation|2
2984205|NCT01059773|10268088|P1|Overall Study|Protocol Violation|6
2984206|NCT01059773|10268087|P2|Overall Study|Pregnancy|1
2984207|NCT01059773|10268088|P1|Overall Study|Pregnancy|1
2984208|NCT01059773|10268087|P2|Overall Study|Lost to Follow-up|1
2984209|NCT01059773|10268088|P1|Overall Study|Lost to Follow-up|1
2984210|NCT01059773|10268087|P2|Overall Study|Withdrawal by Subject|5
2984211|NCT01059773|10268088|P1|Overall Study|Withdrawal by Subject|1
2984212|NCT01059773|10268087|P2|Overall Study|Adverse Event|2
2984213|NCT01059773|10268088|P1|Overall Study|Adverse Event|2
2984214|NCT01059643|10268244|P1|Overall Study|Physician Decision|1
2984215|NCT01059643|10268244|P1|Overall Study|Withdrawal by Subject|2
2984216|NCT01059643|10268244|P1|Overall Study|Adverse Event|3
2984217|NCT01059630|10268259|P2|Overall Study|Withdrawal by Subject|14
2984218|NCT01059630|10268260|P1|Overall Study|Withdrawal by Subject|21
2984219|NCT01059630|10268259|P2|Overall Study|Physician Decision|4
2984220|NCT01059630|10268260|P1|Overall Study|Physician Decision|2
2984221|NCT01059630|10268259|P2|Overall Study|Lost to Follow-up|1
2984222|NCT01059630|10268260|P1|Overall Study|Lost to Follow-up|4
2984223|NCT01059630|10268259|P2|Overall Study|Death|84
2984224|NCT01059630|10268260|P1|Overall Study|Death|100
2984225|NCT01059617|10268334|P4|Overall Study|Other|6
2984226|NCT01059617|10268335|P3|Overall Study|Other|8
2984227|NCT01059617|10268336|P2|Overall Study|Other|1
2984228|NCT01059617|10268337|P1|Overall Study|Other|7
2984229|NCT01059565|10268507|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
2984230|NCT01059565|10268508|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
2984231|NCT01059565|10268507|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
2984232|NCT01059565|10268508|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
2984233|NCT01059565|10268507|P2|24-Week Open-Label Phase|Subject noncompliance|0
2984234|NCT01059565|10268508|P1|24-Week Open-Label Phase|Subject noncompliance|1
2984235|NCT01059565|10268507|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
2984236|NCT01059565|10268508|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
2984237|NCT01059565|10268507|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
2984238|NCT01059565|10268508|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
2984239|NCT01059565|10268507|P2|24-Week Open-Label Phase|Adverse Event|0
2984240|NCT01059565|10268508|P1|24-Week Open-Label Phase|Adverse Event|2
2984241|NCT01059565|10268507|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
2984242|NCT01059565|10268508|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
2984243|NCT01059565|10268507|P2|24-Week Randomized Phase|Lost to Follow-up|1
2984244|NCT01059565|10268508|P1|24-Week Randomized Phase|Lost to Follow-up|0
2984245|NCT01059565|10268507|P2|24-Week Randomized Phase|Withdrawal by Subject|1
2984246|NCT01059565|10268508|P1|24-Week Randomized Phase|Withdrawal by Subject|3
2984247|NCT01059565|10268507|P2|24-Week Randomized Phase|Adverse Event|0
2984248|NCT01059565|10268508|P1|24-Week Randomized Phase|Adverse Event|5
2984249|NCT01059565|10268507|P2|24-Week Randomized Phase|Randomized but not treated|0
2984250|NCT01059565|10268508|P1|24-Week Randomized Phase|Randomized but not treated|1
2984251|NCT01059539|10268542|P1|Overall Study|Reason Not Specified|2
2984252|NCT01059539|10268542|P1|Overall Study|Lost to Follow-up|42
2984253|NCT01059539|10268542|P1|Overall Study|Withdrawal of Consent|80
2984254|NCT01059539|10268542|P1|Overall Study|Protocol Violation|55
2984255|NCT01059539|10268542|P1|Overall Study|Insufficient Therapeutic Response|26
2984256|NCT01059539|10268542|P1|Overall Study|Adverse Event|66
2984257|NCT01059526|10268549|P2|Overall Study|Patient found to be dermatographic|0
2984258|NCT01059526|10268550|P1|Overall Study|Patient found to be dermatographic|1
2984259|NCT01059526|10268549|P2|Overall Study|Lost to Follow-up|1
2984260|NCT01059526|10268550|P1|Overall Study|Lost to Follow-up|4
2984261|NCT01059526|10268549|P2|Overall Study|Withdrawal by Subject|1
2984262|NCT01059526|10268550|P1|Overall Study|Withdrawal by Subject|3
2984263|NCT01059526|10268549|P2|Overall Study|Protocol Violation|1
2984264|NCT01059526|10268550|P1|Overall Study|Protocol Violation|0
2984265|NCT01059526|10268549|P2|Overall Study|Adverse Event|2
2984266|NCT01059526|10268550|P1|Overall Study|Adverse Event|2
2984267|NCT01059526|10268549|P2|Overall Study|Patient enrolled but not treated|17
2984268|NCT01059526|10268550|P1|Overall Study|Patient enrolled but not treated|20
2984269|NCT01059344|10268896|P2|Overall Study|Other|6
2984270|NCT01059344|10268897|P1|Overall Study|Other|3
2984271|NCT01059344|10268896|P2|Overall Study|Lost to Follow-up|1
2984272|NCT01059344|10268897|P1|Overall Study|Lost to Follow-up|1
2984273|NCT01059344|10268896|P2|Overall Study|Withdrawal by Subject|9
2984274|NCT01059344|10268897|P1|Overall Study|Withdrawal by Subject|6
2984275|NCT01059344|10268896|P2|Overall Study|Adverse Event|30
2984276|NCT01059344|10268897|P1|Overall Study|Adverse Event|12
2984277|NCT01059175|10268921|P2|Overall Study|Lost to Follow-up|1
2984278|NCT01059175|10268922|P1|Overall Study|Lost to Follow-up|0
2984279|NCT01059175|10268921|P2|Overall Study|Adverse Event|2
2984280|NCT01059175|10268922|P1|Overall Study|Adverse Event|4
2984281|NCT01059175|10268921|P2|Overall Study|Death|17
2984282|NCT01059175|10268922|P1|Overall Study|Death|17
2984283|NCT01059071|10268944|P4|Overall Study|Physician Decision|1
2984284|NCT01059071|10268945|P3|Overall Study|Physician Decision|0
2984285|NCT01059071|10268946|P2|Overall Study|Physician Decision|0
2984286|NCT01059071|10268947|P1|Overall Study|Physician Decision|0
2984287|NCT01059071|10268944|P4|Overall Study|Withdrawal by Subject|2
2984288|NCT01059071|10268945|P3|Overall Study|Withdrawal by Subject|0
2984289|NCT01059071|10268946|P2|Overall Study|Withdrawal by Subject|0
2984290|NCT01059071|10268947|P1|Overall Study|Withdrawal by Subject|1
2984291|NCT01059071|10268944|P4|Overall Study|Lack of Efficacy|3
2984292|NCT01059071|10268945|P3|Overall Study|Lack of Efficacy|2
2984293|NCT01059071|10268946|P2|Overall Study|Lack of Efficacy|4
2984294|NCT01059071|10268947|P1|Overall Study|Lack of Efficacy|1
2984295|NCT01058863|10268974|P1|Overall Study|Randomized in error|1
2984296|NCT01058863|10268974|P1|Overall Study|Sponsor requested withdrawal|1
2984297|NCT01058863|10268974|P1|Overall Study|Withdrawal by Subject|1
2984298|NCT01058863|10268974|P1|Overall Study|Lost to Follow-up|1
2984299|NCT01058707|10268999|P7|Overall Study|Reason Not Specified|7
2984300|NCT01058707|10269000|P6|Overall Study|Reason Not Specified|1
2984301|NCT01058707|10269001|P5|Overall Study|Reason Not Specified|7
2984302|NCT01058707|10269002|P4|Overall Study|Reason Not Specified|0
2984303|NCT01058707|10269003|P3|Overall Study|Reason Not Specified|2
2984304|NCT01058707|10269004|P2|Overall Study|Reason Not Specified|3
2984305|NCT01058707|10269005|P1|Overall Study|Reason Not Specified|0
2984306|NCT01058707|10268999|P7|Overall Study|Lost to Follow-up|0
2984307|NCT01058707|10269000|P6|Overall Study|Lost to Follow-up|0
2984308|NCT01058707|10269001|P5|Overall Study|Lost to Follow-up|0
2984309|NCT01058707|10269002|P4|Overall Study|Lost to Follow-up|0
2984310|NCT01058707|10269003|P3|Overall Study|Lost to Follow-up|1
2984311|NCT01058707|10269004|P2|Overall Study|Lost to Follow-up|0
2984312|NCT01058707|10269005|P1|Overall Study|Lost to Follow-up|0
2984313|NCT01058707|10268999|P7|Overall Study|Subject Decision|6
2984314|NCT01058707|10269000|P6|Overall Study|Subject Decision|3
2984315|NCT01058707|10269001|P5|Overall Study|Subject Decision|2
2984316|NCT01058707|10269002|P4|Overall Study|Subject Decision|1
2984317|NCT01058707|10269003|P3|Overall Study|Subject Decision|3
2984318|NCT01058707|10269004|P2|Overall Study|Subject Decision|3
2984319|NCT01058707|10269005|P1|Overall Study|Subject Decision|5
2984320|NCT01058707|10268999|P7|Overall Study|Adverse Event|1
2984321|NCT01058707|10269000|P6|Overall Study|Adverse Event|3
2984322|NCT01058707|10269001|P5|Overall Study|Adverse Event|7
2984323|NCT01058707|10269002|P4|Overall Study|Adverse Event|6
2984324|NCT01058707|10269003|P3|Overall Study|Adverse Event|7
2984325|NCT01058707|10269004|P2|Overall Study|Adverse Event|4
2984326|NCT01058707|10269005|P1|Overall Study|Adverse Event|11
2984327|NCT01058707|10268999|P7|Overall Study|Disease Progression|12
2984328|NCT01058707|10269000|P6|Overall Study|Disease Progression|10
2984329|NCT01058707|10269001|P5|Overall Study|Disease Progression|23
2984330|NCT01058707|10269002|P4|Overall Study|Disease Progression|15
2984331|NCT01058707|10269003|P3|Overall Study|Disease Progression|20
2984332|NCT01058707|10269004|P2|Overall Study|Disease Progression|20
2984333|NCT01058707|10269005|P1|Overall Study|Disease Progression|15
2984334|NCT01058668|10269171|P3|Double-blind Treatment Phase|Other Unspecified|0
2984335|NCT01058668|10269172|P2|Double-blind Treatment Phase|Other Unspecified|1
2984336|NCT01058668|10269173|P1|Double-blind Treatment Phase|Other Unspecified|1
2984337|NCT01058668|10269171|P3|Double-blind Treatment Phase|Lost to Follow-up|1
2984338|NCT01058668|10269172|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2984339|NCT01058668|10269173|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2984340|NCT01058668|10269171|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
2984341|NCT01058668|10269172|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
2984342|NCT01058668|10269173|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
2984343|NCT01058668|10269171|P3|Double-blind Treatment Phase|Protocol Violation|2
2984344|NCT01058668|10269172|P2|Double-blind Treatment Phase|Protocol Violation|1
2984345|NCT01058668|10269173|P1|Double-blind Treatment Phase|Protocol Violation|1
2984431|NCT01058356|10269257|P1|Overall Study|Withdrawal by Subject|21
2984346|NCT01058668|10269171|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
2984347|NCT01058668|10269172|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
2984348|NCT01058668|10269173|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
2984349|NCT01058668|10269171|P3|Double-blind Treatment Phase|Adverse Event|25
2984350|NCT01058668|10269172|P2|Double-blind Treatment Phase|Adverse Event|15
2984351|NCT01058668|10269173|P1|Double-blind Treatment Phase|Adverse Event|8
2984352|NCT01058655|10269188|P4|Overall Study|Other|4
2984353|NCT01058655|10269189|P3|Overall Study|Other|0
2984354|NCT01058655|10269190|P2|Overall Study|Other|0
2984355|NCT01058655|10269191|P1|Overall Study|Other|0
2984356|NCT01058655|10269188|P4|Overall Study|Disease Progression|24
2984357|NCT01058655|10269189|P3|Overall Study|Disease Progression|4
2984358|NCT01058655|10269190|P2|Overall Study|Disease Progression|2
2984359|NCT01058655|10269191|P1|Overall Study|Disease Progression|1
2984360|NCT01058655|10269188|P4|Overall Study|Death|0
2984361|NCT01058655|10269189|P3|Overall Study|Death|1
2984362|NCT01058655|10269190|P2|Overall Study|Death|1
2984363|NCT01058655|10269191|P1|Overall Study|Death|0
2984364|NCT01058655|10269188|P4|Overall Study|Clinical Progression (non-RECIST)|7
2984365|NCT01058655|10269189|P3|Overall Study|Clinical Progression (non-RECIST)|0
2984366|NCT01058655|10269190|P2|Overall Study|Clinical Progression (non-RECIST)|0
2984367|NCT01058655|10269191|P1|Overall Study|Clinical Progression (non-RECIST)|1
2984368|NCT01058655|10269188|P4|Overall Study|Symptomatic Deterioration|1
2984369|NCT01058655|10269189|P3|Overall Study|Symptomatic Deterioration|0
2984370|NCT01058655|10269190|P2|Overall Study|Symptomatic Deterioration|0
2984371|NCT01058655|10269191|P1|Overall Study|Symptomatic Deterioration|0
2984372|NCT01058655|10269188|P4|Overall Study|Prolonged Treatment Delay|2
2984373|NCT01058655|10269189|P3|Overall Study|Prolonged Treatment Delay|0
2984374|NCT01058655|10269190|P2|Overall Study|Prolonged Treatment Delay|0
2984375|NCT01058655|10269191|P1|Overall Study|Prolonged Treatment Delay|0
2984376|NCT01058655|10269188|P4|Overall Study|Withdrawal by Subject|4
2984377|NCT01058655|10269189|P3|Overall Study|Withdrawal by Subject|3
2984378|NCT01058655|10269190|P2|Overall Study|Withdrawal by Subject|0
2984379|NCT01058655|10269191|P1|Overall Study|Withdrawal by Subject|1
2984380|NCT01058642|10269209|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
2984381|NCT01058642|10269210|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
2984382|NCT01058642|10269211|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
2984383|NCT01058642|10269212|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
2984384|NCT01058642|10269209|P4|Treatment Period 1|Protocol Violation|1
2984385|NCT01058642|10269210|P3|Treatment Period 1|Protocol Violation|0
2984386|NCT01058642|10269211|P2|Treatment Period 1|Protocol Violation|0
2984387|NCT01058642|10269212|P1|Treatment Period 1|Protocol Violation|0
2984388|NCT01058642|10269209|P4|Treatment Period 1|Lack of Efficacy|1
2984389|NCT01058642|10269210|P3|Treatment Period 1|Lack of Efficacy|0
2984390|NCT01058642|10269211|P2|Treatment Period 1|Lack of Efficacy|0
2984391|NCT01058642|10269212|P1|Treatment Period 1|Lack of Efficacy|0
2984392|NCT01058642|10269209|P4|Treatment Period 1|Withdrawal by Subject|0
2984393|NCT01058642|10269210|P3|Treatment Period 1|Withdrawal by Subject|0
2984394|NCT01058642|10269211|P2|Treatment Period 1|Withdrawal by Subject|0
2984395|NCT01058642|10269212|P1|Treatment Period 1|Withdrawal by Subject|1
2984396|NCT01058642|10269209|P4|Treatment Period 1|Physician Decision|0
2984397|NCT01058642|10269210|P3|Treatment Period 1|Physician Decision|1
2984398|NCT01058642|10269211|P2|Treatment Period 1|Physician Decision|0
2984399|NCT01058642|10269212|P1|Treatment Period 1|Physician Decision|0
2984400|NCT01058642|10269209|P4|Treatment Period 1|Adverse Event|0
2984401|NCT01058642|10269210|P3|Treatment Period 1|Adverse Event|1
2984402|NCT01058642|10269211|P2|Treatment Period 1|Adverse Event|1
2984403|NCT01058642|10269212|P1|Treatment Period 1|Adverse Event|0
2984404|NCT01058421|10269222|P2|6 Month Outcomes|Remained in Other Facility|3
2984405|NCT01058421|10269223|P1|6 Month Outcomes|Remained in Other Facility|1
2984406|NCT01058421|10269222|P2|6 Month Outcomes|Lost to Follow-up|21
2984407|NCT01058421|10269223|P1|6 Month Outcomes|Lost to Follow-up|16
2984408|NCT01058421|10269222|P2|6 Month Outcomes|Death|2
2984409|NCT01058421|10269223|P1|6 Month Outcomes|Death|2
2984410|NCT01058421|10269222|P2|3 Month Outcomes|Remained in Other Facility|8
2984411|NCT01058421|10269223|P1|3 Month Outcomes|Remained in Other Facility|5
2984412|NCT01058421|10269222|P2|3 Month Outcomes|Remained in Hospital|2
2984413|NCT01058421|10269223|P1|3 Month Outcomes|Remained in Hospital|0
2984414|NCT01058421|10269222|P2|3 Month Outcomes|Lost to Follow-up|11
2984415|NCT01058421|10269223|P1|3 Month Outcomes|Lost to Follow-up|12
2984416|NCT01058421|10269222|P2|3 Month Outcomes|Death|5
2984417|NCT01058421|10269223|P1|3 Month Outcomes|Death|3
2984418|NCT01058421|10269222|P2|1 Month Outcomes|Remained in Other Facility|17
2984419|NCT01058421|10269223|P1|1 Month Outcomes|Remained in Other Facility|16
2984420|NCT01058421|10269222|P2|1 Month Outcomes|Remained in Hospital|12
2984421|NCT01058421|10269223|P1|1 Month Outcomes|Remained in Hospital|5
2984422|NCT01058421|10269222|P2|1 Month Outcomes|Lost to Follow-up|7
2984423|NCT01058421|10269223|P1|1 Month Outcomes|Lost to Follow-up|8
2984424|NCT01058421|10269222|P2|1 Month Outcomes|Death|6
2984425|NCT01058421|10269223|P1|1 Month Outcomes|Death|10
2984426|NCT01058395|10269247|P2|Overall Study|Lost to Follow-up|0
2984427|NCT01058395|10269248|P1|Overall Study|Lost to Follow-up|1
2984428|NCT01058395|10269247|P2|Overall Study|Death|1
2984429|NCT01058395|10269248|P1|Overall Study|Death|2
2984430|NCT01058356|10269257|P1|Overall Study|Lost to Follow-up|4
2984432|NCT01058356|10269257|P1|Overall Study|Administration of contraindicated drugs|12
2984433|NCT01058356|10269257|P1|Overall Study|Adverse Event|5
2984434|NCT01058304|10269264|P2|Overall Study|Developed exclusion criterion|12
2984435|NCT01058304|10269265|P1|Overall Study|Developed exclusion criterion|6
2984436|NCT01058304|10269264|P2|Overall Study|Lost to Follow-up|16
2984437|NCT01058304|10269265|P1|Overall Study|Lost to Follow-up|13
2984438|NCT01058304|10269264|P2|Overall Study|Withdrawal by Subject|5
2984439|NCT01058304|10269265|P1|Overall Study|Withdrawal by Subject|8
2984440|NCT01058265|10269275|P2|Overall Study|Lost to Follow-up|12
2984441|NCT01058265|10269276|P1|Overall Study|Lost to Follow-up|11
2984442|NCT01058096|10269295|P2|Double-blind Treatment Phase|Other Unspecified|0
2984443|NCT01058096|10269296|P1|Double-blind Treatment Phase|Other Unspecified|2
2984444|NCT01058096|10269295|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2984445|NCT01058096|10269296|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2984446|NCT01058096|10269295|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
2984447|NCT01058096|10269296|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
2984448|NCT01058096|10269295|P2|Double-blind Treatment Phase|Protocol Violation|1
2984449|NCT01058096|10269296|P1|Double-blind Treatment Phase|Protocol Violation|2
2984450|NCT01058096|10269295|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
2984451|NCT01058096|10269296|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
2984452|NCT01058096|10269295|P2|Double-blind Treatment Phase|Adverse Event|15
2984453|NCT01058096|10269296|P1|Double-blind Treatment Phase|Adverse Event|11
2984454|NCT01058005|10269312|P3|Overall Study|Reason Missing|1
2984455|NCT01058005|10269313|P2|Overall Study|Reason Missing|3
2984456|NCT01058005|10269314|P1|Overall Study|Reason Missing|5
2984457|NCT01058005|10269312|P3|Overall Study|Withdrawn Due to Study Termination|7
2984458|NCT01058005|10269313|P2|Overall Study|Withdrawn Due to Study Termination|13
2984459|NCT01058005|10269314|P1|Overall Study|Withdrawn Due to Study Termination|27
2984460|NCT01058005|10269312|P3|Overall Study|Withdrawal by Subject|11
2984461|NCT01058005|10269313|P2|Overall Study|Withdrawal by Subject|5
2984462|NCT01058005|10269314|P1|Overall Study|Withdrawal by Subject|4
2984463|NCT01058005|10269312|P3|Overall Study|Physician Decision|0
2984464|NCT01058005|10269313|P2|Overall Study|Physician Decision|2
2984465|NCT01058005|10269314|P1|Overall Study|Physician Decision|2
2984466|NCT01058005|10269312|P3|Overall Study|Adverse Event|1
2984467|NCT01058005|10269313|P2|Overall Study|Adverse Event|2
2984468|NCT01058005|10269314|P1|Overall Study|Adverse Event|0
2984469|NCT01057862|10269349|P2|Overall Study|Withdrawal by Subject|2
2984470|NCT01057862|10269350|P1|Overall Study|Withdrawal by Subject|1
2984471|NCT01057810|10269360|P2|Overall Study|Other|14
2984472|NCT01057810|10269361|P1|Overall Study|Other|7
2984473|NCT01057810|10269360|P2|Overall Study|No longer met study criteria|1
2984474|NCT01057810|10269361|P1|Overall Study|No longer met study criteria|0
2984475|NCT01057810|10269360|P2|Overall Study|Poor/non-compliance|1
2984476|NCT01057810|10269361|P1|Overall Study|Poor/non-compliance|0
2984477|NCT01057810|10269360|P2|Overall Study|Maximum clinical benefit|5
2984478|NCT01057810|10269361|P1|Overall Study|Maximum clinical benefit|5
2984479|NCT01057810|10269360|P2|Overall Study|Death|12
2984480|NCT01057810|10269361|P1|Overall Study|Death|2
2984481|NCT01057810|10269360|P2|Overall Study|Withdrawal by Subject|25
2984482|NCT01057810|10269361|P1|Overall Study|Withdrawal by Subject|10
2984483|NCT01057810|10269360|P2|Overall Study|Adverse event unrelated to study drug|29
2984484|NCT01057810|10269361|P1|Overall Study|Adverse event unrelated to study drug|13
2984485|NCT01057810|10269360|P2|Overall Study|Study drug toxicity|114
2984486|NCT01057810|10269361|P1|Overall Study|Study drug toxicity|5
2984487|NCT01057810|10269360|P2|Overall Study|Disease progression|197
2984488|NCT01057810|10269361|P1|Overall Study|Disease progression|156
2984489|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
2984490|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2984491|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2984492|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
2984493|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
2984494|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
2984495|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
2984496|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
2984497|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
2984498|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
2984499|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2984500|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2984501|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
2984502|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
2984503|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
2984504|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
2984505|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
2984506|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
2984507|NCT01057693|10269377|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
2984508|NCT01057693|10269378|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
2984509|NCT01057693|10269379|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
2984510|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Other|0
2984511|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Other|0
2984512|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Other|6
2984513|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2984514|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2984515|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
2984516|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
2984517|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
2984518|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
2984519|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2984520|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2984521|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
2984522|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2984523|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2984524|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
2984525|NCT01057693|10269377|P3|Between Single-Blind and Double-Blind|Adverse Event|0
2984526|NCT01057693|10269378|P2|Between Single-Blind and Double-Blind|Adverse Event|0
2984527|NCT01057693|10269379|P1|Between Single-Blind and Double-Blind|Adverse Event|5
2984528|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Other|0
2984529|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Other|0
2984530|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Other|2
2984531|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2984532|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2984533|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
2984534|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2984535|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2984536|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
2984537|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2984538|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2984539|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
2984540|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2984541|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2984542|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
2984543|NCT01057693|10269377|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2984544|NCT01057693|10269378|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2984545|NCT01057693|10269379|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
2984546|NCT01057589|10269425|P1|Overall Study|Lost to Follow-up|1
2984547|NCT01057589|10269425|P1|Overall Study|Death|8
2984548|NCT01057589|10269425|P1|Overall Study|Sponsor Decision|1
2984549|NCT01057589|10269425|P1|Overall Study|Withdrawal by Subject|3
2984550|NCT01057589|10269425|P1|Overall Study|Physician Decision|8
2984551|NCT01057589|10269425|P1|Overall Study|Adverse Event|10
2984552|NCT01057589|10269425|P1|Overall Study|Disease Progression|35
2984553|NCT01057433|10269434|P1|Overall Study|Adverse Event|1
2984554|NCT01057394|10269438|P2|Overall Study|Not eligible|2
2984555|NCT01057394|10269439|P1|Overall Study|Not eligible|0
2984556|NCT01057251|10269449|P2|Overall Study|Other Reason|1
2984557|NCT01057251|10269450|P1|Overall Study|Other Reason|1
2984558|NCT01057251|10269449|P2|Overall Study|Lost to Follow-up|6
2984559|NCT01057251|10269450|P1|Overall Study|Lost to Follow-up|7
2984560|NCT01057251|10269449|P2|Overall Study|Withdrawal by Subject|5
2984561|NCT01057251|10269450|P1|Overall Study|Withdrawal by Subject|4
2984562|NCT01057251|10269449|P2|Overall Study|Protocol Violation|2
2984563|NCT01057251|10269450|P1|Overall Study|Protocol Violation|6
2984564|NCT01057251|10269449|P2|Overall Study|Lack of Efficacy|11
2984565|NCT01057251|10269450|P1|Overall Study|Lack of Efficacy|2
2984566|NCT01057251|10269449|P2|Overall Study|Adverse Event|2
2984567|NCT01057251|10269450|P1|Overall Study|Adverse Event|4
2984568|NCT01057251|10269449|P2|Overall Study|Did not meet InclusionExclusion criteria|2
2984569|NCT01057251|10269450|P1|Overall Study|Did not meet InclusionExclusion criteria|4
2984570|NCT01056822|10269528|P2|Overall Study|Lost to Follow-up|0
2984571|NCT01056822|10269529|P1|Overall Study|Lost to Follow-up|1
2984572|NCT01056822|10269528|P2|Overall Study|Withdrawal by Subject|1
2984573|NCT01056822|10269529|P1|Overall Study|Withdrawal by Subject|1
2984574|NCT01056822|10269528|P2|Overall Study|Protocol Violation|5
2984575|NCT01056822|10269529|P1|Overall Study|Protocol Violation|6
2984576|NCT01056822|10269528|P2|Overall Study|Adverse Event|1
2984577|NCT01056822|10269529|P1|Overall Study|Adverse Event|0
2984578|NCT01056718|10269578|P1|Overall Study|Ischemia on baseline stress test|1
2984579|NCT01056718|10269578|P1|Overall Study|Withdrawal by Subject|2
2984580|NCT01056653|10269611|P3|Overall Study|Lost to Follow-up|2
2984581|NCT01056653|10269612|P2|Overall Study|Lost to Follow-up|0
2984582|NCT01056653|10269613|P1|Overall Study|Lost to Follow-up|0
2984583|NCT01056640|10269629|P2|Overall Study|Death|4
2984584|NCT01056640|10269630|P1|Overall Study|Death|15
2984585|NCT01056640|10269629|P2|Overall Study|Withdrawal by Subject|8
2984586|NCT01056640|10269630|P1|Overall Study|Withdrawal by Subject|11
2984587|NCT01056536|10269645|P3|Overall Study|Lost to Follow-up|248
2984588|NCT01056536|10269646|P2|Overall Study|Lost to Follow-up|116
2984589|NCT01056536|10269647|P1|Overall Study|Lost to Follow-up|202
2984590|NCT01056523|10269658|P7|Overall Study|Death|1
2984591|NCT01056523|10269659|P6|Overall Study|Death|0
2984592|NCT01056523|10269660|P5|Overall Study|Death|0
2984593|NCT01056523|10269661|P4|Overall Study|Death|3
2984594|NCT01056523|10269662|P3|Overall Study|Death|2
2984595|NCT01056523|10269663|P2|Overall Study|Death|0
2984596|NCT01056523|10269664|P1|Overall Study|Death|1
2984597|NCT01056510|10269674|P2|Overall Study|Missing|1
2984598|NCT01056510|10269675|P1|Overall Study|Missing|0
2984599|NCT01056510|10269674|P2|Overall Study|Other|12
2984600|NCT01056510|10269675|P1|Overall Study|Other|10
2984601|NCT01056510|10269674|P2|Overall Study|Lost to Follow-up|6
2984602|NCT01056510|10269675|P1|Overall Study|Lost to Follow-up|5
2984603|NCT01056510|10269674|P2|Overall Study|Physician Decision|5
2984604|NCT01056510|10269675|P1|Overall Study|Physician Decision|4
2984605|NCT01056510|10269674|P2|Overall Study|Noncompliance|3
2984606|NCT01056510|10269675|P1|Overall Study|Noncompliance|1
2984607|NCT01056510|10269674|P2|Overall Study|Death|34
2984608|NCT01056510|10269675|P1|Overall Study|Death|29
2984609|NCT01056510|10269674|P2|Overall Study|Withdrawal by Subject|2
2984610|NCT01056510|10269675|P1|Overall Study|Withdrawal by Subject|4
2984611|NCT01056510|10269674|P2|Overall Study|Dropout Before Start of Treatment|1
2984612|NCT01056510|10269675|P1|Overall Study|Dropout Before Start of Treatment|1
2984613|NCT01056484|10269721|P2|Follow up - Non-randomized|Withdrawal by Subject|2
2984614|NCT01056484|10269722|P1|Follow up - Non-randomized|Withdrawal by Subject|0
2984615|NCT01056484|10269721|P2|Randomized Controlled Trial|Physician Decision|0
2984616|NCT01056484|10269722|P1|Randomized Controlled Trial|Physician Decision|1
2984617|NCT01056484|10269721|P2|Randomized Controlled Trial|Withdrawal by Subject|1
2984618|NCT01056484|10269722|P1|Randomized Controlled Trial|Withdrawal by Subject|6
2984619|NCT01056380|10269738|P2|Overall Study|Lost to Follow-up|3
2984620|NCT01056380|10269739|P1|Overall Study|Lost to Follow-up|2
2984621|NCT01056341|10269766|P5|Overall Study|Other reasons|5
2984622|NCT01056341|10269767|P4|Overall Study|Other reasons|9
2984623|NCT01056341|10269768|P3|Overall Study|Other reasons|8
2984624|NCT01056341|10269769|P2|Overall Study|Other reasons|4
2984625|NCT01056341|10269770|P1|Overall Study|Other reasons|4
2984626|NCT01056341|10269766|P5|Overall Study|Lack of Efficacy|9
2984627|NCT01056341|10269767|P4|Overall Study|Lack of Efficacy|25
2984628|NCT01056341|10269768|P3|Overall Study|Lack of Efficacy|7
2984629|NCT01056341|10269769|P2|Overall Study|Lack of Efficacy|30
2984630|NCT01056341|10269770|P1|Overall Study|Lack of Efficacy|32
2984631|NCT01056341|10269766|P5|Overall Study|Treatment Intolerance|0
2984632|NCT01056341|10269767|P4|Overall Study|Treatment Intolerance|2
2984633|NCT01056341|10269768|P3|Overall Study|Treatment Intolerance|0
2984634|NCT01056341|10269769|P2|Overall Study|Treatment Intolerance|2
2984635|NCT01056341|10269770|P1|Overall Study|Treatment Intolerance|0
2984636|NCT01056289|10269843|P4|Double-blind Phase|Physician Decision|0
2984637|NCT01056289|10269844|P3|Double-blind Phase|Physician Decision|1
2984638|NCT01056289|10269845|P2|Double-blind Phase|Physician Decision|0
2984639|NCT01056289|10269846|P1|Double-blind Phase|Physician Decision|0
2984640|NCT01056289|10269843|P4|Double-blind Phase|Discontinuation symptom|2
2984641|NCT01056289|10269844|P3|Double-blind Phase|Discontinuation symptom|2
2984642|NCT01056289|10269845|P2|Double-blind Phase|Discontinuation symptom|1
2984643|NCT01056289|10269846|P1|Double-blind Phase|Discontinuation symptom|0
2984644|NCT01056289|10269843|P4|Double-blind Phase|Withdrawal by Subject|2
2984645|NCT01056289|10269844|P3|Double-blind Phase|Withdrawal by Subject|4
2984646|NCT01056289|10269845|P2|Double-blind Phase|Withdrawal by Subject|0
2984647|NCT01056289|10269846|P1|Double-blind Phase|Withdrawal by Subject|0
2984648|NCT01056289|10269843|P4|Double-blind Phase|Protocol Violation|1
2984649|NCT01056289|10269844|P3|Double-blind Phase|Protocol Violation|1
2984650|NCT01056289|10269845|P2|Double-blind Phase|Protocol Violation|0
2984651|NCT01056289|10269846|P1|Double-blind Phase|Protocol Violation|0
2984652|NCT01056289|10269843|P4|Double-blind Phase|Other|2
2984653|NCT01056289|10269844|P3|Double-blind Phase|Other|1
2984654|NCT01056289|10269845|P2|Double-blind Phase|Other|0
2984655|NCT01056289|10269846|P1|Double-blind Phase|Other|0
2984656|NCT01056289|10269843|P4|Double-blind Phase|Lost to Follow-up|2
2984657|NCT01056289|10269844|P3|Double-blind Phase|Lost to Follow-up|2
2984658|NCT01056289|10269845|P2|Double-blind Phase|Lost to Follow-up|2
2984659|NCT01056289|10269846|P1|Double-blind Phase|Lost to Follow-up|0
2984660|NCT01056289|10269843|P4|Double-blind Phase|Adverse Event|1
2984661|NCT01056289|10269844|P3|Double-blind Phase|Adverse Event|2
2984662|NCT01056289|10269845|P2|Double-blind Phase|Adverse Event|1
2984663|NCT01056289|10269846|P1|Double-blind Phase|Adverse Event|0
2984664|NCT01056289|10269843|P4|Open-label Phase|Not randomized to Double-blind phase|0
2984665|NCT01056289|10269844|P3|Open-label Phase|Not randomized to Double-blind phase|0
2984666|NCT01056289|10269845|P2|Open-label Phase|Not randomized to Double-blind phase|0
2984667|NCT01056289|10269846|P1|Open-label Phase|Not randomized to Double-blind phase|1
2984668|NCT01056289|10269843|P4|Open-label Phase|Lack of Efficacy|0
2984669|NCT01056289|10269844|P3|Open-label Phase|Lack of Efficacy|0
2984670|NCT01056289|10269845|P2|Open-label Phase|Lack of Efficacy|0
2984671|NCT01056289|10269846|P1|Open-label Phase|Lack of Efficacy|18
2984672|NCT01056289|10269843|P4|Open-label Phase|Withdrawal by Subject|0
2984673|NCT01056289|10269844|P3|Open-label Phase|Withdrawal by Subject|0
2984674|NCT01056289|10269845|P2|Open-label Phase|Withdrawal by Subject|0
2984675|NCT01056289|10269846|P1|Open-label Phase|Withdrawal by Subject|26
2984676|NCT01056289|10269843|P4|Open-label Phase|Protocol Violation|0
2984677|NCT01056289|10269844|P3|Open-label Phase|Protocol Violation|0
2984678|NCT01056289|10269845|P2|Open-label Phase|Protocol Violation|0
2984679|NCT01056289|10269846|P1|Open-label Phase|Protocol Violation|6
2984680|NCT01056289|10269843|P4|Open-label Phase|Other|0
2984681|NCT01056289|10269844|P3|Open-label Phase|Other|0
2984682|NCT01056289|10269845|P2|Open-label Phase|Other|0
2984683|NCT01056289|10269846|P1|Open-label Phase|Other|9
2984684|NCT01056289|10269843|P4|Open-label Phase|Lost to Follow-up|0
2984685|NCT01056289|10269844|P3|Open-label Phase|Lost to Follow-up|0
2984686|NCT01056289|10269845|P2|Open-label Phase|Lost to Follow-up|0
2984687|NCT01056289|10269846|P1|Open-label Phase|Lost to Follow-up|30
2984688|NCT01056289|10269843|P4|Open-label Phase|Adverse Event|0
2984689|NCT01056289|10269844|P3|Open-label Phase|Adverse Event|0
2984690|NCT01056289|10269845|P2|Open-label Phase|Adverse Event|0
2984691|NCT01056289|10269846|P1|Open-label Phase|Adverse Event|29
2984692|NCT01056276|10269863|P2|Maintenance Therapy|Continuing maintenance therapy|14
2984693|NCT01056276|10269864|P1|Maintenance Therapy|Continuing maintenance therapy|0
2984694|NCT01056276|10269863|P2|Maintenance Therapy|Intercurrent Illness|1
2984695|NCT01056276|10269864|P1|Maintenance Therapy|Intercurrent Illness|0
2984696|NCT01056276|10269863|P2|Maintenance Therapy|Withdrawal by Subject|1
2984697|NCT01056276|10269864|P1|Maintenance Therapy|Withdrawal by Subject|0
2984698|NCT01056276|10269863|P2|Maintenance Therapy|Physician Decision|1
2984699|NCT01056276|10269864|P1|Maintenance Therapy|Physician Decision|0
2984700|NCT01056276|10269863|P2|Maintenance Therapy|Progressive Disease|9
2984701|NCT01056276|10269864|P1|Maintenance Therapy|Progressive Disease|0
2984702|NCT01056276|10269863|P2|Maintenance Therapy|Toxicity|2
2984703|NCT01056276|10269864|P1|Maintenance Therapy|Toxicity|0
2984704|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
2984705|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
2984706|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Death|1
2984707|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Death|3
2984708|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Physician Decision|0
2984709|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Physician Decision|3
2984710|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
2984711|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
2984712|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Disease Progression|2
2984713|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Disease Progression|2
2984714|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
2984715|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
2984716|NCT01056276|10269863|P2|Treatment Period-Cycles 1-8|Toxicity|1
2984717|NCT01056276|10269864|P1|Treatment Period-Cycles 1-8|Toxicity|2
2984718|NCT01056263|10269878|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
2984719|NCT01056263|10269878|P1|Overall Study|Objective progression or relapse|1
2984720|NCT01056263|10269878|P1|Overall Study|Neoplasm progression|1
2984721|NCT01056263|10269878|P1|Overall Study|Progressive disease|2
2984722|NCT01056263|10269878|P1|Overall Study|Lack of Efficacy|29
2984723|NCT01056263|10269878|P1|Overall Study|Withdrawal by Subject|1
2984724|NCT01056263|10269878|P1|Overall Study|Death|1
2984725|NCT01056263|10269878|P1|Overall Study|Adverse Event|12
2984726|NCT01056107|10269901|P4|Overall Study|Withdrawal by Subject|0
2984727|NCT01056107|10269902|P3|Overall Study|Withdrawal by Subject|3
2984728|NCT01056107|10269903|P2|Overall Study|Withdrawal by Subject|1
2984729|NCT01056107|10269904|P1|Overall Study|Withdrawal by Subject|0
2984730|NCT01055886|10269961|P2|Overall Study|Withdrawal by PI|1
2984731|NCT01055886|10269962|P1|Overall Study|Withdrawal by PI|0
2984732|NCT01055886|10269961|P2|Overall Study|Lost to Follow-up|1
2984733|NCT01055886|10269962|P1|Overall Study|Lost to Follow-up|1
2984734|NCT01055886|10269961|P2|Overall Study|Withdrawal by Subject|9
2984735|NCT01055886|10269962|P1|Overall Study|Withdrawal by Subject|4
2984736|NCT01055834|10269974|P2|Treatment Period I|Adverse Event|0
2984737|NCT01055834|10269975|P1|Treatment Period I|Adverse Event|1
2984738|NCT01055639|10270060|P2|Overall Study|Withdrawal by Subject|11
2984739|NCT01055639|10270061|P1|Overall Study|Withdrawal by Subject|8
2984740|NCT01055639|10270060|P2|Overall Study|Protocol Violation|5
2984741|NCT01055639|10270061|P1|Overall Study|Protocol Violation|5
2984742|NCT01055639|10270060|P2|Overall Study|Lost to Follow-up|11
2984743|NCT01055639|10270061|P1|Overall Study|Lost to Follow-up|8
2984744|NCT01055639|10270060|P2|Overall Study|Lack of Efficacy|1
2984745|NCT01055639|10270061|P1|Overall Study|Lack of Efficacy|0
2984746|NCT01055639|10270060|P2|Overall Study|Adverse Event|1
2984747|NCT01055639|10270061|P1|Overall Study|Adverse Event|0
2984748|NCT01055613|10270085|P2|Overall Study|Subject Disinterest|1
2984749|NCT01055613|10270086|P1|Overall Study|Subject Disinterest|1
2984750|NCT01055613|10270085|P2|Overall Study|Protocol Violation|1
2984751|NCT01055613|10270086|P1|Overall Study|Protocol Violation|1
2984752|NCT01055613|10270085|P2|Overall Study|Lost to Follow-up|1
2984753|NCT01055613|10270086|P1|Overall Study|Lost to Follow-up|1
2984754|NCT01055613|10270085|P2|Overall Study|Discomfort|1
2984755|NCT01055613|10270086|P1|Overall Study|Discomfort|2
2984756|NCT01055613|10270085|P2|Overall Study|Unacceptable lens fit|0
2984757|NCT01055613|10270086|P1|Overall Study|Unacceptable lens fit|1
2984758|NCT01055613|10270085|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2984759|NCT01055613|10270086|P1|Overall Study|No Longer Meets Eligibility Criteria|3
2984760|NCT01055496|10270096|P2|Overall Study|Other - Unspecified|1
2984761|NCT01055496|10270097|P1|Overall Study|Other - Unspecified|0
2984762|NCT01055496|10270096|P2|Overall Study|Lost to Follow-up|2
2984763|NCT01055496|10270097|P1|Overall Study|Lost to Follow-up|0
2984764|NCT01055496|10270096|P2|Overall Study|Death|23
2984765|NCT01055496|10270097|P1|Overall Study|Death|13
2984766|NCT01055496|10270096|P2|Overall Study|Withdrawal by Subject|4
2984767|NCT01055496|10270097|P1|Overall Study|Withdrawal by Subject|2
2984768|NCT01055457|10270154|P10|Overall Study|Adverse Event|0
2984769|NCT01055457|10270155|P9|Overall Study|Adverse Event|0
2984770|NCT01055457|10270156|P8|Overall Study|Adverse Event|0
2984771|NCT01055457|10270157|P7|Overall Study|Adverse Event|0
2984772|NCT01055457|10270158|P6|Overall Study|Adverse Event|0
2984773|NCT01055457|10270159|P5|Overall Study|Adverse Event|0
2984774|NCT01055457|10270160|P4|Overall Study|Adverse Event|1
2984775|NCT01055457|10270161|P3|Overall Study|Adverse Event|0
2984776|NCT01055457|10270162|P2|Overall Study|Adverse Event|0
2984777|NCT01055457|10270163|P1|Overall Study|Adverse Event|0
2984778|NCT01055457|10270154|P10|Overall Study|Pregnancy|0
2984779|NCT01055457|10270155|P9|Overall Study|Pregnancy|0
2984780|NCT01055457|10270156|P8|Overall Study|Pregnancy|0
2984781|NCT01055457|10270157|P7|Overall Study|Pregnancy|0
2984782|NCT01055457|10270158|P6|Overall Study|Pregnancy|0
2984783|NCT01055457|10270159|P5|Overall Study|Pregnancy|0
2984784|NCT01055457|10270160|P4|Overall Study|Pregnancy|1
2984785|NCT01055457|10270161|P3|Overall Study|Pregnancy|0
2984786|NCT01055457|10270162|P2|Overall Study|Pregnancy|0
2984787|NCT01055457|10270163|P1|Overall Study|Pregnancy|0
2984788|NCT01055457|10270154|P10|Overall Study|Discomfort|0
2984789|NCT01055457|10270155|P9|Overall Study|Discomfort|0
2984790|NCT01055457|10270156|P8|Overall Study|Discomfort|0
2984791|NCT01055457|10270157|P7|Overall Study|Discomfort|0
2984792|NCT01055457|10270158|P6|Overall Study|Discomfort|0
2984793|NCT01055457|10270159|P5|Overall Study|Discomfort|1
2984794|NCT01055457|10270160|P4|Overall Study|Discomfort|0
2984795|NCT01055457|10270161|P3|Overall Study|Discomfort|0
2984796|NCT01055457|10270162|P2|Overall Study|Discomfort|0
2984797|NCT01055457|10270163|P1|Overall Study|Discomfort|0
2984798|NCT01055457|10270154|P10|Overall Study|Subject Ineligible|0
2984799|NCT01055457|10270155|P9|Overall Study|Subject Ineligible|0
2984800|NCT01055457|10270156|P8|Overall Study|Subject Ineligible|0
2984801|NCT01055457|10270157|P7|Overall Study|Subject Ineligible|0
2984802|NCT01055457|10270158|P6|Overall Study|Subject Ineligible|0
2984803|NCT01055457|10270159|P5|Overall Study|Subject Ineligible|1
2984804|NCT01055457|10270160|P4|Overall Study|Subject Ineligible|0
2984805|NCT01055457|10270161|P3|Overall Study|Subject Ineligible|1
2984806|NCT01055457|10270162|P2|Overall Study|Subject Ineligible|0
2984807|NCT01055457|10270163|P1|Overall Study|Subject Ineligible|1
2984808|NCT01055457|10270154|P10|Overall Study|Subject Disinterest|0
2984809|NCT01055457|10270155|P9|Overall Study|Subject Disinterest|0
2984810|NCT01055457|10270156|P8|Overall Study|Subject Disinterest|1
2984811|NCT01055457|10270157|P7|Overall Study|Subject Disinterest|0
2984812|NCT01055457|10270158|P6|Overall Study|Subject Disinterest|0
2984813|NCT01055457|10270159|P5|Overall Study|Subject Disinterest|0
2984814|NCT01055457|10270160|P4|Overall Study|Subject Disinterest|0
2984815|NCT01055457|10270161|P3|Overall Study|Subject Disinterest|0
2984816|NCT01055457|10270162|P2|Overall Study|Subject Disinterest|0
2984817|NCT01055457|10270163|P1|Overall Study|Subject Disinterest|0
2984818|NCT01055457|10270154|P10|Overall Study|Protocol Violation|1
2984819|NCT01055457|10270155|P9|Overall Study|Protocol Violation|0
2984820|NCT01055457|10270156|P8|Overall Study|Protocol Violation|0
2984821|NCT01055457|10270157|P7|Overall Study|Protocol Violation|1
2984822|NCT01055457|10270158|P6|Overall Study|Protocol Violation|2
2984823|NCT01055457|10270159|P5|Overall Study|Protocol Violation|1
2984824|NCT01055457|10270160|P4|Overall Study|Protocol Violation|1
2984825|NCT01055457|10270161|P3|Overall Study|Protocol Violation|1
2984826|NCT01055457|10270162|P2|Overall Study|Protocol Violation|0
2984827|NCT01055457|10270163|P1|Overall Study|Protocol Violation|0
2984828|NCT01055457|10270154|P10|Overall Study|Lost to Follow-up|0
2984829|NCT01055457|10270155|P9|Overall Study|Lost to Follow-up|0
2984830|NCT01055457|10270156|P8|Overall Study|Lost to Follow-up|0
2984831|NCT01055457|10270157|P7|Overall Study|Lost to Follow-up|0
2984832|NCT01055457|10270158|P6|Overall Study|Lost to Follow-up|1
2984833|NCT01055457|10270159|P5|Overall Study|Lost to Follow-up|0
2984834|NCT01055457|10270160|P4|Overall Study|Lost to Follow-up|0
2984835|NCT01055457|10270161|P3|Overall Study|Lost to Follow-up|0
2984836|NCT01055457|10270162|P2|Overall Study|Lost to Follow-up|1
2984837|NCT01055457|10270163|P1|Overall Study|Lost to Follow-up|0
2984838|NCT01055314|10270197|P2|Overall Study|No treatment|0
2984839|NCT01055314|10270198|P1|Overall Study|No treatment|1
2984840|NCT01055314|10270197|P2|Overall Study|Refusal of further protocol therapy|4
2984841|NCT01055314|10270198|P1|Overall Study|Refusal of further protocol therapy|10
2984842|NCT01055314|10270197|P2|Overall Study|Ineligible|5
2984843|NCT01055314|10270198|P1|Overall Study|Ineligible|3
2984844|NCT01055314|10270197|P2|Overall Study|Withdrawal by Subject|0
2984845|NCT01055314|10270198|P1|Overall Study|Withdrawal by Subject|1
2984846|NCT01055314|10270197|P2|Overall Study|Physician Decision|5
2984847|NCT01055314|10270198|P1|Overall Study|Physician Decision|10
2984848|NCT01055314|10270197|P2|Overall Study|Lack of Efficacy|19
2984849|NCT01055314|10270198|P1|Overall Study|Lack of Efficacy|11
2984850|NCT01055314|10270197|P2|Overall Study|Death|1
2984851|NCT01055314|10270198|P1|Overall Study|Death|2
2984852|NCT01055314|10270197|P2|Overall Study|Adverse Event|4
2984853|NCT01055314|10270198|P1|Overall Study|Adverse Event|7
2984854|NCT01055262|10270210|P1|Overall Study|Uncooperativeness|1
2984855|NCT01055262|10270210|P1|Overall Study|Protocol Violation|3
2984856|NCT01055262|10270210|P1|Overall Study|Adverse Event|5
2984857|NCT01055197|10270251|P2|Overall Study|Withdrawal by Subject|0
2984858|NCT01055197|10270252|P1|Overall Study|Withdrawal by Subject|2
2984859|NCT01055197|10270251|P2|Overall Study|Protocol Violation|2
2984860|NCT01055197|10270252|P1|Overall Study|Protocol Violation|7
2984861|NCT01055132|10270287|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
2984862|NCT01055132|10270288|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
2984863|NCT01055132|10270287|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
2984864|NCT01055132|10270288|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
2984865|NCT01055028|10270301|P2|Inter-treatment Period|Did not start Cycle 4|3
2984866|NCT01055028|10270302|P1|Inter-treatment Period|Did not start Cycle 4|0
2984867|NCT01055028|10270301|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2984868|NCT01055028|10270302|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2984869|NCT01055028|10270301|P2|Treatment Cycles 1 to 3|Adverse Event|1
2984870|NCT01055028|10270302|P1|Treatment Cycles 1 to 3|Adverse Event|0
2984871|NCT01055028|10270301|P2|Screening|Screen Failure|1
2984872|NCT01055028|10270302|P1|Screening|Screen Failure|1
2984873|NCT01054976|10270316|P1|Overall Study|Other|8
2984874|NCT01054976|10270316|P1|Overall Study|Withdrawal by Subject|4
2984875|NCT01054976|10270316|P1|Overall Study|Uncooperative participations to study|7
2984876|NCT01054976|10270316|P1|Overall Study|Adverse Event|16
2984877|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
2984878|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2984879|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2984880|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2984881|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2984882|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
2984883|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2984884|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Physician Decision|1
2984885|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Physician Decision|1
2984886|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Physician Decision|3
2984887|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Physician Decision|6
2984888|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2984889|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Physician Decision|4
2984890|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2984891|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2984892|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2984893|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2984894|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2984895|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2984896|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2984897|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2984898|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2984899|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2984900|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2984901|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2984902|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2984903|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2984904|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2984905|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2984906|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
2984907|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2984908|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2984909|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2984910|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2984911|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
2984912|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
2984913|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
2984914|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
2984915|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2984916|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
2984917|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
2984918|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2984919|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2984920|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2984921|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
2984922|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
2984923|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
2984924|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2984925|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2984926|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2984927|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2984928|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2984929|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2984930|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2984931|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2984932|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2984933|NCT01054885|10270337|P7|24-week, Double-blind Treatment Period|Adverse Event|19
2984934|NCT01054885|10270338|P6|24-week, Double-blind Treatment Period|Adverse Event|17
2984935|NCT01054885|10270339|P5|24-week, Double-blind Treatment Period|Adverse Event|15
2984936|NCT01054885|10270340|P4|24-week, Double-blind Treatment Period|Adverse Event|15
2984937|NCT01054885|10270341|P3|24-week, Double-blind Treatment Period|Adverse Event|12
2984938|NCT01054885|10270342|P2|24-week, Double-blind Treatment Period|Adverse Event|18
2984939|NCT01054885|10270343|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2984940|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984941|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984942|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984943|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984944|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984945|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2984946|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
2984947|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Adverse Event|0
2984948|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Adverse Event|0
2984949|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Adverse Event|0
2984950|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2984951|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2984952|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2984953|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Adverse Event|7
2984954|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984955|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984956|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984957|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984958|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984959|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2984960|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2984961|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984962|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984963|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984964|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984965|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984966|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2984967|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
2984968|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Physician Decision|0
2984969|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Physician Decision|0
2984970|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Physician Decision|0
2984971|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2984972|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2984973|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2984974|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Physician Decision|6
2984975|NCT01054885|10270337|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984976|NCT01054885|10270338|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984977|NCT01054885|10270339|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984978|NCT01054885|10270340|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984979|NCT01054885|10270341|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984980|NCT01054885|10270342|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2984981|NCT01054885|10270343|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
2984982|NCT01054846|10270383|P2|Overall Study|Lost to Follow-up|17
2984983|NCT01054846|10270384|P1|Overall Study|Lost to Follow-up|76
2984984|NCT01054820|10270391|P1|Overall Study|Withdrawal by Subject|2
2984985|NCT01054729|10270413|P4|Overall Study|Lack of Efficacy|1
2984986|NCT01054729|10270414|P3|Overall Study|Lack of Efficacy|0
2984987|NCT01054729|10270415|P2|Overall Study|Lack of Efficacy|0
2984988|NCT01054729|10270416|P1|Overall Study|Lack of Efficacy|0
2984989|NCT01054729|10270413|P4|Overall Study|Subject moved|0
2984990|NCT01054729|10270414|P3|Overall Study|Subject moved|1
2984991|NCT01054729|10270415|P2|Overall Study|Subject moved|0
2984992|NCT01054729|10270416|P1|Overall Study|Subject moved|0
2984993|NCT01054729|10270413|P4|Overall Study|Personal/Obligations|0
2984994|NCT01054729|10270414|P3|Overall Study|Personal/Obligations|0
2984995|NCT01054729|10270415|P2|Overall Study|Personal/Obligations|1
2984996|NCT01054729|10270416|P1|Overall Study|Personal/Obligations|0
2984997|NCT01054729|10270413|P4|Overall Study|PEG/RBV Non-responder|0
2984998|NCT01054729|10270414|P3|Overall Study|PEG/RBV Non-responder|1
2984999|NCT01054729|10270415|P2|Overall Study|PEG/RBV Non-responder|0
2985000|NCT01054729|10270416|P1|Overall Study|PEG/RBV Non-responder|1
2985001|NCT01054729|10270413|P4|Overall Study|Non-responder|1
2985002|NCT01054729|10270414|P3|Overall Study|Non-responder|1
2985003|NCT01054729|10270415|P2|Overall Study|Non-responder|0
2985004|NCT01054729|10270416|P1|Overall Study|Non-responder|1
2985005|NCT01054729|10270413|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
2985006|NCT01054729|10270414|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
2985007|NCT01054729|10270415|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
2985008|NCT01054729|10270416|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
2985009|NCT01054729|10270413|P4|Overall Study|Lost to Follow-up|0
2985010|NCT01054729|10270414|P3|Overall Study|Lost to Follow-up|0
2985011|NCT01054729|10270415|P2|Overall Study|Lost to Follow-up|1
2985012|NCT01054729|10270416|P1|Overall Study|Lost to Follow-up|0
2985013|NCT01054729|10270413|P4|Overall Study|Withdrawal by Subject|0
2985014|NCT01054729|10270414|P3|Overall Study|Withdrawal by Subject|1
2985015|NCT01054729|10270415|P2|Overall Study|Withdrawal by Subject|0
2985016|NCT01054729|10270416|P1|Overall Study|Withdrawal by Subject|1
2985017|NCT01054729|10270413|P4|Overall Study|Adverse Event|1
2985018|NCT01054729|10270414|P3|Overall Study|Adverse Event|2
2985019|NCT01054729|10270415|P2|Overall Study|Adverse Event|1
2985020|NCT01054729|10270416|P1|Overall Study|Adverse Event|1
2985021|NCT01054729|10270413|P4|Overall Study|Randomized but Not Treated|0
2985022|NCT01054729|10270414|P3|Overall Study|Randomized but Not Treated|0
2985023|NCT01054729|10270415|P2|Overall Study|Randomized but Not Treated|1
2985024|NCT01054729|10270416|P1|Overall Study|Randomized but Not Treated|0
2985025|NCT01054599|10270514|P2|Overall Study|Withdrawal by Subject|1
2985026|NCT01054599|10270515|P1|Overall Study|Withdrawal by Subject|0
2985027|NCT01054599|10270514|P2|Overall Study|Adverse Event|1
2985028|NCT01054599|10270515|P1|Overall Study|Adverse Event|0
2985029|NCT01054599|10270514|P2|Overall Study|Lost to Follow-up|2
2985030|NCT01054599|10270515|P1|Overall Study|Lost to Follow-up|0
2985031|NCT01054599|10270514|P2|Overall Study|Visual impairment, WTAR <80|1
2985032|NCT01054599|10270515|P1|Overall Study|Visual impairment, WTAR <80|0
2985033|NCT01054599|10270514|P2|Overall Study|Timing/scheduling difficulties|1
2985034|NCT01054599|10270515|P1|Overall Study|Timing/scheduling difficulties|1
2985035|NCT01054599|10270514|P2|Overall Study|Spells/seizure-like episodes|1
2985036|NCT01054599|10270515|P1|Overall Study|Spells/seizure-like episodes|1
2985037|NCT01054599|10270514|P2|Overall Study|Protocol Violation|0
2985038|NCT01054599|10270515|P1|Overall Study|Protocol Violation|1
2985039|NCT01054599|10270514|P2|Overall Study|Dizziness due to phenytoin toxicity|0
2985040|NCT01054599|10270515|P1|Overall Study|Dizziness due to phenytoin toxicity|1
2985041|NCT01054573|10270622|P4|Overall Study|Withdrawal by Subject|1
2985042|NCT01054573|10270623|P3|Overall Study|Withdrawal by Subject|2
2985043|NCT01054573|10270624|P2|Overall Study|Withdrawal by Subject|2
2985044|NCT01054573|10270625|P1|Overall Study|Withdrawal by Subject|0
2985045|NCT01054573|10270622|P4|Overall Study|Lost to Follow-up|0
2985046|NCT01054573|10270623|P3|Overall Study|Lost to Follow-up|0
2985047|NCT01054573|10270624|P2|Overall Study|Lost to Follow-up|2
2985048|NCT01054573|10270625|P1|Overall Study|Lost to Follow-up|0
2985049|NCT01054573|10270622|P4|Overall Study|Adverse Event|1
2985050|NCT01054573|10270623|P3|Overall Study|Adverse Event|1
2985051|NCT01054573|10270624|P2|Overall Study|Adverse Event|0
2985052|NCT01054573|10270625|P1|Overall Study|Adverse Event|1
2985053|NCT01054560|10270671|P2|Overall Study|Physician Decision|0
2985054|NCT01054560|10270672|P1|Overall Study|Physician Decision|1
2985055|NCT01054560|10270671|P2|Overall Study|Withdrawal by Subject|2
2985056|NCT01054560|10270672|P1|Overall Study|Withdrawal by Subject|0
2985057|NCT01054560|10270671|P2|Overall Study|Lost to Follow-up|5
2985058|NCT01054560|10270672|P1|Overall Study|Lost to Follow-up|2
2985059|NCT01054560|10270671|P2|Overall Study|Death|21
2985060|NCT01054560|10270672|P1|Overall Study|Death|10
2985061|NCT01054300|10270724|P4|Period 2|Withdrawal by Subject|0
2985062|NCT01054300|10270725|P3|Period 2|Withdrawal by Subject|1
2985063|NCT01054300|10270726|P2|Period 2|Withdrawal by Subject|0
2985064|NCT01054300|10270727|P1|Period 2|Withdrawal by Subject|0
2985065|NCT01054300|10270724|P4|Period 1|Adverse Event|0
2985066|NCT01054300|10270725|P3|Period 1|Adverse Event|0
2985067|NCT01054300|10270726|P2|Period 1|Adverse Event|0
2985068|NCT01054300|10270727|P1|Period 1|Adverse Event|1
2985069|NCT01054222|10270777|P1|Overall Study|Withdrawal by Subject|6
2985070|NCT01054222|10270777|P1|Overall Study|Lost to Follow-up|4
2985071|NCT01054222|10270777|P1|Overall Study|Lack of Efficacy|1
2985072|NCT01054170|10270818|P2|Overall Study|Adverse Event|4
2985073|NCT01054170|10270819|P1|Overall Study|Adverse Event|0
2985074|NCT01054170|10270818|P2|Overall Study|Withdrawal by Subject|2
2985075|NCT01054170|10270819|P1|Overall Study|Withdrawal by Subject|3
2985076|NCT01054170|10270818|P2|Overall Study|Protocol Violation|0
2985077|NCT01054170|10270819|P1|Overall Study|Protocol Violation|1
2985078|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2985079|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
2985080|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2985081|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2985082|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
2985083|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2985084|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Physician Decision|4
2985085|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Physician Decision|5
2985086|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Physician Decision|5
2985237|NCT01052779|10271217|P1|Overall Study|Withdrawal by Subject|1
2985087|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Physician Decision|2
2985088|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Physician Decision|5
2985089|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2985090|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2985091|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2985092|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2985093|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2985094|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
2985095|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2985096|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2985097|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2985098|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
2985099|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
2985100|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2985101|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2985102|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
2985103|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
2985104|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2985105|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
2985106|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
2985107|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2985108|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2985109|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
2985110|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2985111|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
2985112|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
2985113|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2985114|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2985115|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2985116|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2985117|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2985118|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2985119|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2985120|NCT01053988|10270884|P6|24-week, Double-blind Treatment Period|Adverse Event|14
2985121|NCT01053988|10270885|P5|24-week, Double-blind Treatment Period|Adverse Event|17
2985122|NCT01053988|10270886|P4|24-week, Double-blind Treatment Period|Adverse Event|24
2985123|NCT01053988|10270887|P3|24-week, Double-blind Treatment Period|Adverse Event|23
2985124|NCT01053988|10270888|P2|24-week, Double-blind Treatment Period|Adverse Event|15
2985125|NCT01053988|10270889|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2985126|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2985127|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2985128|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2985129|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2985130|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2985131|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2985132|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Physician Decision|0
2985133|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Physician Decision|0
2985134|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2985135|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2985136|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2985137|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Physician Decision|5
2985138|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Adverse Event|0
2985139|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Adverse Event|0
2985140|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2985141|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2985142|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2985143|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Adverse Event|6
2985144|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2985145|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2985146|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2985147|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2985148|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2985149|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
2985150|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2985151|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2985152|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2985153|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2985154|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2985155|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
2985156|NCT01053988|10270884|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2985157|NCT01053988|10270885|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2985158|NCT01053988|10270886|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2985159|NCT01053988|10270887|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2985160|NCT01053988|10270888|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2985161|NCT01053988|10270889|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
2985162|NCT01053962|10270926|P5|Treatment Period|Noncompliance with protocol|0
2985163|NCT01053962|10270927|P4|Treatment Period|Noncompliance with protocol|0
2985164|NCT01053962|10270928|P3|Treatment Period|Noncompliance with protocol|0
2985165|NCT01053962|10270929|P2|Treatment Period|Noncompliance with protocol|0
2985166|NCT01053962|10270930|P1|Treatment Period|Noncompliance with protocol|1
2985167|NCT01053962|10270926|P5|Treatment Period|Withdrawal by Subject|1
2985168|NCT01053962|10270927|P4|Treatment Period|Withdrawal by Subject|0
2985169|NCT01053962|10270928|P3|Treatment Period|Withdrawal by Subject|0
2985170|NCT01053962|10270929|P2|Treatment Period|Withdrawal by Subject|0
2985171|NCT01053962|10270930|P1|Treatment Period|Withdrawal by Subject|0
2985172|NCT01053962|10270926|P5|Treatment Period|Adverse Event|1
2985173|NCT01053962|10270927|P4|Treatment Period|Adverse Event|0
2985174|NCT01053962|10270928|P3|Treatment Period|Adverse Event|0
2985175|NCT01053962|10270929|P2|Treatment Period|Adverse Event|0
2985176|NCT01053962|10270930|P1|Treatment Period|Adverse Event|0
2985177|NCT01053962|10270926|P5|Treatment Period|Lack of Efficacy|1
2985178|NCT01053962|10270927|P4|Treatment Period|Lack of Efficacy|0
2985179|NCT01053962|10270928|P3|Treatment Period|Lack of Efficacy|0
2985180|NCT01053962|10270929|P2|Treatment Period|Lack of Efficacy|0
2985181|NCT01053962|10270930|P1|Treatment Period|Lack of Efficacy|0
2985182|NCT01053962|10270926|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
2985183|NCT01053962|10270927|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
2985184|NCT01053962|10270928|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
2985185|NCT01053962|10270929|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
2985186|NCT01053962|10270930|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
2985187|NCT01053962|10270926|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
2985188|NCT01053962|10270927|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
2985189|NCT01053962|10270928|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
2985190|NCT01053962|10270929|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
2985191|NCT01053962|10270930|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
2985192|NCT01053962|10270926|P5|Pretreatment Period|Venipuncture Failure|0
2985193|NCT01053962|10270927|P4|Pretreatment Period|Venipuncture Failure|0
2985194|NCT01053962|10270928|P3|Pretreatment Period|Venipuncture Failure|1
2985195|NCT01053962|10270929|P2|Pretreatment Period|Venipuncture Failure|0
2985196|NCT01053962|10270930|P1|Pretreatment Period|Venipuncture Failure|0
2985197|NCT01053962|10270926|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
2985198|NCT01053962|10270927|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
2985199|NCT01053962|10270928|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2985200|NCT01053962|10270929|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2985201|NCT01053962|10270930|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2985202|NCT01053741|10270981|P2|2nd Study Intervention|Physician Decision|1
2985203|NCT01053741|10270982|P1|2nd Study Intervention|Physician Decision|0
2985204|NCT01053663|10270991|P1|Overall Study|Negative Influenza Diagnosis|1
2985205|NCT01053663|10270991|P1|Overall Study|Transferred to Another Hospital|1
2985206|NCT01053663|10270991|P1|Overall Study|Poor IV Access|1
2985207|NCT01053663|10270991|P1|Overall Study|Lost to Follow-up|1
2985208|NCT01053663|10270991|P1|Overall Study|Death|2
2985209|NCT01053429|10271049|P1|Overall Study|Other|309
2985210|NCT01053429|10271049|P1|Overall Study|Adverse Event|64
2985211|NCT01053247|10271079|P3|Overall Study|Adverse Event|3
2985212|NCT01053247|10271080|P2|Overall Study|Adverse Event|9
2985213|NCT01053247|10271081|P1|Overall Study|Adverse Event|0
2985214|NCT01053247|10271079|P3|Overall Study|Lost to Follow-up|7
2985215|NCT01053247|10271080|P2|Overall Study|Lost to Follow-up|5
2985216|NCT01053247|10271081|P1|Overall Study|Lost to Follow-up|8
2985217|NCT01053247|10271079|P3|Overall Study|Protocol Violation|2
2985218|NCT01053247|10271080|P2|Overall Study|Protocol Violation|1
2985219|NCT01053247|10271081|P1|Overall Study|Protocol Violation|2
2985220|NCT01053247|10271079|P3|Overall Study|Lack of Efficacy|1
2985221|NCT01053247|10271080|P2|Overall Study|Lack of Efficacy|0
2985222|NCT01053247|10271081|P1|Overall Study|Lack of Efficacy|1
2985223|NCT01053247|10271079|P3|Overall Study|Withdrawal by Subject|15
2985224|NCT01053247|10271080|P2|Overall Study|Withdrawal by Subject|4
2985225|NCT01053247|10271081|P1|Overall Study|Withdrawal by Subject|9
2985226|NCT01053221|10271091|P2|Overall Study|The study was closed prematurely|9
2985227|NCT01053221|10271092|P1|Overall Study|The study was closed prematurely|5
2985228|NCT01052844|10271194|P2|Overall Study|Adverse Event|1
2985229|NCT01052844|10271195|P1|Overall Study|Adverse Event|0
2985230|NCT01052779|10271216|P2|Overall Study|Other-Missed Week 5 Visit|0
2985231|NCT01052779|10271217|P1|Overall Study|Other-Missed Week 5 Visit|2
2985232|NCT01052779|10271216|P2|Overall Study|Other-Surgery|2
2985233|NCT01052779|10271217|P1|Overall Study|Other-Surgery|0
2985234|NCT01052779|10271216|P2|Overall Study|Other-Protocol Violation|1
2985235|NCT01052779|10271217|P1|Overall Study|Other-Protocol Violation|1
2985236|NCT01052779|10271216|P2|Overall Study|Withdrawal by Subject|2
2985238|NCT01052779|10271216|P2|Overall Study|Adverse Event|4
2985239|NCT01052779|10271217|P1|Overall Study|Adverse Event|1
2985240|NCT01052714|10271227|P3|Overall Study|Withdrawal by Subject|1
2985241|NCT01052714|10271228|P2|Overall Study|Withdrawal by Subject|12
2985242|NCT01052714|10271229|P1|Overall Study|Withdrawal by Subject|7
2985243|NCT01052714|10271227|P3|Overall Study|Physician Decision|1
2985244|NCT01052714|10271228|P2|Overall Study|Physician Decision|9
2985245|NCT01052714|10271229|P1|Overall Study|Physician Decision|9
2985246|NCT01052714|10271227|P3|Overall Study|Lost to Follow-up|0
2985247|NCT01052714|10271228|P2|Overall Study|Lost to Follow-up|3
2985248|NCT01052714|10271229|P1|Overall Study|Lost to Follow-up|2
2985249|NCT01052714|10271227|P3|Overall Study|Death|0
2985250|NCT01052714|10271228|P2|Overall Study|Death|2
2985251|NCT01052714|10271229|P1|Overall Study|Death|1
2985252|NCT01052714|10271227|P3|Overall Study|Adverse Event|0
2985253|NCT01052714|10271228|P2|Overall Study|Adverse Event|3
2985254|NCT01052714|10271229|P1|Overall Study|Adverse Event|6
2985255|NCT01052662|10271283|P3|Overall Study|Administrative|0
2985256|NCT01052662|10271284|P2|Overall Study|Administrative|3
2985257|NCT01052662|10271285|P1|Overall Study|Administrative|0
2985258|NCT01052662|10271283|P3|Overall Study|Legal Problem|0
2985259|NCT01052662|10271284|P2|Overall Study|Legal Problem|0
2985260|NCT01052662|10271285|P1|Overall Study|Legal Problem|2
2985261|NCT01052662|10271283|P3|Overall Study|Adverse Event|0
2985262|NCT01052662|10271284|P2|Overall Study|Adverse Event|1
2985263|NCT01052662|10271285|P1|Overall Study|Adverse Event|1
2985264|NCT01052662|10271283|P3|Overall Study|Pharmacy issue|3
2985265|NCT01052662|10271284|P2|Overall Study|Pharmacy issue|3
2985266|NCT01052662|10271285|P1|Overall Study|Pharmacy issue|1
2985267|NCT01052662|10271283|P3|Overall Study|Withdrawal by Subject|1
2985268|NCT01052662|10271284|P2|Overall Study|Withdrawal by Subject|2
2985269|NCT01052662|10271285|P1|Overall Study|Withdrawal by Subject|3
2985270|NCT01052662|10271283|P3|Overall Study|Lost to Follow-up|18
2985271|NCT01052662|10271284|P2|Overall Study|Lost to Follow-up|13
2985272|NCT01052662|10271285|P1|Overall Study|Lost to Follow-up|15
2985273|NCT01052480|10271326|P2|Overall Study|Death|5
2985274|NCT01052480|10271327|P1|Overall Study|Death|1
2985275|NCT01052480|10271326|P2|Overall Study|Physician Decision|2
2985276|NCT01052480|10271327|P1|Overall Study|Physician Decision|0
2985277|NCT01052480|10271326|P2|Overall Study|Withdrawal by Subject|7
2985278|NCT01052480|10271327|P1|Overall Study|Withdrawal by Subject|3
2985279|NCT01052480|10271326|P2|Overall Study|Protocol Violation|0
2985280|NCT01052480|10271327|P1|Overall Study|Protocol Violation|1
2985281|NCT01052480|10271326|P2|Overall Study|Lost to Follow-up|3
2985282|NCT01052480|10271327|P1|Overall Study|Lost to Follow-up|3
2985283|NCT01052428|10271377|P2|Overall Study|Withdrawal by Subject|1
2985284|NCT01052428|10271378|P1|Overall Study|Withdrawal by Subject|0
2985285|NCT01052428|10271377|P2|Overall Study|Death|0
2985286|NCT01052428|10271378|P1|Overall Study|Death|1
2985287|NCT01052272|10271400|P4|Overall Study|decline in health|0
2985288|NCT01052272|10271401|P3|Overall Study|decline in health|1
2985289|NCT01052272|10271402|P2|Overall Study|decline in health|0
2985290|NCT01052272|10271403|P1|Overall Study|decline in health|0
2985291|NCT01052272|10271400|P4|Overall Study|placed in long-term care|0
2985292|NCT01052272|10271401|P3|Overall Study|placed in long-term care|1
2985293|NCT01052272|10271402|P2|Overall Study|placed in long-term care|0
2985294|NCT01052272|10271403|P1|Overall Study|placed in long-term care|0
2985295|NCT01052272|10271400|P4|Overall Study|Withdrawal by Subject|2
2985296|NCT01052272|10271401|P3|Overall Study|Withdrawal by Subject|3
2985297|NCT01052272|10271402|P2|Overall Study|Withdrawal by Subject|2
2985298|NCT01052272|10271403|P1|Overall Study|Withdrawal by Subject|0
2985299|NCT01052272|10271400|P4|Overall Study|patient refuses follow-up|4
2985300|NCT01052272|10271401|P3|Overall Study|patient refuses follow-up|2
2985301|NCT01052272|10271402|P2|Overall Study|patient refuses follow-up|4
2985302|NCT01052272|10271403|P1|Overall Study|patient refuses follow-up|5
2985303|NCT01052272|10271400|P4|Overall Study|Physician Decision|0
2985304|NCT01052272|10271401|P3|Overall Study|Physician Decision|0
2985305|NCT01052272|10271402|P2|Overall Study|Physician Decision|1
2985306|NCT01052272|10271403|P1|Overall Study|Physician Decision|0
2985307|NCT01052272|10271400|P4|Overall Study|Death|1
2985308|NCT01052272|10271401|P3|Overall Study|Death|1
2985309|NCT01052272|10271402|P2|Overall Study|Death|0
2985310|NCT01052272|10271403|P1|Overall Study|Death|0
2985311|NCT01052116|10271448|P2|Overall Study|Spirometry not performed|4
2985312|NCT01052116|10271449|P1|Overall Study|Spirometry not performed|0
2985313|NCT01052116|10271448|P2|Overall Study|Withdrawal by Subject|6
2985314|NCT01052116|10271449|P1|Overall Study|Withdrawal by Subject|3
2985315|NCT01052116|10271448|P2|Overall Study|Lost to Follow-up|17
2985316|NCT01052116|10271449|P1|Overall Study|Lost to Follow-up|11
2985317|NCT01052077|10271457|P4|Phase A+|Withdrawal by Subject|7
2985318|NCT01052077|10271458|P3|Phase A+|Withdrawal by Subject|0
2985319|NCT01052077|10271459|P2|Phase A+|Withdrawal by Subject|0
2985320|NCT01052077|10271460|P1|Phase A+|Withdrawal by Subject|0
2985321|NCT01052077|10271457|P4|Phase A+|Met Withdrawal Criteria|2
2985322|NCT01052077|10271458|P3|Phase A+|Met Withdrawal Criteria|0
2985323|NCT01052077|10271459|P2|Phase A+|Met Withdrawal Criteria|0
2985324|NCT01052077|10271460|P1|Phase A+|Met Withdrawal Criteria|0
2985325|NCT01052077|10271457|P4|Phase A+|Adverse Event|4
2985326|NCT01052077|10271458|P3|Phase A+|Adverse Event|0
2985327|NCT01052077|10271459|P2|Phase A+|Adverse Event|0
2985328|NCT01052077|10271460|P1|Phase A+|Adverse Event|0
2985329|NCT01052077|10271457|P4|Phase A+|Lost to Follow-up|8
2985330|NCT01052077|10271458|P3|Phase A+|Lost to Follow-up|0
2985331|NCT01052077|10271459|P2|Phase A+|Lost to Follow-up|0
2985332|NCT01052077|10271460|P1|Phase A+|Lost to Follow-up|0
2985333|NCT01052077|10271457|P4|Phase B|Lack of Efficacy|0
2985334|NCT01052077|10271458|P3|Phase B|Lack of Efficacy|0
2985335|NCT01052077|10271459|P2|Phase B|Lack of Efficacy|1
2985336|NCT01052077|10271460|P1|Phase B|Lack of Efficacy|0
2985337|NCT01052077|10271457|P4|Phase B|Protocol Deviation|0
2985338|NCT01052077|10271458|P3|Phase B|Protocol Deviation|4
2985339|NCT01052077|10271459|P2|Phase B|Protocol Deviation|3
2985340|NCT01052077|10271460|P1|Phase B|Protocol Deviation|0
2985341|NCT01052077|10271457|P4|Phase B|Withdrawal by Subject|0
2985342|NCT01052077|10271458|P3|Phase B|Withdrawal by Subject|5
2985343|NCT01052077|10271459|P2|Phase B|Withdrawal by Subject|0
2985344|NCT01052077|10271460|P1|Phase B|Withdrawal by Subject|0
2985345|NCT01052077|10271457|P4|Phase B|Physician Decision|0
2985346|NCT01052077|10271458|P3|Phase B|Physician Decision|1
2985347|NCT01052077|10271459|P2|Phase B|Physician Decision|1
2985348|NCT01052077|10271460|P1|Phase B|Physician Decision|0
2985349|NCT01052077|10271457|P4|Phase B|Met Withdrawal Criteria|0
2985350|NCT01052077|10271458|P3|Phase B|Met Withdrawal Criteria|1
2985351|NCT01052077|10271459|P2|Phase B|Met Withdrawal Criteria|2
2985352|NCT01052077|10271460|P1|Phase B|Met Withdrawal Criteria|0
2985353|NCT01052077|10271457|P4|Phase B|Adverse Event|0
2985354|NCT01052077|10271458|P3|Phase B|Adverse Event|2
2985355|NCT01052077|10271459|P2|Phase B|Adverse Event|9
2985356|NCT01052077|10271460|P1|Phase B|Adverse Event|0
2985357|NCT01052077|10271457|P4|Phase B|Lost to Follow-up|0
2985358|NCT01052077|10271458|P3|Phase B|Lost to Follow-up|3
2985359|NCT01052077|10271459|P2|Phase B|Lost to Follow-up|2
2985360|NCT01052077|10271460|P1|Phase B|Lost to Follow-up|0
2985361|NCT01052077|10271457|P4|Phase A|Protocol Deviation|0
2985362|NCT01052077|10271458|P3|Phase A|Protocol Deviation|0
2985363|NCT01052077|10271459|P2|Phase A|Protocol Deviation|0
2985364|NCT01052077|10271460|P1|Phase A|Protocol Deviation|27
2985365|NCT01052077|10271457|P4|Phase A|Withdrawal by Subject|0
2985366|NCT01052077|10271458|P3|Phase A|Withdrawal by Subject|0
2985367|NCT01052077|10271459|P2|Phase A|Withdrawal by Subject|0
2985368|NCT01052077|10271460|P1|Phase A|Withdrawal by Subject|29
2985369|NCT01052077|10271457|P4|Phase A|Physician Decision|0
2985370|NCT01052077|10271458|P3|Phase A|Physician Decision|0
2985371|NCT01052077|10271459|P2|Phase A|Physician Decision|0
2985372|NCT01052077|10271460|P1|Phase A|Physician Decision|10
2985373|NCT01052077|10271457|P4|Phase A|Met Withdrawal Criteria|0
2985374|NCT01052077|10271458|P3|Phase A|Met Withdrawal Criteria|0
2985375|NCT01052077|10271459|P2|Phase A|Met Withdrawal Criteria|0
2985376|NCT01052077|10271460|P1|Phase A|Met Withdrawal Criteria|26
2985377|NCT01052077|10271457|P4|Phase A|Adverse Event|0
2985378|NCT01052077|10271458|P3|Phase A|Adverse Event|0
2985379|NCT01052077|10271459|P2|Phase A|Adverse Event|0
2985380|NCT01052077|10271460|P1|Phase A|Adverse Event|32
2985381|NCT01052077|10271457|P4|Phase A|Lost to Follow-up|0
2985382|NCT01052077|10271458|P3|Phase A|Lost to Follow-up|0
2985383|NCT01052077|10271459|P2|Phase A|Lost to Follow-up|0
2985384|NCT01052077|10271460|P1|Phase A|Lost to Follow-up|22
2985385|NCT01052038|10271487|P3|Overall Study|Protocol Violation|3
2985386|NCT01052038|10271488|P2|Overall Study|Protocol Violation|3
2985387|NCT01052038|10271489|P1|Overall Study|Protocol Violation|2
2985388|NCT01052038|10271487|P3|Overall Study|Lost to Follow-up|1
2985389|NCT01052038|10271488|P2|Overall Study|Lost to Follow-up|3
2985390|NCT01052038|10271489|P1|Overall Study|Lost to Follow-up|2
2985391|NCT01051986|10271511|P2|Overall Study|Protocol Violation|3
2985392|NCT01051986|10271512|P1|Overall Study|Protocol Violation|2
2985393|NCT01051986|10271511|P2|Overall Study|Withdrawal by Subject|1
2985394|NCT01051986|10271512|P1|Overall Study|Withdrawal by Subject|2
2985395|NCT01051986|10271511|P2|Overall Study|Death|0
2985396|NCT01051986|10271512|P1|Overall Study|Death|1
2985397|NCT01051921|10271526|P1|Overall Study|patient moved|1
2985398|NCT01051921|10271526|P1|Overall Study|virological failure|1
2985399|NCT01051921|10271526|P1|Overall Study|Lost to Follow-up|4
2985400|NCT01051921|10271526|P1|Overall Study|Withdrawal by Subject|7
2985401|NCT01051921|10271526|P1|Overall Study|Adverse Event|8
2985402|NCT01051921|10271526|P1|Overall Study|Physician Decision|9
2985403|NCT01051856|10271533|P2|Overall Study|Withdrawal by Subject|0
2985404|NCT01051856|10271534|P1|Overall Study|Withdrawal by Subject|1
2985405|NCT01051817|10271544|P2|Overall Study|Protocol Violation|1
2985406|NCT01051817|10271545|P1|Overall Study|Protocol Violation|0
2985407|NCT01051817|10271544|P2|Overall Study|Withdrawal by Subject|5
2985408|NCT01051817|10271545|P1|Overall Study|Withdrawal by Subject|3
2985409|NCT01051817|10271544|P2|Overall Study|Abnormal Test Proceedure reults|1
2985410|NCT01051817|10271545|P1|Overall Study|Abnormal Test Proceedure reults|0
2985411|NCT01051817|10271544|P2|Overall Study|Adverse Event|2
2985412|NCT01051817|10271545|P1|Overall Study|Adverse Event|0
2985413|NCT01051791|10271555|P1|Overall Study|Withdrawal by Subject|1
2985414|NCT01051791|10271555|P1|Overall Study|Failed screening|3
2985415|NCT01051739|10271573|P2|Overall Study|Withdrawal by Subject|10
2985416|NCT01051739|10271574|P1|Overall Study|Withdrawal by Subject|25
2985417|NCT01051739|10271573|P2|Overall Study|Death|3
2985418|NCT01051739|10271574|P1|Overall Study|Death|3
2985419|NCT01051661|10271586|P6|Overall Study|Withdrawal by Subject|34
2985420|NCT01051661|10271587|P5|Overall Study|Withdrawal by Subject|12
2985421|NCT01051661|10271588|P4|Overall Study|Withdrawal by Subject|28
2985422|NCT01051661|10271589|P3|Overall Study|Withdrawal by Subject|13
2985423|NCT01051661|10271590|P2|Overall Study|Withdrawal by Subject|30
2985424|NCT01051661|10271591|P1|Overall Study|Withdrawal by Subject|16
2985425|NCT01051661|10271586|P6|Overall Study|Protocol Violation|1
2985426|NCT01051661|10271587|P5|Overall Study|Protocol Violation|2
2985427|NCT01051661|10271588|P4|Overall Study|Protocol Violation|1
2985428|NCT01051661|10271589|P3|Overall Study|Protocol Violation|0
2985429|NCT01051661|10271590|P2|Overall Study|Protocol Violation|0
2985430|NCT01051661|10271591|P1|Overall Study|Protocol Violation|0
2985431|NCT01051661|10271586|P6|Overall Study|Subject lost legal representation|0
2985432|NCT01051661|10271587|P5|Overall Study|Subject lost legal representation|1
2985433|NCT01051661|10271588|P4|Overall Study|Subject lost legal representation|0
2985434|NCT01051661|10271589|P3|Overall Study|Subject lost legal representation|0
2985435|NCT01051661|10271590|P2|Overall Study|Subject lost legal representation|0
2985436|NCT01051661|10271591|P1|Overall Study|Subject lost legal representation|0
2985437|NCT01051661|10271586|P6|Overall Study|Failure to comply with protocol|0
2985438|NCT01051661|10271587|P5|Overall Study|Failure to comply with protocol|0
2985439|NCT01051661|10271588|P4|Overall Study|Failure to comply with protocol|0
2985440|NCT01051661|10271589|P3|Overall Study|Failure to comply with protocol|2
2985441|NCT01051661|10271590|P2|Overall Study|Failure to comply with protocol|0
2985442|NCT01051661|10271591|P1|Overall Study|Failure to comply with protocol|0
2985443|NCT01051661|10271586|P6|Overall Study|Consent not received from both parents|1
2985444|NCT01051661|10271587|P5|Overall Study|Consent not received from both parents|0
2985445|NCT01051661|10271588|P4|Overall Study|Consent not received from both parents|0
2985446|NCT01051661|10271589|P3|Overall Study|Consent not received from both parents|0
2985447|NCT01051661|10271590|P2|Overall Study|Consent not received from both parents|0
2985448|NCT01051661|10271591|P1|Overall Study|Consent not received from both parents|0
2985449|NCT01051661|10271586|P6|Overall Study|Unable to attend visit(s)|2
2985450|NCT01051661|10271587|P5|Overall Study|Unable to attend visit(s)|3
2985451|NCT01051661|10271588|P4|Overall Study|Unable to attend visit(s)|1
2985452|NCT01051661|10271589|P3|Overall Study|Unable to attend visit(s)|2
2985453|NCT01051661|10271590|P2|Overall Study|Unable to attend visit(s)|4
2985454|NCT01051661|10271591|P1|Overall Study|Unable to attend visit(s)|2
2985455|NCT01051661|10271586|P6|Overall Study|Data not reliable|1
2985456|NCT01051661|10271587|P5|Overall Study|Data not reliable|0
2985457|NCT01051661|10271588|P4|Overall Study|Data not reliable|0
2985458|NCT01051661|10271589|P3|Overall Study|Data not reliable|0
2985459|NCT01051661|10271590|P2|Overall Study|Data not reliable|0
2985460|NCT01051661|10271591|P1|Overall Study|Data not reliable|1
2985461|NCT01051661|10271586|P6|Overall Study|Refused blood sampling|1
2985462|NCT01051661|10271587|P5|Overall Study|Refused blood sampling|0
2985463|NCT01051661|10271588|P4|Overall Study|Refused blood sampling|0
2985464|NCT01051661|10271589|P3|Overall Study|Refused blood sampling|0
2985465|NCT01051661|10271590|P2|Overall Study|Refused blood sampling|0
2985466|NCT01051661|10271591|P1|Overall Study|Refused blood sampling|0
2985467|NCT01051661|10271586|P6|Overall Study|Migrated/moved from study area|3
2985468|NCT01051661|10271587|P5|Overall Study|Migrated/moved from study area|7
2985469|NCT01051661|10271588|P4|Overall Study|Migrated/moved from study area|8
2985470|NCT01051661|10271589|P3|Overall Study|Migrated/moved from study area|6
2985471|NCT01051661|10271590|P2|Overall Study|Migrated/moved from study area|6
2985472|NCT01051661|10271591|P1|Overall Study|Migrated/moved from study area|1
2985473|NCT01051661|10271586|P6|Overall Study|Lost to Follow-up|24
2985474|NCT01051661|10271587|P5|Overall Study|Lost to Follow-up|10
2985475|NCT01051661|10271588|P4|Overall Study|Lost to Follow-up|17
2985476|NCT01051661|10271589|P3|Overall Study|Lost to Follow-up|15
2985477|NCT01051661|10271590|P2|Overall Study|Lost to Follow-up|22
2985478|NCT01051661|10271591|P1|Overall Study|Lost to Follow-up|13
2985479|NCT01051661|10271586|P6|Overall Study|Adverse Event|0
2985480|NCT01051661|10271587|P5|Overall Study|Adverse Event|0
2985481|NCT01051661|10271588|P4|Overall Study|Adverse Event|1
2985482|NCT01051661|10271589|P3|Overall Study|Adverse Event|1
2985483|NCT01051661|10271590|P2|Overall Study|Adverse Event|1
2985484|NCT01051661|10271591|P1|Overall Study|Adverse Event|1
2985485|NCT01051557|10271788|P7|Overall Study|Adverse Event|4
2985486|NCT01051557|10271789|P6|Overall Study|Adverse Event|3
2985487|NCT01051557|10271790|P5|Overall Study|Adverse Event|1
2985488|NCT01051557|10271791|P4|Overall Study|Adverse Event|1
2985489|NCT01051557|10271792|P3|Overall Study|Adverse Event|0
2985490|NCT01051557|10271793|P2|Overall Study|Adverse Event|0
2985491|NCT01051557|10271794|P1|Overall Study|Adverse Event|0
2985492|NCT01051557|10271788|P7|Overall Study|Withdrawal by Subject|1
2985493|NCT01051557|10271789|P6|Overall Study|Withdrawal by Subject|0
2985494|NCT01051557|10271790|P5|Overall Study|Withdrawal by Subject|2
2985495|NCT01051557|10271791|P4|Overall Study|Withdrawal by Subject|0
2985496|NCT01051557|10271792|P3|Overall Study|Withdrawal by Subject|1
2985497|NCT01051557|10271793|P2|Overall Study|Withdrawal by Subject|0
2985498|NCT01051557|10271794|P1|Overall Study|Withdrawal by Subject|0
2985499|NCT01051557|10271788|P7|Overall Study|disease progression|1
2985500|NCT01051557|10271789|P6|Overall Study|disease progression|3
2985501|NCT01051557|10271790|P5|Overall Study|disease progression|4
2985502|NCT01051557|10271791|P4|Overall Study|disease progression|2
2985503|NCT01051557|10271792|P3|Overall Study|disease progression|5
2985504|NCT01051557|10271793|P2|Overall Study|disease progression|3
2985505|NCT01051557|10271794|P1|Overall Study|disease progression|3
2985506|NCT01051557|10271788|P7|Overall Study|Physician Decision|0
2985507|NCT01051557|10271789|P6|Overall Study|Physician Decision|0
2985508|NCT01051557|10271790|P5|Overall Study|Physician Decision|0
2985509|NCT01051557|10271791|P4|Overall Study|Physician Decision|0
2985510|NCT01051557|10271792|P3|Overall Study|Physician Decision|0
2985511|NCT01051557|10271793|P2|Overall Study|Physician Decision|0
2985512|NCT01051557|10271794|P1|Overall Study|Physician Decision|1
2985513|NCT01051466|10271825|P2|Overall Study|Physician Decision|0
2985514|NCT01051466|10271826|P1|Overall Study|Physician Decision|1
2985515|NCT01051466|10271825|P2|Overall Study|Entry Criteria Not Met|3
2985516|NCT01051466|10271826|P1|Overall Study|Entry Criteria Not Met|0
2985517|NCT01051466|10271825|P2|Overall Study|Withdrawal by Subject|1
2985518|NCT01051466|10271826|P1|Overall Study|Withdrawal by Subject|5
2985519|NCT01051466|10271825|P2|Overall Study|Lost to Follow-up|1
2985520|NCT01051466|10271826|P1|Overall Study|Lost to Follow-up|1
2985521|NCT01051466|10271825|P2|Overall Study|Adverse Event|0
2985522|NCT01051466|10271826|P1|Overall Study|Adverse Event|1
2985523|NCT01051349|10271871|P1|Overall Study|Reason not Specified|12
2985524|NCT01051349|10271871|P1|Overall Study|Subject non-compliance|7
2985525|NCT01051349|10271871|P1|Overall Study|Lost to Follow-up|6
2985526|NCT01051349|10271871|P1|Overall Study|Investigator Decision|6
2985527|NCT01051349|10271871|P1|Overall Study|Consent Withdrawn|54
2985528|NCT01051349|10271871|P1|Overall Study|Adverse Event|88
2985529|NCT01051323|10271900|P1|Overall Study|Missing|37
2985530|NCT01051323|10271900|P1|Overall Study|Other|148
2985531|NCT01051323|10271900|P1|Overall Study|Hospitalization|28
2985532|NCT01051323|10271900|P1|Overall Study|Death|129
2985533|NCT01051323|10271900|P1|Overall Study|Lost to Follow-up|31
2985534|NCT01051323|10271900|P1|Overall Study|Withdrawal by Subject|13
2985535|NCT01051323|10271900|P1|Overall Study|Dialysis dependency|22
2985536|NCT01051323|10271900|P1|Overall Study|Transplantation|28
2985537|NCT01051323|10271900|P1|Overall Study|Discontinuation of treatment|103
2985538|NCT01051063|10271929|P2|Overall Study|Lost to Follow-up|1
2985539|NCT01051063|10271930|P1|Overall Study|Lost to Follow-up|0
2985540|NCT01051063|10271929|P2|Overall Study|Other|0
2985541|NCT01051063|10271930|P1|Overall Study|Other|1
2985542|NCT01051063|10271929|P2|Overall Study|Moved from the study site area|0
2985543|NCT01051063|10271930|P1|Overall Study|Moved from the study site area|1
2985544|NCT01051063|10271929|P2|Overall Study|Termination of the study|0
2985545|NCT01051063|10271930|P1|Overall Study|Termination of the study|5
2985546|NCT01051063|10271929|P2|Overall Study|Withdrawal by Subject|1
2985547|NCT01051063|10271930|P1|Overall Study|Withdrawal by Subject|1
2985548|NCT01051063|10271929|P2|Overall Study|Death|2
2985549|NCT01051063|10271930|P1|Overall Study|Death|2
2985550|NCT01050998|10271950|P5|Overall Study|Data integrity issues|4
2985551|NCT01050998|10271951|P4|Overall Study|Data integrity issues|1
2985552|NCT01050998|10271952|P3|Overall Study|Data integrity issues|1
2985553|NCT01050998|10271953|P2|Overall Study|Data integrity issues|0
2985554|NCT01050998|10271954|P1|Overall Study|Data integrity issues|0
2985555|NCT01050998|10271950|P5|Overall Study|Other|5
2985556|NCT01050998|10271951|P4|Overall Study|Other|1
2985557|NCT01050998|10271952|P3|Overall Study|Other|1
2985558|NCT01050998|10271953|P2|Overall Study|Other|2
2985559|NCT01050998|10271954|P1|Overall Study|Other|3
2985560|NCT01050998|10271950|P5|Overall Study|Withdrawal by Subject|3
2985561|NCT01050998|10271951|P4|Overall Study|Withdrawal by Subject|1
2985562|NCT01050998|10271952|P3|Overall Study|Withdrawal by Subject|0
2985563|NCT01050998|10271953|P2|Overall Study|Withdrawal by Subject|0
2985564|NCT01050998|10271954|P1|Overall Study|Withdrawal by Subject|0
2985565|NCT01050998|10271950|P5|Overall Study|Adverse Event|2
2985566|NCT01050998|10271951|P4|Overall Study|Adverse Event|0
2985567|NCT01050998|10271952|P3|Overall Study|Adverse Event|1
2985568|NCT01050998|10271953|P2|Overall Study|Adverse Event|0
2985569|NCT01050998|10271954|P1|Overall Study|Adverse Event|1
2985570|NCT01050816|10272288|P1|Overall Study|patient's refusal|2
2985571|NCT01050816|10272288|P1|Overall Study|Lost to Follow-up|2
2985572|NCT01050790|10272294|P1|Overall Study|Adverse Event|1
2985573|NCT01050764|10272304|P1|Overall Study|Death after HSCT, before T-cell infusion|1
2985574|NCT01050764|10272304|P1|Overall Study|Donor mobilization failure, death|1
2985575|NCT01050764|10272304|P1|Overall Study|Death, before HSCT|1
2985576|NCT01050673|10272315|P2|Overall Study|Physician Decision|5
2985577|NCT01050673|10272316|P1|Overall Study|Physician Decision|4
2985578|NCT01050634|10272384|P1|Overall Study|Ongoing at Date of Cut-Off|5
2985579|NCT01050634|10272384|P1|Overall Study|Other|21
2985580|NCT01050634|10272384|P1|Overall Study|Lost to Follow-up|2
2985581|NCT01050634|10272384|P1|Overall Study|Adverse Event|42
2985582|NCT01050634|10272384|P1|Overall Study|Death|2
2985583|NCT01050634|10272384|P1|Overall Study|Enrolled, but Not Treated|56
2985584|NCT01050569|10272408|P3|Overall Study|Physician Decision|3
2985585|NCT01050569|10272409|P2|Overall Study|Physician Decision|3
2985586|NCT01050569|10272410|P1|Overall Study|Physician Decision|3
2985587|NCT01050569|10272408|P3|Overall Study|Adverse Event|0
2985588|NCT01050569|10272409|P2|Overall Study|Adverse Event|0
2985589|NCT01050569|10272410|P1|Overall Study|Adverse Event|1
2985590|NCT01050569|10272408|P3|Overall Study|Lack of Efficacy|3
2985591|NCT01050569|10272409|P2|Overall Study|Lack of Efficacy|4
2985592|NCT01050569|10272410|P1|Overall Study|Lack of Efficacy|5
2985593|NCT01050569|10272408|P3|Overall Study|Withdrawal by Subject|11
2985594|NCT01050569|10272409|P2|Overall Study|Withdrawal by Subject|3
2985595|NCT01050569|10272410|P1|Overall Study|Withdrawal by Subject|9
2985596|NCT01050569|10272408|P3|Overall Study|Lost to Follow-up|16
2985597|NCT01050569|10272409|P2|Overall Study|Lost to Follow-up|14
2985598|NCT01050569|10272410|P1|Overall Study|Lost to Follow-up|20
2985599|NCT01050543|10272429|P2|Overall Study|Administrative|1
2985600|NCT01050543|10272430|P1|Overall Study|Administrative|4
2985601|NCT01050543|10272429|P2|Overall Study|Protocol Violation|1
2985602|NCT01050543|10272430|P1|Overall Study|Protocol Violation|0
2985603|NCT01050543|10272429|P2|Overall Study|Withdrawal by Subject|2
2985604|NCT01050543|10272430|P1|Overall Study|Withdrawal by Subject|0
2985605|NCT01050530|10272438|P2|Overall Study|Protocol Violation|0
2985606|NCT01050530|10272439|P1|Overall Study|Protocol Violation|1
2985607|NCT01050530|10272438|P2|Overall Study|Withdrawal by Subject|3
2985608|NCT01050530|10272439|P1|Overall Study|Withdrawal by Subject|0
2985609|NCT01050530|10272438|P2|Overall Study|Lack of Efficacy|4
2985610|NCT01050530|10272439|P1|Overall Study|Lack of Efficacy|1
2985611|NCT01050530|10272438|P2|Overall Study|Adverse Event|3
2985612|NCT01050530|10272439|P1|Overall Study|Adverse Event|6
2985613|NCT01050257|10272450|P3|Overall Study|Death|1
2985614|NCT01050257|10272451|P2|Overall Study|Death|0
2985615|NCT01050257|10272452|P1|Overall Study|Death|0
2985616|NCT01050257|10272450|P3|Overall Study|Failure to return|0
2985617|NCT01050257|10272451|P2|Overall Study|Failure to return|2
2985618|NCT01050257|10272452|P1|Overall Study|Failure to return|0
2985619|NCT01050257|10272450|P3|Overall Study|Violation criteria|0
2985620|NCT01050257|10272451|P2|Overall Study|Violation criteria|1
2985621|NCT01050257|10272452|P1|Overall Study|Violation criteria|0
2985622|NCT01050257|10272450|P3|Overall Study|Refused treatment/ Did not Cooperate|0
2985623|NCT01050257|10272451|P2|Overall Study|Refused treatment/ Did not Cooperate|1
2985624|NCT01050257|10272452|P1|Overall Study|Refused treatment/ Did not Cooperate|1
2985625|NCT01050257|10272450|P3|Overall Study|No reason specified|2
2985626|NCT01050257|10272451|P2|Overall Study|No reason specified|0
2985627|NCT01050257|10272452|P1|Overall Study|No reason specified|0
2985628|NCT01050257|10272450|P3|Overall Study|Withdrawal by Subject|0
2985629|NCT01050257|10272451|P2|Overall Study|Withdrawal by Subject|3
2985630|NCT01050257|10272452|P1|Overall Study|Withdrawal by Subject|0
2985631|NCT01050257|10272450|P3|Overall Study|Admin/Other (did not switch to oral)|2
2985632|NCT01050257|10272451|P2|Overall Study|Admin/Other (did not switch to oral)|2
2985633|NCT01050257|10272452|P1|Overall Study|Admin/Other (did not switch to oral)|6
2985634|NCT01050257|10272450|P3|Overall Study|Adverse Event|2
2985635|NCT01050257|10272451|P2|Overall Study|Adverse Event|4
2985636|NCT01050257|10272452|P1|Overall Study|Adverse Event|4
2985637|NCT01050218|10272487|P1|Overall Study|Family emergency|1
2985638|NCT01050218|10272487|P1|Overall Study|Serious Adverse Event|1
2985639|NCT01050218|10272487|P1|Overall Study|Failed to return|7
2985640|NCT01050218|10272487|P1|Overall Study|Compliance|2
2985641|NCT01050218|10272487|P1|Overall Study|Discontinued by sponsor|18
2985642|NCT01050218|10272487|P1|Overall Study|Withdrawal by Subject|18
2985643|NCT01050218|10272487|P1|Overall Study|Protocol Violation|3
2985644|NCT01050218|10272487|P1|Overall Study|Lack of Efficacy|8
2985645|NCT01050218|10272487|P1|Overall Study|Adverse Event|37
2985646|NCT01050205|10272493|P2|Overall Study|Discontinued Intervention|0
2985647|NCT01050205|10272494|P1|Overall Study|Discontinued Intervention|2
2985648|NCT01050205|10272493|P2|Overall Study|Relocated from area|2
2985649|NCT01050205|10272494|P1|Overall Study|Relocated from area|1
2985650|NCT01050205|10272493|P2|Overall Study|Withdrawal by Subject|1
2985651|NCT01050205|10272494|P1|Overall Study|Withdrawal by Subject|1
2985652|NCT01050205|10272493|P2|Overall Study|Lost to Follow-up|1
2985653|NCT01050205|10272494|P1|Overall Study|Lost to Follow-up|7
2985654|NCT01050062|10272551|P2|Overall Study|Others|11
2985655|NCT01050062|10272552|P1|Overall Study|Others|17
2985656|NCT01050062|10272551|P2|Overall Study|Physician Decision|9
2985657|NCT01050062|10272552|P1|Overall Study|Physician Decision|74
2985658|NCT01050062|10272551|P2|Overall Study|Lack of Efficacy|35
2985659|NCT01050062|10272552|P1|Overall Study|Lack of Efficacy|22
2985660|NCT01050062|10272551|P2|Overall Study|Lost to Follow-up|35
2985661|NCT01050062|10272552|P1|Overall Study|Lost to Follow-up|83
2985662|NCT01050062|10272551|P2|Overall Study|Adverse Event|22
2985663|NCT01050062|10272552|P1|Overall Study|Adverse Event|75
2985664|NCT01049984|10272574|P2|Overall Study|Treatment failure|2
2985665|NCT01049984|10272575|P1|Overall Study|Treatment failure|0
2985666|NCT01049984|10272574|P2|Overall Study|Adverse Event|7
2985667|NCT01049984|10272575|P1|Overall Study|Adverse Event|13
2985668|NCT01049984|10272574|P2|Overall Study|Lost to Follow-up|1
2985669|NCT01049984|10272575|P1|Overall Study|Lost to Follow-up|2
2985670|NCT01049984|10272574|P2|Overall Study|Protocol Violation|4
2985671|NCT01049984|10272575|P1|Overall Study|Protocol Violation|3
2985672|NCT01049984|10272574|P2|Overall Study|Withdrawal by Subject|5
2985673|NCT01049984|10272575|P1|Overall Study|Withdrawal by Subject|1
2985674|NCT01049581|10272639|P2|Overall Study|Lost to Follow-up|1
2985675|NCT01049581|10272640|P1|Overall Study|Lost to Follow-up|2
2985676|NCT01049503|10272655|P6|Overall Study|Lost to Follow-up|8
2985677|NCT01049503|10272656|P5|Overall Study|Lost to Follow-up|27
2985678|NCT01049503|10272657|P4|Overall Study|Lost to Follow-up|26
2985679|NCT01049503|10272658|P3|Overall Study|Lost to Follow-up|24
2985680|NCT01049503|10272659|P2|Overall Study|Lost to Follow-up|12
2985681|NCT01049503|10272660|P1|Overall Study|Lost to Follow-up|11
2985682|NCT01049412|10272691|P2|Period II|Lost to Follow-up|0
2985683|NCT01049412|10272692|P1|Period II|Lost to Follow-up|1
2985684|NCT01049412|10272691|P2|Period II|Adverse Event|0
2985685|NCT01049412|10272692|P1|Period II|Adverse Event|1
2985686|NCT01049412|10272691|P2|Period II|Withdrawal by Subject|3
2985687|NCT01049412|10272692|P1|Period II|Withdrawal by Subject|2
2985688|NCT01049412|10272691|P2|Period I|Adverse Event|0
2985689|NCT01049412|10272692|P1|Period I|Adverse Event|1
2985690|NCT01049412|10272691|P2|Period I|Protocol Violation|2
2985691|NCT01049412|10272692|P1|Period I|Protocol Violation|1
2985692|NCT01049412|10272691|P2|Period I|Physician Decision|3
2985693|NCT01049412|10272692|P1|Period I|Physician Decision|0
2985694|NCT01049412|10272691|P2|Period I|Lost to Follow-up|2
2985695|NCT01049412|10272692|P1|Period I|Lost to Follow-up|2
2985696|NCT01049412|10272691|P2|Period I|Withdrawal by Subject|6
2985697|NCT01049412|10272692|P1|Period I|Withdrawal by Subject|4
2985698|NCT01049373|10272721|P2|Overall Study|Non-cooperation|1
2985699|NCT01049373|10272722|P1|Overall Study|Non-cooperation|0
2985700|NCT01049373|10272721|P2|Overall Study|Other|1
2985701|NCT01049373|10272722|P1|Overall Study|Other|1
2985702|NCT01049373|10272721|P2|Overall Study|no evaluable study values|21
2985703|NCT01049373|10272722|P1|Overall Study|no evaluable study values|9
2985704|NCT01049373|10272721|P2|Overall Study|Lost to Follow-up|4
2985705|NCT01049373|10272722|P1|Overall Study|Lost to Follow-up|9
2985706|NCT01049373|10272721|P2|Overall Study|Adverse Event|3
2985707|NCT01049373|10272722|P1|Overall Study|Adverse Event|3
2985708|NCT01049373|10272721|P2|Overall Study|Withdrawal by Subject|5
2985709|NCT01049373|10272722|P1|Overall Study|Withdrawal by Subject|8
2985710|NCT01049373|10272721|P2|Overall Study|Protocol Violation|9
2985711|NCT01049373|10272722|P1|Overall Study|Protocol Violation|9
2985712|NCT01049360|10272736|P20|Period 4|Withdrawal by Subject|0
2985713|NCT01049360|10272737|P19|Period 4|Withdrawal by Subject|0
2985714|NCT01049360|10272738|P18|Period 4|Withdrawal by Subject|0
2985715|NCT01049360|10272739|P17|Period 4|Withdrawal by Subject|0
2985716|NCT01049360|10272740|P16|Period 4|Withdrawal by Subject|0
2985717|NCT01049360|10272741|P15|Period 4|Withdrawal by Subject|0
2985718|NCT01049360|10272742|P14|Period 4|Withdrawal by Subject|0
2985719|NCT01049360|10272743|P13|Period 4|Withdrawal by Subject|0
2985720|NCT01049360|10272744|P12|Period 4|Withdrawal by Subject|0
2985721|NCT01049360|10272745|P11|Period 4|Withdrawal by Subject|0
2985722|NCT01049360|10272746|P10|Period 4|Withdrawal by Subject|0
2985723|NCT01049360|10272747|P9|Period 4|Withdrawal by Subject|0
2985724|NCT01049360|10272748|P8|Period 4|Withdrawal by Subject|0
2985725|NCT01049360|10272749|P7|Period 4|Withdrawal by Subject|0
2985726|NCT01049360|10272750|P6|Period 4|Withdrawal by Subject|0
2985727|NCT01049360|10272751|P5|Period 4|Withdrawal by Subject|0
2985728|NCT01049360|10272752|P4|Period 4|Withdrawal by Subject|1
2985729|NCT01049360|10272753|P3|Period 4|Withdrawal by Subject|0
2985730|NCT01049360|10272754|P2|Period 4|Withdrawal by Subject|0
2985731|NCT01049360|10272755|P1|Period 4|Withdrawal by Subject|0
2985732|NCT01049360|10272736|P20|Period 4|Protocol Violation|0
2985733|NCT01049360|10272737|P19|Period 4|Protocol Violation|0
2985734|NCT01049360|10272738|P18|Period 4|Protocol Violation|1
2985735|NCT01049360|10272739|P17|Period 4|Protocol Violation|0
2985736|NCT01049360|10272740|P16|Period 4|Protocol Violation|0
2985737|NCT01049360|10272741|P15|Period 4|Protocol Violation|0
2985738|NCT01049360|10272742|P14|Period 4|Protocol Violation|0
2985739|NCT01049360|10272743|P13|Period 4|Protocol Violation|0
2985740|NCT01049360|10272744|P12|Period 4|Protocol Violation|0
2985741|NCT01049360|10272745|P11|Period 4|Protocol Violation|0
2985742|NCT01049360|10272746|P10|Period 4|Protocol Violation|0
2985743|NCT01049360|10272747|P9|Period 4|Protocol Violation|0
2985744|NCT01049360|10272748|P8|Period 4|Protocol Violation|0
2985745|NCT01049360|10272749|P7|Period 4|Protocol Violation|0
2985746|NCT01049360|10272750|P6|Period 4|Protocol Violation|0
2985747|NCT01049360|10272751|P5|Period 4|Protocol Violation|0
2985748|NCT01049360|10272752|P4|Period 4|Protocol Violation|0
2985749|NCT01049360|10272753|P3|Period 4|Protocol Violation|0
2985750|NCT01049360|10272754|P2|Period 4|Protocol Violation|0
2985751|NCT01049360|10272755|P1|Period 4|Protocol Violation|0
2985752|NCT01049360|10272736|P20|Period 2|Lack of Efficacy|0
2985753|NCT01049360|10272737|P19|Period 2|Lack of Efficacy|0
2985754|NCT01049360|10272738|P18|Period 2|Lack of Efficacy|0
2985755|NCT01049360|10272739|P17|Period 2|Lack of Efficacy|0
2985756|NCT01049360|10272740|P16|Period 2|Lack of Efficacy|0
2985757|NCT01049360|10272741|P15|Period 2|Lack of Efficacy|0
2985758|NCT01049360|10272742|P14|Period 2|Lack of Efficacy|0
2985759|NCT01049360|10272743|P13|Period 2|Lack of Efficacy|0
2985760|NCT01049360|10272744|P12|Period 2|Lack of Efficacy|0
2985761|NCT01049360|10272745|P11|Period 2|Lack of Efficacy|0
2985762|NCT01049360|10272746|P10|Period 2|Lack of Efficacy|0
2985763|NCT01049360|10272747|P9|Period 2|Lack of Efficacy|0
2985764|NCT01049360|10272748|P8|Period 2|Lack of Efficacy|0
2985765|NCT01049360|10272749|P7|Period 2|Lack of Efficacy|0
2985766|NCT01049360|10272750|P6|Period 2|Lack of Efficacy|1
2985767|NCT01049360|10272751|P5|Period 2|Lack of Efficacy|0
2985768|NCT01049360|10272752|P4|Period 2|Lack of Efficacy|0
2985769|NCT01049360|10272753|P3|Period 2|Lack of Efficacy|0
2985770|NCT01049360|10272754|P2|Period 2|Lack of Efficacy|0
2985771|NCT01049360|10272755|P1|Period 2|Lack of Efficacy|0
2985772|NCT01049360|10272736|P20|Period 2|Withdrawal by Subject|1
2985773|NCT01049360|10272737|P19|Period 2|Withdrawal by Subject|0
2985774|NCT01049360|10272738|P18|Period 2|Withdrawal by Subject|0
2985775|NCT01049360|10272739|P17|Period 2|Withdrawal by Subject|0
2985776|NCT01049360|10272740|P16|Period 2|Withdrawal by Subject|0
2985777|NCT01049360|10272741|P15|Period 2|Withdrawal by Subject|1
2985778|NCT01049360|10272742|P14|Period 2|Withdrawal by Subject|0
2985779|NCT01049360|10272743|P13|Period 2|Withdrawal by Subject|0
2985780|NCT01049360|10272744|P12|Period 2|Withdrawal by Subject|0
2985781|NCT01049360|10272745|P11|Period 2|Withdrawal by Subject|0
2985782|NCT01049360|10272746|P10|Period 2|Withdrawal by Subject|0
2985783|NCT01049360|10272747|P9|Period 2|Withdrawal by Subject|0
2985784|NCT01049360|10272748|P8|Period 2|Withdrawal by Subject|0
2985785|NCT01049360|10272749|P7|Period 2|Withdrawal by Subject|0
2985786|NCT01049360|10272750|P6|Period 2|Withdrawal by Subject|0
2985787|NCT01049360|10272751|P5|Period 2|Withdrawal by Subject|0
2985788|NCT01049360|10272752|P4|Period 2|Withdrawal by Subject|1
2985789|NCT01049360|10272753|P3|Period 2|Withdrawal by Subject|0
2985790|NCT01049360|10272754|P2|Period 2|Withdrawal by Subject|0
2985791|NCT01049360|10272755|P1|Period 2|Withdrawal by Subject|0
2985792|NCT01049360|10272736|P20|Period 2|Adverse Event|1
2985793|NCT01049360|10272737|P19|Period 2|Adverse Event|0
2985794|NCT01049360|10272738|P18|Period 2|Adverse Event|0
2985795|NCT01049360|10272739|P17|Period 2|Adverse Event|0
2985796|NCT01049360|10272740|P16|Period 2|Adverse Event|0
2985797|NCT01049360|10272741|P15|Period 2|Adverse Event|0
2985798|NCT01049360|10272742|P14|Period 2|Adverse Event|0
2985799|NCT01049360|10272743|P13|Period 2|Adverse Event|0
2985800|NCT01049360|10272744|P12|Period 2|Adverse Event|0
2985801|NCT01049360|10272745|P11|Period 2|Adverse Event|0
2985802|NCT01049360|10272746|P10|Period 2|Adverse Event|0
2985803|NCT01049360|10272747|P9|Period 2|Adverse Event|1
2985804|NCT01049360|10272748|P8|Period 2|Adverse Event|0
2985805|NCT01049360|10272749|P7|Period 2|Adverse Event|0
2985806|NCT01049360|10272750|P6|Period 2|Adverse Event|0
2985807|NCT01049360|10272751|P5|Period 2|Adverse Event|0
2985808|NCT01049360|10272752|P4|Period 2|Adverse Event|0
2985809|NCT01049360|10272753|P3|Period 2|Adverse Event|0
2985810|NCT01049360|10272754|P2|Period 2|Adverse Event|1
2985811|NCT01049360|10272755|P1|Period 2|Adverse Event|0
2985812|NCT01049360|10272736|P20|Period 2|Protocol Violation|0
2985813|NCT01049360|10272737|P19|Period 2|Protocol Violation|0
2985814|NCT01049360|10272738|P18|Period 2|Protocol Violation|0
2985815|NCT01049360|10272739|P17|Period 2|Protocol Violation|0
2985816|NCT01049360|10272740|P16|Period 2|Protocol Violation|1
2985817|NCT01049360|10272741|P15|Period 2|Protocol Violation|1
2985818|NCT01049360|10272742|P14|Period 2|Protocol Violation|0
2985819|NCT01049360|10272743|P13|Period 2|Protocol Violation|0
2985820|NCT01049360|10272744|P12|Period 2|Protocol Violation|0
2985821|NCT01049360|10272745|P11|Period 2|Protocol Violation|0
2985822|NCT01049360|10272746|P10|Period 2|Protocol Violation|0
2985823|NCT01049360|10272747|P9|Period 2|Protocol Violation|0
2985824|NCT01049360|10272748|P8|Period 2|Protocol Violation|0
2985825|NCT01049360|10272749|P7|Period 2|Protocol Violation|0
2985826|NCT01049360|10272750|P6|Period 2|Protocol Violation|0
2985827|NCT01049360|10272751|P5|Period 2|Protocol Violation|0
2985828|NCT01049360|10272752|P4|Period 2|Protocol Violation|1
2985829|NCT01049360|10272753|P3|Period 2|Protocol Violation|0
2985830|NCT01049360|10272754|P2|Period 2|Protocol Violation|0
2985831|NCT01049360|10272755|P1|Period 2|Protocol Violation|0
2985832|NCT01049360|10272736|P20|Period 1|Withdrawal by Subject|0
2985833|NCT01049360|10272737|P19|Period 1|Withdrawal by Subject|0
2985834|NCT01049360|10272738|P18|Period 1|Withdrawal by Subject|0
2985835|NCT01049360|10272739|P17|Period 1|Withdrawal by Subject|0
2985836|NCT01049360|10272740|P16|Period 1|Withdrawal by Subject|0
2985837|NCT01049360|10272741|P15|Period 1|Withdrawal by Subject|0
2985838|NCT01049360|10272742|P14|Period 1|Withdrawal by Subject|0
2985839|NCT01049360|10272743|P13|Period 1|Withdrawal by Subject|1
2985840|NCT01049360|10272744|P12|Period 1|Withdrawal by Subject|0
2985841|NCT01049360|10272745|P11|Period 1|Withdrawal by Subject|1
2985842|NCT01049360|10272746|P10|Period 1|Withdrawal by Subject|0
2985843|NCT01049360|10272747|P9|Period 1|Withdrawal by Subject|1
2985844|NCT01049360|10272748|P8|Period 1|Withdrawal by Subject|0
2985845|NCT01049360|10272749|P7|Period 1|Withdrawal by Subject|0
2985846|NCT01049360|10272750|P6|Period 1|Withdrawal by Subject|0
2985847|NCT01049360|10272751|P5|Period 1|Withdrawal by Subject|0
2985848|NCT01049360|10272752|P4|Period 1|Withdrawal by Subject|0
2985849|NCT01049360|10272753|P3|Period 1|Withdrawal by Subject|0
2985850|NCT01049360|10272754|P2|Period 1|Withdrawal by Subject|0
2985851|NCT01049360|10272755|P1|Period 1|Withdrawal by Subject|0
2985852|NCT01049360|10272736|P20|Period 1|Did not meet inc/exc criteria|0
2985853|NCT01049360|10272737|P19|Period 1|Did not meet inc/exc criteria|0
2985854|NCT01049360|10272738|P18|Period 1|Did not meet inc/exc criteria|0
2985855|NCT01049360|10272739|P17|Period 1|Did not meet inc/exc criteria|0
2985856|NCT01049360|10272740|P16|Period 1|Did not meet inc/exc criteria|0
2985857|NCT01049360|10272741|P15|Period 1|Did not meet inc/exc criteria|0
2985858|NCT01049360|10272742|P14|Period 1|Did not meet inc/exc criteria|0
2985859|NCT01049360|10272743|P13|Period 1|Did not meet inc/exc criteria|0
2985860|NCT01049360|10272744|P12|Period 1|Did not meet inc/exc criteria|0
2985861|NCT01049360|10272745|P11|Period 1|Did not meet inc/exc criteria|0
2985862|NCT01049360|10272746|P10|Period 1|Did not meet inc/exc criteria|0
2985863|NCT01049360|10272747|P9|Period 1|Did not meet inc/exc criteria|1
2985864|NCT01049360|10272748|P8|Period 1|Did not meet inc/exc criteria|1
2985865|NCT01049360|10272749|P7|Period 1|Did not meet inc/exc criteria|0
2985866|NCT01049360|10272750|P6|Period 1|Did not meet inc/exc criteria|0
2985867|NCT01049360|10272751|P5|Period 1|Did not meet inc/exc criteria|0
2985868|NCT01049360|10272752|P4|Period 1|Did not meet inc/exc criteria|0
2985869|NCT01049360|10272753|P3|Period 1|Did not meet inc/exc criteria|0
2985870|NCT01049360|10272754|P2|Period 1|Did not meet inc/exc criteria|0
2985871|NCT01049360|10272755|P1|Period 1|Did not meet inc/exc criteria|0
2985872|NCT01049360|10272736|P20|Period 1|Adverse Event|0
2985873|NCT01049360|10272737|P19|Period 1|Adverse Event|1
2985874|NCT01049360|10272738|P18|Period 1|Adverse Event|0
2985875|NCT01049360|10272739|P17|Period 1|Adverse Event|1
2985876|NCT01049360|10272740|P16|Period 1|Adverse Event|0
2985877|NCT01049360|10272741|P15|Period 1|Adverse Event|0
2985878|NCT01049360|10272742|P14|Period 1|Adverse Event|1
2985879|NCT01049360|10272743|P13|Period 1|Adverse Event|1
2985880|NCT01049360|10272744|P12|Period 1|Adverse Event|0
2985881|NCT01049360|10272745|P11|Period 1|Adverse Event|0
2985882|NCT01049360|10272746|P10|Period 1|Adverse Event|0
2985883|NCT01049360|10272747|P9|Period 1|Adverse Event|0
2985884|NCT01049360|10272748|P8|Period 1|Adverse Event|1
2985885|NCT01049360|10272749|P7|Period 1|Adverse Event|0
2985886|NCT01049360|10272750|P6|Period 1|Adverse Event|0
2985887|NCT01049360|10272751|P5|Period 1|Adverse Event|0
2985888|NCT01049360|10272752|P4|Period 1|Adverse Event|1
2985889|NCT01049360|10272753|P3|Period 1|Adverse Event|0
2985890|NCT01049360|10272754|P2|Period 1|Adverse Event|1
2985891|NCT01049360|10272755|P1|Period 1|Adverse Event|0
2985892|NCT01049334|10272779|P2|Overall Study|Protocol Violation|1
2985893|NCT01049334|10272780|P1|Overall Study|Protocol Violation|0
2985894|NCT01049334|10272779|P2|Overall Study|Physician Decision|0
2985895|NCT01049334|10272780|P1|Overall Study|Physician Decision|2
2985896|NCT01049334|10272779|P2|Overall Study|Adverse Event|3
2985897|NCT01049334|10272780|P1|Overall Study|Adverse Event|2
2985898|NCT01049334|10272779|P2|Overall Study|Withdrawal by Subject|3
2985899|NCT01049334|10272780|P1|Overall Study|Withdrawal by Subject|5
2985900|NCT01049308|10272816|P1|Pill Counts|Withdrawal by Subject|83
2985901|NCT01049217|10272830|P2|Overall Study|Randomized but not Treated|2
2985902|NCT01049217|10272831|P1|Overall Study|Randomized but not Treated|0
2985903|NCT01049217|10272830|P2|Overall Study|Other|2
2985904|NCT01049217|10272831|P1|Overall Study|Other|1
2985905|NCT01049217|10272830|P2|Overall Study|Study Terminated by Sponsor|43
2985906|NCT01049217|10272831|P1|Overall Study|Study Terminated by Sponsor|43
2985907|NCT01049217|10272830|P2|Overall Study|Pregnancy|0
2985908|NCT01049217|10272831|P1|Overall Study|Pregnancy|1
2985909|NCT01049217|10272830|P2|Overall Study|Protocol Violation|3
2985910|NCT01049217|10272831|P1|Overall Study|Protocol Violation|1
2985911|NCT01049217|10272830|P2|Overall Study|Withdrawal by Subject|3
2985912|NCT01049217|10272831|P1|Overall Study|Withdrawal by Subject|4
2985913|NCT01049217|10272830|P2|Overall Study|Lost to Follow-up|8
2985914|NCT01049217|10272831|P1|Overall Study|Lost to Follow-up|3
2985915|NCT01049217|10272830|P2|Overall Study|Lack of Efficacy|1
2985916|NCT01049217|10272831|P1|Overall Study|Lack of Efficacy|1
2985917|NCT01049217|10272830|P2|Overall Study|Adverse Event|1
2985918|NCT01049217|10272831|P1|Overall Study|Adverse Event|2
2985919|NCT01049009|10272903|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
2985920|NCT01049009|10272904|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
2985921|NCT01049009|10272903|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
2985922|NCT01049009|10272904|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2985923|NCT01049009|10272903|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2985924|NCT01049009|10272904|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2985925|NCT01049009|10272903|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2985926|NCT01049009|10272904|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2985927|NCT01048944|10272916|P4|Overall Study|Protocol Violation|2
2985928|NCT01048944|10272917|P3|Overall Study|Protocol Violation|10
2985929|NCT01048944|10272918|P2|Overall Study|Protocol Violation|10
2985930|NCT01048944|10272919|P1|Overall Study|Protocol Violation|8
2985931|NCT01048866|10272951|P2|Overall Study|Other|1
2985932|NCT01048866|10272952|P1|Overall Study|Other|1
2985933|NCT01048866|10272951|P2|Overall Study|Lost to Follow-up|2
2985934|NCT01048866|10272952|P1|Overall Study|Lost to Follow-up|0
2985935|NCT01048866|10272951|P2|Overall Study|Withdrawal by Subject|2
2985936|NCT01048866|10272952|P1|Overall Study|Withdrawal by Subject|0
2985937|NCT01048866|10272951|P2|Overall Study|Physician Decision|0
2985938|NCT01048866|10272952|P1|Overall Study|Physician Decision|1
2985939|NCT01048866|10272951|P2|Overall Study|Protocol Violation|0
2985940|NCT01048866|10272952|P1|Overall Study|Protocol Violation|1
2985941|NCT01048866|10272951|P2|Overall Study|Adverse Event|0
2985942|NCT01048866|10272952|P1|Overall Study|Adverse Event|1
2985943|NCT01048788|10272997|P3|Overall Study|Withdrawal by Subject|0
2985944|NCT01048788|10272998|P2|Overall Study|Withdrawal by Subject|1
2985945|NCT01048788|10272999|P1|Overall Study|Withdrawal by Subject|0
2985946|NCT01048788|10272997|P3|Overall Study|Lack of Efficacy|1
2985947|NCT01048788|10272998|P2|Overall Study|Lack of Efficacy|0
2985948|NCT01048788|10272999|P1|Overall Study|Lack of Efficacy|0
2985949|NCT01048788|10272997|P3|Overall Study|Adverse Event|1
2985950|NCT01048788|10272998|P2|Overall Study|Adverse Event|1
2985951|NCT01048788|10272999|P1|Overall Study|Adverse Event|5
2985952|NCT01048671|10273021|P3|Overall Study|Protocol Violation|1
2985953|NCT01048671|10273022|P2|Overall Study|Protocol Violation|1
2985954|NCT01048671|10273023|P1|Overall Study|Protocol Violation|0
2985955|NCT01048541|10273103|P2|Overall Study|Withdrawal by Subject|0
2985956|NCT01048541|10273104|P1|Overall Study|Withdrawal by Subject|1
2985957|NCT01048502|10273114|P4|Overall Study|Physician Decision|1
2985958|NCT01048502|10273115|P3|Overall Study|Physician Decision|0
2985959|NCT01048502|10273116|P2|Overall Study|Physician Decision|3
2985960|NCT01048502|10273117|P1|Overall Study|Physician Decision|0
2985961|NCT01048502|10273114|P4|Overall Study|Withdrawal by Subject|3
2985962|NCT01048502|10273115|P3|Overall Study|Withdrawal by Subject|5
2985963|NCT01048502|10273116|P2|Overall Study|Withdrawal by Subject|4
2985964|NCT01048502|10273117|P1|Overall Study|Withdrawal by Subject|1
2985965|NCT01048502|10273114|P4|Overall Study|Adverse Event|0
2985966|NCT01048502|10273115|P3|Overall Study|Adverse Event|0
2985967|NCT01048502|10273116|P2|Overall Study|Adverse Event|0
2985968|NCT01048502|10273117|P1|Overall Study|Adverse Event|1
2985969|NCT01048502|10273114|P4|Overall Study|Lost to Follow-up|0
2985970|NCT01048502|10273115|P3|Overall Study|Lost to Follow-up|0
2985971|NCT01048502|10273116|P2|Overall Study|Lost to Follow-up|0
2985972|NCT01048502|10273117|P1|Overall Study|Lost to Follow-up|2
2985973|NCT01048333|10273153|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2985974|NCT01048333|10273154|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2985975|NCT01048333|10273155|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2985976|NCT01048333|10273156|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2985977|NCT01048333|10273157|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
2985978|NCT01048333|10273158|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2985979|NCT01048242|10273180|P2|Overall Study|See study flow chart|2
2985980|NCT01048242|10273181|P1|Overall Study|See study flow chart|4
2985981|NCT01048099|10273196|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
2985982|NCT01048099|10273196|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
2985983|NCT01047553|10273226|P2|Overall Study|PI's decision|1
2985984|NCT01047553|10273227|P1|Overall Study|PI's decision|0
2985985|NCT01047553|10273226|P2|Overall Study|Sever Non-Compliance to Protocol|0
2985986|NCT01047553|10273227|P1|Overall Study|Sever Non-Compliance to Protocol|1
2985987|NCT01047553|10273226|P2|Overall Study|Lost to Follow-up|0
2985988|NCT01047553|10273227|P1|Overall Study|Lost to Follow-up|1
2985989|NCT01047553|10273226|P2|Overall Study|Development of Study-Specific Withdrawal|1
2985990|NCT01047553|10273227|P1|Overall Study|Development of Study-Specific Withdrawal|1
2985991|NCT01047553|10273226|P2|Overall Study|Withdrawal by Subject|2
2985992|NCT01047553|10273227|P1|Overall Study|Withdrawal by Subject|4
2985993|NCT01047553|10273226|P2|Overall Study|Adverse Event|5
2985994|NCT01047553|10273227|P1|Overall Study|Adverse Event|10
2985995|NCT01047436|10273334|P2|Overall Study|Protocol Violation|0
2985996|NCT01047436|10273335|P1|Overall Study|Protocol Violation|1
2985997|NCT01047345|10273360|P3|Extension|Lost to Follow-up|5
2985998|NCT01047345|10273361|P2|Extension|Lost to Follow-up|0
2985999|NCT01047345|10273362|P1|Extension|Lost to Follow-up|0
2986000|NCT01047345|10273360|P3|Extension|Withdrawal by Subject|1
2986001|NCT01047345|10273361|P2|Extension|Withdrawal by Subject|0
2986002|NCT01047345|10273362|P1|Extension|Withdrawal by Subject|0
2986003|NCT01047345|10273360|P3|Base Study|Withdrawal by Subject|0
2986004|NCT01047345|10273361|P2|Base Study|Withdrawal by Subject|4
2986005|NCT01047345|10273362|P1|Base Study|Withdrawal by Subject|12
2986006|NCT01047345|10273360|P3|Base Study|Protocol Violation|0
2986007|NCT01047345|10273361|P2|Base Study|Protocol Violation|1
2986008|NCT01047345|10273362|P1|Base Study|Protocol Violation|3
2986009|NCT01047345|10273360|P3|Base Study|Lost to Follow-up|0
2986010|NCT01047345|10273361|P2|Base Study|Lost to Follow-up|1
2986011|NCT01047345|10273362|P1|Base Study|Lost to Follow-up|4
2986012|NCT01047345|10273360|P3|Base Study|Adverse Event|0
2986013|NCT01047345|10273361|P2|Base Study|Adverse Event|0
2986014|NCT01047345|10273362|P1|Base Study|Adverse Event|3
2986015|NCT01047332|10273384|P2|Overall Study|Lost to Follow-up|3
2986016|NCT01047332|10273385|P1|Overall Study|Lost to Follow-up|8
2986017|NCT01047332|10273384|P2|Overall Study|Died Unobstructed|41
2986018|NCT01047332|10273385|P1|Overall Study|Died Unobstructed|38
2986019|NCT01047332|10273384|P2|Overall Study|SEMS Obstruction|20
2986020|NCT01047332|10273385|P1|Overall Study|SEMS Obstruction|11
2986021|NCT01047319|10273400|P3|Overall Study|Study terminated by Sponsor|203
2986022|NCT01047319|10273401|P2|Overall Study|Study terminated by Sponsor|215
2986023|NCT01047319|10273402|P1|Overall Study|Study terminated by Sponsor|198
2986024|NCT01047319|10273400|P3|Overall Study|Withdrawal by Subject|87
2986025|NCT01047319|10273401|P2|Overall Study|Withdrawal by Subject|75
2986026|NCT01047319|10273402|P1|Overall Study|Withdrawal by Subject|77
2986027|NCT01047319|10273400|P3|Overall Study|Adverse Event|21
2986028|NCT01047319|10273401|P2|Overall Study|Adverse Event|27
2986029|NCT01047319|10273402|P1|Overall Study|Adverse Event|16
2986030|NCT01047319|10273400|P3|Overall Study|Lost to Follow-up|10
2986031|NCT01047319|10273401|P2|Overall Study|Lost to Follow-up|10
2986032|NCT01047319|10273402|P1|Overall Study|Lost to Follow-up|14
2986033|NCT01047319|10273400|P3|Overall Study|Physician Decision|10
2986034|NCT01047319|10273401|P2|Overall Study|Physician Decision|9
2986035|NCT01047319|10273402|P1|Overall Study|Physician Decision|12
2986036|NCT01047319|10273400|P3|Overall Study|Pregnancy|8
2986037|NCT01047319|10273401|P2|Overall Study|Pregnancy|8
2986038|NCT01047319|10273402|P1|Overall Study|Pregnancy|13
2986039|NCT01047319|10273400|P3|Overall Study|Death|5
2986040|NCT01047319|10273401|P2|Overall Study|Death|1
2986041|NCT01047319|10273402|P1|Overall Study|Death|5
2986042|NCT01047319|10273400|P3|Overall Study|Lack of Efficacy|3
2986043|NCT01047319|10273401|P2|Overall Study|Lack of Efficacy|3
2986044|NCT01047319|10273402|P1|Overall Study|Lack of Efficacy|4
2986045|NCT01047319|10273400|P3|Overall Study|Protocol Violation|4
2986046|NCT01047319|10273401|P2|Overall Study|Protocol Violation|2
2986047|NCT01047319|10273402|P1|Overall Study|Protocol Violation|3
2986048|NCT01047319|10273400|P3|Overall Study|Teva requested participant withdrawal|1
2986049|NCT01047319|10273401|P2|Overall Study|Teva requested participant withdrawal|0
2986050|NCT01047319|10273402|P1|Overall Study|Teva requested participant withdrawal|3
2986051|NCT01047306|10273424|P2|Overall Study|Lost to Follow-up|0
2986052|NCT01047306|10273425|P1|Overall Study|Lost to Follow-up|1
2986053|NCT01047306|10273424|P2|Overall Study|Withdrawal by Subject|0
2986054|NCT01047306|10273425|P1|Overall Study|Withdrawal by Subject|2
2986055|NCT01047293|10273499|P4|Overall Study|DLT criteria not fulfilled|0
2986056|NCT01047293|10273500|P3|Overall Study|DLT criteria not fulfilled|0
2986057|NCT01047293|10273501|P2|Overall Study|DLT criteria not fulfilled|1
2986058|NCT01047293|10273502|P1|Overall Study|DLT criteria not fulfilled|1
2986059|NCT01047007|10273533|P4|Overall Study|Progressive Disease|0
2986060|NCT01047007|10273534|P3|Overall Study|Progressive Disease|1
2986061|NCT01047007|10273535|P2|Overall Study|Progressive Disease|4
2986062|NCT01047007|10273536|P1|Overall Study|Progressive Disease|2
2986063|NCT01047007|10273533|P4|Overall Study|Adverse Event|0
2986064|NCT01047007|10273534|P3|Overall Study|Adverse Event|1
2986065|NCT01047007|10273535|P2|Overall Study|Adverse Event|2
2986066|NCT01047007|10273536|P1|Overall Study|Adverse Event|0
2986067|NCT01046903|10273547|P1|Overall Study|Other|5
2986068|NCT01046903|10273547|P1|Overall Study|Withdrawal by Subject|3
2986069|NCT01046903|10273547|P1|Overall Study|Adverse Event|4
2986070|NCT01046903|10273547|P1|Overall Study|Lost to Follow-up|16
2986071|NCT01046877|10273560|P1|Overall Study|Exited voluntarily after tube extrusion|11
2986072|NCT01046877|10273560|P1|Overall Study|Exited voluntarily before tube extrusion|7
2986073|NCT01046695|10273576|P2|Overall Study|TENS interfered with the cardiac monitor|1
2986074|NCT01046695|10273577|P1|Overall Study|TENS interfered with the cardiac monitor|0
2986075|NCT01046695|10273576|P2|Overall Study|Subject had a pacemaker|1
2986076|NCT01046695|10273577|P1|Overall Study|Subject had a pacemaker|0
2986077|NCT01046682|10273589|P2|Overall Study|Adverse Event|0
2986078|NCT01046682|10273590|P1|Overall Study|Adverse Event|2
2986079|NCT01046643|10273607|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
2986080|NCT01046643|10273608|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
2986081|NCT01046643|10273609|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
2986082|NCT01046643|10273610|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
2986083|NCT01046565|10273632|P1|Overall Study|Withdrawal by Subject|7
2986084|NCT01046565|10273632|P1|Overall Study|Adverse Event|2
2986085|NCT01046396|10273641|P1|Overall Study|Withdrawal by Subject|5
2986086|NCT01046253|10273652|P2|Second Intervention|Protocol Violation|1
2986087|NCT01046253|10273653|P1|Second Intervention|Protocol Violation|0
2986088|NCT01046253|10273652|P2|Second Intervention|Adverse Event|1
2986089|NCT01046253|10273653|P1|Second Intervention|Adverse Event|0
2986090|NCT01046136|10273665|P2|Overall Study|Lost to Follow-up|3
2986091|NCT01046136|10273666|P1|Overall Study|Lost to Follow-up|3
2986092|NCT01046136|10273665|P2|Overall Study|Physician Decision|1
2986093|NCT01046136|10273666|P1|Overall Study|Physician Decision|1
2986094|NCT01046136|10273665|P2|Overall Study|Withdrawal by Subject|4
2986095|NCT01046136|10273666|P1|Overall Study|Withdrawal by Subject|0
2986096|NCT01046110|10273678|P2|Overall Study|Unclassified|35
2986097|NCT01046110|10273679|P1|Overall Study|Unclassified|36
2986098|NCT01046110|10273678|P2|Overall Study|Withdrawal Criteria|5
2986099|NCT01046110|10273679|P1|Overall Study|Withdrawal Criteria|3
2986100|NCT01046110|10273678|P2|Overall Study|Protocol Violation|12
2986101|NCT01046110|10273679|P1|Overall Study|Protocol Violation|7
2986102|NCT01046110|10273678|P2|Overall Study|Lack of Efficacy|1
2986103|NCT01046110|10273679|P1|Overall Study|Lack of Efficacy|0
2986104|NCT01046110|10273678|P2|Overall Study|Adverse Event|2
2986105|NCT01046110|10273679|P1|Overall Study|Adverse Event|9
2986106|NCT01046084|10273689|P2|Third Washout of 7 Days|Withdrawal by Subject|0
2986107|NCT01046084|10273690|P1|Third Washout of 7 Days|Withdrawal by Subject|2
2986108|NCT01045993|10273704|P4|Overall Study|Treated-later found eligibility not met|0
2986109|NCT01045993|10273705|P3|Overall Study|Treated-later found eligibility not met|0
2986110|NCT01045993|10273706|P2|Overall Study|Treated-later found eligibility not met|1
2986111|NCT01045993|10273707|P1|Overall Study|Treated-later found eligibility not met|0
2986112|NCT01045967|10273783|P2|Second Intervention|Protocol Violation|1
2986113|NCT01045967|10273784|P1|Second Intervention|Protocol Violation|0
2986114|NCT01045798|10273796|P2|Overall Study|Received Systemic Antifungal Prestudy|1
2986115|NCT01045798|10273797|P1|Overall Study|Received Systemic Antifungal Prestudy|0
2986116|NCT01045798|10273796|P2|Overall Study|Changed to Other Antifungal Therapy|2
2986117|NCT01045798|10273797|P1|Overall Study|Changed to Other Antifungal Therapy|1
2986118|NCT01045798|10273796|P2|Overall Study|Invasive Fungal Infection at Baseline|1
2986119|NCT01045798|10273797|P1|Overall Study|Invasive Fungal Infection at Baseline|0
2986120|NCT01045798|10273796|P2|Overall Study|Changed to Open-Label Caspofungin|0
2986121|NCT01045798|10273797|P1|Overall Study|Changed to Open-Label Caspofungin|1
2986122|NCT01045707|10273805|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
2986123|NCT01045707|10273806|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
2986124|NCT01045707|10273805|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
2986125|NCT01045707|10273806|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
2986126|NCT01045707|10273805|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
2986127|NCT01045707|10273806|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
2986128|NCT01045707|10273805|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2986129|NCT01045707|10273806|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2986130|NCT01045707|10273805|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
2986131|NCT01045707|10273806|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
2986132|NCT01045707|10273805|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
2986133|NCT01045707|10273806|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
2986134|NCT01045707|10273805|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
2986135|NCT01045707|10273806|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
2986136|NCT01045707|10273805|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
2986137|NCT01045707|10273806|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
2986138|NCT01045707|10273805|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
2986139|NCT01045707|10273806|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
2986140|NCT01045694|10273822|P1|Overall Study|Withdrawal by Subject|2
2986141|NCT01045460|10273843|P2|Overall Study|Lack of Efficacy|0
2986142|NCT01045460|10273844|P1|Overall Study|Lack of Efficacy|3
2986143|NCT01045460|10273843|P2|Overall Study|Lost to Follow-up|1
2986144|NCT01045460|10273844|P1|Overall Study|Lost to Follow-up|0
2986145|NCT01045460|10273843|P2|Overall Study|Physician Decision|2
2986146|NCT01045460|10273844|P1|Overall Study|Physician Decision|3
2986147|NCT01045447|10273856|P2|Overall Study|Unclassified|13
2986148|NCT01045447|10273857|P1|Overall Study|Unclassified|17
2986149|NCT01045447|10273856|P2|Overall Study|Withdrawal Criteria|10
2986150|NCT01045447|10273857|P1|Overall Study|Withdrawal Criteria|10
2986151|NCT01045447|10273856|P2|Overall Study|Protocol Violation|3
2986152|NCT01045447|10273857|P1|Overall Study|Protocol Violation|6
2986153|NCT01045447|10273856|P2|Overall Study|Lack of Efficacy|1
2986154|NCT01045447|10273857|P1|Overall Study|Lack of Efficacy|3
2986155|NCT01045447|10273856|P2|Overall Study|Adverse Event|1
2986156|NCT01045447|10273857|P1|Overall Study|Adverse Event|0
2986157|NCT01045421|10273871|P11|Phase 2|Other|1
2986158|NCT01045421|10273872|P10|Phase 2|Other|0
2986159|NCT01045421|10273873|P9|Phase 2|Other|0
2986160|NCT01045421|10273874|P8|Phase 2|Other|3
2986161|NCT01045421|10273875|P7|Phase 2|Other|0
2986162|NCT01045421|10273876|P6|Phase 2|Other|0
2986163|NCT01045421|10273877|P5|Phase 2|Other|0
2986164|NCT01045421|10273878|P4|Phase 2|Other|0
2986165|NCT01045421|10273879|P3|Phase 2|Other|0
2986166|NCT01045421|10273880|P2|Phase 2|Other|0
2986167|NCT01045421|10273881|P1|Phase 2|Other|0
2986168|NCT01045421|10273871|P11|Phase 2|Death|0
2986169|NCT01045421|10273872|P10|Phase 2|Death|2
2986170|NCT01045421|10273873|P9|Phase 2|Death|1
2986171|NCT01045421|10273874|P8|Phase 2|Death|1
2986172|NCT01045421|10273875|P7|Phase 2|Death|0
2986173|NCT01045421|10273876|P6|Phase 2|Death|0
2986174|NCT01045421|10273877|P5|Phase 2|Death|0
2986175|NCT01045421|10273878|P4|Phase 2|Death|0
2986176|NCT01045421|10273879|P3|Phase 2|Death|0
2986177|NCT01045421|10273880|P2|Phase 2|Death|0
2986178|NCT01045421|10273881|P1|Phase 2|Death|0
2986179|NCT01045421|10273871|P11|Phase 2|Progressive Disease|1
2986180|NCT01045421|10273872|P10|Phase 2|Progressive Disease|1
2986181|NCT01045421|10273873|P9|Phase 2|Progressive Disease|1
2986182|NCT01045421|10273874|P8|Phase 2|Progressive Disease|1
2986183|NCT01045421|10273875|P7|Phase 2|Progressive Disease|0
2986184|NCT01045421|10273876|P6|Phase 2|Progressive Disease|0
2986185|NCT01045421|10273877|P5|Phase 2|Progressive Disease|0
2986186|NCT01045421|10273878|P4|Phase 2|Progressive Disease|0
2986187|NCT01045421|10273879|P3|Phase 2|Progressive Disease|0
2986188|NCT01045421|10273880|P2|Phase 2|Progressive Disease|0
2986189|NCT01045421|10273881|P1|Phase 2|Progressive Disease|0
2986190|NCT01045421|10273871|P11|Phase 1|Withdrawal by Subject|0
2986191|NCT01045421|10273872|P10|Phase 1|Withdrawal by Subject|0
2986192|NCT01045421|10273873|P9|Phase 1|Withdrawal by Subject|0
2986193|NCT01045421|10273874|P8|Phase 1|Withdrawal by Subject|0
2986194|NCT01045421|10273875|P7|Phase 1|Withdrawal by Subject|0
2986195|NCT01045421|10273876|P6|Phase 1|Withdrawal by Subject|0
2986196|NCT01045421|10273877|P5|Phase 1|Withdrawal by Subject|0
2986197|NCT01045421|10273878|P4|Phase 1|Withdrawal by Subject|1
2986198|NCT01045421|10273879|P3|Phase 1|Withdrawal by Subject|0
2986199|NCT01045421|10273880|P2|Phase 1|Withdrawal by Subject|0
2986200|NCT01045421|10273881|P1|Phase 1|Withdrawal by Subject|0
2986201|NCT01045421|10273871|P11|Phase 1|Progressive Disease|0
2986202|NCT01045421|10273872|P10|Phase 1|Progressive Disease|0
2986203|NCT01045421|10273873|P9|Phase 1|Progressive Disease|0
2986204|NCT01045421|10273874|P8|Phase 1|Progressive Disease|0
2986205|NCT01045421|10273875|P7|Phase 1|Progressive Disease|0
2986206|NCT01045421|10273876|P6|Phase 1|Progressive Disease|0
2986207|NCT01045421|10273877|P5|Phase 1|Progressive Disease|1
2986208|NCT01045421|10273878|P4|Phase 1|Progressive Disease|0
2986209|NCT01045421|10273879|P3|Phase 1|Progressive Disease|0
2986210|NCT01045421|10273880|P2|Phase 1|Progressive Disease|0
2986211|NCT01045421|10273881|P1|Phase 1|Progressive Disease|0
2986212|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
2986213|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
2986214|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
2986215|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2986216|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
2986217|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2986218|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
2986219|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
2986220|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
2986221|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2986222|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
2986223|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2986224|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2986225|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2986226|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
2986227|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
2986228|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2986229|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2986230|NCT01045161|10273975|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
2986231|NCT01045161|10273976|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
2986232|NCT01045161|10273977|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
2986233|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
2986234|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2986235|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2986236|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2986237|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
2986238|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2986239|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2986240|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2986241|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2986242|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
2986243|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
2986244|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
2986245|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
2986246|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
2986247|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
2986248|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
2986249|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
2986250|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
2986251|NCT01045161|10273975|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
2986252|NCT01045161|10273976|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
2986253|NCT01045161|10273977|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
2986254|NCT01045096|10274014|P3|Overall Study|Other|0
2986255|NCT01045096|10274015|P2|Overall Study|Other|0
2986256|NCT01045096|10274016|P1|Overall Study|Other|1
2986257|NCT01045096|10274014|P3|Overall Study|Withdrawal by Subject|0
2986258|NCT01045096|10274015|P2|Overall Study|Withdrawal by Subject|0
2986259|NCT01045096|10274016|P1|Overall Study|Withdrawal by Subject|2
2986260|NCT01044745|10274133|P1|Overall Study|Ineiligible|2
2986261|NCT01044732|10274142|P2|Overall Study|Technical error or malfunction|14
2986262|NCT01044732|10274143|P1|Overall Study|Technical error or malfunction|15
2986263|NCT01044732|10274142|P2|Overall Study|Inability to reach cecum|2
2986264|NCT01044732|10274143|P1|Overall Study|Inability to reach cecum|5
2986265|NCT01044732|10274142|P2|Overall Study|Inadequate bowel preparation|17
2986266|NCT01044732|10274143|P1|Overall Study|Inadequate bowel preparation|11
2986267|NCT01044732|10274142|P2|Overall Study|Withdrawal by Subject|1
2986268|NCT01044732|10274143|P1|Overall Study|Withdrawal by Subject|0
2986269|NCT01044732|10274142|P2|Overall Study|Protocol Violation|12
2986270|NCT01044732|10274143|P1|Overall Study|Protocol Violation|11
2986271|NCT01044732|10274142|P2|Overall Study|Physician Decision|3
2986272|NCT01044732|10274143|P1|Overall Study|Physician Decision|5
2986273|NCT01044732|10274142|P2|Overall Study|Lost to Follow-up|1
2986274|NCT01044732|10274143|P1|Overall Study|Lost to Follow-up|2
2986275|NCT01044498|10274332|P2|Overall Study|Other|0
2986276|NCT01044498|10274333|P1|Overall Study|Other|1
2986277|NCT01044498|10274332|P2|Overall Study|Adverse Event|1
2986278|NCT01044498|10274333|P1|Overall Study|Adverse Event|1
2986279|NCT01044498|10274332|P2|Overall Study|Withdrew consent|1
2986280|NCT01044498|10274333|P1|Overall Study|Withdrew consent|1
2986281|NCT01044459|10274359|P2|Overall Study|Lost to Follow-up|12
2986282|NCT01044459|10274360|P1|Overall Study|Lost to Follow-up|18
2986283|NCT01044459|10274359|P2|Overall Study|COPD exacerbation|8
2986284|NCT01044459|10274360|P1|Overall Study|COPD exacerbation|9
2986285|NCT01044459|10274359|P2|Overall Study|Other Reason|14
2986286|NCT01044459|10274360|P1|Overall Study|Other Reason|7
2986287|NCT01044459|10274359|P2|Overall Study|Protocol Violation|16
2986288|NCT01044459|10274360|P1|Overall Study|Protocol Violation|11
2986289|NCT01044459|10274359|P2|Overall Study|Lack of Efficacy|12
2986290|NCT01044459|10274360|P1|Overall Study|Lack of Efficacy|23
2986291|NCT01044459|10274359|P2|Overall Study|Adverse Event|20
2986292|NCT01044459|10274360|P1|Overall Study|Adverse Event|22
2986293|NCT01044459|10274359|P2|Overall Study|Terminated by Sponsor|21
2986294|NCT01044459|10274360|P1|Overall Study|Terminated by Sponsor|22
2986295|NCT01044459|10274359|P2|Overall Study|Withdrawal by Subject|28
2986296|NCT01044459|10274360|P1|Overall Study|Withdrawal by Subject|21
2986297|NCT01044433|10274368|P1|Overall Study|Withdrawal by Subject|3
2986298|NCT01044433|10274368|P1|Overall Study|Lost to Follow-up|3
2986299|NCT01044303|10274376|P1|Overall Study|Lost to Follow-up|2
2986300|NCT01044290|10274386|P3|Follow-Up 2|Withdrawal by Subject|1
2986301|NCT01044290|10274387|P2|Follow-Up 2|Withdrawal by Subject|1
2986302|NCT01044290|10274388|P1|Follow-Up 2|Withdrawal by Subject|0
2986303|NCT01044290|10274386|P3|Follow-Up 2|Death|1
2986304|NCT01044290|10274387|P2|Follow-Up 2|Death|1
2986305|NCT01044290|10274388|P1|Follow-Up 2|Death|0
2986306|NCT01044290|10274386|P3|Follow-up 1|Withdrawal by Subject|0
2986307|NCT01044290|10274387|P2|Follow-up 1|Withdrawal by Subject|2
2986308|NCT01044290|10274388|P1|Follow-up 1|Withdrawal by Subject|2
2986309|NCT01044290|10274386|P3|Follow-up 1|Death|1
2986310|NCT01044290|10274387|P2|Follow-up 1|Death|3
2986311|NCT01044290|10274388|P1|Follow-up 1|Death|3
2986312|NCT01043874|10274508|P1|Overall Study|Administrative Problems|1
2986313|NCT01043874|10274508|P1|Overall Study|Lack of Efficacy|1
2986314|NCT01043874|10274508|P1|Overall Study|Withdrawal by Subject|1
2986315|NCT01043874|10274508|P1|Overall Study|Adverse Event|3
2986316|NCT01043705|10274518|P3|Overall Study|Other|25
2986317|NCT01043705|10274519|P2|Overall Study|Other|19
2986318|NCT01043705|10274520|P1|Overall Study|Other|0
2986319|NCT01043705|10274518|P3|Overall Study|Screen Fail|0
2986320|NCT01043705|10274519|P2|Overall Study|Screen Fail|0
2986321|NCT01043705|10274520|P1|Overall Study|Screen Fail|21
2986322|NCT01043705|10274518|P3|Overall Study|Adverse Event|0
2986323|NCT01043705|10274519|P2|Overall Study|Adverse Event|2
2986324|NCT01043705|10274520|P1|Overall Study|Adverse Event|0
2986325|NCT01043705|10274518|P3|Overall Study|Subsequent Procedure|29
2986326|NCT01043705|10274519|P2|Overall Study|Subsequent Procedure|24
2986327|NCT01043705|10274520|P1|Overall Study|Subsequent Procedure|9
2986328|NCT01043705|10274518|P3|Overall Study|Site Closure|0
2986329|NCT01043705|10274519|P2|Overall Study|Site Closure|0
2986330|NCT01043705|10274520|P1|Overall Study|Site Closure|8
2986331|NCT01043705|10274518|P3|Overall Study|Withdrawal by Subject|0
2986332|NCT01043705|10274519|P2|Overall Study|Withdrawal by Subject|6
2986333|NCT01043705|10274520|P1|Overall Study|Withdrawal by Subject|8
2986334|NCT01043705|10274518|P3|Overall Study|Protocol Violation|0
2986335|NCT01043705|10274519|P2|Overall Study|Protocol Violation|1
2986336|NCT01043705|10274520|P1|Overall Study|Protocol Violation|2
2986337|NCT01043705|10274518|P3|Overall Study|Multiple Reasons|0
2986338|NCT01043705|10274519|P2|Overall Study|Multiple Reasons|7
2986339|NCT01043705|10274520|P1|Overall Study|Multiple Reasons|4
2986340|NCT01043705|10274518|P3|Overall Study|Lost to Follow-up|0
2986341|NCT01043705|10274519|P2|Overall Study|Lost to Follow-up|12
2986342|NCT01043705|10274520|P1|Overall Study|Lost to Follow-up|27
2986343|NCT01043705|10274518|P3|Overall Study|Death|26
2986344|NCT01043705|10274519|P2|Overall Study|Death|60
2986345|NCT01043705|10274520|P1|Overall Study|Death|28
2986346|NCT01043185|10274609|P10|Period 6 - Third Washout Period|Protocol Violation|0
2986347|NCT01043185|10274610|P9|Period 6 - Third Washout Period|Protocol Violation|1
2986348|NCT01043185|10274611|P8|Period 6 - Third Washout Period|Protocol Violation|0
2986349|NCT01043185|10274612|P7|Period 6 - Third Washout Period|Protocol Violation|0
2986350|NCT01043185|10274613|P6|Period 6 - Third Washout Period|Protocol Violation|0
2986351|NCT01043185|10274614|P5|Period 6 - Third Washout Period|Protocol Violation|0
2986352|NCT01043185|10274615|P4|Period 6 - Third Washout Period|Protocol Violation|0
2986353|NCT01043185|10274616|P3|Period 6 - Third Washout Period|Protocol Violation|0
2986354|NCT01043185|10274617|P2|Period 6 - Third Washout Period|Protocol Violation|0
2986355|NCT01043185|10274618|P1|Period 6 - Third Washout Period|Protocol Violation|0
2986356|NCT01042977|10274694|P2|Overall Study|Various|0
2986357|NCT01042977|10274695|P1|Overall Study|Various|3
2986358|NCT01042977|10274694|P2|Overall Study|Administrative reason by sponsor|1
2986359|NCT01042977|10274695|P1|Overall Study|Administrative reason by sponsor|0
2986360|NCT01042977|10274694|P2|Overall Study|Safety|2
2986361|NCT01042977|10274695|P1|Overall Study|Safety|0
2986362|NCT01042977|10274694|P2|Overall Study|Incorrect enrollment|4
2986363|NCT01042977|10274695|P1|Overall Study|Incorrect enrollment|6
2986364|NCT01042977|10274694|P2|Overall Study|Subject no longer meets study criteria|13
2986365|NCT01042977|10274695|P1|Overall Study|Subject no longer meets study criteria|15
2986366|NCT01042977|10274694|P2|Overall Study|Poor/non-compliance|4
2986367|NCT01042977|10274695|P1|Overall Study|Poor/non-compliance|3
2986368|NCT01042977|10274694|P2|Overall Study|Lost to Follow-up|2
2986369|NCT01042977|10274695|P1|Overall Study|Lost to Follow-up|0
2986370|NCT01042977|10274694|P2|Overall Study|Withdrawal by Subject|16
2986371|NCT01042977|10274695|P1|Overall Study|Withdrawal by Subject|8
2986372|NCT01042977|10274694|P2|Overall Study|Death|1
2986373|NCT01042977|10274695|P1|Overall Study|Death|2
2986374|NCT01042977|10274694|P2|Overall Study|Adverse Event|12
2986375|NCT01042977|10274695|P1|Overall Study|Adverse Event|4
2986376|NCT01042938|10274715|P2|Overall Study|Ineligible: RTOG study conflict|0
2986377|NCT01042938|10274716|P1|Overall Study|Ineligible: RTOG study conflict|1
2986378|NCT01042938|10274715|P2|Overall Study|Protocol Violation|1
2986379|NCT01042938|10274716|P1|Overall Study|Protocol Violation|1
2986380|NCT01042938|10274715|P2|Overall Study|Withdrawal by Subject|1
2986381|NCT01042938|10274716|P1|Overall Study|Withdrawal by Subject|1
2986382|NCT01042678|10274735|P6|Overall Study|Physician Decision|0
2986383|NCT01042678|10274736|P5|Overall Study|Physician Decision|0
2986384|NCT01042678|10274737|P4|Overall Study|Physician Decision|0
2986385|NCT01042678|10274738|P3|Overall Study|Physician Decision|0
2986386|NCT01042678|10274739|P2|Overall Study|Physician Decision|0
2986387|NCT01042678|10274740|P1|Overall Study|Physician Decision|1
2986388|NCT01042600|10274778|P2|Overall Study|Ineligible|0
2986389|NCT01042600|10274779|P1|Overall Study|Ineligible|1
2986390|NCT01042535|10274799|P1|Overall Study|complications from other disease|2
2986391|NCT01042535|10274799|P1|Overall Study|disease progression during treatment|3
2986392|NCT01042535|10274799|P1|Overall Study|disease progression prior to treatment|3
2986393|NCT01042392|10274833|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2986394|NCT01042392|10274834|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2986395|NCT01042392|10274835|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2986396|NCT01042392|10274836|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
2986397|NCT01042392|10274833|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2986398|NCT01042392|10274834|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
2986399|NCT01042392|10274835|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2986400|NCT01042392|10274836|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2986401|NCT01042392|10274833|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2986402|NCT01042392|10274834|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2986403|NCT01042392|10274835|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2986404|NCT01042392|10274836|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
2986405|NCT01042392|10274833|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2986406|NCT01042392|10274834|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
2986407|NCT01042392|10274835|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2986408|NCT01042392|10274836|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2986409|NCT01042392|10274833|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2986410|NCT01042392|10274834|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2986411|NCT01042392|10274835|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2986412|NCT01042392|10274836|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
2986413|NCT01042392|10274833|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2986414|NCT01042392|10274834|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
2986415|NCT01042392|10274835|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2986416|NCT01042392|10274836|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2986417|NCT01042392|10274833|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2986418|NCT01042392|10274834|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
2986419|NCT01042392|10274835|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2986420|NCT01042392|10274836|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
2986421|NCT01042392|10274833|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2986422|NCT01042392|10274834|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2986423|NCT01042392|10274835|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2986424|NCT01042392|10274836|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
2986425|NCT01042392|10274833|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2986426|NCT01042392|10274834|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
2986427|NCT01042392|10274835|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2986428|NCT01042392|10274836|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
2986429|NCT01042236|10274884|P6|Treatment Period 3|Protocol Violation|0
2986430|NCT01042236|10274885|P5|Treatment Period 3|Protocol Violation|0
2986431|NCT01042236|10274886|P4|Treatment Period 3|Protocol Violation|1
2986432|NCT01042236|10274887|P3|Treatment Period 3|Protocol Violation|0
2986433|NCT01042236|10274888|P2|Treatment Period 3|Protocol Violation|0
2986434|NCT01042236|10274889|P1|Treatment Period 3|Protocol Violation|0
2986435|NCT01042236|10274884|P6|Treatment Period 3|Adverse Event|0
2986436|NCT01042236|10274885|P5|Treatment Period 3|Adverse Event|0
2986437|NCT01042236|10274886|P4|Treatment Period 3|Adverse Event|1
2986438|NCT01042236|10274887|P3|Treatment Period 3|Adverse Event|0
2986439|NCT01042236|10274888|P2|Treatment Period 3|Adverse Event|0
2986440|NCT01042236|10274889|P1|Treatment Period 3|Adverse Event|0
2986441|NCT01042236|10274884|P6|Treatment Period 1|Adverse Event|0
2986442|NCT01042236|10274885|P5|Treatment Period 1|Adverse Event|1
2986443|NCT01042236|10274886|P4|Treatment Period 1|Adverse Event|0
2986444|NCT01042236|10274887|P3|Treatment Period 1|Adverse Event|0
2986445|NCT01042236|10274888|P2|Treatment Period 1|Adverse Event|1
2986446|NCT01042236|10274889|P1|Treatment Period 1|Adverse Event|0
2986447|NCT01042158|10274926|P1|Overall Study|Physician Decision|1
2986448|NCT01042093|10274956|P4|Overall Study|Withdrawal by Subject|1
2986449|NCT01042093|10274957|P3|Overall Study|Withdrawal by Subject|0
2986450|NCT01042093|10274958|P2|Overall Study|Withdrawal by Subject|0
2986451|NCT01042093|10274959|P1|Overall Study|Withdrawal by Subject|0
2986452|NCT01042093|10274956|P4|Overall Study|Protocol Violation|3
2986453|NCT01042093|10274957|P3|Overall Study|Protocol Violation|2
2986454|NCT01042093|10274958|P2|Overall Study|Protocol Violation|2
2986455|NCT01042093|10274959|P1|Overall Study|Protocol Violation|2
2986456|NCT01041976|10274979|P2|Overall Study|Death|4
2986457|NCT01041976|10274980|P1|Overall Study|Death|0
2986458|NCT01041976|10274979|P2|Overall Study|Incarceration|0
2986459|NCT01041976|10274980|P1|Overall Study|Incarceration|2
2986460|NCT01041976|10274979|P2|Overall Study|Withdrawal by Subject|0
2986461|NCT01041976|10274980|P1|Overall Study|Withdrawal by Subject|3
2986462|NCT01041859|10274990|P3|Double-Blind Maintenance|Withdrawal by Subject|9
2986463|NCT01041859|10274991|P2|Double-Blind Maintenance|Withdrawal by Subject|8
2986464|NCT01041859|10274992|P1|Double-Blind Maintenance|Withdrawal by Subject|0
2986465|NCT01041859|10274990|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
2986466|NCT01041859|10274991|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
2986467|NCT01041859|10274992|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
2986468|NCT01041859|10274990|P3|Double-Blind Maintenance|Other|2
2986469|NCT01041859|10274991|P2|Double-Blind Maintenance|Other|6
2986470|NCT01041859|10274992|P1|Double-Blind Maintenance|Other|0
2986471|NCT01041859|10274990|P3|Double-Blind Maintenance|Protocol Violation|3
2986472|NCT01041859|10274991|P2|Double-Blind Maintenance|Protocol Violation|1
2986473|NCT01041859|10274992|P1|Double-Blind Maintenance|Protocol Violation|0
2986474|NCT01041859|10274990|P3|Double-Blind Maintenance|Physician Decision|1
2986475|NCT01041859|10274991|P2|Double-Blind Maintenance|Physician Decision|2
2986476|NCT01041859|10274992|P1|Double-Blind Maintenance|Physician Decision|0
2986477|NCT01041859|10274990|P3|Double-Blind Maintenance|Lost to Follow-up|0
2986478|NCT01041859|10274991|P2|Double-Blind Maintenance|Lost to Follow-up|1
2986479|NCT01041859|10274992|P1|Double-Blind Maintenance|Lost to Follow-up|0
2986480|NCT01041859|10274990|P3|Double-Blind Maintenance|Lack of Efficacy|11
2986481|NCT01041859|10274991|P2|Double-Blind Maintenance|Lack of Efficacy|3
2986482|NCT01041859|10274992|P1|Double-Blind Maintenance|Lack of Efficacy|0
2986483|NCT01041859|10274990|P3|Double-Blind Maintenance|Adverse Event|13
2986484|NCT01041859|10274991|P2|Double-Blind Maintenance|Adverse Event|23
2986485|NCT01041859|10274992|P1|Double-Blind Maintenance|Adverse Event|0
2986486|NCT01041859|10274990|P3|Open-Label Titration|Withdrawal by Subject|0
2986487|NCT01041859|10274991|P2|Open-Label Titration|Withdrawal by Subject|0
2986488|NCT01041859|10274992|P1|Open-Label Titration|Withdrawal by Subject|11
2986489|NCT01041859|10274990|P3|Open-Label Titration|Noncompliance With Study Drug|0
2986490|NCT01041859|10274991|P2|Open-Label Titration|Noncompliance With Study Drug|0
2986491|NCT01041859|10274992|P1|Open-Label Titration|Noncompliance With Study Drug|8
2986492|NCT01041859|10274990|P3|Open-Label Titration|Other|0
2986493|NCT01041859|10274991|P2|Open-Label Titration|Other|0
2986494|NCT01041859|10274992|P1|Open-Label Titration|Other|7
2986495|NCT01041859|10274990|P3|Open-Label Titration|Protocol Violation|0
2986496|NCT01041859|10274991|P2|Open-Label Titration|Protocol Violation|0
2986497|NCT01041859|10274992|P1|Open-Label Titration|Protocol Violation|1
2986498|NCT01041859|10274990|P3|Open-Label Titration|Physician Decision|0
2986499|NCT01041859|10274991|P2|Open-Label Titration|Physician Decision|0
2986500|NCT01041859|10274992|P1|Open-Label Titration|Physician Decision|1
2986501|NCT01041859|10274990|P3|Open-Label Titration|Lost to Follow-up|0
2986502|NCT01041859|10274991|P2|Open-Label Titration|Lost to Follow-up|0
2986503|NCT01041859|10274992|P1|Open-Label Titration|Lost to Follow-up|1
2986504|NCT01041859|10274990|P3|Open-Label Titration|Lack of Efficacy|0
2986505|NCT01041859|10274991|P2|Open-Label Titration|Lack of Efficacy|0
2986506|NCT01041859|10274992|P1|Open-Label Titration|Lack of Efficacy|3
2986507|NCT01041859|10274990|P3|Open-Label Titration|Adverse Event|0
2986508|NCT01041859|10274991|P2|Open-Label Titration|Adverse Event|0
2986509|NCT01041859|10274992|P1|Open-Label Titration|Adverse Event|69
2986510|NCT01041638|10275028|P1|Overall Study|Withdrawal by Subject|11
2986511|NCT01041638|10275028|P1|Overall Study|Physician Decision|4
2986512|NCT01041638|10275028|P1|Overall Study|Lack of Efficacy|7
2986513|NCT01041638|10275028|P1|Overall Study|Death|1
2986514|NCT01041638|10275028|P1|Overall Study|Adverse Event|4
2986515|NCT01041573|10275038|P4|Overall Study|positive to anti-HCV|0
2986516|NCT01041573|10275039|P3|Overall Study|positive to anti-HCV|0
2986517|NCT01041573|10275040|P2|Overall Study|positive to anti-HCV|0
2986518|NCT01041573|10275041|P1|Overall Study|positive to anti-HCV|1
2986519|NCT01041573|10275038|P4|Overall Study|further blood extraction|0
2986520|NCT01041573|10275039|P3|Overall Study|further blood extraction|0
2986521|NCT01041573|10275040|P2|Overall Study|further blood extraction|1
2986522|NCT01041573|10275041|P1|Overall Study|further blood extraction|0
2986523|NCT01041573|10275038|P4|Overall Study|relocation|1
2986524|NCT01041573|10275039|P3|Overall Study|relocation|3
2986525|NCT01041573|10275040|P2|Overall Study|relocation|4
2986526|NCT01041573|10275041|P1|Overall Study|relocation|1
2986527|NCT01041573|10275038|P4|Overall Study|Adverse Event|0
2986528|NCT01041573|10275039|P3|Overall Study|Adverse Event|0
2986529|NCT01041573|10275040|P2|Overall Study|Adverse Event|2
2986530|NCT01041573|10275041|P1|Overall Study|Adverse Event|0
2986531|NCT01041573|10275038|P4|Overall Study|Lost to Follow-up|1
2986532|NCT01041573|10275039|P3|Overall Study|Lost to Follow-up|2
2986533|NCT01041573|10275040|P2|Overall Study|Lost to Follow-up|1
2986534|NCT01041573|10275041|P1|Overall Study|Lost to Follow-up|0
2986535|NCT01041573|10275038|P4|Overall Study|Death|0
2986536|NCT01041573|10275039|P3|Overall Study|Death|0
2986537|NCT01041573|10275040|P2|Overall Study|Death|0
2986538|NCT01041573|10275041|P1|Overall Study|Death|1
2986539|NCT01041573|10275038|P4|Overall Study|Withdrawal by Subject|0
2986540|NCT01041573|10275039|P3|Overall Study|Withdrawal by Subject|2
2986541|NCT01041573|10275040|P2|Overall Study|Withdrawal by Subject|5
2986542|NCT01041573|10275041|P1|Overall Study|Withdrawal by Subject|2
2986543|NCT01041417|10275064|P2|Overall Study|Death|0
2986544|NCT01041417|10275065|P1|Overall Study|Death|1
2986545|NCT01041417|10275064|P2|Overall Study|Lost to Follow-up|1
2986546|NCT01041417|10275065|P1|Overall Study|Lost to Follow-up|1
2986547|NCT01041417|10275064|P2|Overall Study|Adverse Event|2
2986548|NCT01041417|10275065|P1|Overall Study|Adverse Event|5
2986549|NCT01041404|10275103|P2|Overall Study|Other|23
2986550|NCT01041404|10275104|P1|Overall Study|Other|11
2986551|NCT01041404|10275103|P2|Overall Study|Failure to Return|2
2986552|NCT01041404|10275104|P1|Overall Study|Failure to Return|1
2986553|NCT01041404|10275103|P2|Overall Study|Withdrawal by Subject|23
2986554|NCT01041404|10275104|P1|Overall Study|Withdrawal by Subject|29
2986555|NCT01041404|10275103|P2|Overall Study|Protocol Violation|0
2986556|NCT01041404|10275104|P1|Overall Study|Protocol Violation|4
2986557|NCT01041404|10275103|P2|Overall Study|Violation of Selection Criteria|1
2986558|NCT01041404|10275104|P1|Overall Study|Violation of Selection Criteria|0
2986559|NCT01041404|10275103|P2|Overall Study|Lack of Efficacy|210
2986560|NCT01041404|10275104|P1|Overall Study|Lack of Efficacy|200
2986561|NCT01041404|10275103|P2|Overall Study|Adverse Event|35
2986562|NCT01041404|10275104|P1|Overall Study|Adverse Event|45
2986563|NCT01041287|10275145|P2|Treatment Period 2 (3 Months)|Adverse Event|2
2986564|NCT01041287|10275146|P1|Treatment Period 2 (3 Months)|Adverse Event|0
2986565|NCT01041287|10275145|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2986566|NCT01041287|10275146|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2986567|NCT01040871|10275186|P2|Overall Study|Randomized and Not Treated|1
2986568|NCT01040871|10275187|P1|Overall Study|Randomized and Not Treated|2
2986569|NCT01040871|10275186|P2|Overall Study|drug supply issue|0
2986570|NCT01040871|10275187|P1|Overall Study|drug supply issue|1
2986571|NCT01040871|10275186|P2|Overall Study|Lack of Efficacy|1
2986572|NCT01040871|10275187|P1|Overall Study|Lack of Efficacy|1
2986573|NCT01040871|10275186|P2|Overall Study|Death|3
2986574|NCT01040871|10275187|P1|Overall Study|Death|1
2986575|NCT01040871|10275186|P2|Overall Study|Withdrawal by Subject|0
2986576|NCT01040871|10275187|P1|Overall Study|Withdrawal by Subject|2
2986577|NCT01040871|10275186|P2|Overall Study|Adverse Event|2
2986578|NCT01040871|10275187|P1|Overall Study|Adverse Event|6
2986579|NCT01040845|10275238|P2|Overall Study|Physician Decision|0
2986580|NCT01040845|10275239|P1|Overall Study|Physician Decision|1
2986581|NCT01040845|10275238|P2|Overall Study|Withdrawal by Subject|1
2986582|NCT01040845|10275239|P1|Overall Study|Withdrawal by Subject|1
2986583|NCT01040832|10275254|P2|Overall Study|Other|1
2986584|NCT01040832|10275255|P1|Overall Study|Other|2
2986585|NCT01040832|10275254|P2|Overall Study|Symptomatic deterioration|5
2986586|NCT01040832|10275255|P1|Overall Study|Symptomatic deterioration|2
2986587|NCT01040832|10275254|P2|Overall Study|Progressive disease|17
2986588|NCT01040832|10275255|P1|Overall Study|Progressive disease|32
2986589|NCT01040832|10275254|P2|Overall Study|Withdrawal by Subject|3
2986590|NCT01040832|10275255|P1|Overall Study|Withdrawal by Subject|2
2986591|NCT01040832|10275254|P2|Overall Study|Death|6
2986592|NCT01040832|10275255|P1|Overall Study|Death|4
2986593|NCT01040832|10275254|P2|Overall Study|Adverse Event|5
2986594|NCT01040832|10275255|P1|Overall Study|Adverse Event|4
2986595|NCT01040793|10275278|P6|Overall Study|Other reasons not listed above|0
2986596|NCT01040793|10275279|P5|Overall Study|Other reasons not listed above|1
2986597|NCT01040793|10275280|P4|Overall Study|Other reasons not listed above|0
2986598|NCT01040793|10275281|P3|Overall Study|Other reasons not listed above|1
2986599|NCT01040793|10275282|P2|Overall Study|Other reasons not listed above|0
2986600|NCT01040793|10275283|P1|Overall Study|Other reasons not listed above|0
2986601|NCT01040793|10275278|P6|Overall Study|Withdrawal by Subject|0
2986602|NCT01040793|10275279|P5|Overall Study|Withdrawal by Subject|0
2986603|NCT01040793|10275280|P4|Overall Study|Withdrawal by Subject|2
2986604|NCT01040793|10275281|P3|Overall Study|Withdrawal by Subject|0
2986605|NCT01040793|10275282|P2|Overall Study|Withdrawal by Subject|0
2986606|NCT01040793|10275283|P1|Overall Study|Withdrawal by Subject|0
2986607|NCT01040793|10275278|P6|Overall Study|Lost to Follow-up|0
2986608|NCT01040793|10275279|P5|Overall Study|Lost to Follow-up|0
2986609|NCT01040793|10275280|P4|Overall Study|Lost to Follow-up|0
2986610|NCT01040793|10275281|P3|Overall Study|Lost to Follow-up|1
2986611|NCT01040793|10275282|P2|Overall Study|Lost to Follow-up|1
2986612|NCT01040793|10275283|P1|Overall Study|Lost to Follow-up|0
2986613|NCT01040793|10275278|P6|Overall Study|Protocol Violation|0
2986614|NCT01040793|10275279|P5|Overall Study|Protocol Violation|1
2986615|NCT01040793|10275280|P4|Overall Study|Protocol Violation|0
2986616|NCT01040793|10275281|P3|Overall Study|Protocol Violation|1
2986617|NCT01040793|10275282|P2|Overall Study|Protocol Violation|1
2986618|NCT01040793|10275283|P1|Overall Study|Protocol Violation|1
2986619|NCT01040793|10275278|P6|Overall Study|Adverse Event|1
2986620|NCT01040793|10275279|P5|Overall Study|Adverse Event|2
2986621|NCT01040793|10275280|P4|Overall Study|Adverse Event|2
2986622|NCT01040793|10275281|P3|Overall Study|Adverse Event|0
2986623|NCT01040793|10275282|P2|Overall Study|Adverse Event|3
2986624|NCT01040793|10275283|P1|Overall Study|Adverse Event|5
2986625|NCT01040780|10275362|P2|Overall Study|Protocol Violation|3
2986626|NCT01040780|10275363|P1|Overall Study|Protocol Violation|1
2986627|NCT01040728|10275377|P4|Overall Study|Other reasons not listed above|0
2986628|NCT01040728|10275378|P3|Overall Study|Other reasons not listed above|0
2986629|NCT01040728|10275379|P2|Overall Study|Other reasons not listed above|1
2986630|NCT01040728|10275380|P1|Overall Study|Other reasons not listed above|0
2986631|NCT01040728|10275377|P4|Overall Study|Lack of Efficacy|1
2986632|NCT01040728|10275378|P3|Overall Study|Lack of Efficacy|0
2986633|NCT01040728|10275379|P2|Overall Study|Lack of Efficacy|1
2986634|NCT01040728|10275380|P1|Overall Study|Lack of Efficacy|0
2986635|NCT01040728|10275377|P4|Overall Study|Protocol Violation|1
2986636|NCT01040728|10275378|P3|Overall Study|Protocol Violation|0
2986637|NCT01040728|10275379|P2|Overall Study|Protocol Violation|0
2986638|NCT01040728|10275380|P1|Overall Study|Protocol Violation|0
2986639|NCT01040728|10275377|P4|Overall Study|Withdrawal by Subject|0
2986640|NCT01040728|10275378|P3|Overall Study|Withdrawal by Subject|1
2986641|NCT01040728|10275379|P2|Overall Study|Withdrawal by Subject|1
2986642|NCT01040728|10275380|P1|Overall Study|Withdrawal by Subject|0
2986643|NCT01040728|10275377|P4|Overall Study|Adverse Event|4
2986644|NCT01040728|10275378|P3|Overall Study|Adverse Event|0
2986645|NCT01040728|10275379|P2|Overall Study|Adverse Event|8
2986646|NCT01040728|10275380|P1|Overall Study|Adverse Event|4
2986647|NCT01040689|10275450|P4|Overall Study|Other reasons not listed above|0
2986648|NCT01040689|10275451|P3|Overall Study|Other reasons not listed above|0
2986649|NCT01040689|10275452|P2|Overall Study|Other reasons not listed above|1
2986650|NCT01040689|10275453|P1|Overall Study|Other reasons not listed above|0
2986651|NCT01040689|10275450|P4|Overall Study|Withdrawal by Subject|0
2986652|NCT01040689|10275451|P3|Overall Study|Withdrawal by Subject|1
2986653|NCT01040689|10275452|P2|Overall Study|Withdrawal by Subject|1
2986654|NCT01040689|10275453|P1|Overall Study|Withdrawal by Subject|2
2986655|NCT01040689|10275450|P4|Overall Study|Lost to Follow-up|0
2986656|NCT01040689|10275451|P3|Overall Study|Lost to Follow-up|0
2986657|NCT01040689|10275452|P2|Overall Study|Lost to Follow-up|0
2986658|NCT01040689|10275453|P1|Overall Study|Lost to Follow-up|1
2986659|NCT01040689|10275450|P4|Overall Study|Lack of Efficacy|0
2986660|NCT01040689|10275451|P3|Overall Study|Lack of Efficacy|1
2986661|NCT01040689|10275452|P2|Overall Study|Lack of Efficacy|0
2986662|NCT01040689|10275453|P1|Overall Study|Lack of Efficacy|0
2986663|NCT01040689|10275450|P4|Overall Study|Adverse Event|4
2986664|NCT01040689|10275451|P3|Overall Study|Adverse Event|2
2986665|NCT01040689|10275452|P2|Overall Study|Adverse Event|0
2986666|NCT01040689|10275453|P1|Overall Study|Adverse Event|0
2986667|NCT01040403|10275532|P1|Overall Study|Other reason not defined above|6
2986668|NCT01040403|10275532|P1|Overall Study|Not treated|1
2986669|NCT01040403|10275532|P1|Overall Study|Lost to Follow-up|1
2986670|NCT01040403|10275532|P1|Overall Study|Protocol Violation|2
2986671|NCT01040403|10275532|P1|Overall Study|Adverse Event|10
2986672|NCT01040351|10275720|P2|Overall Study|poor ovarian response|2
2986673|NCT01040351|10275721|P1|Overall Study|poor ovarian response|1
2986674|NCT01040260|10275731|P2|Overall Study|Lost to Follow-up|5
2986675|NCT01040260|10275732|P1|Overall Study|Lost to Follow-up|3
2986676|NCT01040260|10275731|P2|Overall Study|Withdrawal by Subject|6
2986677|NCT01040260|10275732|P1|Overall Study|Withdrawal by Subject|12
2986678|NCT01040169|10275759|P2|Overall Study|Lost to Follow-up|8
2986679|NCT01040169|10275760|P1|Overall Study|Lost to Follow-up|3
2986680|NCT01040130|10275768|P6|Overall Study|Other reasons not listed above|0
2986681|NCT01040130|10275769|P5|Overall Study|Other reasons not listed above|0
2986682|NCT01040130|10275770|P4|Overall Study|Other reasons not listed above|0
2986683|NCT01040130|10275771|P3|Overall Study|Other reasons not listed above|0
2986684|NCT01040130|10275772|P2|Overall Study|Other reasons not listed above|0
2986685|NCT01040130|10275773|P1|Overall Study|Other reasons not listed above|2
2986686|NCT01040130|10275768|P6|Overall Study|Withdrawal by Subject|1
2986687|NCT01040130|10275769|P5|Overall Study|Withdrawal by Subject|0
2986688|NCT01040130|10275770|P4|Overall Study|Withdrawal by Subject|0
2986689|NCT01040130|10275771|P3|Overall Study|Withdrawal by Subject|0
2986690|NCT01040130|10275772|P2|Overall Study|Withdrawal by Subject|2
2986691|NCT01040130|10275773|P1|Overall Study|Withdrawal by Subject|0
2986692|NCT01040130|10275768|P6|Overall Study|Protocol Violation|0
2986693|NCT01040130|10275769|P5|Overall Study|Protocol Violation|0
2986694|NCT01040130|10275770|P4|Overall Study|Protocol Violation|0
2986695|NCT01040130|10275771|P3|Overall Study|Protocol Violation|2
2986696|NCT01040130|10275772|P2|Overall Study|Protocol Violation|0
2986697|NCT01040130|10275773|P1|Overall Study|Protocol Violation|0
2986698|NCT01040130|10275768|P6|Overall Study|Adverse Event|3
2986699|NCT01040130|10275769|P5|Overall Study|Adverse Event|0
2986700|NCT01040130|10275770|P4|Overall Study|Adverse Event|5
2986701|NCT01040130|10275771|P3|Overall Study|Adverse Event|0
2986702|NCT01040130|10275772|P2|Overall Study|Adverse Event|1
2986703|NCT01040130|10275773|P1|Overall Study|Adverse Event|1
2986704|NCT01039688|10275866|P3|Overall Study|Death|0
2986705|NCT01039688|10275867|P2|Overall Study|Death|0
2986706|NCT01039688|10275868|P1|Overall Study|Death|2
2986707|NCT01039688|10275866|P3|Overall Study|Withdrawal by Subject|13
2986708|NCT01039688|10275867|P2|Overall Study|Withdrawal by Subject|27
2986709|NCT01039688|10275868|P1|Overall Study|Withdrawal by Subject|23
2986710|NCT01039688|10275866|P3|Overall Study|Other|12
2986711|NCT01039688|10275867|P2|Overall Study|Other|25
2986712|NCT01039688|10275868|P1|Overall Study|Other|13
2986713|NCT01039688|10275866|P3|Overall Study|Lost to Follow-up|5
2986714|NCT01039688|10275867|P2|Overall Study|Lost to Follow-up|9
2986715|NCT01039688|10275868|P1|Overall Study|Lost to Follow-up|11
2986716|NCT01039688|10275866|P3|Overall Study|Lack of Efficacy|26
2986717|NCT01039688|10275867|P2|Overall Study|Lack of Efficacy|11
2986718|NCT01039688|10275868|P1|Overall Study|Lack of Efficacy|20
2986719|NCT01039688|10275866|P3|Overall Study|Adverse Event|24
2986720|NCT01039688|10275867|P2|Overall Study|Adverse Event|39
2986721|NCT01039688|10275868|P1|Overall Study|Adverse Event|38
2986722|NCT01039675|10276139|P2|Overall Study|Physician Decision|1
2986723|NCT01039675|10276140|P1|Overall Study|Physician Decision|0
2986724|NCT01039675|10276139|P2|Overall Study|Lost to Follow-up|1
2986725|NCT01039675|10276140|P1|Overall Study|Lost to Follow-up|0
2986726|NCT01039675|10276139|P2|Overall Study|Withdrawal by Subject|1
2986727|NCT01039675|10276140|P1|Overall Study|Withdrawal by Subject|0
2986728|NCT01039675|10276139|P2|Overall Study|Lack of Efficacy|2
2986729|NCT01039675|10276140|P1|Overall Study|Lack of Efficacy|0
2986730|NCT01039675|10276139|P2|Overall Study|Adverse Event|2
2986731|NCT01039675|10276140|P1|Overall Study|Adverse Event|0
2986732|NCT01039584|10276153|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
2986733|NCT01039584|10276154|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
2986734|NCT01039584|10276155|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
2986735|NCT01039584|10276153|P3|Overall Study|Pap smear with significant pathology|3
2986736|NCT01039584|10276154|P2|Overall Study|Pap smear with significant pathology|10
2986737|NCT01039584|10276155|P1|Overall Study|Pap smear with significant pathology|10
2986738|NCT01039584|10276153|P3|Overall Study|other|1
2986739|NCT01039584|10276154|P2|Overall Study|other|3
2986740|NCT01039584|10276155|P1|Overall Study|other|1
2986741|NCT01039584|10276153|P3|Overall Study|Lack of Efficacy|10
2986742|NCT01039584|10276154|P2|Overall Study|Lack of Efficacy|6
2986743|NCT01039584|10276155|P1|Overall Study|Lack of Efficacy|7
2986744|NCT01039584|10276153|P3|Overall Study|Negative Baseline culture for Candida|24
2986745|NCT01039584|10276154|P2|Overall Study|Negative Baseline culture for Candida|59
2986746|NCT01039584|10276155|P1|Overall Study|Negative Baseline culture for Candida|59
2986747|NCT01039584|10276153|P3|Overall Study|Lost to Follow-up|4
2986748|NCT01039584|10276154|P2|Overall Study|Lost to Follow-up|3
2986749|NCT01039584|10276155|P1|Overall Study|Lost to Follow-up|5
2986750|NCT01039584|10276153|P3|Overall Study|Protocol Violation|6
2986751|NCT01039584|10276154|P2|Overall Study|Protocol Violation|4
2986752|NCT01039584|10276155|P1|Overall Study|Protocol Violation|10
2986753|NCT01039584|10276153|P3|Overall Study|Withdrawal by Subject|1
2986754|NCT01039584|10276154|P2|Overall Study|Withdrawal by Subject|2
2986755|NCT01039584|10276155|P1|Overall Study|Withdrawal by Subject|4
2986756|NCT01039519|10276169|P1|Survival Follow-up|Sponsor decision|4
2986757|NCT01039519|10276169|P1|Survival Follow-up|Death|23
2986758|NCT01039519|10276169|P1|Treatment|Physician Decision|2
2986759|NCT01039519|10276169|P1|Treatment|Adverse Event|3
2986760|NCT01039519|10276169|P1|Treatment|Treatment failure|2
2986761|NCT01039519|10276169|P1|Treatment|Progressive disease|20
2986762|NCT01039428|10276205|P2|Overall Study|Withdrawal by Subject|0
2986763|NCT01039428|10276206|P1|Overall Study|Withdrawal by Subject|1
2986764|NCT01039428|10276205|P2|Overall Study|Protocol Violation|0
2986765|NCT01039428|10276206|P1|Overall Study|Protocol Violation|1
2986766|NCT01039376|10276230|P2|Overall Study|Study terminated by Sponsor|72
2986767|NCT01039376|10276231|P1|Overall Study|Study terminated by Sponsor|90
2986768|NCT01039376|10276230|P2|Overall Study|Withdrawal by Subject|32
2986769|NCT01039376|10276231|P1|Overall Study|Withdrawal by Subject|20
2986770|NCT01039376|10276230|P2|Overall Study|Physician Decision|10
2986771|NCT01039376|10276231|P1|Overall Study|Physician Decision|15
2986772|NCT01039376|10276230|P2|Overall Study|Lost to Follow-up|12
2986773|NCT01039376|10276231|P1|Overall Study|Lost to Follow-up|5
2986774|NCT01038921|10276300|P2|Overall Study|Physician Decision|0
2986775|NCT01038921|10276301|P1|Overall Study|Physician Decision|1
2986776|NCT01038921|10276300|P2|Overall Study|Withdrawal by Subject|0
2986777|NCT01038921|10276301|P1|Overall Study|Withdrawal by Subject|1
2986778|NCT01038869|10276307|P1|Overall Study|Lost to Follow-up|6
2986779|NCT01038869|10276307|P1|Overall Study|Withdrawal by Subject|1
2986780|NCT01038856|10276315|P1|Overall Study|Adverse Event|2
2986781|NCT01038752|10276324|P2|Overall Study|Lost to Follow-up|3
2986782|NCT01038752|10276325|P1|Overall Study|Lost to Follow-up|3
2986783|NCT01038752|10276324|P2|Overall Study|Tumor Progression|2
2986784|NCT01038752|10276325|P1|Overall Study|Tumor Progression|2
2986785|NCT01038713|10276348|P3|Overall Study|Autoimmune Pancreatitis|0
2986786|NCT01038713|10276349|P2|Overall Study|Autoimmune Pancreatitis|0
2986787|NCT01038713|10276350|P1|Overall Study|Autoimmune Pancreatitis|1
2986788|NCT01038713|10276348|P3|Overall Study|died from PEP|0
2986789|NCT01038713|10276349|P2|Overall Study|died from PEP|1
2986790|NCT01038713|10276350|P1|Overall Study|died from PEP|0
2986791|NCT01038713|10276348|P3|Overall Study|Neuroendocrine Tumor|0
2986792|NCT01038713|10276349|P2|Overall Study|Neuroendocrine Tumor|1
2986793|NCT01038713|10276350|P1|Overall Study|Neuroendocrine Tumor|0
2986794|NCT01038713|10276348|P3|Overall Study|Lost to Follow-up|0
2986795|NCT01038713|10276349|P2|Overall Study|Lost to Follow-up|0
2986796|NCT01038713|10276350|P1|Overall Study|Lost to Follow-up|3
2986797|NCT01038713|10276348|P3|Overall Study|Patient to hospice|1
2986798|NCT01038713|10276349|P2|Overall Study|Patient to hospice|1
2986799|NCT01038713|10276350|P1|Overall Study|Patient to hospice|1
2986800|NCT01038635|10276379|P9|Overall Study|Death|2
2986801|NCT01038635|10276380|P8|Overall Study|Death|1
2986802|NCT01038635|10276381|P7|Overall Study|Death|1
2986803|NCT01038635|10276382|P6|Overall Study|Death|0
2986804|NCT01038635|10276383|P5|Overall Study|Death|1
2986805|NCT01038635|10276384|P4|Overall Study|Death|0
2986806|NCT01038635|10276385|P3|Overall Study|Death|0
2986807|NCT01038635|10276386|P2|Overall Study|Death|0
2986808|NCT01038635|10276387|P1|Overall Study|Death|0
2986809|NCT01038635|10276379|P9|Overall Study|Disease Progression|0
2986810|NCT01038635|10276380|P8|Overall Study|Disease Progression|4
2986811|NCT01038635|10276381|P7|Overall Study|Disease Progression|1
2986812|NCT01038635|10276382|P6|Overall Study|Disease Progression|0
2986813|NCT01038635|10276383|P5|Overall Study|Disease Progression|0
2986814|NCT01038635|10276384|P4|Overall Study|Disease Progression|0
2986815|NCT01038635|10276385|P3|Overall Study|Disease Progression|0
2986816|NCT01038635|10276386|P2|Overall Study|Disease Progression|0
2986817|NCT01038635|10276387|P1|Overall Study|Disease Progression|2
2986818|NCT01038609|10276413|P5|Overall Study|Refusal of Blood Draws|0
2986819|NCT01038609|10276414|P4|Overall Study|Refusal of Blood Draws|0
2986820|NCT01038609|10276415|P3|Overall Study|Refusal of Blood Draws|0
2986821|NCT01038609|10276416|P2|Overall Study|Refusal of Blood Draws|1
2986822|NCT01038609|10276417|P1|Overall Study|Refusal of Blood Draws|0
2986823|NCT01038609|10276413|P5|Overall Study|Death in the Family|0
2986824|NCT01038609|10276414|P4|Overall Study|Death in the Family|0
2986825|NCT01038609|10276415|P3|Overall Study|Death in the Family|0
2986826|NCT01038609|10276416|P2|Overall Study|Death in the Family|0
2986827|NCT01038609|10276417|P1|Overall Study|Death in the Family|1
2986828|NCT01038609|10276413|P5|Overall Study|Dosing Error|1
2986829|NCT01038609|10276414|P4|Overall Study|Dosing Error|1
2986830|NCT01038609|10276415|P3|Overall Study|Dosing Error|0
2986831|NCT01038609|10276416|P2|Overall Study|Dosing Error|0
2986832|NCT01038609|10276417|P1|Overall Study|Dosing Error|0
2986833|NCT01038609|10276413|P5|Overall Study|Adverse Event|0
2986834|NCT01038609|10276414|P4|Overall Study|Adverse Event|0
2986835|NCT01038609|10276415|P3|Overall Study|Adverse Event|1
2986836|NCT01038609|10276416|P2|Overall Study|Adverse Event|0
2986837|NCT01038609|10276417|P1|Overall Study|Adverse Event|0
2986838|NCT01038323|10276536|P3|Overall Study|Withdrawal by Subject|4
2986839|NCT01038323|10276537|P2|Overall Study|Withdrawal by Subject|2
2986840|NCT01038323|10276538|P1|Overall Study|Withdrawal by Subject|3
2986841|NCT01038128|10276552|P1|Overall Study|Withdrawal by Subject|2
2986842|NCT01038128|10276552|P1|Overall Study|Lost to Follow-up|1
2986843|NCT01038128|10276552|P1|Overall Study|Lack of Efficacy|1
2986844|NCT01037244|10276716|P4|Overall Study|Various|1
2986845|NCT01037244|10276717|P3|Overall Study|Various|1
2986846|NCT01037244|10276718|P2|Overall Study|Various|2
2986847|NCT01037244|10276719|P1|Overall Study|Various|3
2986848|NCT01037244|10276716|P4|Overall Study|Partner Withdrew Consent|0
2986849|NCT01037244|10276717|P3|Overall Study|Partner Withdrew Consent|0
2986850|NCT01037244|10276718|P2|Overall Study|Partner Withdrew Consent|1
2986851|NCT01037244|10276719|P1|Overall Study|Partner Withdrew Consent|2
2986852|NCT01037244|10276716|P4|Overall Study|Withdrawal by Subject|5
2986853|NCT01037244|10276717|P3|Overall Study|Withdrawal by Subject|3
2986854|NCT01037244|10276718|P2|Overall Study|Withdrawal by Subject|5
2986855|NCT01037244|10276719|P1|Overall Study|Withdrawal by Subject|1
2986856|NCT01037244|10276716|P4|Overall Study|Lost to Follow-up|4
2986857|NCT01037244|10276717|P3|Overall Study|Lost to Follow-up|4
2986858|NCT01037244|10276718|P2|Overall Study|Lost to Follow-up|3
2986859|NCT01037244|10276719|P1|Overall Study|Lost to Follow-up|3
2986860|NCT01037244|10276716|P4|Overall Study|Lack of Efficacy|1
2986861|NCT01037244|10276717|P3|Overall Study|Lack of Efficacy|0
2986862|NCT01037244|10276718|P2|Overall Study|Lack of Efficacy|1
2986863|NCT01037244|10276719|P1|Overall Study|Lack of Efficacy|1
2986864|NCT01037244|10276716|P4|Overall Study|Adverse Event|3
2986865|NCT01037244|10276717|P3|Overall Study|Adverse Event|6
2986866|NCT01037244|10276718|P2|Overall Study|Adverse Event|2
2986867|NCT01037244|10276719|P1|Overall Study|Adverse Event|3
2986868|NCT01037218|10276781|P4|Overall Study|Various|1
2986869|NCT01037218|10276782|P3|Overall Study|Various|3
2986870|NCT01037218|10276783|P2|Overall Study|Various|2
2986871|NCT01037218|10276784|P1|Overall Study|Various|3
2986872|NCT01037218|10276781|P4|Overall Study|Protocol Violation|2
2986873|NCT01037218|10276782|P3|Overall Study|Protocol Violation|2
2986874|NCT01037218|10276783|P2|Overall Study|Protocol Violation|0
2986875|NCT01037218|10276784|P1|Overall Study|Protocol Violation|0
2986876|NCT01037218|10276781|P4|Overall Study|Partner Withdrew Consent|1
2986877|NCT01037218|10276782|P3|Overall Study|Partner Withdrew Consent|2
2986878|NCT01037218|10276783|P2|Overall Study|Partner Withdrew Consent|3
2986879|NCT01037218|10276784|P1|Overall Study|Partner Withdrew Consent|0
2986880|NCT01037218|10276781|P4|Overall Study|Withdrawal by Subject|4
2986881|NCT01037218|10276782|P3|Overall Study|Withdrawal by Subject|7
2986882|NCT01037218|10276783|P2|Overall Study|Withdrawal by Subject|7
2986883|NCT01037218|10276784|P1|Overall Study|Withdrawal by Subject|6
2986884|NCT01037218|10276781|P4|Overall Study|Lost to Follow-up|2
2986885|NCT01037218|10276782|P3|Overall Study|Lost to Follow-up|4
2986886|NCT01037218|10276783|P2|Overall Study|Lost to Follow-up|5
2986887|NCT01037218|10276784|P1|Overall Study|Lost to Follow-up|3
2986888|NCT01037218|10276781|P4|Overall Study|Lack of Efficacy|5
2986889|NCT01037218|10276782|P3|Overall Study|Lack of Efficacy|1
2986890|NCT01037218|10276783|P2|Overall Study|Lack of Efficacy|2
2986891|NCT01037218|10276784|P1|Overall Study|Lack of Efficacy|0
2986892|NCT01037218|10276781|P4|Overall Study|Adverse Event|1
2986893|NCT01037218|10276782|P3|Overall Study|Adverse Event|2
2986894|NCT01037218|10276783|P2|Overall Study|Adverse Event|2
2986895|NCT01037218|10276784|P1|Overall Study|Adverse Event|4
2986896|NCT01037127|10276855|P2|Overall Study|Study Closed Terminated|17
2986897|NCT01037127|10276856|P1|Overall Study|Study Closed Terminated|2
2986898|NCT01037127|10276855|P2|Overall Study|Physician Decision|0
2986899|NCT01037127|10276856|P1|Overall Study|Physician Decision|1
2986900|NCT01037127|10276855|P2|Overall Study|Lost to Follow-up|4
2986901|NCT01037127|10276856|P1|Overall Study|Lost to Follow-up|2
2986902|NCT01037114|10276888|P1|Year 20|Others|1
2986903|NCT01037088|10276901|P1|Overall Study|Withdrawal by Subject|3
2986904|NCT01036763|10276933|P1|Overall Study|Other reason (not specified)|40
2986905|NCT01036763|10276933|P1|Overall Study|Lost to Follow-up|28
2986906|NCT01036763|10276933|P1|Overall Study|Adverse Event|25
2986907|NCT01036724|10276945|P2|Overall Study|Protocol Violation|5
2986908|NCT01036724|10276946|P1|Overall Study|Protocol Violation|4
2986909|NCT01036724|10276945|P2|Overall Study|Lack of Efficacy|1
2986910|NCT01036724|10276946|P1|Overall Study|Lack of Efficacy|1
2986911|NCT01036724|10276945|P2|Overall Study|Adverse Event|2
2986912|NCT01036724|10276946|P1|Overall Study|Adverse Event|1
2986913|NCT01036529|10276956|P2|Overall Study|Sponsor study termination|12
2986914|NCT01036529|10276957|P1|Overall Study|Sponsor study termination|11
2986915|NCT01036529|10276956|P2|Overall Study|Withdrawal by Subject|1
2986916|NCT01036529|10276957|P1|Overall Study|Withdrawal by Subject|1
2986917|NCT01036529|10276956|P2|Overall Study|Physician Decision|0
2986918|NCT01036529|10276957|P1|Overall Study|Physician Decision|1
2986919|NCT01036529|10276956|P2|Overall Study|Lost to Follow-up|1
2986920|NCT01036529|10276957|P1|Overall Study|Lost to Follow-up|0
2986921|NCT01036529|10276956|P2|Overall Study|Adverse Event|1
2986922|NCT01036529|10276957|P1|Overall Study|Adverse Event|0
2986923|NCT01036438|10276984|P2|Overall Study|No effect of study treatment|1
2986924|NCT01036438|10276985|P1|Overall Study|No effect of study treatment|3
2986925|NCT01036438|10276984|P2|Overall Study|Death|1
2986926|NCT01036438|10276985|P1|Overall Study|Death|0
2986927|NCT01036438|10276984|P2|Overall Study|Adverse Event|8
2986928|NCT01036438|10276985|P1|Overall Study|Adverse Event|7
2986929|NCT01036321|10276993|P2|Overall Study|Adverse Event|1
2986930|NCT01036321|10276994|P1|Overall Study|Adverse Event|2
2986931|NCT01036321|10276993|P2|Overall Study|Withdrawal by Subject|2
2986932|NCT01036321|10276994|P1|Overall Study|Withdrawal by Subject|3
2986933|NCT01036321|10276993|P2|Overall Study|Ineligible after randomization|1
2986934|NCT01036321|10276994|P1|Overall Study|Ineligible after randomization|0
2986935|NCT01036165|10277018|P1|Overall Study|Problems finding proper area to inject|1
2986936|NCT01036165|10277018|P1|Overall Study|Device Related Issues|3
2986937|NCT01036165|10277018|P1|Overall Study|Withdrawal by Subject|3
2986938|NCT01036165|10277018|P1|Overall Study|Lost to Follow-up|2
2986939|NCT01036165|10277018|P1|Overall Study|Adverse Event|6
2986940|NCT01036022|10277029|P6|Overall Study|Withdrawal by Subject|0
2986941|NCT01036022|10277030|P5|Overall Study|Withdrawal by Subject|2
2986942|NCT01036022|10277031|P4|Overall Study|Withdrawal by Subject|1
2986943|NCT01036022|10277032|P3|Overall Study|Withdrawal by Subject|0
2986944|NCT01036022|10277033|P2|Overall Study|Withdrawal by Subject|0
2986945|NCT01036022|10277034|P1|Overall Study|Withdrawal by Subject|0
2986946|NCT01036022|10277029|P6|Overall Study|Physician Decision|0
2986947|NCT01036022|10277030|P5|Overall Study|Physician Decision|0
2986948|NCT01036022|10277031|P4|Overall Study|Physician Decision|0
2986949|NCT01036022|10277032|P3|Overall Study|Physician Decision|1
2986950|NCT01036022|10277033|P2|Overall Study|Physician Decision|0
2986951|NCT01036022|10277034|P1|Overall Study|Physician Decision|0
2986952|NCT01036022|10277029|P6|Overall Study|Lack of Efficacy|1
2986953|NCT01036022|10277030|P5|Overall Study|Lack of Efficacy|1
2986954|NCT01036022|10277031|P4|Overall Study|Lack of Efficacy|0
2986955|NCT01036022|10277032|P3|Overall Study|Lack of Efficacy|1
2986956|NCT01036022|10277033|P2|Overall Study|Lack of Efficacy|1
2986957|NCT01036022|10277034|P1|Overall Study|Lack of Efficacy|1
2986958|NCT01036022|10277029|P6|Overall Study|Adverse Event|2
2986959|NCT01036022|10277030|P5|Overall Study|Adverse Event|0
2986960|NCT01036022|10277031|P4|Overall Study|Adverse Event|1
2986961|NCT01036022|10277032|P3|Overall Study|Adverse Event|2
2986962|NCT01036022|10277033|P2|Overall Study|Adverse Event|3
2986963|NCT01036022|10277034|P1|Overall Study|Adverse Event|1
2986964|NCT01035905|10277170|P2|Overall Study|Lack of Efficacy|1
2986965|NCT01035905|10277171|P1|Overall Study|Lack of Efficacy|1
2986966|NCT01035606|10277344|P3|Overall Study|change in health, job demands,family|4
2986967|NCT01035606|10277345|P2|Overall Study|change in health, job demands,family|3
2986968|NCT01035606|10277346|P1|Overall Study|change in health, job demands,family|3
2986969|NCT01035463|10277362|P6|Overall Study|Other|2
2986970|NCT01035463|10277363|P5|Overall Study|Other|0
2986971|NCT01035463|10277364|P4|Overall Study|Other|1
2986972|NCT01035463|10277365|P3|Overall Study|Other|0
2986973|NCT01035463|10277366|P2|Overall Study|Other|0
2986974|NCT01035463|10277367|P1|Overall Study|Other|0
2986975|NCT01035463|10277362|P6|Overall Study|Other Malignancy|2
2986976|NCT01035463|10277363|P5|Overall Study|Other Malignancy|0
2986977|NCT01035463|10277364|P4|Overall Study|Other Malignancy|0
2986978|NCT01035463|10277365|P3|Overall Study|Other Malignancy|0
2986979|NCT01035463|10277366|P2|Overall Study|Other Malignancy|0
2986980|NCT01035463|10277367|P1|Overall Study|Other Malignancy|0
2986981|NCT01035463|10277362|P6|Overall Study|Disease progression|3
2986982|NCT01035463|10277363|P5|Overall Study|Disease progression|0
2986983|NCT01035463|10277364|P4|Overall Study|Disease progression|0
2986984|NCT01035463|10277365|P3|Overall Study|Disease progression|0
2986985|NCT01035463|10277366|P2|Overall Study|Disease progression|0
2986986|NCT01035463|10277367|P1|Overall Study|Disease progression|0
2986987|NCT01035463|10277362|P6|Overall Study|Withdrawal by Subject|4
2986988|NCT01035463|10277363|P5|Overall Study|Withdrawal by Subject|1
2986989|NCT01035463|10277364|P4|Overall Study|Withdrawal by Subject|0
2986990|NCT01035463|10277365|P3|Overall Study|Withdrawal by Subject|1
2986991|NCT01035463|10277366|P2|Overall Study|Withdrawal by Subject|2
2986992|NCT01035463|10277367|P1|Overall Study|Withdrawal by Subject|0
2986993|NCT01035463|10277362|P6|Overall Study|Adverse Event|7
2986994|NCT01035463|10277363|P5|Overall Study|Adverse Event|5
2986995|NCT01035463|10277364|P4|Overall Study|Adverse Event|1
2986996|NCT01035463|10277365|P3|Overall Study|Adverse Event|4
2986997|NCT01035463|10277366|P2|Overall Study|Adverse Event|0
2986998|NCT01035463|10277367|P1|Overall Study|Adverse Event|0
2986999|NCT01035255|10277404|P2|Overall Study|patient's request|13
2987000|NCT01035255|10277405|P1|Overall Study|patient's request|15
2987001|NCT01035255|10277404|P2|Overall Study|Lost to Follow-up|5
2987002|NCT01035255|10277405|P1|Overall Study|Lost to Follow-up|2
2987003|NCT01035255|10277404|P2|Overall Study|Death|844
2987004|NCT01035255|10277405|P1|Overall Study|Death|724
2987005|NCT01035229|10277423|P2|Overall Study|Disease Progression|152
2987006|NCT01035229|10277424|P1|Overall Study|Disease Progression|261
2987007|NCT01035229|10277423|P2|Overall Study|Sponsor's decision to end study|3
2987008|NCT01035229|10277424|P1|Overall Study|Sponsor's decision to end study|3
2987009|NCT01035229|10277423|P2|Overall Study|Protocol Violation|2
2987010|NCT01035229|10277424|P1|Overall Study|Protocol Violation|0
2987011|NCT01035229|10277423|P2|Overall Study|New cancer therapy|0
2987012|NCT01035229|10277424|P1|Overall Study|New cancer therapy|2
2987013|NCT01035229|10277423|P2|Overall Study|Death|5
2987014|NCT01035229|10277424|P1|Overall Study|Death|13
2987015|NCT01035229|10277423|P2|Overall Study|Administrative problems|1
2987016|NCT01035229|10277424|P1|Overall Study|Administrative problems|1
2987017|NCT01035229|10277423|P2|Overall Study|Lost to Follow-up|0
2987018|NCT01035229|10277424|P1|Overall Study|Lost to Follow-up|1
2987019|NCT01035229|10277423|P2|Overall Study|Withdrawal by Subject|7
2987020|NCT01035229|10277424|P1|Overall Study|Withdrawal by Subject|20
2987021|NCT01035229|10277423|P2|Overall Study|Adverse Event|14
2987022|NCT01035229|10277424|P1|Overall Study|Adverse Event|61
2987023|NCT01035138|10277454|P3|Overall Study|Lost to Follow-up|1
2987024|NCT01035138|10277455|P2|Overall Study|Lost to Follow-up|0
2987025|NCT01035138|10277456|P1|Overall Study|Lost to Follow-up|0
2987026|NCT01035138|10277454|P3|Overall Study|Sponsor Decision|42
2987027|NCT01035138|10277455|P2|Overall Study|Sponsor Decision|60
2987028|NCT01035138|10277456|P1|Overall Study|Sponsor Decision|66
2987029|NCT01035138|10277454|P3|Overall Study|Physician Decision|1
2987030|NCT01035138|10277455|P2|Overall Study|Physician Decision|0
2987031|NCT01035138|10277456|P1|Overall Study|Physician Decision|0
2987032|NCT01035138|10277454|P3|Overall Study|Withdrawal by Subject|0
2987033|NCT01035138|10277455|P2|Overall Study|Withdrawal by Subject|0
2987034|NCT01035138|10277456|P1|Overall Study|Withdrawal by Subject|1
2987035|NCT01035138|10277454|P3|Overall Study|Caregiver Decision|1
2987036|NCT01035138|10277455|P2|Overall Study|Caregiver Decision|0
2987037|NCT01035138|10277456|P1|Overall Study|Caregiver Decision|2
2987038|NCT01035138|10277454|P3|Overall Study|Adverse Event|2
2987039|NCT01035138|10277455|P2|Overall Study|Adverse Event|0
2987040|NCT01035138|10277456|P1|Overall Study|Adverse Event|4
2987041|NCT01035060|10277517|P2|Overall Study|Physician Decision|0
2987042|NCT01035060|10277518|P1|Overall Study|Physician Decision|2
2987043|NCT01035060|10277517|P2|Overall Study|Withdrawal by Subject|6
2987044|NCT01035060|10277518|P1|Overall Study|Withdrawal by Subject|8
2987045|NCT01035060|10277517|P2|Overall Study|Did not quality after 2nd screening|1
2987046|NCT01035060|10277518|P1|Overall Study|Did not quality after 2nd screening|14
2987047|NCT01035060|10277517|P2|Overall Study|Lost to Follow-up|7
2987048|NCT01035060|10277518|P1|Overall Study|Lost to Follow-up|0
2987049|NCT01034709|10277543|P2|Overall Study|Protocol Violation|16
2987050|NCT01034709|10277544|P1|Overall Study|Protocol Violation|9
2987051|NCT01034657|10277550|P3|Randomized Phase|Adverse Event|1
2987052|NCT01034657|10277551|P2|Randomized Phase|Adverse Event|2
2987053|NCT01034657|10277552|P1|Randomized Phase|Adverse Event|0
2987054|NCT01034657|10277550|P3|Randomized Phase|Abnormal laboratory value|0
2987055|NCT01034657|10277551|P2|Randomized Phase|Abnormal laboratory value|1
2987056|NCT01034657|10277552|P1|Randomized Phase|Abnormal laboratory value|0
2987057|NCT01034657|10277550|P3|Randomized Phase|Lack of Efficacy|0
2987058|NCT01034657|10277551|P2|Randomized Phase|Lack of Efficacy|1
2987059|NCT01034657|10277552|P1|Randomized Phase|Lack of Efficacy|5
2987060|NCT01034657|10277550|P3|Randomized Phase|Withdrawal by Subject|0
2987061|NCT01034657|10277551|P2|Randomized Phase|Withdrawal by Subject|2
2987062|NCT01034657|10277552|P1|Randomized Phase|Withdrawal by Subject|0
2987063|NCT01034657|10277550|P3|Core Phase|Protocol Violation|0
2987064|NCT01034657|10277551|P2|Core Phase|Protocol Violation|0
2987065|NCT01034657|10277552|P1|Core Phase|Protocol Violation|2
2987066|NCT01034657|10277550|P3|Core Phase|Adverse Event|0
2987067|NCT01034657|10277551|P2|Core Phase|Adverse Event|0
2987068|NCT01034657|10277552|P1|Core Phase|Adverse Event|8
2987069|NCT01034657|10277550|P3|Core Phase|Abnormal laboratory value|0
2987070|NCT01034657|10277551|P2|Core Phase|Abnormal laboratory value|0
2987071|NCT01034657|10277552|P1|Core Phase|Abnormal laboratory value|1
2987072|NCT01034657|10277550|P3|Core Phase|Lack of Efficacy|0
2987073|NCT01034657|10277551|P2|Core Phase|Lack of Efficacy|0
2987074|NCT01034657|10277552|P1|Core Phase|Lack of Efficacy|2
2987075|NCT01034657|10277550|P3|Core Phase|Withdrawal by Subject|0
2987076|NCT01034657|10277551|P2|Core Phase|Withdrawal by Subject|0
2987077|NCT01034657|10277552|P1|Core Phase|Withdrawal by Subject|1
2987078|NCT01034631|10277593|P3|Phase II|Determined Ineligible per protocol|0
2987079|NCT01034631|10277594|P2|Phase II|Determined Ineligible per protocol|1
2987080|NCT01034631|10277595|P1|Phase II|Determined Ineligible per protocol|0
2987081|NCT01034631|10277593|P3|Phase II|Not Evaluable per protocol|2
2987082|NCT01034631|10277594|P2|Phase II|Not Evaluable per protocol|0
2987083|NCT01034631|10277595|P1|Phase II|Not Evaluable per protocol|0
2987084|NCT01034631|10277593|P3|Phase I|Symptomatic Deterioration before Treatme|0
2987085|NCT01034631|10277594|P2|Phase I|Symptomatic Deterioration before Treatme|0
2987086|NCT01034631|10277595|P1|Phase I|Symptomatic Deterioration before Treatme|3
2987087|NCT01034540|10277662|P2|Overall Study|Adverse Event|1
2987088|NCT01034540|10277663|P1|Overall Study|Adverse Event|0
2987089|NCT01034462|10277682|P2|Overall Study|Other reasons|2
2987090|NCT01034462|10277683|P1|Overall Study|Other reasons|1
2987091|NCT01034462|10277682|P2|Overall Study|Lost to Follow-up|16
2987092|NCT01034462|10277683|P1|Overall Study|Lost to Follow-up|14
2987093|NCT01034462|10277682|P2|Overall Study|Withdrawal by Subject|8
2987094|NCT01034462|10277683|P1|Overall Study|Withdrawal by Subject|9
2987095|NCT01034462|10277682|P2|Overall Study|Protocol Violation|7
2987096|NCT01034462|10277683|P1|Overall Study|Protocol Violation|10
2987097|NCT01034462|10277682|P2|Overall Study|Lack of Efficacy|4
2987098|NCT01034462|10277683|P1|Overall Study|Lack of Efficacy|4
2987099|NCT01034462|10277682|P2|Overall Study|Adverse Event|17
2987100|NCT01034462|10277683|P1|Overall Study|Adverse Event|7
2987101|NCT01034397|10277693|P2|Overall Study|Other|1
2987102|NCT01034397|10277694|P1|Overall Study|Other|0
2987103|NCT01034397|10277693|P2|Overall Study|Adverse Event|0
2987104|NCT01034397|10277694|P1|Overall Study|Adverse Event|4
2987105|NCT01034397|10277693|P2|Overall Study|Lack of Efficacy|0
2987106|NCT01034397|10277694|P1|Overall Study|Lack of Efficacy|3
2987107|NCT01034397|10277693|P2|Overall Study|Lack of compliance|1
2987108|NCT01034397|10277694|P1|Overall Study|Lack of compliance|0
2987109|NCT01034358|10277843|P1|Overall Study|Protocol Violation|1
2987110|NCT01034358|10277843|P1|Overall Study|Withdrawal by Subject|1
2987111|NCT01034306|10277849|P2|Overall Study|Noncomplience|0
2987112|NCT01034306|10277850|P1|Overall Study|Noncomplience|1
2987113|NCT01034306|10277849|P2|Overall Study|hospitalized and decided to stop|0
2987114|NCT01034306|10277850|P1|Overall Study|hospitalized and decided to stop|1
2987115|NCT01034306|10277849|P2|Overall Study|Withdrawal by Subject|2
2987116|NCT01034306|10277850|P1|Overall Study|Withdrawal by Subject|2
2987117|NCT01034306|10277849|P2|Overall Study|Lost to Follow-up|1
2987118|NCT01034306|10277850|P1|Overall Study|Lost to Follow-up|0
2987119|NCT01034306|10277849|P2|Overall Study|Adverse Event|0
2987120|NCT01034306|10277850|P1|Overall Study|Adverse Event|1
2987121|NCT01034176|10277858|P2|Overall Study|Lost to Follow-up|1
2987122|NCT01034176|10277859|P1|Overall Study|Lost to Follow-up|0
2987123|NCT01034176|10277858|P2|Overall Study|Withdrawal by Subject|1
2987124|NCT01034176|10277859|P1|Overall Study|Withdrawal by Subject|0
2987125|NCT01034176|10277858|P2|Overall Study|Physician Decision|0
2987126|NCT01034176|10277859|P1|Overall Study|Physician Decision|2
2987127|NCT01034163|10277869|P2|Overall Study|Abnormal laboratory value|0
2987128|NCT01034163|10277870|P1|Overall Study|Abnormal laboratory value|1
2987129|NCT01034163|10277869|P2|Overall Study|Administrative problems|1
2987130|NCT01034163|10277870|P1|Overall Study|Administrative problems|0
2987131|NCT01034163|10277869|P2|Overall Study|Adverse Event|0
2987132|NCT01034163|10277870|P1|Overall Study|Adverse Event|6
2987133|NCT01034163|10277869|P2|Overall Study|Disease progression|4
2987134|NCT01034163|10277870|P1|Overall Study|Disease progression|3
2987135|NCT01034163|10277869|P2|Overall Study|Protocol deviation|0
2987136|NCT01034163|10277870|P1|Overall Study|Protocol deviation|1
2987137|NCT01034163|10277869|P2|Overall Study|Withdrawal by Subject|2
2987138|NCT01034163|10277870|P1|Overall Study|Withdrawal by Subject|8
2987139|NCT01034163|10277869|P2|Overall Study|Treatment completed as per protocol|7
2987140|NCT01034163|10277870|P1|Overall Study|Treatment completed as per protocol|8
2987141|NCT01034137|10277879|P3|Overall Study|Administrative or other|4
2987142|NCT01034137|10277880|P2|Overall Study|Administrative or other|3
2987143|NCT01034137|10277881|P1|Overall Study|Administrative or other|2
2987144|NCT01034137|10277879|P3|Overall Study|Refused treatment or did not cooperate|1
2987145|NCT01034137|10277880|P2|Overall Study|Refused treatment or did not cooperate|0
2987146|NCT01034137|10277881|P1|Overall Study|Refused treatment or did not cooperate|2
2987147|NCT01034137|10277879|P3|Overall Study|Protocol Violation|1
2987148|NCT01034137|10277880|P2|Overall Study|Protocol Violation|2
2987149|NCT01034137|10277881|P1|Overall Study|Protocol Violation|2
2987150|NCT01034137|10277879|P3|Overall Study|Lack of Efficacy|13
2987151|NCT01034137|10277880|P2|Overall Study|Lack of Efficacy|4
2987152|NCT01034137|10277881|P1|Overall Study|Lack of Efficacy|9
2987153|NCT01034137|10277879|P3|Overall Study|Withdrawal by Subject|3
2987154|NCT01034137|10277880|P2|Overall Study|Withdrawal by Subject|3
2987155|NCT01034137|10277881|P1|Overall Study|Withdrawal by Subject|4
2987156|NCT01034137|10277879|P3|Overall Study|Adverse Event|8
2987157|NCT01034137|10277880|P2|Overall Study|Adverse Event|10
2987158|NCT01034137|10277881|P1|Overall Study|Adverse Event|9
2987159|NCT01033942|10278020|P3|Overall Study|Enrolled in Extension Study|0
2987160|NCT01033942|10278021|P2|Overall Study|Enrolled in Extension Study|3
2987161|NCT01033942|10278022|P1|Overall Study|Enrolled in Extension Study|0
2987162|NCT01033942|10278020|P3|Overall Study|Lost to Follow-up|0
2987163|NCT01033942|10278021|P2|Overall Study|Lost to Follow-up|0
2987164|NCT01033942|10278022|P1|Overall Study|Lost to Follow-up|1
2987165|NCT01033942|10278020|P3|Overall Study|Withdrawal by Subject|1
2987166|NCT01033942|10278021|P2|Overall Study|Withdrawal by Subject|1
2987167|NCT01033942|10278022|P1|Overall Study|Withdrawal by Subject|1
2987168|NCT01033851|10278320|P2|Overall Study|Withdrawal by Subject|7
2987169|NCT01033851|10278321|P1|Overall Study|Withdrawal by Subject|3
2987170|NCT01033825|10278336|P7|Overall Study|Other|0
2987171|NCT01033825|10278337|P6|Overall Study|Other|0
2987172|NCT01033825|10278338|P5|Overall Study|Other|1
2987173|NCT01033825|10278339|P4|Overall Study|Other|0
2987174|NCT01033825|10278340|P3|Overall Study|Other|0
2987175|NCT01033825|10278341|P2|Overall Study|Other|0
2987176|NCT01033825|10278342|P1|Overall Study|Other|0
2987177|NCT01033825|10278336|P7|Overall Study|Protocol Violation|0
2987178|NCT01033825|10278337|P6|Overall Study|Protocol Violation|0
2987179|NCT01033825|10278338|P5|Overall Study|Protocol Violation|0
2987180|NCT01033825|10278339|P4|Overall Study|Protocol Violation|0
2987181|NCT01033825|10278340|P3|Overall Study|Protocol Violation|0
2987182|NCT01033825|10278341|P2|Overall Study|Protocol Violation|0
2987183|NCT01033825|10278342|P1|Overall Study|Protocol Violation|1
2987184|NCT01033825|10278336|P7|Overall Study|Adverse Event|0
2987185|NCT01033825|10278337|P6|Overall Study|Adverse Event|0
2987186|NCT01033825|10278338|P5|Overall Study|Adverse Event|0
2987187|NCT01033825|10278339|P4|Overall Study|Adverse Event|1
2987188|NCT01033825|10278340|P3|Overall Study|Adverse Event|0
2987189|NCT01033825|10278341|P2|Overall Study|Adverse Event|0
2987190|NCT01033825|10278342|P1|Overall Study|Adverse Event|0
2987191|NCT01033825|10278336|P7|Overall Study|Withdrawal by Subject|0
2987192|NCT01033825|10278337|P6|Overall Study|Withdrawal by Subject|0
2987193|NCT01033825|10278338|P5|Overall Study|Withdrawal by Subject|1
2987194|NCT01033825|10278339|P4|Overall Study|Withdrawal by Subject|1
2987195|NCT01033825|10278340|P3|Overall Study|Withdrawal by Subject|2
2987196|NCT01033825|10278341|P2|Overall Study|Withdrawal by Subject|3
2987197|NCT01033825|10278342|P1|Overall Study|Withdrawal by Subject|2
2987198|NCT01033747|10278563|P2|Overall Study|Stopped at end of Extension 1|0
2987199|NCT01033747|10278564|P1|Overall Study|Stopped at end of Extension 1|2
2987200|NCT01033747|10278563|P2|Overall Study|Stopped at end of prolongation visit 1|0
2987201|NCT01033747|10278564|P1|Overall Study|Stopped at end of prolongation visit 1|1
2987202|NCT01033747|10278563|P2|Overall Study|Withdrawal by Subject|6
2987203|NCT01033747|10278564|P1|Overall Study|Withdrawal by Subject|9
2987204|NCT01033747|10278563|P2|Overall Study|Protocol Violation|0
2987205|NCT01033747|10278564|P1|Overall Study|Protocol Violation|1
2987206|NCT01033747|10278563|P2|Overall Study|Unsatisfactory therapeutic effect|4
2987207|NCT01033747|10278564|P1|Overall Study|Unsatisfactory therapeutic effect|14
2987208|NCT01033747|10278563|P2|Overall Study|Abnormal test procedure|1
2987209|NCT01033747|10278564|P1|Overall Study|Abnormal test procedure|0
2987210|NCT01033747|10278563|P2|Overall Study|Abnormal Laboratory Value|0
2987211|NCT01033747|10278564|P1|Overall Study|Abnormal Laboratory Value|1
2987212|NCT01033747|10278563|P2|Overall Study|Adverse Event|4
2987213|NCT01033747|10278564|P1|Overall Study|Adverse Event|9
2987214|NCT01033734|10278572|P1|Overall Study|Withdrawal by Subject|1
2987215|NCT01033487|10278628|P10|Fourth Intervention Period|Adverse Event|0
2987216|NCT01033487|10278629|P9|Fourth Intervention Period|Adverse Event|1
2987217|NCT01033487|10278630|P8|Fourth Intervention Period|Adverse Event|0
2987218|NCT01033487|10278631|P7|Fourth Intervention Period|Adverse Event|0
2987219|NCT01033487|10278632|P6|Fourth Intervention Period|Adverse Event|0
2987220|NCT01033487|10278633|P5|Fourth Intervention Period|Adverse Event|0
2987221|NCT01033487|10278634|P4|Fourth Intervention Period|Adverse Event|0
2987222|NCT01033487|10278635|P3|Fourth Intervention Period|Adverse Event|0
2987223|NCT01033487|10278636|P2|Fourth Intervention Period|Adverse Event|0
2987224|NCT01033487|10278637|P1|Fourth Intervention Period|Adverse Event|0
2987225|NCT01033448|10278691|P1|Overall Study|Unknown disposition|1
2987226|NCT01033448|10278691|P1|Overall Study|Withdrew due to other reasons|3
2987227|NCT01033448|10278691|P1|Overall Study|Lost to Follow-up|3
2987228|NCT01033448|10278691|P1|Overall Study|Positive HCV-RNA at week 48|1
2987229|NCT01033448|10278691|P1|Overall Study|Withdrawal by Subject|4
2987230|NCT01033136|10278750|P2|Follow-Up (3 Month)|Lost to Follow-up|2
2987231|NCT01033136|10278751|P1|Follow-Up (3 Month)|Lost to Follow-up|2
2987232|NCT01033071|10278762|P3|Overall Study|Other|3
2987233|NCT01033071|10278763|P2|Overall Study|Other|4
2987234|NCT01033071|10278764|P1|Overall Study|Other|6
2987235|NCT01033071|10278762|P3|Overall Study|Lack of Efficacy|1
2987236|NCT01033071|10278763|P2|Overall Study|Lack of Efficacy|1
2987237|NCT01033071|10278764|P1|Overall Study|Lack of Efficacy|0
2987238|NCT01033071|10278762|P3|Overall Study|Withdrawal by Subject|11
2987239|NCT01033071|10278763|P2|Overall Study|Withdrawal by Subject|14
2987240|NCT01033071|10278764|P1|Overall Study|Withdrawal by Subject|17
2987241|NCT01033071|10278762|P3|Overall Study|Lost to Follow-up|5
2987242|NCT01033071|10278763|P2|Overall Study|Lost to Follow-up|5
2987243|NCT01033071|10278764|P1|Overall Study|Lost to Follow-up|4
2987244|NCT01033071|10278762|P3|Overall Study|Protocol Violation|1
2987245|NCT01033071|10278763|P2|Overall Study|Protocol Violation|2
2987246|NCT01033071|10278764|P1|Overall Study|Protocol Violation|0
2987247|NCT01033071|10278762|P3|Overall Study|Adverse Event|26
2987248|NCT01033071|10278763|P2|Overall Study|Adverse Event|51
2987249|NCT01033071|10278764|P1|Overall Study|Adverse Event|28
2987250|NCT01033019|10278835|P2|Overall Study|Withdrawal by Subject|0
2987251|NCT01033019|10278836|P1|Overall Study|Withdrawal by Subject|1
2987252|NCT01032915|10278874|P4|Overall Study|Protocol Violation|1
2987253|NCT01032915|10278875|P3|Overall Study|Protocol Violation|0
2987254|NCT01032915|10278876|P2|Overall Study|Protocol Violation|0
2987255|NCT01032915|10278877|P1|Overall Study|Protocol Violation|1
2987256|NCT01032915|10278874|P4|Overall Study|Administrative reasons|4
2987257|NCT01032915|10278875|P3|Overall Study|Administrative reasons|4
2987258|NCT01032915|10278876|P2|Overall Study|Administrative reasons|6
2987259|NCT01032915|10278877|P1|Overall Study|Administrative reasons|5
2987260|NCT01032915|10278874|P4|Overall Study|Withdrawal by Subject|1
2987261|NCT01032915|10278875|P3|Overall Study|Withdrawal by Subject|1
2987262|NCT01032915|10278876|P2|Overall Study|Withdrawal by Subject|3
2987263|NCT01032915|10278877|P1|Overall Study|Withdrawal by Subject|0
2987264|NCT01032915|10278874|P4|Overall Study|Abnormal test procedure result|0
2987265|NCT01032915|10278875|P3|Overall Study|Abnormal test procedure result|1
2987266|NCT01032915|10278876|P2|Overall Study|Abnormal test procedure result|0
2987267|NCT01032915|10278877|P1|Overall Study|Abnormal test procedure result|0
2987268|NCT01032915|10278874|P4|Overall Study|Adverse Event|1
2987269|NCT01032915|10278875|P3|Overall Study|Adverse Event|1
2987270|NCT01032915|10278876|P2|Overall Study|Adverse Event|2
2987271|NCT01032915|10278877|P1|Overall Study|Adverse Event|2
2987272|NCT01032889|10278902|P3|Overall Study|Miscellaneous Reasons|1
2987273|NCT01032889|10278903|P2|Overall Study|Miscellaneous Reasons|1
2987274|NCT01032889|10278904|P1|Overall Study|Miscellaneous Reasons|2
2987275|NCT01032889|10278902|P3|Overall Study|Lack of Submental Fat|1
2987276|NCT01032889|10278903|P2|Overall Study|Lack of Submental Fat|8
2987277|NCT01032889|10278904|P1|Overall Study|Lack of Submental Fat|2
2987278|NCT01032889|10278902|P3|Overall Study|Lost to Follow-up|0
2987279|NCT01032889|10278903|P2|Overall Study|Lost to Follow-up|1
2987280|NCT01032889|10278904|P1|Overall Study|Lost to Follow-up|1
2987281|NCT01032889|10278902|P3|Overall Study|Patient Request|0
2987282|NCT01032889|10278903|P2|Overall Study|Patient Request|1
2987283|NCT01032889|10278904|P1|Overall Study|Patient Request|0
2987284|NCT01032889|10278902|P3|Overall Study|Withdrawal of Consent|1
2987285|NCT01032889|10278903|P2|Overall Study|Withdrawal of Consent|2
2987286|NCT01032889|10278904|P1|Overall Study|Withdrawal of Consent|1
2987287|NCT01032889|10278902|P3|Overall Study|Adverse Event|0
2987288|NCT01032889|10278903|P2|Overall Study|Adverse Event|2
2987289|NCT01032889|10278904|P1|Overall Study|Adverse Event|2
2987290|NCT01032837|10278935|P4|Overall Study|Refused treatment|1
2987291|NCT01032837|10278936|P3|Overall Study|Refused treatment|0
2987292|NCT01032837|10278937|P2|Overall Study|Refused treatment|0
2987293|NCT01032837|10278938|P1|Overall Study|Refused treatment|0
2987294|NCT01032837|10278935|P4|Overall Study|Failed to return|0
2987295|NCT01032837|10278936|P3|Overall Study|Failed to return|1
2987296|NCT01032837|10278937|P2|Overall Study|Failed to return|0
2987297|NCT01032837|10278938|P1|Overall Study|Failed to return|0
2987298|NCT01032837|10278935|P4|Overall Study|Withdrew consent|1
2987299|NCT01032837|10278936|P3|Overall Study|Withdrew consent|0
2987300|NCT01032837|10278937|P2|Overall Study|Withdrew consent|2
2987301|NCT01032837|10278938|P1|Overall Study|Withdrew consent|0
2987302|NCT01032837|10278935|P4|Overall Study|Adverse event/internal illness|1
2987303|NCT01032837|10278936|P3|Overall Study|Adverse event/internal illness|0
2987304|NCT01032837|10278937|P2|Overall Study|Adverse event/internal illness|1
2987305|NCT01032837|10278938|P1|Overall Study|Adverse event/internal illness|0
2987306|NCT01032629|10279038|P3|Overall Study|Lost to Follow-up|37
2987307|NCT01032629|10279039|P2|Overall Study|Lost to Follow-up|47
2987308|NCT01032629|10279040|P1|Overall Study|Lost to Follow-up|74
2987309|NCT01032629|10279038|P3|Overall Study|Withdrawal by Subject|35
2987310|NCT01032629|10279039|P2|Overall Study|Withdrawal by Subject|36
2987311|NCT01032629|10279040|P1|Overall Study|Withdrawal by Subject|50
2987312|NCT01032629|10279038|P3|Overall Study|Closed Site|16
2987313|NCT01032629|10279039|P2|Overall Study|Closed Site|18
2987314|NCT01032629|10279040|P1|Overall Study|Closed Site|21
2987315|NCT01032382|10279152|P2|Overall Study|Index lesion relapse|3
2987316|NCT01032382|10279153|P1|Overall Study|Index lesion relapse|1
2987317|NCT01032382|10279152|P2|Overall Study|Treatment failure|1
2987318|NCT01032382|10279153|P1|Overall Study|Treatment failure|3
2987319|NCT01032382|10279152|P2|Overall Study|Disease dissemination|1
2987320|NCT01032382|10279153|P1|Overall Study|Disease dissemination|1
2987321|NCT01032291|10279241|P3|Proof of Concept|Never Received Study Drug|0
2987322|NCT01032291|10279242|P2|Proof of Concept|Never Received Study Drug|1
2987323|NCT01032291|10279243|P1|Proof of Concept|Never Received Study Drug|0
2987324|NCT01032291|10279241|P3|Proof of Concept|Lack of Efficacy|0
2987325|NCT01032291|10279242|P2|Proof of Concept|Lack of Efficacy|1
2987326|NCT01032291|10279243|P1|Proof of Concept|Lack of Efficacy|0
2987327|NCT01032291|10279241|P3|Proof of Concept|Death|2
2987328|NCT01032291|10279242|P2|Proof of Concept|Death|1
2987329|NCT01032291|10279243|P1|Proof of Concept|Death|0
2987330|NCT01032291|10279241|P3|Proof of Concept|Adverse Event|1
2987331|NCT01032291|10279242|P2|Proof of Concept|Adverse Event|5
2987332|NCT01032291|10279243|P1|Proof of Concept|Adverse Event|0
2987333|NCT01032291|10279241|P3|Safety Lead-in|Death|0
2987334|NCT01032291|10279242|P2|Safety Lead-in|Death|0
2987335|NCT01032291|10279243|P1|Safety Lead-in|Death|1
2987336|NCT01032291|10279241|P3|Safety Lead-in|Adverse Event|0
2987337|NCT01032291|10279242|P2|Safety Lead-in|Adverse Event|0
2987338|NCT01032291|10279243|P1|Safety Lead-in|Adverse Event|1
2987339|NCT01032239|10279290|P2|Overall Study|Protocol Violation|0
2987340|NCT01032239|10279291|P1|Overall Study|Protocol Violation|1
2987341|NCT01032239|10279290|P2|Overall Study|Death|0
2987342|NCT01032239|10279291|P1|Overall Study|Death|1
2987343|NCT01032239|10279290|P2|Overall Study|Withdrawal by Subject|3
2987344|NCT01032239|10279291|P1|Overall Study|Withdrawal by Subject|2
2987345|NCT01032239|10279290|P2|Overall Study|Lost to Follow-up|2
2987346|NCT01032239|10279291|P1|Overall Study|Lost to Follow-up|3
2987347|NCT01032200|10279321|P2|Overall Study|Multiple|1
2987348|NCT01032200|10279322|P1|Overall Study|Multiple|1
2987349|NCT01032200|10279321|P2|Overall Study|Progression|0
2987350|NCT01032200|10279322|P1|Overall Study|Progression|1
2987351|NCT01032200|10279321|P2|Overall Study|Toxicity|2
2987352|NCT01032200|10279322|P1|Overall Study|Toxicity|0
2987353|NCT01032200|10279321|P2|Overall Study|Withdrawal by Subject|3
2987354|NCT01032200|10279322|P1|Overall Study|Withdrawal by Subject|1
2987355|NCT01032200|10279321|P2|Overall Study|Death|1
2987356|NCT01032200|10279322|P1|Overall Study|Death|1
2987357|NCT01032174|10279338|P2|Overall Study|Adverse Event|1
2987358|NCT01032174|10279339|P1|Overall Study|Adverse Event|0
2987359|NCT01032070|10279579|P2|Overall Study|Withdrawal by Subject|2
2987360|NCT01032070|10279580|P1|Overall Study|Withdrawal by Subject|0
2987361|NCT01032070|10279579|P2|Overall Study|Medical or ethical reasons|2
2987362|NCT01032070|10279580|P1|Overall Study|Medical or ethical reasons|0
2987363|NCT01032070|10279579|P2|Overall Study|Disease progression|8
2987364|NCT01032070|10279580|P1|Overall Study|Disease progression|13
2987365|NCT01032044|10279609|P2|Overall Study|Lost to Follow-up|11
2987366|NCT01032044|10279610|P1|Overall Study|Lost to Follow-up|11
2987367|NCT01032044|10279609|P2|Overall Study|Adverse Event|1
2987368|NCT01032044|10279610|P1|Overall Study|Adverse Event|0
2987369|NCT01032044|10279609|P2|Overall Study|Protocol Violation|8
2987370|NCT01032044|10279610|P1|Overall Study|Protocol Violation|14
2987371|NCT01032018|10279618|P2|Overall Study|Death|1
2987372|NCT01032018|10279619|P1|Overall Study|Death|0
2987373|NCT01032018|10279618|P2|Overall Study|Lost to Follow-up|5
2987374|NCT01032018|10279619|P1|Overall Study|Lost to Follow-up|6
2987375|NCT01031979|10279629|P2|Overall Study|Lost to Follow-up|4
2987376|NCT01031979|10279630|P1|Overall Study|Lost to Follow-up|5
2987377|NCT01031836|10279663|P6|Stage II|Other|0
2987378|NCT01031836|10279664|P5|Stage II|Other|1
2987379|NCT01031836|10279665|P4|Stage II|Other|1
2987380|NCT01031836|10279666|P3|Stage II|Other|0
2987381|NCT01031836|10279667|P2|Stage II|Other|0
2987382|NCT01031836|10279668|P1|Stage II|Other|2
2987383|NCT01031836|10279663|P6|Stage II|Adverse Event|1
2987384|NCT01031836|10279664|P5|Stage II|Adverse Event|1
2987385|NCT01031836|10279665|P4|Stage II|Adverse Event|2
2987386|NCT01031836|10279666|P3|Stage II|Adverse Event|2
2987387|NCT01031836|10279667|P2|Stage II|Adverse Event|0
2987388|NCT01031836|10279668|P1|Stage II|Adverse Event|0
2987389|NCT01031836|10279663|P6|Stage I|Other|1
2987390|NCT01031836|10279664|P5|Stage I|Other|0
2987391|NCT01031836|10279665|P4|Stage I|Other|0
2987392|NCT01031836|10279666|P3|Stage I|Other|0
2987393|NCT01031836|10279667|P2|Stage I|Other|1
2987394|NCT01031836|10279668|P1|Stage I|Other|0
2987395|NCT01031836|10279663|P6|Stage I|Adverse Event|0
2987396|NCT01031836|10279664|P5|Stage I|Adverse Event|0
2987397|NCT01031836|10279665|P4|Stage I|Adverse Event|0
2987398|NCT01031836|10279666|P3|Stage I|Adverse Event|0
2987399|NCT01031836|10279667|P2|Stage I|Adverse Event|1
2987400|NCT01031836|10279668|P1|Stage I|Adverse Event|1
2987401|NCT01031706|10279729|P2|Overall Study|Withdrawal by Subject|1
2987402|NCT01031706|10279730|P1|Overall Study|Withdrawal by Subject|1
2987403|NCT01031706|10279729|P2|Overall Study|Adverse Event|0
2987404|NCT01031706|10279730|P1|Overall Study|Adverse Event|1
2987405|NCT01031680|10279740|P2|Overall Study|Various|2
2987406|NCT01031680|10279741|P1|Overall Study|Various|0
2987407|NCT01031680|10279740|P2|Overall Study|Administrative Reason by Sponsor|1
2987408|NCT01031680|10279741|P1|Overall Study|Administrative Reason by Sponsor|0
2987409|NCT01031680|10279740|P2|Overall Study|Incorrect Enrolment|2
2987410|NCT01031680|10279741|P1|Overall Study|Incorrect Enrolment|1
2987411|NCT01031680|10279740|P2|Overall Study|Safety|0
2987412|NCT01031680|10279741|P1|Overall Study|Safety|1
2987413|NCT01031680|10279740|P2|Overall Study|Poor/Non-compliance|6
2987414|NCT01031680|10279741|P1|Overall Study|Poor/Non-compliance|5
2987415|NCT01031680|10279740|P2|Overall Study|Subject No Longer Meets Study Criteria|17
2987416|NCT01031680|10279741|P1|Overall Study|Subject No Longer Meets Study Criteria|26
2987417|NCT01031680|10279740|P2|Overall Study|Death|1
2987418|NCT01031680|10279741|P1|Overall Study|Death|2
2987419|NCT01031680|10279740|P2|Overall Study|Withdrawal by Subject|16
2987420|NCT01031680|10279741|P1|Overall Study|Withdrawal by Subject|12
2987421|NCT01031680|10279740|P2|Overall Study|Lost to Follow-up|10
2987422|NCT01031680|10279741|P1|Overall Study|Lost to Follow-up|2
2987423|NCT01031680|10279740|P2|Overall Study|Adverse Event|3
2987424|NCT01031680|10279741|P1|Overall Study|Adverse Event|8
2987425|NCT01031628|10279761|P4|Overall Study|Study terminated early|0
2987426|NCT01031628|10279762|P3|Overall Study|Study terminated early|3
2987427|NCT01031628|10279763|P2|Overall Study|Study terminated early|1
2987428|NCT01031628|10279764|P1|Overall Study|Study terminated early|0
2987429|NCT01031537|10279789|P1|Overall Study|PI removal, no longer met eligibility|12
2987430|NCT01031537|10279789|P1|Overall Study|Withdrawal by Subject|5
2987431|NCT01031537|10279789|P1|Overall Study|moved, met exclusion criteria|10
2987432|NCT01031537|10279789|P1|Overall Study|retired from NIH, met exclusion criteria|1
2987433|NCT01031537|10279789|P1|Overall Study|Lack of Efficacy|1
2987434|NCT01031537|10279789|P1|Overall Study|medical reasons not related to study|3
2987435|NCT01031446|10279807|P1|Overall Study|Still on treatment|1
2987436|NCT01031446|10279807|P1|Overall Study|Withdrawal by Subject|3
2987437|NCT01031446|10279807|P1|Overall Study|Physician Decision|4
2987438|NCT01031446|10279807|P1|Overall Study|Adverse Event|9
2987439|NCT01031446|10279807|P1|Overall Study|Disease Progression|38
2987440|NCT01031381|10279821|P1|Overall Study|Withdrawal by Subject|6
2987441|NCT01031381|10279821|P1|Overall Study|Physician Decision|3
2987442|NCT01031069|10279850|P4|Overall Study|Other|0
2987443|NCT01031069|10279851|P3|Overall Study|Other|1
2987444|NCT01031069|10279852|P2|Overall Study|Other|0
2987445|NCT01031069|10279853|P1|Overall Study|Other|0
2987446|NCT01031069|10279850|P4|Overall Study|Lost to Follow-up|15
2987447|NCT01031069|10279851|P3|Overall Study|Lost to Follow-up|21
2987448|NCT01031069|10279852|P2|Overall Study|Lost to Follow-up|5
2987449|NCT01031069|10279853|P1|Overall Study|Lost to Follow-up|9
2987450|NCT01031069|10279850|P4|Overall Study|Migrated/moved from study area|1
2987451|NCT01031069|10279851|P3|Overall Study|Migrated/moved from study area|1
2987452|NCT01031069|10279852|P2|Overall Study|Migrated/moved from study area|2
2987453|NCT01031069|10279853|P1|Overall Study|Migrated/moved from study area|1
2987454|NCT01031069|10279850|P4|Overall Study|Withdrawal by Subject|18
2987455|NCT01031069|10279851|P3|Overall Study|Withdrawal by Subject|18
2987456|NCT01031069|10279852|P2|Overall Study|Withdrawal by Subject|3
2987457|NCT01031069|10279853|P1|Overall Study|Withdrawal by Subject|2
2987458|NCT01031069|10279850|P4|Overall Study|Serious Adverse Event|0
2987459|NCT01031069|10279851|P3|Overall Study|Serious Adverse Event|0
2987460|NCT01031069|10279852|P2|Overall Study|Serious Adverse Event|1
2987461|NCT01031069|10279853|P1|Overall Study|Serious Adverse Event|0
2987462|NCT01031004|10279955|P2|Overall Study|Lost to Follow-up|0
2987463|NCT01031004|10279956|P1|Overall Study|Lost to Follow-up|1
2987464|NCT01031004|10279955|P2|Overall Study|Protocol Violation|1
2987465|NCT01031004|10279956|P1|Overall Study|Protocol Violation|0
2987466|NCT01030965|10280000|P4|Overall Study|Withdrawal by Subject|2
2987467|NCT01030965|10280001|P3|Overall Study|Withdrawal by Subject|0
2987468|NCT01030965|10280002|P2|Overall Study|Withdrawal by Subject|1
2987469|NCT01030965|10280003|P1|Overall Study|Withdrawal by Subject|0
2987470|NCT01030965|10280000|P4|Overall Study|Protocol-defined Stopping Criteria|0
2987471|NCT01030965|10280001|P3|Overall Study|Protocol-defined Stopping Criteria|1
2987472|NCT01030965|10280002|P2|Overall Study|Protocol-defined Stopping Criteria|1
2987473|NCT01030965|10280003|P1|Overall Study|Protocol-defined Stopping Criteria|0
2987474|NCT01030965|10280000|P4|Overall Study|Adverse Event|1
2987475|NCT01030965|10280001|P3|Overall Study|Adverse Event|2
2987476|NCT01030965|10280002|P2|Overall Study|Adverse Event|1
2987477|NCT01030965|10280003|P1|Overall Study|Adverse Event|0
2987478|NCT01030965|10280000|P4|Overall Study|Protocol Violation|1
2987479|NCT01030965|10280001|P3|Overall Study|Protocol Violation|1
2987480|NCT01030965|10280002|P2|Overall Study|Protocol Violation|1
2987481|NCT01030965|10280003|P1|Overall Study|Protocol Violation|1
2987482|NCT01030965|10280000|P4|Overall Study|Lack of Efficacy|3
2987483|NCT01030965|10280001|P3|Overall Study|Lack of Efficacy|0
2987484|NCT01030965|10280002|P2|Overall Study|Lack of Efficacy|2
2987485|NCT01030965|10280003|P1|Overall Study|Lack of Efficacy|3
2987486|NCT01030952|10280023|P2|Overall Study|Unexplained|1
2987487|NCT01030952|10280024|P1|Overall Study|Unexplained|1
2987488|NCT01030952|10280023|P2|Overall Study|Lost to Follow-up|1
2987489|NCT01030952|10280024|P1|Overall Study|Lost to Follow-up|0
2987490|NCT01030952|10280023|P2|Overall Study|Informed consent withdrawal|0
2987491|NCT01030952|10280024|P1|Overall Study|Informed consent withdrawal|1
2987492|NCT01030952|10280023|P2|Overall Study|Protocol Violation|1
2987493|NCT01030952|10280024|P1|Overall Study|Protocol Violation|0
2987494|NCT01030822|10280061|P3|Overall Study|Lost to Follow-up|7
2987495|NCT01030822|10280062|P2|Overall Study|Lost to Follow-up|4
2987496|NCT01030822|10280063|P1|Overall Study|Lost to Follow-up|9
2987497|NCT01030822|10280061|P3|Overall Study|Withdrawal by Subject|16
2987498|NCT01030822|10280062|P2|Overall Study|Withdrawal by Subject|13
2987499|NCT01030822|10280063|P1|Overall Study|Withdrawal by Subject|16
2987500|NCT01030822|10280061|P3|Overall Study|Moved/migrated from study area|3
2987501|NCT01030822|10280062|P2|Overall Study|Moved/migrated from study area|7
2987502|NCT01030822|10280063|P1|Overall Study|Moved/migrated from study area|6
2987503|NCT01030718|10280138|P3|Study CA180-036 Only|Other Reasons|0
2987504|NCT01030718|10280139|P2|Study CA180-036 Only|Other Reasons|2
2987505|NCT01030718|10280140|P1|Study CA180-036 Only|Other Reasons|0
2987506|NCT01030718|10280138|P3|Study CA180-036 Only|Death|0
2987507|NCT01030718|10280139|P2|Study CA180-036 Only|Death|1
2987508|NCT01030718|10280140|P1|Study CA180-036 Only|Death|0
2987509|NCT01030718|10280138|P3|Study CA180-036 Only|Adverse Event|0
2987510|NCT01030718|10280139|P2|Study CA180-036 Only|Adverse Event|3
2987511|NCT01030718|10280140|P1|Study CA180-036 Only|Adverse Event|2
2987512|NCT01030718|10280138|P3|Study CA180-036 Only|insufficient effect|5
2987513|NCT01030718|10280139|P2|Study CA180-036 Only|insufficient effect|1
2987514|NCT01030718|10280140|P1|Study CA180-036 Only|insufficient effect|1
2987515|NCT01030718|10280138|P3|Studies CA180-031 and -036 Combined|other reasons|0
2987516|NCT01030718|10280139|P2|Studies CA180-031 and -036 Combined|other reasons|2
2987517|NCT01030718|10280140|P1|Studies CA180-031 and -036 Combined|other reasons|0
2987518|NCT01030718|10280138|P3|Studies CA180-031 and -036 Combined|Death|0
2987519|NCT01030718|10280139|P2|Studies CA180-031 and -036 Combined|Death|1
2987520|NCT01030718|10280140|P1|Studies CA180-031 and -036 Combined|Death|0
2987521|NCT01030718|10280138|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
2987522|NCT01030718|10280139|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
2987523|NCT01030718|10280140|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
2987524|NCT01030718|10280138|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
2987525|NCT01030718|10280139|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
2987526|NCT01030718|10280140|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
2987527|NCT01030666|10280201|P2|Overall Study|Lost to Follow-up|2
2987528|NCT01030666|10280202|P1|Overall Study|Lost to Follow-up|3
2987529|NCT01030536|10280227|P5|Overall Study|Death|0
2987530|NCT01030536|10280228|P4|Overall Study|Death|0
2987531|NCT01030536|10280229|P3|Overall Study|Death|0
2987532|NCT01030536|10280230|P2|Overall Study|Death|1
2987533|NCT01030536|10280231|P1|Overall Study|Death|0
2987534|NCT01030536|10280227|P5|Overall Study|Progressive disease|0
2987535|NCT01030536|10280228|P4|Overall Study|Progressive disease|2
2987536|NCT01030536|10280229|P3|Overall Study|Progressive disease|3
2987537|NCT01030536|10280230|P2|Overall Study|Progressive disease|2
2987538|NCT01030536|10280231|P1|Overall Study|Progressive disease|6
2987539|NCT01030536|10280227|P5|Overall Study|Adverse Event|1
2987540|NCT01030536|10280228|P4|Overall Study|Adverse Event|0
2987541|NCT01030536|10280229|P3|Overall Study|Adverse Event|1
2987542|NCT01030536|10280230|P2|Overall Study|Adverse Event|3
2987543|NCT01030536|10280231|P1|Overall Study|Adverse Event|0
2987544|NCT01030536|10280227|P5|Overall Study|undefined|0
2987545|NCT01030536|10280228|P4|Overall Study|undefined|1
2987546|NCT01030536|10280229|P3|Overall Study|undefined|1
2987547|NCT01030536|10280230|P2|Overall Study|undefined|0
2987548|NCT01030536|10280231|P1|Overall Study|undefined|1
2987549|NCT01030536|10280227|P5|Overall Study|Withdrawal by Subject|0
2987550|NCT01030536|10280228|P4|Overall Study|Withdrawal by Subject|0
2987551|NCT01030536|10280229|P3|Overall Study|Withdrawal by Subject|1
2987552|NCT01030536|10280230|P2|Overall Study|Withdrawal by Subject|0
2987553|NCT01030536|10280231|P1|Overall Study|Withdrawal by Subject|0
2987554|NCT01030458|10280336|P2|Overall Study|Side effect of medication|1
2987555|NCT01030458|10280337|P1|Overall Study|Side effect of medication|1
2987556|NCT01030458|10280336|P2|Overall Study|Moved or changed job|13
2987557|NCT01030458|10280337|P1|Overall Study|Moved or changed job|6
2987558|NCT01030458|10280336|P2|Overall Study|Logistical reasons|5
2987559|NCT01030458|10280337|P1|Overall Study|Logistical reasons|9
2987560|NCT01030458|10280336|P2|Overall Study|Withdrawal by Subject|3
2987561|NCT01030458|10280337|P1|Overall Study|Withdrawal by Subject|2
2987562|NCT01030458|10280336|P2|Overall Study|Lost to Follow-up|10
2987563|NCT01030458|10280337|P1|Overall Study|Lost to Follow-up|9
2987564|NCT01030341|10280370|P1|Overall Study|Lost to Follow-up|2
2987565|NCT01030341|10280370|P1|Overall Study|Withdrawal by Subject|1
2987566|NCT01030133|10280393|P2|Overall Study|failed to experience pain at level 7/10|2
2987567|NCT01030133|10280394|P1|Overall Study|failed to experience pain at level 7/10|2
2987568|NCT01029925|10280406|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
2987569|NCT01029925|10280406|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
2987570|NCT01029925|10280406|P1|Completion of Cycle 1 (28 Days)|Death|2
2987571|NCT01029886|10280425|P2|Overall Study|Loss Glucose Control|1
2987572|NCT01029886|10280426|P1|Overall Study|Loss Glucose Control|7
2987573|NCT01029886|10280425|P2|Overall Study|Sponsor Decision|0
2987574|NCT01029886|10280426|P1|Overall Study|Sponsor Decision|1
2987575|NCT01029886|10280425|P2|Overall Study|Entry Criteria Not Met|5
2987576|NCT01029886|10280426|P1|Overall Study|Entry Criteria Not Met|13
2987577|NCT01029886|10280425|P2|Overall Study|Withdrawal by Subject|18
2987578|NCT01029886|10280426|P1|Overall Study|Withdrawal by Subject|8
2987579|NCT01029886|10280425|P2|Overall Study|Protocol Violation|5
2987580|NCT01029886|10280426|P1|Overall Study|Protocol Violation|17
2987581|NCT01029886|10280425|P2|Overall Study|Physician Decision|6
2987582|NCT01029886|10280426|P1|Overall Study|Physician Decision|2
2987583|NCT01029886|10280425|P2|Overall Study|Lost to Follow-up|0
2987584|NCT01029886|10280426|P1|Overall Study|Lost to Follow-up|1
2987585|NCT01029886|10280425|P2|Overall Study|Adverse Event|25
2987586|NCT01029886|10280426|P1|Overall Study|Adverse Event|12
2987587|NCT01029795|10280454|P2|Overall Study|Withdrawal by Subject|3
2987588|NCT01029795|10280455|P1|Overall Study|Withdrawal by Subject|1
2987589|NCT01029795|10280454|P2|Overall Study|Sponsor Decision|17
2987590|NCT01029795|10280455|P1|Overall Study|Sponsor Decision|11
2987591|NCT01029795|10280454|P2|Overall Study|Physician Decision|1
2987592|NCT01029795|10280455|P1|Overall Study|Physician Decision|2
2987593|NCT01029795|10280454|P2|Overall Study|Entry Criteria Not Met|1
2987594|NCT01029795|10280455|P1|Overall Study|Entry Criteria Not Met|2
2987595|NCT01029782|10280509|P2|Overall Study|Withdrawal by Subject|1
2987596|NCT01029782|10280510|P1|Overall Study|Withdrawal by Subject|0
2987597|NCT01029782|10280509|P2|Overall Study|Protocol Violation|2
2987598|NCT01029782|10280510|P1|Overall Study|Protocol Violation|0
2987599|NCT01029782|10280509|P2|Overall Study|Physician Decision|1
2987600|NCT01029782|10280510|P1|Overall Study|Physician Decision|0
2987601|NCT01029782|10280509|P2|Overall Study|Adverse Event|1
2987602|NCT01029782|10280510|P1|Overall Study|Adverse Event|0
2987603|NCT01029782|10280509|P2|Overall Study|Diagnosis changed|1
2987604|NCT01029782|10280510|P1|Overall Study|Diagnosis changed|1
2987605|NCT01029782|10280509|P2|Overall Study|Lost to Follow-up|2
2987606|NCT01029782|10280510|P1|Overall Study|Lost to Follow-up|2
2987607|NCT01029691|10280562|P3|Continued APAP to Delivery|Death|1
2987608|NCT01029691|10280563|P2|Continued APAP to Delivery|Death|0
2987609|NCT01029691|10280564|P1|Continued APAP to Delivery|Death|0
2987610|NCT01029652|10280589|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
2987611|NCT01029652|10280590|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
2987612|NCT01029652|10280589|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
2987613|NCT01029652|10280590|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
2987614|NCT01029652|10280589|P2|Extension Study 2 (25-72 Weeks)|Death|1
2987615|NCT01029652|10280590|P1|Extension Study 2 (25-72 Weeks)|Death|1
2987616|NCT01029652|10280589|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
2987617|NCT01029652|10280590|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
2987618|NCT01029652|10280589|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
2987619|NCT01029652|10280590|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
2987620|NCT01029652|10280589|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
2987621|NCT01029652|10280590|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
2987622|NCT01029652|10280589|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
2987623|NCT01029652|10280590|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
2987624|NCT01029652|10280589|P2|Core Study (0-12 Weeks)|Death|1
2987625|NCT01029652|10280590|P1|Core Study (0-12 Weeks)|Death|0
2987626|NCT01029652|10280589|P2|Core Study (0-12 Weeks)|Administrative problems|1
2987627|NCT01029652|10280590|P1|Core Study (0-12 Weeks)|Administrative problems|2
2987628|NCT01029652|10280589|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
2987629|NCT01029652|10280590|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
2987630|NCT01029652|10280589|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
2987631|NCT01029652|10280590|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
2987632|NCT01029652|10280589|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
2987633|NCT01029652|10280590|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
2987634|NCT01029535|10280668|P1|Overall Study|Death|1
2987635|NCT01029535|10280668|P1|Overall Study|Use of Another Treatment|1
2987636|NCT01029535|10280668|P1|Overall Study|Adverse Event|1
2987637|NCT01029535|10280668|P1|Overall Study|Participant Withdrew Consent|2
2987638|NCT01029535|10280668|P1|Overall Study|Protocol Violation|2
2987639|NCT01029535|10280668|P1|Overall Study|Lost to Follow-up|24
2987640|NCT01029405|10280697|P4|Overall Study|Other|1
2987641|NCT01029405|10280698|P3|Overall Study|Other|0
2987642|NCT01029405|10280699|P2|Overall Study|Other|1
2987643|NCT01029405|10280700|P1|Overall Study|Other|0
2987644|NCT01029405|10280697|P4|Overall Study|Lost to Follow-up|2
2987645|NCT01029405|10280698|P3|Overall Study|Lost to Follow-up|1
2987646|NCT01029405|10280699|P2|Overall Study|Lost to Follow-up|1
2987647|NCT01029405|10280700|P1|Overall Study|Lost to Follow-up|2
2987648|NCT01029405|10280697|P4|Overall Study|Adverse Event|1
2987649|NCT01029405|10280698|P3|Overall Study|Adverse Event|1
2987650|NCT01029405|10280699|P2|Overall Study|Adverse Event|0
2987651|NCT01029405|10280700|P1|Overall Study|Adverse Event|0
2987652|NCT01029405|10280697|P4|Overall Study|Protocol Violation|1
2987653|NCT01029405|10280698|P3|Overall Study|Protocol Violation|0
2987654|NCT01029405|10280699|P2|Overall Study|Protocol Violation|0
2987655|NCT01029405|10280700|P1|Overall Study|Protocol Violation|0
2987656|NCT01029405|10280697|P4|Overall Study|Withdrawal by Subject|0
2987657|NCT01029405|10280698|P3|Overall Study|Withdrawal by Subject|2
2987658|NCT01029405|10280699|P2|Overall Study|Withdrawal by Subject|1
2987659|NCT01029405|10280700|P1|Overall Study|Withdrawal by Subject|0
2987660|NCT01029392|10280712|P2|Overall Study|Physician Decision|0
2987661|NCT01029392|10280713|P1|Overall Study|Physician Decision|2
2987662|NCT01029392|10280712|P2|Overall Study|Withdrawal by Subject|11
2987663|NCT01029392|10280713|P1|Overall Study|Withdrawal by Subject|18
2987664|NCT01029366|10280723|P2|Overall Study|manufacturing failure|1
2987665|NCT01029366|10280724|P1|Overall Study|manufacturing failure|0
2987666|NCT01029366|10280723|P2|Overall Study|disease progression|0
2987667|NCT01029366|10280724|P1|Overall Study|disease progression|2
2987668|NCT01029366|10280723|P2|Overall Study|Death|1
2987669|NCT01029366|10280724|P1|Overall Study|Death|1
2987670|NCT01029366|10280723|P2|Overall Study|Withdrawal by Subject|0
2987671|NCT01029366|10280724|P1|Overall Study|Withdrawal by Subject|1
2987672|NCT01029340|10280736|P6|Extension Period|Physician Decision|1
2987673|NCT01029340|10280737|P5|Extension Period|Physician Decision|0
2987674|NCT01029340|10280738|P4|Extension Period|Physician Decision|0
2987675|NCT01029340|10280739|P3|Extension Period|Physician Decision|0
2987676|NCT01029340|10280740|P2|Extension Period|Physician Decision|0
2987677|NCT01029340|10280741|P1|Extension Period|Physician Decision|0
2987678|NCT01029340|10280736|P6|Extension Period|Withdrawal by Subject|1
2987679|NCT01029340|10280737|P5|Extension Period|Withdrawal by Subject|0
2987680|NCT01029340|10280738|P4|Extension Period|Withdrawal by Subject|0
2987681|NCT01029340|10280739|P3|Extension Period|Withdrawal by Subject|0
2987682|NCT01029340|10280740|P2|Extension Period|Withdrawal by Subject|0
2987683|NCT01029340|10280741|P1|Extension Period|Withdrawal by Subject|0
2987684|NCT01029340|10280736|P6|Extension Period|non-compliance|1
2987685|NCT01029340|10280737|P5|Extension Period|non-compliance|0
2987686|NCT01029340|10280738|P4|Extension Period|non-compliance|0
2987687|NCT01029340|10280739|P3|Extension Period|non-compliance|0
2987688|NCT01029340|10280740|P2|Extension Period|non-compliance|0
2987689|NCT01029340|10280741|P1|Extension Period|non-compliance|0
2987690|NCT01029340|10280736|P6|Extension Period|starting another study|8
2987691|NCT01029340|10280737|P5|Extension Period|starting another study|0
2987692|NCT01029340|10280738|P4|Extension Period|starting another study|0
2987693|NCT01029340|10280739|P3|Extension Period|starting another study|0
2987694|NCT01029340|10280740|P2|Extension Period|starting another study|0
2987695|NCT01029340|10280741|P1|Extension Period|starting another study|0
2987696|NCT01029340|10280736|P6|Extension Period|Adverse Event|1
2987697|NCT01029340|10280737|P5|Extension Period|Adverse Event|0
2987698|NCT01029340|10280738|P4|Extension Period|Adverse Event|0
2987699|NCT01029340|10280739|P3|Extension Period|Adverse Event|0
2987700|NCT01029340|10280740|P2|Extension Period|Adverse Event|0
2987701|NCT01029340|10280741|P1|Extension Period|Adverse Event|0
2987702|NCT01029340|10280736|P6|Part B Treatment Period|Protocol Violation|0
2987703|NCT01029340|10280737|P5|Part B Treatment Period|Protocol Violation|0
2987704|NCT01029340|10280738|P4|Part B Treatment Period|Protocol Violation|0
2987705|NCT01029340|10280739|P3|Part B Treatment Period|Protocol Violation|1
2987706|NCT01029340|10280740|P2|Part B Treatment Period|Protocol Violation|0
2987707|NCT01029340|10280741|P1|Part B Treatment Period|Protocol Violation|0
2987708|NCT01029340|10280736|P6|Part B Treatment Period|Withdrawal by Subject|0
2987709|NCT01029340|10280737|P5|Part B Treatment Period|Withdrawal by Subject|0
2987710|NCT01029340|10280738|P4|Part B Treatment Period|Withdrawal by Subject|0
2987711|NCT01029340|10280739|P3|Part B Treatment Period|Withdrawal by Subject|1
2987712|NCT01029340|10280740|P2|Part B Treatment Period|Withdrawal by Subject|0
2987713|NCT01029340|10280741|P1|Part B Treatment Period|Withdrawal by Subject|0
2987714|NCT01029262|10280772|P2|Overall Study|Death|3
2987715|NCT01029262|10280773|P1|Overall Study|Death|0
2987716|NCT01029262|10280772|P2|Overall Study|Miscellaneous|9
2987717|NCT01029262|10280773|P1|Overall Study|Miscellaneous|1
2987718|NCT01029262|10280772|P2|Overall Study|Protocol Violation|3
2987719|NCT01029262|10280773|P1|Overall Study|Protocol Violation|2
2987720|NCT01029262|10280772|P2|Overall Study|Withdrawal by Subject|17
2987721|NCT01029262|10280773|P1|Overall Study|Withdrawal by Subject|10
2987722|NCT01029262|10280772|P2|Overall Study|Lack of therapeutic effect|76
2987723|NCT01029262|10280773|P1|Overall Study|Lack of therapeutic effect|57
2987724|NCT01029262|10280772|P2|Overall Study|Adverse Event|52
2987725|NCT01029262|10280773|P1|Overall Study|Adverse Event|9
2987726|NCT01028651|10280942|P1|Overall Study|Adverse Event|1
2987727|NCT01028651|10280942|P1|Overall Study|Death|2
2987728|NCT01028560|10280965|P2|Overall Study|Withdrawal by Subject|12
2987729|NCT01028560|10280966|P1|Overall Study|Withdrawal by Subject|7
2987730|NCT01028560|10280965|P2|Overall Study|Lack of Efficacy|6
2987731|NCT01028560|10280966|P1|Overall Study|Lack of Efficacy|3
2987732|NCT01028391|10280980|P2|Overall Study|Needed excluded medication|1
2987733|NCT01028391|10280981|P1|Overall Study|Needed excluded medication|1
2987734|NCT01028391|10280980|P2|Overall Study|Withdrawal by Subject|3
2987735|NCT01028391|10280981|P1|Overall Study|Withdrawal by Subject|6
2987736|NCT01028391|10280980|P2|Overall Study|Physician Decision|1
2987737|NCT01028391|10280981|P1|Overall Study|Physician Decision|0
2987738|NCT01028391|10280980|P2|Overall Study|Lost to Follow-up|4
2987739|NCT01028391|10280981|P1|Overall Study|Lost to Follow-up|3
2987740|NCT01028391|10280980|P2|Overall Study|Lack of Efficacy|2
2987741|NCT01028391|10280981|P1|Overall Study|Lack of Efficacy|0
2987742|NCT01028391|10280980|P2|Overall Study|Adverse Event|0
2987743|NCT01028391|10280981|P1|Overall Study|Adverse Event|4
2987744|NCT01028378|10280989|P1|Overall Study|Adminstrative Reasons|4
2987745|NCT01028378|10280989|P1|Overall Study|Withdrawal by Subject|1
2987746|NCT01028378|10280989|P1|Overall Study|Lost to Follow-up|12
2987747|NCT01028352|10281001|P1|Overall Study|Withdrawal by Subject|1
2987748|NCT01028352|10281001|P1|Overall Study|Ineligible due to baseline average pain|5
2987749|NCT01028300|10281006|P1|Overall Study|Study Terminated|4
2987750|NCT01028222|10281015|P2|Overall Study|Adverse Event|0
2987751|NCT01028222|10281016|P1|Overall Study|Adverse Event|2
2987752|NCT01028222|10281015|P2|Overall Study|Crossover to nilotinib w/out progression|2
2987753|NCT01028222|10281016|P1|Overall Study|Crossover to nilotinib w/out progression|0
2987754|NCT01028222|10281015|P2|Overall Study|Withdrawal by Subject|0
2987755|NCT01028222|10281016|P1|Overall Study|Withdrawal by Subject|1
2987756|NCT01028222|10281015|P2|Overall Study|Lost to Follow-up|1
2987757|NCT01028222|10281016|P1|Overall Study|Lost to Follow-up|0
2987758|NCT01028222|10281015|P2|Overall Study|Administrative problems|1
2987759|NCT01028222|10281016|P1|Overall Study|Administrative problems|1
2987760|NCT01028222|10281015|P2|Overall Study|Disease progression|9
2987761|NCT01028222|10281016|P1|Overall Study|Disease progression|33
2987762|NCT01028222|10281015|P2|Overall Study|Protocol deviation|0
2987763|NCT01028222|10281016|P1|Overall Study|Protocol deviation|1
2987764|NCT01028053|10281058|P1|Overall Study|Various reasons|4
2987765|NCT01028053|10281058|P1|Overall Study|Terminated by Sponsor|1
2987766|NCT01028053|10281058|P1|Overall Study|Technical Problem|1
2987767|NCT01028053|10281058|P1|Overall Study|Physician Decision|2
2987768|NCT01028053|10281058|P1|Overall Study|Protocol Violation|1
2987769|NCT01028053|10281058|P1|Overall Study|Patient Request|11
2987770|NCT01028053|10281058|P1|Overall Study|Screen Failure|113
2987771|NCT01028027|10281066|P2|Overall Study|Lack of Efficacy|1
2987772|NCT01028027|10281067|P1|Overall Study|Lack of Efficacy|0
2987773|NCT01028027|10281066|P2|Overall Study|Protocol Violation|1
2987774|NCT01028027|10281067|P1|Overall Study|Protocol Violation|3
2987775|NCT01028027|10281066|P2|Overall Study|Adverse Event|7
2987776|NCT01028027|10281067|P1|Overall Study|Adverse Event|4
2987777|NCT01028027|10281066|P2|Overall Study|Withdrawal by Subject|3
2987778|NCT01028027|10281067|P1|Overall Study|Withdrawal by Subject|5
2987779|NCT01028027|10281066|P2|Overall Study|Lost to Follow-up|1
2987780|NCT01028027|10281067|P1|Overall Study|Lost to Follow-up|4
2987781|NCT01028014|10281089|P6|Overall Study|Lost to Follow-up|2
2987782|NCT01028014|10281090|P5|Overall Study|Lost to Follow-up|1
2987783|NCT01028014|10281091|P4|Overall Study|Lost to Follow-up|1
2987784|NCT01028014|10281092|P3|Overall Study|Lost to Follow-up|0
2987785|NCT01028014|10281093|P2|Overall Study|Lost to Follow-up|2
2987786|NCT01028014|10281094|P1|Overall Study|Lost to Follow-up|1
2987787|NCT01027897|10281135|P1|Overall Study|Withdrawal by Subject|1
2987788|NCT01027897|10281135|P1|Overall Study|Protocol Violation|1
2987789|NCT01027884|10281143|P2|Overall Study|Spinal fixation surgery|3
2987790|NCT01027884|10281144|P1|Overall Study|Spinal fixation surgery|0
2987791|NCT01027884|10281143|P2|Overall Study|Lost to Follow-up|1
2987792|NCT01027884|10281144|P1|Overall Study|Lost to Follow-up|0
2987793|NCT01027884|10281143|P2|Overall Study|Withdrawal by Subject|1
2987794|NCT01027884|10281144|P1|Overall Study|Withdrawal by Subject|0
2987795|NCT01027884|10281143|P2|Overall Study|Non-compliance|1
2987796|NCT01027884|10281144|P1|Overall Study|Non-compliance|1
2987797|NCT01027884|10281143|P2|Overall Study|Protocol Violation|0
2987798|NCT01027884|10281144|P1|Overall Study|Protocol Violation|1
2987799|NCT01027884|10281143|P2|Overall Study|Adverse Event|1
2987800|NCT01027884|10281144|P1|Overall Study|Adverse Event|2
2987801|NCT01027871|10281161|P3|Overall Study|Discontinued Prior to Treatment|1
2987802|NCT01027871|10281162|P2|Overall Study|Discontinued Prior to Treatment|0
2987803|NCT01027871|10281163|P1|Overall Study|Discontinued Prior to Treatment|0
2987804|NCT01027871|10281161|P3|Overall Study|Sponsor Decision|0
2987805|NCT01027871|10281162|P2|Overall Study|Sponsor Decision|2
2987806|NCT01027871|10281163|P1|Overall Study|Sponsor Decision|0
2987807|NCT01027871|10281161|P3|Overall Study|Adverse Event|2
2987808|NCT01027871|10281162|P2|Overall Study|Adverse Event|2
2987809|NCT01027871|10281163|P1|Overall Study|Adverse Event|0
2987810|NCT01027871|10281161|P3|Overall Study|Withdrawal by Subject|2
2987811|NCT01027871|10281162|P2|Overall Study|Withdrawal by Subject|2
2987812|NCT01027871|10281163|P1|Overall Study|Withdrawal by Subject|1
2987813|NCT01027871|10281161|P3|Overall Study|Protocol Violation|2
2987814|NCT01027871|10281162|P2|Overall Study|Protocol Violation|2
2987815|NCT01027871|10281163|P1|Overall Study|Protocol Violation|0
2987816|NCT01027871|10281161|P3|Overall Study|Physician Decision|0
2987817|NCT01027871|10281162|P2|Overall Study|Physician Decision|5
2987818|NCT01027871|10281163|P1|Overall Study|Physician Decision|1
2987819|NCT01027845|10281222|P4|Booster Vaccination Phase|Migrated/moved from study area|0
2987820|NCT01027845|10281223|P3|Booster Vaccination Phase|Migrated/moved from study area|0
2987821|NCT01027845|10281224|P2|Booster Vaccination Phase|Migrated/moved from study area|0
2987822|NCT01027845|10281225|P1|Booster Vaccination Phase|Migrated/moved from study area|1
2987823|NCT01027845|10281222|P4|Booster Vaccination Phase|Withdrawal by Subject|0
2987824|NCT01027845|10281223|P3|Booster Vaccination Phase|Withdrawal by Subject|0
2987825|NCT01027845|10281224|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2987826|NCT01027845|10281225|P1|Booster Vaccination Phase|Withdrawal by Subject|1
2987827|NCT01027845|10281222|P4|Primary Vaccination Phase|Migrated/moved from study area|0
2987828|NCT01027845|10281223|P3|Primary Vaccination Phase|Migrated/moved from study area|0
2987829|NCT01027845|10281224|P2|Primary Vaccination Phase|Migrated/moved from study area|1
2987830|NCT01027845|10281225|P1|Primary Vaccination Phase|Migrated/moved from study area|0
2987831|NCT01027845|10281222|P4|Primary Vaccination Phase|Protocol Violation|0
2987832|NCT01027845|10281223|P3|Primary Vaccination Phase|Protocol Violation|0
2987833|NCT01027845|10281224|P2|Primary Vaccination Phase|Protocol Violation|0
2987834|NCT01027845|10281225|P1|Primary Vaccination Phase|Protocol Violation|1
2987835|NCT01027845|10281222|P4|Primary Vaccination Phase|Adverse Event|0
2987836|NCT01027845|10281223|P3|Primary Vaccination Phase|Adverse Event|0
2987837|NCT01027845|10281224|P2|Primary Vaccination Phase|Adverse Event|0
2987838|NCT01027845|10281225|P1|Primary Vaccination Phase|Adverse Event|1
2987839|NCT01027845|10281222|P4|Primary Vaccination Phase|Serious Adverse Event|0
2987840|NCT01027845|10281223|P3|Primary Vaccination Phase|Serious Adverse Event|0
2987841|NCT01027845|10281224|P2|Primary Vaccination Phase|Serious Adverse Event|0
2987842|NCT01027845|10281225|P1|Primary Vaccination Phase|Serious Adverse Event|2
2987843|NCT01027754|10281308|P2|Overall Study|Withdrawal by Subject|5
2987844|NCT01027754|10281309|P1|Overall Study|Withdrawal by Subject|0
2987845|NCT01027754|10281308|P2|Overall Study|withdrew/lost to follow-up after interve|3
2987846|NCT01027754|10281309|P1|Overall Study|withdrew/lost to follow-up after interve|2
2987847|NCT01027702|10281343|P7|Overall Study|Death|0
2987848|NCT01027702|10281344|P6|Overall Study|Death|0
2987849|NCT01027702|10281345|P5|Overall Study|Death|0
2987850|NCT01027702|10281346|P4|Overall Study|Death|0
2987851|NCT01027702|10281347|P3|Overall Study|Death|1
2987852|NCT01027702|10281348|P2|Overall Study|Death|0
2987853|NCT01027702|10281349|P1|Overall Study|Death|0
2987854|NCT01027702|10281343|P7|Overall Study|Received subsequent therapy|1
2987855|NCT01027702|10281344|P6|Overall Study|Received subsequent therapy|0
2987856|NCT01027702|10281345|P5|Overall Study|Received subsequent therapy|1
2987857|NCT01027702|10281346|P4|Overall Study|Received subsequent therapy|4
2987858|NCT01027702|10281347|P3|Overall Study|Received subsequent therapy|0
2987859|NCT01027702|10281348|P2|Overall Study|Received subsequent therapy|2
2987860|NCT01027702|10281349|P1|Overall Study|Received subsequent therapy|1
2987861|NCT01027650|10281375|P8|Overall Study|Lack of Efficacy|0
2987862|NCT01027650|10281376|P7|Overall Study|Lack of Efficacy|0
2987863|NCT01027650|10281377|P6|Overall Study|Lack of Efficacy|1
2987864|NCT01027650|10281378|P5|Overall Study|Lack of Efficacy|0
2987865|NCT01027650|10281379|P4|Overall Study|Lack of Efficacy|0
2987866|NCT01027650|10281380|P3|Overall Study|Lack of Efficacy|0
2987867|NCT01027650|10281381|P2|Overall Study|Lack of Efficacy|0
2987868|NCT01027650|10281382|P1|Overall Study|Lack of Efficacy|0
2987869|NCT01027650|10281375|P8|Overall Study|Lost to Follow-up|0
2987870|NCT01027650|10281376|P7|Overall Study|Lost to Follow-up|1
2987871|NCT01027650|10281377|P6|Overall Study|Lost to Follow-up|0
2987872|NCT01027650|10281378|P5|Overall Study|Lost to Follow-up|0
2987873|NCT01027650|10281379|P4|Overall Study|Lost to Follow-up|0
2987874|NCT01027650|10281380|P3|Overall Study|Lost to Follow-up|0
2987875|NCT01027650|10281381|P2|Overall Study|Lost to Follow-up|0
2987876|NCT01027650|10281382|P1|Overall Study|Lost to Follow-up|0
2987877|NCT01027650|10281375|P8|Overall Study|Personal Reasons|0
2987878|NCT01027650|10281376|P7|Overall Study|Personal Reasons|0
2987879|NCT01027650|10281377|P6|Overall Study|Personal Reasons|1
2987880|NCT01027650|10281378|P5|Overall Study|Personal Reasons|2
2987881|NCT01027650|10281379|P4|Overall Study|Personal Reasons|0
2987882|NCT01027650|10281380|P3|Overall Study|Personal Reasons|0
2987883|NCT01027650|10281381|P2|Overall Study|Personal Reasons|0
2987884|NCT01027650|10281382|P1|Overall Study|Personal Reasons|0
2987885|NCT01027416|10281460|P2|Overall Study|Physician Decision|4
2987886|NCT01027416|10281461|P1|Overall Study|Physician Decision|1
2987887|NCT01027416|10281460|P2|Overall Study|Withdrawal by Subject|1
2987888|NCT01027416|10281461|P1|Overall Study|Withdrawal by Subject|0
2987889|NCT01027364|10281473|P4|Overall Study|Withdrawal by Subject|0
2987890|NCT01027364|10281474|P3|Overall Study|Withdrawal by Subject|0
2987891|NCT01027364|10281475|P2|Overall Study|Withdrawal by Subject|2
2987892|NCT01027364|10281476|P1|Overall Study|Withdrawal by Subject|1
2987893|NCT01027364|10281473|P4|Overall Study|Protocol Violation|1
2987894|NCT01027364|10281474|P3|Overall Study|Protocol Violation|0
2987895|NCT01027364|10281475|P2|Overall Study|Protocol Violation|0
2987896|NCT01027364|10281476|P1|Overall Study|Protocol Violation|1
2987897|NCT01027364|10281473|P4|Overall Study|Lost to Follow-up|0
2987898|NCT01027364|10281474|P3|Overall Study|Lost to Follow-up|0
2987899|NCT01027364|10281475|P2|Overall Study|Lost to Follow-up|0
2987900|NCT01027364|10281476|P1|Overall Study|Lost to Follow-up|1
2987901|NCT01027364|10281473|P4|Overall Study|Adverse Event|0
2987902|NCT01027364|10281474|P3|Overall Study|Adverse Event|1
2987903|NCT01027364|10281475|P2|Overall Study|Adverse Event|0
2987904|NCT01027364|10281476|P1|Overall Study|Adverse Event|1
2987905|NCT01027351|10281571|P6|Overall Study|Protocol Violation|0
2987906|NCT01027351|10281572|P5|Overall Study|Protocol Violation|1
2987907|NCT01027351|10281573|P4|Overall Study|Protocol Violation|1
2987908|NCT01027351|10281574|P3|Overall Study|Protocol Violation|0
2987909|NCT01027351|10281575|P2|Overall Study|Protocol Violation|0
2987910|NCT01027351|10281576|P1|Overall Study|Protocol Violation|1
2987911|NCT01027351|10281571|P6|Overall Study|Inappropriate enrollment|0
2987912|NCT01027351|10281572|P5|Overall Study|Inappropriate enrollment|1
2987913|NCT01027351|10281573|P4|Overall Study|Inappropriate enrollment|0
2987914|NCT01027351|10281574|P3|Overall Study|Inappropriate enrollment|0
2987915|NCT01027351|10281575|P2|Overall Study|Inappropriate enrollment|0
2987916|NCT01027351|10281576|P1|Overall Study|Inappropriate enrollment|0
2987917|NCT01027351|10281571|P6|Overall Study|Lost to Follow-up|0
2987918|NCT01027351|10281572|P5|Overall Study|Lost to Follow-up|6
2987919|NCT01027351|10281573|P4|Overall Study|Lost to Follow-up|1
2987920|NCT01027351|10281574|P3|Overall Study|Lost to Follow-up|0
2987921|NCT01027351|10281575|P2|Overall Study|Lost to Follow-up|1
2987922|NCT01027351|10281576|P1|Overall Study|Lost to Follow-up|1
2987923|NCT01027351|10281571|P6|Overall Study|Withdrawal by Subject|5
2987924|NCT01027351|10281572|P5|Overall Study|Withdrawal by Subject|3
2987925|NCT01027351|10281573|P4|Overall Study|Withdrawal by Subject|0
2987926|NCT01027351|10281574|P3|Overall Study|Withdrawal by Subject|1
2987927|NCT01027351|10281575|P2|Overall Study|Withdrawal by Subject|0
2987928|NCT01027351|10281576|P1|Overall Study|Withdrawal by Subject|1
2987929|NCT01027286|10281660|P2|Overall Study|Lost to Follow-up|1
2987930|NCT01027286|10281661|P1|Overall Study|Lost to Follow-up|0
2987931|NCT01027286|10281660|P2|Overall Study|Unable to Obtain Required Blood Volume|0
2987932|NCT01027286|10281661|P1|Overall Study|Unable to Obtain Required Blood Volume|1
2987933|NCT01027273|10281681|P2|Overall Study|Death|2
2987934|NCT01027273|10281682|P1|Overall Study|Death|2
2987935|NCT01027273|10281681|P2|Overall Study|Lost to Follow-up|31
2987936|NCT01027273|10281682|P1|Overall Study|Lost to Follow-up|57
2987937|NCT01026974|10281729|P4|Overall Study|Inappropriate enrollment|0
2987938|NCT01026974|10281730|P3|Overall Study|Inappropriate enrollment|1
2987939|NCT01026974|10281731|P2|Overall Study|Inappropriate enrollment|0
2987940|NCT01026974|10281732|P1|Overall Study|Inappropriate enrollment|0
2987941|NCT01026974|10281729|P4|Overall Study|Adverse Event|1
2987942|NCT01026974|10281730|P3|Overall Study|Adverse Event|0
2987943|NCT01026974|10281731|P2|Overall Study|Adverse Event|0
2987944|NCT01026974|10281732|P1|Overall Study|Adverse Event|0
2987945|NCT01026974|10281729|P4|Overall Study|Lost to Follow-up|0
2987946|NCT01026974|10281730|P3|Overall Study|Lost to Follow-up|4
2987947|NCT01026974|10281731|P2|Overall Study|Lost to Follow-up|1
2987948|NCT01026974|10281732|P1|Overall Study|Lost to Follow-up|1
2987949|NCT01026974|10281729|P4|Overall Study|Withdrawal by Subject|2
2987950|NCT01026974|10281730|P3|Overall Study|Withdrawal by Subject|7
2987951|NCT01026974|10281731|P2|Overall Study|Withdrawal by Subject|1
2987952|NCT01026974|10281732|P1|Overall Study|Withdrawal by Subject|0
2987953|NCT01026948|10281789|P1|Overall Study|Physician Decision|8
2987954|NCT01026831|10281822|P2|Overall Study|Withdrawal by Subject|5
2987955|NCT01026831|10281823|P1|Overall Study|Withdrawal by Subject|7
2987956|NCT01026831|10281822|P2|Overall Study|Protocol Violation|2
2987957|NCT01026831|10281823|P1|Overall Study|Protocol Violation|0
2987958|NCT01026831|10281822|P2|Overall Study|Physician Decision|1
2987959|NCT01026831|10281823|P1|Overall Study|Physician Decision|1
2987960|NCT01026831|10281822|P2|Overall Study|Lost to Follow-up|0
2987961|NCT01026831|10281823|P1|Overall Study|Lost to Follow-up|2
2987962|NCT01026831|10281822|P2|Overall Study|Adverse Event|3
2987963|NCT01026831|10281823|P1|Overall Study|Adverse Event|4
2987964|NCT01026818|10281834|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
2987965|NCT01026818|10281835|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2987966|NCT01026818|10281836|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
2987967|NCT01026818|10281837|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2987968|NCT01026818|10281834|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2987969|NCT01026818|10281835|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
2987970|NCT01026818|10281836|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2987971|NCT01026818|10281837|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
2987972|NCT01026818|10281834|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2987973|NCT01026818|10281835|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
2987974|NCT01026818|10281836|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2987975|NCT01026818|10281837|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
2987976|NCT01026818|10281834|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2987977|NCT01026818|10281835|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2987978|NCT01026818|10281836|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
2987979|NCT01026818|10281837|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2987980|NCT01026818|10281834|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2987981|NCT01026818|10281835|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2987982|NCT01026818|10281836|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
2987983|NCT01026818|10281837|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2987984|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
2987985|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
2987986|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
2987987|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
2987988|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2987989|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
2987990|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
2987991|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2987992|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2987993|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2987994|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
2987995|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2987996|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2987997|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2987998|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2987999|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2988000|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
2988001|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2988002|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
2988003|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2988004|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2988005|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2988006|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
2988007|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2988008|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2988009|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
2988010|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2988011|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
2988012|NCT01026818|10281834|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2988013|NCT01026818|10281835|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
2988014|NCT01026818|10281836|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2988015|NCT01026818|10281837|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
2988016|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
2988017|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
2988018|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2988019|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2988020|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
2988021|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
2988022|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
2988023|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
2988024|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
2988025|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2988026|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
2988027|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2988028|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
2988029|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
2988030|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
2988031|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
2988032|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2988033|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2988034|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
2988035|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
2988036|NCT01026818|10281834|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
2988037|NCT01026818|10281835|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
2988038|NCT01026818|10281836|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
2988039|NCT01026818|10281837|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
2988040|NCT01026818|10281834|P4|Screening Period|Physician Decision|0
2988041|NCT01026818|10281835|P3|Screening Period|Physician Decision|0
2988042|NCT01026818|10281836|P2|Screening Period|Physician Decision|0
2988043|NCT01026818|10281837|P1|Screening Period|Physician Decision|1
2988044|NCT01026818|10281834|P4|Screening Period|Adverse Event|0
2988045|NCT01026818|10281835|P3|Screening Period|Adverse Event|0
2988046|NCT01026818|10281836|P2|Screening Period|Adverse Event|0
2988047|NCT01026818|10281837|P1|Screening Period|Adverse Event|2
2988048|NCT01026818|10281834|P4|Screening Period|Protocol Deviation|0
2988049|NCT01026818|10281835|P3|Screening Period|Protocol Deviation|0
2988050|NCT01026818|10281836|P2|Screening Period|Protocol Deviation|0
2988051|NCT01026818|10281837|P1|Screening Period|Protocol Deviation|3
2988052|NCT01026818|10281834|P4|Screening Period|Withdrawal by Subject|0
2988053|NCT01026818|10281835|P3|Screening Period|Withdrawal by Subject|0
2988054|NCT01026818|10281836|P2|Screening Period|Withdrawal by Subject|0
2988055|NCT01026818|10281837|P1|Screening Period|Withdrawal by Subject|49
2988056|NCT01026818|10281834|P4|Screening Period|Entry Criteria Not Met|0
2988057|NCT01026818|10281835|P3|Screening Period|Entry Criteria Not Met|0
2988058|NCT01026818|10281836|P2|Screening Period|Entry Criteria Not Met|0
2988059|NCT01026818|10281837|P1|Screening Period|Entry Criteria Not Met|105
2988060|NCT01026792|10281925|P1|Overall Study|Protocol Violation|1
2988061|NCT01026493|10281968|P8|Overall Study|Protocol Violation|1
2988062|NCT01026493|10281969|P7|Overall Study|Protocol Violation|4
2988063|NCT01026493|10281970|P6|Overall Study|Protocol Violation|3
2988064|NCT01026493|10281971|P5|Overall Study|Protocol Violation|2
2988065|NCT01026493|10281972|P4|Overall Study|Protocol Violation|0
2988066|NCT01026493|10281973|P3|Overall Study|Protocol Violation|0
2988067|NCT01026493|10281974|P2|Overall Study|Protocol Violation|1
2988068|NCT01026493|10281975|P1|Overall Study|Protocol Violation|0
2988069|NCT01026454|10282003|P2|Second Intervention|Pregnancy|1
2988070|NCT01026454|10282004|P1|Second Intervention|Pregnancy|1
2988071|NCT01026389|10282353|P2|Overall Study|change of treatment, patient moved|2
2988072|NCT01026389|10282354|P1|Overall Study|change of treatment, patient moved|4
2988073|NCT01026389|10282353|P2|Overall Study|Withdrawal by Subject|3
2988074|NCT01026389|10282354|P1|Overall Study|Withdrawal by Subject|1
2988075|NCT01026324|10282369|P3|Follow up/Survival|Withdrawal by Subject|0
2988076|NCT01026324|10282370|P2|Follow up/Survival|Withdrawal by Subject|0
2988077|NCT01026324|10282371|P1|Follow up/Survival|Withdrawal by Subject|1
2988078|NCT01026220|10282381|P3|Consolidation Maintenance|Withdrawal by Subject|6
2988079|NCT01026220|10282382|P2|Consolidation Maintenance|Withdrawal by Subject|2
2988080|NCT01026220|10282383|P1|Consolidation Maintenance|Withdrawal by Subject|0
2988081|NCT01026220|10282381|P3|Consolidation Maintenance|Physician Decision|7
2988082|NCT01026220|10282382|P2|Consolidation Maintenance|Physician Decision|2
2988083|NCT01026220|10282383|P1|Consolidation Maintenance|Physician Decision|0
2988084|NCT01026220|10282381|P3|Consolidation Maintenance|Lack of Efficacy|1
2988085|NCT01026220|10282382|P2|Consolidation Maintenance|Lack of Efficacy|1
2988086|NCT01026220|10282383|P1|Consolidation Maintenance|Lack of Efficacy|0
2988087|NCT01026220|10282381|P3|Consolidation Maintenance|Death|0
2988088|NCT01026220|10282382|P2|Consolidation Maintenance|Death|1
2988089|NCT01026220|10282383|P1|Consolidation Maintenance|Death|0
2988090|NCT01026220|10282381|P3|Induction|Ineligible|0
2988091|NCT01026220|10282382|P2|Induction|Ineligible|0
2988092|NCT01026220|10282383|P1|Induction|Ineligible|1
2988093|NCT01026220|10282381|P3|Induction|Withdrawal by Subject|0
2988094|NCT01026220|10282382|P2|Induction|Withdrawal by Subject|0
2988095|NCT01026220|10282383|P1|Induction|Withdrawal by Subject|9
2988096|NCT01026220|10282381|P3|Induction|Physician Decision|0
2988097|NCT01026220|10282382|P2|Induction|Physician Decision|0
2988098|NCT01026220|10282383|P1|Induction|Physician Decision|12
2988099|NCT01026220|10282381|P3|Induction|Lack of Efficacy|0
2988100|NCT01026220|10282382|P2|Induction|Lack of Efficacy|0
2988101|NCT01026220|10282383|P1|Induction|Lack of Efficacy|2
2988102|NCT01026220|10282381|P3|Induction|Death|0
2988103|NCT01026220|10282382|P2|Induction|Death|0
2988104|NCT01026220|10282383|P1|Induction|Death|1
2988105|NCT01026194|10282407|P2|Period 2：Open-label Period|Withdrawal by Subject|4
2988106|NCT01026194|10282408|P1|Period 2：Open-label Period|Withdrawal by Subject|0
2988107|NCT01026194|10282407|P2|Period 2：Open-label Period|Physician Decision|1
2988108|NCT01026194|10282408|P1|Period 2：Open-label Period|Physician Decision|3
2988109|NCT01026194|10282407|P2|Period 2：Open-label Period|Adverse Event|5
2988110|NCT01026194|10282408|P1|Period 2：Open-label Period|Adverse Event|4
2988111|NCT01026194|10282407|P2|Period 1：Double Blind Period|Physician Decision|4
2988112|NCT01026194|10282408|P1|Period 1：Double Blind Period|Physician Decision|0
2988113|NCT01026194|10282407|P2|Period 1：Double Blind Period|Lack of Efficacy|0
2988114|NCT01026194|10282408|P1|Period 1：Double Blind Period|Lack of Efficacy|1
2988115|NCT01026194|10282407|P2|Period 1：Double Blind Period|Adverse Event|1
2988116|NCT01026194|10282408|P1|Period 1：Double Blind Period|Adverse Event|2
2988117|NCT01026142|10282440|P2|Overall Study|Withdrew consent or lost to follow-up|29
2988118|NCT01026142|10282441|P1|Overall Study|Withdrew consent or lost to follow-up|36
2988119|NCT01026142|10282440|P2|Overall Study|Death|134
2988120|NCT01026142|10282441|P1|Overall Study|Death|136
2988121|NCT01026103|10282463|P1|Overall Study|did not receive study device bc of error|1
2988122|NCT01026103|10282463|P1|Overall Study|Physician Decision|1
2988123|NCT01026038|10282473|P3|Overall Study|Lost to Follow-up|0
2988124|NCT01026038|10282474|P2|Overall Study|Lost to Follow-up|1
2988125|NCT01026038|10282475|P1|Overall Study|Lost to Follow-up|1
2988126|NCT01025843|10282524|P10|Washout 4|Withdrawal by Subject|0
2988127|NCT01025843|10282525|P9|Washout 4|Withdrawal by Subject|0
2988128|NCT01025843|10282526|P8|Washout 4|Withdrawal by Subject|0
2988129|NCT01025843|10282527|P7|Washout 4|Withdrawal by Subject|0
2988130|NCT01025843|10282528|P6|Washout 4|Withdrawal by Subject|0
2988131|NCT01025843|10282529|P5|Washout 4|Withdrawal by Subject|0
2988132|NCT01025843|10282530|P4|Washout 4|Withdrawal by Subject|1
2988133|NCT01025843|10282531|P3|Washout 4|Withdrawal by Subject|1
2988134|NCT01025843|10282532|P2|Washout 4|Withdrawal by Subject|0
2988135|NCT01025843|10282533|P1|Washout 4|Withdrawal by Subject|0
2988136|NCT01025817|10282627|P2|Completed Study|Lost to Follow-up|1
2988137|NCT01025817|10282628|P1|Completed Study|Lost to Follow-up|0
2988138|NCT01025817|10282627|P2|Completed Study|Missing|0
2988139|NCT01025817|10282628|P1|Completed Study|Missing|2
2988140|NCT01025817|10282627|P2|Completed Study|Death|5
2988141|NCT01025817|10282628|P1|Completed Study|Death|6
2988142|NCT01025817|10282627|P2|Completed Study|Withdrawal by Subject|16
2988143|NCT01025817|10282628|P1|Completed Study|Withdrawal by Subject|8
2988144|NCT01025817|10282627|P2|Completed Study Medication|Lost to Follow-up|1
2988145|NCT01025817|10282628|P1|Completed Study Medication|Lost to Follow-up|0
2988146|NCT01025817|10282627|P2|Completed Study Medication|Subject no longer required study drug|1
2988147|NCT01025817|10282628|P1|Completed Study Medication|Subject no longer required study drug|0
2988148|NCT01025817|10282627|P2|Completed Study Medication|Abnormal lab values|2
2988149|NCT01025817|10282628|P1|Completed Study Medication|Abnormal lab values|0
2988150|NCT01025817|10282627|P2|Completed Study Medication|Death|2
2988151|NCT01025817|10282628|P1|Completed Study Medication|Death|2
2988152|NCT01025817|10282627|P2|Completed Study Medication|Graft loss|5
2988153|NCT01025817|10282628|P1|Completed Study Medication|Graft loss|2
2988154|NCT01025817|10282627|P2|Completed Study Medication|Abnormal test procedure|0
2988155|NCT01025817|10282628|P1|Completed Study Medication|Abnormal test procedure|4
2988156|NCT01025817|10282627|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
2988157|NCT01025817|10282628|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
2988158|NCT01025817|10282627|P2|Completed Study Medication|Administrative problems|5
2988159|NCT01025817|10282628|P1|Completed Study Medication|Administrative problems|7
2988160|NCT01025817|10282627|P2|Completed Study Medication|Withdrawal by Subject|9
2988161|NCT01025817|10282628|P1|Completed Study Medication|Withdrawal by Subject|8
2988162|NCT01025817|10282627|P2|Completed Study Medication|Protocol Deviation|8
2988163|NCT01025817|10282628|P1|Completed Study Medication|Protocol Deviation|9
2988164|NCT01025817|10282627|P2|Completed Study Medication|Adverse Event|39
2988165|NCT01025817|10282628|P1|Completed Study Medication|Adverse Event|66
2988166|NCT01025752|10282794|P2|Overall Study|Physician Decision|3
2988167|NCT01025752|10282795|P1|Overall Study|Physician Decision|1
2988168|NCT01025752|10282794|P2|Overall Study|Lost to Follow-up|10
2988169|NCT01025752|10282795|P1|Overall Study|Lost to Follow-up|7
2988170|NCT01025635|10282815|P2|Overall Study|Reason not known|2
2988171|NCT01025635|10282816|P1|Overall Study|Reason not known|4
2988172|NCT01025635|10282815|P2|Overall Study|Lost to Follow-up|13
2988173|NCT01025635|10282816|P1|Overall Study|Lost to Follow-up|9
2988174|NCT01025635|10282815|P2|Overall Study|Lack of Efficacy|1
2988175|NCT01025635|10282816|P1|Overall Study|Lack of Efficacy|0
2988176|NCT01025635|10282815|P2|Overall Study|Protocol Violation|2
2988177|NCT01025635|10282816|P1|Overall Study|Protocol Violation|4
2988178|NCT01025635|10282815|P2|Overall Study|Withdrawal by Subject|7
2988179|NCT01025635|10282816|P1|Overall Study|Withdrawal by Subject|6
2988180|NCT01025336|10282844|P5|Overall Study|Protocol Violation|0
2988181|NCT01025336|10282845|P4|Overall Study|Protocol Violation|2
2988182|NCT01025336|10282846|P3|Overall Study|Protocol Violation|0
2988183|NCT01025336|10282847|P2|Overall Study|Protocol Violation|0
2988184|NCT01025336|10282848|P1|Overall Study|Protocol Violation|0
2988185|NCT01025284|10282903|P3|Overall Study|Withdrawal by Subject|0
2988186|NCT01025284|10282904|P2|Overall Study|Withdrawal by Subject|1
2988187|NCT01025284|10282905|P1|Overall Study|Withdrawal by Subject|0
2988188|NCT01025284|10282903|P3|Overall Study|Investigator Decision|0
2988189|NCT01025284|10282904|P2|Overall Study|Investigator Decision|1
2988190|NCT01025284|10282905|P1|Overall Study|Investigator Decision|0
2988191|NCT01025232|10282930|P2|Overall Study|Study drug no longer available|6
2988192|NCT01025232|10282931|P1|Overall Study|Study drug no longer available|3
2988193|NCT01025193|10282949|P1|Overall Study|Adverse Event|3
2988194|NCT01025193|10282949|P1|Overall Study|Protocol Violation|1
2988195|NCT01025154|10282959|P1|Overall Study|Withdrawal by Subject|1
2988196|NCT01025154|10282959|P1|Overall Study|Lost to Follow-up|1
2988197|NCT01025037|10282968|P1|Overall Study|Withdrawal by Subject|1
2988198|NCT01025037|10282968|P1|Overall Study|Lost to Follow-up|7
2988199|NCT01025037|10282968|P1|Overall Study|Adverse Event|3
2988200|NCT01024959|10282990|P1|Overall Study|missing results required for analysis|17
2988201|NCT01024959|10282990|P1|Overall Study|results not evaluable|12
2988202|NCT01024959|10282990|P1|Overall Study|ineligible|12
2988203|NCT01024946|10282999|P1|Overall Study|Adverse Event|1
2988204|NCT01024946|10282999|P1|Overall Study|Withdrawal by Subject|1
2988205|NCT01024946|10282999|P1|Overall Study|Screen Failure|3
2988206|NCT01024855|10283003|P1|Overall Study|Inclusion/exclusion criteria|1
2988207|NCT01024751|10283010|P2|Eligible Participants|Ineligible|1
2988208|NCT01024751|10283011|P1|Eligible Participants|Ineligible|0
2988209|NCT01024751|10283010|P2|Eligible Participants|Lost to Follow-up|1
2988210|NCT01024751|10283011|P1|Eligible Participants|Lost to Follow-up|0
2988211|NCT01024751|10283010|P2|Eligible Participants|Withdrawal by Subject|1
2988212|NCT01024751|10283011|P1|Eligible Participants|Withdrawal by Subject|0
2988213|NCT01024751|10283010|P2|Enrolled Participants|Ineligible at baseline|4
2988214|NCT01024751|10283011|P1|Enrolled Participants|Ineligible at baseline|3
2988215|NCT01024608|10283068|P2|Overall Study|Never received study treatment|0
2988216|NCT01024608|10283069|P1|Overall Study|Never received study treatment|2
2988217|NCT01024608|10283068|P2|Overall Study|Protocol Violation|3
2988218|NCT01024608|10283069|P1|Overall Study|Protocol Violation|0
2988219|NCT01024608|10283068|P2|Overall Study|Lost to Follow-up|1
2988220|NCT01024608|10283069|P1|Overall Study|Lost to Follow-up|0
2988221|NCT01024608|10283068|P2|Overall Study|Withdrawal by Subject|0
2988222|NCT01024608|10283069|P1|Overall Study|Withdrawal by Subject|1
2988223|NCT01024608|10283068|P2|Overall Study|Adverse Event|0
2988224|NCT01024608|10283069|P1|Overall Study|Adverse Event|1
2988225|NCT01024465|10283098|P1|Overall Study|Physician Decision|1
2988226|NCT01024465|10283098|P1|Overall Study|Adverse Event|2
2988227|NCT01024387|10283102|P1|Overall Study|Other|5
2988228|NCT01024387|10283102|P1|Overall Study|Adverse Event|3
2988229|NCT01024387|10283102|P1|Overall Study|Prolonged Treatment Delay|1
2988230|NCT01024387|10283102|P1|Overall Study|Death|2
2988231|NCT01024387|10283102|P1|Overall Study|Withdrawal by Subject|5
2988232|NCT01024387|10283102|P1|Overall Study|Physician Decision|5
2988233|NCT01024387|10283102|P1|Overall Study|Symptomatic Progression|10
2988234|NCT01024387|10283102|P1|Overall Study|Radiographic Progression|29
2988235|NCT01024309|10283123|P2|Overall Study|Withdrawal by Subject|4
2988236|NCT01024309|10283124|P1|Overall Study|Withdrawal by Subject|4
2988237|NCT01024309|10283123|P2|Overall Study|Physician Decision|0
2988238|NCT01024309|10283124|P1|Overall Study|Physician Decision|4
2988239|NCT01024244|10283156|P5|Overall Study|Withdrawal by Subject|0
2988240|NCT01024244|10283157|P4|Overall Study|Withdrawal by Subject|0
2988241|NCT01024244|10283158|P3|Overall Study|Withdrawal by Subject|0
2988242|NCT01024244|10283159|P2|Overall Study|Withdrawal by Subject|1
2988243|NCT01024244|10283160|P1|Overall Study|Withdrawal by Subject|0
2988244|NCT01024244|10283156|P5|Overall Study|Sponsor Decision|10
2988245|NCT01024244|10283157|P4|Overall Study|Sponsor Decision|12
2988246|NCT01024244|10283158|P3|Overall Study|Sponsor Decision|14
2988247|NCT01024244|10283159|P2|Overall Study|Sponsor Decision|7
2988248|NCT01024244|10283160|P1|Overall Study|Sponsor Decision|14
2988249|NCT01024244|10283156|P5|Overall Study|Protocol Violation|2
2988250|NCT01024244|10283157|P4|Overall Study|Protocol Violation|0
2988251|NCT01024244|10283158|P3|Overall Study|Protocol Violation|0
2988252|NCT01024244|10283159|P2|Overall Study|Protocol Violation|0
2988253|NCT01024244|10283160|P1|Overall Study|Protocol Violation|1
2988254|NCT01024244|10283156|P5|Overall Study|Lack of Efficacy|0
2988255|NCT01024244|10283157|P4|Overall Study|Lack of Efficacy|0
2988256|NCT01024244|10283158|P3|Overall Study|Lack of Efficacy|0
2988257|NCT01024244|10283159|P2|Overall Study|Lack of Efficacy|0
2988258|NCT01024244|10283160|P1|Overall Study|Lack of Efficacy|1
2988259|NCT01024244|10283156|P5|Overall Study|Entry Criteria Not Met|0
2988260|NCT01024244|10283157|P4|Overall Study|Entry Criteria Not Met|0
2988261|NCT01024244|10283158|P3|Overall Study|Entry Criteria Not Met|0
2988262|NCT01024244|10283159|P2|Overall Study|Entry Criteria Not Met|1
2988263|NCT01024244|10283160|P1|Overall Study|Entry Criteria Not Met|0
2988264|NCT01024244|10283156|P5|Overall Study|Adverse Event|2
2988265|NCT01024244|10283157|P4|Overall Study|Adverse Event|1
2988266|NCT01024244|10283158|P3|Overall Study|Adverse Event|0
2988267|NCT01024244|10283159|P2|Overall Study|Adverse Event|2
2988268|NCT01024244|10283160|P1|Overall Study|Adverse Event|1
2988269|NCT01024036|10283274|P2|Follow-Up Period|Adverse Event|1
2988270|NCT01024036|10283275|P1|Follow-Up Period|Adverse Event|4
2988271|NCT01024036|10283274|P2|Follow-Up Period|Withdrawal by Subject|1
2988272|NCT01024036|10283275|P1|Follow-Up Period|Withdrawal by Subject|0
2988273|NCT01024036|10283274|P2|Follow-Up Period|Lost to Follow-up|1
2988274|NCT01024036|10283275|P1|Follow-Up Period|Lost to Follow-up|1
2988275|NCT01024036|10283274|P2|Unblinded Treatment|Lack of Efficacy|2
2988276|NCT01024036|10283275|P1|Unblinded Treatment|Lack of Efficacy|0
2988277|NCT01024036|10283274|P2|Unblinded Treatment|Adverse Event|1
2988278|NCT01024036|10283275|P1|Unblinded Treatment|Adverse Event|0
2988279|NCT01024036|10283274|P2|Blinded Treatment|Withdrawal by Subject|3
2988280|NCT01024036|10283275|P1|Blinded Treatment|Withdrawal by Subject|4
2988281|NCT01024036|10283274|P2|Blinded Treatment|Death|2
2988282|NCT01024036|10283275|P1|Blinded Treatment|Death|0
2988283|NCT01024036|10283274|P2|Blinded Treatment|Physician Decision|0
2988284|NCT01024036|10283275|P1|Blinded Treatment|Physician Decision|1
2988285|NCT01024036|10283274|P2|Blinded Treatment|Lack of Efficacy|14
2988286|NCT01024036|10283275|P1|Blinded Treatment|Lack of Efficacy|16
2988287|NCT01024036|10283274|P2|Blinded Treatment|Adverse Event|1
2988288|NCT01024036|10283275|P1|Blinded Treatment|Adverse Event|1
2988289|NCT01023958|10283322|P1|Overall Study|Refused to continue medication|1
2988290|NCT01023958|10283322|P1|Overall Study|Other adverse event|1
2988291|NCT01023958|10283322|P1|Overall Study|Progressive disease|48
2988292|NCT01023815|10283370|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2988293|NCT01023815|10283371|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2988294|NCT01023815|10283372|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
2988295|NCT01023815|10283373|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2988296|NCT01023815|10283370|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
2988297|NCT01023815|10283371|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
2988298|NCT01023815|10283372|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
2988299|NCT01023815|10283373|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
2988300|NCT01023815|10283370|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2988301|NCT01023815|10283371|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2988302|NCT01023815|10283372|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2988303|NCT01023815|10283373|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2988304|NCT01023815|10283370|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2988305|NCT01023815|10283371|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2988306|NCT01023815|10283372|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2988307|NCT01023815|10283373|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2988308|NCT01023815|10283370|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2988309|NCT01023815|10283371|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2988310|NCT01023815|10283372|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2988311|NCT01023815|10283373|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
2988312|NCT01023789|10283392|P1|3 - Year Visit|Lost to Follow-up|13
2988313|NCT01023789|10283392|P1|3 - Year Visit|Withdrawal of consent|1
2988314|NCT01023789|10283392|P1|3 - Year Visit|Death|29
2988315|NCT01023672|10283478|P1|Overall Study|Death|1
2988316|NCT01023672|10283478|P1|Overall Study|Worsening disease|2
2988317|NCT01023659|10283485|P3|Overall Study|Lost to Follow-up|99
2988318|NCT01023659|10283486|P2|Overall Study|Lost to Follow-up|228
2988319|NCT01023659|10283487|P1|Overall Study|Lost to Follow-up|73
2988320|NCT01023581|10283514|P7|Overall Study|Other|0
2988321|NCT01023581|10283515|P6|Overall Study|Other|0
2988322|NCT01023581|10283516|P5|Overall Study|Other|1
2988323|NCT01023581|10283517|P4|Overall Study|Other|0
2988324|NCT01023581|10283518|P3|Overall Study|Other|1
2988325|NCT01023581|10283519|P2|Overall Study|Other|0
2988326|NCT01023581|10283520|P1|Overall Study|Other|1
2988327|NCT01023581|10283514|P7|Overall Study|Physician Decision|1
2988328|NCT01023581|10283515|P6|Overall Study|Physician Decision|1
2988329|NCT01023581|10283516|P5|Overall Study|Physician Decision|1
2988330|NCT01023581|10283517|P4|Overall Study|Physician Decision|1
2988331|NCT01023581|10283518|P3|Overall Study|Physician Decision|2
2988332|NCT01023581|10283519|P2|Overall Study|Physician Decision|0
2988333|NCT01023581|10283520|P1|Overall Study|Physician Decision|2
2988334|NCT01023581|10283514|P7|Overall Study|Lack of Efficacy|1
2988335|NCT01023581|10283515|P6|Overall Study|Lack of Efficacy|2
2988336|NCT01023581|10283516|P5|Overall Study|Lack of Efficacy|1
2988337|NCT01023581|10283517|P4|Overall Study|Lack of Efficacy|2
2988338|NCT01023581|10283518|P3|Overall Study|Lack of Efficacy|6
2988339|NCT01023581|10283519|P2|Overall Study|Lack of Efficacy|3
2988340|NCT01023581|10283520|P1|Overall Study|Lack of Efficacy|9
2988341|NCT01023581|10283514|P7|Overall Study|Pregnancy|0
2988342|NCT01023581|10283515|P6|Overall Study|Pregnancy|1
2988343|NCT01023581|10283516|P5|Overall Study|Pregnancy|0
2988344|NCT01023581|10283517|P4|Overall Study|Pregnancy|2
2988345|NCT01023581|10283518|P3|Overall Study|Pregnancy|0
2988346|NCT01023581|10283519|P2|Overall Study|Pregnancy|0
2988347|NCT01023581|10283520|P1|Overall Study|Pregnancy|0
2988348|NCT01023581|10283514|P7|Overall Study|Withdrawal by Subject|5
2988349|NCT01023581|10283515|P6|Overall Study|Withdrawal by Subject|8
2988350|NCT01023581|10283516|P5|Overall Study|Withdrawal by Subject|6
2988351|NCT01023581|10283517|P4|Overall Study|Withdrawal by Subject|10
2988352|NCT01023581|10283518|P3|Overall Study|Withdrawal by Subject|16
2988353|NCT01023581|10283519|P2|Overall Study|Withdrawal by Subject|8
2988354|NCT01023581|10283520|P1|Overall Study|Withdrawal by Subject|13
2988355|NCT01023581|10283514|P7|Overall Study|Lost to Follow-up|2
2988356|NCT01023581|10283515|P6|Overall Study|Lost to Follow-up|2
2988357|NCT01023581|10283516|P5|Overall Study|Lost to Follow-up|5
2988358|NCT01023581|10283517|P4|Overall Study|Lost to Follow-up|2
2988359|NCT01023581|10283518|P3|Overall Study|Lost to Follow-up|7
2988360|NCT01023581|10283519|P2|Overall Study|Lost to Follow-up|8
2988361|NCT01023581|10283520|P1|Overall Study|Lost to Follow-up|4
2988362|NCT01023581|10283514|P7|Overall Study|Major protocol deviation|0
2988363|NCT01023581|10283515|P6|Overall Study|Major protocol deviation|0
2988364|NCT01023581|10283516|P5|Overall Study|Major protocol deviation|0
2988365|NCT01023581|10283517|P4|Overall Study|Major protocol deviation|0
2988366|NCT01023581|10283518|P3|Overall Study|Major protocol deviation|3
2988367|NCT01023581|10283519|P2|Overall Study|Major protocol deviation|0
2988368|NCT01023581|10283520|P1|Overall Study|Major protocol deviation|2
2988369|NCT01023581|10283514|P7|Overall Study|Adverse Event|11
2988370|NCT01023581|10283515|P6|Overall Study|Adverse Event|5
2988371|NCT01023581|10283516|P5|Overall Study|Adverse Event|2
2988372|NCT01023581|10283517|P4|Overall Study|Adverse Event|3
2988373|NCT01023581|10283518|P3|Overall Study|Adverse Event|7
2988374|NCT01023581|10283519|P2|Overall Study|Adverse Event|4
2988375|NCT01023581|10283520|P1|Overall Study|Adverse Event|4
2988376|NCT01023516|10283577|P2|Overall Study|Incorrect enrolment|2
2988377|NCT01023516|10283578|P1|Overall Study|Incorrect enrolment|4
2988378|NCT01023516|10283577|P2|Overall Study|Study-specific criteria|2
2988379|NCT01023516|10283578|P1|Overall Study|Study-specific criteria|4
2988380|NCT01023516|10283577|P2|Overall Study|Safety reason|3
2988381|NCT01023516|10283578|P1|Overall Study|Safety reason|0
2988382|NCT01023516|10283577|P2|Overall Study|Adverse Event|6
2988383|NCT01023516|10283578|P1|Overall Study|Adverse Event|9
2988384|NCT01023516|10283577|P2|Overall Study|Voluntary discontinuation|5
2988385|NCT01023516|10283578|P1|Overall Study|Voluntary discontinuation|7
2988386|NCT01023308|10283660|P2|Overall Study|Withdrawal by Subject|18
2988387|NCT01023308|10283661|P1|Overall Study|Withdrawal by Subject|34
2988388|NCT01023308|10283660|P2|Overall Study|Lost to Follow-up|0
2988389|NCT01023308|10283661|P1|Overall Study|Lost to Follow-up|1
2988390|NCT01023308|10283660|P2|Overall Study|Untreated|5
2988391|NCT01023308|10283661|P1|Overall Study|Untreated|5
2988392|NCT01023308|10283660|P2|Overall Study|Protocol Violation|4
2988393|NCT01023308|10283661|P1|Overall Study|Protocol Violation|3
2988394|NCT01023308|10283660|P2|Overall Study|New Cancer therapy|7
2988395|NCT01023308|10283661|P1|Overall Study|New Cancer therapy|4
2988396|NCT01023308|10283660|P2|Overall Study|Disease progression|153
2988397|NCT01023308|10283661|P1|Overall Study|Disease progression|82
2988398|NCT01023308|10283660|P2|Overall Study|Death|17
2988399|NCT01023308|10283661|P1|Overall Study|Death|21
2988400|NCT01023308|10283660|P2|Overall Study|Adverse Event|66
2988401|NCT01023308|10283661|P1|Overall Study|Adverse Event|130
2988402|NCT01023308|10283660|P2|Overall Study|Administrative problems|1
2988403|NCT01023308|10283661|P1|Overall Study|Administrative problems|2
2988404|NCT01023308|10283660|P2|Overall Study|Abnormal test proceedure results|8
2988405|NCT01023308|10283661|P1|Overall Study|Abnormal test proceedure results|3
2988406|NCT01023269|10283687|P2|Overall Study|early termination of the study|0
2988407|NCT01023269|10283688|P1|Overall Study|early termination of the study|2
2988408|NCT01023256|10283696|P4|Overall Study|Withdrawal by Subject|2
2988409|NCT01023256|10283697|P3|Overall Study|Withdrawal by Subject|0
2988410|NCT01023256|10283698|P2|Overall Study|Withdrawal by Subject|0
2988411|NCT01023256|10283699|P1|Overall Study|Withdrawal by Subject|0
2988412|NCT01023256|10283696|P4|Overall Study|Adverse Event|1
2988413|NCT01023256|10283697|P3|Overall Study|Adverse Event|0
2988414|NCT01023256|10283698|P2|Overall Study|Adverse Event|0
2988415|NCT01023256|10283699|P1|Overall Study|Adverse Event|0
2988416|NCT01023256|10283696|P4|Overall Study|Other|2
2988417|NCT01023256|10283697|P3|Overall Study|Other|0
2988418|NCT01023256|10283698|P2|Overall Study|Other|0
2988419|NCT01023256|10283699|P1|Overall Study|Other|1
2988420|NCT01023256|10283696|P4|Overall Study|Randomized but not treated|0
2988421|NCT01023256|10283697|P3|Overall Study|Randomized but not treated|1
2988422|NCT01023256|10283698|P2|Overall Study|Randomized but not treated|0
2988423|NCT01023256|10283699|P1|Overall Study|Randomized but not treated|1
2988424|NCT01023256|10283696|P4|Overall Study|Protocol Violation|0
2988425|NCT01023256|10283697|P3|Overall Study|Protocol Violation|0
2988426|NCT01023256|10283698|P2|Overall Study|Protocol Violation|3
2988427|NCT01023256|10283699|P1|Overall Study|Protocol Violation|2
2988428|NCT01023217|10283741|P2|Overall Study|Withdrawal by Subject|0
2988429|NCT01023217|10283742|P1|Overall Study|Withdrawal by Subject|1
2988430|NCT01023061|10283780|P1|Overall Study|Withdrawal prior to treatment|2
2988431|NCT01023035|10283789|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
2988432|NCT01023035|10283790|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
2988433|NCT01023035|10283791|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
2988434|NCT01023035|10283789|P3|Follow-up Period (up to Week 72)|Adverse Event|1
2988435|NCT01023035|10283790|P2|Follow-up Period (up to Week 72)|Adverse Event|0
2988436|NCT01023035|10283791|P1|Follow-up Period (up to Week 72)|Adverse Event|2
2988437|NCT01023035|10283789|P3|Treatment Period|Treatment Failure|24
2988438|NCT01023035|10283790|P2|Treatment Period|Treatment Failure|31
2988439|NCT01023035|10283791|P1|Treatment Period|Treatment Failure|26
2988440|NCT01023035|10283789|P3|Treatment Period|Non-Medical Reasons|44
2988441|NCT01023035|10283790|P2|Treatment Period|Non-Medical Reasons|22
2988442|NCT01023035|10283791|P1|Treatment Period|Non-Medical Reasons|19
2988443|NCT01023035|10283789|P3|Treatment Period|Adverse Event|50
2988444|NCT01023035|10283790|P2|Treatment Period|Adverse Event|32
2988445|NCT01023035|10283791|P1|Treatment Period|Adverse Event|27
2988446|NCT01023022|10283801|P1|Overall Study|due to technical issues|2
2988447|NCT01023022|10283801|P1|Overall Study|Lost to Follow-up|7
2988448|NCT01023022|10283801|P1|Overall Study|Death|5
2988449|NCT01022996|10283807|P1|Overall Study|Protocol Violation|1
2988450|NCT01022996|10283807|P1|Overall Study|Disease Progression|32
2988451|NCT01022996|10283807|P1|Overall Study|Administrative problems|6
2988452|NCT01022996|10283807|P1|Overall Study|Lost to Follow-up|1
2988453|NCT01022996|10283807|P1|Overall Study|Withdrawal by Subject|3
2988454|NCT01022996|10283807|P1|Overall Study|Adverse Event|14
2988455|NCT01022853|10283821|P5|Overall Study|Other not stated above|0
2988456|NCT01022853|10283822|P4|Overall Study|Other not stated above|0
2988457|NCT01022853|10283823|P3|Overall Study|Other not stated above|1
2988458|NCT01022853|10283824|P2|Overall Study|Other not stated above|0
2988459|NCT01022853|10283825|P1|Overall Study|Other not stated above|1
2988460|NCT01022853|10283821|P5|Overall Study|Withdrawal by Subject|0
2988461|NCT01022853|10283822|P4|Overall Study|Withdrawal by Subject|1
2988462|NCT01022853|10283823|P3|Overall Study|Withdrawal by Subject|1
2988463|NCT01022853|10283824|P2|Overall Study|Withdrawal by Subject|1
2988464|NCT01022853|10283825|P1|Overall Study|Withdrawal by Subject|0
2988465|NCT01022853|10283821|P5|Overall Study|Dose-limiting toxicity|1
2988466|NCT01022853|10283822|P4|Overall Study|Dose-limiting toxicity|0
2988467|NCT01022853|10283823|P3|Overall Study|Dose-limiting toxicity|0
2988468|NCT01022853|10283824|P2|Overall Study|Dose-limiting toxicity|0
2988469|NCT01022853|10283825|P1|Overall Study|Dose-limiting toxicity|0
2988470|NCT01022853|10283821|P5|Overall Study|Progressive disease|1
2988471|NCT01022853|10283822|P4|Overall Study|Progressive disease|7
2988472|NCT01022853|10283823|P3|Overall Study|Progressive disease|11
2988473|NCT01022853|10283824|P2|Overall Study|Progressive disease|3
2988474|NCT01022853|10283825|P1|Overall Study|Progressive disease|2
2988475|NCT01022762|10283904|P2|Overall Study|Unclassified|20
2988476|NCT01022762|10283905|P1|Overall Study|Unclassified|12
2988477|NCT01022762|10283904|P2|Overall Study|Protocol Violation|6
2988478|NCT01022762|10283905|P1|Overall Study|Protocol Violation|7
2988479|NCT01022762|10283904|P2|Overall Study|Lack of Efficacy|1
2988480|NCT01022762|10283905|P1|Overall Study|Lack of Efficacy|0
2988481|NCT01022762|10283904|P2|Overall Study|Adverse Event|1
2988482|NCT01022762|10283905|P1|Overall Study|Adverse Event|3
2988483|NCT01022502|10283940|P1|Overall Study|Withdrawal by Subject|1
2988484|NCT01022502|10283940|P1|Overall Study|employment related reasons|1
2988485|NCT01022502|10283940|P1|Overall Study|Adverse Event|1
2988486|NCT01022424|10283954|P1|Overall Study|eGFR under the withdrawal criteria|2
2988487|NCT01022424|10283954|P1|Overall Study|Physician Decision|1
2988488|NCT01022424|10283954|P1|Overall Study|Adverse Event|1
2988489|NCT01022398|10283969|P2|Overall Study|Study terminated|2
2988490|NCT01022398|10283970|P1|Overall Study|Study terminated|2
2988491|NCT01022203|10283995|P2|Follow-Up Assessment|Lost to Follow-up|2
2988492|NCT01022203|10283996|P1|Follow-Up Assessment|Lost to Follow-up|2
2988493|NCT01022203|10283995|P2|Post Treatment Assessment|Adverse Event|2
2988494|NCT01022203|10283996|P1|Post Treatment Assessment|Adverse Event|0
2988495|NCT01022203|10283995|P2|Post Treatment Assessment|Physician Decision|0
2988496|NCT01022203|10283996|P1|Post Treatment Assessment|Physician Decision|2
2988497|NCT01022203|10283995|P2|Post Treatment Assessment|Withdrawal by Subject|12
2988498|NCT01022203|10283996|P1|Post Treatment Assessment|Withdrawal by Subject|12
2988499|NCT01022112|10284015|P5|Overall Study|Fasting plasma glucose level increased|7
2988500|NCT01022112|10284016|P4|Overall Study|Fasting plasma glucose level increased|0
2988501|NCT01022112|10284017|P3|Overall Study|Fasting plasma glucose level increased|0
2988502|NCT01022112|10284018|P2|Overall Study|Fasting plasma glucose level increased|0
2988503|NCT01022112|10284019|P1|Overall Study|Fasting plasma glucose level increased|1
2988504|NCT01022112|10284015|P5|Overall Study|Withdrawal by Subject|1
2988505|NCT01022112|10284016|P4|Overall Study|Withdrawal by Subject|2
2988506|NCT01022112|10284017|P3|Overall Study|Withdrawal by Subject|2
2988507|NCT01022112|10284018|P2|Overall Study|Withdrawal by Subject|1
2988508|NCT01022112|10284019|P1|Overall Study|Withdrawal by Subject|0
2988509|NCT01022112|10284015|P5|Overall Study|Physician Decision|1
2988510|NCT01022112|10284016|P4|Overall Study|Physician Decision|0
2988511|NCT01022112|10284017|P3|Overall Study|Physician Decision|1
2988512|NCT01022112|10284018|P2|Overall Study|Physician Decision|0
2988513|NCT01022112|10284019|P1|Overall Study|Physician Decision|0
2988514|NCT01022112|10284015|P5|Overall Study|Lack of Efficacy|1
2988515|NCT01022112|10284016|P4|Overall Study|Lack of Efficacy|0
2988516|NCT01022112|10284017|P3|Overall Study|Lack of Efficacy|0
2988517|NCT01022112|10284018|P2|Overall Study|Lack of Efficacy|0
2988518|NCT01022112|10284019|P1|Overall Study|Lack of Efficacy|1
2988519|NCT01022112|10284015|P5|Overall Study|Adverse Event|0
2988520|NCT01022112|10284016|P4|Overall Study|Adverse Event|1
2988521|NCT01022112|10284017|P3|Overall Study|Adverse Event|0
2988522|NCT01022112|10284018|P2|Overall Study|Adverse Event|2
2988523|NCT01022112|10284019|P1|Overall Study|Adverse Event|1
2988524|NCT01021878|10284068|P2|Overall Study|Transplantation|1
2988525|NCT01021878|10284069|P1|Overall Study|Transplantation|6
2988526|NCT01021878|10284068|P2|Overall Study|Adverse Event|5
2988527|NCT01021878|10284069|P1|Overall Study|Adverse Event|6
2988528|NCT01021878|10284068|P2|Overall Study|Death|1
2988529|NCT01021878|10284069|P1|Overall Study|Death|0
2988530|NCT01021878|10284068|P2|Overall Study|Lost to Follow-up|3
2988531|NCT01021878|10284069|P1|Overall Study|Lost to Follow-up|4
2988532|NCT01021852|10284091|P8|Treatment Period 2|Withdrawal by Subject|2
2988533|NCT01021852|10284092|P7|Treatment Period 2|Withdrawal by Subject|1
2988534|NCT01021852|10284093|P6|Treatment Period 2|Withdrawal by Subject|0
2988535|NCT01021852|10284094|P5|Treatment Period 2|Withdrawal by Subject|0
2988536|NCT01021852|10284095|P4|Treatment Period 2|Withdrawal by Subject|0
2988537|NCT01021852|10284096|P3|Treatment Period 2|Withdrawal by Subject|0
2988538|NCT01021852|10284097|P2|Treatment Period 2|Withdrawal by Subject|0
2988539|NCT01021852|10284098|P1|Treatment Period 2|Withdrawal by Subject|0
2988540|NCT01021852|10284091|P8|Treatment Period 2|Protocol Violation|0
2988541|NCT01021852|10284092|P7|Treatment Period 2|Protocol Violation|1
2988542|NCT01021852|10284093|P6|Treatment Period 2|Protocol Violation|0
2988543|NCT01021852|10284094|P5|Treatment Period 2|Protocol Violation|1
2988544|NCT01021852|10284095|P4|Treatment Period 2|Protocol Violation|0
2988545|NCT01021852|10284096|P3|Treatment Period 2|Protocol Violation|0
2988546|NCT01021852|10284097|P2|Treatment Period 2|Protocol Violation|0
2988547|NCT01021852|10284098|P1|Treatment Period 2|Protocol Violation|0
2988548|NCT01021852|10284091|P8|Treatment Period 2|Physician Decision|0
2988549|NCT01021852|10284092|P7|Treatment Period 2|Physician Decision|0
2988550|NCT01021852|10284093|P6|Treatment Period 2|Physician Decision|0
2988551|NCT01021852|10284094|P5|Treatment Period 2|Physician Decision|0
2988552|NCT01021852|10284095|P4|Treatment Period 2|Physician Decision|0
2988553|NCT01021852|10284096|P3|Treatment Period 2|Physician Decision|1
2988554|NCT01021852|10284097|P2|Treatment Period 2|Physician Decision|0
2988555|NCT01021852|10284098|P1|Treatment Period 2|Physician Decision|0
2988556|NCT01021852|10284091|P8|Treatment Period 2|Lack of Efficacy|0
2988557|NCT01021852|10284092|P7|Treatment Period 2|Lack of Efficacy|0
2988558|NCT01021852|10284093|P6|Treatment Period 2|Lack of Efficacy|1
2988559|NCT01021852|10284094|P5|Treatment Period 2|Lack of Efficacy|0
2988560|NCT01021852|10284095|P4|Treatment Period 2|Lack of Efficacy|0
2988561|NCT01021852|10284096|P3|Treatment Period 2|Lack of Efficacy|0
2988562|NCT01021852|10284097|P2|Treatment Period 2|Lack of Efficacy|0
2988563|NCT01021852|10284098|P1|Treatment Period 2|Lack of Efficacy|0
2988564|NCT01021852|10284091|P8|Treatment Period 2|Adverse Event|0
2988565|NCT01021852|10284092|P7|Treatment Period 2|Adverse Event|1
2988566|NCT01021852|10284093|P6|Treatment Period 2|Adverse Event|0
2988567|NCT01021852|10284094|P5|Treatment Period 2|Adverse Event|1
2988568|NCT01021852|10284095|P4|Treatment Period 2|Adverse Event|0
2988569|NCT01021852|10284096|P3|Treatment Period 2|Adverse Event|0
2988570|NCT01021852|10284097|P2|Treatment Period 2|Adverse Event|1
2988571|NCT01021852|10284098|P1|Treatment Period 2|Adverse Event|0
2988572|NCT01021852|10284091|P8|Washout Period-No Drug|Adverse Event|0
2988573|NCT01021852|10284092|P7|Washout Period-No Drug|Adverse Event|0
2988574|NCT01021852|10284093|P6|Washout Period-No Drug|Adverse Event|1
2988575|NCT01021852|10284094|P5|Washout Period-No Drug|Adverse Event|0
2988576|NCT01021852|10284095|P4|Washout Period-No Drug|Adverse Event|0
2988577|NCT01021852|10284096|P3|Washout Period-No Drug|Adverse Event|0
2988578|NCT01021852|10284097|P2|Washout Period-No Drug|Adverse Event|0
2988579|NCT01021852|10284098|P1|Washout Period-No Drug|Adverse Event|1
2988580|NCT01021852|10284091|P8|Washout Period-Placebo|Protocol Violation|0
2988581|NCT01021852|10284092|P7|Washout Period-Placebo|Protocol Violation|1
2988582|NCT01021852|10284093|P6|Washout Period-Placebo|Protocol Violation|0
2988583|NCT01021852|10284094|P5|Washout Period-Placebo|Protocol Violation|0
2988584|NCT01021852|10284095|P4|Washout Period-Placebo|Protocol Violation|0
2988585|NCT01021852|10284096|P3|Washout Period-Placebo|Protocol Violation|0
2988586|NCT01021852|10284097|P2|Washout Period-Placebo|Protocol Violation|0
2988587|NCT01021852|10284098|P1|Washout Period-Placebo|Protocol Violation|0
2988588|NCT01021852|10284091|P8|Washout Period-Placebo|Lost to Follow-up|0
2988589|NCT01021852|10284092|P7|Washout Period-Placebo|Lost to Follow-up|0
2988590|NCT01021852|10284093|P6|Washout Period-Placebo|Lost to Follow-up|0
2988591|NCT01021852|10284094|P5|Washout Period-Placebo|Lost to Follow-up|1
2988592|NCT01021852|10284095|P4|Washout Period-Placebo|Lost to Follow-up|0
2988593|NCT01021852|10284096|P3|Washout Period-Placebo|Lost to Follow-up|0
2988594|NCT01021852|10284097|P2|Washout Period-Placebo|Lost to Follow-up|0
2988595|NCT01021852|10284098|P1|Washout Period-Placebo|Lost to Follow-up|0
2988596|NCT01021852|10284091|P8|Washout Period-Placebo|Adverse Event|0
2988597|NCT01021852|10284092|P7|Washout Period-Placebo|Adverse Event|0
2988598|NCT01021852|10284093|P6|Washout Period-Placebo|Adverse Event|1
2988599|NCT01021852|10284094|P5|Washout Period-Placebo|Adverse Event|0
2988600|NCT01021852|10284095|P4|Washout Period-Placebo|Adverse Event|1
2988601|NCT01021852|10284096|P3|Washout Period-Placebo|Adverse Event|0
2988602|NCT01021852|10284097|P2|Washout Period-Placebo|Adverse Event|0
2988603|NCT01021852|10284098|P1|Washout Period-Placebo|Adverse Event|0
2988604|NCT01021852|10284091|P8|Treatment Period 1|Not Treated|0
2988605|NCT01021852|10284092|P7|Treatment Period 1|Not Treated|0
2988606|NCT01021852|10284093|P6|Treatment Period 1|Not Treated|0
2988607|NCT01021852|10284094|P5|Treatment Period 1|Not Treated|0
2988608|NCT01021852|10284095|P4|Treatment Period 1|Not Treated|2
2988609|NCT01021852|10284096|P3|Treatment Period 1|Not Treated|0
2988610|NCT01021852|10284097|P2|Treatment Period 1|Not Treated|0
2988611|NCT01021852|10284098|P1|Treatment Period 1|Not Treated|0
2988612|NCT01021852|10284091|P8|Treatment Period 1|Withdrawal by Subject|1
2988613|NCT01021852|10284092|P7|Treatment Period 1|Withdrawal by Subject|0
2988614|NCT01021852|10284093|P6|Treatment Period 1|Withdrawal by Subject|0
2988615|NCT01021852|10284094|P5|Treatment Period 1|Withdrawal by Subject|1
2988616|NCT01021852|10284095|P4|Treatment Period 1|Withdrawal by Subject|0
2988617|NCT01021852|10284096|P3|Treatment Period 1|Withdrawal by Subject|0
2988618|NCT01021852|10284097|P2|Treatment Period 1|Withdrawal by Subject|0
2988619|NCT01021852|10284098|P1|Treatment Period 1|Withdrawal by Subject|0
2988620|NCT01021852|10284091|P8|Treatment Period 1|Pregnancy|0
2988621|NCT01021852|10284092|P7|Treatment Period 1|Pregnancy|0
2988622|NCT01021852|10284093|P6|Treatment Period 1|Pregnancy|0
2988623|NCT01021852|10284094|P5|Treatment Period 1|Pregnancy|0
2988624|NCT01021852|10284095|P4|Treatment Period 1|Pregnancy|0
2988625|NCT01021852|10284096|P3|Treatment Period 1|Pregnancy|1
2988626|NCT01021852|10284097|P2|Treatment Period 1|Pregnancy|0
2988627|NCT01021852|10284098|P1|Treatment Period 1|Pregnancy|0
2988628|NCT01021852|10284091|P8|Treatment Period 1|Adverse Event|0
2988629|NCT01021852|10284092|P7|Treatment Period 1|Adverse Event|0
2988630|NCT01021852|10284093|P6|Treatment Period 1|Adverse Event|2
2988631|NCT01021852|10284094|P5|Treatment Period 1|Adverse Event|2
2988632|NCT01021852|10284095|P4|Treatment Period 1|Adverse Event|0
2988633|NCT01021852|10284096|P3|Treatment Period 1|Adverse Event|1
2988634|NCT01021852|10284097|P2|Treatment Period 1|Adverse Event|1
2988635|NCT01021852|10284098|P1|Treatment Period 1|Adverse Event|3
2988636|NCT01021813|10284134|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2988637|NCT01021813|10284135|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
2988638|NCT01021813|10284136|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2988639|NCT01021813|10284137|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2988640|NCT01021813|10284138|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2988641|NCT01021813|10284134|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
2988642|NCT01021813|10284135|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
2988643|NCT01021813|10284136|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
2988644|NCT01021813|10284137|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
2988645|NCT01021813|10284138|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
2988646|NCT01021813|10284134|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
2988647|NCT01021813|10284135|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2988648|NCT01021813|10284136|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2988649|NCT01021813|10284137|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2988650|NCT01021813|10284138|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2988651|NCT01021813|10284134|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2988652|NCT01021813|10284135|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
2988653|NCT01021813|10284136|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2988654|NCT01021813|10284137|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2988655|NCT01021813|10284138|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2988656|NCT01021813|10284134|P5|DB Randomized Discontinuation Phase|Adverse Event|1
2988657|NCT01021813|10284135|P4|DB Randomized Discontinuation Phase|Adverse Event|3
2988658|NCT01021813|10284136|P3|DB Randomized Discontinuation Phase|Adverse Event|0
2988659|NCT01021813|10284137|P2|DB Randomized Discontinuation Phase|Adverse Event|0
2988660|NCT01021813|10284138|P1|DB Randomized Discontinuation Phase|Adverse Event|0
2988661|NCT01021813|10284134|P5|DB Treatment Phase|Withdrawal by Subject|0
2988662|NCT01021813|10284135|P4|DB Treatment Phase|Withdrawal by Subject|0
2988663|NCT01021813|10284136|P3|DB Treatment Phase|Withdrawal by Subject|0
2988664|NCT01021813|10284137|P2|DB Treatment Phase|Withdrawal by Subject|24
2988665|NCT01021813|10284138|P1|DB Treatment Phase|Withdrawal by Subject|60
2988666|NCT01021813|10284134|P5|DB Treatment Phase|Protocol Violation|0
2988667|NCT01021813|10284135|P4|DB Treatment Phase|Protocol Violation|0
2988668|NCT01021813|10284136|P3|DB Treatment Phase|Protocol Violation|0
2988669|NCT01021813|10284137|P2|DB Treatment Phase|Protocol Violation|3
2988670|NCT01021813|10284138|P1|DB Treatment Phase|Protocol Violation|4
2988671|NCT01021813|10284134|P5|DB Treatment Phase|Pregnancy|0
2988672|NCT01021813|10284135|P4|DB Treatment Phase|Pregnancy|0
2988673|NCT01021813|10284136|P3|DB Treatment Phase|Pregnancy|0
2988674|NCT01021813|10284137|P2|DB Treatment Phase|Pregnancy|0
2988675|NCT01021813|10284138|P1|DB Treatment Phase|Pregnancy|1
2988676|NCT01021813|10284134|P5|DB Treatment Phase|Physician Decision|0
2988677|NCT01021813|10284135|P4|DB Treatment Phase|Physician Decision|0
2988678|NCT01021813|10284136|P3|DB Treatment Phase|Physician Decision|0
2988679|NCT01021813|10284137|P2|DB Treatment Phase|Physician Decision|8
2988680|NCT01021813|10284138|P1|DB Treatment Phase|Physician Decision|17
2988681|NCT01021813|10284134|P5|DB Treatment Phase|Lost to Follow-up|0
2988682|NCT01021813|10284135|P4|DB Treatment Phase|Lost to Follow-up|0
2988683|NCT01021813|10284136|P3|DB Treatment Phase|Lost to Follow-up|0
2988684|NCT01021813|10284137|P2|DB Treatment Phase|Lost to Follow-up|12
2988685|NCT01021813|10284138|P1|DB Treatment Phase|Lost to Follow-up|14
2988686|NCT01021813|10284134|P5|DB Treatment Phase|Lack of Efficacy|0
2988687|NCT01021813|10284135|P4|DB Treatment Phase|Lack of Efficacy|0
2988688|NCT01021813|10284136|P3|DB Treatment Phase|Lack of Efficacy|0
2988689|NCT01021813|10284137|P2|DB Treatment Phase|Lack of Efficacy|28
2988690|NCT01021813|10284138|P1|DB Treatment Phase|Lack of Efficacy|44
2988691|NCT01021813|10284134|P5|DB Treatment Phase|Adverse Event|0
2988692|NCT01021813|10284135|P4|DB Treatment Phase|Adverse Event|0
2988693|NCT01021813|10284136|P3|DB Treatment Phase|Adverse Event|0
2988694|NCT01021813|10284137|P2|DB Treatment Phase|Adverse Event|22
2988695|NCT01021813|10284138|P1|DB Treatment Phase|Adverse Event|60
2988696|NCT01021748|10284199|P9|Overall Study|Not Treated|0
2988697|NCT01021748|10284200|P8|Overall Study|Not Treated|0
2988698|NCT01021748|10284201|P7|Overall Study|Not Treated|0
2988699|NCT01021748|10284202|P6|Overall Study|Not Treated|0
2988700|NCT01021748|10284203|P5|Overall Study|Not Treated|0
2988701|NCT01021748|10284204|P4|Overall Study|Not Treated|0
2988702|NCT01021748|10284205|P3|Overall Study|Not Treated|0
2988703|NCT01021748|10284206|P2|Overall Study|Not Treated|1
2988704|NCT01021748|10284207|P1|Overall Study|Not Treated|0
2988705|NCT01021748|10284199|P9|Overall Study|Withdrawal by Subject|1
2988706|NCT01021748|10284200|P8|Overall Study|Withdrawal by Subject|0
2988707|NCT01021748|10284201|P7|Overall Study|Withdrawal by Subject|1
2988708|NCT01021748|10284202|P6|Overall Study|Withdrawal by Subject|0
2988709|NCT01021748|10284203|P5|Overall Study|Withdrawal by Subject|0
2988710|NCT01021748|10284204|P4|Overall Study|Withdrawal by Subject|0
2988711|NCT01021748|10284205|P3|Overall Study|Withdrawal by Subject|0
2988712|NCT01021748|10284206|P2|Overall Study|Withdrawal by Subject|0
2988713|NCT01021748|10284207|P1|Overall Study|Withdrawal by Subject|0
2988714|NCT01021748|10284199|P9|Overall Study|Progressive Disease|6
2988715|NCT01021748|10284200|P8|Overall Study|Progressive Disease|5
2988716|NCT01021748|10284201|P7|Overall Study|Progressive Disease|0
2988717|NCT01021748|10284202|P6|Overall Study|Progressive Disease|3
2988718|NCT01021748|10284203|P5|Overall Study|Progressive Disease|7
2988719|NCT01021748|10284204|P4|Overall Study|Progressive Disease|6
2988720|NCT01021748|10284205|P3|Overall Study|Progressive Disease|4
2988721|NCT01021748|10284206|P2|Overall Study|Progressive Disease|3
2988722|NCT01021748|10284207|P1|Overall Study|Progressive Disease|3
2988723|NCT01021748|10284199|P9|Overall Study|Physician Decision|2
2988724|NCT01021748|10284200|P8|Overall Study|Physician Decision|1
2988725|NCT01021748|10284201|P7|Overall Study|Physician Decision|1
2988726|NCT01021748|10284202|P6|Overall Study|Physician Decision|0
2988727|NCT01021748|10284203|P5|Overall Study|Physician Decision|0
2988728|NCT01021748|10284204|P4|Overall Study|Physician Decision|1
2988729|NCT01021748|10284205|P3|Overall Study|Physician Decision|1
2988730|NCT01021748|10284206|P2|Overall Study|Physician Decision|0
2988731|NCT01021748|10284207|P1|Overall Study|Physician Decision|1
2988732|NCT01021748|10284199|P9|Overall Study|Adverse Event|7
2988733|NCT01021748|10284200|P8|Overall Study|Adverse Event|0
2988734|NCT01021748|10284201|P7|Overall Study|Adverse Event|1
2988735|NCT01021748|10284202|P6|Overall Study|Adverse Event|0
2988736|NCT01021748|10284203|P5|Overall Study|Adverse Event|2
2988737|NCT01021748|10284204|P4|Overall Study|Adverse Event|0
2988738|NCT01021748|10284205|P3|Overall Study|Adverse Event|2
2988739|NCT01021748|10284206|P2|Overall Study|Adverse Event|1
2988740|NCT01021748|10284207|P1|Overall Study|Adverse Event|2
2988741|NCT01021683|10284254|P1|Overall Study|Other|8
2988742|NCT01021683|10284254|P1|Overall Study|Recovery of neutrophil count|51
2988743|NCT01021683|10284254|P1|Overall Study|Lack of Efficacy|12
2988744|NCT01021553|10284280|P3|Overall Study|Withdrawal by Subject|0
2988745|NCT01021553|10284281|P2|Overall Study|Withdrawal by Subject|1
2988746|NCT01021553|10284282|P1|Overall Study|Withdrawal by Subject|1
2988747|NCT01021553|10284280|P3|Overall Study|Lost to Follow-up|1
2988748|NCT01021553|10284281|P2|Overall Study|Lost to Follow-up|0
2988749|NCT01021553|10284282|P1|Overall Study|Lost to Follow-up|0
2988750|NCT01021553|10284280|P3|Overall Study|Protocol Violation|2
2988751|NCT01021553|10284281|P2|Overall Study|Protocol Violation|2
2988752|NCT01021553|10284282|P1|Overall Study|Protocol Violation|0
2988753|NCT01021553|10284280|P3|Overall Study|Lack of Efficacy|0
2988754|NCT01021553|10284281|P2|Overall Study|Lack of Efficacy|2
2988755|NCT01021553|10284282|P1|Overall Study|Lack of Efficacy|2
2988756|NCT01021553|10284280|P3|Overall Study|Adverse Event|0
2988757|NCT01021553|10284281|P2|Overall Study|Adverse Event|0
2988758|NCT01021553|10284282|P1|Overall Study|Adverse Event|1
2988759|NCT01021423|10284336|P2|Overall Study|Study terminated|5
2988760|NCT01021423|10284337|P1|Overall Study|Study terminated|4
2988761|NCT01021332|10284353|P1|Overall Study|Miscellaneous|3
2988762|NCT01021332|10284353|P1|Overall Study|Protocol Violation|9
2988763|NCT01021332|10284353|P1|Overall Study|Lost to Follow-up|4
2988764|NCT01021332|10284353|P1|Overall Study|Withdrawal of Consent|23
2988765|NCT01021332|10284353|P1|Overall Study|Lack of Efficacy|19
2988766|NCT01021332|10284353|P1|Overall Study|Adverse Event|43
2988767|NCT01021332|10284353|P1|Overall Study|Not fulfilling incl./excl.criteria|5
2988768|NCT01021293|10284414|P2|Overall Study|Lost to Follow-up|1
2988769|NCT01021293|10284415|P1|Overall Study|Lost to Follow-up|1
2988770|NCT01021293|10284414|P2|Overall Study|Migrated/moved from study area|18
2988771|NCT01021293|10284415|P1|Overall Study|Migrated/moved from study area|6
2988772|NCT01021293|10284414|P2|Overall Study|Withdrawal by Subject|3
2988773|NCT01021293|10284415|P1|Overall Study|Withdrawal by Subject|1
2988774|NCT01021293|10284414|P2|Overall Study|Adverse Event|1
2988775|NCT01021293|10284415|P1|Overall Study|Adverse Event|2
2988776|NCT01021293|10284414|P2|Overall Study|Serious Adverse Event|1
2988777|NCT01021293|10284415|P1|Overall Study|Serious Adverse Event|2
2988778|NCT01021215|10284434|P2|Overall Study|Lost to Follow-up|0
2988779|NCT01021215|10284435|P1|Overall Study|Lost to Follow-up|3
2988780|NCT01021137|10284449|P4|Overall Study|Withdrawal by Subject|3
2988781|NCT01021137|10284450|P3|Overall Study|Withdrawal by Subject|0
2988782|NCT01021137|10284451|P2|Overall Study|Withdrawal by Subject|0
2988783|NCT01021137|10284452|P1|Overall Study|Withdrawal by Subject|1
2988784|NCT01021137|10284449|P4|Overall Study|Lost to Follow-up|6
2988785|NCT01021137|10284450|P3|Overall Study|Lost to Follow-up|2
2988786|NCT01021137|10284451|P2|Overall Study|Lost to Follow-up|4
2988787|NCT01021137|10284452|P1|Overall Study|Lost to Follow-up|9
2988788|NCT01021020|10284495|P1|14 Day Washout Period A|Physician Decision|1
2988789|NCT01021020|10284495|P1|Period I|Withdrawal by Subject|1
2988790|NCT01021020|10284495|P1|Period I|Protocol Violation|1
2988791|NCT01021007|10284511|P2|Overall Study|Adverse Event|3
2988792|NCT01021007|10284512|P1|Overall Study|Adverse Event|1
2988793|NCT01021007|10284511|P2|Overall Study|Lost to Follow-up|1
2988794|NCT01021007|10284512|P1|Overall Study|Lost to Follow-up|1
2988795|NCT01020981|10284524|P2|Overall Study|Participant declined to complete survey|0
2988796|NCT01020981|10284525|P1|Overall Study|Participant declined to complete survey|2
2988797|NCT01020981|10284524|P2|Overall Study|Survey returned undeliverable|32
2988798|NCT01020981|10284525|P1|Overall Study|Survey returned undeliverable|8
2988799|NCT01020981|10284524|P2|Overall Study|Did not return mailed survey|58
2988800|NCT01020981|10284525|P1|Overall Study|Did not return mailed survey|74
2988801|NCT01020877|10284546|P2|Second Intervention|Withdrawal by Subject|0
2988802|NCT01020877|10284547|P1|Second Intervention|Withdrawal by Subject|1
2988803|NCT01020838|10284557|P1|Overall Study|Most common: Study ended by sponsor|77
2988804|NCT01020838|10284557|P1|Overall Study|Lost to Follow-up|6
2988805|NCT01020838|10284557|P1|Overall Study|Withdrawal by Subject|9
2988806|NCT01020838|10284557|P1|Overall Study|Adverse Event|1
2988807|NCT01020838|10284557|P1|Overall Study|Death|90
2988808|NCT01020812|10284572|P1|Overall Study|Protocol Violation|1
2988809|NCT01020812|10284572|P1|Overall Study|Withdrawal by Subject|1
2988810|NCT01020812|10284572|P1|Overall Study|Physician Decision|1
2988811|NCT01020799|10284582|P3|Overall Study|Lost to Follow-up|2
2988812|NCT01020799|10284583|P2|Overall Study|Lost to Follow-up|4
2988813|NCT01020799|10284584|P1|Overall Study|Lost to Follow-up|6
2988814|NCT01020799|10284582|P3|Overall Study|Withdrawal by Subject|3
2988815|NCT01020799|10284583|P2|Overall Study|Withdrawal by Subject|2
2988816|NCT01020799|10284584|P1|Overall Study|Withdrawal by Subject|2
2988817|NCT01020799|10284582|P3|Overall Study|Protocol Violation|0
2988818|NCT01020799|10284583|P2|Overall Study|Protocol Violation|2
2988819|NCT01020799|10284584|P1|Overall Study|Protocol Violation|3
2988820|NCT01020799|10284582|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
2988821|NCT01020799|10284583|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
2988822|NCT01020799|10284584|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
2988823|NCT01020799|10284582|P3|Overall Study|Adverse Event|2
2988824|NCT01020799|10284583|P2|Overall Study|Adverse Event|3
2988825|NCT01020799|10284584|P1|Overall Study|Adverse Event|4
2988826|NCT01020786|10284607|P1|Maintenance Period|Sponsor Decision|1
2988827|NCT01020786|10284607|P1|Maintenance Period|Withdrawal by Subject|8
2988828|NCT01020786|10284607|P1|Maintenance Period|Progressive Disease|43
2988829|NCT01020786|10284607|P1|Maintenance Period|Adverse Event|8
2988830|NCT01020786|10284607|P1|Induction Period|Withdrawal by Subject|3
2988831|NCT01020786|10284607|P1|Induction Period|Investigator Decision|3
2988832|NCT01020786|10284607|P1|Induction Period|Progressive Disease|31
2988833|NCT01020786|10284607|P1|Induction Period|Adverse Event|10
2988834|NCT01020786|10284607|P1|Induction Period|Entry Criteria Not Met|2
2988835|NCT01020773|10284621|P2|Overall Study|Withdrawal by Subject|3
2988836|NCT01020773|10284622|P1|Overall Study|Withdrawal by Subject|4
2988837|NCT01020747|10284628|P1|Overall Study|Withdrawal by Subject|1
2988838|NCT01020526|10284644|P1|Overall Study|Adverse Event|2
2988839|NCT01020526|10284644|P1|Overall Study|Lost to Follow-up|1
2988840|NCT01020526|10284644|P1|Overall Study|Insufficient clinical response|3
2988841|NCT01020526|10284644|P1|Overall Study|Other reasons|3
2988842|NCT01020526|10284644|P1|Overall Study|Withdrawal by Subject|5
2988843|NCT01020474|10284650|P2|Overall Study|Insufficient Clinical Response|3
2988844|NCT01020474|10284651|P1|Overall Study|Insufficient Clinical Response|0
2988845|NCT01020474|10284650|P2|Overall Study|Other Reasons|1
2988846|NCT01020474|10284651|P1|Overall Study|Other Reasons|1
2988847|NCT01020474|10284650|P2|Overall Study|Withdrawal by Subject|7
2988848|NCT01020474|10284651|P1|Overall Study|Withdrawal by Subject|5
2988849|NCT01020474|10284650|P2|Overall Study|Protocol Violation|2
2988850|NCT01020474|10284651|P1|Overall Study|Protocol Violation|0
2988851|NCT01020474|10284650|P2|Overall Study|Adverse Event|4
2988852|NCT01020474|10284651|P1|Overall Study|Adverse Event|4
2988853|NCT01020448|10284671|P1|Treatment|Lost to Follow-up|2
2988854|NCT01020448|10284671|P1|Treatment|Lack of Efficacy|8
2988855|NCT01020448|10284671|P1|Treatment|Disease Progression|2
2988856|NCT01020448|10284671|P1|Treatment|Consent Withdrawn|3
2988857|NCT01020448|10284671|P1|Treatment|Adverse Event|11
2988858|NCT01020448|10284671|P1|Pre-assignment|Does Not Meet Entry Criteria|2
2988859|NCT01020448|10284671|P1|Pre-assignment|Withdrawal by Subject|5
2988860|NCT01020448|10284671|P1|Pre-assignment|Adverse Event|6
2988861|NCT01020435|10284682|P2|Overall Study|Lost to Follow-up|1
2988862|NCT01020435|10284683|P1|Overall Study|Lost to Follow-up|0
2988863|NCT01020305|10284691|P1|Overall Study|Adverse Event|2
2988864|NCT01020123|10284702|P7|Extention Period|Lost to Follow-up|0
2988865|NCT01020123|10284703|P6|Extention Period|Lost to Follow-up|2
2988866|NCT01020123|10284704|P5|Extention Period|Lost to Follow-up|0
2988867|NCT01020123|10284705|P4|Extention Period|Lost to Follow-up|0
2988868|NCT01020123|10284706|P3|Extention Period|Lost to Follow-up|0
2988869|NCT01020123|10284707|P2|Extention Period|Lost to Follow-up|0
2988870|NCT01020123|10284708|P1|Extention Period|Lost to Follow-up|0
2988871|NCT01020123|10284702|P7|Extention Period|Protocol Violation|1
2988872|NCT01020123|10284703|P6|Extention Period|Protocol Violation|0
2988873|NCT01020123|10284704|P5|Extention Period|Protocol Violation|0
2988874|NCT01020123|10284705|P4|Extention Period|Protocol Violation|0
2988875|NCT01020123|10284706|P3|Extention Period|Protocol Violation|1
2988876|NCT01020123|10284707|P2|Extention Period|Protocol Violation|1
2988877|NCT01020123|10284708|P1|Extention Period|Protocol Violation|1
2988878|NCT01020123|10284702|P7|Extention Period|Adverse Event|0
2988879|NCT01020123|10284703|P6|Extention Period|Adverse Event|0
2988880|NCT01020123|10284704|P5|Extention Period|Adverse Event|0
2988881|NCT01020123|10284705|P4|Extention Period|Adverse Event|1
2988882|NCT01020123|10284706|P3|Extention Period|Adverse Event|0
2988883|NCT01020123|10284707|P2|Extention Period|Adverse Event|0
2988884|NCT01020123|10284708|P1|Extention Period|Adverse Event|0
2988885|NCT01020123|10284702|P7|Extention Period|Withdrawal by Subject|0
2988886|NCT01020123|10284703|P6|Extention Period|Withdrawal by Subject|0
2988887|NCT01020123|10284704|P5|Extention Period|Withdrawal by Subject|0
2988888|NCT01020123|10284705|P4|Extention Period|Withdrawal by Subject|0
2988889|NCT01020123|10284706|P3|Extention Period|Withdrawal by Subject|1
2988890|NCT01020123|10284707|P2|Extention Period|Withdrawal by Subject|1
2988891|NCT01020123|10284708|P1|Extention Period|Withdrawal by Subject|2
2988892|NCT01020123|10284702|P7|Main Period|Unclasified|6
2988893|NCT01020123|10284703|P6|Main Period|Unclasified|3
2988894|NCT01020123|10284704|P5|Main Period|Unclasified|1
2988895|NCT01020123|10284705|P4|Main Period|Unclasified|0
2988896|NCT01020123|10284706|P3|Main Period|Unclasified|1
2988897|NCT01020123|10284707|P2|Main Period|Unclasified|0
2988898|NCT01020123|10284708|P1|Main Period|Unclasified|2
2988899|NCT01020123|10284702|P7|Main Period|Lost to Follow-up|0
2988900|NCT01020123|10284703|P6|Main Period|Lost to Follow-up|0
2988901|NCT01020123|10284704|P5|Main Period|Lost to Follow-up|0
2988902|NCT01020123|10284705|P4|Main Period|Lost to Follow-up|0
2988903|NCT01020123|10284706|P3|Main Period|Lost to Follow-up|0
2988904|NCT01020123|10284707|P2|Main Period|Lost to Follow-up|2
2988905|NCT01020123|10284708|P1|Main Period|Lost to Follow-up|0
2988906|NCT01020123|10284702|P7|Main Period|Protocol Violation|2
2988907|NCT01020123|10284703|P6|Main Period|Protocol Violation|3
2988908|NCT01020123|10284704|P5|Main Period|Protocol Violation|2
2988909|NCT01020123|10284705|P4|Main Period|Protocol Violation|5
2988910|NCT01020123|10284706|P3|Main Period|Protocol Violation|2
2988911|NCT01020123|10284707|P2|Main Period|Protocol Violation|4
2988912|NCT01020123|10284708|P1|Main Period|Protocol Violation|4
2988913|NCT01020123|10284702|P7|Main Period|Adverse Event|1
2988914|NCT01020123|10284703|P6|Main Period|Adverse Event|2
2988915|NCT01020123|10284704|P5|Main Period|Adverse Event|1
2988916|NCT01020123|10284705|P4|Main Period|Adverse Event|1
2988917|NCT01020123|10284706|P3|Main Period|Adverse Event|2
2988918|NCT01020123|10284707|P2|Main Period|Adverse Event|2
2988919|NCT01020123|10284708|P1|Main Period|Adverse Event|5
2988920|NCT01020123|10284702|P7|Main Period|Eligibility Criteria not fullfilled|0
2988921|NCT01020123|10284703|P6|Main Period|Eligibility Criteria not fullfilled|0
2988922|NCT01020123|10284704|P5|Main Period|Eligibility Criteria not fullfilled|1
2988923|NCT01020123|10284705|P4|Main Period|Eligibility Criteria not fullfilled|0
2988924|NCT01020123|10284706|P3|Main Period|Eligibility Criteria not fullfilled|0
2988925|NCT01020123|10284707|P2|Main Period|Eligibility Criteria not fullfilled|1
2988926|NCT01020123|10284708|P1|Main Period|Eligibility Criteria not fullfilled|0
2988927|NCT01020123|10284702|P7|Main Period|Withdrawal by Subject|2
2988928|NCT01020123|10284703|P6|Main Period|Withdrawal by Subject|3
2988929|NCT01020123|10284704|P5|Main Period|Withdrawal by Subject|6
2988930|NCT01020123|10284705|P4|Main Period|Withdrawal by Subject|1
2988931|NCT01020123|10284706|P3|Main Period|Withdrawal by Subject|3
2988932|NCT01020123|10284707|P2|Main Period|Withdrawal by Subject|5
2988933|NCT01020123|10284708|P1|Main Period|Withdrawal by Subject|6
2988934|NCT01020019|10284903|P2|Overall Study|moving|2
2988935|NCT01020019|10284904|P1|Overall Study|moving|0
2988936|NCT01020019|10284903|P2|Overall Study|not interested in treatment|4
2988937|NCT01020019|10284904|P1|Overall Study|not interested in treatment|4
2988938|NCT01020019|10284903|P2|Overall Study|Adverse Event|5
2988939|NCT01020019|10284904|P1|Overall Study|Adverse Event|1
2988940|NCT01020019|10284903|P2|Overall Study|Lost to Follow-up|18
2988941|NCT01020019|10284904|P1|Overall Study|Lost to Follow-up|21
2988942|NCT01019980|10284925|P2|Overall Study|Drug not available.|0
2988943|NCT01019980|10284926|P1|Overall Study|Drug not available.|2
2988944|NCT01019694|10284989|P3|Overall Study|Other reason (not specified)|6
2988945|NCT01019694|10284990|P2|Overall Study|Other reason (not specified)|5
2988946|NCT01019694|10284991|P1|Overall Study|Other reason (not specified)|1
2988947|NCT01019694|10284989|P3|Overall Study|Not treated|3
2988948|NCT01019694|10284990|P2|Overall Study|Not treated|2
2988949|NCT01019694|10284991|P1|Overall Study|Not treated|0
2988950|NCT01019694|10284989|P3|Overall Study|Withdrawal by Subject|12
2988951|NCT01019694|10284990|P2|Overall Study|Withdrawal by Subject|6
2988952|NCT01019694|10284991|P1|Overall Study|Withdrawal by Subject|4
2988953|NCT01019694|10284989|P3|Overall Study|Lost to Follow-up|3
2988954|NCT01019694|10284990|P2|Overall Study|Lost to Follow-up|3
2988955|NCT01019694|10284991|P1|Overall Study|Lost to Follow-up|5
2988956|NCT01019694|10284989|P3|Overall Study|Protocol Violation|4
2988957|NCT01019694|10284990|P2|Overall Study|Protocol Violation|6
2988958|NCT01019694|10284991|P1|Overall Study|Protocol Violation|2
2988959|NCT01019694|10284989|P3|Overall Study|Adverse Event|19
2988960|NCT01019694|10284990|P2|Overall Study|Adverse Event|16
2988961|NCT01019694|10284991|P1|Overall Study|Adverse Event|12
2988962|NCT01019486|10285116|P3|Overall Study|Withdrawal by Subject|1
2988963|NCT01019486|10285117|P2|Overall Study|Withdrawal by Subject|1
2988964|NCT01019486|10285118|P1|Overall Study|Withdrawal by Subject|1
2988965|NCT01019369|10285132|P2|Overall Study|Withdrawal by Subject|1
2988966|NCT01019369|10285133|P1|Overall Study|Withdrawal by Subject|0
2988967|NCT01019369|10285132|P2|Overall Study|Lost to Follow-up|6
2988968|NCT01019369|10285133|P1|Overall Study|Lost to Follow-up|10
2988969|NCT01019317|10285149|P1|Overall Study|Not Eligible|4
2988970|NCT01019252|10285155|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
2988971|NCT01019252|10285156|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
2988972|NCT01019252|10285155|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
2988973|NCT01019252|10285156|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
2988974|NCT01019252|10285155|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
2988975|NCT01019252|10285156|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
2988976|NCT01019252|10285155|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
2988977|NCT01019252|10285156|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
2988978|NCT01019135|10285169|P3|Overall Study|Did not attend CR|6
2988979|NCT01019135|10285170|P2|Overall Study|Did not attend CR|13
2988980|NCT01019135|10285171|P1|Overall Study|Did not attend CR|8
2988981|NCT01019135|10285169|P3|Overall Study|Did not receive allocated intervention|25
2988982|NCT01019135|10285170|P2|Overall Study|Did not receive allocated intervention|6
2988983|NCT01019135|10285171|P1|Overall Study|Did not receive allocated intervention|12
2988984|NCT01018992|10285199|P2|Overall Study|Lost to Follow-up|1
2988985|NCT01018992|10285200|P1|Overall Study|Lost to Follow-up|5
2988986|NCT01018992|10285199|P2|Overall Study|Protocol Violation|4
2988987|NCT01018992|10285200|P1|Overall Study|Protocol Violation|0
2988988|NCT01018992|10285199|P2|Overall Study|Withdrawal by Subject|8
2988989|NCT01018992|10285200|P1|Overall Study|Withdrawal by Subject|3
2988990|NCT01018992|10285199|P2|Overall Study|Adverse Event|3
2988991|NCT01018992|10285200|P1|Overall Study|Adverse Event|8
2988992|NCT01018979|10285214|P2|Overall Study|Not received at least one dose|1
2988993|NCT01018979|10285215|P1|Overall Study|Not received at least one dose|0
2988994|NCT01018979|10285214|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
2988995|NCT01018979|10285215|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
2988996|NCT01018953|10285245|P1|Overall Study|Study termination by sponsor|5
2988997|NCT01018953|10285245|P1|Overall Study|Withdrawal by Subject|1
2988998|NCT01018953|10285245|P1|Overall Study|Adverse Event|2
2988999|NCT01018862|10285258|P3|Overall Study|administrative problems|4
2989000|NCT01018862|10285259|P2|Overall Study|administrative problems|4
2989001|NCT01018862|10285260|P1|Overall Study|administrative problems|5
2989002|NCT01018862|10285258|P3|Overall Study|Withdrawal by Subject|1
2989003|NCT01018862|10285259|P2|Overall Study|Withdrawal by Subject|2
2989004|NCT01018862|10285260|P1|Overall Study|Withdrawal by Subject|1
2989005|NCT01018862|10285258|P3|Overall Study|Protocol Violation|3
2989006|NCT01018862|10285259|P2|Overall Study|Protocol Violation|3
2989007|NCT01018862|10285260|P1|Overall Study|Protocol Violation|1
2989008|NCT01018862|10285258|P3|Overall Study|Lost to Follow-up|0
2989009|NCT01018862|10285259|P2|Overall Study|Lost to Follow-up|1
2989010|NCT01018862|10285260|P1|Overall Study|Lost to Follow-up|3
2989011|NCT01018862|10285258|P3|Overall Study|Lack of Efficacy|2
2989012|NCT01018862|10285259|P2|Overall Study|Lack of Efficacy|0
2989013|NCT01018862|10285260|P1|Overall Study|Lack of Efficacy|1
2989014|NCT01018862|10285258|P3|Overall Study|Adverse Event|6
2989015|NCT01018862|10285259|P2|Overall Study|Adverse Event|0
2989016|NCT01018862|10285260|P1|Overall Study|Adverse Event|2
2989017|NCT01018810|10285282|P5|Overall Study|Sponsor Decision|1
2989018|NCT01018810|10285283|P4|Overall Study|Sponsor Decision|1
2989019|NCT01018810|10285284|P3|Overall Study|Sponsor Decision|1
2989020|NCT01018810|10285285|P2|Overall Study|Sponsor Decision|0
2989021|NCT01018810|10285286|P1|Overall Study|Sponsor Decision|2
2989022|NCT01018810|10285282|P5|Overall Study|Withdrawal by Subject|0
2989023|NCT01018810|10285283|P4|Overall Study|Withdrawal by Subject|0
2989024|NCT01018810|10285284|P3|Overall Study|Withdrawal by Subject|0
2989025|NCT01018810|10285285|P2|Overall Study|Withdrawal by Subject|1
2989026|NCT01018810|10285286|P1|Overall Study|Withdrawal by Subject|0
2989027|NCT01018732|10285346|P3|Overall Study|Unable to Classify|1
2989028|NCT01018732|10285347|P2|Overall Study|Unable to Classify|0
2989029|NCT01018732|10285348|P1|Overall Study|Unable to Classify|0
2989030|NCT01018732|10285346|P3|Overall Study|Inappropriate Enrollment|0
2989031|NCT01018732|10285347|P2|Overall Study|Inappropriate Enrollment|1
2989032|NCT01018732|10285348|P1|Overall Study|Inappropriate Enrollment|0
2989033|NCT01018732|10285346|P3|Overall Study|Protocol Violation|0
2989034|NCT01018732|10285347|P2|Overall Study|Protocol Violation|1
2989035|NCT01018732|10285348|P1|Overall Study|Protocol Violation|1
2989036|NCT01018732|10285346|P3|Overall Study|Lost to Follow-up|3
2989037|NCT01018732|10285347|P2|Overall Study|Lost to Follow-up|0
2989038|NCT01018732|10285348|P1|Overall Study|Lost to Follow-up|0
2989039|NCT01018680|10285382|P2|Overall Study|Physician Decision|1
2989040|NCT01018680|10285383|P1|Overall Study|Physician Decision|3
2989041|NCT01018680|10285382|P2|Overall Study|Entry Criteria Not Met|4
2989042|NCT01018680|10285383|P1|Overall Study|Entry Criteria Not Met|1
2989043|NCT01018680|10285382|P2|Overall Study|Lost to Follow-up|3
2989044|NCT01018680|10285383|P1|Overall Study|Lost to Follow-up|5
2989045|NCT01018680|10285382|P2|Overall Study|Lack of Efficacy|2
2989046|NCT01018680|10285383|P1|Overall Study|Lack of Efficacy|8
2989047|NCT01018680|10285382|P2|Overall Study|Sponsor Decision|7
2989048|NCT01018680|10285383|P1|Overall Study|Sponsor Decision|6
2989049|NCT01018680|10285382|P2|Overall Study|Protocol Violation|8
2989050|NCT01018680|10285383|P1|Overall Study|Protocol Violation|5
2989051|NCT01018680|10285382|P2|Overall Study|Withdrawal by Subject|10
2989052|NCT01018680|10285383|P1|Overall Study|Withdrawal by Subject|10
2989053|NCT01018680|10285382|P2|Overall Study|Adverse Event|40
2989054|NCT01018680|10285383|P1|Overall Study|Adverse Event|23
2989055|NCT01020487|10285426|P3|Part 2 Open-label Period|Adverse Event|1
2989056|NCT01020487|10285427|P2|Part 2 Open-label Period|Adverse Event|4
2989057|NCT01020487|10285428|P1|Part 2 Open-label Period|Adverse Event|0
2989058|NCT01020487|10285426|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
2989059|NCT01020487|10285427|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
2989060|NCT01020487|10285428|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
2989061|NCT01020487|10285426|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
2989062|NCT01020487|10285427|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2989063|NCT01020487|10285428|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2989064|NCT01020487|10285426|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
2989065|NCT01020487|10285427|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2989066|NCT01020487|10285428|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2989067|NCT01020487|10285426|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
2989068|NCT01020487|10285427|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
2989069|NCT01020487|10285428|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
2989070|NCT01018511|10285453|P4|Overall Study|Miscellaneous|0
2989071|NCT01018511|10285454|P3|Overall Study|Miscellaneous|0
2989072|NCT01018511|10285455|P2|Overall Study|Miscellaneous|2
2989073|NCT01018511|10285456|P1|Overall Study|Miscellaneous|0
2989074|NCT01018511|10285453|P4|Overall Study|Protocol Violation|9
2989075|NCT01018511|10285454|P3|Overall Study|Protocol Violation|7
2989076|NCT01018511|10285455|P2|Overall Study|Protocol Violation|8
2989077|NCT01018511|10285456|P1|Overall Study|Protocol Violation|5
2989078|NCT01018511|10285453|P4|Overall Study|Lost to Follow-up|0
2989079|NCT01018511|10285454|P3|Overall Study|Lost to Follow-up|1
2989080|NCT01018511|10285455|P2|Overall Study|Lost to Follow-up|0
2989081|NCT01018511|10285456|P1|Overall Study|Lost to Follow-up|0
2989082|NCT01018511|10285453|P4|Overall Study|Withdrawal by Subject|9
2989083|NCT01018511|10285454|P3|Overall Study|Withdrawal by Subject|11
2989084|NCT01018511|10285455|P2|Overall Study|Withdrawal by Subject|5
2989085|NCT01018511|10285456|P1|Overall Study|Withdrawal by Subject|6
2989086|NCT01018511|10285453|P4|Overall Study|Lack of Efficacy|2
2989087|NCT01018511|10285454|P3|Overall Study|Lack of Efficacy|1
2989088|NCT01018511|10285455|P2|Overall Study|Lack of Efficacy|1
2989089|NCT01018511|10285456|P1|Overall Study|Lack of Efficacy|4
2989090|NCT01018511|10285453|P4|Overall Study|Adverse Event|10
2989091|NCT01018511|10285454|P3|Overall Study|Adverse Event|13
2989092|NCT01018511|10285455|P2|Overall Study|Adverse Event|9
2989093|NCT01018511|10285456|P1|Overall Study|Adverse Event|5
2989094|NCT01018511|10285453|P4|Overall Study|Not fulfilling eligibility criteria|3
2989095|NCT01018511|10285454|P3|Overall Study|Not fulfilling eligibility criteria|7
2989096|NCT01018511|10285455|P2|Overall Study|Not fulfilling eligibility criteria|7
2989097|NCT01018511|10285456|P1|Overall Study|Not fulfilling eligibility criteria|6
2989098|NCT01018394|10285653|P2|Overall Study|Lost to Follow-up|3
2989099|NCT01018394|10285654|P1|Overall Study|Lost to Follow-up|4
2989100|NCT01018394|10285653|P2|Overall Study|Withdrawal by Subject|5
2989101|NCT01018394|10285654|P1|Overall Study|Withdrawal by Subject|5
2989102|NCT01018264|10285664|P2|Overall Study|Lost to Follow-up|1
2989103|NCT01018264|10285665|P1|Overall Study|Lost to Follow-up|0
2989104|NCT01018264|10285664|P2|Overall Study|Withdrawal by Subject|0
2989105|NCT01018264|10285665|P1|Overall Study|Withdrawal by Subject|1
2989106|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
2989107|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
2989108|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
2989109|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
2989110|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Physician Decision|3
2989111|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Physician Decision|0
2989112|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Physician Decision|1
2989113|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Physician Decision|0
2989114|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
2989115|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
2989116|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
2989117|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
2989118|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2989119|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
2989120|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
2989121|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2989122|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Protocol Violation|2
2989123|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Protocol Violation|8
2989124|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Protocol Violation|8
2989125|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Protocol Violation|0
2989126|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
2989127|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
2989128|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
2989129|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
2989130|NCT01018186|10285682|P4|52-week Double-blind Treatment Period|Adverse Event|6
2989131|NCT01018186|10285683|P3|52-week Double-blind Treatment Period|Adverse Event|3
2989132|NCT01018186|10285684|P2|52-week Double-blind Treatment Period|Adverse Event|5
2989133|NCT01018186|10285685|P1|52-week Double-blind Treatment Period|Adverse Event|0
2989134|NCT01018186|10285682|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2989135|NCT01018186|10285683|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2989136|NCT01018186|10285684|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2989137|NCT01018186|10285685|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
2989138|NCT01018186|10285682|P4|2-week Run-in Period|Withdrawal by Subject|0
2989139|NCT01018186|10285683|P3|2-week Run-in Period|Withdrawal by Subject|0
2989140|NCT01018186|10285684|P2|2-week Run-in Period|Withdrawal by Subject|0
2989141|NCT01018186|10285685|P1|2-week Run-in Period|Withdrawal by Subject|11
2989142|NCT01018186|10285682|P4|2-week Run-in Period|Physician Decision|0
2989143|NCT01018186|10285683|P3|2-week Run-in Period|Physician Decision|0
2989144|NCT01018186|10285684|P2|2-week Run-in Period|Physician Decision|0
2989145|NCT01018186|10285685|P1|2-week Run-in Period|Physician Decision|3
2989146|NCT01018186|10285682|P4|2-week Run-in Period|Lost to Follow-up|0
2989147|NCT01018186|10285683|P3|2-week Run-in Period|Lost to Follow-up|0
2989148|NCT01018186|10285684|P2|2-week Run-in Period|Lost to Follow-up|0
2989149|NCT01018186|10285685|P1|2-week Run-in Period|Lost to Follow-up|2
2989150|NCT01018186|10285682|P4|2-week Run-in Period|Protocol Violation|0
2989151|NCT01018186|10285683|P3|2-week Run-in Period|Protocol Violation|0
2989152|NCT01018186|10285684|P2|2-week Run-in Period|Protocol Violation|0
2989153|NCT01018186|10285685|P1|2-week Run-in Period|Protocol Violation|1
2989154|NCT01018030|10285886|P3|Overall Study|Did Not Receive Study Drug|0
2989155|NCT01018030|10285887|P2|Overall Study|Did Not Receive Study Drug|3
2989156|NCT01018030|10285888|P1|Overall Study|Did Not Receive Study Drug|1
2989157|NCT01018030|10285886|P3|Overall Study|Lack of Efficacy|0
2989158|NCT01018030|10285887|P2|Overall Study|Lack of Efficacy|0
2989159|NCT01018030|10285888|P1|Overall Study|Lack of Efficacy|1
2989160|NCT01018030|10285886|P3|Overall Study|Physician Decision|1
2989161|NCT01018030|10285887|P2|Overall Study|Physician Decision|0
2989162|NCT01018030|10285888|P1|Overall Study|Physician Decision|1
2989163|NCT01018030|10285886|P3|Overall Study|Protocol Violation|0
2989164|NCT01018030|10285887|P2|Overall Study|Protocol Violation|1
2989165|NCT01018030|10285888|P1|Overall Study|Protocol Violation|2
2989166|NCT01018030|10285886|P3|Overall Study|Lost to Follow-up|3
2989167|NCT01018030|10285887|P2|Overall Study|Lost to Follow-up|0
2989168|NCT01018030|10285888|P1|Overall Study|Lost to Follow-up|2
2989169|NCT01018030|10285886|P3|Overall Study|Withdrawal by Subject|4
2989170|NCT01018030|10285887|P2|Overall Study|Withdrawal by Subject|2
2989171|NCT01018030|10285888|P1|Overall Study|Withdrawal by Subject|2
2989172|NCT01018030|10285886|P3|Overall Study|Adverse Event|5
2989173|NCT01018030|10285887|P2|Overall Study|Adverse Event|5
2989174|NCT01018030|10285888|P1|Overall Study|Adverse Event|10
2989175|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Physician Decision|7
2989176|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Physician Decision|9
2989177|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Physician Decision|8
2989178|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Physician Decision|10
2989179|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Physician Decision|0
2989180|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
2989181|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2989182|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
2989183|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2989184|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2989185|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2989186|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2989187|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2989188|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2989189|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2989190|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2989191|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
2989192|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2989193|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2989194|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2989195|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
2989196|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
2989197|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
2989198|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
2989199|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
2989200|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2989201|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2989202|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2989203|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
2989204|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2989205|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2989206|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2989207|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2989208|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
2989209|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2989210|NCT01017952|10285939|P5|52-week, Double-blind Treatment Period|Adverse Event|30
2989211|NCT01017952|10285940|P4|52-week, Double-blind Treatment Period|Adverse Event|35
2989212|NCT01017952|10285941|P3|52-week, Double-blind Treatment Period|Adverse Event|32
2989213|NCT01017952|10285942|P2|52-week, Double-blind Treatment Period|Adverse Event|25
2989214|NCT01017952|10285943|P1|52-week, Double-blind Treatment Period|Adverse Event|0
2989215|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2989216|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2989217|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2989218|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2989219|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
2989220|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Physician Decision|0
2989221|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Physician Decision|0
2989222|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Physician Decision|0
2989223|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Physician Decision|0
2989224|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Physician Decision|10
2989225|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
2989226|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
2989227|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
2989228|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
2989229|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
2989230|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2989231|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2989232|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2989233|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2989234|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
2989235|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Adverse Event|0
2989236|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Adverse Event|0
2989237|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Adverse Event|0
2989238|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Adverse Event|0
2989239|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Adverse Event|23
2989240|NCT01017952|10285939|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2989241|NCT01017952|10285940|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2989242|NCT01017952|10285941|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2989243|NCT01017952|10285942|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2989244|NCT01017952|10285943|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
2989245|NCT01017874|10285967|P2|Overall Study|Physician Decision|3
2989246|NCT01017874|10285968|P1|Overall Study|Physician Decision|1
2989247|NCT01017874|10285967|P2|Overall Study|Lost to Follow-up|2
2989248|NCT01017874|10285968|P1|Overall Study|Lost to Follow-up|3
2989249|NCT01017874|10285967|P2|Overall Study|Sponsor decision|1
2989250|NCT01017874|10285968|P1|Overall Study|Sponsor decision|3
2989251|NCT01017874|10285967|P2|Overall Study|Withdrawal by Subject|20
2989252|NCT01017874|10285968|P1|Overall Study|Withdrawal by Subject|23
2989253|NCT01017731|10285986|P1|Overall Study|Adverse Event|1
2989254|NCT01017731|10285986|P1|Overall Study|Physician Decision|2
2989255|NCT01017731|10285986|P1|Overall Study|Withdrawal by Subject|3
2989256|NCT01017731|10285986|P1|Overall Study|Lost to Follow-up|2
2989257|NCT01017601|10286015|P2|Overall Study|Withdrawal by Subject|1
2989258|NCT01017601|10286016|P1|Overall Study|Withdrawal by Subject|0
2989259|NCT01017601|10286015|P2|Overall Study|Disease Progression|12
2989260|NCT01017601|10286016|P1|Overall Study|Disease Progression|12
2989261|NCT01017575|10286043|P5|Overall Study|Withdrawal by Subject|0
2989262|NCT01017575|10286044|P4|Overall Study|Withdrawal by Subject|0
2989263|NCT01017575|10286045|P3|Overall Study|Withdrawal by Subject|0
2989264|NCT01017575|10286046|P2|Overall Study|Withdrawal by Subject|0
2989265|NCT01017575|10286047|P1|Overall Study|Withdrawal by Subject|1
2989266|NCT01017575|10286043|P5|Overall Study|Adverse Event|2
2989267|NCT01017575|10286044|P4|Overall Study|Adverse Event|0
2989268|NCT01017575|10286045|P3|Overall Study|Adverse Event|0
2989269|NCT01017575|10286046|P2|Overall Study|Adverse Event|1
2989270|NCT01017575|10286047|P1|Overall Study|Adverse Event|0
2989271|NCT01017575|10286043|P5|Overall Study|Lack of Efficacy|1
2989272|NCT01017575|10286044|P4|Overall Study|Lack of Efficacy|1
2989273|NCT01017575|10286045|P3|Overall Study|Lack of Efficacy|0
2989274|NCT01017575|10286046|P2|Overall Study|Lack of Efficacy|1
2989275|NCT01017575|10286047|P1|Overall Study|Lack of Efficacy|0
2989276|NCT01017549|10286084|P1|One-year Follow-up|Withdrawal by Subject|5
2989277|NCT01017549|10286084|P1|One-year Follow-up|Lost to Follow-up|2
2989278|NCT01017549|10286084|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
2989279|NCT01017263|10286115|P1|Overall Study|not eligible|12
2989280|NCT01017146|10286196|P2|Overall Study|Change in Work Situation|0
2989281|NCT01017146|10286197|P1|Overall Study|Change in Work Situation|1
2989282|NCT01017146|10286196|P2|Overall Study|Did Not Meet Eligibility Criteria|2
2989283|NCT01017146|10286197|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2989284|NCT01017146|10286196|P2|Overall Study|Took Excluded Medication|0
2989285|NCT01017146|10286197|P1|Overall Study|Took Excluded Medication|2
2989286|NCT01017146|10286196|P2|Overall Study|Protocol Violation|0
2989287|NCT01017146|10286197|P1|Overall Study|Protocol Violation|2
2989288|NCT01017146|10286196|P2|Overall Study|Pregnancy|1
2989289|NCT01017146|10286197|P1|Overall Study|Pregnancy|2
2989290|NCT01017146|10286196|P2|Overall Study|Relocation|4
2989291|NCT01017146|10286197|P1|Overall Study|Relocation|0
2989292|NCT01017146|10286196|P2|Overall Study|Withdrawal by Subject|16
2989293|NCT01017146|10286197|P1|Overall Study|Withdrawal by Subject|32
2989294|NCT01017146|10286196|P2|Overall Study|Noncompliance with Study Product|1
2989295|NCT01017146|10286197|P1|Overall Study|Noncompliance with Study Product|1
2989296|NCT01017146|10286196|P2|Overall Study|Lost to Follow-up|14
2989297|NCT01017146|10286197|P1|Overall Study|Lost to Follow-up|14
2989298|NCT01017146|10286196|P2|Overall Study|Adverse Event|1
2989299|NCT01017146|10286197|P1|Overall Study|Adverse Event|11
2989300|NCT01017120|10286235|P2|Overall Study|Parent Unable to Provide Transportation|0
2989301|NCT01017120|10286236|P1|Overall Study|Parent Unable to Provide Transportation|1
2989302|NCT01017120|10286235|P2|Overall Study|Protocol Violation|0
2989303|NCT01017120|10286236|P1|Overall Study|Protocol Violation|1
2989304|NCT01017120|10286235|P2|Overall Study|Relocated Out of Town|2
2989305|NCT01017120|10286236|P1|Overall Study|Relocated Out of Town|0
2989306|NCT01017120|10286235|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2989307|NCT01017120|10286236|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2989308|NCT01017120|10286235|P2|Overall Study|Pregnancy|1
2989309|NCT01017120|10286236|P1|Overall Study|Pregnancy|1
2989310|NCT01017120|10286235|P2|Overall Study|Withdrawal by Subject|21
2989311|NCT01017120|10286236|P1|Overall Study|Withdrawal by Subject|39
2989312|NCT01017120|10286235|P2|Overall Study|Lack of Efficacy|0
2989313|NCT01017120|10286236|P1|Overall Study|Lack of Efficacy|1
2989314|NCT01017120|10286235|P2|Overall Study|Lost to Follow-up|11
2989315|NCT01017120|10286236|P1|Overall Study|Lost to Follow-up|13
2989316|NCT01017120|10286235|P2|Overall Study|Adverse Event|0
2989317|NCT01017120|10286236|P1|Overall Study|Adverse Event|9
2989318|NCT01017029|10286297|P2|Overall Study|Death|1
2989319|NCT01017029|10286298|P1|Overall Study|Death|3
2989320|NCT01017029|10286297|P2|Overall Study|Administrative problem|1
2989321|NCT01017029|10286298|P1|Overall Study|Administrative problem|0
2989322|NCT01017029|10286297|P2|Overall Study|Lost to Follow-up|0
2989323|NCT01017029|10286298|P1|Overall Study|Lost to Follow-up|1
2989324|NCT01016977|10286326|P2|Overall Study|Withdrawal by Subject|2
2989325|NCT01016977|10286327|P1|Overall Study|Withdrawal by Subject|2
2989326|NCT01016977|10286326|P2|Overall Study|Lost to Follow-up|0
2989327|NCT01016977|10286327|P1|Overall Study|Lost to Follow-up|1
2989328|NCT01016964|10286363|P2|Overall Study|Lost to Follow-up|3
2989329|NCT01016964|10286364|P1|Overall Study|Lost to Follow-up|3
2989330|NCT01016912|10286380|P5|Follow-up Period|Other reason|0
2989331|NCT01016912|10286381|P4|Follow-up Period|Other reason|1
2989332|NCT01016912|10286382|P3|Follow-up Period|Other reason|1
2989333|NCT01016912|10286383|P2|Follow-up Period|Other reason|0
2989334|NCT01016912|10286384|P1|Follow-up Period|Other reason|0
2989335|NCT01016912|10286380|P5|End of Treatment Period|Completed double-blind period only|0
2989336|NCT01016912|10286381|P4|End of Treatment Period|Completed double-blind period only|0
2989337|NCT01016912|10286382|P3|End of Treatment Period|Completed double-blind period only|0
2989338|NCT01016912|10286383|P2|End of Treatment Period|Completed double-blind period only|1
2989339|NCT01016912|10286384|P1|End of Treatment Period|Completed double-blind period only|0
2989340|NCT01016912|10286380|P5|End of Treatment Period|Adverse Event|0
2989341|NCT01016912|10286381|P4|End of Treatment Period|Adverse Event|0
2989342|NCT01016912|10286382|P3|End of Treatment Period|Adverse Event|1
2989343|NCT01016912|10286383|P2|End of Treatment Period|Adverse Event|1
2989344|NCT01016912|10286384|P1|End of Treatment Period|Adverse Event|0
2989345|NCT01016912|10286380|P5|End of Treatment Period|Lack of Efficacy|4
2989346|NCT01016912|10286381|P4|End of Treatment Period|Lack of Efficacy|4
2989347|NCT01016912|10286382|P3|End of Treatment Period|Lack of Efficacy|0
2989348|NCT01016912|10286383|P2|End of Treatment Period|Lack of Efficacy|1
2989349|NCT01016912|10286384|P1|End of Treatment Period|Lack of Efficacy|0
2989350|NCT01016600|10286563|P4|Overall Study|Did not start treatment|0
2989351|NCT01016600|10286564|P3|Overall Study|Did not start treatment|0
2989352|NCT01016600|10286565|P2|Overall Study|Did not start treatment|0
2989353|NCT01016600|10286566|P1|Overall Study|Did not start treatment|1
2989354|NCT01016262|10286754|P6|Open-Label Phase|Withdrawal of Informed Consent|0
2989355|NCT01016262|10286755|P5|Open-Label Phase|Withdrawal of Informed Consent|1
2989356|NCT01016262|10286756|P4|Open-Label Phase|Withdrawal of Informed Consent|0
2989357|NCT01016262|10286757|P3|Open-Label Phase|Withdrawal of Informed Consent|0
2989358|NCT01016262|10286758|P2|Open-Label Phase|Withdrawal of Informed Consent|0
2989359|NCT01016262|10286759|P1|Open-Label Phase|Withdrawal of Informed Consent|0
2989360|NCT01016262|10286754|P6|Open-Label Phase|Lack of Efficacy|0
2989361|NCT01016262|10286755|P5|Open-Label Phase|Lack of Efficacy|0
2989362|NCT01016262|10286756|P4|Open-Label Phase|Lack of Efficacy|1
2989363|NCT01016262|10286757|P3|Open-Label Phase|Lack of Efficacy|0
2989364|NCT01016262|10286758|P2|Open-Label Phase|Lack of Efficacy|0
2989365|NCT01016262|10286759|P1|Open-Label Phase|Lack of Efficacy|0
2989366|NCT01016262|10286754|P6|Open-Label Phase|Lost to Follow-up|0
2989367|NCT01016262|10286755|P5|Open-Label Phase|Lost to Follow-up|1
2989368|NCT01016262|10286756|P4|Open-Label Phase|Lost to Follow-up|0
2989369|NCT01016262|10286757|P3|Open-Label Phase|Lost to Follow-up|0
2989370|NCT01016262|10286758|P2|Open-Label Phase|Lost to Follow-up|0
2989371|NCT01016262|10286759|P1|Open-Label Phase|Lost to Follow-up|0
2989372|NCT01016262|10286754|P6|Open-Label Phase|Adverse Event|0
2989373|NCT01016262|10286755|P5|Open-Label Phase|Adverse Event|0
2989374|NCT01016262|10286756|P4|Open-Label Phase|Adverse Event|1
2989375|NCT01016262|10286757|P3|Open-Label Phase|Adverse Event|0
2989376|NCT01016262|10286758|P2|Open-Label Phase|Adverse Event|0
2989377|NCT01016262|10286759|P1|Open-Label Phase|Adverse Event|0
2989378|NCT01016262|10286754|P6|Double-blind Phase|Withdrawal of Informed Consent|0
2989379|NCT01016262|10286755|P5|Double-blind Phase|Withdrawal of Informed Consent|0
2989380|NCT01016262|10286756|P4|Double-blind Phase|Withdrawal of Informed Consent|0
2989381|NCT01016262|10286757|P3|Double-blind Phase|Withdrawal of Informed Consent|1
2989382|NCT01016262|10286758|P2|Double-blind Phase|Withdrawal of Informed Consent|0
2989383|NCT01016262|10286759|P1|Double-blind Phase|Withdrawal of Informed Consent|0
2989384|NCT01016262|10286754|P6|Double-blind Phase|Disease Progression|0
2989385|NCT01016262|10286755|P5|Double-blind Phase|Disease Progression|0
2989386|NCT01016262|10286756|P4|Double-blind Phase|Disease Progression|0
2989387|NCT01016262|10286757|P3|Double-blind Phase|Disease Progression|2
2989388|NCT01016262|10286758|P2|Double-blind Phase|Disease Progression|1
2989389|NCT01016262|10286759|P1|Double-blind Phase|Disease Progression|0
2989390|NCT01016262|10286754|P6|Double-blind Phase|Lack of Efficacy|0
2989391|NCT01016262|10286755|P5|Double-blind Phase|Lack of Efficacy|0
2989392|NCT01016262|10286756|P4|Double-blind Phase|Lack of Efficacy|0
2989393|NCT01016262|10286757|P3|Double-blind Phase|Lack of Efficacy|5
2989394|NCT01016262|10286758|P2|Double-blind Phase|Lack of Efficacy|0
2989395|NCT01016262|10286759|P1|Double-blind Phase|Lack of Efficacy|1
2989396|NCT01016262|10286754|P6|Double-blind Phase|Adverse Event|0
2989397|NCT01016262|10286755|P5|Double-blind Phase|Adverse Event|0
2989398|NCT01016262|10286756|P4|Double-blind Phase|Adverse Event|0
2989399|NCT01016262|10286757|P3|Double-blind Phase|Adverse Event|1
2989400|NCT01016262|10286758|P2|Double-blind Phase|Adverse Event|0
2989401|NCT01016262|10286759|P1|Double-blind Phase|Adverse Event|0
2989402|NCT01016132|10286782|P1|Overall Study|Discomfort|1
2989403|NCT01016067|10286797|P2|Overall Study|Withdrew due to Relocation|1
2989404|NCT01016067|10286798|P1|Overall Study|Withdrew due to Relocation|0
2989405|NCT01016067|10286797|P2|Overall Study|Physician Decision|1
2989406|NCT01016067|10286798|P1|Overall Study|Physician Decision|1
2989407|NCT01016067|10286797|P2|Overall Study|Lost to Follow-up|2
2989408|NCT01016067|10286798|P1|Overall Study|Lost to Follow-up|1
2989409|NCT01016015|10286816|P1|Overall Study|Adverse Event|15
2989410|NCT01016015|10286816|P1|Overall Study|Withdrawal by Subject|1
2989411|NCT01016015|10286816|P1|Overall Study|Not Treated|3
2989412|NCT01015833|10286827|P2|Overall Study|Did not start treatment|0
2989413|NCT01015833|10286828|P1|Overall Study|Did not start treatment|1
2989414|NCT01015833|10286827|P2|Overall Study|Motor Vehicle Accidents|0
2989415|NCT01015833|10286828|P1|Overall Study|Motor Vehicle Accidents|1
2989416|NCT01015833|10286827|P2|Overall Study|Other|1
2989417|NCT01015833|10286828|P1|Overall Study|Other|5
2989418|NCT01015833|10286827|P2|Overall Study|Symptomatic deterioration|1
2989419|NCT01015833|10286828|P1|Overall Study|Symptomatic deterioration|0
2989420|NCT01015833|10286827|P2|Overall Study|Physician Decision|0
2989421|NCT01015833|10286828|P1|Overall Study|Physician Decision|2
2989422|NCT01015833|10286827|P2|Overall Study|Adverse Event|1
2989423|NCT01015833|10286828|P1|Overall Study|Adverse Event|0
2989424|NCT01015833|10286827|P2|Overall Study|Withdrawal by Subject|2
2989425|NCT01015833|10286828|P1|Overall Study|Withdrawal by Subject|3
2989426|NCT01015833|10286827|P2|Overall Study|Death|0
2989427|NCT01015833|10286828|P1|Overall Study|Death|1
2989428|NCT01015820|10286844|P2|Overall Study|Suboptimal measurements|0
2989429|NCT01015820|10286845|P1|Overall Study|Suboptimal measurements|1
2989430|NCT01015703|10286880|P5|Overall Study|Protocol Violation|0
2989431|NCT01015703|10286881|P4|Overall Study|Protocol Violation|0
2989432|NCT01015703|10286882|P3|Overall Study|Protocol Violation|0
2989433|NCT01015703|10286883|P2|Overall Study|Protocol Violation|0
2989434|NCT01015703|10286884|P1|Overall Study|Protocol Violation|1
2989435|NCT01015703|10286880|P5|Overall Study|Adverse Event|0
2989436|NCT01015703|10286881|P4|Overall Study|Adverse Event|0
2989437|NCT01015703|10286882|P3|Overall Study|Adverse Event|0
2989438|NCT01015703|10286883|P2|Overall Study|Adverse Event|0
2989439|NCT01015703|10286884|P1|Overall Study|Adverse Event|1
2989440|NCT01015703|10286880|P5|Overall Study|Withdrawal by Subject|0
2989441|NCT01015703|10286881|P4|Overall Study|Withdrawal by Subject|0
2989442|NCT01015703|10286882|P3|Overall Study|Withdrawal by Subject|0
2989443|NCT01015703|10286883|P2|Overall Study|Withdrawal by Subject|1
2989444|NCT01015703|10286884|P1|Overall Study|Withdrawal by Subject|0
2989445|NCT01015677|10286899|P3|Overall Study|Withdrawal by Subject|0
2989446|NCT01015677|10286900|P2|Overall Study|Withdrawal by Subject|1
2989447|NCT01015677|10286901|P1|Overall Study|Withdrawal by Subject|1
2989448|NCT01015677|10286899|P3|Overall Study|Protocol Violation|0
2989449|NCT01015677|10286900|P2|Overall Study|Protocol Violation|1
2989450|NCT01015677|10286901|P1|Overall Study|Protocol Violation|0
2989451|NCT01015677|10286899|P3|Overall Study|Lack of Efficacy|0
2989452|NCT01015677|10286900|P2|Overall Study|Lack of Efficacy|1
2989453|NCT01015677|10286901|P1|Overall Study|Lack of Efficacy|0
2989454|NCT01015677|10286899|P3|Overall Study|Adverse Event|0
2989455|NCT01015677|10286900|P2|Overall Study|Adverse Event|1
2989456|NCT01015677|10286901|P1|Overall Study|Adverse Event|0
2989457|NCT01015638|10286923|P2|Overall Study|Withdrawal by Subject|0
2989458|NCT01015638|10286924|P1|Overall Study|Withdrawal by Subject|1
2989459|NCT01015612|10286952|P1|Overall Study|Withdrawal by Subject|40
2989460|NCT01015612|10286952|P1|Overall Study|Death|113
2989461|NCT01015560|10286983|P1|Overall Study|Withdrawal by Subject|1
2989462|NCT01015560|10286983|P1|Overall Study|Not protocol specified|1
2989463|NCT01015560|10286983|P1|Overall Study|Adverse Event|1
2989464|NCT01015287|10287032|P2|Overall Study|Protocol Violation|1
2989465|NCT01015287|10287033|P1|Overall Study|Protocol Violation|1
2989466|NCT01015287|10287032|P2|Overall Study|Lost to Follow-up|1
2989467|NCT01015287|10287033|P1|Overall Study|Lost to Follow-up|2
2989468|NCT01015287|10287032|P2|Overall Study|Entry Criteria not Met|14
2989469|NCT01015287|10287033|P1|Overall Study|Entry Criteria not Met|11
2989470|NCT01015287|10287032|P2|Overall Study|Withdrawal by Subject|19
2989471|NCT01015287|10287033|P1|Overall Study|Withdrawal by Subject|14
2989472|NCT01015287|10287032|P2|Overall Study|Physician Decision|21
2989473|NCT01015287|10287033|P1|Overall Study|Physician Decision|19
2989474|NCT01015287|10287032|P2|Overall Study|Sponsor Decision|7
2989475|NCT01015287|10287033|P1|Overall Study|Sponsor Decision|3
2989476|NCT01015287|10287032|P2|Overall Study|Adverse Event|0
2989477|NCT01015287|10287033|P1|Overall Study|Adverse Event|1
2989478|NCT01015287|10287032|P2|Overall Study|Death|16
2989479|NCT01015287|10287033|P1|Overall Study|Death|21
2989480|NCT01015131|10287065|P1|Overall Study|Other Protocol Specified Criteria|4
2989481|NCT01015131|10287065|P1|Overall Study|Withdrawal by Subject|2
2989482|NCT01015131|10287065|P1|Overall Study|Protocol Violation|1
2989483|NCT01015131|10287065|P1|Overall Study|Physician Decision|1
2989484|NCT01015118|10287081|P2|Overall Study|Other than stated above|23
2989485|NCT01015118|10287082|P1|Overall Study|Other than stated above|42
2989486|NCT01015118|10287081|P2|Overall Study|Not treated|5
2989487|NCT01015118|10287082|P1|Overall Study|Not treated|9
2989488|NCT01015118|10287081|P2|Overall Study|Progressive disease|229
2989489|NCT01015118|10287082|P1|Overall Study|Progressive disease|364
2989490|NCT01015118|10287081|P2|Overall Study|Worsening or AE of underlying disease|4
2989491|NCT01015118|10287082|P1|Overall Study|Worsening or AE of underlying disease|5
2989492|NCT01015118|10287081|P2|Overall Study|Other Adverse Event (AE)|33
2989493|NCT01015118|10287082|P1|Overall Study|Other Adverse Event (AE)|141
2989494|NCT01015118|10287081|P2|Overall Study|Withdrawal by Subject|27
2989495|NCT01015118|10287082|P1|Overall Study|Withdrawal by Subject|103
2989496|NCT01015118|10287081|P2|Overall Study|Protocol Violation|6
2989497|NCT01015118|10287082|P1|Overall Study|Protocol Violation|5
2989498|NCT01014988|10287110|P6|Overall Study|Withdrawal by Subject|0
2989499|NCT01014988|10287111|P5|Overall Study|Withdrawal by Subject|0
2989500|NCT01014988|10287112|P4|Overall Study|Withdrawal by Subject|0
2989501|NCT01014988|10287113|P3|Overall Study|Withdrawal by Subject|0
2989502|NCT01014988|10287114|P2|Overall Study|Withdrawal by Subject|0
2989503|NCT01014988|10287115|P1|Overall Study|Withdrawal by Subject|1
2989504|NCT01014988|10287110|P6|Overall Study|Physician Decision|0
2989505|NCT01014988|10287111|P5|Overall Study|Physician Decision|0
2989506|NCT01014988|10287112|P4|Overall Study|Physician Decision|0
2989507|NCT01014988|10287113|P3|Overall Study|Physician Decision|0
2989508|NCT01014988|10287114|P2|Overall Study|Physician Decision|0
2989509|NCT01014988|10287115|P1|Overall Study|Physician Decision|1
2989510|NCT01014988|10287110|P6|Overall Study|Lost to Follow-up|0
2989511|NCT01014988|10287111|P5|Overall Study|Lost to Follow-up|0
2989512|NCT01014988|10287112|P4|Overall Study|Lost to Follow-up|0
2989513|NCT01014988|10287113|P3|Overall Study|Lost to Follow-up|1
2989514|NCT01014988|10287114|P2|Overall Study|Lost to Follow-up|0
2989515|NCT01014988|10287115|P1|Overall Study|Lost to Follow-up|1
2989516|NCT01014988|10287110|P6|Overall Study|Adverse Event|3
2989517|NCT01014988|10287111|P5|Overall Study|Adverse Event|1
2989518|NCT01014988|10287112|P4|Overall Study|Adverse Event|0
2989519|NCT01014988|10287113|P3|Overall Study|Adverse Event|1
2989520|NCT01014988|10287114|P2|Overall Study|Adverse Event|0
2989521|NCT01014988|10287115|P1|Overall Study|Adverse Event|20
2989522|NCT01014975|10287287|P3|Overall Study|Lost to Follow-up|1
2989523|NCT01014975|10287288|P2|Overall Study|Lost to Follow-up|0
2989524|NCT01014975|10287289|P1|Overall Study|Lost to Follow-up|0
2989525|NCT01014975|10287287|P3|Overall Study|Death|4
2989526|NCT01014975|10287288|P2|Overall Study|Death|3
2989527|NCT01014975|10287289|P1|Overall Study|Death|3
2989528|NCT01014975|10287287|P3|Overall Study|Withdrawal by Subject|1
2989529|NCT01014975|10287288|P2|Overall Study|Withdrawal by Subject|0
2989530|NCT01014975|10287289|P1|Overall Study|Withdrawal by Subject|1
2989531|NCT01014910|10287794|P2|Overall Study|Withdrawal by Subject|2
2989532|NCT01014910|10287795|P1|Overall Study|Withdrawal by Subject|0
2989533|NCT01014767|10287813|P4|Overall Study|PI left institution, data unavailable|1
2989534|NCT01014767|10287814|P3|Overall Study|PI left institution, data unavailable|4
2989535|NCT01014767|10287815|P2|Overall Study|PI left institution, data unavailable|1
2989536|NCT01014767|10287816|P1|Overall Study|PI left institution, data unavailable|12
2989537|NCT01014689|10287860|P2|Overall Study|Pregnancy|0
2989538|NCT01014689|10287861|P1|Overall Study|Pregnancy|1
2989539|NCT01014689|10287860|P2|Overall Study|Lost to Follow-up|7
2989540|NCT01014689|10287861|P1|Overall Study|Lost to Follow-up|3
2989541|NCT01014689|10287860|P2|Overall Study|Protocol Violation|1
2989542|NCT01014689|10287861|P1|Overall Study|Protocol Violation|1
2989543|NCT01014689|10287860|P2|Overall Study|Withdrawal by Subject|4
2989544|NCT01014689|10287861|P1|Overall Study|Withdrawal by Subject|5
2989545|NCT01014689|10287860|P2|Overall Study|Adverse Event|0
2989546|NCT01014689|10287861|P1|Overall Study|Adverse Event|3
2989547|NCT01014689|10287860|P2|Overall Study|Lack of Efficacy|1
2989548|NCT01014689|10287861|P1|Overall Study|Lack of Efficacy|0
2989549|NCT01014585|10287896|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2989550|NCT01014585|10287897|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2989551|NCT01014585|10287898|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
2989552|NCT01014585|10287899|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
2989553|NCT01014585|10287896|P4|Overall Study|Lost to Follow-up|2
2989554|NCT01014585|10287897|P3|Overall Study|Lost to Follow-up|0
2989555|NCT01014585|10287898|P2|Overall Study|Lost to Follow-up|0
2989556|NCT01014585|10287899|P1|Overall Study|Lost to Follow-up|0
2989557|NCT01014585|10287896|P4|Overall Study|Withdrawal by Subject|3
2989558|NCT01014585|10287897|P3|Overall Study|Withdrawal by Subject|1
2989559|NCT01014585|10287898|P2|Overall Study|Withdrawal by Subject|0
2989560|NCT01014585|10287899|P1|Overall Study|Withdrawal by Subject|2
2989561|NCT01014585|10287896|P4|Overall Study|Adverse Event|3
2989562|NCT01014585|10287897|P3|Overall Study|Adverse Event|0
2989563|NCT01014585|10287898|P2|Overall Study|Adverse Event|2
2989564|NCT01014585|10287899|P1|Overall Study|Adverse Event|0
2989565|NCT01014533|10287919|P2|Overall Study|unable to come to appointment|3
2989566|NCT01014533|10287920|P1|Overall Study|unable to come to appointment|0
2989567|NCT01014533|10287919|P2|Overall Study|Withdrawal by Subject|0
2989568|NCT01014533|10287920|P1|Overall Study|Withdrawal by Subject|2
2989569|NCT01014533|10287919|P2|Overall Study|Protocol Violation|2
2989570|NCT01014533|10287920|P1|Overall Study|Protocol Violation|3
2989571|NCT01014442|10287941|P2|Overall Study|Unspecified Reason|1
2989572|NCT01014442|10287942|P1|Overall Study|Unspecified Reason|1
2989573|NCT01014442|10287941|P2|Overall Study|Lack of Compliance|1
2989574|NCT01014442|10287942|P1|Overall Study|Lack of Compliance|0
2989575|NCT01014442|10287941|P2|Overall Study|Protocol Violation|5
2989576|NCT01014442|10287942|P1|Overall Study|Protocol Violation|2
2989577|NCT01014442|10287941|P2|Overall Study|Withdrawal by Subject|4
2989578|NCT01014442|10287942|P1|Overall Study|Withdrawal by Subject|4
2989579|NCT01014442|10287941|P2|Overall Study|Adverse Event|8
2989580|NCT01014442|10287942|P1|Overall Study|Adverse Event|0
2989581|NCT01014208|10288066|P2|Overall Study|Study Closed/terminated|83
2989582|NCT01014208|10288067|P1|Overall Study|Study Closed/terminated|78
2989583|NCT01014208|10288066|P2|Overall Study|Did Not Receive Study Drug|0
2989584|NCT01014208|10288067|P1|Overall Study|Did Not Receive Study Drug|2
2989585|NCT01014208|10288066|P2|Overall Study|Participant Withdrew Consent|12
2989586|NCT01014208|10288067|P1|Overall Study|Participant Withdrew Consent|12
2989587|NCT01014208|10288066|P2|Overall Study|Lost to Follow-up|5
2989588|NCT01014208|10288067|P1|Overall Study|Lost to Follow-up|2
2989589|NCT01014143|10288109|P3|Second Intervention|Lost to Follow-up|0
2989590|NCT01014143|10288110|P2|Second Intervention|Lost to Follow-up|0
2989591|NCT01014143|10288111|P1|Second Intervention|Lost to Follow-up|2
2989592|NCT01014013|10288206|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
2989593|NCT01014013|10288207|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
2989594|NCT01014013|10288206|P2|Overall Study|Appendectomy|0
2989595|NCT01014013|10288207|P1|Overall Study|Appendectomy|1
2989596|NCT01014013|10288206|P2|Overall Study|Another antibiotic therapy required|1
2989597|NCT01014013|10288207|P1|Overall Study|Another antibiotic therapy required|0
2989598|NCT01014013|10288206|P2|Overall Study|Physician Decision|1
2989599|NCT01014013|10288207|P1|Overall Study|Physician Decision|0
2989600|NCT01014013|10288206|P2|Overall Study|Pathogen resistant|4
2989601|NCT01014013|10288207|P1|Overall Study|Pathogen resistant|7
2989602|NCT01014013|10288206|P2|Overall Study|Negative urine culture|0
2989603|NCT01014013|10288207|P1|Overall Study|Negative urine culture|2
2989604|NCT01014013|10288206|P2|Overall Study|Pathogen culture = no growth|34
2989605|NCT01014013|10288207|P1|Overall Study|Pathogen culture = no growth|26
2989606|NCT01014013|10288206|P2|Overall Study|Clinical/microbiologic failure|2
2989607|NCT01014013|10288207|P1|Overall Study|Clinical/microbiologic failure|1
2989608|NCT01014013|10288206|P2|Overall Study|Withdrawal by Subject|4
2989609|NCT01014013|10288207|P1|Overall Study|Withdrawal by Subject|7
2989610|NCT01014013|10288206|P2|Overall Study|Protocol Violation|3
2989611|NCT01014013|10288207|P1|Overall Study|Protocol Violation|1
2989612|NCT01014013|10288206|P2|Overall Study|Laboratory adverse experience|1
2989613|NCT01014013|10288207|P1|Overall Study|Laboratory adverse experience|1
2989614|NCT01014013|10288206|P2|Overall Study|Clinical adverse experience|2
2989615|NCT01014013|10288207|P1|Overall Study|Clinical adverse experience|4
2989616|NCT01014013|10288206|P2|Overall Study|Inclusion/Exclusion criteria not met|3
2989617|NCT01014013|10288207|P1|Overall Study|Inclusion/Exclusion criteria not met|1
2989618|NCT01013961|10288219|P2|Overall Study|Physician Decision|1
2989619|NCT01013961|10288220|P1|Overall Study|Physician Decision|0
2989620|NCT01013961|10288219|P2|Overall Study|Withdrawal by Subject|0
2989621|NCT01013961|10288220|P1|Overall Study|Withdrawal by Subject|1
2989622|NCT01013961|10288219|P2|Overall Study|Adverse Event|2
2989623|NCT01013961|10288220|P1|Overall Study|Adverse Event|2
2989624|NCT01013883|10288238|P2|Overall Study|Lost to Follow-up|2
2989625|NCT01013883|10288239|P1|Overall Study|Lost to Follow-up|2
2989626|NCT01013870|10288251|P2|Overall Study|Lost to Follow-up|3
2989627|NCT01013870|10288252|P1|Overall Study|Lost to Follow-up|1
2989628|NCT01013792|10288301|P2|Overall Study|Lost to Follow-up|1
2989629|NCT01013792|10288302|P1|Overall Study|Lost to Follow-up|0
2989630|NCT01013792|10288301|P2|Overall Study|Adverse Event|3
2989631|NCT01013792|10288302|P1|Overall Study|Adverse Event|0
2989632|NCT01013792|10288301|P2|Overall Study|Study suspended|1
2989633|NCT01013792|10288302|P1|Overall Study|Study suspended|2
2989634|NCT01013753|10288308|P1|Overall Study|Other|2
2989635|NCT01013753|10288308|P1|Overall Study|Withdrawal by Subject|2
2989636|NCT01013753|10288308|P1|Overall Study|Lost to Follow-up|1
2989637|NCT01013753|10288308|P1|Overall Study|Protocol Violation|3
2989638|NCT01013753|10288308|P1|Overall Study|Adverse Event|8
2989639|NCT01013740|10288504|P2|Overall Study|Ongoing: Study records not completed|2
2989640|NCT01013740|10288505|P1|Overall Study|Ongoing: Study records not completed|0
2989641|NCT01013740|10288504|P2|Overall Study|Missing|1
2989642|NCT01013740|10288505|P1|Overall Study|Missing|2
2989643|NCT01013740|10288504|P2|Overall Study|study close / terminated : done in error|1
2989644|NCT01013740|10288505|P1|Overall Study|study close / terminated : done in error|2
2989645|NCT01013740|10288504|P2|Overall Study|Withdrawal by Subject|10
2989646|NCT01013740|10288505|P1|Overall Study|Withdrawal by Subject|2
2989647|NCT01013740|10288504|P2|Overall Study|Physician Decision|0
2989648|NCT01013740|10288505|P1|Overall Study|Physician Decision|2
2989649|NCT01013740|10288504|P2|Overall Study|Lost to Follow-up|5
2989650|NCT01013740|10288505|P1|Overall Study|Lost to Follow-up|3
2989651|NCT01013701|10288529|P1|Overall Study|study prematurely terminated|7
2989652|NCT01013597|10288536|P1|Overall Study|Withdrawal by Subject|1
2989653|NCT01013350|10288548|P2|Overall Study|Other|25
2989654|NCT01013350|10288549|P1|Overall Study|Other|1
2989655|NCT01013350|10288548|P2|Overall Study|Participant entered interventional study|8
2989656|NCT01013350|10288549|P1|Overall Study|Participant entered interventional study|0
2989657|NCT01013350|10288548|P2|Overall Study|Death|5
2989658|NCT01013350|10288549|P1|Overall Study|Death|3
2989659|NCT01013350|10288548|P2|Overall Study|Withdrawal by Subject|38
2989660|NCT01013350|10288549|P1|Overall Study|Withdrawal by Subject|15
2989661|NCT01013350|10288548|P2|Overall Study|Physician Decision|20
2989662|NCT01013350|10288549|P1|Overall Study|Physician Decision|4
2989663|NCT01013350|10288548|P2|Overall Study|Adverse Event|1
2989664|NCT01013350|10288549|P1|Overall Study|Adverse Event|0
2989665|NCT01013350|10288548|P2|Overall Study|Lost to Follow-up|95
2989666|NCT01013350|10288549|P1|Overall Study|Lost to Follow-up|15
2989667|NCT01013207|10288560|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
2989668|NCT01012999|10288578|P1|Overall Study|Protocol Violation|1
2989669|NCT01012973|10288584|P2|Overall Study|Withdrawal by Subject|6
2989670|NCT01012973|10288585|P1|Overall Study|Withdrawal by Subject|4
2989671|NCT01012973|10288584|P2|Overall Study|Protocol Violation|2
2989672|NCT01012973|10288585|P1|Overall Study|Protocol Violation|5
2989673|NCT01012973|10288584|P2|Overall Study|Increase in vis. acuity, never injected|1
2989674|NCT01012973|10288585|P1|Overall Study|Increase in vis. acuity, never injected|0
2989675|NCT01012973|10288584|P2|Overall Study|(Overseas travel - indefinite period)|0
2989676|NCT01012973|10288585|P1|Overall Study|(Overseas travel - indefinite period)|1
2989677|NCT01012973|10288584|P2|Overall Study|Lost to Follow-up|0
2989678|NCT01012973|10288585|P1|Overall Study|Lost to Follow-up|1
2989679|NCT01012973|10288584|P2|Overall Study|Lack of Efficacy|5
2989680|NCT01012973|10288585|P1|Overall Study|Lack of Efficacy|0
2989681|NCT01012973|10288584|P2|Overall Study|Adverse Event|5
2989682|NCT01012973|10288585|P1|Overall Study|Adverse Event|5
2989683|NCT01012947|10288610|P5|Overall Study|Lost to Follow-up|142
2989684|NCT01012947|10288611|P4|Overall Study|Lost to Follow-up|118
2989685|NCT01012947|10288612|P3|Overall Study|Lost to Follow-up|130
2989686|NCT01012947|10288613|P2|Overall Study|Lost to Follow-up|135
2989687|NCT01012947|10288614|P1|Overall Study|Lost to Follow-up|131
2989688|NCT01012765|10288635|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
2989689|NCT01012765|10288636|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
2989690|NCT01012765|10288637|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
2989691|NCT01012765|10288638|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
2989692|NCT01012765|10288639|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
2989693|NCT01012765|10288640|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
2989694|NCT01012765|10288635|P6|Treatment Period 2|Adverse Event|0
2989695|NCT01012765|10288636|P5|Treatment Period 2|Adverse Event|0
2989696|NCT01012765|10288637|P4|Treatment Period 2|Adverse Event|0
2989697|NCT01012765|10288638|P3|Treatment Period 2|Adverse Event|1
2989698|NCT01012765|10288639|P2|Treatment Period 2|Adverse Event|1
2989699|NCT01012765|10288640|P1|Treatment Period 2|Adverse Event|0
2989700|NCT01012765|10288635|P6|Treatment Period 2|Abnormal laboratory value(s)|1
2989701|NCT01012765|10288636|P5|Treatment Period 2|Abnormal laboratory value(s)|0
2989702|NCT01012765|10288637|P4|Treatment Period 2|Abnormal laboratory value(s)|0
2989703|NCT01012765|10288638|P3|Treatment Period 2|Abnormal laboratory value(s)|0
2989704|NCT01012765|10288639|P2|Treatment Period 2|Abnormal laboratory value(s)|0
2989705|NCT01012765|10288640|P1|Treatment Period 2|Abnormal laboratory value(s)|0
2989706|NCT01012765|10288635|P6|Treatment Period 2|Withdrawal by Subject|0
2989707|NCT01012765|10288636|P5|Treatment Period 2|Withdrawal by Subject|1
2989708|NCT01012765|10288637|P4|Treatment Period 2|Withdrawal by Subject|0
2989709|NCT01012765|10288638|P3|Treatment Period 2|Withdrawal by Subject|1
2989710|NCT01012765|10288639|P2|Treatment Period 2|Withdrawal by Subject|0
2989711|NCT01012765|10288640|P1|Treatment Period 2|Withdrawal by Subject|1
2989712|NCT01012765|10288635|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
2989713|NCT01012765|10288636|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
2989714|NCT01012765|10288637|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
2989715|NCT01012765|10288638|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
2989716|NCT01012765|10288639|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
2989717|NCT01012765|10288640|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
2989718|NCT01012765|10288635|P6|Treatment Period 1|Protocol Violation|0
2989719|NCT01012765|10288636|P5|Treatment Period 1|Protocol Violation|1
2989720|NCT01012765|10288637|P4|Treatment Period 1|Protocol Violation|2
2989721|NCT01012765|10288638|P3|Treatment Period 1|Protocol Violation|0
2989722|NCT01012765|10288639|P2|Treatment Period 1|Protocol Violation|0
2989723|NCT01012765|10288640|P1|Treatment Period 1|Protocol Violation|0
2989724|NCT01012765|10288635|P6|Treatment Period 1|Administrative problems|0
2989725|NCT01012765|10288636|P5|Treatment Period 1|Administrative problems|1
2989726|NCT01012765|10288637|P4|Treatment Period 1|Administrative problems|1
2989727|NCT01012765|10288638|P3|Treatment Period 1|Administrative problems|1
2989728|NCT01012765|10288639|P2|Treatment Period 1|Administrative problems|0
2989729|NCT01012765|10288640|P1|Treatment Period 1|Administrative problems|0
2989730|NCT01012765|10288635|P6|Treatment Period 1|Withdrawal by Subject|0
2989731|NCT01012765|10288636|P5|Treatment Period 1|Withdrawal by Subject|0
2989732|NCT01012765|10288637|P4|Treatment Period 1|Withdrawal by Subject|0
2989733|NCT01012765|10288638|P3|Treatment Period 1|Withdrawal by Subject|0
2989734|NCT01012765|10288639|P2|Treatment Period 1|Withdrawal by Subject|0
2989735|NCT01012765|10288640|P1|Treatment Period 1|Withdrawal by Subject|2
2989736|NCT01012765|10288635|P6|Treatment Period 1|Adverse Event|0
2989737|NCT01012765|10288636|P5|Treatment Period 1|Adverse Event|0
2989738|NCT01012765|10288637|P4|Treatment Period 1|Adverse Event|0
2989739|NCT01012765|10288638|P3|Treatment Period 1|Adverse Event|1
2989740|NCT01012765|10288639|P2|Treatment Period 1|Adverse Event|0
2989741|NCT01012765|10288640|P1|Treatment Period 1|Adverse Event|1
2989742|NCT01012739|10288669|P4|Treatment Period 2|Abnormal test procedure results|1
2989743|NCT01012739|10288670|P3|Treatment Period 2|Abnormal test procedure results|0
2989744|NCT01012739|10288671|P2|Treatment Period 2|Abnormal test procedure results|0
2989745|NCT01012739|10288672|P1|Treatment Period 2|Abnormal test procedure results|0
2989746|NCT01012739|10288669|P4|Treatment Period 1|Adverse Event|1
2989747|NCT01012739|10288670|P3|Treatment Period 1|Adverse Event|0
2989748|NCT01012739|10288671|P2|Treatment Period 1|Adverse Event|0
2989749|NCT01012739|10288672|P1|Treatment Period 1|Adverse Event|0
2989750|NCT01012713|10288700|P1|Overall Study|Lack of Efficacy|3
2989751|NCT01012622|10288726|P1|Overall Study|withdrawal of consent by a parent|2
2989752|NCT01012622|10288726|P1|Overall Study|screening failure|1
2989753|NCT01012622|10288726|P1|Overall Study|Other|1
2989754|NCT01012622|10288726|P1|Overall Study|non-compliance with the drug|9
2989755|NCT01012622|10288726|P1|Overall Study|Adverse Event|7
2989756|NCT01012622|10288726|P1|Overall Study|Lost to Follow-up|5
2989757|NCT01012622|10288726|P1|Overall Study|Withdrawal by Subject|6
2989758|NCT01012440|10288752|P1|Overall Study|Withdrawal by Subject|2
2989759|NCT01012414|10288756|P1|Overall Study|Trial was stopped before completed|7
2989760|NCT01012414|10288756|P1|Overall Study|Lost to Follow-up|1
2989761|NCT01012414|10288756|P1|Overall Study|Withdrawal by Subject|2
2989762|NCT01012323|10288797|P1|Overall Study|Investigator Judgment|1
2989763|NCT01012258|10288834|P1|Overall Study|Ongoing|29
2989764|NCT01012258|10288834|P1|Overall Study|Another Tumor Discovered|1
2989765|NCT01012258|10288834|P1|Overall Study|Another Anti-cancer Drug Received|1
2989766|NCT01012258|10288834|P1|Overall Study|Symptomatic Deterioration|1
2989767|NCT01012258|10288834|P1|Overall Study|Progressive Disease (PD)|18
2989768|NCT01012258|10288834|P1|Overall Study|Adverse Event|1
2989769|NCT01012258|10288834|P1|Overall Study|Lost to Follow-up|1
2989770|NCT01012258|10288834|P1|Overall Study|Death|14
2989771|NCT01012219|10288881|P1|Period 2|Withdrawal by Subject|1
2989772|NCT01012219|10288881|P1|Period 1|Withdrawal by Subject|1
2989773|NCT01012037|10289172|P3|Overall Study|Other reason (not specified)|1
2989774|NCT01012037|10289173|P2|Overall Study|Other reason (not specified)|1
2989775|NCT01012037|10289174|P1|Overall Study|Other reason (not specified)|1
2989776|NCT01012037|10289172|P3|Overall Study|Withdrawal by Subject|1
2989777|NCT01012037|10289173|P2|Overall Study|Withdrawal by Subject|4
2989778|NCT01012037|10289174|P1|Overall Study|Withdrawal by Subject|0
2989779|NCT01012037|10289172|P3|Overall Study|Protocol Violation|5
2989780|NCT01012037|10289173|P2|Overall Study|Protocol Violation|3
2989781|NCT01012037|10289174|P1|Overall Study|Protocol Violation|0
2989782|NCT01012037|10289172|P3|Overall Study|Adverse Event|3
2989783|NCT01012037|10289173|P2|Overall Study|Adverse Event|8
2989784|NCT01012037|10289174|P1|Overall Study|Adverse Event|0
2989785|NCT01011946|10289209|P1|Overall Study|No pathological lab value|1
2989786|NCT01011946|10289209|P1|Overall Study|Transferred to another hospital|2
2989787|NCT01011933|10289213|P1|Overall Study|Never treated|1
2989788|NCT01011933|10289213|P1|Overall Study|Inadequate pathology|1
2989789|NCT01011933|10289213|P1|Overall Study|Improper pre-protocol Rx|1
2989790|NCT01011933|10289213|P1|Overall Study|Wrong cell type|1
2989791|NCT01011907|10289230|P2|Overall Study|Adverse Event|4
2989792|NCT01011907|10289231|P1|Overall Study|Adverse Event|1
2989793|NCT01011907|10289230|P2|Overall Study|Withdrawal by Subject|11
2989794|NCT01011907|10289231|P1|Overall Study|Withdrawal by Subject|13
2989795|NCT01011868|10289248|P3|After Week 78 Follow-up|Other reason not defined above|16
2989796|NCT01011868|10289249|P2|After Week 78 Follow-up|Other reason not defined above|5
2989797|NCT01011868|10289250|P1|After Week 78 Follow-up|Other reason not defined above|5
2989798|NCT01011868|10289248|P3|After Week 78 Follow-up|Withdrawal by Subject|1
2989799|NCT01011868|10289249|P2|After Week 78 Follow-up|Withdrawal by Subject|8
2989800|NCT01011868|10289250|P1|After Week 78 Follow-up|Withdrawal by Subject|9
2989801|NCT01011868|10289248|P3|After Week 78 Follow-up|Lost to Follow-up|4
2989802|NCT01011868|10289249|P2|After Week 78 Follow-up|Lost to Follow-up|6
2989803|NCT01011868|10289250|P1|After Week 78 Follow-up|Lost to Follow-up|11
2989804|NCT01011868|10289248|P3|After Week 78 Follow-up|Protocol Violation|2
2989805|NCT01011868|10289249|P2|After Week 78 Follow-up|Protocol Violation|1
2989806|NCT01011868|10289250|P1|After Week 78 Follow-up|Protocol Violation|9
2989807|NCT01011868|10289248|P3|After Week 78 Follow-up|Lack of Efficacy|0
2989808|NCT01011868|10289249|P2|After Week 78 Follow-up|Lack of Efficacy|0
2989809|NCT01011868|10289250|P1|After Week 78 Follow-up|Lack of Efficacy|4
2989810|NCT01011868|10289248|P3|After Week 78 Follow-up|Adverse Event|21
2989811|NCT01011868|10289249|P2|After Week 78 Follow-up|Adverse Event|18
2989812|NCT01011868|10289250|P1|After Week 78 Follow-up|Adverse Event|14
2989813|NCT01011868|10289248|P3|After Week 18 Follow-up|Other reason not defined above|12
2989814|NCT01011868|10289249|P2|After Week 18 Follow-up|Other reason not defined above|3
2989815|NCT01011868|10289250|P1|After Week 18 Follow-up|Other reason not defined above|2
2989816|NCT01011868|10289248|P3|After Week 18 Follow-up|Withdrawal by Subject|0
2989817|NCT01011868|10289249|P2|After Week 18 Follow-up|Withdrawal by Subject|3
2989818|NCT01011868|10289250|P1|After Week 18 Follow-up|Withdrawal by Subject|6
2989819|NCT01011868|10289248|P3|After Week 18 Follow-up|Lost to Follow-up|0
2989820|NCT01011868|10289249|P2|After Week 18 Follow-up|Lost to Follow-up|3
2989821|NCT01011868|10289250|P1|After Week 18 Follow-up|Lost to Follow-up|5
2989822|NCT01011868|10289248|P3|After Week 18 Follow-up|Protocol Violation|1
2989823|NCT01011868|10289249|P2|After Week 18 Follow-up|Protocol Violation|1
2989824|NCT01011868|10289250|P1|After Week 18 Follow-up|Protocol Violation|1
2989825|NCT01011868|10289248|P3|After Week 18 Follow-up|Lack of Efficacy|0
2989826|NCT01011868|10289249|P2|After Week 18 Follow-up|Lack of Efficacy|0
2989827|NCT01011868|10289250|P1|After Week 18 Follow-up|Lack of Efficacy|1
2989828|NCT01011868|10289248|P3|After Week 18 Follow-up|Adverse Event|13
2989829|NCT01011868|10289249|P2|After Week 18 Follow-up|Adverse Event|6
2989830|NCT01011868|10289250|P1|After Week 18 Follow-up|Adverse Event|8
2989831|NCT01011738|10289312|P3|Overall Study|Unknown reasons|17
2989832|NCT01011738|10289313|P2|Overall Study|Unknown reasons|291
2989833|NCT01011738|10289314|P1|Overall Study|Unknown reasons|312
2989834|NCT01011738|10289312|P3|Overall Study|Death|0
2989835|NCT01011738|10289313|P2|Overall Study|Death|3
2989836|NCT01011738|10289314|P1|Overall Study|Death|12
2989837|NCT01011673|10289354|P2|24 Hour Follow-up|Lost to Follow-up|3
2989838|NCT01011673|10289355|P1|24 Hour Follow-up|Lost to Follow-up|3
2989839|NCT01011673|10289354|P2|Randomized|Secondary headache|1
2989840|NCT01011673|10289355|P1|Randomized|Secondary headache|2
2989841|NCT01011556|10289378|P4|Overall Study|Inclusion/exclusion criteria not met|5
2989842|NCT01011556|10289379|P3|Overall Study|Inclusion/exclusion criteria not met|3
2989843|NCT01011556|10289380|P2|Overall Study|Inclusion/exclusion criteria not met|1
2989844|NCT01011556|10289381|P1|Overall Study|Inclusion/exclusion criteria not met|2
2989845|NCT01011556|10289378|P4|Overall Study|Sponsor decision|2
2989846|NCT01011556|10289379|P3|Overall Study|Sponsor decision|1
2989847|NCT01011556|10289380|P2|Overall Study|Sponsor decision|1
2989848|NCT01011556|10289381|P1|Overall Study|Sponsor decision|0
2989849|NCT01011556|10289378|P4|Overall Study|Withdrawal by Subject|4
2989850|NCT01011556|10289379|P3|Overall Study|Withdrawal by Subject|4
2989851|NCT01011556|10289380|P2|Overall Study|Withdrawal by Subject|2
2989852|NCT01011556|10289381|P1|Overall Study|Withdrawal by Subject|1
2989853|NCT01011556|10289378|P4|Overall Study|Protocol Violation|0
2989854|NCT01011556|10289379|P3|Overall Study|Protocol Violation|0
2989855|NCT01011556|10289380|P2|Overall Study|Protocol Violation|1
2989856|NCT01011556|10289381|P1|Overall Study|Protocol Violation|0
2989857|NCT01011556|10289378|P4|Overall Study|Physician Decision|1
2989858|NCT01011556|10289379|P3|Overall Study|Physician Decision|0
2989859|NCT01011556|10289380|P2|Overall Study|Physician Decision|0
2989860|NCT01011556|10289381|P1|Overall Study|Physician Decision|1
2989861|NCT01011556|10289378|P4|Overall Study|Lost to Follow-up|0
2989862|NCT01011556|10289379|P3|Overall Study|Lost to Follow-up|0
2989863|NCT01011556|10289380|P2|Overall Study|Lost to Follow-up|0
2989864|NCT01011556|10289381|P1|Overall Study|Lost to Follow-up|1
2989865|NCT01011556|10289378|P4|Overall Study|Adverse Event|1
2989866|NCT01011556|10289379|P3|Overall Study|Adverse Event|2
2989867|NCT01011556|10289380|P2|Overall Study|Adverse Event|3
2989868|NCT01011556|10289381|P1|Overall Study|Adverse Event|1
2989869|NCT01011465|10289459|P8|Overall Study|Withdrawal by Subject|0
2989870|NCT01011465|10289460|P7|Overall Study|Withdrawal by Subject|1
2989871|NCT01011465|10289461|P6|Overall Study|Withdrawal by Subject|0
2989872|NCT01011465|10289462|P5|Overall Study|Withdrawal by Subject|1
2989873|NCT01011465|10289463|P4|Overall Study|Withdrawal by Subject|0
2989874|NCT01011465|10289464|P3|Overall Study|Withdrawal by Subject|0
2989875|NCT01011465|10289465|P2|Overall Study|Withdrawal by Subject|1
2989876|NCT01011465|10289466|P1|Overall Study|Withdrawal by Subject|2
2989877|NCT01011439|10289494|P1|Overall Study|Sponsor's decision|15
2989878|NCT01011439|10289494|P1|Overall Study|Withdrawal by Subject|1
2989879|NCT01011439|10289494|P1|Overall Study|Lost to Follow-up|4
2989880|NCT01011439|10289494|P1|Overall Study|Death|37
2989881|NCT01011387|10289531|P1|Overall Study|Protocol Violation|1
2989882|NCT01011387|10289531|P1|Overall Study|Adverse Event|2
2989883|NCT01011387|10289531|P1|Overall Study|Withdrawal by Subject|3
2989884|NCT01011335|10289539|P13|Overall Study|Adverse Event|1
2989885|NCT01011335|10289540|P12|Overall Study|Adverse Event|0
2989886|NCT01011335|10289541|P11|Overall Study|Adverse Event|4
2989887|NCT01011335|10289542|P10|Overall Study|Adverse Event|0
2989888|NCT01011335|10289543|P9|Overall Study|Adverse Event|0
2989889|NCT01011335|10289544|P8|Overall Study|Adverse Event|0
2989890|NCT01011335|10289545|P7|Overall Study|Adverse Event|0
2989891|NCT01011335|10289546|P6|Overall Study|Adverse Event|0
2989892|NCT01011335|10289547|P5|Overall Study|Adverse Event|0
2989893|NCT01011335|10289548|P4|Overall Study|Adverse Event|0
2989894|NCT01011335|10289549|P3|Overall Study|Adverse Event|0
2989895|NCT01011335|10289550|P2|Overall Study|Adverse Event|0
2989896|NCT01011335|10289551|P1|Overall Study|Adverse Event|0
2989897|NCT01011335|10289539|P13|Overall Study|Moved/deployed or no booster|0
2989898|NCT01011335|10289540|P12|Overall Study|Moved/deployed or no booster|0
2989899|NCT01011335|10289541|P11|Overall Study|Moved/deployed or no booster|2
2989900|NCT01011335|10289542|P10|Overall Study|Moved/deployed or no booster|0
2989901|NCT01011335|10289543|P9|Overall Study|Moved/deployed or no booster|1
2989902|NCT01011335|10289544|P8|Overall Study|Moved/deployed or no booster|0
2989903|NCT01011335|10289545|P7|Overall Study|Moved/deployed or no booster|1
2989904|NCT01011335|10289546|P6|Overall Study|Moved/deployed or no booster|0
2989905|NCT01011335|10289547|P5|Overall Study|Moved/deployed or no booster|0
2989906|NCT01011335|10289548|P4|Overall Study|Moved/deployed or no booster|1
2989907|NCT01011335|10289549|P3|Overall Study|Moved/deployed or no booster|0
2989908|NCT01011335|10289550|P2|Overall Study|Moved/deployed or no booster|0
2989909|NCT01011335|10289551|P1|Overall Study|Moved/deployed or no booster|1
2989910|NCT01011335|10289539|P13|Overall Study|Protocol Violation|0
2989911|NCT01011335|10289540|P12|Overall Study|Protocol Violation|0
2989912|NCT01011335|10289541|P11|Overall Study|Protocol Violation|0
2989913|NCT01011335|10289542|P10|Overall Study|Protocol Violation|0
2989914|NCT01011335|10289543|P9|Overall Study|Protocol Violation|0
2989915|NCT01011335|10289544|P8|Overall Study|Protocol Violation|0
2989916|NCT01011335|10289545|P7|Overall Study|Protocol Violation|0
2989917|NCT01011335|10289546|P6|Overall Study|Protocol Violation|0
2989918|NCT01011335|10289547|P5|Overall Study|Protocol Violation|0
2989919|NCT01011335|10289548|P4|Overall Study|Protocol Violation|0
2989920|NCT01011335|10289549|P3|Overall Study|Protocol Violation|0
2989921|NCT01011335|10289550|P2|Overall Study|Protocol Violation|1
2989922|NCT01011335|10289551|P1|Overall Study|Protocol Violation|0
2989923|NCT01011335|10289539|P13|Overall Study|Lost to Follow-up|2
2989924|NCT01011335|10289540|P12|Overall Study|Lost to Follow-up|1
2989925|NCT01011335|10289541|P11|Overall Study|Lost to Follow-up|0
2989926|NCT01011335|10289542|P10|Overall Study|Lost to Follow-up|0
2989927|NCT01011335|10289543|P9|Overall Study|Lost to Follow-up|1
2989928|NCT01011335|10289544|P8|Overall Study|Lost to Follow-up|2
2989929|NCT01011335|10289545|P7|Overall Study|Lost to Follow-up|2
2989930|NCT01011335|10289546|P6|Overall Study|Lost to Follow-up|1
2989931|NCT01011335|10289547|P5|Overall Study|Lost to Follow-up|1
2989932|NCT01011335|10289548|P4|Overall Study|Lost to Follow-up|1
2989933|NCT01011335|10289549|P3|Overall Study|Lost to Follow-up|1
2989934|NCT01011335|10289550|P2|Overall Study|Lost to Follow-up|0
2989935|NCT01011335|10289551|P1|Overall Study|Lost to Follow-up|0
2989936|NCT01011309|10289591|P3|Overall Study|Protocol Violation|3
2989937|NCT01011309|10289592|P2|Overall Study|Protocol Violation|1
2989938|NCT01011309|10289593|P1|Overall Study|Protocol Violation|0
2989939|NCT01011309|10289591|P3|Overall Study|Lack of Efficacy|0
2989940|NCT01011309|10289592|P2|Overall Study|Lack of Efficacy|1
2989941|NCT01011309|10289593|P1|Overall Study|Lack of Efficacy|0
2989942|NCT01011309|10289591|P3|Overall Study|Adverse Event|2
2989943|NCT01011309|10289592|P2|Overall Study|Adverse Event|1
2989944|NCT01011309|10289593|P1|Overall Study|Adverse Event|2
2989945|NCT01011283|10289609|P2|Overall Study|Other|2
2989946|NCT01011283|10289610|P1|Overall Study|Other|2
2989947|NCT01011283|10289609|P2|Overall Study|Terminated by Sponsor|5
2989948|NCT01011283|10289610|P1|Overall Study|Terminated by Sponsor|5
2989949|NCT01011283|10289609|P2|Overall Study|Progressive Disease|2
2989950|NCT01011283|10289610|P1|Overall Study|Progressive Disease|0
2989951|NCT01011283|10289609|P2|Overall Study|Adverse Event|2
2989952|NCT01011283|10289610|P1|Overall Study|Adverse Event|4
2989953|NCT01011153|10289659|P3|Overall Study|Less than 78 cases completed|9
2989954|NCT01011153|10289660|P2|Overall Study|Less than 78 cases completed|11
2989955|NCT01011153|10289661|P1|Overall Study|Less than 78 cases completed|8
2989956|NCT01011049|10289690|P4|Overall Study|Withdrawal by Subject|0
2989957|NCT01011049|10289691|P3|Overall Study|Withdrawal by Subject|1
2989958|NCT01011049|10289692|P2|Overall Study|Withdrawal by Subject|0
2989959|NCT01011049|10289693|P1|Overall Study|Withdrawal by Subject|0
2989960|NCT01011049|10289690|P4|Overall Study|Lost to Follow-up|0
2989961|NCT01011049|10289691|P3|Overall Study|Lost to Follow-up|1
2989962|NCT01011049|10289692|P2|Overall Study|Lost to Follow-up|2
2989963|NCT01011049|10289693|P1|Overall Study|Lost to Follow-up|1
2989964|NCT01011049|10289690|P4|Overall Study|Protocol Violation|0
2989965|NCT01011049|10289691|P3|Overall Study|Protocol Violation|2
2989966|NCT01011049|10289692|P2|Overall Study|Protocol Violation|0
2989967|NCT01011049|10289693|P1|Overall Study|Protocol Violation|0
2989968|NCT01010971|10289723|P3|Overall Study|Other|2
2989969|NCT01010971|10289724|P2|Overall Study|Other|0
2989970|NCT01010971|10289725|P1|Overall Study|Other|1
2989971|NCT01010971|10289723|P3|Overall Study|Lost to Follow-up|3
2989972|NCT01010971|10289724|P2|Overall Study|Lost to Follow-up|2
2989973|NCT01010971|10289725|P1|Overall Study|Lost to Follow-up|0
2989974|NCT01010971|10289723|P3|Overall Study|Withdrawal by Subject|5
2989975|NCT01010971|10289724|P2|Overall Study|Withdrawal by Subject|2
2989976|NCT01010971|10289725|P1|Overall Study|Withdrawal by Subject|0
2989977|NCT01010971|10289723|P3|Overall Study|Adverse Event|3
2989978|NCT01010971|10289724|P2|Overall Study|Adverse Event|4
2989979|NCT01010971|10289725|P1|Overall Study|Adverse Event|2
2989980|NCT01010867|10289853|P1|Overall Study|< 50% adherence to probiotic|1
2989981|NCT01010776|10289865|P1|Extension Phase|Other|3
2989982|NCT01010776|10289865|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
2989983|NCT01010776|10289865|P1|Main Phase|Did not received study medication|5
2989984|NCT01010776|10289865|P1|Main Phase|Other|1
2989985|NCT01010776|10289865|P1|Main Phase|Inform consent withdrawal|1
2989986|NCT01010776|10289865|P1|Main Phase|Selection failure|2
2989987|NCT01010776|10289865|P1|Main Phase|Non-compliance to study medication|5
2989988|NCT01010776|10289865|P1|Main Phase|Lost to Follow-up|6
2989989|NCT01010776|10289865|P1|Main Phase|Adverse Event|7
2989990|NCT01010776|10289865|P1|Main Phase|Lack of Efficacy|8
2989991|NCT01010776|10289865|P1|Main Phase|Withdrawal by Subject|14
2989992|NCT01010750|10289922|P6|Second Intervention|Adverse Event|0
2989993|NCT01010750|10289923|P5|Second Intervention|Adverse Event|0
2989994|NCT01010750|10289924|P4|Second Intervention|Adverse Event|0
2989995|NCT01010750|10289925|P3|Second Intervention|Adverse Event|0
2989996|NCT01010750|10289926|P2|Second Intervention|Adverse Event|1
2989997|NCT01010750|10289927|P1|Second Intervention|Adverse Event|0
2989998|NCT01010633|10289952|P2|Overall Study|Investigator decision|1
2989999|NCT01010633|10289953|P1|Overall Study|Investigator decision|0
2990000|NCT01010633|10289952|P2|Overall Study|Withdrawal by Subject|1
2990001|NCT01010633|10289953|P1|Overall Study|Withdrawal by Subject|2
2990002|NCT01010633|10289952|P2|Overall Study|Protocol Violation|2
2990003|NCT01010633|10289953|P1|Overall Study|Protocol Violation|1
2990004|NCT01010633|10289952|P2|Overall Study|Adverse Event|1
2990005|NCT01010633|10289953|P1|Overall Study|Adverse Event|1
2990006|NCT01010503|10289980|P1|Overall Study|Death|1
2990007|NCT01010503|10289980|P1|Overall Study|Adverse Event|1
2990008|NCT01010230|10290039|P2|Overall Study|Lost to Follow-up|2
2990009|NCT01010230|10290040|P1|Overall Study|Lost to Follow-up|4
2990010|NCT01010230|10290039|P2|Overall Study|Withdrawal by Subject|5
2990011|NCT01010230|10290040|P1|Overall Study|Withdrawal by Subject|6
2990012|NCT01010217|10290075|P5|Overall Study|Physician Decision|3
2990013|NCT01010217|10290076|P4|Overall Study|Physician Decision|6
2990014|NCT01010217|10290077|P3|Overall Study|Physician Decision|0
2990015|NCT01010217|10290078|P2|Overall Study|Physician Decision|0
2990016|NCT01010217|10290079|P1|Overall Study|Physician Decision|0
2990017|NCT01010217|10290075|P5|Overall Study|Withdrawal by Subject|0
2990018|NCT01010217|10290076|P4|Overall Study|Withdrawal by Subject|0
2990019|NCT01010217|10290077|P3|Overall Study|Withdrawal by Subject|0
2990020|NCT01010217|10290078|P2|Overall Study|Withdrawal by Subject|0
2990021|NCT01010217|10290079|P1|Overall Study|Withdrawal by Subject|1
2990022|NCT01010217|10290075|P5|Overall Study|Lost to Follow-up|0
2990023|NCT01010217|10290076|P4|Overall Study|Lost to Follow-up|0
2990024|NCT01010217|10290077|P3|Overall Study|Lost to Follow-up|1
2990025|NCT01010217|10290078|P2|Overall Study|Lost to Follow-up|5
2990026|NCT01010217|10290079|P1|Overall Study|Lost to Follow-up|4
2990027|NCT01010204|10290118|P2|Overall Study|psychiatric hospitalization|1
2990028|NCT01010204|10290119|P1|Overall Study|psychiatric hospitalization|2
2990029|NCT01010204|10290118|P2|Overall Study|Withdrawal by Subject|3
2990030|NCT01010204|10290119|P1|Overall Study|Withdrawal by Subject|2
2990031|NCT01010204|10290118|P2|Overall Study|Adverse Event|3
2990032|NCT01010204|10290119|P1|Overall Study|Adverse Event|1
2990033|NCT01010204|10290118|P2|Overall Study|Lost to Follow-up|2
2990034|NCT01010204|10290119|P1|Overall Study|Lost to Follow-up|2
2990035|NCT01010126|10290135|P6|Overall Study|Withdrawal by Subject|0
2990036|NCT01010126|10290136|P5|Overall Study|Withdrawal by Subject|3
2990037|NCT01010126|10290137|P4|Overall Study|Withdrawal by Subject|0
2990038|NCT01010126|10290138|P3|Overall Study|Withdrawal by Subject|1
2990039|NCT01010126|10290139|P2|Overall Study|Withdrawal by Subject|0
2990040|NCT01010126|10290140|P1|Overall Study|Withdrawal by Subject|1
2990041|NCT01010061|10290192|P2|Overall Study|Did Not Receive Treatment|2
2990042|NCT01010061|10290193|P1|Overall Study|Did Not Receive Treatment|2
2990043|NCT01010061|10290192|P2|Overall Study|Violation of Selection Criteria|1
2990044|NCT01010061|10290193|P1|Overall Study|Violation of Selection Criteria|0
2990045|NCT01010061|10290192|P2|Overall Study|Insufficient Therapeutic Response|5
2990046|NCT01010061|10290193|P1|Overall Study|Insufficient Therapeutic Response|1
2990047|NCT01010061|10290192|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
2990048|NCT01010061|10290193|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
2990049|NCT01010061|10290192|P2|Overall Study|Administrative/Other|1
2990050|NCT01010061|10290193|P1|Overall Study|Administrative/Other|0
2990051|NCT01010061|10290192|P2|Overall Study|Death|6
2990052|NCT01010061|10290193|P1|Overall Study|Death|3
2990053|NCT01010061|10290192|P2|Overall Study|Withdrew Consent|1
2990054|NCT01010061|10290193|P1|Overall Study|Withdrew Consent|5
2990055|NCT01010061|10290192|P2|Overall Study|Disease Progression|8
2990056|NCT01010061|10290193|P1|Overall Study|Disease Progression|2
2990057|NCT01010061|10290192|P2|Overall Study|Adverse Events or Intercurrent Illness|16
2990058|NCT01010061|10290193|P1|Overall Study|Adverse Events or Intercurrent Illness|33
2990059|NCT01009983|10290244|P1|Overall Study|necessary scans not completed|1
2990060|NCT01009840|10290257|P1|Overall Study|Subject Withdrew Consent to Participate|1
2990061|NCT01009840|10290257|P1|Overall Study|Subject was Withdrawn by Investigator|1
2990062|NCT01009840|10290257|P1|Overall Study|Subject Met Withdrawal Criteria|7
2990063|NCT01009840|10290257|P1|Overall Study|Adverse Event|4
2990064|NCT01009840|10290257|P1|Overall Study|Lost to Follow-up|1
2990065|NCT01009814|10290275|P5|Overall Study|No longer met study criteria|0
2990066|NCT01009814|10290276|P4|Overall Study|No longer met study criteria|0
2990067|NCT01009814|10290277|P3|Overall Study|No longer met study criteria|0
2990068|NCT01009814|10290278|P2|Overall Study|No longer met study criteria|1
2990069|NCT01009814|10290279|P1|Overall Study|No longer met study criteria|1
2990070|NCT01009645|10290403|P4|Overall Study|Lost to Follow-up|5
2990071|NCT01009645|10290404|P3|Overall Study|Lost to Follow-up|4
2990072|NCT01009645|10290405|P2|Overall Study|Lost to Follow-up|8
2990073|NCT01009645|10290406|P1|Overall Study|Lost to Follow-up|2
2990074|NCT01009580|10290443|P2|Overall Study|Unclassified|21
2990075|NCT01009580|10290444|P1|Overall Study|Unclassified|17
2990076|NCT01009580|10290443|P2|Overall Study|Withdrawal Criteria|6
2990077|NCT01009580|10290444|P1|Overall Study|Withdrawal Criteria|4
2990078|NCT01009580|10290443|P2|Overall Study|Protocol Violation|3
2990079|NCT01009580|10290444|P1|Overall Study|Protocol Violation|2
2990080|NCT01009580|10290443|P2|Overall Study|Lack of Efficacy|1
2990081|NCT01009580|10290444|P1|Overall Study|Lack of Efficacy|0
2990082|NCT01009580|10290443|P2|Overall Study|Adverse Event|4
2990083|NCT01009580|10290444|P1|Overall Study|Adverse Event|4
2990084|NCT01009554|10290458|P2|Overall Study|Noncompliant with Study Product|3
2990085|NCT01009554|10290459|P1|Overall Study|Noncompliant with Study Product|0
2990086|NCT01009554|10290458|P2|Overall Study|Withdrawal by Subject|3
2990087|NCT01009554|10290459|P1|Overall Study|Withdrawal by Subject|1
2990088|NCT01009554|10290458|P2|Overall Study|Adverse Event|1
2990089|NCT01009554|10290459|P1|Overall Study|Adverse Event|1
2990090|NCT01009515|10290591|P1|Overall Study|Withdrawal by Subject|3
2990091|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Physician Decision|8
2990092|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Physician Decision|6
2990093|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Physician Decision|6
2990094|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Physician Decision|4
2990095|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Physician Decision|0
2990096|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
2990097|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2990098|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
2990099|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
2990100|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2990101|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2990102|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2990103|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2990104|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
2990105|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2990106|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2990107|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2990108|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
2990109|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2990110|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2990111|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
2990112|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
2990113|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
2990114|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
2990115|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
2990116|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
2990117|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
2990118|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2990119|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
2990120|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2990121|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2990122|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
2990123|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
2990124|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
2990125|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2990126|NCT01009463|10290602|P5|52-week, Double-blind Treatment Period|Adverse Event|31
2990127|NCT01009463|10290603|P4|52-week, Double-blind Treatment Period|Adverse Event|29
2990128|NCT01009463|10290604|P3|52-week, Double-blind Treatment Period|Adverse Event|25
2990129|NCT01009463|10290605|P2|52-week, Double-blind Treatment Period|Adverse Event|22
2990130|NCT01009463|10290606|P1|52-week, Double-blind Treatment Period|Adverse Event|0
2990131|NCT01009463|10290602|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2990132|NCT01009463|10290603|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2990133|NCT01009463|10290604|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2990134|NCT01009463|10290605|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2990135|NCT01009463|10290606|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
2990136|NCT01009463|10290602|P5|4-week, Open-label Run-In Period|Physician Decision|0
2990137|NCT01009463|10290603|P4|4-week, Open-label Run-In Period|Physician Decision|0
2990138|NCT01009463|10290604|P3|4-week, Open-label Run-In Period|Physician Decision|0
2990139|NCT01009463|10290605|P2|4-week, Open-label Run-In Period|Physician Decision|0
2990140|NCT01009463|10290606|P1|4-week, Open-label Run-In Period|Physician Decision|10
2990141|NCT01009463|10290602|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
2990142|NCT01009463|10290603|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
2990143|NCT01009463|10290604|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
2990144|NCT01009463|10290605|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
2990145|NCT01009463|10290606|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
2990146|NCT01009463|10290602|P5|4-week, Open-label Run-In Period|Adverse Event|0
2990147|NCT01009463|10290603|P4|4-week, Open-label Run-In Period|Adverse Event|0
2990148|NCT01009463|10290604|P3|4-week, Open-label Run-In Period|Adverse Event|0
2990149|NCT01009463|10290605|P2|4-week, Open-label Run-In Period|Adverse Event|0
2990150|NCT01009463|10290606|P1|4-week, Open-label Run-In Period|Adverse Event|10
2990151|NCT01009463|10290602|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2990152|NCT01009463|10290603|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2990153|NCT01009463|10290604|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2990154|NCT01009463|10290605|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2990155|NCT01009463|10290606|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
2990156|NCT01009346|10290628|P1|Overall Study|Adverse Event|4
2990157|NCT01009203|10290652|P1|Overall Study|Treatment-unrelated death|1
2990158|NCT01009203|10290652|P1|Overall Study|Adverse Event|5
2990159|NCT01009203|10290652|P1|Overall Study|Withdrawal by Subject|1
2990160|NCT01009099|10290692|P2|Overall Study|Death|1
2990161|NCT01009099|10290693|P1|Overall Study|Death|0
2990162|NCT01009099|10290692|P2|Overall Study|Withdrawal by Subject|1
2990163|NCT01009099|10290693|P1|Overall Study|Withdrawal by Subject|1
2990164|NCT01009099|10290692|P2|Overall Study|Physician Decision|2
2990165|NCT01009099|10290693|P1|Overall Study|Physician Decision|3
2990166|NCT01009099|10290692|P2|Overall Study|Lost to Follow-up|0
2990167|NCT01009099|10290693|P1|Overall Study|Lost to Follow-up|1
2990168|NCT01009086|10290702|P3|Overall Study|Other|1
2990169|NCT01009086|10290703|P2|Overall Study|Other|5
2990170|NCT01009086|10290704|P1|Overall Study|Other|3
2990171|NCT01009086|10290702|P3|Overall Study|Withdrawal by Subject|13
2990172|NCT01009086|10290703|P2|Overall Study|Withdrawal by Subject|11
2990173|NCT01009086|10290704|P1|Overall Study|Withdrawal by Subject|9
2990174|NCT01009086|10290702|P3|Overall Study|Adverse Event|8
2990175|NCT01009086|10290703|P2|Overall Study|Adverse Event|11
2990176|NCT01009086|10290704|P1|Overall Study|Adverse Event|12
2990177|NCT01009086|10290702|P3|Overall Study|Lost to Follow-up|3
2990178|NCT01009086|10290703|P2|Overall Study|Lost to Follow-up|5
2990179|NCT01009086|10290704|P1|Overall Study|Lost to Follow-up|4
2990180|NCT01009086|10290702|P3|Overall Study|Lack of Efficacy|9
2990181|NCT01009086|10290703|P2|Overall Study|Lack of Efficacy|15
2990182|NCT01009086|10290704|P1|Overall Study|Lack of Efficacy|16
2990183|NCT01009060|10290739|P2|Overall Study|Withdrawal by Subject|1
2990184|NCT01009060|10290740|P1|Overall Study|Withdrawal by Subject|1
2990185|NCT01009060|10290739|P2|Overall Study|Physician Decision|1
2990186|NCT01009060|10290740|P1|Overall Study|Physician Decision|1
2990187|NCT01009060|10290739|P2|Overall Study|Lost to Follow-up|0
2990188|NCT01009060|10290740|P1|Overall Study|Lost to Follow-up|1
2990189|NCT01009060|10290739|P2|Overall Study|Protocol Violation|1
2990190|NCT01009060|10290740|P1|Overall Study|Protocol Violation|0
2990191|NCT01009060|10290739|P2|Overall Study|Adverse Event|2
2990192|NCT01009060|10290740|P1|Overall Study|Adverse Event|1
2990193|NCT01009047|10290778|P2|Overall Study|Other|2
2990194|NCT01009047|10290779|P1|Overall Study|Other|3
2990195|NCT01009047|10290778|P2|Overall Study|Withdrawal by consent|11
2990196|NCT01009047|10290779|P1|Overall Study|Withdrawal by consent|16
2990197|NCT01009047|10290778|P2|Overall Study|Lack of Efficacy|11
2990198|NCT01009047|10290779|P1|Overall Study|Lack of Efficacy|4
2990199|NCT01009047|10290778|P2|Overall Study|Lost to Follow-up|2
2990200|NCT01009047|10290779|P1|Overall Study|Lost to Follow-up|0
2990201|NCT01009047|10290778|P2|Overall Study|Adverse Event|0
2990202|NCT01009047|10290779|P1|Overall Study|Adverse Event|5
2990203|NCT01009034|10290801|P1|Overall Study|Withdrawal by Subject|2
2990204|NCT01009034|10290801|P1|Overall Study|Lost to Follow-up|2
2990205|NCT01008995|10290809|P4|After Controlled Period|Other|0
2990206|NCT01008995|10290810|P3|After Controlled Period|Other|1
2990207|NCT01008995|10290811|P2|After Controlled Period|Other|0
2990208|NCT01008995|10290812|P1|After Controlled Period|Other|0
2990209|NCT01008995|10290809|P4|After Controlled Period|Adverse Event|1
2990210|NCT01008995|10290810|P3|After Controlled Period|Adverse Event|1
2990211|NCT01008995|10290811|P2|After Controlled Period|Adverse Event|0
2990212|NCT01008995|10290812|P1|After Controlled Period|Adverse Event|0
2990213|NCT01008995|10290809|P4|Controlled Period|Other|0
2990214|NCT01008995|10290810|P3|Controlled Period|Other|0
2990215|NCT01008995|10290811|P2|Controlled Period|Other|1
2990216|NCT01008995|10290812|P1|Controlled Period|Other|2
2990217|NCT01008995|10290809|P4|Controlled Period|Adverse Event|0
2990218|NCT01008995|10290810|P3|Controlled Period|Adverse Event|0
2990219|NCT01008995|10290811|P2|Controlled Period|Adverse Event|2
2990220|NCT01008995|10290812|P1|Controlled Period|Adverse Event|1
2990221|NCT01008943|10290829|P1|Overall Study|Withdrawal by Subject|1
2990222|NCT01008904|10290836|P1|Overall Study|unexpected unrelated surgery|1
2990223|NCT01008904|10290836|P1|Overall Study|Adverse Event|2
2990224|NCT01008904|10290836|P1|Overall Study|Lost to Follow-up|1
2990225|NCT01008748|10290841|P1|Overall Study|Other|1
2990226|NCT01008748|10290841|P1|Overall Study|Lost to Follow-up|80
2990227|NCT01008696|10290866|P2|Overall Study|Other|2
2990228|NCT01008696|10290867|P1|Overall Study|Other|0
2990229|NCT01008696|10290866|P2|Overall Study|Other|3
2990230|NCT01008696|10290867|P1|Overall Study|Other|2
2990231|NCT01008696|10290866|P2|Overall Study|Participants' non-cooperation|3
2990232|NCT01008696|10290867|P1|Overall Study|Participants' non-cooperation|2
2990233|NCT01008696|10290866|P2|Overall Study|Adverse Event|0
2990234|NCT01008696|10290867|P1|Overall Study|Adverse Event|1
2990235|NCT01008696|10290866|P2|Overall Study|Physician Decision|1
2990236|NCT01008696|10290867|P1|Overall Study|Physician Decision|5
2990237|NCT01008696|10290866|P2|Overall Study|Withdrawal by Subject|4
2990238|NCT01008696|10290867|P1|Overall Study|Withdrawal by Subject|2
2990239|NCT01008696|10290866|P2|Overall Study|Participant's evasion of hospital visit|4
2990240|NCT01008696|10290867|P1|Overall Study|Participant's evasion of hospital visit|5
2990241|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
2990242|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2990243|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2990244|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
2990245|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
2990246|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2990247|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2990248|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2990249|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2990250|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
2990251|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2990252|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2990253|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|Physician Decision|0
2990254|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|Physician Decision|1
2990255|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|Physician Decision|0
2990256|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2990257|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
2990258|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2990259|NCT01008618|10290877|P3|Period 2 (Double-Blind Period)|Adverse Event|2
2990260|NCT01008618|10290878|P2|Period 2 (Double-Blind Period)|Adverse Event|11
2990261|NCT01008618|10290879|P1|Period 2 (Double-Blind Period)|Adverse Event|0
2990262|NCT01008618|10290877|P3|Period 1 (Titration Period)|Aggravated symptom|0
2990263|NCT01008618|10290878|P2|Period 1 (Titration Period)|Aggravated symptom|0
2990264|NCT01008618|10290879|P1|Period 1 (Titration Period)|Aggravated symptom|2
2990265|NCT01008618|10290877|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2990266|NCT01008618|10290878|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2990267|NCT01008618|10290879|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
2990268|NCT01008618|10290877|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
2990269|NCT01008618|10290878|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
2990270|NCT01008618|10290879|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
2990271|NCT01008618|10290877|P3|Period 1 (Titration Period)|Adverse Event|0
2990272|NCT01008618|10290878|P2|Period 1 (Titration Period)|Adverse Event|0
2990273|NCT01008618|10290879|P1|Period 1 (Titration Period)|Adverse Event|33
2990274|NCT01008618|10290877|P3|Period 1 (Titration Period)|Physician Decision|0
2990275|NCT01008618|10290878|P2|Period 1 (Titration Period)|Physician Decision|0
2990276|NCT01008618|10290879|P1|Period 1 (Titration Period)|Physician Decision|2
2990277|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
2990278|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
2990279|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2990280|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2990281|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2990282|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2990283|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
2990284|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2990285|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2990286|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
2990287|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
2990288|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2990289|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2990290|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
2990291|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2990292|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2990293|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2990294|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2990295|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Adverse Event|4
2990296|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Adverse Event|14
2990297|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Adverse Event|0
2990298|NCT01008553|10290928|P3|Period 2 (Double-Blind Period)|Physician Decision|2
2990299|NCT01008553|10290929|P2|Period 2 (Double-Blind Period)|Physician Decision|1
2990300|NCT01008553|10290930|P1|Period 2 (Double-Blind Period)|Physician Decision|0
2990301|NCT01008553|10290928|P3|Period 1 (Titration Period)|Not appropriate for this study|0
2990302|NCT01008553|10290929|P2|Period 1 (Titration Period)|Not appropriate for this study|0
2990303|NCT01008553|10290930|P1|Period 1 (Titration Period)|Not appropriate for this study|1
2990304|NCT01008553|10290928|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2990305|NCT01008553|10290929|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2990306|NCT01008553|10290930|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
2990307|NCT01008553|10290928|P3|Period 1 (Titration Period)|Determined to increase dosage|0
2990308|NCT01008553|10290929|P2|Period 1 (Titration Period)|Determined to increase dosage|0
2990309|NCT01008553|10290930|P1|Period 1 (Titration Period)|Determined to increase dosage|3
2990310|NCT01008553|10290928|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
2990311|NCT01008553|10290929|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
2990312|NCT01008553|10290930|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
2990313|NCT01008553|10290928|P3|Period 1 (Titration Period)|Adverse Event|0
2990314|NCT01008553|10290929|P2|Period 1 (Titration Period)|Adverse Event|0
2990315|NCT01008553|10290930|P1|Period 1 (Titration Period)|Adverse Event|33
2990316|NCT01008553|10290928|P3|Period 1 (Titration Period)|Physician Decision|0
2990317|NCT01008553|10290929|P2|Period 1 (Titration Period)|Physician Decision|0
2990318|NCT01008553|10290930|P1|Period 1 (Titration Period)|Physician Decision|2
2990319|NCT01008475|10290962|P7|Overall Study|Ongoing treatment at data cut-off date|4
2990320|NCT01008475|10290963|P6|Overall Study|Ongoing treatment at data cut-off date|6
2990321|NCT01008475|10290964|P5|Overall Study|Ongoing treatment at data cut-off date|5
2990322|NCT01008475|10290965|P4|Overall Study|Ongoing treatment at data cut-off date|0
2990323|NCT01008475|10290966|P3|Overall Study|Ongoing treatment at data cut-off date|0
2990324|NCT01008475|10290967|P2|Overall Study|Ongoing treatment at data cut-off date|0
2990325|NCT01008475|10290968|P1|Overall Study|Ongoing treatment at data cut-off date|0
2990326|NCT01008449|10291008|P2|Overall Study|Lost to Follow-up|19
2990327|NCT01008449|10291009|P1|Overall Study|Lost to Follow-up|29
2990328|NCT01008423|10291031|P2|Overall Study|Other|1
2990329|NCT01008423|10291032|P1|Overall Study|Other|0
2990330|NCT01008423|10291031|P2|Overall Study|Personal Conflict|0
2990331|NCT01008423|10291032|P1|Overall Study|Personal Conflict|1
2990332|NCT01008423|10291031|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
2990333|NCT01008423|10291032|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
2990334|NCT01008423|10291031|P2|Overall Study|Lack of Efficacy|5
2990335|NCT01008423|10291032|P1|Overall Study|Lack of Efficacy|0
2990336|NCT01008423|10291031|P2|Overall Study|Low Cortisol|1
2990337|NCT01008423|10291032|P1|Overall Study|Low Cortisol|0
2990338|NCT01008423|10291031|P2|Overall Study|Lost to Follow-up|2
2990339|NCT01008423|10291032|P1|Overall Study|Lost to Follow-up|0
2990340|NCT01008423|10291031|P2|Overall Study|Withdrawal by Subject|7
2990341|NCT01008423|10291032|P1|Overall Study|Withdrawal by Subject|4
2990342|NCT01008423|10291031|P2|Overall Study|Adverse Event|6
2990343|NCT01008423|10291032|P1|Overall Study|Adverse Event|13
2990344|NCT01008410|10291058|P2|Overall Study|Met Exclusion Criterion|1
2990345|NCT01008410|10291059|P1|Overall Study|Met Exclusion Criterion|0
2990346|NCT01008410|10291058|P2|Overall Study|Lack of Efficacy|6
2990347|NCT01008410|10291059|P1|Overall Study|Lack of Efficacy|2
2990348|NCT01008410|10291058|P2|Overall Study|Low Cortisol|0
2990349|NCT01008410|10291059|P1|Overall Study|Low Cortisol|2
2990350|NCT01008410|10291058|P2|Overall Study|Noncompliance|0
2990351|NCT01008410|10291059|P1|Overall Study|Noncompliance|1
2990352|NCT01008410|10291058|P2|Overall Study|Lost to Follow-up|0
2990353|NCT01008410|10291059|P1|Overall Study|Lost to Follow-up|1
2990354|NCT01008410|10291058|P2|Overall Study|Withdrawal by Subject|2
2990355|NCT01008410|10291059|P1|Overall Study|Withdrawal by Subject|6
2990356|NCT01008410|10291058|P2|Overall Study|Adverse Event|7
2990357|NCT01008410|10291059|P1|Overall Study|Adverse Event|13
2990358|NCT01008150|10291113|P4|Overall Study|did not receive study drug|0
2990359|NCT01008150|10291114|P3|Overall Study|did not receive study drug|1
2990360|NCT01008150|10291115|P2|Overall Study|did not receive study drug|1
2990361|NCT01008150|10291116|P1|Overall Study|did not receive study drug|1
2990362|NCT01007916|10291164|P2|Period 2, 4 Weeks of Wear|Relocation|0
2990363|NCT01007916|10291165|P1|Period 2, 4 Weeks of Wear|Relocation|1
2990364|NCT01007916|10291164|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
2990365|NCT01007916|10291165|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
2990366|NCT01007942|10291173|P2|Overall Study|Patients untreated|3
2990367|NCT01007942|10291174|P1|Overall Study|Patients untreated|4
2990368|NCT01007942|10291173|P2|Overall Study|Death|2
2990369|NCT01007942|10291174|P1|Overall Study|Death|3
2990370|NCT01007942|10291173|P2|Overall Study|Administrative problems|0
2990371|NCT01007942|10291174|P1|Overall Study|Administrative problems|2
2990372|NCT01007942|10291173|P2|Overall Study|Lost to Follow-up|0
2990373|NCT01007942|10291174|P1|Overall Study|Lost to Follow-up|1
2990374|NCT01007942|10291173|P2|Overall Study|Withdrawal by Subject|14
2990375|NCT01007942|10291174|P1|Overall Study|Withdrawal by Subject|19
2990376|NCT01007942|10291173|P2|Overall Study|Protocol Violation|1
2990377|NCT01007942|10291174|P1|Overall Study|Protocol Violation|1
2990378|NCT01007942|10291173|P2|Overall Study|New cancer therapy|1
2990379|NCT01007942|10291174|P1|Overall Study|New cancer therapy|5
2990380|NCT01007942|10291173|P2|Overall Study|Disease progression|242
2990381|NCT01007942|10291174|P1|Overall Study|Disease progression|217
2990382|NCT01007942|10291173|P2|Overall Study|Abnormal test procedure|1
2990383|NCT01007942|10291174|P1|Overall Study|Abnormal test procedure|0
2990384|NCT01007942|10291173|P2|Overall Study|Adverse Event|14
2990385|NCT01007942|10291174|P1|Overall Study|Adverse Event|29
2990386|NCT01007838|10291200|P4|Overall Study|Started home haemodialysis|0
2990387|NCT01007838|10291201|P3|Overall Study|Started home haemodialysis|0
2990388|NCT01007838|10291202|P2|Overall Study|Started home haemodialysis|0
2990389|NCT01007838|10291203|P1|Overall Study|Started home haemodialysis|1
2990390|NCT01007838|10291200|P4|Overall Study|Physician Decision|0
2990391|NCT01007838|10291201|P3|Overall Study|Physician Decision|0
2990392|NCT01007838|10291202|P2|Overall Study|Physician Decision|0
2990393|NCT01007838|10291203|P1|Overall Study|Physician Decision|1
2990394|NCT01007838|10291200|P4|Overall Study|Withdrawal by Subject|0
2990395|NCT01007838|10291201|P3|Overall Study|Withdrawal by Subject|0
2990396|NCT01007838|10291202|P2|Overall Study|Withdrawal by Subject|0
2990397|NCT01007838|10291203|P1|Overall Study|Withdrawal by Subject|1
2990398|NCT01007812|10291213|P2|Period 1, One Week|Discomfort|0
2990399|NCT01007812|10291214|P1|Period 1, One Week|Discomfort|1
2990400|NCT01007812|10291213|P2|Period 1, One Week|Lost to Follow-up|1
2990401|NCT01007812|10291214|P1|Period 1, One Week|Lost to Follow-up|0
2990402|NCT01007552|10291264|P1|Overall Study|Withdrawal by Subject|1
2990403|NCT01007448|10291280|P2|Overall Study|Adverse Event|4
2990404|NCT01007448|10291281|P1|Overall Study|Adverse Event|1
2990405|NCT01007448|10291280|P2|Overall Study|Withdrawal by Subject|3
2990406|NCT01007448|10291281|P1|Overall Study|Withdrawal by Subject|2
2990407|NCT01007448|10291280|P2|Overall Study|Lack of Efficacy|0
2990408|NCT01007448|10291281|P1|Overall Study|Lack of Efficacy|2
2990409|NCT01007448|10291280|P2|Overall Study|Progressive Disease|2
2990410|NCT01007448|10291281|P1|Overall Study|Progressive Disease|1
2990411|NCT01007448|10291280|P2|Overall Study|Participant Given Prohibited Medication|0
2990412|NCT01007448|10291281|P1|Overall Study|Participant Given Prohibited Medication|1
2990413|NCT01007448|10291280|P2|Overall Study|Participant Leaving the Country|0
2990414|NCT01007448|10291281|P1|Overall Study|Participant Leaving the Country|1
2990415|NCT01007448|10291280|P2|Overall Study|Staph Skin Infection Flare|0
2990416|NCT01007448|10291281|P1|Overall Study|Staph Skin Infection Flare|1
2990417|NCT01007448|10291280|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
2990418|NCT01007448|10291281|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
2990419|NCT01007435|10291313|P4|Overall Study|Reason not Specified|1
2990420|NCT01007435|10291314|P3|Overall Study|Reason not Specified|2
2990421|NCT01007435|10291315|P2|Overall Study|Reason not Specified|1
2990422|NCT01007435|10291316|P1|Overall Study|Reason not Specified|1
2990423|NCT01007435|10291313|P4|Overall Study|Failure to Return|6
2990424|NCT01007435|10291314|P3|Overall Study|Failure to Return|3
2990425|NCT01007435|10291315|P2|Overall Study|Failure to Return|4
2990426|NCT01007435|10291316|P1|Overall Study|Failure to Return|5
2990427|NCT01007435|10291313|P4|Overall Study|Refused Treatment|8
2990428|NCT01007435|10291314|P3|Overall Study|Refused Treatment|5
2990429|NCT01007435|10291315|P2|Overall Study|Refused Treatment|13
2990430|NCT01007435|10291316|P1|Overall Study|Refused Treatment|13
2990431|NCT01007435|10291313|P4|Overall Study|Other Protocol Violation|0
2990432|NCT01007435|10291314|P3|Overall Study|Other Protocol Violation|1
2990433|NCT01007435|10291315|P2|Overall Study|Other Protocol Violation|0
2990434|NCT01007435|10291316|P1|Overall Study|Other Protocol Violation|2
2990435|NCT01007435|10291313|P4|Overall Study|Violation of Selection Criteria at Entry|0
2990436|NCT01007435|10291314|P3|Overall Study|Violation of Selection Criteria at Entry|2
2990437|NCT01007435|10291315|P2|Overall Study|Violation of Selection Criteria at Entry|5
2990438|NCT01007435|10291316|P1|Overall Study|Violation of Selection Criteria at Entry|3
2990439|NCT01007435|10291313|P4|Overall Study|Insufficient Therapeutic Response|9
2990440|NCT01007435|10291314|P3|Overall Study|Insufficient Therapeutic Response|2
2990441|NCT01007435|10291315|P2|Overall Study|Insufficient Therapeutic Response|7
2990442|NCT01007435|10291316|P1|Overall Study|Insufficient Therapeutic Response|21
2990443|NCT01007435|10291313|P4|Overall Study|Death|1
2990444|NCT01007435|10291314|P3|Overall Study|Death|2
2990445|NCT01007435|10291315|P2|Overall Study|Death|4
2990446|NCT01007435|10291316|P1|Overall Study|Death|2
2990447|NCT01007435|10291313|P4|Overall Study|Adverse Event|31
2990448|NCT01007435|10291314|P3|Overall Study|Adverse Event|47
2990449|NCT01007435|10291315|P2|Overall Study|Adverse Event|25
2990450|NCT01007435|10291316|P1|Overall Study|Adverse Event|16
2990451|NCT01007396|10291358|P1|Overall Study|Lost to Follow-up|47
2990452|NCT01007253|10291363|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
2990453|NCT01007253|10291364|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
2990454|NCT01007253|10291365|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
2990455|NCT01007253|10291366|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
2990456|NCT01007149|10291398|P2|Overall Study|Administrative problems|1
2990457|NCT01007149|10291399|P1|Overall Study|Administrative problems|0
2990458|NCT01007123|10291425|P4|Overall Study|Lost to Follow-up|0
2990459|NCT01007123|10291426|P3|Overall Study|Lost to Follow-up|0
2990460|NCT01007123|10291427|P2|Overall Study|Lost to Follow-up|1
2990461|NCT01007123|10291428|P1|Overall Study|Lost to Follow-up|0
2990462|NCT01007123|10291425|P4|Overall Study|Withdrawal by Subject|0
2990463|NCT01007123|10291426|P3|Overall Study|Withdrawal by Subject|1
2990464|NCT01007123|10291427|P2|Overall Study|Withdrawal by Subject|0
2990465|NCT01007123|10291428|P1|Overall Study|Withdrawal by Subject|1
2990466|NCT01007123|10291425|P4|Overall Study|Protocol Violation|1
2990467|NCT01007123|10291426|P3|Overall Study|Protocol Violation|2
2990468|NCT01007123|10291427|P2|Overall Study|Protocol Violation|1
2990469|NCT01007123|10291428|P1|Overall Study|Protocol Violation|1
2990470|NCT01007123|10291425|P4|Overall Study|Lack of Efficacy|4
2990471|NCT01007123|10291426|P3|Overall Study|Lack of Efficacy|1
2990472|NCT01007123|10291427|P2|Overall Study|Lack of Efficacy|0
2990473|NCT01007123|10291428|P1|Overall Study|Lack of Efficacy|1
2990474|NCT01007123|10291425|P4|Overall Study|Adverse Event|1
2990475|NCT01007123|10291426|P3|Overall Study|Adverse Event|7
2990476|NCT01007123|10291427|P2|Overall Study|Adverse Event|4
2990477|NCT01007123|10291428|P1|Overall Study|Adverse Event|3
2990478|NCT01007032|10291489|P4|Overall Study|Withdrawal by Subject|1
2990479|NCT01007032|10291490|P3|Overall Study|Withdrawal by Subject|0
2990480|NCT01007032|10291491|P2|Overall Study|Withdrawal by Subject|0
2990481|NCT01007032|10291492|P1|Overall Study|Withdrawal by Subject|0
2990482|NCT01007032|10291489|P4|Overall Study|On Study Treatment at Cut-off Date|0
2990483|NCT01007032|10291490|P3|Overall Study|On Study Treatment at Cut-off Date|1
2990484|NCT01007032|10291491|P2|Overall Study|On Study Treatment at Cut-off Date|1
2990485|NCT01007032|10291492|P1|Overall Study|On Study Treatment at Cut-off Date|0
2990486|NCT01006980|10291536|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
2990487|NCT01006980|10291537|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
2990488|NCT01006980|10291536|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
2990489|NCT01006980|10291537|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
2990490|NCT01006980|10291536|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
2990491|NCT01006980|10291537|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
2990492|NCT01006980|10291536|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
2990493|NCT01006980|10291537|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
2990494|NCT01006980|10291536|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
2990495|NCT01006980|10291537|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
2990496|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
2990497|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
2990498|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
2990499|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
2990500|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
2990501|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
2990502|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
2990503|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
2990504|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Progression|218
2990505|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Progression|257
2990506|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Death|12
2990507|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Death|13
2990508|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Adverse Event|5
2990509|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Adverse Event|25
2990510|NCT01006980|10291536|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
2990511|NCT01006980|10291537|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
2990512|NCT01006889|10291576|P1|Overall Study|Withdrawal by Subject|3
2990513|NCT01006707|10291587|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
2990514|NCT01006707|10291588|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
2990515|NCT01006707|10291589|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
2990516|NCT01006707|10291587|P3|Study Session 1|Lost to Follow-up|0
2990517|NCT01006707|10291588|P2|Study Session 1|Lost to Follow-up|0
2990518|NCT01006707|10291589|P1|Study Session 1|Lost to Follow-up|2
2990519|NCT01006629|10291609|P1|Overall Study|Parent unable to perform site visit|4
2990520|NCT01006629|10291609|P1|Overall Study|Parent refused to continue participation|1
2990521|NCT01006629|10291609|P1|Overall Study|Adverse Event|1
2990522|NCT01006616|10291624|P4|Period 2 (18 Months)|Study Terminated|70
2990523|NCT01006616|10291625|P3|Period 2 (18 Months)|Study Terminated|44
2990524|NCT01006616|10291626|P2|Period 2 (18 Months)|Study Terminated|46
2990525|NCT01006616|10291627|P1|Period 2 (18 Months)|Study Terminated|63
2990526|NCT01006616|10291624|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
2990527|NCT01006616|10291625|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
2990528|NCT01006616|10291626|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
2990529|NCT01006616|10291627|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
2990530|NCT01006616|10291624|P4|Period 2 (18 Months)|Withdrawal by Subject|1
2990531|NCT01006616|10291625|P3|Period 2 (18 Months)|Withdrawal by Subject|0
2990532|NCT01006616|10291626|P2|Period 2 (18 Months)|Withdrawal by Subject|4
2990533|NCT01006616|10291627|P1|Period 2 (18 Months)|Withdrawal by Subject|1
2990534|NCT01006616|10291624|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
2990535|NCT01006616|10291625|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
2990536|NCT01006616|10291626|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
2990537|NCT01006616|10291627|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
2990538|NCT01006616|10291624|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
2990539|NCT01006616|10291625|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2990540|NCT01006616|10291626|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
2990541|NCT01006616|10291627|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2990542|NCT01006616|10291624|P4|Period 2 (18 Months)|Lost to Follow-up|0
2990543|NCT01006616|10291625|P3|Period 2 (18 Months)|Lost to Follow-up|0
2990544|NCT01006616|10291626|P2|Period 2 (18 Months)|Lost to Follow-up|0
2990545|NCT01006616|10291627|P1|Period 2 (18 Months)|Lost to Follow-up|2
2990546|NCT01006616|10291624|P4|Period 2 (18 Months)|Lack of Efficacy|2
2990547|NCT01006616|10291625|P3|Period 2 (18 Months)|Lack of Efficacy|1
2990548|NCT01006616|10291626|P2|Period 2 (18 Months)|Lack of Efficacy|0
2990549|NCT01006616|10291627|P1|Period 2 (18 Months)|Lack of Efficacy|0
2990550|NCT01006616|10291624|P4|Period 2 (18 Months)|Adverse Event|4
2990551|NCT01006616|10291625|P3|Period 2 (18 Months)|Adverse Event|6
2990552|NCT01006616|10291626|P2|Period 2 (18 Months)|Adverse Event|6
2990553|NCT01006616|10291627|P1|Period 2 (18 Months)|Adverse Event|6
2990554|NCT01006616|10291624|P4|Period 1 (6 Months)|Not Treated|1
2990555|NCT01006616|10291625|P3|Period 1 (6 Months)|Not Treated|1
2990556|NCT01006616|10291626|P2|Period 1 (6 Months)|Not Treated|0
2990557|NCT01006616|10291627|P1|Period 1 (6 Months)|Not Treated|0
2990558|NCT01006616|10291624|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
2990559|NCT01006616|10291625|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
2990560|NCT01006616|10291626|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
2990561|NCT01006616|10291627|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
2990562|NCT01006616|10291624|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2990563|NCT01006616|10291625|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2990564|NCT01006616|10291626|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
2990565|NCT01006616|10291627|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2990566|NCT01006616|10291624|P4|Period 1 (6 Months)|Withdrawal by Subject|0
2990567|NCT01006616|10291625|P3|Period 1 (6 Months)|Withdrawal by Subject|2
2990568|NCT01006616|10291626|P2|Period 1 (6 Months)|Withdrawal by Subject|2
2990569|NCT01006616|10291627|P1|Period 1 (6 Months)|Withdrawal by Subject|2
2990570|NCT01006616|10291624|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
2990571|NCT01006616|10291625|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
2990572|NCT01006616|10291626|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
2990573|NCT01006616|10291627|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
2990574|NCT01006616|10291624|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
2990575|NCT01006616|10291625|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
2990576|NCT01006616|10291626|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
2990577|NCT01006616|10291627|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
2990578|NCT01006616|10291624|P4|Period 1 (6 Months)|Lost to Follow-up|0
2990579|NCT01006616|10291625|P3|Period 1 (6 Months)|Lost to Follow-up|1
2990580|NCT01006616|10291626|P2|Period 1 (6 Months)|Lost to Follow-up|0
2990581|NCT01006616|10291627|P1|Period 1 (6 Months)|Lost to Follow-up|0
2990582|NCT01006616|10291624|P4|Period 1 (6 Months)|Lack of Efficacy|4
2990583|NCT01006616|10291625|P3|Period 1 (6 Months)|Lack of Efficacy|0
2990584|NCT01006616|10291626|P2|Period 1 (6 Months)|Lack of Efficacy|4
2990585|NCT01006616|10291627|P1|Period 1 (6 Months)|Lack of Efficacy|3
2990586|NCT01006616|10291624|P4|Period 1 (6 Months)|Adverse Event|9
2990587|NCT01006616|10291625|P3|Period 1 (6 Months)|Adverse Event|37
2990588|NCT01006616|10291626|P2|Period 1 (6 Months)|Adverse Event|31
2990589|NCT01006616|10291627|P1|Period 1 (6 Months)|Adverse Event|10
2990590|NCT01006603|10291763|P2|Overall Study|Other|7
2990591|NCT01006603|10291764|P1|Overall Study|Other|3
2990592|NCT01006603|10291763|P2|Overall Study|Study specific discontinuation criteria|34
2990593|NCT01006603|10291764|P1|Overall Study|Study specific discontinuation criteria|33
2990594|NCT01006603|10291763|P2|Overall Study|Death|1
2990595|NCT01006603|10291764|P1|Overall Study|Death|1
2990596|NCT01006603|10291763|P2|Overall Study|Adverse Event|7
2990597|NCT01006603|10291764|P1|Overall Study|Adverse Event|15
2990598|NCT01006603|10291763|P2|Overall Study|Incorrect enrolment|2
2990599|NCT01006603|10291764|P1|Overall Study|Incorrect enrolment|0
2990600|NCT01006603|10291763|P2|Overall Study|Protocol Violation|3
2990601|NCT01006603|10291764|P1|Overall Study|Protocol Violation|1
2990602|NCT01006603|10291763|P2|Overall Study|Safety reason|1
2990603|NCT01006603|10291764|P1|Overall Study|Safety reason|1
2990604|NCT01006603|10291763|P2|Overall Study|Lost to Follow-up|1
2990605|NCT01006603|10291764|P1|Overall Study|Lost to Follow-up|0
2990606|NCT01006603|10291763|P2|Overall Study|Withdrawal by Subject|19
2990607|NCT01006603|10291764|P1|Overall Study|Withdrawal by Subject|17
2990608|NCT01006590|10291784|P2|Overall Study|Other|2
2990609|NCT01006590|10291785|P1|Overall Study|Other|3
2990610|NCT01006590|10291784|P2|Overall Study|Study specific discontinuation criteria|23
2990611|NCT01006590|10291785|P1|Overall Study|Study specific discontinuation criteria|16
2990612|NCT01006590|10291784|P2|Overall Study|Withdrawal by Subject|2
2990613|NCT01006590|10291785|P1|Overall Study|Withdrawal by Subject|4
2990614|NCT01006590|10291784|P2|Overall Study|Protocol Violation|0
2990615|NCT01006590|10291785|P1|Overall Study|Protocol Violation|1
2990616|NCT01006590|10291784|P2|Overall Study|Lost to Follow-up|1
2990617|NCT01006590|10291785|P1|Overall Study|Lost to Follow-up|1
2990618|NCT01006590|10291784|P2|Overall Study|Death|1
2990619|NCT01006590|10291785|P1|Overall Study|Death|1
2990620|NCT01006590|10291784|P2|Overall Study|Adverse Event|3
2990621|NCT01006590|10291785|P1|Overall Study|Adverse Event|2
2990622|NCT01006356|10291824|P1|Overall Study|Other|23
2990623|NCT01006356|10291824|P1|Overall Study|Protocol Violation|3
2990624|NCT01006356|10291824|P1|Overall Study|Choice by participants|2
2990625|NCT01006356|10291824|P1|Overall Study|Withdrawal by Subject|1
2990626|NCT01006356|10291824|P1|Overall Study|Paticipants did not cooperate|6
2990627|NCT01006356|10291824|P1|Overall Study|Physician Decision|1
2990628|NCT01006356|10291824|P1|Overall Study|Adverse Event|6
2990629|NCT01006291|10291839|P3|Overall Study|Other|17
2990630|NCT01006291|10291840|P2|Overall Study|Other|14
2990631|NCT01006291|10291841|P1|Overall Study|Other|14
2990632|NCT01006291|10291839|P3|Overall Study|Withdrawal criteria|4
2990633|NCT01006291|10291840|P2|Overall Study|Withdrawal criteria|4
2990634|NCT01006291|10291841|P1|Overall Study|Withdrawal criteria|5
2990635|NCT01006291|10291839|P3|Overall Study|Protocol Violation|3
2990636|NCT01006291|10291840|P2|Overall Study|Protocol Violation|3
2990637|NCT01006291|10291841|P1|Overall Study|Protocol Violation|3
2990638|NCT01006291|10291839|P3|Overall Study|Lack of Efficacy|1
2990639|NCT01006291|10291840|P2|Overall Study|Lack of Efficacy|2
2990640|NCT01006291|10291841|P1|Overall Study|Lack of Efficacy|2
2990641|NCT01006291|10291839|P3|Overall Study|Adverse Event|2
2990642|NCT01006291|10291840|P2|Overall Study|Adverse Event|1
2990643|NCT01006291|10291841|P1|Overall Study|Adverse Event|2
2990644|NCT01006135|10291891|P1|Overall Study|Other|72
2990645|NCT01006135|10291891|P1|Overall Study|Lost to Follow-up|32
2990646|NCT01006135|10291891|P1|Overall Study|Protocol Violation|14
2990647|NCT01006135|10291891|P1|Overall Study|Adverse Event|22
2990648|NCT01006122|10291898|P2|Second Double-blind Intervention Period|Death|1
2990649|NCT01006122|10291899|P1|Second Double-blind Intervention Period|Death|0
2990650|NCT01006122|10291898|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
2990651|NCT01006122|10291899|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
2990652|NCT01006122|10291898|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
2990653|NCT01006122|10291899|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
2990654|NCT01006122|10291898|P2|Second Double-blind Intervention Period|Protocol Violation|0
2990655|NCT01006122|10291899|P1|Second Double-blind Intervention Period|Protocol Violation|1
2990656|NCT01006122|10291898|P2|Second Double-blind Intervention Period|Adverse Event|1
2990657|NCT01006122|10291899|P1|Second Double-blind Intervention Period|Adverse Event|1
2990658|NCT01006122|10291898|P2|First Double-blind Intervention Period|Adverse Event|4
2990659|NCT01006122|10291899|P1|First Double-blind Intervention Period|Adverse Event|0
2990660|NCT01006122|10291898|P2|First Double-blind Intervention Period|Other|0
2990661|NCT01006122|10291899|P1|First Double-blind Intervention Period|Other|3
2990662|NCT01006122|10291898|P2|First Double-blind Intervention Period|Lack of Efficacy|1
2990663|NCT01006122|10291899|P1|First Double-blind Intervention Period|Lack of Efficacy|2
2990664|NCT01006122|10291898|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
2990665|NCT01006122|10291899|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
2990666|NCT01006122|10291898|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
2990667|NCT01006122|10291899|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
2990668|NCT01006122|10291898|P2|First Double-blind Intervention Period|Pregnancy|1
2990669|NCT01006122|10291899|P1|First Double-blind Intervention Period|Pregnancy|0
2990670|NCT01006122|10291898|P2|First Double-blind Intervention Period|Protocol Violation|1
2990671|NCT01006122|10291899|P1|First Double-blind Intervention Period|Protocol Violation|1
2990672|NCT01006122|10291898|P2|First Double-blind Intervention Period|Lost to Follow-up|2
2990673|NCT01006122|10291899|P1|First Double-blind Intervention Period|Lost to Follow-up|0
2990674|NCT01005966|10291950|P5|Treatment Period 4 (14 Days)|Other Reason|1
2990675|NCT01005966|10291951|P4|Treatment Period 4 (14 Days)|Other Reason|0
2990676|NCT01005966|10291952|P3|Treatment Period 4 (14 Days)|Other Reason|0
2990677|NCT01005966|10291953|P2|Treatment Period 4 (14 Days)|Other Reason|0
2990678|NCT01005966|10291954|P1|Treatment Period 4 (14 Days)|Other Reason|0
2990679|NCT01005966|10291950|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
2990680|NCT01005966|10291951|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
2990681|NCT01005966|10291952|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
2990682|NCT01005966|10291953|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
2990683|NCT01005966|10291954|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
2990684|NCT01005966|10291950|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
2990685|NCT01005966|10291951|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
2990686|NCT01005966|10291952|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
2990687|NCT01005966|10291953|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
2990688|NCT01005966|10291954|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
2990689|NCT01005966|10291950|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2990690|NCT01005966|10291951|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2990691|NCT01005966|10291952|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2990692|NCT01005966|10291953|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2990693|NCT01005966|10291954|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2990694|NCT01005966|10291950|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
2990695|NCT01005966|10291951|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
2990696|NCT01005966|10291952|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
2990697|NCT01005966|10291953|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
2990698|NCT01005966|10291954|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
2990699|NCT01005966|10291950|P5|Treatment Period 2 (14 Days)|Adverse Event|0
2990700|NCT01005966|10291951|P4|Treatment Period 2 (14 Days)|Adverse Event|0
2990701|NCT01005966|10291952|P3|Treatment Period 2 (14 Days)|Adverse Event|1
2990702|NCT01005966|10291953|P2|Treatment Period 2 (14 Days)|Adverse Event|1
2990703|NCT01005966|10291954|P1|Treatment Period 2 (14 Days)|Adverse Event|0
2990704|NCT01005966|10291950|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2990705|NCT01005966|10291951|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
2990706|NCT01005966|10291952|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2990707|NCT01005966|10291953|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2990708|NCT01005966|10291954|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2990709|NCT01005966|10291950|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
2990710|NCT01005966|10291951|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
2990711|NCT01005966|10291952|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
2990712|NCT01005966|10291953|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
2990713|NCT01005966|10291954|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
2990714|NCT01005966|10291950|P5|Treatment Period 1 (14 Days)|Adverse Event|0
2990715|NCT01005966|10291951|P4|Treatment Period 1 (14 Days)|Adverse Event|0
2990716|NCT01005966|10291952|P3|Treatment Period 1 (14 Days)|Adverse Event|0
2990717|NCT01005966|10291953|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2990718|NCT01005966|10291954|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2990719|NCT01005914|10291974|P1|Overall Study|Withdrawal by Subject|1
2990720|NCT01005914|10291974|P1|Overall Study|Lack of Efficacy|1
2990721|NCT01005914|10291974|P1|Overall Study|Death|4
2990722|NCT01005914|10291974|P1|Overall Study|Adverse Event|4
2990723|NCT01005901|10291980|P2|Overall Study|No longer requires study drug|1
2990724|NCT01005901|10291981|P1|Overall Study|No longer requires study drug|0
2990725|NCT01005901|10291980|P2|Overall Study|Patient's inability to use the device|1
2990726|NCT01005901|10291981|P1|Overall Study|Patient's inability to use the device|1
2990727|NCT01005901|10291980|P2|Overall Study|Lost to Follow-up|2
2990728|NCT01005901|10291981|P1|Overall Study|Lost to Follow-up|1
2990729|NCT01005901|10291980|P2|Overall Study|Death|3
2990730|NCT01005901|10291981|P1|Overall Study|Death|2
2990731|NCT01005901|10291980|P2|Overall Study|Protocol Violation|3
2990732|NCT01005901|10291981|P1|Overall Study|Protocol Violation|4
2990733|NCT01005901|10291980|P2|Overall Study|Unsatisfactory therapeutic effect|5
2990734|NCT01005901|10291981|P1|Overall Study|Unsatisfactory therapeutic effect|5
2990735|NCT01005901|10291980|P2|Overall Study|Administrative problems|13
2990736|NCT01005901|10291981|P1|Overall Study|Administrative problems|21
2990737|NCT01005901|10291980|P2|Overall Study|Adverse Event|16
2990738|NCT01005901|10291981|P1|Overall Study|Adverse Event|30
2990739|NCT01005901|10291980|P2|Overall Study|Withdrawal by Subject|14
2990740|NCT01005901|10291981|P1|Overall Study|Withdrawal by Subject|38
2990741|NCT01005875|10292044|P1|Overall Study|Death|3
2990742|NCT01005745|10292061|P1|Overall Study|Inappropriate antidiuretic hormone|1
2990743|NCT01005745|10292061|P1|Overall Study|Death prior to treatment|1
2990744|NCT01005745|10292061|P1|Overall Study|Disease progressed during TIL growth|3
2990745|NCT01005745|10292061|P1|Overall Study|No TIL growth|1
2990746|NCT01005732|10292066|P1|Overall Study|Death|1
2990747|NCT01005732|10292066|P1|Overall Study|Lost to Follow-up|10
2990748|NCT01005719|10292082|P6|Period 2|Adverse Event|1
2990749|NCT01005719|10292083|P5|Period 2|Adverse Event|1
2990750|NCT01005719|10292084|P4|Period 2|Adverse Event|0
2990751|NCT01005719|10292085|P3|Period 2|Adverse Event|0
2990752|NCT01005719|10292086|P2|Period 2|Adverse Event|0
2990753|NCT01005719|10292087|P1|Period 2|Adverse Event|0
2990754|NCT01005719|10292082|P6|Period 1|Delay in completing study procedures|1
2990755|NCT01005719|10292083|P5|Period 1|Delay in completing study procedures|0
2990756|NCT01005719|10292084|P4|Period 1|Delay in completing study procedures|0
2990757|NCT01005719|10292085|P3|Period 1|Delay in completing study procedures|0
2990758|NCT01005719|10292086|P2|Period 1|Delay in completing study procedures|0
2990759|NCT01005719|10292087|P1|Period 1|Delay in completing study procedures|0
2990760|NCT01005719|10292082|P6|Period 1|Adverse Event|0
2990761|NCT01005719|10292083|P5|Period 1|Adverse Event|0
2990762|NCT01005719|10292084|P4|Period 1|Adverse Event|1
2990763|NCT01005719|10292085|P3|Period 1|Adverse Event|0
2990764|NCT01005719|10292086|P2|Period 1|Adverse Event|0
2990765|NCT01005719|10292087|P1|Period 1|Adverse Event|0
2990766|NCT01005680|10292154|P2|Overall Study|Physician Decision|1
2990767|NCT01005680|10292155|P1|Overall Study|Physician Decision|1
2990768|NCT01005680|10292154|P2|Overall Study|Withdrawal by Subject|4
2990769|NCT01005680|10292155|P1|Overall Study|Withdrawal by Subject|1
2990770|NCT01005680|10292154|P2|Overall Study|Lost to Follow-up|6
2990771|NCT01005680|10292155|P1|Overall Study|Lost to Follow-up|4
2990772|NCT01005602|10292179|P2|Overall Study|Excluded due to unreliable clinical data|0
2990773|NCT01005602|10292180|P1|Overall Study|Excluded due to unreliable clinical data|1
2990774|NCT01005329|10292268|P1|Overall Study|Ineligible or received no protocol trt.|4
2990775|NCT01005316|10292281|P4|Overall Study|Retransplanted|0
2990776|NCT01005316|10292282|P3|Overall Study|Retransplanted|0
2990777|NCT01005316|10292283|P2|Overall Study|Retransplanted|1
2990778|NCT01005316|10292284|P1|Overall Study|Retransplanted|0
2990779|NCT01005316|10292281|P4|Overall Study|Transferred Care|3
2990780|NCT01005316|10292282|P3|Overall Study|Transferred Care|1
2990781|NCT01005316|10292283|P2|Overall Study|Transferred Care|0
2990782|NCT01005316|10292284|P1|Overall Study|Transferred Care|1
2990783|NCT01005316|10292281|P4|Overall Study|Delisted|0
2990784|NCT01005316|10292282|P3|Overall Study|Delisted|0
2990785|NCT01005316|10292283|P2|Overall Study|Delisted|0
2990786|NCT01005316|10292284|P1|Overall Study|Delisted|8
2990787|NCT01005316|10292281|P4|Overall Study|Consented to Another Study|0
2990788|NCT01005316|10292282|P3|Overall Study|Consented to Another Study|0
2990789|NCT01005316|10292283|P2|Overall Study|Consented to Another Study|0
2990790|NCT01005316|10292284|P1|Overall Study|Consented to Another Study|2
2990791|NCT01005316|10292281|P4|Overall Study|Withdrawal by Subject|2
2990792|NCT01005316|10292282|P3|Overall Study|Withdrawal by Subject|0
2990793|NCT01005316|10292283|P2|Overall Study|Withdrawal by Subject|1
2990794|NCT01005316|10292284|P1|Overall Study|Withdrawal by Subject|1
2990795|NCT01005316|10292281|P4|Overall Study|Sponsor Decision|0
2990796|NCT01005316|10292282|P3|Overall Study|Sponsor Decision|0
2990797|NCT01005316|10292283|P2|Overall Study|Sponsor Decision|3
2990798|NCT01005316|10292284|P1|Overall Study|Sponsor Decision|6
2990799|NCT01005316|10292281|P4|Overall Study|Physician Decision|0
2990800|NCT01005316|10292282|P3|Overall Study|Physician Decision|0
2990801|NCT01005316|10292283|P2|Overall Study|Physician Decision|0
2990802|NCT01005316|10292284|P1|Overall Study|Physician Decision|6
2990803|NCT01005316|10292281|P4|Overall Study|Lost to Follow-up|2
2990804|NCT01005316|10292282|P3|Overall Study|Lost to Follow-up|0
2990805|NCT01005316|10292283|P2|Overall Study|Lost to Follow-up|3
2990806|NCT01005316|10292284|P1|Overall Study|Lost to Follow-up|1
2990807|NCT01005316|10292281|P4|Overall Study|Study Termination|85
2990808|NCT01005316|10292282|P3|Overall Study|Study Termination|9
2990809|NCT01005316|10292283|P2|Overall Study|Study Termination|63
2990810|NCT01005316|10292284|P1|Overall Study|Study Termination|5
2990811|NCT01005316|10292281|P4|Overall Study|Death|15
2990812|NCT01005316|10292282|P3|Overall Study|Death|1
2990813|NCT01005316|10292283|P2|Overall Study|Death|5
2990814|NCT01005316|10292284|P1|Overall Study|Death|20
2990815|NCT01005316|10292281|P4|Overall Study|Adverse Event|1
2990816|NCT01005316|10292282|P3|Overall Study|Adverse Event|0
2990817|NCT01005316|10292283|P2|Overall Study|Adverse Event|0
2990818|NCT01005316|10292284|P1|Overall Study|Adverse Event|0
2990819|NCT01005251|10292351|P5|Overall Study|Lack of Efficacy|0
2990820|NCT01005251|10292352|P4|Overall Study|Lack of Efficacy|1
2990821|NCT01005251|10292353|P3|Overall Study|Lack of Efficacy|1
2990822|NCT01005251|10292354|P2|Overall Study|Lack of Efficacy|0
2990823|NCT01005251|10292355|P1|Overall Study|Lack of Efficacy|0
2990824|NCT01005251|10292351|P5|Overall Study|Randomized in error|0
2990825|NCT01005251|10292352|P4|Overall Study|Randomized in error|1
2990826|NCT01005251|10292353|P3|Overall Study|Randomized in error|1
2990827|NCT01005251|10292354|P2|Overall Study|Randomized in error|0
2990828|NCT01005251|10292355|P1|Overall Study|Randomized in error|0
2990829|NCT01005251|10292351|P5|Overall Study|Wrong drug dispensed|0
2990830|NCT01005251|10292352|P4|Overall Study|Wrong drug dispensed|0
2990831|NCT01005251|10292353|P3|Overall Study|Wrong drug dispensed|0
2990832|NCT01005251|10292354|P2|Overall Study|Wrong drug dispensed|1
2990833|NCT01005251|10292355|P1|Overall Study|Wrong drug dispensed|0
2990834|NCT01005251|10292351|P5|Overall Study|Patient moved|0
2990835|NCT01005251|10292352|P4|Overall Study|Patient moved|0
2990836|NCT01005251|10292353|P3|Overall Study|Patient moved|0
2990837|NCT01005251|10292354|P2|Overall Study|Patient moved|0
2990838|NCT01005251|10292355|P1|Overall Study|Patient moved|1
2990839|NCT01005251|10292351|P5|Overall Study|Physician Decision|2
2990840|NCT01005251|10292352|P4|Overall Study|Physician Decision|0
2990841|NCT01005251|10292353|P3|Overall Study|Physician Decision|0
2990842|NCT01005251|10292354|P2|Overall Study|Physician Decision|0
2990843|NCT01005251|10292355|P1|Overall Study|Physician Decision|0
2990844|NCT01005251|10292351|P5|Overall Study|Lost to Follow-up|0
2990845|NCT01005251|10292352|P4|Overall Study|Lost to Follow-up|0
2990846|NCT01005251|10292353|P3|Overall Study|Lost to Follow-up|2
2990847|NCT01005251|10292354|P2|Overall Study|Lost to Follow-up|4
2990848|NCT01005251|10292355|P1|Overall Study|Lost to Follow-up|1
2990849|NCT01005251|10292351|P5|Overall Study|Developed study-specific withdrawal crit|1
2990850|NCT01005251|10292352|P4|Overall Study|Developed study-specific withdrawal crit|0
2990851|NCT01005251|10292353|P3|Overall Study|Developed study-specific withdrawal crit|3
2990852|NCT01005251|10292354|P2|Overall Study|Developed study-specific withdrawal crit|0
2990853|NCT01005251|10292355|P1|Overall Study|Developed study-specific withdrawal crit|2
2990854|NCT01005251|10292351|P5|Overall Study|Protocol Violation|2
2990855|NCT01005251|10292352|P4|Overall Study|Protocol Violation|0
2990856|NCT01005251|10292353|P3|Overall Study|Protocol Violation|0
2990857|NCT01005251|10292354|P2|Overall Study|Protocol Violation|0
2990858|NCT01005251|10292355|P1|Overall Study|Protocol Violation|1
2990859|NCT01005251|10292351|P5|Overall Study|Adverse Event|4
2990860|NCT01005251|10292352|P4|Overall Study|Adverse Event|5
2990861|NCT01005251|10292353|P3|Overall Study|Adverse Event|8
2990862|NCT01005251|10292354|P2|Overall Study|Adverse Event|6
2990863|NCT01005251|10292355|P1|Overall Study|Adverse Event|2
2990864|NCT01005251|10292351|P5|Overall Study|Eligibility criteria not fulfilled|0
2990865|NCT01005251|10292352|P4|Overall Study|Eligibility criteria not fulfilled|1
2990866|NCT01005251|10292353|P3|Overall Study|Eligibility criteria not fulfilled|4
2990867|NCT01005251|10292354|P2|Overall Study|Eligibility criteria not fulfilled|0
2990868|NCT01005251|10292355|P1|Overall Study|Eligibility criteria not fulfilled|4
2990869|NCT01005251|10292351|P5|Overall Study|Withdrawal by Subject|9
2990870|NCT01005251|10292352|P4|Overall Study|Withdrawal by Subject|4
2990871|NCT01005251|10292353|P3|Overall Study|Withdrawal by Subject|3
2990872|NCT01005251|10292354|P2|Overall Study|Withdrawal by Subject|5
2990873|NCT01005251|10292355|P1|Overall Study|Withdrawal by Subject|2
2990874|NCT01004861|10292439|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990875|NCT01004861|10292440|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990876|NCT01004861|10292441|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990877|NCT01004861|10292442|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990878|NCT01004861|10292443|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
2990879|NCT01004861|10292444|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990880|NCT01004861|10292445|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990881|NCT01004861|10292446|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990882|NCT01004861|10292447|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990883|NCT01004861|10292448|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990884|NCT01004861|10292449|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990885|NCT01004861|10292450|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990886|NCT01004861|10292451|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
2990887|NCT01004861|10292439|P13|Overall Study|Other|3
2990888|NCT01004861|10292440|P12|Overall Study|Other|2
2990889|NCT01004861|10292441|P11|Overall Study|Other|1
2990890|NCT01004861|10292442|P10|Overall Study|Other|2
2990891|NCT01004861|10292443|P9|Overall Study|Other|1
2990892|NCT01004861|10292444|P8|Overall Study|Other|0
2990893|NCT01004861|10292445|P7|Overall Study|Other|0
2990894|NCT01004861|10292446|P6|Overall Study|Other|0
2990895|NCT01004861|10292447|P5|Overall Study|Other|0
2990896|NCT01004861|10292448|P4|Overall Study|Other|0
2990897|NCT01004861|10292449|P3|Overall Study|Other|0
2990898|NCT01004861|10292450|P2|Overall Study|Other|0
2990899|NCT01004861|10292451|P1|Overall Study|Other|0
2990900|NCT01004861|10292439|P13|Overall Study|Non-compliance|1
2990901|NCT01004861|10292440|P12|Overall Study|Non-compliance|0
2990902|NCT01004861|10292441|P11|Overall Study|Non-compliance|0
2990903|NCT01004861|10292442|P10|Overall Study|Non-compliance|0
2990904|NCT01004861|10292443|P9|Overall Study|Non-compliance|5
2990905|NCT01004861|10292444|P8|Overall Study|Non-compliance|0
2990906|NCT01004861|10292445|P7|Overall Study|Non-compliance|0
2990907|NCT01004861|10292446|P6|Overall Study|Non-compliance|0
2990908|NCT01004861|10292447|P5|Overall Study|Non-compliance|0
2990909|NCT01004861|10292448|P4|Overall Study|Non-compliance|0
2990910|NCT01004861|10292449|P3|Overall Study|Non-compliance|0
2990911|NCT01004861|10292450|P2|Overall Study|Non-compliance|0
2990912|NCT01004861|10292451|P1|Overall Study|Non-compliance|0
2990913|NCT01004861|10292439|P13|Overall Study|Lost to Follow-up|0
2990914|NCT01004861|10292440|P12|Overall Study|Lost to Follow-up|1
2990915|NCT01004861|10292441|P11|Overall Study|Lost to Follow-up|0
2990916|NCT01004861|10292442|P10|Overall Study|Lost to Follow-up|0
2990917|NCT01004861|10292443|P9|Overall Study|Lost to Follow-up|1
2990918|NCT01004861|10292444|P8|Overall Study|Lost to Follow-up|1
2990919|NCT01004861|10292445|P7|Overall Study|Lost to Follow-up|0
2990920|NCT01004861|10292446|P6|Overall Study|Lost to Follow-up|0
2990921|NCT01004861|10292447|P5|Overall Study|Lost to Follow-up|0
2990922|NCT01004861|10292448|P4|Overall Study|Lost to Follow-up|0
2990923|NCT01004861|10292449|P3|Overall Study|Lost to Follow-up|0
2990924|NCT01004861|10292450|P2|Overall Study|Lost to Follow-up|0
2990925|NCT01004861|10292451|P1|Overall Study|Lost to Follow-up|0
2990926|NCT01004861|10292439|P13|Overall Study|Withdrawal by Subject|3
2990927|NCT01004861|10292440|P12|Overall Study|Withdrawal by Subject|2
2990928|NCT01004861|10292441|P11|Overall Study|Withdrawal by Subject|1
2990929|NCT01004861|10292442|P10|Overall Study|Withdrawal by Subject|1
2990930|NCT01004861|10292443|P9|Overall Study|Withdrawal by Subject|2
2990931|NCT01004861|10292444|P8|Overall Study|Withdrawal by Subject|0
2990932|NCT01004861|10292445|P7|Overall Study|Withdrawal by Subject|1
2990933|NCT01004861|10292446|P6|Overall Study|Withdrawal by Subject|0
2990934|NCT01004861|10292447|P5|Overall Study|Withdrawal by Subject|1
2990935|NCT01004861|10292448|P4|Overall Study|Withdrawal by Subject|0
2990936|NCT01004861|10292449|P3|Overall Study|Withdrawal by Subject|0
2990937|NCT01004861|10292450|P2|Overall Study|Withdrawal by Subject|0
2990938|NCT01004861|10292451|P1|Overall Study|Withdrawal by Subject|0
2990939|NCT01004861|10292439|P13|Overall Study|Protocol Violation|0
2990940|NCT01004861|10292440|P12|Overall Study|Protocol Violation|0
2990941|NCT01004861|10292441|P11|Overall Study|Protocol Violation|0
2990942|NCT01004861|10292442|P10|Overall Study|Protocol Violation|0
2990943|NCT01004861|10292443|P9|Overall Study|Protocol Violation|0
2990944|NCT01004861|10292444|P8|Overall Study|Protocol Violation|0
2990945|NCT01004861|10292445|P7|Overall Study|Protocol Violation|0
2990946|NCT01004861|10292446|P6|Overall Study|Protocol Violation|0
2990947|NCT01004861|10292447|P5|Overall Study|Protocol Violation|1
2990948|NCT01004861|10292448|P4|Overall Study|Protocol Violation|0
2990949|NCT01004861|10292449|P3|Overall Study|Protocol Violation|0
2990950|NCT01004861|10292450|P2|Overall Study|Protocol Violation|0
2990951|NCT01004861|10292451|P1|Overall Study|Protocol Violation|0
2990952|NCT01004861|10292439|P13|Overall Study|Adverse Event|2
2990953|NCT01004861|10292440|P12|Overall Study|Adverse Event|0
2990954|NCT01004861|10292441|P11|Overall Study|Adverse Event|1
2990955|NCT01004861|10292442|P10|Overall Study|Adverse Event|1
2990956|NCT01004861|10292443|P9|Overall Study|Adverse Event|13
2990957|NCT01004861|10292444|P8|Overall Study|Adverse Event|1
2990958|NCT01004861|10292445|P7|Overall Study|Adverse Event|1
2990959|NCT01004861|10292446|P6|Overall Study|Adverse Event|2
2990960|NCT01004861|10292447|P5|Overall Study|Adverse Event|0
2990961|NCT01004861|10292448|P4|Overall Study|Adverse Event|1
2990962|NCT01004861|10292449|P3|Overall Study|Adverse Event|0
2990963|NCT01004861|10292450|P2|Overall Study|Adverse Event|0
2990964|NCT01004861|10292451|P1|Overall Study|Adverse Event|0
2990965|NCT01004861|10292439|P13|Overall Study|Physician Decision|3
2990966|NCT01004861|10292440|P12|Overall Study|Physician Decision|0
2990967|NCT01004861|10292441|P11|Overall Study|Physician Decision|0
2990968|NCT01004861|10292442|P10|Overall Study|Physician Decision|0
2990969|NCT01004861|10292443|P9|Overall Study|Physician Decision|0
2990970|NCT01004861|10292444|P8|Overall Study|Physician Decision|1
2990971|NCT01004861|10292445|P7|Overall Study|Physician Decision|0
2990972|NCT01004861|10292446|P6|Overall Study|Physician Decision|0
2990973|NCT01004861|10292447|P5|Overall Study|Physician Decision|1
2990974|NCT01004861|10292448|P4|Overall Study|Physician Decision|1
2990975|NCT01004861|10292449|P3|Overall Study|Physician Decision|1
2990976|NCT01004861|10292450|P2|Overall Study|Physician Decision|2
2990977|NCT01004861|10292451|P1|Overall Study|Physician Decision|0
2990978|NCT01004861|10292439|P13|Overall Study|Disease progression|8
2990979|NCT01004861|10292440|P12|Overall Study|Disease progression|3
2990980|NCT01004861|10292441|P11|Overall Study|Disease progression|6
2990981|NCT01004861|10292442|P10|Overall Study|Disease progression|7
2990982|NCT01004861|10292443|P9|Overall Study|Disease progression|4
2990983|NCT01004861|10292444|P8|Overall Study|Disease progression|1
2990984|NCT01004861|10292445|P7|Overall Study|Disease progression|5
2990985|NCT01004861|10292446|P6|Overall Study|Disease progression|4
2990986|NCT01004861|10292447|P5|Overall Study|Disease progression|4
2990987|NCT01004861|10292448|P4|Overall Study|Disease progression|4
2990988|NCT01004861|10292449|P3|Overall Study|Disease progression|5
2990989|NCT01004861|10292450|P2|Overall Study|Disease progression|4
2990990|NCT01004861|10292451|P1|Overall Study|Disease progression|3
2990991|NCT01004848|10292517|P2|Overall Study|Lost to Follow-up|45
2990992|NCT01004848|10292518|P1|Overall Study|Lost to Follow-up|55
2990993|NCT01004822|10292556|P8|Overall Study|Other|0
2990994|NCT01004822|10292557|P7|Overall Study|Other|0
2990995|NCT01004822|10292558|P6|Overall Study|Other|1
2990996|NCT01004822|10292559|P5|Overall Study|Other|0
2990997|NCT01004822|10292560|P4|Overall Study|Other|1
2990998|NCT01004822|10292561|P3|Overall Study|Other|4
2990999|NCT01004822|10292562|P2|Overall Study|Other|0
2991000|NCT01004822|10292563|P1|Overall Study|Other|0
2991001|NCT01004822|10292556|P8|Overall Study|Adverse Event|1
2991002|NCT01004822|10292557|P7|Overall Study|Adverse Event|1
2991003|NCT01004822|10292558|P6|Overall Study|Adverse Event|0
2991004|NCT01004822|10292559|P5|Overall Study|Adverse Event|0
2991005|NCT01004822|10292560|P4|Overall Study|Adverse Event|0
2991006|NCT01004822|10292561|P3|Overall Study|Adverse Event|0
2991007|NCT01004822|10292562|P2|Overall Study|Adverse Event|0
2991008|NCT01004822|10292563|P1|Overall Study|Adverse Event|0
2991009|NCT01004822|10292556|P8|Overall Study|No longer willing to continue|0
2991010|NCT01004822|10292557|P7|Overall Study|No longer willing to continue|1
2991011|NCT01004822|10292558|P6|Overall Study|No longer willing to continue|1
2991012|NCT01004822|10292559|P5|Overall Study|No longer willing to continue|2
2991013|NCT01004822|10292560|P4|Overall Study|No longer willing to continue|1
2991014|NCT01004822|10292561|P3|Overall Study|No longer willing to continue|0
2991015|NCT01004822|10292562|P2|Overall Study|No longer willing to continue|0
2991016|NCT01004822|10292563|P1|Overall Study|No longer willing to continue|0
2991017|NCT01004822|10292556|P8|Overall Study|Global deterioration of health status|0
2991018|NCT01004822|10292557|P7|Overall Study|Global deterioration of health status|1
2991019|NCT01004822|10292558|P6|Overall Study|Global deterioration of health status|0
2991020|NCT01004822|10292559|P5|Overall Study|Global deterioration of health status|0
2991021|NCT01004822|10292560|P4|Overall Study|Global deterioration of health status|1
2991022|NCT01004822|10292561|P3|Overall Study|Global deterioration of health status|0
2991023|NCT01004822|10292562|P2|Overall Study|Global deterioration of health status|0
2991024|NCT01004822|10292563|P1|Overall Study|Global deterioration of health status|0
2991025|NCT01004822|10292556|P8|Overall Study|Objective progression or relapse|4
2991026|NCT01004822|10292557|P7|Overall Study|Objective progression or relapse|1
2991027|NCT01004822|10292558|P6|Overall Study|Objective progression or relapse|2
2991028|NCT01004822|10292559|P5|Overall Study|Objective progression or relapse|2
2991029|NCT01004822|10292560|P4|Overall Study|Objective progression or relapse|1
2991030|NCT01004822|10292561|P3|Overall Study|Objective progression or relapse|0
2991031|NCT01004822|10292562|P2|Overall Study|Objective progression or relapse|3
2991032|NCT01004822|10292563|P1|Overall Study|Objective progression or relapse|3
2991033|NCT01004614|10292728|P4|Washout|Withdrawal by Subject|0
2991034|NCT01004614|10292729|P3|Washout|Withdrawal by Subject|0
2991035|NCT01004614|10292730|P2|Washout|Withdrawal by Subject|1
2991036|NCT01004614|10292731|P1|Washout|Withdrawal by Subject|0
2991037|NCT01004510|10292765|P1|Overall Study|Adverse Event|1
2991038|NCT01004432|10292769|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
2991039|NCT01004432|10292770|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2991040|NCT01004432|10292771|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2991041|NCT01004432|10292772|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2991042|NCT01004432|10292773|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2991043|NCT01004432|10292769|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
2991044|NCT01004432|10292770|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2991045|NCT01004432|10292771|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2991046|NCT01004432|10292772|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2991047|NCT01004432|10292773|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2991048|NCT01004432|10292769|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
2991049|NCT01004432|10292770|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2991050|NCT01004432|10292771|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2991051|NCT01004432|10292772|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2991052|NCT01004432|10292773|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2991053|NCT01004432|10292769|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
2991054|NCT01004432|10292770|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
2991055|NCT01004432|10292771|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
2991056|NCT01004432|10292772|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
2991057|NCT01004432|10292773|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
2991058|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2991059|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2991060|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
2991061|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2991062|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2991063|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2991064|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
2991065|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
2991066|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
2991067|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2991068|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2991069|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
2991070|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2991071|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2991072|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2991073|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2991074|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
2991075|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
2991076|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
2991077|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2991078|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2991079|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
2991080|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2991081|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2991082|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2991083|NCT01004432|10292769|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2991084|NCT01004432|10292770|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
2991085|NCT01004432|10292771|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
2991086|NCT01004432|10292772|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
2991087|NCT01004432|10292773|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2991088|NCT01004432|10292769|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2991089|NCT01004432|10292770|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2991090|NCT01004432|10292771|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2991091|NCT01004432|10292772|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2991092|NCT01004432|10292773|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
2991093|NCT01004432|10292769|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2991094|NCT01004432|10292770|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2991095|NCT01004432|10292771|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2991096|NCT01004432|10292772|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2991097|NCT01004432|10292773|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
2991098|NCT01004432|10292769|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2991099|NCT01004432|10292770|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2991100|NCT01004432|10292771|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2991101|NCT01004432|10292772|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2991102|NCT01004432|10292773|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
2991103|NCT01004432|10292769|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2991104|NCT01004432|10292770|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2991105|NCT01004432|10292771|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2991106|NCT01004432|10292772|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2991107|NCT01004432|10292773|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
2991108|NCT01004432|10292769|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2991109|NCT01004432|10292770|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2991110|NCT01004432|10292771|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2991111|NCT01004432|10292772|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2991112|NCT01004432|10292773|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
2991113|NCT01004406|10292795|P2|Overall Study|Lost to Follow-up|0
2991114|NCT01004406|10292796|P1|Overall Study|Lost to Follow-up|1
2991115|NCT01004406|10292795|P2|Overall Study|Withdrawal by Subject|0
2991116|NCT01004406|10292796|P1|Overall Study|Withdrawal by Subject|2
2991117|NCT01004263|10292831|P1|Overall Study|Lack of Qualifying Event|2
2991118|NCT01004263|10292831|P1|Overall Study|Physician Decision|15
2991119|NCT01004263|10292831|P1|Overall Study|Pregnancy|2
2991120|NCT01004263|10292831|P1|Overall Study|Lack of Efficacy|13
2991121|NCT01004263|10292831|P1|Overall Study|Lost to Follow-up|64
2991122|NCT01004263|10292831|P1|Overall Study|Protocol Violation|10
2991123|NCT01004263|10292831|P1|Overall Study|Withdrawal by Subject|58
2991124|NCT01004263|10292831|P1|Overall Study|Adverse Event|15
2991125|NCT01004250|10292839|P1|Follow-Up (FU) Period|Lost to Follow-up|1
2991126|NCT01004250|10292839|P1|Maintenance Therapy Period|Physician Decision|4
2991127|NCT01004250|10292839|P1|Maintenance Therapy Period|Withdrawal by Subject|5
2991128|NCT01004250|10292839|P1|Maintenance Therapy Period|Protocol Violation|1
2991129|NCT01004250|10292839|P1|Maintenance Therapy Period|Lost to Follow-up|1
2991130|NCT01004250|10292839|P1|Maintenance Therapy Period|Adverse Event|15
2991131|NCT01004250|10292839|P1|Induction Therapy Period|Physician Decision|2
2991132|NCT01004250|10292839|P1|Induction Therapy Period|Withdrawal by Subject|2
2991133|NCT01004250|10292839|P1|Induction Therapy Period|Entry Criteria Not Met|1
2991134|NCT01004250|10292839|P1|Induction Therapy Period|Adverse Event|10
2991135|NCT01004185|10292851|P2|Overall Study|Withdrawal by Subject|1
2991136|NCT01004185|10292852|P1|Overall Study|Withdrawal by Subject|2
2991137|NCT01004185|10292851|P2|Overall Study|Sponsor Terminated Study|5
2991138|NCT01004185|10292852|P1|Overall Study|Sponsor Terminated Study|4
2991139|NCT01004185|10292851|P2|Overall Study|Lack of Efficacy|1
2991140|NCT01004185|10292852|P1|Overall Study|Lack of Efficacy|2
2991141|NCT01004185|10292851|P2|Overall Study|Lost to Follow-up|1
2991142|NCT01004185|10292852|P1|Overall Study|Lost to Follow-up|0
2991143|NCT01004185|10292851|P2|Overall Study|Adverse Event|1
2991144|NCT01004185|10292852|P1|Overall Study|Adverse Event|1
2991145|NCT01004172|10292860|P1|Overall Study|Symptomatic Deterioration|2
2991146|NCT01004172|10292860|P1|Overall Study|Physician Decision|1
2991147|NCT01004172|10292860|P1|Overall Study|Adverse Event|1
2991148|NCT01004172|10292860|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
2991149|NCT01004172|10292860|P1|Overall Study|Progressive Disease in Non-CNS Only|16
2991150|NCT01004172|10292860|P1|Overall Study|Progressive Disease in CNS Only|16
2991151|NCT01004159|10292868|P1|Overall Study|Disease Progression|18
2991152|NCT01004159|10292868|P1|Overall Study|Adverse Event|2
2991153|NCT01004146|10292875|P2|Overall Study|Withdrawal by Subject|5
2991154|NCT01004146|10292876|P1|Overall Study|Withdrawal by Subject|4
2991155|NCT01004003|10292970|P9|Overall Study|Other|0
2991156|NCT01004003|10292971|P8|Overall Study|Other|0
2991157|NCT01004003|10292972|P7|Overall Study|Other|0
2991158|NCT01004003|10292973|P6|Overall Study|Other|1
2991159|NCT01004003|10292974|P5|Overall Study|Other|0
2991160|NCT01004003|10292975|P4|Overall Study|Other|0
2991161|NCT01004003|10292976|P3|Overall Study|Other|0
2991162|NCT01004003|10292977|P2|Overall Study|Other|0
2991163|NCT01004003|10292978|P1|Overall Study|Other|0
2991164|NCT01004003|10292970|P9|Overall Study|Refused to continue taking trial med.|2
2991165|NCT01004003|10292971|P8|Overall Study|Refused to continue taking trial med.|0
2991166|NCT01004003|10292972|P7|Overall Study|Refused to continue taking trial med.|0
2991167|NCT01004003|10292973|P6|Overall Study|Refused to continue taking trial med.|0
2991168|NCT01004003|10292974|P5|Overall Study|Refused to continue taking trial med.|0
2991169|NCT01004003|10292975|P4|Overall Study|Refused to continue taking trial med.|0
2991170|NCT01004003|10292976|P3|Overall Study|Refused to continue taking trial med.|0
2991171|NCT01004003|10292977|P2|Overall Study|Refused to continue taking trial med.|0
2991172|NCT01004003|10292978|P1|Overall Study|Refused to continue taking trial med.|0
2991173|NCT01004003|10292970|P9|Overall Study|Adverse Event|6
2991174|NCT01004003|10292971|P8|Overall Study|Adverse Event|21
2991175|NCT01004003|10292972|P7|Overall Study|Adverse Event|7
2991176|NCT01004003|10292973|P6|Overall Study|Adverse Event|2
2991177|NCT01004003|10292974|P5|Overall Study|Adverse Event|2
2991178|NCT01004003|10292975|P4|Overall Study|Adverse Event|3
2991179|NCT01004003|10292976|P3|Overall Study|Adverse Event|3
2991180|NCT01004003|10292977|P2|Overall Study|Adverse Event|2
2991181|NCT01004003|10292978|P1|Overall Study|Adverse Event|4
2991182|NCT01004003|10292970|P9|Overall Study|Progressive disease|22
2991183|NCT01004003|10292971|P8|Overall Study|Progressive disease|39
2991184|NCT01004003|10292972|P7|Overall Study|Progressive disease|1
2991185|NCT01004003|10292973|P6|Overall Study|Progressive disease|1
2991186|NCT01004003|10292974|P5|Overall Study|Progressive disease|2
2991187|NCT01004003|10292975|P4|Overall Study|Progressive disease|0
2991188|NCT01004003|10292976|P3|Overall Study|Progressive disease|1
2991189|NCT01004003|10292977|P2|Overall Study|Progressive disease|1
2991190|NCT01004003|10292978|P1|Overall Study|Progressive disease|2
2991191|NCT01003990|10293009|P3|Overall Study|Subject Withdrew Consent|7
2991192|NCT01003990|10293010|P2|Overall Study|Subject Withdrew Consent|5
2991193|NCT01003990|10293011|P1|Overall Study|Subject Withdrew Consent|12
2991194|NCT01003990|10293009|P3|Overall Study|No Longer Met Study Criteria|0
2991195|NCT01003990|10293010|P2|Overall Study|No Longer Met Study Criteria|1
2991196|NCT01003990|10293011|P1|Overall Study|No Longer Met Study Criteria|4
2991197|NCT01003990|10293009|P3|Overall Study|Pregnancy|4
2991198|NCT01003990|10293010|P2|Overall Study|Pregnancy|2
2991199|NCT01003990|10293011|P1|Overall Study|Pregnancy|10
2991200|NCT01003990|10293009|P3|Overall Study|Poor/Non-compliance|2
2991201|NCT01003990|10293010|P2|Overall Study|Poor/Non-compliance|3
2991202|NCT01003990|10293011|P1|Overall Study|Poor/Non-compliance|4
2991203|NCT01003990|10293009|P3|Overall Study|Reasons Not Identified|8
2991204|NCT01003990|10293010|P2|Overall Study|Reasons Not Identified|13
2991205|NCT01003990|10293011|P1|Overall Study|Reasons Not Identified|14
2991206|NCT01003990|10293009|P3|Overall Study|Lost to Follow-up|7
2991207|NCT01003990|10293010|P2|Overall Study|Lost to Follow-up|12
2991208|NCT01003990|10293011|P1|Overall Study|Lost to Follow-up|30
2991209|NCT01003990|10293009|P3|Overall Study|Lack of Efficacy|3
2991210|NCT01003990|10293010|P2|Overall Study|Lack of Efficacy|2
2991211|NCT01003990|10293011|P1|Overall Study|Lack of Efficacy|10
2991212|NCT01003990|10293009|P3|Overall Study|Death|1
2991213|NCT01003990|10293010|P2|Overall Study|Death|8
2991214|NCT01003990|10293011|P1|Overall Study|Death|0
2991215|NCT01003990|10293009|P3|Overall Study|Adverse Event|11
2991216|NCT01003990|10293010|P2|Overall Study|Adverse Event|5
2991217|NCT01003990|10293011|P1|Overall Study|Adverse Event|8
2991218|NCT01003899|10293028|P1|Overall Study|Progressive disease|34
2991219|NCT01003899|10293028|P1|Overall Study|Not treated|1
2991220|NCT01003899|10293028|P1|Overall Study|Not entered|4
2991221|NCT01003899|10293028|P1|Overall Study|Other Adverse Event|8
2991222|NCT01003886|10293037|P1|Overall Study|Adverse Event|3
2991223|NCT01003886|10293037|P1|Overall Study|Other|14
2991224|NCT01003886|10293037|P1|Overall Study|Withdrawal by Subject|39
2991225|NCT01003886|10293037|P1|Overall Study|Lost to Follow-up|169
2991226|NCT01003886|10293037|P1|Overall Study|Lack of Efficacy|5
2991227|NCT01003639|10293048|P2|Overall Study|Physician Decision|0
2991228|NCT01003639|10293049|P1|Overall Study|Physician Decision|1
2991229|NCT01003639|10293048|P2|Overall Study|Protocol Violation|1
2991230|NCT01003639|10293049|P1|Overall Study|Protocol Violation|0
2991231|NCT01003639|10293048|P2|Overall Study|Adverse Event|1
2991232|NCT01003639|10293049|P1|Overall Study|Adverse Event|0
2991233|NCT01003639|10293048|P2|Overall Study|Lack of Efficacy|6
2991234|NCT01003639|10293049|P1|Overall Study|Lack of Efficacy|1
2991235|NCT01003639|10293048|P2|Overall Study|Withdrawal by Subject|5
2991236|NCT01003639|10293049|P1|Overall Study|Withdrawal by Subject|9
2991237|NCT01003639|10293048|P2|Overall Study|Lost to Follow-up|9
2991238|NCT01003639|10293049|P1|Overall Study|Lost to Follow-up|6
2991239|NCT01003249|10293105|P2|Second Intervention (4 Weeks)|Adverse Event|0
2991240|NCT01003249|10293106|P1|Second Intervention (4 Weeks)|Adverse Event|1
2991241|NCT01003249|10293105|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2991242|NCT01003249|10293106|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2991243|NCT01003249|10293105|P2|First Intervention (4 Weeks)|Non-Serious Event|1
2991244|NCT01003249|10293106|P1|First Intervention (4 Weeks)|Non-Serious Event|1
2991245|NCT01003249|10293105|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
2991246|NCT01003249|10293106|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
2991247|NCT01003210|10293124|P2|Overall Study|Lost to Follow-up|3
2991248|NCT01003210|10293125|P1|Overall Study|Lost to Follow-up|1
2991249|NCT01003184|10293137|P2|Overall Study|Physician Decision|0
2991250|NCT01003184|10293138|P1|Overall Study|Physician Decision|1
2991251|NCT01003184|10293137|P2|Overall Study|Withdrawal by Subject|6
2991252|NCT01003184|10293138|P1|Overall Study|Withdrawal by Subject|1
2991253|NCT01003184|10293137|P2|Overall Study|Protocol Violation|0
2991254|NCT01003184|10293138|P1|Overall Study|Protocol Violation|3
2991255|NCT01003184|10293137|P2|Overall Study|Loss of glucose control|1
2991256|NCT01003184|10293138|P1|Overall Study|Loss of glucose control|1
2991257|NCT01003184|10293137|P2|Overall Study|Lost to Follow-up|0
2991258|NCT01003184|10293138|P1|Overall Study|Lost to Follow-up|1
2991259|NCT01003184|10293137|P2|Overall Study|Adverse Event|5
2991260|NCT01003184|10293138|P1|Overall Study|Adverse Event|12
2991261|NCT01002989|10293221|P1|Overall Study|exclusion criteria, no consent|5
2991262|NCT01002742|10293236|P2|Overall Study|Determined to be ineligible|1
2991263|NCT01002742|10293237|P1|Overall Study|Determined to be ineligible|0
2991264|NCT01002573|10293273|P2|Overall Study|Subject did not receive at least 1 dose|7
2991265|NCT01002573|10293274|P1|Overall Study|Subject did not receive at least 1 dose|11
2991266|NCT01002547|10293295|P3|Overall Study|Adverse Event|0
2991267|NCT01002547|10293296|P2|Overall Study|Adverse Event|0
2991268|NCT01002547|10293297|P1|Overall Study|Adverse Event|1
2991269|NCT01002547|10293295|P3|Overall Study|Death|2
2991270|NCT01002547|10293296|P2|Overall Study|Death|2
2991271|NCT01002547|10293297|P1|Overall Study|Death|0
2991272|NCT01002547|10293295|P3|Overall Study|Physician Decision|0
2991273|NCT01002547|10293296|P2|Overall Study|Physician Decision|0
2991274|NCT01002547|10293297|P1|Overall Study|Physician Decision|1
2991275|NCT01002547|10293295|P3|Overall Study|Lost to Follow-up|1
2991276|NCT01002547|10293296|P2|Overall Study|Lost to Follow-up|1
2991277|NCT01002547|10293297|P1|Overall Study|Lost to Follow-up|2
2991278|NCT01002547|10293295|P3|Overall Study|Withdrawal by Subject|5
2991279|NCT01002547|10293296|P2|Overall Study|Withdrawal by Subject|0
2991280|NCT01002547|10293297|P1|Overall Study|Withdrawal by Subject|4
2991281|NCT01002482|10293355|P2|Overall Study|Included twice|0
2991282|NCT01002482|10293356|P1|Overall Study|Included twice|1
2991283|NCT01002482|10293355|P2|Overall Study|Withdrawal by Subject|21
2991284|NCT01002482|10293356|P1|Overall Study|Withdrawal by Subject|14
2991285|NCT01002339|10293390|P3|Overall Study|Randomized. Not transplanted|1
2991286|NCT01002339|10293391|P2|Overall Study|Randomized. Not transplanted|0
2991287|NCT01002339|10293392|P1|Overall Study|Randomized. Not transplanted|0
2991288|NCT01002339|10293390|P3|Overall Study|Lung cancer detected before transplant|1
2991289|NCT01002339|10293391|P2|Overall Study|Lung cancer detected before transplant|0
2991290|NCT01002339|10293392|P1|Overall Study|Lung cancer detected before transplant|0
2991291|NCT01002339|10293390|P3|Overall Study|Protocol Violation|2
2991292|NCT01002339|10293391|P2|Overall Study|Protocol Violation|0
2991293|NCT01002339|10293392|P1|Overall Study|Protocol Violation|0
2991294|NCT01002339|10293390|P3|Overall Study|Incorrect treatment assignment|1
2991295|NCT01002339|10293391|P2|Overall Study|Incorrect treatment assignment|0
2991296|NCT01002339|10293392|P1|Overall Study|Incorrect treatment assignment|0
2991297|NCT01002339|10293390|P3|Overall Study|Withdrawal by Subject|0
2991298|NCT01002339|10293391|P2|Overall Study|Withdrawal by Subject|1
2991299|NCT01002339|10293392|P1|Overall Study|Withdrawal by Subject|0
2991300|NCT01002105|10293468|P2|Overall Study|condition worsened|2
2991301|NCT01002105|10293469|P1|Overall Study|condition worsened|4
2991302|NCT01002105|10293468|P2|Overall Study|non compliance|3
2991303|NCT01002105|10293469|P1|Overall Study|non compliance|5
2991304|NCT01002105|10293468|P2|Overall Study|Lost to Follow-up|16
2991305|NCT01002105|10293469|P1|Overall Study|Lost to Follow-up|10
2991306|NCT01001988|10293485|P1|Overall Study|Lost to Follow-up|15
2991307|NCT01001988|10293485|P1|Overall Study|Withdrawal by Subject|18
2991308|NCT01001988|10293485|P1|Overall Study|Protocol Violation|84
2991309|NCT01001832|10293503|P2|Follow-up Period|Other|1
2991310|NCT01001832|10293504|P1|Follow-up Period|Other|2
2991311|NCT01001832|10293503|P2|Follow-up Period|Follow-up no longer required /protocol|20
2991312|NCT01001832|10293504|P1|Follow-up Period|Follow-up no longer required /protocol|15
2991313|NCT01001832|10293503|P2|Follow-up Period|Withdrawal by Subject|0
2991314|NCT01001832|10293504|P1|Follow-up Period|Withdrawal by Subject|1
2991315|NCT01001832|10293503|P2|Long-term Period|Other|2
2991316|NCT01001832|10293504|P1|Long-term Period|Other|1
2991317|NCT01001832|10293503|P2|Long-term Period|Lack of Efficacy|2
2991318|NCT01001832|10293504|P1|Long-term Period|Lack of Efficacy|0
2991319|NCT01001832|10293503|P2|Long-term Period|Withdrawal by Subject|0
2991320|NCT01001832|10293504|P1|Long-term Period|Withdrawal by Subject|1
2991321|NCT01001832|10293503|P2|Long-term Period|Adverse Event|1
2991322|NCT01001832|10293504|P1|Long-term Period|Adverse Event|2
2991323|NCT01001832|10293503|P2|Short-term Period|Adverse Event|3
2991324|NCT01001832|10293504|P1|Short-term Period|Adverse Event|2
2991325|NCT01001767|10293562|P2|Overall Study|Physician Decision|0
2991326|NCT01001767|10293563|P1|Overall Study|Physician Decision|1
2991327|NCT01001767|10293562|P2|Overall Study|Lost to Follow-up|0
2991328|NCT01001767|10293563|P1|Overall Study|Lost to Follow-up|1
2991329|NCT01001767|10293562|P2|Overall Study|Protocol Violation|0
2991330|NCT01001767|10293563|P1|Overall Study|Protocol Violation|1
2991331|NCT01001767|10293562|P2|Overall Study|no baseline study performed|0
2991332|NCT01001767|10293563|P1|Overall Study|no baseline study performed|1
2991333|NCT01001702|10293569|P1|Overall Study|Lack of Efficacy per Investigator|3
2991334|NCT01001702|10293569|P1|Overall Study|Withdrawal by Subject|19
2991335|NCT01001702|10293569|P1|Overall Study|Investigator withdrew Subject|10
2991336|NCT01001702|10293569|P1|Overall Study|Subject met Withdrawal Criteria|22
2991337|NCT01001702|10293569|P1|Overall Study|Sponsor Discontinued Study|4
2991338|NCT01001702|10293569|P1|Overall Study|Adverse Event|7
2991339|NCT01001702|10293569|P1|Overall Study|Lost to Follow-up|7
2991340|NCT01001598|10293580|P1|Overall Study|Adverse Event|1
2991341|NCT01001598|10293580|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
2991342|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
2991343|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
2991344|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
2991345|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Protocol deviation|1
2991346|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Protocol deviation|0
2991347|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Protocol deviation|0
2991348|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
2991349|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2991350|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2991351|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
2991352|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2991353|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2991354|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
2991355|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
2991356|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
2991357|NCT01001572|10293588|P3|Double-Blind Treatment Phase|Adverse Event|2
2991358|NCT01001572|10293589|P2|Double-Blind Treatment Phase|Adverse Event|2
2991359|NCT01001572|10293590|P1|Double-Blind Treatment Phase|Adverse Event|0
2991360|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2991361|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2991362|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
2991363|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
2991364|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
2991365|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
2991366|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2991367|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2991368|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
2991369|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2991370|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2991371|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
2991372|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2991373|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2991374|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
2991375|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2991376|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2991377|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
2991378|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
2991379|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
2991380|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
2991381|NCT01001572|10293588|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2991382|NCT01001572|10293589|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2991383|NCT01001572|10293590|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
2991384|NCT01001520|10293628|P2|Medication Period 2|Withdrawal by Subject|3
2991385|NCT01001520|10293629|P1|Medication Period 2|Withdrawal by Subject|0
2991386|NCT01001520|10293628|P2|Washout Period|Withdrawal by Subject|1
2991387|NCT01001520|10293629|P1|Washout Period|Withdrawal by Subject|2
2991388|NCT01001520|10293628|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
2991389|NCT01001520|10293629|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
2991390|NCT01001520|10293628|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
2991391|NCT01001520|10293629|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
2991392|NCT01001520|10293628|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
2991393|NCT01001520|10293629|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
2991394|NCT01001520|10293628|P2|Medication Period 1|Withdrawal by Subject|2
2991395|NCT01001520|10293629|P1|Medication Period 1|Withdrawal by Subject|2
2991396|NCT01001494|10293656|P3|Overall Study|Other|3
2991397|NCT01001494|10293657|P2|Overall Study|Other|1
2991398|NCT01001494|10293658|P1|Overall Study|Other|0
2991399|NCT01001494|10293656|P3|Overall Study|Lack of Efficacy|8
2991400|NCT01001494|10293657|P2|Overall Study|Lack of Efficacy|0
2991401|NCT01001494|10293658|P1|Overall Study|Lack of Efficacy|2
2991402|NCT01001494|10293656|P3|Overall Study|COPD exacerbation|5
2991403|NCT01001494|10293657|P2|Overall Study|COPD exacerbation|4
2991404|NCT01001494|10293658|P1|Overall Study|COPD exacerbation|3
2991405|NCT01001494|10293656|P3|Overall Study|Withdrawal by Subject|17
2991406|NCT01001494|10293657|P2|Overall Study|Withdrawal by Subject|7
2991407|NCT01001494|10293658|P1|Overall Study|Withdrawal by Subject|9
2991408|NCT01001494|10293656|P3|Overall Study|Lost to Follow-up|1
2991409|NCT01001494|10293657|P2|Overall Study|Lost to Follow-up|0
2991410|NCT01001494|10293658|P1|Overall Study|Lost to Follow-up|2
2991411|NCT01001494|10293656|P3|Overall Study|Protocol Violation|1
2991412|NCT01001494|10293657|P2|Overall Study|Protocol Violation|1
2991413|NCT01001494|10293658|P1|Overall Study|Protocol Violation|0
2991414|NCT01001494|10293656|P3|Overall Study|Adverse Event|6
2991415|NCT01001494|10293657|P2|Overall Study|Adverse Event|4
2991416|NCT01001494|10293658|P1|Overall Study|Adverse Event|8
2991417|NCT01001429|10293743|P2|Overall Study|surgery cancelled|1
2991418|NCT01001429|10293744|P1|Overall Study|surgery cancelled|0
2991419|NCT01001390|10293783|P2|Overall Study|Failure to wear AFO device|0
2991420|NCT01001390|10293784|P1|Overall Study|Failure to wear AFO device|2
2991421|NCT01001377|10293792|P2|Overall Study|Death|384
2991422|NCT01001377|10293793|P1|Overall Study|Death|391
2991423|NCT01001377|10293792|P2|Overall Study|Lost to Follow-up|17
2991424|NCT01001377|10293793|P1|Overall Study|Lost to Follow-up|14
2991425|NCT01001377|10293792|P2|Overall Study|Withdrawal by Subject|20
2991426|NCT01001377|10293793|P1|Overall Study|Withdrawal by Subject|19
2991427|NCT01001377|10293792|P2|Overall Study|Ineligibility determined|0
2991428|NCT01001377|10293793|P1|Overall Study|Ineligibility determined|2
2991429|NCT01001325|10293823|P2|Overall Study|Protocol Violation|0
2991430|NCT01001325|10293824|P1|Overall Study|Protocol Violation|2
2991431|NCT01001325|10293823|P2|Overall Study|Lost to Follow-up|10
2991432|NCT01001325|10293824|P1|Overall Study|Lost to Follow-up|16
2991433|NCT01001299|10293830|P1|Overall Study|Withdrew Consent|1
2991434|NCT01001299|10293830|P1|Overall Study|Began Taking Commercially Available Drug|2
2991435|NCT01001299|10293830|P1|Overall Study|Death|1
2991436|NCT01001299|10293830|P1|Overall Study|Adverse event or Intercurrent Illness|1
2991437|NCT01001299|10293830|P1|Overall Study|Insufficient Therapeutic Response|20
2991438|NCT01001234|10293859|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
2991439|NCT01001234|10293860|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
2991440|NCT01001234|10293861|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
2991441|NCT01001234|10293862|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
2991442|NCT01001234|10293863|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
2991443|NCT01001234|10293859|P5|Overall Study|Not Treated: Physician Decision|0
2991444|NCT01001234|10293860|P4|Overall Study|Not Treated: Physician Decision|0
2991445|NCT01001234|10293861|P3|Overall Study|Not Treated: Physician Decision|0
2991446|NCT01001234|10293862|P2|Overall Study|Not Treated: Physician Decision|4
2991447|NCT01001234|10293863|P1|Overall Study|Not Treated: Physician Decision|37
2991448|NCT01001234|10293859|P5|Overall Study|Not Treated: Pregnancy|0
2991449|NCT01001234|10293860|P4|Overall Study|Not Treated: Pregnancy|0
2991450|NCT01001234|10293861|P3|Overall Study|Not Treated: Pregnancy|0
2991451|NCT01001234|10293862|P2|Overall Study|Not Treated: Pregnancy|0
2991452|NCT01001234|10293863|P1|Overall Study|Not Treated: Pregnancy|3
2991453|NCT01001234|10293859|P5|Overall Study|Not Treated: Lost to Follow-up|0
2991454|NCT01001234|10293860|P4|Overall Study|Not Treated: Lost to Follow-up|5
2991455|NCT01001234|10293861|P3|Overall Study|Not Treated: Lost to Follow-up|7
2991456|NCT01001234|10293862|P2|Overall Study|Not Treated: Lost to Follow-up|4
2991457|NCT01001234|10293863|P1|Overall Study|Not Treated: Lost to Follow-up|53
2991458|NCT01001234|10293859|P5|Overall Study|Not Treated: Protocol Violation|0
2991459|NCT01001234|10293860|P4|Overall Study|Not Treated: Protocol Violation|0
2991460|NCT01001234|10293861|P3|Overall Study|Not Treated: Protocol Violation|0
2991461|NCT01001234|10293862|P2|Overall Study|Not Treated: Protocol Violation|0
2991462|NCT01001234|10293863|P1|Overall Study|Not Treated: Protocol Violation|3
2991463|NCT01001234|10293859|P5|Overall Study|Not Treated: Withdrawal by Subject|0
2991464|NCT01001234|10293860|P4|Overall Study|Not Treated: Withdrawal by Subject|0
2991465|NCT01001234|10293861|P3|Overall Study|Not Treated: Withdrawal by Subject|2
2991466|NCT01001234|10293862|P2|Overall Study|Not Treated: Withdrawal by Subject|2
2991467|NCT01001234|10293863|P1|Overall Study|Not Treated: Withdrawal by Subject|23
2991468|NCT01001234|10293859|P5|Overall Study|Not Treated: Adverse Event|0
2991469|NCT01001234|10293860|P4|Overall Study|Not Treated: Adverse Event|0
2991470|NCT01001234|10293861|P3|Overall Study|Not Treated: Adverse Event|0
2991471|NCT01001234|10293862|P2|Overall Study|Not Treated: Adverse Event|0
2991472|NCT01001234|10293863|P1|Overall Study|Not Treated: Adverse Event|1
2991473|NCT01001234|10293859|P5|Overall Study|Physician Decision|0
2991474|NCT01001234|10293860|P4|Overall Study|Physician Decision|0
2991475|NCT01001234|10293861|P3|Overall Study|Physician Decision|0
2991476|NCT01001234|10293862|P2|Overall Study|Physician Decision|0
2991477|NCT01001234|10293863|P1|Overall Study|Physician Decision|1
2991478|NCT01001234|10293859|P5|Overall Study|Lost to Follow-up|0
2991479|NCT01001234|10293860|P4|Overall Study|Lost to Follow-up|2
2991480|NCT01001234|10293861|P3|Overall Study|Lost to Follow-up|1
2991481|NCT01001234|10293862|P2|Overall Study|Lost to Follow-up|0
2991482|NCT01001234|10293863|P1|Overall Study|Lost to Follow-up|0
2991483|NCT01001234|10293859|P5|Overall Study|Protocol Violation|0
2991484|NCT01001234|10293860|P4|Overall Study|Protocol Violation|18
2991485|NCT01001234|10293861|P3|Overall Study|Protocol Violation|19
2991486|NCT01001234|10293862|P2|Overall Study|Protocol Violation|3
2991487|NCT01001234|10293863|P1|Overall Study|Protocol Violation|34
2991488|NCT01001234|10293859|P5|Overall Study|Withdrawal by Subject|0
2991489|NCT01001234|10293860|P4|Overall Study|Withdrawal by Subject|0
2991490|NCT01001234|10293861|P3|Overall Study|Withdrawal by Subject|3
2991491|NCT01001234|10293862|P2|Overall Study|Withdrawal by Subject|0
2991492|NCT01001234|10293863|P1|Overall Study|Withdrawal by Subject|2
2991493|NCT01001221|10293879|P5|Overall Study|Not treated; protocol exclusion|0
2991494|NCT01001221|10293880|P4|Overall Study|Not treated; protocol exclusion|0
2991495|NCT01001221|10293881|P3|Overall Study|Not treated; protocol exclusion|1
2991496|NCT01001221|10293882|P2|Overall Study|Not treated; protocol exclusion|0
2991497|NCT01001221|10293883|P1|Overall Study|Not treated; protocol exclusion|0
2991498|NCT01001221|10293879|P5|Overall Study|Other|0
2991499|NCT01001221|10293880|P4|Overall Study|Other|0
2991500|NCT01001221|10293881|P3|Overall Study|Other|0
2991501|NCT01001221|10293882|P2|Overall Study|Other|1
2991502|NCT01001221|10293883|P1|Overall Study|Other|1
2991503|NCT01001221|10293879|P5|Overall Study|Disease progression|0
2991504|NCT01001221|10293880|P4|Overall Study|Disease progression|4
2991505|NCT01001221|10293881|P3|Overall Study|Disease progression|2
2991506|NCT01001221|10293882|P2|Overall Study|Disease progression|2
2991507|NCT01001221|10293883|P1|Overall Study|Disease progression|3
2991508|NCT01001221|10293879|P5|Overall Study|Adverse Event|0
2991509|NCT01001221|10293880|P4|Overall Study|Adverse Event|2
2991510|NCT01001221|10293881|P3|Overall Study|Adverse Event|0
2991511|NCT01001221|10293882|P2|Overall Study|Adverse Event|2
2991512|NCT01001221|10293883|P1|Overall Study|Adverse Event|1
2991513|NCT01001208|10294058|P2|Overall Study|Other|2
2991514|NCT01001208|10294059|P1|Overall Study|Other|0
2991515|NCT01001208|10294058|P2|Overall Study|Disease Progression|3
2991516|NCT01001208|10294059|P1|Overall Study|Disease Progression|0
2991517|NCT01001208|10294058|P2|Overall Study|Noncompliance|7
2991518|NCT01001208|10294059|P1|Overall Study|Noncompliance|4
2991519|NCT01001208|10294058|P2|Overall Study|Ineligibility Determined|2
2991520|NCT01001208|10294059|P1|Overall Study|Ineligibility Determined|4
2991521|NCT01001208|10294058|P2|Overall Study|Withdrawal by Subject|5
2991522|NCT01001208|10294059|P1|Overall Study|Withdrawal by Subject|4
2991523|NCT01001208|10294058|P2|Overall Study|Physician Decision|0
2991524|NCT01001208|10294059|P1|Overall Study|Physician Decision|1
2991525|NCT01001208|10294058|P2|Overall Study|Lost to Follow-up|9
2991526|NCT01001208|10294059|P1|Overall Study|Lost to Follow-up|5
2991527|NCT01001208|10294058|P2|Overall Study|Adverse Event|5
2991528|NCT01001208|10294059|P1|Overall Study|Adverse Event|10
2991529|NCT01001169|10294102|P2|Overall Study|Withdrawal by Subject|1
2991530|NCT01001169|10294103|P1|Overall Study|Withdrawal by Subject|2
2991531|NCT01001104|10294211|P4|Overall Study|Withdrawal by Subject|2
2991532|NCT01001104|10294212|P3|Overall Study|Withdrawal by Subject|0
2991533|NCT01001104|10294213|P2|Overall Study|Withdrawal by Subject|0
2991534|NCT01001104|10294214|P1|Overall Study|Withdrawal by Subject|0
2991535|NCT01001104|10294211|P4|Overall Study|Entry Criteria Not Met|1
2991536|NCT01001104|10294212|P3|Overall Study|Entry Criteria Not Met|0
2991537|NCT01001104|10294213|P2|Overall Study|Entry Criteria Not Met|0
2991538|NCT01001104|10294214|P1|Overall Study|Entry Criteria Not Met|0
2991539|NCT01001104|10294211|P4|Overall Study|Lost to Follow-up|0
2991540|NCT01001104|10294212|P3|Overall Study|Lost to Follow-up|1
2991541|NCT01001104|10294213|P2|Overall Study|Lost to Follow-up|0
2991542|NCT01001104|10294214|P1|Overall Study|Lost to Follow-up|0
2991543|NCT01001104|10294211|P4|Overall Study|Adverse Event|0
2991544|NCT01001104|10294212|P3|Overall Study|Adverse Event|0
2991545|NCT01001104|10294213|P2|Overall Study|Adverse Event|1
2991546|NCT01001104|10294214|P1|Overall Study|Adverse Event|2
2991547|NCT01000974|10294305|P3|Booster Vaccination Phase|Other|4
2991548|NCT01000974|10294306|P2|Booster Vaccination Phase|Other|6
2991549|NCT01000974|10294307|P1|Booster Vaccination Phase|Other|24
2991550|NCT01000974|10294305|P3|Booster Vaccination Phase|Lost to Follow-up|7
2991551|NCT01000974|10294306|P2|Booster Vaccination Phase|Lost to Follow-up|5
2991552|NCT01000974|10294307|P1|Booster Vaccination Phase|Lost to Follow-up|40
2991553|NCT01000974|10294305|P3|Booster Vaccination Phase|Withdrawal by Subject|1
2991554|NCT01000974|10294306|P2|Booster Vaccination Phase|Withdrawal by Subject|1
2991555|NCT01000974|10294307|P1|Booster Vaccination Phase|Withdrawal by Subject|3
2991556|NCT01000974|10294305|P3|Booster Vaccination Phase|Protocol Violation|2
2991557|NCT01000974|10294306|P2|Booster Vaccination Phase|Protocol Violation|0
2991558|NCT01000974|10294307|P1|Booster Vaccination Phase|Protocol Violation|0
2991559|NCT01000974|10294305|P3|Primary Vaccination Phase|Other|12
2991560|NCT01000974|10294306|P2|Primary Vaccination Phase|Other|9
2991561|NCT01000974|10294307|P1|Primary Vaccination Phase|Other|4
2991562|NCT01000974|10294305|P3|Primary Vaccination Phase|Adverse Event|2
2991563|NCT01000974|10294306|P2|Primary Vaccination Phase|Adverse Event|2
2991564|NCT01000974|10294307|P1|Primary Vaccination Phase|Adverse Event|14
2991565|NCT01000974|10294305|P3|Primary Vaccination Phase|Protocol Violation|2
2991566|NCT01000974|10294306|P2|Primary Vaccination Phase|Protocol Violation|3
2991567|NCT01000974|10294307|P1|Primary Vaccination Phase|Protocol Violation|40
2991568|NCT01000974|10294305|P3|Primary Vaccination Phase|Lost to Follow-up|26
2991569|NCT01000974|10294306|P2|Primary Vaccination Phase|Lost to Follow-up|19
2991570|NCT01000974|10294307|P1|Primary Vaccination Phase|Lost to Follow-up|171
2991571|NCT01000974|10294305|P3|Primary Vaccination Phase|Withdrawal by Subject|21
2991572|NCT01000974|10294306|P2|Primary Vaccination Phase|Withdrawal by Subject|17
2991573|NCT01000974|10294307|P1|Primary Vaccination Phase|Withdrawal by Subject|109
2991574|NCT01000961|10294414|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
2991575|NCT01000961|10294415|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
2991576|NCT01000961|10294414|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
2991577|NCT01000961|10294415|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
2991578|NCT01000805|10294438|P2|Overall Study|Sponsor Decision|1
2991579|NCT01000805|10294439|P1|Overall Study|Sponsor Decision|0
2991580|NCT01000805|10294438|P2|Overall Study|Withdrawal by Subject|6
2991581|NCT01000805|10294439|P1|Overall Study|Withdrawal by Subject|16
2991582|NCT01000805|10294438|P2|Overall Study|Protocol Violation|8
2991583|NCT01000805|10294439|P1|Overall Study|Protocol Violation|12
2991584|NCT01000805|10294438|P2|Overall Study|Physician Decision|1
2991585|NCT01000805|10294439|P1|Overall Study|Physician Decision|0
2991586|NCT01000805|10294438|P2|Overall Study|Lost to Follow-up|21
2991587|NCT01000805|10294439|P1|Overall Study|Lost to Follow-up|16
2991588|NCT01000805|10294438|P2|Overall Study|Lack of Efficacy|16
2991589|NCT01000805|10294439|P1|Overall Study|Lack of Efficacy|5
2991590|NCT01000805|10294438|P2|Overall Study|Adverse Event|9
2991591|NCT01000805|10294439|P1|Overall Study|Adverse Event|21
2991592|NCT01000727|10294473|P2|Overall Study|Study closed/terminated|24
2991593|NCT01000727|10294474|P1|Overall Study|Study closed/terminated|23
2991594|NCT01000727|10294473|P2|Overall Study|Withdrawal by Subject|109
2991595|NCT01000727|10294474|P1|Overall Study|Withdrawal by Subject|111
2991596|NCT01000727|10294473|P2|Overall Study|Lost to Follow-up|43
2991597|NCT01000727|10294474|P1|Overall Study|Lost to Follow-up|41
2991598|NCT01000649|10294515|P4|Overall Study|Lost to Follow-up|2
2991599|NCT01000649|10294516|P3|Overall Study|Lost to Follow-up|0
2991600|NCT01000649|10294517|P2|Overall Study|Lost to Follow-up|2
2991601|NCT01000649|10294518|P1|Overall Study|Lost to Follow-up|0
2991602|NCT01000649|10294515|P4|Overall Study|Adverse Event|4
2991603|NCT01000649|10294516|P3|Overall Study|Adverse Event|2
2991604|NCT01000649|10294517|P2|Overall Study|Adverse Event|1
2991605|NCT01000649|10294518|P1|Overall Study|Adverse Event|5
2991606|NCT01000610|10294599|P1|Overall Study|Treatment failure|1
2991607|NCT01000610|10294599|P1|Overall Study|Lost to Follow-up|4
2991608|NCT01000610|10294599|P1|Overall Study|Adverse Event|1
2991609|NCT01000506|10294610|P4|Overall Study|Withdrawal by Subject|7
2991610|NCT01000506|10294611|P3|Overall Study|Withdrawal by Subject|2
2991611|NCT01000506|10294612|P2|Overall Study|Withdrawal by Subject|8
2991612|NCT01000506|10294613|P1|Overall Study|Withdrawal by Subject|11
2991613|NCT01000506|10294610|P4|Overall Study|Physician Decision|3
2991614|NCT01000506|10294611|P3|Overall Study|Physician Decision|3
2991615|NCT01000506|10294612|P2|Overall Study|Physician Decision|3
2991616|NCT01000506|10294613|P1|Overall Study|Physician Decision|1
2991617|NCT01000506|10294610|P4|Overall Study|Lost to Follow-up|0
2991618|NCT01000506|10294611|P3|Overall Study|Lost to Follow-up|4
2991619|NCT01000506|10294612|P2|Overall Study|Lost to Follow-up|1
2991620|NCT01000506|10294613|P1|Overall Study|Lost to Follow-up|1
2991621|NCT01000506|10294610|P4|Overall Study|Protocol Violation|0
2991622|NCT01000506|10294611|P3|Overall Study|Protocol Violation|0
2991623|NCT01000506|10294612|P2|Overall Study|Protocol Violation|1
2991624|NCT01000506|10294613|P1|Overall Study|Protocol Violation|1
2991625|NCT01000506|10294610|P4|Overall Study|Lack of Efficacy|4
2991626|NCT01000506|10294611|P3|Overall Study|Lack of Efficacy|4
2991627|NCT01000506|10294612|P2|Overall Study|Lack of Efficacy|6
2991628|NCT01000506|10294613|P1|Overall Study|Lack of Efficacy|8
2991629|NCT01000506|10294610|P4|Overall Study|Adverse Event|9
2991630|NCT01000506|10294611|P3|Overall Study|Adverse Event|8
2991631|NCT01000506|10294612|P2|Overall Study|Adverse Event|5
2991632|NCT01000506|10294613|P1|Overall Study|Adverse Event|6
2991633|NCT01000493|10294657|P2|Overall Study|Withdrawal by Subject|7
2991634|NCT01000493|10294658|P1|Overall Study|Withdrawal by Subject|3
2991635|NCT01000493|10294657|P2|Overall Study|Physician Decision|1
2991636|NCT01000493|10294658|P1|Overall Study|Physician Decision|1
2991637|NCT01000493|10294657|P2|Overall Study|Lost to Follow-up|9
2991638|NCT01000493|10294658|P1|Overall Study|Lost to Follow-up|5
2991639|NCT01000493|10294657|P2|Overall Study|Study closed/terminated|23
2991640|NCT01000493|10294658|P1|Overall Study|Study closed/terminated|25
2991641|NCT01000493|10294657|P2|Overall Study|Protocol Violation|8
2991642|NCT01000493|10294658|P1|Overall Study|Protocol Violation|1
2991643|NCT01000493|10294657|P2|Overall Study|Lack of Efficacy|1
2991644|NCT01000493|10294658|P1|Overall Study|Lack of Efficacy|1
2991645|NCT01000493|10294657|P2|Overall Study|Adverse Event|6
2991646|NCT01000493|10294658|P1|Overall Study|Adverse Event|3
2991647|NCT01000480|10294708|P1|Concurrent Therapy Phase|Physician Decision|1
2991648|NCT01000480|10294708|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
2991649|NCT01000480|10294708|P1|Concurrent Therapy Phase|Protocol Violation|2
2991650|NCT01000480|10294708|P1|Concurrent Therapy Phase|Adverse Event|4
2991651|NCT01000480|10294708|P1|Induction Phase|Entry Criteria Not Met|3
2991652|NCT01000480|10294708|P1|Induction Phase|Physician Decision|1
2991653|NCT01000480|10294708|P1|Induction Phase|Lost to Follow-up|1
2991654|NCT01000480|10294708|P1|Induction Phase|Adverse Event|2
2991655|NCT01000376|10294716|P2|Cycle 1 Day 1|Progressive Disease|0
2991656|NCT01000376|10294717|P1|Cycle 1 Day 1|Progressive Disease|1
2991657|NCT01000376|10294716|P2|Cycle 1 Day 1|Adverse Event|0
2991658|NCT01000376|10294717|P1|Cycle 1 Day 1|Adverse Event|1
2991659|NCT01000337|10294727|P2|Overall Study|Lost to Follow-up|3
2991660|NCT01000337|10294728|P1|Overall Study|Lost to Follow-up|4
2991661|NCT01000311|10294746|P2|Overall Study|Administrative reason|15
2991662|NCT01000311|10294747|P1|Overall Study|Administrative reason|9
2991663|NCT01000311|10294746|P2|Overall Study|Inappropriate enrollment|0
2991664|NCT01000311|10294747|P1|Overall Study|Inappropriate enrollment|2
2991665|NCT01000311|10294746|P2|Overall Study|Protocol Violation|2
2991666|NCT01000311|10294747|P1|Overall Study|Protocol Violation|1
2991667|NCT01000311|10294746|P2|Overall Study|Lost to Follow-up|24
2991668|NCT01000311|10294747|P1|Overall Study|Lost to Follow-up|15
2991669|NCT01000311|10294746|P2|Overall Study|Withdrawal by Subject|24
2991670|NCT01000311|10294747|P1|Overall Study|Withdrawal by Subject|16
2991671|NCT01000311|10294746|P2|Overall Study|Adverse Event|5
2991672|NCT01000311|10294747|P1|Overall Study|Adverse Event|2
2991673|NCT01000155|10294797|P1|Overall Study|Adverse Event|1
2991674|NCT01000155|10294797|P1|Overall Study|Withdrawal by Subject|1
2991675|NCT01000064|10294803|P2|Overall Study|Withdrawal by Subject|1
2991676|NCT01000064|10294804|P1|Overall Study|Withdrawal by Subject|1
2991677|NCT01000051|10294827|P2|Overall Study|Serious noncompliance|0
2991678|NCT01000051|10294828|P1|Overall Study|Serious noncompliance|1
2991679|NCT01000051|10294827|P2|Overall Study|Disease Progression|0
2991680|NCT01000051|10294828|P1|Overall Study|Disease Progression|1
2991681|NCT01000051|10294827|P2|Overall Study|Withdrawal by Subject|1
2991682|NCT01000051|10294828|P1|Overall Study|Withdrawal by Subject|1
2991683|NCT01000025|10294836|P2|Overall Study|Intercurrent Illness|7
2991684|NCT01000025|10294837|P1|Overall Study|Intercurrent Illness|26
2991685|NCT01000025|10294836|P2|Overall Study|Lack of Efficacy|208
2991686|NCT01000025|10294837|P1|Overall Study|Lack of Efficacy|363
2991687|NCT01000025|10294836|P2|Overall Study|Death|13
2991688|NCT01000025|10294837|P1|Overall Study|Death|23
2991689|NCT01000025|10294836|P2|Overall Study|Withdrawal by Subject|8
2991690|NCT01000025|10294837|P1|Overall Study|Withdrawal by Subject|13
2991691|NCT01000025|10294836|P2|Overall Study|Adverse Event|2
2991692|NCT01000025|10294837|P1|Overall Study|Adverse Event|43
2991693|NCT00999921|10294855|P2|Overall Study|Lost to Follow-up|19
2991694|NCT00999921|10294856|P1|Overall Study|Lost to Follow-up|10
2991695|NCT00999908|10294866|P3|Treatment Period 2|Protocol Violation|0
2991696|NCT00999908|10294867|P2|Treatment Period 2|Protocol Violation|0
2991697|NCT00999908|10294868|P1|Treatment Period 2|Protocol Violation|1
2991698|NCT00999908|10294866|P3|Treatment Period 1|Subject withdrew consent|0
2991699|NCT00999908|10294867|P2|Treatment Period 1|Subject withdrew consent|0
2991700|NCT00999908|10294868|P1|Treatment Period 1|Subject withdrew consent|2
2991701|NCT00999804|10294897|P2|Overall Study|Ineligible|0
2991702|NCT00999804|10294898|P1|Overall Study|Ineligible|3
2991703|NCT00999804|10294897|P2|Overall Study|Death|0
2991704|NCT00999804|10294898|P1|Overall Study|Death|1
2991705|NCT00999804|10294897|P2|Overall Study|Withdrawal by Subject|0
2991706|NCT00999804|10294898|P1|Overall Study|Withdrawal by Subject|4
2991707|NCT00999804|10294897|P2|Overall Study|Adverse Event|3
2991708|NCT00999804|10294898|P1|Overall Study|Adverse Event|4
2991709|NCT00999804|10294897|P2|Overall Study|Lack of Efficacy|2
2991710|NCT00999804|10294898|P1|Overall Study|Lack of Efficacy|9
2991711|NCT00999713|10294912|P2|Overall Study|Physician Decision|0
2991712|NCT00999713|10294913|P1|Overall Study|Physician Decision|2
2991713|NCT00999687|10294927|P1|Second Intervention|Lack of Efficacy|1
2991714|NCT00999687|10294927|P1|Second Intervention|Withdrawal by Subject|2
2991715|NCT00999687|10294927|P1|First Intervention|Withdrawal by Subject|1
2991716|NCT00999661|10294934|P1|Overall Study|Not meeting eligibility criteria|9
2991717|NCT00999661|10294934|P1|Overall Study|Withdrawal by Subject|1
2991718|NCT00999661|10294934|P1|Overall Study|Adverse Event|1
2991719|NCT00999661|10294934|P1|Overall Study|Lost to Follow-up|59
2991720|NCT00999596|10294955|P1|Overall Study|Statistical population not required|101
2991721|NCT00999544|10294960|P1|Overall Study|Withdrawal by Subject|1
2991722|NCT00999466|10294996|P3|Main Part|Adverse Event|2
2991723|NCT00999466|10294997|P2|Main Part|Adverse Event|4
2991724|NCT00999466|10294998|P1|Main Part|Adverse Event|0
2991725|NCT00999466|10294996|P3|Main Part|Withdrawal by Subject|2
2991726|NCT00999466|10294997|P2|Main Part|Withdrawal by Subject|0
2991727|NCT00999466|10294998|P1|Main Part|Withdrawal by Subject|0
2991728|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2991729|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
2991730|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2991731|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
2991732|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
2991733|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
2991734|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
2991735|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
2991736|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
2991737|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
2991738|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
2991739|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
2991740|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
2991741|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
2991742|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
2991743|NCT00999167|10295275|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
2991744|NCT00999167|10295276|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
2991745|NCT00999167|10295277|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
2991746|NCT00999167|10295275|P3|Part A: Open Label Safety run-in|Adverse Event|0
2991747|NCT00999167|10295276|P2|Part A: Open Label Safety run-in|Adverse Event|0
2991748|NCT00999167|10295277|P1|Part A: Open Label Safety run-in|Adverse Event|3
2991749|NCT00999167|10295275|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2991750|NCT00999167|10295276|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2991751|NCT00999167|10295277|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
2991752|NCT00998985|10295415|P14|Overall Study|Protocol Violation|0
2991753|NCT00998985|10295416|P13|Overall Study|Protocol Violation|0
2991754|NCT00998985|10295417|P12|Overall Study|Protocol Violation|0
2991755|NCT00998985|10295418|P11|Overall Study|Protocol Violation|0
2991756|NCT00998985|10295419|P10|Overall Study|Protocol Violation|0
2991757|NCT00998985|10295420|P9|Overall Study|Protocol Violation|0
2991758|NCT00998985|10295421|P8|Overall Study|Protocol Violation|0
2991759|NCT00998985|10295422|P7|Overall Study|Protocol Violation|0
2991760|NCT00998985|10295423|P6|Overall Study|Protocol Violation|1
2991761|NCT00998985|10295424|P5|Overall Study|Protocol Violation|0
2991762|NCT00998985|10295425|P4|Overall Study|Protocol Violation|0
2991763|NCT00998985|10295426|P3|Overall Study|Protocol Violation|0
2991764|NCT00998985|10295427|P2|Overall Study|Protocol Violation|0
2991765|NCT00998985|10295428|P1|Overall Study|Protocol Violation|0
2991766|NCT00998985|10295415|P14|Overall Study|Withdrawal by Subject|0
2991767|NCT00998985|10295416|P13|Overall Study|Withdrawal by Subject|0
2991768|NCT00998985|10295417|P12|Overall Study|Withdrawal by Subject|0
2991769|NCT00998985|10295418|P11|Overall Study|Withdrawal by Subject|0
2991770|NCT00998985|10295419|P10|Overall Study|Withdrawal by Subject|0
2991771|NCT00998985|10295420|P9|Overall Study|Withdrawal by Subject|1
2991772|NCT00998985|10295421|P8|Overall Study|Withdrawal by Subject|0
2991773|NCT00998985|10295422|P7|Overall Study|Withdrawal by Subject|0
2991774|NCT00998985|10295423|P6|Overall Study|Withdrawal by Subject|0
2991775|NCT00998985|10295424|P5|Overall Study|Withdrawal by Subject|0
2991776|NCT00998985|10295425|P4|Overall Study|Withdrawal by Subject|0
2991777|NCT00998985|10295426|P3|Overall Study|Withdrawal by Subject|0
2991778|NCT00998985|10295427|P2|Overall Study|Withdrawal by Subject|0
2991779|NCT00998985|10295428|P1|Overall Study|Withdrawal by Subject|0
2991780|NCT00998881|10295496|P2|Overall Study|Personal matter|0
2991781|NCT00998881|10295497|P1|Overall Study|Personal matter|1
2991782|NCT00998881|10295496|P2|Overall Study|Withdrawal by Subject|0
2991783|NCT00998881|10295497|P1|Overall Study|Withdrawal by Subject|1
2991784|NCT00998881|10295496|P2|Overall Study|Physician Decision|0
2991785|NCT00998881|10295497|P1|Overall Study|Physician Decision|3
2991786|NCT00998881|10295496|P2|Overall Study|Lack of Efficacy|0
2991787|NCT00998881|10295497|P1|Overall Study|Lack of Efficacy|1
2991788|NCT00998881|10295496|P2|Overall Study|Adverse Event|2
2991789|NCT00998881|10295497|P1|Overall Study|Adverse Event|2
2991790|NCT00998790|10295516|P1|Overall Study|Withdrawal by Subject|21
2991791|NCT00998764|10295526|P2|Overall Study|Recurrent Episode of vasogenic edema|0
2991792|NCT00998764|10295527|P1|Overall Study|Recurrent Episode of vasogenic edema|1
2991793|NCT00998764|10295526|P2|Overall Study|Other|4
2991794|NCT00998764|10295527|P1|Overall Study|Other|4
2991795|NCT00998764|10295526|P2|Overall Study|Loss of Caregiver|3
2991796|NCT00998764|10295527|P1|Overall Study|Loss of Caregiver|0
2991797|NCT00998764|10295526|P2|Overall Study|Lost to Follow-up|1
2991798|NCT00998764|10295527|P1|Overall Study|Lost to Follow-up|1
2991799|NCT00998764|10295526|P2|Overall Study|Failed to Return|1
2991800|NCT00998764|10295527|P1|Overall Study|Failed to Return|1
2991801|NCT00998764|10295526|P2|Overall Study|Protocol Violation|1
2991802|NCT00998764|10295527|P1|Overall Study|Protocol Violation|0
2991803|NCT00998764|10295526|P2|Overall Study|Discontinuation of Study by Sponsor|217
2991804|NCT00998764|10295527|P1|Overall Study|Discontinuation of Study by Sponsor|164
2991805|NCT00998764|10295526|P2|Overall Study|Death|1
2991806|NCT00998764|10295527|P1|Overall Study|Death|3
2991807|NCT00998764|10295526|P2|Overall Study|Physician Decision|3
2991808|NCT00998764|10295527|P1|Overall Study|Physician Decision|3
2991809|NCT00998764|10295526|P2|Overall Study|Withdrawal by Subject|25
2991810|NCT00998764|10295527|P1|Overall Study|Withdrawal by Subject|19
2991811|NCT00998764|10295526|P2|Overall Study|Adverse Event|12
2991812|NCT00998764|10295527|P1|Overall Study|Adverse Event|17
2991813|NCT00998764|10295526|P2|Overall Study|Lack of Efficacy|6
2991814|NCT00998764|10295527|P1|Overall Study|Lack of Efficacy|3
2991815|NCT00998738|10295549|P1|Overall Study|Uknown|1
2991816|NCT00998400|10295617|P2|Overall Study|Logistical problems|0
2991817|NCT00998400|10295618|P1|Overall Study|Logistical problems|1
2991818|NCT00998400|10295617|P2|Overall Study|Lack of interest/motivation|2
2991819|NCT00998400|10295618|P1|Overall Study|Lack of interest/motivation|1
2991820|NCT00998335|10295663|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
2991821|NCT00998335|10295664|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
2991822|NCT00998309|10295692|P1|Overall Study|Protocol Violation|4
2991823|NCT00998296|10295759|P11|Overall Study|Reason other than those specified above|0
2991824|NCT00998296|10295760|P10|Overall Study|Reason other than those specified above|1
2991825|NCT00998296|10295761|P9|Overall Study|Reason other than those specified above|0
2991826|NCT00998296|10295762|P8|Overall Study|Reason other than those specified above|0
2991827|NCT00998296|10295763|P7|Overall Study|Reason other than those specified above|0
2991828|NCT00998296|10295764|P6|Overall Study|Reason other than those specified above|0
2991829|NCT00998296|10295765|P5|Overall Study|Reason other than those specified above|0
2991830|NCT00998296|10295766|P4|Overall Study|Reason other than those specified above|0
2991831|NCT00998296|10295767|P3|Overall Study|Reason other than those specified above|0
2991832|NCT00998296|10295768|P2|Overall Study|Reason other than those specified above|0
2991833|NCT00998296|10295769|P1|Overall Study|Reason other than those specified above|0
2991834|NCT00998296|10295759|P11|Overall Study|Refused to continue taking trial med.|0
2991835|NCT00998296|10295760|P10|Overall Study|Refused to continue taking trial med.|2
2991836|NCT00998296|10295761|P9|Overall Study|Refused to continue taking trial med.|0
2991837|NCT00998296|10295762|P8|Overall Study|Refused to continue taking trial med.|0
2991838|NCT00998296|10295763|P7|Overall Study|Refused to continue taking trial med.|0
2991839|NCT00998296|10295764|P6|Overall Study|Refused to continue taking trial med.|0
2991840|NCT00998296|10295765|P5|Overall Study|Refused to continue taking trial med.|0
2991841|NCT00998296|10295766|P4|Overall Study|Refused to continue taking trial med.|0
2991842|NCT00998296|10295767|P3|Overall Study|Refused to continue taking trial med.|0
2991843|NCT00998296|10295768|P2|Overall Study|Refused to continue taking trial med.|0
2991844|NCT00998296|10295769|P1|Overall Study|Refused to continue taking trial med.|0
2991845|NCT00998296|10295759|P11|Overall Study|Other adverse event|2
2991846|NCT00998296|10295760|P10|Overall Study|Other adverse event|1
2991847|NCT00998296|10295761|P9|Overall Study|Other adverse event|0
2991848|NCT00998296|10295762|P8|Overall Study|Other adverse event|0
2991849|NCT00998296|10295763|P7|Overall Study|Other adverse event|0
2991850|NCT00998296|10295764|P6|Overall Study|Other adverse event|0
2991851|NCT00998296|10295765|P5|Overall Study|Other adverse event|1
2991852|NCT00998296|10295766|P4|Overall Study|Other adverse event|0
2991853|NCT00998296|10295767|P3|Overall Study|Other adverse event|0
2991854|NCT00998296|10295768|P2|Overall Study|Other adverse event|0
2991855|NCT00998296|10295769|P1|Overall Study|Other adverse event|0
2991856|NCT00998296|10295759|P11|Overall Study|Dose limiting or dose reducing toxicity|0
2991857|NCT00998296|10295760|P10|Overall Study|Dose limiting or dose reducing toxicity|0
2991858|NCT00998296|10295761|P9|Overall Study|Dose limiting or dose reducing toxicity|2
2991859|NCT00998296|10295762|P8|Overall Study|Dose limiting or dose reducing toxicity|2
2991860|NCT00998296|10295763|P7|Overall Study|Dose limiting or dose reducing toxicity|0
2991861|NCT00998296|10295764|P6|Overall Study|Dose limiting or dose reducing toxicity|0
2991862|NCT00998296|10295765|P5|Overall Study|Dose limiting or dose reducing toxicity|1
2991863|NCT00998296|10295766|P4|Overall Study|Dose limiting or dose reducing toxicity|0
2991864|NCT00998296|10295767|P3|Overall Study|Dose limiting or dose reducing toxicity|0
2991865|NCT00998296|10295768|P2|Overall Study|Dose limiting or dose reducing toxicity|0
2991866|NCT00998296|10295769|P1|Overall Study|Dose limiting or dose reducing toxicity|0
2991867|NCT00998296|10295759|P11|Overall Study|Progressive disease|5
2991868|NCT00998296|10295760|P10|Overall Study|Progressive disease|14
2991869|NCT00998296|10295761|P9|Overall Study|Progressive disease|0
2991870|NCT00998296|10295762|P8|Overall Study|Progressive disease|0
2991871|NCT00998296|10295763|P7|Overall Study|Progressive disease|1
2991872|NCT00998296|10295764|P6|Overall Study|Progressive disease|0
2991873|NCT00998296|10295765|P5|Overall Study|Progressive disease|0
2991874|NCT00998296|10295766|P4|Overall Study|Progressive disease|0
2991875|NCT00998296|10295767|P3|Overall Study|Progressive disease|0
2991876|NCT00998296|10295768|P2|Overall Study|Progressive disease|1
2991877|NCT00998296|10295769|P1|Overall Study|Progressive disease|0
2991878|NCT00997984|10295864|P3|Overall Study|Work schedule|2
2991879|NCT00997984|10295865|P2|Overall Study|Work schedule|0
2991880|NCT00997984|10295866|P1|Overall Study|Work schedule|0
2991881|NCT00997984|10295864|P3|Overall Study|Suicidal ideation|1
2991882|NCT00997984|10295865|P2|Overall Study|Suicidal ideation|0
2991883|NCT00997984|10295866|P1|Overall Study|Suicidal ideation|0
2991884|NCT00997984|10295864|P3|Overall Study|Wrong medication dispensed|0
2991885|NCT00997984|10295865|P2|Overall Study|Wrong medication dispensed|1
2991886|NCT00997984|10295866|P1|Overall Study|Wrong medication dispensed|0
2991887|NCT00997984|10295864|P3|Overall Study|non-compliance|3
2991888|NCT00997984|10295865|P2|Overall Study|non-compliance|2
2991889|NCT00997984|10295866|P1|Overall Study|non-compliance|0
2991890|NCT00997984|10295864|P3|Overall Study|Met exclusion criteria|0
2991891|NCT00997984|10295865|P2|Overall Study|Met exclusion criteria|0
2991892|NCT00997984|10295866|P1|Overall Study|Met exclusion criteria|1
2991893|NCT00997984|10295864|P3|Overall Study|Lack of Efficacy|3
2991894|NCT00997984|10295865|P2|Overall Study|Lack of Efficacy|6
2991895|NCT00997984|10295866|P1|Overall Study|Lack of Efficacy|20
2991896|NCT00997984|10295864|P3|Overall Study|Lost to Follow-up|4
2991897|NCT00997984|10295865|P2|Overall Study|Lost to Follow-up|5
2991898|NCT00997984|10295866|P1|Overall Study|Lost to Follow-up|8
2991899|NCT00997984|10295864|P3|Overall Study|Withdrawal by Subject|5
2991900|NCT00997984|10295865|P2|Overall Study|Withdrawal by Subject|9
2991901|NCT00997984|10295866|P1|Overall Study|Withdrawal by Subject|6
2991902|NCT00997984|10295864|P3|Overall Study|Protocol Violation|0
2991903|NCT00997984|10295865|P2|Overall Study|Protocol Violation|3
2991904|NCT00997984|10295866|P1|Overall Study|Protocol Violation|1
2991905|NCT00997984|10295864|P3|Overall Study|Adverse Event|8
2991906|NCT00997984|10295865|P2|Overall Study|Adverse Event|8
2991907|NCT00997984|10295866|P1|Overall Study|Adverse Event|1
2991908|NCT00997503|10296024|P1|Overall Study|Other reason|13
2991909|NCT00997503|10296024|P1|Overall Study|Missed 12-month follow-up|85
2991910|NCT00997503|10296024|P1|Overall Study|Physician Decision|10
2991911|NCT00997503|10296024|P1|Overall Study|Adverse Event|3
2991912|NCT00997503|10296024|P1|Overall Study|Lost to Follow-up|33
2991913|NCT00997503|10296024|P1|Overall Study|Withdrawal by Subject|76
2991914|NCT00997503|10296024|P1|Overall Study|Death|53
2991915|NCT00997438|10296067|P3|Overall Study|Exclusion criteria at visit 1|3
2991916|NCT00997438|10296068|P2|Overall Study|Exclusion criteria at visit 1|2
2991917|NCT00997438|10296069|P1|Overall Study|Exclusion criteria at visit 1|2
2991918|NCT00997438|10296067|P3|Overall Study|Withdrawal by Subject|0
2991919|NCT00997438|10296068|P2|Overall Study|Withdrawal by Subject|1
2991920|NCT00997438|10296069|P1|Overall Study|Withdrawal by Subject|1
2991921|NCT00997438|10296067|P3|Overall Study|Blood draw difficulty|1
2991922|NCT00997438|10296068|P2|Overall Study|Blood draw difficulty|0
2991923|NCT00997438|10296069|P1|Overall Study|Blood draw difficulty|2
2991924|NCT00997386|10296109|P1|Overall Study|Death|7
2991925|NCT00997373|10296118|P2|Overall Study|could not have hysterectomy|0
2991926|NCT00997373|10296119|P1|Overall Study|could not have hysterectomy|6
2991927|NCT00997373|10296118|P2|Overall Study|wrong tumor type|0
2991928|NCT00997373|10296119|P1|Overall Study|wrong tumor type|4
2991929|NCT00997373|10296118|P2|Overall Study|Withdrawal by Subject|0
2991930|NCT00997373|10296119|P1|Overall Study|Withdrawal by Subject|5
2991931|NCT00997334|10296125|P1|Overall Study|Ineligible|1
2991932|NCT00997334|10296125|P1|Overall Study|No lesion amenable|1
2991933|NCT00997334|10296125|P1|Overall Study|Urgent Palliative Care|2
2991934|NCT00997334|10296125|P1|Overall Study|Death|2
2991935|NCT00997334|10296125|P1|Overall Study|Withdrawal by Subject|3
2991936|NCT00997334|10296125|P1|Overall Study|Patient non-compliance|1
2991937|NCT00997334|10296125|P1|Overall Study|Adverse Event|3
2991938|NCT00997334|10296125|P1|Overall Study|still on therapy|12
2991939|NCT00997321|10296134|P2|Overall Study|did not undergo sedation after enrollmen|3
2991940|NCT00997321|10296135|P1|Overall Study|did not undergo sedation after enrollmen|0
2991941|NCT00997243|10296147|P1|Overall Study|Early termination of study by sponsor|7
2991942|NCT00997126|10296179|P2|Overall Study|Physician Decision|11
2991943|NCT00997126|10296180|P1|Overall Study|Physician Decision|7
2991944|NCT00997035|10296209|P2|3-month Follow-up Visit|Lost to Follow-up|6
2991945|NCT00997035|10296210|P1|3-month Follow-up Visit|Lost to Follow-up|12
2991946|NCT00997035|10296209|P2|3-week Followup Visit|Lost to Follow-up|6
2991947|NCT00997035|10296210|P1|3-week Followup Visit|Lost to Follow-up|9
2991948|NCT00996996|10296234|P1|Overall Study|Did Not Receive Study Medications|1
2991949|NCT00996996|10296234|P1|Overall Study|Death|5
2991950|NCT00996996|10296234|P1|Overall Study|Lost to Follow-up|9
2991951|NCT00996996|10296234|P1|Overall Study|Non-compliance|8
2991952|NCT00996996|10296234|P1|Overall Study|Progressive Disease|10
2991953|NCT00996944|10296268|P2|Long-term Treatment Period|Study Closed/Terminated|5
2991954|NCT00996944|10296269|P1|Long-term Treatment Period|Study Closed/Terminated|12
2991955|NCT00996944|10296268|P2|Double-blind Treatment Period|Withdrawal by Subject|1
2991956|NCT00996944|10296269|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2991957|NCT00996944|10296268|P2|Double-blind Treatment Period|Study Closed/Terminated|5
2991958|NCT00996944|10296269|P1|Double-blind Treatment Period|Study Closed/Terminated|6
2991959|NCT00996944|10296268|P2|Double-blind Treatment Period|Protocol Violation|0
2991960|NCT00996944|10296269|P1|Double-blind Treatment Period|Protocol Violation|1
2991961|NCT00996944|10296268|P2|Double-blind Treatment Period|Adverse Event|1
2991962|NCT00996944|10296269|P1|Double-blind Treatment Period|Adverse Event|2
2991963|NCT00996918|10296321|P5|Overall Study|Other|0
2991964|NCT00996918|10296322|P4|Overall Study|Other|0
2991965|NCT00996918|10296323|P3|Overall Study|Other|0
2991966|NCT00996918|10296324|P2|Overall Study|Other|1
2991967|NCT00996918|10296325|P1|Overall Study|Other|3
2991968|NCT00996918|10296321|P5|Overall Study|Loss of Caregiver|0
2991969|NCT00996918|10296322|P4|Overall Study|Loss of Caregiver|0
2991970|NCT00996918|10296323|P3|Overall Study|Loss of Caregiver|0
2991971|NCT00996918|10296324|P2|Overall Study|Loss of Caregiver|1
2991972|NCT00996918|10296325|P1|Overall Study|Loss of Caregiver|0
2991973|NCT00996918|10296321|P5|Overall Study|Discontinuation of Study by Sponsor|2
2991974|NCT00996918|10296322|P4|Overall Study|Discontinuation of Study by Sponsor|45
2991975|NCT00996918|10296323|P3|Overall Study|Discontinuation of Study by Sponsor|30
2991976|NCT00996918|10296324|P2|Overall Study|Discontinuation of Study by Sponsor|54
2991977|NCT00996918|10296325|P1|Overall Study|Discontinuation of Study by Sponsor|31
2991978|NCT00996918|10296321|P5|Overall Study|Physician Decision|0
2991979|NCT00996918|10296322|P4|Overall Study|Physician Decision|0
2991980|NCT00996918|10296323|P3|Overall Study|Physician Decision|0
2991981|NCT00996918|10296324|P2|Overall Study|Physician Decision|0
2991982|NCT00996918|10296325|P1|Overall Study|Physician Decision|1
2991983|NCT00996918|10296321|P5|Overall Study|Withdrawal by Subject|2
2991984|NCT00996918|10296322|P4|Overall Study|Withdrawal by Subject|3
2991985|NCT00996918|10296323|P3|Overall Study|Withdrawal by Subject|3
2991986|NCT00996918|10296324|P2|Overall Study|Withdrawal by Subject|4
2991987|NCT00996918|10296325|P1|Overall Study|Withdrawal by Subject|1
2991988|NCT00996918|10296321|P5|Overall Study|Adverse Event|0
2991989|NCT00996918|10296322|P4|Overall Study|Adverse Event|6
2991990|NCT00996918|10296323|P3|Overall Study|Adverse Event|2
2991991|NCT00996918|10296324|P2|Overall Study|Adverse Event|5
2991992|NCT00996918|10296325|P1|Overall Study|Adverse Event|2
2991993|NCT00996918|10296321|P5|Overall Study|Lack of Efficacy|0
2991994|NCT00996918|10296322|P4|Overall Study|Lack of Efficacy|2
2991995|NCT00996918|10296323|P3|Overall Study|Lack of Efficacy|2
2991996|NCT00996918|10296324|P2|Overall Study|Lack of Efficacy|1
2991997|NCT00996918|10296325|P1|Overall Study|Lack of Efficacy|1
2991998|NCT00996892|10296369|P20|Expansion Stage 2A|Disease Progression|31
2991999|NCT00996892|10296370|P19|Expansion Stage 2A|Disease Progression|0
2992000|NCT00996892|10296371|P18|Expansion Stage 2A|Disease Progression|0
2992001|NCT00996892|10296372|P17|Expansion Stage 2A|Disease Progression|0
2992002|NCT00996892|10296373|P16|Expansion Stage 2A|Disease Progression|0
2992003|NCT00996892|10296374|P15|Expansion Stage 2A|Disease Progression|0
2992004|NCT00996892|10296375|P14|Expansion Stage 2A|Disease Progression|0
2992005|NCT00996892|10296376|P13|Expansion Stage 2A|Disease Progression|0
2992006|NCT00996892|10296377|P12|Expansion Stage 2A|Disease Progression|0
2992007|NCT00996892|10296378|P11|Expansion Stage 2A|Disease Progression|0
2992008|NCT00996892|10296379|P10|Expansion Stage 2A|Disease Progression|0
2992009|NCT00996892|10296380|P9|Expansion Stage 2A|Disease Progression|0
2992010|NCT00996892|10296381|P8|Expansion Stage 2A|Disease Progression|0
2992011|NCT00996892|10296382|P7|Expansion Stage 2A|Disease Progression|0
2992012|NCT00996892|10296383|P6|Expansion Stage 2A|Disease Progression|0
2992013|NCT00996892|10296384|P5|Expansion Stage 2A|Disease Progression|0
2992014|NCT00996892|10296385|P4|Expansion Stage 2A|Disease Progression|0
2992015|NCT00996892|10296386|P3|Expansion Stage 2A|Disease Progression|0
2992016|NCT00996892|10296387|P2|Expansion Stage 2A|Disease Progression|0
2992017|NCT00996892|10296388|P1|Expansion Stage 2A|Disease Progression|0
2992018|NCT00996892|10296369|P20|Expansion Stage 2A|Withdrawal by Subject|4
2992019|NCT00996892|10296370|P19|Expansion Stage 2A|Withdrawal by Subject|0
2992020|NCT00996892|10296371|P18|Expansion Stage 2A|Withdrawal by Subject|0
2992021|NCT00996892|10296372|P17|Expansion Stage 2A|Withdrawal by Subject|0
2992022|NCT00996892|10296373|P16|Expansion Stage 2A|Withdrawal by Subject|0
2992023|NCT00996892|10296374|P15|Expansion Stage 2A|Withdrawal by Subject|0
2992024|NCT00996892|10296375|P14|Expansion Stage 2A|Withdrawal by Subject|0
2992025|NCT00996892|10296376|P13|Expansion Stage 2A|Withdrawal by Subject|0
2992026|NCT00996892|10296377|P12|Expansion Stage 2A|Withdrawal by Subject|0
2992027|NCT00996892|10296378|P11|Expansion Stage 2A|Withdrawal by Subject|0
2992028|NCT00996892|10296379|P10|Expansion Stage 2A|Withdrawal by Subject|0
2992029|NCT00996892|10296380|P9|Expansion Stage 2A|Withdrawal by Subject|0
2992030|NCT00996892|10296381|P8|Expansion Stage 2A|Withdrawal by Subject|0
2992031|NCT00996892|10296382|P7|Expansion Stage 2A|Withdrawal by Subject|0
2992032|NCT00996892|10296383|P6|Expansion Stage 2A|Withdrawal by Subject|0
2992033|NCT00996892|10296384|P5|Expansion Stage 2A|Withdrawal by Subject|0
2992034|NCT00996892|10296385|P4|Expansion Stage 2A|Withdrawal by Subject|0
2992035|NCT00996892|10296386|P3|Expansion Stage 2A|Withdrawal by Subject|0
2992036|NCT00996892|10296387|P2|Expansion Stage 2A|Withdrawal by Subject|0
2992037|NCT00996892|10296388|P1|Expansion Stage 2A|Withdrawal by Subject|0
2992038|NCT00996892|10296369|P20|Expansion Stage 2A|Physician Decision|2
2992039|NCT00996892|10296370|P19|Expansion Stage 2A|Physician Decision|0
2992040|NCT00996892|10296371|P18|Expansion Stage 2A|Physician Decision|0
2992041|NCT00996892|10296372|P17|Expansion Stage 2A|Physician Decision|0
2992042|NCT00996892|10296373|P16|Expansion Stage 2A|Physician Decision|0
2992043|NCT00996892|10296374|P15|Expansion Stage 2A|Physician Decision|0
2992044|NCT00996892|10296375|P14|Expansion Stage 2A|Physician Decision|0
2992045|NCT00996892|10296376|P13|Expansion Stage 2A|Physician Decision|0
2992046|NCT00996892|10296377|P12|Expansion Stage 2A|Physician Decision|0
2992047|NCT00996892|10296378|P11|Expansion Stage 2A|Physician Decision|0
2992048|NCT00996892|10296379|P10|Expansion Stage 2A|Physician Decision|0
2992049|NCT00996892|10296380|P9|Expansion Stage 2A|Physician Decision|0
2992050|NCT00996892|10296381|P8|Expansion Stage 2A|Physician Decision|0
2992051|NCT00996892|10296382|P7|Expansion Stage 2A|Physician Decision|0
2992052|NCT00996892|10296383|P6|Expansion Stage 2A|Physician Decision|0
2992053|NCT00996892|10296384|P5|Expansion Stage 2A|Physician Decision|0
2992054|NCT00996892|10296385|P4|Expansion Stage 2A|Physician Decision|0
2992055|NCT00996892|10296386|P3|Expansion Stage 2A|Physician Decision|0
2992056|NCT00996892|10296387|P2|Expansion Stage 2A|Physician Decision|0
2992057|NCT00996892|10296388|P1|Expansion Stage 2A|Physician Decision|0
2992058|NCT00996892|10296369|P20|Expansion Stage 2A|Adverse Event|8
2992059|NCT00996892|10296370|P19|Expansion Stage 2A|Adverse Event|0
2992060|NCT00996892|10296371|P18|Expansion Stage 2A|Adverse Event|0
2992061|NCT00996892|10296372|P17|Expansion Stage 2A|Adverse Event|0
2992062|NCT00996892|10296373|P16|Expansion Stage 2A|Adverse Event|0
2992063|NCT00996892|10296374|P15|Expansion Stage 2A|Adverse Event|0
2992064|NCT00996892|10296375|P14|Expansion Stage 2A|Adverse Event|0
2992065|NCT00996892|10296376|P13|Expansion Stage 2A|Adverse Event|0
2992066|NCT00996892|10296377|P12|Expansion Stage 2A|Adverse Event|0
2992067|NCT00996892|10296378|P11|Expansion Stage 2A|Adverse Event|0
2992068|NCT00996892|10296379|P10|Expansion Stage 2A|Adverse Event|0
2992069|NCT00996892|10296380|P9|Expansion Stage 2A|Adverse Event|0
2992070|NCT00996892|10296381|P8|Expansion Stage 2A|Adverse Event|0
2992071|NCT00996892|10296382|P7|Expansion Stage 2A|Adverse Event|0
2992072|NCT00996892|10296383|P6|Expansion Stage 2A|Adverse Event|0
2992073|NCT00996892|10296384|P5|Expansion Stage 2A|Adverse Event|0
2992074|NCT00996892|10296385|P4|Expansion Stage 2A|Adverse Event|0
2992075|NCT00996892|10296386|P3|Expansion Stage 2A|Adverse Event|0
2992076|NCT00996892|10296387|P2|Expansion Stage 2A|Adverse Event|0
2992077|NCT00996892|10296388|P1|Expansion Stage 2A|Adverse Event|0
2992078|NCT00996892|10296369|P20|Expansion Stage 2|Disease Progression|0
2992079|NCT00996892|10296370|P19|Expansion Stage 2|Disease Progression|28
2992080|NCT00996892|10296371|P18|Expansion Stage 2|Disease Progression|0
2992081|NCT00996892|10296372|P17|Expansion Stage 2|Disease Progression|0
2992082|NCT00996892|10296373|P16|Expansion Stage 2|Disease Progression|0
2992083|NCT00996892|10296374|P15|Expansion Stage 2|Disease Progression|0
2992084|NCT00996892|10296375|P14|Expansion Stage 2|Disease Progression|0
2992085|NCT00996892|10296376|P13|Expansion Stage 2|Disease Progression|0
2992086|NCT00996892|10296377|P12|Expansion Stage 2|Disease Progression|0
2992087|NCT00996892|10296378|P11|Expansion Stage 2|Disease Progression|0
2992088|NCT00996892|10296379|P10|Expansion Stage 2|Disease Progression|0
2992089|NCT00996892|10296380|P9|Expansion Stage 2|Disease Progression|0
2992090|NCT00996892|10296381|P8|Expansion Stage 2|Disease Progression|0
2992091|NCT00996892|10296382|P7|Expansion Stage 2|Disease Progression|0
2992092|NCT00996892|10296383|P6|Expansion Stage 2|Disease Progression|0
2992093|NCT00996892|10296384|P5|Expansion Stage 2|Disease Progression|0
2992094|NCT00996892|10296385|P4|Expansion Stage 2|Disease Progression|0
2992095|NCT00996892|10296386|P3|Expansion Stage 2|Disease Progression|0
2992096|NCT00996892|10296387|P2|Expansion Stage 2|Disease Progression|0
2992097|NCT00996892|10296388|P1|Expansion Stage 2|Disease Progression|0
2992098|NCT00996892|10296369|P20|Expansion Stage 2|Withdrawal by Subject|0
2992099|NCT00996892|10296370|P19|Expansion Stage 2|Withdrawal by Subject|1
2992100|NCT00996892|10296371|P18|Expansion Stage 2|Withdrawal by Subject|0
2992101|NCT00996892|10296372|P17|Expansion Stage 2|Withdrawal by Subject|0
2992102|NCT00996892|10296373|P16|Expansion Stage 2|Withdrawal by Subject|0
2992103|NCT00996892|10296374|P15|Expansion Stage 2|Withdrawal by Subject|0
2992104|NCT00996892|10296375|P14|Expansion Stage 2|Withdrawal by Subject|0
2992105|NCT00996892|10296376|P13|Expansion Stage 2|Withdrawal by Subject|0
2992106|NCT00996892|10296377|P12|Expansion Stage 2|Withdrawal by Subject|0
2992107|NCT00996892|10296378|P11|Expansion Stage 2|Withdrawal by Subject|0
2992108|NCT00996892|10296379|P10|Expansion Stage 2|Withdrawal by Subject|0
2992109|NCT00996892|10296380|P9|Expansion Stage 2|Withdrawal by Subject|0
2992110|NCT00996892|10296381|P8|Expansion Stage 2|Withdrawal by Subject|0
2992111|NCT00996892|10296382|P7|Expansion Stage 2|Withdrawal by Subject|0
2992112|NCT00996892|10296383|P6|Expansion Stage 2|Withdrawal by Subject|0
2992113|NCT00996892|10296384|P5|Expansion Stage 2|Withdrawal by Subject|0
2992114|NCT00996892|10296385|P4|Expansion Stage 2|Withdrawal by Subject|0
2992115|NCT00996892|10296386|P3|Expansion Stage 2|Withdrawal by Subject|0
2992116|NCT00996892|10296387|P2|Expansion Stage 2|Withdrawal by Subject|0
2992117|NCT00996892|10296388|P1|Expansion Stage 2|Withdrawal by Subject|0
2992118|NCT00996892|10296369|P20|Expansion Stage 2|Physician Decision|0
2992119|NCT00996892|10296370|P19|Expansion Stage 2|Physician Decision|1
2992120|NCT00996892|10296371|P18|Expansion Stage 2|Physician Decision|0
2992121|NCT00996892|10296372|P17|Expansion Stage 2|Physician Decision|0
2992122|NCT00996892|10296373|P16|Expansion Stage 2|Physician Decision|0
2992123|NCT00996892|10296374|P15|Expansion Stage 2|Physician Decision|0
2992124|NCT00996892|10296375|P14|Expansion Stage 2|Physician Decision|0
2992125|NCT00996892|10296376|P13|Expansion Stage 2|Physician Decision|0
2992126|NCT00996892|10296377|P12|Expansion Stage 2|Physician Decision|0
2992127|NCT00996892|10296378|P11|Expansion Stage 2|Physician Decision|0
2992128|NCT00996892|10296379|P10|Expansion Stage 2|Physician Decision|0
2992129|NCT00996892|10296380|P9|Expansion Stage 2|Physician Decision|0
2992130|NCT00996892|10296381|P8|Expansion Stage 2|Physician Decision|0
2992131|NCT00996892|10296382|P7|Expansion Stage 2|Physician Decision|0
2992132|NCT00996892|10296383|P6|Expansion Stage 2|Physician Decision|0
2992133|NCT00996892|10296384|P5|Expansion Stage 2|Physician Decision|0
2992134|NCT00996892|10296385|P4|Expansion Stage 2|Physician Decision|0
2992135|NCT00996892|10296386|P3|Expansion Stage 2|Physician Decision|0
2992136|NCT00996892|10296387|P2|Expansion Stage 2|Physician Decision|0
2992137|NCT00996892|10296388|P1|Expansion Stage 2|Physician Decision|0
2992138|NCT00996892|10296369|P20|Expansion Stage 2|Death|0
2992139|NCT00996892|10296370|P19|Expansion Stage 2|Death|2
2992140|NCT00996892|10296371|P18|Expansion Stage 2|Death|0
2992141|NCT00996892|10296372|P17|Expansion Stage 2|Death|0
2992142|NCT00996892|10296373|P16|Expansion Stage 2|Death|0
2992143|NCT00996892|10296374|P15|Expansion Stage 2|Death|0
2992144|NCT00996892|10296375|P14|Expansion Stage 2|Death|0
2992145|NCT00996892|10296376|P13|Expansion Stage 2|Death|0
2992146|NCT00996892|10296377|P12|Expansion Stage 2|Death|0
2992147|NCT00996892|10296378|P11|Expansion Stage 2|Death|0
2992148|NCT00996892|10296379|P10|Expansion Stage 2|Death|0
2992149|NCT00996892|10296380|P9|Expansion Stage 2|Death|0
2992150|NCT00996892|10296381|P8|Expansion Stage 2|Death|0
2992151|NCT00996892|10296382|P7|Expansion Stage 2|Death|0
2992152|NCT00996892|10296383|P6|Expansion Stage 2|Death|0
2992153|NCT00996892|10296384|P5|Expansion Stage 2|Death|0
2992154|NCT00996892|10296385|P4|Expansion Stage 2|Death|0
2992155|NCT00996892|10296386|P3|Expansion Stage 2|Death|0
2992156|NCT00996892|10296387|P2|Expansion Stage 2|Death|0
2992157|NCT00996892|10296388|P1|Expansion Stage 2|Death|0
2992158|NCT00996892|10296369|P20|Expansion Stage 2|Adverse Event|0
2992159|NCT00996892|10296370|P19|Expansion Stage 2|Adverse Event|3
2992160|NCT00996892|10296371|P18|Expansion Stage 2|Adverse Event|0
2992161|NCT00996892|10296372|P17|Expansion Stage 2|Adverse Event|0
2992162|NCT00996892|10296373|P16|Expansion Stage 2|Adverse Event|0
2992163|NCT00996892|10296374|P15|Expansion Stage 2|Adverse Event|0
2992164|NCT00996892|10296375|P14|Expansion Stage 2|Adverse Event|0
2992165|NCT00996892|10296376|P13|Expansion Stage 2|Adverse Event|0
2992166|NCT00996892|10296377|P12|Expansion Stage 2|Adverse Event|0
2992167|NCT00996892|10296378|P11|Expansion Stage 2|Adverse Event|0
2992168|NCT00996892|10296379|P10|Expansion Stage 2|Adverse Event|0
2992169|NCT00996892|10296380|P9|Expansion Stage 2|Adverse Event|0
2992170|NCT00996892|10296381|P8|Expansion Stage 2|Adverse Event|0
2992171|NCT00996892|10296382|P7|Expansion Stage 2|Adverse Event|0
2992172|NCT00996892|10296383|P6|Expansion Stage 2|Adverse Event|0
2992173|NCT00996892|10296384|P5|Expansion Stage 2|Adverse Event|0
2992174|NCT00996892|10296385|P4|Expansion Stage 2|Adverse Event|0
2992175|NCT00996892|10296386|P3|Expansion Stage 2|Adverse Event|0
2992176|NCT00996892|10296387|P2|Expansion Stage 2|Adverse Event|0
2992177|NCT00996892|10296388|P1|Expansion Stage 2|Adverse Event|0
2992178|NCT00996892|10296369|P20|Dose-Escalation Stage 1B|Disease Progression|0
2992179|NCT00996892|10296370|P19|Dose-Escalation Stage 1B|Disease Progression|0
2992180|NCT00996892|10296371|P18|Dose-Escalation Stage 1B|Disease Progression|3
2992181|NCT00996892|10296372|P17|Dose-Escalation Stage 1B|Disease Progression|3
2992182|NCT00996892|10296373|P16|Dose-Escalation Stage 1B|Disease Progression|3
2992183|NCT00996892|10296374|P15|Dose-Escalation Stage 1B|Disease Progression|4
2992184|NCT00996892|10296375|P14|Dose-Escalation Stage 1B|Disease Progression|0
2992185|NCT00996892|10296376|P13|Dose-Escalation Stage 1B|Disease Progression|0
2992186|NCT00996892|10296377|P12|Dose-Escalation Stage 1B|Disease Progression|0
2992187|NCT00996892|10296378|P11|Dose-Escalation Stage 1B|Disease Progression|0
2992188|NCT00996892|10296379|P10|Dose-Escalation Stage 1B|Disease Progression|0
2992189|NCT00996892|10296380|P9|Dose-Escalation Stage 1B|Disease Progression|0
2992190|NCT00996892|10296381|P8|Dose-Escalation Stage 1B|Disease Progression|0
2992191|NCT00996892|10296382|P7|Dose-Escalation Stage 1B|Disease Progression|0
2992192|NCT00996892|10296383|P6|Dose-Escalation Stage 1B|Disease Progression|0
2992193|NCT00996892|10296384|P5|Dose-Escalation Stage 1B|Disease Progression|0
2992194|NCT00996892|10296385|P4|Dose-Escalation Stage 1B|Disease Progression|0
2992195|NCT00996892|10296386|P3|Dose-Escalation Stage 1B|Disease Progression|0
2992196|NCT00996892|10296387|P2|Dose-Escalation Stage 1B|Disease Progression|0
2992197|NCT00996892|10296388|P1|Dose-Escalation Stage 1B|Disease Progression|0
2992198|NCT00996892|10296369|P20|Dose-Escalation Stage 1B|Physician Decision|0
2992199|NCT00996892|10296370|P19|Dose-Escalation Stage 1B|Physician Decision|0
2992200|NCT00996892|10296371|P18|Dose-Escalation Stage 1B|Physician Decision|2
2992201|NCT00996892|10296372|P17|Dose-Escalation Stage 1B|Physician Decision|0
2992202|NCT00996892|10296373|P16|Dose-Escalation Stage 1B|Physician Decision|0
2992203|NCT00996892|10296374|P15|Dose-Escalation Stage 1B|Physician Decision|0
2992204|NCT00996892|10296375|P14|Dose-Escalation Stage 1B|Physician Decision|0
2992205|NCT00996892|10296376|P13|Dose-Escalation Stage 1B|Physician Decision|0
2992206|NCT00996892|10296377|P12|Dose-Escalation Stage 1B|Physician Decision|0
2992207|NCT00996892|10296378|P11|Dose-Escalation Stage 1B|Physician Decision|0
2992208|NCT00996892|10296379|P10|Dose-Escalation Stage 1B|Physician Decision|0
2992209|NCT00996892|10296380|P9|Dose-Escalation Stage 1B|Physician Decision|0
2992210|NCT00996892|10296381|P8|Dose-Escalation Stage 1B|Physician Decision|0
2992211|NCT00996892|10296382|P7|Dose-Escalation Stage 1B|Physician Decision|0
2992212|NCT00996892|10296383|P6|Dose-Escalation Stage 1B|Physician Decision|0
2992213|NCT00996892|10296384|P5|Dose-Escalation Stage 1B|Physician Decision|0
2992214|NCT00996892|10296385|P4|Dose-Escalation Stage 1B|Physician Decision|0
2992215|NCT00996892|10296386|P3|Dose-Escalation Stage 1B|Physician Decision|0
2992216|NCT00996892|10296387|P2|Dose-Escalation Stage 1B|Physician Decision|0
2992217|NCT00996892|10296388|P1|Dose-Escalation Stage 1B|Physician Decision|0
2992218|NCT00996892|10296369|P20|Dose-Escalation Stage 1A|Disease Progression|0
2992219|NCT00996892|10296370|P19|Dose-Escalation Stage 1A|Disease Progression|0
2992220|NCT00996892|10296371|P18|Dose-Escalation Stage 1A|Disease Progression|0
2992221|NCT00996892|10296372|P17|Dose-Escalation Stage 1A|Disease Progression|0
2992222|NCT00996892|10296373|P16|Dose-Escalation Stage 1A|Disease Progression|0
2992223|NCT00996892|10296374|P15|Dose-Escalation Stage 1A|Disease Progression|0
2992224|NCT00996892|10296375|P14|Dose-Escalation Stage 1A|Disease Progression|4
2992225|NCT00996892|10296376|P13|Dose-Escalation Stage 1A|Disease Progression|6
2992226|NCT00996892|10296377|P12|Dose-Escalation Stage 1A|Disease Progression|7
2992227|NCT00996892|10296378|P11|Dose-Escalation Stage 1A|Disease Progression|5
2992228|NCT00996892|10296379|P10|Dose-Escalation Stage 1A|Disease Progression|1
2992229|NCT00996892|10296380|P9|Dose-Escalation Stage 1A|Disease Progression|3
2992230|NCT00996892|10296381|P8|Dose-Escalation Stage 1A|Disease Progression|2
2992231|NCT00996892|10296382|P7|Dose-Escalation Stage 1A|Disease Progression|0
2992232|NCT00996892|10296383|P6|Dose-Escalation Stage 1A|Disease Progression|0
2992233|NCT00996892|10296384|P5|Dose-Escalation Stage 1A|Disease Progression|0
2992234|NCT00996892|10296385|P4|Dose-Escalation Stage 1A|Disease Progression|0
2992235|NCT00996892|10296386|P3|Dose-Escalation Stage 1A|Disease Progression|0
2992236|NCT00996892|10296387|P2|Dose-Escalation Stage 1A|Disease Progression|0
2992237|NCT00996892|10296388|P1|Dose-Escalation Stage 1A|Disease Progression|0
2992238|NCT00996892|10296369|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992239|NCT00996892|10296370|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992240|NCT00996892|10296371|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992241|NCT00996892|10296372|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992242|NCT00996892|10296373|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992243|NCT00996892|10296374|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992244|NCT00996892|10296375|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992245|NCT00996892|10296376|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2992246|NCT00996892|10296377|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2992247|NCT00996892|10296378|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2992248|NCT00996892|10296379|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2992249|NCT00996892|10296380|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992250|NCT00996892|10296381|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992251|NCT00996892|10296382|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992252|NCT00996892|10296383|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992253|NCT00996892|10296384|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992254|NCT00996892|10296385|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992255|NCT00996892|10296386|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992256|NCT00996892|10296387|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992257|NCT00996892|10296388|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2992258|NCT00996892|10296369|P20|Dose-Escalation Stage 1A|Physician Decision|0
2992259|NCT00996892|10296370|P19|Dose-Escalation Stage 1A|Physician Decision|0
2992260|NCT00996892|10296371|P18|Dose-Escalation Stage 1A|Physician Decision|0
2992261|NCT00996892|10296372|P17|Dose-Escalation Stage 1A|Physician Decision|0
2992262|NCT00996892|10296373|P16|Dose-Escalation Stage 1A|Physician Decision|0
2992263|NCT00996892|10296374|P15|Dose-Escalation Stage 1A|Physician Decision|0
2992264|NCT00996892|10296375|P14|Dose-Escalation Stage 1A|Physician Decision|0
2992265|NCT00996892|10296376|P13|Dose-Escalation Stage 1A|Physician Decision|0
2992266|NCT00996892|10296377|P12|Dose-Escalation Stage 1A|Physician Decision|0
2992267|NCT00996892|10296378|P11|Dose-Escalation Stage 1A|Physician Decision|0
2992268|NCT00996892|10296379|P10|Dose-Escalation Stage 1A|Physician Decision|0
2992269|NCT00996892|10296380|P9|Dose-Escalation Stage 1A|Physician Decision|0
2992270|NCT00996892|10296381|P8|Dose-Escalation Stage 1A|Physician Decision|1
2992271|NCT00996892|10296382|P7|Dose-Escalation Stage 1A|Physician Decision|0
2992272|NCT00996892|10296383|P6|Dose-Escalation Stage 1A|Physician Decision|0
2992273|NCT00996892|10296384|P5|Dose-Escalation Stage 1A|Physician Decision|0
2992274|NCT00996892|10296385|P4|Dose-Escalation Stage 1A|Physician Decision|0
2992275|NCT00996892|10296386|P3|Dose-Escalation Stage 1A|Physician Decision|0
2992276|NCT00996892|10296387|P2|Dose-Escalation Stage 1A|Physician Decision|0
2992277|NCT00996892|10296388|P1|Dose-Escalation Stage 1A|Physician Decision|0
2992278|NCT00996892|10296369|P20|Dose-Escalation Stage 1A|Death|0
2992279|NCT00996892|10296370|P19|Dose-Escalation Stage 1A|Death|0
2992280|NCT00996892|10296371|P18|Dose-Escalation Stage 1A|Death|0
2992281|NCT00996892|10296372|P17|Dose-Escalation Stage 1A|Death|0
2992282|NCT00996892|10296373|P16|Dose-Escalation Stage 1A|Death|0
2992283|NCT00996892|10296374|P15|Dose-Escalation Stage 1A|Death|0
2992284|NCT00996892|10296375|P14|Dose-Escalation Stage 1A|Death|0
2992285|NCT00996892|10296376|P13|Dose-Escalation Stage 1A|Death|1
2992286|NCT00996892|10296377|P12|Dose-Escalation Stage 1A|Death|1
2992287|NCT00996892|10296378|P11|Dose-Escalation Stage 1A|Death|0
2992288|NCT00996892|10296379|P10|Dose-Escalation Stage 1A|Death|2
2992289|NCT00996892|10296380|P9|Dose-Escalation Stage 1A|Death|0
2992290|NCT00996892|10296381|P8|Dose-Escalation Stage 1A|Death|0
2992291|NCT00996892|10296382|P7|Dose-Escalation Stage 1A|Death|0
2992292|NCT00996892|10296383|P6|Dose-Escalation Stage 1A|Death|0
2992293|NCT00996892|10296384|P5|Dose-Escalation Stage 1A|Death|0
2992294|NCT00996892|10296385|P4|Dose-Escalation Stage 1A|Death|0
2992295|NCT00996892|10296386|P3|Dose-Escalation Stage 1A|Death|0
2992296|NCT00996892|10296387|P2|Dose-Escalation Stage 1A|Death|0
2992297|NCT00996892|10296388|P1|Dose-Escalation Stage 1A|Death|0
2992298|NCT00996892|10296369|P20|Dose-Escalation Stage 1A|Adverse Event|0
2992299|NCT00996892|10296370|P19|Dose-Escalation Stage 1A|Adverse Event|0
2992300|NCT00996892|10296371|P18|Dose-Escalation Stage 1A|Adverse Event|0
2992301|NCT00996892|10296372|P17|Dose-Escalation Stage 1A|Adverse Event|0
2992302|NCT00996892|10296373|P16|Dose-Escalation Stage 1A|Adverse Event|0
2992303|NCT00996892|10296374|P15|Dose-Escalation Stage 1A|Adverse Event|0
2992304|NCT00996892|10296375|P14|Dose-Escalation Stage 1A|Adverse Event|1
2992305|NCT00996892|10296376|P13|Dose-Escalation Stage 1A|Adverse Event|0
2992306|NCT00996892|10296377|P12|Dose-Escalation Stage 1A|Adverse Event|0
2992307|NCT00996892|10296378|P11|Dose-Escalation Stage 1A|Adverse Event|1
2992308|NCT00996892|10296379|P10|Dose-Escalation Stage 1A|Adverse Event|0
2992309|NCT00996892|10296380|P9|Dose-Escalation Stage 1A|Adverse Event|0
2992310|NCT00996892|10296381|P8|Dose-Escalation Stage 1A|Adverse Event|0
2992311|NCT00996892|10296382|P7|Dose-Escalation Stage 1A|Adverse Event|0
2992312|NCT00996892|10296383|P6|Dose-Escalation Stage 1A|Adverse Event|0
2992313|NCT00996892|10296384|P5|Dose-Escalation Stage 1A|Adverse Event|0
2992314|NCT00996892|10296385|P4|Dose-Escalation Stage 1A|Adverse Event|0
2992315|NCT00996892|10296386|P3|Dose-Escalation Stage 1A|Adverse Event|0
2992316|NCT00996892|10296387|P2|Dose-Escalation Stage 1A|Adverse Event|0
2992317|NCT00996892|10296388|P1|Dose-Escalation Stage 1A|Adverse Event|0
2992318|NCT00996892|10296369|P20|Dose-Escalation Stage 1|Disease Progression|0
2992319|NCT00996892|10296370|P19|Dose-Escalation Stage 1|Disease Progression|0
2992320|NCT00996892|10296371|P18|Dose-Escalation Stage 1|Disease Progression|0
2992321|NCT00996892|10296372|P17|Dose-Escalation Stage 1|Disease Progression|0
2992322|NCT00996892|10296373|P16|Dose-Escalation Stage 1|Disease Progression|0
2992323|NCT00996892|10296374|P15|Dose-Escalation Stage 1|Disease Progression|0
2992324|NCT00996892|10296375|P14|Dose-Escalation Stage 1|Disease Progression|0
2992325|NCT00996892|10296376|P13|Dose-Escalation Stage 1|Disease Progression|0
2992326|NCT00996892|10296377|P12|Dose-Escalation Stage 1|Disease Progression|0
2992327|NCT00996892|10296378|P11|Dose-Escalation Stage 1|Disease Progression|0
2992328|NCT00996892|10296379|P10|Dose-Escalation Stage 1|Disease Progression|0
2992329|NCT00996892|10296380|P9|Dose-Escalation Stage 1|Disease Progression|0
2992330|NCT00996892|10296381|P8|Dose-Escalation Stage 1|Disease Progression|0
2992331|NCT00996892|10296382|P7|Dose-Escalation Stage 1|Disease Progression|0
2992332|NCT00996892|10296383|P6|Dose-Escalation Stage 1|Disease Progression|7
2992333|NCT00996892|10296384|P5|Dose-Escalation Stage 1|Disease Progression|10
2992334|NCT00996892|10296385|P4|Dose-Escalation Stage 1|Disease Progression|4
2992335|NCT00996892|10296386|P3|Dose-Escalation Stage 1|Disease Progression|3
2992336|NCT00996892|10296387|P2|Dose-Escalation Stage 1|Disease Progression|2
2992337|NCT00996892|10296388|P1|Dose-Escalation Stage 1|Disease Progression|2
2992338|NCT00996892|10296369|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992339|NCT00996892|10296370|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992340|NCT00996892|10296371|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992341|NCT00996892|10296372|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992342|NCT00996892|10296373|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992343|NCT00996892|10296374|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992344|NCT00996892|10296375|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992345|NCT00996892|10296376|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992346|NCT00996892|10296377|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992347|NCT00996892|10296378|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992348|NCT00996892|10296379|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992349|NCT00996892|10296380|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992350|NCT00996892|10296381|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992351|NCT00996892|10296382|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
2992352|NCT00996892|10296383|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
2992353|NCT00996892|10296384|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
2992354|NCT00996892|10296385|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
2992355|NCT00996892|10296386|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992356|NCT00996892|10296387|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
2992357|NCT00996892|10296388|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
2992358|NCT00996892|10296369|P20|Dose-Escalation Stage 1|Physician Decision|0
2992359|NCT00996892|10296370|P19|Dose-Escalation Stage 1|Physician Decision|0
2992360|NCT00996892|10296371|P18|Dose-Escalation Stage 1|Physician Decision|0
2992361|NCT00996892|10296372|P17|Dose-Escalation Stage 1|Physician Decision|0
2992362|NCT00996892|10296373|P16|Dose-Escalation Stage 1|Physician Decision|0
2992363|NCT00996892|10296374|P15|Dose-Escalation Stage 1|Physician Decision|0
2992364|NCT00996892|10296375|P14|Dose-Escalation Stage 1|Physician Decision|0
2992365|NCT00996892|10296376|P13|Dose-Escalation Stage 1|Physician Decision|0
2992366|NCT00996892|10296377|P12|Dose-Escalation Stage 1|Physician Decision|0
2992367|NCT00996892|10296378|P11|Dose-Escalation Stage 1|Physician Decision|0
2992368|NCT00996892|10296379|P10|Dose-Escalation Stage 1|Physician Decision|0
2992369|NCT00996892|10296380|P9|Dose-Escalation Stage 1|Physician Decision|0
2992370|NCT00996892|10296381|P8|Dose-Escalation Stage 1|Physician Decision|0
2992371|NCT00996892|10296382|P7|Dose-Escalation Stage 1|Physician Decision|2
2992372|NCT00996892|10296383|P6|Dose-Escalation Stage 1|Physician Decision|1
2992373|NCT00996892|10296384|P5|Dose-Escalation Stage 1|Physician Decision|0
2992374|NCT00996892|10296385|P4|Dose-Escalation Stage 1|Physician Decision|1
2992375|NCT00996892|10296386|P3|Dose-Escalation Stage 1|Physician Decision|0
2992376|NCT00996892|10296387|P2|Dose-Escalation Stage 1|Physician Decision|0
2992377|NCT00996892|10296388|P1|Dose-Escalation Stage 1|Physician Decision|1
2992378|NCT00996892|10296369|P20|Dose-Escalation Stage 1|Death|0
2992379|NCT00996892|10296370|P19|Dose-Escalation Stage 1|Death|0
2992380|NCT00996892|10296371|P18|Dose-Escalation Stage 1|Death|0
2992381|NCT00996892|10296372|P17|Dose-Escalation Stage 1|Death|0
2992382|NCT00996892|10296373|P16|Dose-Escalation Stage 1|Death|0
2992383|NCT00996892|10296374|P15|Dose-Escalation Stage 1|Death|0
2992384|NCT00996892|10296375|P14|Dose-Escalation Stage 1|Death|0
2992385|NCT00996892|10296376|P13|Dose-Escalation Stage 1|Death|0
2992386|NCT00996892|10296377|P12|Dose-Escalation Stage 1|Death|0
2992387|NCT00996892|10296378|P11|Dose-Escalation Stage 1|Death|0
2992388|NCT00996892|10296379|P10|Dose-Escalation Stage 1|Death|0
2992389|NCT00996892|10296380|P9|Dose-Escalation Stage 1|Death|0
2992390|NCT00996892|10296381|P8|Dose-Escalation Stage 1|Death|0
2992391|NCT00996892|10296382|P7|Dose-Escalation Stage 1|Death|0
2992392|NCT00996892|10296383|P6|Dose-Escalation Stage 1|Death|1
2992393|NCT00996892|10296384|P5|Dose-Escalation Stage 1|Death|0
2992394|NCT00996892|10296385|P4|Dose-Escalation Stage 1|Death|0
2992395|NCT00996892|10296386|P3|Dose-Escalation Stage 1|Death|0
2992396|NCT00996892|10296387|P2|Dose-Escalation Stage 1|Death|0
2992397|NCT00996892|10296388|P1|Dose-Escalation Stage 1|Death|1
2992398|NCT00996892|10296369|P20|Dose-Escalation Stage 1|Adverse Event|0
2992399|NCT00996892|10296370|P19|Dose-Escalation Stage 1|Adverse Event|0
2992400|NCT00996892|10296371|P18|Dose-Escalation Stage 1|Adverse Event|0
2992401|NCT00996892|10296372|P17|Dose-Escalation Stage 1|Adverse Event|0
2992402|NCT00996892|10296373|P16|Dose-Escalation Stage 1|Adverse Event|0
2992403|NCT00996892|10296374|P15|Dose-Escalation Stage 1|Adverse Event|0
2992404|NCT00996892|10296375|P14|Dose-Escalation Stage 1|Adverse Event|0
2992405|NCT00996892|10296376|P13|Dose-Escalation Stage 1|Adverse Event|0
2992406|NCT00996892|10296377|P12|Dose-Escalation Stage 1|Adverse Event|0
2992407|NCT00996892|10296378|P11|Dose-Escalation Stage 1|Adverse Event|0
2992408|NCT00996892|10296379|P10|Dose-Escalation Stage 1|Adverse Event|0
2992409|NCT00996892|10296380|P9|Dose-Escalation Stage 1|Adverse Event|0
2992410|NCT00996892|10296381|P8|Dose-Escalation Stage 1|Adverse Event|0
2992411|NCT00996892|10296382|P7|Dose-Escalation Stage 1|Adverse Event|1
2992412|NCT00996892|10296383|P6|Dose-Escalation Stage 1|Adverse Event|0
2992413|NCT00996892|10296384|P5|Dose-Escalation Stage 1|Adverse Event|0
2992414|NCT00996892|10296385|P4|Dose-Escalation Stage 1|Adverse Event|2
2992415|NCT00996892|10296386|P3|Dose-Escalation Stage 1|Adverse Event|0
2992416|NCT00996892|10296387|P2|Dose-Escalation Stage 1|Adverse Event|0
2992417|NCT00996892|10296388|P1|Dose-Escalation Stage 1|Adverse Event|0
2992418|NCT00996840|10296982|P5|Overall Study|Withdrawal by Subject|0
2992419|NCT00996840|10296983|P4|Overall Study|Withdrawal by Subject|0
2992420|NCT00996840|10296984|P3|Overall Study|Withdrawal by Subject|0
2992421|NCT00996840|10296985|P2|Overall Study|Withdrawal by Subject|1
2992422|NCT00996840|10296986|P1|Overall Study|Withdrawal by Subject|1
2992423|NCT00996840|10296982|P5|Overall Study|Physician Decision|2
2992424|NCT00996840|10296983|P4|Overall Study|Physician Decision|1
2992425|NCT00996840|10296984|P3|Overall Study|Physician Decision|1
2992426|NCT00996840|10296985|P2|Overall Study|Physician Decision|0
2992427|NCT00996840|10296986|P1|Overall Study|Physician Decision|0
2992428|NCT00996840|10296982|P5|Overall Study|Adverse Event|0
2992429|NCT00996840|10296983|P4|Overall Study|Adverse Event|0
2992430|NCT00996840|10296984|P3|Overall Study|Adverse Event|0
2992431|NCT00996840|10296985|P2|Overall Study|Adverse Event|1
2992432|NCT00996840|10296986|P1|Overall Study|Adverse Event|0
2992433|NCT00996801|10297136|P6|Overall Study|Withdrawal by Subject|9
2992434|NCT00996801|10297137|P5|Overall Study|Withdrawal by Subject|5
2992435|NCT00996801|10297138|P4|Overall Study|Withdrawal by Subject|5
2992436|NCT00996801|10297139|P3|Overall Study|Withdrawal by Subject|9
2992437|NCT00996801|10297140|P2|Overall Study|Withdrawal by Subject|6
2992438|NCT00996801|10297141|P1|Overall Study|Withdrawal by Subject|8
2992439|NCT00996801|10297136|P6|Overall Study|Study Terminated by Sponsor|0
2992440|NCT00996801|10297137|P5|Overall Study|Study Terminated by Sponsor|46
2992441|NCT00996801|10297138|P4|Overall Study|Study Terminated by Sponsor|0
2992442|NCT00996801|10297139|P3|Overall Study|Study Terminated by Sponsor|0
2992443|NCT00996801|10297140|P2|Overall Study|Study Terminated by Sponsor|1
2992444|NCT00996801|10297141|P1|Overall Study|Study Terminated by Sponsor|0
2992445|NCT00996801|10297136|P6|Overall Study|Protocol Violation|4
2992446|NCT00996801|10297137|P5|Overall Study|Protocol Violation|3
2992447|NCT00996801|10297138|P4|Overall Study|Protocol Violation|2
2992448|NCT00996801|10297139|P3|Overall Study|Protocol Violation|1
2992449|NCT00996801|10297140|P2|Overall Study|Protocol Violation|4
2992450|NCT00996801|10297141|P1|Overall Study|Protocol Violation|3
2992451|NCT00996801|10297136|P6|Overall Study|Progressive Disease|0
2992452|NCT00996801|10297137|P5|Overall Study|Progressive Disease|0
2992453|NCT00996801|10297138|P4|Overall Study|Progressive Disease|0
2992454|NCT00996801|10297139|P3|Overall Study|Progressive Disease|0
2992455|NCT00996801|10297140|P2|Overall Study|Progressive Disease|1
2992456|NCT00996801|10297141|P1|Overall Study|Progressive Disease|0
2992457|NCT00996801|10297136|P6|Overall Study|Physician Decision|0
2992458|NCT00996801|10297137|P5|Overall Study|Physician Decision|0
2992459|NCT00996801|10297138|P4|Overall Study|Physician Decision|1
2992460|NCT00996801|10297139|P3|Overall Study|Physician Decision|0
2992461|NCT00996801|10297140|P2|Overall Study|Physician Decision|0
2992462|NCT00996801|10297141|P1|Overall Study|Physician Decision|0
2992463|NCT00996801|10297136|P6|Overall Study|Lost to Follow-up|2
2992464|NCT00996801|10297137|P5|Overall Study|Lost to Follow-up|3
2992465|NCT00996801|10297138|P4|Overall Study|Lost to Follow-up|3
2992466|NCT00996801|10297139|P3|Overall Study|Lost to Follow-up|0
2992467|NCT00996801|10297140|P2|Overall Study|Lost to Follow-up|0
2992468|NCT00996801|10297141|P1|Overall Study|Lost to Follow-up|0
2992469|NCT00996801|10297136|P6|Overall Study|Lack of Efficacy|1
2992470|NCT00996801|10297137|P5|Overall Study|Lack of Efficacy|0
2992471|NCT00996801|10297138|P4|Overall Study|Lack of Efficacy|3
2992472|NCT00996801|10297139|P3|Overall Study|Lack of Efficacy|1
2992473|NCT00996801|10297140|P2|Overall Study|Lack of Efficacy|0
2992474|NCT00996801|10297141|P1|Overall Study|Lack of Efficacy|3
2992475|NCT00996801|10297136|P6|Overall Study|Adverse Event|3
2992476|NCT00996801|10297137|P5|Overall Study|Adverse Event|31
2992477|NCT00996801|10297138|P4|Overall Study|Adverse Event|17
2992478|NCT00996801|10297139|P3|Overall Study|Adverse Event|12
2992479|NCT00996801|10297140|P2|Overall Study|Adverse Event|4
2992480|NCT00996801|10297141|P1|Overall Study|Adverse Event|6
2992481|NCT00996736|10297253|P2|Overall Study|Visit not within 3-month window|3
2992482|NCT00996736|10297254|P1|Overall Study|Visit not within 3-month window|5
2992483|NCT00996736|10297253|P2|Overall Study|Lost to Follow-up|14
2992484|NCT00996736|10297254|P1|Overall Study|Lost to Follow-up|15
2992485|NCT00996736|10297253|P2|Overall Study|Death|1
2992486|NCT00996736|10297254|P1|Overall Study|Death|1
2992487|NCT00996658|10297274|P2|Overall Study|Other|7
2992488|NCT00996658|10297275|P1|Overall Study|Other|9
2992489|NCT00996658|10297274|P2|Overall Study|Non-compliance issues|3
2992490|NCT00996658|10297275|P1|Overall Study|Non-compliance issues|3
2992491|NCT00996658|10297274|P2|Overall Study|Lost to Follow-up|5
2992492|NCT00996658|10297275|P1|Overall Study|Lost to Follow-up|2
2992493|NCT00996658|10297274|P2|Overall Study|Protocol Violation|1
2992494|NCT00996658|10297275|P1|Overall Study|Protocol Violation|0
2992495|NCT00996658|10297274|P2|Overall Study|Adverse Event|5
2992496|NCT00996658|10297275|P1|Overall Study|Adverse Event|2
2992497|NCT00996632|10297303|P2|Overall Study|Physician Decision|0
2992498|NCT00996632|10297304|P1|Overall Study|Physician Decision|0
2992499|NCT00996606|10297312|P1|Overall Study|Withdrawal by Subject|3
2992500|NCT00996606|10297312|P1|Overall Study|Protocol Violation|1
2992501|NCT00996606|10297312|P1|Overall Study|Insufficient Therapeutic Response|2
2992502|NCT00996606|10297312|P1|Overall Study|Adverse Event or Intercurrent Illness|2
2992503|NCT00996593|10297406|P1|Long-Term Follow-Up|Site Closed|1
2992504|NCT00996593|10297406|P1|Long-Term Follow-Up|Withdrawal by Subject|2
2992505|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
2992506|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
2992507|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
2992508|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Death|1
2992509|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
2992510|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
2992511|NCT00996593|10297406|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
2992512|NCT00996580|10297434|P1|Overall Study|Other|29
2992513|NCT00996580|10297434|P1|Overall Study|Withdrawal by Subject|217
2992514|NCT00996580|10297434|P1|Overall Study|Sponsor requested participant withdrawal|35
2992515|NCT00996580|10297434|P1|Overall Study|Protocol Violation|16
2992516|NCT00996580|10297434|P1|Overall Study|Pregnancy|68
2992517|NCT00996580|10297434|P1|Overall Study|Physician Decision|5
2992518|NCT00996580|10297434|P1|Overall Study|Noncompliance with the protocol|137
2992519|NCT00996580|10297434|P1|Overall Study|Lost to Follow-up|480
2992520|NCT00996580|10297434|P1|Overall Study|Adverse Event|466
2992521|NCT00996489|10297469|P1|Overall Study|Discontinued|116
2992522|NCT00996489|10297469|P1|Overall Study|Device failure|45
2992523|NCT00996476|10297489|P5|Overall Study|Adverse Event|1
2992524|NCT00996476|10297490|P4|Overall Study|Adverse Event|0
2992525|NCT00996476|10297491|P3|Overall Study|Adverse Event|0
2992526|NCT00996476|10297492|P2|Overall Study|Adverse Event|1
2992527|NCT00996476|10297493|P1|Overall Study|Adverse Event|0
2992528|NCT00996476|10297489|P5|Overall Study|Withdrawal by Subject|1
2992529|NCT00996476|10297490|P4|Overall Study|Withdrawal by Subject|0
2992530|NCT00996476|10297491|P3|Overall Study|Withdrawal by Subject|1
2992531|NCT00996476|10297492|P2|Overall Study|Withdrawal by Subject|2
2992532|NCT00996476|10297493|P1|Overall Study|Withdrawal by Subject|1
2992533|NCT00996437|10297561|P2|Overall Study|Missed|5
2992534|NCT00996437|10297562|P1|Overall Study|Missed|2
2992535|NCT00996437|10297561|P2|Overall Study|Dropped|2
2992536|NCT00996437|10297562|P1|Overall Study|Dropped|2
2992537|NCT00996437|10297561|P2|Overall Study|Death|0
2992538|NCT00996437|10297562|P1|Overall Study|Death|1
2992539|NCT00996333|10297607|P1|Overall Study|Other|5
2992540|NCT00996333|10297607|P1|Overall Study|Physician Decision|1
2992541|NCT00996333|10297607|P1|Overall Study|Adverse Event|1
2992542|NCT00996333|10297607|P1|Overall Study|Death|4
2992543|NCT00996333|10297607|P1|Overall Study|Withdrawal by Subject|1
2992544|NCT00996333|10297607|P1|Overall Study|Screen failure|1
2992545|NCT00996307|10297617|P4|Overall Study|Unable to classify|1
2992546|NCT00996307|10297618|P3|Overall Study|Unable to classify|2
2992547|NCT00996307|10297619|P2|Overall Study|Unable to classify|0
2992548|NCT00996307|10297620|P1|Overall Study|Unable to classify|4
2992549|NCT00996307|10297617|P4|Overall Study|Administrative reason|0
2992550|NCT00996307|10297618|P3|Overall Study|Administrative reason|0
2992551|NCT00996307|10297619|P2|Overall Study|Administrative reason|1
2992552|NCT00996307|10297620|P1|Overall Study|Administrative reason|0
2992553|NCT00996307|10297617|P4|Overall Study|Lost to Follow-up|15
2992554|NCT00996307|10297618|P3|Overall Study|Lost to Follow-up|7
2992555|NCT00996307|10297619|P2|Overall Study|Lost to Follow-up|13
2992556|NCT00996307|10297620|P1|Overall Study|Lost to Follow-up|13
2992557|NCT00996307|10297617|P4|Overall Study|Withdrawal by Subject|5
2992558|NCT00996307|10297618|P3|Overall Study|Withdrawal by Subject|5
2992559|NCT00996307|10297619|P2|Overall Study|Withdrawal by Subject|2
2992560|NCT00996307|10297620|P1|Overall Study|Withdrawal by Subject|3
2992561|NCT00996307|10297617|P4|Overall Study|Adverse Event|0
2992562|NCT00996307|10297618|P3|Overall Study|Adverse Event|0
2992563|NCT00996307|10297619|P2|Overall Study|Adverse Event|1
2992564|NCT00996307|10297620|P1|Overall Study|Adverse Event|0
2992565|NCT00996281|10297680|P2|Overall Study|Other|7
2992566|NCT00996281|10297681|P1|Overall Study|Other|5
2992567|NCT00996281|10297680|P2|Overall Study|Lack of Efficacy|2
2992568|NCT00996281|10297681|P1|Overall Study|Lack of Efficacy|0
2992569|NCT00996281|10297680|P2|Overall Study|Withdrawal by Subject|20
2992570|NCT00996281|10297681|P1|Overall Study|Withdrawal by Subject|31
2992571|NCT00996281|10297680|P2|Overall Study|Lost to Follow-up|16
2992572|NCT00996281|10297681|P1|Overall Study|Lost to Follow-up|14
2992573|NCT00996281|10297680|P2|Overall Study|Major Protocol Deviation|7
2992574|NCT00996281|10297681|P1|Overall Study|Major Protocol Deviation|6
2992575|NCT00996281|10297680|P2|Overall Study|Adverse Event|37
2992576|NCT00996281|10297681|P1|Overall Study|Adverse Event|75
2992577|NCT00996216|10297689|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
2992578|NCT00996216|10297689|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
2992579|NCT00996216|10297689|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
2992580|NCT00996203|10297705|P1|Overall Study|Protocol Violation|2
2992581|NCT00996203|10297705|P1|Overall Study|Lack of Efficacy|1
2992582|NCT00996203|10297705|P1|Overall Study|Lost to Follow-up|1
2992583|NCT00996203|10297705|P1|Overall Study|Adverse Event|3
2992584|NCT00996125|10297737|P2|Overall Study|Withdrawal by Subject|3
2992585|NCT00996125|10297738|P1|Overall Study|Withdrawal by Subject|4
2992586|NCT00996125|10297737|P2|Overall Study|Lost to Follow-up|6
2992587|NCT00996125|10297738|P1|Overall Study|Lost to Follow-up|1
2992588|NCT00996125|10297737|P2|Overall Study|Adverse Event|2
2992589|NCT00996125|10297738|P1|Overall Study|Adverse Event|0
2992590|NCT00996034|10297758|P1|Overall Study|withdrawn by PI|1
2992591|NCT00996034|10297758|P1|Overall Study|Lost to Follow-up|2
2992592|NCT00995930|10297764|P2|Overall Study|Adverse Event|14
2992593|NCT00995930|10297765|P1|Overall Study|Adverse Event|11
2992594|NCT00995930|10297764|P2|Overall Study|Withdrawal by Subject|4
2992595|NCT00995930|10297765|P1|Overall Study|Withdrawal by Subject|3
2992596|NCT00995930|10297764|P2|Overall Study|Lost to Follow-up|2
2992597|NCT00995930|10297765|P1|Overall Study|Lost to Follow-up|1
2992598|NCT00995930|10297764|P2|Overall Study|Administrative problems|2
2992599|NCT00995930|10297765|P1|Overall Study|Administrative problems|4
2992600|NCT00995930|10297764|P2|Overall Study|Death|1
2992601|NCT00995930|10297765|P1|Overall Study|Death|0
2992602|NCT00995930|10297764|P2|Overall Study|Protocol deviation|5
2992603|NCT00995930|10297765|P1|Overall Study|Protocol deviation|2
2992604|NCT00995865|10297816|P3|Overall Study|Lost to Follow-up|1
2992605|NCT00995865|10297817|P2|Overall Study|Lost to Follow-up|0
2992606|NCT00995865|10297818|P1|Overall Study|Lost to Follow-up|0
2992607|NCT00995865|10297816|P3|Overall Study|Protocol Violation|0
2992608|NCT00995865|10297817|P2|Overall Study|Protocol Violation|0
2992609|NCT00995865|10297818|P1|Overall Study|Protocol Violation|2
2992610|NCT00995774|10297840|P2|Training Period 2|Withdrawal by Subject|0
2992611|NCT00995774|10297841|P1|Training Period 2|Withdrawal by Subject|2
2992612|NCT00995709|10297875|P3|Overall Study|Protocol Violation|0
2992613|NCT00995709|10297876|P2|Overall Study|Protocol Violation|1
2992614|NCT00995709|10297877|P1|Overall Study|Protocol Violation|2
2992615|NCT00995709|10297875|P3|Overall Study|Death|0
2992616|NCT00995709|10297876|P2|Overall Study|Death|1
2992617|NCT00995709|10297877|P1|Overall Study|Death|0
2992618|NCT00995709|10297875|P3|Overall Study|Lost to Follow-up|0
2992619|NCT00995709|10297876|P2|Overall Study|Lost to Follow-up|0
2992620|NCT00995709|10297877|P1|Overall Study|Lost to Follow-up|1
2992621|NCT00995709|10297875|P3|Overall Study|Withdrawal by Subject|1
2992622|NCT00995709|10297876|P2|Overall Study|Withdrawal by Subject|4
2992623|NCT00995709|10297877|P1|Overall Study|Withdrawal by Subject|0
2992624|NCT00995709|10297875|P3|Overall Study|Lack of Efficacy|4
2992625|NCT00995709|10297876|P2|Overall Study|Lack of Efficacy|1
2992626|NCT00995709|10297877|P1|Overall Study|Lack of Efficacy|0
2992627|NCT00995709|10297875|P3|Overall Study|Adverse Event|0
2992628|NCT00995709|10297876|P2|Overall Study|Adverse Event|2
2992629|NCT00995709|10297877|P1|Overall Study|Adverse Event|4
2992630|NCT00995670|10297903|P3|Overall Study|Failed arterial cannulation|3
2992631|NCT00995670|10297904|P2|Overall Study|Failed arterial cannulation|0
2992632|NCT00995670|10297905|P1|Overall Study|Failed arterial cannulation|1
2992633|NCT00995566|10297913|P1|Overall Study|Early study termination|52
2992634|NCT00995566|10297913|P1|Overall Study|Adverse Event|2
2992635|NCT00995553|10297927|P2|Overall Study|Withdrawal by Subject|6
2992636|NCT00995553|10297928|P1|Overall Study|Withdrawal by Subject|2
2992637|NCT00995488|10297977|P1|Overall Study|Withdrawal by Subject|1
2992638|NCT00995436|10298011|P3|Overall Study|Withdrawal by Subject|0
2992639|NCT00995436|10298012|P2|Overall Study|Withdrawal by Subject|5
2992640|NCT00995436|10298013|P1|Overall Study|Withdrawal by Subject|2
2992641|NCT00995410|10298021|P1|Overall Study|Misc|28
2992642|NCT00995410|10298021|P1|Overall Study|Lost to Follow-up|2
2992643|NCT00995410|10298021|P1|Overall Study|Withdrawal by Subject|7
2992644|NCT00995410|10298021|P1|Overall Study|Adverse Event|51
2992645|NCT00995371|10298028|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2992646|NCT00995371|10298029|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2992647|NCT00995345|10298047|P5|Overall Study|all other reasons combined|3
2992648|NCT00995345|10298048|P4|Overall Study|all other reasons combined|1
2992649|NCT00995345|10298049|P3|Overall Study|all other reasons combined|2
2992650|NCT00995345|10298050|P2|Overall Study|all other reasons combined|2
2992651|NCT00995345|10298051|P1|Overall Study|all other reasons combined|2
2992652|NCT00995345|10298047|P5|Overall Study|Lost to Follow-up|0
2992653|NCT00995345|10298048|P4|Overall Study|Lost to Follow-up|1
2992654|NCT00995345|10298049|P3|Overall Study|Lost to Follow-up|2
2992655|NCT00995345|10298050|P2|Overall Study|Lost to Follow-up|2
2992656|NCT00995345|10298051|P1|Overall Study|Lost to Follow-up|2
2992657|NCT00995345|10298047|P5|Overall Study|Adverse Event|1
2992658|NCT00995345|10298048|P4|Overall Study|Adverse Event|0
2992659|NCT00995345|10298049|P3|Overall Study|Adverse Event|2
2992660|NCT00995345|10298050|P2|Overall Study|Adverse Event|1
2992661|NCT00995345|10298051|P1|Overall Study|Adverse Event|3
2992662|NCT00995345|10298047|P5|Overall Study|Withdrawal by Subject|1
2992663|NCT00995345|10298048|P4|Overall Study|Withdrawal by Subject|3
2992664|NCT00995345|10298049|P3|Overall Study|Withdrawal by Subject|1
2992665|NCT00995345|10298050|P2|Overall Study|Withdrawal by Subject|2
2992666|NCT00995345|10298051|P1|Overall Study|Withdrawal by Subject|4
2992667|NCT00995085|10298083|P1|Overall Study|Withdrawal by Subject|5
2992668|NCT00995020|10298100|P2|Overall Study|specimen fragmentation, thermal damage|2
2992669|NCT00995020|10298101|P1|Overall Study|specimen fragmentation, thermal damage|1
2992670|NCT00995020|10298100|P2|Overall Study|margin analysis not performed|5
2992671|NCT00995020|10298101|P1|Overall Study|margin analysis not performed|2
2992672|NCT00995007|10298111|P2|Overall Study|Toxicity|0
2992673|NCT00995007|10298112|P1|Overall Study|Toxicity|8
2992674|NCT00995007|10298111|P2|Overall Study|Refused further treatment|2
2992675|NCT00995007|10298112|P1|Overall Study|Refused further treatment|8
2992676|NCT00995007|10298111|P2|Overall Study|Withdrew consent|0
2992677|NCT00995007|10298112|P1|Overall Study|Withdrew consent|1
2992678|NCT00994682|10298175|P2|Pioglitazone Open Label|Physician Decision|1
2992679|NCT00994682|10298176|P1|Pioglitazone Open Label|Physician Decision|6
2992680|NCT00994682|10298175|P2|Pioglitazone Open Label|Lost to Follow-up|2
2992681|NCT00994682|10298176|P1|Pioglitazone Open Label|Lost to Follow-up|3
2992682|NCT00994682|10298175|P2|Pioglitazone Open Label|Withdrawal by Subject|4
2992683|NCT00994682|10298176|P1|Pioglitazone Open Label|Withdrawal by Subject|4
2992684|NCT00994682|10298175|P2|Double Bilnd|Adverse Event|0
2992685|NCT00994682|10298176|P1|Double Bilnd|Adverse Event|1
2992686|NCT00994682|10298175|P2|Double Bilnd|Lost to Follow-up|3
2992687|NCT00994682|10298176|P1|Double Bilnd|Lost to Follow-up|3
2992688|NCT00994682|10298175|P2|Double Bilnd|Withdrawal by Subject|6
2992689|NCT00994682|10298176|P1|Double Bilnd|Withdrawal by Subject|5
2992690|NCT00994643|10298220|P1|Overall Study|Withdrawal by Subject|1
2992691|NCT00994461|10298234|P3|Overall Study|Adverse Event|0
2992692|NCT00994461|10298235|P2|Overall Study|Adverse Event|1
2992693|NCT00994461|10298236|P1|Overall Study|Adverse Event|2
2992694|NCT00994448|10298264|P2|Overall Study|Physician Decision|0
2992695|NCT00994448|10298265|P1|Overall Study|Physician Decision|1
2992696|NCT00994448|10298264|P2|Overall Study|Withdrawal by Subject|1
2992697|NCT00994448|10298265|P1|Overall Study|Withdrawal by Subject|1
2992698|NCT00994448|10298264|P2|Overall Study|Lost to Follow-up|1
2992699|NCT00994448|10298265|P1|Overall Study|Lost to Follow-up|5
2992700|NCT00994448|10298264|P2|Overall Study|Adverse Event|0
2992701|NCT00994448|10298265|P1|Overall Study|Adverse Event|1
2992702|NCT00994422|10298273|P2|Overall Study|Lost to Follow-up|1
2992703|NCT00994422|10298274|P1|Overall Study|Lost to Follow-up|7
2992704|NCT00994279|10298299|P2|Overall Study|Multiple reasons|3
2992705|NCT00994279|10298300|P1|Overall Study|Multiple reasons|1
2992706|NCT00994279|10298299|P2|Overall Study|Toxicity|0
2992707|NCT00994279|10298300|P1|Overall Study|Toxicity|1
2992708|NCT00994279|10298299|P2|Overall Study|Withdrawal by Subject|2
2992709|NCT00994279|10298300|P1|Overall Study|Withdrawal by Subject|2
2992710|NCT00994240|10298310|P2|Overall Study|study termination|3
2992711|NCT00994240|10298311|P1|Overall Study|study termination|2
2992712|NCT00994240|10298310|P2|Overall Study|Withdrawal by Subject|0
2992713|NCT00994240|10298311|P1|Overall Study|Withdrawal by Subject|1
2992714|NCT00994240|10298310|P2|Overall Study|Lost to Follow-up|2
2992715|NCT00994240|10298311|P1|Overall Study|Lost to Follow-up|3
2992716|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2992717|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2992718|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
2992719|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
2992720|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
2992721|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2992722|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2992723|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2992724|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
2992725|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2992726|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
2992727|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2992728|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2992729|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2992730|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2992731|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
2992732|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
2992733|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2992734|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2992735|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2992736|NCT00994214|10298321|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2992737|NCT00994214|10298322|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2992738|NCT00994214|10298323|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
2992739|NCT00994214|10298324|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2992740|NCT00994110|10298403|P2|Overall Study|Pt not eligible|5
2992741|NCT00994110|10298404|P1|Overall Study|Pt not eligible|10
2992742|NCT00994110|10298403|P2|Overall Study|Patient not resected|52
2992743|NCT00994110|10298404|P1|Overall Study|Patient not resected|41
2992744|NCT00994110|10298403|P2|Overall Study|Adverse Event|0
2992745|NCT00994110|10298404|P1|Overall Study|Adverse Event|1
2992746|NCT00994110|10298403|P2|Overall Study|Not Treated|8
2992747|NCT00994110|10298404|P1|Overall Study|Not Treated|4
2992748|NCT00994110|10298403|P2|Overall Study|Withdrawal by Subject|9
2992749|NCT00994110|10298404|P1|Overall Study|Withdrawal by Subject|9
2992750|NCT00993967|10298410|P1|Overall Study|Protocol Violation|2
2992751|NCT00993967|10298410|P1|Overall Study|Withdrawal by Subject|36
2992752|NCT00993967|10298410|P1|Overall Study|Lost to Follow-up|14
2992753|NCT00993967|10298410|P1|Overall Study|Death|1
2992754|NCT00993967|10298410|P1|Overall Study|Adverse Event|8
2992755|NCT00993954|10298417|P2|Overall Study|Protocol Violation|2
2992756|NCT00993954|10298418|P1|Overall Study|Protocol Violation|21
2992757|NCT00993928|10298431|P2|Overall Study|ineligible|0
2992758|NCT00993928|10298432|P1|Overall Study|ineligible|1
2992759|NCT00993928|10298431|P2|Overall Study|Withdrawal by Subject|7
2992760|NCT00993928|10298432|P1|Overall Study|Withdrawal by Subject|4
2992761|NCT00993915|10298446|P1|Overall Study|Ongoing|3
2992762|NCT00993915|10298446|P1|Overall Study|Other|1
2992763|NCT00993915|10298446|P1|Overall Study|Withdrawal by Subject|2
2992764|NCT00993915|10298446|P1|Overall Study|Insufficient clinical response|3
2992765|NCT00993668|10298472|P2|Open-Label Period|Lost to Follow-up|1
2992766|NCT00993668|10298473|P1|Open-Label Period|Lost to Follow-up|6
2992767|NCT00993668|10298472|P2|Open-Label Period|Withdrawal by Subject|3
2992768|NCT00993668|10298473|P1|Open-Label Period|Withdrawal by Subject|4
2992769|NCT00993668|10298472|P2|Open-Label Period|Lack of Efficacy|3
2992770|NCT00993668|10298473|P1|Open-Label Period|Lack of Efficacy|4
2992771|NCT00993668|10298472|P2|Open-Label Period|Adverse Event|8
2992772|NCT00993668|10298473|P1|Open-Label Period|Adverse Event|9
2992773|NCT00993668|10298472|P2|Single-Blind Period|Lost to Follow-up|1
2992774|NCT00993668|10298473|P1|Single-Blind Period|Lost to Follow-up|3
2992775|NCT00993668|10298472|P2|Single-Blind Period|Lack of Efficacy|1
2992776|NCT00993668|10298473|P1|Single-Blind Period|Lack of Efficacy|0
2992777|NCT00993668|10298472|P2|Single-Blind Period|Adverse Event|1
2992778|NCT00993668|10298473|P1|Single-Blind Period|Adverse Event|1
2992779|NCT00993616|10298517|P1|Overall Study|Never treated|1
2992780|NCT00993616|10298517|P1|Overall Study|No tumor at entry|1
2992781|NCT00993499|10298535|P6|Discontinued After Starting Course 3|Other adverse event|0
2992782|NCT00993499|10298536|P5|Discontinued After Starting Course 3|Other adverse event|0
2992783|NCT00993499|10298537|P4|Discontinued After Starting Course 3|Other adverse event|0
2992784|NCT00993499|10298538|P3|Discontinued After Starting Course 3|Other adverse event|1
2992785|NCT00993499|10298539|P2|Discontinued After Starting Course 3|Other adverse event|0
2992786|NCT00993499|10298540|P1|Discontinued After Starting Course 3|Other adverse event|1
2992787|NCT00993499|10298535|P6|Discontinued After Starting Course 3|DLT|0
2992788|NCT00993499|10298536|P5|Discontinued After Starting Course 3|DLT|0
2992789|NCT00993499|10298537|P4|Discontinued After Starting Course 3|DLT|1
2992790|NCT00993499|10298538|P3|Discontinued After Starting Course 3|DLT|2
2992791|NCT00993499|10298539|P2|Discontinued After Starting Course 3|DLT|0
2992792|NCT00993499|10298540|P1|Discontinued After Starting Course 3|DLT|1
2992793|NCT00993499|10298535|P6|Discontinued After Starting Course 3|Progressive Disease|3
2992794|NCT00993499|10298536|P5|Discontinued After Starting Course 3|Progressive Disease|3
2992795|NCT00993499|10298537|P4|Discontinued After Starting Course 3|Progressive Disease|1
2992796|NCT00993499|10298538|P3|Discontinued After Starting Course 3|Progressive Disease|3
2992797|NCT00993499|10298539|P2|Discontinued After Starting Course 3|Progressive Disease|4
2992798|NCT00993499|10298540|P1|Discontinued After Starting Course 3|Progressive Disease|6
2992799|NCT00993499|10298535|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
2992800|NCT00993499|10298536|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
2992801|NCT00993499|10298537|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
2992802|NCT00993499|10298538|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
2992803|NCT00993499|10298539|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
2992804|NCT00993499|10298540|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
2992805|NCT00993499|10298535|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2992806|NCT00993499|10298536|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2992807|NCT00993499|10298537|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2992808|NCT00993499|10298538|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
2992809|NCT00993499|10298539|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2992810|NCT00993499|10298540|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2992811|NCT00993499|10298535|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2992812|NCT00993499|10298536|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2992813|NCT00993499|10298537|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2992814|NCT00993499|10298538|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2992815|NCT00993499|10298539|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2992816|NCT00993499|10298540|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2992817|NCT00993499|10298535|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2992818|NCT00993499|10298536|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2992819|NCT00993499|10298537|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2992820|NCT00993499|10298538|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2992821|NCT00993499|10298539|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2992822|NCT00993499|10298540|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2992823|NCT00993499|10298535|P6|Discontinued Before Starting Course 3|Progressive Disease|0
2992824|NCT00993499|10298536|P5|Discontinued Before Starting Course 3|Progressive Disease|0
2992825|NCT00993499|10298537|P4|Discontinued Before Starting Course 3|Progressive Disease|0
2992826|NCT00993499|10298538|P3|Discontinued Before Starting Course 3|Progressive Disease|0
2992827|NCT00993499|10298539|P2|Discontinued Before Starting Course 3|Progressive Disease|2
2992828|NCT00993499|10298540|P1|Discontinued Before Starting Course 3|Progressive Disease|2
2992829|NCT00993499|10298535|P6|Run-in Period (8 Days)|Progressive disease|0
2992830|NCT00993499|10298536|P5|Run-in Period (8 Days)|Progressive disease|0
2992831|NCT00993499|10298537|P4|Run-in Period (8 Days)|Progressive disease|0
2992832|NCT00993499|10298538|P3|Run-in Period (8 Days)|Progressive disease|1
2992833|NCT00993499|10298539|P2|Run-in Period (8 Days)|Progressive disease|1
2992834|NCT00993499|10298540|P1|Run-in Period (8 Days)|Progressive disease|0
2992835|NCT00993499|10298535|P6|Run-in Period (8 Days)|Consent withdrawn|0
2992836|NCT00993499|10298536|P5|Run-in Period (8 Days)|Consent withdrawn|0
2992837|NCT00993499|10298537|P4|Run-in Period (8 Days)|Consent withdrawn|0
2992838|NCT00993499|10298538|P3|Run-in Period (8 Days)|Consent withdrawn|0
2992839|NCT00993499|10298539|P2|Run-in Period (8 Days)|Consent withdrawn|1
2992840|NCT00993499|10298540|P1|Run-in Period (8 Days)|Consent withdrawn|0
2992841|NCT00993499|10298535|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2992842|NCT00993499|10298536|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2992843|NCT00993499|10298537|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2992844|NCT00993499|10298538|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2992845|NCT00993499|10298539|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2992846|NCT00993499|10298540|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
2992847|NCT00993499|10298535|P6|Run-in Period (8 Days)|Adverse Event|0
2992848|NCT00993499|10298536|P5|Run-in Period (8 Days)|Adverse Event|0
2992849|NCT00993499|10298537|P4|Run-in Period (8 Days)|Adverse Event|0
2992850|NCT00993499|10298538|P3|Run-in Period (8 Days)|Adverse Event|0
2992851|NCT00993499|10298539|P2|Run-in Period (8 Days)|Adverse Event|1
2992852|NCT00993499|10298540|P1|Run-in Period (8 Days)|Adverse Event|0
2992853|NCT00993473|10298622|P2|Overall Study|Family event|0
2992854|NCT00993473|10298623|P1|Overall Study|Family event|1
2992855|NCT00993473|10298622|P2|Overall Study|Technical problem with CGM device|1
2992856|NCT00993473|10298623|P1|Overall Study|Technical problem with CGM device|0
2992857|NCT00993473|10298622|P2|Overall Study|Withdrawal by Subject|5
2992858|NCT00993473|10298623|P1|Overall Study|Withdrawal by Subject|1
2992859|NCT00993473|10298622|P2|Overall Study|Lost to Follow-up|0
2992860|NCT00993473|10298623|P1|Overall Study|Lost to Follow-up|1
2992861|NCT00993473|10298622|P2|Overall Study|Protocol Violation|2
2992862|NCT00993473|10298623|P1|Overall Study|Protocol Violation|1
2992863|NCT00993473|10298622|P2|Overall Study|Adverse Event|2
2992864|NCT00993473|10298623|P1|Overall Study|Adverse Event|0
2992865|NCT00993447|10298661|P2|Overall Study|Adverse Event|0
2992866|NCT00993447|10298662|P1|Overall Study|Adverse Event|1
2992867|NCT00993447|10298661|P2|Overall Study|Lost to Follow-up|3
2992868|NCT00993447|10298662|P1|Overall Study|Lost to Follow-up|1
2992869|NCT00993447|10298661|P2|Overall Study|Protocol Violation|8
2992870|NCT00993447|10298662|P1|Overall Study|Protocol Violation|12
2992871|NCT00993447|10298661|P2|Overall Study|Withdrawal by Subject|8
2992872|NCT00993447|10298662|P1|Overall Study|Withdrawal by Subject|23
2992873|NCT00993421|10298699|P7|Overall Study|Protocol Violation|1
2992874|NCT00993421|10298700|P6|Overall Study|Protocol Violation|2
2992875|NCT00993421|10298701|P5|Overall Study|Protocol Violation|0
2992876|NCT00993421|10298702|P4|Overall Study|Protocol Violation|0
2992877|NCT00993421|10298703|P3|Overall Study|Protocol Violation|0
2992878|NCT00993421|10298704|P2|Overall Study|Protocol Violation|0
2992879|NCT00993421|10298705|P1|Overall Study|Protocol Violation|0
2992880|NCT00993421|10298699|P7|Overall Study|Physician Decision|1
2992881|NCT00993421|10298700|P6|Overall Study|Physician Decision|1
2992882|NCT00993421|10298701|P5|Overall Study|Physician Decision|0
2992883|NCT00993421|10298702|P4|Overall Study|Physician Decision|0
2992884|NCT00993421|10298703|P3|Overall Study|Physician Decision|0
2992885|NCT00993421|10298704|P2|Overall Study|Physician Decision|0
2992886|NCT00993421|10298705|P1|Overall Study|Physician Decision|0
2992887|NCT00993421|10298699|P7|Overall Study|Entry Criteria Exclusion|0
2992888|NCT00993421|10298700|P6|Overall Study|Entry Criteria Exclusion|1
2992889|NCT00993421|10298701|P5|Overall Study|Entry Criteria Exclusion|0
2992890|NCT00993421|10298702|P4|Overall Study|Entry Criteria Exclusion|3
2992891|NCT00993421|10298703|P3|Overall Study|Entry Criteria Exclusion|1
2992892|NCT00993421|10298704|P2|Overall Study|Entry Criteria Exclusion|0
2992893|NCT00993421|10298705|P1|Overall Study|Entry Criteria Exclusion|0
2992894|NCT00993421|10298699|P7|Overall Study|Death|1
2992895|NCT00993421|10298700|P6|Overall Study|Death|0
2992896|NCT00993421|10298701|P5|Overall Study|Death|0
2992897|NCT00993421|10298702|P4|Overall Study|Death|0
2992898|NCT00993421|10298703|P3|Overall Study|Death|0
2992899|NCT00993421|10298704|P2|Overall Study|Death|0
2992900|NCT00993421|10298705|P1|Overall Study|Death|0
2992901|NCT00993421|10298699|P7|Overall Study|Withdrawal by Subject|3
2992902|NCT00993421|10298700|P6|Overall Study|Withdrawal by Subject|5
2992903|NCT00993421|10298701|P5|Overall Study|Withdrawal by Subject|3
2992904|NCT00993421|10298702|P4|Overall Study|Withdrawal by Subject|3
2992905|NCT00993421|10298703|P3|Overall Study|Withdrawal by Subject|3
2992906|NCT00993421|10298704|P2|Overall Study|Withdrawal by Subject|2
2992907|NCT00993421|10298705|P1|Overall Study|Withdrawal by Subject|3
2992908|NCT00993421|10298699|P7|Overall Study|Lost to Follow-up|6
2992909|NCT00993421|10298700|P6|Overall Study|Lost to Follow-up|0
2992910|NCT00993421|10298701|P5|Overall Study|Lost to Follow-up|0
2992911|NCT00993421|10298702|P4|Overall Study|Lost to Follow-up|0
2992912|NCT00993421|10298703|P3|Overall Study|Lost to Follow-up|5
2992913|NCT00993421|10298704|P2|Overall Study|Lost to Follow-up|5
2992914|NCT00993421|10298705|P1|Overall Study|Lost to Follow-up|3
2992915|NCT00993421|10298699|P7|Overall Study|Sponsor Decision|29
2992916|NCT00993421|10298700|P6|Overall Study|Sponsor Decision|30
2992917|NCT00993421|10298701|P5|Overall Study|Sponsor Decision|38
2992918|NCT00993421|10298702|P4|Overall Study|Sponsor Decision|30
2992919|NCT00993421|10298703|P3|Overall Study|Sponsor Decision|28
2992920|NCT00993421|10298704|P2|Overall Study|Sponsor Decision|31
2992921|NCT00993421|10298705|P1|Overall Study|Sponsor Decision|36
2992922|NCT00993421|10298699|P7|Overall Study|Adverse Event|1
2992923|NCT00993421|10298700|P6|Overall Study|Adverse Event|7
2992924|NCT00993421|10298701|P5|Overall Study|Adverse Event|5
2992925|NCT00993421|10298702|P4|Overall Study|Adverse Event|9
2992926|NCT00993421|10298703|P3|Overall Study|Adverse Event|6
2992927|NCT00993421|10298704|P2|Overall Study|Adverse Event|7
2992928|NCT00993421|10298705|P1|Overall Study|Adverse Event|2
2992929|NCT00993317|10298856|P2|Overall Study|Early study termination at the site|0
2992930|NCT00993317|10298857|P1|Overall Study|Early study termination at the site|1
2992931|NCT00993317|10298856|P2|Overall Study|Investigator's opinion|1
2992932|NCT00993317|10298857|P1|Overall Study|Investigator's opinion|0
2992933|NCT00993317|10298856|P2|Overall Study|Withdrawal by Subject|2
2992934|NCT00993317|10298857|P1|Overall Study|Withdrawal by Subject|0
2992935|NCT00993317|10298856|P2|Overall Study|Lack of Efficacy|18
2992936|NCT00993317|10298857|P1|Overall Study|Lack of Efficacy|18
2992937|NCT00993317|10298856|P2|Overall Study|Adverse Event|4
2992938|NCT00993317|10298857|P1|Overall Study|Adverse Event|2
2992939|NCT00993291|10298875|P1|Overall Study|Withdrawal by Subject|1
2992940|NCT00993265|10298881|P2|Overall Study|Non-compliant with study medication|0
2992941|NCT00993265|10298882|P1|Overall Study|Non-compliant with study medication|1
2992942|NCT00993265|10298881|P2|Overall Study|Changed dose of concomitant drug|0
2992943|NCT00993265|10298882|P1|Overall Study|Changed dose of concomitant drug|2
2992944|NCT00993265|10298881|P2|Overall Study|Adverse Event|0
2992945|NCT00993265|10298882|P1|Overall Study|Adverse Event|1
2992946|NCT00993148|10298934|P1|Overall Study|never initiated treatment|1
2992947|NCT00993148|10298934|P1|Overall Study|Lost to Follow-up|2
2992948|NCT00993044|10298946|P1|Irinotecan 50 mg|Physician Decision|1
2992949|NCT00993031|10298953|P2|Overall Study|Lost to Follow-up|13
2992950|NCT00993031|10298954|P1|Overall Study|Lost to Follow-up|19
2992951|NCT00993031|10298953|P2|Overall Study|Withdrawal by Subject|3
2992952|NCT00993031|10298954|P1|Overall Study|Withdrawal by Subject|3
2992953|NCT00993031|10298953|P2|Overall Study|Physician Decision|2
2992954|NCT00993031|10298954|P1|Overall Study|Physician Decision|0
2992955|NCT00993031|10298953|P2|Overall Study|Death|1
2992956|NCT00993031|10298954|P1|Overall Study|Death|0
2992957|NCT00992992|10298986|P1|Overall Study|Sponsor Closed the Study|4
2992958|NCT00992992|10298986|P1|Overall Study|GlaxoSmithKline Closed the Study|2
2992959|NCT00992992|10298986|P1|Overall Study|Death|16
2992960|NCT00992992|10298986|P1|Overall Study|Lost to Follow-up|3
2992961|NCT00992836|10299017|P1|Overall Study|Protocol Violation|2
2992962|NCT00992836|10299017|P1|Overall Study|Withdrawal by Subject|2
2992963|NCT00992836|10299017|P1|Overall Study|Lost to Follow-up|1
2992964|NCT00992784|10299032|P3|Overall Study|Withdrawal by Subject|1
2992965|NCT00992784|10299033|P2|Overall Study|Withdrawal by Subject|1
2992966|NCT00992784|10299034|P1|Overall Study|Withdrawal by Subject|1
2992967|NCT00992784|10299032|P3|Overall Study|Adverse Event|0
2992968|NCT00992784|10299033|P2|Overall Study|Adverse Event|1
2992969|NCT00992784|10299034|P1|Overall Study|Adverse Event|2
2992970|NCT00992589|10299146|P4|Double-Blind Phase|Other|3
2992971|NCT00992589|10299147|P3|Double-Blind Phase|Other|6
2992972|NCT00992589|10299148|P2|Double-Blind Phase|Other|1
2992973|NCT00992589|10299149|P1|Double-Blind Phase|Other|0
2992974|NCT00992589|10299146|P4|Double-Blind Phase|Lost to Follow-up|2
2992975|NCT00992589|10299147|P3|Double-Blind Phase|Lost to Follow-up|0
2992976|NCT00992589|10299148|P2|Double-Blind Phase|Lost to Follow-up|0
2992977|NCT00992589|10299149|P1|Double-Blind Phase|Lost to Follow-up|0
2992978|NCT00992589|10299146|P4|Double-Blind Phase|Withdrawal by Subject|2
2992979|NCT00992589|10299147|P3|Double-Blind Phase|Withdrawal by Subject|5
2992980|NCT00992589|10299148|P2|Double-Blind Phase|Withdrawal by Subject|6
2992981|NCT00992589|10299149|P1|Double-Blind Phase|Withdrawal by Subject|0
2992982|NCT00992589|10299146|P4|Double-Blind Phase|Adverse Event|3
2992983|NCT00992589|10299147|P3|Double-Blind Phase|Adverse Event|2
2992984|NCT00992589|10299148|P2|Double-Blind Phase|Adverse Event|6
2992985|NCT00992589|10299149|P1|Double-Blind Phase|Adverse Event|0
2992986|NCT00992589|10299146|P4|Open-Label Phase|Other|0
2992987|NCT00992589|10299147|P3|Open-Label Phase|Other|0
2992988|NCT00992589|10299148|P2|Open-Label Phase|Other|0
2992989|NCT00992589|10299149|P1|Open-Label Phase|Other|45
2992990|NCT00992589|10299146|P4|Open-Label Phase|Physician Decision|0
2992991|NCT00992589|10299147|P3|Open-Label Phase|Physician Decision|0
2992992|NCT00992589|10299148|P2|Open-Label Phase|Physician Decision|0
2992993|NCT00992589|10299149|P1|Open-Label Phase|Physician Decision|4
2992994|NCT00992589|10299146|P4|Open-Label Phase|Protocol Violation|0
2992995|NCT00992589|10299147|P3|Open-Label Phase|Protocol Violation|0
2992996|NCT00992589|10299148|P2|Open-Label Phase|Protocol Violation|0
2992997|NCT00992589|10299149|P1|Open-Label Phase|Protocol Violation|3
2992998|NCT00992589|10299146|P4|Open-Label Phase|Lost to Follow-up|0
2992999|NCT00992589|10299147|P3|Open-Label Phase|Lost to Follow-up|0
2993000|NCT00992589|10299148|P2|Open-Label Phase|Lost to Follow-up|0
2993001|NCT00992589|10299149|P1|Open-Label Phase|Lost to Follow-up|1
2993002|NCT00992589|10299146|P4|Open-Label Phase|Withdrawal by Subject|0
2993003|NCT00992589|10299147|P3|Open-Label Phase|Withdrawal by Subject|0
2993004|NCT00992589|10299148|P2|Open-Label Phase|Withdrawal by Subject|0
2993005|NCT00992589|10299149|P1|Open-Label Phase|Withdrawal by Subject|20
2993006|NCT00992589|10299146|P4|Open-Label Phase|Adverse Event|0
2993007|NCT00992589|10299147|P3|Open-Label Phase|Adverse Event|0
2993008|NCT00992589|10299148|P2|Open-Label Phase|Adverse Event|0
2993009|NCT00992589|10299149|P1|Open-Label Phase|Adverse Event|4
2993010|NCT00992511|10299195|P4|Overall Study|Withdrawal by Subject|1
2993011|NCT00992511|10299196|P3|Overall Study|Withdrawal by Subject|1
2993012|NCT00992511|10299197|P2|Overall Study|Withdrawal by Subject|0
2993013|NCT00992511|10299198|P1|Overall Study|Withdrawal by Subject|0
2993014|NCT00992511|10299195|P4|Overall Study|Lost to Follow-up|2
2993015|NCT00992511|10299196|P3|Overall Study|Lost to Follow-up|0
2993016|NCT00992511|10299197|P2|Overall Study|Lost to Follow-up|0
2993017|NCT00992511|10299198|P1|Overall Study|Lost to Follow-up|1
2993018|NCT00992511|10299195|P4|Overall Study|Migrated/moved from study area|2
2993019|NCT00992511|10299196|P3|Overall Study|Migrated/moved from study area|1
2993020|NCT00992511|10299197|P2|Overall Study|Migrated/moved from study area|0
2993021|NCT00992511|10299198|P1|Overall Study|Migrated/moved from study area|1
2993022|NCT00992459|10299282|P2|Overall Study|Adverse Event|0
2993023|NCT00992459|10299283|P1|Overall Study|Adverse Event|1
2993024|NCT00992459|10299282|P2|Overall Study|Withdrawal by Subject|1
2993025|NCT00992459|10299283|P1|Overall Study|Withdrawal by Subject|0
2993026|NCT00992446|10299307|P1|Overall Study|Maintenance Therapy Screen Fail|5
2993027|NCT00992446|10299307|P1|Overall Study|Withdrawal by Subject|2
2993028|NCT00992446|10299307|P1|Overall Study|Disease Progression|1
2993029|NCT00992407|10299382|P2|Overall Study|Study medication not administered|13
2993030|NCT00992407|10299383|P1|Overall Study|Study medication not administered|17
2993031|NCT00992407|10299382|P2|Overall Study|Loss of follow-up & Adverse events|1
2993032|NCT00992407|10299383|P1|Overall Study|Loss of follow-up & Adverse events|2
2993033|NCT00992407|10299382|P2|Overall Study|Other|0
2993034|NCT00992407|10299383|P1|Overall Study|Other|2
2993035|NCT00992407|10299382|P2|Overall Study|protocol Violation & Adverse events|4
2993036|NCT00992407|10299383|P1|Overall Study|protocol Violation & Adverse events|2
2993037|NCT00992407|10299382|P2|Overall Study|Adverse Event|2
2993038|NCT00992407|10299383|P1|Overall Study|Adverse Event|3
2993039|NCT00992407|10299382|P2|Overall Study|Lost to Follow-up|3
2993040|NCT00992407|10299383|P1|Overall Study|Lost to Follow-up|3
2993041|NCT00992407|10299382|P2|Overall Study|Protocol Violation|1
2993042|NCT00992407|10299383|P1|Overall Study|Protocol Violation|2
2993043|NCT00992394|10299433|P2|Overall Study|Other event|0
2993044|NCT00992394|10299434|P1|Overall Study|Other event|1
2993045|NCT00992394|10299433|P2|Overall Study|Lost to Follow-up|0
2993046|NCT00992394|10299434|P1|Overall Study|Lost to Follow-up|2
2993047|NCT00992394|10299433|P2|Overall Study|Protocol Violation|4
2993048|NCT00992394|10299434|P1|Overall Study|Protocol Violation|2
2993049|NCT00992394|10299433|P2|Overall Study|Physician Decision|0
2993050|NCT00992394|10299434|P1|Overall Study|Physician Decision|1
2993051|NCT00992394|10299433|P2|Overall Study|Withdrawal by Subject|2
2993052|NCT00992394|10299434|P1|Overall Study|Withdrawal by Subject|8
2993053|NCT00992394|10299433|P2|Overall Study|Adverse Event|5
2993054|NCT00992394|10299434|P1|Overall Study|Adverse Event|4
2993055|NCT00992394|10299433|P2|Overall Study|Lack of Efficacy|3
2993056|NCT00992394|10299434|P1|Overall Study|Lack of Efficacy|6
2993057|NCT00992225|10299521|P1|Overall Study|Adverse Event|2
2993058|NCT00992225|10299521|P1|Overall Study|Entry Criteria Not Met|8
2993059|NCT00992186|10299531|P1|Overall Study|Refusal To Receive Study Agent|3
2993060|NCT00992186|10299531|P1|Overall Study|Progressive Disease|30
2993061|NCT00992186|10299531|P1|Overall Study|Adverse Event|9
2993062|NCT00992186|10299531|P1|Overall Study|Physician Decision|1
2993063|NCT00992186|10299531|P1|Overall Study|Protocol Violation|1
2993064|NCT00992186|10299531|P1|Overall Study|Withdrawal by Subject|2
2993065|NCT00992108|10299550|P2|Overall Study|Lost to Follow-up|1
2993066|NCT00992108|10299551|P1|Overall Study|Lost to Follow-up|0
2993067|NCT00992056|10299565|P2|Washout Period (2 Weeks)|Physician Decision|0
2993068|NCT00992056|10299566|P1|Washout Period (2 Weeks)|Physician Decision|1
2993069|NCT00992056|10299565|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
2993070|NCT00992056|10299566|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
2993071|NCT00992017|10299572|P1|Overall Study|Not adhere to study requirements|1
2993072|NCT00992017|10299572|P1|Overall Study|Unable to get to clinic|5
2993073|NCT00992017|10299572|P1|Overall Study|Withdrawal by Subject|2
2993074|NCT00992017|10299572|P1|Overall Study|Lost to Follow-up|2
2993075|NCT00991952|10299587|P2|Overall Study|Adverse Event|1
2993076|NCT00991952|10299588|P1|Overall Study|Adverse Event|0
2993077|NCT00991939|10299596|P2|Overall Study|Entire study terminated|1
2993078|NCT00991939|10299597|P1|Overall Study|Entire study terminated|4
2993079|NCT00991939|10299596|P2|Overall Study|Withdrawal by Subject|0
2993080|NCT00991939|10299597|P1|Overall Study|Withdrawal by Subject|1
2993081|NCT00991939|10299596|P2|Overall Study|Lost to Follow-up|1
2993082|NCT00991939|10299597|P1|Overall Study|Lost to Follow-up|0
2993083|NCT00991887|10299631|P2|Overall Study|Lost to Follow-up|1
2993084|NCT00991887|10299632|P1|Overall Study|Lost to Follow-up|2
2993085|NCT00991510|10299651|P2|Period III (Days 29-112)|Adverse Event|1
2993086|NCT00991510|10299652|P1|Period III (Days 29-112)|Adverse Event|1
2993087|NCT00991510|10299651|P2|Period I (Days 1-14)|Adverse Event|0
2993088|NCT00991510|10299652|P1|Period I (Days 1-14)|Adverse Event|1
2993089|NCT00991406|10299696|P1|Overall Study|One participant did not respond to FES.|1
2993090|NCT00991341|10299705|P2|Overall Study|Withdrawal by Subject|4
2993091|NCT00991341|10299706|P1|Overall Study|Withdrawal by Subject|3
2993092|NCT00991341|10299705|P2|Overall Study|Physician Decision|2
2993093|NCT00991341|10299706|P1|Overall Study|Physician Decision|1
2993094|NCT00991341|10299705|P2|Overall Study|no RBCs received 96hrs after randomized|155
2993095|NCT00991341|10299706|P1|Overall Study|no RBCs received 96hrs after randomized|186
2993096|NCT00991341|10299705|P2|Overall Study|Death|0
2993097|NCT00991341|10299706|P1|Overall Study|Death|3
2993098|NCT00991341|10299705|P2|Overall Study|no surgery w/in 30 days of randomization|18
2993099|NCT00991341|10299706|P1|Overall Study|no surgery w/in 30 days of randomization|11
2993100|NCT00991302|10299744|P2|Overall Study|Lost to Follow-up|12
2993101|NCT00991302|10299745|P1|Overall Study|Lost to Follow-up|14
2993102|NCT00991302|10299744|P2|Overall Study|Death|1
2993103|NCT00991302|10299745|P1|Overall Study|Death|0
2993104|NCT00991289|10299761|P1|Overall Study|Protocol Violation|2
2993105|NCT00991289|10299761|P1|Overall Study|Lost to Follow-up|4
2993106|NCT00991289|10299761|P1|Overall Study|Withdrawal by Subject|3
2993107|NCT00991289|10299761|P1|Overall Study|Physician Decision|2
2993108|NCT00991289|10299761|P1|Overall Study|Adverse Event|1
2993109|NCT00991276|10299781|P6|Third Intervention Period|Withdrawal by Subject|0
2993110|NCT00991276|10299782|P5|Third Intervention Period|Withdrawal by Subject|0
2993111|NCT00991276|10299783|P4|Third Intervention Period|Withdrawal by Subject|1
2993112|NCT00991276|10299784|P3|Third Intervention Period|Withdrawal by Subject|0
2993113|NCT00991276|10299785|P2|Third Intervention Period|Withdrawal by Subject|0
2993114|NCT00991276|10299786|P1|Third Intervention Period|Withdrawal by Subject|0
2993115|NCT00991276|10299781|P6|Third Intervention Period|Adverse Event|0
2993116|NCT00991276|10299782|P5|Third Intervention Period|Adverse Event|0
2993117|NCT00991276|10299783|P4|Third Intervention Period|Adverse Event|0
2993118|NCT00991276|10299784|P3|Third Intervention Period|Adverse Event|1
2993119|NCT00991276|10299785|P2|Third Intervention Period|Adverse Event|0
2993120|NCT00991276|10299786|P1|Third Intervention Period|Adverse Event|0
2993121|NCT00991276|10299781|P6|Third Intervention Period|Other|1
2993122|NCT00991276|10299782|P5|Third Intervention Period|Other|0
2993123|NCT00991276|10299783|P4|Third Intervention Period|Other|0
2993124|NCT00991276|10299784|P3|Third Intervention Period|Other|0
2993125|NCT00991276|10299785|P2|Third Intervention Period|Other|0
2993126|NCT00991276|10299786|P1|Third Intervention Period|Other|0
2993127|NCT00991276|10299781|P6|Third Intervention Period|Protocol Violation|0
2993128|NCT00991276|10299782|P5|Third Intervention Period|Protocol Violation|0
2993129|NCT00991276|10299783|P4|Third Intervention Period|Protocol Violation|0
2993130|NCT00991276|10299784|P3|Third Intervention Period|Protocol Violation|0
2993131|NCT00991276|10299785|P2|Third Intervention Period|Protocol Violation|0
2993132|NCT00991276|10299786|P1|Third Intervention Period|Protocol Violation|1
2993133|NCT00991276|10299781|P6|Second Intervention Period|Other|1
2993134|NCT00991276|10299782|P5|Second Intervention Period|Other|0
2993135|NCT00991276|10299783|P4|Second Intervention Period|Other|1
2993136|NCT00991276|10299784|P3|Second Intervention Period|Other|0
2993137|NCT00991276|10299785|P2|Second Intervention Period|Other|0
2993138|NCT00991276|10299786|P1|Second Intervention Period|Other|0
2993139|NCT00991276|10299781|P6|Second Intervention Period|Protocol Violation|0
2993140|NCT00991276|10299782|P5|Second Intervention Period|Protocol Violation|0
2993141|NCT00991276|10299783|P4|Second Intervention Period|Protocol Violation|0
2993142|NCT00991276|10299784|P3|Second Intervention Period|Protocol Violation|0
2993143|NCT00991276|10299785|P2|Second Intervention Period|Protocol Violation|0
2993144|NCT00991276|10299786|P1|Second Intervention Period|Protocol Violation|1
2993145|NCT00991276|10299781|P6|Second Intervention Period|Adverse Event|0
2993146|NCT00991276|10299782|P5|Second Intervention Period|Adverse Event|1
2993147|NCT00991276|10299783|P4|Second Intervention Period|Adverse Event|1
2993148|NCT00991276|10299784|P3|Second Intervention Period|Adverse Event|0
2993149|NCT00991276|10299785|P2|Second Intervention Period|Adverse Event|2
2993150|NCT00991276|10299786|P1|Second Intervention Period|Adverse Event|0
2993151|NCT00991276|10299781|P6|First Intervention Period|Lost to Follow-up|0
2993152|NCT00991276|10299782|P5|First Intervention Period|Lost to Follow-up|0
2993153|NCT00991276|10299783|P4|First Intervention Period|Lost to Follow-up|1
2993154|NCT00991276|10299784|P3|First Intervention Period|Lost to Follow-up|0
2993155|NCT00991276|10299785|P2|First Intervention Period|Lost to Follow-up|1
2993156|NCT00991276|10299786|P1|First Intervention Period|Lost to Follow-up|0
2993157|NCT00991276|10299781|P6|First Intervention Period|Withdrawal by Subject|1
2993158|NCT00991276|10299782|P5|First Intervention Period|Withdrawal by Subject|0
2993159|NCT00991276|10299783|P4|First Intervention Period|Withdrawal by Subject|1
2993160|NCT00991276|10299784|P3|First Intervention Period|Withdrawal by Subject|0
2993161|NCT00991276|10299785|P2|First Intervention Period|Withdrawal by Subject|1
2993162|NCT00991276|10299786|P1|First Intervention Period|Withdrawal by Subject|0
2993163|NCT00991276|10299781|P6|First Intervention Period|Other|0
2993164|NCT00991276|10299782|P5|First Intervention Period|Other|1
2993165|NCT00991276|10299783|P4|First Intervention Period|Other|1
2993166|NCT00991276|10299784|P3|First Intervention Period|Other|0
2993167|NCT00991276|10299785|P2|First Intervention Period|Other|0
2993168|NCT00991276|10299786|P1|First Intervention Period|Other|0
2993169|NCT00991276|10299781|P6|First Intervention Period|Insufficient clinical response|0
2993170|NCT00991276|10299782|P5|First Intervention Period|Insufficient clinical response|1
2993171|NCT00991276|10299783|P4|First Intervention Period|Insufficient clinical response|0
2993172|NCT00991276|10299784|P3|First Intervention Period|Insufficient clinical response|0
2993173|NCT00991276|10299785|P2|First Intervention Period|Insufficient clinical response|0
2993174|NCT00991276|10299786|P1|First Intervention Period|Insufficient clinical response|0
2993175|NCT00991276|10299781|P6|First Intervention Period|Protocol Violation|0
2993176|NCT00991276|10299782|P5|First Intervention Period|Protocol Violation|2
2993177|NCT00991276|10299783|P4|First Intervention Period|Protocol Violation|0
2993178|NCT00991276|10299784|P3|First Intervention Period|Protocol Violation|0
2993179|NCT00991276|10299785|P2|First Intervention Period|Protocol Violation|0
2993180|NCT00991276|10299786|P1|First Intervention Period|Protocol Violation|0
2993181|NCT00991276|10299781|P6|First Intervention Period|Adverse Event|0
2993182|NCT00991276|10299782|P5|First Intervention Period|Adverse Event|0
2993183|NCT00991276|10299783|P4|First Intervention Period|Adverse Event|1
2993184|NCT00991276|10299784|P3|First Intervention Period|Adverse Event|0
2993185|NCT00991276|10299785|P2|First Intervention Period|Adverse Event|1
2993186|NCT00991276|10299786|P1|First Intervention Period|Adverse Event|0
2993187|NCT00990821|10300001|P14|Overall Study|Withdrawal by Subject|1
2993188|NCT00990821|10300002|P13|Overall Study|Withdrawal by Subject|2
2993189|NCT00990821|10300003|P12|Overall Study|Withdrawal by Subject|5
2993190|NCT00990821|10300004|P11|Overall Study|Withdrawal by Subject|3
2993191|NCT00990821|10300005|P10|Overall Study|Withdrawal by Subject|1
2993192|NCT00990821|10300006|P9|Overall Study|Withdrawal by Subject|0
2993193|NCT00990821|10300007|P8|Overall Study|Withdrawal by Subject|0
2993194|NCT00990821|10300008|P7|Overall Study|Withdrawal by Subject|1
2993195|NCT00990821|10300009|P6|Overall Study|Withdrawal by Subject|3
2993196|NCT00990821|10300010|P5|Overall Study|Withdrawal by Subject|3
2993197|NCT00990821|10300011|P4|Overall Study|Withdrawal by Subject|0
2993198|NCT00990821|10300012|P3|Overall Study|Withdrawal by Subject|0
2993199|NCT00990821|10300013|P2|Overall Study|Withdrawal by Subject|2
2993200|NCT00990821|10300014|P1|Overall Study|Withdrawal by Subject|0
2993201|NCT00990704|10300051|P2|Overall Study|Physician Decision|1
2993202|NCT00990704|10300052|P1|Overall Study|Physician Decision|0
2993203|NCT00990704|10300051|P2|Overall Study|Adverse Event|1
2993204|NCT00990704|10300052|P1|Overall Study|Adverse Event|1
2993205|NCT00990665|10300072|P1|Overall Study|System Explant|3
2993206|NCT00990665|10300072|P1|Overall Study|Lost to Follow-up|1
2993207|NCT00990665|10300072|P1|Overall Study|Withdrawal by Subject|6
2993208|NCT00990665|10300072|P1|Overall Study|Heart Transplant|1
2993209|NCT00990665|10300072|P1|Overall Study|Death|29
2993210|NCT00990665|10300072|P1|Overall Study|Unsuccessful Implant|8
2993211|NCT00990652|10300079|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
2993212|NCT00990652|10300079|P1|Pre-surgical Bortezomib|Adverse Event|1
2993213|NCT00990340|10300113|P2|First 14-day Treatment|Protocol Violation|2
2993214|NCT00990340|10300114|P1|First 14-day Treatment|Protocol Violation|2
2993215|NCT00990340|10300113|P2|First 14-day Treatment|Lost to Follow-up|1
2993216|NCT00990340|10300114|P1|First 14-day Treatment|Lost to Follow-up|2
2993217|NCT00990340|10300113|P2|First 14-day Treatment|Not Compliant|1
2993218|NCT00990340|10300114|P1|First 14-day Treatment|Not Compliant|2
2993219|NCT00990314|10300128|P1|Overall Study|Lack of Efficacy|1
2993220|NCT00990314|10300128|P1|Overall Study|Physician Decision|3
2993221|NCT00990314|10300128|P1|Overall Study|Non-Compliance|1
2993222|NCT00990314|10300128|P1|Overall Study|Withdrawal by Subject|3
2993223|NCT00990314|10300128|P1|Overall Study|Adverse Event|2
2993224|NCT00990314|10300128|P1|Overall Study|Death|2
2993225|NCT00990249|10300170|P1|Overall Study|Not treated|2
2993226|NCT00990249|10300170|P1|Overall Study|Death|2
2993227|NCT00990249|10300170|P1|Overall Study|Non-Compliance|1
2993228|NCT00990249|10300170|P1|Overall Study|Disease Progression|8
2993229|NCT00990184|10300185|P1|Overall Study|Physician Decision|1
2993230|NCT00990106|10300193|P2|Overall Study|scheduling conflicts|2
2993231|NCT00990106|10300194|P1|Overall Study|scheduling conflicts|0
2993232|NCT00990106|10300193|P2|Overall Study|planned major surgery|1
2993233|NCT00990106|10300194|P1|Overall Study|planned major surgery|0
2993234|NCT00990106|10300193|P2|Overall Study|started exclusionary medication|1
2993235|NCT00990106|10300194|P1|Overall Study|started exclusionary medication|0
2993236|NCT00990106|10300193|P2|Overall Study|relocation/deployment|1
2993237|NCT00990106|10300194|P1|Overall Study|relocation/deployment|4
2993238|NCT00990106|10300193|P2|Overall Study|opted for open label prazosin|1
2993239|NCT00990106|10300194|P1|Overall Study|opted for open label prazosin|1
2993240|NCT00990106|10300193|P2|Overall Study|Withdrawal by Subject|1
2993241|NCT00990106|10300194|P1|Overall Study|Withdrawal by Subject|2
2993242|NCT00990106|10300193|P2|Overall Study|Lost to Follow-up|3
2993243|NCT00990106|10300194|P1|Overall Study|Lost to Follow-up|1
2993244|NCT00990106|10300193|P2|Overall Study|"too busy to continue"|2
2993245|NCT00990106|10300194|P1|Overall Study|"too busy to continue"|1
2993246|NCT00990093|10300204|P2|Test Period 2 (15-28 Days)|Other|1
2993247|NCT00990093|10300205|P1|Test Period 2 (15-28 Days)|Other|0
2993248|NCT00990093|10300204|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
2993249|NCT00990093|10300205|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
2993250|NCT00990093|10300204|P2|Test Period 2 (15-28 Days)|Adverse Event|0
2993251|NCT00990093|10300205|P1|Test Period 2 (15-28 Days)|Adverse Event|1
2993252|NCT00990093|10300204|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
2993253|NCT00990093|10300205|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
2993254|NCT00990093|10300204|P2|Test Period 1 (1-14 Days)|Other|0
2993255|NCT00990093|10300205|P1|Test Period 1 (1-14 Days)|Other|1
2993256|NCT00990093|10300204|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
2993257|NCT00990093|10300205|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
2993258|NCT00990093|10300204|P2|Test Period 1 (1-14 Days)|Adverse Event|0
2993259|NCT00990093|10300205|P1|Test Period 1 (1-14 Days)|Adverse Event|1
2993260|NCT00989950|10300258|P4|Randomized Phase|Adverse Event|0
2993261|NCT00989950|10300259|P3|Randomized Phase|Adverse Event|0
2993262|NCT00989950|10300260|P2|Randomized Phase|Adverse Event|1
2993263|NCT00989950|10300261|P1|Randomized Phase|Adverse Event|0
2993264|NCT00989950|10300258|P4|Randomized Phase|Protocol Violation|0
2993265|NCT00989950|10300259|P3|Randomized Phase|Protocol Violation|0
2993266|NCT00989950|10300260|P2|Randomized Phase|Protocol Violation|0
2993267|NCT00989950|10300261|P1|Randomized Phase|Protocol Violation|1
2993268|NCT00989833|10300293|P3|Overall Study|Incorrectly randomized|0
2993269|NCT00989833|10300294|P2|Overall Study|Incorrectly randomized|0
2993270|NCT00989833|10300295|P1|Overall Study|Incorrectly randomized|1
2993271|NCT00989833|10300293|P3|Overall Study|Withdrawal by Subject|1
2993272|NCT00989833|10300294|P2|Overall Study|Withdrawal by Subject|0
2993273|NCT00989833|10300295|P1|Overall Study|Withdrawal by Subject|0
2993274|NCT00989833|10300293|P3|Overall Study|Protocol Violation|1
2993275|NCT00989833|10300294|P2|Overall Study|Protocol Violation|2
2993276|NCT00989833|10300295|P1|Overall Study|Protocol Violation|1
2993277|NCT00989833|10300293|P3|Overall Study|Lost to Follow-up|0
2993278|NCT00989833|10300294|P2|Overall Study|Lost to Follow-up|1
2993279|NCT00989833|10300295|P1|Overall Study|Lost to Follow-up|0
2993280|NCT00989781|10300326|P2|Ovarian Response to hCG|Lost to Follow-up|2
2993281|NCT00989781|10300327|P1|Ovarian Response to hCG|Lost to Follow-up|3
2993282|NCT00989664|10300357|P1|Long-Term Follow-Up|Death|3
2993283|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
2993284|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
2993285|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Death|1
2993286|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
2993287|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
2993288|NCT00989664|10300357|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
2993289|NCT00989287|10300442|P2|Overall Study|Lost to Follow-up|1
2993290|NCT00989287|10300443|P1|Overall Study|Lost to Follow-up|0
2993291|NCT00989287|10300442|P2|Overall Study|Adverse Event|0
2993292|NCT00989287|10300443|P1|Overall Study|Adverse Event|1
2993293|NCT00989261|10300545|P2|Overall Study|Lost to Follow-up|0
2993294|NCT00989261|10300546|P1|Overall Study|Lost to Follow-up|3
2993295|NCT00989261|10300545|P2|Overall Study|Withdrawal by Subject|1
2993296|NCT00989261|10300546|P1|Overall Study|Withdrawal by Subject|0
2993297|NCT00989261|10300545|P2|Overall Study|Still in follow up|21
2993298|NCT00989261|10300546|P1|Overall Study|Still in follow up|12
2993299|NCT00989235|10300576|P2|Overall Study|Lost to Follow-up|1
2993300|NCT00989235|10300577|P1|Overall Study|Lost to Follow-up|0
2993301|NCT00989235|10300576|P2|Overall Study|Randomized by Mistake|2
2993302|NCT00989235|10300577|P1|Overall Study|Randomized by Mistake|0
2993303|NCT00989235|10300576|P2|Overall Study|Desire to Become Pregnant|0
2993304|NCT00989235|10300577|P1|Overall Study|Desire to Become Pregnant|1
2993305|NCT00989235|10300576|P2|Overall Study|Withdrawal of Consent|1
2993306|NCT00989235|10300577|P1|Overall Study|Withdrawal of Consent|1
2993307|NCT00989235|10300576|P2|Overall Study|Lack of Efficacy|0
2993308|NCT00989235|10300577|P1|Overall Study|Lack of Efficacy|1
2993309|NCT00989235|10300576|P2|Overall Study|Adverse Event|1
2993310|NCT00989235|10300577|P1|Overall Study|Adverse Event|0
2993311|NCT00989235|10300576|P2|Overall Study|Death|1
2993312|NCT00989235|10300577|P1|Overall Study|Death|0
2993313|NCT00989196|10300622|P2|Treatment Period|Lost to Follow-up|0
2993314|NCT00989196|10300623|P1|Treatment Period|Lost to Follow-up|1
2993315|NCT00989092|10300661|P2|Overall Study|Did not receive study drug|0
2993316|NCT00989092|10300662|P1|Overall Study|Did not receive study drug|2
2993317|NCT00989092|10300661|P2|Overall Study|Erythropoietin therapy initiated|0
2993318|NCT00989092|10300662|P1|Overall Study|Erythropoietin therapy initiated|2
2993319|NCT00989092|10300661|P2|Overall Study|Protocol deviation|0
2993320|NCT00989092|10300662|P1|Overall Study|Protocol deviation|2
2993321|NCT00989092|10300661|P2|Overall Study|Other|1
2993322|NCT00989092|10300662|P1|Overall Study|Other|3
2993323|NCT00989092|10300661|P2|Overall Study|Lost to Follow-up|2
2993324|NCT00989092|10300662|P1|Overall Study|Lost to Follow-up|6
2993325|NCT00989092|10300661|P2|Overall Study|Ineligibility determined|3
2993326|NCT00989092|10300662|P1|Overall Study|Ineligibility determined|3
2993327|NCT00989092|10300661|P2|Overall Study|Death|2
2993328|NCT00989092|10300662|P1|Overall Study|Death|14
2993329|NCT00989092|10300661|P2|Overall Study|Withdrawal by Subject|9
2993330|NCT00989092|10300662|P1|Overall Study|Withdrawal by Subject|17
2993331|NCT00989092|10300661|P2|Overall Study|Chemotherapy initiated|4
2993332|NCT00989092|10300662|P1|Overall Study|Chemotherapy initiated|12
2993333|NCT00989092|10300661|P2|Overall Study|Adverse Event|1
2993334|NCT00989092|10300662|P1|Overall Study|Adverse Event|20
2993335|NCT00989092|10300661|P2|Overall Study|Physician Decision|6
2993336|NCT00989092|10300662|P1|Overall Study|Physician Decision|9
2993337|NCT00988884|10300714|P2|Overall Study|Withdrawal by Subject|18
2993338|NCT00988884|10300715|P1|Overall Study|Withdrawal by Subject|15
2993339|NCT00988884|10300714|P2|Overall Study|Protocol Violation|1
2993340|NCT00988884|10300715|P1|Overall Study|Protocol Violation|0
2993341|NCT00988884|10300714|P2|Overall Study|Lost to Follow-up|16
2993342|NCT00988884|10300715|P1|Overall Study|Lost to Follow-up|20
2993343|NCT00988884|10300714|P2|Overall Study|Adverse Event|1
2993344|NCT00988884|10300715|P1|Overall Study|Adverse Event|0
2993345|NCT00988858|10300737|P1|Overall Study|Sponsor Decision|1
2993346|NCT00988858|10300737|P1|Overall Study|Physician Decision|1
2993347|NCT00988858|10300737|P1|Overall Study|Death|1
2993348|NCT00988858|10300737|P1|Overall Study|Adverse Event|7
2993349|NCT00988637|10300786|P2|Overall Study|non-compliance with study drug|1
2993350|NCT00988637|10300787|P1|Overall Study|non-compliance with study drug|0
2993351|NCT00988637|10300786|P2|Overall Study|Withdrawal by Subject|1
2993352|NCT00988637|10300787|P1|Overall Study|Withdrawal by Subject|1
2993353|NCT00988637|10300786|P2|Overall Study|Lost to Follow-up|1
2993354|NCT00988637|10300787|P1|Overall Study|Lost to Follow-up|2
2993355|NCT00988559|10300821|P4|Overall Study|Lost to Follow-up|0
2993356|NCT00988559|10300822|P3|Overall Study|Lost to Follow-up|1
2993357|NCT00988559|10300823|P2|Overall Study|Lost to Follow-up|0
2993358|NCT00988559|10300824|P1|Overall Study|Lost to Follow-up|0
2993359|NCT00988559|10300821|P4|Overall Study|Pregnancy|0
2993360|NCT00988559|10300822|P3|Overall Study|Pregnancy|1
2993361|NCT00988559|10300823|P2|Overall Study|Pregnancy|1
2993362|NCT00988559|10300824|P1|Overall Study|Pregnancy|0
2993363|NCT00988559|10300821|P4|Overall Study|Withdrawal by Subject|1
2993364|NCT00988559|10300822|P3|Overall Study|Withdrawal by Subject|0
2993365|NCT00988559|10300823|P2|Overall Study|Withdrawal by Subject|1
2993366|NCT00988559|10300824|P1|Overall Study|Withdrawal by Subject|1
2993367|NCT00988533|10300838|P1|Overall Study|Lost to Follow-up|3
2993368|NCT00988442|10300852|P2|Overall Study|Early Study Closure|25
2993369|NCT00988442|10300853|P1|Overall Study|Early Study Closure|29
2993370|NCT00988442|10300852|P2|Overall Study|Lost to Follow-up|1
2993371|NCT00988442|10300853|P1|Overall Study|Lost to Follow-up|0
2993372|NCT00988442|10300852|P2|Overall Study|Death|2
2993373|NCT00988442|10300853|P1|Overall Study|Death|1
2993374|NCT00988429|10300916|P3|Overall Study|other reasons|1
2993375|NCT00988429|10300917|P2|Overall Study|other reasons|8
2993376|NCT00988429|10300918|P1|Overall Study|other reasons|8
2993377|NCT00988429|10300916|P3|Overall Study|Administrative Reasons|1
2993378|NCT00988429|10300917|P2|Overall Study|Administrative Reasons|2
2993379|NCT00988429|10300918|P1|Overall Study|Administrative Reasons|1
2993380|NCT00988429|10300916|P3|Overall Study|Withdrawal by Subject|12
2993381|NCT00988429|10300917|P2|Overall Study|Withdrawal by Subject|7
2993382|NCT00988429|10300918|P1|Overall Study|Withdrawal by Subject|7
2993383|NCT00988429|10300916|P3|Overall Study|Protocol Violation|3
2993384|NCT00988429|10300917|P2|Overall Study|Protocol Violation|3
2993385|NCT00988429|10300918|P1|Overall Study|Protocol Violation|4
2993386|NCT00988429|10300916|P3|Overall Study|Pregnancy|0
2993387|NCT00988429|10300917|P2|Overall Study|Pregnancy|1
2993388|NCT00988429|10300918|P1|Overall Study|Pregnancy|2
2993389|NCT00988429|10300916|P3|Overall Study|Physician Decision|3
2993390|NCT00988429|10300917|P2|Overall Study|Physician Decision|0
2993391|NCT00988429|10300918|P1|Overall Study|Physician Decision|1
2993392|NCT00988429|10300916|P3|Overall Study|Non-Compliance with Study Drug|3
2993393|NCT00988429|10300917|P2|Overall Study|Non-Compliance with Study Drug|1
2993394|NCT00988429|10300918|P1|Overall Study|Non-Compliance with Study Drug|5
2993395|NCT00988429|10300916|P3|Overall Study|Lack of Efficacy|1
2993396|NCT00988429|10300917|P2|Overall Study|Lack of Efficacy|0
2993397|NCT00988429|10300918|P1|Overall Study|Lack of Efficacy|0
2993398|NCT00988429|10300916|P3|Overall Study|Adverse Event|45
2993399|NCT00988429|10300917|P2|Overall Study|Adverse Event|21
2993400|NCT00988429|10300918|P1|Overall Study|Adverse Event|9
2993401|NCT00988351|10300931|P2|Overall Study|not using CPAP|3
2993402|NCT00988351|10300932|P1|Overall Study|not using CPAP|5
2993403|NCT00988351|10300931|P2|Overall Study|Lost to Follow-up|9
2993404|NCT00988351|10300932|P1|Overall Study|Lost to Follow-up|6
2993405|NCT00988351|10300931|P2|Overall Study|Withdrawal by Subject|0
2993406|NCT00988351|10300932|P1|Overall Study|Withdrawal by Subject|8
2993407|NCT00988247|10301009|P2|Overall Study|Other|0
2993408|NCT00988247|10301010|P1|Overall Study|Other|3
2993409|NCT00988247|10301009|P2|Overall Study|Sponsor requested withdrawal|1
2993410|NCT00988247|10301010|P1|Overall Study|Sponsor requested withdrawal|3
2993411|NCT00988247|10301009|P2|Overall Study|Protocol Violation|5
2993412|NCT00988247|10301010|P1|Overall Study|Protocol Violation|4
2993413|NCT00988247|10301009|P2|Overall Study|Lost to Follow-up|2
2993414|NCT00988247|10301010|P1|Overall Study|Lost to Follow-up|11
2993415|NCT00988247|10301009|P2|Overall Study|Pregnancy|2
2993416|NCT00988247|10301010|P1|Overall Study|Pregnancy|1
2993417|NCT00988247|10301009|P2|Overall Study|Withdrawal by Subject|13
2993418|NCT00988247|10301010|P1|Overall Study|Withdrawal by Subject|44
2993419|NCT00988247|10301009|P2|Overall Study|Adverse Event|3
2993420|NCT00988247|10301010|P1|Overall Study|Adverse Event|17
2993421|NCT00988221|10301029|P4|Part III|Refused Treatment|0
2993422|NCT00988221|10301030|P3|Part III|Refused Treatment|1
2993423|NCT00988221|10301031|P2|Part III|Refused Treatment|0
2993424|NCT00988221|10301032|P1|Part III|Refused Treatment|0
2993425|NCT00988221|10301029|P4|Part III|Insufficient Therapeutic Response|0
2993426|NCT00988221|10301030|P3|Part III|Insufficient Therapeutic Response|1
2993427|NCT00988221|10301031|P2|Part III|Insufficient Therapeutic Response|1
2993428|NCT00988221|10301032|P1|Part III|Insufficient Therapeutic Response|0
2993429|NCT00988221|10301029|P4|Part III|Adverse Event|0
2993430|NCT00988221|10301030|P3|Part III|Adverse Event|1
2993431|NCT00988221|10301031|P2|Part III|Adverse Event|0
2993432|NCT00988221|10301032|P1|Part III|Adverse Event|1
2993433|NCT00988221|10301029|P4|Part II|Reason not Specified|0
2993434|NCT00988221|10301030|P3|Part II|Reason not Specified|1
2993435|NCT00988221|10301031|P2|Part II|Reason not Specified|0
2993436|NCT00988221|10301032|P1|Part II|Reason not Specified|0
2993437|NCT00988221|10301029|P4|Part II|Withdrawal by Subject|2
2993438|NCT00988221|10301030|P3|Part II|Withdrawal by Subject|2
2993439|NCT00988221|10301031|P2|Part II|Withdrawal by Subject|0
2993440|NCT00988221|10301032|P1|Part II|Withdrawal by Subject|0
2993441|NCT00988221|10301029|P4|Part II|Adverse Event|1
2993442|NCT00988221|10301030|P3|Part II|Adverse Event|0
2993443|NCT00988221|10301031|P2|Part II|Adverse Event|0
2993444|NCT00988221|10301032|P1|Part II|Adverse Event|1
2993445|NCT00988221|10301029|P4|Part I|Lost to Follow-up|0
2993446|NCT00988221|10301030|P3|Part I|Lost to Follow-up|0
2993447|NCT00988221|10301031|P2|Part I|Lost to Follow-up|1
2993448|NCT00988221|10301032|P1|Part I|Lost to Follow-up|0
2993449|NCT00988221|10301029|P4|Part I|Refused Treatment|0
2993450|NCT00988221|10301030|P3|Part I|Refused Treatment|1
2993451|NCT00988221|10301031|P2|Part I|Refused Treatment|2
2993452|NCT00988221|10301032|P1|Part I|Refused Treatment|0
2993453|NCT00988221|10301029|P4|Part I|Insufficient Therapeutic Response|0
2993454|NCT00988221|10301030|P3|Part I|Insufficient Therapeutic Response|5
2993455|NCT00988221|10301031|P2|Part I|Insufficient Therapeutic Response|6
2993456|NCT00988221|10301032|P1|Part I|Insufficient Therapeutic Response|4
2993457|NCT00988221|10301029|P4|Part I|Adverse Event|0
2993458|NCT00988221|10301030|P3|Part I|Adverse Event|2
2993459|NCT00988221|10301031|P2|Part I|Adverse Event|1
2993460|NCT00988221|10301032|P1|Part I|Adverse Event|0
2993461|NCT00988208|10301205|P2|Overall Study|Other|3
2993462|NCT00988208|10301206|P1|Overall Study|Other|8
2993463|NCT00988208|10301205|P2|Overall Study|Subject Decision/Investigator Discretion|32
2993464|NCT00988208|10301206|P1|Overall Study|Subject Decision/Investigator Discretion|32
2993465|NCT00988208|10301205|P2|Overall Study|Clinical Deterioration|14
2993466|NCT00988208|10301206|P1|Overall Study|Clinical Deterioration|7
2993467|NCT00988208|10301205|P2|Overall Study|Biochemical Progression|7
2993468|NCT00988208|10301206|P1|Overall Study|Biochemical Progression|21
2993469|NCT00988208|10301205|P2|Overall Study|Clinical Progression|16
2993470|NCT00988208|10301206|P1|Overall Study|Clinical Progression|17
2993471|NCT00988208|10301205|P2|Overall Study|Sponsor Decision|78
2993472|NCT00988208|10301206|P1|Overall Study|Sponsor Decision|102
2993473|NCT00988208|10301205|P2|Overall Study|Protocol Violation|2
2993474|NCT00988208|10301206|P1|Overall Study|Protocol Violation|9
2993475|NCT00988208|10301205|P2|Overall Study|Lost to Follow-up|3
2993476|NCT00988208|10301206|P1|Overall Study|Lost to Follow-up|2
2993477|NCT00988208|10301205|P2|Overall Study|Death|15
2993478|NCT00988208|10301206|P1|Overall Study|Death|9
2993479|NCT00988208|10301205|P2|Overall Study|Withdrawal by Subject|57
2993480|NCT00988208|10301206|P1|Overall Study|Withdrawal by Subject|50
2993481|NCT00988208|10301205|P2|Overall Study|Disease Progression|89
2993482|NCT00988208|10301206|P1|Overall Study|Disease Progression|103
2993483|NCT00988208|10301205|P2|Overall Study|Adverse Event|122
2993484|NCT00988208|10301206|P1|Overall Study|Adverse Event|71
2993485|NCT00988169|10301224|P1|Overall Study|Withdrawal by Subject|1
2993486|NCT00988117|10301276|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
2993487|NCT00988117|10301276|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
2993488|NCT00988091|10301285|P2|Open-label Period|Other|3
2993489|NCT00988091|10301286|P1|Open-label Period|Other|2
2993490|NCT00988091|10301285|P2|Open-label Period|Lost to Follow-up|5
2993491|NCT00988091|10301286|P1|Open-label Period|Lost to Follow-up|3
2993492|NCT00988091|10301285|P2|Open-label Period|Withdrawal by Subject|16
2993493|NCT00988091|10301286|P1|Open-label Period|Withdrawal by Subject|10
2993494|NCT00988091|10301285|P2|Open-label Period|Protocol Violation|1
2993495|NCT00988091|10301286|P1|Open-label Period|Protocol Violation|1
2993496|NCT00988091|10301285|P2|Open-label Period|Use of exclusionary medication|1
2993497|NCT00988091|10301286|P1|Open-label Period|Use of exclusionary medication|1
2993498|NCT00988091|10301285|P2|Open-label Period|Adverse Event|7
2993499|NCT00988091|10301286|P1|Open-label Period|Adverse Event|4
2993500|NCT00988091|10301285|P2|Double-blind Period|Use of exclusionary medication|3
2993501|NCT00988091|10301286|P1|Double-blind Period|Use of exclusionary medication|2
2993502|NCT00988091|10301285|P2|Double-blind Period|Adverse Event|9
2993503|NCT00988091|10301286|P1|Double-blind Period|Adverse Event|6
2993504|NCT00988091|10301285|P2|Double-blind Period|Other|8
2993505|NCT00988091|10301286|P1|Double-blind Period|Other|8
2993506|NCT00988091|10301285|P2|Double-blind Period|Lost to Follow-up|14
2993507|NCT00988091|10301286|P1|Double-blind Period|Lost to Follow-up|12
2993508|NCT00988091|10301285|P2|Double-blind Period|Withdrawal by Subject|13
2993509|NCT00988091|10301286|P1|Double-blind Period|Withdrawal by Subject|15
2993510|NCT00988065|10301308|P3|Overall Study|Noncompliance with protocol|9
2993511|NCT00988065|10301309|P2|Overall Study|Noncompliance with protocol|6
2993512|NCT00988065|10301310|P1|Overall Study|Noncompliance with protocol|5
2993513|NCT00988065|10301308|P3|Overall Study|Subject withdrew consent|2
2993514|NCT00988065|10301309|P2|Overall Study|Subject withdrew consent|5
2993515|NCT00988065|10301310|P1|Overall Study|Subject withdrew consent|3
2993516|NCT00988065|10301308|P3|Overall Study|Lost to Follow-up|2
2993517|NCT00988065|10301309|P2|Overall Study|Lost to Follow-up|2
2993518|NCT00988065|10301310|P1|Overall Study|Lost to Follow-up|1
2993519|NCT00988065|10301308|P3|Overall Study|Adverse Event|2
2993520|NCT00988065|10301309|P2|Overall Study|Adverse Event|10
2993521|NCT00988065|10301310|P1|Overall Study|Adverse Event|4
2993522|NCT00988052|10301332|P2|Overall Study|Study terminated by sponsor|236
2993523|NCT00988052|10301333|P1|Overall Study|Study terminated by sponsor|240
2993524|NCT00988052|10301332|P2|Overall Study|Withdrawal by Subject|91
2993525|NCT00988052|10301333|P1|Overall Study|Withdrawal by Subject|90
2993526|NCT00988052|10301332|P2|Overall Study|Adverse Event|28
2993527|NCT00988052|10301333|P1|Overall Study|Adverse Event|35
2993528|NCT00988052|10301332|P2|Overall Study|Physician Decision|28
2993529|NCT00988052|10301333|P1|Overall Study|Physician Decision|27
2993530|NCT00988052|10301332|P2|Overall Study|Lost to Follow-up|11
2993531|NCT00988052|10301333|P1|Overall Study|Lost to Follow-up|6
2993532|NCT00988052|10301332|P2|Overall Study|Lack of Efficacy|7
2993533|NCT00988052|10301333|P1|Overall Study|Lack of Efficacy|8
2993534|NCT00988052|10301332|P2|Overall Study|Pregnancy|6
2993535|NCT00988052|10301333|P1|Overall Study|Pregnancy|6
2993536|NCT00988052|10301332|P2|Overall Study|Protocol Violation|5
2993537|NCT00988052|10301333|P1|Overall Study|Protocol Violation|6
2993538|NCT00988052|10301332|P2|Overall Study|Death|3
2993539|NCT00988052|10301333|P1|Overall Study|Death|1
2993540|NCT00988052|10301332|P2|Overall Study|Teva requested subject withdrawal|1
2993541|NCT00988052|10301333|P1|Overall Study|Teva requested subject withdrawal|3
2993542|NCT00988052|10301332|P2|Overall Study|Missing|0
2993543|NCT00988052|10301333|P1|Overall Study|Missing|1
2993544|NCT00987935|10301377|P9|Overall Study|Reason other than those specified above|1
2993545|NCT00987935|10301378|P8|Overall Study|Reason other than those specified above|0
2993546|NCT00987935|10301379|P7|Overall Study|Reason other than those specified above|0
2993547|NCT00987935|10301380|P6|Overall Study|Reason other than those specified above|0
2993548|NCT00987935|10301381|P5|Overall Study|Reason other than those specified above|0
2993549|NCT00987935|10301382|P4|Overall Study|Reason other than those specified above|0
2993550|NCT00987935|10301383|P3|Overall Study|Reason other than those specified above|0
2993551|NCT00987935|10301384|P2|Overall Study|Reason other than those specified above|0
2993552|NCT00987935|10301385|P1|Overall Study|Reason other than those specified above|0
2993553|NCT00987935|10301377|P9|Overall Study|Refused to continue taking trial med.|2
2993554|NCT00987935|10301378|P8|Overall Study|Refused to continue taking trial med.|4
2993555|NCT00987935|10301379|P7|Overall Study|Refused to continue taking trial med.|4
2993556|NCT00987935|10301380|P6|Overall Study|Refused to continue taking trial med.|0
2993557|NCT00987935|10301381|P5|Overall Study|Refused to continue taking trial med.|1
2993558|NCT00987935|10301382|P4|Overall Study|Refused to continue taking trial med.|0
2993559|NCT00987935|10301383|P3|Overall Study|Refused to continue taking trial med.|0
2993560|NCT00987935|10301384|P2|Overall Study|Refused to continue taking trial med.|0
2993561|NCT00987935|10301385|P1|Overall Study|Refused to continue taking trial med.|1
2993562|NCT00987935|10301377|P9|Overall Study|Adverse Event|6
2993563|NCT00987935|10301378|P8|Overall Study|Adverse Event|10
2993564|NCT00987935|10301379|P7|Overall Study|Adverse Event|2
2993565|NCT00987935|10301380|P6|Overall Study|Adverse Event|0
2993566|NCT00987935|10301381|P5|Overall Study|Adverse Event|1
2993567|NCT00987935|10301382|P4|Overall Study|Adverse Event|1
2993568|NCT00987935|10301383|P3|Overall Study|Adverse Event|0
2993569|NCT00987935|10301384|P2|Overall Study|Adverse Event|1
2993570|NCT00987935|10301385|P1|Overall Study|Adverse Event|0
2993571|NCT00987935|10301377|P9|Overall Study|Progressive disease|23
2993572|NCT00987935|10301378|P8|Overall Study|Progressive disease|48
2993573|NCT00987935|10301379|P7|Overall Study|Progressive disease|9
2993574|NCT00987935|10301380|P6|Overall Study|Progressive disease|3
2993575|NCT00987935|10301381|P5|Overall Study|Progressive disease|5
2993576|NCT00987935|10301382|P4|Overall Study|Progressive disease|2
2993577|NCT00987935|10301383|P3|Overall Study|Progressive disease|3
2993578|NCT00987935|10301384|P2|Overall Study|Progressive disease|2
2993579|NCT00987935|10301385|P1|Overall Study|Progressive disease|3
2993580|NCT00987831|10301441|P3|Overall Study|Lost to Follow-up|0
2993581|NCT00987831|10301442|P2|Overall Study|Lost to Follow-up|3
2993582|NCT00987831|10301443|P1|Overall Study|Lost to Follow-up|0
2993583|NCT00987831|10301441|P3|Overall Study|Never flared in 12 months|0
2993584|NCT00987831|10301442|P2|Overall Study|Never flared in 12 months|0
2993585|NCT00987831|10301443|P1|Overall Study|Never flared in 12 months|1
2993586|NCT00987623|10301465|P2|Overall Study|Influenza|1
2993587|NCT00987623|10301466|P1|Overall Study|Influenza|0
2993588|NCT00987623|10301465|P2|Overall Study|Biomicroscopy|1
2993589|NCT00987623|10301466|P1|Overall Study|Biomicroscopy|0
2993590|NCT00987623|10301465|P2|Overall Study|Discomfort|0
2993591|NCT00987623|10301466|P1|Overall Study|Discomfort|1
2993592|NCT00987623|10301465|P2|Overall Study|Time/job conflict|0
2993593|NCT00987623|10301466|P1|Overall Study|Time/job conflict|2
2993594|NCT00987623|10301465|P2|Overall Study|Lost to Follow-up|1
2993595|NCT00987623|10301466|P1|Overall Study|Lost to Follow-up|2
2993596|NCT00987467|10301495|P1|Overall Study|Lost to Follow-up|2
2993597|NCT00987402|10301519|P2|Overall Study|Insufficient data entry|98
2993598|NCT00987402|10301520|P1|Overall Study|Insufficient data entry|86
2993599|NCT00987389|10301528|P4|Overall Study|Multiple different reasons|1
2993600|NCT00987389|10301529|P3|Overall Study|Multiple different reasons|3
2993601|NCT00987389|10301530|P2|Overall Study|Multiple different reasons|0
2993602|NCT00987389|10301531|P1|Overall Study|Multiple different reasons|1
2993603|NCT00987389|10301528|P4|Overall Study|Withdrawn from Treatment|0
2993604|NCT00987389|10301529|P3|Overall Study|Withdrawn from Treatment|0
2993605|NCT00987389|10301530|P2|Overall Study|Withdrawn from Treatment|1
2993606|NCT00987389|10301531|P1|Overall Study|Withdrawn from Treatment|0
2993607|NCT00987389|10301528|P4|Overall Study|Withdrawal by Subject|1
2993608|NCT00987389|10301529|P3|Overall Study|Withdrawal by Subject|2
2993609|NCT00987389|10301530|P2|Overall Study|Withdrawal by Subject|3
2993610|NCT00987389|10301531|P1|Overall Study|Withdrawal by Subject|4
2993611|NCT00987389|10301528|P4|Overall Study|Lost to Follow-up|1
2993612|NCT00987389|10301529|P3|Overall Study|Lost to Follow-up|3
2993613|NCT00987389|10301530|P2|Overall Study|Lost to Follow-up|1
2993614|NCT00987389|10301531|P1|Overall Study|Lost to Follow-up|4
2993615|NCT00987389|10301528|P4|Overall Study|Ineligible|0
2993616|NCT00987389|10301529|P3|Overall Study|Ineligible|0
2993617|NCT00987389|10301530|P2|Overall Study|Ineligible|3
2993618|NCT00987389|10301531|P1|Overall Study|Ineligible|0
2993619|NCT00987337|10301550|P3|Overall Study|Participant Relapsed|5
2993620|NCT00987337|10301551|P2|Overall Study|Participant Relapsed|20
2993621|NCT00987337|10301552|P1|Overall Study|Participant Relapsed|18
2993622|NCT00987337|10301550|P3|Overall Study|Protocol Violation|2
2993623|NCT00987337|10301551|P2|Overall Study|Protocol Violation|0
2993624|NCT00987337|10301552|P1|Overall Study|Protocol Violation|1
2993625|NCT00987337|10301550|P3|Overall Study|Other|5
2993626|NCT00987337|10301551|P2|Overall Study|Other|2
2993627|NCT00987337|10301552|P1|Overall Study|Other|0
2993628|NCT00987337|10301550|P3|Overall Study|Withdrawal by Subject|9
2993629|NCT00987337|10301551|P2|Overall Study|Withdrawal by Subject|9
2993630|NCT00987337|10301552|P1|Overall Study|Withdrawal by Subject|6
2993631|NCT00987337|10301550|P3|Overall Study|Lost to Follow-up|2
2993632|NCT00987337|10301551|P2|Overall Study|Lost to Follow-up|6
2993633|NCT00987337|10301552|P1|Overall Study|Lost to Follow-up|10
2993634|NCT00987337|10301550|P3|Overall Study|Virologic Breakthrough|8
2993635|NCT00987337|10301551|P2|Overall Study|Virologic Breakthrough|2
2993636|NCT00987337|10301552|P1|Overall Study|Virologic Breakthrough|2
2993637|NCT00987337|10301550|P3|Overall Study|Insufficient Virologic Response|12
2993638|NCT00987337|10301551|P2|Overall Study|Insufficient Virologic Response|7
2993639|NCT00987337|10301552|P1|Overall Study|Insufficient Virologic Response|10
2993640|NCT00987337|10301550|P3|Overall Study|Adverse Event|8
2993641|NCT00987337|10301551|P2|Overall Study|Adverse Event|9
2993642|NCT00987337|10301552|P1|Overall Study|Adverse Event|10
2993643|NCT00986986|10301607|P2|Overall Study|Lost to Follow-up|1
2993644|NCT00986986|10301608|P1|Overall Study|Lost to Follow-up|0
2993645|NCT00986973|10301618|P1|Overall Study|Withdrawn by study team|1
2993646|NCT00986921|10301644|P2|Overall Study|Physician Decision|0
2993647|NCT00986921|10301645|P1|Overall Study|Physician Decision|1
2993648|NCT00986674|10301681|P3|Overall Study|unknown/not specify|9
2993649|NCT00986674|10301682|P2|Overall Study|unknown/not specify|7
2993650|NCT00986674|10301683|P1|Overall Study|unknown/not specify|0
2993651|NCT00986674|10301681|P3|Overall Study|not start protocol therapy|1
2993652|NCT00986674|10301682|P2|Overall Study|not start protocol therapy|3
2993653|NCT00986674|10301683|P1|Overall Study|not start protocol therapy|4
2993654|NCT00986674|10301681|P3|Overall Study|alternative therapy|1
2993655|NCT00986674|10301682|P2|Overall Study|alternative therapy|0
2993656|NCT00986674|10301683|P1|Overall Study|alternative therapy|0
2993657|NCT00986674|10301681|P3|Overall Study|Withdrawal by Subject|1
2993658|NCT00986674|10301682|P2|Overall Study|Withdrawal by Subject|2
2993659|NCT00986674|10301683|P1|Overall Study|Withdrawal by Subject|6
2993660|NCT00986674|10301681|P3|Overall Study|Death|4
2993661|NCT00986674|10301682|P2|Overall Study|Death|0
2993662|NCT00986674|10301683|P1|Overall Study|Death|5
2993663|NCT00986674|10301681|P3|Overall Study|Adverse Event|9
2993664|NCT00986674|10301682|P2|Overall Study|Adverse Event|8
2993665|NCT00986674|10301683|P1|Overall Study|Adverse Event|4
2993666|NCT00986674|10301681|P3|Overall Study|Lack of Efficacy|23
2993667|NCT00986674|10301682|P2|Overall Study|Lack of Efficacy|25
2993668|NCT00986674|10301683|P1|Overall Study|Lack of Efficacy|28
2993669|NCT00986570|10301716|P1|Overall Study|Potential bias for objective assessment|1
2993670|NCT00986570|10301716|P1|Overall Study|Lost to Follow-up|6
2993671|NCT00986479|10301733|P2|Period 1|Administrative reasons|0
2993672|NCT00986479|10301734|P1|Period 1|Administrative reasons|1
2993673|NCT00986479|10301733|P2|Period 1|Improved mood|0
2993674|NCT00986479|10301734|P1|Period 1|Improved mood|1
2993675|NCT00986427|10301780|P2|Overall Study|Withdrawal by Subject|0
2993676|NCT00986427|10301781|P1|Overall Study|Withdrawal by Subject|1
2993677|NCT00986427|10301780|P2|Overall Study|Lack of Efficacy|0
2993678|NCT00986427|10301781|P1|Overall Study|Lack of Efficacy|1
2993679|NCT00986427|10301780|P2|Overall Study|Lost to Follow-up|0
2993680|NCT00986427|10301781|P1|Overall Study|Lost to Follow-up|2
2993681|NCT00986362|10301809|P2|Overall Study|Lost to Follow-up|1
2993682|NCT00986362|10301810|P1|Overall Study|Lost to Follow-up|0
2993683|NCT00986362|10301809|P2|Overall Study|Death|0
2993684|NCT00986362|10301810|P1|Overall Study|Death|2
2993685|NCT00986349|10301816|P1|Overall Study|device migration|1
2993686|NCT00986349|10301816|P1|Overall Study|Physician Decision|1
2993687|NCT00986349|10301816|P1|Overall Study|Adverse Event|2
2993688|NCT00986349|10301816|P1|Overall Study|Unsuccessful implant procedure|3
2993689|NCT00986258|10301840|P1|Maintenance Period|Withdrawal by Subject|2
2993690|NCT00986258|10301840|P1|Maintenance Period|Lack of Efficacy|2
2993691|NCT00986258|10301840|P1|Maintenance Period|Adverse Event|5
2993692|NCT00986258|10301840|P1|Titration and Optimal Dose Period|Other|1
2993693|NCT00986258|10301840|P1|Titration and Optimal Dose Period|Non-Compliance|1
2993694|NCT00986258|10301840|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
2993695|NCT00986258|10301840|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
2993696|NCT00986258|10301840|P1|Titration and Optimal Dose Period|Adverse Event|15
2993697|NCT00986258|10301840|P1|Observation Period|Not eligible to be dosed|11
2993698|NCT00986245|10301868|P2|Second Intervention|Protocol Violation|1
2993699|NCT00986245|10301869|P1|Second Intervention|Protocol Violation|0
2993700|NCT00986245|10301868|P2|Second Intervention|Lost to Follow-up|0
2993701|NCT00986245|10301869|P1|Second Intervention|Lost to Follow-up|1
2993702|NCT00986245|10301868|P2|Second Intervention|Poor compliance|0
2993703|NCT00986245|10301869|P1|Second Intervention|Poor compliance|1
2993704|NCT00986245|10301868|P2|First Intervention|Out of indication|0
2993705|NCT00986245|10301869|P1|First Intervention|Out of indication|1
2993706|NCT00986245|10301868|P2|First Intervention|Protocol Violation|1
2993707|NCT00986245|10301869|P1|First Intervention|Protocol Violation|0
2993708|NCT00986245|10301868|P2|First Intervention|Withdrawal by Subject|1
2993709|NCT00986245|10301869|P1|First Intervention|Withdrawal by Subject|0
2993710|NCT00986245|10301868|P2|First Intervention|Lack of Efficacy|2
2993711|NCT00986245|10301869|P1|First Intervention|Lack of Efficacy|1
2993712|NCT00986245|10301868|P2|First Intervention|Poor compliance|4
2993713|NCT00986245|10301869|P1|First Intervention|Poor compliance|8
2993714|NCT00986232|10301906|P4|Overall Study|Incomplete safety follow-up|2
2993715|NCT00986232|10301907|P3|Overall Study|Incomplete safety follow-up|2
2993716|NCT00986232|10301908|P2|Overall Study|Incomplete safety follow-up|7
2993717|NCT00986232|10301909|P1|Overall Study|Incomplete safety follow-up|3
2993718|NCT00986232|10301906|P4|Overall Study|Missed one or more bleeds|7
2993719|NCT00986232|10301907|P3|Overall Study|Missed one or more bleeds|6
2993720|NCT00986232|10301908|P2|Overall Study|Missed one or more bleeds|10
2993721|NCT00986232|10301909|P1|Overall Study|Missed one or more bleeds|13
2993722|NCT00986232|10301906|P4|Overall Study|Withdrawal by Subject|3
2993723|NCT00986232|10301907|P3|Overall Study|Withdrawal by Subject|12
2993724|NCT00986232|10301908|P2|Overall Study|Withdrawal by Subject|16
2993725|NCT00986232|10301909|P1|Overall Study|Withdrawal by Subject|13
2993726|NCT00986232|10301906|P4|Overall Study|Protocol Violation|1
2993727|NCT00986232|10301907|P3|Overall Study|Protocol Violation|0
2993728|NCT00986232|10301908|P2|Overall Study|Protocol Violation|3
2993729|NCT00986232|10301909|P1|Overall Study|Protocol Violation|2
2993730|NCT00986232|10301906|P4|Overall Study|Lost to Follow-up|7
2993731|NCT00986232|10301907|P3|Overall Study|Lost to Follow-up|12
2993732|NCT00986232|10301908|P2|Overall Study|Lost to Follow-up|12
2993733|NCT00986232|10301909|P1|Overall Study|Lost to Follow-up|19
2993734|NCT00986232|10301906|P4|Overall Study|Adverse Event|0
2993735|NCT00986232|10301907|P3|Overall Study|Adverse Event|3
2993736|NCT00986232|10301908|P2|Overall Study|Adverse Event|2
2993737|NCT00986232|10301909|P1|Overall Study|Adverse Event|1
2993738|NCT00986180|10301983|P2|Overall Study|Miscellanies|11
2993739|NCT00986180|10301984|P1|Overall Study|Miscellanies|10
2993740|NCT00986180|10301983|P2|Overall Study|Withdrawal by Subject|9
2993741|NCT00986180|10301984|P1|Overall Study|Withdrawal by Subject|1
2993742|NCT00986180|10301983|P2|Overall Study|Protocol Violation|0
2993743|NCT00986180|10301984|P1|Overall Study|Protocol Violation|2
2993744|NCT00986180|10301983|P2|Overall Study|Physician Decision|3
2993745|NCT00986180|10301984|P1|Overall Study|Physician Decision|1
2993746|NCT00986180|10301983|P2|Overall Study|Lost to Follow-up|7
2993747|NCT00986180|10301984|P1|Overall Study|Lost to Follow-up|5
2993748|NCT00986180|10301983|P2|Overall Study|Lack of Efficacy|3
2993749|NCT00986180|10301984|P1|Overall Study|Lack of Efficacy|4
2993750|NCT00986180|10301983|P2|Overall Study|Adverse Event|23
2993751|NCT00986180|10301984|P1|Overall Study|Adverse Event|21
2993752|NCT00986154|10302062|P2|Overall Study|never received study drug|27
2993753|NCT00986154|10302063|P1|Overall Study|never received study drug|25
2993754|NCT00986154|10302062|P2|Overall Study|investigator/subject decide not continue|3
2993755|NCT00986154|10302063|P1|Overall Study|investigator/subject decide not continue|6
2993756|NCT00986154|10302062|P2|Overall Study|Withdrawal by Subject|33
2993757|NCT00986154|10302063|P1|Overall Study|Withdrawal by Subject|32
2993758|NCT00986154|10302062|P2|Overall Study|Lost to Follow-up|4
2993759|NCT00986154|10302063|P1|Overall Study|Lost to Follow-up|7
2993760|NCT00986154|10302062|P2|Overall Study|Death|127
2993761|NCT00986154|10302063|P1|Overall Study|Death|136
2993762|NCT00986102|10302077|P4|Overall Study|Withdrawal by Subject|0
2993763|NCT00986102|10302078|P3|Overall Study|Withdrawal by Subject|0
2993764|NCT00986102|10302079|P2|Overall Study|Withdrawal by Subject|1
2993765|NCT00986102|10302080|P1|Overall Study|Withdrawal by Subject|1
2993766|NCT00986102|10302077|P4|Overall Study|Lost to Follow-up|1
2993767|NCT00986102|10302078|P3|Overall Study|Lost to Follow-up|0
2993768|NCT00986102|10302079|P2|Overall Study|Lost to Follow-up|1
2993769|NCT00986102|10302080|P1|Overall Study|Lost to Follow-up|0
2993770|NCT00985985|10302130|P4|Overall Study|Other Reason|2
2993771|NCT00985985|10302131|P3|Overall Study|Other Reason|4
2993772|NCT00985985|10302132|P2|Overall Study|Other Reason|1
2993773|NCT00985985|10302133|P1|Overall Study|Other Reason|6
2993774|NCT00985985|10302130|P4|Overall Study|Withdrawal by Subject|2
2993775|NCT00985985|10302131|P3|Overall Study|Withdrawal by Subject|2
2993776|NCT00985985|10302132|P2|Overall Study|Withdrawal by Subject|2
2993777|NCT00985985|10302133|P1|Overall Study|Withdrawal by Subject|4
2993778|NCT00985985|10302130|P4|Overall Study|Lack of Efficacy|3
2993779|NCT00985985|10302131|P3|Overall Study|Lack of Efficacy|1
2993780|NCT00985985|10302132|P2|Overall Study|Lack of Efficacy|6
2993781|NCT00985985|10302133|P1|Overall Study|Lack of Efficacy|5
2993782|NCT00985985|10302130|P4|Overall Study|Protocol Violation|1
2993783|NCT00985985|10302131|P3|Overall Study|Protocol Violation|0
2993784|NCT00985985|10302132|P2|Overall Study|Protocol Violation|2
2993785|NCT00985985|10302133|P1|Overall Study|Protocol Violation|1
2993786|NCT00985985|10302130|P4|Overall Study|Lost to Follow-up|3
2993787|NCT00985985|10302131|P3|Overall Study|Lost to Follow-up|2
2993788|NCT00985985|10302132|P2|Overall Study|Lost to Follow-up|11
2993789|NCT00985985|10302133|P1|Overall Study|Lost to Follow-up|4
2993790|NCT00985985|10302130|P4|Overall Study|Adverse Event|2
2993791|NCT00985985|10302131|P3|Overall Study|Adverse Event|2
2993792|NCT00985985|10302132|P2|Overall Study|Adverse Event|2
2993793|NCT00985985|10302133|P1|Overall Study|Adverse Event|4
2993794|NCT00985959|10302174|P3|Overall Study|Other|11
2993795|NCT00985959|10302175|P2|Overall Study|Other|0
2993796|NCT00985959|10302176|P1|Overall Study|Other|0
2993797|NCT00985959|10302174|P3|Overall Study|Complete response observed over 2 cycles|4
2993798|NCT00985959|10302175|P2|Overall Study|Complete response observed over 2 cycles|1
2993799|NCT00985959|10302176|P1|Overall Study|Complete response observed over 2 cycles|0
2993800|NCT00985959|10302174|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
2993801|NCT00985959|10302175|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
2993802|NCT00985959|10302176|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
2993803|NCT00985959|10302174|P3|Overall Study|Unrecovered toxicity|7
2993804|NCT00985959|10302175|P2|Overall Study|Unrecovered toxicity|0
2993805|NCT00985959|10302176|P1|Overall Study|Unrecovered toxicity|0
2993806|NCT00985959|10302174|P3|Overall Study|Progressive disease|8
2993807|NCT00985959|10302175|P2|Overall Study|Progressive disease|2
2993808|NCT00985959|10302176|P1|Overall Study|Progressive disease|1
2993809|NCT00985959|10302174|P3|Overall Study|Withdrawal by Subject|8
2993810|NCT00985959|10302175|P2|Overall Study|Withdrawal by Subject|0
2993811|NCT00985959|10302176|P1|Overall Study|Withdrawal by Subject|0
2993812|NCT00985959|10302174|P3|Overall Study|Adverse Event|19
2993813|NCT00985959|10302175|P2|Overall Study|Adverse Event|0
2993814|NCT00985959|10302176|P1|Overall Study|Adverse Event|0
2993815|NCT00985946|10302199|P1|Overall Study|Withdrawal by Subject|1
2993816|NCT00985946|10302199|P1|Overall Study|Lost to Follow-up|6
2993817|NCT00985790|10302218|P2|Overall Study|Lost to Follow-up|7
2993818|NCT00985790|10302219|P1|Overall Study|Lost to Follow-up|6
2993819|NCT00985790|10302218|P2|Overall Study|Withdrawal by Subject|1
2993820|NCT00985790|10302219|P1|Overall Study|Withdrawal by Subject|1
2993821|NCT00985751|10302260|P5|Overall Study|Adverse Event|1
2993822|NCT00985751|10302261|P4|Overall Study|Adverse Event|0
2993823|NCT00985751|10302262|P3|Overall Study|Adverse Event|0
2993824|NCT00985751|10302263|P2|Overall Study|Adverse Event|0
2993825|NCT00985751|10302264|P1|Overall Study|Adverse Event|0
2993826|NCT00985738|10302327|P2|Overall Study|Study closed prematurely|8
2993827|NCT00985738|10302328|P1|Overall Study|Study closed prematurely|8
2993828|NCT00985725|10302336|P2|Overall Study|Out-of-window visits|1
2993829|NCT00985725|10302337|P1|Overall Study|Out-of-window visits|0
2993830|NCT00985725|10302336|P2|Overall Study|Non-compliance|2
2993831|NCT00985725|10302337|P1|Overall Study|Non-compliance|1
2993832|NCT00985725|10302336|P2|Overall Study|Lack of Efficacy|1
2993833|NCT00985725|10302337|P1|Overall Study|Lack of Efficacy|0
2993834|NCT00985725|10302336|P2|Overall Study|Lost to Follow-up|1
2993835|NCT00985725|10302337|P1|Overall Study|Lost to Follow-up|1
2993836|NCT00985725|10302336|P2|Overall Study|Withdrawal by Subject|4
2993837|NCT00985725|10302337|P1|Overall Study|Withdrawal by Subject|4
2993838|NCT00985725|10302336|P2|Overall Study|Protocol Violation|3
2993839|NCT00985725|10302337|P1|Overall Study|Protocol Violation|1
2993840|NCT00985725|10302336|P2|Overall Study|Adverse Event|1
2993841|NCT00985725|10302337|P1|Overall Study|Adverse Event|4
2993842|NCT00985712|10302373|P2|Overall Study|Sponsor decision|2
2993843|NCT00985712|10302374|P1|Overall Study|Sponsor decision|0
2993844|NCT00985712|10302373|P2|Overall Study|Withdrawal by Subject|1
2993845|NCT00985712|10302374|P1|Overall Study|Withdrawal by Subject|4
2993846|NCT00985712|10302373|P2|Overall Study|Protocol Violation|1
2993847|NCT00985712|10302374|P1|Overall Study|Protocol Violation|0
2993848|NCT00985712|10302373|P2|Overall Study|Lost to Follow-up|2
2993849|NCT00985712|10302374|P1|Overall Study|Lost to Follow-up|2
2993850|NCT00985712|10302373|P2|Overall Study|Adverse Event|1
2993851|NCT00985712|10302374|P1|Overall Study|Adverse Event|0
2993852|NCT00985686|10302392|P4|Overall Study|Lost to Follow-up|2
2993853|NCT00985686|10302393|P3|Overall Study|Lost to Follow-up|0
2993854|NCT00985686|10302394|P2|Overall Study|Lost to Follow-up|1
2993855|NCT00985686|10302395|P1|Overall Study|Lost to Follow-up|1
2993856|NCT00985673|10302409|P6|Overall Study|Other|0
2993857|NCT00985673|10302410|P5|Overall Study|Other|1
2993858|NCT00985673|10302411|P4|Overall Study|Other|0
2993859|NCT00985673|10302412|P3|Overall Study|Other|1
2993860|NCT00985673|10302413|P2|Overall Study|Other|0
2993861|NCT00985673|10302414|P1|Overall Study|Other|1
2993862|NCT00985673|10302409|P6|Overall Study|Withdrawal by Subject|3
2993863|NCT00985673|10302410|P5|Overall Study|Withdrawal by Subject|2
2993864|NCT00985673|10302411|P4|Overall Study|Withdrawal by Subject|2
2993865|NCT00985673|10302412|P3|Overall Study|Withdrawal by Subject|5
2993866|NCT00985673|10302413|P2|Overall Study|Withdrawal by Subject|4
2993867|NCT00985673|10302414|P1|Overall Study|Withdrawal by Subject|0
2993868|NCT00985673|10302409|P6|Overall Study|Lost to Follow-up|3
2993869|NCT00985673|10302410|P5|Overall Study|Lost to Follow-up|5
2993870|NCT00985673|10302411|P4|Overall Study|Lost to Follow-up|10
2993871|NCT00985673|10302412|P3|Overall Study|Lost to Follow-up|6
2993872|NCT00985673|10302413|P2|Overall Study|Lost to Follow-up|7
2993873|NCT00985673|10302414|P1|Overall Study|Lost to Follow-up|6
2993874|NCT00985504|10302697|P2|Optimization Period|Withdrawal by Subject|8
2993875|NCT00985504|10302698|P1|Optimization Period|Withdrawal by Subject|10
2993876|NCT00985504|10302697|P2|Optimization Period|Protocol Violation|1
2993877|NCT00985504|10302698|P1|Optimization Period|Protocol Violation|3
2993878|NCT00985504|10302697|P2|Optimization Period|Physician Decision|0
2993879|NCT00985504|10302698|P1|Optimization Period|Physician Decision|1
2993880|NCT00985504|10302697|P2|Optimization Period|Lost to Follow-up|1
2993881|NCT00985504|10302698|P1|Optimization Period|Lost to Follow-up|0
2993882|NCT00985504|10302697|P2|Optimization Period|Lack of Efficacy|3
2993883|NCT00985504|10302698|P1|Optimization Period|Lack of Efficacy|5
2993884|NCT00985504|10302697|P2|Optimization Period|Death|1
2993885|NCT00985504|10302698|P1|Optimization Period|Death|0
2993886|NCT00985504|10302697|P2|Optimization Period|Adverse Event|9
2993887|NCT00985504|10302698|P1|Optimization Period|Adverse Event|7
2993888|NCT00985504|10302697|P2|Acute Treatment Period|Withdrawal by Subject|5
2993889|NCT00985504|10302698|P1|Acute Treatment Period|Withdrawal by Subject|9
2993890|NCT00985504|10302697|P2|Acute Treatment Period|Sponsor Decision|1
2993891|NCT00985504|10302698|P1|Acute Treatment Period|Sponsor Decision|0
2993892|NCT00985504|10302697|P2|Acute Treatment Period|Protocol Violation|0
2993893|NCT00985504|10302698|P1|Acute Treatment Period|Protocol Violation|2
2993894|NCT00985504|10302697|P2|Acute Treatment Period|Entry Criteria Not Met|2
2993895|NCT00985504|10302698|P1|Acute Treatment Period|Entry Criteria Not Met|1
2993896|NCT00985504|10302697|P2|Acute Treatment Period|Adverse Event|4
2993897|NCT00985504|10302698|P1|Acute Treatment Period|Adverse Event|3
2993898|NCT00985491|10302724|P1|Overall Study|implant failure|3
2993899|NCT00985491|10302724|P1|Overall Study|Withdrawal by Subject|1
2993900|NCT00985491|10302724|P1|Overall Study|device migration|7
2993901|NCT00985491|10302724|P1|Overall Study|Adverse Event|8
2993902|NCT00985465|10302731|P2|Overall Study|Considered to be part of the other group|1
2993903|NCT00985465|10302732|P1|Overall Study|Considered to be part of the other group|0
2993904|NCT00985465|10302731|P2|Overall Study|Withdrawal by Subject|2
2993905|NCT00985465|10302732|P1|Overall Study|Withdrawal by Subject|1
2993906|NCT00985439|10302759|P4|Overall Study|Adverse Event|0
2993907|NCT00985439|10302760|P3|Overall Study|Adverse Event|1
2993908|NCT00985439|10302761|P2|Overall Study|Adverse Event|0
2993909|NCT00985439|10302762|P1|Overall Study|Adverse Event|0
2993910|NCT00985231|10302778|P2|Overall Study|Study related symptoms & complaints|2
2993911|NCT00985231|10302779|P1|Overall Study|Study related symptoms & complaints|0
2993912|NCT00985231|10302778|P2|Overall Study|Lost to Follow-up|1
2993913|NCT00985231|10302779|P1|Overall Study|Lost to Follow-up|0
2993914|NCT00985231|10302778|P2|Overall Study|Withdrawal by Subject|0
2993915|NCT00985231|10302779|P1|Overall Study|Withdrawal by Subject|1
2993916|NCT00985231|10302778|P2|Overall Study|Protocol Violation|0
2993917|NCT00985231|10302779|P1|Overall Study|Protocol Violation|1
2993918|NCT00985231|10302778|P2|Overall Study|ineligible|0
2993919|NCT00985231|10302779|P1|Overall Study|ineligible|1
2993920|NCT00985192|10302787|P1|Overall Study|Determined to be Ineligible During Trial|2
2993921|NCT00985192|10302787|P1|Overall Study|Disease Progression|1
2993922|NCT00985192|10302787|P1|Overall Study|Withdrawal by Subject|1
2993923|NCT00985166|10302799|P3|Overall Study|Other|1
2993924|NCT00985166|10302800|P2|Overall Study|Other|0
2993925|NCT00985166|10302801|P1|Overall Study|Other|1
2993926|NCT00985166|10302799|P3|Overall Study|Test not done|4
2993927|NCT00985166|10302800|P2|Overall Study|Test not done|0
2993928|NCT00985166|10302801|P1|Overall Study|Test not done|2
2993929|NCT00985166|10302799|P3|Overall Study|Withdrawal by Subject|0
2993930|NCT00985166|10302800|P2|Overall Study|Withdrawal by Subject|2
2993931|NCT00985166|10302801|P1|Overall Study|Withdrawal by Subject|3
2993932|NCT00985166|10302799|P3|Overall Study|Lost to Follow-up|2
2993933|NCT00985166|10302800|P2|Overall Study|Lost to Follow-up|2
2993934|NCT00985166|10302801|P1|Overall Study|Lost to Follow-up|3
2993935|NCT00985153|10302821|P4|Overall Study|Incomplete Safety Follow-up|4
2993936|NCT00985153|10302822|P3|Overall Study|Incomplete Safety Follow-up|4
2993937|NCT00985153|10302823|P2|Overall Study|Incomplete Safety Follow-up|5
2993938|NCT00985153|10302824|P1|Overall Study|Incomplete Safety Follow-up|3
2993939|NCT00985153|10302821|P4|Overall Study|Missed One or More Bleeds|10
2993940|NCT00985153|10302822|P3|Overall Study|Missed One or More Bleeds|8
2993941|NCT00985153|10302823|P2|Overall Study|Missed One or More Bleeds|7
2993942|NCT00985153|10302824|P1|Overall Study|Missed One or More Bleeds|7
2993943|NCT00985153|10302821|P4|Overall Study|Withdrawal by Subject|10
2993944|NCT00985153|10302822|P3|Overall Study|Withdrawal by Subject|11
2993945|NCT00985153|10302823|P2|Overall Study|Withdrawal by Subject|11
2993946|NCT00985153|10302824|P1|Overall Study|Withdrawal by Subject|6
2993947|NCT00985153|10302821|P4|Overall Study|Protocol Violation|3
2993948|NCT00985153|10302822|P3|Overall Study|Protocol Violation|4
2993949|NCT00985153|10302823|P2|Overall Study|Protocol Violation|2
2993950|NCT00985153|10302824|P1|Overall Study|Protocol Violation|3
2993951|NCT00985153|10302821|P4|Overall Study|Lost to Follow-up|20
2993952|NCT00985153|10302822|P3|Overall Study|Lost to Follow-up|17
2993953|NCT00985153|10302823|P2|Overall Study|Lost to Follow-up|19
2993954|NCT00985153|10302824|P1|Overall Study|Lost to Follow-up|16
2993955|NCT00985114|10302872|P2|Overall Study|Withdrawal by Subject|2
2993956|NCT00985114|10302873|P1|Overall Study|Withdrawal by Subject|0
2993957|NCT00985114|10302872|P2|Overall Study|Adverse Event|0
2993958|NCT00985114|10302873|P1|Overall Study|Adverse Event|1
2993959|NCT00985088|10302887|P8|Overall Study|Lost to Follow-up|2
2993960|NCT00985088|10302888|P7|Overall Study|Lost to Follow-up|3
2993961|NCT00985088|10302889|P6|Overall Study|Lost to Follow-up|5
2993962|NCT00985088|10302890|P5|Overall Study|Lost to Follow-up|6
2993963|NCT00985088|10302891|P4|Overall Study|Lost to Follow-up|6
2993964|NCT00985088|10302892|P3|Overall Study|Lost to Follow-up|2
2993965|NCT00985088|10302893|P2|Overall Study|Lost to Follow-up|1
2993966|NCT00985088|10302894|P1|Overall Study|Lost to Follow-up|6
2993967|NCT00985088|10302887|P8|Overall Study|Migrated/moved from study area|1
2993968|NCT00985088|10302888|P7|Overall Study|Migrated/moved from study area|0
2993969|NCT00985088|10302889|P6|Overall Study|Migrated/moved from study area|0
2993970|NCT00985088|10302890|P5|Overall Study|Migrated/moved from study area|0
2993971|NCT00985088|10302891|P4|Overall Study|Migrated/moved from study area|0
2993972|NCT00985088|10302892|P3|Overall Study|Migrated/moved from study area|1
2993973|NCT00985088|10302893|P2|Overall Study|Migrated/moved from study area|0
2993974|NCT00985088|10302894|P1|Overall Study|Migrated/moved from study area|0
2993975|NCT00985088|10302887|P8|Overall Study|Withdrawal by Subject|2
2993976|NCT00985088|10302888|P7|Overall Study|Withdrawal by Subject|1
2993977|NCT00985088|10302889|P6|Overall Study|Withdrawal by Subject|2
2993978|NCT00985088|10302890|P5|Overall Study|Withdrawal by Subject|3
2993979|NCT00985088|10302891|P4|Overall Study|Withdrawal by Subject|1
2993980|NCT00985088|10302892|P3|Overall Study|Withdrawal by Subject|0
2993981|NCT00985088|10302893|P2|Overall Study|Withdrawal by Subject|0
2993982|NCT00985088|10302894|P1|Overall Study|Withdrawal by Subject|4
2993983|NCT00985088|10302887|P8|Overall Study|Adverse Event|0
2993984|NCT00985088|10302888|P7|Overall Study|Adverse Event|0
2993985|NCT00985088|10302889|P6|Overall Study|Adverse Event|0
2993986|NCT00985088|10302890|P5|Overall Study|Adverse Event|0
2993987|NCT00985088|10302891|P4|Overall Study|Adverse Event|0
2993988|NCT00985088|10302892|P3|Overall Study|Adverse Event|1
2993989|NCT00985088|10302893|P2|Overall Study|Adverse Event|0
2993990|NCT00985088|10302894|P1|Overall Study|Adverse Event|0
2993991|NCT00985088|10302887|P8|Overall Study|Serious Adverse Event|1
2993992|NCT00985088|10302888|P7|Overall Study|Serious Adverse Event|0
2993993|NCT00985088|10302889|P6|Overall Study|Serious Adverse Event|0
2993994|NCT00985088|10302890|P5|Overall Study|Serious Adverse Event|0
2993995|NCT00985088|10302891|P4|Overall Study|Serious Adverse Event|0
2993996|NCT00985088|10302892|P3|Overall Study|Serious Adverse Event|0
2993997|NCT00985088|10302893|P2|Overall Study|Serious Adverse Event|1
2993998|NCT00985088|10302894|P1|Overall Study|Serious Adverse Event|1
2993999|NCT00984867|10303163|P2|Overall Study|lack of efficacy and subject compliance|0
2994000|NCT00984867|10303164|P1|Overall Study|lack of efficacy and subject compliance|1
2994001|NCT00984867|10303163|P2|Overall Study|site closing|0
2994002|NCT00984867|10303164|P1|Overall Study|site closing|1
2994003|NCT00984867|10303163|P2|Overall Study|Subject no longer meets study criteria|1
2994004|NCT00984867|10303164|P1|Overall Study|Subject no longer meets study criteria|1
2994005|NCT00984867|10303163|P2|Overall Study|Poor/non-compliance|1
2994006|NCT00984867|10303164|P1|Overall Study|Poor/non-compliance|0
2994007|NCT00984867|10303163|P2|Overall Study|Lost to Follow-up|4
2994008|NCT00984867|10303164|P1|Overall Study|Lost to Follow-up|3
2994009|NCT00984867|10303163|P2|Overall Study|Withdrawal by Subject|4
2994010|NCT00984867|10303164|P1|Overall Study|Withdrawal by Subject|13
2994011|NCT00984867|10303163|P2|Overall Study|Death|0
2994012|NCT00984867|10303164|P1|Overall Study|Death|1
2994013|NCT00984867|10303163|P2|Overall Study|Adverse Event|7
2994014|NCT00984867|10303164|P1|Overall Study|Adverse Event|3
2994015|NCT00984659|10303204|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2994016|NCT00984659|10303205|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
2994017|NCT00984659|10303206|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2994018|NCT00984659|10303207|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
2994019|NCT00984659|10303204|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2994020|NCT00984659|10303205|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
2994021|NCT00984659|10303206|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2994022|NCT00984659|10303207|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2994023|NCT00984659|10303204|P4|6-week Double-blind Treatment Period|Protocol Violation|4
2994024|NCT00984659|10303205|P3|6-week Double-blind Treatment Period|Protocol Violation|0
2994025|NCT00984659|10303206|P2|6-week Double-blind Treatment Period|Protocol Violation|0
2994026|NCT00984659|10303207|P1|6-week Double-blind Treatment Period|Protocol Violation|0
2994027|NCT00984659|10303204|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
2994028|NCT00984659|10303205|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
2994029|NCT00984659|10303206|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
2994030|NCT00984659|10303207|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
2994031|NCT00984659|10303204|P4|6-week Double-blind Treatment Period|Adverse Event|7
2994032|NCT00984659|10303205|P3|6-week Double-blind Treatment Period|Adverse Event|3
2994033|NCT00984659|10303206|P2|6-week Double-blind Treatment Period|Adverse Event|3
2994034|NCT00984659|10303207|P1|6-week Double-blind Treatment Period|Adverse Event|0
2994035|NCT00984659|10303204|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2994036|NCT00984659|10303205|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2994037|NCT00984659|10303206|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2994038|NCT00984659|10303207|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
2994039|NCT00984659|10303204|P4|2-week Run-in Period|Withdrawal by Subject|0
2994040|NCT00984659|10303205|P3|2-week Run-in Period|Withdrawal by Subject|0
2994041|NCT00984659|10303206|P2|2-week Run-in Period|Withdrawal by Subject|0
2994042|NCT00984659|10303207|P1|2-week Run-in Period|Withdrawal by Subject|10
2994043|NCT00984659|10303204|P4|2-week Run-in Period|Physician Decision|0
2994044|NCT00984659|10303205|P3|2-week Run-in Period|Physician Decision|0
2994045|NCT00984659|10303206|P2|2-week Run-in Period|Physician Decision|0
2994046|NCT00984659|10303207|P1|2-week Run-in Period|Physician Decision|10
2994047|NCT00984659|10303204|P4|2-week Run-in Period|Lost to Follow-up|0
2994048|NCT00984659|10303205|P3|2-week Run-in Period|Lost to Follow-up|0
2994049|NCT00984659|10303206|P2|2-week Run-in Period|Lost to Follow-up|0
2994050|NCT00984659|10303207|P1|2-week Run-in Period|Lost to Follow-up|3
2994051|NCT00984659|10303204|P4|2-week Run-in Period|Study Closed/Terminated|0
2994052|NCT00984659|10303205|P3|2-week Run-in Period|Study Closed/Terminated|0
2994053|NCT00984659|10303206|P2|2-week Run-in Period|Study Closed/Terminated|0
2994054|NCT00984659|10303207|P1|2-week Run-in Period|Study Closed/Terminated|2
2994055|NCT00984659|10303204|P4|2-week Run-in Period|Protocol Violation|0
2994056|NCT00984659|10303205|P3|2-week Run-in Period|Protocol Violation|0
2994057|NCT00984659|10303206|P2|2-week Run-in Period|Protocol Violation|0
2994058|NCT00984659|10303207|P1|2-week Run-in Period|Protocol Violation|5
2994059|NCT00984659|10303204|P4|2-week Run-in Period|Adverse Event|0
2994060|NCT00984659|10303205|P3|2-week Run-in Period|Adverse Event|0
2994061|NCT00984659|10303206|P2|2-week Run-in Period|Adverse Event|0
2994062|NCT00984659|10303207|P1|2-week Run-in Period|Adverse Event|8
2994063|NCT00984620|10303234|P2|Overall Study|reason other than listed above|4
2994064|NCT00984620|10303235|P1|Overall Study|reason other than listed above|0
2994065|NCT00984620|10303234|P2|Overall Study|Withdrawal by Subject|2
2994066|NCT00984620|10303235|P1|Overall Study|Withdrawal by Subject|0
2994067|NCT00984620|10303234|P2|Overall Study|Lost to Follow-up|1
2994068|NCT00984620|10303235|P1|Overall Study|Lost to Follow-up|1
2994069|NCT00984620|10303234|P2|Overall Study|Adverse Event|5
2994070|NCT00984620|10303235|P1|Overall Study|Adverse Event|5
2994071|NCT00984594|10303273|P2|Overall Study|Withdrawal by Subject|1
2994072|NCT00984594|10303274|P1|Overall Study|Withdrawal by Subject|0
2994073|NCT00984594|10303273|P2|Overall Study|Lost to Follow-up|0
2994074|NCT00984594|10303274|P1|Overall Study|Lost to Follow-up|1
2994075|NCT00984568|10303290|P2|Overall Study|Unknown Reason|3
2994076|NCT00984568|10303291|P1|Overall Study|Unknown Reason|1
2994077|NCT00984568|10303290|P2|Overall Study|Opportunistic Infection|0
2994078|NCT00984568|10303291|P1|Overall Study|Opportunistic Infection|1
2994079|NCT00984568|10303290|P2|Overall Study|Lost to Follow-up|1
2994080|NCT00984568|10303291|P1|Overall Study|Lost to Follow-up|0
2994081|NCT00984568|10303290|P2|Overall Study|Did Not Meet Randomization Criteria|0
2994082|NCT00984568|10303291|P1|Overall Study|Did Not Meet Randomization Criteria|1
2994083|NCT00984568|10303290|P2|Overall Study|Adverse Event|0
2994084|NCT00984568|10303291|P1|Overall Study|Adverse Event|2
2994085|NCT00984568|10303290|P2|Overall Study|Lack of Efficacy|0
2994086|NCT00984568|10303291|P1|Overall Study|Lack of Efficacy|2
2994087|NCT00984568|10303290|P2|Overall Study|Withdrawal by Subject|2
2994088|NCT00984568|10303291|P1|Overall Study|Withdrawal by Subject|1
2994089|NCT00984542|10303299|P1|Overall Study|clinical deterioration|2
2994090|NCT00984542|10303299|P1|Overall Study|Withdrawal by Subject|3
2994091|NCT00984542|10303299|P1|Overall Study|complicating disease|3
2994092|NCT00984542|10303299|P1|Overall Study|Death|7
2994093|NCT00984542|10303299|P1|Overall Study|toxicity|7
2994094|NCT00984542|10303299|P1|Overall Study|disease progression|19
2994095|NCT00984295|10303349|P3|Overall Study|Incomplete safety follow-up|3
2994096|NCT00984295|10303350|P2|Overall Study|Incomplete safety follow-up|2
2994097|NCT00984295|10303351|P1|Overall Study|Incomplete safety follow-up|11
2994098|NCT00984295|10303349|P3|Overall Study|Missed one or more blood samplings|2
2994099|NCT00984295|10303350|P2|Overall Study|Missed one or more blood samplings|7
2994100|NCT00984295|10303351|P1|Overall Study|Missed one or more blood samplings|3
2994101|NCT00984295|10303349|P3|Overall Study|CAE – discontinued test vaccine|3
2994102|NCT00984295|10303350|P2|Overall Study|CAE – discontinued test vaccine|1
2994103|NCT00984295|10303351|P1|Overall Study|CAE – discontinued test vaccine|0
2994104|NCT00984295|10303349|P3|Overall Study|Withdrawal by Subject|12
2994105|NCT00984295|10303350|P2|Overall Study|Withdrawal by Subject|9
2994106|NCT00984295|10303351|P1|Overall Study|Withdrawal by Subject|18
2994107|NCT00984295|10303349|P3|Overall Study|Protocol Violation|4
2994108|NCT00984295|10303350|P2|Overall Study|Protocol Violation|1
2994109|NCT00984295|10303351|P1|Overall Study|Protocol Violation|2
2994110|NCT00984295|10303349|P3|Overall Study|Lost to Follow-up|13
2994111|NCT00984295|10303350|P2|Overall Study|Lost to Follow-up|12
2994112|NCT00984295|10303351|P1|Overall Study|Lost to Follow-up|31
2994113|NCT00984282|10303418|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
2994114|NCT00984282|10303419|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
2994115|NCT00984282|10303418|P2|Long Term Follow-up|Switched to commercial drug|2
2994116|NCT00984282|10303419|P1|Long Term Follow-up|Switched to commercial drug|4
2994117|NCT00984282|10303418|P2|Long Term Follow-up|Transferred to treat. continuation study|3
2994118|NCT00984282|10303419|P1|Long Term Follow-up|Transferred to treat. continuation study|2
2994119|NCT00984282|10303418|P2|Long Term Follow-up|Protocol driven decision point|26
2994120|NCT00984282|10303419|P1|Long Term Follow-up|Protocol driven decision point|25
2994121|NCT00984282|10303418|P2|Long Term Follow-up|Lost to Follow-up|6
2994122|NCT00984282|10303419|P1|Long Term Follow-up|Lost to Follow-up|3
2994123|NCT00984282|10303418|P2|Long Term Follow-up|Death|68
2994124|NCT00984282|10303419|P1|Long Term Follow-up|Death|27
2994125|NCT00984282|10303418|P2|Long Term Follow-up|Withdrawal by Subject|14
2994126|NCT00984282|10303419|P1|Long Term Follow-up|Withdrawal by Subject|8
2994127|NCT00984282|10303418|P2|Open-label Treatment|Physician Decision|0
2994128|NCT00984282|10303419|P1|Open-label Treatment|Physician Decision|1
2994129|NCT00984282|10303418|P2|Open-label Treatment|Switched to commercial drug|7
2994130|NCT00984282|10303419|P1|Open-label Treatment|Switched to commercial drug|6
2994131|NCT00984282|10303418|P2|Open-label Treatment|Transferred to treat. continuation study|3
2994132|NCT00984282|10303419|P1|Open-label Treatment|Transferred to treat. continuation study|2
2994133|NCT00984282|10303418|P2|Open-label Treatment|Protocol driven decision point|1
2994134|NCT00984282|10303419|P1|Open-label Treatment|Protocol driven decision point|1
2994135|NCT00984282|10303418|P2|Open-label Treatment|Target lesion removed|1
2994136|NCT00984282|10303419|P1|Open-label Treatment|Target lesion removed|0
2994137|NCT00984282|10303418|P2|Open-label Treatment|Non-compliant with study medication|0
2994138|NCT00984282|10303419|P1|Open-label Treatment|Non-compliant with study medication|1
2994139|NCT00984282|10303418|P2|Open-label Treatment|Patient convenience|0
2994140|NCT00984282|10303419|P1|Open-label Treatment|Patient convenience|1
2994141|NCT00984282|10303418|P2|Open-label Treatment|Lost to Follow-up|1
2994142|NCT00984282|10303419|P1|Open-label Treatment|Lost to Follow-up|1
2994143|NCT00984282|10303418|P2|Open-label Treatment|Progression, recurrence or relapse|82
2994144|NCT00984282|10303419|P1|Open-label Treatment|Progression, recurrence or relapse|40
2994145|NCT00984282|10303418|P2|Open-label Treatment|Death|15
2994146|NCT00984282|10303419|P1|Open-label Treatment|Death|7
2994147|NCT00984282|10303418|P2|Open-label Treatment|Withdrawal by Subject|21
2994148|NCT00984282|10303419|P1|Open-label Treatment|Withdrawal by Subject|6
2994149|NCT00984282|10303418|P2|Open-label Treatment|Adverse Event|30
2994150|NCT00984282|10303419|P1|Open-label Treatment|Adverse Event|20
2994151|NCT00984282|10303418|P2|Double Blind Treatment|Transferred to treat. continuation study|1
2994152|NCT00984282|10303419|P1|Double Blind Treatment|Transferred to treat. continuation study|2
2994153|NCT00984282|10303418|P2|Double Blind Treatment|Radiological and clinical progression|1
2994154|NCT00984282|10303419|P1|Double Blind Treatment|Radiological and clinical progression|0
2994155|NCT00984282|10303418|P2|Double Blind Treatment|protocol driven decision point|1
2994156|NCT00984282|10303419|P1|Double Blind Treatment|protocol driven decision point|1
2994157|NCT00984282|10303418|P2|Double Blind Treatment|Switched to commercial drug|1
2994158|NCT00984282|10303419|P1|Double Blind Treatment|Switched to commercial drug|6
2994159|NCT00984282|10303418|P2|Double Blind Treatment|Not treated|1
2994160|NCT00984282|10303419|P1|Double Blind Treatment|Not treated|0
2994161|NCT00984282|10303418|P2|Double Blind Treatment|Death|4
2994162|NCT00984282|10303419|P1|Double Blind Treatment|Death|8
2994163|NCT00984282|10303418|P2|Double Blind Treatment|Lost to Follow-up|0
2994164|NCT00984282|10303419|P1|Double Blind Treatment|Lost to Follow-up|3
2994165|NCT00984282|10303418|P2|Double Blind Treatment|Withdrawal by Subject|18
2994166|NCT00984282|10303419|P1|Double Blind Treatment|Withdrawal by Subject|13
2994167|NCT00984282|10303418|P2|Double Blind Treatment|Progression by clinical judgment|0
2994168|NCT00984282|10303419|P1|Double Blind Treatment|Progression by clinical judgment|2
2994169|NCT00984282|10303418|P2|Double Blind Treatment|Noncompliance with study medication|0
2994170|NCT00984282|10303419|P1|Double Blind Treatment|Noncompliance with study medication|3
2994171|NCT00984282|10303418|P2|Double Blind Treatment|Physician Decision|2
2994172|NCT00984282|10303419|P1|Double Blind Treatment|Physician Decision|1
2994173|NCT00984282|10303418|P2|Double Blind Treatment|Progression, recurrence or relapse|3
2994174|NCT00984282|10303419|P1|Double Blind Treatment|Progression, recurrence or relapse|25
2994175|NCT00984282|10303418|P2|Double Blind Treatment|Adverse Event|6
2994176|NCT00984282|10303419|P1|Double Blind Treatment|Adverse Event|40
2994177|NCT00984256|10303442|P2|Overall Study|Withdrawal by Subject|1
2994178|NCT00984256|10303443|P1|Overall Study|Withdrawal by Subject|0
2994179|NCT00984204|10303463|P1|Overall Study|Lack of Efficacy|10
2994180|NCT00984204|10303463|P1|Overall Study|Lost to Follow-up|4
2994181|NCT00984204|10303463|P1|Overall Study|Death|1
2994182|NCT00984165|10303473|P4|Overall Study|removed with a pair recipient|1
2994183|NCT00984165|10303474|P3|Overall Study|removed with a pair recipient|0
2994184|NCT00984165|10303475|P2|Overall Study|removed with a pair recipient|0
2994185|NCT00984165|10303476|P1|Overall Study|removed with a pair recipient|0
2994186|NCT00984165|10303473|P4|Overall Study|P+/donor pair removed from protocol|1
2994187|NCT00984165|10303474|P3|Overall Study|P+/donor pair removed from protocol|0
2994188|NCT00984165|10303475|P2|Overall Study|P+/donor pair removed from protocol|0
2994189|NCT00984165|10303476|P1|Overall Study|P+/donor pair removed from protocol|0
2994190|NCT00984165|10303473|P4|Overall Study|New protocol|1
2994191|NCT00984165|10303474|P3|Overall Study|New protocol|0
2994192|NCT00984165|10303475|P2|Overall Study|New protocol|0
2994193|NCT00984165|10303476|P1|Overall Study|New protocol|0
2994194|NCT00984165|10303473|P4|Overall Study|Death of recipient|1
2994195|NCT00984165|10303474|P3|Overall Study|Death of recipient|0
2994196|NCT00984165|10303475|P2|Overall Study|Death of recipient|0
2994197|NCT00984165|10303476|P1|Overall Study|Death of recipient|0
2994198|NCT00984165|10303473|P4|Overall Study|Disease progression on study|0
2994199|NCT00984165|10303474|P3|Overall Study|Disease progression on study|0
2994200|NCT00984165|10303475|P2|Overall Study|Disease progression on study|1
2994201|NCT00984165|10303476|P1|Overall Study|Disease progression on study|5
2994202|NCT00984165|10303473|P4|Overall Study|Death on study|0
2994203|NCT00984165|10303474|P3|Overall Study|Death on study|0
2994204|NCT00984165|10303475|P2|Overall Study|Death on study|0
2994205|NCT00984165|10303476|P1|Overall Study|Death on study|2
2994206|NCT00984126|10303505|P4|Overall Study|Withdrawal criteria|9
2994207|NCT00984126|10303506|P3|Overall Study|Withdrawal criteria|3
2994208|NCT00984126|10303507|P2|Overall Study|Withdrawal criteria|1
2994209|NCT00984126|10303508|P1|Overall Study|Withdrawal criteria|0
2994210|NCT00984126|10303505|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
2994211|NCT00984126|10303506|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
2994212|NCT00984126|10303507|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
2994213|NCT00984126|10303508|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
2994214|NCT00984126|10303505|P4|Overall Study|Adverse Event|2
2994215|NCT00984126|10303506|P3|Overall Study|Adverse Event|0
2994216|NCT00984126|10303507|P2|Overall Study|Adverse Event|0
2994217|NCT00984126|10303508|P1|Overall Study|Adverse Event|0
2994218|NCT00984126|10303505|P4|Overall Study|Protocol Violation|2
2994219|NCT00984126|10303506|P3|Overall Study|Protocol Violation|1
2994220|NCT00984126|10303507|P2|Overall Study|Protocol Violation|0
2994221|NCT00984126|10303508|P1|Overall Study|Protocol Violation|0
2994222|NCT00984061|10303533|P1|Clarithromycin Alone|Protocol Violation|1
2994223|NCT00984022|10303546|P2|Overall Study|Lost to Follow-up|14
2994224|NCT00984022|10303547|P1|Overall Study|Lost to Follow-up|10
2994225|NCT00984009|10303557|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
2994226|NCT00983957|10303590|P1|Overall Study|Personal Reasons|1
2994227|NCT00983957|10303590|P1|Overall Study|Adverse Event|1
2994228|NCT00983931|10303624|P1|14 Day Washout Period|Physician Decision|1
2994229|NCT00983918|10303638|P4|Overall Study|conversion to open cholecystectomy|2
2994230|NCT00983918|10303639|P3|Overall Study|conversion to open cholecystectomy|2
2994231|NCT00983918|10303640|P2|Overall Study|conversion to open cholecystectomy|2
2994232|NCT00983918|10303641|P1|Overall Study|conversion to open cholecystectomy|0
2994233|NCT00983905|10303651|P1|Colchicine Alone|Adverse Event|2
2994234|NCT00983905|10303651|P1|Theophylline Alone|Adverse Event|1
2994235|NCT00983892|10303664|P2|Overall Study|Withdrawal by Subject|12
2994236|NCT00983892|10303665|P1|Overall Study|Withdrawal by Subject|10
2994237|NCT00983853|10303677|P6|Overall Study|Unable to come to study follow-up visits|0
2994238|NCT00983853|10303678|P5|Overall Study|Unable to come to study follow-up visits|0
2994239|NCT00983853|10303679|P4|Overall Study|Unable to come to study follow-up visits|0
2994240|NCT00983853|10303680|P3|Overall Study|Unable to come to study follow-up visits|0
2994241|NCT00983853|10303681|P2|Overall Study|Unable to come to study follow-up visits|1
2994242|NCT00983853|10303682|P1|Overall Study|Unable to come to study follow-up visits|0
2994243|NCT00983853|10303677|P6|Overall Study|Withdrawal by Subject|0
2994244|NCT00983853|10303678|P5|Overall Study|Withdrawal by Subject|1
2994245|NCT00983853|10303679|P4|Overall Study|Withdrawal by Subject|0
2994246|NCT00983853|10303680|P3|Overall Study|Withdrawal by Subject|1
2994247|NCT00983853|10303681|P2|Overall Study|Withdrawal by Subject|0
2994248|NCT00983853|10303682|P1|Overall Study|Withdrawal by Subject|0
2994249|NCT00983853|10303677|P6|Overall Study|Lost to Follow-up|1
2994250|NCT00983853|10303678|P5|Overall Study|Lost to Follow-up|2
2994251|NCT00983853|10303679|P4|Overall Study|Lost to Follow-up|2
2994252|NCT00983853|10303680|P3|Overall Study|Lost to Follow-up|2
2994253|NCT00983853|10303681|P2|Overall Study|Lost to Follow-up|1
2994254|NCT00983853|10303682|P1|Overall Study|Lost to Follow-up|1
2994255|NCT00983827|10303710|P1|Overall Study|Withdrawal by Subject|1
2994256|NCT00983749|10303728|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
2994257|NCT00983749|10303729|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
2994258|NCT00983619|10303764|P12|Overall Study|Other|0
2994259|NCT00983619|10303765|P11|Overall Study|Other|1
2994260|NCT00983619|10303766|P10|Overall Study|Other|1
2994261|NCT00983619|10303767|P9|Overall Study|Other|0
2994262|NCT00983619|10303768|P8|Overall Study|Other|2
2994263|NCT00983619|10303769|P7|Overall Study|Other|2
2994264|NCT00983619|10303770|P6|Overall Study|Other|12
2994265|NCT00983619|10303771|P5|Overall Study|Other|0
2994266|NCT00983619|10303772|P4|Overall Study|Other|1
2994267|NCT00983619|10303773|P3|Overall Study|Other|0
2994268|NCT00983619|10303774|P2|Overall Study|Other|0
2994269|NCT00983619|10303775|P1|Overall Study|Other|1
2994270|NCT00983619|10303764|P12|Overall Study|Death|8
2994271|NCT00983619|10303765|P11|Overall Study|Death|9
2994272|NCT00983619|10303766|P10|Overall Study|Death|2
2994273|NCT00983619|10303767|P9|Overall Study|Death|1
2994274|NCT00983619|10303768|P8|Overall Study|Death|0
2994275|NCT00983619|10303769|P7|Overall Study|Death|1
2994276|NCT00983619|10303770|P6|Overall Study|Death|30
2994277|NCT00983619|10303771|P5|Overall Study|Death|2
2994278|NCT00983619|10303772|P4|Overall Study|Death|1
2994279|NCT00983619|10303773|P3|Overall Study|Death|2
2994280|NCT00983619|10303774|P2|Overall Study|Death|2
2994281|NCT00983619|10303775|P1|Overall Study|Death|0
2994282|NCT00983619|10303764|P12|Overall Study|Withdrawal by Subject|1
2994283|NCT00983619|10303765|P11|Overall Study|Withdrawal by Subject|1
2994284|NCT00983619|10303766|P10|Overall Study|Withdrawal by Subject|0
2994285|NCT00983619|10303767|P9|Overall Study|Withdrawal by Subject|0
2994286|NCT00983619|10303768|P8|Overall Study|Withdrawal by Subject|0
2994287|NCT00983619|10303769|P7|Overall Study|Withdrawal by Subject|0
2994288|NCT00983619|10303770|P6|Overall Study|Withdrawal by Subject|23
2994289|NCT00983619|10303771|P5|Overall Study|Withdrawal by Subject|1
2994290|NCT00983619|10303772|P4|Overall Study|Withdrawal by Subject|3
2994291|NCT00983619|10303773|P3|Overall Study|Withdrawal by Subject|1
2994292|NCT00983619|10303774|P2|Overall Study|Withdrawal by Subject|1
2994293|NCT00983619|10303775|P1|Overall Study|Withdrawal by Subject|2
2994294|NCT00983619|10303764|P12|Overall Study|Lost to Follow-up|2
2994295|NCT00983619|10303765|P11|Overall Study|Lost to Follow-up|0
2994296|NCT00983619|10303766|P10|Overall Study|Lost to Follow-up|0
2994297|NCT00983619|10303767|P9|Overall Study|Lost to Follow-up|0
2994298|NCT00983619|10303768|P8|Overall Study|Lost to Follow-up|0
2994299|NCT00983619|10303769|P7|Overall Study|Lost to Follow-up|0
2994300|NCT00983619|10303770|P6|Overall Study|Lost to Follow-up|2
2994301|NCT00983619|10303771|P5|Overall Study|Lost to Follow-up|0
2994302|NCT00983619|10303772|P4|Overall Study|Lost to Follow-up|0
2994303|NCT00983619|10303773|P3|Overall Study|Lost to Follow-up|0
2994304|NCT00983619|10303774|P2|Overall Study|Lost to Follow-up|1
2994305|NCT00983619|10303775|P1|Overall Study|Lost to Follow-up|0
2994306|NCT00983580|10304080|P2|Overall Study|Ineligible|0
2994307|NCT00983580|10304081|P1|Overall Study|Ineligible|3
2994308|NCT00983580|10304080|P2|Overall Study|Protocol Violation|1
2994309|NCT00983580|10304081|P1|Overall Study|Protocol Violation|1
2994310|NCT00983580|10304080|P2|Overall Study|Cancel Prior to treatment|3
2994311|NCT00983580|10304081|P1|Overall Study|Cancel Prior to treatment|1
2994312|NCT00983515|10304107|P1|Colchicine With Ritonavir|Lost to Follow-up|1
2994313|NCT00983515|10304107|P1|Ritonavir Alone|liver panel out of range|6
2994314|NCT00983476|10304134|P3|Overall Study|Did not receive intervention|0
2994315|NCT00983476|10304135|P2|Overall Study|Did not receive intervention|22
2994316|NCT00983476|10304136|P1|Overall Study|Did not receive intervention|17
2994317|NCT00983437|10304168|P1|Overall Study|Other Reason|26
2994318|NCT00983437|10304168|P1|Overall Study|Lost to Follow-up|2
2994319|NCT00983437|10304168|P1|Overall Study|Noncompliance to Study Procedures|1
2994320|NCT00983437|10304168|P1|Overall Study|Withdrawal by Subject|8
2994321|NCT00983437|10304168|P1|Overall Study|Lack of Efficacy|1
2994322|NCT00983437|10304168|P1|Overall Study|Adverse Event|9
2994323|NCT00983385|10304187|P1|Observation Period|Not Evaluable due to Non Compliance|12
2994324|NCT00983385|10304187|P1|Observation Period|Not eligible to be dosed|20
2994325|NCT00983372|10304232|P1|Diltiazem ER Alone|Adverse Event|1
2994326|NCT00983372|10304232|P1|Diltiazem ER Alone|missed diltiazem dose|2
2994327|NCT00983372|10304232|P1|14 Day Washout Period|Withdrawal by Subject|1
2994328|NCT00983294|10304259|P1|Colchicine With Azithromycin|Adverse Event|1
2994329|NCT00983294|10304259|P1|14 Day Washout Period|Withdrawal by Subject|2
2994330|NCT00983073|10304301|P1|Maintenance Period|Other Reason|7
2994331|NCT00983073|10304301|P1|Maintenance Period|Lack of Efficacy|2
2994332|NCT00983073|10304301|P1|Maintenance Period|Withdrawal by Subject|2
2994333|NCT00983073|10304301|P1|Maintenance Period|Adverse Event|5
2994334|NCT00983073|10304301|P1|Titration and Optimal Dose Period|Other reason|4
2994335|NCT00983073|10304301|P1|Titration and Optimal Dose Period|Non-Compliance|1
2994336|NCT00983073|10304301|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
2994337|NCT00983073|10304301|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
2994338|NCT00983073|10304301|P1|Titration and Optimal Dose Period|Adverse Event|19
2994339|NCT00982878|10304327|P1|Overall Study|Physician Decision|1
2994340|NCT00982735|10304625|P1|Overall Study|Patient ineligible for trial|224
2994341|NCT00982735|10304625|P1|Overall Study|Lost to Follow-up|6
2994342|NCT00982657|10304635|P4|Overall Study|On going at date of cut-off|1
2994343|NCT00982657|10304636|P3|Overall Study|On going at date of cut-off|0
2994344|NCT00982657|10304637|P2|Overall Study|On going at date of cut-off|0
2994345|NCT00982657|10304638|P1|Overall Study|On going at date of cut-off|0
2994346|NCT00982657|10304635|P4|Overall Study|Other|4
2994347|NCT00982657|10304636|P3|Overall Study|Other|0
2994348|NCT00982657|10304637|P2|Overall Study|Other|0
2994349|NCT00982657|10304638|P1|Overall Study|Other|0
2994350|NCT00982657|10304635|P4|Overall Study|Withdrawal by Subject|3
2994351|NCT00982657|10304636|P3|Overall Study|Withdrawal by Subject|1
2994352|NCT00982657|10304637|P2|Overall Study|Withdrawal by Subject|0
2994353|NCT00982657|10304638|P1|Overall Study|Withdrawal by Subject|0
2994354|NCT00982657|10304635|P4|Overall Study|Death|1
2994355|NCT00982657|10304636|P3|Overall Study|Death|1
2994356|NCT00982657|10304637|P2|Overall Study|Death|0
2994357|NCT00982657|10304638|P1|Overall Study|Death|1
2994358|NCT00982644|10304679|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
2994359|NCT00982644|10304680|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
2994360|NCT00982644|10304679|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
2994361|NCT00982644|10304680|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
2994362|NCT00982644|10304679|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
2994363|NCT00982644|10304680|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
2994364|NCT00982644|10304679|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
2994365|NCT00982644|10304680|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
2994366|NCT00982644|10304679|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
2994367|NCT00982644|10304680|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
2994368|NCT00982644|10304679|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
2994369|NCT00982644|10304680|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
2994370|NCT00982644|10304679|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
2994371|NCT00982644|10304680|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
2994372|NCT00982644|10304679|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
2994373|NCT00982644|10304680|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
2994374|NCT00982644|10304679|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
2994375|NCT00982644|10304680|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
2994376|NCT00982644|10304679|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
2994377|NCT00982644|10304680|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
2994378|NCT00982488|10304735|P5|Overall Study|Withdrawal by Subject|0
2994379|NCT00982488|10304736|P4|Overall Study|Withdrawal by Subject|0
2994380|NCT00982488|10304737|P3|Overall Study|Withdrawal by Subject|1
2994381|NCT00982488|10304738|P2|Overall Study|Withdrawal by Subject|1
2994382|NCT00982488|10304739|P1|Overall Study|Withdrawal by Subject|5
2994383|NCT00982488|10304735|P5|Overall Study|Study drug toxicity|0
2994384|NCT00982488|10304736|P4|Overall Study|Study drug toxicity|0
2994385|NCT00982488|10304737|P3|Overall Study|Study drug toxicity|6
2994386|NCT00982488|10304738|P2|Overall Study|Study drug toxicity|1
2994387|NCT00982488|10304739|P1|Overall Study|Study drug toxicity|34
2994388|NCT00982488|10304735|P5|Overall Study|Stem cell transplant|0
2994389|NCT00982488|10304736|P4|Overall Study|Stem cell transplant|1
2994390|NCT00982488|10304737|P3|Overall Study|Stem cell transplant|0
2994391|NCT00982488|10304738|P2|Overall Study|Stem cell transplant|0
2994392|NCT00982488|10304739|P1|Overall Study|Stem cell transplant|2
2994393|NCT00982488|10304735|P5|Overall Study|Poor compliance/noncompliance|0
2994394|NCT00982488|10304736|P4|Overall Study|Poor compliance/noncompliance|0
2994395|NCT00982488|10304737|P3|Overall Study|Poor compliance/noncompliance|0
2994396|NCT00982488|10304738|P2|Overall Study|Poor compliance/noncompliance|1
2994397|NCT00982488|10304739|P1|Overall Study|Poor compliance/noncompliance|0
2994398|NCT00982488|10304735|P5|Overall Study|Other|0
2994399|NCT00982488|10304736|P4|Overall Study|Other|1
2994400|NCT00982488|10304737|P3|Overall Study|Other|3
2994401|NCT00982488|10304738|P2|Overall Study|Other|1
2994402|NCT00982488|10304739|P1|Overall Study|Other|15
2994403|NCT00982488|10304735|P5|Overall Study|Maximum clinical benefit|0
2994404|NCT00982488|10304736|P4|Overall Study|Maximum clinical benefit|0
2994405|NCT00982488|10304737|P3|Overall Study|Maximum clinical benefit|1
2994406|NCT00982488|10304738|P2|Overall Study|Maximum clinical benefit|1
2994407|NCT00982488|10304739|P1|Overall Study|Maximum clinical benefit|1
2994408|NCT00982488|10304735|P5|Overall Study|Lost to Follow-up|0
2994409|NCT00982488|10304736|P4|Overall Study|Lost to Follow-up|0
2994410|NCT00982488|10304737|P3|Overall Study|Lost to Follow-up|0
2994411|NCT00982488|10304738|P2|Overall Study|Lost to Follow-up|0
2994412|NCT00982488|10304739|P1|Overall Study|Lost to Follow-up|1
2994413|NCT00982488|10304735|P5|Overall Study|Disease progression|1
2994414|NCT00982488|10304736|P4|Overall Study|Disease progression|1
2994415|NCT00982488|10304737|P3|Overall Study|Disease progression|10
2994416|NCT00982488|10304738|P2|Overall Study|Disease progression|5
2994417|NCT00982488|10304739|P1|Overall Study|Disease progression|30
2994418|NCT00982488|10304735|P5|Overall Study|Death|0
2994419|NCT00982488|10304736|P4|Overall Study|Death|0
2994420|NCT00982488|10304737|P3|Overall Study|Death|2
2994421|NCT00982488|10304738|P2|Overall Study|Death|0
2994422|NCT00982488|10304739|P1|Overall Study|Death|11
2994423|NCT00982488|10304735|P5|Overall Study|Adverse event unrelated to study drug|0
2994424|NCT00982488|10304736|P4|Overall Study|Adverse event unrelated to study drug|0
2994425|NCT00982488|10304737|P3|Overall Study|Adverse event unrelated to study drug|0
2994426|NCT00982488|10304738|P2|Overall Study|Adverse event unrelated to study drug|1
2994427|NCT00982488|10304739|P1|Overall Study|Adverse event unrelated to study drug|5
2994428|NCT00982488|10304735|P5|Overall Study|Administrative reason by sponsor|0
2994429|NCT00982488|10304736|P4|Overall Study|Administrative reason by sponsor|0
2994430|NCT00982488|10304737|P3|Overall Study|Administrative reason by sponsor|11
2994431|NCT00982488|10304738|P2|Overall Study|Administrative reason by sponsor|3
2994432|NCT00982488|10304739|P1|Overall Study|Administrative reason by sponsor|81
2994433|NCT00982410|10304772|P2|12-month Follow-up Assessment|scheduled, no-show|0
2994434|NCT00982410|10304773|P1|12-month Follow-up Assessment|scheduled, no-show|1
2994435|NCT00982410|10304772|P2|12-month Follow-up Assessment|incarceration|1
2994436|NCT00982410|10304773|P1|12-month Follow-up Assessment|incarceration|2
2994437|NCT00982410|10304772|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
2994438|NCT00982410|10304773|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
2994439|NCT00982410|10304772|P2|12-month Follow-up Assessment|could not reach to schedule|5
2994440|NCT00982410|10304773|P1|12-month Follow-up Assessment|could not reach to schedule|6
2994441|NCT00982410|10304772|P2|12-month Follow-up Assessment|Death|2
2994442|NCT00982410|10304773|P1|12-month Follow-up Assessment|Death|0
2994443|NCT00982410|10304772|P2|6-month Follow-up Assessment|scheduled, no-show|1
2994444|NCT00982410|10304773|P1|6-month Follow-up Assessment|scheduled, no-show|0
2994445|NCT00982410|10304772|P2|6-month Follow-up Assessment|patent surgery|1
2994446|NCT00982410|10304773|P1|6-month Follow-up Assessment|patent surgery|0
2994447|NCT00982410|10304772|P2|6-month Follow-up Assessment|incarceration|2
2994448|NCT00982410|10304773|P1|6-month Follow-up Assessment|incarceration|0
2994449|NCT00982410|10304772|P2|6-month Follow-up Assessment|participant no transportation|0
2994450|NCT00982410|10304773|P1|6-month Follow-up Assessment|participant no transportation|1
2994451|NCT00982410|10304772|P2|6-month Follow-up Assessment|Could not reach to schedule|7
2994452|NCT00982410|10304773|P1|6-month Follow-up Assessment|Could not reach to schedule|5
2994453|NCT00982410|10304772|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
2994454|NCT00982410|10304773|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
2994455|NCT00982410|10304772|P2|3-month Follow-up Assessment|Scheduled, no-show|2
2994456|NCT00982410|10304773|P1|3-month Follow-up Assessment|Scheduled, no-show|1
2994457|NCT00982410|10304772|P2|3-month Follow-up Assessment|Could not reach to schedule|9
2994458|NCT00982410|10304773|P1|3-month Follow-up Assessment|Could not reach to schedule|8
2994459|NCT00982319|10304814|P2|Overall Study|Pregnancy|1
2994460|NCT00982319|10304815|P1|Overall Study|Pregnancy|0
2994461|NCT00982319|10304814|P2|Overall Study|Preop values out of acceptable range|1
2994462|NCT00982319|10304815|P1|Overall Study|Preop values out of acceptable range|1
2994463|NCT00982319|10304814|P2|Overall Study|Surgery date change|0
2994464|NCT00982319|10304815|P1|Overall Study|Surgery date change|1
2994465|NCT00982280|10304823|P1|Maintenance Period|Adverse Event|1
2994466|NCT00982280|10304823|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
2994467|NCT00982280|10304823|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
2994468|NCT00982280|10304823|P1|Titration and Optimal Dose Period|Adverse Event|5
2994469|NCT00982280|10304823|P1|Observation Period|Not eligible to be dosed|19
2994470|NCT00982228|10304848|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
2994471|NCT00982228|10304849|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
2994472|NCT00982228|10304848|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
2994473|NCT00982228|10304849|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
2994474|NCT00982228|10304848|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
2994475|NCT00982228|10304849|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
2994476|NCT00982228|10304848|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
2994477|NCT00982228|10304849|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
2994478|NCT00982228|10304848|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
2994479|NCT00982228|10304849|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
2994480|NCT00982228|10304848|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
2994481|NCT00982228|10304849|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
2994482|NCT00982228|10304848|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
2994483|NCT00982228|10304849|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
2994484|NCT00982228|10304848|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
2994485|NCT00982228|10304849|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
2994486|NCT00982228|10304848|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
2994487|NCT00982228|10304849|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
2994488|NCT00982228|10304848|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
2994489|NCT00982228|10304849|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
2994490|NCT00982137|10304908|P4|Overall Study|Withdrawal by Subject|0
2994491|NCT00982137|10304909|P3|Overall Study|Withdrawal by Subject|0
2994492|NCT00982137|10304910|P2|Overall Study|Withdrawal by Subject|1
2994493|NCT00982137|10304911|P1|Overall Study|Withdrawal by Subject|0
2994494|NCT00982137|10304908|P4|Overall Study|Lost to Follow-up|1
2994495|NCT00982137|10304909|P3|Overall Study|Lost to Follow-up|0
2994496|NCT00982137|10304910|P2|Overall Study|Lost to Follow-up|0
2994497|NCT00982137|10304911|P1|Overall Study|Lost to Follow-up|0
2994498|NCT00982111|10304943|P2|Overall Study|Withdrawal by Subject|17
2994499|NCT00982111|10304944|P1|Overall Study|Withdrawal by Subject|16
2994500|NCT00982111|10304943|P2|Overall Study|On Study Treatment at Conclusion|0
2994501|NCT00982111|10304944|P1|Overall Study|On Study Treatment at Conclusion|7
2994502|NCT00982111|10304943|P2|Overall Study|New Anti-Cancer Therapy|5
2994503|NCT00982111|10304944|P1|Overall Study|New Anti-Cancer Therapy|5
2994504|NCT00982111|10304943|P2|Overall Study|Lost to Follow-up|6
2994505|NCT00982111|10304944|P1|Overall Study|Lost to Follow-up|9
2994506|NCT00982111|10304943|P2|Overall Study|Progressive Disease|37
2994507|NCT00982111|10304944|P1|Overall Study|Progressive Disease|37
2994508|NCT00982111|10304943|P2|Overall Study|Adverse Event|1
2994509|NCT00982111|10304944|P1|Overall Study|Adverse Event|1
2994510|NCT00982020|10304977|P2|Overall Study|Clinical Relapse|1
2994511|NCT00982020|10304978|P1|Overall Study|Clinical Relapse|0
2994512|NCT00982020|10304977|P2|Overall Study|Protocol Violation|2
2994513|NCT00982020|10304978|P1|Overall Study|Protocol Violation|0
2994514|NCT00982020|10304977|P2|Overall Study|Entry Criteria Not Met|1
2994515|NCT00982020|10304978|P1|Overall Study|Entry Criteria Not Met|2
2994516|NCT00982020|10304977|P2|Overall Study|Physician Decision|5
2994517|NCT00982020|10304978|P1|Overall Study|Physician Decision|2
2994518|NCT00982020|10304977|P2|Overall Study|Treatment Non-compliance|6
2994519|NCT00982020|10304978|P1|Overall Study|Treatment Non-compliance|3
2994520|NCT00982020|10304977|P2|Overall Study|Parent/Caregiver Decision|5
2994521|NCT00982020|10304978|P1|Overall Study|Parent/Caregiver Decision|5
2994522|NCT00982020|10304977|P2|Overall Study|Lack of Efficacy|4
2994523|NCT00982020|10304978|P1|Overall Study|Lack of Efficacy|10
2994524|NCT00982020|10304977|P2|Overall Study|Lost to Follow-up|11
2994525|NCT00982020|10304978|P1|Overall Study|Lost to Follow-up|5
2994526|NCT00982020|10304977|P2|Overall Study|Withdrawal by Subject|14
2994527|NCT00982020|10304978|P1|Overall Study|Withdrawal by Subject|11
2994528|NCT00982020|10304977|P2|Overall Study|Adverse Event|15
2994529|NCT00982020|10304978|P1|Overall Study|Adverse Event|19
2994530|NCT00981747|10305028|P1|Placebo Oral Tablet|Withdrawal by Subject|1
2994531|NCT00981747|10305028|P1|Losartan|Death|1
2994532|NCT00981747|10305028|P1|Losartan|Withdrawal by Subject|1
2994533|NCT00981578|10305094|P1|Overall Study|Withdrawal by Subject|2
2994534|NCT00981578|10305094|P1|Overall Study|Death|1
2994535|NCT00981526|10305102|P2|Overall Study|Physician Decision|4
2994536|NCT00981526|10305103|P1|Overall Study|Physician Decision|4
2994537|NCT00981526|10305102|P2|Overall Study|Withdrawal by Subject|2
2994538|NCT00981526|10305103|P1|Overall Study|Withdrawal by Subject|0
2994539|NCT00981461|10305121|P2|Overall Study|Lost to Follow-up|2
2994540|NCT00981461|10305122|P1|Overall Study|Lost to Follow-up|5
2994541|NCT00981409|10305146|P2|Overall Study|Prostate Cancer Treatment before Trial|0
2994542|NCT00981409|10305147|P1|Overall Study|Prostate Cancer Treatment before Trial|2
2994543|NCT00981409|10305146|P2|Overall Study|Protocol Violation|1
2994544|NCT00981409|10305147|P1|Overall Study|Protocol Violation|0
2994545|NCT00981409|10305146|P2|Overall Study|Adverse Event|0
2994546|NCT00981409|10305147|P1|Overall Study|Adverse Event|4
2994547|NCT00981292|10305186|P6|Day 3|Protocol Violation|1
2994548|NCT00981292|10305187|P5|Day 3|Protocol Violation|0
2994549|NCT00981292|10305188|P4|Day 3|Protocol Violation|0
2994550|NCT00981292|10305189|P3|Day 3|Protocol Violation|0
2994551|NCT00981292|10305190|P2|Day 3|Protocol Violation|0
2994552|NCT00981292|10305191|P1|Day 3|Protocol Violation|0
2994553|NCT00981292|10305186|P6|Day 2|Protocol Violation|0
2994554|NCT00981292|10305187|P5|Day 2|Protocol Violation|0
2994555|NCT00981292|10305188|P4|Day 2|Protocol Violation|0
2994556|NCT00981292|10305189|P3|Day 2|Protocol Violation|0
2994557|NCT00981292|10305190|P2|Day 2|Protocol Violation|0
2994558|NCT00981292|10305191|P1|Day 2|Protocol Violation|2
2994559|NCT00981292|10305186|P6|Day 1|Protocol Violation|2
2994560|NCT00981292|10305187|P5|Day 1|Protocol Violation|0
2994561|NCT00981292|10305188|P4|Day 1|Protocol Violation|0
2994562|NCT00981292|10305189|P3|Day 1|Protocol Violation|0
2994563|NCT00981292|10305190|P2|Day 1|Protocol Violation|0
2994564|NCT00981292|10305191|P1|Day 1|Protocol Violation|1
2994565|NCT00981175|10305275|P2|Booster Dose Vaccination|Lost to Follow-up|3
2994566|NCT00981175|10305276|P1|Booster Dose Vaccination|Lost to Follow-up|2
2994567|NCT00981175|10305275|P2|Primary Dose Vaccination|Lost to Follow-up|1
2994568|NCT00981175|10305276|P1|Primary Dose Vaccination|Lost to Follow-up|2
2994569|NCT00981175|10305275|P2|Primary Dose Vaccination|Protocol Violation|1
2994570|NCT00981175|10305276|P1|Primary Dose Vaccination|Protocol Violation|0
2994571|NCT00981175|10305275|P2|Primary Dose Vaccination|Adverse Event|0
2994572|NCT00981175|10305276|P1|Primary Dose Vaccination|Adverse Event|1
2994573|NCT00981149|10305301|P2|Overall Study|Withdrawal by Subject|1
2994574|NCT00981149|10305302|P1|Overall Study|Withdrawal by Subject|1
2994575|NCT00981149|10305301|P2|Overall Study|Lost to Follow-up|2
2994576|NCT00981149|10305302|P1|Overall Study|Lost to Follow-up|1
2994577|NCT00981084|10305312|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
2994578|NCT00981084|10305313|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
2994579|NCT00981084|10305312|P2|Post Intervention (Data Analysis)|poor effort|1
2994580|NCT00981084|10305313|P1|Post Intervention (Data Analysis)|poor effort|1
2994581|NCT00981058|10305329|P2|Overall Study|On study treatment at conclusion|0
2994582|NCT00981058|10305330|P1|Overall Study|On study treatment at conclusion|9
2994583|NCT00981058|10305329|P2|Overall Study|Withdrawal by Subject|23
2994584|NCT00981058|10305330|P1|Overall Study|Withdrawal by Subject|25
2994585|NCT00981058|10305329|P2|Overall Study|Randomization Error|2
2994586|NCT00981058|10305330|P1|Overall Study|Randomization Error|1
2994587|NCT00981058|10305329|P2|Overall Study|Radiologist Error|1
2994588|NCT00981058|10305330|P1|Overall Study|Radiologist Error|0
2994589|NCT00981058|10305329|P2|Overall Study|Noncompliance|0
2994590|NCT00981058|10305330|P1|Overall Study|Noncompliance|1
2994591|NCT00981058|10305329|P2|Overall Study|New Anticancer Therapy|6
2994592|NCT00981058|10305330|P1|Overall Study|New Anticancer Therapy|6
2994593|NCT00981058|10305329|P2|Overall Study|Lost to Follow-up|15
2994594|NCT00981058|10305330|P1|Overall Study|Lost to Follow-up|16
2994595|NCT00981058|10305329|P2|Overall Study|Progressive Disease|49
2994596|NCT00981058|10305330|P1|Overall Study|Progressive Disease|61
2994597|NCT00981058|10305329|P2|Overall Study|Adverse Event|1
2994598|NCT00981058|10305330|P1|Overall Study|Adverse Event|1
2994599|NCT00981019|10305361|P1|Overall Study|Hit the survey after closure|79
2994600|NCT00981019|10305361|P1|Overall Study|Inadvertent exclusion|239
2994601|NCT00981019|10305361|P1|Overall Study|Did not match target population|94
2994602|NCT00981019|10305361|P1|Overall Study|Did not respond|65
2994603|NCT00980980|10305368|P3|Overall Study|Withdrawal by Hospital|0
2994604|NCT00980980|10305369|P2|Overall Study|Withdrawal by Hospital|1
2994605|NCT00980980|10305370|P1|Overall Study|Withdrawal by Hospital|0
2994606|NCT00980798|10305401|P2|Overall Study|Other|1
2994607|NCT00980798|10305402|P1|Overall Study|Other|0
2994608|NCT00980798|10305401|P2|Overall Study|Withdrawal by Subject|11
2994609|NCT00980798|10305402|P1|Overall Study|Withdrawal by Subject|8
2994610|NCT00980798|10305401|P2|Overall Study|Physician Decision|1
2994611|NCT00980798|10305402|P1|Overall Study|Physician Decision|2
2994612|NCT00980798|10305401|P2|Overall Study|Lost to Follow-up|1
2994613|NCT00980798|10305402|P1|Overall Study|Lost to Follow-up|0
2994614|NCT00980798|10305401|P2|Overall Study|Lack of Efficacy|5
2994615|NCT00980798|10305402|P1|Overall Study|Lack of Efficacy|16
2994616|NCT00980798|10305401|P2|Overall Study|Adverse Event|36
2994617|NCT00980798|10305402|P1|Overall Study|Adverse Event|7
2994618|NCT00980655|10305443|P2|Overall Study|Other|1
2994619|NCT00980655|10305444|P1|Overall Study|Other|0
2994620|NCT00980655|10305443|P2|Overall Study|Parent/legal guardian request|0
2994621|NCT00980655|10305444|P1|Overall Study|Parent/legal guardian request|1
2994622|NCT00980655|10305443|P2|Overall Study|Lost to Follow-up|1
2994623|NCT00980655|10305444|P1|Overall Study|Lost to Follow-up|0
2994624|NCT00980655|10305443|P2|Overall Study|Withdrawal by Subject|4
2994625|NCT00980655|10305444|P1|Overall Study|Withdrawal by Subject|0
2994626|NCT00980655|10305443|P2|Overall Study|Protocol Violation|7
2994627|NCT00980655|10305444|P1|Overall Study|Protocol Violation|2
2994628|NCT00980655|10305443|P2|Overall Study|Death|7
2994629|NCT00980655|10305444|P1|Overall Study|Death|0
2994630|NCT00980655|10305443|P2|Overall Study|Adverse Event|31
2994631|NCT00980655|10305444|P1|Overall Study|Adverse Event|13
2994632|NCT00980343|10305527|P2|Overall Study|no tumor at surgery - treatment effect|3
2994633|NCT00980343|10305528|P1|Overall Study|no tumor at surgery - treatment effect|1
2994634|NCT00980330|10305552|P7|Overall Study|(not specified)|0
2994635|NCT00980330|10305553|P6|Overall Study|(not specified)|1
2994636|NCT00980330|10305554|P5|Overall Study|(not specified)|1
2994637|NCT00980330|10305555|P4|Overall Study|(not specified)|1
2994638|NCT00980330|10305556|P3|Overall Study|(not specified)|0
2994639|NCT00980330|10305557|P2|Overall Study|(not specified)|0
2994640|NCT00980330|10305558|P1|Overall Study|(not specified)|2
2994641|NCT00980330|10305552|P7|Overall Study|Withdrawal by Subject|5
2994642|NCT00980330|10305553|P6|Overall Study|Withdrawal by Subject|2
2994643|NCT00980330|10305554|P5|Overall Study|Withdrawal by Subject|3
2994644|NCT00980330|10305555|P4|Overall Study|Withdrawal by Subject|1
2994645|NCT00980330|10305556|P3|Overall Study|Withdrawal by Subject|4
2994646|NCT00980330|10305557|P2|Overall Study|Withdrawal by Subject|4
2994647|NCT00980330|10305558|P1|Overall Study|Withdrawal by Subject|2
2994648|NCT00980330|10305552|P7|Overall Study|Lost to Follow-up|2
2994649|NCT00980330|10305553|P6|Overall Study|Lost to Follow-up|1
2994650|NCT00980330|10305554|P5|Overall Study|Lost to Follow-up|1
2994651|NCT00980330|10305555|P4|Overall Study|Lost to Follow-up|2
2994652|NCT00980330|10305556|P3|Overall Study|Lost to Follow-up|4
2994653|NCT00980330|10305557|P2|Overall Study|Lost to Follow-up|1
2994654|NCT00980330|10305558|P1|Overall Study|Lost to Follow-up|1
2994655|NCT00980330|10305552|P7|Overall Study|Adverse Event|0
2994656|NCT00980330|10305553|P6|Overall Study|Adverse Event|0
2994657|NCT00980330|10305554|P5|Overall Study|Adverse Event|0
2994658|NCT00980330|10305555|P4|Overall Study|Adverse Event|1
2994659|NCT00980330|10305556|P3|Overall Study|Adverse Event|0
2994660|NCT00980330|10305557|P2|Overall Study|Adverse Event|0
2994661|NCT00980330|10305558|P1|Overall Study|Adverse Event|0
2994662|NCT00980200|10305673|P5|7-day Treatment Period 3|Lack of Efficacy|1
2994663|NCT00980200|10305674|P4|7-day Treatment Period 3|Lack of Efficacy|0
2994664|NCT00980200|10305675|P3|7-day Treatment Period 3|Lack of Efficacy|0
2994665|NCT00980200|10305676|P2|7-day Treatment Period 3|Lack of Efficacy|1
2994666|NCT00980200|10305677|P1|7-day Treatment Period 3|Lack of Efficacy|0
2994667|NCT00980200|10305673|P5|7-day Treatment Period 1|Withdrawal by Subject|0
2994668|NCT00980200|10305674|P4|7-day Treatment Period 1|Withdrawal by Subject|0
2994669|NCT00980200|10305675|P3|7-day Treatment Period 1|Withdrawal by Subject|0
2994670|NCT00980200|10305676|P2|7-day Treatment Period 1|Withdrawal by Subject|1
2994671|NCT00980200|10305677|P1|7-day Treatment Period 1|Withdrawal by Subject|0
2994672|NCT00980174|10305696|P2|Overall Study|Other|1
2994673|NCT00980174|10305697|P1|Overall Study|Other|0
2994674|NCT00980174|10305696|P2|Overall Study|Death|1
2994675|NCT00980174|10305697|P1|Overall Study|Death|1
2994676|NCT00980174|10305696|P2|Overall Study|Ineligibility determined|1
2994677|NCT00980174|10305697|P1|Overall Study|Ineligibility determined|2
2994678|NCT00980174|10305696|P2|Overall Study|Adverse Event|3
2994679|NCT00980174|10305697|P1|Overall Study|Adverse Event|0
2994680|NCT00980174|10305696|P2|Overall Study|Withdrawal by Subject|4
2994681|NCT00980174|10305697|P1|Overall Study|Withdrawal by Subject|1
2994682|NCT00980148|10305715|P2|Overall Study|Various other reasons|9
2994683|NCT00980148|10305716|P1|Overall Study|Various other reasons|8
2994684|NCT00980148|10305715|P2|Overall Study|Negative for chlamydia at enrollment|9
2994685|NCT00980148|10305716|P1|Overall Study|Negative for chlamydia at enrollment|12
2994686|NCT00980148|10305715|P2|Overall Study|Received other antichlamydia treatment|14
2994687|NCT00980148|10305716|P1|Overall Study|Received other antichlamydia treatment|20
2994688|NCT00980148|10305715|P2|Overall Study|Discharged from facility|96
2994689|NCT00980148|10305716|P1|Overall Study|Discharged from facility|89
2994690|NCT00980057|10305724|P2|Overall Study|Withdrawal by Subject|1
2994691|NCT00980057|10305725|P1|Overall Study|Withdrawal by Subject|1
2994692|NCT00980057|10305724|P2|Overall Study|Lost to Follow-up|0
2994693|NCT00980057|10305725|P1|Overall Study|Lost to Follow-up|1
2994694|NCT00980057|10305724|P2|Overall Study|Physician Decision|0
2994695|NCT00980057|10305725|P1|Overall Study|Physician Decision|4
2994696|NCT00980057|10305724|P2|Overall Study|Adverse Event|1
2994697|NCT00980057|10305725|P1|Overall Study|Adverse Event|0
2994698|NCT00980057|10305724|P2|Overall Study|Death|3
2994699|NCT00980057|10305725|P1|Overall Study|Death|13
2994700|NCT00980044|10305748|P3|Overall Study|Protocol Violation|2
2994701|NCT00980044|10305749|P2|Overall Study|Protocol Violation|0
2994702|NCT00980044|10305750|P1|Overall Study|Protocol Violation|0
2994703|NCT00980044|10305748|P3|Overall Study|Withdrawal by Subject|3
2994704|NCT00980044|10305749|P2|Overall Study|Withdrawal by Subject|7
2994705|NCT00980044|10305750|P1|Overall Study|Withdrawal by Subject|5
2994706|NCT00980005|10305769|P2|Overall Study|Other|3
2994707|NCT00980005|10305770|P1|Overall Study|Other|4
2994708|NCT00980005|10305769|P2|Overall Study|Lost to Follow-up|43
2994709|NCT00980005|10305770|P1|Overall Study|Lost to Follow-up|37
2994710|NCT00980005|10305769|P2|Overall Study|Withdrawal by Subject|17
2994711|NCT00980005|10305770|P1|Overall Study|Withdrawal by Subject|6
2994712|NCT00979992|10305810|P1|Overall Study|Refused – Never Treated|2
2994713|NCT00979992|10305810|P1|Overall Study|Ineligible - wrong cell type|2
2994714|NCT00979992|10305810|P1|Overall Study|Ineligible - inadequate pathology|1
2994715|NCT00979953|10305822|P4|Overall Study|Protocol Violation|2
2994716|NCT00979953|10305823|P3|Overall Study|Protocol Violation|2
2994717|NCT00979953|10305824|P2|Overall Study|Protocol Violation|0
2994718|NCT00979953|10305825|P1|Overall Study|Protocol Violation|1
2994719|NCT00979953|10305822|P4|Overall Study|Withdrawal by Subject|1
2994720|NCT00979953|10305823|P3|Overall Study|Withdrawal by Subject|2
2994721|NCT00979953|10305824|P2|Overall Study|Withdrawal by Subject|0
2994722|NCT00979953|10305825|P1|Overall Study|Withdrawal by Subject|0
2994723|NCT00979953|10305822|P4|Overall Study|Lost to Follow-up|0
2994724|NCT00979953|10305823|P3|Overall Study|Lost to Follow-up|1
2994725|NCT00979953|10305824|P2|Overall Study|Lost to Follow-up|1
2994726|NCT00979953|10305825|P1|Overall Study|Lost to Follow-up|1
2994727|NCT00979953|10305822|P4|Overall Study|Lack of Efficacy|0
2994728|NCT00979953|10305823|P3|Overall Study|Lack of Efficacy|0
2994729|NCT00979953|10305824|P2|Overall Study|Lack of Efficacy|2
2994730|NCT00979953|10305825|P1|Overall Study|Lack of Efficacy|1
2994731|NCT00979953|10305822|P4|Overall Study|Adverse Event|4
2994732|NCT00979953|10305823|P3|Overall Study|Adverse Event|17
2994733|NCT00979953|10305824|P2|Overall Study|Adverse Event|2
2994734|NCT00979953|10305825|P1|Overall Study|Adverse Event|5
2994735|NCT00979901|10305848|P4|Overall Study|Treatment Group Terminated by Sponsor|112
2994736|NCT00979901|10305849|P3|Overall Study|Treatment Group Terminated by Sponsor|0
2994737|NCT00979901|10305850|P2|Overall Study|Treatment Group Terminated by Sponsor|0
2994738|NCT00979901|10305851|P1|Overall Study|Treatment Group Terminated by Sponsor|0
2994739|NCT00979901|10305848|P4|Overall Study|Left Country|0
2994740|NCT00979901|10305849|P3|Overall Study|Left Country|1
2994741|NCT00979901|10305850|P2|Overall Study|Left Country|0
2994742|NCT00979901|10305851|P1|Overall Study|Left Country|0
2994743|NCT00979901|10305848|P4|Overall Study|Discontinued in Error|0
2994744|NCT00979901|10305849|P3|Overall Study|Discontinued in Error|0
2994745|NCT00979901|10305850|P2|Overall Study|Discontinued in Error|1
2994746|NCT00979901|10305851|P1|Overall Study|Discontinued in Error|0
2994747|NCT00979901|10305848|P4|Overall Study|elevated lab values pre-randomization|0
2994748|NCT00979901|10305849|P3|Overall Study|elevated lab values pre-randomization|0
2994749|NCT00979901|10305850|P2|Overall Study|elevated lab values pre-randomization|0
2994750|NCT00979901|10305851|P1|Overall Study|elevated lab values pre-randomization|1
2994751|NCT00979901|10305848|P4|Overall Study|vacation|0
2994752|NCT00979901|10305849|P3|Overall Study|vacation|0
2994753|NCT00979901|10305850|P2|Overall Study|vacation|0
2994754|NCT00979901|10305851|P1|Overall Study|vacation|1
2994755|NCT00979901|10305848|P4|Overall Study|out-of-state|0
2994756|NCT00979901|10305849|P3|Overall Study|out-of-state|0
2994757|NCT00979901|10305850|P2|Overall Study|out-of-state|0
2994758|NCT00979901|10305851|P1|Overall Study|out-of-state|1
2994759|NCT00979901|10305848|P4|Overall Study|Noncompliance|0
2994760|NCT00979901|10305849|P3|Overall Study|Noncompliance|0
2994761|NCT00979901|10305850|P2|Overall Study|Noncompliance|0
2994762|NCT00979901|10305851|P1|Overall Study|Noncompliance|1
2994763|NCT00979901|10305848|P4|Overall Study|Withdrawal by Subject|1
2994764|NCT00979901|10305849|P3|Overall Study|Withdrawal by Subject|1
2994765|NCT00979901|10305850|P2|Overall Study|Withdrawal by Subject|1
2994766|NCT00979901|10305851|P1|Overall Study|Withdrawal by Subject|2
2994767|NCT00979901|10305848|P4|Overall Study|Protocol Violation|1
2994768|NCT00979901|10305849|P3|Overall Study|Protocol Violation|7
2994769|NCT00979901|10305850|P2|Overall Study|Protocol Violation|2
2994770|NCT00979901|10305851|P1|Overall Study|Protocol Violation|2
2994771|NCT00979901|10305848|P4|Overall Study|Lost to Follow-up|0
2994772|NCT00979901|10305849|P3|Overall Study|Lost to Follow-up|2
2994773|NCT00979901|10305850|P2|Overall Study|Lost to Follow-up|1
2994774|NCT00979901|10305851|P1|Overall Study|Lost to Follow-up|1
2994775|NCT00979901|10305848|P4|Overall Study|Lack of Efficacy|0
2994776|NCT00979901|10305849|P3|Overall Study|Lack of Efficacy|9
2994777|NCT00979901|10305850|P2|Overall Study|Lack of Efficacy|4
2994778|NCT00979901|10305851|P1|Overall Study|Lack of Efficacy|8
2994779|NCT00979901|10305848|P4|Overall Study|Adverse Event|2
2994780|NCT00979901|10305849|P3|Overall Study|Adverse Event|9
2994781|NCT00979901|10305850|P2|Overall Study|Adverse Event|3
2994782|NCT00979901|10305851|P1|Overall Study|Adverse Event|1
2994783|NCT00979654|10305924|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
2994784|NCT00979654|10305924|P1|Overall Study|Serious Adverse Event|1
2994785|NCT00979654|10305924|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
2994786|NCT00979654|10305924|P1|Overall Study|Per Principal Investigator’s Discretion|1
2994787|NCT00979654|10305924|P1|Overall Study|Adverse Event of Diverticulitis|1
2994788|NCT00979654|10305924|P1|Overall Study|Adverse Event|1
2994789|NCT00979654|10305924|P1|Overall Study|Lack of Efficacy|6
2994790|NCT00979654|10305924|P1|Overall Study|Death|1
2994791|NCT00979654|10305924|P1|Overall Study|Withdrawal by Subject|22
2994792|NCT00979654|10305924|P1|Overall Study|Lost to Follow-up|1
2994793|NCT00979628|10305939|P3|Overall Study|transferred to ICU|1
2994794|NCT00979628|10305940|P2|Overall Study|transferred to ICU|2
2994795|NCT00979628|10305941|P1|Overall Study|transferred to ICU|1
2994796|NCT00979628|10305939|P3|Overall Study|received steroids|0
2994797|NCT00979628|10305940|P2|Overall Study|received steroids|1
2994798|NCT00979628|10305941|P1|Overall Study|received steroids|1
2994799|NCT00979628|10305939|P3|Overall Study|received regimen < 24 hours|5
2994800|NCT00979628|10305940|P2|Overall Study|received regimen < 24 hours|6
2994801|NCT00979628|10305941|P1|Overall Study|received regimen < 24 hours|7
2994802|NCT00979602|10305971|P2|Overall Study|Others|3
2994803|NCT00979602|10305972|P1|Overall Study|Others|3
2994804|NCT00979602|10305971|P2|Overall Study|Migrated/moved from study area|6
2994805|NCT00979602|10305972|P1|Overall Study|Migrated/moved from study area|3
2994806|NCT00979602|10305971|P2|Overall Study|Lost to Follow-up|96
2994807|NCT00979602|10305972|P1|Overall Study|Lost to Follow-up|100
2994808|NCT00979602|10305971|P2|Overall Study|Withdrawal by Subject|25
2994809|NCT00979602|10305972|P1|Overall Study|Withdrawal by Subject|31
2994810|NCT00979602|10305971|P2|Overall Study|Protocol Violation|0
2994811|NCT00979602|10305972|P1|Overall Study|Protocol Violation|3
2994812|NCT00979602|10305971|P2|Overall Study|Serious Adverse Event|3
2994813|NCT00979602|10305972|P1|Overall Study|Serious Adverse Event|5
2994814|NCT00979576|10306143|P3|Combination Followed by Monotherapy|Progressive Disease|1
2994815|NCT00979576|10306144|P2|Combination Followed by Monotherapy|Progressive Disease|2
2994816|NCT00979576|10306145|P1|Combination Followed by Monotherapy|Progressive Disease|0
2994817|NCT00979576|10306143|P3|Combination Treatment Phase|Adverse Event|2
2994818|NCT00979576|10306144|P2|Combination Treatment Phase|Adverse Event|2
2994819|NCT00979576|10306145|P1|Combination Treatment Phase|Adverse Event|0
2994820|NCT00979576|10306143|P3|Combination Treatment Phase|Dose limiting toxicity|2
2994821|NCT00979576|10306144|P2|Combination Treatment Phase|Dose limiting toxicity|3
2994822|NCT00979576|10306145|P1|Combination Treatment Phase|Dose limiting toxicity|0
2994823|NCT00979576|10306143|P3|Combination Treatment Phase|Progressive disease|5
2994824|NCT00979576|10306144|P2|Combination Treatment Phase|Progressive disease|1
2994825|NCT00979576|10306145|P1|Combination Treatment Phase|Progressive disease|3
2994826|NCT00979420|10306202|P4|Overall Study|Other reasons not related to Viramune|1
2994827|NCT00979420|10306203|P3|Overall Study|Other reasons not related to Viramune|0
2994828|NCT00979420|10306204|P2|Overall Study|Other reasons not related to Viramune|0
2994829|NCT00979420|10306205|P1|Overall Study|Other reasons not related to Viramune|3
2994830|NCT00979420|10306202|P4|Overall Study|Lack of Efficacy|1
2994831|NCT00979420|10306203|P3|Overall Study|Lack of Efficacy|1
2994832|NCT00979420|10306204|P2|Overall Study|Lack of Efficacy|0
2994833|NCT00979420|10306205|P1|Overall Study|Lack of Efficacy|3
2994834|NCT00979420|10306202|P4|Overall Study|Adverse Event|0
2994835|NCT00979420|10306203|P3|Overall Study|Adverse Event|0
2994836|NCT00979420|10306204|P2|Overall Study|Adverse Event|0
2994837|NCT00979420|10306205|P1|Overall Study|Adverse Event|1
2994838|NCT00979407|10306275|P2|Overall Study|Lost to Follow-up|3
2994839|NCT00979407|10306276|P1|Overall Study|Lost to Follow-up|3
2994840|NCT00979407|10306275|P2|Overall Study|Withdrawal by Subject|4
2994841|NCT00979407|10306276|P1|Overall Study|Withdrawal by Subject|3
2994842|NCT00979212|10306329|P2|Overall Study|No protocol therapy received|0
2994843|NCT00979212|10306330|P1|Overall Study|No protocol therapy received|1
2994844|NCT00979212|10306329|P2|Overall Study|Protocol Violation|8
2994845|NCT00979212|10306330|P1|Overall Study|Protocol Violation|1
2994846|NCT00979134|10306356|P3|Overall Study|Other|5
2994847|NCT00979134|10306357|P2|Overall Study|Other|1
2994848|NCT00979134|10306358|P1|Overall Study|Other|8
2994849|NCT00979134|10306356|P3|Overall Study|Death|26
2994850|NCT00979134|10306357|P2|Overall Study|Death|0
2994851|NCT00979134|10306358|P1|Overall Study|Death|4
2994852|NCT00979134|10306356|P3|Overall Study|Lost to Follow-up|0
2994853|NCT00979134|10306357|P2|Overall Study|Lost to Follow-up|2
2994854|NCT00979134|10306358|P1|Overall Study|Lost to Follow-up|2
2994855|NCT00979134|10306356|P3|Overall Study|Withdrawal by Subject|2
2994856|NCT00979134|10306357|P2|Overall Study|Withdrawal by Subject|1
2994857|NCT00979134|10306358|P1|Overall Study|Withdrawal by Subject|1
2994858|NCT00979134|10306356|P3|Overall Study|Adverse Event|2
2994859|NCT00979134|10306357|P2|Overall Study|Adverse Event|0
2994860|NCT00979134|10306358|P1|Overall Study|Adverse Event|0
2994861|NCT00979134|10306356|P3|Overall Study|Disease progression|5
2994862|NCT00979134|10306357|P2|Overall Study|Disease progression|2
2994863|NCT00979134|10306358|P1|Overall Study|Disease progression|18
2994864|NCT00978757|10306446|P2|Overall Study|Physician Decision|3
2994865|NCT00978757|10306447|P1|Overall Study|Physician Decision|1
2994866|NCT00978731|10306457|P4|Overall Study|No response|0
2994867|NCT00978731|10306458|P3|Overall Study|No response|0
2994868|NCT00978731|10306459|P2|Overall Study|No response|0
2994869|NCT00978731|10306460|P1|Overall Study|No response|1
2994870|NCT00978731|10306457|P4|Overall Study|Study closure|1
2994871|NCT00978731|10306458|P3|Overall Study|Study closure|1
2994872|NCT00978731|10306459|P2|Overall Study|Study closure|4
2994873|NCT00978731|10306460|P1|Overall Study|Study closure|3
2994874|NCT00978731|10306457|P4|Overall Study|Disease progression/relapse|2
2994875|NCT00978731|10306458|P3|Overall Study|Disease progression/relapse|2
2994876|NCT00978731|10306459|P2|Overall Study|Disease progression/relapse|4
2994877|NCT00978731|10306460|P1|Overall Study|Disease progression/relapse|5
2994878|NCT00978731|10306457|P4|Overall Study|Deterioration without progression|0
2994879|NCT00978731|10306458|P3|Overall Study|Deterioration without progression|0
2994880|NCT00978731|10306459|P2|Overall Study|Deterioration without progression|1
2994881|NCT00978731|10306460|P1|Overall Study|Deterioration without progression|0
2994882|NCT00978731|10306457|P4|Overall Study|Administrative reason|0
2994883|NCT00978731|10306458|P3|Overall Study|Administrative reason|1
2994884|NCT00978731|10306459|P2|Overall Study|Administrative reason|3
2994885|NCT00978731|10306460|P1|Overall Study|Administrative reason|3
2994886|NCT00978731|10306457|P4|Overall Study|Participant's request|0
2994887|NCT00978731|10306458|P3|Overall Study|Participant's request|0
2994888|NCT00978731|10306459|P2|Overall Study|Participant's request|0
2994889|NCT00978731|10306460|P1|Overall Study|Participant's request|1
2994890|NCT00978731|10306457|P4|Overall Study|Adverse Event|0
2994891|NCT00978731|10306458|P3|Overall Study|Adverse Event|0
2994892|NCT00978731|10306459|P2|Overall Study|Adverse Event|2
2994893|NCT00978731|10306460|P1|Overall Study|Adverse Event|5
2994894|NCT00978731|10306457|P4|Overall Study|Lost to Follow-up|1
2994895|NCT00978731|10306458|P3|Overall Study|Lost to Follow-up|0
2994896|NCT00978731|10306459|P2|Overall Study|Lost to Follow-up|0
2994897|NCT00978731|10306460|P1|Overall Study|Lost to Follow-up|0
2994898|NCT00978731|10306457|P4|Overall Study|Death|0
2994899|NCT00978731|10306458|P3|Overall Study|Death|1
2994900|NCT00978731|10306459|P2|Overall Study|Death|1
2994901|NCT00978731|10306460|P1|Overall Study|Death|4
2994902|NCT00978627|10306500|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
2994903|NCT00978627|10306501|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
2994904|NCT00978627|10306500|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
2994905|NCT00978627|10306501|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
2994906|NCT00978627|10306500|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
2994907|NCT00978627|10306501|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
2994908|NCT00978627|10306500|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
2994909|NCT00978627|10306501|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
2994910|NCT00978627|10306500|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
2994911|NCT00978627|10306501|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
2994912|NCT00978627|10306500|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
2994913|NCT00978627|10306501|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
2994914|NCT00978627|10306500|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
2994915|NCT00978627|10306501|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
2994916|NCT00978627|10306500|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
2994917|NCT00978627|10306501|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
2994918|NCT00978627|10306500|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
2994919|NCT00978627|10306501|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
2994920|NCT00978432|10306539|P3|Overall Study|Adverse Event|1
2994921|NCT00978432|10306540|P2|Overall Study|Adverse Event|0
2994922|NCT00978432|10306541|P1|Overall Study|Adverse Event|2
2994923|NCT00978432|10306539|P3|Overall Study|Lack of Efficacy|3
2994924|NCT00978432|10306540|P2|Overall Study|Lack of Efficacy|1
2994925|NCT00978432|10306541|P1|Overall Study|Lack of Efficacy|1
2994926|NCT00978432|10306539|P3|Overall Study|Withdrawal by Subject|1
2994927|NCT00978432|10306540|P2|Overall Study|Withdrawal by Subject|0
2994928|NCT00978432|10306541|P1|Overall Study|Withdrawal by Subject|0
2994929|NCT00978380|10306592|P1|Overall Study|Unclassified|8
2994930|NCT00978380|10306592|P1|Overall Study|Withdrawal criteria|9
2994931|NCT00978380|10306592|P1|Overall Study|Protocol Violation|2
2994932|NCT00978341|10306598|P2|Washout Period of 2 Weeks|Adverse Event|0
2994933|NCT00978341|10306599|P1|Washout Period of 2 Weeks|Adverse Event|1
2994934|NCT00978250|10306621|P4|Overall Study|Late determination of ineligibility|1
2994935|NCT00978250|10306622|P3|Overall Study|Late determination of ineligibility|0
2994936|NCT00978250|10306623|P2|Overall Study|Late determination of ineligibility|1
2994937|NCT00978250|10306624|P1|Overall Study|Late determination of ineligibility|0
2994938|NCT00978120|10306640|P4|Overall Study|Moved out of state|1
2994939|NCT00978120|10306641|P3|Overall Study|Moved out of state|0
2994940|NCT00978120|10306642|P2|Overall Study|Moved out of state|0
2994941|NCT00978120|10306643|P1|Overall Study|Moved out of state|0
2994942|NCT00978120|10306640|P4|Overall Study|Withdrawal by Subject|0
2994943|NCT00978120|10306641|P3|Overall Study|Withdrawal by Subject|0
2994944|NCT00978120|10306642|P2|Overall Study|Withdrawal by Subject|0
2994945|NCT00978120|10306643|P1|Overall Study|Withdrawal by Subject|2
2994946|NCT00978120|10306640|P4|Overall Study|Lost to Follow-up|0
2994947|NCT00978120|10306641|P3|Overall Study|Lost to Follow-up|3
2994948|NCT00978120|10306642|P2|Overall Study|Lost to Follow-up|0
2994949|NCT00978120|10306643|P1|Overall Study|Lost to Follow-up|0
2994950|NCT00978120|10306640|P4|Overall Study|Death|1
2994951|NCT00978120|10306641|P3|Overall Study|Death|0
2994952|NCT00978120|10306642|P2|Overall Study|Death|0
2994953|NCT00978120|10306643|P1|Overall Study|Death|0
2994954|NCT00978068|10306695|P2|Overall Study|Unable to Comply with Study|2
2994955|NCT00978068|10306696|P1|Overall Study|Unable to Comply with Study|0
2994956|NCT00978068|10306695|P2|Overall Study|Physician Decision|1
2994957|NCT00978068|10306696|P1|Overall Study|Physician Decision|0
2994958|NCT00978068|10306695|P2|Overall Study|Lost to Follow-up|2
2994959|NCT00978068|10306696|P1|Overall Study|Lost to Follow-up|1
2994960|NCT00978068|10306695|P2|Overall Study|Death|2
2994961|NCT00978068|10306696|P1|Overall Study|Death|1
2994962|NCT00978068|10306695|P2|Overall Study|Were Awaiting Initiation of ART|2
2994963|NCT00978068|10306696|P1|Overall Study|Were Awaiting Initiation of ART|2
2994964|NCT00978042|10306714|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
2994965|NCT00978042|10306715|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
2994966|NCT00978042|10306714|P2|Initial Treatment Period|Consent withdrawn|9
2994967|NCT00978042|10306715|P1|Initial Treatment Period|Consent withdrawn|22
2994968|NCT00978042|10306714|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
2994969|NCT00978042|10306715|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
2994970|NCT00978042|10306714|P2|Initial Treatment Period|Adverse Event|0
2994971|NCT00978042|10306715|P1|Initial Treatment Period|Adverse Event|2
2994972|NCT00978042|10306714|P2|Initial Treatment Period|Lost to Follow-up|3
2994973|NCT00978042|10306715|P1|Initial Treatment Period|Lost to Follow-up|21
2994974|NCT00978042|10306714|P2|Initial Treatment Period|Ineligibility|0
2994975|NCT00978042|10306715|P1|Initial Treatment Period|Ineligibility|1
2994976|NCT00978042|10306714|P2|Initial Treatment Period|Treated in Error|3
2994977|NCT00978042|10306715|P1|Initial Treatment Period|Treated in Error|0
2994978|NCT00978029|10306728|P3|Overall Study|Protocol Violation|0
2994979|NCT00978029|10306729|P2|Overall Study|Protocol Violation|1
2994980|NCT00978029|10306730|P1|Overall Study|Protocol Violation|0
2994981|NCT00978029|10306728|P3|Overall Study|Withdrawal by Subject|1
2994982|NCT00978029|10306729|P2|Overall Study|Withdrawal by Subject|0
2994983|NCT00978029|10306730|P1|Overall Study|Withdrawal by Subject|0
2994984|NCT00978029|10306728|P3|Overall Study|Adverse Event|5
2994985|NCT00978029|10306729|P2|Overall Study|Adverse Event|2
2994986|NCT00978029|10306730|P1|Overall Study|Adverse Event|1
2994987|NCT00977938|10306757|P4|Observation (30-33 mo. Post Procedure)|Other|0
2994988|NCT00977938|10306758|P3|Observation (30-33 mo. Post Procedure)|Other|0
2994989|NCT00977938|10306759|P2|Observation (30-33 mo. Post Procedure)|Other|4
2994990|NCT00977938|10306760|P1|Observation (30-33 mo. Post Procedure)|Other|8
2994991|NCT00977938|10306757|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
2994992|NCT00977938|10306758|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
2994993|NCT00977938|10306759|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
2994994|NCT00977938|10306760|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
2994995|NCT00977938|10306757|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
2994996|NCT00977938|10306758|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
2994997|NCT00977938|10306759|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
2994998|NCT00977938|10306760|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
2994999|NCT00977938|10306757|P4|Treatment (12-30 mo. Post Procedure)|Other|4
2995000|NCT00977938|10306758|P3|Treatment (12-30 mo. Post Procedure)|Other|3
2995001|NCT00977938|10306759|P2|Treatment (12-30 mo. Post Procedure)|Other|18
2995002|NCT00977938|10306760|P1|Treatment (12-30 mo. Post Procedure)|Other|17
2995003|NCT00977938|10306757|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
2995004|NCT00977938|10306758|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
2995005|NCT00977938|10306759|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
2995006|NCT00977938|10306760|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
2995007|NCT00977938|10306757|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
2995008|NCT00977938|10306758|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
2995009|NCT00977938|10306759|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
2995010|NCT00977938|10306760|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
2995011|NCT00977665|10306837|P2|Overall Study|Treatment failure|1
2995012|NCT00977665|10306838|P1|Overall Study|Treatment failure|0
2995013|NCT00977665|10306837|P2|Overall Study|Adverse Event|7
2995014|NCT00977665|10306838|P1|Overall Study|Adverse Event|14
2995015|NCT00977665|10306837|P2|Overall Study|Death|2
2995016|NCT00977665|10306838|P1|Overall Study|Death|3
2995017|NCT00977665|10306837|P2|Overall Study|Lost to Follow-up|0
2995018|NCT00977665|10306838|P1|Overall Study|Lost to Follow-up|1
2995019|NCT00977665|10306837|P2|Overall Study|Sponsor requested withdrawal|1
2995020|NCT00977665|10306838|P1|Overall Study|Sponsor requested withdrawal|0
2995021|NCT00977665|10306837|P2|Overall Study|Physician Decision|1
2995022|NCT00977665|10306838|P1|Overall Study|Physician Decision|2
2995023|NCT00977665|10306837|P2|Overall Study|Withdrawal by Subject|3
2995024|NCT00977665|10306838|P1|Overall Study|Withdrawal by Subject|1
2995025|NCT00977613|10306870|P1|Overall Study|Lost to Follow-up|16
2995026|NCT00977574|10306877|P3|Overall Study|Never Treated|4
2995027|NCT00977574|10306878|P2|Overall Study|Never Treated|2
2995028|NCT00977574|10306879|P1|Overall Study|Never Treated|4
2995029|NCT00977561|10306898|P2|Overall Study|Other|0
2995030|NCT00977561|10306899|P1|Overall Study|Other|2
2995031|NCT00977561|10306898|P2|Overall Study|Study terminated|2
2995032|NCT00977561|10306899|P1|Overall Study|Study terminated|0
2995033|NCT00977561|10306898|P2|Overall Study|Death|2
2995034|NCT00977561|10306899|P1|Overall Study|Death|3
2995035|NCT00977548|10306926|P1|Overall Study|Withdrawal by Subject|1
2995036|NCT00977548|10306926|P1|Overall Study|Adverse Event|8
2995037|NCT00977548|10306926|P1|Overall Study|Ineligible|4
2995038|NCT00977470|10306935|P2|Overall Study|Still on-study|0
2995039|NCT00977470|10306936|P1|Overall Study|Still on-study|2
2995040|NCT00977470|10306935|P2|Overall Study|prolonged recovery post-surgery|1
2995041|NCT00977470|10306936|P1|Overall Study|prolonged recovery post-surgery|0
2995042|NCT00977470|10306935|P2|Overall Study|clinical decline|1
2995043|NCT00977470|10306936|P1|Overall Study|clinical decline|0
2995044|NCT00977470|10306935|P2|Overall Study|Death|2
2995045|NCT00977470|10306936|P1|Overall Study|Death|0
2995046|NCT00977470|10306935|P2|Overall Study|Withdrawal by Subject|2
2995047|NCT00977470|10306936|P1|Overall Study|Withdrawal by Subject|0
2995048|NCT00977470|10306935|P2|Overall Study|Protocol Violation|0
2995049|NCT00977470|10306936|P1|Overall Study|Protocol Violation|1
2995050|NCT00977470|10306935|P2|Overall Study|Adverse Event|2
2995051|NCT00977470|10306936|P1|Overall Study|Adverse Event|1
2995052|NCT00977470|10306935|P2|Overall Study|Physician Decision|0
2995053|NCT00977470|10306936|P1|Overall Study|Physician Decision|2
2995054|NCT00977470|10306935|P2|Overall Study|Lack of Efficacy|30
2995055|NCT00977470|10306936|P1|Overall Study|Lack of Efficacy|32
2995056|NCT00977431|10306959|P5|Overall Study|Progressive disease|5
2995057|NCT00977431|10306960|P4|Overall Study|Progressive disease|3
2995058|NCT00977431|10306961|P3|Overall Study|Progressive disease|1
2995059|NCT00977431|10306962|P2|Overall Study|Progressive disease|6
2995060|NCT00977431|10306963|P1|Overall Study|Progressive disease|2
2995061|NCT00977431|10306959|P5|Overall Study|Dose-limiting toxicity (DLT)|0
2995062|NCT00977431|10306960|P4|Overall Study|Dose-limiting toxicity (DLT)|0
2995063|NCT00977431|10306961|P3|Overall Study|Dose-limiting toxicity (DLT)|1
2995064|NCT00977431|10306962|P2|Overall Study|Dose-limiting toxicity (DLT)|0
2995065|NCT00977431|10306963|P1|Overall Study|Dose-limiting toxicity (DLT)|1
2995066|NCT00977431|10306959|P5|Overall Study|Adverse Event|6
2995067|NCT00977431|10306960|P4|Overall Study|Adverse Event|0
2995068|NCT00977431|10306961|P3|Overall Study|Adverse Event|4
2995069|NCT00977431|10306962|P2|Overall Study|Adverse Event|0
2995070|NCT00977431|10306963|P1|Overall Study|Adverse Event|3
2995071|NCT00977431|10306959|P5|Overall Study|Protocol Violation|0
2995072|NCT00977431|10306960|P4|Overall Study|Protocol Violation|0
2995073|NCT00977431|10306961|P3|Overall Study|Protocol Violation|1
2995074|NCT00977431|10306962|P2|Overall Study|Protocol Violation|0
2995075|NCT00977431|10306963|P1|Overall Study|Protocol Violation|0
2995076|NCT00977431|10306959|P5|Overall Study|Other than listed|2
2995077|NCT00977431|10306960|P4|Overall Study|Other than listed|0
2995078|NCT00977431|10306961|P3|Overall Study|Other than listed|0
2995079|NCT00977431|10306962|P2|Overall Study|Other than listed|0
2995080|NCT00977431|10306963|P1|Overall Study|Other than listed|1
2995081|NCT00977379|10306996|P2|Overall Study|Randomization Error|1
2995082|NCT00977379|10306997|P1|Overall Study|Randomization Error|0
2995083|NCT00977379|10306996|P2|Overall Study|Participant Moving House|1
2995084|NCT00977379|10306997|P1|Overall Study|Participant Moving House|0
2995085|NCT00977379|10306996|P2|Overall Study|Premature Study Termination|0
2995086|NCT00977379|10306997|P1|Overall Study|Premature Study Termination|4
2995087|NCT00977379|10306996|P2|Overall Study|Death|9
2995088|NCT00977379|10306997|P1|Overall Study|Death|7
2995089|NCT00977379|10306996|P2|Overall Study|Withdrawal by Subject|1
2995090|NCT00977379|10306997|P1|Overall Study|Withdrawal by Subject|1
2995091|NCT00977314|10307033|P2|Overall Study|Physician Decision|0
2995092|NCT00977314|10307034|P1|Overall Study|Physician Decision|1
2995093|NCT00977314|10307033|P2|Overall Study|Withdrawal by Subject|0
2995094|NCT00977314|10307034|P1|Overall Study|Withdrawal by Subject|1
2995095|NCT00977197|10307042|P2|Overall Study|Nonadherence|1
2995096|NCT00977197|10307043|P1|Overall Study|Nonadherence|1
2995097|NCT00977197|10307042|P2|Overall Study|Lost to Follow-up|3
2995098|NCT00977197|10307043|P1|Overall Study|Lost to Follow-up|1
2995099|NCT00977197|10307042|P2|Overall Study|Lack of Efficacy|0
2995100|NCT00977197|10307043|P1|Overall Study|Lack of Efficacy|1
2995101|NCT00977197|10307042|P2|Overall Study|Adverse Event|1
2995102|NCT00977197|10307043|P1|Overall Study|Adverse Event|3
2995103|NCT00977197|10307042|P2|Overall Study|Withdrawal by Subject|4
2995104|NCT00977197|10307043|P1|Overall Study|Withdrawal by Subject|3
2995105|NCT00977106|10307106|P2|Overall Study|Other|0
2995106|NCT00977106|10307107|P1|Overall Study|Other|1
2995107|NCT00977106|10307106|P2|Overall Study|Protocol Violation|1
2995108|NCT00977106|10307107|P1|Overall Study|Protocol Violation|0
2995109|NCT00977106|10307106|P2|Overall Study|Lack of Efficacy|2
2995110|NCT00977106|10307107|P1|Overall Study|Lack of Efficacy|2
2995111|NCT00977106|10307106|P2|Overall Study|Withdrawal by Subject|2
2995112|NCT00977106|10307107|P1|Overall Study|Withdrawal by Subject|2
2995113|NCT00977106|10307106|P2|Overall Study|Adverse Event|6
2995114|NCT00977106|10307107|P1|Overall Study|Adverse Event|5
2995115|NCT00977080|10307199|P4|Overall Study|Travel for family reasons|0
2995116|NCT00977080|10307200|P3|Overall Study|Travel for family reasons|0
2995117|NCT00977080|10307201|P2|Overall Study|Travel for family reasons|0
2995118|NCT00977080|10307202|P1|Overall Study|Travel for family reasons|1
2995119|NCT00977080|10307199|P4|Overall Study|Required kidney transplantation|1
2995120|NCT00977080|10307200|P3|Overall Study|Required kidney transplantation|3
2995121|NCT00977080|10307201|P2|Overall Study|Required kidney transplantation|3
2995122|NCT00977080|10307202|P1|Overall Study|Required kidney transplantation|1
2995123|NCT00977080|10307199|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
2995124|NCT00977080|10307200|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2995125|NCT00977080|10307201|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2995126|NCT00977080|10307202|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2995127|NCT00977080|10307199|P4|Overall Study|Noncompliance|0
2995128|NCT00977080|10307200|P3|Overall Study|Noncompliance|1
2995129|NCT00977080|10307201|P2|Overall Study|Noncompliance|2
2995130|NCT00977080|10307202|P1|Overall Study|Noncompliance|0
2995131|NCT00977080|10307199|P4|Overall Study|Protocol Violation|3
2995132|NCT00977080|10307200|P3|Overall Study|Protocol Violation|4
2995133|NCT00977080|10307201|P2|Overall Study|Protocol Violation|3
2995134|NCT00977080|10307202|P1|Overall Study|Protocol Violation|7
2995135|NCT00977080|10307199|P4|Overall Study|Withdrawal by Subject|5
2995136|NCT00977080|10307200|P3|Overall Study|Withdrawal by Subject|1
2995137|NCT00977080|10307201|P2|Overall Study|Withdrawal by Subject|5
2995138|NCT00977080|10307202|P1|Overall Study|Withdrawal by Subject|1
2995139|NCT00977080|10307199|P4|Overall Study|Adverse Event|7
2995140|NCT00977080|10307200|P3|Overall Study|Adverse Event|7
2995141|NCT00977080|10307201|P2|Overall Study|Adverse Event|7
2995142|NCT00977080|10307202|P1|Overall Study|Adverse Event|2
2995143|NCT00976989|10307235|P3|Overall Study|Other|1
2995144|NCT00976989|10307236|P2|Overall Study|Other|0
2995145|NCT00976989|10307237|P1|Overall Study|Other|1
2995146|NCT00976989|10307235|P3|Overall Study|Recurrence of Disease|0
2995147|NCT00976989|10307236|P2|Overall Study|Recurrence of Disease|1
2995148|NCT00976989|10307237|P1|Overall Study|Recurrence of Disease|0
2995149|NCT00976989|10307235|P3|Overall Study|Failure to Return|0
2995150|NCT00976989|10307236|P2|Overall Study|Failure to Return|1
2995151|NCT00976989|10307237|P1|Overall Study|Failure to Return|2
2995152|NCT00976989|10307235|P3|Overall Study|Refused Treatment|5
2995153|NCT00976989|10307236|P2|Overall Study|Refused Treatment|3
2995154|NCT00976989|10307237|P1|Overall Study|Refused Treatment|4
2995155|NCT00976989|10307235|P3|Overall Study|Death|10
2995156|NCT00976989|10307236|P2|Overall Study|Death|7
2995157|NCT00976989|10307237|P1|Overall Study|Death|5
2995245|NCT00976495|10308059|P3|Overall Study|Withdrawal by Subject|0
2995158|NCT00976989|10307235|P3|Overall Study|Violation of Selection Criteria at Entry|1
2995159|NCT00976989|10307236|P2|Overall Study|Violation of Selection Criteria at Entry|0
2995160|NCT00976989|10307237|P1|Overall Study|Violation of Selection Criteria at Entry|1
2995161|NCT00976950|10307278|P1|Overall Study|Events with no relationship to Aptivus|3
2995162|NCT00976950|10307278|P1|Overall Study|Adverse Event|3
2995163|NCT00976937|10307286|P2|Overall Study|Personal and Familial Reason|2
2995164|NCT00976937|10307287|P1|Overall Study|Personal and Familial Reason|2
2995165|NCT00976937|10307286|P2|Overall Study|Poor compliance to protocol|0
2995166|NCT00976937|10307287|P1|Overall Study|Poor compliance to protocol|3
2995167|NCT00976937|10307286|P2|Overall Study|Withdrawal by Subject|3
2995168|NCT00976937|10307287|P1|Overall Study|Withdrawal by Subject|5
2995169|NCT00976937|10307286|P2|Overall Study|Lost to Follow-up|1
2995170|NCT00976937|10307287|P1|Overall Study|Lost to Follow-up|2
2995171|NCT00976937|10307286|P2|Overall Study|Adverse Event|5
2995172|NCT00976937|10307287|P1|Overall Study|Adverse Event|4
2995173|NCT00976911|10307329|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
2995174|NCT00976911|10307330|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
2995175|NCT00976911|10307329|P2|Overall Study|Other|9
2995176|NCT00976911|10307330|P1|Overall Study|Other|8
2995177|NCT00976911|10307329|P2|Overall Study|Protocol Violation|0
2995178|NCT00976911|10307330|P1|Overall Study|Protocol Violation|2
2995179|NCT00976911|10307329|P2|Overall Study|Adverse Event|1
2995180|NCT00976911|10307330|P1|Overall Study|Adverse Event|0
2995181|NCT00976911|10307329|P2|Overall Study|Death|126
2995182|NCT00976911|10307330|P1|Overall Study|Death|138
2995183|NCT00976911|10307329|P2|Overall Study|Withdrawal by Subject|6
2995184|NCT00976911|10307330|P1|Overall Study|Withdrawal by Subject|4
2995185|NCT00976898|10307348|P1|Overall Study|Progressive Disease|1
2995186|NCT00976898|10307348|P1|Overall Study|Liver Transplant|1
2995187|NCT00976898|10307348|P1|Overall Study|Physician Decision|1
2995188|NCT00976898|10307348|P1|Overall Study|Adverse Event|1
2995189|NCT00976898|10307348|P1|Overall Study|Protocol Violation|1
2995190|NCT00976820|10307359|P4|Overall Study|Withdrawal by Subject|4
2995191|NCT00976820|10307360|P3|Overall Study|Withdrawal by Subject|1
2995192|NCT00976820|10307361|P2|Overall Study|Withdrawal by Subject|4
2995193|NCT00976820|10307362|P1|Overall Study|Withdrawal by Subject|2
2995194|NCT00976820|10307359|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
2995195|NCT00976820|10307360|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
2995196|NCT00976820|10307361|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
2995197|NCT00976820|10307362|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
2995198|NCT00976820|10307359|P4|Overall Study|Lost to Follow-up|3
2995199|NCT00976820|10307360|P3|Overall Study|Lost to Follow-up|2
2995200|NCT00976820|10307361|P2|Overall Study|Lost to Follow-up|16
2995201|NCT00976820|10307362|P1|Overall Study|Lost to Follow-up|5
2995202|NCT00976716|10307698|P1|Overall Study|Adverse Event|1
2995203|NCT00976703|10307716|P2|Overall Study|ineligible for study|2
2995204|NCT00976703|10307717|P1|Overall Study|ineligible for study|2
2995205|NCT00976703|10307716|P2|Overall Study|Physician Decision|1
2995206|NCT00976703|10307717|P1|Overall Study|Physician Decision|1
2995207|NCT00976677|10307731|P2|Overall Study|Unknown/Missing|0
2995208|NCT00976677|10307732|P1|Overall Study|Unknown/Missing|1
2995209|NCT00976677|10307731|P2|Overall Study|Trial unblinded|2
2995210|NCT00976677|10307732|P1|Overall Study|Trial unblinded|2
2995211|NCT00976677|10307731|P2|Overall Study|Disease progression|1
2995212|NCT00976677|10307732|P1|Overall Study|Disease progression|1
2995213|NCT00976677|10307731|P2|Overall Study|Withdrawal by Subject|2
2995214|NCT00976677|10307732|P1|Overall Study|Withdrawal by Subject|0
2995215|NCT00976677|10307731|P2|Overall Study|Adverse Event|0
2995216|NCT00976677|10307732|P1|Overall Study|Adverse Event|1
2995217|NCT00976573|10307940|P2|Overall Study|Cancel prior to receiving treatment|2
2995218|NCT00976573|10307941|P1|Overall Study|Cancel prior to receiving treatment|4
2995219|NCT00976573|10307940|P2|Overall Study|Ineligible|1
2995220|NCT00976573|10307941|P1|Overall Study|Ineligible|0
2995221|NCT00976560|10307955|P2|Overall Study|Withdrawal by Subject|3
2995222|NCT00976560|10307956|P1|Overall Study|Withdrawal by Subject|2
2995223|NCT00976560|10307955|P2|Overall Study|Physician Decision|0
2995224|NCT00976560|10307956|P1|Overall Study|Physician Decision|2
2995225|NCT00976560|10307955|P2|Overall Study|Lost to Follow-up|0
2995226|NCT00976560|10307956|P1|Overall Study|Lost to Follow-up|1
2995227|NCT00976560|10307955|P2|Overall Study|Protocol Violation|0
2995228|NCT00976560|10307956|P1|Overall Study|Protocol Violation|1
2995229|NCT00976560|10307955|P2|Overall Study|Lack of Efficacy|5
2995230|NCT00976560|10307956|P1|Overall Study|Lack of Efficacy|3
2995231|NCT00976560|10307955|P2|Overall Study|Adverse Event|5
2995232|NCT00976560|10307956|P1|Overall Study|Adverse Event|5
2995233|NCT00976508|10308025|P2|Overall Study|Terminated by the Sponsor|1
2995234|NCT00976508|10308026|P1|Overall Study|Terminated by the Sponsor|0
2995235|NCT00976508|10308025|P2|Overall Study|Subject Enrolled in Hospice|0
2995236|NCT00976508|10308026|P1|Overall Study|Subject Enrolled in Hospice|1
2995237|NCT00976508|10308025|P2|Overall Study|Disease Progression|4
2995238|NCT00976508|10308026|P1|Overall Study|Disease Progression|4
2995239|NCT00976508|10308025|P2|Overall Study|Withdrawal by Subject|0
2995240|NCT00976508|10308026|P1|Overall Study|Withdrawal by Subject|1
2995241|NCT00976508|10308025|P2|Overall Study|Lost to Follow-up|0
2995242|NCT00976508|10308026|P1|Overall Study|Lost to Follow-up|1
2995243|NCT00976508|10308025|P2|Overall Study|Death|1
2995244|NCT00976508|10308026|P1|Overall Study|Death|7
2996690|NCT00966875|10312487|P8|Part B|Death|1
2995246|NCT00976495|10308060|P2|Overall Study|Withdrawal by Subject|1
2995247|NCT00976495|10308061|P1|Overall Study|Withdrawal by Subject|0
2995248|NCT00976482|10308078|P1|Overall Study|Protocol Violation|5
2995249|NCT00976482|10308078|P1|Overall Study|Center terminated|1
2995250|NCT00976482|10308078|P1|Overall Study|Withdrawal by Subject|45
2995251|NCT00976482|10308078|P1|Overall Study|Death|208
2995252|NCT00976456|10308084|P2|Overall Study|screening failure, unknown|4
2995253|NCT00976456|10308085|P1|Overall Study|screening failure, unknown|11
2995254|NCT00976456|10308084|P2|Overall Study|Withdrawal by Subject|1
2995255|NCT00976456|10308085|P1|Overall Study|Withdrawal by Subject|3
2995256|NCT00976456|10308084|P2|Overall Study|Lack of Efficacy|2
2995257|NCT00976456|10308085|P1|Overall Study|Lack of Efficacy|5
2995258|NCT00976456|10308084|P2|Overall Study|Death|9
2995259|NCT00976456|10308085|P1|Overall Study|Death|7
2995260|NCT00976456|10308084|P2|Overall Study|Adverse Event|22
2995261|NCT00976456|10308085|P1|Overall Study|Adverse Event|17
2995262|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2995263|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
2995264|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
2995265|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
2995266|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
2995267|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
2995268|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
2995269|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
2995270|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Noncompliance|2
2995271|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Noncompliance|2
2995272|NCT00976391|10308112|P2|Follow-up Period (8 Weeks)|Adverse Event|1
2995273|NCT00976391|10308113|P1|Follow-up Period (8 Weeks)|Adverse Event|3
2995274|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Pregnancy|0
2995275|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Pregnancy|1
2995276|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
2995277|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
2995278|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Physician Decision|1
2995279|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Physician Decision|1
2995280|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
2995281|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
2995282|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
2995283|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
2995284|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Noncompliance|4
2995285|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Noncompliance|4
2995286|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Protocol Violation|1
2995287|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Protocol Violation|1
2995288|NCT00976391|10308112|P2|Treatment Period (52 Weeks)|Adverse Event|2
2995289|NCT00976391|10308113|P1|Treatment Period (52 Weeks)|Adverse Event|16
2995290|NCT00976274|10308161|P2|Overall Study|Physician Decision|2
2995291|NCT00976274|10308162|P1|Overall Study|Physician Decision|1
2995292|NCT00976274|10308161|P2|Overall Study|Withdrawal by Subject|1
2995293|NCT00976274|10308162|P1|Overall Study|Withdrawal by Subject|1
2995294|NCT00976274|10308161|P2|Overall Study|Lost to Follow-up|5
2995295|NCT00976274|10308162|P1|Overall Study|Lost to Follow-up|5
2995296|NCT00976209|10308178|P2|Treatment Period 2|Lost to Follow-up|1
2995297|NCT00976209|10308179|P1|Treatment Period 2|Lost to Follow-up|0
2995298|NCT00976209|10308178|P2|Treatment Period 2|Withdrawal by Subject|1
2995299|NCT00976209|10308179|P1|Treatment Period 2|Withdrawal by Subject|0
2995300|NCT00976209|10308178|P2|Wash-out Period|Other|0
2995301|NCT00976209|10308179|P1|Wash-out Period|Other|1
2995302|NCT00976209|10308178|P2|Wash-out Period|Protocol Violation|0
2995303|NCT00976209|10308179|P1|Wash-out Period|Protocol Violation|1
2995304|NCT00976209|10308178|P2|Wash-out Period|Lost to Follow-up|0
2995305|NCT00976209|10308179|P1|Wash-out Period|Lost to Follow-up|1
2995306|NCT00976209|10308178|P2|Wash-out Period|Adverse Event|2
2995307|NCT00976209|10308179|P1|Wash-out Period|Adverse Event|1
2995308|NCT00976209|10308178|P2|Treatment Period 1|Other|1
2995309|NCT00976209|10308179|P1|Treatment Period 1|Other|0
2995310|NCT00976209|10308178|P2|Treatment Period 1|Lost to Follow-up|0
2995311|NCT00976209|10308179|P1|Treatment Period 1|Lost to Follow-up|2
2995312|NCT00976209|10308178|P2|Treatment Period 1|Protocol Violation|0
2995313|NCT00976209|10308179|P1|Treatment Period 1|Protocol Violation|1
2995314|NCT00976027|10308192|P2|Overall Study|Withdrawal by Subject|66
2995315|NCT00976027|10308193|P1|Overall Study|Withdrawal by Subject|107
2995316|NCT00976027|10308192|P2|Overall Study|Lost to Follow-up|103
2995317|NCT00976027|10308193|P1|Overall Study|Lost to Follow-up|208
2995318|NCT00976027|10308192|P2|Overall Study|Protocol Violation|27
2995319|NCT00976027|10308193|P1|Overall Study|Protocol Violation|60
2995320|NCT00976027|10308192|P2|Overall Study|Adverse Event|2
2995321|NCT00976027|10308193|P1|Overall Study|Adverse Event|0
2995322|NCT00976027|10308192|P2|Overall Study|Serious Adverse Event|17
2995323|NCT00976027|10308193|P1|Overall Study|Serious Adverse Event|36
2995324|NCT00975975|10308205|P1|Overall Study|Death|6
2995325|NCT00975923|10308213|P2|Overall Study|Withdrawal by Subject|1
2995326|NCT00975923|10308214|P1|Overall Study|Withdrawal by Subject|0
2995327|NCT00975884|10308224|P2|Overall Study|Other|3
2995328|NCT00975884|10308225|P1|Overall Study|Other|1
2995329|NCT00975884|10308224|P2|Overall Study|Withdrawal by Subject|9
2995330|NCT00975884|10308225|P1|Overall Study|Withdrawal by Subject|9
2996691|NCT00966875|10312488|P7|Part B|Death|0
2995331|NCT00975884|10308224|P2|Overall Study|Lost to Follow-up|3
2995332|NCT00975884|10308225|P1|Overall Study|Lost to Follow-up|5
2995333|NCT00975884|10308224|P2|Overall Study|Adverse Event|0
2995334|NCT00975884|10308225|P1|Overall Study|Adverse Event|1
2995335|NCT00975806|10308382|P3|Overall Study|Physician decision and disease related|1
2995336|NCT00975806|10308383|P2|Overall Study|Physician decision and disease related|0
2995337|NCT00975806|10308384|P1|Overall Study|Physician decision and disease related|1
2995338|NCT00975806|10308382|P3|Overall Study|Death|0
2995339|NCT00975806|10308383|P2|Overall Study|Death|1
2995340|NCT00975806|10308384|P1|Overall Study|Death|0
2995341|NCT00975806|10308382|P3|Overall Study|Withdrawal by Subject|0
2995342|NCT00975806|10308383|P2|Overall Study|Withdrawal by Subject|0
2995343|NCT00975806|10308384|P1|Overall Study|Withdrawal by Subject|1
2995344|NCT00975806|10308382|P3|Overall Study|Disease Progression|1
2995345|NCT00975806|10308383|P2|Overall Study|Disease Progression|5
2995346|NCT00975806|10308384|P1|Overall Study|Disease Progression|1
2995347|NCT00975806|10308382|P3|Overall Study|Adverse Event|2
2995348|NCT00975806|10308383|P2|Overall Study|Adverse Event|1
2995349|NCT00975806|10308384|P1|Overall Study|Adverse Event|2
2995350|NCT00975780|10308408|P2|Follow Up|Discharged from Facility|12
2995351|NCT00975780|10308409|P1|Follow Up|Discharged from Facility|7
2995352|NCT00975780|10308408|P2|Follow Up|Facility Withdrawal|23
2995353|NCT00975780|10308409|P1|Follow Up|Facility Withdrawal|7
2995354|NCT00975780|10308408|P2|Follow Up|Death|122
2995355|NCT00975780|10308409|P1|Follow Up|Death|88
2995356|NCT00975715|10308419|P2|Maintenance Period|Adverse Event|1
2995357|NCT00975715|10308420|P1|Maintenance Period|Adverse Event|2
2995358|NCT00975715|10308419|P2|Titration Period|Protocol Violation|0
2995359|NCT00975715|10308420|P1|Titration Period|Protocol Violation|1
2995360|NCT00975715|10308419|P2|Titration Period|Adverse Event|0
2995361|NCT00975715|10308420|P1|Titration Period|Adverse Event|6
2995362|NCT00975689|10308436|P2|Overall Study|Physician Decision|0
2995363|NCT00975689|10308437|P1|Overall Study|Physician Decision|1
2995364|NCT00975689|10308436|P2|Overall Study|Withdrawal by Subject|0
2995365|NCT00975689|10308437|P1|Overall Study|Withdrawal by Subject|1
2995366|NCT00975689|10308436|P2|Overall Study|Adverse Event|3
2995367|NCT00975689|10308437|P1|Overall Study|Adverse Event|0
2995368|NCT00975611|10308506|P1|Overall Study|Physician Decision|1
2995369|NCT00975611|10308506|P1|Overall Study|Screen Fail|16
2995370|NCT00975585|10308512|P2|Overall Study|Lens issue|2
2995371|NCT00975585|10308513|P1|Overall Study|Lens issue|2
2995372|NCT00975585|10308512|P2|Overall Study|Withdrawal by Subject|1
2995373|NCT00975585|10308513|P1|Overall Study|Withdrawal by Subject|2
2995374|NCT00975585|10308512|P2|Overall Study|Lost to Follow-up|5
2995375|NCT00975585|10308513|P1|Overall Study|Lost to Follow-up|3
2995376|NCT00975585|10308512|P2|Overall Study|Adverse Event|4
2995377|NCT00975585|10308513|P1|Overall Study|Adverse Event|0
2995378|NCT00975507|10308533|P2|Overall Study|Withdrawal by Subject|3
2995379|NCT00975507|10308534|P1|Overall Study|Withdrawal by Subject|10
2995380|NCT00975507|10308533|P2|Overall Study|Protocol Violation|0
2995381|NCT00975507|10308534|P1|Overall Study|Protocol Violation|2
2995382|NCT00975507|10308533|P2|Overall Study|Lost to Follow-up|1
2995383|NCT00975507|10308534|P1|Overall Study|Lost to Follow-up|7
2995384|NCT00975507|10308533|P2|Overall Study|Adverse Event|0
2995385|NCT00975507|10308534|P1|Overall Study|Adverse Event|1
2995386|NCT00975481|10308554|P6|Fifth Intervention Period|Withdrawal by Subject|0
2995387|NCT00975481|10308555|P5|Fifth Intervention Period|Withdrawal by Subject|1
2995388|NCT00975481|10308556|P4|Fifth Intervention Period|Withdrawal by Subject|0
2995389|NCT00975481|10308557|P3|Fifth Intervention Period|Withdrawal by Subject|0
2995390|NCT00975481|10308558|P2|Fifth Intervention Period|Withdrawal by Subject|0
2995391|NCT00975481|10308559|P1|Fifth Intervention Period|Withdrawal by Subject|0
2995392|NCT00975481|10308554|P6|Fourth Intervention Period|Withdrawal by Subject|0
2995393|NCT00975481|10308555|P5|Fourth Intervention Period|Withdrawal by Subject|0
2995394|NCT00975481|10308556|P4|Fourth Intervention Period|Withdrawal by Subject|1
2995395|NCT00975481|10308557|P3|Fourth Intervention Period|Withdrawal by Subject|1
2995396|NCT00975481|10308558|P2|Fourth Intervention Period|Withdrawal by Subject|0
2995397|NCT00975481|10308559|P1|Fourth Intervention Period|Withdrawal by Subject|0
2995398|NCT00975481|10308554|P6|Second Intervention Period|Withdrawal by Subject|0
2995399|NCT00975481|10308555|P5|Second Intervention Period|Withdrawal by Subject|0
2995400|NCT00975481|10308556|P4|Second Intervention Period|Withdrawal by Subject|0
2995401|NCT00975481|10308557|P3|Second Intervention Period|Withdrawal by Subject|1
2995402|NCT00975481|10308558|P2|Second Intervention Period|Withdrawal by Subject|0
2995403|NCT00975481|10308559|P1|Second Intervention Period|Withdrawal by Subject|0
2995404|NCT00975481|10308554|P6|Second Intervention Period|Adverse Event|0
2995405|NCT00975481|10308555|P5|Second Intervention Period|Adverse Event|0
2995406|NCT00975481|10308556|P4|Second Intervention Period|Adverse Event|0
2995407|NCT00975481|10308557|P3|Second Intervention Period|Adverse Event|0
2995408|NCT00975481|10308558|P2|Second Intervention Period|Adverse Event|1
2995409|NCT00975481|10308559|P1|Second Intervention Period|Adverse Event|2
2995410|NCT00975416|10308659|P2|Overall Study|early discharge from tx|5
2995411|NCT00975416|10308660|P1|Overall Study|early discharge from tx|3
2995412|NCT00975286|10308669|P2|Overall Study|Sponsor Decision|2
2995413|NCT00975286|10308670|P1|Overall Study|Sponsor Decision|0
2995414|NCT00975286|10308669|P2|Overall Study|Poor Compliance to Protocol|2
2995415|NCT00975286|10308670|P1|Overall Study|Poor Compliance to Protocol|0
2995416|NCT00975286|10308669|P2|Overall Study|Familial and Personal Reasons|2
2995417|NCT00975286|10308670|P1|Overall Study|Familial and Personal Reasons|2
2995418|NCT00975286|10308669|P2|Overall Study|Withdrawal by Subject|2
2995419|NCT00975286|10308670|P1|Overall Study|Withdrawal by Subject|0
2995420|NCT00975286|10308669|P2|Overall Study|Protocol Violation|2
2995421|NCT00975286|10308670|P1|Overall Study|Protocol Violation|1
2995422|NCT00975286|10308669|P2|Overall Study|Adverse Event|19
2995423|NCT00975286|10308670|P1|Overall Study|Adverse Event|9
2995424|NCT00975221|10308702|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
2995425|NCT00975221|10308703|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
2995426|NCT00975221|10308702|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2995427|NCT00975221|10308703|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2995428|NCT00975221|10308702|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
2995429|NCT00975221|10308703|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
2995430|NCT00975221|10308702|P2|Titration Phase (Weeks 1-12)|Other|1
2995431|NCT00975221|10308703|P1|Titration Phase (Weeks 1-12)|Other|0
2995432|NCT00975221|10308702|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
2995433|NCT00975221|10308703|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
2995434|NCT00975221|10308702|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
2995435|NCT00975221|10308703|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
2995436|NCT00975195|10308719|P2|Overall Study|Not treated|2
2995437|NCT00975195|10308720|P1|Overall Study|Not treated|1
2995438|NCT00975195|10308719|P2|Overall Study|Other reason not defined above|33
2995439|NCT00975195|10308720|P1|Overall Study|Other reason not defined above|29
2995440|NCT00975195|10308719|P2|Overall Study|Withdrawal by Subject|61
2995441|NCT00975195|10308720|P1|Overall Study|Withdrawal by Subject|48
2995442|NCT00975195|10308719|P2|Overall Study|Lost to Follow-up|7
2995443|NCT00975195|10308720|P1|Overall Study|Lost to Follow-up|9
2995444|NCT00975195|10308719|P2|Overall Study|Protocol Violation|23
2995445|NCT00975195|10308720|P1|Overall Study|Protocol Violation|27
2995446|NCT00975195|10308719|P2|Overall Study|Lack of Efficacy|6
2995447|NCT00975195|10308720|P1|Overall Study|Lack of Efficacy|6
2995448|NCT00975195|10308719|P2|Overall Study|Adverse Event|101
2995449|NCT00975195|10308720|P1|Overall Study|Adverse Event|108
2995450|NCT00975156|10308780|P2|Overall Study|Protocol Violation|1
2995451|NCT00975156|10308781|P1|Overall Study|Protocol Violation|0
2995452|NCT00975143|10308793|P2|Overall Study|Details not available|4
2995453|NCT00975143|10308794|P1|Overall Study|Details not available|10
2995454|NCT00975143|10308793|P2|Overall Study|Physician Decision|2
2995455|NCT00975143|10308794|P1|Overall Study|Physician Decision|1
2995456|NCT00975143|10308793|P2|Overall Study|Non-compliance|8
2995457|NCT00975143|10308794|P1|Overall Study|Non-compliance|5
2995458|NCT00975143|10308793|P2|Overall Study|Lost to Follow-up|16
2995459|NCT00975143|10308794|P1|Overall Study|Lost to Follow-up|20
2995460|NCT00975143|10308793|P2|Overall Study|Withdrawal by Subject|15
2995461|NCT00975143|10308794|P1|Overall Study|Withdrawal by Subject|15
2995462|NCT00975143|10308793|P2|Overall Study|Adverse Event|15
2995463|NCT00975143|10308794|P1|Overall Study|Adverse Event|19
2995464|NCT00975130|10308804|P3|Study Part 2|Protocol Violation|1
2995465|NCT00975130|10308805|P2|Study Part 2|Protocol Violation|0
2995466|NCT00975130|10308806|P1|Study Part 2|Protocol Violation|0
2995467|NCT00975130|10308804|P3|Study Part 2|Administrative|0
2995468|NCT00975130|10308805|P2|Study Part 2|Administrative|1
2995469|NCT00975130|10308806|P1|Study Part 2|Administrative|0
2995470|NCT00975130|10308804|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
2995471|NCT00975130|10308805|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
2995472|NCT00975130|10308806|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
2995473|NCT00975130|10308804|P3|Study Part 2|Withdrew Consent|2
2995474|NCT00975130|10308805|P2|Study Part 2|Withdrew Consent|6
2995475|NCT00975130|10308806|P1|Study Part 2|Withdrew Consent|0
2995476|NCT00975130|10308804|P3|Study Part 2|Withdrawal by Subject|5
2995477|NCT00975130|10308805|P2|Study Part 2|Withdrawal by Subject|13
2995478|NCT00975130|10308806|P1|Study Part 2|Withdrawal by Subject|0
2995479|NCT00975130|10308804|P3|Study Part 2|Lost to Follow-up|1
2995480|NCT00975130|10308805|P2|Study Part 2|Lost to Follow-up|0
2995481|NCT00975130|10308806|P1|Study Part 2|Lost to Follow-up|0
2995482|NCT00975130|10308804|P3|Study Part 2|Adverse Event|7
2995483|NCT00975130|10308805|P2|Study Part 2|Adverse Event|14
2995484|NCT00975130|10308806|P1|Study Part 2|Adverse Event|0
2995485|NCT00975130|10308804|P3|Study Part 1|Withdrew Consent|0
2995486|NCT00975130|10308805|P2|Study Part 1|Withdrew Consent|0
2995487|NCT00975130|10308806|P1|Study Part 1|Withdrew Consent|24
2995488|NCT00975130|10308804|P3|Study Part 1|Administrative|0
2995489|NCT00975130|10308805|P2|Study Part 1|Administrative|0
2995490|NCT00975130|10308806|P1|Study Part 1|Administrative|4
2995491|NCT00975130|10308804|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
2995492|NCT00975130|10308805|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
2995493|NCT00975130|10308806|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
2995494|NCT00975130|10308804|P3|Study Part 1|Protocol Violation|0
2995495|NCT00975130|10308805|P2|Study Part 1|Protocol Violation|0
2995496|NCT00975130|10308806|P1|Study Part 1|Protocol Violation|13
2995497|NCT00975130|10308804|P3|Study Part 1|Withdrawal by Subject|0
2995498|NCT00975130|10308805|P2|Study Part 1|Withdrawal by Subject|0
2995499|NCT00975130|10308806|P1|Study Part 1|Withdrawal by Subject|61
2995500|NCT00975130|10308804|P3|Study Part 1|Lost to Follow-up|0
2995501|NCT00975130|10308805|P2|Study Part 1|Lost to Follow-up|0
2995502|NCT00975130|10308806|P1|Study Part 1|Lost to Follow-up|19
2995503|NCT00975130|10308804|P3|Study Part 1|Adverse Event|0
2995504|NCT00975130|10308805|P2|Study Part 1|Adverse Event|0
2995505|NCT00975130|10308806|P1|Study Part 1|Adverse Event|150
2995506|NCT00975000|10308990|P2|Overall Study|Non-compliance|1
2995507|NCT00975000|10308991|P1|Overall Study|Non-compliance|0
2995508|NCT00975000|10308990|P2|Overall Study|Protocol-specified Criteria|0
2995509|NCT00975000|10308991|P1|Overall Study|Protocol-specified Criteria|1
2995510|NCT00975000|10308990|P2|Overall Study|Lost to Follow-up|1
2995511|NCT00975000|10308991|P1|Overall Study|Lost to Follow-up|0
2995512|NCT00975000|10308990|P2|Overall Study|Withdrawal by Subject|2
2995513|NCT00975000|10308991|P1|Overall Study|Withdrawal by Subject|2
2995514|NCT00975000|10308990|P2|Overall Study|Adverse Event|1
2995515|NCT00975000|10308991|P1|Overall Study|Adverse Event|1
2995516|NCT00975000|10308990|P2|Overall Study|Other|0
2995517|NCT00975000|10308991|P1|Overall Study|Other|1
2995518|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Various|0
2995519|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Various|4
2995520|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
2995521|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
2995522|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
2995523|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
2995524|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2995525|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2995526|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
2995527|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
2995528|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
2995529|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
2995530|NCT00974974|10309015|P2|Maintenance - Double Blind Treatment|Adverse Event|3
2995531|NCT00974974|10309016|P1|Maintenance - Double Blind Treatment|Adverse Event|3
2995532|NCT00974974|10309015|P2|IPX066 Dose Conversion|Protocol Violation|0
2995533|NCT00974974|10309016|P1|IPX066 Dose Conversion|Protocol Violation|4
2995534|NCT00974974|10309015|P2|IPX066 Dose Conversion|Various|0
2995535|NCT00974974|10309016|P1|IPX066 Dose Conversion|Various|3
2995536|NCT00974974|10309015|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
2995537|NCT00974974|10309016|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
2995538|NCT00974974|10309015|P2|IPX066 Dose Conversion|Lack of Efficacy|0
2995539|NCT00974974|10309016|P1|IPX066 Dose Conversion|Lack of Efficacy|13
2995540|NCT00974974|10309015|P2|IPX066 Dose Conversion|Death|0
2995541|NCT00974974|10309016|P1|IPX066 Dose Conversion|Death|2
2995542|NCT00974974|10309015|P2|IPX066 Dose Conversion|Adverse Event|0
2995543|NCT00974974|10309016|P1|IPX066 Dose Conversion|Adverse Event|23
2995544|NCT00974974|10309015|P2|IR CD-LD Dose Adjustment|Various|9
2995545|NCT00974974|10309016|P1|IR CD-LD Dose Adjustment|Various|0
2995546|NCT00974974|10309015|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
2995547|NCT00974974|10309016|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
2995548|NCT00974974|10309015|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
2995549|NCT00974974|10309016|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
2995550|NCT00974974|10309015|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
2995551|NCT00974974|10309016|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
2995552|NCT00974974|10309015|P2|IR CD-LD Dose Adjustment|Adverse Event|3
2995553|NCT00974974|10309016|P1|IR CD-LD Dose Adjustment|Adverse Event|0
2995554|NCT00974922|10309026|P1|Overall Study|study terminated|24
2995555|NCT00974675|10309044|P4|Overall Study|Participant on holiday; unable to attend|1
2995556|NCT00974675|10309045|P3|Overall Study|Participant on holiday; unable to attend|0
2995557|NCT00974675|10309046|P2|Overall Study|Participant on holiday; unable to attend|0
2995558|NCT00974675|10309047|P1|Overall Study|Participant on holiday; unable to attend|0
2995559|NCT00974675|10309044|P4|Overall Study|Physician Decision|0
2995560|NCT00974675|10309045|P3|Overall Study|Physician Decision|1
2995561|NCT00974675|10309046|P2|Overall Study|Physician Decision|0
2995562|NCT00974675|10309047|P1|Overall Study|Physician Decision|0
2995563|NCT00974675|10309044|P4|Overall Study|Adverse Event|1
2995564|NCT00974675|10309045|P3|Overall Study|Adverse Event|1
2995565|NCT00974675|10309046|P2|Overall Study|Adverse Event|1
2995566|NCT00974675|10309047|P1|Overall Study|Adverse Event|2
2995567|NCT00974571|10309096|P3|Overall Study|Other|10
2995568|NCT00974571|10309097|P2|Overall Study|Other|0
2995569|NCT00974571|10309098|P1|Overall Study|Other|4
2995570|NCT00974571|10309096|P3|Overall Study|Patient Moved|1
2995571|NCT00974571|10309097|P2|Overall Study|Patient Moved|0
2995572|NCT00974571|10309098|P1|Overall Study|Patient Moved|1
2995573|NCT00974571|10309096|P3|Overall Study|Withdrawal by Subject|16
2995574|NCT00974571|10309097|P2|Overall Study|Withdrawal by Subject|5
2995575|NCT00974571|10309098|P1|Overall Study|Withdrawal by Subject|14
2995576|NCT00974571|10309096|P3|Overall Study|Protocol Violation|18
2995577|NCT00974571|10309097|P2|Overall Study|Protocol Violation|4
2995578|NCT00974571|10309098|P1|Overall Study|Protocol Violation|13
2995579|NCT00974571|10309096|P3|Overall Study|Lost to Follow-up|2
2995580|NCT00974571|10309097|P2|Overall Study|Lost to Follow-up|1
2995581|NCT00974571|10309098|P1|Overall Study|Lost to Follow-up|2
2995582|NCT00974571|10309096|P3|Overall Study|Lack of Efficacy|9
2995583|NCT00974571|10309097|P2|Overall Study|Lack of Efficacy|2
2995584|NCT00974571|10309098|P1|Overall Study|Lack of Efficacy|3
2995585|NCT00974571|10309096|P3|Overall Study|Adverse Event|27
2995586|NCT00974571|10309097|P2|Overall Study|Adverse Event|4
2995587|NCT00974571|10309098|P1|Overall Study|Adverse Event|31
2995588|NCT00974311|10309195|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
2995589|NCT00974311|10309196|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
2995590|NCT00974311|10309195|P2|OLE Phase (up to 77 Months)|Other|2
2995591|NCT00974311|10309196|P1|OLE Phase (up to 77 Months)|Other|15
2995592|NCT00974311|10309195|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
2995593|NCT00974311|10309196|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
2995594|NCT00974311|10309195|P2|OLE Phase (up to 77 Months)|Death|21
2995595|NCT00974311|10309196|P1|OLE Phase (up to 77 Months)|Death|14
2995596|NCT00974311|10309195|P2|DB Phase (up to 24 Months)|Other|0
2995597|NCT00974311|10309196|P1|DB Phase (up to 24 Months)|Other|1
2995598|NCT00974311|10309195|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
2995599|NCT00974311|10309196|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
2995600|NCT00974311|10309195|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
2995601|NCT00974311|10309196|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
2995602|NCT00974311|10309195|P2|DB Phase (up to 24 Months)|Death|298
2995603|NCT00974311|10309196|P1|DB Phase (up to 24 Months)|Death|561
2995604|NCT00974311|10309195|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
2995605|NCT00974311|10309196|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
2995606|NCT00974259|10309234|P2|Overall Study|Technically inadequate PbtO2 recordings|1
2995607|NCT00974259|10309235|P1|Overall Study|Technically inadequate PbtO2 recordings|2
2995608|NCT00974233|10309253|P1|Maintenance Lenalidomide|Adverse Event|8
2995609|NCT00974233|10309253|P1|Maintenance Lenalidomide|Lack of Efficacy|5
2995610|NCT00974233|10309253|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
2995611|NCT00974233|10309253|P1|Induction Chemoimmunotherapy|Adverse Event|7
2995612|NCT00974233|10309253|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
2995613|NCT00974233|10309253|P1|Induction Chemoimmunotherapy|Death|2
2995614|NCT00974220|10309268|P2|Treatment Period 1|noncompliant subjects|1
2995615|NCT00974220|10309269|P1|Treatment Period 1|noncompliant subjects|0
2995616|NCT00974220|10309268|P2|Treatment Period 1|Adverse Event|1
2995617|NCT00974220|10309269|P1|Treatment Period 1|Adverse Event|2
2995618|NCT00974090|10309314|P2|Period 2: Open-label Period|Withdrawal by Subject|0
2995619|NCT00974090|10309315|P1|Period 2: Open-label Period|Withdrawal by Subject|1
2995620|NCT00974090|10309314|P2|Period 2: Open-label Period|Physician Decision|3
2995621|NCT00974090|10309315|P1|Period 2: Open-label Period|Physician Decision|0
2995622|NCT00974090|10309314|P2|Period 2: Open-label Period|Lack of Efficacy|1
2995623|NCT00974090|10309315|P1|Period 2: Open-label Period|Lack of Efficacy|3
2995624|NCT00974090|10309314|P2|Period 2: Open-label Period|Adverse Event|6
2995625|NCT00974090|10309315|P1|Period 2: Open-label Period|Adverse Event|4
2995626|NCT00974090|10309314|P2|Period 1: Double Blind Period|Physician Decision|0
2995627|NCT00974090|10309315|P1|Period 1: Double Blind Period|Physician Decision|1
2995628|NCT00974090|10309314|P2|Period 1: Double Blind Period|Adverse Event|1
2995629|NCT00974090|10309315|P1|Period 1: Double Blind Period|Adverse Event|2
2995630|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
2995631|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
2995632|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
2995633|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
2995634|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
2995635|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
2995636|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
2995637|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
2995638|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
2995639|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
2995640|NCT00973973|10309351|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
2995641|NCT00973973|10309352|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
2995642|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2995643|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2995644|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2995645|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2995646|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
2995647|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
2995648|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
2995649|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
2995650|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
2995651|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
2995652|NCT00973973|10309351|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
2995653|NCT00973973|10309352|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
2995654|NCT00973921|10309412|P1|Overall Study|IVUS results were not available|9
2995655|NCT00973765|10309429|P2|Overall Study|Lost to Follow-up|14
2995656|NCT00973765|10309430|P1|Overall Study|Lost to Follow-up|8
2995657|NCT00973700|10309452|P5|Overall Study|Unable to Classify|1
2995658|NCT00973700|10309453|P4|Overall Study|Unable to Classify|2
2995659|NCT00973700|10309454|P3|Overall Study|Unable to Classify|1
2995660|NCT00973700|10309455|P2|Overall Study|Unable to Classify|0
2995661|NCT00973700|10309456|P1|Overall Study|Unable to Classify|0
2995662|NCT00973700|10309452|P5|Overall Study|Inappropriate enrolment|0
2995663|NCT00973700|10309453|P4|Overall Study|Inappropriate enrolment|4
2995664|NCT00973700|10309454|P3|Overall Study|Inappropriate enrolment|0
2995665|NCT00973700|10309455|P2|Overall Study|Inappropriate enrolment|0
2995666|NCT00973700|10309456|P1|Overall Study|Inappropriate enrolment|0
2995667|NCT00973700|10309452|P5|Overall Study|Lost to Follow-up|5
2995668|NCT00973700|10309453|P4|Overall Study|Lost to Follow-up|8
2995669|NCT00973700|10309454|P3|Overall Study|Lost to Follow-up|1
2995670|NCT00973700|10309455|P2|Overall Study|Lost to Follow-up|0
2995671|NCT00973700|10309456|P1|Overall Study|Lost to Follow-up|5
2995672|NCT00973700|10309452|P5|Overall Study|Withdrawal by Subject|4
2995673|NCT00973700|10309453|P4|Overall Study|Withdrawal by Subject|4
2995674|NCT00973700|10309454|P3|Overall Study|Withdrawal by Subject|8
2995675|NCT00973700|10309455|P2|Overall Study|Withdrawal by Subject|2
2995676|NCT00973700|10309456|P1|Overall Study|Withdrawal by Subject|2
2995677|NCT00973674|10309505|P2|Overall Study|Protocol Violation|0
2995678|NCT00973674|10309506|P1|Overall Study|Protocol Violation|2
2995679|NCT00973622|10309520|P2|Overall Study|did not complete rTMS sessions|2
2995680|NCT00973622|10309521|P1|Overall Study|did not complete rTMS sessions|11
2995681|NCT00973622|10309520|P2|Overall Study|did not pass MRI screen|0
2995682|NCT00973622|10309521|P1|Overall Study|did not pass MRI screen|6
2995683|NCT00973622|10309520|P2|Overall Study|did not attend MRI|3
2995684|NCT00973622|10309521|P1|Overall Study|did not attend MRI|14
2995685|NCT00973479|10309529|P2|Overall Study|Other|7
2995686|NCT00973479|10309530|P1|Overall Study|Other|1
2995687|NCT00973479|10309529|P2|Overall Study|Protocol Violation|2
2995688|NCT00973479|10309530|P1|Overall Study|Protocol Violation|2
2995689|NCT00973479|10309529|P2|Overall Study|Adverse Event|32
2995690|NCT00973479|10309530|P1|Overall Study|Adverse Event|12
2995691|NCT00973479|10309529|P2|Overall Study|Lack of Efficacy|7
2995692|NCT00973479|10309530|P1|Overall Study|Lack of Efficacy|5
2995693|NCT00973479|10309529|P2|Overall Study|Withdrawal by Subject|16
2995694|NCT00973479|10309530|P1|Overall Study|Withdrawal by Subject|15
2995695|NCT00973479|10309529|P2|Overall Study|Death|2
2995696|NCT00973479|10309530|P1|Overall Study|Death|2
2995697|NCT00973479|10309529|P2|Overall Study|Lost to Follow-up|3
2995698|NCT00973479|10309530|P1|Overall Study|Lost to Follow-up|0
2995699|NCT00973362|10309548|P2|3-Year Follow-up|Lost to Follow-up|0
2995700|NCT00973362|10309549|P1|3-Year Follow-up|Lost to Follow-up|17
2995701|NCT00973362|10309548|P2|Baseline Evaluation|Inevaluable|223
2995702|NCT00973362|10309549|P1|Baseline Evaluation|Inevaluable|686
2995703|NCT00973362|10309548|P2|Baseline Evaluation|No colposcopy visit|0
2995704|NCT00973362|10309549|P1|Baseline Evaluation|No colposcopy visit|62
2995705|NCT00973362|10309548|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
2995706|NCT00973362|10309549|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
2995707|NCT00973349|10309574|P16|Overall Study|Unable to classify|0
2995708|NCT00973349|10309575|P15|Overall Study|Unable to classify|0
2995709|NCT00973349|10309576|P14|Overall Study|Unable to classify|0
2995710|NCT00973349|10309577|P13|Overall Study|Unable to classify|0
2995711|NCT00973349|10309578|P12|Overall Study|Unable to classify|0
2995712|NCT00973349|10309579|P11|Overall Study|Unable to classify|0
2995713|NCT00973349|10309580|P10|Overall Study|Unable to classify|1
2995714|NCT00973349|10309581|P9|Overall Study|Unable to classify|0
2995715|NCT00973349|10309582|P8|Overall Study|Unable to classify|0
2995716|NCT00973349|10309583|P7|Overall Study|Unable to classify|0
2995717|NCT00973349|10309584|P6|Overall Study|Unable to classify|1
2995718|NCT00973349|10309585|P5|Overall Study|Unable to classify|1
2995719|NCT00973349|10309586|P4|Overall Study|Unable to classify|0
2995720|NCT00973349|10309587|P3|Overall Study|Unable to classify|0
2995721|NCT00973349|10309588|P2|Overall Study|Unable to classify|0
2995722|NCT00973349|10309589|P1|Overall Study|Unable to classify|0
2995723|NCT00973349|10309574|P16|Overall Study|Protocol Violation|0
2995724|NCT00973349|10309575|P15|Overall Study|Protocol Violation|0
2995725|NCT00973349|10309576|P14|Overall Study|Protocol Violation|0
2995726|NCT00973349|10309577|P13|Overall Study|Protocol Violation|0
2995727|NCT00973349|10309578|P12|Overall Study|Protocol Violation|0
2995728|NCT00973349|10309579|P11|Overall Study|Protocol Violation|0
2995729|NCT00973349|10309580|P10|Overall Study|Protocol Violation|0
2995730|NCT00973349|10309581|P9|Overall Study|Protocol Violation|1
2995731|NCT00973349|10309582|P8|Overall Study|Protocol Violation|0
2995732|NCT00973349|10309583|P7|Overall Study|Protocol Violation|0
2995733|NCT00973349|10309584|P6|Overall Study|Protocol Violation|0
2995734|NCT00973349|10309585|P5|Overall Study|Protocol Violation|0
2995735|NCT00973349|10309586|P4|Overall Study|Protocol Violation|0
2995736|NCT00973349|10309587|P3|Overall Study|Protocol Violation|0
2995737|NCT00973349|10309588|P2|Overall Study|Protocol Violation|0
2995738|NCT00973349|10309589|P1|Overall Study|Protocol Violation|0
2995739|NCT00973349|10309574|P16|Overall Study|Inappropriate enrolment|1
2995740|NCT00973349|10309575|P15|Overall Study|Inappropriate enrolment|1
2995741|NCT00973349|10309576|P14|Overall Study|Inappropriate enrolment|0
2995742|NCT00973349|10309577|P13|Overall Study|Inappropriate enrolment|1
2995743|NCT00973349|10309578|P12|Overall Study|Inappropriate enrolment|0
2995744|NCT00973349|10309579|P11|Overall Study|Inappropriate enrolment|0
2995745|NCT00973349|10309580|P10|Overall Study|Inappropriate enrolment|2
2995746|NCT00973349|10309581|P9|Overall Study|Inappropriate enrolment|0
2995747|NCT00973349|10309582|P8|Overall Study|Inappropriate enrolment|0
2995748|NCT00973349|10309583|P7|Overall Study|Inappropriate enrolment|0
2995749|NCT00973349|10309584|P6|Overall Study|Inappropriate enrolment|0
2995750|NCT00973349|10309585|P5|Overall Study|Inappropriate enrolment|0
2995751|NCT00973349|10309586|P4|Overall Study|Inappropriate enrolment|0
2995752|NCT00973349|10309587|P3|Overall Study|Inappropriate enrolment|1
2995753|NCT00973349|10309588|P2|Overall Study|Inappropriate enrolment|0
2995754|NCT00973349|10309589|P1|Overall Study|Inappropriate enrolment|0
2995755|NCT00973349|10309574|P16|Overall Study|Lost to Follow-up|1
2995756|NCT00973349|10309575|P15|Overall Study|Lost to Follow-up|0
2995757|NCT00973349|10309576|P14|Overall Study|Lost to Follow-up|0
2995758|NCT00973349|10309577|P13|Overall Study|Lost to Follow-up|0
2995759|NCT00973349|10309578|P12|Overall Study|Lost to Follow-up|1
2995760|NCT00973349|10309579|P11|Overall Study|Lost to Follow-up|0
2995761|NCT00973349|10309580|P10|Overall Study|Lost to Follow-up|1
2995762|NCT00973349|10309581|P9|Overall Study|Lost to Follow-up|2
2995763|NCT00973349|10309582|P8|Overall Study|Lost to Follow-up|1
2995764|NCT00973349|10309583|P7|Overall Study|Lost to Follow-up|0
2995765|NCT00973349|10309584|P6|Overall Study|Lost to Follow-up|3
2995766|NCT00973349|10309585|P5|Overall Study|Lost to Follow-up|1
2995767|NCT00973349|10309586|P4|Overall Study|Lost to Follow-up|2
2995768|NCT00973349|10309587|P3|Overall Study|Lost to Follow-up|2
2995769|NCT00973349|10309588|P2|Overall Study|Lost to Follow-up|1
2995770|NCT00973349|10309589|P1|Overall Study|Lost to Follow-up|3
2995771|NCT00973349|10309574|P16|Overall Study|Withdrawal by Subject|0
2995772|NCT00973349|10309575|P15|Overall Study|Withdrawal by Subject|0
2995773|NCT00973349|10309576|P14|Overall Study|Withdrawal by Subject|0
2995774|NCT00973349|10309577|P13|Overall Study|Withdrawal by Subject|0
2995775|NCT00973349|10309578|P12|Overall Study|Withdrawal by Subject|1
2995776|NCT00973349|10309579|P11|Overall Study|Withdrawal by Subject|0
2995777|NCT00973349|10309580|P10|Overall Study|Withdrawal by Subject|2
2995778|NCT00973349|10309581|P9|Overall Study|Withdrawal by Subject|0
2995779|NCT00973349|10309582|P8|Overall Study|Withdrawal by Subject|2
2995780|NCT00973349|10309583|P7|Overall Study|Withdrawal by Subject|2
2995781|NCT00973349|10309584|P6|Overall Study|Withdrawal by Subject|0
2995782|NCT00973349|10309585|P5|Overall Study|Withdrawal by Subject|2
2995783|NCT00973349|10309586|P4|Overall Study|Withdrawal by Subject|3
2995784|NCT00973349|10309587|P3|Overall Study|Withdrawal by Subject|2
2995785|NCT00973349|10309588|P2|Overall Study|Withdrawal by Subject|2
2995786|NCT00973349|10309589|P1|Overall Study|Withdrawal by Subject|1
2995787|NCT00973349|10309574|P16|Overall Study|Adverse Event|0
2995788|NCT00973349|10309575|P15|Overall Study|Adverse Event|1
2995789|NCT00973349|10309576|P14|Overall Study|Adverse Event|0
2995790|NCT00973349|10309577|P13|Overall Study|Adverse Event|0
2995791|NCT00973349|10309578|P12|Overall Study|Adverse Event|0
2995792|NCT00973349|10309579|P11|Overall Study|Adverse Event|0
2995793|NCT00973349|10309580|P10|Overall Study|Adverse Event|0
2995794|NCT00973349|10309581|P9|Overall Study|Adverse Event|1
2995795|NCT00973349|10309582|P8|Overall Study|Adverse Event|0
2995796|NCT00973349|10309583|P7|Overall Study|Adverse Event|0
2995797|NCT00973349|10309584|P6|Overall Study|Adverse Event|0
2995798|NCT00973349|10309585|P5|Overall Study|Adverse Event|1
2995799|NCT00973349|10309586|P4|Overall Study|Adverse Event|0
2995800|NCT00973349|10309587|P3|Overall Study|Adverse Event|0
2995801|NCT00973349|10309588|P2|Overall Study|Adverse Event|0
2995802|NCT00973349|10309589|P1|Overall Study|Adverse Event|0
2995803|NCT00973102|10309689|P2|Overall Study|Prisoner|1
2995804|NCT00973102|10309690|P1|Overall Study|Prisoner|0
2995805|NCT00973102|10309689|P2|Overall Study|Protocol Violation|0
2995806|NCT00973102|10309690|P1|Overall Study|Protocol Violation|1
2995807|NCT00972816|10309721|P8|Overall Study|Unable to classify|0
2995808|NCT00972816|10309722|P7|Overall Study|Unable to classify|0
2995809|NCT00972816|10309723|P6|Overall Study|Unable to classify|0
2995810|NCT00972816|10309724|P5|Overall Study|Unable to classify|1
2995811|NCT00972816|10309725|P4|Overall Study|Unable to classify|0
2995812|NCT00972816|10309726|P3|Overall Study|Unable to classify|0
2995813|NCT00972816|10309727|P2|Overall Study|Unable to classify|0
2995814|NCT00972816|10309728|P1|Overall Study|Unable to classify|2
2995815|NCT00972816|10309721|P8|Overall Study|Inappropriate enrolment|0
2995816|NCT00972816|10309722|P7|Overall Study|Inappropriate enrolment|2
2995817|NCT00972816|10309723|P6|Overall Study|Inappropriate enrolment|0
2995818|NCT00972816|10309724|P5|Overall Study|Inappropriate enrolment|0
2995819|NCT00972816|10309725|P4|Overall Study|Inappropriate enrolment|0
2995820|NCT00972816|10309726|P3|Overall Study|Inappropriate enrolment|0
2995821|NCT00972816|10309727|P2|Overall Study|Inappropriate enrolment|0
2995822|NCT00972816|10309728|P1|Overall Study|Inappropriate enrolment|0
2995823|NCT00972816|10309721|P8|Overall Study|Lost to Follow-up|7
2995824|NCT00972816|10309722|P7|Overall Study|Lost to Follow-up|7
2995825|NCT00972816|10309723|P6|Overall Study|Lost to Follow-up|10
2995826|NCT00972816|10309724|P5|Overall Study|Lost to Follow-up|11
2995827|NCT00972816|10309725|P4|Overall Study|Lost to Follow-up|5
2995828|NCT00972816|10309726|P3|Overall Study|Lost to Follow-up|7
2995829|NCT00972816|10309727|P2|Overall Study|Lost to Follow-up|9
2995830|NCT00972816|10309728|P1|Overall Study|Lost to Follow-up|11
2995831|NCT00972816|10309721|P8|Overall Study|Withdrawal by Subject|2
2995832|NCT00972816|10309722|P7|Overall Study|Withdrawal by Subject|1
2995833|NCT00972816|10309723|P6|Overall Study|Withdrawal by Subject|1
2995834|NCT00972816|10309724|P5|Overall Study|Withdrawal by Subject|0
2995835|NCT00972816|10309725|P4|Overall Study|Withdrawal by Subject|3
2995836|NCT00972816|10309726|P3|Overall Study|Withdrawal by Subject|1
2995837|NCT00972816|10309727|P2|Overall Study|Withdrawal by Subject|2
2995838|NCT00972816|10309728|P1|Overall Study|Withdrawal by Subject|4
2995839|NCT00972816|10309721|P8|Overall Study|Adverse Event|0
2995840|NCT00972816|10309722|P7|Overall Study|Adverse Event|0
2995841|NCT00972816|10309723|P6|Overall Study|Adverse Event|0
2995842|NCT00972816|10309724|P5|Overall Study|Adverse Event|0
2995843|NCT00972816|10309725|P4|Overall Study|Adverse Event|0
2995844|NCT00972816|10309726|P3|Overall Study|Adverse Event|1
2995845|NCT00972816|10309727|P2|Overall Study|Adverse Event|0
2995846|NCT00972816|10309728|P1|Overall Study|Adverse Event|0
2995847|NCT00972777|10309812|P2|Overall Study|Missed visit|0
2995848|NCT00972777|10309813|P1|Overall Study|Missed visit|1
2995849|NCT00972777|10309812|P2|Overall Study|Screening Failure|1
2995850|NCT00972777|10309813|P1|Overall Study|Screening Failure|2
2995851|NCT00972777|10309812|P2|Overall Study|Protocol Violation|2
2995852|NCT00972777|10309813|P1|Overall Study|Protocol Violation|0
2995853|NCT00972777|10309812|P2|Overall Study|Physician Decision|0
2995854|NCT00972777|10309813|P1|Overall Study|Physician Decision|4
2995855|NCT00972777|10309812|P2|Overall Study|Withdrawal by Subject|5
2995856|NCT00972777|10309813|P1|Overall Study|Withdrawal by Subject|4
2995857|NCT00972777|10309812|P2|Overall Study|Lost to Follow-up|4
2995858|NCT00972777|10309813|P1|Overall Study|Lost to Follow-up|0
2995859|NCT00972777|10309812|P2|Overall Study|Adverse Event|2
2995860|NCT00972777|10309813|P1|Overall Study|Adverse Event|3
2995861|NCT00972738|10309828|P3|Overall Study|Other|1
2995862|NCT00972738|10309829|P2|Overall Study|Other|2
2995863|NCT00972738|10309830|P1|Overall Study|Other|1
2995864|NCT00972738|10309828|P3|Overall Study|Moved|1
2995865|NCT00972738|10309829|P2|Overall Study|Moved|0
2995866|NCT00972738|10309830|P1|Overall Study|Moved|0
2995867|NCT00972738|10309828|P3|Overall Study|Withdrawal by Subject|4
2995868|NCT00972738|10309829|P2|Overall Study|Withdrawal by Subject|1
2995869|NCT00972738|10309830|P1|Overall Study|Withdrawal by Subject|5
2995870|NCT00972738|10309828|P3|Overall Study|Lack of Efficacy|11
2995871|NCT00972738|10309829|P2|Overall Study|Lack of Efficacy|1
2995872|NCT00972738|10309830|P1|Overall Study|Lack of Efficacy|5
2995873|NCT00972738|10309828|P3|Overall Study|Lost to Follow-up|1
2995874|NCT00972738|10309829|P2|Overall Study|Lost to Follow-up|0
2995875|NCT00972738|10309830|P1|Overall Study|Lost to Follow-up|1
2995876|NCT00972738|10309828|P3|Overall Study|Protocol Violation|3
2995877|NCT00972738|10309829|P2|Overall Study|Protocol Violation|1
2995878|NCT00972738|10309830|P1|Overall Study|Protocol Violation|2
2995879|NCT00972738|10309828|P3|Overall Study|Adverse Event|8
2995880|NCT00972738|10309829|P2|Overall Study|Adverse Event|1
2995881|NCT00972738|10309830|P1|Overall Study|Adverse Event|7
2995882|NCT00972595|10309947|P2|Period 1|Adverse Event|0
2995883|NCT00972595|10309948|P1|Period 1|Adverse Event|1
2995884|NCT00972543|10309958|P2|Overall Study|Early study termination by sponsor|1
2995885|NCT00972543|10309959|P1|Overall Study|Early study termination by sponsor|4
2995886|NCT00972543|10309958|P2|Overall Study|Adverse Event|0
2995887|NCT00972543|10309959|P1|Overall Study|Adverse Event|1
2995888|NCT00972517|10310042|P6|Overall Study|Withdrawal by Subject|0
2995889|NCT00972517|10310043|P5|Overall Study|Withdrawal by Subject|1
2995890|NCT00972517|10310044|P4|Overall Study|Withdrawal by Subject|2
2995891|NCT00972517|10310045|P3|Overall Study|Withdrawal by Subject|0
2995892|NCT00972517|10310046|P2|Overall Study|Withdrawal by Subject|1
2995893|NCT00972517|10310047|P1|Overall Study|Withdrawal by Subject|0
2995894|NCT00972517|10310042|P6|Overall Study|Adverse Event|0
2995895|NCT00972517|10310043|P5|Overall Study|Adverse Event|0
2995896|NCT00972517|10310044|P4|Overall Study|Adverse Event|1
2995897|NCT00972517|10310045|P3|Overall Study|Adverse Event|0
2995898|NCT00972517|10310046|P2|Overall Study|Adverse Event|0
2995899|NCT00972517|10310047|P1|Overall Study|Adverse Event|0
2995900|NCT00972504|10310142|P1|Overall Study|Investigator discretion|1
2995901|NCT00972504|10310142|P1|Overall Study|Adverse Event|2
2995902|NCT00972478|10310174|P2|Overall Study|Not start protocol treatment|2
2995903|NCT00972478|10310175|P1|Overall Study|Not start protocol treatment|1
2995904|NCT00972478|10310174|P2|Overall Study|Ineligible|7
2995905|NCT00972478|10310175|P1|Overall Study|Ineligible|1
2995906|NCT00972478|10310174|P2|Overall Study|Not protocol specified|1
2995907|NCT00972478|10310175|P1|Overall Study|Not protocol specified|1
2995908|NCT00972478|10310174|P2|Overall Study|Death|2
2995909|NCT00972478|10310175|P1|Overall Study|Death|0
2995910|NCT00972478|10310174|P2|Overall Study|Progression/Relapse|2
2995911|NCT00972478|10310175|P1|Overall Study|Progression/Relapse|0
2995912|NCT00972478|10310174|P2|Overall Study|Withdrawal by Subject|8
2995913|NCT00972478|10310175|P1|Overall Study|Withdrawal by Subject|1
2995914|NCT00972478|10310174|P2|Overall Study|Adverse Event|16
2995915|NCT00972478|10310175|P1|Overall Study|Adverse Event|3
2995916|NCT00972322|10310220|P2|Overall Study|Consistently high glucose values|0
2995917|NCT00972322|10310221|P1|Overall Study|Consistently high glucose values|1
2995918|NCT00972322|10310220|P2|Overall Study|Lost to Follow-up|1
2995919|NCT00972322|10310221|P1|Overall Study|Lost to Follow-up|0
2995920|NCT00972322|10310220|P2|Overall Study|Positive drug screen|1
2995921|NCT00972322|10310221|P1|Overall Study|Positive drug screen|0
2995922|NCT00972322|10310220|P2|Overall Study|Adverse Event|1
2995923|NCT00972322|10310221|P1|Overall Study|Adverse Event|2
2995924|NCT00972283|10310233|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
2995925|NCT00972283|10310234|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
2995926|NCT00972283|10310233|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
2995927|NCT00972283|10310234|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
2995928|NCT00972283|10310233|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
2995929|NCT00972283|10310234|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
2995930|NCT00972283|10310233|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2995931|NCT00972283|10310234|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2995932|NCT00972283|10310233|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
2995933|NCT00972283|10310234|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
2995934|NCT00972283|10310233|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
2995935|NCT00972283|10310234|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
2995936|NCT00972283|10310233|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
2995937|NCT00972283|10310234|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
2995938|NCT00972283|10310233|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
2995939|NCT00972283|10310234|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
2995940|NCT00972283|10310233|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
2995941|NCT00972283|10310234|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
2995942|NCT00972283|10310233|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
2995943|NCT00972283|10310234|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
2995944|NCT00972244|10310261|P5|Overall Study|Various|2
2995945|NCT00972244|10310262|P4|Overall Study|Various|0
2995946|NCT00972244|10310263|P3|Overall Study|Various|0
2995947|NCT00972244|10310264|P2|Overall Study|Various|0
2995948|NCT00972244|10310265|P1|Overall Study|Various|0
2995949|NCT00972244|10310261|P5|Overall Study|Death|0
2995950|NCT00972244|10310262|P4|Overall Study|Death|0
2995951|NCT00972244|10310263|P3|Overall Study|Death|0
2995952|NCT00972244|10310264|P2|Overall Study|Death|0
2995953|NCT00972244|10310265|P1|Overall Study|Death|1
2995954|NCT00972244|10310261|P5|Overall Study|Safety|1
2995955|NCT00972244|10310262|P4|Overall Study|Safety|0
2995956|NCT00972244|10310263|P3|Overall Study|Safety|0
2995957|NCT00972244|10310264|P2|Overall Study|Safety|0
2995958|NCT00972244|10310265|P1|Overall Study|Safety|0
2995959|NCT00972244|10310261|P5|Overall Study|Withdrawal by Subject|1
2995960|NCT00972244|10310262|P4|Overall Study|Withdrawal by Subject|0
2995961|NCT00972244|10310263|P3|Overall Study|Withdrawal by Subject|1
2995962|NCT00972244|10310264|P2|Overall Study|Withdrawal by Subject|2
2995963|NCT00972244|10310265|P1|Overall Study|Withdrawal by Subject|1
2995964|NCT00972244|10310261|P5|Overall Study|Subject No Longer Meets Study Criteria|5
2995965|NCT00972244|10310262|P4|Overall Study|Subject No Longer Meets Study Criteria|0
2995966|NCT00972244|10310263|P3|Overall Study|Subject No Longer Meets Study Criteria|0
2995967|NCT00972244|10310264|P2|Overall Study|Subject No Longer Meets Study Criteria|2
2995968|NCT00972244|10310265|P1|Overall Study|Subject No Longer Meets Study Criteria|2
2995969|NCT00972244|10310261|P5|Overall Study|Adverse Event|0
2995970|NCT00972244|10310262|P4|Overall Study|Adverse Event|0
2995971|NCT00972244|10310263|P3|Overall Study|Adverse Event|1
2995972|NCT00972244|10310264|P2|Overall Study|Adverse Event|1
2995973|NCT00972244|10310265|P1|Overall Study|Adverse Event|0
2995974|NCT00972244|10310261|P5|Overall Study|Incorrect Enrolment|0
2995975|NCT00972244|10310262|P4|Overall Study|Incorrect Enrolment|0
2995976|NCT00972244|10310263|P3|Overall Study|Incorrect Enrolment|0
2995977|NCT00972244|10310264|P2|Overall Study|Incorrect Enrolment|0
2995978|NCT00972244|10310265|P1|Overall Study|Incorrect Enrolment|1
2995979|NCT00972153|10310297|P3|Overall Study|Equipment malfunction during case|0
2995980|NCT00972153|10310298|P2|Overall Study|Equipment malfunction during case|1
2995981|NCT00972153|10310299|P1|Overall Study|Equipment malfunction during case|0
2995982|NCT00972023|10310314|P1|Overall Study|Withdrawal by Subject|1
2995983|NCT00971997|10310321|P1|Overall Study|Physician Decision|7
2995984|NCT00971997|10310321|P1|Overall Study|Withdrawal by Subject|5
2995985|NCT00971997|10310321|P1|Overall Study|Protocol Violation|4
2995986|NCT00971997|10310321|P1|Overall Study|Death|1
2995987|NCT00971997|10310321|P1|Overall Study|Adverse Event|2
2995988|NCT00971932|10310339|P1|Overall Study|Ongoing|4
2995989|NCT00971932|10310339|P1|Overall Study|Investigator's decision|2
2995990|NCT00971932|10310339|P1|Overall Study|Withdrawal by Subject|1
2995991|NCT00971425|10310440|P2|Overall Study|Withdrawal by Subject|1
2995992|NCT00971425|10310441|P1|Overall Study|Withdrawal by Subject|0
2995993|NCT00971425|10310440|P2|Overall Study|Adverse Event|1
2995994|NCT00971425|10310441|P1|Overall Study|Adverse Event|1
2995995|NCT00971321|10310477|P2|Up to Month 11-12|Lost to Follow-up|0
2995996|NCT00971321|10310478|P1|Up to Month 11-12|Lost to Follow-up|1
2995997|NCT00971321|10310477|P2|Up to Month 11-12|Migrated/moved from study area|2
2995998|NCT00971321|10310478|P1|Up to Month 11-12|Migrated/moved from study area|2
2995999|NCT00971321|10310477|P2|Up to Month 11-12|Withdrawal by Subject|1
2996000|NCT00971321|10310478|P1|Up to Month 11-12|Withdrawal by Subject|2
2996001|NCT00971321|10310477|P2|Up to Month 7|Migrated/moved from study area|2
2996002|NCT00971321|10310478|P1|Up to Month 7|Migrated/moved from study area|3
2996003|NCT00971321|10310477|P2|Up to Month 7|Withdrawal by Subject|0
2996004|NCT00971321|10310478|P1|Up to Month 7|Withdrawal by Subject|1
2996005|NCT00971243|10310558|P5|Open-label Period|Other reason|2
2996006|NCT00971243|10310559|P4|Open-label Period|Other reason|0
2996007|NCT00971243|10310560|P3|Open-label Period|Other reason|0
2996008|NCT00971243|10310561|P2|Open-label Period|Other reason|0
2996009|NCT00971243|10310562|P1|Open-label Period|Other reason|0
2996010|NCT00971243|10310558|P5|Open-label Period|Withdrawal by Subject|1
2996011|NCT00971243|10310559|P4|Open-label Period|Withdrawal by Subject|2
2996012|NCT00971243|10310560|P3|Open-label Period|Withdrawal by Subject|0
2996013|NCT00971243|10310561|P2|Open-label Period|Withdrawal by Subject|0
2996014|NCT00971243|10310562|P1|Open-label Period|Withdrawal by Subject|1
2996015|NCT00971243|10310558|P5|Open-label Period|Protocol Violation|1
2996016|NCT00971243|10310559|P4|Open-label Period|Protocol Violation|0
2996017|NCT00971243|10310560|P3|Open-label Period|Protocol Violation|1
2996018|NCT00971243|10310561|P2|Open-label Period|Protocol Violation|1
2996019|NCT00971243|10310562|P1|Open-label Period|Protocol Violation|1
2996020|NCT00971243|10310558|P5|Open-label Period|Physician Decision|2
2996021|NCT00971243|10310559|P4|Open-label Period|Physician Decision|7
2996022|NCT00971243|10310560|P3|Open-label Period|Physician Decision|3
2996023|NCT00971243|10310561|P2|Open-label Period|Physician Decision|9
2996024|NCT00971243|10310562|P1|Open-label Period|Physician Decision|5
2996025|NCT00971243|10310558|P5|Open-label Period|Adverse Event|0
2996026|NCT00971243|10310559|P4|Open-label Period|Adverse Event|1
2996027|NCT00971243|10310560|P3|Open-label Period|Adverse Event|1
2996028|NCT00971243|10310561|P2|Open-label Period|Adverse Event|0
2996029|NCT00971243|10310562|P1|Open-label Period|Adverse Event|1
2996030|NCT00971243|10310558|P5|Double Blind Period|Other reasons|1
2996031|NCT00971243|10310559|P4|Double Blind Period|Other reasons|0
2996032|NCT00971243|10310560|P3|Double Blind Period|Other reasons|2
2996033|NCT00971243|10310561|P2|Double Blind Period|Other reasons|0
2996034|NCT00971243|10310562|P1|Double Blind Period|Other reasons|1
2996035|NCT00971243|10310558|P5|Double Blind Period|Withdrawal by Subject|4
2996036|NCT00971243|10310559|P4|Double Blind Period|Withdrawal by Subject|4
2996037|NCT00971243|10310560|P3|Double Blind Period|Withdrawal by Subject|4
2996038|NCT00971243|10310561|P2|Double Blind Period|Withdrawal by Subject|1
2996039|NCT00971243|10310562|P1|Double Blind Period|Withdrawal by Subject|4
2996040|NCT00971243|10310558|P5|Double Blind Period|Protocol Violation|2
2996041|NCT00971243|10310559|P4|Double Blind Period|Protocol Violation|2
2996042|NCT00971243|10310560|P3|Double Blind Period|Protocol Violation|3
2996043|NCT00971243|10310561|P2|Double Blind Period|Protocol Violation|0
2996044|NCT00971243|10310562|P1|Double Blind Period|Protocol Violation|2
2996045|NCT00971243|10310558|P5|Double Blind Period|Physician Decision|7
2996046|NCT00971243|10310559|P4|Double Blind Period|Physician Decision|6
2996047|NCT00971243|10310560|P3|Double Blind Period|Physician Decision|7
2996048|NCT00971243|10310561|P2|Double Blind Period|Physician Decision|6
2996049|NCT00971243|10310562|P1|Double Blind Period|Physician Decision|10
2996050|NCT00971243|10310558|P5|Double Blind Period|Lost to Follow-up|1
2996051|NCT00971243|10310559|P4|Double Blind Period|Lost to Follow-up|0
2996052|NCT00971243|10310560|P3|Double Blind Period|Lost to Follow-up|1
2996053|NCT00971243|10310561|P2|Double Blind Period|Lost to Follow-up|1
2996054|NCT00971243|10310562|P1|Double Blind Period|Lost to Follow-up|0
2996055|NCT00971243|10310558|P5|Double Blind Period|Adverse Event|3
2996056|NCT00971243|10310559|P4|Double Blind Period|Adverse Event|2
2996057|NCT00971243|10310560|P3|Double Blind Period|Adverse Event|2
2996058|NCT00971243|10310561|P2|Double Blind Period|Adverse Event|3
2996059|NCT00971243|10310562|P1|Double Blind Period|Adverse Event|2
2996060|NCT00971204|10310579|P1|Overall Study|Lost to Follow-up|10
2996061|NCT00971204|10310579|P1|Overall Study|Did not meet all criteria-not treated|14
2996062|NCT00971048|10310587|P4|Overall Study|Physician Decision|1
2996063|NCT00971048|10310588|P3|Overall Study|Physician Decision|0
2996064|NCT00971048|10310589|P2|Overall Study|Physician Decision|0
2996065|NCT00971048|10310590|P1|Overall Study|Physician Decision|0
2996066|NCT00971048|10310587|P4|Overall Study|Adverse Event|0
2996067|NCT00971048|10310588|P3|Overall Study|Adverse Event|1
2996068|NCT00971048|10310589|P2|Overall Study|Adverse Event|0
2996069|NCT00971048|10310590|P1|Overall Study|Adverse Event|0
2996070|NCT00971048|10310587|P4|Overall Study|Protocol Violation|1
2996071|NCT00971048|10310588|P3|Overall Study|Protocol Violation|0
2996072|NCT00971048|10310589|P2|Overall Study|Protocol Violation|2
2996073|NCT00971048|10310590|P1|Overall Study|Protocol Violation|1
2996074|NCT00970944|10310614|P2|Overall Study|Physician Decision|2
2996075|NCT00970944|10310615|P1|Overall Study|Physician Decision|0
2996076|NCT00970944|10310614|P2|Overall Study|Death|0
2996077|NCT00970944|10310615|P1|Overall Study|Death|1
2996078|NCT00970684|10310667|P1|Overall Study|Withdrawal by Subject|1
2996079|NCT00970684|10310667|P1|Overall Study|Adverse Event|4
2996080|NCT00970684|10310667|P1|Overall Study|Lack of Efficacy|5
2996081|NCT00970632|10310676|P3|Overall Study|Sponsor decision|1
2996082|NCT00970632|10310677|P2|Overall Study|Sponsor decision|0
2996083|NCT00970632|10310678|P1|Overall Study|Sponsor decision|1
2996084|NCT00970632|10310676|P3|Overall Study|Entry criteria not met|2
2996085|NCT00970632|10310677|P2|Overall Study|Entry criteria not met|2
2996086|NCT00970632|10310678|P1|Overall Study|Entry criteria not met|0
2996087|NCT00970632|10310676|P3|Overall Study|Withdrawal by Subject|4
2996088|NCT00970632|10310677|P2|Overall Study|Withdrawal by Subject|6
2996089|NCT00970632|10310678|P1|Overall Study|Withdrawal by Subject|7
2996090|NCT00970632|10310676|P3|Overall Study|Protocol Violation|8
2996091|NCT00970632|10310677|P2|Overall Study|Protocol Violation|5
2996092|NCT00970632|10310678|P1|Overall Study|Protocol Violation|8
2996093|NCT00970632|10310676|P3|Overall Study|Lost to Follow-up|2
2996094|NCT00970632|10310677|P2|Overall Study|Lost to Follow-up|0
2996095|NCT00970632|10310678|P1|Overall Study|Lost to Follow-up|3
2996096|NCT00970632|10310676|P3|Overall Study|Lack of Efficacy|0
2996097|NCT00970632|10310677|P2|Overall Study|Lack of Efficacy|0
2996098|NCT00970632|10310678|P1|Overall Study|Lack of Efficacy|3
2996099|NCT00970632|10310676|P3|Overall Study|Adverse Event|1
2996100|NCT00970632|10310677|P2|Overall Study|Adverse Event|2
2996101|NCT00970632|10310678|P1|Overall Study|Adverse Event|2
2996102|NCT00970502|10310743|P1|Overall Study|Withdrawal by Subject|1
2996692|NCT00966875|10312489|P6|Part B|Death|0
2996103|NCT00970489|10310754|P2|Overall Study|Death/Withdrew/Criteria Violation|41
2996104|NCT00970489|10310755|P1|Overall Study|Death/Withdrew/Criteria Violation|54
2996105|NCT00970359|10310767|P1|Overall Study|Not Treated|4
2996106|NCT00970307|10310797|P3|Overall Study|Withdrawal by Subject|2
2996107|NCT00970307|10310798|P2|Overall Study|Withdrawal by Subject|3
2996108|NCT00970307|10310799|P1|Overall Study|Withdrawal by Subject|2
2996109|NCT00970307|10310797|P3|Overall Study|Serious Adverse Event|0
2996110|NCT00970307|10310798|P2|Overall Study|Serious Adverse Event|0
2996111|NCT00970307|10310799|P1|Overall Study|Serious Adverse Event|1
2996112|NCT00970294|10310873|P1|Overall Study|Withdrawal by Subject|1
2996113|NCT00970294|10310873|P1|Overall Study|Physician Decision|4
2996114|NCT00970281|10310881|P2|Overall Study|Physician Decision|1
2996115|NCT00970281|10310882|P1|Overall Study|Physician Decision|1
2996116|NCT00970281|10310881|P2|Overall Study|Withdrawal by Subject|1
2996117|NCT00970281|10310882|P1|Overall Study|Withdrawal by Subject|0
2996118|NCT00970281|10310881|P2|Overall Study|Lack of Efficacy|14
2996119|NCT00970281|10310882|P1|Overall Study|Lack of Efficacy|1
2996120|NCT00970268|10310900|P2|Overall Study|Inclusion/Exclusion Criteria|0
2996121|NCT00970268|10310901|P1|Overall Study|Inclusion/Exclusion Criteria|1
2996122|NCT00970268|10310900|P2|Overall Study|Lost to Follow-up|2
2996123|NCT00970268|10310901|P1|Overall Study|Lost to Follow-up|1
2996124|NCT00970268|10310900|P2|Overall Study|COPD Exacerbation|2
2996125|NCT00970268|10310901|P1|Overall Study|COPD Exacerbation|4
2996126|NCT00970268|10310900|P2|Overall Study|Other Reason|1
2996127|NCT00970268|10310901|P1|Overall Study|Other Reason|3
2996128|NCT00970268|10310900|P2|Overall Study|Protocol Violation|7
2996129|NCT00970268|10310901|P1|Overall Study|Protocol Violation|4
2996130|NCT00970268|10310900|P2|Overall Study|Lack of Efficacy|6
2996131|NCT00970268|10310901|P1|Overall Study|Lack of Efficacy|3
2996132|NCT00970268|10310900|P2|Overall Study|Adverse Event|12
2996133|NCT00970268|10310901|P1|Overall Study|Adverse Event|15
2996134|NCT00970268|10310900|P2|Overall Study|Withdrawal by Subject|19
2996135|NCT00970268|10310901|P1|Overall Study|Withdrawal by Subject|12
2996136|NCT00969761|10310977|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996137|NCT00969761|10310978|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996138|NCT00969761|10310979|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996139|NCT00969761|10310980|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2996140|NCT00969761|10310981|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996141|NCT00969761|10310982|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996142|NCT00969761|10310983|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996143|NCT00969761|10310984|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
2996144|NCT00969761|10310985|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2996145|NCT00969761|10310986|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996146|NCT00969761|10310987|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996147|NCT00969761|10310988|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2996148|NCT00969761|10310977|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996149|NCT00969761|10310978|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996150|NCT00969761|10310979|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2996151|NCT00969761|10310980|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
2996152|NCT00969761|10310981|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
2996153|NCT00969761|10310982|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996154|NCT00969761|10310983|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996155|NCT00969761|10310984|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2996156|NCT00969761|10310985|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996157|NCT00969761|10310986|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
2996158|NCT00969761|10310987|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2996159|NCT00969761|10310988|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2996160|NCT00969761|10310977|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996161|NCT00969761|10310978|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996162|NCT00969761|10310979|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996163|NCT00969761|10310980|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
2996164|NCT00969761|10310981|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996165|NCT00969761|10310982|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996166|NCT00969761|10310983|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996167|NCT00969761|10310984|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996168|NCT00969761|10310985|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996169|NCT00969761|10310986|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996170|NCT00969761|10310987|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996171|NCT00969761|10310988|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2996172|NCT00969761|10310977|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996173|NCT00969761|10310978|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996174|NCT00969761|10310979|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996175|NCT00969761|10310980|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996176|NCT00969761|10310981|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996177|NCT00969761|10310982|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996178|NCT00969761|10310983|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996179|NCT00969761|10310984|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996180|NCT00969761|10310985|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996181|NCT00969761|10310986|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
2996182|NCT00969761|10310987|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996183|NCT00969761|10310988|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2996184|NCT00969761|10310977|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996185|NCT00969761|10310978|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996186|NCT00969761|10310979|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996187|NCT00969761|10310980|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996188|NCT00969761|10310981|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996189|NCT00969761|10310982|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996190|NCT00969761|10310983|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996191|NCT00969761|10310984|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996192|NCT00969761|10310985|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996193|NCT00969761|10310986|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
2996194|NCT00969761|10310987|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996195|NCT00969761|10310988|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2996196|NCT00969761|10310977|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996197|NCT00969761|10310978|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996198|NCT00969761|10310979|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2996199|NCT00969761|10310980|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2996200|NCT00969761|10310981|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996201|NCT00969761|10310982|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996202|NCT00969761|10310983|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996203|NCT00969761|10310984|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996204|NCT00969761|10310985|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2996205|NCT00969761|10310986|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996206|NCT00969761|10310987|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2996207|NCT00969761|10310988|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2996208|NCT00969709|10311294|P4|Overall Study|Other reasons|0
2996209|NCT00969709|10311295|P3|Overall Study|Other reasons|3
2996210|NCT00969709|10311296|P2|Overall Study|Other reasons|0
2996211|NCT00969709|10311297|P1|Overall Study|Other reasons|0
2996212|NCT00969709|10311294|P4|Overall Study|Lost to Follow-up|15
2996213|NCT00969709|10311295|P3|Overall Study|Lost to Follow-up|8
2996214|NCT00969709|10311296|P2|Overall Study|Lost to Follow-up|14
2996215|NCT00969709|10311297|P1|Overall Study|Lost to Follow-up|10
2996216|NCT00969709|10311294|P4|Overall Study|Withdrawal by Subject|23
2996217|NCT00969709|10311295|P3|Overall Study|Withdrawal by Subject|11
2996218|NCT00969709|10311296|P2|Overall Study|Withdrawal by Subject|12
2996219|NCT00969709|10311297|P1|Overall Study|Withdrawal by Subject|9
2996220|NCT00969709|10311294|P4|Overall Study|Protocol Violation|10
2996221|NCT00969709|10311295|P3|Overall Study|Protocol Violation|9
2996222|NCT00969709|10311296|P2|Overall Study|Protocol Violation|5
2996223|NCT00969709|10311297|P1|Overall Study|Protocol Violation|9
2996224|NCT00969709|10311294|P4|Overall Study|Lack of Efficacy|3
2996225|NCT00969709|10311295|P3|Overall Study|Lack of Efficacy|1
2996226|NCT00969709|10311296|P2|Overall Study|Lack of Efficacy|4
2996227|NCT00969709|10311297|P1|Overall Study|Lack of Efficacy|7
2996228|NCT00969709|10311294|P4|Overall Study|Adverse Event|12
2996229|NCT00969709|10311295|P3|Overall Study|Adverse Event|26
2996230|NCT00969709|10311296|P2|Overall Study|Adverse Event|13
2996231|NCT00969709|10311297|P1|Overall Study|Adverse Event|3
2996232|NCT00969618|10311311|P1|Overall Study|Withdrawal by Subject|27
2996233|NCT00969618|10311311|P1|Overall Study|Protocol Violation|9
2996234|NCT00969618|10311311|P1|Overall Study|Physician Decision|1
2996235|NCT00969618|10311311|P1|Overall Study|Lost to Follow-up|7
2996236|NCT00969618|10311311|P1|Overall Study|Lack of Efficacy|2
2996237|NCT00969618|10311311|P1|Overall Study|Entry Criteria Not Met|3
2996238|NCT00969618|10311311|P1|Overall Study|Adverse Event|29
2996239|NCT00969553|10311331|P9|Overall Study|Not specified above|0
2996240|NCT00969553|10311332|P8|Overall Study|Not specified above|1
2996241|NCT00969553|10311333|P7|Overall Study|Not specified above|1
2996242|NCT00969553|10311334|P6|Overall Study|Not specified above|0
2996243|NCT00969553|10311335|P5|Overall Study|Not specified above|0
2996244|NCT00969553|10311336|P4|Overall Study|Not specified above|4
2996245|NCT00969553|10311337|P3|Overall Study|Not specified above|0
2996246|NCT00969553|10311338|P2|Overall Study|Not specified above|0
2996247|NCT00969553|10311339|P1|Overall Study|Not specified above|0
2996248|NCT00969553|10311331|P9|Overall Study|Refused cont. medication|0
2996249|NCT00969553|10311332|P8|Overall Study|Refused cont. medication|1
2996250|NCT00969553|10311333|P7|Overall Study|Refused cont. medication|0
2996251|NCT00969553|10311334|P6|Overall Study|Refused cont. medication|0
2996252|NCT00969553|10311335|P5|Overall Study|Refused cont. medication|0
2996253|NCT00969553|10311336|P4|Overall Study|Refused cont. medication|2
2996254|NCT00969553|10311337|P3|Overall Study|Refused cont. medication|0
2996255|NCT00969553|10311338|P2|Overall Study|Refused cont. medication|1
2996256|NCT00969553|10311339|P1|Overall Study|Refused cont. medication|1
2996257|NCT00969553|10311331|P9|Overall Study|Other Adverse Event|0
2996693|NCT00966875|10312490|P5|Part B|Death|0
2996258|NCT00969553|10311332|P8|Overall Study|Other Adverse Event|0
2996259|NCT00969553|10311333|P7|Overall Study|Other Adverse Event|1
2996260|NCT00969553|10311334|P6|Overall Study|Other Adverse Event|0
2996261|NCT00969553|10311335|P5|Overall Study|Other Adverse Event|0
2996262|NCT00969553|10311336|P4|Overall Study|Other Adverse Event|1
2996263|NCT00969553|10311337|P3|Overall Study|Other Adverse Event|0
2996264|NCT00969553|10311338|P2|Overall Study|Other Adverse Event|0
2996265|NCT00969553|10311339|P1|Overall Study|Other Adverse Event|0
2996266|NCT00969553|10311331|P9|Overall Study|Dose limiting Toxicity (DLT)|0
2996267|NCT00969553|10311332|P8|Overall Study|Dose limiting Toxicity (DLT)|0
2996268|NCT00969553|10311333|P7|Overall Study|Dose limiting Toxicity (DLT)|0
2996269|NCT00969553|10311334|P6|Overall Study|Dose limiting Toxicity (DLT)|0
2996270|NCT00969553|10311335|P5|Overall Study|Dose limiting Toxicity (DLT)|1
2996271|NCT00969553|10311336|P4|Overall Study|Dose limiting Toxicity (DLT)|0
2996272|NCT00969553|10311337|P3|Overall Study|Dose limiting Toxicity (DLT)|0
2996273|NCT00969553|10311338|P2|Overall Study|Dose limiting Toxicity (DLT)|0
2996274|NCT00969553|10311339|P1|Overall Study|Dose limiting Toxicity (DLT)|0
2996275|NCT00969553|10311331|P9|Overall Study|Progressive disease (PD)|3
2996276|NCT00969553|10311332|P8|Overall Study|Progressive disease (PD)|12
2996277|NCT00969553|10311333|P7|Overall Study|Progressive disease (PD)|2
2996278|NCT00969553|10311334|P6|Overall Study|Progressive disease (PD)|4
2996279|NCT00969553|10311335|P5|Overall Study|Progressive disease (PD)|2
2996280|NCT00969553|10311336|P4|Overall Study|Progressive disease (PD)|9
2996281|NCT00969553|10311337|P3|Overall Study|Progressive disease (PD)|6
2996282|NCT00969553|10311338|P2|Overall Study|Progressive disease (PD)|2
2996283|NCT00969553|10311339|P1|Overall Study|Progressive disease (PD)|2
2996284|NCT00969540|10311482|P2|Overall Study|Lost to Follow-up|1
2996285|NCT00969540|10311483|P1|Overall Study|Lost to Follow-up|1
2996286|NCT00969436|10311508|P3|Overall Study|Lost to Follow-up|5
2996287|NCT00969436|10311509|P2|Overall Study|Lost to Follow-up|8
2996288|NCT00969436|10311510|P1|Overall Study|Lost to Follow-up|8
2996289|NCT00969436|10311508|P3|Overall Study|Withdrawal by Subject|2
2996290|NCT00969436|10311509|P2|Overall Study|Withdrawal by Subject|0
2996291|NCT00969436|10311510|P1|Overall Study|Withdrawal by Subject|3
2996292|NCT00969436|10311508|P3|Overall Study|Subject eliminated (other vaccine)|0
2996293|NCT00969436|10311509|P2|Overall Study|Subject eliminated (other vaccine)|0
2996294|NCT00969436|10311510|P1|Overall Study|Subject eliminated (other vaccine)|1
2996295|NCT00969436|10311508|P3|Overall Study|Parents personal problem|1
2996296|NCT00969436|10311509|P2|Overall Study|Parents personal problem|0
2996297|NCT00969436|10311510|P1|Overall Study|Parents personal problem|0
2996298|NCT00969436|10311508|P3|Overall Study|Father - serious health problem|1
2996299|NCT00969436|10311509|P2|Overall Study|Father - serious health problem|0
2996300|NCT00969436|10311510|P1|Overall Study|Father - serious health problem|0
2996301|NCT00969436|10311508|P3|Overall Study|Migrated/moved from study area|2
2996302|NCT00969436|10311509|P2|Overall Study|Migrated/moved from study area|10
2996303|NCT00969436|10311510|P1|Overall Study|Migrated/moved from study area|12
2996304|NCT00969436|10311508|P3|Overall Study|Protocol Violation|0
2996305|NCT00969436|10311509|P2|Overall Study|Protocol Violation|3
2996306|NCT00969436|10311510|P1|Overall Study|Protocol Violation|1
2996307|NCT00969332|10311542|P1|Overall Study|Withdrawal by Subject|3
2996308|NCT00969332|10311542|P1|Overall Study|Physician Decision|8
2996309|NCT00969280|10311558|P2|Overall Study|infection of influenza A(H1N1)|1
2996310|NCT00969280|10311559|P1|Overall Study|infection of influenza A(H1N1)|0
2996311|NCT00969280|10311558|P2|Overall Study|Withdrawal by Subject|1
2996312|NCT00969280|10311559|P1|Overall Study|Withdrawal by Subject|0
2996313|NCT00969280|10311558|P2|Overall Study|Protocol Violation|1
2996314|NCT00969280|10311559|P1|Overall Study|Protocol Violation|2
2996315|NCT00969228|10311567|P2|Overall Study|Porcine circovirus detection in vaccine|14
2996316|NCT00969228|10311568|P1|Overall Study|Porcine circovirus detection in vaccine|38
2996317|NCT00969228|10311567|P2|Overall Study|Withdrawal by Subject|0
2996318|NCT00969228|10311568|P1|Overall Study|Withdrawal by Subject|4
2996319|NCT00969228|10311567|P2|Overall Study|Adverse Event|0
2996320|NCT00969228|10311568|P1|Overall Study|Adverse Event|1
2996321|NCT00969150|10311586|P2|Overall Study|Other reasons|0
2996322|NCT00969150|10311587|P1|Overall Study|Other reasons|1
2996323|NCT00969150|10311586|P2|Overall Study|Lost to Follow-up|4
2996324|NCT00969150|10311587|P1|Overall Study|Lost to Follow-up|5
2996325|NCT00969150|10311586|P2|Overall Study|Withdrawal by Subject|9
2996326|NCT00969150|10311587|P1|Overall Study|Withdrawal by Subject|13
2996327|NCT00969150|10311586|P2|Overall Study|Protocol Violation|12
2996328|NCT00969150|10311587|P1|Overall Study|Protocol Violation|9
2996329|NCT00969150|10311586|P2|Overall Study|Lack of Efficacy|1
2996330|NCT00969150|10311587|P1|Overall Study|Lack of Efficacy|1
2996331|NCT00969150|10311586|P2|Overall Study|Adverse Event|14
2996332|NCT00969150|10311587|P1|Overall Study|Adverse Event|4
2996333|NCT00969124|10311595|P1|Overall Study|Technical error|1
2996334|NCT00969124|10311595|P1|Overall Study|Previously unrecognized disease|3
2996335|NCT00969124|10311595|P1|Overall Study|Inability to reach cecum|9
2996336|NCT00969124|10311595|P1|Overall Study|Inadequate bowel preparation|15
2996337|NCT00969124|10311595|P1|Overall Study|Protocol Violation|2
2996338|NCT00968981|10311604|P3|Overall Study|Withdrawal by Subject|3
2996339|NCT00968981|10311605|P2|Overall Study|Withdrawal by Subject|3
2996340|NCT00968981|10311606|P1|Overall Study|Withdrawal by Subject|1
2996341|NCT00968981|10311604|P3|Overall Study|Physician Decision|5
2996342|NCT00968981|10311605|P2|Overall Study|Physician Decision|3
2996343|NCT00968981|10311606|P1|Overall Study|Physician Decision|5
2996344|NCT00968981|10311604|P3|Overall Study|Lost to Follow-up|1
2996345|NCT00968981|10311605|P2|Overall Study|Lost to Follow-up|0
2996346|NCT00968981|10311606|P1|Overall Study|Lost to Follow-up|0
2996347|NCT00968981|10311604|P3|Overall Study|Disease Progression|13
2996348|NCT00968981|10311605|P2|Overall Study|Disease Progression|16
2996349|NCT00968981|10311606|P1|Overall Study|Disease Progression|14
2996350|NCT00968981|10311604|P3|Overall Study|Adverse Event|0
2996351|NCT00968981|10311605|P2|Overall Study|Adverse Event|0
2996352|NCT00968981|10311606|P1|Overall Study|Adverse Event|2
2996353|NCT00968968|10311644|P2|Overall Study|Lost to Follow-up|1
2996354|NCT00968968|10311645|P1|Overall Study|Lost to Follow-up|0
2996355|NCT00968968|10311644|P2|Overall Study|Physician Decision|2
2996356|NCT00968968|10311645|P1|Overall Study|Physician Decision|1
2996357|NCT00968968|10311644|P2|Overall Study|Withdrawal by Subject|0
2996358|NCT00968968|10311645|P1|Overall Study|Withdrawal by Subject|2
2996359|NCT00968968|10311644|P2|Overall Study|Protocol defined stopping criteria|1
2996360|NCT00968968|10311645|P1|Overall Study|Protocol defined stopping criteria|3
2996361|NCT00968968|10311644|P2|Overall Study|Study closed/terminated|10
2996362|NCT00968968|10311645|P1|Overall Study|Study closed/terminated|10
2996363|NCT00968864|10311691|P1|Overall Study|Protocol exception/ not evaluable|1
2996364|NCT00968812|10311719|P3|Overall Study|Other|40
2996365|NCT00968812|10311720|P2|Overall Study|Other|37
2996366|NCT00968812|10311721|P1|Overall Study|Other|25
2996367|NCT00968812|10311719|P3|Overall Study|Unable to take rescue therapy|17
2996368|NCT00968812|10311720|P2|Overall Study|Unable to take rescue therapy|12
2996369|NCT00968812|10311721|P1|Overall Study|Unable to take rescue therapy|12
2996370|NCT00968812|10311719|P3|Overall Study|Noncompliance with study drug|6
2996371|NCT00968812|10311720|P2|Overall Study|Noncompliance with study drug|1
2996372|NCT00968812|10311721|P1|Overall Study|Noncompliance with study drug|4
2996373|NCT00968812|10311719|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
2996374|NCT00968812|10311720|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
2996375|NCT00968812|10311721|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
2996376|NCT00968812|10311719|P3|Overall Study|Withdrawal by Subject|25
2996377|NCT00968812|10311720|P2|Overall Study|Withdrawal by Subject|23
2996378|NCT00968812|10311721|P1|Overall Study|Withdrawal by Subject|17
2996379|NCT00968812|10311719|P3|Overall Study|Protocol Violation|3
2996380|NCT00968812|10311720|P2|Overall Study|Protocol Violation|4
2996381|NCT00968812|10311721|P1|Overall Study|Protocol Violation|7
2996382|NCT00968812|10311719|P3|Overall Study|Physician Decision|9
2996383|NCT00968812|10311720|P2|Overall Study|Physician Decision|5
2996384|NCT00968812|10311721|P1|Overall Study|Physician Decision|8
2996385|NCT00968812|10311719|P3|Overall Study|Lost to Follow-up|11
2996386|NCT00968812|10311720|P2|Overall Study|Lost to Follow-up|12
2996387|NCT00968812|10311721|P1|Overall Study|Lost to Follow-up|17
2996388|NCT00968812|10311719|P3|Overall Study|Lack of Efficacy|16
2996389|NCT00968812|10311720|P2|Overall Study|Lack of Efficacy|7
2996390|NCT00968812|10311721|P1|Overall Study|Lack of Efficacy|9
2996391|NCT00968812|10311719|P3|Overall Study|Death|1
2996392|NCT00968812|10311720|P2|Overall Study|Death|2
2996393|NCT00968812|10311721|P1|Overall Study|Death|2
2996394|NCT00968812|10311719|P3|Overall Study|Adverse Event|33
2996395|NCT00968812|10311720|P2|Overall Study|Adverse Event|46
2996396|NCT00968812|10311721|P1|Overall Study|Adverse Event|30
2996397|NCT00968799|10311741|P1|Overall Study|Advanced disease, HIPEC not applicable|2
2996398|NCT00968708|10311751|P2|Overall Study|Other|34
2996399|NCT00968708|10311752|P1|Overall Study|Other|26
2996400|NCT00968708|10311751|P2|Overall Study|Investigator Discretion|1
2996401|NCT00968708|10311752|P1|Overall Study|Investigator Discretion|0
2996402|NCT00968708|10311751|P2|Overall Study|Voluntary Withdrawal|101
2996403|NCT00968708|10311752|P1|Overall Study|Voluntary Withdrawal|104
2996404|NCT00968708|10311751|P2|Overall Study|Lost to Follow-up|11
2996405|NCT00968708|10311752|P1|Overall Study|Lost to Follow-up|19
2996406|NCT00968708|10311751|P2|Overall Study|Major Protocol Deviation|1
2996407|NCT00968708|10311752|P1|Overall Study|Major Protocol Deviation|0
2996408|NCT00968708|10311751|P2|Overall Study|Adverse Event|150
2996409|NCT00968708|10311752|P1|Overall Study|Adverse Event|169
2996410|NCT00968669|10311764|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
2996411|NCT00968669|10311765|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2996412|NCT00968669|10311766|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2996413|NCT00968669|10311767|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2996414|NCT00968669|10311764|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2996415|NCT00968669|10311765|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2996416|NCT00968669|10311766|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
2996417|NCT00968669|10311767|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2996418|NCT00968669|10311764|P4|Overall Study|SUBJECT INCARCERATED|0
2996419|NCT00968669|10311765|P3|Overall Study|SUBJECT INCARCERATED|0
2996420|NCT00968669|10311766|P2|Overall Study|SUBJECT INCARCERATED|1
2996421|NCT00968669|10311767|P1|Overall Study|SUBJECT INCARCERATED|0
2996422|NCT00968669|10311764|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2996423|NCT00968669|10311765|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2996424|NCT00968669|10311766|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
2996425|NCT00968669|10311767|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2996426|NCT00968669|10311764|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2996427|NCT00968669|10311765|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
2996428|NCT00968669|10311766|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2996429|NCT00968669|10311767|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2996430|NCT00968669|10311764|P4|Overall Study|SPONSOR DECISION|0
2996431|NCT00968669|10311765|P3|Overall Study|SPONSOR DECISION|0
2996432|NCT00968669|10311766|P2|Overall Study|SPONSOR DECISION|1
2996433|NCT00968669|10311767|P1|Overall Study|SPONSOR DECISION|0
2996434|NCT00968669|10311764|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2996435|NCT00968669|10311765|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2996436|NCT00968669|10311766|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
2996437|NCT00968669|10311767|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2996438|NCT00968669|10311764|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2996439|NCT00968669|10311765|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2996440|NCT00968669|10311766|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
2996441|NCT00968669|10311767|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2996442|NCT00968669|10311764|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2996443|NCT00968669|10311765|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2996444|NCT00968669|10311766|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
2996445|NCT00968669|10311767|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2996446|NCT00968669|10311764|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2996447|NCT00968669|10311765|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2996448|NCT00968669|10311766|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
2996449|NCT00968669|10311767|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2996450|NCT00968669|10311764|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2996451|NCT00968669|10311765|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2996452|NCT00968669|10311766|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2996453|NCT00968669|10311767|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
2996454|NCT00968669|10311764|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
2996455|NCT00968669|10311765|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
2996456|NCT00968669|10311766|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
2996457|NCT00968669|10311767|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
2996458|NCT00968669|10311764|P4|Overall Study|EARLY WITHDRAWAL|0
2996459|NCT00968669|10311765|P3|Overall Study|EARLY WITHDRAWAL|0
2996460|NCT00968669|10311766|P2|Overall Study|EARLY WITHDRAWAL|1
2996461|NCT00968669|10311767|P1|Overall Study|EARLY WITHDRAWAL|0
2996462|NCT00968669|10311764|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2996463|NCT00968669|10311765|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
2996464|NCT00968669|10311766|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2996465|NCT00968669|10311767|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2996466|NCT00968669|10311764|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2996467|NCT00968669|10311765|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2996468|NCT00968669|10311766|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2996469|NCT00968669|10311767|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
2996470|NCT00968669|10311764|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2996471|NCT00968669|10311765|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2996472|NCT00968669|10311766|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2996473|NCT00968669|10311767|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
2996474|NCT00968669|10311764|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
2996475|NCT00968669|10311765|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2996476|NCT00968669|10311766|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2996477|NCT00968669|10311767|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2996478|NCT00968669|10311764|P4|Overall Study|AE|0
2996479|NCT00968669|10311765|P3|Overall Study|AE|0
2996480|NCT00968669|10311766|P2|Overall Study|AE|0
2996481|NCT00968669|10311767|P1|Overall Study|AE|1
2996482|NCT00968669|10311764|P4|Overall Study|Pregnancy|0
2996483|NCT00968669|10311765|P3|Overall Study|Pregnancy|2
2996484|NCT00968669|10311766|P2|Overall Study|Pregnancy|0
2996485|NCT00968669|10311767|P1|Overall Study|Pregnancy|0
2996486|NCT00968669|10311764|P4|Overall Study|Withdrawal by Subject|3
2996487|NCT00968669|10311765|P3|Overall Study|Withdrawal by Subject|5
2996488|NCT00968669|10311766|P2|Overall Study|Withdrawal by Subject|7
2996489|NCT00968669|10311767|P1|Overall Study|Withdrawal by Subject|9
2996490|NCT00968669|10311764|P4|Overall Study|Lost to Follow-up|4
2996491|NCT00968669|10311765|P3|Overall Study|Lost to Follow-up|1
2996492|NCT00968669|10311766|P2|Overall Study|Lost to Follow-up|2
2996493|NCT00968669|10311767|P1|Overall Study|Lost to Follow-up|5
2996494|NCT00968617|10311857|P1|Overall Study|Study terminated by sponsor|6
2996495|NCT00968539|10311871|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
2996496|NCT00968539|10311872|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
2996497|NCT00968526|10311932|P2|Overall Study|Migrated/moved from study area|0
2996498|NCT00968526|10311933|P1|Overall Study|Migrated/moved from study area|1
2996499|NCT00968526|10311932|P2|Overall Study|Adverse Event|0
2996500|NCT00968526|10311933|P1|Overall Study|Adverse Event|2
2996501|NCT00968253|10312035|P3|Overall Study|Adverse Event|1
2996502|NCT00968253|10312036|P2|Overall Study|Adverse Event|0
2996503|NCT00968253|10312037|P1|Overall Study|Adverse Event|0
2996504|NCT00968253|10312035|P3|Overall Study|Disease Progression|3
2996505|NCT00968253|10312036|P2|Overall Study|Disease Progression|3
2996506|NCT00968253|10312037|P1|Overall Study|Disease Progression|0
2996507|NCT00968253|10312035|P3|Overall Study|Withdrawal by Subject|1
2996508|NCT00968253|10312036|P2|Overall Study|Withdrawal by Subject|0
2996509|NCT00968253|10312037|P1|Overall Study|Withdrawal by Subject|0
2996510|NCT00968253|10312035|P3|Overall Study|Death|2
2996511|NCT00968253|10312036|P2|Overall Study|Death|0
2996694|NCT00966875|10312491|P4|Part B|Death|0
2996512|NCT00968253|10312037|P1|Overall Study|Death|0
2996513|NCT00968201|10312058|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
2996514|NCT00968201|10312059|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
2996515|NCT00968201|10312060|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
2996516|NCT00968201|10312058|P3|Extension Study - (Period III)|Other|2
2996517|NCT00968201|10312059|P2|Extension Study - (Period III)|Other|0
2996518|NCT00968201|10312060|P1|Extension Study - (Period III)|Other|0
2996519|NCT00968201|10312058|P3|Extension Study - (Period III)|Noncompliance|3
2996520|NCT00968201|10312059|P2|Extension Study - (Period III)|Noncompliance|0
2996521|NCT00968201|10312060|P1|Extension Study - (Period III)|Noncompliance|0
2996522|NCT00968201|10312058|P3|Extension Study - (Period III)|Patient Relocated|1
2996523|NCT00968201|10312059|P2|Extension Study - (Period III)|Patient Relocated|1
2996524|NCT00968201|10312060|P1|Extension Study - (Period III)|Patient Relocated|0
2996525|NCT00968201|10312058|P3|Extension Study - (Period III)|Withdrawal by Subject|40
2996526|NCT00968201|10312059|P2|Extension Study - (Period III)|Withdrawal by Subject|20
2996527|NCT00968201|10312060|P1|Extension Study - (Period III)|Withdrawal by Subject|0
2996528|NCT00968201|10312058|P3|Extension Study - (Period III)|Protocol Violation|14
2996529|NCT00968201|10312059|P2|Extension Study - (Period III)|Protocol Violation|17
2996530|NCT00968201|10312060|P1|Extension Study - (Period III)|Protocol Violation|0
2996531|NCT00968201|10312058|P3|Extension Study - (Period III)|Lost to Follow-up|13
2996532|NCT00968201|10312059|P2|Extension Study - (Period III)|Lost to Follow-up|7
2996533|NCT00968201|10312060|P1|Extension Study - (Period III)|Lost to Follow-up|0
2996534|NCT00968201|10312058|P3|Extension Study - (Period III)|Adverse Event|22
2996535|NCT00968201|10312059|P2|Extension Study - (Period III)|Adverse Event|5
2996536|NCT00968201|10312060|P1|Extension Study - (Period III)|Adverse Event|0
2996537|NCT00968201|10312058|P3|Base Study - (Period II)|Site Error|1
2996538|NCT00968201|10312059|P2|Base Study - (Period II)|Site Error|0
2996539|NCT00968201|10312060|P1|Base Study - (Period II)|Site Error|0
2996540|NCT00968201|10312058|P3|Base Study - (Period II)|Withdrawal by Subject|8
2996541|NCT00968201|10312059|P2|Base Study - (Period II)|Withdrawal by Subject|0
2996542|NCT00968201|10312060|P1|Base Study - (Period II)|Withdrawal by Subject|4
2996543|NCT00968201|10312058|P3|Base Study - (Period II)|Protocol Violation|12
2996544|NCT00968201|10312059|P2|Base Study - (Period II)|Protocol Violation|0
2996545|NCT00968201|10312060|P1|Base Study - (Period II)|Protocol Violation|12
2996546|NCT00968201|10312058|P3|Base Study - (Period II)|Lost to Follow-up|7
2996547|NCT00968201|10312059|P2|Base Study - (Period II)|Lost to Follow-up|0
2996548|NCT00968201|10312060|P1|Base Study - (Period II)|Lost to Follow-up|2
2996549|NCT00968201|10312058|P3|Base Study - (Period II)|Lack of Efficacy|1
2996550|NCT00968201|10312059|P2|Base Study - (Period II)|Lack of Efficacy|0
2996551|NCT00968201|10312060|P1|Base Study - (Period II)|Lack of Efficacy|0
2996552|NCT00968201|10312058|P3|Base Study - (Period II)|Adverse Event|16
2996553|NCT00968201|10312059|P2|Base Study - (Period II)|Adverse Event|0
2996554|NCT00968201|10312060|P1|Base Study - (Period II)|Adverse Event|8
2996555|NCT00968149|10312121|P2|Overall Study|Withdrawal by Subject|0
2996556|NCT00968149|10312122|P1|Overall Study|Withdrawal by Subject|2
2996557|NCT00968149|10312121|P2|Overall Study|Protocol Violation|0
2996558|NCT00968149|10312122|P1|Overall Study|Protocol Violation|4
2996559|NCT00968149|10312121|P2|Overall Study|Lost to Follow-up|1
2996560|NCT00968149|10312122|P1|Overall Study|Lost to Follow-up|0
2996561|NCT00968149|10312121|P2|Overall Study|Lack of Efficacy|4
2996562|NCT00968149|10312122|P1|Overall Study|Lack of Efficacy|0
2996563|NCT00968149|10312121|P2|Overall Study|Adverse Event|1
2996564|NCT00968149|10312122|P1|Overall Study|Adverse Event|5
2996565|NCT00967798|10312190|P2|Overall Study|Lost to Follow-up|1
2996566|NCT00967798|10312191|P1|Overall Study|Lost to Follow-up|4
2996567|NCT00967798|10312190|P2|Overall Study|Withdrawal by Subject|2
2996568|NCT00967798|10312191|P1|Overall Study|Withdrawal by Subject|5
2996569|NCT00967694|10312205|P1|Overall Study|Withdrawal by Subject|6
2996570|NCT00967668|10312212|P3|Overall Study|Pregnancy|0
2996571|NCT00967668|10312213|P2|Overall Study|Pregnancy|0
2996572|NCT00967668|10312214|P1|Overall Study|Pregnancy|1
2996573|NCT00967668|10312212|P3|Overall Study|Refused 12-mo assessment|9
2996574|NCT00967668|10312213|P2|Overall Study|Refused 12-mo assessment|1
2996575|NCT00967668|10312214|P1|Overall Study|Refused 12-mo assessment|3
2996576|NCT00967668|10312212|P3|Overall Study|Lost to Follow-up|16
2996577|NCT00967668|10312213|P2|Overall Study|Lost to Follow-up|9
2996578|NCT00967668|10312214|P1|Overall Study|Lost to Follow-up|15
2996579|NCT00967668|10312212|P3|Overall Study|Lost to follow-up at 12-mo|26
2996580|NCT00967668|10312213|P2|Overall Study|Lost to follow-up at 12-mo|29
2996581|NCT00967668|10312214|P1|Overall Study|Lost to follow-up at 12-mo|27
2996582|NCT00967668|10312212|P3|Overall Study|Refused Year 2|4
2996583|NCT00967668|10312213|P2|Overall Study|Refused Year 2|6
2996584|NCT00967668|10312214|P1|Overall Study|Refused Year 2|11
2996585|NCT00967668|10312212|P3|Overall Study|Removed due to behavior|2
2996586|NCT00967668|10312213|P2|Overall Study|Removed due to behavior|1
2996587|NCT00967668|10312214|P1|Overall Study|Removed due to behavior|1
2996588|NCT00967668|10312212|P3|Overall Study|Death|4
2996589|NCT00967668|10312213|P2|Overall Study|Death|2
2996590|NCT00967668|10312214|P1|Overall Study|Death|0
2996591|NCT00967668|10312212|P3|Overall Study|Withdrawal by Subject|8
2996592|NCT00967668|10312213|P2|Overall Study|Withdrawal by Subject|8
2996593|NCT00967668|10312214|P1|Overall Study|Withdrawal by Subject|13
2996594|NCT00967616|10312227|P2|Overall Study|Protocol Violation|0
2996595|NCT00967616|10312228|P1|Overall Study|Protocol Violation|1
2996596|NCT00967616|10312227|P2|Overall Study|Other|8
2996597|NCT00967616|10312228|P1|Overall Study|Other|8
2996598|NCT00967616|10312227|P2|Overall Study|Progressive Disease|18
2996599|NCT00967616|10312228|P1|Overall Study|Progressive Disease|31
2996600|NCT00967616|10312227|P2|Overall Study|Withdrawal by Subject|4
2996601|NCT00967616|10312228|P1|Overall Study|Withdrawal by Subject|8
2996602|NCT00967616|10312227|P2|Overall Study|Death|3
2996603|NCT00967616|10312228|P1|Overall Study|Death|0
2996604|NCT00967616|10312227|P2|Overall Study|Adverse Event or Serious Adverse Event|17
2996605|NCT00967616|10312228|P1|Overall Study|Adverse Event or Serious Adverse Event|2
2996606|NCT00967330|10312296|P2|Overall Study|Severe protocol deviation|1
2996607|NCT00967330|10312297|P1|Overall Study|Severe protocol deviation|0
2996608|NCT00967330|10312296|P2|Overall Study|Death|51
2996609|NCT00967330|10312297|P1|Overall Study|Death|102
2996610|NCT00967330|10312296|P2|Overall Study|Lost to Follow-up|1
2996611|NCT00967330|10312297|P1|Overall Study|Lost to Follow-up|1
2996612|NCT00967330|10312296|P2|Overall Study|Withdrawal by Subject|0
2996613|NCT00967330|10312297|P1|Overall Study|Withdrawal by Subject|6
2996614|NCT00967330|10312296|P2|Overall Study|Regular|3
2996615|NCT00967330|10312297|P1|Overall Study|Regular|10
2996616|NCT00967330|10312296|P2|Overall Study|Protocol Violation|4
2996617|NCT00967330|10312297|P1|Overall Study|Protocol Violation|3
2996618|NCT00967226|10312327|P2|Overall Study|Physician Decision|1
2996619|NCT00967226|10312328|P1|Overall Study|Physician Decision|0
2996620|NCT00967226|10312327|P2|Overall Study|Protocol Violation|0
2996621|NCT00967226|10312328|P1|Overall Study|Protocol Violation|2
2996622|NCT00967226|10312327|P2|Overall Study|Adverse Event|5
2996623|NCT00967226|10312328|P1|Overall Study|Adverse Event|0
2996624|NCT00967018|10312362|P1|Overall Study|Miscellaneous Reasons|9
2996625|NCT00967018|10312362|P1|Overall Study|Withdrawal by Subject|1
2996626|NCT00967018|10312362|P1|Overall Study|Lost to Follow-up|2
2996627|NCT00967018|10312362|P1|Overall Study|Physician Decision|7
2996628|NCT00967018|10312362|P1|Overall Study|Adverse Event|2
2996629|NCT00967005|10312371|P2|Overall Study|Lost to Follow-up|10
2996630|NCT00967005|10312372|P1|Overall Study|Lost to Follow-up|7
2996631|NCT00966940|10312458|P2|Period 1, First 6 Weeks|Protocol Violation|0
2996632|NCT00966940|10312459|P1|Period 1, First 6 Weeks|Protocol Violation|1
2996633|NCT00966940|10312458|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
2996634|NCT00966940|10312459|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
2996635|NCT00966875|10312486|P9|Part B|Entry Criteria|1
2996636|NCT00966875|10312487|P8|Part B|Entry Criteria|0
2996637|NCT00966875|10312488|P7|Part B|Entry Criteria|1
2996638|NCT00966875|10312489|P6|Part B|Entry Criteria|0
2996639|NCT00966875|10312490|P5|Part B|Entry Criteria|0
2996640|NCT00966875|10312491|P4|Part B|Entry Criteria|0
2996641|NCT00966875|10312492|P3|Part B|Entry Criteria|0
2996642|NCT00966875|10312493|P2|Part B|Entry Criteria|0
2996643|NCT00966875|10312494|P1|Part B|Entry Criteria|0
2996644|NCT00966875|10312486|P9|Part B|Withdrawal by Subject|5
2996645|NCT00966875|10312487|P8|Part B|Withdrawal by Subject|5
2996646|NCT00966875|10312488|P7|Part B|Withdrawal by Subject|4
2996647|NCT00966875|10312489|P6|Part B|Withdrawal by Subject|1
2996648|NCT00966875|10312490|P5|Part B|Withdrawal by Subject|2
2996649|NCT00966875|10312491|P4|Part B|Withdrawal by Subject|1
2996650|NCT00966875|10312492|P3|Part B|Withdrawal by Subject|2
2996651|NCT00966875|10312493|P2|Part B|Withdrawal by Subject|1
2996652|NCT00966875|10312494|P1|Part B|Withdrawal by Subject|2
2996653|NCT00966875|10312486|P9|Part B|Sponsor Decision|1
2996654|NCT00966875|10312487|P8|Part B|Sponsor Decision|2
2996655|NCT00966875|10312488|P7|Part B|Sponsor Decision|0
2996656|NCT00966875|10312489|P6|Part B|Sponsor Decision|1
2996657|NCT00966875|10312490|P5|Part B|Sponsor Decision|0
2996658|NCT00966875|10312491|P4|Part B|Sponsor Decision|0
2996659|NCT00966875|10312492|P3|Part B|Sponsor Decision|0
2996660|NCT00966875|10312493|P2|Part B|Sponsor Decision|0
2996661|NCT00966875|10312494|P1|Part B|Sponsor Decision|1
2996662|NCT00966875|10312486|P9|Part B|Physician Decision|2
2996663|NCT00966875|10312487|P8|Part B|Physician Decision|0
2996664|NCT00966875|10312488|P7|Part B|Physician Decision|0
2996665|NCT00966875|10312489|P6|Part B|Physician Decision|1
2996666|NCT00966875|10312490|P5|Part B|Physician Decision|2
2996667|NCT00966875|10312491|P4|Part B|Physician Decision|0
2996668|NCT00966875|10312492|P3|Part B|Physician Decision|1
2996669|NCT00966875|10312493|P2|Part B|Physician Decision|0
2996670|NCT00966875|10312494|P1|Part B|Physician Decision|0
2996671|NCT00966875|10312486|P9|Part B|Lost to Follow-up|1
2996672|NCT00966875|10312487|P8|Part B|Lost to Follow-up|0
2996673|NCT00966875|10312488|P7|Part B|Lost to Follow-up|0
2996674|NCT00966875|10312489|P6|Part B|Lost to Follow-up|0
2996675|NCT00966875|10312490|P5|Part B|Lost to Follow-up|0
2996676|NCT00966875|10312491|P4|Part B|Lost to Follow-up|1
2996677|NCT00966875|10312492|P3|Part B|Lost to Follow-up|0
2996678|NCT00966875|10312493|P2|Part B|Lost to Follow-up|0
2996679|NCT00966875|10312494|P1|Part B|Lost to Follow-up|0
2996680|NCT00966875|10312486|P9|Part B|Lack of Efficacy|6
2996681|NCT00966875|10312487|P8|Part B|Lack of Efficacy|9
2996682|NCT00966875|10312488|P7|Part B|Lack of Efficacy|12
2996683|NCT00966875|10312489|P6|Part B|Lack of Efficacy|3
2996684|NCT00966875|10312490|P5|Part B|Lack of Efficacy|2
2996685|NCT00966875|10312491|P4|Part B|Lack of Efficacy|1
2996686|NCT00966875|10312492|P3|Part B|Lack of Efficacy|1
2996687|NCT00966875|10312493|P2|Part B|Lack of Efficacy|1
2996688|NCT00966875|10312494|P1|Part B|Lack of Efficacy|2
2996689|NCT00966875|10312486|P9|Part B|Death|0
2996698|NCT00966875|10312486|P9|Part B|Adverse Event|2
2996699|NCT00966875|10312487|P8|Part B|Adverse Event|2
2996700|NCT00966875|10312488|P7|Part B|Adverse Event|5
2996701|NCT00966875|10312489|P6|Part B|Adverse Event|0
2996702|NCT00966875|10312490|P5|Part B|Adverse Event|1
2996703|NCT00966875|10312491|P4|Part B|Adverse Event|0
2996704|NCT00966875|10312492|P3|Part B|Adverse Event|1
2996705|NCT00966875|10312493|P2|Part B|Adverse Event|1
2996706|NCT00966875|10312494|P1|Part B|Adverse Event|0
2996707|NCT00966875|10312486|P9|Part A|Protocol Violation|1
2996708|NCT00966875|10312487|P8|Part A|Protocol Violation|1
2996709|NCT00966875|10312488|P7|Part A|Protocol Violation|2
2996710|NCT00966875|10312489|P6|Part A|Protocol Violation|0
2996711|NCT00966875|10312490|P5|Part A|Protocol Violation|0
2996712|NCT00966875|10312491|P4|Part A|Protocol Violation|0
2996713|NCT00966875|10312492|P3|Part A|Protocol Violation|0
2996714|NCT00966875|10312493|P2|Part A|Protocol Violation|0
2996715|NCT00966875|10312494|P1|Part A|Protocol Violation|0
2996716|NCT00966875|10312486|P9|Part A|Withdrawal by Subject|1
2996717|NCT00966875|10312487|P8|Part A|Withdrawal by Subject|1
2996718|NCT00966875|10312488|P7|Part A|Withdrawal by Subject|5
2996719|NCT00966875|10312489|P6|Part A|Withdrawal by Subject|0
2996720|NCT00966875|10312490|P5|Part A|Withdrawal by Subject|3
2996721|NCT00966875|10312491|P4|Part A|Withdrawal by Subject|1
2996722|NCT00966875|10312492|P3|Part A|Withdrawal by Subject|1
2996723|NCT00966875|10312493|P2|Part A|Withdrawal by Subject|2
2996724|NCT00966875|10312494|P1|Part A|Withdrawal by Subject|2
2996725|NCT00966875|10312486|P9|Part A|Sponsor Decision|1
2996726|NCT00966875|10312487|P8|Part A|Sponsor Decision|2
2996727|NCT00966875|10312488|P7|Part A|Sponsor Decision|0
2996728|NCT00966875|10312489|P6|Part A|Sponsor Decision|0
2996729|NCT00966875|10312490|P5|Part A|Sponsor Decision|1
2996730|NCT00966875|10312491|P4|Part A|Sponsor Decision|0
2996731|NCT00966875|10312492|P3|Part A|Sponsor Decision|1
2996732|NCT00966875|10312493|P2|Part A|Sponsor Decision|0
2996733|NCT00966875|10312494|P1|Part A|Sponsor Decision|0
2996734|NCT00966875|10312486|P9|Part A|Physician Decision|2
2996735|NCT00966875|10312487|P8|Part A|Physician Decision|0
2996736|NCT00966875|10312488|P7|Part A|Physician Decision|1
2996737|NCT00966875|10312489|P6|Part A|Physician Decision|0
2996738|NCT00966875|10312490|P5|Part A|Physician Decision|1
2996739|NCT00966875|10312491|P4|Part A|Physician Decision|0
2996740|NCT00966875|10312492|P3|Part A|Physician Decision|0
2996741|NCT00966875|10312493|P2|Part A|Physician Decision|0
2996742|NCT00966875|10312494|P1|Part A|Physician Decision|0
2996743|NCT00966875|10312486|P9|Part A|Parent/Caregiver Decision|0
2996744|NCT00966875|10312487|P8|Part A|Parent/Caregiver Decision|0
2996745|NCT00966875|10312488|P7|Part A|Parent/Caregiver Decision|0
2996746|NCT00966875|10312489|P6|Part A|Parent/Caregiver Decision|0
2996747|NCT00966875|10312490|P5|Part A|Parent/Caregiver Decision|0
2996748|NCT00966875|10312491|P4|Part A|Parent/Caregiver Decision|1
2996749|NCT00966875|10312492|P3|Part A|Parent/Caregiver Decision|0
2996750|NCT00966875|10312493|P2|Part A|Parent/Caregiver Decision|0
2996751|NCT00966875|10312494|P1|Part A|Parent/Caregiver Decision|0
2996752|NCT00966875|10312486|P9|Part A|Lost to Follow-up|0
2996753|NCT00966875|10312487|P8|Part A|Lost to Follow-up|0
2996754|NCT00966875|10312488|P7|Part A|Lost to Follow-up|0
2996755|NCT00966875|10312489|P6|Part A|Lost to Follow-up|1
2996756|NCT00966875|10312490|P5|Part A|Lost to Follow-up|0
2996757|NCT00966875|10312491|P4|Part A|Lost to Follow-up|0
2996758|NCT00966875|10312492|P3|Part A|Lost to Follow-up|0
2996759|NCT00966875|10312493|P2|Part A|Lost to Follow-up|0
2996760|NCT00966875|10312494|P1|Part A|Lost to Follow-up|2
2996761|NCT00966875|10312486|P9|Part A|Lack of Efficacy|0
2996762|NCT00966875|10312487|P8|Part A|Lack of Efficacy|0
2996763|NCT00966875|10312488|P7|Part A|Lack of Efficacy|4
2996764|NCT00966875|10312489|P6|Part A|Lack of Efficacy|0
2996765|NCT00966875|10312490|P5|Part A|Lack of Efficacy|0
2996766|NCT00966875|10312491|P4|Part A|Lack of Efficacy|0
2996767|NCT00966875|10312492|P3|Part A|Lack of Efficacy|0
2996768|NCT00966875|10312493|P2|Part A|Lack of Efficacy|1
2996769|NCT00966875|10312494|P1|Part A|Lack of Efficacy|0
2996770|NCT00966875|10312486|P9|Part A|Entry Criteria|0
2996771|NCT00966875|10312487|P8|Part A|Entry Criteria|0
2996772|NCT00966875|10312488|P7|Part A|Entry Criteria|0
2996773|NCT00966875|10312489|P6|Part A|Entry Criteria|2
2996774|NCT00966875|10312490|P5|Part A|Entry Criteria|0
2996775|NCT00966875|10312491|P4|Part A|Entry Criteria|0
2996776|NCT00966875|10312492|P3|Part A|Entry Criteria|0
2996777|NCT00966875|10312493|P2|Part A|Entry Criteria|0
2996778|NCT00966875|10312494|P1|Part A|Entry Criteria|0
2996779|NCT00966875|10312486|P9|Part A|Adverse Event|3
2996780|NCT00966875|10312487|P8|Part A|Adverse Event|3
2996781|NCT00966875|10312488|P7|Part A|Adverse Event|0
2996782|NCT00966875|10312489|P6|Part A|Adverse Event|1
2996783|NCT00966875|10312490|P5|Part A|Adverse Event|0
2996784|NCT00966875|10312491|P4|Part A|Adverse Event|1
2996785|NCT00966875|10312492|P3|Part A|Adverse Event|0
2996786|NCT00966875|10312493|P2|Part A|Adverse Event|1
2996787|NCT00966875|10312494|P1|Part A|Adverse Event|2
2996788|NCT00966719|10312845|P2|Overall Study|Lost to Follow-up|11
2996789|NCT00966719|10312846|P1|Overall Study|Lost to Follow-up|6
2996790|NCT00966654|10312866|P1|Overall Study|Study was terminated,PI left institution|12
2996791|NCT00966355|10312940|P3|Overall Study|Lost to Follow-up|3
2996792|NCT00966355|10312941|P2|Overall Study|Lost to Follow-up|4
2996793|NCT00966355|10312942|P1|Overall Study|Lost to Follow-up|5
2996794|NCT00966355|10312940|P3|Overall Study|newly diagnosed advanced HCC|10
2996795|NCT00966355|10312941|P2|Overall Study|newly diagnosed advanced HCC|12
2996796|NCT00966355|10312942|P1|Overall Study|newly diagnosed advanced HCC|11
2996797|NCT00966355|10312940|P3|Overall Study|non-variceal bleeding on endoscopy|71
2996798|NCT00966355|10312941|P2|Overall Study|non-variceal bleeding on endoscopy|70
2996799|NCT00966355|10312942|P1|Overall Study|non-variceal bleeding on endoscopy|68
2996800|NCT00966277|10312955|P2|Overall Study|Treatment Plan Changed|1
2996801|NCT00966277|10312956|P1|Overall Study|Treatment Plan Changed|0
2996802|NCT00966277|10312955|P2|Overall Study|Ineligible|3
2996803|NCT00966277|10312956|P1|Overall Study|Ineligible|1
2996804|NCT00966277|10312955|P2|Overall Study|Withdrawal by Subject|0
2996805|NCT00966277|10312956|P1|Overall Study|Withdrawal by Subject|3
2996806|NCT00966264|10312964|P2|Overall Study|Lost to Follow-up|3
2996807|NCT00966264|10312965|P1|Overall Study|Lost to Follow-up|4
2996808|NCT00965848|10313011|P3|Overall Study|Other|1
2996809|NCT00965848|10313012|P2|Overall Study|Other|0
2996810|NCT00965848|10313013|P1|Overall Study|Other|5
2996811|NCT00965848|10313011|P3|Overall Study|Not Clinically Evaluable|1
2996812|NCT00965848|10313012|P2|Overall Study|Not Clinically Evaluable|1
2996813|NCT00965848|10313013|P1|Overall Study|Not Clinically Evaluable|7
2996814|NCT00965848|10313011|P3|Overall Study|Indeterminate Clinical Outcome|1
2996815|NCT00965848|10313012|P2|Overall Study|Indeterminate Clinical Outcome|0
2996816|NCT00965848|10313013|P1|Overall Study|Indeterminate Clinical Outcome|2
2996817|NCT00965848|10313011|P3|Overall Study|Withdrawal by Subject|0
2996818|NCT00965848|10313012|P2|Overall Study|Withdrawal by Subject|0
2996819|NCT00965848|10313013|P1|Overall Study|Withdrawal by Subject|1
2996820|NCT00965848|10313011|P3|Overall Study|Lost to Follow-up|1
2996821|NCT00965848|10313012|P2|Overall Study|Lost to Follow-up|0
2996822|NCT00965848|10313013|P1|Overall Study|Lost to Follow-up|0
2996823|NCT00965848|10313011|P3|Overall Study|Death|5
2996824|NCT00965848|10313012|P2|Overall Study|Death|1
2996825|NCT00965848|10313013|P1|Overall Study|Death|11
2996826|NCT00965848|10313011|P3|Overall Study|Protocol Violation|1
2996827|NCT00965848|10313012|P2|Overall Study|Protocol Violation|0
2996828|NCT00965848|10313013|P1|Overall Study|Protocol Violation|3
2996829|NCT00965757|10313032|P4|Extension Phase|Other|1
2996830|NCT00965757|10313033|P3|Extension Phase|Other|2
2996831|NCT00965757|10313034|P2|Extension Phase|Other|0
2996832|NCT00965757|10313035|P1|Extension Phase|Other|0
2996833|NCT00965757|10313032|P4|Extension Phase|Protocol Violation|1
2996834|NCT00965757|10313033|P3|Extension Phase|Protocol Violation|0
2996835|NCT00965757|10313034|P2|Extension Phase|Protocol Violation|0
2996836|NCT00965757|10313035|P1|Extension Phase|Protocol Violation|0
2996837|NCT00965757|10313032|P4|Extension Phase|Ineligible after Taking Study Drug|3
2996838|NCT00965757|10313033|P3|Extension Phase|Ineligible after Taking Study Drug|3
2996839|NCT00965757|10313034|P2|Extension Phase|Ineligible after Taking Study Drug|0
2996840|NCT00965757|10313035|P1|Extension Phase|Ineligible after Taking Study Drug|0
2996841|NCT00965757|10313032|P4|Extension Phase|Lost to Follow-up|1
2996842|NCT00965757|10313033|P3|Extension Phase|Lost to Follow-up|0
2996843|NCT00965757|10313034|P2|Extension Phase|Lost to Follow-up|0
2996844|NCT00965757|10313035|P1|Extension Phase|Lost to Follow-up|0
2996845|NCT00965757|10313032|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
2996846|NCT00965757|10313033|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
2996847|NCT00965757|10313034|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
2996848|NCT00965757|10313035|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
2996849|NCT00965757|10313032|P4|Extension Phase|Lack of Efficacy|12
2996850|NCT00965757|10313033|P3|Extension Phase|Lack of Efficacy|8
2996851|NCT00965757|10313034|P2|Extension Phase|Lack of Efficacy|0
2996852|NCT00965757|10313035|P1|Extension Phase|Lack of Efficacy|0
2996853|NCT00965757|10313032|P4|Extension Phase|Abnormal Laboratory Value|1
2996854|NCT00965757|10313033|P3|Extension Phase|Abnormal Laboratory Value|6
2996855|NCT00965757|10313034|P2|Extension Phase|Abnormal Laboratory Value|0
2996856|NCT00965757|10313035|P1|Extension Phase|Abnormal Laboratory Value|0
2996857|NCT00965757|10313032|P4|Extension Phase|Adverse drug reaction|3
2996858|NCT00965757|10313033|P3|Extension Phase|Adverse drug reaction|6
2996859|NCT00965757|10313034|P2|Extension Phase|Adverse drug reaction|0
2996860|NCT00965757|10313035|P1|Extension Phase|Adverse drug reaction|0
2996861|NCT00965757|10313032|P4|Extension Phase|Progression of concomitant disease|2
2996862|NCT00965757|10313033|P3|Extension Phase|Progression of concomitant disease|4
2996863|NCT00965757|10313034|P2|Extension Phase|Progression of concomitant disease|0
2996864|NCT00965757|10313035|P1|Extension Phase|Progression of concomitant disease|0
2996865|NCT00965757|10313032|P4|Double-blind Phase|Other|0
2996866|NCT00965757|10313033|P3|Double-blind Phase|Other|0
2996867|NCT00965757|10313034|P2|Double-blind Phase|Other|0
2996868|NCT00965757|10313035|P1|Double-blind Phase|Other|1
2996869|NCT00965757|10313032|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
2996870|NCT00965757|10313033|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
2996871|NCT00965757|10313034|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
2996872|NCT00965757|10313035|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
2996873|NCT00965757|10313032|P4|Double-blind Phase|Lost to Follow-up|0
2996874|NCT00965757|10313033|P3|Double-blind Phase|Lost to Follow-up|0
2996875|NCT00965757|10313034|P2|Double-blind Phase|Lost to Follow-up|1
2996876|NCT00965757|10313035|P1|Double-blind Phase|Lost to Follow-up|0
2996877|NCT00965757|10313032|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2996878|NCT00965757|10313033|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2996879|NCT00965757|10313034|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2996880|NCT00965757|10313035|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
2996881|NCT00965757|10313032|P4|Double-blind Phase|Lack of Efficacy|0
2996882|NCT00965757|10313033|P3|Double-blind Phase|Lack of Efficacy|0
2996883|NCT00965757|10313034|P2|Double-blind Phase|Lack of Efficacy|11
2996884|NCT00965757|10313035|P1|Double-blind Phase|Lack of Efficacy|7
2996885|NCT00965757|10313032|P4|Double-blind Phase|Abnormal Laboratory Value|0
2996886|NCT00965757|10313033|P3|Double-blind Phase|Abnormal Laboratory Value|0
2996887|NCT00965757|10313034|P2|Double-blind Phase|Abnormal Laboratory Value|0
2996888|NCT00965757|10313035|P1|Double-blind Phase|Abnormal Laboratory Value|2
2996889|NCT00965757|10313032|P4|Double-blind Phase|Adverse drug reaction|0
2996890|NCT00965757|10313033|P3|Double-blind Phase|Adverse drug reaction|0
2996891|NCT00965757|10313034|P2|Double-blind Phase|Adverse drug reaction|1
2996892|NCT00965757|10313035|P1|Double-blind Phase|Adverse drug reaction|2
2996893|NCT00965757|10313032|P4|Double-blind Phase|Progression of concomitant disease|0
2996894|NCT00965757|10313033|P3|Double-blind Phase|Progression of concomitant disease|0
2996895|NCT00965757|10313034|P2|Double-blind Phase|Progression of concomitant disease|2
2996896|NCT00965757|10313035|P1|Double-blind Phase|Progression of concomitant disease|1
2996897|NCT00965731|10313069|P2|Overall Study|Other|15
2996898|NCT00965731|10313070|P1|Overall Study|Other|7
2996899|NCT00965731|10313069|P2|Overall Study|Withdrawal by Subject|1
2996900|NCT00965731|10313070|P1|Overall Study|Withdrawal by Subject|0
2996901|NCT00965731|10313069|P2|Overall Study|Death|4
2996902|NCT00965731|10313070|P1|Overall Study|Death|0
2996903|NCT00965718|10313134|P1|Overall Study|Withdrawal by Subject|4
2996904|NCT00965562|10313147|P3|Overall Study|Withdrawal by Subject|0
2996905|NCT00965562|10313148|P2|Overall Study|Withdrawal by Subject|2
2996906|NCT00965562|10313149|P1|Overall Study|Withdrawal by Subject|2
2996907|NCT00965562|10313147|P3|Overall Study|Lost to Follow-up|3
2996908|NCT00965562|10313148|P2|Overall Study|Lost to Follow-up|2
2996909|NCT00965562|10313149|P1|Overall Study|Lost to Follow-up|1
2996910|NCT00965523|10313187|P1|Study 224|Physician Decision|1
2996911|NCT00965523|10313187|P1|Study 224|Progressive Disease|5
2996912|NCT00965523|10313187|P1|Study 221|Physician Decision|3
2996913|NCT00965523|10313187|P1|Study 221|Progressive Disease|4
2996914|NCT00965497|10313192|P1|Overall Study|Physician Decision|1
2996915|NCT00965484|10313197|P1|Overall Study|Withdrawal by Subject|1
2996916|NCT00965484|10313197|P1|Overall Study|Protocol Violation|1
2996917|NCT00965458|10313206|P2|Overall Study|Withdrawal by Subject|1
2996918|NCT00965458|10313207|P1|Overall Study|Withdrawal by Subject|0
2996919|NCT00965458|10313206|P2|Overall Study|Lost to Follow-up|3
2996920|NCT00965458|10313207|P1|Overall Study|Lost to Follow-up|1
2996921|NCT00965458|10313206|P2|Overall Study|Adverse Event|0
2996922|NCT00965458|10313207|P1|Overall Study|Adverse Event|1
2996923|NCT00965419|10313223|P1|Follow-up Phase|Lack of Efficacy|28
2996924|NCT00965419|10313223|P1|Follow-up Phase|Parent/Caregiver Decision|9
2996925|NCT00965419|10313223|P1|Follow-up Phase|Physician Decision|4
2996926|NCT00965419|10313223|P1|Follow-up Phase|Withdrawal by Subject|8
2996927|NCT00965419|10313223|P1|Follow-up Phase|Protocol Violation|4
2996928|NCT00965419|10313223|P1|Follow-up Phase|Adverse Event|9
2996929|NCT00965419|10313223|P1|Open Label Treatment for Responders|Lost to Follow-up|46
2996930|NCT00965419|10313223|P1|Open Label Treatment for Responders|Lack of Efficacy|67
2996931|NCT00965419|10313223|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
2996932|NCT00965419|10313223|P1|Open Label Treatment for Responders|Sponsor Decision|5
2996933|NCT00965419|10313223|P1|Open Label Treatment for Responders|Physician Decision|6
2996934|NCT00965419|10313223|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
2996935|NCT00965419|10313223|P1|Open Label Treatment for Responders|Protocol Violation|21
2996936|NCT00965419|10313223|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
2996937|NCT00965419|10313223|P1|Open Label Treatment for Responders|Adverse Event|33
2996938|NCT00965341|10313269|P2|Overall Study|Transportation issues|3
2996939|NCT00965341|10313270|P1|Overall Study|Transportation issues|4
2996940|NCT00965341|10313269|P2|Overall Study|Lost to Follow-up|0
2996941|NCT00965341|10313270|P1|Overall Study|Lost to Follow-up|1
2996942|NCT00965341|10313269|P2|Overall Study|Withdrew consent|5
2996943|NCT00965341|10313270|P1|Overall Study|Withdrew consent|1
2996944|NCT00965263|10313280|P2|Overall Study|Protocol Violation|2
2996945|NCT00965263|10313281|P1|Overall Study|Protocol Violation|0
2996946|NCT00965263|10313280|P2|Overall Study|Family emergency|1
2996947|NCT00965263|10313281|P1|Overall Study|Family emergency|0
2996948|NCT00965263|10313280|P2|Overall Study|Physician Decision|0
2996949|NCT00965263|10313281|P1|Overall Study|Physician Decision|2
2996950|NCT00965185|10313341|P2|Overall Study|Withdrawal by Subject|1
2996951|NCT00965185|10313342|P1|Overall Study|Withdrawal by Subject|0
2996952|NCT00965185|10313341|P2|Overall Study|Lost to Follow-up|0
2996953|NCT00965185|10313342|P1|Overall Study|Lost to Follow-up|2
2996954|NCT00965146|10313362|P1|Overall Study|Overall Study Termination|145
2996955|NCT00965146|10313362|P1|Overall Study|Revision / Removal of Study Implant|6
2996956|NCT00965146|10313362|P1|Overall Study|Intercurrent illness|1
2996957|NCT00965146|10313362|P1|Overall Study|Unwilling to return|11
2996958|NCT00965146|10313362|P1|Overall Study|Unable to return|1
2996959|NCT00965146|10313362|P1|Overall Study|Withdrawal by Subject|17
2996960|NCT00965146|10313362|P1|Overall Study|Lost to Follow-up|22
2996961|NCT00965146|10313362|P1|Overall Study|Death|7
2996962|NCT00965094|10313369|P2|Overall Study|Lost to Follow-up|1
2996963|NCT00965094|10313370|P1|Overall Study|Lost to Follow-up|0
2996964|NCT00965094|10313369|P2|Overall Study|Adverse Event|0
2996965|NCT00965094|10313370|P1|Overall Study|Adverse Event|5
2996966|NCT00965081|10313386|P2|Overall Study|Switched to Rescue Arm|12
2996967|NCT00965081|10313387|P1|Overall Study|Switched to Rescue Arm|5
2996968|NCT00965081|10313386|P2|Overall Study|Withdrawal by Subject|7
2996969|NCT00965081|10313387|P1|Overall Study|Withdrawal by Subject|4
2996970|NCT00965081|10313386|P2|Overall Study|Sponsor Decision|0
2996971|NCT00965081|10313387|P1|Overall Study|Sponsor Decision|1
2996972|NCT00965081|10313386|P2|Overall Study|Protocol Violation|5
2996973|NCT00965081|10313387|P1|Overall Study|Protocol Violation|2
2996974|NCT00965081|10313386|P2|Overall Study|Physician Decision|0
2996975|NCT00965081|10313387|P1|Overall Study|Physician Decision|2
2996976|NCT00965081|10313386|P2|Overall Study|Lost to Follow-up|5
2996977|NCT00965081|10313387|P1|Overall Study|Lost to Follow-up|4
2996978|NCT00965081|10313386|P2|Overall Study|Lack of Efficacy|5
2996979|NCT00965081|10313387|P1|Overall Study|Lack of Efficacy|2
2996980|NCT00965081|10313386|P2|Overall Study|Adverse Event|9
2996981|NCT00965081|10313387|P1|Overall Study|Adverse Event|14
2996982|NCT00964886|10313419|P4|Overall Study|Protocol Violation|0
2996983|NCT00964886|10313420|P3|Overall Study|Protocol Violation|0
2996984|NCT00964886|10313421|P2|Overall Study|Protocol Violation|2
2996985|NCT00964886|10313422|P1|Overall Study|Protocol Violation|0
2996986|NCT00964886|10313419|P4|Overall Study|Adverse Event|2
2996987|NCT00964886|10313420|P3|Overall Study|Adverse Event|5
2996988|NCT00964886|10313421|P2|Overall Study|Adverse Event|1
2996989|NCT00964886|10313422|P1|Overall Study|Adverse Event|3
2996990|NCT00964886|10313419|P4|Overall Study|Withdrawal by Subject|3
2996991|NCT00964886|10313420|P3|Overall Study|Withdrawal by Subject|5
2996992|NCT00964886|10313421|P2|Overall Study|Withdrawal by Subject|2
2996993|NCT00964886|10313422|P1|Overall Study|Withdrawal by Subject|6
2996994|NCT00964886|10313419|P4|Overall Study|Lost to Follow-up|4
2996995|NCT00964886|10313420|P3|Overall Study|Lost to Follow-up|6
2996996|NCT00964886|10313421|P2|Overall Study|Lost to Follow-up|2
2996997|NCT00964886|10313422|P1|Overall Study|Lost to Follow-up|2
2996998|NCT00964860|10313438|P2|Overall Study|Withdrawal by Subject|1
2996999|NCT00964860|10313439|P1|Overall Study|Withdrawal by Subject|0
2997000|NCT00964795|10313447|P1|Overall Study|Other|23
2997001|NCT00964795|10313447|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
2997002|NCT00964795|10313447|P1|Overall Study|Termination of Study by Sponsor|169
2997003|NCT00964795|10313447|P1|Overall Study|Lost to Follow-up|7
2997004|NCT00964795|10313447|P1|Overall Study|Death|14
2997005|NCT00964795|10313447|P1|Overall Study|Adverse Event|12
2997006|NCT00964795|10313447|P1|Overall Study|Withdrawal by Subject|79
2997007|NCT00964782|10313456|P2|Overall Study|Lost to Follow-up|0
2997008|NCT00964782|10313457|P1|Overall Study|Lost to Follow-up|1
2997009|NCT00964743|10313471|P1|Overall Study|Neither patient completed 8 weeks of tre|2
2997010|NCT00964678|10313479|P1|Overall Study|Physician Decision|4
2997011|NCT00964392|10313543|P2|Overall Study|Not completed|168
2997012|NCT00964392|10313544|P1|Overall Study|Not completed|44
2997013|NCT00964392|10313543|P2|Overall Study|Early Termination, non-study arrhythmia|6
2997014|NCT00964392|10313544|P1|Overall Study|Early Termination, non-study arrhythmia|1
2997015|NCT00964392|10313543|P2|Overall Study|Lost to Follow-up|10
2997016|NCT00964392|10313544|P1|Overall Study|Lost to Follow-up|4
2997017|NCT00964392|10313543|P2|Overall Study|Withdrawal by Subject|6
2997018|NCT00964392|10313544|P1|Overall Study|Withdrawal by Subject|4
2997019|NCT00964366|10313554|P2|Overall Study|Withdrawal by Subject|1
2997020|NCT00964366|10313555|P1|Overall Study|Withdrawal by Subject|0
2997021|NCT00964366|10313554|P2|Overall Study|Did not qualify at Day 1|0
2997022|NCT00964366|10313555|P1|Overall Study|Did not qualify at Day 1|1
2997023|NCT00964223|10313580|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
2997024|NCT00964158|10313648|P3|Overall Study|Withdrawal by Subject|6
2997025|NCT00964158|10313649|P2|Overall Study|Withdrawal by Subject|0
2997026|NCT00964158|10313650|P1|Overall Study|Withdrawal by Subject|0
2997027|NCT00964158|10313648|P3|Overall Study|Lost to Follow-up|2
2997028|NCT00964158|10313649|P2|Overall Study|Lost to Follow-up|1
2997029|NCT00964158|10313650|P1|Overall Study|Lost to Follow-up|0
2997030|NCT00964028|10313725|P2|Overall Study|Withdrawal by Subject|1
2997031|NCT00964028|10313726|P1|Overall Study|Withdrawal by Subject|0
2997032|NCT00963937|10313741|P3|Overall Study|Physician Decision|4
2997033|NCT00963937|10313742|P2|Overall Study|Physician Decision|10
2997034|NCT00963937|10313743|P1|Overall Study|Physician Decision|18
2997035|NCT00963937|10313741|P3|Overall Study|Protocol Violation|0
2997036|NCT00963937|10313742|P2|Overall Study|Protocol Violation|1
2997037|NCT00963937|10313743|P1|Overall Study|Protocol Violation|1
2997038|NCT00963924|10313781|P2|Overall Study|Lost to Follow-up|1
2997039|NCT00963924|10313782|P1|Overall Study|Lost to Follow-up|0
2997040|NCT00963924|10313781|P2|Overall Study|Changed antipsychotic|1
2997041|NCT00963924|10313782|P1|Overall Study|Changed antipsychotic|0
2997042|NCT00963924|10313781|P2|Overall Study|Withdrawal by Subject|1
2997043|NCT00963924|10313782|P1|Overall Study|Withdrawal by Subject|0
2997044|NCT00963924|10313781|P2|Overall Study|Adverse Event|0
2997045|NCT00963924|10313782|P1|Overall Study|Adverse Event|1
2997046|NCT00963820|10313856|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
2997047|NCT00963820|10313857|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997048|NCT00963820|10313858|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997049|NCT00963820|10313859|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997050|NCT00963820|10313860|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997051|NCT00963820|10313861|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997052|NCT00963820|10313862|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997053|NCT00963820|10313863|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997054|NCT00963820|10313864|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997055|NCT00963820|10313865|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997056|NCT00963820|10313866|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997057|NCT00963820|10313867|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
2997058|NCT00963820|10313856|P12|Expansion Phase|Withdrawal by Subject|1
2997059|NCT00963820|10313857|P11|Expansion Phase|Withdrawal by Subject|1
2997060|NCT00963820|10313858|P10|Expansion Phase|Withdrawal by Subject|0
2997061|NCT00963820|10313859|P9|Expansion Phase|Withdrawal by Subject|1
2997062|NCT00963820|10313860|P8|Expansion Phase|Withdrawal by Subject|0
2997063|NCT00963820|10313861|P7|Expansion Phase|Withdrawal by Subject|0
2997064|NCT00963820|10313862|P6|Expansion Phase|Withdrawal by Subject|0
2997065|NCT00963820|10313863|P5|Expansion Phase|Withdrawal by Subject|0
2997066|NCT00963820|10313864|P4|Expansion Phase|Withdrawal by Subject|0
2997067|NCT00963820|10313865|P3|Expansion Phase|Withdrawal by Subject|0
2997068|NCT00963820|10313866|P2|Expansion Phase|Withdrawal by Subject|0
2997069|NCT00963820|10313867|P1|Expansion Phase|Withdrawal by Subject|0
2997070|NCT00963820|10313856|P12|Expansion Phase|Adverse Event|0
2997071|NCT00963820|10313857|P11|Expansion Phase|Adverse Event|0
2997072|NCT00963820|10313858|P10|Expansion Phase|Adverse Event|3
2997073|NCT00963820|10313859|P9|Expansion Phase|Adverse Event|1
2997074|NCT00963820|10313860|P8|Expansion Phase|Adverse Event|0
2997075|NCT00963820|10313861|P7|Expansion Phase|Adverse Event|0
2997076|NCT00963820|10313862|P6|Expansion Phase|Adverse Event|0
2997077|NCT00963820|10313863|P5|Expansion Phase|Adverse Event|0
2997078|NCT00963820|10313864|P4|Expansion Phase|Adverse Event|0
2997079|NCT00963820|10313865|P3|Expansion Phase|Adverse Event|0
2997080|NCT00963820|10313866|P2|Expansion Phase|Adverse Event|0
2997081|NCT00963820|10313867|P1|Expansion Phase|Adverse Event|0
2997082|NCT00963820|10313856|P12|Expansion Phase|Progressive Disease|2
2997083|NCT00963820|10313857|P11|Expansion Phase|Progressive Disease|4
2997084|NCT00963820|10313858|P10|Expansion Phase|Progressive Disease|6
2997085|NCT00963820|10313859|P9|Expansion Phase|Progressive Disease|8
2997086|NCT00963820|10313860|P8|Expansion Phase|Progressive Disease|0
2997087|NCT00963820|10313861|P7|Expansion Phase|Progressive Disease|0
2997088|NCT00963820|10313862|P6|Expansion Phase|Progressive Disease|0
2997089|NCT00963820|10313863|P5|Expansion Phase|Progressive Disease|0
2997090|NCT00963820|10313864|P4|Expansion Phase|Progressive Disease|0
2997091|NCT00963820|10313865|P3|Expansion Phase|Progressive Disease|0
2997092|NCT00963820|10313866|P2|Expansion Phase|Progressive Disease|0
2997093|NCT00963820|10313867|P1|Expansion Phase|Progressive Disease|0
2997094|NCT00963820|10313856|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997095|NCT00963820|10313857|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997096|NCT00963820|10313858|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997097|NCT00963820|10313859|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997098|NCT00963820|10313860|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997099|NCT00963820|10313861|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2997100|NCT00963820|10313862|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997101|NCT00963820|10313863|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997102|NCT00963820|10313864|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997103|NCT00963820|10313865|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997104|NCT00963820|10313866|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997105|NCT00963820|10313867|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2997106|NCT00963820|10313856|P12|Dose Escalation Phase|Withdrawal by Subject|0
2997107|NCT00963820|10313857|P11|Dose Escalation Phase|Withdrawal by Subject|0
2997108|NCT00963820|10313858|P10|Dose Escalation Phase|Withdrawal by Subject|0
2997109|NCT00963820|10313859|P9|Dose Escalation Phase|Withdrawal by Subject|0
2997110|NCT00963820|10313860|P8|Dose Escalation Phase|Withdrawal by Subject|2
2997111|NCT00963820|10313861|P7|Dose Escalation Phase|Withdrawal by Subject|1
2997112|NCT00963820|10313862|P6|Dose Escalation Phase|Withdrawal by Subject|0
2997113|NCT00963820|10313863|P5|Dose Escalation Phase|Withdrawal by Subject|0
2997114|NCT00963820|10313864|P4|Dose Escalation Phase|Withdrawal by Subject|0
2997115|NCT00963820|10313865|P3|Dose Escalation Phase|Withdrawal by Subject|0
2997116|NCT00963820|10313866|P2|Dose Escalation Phase|Withdrawal by Subject|0
2997117|NCT00963820|10313867|P1|Dose Escalation Phase|Withdrawal by Subject|0
2997118|NCT00963820|10313856|P12|Dose Escalation Phase|Adverse Event|0
2997119|NCT00963820|10313857|P11|Dose Escalation Phase|Adverse Event|0
2997120|NCT00963820|10313858|P10|Dose Escalation Phase|Adverse Event|0
2997121|NCT00963820|10313859|P9|Dose Escalation Phase|Adverse Event|0
2997122|NCT00963820|10313860|P8|Dose Escalation Phase|Adverse Event|1
2997123|NCT00963820|10313861|P7|Dose Escalation Phase|Adverse Event|3
2997124|NCT00963820|10313862|P6|Dose Escalation Phase|Adverse Event|0
2997125|NCT00963820|10313863|P5|Dose Escalation Phase|Adverse Event|0
2997126|NCT00963820|10313864|P4|Dose Escalation Phase|Adverse Event|0
2997127|NCT00963820|10313865|P3|Dose Escalation Phase|Adverse Event|0
2997128|NCT00963820|10313866|P2|Dose Escalation Phase|Adverse Event|0
2997129|NCT00963820|10313867|P1|Dose Escalation Phase|Adverse Event|0
2997130|NCT00963820|10313856|P12|Dose Escalation Phase|Progressive Disease|0
2997131|NCT00963820|10313857|P11|Dose Escalation Phase|Progressive Disease|0
2997132|NCT00963820|10313858|P10|Dose Escalation Phase|Progressive Disease|0
2997133|NCT00963820|10313859|P9|Dose Escalation Phase|Progressive Disease|0
2997134|NCT00963820|10313860|P8|Dose Escalation Phase|Progressive Disease|2
2997135|NCT00963820|10313861|P7|Dose Escalation Phase|Progressive Disease|3
2997136|NCT00963820|10313862|P6|Dose Escalation Phase|Progressive Disease|3
2997137|NCT00963820|10313863|P5|Dose Escalation Phase|Progressive Disease|4
2997138|NCT00963820|10313864|P4|Dose Escalation Phase|Progressive Disease|3
2997139|NCT00963820|10313865|P3|Dose Escalation Phase|Progressive Disease|3
2997140|NCT00963820|10313866|P2|Dose Escalation Phase|Progressive Disease|3
2997141|NCT00963820|10313867|P1|Dose Escalation Phase|Progressive Disease|3
2997142|NCT00963807|10314003|P1|Overall Study|Disease progression|15
2997143|NCT00963807|10314003|P1|Overall Study|Reaction to study chemotherapy regimen|1
2997144|NCT00963807|10314003|P1|Overall Study|Physician Decision|2
2997145|NCT00963599|10314036|P4|Overall Study|Withdrawal by Subject|3
2997146|NCT00963599|10314037|P3|Overall Study|Withdrawal by Subject|3
2997147|NCT00963599|10314038|P2|Overall Study|Withdrawal by Subject|1
2997148|NCT00963599|10314039|P1|Overall Study|Withdrawal by Subject|2
2997149|NCT00963599|10314036|P4|Overall Study|Protocol Violation|4
2997150|NCT00963599|10314037|P3|Overall Study|Protocol Violation|3
2997151|NCT00963599|10314038|P2|Overall Study|Protocol Violation|2
2997152|NCT00963599|10314039|P1|Overall Study|Protocol Violation|2
2997153|NCT00963599|10314036|P4|Overall Study|Lost to Follow-up|1
2997154|NCT00963599|10314037|P3|Overall Study|Lost to Follow-up|1
2997155|NCT00963599|10314038|P2|Overall Study|Lost to Follow-up|1
2997156|NCT00963599|10314039|P1|Overall Study|Lost to Follow-up|0
2997157|NCT00963599|10314036|P4|Overall Study|Lack of Efficacy|4
2997158|NCT00963599|10314037|P3|Overall Study|Lack of Efficacy|1
2997159|NCT00963599|10314038|P2|Overall Study|Lack of Efficacy|2
2997160|NCT00963599|10314039|P1|Overall Study|Lack of Efficacy|0
2997161|NCT00963599|10314036|P4|Overall Study|Adverse Event|2
2997162|NCT00963599|10314037|P3|Overall Study|Adverse Event|1
2997163|NCT00963599|10314038|P2|Overall Study|Adverse Event|0
2997164|NCT00963599|10314039|P1|Overall Study|Adverse Event|2
2997165|NCT00963547|10314110|P7|Overall Study|Reason Unknown|0
2997166|NCT00963547|10314111|P6|Overall Study|Reason Unknown|0
2997167|NCT00963547|10314112|P5|Overall Study|Reason Unknown|0
2997168|NCT00963547|10314113|P4|Overall Study|Reason Unknown|0
2997169|NCT00963547|10314114|P3|Overall Study|Reason Unknown|0
2997170|NCT00963547|10314115|P2|Overall Study|Reason Unknown|1
2997171|NCT00963547|10314116|P1|Overall Study|Reason Unknown|0
2997172|NCT00963547|10314110|P7|Overall Study|Withdrawal by Subject|0
2997173|NCT00963547|10314111|P6|Overall Study|Withdrawal by Subject|0
2997174|NCT00963547|10314112|P5|Overall Study|Withdrawal by Subject|0
2997175|NCT00963547|10314113|P4|Overall Study|Withdrawal by Subject|0
2997176|NCT00963547|10314114|P3|Overall Study|Withdrawal by Subject|3
2997177|NCT00963547|10314115|P2|Overall Study|Withdrawal by Subject|0
2997178|NCT00963547|10314116|P1|Overall Study|Withdrawal by Subject|0
2997179|NCT00963547|10314110|P7|Overall Study|Progressive Disease|0
2997180|NCT00963547|10314111|P6|Overall Study|Progressive Disease|0
2997181|NCT00963547|10314112|P5|Overall Study|Progressive Disease|0
2997182|NCT00963547|10314113|P4|Overall Study|Progressive Disease|5
2997183|NCT00963547|10314114|P3|Overall Study|Progressive Disease|9
2997184|NCT00963547|10314115|P2|Overall Study|Progressive Disease|8
2997185|NCT00963547|10314116|P1|Overall Study|Progressive Disease|3
2997186|NCT00963547|10314110|P7|Overall Study|Physician Decision|0
2997187|NCT00963547|10314111|P6|Overall Study|Physician Decision|0
2997188|NCT00963547|10314112|P5|Overall Study|Physician Decision|0
2997189|NCT00963547|10314113|P4|Overall Study|Physician Decision|0
2997190|NCT00963547|10314114|P3|Overall Study|Physician Decision|0
2997191|NCT00963547|10314115|P2|Overall Study|Physician Decision|1
2997192|NCT00963547|10314116|P1|Overall Study|Physician Decision|1
2997193|NCT00963547|10314110|P7|Overall Study|Adverse Event|0
2997194|NCT00963547|10314111|P6|Overall Study|Adverse Event|0
2997195|NCT00963547|10314112|P5|Overall Study|Adverse Event|0
2997196|NCT00963547|10314113|P4|Overall Study|Adverse Event|1
2997197|NCT00963547|10314114|P3|Overall Study|Adverse Event|0
2997198|NCT00963547|10314115|P2|Overall Study|Adverse Event|1
2997199|NCT00963547|10314116|P1|Overall Study|Adverse Event|0
2997200|NCT00963469|10314163|P3|Overall Study|Site closed (local pollen Season ended)|3
2997201|NCT00963469|10314164|P2|Overall Study|Site closed (local pollen Season ended)|1
2997202|NCT00963469|10314165|P1|Overall Study|Site closed (local pollen Season ended)|4
2997203|NCT00963469|10314163|P3|Overall Study|Moved|0
2997204|NCT00963469|10314164|P2|Overall Study|Moved|0
2997205|NCT00963469|10314165|P1|Overall Study|Moved|1
2997206|NCT00963469|10314163|P3|Overall Study|Pre-randomization Adverse Event|0
2997207|NCT00963469|10314164|P2|Overall Study|Pre-randomization Adverse Event|2
2997208|NCT00963469|10314165|P1|Overall Study|Pre-randomization Adverse Event|1
2997209|NCT00963469|10314163|P3|Overall Study|Withdrawal by Subject|1
2997210|NCT00963469|10314164|P2|Overall Study|Withdrawal by Subject|1
2997211|NCT00963469|10314165|P1|Overall Study|Withdrawal by Subject|4
2997212|NCT00963469|10314163|P3|Overall Study|Protocol Violation|3
2997213|NCT00963469|10314164|P2|Overall Study|Protocol Violation|5
2997214|NCT00963469|10314165|P1|Overall Study|Protocol Violation|5
2997215|NCT00963469|10314163|P3|Overall Study|Lost to Follow-up|0
2997216|NCT00963469|10314164|P2|Overall Study|Lost to Follow-up|1
2997217|NCT00963469|10314165|P1|Overall Study|Lost to Follow-up|1
2997218|NCT00963469|10314163|P3|Overall Study|Lack of Efficacy|2
2997219|NCT00963469|10314164|P2|Overall Study|Lack of Efficacy|7
2997220|NCT00963469|10314165|P1|Overall Study|Lack of Efficacy|10
2997221|NCT00963469|10314163|P3|Overall Study|Adverse Event|1
2997222|NCT00963469|10314164|P2|Overall Study|Adverse Event|11
2997223|NCT00963469|10314165|P1|Overall Study|Adverse Event|15
2997224|NCT00963235|10314232|P1|Overall Study|Other|1
2997225|NCT00963235|10314232|P1|Overall Study|Physician Decision|2
2997226|NCT00963235|10314232|P1|Overall Study|Adverse Event|5
2997227|NCT00963235|10314232|P1|Overall Study|Protocol Violation|7
2997228|NCT00963235|10314232|P1|Overall Study|Failed to return|9
2997229|NCT00963235|10314232|P1|Overall Study|Lost to Follow-up|14
2997230|NCT00963235|10314232|P1|Overall Study|Withdrawal by Subject|22
2997231|NCT00962780|10314524|P2|Overall Study|Other|1
2997232|NCT00962780|10314525|P1|Overall Study|Other|0
2997233|NCT00962780|10314524|P2|Overall Study|Withdrawal by Subject|8
2997234|NCT00962780|10314525|P1|Overall Study|Withdrawal by Subject|1
2997235|NCT00962780|10314524|P2|Overall Study|Protocol Violation|4
2997236|NCT00962780|10314525|P1|Overall Study|Protocol Violation|9
2997237|NCT00962780|10314524|P2|Overall Study|Death|1
2997238|NCT00962780|10314525|P1|Overall Study|Death|0
2997239|NCT00962741|10314600|P1|Overall Study|drug ineffective+prohibited drug taken|1
2997240|NCT00962741|10314600|P1|Overall Study|Lack of Efficacy|1
2997241|NCT00962741|10314600|P1|Overall Study|Withdrawal by Subject|1
2997242|NCT00962741|10314600|P1|Overall Study|Lost to Follow-up|2
2997243|NCT00962741|10314600|P1|Overall Study|Failed to return|3
2997244|NCT00962650|10314691|P1|Overall Study|Transgastric DP was not completed|2
2997245|NCT00962585|10314710|P4|Overall Study|Withdrew Consent|0
2997246|NCT00962585|10314711|P3|Overall Study|Withdrew Consent|0
2997247|NCT00962585|10314712|P2|Overall Study|Withdrew Consent|0
2997248|NCT00962585|10314713|P1|Overall Study|Withdrew Consent|2
2997249|NCT00962585|10314710|P4|Overall Study|Withdrawal by Subject|0
2997250|NCT00962585|10314711|P3|Overall Study|Withdrawal by Subject|0
2997251|NCT00962585|10314712|P2|Overall Study|Withdrawal by Subject|0
2997252|NCT00962585|10314713|P1|Overall Study|Withdrawal by Subject|1
2997253|NCT00962585|10314710|P4|Overall Study|Protocol Violation|0
2997254|NCT00962585|10314711|P3|Overall Study|Protocol Violation|1
2997255|NCT00962585|10314712|P2|Overall Study|Protocol Violation|0
2997256|NCT00962585|10314713|P1|Overall Study|Protocol Violation|0
2997257|NCT00962585|10314710|P4|Overall Study|Lost to Follow-up|0
2997258|NCT00962585|10314711|P3|Overall Study|Lost to Follow-up|1
2997259|NCT00962585|10314712|P2|Overall Study|Lost to Follow-up|0
2997260|NCT00962585|10314713|P1|Overall Study|Lost to Follow-up|3
2997261|NCT00962585|10314710|P4|Overall Study|Adverse Event|0
2997262|NCT00962585|10314711|P3|Overall Study|Adverse Event|1
2997263|NCT00962585|10314712|P2|Overall Study|Adverse Event|2
2997264|NCT00962585|10314713|P1|Overall Study|Adverse Event|0
2997265|NCT00962390|10314775|P4|Overall Study|Withdrawal by Subject|0
2997266|NCT00962390|10314776|P3|Overall Study|Withdrawal by Subject|1
2997267|NCT00962390|10314777|P2|Overall Study|Withdrawal by Subject|1
2997268|NCT00962390|10314778|P1|Overall Study|Withdrawal by Subject|1
2997269|NCT00962390|10314775|P4|Overall Study|Protocol Violation|0
2997270|NCT00962390|10314776|P3|Overall Study|Protocol Violation|0
2997271|NCT00962390|10314777|P2|Overall Study|Protocol Violation|0
2997272|NCT00962390|10314778|P1|Overall Study|Protocol Violation|1
2997273|NCT00962390|10314775|P4|Overall Study|Lost to Follow-up|0
2997274|NCT00962390|10314776|P3|Overall Study|Lost to Follow-up|0
2997275|NCT00962390|10314777|P2|Overall Study|Lost to Follow-up|2
2997276|NCT00962390|10314778|P1|Overall Study|Lost to Follow-up|2
2997277|NCT00962390|10314775|P4|Overall Study|Adverse Event|1
2997278|NCT00962390|10314776|P3|Overall Study|Adverse Event|3
2997279|NCT00962390|10314777|P2|Overall Study|Adverse Event|0
2997280|NCT00962390|10314778|P1|Overall Study|Adverse Event|0
2997281|NCT00962247|10314840|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
2997282|NCT00962247|10314840|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
2997283|NCT00962208|10314851|P2|Overall Study|Lost to Follow-up|9
2997284|NCT00962208|10314852|P1|Overall Study|Lost to Follow-up|0
2997285|NCT00962208|10314851|P2|Overall Study|Contraindicated to continue study|1
2997286|NCT00962208|10314852|P1|Overall Study|Contraindicated to continue study|5
2997287|NCT00962208|10314851|P2|Overall Study|Could not achieve good vision|0
2997288|NCT00962208|10314852|P1|Overall Study|Could not achieve good vision|9
2997289|NCT00962104|10314860|P2|Overall Study|Other|0
2997290|NCT00962104|10314861|P1|Overall Study|Other|2
2997291|NCT00962104|10314860|P2|Overall Study|Withdrawal by Subject|6
2997292|NCT00962104|10314861|P1|Overall Study|Withdrawal by Subject|10
2997293|NCT00962104|10314860|P2|Overall Study|Sponsor Decision|1
2997294|NCT00962104|10314861|P1|Overall Study|Sponsor Decision|0
2997295|NCT00962104|10314860|P2|Overall Study|Protocol Violation|8
2997296|NCT00962104|10314861|P1|Overall Study|Protocol Violation|6
2997297|NCT00962104|10314860|P2|Overall Study|Physician Decision|0
2997298|NCT00962104|10314861|P1|Overall Study|Physician Decision|1
2997299|NCT00962104|10314860|P2|Overall Study|Lost to Follow-up|4
2997300|NCT00962104|10314861|P1|Overall Study|Lost to Follow-up|10
2997301|NCT00962104|10314860|P2|Overall Study|Lack of Efficacy|1
2997302|NCT00962104|10314861|P1|Overall Study|Lack of Efficacy|0
2997303|NCT00962104|10314860|P2|Overall Study|Entry Criteria Not Met|2
2997304|NCT00962104|10314861|P1|Overall Study|Entry Criteria Not Met|1
2997305|NCT00962104|10314860|P2|Overall Study|Adverse Event|3
2997306|NCT00962104|10314861|P1|Overall Study|Adverse Event|10
2997307|NCT00962091|10314894|P7|Overall Study|Adverse Event|1
2997308|NCT00962091|10314895|P6|Overall Study|Adverse Event|0
2997309|NCT00962091|10314896|P5|Overall Study|Adverse Event|0
2997310|NCT00962091|10314897|P4|Overall Study|Adverse Event|0
2997311|NCT00962091|10314898|P3|Overall Study|Adverse Event|0
2997312|NCT00962091|10314899|P2|Overall Study|Adverse Event|0
2997313|NCT00962091|10314900|P1|Overall Study|Adverse Event|0
2997314|NCT00962091|10314894|P7|Overall Study|Withdrawal by Subject|0
2997315|NCT00962091|10314895|P6|Overall Study|Withdrawal by Subject|1
2997316|NCT00962091|10314896|P5|Overall Study|Withdrawal by Subject|0
2997317|NCT00962091|10314897|P4|Overall Study|Withdrawal by Subject|1
2997318|NCT00962091|10314898|P3|Overall Study|Withdrawal by Subject|1
2997319|NCT00962091|10314899|P2|Overall Study|Withdrawal by Subject|2
2997320|NCT00962091|10314900|P1|Overall Study|Withdrawal by Subject|1
2997321|NCT00962013|10314984|P1|Overall Study|No 5 year evaluation|6
2997322|NCT00962013|10314984|P1|Overall Study|Site Termination|24
2997323|NCT00962013|10314984|P1|Overall Study|Removal of study device|3
2997324|NCT00962013|10314984|P1|Overall Study|Withdrawal by Subject|8
2997325|NCT00962013|10314984|P1|Overall Study|Unable/Unwilling to return|6
2997326|NCT00962013|10314984|P1|Overall Study|Lost to Follow-up|12
2997327|NCT00962013|10314984|P1|Overall Study|Death|8
2997328|NCT00962013|10314984|P1|Overall Study|Did not have surgery|1
2997329|NCT00961896|10315007|P3|Overall Study|Abnormal laboratory value|1
2997330|NCT00961896|10315008|P2|Overall Study|Abnormal laboratory value|0
2997331|NCT00961896|10315009|P1|Overall Study|Abnormal laboratory value|0
2997332|NCT00961649|10315076|P4|Overall Study|Study terminated by sponsor|1
2997333|NCT00961649|10315077|P3|Overall Study|Study terminated by sponsor|4
2997334|NCT00961649|10315078|P2|Overall Study|Study terminated by sponsor|4
2997335|NCT00961649|10315079|P1|Overall Study|Study terminated by sponsor|4
2997336|NCT00961649|10315076|P4|Overall Study|Patient left to Mexico-family emergency|0
2997337|NCT00961649|10315077|P3|Overall Study|Patient left to Mexico-family emergency|0
2997338|NCT00961649|10315078|P2|Overall Study|Patient left to Mexico-family emergency|0
2997339|NCT00961649|10315079|P1|Overall Study|Patient left to Mexico-family emergency|1
2997340|NCT00961649|10315076|P4|Overall Study|Patient has travel plans during holidays|0
2997341|NCT00961649|10315077|P3|Overall Study|Patient has travel plans during holidays|1
2997342|NCT00961649|10315078|P2|Overall Study|Patient has travel plans during holidays|0
2997343|NCT00961649|10315079|P1|Overall Study|Patient has travel plans during holidays|0
2997344|NCT00961649|10315076|P4|Overall Study|Inadequate control of IOP|1
2997345|NCT00961649|10315077|P3|Overall Study|Inadequate control of IOP|0
2997346|NCT00961649|10315078|P2|Overall Study|Inadequate control of IOP|0
2997347|NCT00961649|10315079|P1|Overall Study|Inadequate control of IOP|0
2997348|NCT00961649|10315076|P4|Overall Study|Adverse Event|2
2997349|NCT00961649|10315077|P3|Overall Study|Adverse Event|0
2997350|NCT00961649|10315078|P2|Overall Study|Adverse Event|0
2997351|NCT00961649|10315079|P1|Overall Study|Adverse Event|4
2997352|NCT00961636|10315093|P3|Overall Study|Withdrawal by Subject|13
2997353|NCT00961636|10315094|P2|Overall Study|Withdrawal by Subject|22
2997354|NCT00961636|10315095|P1|Overall Study|Withdrawal by Subject|29
2997355|NCT00961636|10315093|P3|Overall Study|Protocol Violation|1
2997356|NCT00961636|10315094|P2|Overall Study|Protocol Violation|5
2997357|NCT00961636|10315095|P1|Overall Study|Protocol Violation|9
2997358|NCT00961636|10315093|P3|Overall Study|Physician Decision|1
2997359|NCT00961636|10315094|P2|Overall Study|Physician Decision|1
2997360|NCT00961636|10315095|P1|Overall Study|Physician Decision|3
2997361|NCT00961636|10315093|P3|Overall Study|Lost to Follow-up|1
2997362|NCT00961636|10315094|P2|Overall Study|Lost to Follow-up|3
2997363|NCT00961636|10315095|P1|Overall Study|Lost to Follow-up|2
2997364|NCT00961636|10315093|P3|Overall Study|Flushing Symptoms|3
2997365|NCT00961636|10315094|P2|Overall Study|Flushing Symptoms|46
2997366|NCT00961636|10315095|P1|Overall Study|Flushing Symptoms|29
2997367|NCT00961636|10315093|P3|Overall Study|Adverse Event|13
2997368|NCT00961636|10315094|P2|Overall Study|Adverse Event|54
2997369|NCT00961636|10315095|P1|Overall Study|Adverse Event|35
2997370|NCT00961571|10315106|P1|Overall Study|Physician Decision|39
2997371|NCT00961415|10315134|P3|Maintenance Treatment Phase|Other reason|3
2997372|NCT00961415|10315135|P2|Maintenance Treatment Phase|Other reason|1
2997373|NCT00961415|10315136|P1|Maintenance Treatment Phase|Other reason|0
2997374|NCT00961415|10315134|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
2997375|NCT00961415|10315135|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
2997376|NCT00961415|10315136|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
2997377|NCT00961415|10315134|P3|Maintenance Treatment Phase|Investigators decision|0
2997378|NCT00961415|10315135|P2|Maintenance Treatment Phase|Investigators decision|2
2997379|NCT00961415|10315136|P1|Maintenance Treatment Phase|Investigators decision|0
2997380|NCT00961415|10315134|P3|Maintenance Treatment Phase|Death|34
2997381|NCT00961415|10315135|P2|Maintenance Treatment Phase|Death|42
2997382|NCT00961415|10315136|P1|Maintenance Treatment Phase|Death|0
2997383|NCT00961415|10315134|P3|Induction Treatment Phase|Other Reason|0
2997384|NCT00961415|10315135|P2|Induction Treatment Phase|Other Reason|0
2997385|NCT00961415|10315136|P1|Induction Treatment Phase|Other Reason|5
2997386|NCT00961415|10315134|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
2997387|NCT00961415|10315135|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
2997388|NCT00961415|10315136|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
2997389|NCT00961415|10315134|P3|Induction Treatment Phase|Physician Decision|0
2997390|NCT00961415|10315135|P2|Induction Treatment Phase|Physician Decision|0
2997391|NCT00961415|10315136|P1|Induction Treatment Phase|Physician Decision|2
2997392|NCT00961415|10315134|P3|Induction Treatment Phase|Protocol Violation|0
2997393|NCT00961415|10315135|P2|Induction Treatment Phase|Protocol Violation|0
2997394|NCT00961415|10315136|P1|Induction Treatment Phase|Protocol Violation|1
2997395|NCT00961415|10315134|P3|Induction Treatment Phase|Death|0
2997396|NCT00961415|10315135|P2|Induction Treatment Phase|Death|0
2997397|NCT00961415|10315136|P1|Induction Treatment Phase|Death|77
2997398|NCT00961415|10315134|P3|Induction Treatment Phase|Withdrawal by Subject|0
2997399|NCT00961415|10315135|P2|Induction Treatment Phase|Withdrawal by Subject|0
2997400|NCT00961415|10315136|P1|Induction Treatment Phase|Withdrawal by Subject|11
2997401|NCT00961350|10315176|P2|Overall Study|Misc|21
2997402|NCT00961350|10315177|P1|Overall Study|Misc|16
2997403|NCT00961350|10315176|P2|Overall Study|Lost to Follow-up|3
2997404|NCT00961350|10315177|P1|Overall Study|Lost to Follow-up|3
2997405|NCT00961350|10315176|P2|Overall Study|Withdrawal by Subject|10
2997406|NCT00961350|10315177|P1|Overall Study|Withdrawal by Subject|10
2997407|NCT00961350|10315176|P2|Overall Study|Adverse Event|33
2997408|NCT00961350|10315177|P1|Overall Study|Adverse Event|18
2997409|NCT00961298|10315198|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
2997410|NCT00961298|10315198|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
2997411|NCT00961298|10315198|P1|Two Week Placebo Run in|Withdrawal by Subject|1
2997412|NCT00961259|10315205|P3|Washout Period of 7 Days|due to concomitant medication used|0
2997413|NCT00961259|10315206|P2|Washout Period of 7 Days|due to concomitant medication used|1
2997414|NCT00961259|10315207|P1|Washout Period of 7 Days|due to concomitant medication used|0
2997415|NCT00961220|10315235|P1|Overall Study|Complete Response prior to 12 courses|1
2997416|NCT00961220|10315235|P1|Overall Study|O6BG no longer supplied|1
2997417|NCT00961220|10315235|P1|Overall Study|No IV access for O6BG|1
2997418|NCT00961220|10315235|P1|Overall Study|Lack of Efficacy|1
2997419|NCT00961220|10315235|P1|Overall Study|Adverse Event|3
2997420|NCT00961181|10315251|P1|Overall Study|Lost to Follow-up|1
2997421|NCT00961181|10315251|P1|Overall Study|Withdrawal by Subject|2
2997422|NCT00961181|10315251|P1|Overall Study|Death|2
2997423|NCT00961116|10315264|P2|Washout Period of 7 Days|Protocol Violation|1
2997424|NCT00961116|10315265|P1|Washout Period of 7 Days|Protocol Violation|0
2997425|NCT00961116|10315264|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2997426|NCT00961116|10315265|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2997427|NCT00961116|10315264|P2|Washout Period of 7 Days|Adverse Event|1
2997428|NCT00961116|10315265|P1|Washout Period of 7 Days|Adverse Event|1
2997429|NCT00960999|10315292|P2|Overall Study|RT dose constraints not met|0
2997430|NCT00960999|10315293|P1|Overall Study|RT dose constraints not met|2
2997431|NCT00960999|10315292|P2|Overall Study|Protocol Violation|2
2997432|NCT00960999|10315293|P1|Overall Study|Protocol Violation|5
2997433|NCT00960999|10315292|P2|Overall Study|Withdrawal by Subject|0
2997434|NCT00960999|10315293|P1|Overall Study|Withdrawal by Subject|1
2997435|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
2997436|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2997437|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
2997438|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2997439|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2997440|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
2997441|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2997442|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2997443|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
2997444|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
2997445|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
2997446|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
2997447|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2997448|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
2997449|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2997450|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2997451|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Death|0
2997452|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Death|1
2997453|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Death|0
2997454|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Death|0
2997455|NCT00960986|10315325|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
2997456|NCT00960986|10315326|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
2997457|NCT00960986|10315327|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
2997458|NCT00960986|10315328|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
2997459|NCT00960986|10315325|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2997460|NCT00960986|10315326|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2997461|NCT00960986|10315327|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
2997462|NCT00960986|10315328|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2997463|NCT00960986|10315325|P4|Period 1 (Screening and Washout)|Protocol Violation|0
2997464|NCT00960986|10315326|P3|Period 1 (Screening and Washout)|Protocol Violation|0
2997465|NCT00960986|10315327|P2|Period 1 (Screening and Washout)|Protocol Violation|0
2997466|NCT00960986|10315328|P1|Period 1 (Screening and Washout)|Protocol Violation|1
2997467|NCT00960986|10315325|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
2997468|NCT00960986|10315326|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
2997469|NCT00960986|10315327|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
2997470|NCT00960986|10315328|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
2997471|NCT00960986|10315325|P4|Period 1 (Screening and Washout)|Adverse Event|1
2997472|NCT00960986|10315326|P3|Period 1 (Screening and Washout)|Adverse Event|1
2997473|NCT00960986|10315327|P2|Period 1 (Screening and Washout)|Adverse Event|2
2997474|NCT00960986|10315328|P1|Period 1 (Screening and Washout)|Adverse Event|1
2997475|NCT00960934|10315404|P6|Overall Study|Study Terminated by Sponsor|49
2997476|NCT00960934|10315405|P5|Overall Study|Study Terminated by Sponsor|49
2997477|NCT00960934|10315406|P4|Overall Study|Study Terminated by Sponsor|50
2997478|NCT00960934|10315407|P3|Overall Study|Study Terminated by Sponsor|52
2997479|NCT00960934|10315408|P2|Overall Study|Study Terminated by Sponsor|46
2997480|NCT00960934|10315409|P1|Overall Study|Study Terminated by Sponsor|50
2997481|NCT00960934|10315404|P6|Overall Study|Withdrawal by Subject|7
2997482|NCT00960934|10315405|P5|Overall Study|Withdrawal by Subject|5
2997483|NCT00960934|10315406|P4|Overall Study|Withdrawal by Subject|5
2997484|NCT00960934|10315407|P3|Overall Study|Withdrawal by Subject|4
2997485|NCT00960934|10315408|P2|Overall Study|Withdrawal by Subject|6
2997486|NCT00960934|10315409|P1|Overall Study|Withdrawal by Subject|5
2997487|NCT00960934|10315404|P6|Overall Study|Protocol Violation|2
2997488|NCT00960934|10315405|P5|Overall Study|Protocol Violation|3
2997489|NCT00960934|10315406|P4|Overall Study|Protocol Violation|3
2997490|NCT00960934|10315407|P3|Overall Study|Protocol Violation|0
2997491|NCT00960934|10315408|P2|Overall Study|Protocol Violation|4
2997492|NCT00960934|10315409|P1|Overall Study|Protocol Violation|3
2997493|NCT00960934|10315404|P6|Overall Study|Progressive Disease|1
2997494|NCT00960934|10315405|P5|Overall Study|Progressive Disease|1
2997495|NCT00960934|10315406|P4|Overall Study|Progressive Disease|0
2997496|NCT00960934|10315407|P3|Overall Study|Progressive Disease|0
2997497|NCT00960934|10315408|P2|Overall Study|Progressive Disease|1
2997498|NCT00960934|10315409|P1|Overall Study|Progressive Disease|1
2997499|NCT00960934|10315404|P6|Overall Study|Physician Decision|0
2997500|NCT00960934|10315405|P5|Overall Study|Physician Decision|0
2997501|NCT00960934|10315406|P4|Overall Study|Physician Decision|0
2997502|NCT00960934|10315407|P3|Overall Study|Physician Decision|0
2997503|NCT00960934|10315408|P2|Overall Study|Physician Decision|1
2997504|NCT00960934|10315409|P1|Overall Study|Physician Decision|0
2997505|NCT00960934|10315404|P6|Overall Study|Other|2
2997506|NCT00960934|10315405|P5|Overall Study|Other|2
2997507|NCT00960934|10315406|P4|Overall Study|Other|4
2997508|NCT00960934|10315407|P3|Overall Study|Other|5
2997509|NCT00960934|10315408|P2|Overall Study|Other|1
2997510|NCT00960934|10315409|P1|Overall Study|Other|2
2997511|NCT00960934|10315404|P6|Overall Study|Lost to Follow-up|0
2997512|NCT00960934|10315405|P5|Overall Study|Lost to Follow-up|0
2997513|NCT00960934|10315406|P4|Overall Study|Lost to Follow-up|0
2997514|NCT00960934|10315407|P3|Overall Study|Lost to Follow-up|0
2997515|NCT00960934|10315408|P2|Overall Study|Lost to Follow-up|1
2997516|NCT00960934|10315409|P1|Overall Study|Lost to Follow-up|0
2997517|NCT00960934|10315404|P6|Overall Study|Lack of Efficacy|0
2997518|NCT00960934|10315405|P5|Overall Study|Lack of Efficacy|0
2997519|NCT00960934|10315406|P4|Overall Study|Lack of Efficacy|0
2997520|NCT00960934|10315407|P3|Overall Study|Lack of Efficacy|0
2997521|NCT00960934|10315408|P2|Overall Study|Lack of Efficacy|0
2997522|NCT00960934|10315409|P1|Overall Study|Lack of Efficacy|1
2997523|NCT00960934|10315404|P6|Overall Study|Adverse Event|3
2997524|NCT00960934|10315405|P5|Overall Study|Adverse Event|4
2997525|NCT00960934|10315406|P4|Overall Study|Adverse Event|2
2997526|NCT00960934|10315407|P3|Overall Study|Adverse Event|3
2997527|NCT00960934|10315408|P2|Overall Study|Adverse Event|3
2997528|NCT00960934|10315409|P1|Overall Study|Adverse Event|2
2997529|NCT00960869|10315521|P2|Overall Study|Misc|18
2997530|NCT00960869|10315522|P1|Overall Study|Misc|19
2997531|NCT00960869|10315521|P2|Overall Study|Lost to Follow-up|4
2997532|NCT00960869|10315522|P1|Overall Study|Lost to Follow-up|1
2997533|NCT00960869|10315521|P2|Overall Study|Withdrawal by Subject|14
2997534|NCT00960869|10315522|P1|Overall Study|Withdrawal by Subject|16
2997535|NCT00960869|10315521|P2|Overall Study|Adverse Event|26
2997536|NCT00960869|10315522|P1|Overall Study|Adverse Event|17
2997537|NCT00960856|10315536|P4|Washout Period of 7 Days|Adverse Event|0
2997538|NCT00960856|10315537|P3|Washout Period of 7 Days|Adverse Event|1
2997539|NCT00960856|10315538|P2|Washout Period of 7 Days|Adverse Event|0
2997540|NCT00960856|10315539|P1|Washout Period of 7 Days|Adverse Event|0
2997541|NCT00960856|10315536|P4|Washout Period of 7 Days|Withdrawal by Subject|0
2997542|NCT00960856|10315537|P3|Washout Period of 7 Days|Withdrawal by Subject|0
2997543|NCT00960856|10315538|P2|Washout Period of 7 Days|Withdrawal by Subject|2
2997544|NCT00960856|10315539|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2997545|NCT00960843|10315559|P2|Overall Study|Repeated needle dislodgment|1
2997546|NCT00960843|10315560|P1|Overall Study|Repeated needle dislodgment|0
2997547|NCT00960843|10315559|P2|Overall Study|Protocol Violation|4
2997548|NCT00960843|10315560|P1|Overall Study|Protocol Violation|0
2997549|NCT00960843|10315559|P2|Overall Study|Lost to Follow-up|0
2997550|NCT00960843|10315560|P1|Overall Study|Lost to Follow-up|2
2997551|NCT00960687|10315581|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2997552|NCT00960687|10315582|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2997553|NCT00960687|10315581|P2|Washout Period of 7 Days|Adverse Event|2
2997554|NCT00960687|10315582|P1|Washout Period of 7 Days|Adverse Event|3
2997555|NCT00960661|10315594|P3|Interventional Phase|Lack of Efficacy|0
2997556|NCT00960661|10315595|P2|Interventional Phase|Lack of Efficacy|2
2997557|NCT00960661|10315596|P1|Interventional Phase|Lack of Efficacy|0
2997558|NCT00960661|10315594|P3|Interventional Phase|sponsor decision|0
2997559|NCT00960661|10315595|P2|Interventional Phase|sponsor decision|1
2997560|NCT00960661|10315596|P1|Interventional Phase|sponsor decision|0
2997561|NCT00960661|10315594|P3|Interventional Phase|Physician Decision|5
2997562|NCT00960661|10315595|P2|Interventional Phase|Physician Decision|3
2997563|NCT00960661|10315596|P1|Interventional Phase|Physician Decision|0
2997564|NCT00960661|10315594|P3|Interventional Phase|Withdrawal by Subject|29
2997565|NCT00960661|10315595|P2|Interventional Phase|Withdrawal by Subject|18
2997566|NCT00960661|10315596|P1|Interventional Phase|Withdrawal by Subject|0
2997567|NCT00960661|10315594|P3|Interventional Phase|Protocol Violation|2
2997568|NCT00960661|10315595|P2|Interventional Phase|Protocol Violation|7
2997569|NCT00960661|10315596|P1|Interventional Phase|Protocol Violation|0
2997570|NCT00960661|10315594|P3|Interventional Phase|entry criteria not met|0
2997571|NCT00960661|10315595|P2|Interventional Phase|entry criteria not met|3
2997572|NCT00960661|10315596|P1|Interventional Phase|entry criteria not met|0
2997573|NCT00960661|10315594|P3|Interventional Phase|Lost to Follow-up|2
2997574|NCT00960661|10315595|P2|Interventional Phase|Lost to Follow-up|0
2997575|NCT00960661|10315596|P1|Interventional Phase|Lost to Follow-up|0
2997576|NCT00960661|10315594|P3|Interventional Phase|Death|0
2997577|NCT00960661|10315595|P2|Interventional Phase|Death|1
2997578|NCT00960661|10315596|P1|Interventional Phase|Death|0
2997579|NCT00960661|10315594|P3|Interventional Phase|Adverse Event|8
2997580|NCT00960661|10315595|P2|Interventional Phase|Adverse Event|17
2997581|NCT00960661|10315596|P1|Interventional Phase|Adverse Event|0
2997582|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2997583|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2997584|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
2997585|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2997586|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2997587|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
2997588|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2997589|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2997590|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
2997591|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2997592|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2997593|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
2997594|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2997595|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2997596|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
2997597|NCT00960661|10315594|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2997598|NCT00960661|10315595|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2997599|NCT00960661|10315596|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
2997600|NCT00960570|10315635|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
2997601|NCT00960570|10315635|P1|1 Day Period Between Dosing|Adverse Event|2
2997602|NCT00960570|10315635|P1|21 Day Washout Period|Withdrawal by Subject|1
2997603|NCT00960570|10315635|P1|21 Day Washout Period|Adverse Event|1
2997604|NCT00960531|10315656|P10|Overall Study|Reason not Specified|1
2997605|NCT00960531|10315657|P9|Overall Study|Reason not Specified|8
2997606|NCT00960531|10315658|P8|Overall Study|Reason not Specified|0
2997607|NCT00960531|10315659|P7|Overall Study|Reason not Specified|16
2997608|NCT00960531|10315660|P6|Overall Study|Reason not Specified|0
2997609|NCT00960531|10315661|P5|Overall Study|Reason not Specified|2
2997610|NCT00960531|10315662|P4|Overall Study|Reason not Specified|1
2997611|NCT00960531|10315663|P3|Overall Study|Reason not Specified|13
2997612|NCT00960531|10315664|P2|Overall Study|Reason not Specified|1
2997613|NCT00960531|10315665|P1|Overall Study|Reason not Specified|2
2997614|NCT00960531|10315656|P10|Overall Study|Adverse Event (AE)|0
2997615|NCT00960531|10315657|P9|Overall Study|Adverse Event (AE)|2
2997616|NCT00960531|10315658|P8|Overall Study|Adverse Event (AE)|0
2997617|NCT00960531|10315659|P7|Overall Study|Adverse Event (AE)|2
2997618|NCT00960531|10315660|P6|Overall Study|Adverse Event (AE)|1
2997619|NCT00960531|10315661|P5|Overall Study|Adverse Event (AE)|0
2997620|NCT00960531|10315662|P4|Overall Study|Adverse Event (AE)|0
2997621|NCT00960531|10315663|P3|Overall Study|Adverse Event (AE)|0
2997622|NCT00960531|10315664|P2|Overall Study|Adverse Event (AE)|0
2997623|NCT00960531|10315665|P1|Overall Study|Adverse Event (AE)|2
2997624|NCT00960531|10315656|P10|Overall Study|Failed to Return|0
2997625|NCT00960531|10315657|P9|Overall Study|Failed to Return|0
2997626|NCT00960531|10315658|P8|Overall Study|Failed to Return|2
2997627|NCT00960531|10315659|P7|Overall Study|Failed to Return|0
2997628|NCT00960531|10315660|P6|Overall Study|Failed to Return|0
2997629|NCT00960531|10315661|P5|Overall Study|Failed to Return|0
2997630|NCT00960531|10315662|P4|Overall Study|Failed to Return|0
2997631|NCT00960531|10315663|P3|Overall Study|Failed to Return|0
2997632|NCT00960531|10315664|P2|Overall Study|Failed to Return|0
2997633|NCT00960531|10315665|P1|Overall Study|Failed to Return|2
2997634|NCT00960531|10315656|P10|Overall Study|Lost to Follow-up|0
2997635|NCT00960531|10315657|P9|Overall Study|Lost to Follow-up|0
2997636|NCT00960531|10315658|P8|Overall Study|Lost to Follow-up|0
2997637|NCT00960531|10315659|P7|Overall Study|Lost to Follow-up|1
2997638|NCT00960531|10315660|P6|Overall Study|Lost to Follow-up|0
2997639|NCT00960531|10315661|P5|Overall Study|Lost to Follow-up|0
2997640|NCT00960531|10315662|P4|Overall Study|Lost to Follow-up|0
2997641|NCT00960531|10315663|P3|Overall Study|Lost to Follow-up|1
2997642|NCT00960531|10315664|P2|Overall Study|Lost to Follow-up|0
2997643|NCT00960531|10315665|P1|Overall Study|Lost to Follow-up|0
2997644|NCT00960531|10315656|P10|Overall Study|Discontinuation of Study by Sponsor|0
2997645|NCT00960531|10315657|P9|Overall Study|Discontinuation of Study by Sponsor|0
2997646|NCT00960531|10315658|P8|Overall Study|Discontinuation of Study by Sponsor|1
2997647|NCT00960531|10315659|P7|Overall Study|Discontinuation of Study by Sponsor|0
2997648|NCT00960531|10315660|P6|Overall Study|Discontinuation of Study by Sponsor|0
2997649|NCT00960531|10315661|P5|Overall Study|Discontinuation of Study by Sponsor|0
2997650|NCT00960531|10315662|P4|Overall Study|Discontinuation of Study by Sponsor|0
2997651|NCT00960531|10315663|P3|Overall Study|Discontinuation of Study by Sponsor|0
2997652|NCT00960531|10315664|P2|Overall Study|Discontinuation of Study by Sponsor|0
2997653|NCT00960531|10315665|P1|Overall Study|Discontinuation of Study by Sponsor|0
2997654|NCT00960531|10315656|P10|Overall Study|Investigator Request|0
2997655|NCT00960531|10315657|P9|Overall Study|Investigator Request|0
2997656|NCT00960531|10315658|P8|Overall Study|Investigator Request|0
2997657|NCT00960531|10315659|P7|Overall Study|Investigator Request|0
2997658|NCT00960531|10315660|P6|Overall Study|Investigator Request|0
2997659|NCT00960531|10315661|P5|Overall Study|Investigator Request|0
2997660|NCT00960531|10315662|P4|Overall Study|Investigator Request|0
2997661|NCT00960531|10315663|P3|Overall Study|Investigator Request|1
2997662|NCT00960531|10315664|P2|Overall Study|Investigator Request|0
2997663|NCT00960531|10315665|P1|Overall Study|Investigator Request|0
2997664|NCT00960531|10315656|P10|Overall Study|Caregiver Request|0
2997665|NCT00960531|10315657|P9|Overall Study|Caregiver Request|3
2997666|NCT00960531|10315658|P8|Overall Study|Caregiver Request|1
2997667|NCT00960531|10315659|P7|Overall Study|Caregiver Request|3
2997668|NCT00960531|10315660|P6|Overall Study|Caregiver Request|2
2997669|NCT00960531|10315661|P5|Overall Study|Caregiver Request|0
2997670|NCT00960531|10315662|P4|Overall Study|Caregiver Request|5
2997671|NCT00960531|10315663|P3|Overall Study|Caregiver Request|6
2997672|NCT00960531|10315664|P2|Overall Study|Caregiver Request|0
2997673|NCT00960531|10315665|P1|Overall Study|Caregiver Request|2
2997674|NCT00960531|10315656|P10|Overall Study|Withdrawal by Subject|0
2997675|NCT00960531|10315657|P9|Overall Study|Withdrawal by Subject|1
2997676|NCT00960531|10315658|P8|Overall Study|Withdrawal by Subject|0
2997677|NCT00960531|10315659|P7|Overall Study|Withdrawal by Subject|2
2997678|NCT00960531|10315660|P6|Overall Study|Withdrawal by Subject|0
2997679|NCT00960531|10315661|P5|Overall Study|Withdrawal by Subject|0
2997680|NCT00960531|10315662|P4|Overall Study|Withdrawal by Subject|2
2997681|NCT00960531|10315663|P3|Overall Study|Withdrawal by Subject|5
2997682|NCT00960531|10315664|P2|Overall Study|Withdrawal by Subject|0
2997683|NCT00960531|10315665|P1|Overall Study|Withdrawal by Subject|1
2997684|NCT00960531|10315656|P10|Overall Study|Lack of Efficacy|0
2997685|NCT00960531|10315657|P9|Overall Study|Lack of Efficacy|0
2997686|NCT00960531|10315658|P8|Overall Study|Lack of Efficacy|0
2997687|NCT00960531|10315659|P7|Overall Study|Lack of Efficacy|0
2997688|NCT00960531|10315660|P6|Overall Study|Lack of Efficacy|0
2997689|NCT00960531|10315661|P5|Overall Study|Lack of Efficacy|0
2997690|NCT00960531|10315662|P4|Overall Study|Lack of Efficacy|0
2997691|NCT00960531|10315663|P3|Overall Study|Lack of Efficacy|0
2997692|NCT00960531|10315664|P2|Overall Study|Lack of Efficacy|0
2997693|NCT00960531|10315665|P1|Overall Study|Lack of Efficacy|1
2997694|NCT00960440|10315713|P4|Overall Study|Other|0
2997695|NCT00960440|10315714|P3|Overall Study|Other|1
2997696|NCT00960440|10315715|P2|Overall Study|Other|1
2997697|NCT00960440|10315716|P1|Overall Study|Other|1
2997698|NCT00960440|10315713|P4|Overall Study|Withdrawal by Subject|1
2997699|NCT00960440|10315714|P3|Overall Study|Withdrawal by Subject|2
2997700|NCT00960440|10315715|P2|Overall Study|Withdrawal by Subject|5
2997701|NCT00960440|10315716|P1|Overall Study|Withdrawal by Subject|9
2997702|NCT00960440|10315713|P4|Overall Study|Protocol Violation|4
2997703|NCT00960440|10315714|P3|Overall Study|Protocol Violation|3
2997704|NCT00960440|10315715|P2|Overall Study|Protocol Violation|8
2997705|NCT00960440|10315716|P1|Overall Study|Protocol Violation|2
2997706|NCT00960440|10315713|P4|Overall Study|Lack of Efficacy|8
2997707|NCT00960440|10315714|P3|Overall Study|Lack of Efficacy|3
2997708|NCT00960440|10315715|P2|Overall Study|Lack of Efficacy|5
2997709|NCT00960440|10315716|P1|Overall Study|Lack of Efficacy|2
2997710|NCT00960440|10315713|P4|Overall Study|Adverse Event|4
2997711|NCT00960440|10315714|P3|Overall Study|Adverse Event|4
2997712|NCT00960440|10315715|P2|Overall Study|Adverse Event|12
2997713|NCT00960440|10315716|P1|Overall Study|Adverse Event|12
2997714|NCT00960440|10315713|P4|Overall Study|Death|1
2997715|NCT00960440|10315714|P3|Overall Study|Death|0
2997716|NCT00960440|10315715|P2|Overall Study|Death|0
2997717|NCT00960440|10315716|P1|Overall Study|Death|0
2997718|NCT00960375|10315888|P2|Overall Study|Lost to Follow-up|22
2997719|NCT00960375|10315889|P1|Overall Study|Lost to Follow-up|20
2997720|NCT00960323|10315897|P1|Atorvastatin Alone|Withdrawal by Subject|1
2997721|NCT00960297|10315908|P1|Overall Study|Disease progression|1
2997722|NCT00960297|10315908|P1|Overall Study|Venous port infection|1
2997723|NCT00960297|10315908|P1|Overall Study|Physician Decision|1
2997724|NCT00960206|10315915|P3|Overall Study|Missing 10 year data|1
2997725|NCT00960206|10315916|P2|Overall Study|Missing 10 year data|1
2997726|NCT00960206|10315917|P1|Overall Study|Missing 10 year data|20
2997727|NCT00960206|10315915|P3|Overall Study|Revision of study component|2
2997728|NCT00960206|10315916|P2|Overall Study|Revision of study component|2
2997729|NCT00960206|10315917|P1|Overall Study|Revision of study component|2
2997730|NCT00960206|10315915|P3|Overall Study|Withdrawal by Subject|0
2997731|NCT00960206|10315916|P2|Overall Study|Withdrawal by Subject|4
2997732|NCT00960206|10315917|P1|Overall Study|Withdrawal by Subject|2
2997733|NCT00960206|10315915|P3|Overall Study|Lost to Follow-up|8
2997734|NCT00960206|10315916|P2|Overall Study|Lost to Follow-up|14
2997735|NCT00960206|10315917|P1|Overall Study|Lost to Follow-up|8
2997736|NCT00960206|10315915|P3|Overall Study|Unwilling/Unable to return|0
2997737|NCT00960206|10315916|P2|Overall Study|Unwilling/Unable to return|2
2997738|NCT00960206|10315917|P1|Overall Study|Unwilling/Unable to return|1
2997739|NCT00960206|10315915|P3|Overall Study|Death|1
2997740|NCT00960206|10315916|P2|Overall Study|Death|4
2997741|NCT00960206|10315917|P1|Overall Study|Death|7
2997742|NCT00960193|10315935|P1|14 Day Washout Period|Withdrawal by Subject|1
2997743|NCT00960154|10315948|P2|Overall Study|Study termination|25
2997744|NCT00960154|10315949|P1|Overall Study|Study termination|25
2997745|NCT00960141|10315960|P3|Overall Study|Withdrawal by Subject|1
2997746|NCT00960141|10315961|P2|Overall Study|Withdrawal by Subject|2
2997747|NCT00960141|10315962|P1|Overall Study|Withdrawal by Subject|1
2997748|NCT00960141|10315960|P3|Overall Study|Protocol Violation|2
2997749|NCT00960141|10315961|P2|Overall Study|Protocol Violation|3
2997750|NCT00960141|10315962|P1|Overall Study|Protocol Violation|1
2997751|NCT00960141|10315960|P3|Overall Study|Lost to Follow-up|0
2997752|NCT00960141|10315961|P2|Overall Study|Lost to Follow-up|0
2997753|NCT00960141|10315962|P1|Overall Study|Lost to Follow-up|1
2997754|NCT00960141|10315960|P3|Overall Study|Lack of Efficacy|2
2997755|NCT00960141|10315961|P2|Overall Study|Lack of Efficacy|4
2997756|NCT00960141|10315962|P1|Overall Study|Lack of Efficacy|3
2997757|NCT00960141|10315960|P3|Overall Study|Adverse Event|2
2997758|NCT00960141|10315961|P2|Overall Study|Adverse Event|8
2997759|NCT00960141|10315962|P1|Overall Study|Adverse Event|4
2997760|NCT00960115|10315987|P2|Overall Study|Ongoing treatment at data cut-off date|15
2997761|NCT00960115|10315988|P1|Overall Study|Ongoing treatment at data cut-off date|19
2997762|NCT00960076|10316002|P2|Overall Study|Did not attend the termination visit|1
2997763|NCT00960076|10316003|P1|Overall Study|Did not attend the termination visit|0
2997764|NCT00960076|10316002|P2|Overall Study|Hyperglycemia|5
2997765|NCT00960076|10316003|P1|Overall Study|Hyperglycemia|1
2997766|NCT00960076|10316002|P2|Overall Study|Severe non-compliance to protocol|2
2997767|NCT00960076|10316003|P1|Overall Study|Severe non-compliance to protocol|1
2997768|NCT00960076|10316002|P2|Overall Study|Lost to Follow-up|3
2997769|NCT00960076|10316003|P1|Overall Study|Lost to Follow-up|3
2997770|NCT00960076|10316002|P2|Overall Study|Withdrawal by Subject|2
2997771|NCT00960076|10316003|P1|Overall Study|Withdrawal by Subject|1
2997772|NCT00960076|10316002|P2|Overall Study|No longer met study criteria|5
2997773|NCT00960076|10316003|P1|Overall Study|No longer met study criteria|1
2997774|NCT00960076|10316002|P2|Overall Study|Adverse Event|7
2997775|NCT00960076|10316003|P1|Overall Study|Adverse Event|1
2997776|NCT00960063|10316018|P3|Overall Study|Progression of Disease|3
2997777|NCT00960063|10316019|P2|Overall Study|Progression of Disease|0
2997778|NCT00960063|10316020|P1|Overall Study|Progression of Disease|0
2997779|NCT00960063|10316018|P3|Overall Study|Adverse Event|0
2997780|NCT00960063|10316019|P2|Overall Study|Adverse Event|0
2997781|NCT00960063|10316020|P1|Overall Study|Adverse Event|1
2997782|NCT00960011|10316060|P2|Overall Study|Lost to Follow-up|2
2997783|NCT00960011|10316061|P1|Overall Study|Lost to Follow-up|6
2997784|NCT00960011|10316060|P2|Overall Study|Death|0
2997785|NCT00960011|10316061|P1|Overall Study|Death|5
2997786|NCT00959946|10316154|P8|Overall Study|Withdrawal by Subject|0
2997787|NCT00959946|10316155|P7|Overall Study|Withdrawal by Subject|0
2997788|NCT00959946|10316156|P6|Overall Study|Withdrawal by Subject|1
2997789|NCT00959946|10316157|P5|Overall Study|Withdrawal by Subject|0
2997790|NCT00959946|10316158|P4|Overall Study|Withdrawal by Subject|0
2997791|NCT00959946|10316159|P3|Overall Study|Withdrawal by Subject|0
2997792|NCT00959946|10316160|P2|Overall Study|Withdrawal by Subject|0
2997793|NCT00959946|10316161|P1|Overall Study|Withdrawal by Subject|0
2997794|NCT00959946|10316154|P8|Overall Study|Disease Progression|2
2997795|NCT00959946|10316155|P7|Overall Study|Disease Progression|2
2997796|NCT00959946|10316156|P6|Overall Study|Disease Progression|6
2997797|NCT00959946|10316157|P5|Overall Study|Disease Progression|4
2997798|NCT00959946|10316158|P4|Overall Study|Disease Progression|4
2997799|NCT00959946|10316159|P3|Overall Study|Disease Progression|2
2997800|NCT00959946|10316160|P2|Overall Study|Disease Progression|4
2997801|NCT00959946|10316161|P1|Overall Study|Disease Progression|2
2997802|NCT00959946|10316154|P8|Overall Study|Death|0
2997803|NCT00959946|10316155|P7|Overall Study|Death|0
2997804|NCT00959946|10316156|P6|Overall Study|Death|1
2997805|NCT00959946|10316157|P5|Overall Study|Death|0
2997806|NCT00959946|10316158|P4|Overall Study|Death|0
2997807|NCT00959946|10316159|P3|Overall Study|Death|0
2997808|NCT00959946|10316160|P2|Overall Study|Death|0
2997809|NCT00959946|10316161|P1|Overall Study|Death|0
2997810|NCT00959946|10316154|P8|Overall Study|Adverse Event|0
2997811|NCT00959946|10316155|P7|Overall Study|Adverse Event|0
2997812|NCT00959946|10316156|P6|Overall Study|Adverse Event|1
2997813|NCT00959946|10316157|P5|Overall Study|Adverse Event|0
2997814|NCT00959946|10316158|P4|Overall Study|Adverse Event|1
2997815|NCT00959946|10316159|P3|Overall Study|Adverse Event|2
2997816|NCT00959946|10316160|P2|Overall Study|Adverse Event|0
2997817|NCT00959946|10316161|P1|Overall Study|Adverse Event|0
2997818|NCT00959907|10316225|P2|Overall Study|Withdrawal by Subject|0
2997819|NCT00959907|10316226|P1|Overall Study|Withdrawal by Subject|2
2997820|NCT00959907|10316225|P2|Overall Study|Adverse Event|0
2997821|NCT00959907|10316226|P1|Overall Study|Adverse Event|1
2997822|NCT00959907|10316225|P2|Overall Study|Protocol Violation|1
2997823|NCT00959907|10316226|P1|Overall Study|Protocol Violation|0
2997824|NCT00959894|10316236|P1|Overall Study|Subject moved out of town|1
2997825|NCT00959894|10316236|P1|Overall Study|Need for contraindicated medication|1
2997826|NCT00959894|10316236|P1|Overall Study|Withdrawal by Subject|1
2997827|NCT00959894|10316236|P1|Overall Study|Adverse Event|3
2997828|NCT00959894|10316236|P1|Overall Study|Lost to Follow-up|10
2997829|NCT00959751|10316285|P2|Overall Study|No migraine headache without aura|7
2997830|NCT00959751|10316286|P1|Overall Study|No migraine headache without aura|7
2997831|NCT00959751|10316285|P2|Overall Study|Non-compliance to Study Procedures|1
2997832|NCT00959751|10316286|P1|Overall Study|Non-compliance to Study Procedures|0
2997833|NCT00959751|10316285|P2|Overall Study|Consent Withdrawn|1
2997834|NCT00959751|10316286|P1|Overall Study|Consent Withdrawn|0
2997835|NCT00959751|10316285|P2|Overall Study|Lost to Follow-up|3
2997836|NCT00959751|10316286|P1|Overall Study|Lost to Follow-up|2
2997837|NCT00959699|10316308|P2|Follow-up Period|Withdrawal by Subject|4
2997838|NCT00959699|10316309|P1|Follow-up Period|Withdrawal by Subject|3
2997839|NCT00959699|10316308|P2|Follow-up Period|Lost to Follow-up|2
2997840|NCT00959699|10316309|P1|Follow-up Period|Lost to Follow-up|3
2997841|NCT00959699|10316308|P2|Treatment Period|Futility/crossover to boceprevir|0
2997842|NCT00959699|10316309|P1|Treatment Period|Futility/crossover to boceprevir|4
2997843|NCT00959699|10316308|P2|Treatment Period|Did not receive treatment|1
2997844|NCT00959699|10316309|P1|Treatment Period|Did not receive treatment|0
2997845|NCT00959699|10316308|P2|Treatment Period|Non-Compliance with Protocol|1
2997846|NCT00959699|10316309|P1|Treatment Period|Non-Compliance with Protocol|0
2997847|NCT00959699|10316308|P2|Treatment Period|Withdrawal by Subject|3
2997848|NCT00959699|10316309|P1|Treatment Period|Withdrawal by Subject|1
2997849|NCT00959699|10316308|P2|Treatment Period|Lost to Follow-up|1
2997850|NCT00959699|10316309|P1|Treatment Period|Lost to Follow-up|0
2997851|NCT00959699|10316308|P2|Treatment Period|Lack of Efficacy|6
2997852|NCT00959699|10316309|P1|Treatment Period|Lack of Efficacy|15
2997853|NCT00959699|10316308|P2|Treatment Period|Adverse Event|13
2997854|NCT00959699|10316309|P1|Treatment Period|Adverse Event|3
2997855|NCT00959647|10316355|P1|Overall Study|Withdrawal by Subject|7
2997856|NCT00959647|10316355|P1|Overall Study|Study terminated by sponsor|4
2997857|NCT00959647|10316355|P1|Overall Study|Progressive disease|6
2997858|NCT00959647|10316355|P1|Overall Study|Adverse Event|2
2997859|NCT00959374|10316360|P1|Overall Study|Physician Decision|1
2997860|NCT00959374|10316360|P1|Overall Study|Implant Removed/Not Replaced|4
2997861|NCT00959374|10316360|P1|Overall Study|Protocol Violation|1
2997862|NCT00959374|10316360|P1|Overall Study|Death|1
2997863|NCT00959374|10316360|P1|Overall Study|Lost to Follow-up|14
2997864|NCT00959374|10316360|P1|Overall Study|Withdrawal by Subject|2
2997865|NCT00959192|10316374|P4|Overall Study|Caregiver Request|1
2997866|NCT00959192|10316375|P3|Overall Study|Caregiver Request|2
2997867|NCT00959192|10316376|P2|Overall Study|Caregiver Request|0
2997868|NCT00959192|10316377|P1|Overall Study|Caregiver Request|0
2997869|NCT00959192|10316374|P4|Overall Study|Investigator Request|0
2997870|NCT00959192|10316375|P3|Overall Study|Investigator Request|0
2997871|NCT00959192|10316376|P2|Overall Study|Investigator Request|0
2997872|NCT00959192|10316377|P1|Overall Study|Investigator Request|1
2997873|NCT00959192|10316374|P4|Overall Study|Adverse Event|0
2997874|NCT00959192|10316375|P3|Overall Study|Adverse Event|1
2997875|NCT00959192|10316376|P2|Overall Study|Adverse Event|1
2997876|NCT00959192|10316377|P1|Overall Study|Adverse Event|1
2997877|NCT00959049|10316436|P6|Overall Study|Withdrawal by Subject|0
2997878|NCT00959049|10316437|P5|Overall Study|Withdrawal by Subject|0
2997879|NCT00959049|10316438|P4|Overall Study|Withdrawal by Subject|0
2997880|NCT00959049|10316439|P3|Overall Study|Withdrawal by Subject|0
2997881|NCT00959049|10316440|P2|Overall Study|Withdrawal by Subject|2
2997882|NCT00959049|10316441|P1|Overall Study|Withdrawal by Subject|0
2997883|NCT00959049|10316436|P6|Overall Study|Contraindicated medication|0
2997884|NCT00959049|10316437|P5|Overall Study|Contraindicated medication|0
2997885|NCT00959049|10316438|P4|Overall Study|Contraindicated medication|1
2997886|NCT00959049|10316439|P3|Overall Study|Contraindicated medication|0
2997887|NCT00959049|10316440|P2|Overall Study|Contraindicated medication|0
2997888|NCT00959049|10316441|P1|Overall Study|Contraindicated medication|0
2997889|NCT00959049|10316436|P6|Overall Study|Lost to Follow-up|1
2997890|NCT00959049|10316437|P5|Overall Study|Lost to Follow-up|9
2997891|NCT00959049|10316438|P4|Overall Study|Lost to Follow-up|10
2997892|NCT00959049|10316439|P3|Overall Study|Lost to Follow-up|1
2997893|NCT00959049|10316440|P2|Overall Study|Lost to Follow-up|5
2997894|NCT00959049|10316441|P1|Overall Study|Lost to Follow-up|17
2997895|NCT00959049|10316436|P6|Overall Study|Adverse Event|0
2997896|NCT00959049|10316437|P5|Overall Study|Adverse Event|0
2997897|NCT00959049|10316438|P4|Overall Study|Adverse Event|0
2997898|NCT00959049|10316439|P3|Overall Study|Adverse Event|0
2997899|NCT00959049|10316440|P2|Overall Study|Adverse Event|0
2997900|NCT00959049|10316441|P1|Overall Study|Adverse Event|1
2997901|NCT00958893|10316506|P1|Overall Study|Study prematurely terminated|4
2997902|NCT00958880|10316512|P2|Overall Study|Lost to Follow-up|2
2997903|NCT00958880|10316513|P1|Overall Study|Lost to Follow-up|2
2997904|NCT00958841|10316521|P1|Overall Study|Discontinued prior to M*|28
2997905|NCT00958841|10316521|P1|Overall Study|Completed M6/did not enter extension|27
2997906|NCT00958841|10316521|P1|Overall Study|Unsatisfactory therapeutic effect|22
2997907|NCT00958841|10316521|P1|Overall Study|Withdrawal by Subject|1
2997908|NCT00958841|10316521|P1|Overall Study|New cancer therapy|5
2997909|NCT00958841|10316521|P1|Overall Study|Adverse Event|8
2997910|NCT00958841|10316521|P1|Overall Study|Administrative problems|1
2997911|NCT00958841|10316521|P1|Overall Study|Abnormal test procedure result(s)|3
2997912|NCT00958841|10316521|P1|Overall Study|Abnormal laboratory value(s)|1
2997913|NCT00958828|10316539|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
2997914|NCT00958828|10316540|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
2997915|NCT00958828|10316539|P2|Period 1, 1 Week of Wear|Randomization break|1
2997916|NCT00958828|10316540|P1|Period 1, 1 Week of Wear|Randomization break|0
2997917|NCT00958789|10316546|P1|Overall Study|Revision|7
2997918|NCT00958789|10316546|P1|Overall Study|Subject terminated|2
2997919|NCT00958789|10316546|P1|Overall Study|2 yr. Knee Society Score not calculable|1
2997920|NCT00958789|10316546|P1|Overall Study|No 2 yr. Knee Society Score data|4
2997921|NCT00958789|10316546|P1|Overall Study|Withdrawal by Subject|17
2997922|NCT00958789|10316546|P1|Overall Study|Lost to Follow-up|14
2997923|NCT00958789|10316546|P1|Overall Study|Death|5
2997924|NCT00958776|10316566|P2|Overall Study|Missing|1
2997925|NCT00958776|10316567|P1|Overall Study|Missing|1
2997926|NCT00958776|10316566|P2|Overall Study|Noncompliance; Protocol Deviations|3
2997927|NCT00958776|10316567|P1|Overall Study|Noncompliance; Protocol Deviations|2
2997928|NCT00958776|10316566|P2|Overall Study|Death|1
2997929|NCT00958776|10316567|P1|Overall Study|Death|2
2997930|NCT00958776|10316566|P2|Overall Study|Protocol Violation|1
2997931|NCT00958776|10316567|P1|Overall Study|Protocol Violation|1
2997932|NCT00958776|10316566|P2|Overall Study|Withdrawal by Subject|16
2997933|NCT00958776|10316567|P1|Overall Study|Withdrawal by Subject|7
2997934|NCT00958776|10316566|P2|Overall Study|Lost to Follow-up|6
2997935|NCT00958776|10316567|P1|Overall Study|Lost to Follow-up|2
2997936|NCT00958776|10316566|P2|Overall Study|Physician Decision|0
2997937|NCT00958776|10316567|P1|Overall Study|Physician Decision|1
2997938|NCT00958776|10316566|P2|Overall Study|Adverse Event|1
2997939|NCT00958776|10316567|P1|Overall Study|Adverse Event|0
2997940|NCT00958724|10316597|P1|Overall Study|Disease Progression|6
2997941|NCT00958711|10316609|P2|Overall Study|Adverse Event|2
2997942|NCT00958711|10316610|P1|Overall Study|Adverse Event|1
2997943|NCT00958711|10316609|P2|Overall Study|Death|2
2997944|NCT00958711|10316610|P1|Overall Study|Death|1
2997945|NCT00958711|10316609|P2|Overall Study|Other|5
2997946|NCT00958711|10316610|P1|Overall Study|Other|2
2997947|NCT00958711|10316609|P2|Overall Study|Lost to Follow-up|1
2997948|NCT00958711|10316610|P1|Overall Study|Lost to Follow-up|4
2997949|NCT00958711|10316609|P2|Overall Study|Physician Decision|7
2997950|NCT00958711|10316610|P1|Overall Study|Physician Decision|5
2997951|NCT00958711|10316609|P2|Overall Study|Withdrawal by Subject|4
2997952|NCT00958711|10316610|P1|Overall Study|Withdrawal by Subject|0
2997953|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2997954|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
2997955|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2997956|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2997957|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2997958|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
2997959|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2997960|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2997961|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
2997962|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
2997963|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2997964|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2997965|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
2997966|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
2997967|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2997968|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2997969|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
2997970|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
2997971|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2997972|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2997973|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
2997974|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
2997975|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2997976|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2997977|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
2997978|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
2997979|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2997980|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2997981|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
2997982|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
2997983|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2997984|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2997985|NCT00958568|10316655|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
2997986|NCT00958568|10316656|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
2997987|NCT00958568|10316657|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2997988|NCT00958568|10316658|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2997989|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2997990|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2997991|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
2997992|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2997993|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2997994|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2997995|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
2997996|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2997997|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2997998|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2997999|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
2998000|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2998001|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2998002|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2998003|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
2998004|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2998005|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2998006|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2998007|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
2998008|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2998009|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2998010|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2998011|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
2998012|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2998013|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2998014|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2998015|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
2998016|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2998017|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2998018|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2998019|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
2998020|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2998021|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2998022|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2998023|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
2998024|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2998025|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2998026|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2998027|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
2998028|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2998029|NCT00958568|10316655|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2998030|NCT00958568|10316656|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2998031|NCT00958568|10316657|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
2998032|NCT00958568|10316658|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2998033|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2998034|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2998035|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2998036|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
2998037|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2998038|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2998039|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2998040|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
2998041|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2998042|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2998043|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2998044|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
2998045|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2998046|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2998047|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2998048|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
2998049|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2998050|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2998051|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2998052|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
2998053|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2998054|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2998055|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2998056|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
2998057|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2998058|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2998059|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2998060|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
2998061|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2998062|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2998063|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2998064|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
2998065|NCT00958568|10316655|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2998066|NCT00958568|10316656|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2998067|NCT00958568|10316657|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2998068|NCT00958568|10316658|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
2998069|NCT00958438|10316895|P3|Overall Study|Other than specified above|2
2998070|NCT00958438|10316896|P2|Overall Study|Other than specified above|3
2998071|NCT00958438|10316897|P1|Overall Study|Other than specified above|2
2998072|NCT00958438|10316895|P3|Overall Study|Physician Decision|1
2998073|NCT00958438|10316896|P2|Overall Study|Physician Decision|0
2998074|NCT00958438|10316897|P1|Overall Study|Physician Decision|1
2998075|NCT00958438|10316895|P3|Overall Study|Adverse Event|0
2998076|NCT00958438|10316896|P2|Overall Study|Adverse Event|3
2998077|NCT00958438|10316897|P1|Overall Study|Adverse Event|0
2998078|NCT00958438|10316895|P3|Overall Study|Withdrawal by Subject|1
2998079|NCT00958438|10316896|P2|Overall Study|Withdrawal by Subject|2
2998080|NCT00958438|10316897|P1|Overall Study|Withdrawal by Subject|4
2998081|NCT00958438|10316895|P3|Overall Study|Protocol Violation|2
2998082|NCT00958438|10316896|P2|Overall Study|Protocol Violation|2
2998083|NCT00958438|10316897|P1|Overall Study|Protocol Violation|3
2998084|NCT00958412|10316920|P1|Overall Study|Study prematurely terminated|18
2998085|NCT00958360|10316926|P2|Overall Study|Lost to Follow-up|1
2998086|NCT00958360|10316927|P1|Overall Study|Lost to Follow-up|0
2998087|NCT00958360|10316926|P2|Overall Study|Physician Decision|1
2998088|NCT00958360|10316927|P1|Overall Study|Physician Decision|2
2998089|NCT00958360|10316926|P2|Overall Study|Death|7
2998090|NCT00958360|10316927|P1|Overall Study|Death|6
2998091|NCT00958360|10316926|P2|Overall Study|Withdrawal by Subject|1
2998092|NCT00958360|10316927|P1|Overall Study|Withdrawal by Subject|3
2998093|NCT00958347|10316941|P1|Overall Study|study termination|135
2998094|NCT00958347|10316941|P1|Overall Study|revision/removal|10
2998095|NCT00958347|10316941|P1|Overall Study|Lost to Follow-up|15
2998096|NCT00958347|10316941|P1|Overall Study|Withdrawal by Subject|23
2998097|NCT00958347|10316941|P1|Overall Study|Death|43
2998098|NCT00958256|10316985|P1|Overall Study|Adverse Event|3
2998099|NCT00958243|10316995|P6|Overall Study|Lost to Follow-up|5
2998100|NCT00958243|10316996|P5|Overall Study|Lost to Follow-up|8
2998101|NCT00958243|10316997|P4|Overall Study|Lost to Follow-up|2
2998102|NCT00958243|10316998|P3|Overall Study|Lost to Follow-up|11
2998103|NCT00958243|10316999|P2|Overall Study|Lost to Follow-up|5
2998104|NCT00958243|10317000|P1|Overall Study|Lost to Follow-up|2
2998105|NCT00958243|10316995|P6|Overall Study|Withdrawal by Subject|5
2998106|NCT00958243|10316996|P5|Overall Study|Withdrawal by Subject|1
2998107|NCT00958243|10316997|P4|Overall Study|Withdrawal by Subject|1
2998108|NCT00958243|10316998|P3|Overall Study|Withdrawal by Subject|3
2998109|NCT00958243|10316999|P2|Overall Study|Withdrawal by Subject|1
2998110|NCT00958243|10317000|P1|Overall Study|Withdrawal by Subject|0
2998111|NCT00958217|10317058|P2|Overall Study|Inpatient hospitalization|1
2998112|NCT00958217|10317059|P1|Overall Study|Inpatient hospitalization|0
2998113|NCT00958217|10317058|P2|Overall Study|Moved out of area|1
2998114|NCT00958217|10317059|P1|Overall Study|Moved out of area|1
2998115|NCT00958217|10317058|P2|Overall Study|Lost to Follow-up|19
2998116|NCT00958217|10317059|P1|Overall Study|Lost to Follow-up|17
2998117|NCT00958217|10317058|P2|Overall Study|Withdrawal by Subject|3
2998118|NCT00958217|10317059|P1|Overall Study|Withdrawal by Subject|4
2998119|NCT00958217|10317058|P2|Overall Study|Death|1
2998120|NCT00958217|10317059|P1|Overall Study|Death|2
2998121|NCT00958191|10317070|P1|Overall Study|No 5 yr x-rays|56
2998122|NCT00958191|10317070|P1|Overall Study|Site termination|11
2998123|NCT00958191|10317070|P1|Overall Study|Revision of study device|4
2998124|NCT00958191|10317070|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
2998125|NCT00958191|10317070|P1|Overall Study|Inadequate 5 yr x-ray quality|10
2998126|NCT00958191|10317070|P1|Overall Study|Lost to Follow-up|5
2998127|NCT00958191|10317070|P1|Overall Study|Death|4
2998128|NCT00958165|10317085|P1|Overall Study|Not eligible|9
2998129|NCT00958165|10317085|P1|Overall Study|Lost to Follow-up|5
2998130|NCT00958126|10317097|P8|Overall Study|Other Reason|0
2998131|NCT00958126|10317098|P7|Overall Study|Other Reason|0
2998132|NCT00958126|10317099|P6|Overall Study|Other Reason|1
2998133|NCT00958126|10317100|P5|Overall Study|Other Reason|0
2998134|NCT00958126|10317101|P4|Overall Study|Other Reason|1
2998135|NCT00958126|10317102|P3|Overall Study|Other Reason|0
2998136|NCT00958126|10317103|P2|Overall Study|Other Reason|0
2998137|NCT00958126|10317104|P1|Overall Study|Other Reason|0
2998138|NCT00958126|10317097|P8|Overall Study|Sponsor/Investigator decision|0
2998139|NCT00958126|10317098|P7|Overall Study|Sponsor/Investigator decision|0
2998140|NCT00958126|10317099|P6|Overall Study|Sponsor/Investigator decision|0
2998141|NCT00958126|10317100|P5|Overall Study|Sponsor/Investigator decision|0
2998142|NCT00958126|10317101|P4|Overall Study|Sponsor/Investigator decision|1
2998143|NCT00958126|10317102|P3|Overall Study|Sponsor/Investigator decision|0
2998144|NCT00958126|10317103|P2|Overall Study|Sponsor/Investigator decision|0
2998145|NCT00958126|10317104|P1|Overall Study|Sponsor/Investigator decision|0
2998146|NCT00958126|10317097|P8|Overall Study|Lost to Follow-up|0
2998147|NCT00958126|10317098|P7|Overall Study|Lost to Follow-up|0
2998148|NCT00958126|10317099|P6|Overall Study|Lost to Follow-up|0
2998149|NCT00958126|10317100|P5|Overall Study|Lost to Follow-up|0
2998150|NCT00958126|10317101|P4|Overall Study|Lost to Follow-up|8
2998151|NCT00958126|10317102|P3|Overall Study|Lost to Follow-up|9
2998152|NCT00958126|10317103|P2|Overall Study|Lost to Follow-up|5
2998153|NCT00958126|10317104|P1|Overall Study|Lost to Follow-up|1
2998154|NCT00958126|10317097|P8|Overall Study|Moved away from study area|0
2998155|NCT00958126|10317098|P7|Overall Study|Moved away from study area|0
2998156|NCT00958126|10317099|P6|Overall Study|Moved away from study area|0
2998157|NCT00958126|10317100|P5|Overall Study|Moved away from study area|0
2998158|NCT00958126|10317101|P4|Overall Study|Moved away from study area|1
2998159|NCT00958126|10317102|P3|Overall Study|Moved away from study area|1
2998160|NCT00958126|10317103|P2|Overall Study|Moved away from study area|0
2998161|NCT00958126|10317104|P1|Overall Study|Moved away from study area|0
2998162|NCT00958126|10317097|P8|Overall Study|Withdrawal by Subject|0
2998163|NCT00958126|10317098|P7|Overall Study|Withdrawal by Subject|0
2998164|NCT00958126|10317099|P6|Overall Study|Withdrawal by Subject|0
2998165|NCT00958126|10317100|P5|Overall Study|Withdrawal by Subject|0
2998166|NCT00958126|10317101|P4|Overall Study|Withdrawal by Subject|0
2998167|NCT00958126|10317102|P3|Overall Study|Withdrawal by Subject|0
2998168|NCT00958126|10317103|P2|Overall Study|Withdrawal by Subject|2
2998169|NCT00958126|10317104|P1|Overall Study|Withdrawal by Subject|0
2998170|NCT00958126|10317097|P8|Overall Study|Serious Adverse Event|0
2998171|NCT00958126|10317098|P7|Overall Study|Serious Adverse Event|1
2998172|NCT00958126|10317099|P6|Overall Study|Serious Adverse Event|0
2998173|NCT00958126|10317100|P5|Overall Study|Serious Adverse Event|0
2998174|NCT00958126|10317101|P4|Overall Study|Serious Adverse Event|0
2998175|NCT00958126|10317102|P3|Overall Study|Serious Adverse Event|0
2998176|NCT00958126|10317103|P2|Overall Study|Serious Adverse Event|2
2998177|NCT00958126|10317104|P1|Overall Study|Serious Adverse Event|0
2998178|NCT00958074|10317176|P2|Overall Study|Withdrawal by Subject|1
2998179|NCT00958074|10317177|P1|Overall Study|Withdrawal by Subject|0
2998180|NCT00958009|10317200|P1|Overall Study|Subject found device difficult to use|1
2998181|NCT00958009|10317200|P1|Overall Study|Adverse Event|1
2998182|NCT00957996|10317207|P2|Overall Study|Noncompliance; Protocol Deviations|6
2998183|NCT00957996|10317208|P1|Overall Study|Noncompliance; Protocol Deviations|5
2998184|NCT00957996|10317207|P2|Overall Study|Missing|0
2998185|NCT00957996|10317208|P1|Overall Study|Missing|1
2998186|NCT00957996|10317207|P2|Overall Study|Influenza-related complication|1
2998187|NCT00957996|10317208|P1|Overall Study|Influenza-related complication|0
2998188|NCT00957996|10317207|P2|Overall Study|Physician Decision|1
2998189|NCT00957996|10317208|P1|Overall Study|Physician Decision|1
2998190|NCT00957996|10317207|P2|Overall Study|Adverse Event|1
2998191|NCT00957996|10317208|P1|Overall Study|Adverse Event|2
2998192|NCT00957996|10317207|P2|Overall Study|Withdrawal by Subject|2
2998193|NCT00957996|10317208|P1|Overall Study|Withdrawal by Subject|9
2998194|NCT00957996|10317207|P2|Overall Study|Lost to Follow-up|7
2998195|NCT00957996|10317208|P1|Overall Study|Lost to Follow-up|4
2998196|NCT00957996|10317207|P2|Overall Study|Death|10
2998197|NCT00957996|10317208|P1|Overall Study|Death|4
2998198|NCT00957944|10317240|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
2998199|NCT00957944|10317241|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
2998200|NCT00957931|10317275|P1|Overall Study|Death|4
2998201|NCT00957905|10317285|P2|Part B|Protocol Violation|1
2998202|NCT00957905|10317286|P1|Part B|Protocol Violation|0
2998203|NCT00957905|10317285|P2|Part B|Death|1
2998204|NCT00957905|10317286|P1|Part B|Death|0
2998205|NCT00957905|10317285|P2|Part B|Physician Decision|1
2998206|NCT00957905|10317286|P1|Part B|Physician Decision|0
2998207|NCT00957905|10317285|P2|Part B|Not Treated|1
2998208|NCT00957905|10317286|P1|Part B|Not Treated|0
2998209|NCT00957853|10317295|P3|Overall Study|Withdrawal by Subject|0
2998210|NCT00957853|10317296|P2|Overall Study|Withdrawal by Subject|0
2998211|NCT00957853|10317297|P1|Overall Study|Withdrawal by Subject|1
2998212|NCT00957801|10317321|P4|Overall Study|Withdrawal by Subject|1
2998213|NCT00957801|10317322|P3|Overall Study|Withdrawal by Subject|0
2998214|NCT00957801|10317323|P2|Overall Study|Withdrawal by Subject|0
2998215|NCT00957801|10317324|P1|Overall Study|Withdrawal by Subject|0
2998216|NCT00957723|10317490|P1|Overall Study|2yr ROM Data Not Evaluable|12
2998217|NCT00957723|10317490|P1|Overall Study|Intercurrent Illness|2
2998218|NCT00957723|10317490|P1|Overall Study|Investigative Site Terminated|61
2998219|NCT00957723|10317490|P1|Overall Study|Withdrawal by Subject|24
2998220|NCT00957723|10317490|P1|Overall Study|Lost to Follow-up|8
2998221|NCT00957723|10317490|P1|Overall Study|Revision/ Removal of Study Implant|3
2998222|NCT00957723|10317490|P1|Overall Study|Death|3
2998223|NCT00957658|10317579|P1|Overall Study|Protocol Violation|5
2998224|NCT00957658|10317579|P1|Overall Study|surgery cancelled|2
2998225|NCT00957658|10317579|P1|Overall Study|unwilling/unable to return|2
2998226|NCT00957658|10317579|P1|Overall Study|Site termination|10
2998227|NCT00957658|10317579|P1|Overall Study|Incomplete 2 yr data|28
2998228|NCT00957658|10317579|P1|Overall Study|Revision|1
2998229|NCT00957658|10317579|P1|Overall Study|Withdrawal by Subject|12
2998230|NCT00957658|10317579|P1|Overall Study|Lost to Follow-up|4
2998231|NCT00957658|10317579|P1|Overall Study|Death|1
2998232|NCT00957580|10317606|P3|Overall Study|Enrolled but not treated|0
2998233|NCT00957580|10317607|P2|Overall Study|Enrolled but not treated|1
2998234|NCT00957580|10317608|P1|Overall Study|Enrolled but not treated|0
2998235|NCT00957580|10317606|P3|Overall Study|Ongoing at data cut-off|0
2998236|NCT00957580|10317607|P2|Overall Study|Ongoing at data cut-off|1
2998237|NCT00957580|10317608|P1|Overall Study|Ongoing at data cut-off|0
2998238|NCT00957528|10317755|P3|Overall Study|Withdrawal by Subject|1
2998239|NCT00957528|10317756|P2|Overall Study|Withdrawal by Subject|0
2998240|NCT00957528|10317757|P1|Overall Study|Withdrawal by Subject|0
2998241|NCT00957528|10317755|P3|Overall Study|Protocol Violation|0
2998242|NCT00957528|10317756|P2|Overall Study|Protocol Violation|1
2998243|NCT00957528|10317757|P1|Overall Study|Protocol Violation|0
2998244|NCT00957424|10317780|P1|Overall Study|Withdrawal by Subject|1
2998245|NCT00957424|10317780|P1|Overall Study|Protocol Violation|3
2998246|NCT00957424|10317780|P1|Overall Study|Lost to Follow-up|19
2998247|NCT00957372|10317790|P4|PART II|Patient non-compliance|4
2998248|NCT00957372|10317791|P3|PART II|Patient non-compliance|0
2998249|NCT00957372|10317792|P2|PART II|Patient non-compliance|0
2998250|NCT00957372|10317793|P1|PART II|Patient non-compliance|0
2998251|NCT00957372|10317790|P4|PART II|Adverse Event|10
2998252|NCT00957372|10317791|P3|PART II|Adverse Event|0
2998253|NCT00957372|10317792|P2|PART II|Adverse Event|0
2998254|NCT00957372|10317793|P1|PART II|Adverse Event|0
2998255|NCT00957372|10317790|P4|PART II|Not Know|20
2998256|NCT00957372|10317791|P3|PART II|Not Know|0
2998257|NCT00957372|10317792|P2|PART II|Not Know|0
2998258|NCT00957372|10317793|P1|PART II|Not Know|0
2998259|NCT00957372|10317790|P4|PART II|Pregnancy|1
2998260|NCT00957372|10317791|P3|PART II|Pregnancy|0
2998261|NCT00957372|10317792|P2|PART II|Pregnancy|0
2998262|NCT00957372|10317793|P1|PART II|Pregnancy|0
2998263|NCT00957372|10317790|P4|PART II|Physician Decision|1
2998264|NCT00957372|10317791|P3|PART II|Physician Decision|0
2998265|NCT00957372|10317792|P2|PART II|Physician Decision|0
2998266|NCT00957372|10317793|P1|PART II|Physician Decision|0
2998267|NCT00957372|10317790|P4|PART II|Withdrawal by Subject|8
2998268|NCT00957372|10317791|P3|PART II|Withdrawal by Subject|0
2998269|NCT00957372|10317792|P2|PART II|Withdrawal by Subject|0
2998270|NCT00957372|10317793|P1|PART II|Withdrawal by Subject|0
2998271|NCT00957372|10317790|P4|PART I|Lost to Follow-up|0
2998272|NCT00957372|10317791|P3|PART I|Lost to Follow-up|1
2998273|NCT00957372|10317792|P2|PART I|Lost to Follow-up|0
2998274|NCT00957372|10317793|P1|PART I|Lost to Follow-up|0
2998275|NCT00957268|10317933|P5|Overall Study|Voluntary Withdrawal|0
2998276|NCT00957268|10317934|P4|Overall Study|Voluntary Withdrawal|0
2998277|NCT00957268|10317935|P3|Overall Study|Voluntary Withdrawal|1
2998278|NCT00957268|10317936|P2|Overall Study|Voluntary Withdrawal|0
2998279|NCT00957268|10317937|P1|Overall Study|Voluntary Withdrawal|0
2998280|NCT00957034|10318059|P3|Overall Study|Withdrawal by Subject|0
2998281|NCT00957034|10318060|P2|Overall Study|Withdrawal by Subject|2
2998282|NCT00957034|10318061|P1|Overall Study|Withdrawal by Subject|0
2998283|NCT00957034|10318059|P3|Overall Study|Sponsor Terminated Study|5
2998284|NCT00957034|10318060|P2|Overall Study|Sponsor Terminated Study|1
2998285|NCT00957034|10318061|P1|Overall Study|Sponsor Terminated Study|6
2998286|NCT00957034|10318059|P3|Overall Study|Adverse Event|1
2998287|NCT00957034|10318060|P2|Overall Study|Adverse Event|1
2998288|NCT00957034|10318061|P1|Overall Study|Adverse Event|0
2998289|NCT00957021|10318084|P1|Overall Study|Termination due to language issue|2
2998290|NCT00957021|10318084|P1|Overall Study|Surgery Cancelled|9
2998291|NCT00957021|10318084|P1|Overall Study|Site Termination by the 2 yr visit|16
2998292|NCT00957021|10318084|P1|Overall Study|Revised study component by 2 yr visit|8
2998293|NCT00957021|10318084|P1|Overall Study|No 2 yr ROM data|35
2998294|NCT00957021|10318084|P1|Overall Study|Withdrawal by Subject|34
2998295|NCT00957021|10318084|P1|Overall Study|Lost to Follow-up|8
2998296|NCT00957021|10318084|P1|Overall Study|Death|5
2998297|NCT00957008|10318097|P4|Overall Study|Relocated; Family conflict|3
2998298|NCT00957008|10318098|P3|Overall Study|Relocated; Family conflict|1
2998299|NCT00957008|10318099|P2|Overall Study|Relocated; Family conflict|1
2998300|NCT00957008|10318100|P1|Overall Study|Relocated; Family conflict|4
2998301|NCT00957008|10318097|P4|Overall Study|Physician Decision|1
2998302|NCT00957008|10318098|P3|Overall Study|Physician Decision|1
2998303|NCT00957008|10318099|P2|Overall Study|Physician Decision|0
2998304|NCT00957008|10318100|P1|Overall Study|Physician Decision|1
2998305|NCT00957008|10318097|P4|Overall Study|Lost to Follow-up|4
2998306|NCT00957008|10318098|P3|Overall Study|Lost to Follow-up|3
2998307|NCT00957008|10318099|P2|Overall Study|Lost to Follow-up|1
2998308|NCT00957008|10318100|P1|Overall Study|Lost to Follow-up|3
2998309|NCT00957008|10318097|P4|Overall Study|Withdrawal by Subject|16
2998310|NCT00957008|10318098|P3|Overall Study|Withdrawal by Subject|12
2998311|NCT00957008|10318099|P2|Overall Study|Withdrawal by Subject|10
2998312|NCT00957008|10318100|P1|Overall Study|Withdrawal by Subject|13
2998313|NCT00956943|10318128|P2|Overall Study|Lost to Follow-up|10
2998314|NCT00956943|10318129|P1|Overall Study|Lost to Follow-up|9
2998315|NCT00956839|10318153|P3|Overall Study|Lost to Follow-up|3
2998316|NCT00956839|10318154|P2|Overall Study|Lost to Follow-up|0
2998317|NCT00956839|10318155|P1|Overall Study|Lost to Follow-up|3
2998318|NCT00956813|10318168|P2|Flaxseed and Placebo|Ineligible|1
2998319|NCT00956813|10318169|P1|Flaxseed and Placebo|Ineligible|3
2998320|NCT00956813|10318168|P2|Flaxseed and Placebo|Withdrawal by Subject|4
2998321|NCT00956813|10318169|P1|Flaxseed and Placebo|Withdrawal by Subject|5
2998322|NCT00956592|10318221|P2|Overall Study|Protocol Violation|3
2998323|NCT00956592|10318222|P1|Overall Study|Protocol Violation|1
2998324|NCT00956293|10318257|P3|Follow-up Period|Follow-up period was terminated.|0
2998325|NCT00956293|10318258|P2|Follow-up Period|Follow-up period was terminated.|32
2998326|NCT00956293|10318259|P1|Follow-up Period|Follow-up period was terminated.|20
2998327|NCT00956293|10318257|P3|Main Period (Randomization)|Adverse Event|0
2998328|NCT00956293|10318258|P2|Main Period (Randomization)|Adverse Event|15
2998329|NCT00956293|10318259|P1|Main Period (Randomization)|Adverse Event|0
2998330|NCT00956293|10318257|P3|Main Period (Randomization)|Lack of Efficacy|0
2998331|NCT00956293|10318258|P2|Main Period (Randomization)|Lack of Efficacy|10
2998332|NCT00956293|10318259|P1|Main Period (Randomization)|Lack of Efficacy|1
2998333|NCT00956293|10318257|P3|Main Period (Randomization)|Abnormal laboratory value|0
2998334|NCT00956293|10318258|P2|Main Period (Randomization)|Abnormal laboratory value|2
2998335|NCT00956293|10318259|P1|Main Period (Randomization)|Abnormal laboratory value|0
2998336|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
2998337|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
2998338|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
2998339|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Adverse Event|36
2998340|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Adverse Event|0
2998341|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Adverse Event|0
2998342|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
2998343|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
2998344|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
2998345|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
2998346|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
2998347|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
2998348|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Graft loss|7
2998349|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Graft loss|0
2998350|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Graft loss|0
2998351|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Administrative problems|6
2998352|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Administrative problems|0
2998353|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Administrative problems|0
2998354|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
2998355|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
2998356|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
2998357|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Protocol Violation|1
2998358|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Protocol Violation|0
2998359|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Protocol Violation|0
2998360|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Death|1
2998361|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Death|0
2998362|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Death|0
2998363|NCT00956293|10318257|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
2998364|NCT00956293|10318258|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
2998365|NCT00956293|10318259|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
2998366|NCT00955968|10318314|P2|Overall Study|Site closed|52
2998367|NCT00955968|10318315|P1|Overall Study|Site closed|55
2998368|NCT00955968|10318314|P2|Overall Study|Lost to Follow-up|39
2998369|NCT00955968|10318315|P1|Overall Study|Lost to Follow-up|45
2998370|NCT00955968|10318314|P2|Overall Study|Withdrawal by Subject|31
2998371|NCT00955968|10318315|P1|Overall Study|Withdrawal by Subject|35
2998372|NCT00955968|10318314|P2|Overall Study|Death|4
2998373|NCT00955968|10318315|P1|Overall Study|Death|2
2998374|NCT00955955|10318353|P3|Overall Study|Lost to Follow-up|0
2998375|NCT00955955|10318354|P2|Overall Study|Lost to Follow-up|0
2998376|NCT00955955|10318355|P1|Overall Study|Lost to Follow-up|2
2998377|NCT00955825|10318439|P2|Overall Study|Any other reason not above-mentioned|9
2998378|NCT00955825|10318440|P1|Overall Study|Any other reason not above-mentioned|7
2998379|NCT00955825|10318439|P2|Overall Study|Withdrawal by Subject|6
2998380|NCT00955825|10318440|P1|Overall Study|Withdrawal by Subject|4
2998381|NCT00955825|10318439|P2|Overall Study|Adverse Event|2
2998382|NCT00955825|10318440|P1|Overall Study|Adverse Event|15
2998383|NCT00955721|10318457|P2|Overall Study|Withdrawal by Subject|0
2998384|NCT00955721|10318458|P1|Overall Study|Withdrawal by Subject|1
2998385|NCT00955721|10318457|P2|Overall Study|Death|0
2998386|NCT00955721|10318458|P1|Overall Study|Death|1
2998387|NCT00955721|10318457|P2|Overall Study|Physician Decision|0
2998388|NCT00955721|10318458|P1|Overall Study|Physician Decision|1
2998389|NCT00955708|10318468|P1|Overall Study|Patient changed care provider/moved|91
2998390|NCT00955708|10318468|P1|Overall Study|Closure of study location|60
2998391|NCT00955708|10318468|P1|Overall Study|Patient Refused to participate further|116
2998392|NCT00955708|10318468|P1|Overall Study|Product removed from service|94
2998393|NCT00955708|10318468|P1|Overall Study|Registry Conclusion|186
2998394|NCT00955708|10318468|P1|Overall Study|Protocol Violation|134
2998395|NCT00955708|10318468|P1|Overall Study|Physician Decision|36
2998396|NCT00955708|10318468|P1|Overall Study|Lost to Follow-up|72
2998397|NCT00955708|10318468|P1|Overall Study|Death|269
2998398|NCT00955682|10318474|P2|Booster Period (Month 49)|Lost to Follow-up|1
2998399|NCT00955682|10318475|P1|Booster Period (Month 49)|Lost to Follow-up|1
2998400|NCT00955617|10318585|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
2998401|NCT00955617|10318586|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
2998402|NCT00955617|10318585|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
2998403|NCT00955617|10318586|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
2998404|NCT00955617|10318585|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
2998405|NCT00955617|10318586|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
2998406|NCT00955617|10318585|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
2998407|NCT00955617|10318586|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
2998408|NCT00955474|10318650|P2|Overall Study|Physician Decision|5
2998409|NCT00955474|10318651|P1|Overall Study|Physician Decision|7
2998410|NCT00955357|10318687|P2|Maintenance Phase|Non compliance to study procedures|0
2998411|NCT00955357|10318688|P1|Maintenance Phase|Non compliance to study procedures|1
2998412|NCT00955357|10318687|P2|Maintenance Phase|Patient moving out of area|1
2998413|NCT00955357|10318688|P1|Maintenance Phase|Patient moving out of area|0
2998414|NCT00955357|10318687|P2|Maintenance Phase|Withdrawal by Subject|4
2998415|NCT00955357|10318688|P1|Maintenance Phase|Withdrawal by Subject|4
2998416|NCT00955357|10318687|P2|Maintenance Phase|Lost to Follow-up|7
2998417|NCT00955357|10318688|P1|Maintenance Phase|Lost to Follow-up|2
2998418|NCT00955357|10318687|P2|Maintenance Phase|Protocol Violation|6
2998419|NCT00955357|10318688|P1|Maintenance Phase|Protocol Violation|2
2998420|NCT00955357|10318687|P2|Maintenance Phase|Lack of Efficacy|4
2998421|NCT00955357|10318688|P1|Maintenance Phase|Lack of Efficacy|0
2998422|NCT00955357|10318687|P2|Maintenance Phase|Adverse Event|23
2998423|NCT00955357|10318688|P1|Maintenance Phase|Adverse Event|3
2998424|NCT00955357|10318687|P2|Titration Phase|Non compliance to study procedures|1
2998425|NCT00955357|10318688|P1|Titration Phase|Non compliance to study procedures|0
2998426|NCT00955357|10318687|P2|Titration Phase|Study medication not tolerated|1
2998427|NCT00955357|10318688|P1|Titration Phase|Study medication not tolerated|0
2998428|NCT00955357|10318687|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
2998429|NCT00955357|10318688|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
2998430|NCT00955357|10318687|P2|Titration Phase|Withdrawal by Subject|5
2998431|NCT00955357|10318688|P1|Titration Phase|Withdrawal by Subject|3
2998432|NCT00955357|10318687|P2|Titration Phase|Lost to Follow-up|3
2998433|NCT00955357|10318688|P1|Titration Phase|Lost to Follow-up|1
2998434|NCT00955357|10318687|P2|Titration Phase|Protocol Violation|7
2998435|NCT00955357|10318688|P1|Titration Phase|Protocol Violation|3
2998436|NCT00955357|10318687|P2|Titration Phase|Lack of Efficacy|2
2998437|NCT00955357|10318688|P1|Titration Phase|Lack of Efficacy|0
2998438|NCT00955357|10318687|P2|Titration Phase|Adverse Event|46
2998439|NCT00955357|10318688|P1|Titration Phase|Adverse Event|9
2998440|NCT00955305|10318696|P2|Overall Study|Ineligible|7
2998441|NCT00955305|10318697|P1|Overall Study|Ineligible|5
2998442|NCT00955305|10318696|P2|Overall Study|Never started protocol treatment|5
2998443|NCT00955305|10318697|P1|Overall Study|Never started protocol treatment|5
2998444|NCT00955305|10318696|P2|Overall Study|No off-treatment reason submitted|0
2998445|NCT00955305|10318697|P1|Overall Study|No off-treatment reason submitted|1
2998446|NCT00955305|10318696|P2|Overall Study|Lost to Follow-up|1
2998447|NCT00955305|10318697|P1|Overall Study|Lost to Follow-up|0
2998448|NCT00955305|10318696|P2|Overall Study|Maximum response achieved|1
2998449|NCT00955305|10318697|P1|Overall Study|Maximum response achieved|0
2998450|NCT00955305|10318696|P2|Overall Study|Functional decline|0
2998451|NCT00955305|10318697|P1|Overall Study|Functional decline|2
2998452|NCT00955305|10318696|P2|Overall Study|Continued presence of residual disease|1
2998453|NCT00955305|10318697|P1|Overall Study|Continued presence of residual disease|0
2998454|NCT00955305|10318696|P2|Overall Study|Physician Decision|0
2998455|NCT00955305|10318697|P1|Overall Study|Physician Decision|1
2998456|NCT00955305|10318696|P2|Overall Study|Other complicating disease|4
2998457|NCT00955305|10318697|P1|Overall Study|Other complicating disease|2
2998458|NCT00955305|10318696|P2|Overall Study|Alternative therapy|0
2998459|NCT00955305|10318697|P1|Overall Study|Alternative therapy|4
2998460|NCT00955305|10318696|P2|Overall Study|Withdrawal by Subject|4
2998461|NCT00955305|10318697|P1|Overall Study|Withdrawal by Subject|5
2998462|NCT00955305|10318696|P2|Overall Study|Death|1
2998463|NCT00955305|10318697|P1|Overall Study|Death|2
2998464|NCT00955305|10318696|P2|Overall Study|Adverse Event|22
2998465|NCT00955305|10318697|P1|Overall Study|Adverse Event|22
2998466|NCT00955305|10318696|P2|Overall Study|Disease progression|41
2998467|NCT00955305|10318697|P1|Overall Study|Disease progression|39
2998468|NCT00955279|10318710|P3|Overall Study|Withdrawal by Subject|3
2998469|NCT00955279|10318711|P2|Overall Study|Withdrawal by Subject|0
2998470|NCT00955279|10318712|P1|Overall Study|Withdrawal by Subject|2
2998471|NCT00955279|10318710|P3|Overall Study|Lost to Follow-up|1
2998472|NCT00955279|10318711|P2|Overall Study|Lost to Follow-up|3
2998473|NCT00955279|10318712|P1|Overall Study|Lost to Follow-up|0
2998474|NCT00955279|10318710|P3|Overall Study|Death|1
2998475|NCT00955279|10318711|P2|Overall Study|Death|1
2998476|NCT00955279|10318712|P1|Overall Study|Death|1
2998477|NCT00955279|10318710|P3|Overall Study|Other|3
2998478|NCT00955279|10318711|P2|Overall Study|Other|0
2998479|NCT00955279|10318712|P1|Overall Study|Other|0
2998480|NCT00955110|10318920|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
2998481|NCT00955110|10318920|P1|Treatment Phase|Non-compliance with study restrictions|1
2998482|NCT00955110|10318920|P1|Treatment Phase|Administrative reasons|2
2998483|NCT00955110|10318920|P1|Treatment Phase|Adverse Event|2
2998484|NCT00955110|10318920|P1|Qualification Phase|Did not meet eligibility criteria|24
2998485|NCT00954941|10318967|P2|Overall Study|Adverse Event|1
2998486|NCT00954941|10318968|P1|Overall Study|Adverse Event|0
2998487|NCT00954941|10318967|P2|Overall Study|Ineligible|2
2998488|NCT00954941|10318968|P1|Overall Study|Ineligible|2
2998489|NCT00954941|10318967|P2|Overall Study|Physician Decision|2
2998490|NCT00954941|10318968|P1|Overall Study|Physician Decision|2
2998491|NCT00954941|10318967|P2|Overall Study|Insurance Denial|2
2998492|NCT00954941|10318968|P1|Overall Study|Insurance Denial|2
2998493|NCT00954941|10318967|P2|Overall Study|Withdrawal by Subject|0
2998494|NCT00954941|10318968|P1|Overall Study|Withdrawal by Subject|1
2998495|NCT00954941|10318967|P2|Overall Study|Received treatment at home|0
2998496|NCT00954941|10318968|P1|Overall Study|Received treatment at home|1
2998497|NCT00954733|10318984|P1|Overall Study|blood gas machine did not work|1
2998498|NCT00954707|10318988|P1|Overall Study|Lost to Follow-up|33
2998499|NCT00954707|10318988|P1|Overall Study|Withdrawal by Subject|100
2998500|NCT00954707|10318988|P1|Overall Study|Death|34
2998501|NCT00954538|10319010|P6|Part III|Withdrawal by Subject|0
2998502|NCT00954538|10319011|P5|Part III|Withdrawal by Subject|1
2998503|NCT00954538|10319012|P4|Part III|Withdrawal by Subject|0
2998504|NCT00954538|10319013|P3|Part III|Withdrawal by Subject|0
2998505|NCT00954538|10319014|P2|Part III|Withdrawal by Subject|0
2998506|NCT00954538|10319015|P1|Part III|Withdrawal by Subject|0
2998507|NCT00954512|10319032|P6|Overall Study|Progression of Disease|1
2998508|NCT00954512|10319033|P5|Overall Study|Progression of Disease|1
2998509|NCT00954512|10319034|P4|Overall Study|Progression of Disease|1
2998510|NCT00954512|10319035|P3|Overall Study|Progression of Disease|0
2998511|NCT00954512|10319036|P2|Overall Study|Progression of Disease|1
2998512|NCT00954512|10319037|P1|Overall Study|Progression of Disease|2
2998513|NCT00954512|10319032|P6|Overall Study|Symptomatic Deterioration|0
2998514|NCT00954512|10319033|P5|Overall Study|Symptomatic Deterioration|2
2998515|NCT00954512|10319034|P4|Overall Study|Symptomatic Deterioration|0
2998516|NCT00954512|10319035|P3|Overall Study|Symptomatic Deterioration|0
2998517|NCT00954512|10319036|P2|Overall Study|Symptomatic Deterioration|1
2998518|NCT00954512|10319037|P1|Overall Study|Symptomatic Deterioration|0
2998519|NCT00954512|10319032|P6|Overall Study|Physician Decision|0
2998520|NCT00954512|10319033|P5|Overall Study|Physician Decision|0
2998521|NCT00954512|10319034|P4|Overall Study|Physician Decision|1
2998522|NCT00954512|10319035|P3|Overall Study|Physician Decision|0
2998523|NCT00954512|10319036|P2|Overall Study|Physician Decision|1
2998524|NCT00954512|10319037|P1|Overall Study|Physician Decision|0
2998525|NCT00954512|10319032|P6|Overall Study|Adverse Event|2
2998526|NCT00954512|10319033|P5|Overall Study|Adverse Event|1
2998527|NCT00954512|10319034|P4|Overall Study|Adverse Event|0
2998528|NCT00954512|10319035|P3|Overall Study|Adverse Event|0
2998529|NCT00954512|10319036|P2|Overall Study|Adverse Event|0
2998530|NCT00954512|10319037|P1|Overall Study|Adverse Event|0
2998531|NCT00954512|10319032|P6|Overall Study|Withdrawal by Subject|1
2998532|NCT00954512|10319033|P5|Overall Study|Withdrawal by Subject|0
2998533|NCT00954512|10319034|P4|Overall Study|Withdrawal by Subject|0
2998534|NCT00954512|10319035|P3|Overall Study|Withdrawal by Subject|0
2998535|NCT00954512|10319036|P2|Overall Study|Withdrawal by Subject|0
2998536|NCT00954512|10319037|P1|Overall Study|Withdrawal by Subject|0
2998537|NCT00954447|10319058|P2|Overall Study|Other|18
2998538|NCT00954447|10319059|P1|Overall Study|Other|21
2998539|NCT00954447|10319058|P2|Overall Study|Withdrawal by Subject|21
2998540|NCT00954447|10319059|P1|Overall Study|Withdrawal by Subject|26
2998541|NCT00954447|10319058|P2|Overall Study|Lost to Follow-up|14
2998542|NCT00954447|10319059|P1|Overall Study|Lost to Follow-up|8
2998543|NCT00954447|10319058|P2|Overall Study|Protocol Violation|7
2998544|NCT00954447|10319059|P1|Overall Study|Protocol Violation|5
2998545|NCT00954447|10319058|P2|Overall Study|Lack of Efficacy|3
2998546|NCT00954447|10319059|P1|Overall Study|Lack of Efficacy|17
2998547|NCT00954447|10319058|P2|Overall Study|Adverse Event|25
2998548|NCT00954447|10319059|P1|Overall Study|Adverse Event|33
2998549|NCT00954421|10319095|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
2998550|NCT00954421|10319095|P1|6 Months of DBS|Withdrawal by Subject|1
2998551|NCT00954421|10319095|P1|Screening|screen failures|3
2998552|NCT00954122|10319141|P1|Overall Study|Safety Reason|1
2998553|NCT00954122|10319141|P1|Overall Study|Adverse Event|1
2998554|NCT00954122|10319141|P1|Overall Study|Withdrawal by Subject|5
2998555|NCT00953927|10319158|P2|Overall Study|Other study discontinuation|1
2998556|NCT00953927|10319159|P1|Overall Study|Other study discontinuation|1
2998557|NCT00953927|10319158|P2|Overall Study|Death|4
2998558|NCT00953927|10319159|P1|Overall Study|Death|7
2998559|NCT00953927|10319158|P2|Overall Study|Withdrawal by Subject|25
2998560|NCT00953927|10319159|P1|Overall Study|Withdrawal by Subject|36
2998561|NCT00953927|10319158|P2|Overall Study|Lost to Follow-up|65
2998562|NCT00953927|10319159|P1|Overall Study|Lost to Follow-up|61
2998563|NCT00953745|10319214|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
2998564|NCT00953745|10319215|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
2998565|NCT00953745|10319214|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
2998566|NCT00953745|10319215|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
2998567|NCT00953745|10319214|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
2998568|NCT00953745|10319215|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
2998569|NCT00953745|10319214|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
2998570|NCT00953745|10319215|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
2998571|NCT00953745|10319214|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
2998572|NCT00953745|10319215|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
2998573|NCT00953745|10319214|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
2998574|NCT00953745|10319215|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
2998575|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Other|2
2998576|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Other|0
2998577|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Other|0
2998578|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Other|0
2998579|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
2998580|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
2998581|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2998582|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2998583|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
2998584|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
2998585|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2998586|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2998587|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
2998588|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2998589|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2998590|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2998591|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
2998592|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2998593|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2998594|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2998595|NCT00953706|10319248|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
2998596|NCT00953706|10319249|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
2998597|NCT00953706|10319250|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
2998598|NCT00953706|10319251|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
2998599|NCT00953706|10319248|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2998600|NCT00953706|10319249|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2998601|NCT00953706|10319250|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
2998602|NCT00953706|10319251|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2998603|NCT00953706|10319248|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2998604|NCT00953706|10319249|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2998605|NCT00953706|10319250|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
2998606|NCT00953706|10319251|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2998607|NCT00953706|10319248|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2998608|NCT00953706|10319249|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2998609|NCT00953706|10319250|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
2998610|NCT00953706|10319251|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2998611|NCT00953706|10319248|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2998612|NCT00953706|10319249|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2998613|NCT00953706|10319250|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
2998614|NCT00953706|10319251|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2998615|NCT00953706|10319248|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2998616|NCT00953706|10319249|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2998617|NCT00953706|10319250|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
2998618|NCT00953706|10319251|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
2998619|NCT00953680|10319283|P2|Period 1|Withdrawal by Subject|1
2998620|NCT00953680|10319284|P1|Period 1|Withdrawal by Subject|0
2998621|NCT00953667|10319296|P1|Overall Study|poor venous access,unable to draw blood|4
2998622|NCT00953667|10319296|P1|Overall Study|Adverse Event|10
2998623|NCT00953667|10319296|P1|Overall Study|Withdrawal by Subject|63
2998624|NCT00953667|10319296|P1|Overall Study|Physician Decision|35
2998625|NCT00953667|10319296|P1|Overall Study|Lost to Follow-up|11
2998626|NCT00953615|10319317|P1|Overall Study|Adverse Event|1
2998627|NCT00953576|10319326|P2|Overall Study|Ineligible after Consent|0
2998628|NCT00953576|10319327|P1|Overall Study|Ineligible after Consent|2
2998629|NCT00953576|10319326|P2|Overall Study|Adverse Event|1
2998630|NCT00953576|10319327|P1|Overall Study|Adverse Event|0
2998631|NCT00953524|10319342|P4|Overall Study|Withdrawal by Subject|0
2998632|NCT00953524|10319343|P3|Overall Study|Withdrawal by Subject|1
2998633|NCT00953524|10319344|P2|Overall Study|Withdrawal by Subject|4
2998634|NCT00953524|10319345|P1|Overall Study|Withdrawal by Subject|2
2998635|NCT00953524|10319342|P4|Overall Study|Lost to Follow-up|0
2998636|NCT00953524|10319343|P3|Overall Study|Lost to Follow-up|1
2998637|NCT00953524|10319344|P2|Overall Study|Lost to Follow-up|1
2998638|NCT00953524|10319345|P1|Overall Study|Lost to Follow-up|0
2998639|NCT00953524|10319342|P4|Overall Study|Protocol Violation|6
2998640|NCT00953524|10319343|P3|Overall Study|Protocol Violation|11
2998641|NCT00953524|10319344|P2|Overall Study|Protocol Violation|10
2998642|NCT00953524|10319345|P1|Overall Study|Protocol Violation|18
2998643|NCT00953524|10319342|P4|Overall Study|Adverse Event|2
2998644|NCT00953524|10319343|P3|Overall Study|Adverse Event|1
2998645|NCT00953524|10319344|P2|Overall Study|Adverse Event|0
2998646|NCT00953524|10319345|P1|Overall Study|Adverse Event|2
2998647|NCT00953407|10319388|P5|Overall Study|Lost to Follow-up|0
2998648|NCT00953407|10319389|P4|Overall Study|Lost to Follow-up|1
2998649|NCT00953407|10319390|P3|Overall Study|Lost to Follow-up|0
2998650|NCT00953407|10319391|P2|Overall Study|Lost to Follow-up|0
2998651|NCT00953407|10319392|P1|Overall Study|Lost to Follow-up|0
2998652|NCT00953407|10319388|P5|Overall Study|Failed inclusion criteria|1
2998653|NCT00953407|10319389|P4|Overall Study|Failed inclusion criteria|1
2998654|NCT00953407|10319390|P3|Overall Study|Failed inclusion criteria|1
2998655|NCT00953407|10319391|P2|Overall Study|Failed inclusion criteria|1
2998656|NCT00953407|10319392|P1|Overall Study|Failed inclusion criteria|1
2998657|NCT00953329|10319404|P1|Overall Study|Lack of Efficacy|1
2998658|NCT00953225|10319417|P2|Overall Study|Withdrawal by Subject|0
2998659|NCT00953225|10319418|P1|Overall Study|Withdrawal by Subject|2
2998660|NCT00953160|10319502|P1|Overall Study|Withdrawal by Subject|4
2998661|NCT00953160|10319502|P1|Overall Study|Lost to Follow-up|23
2998662|NCT00953147|10319511|P3|Overall Study|Other|13
2998663|NCT00953147|10319512|P2|Overall Study|Other|11
2998664|NCT00953147|10319513|P1|Overall Study|Other|4
2998665|NCT00953147|10319511|P3|Overall Study|Physician Decision|3
2998666|NCT00953147|10319512|P2|Overall Study|Physician Decision|7
2998667|NCT00953147|10319513|P1|Overall Study|Physician Decision|2
2998668|NCT00953147|10319511|P3|Overall Study|Lost to Follow-up|4
2998669|NCT00953147|10319512|P2|Overall Study|Lost to Follow-up|9
2998670|NCT00953147|10319513|P1|Overall Study|Lost to Follow-up|8
2998671|NCT00953147|10319511|P3|Overall Study|Withdrawal by Subject|12
2998672|NCT00953147|10319512|P2|Overall Study|Withdrawal by Subject|15
2998673|NCT00953147|10319513|P1|Overall Study|Withdrawal by Subject|13
2998674|NCT00953147|10319511|P3|Overall Study|Protocol Violation|4
2998675|NCT00953147|10319512|P2|Overall Study|Protocol Violation|8
2998676|NCT00953147|10319513|P1|Overall Study|Protocol Violation|2
2998677|NCT00953147|10319511|P3|Overall Study|Adverse Event|6
2998678|NCT00953147|10319512|P2|Overall Study|Adverse Event|16
2998679|NCT00953147|10319513|P1|Overall Study|Adverse Event|8
2998680|NCT00953056|10319591|P6|Overall Study|Serious Adverse Event|1
2998681|NCT00953056|10319592|P5|Overall Study|Serious Adverse Event|0
2998682|NCT00953056|10319593|P4|Overall Study|Serious Adverse Event|0
2998683|NCT00953056|10319594|P3|Overall Study|Serious Adverse Event|0
2998684|NCT00953056|10319595|P2|Overall Study|Serious Adverse Event|0
2998685|NCT00953056|10319596|P1|Overall Study|Serious Adverse Event|0
2998686|NCT00953056|10319591|P6|Overall Study|Withdrew Consent|3
2998687|NCT00953056|10319592|P5|Overall Study|Withdrew Consent|2
2998688|NCT00953056|10319593|P4|Overall Study|Withdrew Consent|0
2998689|NCT00953056|10319594|P3|Overall Study|Withdrew Consent|0
2998690|NCT00953056|10319595|P2|Overall Study|Withdrew Consent|0
2998691|NCT00953056|10319596|P1|Overall Study|Withdrew Consent|0
2998692|NCT00953043|10319620|P2|Overall Study|Physician Decision|2
2998693|NCT00953043|10319621|P1|Overall Study|Physician Decision|0
2998694|NCT00953043|10319620|P2|Overall Study|Withdrawal by Subject|0
2998695|NCT00953043|10319621|P1|Overall Study|Withdrawal by Subject|4
2998696|NCT00953017|10319645|P4|Overall Study|Brown stool prior to procedure|0
2998697|NCT00953017|10319646|P3|Overall Study|Brown stool prior to procedure|1
2998698|NCT00953017|10319647|P2|Overall Study|Brown stool prior to procedure|0
2998699|NCT00953017|10319648|P1|Overall Study|Brown stool prior to procedure|0
2998700|NCT00953017|10319645|P4|Overall Study|Procedure incomplete due to pain/looping|1
2998701|NCT00953017|10319646|P3|Overall Study|Procedure incomplete due to pain/looping|0
2998702|NCT00953017|10319647|P2|Overall Study|Procedure incomplete due to pain/looping|1
2998703|NCT00953017|10319648|P1|Overall Study|Procedure incomplete due to pain/looping|0
2998704|NCT00953017|10319645|P4|Overall Study|Incomplete data|0
2998705|NCT00953017|10319646|P3|Overall Study|Incomplete data|0
2998706|NCT00953017|10319647|P2|Overall Study|Incomplete data|1
2998707|NCT00953017|10319648|P1|Overall Study|Incomplete data|1
2998708|NCT00953017|10319645|P4|Overall Study|DId not show up for colonoscopy|4
2998709|NCT00953017|10319646|P3|Overall Study|DId not show up for colonoscopy|5
2998710|NCT00953017|10319647|P2|Overall Study|DId not show up for colonoscopy|4
2998711|NCT00953017|10319648|P1|Overall Study|DId not show up for colonoscopy|4
2998712|NCT00952848|10319670|P1|Overall Study|Withdrawal by Subject|4
2998713|NCT00952822|10319677|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2998714|NCT00952822|10319678|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
2998715|NCT00952822|10319679|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2998716|NCT00952822|10319680|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2998717|NCT00952822|10319677|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2998718|NCT00952822|10319678|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2998719|NCT00952822|10319679|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
2998720|NCT00952822|10319680|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2998721|NCT00952731|10319712|P2|Overall Study|Drug supply expired|0
2998722|NCT00952731|10319713|P1|Overall Study|Drug supply expired|1
2998723|NCT00952705|10319745|P3|Overall Study|Exclusion criteria not met pre dose|0
2998724|NCT00952705|10319746|P2|Overall Study|Exclusion criteria not met pre dose|1
2998725|NCT00952705|10319747|P1|Overall Study|Exclusion criteria not met pre dose|0
2998726|NCT00952705|10319745|P3|Overall Study|Incarcerated post dose|0
2998727|NCT00952705|10319746|P2|Overall Study|Incarcerated post dose|0
2998728|NCT00952705|10319747|P1|Overall Study|Incarcerated post dose|5
2998729|NCT00952705|10319745|P3|Overall Study|Death|0
2998730|NCT00952705|10319746|P2|Overall Study|Death|0
2998731|NCT00952705|10319747|P1|Overall Study|Death|2
2998732|NCT00952705|10319745|P3|Overall Study|Withdrawal by Subject|1
2998733|NCT00952705|10319746|P2|Overall Study|Withdrawal by Subject|1
2998734|NCT00952705|10319747|P1|Overall Study|Withdrawal by Subject|2
2998735|NCT00952705|10319745|P3|Overall Study|Lost to Follow-up|9
2998736|NCT00952705|10319746|P2|Overall Study|Lost to Follow-up|8
2998737|NCT00952705|10319747|P1|Overall Study|Lost to Follow-up|24
2998738|NCT00952614|10319834|P1|Overall Study|other reason|1
2998739|NCT00952614|10319834|P1|Overall Study|Lost to Follow-up|3
2998740|NCT00952614|10319834|P1|Overall Study|Death|3
2998741|NCT00952588|10319841|P2|Overall Study|Lack of Efficacy|2
2998742|NCT00952588|10319842|P1|Overall Study|Lack of Efficacy|2
2998743|NCT00952588|10319841|P2|Overall Study|Physician Decision|1
2998744|NCT00952588|10319842|P1|Overall Study|Physician Decision|0
2998745|NCT00952588|10319841|P2|Overall Study|Lost to Follow-up|0
2998746|NCT00952588|10319842|P1|Overall Study|Lost to Follow-up|2
2998747|NCT00952588|10319841|P2|Overall Study|Adverse Event|3
2998748|NCT00952588|10319842|P1|Overall Study|Adverse Event|2
2998749|NCT00952588|10319841|P2|Overall Study|Withdrawal by Subject|5
2998750|NCT00952588|10319842|P1|Overall Study|Withdrawal by Subject|2
2998751|NCT00952588|10319841|P2|Overall Study|Death|13
2998752|NCT00952588|10319842|P1|Overall Study|Death|28
2998753|NCT00952523|10319860|P1|Overall Study|Withdrawal by Subject|7
2998754|NCT00952484|10319869|P3|Overall Study|Withdrawal by Subject|0
2998755|NCT00952484|10319870|P2|Overall Study|Withdrawal by Subject|1
2998756|NCT00952484|10319871|P1|Overall Study|Withdrawal by Subject|0
2998757|NCT00952419|10319898|P3|Overall Study|Withdrawal by Subject|0
2998758|NCT00952419|10319899|P2|Overall Study|Withdrawal by Subject|3
2998759|NCT00952419|10319900|P1|Overall Study|Withdrawal by Subject|1
2998760|NCT00952419|10319898|P3|Overall Study|Protocol Violation|0
2998761|NCT00952419|10319899|P2|Overall Study|Protocol Violation|7
2998762|NCT00952419|10319900|P1|Overall Study|Protocol Violation|3
2998763|NCT00952419|10319898|P3|Overall Study|Adverse Event|0
2998764|NCT00952419|10319899|P2|Overall Study|Adverse Event|0
2998765|NCT00952419|10319900|P1|Overall Study|Adverse Event|2
2998766|NCT00952380|10319941|P5|Overall Study|Non-compliant to protocol|0
2998767|NCT00952380|10319942|P4|Overall Study|Non-compliant to protocol|1
2998768|NCT00952380|10319943|P3|Overall Study|Non-compliant to protocol|0
2998769|NCT00952380|10319944|P2|Overall Study|Non-compliant to protocol|0
2998770|NCT00952380|10319945|P1|Overall Study|Non-compliant to protocol|0
2998771|NCT00952380|10319941|P5|Overall Study|Physician Decision|0
2998772|NCT00952380|10319942|P4|Overall Study|Physician Decision|2
2998773|NCT00952380|10319943|P3|Overall Study|Physician Decision|1
2998774|NCT00952380|10319944|P2|Overall Study|Physician Decision|0
2998775|NCT00952380|10319945|P1|Overall Study|Physician Decision|0
2998776|NCT00952380|10319941|P5|Overall Study|Adverse Event|3
2998777|NCT00952380|10319942|P4|Overall Study|Adverse Event|0
2998778|NCT00952380|10319943|P3|Overall Study|Adverse Event|0
2998779|NCT00952380|10319944|P2|Overall Study|Adverse Event|1
2998780|NCT00952380|10319945|P1|Overall Study|Adverse Event|0
2998781|NCT00952380|10319941|P5|Overall Study|Withdrawal by Subject|2
2998782|NCT00952380|10319942|P4|Overall Study|Withdrawal by Subject|0
2998783|NCT00952380|10319943|P3|Overall Study|Withdrawal by Subject|1
2998784|NCT00952380|10319944|P2|Overall Study|Withdrawal by Subject|0
2998785|NCT00952380|10319945|P1|Overall Study|Withdrawal by Subject|0
2998786|NCT00952380|10319941|P5|Overall Study|Other|1
2998787|NCT00952380|10319942|P4|Overall Study|Other|0
2998788|NCT00952380|10319943|P3|Overall Study|Other|0
2998789|NCT00952380|10319944|P2|Overall Study|Other|0
2998790|NCT00952380|10319945|P1|Overall Study|Other|0
2998791|NCT00952367|10320046|P1|Overall Study|Protocol Violation|3
2998792|NCT00952367|10320046|P1|Overall Study|Noncoordination|1
2998793|NCT00952367|10320046|P1|Overall Study|Withdrawal by Subject|2
2998794|NCT00952341|10320061|P2|Cycle 2|Progressive Disease|1
2998795|NCT00952341|10320062|P1|Cycle 2|Progressive Disease|0
2998796|NCT00952341|10320061|P2|Cycle 2|Physician Decision|1
2998797|NCT00952341|10320062|P1|Cycle 2|Physician Decision|1
2998798|NCT00952341|10320061|P2|Cycle 2|Lost to Follow-up|9
2998799|NCT00952341|10320062|P1|Cycle 2|Lost to Follow-up|6
2998800|NCT00952341|10320061|P2|Cycle 2|Protocol Violation|0
2998801|NCT00952341|10320062|P1|Cycle 2|Protocol Violation|1
2998802|NCT00952341|10320061|P2|Cycle 2|Withdrawal by Subject|1
2998803|NCT00952341|10320062|P1|Cycle 2|Withdrawal by Subject|1
2998804|NCT00952341|10320061|P2|Cycle 1|Physician Decision|1
2998805|NCT00952341|10320062|P1|Cycle 1|Physician Decision|0
2998806|NCT00952341|10320061|P2|Cycle 1|Lost to Follow-up|2
2998807|NCT00952341|10320062|P1|Cycle 1|Lost to Follow-up|11
2998808|NCT00952341|10320061|P2|Cycle 1|Protocol Violation|1
2998809|NCT00952341|10320062|P1|Cycle 1|Protocol Violation|2
2998810|NCT00952341|10320061|P2|Cycle 1|Withdrawal by Subject|8
2998811|NCT00952341|10320062|P1|Cycle 1|Withdrawal by Subject|3
2998812|NCT00952341|10320061|P2|Cycle 1|Adverse Event|1
2998813|NCT00952341|10320062|P1|Cycle 1|Adverse Event|4
2998814|NCT00952289|10320124|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
2998815|NCT00952289|10320125|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
2998816|NCT00952289|10320124|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
2998817|NCT00952289|10320125|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
2998818|NCT00952289|10320124|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
2998819|NCT00952289|10320125|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
2998820|NCT00952289|10320124|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
2998821|NCT00952289|10320125|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
2998822|NCT00952289|10320124|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
2998823|NCT00952289|10320125|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
2998824|NCT00952289|10320124|P2|All Participants|Data lost during site relocation|1
2998825|NCT00952289|10320125|P1|All Participants|Data lost during site relocation|0
2998826|NCT00952289|10320124|P2|All Participants|Withdrawal by Subject|10
2998827|NCT00952289|10320125|P1|All Participants|Withdrawal by Subject|1
2998828|NCT00952289|10320124|P2|All Participants|Disease progression|12
2998829|NCT00952289|10320125|P1|All Participants|Disease progression|3
2998830|NCT00952289|10320124|P2|All Participants|Adverse Event|8
2998831|NCT00952289|10320125|P1|All Participants|Adverse Event|8
2998832|NCT00952289|10320124|P2|All Participants|Death|9
2998833|NCT00952289|10320125|P1|All Participants|Death|9
2998834|NCT00952276|10320154|P5|Overall Study|Withdrawal by Subject|0
2998835|NCT00952276|10320155|P4|Overall Study|Withdrawal by Subject|1
2998836|NCT00952276|10320156|P3|Overall Study|Withdrawal by Subject|0
2998837|NCT00952276|10320157|P2|Overall Study|Withdrawal by Subject|0
2998838|NCT00952276|10320158|P1|Overall Study|Withdrawal by Subject|1
2998839|NCT00952068|10320244|P1|Overall Study|Withdrawal by Subject|4
2998840|NCT00952068|10320244|P1|Overall Study|Adverse Event|3
2998841|NCT00951912|10320255|P3|Overall Study|Other: Stroke|0
2998842|NCT00951912|10320256|P2|Overall Study|Other: Stroke|1
2998843|NCT00951912|10320257|P1|Overall Study|Other: Stroke|0
2998844|NCT00951912|10320255|P3|Overall Study|Other: Colon cancer|0
2998845|NCT00951912|10320256|P2|Overall Study|Other: Colon cancer|0
2998846|NCT00951912|10320257|P1|Overall Study|Other: Colon cancer|1
2998847|NCT00951912|10320255|P3|Overall Study|Other:Depression|0
2998848|NCT00951912|10320256|P2|Overall Study|Other:Depression|0
2998849|NCT00951912|10320257|P1|Overall Study|Other:Depression|1
2998850|NCT00951912|10320255|P3|Overall Study|Withdrawal by Subject|0
2998851|NCT00951912|10320256|P2|Overall Study|Withdrawal by Subject|1
2998852|NCT00951912|10320257|P1|Overall Study|Withdrawal by Subject|1
2998853|NCT00951912|10320255|P3|Overall Study|Physician Decision|1
2998854|NCT00951912|10320256|P2|Overall Study|Physician Decision|0
2998855|NCT00951912|10320257|P1|Overall Study|Physician Decision|1
2998856|NCT00951912|10320255|P3|Overall Study|Lost to Follow-up|0
2998857|NCT00951912|10320256|P2|Overall Study|Lost to Follow-up|2
2998858|NCT00951912|10320257|P1|Overall Study|Lost to Follow-up|2
2998859|NCT00951912|10320255|P3|Overall Study|Adverse Event|1
2998860|NCT00951912|10320256|P2|Overall Study|Adverse Event|1
2998861|NCT00951912|10320257|P1|Overall Study|Adverse Event|0
2998862|NCT00951912|10320255|P3|Overall Study|Lack of Efficacy|0
2998863|NCT00951912|10320256|P2|Overall Study|Lack of Efficacy|0
2998864|NCT00951912|10320257|P1|Overall Study|Lack of Efficacy|1
2998865|NCT00951665|10320357|P6|Phase 2a|Disease Progression|5
2998866|NCT00951665|10320358|P5|Phase 2a|Disease Progression|6
2998867|NCT00951665|10320359|P4|Phase 2a|Disease Progression|0
2998868|NCT00951665|10320360|P3|Phase 2a|Disease Progression|0
2998869|NCT00951665|10320361|P2|Phase 2a|Disease Progression|0
2998870|NCT00951665|10320362|P1|Phase 2a|Disease Progression|0
2998871|NCT00951665|10320357|P6|Phase 2a|Withdrawal by Subject|0
2998872|NCT00951665|10320358|P5|Phase 2a|Withdrawal by Subject|2
2998873|NCT00951665|10320359|P4|Phase 2a|Withdrawal by Subject|0
2998874|NCT00951665|10320360|P3|Phase 2a|Withdrawal by Subject|0
2998875|NCT00951665|10320361|P2|Phase 2a|Withdrawal by Subject|0
2998876|NCT00951665|10320362|P1|Phase 2a|Withdrawal by Subject|0
2998877|NCT00951665|10320357|P6|Phase 2a|Physician Decision|1
2998878|NCT00951665|10320358|P5|Phase 2a|Physician Decision|0
2998879|NCT00951665|10320359|P4|Phase 2a|Physician Decision|0
2998880|NCT00951665|10320360|P3|Phase 2a|Physician Decision|0
2998881|NCT00951665|10320361|P2|Phase 2a|Physician Decision|0
2998882|NCT00951665|10320362|P1|Phase 2a|Physician Decision|0
2998883|NCT00951665|10320357|P6|Phase 2a|Lost to Follow-up|0
2998884|NCT00951665|10320358|P5|Phase 2a|Lost to Follow-up|1
2998885|NCT00951665|10320359|P4|Phase 2a|Lost to Follow-up|0
2998886|NCT00951665|10320360|P3|Phase 2a|Lost to Follow-up|0
2998887|NCT00951665|10320361|P2|Phase 2a|Lost to Follow-up|0
2998888|NCT00951665|10320362|P1|Phase 2a|Lost to Follow-up|0
2998889|NCT00951665|10320357|P6|Phase 2a|Death|1
2998890|NCT00951665|10320358|P5|Phase 2a|Death|1
2998891|NCT00951665|10320359|P4|Phase 2a|Death|0
2998892|NCT00951665|10320360|P3|Phase 2a|Death|0
2998893|NCT00951665|10320361|P2|Phase 2a|Death|0
2998894|NCT00951665|10320362|P1|Phase 2a|Death|0
2998895|NCT00951665|10320357|P6|Phase 2a|Adverse Event|0
2998896|NCT00951665|10320358|P5|Phase 2a|Adverse Event|2
2998897|NCT00951665|10320359|P4|Phase 2a|Adverse Event|0
2998898|NCT00951665|10320360|P3|Phase 2a|Adverse Event|0
2998899|NCT00951665|10320361|P2|Phase 2a|Adverse Event|0
2998900|NCT00951665|10320362|P1|Phase 2a|Adverse Event|0
2998901|NCT00951665|10320357|P6|Phase 1b|Protocol Violation|0
2998902|NCT00951665|10320358|P5|Phase 1b|Protocol Violation|0
2998903|NCT00951665|10320359|P4|Phase 1b|Protocol Violation|0
2998904|NCT00951665|10320360|P3|Phase 1b|Protocol Violation|0
2998905|NCT00951665|10320361|P2|Phase 1b|Protocol Violation|0
2998906|NCT00951665|10320362|P1|Phase 1b|Protocol Violation|2
2998907|NCT00951665|10320357|P6|Phase 1b|Disease Progression|0
2998908|NCT00951665|10320358|P5|Phase 1b|Disease Progression|0
2998909|NCT00951665|10320359|P4|Phase 1b|Disease Progression|0
2998910|NCT00951665|10320360|P3|Phase 1b|Disease Progression|14
2998911|NCT00951665|10320361|P2|Phase 1b|Disease Progression|2
2998912|NCT00951665|10320362|P1|Phase 1b|Disease Progression|13
2998913|NCT00951665|10320357|P6|Phase 1b|Withdrawal by Subject|0
2998914|NCT00951665|10320358|P5|Phase 1b|Withdrawal by Subject|0
2998915|NCT00951665|10320359|P4|Phase 1b|Withdrawal by Subject|0
2998916|NCT00951665|10320360|P3|Phase 1b|Withdrawal by Subject|0
2998917|NCT00951665|10320361|P2|Phase 1b|Withdrawal by Subject|1
2998918|NCT00951665|10320362|P1|Phase 1b|Withdrawal by Subject|0
2998919|NCT00951665|10320357|P6|Phase 1b|Physician Decision|0
2998920|NCT00951665|10320358|P5|Phase 1b|Physician Decision|0
2998921|NCT00951665|10320359|P4|Phase 1b|Physician Decision|0
2998922|NCT00951665|10320360|P3|Phase 1b|Physician Decision|1
2998923|NCT00951665|10320361|P2|Phase 1b|Physician Decision|0
2998924|NCT00951665|10320362|P1|Phase 1b|Physician Decision|4
2998925|NCT00951665|10320357|P6|Phase 1b|Death|0
2998926|NCT00951665|10320358|P5|Phase 1b|Death|0
2998927|NCT00951665|10320359|P4|Phase 1b|Death|0
2998928|NCT00951665|10320360|P3|Phase 1b|Death|2
2998929|NCT00951665|10320361|P2|Phase 1b|Death|0
2998930|NCT00951665|10320362|P1|Phase 1b|Death|1
2998931|NCT00951665|10320357|P6|Phase 1b|Adverse Event|0
2998932|NCT00951665|10320358|P5|Phase 1b|Adverse Event|0
2998933|NCT00951665|10320359|P4|Phase 1b|Adverse Event|1
2998934|NCT00951665|10320360|P3|Phase 1b|Adverse Event|0
2998935|NCT00951665|10320361|P2|Phase 1b|Adverse Event|1
2998936|NCT00951665|10320362|P1|Phase 1b|Adverse Event|2
2998937|NCT00951509|10320471|P1|Overall Study|Withdrawal by Subject|2
2998938|NCT00951496|10320482|P3|Overall Study|Did not initiate study treatment|13
2998939|NCT00951496|10320483|P2|Overall Study|Did not initiate study treatment|8
2998940|NCT00951496|10320484|P1|Overall Study|Did not initiate study treatment|10
2998941|NCT00951483|10320512|P2|Overall Study|Withdrawal by Subject|0
2998942|NCT00951483|10320513|P1|Overall Study|Withdrawal by Subject|15
2998943|NCT00951483|10320512|P2|Overall Study|Physician Decision|0
2998944|NCT00951483|10320513|P1|Overall Study|Physician Decision|4
2998945|NCT00951379|10320533|P2|Overall Study|Disease Progression|1
2998946|NCT00951379|10320534|P1|Overall Study|Disease Progression|0
2998947|NCT00951379|10320533|P2|Overall Study|Noncompliance|0
2998948|NCT00951379|10320534|P1|Overall Study|Noncompliance|1
2998949|NCT00951379|10320533|P2|Overall Study|Withdrawal by Subject|0
2998950|NCT00951379|10320534|P1|Overall Study|Withdrawal by Subject|1
2998951|NCT00951379|10320533|P2|Overall Study|Adverse Event|1
2998952|NCT00951379|10320534|P1|Overall Study|Adverse Event|4
2998953|NCT00951275|10320576|P1|Overall Study|Protocol Violation|1
2998954|NCT00951275|10320576|P1|Overall Study|Withdrawal by Subject|4
2998955|NCT00951275|10320576|P1|Overall Study|Adverse Event|7
2998956|NCT00951275|10320576|P1|Overall Study|Administrative Reason|1
2998957|NCT00951171|10320608|P2|Overall Study|Adverse Event|0
2998958|NCT00951171|10320609|P1|Overall Study|Adverse Event|2
2998959|NCT00951041|10320641|P2|Overall Study|Other|0
2998960|NCT00951041|10320642|P1|Overall Study|Other|3
2998961|NCT00951041|10320641|P2|Overall Study|Lost to Follow-up|0
2998962|NCT00951041|10320642|P1|Overall Study|Lost to Follow-up|1
2998963|NCT00951041|10320641|P2|Overall Study|Withdrawal by Subject|1
2998964|NCT00951041|10320642|P1|Overall Study|Withdrawal by Subject|1
2998965|NCT00951015|10320697|P5|Open-label Phase|Physician Decision|8
2998966|NCT00951015|10320698|P4|Open-label Phase|Physician Decision|0
2998967|NCT00951015|10320699|P3|Open-label Phase|Physician Decision|0
2998968|NCT00951015|10320700|P2|Open-label Phase|Physician Decision|0
2998969|NCT00951015|10320701|P1|Open-label Phase|Physician Decision|0
2998970|NCT00951015|10320697|P5|Open-label Phase|Withdrawal by Subject|14
2998971|NCT00951015|10320698|P4|Open-label Phase|Withdrawal by Subject|0
2998972|NCT00951015|10320699|P3|Open-label Phase|Withdrawal by Subject|0
2998973|NCT00951015|10320700|P2|Open-label Phase|Withdrawal by Subject|0
2998974|NCT00951015|10320701|P1|Open-label Phase|Withdrawal by Subject|0
2998975|NCT00951015|10320697|P5|Open-label Phase|Lost to Follow-up|12
2998976|NCT00951015|10320698|P4|Open-label Phase|Lost to Follow-up|0
2998977|NCT00951015|10320699|P3|Open-label Phase|Lost to Follow-up|0
2998978|NCT00951015|10320700|P2|Open-label Phase|Lost to Follow-up|0
2998979|NCT00951015|10320701|P1|Open-label Phase|Lost to Follow-up|0
2998980|NCT00951015|10320697|P5|Open-label Phase|Protocol Violation|12
2998981|NCT00951015|10320698|P4|Open-label Phase|Protocol Violation|0
2998982|NCT00951015|10320699|P3|Open-label Phase|Protocol Violation|0
2998983|NCT00951015|10320700|P2|Open-label Phase|Protocol Violation|0
2998984|NCT00951015|10320701|P1|Open-label Phase|Protocol Violation|0
2998985|NCT00951015|10320697|P5|Open-label Phase|Lack of Efficacy|1
2998986|NCT00951015|10320698|P4|Open-label Phase|Lack of Efficacy|0
2998987|NCT00951015|10320699|P3|Open-label Phase|Lack of Efficacy|0
2998988|NCT00951015|10320700|P2|Open-label Phase|Lack of Efficacy|0
2998989|NCT00951015|10320701|P1|Open-label Phase|Lack of Efficacy|0
2998990|NCT00951015|10320697|P5|Open-label Phase|Adverse Event|3
2998991|NCT00951015|10320698|P4|Open-label Phase|Adverse Event|0
2998992|NCT00951015|10320699|P3|Open-label Phase|Adverse Event|0
2998993|NCT00951015|10320700|P2|Open-label Phase|Adverse Event|0
2998994|NCT00951015|10320701|P1|Open-label Phase|Adverse Event|0
2998995|NCT00951015|10320697|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
2998996|NCT00951015|10320698|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
2998997|NCT00951015|10320699|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
2998998|NCT00951015|10320700|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
2998999|NCT00951015|10320701|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
2999000|NCT00951015|10320697|P5|Randomization Phase 96 Week|Lost to Follow-up|0
2999001|NCT00951015|10320698|P4|Randomization Phase 96 Week|Lost to Follow-up|2
2999002|NCT00951015|10320699|P3|Randomization Phase 96 Week|Lost to Follow-up|1
2999003|NCT00951015|10320700|P2|Randomization Phase 96 Week|Lost to Follow-up|3
2999004|NCT00951015|10320701|P1|Randomization Phase 96 Week|Lost to Follow-up|0
2999005|NCT00951015|10320697|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2999006|NCT00951015|10320698|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
2999007|NCT00951015|10320699|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2999008|NCT00951015|10320700|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2999009|NCT00951015|10320701|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2999010|NCT00951015|10320697|P5|Randomization Phase 96 Week|Protocol Violation|0
2999011|NCT00951015|10320698|P4|Randomization Phase 96 Week|Protocol Violation|0
2999012|NCT00951015|10320699|P3|Randomization Phase 96 Week|Protocol Violation|1
2999013|NCT00951015|10320700|P2|Randomization Phase 96 Week|Protocol Violation|1
2999014|NCT00951015|10320701|P1|Randomization Phase 96 Week|Protocol Violation|1
2999015|NCT00951015|10320697|P5|Randomization Phase 96 Week|Lack of Efficacy|0
2999016|NCT00951015|10320698|P4|Randomization Phase 96 Week|Lack of Efficacy|0
2999017|NCT00951015|10320699|P3|Randomization Phase 96 Week|Lack of Efficacy|0
2999018|NCT00951015|10320700|P2|Randomization Phase 96 Week|Lack of Efficacy|1
2999019|NCT00951015|10320701|P1|Randomization Phase 96 Week|Lack of Efficacy|1
2999020|NCT00951015|10320697|P5|Randomization Phase 96 Week|Adverse Event|0
2999021|NCT00951015|10320698|P4|Randomization Phase 96 Week|Adverse Event|5
2999022|NCT00951015|10320699|P3|Randomization Phase 96 Week|Adverse Event|2
2999023|NCT00951015|10320700|P2|Randomization Phase 96 Week|Adverse Event|1
2999024|NCT00951015|10320701|P1|Randomization Phase 96 Week|Adverse Event|1
2999025|NCT00950963|10320798|P2|Overall Study|Lost to Follow-up|24
2999026|NCT00950963|10320799|P1|Overall Study|Lost to Follow-up|29
2999027|NCT00950950|10320815|P2|Overall Study|Withdrawal by Subject|1
2999028|NCT00950950|10320816|P1|Overall Study|Withdrawal by Subject|0
2999029|NCT00950950|10320815|P2|Overall Study|Adverse Event|0
2999030|NCT00950950|10320816|P1|Overall Study|Adverse Event|1
2999031|NCT00950911|10320898|P2|Overall Study|Poor performance status|1
2999032|NCT00950911|10320899|P1|Overall Study|Poor performance status|0
2999033|NCT00950911|10320898|P2|Overall Study|Noncompliance|0
2999034|NCT00950911|10320899|P1|Overall Study|Noncompliance|1
2999035|NCT00950911|10320898|P2|Overall Study|Ineligibility determined|0
2999036|NCT00950911|10320899|P1|Overall Study|Ineligibility determined|1
2999037|NCT00950911|10320898|P2|Overall Study|Administrative decision|1
2999038|NCT00950911|10320899|P1|Overall Study|Administrative decision|3
2999039|NCT00950911|10320898|P2|Overall Study|Consent withdrawn|3
2999040|NCT00950911|10320899|P1|Overall Study|Consent withdrawn|1
2999041|NCT00950911|10320898|P2|Overall Study|Disease progression|2
2999042|NCT00950911|10320899|P1|Overall Study|Disease progression|2
2999043|NCT00950911|10320898|P2|Overall Study|Death|6
2999044|NCT00950911|10320899|P1|Overall Study|Death|4
2999045|NCT00950911|10320898|P2|Overall Study|Adverse Event|2
2999046|NCT00950911|10320899|P1|Overall Study|Adverse Event|0
2999047|NCT00950872|10320905|P1|Overall Study|Did not have surgery|2
2999048|NCT00950872|10320905|P1|Overall Study|Withdrawal by Subject|1
2999049|NCT00950859|10320914|P2|Overall Study|Lost to Follow-up|3
2999050|NCT00950859|10320915|P1|Overall Study|Lost to Follow-up|0
2999051|NCT00950859|10320914|P2|Overall Study|Protocol Violation|1
2999052|NCT00950859|10320915|P1|Overall Study|Protocol Violation|1
2999053|NCT00950859|10320914|P2|Overall Study|Insufficient Viral Load Response|3
2999054|NCT00950859|10320915|P1|Overall Study|Insufficient Viral Load Response|12
2999055|NCT00950859|10320914|P2|Overall Study|Adverse Event|3
2999056|NCT00950859|10320915|P1|Overall Study|Adverse Event|3
2999057|NCT00950807|10321014|P10|Treatment Period 3|Adverse Event|0
2999058|NCT00950807|10321015|P9|Treatment Period 3|Adverse Event|0
2999059|NCT00950807|10321016|P8|Treatment Period 3|Adverse Event|0
2999060|NCT00950807|10321017|P7|Treatment Period 3|Adverse Event|1
2999061|NCT00950807|10321018|P6|Treatment Period 3|Adverse Event|0
2999062|NCT00950807|10321019|P5|Treatment Period 3|Adverse Event|0
2999063|NCT00950807|10321020|P4|Treatment Period 3|Adverse Event|0
2999064|NCT00950807|10321021|P3|Treatment Period 3|Adverse Event|0
2999065|NCT00950807|10321022|P2|Treatment Period 3|Adverse Event|0
2999066|NCT00950807|10321023|P1|Treatment Period 3|Adverse Event|0
2999067|NCT00950807|10321014|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999068|NCT00950807|10321015|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999069|NCT00950807|10321016|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
2999070|NCT00950807|10321017|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999071|NCT00950807|10321018|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999072|NCT00950807|10321019|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999073|NCT00950807|10321020|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999074|NCT00950807|10321021|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999075|NCT00950807|10321022|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
2999076|NCT00950807|10321023|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
2999077|NCT00950807|10321014|P10|Treatment Period 3|Withdrawal by Subject|1
2999078|NCT00950807|10321015|P9|Treatment Period 3|Withdrawal by Subject|0
2999079|NCT00950807|10321016|P8|Treatment Period 3|Withdrawal by Subject|0
2999080|NCT00950807|10321017|P7|Treatment Period 3|Withdrawal by Subject|0
2999081|NCT00950807|10321018|P6|Treatment Period 3|Withdrawal by Subject|0
2999082|NCT00950807|10321019|P5|Treatment Period 3|Withdrawal by Subject|0
2999083|NCT00950807|10321020|P4|Treatment Period 3|Withdrawal by Subject|0
2999084|NCT00950807|10321021|P3|Treatment Period 3|Withdrawal by Subject|0
2999085|NCT00950807|10321022|P2|Treatment Period 3|Withdrawal by Subject|0
2999086|NCT00950807|10321023|P1|Treatment Period 3|Withdrawal by Subject|0
2999087|NCT00950807|10321014|P10|Washout Period 2|Adverse Event|0
2999088|NCT00950807|10321015|P9|Washout Period 2|Adverse Event|0
2999089|NCT00950807|10321016|P8|Washout Period 2|Adverse Event|0
2999090|NCT00950807|10321017|P7|Washout Period 2|Adverse Event|0
2999091|NCT00950807|10321018|P6|Washout Period 2|Adverse Event|0
2999092|NCT00950807|10321019|P5|Washout Period 2|Adverse Event|0
2999093|NCT00950807|10321020|P4|Washout Period 2|Adverse Event|1
2999094|NCT00950807|10321021|P3|Washout Period 2|Adverse Event|0
2999095|NCT00950807|10321022|P2|Washout Period 2|Adverse Event|0
2999096|NCT00950807|10321023|P1|Washout Period 2|Adverse Event|3
2999097|NCT00950807|10321014|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
2999098|NCT00950807|10321015|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
2999099|NCT00950807|10321016|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
2999100|NCT00950807|10321017|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
2999101|NCT00950807|10321018|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
2999102|NCT00950807|10321019|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
2999103|NCT00950807|10321020|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
2999104|NCT00950807|10321021|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
2999105|NCT00950807|10321022|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
2999106|NCT00950807|10321023|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
2999107|NCT00950807|10321014|P10|Washout Period 2|Lack of Efficacy|0
2999108|NCT00950807|10321015|P9|Washout Period 2|Lack of Efficacy|0
2999109|NCT00950807|10321016|P8|Washout Period 2|Lack of Efficacy|0
2999110|NCT00950807|10321017|P7|Washout Period 2|Lack of Efficacy|0
2999111|NCT00950807|10321018|P6|Washout Period 2|Lack of Efficacy|0
2999112|NCT00950807|10321019|P5|Washout Period 2|Lack of Efficacy|0
2999113|NCT00950807|10321020|P4|Washout Period 2|Lack of Efficacy|0
2999114|NCT00950807|10321021|P3|Washout Period 2|Lack of Efficacy|0
2999115|NCT00950807|10321022|P2|Washout Period 2|Lack of Efficacy|0
2999116|NCT00950807|10321023|P1|Washout Period 2|Lack of Efficacy|1
2999117|NCT00950807|10321014|P10|Treatment Period 2|Adverse Event|0
2999118|NCT00950807|10321015|P9|Treatment Period 2|Adverse Event|0
2999119|NCT00950807|10321016|P8|Treatment Period 2|Adverse Event|1
2999120|NCT00950807|10321017|P7|Treatment Period 2|Adverse Event|0
2999121|NCT00950807|10321018|P6|Treatment Period 2|Adverse Event|1
2999122|NCT00950807|10321019|P5|Treatment Period 2|Adverse Event|0
2999123|NCT00950807|10321020|P4|Treatment Period 2|Adverse Event|1
2999124|NCT00950807|10321021|P3|Treatment Period 2|Adverse Event|0
2999125|NCT00950807|10321022|P2|Treatment Period 2|Adverse Event|1
2999126|NCT00950807|10321023|P1|Treatment Period 2|Adverse Event|0
2999127|NCT00950807|10321014|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999128|NCT00950807|10321015|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999129|NCT00950807|10321016|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999130|NCT00950807|10321017|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999131|NCT00950807|10321018|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999132|NCT00950807|10321019|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999133|NCT00950807|10321020|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999134|NCT00950807|10321021|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999135|NCT00950807|10321022|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
2999136|NCT00950807|10321023|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
2999137|NCT00950807|10321014|P10|Treatment Period 2|Withdrawal by Subject|0
2999138|NCT00950807|10321015|P9|Treatment Period 2|Withdrawal by Subject|0
2999139|NCT00950807|10321016|P8|Treatment Period 2|Withdrawal by Subject|2
2999140|NCT00950807|10321017|P7|Treatment Period 2|Withdrawal by Subject|1
2999141|NCT00950807|10321018|P6|Treatment Period 2|Withdrawal by Subject|0
2999142|NCT00950807|10321019|P5|Treatment Period 2|Withdrawal by Subject|0
2999143|NCT00950807|10321020|P4|Treatment Period 2|Withdrawal by Subject|0
2999144|NCT00950807|10321021|P3|Treatment Period 2|Withdrawal by Subject|0
2999145|NCT00950807|10321022|P2|Treatment Period 2|Withdrawal by Subject|0
2999146|NCT00950807|10321023|P1|Treatment Period 2|Withdrawal by Subject|0
2999147|NCT00950807|10321014|P10|Treatment Period 2|Lack of Efficacy|0
2999148|NCT00950807|10321015|P9|Treatment Period 2|Lack of Efficacy|0
2999149|NCT00950807|10321016|P8|Treatment Period 2|Lack of Efficacy|0
2999150|NCT00950807|10321017|P7|Treatment Period 2|Lack of Efficacy|0
2999151|NCT00950807|10321018|P6|Treatment Period 2|Lack of Efficacy|0
2999152|NCT00950807|10321019|P5|Treatment Period 2|Lack of Efficacy|0
2999153|NCT00950807|10321020|P4|Treatment Period 2|Lack of Efficacy|0
2999154|NCT00950807|10321021|P3|Treatment Period 2|Lack of Efficacy|0
2999155|NCT00950807|10321022|P2|Treatment Period 2|Lack of Efficacy|0
2999156|NCT00950807|10321023|P1|Treatment Period 2|Lack of Efficacy|1
2999157|NCT00950807|10321014|P10|Washout Period 1|Adverse Event|0
2999158|NCT00950807|10321015|P9|Washout Period 1|Adverse Event|0
2999159|NCT00950807|10321016|P8|Washout Period 1|Adverse Event|0
2999160|NCT00950807|10321017|P7|Washout Period 1|Adverse Event|0
2999161|NCT00950807|10321018|P6|Washout Period 1|Adverse Event|0
2999162|NCT00950807|10321019|P5|Washout Period 1|Adverse Event|1
2999163|NCT00950807|10321020|P4|Washout Period 1|Adverse Event|1
2999164|NCT00950807|10321021|P3|Washout Period 1|Adverse Event|0
2999165|NCT00950807|10321022|P2|Washout Period 1|Adverse Event|0
2999166|NCT00950807|10321023|P1|Washout Period 1|Adverse Event|2
2999167|NCT00950807|10321014|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
2999168|NCT00950807|10321015|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
2999169|NCT00950807|10321016|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
2999170|NCT00950807|10321017|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
2999171|NCT00950807|10321018|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
2999172|NCT00950807|10321019|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
2999173|NCT00950807|10321020|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
2999174|NCT00950807|10321021|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
2999175|NCT00950807|10321022|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
2999176|NCT00950807|10321023|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
2999177|NCT00950807|10321014|P10|Washout Period 1|Withdrawal by Subject|0
2999178|NCT00950807|10321015|P9|Washout Period 1|Withdrawal by Subject|1
2999179|NCT00950807|10321016|P8|Washout Period 1|Withdrawal by Subject|0
2999180|NCT00950807|10321017|P7|Washout Period 1|Withdrawal by Subject|0
2999181|NCT00950807|10321018|P6|Washout Period 1|Withdrawal by Subject|0
2999182|NCT00950807|10321019|P5|Washout Period 1|Withdrawal by Subject|0
2999183|NCT00950807|10321020|P4|Washout Period 1|Withdrawal by Subject|0
2999184|NCT00950807|10321021|P3|Washout Period 1|Withdrawal by Subject|0
2999185|NCT00950807|10321022|P2|Washout Period 1|Withdrawal by Subject|0
2999186|NCT00950807|10321023|P1|Washout Period 1|Withdrawal by Subject|0
2999187|NCT00950807|10321014|P10|Washout Period 1|Lack of Efficacy|0
2999188|NCT00950807|10321015|P9|Washout Period 1|Lack of Efficacy|0
2999189|NCT00950807|10321016|P8|Washout Period 1|Lack of Efficacy|0
2999190|NCT00950807|10321017|P7|Washout Period 1|Lack of Efficacy|1
2999191|NCT00950807|10321018|P6|Washout Period 1|Lack of Efficacy|0
2999192|NCT00950807|10321019|P5|Washout Period 1|Lack of Efficacy|0
2999193|NCT00950807|10321020|P4|Washout Period 1|Lack of Efficacy|0
2999194|NCT00950807|10321021|P3|Washout Period 1|Lack of Efficacy|0
2999195|NCT00950807|10321022|P2|Washout Period 1|Lack of Efficacy|0
2999196|NCT00950807|10321023|P1|Washout Period 1|Lack of Efficacy|0
2999197|NCT00950807|10321014|P10|Treatment Period 1|Adverse Event|0
2999198|NCT00950807|10321015|P9|Treatment Period 1|Adverse Event|0
2999199|NCT00950807|10321016|P8|Treatment Period 1|Adverse Event|0
2999200|NCT00950807|10321017|P7|Treatment Period 1|Adverse Event|0
2999201|NCT00950807|10321018|P6|Treatment Period 1|Adverse Event|1
2999202|NCT00950807|10321019|P5|Treatment Period 1|Adverse Event|0
2999203|NCT00950807|10321020|P4|Treatment Period 1|Adverse Event|0
2999204|NCT00950807|10321021|P3|Treatment Period 1|Adverse Event|0
2999205|NCT00950807|10321022|P2|Treatment Period 1|Adverse Event|0
2999206|NCT00950807|10321023|P1|Treatment Period 1|Adverse Event|0
2999207|NCT00950807|10321014|P10|Treatment Period 1|Withdrawal by Subject|0
2999208|NCT00950807|10321015|P9|Treatment Period 1|Withdrawal by Subject|1
2999209|NCT00950807|10321016|P8|Treatment Period 1|Withdrawal by Subject|0
2999210|NCT00950807|10321017|P7|Treatment Period 1|Withdrawal by Subject|0
2999211|NCT00950807|10321018|P6|Treatment Period 1|Withdrawal by Subject|0
2999212|NCT00950807|10321019|P5|Treatment Period 1|Withdrawal by Subject|1
2999213|NCT00950807|10321020|P4|Treatment Period 1|Withdrawal by Subject|0
2999214|NCT00950807|10321021|P3|Treatment Period 1|Withdrawal by Subject|0
2999215|NCT00950807|10321022|P2|Treatment Period 1|Withdrawal by Subject|0
2999216|NCT00950807|10321023|P1|Treatment Period 1|Withdrawal by Subject|1
2999217|NCT00950807|10321014|P10|Treatment Period 1|Lost to Follow-up|0
2999218|NCT00950807|10321015|P9|Treatment Period 1|Lost to Follow-up|0
2999219|NCT00950807|10321016|P8|Treatment Period 1|Lost to Follow-up|0
2999220|NCT00950807|10321017|P7|Treatment Period 1|Lost to Follow-up|0
2999221|NCT00950807|10321018|P6|Treatment Period 1|Lost to Follow-up|0
2999222|NCT00950807|10321019|P5|Treatment Period 1|Lost to Follow-up|0
2999223|NCT00950807|10321020|P4|Treatment Period 1|Lost to Follow-up|0
2999224|NCT00950807|10321021|P3|Treatment Period 1|Lost to Follow-up|1
2999225|NCT00950807|10321022|P2|Treatment Period 1|Lost to Follow-up|0
2999226|NCT00950807|10321023|P1|Treatment Period 1|Lost to Follow-up|0
2999227|NCT00950807|10321014|P10|Treatment Period 1|Protocol Violation|0
2999228|NCT00950807|10321015|P9|Treatment Period 1|Protocol Violation|0
2999229|NCT00950807|10321016|P8|Treatment Period 1|Protocol Violation|0
2999230|NCT00950807|10321017|P7|Treatment Period 1|Protocol Violation|0
2999231|NCT00950807|10321018|P6|Treatment Period 1|Protocol Violation|0
2999232|NCT00950807|10321019|P5|Treatment Period 1|Protocol Violation|0
2999233|NCT00950807|10321020|P4|Treatment Period 1|Protocol Violation|0
2999234|NCT00950807|10321021|P3|Treatment Period 1|Protocol Violation|0
2999235|NCT00950807|10321022|P2|Treatment Period 1|Protocol Violation|0
2999236|NCT00950807|10321023|P1|Treatment Period 1|Protocol Violation|1
2999237|NCT00950807|10321014|P10|Treatment Period 1|Lack of Efficacy|0
2999238|NCT00950807|10321015|P9|Treatment Period 1|Lack of Efficacy|0
2999239|NCT00950807|10321016|P8|Treatment Period 1|Lack of Efficacy|0
2999240|NCT00950807|10321017|P7|Treatment Period 1|Lack of Efficacy|0
2999241|NCT00950807|10321018|P6|Treatment Period 1|Lack of Efficacy|1
2999242|NCT00950807|10321019|P5|Treatment Period 1|Lack of Efficacy|0
2999243|NCT00950807|10321020|P4|Treatment Period 1|Lack of Efficacy|0
2999244|NCT00950807|10321021|P3|Treatment Period 1|Lack of Efficacy|0
2999245|NCT00950807|10321022|P2|Treatment Period 1|Lack of Efficacy|0
2999246|NCT00950807|10321023|P1|Treatment Period 1|Lack of Efficacy|1
2999247|NCT00950755|10321065|P1|Long-Term Follow-Up|Death|8
2999248|NCT00950755|10321065|P1|Long-Term Follow-Up|Lost to Follow-up|1
2999249|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
2999250|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
2999251|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
2999252|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
2999253|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Death|1
2999254|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
2999255|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
2999256|NCT00950755|10321065|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2999257|NCT00950742|10321091|P2|Overall Study|Dose limiting toxicity|0
2999258|NCT00950742|10321092|P1|Overall Study|Dose limiting toxicity|6
2999259|NCT00950742|10321091|P2|Overall Study|Progressive Disease|2
2999260|NCT00950742|10321092|P1|Overall Study|Progressive Disease|6
2999261|NCT00950742|10321091|P2|Overall Study|Withdrawal by Subject|0
2999262|NCT00950742|10321092|P1|Overall Study|Withdrawal by Subject|3
2999263|NCT00950742|10321091|P2|Overall Study|Other Adverse Event|0
2999264|NCT00950742|10321092|P1|Overall Study|Other Adverse Event|1
2999265|NCT00950690|10321113|P1|Overall Study|Other|163
2999266|NCT00950690|10321113|P1|Overall Study|Lost to Follow-up|40
2999267|NCT00950690|10321113|P1|Overall Study|Lack of Efficacy|22
2999268|NCT00950690|10321113|P1|Overall Study|Adverse Event|15
2999269|NCT00950690|10321113|P1|Overall Study|Death|4
2999270|NCT00950664|10321120|P2|First Intervention|Withdrawal by Subject|2
2999271|NCT00950664|10321121|P1|First Intervention|Withdrawal by Subject|2
2999272|NCT00950664|10321120|P2|First Intervention|Lost to Follow-up|3
2999273|NCT00950664|10321121|P1|First Intervention|Lost to Follow-up|1
2999274|NCT00950651|10321141|P2|Overall Study|Withdrawal by Subject|9
2999275|NCT00950651|10321142|P1|Overall Study|Withdrawal by Subject|8
2999276|NCT00950651|10321141|P2|Overall Study|Protocol Violation|4
2999277|NCT00950651|10321142|P1|Overall Study|Protocol Violation|3
2999278|NCT00950651|10321141|P2|Overall Study|Lack of Efficacy|2
2999279|NCT00950651|10321142|P1|Overall Study|Lack of Efficacy|2
2999280|NCT00950651|10321141|P2|Overall Study|Death|0
2999281|NCT00950651|10321142|P1|Overall Study|Death|1
2999282|NCT00950651|10321141|P2|Overall Study|Adverse Event|20
2999283|NCT00950651|10321142|P1|Overall Study|Adverse Event|17
2999284|NCT00950599|10321235|P10|Follow-Up Period|Subject withdrew Consent|1
2999285|NCT00950599|10321236|P9|Follow-Up Period|Subject withdrew Consent|2
2999286|NCT00950599|10321237|P8|Follow-Up Period|Subject withdrew Consent|0
2999287|NCT00950599|10321238|P7|Follow-Up Period|Subject withdrew Consent|0
2999288|NCT00950599|10321239|P6|Follow-Up Period|Subject withdrew Consent|0
2999289|NCT00950599|10321240|P5|Follow-Up Period|Subject withdrew Consent|0
2999290|NCT00950599|10321241|P4|Follow-Up Period|Subject withdrew Consent|0
2999291|NCT00950599|10321242|P3|Follow-Up Period|Subject withdrew Consent|0
2999292|NCT00950599|10321243|P2|Follow-Up Period|Subject withdrew Consent|0
2999293|NCT00950599|10321244|P1|Follow-Up Period|Subject withdrew Consent|0
2999294|NCT00950599|10321235|P10|Follow-Up Period|Poor/Noncompliance|0
2999295|NCT00950599|10321236|P9|Follow-Up Period|Poor/Noncompliance|1
2999296|NCT00950599|10321237|P8|Follow-Up Period|Poor/Noncompliance|0
2999297|NCT00950599|10321238|P7|Follow-Up Period|Poor/Noncompliance|0
2999298|NCT00950599|10321239|P6|Follow-Up Period|Poor/Noncompliance|0
2999299|NCT00950599|10321240|P5|Follow-Up Period|Poor/Noncompliance|0
2999300|NCT00950599|10321241|P4|Follow-Up Period|Poor/Noncompliance|0
2999301|NCT00950599|10321242|P3|Follow-Up Period|Poor/Noncompliance|0
2999302|NCT00950599|10321243|P2|Follow-Up Period|Poor/Noncompliance|0
2999303|NCT00950599|10321244|P1|Follow-Up Period|Poor/Noncompliance|0
2999304|NCT00950599|10321235|P10|Follow-Up Period|Physician Decision|0
2999305|NCT00950599|10321236|P9|Follow-Up Period|Physician Decision|1
2999306|NCT00950599|10321237|P8|Follow-Up Period|Physician Decision|0
2999307|NCT00950599|10321238|P7|Follow-Up Period|Physician Decision|0
2999308|NCT00950599|10321239|P6|Follow-Up Period|Physician Decision|0
2999309|NCT00950599|10321240|P5|Follow-Up Period|Physician Decision|0
2999310|NCT00950599|10321241|P4|Follow-Up Period|Physician Decision|0
2999311|NCT00950599|10321242|P3|Follow-Up Period|Physician Decision|0
2999312|NCT00950599|10321243|P2|Follow-Up Period|Physician Decision|0
2999313|NCT00950599|10321244|P1|Follow-Up Period|Physician Decision|0
2999314|NCT00950599|10321235|P10|Follow-Up Period|Lost to Follow-up|1
2999315|NCT00950599|10321236|P9|Follow-Up Period|Lost to Follow-up|5
2999316|NCT00950599|10321237|P8|Follow-Up Period|Lost to Follow-up|0
2999317|NCT00950599|10321238|P7|Follow-Up Period|Lost to Follow-up|0
2999318|NCT00950599|10321239|P6|Follow-Up Period|Lost to Follow-up|0
2999319|NCT00950599|10321240|P5|Follow-Up Period|Lost to Follow-up|0
2999320|NCT00950599|10321241|P4|Follow-Up Period|Lost to Follow-up|0
2999321|NCT00950599|10321242|P3|Follow-Up Period|Lost to Follow-up|0
2999322|NCT00950599|10321243|P2|Follow-Up Period|Lost to Follow-up|0
2999323|NCT00950599|10321244|P1|Follow-Up Period|Lost to Follow-up|0
2999324|NCT00950599|10321235|P10|Follow-Up Period|Lack of Efficacy|0
2999325|NCT00950599|10321236|P9|Follow-Up Period|Lack of Efficacy|3
2999326|NCT00950599|10321237|P8|Follow-Up Period|Lack of Efficacy|0
2999327|NCT00950599|10321238|P7|Follow-Up Period|Lack of Efficacy|0
2999328|NCT00950599|10321239|P6|Follow-Up Period|Lack of Efficacy|0
2999329|NCT00950599|10321240|P5|Follow-Up Period|Lack of Efficacy|0
2999330|NCT00950599|10321241|P4|Follow-Up Period|Lack of Efficacy|0
2999331|NCT00950599|10321242|P3|Follow-Up Period|Lack of Efficacy|0
2999332|NCT00950599|10321243|P2|Follow-Up Period|Lack of Efficacy|0
2999333|NCT00950599|10321244|P1|Follow-Up Period|Lack of Efficacy|0
2999334|NCT00950599|10321235|P10|Follow-Up Period|Adverse Event|0
2999335|NCT00950599|10321236|P9|Follow-Up Period|Adverse Event|1
2999336|NCT00950599|10321237|P8|Follow-Up Period|Adverse Event|0
2999337|NCT00950599|10321238|P7|Follow-Up Period|Adverse Event|0
2999338|NCT00950599|10321239|P6|Follow-Up Period|Adverse Event|0
2999339|NCT00950599|10321240|P5|Follow-Up Period|Adverse Event|0
2999340|NCT00950599|10321241|P4|Follow-Up Period|Adverse Event|0
2999341|NCT00950599|10321242|P3|Follow-Up Period|Adverse Event|0
2999342|NCT00950599|10321243|P2|Follow-Up Period|Adverse Event|0
2999343|NCT00950599|10321244|P1|Follow-Up Period|Adverse Event|0
2999344|NCT00950599|10321235|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
2999345|NCT00950599|10321236|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
2999346|NCT00950599|10321237|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
2999347|NCT00950599|10321238|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
2999348|NCT00950599|10321239|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
2999349|NCT00950599|10321240|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
2999350|NCT00950599|10321241|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
2999351|NCT00950599|10321242|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
2999352|NCT00950599|10321243|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
2999353|NCT00950599|10321244|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
2999354|NCT00950599|10321235|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999355|NCT00950599|10321236|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999356|NCT00950599|10321237|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999357|NCT00950599|10321238|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999358|NCT00950599|10321239|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2999359|NCT00950599|10321240|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2999360|NCT00950599|10321241|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999361|NCT00950599|10321242|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999362|NCT00950599|10321243|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999363|NCT00950599|10321244|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2999364|NCT00950599|10321235|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
2999365|NCT00950599|10321236|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
2999366|NCT00950599|10321237|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
2999367|NCT00950599|10321238|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
2999368|NCT00950599|10321239|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
2999369|NCT00950599|10321240|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
2999370|NCT00950599|10321241|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
2999371|NCT00950599|10321242|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
2999372|NCT00950599|10321243|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
2999373|NCT00950599|10321244|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
2999374|NCT00950599|10321235|P10|Double-Blind Treatment Period|Lost to Follow-up|0
2999375|NCT00950599|10321236|P9|Double-Blind Treatment Period|Lost to Follow-up|0
2999376|NCT00950599|10321237|P8|Double-Blind Treatment Period|Lost to Follow-up|1
2999377|NCT00950599|10321238|P7|Double-Blind Treatment Period|Lost to Follow-up|0
2999378|NCT00950599|10321239|P6|Double-Blind Treatment Period|Lost to Follow-up|2
2999379|NCT00950599|10321240|P5|Double-Blind Treatment Period|Lost to Follow-up|1
2999380|NCT00950599|10321241|P4|Double-Blind Treatment Period|Lost to Follow-up|1
2999381|NCT00950599|10321242|P3|Double-Blind Treatment Period|Lost to Follow-up|0
2999382|NCT00950599|10321243|P2|Double-Blind Treatment Period|Lost to Follow-up|0
2999383|NCT00950599|10321244|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2999384|NCT00950599|10321235|P10|Double-Blind Treatment Period|Lack of Efficacy|0
2999385|NCT00950599|10321236|P9|Double-Blind Treatment Period|Lack of Efficacy|0
2999386|NCT00950599|10321237|P8|Double-Blind Treatment Period|Lack of Efficacy|1
2999387|NCT00950599|10321238|P7|Double-Blind Treatment Period|Lack of Efficacy|0
2999388|NCT00950599|10321239|P6|Double-Blind Treatment Period|Lack of Efficacy|6
2999389|NCT00950599|10321240|P5|Double-Blind Treatment Period|Lack of Efficacy|3
2999390|NCT00950599|10321241|P4|Double-Blind Treatment Period|Lack of Efficacy|7
2999391|NCT00950599|10321242|P3|Double-Blind Treatment Period|Lack of Efficacy|5
2999392|NCT00950599|10321243|P2|Double-Blind Treatment Period|Lack of Efficacy|5
2999393|NCT00950599|10321244|P1|Double-Blind Treatment Period|Lack of Efficacy|2
2999394|NCT00950599|10321235|P10|Double-Blind Treatment Period|Adverse Event|0
2999395|NCT00950599|10321236|P9|Double-Blind Treatment Period|Adverse Event|0
2999396|NCT00950599|10321237|P8|Double-Blind Treatment Period|Adverse Event|0
2999397|NCT00950599|10321238|P7|Double-Blind Treatment Period|Adverse Event|0
2999398|NCT00950599|10321239|P6|Double-Blind Treatment Period|Adverse Event|1
2999399|NCT00950599|10321240|P5|Double-Blind Treatment Period|Adverse Event|1
2999400|NCT00950599|10321241|P4|Double-Blind Treatment Period|Adverse Event|1
2999401|NCT00950599|10321242|P3|Double-Blind Treatment Period|Adverse Event|1
2999402|NCT00950599|10321243|P2|Double-Blind Treatment Period|Adverse Event|1
2999403|NCT00950599|10321244|P1|Double-Blind Treatment Period|Adverse Event|0
2999404|NCT00950599|10321235|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999405|NCT00950599|10321236|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999406|NCT00950599|10321237|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999407|NCT00950599|10321238|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999408|NCT00950599|10321239|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999409|NCT00950599|10321240|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999410|NCT00950599|10321241|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
2999411|NCT00950599|10321242|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999412|NCT00950599|10321243|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999413|NCT00950599|10321244|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
2999414|NCT00950300|10321817|P2|SFU Period|Withdrawal by Subject|8
2999415|NCT00950300|10321818|P1|SFU Period|Withdrawal by Subject|4
2999416|NCT00950300|10321817|P2|SFU Period|Lost to Follow-up|28
2999417|NCT00950300|10321818|P1|SFU Period|Lost to Follow-up|30
2999418|NCT00950300|10321817|P2|SFU Period|Death|42
2999419|NCT00950300|10321818|P1|SFU Period|Death|44
2999420|NCT00950300|10321817|P2|TFFU Period|Other|3
2999421|NCT00950300|10321818|P1|TFFU Period|Other|4
2999422|NCT00950300|10321817|P2|TFFU Period|Recurrence of Disease|72
2999423|NCT00950300|10321818|P1|TFFU Period|Recurrence of Disease|63
2999424|NCT00950300|10321817|P2|TFFU Period|Failure to Return|16
2999425|NCT00950300|10321818|P1|TFFU Period|Failure to Return|16
2999426|NCT00950300|10321817|P2|TFFU Period|Refused Treatment|11
2999427|NCT00950300|10321818|P1|TFFU Period|Refused Treatment|10
2999428|NCT00950300|10321817|P2|TFFU Period|Death|1
2999429|NCT00950300|10321818|P1|TFFU Period|Death|4
2999430|NCT00950300|10321817|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
2999431|NCT00950300|10321818|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
2999432|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2999433|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2999434|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
2999435|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
2999436|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
2999437|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
2999438|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
2999439|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
2999440|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
2999441|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
2999442|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
2999443|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
2999444|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
2999445|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
2999446|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
2999447|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
2999448|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
2999449|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
2999450|NCT00950300|10321817|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
2999451|NCT00950300|10321818|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
2999452|NCT00950248|10321867|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
2999453|NCT00950248|10321868|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
2999454|NCT00950248|10321869|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
2999455|NCT00950248|10321867|P3|Year 2&3 Treatment Randomization|Death|1
2999456|NCT00950248|10321868|P2|Year 2&3 Treatment Randomization|Death|0
2999457|NCT00950248|10321869|P1|Year 2&3 Treatment Randomization|Death|0
2999458|NCT00950248|10321867|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2999459|NCT00950248|10321868|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
2999460|NCT00950248|10321869|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2999461|NCT00950248|10321867|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
2999462|NCT00950248|10321868|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
2999463|NCT00950248|10321869|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
2999464|NCT00950248|10321867|P3|Year 1: Baseline|worsening of symptoms|0
2999465|NCT00950248|10321868|P2|Year 1: Baseline|worsening of symptoms|0
2999466|NCT00950248|10321869|P1|Year 1: Baseline|worsening of symptoms|2
2999467|NCT00950248|10321867|P3|Year 1: Baseline|Withdrawal by Subject|0
2999468|NCT00950248|10321868|P2|Year 1: Baseline|Withdrawal by Subject|0
2999469|NCT00950248|10321869|P1|Year 1: Baseline|Withdrawal by Subject|6
2999470|NCT00950170|10321909|P1|Overall Study|Discontinuation of Study by Sponsor|1
2999471|NCT00950170|10321909|P1|Overall Study|Adverse Event|2
2999472|NCT00950170|10321909|P1|Overall Study|Parent/Legal Guardian Request|1
2999473|NCT00949988|10321960|P1|Overall Study|Withdrawal by Subject|3
2999474|NCT00949975|10321975|P4|Overall Study|Other|0
2999475|NCT00949975|10321976|P3|Overall Study|Other|0
2999476|NCT00949975|10321977|P2|Overall Study|Other|0
2999477|NCT00949975|10321978|P1|Overall Study|Other|1
2999478|NCT00949975|10321975|P4|Overall Study|Lost to Follow-up|3
2999479|NCT00949975|10321976|P3|Overall Study|Lost to Follow-up|1
2999480|NCT00949975|10321977|P2|Overall Study|Lost to Follow-up|0
2999481|NCT00949975|10321978|P1|Overall Study|Lost to Follow-up|1
2999482|NCT00949975|10321975|P4|Overall Study|Severe non-compliance|2
2999483|NCT00949975|10321976|P3|Overall Study|Severe non-compliance|0
2999484|NCT00949975|10321977|P2|Overall Study|Severe non-compliance|1
2999485|NCT00949975|10321978|P1|Overall Study|Severe non-compliance|3
2999486|NCT00949975|10321975|P4|Overall Study|Incorrect enrolment|7
2999487|NCT00949975|10321976|P3|Overall Study|Incorrect enrolment|4
2999488|NCT00949975|10321977|P2|Overall Study|Incorrect enrolment|10
2999489|NCT00949975|10321978|P1|Overall Study|Incorrect enrolment|5
2999490|NCT00949975|10321975|P4|Overall Study|Study-specific criteria|0
2999491|NCT00949975|10321976|P3|Overall Study|Study-specific criteria|1
2999492|NCT00949975|10321977|P2|Overall Study|Study-specific criteria|1
2999493|NCT00949975|10321978|P1|Overall Study|Study-specific criteria|0
2999494|NCT00949975|10321975|P4|Overall Study|Safety reason|0
2999495|NCT00949975|10321976|P3|Overall Study|Safety reason|0
2999496|NCT00949975|10321977|P2|Overall Study|Safety reason|1
2999497|NCT00949975|10321978|P1|Overall Study|Safety reason|0
2999498|NCT00949975|10321975|P4|Overall Study|Adverse Event|10
2999499|NCT00949975|10321976|P3|Overall Study|Adverse Event|10
2999500|NCT00949975|10321977|P2|Overall Study|Adverse Event|11
2999501|NCT00949975|10321978|P1|Overall Study|Adverse Event|11
2999502|NCT00949975|10321975|P4|Overall Study|Voluntary discontinuation|6
2999503|NCT00949975|10321976|P3|Overall Study|Voluntary discontinuation|3
2999504|NCT00949975|10321977|P2|Overall Study|Voluntary discontinuation|5
2999505|NCT00949975|10321978|P1|Overall Study|Voluntary discontinuation|6
2999506|NCT00949910|10322096|P1|Overall Study|No Data|9
2999507|NCT00949910|10322096|P1|Overall Study|Other|4
2999508|NCT00949910|10322096|P1|Overall Study|Physician/Participant Decision|7
2999509|NCT00949910|10322096|P1|Overall Study|Serious Adverse Event|6
2999510|NCT00949910|10322096|P1|Overall Study|Adverse Event|83
2999511|NCT00949910|10322096|P1|Overall Study|Prolonged Dosing Interruption|4
2999512|NCT00949910|10322096|P1|Overall Study|Non-Compliance|10
2999513|NCT00949910|10322096|P1|Overall Study|Logistical Reasons|13
2999514|NCT00949910|10322096|P1|Overall Study|Violation of Eligibility|23
2999515|NCT00949910|10322096|P1|Overall Study|Switched to Commercial Treatment|4
2999516|NCT00949910|10322096|P1|Overall Study|Switched to Compassionate/Other Use|174
2999517|NCT00949910|10322096|P1|Overall Study|Unspecified Progression/Deterioration|13
2999518|NCT00949910|10322096|P1|Overall Study|Death from Unknown Cause|5
2999519|NCT00949910|10322096|P1|Overall Study|Death Due to Toxicity|3
2999520|NCT00949910|10322096|P1|Overall Study|Death Due to Adverse Event|115
2999521|NCT00949910|10322096|P1|Overall Study|Death Due to Progression/Deterioration|4
2999522|NCT00949910|10322096|P1|Overall Study|Death Due to Malignant Disease|456
2999523|NCT00949910|10322096|P1|Overall Study|Participant Refusal|390
2999524|NCT00949910|10322096|P1|Overall Study|Study Drug-Related Adverse Event|315
2999525|NCT00949910|10322096|P1|Overall Study|Lost to Follow-up|100
2999526|NCT00949910|10322096|P1|Overall Study|Symptomatic Deterioration|1088
2999527|NCT00949910|10322096|P1|Overall Study|Progressive Disease|3750
2999528|NCT00949884|10322109|P3|Overall Study|Study terminated by sponsor|1
2999529|NCT00949884|10322110|P2|Overall Study|Study terminated by sponsor|0
2999530|NCT00949884|10322111|P1|Overall Study|Study terminated by sponsor|0
2999531|NCT00949884|10322109|P3|Overall Study|Lack of Efficacy|7
2999532|NCT00949884|10322110|P2|Overall Study|Lack of Efficacy|2
2999533|NCT00949884|10322111|P1|Overall Study|Lack of Efficacy|4
2999534|NCT00949884|10322109|P3|Overall Study|Withdrawal by Subject|16
2999535|NCT00949884|10322110|P2|Overall Study|Withdrawal by Subject|4
2999536|NCT00949884|10322111|P1|Overall Study|Withdrawal by Subject|13
2999537|NCT00949884|10322109|P3|Overall Study|Treatment non-compliance|8
2999538|NCT00949884|10322110|P2|Overall Study|Treatment non-compliance|0
2999539|NCT00949884|10322111|P1|Overall Study|Treatment non-compliance|5
2999540|NCT00949884|10322109|P3|Overall Study|Physician Decision|6
2999541|NCT00949884|10322110|P2|Overall Study|Physician Decision|0
2999542|NCT00949884|10322111|P1|Overall Study|Physician Decision|5
2999543|NCT00949884|10322109|P3|Overall Study|Lost to Follow-up|5
2999544|NCT00949884|10322110|P2|Overall Study|Lost to Follow-up|5
2999545|NCT00949884|10322111|P1|Overall Study|Lost to Follow-up|7
2999546|NCT00949884|10322109|P3|Overall Study|Did not meet inclusion/exclusion|3
2999547|NCT00949884|10322110|P2|Overall Study|Did not meet inclusion/exclusion|1
2999548|NCT00949884|10322111|P1|Overall Study|Did not meet inclusion/exclusion|2
2999549|NCT00949884|10322109|P3|Overall Study|Adverse Event|12
2999550|NCT00949884|10322110|P2|Overall Study|Adverse Event|3
2999551|NCT00949884|10322111|P1|Overall Study|Adverse Event|14
2999552|NCT00949715|10322166|P2|Overall Study|Missing 24 month LVEF measurement|0
2999553|NCT00949715|10322167|P1|Overall Study|Missing 24 month LVEF measurement|2
2999554|NCT00949715|10322166|P2|Overall Study|Lost to Follow-up|0
2999555|NCT00949715|10322167|P1|Overall Study|Lost to Follow-up|1
2999556|NCT00949715|10322166|P2|Overall Study|Physician Decision|0
2999557|NCT00949715|10322167|P1|Overall Study|Physician Decision|1
2999558|NCT00949702|10322178|P1|Overall Study|Withdrawal of consent|1
2999559|NCT00949702|10322178|P1|Overall Study|Disease progression|7
2999560|NCT00949702|10322178|P1|Overall Study|Death|40
2999561|NCT00949650|10322195|P2|Overall Study|Other not specified above|0
2999562|NCT00949650|10322196|P1|Overall Study|Other not specified above|5
2999563|NCT00949650|10322195|P2|Overall Study|Not treated|4
2999564|NCT00949650|10322196|P1|Overall Study|Not treated|1
2999565|NCT00949650|10322195|P2|Overall Study|Refusal to continue medication|11
2999566|NCT00949650|10322196|P1|Overall Study|Refusal to continue medication|7
2999567|NCT00949650|10322195|P2|Overall Study|Protocol Violation|4
2999568|NCT00949650|10322196|P1|Overall Study|Protocol Violation|1
2999569|NCT00949650|10322195|P2|Overall Study|Other Adverse Event (AE)|17
2999570|NCT00949650|10322196|P1|Overall Study|Other Adverse Event (AE)|28
2999571|NCT00949650|10322195|P2|Overall Study|Completed 6 courses of chemotherapy|60
2999572|NCT00949650|10322196|P1|Overall Study|Completed 6 courses of chemotherapy|0
2999573|NCT00949650|10322195|P2|Overall Study|Progressive disease|19
2999574|NCT00949650|10322196|P1|Overall Study|Progressive disease|188
2999575|NCT00949533|10322234|P2|Overall Study|Lost to Follow-up|1
2999576|NCT00949533|10322235|P1|Overall Study|Lost to Follow-up|0
2999577|NCT00949325|10322247|P3|Overall Study|Adverse Event|0
2999578|NCT00949325|10322248|P2|Overall Study|Adverse Event|2
2999579|NCT00949325|10322249|P1|Overall Study|Adverse Event|0
2999580|NCT00949117|10322273|P2|Overall Study|Adverse Event|1
2999581|NCT00949117|10322274|P1|Overall Study|Adverse Event|0
2999582|NCT00949117|10322273|P2|Overall Study|Protocol Violation|1
2999583|NCT00949117|10322274|P1|Overall Study|Protocol Violation|1
2999584|NCT00949117|10322273|P2|Overall Study|Lack of Efficacy|3
2999585|NCT00949117|10322274|P1|Overall Study|Lack of Efficacy|2
2999586|NCT00948974|10322315|P2|Overall Study|Lost to Follow-up|20
2999587|NCT00948974|10322316|P1|Overall Study|Lost to Follow-up|23
2999588|NCT00948922|10322334|P3|Overall Study|Not evaluable at time of analysis|0
2999589|NCT00948922|10322335|P2|Overall Study|Not evaluable at time of analysis|3
2999590|NCT00948922|10322336|P1|Overall Study|Not evaluable at time of analysis|0
2999591|NCT00948922|10322334|P3|Overall Study|Transplant eligibility issues|0
2999592|NCT00948922|10322335|P2|Overall Study|Transplant eligibility issues|3
2999593|NCT00948922|10322336|P1|Overall Study|Transplant eligibility issues|2
2999594|NCT00948922|10322334|P3|Overall Study|Insurance issues|0
2999595|NCT00948922|10322335|P2|Overall Study|Insurance issues|0
2999596|NCT00948922|10322336|P1|Overall Study|Insurance issues|1
2999597|NCT00948922|10322334|P3|Overall Study|Disease progression|0
2999598|NCT00948922|10322335|P2|Overall Study|Disease progression|1
2999599|NCT00948922|10322336|P1|Overall Study|Disease progression|0
2999600|NCT00948922|10322334|P3|Overall Study|Death|0
2999601|NCT00948922|10322335|P2|Overall Study|Death|0
2999602|NCT00948922|10322336|P1|Overall Study|Death|3
2999603|NCT00948922|10322334|P3|Overall Study|Withdrawal by Subject|1
2999604|NCT00948922|10322335|P2|Overall Study|Withdrawal by Subject|2
2999605|NCT00948922|10322336|P1|Overall Study|Withdrawal by Subject|0
2999606|NCT00948922|10322334|P3|Overall Study|Did not start study treatment|0
2999607|NCT00948922|10322335|P2|Overall Study|Did not start study treatment|5
2999608|NCT00948922|10322336|P1|Overall Study|Did not start study treatment|2
2999609|NCT00948896|10322359|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999610|NCT00948896|10322360|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999611|NCT00948896|10322361|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999612|NCT00948896|10322362|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999613|NCT00948896|10322363|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
2999614|NCT00948896|10322364|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999615|NCT00948896|10322365|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999616|NCT00948896|10322366|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2999617|NCT00948896|10322359|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999618|NCT00948896|10322360|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999619|NCT00948896|10322361|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
2999620|NCT00948896|10322362|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999621|NCT00948896|10322363|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999622|NCT00948896|10322364|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
2999623|NCT00948896|10322365|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999624|NCT00948896|10322366|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
2999625|NCT00948896|10322359|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2999626|NCT00948896|10322360|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2999627|NCT00948896|10322361|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2999628|NCT00948896|10322362|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2999629|NCT00948896|10322363|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2999630|NCT00948896|10322364|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2999631|NCT00948896|10322365|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2999632|NCT00948896|10322366|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
2999633|NCT00948896|10322359|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2999634|NCT00948896|10322360|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2999635|NCT00948896|10322361|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2999636|NCT00948896|10322362|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2999637|NCT00948896|10322363|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2999638|NCT00948896|10322364|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2999639|NCT00948896|10322365|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2999640|NCT00948896|10322366|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2999641|NCT00948896|10322359|P8|24 Months of Age to 36 Months of Age|Death|0
2999642|NCT00948896|10322360|P7|24 Months of Age to 36 Months of Age|Death|0
2999643|NCT00948896|10322361|P6|24 Months of Age to 36 Months of Age|Death|1
2999644|NCT00948896|10322362|P5|24 Months of Age to 36 Months of Age|Death|0
2999645|NCT00948896|10322363|P4|24 Months of Age to 36 Months of Age|Death|0
2999646|NCT00948896|10322364|P3|24 Months of Age to 36 Months of Age|Death|2
2999647|NCT00948896|10322365|P2|24 Months of Age to 36 Months of Age|Death|2
2999648|NCT00948896|10322366|P1|24 Months of Age to 36 Months of Age|Death|0
2999649|NCT00948896|10322359|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
2999650|NCT00948896|10322360|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
2999651|NCT00948896|10322361|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
2999652|NCT00948896|10322362|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
2999653|NCT00948896|10322363|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
2999654|NCT00948896|10322364|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
2999655|NCT00948896|10322365|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
2999656|NCT00948896|10322366|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
2999657|NCT00948896|10322359|P8|Randomization to 24 Months of Age|Protocol Violation|1
2999658|NCT00948896|10322360|P7|Randomization to 24 Months of Age|Protocol Violation|1
2999659|NCT00948896|10322361|P6|Randomization to 24 Months of Age|Protocol Violation|0
2999660|NCT00948896|10322362|P5|Randomization to 24 Months of Age|Protocol Violation|0
2999661|NCT00948896|10322363|P4|Randomization to 24 Months of Age|Protocol Violation|1
2999662|NCT00948896|10322364|P3|Randomization to 24 Months of Age|Protocol Violation|0
2999663|NCT00948896|10322365|P2|Randomization to 24 Months of Age|Protocol Violation|1
2999664|NCT00948896|10322366|P1|Randomization to 24 Months of Age|Protocol Violation|0
2999665|NCT00948896|10322359|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
2999666|NCT00948896|10322360|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
2999667|NCT00948896|10322361|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
2999668|NCT00948896|10322362|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
2999669|NCT00948896|10322363|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
2999670|NCT00948896|10322364|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
2999671|NCT00948896|10322365|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
2999672|NCT00948896|10322366|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
2999673|NCT00948896|10322359|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
2999674|NCT00948896|10322360|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
2999675|NCT00948896|10322361|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
2999676|NCT00948896|10322362|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
2999677|NCT00948896|10322363|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
2999678|NCT00948896|10322364|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
2999679|NCT00948896|10322365|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
2999680|NCT00948896|10322366|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
2999681|NCT00948896|10322359|P8|Randomization to 24 Months of Age|Death|1
2999682|NCT00948896|10322360|P7|Randomization to 24 Months of Age|Death|2
2999683|NCT00948896|10322361|P6|Randomization to 24 Months of Age|Death|1
2999684|NCT00948896|10322362|P5|Randomization to 24 Months of Age|Death|2
2999685|NCT00948896|10322363|P4|Randomization to 24 Months of Age|Death|0
2999686|NCT00948896|10322364|P3|Randomization to 24 Months of Age|Death|0
2999687|NCT00948896|10322365|P2|Randomization to 24 Months of Age|Death|0
2999688|NCT00948896|10322366|P1|Randomization to 24 Months of Age|Death|1
2999689|NCT00948857|10322402|P2|Overall Study|Lost to Follow-up|0
2999690|NCT00948857|10322403|P1|Overall Study|Lost to Follow-up|1
2999691|NCT00948818|10322411|P2|Overall Study|Other Reason|5
2999692|NCT00948818|10322412|P1|Overall Study|Other Reason|4
2999693|NCT00948818|10322411|P2|Overall Study|Lack of Efficacy|5
2999694|NCT00948818|10322412|P1|Overall Study|Lack of Efficacy|4
2999695|NCT00948818|10322411|P2|Overall Study|Lost to Follow-up|17
2999696|NCT00948818|10322412|P1|Overall Study|Lost to Follow-up|10
2999697|NCT00948818|10322411|P2|Overall Study|Withdrawal by Subject|25
2999698|NCT00948818|10322412|P1|Overall Study|Withdrawal by Subject|25
2999699|NCT00948818|10322411|P2|Overall Study|Protocol Violation|10
2999700|NCT00948818|10322412|P1|Overall Study|Protocol Violation|9
2999701|NCT00948818|10322411|P2|Overall Study|Adverse Event|32
2999702|NCT00948818|10322412|P1|Overall Study|Adverse Event|10
2999703|NCT00948766|10322459|P2|Extension Study|Death|0
2999704|NCT00948766|10322460|P1|Extension Study|Death|4
2999705|NCT00948766|10322459|P2|Extension Study|Administrative Problems|0
2999706|NCT00948766|10322460|P1|Extension Study|Administrative Problems|1
2999707|NCT00948766|10322459|P2|Extension Study|Lost to Follow-up|0
2999708|NCT00948766|10322460|P1|Extension Study|Lost to Follow-up|8
2999709|NCT00948766|10322459|P2|Extension Study|Patient Withdrew Consent|0
2999710|NCT00948766|10322460|P1|Extension Study|Patient Withdrew Consent|32
2999711|NCT00948766|10322459|P2|Extension Study|Study Drug No Longer Required|0
2999712|NCT00948766|10322460|P1|Extension Study|Study Drug No Longer Required|1
2999713|NCT00948766|10322459|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
2999714|NCT00948766|10322460|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
2999715|NCT00948766|10322459|P2|Extension Study|Adverse Event|0
2999716|NCT00948766|10322460|P1|Extension Study|Adverse Event|43
2999717|NCT00948766|10322459|P2|Core Study|Protocol Deviation|10
2999718|NCT00948766|10322460|P1|Core Study|Protocol Deviation|8
2999719|NCT00948766|10322459|P2|Core Study|Death|1
2999720|NCT00948766|10322460|P1|Core Study|Death|1
2999721|NCT00948766|10322459|P2|Core Study|Administrative Problems|2
2999722|NCT00948766|10322460|P1|Core Study|Administrative Problems|2
2999723|NCT00948766|10322459|P2|Core Study|Lost to Follow-up|2
2999724|NCT00948766|10322460|P1|Core Study|Lost to Follow-up|3
2999725|NCT00948766|10322459|P2|Core Study|Patient Withdrew Consent|46
2999726|NCT00948766|10322460|P1|Core Study|Patient Withdrew Consent|27
2999727|NCT00948766|10322459|P2|Core Study|Unsatisfactory Therapeutic Effect|14
2999728|NCT00948766|10322460|P1|Core Study|Unsatisfactory Therapeutic Effect|13
2999729|NCT00948766|10322459|P2|Core Study|Adverse Event|51
2999730|NCT00948766|10322460|P1|Core Study|Adverse Event|73
2999731|NCT00948688|10322476|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
2999732|NCT00948688|10322477|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
2999733|NCT00948688|10322476|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
2999734|NCT00948688|10322477|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
2999735|NCT00948688|10322476|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
2999736|NCT00948688|10322477|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
2999737|NCT00948675|10322491|P2|Overall Study|Treatment ongoing|4
2999738|NCT00948675|10322492|P1|Overall Study|Treatment ongoing|5
2999739|NCT00948675|10322491|P2|Overall Study|Lost to Follow-up|0
2999740|NCT00948675|10322492|P1|Overall Study|Lost to Follow-up|2
2999741|NCT00948506|10322519|P2|Overall Study|Withdrawal by Subject|1
2999742|NCT00948506|10322520|P1|Overall Study|Withdrawal by Subject|3
2999743|NCT00948441|10322531|P2|Overall Study|no longer meet inclusion criteria|4
2999744|NCT00948441|10322532|P1|Overall Study|no longer meet inclusion criteria|1
2999745|NCT00948389|10322545|P5|Overall Study|Both Progression and Toxicity|0
2999746|NCT00948389|10322546|P4|Overall Study|Both Progression and Toxicity|0
2999747|NCT00948389|10322547|P3|Overall Study|Both Progression and Toxicity|0
2999748|NCT00948389|10322548|P2|Overall Study|Both Progression and Toxicity|0
2999749|NCT00948389|10322549|P1|Overall Study|Both Progression and Toxicity|1
2999750|NCT00948389|10322545|P5|Overall Study|Thrombocytopenia, Grade 4|0
2999751|NCT00948389|10322546|P4|Overall Study|Thrombocytopenia, Grade 4|1
2999752|NCT00948389|10322547|P3|Overall Study|Thrombocytopenia, Grade 4|0
2999753|NCT00948389|10322548|P2|Overall Study|Thrombocytopenia, Grade 4|0
2999754|NCT00948389|10322549|P1|Overall Study|Thrombocytopenia, Grade 4|2
2999755|NCT00948389|10322545|P5|Overall Study|Disease Progression/Relapse/Death|1
2999756|NCT00948389|10322546|P4|Overall Study|Disease Progression/Relapse/Death|8
2999757|NCT00948389|10322547|P3|Overall Study|Disease Progression/Relapse/Death|7
2999758|NCT00948389|10322548|P2|Overall Study|Disease Progression/Relapse/Death|3
2999759|NCT00948389|10322549|P1|Overall Study|Disease Progression/Relapse/Death|3
2999760|NCT00948246|10322597|P1|Overall Study|Withdrawal by Subject|1
2999761|NCT00948246|10322597|P1|Overall Study|Death|1
2999762|NCT00948246|10322597|P1|Overall Study|Adverse Event|11
2999763|NCT00948246|10322597|P1|Overall Study|Lost to Follow-up|11
2999764|NCT00948155|10322606|P2|Washout 14 Days|Lost to Follow-up|2
2999765|NCT00948155|10322607|P1|Washout 14 Days|Lost to Follow-up|1
2999766|NCT00948155|10322606|P2|First Intervention 21 Days|Lost to Follow-up|2
2999767|NCT00948155|10322607|P1|First Intervention 21 Days|Lost to Follow-up|2
2999768|NCT00948064|10322654|P3|Phase II|Withdrawal by Subject|0
2999769|NCT00948064|10322655|P2|Phase II|Withdrawal by Subject|1
2999770|NCT00948064|10322656|P1|Phase II|Withdrawal by Subject|0
2999771|NCT00948064|10322654|P3|Phase II|Physician Decision|1
2999772|NCT00948064|10322655|P2|Phase II|Physician Decision|0
2999773|NCT00948064|10322656|P1|Phase II|Physician Decision|0
2999774|NCT00948064|10322654|P3|Phase I|No treatment received|0
2999775|NCT00948064|10322655|P2|Phase I|No treatment received|0
2999776|NCT00948064|10322656|P1|Phase I|No treatment received|1
2999777|NCT00947882|10322671|P4|Overall Study|Trial Terminated by Sponsor|70
2999778|NCT00947882|10322672|P3|Overall Study|Trial Terminated by Sponsor|62
2999779|NCT00947882|10322673|P2|Overall Study|Trial Terminated by Sponsor|61
2999780|NCT00947882|10322674|P1|Overall Study|Trial Terminated by Sponsor|62
2999781|NCT00947882|10322671|P4|Overall Study|Other/Unknown|6
2999782|NCT00947882|10322672|P3|Overall Study|Other/Unknown|3
2999783|NCT00947882|10322673|P2|Overall Study|Other/Unknown|13
2999784|NCT00947882|10322674|P1|Overall Study|Other/Unknown|10
2999785|NCT00947882|10322671|P4|Overall Study|Lost to Follow-up|0
2999786|NCT00947882|10322672|P3|Overall Study|Lost to Follow-up|1
2999787|NCT00947882|10322673|P2|Overall Study|Lost to Follow-up|2
2999788|NCT00947882|10322674|P1|Overall Study|Lost to Follow-up|0
2999789|NCT00947882|10322671|P4|Overall Study|Protocol Violation|0
2999790|NCT00947882|10322672|P3|Overall Study|Protocol Violation|1
2999791|NCT00947882|10322673|P2|Overall Study|Protocol Violation|0
2999792|NCT00947882|10322674|P1|Overall Study|Protocol Violation|0
2999793|NCT00947882|10322671|P4|Overall Study|Withdrawal by Subject|2
2999794|NCT00947882|10322672|P3|Overall Study|Withdrawal by Subject|8
2999795|NCT00947882|10322673|P2|Overall Study|Withdrawal by Subject|0
2999796|NCT00947882|10322674|P1|Overall Study|Withdrawal by Subject|2
2999797|NCT00947882|10322671|P4|Overall Study|Adverse Event|4
2999798|NCT00947882|10322672|P3|Overall Study|Adverse Event|4
2999799|NCT00947882|10322673|P2|Overall Study|Adverse Event|1
2999800|NCT00947882|10322674|P1|Overall Study|Adverse Event|0
2999801|NCT00947856|10322702|P2|Follow-up Period|Withdrawal by Subject|0
2999802|NCT00947856|10322703|P1|Follow-up Period|Withdrawal by Subject|1
2999803|NCT00947856|10322702|P2|Follow-up Period|Patient unavailable for site visits|0
2999804|NCT00947856|10322703|P1|Follow-up Period|Patient unavailable for site visits|1
2999805|NCT00947856|10322702|P2|Follow-up Period|Lost to Follow-up|0
2999806|NCT00947856|10322703|P1|Follow-up Period|Lost to Follow-up|7
2999807|NCT00947856|10322702|P2|Follow-up Period|Re-enrolled for Retreatment|3
2999808|NCT00947856|10322703|P1|Follow-up Period|Re-enrolled for Retreatment|2
2999809|NCT00947856|10322702|P2|Follow-up Period|Study Stopped by Sponsor|20
2999810|NCT00947856|10322703|P1|Follow-up Period|Study Stopped by Sponsor|40
2999811|NCT00947856|10322702|P2|Treatment Period|Withdrawal by Subject|1
2999812|NCT00947856|10322703|P1|Treatment Period|Withdrawal by Subject|12
2999813|NCT00947856|10322702|P2|Treatment Period|Study Stopped by Sponsor|4
2999814|NCT00947856|10322703|P1|Treatment Period|Study Stopped by Sponsor|4
2999815|NCT00947856|10322702|P2|Treatment Period|Physician Decision|6
2999816|NCT00947856|10322703|P1|Treatment Period|Physician Decision|14
2999817|NCT00947856|10322702|P2|Treatment Period|Adverse Event|9
2999818|NCT00947856|10322703|P1|Treatment Period|Adverse Event|15
2999819|NCT00947856|10322702|P2|Treatment Period|Progressive Disease|12
2999820|NCT00947856|10322703|P1|Treatment Period|Progressive Disease|33
2999821|NCT00947544|10322792|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
2999822|NCT00947544|10322793|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
2999823|NCT00947531|10322819|P2|Overall Study|Other|1
2999824|NCT00947531|10322820|P1|Overall Study|Other|1
2999825|NCT00947531|10322819|P2|Overall Study|Lack of Efficacy|0
2999826|NCT00947531|10322820|P1|Overall Study|Lack of Efficacy|1
2999827|NCT00947531|10322819|P2|Overall Study|Adverse Event|2
2999828|NCT00947531|10322820|P1|Overall Study|Adverse Event|2
2999829|NCT00947531|10322819|P2|Overall Study|Administrative Reason|1
2999830|NCT00947531|10322820|P1|Overall Study|Administrative Reason|0
2999831|NCT00947531|10322819|P2|Overall Study|Withdrawal by Subject|7
2999832|NCT00947531|10322820|P1|Overall Study|Withdrawal by Subject|10
2999833|NCT00947427|10322856|P2|Overall Study|Protocol Violation|1
2999834|NCT00947427|10322857|P1|Overall Study|Protocol Violation|0
2999835|NCT00947427|10322856|P2|Overall Study|Withdrawal by Subject|3
2999836|NCT00947427|10322857|P1|Overall Study|Withdrawal by Subject|1
2999837|NCT00947349|10322867|P4|Overall Study Standard of Care|Other|1
2999838|NCT00947349|10322868|P3|Overall Study Standard of Care|Other|0
2999839|NCT00947349|10322869|P2|Overall Study Standard of Care|Other|0
2999840|NCT00947349|10322870|P1|Overall Study Standard of Care|Other|0
2999841|NCT00947349|10322867|P4|Overall Study Standard of Care|Withdrawal by Subject|0
2999842|NCT00947349|10322868|P3|Overall Study Standard of Care|Withdrawal by Subject|1
2999843|NCT00947349|10322869|P2|Overall Study Standard of Care|Withdrawal by Subject|0
2999844|NCT00947349|10322870|P1|Overall Study Standard of Care|Withdrawal by Subject|0
2999845|NCT00947349|10322867|P4|Overall Study Standard of Care|Lack of Efficacy|1
2999846|NCT00947349|10322868|P3|Overall Study Standard of Care|Lack of Efficacy|1
2999847|NCT00947349|10322869|P2|Overall Study Standard of Care|Lack of Efficacy|0
2999848|NCT00947349|10322870|P1|Overall Study Standard of Care|Lack of Efficacy|0
2999849|NCT00947349|10322867|P4|Triple Treatment Combination Period|Adverse Event|0
2999850|NCT00947349|10322868|P3|Triple Treatment Combination Period|Adverse Event|0
2999851|NCT00947349|10322869|P2|Triple Treatment Combination Period|Adverse Event|1
2999852|NCT00947349|10322870|P1|Triple Treatment Combination Period|Adverse Event|0
2999853|NCT00947154|10323084|P1|Overall Study|Lost to Follow-up|1
2999854|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
2999855|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
2999856|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
2999857|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
2999858|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
2999859|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
2999860|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
2999861|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
2999862|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
2999863|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
2999864|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
2999865|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
2999866|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
2999867|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
2999868|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
2999869|NCT00947115|10323094|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
2999870|NCT00947115|10323095|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
2999871|NCT00947115|10323096|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
2999872|NCT00947011|10323158|P1|Overall Study|Study was terminated,PI left institution|12
2999873|NCT00946998|10323168|P2|Overall Study|Exited prior to first outcome assessment|3
2999874|NCT00946998|10323169|P1|Overall Study|Exited prior to first outcome assessment|5
2999875|NCT00946985|10323183|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
2999876|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
2999877|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
2999878|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
2999879|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
2999880|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
2999881|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
2999882|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
2999883|NCT00946985|10323183|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
2999884|NCT00946920|10323189|P2|Overall Study|Miscellaneous reasons|3
2999885|NCT00946920|10323190|P1|Overall Study|Miscellaneous reasons|18
2999886|NCT00946920|10323189|P2|Overall Study|Protocol Violation|8
2999887|NCT00946920|10323190|P1|Overall Study|Protocol Violation|16
2999888|NCT00946920|10323189|P2|Overall Study|Adverse Event|14
2999889|NCT00946920|10323190|P1|Overall Study|Adverse Event|41
2999890|NCT00946920|10323189|P2|Overall Study|Physician Decision|2
2999891|NCT00946920|10323190|P1|Overall Study|Physician Decision|5
2999892|NCT00946920|10323189|P2|Overall Study|Lost to Follow-up|2
2999893|NCT00946920|10323190|P1|Overall Study|Lost to Follow-up|2
2999894|NCT00946920|10323189|P2|Overall Study|Withdrawal by Subject|15
2999895|NCT00946920|10323190|P1|Overall Study|Withdrawal by Subject|28
2999896|NCT00946881|10323205|P1|Retreatment|Withdrawal by Subject|1
2999897|NCT00946881|10323205|P1|First Treatment|Patient relocated to another state|1
2999898|NCT00946881|10323205|P1|First Treatment|Withdrawal by Subject|1
2999899|NCT00946712|10323236|P2|Overall Study|Ineligible|6
2999900|NCT00946712|10323237|P1|Overall Study|Ineligible|14
2999901|NCT00946712|10323236|P2|Overall Study|On Treatment|4
2999902|NCT00946712|10323237|P1|Overall Study|On Treatment|0
2999903|NCT00946712|10323236|P2|Overall Study|Other reasons|73
2999904|NCT00946712|10323237|P1|Overall Study|Other reasons|61
2999905|NCT00946712|10323236|P2|Overall Study|No treatment given|29
2999906|NCT00946712|10323237|P1|Overall Study|No treatment given|25
2999907|NCT00946712|10323236|P2|Overall Study|Death|22
2999908|NCT00946712|10323237|P1|Overall Study|Death|21
2999909|NCT00946712|10323236|P2|Overall Study|Disease progression|404
2999910|NCT00946712|10323237|P1|Overall Study|Disease progression|308
2999911|NCT00946712|10323236|P2|Overall Study|Adverse Event|124
2999912|NCT00946712|10323237|P1|Overall Study|Adverse Event|118
2999913|NCT00946530|10323255|P4|Overall Study|Physician Decision|1
2999914|NCT00946530|10323256|P3|Overall Study|Physician Decision|1
2999915|NCT00946530|10323257|P2|Overall Study|Physician Decision|1
2999916|NCT00946530|10323258|P1|Overall Study|Physician Decision|1
2999917|NCT00946530|10323255|P4|Overall Study|Withdrawal by Subject|3
2999918|NCT00946530|10323256|P3|Overall Study|Withdrawal by Subject|0
2999919|NCT00946530|10323257|P2|Overall Study|Withdrawal by Subject|3
2999920|NCT00946530|10323258|P1|Overall Study|Withdrawal by Subject|0
2999921|NCT00946322|10323290|P1|Post-treatment|participant failure to follow up|2
2999922|NCT00946322|10323290|P1|Pre-treatment|participant failure to follow up|1
2999923|NCT00946309|10323303|P2|Overall Study|Procedure cancelled/discontinued|3
2999924|NCT00946309|10323304|P1|Overall Study|Procedure cancelled/discontinued|0
2999925|NCT00946309|10323303|P2|Overall Study|Lost to Follow-up|1
2999926|NCT00946309|10323304|P1|Overall Study|Lost to Follow-up|0
2999927|NCT00946309|10323303|P2|Overall Study|Protocol Violation|0
2999928|NCT00946309|10323304|P1|Overall Study|Protocol Violation|1
2999929|NCT00946296|10323322|P2|Overall Study|Physician Decision|0
2999930|NCT00946296|10323323|P1|Overall Study|Physician Decision|3
2999931|NCT00946192|10323345|P3|Overall Study|Did not start medication|0
2999932|NCT00946192|10323346|P2|Overall Study|Did not start medication|0
2999933|NCT00946192|10323347|P1|Overall Study|Did not start medication|2
2999934|NCT00946192|10323345|P3|Overall Study|Withdrawal by Subject|3
2999935|NCT00946192|10323346|P2|Overall Study|Withdrawal by Subject|7
2999936|NCT00946192|10323347|P1|Overall Study|Withdrawal by Subject|10
2999937|NCT00946192|10323345|P3|Overall Study|Lost to Follow-up|9
2999938|NCT00946192|10323346|P2|Overall Study|Lost to Follow-up|11
2999939|NCT00946192|10323347|P1|Overall Study|Lost to Follow-up|6
2999940|NCT00946153|10323363|P5|Phase 2|14 days washout for recovery due to AE|4
2999941|NCT00946153|10323364|P4|Phase 2|14 days washout for recovery due to AE|0
2999942|NCT00946153|10323365|P3|Phase 2|14 days washout for recovery due to AE|0
2999943|NCT00946153|10323366|P2|Phase 2|14 days washout for recovery due to AE|0
2999944|NCT00946153|10323367|P1|Phase 2|14 days washout for recovery due to AE|0
2999945|NCT00946153|10323363|P5|Phase 2|Physician Decision|1
2999946|NCT00946153|10323364|P4|Phase 2|Physician Decision|0
2999947|NCT00946153|10323365|P3|Phase 2|Physician Decision|0
2999948|NCT00946153|10323366|P2|Phase 2|Physician Decision|0
2999949|NCT00946153|10323367|P1|Phase 2|Physician Decision|0
2999950|NCT00946153|10323363|P5|Phase 2|Need more reduction of dose|2
2999951|NCT00946153|10323364|P4|Phase 2|Need more reduction of dose|0
2999952|NCT00946153|10323365|P3|Phase 2|Need more reduction of dose|0
2999953|NCT00946153|10323366|P2|Phase 2|Need more reduction of dose|0
2999954|NCT00946153|10323367|P1|Phase 2|Need more reduction of dose|0
2999955|NCT00946153|10323363|P5|Phase 2|Adverse Event|6
2999956|NCT00946153|10323364|P4|Phase 2|Adverse Event|0
2999957|NCT00946153|10323365|P3|Phase 2|Adverse Event|0
2999958|NCT00946153|10323366|P2|Phase 2|Adverse Event|0
2999959|NCT00946153|10323367|P1|Phase 2|Adverse Event|0
2999960|NCT00946114|10323395|P2|Overall Study|Withdrawal by Subject|0
2999961|NCT00946114|10323396|P1|Overall Study|Withdrawal by Subject|2
2999962|NCT00946114|10323395|P2|Overall Study|Other|0
2999963|NCT00946114|10323396|P1|Overall Study|Other|1
2999964|NCT00946114|10323395|P2|Overall Study|Death|2
2999965|NCT00946114|10323396|P1|Overall Study|Death|5
2999966|NCT00946101|10323404|P2|Overall Study|Physician Decision|1
2999967|NCT00946101|10323405|P1|Overall Study|Physician Decision|0
2999968|NCT00946101|10323404|P2|Overall Study|Withdrawal of consent|0
2999969|NCT00946101|10323405|P1|Overall Study|Withdrawal of consent|2
2999970|NCT00946101|10323404|P2|Overall Study|Lost to Follow-up|1
2999971|NCT00946101|10323405|P1|Overall Study|Lost to Follow-up|2
2999972|NCT00946088|10323471|P2|Overall Study|Withdrawal by Subject|1
2999973|NCT00946088|10323472|P1|Overall Study|Withdrawal by Subject|0
2999974|NCT00945945|10323516|P2|Overall Study|Entry Criteria Not Met|1
2999975|NCT00945945|10323517|P1|Overall Study|Entry Criteria Not Met|0
2999976|NCT00945945|10323516|P2|Overall Study|Protocol Violation|2
2999977|NCT00945945|10323517|P1|Overall Study|Protocol Violation|4
2999978|NCT00945945|10323516|P2|Overall Study|Lack of Efficacy|2
2999979|NCT00945945|10323517|P1|Overall Study|Lack of Efficacy|6
2999980|NCT00945945|10323516|P2|Overall Study|Lost to Follow-up|5
2999981|NCT00945945|10323517|P1|Overall Study|Lost to Follow-up|4
2999982|NCT00945945|10323516|P2|Overall Study|Withdrawal by Subject|10
2999983|NCT00945945|10323517|P1|Overall Study|Withdrawal by Subject|7
2999984|NCT00945945|10323516|P2|Overall Study|Adverse Event|35
2999985|NCT00945945|10323517|P1|Overall Study|Adverse Event|15
2999986|NCT00945906|10323543|P1|Overall Study|Moved to another country|2
2999987|NCT00945906|10323543|P1|Overall Study|Unable to return for last visit|2
2999988|NCT00945906|10323543|P1|Overall Study|Did not want to return for last visit|2
2999989|NCT00945906|10323543|P1|Overall Study|Withdrawal by Subject|1
2999990|NCT00945893|10323554|P2|Overall Study|Withdrawal of consent|2
2999991|NCT00945893|10323555|P1|Overall Study|Withdrawal of consent|1
2999992|NCT00945893|10323554|P2|Overall Study|Lost to Follow-up|8
2999993|NCT00945893|10323555|P1|Overall Study|Lost to Follow-up|2
2999994|NCT00945815|10323632|P1|Overall Study|Did not begin protocol therapy|1
2999995|NCT00945815|10323632|P1|Overall Study|Ineligible|3
2999996|NCT00945815|10323632|P1|Overall Study|Not protocol specified|1
2999997|NCT00945815|10323632|P1|Overall Study|Death|3
2999998|NCT00945659|10323664|P3|Overall Study|Lost to Follow-up|17
2999999|NCT00945659|10323665|P2|Overall Study|Lost to Follow-up|20
3000000|NCT00945659|10323666|P1|Overall Study|Lost to Follow-up|7
3000001|NCT00945555|10323723|P1|Overall Study|Other|1
3000002|NCT00945555|10323723|P1|Overall Study|Death|18
3000003|NCT00945555|10323723|P1|Overall Study|Participant continued treatment at home|1
3000004|NCT00945555|10323723|P1|Overall Study|Withdrawal by Subject|2
3000005|NCT00945555|10323723|P1|Overall Study|Worsening condition, intensive care unit|1
3000006|NCT00945555|10323723|P1|Overall Study|Referred to another hospital|5
3000007|NCT00945477|10323734|P1|Overall Study|Withdrawal by Subject|1
3000008|NCT00945477|10323734|P1|Overall Study|Lack of Efficacy|2
3000009|NCT00945477|10323734|P1|Overall Study|Adverse Event|3
3000010|NCT00945321|10323750|P6|Period 4|Lost to Follow-up|1
3000011|NCT00945321|10323751|P5|Period 4|Lost to Follow-up|0
3000012|NCT00945321|10323752|P4|Period 4|Lost to Follow-up|0
3000013|NCT00945321|10323753|P3|Period 4|Lost to Follow-up|0
3000014|NCT00945321|10323754|P2|Period 4|Lost to Follow-up|0
3000015|NCT00945321|10323755|P1|Period 4|Lost to Follow-up|0
3000016|NCT00945321|10323750|P6|Period 1|Adverse Event|0
3000017|NCT00945321|10323751|P5|Period 1|Adverse Event|1
3000018|NCT00945321|10323752|P4|Period 1|Adverse Event|0
3000019|NCT00945321|10323753|P3|Period 1|Adverse Event|0
3000020|NCT00945321|10323754|P2|Period 1|Adverse Event|0
3000021|NCT00945321|10323755|P1|Period 1|Adverse Event|0
3000022|NCT00945243|10323888|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
3000023|NCT00945009|10323982|P3|Overall Study|Refusal of further protocol|0
3000024|NCT00945009|10323983|P2|Overall Study|Refusal of further protocol|0
3000025|NCT00945009|10323984|P1|Overall Study|Refusal of further protocol|1
3000026|NCT00945009|10323982|P3|Overall Study|Inevaluable|0
3000027|NCT00945009|10323983|P2|Overall Study|Inevaluable|1
3000028|NCT00945009|10323984|P1|Overall Study|Inevaluable|0
3000029|NCT00945009|10323982|P3|Overall Study|Ineligible|0
3000030|NCT00945009|10323983|P2|Overall Study|Ineligible|1
3000031|NCT00945009|10323984|P1|Overall Study|Ineligible|6
3000032|NCT00945009|10323982|P3|Overall Study|Withdrawal by Subject|0
3000033|NCT00945009|10323983|P2|Overall Study|Withdrawal by Subject|0
3000034|NCT00945009|10323984|P1|Overall Study|Withdrawal by Subject|1
3000035|NCT00945009|10323982|P3|Overall Study|Protocol Violation|0
3000036|NCT00945009|10323983|P2|Overall Study|Protocol Violation|1
3000037|NCT00945009|10323984|P1|Overall Study|Protocol Violation|6
3000038|NCT00945009|10323982|P3|Overall Study|Physician Decision|3
3000039|NCT00945009|10323983|P2|Overall Study|Physician Decision|4
3000040|NCT00945009|10323984|P1|Overall Study|Physician Decision|21
3000041|NCT00945009|10323982|P3|Overall Study|Lack of Efficacy|0
3000042|NCT00945009|10323983|P2|Overall Study|Lack of Efficacy|0
3000043|NCT00945009|10323984|P1|Overall Study|Lack of Efficacy|10
3000044|NCT00944697|10324060|P2|Overall Study|Administrative|1
3000045|NCT00944697|10324061|P1|Overall Study|Administrative|1
3000046|NCT00944697|10324060|P2|Overall Study|Adverse Event|3
3000047|NCT00944697|10324061|P1|Overall Study|Adverse Event|0
3000048|NCT00944697|10324060|P2|Overall Study|Withdrawal by Subject|1
3000049|NCT00944697|10324061|P1|Overall Study|Withdrawal by Subject|1
3000050|NCT00944658|10324093|P2|Treatment 12 Weeks|Adverse Event|2
3000051|NCT00944658|10324094|P1|Treatment 12 Weeks|Adverse Event|0
3000052|NCT00944645|10324106|P2|Period 2|Withdrawal by Subject|6
3000053|NCT00944645|10324107|P1|Period 2|Withdrawal by Subject|7
3000054|NCT00944645|10324106|P2|Period 2|Lost to Follow-up|3
3000055|NCT00944645|10324107|P1|Period 2|Lost to Follow-up|0
3000056|NCT00944645|10324106|P2|Period 2|Adverse Event|0
3000057|NCT00944645|10324107|P1|Period 2|Adverse Event|1
3000058|NCT00944229|10324154|P1|Overall Study|Physician Decision|14
3000059|NCT00944229|10324154|P1|Overall Study|Withdrawal by Subject|11
3000060|NCT00944125|10324160|P2|6 Months to Study Completion|Withdrawal by Subject|2
3000061|NCT00944125|10324161|P1|6 Months to Study Completion|Withdrawal by Subject|0
3000062|NCT00944125|10324160|P2|3 to 6 Months|Withdrawal by Subject|2
3000063|NCT00944125|10324161|P1|3 to 6 Months|Withdrawal by Subject|0
3000064|NCT00944034|10324264|P12|Overall Study|Administrative reason|0
3000065|NCT00944034|10324265|P11|Overall Study|Administrative reason|0
3000066|NCT00944034|10324266|P10|Overall Study|Administrative reason|0
3000067|NCT00944034|10324267|P9|Overall Study|Administrative reason|0
3000068|NCT00944034|10324268|P8|Overall Study|Administrative reason|0
3000069|NCT00944034|10324269|P7|Overall Study|Administrative reason|1
3000070|NCT00944034|10324270|P6|Overall Study|Administrative reason|0
3000071|NCT00944034|10324271|P5|Overall Study|Administrative reason|0
3000072|NCT00944034|10324272|P4|Overall Study|Administrative reason|0
3000073|NCT00944034|10324273|P3|Overall Study|Administrative reason|0
3000074|NCT00944034|10324274|P2|Overall Study|Administrative reason|0
3000075|NCT00944034|10324275|P1|Overall Study|Administrative reason|0
3000076|NCT00944034|10324264|P12|Overall Study|Unable to classify|0
3000077|NCT00944034|10324265|P11|Overall Study|Unable to classify|0
3000078|NCT00944034|10324266|P10|Overall Study|Unable to classify|0
3000079|NCT00944034|10324267|P9|Overall Study|Unable to classify|0
3000080|NCT00944034|10324268|P8|Overall Study|Unable to classify|1
3000081|NCT00944034|10324269|P7|Overall Study|Unable to classify|1
3000082|NCT00944034|10324270|P6|Overall Study|Unable to classify|1
3000083|NCT00944034|10324271|P5|Overall Study|Unable to classify|0
3000084|NCT00944034|10324272|P4|Overall Study|Unable to classify|0
3000085|NCT00944034|10324273|P3|Overall Study|Unable to classify|0
3000086|NCT00944034|10324274|P2|Overall Study|Unable to classify|0
3000087|NCT00944034|10324275|P1|Overall Study|Unable to classify|0
3000088|NCT00944034|10324264|P12|Overall Study|Protocol Violation|0
3000089|NCT00944034|10324265|P11|Overall Study|Protocol Violation|0
3000090|NCT00944034|10324266|P10|Overall Study|Protocol Violation|4
3000091|NCT00944034|10324267|P9|Overall Study|Protocol Violation|1
3000092|NCT00944034|10324268|P8|Overall Study|Protocol Violation|1
3000093|NCT00944034|10324269|P7|Overall Study|Protocol Violation|0
3000094|NCT00944034|10324270|P6|Overall Study|Protocol Violation|3
3000095|NCT00944034|10324271|P5|Overall Study|Protocol Violation|2
3000096|NCT00944034|10324272|P4|Overall Study|Protocol Violation|1
3000097|NCT00944034|10324273|P3|Overall Study|Protocol Violation|0
3000098|NCT00944034|10324274|P2|Overall Study|Protocol Violation|0
3000099|NCT00944034|10324275|P1|Overall Study|Protocol Violation|2
3000100|NCT00944034|10324264|P12|Overall Study|Death|0
3000101|NCT00944034|10324265|P11|Overall Study|Death|0
3000102|NCT00944034|10324266|P10|Overall Study|Death|0
3000103|NCT00944034|10324267|P9|Overall Study|Death|0
3000104|NCT00944034|10324268|P8|Overall Study|Death|0
3000105|NCT00944034|10324269|P7|Overall Study|Death|0
3000106|NCT00944034|10324270|P6|Overall Study|Death|0
3000107|NCT00944034|10324271|P5|Overall Study|Death|0
3000108|NCT00944034|10324272|P4|Overall Study|Death|0
3000109|NCT00944034|10324273|P3|Overall Study|Death|1
3000110|NCT00944034|10324274|P2|Overall Study|Death|0
3000111|NCT00944034|10324275|P1|Overall Study|Death|0
3000112|NCT00944034|10324264|P12|Overall Study|Lost to Follow-up|0
3000113|NCT00944034|10324265|P11|Overall Study|Lost to Follow-up|1
3000114|NCT00944034|10324266|P10|Overall Study|Lost to Follow-up|1
3000115|NCT00944034|10324267|P9|Overall Study|Lost to Follow-up|5
3000116|NCT00944034|10324268|P8|Overall Study|Lost to Follow-up|1
3000117|NCT00944034|10324269|P7|Overall Study|Lost to Follow-up|0
3000118|NCT00944034|10324270|P6|Overall Study|Lost to Follow-up|7
3000119|NCT00944034|10324271|P5|Overall Study|Lost to Follow-up|5
3000120|NCT00944034|10324272|P4|Overall Study|Lost to Follow-up|0
3000121|NCT00944034|10324273|P3|Overall Study|Lost to Follow-up|2
3000122|NCT00944034|10324274|P2|Overall Study|Lost to Follow-up|4
3000123|NCT00944034|10324275|P1|Overall Study|Lost to Follow-up|0
3000124|NCT00944034|10324264|P12|Overall Study|Withdrawal by Subject|4
3000125|NCT00944034|10324265|P11|Overall Study|Withdrawal by Subject|0
3000126|NCT00944034|10324266|P10|Overall Study|Withdrawal by Subject|4
3000127|NCT00944034|10324267|P9|Overall Study|Withdrawal by Subject|3
3000128|NCT00944034|10324268|P8|Overall Study|Withdrawal by Subject|2
3000129|NCT00944034|10324269|P7|Overall Study|Withdrawal by Subject|2
3000130|NCT00944034|10324270|P6|Overall Study|Withdrawal by Subject|8
3000131|NCT00944034|10324271|P5|Overall Study|Withdrawal by Subject|5
3000132|NCT00944034|10324272|P4|Overall Study|Withdrawal by Subject|2
3000133|NCT00944034|10324273|P3|Overall Study|Withdrawal by Subject|6
3000134|NCT00944034|10324274|P2|Overall Study|Withdrawal by Subject|2
3000135|NCT00944034|10324275|P1|Overall Study|Withdrawal by Subject|3
3000136|NCT00944034|10324264|P12|Overall Study|Inappropriate enrollment|0
3000137|NCT00944034|10324265|P11|Overall Study|Inappropriate enrollment|0
3000138|NCT00944034|10324266|P10|Overall Study|Inappropriate enrollment|1
3000139|NCT00944034|10324267|P9|Overall Study|Inappropriate enrollment|1
3000140|NCT00944034|10324268|P8|Overall Study|Inappropriate enrollment|0
3000141|NCT00944034|10324269|P7|Overall Study|Inappropriate enrollment|0
3000142|NCT00944034|10324270|P6|Overall Study|Inappropriate enrollment|1
3000143|NCT00944034|10324271|P5|Overall Study|Inappropriate enrollment|2
3000144|NCT00944034|10324272|P4|Overall Study|Inappropriate enrollment|1
3000145|NCT00944034|10324273|P3|Overall Study|Inappropriate enrollment|0
3000146|NCT00944034|10324274|P2|Overall Study|Inappropriate enrollment|1
3000147|NCT00944034|10324275|P1|Overall Study|Inappropriate enrollment|0
3000148|NCT00943917|10324421|P15|Stage II Continuation|A1C elevation|0
3000149|NCT00943917|10324422|P14|Stage II Continuation|A1C elevation|1
3000150|NCT00943917|10324423|P13|Stage II Continuation|A1C elevation|0
3000151|NCT00943917|10324424|P12|Stage II Continuation|A1C elevation|0
3000152|NCT00943917|10324425|P11|Stage II Continuation|A1C elevation|0
3000153|NCT00943917|10324426|P10|Stage II Continuation|A1C elevation|0
3000154|NCT00943917|10324427|P9|Stage II Continuation|A1C elevation|0
3000155|NCT00943917|10324428|P8|Stage II Continuation|A1C elevation|0
3000156|NCT00943917|10324429|P7|Stage II Continuation|A1C elevation|0
3000157|NCT00943917|10324430|P6|Stage II Continuation|A1C elevation|0
3000158|NCT00943917|10324431|P5|Stage II Continuation|A1C elevation|0
3000159|NCT00943917|10324432|P4|Stage II Continuation|A1C elevation|0
3000160|NCT00943917|10324433|P3|Stage II Continuation|A1C elevation|0
3000161|NCT00943917|10324434|P2|Stage II Continuation|A1C elevation|0
3000162|NCT00943917|10324435|P1|Stage II Continuation|A1C elevation|0
3000163|NCT00943917|10324421|P15|Stage II Continuation|hypoglycemia|0
3000164|NCT00943917|10324422|P14|Stage II Continuation|hypoglycemia|0
3000165|NCT00943917|10324423|P13|Stage II Continuation|hypoglycemia|1
3000166|NCT00943917|10324424|P12|Stage II Continuation|hypoglycemia|0
3000167|NCT00943917|10324425|P11|Stage II Continuation|hypoglycemia|0
3000168|NCT00943917|10324426|P10|Stage II Continuation|hypoglycemia|0
3000169|NCT00943917|10324427|P9|Stage II Continuation|hypoglycemia|0
3000170|NCT00943917|10324428|P8|Stage II Continuation|hypoglycemia|0
3000171|NCT00943917|10324429|P7|Stage II Continuation|hypoglycemia|0
3000172|NCT00943917|10324430|P6|Stage II Continuation|hypoglycemia|0
3000173|NCT00943917|10324431|P5|Stage II Continuation|hypoglycemia|0
3000174|NCT00943917|10324432|P4|Stage II Continuation|hypoglycemia|0
3000175|NCT00943917|10324433|P3|Stage II Continuation|hypoglycemia|0
3000176|NCT00943917|10324434|P2|Stage II Continuation|hypoglycemia|0
3000177|NCT00943917|10324435|P1|Stage II Continuation|hypoglycemia|0
3000178|NCT00943917|10324421|P15|Stage II Continuation|Protocol Violation|0
3000179|NCT00943917|10324422|P14|Stage II Continuation|Protocol Violation|0
3000180|NCT00943917|10324423|P13|Stage II Continuation|Protocol Violation|0
3000181|NCT00943917|10324424|P12|Stage II Continuation|Protocol Violation|1
3000182|NCT00943917|10324425|P11|Stage II Continuation|Protocol Violation|0
3000183|NCT00943917|10324426|P10|Stage II Continuation|Protocol Violation|1
3000184|NCT00943917|10324427|P9|Stage II Continuation|Protocol Violation|0
3000185|NCT00943917|10324428|P8|Stage II Continuation|Protocol Violation|0
3000186|NCT00943917|10324429|P7|Stage II Continuation|Protocol Violation|0
3000187|NCT00943917|10324430|P6|Stage II Continuation|Protocol Violation|0
3000188|NCT00943917|10324431|P5|Stage II Continuation|Protocol Violation|0
3000189|NCT00943917|10324432|P4|Stage II Continuation|Protocol Violation|0
3000190|NCT00943917|10324433|P3|Stage II Continuation|Protocol Violation|0
3000191|NCT00943917|10324434|P2|Stage II Continuation|Protocol Violation|0
3000192|NCT00943917|10324435|P1|Stage II Continuation|Protocol Violation|0
3000193|NCT00943917|10324421|P15|Stage II Continuation|Withdrawal by Subject|3
3000194|NCT00943917|10324422|P14|Stage II Continuation|Withdrawal by Subject|1
3000195|NCT00943917|10324423|P13|Stage II Continuation|Withdrawal by Subject|0
3000196|NCT00943917|10324424|P12|Stage II Continuation|Withdrawal by Subject|0
3000197|NCT00943917|10324425|P11|Stage II Continuation|Withdrawal by Subject|0
3000198|NCT00943917|10324426|P10|Stage II Continuation|Withdrawal by Subject|0
3000199|NCT00943917|10324427|P9|Stage II Continuation|Withdrawal by Subject|0
3000200|NCT00943917|10324428|P8|Stage II Continuation|Withdrawal by Subject|0
3000201|NCT00943917|10324429|P7|Stage II Continuation|Withdrawal by Subject|0
3000202|NCT00943917|10324430|P6|Stage II Continuation|Withdrawal by Subject|0
3000203|NCT00943917|10324431|P5|Stage II Continuation|Withdrawal by Subject|0
3000204|NCT00943917|10324432|P4|Stage II Continuation|Withdrawal by Subject|0
3000205|NCT00943917|10324433|P3|Stage II Continuation|Withdrawal by Subject|0
3000206|NCT00943917|10324434|P2|Stage II Continuation|Withdrawal by Subject|0
3000207|NCT00943917|10324435|P1|Stage II Continuation|Withdrawal by Subject|0
3000208|NCT00943917|10324421|P15|Stage II Continuation|Adverse Event|1
3000209|NCT00943917|10324422|P14|Stage II Continuation|Adverse Event|1
3000210|NCT00943917|10324423|P13|Stage II Continuation|Adverse Event|2
3000211|NCT00943917|10324424|P12|Stage II Continuation|Adverse Event|1
3000212|NCT00943917|10324425|P11|Stage II Continuation|Adverse Event|0
3000213|NCT00943917|10324426|P10|Stage II Continuation|Adverse Event|0
3000214|NCT00943917|10324427|P9|Stage II Continuation|Adverse Event|0
3000215|NCT00943917|10324428|P8|Stage II Continuation|Adverse Event|0
3000216|NCT00943917|10324429|P7|Stage II Continuation|Adverse Event|0
3000217|NCT00943917|10324430|P6|Stage II Continuation|Adverse Event|0
3000218|NCT00943917|10324431|P5|Stage II Continuation|Adverse Event|0
3000219|NCT00943917|10324432|P4|Stage II Continuation|Adverse Event|0
3000220|NCT00943917|10324433|P3|Stage II Continuation|Adverse Event|0
3000221|NCT00943917|10324434|P2|Stage II Continuation|Adverse Event|0
3000222|NCT00943917|10324435|P1|Stage II Continuation|Adverse Event|0
3000223|NCT00943917|10324421|P15|Stage II|Pregnancy|0
3000224|NCT00943917|10324422|P14|Stage II|Pregnancy|0
3000225|NCT00943917|10324423|P13|Stage II|Pregnancy|0
3000226|NCT00943917|10324424|P12|Stage II|Pregnancy|0
3000227|NCT00943917|10324425|P11|Stage II|Pregnancy|0
3000228|NCT00943917|10324426|P10|Stage II|Pregnancy|0
3000229|NCT00943917|10324427|P9|Stage II|Pregnancy|0
3000230|NCT00943917|10324428|P8|Stage II|Pregnancy|0
3000231|NCT00943917|10324429|P7|Stage II|Pregnancy|0
3000232|NCT00943917|10324430|P6|Stage II|Pregnancy|1
3000233|NCT00943917|10324431|P5|Stage II|Pregnancy|0
3000234|NCT00943917|10324432|P4|Stage II|Pregnancy|0
3000235|NCT00943917|10324433|P3|Stage II|Pregnancy|0
3000236|NCT00943917|10324434|P2|Stage II|Pregnancy|0
3000237|NCT00943917|10324435|P1|Stage II|Pregnancy|0
3000238|NCT00943917|10324421|P15|Stage II|Withdrawal by Subject|0
3000239|NCT00943917|10324422|P14|Stage II|Withdrawal by Subject|0
3000240|NCT00943917|10324423|P13|Stage II|Withdrawal by Subject|0
3000241|NCT00943917|10324424|P12|Stage II|Withdrawal by Subject|0
3000242|NCT00943917|10324425|P11|Stage II|Withdrawal by Subject|0
3000243|NCT00943917|10324426|P10|Stage II|Withdrawal by Subject|0
3000244|NCT00943917|10324427|P9|Stage II|Withdrawal by Subject|0
3000245|NCT00943917|10324428|P8|Stage II|Withdrawal by Subject|0
3000246|NCT00943917|10324429|P7|Stage II|Withdrawal by Subject|0
3000247|NCT00943917|10324430|P6|Stage II|Withdrawal by Subject|1
3000248|NCT00943917|10324431|P5|Stage II|Withdrawal by Subject|0
3000249|NCT00943917|10324432|P4|Stage II|Withdrawal by Subject|0
3000250|NCT00943917|10324433|P3|Stage II|Withdrawal by Subject|0
3000251|NCT00943917|10324434|P2|Stage II|Withdrawal by Subject|0
3000252|NCT00943917|10324435|P1|Stage II|Withdrawal by Subject|0
3000253|NCT00943917|10324421|P15|Stage II|Adverse Event|0
3000254|NCT00943917|10324422|P14|Stage II|Adverse Event|0
3000255|NCT00943917|10324423|P13|Stage II|Adverse Event|0
3000256|NCT00943917|10324424|P12|Stage II|Adverse Event|0
3000257|NCT00943917|10324425|P11|Stage II|Adverse Event|0
3000258|NCT00943917|10324426|P10|Stage II|Adverse Event|0
3000259|NCT00943917|10324427|P9|Stage II|Adverse Event|1
3000260|NCT00943917|10324428|P8|Stage II|Adverse Event|0
3000261|NCT00943917|10324429|P7|Stage II|Adverse Event|3
3000262|NCT00943917|10324430|P6|Stage II|Adverse Event|1
3000263|NCT00943917|10324431|P5|Stage II|Adverse Event|0
3000264|NCT00943917|10324432|P4|Stage II|Adverse Event|0
3000265|NCT00943917|10324433|P3|Stage II|Adverse Event|0
3000266|NCT00943917|10324434|P2|Stage II|Adverse Event|0
3000267|NCT00943917|10324435|P1|Stage II|Adverse Event|0
3000268|NCT00943917|10324421|P15|Stage I|Withdrawal by Subject|0
3000269|NCT00943917|10324422|P14|Stage I|Withdrawal by Subject|0
3000270|NCT00943917|10324423|P13|Stage I|Withdrawal by Subject|0
3000271|NCT00943917|10324424|P12|Stage I|Withdrawal by Subject|0
3000272|NCT00943917|10324425|P11|Stage I|Withdrawal by Subject|0
3000273|NCT00943917|10324426|P10|Stage I|Withdrawal by Subject|0
3000274|NCT00943917|10324427|P9|Stage I|Withdrawal by Subject|0
3000275|NCT00943917|10324428|P8|Stage I|Withdrawal by Subject|0
3000276|NCT00943917|10324429|P7|Stage I|Withdrawal by Subject|0
3000277|NCT00943917|10324430|P6|Stage I|Withdrawal by Subject|0
3000278|NCT00943917|10324431|P5|Stage I|Withdrawal by Subject|0
3000279|NCT00943917|10324432|P4|Stage I|Withdrawal by Subject|0
3000280|NCT00943917|10324433|P3|Stage I|Withdrawal by Subject|2
3000281|NCT00943917|10324434|P2|Stage I|Withdrawal by Subject|1
3000282|NCT00943917|10324435|P1|Stage I|Withdrawal by Subject|2
3000283|NCT00943917|10324421|P15|Stage I|A1C elevation|0
3000284|NCT00943917|10324422|P14|Stage I|A1C elevation|0
3000285|NCT00943917|10324423|P13|Stage I|A1C elevation|0
3000286|NCT00943917|10324424|P12|Stage I|A1C elevation|0
3000287|NCT00943917|10324425|P11|Stage I|A1C elevation|0
3000288|NCT00943917|10324426|P10|Stage I|A1C elevation|0
3000289|NCT00943917|10324427|P9|Stage I|A1C elevation|0
3000290|NCT00943917|10324428|P8|Stage I|A1C elevation|0
3000291|NCT00943917|10324429|P7|Stage I|A1C elevation|0
3000292|NCT00943917|10324430|P6|Stage I|A1C elevation|0
3000293|NCT00943917|10324431|P5|Stage I|A1C elevation|0
3000294|NCT00943917|10324432|P4|Stage I|A1C elevation|0
3000295|NCT00943917|10324433|P3|Stage I|A1C elevation|0
3000296|NCT00943917|10324434|P2|Stage I|A1C elevation|0
3000297|NCT00943917|10324435|P1|Stage I|A1C elevation|1
3000298|NCT00943917|10324421|P15|Stage I|hyperglycemia|0
3000299|NCT00943917|10324422|P14|Stage I|hyperglycemia|0
3000300|NCT00943917|10324423|P13|Stage I|hyperglycemia|0
3000301|NCT00943917|10324424|P12|Stage I|hyperglycemia|0
3000302|NCT00943917|10324425|P11|Stage I|hyperglycemia|0
3000303|NCT00943917|10324426|P10|Stage I|hyperglycemia|0
3000304|NCT00943917|10324427|P9|Stage I|hyperglycemia|0
3000305|NCT00943917|10324428|P8|Stage I|hyperglycemia|0
3000306|NCT00943917|10324429|P7|Stage I|hyperglycemia|0
3000307|NCT00943917|10324430|P6|Stage I|hyperglycemia|0
3000308|NCT00943917|10324431|P5|Stage I|hyperglycemia|0
3000309|NCT00943917|10324432|P4|Stage I|hyperglycemia|0
3000310|NCT00943917|10324433|P3|Stage I|hyperglycemia|1
3000311|NCT00943917|10324434|P2|Stage I|hyperglycemia|0
3000312|NCT00943917|10324435|P1|Stage I|hyperglycemia|0
3000313|NCT00943917|10324421|P15|Stage I|Lost to Follow-up|0
3000314|NCT00943917|10324422|P14|Stage I|Lost to Follow-up|0
3000315|NCT00943917|10324423|P13|Stage I|Lost to Follow-up|0
3000316|NCT00943917|10324424|P12|Stage I|Lost to Follow-up|0
3000317|NCT00943917|10324425|P11|Stage I|Lost to Follow-up|0
3000318|NCT00943917|10324426|P10|Stage I|Lost to Follow-up|0
3000319|NCT00943917|10324427|P9|Stage I|Lost to Follow-up|0
3000320|NCT00943917|10324428|P8|Stage I|Lost to Follow-up|0
3000321|NCT00943917|10324429|P7|Stage I|Lost to Follow-up|0
3000322|NCT00943917|10324430|P6|Stage I|Lost to Follow-up|0
3000323|NCT00943917|10324431|P5|Stage I|Lost to Follow-up|0
3000324|NCT00943917|10324432|P4|Stage I|Lost to Follow-up|0
3000325|NCT00943917|10324433|P3|Stage I|Lost to Follow-up|1
3000326|NCT00943917|10324434|P2|Stage I|Lost to Follow-up|0
3000327|NCT00943917|10324435|P1|Stage I|Lost to Follow-up|0
3000328|NCT00943917|10324421|P15|Stage I|Adverse Event|0
3000329|NCT00943917|10324422|P14|Stage I|Adverse Event|0
3000330|NCT00943917|10324423|P13|Stage I|Adverse Event|0
3000331|NCT00943917|10324424|P12|Stage I|Adverse Event|0
3000332|NCT00943917|10324425|P11|Stage I|Adverse Event|0
3000333|NCT00943917|10324426|P10|Stage I|Adverse Event|0
3000334|NCT00943917|10324427|P9|Stage I|Adverse Event|0
3000335|NCT00943917|10324428|P8|Stage I|Adverse Event|0
3000336|NCT00943917|10324429|P7|Stage I|Adverse Event|0
3000337|NCT00943917|10324430|P6|Stage I|Adverse Event|0
3000338|NCT00943917|10324431|P5|Stage I|Adverse Event|0
3000339|NCT00943917|10324432|P4|Stage I|Adverse Event|0
3000340|NCT00943917|10324433|P3|Stage I|Adverse Event|2
3000341|NCT00943917|10324434|P2|Stage I|Adverse Event|2
3000342|NCT00943917|10324435|P1|Stage I|Adverse Event|1
3000343|NCT00943852|10324611|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
3000344|NCT00943852|10324612|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
3000345|NCT00943852|10324613|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
3000346|NCT00943852|10324614|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
3000347|NCT00943852|10324615|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
3000348|NCT00943852|10324616|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
3000349|NCT00943852|10324617|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
3000350|NCT00943852|10324618|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
3000351|NCT00943852|10324619|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
3000352|NCT00943852|10324620|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
3000353|NCT00943852|10324611|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000354|NCT00943852|10324612|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000355|NCT00943852|10324613|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
3000356|NCT00943852|10324614|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000357|NCT00943852|10324615|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000358|NCT00943852|10324616|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000359|NCT00943852|10324617|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000360|NCT00943852|10324618|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000361|NCT00943852|10324619|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000362|NCT00943852|10324620|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
3000363|NCT00943852|10324611|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000364|NCT00943852|10324612|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000365|NCT00943852|10324613|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000366|NCT00943852|10324614|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
3000367|NCT00943852|10324615|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000368|NCT00943852|10324616|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000369|NCT00943852|10324617|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000370|NCT00943852|10324618|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000371|NCT00943852|10324619|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000372|NCT00943852|10324620|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
3000373|NCT00943852|10324611|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
3000374|NCT00943852|10324612|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
3000375|NCT00943852|10324613|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
3000376|NCT00943852|10324614|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
3000377|NCT00943852|10324615|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
3000378|NCT00943852|10324616|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
3000379|NCT00943852|10324617|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
3000380|NCT00943852|10324618|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
3000381|NCT00943852|10324619|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
3000382|NCT00943852|10324620|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
3000383|NCT00943852|10324611|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000384|NCT00943852|10324612|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000385|NCT00943852|10324613|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000386|NCT00943852|10324614|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000387|NCT00943852|10324615|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000388|NCT00943852|10324616|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000389|NCT00943852|10324617|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
3000390|NCT00943852|10324618|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000391|NCT00943852|10324619|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000392|NCT00943852|10324620|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
3000393|NCT00943826|10324633|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
3000394|NCT00943826|10324634|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
3000395|NCT00943826|10324633|P2|After Primary Overall Survival Analysis|Progression of Disease|4
3000396|NCT00943826|10324634|P1|After Primary Overall Survival Analysis|Progression of Disease|2
3000397|NCT00943826|10324633|P2|After Primary Overall Survival Analysis|Administrative reasons|16
3000398|NCT00943826|10324634|P1|After Primary Overall Survival Analysis|Administrative reasons|10
3000399|NCT00943826|10324633|P2|After Primary Overall Survival Analysis|Adverse Event|0
3000400|NCT00943826|10324634|P1|After Primary Overall Survival Analysis|Adverse Event|11
3000401|NCT00943826|10324633|P2|Monotherapy Phase|Failure to return|1
3000402|NCT00943826|10324634|P1|Monotherapy Phase|Failure to return|2
3000403|NCT00943826|10324633|P2|Monotherapy Phase|Withdrew Consent|3
3000404|NCT00943826|10324634|P1|Monotherapy Phase|Withdrew Consent|2
3000405|NCT00943826|10324633|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
3000406|NCT00943826|10324634|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
3000407|NCT00943826|10324633|P2|Monotherapy Phase|Administrative reasons|5
3000408|NCT00943826|10324634|P1|Monotherapy Phase|Administrative reasons|11
3000409|NCT00943826|10324633|P2|Monotherapy Phase|Adverse Event|5
3000410|NCT00943826|10324634|P1|Monotherapy Phase|Adverse Event|42
3000411|NCT00943826|10324633|P2|Maintenance Phase|Failure to return|1
3000412|NCT00943826|10324634|P1|Maintenance Phase|Failure to return|0
3000413|NCT00943826|10324633|P2|Maintenance Phase|Administrative reasons|1
3000414|NCT00943826|10324634|P1|Maintenance Phase|Administrative reasons|4
3000415|NCT00943826|10324633|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
3000416|NCT00943826|10324634|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
3000417|NCT00943826|10324633|P2|Maintenance Phase|Withdrew consent|4
3000418|NCT00943826|10324634|P1|Maintenance Phase|Withdrew consent|2
3000419|NCT00943826|10324633|P2|Maintenance Phase|Adverse Event|30
3000420|NCT00943826|10324634|P1|Maintenance Phase|Adverse Event|31
3000421|NCT00943826|10324633|P2|Concurrent Phase|Protocol Violation|0
3000422|NCT00943826|10324634|P1|Concurrent Phase|Protocol Violation|1
3000423|NCT00943826|10324633|P2|Concurrent Phase|Administrative reasons|1
3000424|NCT00943826|10324634|P1|Concurrent Phase|Administrative reasons|2
3000425|NCT00943826|10324633|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
3000426|NCT00943826|10324634|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
3000427|NCT00943826|10324633|P2|Concurrent Phase|Withdrew consent|7
3000428|NCT00943826|10324634|P1|Concurrent Phase|Withdrew consent|3
3000429|NCT00943826|10324633|P2|Concurrent Phase|Adverse Event|27
3000430|NCT00943826|10324634|P1|Concurrent Phase|Adverse Event|50
3000431|NCT00943787|10324652|P1|Overall Study|Withdrawal by Subject|3
3000432|NCT00943787|10324652|P1|Overall Study|Physician Decision|4
3000433|NCT00943761|10324659|P2|Overall Study|Withdrawal by Subject|1
3000434|NCT00943761|10324660|P1|Overall Study|Withdrawal by Subject|2
3000435|NCT00943761|10324659|P2|Overall Study|Lost to Follow-up|0
3000436|NCT00943761|10324660|P1|Overall Study|Lost to Follow-up|2
3000437|NCT00943735|10324672|P1|Overall Study|Other|3
3000438|NCT00943735|10324672|P1|Overall Study|Other|8
3000439|NCT00943735|10324672|P1|Overall Study|Death|1
3000440|NCT00943735|10324672|P1|Overall Study|Withdrawal by Subject|8
3000441|NCT00943735|10324672|P1|Overall Study|Adverse Event|12
3000442|NCT00943722|10324710|P5|Overall Study|Withdrawal by Subject|8
3000443|NCT00943722|10324711|P4|Overall Study|Withdrawal by Subject|13
3000444|NCT00943722|10324712|P3|Overall Study|Withdrawal by Subject|2
3000445|NCT00943722|10324713|P2|Overall Study|Withdrawal by Subject|13
3000446|NCT00943722|10324714|P1|Overall Study|Withdrawal by Subject|12
3000447|NCT00943722|10324710|P5|Overall Study|Protocol Violation|2
3000448|NCT00943722|10324711|P4|Overall Study|Protocol Violation|0
3000449|NCT00943722|10324712|P3|Overall Study|Protocol Violation|0
3000450|NCT00943722|10324713|P2|Overall Study|Protocol Violation|1
3000451|NCT00943722|10324714|P1|Overall Study|Protocol Violation|0
3000452|NCT00943722|10324710|P5|Overall Study|Pregnancy|0
3000453|NCT00943722|10324711|P4|Overall Study|Pregnancy|0
3000454|NCT00943722|10324712|P3|Overall Study|Pregnancy|1
3000455|NCT00943722|10324713|P2|Overall Study|Pregnancy|0
3000456|NCT00943722|10324714|P1|Overall Study|Pregnancy|0
3000457|NCT00943722|10324710|P5|Overall Study|Physician Decision|1
3000458|NCT00943722|10324711|P4|Overall Study|Physician Decision|0
3000459|NCT00943722|10324712|P3|Overall Study|Physician Decision|0
3000460|NCT00943722|10324713|P2|Overall Study|Physician Decision|0
3000461|NCT00943722|10324714|P1|Overall Study|Physician Decision|1
3000462|NCT00943722|10324710|P5|Overall Study|Lost to Follow-up|11
3000463|NCT00943722|10324711|P4|Overall Study|Lost to Follow-up|8
3000464|NCT00943722|10324712|P3|Overall Study|Lost to Follow-up|10
3000465|NCT00943722|10324713|P2|Overall Study|Lost to Follow-up|8
3000466|NCT00943722|10324714|P1|Overall Study|Lost to Follow-up|12
3000467|NCT00943722|10324710|P5|Overall Study|Adverse Event|0
3000468|NCT00943722|10324711|P4|Overall Study|Adverse Event|1
3000469|NCT00943722|10324712|P3|Overall Study|Adverse Event|0
3000470|NCT00943722|10324713|P2|Overall Study|Adverse Event|0
3000471|NCT00943722|10324714|P1|Overall Study|Adverse Event|0
3000472|NCT00943683|10324744|P2|Overall Study|Patient Moved|0
3000473|NCT00943683|10324745|P1|Overall Study|Patient Moved|1
3000474|NCT00943683|10324744|P2|Overall Study|Withdrawal by Subject|0
3000475|NCT00943683|10324745|P1|Overall Study|Withdrawal by Subject|1
3000476|NCT00943683|10324744|P2|Overall Study|Protocol Violation|2
3000477|NCT00943683|10324745|P1|Overall Study|Protocol Violation|1
3000478|NCT00943683|10324744|P2|Overall Study|Lost to Follow-up|1
3000479|NCT00943683|10324745|P1|Overall Study|Lost to Follow-up|1
3000480|NCT00943683|10324744|P2|Overall Study|Adverse Event|3
3000481|NCT00943683|10324745|P1|Overall Study|Adverse Event|3
3000482|NCT00943670|10324751|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
3000483|NCT00943670|10324751|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
3000484|NCT00943670|10324751|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
3000485|NCT00943670|10324751|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
3000486|NCT00943670|10324751|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
3000487|NCT00943670|10324751|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
3000488|NCT00943670|10324751|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
3000489|NCT00943670|10324751|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
3000490|NCT00943670|10324751|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
3000491|NCT00943670|10324751|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
3000492|NCT00943605|10324840|P2|Overall Study|Study termination|30
3000493|NCT00943605|10324841|P1|Overall Study|Study termination|30
3000494|NCT00943592|10324851|P1|Overall Study|Death|3
3000495|NCT00943579|10324864|P2|Overall Study|Lack of Efficacy|2
3000496|NCT00943579|10324865|P1|Overall Study|Lack of Efficacy|2
3000497|NCT00943579|10324864|P2|Overall Study|Adverse Event|3
3000498|NCT00943579|10324865|P1|Overall Study|Adverse Event|4
3000499|NCT00943397|10324966|P2|Overall Study|Site terminated and other|56
3000500|NCT00943397|10324967|P1|Overall Study|Site terminated and other|12
3000501|NCT00943397|10324966|P2|Overall Study|Withdrawal by Subject|1
3000502|NCT00943397|10324967|P1|Overall Study|Withdrawal by Subject|1
3000503|NCT00943397|10324966|P2|Overall Study|Protocol Violation|5
3000504|NCT00943397|10324967|P1|Overall Study|Protocol Violation|2
3000505|NCT00943397|10324966|P2|Overall Study|Lost to Follow-up|4
3000506|NCT00943397|10324967|P1|Overall Study|Lost to Follow-up|0
3000507|NCT00943397|10324966|P2|Overall Study|Adverse Event|6
3000508|NCT00943397|10324967|P1|Overall Study|Adverse Event|0
3000509|NCT00943384|10324973|P1|Overall Study|Withdrawal by Subject|5
3000510|NCT00943384|10324973|P1|Overall Study|Lost to Follow-up|16
3000511|NCT00943384|10324973|P1|Overall Study|Treated off protocol-protocol violation|5
3000512|NCT00943384|10324973|P1|Overall Study|Dispositioned prior to treatment|23
3000513|NCT00943319|10324987|P1|Overall Study|Death|1
3000514|NCT00943306|10324993|P1|Overall Study|Sponsor decision due to non-compliance|1
3000515|NCT00943306|10324993|P1|Overall Study|Death|1
3000516|NCT00943306|10324993|P1|Overall Study|Physician Decision|1
3000517|NCT00943124|10325295|P2|Period 1|Personal Reasons|1
3000518|NCT00943124|10325296|P1|Period 1|Personal Reasons|0
3000519|NCT00943124|10325295|P2|Period 1|Did Not Follow Study Procedures|0
3000520|NCT00943124|10325296|P1|Period 1|Did Not Follow Study Procedures|1
3000521|NCT00943124|10325295|P2|Period 1|Withdrawal by Subject|1
3000522|NCT00943124|10325296|P1|Period 1|Withdrawal by Subject|1
3000523|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Other than specified above|2
3000524|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Other than specified above|0
3000525|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Other than specified above|0
3000526|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
3000527|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
3000528|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
3000529|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Pregnancy|4
3000530|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Pregnancy|0
3000531|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Pregnancy|0
3000532|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
3000533|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
3000534|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
3000535|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Adverse Event|9
3000536|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Adverse Event|0
3000537|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Adverse Event|0
3000538|NCT00943111|10325318|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
3000539|NCT00943111|10325319|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
3000540|NCT00943111|10325320|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
3000541|NCT00943111|10325318|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
3000542|NCT00943111|10325319|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
3000543|NCT00943111|10325320|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
3000544|NCT00943111|10325318|P3|52-Weeks Primary Analysis Period|Adverse Event|0
3000545|NCT00943111|10325319|P2|52-Weeks Primary Analysis Period|Adverse Event|1
3000546|NCT00943111|10325320|P1|52-Weeks Primary Analysis Period|Adverse Event|2
3000547|NCT00943072|10325388|P2|Overall Study|Other|1
3000548|NCT00943072|10325389|P1|Overall Study|Other|1
3000549|NCT00943072|10325388|P2|Overall Study|Lack of Efficacy|4
3000550|NCT00943072|10325389|P1|Overall Study|Lack of Efficacy|0
3000551|NCT00943072|10325388|P2|Overall Study|Lost to Follow-up|2
3000552|NCT00943072|10325389|P1|Overall Study|Lost to Follow-up|1
3000553|NCT00943072|10325388|P2|Overall Study|Protocol Violation|1
3000554|NCT00943072|10325389|P1|Overall Study|Protocol Violation|0
3000555|NCT00943072|10325388|P2|Overall Study|Withdrawal by Subject|1
3000556|NCT00943072|10325389|P1|Overall Study|Withdrawal by Subject|3
3000557|NCT00943072|10325388|P2|Overall Study|Death|2
3000558|NCT00943072|10325389|P1|Overall Study|Death|0
3000559|NCT00943072|10325388|P2|Overall Study|Adverse Event|3
3000560|NCT00943072|10325389|P1|Overall Study|Adverse Event|0
3000561|NCT00942994|10325407|P2|Overall Study|Protocol deviation|2
3000562|NCT00942994|10325408|P1|Overall Study|Protocol deviation|1
3000563|NCT00942994|10325407|P2|Overall Study|Lost to Follow-up|4
3000564|NCT00942994|10325408|P1|Overall Study|Lost to Follow-up|1
3000565|NCT00942994|10325407|P2|Overall Study|Patient withdrew consent|8
3000566|NCT00942994|10325408|P1|Overall Study|Patient withdrew consent|5
3000567|NCT00942994|10325407|P2|Overall Study|Unsatisfactory therapeutic effect|1
3000568|NCT00942994|10325408|P1|Overall Study|Unsatisfactory therapeutic effect|1
3000569|NCT00942994|10325407|P2|Overall Study|Abnormal laboratory value(s)|0
3000570|NCT00942994|10325408|P1|Overall Study|Abnormal laboratory value(s)|1
3000571|NCT00942994|10325407|P2|Overall Study|Adverse Event|4
3000572|NCT00942994|10325408|P1|Overall Study|Adverse Event|7
3000573|NCT00942968|10325424|P1|Overall Study|Deep vein thrombosis (DVT)|2
3000574|NCT00942968|10325424|P1|Overall Study|Participant required pancreatic biopsy|1
3000575|NCT00942968|10325424|P1|Overall Study|Pulmonary embolism (PE)|1
3000576|NCT00942968|10325424|P1|Overall Study|Inferior vena cava filter placement|4
3000577|NCT00942968|10325424|P1|Overall Study|Progression of disease|12
3000578|NCT00942968|10325424|P1|Overall Study|Physician Decision|11
3000579|NCT00942968|10325424|P1|Overall Study|Sponsor request|5
3000580|NCT00942968|10325424|P1|Overall Study|Withdrawal by Subject|44
3000581|NCT00942968|10325424|P1|Overall Study|Lost to Follow-up|4
3000582|NCT00942968|10325424|P1|Overall Study|Protocol Violation|9
3000583|NCT00942968|10325424|P1|Overall Study|Death|76
3000584|NCT00942968|10325424|P1|Overall Study|Adverse Event|60
3000585|NCT00942734|10325502|P1|Overall Study|Physician Decision|1
3000586|NCT00942734|10325502|P1|Overall Study|Disease Progression|2
3000587|NCT00942734|10325502|P1|Overall Study|Protocol Violation|3
3000588|NCT00942734|10325502|P1|Overall Study|Adverse Event|2
3000589|NCT00942708|10325506|P1|Overall Study|Withdrawal by Subject|1
3000590|NCT00942604|10325514|P2|Overall Study|Patient relocation|1
3000591|NCT00942604|10325515|P1|Overall Study|Patient relocation|1
3000592|NCT00942604|10325514|P2|Overall Study|Withdrawal by Subject|1
3000593|NCT00942604|10325515|P1|Overall Study|Withdrawal by Subject|0
3000594|NCT00942604|10325514|P2|Overall Study|Adverse Event|1
3000595|NCT00942604|10325515|P1|Overall Study|Adverse Event|0
3000596|NCT00942604|10325514|P2|Overall Study|Protocol Violation|1
3000597|NCT00942604|10325515|P1|Overall Study|Protocol Violation|1
3000598|NCT00942422|10325623|P1|Overall Study|Progressive diease|1
3000599|NCT00942422|10325623|P1|Overall Study|Death|1
3000600|NCT00942422|10325623|P1|Overall Study|Withdrawal by Subject|1
3000601|NCT00942409|10325627|P1|Overall Study|study drug unavailable|2
3000602|NCT00942409|10325627|P1|Overall Study|Lack of Efficacy|1
3000603|NCT00942357|10325633|P2|Overall Study|Ineligible|40
3000604|NCT00942357|10325634|P1|Overall Study|Ineligible|37
3000605|NCT00942331|10325650|P2|Overall Study|Did not start treatment|22
3000606|NCT00942331|10325651|P1|Overall Study|Did not start treatment|15
3000607|NCT00942266|10325661|P2|Overall Study|medical deterioration (pneumonia)|1
3000608|NCT00942266|10325662|P1|Overall Study|medical deterioration (pneumonia)|0
3000609|NCT00942266|10325661|P2|Overall Study|Physician Decision|0
3000610|NCT00942266|10325662|P1|Overall Study|Physician Decision|2
3000611|NCT00942266|10325661|P2|Overall Study|Intercurrent illness|1
3000612|NCT00942266|10325662|P1|Overall Study|Intercurrent illness|0
3000613|NCT00942266|10325661|P2|Overall Study|Failure to thrive and pt withdrawal|1
3000614|NCT00942266|10325662|P1|Overall Study|Failure to thrive and pt withdrawal|0
3000615|NCT00942266|10325661|P2|Overall Study|Disease Progression|11
3000616|NCT00942266|10325662|P1|Overall Study|Disease Progression|38
3000617|NCT00942266|10325661|P2|Overall Study|Adverse Event|1
3000618|NCT00942266|10325662|P1|Overall Study|Adverse Event|2
3000619|NCT00942266|10325661|P2|Overall Study|Withdrawal by Subject|0
3000620|NCT00942266|10325662|P1|Overall Study|Withdrawal by Subject|1
3000621|NCT00942188|10325684|P4|Overall Study|Sponsor Decision|1
3000622|NCT00942188|10325685|P3|Overall Study|Sponsor Decision|0
3000623|NCT00942188|10325686|P2|Overall Study|Sponsor Decision|2
3000624|NCT00942188|10325687|P1|Overall Study|Sponsor Decision|0
3000625|NCT00942188|10325684|P4|Overall Study|Physician Decision|0
3000626|NCT00942188|10325685|P3|Overall Study|Physician Decision|1
3000627|NCT00942188|10325686|P2|Overall Study|Physician Decision|0
3000628|NCT00942188|10325687|P1|Overall Study|Physician Decision|0
3000629|NCT00942188|10325684|P4|Overall Study|Withdrawal by Subject|2
3000630|NCT00942188|10325685|P3|Overall Study|Withdrawal by Subject|4
3000631|NCT00942188|10325686|P2|Overall Study|Withdrawal by Subject|3
3000632|NCT00942188|10325687|P1|Overall Study|Withdrawal by Subject|1
3000633|NCT00942188|10325684|P4|Overall Study|Lost to Follow-up|0
3000634|NCT00942188|10325685|P3|Overall Study|Lost to Follow-up|2
3000635|NCT00942188|10325686|P2|Overall Study|Lost to Follow-up|1
3000636|NCT00942188|10325687|P1|Overall Study|Lost to Follow-up|2
3000637|NCT00942188|10325684|P4|Overall Study|Protocol Violation|0
3000638|NCT00942188|10325685|P3|Overall Study|Protocol Violation|0
3000639|NCT00942188|10325686|P2|Overall Study|Protocol Violation|1
3000640|NCT00942188|10325687|P1|Overall Study|Protocol Violation|1
3000641|NCT00942188|10325684|P4|Overall Study|Lack of Efficacy|1
3000642|NCT00942188|10325685|P3|Overall Study|Lack of Efficacy|0
3000643|NCT00942188|10325686|P2|Overall Study|Lack of Efficacy|0
3000644|NCT00942188|10325687|P1|Overall Study|Lack of Efficacy|0
3000645|NCT00942188|10325684|P4|Overall Study|Adverse Event|0
3000646|NCT00942188|10325685|P3|Overall Study|Adverse Event|2
3000647|NCT00942188|10325686|P2|Overall Study|Adverse Event|3
3000648|NCT00942188|10325687|P1|Overall Study|Adverse Event|0
3000649|NCT00942175|10325726|P4|Overall Study|Low Platelet Count|0
3000650|NCT00942175|10325727|P3|Overall Study|Low Platelet Count|0
3000651|NCT00942175|10325728|P2|Overall Study|Low Platelet Count|2
3000652|NCT00942175|10325729|P1|Overall Study|Low Platelet Count|0
3000653|NCT00942175|10325726|P4|Overall Study|Elevated Alanine Amino Transferase|1
3000654|NCT00942175|10325727|P3|Overall Study|Elevated Alanine Amino Transferase|0
3000655|NCT00942175|10325728|P2|Overall Study|Elevated Alanine Amino Transferase|0
3000656|NCT00942175|10325729|P1|Overall Study|Elevated Alanine Amino Transferase|0
3000657|NCT00942175|10325726|P4|Overall Study|Pregnancy|1
3000658|NCT00942175|10325727|P3|Overall Study|Pregnancy|0
3000659|NCT00942175|10325728|P2|Overall Study|Pregnancy|0
3000660|NCT00942175|10325729|P1|Overall Study|Pregnancy|0
3000661|NCT00942175|10325726|P4|Overall Study|Protocol Violation|0
3000662|NCT00942175|10325727|P3|Overall Study|Protocol Violation|2
3000663|NCT00942175|10325728|P2|Overall Study|Protocol Violation|1
3000664|NCT00942175|10325729|P1|Overall Study|Protocol Violation|0
3000665|NCT00942175|10325726|P4|Overall Study|Adverse Event|0
3000666|NCT00942175|10325727|P3|Overall Study|Adverse Event|0
3000667|NCT00942175|10325728|P2|Overall Study|Adverse Event|1
3000668|NCT00942175|10325729|P1|Overall Study|Adverse Event|2
3000669|NCT00942162|10325782|P3|Overall Study|Other|0
3000670|NCT00942162|10325783|P2|Overall Study|Other|2
3000671|NCT00942162|10325784|P1|Overall Study|Other|8
3000672|NCT00942162|10325782|P3|Overall Study|Withdrawal by Subject|0
3000673|NCT00942162|10325783|P2|Overall Study|Withdrawal by Subject|2
3000674|NCT00942162|10325784|P1|Overall Study|Withdrawal by Subject|4
3000675|NCT00942162|10325782|P3|Overall Study|Protocol Violation|0
3000676|NCT00942162|10325783|P2|Overall Study|Protocol Violation|0
3000677|NCT00942162|10325784|P1|Overall Study|Protocol Violation|1
3000678|NCT00942162|10325782|P3|Overall Study|Adverse Event|0
3000679|NCT00942162|10325783|P2|Overall Study|Adverse Event|0
3000680|NCT00942162|10325784|P1|Overall Study|Adverse Event|2
3000681|NCT00942162|10325782|P3|Overall Study|Disease progression|1
3000682|NCT00942162|10325783|P2|Overall Study|Disease progression|43
3000683|NCT00942162|10325784|P1|Overall Study|Disease progression|53
3000684|NCT00942084|10325853|P1|Overall Study|Death|2
3000685|NCT00941928|10325870|P1|Overall Study|Disease Progression|1
3000686|NCT00941928|10325870|P1|Overall Study|Withdrawal by Subject|1
3000687|NCT00941863|10325888|P5|Continued After PCD|Disease progression, recurrence, relapse|18
3000688|NCT00941863|10325889|P4|Continued After PCD|Disease progression, recurrence, relapse|0
3000689|NCT00941863|10325890|P3|Continued After PCD|Disease progression, recurrence, relapse|0
3000690|NCT00941863|10325891|P2|Continued After PCD|Disease progression, recurrence, relapse|0
3000691|NCT00941863|10325892|P1|Continued After PCD|Disease progression, recurrence, relapse|0
3000692|NCT00941863|10325888|P5|Continued After PCD|Withdrawal by Subject|1
3000693|NCT00941863|10325889|P4|Continued After PCD|Withdrawal by Subject|0
3000694|NCT00941863|10325890|P3|Continued After PCD|Withdrawal by Subject|0
3000695|NCT00941863|10325891|P2|Continued After PCD|Withdrawal by Subject|0
3000696|NCT00941863|10325892|P1|Continued After PCD|Withdrawal by Subject|0
3000697|NCT00941863|10325888|P5|Until Primary Completion Date (PCD)|Disease progression|73
3000698|NCT00941863|10325889|P4|Until Primary Completion Date (PCD)|Disease progression|14
3000699|NCT00941863|10325890|P3|Until Primary Completion Date (PCD)|Disease progression|8
3000700|NCT00941863|10325891|P2|Until Primary Completion Date (PCD)|Disease progression|1
3000701|NCT00941863|10325892|P1|Until Primary Completion Date (PCD)|Disease progression|6
3000702|NCT00941863|10325888|P5|Until Primary Completion Date (PCD)|Death|7
3000703|NCT00941863|10325889|P4|Until Primary Completion Date (PCD)|Death|2
3000704|NCT00941863|10325890|P3|Until Primary Completion Date (PCD)|Death|1
3000705|NCT00941863|10325891|P2|Until Primary Completion Date (PCD)|Death|0
3000706|NCT00941863|10325892|P1|Until Primary Completion Date (PCD)|Death|0
3000707|NCT00941863|10325888|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
3000708|NCT00941863|10325889|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
3000709|NCT00941863|10325890|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
3000710|NCT00941863|10325891|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
3000711|NCT00941863|10325892|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
3000712|NCT00941863|10325888|P5|Until Primary Completion Date (PCD)|Physician Decision|1
3000713|NCT00941863|10325889|P4|Until Primary Completion Date (PCD)|Physician Decision|0
3000714|NCT00941863|10325890|P3|Until Primary Completion Date (PCD)|Physician Decision|0
3000715|NCT00941863|10325891|P2|Until Primary Completion Date (PCD)|Physician Decision|0
3000716|NCT00941863|10325892|P1|Until Primary Completion Date (PCD)|Physician Decision|0
3000717|NCT00941863|10325888|P5|Until Primary Completion Date (PCD)|Adverse Event|5
3000718|NCT00941863|10325889|P4|Until Primary Completion Date (PCD)|Adverse Event|1
3000719|NCT00941863|10325890|P3|Until Primary Completion Date (PCD)|Adverse Event|2
3000720|NCT00941863|10325891|P2|Until Primary Completion Date (PCD)|Adverse Event|2
3000721|NCT00941863|10325892|P1|Until Primary Completion Date (PCD)|Adverse Event|1
3000722|NCT00941798|10325919|P2|Overall Study|Death|1
3000723|NCT00941798|10325920|P1|Overall Study|Death|0
3000724|NCT00941798|10325919|P2|Overall Study|Abnormal laboratory values|2
3000725|NCT00941798|10325920|P1|Overall Study|Abnormal laboratory values|1
3000726|NCT00941798|10325919|P2|Overall Study|Abnormal test procedure results|1
3000727|NCT00941798|10325920|P1|Overall Study|Abnormal test procedure results|3
3000728|NCT00941798|10325919|P2|Overall Study|Patient's inability to use device|1
3000729|NCT00941798|10325920|P1|Overall Study|Patient's inability to use device|6
3000730|NCT00941798|10325919|P2|Overall Study|Lack of Efficacy|17
3000731|NCT00941798|10325920|P1|Overall Study|Lack of Efficacy|10
3000732|NCT00941798|10325919|P2|Overall Study|Administrative problems|23
3000733|NCT00941798|10325920|P1|Overall Study|Administrative problems|13
3000734|NCT00941798|10325919|P2|Overall Study|Protocol Violation|20
3000735|NCT00941798|10325920|P1|Overall Study|Protocol Violation|17
3000736|NCT00941798|10325919|P2|Overall Study|Lost to Follow-up|23
3000737|NCT00941798|10325920|P1|Overall Study|Lost to Follow-up|29
3000738|NCT00941798|10325919|P2|Overall Study|Adverse Event|23
3000739|NCT00941798|10325920|P1|Overall Study|Adverse Event|43
3000740|NCT00941798|10325919|P2|Overall Study|Withdrawal by Subject|74
3000741|NCT00941798|10325920|P1|Overall Study|Withdrawal by Subject|72
3000742|NCT00941733|10325950|P2|Overall Study|Protocol Violation|6
3000743|NCT00941733|10325951|P1|Overall Study|Protocol Violation|15
3000744|NCT00941733|10325950|P2|Overall Study|Lost to Follow-up|2
3000745|NCT00941733|10325951|P1|Overall Study|Lost to Follow-up|1
3000746|NCT00941733|10325950|P2|Overall Study|Adverse Event|4
3000747|NCT00941733|10325951|P1|Overall Study|Adverse Event|20
3000748|NCT00941733|10325950|P2|Overall Study|Withdrawal by Subject|6
3000749|NCT00941733|10325951|P1|Overall Study|Withdrawal by Subject|14
3000750|NCT00941733|10325950|P2|Overall Study|Death|10
3000751|NCT00941733|10325951|P1|Overall Study|Death|24
3000752|NCT00941720|10325991|P1|Overall Study|ineligible|2
3000753|NCT00941720|10325991|P1|Overall Study|Insurance denied participation|11
3000754|NCT00941720|10325991|P1|Overall Study|Withdrawal by Subject|1
3000755|NCT00941655|10326038|P2|Overall Study|non-compliant|1
3000756|NCT00941655|10326039|P1|Overall Study|non-compliant|0
3000757|NCT00941655|10326038|P2|Overall Study|withdrew consent|1
3000758|NCT00941655|10326039|P1|Overall Study|withdrew consent|0
3000759|NCT00941655|10326038|P2|Overall Study|refused further treatment|1
3000760|NCT00941655|10326039|P1|Overall Study|refused further treatment|0
3000761|NCT00941655|10326038|P2|Overall Study|progressed while on chemo|2
3000762|NCT00941655|10326039|P1|Overall Study|progressed while on chemo|0
3000763|NCT00941655|10326038|P2|Overall Study|not meet criteria for chemo foll surgery|0
3000764|NCT00941655|10326039|P1|Overall Study|not meet criteria for chemo foll surgery|4
3000765|NCT00941655|10326038|P2|Overall Study|received some chemo, 4 and 9 cycles|0
3000766|NCT00941655|10326039|P1|Overall Study|received some chemo, 4 and 9 cycles|1
3000767|NCT00941603|10326064|P6|Overall Study|Did not meet protocol eligibility|0
3000768|NCT00941603|10326065|P5|Overall Study|Did not meet protocol eligibility|0
3000769|NCT00941603|10326066|P4|Overall Study|Did not meet protocol eligibility|0
3000770|NCT00941603|10326067|P3|Overall Study|Did not meet protocol eligibility|0
3000771|NCT00941603|10326068|P2|Overall Study|Did not meet protocol eligibility|0
3000772|NCT00941603|10326069|P1|Overall Study|Did not meet protocol eligibility|1
3000773|NCT00941603|10326064|P6|Overall Study|Protocol Violation|0
3000774|NCT00941603|10326065|P5|Overall Study|Protocol Violation|0
3000775|NCT00941603|10326066|P4|Overall Study|Protocol Violation|0
3000776|NCT00941603|10326067|P3|Overall Study|Protocol Violation|0
3000777|NCT00941603|10326068|P2|Overall Study|Protocol Violation|1
3000778|NCT00941603|10326069|P1|Overall Study|Protocol Violation|0
3000779|NCT00941603|10326064|P6|Overall Study|Withdrawal by Subject|1
3000780|NCT00941603|10326065|P5|Overall Study|Withdrawal by Subject|0
3000781|NCT00941603|10326066|P4|Overall Study|Withdrawal by Subject|2
3000782|NCT00941603|10326067|P3|Overall Study|Withdrawal by Subject|0
3000783|NCT00941603|10326068|P2|Overall Study|Withdrawal by Subject|0
3000784|NCT00941603|10326069|P1|Overall Study|Withdrawal by Subject|0
3000785|NCT00941603|10326064|P6|Overall Study|Lost to Follow-up|2
3000786|NCT00941603|10326065|P5|Overall Study|Lost to Follow-up|0
3000787|NCT00941603|10326066|P4|Overall Study|Lost to Follow-up|1
3000788|NCT00941603|10326067|P3|Overall Study|Lost to Follow-up|0
3000789|NCT00941603|10326068|P2|Overall Study|Lost to Follow-up|0
3000790|NCT00941603|10326069|P1|Overall Study|Lost to Follow-up|0
3000791|NCT00941603|10326064|P6|Overall Study|Adverse Event|0
3000792|NCT00941603|10326065|P5|Overall Study|Adverse Event|4
3000793|NCT00941603|10326066|P4|Overall Study|Adverse Event|1
3000794|NCT00941603|10326067|P3|Overall Study|Adverse Event|5
3000795|NCT00941603|10326068|P2|Overall Study|Adverse Event|15
3000796|NCT00941603|10326069|P1|Overall Study|Adverse Event|10
3000797|NCT00941330|10326091|P2|Overall Study|Physician Decision|2
3000798|NCT00941330|10326092|P1|Overall Study|Physician Decision|0
3000799|NCT00941330|10326091|P2|Overall Study|Other|0
3000800|NCT00941330|10326092|P1|Overall Study|Other|1
3000801|NCT00941304|10326105|P5|Overall Study|Lost to Follow-up|0
3000802|NCT00941304|10326106|P4|Overall Study|Lost to Follow-up|0
3000803|NCT00941304|10326107|P3|Overall Study|Lost to Follow-up|0
3000804|NCT00941304|10326108|P2|Overall Study|Lost to Follow-up|0
3000805|NCT00941304|10326109|P1|Overall Study|Lost to Follow-up|1
3000806|NCT00941070|10326171|P1|Overall Study|Patient non-compliant|1
3000807|NCT00941031|10326191|P7|Maintenance Period|Lack of Efficacy|13
3000808|NCT00941031|10326192|P6|Maintenance Period|Lack of Efficacy|0
3000809|NCT00941031|10326193|P5|Maintenance Period|Lack of Efficacy|0
3000810|NCT00941031|10326194|P4|Maintenance Period|Lack of Efficacy|0
3000811|NCT00941031|10326195|P3|Maintenance Period|Lack of Efficacy|0
3000812|NCT00941031|10326196|P2|Maintenance Period|Lack of Efficacy|0
3000813|NCT00941031|10326197|P1|Maintenance Period|Lack of Efficacy|0
3000814|NCT00941031|10326191|P7|Maintenance Period|Lost to Follow-up|7
3000815|NCT00941031|10326192|P6|Maintenance Period|Lost to Follow-up|2
3000816|NCT00941031|10326193|P5|Maintenance Period|Lost to Follow-up|2
3000817|NCT00941031|10326194|P4|Maintenance Period|Lost to Follow-up|0
3000818|NCT00941031|10326195|P3|Maintenance Period|Lost to Follow-up|0
3000819|NCT00941031|10326196|P2|Maintenance Period|Lost to Follow-up|0
3000820|NCT00941031|10326197|P1|Maintenance Period|Lost to Follow-up|0
3000821|NCT00941031|10326191|P7|Maintenance Period|Adverse Event|8
3000822|NCT00941031|10326192|P6|Maintenance Period|Adverse Event|2
3000823|NCT00941031|10326193|P5|Maintenance Period|Adverse Event|0
3000824|NCT00941031|10326194|P4|Maintenance Period|Adverse Event|0
3000825|NCT00941031|10326195|P3|Maintenance Period|Adverse Event|0
3000826|NCT00941031|10326196|P2|Maintenance Period|Adverse Event|0
3000827|NCT00941031|10326197|P1|Maintenance Period|Adverse Event|0
3000828|NCT00941031|10326191|P7|Maintenance Period|Protocol Violation|1
3000829|NCT00941031|10326192|P6|Maintenance Period|Protocol Violation|0
3000830|NCT00941031|10326193|P5|Maintenance Period|Protocol Violation|0
3000831|NCT00941031|10326194|P4|Maintenance Period|Protocol Violation|0
3000832|NCT00941031|10326195|P3|Maintenance Period|Protocol Violation|0
3000833|NCT00941031|10326196|P2|Maintenance Period|Protocol Violation|0
3000834|NCT00941031|10326197|P1|Maintenance Period|Protocol Violation|0
3000835|NCT00941031|10326191|P7|Maintenance Period|Administrative Problems|1
3000836|NCT00941031|10326192|P6|Maintenance Period|Administrative Problems|0
3000837|NCT00941031|10326193|P5|Maintenance Period|Administrative Problems|1
3000838|NCT00941031|10326194|P4|Maintenance Period|Administrative Problems|0
3000839|NCT00941031|10326195|P3|Maintenance Period|Administrative Problems|0
3000840|NCT00941031|10326196|P2|Maintenance Period|Administrative Problems|0
3000841|NCT00941031|10326197|P1|Maintenance Period|Administrative Problems|0
3000842|NCT00941031|10326191|P7|Maintenance Period|Withdrawal by Subject|13
3000843|NCT00941031|10326192|P6|Maintenance Period|Withdrawal by Subject|2
3000844|NCT00941031|10326193|P5|Maintenance Period|Withdrawal by Subject|6
3000845|NCT00941031|10326194|P4|Maintenance Period|Withdrawal by Subject|0
3000846|NCT00941031|10326195|P3|Maintenance Period|Withdrawal by Subject|0
3000847|NCT00941031|10326196|P2|Maintenance Period|Withdrawal by Subject|0
3000848|NCT00941031|10326197|P1|Maintenance Period|Withdrawal by Subject|0
3000849|NCT00941031|10326191|P7|Induction Period|Adverse Event|0
3000850|NCT00941031|10326192|P6|Induction Period|Adverse Event|0
3000851|NCT00941031|10326193|P5|Induction Period|Adverse Event|0
3000852|NCT00941031|10326194|P4|Induction Period|Adverse Event|2
3000853|NCT00941031|10326195|P3|Induction Period|Adverse Event|3
3000854|NCT00941031|10326196|P2|Induction Period|Adverse Event|0
3000855|NCT00941031|10326197|P1|Induction Period|Adverse Event|1
3000856|NCT00941031|10326191|P7|Induction Period|Adminstative Problems|0
3000857|NCT00941031|10326192|P6|Induction Period|Adminstative Problems|0
3000858|NCT00941031|10326193|P5|Induction Period|Adminstative Problems|0
3000859|NCT00941031|10326194|P4|Induction Period|Adminstative Problems|0
3000860|NCT00941031|10326195|P3|Induction Period|Adminstative Problems|1
3000861|NCT00941031|10326196|P2|Induction Period|Adminstative Problems|1
3000862|NCT00941031|10326197|P1|Induction Period|Adminstative Problems|1
3000863|NCT00941031|10326191|P7|Induction Period|Withdrawal by Subject|0
3000864|NCT00941031|10326192|P6|Induction Period|Withdrawal by Subject|0
3000865|NCT00941031|10326193|P5|Induction Period|Withdrawal by Subject|0
3000866|NCT00941031|10326194|P4|Induction Period|Withdrawal by Subject|2
3000867|NCT00941031|10326195|P3|Induction Period|Withdrawal by Subject|2
3000868|NCT00941031|10326196|P2|Induction Period|Withdrawal by Subject|2
3000869|NCT00941031|10326197|P1|Induction Period|Withdrawal by Subject|1
3000870|NCT00941031|10326191|P7|Induction Period|Lack of Efficacy|0
3000871|NCT00941031|10326192|P6|Induction Period|Lack of Efficacy|0
3000872|NCT00941031|10326193|P5|Induction Period|Lack of Efficacy|0
3000873|NCT00941031|10326194|P4|Induction Period|Lack of Efficacy|5
3000874|NCT00941031|10326195|P3|Induction Period|Lack of Efficacy|0
3000875|NCT00941031|10326196|P2|Induction Period|Lack of Efficacy|1
3000876|NCT00941031|10326197|P1|Induction Period|Lack of Efficacy|2
3000877|NCT00940992|10326223|P3|Overall Study|Lost to Follow-up|1
3000878|NCT00940992|10326224|P2|Overall Study|Lost to Follow-up|1
3000879|NCT00940992|10326225|P1|Overall Study|Lost to Follow-up|0
3000880|NCT00940992|10326223|P3|Overall Study|subject request|0
3000881|NCT00940992|10326224|P2|Overall Study|subject request|1
3000882|NCT00940992|10326225|P1|Overall Study|subject request|2
3000883|NCT00940992|10326223|P3|Overall Study|Adverse Event|1
3000884|NCT00940992|10326224|P2|Overall Study|Adverse Event|0
3000885|NCT00940992|10326225|P1|Overall Study|Adverse Event|2
3000886|NCT00940888|10326254|P1|Overall Study|Lost to Follow-up|6
3000887|NCT00940888|10326254|P1|Overall Study|Withdrawn - Non-Death|364
3000888|NCT00940888|10326254|P1|Overall Study|Death|461
3000889|NCT00940888|10326254|P1|Overall Study|Unsuccessful Implant|4
3000890|NCT00940875|10326261|P2|Post-Study Treatment|Disease Progression|2
3000891|NCT00940875|10326262|P1|Post-Study Treatment|Disease Progression|0
3000892|NCT00940875|10326261|P2|Post-Study Treatment|Death|1
3000893|NCT00940875|10326262|P1|Post-Study Treatment|Death|0
3000894|NCT00940875|10326261|P2|Treatment Phase|Physician Decision|0
3000895|NCT00940875|10326262|P1|Treatment Phase|Physician Decision|1
3000896|NCT00940875|10326261|P2|Treatment Phase|Disease progression|11
3000897|NCT00940875|10326262|P1|Treatment Phase|Disease progression|9
3000898|NCT00940875|10326261|P2|Treatment Phase|Withdrawal by Subject|0
3000899|NCT00940875|10326262|P1|Treatment Phase|Withdrawal by Subject|3
3000900|NCT00940875|10326261|P2|Treatment Phase|Lack of Efficacy|0
3000901|NCT00940875|10326262|P1|Treatment Phase|Lack of Efficacy|1
3000902|NCT00940875|10326261|P2|Treatment Phase|Death|5
3000903|NCT00940875|10326262|P1|Treatment Phase|Death|3
3000904|NCT00940875|10326261|P2|Treatment Phase|Adverse Event|3
3000905|NCT00940875|10326262|P1|Treatment Phase|Adverse Event|9
3000906|NCT00940823|10326282|P2|Overall Study|Lost to Follow-up|20
3000907|NCT00940823|10326283|P1|Overall Study|Lost to Follow-up|27
3000908|NCT00940823|10326282|P2|Overall Study|Death|12
3000909|NCT00940823|10326283|P1|Overall Study|Death|8
3000910|NCT00940498|10326347|P8|Overall Study|Not treated due to disease related pain|0
3000911|NCT00940498|10326348|P7|Overall Study|Not treated due to disease related pain|0
3000912|NCT00940498|10326349|P6|Overall Study|Not treated due to disease related pain|0
3000913|NCT00940498|10326350|P5|Overall Study|Not treated due to disease related pain|1
3000914|NCT00940498|10326351|P4|Overall Study|Not treated due to disease related pain|0
3000915|NCT00940498|10326352|P3|Overall Study|Not treated due to disease related pain|0
3000916|NCT00940498|10326353|P2|Overall Study|Not treated due to disease related pain|0
3000917|NCT00940498|10326354|P1|Overall Study|Not treated due to disease related pain|0
3000918|NCT00940498|10326347|P8|Overall Study|Physician Decision|0
3000919|NCT00940498|10326348|P7|Overall Study|Physician Decision|0
3000920|NCT00940498|10326349|P6|Overall Study|Physician Decision|0
3000921|NCT00940498|10326350|P5|Overall Study|Physician Decision|2
3000922|NCT00940498|10326351|P4|Overall Study|Physician Decision|0
3000923|NCT00940498|10326352|P3|Overall Study|Physician Decision|0
3000924|NCT00940498|10326353|P2|Overall Study|Physician Decision|0
3000925|NCT00940498|10326354|P1|Overall Study|Physician Decision|0
3000926|NCT00940498|10326347|P8|Overall Study|Disease Progression|0
3000927|NCT00940498|10326348|P7|Overall Study|Disease Progression|0
3000928|NCT00940498|10326349|P6|Overall Study|Disease Progression|1
3000929|NCT00940498|10326350|P5|Overall Study|Disease Progression|0
3000930|NCT00940498|10326351|P4|Overall Study|Disease Progression|1
3000931|NCT00940498|10326352|P3|Overall Study|Disease Progression|1
3000932|NCT00940498|10326353|P2|Overall Study|Disease Progression|0
3000933|NCT00940498|10326354|P1|Overall Study|Disease Progression|0
3000934|NCT00940498|10326347|P8|Overall Study|Lost to Follow-up|1
3000935|NCT00940498|10326348|P7|Overall Study|Lost to Follow-up|0
3000936|NCT00940498|10326349|P6|Overall Study|Lost to Follow-up|0
3000937|NCT00940498|10326350|P5|Overall Study|Lost to Follow-up|1
3000938|NCT00940498|10326351|P4|Overall Study|Lost to Follow-up|0
3000939|NCT00940498|10326352|P3|Overall Study|Lost to Follow-up|2
3000940|NCT00940498|10326353|P2|Overall Study|Lost to Follow-up|1
3000941|NCT00940498|10326354|P1|Overall Study|Lost to Follow-up|1
3000942|NCT00940498|10326347|P8|Overall Study|Death|0
3000943|NCT00940498|10326348|P7|Overall Study|Death|1
3000944|NCT00940498|10326349|P6|Overall Study|Death|0
3000945|NCT00940498|10326350|P5|Overall Study|Death|5
3000946|NCT00940498|10326351|P4|Overall Study|Death|1
3000947|NCT00940498|10326352|P3|Overall Study|Death|0
3000948|NCT00940498|10326353|P2|Overall Study|Death|0
3000949|NCT00940498|10326354|P1|Overall Study|Death|2
3000950|NCT00940485|10326472|P2|Overall Study|Others|1
3000951|NCT00940485|10326473|P1|Overall Study|Others|1
3000952|NCT00940485|10326472|P2|Overall Study|Withdrawal by Subject|1
3000953|NCT00940485|10326473|P1|Overall Study|Withdrawal by Subject|1
3000954|NCT00940485|10326472|P2|Overall Study|Adverse Event|0
3000955|NCT00940485|10326473|P1|Overall Study|Adverse Event|8
3000956|NCT00940485|10326472|P2|Overall Study|Lost to Follow-up|3
3000957|NCT00940485|10326473|P1|Overall Study|Lost to Follow-up|2
3000958|NCT00940485|10326472|P2|Overall Study|HBeAb positive at Baseline|2
3000959|NCT00940485|10326473|P1|Overall Study|HBeAb positive at Baseline|3
3000960|NCT00940342|10326511|P3|Overall Study|Adverse Event|1
3000961|NCT00940342|10326512|P2|Overall Study|Adverse Event|2
3000962|NCT00940342|10326513|P1|Overall Study|Adverse Event|0
3000963|NCT00940316|10326524|P3|Treated After Cycle 5|Progressive disease|0
3000964|NCT00940316|10326525|P2|Treated After Cycle 5|Progressive disease|1
3000965|NCT00940316|10326526|P1|Treated After Cycle 5|Progressive disease|0
3000966|NCT00940316|10326524|P3|Treated After Cycle 5|Adverse Event|1
3000967|NCT00940316|10326525|P2|Treated After Cycle 5|Adverse Event|0
3000968|NCT00940316|10326526|P1|Treated After Cycle 5|Adverse Event|0
3000969|NCT00940316|10326524|P3|Moved on to be Treated Cycle 5|Adverse Event|0
3000970|NCT00940316|10326525|P2|Moved on to be Treated Cycle 5|Adverse Event|0
3000971|NCT00940316|10326526|P1|Moved on to be Treated Cycle 5|Adverse Event|2
3000972|NCT00940316|10326524|P3|Reached First Response at 8 Weeks|Progressive disease|0
3000973|NCT00940316|10326525|P2|Reached First Response at 8 Weeks|Progressive disease|3
3000974|NCT00940316|10326526|P1|Reached First Response at 8 Weeks|Progressive disease|1
3000975|NCT00940316|10326524|P3|Reached First Response at 8 Weeks|Adverse Event|0
3000976|NCT00940316|10326525|P2|Reached First Response at 8 Weeks|Adverse Event|1
3000977|NCT00940316|10326526|P1|Reached First Response at 8 Weeks|Adverse Event|2
3000978|NCT00940108|10326569|P4|Overall Study|Diagnosed with H1N1|1
3000979|NCT00940108|10326570|P3|Overall Study|Diagnosed with H1N1|0
3000980|NCT00940108|10326571|P2|Overall Study|Diagnosed with H1N1|0
3000981|NCT00940108|10326572|P1|Overall Study|Diagnosed with H1N1|0
3000982|NCT00940108|10326569|P4|Overall Study|Viral illness after Dose 1|0
3000983|NCT00940108|10326570|P3|Overall Study|Viral illness after Dose 1|0
3000984|NCT00940108|10326571|P2|Overall Study|Viral illness after Dose 1|1
3000985|NCT00940108|10326572|P1|Overall Study|Viral illness after Dose 1|0
3000986|NCT00940108|10326569|P4|Overall Study|Refused - pyrexia after Dose 1|0
3000987|NCT00940108|10326570|P3|Overall Study|Refused - pyrexia after Dose 1|0
3000988|NCT00940108|10326571|P2|Overall Study|Refused - pyrexia after Dose 1|1
3000989|NCT00940108|10326572|P1|Overall Study|Refused - pyrexia after Dose 1|0
3000990|NCT00940108|10326569|P4|Overall Study|Declined further vaccination|0
3000991|NCT00940108|10326570|P3|Overall Study|Declined further vaccination|3
3000992|NCT00940108|10326571|P2|Overall Study|Declined further vaccination|1
3000993|NCT00940108|10326572|P1|Overall Study|Declined further vaccination|0
3000994|NCT00940108|10326569|P4|Overall Study|Dose 2 contraindicated|1
3000995|NCT00940108|10326570|P3|Overall Study|Dose 2 contraindicated|0
3000996|NCT00940108|10326571|P2|Overall Study|Dose 2 contraindicated|1
3000997|NCT00940108|10326572|P1|Overall Study|Dose 2 contraindicated|1
3000998|NCT00940108|10326569|P4|Overall Study|Withdrew Consent|1
3000999|NCT00940108|10326570|P3|Overall Study|Withdrew Consent|0
3001000|NCT00940108|10326571|P2|Overall Study|Withdrew Consent|1
3001001|NCT00940108|10326572|P1|Overall Study|Withdrew Consent|2
3001002|NCT00940108|10326569|P4|Overall Study|Adverse Event|2
3001003|NCT00940108|10326570|P3|Overall Study|Adverse Event|0
3001004|NCT00940108|10326571|P2|Overall Study|Adverse Event|4
3001005|NCT00940108|10326572|P1|Overall Study|Adverse Event|2
3001006|NCT00940017|10326622|P1|Overall Study|Adverse Event|1
3001007|NCT00940017|10326622|P1|Overall Study|did not meet entrance criteria|3
3001008|NCT00939822|10326680|P2|Overall Study|Mental health issues|2
3001009|NCT00939822|10326681|P1|Overall Study|Mental health issues|0
3001010|NCT00939822|10326680|P2|Overall Study|withdrew from study due to busy schedule|1
3001011|NCT00939822|10326681|P1|Overall Study|withdrew from study due to busy schedule|1
3001012|NCT00939822|10326680|P2|Overall Study|Lost to Follow-up|0
3001013|NCT00939822|10326681|P1|Overall Study|Lost to Follow-up|1
3001014|NCT00939809|10326693|P1|Overall Study|Death|1
3001015|NCT00939809|10326693|P1|Overall Study|Adverse Event|2
3001016|NCT00939783|10326708|P1|Overall Study|Enrolled but not treated|1
3001017|NCT00939783|10326708|P1|Overall Study|Protocol Violation|3
3001018|NCT00939783|10326708|P1|Overall Study|Lost to Follow-up|8
3001019|NCT00939783|10326708|P1|Overall Study|Other|16
3001020|NCT00939783|10326708|P1|Overall Study|Withdrawal by Subject|78
3001021|NCT00939783|10326708|P1|Overall Study|Study Terminated by Sponsor|498
3001022|NCT00939783|10326708|P1|Overall Study|Adverse Event|39
3001023|NCT00939783|10326708|P1|Overall Study|Death|6
3001024|NCT00939770|10326723|P8|Overall Study|Withdrawal by Subject|2
3001025|NCT00939770|10326724|P7|Overall Study|Withdrawal by Subject|2
3001026|NCT00939770|10326725|P6|Overall Study|Withdrawal by Subject|0
3001027|NCT00939770|10326726|P5|Overall Study|Withdrawal by Subject|6
3001028|NCT00939770|10326727|P4|Overall Study|Withdrawal by Subject|2
3001029|NCT00939770|10326728|P3|Overall Study|Withdrawal by Subject|5
3001030|NCT00939770|10326729|P2|Overall Study|Withdrawal by Subject|1
3001031|NCT00939770|10326730|P1|Overall Study|Withdrawal by Subject|0
3001032|NCT00939770|10326723|P8|Overall Study|Protocol Violation|0
3001033|NCT00939770|10326724|P7|Overall Study|Protocol Violation|0
3001034|NCT00939770|10326725|P6|Overall Study|Protocol Violation|0
3001035|NCT00939770|10326726|P5|Overall Study|Protocol Violation|1
3001036|NCT00939770|10326727|P4|Overall Study|Protocol Violation|0
3001037|NCT00939770|10326728|P3|Overall Study|Protocol Violation|0
3001038|NCT00939770|10326729|P2|Overall Study|Protocol Violation|0
3001039|NCT00939770|10326730|P1|Overall Study|Protocol Violation|0
3001040|NCT00939770|10326723|P8|Overall Study|Physician Decision|6
3001041|NCT00939770|10326724|P7|Overall Study|Physician Decision|0
3001042|NCT00939770|10326725|P6|Overall Study|Physician Decision|1
3001043|NCT00939770|10326726|P5|Overall Study|Physician Decision|7
3001044|NCT00939770|10326727|P4|Overall Study|Physician Decision|0
3001045|NCT00939770|10326728|P3|Overall Study|Physician Decision|2
3001046|NCT00939770|10326729|P2|Overall Study|Physician Decision|0
3001047|NCT00939770|10326730|P1|Overall Study|Physician Decision|0
3001048|NCT00939770|10326723|P8|Overall Study|Lost to Follow-up|0
3001049|NCT00939770|10326724|P7|Overall Study|Lost to Follow-up|0
3001050|NCT00939770|10326725|P6|Overall Study|Lost to Follow-up|0
3001051|NCT00939770|10326726|P5|Overall Study|Lost to Follow-up|1
3001052|NCT00939770|10326727|P4|Overall Study|Lost to Follow-up|0
3001053|NCT00939770|10326728|P3|Overall Study|Lost to Follow-up|0
3001054|NCT00939770|10326729|P2|Overall Study|Lost to Follow-up|0
3001055|NCT00939770|10326730|P1|Overall Study|Lost to Follow-up|0
3001056|NCT00939770|10326723|P8|Overall Study|Lack of Efficacy|1
3001057|NCT00939770|10326724|P7|Overall Study|Lack of Efficacy|11
3001058|NCT00939770|10326725|P6|Overall Study|Lack of Efficacy|8
3001059|NCT00939770|10326726|P5|Overall Study|Lack of Efficacy|16
3001060|NCT00939770|10326727|P4|Overall Study|Lack of Efficacy|9
3001061|NCT00939770|10326728|P3|Overall Study|Lack of Efficacy|13
3001062|NCT00939770|10326729|P2|Overall Study|Lack of Efficacy|6
3001063|NCT00939770|10326730|P1|Overall Study|Lack of Efficacy|4
3001064|NCT00939770|10326723|P8|Overall Study|Adverse Event|1
3001065|NCT00939770|10326724|P7|Overall Study|Adverse Event|1
3001066|NCT00939770|10326725|P6|Overall Study|Adverse Event|2
3001067|NCT00939770|10326726|P5|Overall Study|Adverse Event|6
3001068|NCT00939770|10326727|P4|Overall Study|Adverse Event|0
3001069|NCT00939770|10326728|P3|Overall Study|Adverse Event|0
3001070|NCT00939770|10326729|P2|Overall Study|Adverse Event|1
3001071|NCT00939770|10326730|P1|Overall Study|Adverse Event|1
3001072|NCT00939692|10326815|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
3001073|NCT00939692|10326816|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
3001074|NCT00939692|10326815|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
3001075|NCT00939692|10326816|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
3001076|NCT00939640|10326831|P1|Overall Study|Physician Decision|1
3001077|NCT00939627|10326852|P3|Overall Study|No off-tx reason given|0
3001078|NCT00939627|10326853|P2|Overall Study|No off-tx reason given|2
3001079|NCT00939627|10326854|P1|Overall Study|No off-tx reason given|0
3001080|NCT00939627|10326852|P3|Overall Study|Not compliant|0
3001081|NCT00939627|10326853|P2|Overall Study|Not compliant|0
3001082|NCT00939627|10326854|P1|Overall Study|Not compliant|2
3001083|NCT00939627|10326852|P3|Overall Study|Other complicating disease|0
3001084|NCT00939627|10326853|P2|Overall Study|Other complicating disease|1
3001085|NCT00939627|10326854|P1|Overall Study|Other complicating disease|1
3001086|NCT00939627|10326852|P3|Overall Study|Withdrawal by Subject|0
3001087|NCT00939627|10326853|P2|Overall Study|Withdrawal by Subject|4
3001088|NCT00939627|10326854|P1|Overall Study|Withdrawal by Subject|2
3001089|NCT00939627|10326852|P3|Overall Study|Death|0
3001090|NCT00939627|10326853|P2|Overall Study|Death|2
3001091|NCT00939627|10326854|P1|Overall Study|Death|0
3001092|NCT00939627|10326852|P3|Overall Study|Adverse Event|0
3001093|NCT00939627|10326853|P2|Overall Study|Adverse Event|7
3001094|NCT00939627|10326854|P1|Overall Study|Adverse Event|6
3001095|NCT00939627|10326852|P3|Overall Study|Disease Progression|0
3001096|NCT00939627|10326853|P2|Overall Study|Disease Progression|12
3001097|NCT00939627|10326854|P1|Overall Study|Disease Progression|16
3001098|NCT00939523|10326894|P1|Overall Study|Physician Decision|2
3001099|NCT00939523|10326894|P1|Overall Study|Lack of Efficacy|1
3001100|NCT00939510|10326901|P1|Overall Study|Withdrawal by Subject|1
3001101|NCT00939484|10326910|P3|Overall Study|Progression/Relapse|3
3001102|NCT00939484|10326911|P2|Overall Study|Progression/Relapse|20
3001103|NCT00939484|10326912|P1|Overall Study|Progression/Relapse|8
3001104|NCT00939393|10326938|P2|Overall Study|Lost to Follow-up|0
3001105|NCT00939393|10326939|P1|Overall Study|Lost to Follow-up|3
3001106|NCT00939393|10326938|P2|Overall Study|Withdrawal by Subject|0
3001107|NCT00939393|10326939|P1|Overall Study|Withdrawal by Subject|1
3001108|NCT00939341|10326970|P1|Overall Study|Incorrect enrolment|8
3001109|NCT00939341|10326970|P1|Overall Study|Protocol Violation|6
3001110|NCT00939341|10326970|P1|Overall Study|Withdrawal by Subject|13
3001111|NCT00939341|10326970|P1|Overall Study|Lost to Follow-up|23
3001112|NCT00939341|10326970|P1|Overall Study|Pregnancy|1
3001113|NCT00939341|10326970|P1|Overall Study|Adverse Event|15
3001114|NCT00939185|10327057|P1|Overall Study|Randomized But Did Not Receive Treatment|10
3001115|NCT00939185|10327057|P1|Overall Study|Withdrawal by Subject|2
3001116|NCT00939185|10327057|P1|Overall Study|Other|3
3001117|NCT00939185|10327057|P1|Overall Study|Lost to Follow-up|6
3001118|NCT00939185|10327057|P1|Overall Study|Lack of Efficacy|1
3001119|NCT00939185|10327057|P1|Overall Study|Adverse Event|3
3001120|NCT00939107|10327095|P2|Overall Study|Lost to Follow-up|12
3001121|NCT00939107|10327096|P1|Overall Study|Lost to Follow-up|14
3001122|NCT00939094|10327110|P2|Overall Study|Abnormal ECG findings|0
3001123|NCT00939094|10327111|P1|Overall Study|Abnormal ECG findings|1
3001124|NCT00939094|10327110|P2|Overall Study|Study stopped by sponsor|2
3001125|NCT00939094|10327111|P1|Overall Study|Study stopped by sponsor|0
3001126|NCT00939094|10327110|P2|Overall Study|Severe non-compliance to protocol|1
3001127|NCT00939094|10327111|P1|Overall Study|Severe non-compliance to protocol|0
3001128|NCT00939094|10327110|P2|Overall Study|Eligibility criteria not fulfilled|0
3001129|NCT00939094|10327111|P1|Overall Study|Eligibility criteria not fulfilled|2
3001130|NCT00939094|10327110|P2|Overall Study|Lost to Follow-up|1
3001131|NCT00939094|10327111|P1|Overall Study|Lost to Follow-up|1
3001132|NCT00939094|10327110|P2|Overall Study|Withdrawal by Subject|6
3001133|NCT00939094|10327111|P1|Overall Study|Withdrawal by Subject|1
3001134|NCT00939094|10327110|P2|Overall Study|Adverse Event|0
3001135|NCT00939094|10327111|P1|Overall Study|Adverse Event|9
3001136|NCT00939055|10327133|P2|Overall Study|Discontinuation prior to procedure|0
3001137|NCT00939055|10327134|P1|Overall Study|Discontinuation prior to procedure|4
3001138|NCT00939029|10327144|P2|Overall Study|Adverse Event|1
3001139|NCT00939029|10327145|P1|Overall Study|Adverse Event|0
3001140|NCT00939029|10327144|P2|Overall Study|Lost to Follow-up|4
3001141|NCT00939029|10327145|P1|Overall Study|Lost to Follow-up|3
3001142|NCT00939029|10327144|P2|Overall Study|Withdrawal by Subject|7
3001143|NCT00939029|10327145|P1|Overall Study|Withdrawal by Subject|3
3001144|NCT00939003|10327157|P2|Open-label Treatment Period|Site Closure|4
3001145|NCT00939003|10327158|P1|Open-label Treatment Period|Site Closure|3
3001146|NCT00939003|10327157|P2|Open-label Treatment Period|Exclusion Criteria|0
3001147|NCT00939003|10327158|P1|Open-label Treatment Period|Exclusion Criteria|1
3001148|NCT00939003|10327157|P2|Open-label Treatment Period|Pregnancy|1
3001149|NCT00939003|10327158|P1|Open-label Treatment Period|Pregnancy|1
3001150|NCT00939003|10327157|P2|Open-label Treatment Period|Lack of Efficacy|9
3001151|NCT00939003|10327158|P1|Open-label Treatment Period|Lack of Efficacy|6
3001152|NCT00939003|10327157|P2|Open-label Treatment Period|Withdrawal by Subject|7
3001153|NCT00939003|10327158|P1|Open-label Treatment Period|Withdrawal by Subject|14
3001154|NCT00939003|10327157|P2|Open-label Treatment Period|Adverse Event|8
3001155|NCT00939003|10327158|P1|Open-label Treatment Period|Adverse Event|4
3001156|NCT00939003|10327157|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
3001157|NCT00939003|10327158|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
3001158|NCT00939003|10327157|P2|Double-blind Treatment Period|Pregnancy|1
3001159|NCT00939003|10327158|P1|Double-blind Treatment Period|Pregnancy|0
3001160|NCT00939003|10327157|P2|Double-blind Treatment Period|Lack of Efficacy|1
3001161|NCT00939003|10327158|P1|Double-blind Treatment Period|Lack of Efficacy|0
3001162|NCT00939003|10327157|P2|Double-blind Treatment Period|Adverse Event|1
3001163|NCT00939003|10327158|P1|Double-blind Treatment Period|Adverse Event|1
3001164|NCT00938964|10327195|P2|Overall Study|Found to Meet Exclusion Criteria|4
3001165|NCT00938964|10327196|P1|Overall Study|Found to Meet Exclusion Criteria|3
3001166|NCT00938964|10327195|P2|Overall Study|Withdrawal by Subject|18
3001167|NCT00938964|10327196|P1|Overall Study|Withdrawal by Subject|22
3001168|NCT00938964|10327195|P2|Overall Study|Lost to Follow-up|3
3001169|NCT00938964|10327196|P1|Overall Study|Lost to Follow-up|2
3001170|NCT00938964|10327195|P2|Overall Study|Death|3
3001171|NCT00938964|10327196|P1|Overall Study|Death|3
3001172|NCT00938886|10327260|P2|Overall Study|Lost to Follow-up|2
3001173|NCT00938886|10327261|P1|Overall Study|Lost to Follow-up|3
3001174|NCT00938886|10327260|P2|Overall Study|Withdrawal by Subject|7
3001175|NCT00938886|10327261|P1|Overall Study|Withdrawal by Subject|4
3001176|NCT00938886|10327260|P2|Overall Study|Death|1
3001177|NCT00938886|10327261|P1|Overall Study|Death|0
3001178|NCT00938860|10327271|P2|Overall Study|Protocol Violation|1
3001179|NCT00938860|10327272|P1|Overall Study|Protocol Violation|3
3001180|NCT00938860|10327271|P2|Overall Study|Death|1
3001181|NCT00938860|10327272|P1|Overall Study|Death|1
3001182|NCT00938860|10327271|P2|Overall Study|Administration problems|0
3001183|NCT00938860|10327272|P1|Overall Study|Administration problems|2
3001184|NCT00938860|10327271|P2|Overall Study|Lost to Follow-up|4
3001185|NCT00938860|10327272|P1|Overall Study|Lost to Follow-up|4
3001186|NCT00938860|10327271|P2|Overall Study|Withdrawal by Subject|8
3001187|NCT00938860|10327272|P1|Overall Study|Withdrawal by Subject|11
3001188|NCT00938860|10327271|P2|Overall Study|Abnormal laboratory values|2
3001189|NCT00938860|10327272|P1|Overall Study|Abnormal laboratory values|2
3001190|NCT00938860|10327271|P2|Overall Study|Adverse Event|1
3001191|NCT00938860|10327272|P1|Overall Study|Adverse Event|2
3001192|NCT00938717|10327305|P2|Overall Study|Other reason|2
3001193|NCT00938717|10327306|P1|Overall Study|Other reason|5
3001194|NCT00938717|10327305|P2|Overall Study|Lack of Efficacy|15
3001195|NCT00938717|10327306|P1|Overall Study|Lack of Efficacy|33
3001196|NCT00938717|10327305|P2|Overall Study|Lost to Follow-up|18
3001197|NCT00938717|10327306|P1|Overall Study|Lost to Follow-up|13
3001198|NCT00938717|10327305|P2|Overall Study|Withdrawal by Subject|24
3001199|NCT00938717|10327306|P1|Overall Study|Withdrawal by Subject|26
3001200|NCT00938717|10327305|P2|Overall Study|Protocol Violation|8
3001201|NCT00938717|10327306|P1|Overall Study|Protocol Violation|11
3001202|NCT00938717|10327305|P2|Overall Study|Adverse Event|41
3001203|NCT00938717|10327306|P1|Overall Study|Adverse Event|10
3001204|NCT00938639|10327357|P2|Overall Study|Participant noncompliance|0
3001205|NCT00938639|10327358|P1|Overall Study|Participant noncompliance|1
3001206|NCT00938639|10327357|P2|Overall Study|Family issues|1
3001207|NCT00938639|10327358|P1|Overall Study|Family issues|1
3001208|NCT00938639|10327357|P2|Overall Study|Lost to Follow-up|2
3001209|NCT00938639|10327358|P1|Overall Study|Lost to Follow-up|1
3001210|NCT00938639|10327357|P2|Overall Study|Moved away from study area|1
3001211|NCT00938639|10327358|P1|Overall Study|Moved away from study area|0
3001212|NCT00938470|10327441|P2|Overall Study|Other Reason|1
3001213|NCT00938470|10327442|P1|Overall Study|Other Reason|0
3001214|NCT00938470|10327441|P2|Overall Study|Death|2
3001215|NCT00938470|10327442|P1|Overall Study|Death|3
3001216|NCT00938470|10327441|P2|Overall Study|Alternate Treatment|0
3001217|NCT00938470|10327442|P1|Overall Study|Alternate Treatment|1
3001218|NCT00938470|10327441|P2|Overall Study|Disease Progression|0
3001219|NCT00938470|10327442|P1|Overall Study|Disease Progression|3
3001220|NCT00938431|10327472|P3|Overall Study|Reached maximum dose early|1
3001221|NCT00938431|10327473|P2|Overall Study|Reached maximum dose early|0
3001222|NCT00938431|10327474|P1|Overall Study|Reached maximum dose early|0
3001223|NCT00938431|10327472|P3|Overall Study|Dosing compliance issue|1
3001224|NCT00938431|10327473|P2|Overall Study|Dosing compliance issue|0
3001225|NCT00938431|10327474|P1|Overall Study|Dosing compliance issue|0
3001226|NCT00938431|10327472|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
3001227|NCT00938431|10327473|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
3001228|NCT00938431|10327474|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
3001229|NCT00938431|10327472|P3|Overall Study|Lack of Efficacy|0
3001230|NCT00938431|10327473|P2|Overall Study|Lack of Efficacy|1
3001231|NCT00938431|10327474|P1|Overall Study|Lack of Efficacy|0
3001232|NCT00938431|10327472|P3|Overall Study|Adverse Event|6
3001233|NCT00938431|10327473|P2|Overall Study|Adverse Event|8
3001234|NCT00938431|10327474|P1|Overall Study|Adverse Event|5
3001235|NCT00938392|10327501|P2|Overall Study|Lost to Follow-up|2
3001236|NCT00938392|10327502|P1|Overall Study|Lost to Follow-up|2
3001237|NCT00938392|10327501|P2|Overall Study|Withdrawal by Subject|1
3001238|NCT00938392|10327502|P1|Overall Study|Withdrawal by Subject|0
3001239|NCT00938392|10327501|P2|Overall Study|Adverse Event|1
3001240|NCT00938392|10327502|P1|Overall Study|Adverse Event|0
3001241|NCT00938366|10327528|P2|Overall Study|Withdrawal by Subject|0
3001242|NCT00938366|10327529|P1|Overall Study|Withdrawal by Subject|1
3001243|NCT00938340|10327549|P1|Overall Study|Adverse Event|1
3001244|NCT00938340|10327549|P1|Overall Study|Protocol Violation|1
3001245|NCT00938340|10327549|P1|Overall Study|Withdrawal by Subject|3
3001246|NCT00938327|10327679|P1|Overall Study|Vaccine not received as out of stock|9
3001247|NCT00938327|10327679|P1|Overall Study|2nd dose received outside of the study|7
3001248|NCT00938327|10327679|P1|Overall Study|Lost to Follow-up|37
3001249|NCT00938327|10327679|P1|Overall Study|Withdrawal by Subject|4
3001250|NCT00938327|10327679|P1|Overall Study|Protocol Violation|1
3001251|NCT00938327|10327679|P1|Overall Study|Adverse Event|2
3001252|NCT00938041|10327747|P1|Overall Study|Adrenal Insufficiency|3
3001253|NCT00938041|10327747|P1|Overall Study|Death|12
3001254|NCT00938041|10327747|P1|Overall Study|Progressive Disease|5
3001255|NCT00938041|10327747|P1|Overall Study|Received Alternative Therapy|1
3001256|NCT00938041|10327747|P1|Overall Study|Lost to Follow-up|6
3001257|NCT00938015|10327756|P1|Overall Study|Reason not related to Etanercept|29
3001258|NCT00938015|10327756|P1|Overall Study|Non-responder|52
3001259|NCT00938015|10327756|P1|Overall Study|Adverse Event|32
3001260|NCT00938015|10327756|P1|Overall Study|Lost to Follow-up|32
3001261|NCT00938015|10327756|P1|Overall Study|Death|2
3001262|NCT00937950|10327772|P1|Overall Study|Other|18
3001263|NCT00937950|10327772|P1|Overall Study|Missing confirmed|4
3001264|NCT00937950|10327772|P1|Overall Study|Lost to Follow-up|144
3001265|NCT00937950|10327772|P1|Overall Study|Migrated/moved from study area|27
3001266|NCT00937950|10327772|P1|Overall Study|Withdrawal by Subject|23
3001267|NCT00937937|10327788|P1|Overall Study|Other|2
3001268|NCT00937937|10327788|P1|Overall Study|Death|1
3001269|NCT00937937|10327788|P1|Overall Study|Progression/relapse|61
3001270|NCT00937937|10327788|P1|Overall Study|Withdrawal by Subject|2
3001271|NCT00937937|10327788|P1|Overall Study|Adverse Event|6
3001272|NCT00937833|10327797|P2|Overall Study|Withdrawal by Subject|6
3001273|NCT00937833|10327798|P1|Overall Study|Withdrawal by Subject|4
3001274|NCT00937833|10327797|P2|Overall Study|Lost to Follow-up|8
3001275|NCT00937833|10327798|P1|Overall Study|Lost to Follow-up|10
3001276|NCT00937833|10327797|P2|Overall Study|Procedure delayed; enrollment closed|1
3001277|NCT00937833|10327798|P1|Overall Study|Procedure delayed; enrollment closed|0
3001278|NCT00937833|10327797|P2|Overall Study|Protocol Violation|2
3001279|NCT00937833|10327798|P1|Overall Study|Protocol Violation|1
3001280|NCT00937768|10327811|P2|Overall Study|No Further Funding|4
3001281|NCT00937768|10327812|P1|Overall Study|No Further Funding|4
3001282|NCT00937768|10327811|P2|Overall Study|Alternate Treatment|1
3001283|NCT00937768|10327812|P1|Overall Study|Alternate Treatment|0
3001284|NCT00937768|10327811|P2|Overall Study|Disease Progression|1
3001285|NCT00937768|10327812|P1|Overall Study|Disease Progression|1
3001286|NCT00937768|10327811|P2|Overall Study|Refused Further Treatment|2
3001287|NCT00937768|10327812|P1|Overall Study|Refused Further Treatment|3
3001288|NCT00937560|10327832|P1|Maintenance Treatment|According to protocol|1
3001289|NCT00937560|10327832|P1|Maintenance Treatment|Withdraw consent|5
3001290|NCT00937560|10327832|P1|Maintenance Treatment|Death|12
3001291|NCT00937560|10327832|P1|Initial Treatment|No end of study page|10
3001292|NCT00937560|10327832|P1|Initial Treatment|Lost to Follow-up|1
3001293|NCT00937560|10327832|P1|Initial Treatment|Adverse Event|1
3001294|NCT00937560|10327832|P1|Initial Treatment|Withdraw consent|3
3001295|NCT00937560|10327832|P1|Initial Treatment|Death|6
3001296|NCT00937547|10327843|P3|Overall Study|misdiagnosis|7
3001297|NCT00937547|10327844|P2|Overall Study|misdiagnosis|6
3001298|NCT00937547|10327845|P1|Overall Study|misdiagnosis|1
3001299|NCT00937521|10327882|P8|Booster Phase|Protocol Deviation|0
3001300|NCT00937521|10327883|P7|Booster Phase|Protocol Deviation|1
3001301|NCT00937521|10327884|P6|Booster Phase|Protocol Deviation|0
3001302|NCT00937521|10327885|P5|Booster Phase|Protocol Deviation|0
3001303|NCT00937521|10327886|P4|Booster Phase|Protocol Deviation|0
3001304|NCT00937521|10327887|P3|Booster Phase|Protocol Deviation|0
3001305|NCT00937521|10327888|P2|Booster Phase|Protocol Deviation|0
3001306|NCT00937521|10327889|P1|Booster Phase|Protocol Deviation|0
3001307|NCT00937521|10327882|P8|Booster Phase|Administrative Reason|0
3001308|NCT00937521|10327883|P7|Booster Phase|Administrative Reason|0
3001309|NCT00937521|10327884|P6|Booster Phase|Administrative Reason|1
3001310|NCT00937521|10327885|P5|Booster Phase|Administrative Reason|1
3001311|NCT00937521|10327886|P4|Booster Phase|Administrative Reason|0
3001312|NCT00937521|10327887|P3|Booster Phase|Administrative Reason|1
3001313|NCT00937521|10327888|P2|Booster Phase|Administrative Reason|0
3001314|NCT00937521|10327889|P1|Booster Phase|Administrative Reason|0
3001315|NCT00937521|10327882|P8|Booster Phase|Lost to Follow-up|0
3001316|NCT00937521|10327883|P7|Booster Phase|Lost to Follow-up|3
3001317|NCT00937521|10327884|P6|Booster Phase|Lost to Follow-up|4
3001318|NCT00937521|10327885|P5|Booster Phase|Lost to Follow-up|4
3001319|NCT00937521|10327886|P4|Booster Phase|Lost to Follow-up|2
3001320|NCT00937521|10327887|P3|Booster Phase|Lost to Follow-up|4
3001321|NCT00937521|10327888|P2|Booster Phase|Lost to Follow-up|2
3001322|NCT00937521|10327889|P1|Booster Phase|Lost to Follow-up|2
3001323|NCT00937521|10327882|P8|Booster Phase|Withdrawal by Subject|2
3001324|NCT00937521|10327883|P7|Booster Phase|Withdrawal by Subject|0
3001325|NCT00937521|10327884|P6|Booster Phase|Withdrawal by Subject|0
3001326|NCT00937521|10327885|P5|Booster Phase|Withdrawal by Subject|0
3001327|NCT00937521|10327886|P4|Booster Phase|Withdrawal by Subject|1
3001328|NCT00937521|10327887|P3|Booster Phase|Withdrawal by Subject|0
3001329|NCT00937521|10327888|P2|Booster Phase|Withdrawal by Subject|0
3001330|NCT00937521|10327889|P1|Booster Phase|Withdrawal by Subject|1
3001331|NCT00937521|10327882|P8|Booster Phase|Adverse Event|0
3001332|NCT00937521|10327883|P7|Booster Phase|Adverse Event|1
3001333|NCT00937521|10327884|P6|Booster Phase|Adverse Event|0
3001334|NCT00937521|10327885|P5|Booster Phase|Adverse Event|0
3001335|NCT00937521|10327886|P4|Booster Phase|Adverse Event|0
3001336|NCT00937521|10327887|P3|Booster Phase|Adverse Event|0
3001337|NCT00937521|10327888|P2|Booster Phase|Adverse Event|0
3001338|NCT00937521|10327889|P1|Booster Phase|Adverse Event|0
3001339|NCT00937521|10327882|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001340|NCT00937521|10327883|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
3001341|NCT00937521|10327884|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001342|NCT00937521|10327885|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001343|NCT00937521|10327886|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001344|NCT00937521|10327887|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001345|NCT00937521|10327888|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
3001346|NCT00937521|10327889|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
3001347|NCT00937521|10327882|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
3001348|NCT00937521|10327883|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
3001349|NCT00937521|10327884|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
3001350|NCT00937521|10327885|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
3001351|NCT00937521|10327886|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
3001352|NCT00937521|10327887|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
3001353|NCT00937521|10327888|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
3001354|NCT00937521|10327889|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
3001355|NCT00937521|10327882|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001356|NCT00937521|10327883|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001357|NCT00937521|10327884|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001358|NCT00937521|10327885|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001359|NCT00937521|10327886|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
3001360|NCT00937521|10327887|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
3001361|NCT00937521|10327888|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001362|NCT00937521|10327889|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
3001363|NCT00937521|10327882|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
3001364|NCT00937521|10327883|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
3001365|NCT00937521|10327884|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
3001366|NCT00937521|10327885|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
3001367|NCT00937521|10327886|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
3001368|NCT00937521|10327887|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
3001369|NCT00937521|10327888|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
3001370|NCT00937521|10327889|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
3001371|NCT00937521|10327882|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
3001372|NCT00937521|10327883|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
3001373|NCT00937521|10327884|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
3001374|NCT00937521|10327885|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
3001375|NCT00937521|10327886|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
3001376|NCT00937521|10327887|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
3001377|NCT00937521|10327888|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
3001378|NCT00937521|10327889|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
3001379|NCT00937495|10327995|P1|Overall Study|Protocol Violation|2
3001380|NCT00937404|10328001|P1|Overall Study|Withdrawal by Subject|1
3001381|NCT00937404|10328001|P1|Overall Study|Protocol Violation|1
3001382|NCT00937391|10328010|P1|Stage 2|Withdrawal by Subject|1
3001383|NCT00937326|10328066|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
3001384|NCT00937326|10328067|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
3001385|NCT00937326|10328068|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
3001386|NCT00937326|10328069|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
3001387|NCT00937326|10328070|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
3001388|NCT00937326|10328066|P5|Overall Study|Withdrawal by Subject|3
3001389|NCT00937326|10328067|P4|Overall Study|Withdrawal by Subject|4
3001390|NCT00937326|10328068|P3|Overall Study|Withdrawal by Subject|1
3001391|NCT00937326|10328069|P2|Overall Study|Withdrawal by Subject|4
3001392|NCT00937326|10328070|P1|Overall Study|Withdrawal by Subject|3
3001393|NCT00937326|10328066|P5|Overall Study|Death|0
3001394|NCT00937326|10328067|P4|Overall Study|Death|0
3001395|NCT00937326|10328068|P3|Overall Study|Death|1
3001396|NCT00937326|10328069|P2|Overall Study|Death|0
3001397|NCT00937326|10328070|P1|Overall Study|Death|0
3001398|NCT00937326|10328066|P5|Overall Study|Adverse Event|2
3001399|NCT00937326|10328067|P4|Overall Study|Adverse Event|1
3001400|NCT00937326|10328068|P3|Overall Study|Adverse Event|1
3001401|NCT00937326|10328069|P2|Overall Study|Adverse Event|3
3001402|NCT00937326|10328070|P1|Overall Study|Adverse Event|0
3001403|NCT00937157|10328319|P1|Overall Study|Lost to Follow-up|3
3001404|NCT00937157|10328319|P1|Overall Study|Pregnancy|1
3001405|NCT00937040|10328350|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
3001406|NCT00937040|10328351|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
3001407|NCT00937040|10328350|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
3001408|NCT00937040|10328351|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
3001409|NCT00937040|10328350|P2|Overall Study|Withdrawal by Subject|7
3001410|NCT00937040|10328351|P1|Overall Study|Withdrawal by Subject|13
3001411|NCT00937040|10328350|P2|Overall Study|Protocol Violation|0
3001412|NCT00937040|10328351|P1|Overall Study|Protocol Violation|3
3001413|NCT00937040|10328350|P2|Overall Study|Lost to Follow-up|12
3001414|NCT00937040|10328351|P1|Overall Study|Lost to Follow-up|12
3001415|NCT00937040|10328350|P2|Overall Study|Adverse Event|8
3001416|NCT00937040|10328351|P1|Overall Study|Adverse Event|5
3001417|NCT00936975|10328393|P1|Overall Study|Post-Tx scan uninterpretable|2
3001418|NCT00936975|10328393|P1|Overall Study|Disease progression|3
3001419|NCT00936975|10328393|P1|Overall Study|Withdrawal by Subject|1
3001420|NCT00936910|10328402|P1|Overall Study|Lack of Efficacy|3
3001421|NCT00936897|10328411|P2|Overall Study|Death|1
3001422|NCT00936897|10328412|P1|Overall Study|Death|0
3001423|NCT00936897|10328411|P2|Overall Study|Noncompliance|2
3001424|NCT00936897|10328412|P1|Overall Study|Noncompliance|0
3001425|NCT00936897|10328411|P2|Overall Study|Ineligibility Determined|3
3001426|NCT00936897|10328412|P1|Overall Study|Ineligibility Determined|0
3001427|NCT00936897|10328411|P2|Overall Study|Protocol Violation|1
3001428|NCT00936897|10328412|P1|Overall Study|Protocol Violation|1
3001429|NCT00936897|10328411|P2|Overall Study|Administrative Decision|2
3001430|NCT00936897|10328412|P1|Overall Study|Administrative Decision|1
3001431|NCT00936897|10328411|P2|Overall Study|Lost to Follow-up|10
3001432|NCT00936897|10328412|P1|Overall Study|Lost to Follow-up|1
3001433|NCT00936897|10328411|P2|Overall Study|Other|9
3001434|NCT00936897|10328412|P1|Overall Study|Other|3
3001435|NCT00936897|10328411|P2|Overall Study|Adverse Event|13
3001436|NCT00936897|10328412|P1|Overall Study|Adverse Event|4
3001437|NCT00936897|10328411|P2|Overall Study|Withdrawal by Subject|19
3001438|NCT00936897|10328412|P1|Overall Study|Withdrawal by Subject|9
3001439|NCT00936884|10328426|P3|Double-blind|Did not receive study drug|0
3001440|NCT00936884|10328427|P2|Double-blind|Did not receive study drug|1
3001441|NCT00936884|10328428|P1|Double-blind|Did not receive study drug|0
3001442|NCT00936884|10328426|P3|Double-blind|No post baseline diary entry|0
3001443|NCT00936884|10328427|P2|Double-blind|No post baseline diary entry|0
3001444|NCT00936884|10328428|P1|Double-blind|No post baseline diary entry|1
3001445|NCT00936884|10328426|P3|Double-blind|Physician Decision|0
3001446|NCT00936884|10328427|P2|Double-blind|Physician Decision|0
3001447|NCT00936884|10328428|P1|Double-blind|Physician Decision|1
3001448|NCT00936884|10328426|P3|Double-blind|Adverse Event|0
3001449|NCT00936884|10328427|P2|Double-blind|Adverse Event|0
3001450|NCT00936884|10328428|P1|Double-blind|Adverse Event|1
3001451|NCT00936884|10328426|P3|Double-blind|Lack of Efficacy|0
3001452|NCT00936884|10328427|P2|Double-blind|Lack of Efficacy|1
3001453|NCT00936884|10328428|P1|Double-blind|Lack of Efficacy|1
3001454|NCT00936884|10328426|P3|Double-blind|Death|0
3001455|NCT00936884|10328427|P2|Double-blind|Death|1
3001456|NCT00936884|10328428|P1|Double-blind|Death|2
3001457|NCT00936884|10328426|P3|Double-blind|Withdrawal by Subject|0
3001458|NCT00936884|10328427|P2|Double-blind|Withdrawal by Subject|4
3001459|NCT00936884|10328428|P1|Double-blind|Withdrawal by Subject|6
3001460|NCT00936715|10328444|P1|Overall Study|Safety or Tolerability Reasons|4
3001461|NCT00936715|10328444|P1|Overall Study|Protocol Violation|1
3001462|NCT00936715|10328444|P1|Overall Study|Investigators Discretion|1
3001463|NCT00936702|10328448|P1|Overall Study|Other|1
3001464|NCT00936702|10328448|P1|Overall Study|Alternative Treatment|1
3001465|NCT00936702|10328448|P1|Overall Study|Withdrawal by Subject|2
3001466|NCT00936702|10328448|P1|Overall Study|Adverse Event|8
3001467|NCT00936702|10328448|P1|Overall Study|Disease progression|34
3001468|NCT00936598|10328481|P2|Overall Study|Ineligible after consent|0
3001469|NCT00936598|10328482|P1|Overall Study|Ineligible after consent|1
3001470|NCT00936598|10328481|P2|Overall Study|Withdrawal by Subject|0
3001471|NCT00936598|10328482|P1|Overall Study|Withdrawal by Subject|1
3001472|NCT00936221|10328584|P2|Overall Study|Withdrawal by Subject|1
3001473|NCT00936221|10328585|P1|Overall Study|Withdrawal by Subject|1
3001474|NCT00936208|10328599|P2|Overall Study|Protocol Violation|22
3001475|NCT00936208|10328600|P1|Overall Study|Protocol Violation|37
3001476|NCT00936117|10328618|P1|Overall Study|Unable to continue oral medication|3
3001477|NCT00936117|10328618|P1|Overall Study|Adverse Event|7
3001478|NCT00936065|10328626|P3|Overall Study|Withdrawal by Subject|4
3001479|NCT00936065|10328627|P2|Overall Study|Withdrawal by Subject|2
3001480|NCT00936065|10328628|P1|Overall Study|Withdrawal by Subject|0
3001481|NCT00936065|10328626|P3|Overall Study|Protocol Violation|1
3001482|NCT00936065|10328627|P2|Overall Study|Protocol Violation|2
3001483|NCT00936065|10328628|P1|Overall Study|Protocol Violation|1
3001484|NCT00936065|10328626|P3|Overall Study|Lost to Follow-up|0
3001485|NCT00936065|10328627|P2|Overall Study|Lost to Follow-up|0
3001486|NCT00936065|10328628|P1|Overall Study|Lost to Follow-up|1
3001487|NCT00936065|10328626|P3|Overall Study|Lack of Efficacy|1
3001488|NCT00936065|10328627|P2|Overall Study|Lack of Efficacy|0
3001489|NCT00936065|10328628|P1|Overall Study|Lack of Efficacy|1
3001490|NCT00936065|10328626|P3|Overall Study|Adverse Event|1
3001491|NCT00936065|10328627|P2|Overall Study|Adverse Event|0
3001492|NCT00936065|10328628|P1|Overall Study|Adverse Event|1
3001493|NCT00935883|10328734|P2|Treatment Period|Withdrawal by Subject|2
3001494|NCT00935883|10328735|P1|Treatment Period|Withdrawal by Subject|0
3001495|NCT00935883|10328734|P2|Treatment Period|Physician Decision|0
3001496|NCT00935883|10328735|P1|Treatment Period|Physician Decision|1
3001497|NCT00935818|10328762|P2|Overall Study|Physician Decision|1
3001498|NCT00935818|10328763|P1|Overall Study|Physician Decision|0
3001499|NCT00935818|10328762|P2|Overall Study|Adverse Event|7
3001500|NCT00935818|10328763|P1|Overall Study|Adverse Event|6
3001501|NCT00935818|10328762|P2|Overall Study|Lost to Follow-up|42
3001502|NCT00935818|10328763|P1|Overall Study|Lost to Follow-up|40
3001503|NCT00935818|10328762|P2|Overall Study|Withdrawal by Subject|50
3001504|NCT00935818|10328763|P1|Overall Study|Withdrawal by Subject|45
3001505|NCT00935701|10328814|P1|Overall Study|Failure to Transition to Acupuncture|1
3001506|NCT00935584|10328831|P2|Overall Study|Provider dropped out of study|4
3001507|NCT00935584|10328832|P1|Overall Study|Provider dropped out of study|14
3001508|NCT00935584|10328831|P2|Overall Study|Patient changed provider|0
3001509|NCT00935584|10328832|P1|Overall Study|Patient changed provider|3
3001510|NCT00935584|10328831|P2|Overall Study|Relocated|0
3001511|NCT00935584|10328832|P1|Overall Study|Relocated|3
3001512|NCT00935584|10328831|P2|Overall Study|No show|0
3001513|NCT00935584|10328832|P1|Overall Study|No show|9
3001514|NCT00935584|10328831|P2|Overall Study|Lost to Follow-up|0
3001515|NCT00935584|10328832|P1|Overall Study|Lost to Follow-up|8
3001516|NCT00935584|10328831|P2|Overall Study|Death|0
3001517|NCT00935584|10328832|P1|Overall Study|Death|3
3001518|NCT00935584|10328831|P2|Overall Study|Withdrawal by Subject|0
3001519|NCT00935584|10328832|P1|Overall Study|Withdrawal by Subject|9
3001520|NCT00935532|10328844|P2|Overall Study|Loss Glucose Control|0
3001521|NCT00935532|10328845|P1|Overall Study|Loss Glucose Control|4
3001522|NCT00935532|10328844|P2|Overall Study|Sponsor Decision|1
3001523|NCT00935532|10328845|P1|Overall Study|Sponsor Decision|0
3001524|NCT00935532|10328844|P2|Overall Study|Subject Decision|1
3001525|NCT00935532|10328845|P1|Overall Study|Subject Decision|2
3001526|NCT00935532|10328844|P2|Overall Study|Protocol Violation|1
3001527|NCT00935532|10328845|P1|Overall Study|Protocol Violation|2
3001528|NCT00935532|10328844|P2|Overall Study|Physician Decision|2
3001529|NCT00935532|10328845|P1|Overall Study|Physician Decision|1
3001530|NCT00935532|10328844|P2|Overall Study|Lost to Follow-up|0
3001531|NCT00935532|10328845|P1|Overall Study|Lost to Follow-up|1
3001532|NCT00935532|10328844|P2|Overall Study|Death|0
3001533|NCT00935532|10328845|P1|Overall Study|Death|1
3001534|NCT00935532|10328844|P2|Overall Study|Adverse Event|6
3001535|NCT00935532|10328845|P1|Overall Study|Adverse Event|11
3001536|NCT00935493|10328874|P3|Overall Study|Treatment Discontinued|0
3001537|NCT00935493|10328875|P2|Overall Study|Treatment Discontinued|1
3001538|NCT00935493|10328876|P1|Overall Study|Treatment Discontinued|0
3001539|NCT00935493|10328874|P3|Overall Study|Lost to Follow-up|1
3001540|NCT00935493|10328875|P2|Overall Study|Lost to Follow-up|1
3001541|NCT00935493|10328876|P1|Overall Study|Lost to Follow-up|1
3001542|NCT00935272|10328925|P2|Overall Study|Protocol Violation|1
3001543|NCT00935272|10328926|P1|Overall Study|Protocol Violation|0
3001544|NCT00935272|10328925|P2|Overall Study|Physician Decision|0
3001545|NCT00935272|10328926|P1|Overall Study|Physician Decision|1
3001546|NCT00935272|10328925|P2|Overall Study|Withdrawal by Subject|2
3001547|NCT00935272|10328926|P1|Overall Study|Withdrawal by Subject|8
3001548|NCT00935272|10328925|P2|Overall Study|Lost to Follow-up|3
3001549|NCT00935272|10328926|P1|Overall Study|Lost to Follow-up|10
3001550|NCT00935259|10328935|P2|Period 1|Administrative (scheduling conflict)|1
3001551|NCT00935259|10328936|P1|Period 1|Administrative (scheduling conflict)|1
3001552|NCT00935220|10328950|P1|Overall Study|Other reason (not specified)|1
3001553|NCT00935220|10328950|P1|Overall Study|Adverse Event|1
3001554|NCT00934947|10328981|P2|Overall Study|Adverse Event|2
3001555|NCT00934947|10328982|P1|Overall Study|Adverse Event|0
3001556|NCT00934856|10329011|P6|Extension Part|Non-compliance with drug|1
3001557|NCT00934856|10329012|P5|Extension Part|Non-compliance with drug|0
3001558|NCT00934856|10329013|P4|Extension Part|Non-compliance with drug|0
3001559|NCT00934856|10329014|P3|Extension Part|Non-compliance with drug|0
3001560|NCT00934856|10329015|P2|Extension Part|Non-compliance with drug|0
3001561|NCT00934856|10329016|P1|Extension Part|Non-compliance with drug|0
3001562|NCT00934856|10329011|P6|Extension Part|Progressive disease|0
3001563|NCT00934856|10329012|P5|Extension Part|Progressive disease|0
3001564|NCT00934856|10329013|P4|Extension Part|Progressive disease|1
3001565|NCT00934856|10329014|P3|Extension Part|Progressive disease|0
3001566|NCT00934856|10329015|P2|Extension Part|Progressive disease|0
3001567|NCT00934856|10329016|P1|Extension Part|Progressive disease|0
3001568|NCT00934856|10329011|P6|Extension Part|Adverse Event|4
3001569|NCT00934856|10329012|P5|Extension Part|Adverse Event|4
3001570|NCT00934856|10329013|P4|Extension Part|Adverse Event|1
3001571|NCT00934856|10329014|P3|Extension Part|Adverse Event|0
3001572|NCT00934856|10329015|P2|Extension Part|Adverse Event|0
3001573|NCT00934856|10329016|P1|Extension Part|Adverse Event|0
3001574|NCT00934856|10329011|P6|Feasibility Part|Withdrawal by Subject|1
3001575|NCT00934856|10329012|P5|Feasibility Part|Withdrawal by Subject|0
3001576|NCT00934856|10329013|P4|Feasibility Part|Withdrawal by Subject|1
3001577|NCT00934856|10329014|P3|Feasibility Part|Withdrawal by Subject|0
3001578|NCT00934856|10329015|P2|Feasibility Part|Withdrawal by Subject|0
3001579|NCT00934856|10329016|P1|Feasibility Part|Withdrawal by Subject|0
3001580|NCT00934856|10329011|P6|Feasibility Part|Adverse Event|2
3001581|NCT00934856|10329012|P5|Feasibility Part|Adverse Event|0
3001582|NCT00934856|10329013|P4|Feasibility Part|Adverse Event|1
3001583|NCT00934856|10329014|P3|Feasibility Part|Adverse Event|0
3001584|NCT00934856|10329015|P2|Feasibility Part|Adverse Event|1
3001585|NCT00934856|10329016|P1|Feasibility Part|Adverse Event|1
3001586|NCT00934856|10329011|P6|Feasibility Part|Physician Decision|0
3001587|NCT00934856|10329012|P5|Feasibility Part|Physician Decision|0
3001588|NCT00934856|10329013|P4|Feasibility Part|Physician Decision|0
3001589|NCT00934856|10329014|P3|Feasibility Part|Physician Decision|1
3001590|NCT00934856|10329015|P2|Feasibility Part|Physician Decision|0
3001591|NCT00934856|10329016|P1|Feasibility Part|Physician Decision|0
3001592|NCT00934856|10329011|P6|Feasibility Part|Progressive disease|0
3001593|NCT00934856|10329012|P5|Feasibility Part|Progressive disease|0
3001594|NCT00934856|10329013|P4|Feasibility Part|Progressive disease|3
3001595|NCT00934856|10329014|P3|Feasibility Part|Progressive disease|2
3001596|NCT00934856|10329015|P2|Feasibility Part|Progressive disease|4
3001597|NCT00934856|10329016|P1|Feasibility Part|Progressive disease|4
3001598|NCT00934843|10329114|P2|Overall Study|Protocol Violation|1
3001599|NCT00934843|10329115|P1|Overall Study|Protocol Violation|0
3001600|NCT00934791|10329131|P2|Overall Study|Withdrawal by Subject|0
3001601|NCT00934791|10329132|P1|Overall Study|Withdrawal by Subject|1
3001602|NCT00934661|10329140|P2|Overall Study|Failure of Combined/Spinal Epidural|0
3001603|NCT00934661|10329141|P1|Overall Study|Failure of Combined/Spinal Epidural|1
3001604|NCT00934648|10329161|P1|Overall Study|Withdrawal by Subject|1
3001605|NCT00934648|10329161|P1|Overall Study|Failure to return|8
3001606|NCT00934622|10329205|P1|Overall Study|2nd Intraoperative exclusion criteria|1
3001607|NCT00934622|10329205|P1|Overall Study|Lost to Follow-up|7
3001608|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
3001609|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
3001610|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
3001611|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
3001612|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
3001613|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
3001614|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
3001615|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
3001616|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
3001617|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
3001618|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
3001619|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
3001620|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
3001621|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
3001622|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
3001623|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
3001624|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
3001625|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
3001626|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
3001627|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
3001628|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
3001629|NCT00934544|10329243|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
3001630|NCT00934544|10329244|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
3001631|NCT00934544|10329245|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
3001632|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
3001633|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
3001634|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
3001635|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
3001636|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
3001637|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
3001638|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
3001639|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
3001640|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
3001641|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
3001642|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
3001643|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
3001644|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
3001645|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
3001646|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
3001647|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
3001648|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
3001649|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
3001650|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
3001651|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
3001652|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
3001653|NCT00934544|10329243|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
3001654|NCT00934544|10329244|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
3001655|NCT00934544|10329245|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
3001656|NCT00934440|10329281|P1|Overall Study|Lost to Follow-up|1
3001657|NCT00934362|10329297|P2|Overall Study|Adverse Event|0
3001658|NCT00934362|10329298|P1|Overall Study|Adverse Event|1
3001659|NCT00934128|10329348|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
3001660|NCT00934128|10329349|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
3001661|NCT00934128|10329348|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
3001662|NCT00934128|10329349|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
3001663|NCT00934128|10329348|P2|Washout Period (1 Hour)|Too tired|0
3001664|NCT00934128|10329349|P1|Washout Period (1 Hour)|Too tired|1
3001665|NCT00934128|10329348|P2|Washout Period (1 Hour)|Pain|0
3001666|NCT00934128|10329349|P1|Washout Period (1 Hour)|Pain|1
3001667|NCT00934128|10329348|P2|Washout Period (1 Hour)|Patient preference|3
3001668|NCT00934128|10329349|P1|Washout Period (1 Hour)|Patient preference|1
3001669|NCT00934128|10329348|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
3001670|NCT00934128|10329349|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
3001671|NCT00934128|10329348|P2|First Intervention (2 Hours)|Adverse Event|1
3001672|NCT00934128|10329349|P1|First Intervention (2 Hours)|Adverse Event|4
3001673|NCT00934128|10329348|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
3001674|NCT00934128|10329349|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
3001675|NCT00934102|10329357|P3|Period 1, One Night of Wear|Personal Reasons|0
3001676|NCT00934102|10329358|P2|Period 1, One Night of Wear|Personal Reasons|0
3001677|NCT00934102|10329359|P1|Period 1, One Night of Wear|Personal Reasons|1
3001678|NCT00934050|10329373|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
3001679|NCT00934050|10329374|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
3001680|NCT00934050|10329375|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
3001681|NCT00934050|10329376|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
3001682|NCT00934050|10329377|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
3001683|NCT00934050|10329378|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
3001684|NCT00934050|10329373|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
3001685|NCT00934050|10329374|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
3001686|NCT00934050|10329375|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
3001687|NCT00934050|10329376|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
3001688|NCT00934050|10329377|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
3001689|NCT00934050|10329378|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
3001690|NCT00934050|10329373|P6|Enrolled After 15 Dec 2009|Death|1
3001691|NCT00934050|10329374|P5|Enrolled After 15 Dec 2009|Death|0
3001692|NCT00934050|10329375|P4|Enrolled After 15 Dec 2009|Death|0
3001693|NCT00934050|10329376|P3|Enrolled After 15 Dec 2009|Death|0
3001694|NCT00934050|10329377|P2|Enrolled After 15 Dec 2009|Death|0
3001695|NCT00934050|10329378|P1|Enrolled After 15 Dec 2009|Death|0
3001696|NCT00934050|10329373|P6|Enrolled After 15 Dec 2009|Adverse Event|0
3001697|NCT00934050|10329374|P5|Enrolled After 15 Dec 2009|Adverse Event|3
3001698|NCT00934050|10329375|P4|Enrolled After 15 Dec 2009|Adverse Event|0
3001699|NCT00934050|10329376|P3|Enrolled After 15 Dec 2009|Adverse Event|0
3001700|NCT00934050|10329377|P2|Enrolled After 15 Dec 2009|Adverse Event|0
3001701|NCT00934050|10329378|P1|Enrolled After 15 Dec 2009|Adverse Event|0
3001702|NCT00934050|10329373|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
3001703|NCT00934050|10329374|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
3001704|NCT00934050|10329375|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
3001705|NCT00934050|10329376|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
3001706|NCT00934050|10329377|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
3001707|NCT00934050|10329378|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
3001708|NCT00934050|10329373|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
3001709|NCT00934050|10329374|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
3001710|NCT00934050|10329375|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
3001711|NCT00934050|10329376|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
3001712|NCT00934050|10329377|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
3001713|NCT00934050|10329378|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
3001714|NCT00934050|10329373|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
3001715|NCT00934050|10329374|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
3001716|NCT00934050|10329375|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
3001717|NCT00934050|10329376|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
3001718|NCT00934050|10329377|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
3001719|NCT00934050|10329378|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
3001720|NCT00933933|10329401|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
3001721|NCT00933933|10329402|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
3001722|NCT00933933|10329403|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
3001723|NCT00933933|10329401|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
3001724|NCT00933933|10329402|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
3001725|NCT00933933|10329403|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
3001726|NCT00933686|10329421|P2|Overall Study|Failure to show up at endpoint visits|2
3001727|NCT00933686|10329422|P1|Overall Study|Failure to show up at endpoint visits|0
3001728|NCT00933686|10329421|P2|Overall Study|Physician Decision|0
3001729|NCT00933686|10329422|P1|Overall Study|Physician Decision|1
3001730|NCT00933686|10329421|P2|Overall Study|Adverse Event|1
3001731|NCT00933686|10329422|P1|Overall Study|Adverse Event|1
3001732|NCT00933686|10329421|P2|Overall Study|Withdrawal by Subject|5
3001733|NCT00933686|10329422|P1|Overall Study|Withdrawal by Subject|6
3001734|NCT00933686|10329421|P2|Overall Study|Lost to Follow-up|2
3001735|NCT00933686|10329422|P1|Overall Study|Lost to Follow-up|2
3001736|NCT00933686|10329421|P2|Overall Study|Protocol Violation|1
3001737|NCT00933686|10329422|P1|Overall Study|Protocol Violation|0
3001738|NCT00933608|10329442|P2|Overall Study|Physician Decision|0
3001739|NCT00933608|10329443|P1|Overall Study|Physician Decision|1
3001740|NCT00933608|10329442|P2|Overall Study|Adverse Event|2
3001741|NCT00933608|10329443|P1|Overall Study|Adverse Event|4
3001742|NCT00933543|10329451|P2|Overall Study|Other|1
3001743|NCT00933543|10329452|P1|Overall Study|Other|1
3001744|NCT00933543|10329451|P2|Overall Study|Lack of Efficacy|3
3001745|NCT00933543|10329452|P1|Overall Study|Lack of Efficacy|0
3001746|NCT00933543|10329451|P2|Overall Study|Withdrawal by Subject|1
3001747|NCT00933543|10329452|P1|Overall Study|Withdrawal by Subject|0
3001748|NCT00933543|10329451|P2|Overall Study|Lost to Follow-up|1
3001749|NCT00933543|10329452|P1|Overall Study|Lost to Follow-up|0
3001750|NCT00933543|10329451|P2|Overall Study|Adverse Event|1
3001751|NCT00933543|10329452|P1|Overall Study|Adverse Event|2
3001752|NCT00933335|10329521|P2|Overall Study|Co-morbid Illness|0
3001753|NCT00933335|10329522|P1|Overall Study|Co-morbid Illness|1
3001754|NCT00933335|10329521|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
3001755|NCT00933335|10329522|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
3001756|NCT00933335|10329521|P2|Overall Study|Progressive Disease|11
3001757|NCT00933335|10329522|P1|Overall Study|Progressive Disease|0
3001758|NCT00933335|10329521|P2|Overall Study|Withdrawal by Subject|1
3001759|NCT00933335|10329522|P1|Overall Study|Withdrawal by Subject|0
3001760|NCT00933335|10329521|P2|Overall Study|Lost to Follow-up|3
3001761|NCT00933335|10329522|P1|Overall Study|Lost to Follow-up|1
3001762|NCT00933270|10329592|P1|Overall Study|Moved or would not return|10
3001763|NCT00933270|10329592|P1|Overall Study|Death|24
3001764|NCT00933270|10329592|P1|Overall Study|Missed Visit|2
3001765|NCT00933270|10329592|P1|Overall Study|Adverse Event|1
3001766|NCT00933270|10329592|P1|Overall Study|Lost to Follow-up|14
3001767|NCT00933270|10329592|P1|Overall Study|Insufficient Follow-up|10
3001768|NCT00933270|10329592|P1|Overall Study|Withdrawal by Subject|26
3001769|NCT00933244|10329686|P3|Overall Study|Withdrawal by Subject|3
3001770|NCT00933244|10329687|P2|Overall Study|Withdrawal by Subject|1
3001771|NCT00933244|10329688|P1|Overall Study|Withdrawal by Subject|5
3001772|NCT00933166|10329705|P1|Overall Study|Withdrawal by Subject|1
3001773|NCT00933166|10329705|P1|Overall Study|Unavailable|4
3001774|NCT00933166|10329705|P1|Overall Study|Lack of Efficacy|9
3001775|NCT00933166|10329705|P1|Overall Study|Lost to Follow-up|4
3001776|NCT00932893|10329711|P2|Overall Study|Other|144
3001777|NCT00932893|10329712|P1|Overall Study|Other|5
3001778|NCT00932893|10329711|P2|Overall Study|Withdrawal by Subject|2
3001779|NCT00932893|10329712|P1|Overall Study|Withdrawal by Subject|5
3001780|NCT00932893|10329711|P2|Overall Study|Lost to Follow-up|0
3001781|NCT00932893|10329712|P1|Overall Study|Lost to Follow-up|8
3001782|NCT00932893|10329711|P2|Overall Study|Death|24
3001783|NCT00932893|10329712|P1|Overall Study|Death|115
3001784|NCT00932698|10329760|P11|Part 2 (Dose Expansion)|Adverse Event|0
3001785|NCT00932698|10329761|P10|Part 2 (Dose Expansion)|Adverse Event|1
3001786|NCT00932698|10329762|P9|Part 2 (Dose Expansion)|Adverse Event|1
3001787|NCT00932698|10329763|P8|Part 2 (Dose Expansion)|Adverse Event|5
3001788|NCT00932698|10329764|P7|Part 2 (Dose Expansion)|Adverse Event|0
3001789|NCT00932698|10329765|P6|Part 2 (Dose Expansion)|Adverse Event|0
3001790|NCT00932698|10329766|P5|Part 2 (Dose Expansion)|Adverse Event|0
3001791|NCT00932698|10329767|P4|Part 2 (Dose Expansion)|Adverse Event|0
3001792|NCT00932698|10329768|P3|Part 2 (Dose Expansion)|Adverse Event|0
3001793|NCT00932698|10329769|P2|Part 2 (Dose Expansion)|Adverse Event|0
3001794|NCT00932698|10329770|P1|Part 2 (Dose Expansion)|Adverse Event|0
3001795|NCT00932698|10329760|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001796|NCT00932698|10329761|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
3001797|NCT00932698|10329762|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
3001798|NCT00932698|10329763|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
3001799|NCT00932698|10329764|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001800|NCT00932698|10329765|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001801|NCT00932698|10329766|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001802|NCT00932698|10329767|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001803|NCT00932698|10329768|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001804|NCT00932698|10329769|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001805|NCT00932698|10329770|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
3001806|NCT00932698|10329760|P11|Part 2 (Dose Expansion)|Progressive Disease|2
3001807|NCT00932698|10329761|P10|Part 2 (Dose Expansion)|Progressive Disease|3
3001808|NCT00932698|10329762|P9|Part 2 (Dose Expansion)|Progressive Disease|8
3001809|NCT00932698|10329763|P8|Part 2 (Dose Expansion)|Progressive Disease|14
3001810|NCT00932698|10329764|P7|Part 2 (Dose Expansion)|Progressive Disease|0
3001811|NCT00932698|10329765|P6|Part 2 (Dose Expansion)|Progressive Disease|0
3001812|NCT00932698|10329766|P5|Part 2 (Dose Expansion)|Progressive Disease|0
3001813|NCT00932698|10329767|P4|Part 2 (Dose Expansion)|Progressive Disease|0
3001814|NCT00932698|10329768|P3|Part 2 (Dose Expansion)|Progressive Disease|0
3001815|NCT00932698|10329769|P2|Part 2 (Dose Expansion)|Progressive Disease|0
3001816|NCT00932698|10329770|P1|Part 2 (Dose Expansion)|Progressive Disease|0
3001817|NCT00932698|10329760|P11|Part 1 (Dose Escalation)|Other|0
3001818|NCT00932698|10329761|P10|Part 1 (Dose Escalation)|Other|0
3001819|NCT00932698|10329762|P9|Part 1 (Dose Escalation)|Other|0
3001820|NCT00932698|10329763|P8|Part 1 (Dose Escalation)|Other|0
3001821|NCT00932698|10329764|P7|Part 1 (Dose Escalation)|Other|1
3001822|NCT00932698|10329765|P6|Part 1 (Dose Escalation)|Other|0
3001823|NCT00932698|10329766|P5|Part 1 (Dose Escalation)|Other|0
3001824|NCT00932698|10329767|P4|Part 1 (Dose Escalation)|Other|0
3001825|NCT00932698|10329768|P3|Part 1 (Dose Escalation)|Other|1
3001826|NCT00932698|10329769|P2|Part 1 (Dose Escalation)|Other|0
3001827|NCT00932698|10329770|P1|Part 1 (Dose Escalation)|Other|0
3001828|NCT00932698|10329760|P11|Part 1 (Dose Escalation)|Adverse Event|0
3001829|NCT00932698|10329761|P10|Part 1 (Dose Escalation)|Adverse Event|0
3001830|NCT00932698|10329762|P9|Part 1 (Dose Escalation)|Adverse Event|0
3001831|NCT00932698|10329763|P8|Part 1 (Dose Escalation)|Adverse Event|0
3001832|NCT00932698|10329764|P7|Part 1 (Dose Escalation)|Adverse Event|0
3001833|NCT00932698|10329765|P6|Part 1 (Dose Escalation)|Adverse Event|1
3001834|NCT00932698|10329766|P5|Part 1 (Dose Escalation)|Adverse Event|0
3001835|NCT00932698|10329767|P4|Part 1 (Dose Escalation)|Adverse Event|0
3001836|NCT00932698|10329768|P3|Part 1 (Dose Escalation)|Adverse Event|0
3001837|NCT00932698|10329769|P2|Part 1 (Dose Escalation)|Adverse Event|0
3001838|NCT00932698|10329770|P1|Part 1 (Dose Escalation)|Adverse Event|0
3001839|NCT00932698|10329760|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001840|NCT00932698|10329761|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001841|NCT00932698|10329762|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001842|NCT00932698|10329763|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001843|NCT00932698|10329764|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
3001844|NCT00932698|10329765|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
3001845|NCT00932698|10329766|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001846|NCT00932698|10329767|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
3001847|NCT00932698|10329768|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001848|NCT00932698|10329769|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
3001849|NCT00932698|10329770|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
3001850|NCT00932698|10329760|P11|Part 1 (Dose Escalation)|Progressive Disease|0
3001851|NCT00932698|10329761|P10|Part 1 (Dose Escalation)|Progressive Disease|0
3001852|NCT00932698|10329762|P9|Part 1 (Dose Escalation)|Progressive Disease|0
3001853|NCT00932698|10329763|P8|Part 1 (Dose Escalation)|Progressive Disease|0
3001854|NCT00932698|10329764|P7|Part 1 (Dose Escalation)|Progressive Disease|2
3001855|NCT00932698|10329765|P6|Part 1 (Dose Escalation)|Progressive Disease|5
3001856|NCT00932698|10329766|P5|Part 1 (Dose Escalation)|Progressive Disease|3
3001857|NCT00932698|10329767|P4|Part 1 (Dose Escalation)|Progressive Disease|2
3001858|NCT00932698|10329768|P3|Part 1 (Dose Escalation)|Progressive Disease|2
3001859|NCT00932698|10329769|P2|Part 1 (Dose Escalation)|Progressive Disease|2
3001860|NCT00932698|10329770|P1|Part 1 (Dose Escalation)|Progressive Disease|3
3001861|NCT00932646|10329944|P4|Overall Study|Withdrawal by Subject|0
3001862|NCT00932646|10329945|P3|Overall Study|Withdrawal by Subject|3
3001863|NCT00932646|10329946|P2|Overall Study|Withdrawal by Subject|1
3001864|NCT00932646|10329947|P1|Overall Study|Withdrawal by Subject|1
3001865|NCT00932646|10329944|P4|Overall Study|Lost to Follow-up|0
3001866|NCT00932646|10329945|P3|Overall Study|Lost to Follow-up|0
3001867|NCT00932646|10329946|P2|Overall Study|Lost to Follow-up|1
3001868|NCT00932646|10329947|P1|Overall Study|Lost to Follow-up|2
3001869|NCT00932646|10329944|P4|Overall Study|Adverse Event|1
3001870|NCT00932646|10329945|P3|Overall Study|Adverse Event|1
3001871|NCT00932646|10329946|P2|Overall Study|Adverse Event|1
3001872|NCT00932646|10329947|P1|Overall Study|Adverse Event|2
3001873|NCT00932451|10330034|P1|Overall Study|Other reasons|5
3001874|NCT00932451|10330034|P1|Overall Study|Death|726
3001875|NCT00932451|10330034|P1|Overall Study|Lost to Follow-up|22
3001876|NCT00932451|10330034|P1|Overall Study|Withdrawal by Subject|69
3001877|NCT00932425|10330058|P2|Overall Study|Withdrawal by Subject|1
3001878|NCT00932425|10330059|P1|Overall Study|Withdrawal by Subject|0
3001879|NCT00932425|10330058|P2|Overall Study|Lost to Follow-up|1
3001880|NCT00932425|10330059|P1|Overall Study|Lost to Follow-up|0
3001881|NCT00932373|10330092|P11|Overall Study|Lack of Efficacy|0
3001882|NCT00932373|10330093|P10|Overall Study|Lack of Efficacy|1
3001883|NCT00932373|10330094|P9|Overall Study|Lack of Efficacy|0
3001884|NCT00932373|10330095|P8|Overall Study|Lack of Efficacy|0
3001885|NCT00932373|10330096|P7|Overall Study|Lack of Efficacy|0
3001886|NCT00932373|10330097|P6|Overall Study|Lack of Efficacy|0
3001887|NCT00932373|10330098|P5|Overall Study|Lack of Efficacy|0
3001888|NCT00932373|10330099|P4|Overall Study|Lack of Efficacy|0
3001889|NCT00932373|10330100|P3|Overall Study|Lack of Efficacy|0
3001890|NCT00932373|10330101|P2|Overall Study|Lack of Efficacy|0
3001891|NCT00932373|10330102|P1|Overall Study|Lack of Efficacy|0
3001892|NCT00932373|10330092|P11|Overall Study|Clinical progression|0
3001893|NCT00932373|10330093|P10|Overall Study|Clinical progression|0
3001894|NCT00932373|10330094|P9|Overall Study|Clinical progression|0
3001895|NCT00932373|10330095|P8|Overall Study|Clinical progression|0
3001896|NCT00932373|10330096|P7|Overall Study|Clinical progression|1
3001897|NCT00932373|10330097|P6|Overall Study|Clinical progression|0
3001898|NCT00932373|10330098|P5|Overall Study|Clinical progression|0
3001899|NCT00932373|10330099|P4|Overall Study|Clinical progression|0
3001900|NCT00932373|10330100|P3|Overall Study|Clinical progression|0
3001901|NCT00932373|10330101|P2|Overall Study|Clinical progression|0
3001902|NCT00932373|10330102|P1|Overall Study|Clinical progression|0
3001903|NCT00932373|10330092|P11|Overall Study|Withdrawal by Subject|0
3001904|NCT00932373|10330093|P10|Overall Study|Withdrawal by Subject|0
3001905|NCT00932373|10330094|P9|Overall Study|Withdrawal by Subject|1
3001906|NCT00932373|10330095|P8|Overall Study|Withdrawal by Subject|0
3001907|NCT00932373|10330096|P7|Overall Study|Withdrawal by Subject|0
3001908|NCT00932373|10330097|P6|Overall Study|Withdrawal by Subject|0
3001909|NCT00932373|10330098|P5|Overall Study|Withdrawal by Subject|0
3001910|NCT00932373|10330099|P4|Overall Study|Withdrawal by Subject|0
3001911|NCT00932373|10330100|P3|Overall Study|Withdrawal by Subject|0
3001912|NCT00932373|10330101|P2|Overall Study|Withdrawal by Subject|0
3001913|NCT00932373|10330102|P1|Overall Study|Withdrawal by Subject|0
3001914|NCT00932373|10330092|P11|Overall Study|Dose limiting toxicity|0
3001915|NCT00932373|10330093|P10|Overall Study|Dose limiting toxicity|0
3001916|NCT00932373|10330094|P9|Overall Study|Dose limiting toxicity|0
3001917|NCT00932373|10330095|P8|Overall Study|Dose limiting toxicity|0
3001918|NCT00932373|10330096|P7|Overall Study|Dose limiting toxicity|0
3001919|NCT00932373|10330097|P6|Overall Study|Dose limiting toxicity|1
3001920|NCT00932373|10330098|P5|Overall Study|Dose limiting toxicity|0
3001921|NCT00932373|10330099|P4|Overall Study|Dose limiting toxicity|0
3001922|NCT00932373|10330100|P3|Overall Study|Dose limiting toxicity|0
3001923|NCT00932373|10330101|P2|Overall Study|Dose limiting toxicity|0
3001924|NCT00932373|10330102|P1|Overall Study|Dose limiting toxicity|0
3001925|NCT00932373|10330092|P11|Overall Study|Physician Decision|0
3001926|NCT00932373|10330093|P10|Overall Study|Physician Decision|1
3001927|NCT00932373|10330094|P9|Overall Study|Physician Decision|0
3001928|NCT00932373|10330095|P8|Overall Study|Physician Decision|0
3001929|NCT00932373|10330096|P7|Overall Study|Physician Decision|0
3001930|NCT00932373|10330097|P6|Overall Study|Physician Decision|0
3001931|NCT00932373|10330098|P5|Overall Study|Physician Decision|2
3001932|NCT00932373|10330099|P4|Overall Study|Physician Decision|0
3001933|NCT00932373|10330100|P3|Overall Study|Physician Decision|1
3001934|NCT00932373|10330101|P2|Overall Study|Physician Decision|0
3001935|NCT00932373|10330102|P1|Overall Study|Physician Decision|0
3001936|NCT00932373|10330092|P11|Overall Study|Adverse Event|1
3001937|NCT00932373|10330093|P10|Overall Study|Adverse Event|2
3001938|NCT00932373|10330094|P9|Overall Study|Adverse Event|0
3001939|NCT00932373|10330095|P8|Overall Study|Adverse Event|1
3001940|NCT00932373|10330096|P7|Overall Study|Adverse Event|0
3001941|NCT00932373|10330097|P6|Overall Study|Adverse Event|1
3001942|NCT00932373|10330098|P5|Overall Study|Adverse Event|2
3001943|NCT00932373|10330099|P4|Overall Study|Adverse Event|0
3001944|NCT00932373|10330100|P3|Overall Study|Adverse Event|0
3001945|NCT00932373|10330101|P2|Overall Study|Adverse Event|0
3001946|NCT00932373|10330102|P1|Overall Study|Adverse Event|0
3001947|NCT00932373|10330092|P11|Overall Study|Progressive disease|2
3001948|NCT00932373|10330093|P10|Overall Study|Progressive disease|9
3001949|NCT00932373|10330094|P9|Overall Study|Progressive disease|1
3001950|NCT00932373|10330095|P8|Overall Study|Progressive disease|2
3001951|NCT00932373|10330096|P7|Overall Study|Progressive disease|0
3001952|NCT00932373|10330097|P6|Overall Study|Progressive disease|1
3001953|NCT00932373|10330098|P5|Overall Study|Progressive disease|10
3001954|NCT00932373|10330099|P4|Overall Study|Progressive disease|0
3001955|NCT00932373|10330100|P3|Overall Study|Progressive disease|0
3001956|NCT00932373|10330101|P2|Overall Study|Progressive disease|1
3001957|NCT00932373|10330102|P1|Overall Study|Progressive disease|3
3001958|NCT00932360|10330202|P6|Washout (One Week)|Withdrawal by Subject|0
3001959|NCT00932360|10330203|P5|Washout (One Week)|Withdrawal by Subject|2
3001960|NCT00932360|10330204|P4|Washout (One Week)|Withdrawal by Subject|0
3001961|NCT00932360|10330205|P3|Washout (One Week)|Withdrawal by Subject|0
3001962|NCT00932360|10330206|P2|Washout (One Week)|Withdrawal by Subject|0
3001963|NCT00932360|10330207|P1|Washout (One Week)|Withdrawal by Subject|0
3001964|NCT00932165|10330264|P1|Overall Study|Lost to Follow-up|1
3001965|NCT00932126|10330288|P8|Overall Study|Other|2
3001966|NCT00932126|10330289|P7|Overall Study|Other|1
3001967|NCT00932126|10330290|P6|Overall Study|Other|0
3001968|NCT00932126|10330291|P5|Overall Study|Other|1
3001969|NCT00932126|10330292|P4|Overall Study|Other|0
3001970|NCT00932126|10330293|P3|Overall Study|Other|0
3001971|NCT00932126|10330294|P2|Overall Study|Other|0
3001972|NCT00932126|10330295|P1|Overall Study|Other|0
3001973|NCT00932126|10330288|P8|Overall Study|Objective progression or relapse|5
3001974|NCT00932126|10330289|P7|Overall Study|Objective progression or relapse|3
3001975|NCT00932126|10330290|P6|Overall Study|Objective progression or relapse|3
3001976|NCT00932126|10330291|P5|Overall Study|Objective progression or relapse|3
3001977|NCT00932126|10330292|P4|Overall Study|Objective progression or relapse|3
3001978|NCT00932126|10330293|P3|Overall Study|Objective progression or relapse|2
3001979|NCT00932126|10330294|P2|Overall Study|Objective progression or relapse|3
3001980|NCT00932126|10330295|P1|Overall Study|Objective progression or relapse|3
3001981|NCT00932126|10330288|P8|Overall Study|Withdrawal by Subject|1
3001982|NCT00932126|10330289|P7|Overall Study|Withdrawal by Subject|0
3001983|NCT00932126|10330290|P6|Overall Study|Withdrawal by Subject|0
3001984|NCT00932126|10330291|P5|Overall Study|Withdrawal by Subject|0
3001985|NCT00932126|10330292|P4|Overall Study|Withdrawal by Subject|0
3001986|NCT00932126|10330293|P3|Overall Study|Withdrawal by Subject|1
3001987|NCT00932126|10330294|P2|Overall Study|Withdrawal by Subject|0
3001988|NCT00932126|10330295|P1|Overall Study|Withdrawal by Subject|0
3001989|NCT00932126|10330288|P8|Overall Study|Protocol Violation|0
3001990|NCT00932126|10330289|P7|Overall Study|Protocol Violation|0
3001991|NCT00932126|10330290|P6|Overall Study|Protocol Violation|0
3001992|NCT00932126|10330291|P5|Overall Study|Protocol Violation|1
3001993|NCT00932126|10330292|P4|Overall Study|Protocol Violation|0
3001994|NCT00932126|10330293|P3|Overall Study|Protocol Violation|0
3001995|NCT00932126|10330294|P2|Overall Study|Protocol Violation|0
3001996|NCT00932126|10330295|P1|Overall Study|Protocol Violation|0
3001997|NCT00932126|10330288|P8|Overall Study|Adverse Event|2
3001998|NCT00932126|10330289|P7|Overall Study|Adverse Event|1
3001999|NCT00932126|10330290|P6|Overall Study|Adverse Event|0
3002000|NCT00932126|10330291|P5|Overall Study|Adverse Event|0
3002001|NCT00932126|10330292|P4|Overall Study|Adverse Event|0
3002002|NCT00932126|10330293|P3|Overall Study|Adverse Event|0
3002003|NCT00932126|10330294|P2|Overall Study|Adverse Event|0
3002004|NCT00932126|10330295|P1|Overall Study|Adverse Event|0
3002005|NCT00932113|10330333|P2|Overall Study|Lost to Follow-up|0
3002006|NCT00932113|10330334|P1|Overall Study|Lost to Follow-up|1
3002007|NCT00931918|10330386|P2|Overall Study|Did not receive study drug|2
3002008|NCT00931918|10330387|P1|Overall Study|Did not receive study drug|3
3002009|NCT00931918|10330386|P2|Overall Study|Other Reason not Specified|4
3002010|NCT00931918|10330387|P1|Overall Study|Other Reason not Specified|4
3002011|NCT00931918|10330386|P2|Overall Study|Withdrawal by Patient|4
3002012|NCT00931918|10330387|P1|Overall Study|Withdrawal by Patient|3
3002013|NCT00931918|10330386|P2|Overall Study|Symptomatic Deterioration|0
3002014|NCT00931918|10330387|P1|Overall Study|Symptomatic Deterioration|1
3002015|NCT00931918|10330386|P2|Overall Study|Progressive Disease|1
3002016|NCT00931918|10330387|P1|Overall Study|Progressive Disease|2
3002017|NCT00931918|10330386|P2|Overall Study|Adverse Event|6
3002018|NCT00931918|10330387|P1|Overall Study|Adverse Event|4
3002019|NCT00931801|10330439|P3|Overall Study|Confirmed Virologic Failure|3
3002020|NCT00931801|10330440|P2|Overall Study|Confirmed Virologic Failure|0
3002021|NCT00931801|10330441|P1|Overall Study|Confirmed Virologic Failure|0
3002022|NCT00931801|10330439|P3|Overall Study|Withdrawal by Subject|0
3002023|NCT00931801|10330440|P2|Overall Study|Withdrawal by Subject|0
3002024|NCT00931801|10330441|P1|Overall Study|Withdrawal by Subject|1
3002025|NCT00931801|10330439|P3|Overall Study|Lost to Follow-up|0
3002026|NCT00931801|10330440|P2|Overall Study|Lost to Follow-up|1
3002027|NCT00931801|10330441|P1|Overall Study|Lost to Follow-up|0
3002028|NCT00931801|10330439|P3|Overall Study|Adverse Event|1
3002029|NCT00931801|10330440|P2|Overall Study|Adverse Event|0
3002030|NCT00931801|10330441|P1|Overall Study|Adverse Event|0
3002031|NCT00931723|10330464|P2|Overall Study|Late hospital discharge|0
3002032|NCT00931723|10330465|P1|Overall Study|Late hospital discharge|1
3002033|NCT00931723|10330464|P2|Overall Study|Sponsor decision|0
3002034|NCT00931723|10330465|P1|Overall Study|Sponsor decision|1
3002035|NCT00931723|10330464|P2|Overall Study|Lack or insufficient theraputic response|5
3002036|NCT00931723|10330465|P1|Overall Study|Lack or insufficient theraputic response|2
3002037|NCT00931723|10330464|P2|Overall Study|Took prohibited concomitant medication|1
3002038|NCT00931723|10330465|P1|Overall Study|Took prohibited concomitant medication|0
3002039|NCT00931723|10330464|P2|Overall Study|Safety reasons|1
3002040|NCT00931723|10330465|P1|Overall Study|Safety reasons|0
3002041|NCT00931723|10330464|P2|Overall Study|Severe non-compliance to protocol|0
3002042|NCT00931723|10330465|P1|Overall Study|Severe non-compliance to protocol|2
3002043|NCT00931723|10330464|P2|Overall Study|Study-specific discontinuation criteria|1
3002044|NCT00931723|10330465|P1|Overall Study|Study-specific discontinuation criteria|1
3002045|NCT00931723|10330464|P2|Overall Study|Lost to Follow-up|2
3002046|NCT00931723|10330465|P1|Overall Study|Lost to Follow-up|1
3002047|NCT00931723|10330464|P2|Overall Study|Condition under investigation worsened|2
3002048|NCT00931723|10330465|P1|Overall Study|Condition under investigation worsened|1
3002049|NCT00931723|10330464|P2|Overall Study|Lithium found in blood|1
3002050|NCT00931723|10330465|P1|Overall Study|Lithium found in blood|0
3002051|NCT00931723|10330464|P2|Overall Study|Adverse Event|13
3002052|NCT00931723|10330465|P1|Overall Study|Adverse Event|6
3002053|NCT00931723|10330464|P2|Overall Study|Withdrawal by Subject|13
3002054|NCT00931723|10330465|P1|Overall Study|Withdrawal by Subject|11
3002055|NCT00931710|10330513|P2|Overall Study|Protocol deviation|2
3002056|NCT00931710|10330514|P1|Overall Study|Protocol deviation|1
3002057|NCT00931710|10330513|P2|Overall Study|Lost to Follow-up|5
3002058|NCT00931710|10330514|P1|Overall Study|Lost to Follow-up|6
3002059|NCT00931710|10330513|P2|Overall Study|Patient withdrew consent|9
3002060|NCT00931710|10330514|P1|Overall Study|Patient withdrew consent|4
3002061|NCT00931710|10330513|P2|Overall Study|Unsatisfactory therapeutic effects|12
3002062|NCT00931710|10330514|P1|Overall Study|Unsatisfactory therapeutic effects|5
3002063|NCT00931710|10330513|P2|Overall Study|Abnormal test procedure results|0
3002064|NCT00931710|10330514|P1|Overall Study|Abnormal test procedure results|2
3002065|NCT00931710|10330513|P2|Overall Study|Adverse Event|10
3002066|NCT00931710|10330514|P1|Overall Study|Adverse Event|16
3002067|NCT00931632|10330532|P2|Overall Study|Adverse Event|15
3002068|NCT00931632|10330533|P1|Overall Study|Adverse Event|19
3002069|NCT00931632|10330532|P2|Overall Study|Withdrawal by Subject|3
3002070|NCT00931632|10330533|P1|Overall Study|Withdrawal by Subject|2
3002071|NCT00931528|10330555|P2|Overall Study|Assessment outside of Time Frame|23
3002072|NCT00931528|10330556|P1|Overall Study|Assessment outside of Time Frame|22
3002073|NCT00931528|10330555|P2|Overall Study|Lost to Follow-up|13
3002074|NCT00931528|10330556|P1|Overall Study|Lost to Follow-up|6
3002075|NCT00931528|10330555|P2|Overall Study|Withdrawal by Subject|12
3002076|NCT00931528|10330556|P1|Overall Study|Withdrawal by Subject|4
3002077|NCT00931528|10330555|P2|Overall Study|Protocol Violation|12
3002078|NCT00931528|10330556|P1|Overall Study|Protocol Violation|9
3002079|NCT00931515|10330576|P2|Overall Study|Lost to Follow-up|5
3002080|NCT00931515|10330577|P1|Overall Study|Lost to Follow-up|2
3002081|NCT00931463|10330607|P2|Overall Study|Lost to Follow-up|1
3002082|NCT00931463|10330608|P1|Overall Study|Lost to Follow-up|4
3002083|NCT00931463|10330607|P2|Overall Study|Withdrawal by Subject|0
3002084|NCT00931463|10330608|P1|Overall Study|Withdrawal by Subject|5
3002085|NCT00931463|10330607|P2|Overall Study|Death|4
3002086|NCT00931463|10330608|P1|Overall Study|Death|8
3002087|NCT00931411|10330624|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
3002088|NCT00931411|10330625|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
3002089|NCT00931411|10330624|P2|First Intervention - 42 Days|Lost to Follow-up|0
3002090|NCT00931411|10330625|P1|First Intervention - 42 Days|Lost to Follow-up|2
3002091|NCT00931411|10330624|P2|First Intervention - 42 Days|Adverse Event|3
3002092|NCT00931411|10330625|P1|First Intervention - 42 Days|Adverse Event|2
3002093|NCT00931385|10330646|P4|Overall Study|Lost to Follow-up|1
3002094|NCT00931385|10330647|P3|Overall Study|Lost to Follow-up|0
3002095|NCT00931385|10330648|P2|Overall Study|Lost to Follow-up|0
3002096|NCT00931385|10330649|P1|Overall Study|Lost to Follow-up|0
3002097|NCT00931385|10330646|P4|Overall Study|Withdrawal by Subject|1
3002098|NCT00931385|10330647|P3|Overall Study|Withdrawal by Subject|0
3002099|NCT00931385|10330648|P2|Overall Study|Withdrawal by Subject|1
3002100|NCT00931385|10330649|P1|Overall Study|Withdrawal by Subject|0
3002101|NCT00931385|10330646|P4|Overall Study|Protocol Violation|0
3002102|NCT00931385|10330647|P3|Overall Study|Protocol Violation|1
3002103|NCT00931385|10330648|P2|Overall Study|Protocol Violation|0
3002104|NCT00931385|10330649|P1|Overall Study|Protocol Violation|0
3002105|NCT00931385|10330646|P4|Overall Study|Adverse Event|3
3002106|NCT00931385|10330647|P3|Overall Study|Adverse Event|0
3002107|NCT00931385|10330648|P2|Overall Study|Adverse Event|1
3002108|NCT00931385|10330649|P1|Overall Study|Adverse Event|2
3002109|NCT00931307|10330718|P1|Overall Study|Biomicroscopy|1
3002110|NCT00931307|10330718|P1|Overall Study|Lack of Efficacy|12
3002111|NCT00931268|10330722|P1|Overall Study|Lost to Follow-up|6
3002112|NCT00931255|10330734|P2|Overall Study|Follow up biopsy not done|3
3002113|NCT00931255|10330735|P1|Overall Study|Follow up biopsy not done|2
3002114|NCT00930982|10330772|P2|Overall Study|Withdrawal by Subject|1
3002115|NCT00930982|10330773|P1|Overall Study|Withdrawal by Subject|1
3002116|NCT00930982|10330772|P2|Overall Study|Protocol Violation|5
3002117|NCT00930982|10330773|P1|Overall Study|Protocol Violation|1
3002118|NCT00930982|10330772|P2|Overall Study|Adverse Event|23
3002119|NCT00930982|10330773|P1|Overall Study|Adverse Event|19
3002120|NCT00930969|10330807|P1|Overall Study|Withdrawal by Subject|19
3002121|NCT00930969|10330807|P1|Overall Study|Physician Decision|13
3002122|NCT00930969|10330807|P1|Overall Study|Lost to Follow-up|1
3002123|NCT00930969|10330807|P1|Overall Study|Death|5
3002124|NCT00930930|10330817|P2|Overall Study|patients not compliant|1
3002125|NCT00930930|10330818|P1|Overall Study|patients not compliant|1
3002126|NCT00930930|10330817|P2|Overall Study|excessive lapse btw txs, not eligible|1
3002127|NCT00930930|10330818|P1|Overall Study|excessive lapse btw txs, not eligible|0
3002128|NCT00930930|10330817|P2|Overall Study|Disease progression|3
3002129|NCT00930930|10330818|P1|Overall Study|Disease progression|2
3002130|NCT00930930|10330817|P2|Overall Study|Withdrawal by Subject|1
3002131|NCT00930930|10330818|P1|Overall Study|Withdrawal by Subject|3
3002132|NCT00930930|10330817|P2|Overall Study|Adverse Event|3
3002133|NCT00930930|10330818|P1|Overall Study|Adverse Event|13
3002134|NCT00930930|10330817|P2|Overall Study|Physician Decision|0
3002135|NCT00930930|10330818|P1|Overall Study|Physician Decision|1
3002136|NCT00930930|10330817|P2|Overall Study|Death|0
3002137|NCT00930930|10330818|P1|Overall Study|Death|1
3002138|NCT00930813|10330832|P2|Overall Study|Lost to Follow-up|4
3002139|NCT00930813|10330833|P1|Overall Study|Lost to Follow-up|2
3002140|NCT00930813|10330832|P2|Overall Study|Withdrawal by Subject|5
3002141|NCT00930813|10330833|P1|Overall Study|Withdrawal by Subject|2
3002142|NCT00930813|10330832|P2|Overall Study|Death|5
3002143|NCT00930813|10330833|P1|Overall Study|Death|4
3002144|NCT00930774|10330854|P4|Overall Study|Withdrawal by Subject|0
3002145|NCT00930774|10330855|P3|Overall Study|Withdrawal by Subject|2
3002146|NCT00930774|10330856|P2|Overall Study|Withdrawal by Subject|9
3002147|NCT00930774|10330857|P1|Overall Study|Withdrawal by Subject|1
3002148|NCT00930761|10330897|P2|Overall Study|less than 3 music therapy sessions|3
3002149|NCT00930761|10330898|P1|Overall Study|less than 3 music therapy sessions|0
3002150|NCT00930761|10330897|P2|Overall Study|3 newborns died; 1 mother quit the study|0
3002151|NCT00930761|10330898|P1|Overall Study|3 newborns died; 1 mother quit the study|4
3002152|NCT00930722|10330910|P1|Overall Study|Study terminated by sponsor|2
3002153|NCT00930722|10330910|P1|Overall Study|No longer willing to participate|9
3002154|NCT00930722|10330910|P1|Overall Study|Lost to Follow-up|16
3002155|NCT00930644|10330925|P1|Overall Study|Adverse Event|16
3002156|NCT00930644|10330925|P1|Overall Study|Death|1
3002157|NCT00930644|10330925|P1|Overall Study|Physician Decision|2
3002158|NCT00930644|10330925|P1|Overall Study|Withdrawal by Subject|4
3002159|NCT00930553|10330938|P1|Overall Study|Other than specified above|28
3002160|NCT00930553|10330938|P1|Overall Study|Study terminated by sponsor|24
3002161|NCT00930553|10330938|P1|Overall Study|Death|9
3002162|NCT00930553|10330938|P1|Overall Study|Lost to Follow-up|25
3002163|NCT00930553|10330938|P1|Overall Study|Withdrawal by Subject|88
3002164|NCT00930553|10330938|P1|Overall Study|Pregnancy|1
3002165|NCT00930553|10330938|P1|Overall Study|Protocol Violation|1
3002166|NCT00930553|10330938|P1|Overall Study|Physician Decision|39
3002167|NCT00930553|10330938|P1|Overall Study|Lack of Efficacy|7
3002168|NCT00930553|10330938|P1|Overall Study|Adverse Event|1
3002169|NCT00930176|10331015|P1|Overall Study|Death|1
3002170|NCT00930046|10331022|P2|Overall Study|Wound catheter malfunctioned|2
3002171|NCT00930046|10331023|P1|Overall Study|Wound catheter malfunctioned|1
3002172|NCT00929994|10331031|P1|Overall Study|employment|1
3002173|NCT00929994|10331031|P1|Overall Study|medical issue unrelated to intervention|4
3002174|NCT00929994|10331031|P1|Overall Study|Withdrawal by Subject|1
3002175|NCT00929864|10331050|P2|Overall Study|Non-specified|7
3002176|NCT00929864|10331051|P1|Overall Study|Non-specified|2
3002177|NCT00929864|10331050|P2|Overall Study|Administrative reason by Sponsor|1
3002178|NCT00929864|10331051|P1|Overall Study|Administrative reason by Sponsor|1
3002179|NCT00929864|10331050|P2|Overall Study|Pregnancy|3
3002180|NCT00929864|10331051|P1|Overall Study|Pregnancy|0
3002181|NCT00929864|10331050|P2|Overall Study|Poor or non-compliance|3
3002182|NCT00929864|10331051|P1|Overall Study|Poor or non-compliance|3
3002183|NCT00929864|10331050|P2|Overall Study|No longer met criteria|1
3002184|NCT00929864|10331051|P1|Overall Study|No longer met criteria|2
3002185|NCT00929864|10331050|P2|Overall Study|Withdrawal by Subject|9
3002186|NCT00929864|10331051|P1|Overall Study|Withdrawal by Subject|20
3002187|NCT00929864|10331050|P2|Overall Study|Lost to Follow-up|12
3002188|NCT00929864|10331051|P1|Overall Study|Lost to Follow-up|7
3002189|NCT00929864|10331050|P2|Overall Study|Lack of Efficacy|16
3002190|NCT00929864|10331051|P1|Overall Study|Lack of Efficacy|19
3002191|NCT00929864|10331050|P2|Overall Study|Adverse Event|30
3002192|NCT00929864|10331051|P1|Overall Study|Adverse Event|11
3002193|NCT00929864|10331050|P2|Overall Study|Death|1
3002194|NCT00929864|10331051|P1|Overall Study|Death|1
3002195|NCT00929734|10331107|P2|Overall Study|Withdrawal by Subject|2
3002196|NCT00929734|10331108|P1|Overall Study|Withdrawal by Subject|0
3002197|NCT00929734|10331107|P2|Overall Study|Lost to Follow-up|1
3002198|NCT00929734|10331108|P1|Overall Study|Lost to Follow-up|2
3002199|NCT00929708|10331125|P5|Overall Study|Lost to Follow-up|0
3002200|NCT00929708|10331126|P4|Overall Study|Lost to Follow-up|1
3002201|NCT00929708|10331127|P3|Overall Study|Lost to Follow-up|0
3002202|NCT00929708|10331128|P2|Overall Study|Lost to Follow-up|0
3002203|NCT00929708|10331129|P1|Overall Study|Lost to Follow-up|0
3002204|NCT00929708|10331125|P5|Overall Study|Physician Decision|1
3002205|NCT00929708|10331126|P4|Overall Study|Physician Decision|2
3002206|NCT00929708|10331127|P3|Overall Study|Physician Decision|2
3002207|NCT00929708|10331128|P2|Overall Study|Physician Decision|2
3002208|NCT00929708|10331129|P1|Overall Study|Physician Decision|0
3002209|NCT00929708|10331125|P5|Overall Study|Adverse Event|3
3002210|NCT00929708|10331126|P4|Overall Study|Adverse Event|0
3002211|NCT00929708|10331127|P3|Overall Study|Adverse Event|0
3002212|NCT00929708|10331128|P2|Overall Study|Adverse Event|0
3002213|NCT00929708|10331129|P1|Overall Study|Adverse Event|0
3002214|NCT00929708|10331125|P5|Overall Study|Withdrawal by Subject|1
3002215|NCT00929708|10331126|P4|Overall Study|Withdrawal by Subject|2
3002216|NCT00929708|10331127|P3|Overall Study|Withdrawal by Subject|0
3002217|NCT00929708|10331128|P2|Overall Study|Withdrawal by Subject|0
3002218|NCT00929708|10331129|P1|Overall Study|Withdrawal by Subject|2
3002219|NCT00929708|10331125|P5|Overall Study|Protocol Violation|1
3002220|NCT00929708|10331126|P4|Overall Study|Protocol Violation|1
3002221|NCT00929708|10331127|P3|Overall Study|Protocol Violation|1
3002222|NCT00929708|10331128|P2|Overall Study|Protocol Violation|1
3002223|NCT00929708|10331129|P1|Overall Study|Protocol Violation|2
3002224|NCT00929695|10331183|P2|Overall Study|incorrect stratification|0
3002225|NCT00929695|10331184|P1|Overall Study|incorrect stratification|2
3002226|NCT00929695|10331183|P2|Overall Study|discharge home|3
3002227|NCT00929695|10331184|P1|Overall Study|discharge home|4
3002228|NCT00929695|10331183|P2|Overall Study|Withdrawal by Subject|2
3002229|NCT00929695|10331184|P1|Overall Study|Withdrawal by Subject|0
3002230|NCT00929695|10331183|P2|Overall Study|Death|1
3002231|NCT00929695|10331184|P1|Overall Study|Death|2
3002232|NCT00929669|10331214|P1|Overall Study|elevated glucose levels|1
3002233|NCT00929656|10331221|P2|Overall Study|Lost to Follow-up|1
3002234|NCT00929656|10331222|P1|Overall Study|Lost to Follow-up|0
3002235|NCT00929643|10331236|P1|Overall Study|Protocol Violation|2
3002236|NCT00929526|10331258|P2|Overall Study|Other|6
3002237|NCT00929526|10331259|P1|Overall Study|Other|8
3002238|NCT00929526|10331258|P2|Overall Study|Lost to Follow-up|12
3002239|NCT00929526|10331259|P1|Overall Study|Lost to Follow-up|8
3002240|NCT00929526|10331258|P2|Overall Study|Withdrawal by Subject|11
3002241|NCT00929526|10331259|P1|Overall Study|Withdrawal by Subject|1
3002242|NCT00929240|10331413|P3|Maintenance Phase|Participant not treated|0
3002243|NCT00929240|10331414|P2|Maintenance Phase|Participant not treated|2
3002244|NCT00929240|10331415|P1|Maintenance Phase|Participant not treated|0
3002245|NCT00929240|10331413|P3|Maintenance Phase|Treatment ongoing at study closure|10
3002246|NCT00929240|10331414|P2|Maintenance Phase|Treatment ongoing at study closure|0
3002247|NCT00929240|10331415|P1|Maintenance Phase|Treatment ongoing at study closure|0
3002248|NCT00929240|10331413|P3|Maintenance Phase|Change of treatment|0
3002249|NCT00929240|10331414|P2|Maintenance Phase|Change of treatment|4
3002250|NCT00929240|10331415|P1|Maintenance Phase|Change of treatment|0
3002251|NCT00929240|10331413|P3|Maintenance Phase|Physician Decision|1
3002252|NCT00929240|10331414|P2|Maintenance Phase|Physician Decision|2
3002253|NCT00929240|10331415|P1|Maintenance Phase|Physician Decision|0
3002254|NCT00929240|10331413|P3|Maintenance Phase|Health authority/Study termination|2
3002255|NCT00929240|10331414|P2|Maintenance Phase|Health authority/Study termination|1
3002256|NCT00929240|10331415|P1|Maintenance Phase|Health authority/Study termination|0
3002257|NCT00929240|10331413|P3|Maintenance Phase|Protocol Violation|0
3002258|NCT00929240|10331414|P2|Maintenance Phase|Protocol Violation|1
3002259|NCT00929240|10331415|P1|Maintenance Phase|Protocol Violation|0
3002260|NCT00929240|10331413|P3|Maintenance Phase|Withdrawal by Subject|6
3002261|NCT00929240|10331414|P2|Maintenance Phase|Withdrawal by Subject|2
3002262|NCT00929240|10331415|P1|Maintenance Phase|Withdrawal by Subject|0
3002263|NCT00929240|10331413|P3|Maintenance Phase|Adverse Event|12
3002264|NCT00929240|10331414|P2|Maintenance Phase|Adverse Event|9
3002265|NCT00929240|10331415|P1|Maintenance Phase|Adverse Event|0
3002266|NCT00929240|10331413|P3|Maintenance Phase|Disease progression|60
3002267|NCT00929240|10331414|P2|Maintenance Phase|Disease progression|73
3002268|NCT00929240|10331415|P1|Maintenance Phase|Disease progression|0
3002269|NCT00929240|10331413|P3|Initial Treatment Phase|Physician Decision|0
3002270|NCT00929240|10331414|P2|Initial Treatment Phase|Physician Decision|0
3002271|NCT00929240|10331415|P1|Initial Treatment Phase|Physician Decision|4
3002272|NCT00929240|10331413|P3|Initial Treatment Phase|Health authority/Study termination|0
3002273|NCT00929240|10331414|P2|Initial Treatment Phase|Health authority/Study termination|0
3002274|NCT00929240|10331415|P1|Initial Treatment Phase|Health authority/Study termination|3
3002275|NCT00929240|10331413|P3|Initial Treatment Phase|Death|0
3002276|NCT00929240|10331414|P2|Initial Treatment Phase|Death|0
3002277|NCT00929240|10331415|P1|Initial Treatment Phase|Death|2
3002278|NCT00929240|10331413|P3|Initial Treatment Phase|Protocol Violation|0
3002279|NCT00929240|10331414|P2|Initial Treatment Phase|Protocol Violation|0
3002280|NCT00929240|10331415|P1|Initial Treatment Phase|Protocol Violation|5
3002281|NCT00929240|10331413|P3|Initial Treatment Phase|Withdrawal by Subject|0
3002282|NCT00929240|10331414|P2|Initial Treatment Phase|Withdrawal by Subject|0
3002283|NCT00929240|10331415|P1|Initial Treatment Phase|Withdrawal by Subject|13
3002284|NCT00929240|10331413|P3|Initial Treatment Phase|Disease progression|0
3002285|NCT00929240|10331414|P2|Initial Treatment Phase|Disease progression|0
3002286|NCT00929240|10331415|P1|Initial Treatment Phase|Disease progression|41
3002287|NCT00929240|10331413|P3|Initial Treatment Phase|Adverse Event|0
3002288|NCT00929240|10331414|P2|Initial Treatment Phase|Adverse Event|0
3002289|NCT00929240|10331415|P1|Initial Treatment Phase|Adverse Event|31
3002290|NCT00929201|10331442|P2|Period 1|Withdrawal by Subject|1
3002291|NCT00929201|10331443|P1|Period 1|Withdrawal by Subject|0
3002292|NCT00929162|10331453|P2|Overall Study|Other termination reason|6
3002293|NCT00929162|10331454|P1|Overall Study|Other termination reason|5
3002294|NCT00929162|10331453|P2|Overall Study|Protocol Violation|30
3002295|NCT00929162|10331454|P1|Overall Study|Protocol Violation|32
3002296|NCT00929162|10331453|P2|Overall Study|Withdrawal by Subject|1
3002297|NCT00929162|10331454|P1|Overall Study|Withdrawal by Subject|3
3002298|NCT00929162|10331453|P2|Overall Study|Adverse Event|5
3002299|NCT00929162|10331454|P1|Overall Study|Adverse Event|8
3002300|NCT00929110|10331467|P3|Overall Study|Patient inability to use the device|0
3002301|NCT00929110|10331468|P2|Overall Study|Patient inability to use the device|1
3002302|NCT00929110|10331469|P1|Overall Study|Patient inability to use the device|0
3002303|NCT00929110|10331467|P3|Overall Study|Abnormal test procedure result(s)|1
3002304|NCT00929110|10331468|P2|Overall Study|Abnormal test procedure result(s)|1
3002305|NCT00929110|10331469|P1|Overall Study|Abnormal test procedure result(s)|0
3002306|NCT00929110|10331467|P3|Overall Study|Abnormal laboratory value(s)|0
3002307|NCT00929110|10331468|P2|Overall Study|Abnormal laboratory value(s)|1
3002308|NCT00929110|10331469|P1|Overall Study|Abnormal laboratory value(s)|0
3002309|NCT00929110|10331467|P3|Overall Study|Death|2
3002310|NCT00929110|10331468|P2|Overall Study|Death|2
3002311|NCT00929110|10331469|P1|Overall Study|Death|2
3002312|NCT00929110|10331467|P3|Overall Study|Administrative problems|2
3002313|NCT00929110|10331468|P2|Overall Study|Administrative problems|1
3002314|NCT00929110|10331469|P1|Overall Study|Administrative problems|4
3002315|NCT00929110|10331467|P3|Overall Study|Protocol deviation|4
3002316|NCT00929110|10331468|P2|Overall Study|Protocol deviation|2
3002317|NCT00929110|10331469|P1|Overall Study|Protocol deviation|5
3002318|NCT00929110|10331467|P3|Overall Study|Lost to Follow-up|3
3002319|NCT00929110|10331468|P2|Overall Study|Lost to Follow-up|7
3002320|NCT00929110|10331469|P1|Overall Study|Lost to Follow-up|7
3002321|NCT00929110|10331467|P3|Overall Study|Unsatisfactory therapeutic effect|6
3002322|NCT00929110|10331468|P2|Overall Study|Unsatisfactory therapeutic effect|9
3002323|NCT00929110|10331469|P1|Overall Study|Unsatisfactory therapeutic effect|20
3002324|NCT00929110|10331467|P3|Overall Study|Subject withdrew consent|26
3002325|NCT00929110|10331468|P2|Overall Study|Subject withdrew consent|23
3002326|NCT00929110|10331469|P1|Overall Study|Subject withdrew consent|40
3002327|NCT00929110|10331467|P3|Overall Study|Adverse Event|18
3002328|NCT00929110|10331468|P2|Overall Study|Adverse Event|29
3002329|NCT00929110|10331469|P1|Overall Study|Adverse Event|40
3002330|NCT00928889|10331552|P2|Overall Study|Other|0
3002331|NCT00928889|10331553|P1|Overall Study|Other|1
3002332|NCT00928889|10331552|P2|Overall Study|Adverse Event|0
3002333|NCT00928889|10331553|P1|Overall Study|Adverse Event|1
3002334|NCT00928889|10331552|P2|Overall Study|Protocol Violation|1
3002335|NCT00928889|10331553|P1|Overall Study|Protocol Violation|0
3002336|NCT00928889|10331552|P2|Overall Study|Lost to Follow-up|1
3002337|NCT00928889|10331553|P1|Overall Study|Lost to Follow-up|3
3002338|NCT00928746|10331599|P1|Overall Study|Other|2
3002339|NCT00928746|10331599|P1|Overall Study|Withdrawal by Subject|1
3002340|NCT00928746|10331599|P1|Overall Study|Protocol Violation|1
3002341|NCT00928746|10331599|P1|Overall Study|Adverse Event|2
3002342|NCT00928707|10331649|P2|Overall Study|Protocol Violation|0
3002343|NCT00928707|10331650|P1|Overall Study|Protocol Violation|1
3002344|NCT00928668|10331671|P5|Overall Study|Other reasons not listed above|0
3002345|NCT00928668|10331672|P4|Overall Study|Other reasons not listed above|1
3002346|NCT00928668|10331673|P3|Overall Study|Other reasons not listed above|0
3002347|NCT00928668|10331674|P2|Overall Study|Other reasons not listed above|0
3002348|NCT00928668|10331675|P1|Overall Study|Other reasons not listed above|0
3002349|NCT00928668|10331671|P5|Overall Study|Withdrawal by Subject|0
3002350|NCT00928668|10331672|P4|Overall Study|Withdrawal by Subject|0
3002351|NCT00928668|10331673|P3|Overall Study|Withdrawal by Subject|1
3002352|NCT00928668|10331674|P2|Overall Study|Withdrawal by Subject|1
3002353|NCT00928668|10331675|P1|Overall Study|Withdrawal by Subject|0
3002354|NCT00928668|10331671|P5|Overall Study|Protocol Violation|1
3002355|NCT00928668|10331672|P4|Overall Study|Protocol Violation|0
3002356|NCT00928668|10331673|P3|Overall Study|Protocol Violation|0
3002357|NCT00928668|10331674|P2|Overall Study|Protocol Violation|0
3002358|NCT00928668|10331675|P1|Overall Study|Protocol Violation|0
3002359|NCT00928668|10331671|P5|Overall Study|Adverse Event|0
3002360|NCT00928668|10331672|P4|Overall Study|Adverse Event|0
3002361|NCT00928668|10331673|P3|Overall Study|Adverse Event|0
3002362|NCT00928668|10331674|P2|Overall Study|Adverse Event|0
3002363|NCT00928668|10331675|P1|Overall Study|Adverse Event|1
3002364|NCT00928512|10331731|P5|Overall Study|Administrative Problems|0
3002365|NCT00928512|10331732|P4|Overall Study|Administrative Problems|0
3002366|NCT00928512|10331733|P3|Overall Study|Administrative Problems|0
3002367|NCT00928512|10331734|P2|Overall Study|Administrative Problems|1
3002368|NCT00928512|10331735|P1|Overall Study|Administrative Problems|0
3002369|NCT00928512|10331731|P5|Overall Study|Lost to Follow-up|3
3002370|NCT00928512|10331732|P4|Overall Study|Lost to Follow-up|1
3002371|NCT00928512|10331733|P3|Overall Study|Lost to Follow-up|2
3002372|NCT00928512|10331734|P2|Overall Study|Lost to Follow-up|1
3002373|NCT00928512|10331735|P1|Overall Study|Lost to Follow-up|1
3002374|NCT00928512|10331731|P5|Overall Study|Withdrawal by Subject|0
3002375|NCT00928512|10331732|P4|Overall Study|Withdrawal by Subject|4
3002376|NCT00928512|10331733|P3|Overall Study|Withdrawal by Subject|3
3002377|NCT00928512|10331734|P2|Overall Study|Withdrawal by Subject|0
3002378|NCT00928512|10331735|P1|Overall Study|Withdrawal by Subject|3
3002379|NCT00928512|10331731|P5|Overall Study|Protocol Violation|3
3002380|NCT00928512|10331732|P4|Overall Study|Protocol Violation|1
3002381|NCT00928512|10331733|P3|Overall Study|Protocol Violation|0
3002382|NCT00928512|10331734|P2|Overall Study|Protocol Violation|1
3002383|NCT00928512|10331735|P1|Overall Study|Protocol Violation|0
3002384|NCT00928512|10331731|P5|Overall Study|Lack of Efficacy|3
3002385|NCT00928512|10331732|P4|Overall Study|Lack of Efficacy|7
3002386|NCT00928512|10331733|P3|Overall Study|Lack of Efficacy|4
3002387|NCT00928512|10331734|P2|Overall Study|Lack of Efficacy|0
3002388|NCT00928512|10331735|P1|Overall Study|Lack of Efficacy|2
3002389|NCT00928512|10331731|P5|Overall Study|Adverse Event|6
3002390|NCT00928512|10331732|P4|Overall Study|Adverse Event|8
3002391|NCT00928512|10331733|P3|Overall Study|Adverse Event|2
3002392|NCT00928512|10331734|P2|Overall Study|Adverse Event|3
3002393|NCT00928512|10331735|P1|Overall Study|Adverse Event|4
3002394|NCT00928486|10331836|P1|Overall Study|Withdrawal by Subject|1
3002395|NCT00928486|10331836|P1|Overall Study|Disease Progression|7
3002396|NCT00928486|10331836|P1|Overall Study|Adverse Event|2
3002397|NCT00928434|10331845|P3|Overall Study|Other (not meeting above criteria)|2
3002398|NCT00928434|10331846|P2|Overall Study|Other (not meeting above criteria)|1
3002399|NCT00928434|10331847|P1|Overall Study|Other (not meeting above criteria)|5
3002400|NCT00928434|10331845|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
3002401|NCT00928434|10331846|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
3002402|NCT00928434|10331847|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
3002403|NCT00928434|10331845|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
3002404|NCT00928434|10331846|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
3002405|NCT00928434|10331847|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
3002406|NCT00928434|10331845|P3|Overall Study|Withdrawal by Subject|2
3002407|NCT00928434|10331846|P2|Overall Study|Withdrawal by Subject|3
3002408|NCT00928434|10331847|P1|Overall Study|Withdrawal by Subject|5
3002409|NCT00928434|10331845|P3|Overall Study|Lost to Follow-up|3
3002410|NCT00928434|10331846|P2|Overall Study|Lost to Follow-up|0
3002411|NCT00928434|10331847|P1|Overall Study|Lost to Follow-up|1
3002412|NCT00928434|10331845|P3|Overall Study|Physician Decision|3
3002413|NCT00928434|10331846|P2|Overall Study|Physician Decision|0
3002414|NCT00928434|10331847|P1|Overall Study|Physician Decision|2
3002415|NCT00928434|10331845|P3|Overall Study|Protocol Violation|8
3002416|NCT00928434|10331846|P2|Overall Study|Protocol Violation|0
3002417|NCT00928434|10331847|P1|Overall Study|Protocol Violation|5
3002418|NCT00928434|10331845|P3|Overall Study|Adverse Event|18
3002419|NCT00928434|10331846|P2|Overall Study|Adverse Event|5
3002420|NCT00928434|10331847|P1|Overall Study|Adverse Event|14
3002421|NCT00928408|10331923|P1|Overall Study|Lost to Follow-up|12
3002422|NCT00928408|10331923|P1|Overall Study|Death|5
3002423|NCT00928408|10331923|P1|Overall Study|Withdrawal by Subject|4
3002424|NCT00928408|10331923|P1|Overall Study|Other|2
3002425|NCT00928252|10331969|P1|Overall Study|Physician Decision|3
3002426|NCT00928187|10332029|P3|Overall Study|Protocol Violation|0
3002427|NCT00928187|10332030|P2|Overall Study|Protocol Violation|1
3002428|NCT00928187|10332031|P1|Overall Study|Protocol Violation|0
3002429|NCT00928187|10332029|P3|Overall Study|Withdrawal by Subject|1
3002430|NCT00928187|10332030|P2|Overall Study|Withdrawal by Subject|1
3002431|NCT00928187|10332031|P1|Overall Study|Withdrawal by Subject|0
3002432|NCT00928187|10332029|P3|Overall Study|Lost to Follow-up|1
3002433|NCT00928187|10332030|P2|Overall Study|Lost to Follow-up|2
3002434|NCT00928187|10332031|P1|Overall Study|Lost to Follow-up|1
3002435|NCT00928187|10332029|P3|Overall Study|Death|3
3002436|NCT00928187|10332030|P2|Overall Study|Death|2
3002437|NCT00928187|10332031|P1|Overall Study|Death|1
3002438|NCT00928070|10332201|P2|Overall Study|Other|5
3002439|NCT00928070|10332202|P1|Overall Study|Other|5
3002440|NCT00928070|10332201|P2|Overall Study|Randomized but not treated|2
3002441|NCT00928070|10332202|P1|Overall Study|Randomized but not treated|2
3002442|NCT00928070|10332201|P2|Overall Study|Protocol Violation|5
3002443|NCT00928070|10332202|P1|Overall Study|Protocol Violation|6
3002444|NCT00928070|10332201|P2|Overall Study|Did not meet entrance criteria|9
3002445|NCT00928070|10332202|P1|Overall Study|Did not meet entrance criteria|16
3002446|NCT00928070|10332201|P2|Overall Study|Lack of Efficacy|5
3002447|NCT00928070|10332202|P1|Overall Study|Lack of Efficacy|9
3002448|NCT00928070|10332201|P2|Overall Study|Adverse Event|26
3002449|NCT00928070|10332202|P1|Overall Study|Adverse Event|14
3002450|NCT00928070|10332201|P2|Overall Study|Withdrawal by Subject|3
3002451|NCT00928070|10332202|P1|Overall Study|Withdrawal by Subject|10
3002452|NCT00928070|10332201|P2|Overall Study|Lost to Follow-up|2
3002453|NCT00928070|10332202|P1|Overall Study|Lost to Follow-up|1
3002454|NCT00928057|10332260|P2|Overall Study|Protocol Violation|1
3002455|NCT00928057|10332261|P1|Overall Study|Protocol Violation|0
3002456|NCT00928057|10332260|P2|Overall Study|Lost to Follow-up|1
3002457|NCT00928057|10332261|P1|Overall Study|Lost to Follow-up|0
3002458|NCT00928057|10332260|P2|Overall Study|Withdrawal by Subject|0
3002459|NCT00928057|10332261|P1|Overall Study|Withdrawal by Subject|1
3002460|NCT00928057|10332260|P2|Overall Study|Adverse Event|2
3002461|NCT00928057|10332261|P1|Overall Study|Adverse Event|1
3002462|NCT00928018|10332286|P2|Overall Study|Withdrawal by Subject|0
3002463|NCT00928018|10332287|P1|Overall Study|Withdrawal by Subject|1
3002464|NCT00927953|10332317|P2|Overall Study|Death|1
3002465|NCT00927953|10332318|P1|Overall Study|Death|2
3002466|NCT00927940|10332332|P1|Overall Study|Death|1
3002467|NCT00927927|10332352|P15|Overall Study|Withdrawal by Subject|0
3002468|NCT00927927|10332353|P14|Overall Study|Withdrawal by Subject|0
3002469|NCT00927927|10332354|P13|Overall Study|Withdrawal by Subject|0
3002470|NCT00927927|10332355|P12|Overall Study|Withdrawal by Subject|2
3002471|NCT00927927|10332356|P11|Overall Study|Withdrawal by Subject|0
3002472|NCT00927927|10332357|P10|Overall Study|Withdrawal by Subject|0
3002473|NCT00927927|10332358|P9|Overall Study|Withdrawal by Subject|0
3002474|NCT00927927|10332359|P8|Overall Study|Withdrawal by Subject|2
3002475|NCT00927927|10332360|P7|Overall Study|Withdrawal by Subject|0
3002476|NCT00927927|10332361|P6|Overall Study|Withdrawal by Subject|0
3002477|NCT00927927|10332362|P5|Overall Study|Withdrawal by Subject|0
3002478|NCT00927927|10332363|P4|Overall Study|Withdrawal by Subject|0
3002479|NCT00927927|10332364|P3|Overall Study|Withdrawal by Subject|0
3002480|NCT00927927|10332365|P2|Overall Study|Withdrawal by Subject|0
3002481|NCT00927927|10332366|P1|Overall Study|Withdrawal by Subject|0
3002482|NCT00927901|10332413|P4|Treatment Period 4|Subject withdrew consent|0
3002483|NCT00927901|10332414|P3|Treatment Period 4|Subject withdrew consent|1
3002484|NCT00927901|10332415|P2|Treatment Period 4|Subject withdrew consent|0
3002485|NCT00927901|10332416|P1|Treatment Period 4|Subject withdrew consent|0
3002486|NCT00927901|10332413|P4|Treatment Period 4|Adverse Event|1
3002487|NCT00927901|10332414|P3|Treatment Period 4|Adverse Event|0
3002488|NCT00927901|10332415|P2|Treatment Period 4|Adverse Event|0
3002489|NCT00927901|10332416|P1|Treatment Period 4|Adverse Event|0
3002490|NCT00927901|10332413|P4|Treatment Period 1|Subject withdrew consent|0
3002491|NCT00927901|10332414|P3|Treatment Period 1|Subject withdrew consent|1
3002492|NCT00927901|10332415|P2|Treatment Period 1|Subject withdrew consent|0
3002493|NCT00927901|10332416|P1|Treatment Period 1|Subject withdrew consent|0
3002494|NCT00927862|10332457|P2|Overall Study|Missing data needed for endpt analyses|45
3002495|NCT00927862|10332458|P1|Overall Study|Missing data needed for endpt analyses|27
3002496|NCT00927823|10332493|P4|Continuous Dosing Period|Other|3
3002497|NCT00927823|10332494|P3|Continuous Dosing Period|Other|9
3002498|NCT00927823|10332495|P2|Continuous Dosing Period|Other|2
3002499|NCT00927823|10332496|P1|Continuous Dosing Period|Other|1
3002500|NCT00927823|10332493|P4|Continuous Dosing Period|Withdrawal by Subject|2
3002501|NCT00927823|10332494|P3|Continuous Dosing Period|Withdrawal by Subject|2
3002502|NCT00927823|10332495|P2|Continuous Dosing Period|Withdrawal by Subject|0
3002503|NCT00927823|10332496|P1|Continuous Dosing Period|Withdrawal by Subject|1
3002504|NCT00927823|10332493|P4|Continuous Dosing Period|Lost to Follow-up|0
3002505|NCT00927823|10332494|P3|Continuous Dosing Period|Lost to Follow-up|9
3002506|NCT00927823|10332495|P2|Continuous Dosing Period|Lost to Follow-up|1
3002507|NCT00927823|10332496|P1|Continuous Dosing Period|Lost to Follow-up|1
3002508|NCT00927823|10332493|P4|Continuous Dosing Period|Death|0
3002509|NCT00927823|10332494|P3|Continuous Dosing Period|Death|6
3002510|NCT00927823|10332495|P2|Continuous Dosing Period|Death|0
3002511|NCT00927823|10332496|P1|Continuous Dosing Period|Death|0
3002512|NCT00927784|10332562|P2|Overall Study|Withdrawal by Subject|0
3002513|NCT00927784|10332563|P1|Overall Study|Withdrawal by Subject|1
3002514|NCT00927784|10332562|P2|Overall Study|Death|0
3002515|NCT00927784|10332563|P1|Overall Study|Death|1
3002516|NCT00927758|10332593|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
3002517|NCT00927758|10332594|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
3002518|NCT00927758|10332595|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
3002519|NCT00927758|10332596|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
3002520|NCT00927758|10332597|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
3002521|NCT00927758|10332598|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
3002522|NCT00927758|10332593|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
3002523|NCT00927758|10332594|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
3002524|NCT00927758|10332595|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
3002525|NCT00927758|10332596|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
3002526|NCT00927758|10332597|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
3002527|NCT00927758|10332598|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
3002528|NCT00927589|10332606|P1|Overall Study|Non-compliance|1
3002529|NCT00927589|10332606|P1|Overall Study|Disease Progression|8
3002530|NCT00927589|10332606|P1|Overall Study|Adverse Event|2
3002531|NCT00927589|10332606|P1|Overall Study|Withdrawal by Subject|3
3002532|NCT00927589|10332606|P1|Overall Study|Physician Decision|1
3002533|NCT00927589|10332606|P1|Overall Study|Death|1
3002534|NCT00927563|10332636|P1|Overall Study|Withdrawal by Subject|1
3002535|NCT00927563|10332636|P1|Overall Study|Lost to Follow-up|1
3002536|NCT00927472|10332644|P2|Overall Study|Post treatment Assessment out of window|4
3002537|NCT00927472|10332645|P1|Overall Study|Post treatment Assessment out of window|0
3002538|NCT00927472|10332644|P2|Overall Study|Protocol Violation|1
3002539|NCT00927472|10332645|P1|Overall Study|Protocol Violation|0
3002540|NCT00927472|10332644|P2|Overall Study|Lost to Follow-up|6
3002541|NCT00927472|10332645|P1|Overall Study|Lost to Follow-up|1
3002542|NCT00927472|10332644|P2|Overall Study|Withdrawal by Subject|11
3002543|NCT00927472|10332645|P1|Overall Study|Withdrawal by Subject|10
3002544|NCT00927394|10332671|P2|Overall Study|Randomized in error|1
3002545|NCT00927394|10332672|P1|Overall Study|Randomized in error|0
3002546|NCT00927394|10332671|P2|Overall Study|Protocol deviation|13
3002547|NCT00927394|10332672|P1|Overall Study|Protocol deviation|16
3002548|NCT00927394|10332671|P2|Overall Study|Death|1
3002549|NCT00927394|10332672|P1|Overall Study|Death|1
3002550|NCT00927394|10332671|P2|Overall Study|Administrative Problem|0
3002551|NCT00927394|10332672|P1|Overall Study|Administrative Problem|1
3002552|NCT00927394|10332671|P2|Overall Study|Lost to Follow-up|14
3002553|NCT00927394|10332672|P1|Overall Study|Lost to Follow-up|8
3002554|NCT00927394|10332671|P2|Overall Study|Withdrawal by Subject|24
3002555|NCT00927394|10332672|P1|Overall Study|Withdrawal by Subject|20
3002556|NCT00927394|10332671|P2|Overall Study|Unsatisfactory therapeutic effect|23
3002557|NCT00927394|10332672|P1|Overall Study|Unsatisfactory therapeutic effect|17
3002558|NCT00927394|10332671|P2|Overall Study|Adverse Event|9
3002559|NCT00927394|10332672|P1|Overall Study|Adverse Event|14
3002560|NCT00927368|10332703|P3|Overall Study|cancellation of surgery|2
3002561|NCT00927368|10332704|P2|Overall Study|cancellation of surgery|1
3002562|NCT00927368|10332705|P1|Overall Study|cancellation of surgery|0
3002563|NCT00927368|10332703|P3|Overall Study|ineligible post randomization|1
3002564|NCT00927368|10332704|P2|Overall Study|ineligible post randomization|3
3002565|NCT00927368|10332705|P1|Overall Study|ineligible post randomization|0
3002566|NCT00927368|10332703|P3|Overall Study|equipment failure|0
3002567|NCT00927368|10332704|P2|Overall Study|equipment failure|0
3002568|NCT00927368|10332705|P1|Overall Study|equipment failure|1
3002569|NCT00927368|10332703|P3|Overall Study|Lost to Follow-up|0
3002570|NCT00927368|10332704|P2|Overall Study|Lost to Follow-up|0
3002571|NCT00927368|10332705|P1|Overall Study|Lost to Follow-up|4
3002572|NCT00927368|10332703|P3|Overall Study|enrollment in another study|2
3002573|NCT00927368|10332704|P2|Overall Study|enrollment in another study|1
3002574|NCT00927368|10332705|P1|Overall Study|enrollment in another study|1
3002575|NCT00927355|10332724|P2|Overall Study|Adverse Event|1
3002576|NCT00927355|10332725|P1|Overall Study|Adverse Event|1
3002577|NCT00927251|10332760|P1|Overall Study|Patients not implanted with 4296 lead|8
3002578|NCT00927186|10332766|P2|12 Months Primary Study|Withdrawal by Subject|1
3002579|NCT00927186|10332767|P1|12 Months Primary Study|Withdrawal by Subject|1
3002580|NCT00927186|10332766|P2|12 Months Primary Study|Protocol Violation|1
3002581|NCT00927186|10332767|P1|12 Months Primary Study|Protocol Violation|0
3002582|NCT00927186|10332766|P2|12 Months Primary Study|Lost to Follow-up|0
3002583|NCT00927186|10332767|P1|12 Months Primary Study|Lost to Follow-up|1
3002584|NCT00927186|10332766|P2|12 Months Primary Study|Adverse Event|2
3002585|NCT00927186|10332767|P1|12 Months Primary Study|Adverse Event|5
3002586|NCT00927095|10332897|P3|Overall Study|Physician Decision|1
3002587|NCT00927095|10332898|P2|Overall Study|Physician Decision|2
3002588|NCT00927095|10332899|P1|Overall Study|Physician Decision|1
3002589|NCT00927095|10332897|P3|Overall Study|Withdrawal by Subject|1
3002590|NCT00927095|10332898|P2|Overall Study|Withdrawal by Subject|1
3002591|NCT00927095|10332899|P1|Overall Study|Withdrawal by Subject|2
3002592|NCT00927095|10332897|P3|Overall Study|Adverse Event|0
3002593|NCT00927095|10332898|P2|Overall Study|Adverse Event|1
3002594|NCT00927095|10332899|P1|Overall Study|Adverse Event|3
3002595|NCT00927082|10332911|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
3002596|NCT00927082|10332912|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
3002597|NCT00927082|10332913|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
3002598|NCT00927082|10332914|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
3002599|NCT00927082|10332911|P4|Overall Study|Death|0
3002600|NCT00927082|10332912|P3|Overall Study|Death|1
3002601|NCT00927082|10332913|P2|Overall Study|Death|0
3002602|NCT00927082|10332914|P1|Overall Study|Death|0
3002603|NCT00927082|10332911|P4|Overall Study|Withdrawal by Subject|2
3002604|NCT00927082|10332912|P3|Overall Study|Withdrawal by Subject|7
3002605|NCT00927082|10332913|P2|Overall Study|Withdrawal by Subject|2
3002606|NCT00927082|10332914|P1|Overall Study|Withdrawal by Subject|3
3002607|NCT00927082|10332911|P4|Overall Study|Lost to Follow-up|16
3002608|NCT00927082|10332912|P3|Overall Study|Lost to Follow-up|12
3002609|NCT00927082|10332913|P2|Overall Study|Lost to Follow-up|8
3002610|NCT00927082|10332914|P1|Overall Study|Lost to Follow-up|9
3002611|NCT00927069|10332978|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
3002612|NCT00927069|10332979|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
3002613|NCT00927069|10332980|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
3002614|NCT00927069|10332981|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
3002615|NCT00927069|10332978|P4|Week 12 to Week 24|Withdrawal by Subject|0
3002616|NCT00927069|10332979|P3|Week 12 to Week 24|Withdrawal by Subject|0
3002617|NCT00927069|10332980|P2|Week 12 to Week 24|Withdrawal by Subject|0
3002618|NCT00927069|10332981|P1|Week 12 to Week 24|Withdrawal by Subject|1
3002619|NCT00927069|10332978|P4|Week 12 to Week 24|Lost to Follow-up|0
3002620|NCT00927069|10332979|P3|Week 12 to Week 24|Lost to Follow-up|1
3002621|NCT00927069|10332980|P2|Week 12 to Week 24|Lost to Follow-up|0
3002622|NCT00927069|10332981|P1|Week 12 to Week 24|Lost to Follow-up|0
3002623|NCT00927069|10332978|P4|Week 12 to Week 24|Lack of Efficacy|3
3002624|NCT00927069|10332979|P3|Week 12 to Week 24|Lack of Efficacy|2
3002625|NCT00927069|10332980|P2|Week 12 to Week 24|Lack of Efficacy|0
3002626|NCT00927069|10332981|P1|Week 12 to Week 24|Lack of Efficacy|0
3002627|NCT00927069|10332978|P4|Week 0 to Week 12|Worsening of psoriasis|0
3002628|NCT00927069|10332979|P3|Week 0 to Week 12|Worsening of psoriasis|0
3002629|NCT00927069|10332980|P2|Week 0 to Week 12|Worsening of psoriasis|1
3002630|NCT00927069|10332981|P1|Week 0 to Week 12|Worsening of psoriasis|1
3002631|NCT00926796|10333037|P2|Overall Study|Withdrawal by Subject|0
3002632|NCT00926796|10333038|P1|Overall Study|Withdrawal by Subject|1
3002633|NCT00926796|10333037|P2|Overall Study|Protocol Violation|11
3002634|NCT00926796|10333038|P1|Overall Study|Protocol Violation|15
3002635|NCT00926796|10333037|P2|Overall Study|Lost to Follow-up|13
3002636|NCT00926796|10333038|P1|Overall Study|Lost to Follow-up|22
3002637|NCT00926796|10333037|P2|Overall Study|Adverse Event|14
3002638|NCT00926796|10333038|P1|Overall Study|Adverse Event|7
3002639|NCT00926796|10333037|P2|Overall Study|Ineligible, but positive for gonorrhea|1
3002640|NCT00926796|10333038|P1|Overall Study|Ineligible, but positive for gonorrhea|1
3002641|NCT00926796|10333037|P2|Overall Study|Ineligible, negative for gonorrhea|60
3002642|NCT00926796|10333038|P1|Overall Study|Ineligible, negative for gonorrhea|57
3002643|NCT00926796|10333037|P2|Overall Study|Did not receive randomized treatment|7
3002644|NCT00926796|10333038|P1|Overall Study|Did not receive randomized treatment|4
3002645|NCT00926783|10333059|P2|Overall Study|Incomplete CFAE Procedures|3
3002646|NCT00926783|10333060|P1|Overall Study|Incomplete CFAE Procedures|3
3002647|NCT00926575|10333087|P2|Overall Study|Withdrawal by Subject|9
3002648|NCT00926575|10333088|P1|Overall Study|Withdrawal by Subject|8
3002649|NCT00926575|10333087|P2|Overall Study|Protocol Violation|0
3002650|NCT00926575|10333088|P1|Overall Study|Protocol Violation|1
3002651|NCT00926575|10333087|P2|Overall Study|Physician Decision|2
3002652|NCT00926575|10333088|P1|Overall Study|Physician Decision|1
3002653|NCT00926575|10333087|P2|Overall Study|Lost to Follow-up|1
3002654|NCT00926575|10333088|P1|Overall Study|Lost to Follow-up|1
3002655|NCT00926575|10333087|P2|Overall Study|Death|4
3002656|NCT00926575|10333088|P1|Overall Study|Death|4
3002657|NCT00926575|10333087|P2|Overall Study|Adverse Event|1
3002658|NCT00926575|10333088|P1|Overall Study|Adverse Event|1
3002659|NCT00926536|10333100|P2|Overall Study|Physician Decision|2
3002660|NCT00926536|10333101|P1|Overall Study|Physician Decision|1
3002661|NCT00926393|10333122|P2|Overall Study|Adverse Event|1
3002662|NCT00926393|10333123|P1|Overall Study|Adverse Event|1
3002663|NCT00926393|10333122|P2|Overall Study|Withdrawal by Subject|2
3002664|NCT00926393|10333123|P1|Overall Study|Withdrawal by Subject|1
3002665|NCT00926367|10333168|P2|Overall Study|Skin Irritation|2
3002666|NCT00926367|10333169|P1|Overall Study|Skin Irritation|1
3002667|NCT00926367|10333168|P2|Overall Study|Lost to Follow-up|0
3002668|NCT00926367|10333169|P1|Overall Study|Lost to Follow-up|1
3002669|NCT00926367|10333168|P2|Overall Study|Withdrawal by Subject|1
3002670|NCT00926367|10333169|P1|Overall Study|Withdrawal by Subject|0
3002671|NCT00926328|10333211|P2|Overall Study|Lost to Follow-up|14
3002672|NCT00926328|10333212|P1|Overall Study|Lost to Follow-up|12
3002673|NCT00926289|10333222|P2|Overall Study|Other|3
3002674|NCT00926289|10333223|P1|Overall Study|Other|1
3002675|NCT00926289|10333222|P2|Overall Study|Withdrawal by Subject|4
3002676|NCT00926289|10333223|P1|Overall Study|Withdrawal by Subject|4
3002677|NCT00926289|10333222|P2|Overall Study|Lost to Follow-up|6
3002678|NCT00926289|10333223|P1|Overall Study|Lost to Follow-up|3
3002679|NCT00926289|10333222|P2|Overall Study|Protocol Violation|12
3002680|NCT00926289|10333223|P1|Overall Study|Protocol Violation|8
3002681|NCT00926289|10333222|P2|Overall Study|Adverse Event|11
3002682|NCT00926289|10333223|P1|Overall Study|Adverse Event|9
3002683|NCT00926211|10333291|P1|Overall Study|Lost to Follow-up|1
3002684|NCT00926029|10333322|P3|Overall Study|Lost to Follow-up|1
3002685|NCT00926029|10333323|P2|Overall Study|Lost to Follow-up|1
3002686|NCT00926029|10333324|P1|Overall Study|Lost to Follow-up|2
3002687|NCT00926003|10333338|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
3002688|NCT00926003|10333339|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
3002689|NCT00926003|10333340|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
3002690|NCT00926003|10333338|P3|Post-Training Evaluation|Withdrawal by Subject|0
3002691|NCT00926003|10333339|P2|Post-Training Evaluation|Withdrawal by Subject|0
3002692|NCT00926003|10333340|P1|Post-Training Evaluation|Withdrawal by Subject|1
3002693|NCT00925990|10333353|P2|Overall Study|moved out of state, missed medication|2
3002694|NCT00925990|10333354|P1|Overall Study|moved out of state, missed medication|0
3002695|NCT00925990|10333353|P2|Overall Study|Physician Decision|1
3002696|NCT00925990|10333354|P1|Overall Study|Physician Decision|1
3002697|NCT00925990|10333353|P2|Overall Study|Lost to Follow-up|3
3002698|NCT00925990|10333354|P1|Overall Study|Lost to Follow-up|1
3002699|NCT00925990|10333353|P2|Overall Study|Withdrawal by Subject|2
3002700|NCT00925990|10333354|P1|Overall Study|Withdrawal by Subject|2
3002701|NCT00925990|10333353|P2|Overall Study|Adverse Event|3
3002702|NCT00925990|10333354|P1|Overall Study|Adverse Event|1
3002703|NCT00925899|10333389|P2|Part 1|Withdrawal by Subject|9
3002704|NCT00925899|10333390|P1|Part 1|Withdrawal by Subject|10
3002705|NCT00925899|10333389|P2|Part 1|Death|2
3002706|NCT00925899|10333390|P1|Part 1|Death|1
3002707|NCT00925769|10333418|P6|Overall Study|Adverse Event|0
3002708|NCT00925769|10333419|P5|Overall Study|Adverse Event|1
3002709|NCT00925769|10333420|P4|Overall Study|Adverse Event|0
3002710|NCT00925769|10333421|P3|Overall Study|Adverse Event|0
3002711|NCT00925769|10333422|P2|Overall Study|Adverse Event|0
3002712|NCT00925769|10333423|P1|Overall Study|Adverse Event|0
3002713|NCT00925769|10333418|P6|Overall Study|Participant is unable to swallow drug|0
3002714|NCT00925769|10333419|P5|Overall Study|Participant is unable to swallow drug|0
3002715|NCT00925769|10333420|P4|Overall Study|Participant is unable to swallow drug|1
3002716|NCT00925769|10333421|P3|Overall Study|Participant is unable to swallow drug|0
3002717|NCT00925769|10333422|P2|Overall Study|Participant is unable to swallow drug|0
3002718|NCT00925769|10333423|P1|Overall Study|Participant is unable to swallow drug|0
3002719|NCT00925769|10333418|P6|Overall Study|End of study visit not done|0
3002720|NCT00925769|10333419|P5|Overall Study|End of study visit not done|0
3002721|NCT00925769|10333420|P4|Overall Study|End of study visit not done|0
3002722|NCT00925769|10333421|P3|Overall Study|End of study visit not done|1
3002723|NCT00925769|10333422|P2|Overall Study|End of study visit not done|0
3002724|NCT00925769|10333423|P1|Overall Study|End of study visit not done|0
3002725|NCT00925769|10333418|P6|Overall Study|Missing documentation|0
3002726|NCT00925769|10333419|P5|Overall Study|Missing documentation|0
3002727|NCT00925769|10333420|P4|Overall Study|Missing documentation|0
3002728|NCT00925769|10333421|P3|Overall Study|Missing documentation|0
3002729|NCT00925769|10333422|P2|Overall Study|Missing documentation|1
3002730|NCT00925769|10333423|P1|Overall Study|Missing documentation|0
3002731|NCT00925769|10333418|P6|Overall Study|Physician Decision|0
3002732|NCT00925769|10333419|P5|Overall Study|Physician Decision|0
3002733|NCT00925769|10333420|P4|Overall Study|Physician Decision|0
3002734|NCT00925769|10333421|P3|Overall Study|Physician Decision|0
3002735|NCT00925769|10333422|P2|Overall Study|Physician Decision|0
3002736|NCT00925769|10333423|P1|Overall Study|Physician Decision|1
3002737|NCT00925769|10333418|P6|Overall Study|Death|0
3002738|NCT00925769|10333419|P5|Overall Study|Death|0
3002739|NCT00925769|10333420|P4|Overall Study|Death|0
3002740|NCT00925769|10333421|P3|Overall Study|Death|1
3002741|NCT00925769|10333422|P2|Overall Study|Death|0
3002742|NCT00925769|10333423|P1|Overall Study|Death|0
3002743|NCT00925769|10333418|P6|Overall Study|Disease progression|3
3002744|NCT00925769|10333419|P5|Overall Study|Disease progression|2
3002745|NCT00925769|10333420|P4|Overall Study|Disease progression|4
3002746|NCT00925769|10333421|P3|Overall Study|Disease progression|3
3002747|NCT00925769|10333422|P2|Overall Study|Disease progression|5
3002748|NCT00925769|10333423|P1|Overall Study|Disease progression|4
3002749|NCT00925769|10333418|P6|Overall Study|Major toxicity|0
3002750|NCT00925769|10333419|P5|Overall Study|Major toxicity|0
3002751|NCT00925769|10333420|P4|Overall Study|Major toxicity|1
3002752|NCT00925769|10333421|P3|Overall Study|Major toxicity|1
3002753|NCT00925769|10333422|P2|Overall Study|Major toxicity|0
3002754|NCT00925769|10333423|P1|Overall Study|Major toxicity|1
3002755|NCT00925704|10333491|P6|Third Intervention|Withdrew consent|1
3002756|NCT00925704|10333492|P5|Third Intervention|Withdrew consent|0
3002757|NCT00925704|10333493|P4|Third Intervention|Withdrew consent|0
3002758|NCT00925704|10333494|P3|Third Intervention|Withdrew consent|0
3002759|NCT00925704|10333495|P2|Third Intervention|Withdrew consent|0
3002760|NCT00925704|10333496|P1|Third Intervention|Withdrew consent|0
3002761|NCT00925704|10333491|P6|Second Intervention|Withdrawal by Subject|0
3002762|NCT00925704|10333492|P5|Second Intervention|Withdrawal by Subject|1
3002763|NCT00925704|10333493|P4|Second Intervention|Withdrawal by Subject|0
3002764|NCT00925704|10333494|P3|Second Intervention|Withdrawal by Subject|0
3002765|NCT00925704|10333495|P2|Second Intervention|Withdrawal by Subject|0
3002766|NCT00925704|10333496|P1|Second Intervention|Withdrawal by Subject|1
3002767|NCT00925704|10333491|P6|First Intervention|Withdrew consent|0
3002768|NCT00925704|10333492|P5|First Intervention|Withdrew consent|1
3002769|NCT00925704|10333493|P4|First Intervention|Withdrew consent|1
3002770|NCT00925704|10333494|P3|First Intervention|Withdrew consent|0
3002771|NCT00925704|10333495|P2|First Intervention|Withdrew consent|0
3002772|NCT00925704|10333496|P1|First Intervention|Withdrew consent|0
3002773|NCT00925600|10333509|P2|Overall Study|Adverse Event|2
3002774|NCT00925600|10333510|P1|Overall Study|Adverse Event|1
3002775|NCT00925600|10333509|P2|Overall Study|Other|1
3002776|NCT00925600|10333510|P1|Overall Study|Other|3
3002777|NCT00925600|10333509|P2|Overall Study|Requirement for Alternative Therapy|1
3002778|NCT00925600|10333510|P1|Overall Study|Requirement for Alternative Therapy|0
3002779|NCT00925600|10333509|P2|Overall Study|Protocol Deviation|1
3002780|NCT00925600|10333510|P1|Overall Study|Protocol Deviation|0
3002781|NCT00925600|10333509|P2|Overall Study|Ineligibility Determined|0
3002782|NCT00925600|10333510|P1|Overall Study|Ineligibility Determined|2
3002783|NCT00925600|10333509|P2|Overall Study|Noncompliance|0
3002784|NCT00925600|10333510|P1|Overall Study|Noncompliance|2
3002785|NCT00925600|10333509|P2|Overall Study|Administrative Decision|1
3002786|NCT00925600|10333510|P1|Overall Study|Administrative Decision|1
3002787|NCT00925600|10333509|P2|Overall Study|Disease Progression|3
3002788|NCT00925600|10333510|P1|Overall Study|Disease Progression|1
3002789|NCT00925600|10333509|P2|Overall Study|Lost to Follow-up|2
3002790|NCT00925600|10333510|P1|Overall Study|Lost to Follow-up|2
3002791|NCT00925600|10333509|P2|Overall Study|Death|3
3002792|NCT00925600|10333510|P1|Overall Study|Death|4
3002793|NCT00925600|10333509|P2|Overall Study|Withdrawal by Subject|14
3002794|NCT00925600|10333510|P1|Overall Study|Withdrawal by Subject|16
3002795|NCT00925587|10333532|P2|Overall Study|Lost to Follow-up|1
3002796|NCT00925587|10333533|P1|Overall Study|Lost to Follow-up|0
3002797|NCT00925587|10333532|P2|Overall Study|Adverse Event|2
3002798|NCT00925587|10333533|P1|Overall Study|Adverse Event|6
3002799|NCT00925587|10333532|P2|Overall Study|Death|5
3002800|NCT00925587|10333533|P1|Overall Study|Death|5
3002801|NCT00925587|10333532|P2|Overall Study|Withdrawal by Subject|6
3002802|NCT00925587|10333533|P1|Overall Study|Withdrawal by Subject|9
3002803|NCT00925587|10333532|P2|Overall Study|Protocol Violation|4
3002804|NCT00925587|10333533|P1|Overall Study|Protocol Violation|6
3002805|NCT00925587|10333532|P2|Overall Study|Physician Decision|1
3002806|NCT00925587|10333533|P1|Overall Study|Physician Decision|4
3002807|NCT00925587|10333532|P2|Overall Study|Protocol Specified Criteria|6
3002808|NCT00925587|10333533|P1|Overall Study|Protocol Specified Criteria|6
3002809|NCT00925548|10333647|P2|Overall Study|Discontinuation of trial by sponsor|5
3002810|NCT00925548|10333648|P1|Overall Study|Discontinuation of trial by sponsor|10
3002811|NCT00925522|10333674|P1|Overall Study|study closed -- business decision|20
3002812|NCT00925353|10333678|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
3002813|NCT00925301|10333684|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
3002814|NCT00925301|10333685|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
3002815|NCT00925301|10333686|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
3002816|NCT00925301|10333687|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
3002817|NCT00925301|10333684|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
3002818|NCT00925301|10333685|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
3002819|NCT00925301|10333686|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
3002820|NCT00925301|10333687|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
3002821|NCT00925301|10333684|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
3002822|NCT00925301|10333685|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
3002823|NCT00925301|10333686|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
3002824|NCT00925301|10333687|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
3002825|NCT00925301|10333684|P4|6-Month Open-label (Stage 2)|Adverse Event|0
3002826|NCT00925301|10333685|P3|6-Month Open-label (Stage 2)|Adverse Event|2
3002827|NCT00925301|10333686|P2|6-Month Open-label (Stage 2)|Adverse Event|0
3002828|NCT00925301|10333687|P1|6-Month Open-label (Stage 2)|Adverse Event|0
3002829|NCT00925301|10333684|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
3002830|NCT00925301|10333685|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
3002831|NCT00925301|10333686|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
3002832|NCT00925301|10333687|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
3002833|NCT00925301|10333684|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
3002834|NCT00925301|10333685|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
3002835|NCT00925301|10333686|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
3002836|NCT00925301|10333687|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
3002837|NCT00925301|10333684|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
3002838|NCT00925301|10333685|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
3002839|NCT00925301|10333686|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
3002840|NCT00925301|10333687|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
3002841|NCT00925288|10333703|P2|Overall Study|Lost to Follow-up|7
3002842|NCT00925288|10333704|P1|Overall Study|Lost to Follow-up|9
3002843|NCT00925132|10333716|P5|Overall Study|Removed due to disease progression|4
3002844|NCT00925132|10333717|P4|Overall Study|Removed due to disease progression|0
3002845|NCT00925132|10333718|P3|Overall Study|Removed due to disease progression|0
3002846|NCT00925132|10333719|P2|Overall Study|Removed due to disease progression|0
3002847|NCT00925132|10333720|P1|Overall Study|Removed due to disease progression|0
3002848|NCT00925132|10333716|P5|Overall Study|Withdrawal by Subject|1
3002849|NCT00925132|10333717|P4|Overall Study|Withdrawal by Subject|0
3002850|NCT00925132|10333718|P3|Overall Study|Withdrawal by Subject|0
3002851|NCT00925132|10333719|P2|Overall Study|Withdrawal by Subject|0
3002852|NCT00925132|10333720|P1|Overall Study|Withdrawal by Subject|2
3002853|NCT00925015|10333815|P3|Overall Study|Withdrawal by Subject|1
3002854|NCT00925015|10333816|P2|Overall Study|Withdrawal by Subject|0
3002855|NCT00925015|10333817|P1|Overall Study|Withdrawal by Subject|0
3002856|NCT00925015|10333815|P3|Overall Study|Progressive Disease|4
3002857|NCT00925015|10333816|P2|Overall Study|Progressive Disease|3
3002858|NCT00925015|10333817|P1|Overall Study|Progressive Disease|7
3002859|NCT00925015|10333815|P3|Overall Study|Physician Decision|0
3002860|NCT00925015|10333816|P2|Overall Study|Physician Decision|1
3002861|NCT00925015|10333817|P1|Overall Study|Physician Decision|0
3002862|NCT00925015|10333815|P3|Overall Study|Adverse Event|1
3002863|NCT00925015|10333816|P2|Overall Study|Adverse Event|2
3002864|NCT00925015|10333817|P1|Overall Study|Adverse Event|1
3002865|NCT00924950|10333873|P1|Overall Study|Lost to Follow-up|2
3002866|NCT00924898|10333880|P1|Overall Study|Withdrawal by Subject|2
3002867|NCT00924781|10333917|P2|Overall Study|Study terminated by sponsor|10
3002868|NCT00924781|10333918|P1|Overall Study|Study terminated by sponsor|12
3002869|NCT00924729|10333952|P2|Overall Study|Protocol Violation|0
3002870|NCT00924729|10333953|P1|Overall Study|Protocol Violation|1
3002871|NCT00924729|10333952|P2|Overall Study|insufficient volume for analysis|0
3002872|NCT00924729|10333953|P1|Overall Study|insufficient volume for analysis|1
3002873|NCT00924651|10333963|P2|Overall Study|Incomplete Form|1
3002874|NCT00924651|10333964|P1|Overall Study|Incomplete Form|2
3002875|NCT00924651|10333963|P2|Overall Study|Changed Mind|1
3002876|NCT00924651|10333964|P1|Overall Study|Changed Mind|10
3002877|NCT00924651|10333963|P2|Overall Study|Medical|3
3002878|NCT00924651|10333964|P1|Overall Study|Medical|1
3002879|NCT00924651|10333963|P2|Overall Study|Noncompliant|4
3002880|NCT00924651|10333964|P1|Overall Study|Noncompliant|1
3002881|NCT00924651|10333963|P2|Overall Study|Overwhelmed|6
3002882|NCT00924651|10333964|P1|Overall Study|Overwhelmed|6
3002883|NCT00924651|10333963|P2|Overall Study|No Reason|7
3002884|NCT00924651|10333964|P1|Overall Study|No Reason|3
3002885|NCT00924651|10333963|P2|Overall Study|Chemo started too soon|3
3002886|NCT00924651|10333964|P1|Overall Study|Chemo started too soon|2
3002887|NCT00924638|10333972|P2|Overall Study|Physician Decision|3
3002888|NCT00924638|10333973|P1|Overall Study|Physician Decision|3
3002889|NCT00924638|10333972|P2|Overall Study|Withdrawal by Subject|7
3002890|NCT00924638|10333973|P1|Overall Study|Withdrawal by Subject|5
3002891|NCT00924638|10333972|P2|Overall Study|Lost to Follow-up|1
3002892|NCT00924638|10333973|P1|Overall Study|Lost to Follow-up|1
3002893|NCT00924638|10333972|P2|Overall Study|Death|2
3002894|NCT00924638|10333973|P1|Overall Study|Death|3
3002895|NCT00924560|10333995|P3|Overall Study|Miscellaneous Reasons|10
3002896|NCT00924560|10333996|P2|Overall Study|Miscellaneous Reasons|10
3002897|NCT00924560|10333997|P1|Overall Study|Miscellaneous Reasons|13
3002898|NCT00924560|10333995|P3|Overall Study|Lost to Follow-up|45
3002899|NCT00924560|10333996|P2|Overall Study|Lost to Follow-up|94
3002900|NCT00924560|10333997|P1|Overall Study|Lost to Follow-up|78
3002901|NCT00924560|10333995|P3|Overall Study|Pregnancy|1
3002902|NCT00924560|10333996|P2|Overall Study|Pregnancy|7
3002903|NCT00924560|10333997|P1|Overall Study|Pregnancy|5
3002904|NCT00924560|10333995|P3|Overall Study|Adverse Event|0
3002905|NCT00924560|10333996|P2|Overall Study|Adverse Event|33
3002906|NCT00924560|10333997|P1|Overall Study|Adverse Event|39
3002907|NCT00924560|10333995|P3|Overall Study|Withdrawal by Subject|18
3002908|NCT00924560|10333996|P2|Overall Study|Withdrawal by Subject|44
3002909|NCT00924560|10333997|P1|Overall Study|Withdrawal by Subject|50
3002910|NCT00924560|10333995|P3|Overall Study|Physician Decision|4
3002911|NCT00924560|10333996|P2|Overall Study|Physician Decision|3
3002912|NCT00924560|10333997|P1|Overall Study|Physician Decision|2
3002913|NCT00924560|10333995|P3|Overall Study|Non Compliance with the Protocol|4
3002914|NCT00924560|10333996|P2|Overall Study|Non Compliance with the Protocol|15
3002915|NCT00924560|10333997|P1|Overall Study|Non Compliance with the Protocol|20
3002916|NCT00924560|10333995|P3|Overall Study|Did Not Meet Protocol Requirements|1
3002917|NCT00924560|10333996|P2|Overall Study|Did Not Meet Protocol Requirements|2
3002918|NCT00924560|10333997|P1|Overall Study|Did Not Meet Protocol Requirements|4
3002919|NCT00924508|10334041|P1|Overall Study|Withdrawal by Subject|3
3002920|NCT00924469|10334055|P2|Overall Study|Lost to Follow-up|1
3002921|NCT00924469|10334056|P1|Overall Study|Lost to Follow-up|0
3002922|NCT00924469|10334055|P2|Overall Study|Withdrawal by Subject|1
3002923|NCT00924469|10334056|P1|Overall Study|Withdrawal by Subject|0
3002924|NCT00924469|10334055|P2|Overall Study|Adverse Event|0
3002925|NCT00924469|10334056|P1|Overall Study|Adverse Event|2
3002926|NCT00924443|10334078|P1|Overall Study|Protocol Violation|1
3002927|NCT00924443|10334078|P1|Overall Study|Physician Decision|2
3002928|NCT00924404|10334088|P2|Overall Study|Lost to Follow-up|4
3002929|NCT00924404|10334089|P1|Overall Study|Lost to Follow-up|6
3002930|NCT00924313|10334160|P1|Overall Study|not imaged due to failed tracer imaging|1
3002931|NCT00924287|10334172|P1|Overall Study|Death|1
3002932|NCT00924170|10334188|P2|Overall Study|Death|0
3002933|NCT00924170|10334189|P1|Overall Study|Death|1
3002934|NCT00924170|10334188|P2|Overall Study|Stopped due to neutralizing antibodies|0
3002935|NCT00924170|10334189|P1|Overall Study|Stopped due to neutralizing antibodies|3
3002936|NCT00924170|10334188|P2|Overall Study|Progressive disease|6
3002937|NCT00924170|10334189|P1|Overall Study|Progressive disease|3
3002938|NCT00924170|10334188|P2|Overall Study|Physician Decision|1
3002939|NCT00924170|10334189|P1|Overall Study|Physician Decision|0
3002940|NCT00924170|10334188|P2|Overall Study|Refused further treatment|1
3002941|NCT00924170|10334189|P1|Overall Study|Refused further treatment|0
3002942|NCT00923975|10334314|P1|Overall Study|Did not meet inclusion criteria|1
3002943|NCT00923936|10334333|P2|Overall Study|Continuing in follow up period|1
3002944|NCT00923936|10334334|P1|Overall Study|Continuing in follow up period|2
3002945|NCT00923936|10334333|P2|Overall Study|Lost to follow up|0
3002946|NCT00923936|10334334|P1|Overall Study|Lost to follow up|2
3002947|NCT00923936|10334333|P2|Overall Study|Adverse Event|1
3002948|NCT00923936|10334334|P1|Overall Study|Adverse Event|2
3002949|NCT00923936|10334333|P2|Overall Study|progressive disease on study|1
3002950|NCT00923936|10334334|P1|Overall Study|progressive disease on study|2
3002951|NCT00923845|10334363|P2|Induction Therapy|Poor performance status|2
3002952|NCT00923845|10334364|P1|Induction Therapy|Poor performance status|0
3002953|NCT00923364|10334399|P2|Overall Study|Did not go to transplant|0
3002954|NCT00923364|10334400|P1|Overall Study|Did not go to transplant|1
3002955|NCT00923364|10334399|P2|Overall Study|Death|0
3002956|NCT00923364|10334400|P1|Overall Study|Death|3
3002957|NCT00923351|10334412|P3|Overall Study|no apheresis/adequate tumor sample|12
3002958|NCT00923351|10334413|P2|Overall Study|no apheresis/adequate tumor sample|0
3002959|NCT00923351|10334414|P1|Overall Study|no apheresis/adequate tumor sample|0
3002960|NCT00923273|10334429|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
3002961|NCT00923273|10334430|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
3002962|NCT00923273|10334431|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
3002963|NCT00923273|10334432|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
3002964|NCT00923273|10334433|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
3002965|NCT00923273|10334429|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
3002966|NCT00923273|10334430|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
3002967|NCT00923273|10334431|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
3002968|NCT00923273|10334432|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
3002969|NCT00923273|10334433|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
3002970|NCT00923260|10334458|P2|Overall Study|Lost to Follow-up|1
3002971|NCT00923260|10334459|P1|Overall Study|Lost to Follow-up|1
3002972|NCT00923195|10334622|P2|Overall Study|Death|1
3002973|NCT00923195|10334623|P1|Overall Study|Death|0
3002974|NCT00923156|10334634|P3|Overall Study|Lack of Efficacy|1
3002975|NCT00923156|10334635|P2|Overall Study|Lack of Efficacy|0
3002976|NCT00923156|10334636|P1|Overall Study|Lack of Efficacy|0
3002977|NCT00923156|10334634|P3|Overall Study|Death|0
3002978|NCT00923156|10334635|P2|Overall Study|Death|1
3002979|NCT00923156|10334636|P1|Overall Study|Death|0
3002980|NCT00923156|10334634|P3|Overall Study|Withdrawal by Subject|0
3002981|NCT00923156|10334635|P2|Overall Study|Withdrawal by Subject|1
3002982|NCT00923156|10334636|P1|Overall Study|Withdrawal by Subject|0
3002983|NCT00923156|10334634|P3|Overall Study|Abnormal laboratory values|1
3002984|NCT00923156|10334635|P2|Overall Study|Abnormal laboratory values|0
3002985|NCT00923156|10334636|P1|Overall Study|Abnormal laboratory values|0
3002986|NCT00923156|10334634|P3|Overall Study|Adverse Event|1
3002987|NCT00923156|10334635|P2|Overall Study|Adverse Event|2
3002988|NCT00923156|10334636|P1|Overall Study|Adverse Event|0
3002989|NCT00923130|10334662|P1|Overall Study|Refused further treatment|2
3002990|NCT00923130|10334662|P1|Overall Study|Switched to alternative treatment|2
3002991|NCT00923130|10334662|P1|Overall Study|Discontinued treatment due to toxicities|3
3002992|NCT00923130|10334662|P1|Overall Study|Death|1
3002993|NCT00923130|10334662|P1|Overall Study|Stopped treatment due to progression|17
3002994|NCT00923091|10334697|P13|Period VI (Open-Label)|Other Reason|0
3002995|NCT00923091|10334698|P12|Period VI (Open-Label)|Other Reason|0
3002996|NCT00923091|10334699|P11|Period VI (Open-Label)|Other Reason|0
3002997|NCT00923091|10334700|P10|Period VI (Open-Label)|Other Reason|0
3002998|NCT00923091|10334701|P9|Period VI (Open-Label)|Other Reason|0
3002999|NCT00923091|10334702|P8|Period VI (Open-Label)|Other Reason|0
3003000|NCT00923091|10334703|P7|Period VI (Open-Label)|Other Reason|0
3003001|NCT00923091|10334704|P6|Period VI (Open-Label)|Other Reason|0
3003002|NCT00923091|10334705|P5|Period VI (Open-Label)|Other Reason|1
3003003|NCT00923091|10334706|P4|Period VI (Open-Label)|Other Reason|1
3003004|NCT00923091|10334707|P3|Period VI (Open-Label)|Other Reason|0
3003005|NCT00923091|10334708|P2|Period VI (Open-Label)|Other Reason|0
3003006|NCT00923091|10334709|P1|Period VI (Open-Label)|Other Reason|0
3003007|NCT00923091|10334697|P13|Period VI (Open-Label)|Lost to Follow-up|0
3003008|NCT00923091|10334698|P12|Period VI (Open-Label)|Lost to Follow-up|0
3003009|NCT00923091|10334699|P11|Period VI (Open-Label)|Lost to Follow-up|0
3003010|NCT00923091|10334700|P10|Period VI (Open-Label)|Lost to Follow-up|0
3003011|NCT00923091|10334701|P9|Period VI (Open-Label)|Lost to Follow-up|0
3003012|NCT00923091|10334702|P8|Period VI (Open-Label)|Lost to Follow-up|0
3003013|NCT00923091|10334703|P7|Period VI (Open-Label)|Lost to Follow-up|0
3003014|NCT00923091|10334704|P6|Period VI (Open-Label)|Lost to Follow-up|0
3003015|NCT00923091|10334705|P5|Period VI (Open-Label)|Lost to Follow-up|0
3003016|NCT00923091|10334706|P4|Period VI (Open-Label)|Lost to Follow-up|0
3003017|NCT00923091|10334707|P3|Period VI (Open-Label)|Lost to Follow-up|1
3003018|NCT00923091|10334708|P2|Period VI (Open-Label)|Lost to Follow-up|0
3003019|NCT00923091|10334709|P1|Period VI (Open-Label)|Lost to Follow-up|1
3003020|NCT00923091|10334697|P13|Period VI (Open-Label)|Protocol Violation|0
3003021|NCT00923091|10334698|P12|Period VI (Open-Label)|Protocol Violation|0
3003022|NCT00923091|10334699|P11|Period VI (Open-Label)|Protocol Violation|0
3003023|NCT00923091|10334700|P10|Period VI (Open-Label)|Protocol Violation|0
3003024|NCT00923091|10334701|P9|Period VI (Open-Label)|Protocol Violation|0
3003025|NCT00923091|10334702|P8|Period VI (Open-Label)|Protocol Violation|0
3003026|NCT00923091|10334703|P7|Period VI (Open-Label)|Protocol Violation|0
3003027|NCT00923091|10334704|P6|Period VI (Open-Label)|Protocol Violation|0
3003028|NCT00923091|10334705|P5|Period VI (Open-Label)|Protocol Violation|4
3003029|NCT00923091|10334706|P4|Period VI (Open-Label)|Protocol Violation|1
3003030|NCT00923091|10334707|P3|Period VI (Open-Label)|Protocol Violation|3
3003031|NCT00923091|10334708|P2|Period VI (Open-Label)|Protocol Violation|1
3003032|NCT00923091|10334709|P1|Period VI (Open-Label)|Protocol Violation|6
3003033|NCT00923091|10334697|P13|Period VI (Open-Label)|Withdrawal by Subject|0
3003034|NCT00923091|10334698|P12|Period VI (Open-Label)|Withdrawal by Subject|0
3003035|NCT00923091|10334699|P11|Period VI (Open-Label)|Withdrawal by Subject|0
3003036|NCT00923091|10334700|P10|Period VI (Open-Label)|Withdrawal by Subject|0
3003037|NCT00923091|10334701|P9|Period VI (Open-Label)|Withdrawal by Subject|0
3003038|NCT00923091|10334702|P8|Period VI (Open-Label)|Withdrawal by Subject|0
3003039|NCT00923091|10334703|P7|Period VI (Open-Label)|Withdrawal by Subject|0
3003040|NCT00923091|10334704|P6|Period VI (Open-Label)|Withdrawal by Subject|0
3003041|NCT00923091|10334705|P5|Period VI (Open-Label)|Withdrawal by Subject|1
3003042|NCT00923091|10334706|P4|Period VI (Open-Label)|Withdrawal by Subject|0
3003043|NCT00923091|10334707|P3|Period VI (Open-Label)|Withdrawal by Subject|5
3003044|NCT00923091|10334708|P2|Period VI (Open-Label)|Withdrawal by Subject|7
3003045|NCT00923091|10334709|P1|Period VI (Open-Label)|Withdrawal by Subject|15
3003046|NCT00923091|10334697|P13|Period VI (Open-Label)|Adverse Event|0
3003047|NCT00923091|10334698|P12|Period VI (Open-Label)|Adverse Event|0
3003048|NCT00923091|10334699|P11|Period VI (Open-Label)|Adverse Event|0
3003049|NCT00923091|10334700|P10|Period VI (Open-Label)|Adverse Event|0
3003050|NCT00923091|10334701|P9|Period VI (Open-Label)|Adverse Event|0
3003051|NCT00923091|10334702|P8|Period VI (Open-Label)|Adverse Event|0
3003052|NCT00923091|10334703|P7|Period VI (Open-Label)|Adverse Event|0
3003053|NCT00923091|10334704|P6|Period VI (Open-Label)|Adverse Event|0
3003054|NCT00923091|10334705|P5|Period VI (Open-Label)|Adverse Event|1
3003055|NCT00923091|10334706|P4|Period VI (Open-Label)|Adverse Event|1
3003056|NCT00923091|10334707|P3|Period VI (Open-Label)|Adverse Event|4
3003057|NCT00923091|10334708|P2|Period VI (Open-Label)|Adverse Event|0
3003058|NCT00923091|10334709|P1|Period VI (Open-Label)|Adverse Event|17
3003059|NCT00923091|10334697|P13|Period V (Double -Blind)|Lost to Follow-up|0
3003060|NCT00923091|10334698|P12|Period V (Double -Blind)|Lost to Follow-up|0
3003061|NCT00923091|10334699|P11|Period V (Double -Blind)|Lost to Follow-up|1
3003062|NCT00923091|10334700|P10|Period V (Double -Blind)|Lost to Follow-up|0
3003063|NCT00923091|10334701|P9|Period V (Double -Blind)|Lost to Follow-up|0
3003064|NCT00923091|10334702|P8|Period V (Double -Blind)|Lost to Follow-up|0
3003065|NCT00923091|10334703|P7|Period V (Double -Blind)|Lost to Follow-up|0
3003066|NCT00923091|10334704|P6|Period V (Double -Blind)|Lost to Follow-up|0
3003067|NCT00923091|10334705|P5|Period V (Double -Blind)|Lost to Follow-up|0
3003068|NCT00923091|10334706|P4|Period V (Double -Blind)|Lost to Follow-up|0
3003069|NCT00923091|10334707|P3|Period V (Double -Blind)|Lost to Follow-up|0
3003070|NCT00923091|10334708|P2|Period V (Double -Blind)|Lost to Follow-up|0
3003071|NCT00923091|10334709|P1|Period V (Double -Blind)|Lost to Follow-up|0
3003072|NCT00923091|10334697|P13|Period V (Double -Blind)|Protocol Violation|1
3003073|NCT00923091|10334698|P12|Period V (Double -Blind)|Protocol Violation|0
3003074|NCT00923091|10334699|P11|Period V (Double -Blind)|Protocol Violation|0
3003075|NCT00923091|10334700|P10|Period V (Double -Blind)|Protocol Violation|0
3003076|NCT00923091|10334701|P9|Period V (Double -Blind)|Protocol Violation|0
3003077|NCT00923091|10334702|P8|Period V (Double -Blind)|Protocol Violation|0
3003078|NCT00923091|10334703|P7|Period V (Double -Blind)|Protocol Violation|0
3003079|NCT00923091|10334704|P6|Period V (Double -Blind)|Protocol Violation|0
3003080|NCT00923091|10334705|P5|Period V (Double -Blind)|Protocol Violation|0
3003081|NCT00923091|10334706|P4|Period V (Double -Blind)|Protocol Violation|0
3003082|NCT00923091|10334707|P3|Period V (Double -Blind)|Protocol Violation|0
3003083|NCT00923091|10334708|P2|Period V (Double -Blind)|Protocol Violation|0
3003084|NCT00923091|10334709|P1|Period V (Double -Blind)|Protocol Violation|0
3003085|NCT00923091|10334697|P13|Period V (Double -Blind)|Withdrawal by Subject|1
3003086|NCT00923091|10334698|P12|Period V (Double -Blind)|Withdrawal by Subject|0
3003087|NCT00923091|10334699|P11|Period V (Double -Blind)|Withdrawal by Subject|0
3003088|NCT00923091|10334700|P10|Period V (Double -Blind)|Withdrawal by Subject|0
3003089|NCT00923091|10334701|P9|Period V (Double -Blind)|Withdrawal by Subject|1
3003090|NCT00923091|10334702|P8|Period V (Double -Blind)|Withdrawal by Subject|0
3003091|NCT00923091|10334703|P7|Period V (Double -Blind)|Withdrawal by Subject|0
3003092|NCT00923091|10334704|P6|Period V (Double -Blind)|Withdrawal by Subject|0
3003093|NCT00923091|10334705|P5|Period V (Double -Blind)|Withdrawal by Subject|0
3003094|NCT00923091|10334706|P4|Period V (Double -Blind)|Withdrawal by Subject|0
3003095|NCT00923091|10334707|P3|Period V (Double -Blind)|Withdrawal by Subject|0
3003096|NCT00923091|10334708|P2|Period V (Double -Blind)|Withdrawal by Subject|0
3003097|NCT00923091|10334709|P1|Period V (Double -Blind)|Withdrawal by Subject|0
3003098|NCT00923091|10334697|P13|Period IV (Double-Blind)|Protocol Violation|0
3003099|NCT00923091|10334698|P12|Period IV (Double-Blind)|Protocol Violation|0
3003100|NCT00923091|10334699|P11|Period IV (Double-Blind)|Protocol Violation|0
3003101|NCT00923091|10334700|P10|Period IV (Double-Blind)|Protocol Violation|0
3003102|NCT00923091|10334701|P9|Period IV (Double-Blind)|Protocol Violation|0
3003103|NCT00923091|10334702|P8|Period IV (Double-Blind)|Protocol Violation|0
3003104|NCT00923091|10334703|P7|Period IV (Double-Blind)|Protocol Violation|0
3003105|NCT00923091|10334704|P6|Period IV (Double-Blind)|Protocol Violation|0
3003106|NCT00923091|10334705|P5|Period IV (Double-Blind)|Protocol Violation|0
3003107|NCT00923091|10334706|P4|Period IV (Double-Blind)|Protocol Violation|0
3003108|NCT00923091|10334707|P3|Period IV (Double-Blind)|Protocol Violation|0
3003109|NCT00923091|10334708|P2|Period IV (Double-Blind)|Protocol Violation|1
3003110|NCT00923091|10334709|P1|Period IV (Double-Blind)|Protocol Violation|0
3003111|NCT00923091|10334697|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
3003112|NCT00923091|10334698|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
3003113|NCT00923091|10334699|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
3003114|NCT00923091|10334700|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
3003115|NCT00923091|10334701|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
3003116|NCT00923091|10334702|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
3003117|NCT00923091|10334703|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
3003118|NCT00923091|10334704|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
3003119|NCT00923091|10334705|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
3003120|NCT00923091|10334706|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
3003121|NCT00923091|10334707|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
3003122|NCT00923091|10334708|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
3003123|NCT00923091|10334709|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
3003124|NCT00923091|10334697|P13|Period IV (Double-Blind)|Adverse Event|0
3003125|NCT00923091|10334698|P12|Period IV (Double-Blind)|Adverse Event|0
3003126|NCT00923091|10334699|P11|Period IV (Double-Blind)|Adverse Event|0
3003127|NCT00923091|10334700|P10|Period IV (Double-Blind)|Adverse Event|0
3003128|NCT00923091|10334701|P9|Period IV (Double-Blind)|Adverse Event|0
3003129|NCT00923091|10334702|P8|Period IV (Double-Blind)|Adverse Event|0
3003130|NCT00923091|10334703|P7|Period IV (Double-Blind)|Adverse Event|0
3003131|NCT00923091|10334704|P6|Period IV (Double-Blind)|Adverse Event|0
3003132|NCT00923091|10334705|P5|Period IV (Double-Blind)|Adverse Event|0
3003133|NCT00923091|10334706|P4|Period IV (Double-Blind)|Adverse Event|0
3003134|NCT00923091|10334707|P3|Period IV (Double-Blind)|Adverse Event|0
3003135|NCT00923091|10334708|P2|Period IV (Double-Blind)|Adverse Event|0
3003136|NCT00923091|10334709|P1|Period IV (Double-Blind)|Adverse Event|2
3003137|NCT00923091|10334697|P13|Period III (Single-Blind)|Lost to Follow-up|0
3003138|NCT00923091|10334698|P12|Period III (Single-Blind)|Lost to Follow-up|0
3003139|NCT00923091|10334699|P11|Period III (Single-Blind)|Lost to Follow-up|0
3003140|NCT00923091|10334700|P10|Period III (Single-Blind)|Lost to Follow-up|0
3003141|NCT00923091|10334701|P9|Period III (Single-Blind)|Lost to Follow-up|0
3003142|NCT00923091|10334702|P8|Period III (Single-Blind)|Lost to Follow-up|0
3003143|NCT00923091|10334703|P7|Period III (Single-Blind)|Lost to Follow-up|0
3003144|NCT00923091|10334704|P6|Period III (Single-Blind)|Lost to Follow-up|0
3003145|NCT00923091|10334705|P5|Period III (Single-Blind)|Lost to Follow-up|0
3003146|NCT00923091|10334706|P4|Period III (Single-Blind)|Lost to Follow-up|0
3003147|NCT00923091|10334707|P3|Period III (Single-Blind)|Lost to Follow-up|0
3003148|NCT00923091|10334708|P2|Period III (Single-Blind)|Lost to Follow-up|0
3003149|NCT00923091|10334709|P1|Period III (Single-Blind)|Lost to Follow-up|2
3003150|NCT00923091|10334697|P13|Period III (Single-Blind)|Protocol Violation|0
3003151|NCT00923091|10334698|P12|Period III (Single-Blind)|Protocol Violation|0
3003152|NCT00923091|10334699|P11|Period III (Single-Blind)|Protocol Violation|0
3003153|NCT00923091|10334700|P10|Period III (Single-Blind)|Protocol Violation|0
3003154|NCT00923091|10334701|P9|Period III (Single-Blind)|Protocol Violation|0
3003155|NCT00923091|10334702|P8|Period III (Single-Blind)|Protocol Violation|0
3003156|NCT00923091|10334703|P7|Period III (Single-Blind)|Protocol Violation|0
3003157|NCT00923091|10334704|P6|Period III (Single-Blind)|Protocol Violation|0
3003158|NCT00923091|10334705|P5|Period III (Single-Blind)|Protocol Violation|0
3003159|NCT00923091|10334706|P4|Period III (Single-Blind)|Protocol Violation|0
3003160|NCT00923091|10334707|P3|Period III (Single-Blind)|Protocol Violation|0
3003161|NCT00923091|10334708|P2|Period III (Single-Blind)|Protocol Violation|0
3003162|NCT00923091|10334709|P1|Period III (Single-Blind)|Protocol Violation|3
3003163|NCT00923091|10334697|P13|Period III (Single-Blind)|Withdrawal by Subject|0
3003164|NCT00923091|10334698|P12|Period III (Single-Blind)|Withdrawal by Subject|0
3003165|NCT00923091|10334699|P11|Period III (Single-Blind)|Withdrawal by Subject|0
3003166|NCT00923091|10334700|P10|Period III (Single-Blind)|Withdrawal by Subject|0
3003167|NCT00923091|10334701|P9|Period III (Single-Blind)|Withdrawal by Subject|0
3003168|NCT00923091|10334702|P8|Period III (Single-Blind)|Withdrawal by Subject|0
3003169|NCT00923091|10334703|P7|Period III (Single-Blind)|Withdrawal by Subject|0
3003170|NCT00923091|10334704|P6|Period III (Single-Blind)|Withdrawal by Subject|0
3003171|NCT00923091|10334705|P5|Period III (Single-Blind)|Withdrawal by Subject|0
3003172|NCT00923091|10334706|P4|Period III (Single-Blind)|Withdrawal by Subject|0
3003173|NCT00923091|10334707|P3|Period III (Single-Blind)|Withdrawal by Subject|0
3003174|NCT00923091|10334708|P2|Period III (Single-Blind)|Withdrawal by Subject|0
3003175|NCT00923091|10334709|P1|Period III (Single-Blind)|Withdrawal by Subject|10
3003176|NCT00923091|10334697|P13|Period III (Single-Blind)|Adverse Event|0
3003177|NCT00923091|10334698|P12|Period III (Single-Blind)|Adverse Event|0
3003178|NCT00923091|10334699|P11|Period III (Single-Blind)|Adverse Event|0
3003179|NCT00923091|10334700|P10|Period III (Single-Blind)|Adverse Event|0
3003180|NCT00923091|10334701|P9|Period III (Single-Blind)|Adverse Event|0
3003181|NCT00923091|10334702|P8|Period III (Single-Blind)|Adverse Event|0
3003182|NCT00923091|10334703|P7|Period III (Single-Blind)|Adverse Event|0
3003183|NCT00923091|10334704|P6|Period III (Single-Blind)|Adverse Event|0
3003184|NCT00923091|10334705|P5|Period III (Single-Blind)|Adverse Event|0
3003185|NCT00923091|10334706|P4|Period III (Single-Blind)|Adverse Event|0
3003186|NCT00923091|10334707|P3|Period III (Single-Blind)|Adverse Event|0
3003187|NCT00923091|10334708|P2|Period III (Single-Blind)|Adverse Event|0
3003188|NCT00923091|10334709|P1|Period III (Single-Blind)|Adverse Event|5
3003189|NCT00923091|10334697|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003190|NCT00923091|10334698|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003191|NCT00923091|10334699|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003192|NCT00923091|10334700|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003193|NCT00923091|10334701|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003194|NCT00923091|10334702|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003195|NCT00923091|10334703|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003196|NCT00923091|10334704|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
3003197|NCT00923091|10334705|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003198|NCT00923091|10334706|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
3003199|NCT00923091|10334707|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003200|NCT00923091|10334708|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
3003201|NCT00923091|10334709|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
3003202|NCT00923091|10334697|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003203|NCT00923091|10334698|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003204|NCT00923091|10334699|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003205|NCT00923091|10334700|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003206|NCT00923091|10334701|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003207|NCT00923091|10334702|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003208|NCT00923091|10334703|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003209|NCT00923091|10334704|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
3003210|NCT00923091|10334705|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003211|NCT00923091|10334706|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003212|NCT00923091|10334707|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003213|NCT00923091|10334708|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003214|NCT00923091|10334709|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
3003215|NCT00923091|10334697|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
3003216|NCT00923091|10334698|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
3003217|NCT00923091|10334699|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
3003218|NCT00923091|10334700|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
3003219|NCT00923091|10334701|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
3003220|NCT00923091|10334702|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
3003221|NCT00923091|10334703|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
3003222|NCT00923091|10334704|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
3003223|NCT00923091|10334705|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
3003224|NCT00923091|10334706|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
3003225|NCT00923091|10334707|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
3003226|NCT00923091|10334708|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
3003227|NCT00923091|10334709|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
3003228|NCT00923091|10334697|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
3003229|NCT00923091|10334698|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
3003230|NCT00923091|10334699|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
3003231|NCT00923091|10334700|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
3003232|NCT00923091|10334701|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
3003233|NCT00923091|10334702|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
3003234|NCT00923091|10334703|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
3003235|NCT00923091|10334704|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
3003236|NCT00923091|10334705|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
3003237|NCT00923091|10334706|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
3003238|NCT00923091|10334707|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
3003239|NCT00923091|10334708|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
3003240|NCT00923091|10334709|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
3003241|NCT00923091|10334697|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
3003242|NCT00923091|10334698|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
3003243|NCT00923091|10334699|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
3003244|NCT00923091|10334700|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
3003245|NCT00923091|10334701|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
3003246|NCT00923091|10334702|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
3003247|NCT00923091|10334703|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
3003248|NCT00923091|10334704|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
3003249|NCT00923091|10334705|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
3003250|NCT00923091|10334706|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
3003251|NCT00923091|10334707|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
3003252|NCT00923091|10334708|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
3003253|NCT00923091|10334709|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
3003254|NCT00923078|10334759|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
3003255|NCT00923078|10334760|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
3003256|NCT00923078|10334761|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
3003257|NCT00923078|10334759|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
3003258|NCT00923078|10334760|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
3003259|NCT00923078|10334761|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
3003260|NCT00922987|10334780|P1|Overall Study|Adverse Event|1
3003261|NCT00922987|10334780|P1|Overall Study|Protocol Violation|2
3003262|NCT00922987|10334780|P1|Overall Study|Insufficient clinical response|1
3003263|NCT00922974|10334795|P2|Phase III Component|Protocol Violation|6
3003264|NCT00922974|10334796|P1|Phase III Component|Protocol Violation|8
3003265|NCT00922974|10334795|P2|Phase II Component|Not evaluable for treatment review|0
3003266|NCT00922974|10334796|P1|Phase II Component|Not evaluable for treatment review|5
3003267|NCT00922974|10334795|P2|Phase II Component|Protocol Violation|0
3003268|NCT00922974|10334796|P1|Phase II Component|Protocol Violation|2
3003269|NCT00922935|10334811|P3|Overall Study|Lost to Follow-up|0
3003270|NCT00922935|10334812|P2|Overall Study|Lost to Follow-up|1
3003271|NCT00922935|10334813|P1|Overall Study|Lost to Follow-up|0
3003272|NCT00922935|10334811|P3|Overall Study|Physician Decision|0
3003273|NCT00922935|10334812|P2|Overall Study|Physician Decision|1
3003274|NCT00922935|10334813|P1|Overall Study|Physician Decision|1
3003275|NCT00922935|10334811|P3|Overall Study|Protocol Violation|0
3003276|NCT00922935|10334812|P2|Overall Study|Protocol Violation|3
3003277|NCT00922935|10334813|P1|Overall Study|Protocol Violation|0
3003278|NCT00922779|10334825|P1|Overall Study|Missing|1874
3003279|NCT00922779|10334825|P1|Overall Study|Other|27
3003280|NCT00922779|10334825|P1|Overall Study|Lost to Follow-up|44
3003281|NCT00922779|10334825|P1|Overall Study|Withdrawal by Subject|308
3003282|NCT00922779|10334825|P1|Overall Study|Pregnancy|7
3003283|NCT00922779|10334825|P1|Overall Study|Adverse Event|67
3003284|NCT00922766|10334832|P1|Overall Study|Adverse Event|1
3003285|NCT00922766|10334832|P1|Overall Study|Other|1
3003286|NCT00922766|10334832|P1|Overall Study|Withdrawal by Subject|2
3003287|NCT00922766|10334832|P1|Overall Study|Death|3
3003288|NCT00922636|10334850|P5|Overall Study|Lost to Follow-up|4
3003289|NCT00922636|10334851|P4|Overall Study|Lost to Follow-up|2
3003290|NCT00922636|10334852|P3|Overall Study|Lost to Follow-up|2
3003291|NCT00922636|10334853|P2|Overall Study|Lost to Follow-up|2
3003292|NCT00922636|10334854|P1|Overall Study|Lost to Follow-up|1
3003293|NCT00922636|10334850|P5|Overall Study|Parent/Caregiver Decision|2
3003294|NCT00922636|10334851|P4|Overall Study|Parent/Caregiver Decision|5
3003295|NCT00922636|10334852|P3|Overall Study|Parent/Caregiver Decision|3
3003296|NCT00922636|10334853|P2|Overall Study|Parent/Caregiver Decision|4
3003297|NCT00922636|10334854|P1|Overall Study|Parent/Caregiver Decision|2
3003298|NCT00922636|10334850|P5|Overall Study|Entry Criteria Not Met|0
3003299|NCT00922636|10334851|P4|Overall Study|Entry Criteria Not Met|1
3003300|NCT00922636|10334852|P3|Overall Study|Entry Criteria Not Met|1
3003301|NCT00922636|10334853|P2|Overall Study|Entry Criteria Not Met|0
3003302|NCT00922636|10334854|P1|Overall Study|Entry Criteria Not Met|0
3003303|NCT00922636|10334850|P5|Overall Study|Protocol Violation|0
3003304|NCT00922636|10334851|P4|Overall Study|Protocol Violation|2
3003305|NCT00922636|10334852|P3|Overall Study|Protocol Violation|2
3003306|NCT00922636|10334853|P2|Overall Study|Protocol Violation|0
3003307|NCT00922636|10334854|P1|Overall Study|Protocol Violation|0
3003308|NCT00922636|10334850|P5|Overall Study|Withdrawal by Subject|4
3003309|NCT00922636|10334851|P4|Overall Study|Withdrawal by Subject|2
3003310|NCT00922636|10334852|P3|Overall Study|Withdrawal by Subject|5
3003311|NCT00922636|10334853|P2|Overall Study|Withdrawal by Subject|0
3003312|NCT00922636|10334854|P1|Overall Study|Withdrawal by Subject|0
3003313|NCT00922636|10334850|P5|Overall Study|Sponsor Decision|0
3003314|NCT00922636|10334851|P4|Overall Study|Sponsor Decision|0
3003315|NCT00922636|10334852|P3|Overall Study|Sponsor Decision|2
3003316|NCT00922636|10334853|P2|Overall Study|Sponsor Decision|0
3003317|NCT00922636|10334854|P1|Overall Study|Sponsor Decision|0
3003318|NCT00922636|10334850|P5|Overall Study|Lack of Efficacy|4
3003319|NCT00922636|10334851|P4|Overall Study|Lack of Efficacy|2
3003320|NCT00922636|10334852|P3|Overall Study|Lack of Efficacy|3
3003321|NCT00922636|10334853|P2|Overall Study|Lack of Efficacy|7
3003322|NCT00922636|10334854|P1|Overall Study|Lack of Efficacy|1
3003323|NCT00922636|10334850|P5|Overall Study|Adverse Event|2
3003324|NCT00922636|10334851|P4|Overall Study|Adverse Event|3
3003325|NCT00922636|10334852|P3|Overall Study|Adverse Event|2
3003326|NCT00922636|10334853|P2|Overall Study|Adverse Event|3
3003327|NCT00922636|10334854|P1|Overall Study|Adverse Event|3
3003328|NCT00922623|10335001|P1|Overall Study|Lost to Follow-up|1
3003329|NCT00922623|10335001|P1|Overall Study|Other|4
3003330|NCT00922480|10335009|P2|Extension Study|Others|1
3003331|NCT00922480|10335010|P1|Extension Study|Others|0
3003332|NCT00922480|10335009|P2|Extension Study|Withdrawal by Subject|1
3003333|NCT00922480|10335010|P1|Extension Study|Withdrawal by Subject|1
3003334|NCT00922480|10335009|P2|Extension Study|Adverse Event|1
3003335|NCT00922480|10335010|P1|Extension Study|Adverse Event|1
3003336|NCT00922480|10335009|P2|Extension Study|Protocol Violation|0
3003337|NCT00922480|10335010|P1|Extension Study|Protocol Violation|3
3003338|NCT00922480|10335009|P2|Main Study|Physician Decision|1
3003339|NCT00922480|10335010|P1|Main Study|Physician Decision|0
3003340|NCT00922480|10335009|P2|Main Study|Lost to Follow-up|0
3003341|NCT00922480|10335010|P1|Main Study|Lost to Follow-up|5
3003342|NCT00922480|10335009|P2|Main Study|Withdrawal by Subject|15
3003343|NCT00922480|10335010|P1|Main Study|Withdrawal by Subject|20
3003344|NCT00922480|10335009|P2|Main Study|Lack of Efficacy|0
3003345|NCT00922480|10335010|P1|Main Study|Lack of Efficacy|3
3003346|NCT00922480|10335009|P2|Main Study|Adverse Event|7
3003347|NCT00922480|10335010|P1|Main Study|Adverse Event|6
3003348|NCT00922480|10335009|P2|Main Study|Protocol Violation|6
3003349|NCT00922480|10335010|P1|Main Study|Protocol Violation|3
3003350|NCT00922441|10335021|P3|Overall Study|Withdrawal by Subject|1
3003351|NCT00922441|10335022|P2|Overall Study|Withdrawal by Subject|0
3003352|NCT00922441|10335023|P1|Overall Study|Withdrawal by Subject|0
3003353|NCT00922441|10335021|P3|Overall Study|Protocol Violation|2
3003354|NCT00922441|10335022|P2|Overall Study|Protocol Violation|0
3003355|NCT00922441|10335023|P1|Overall Study|Protocol Violation|0
3003356|NCT00922428|10335031|P1|Overall Study|no medication use or questionable use|13
3003357|NCT00922428|10335031|P1|Overall Study|retrospective/extremely implausible data|2
3003358|NCT00922272|10335060|P2|Double-blind Phase|Positive urine drug screen|1
3003359|NCT00922272|10335061|P1|Double-blind Phase|Positive urine drug screen|1
3003360|NCT00922272|10335060|P2|Double-blind Phase|Noncompliance|1
3003361|NCT00922272|10335061|P1|Double-blind Phase|Noncompliance|1
3003362|NCT00922272|10335060|P2|Double-blind Phase|Withdrawal criteria met|1
3003363|NCT00922272|10335061|P1|Double-blind Phase|Withdrawal criteria met|1
3003364|NCT00922272|10335060|P2|Double-blind Phase|Lost to Follow-up|1
3003365|NCT00922272|10335061|P1|Double-blind Phase|Lost to Follow-up|2
3003366|NCT00922272|10335060|P2|Double-blind Phase|Withdrawal by Subject|1
3003367|NCT00922272|10335061|P1|Double-blind Phase|Withdrawal by Subject|1
3003368|NCT00922272|10335060|P2|Double-blind Phase|Adverse Event|1
3003369|NCT00922272|10335061|P1|Double-blind Phase|Adverse Event|1
3003370|NCT00922272|10335060|P2|Open-label Phase|Withdrawal criteria met|0
3003371|NCT00922272|10335061|P1|Open-label Phase|Withdrawal criteria met|5
3003372|NCT00922272|10335060|P2|Open-label Phase|Failure to meet randomization criteria|0
3003373|NCT00922272|10335061|P1|Open-label Phase|Failure to meet randomization criteria|1
3003374|NCT00922272|10335060|P2|Open-label Phase|Withdrawal by Subject|0
3003375|NCT00922272|10335061|P1|Open-label Phase|Withdrawal by Subject|11
3003376|NCT00922272|10335060|P2|Open-label Phase|Protocol Violation|0
3003377|NCT00922272|10335061|P1|Open-label Phase|Protocol Violation|1
3003378|NCT00922272|10335060|P2|Open-label Phase|Adverse Event|0
3003379|NCT00922272|10335061|P1|Open-label Phase|Adverse Event|5
3003380|NCT00922207|10335126|P3|Overall Study|Abnormality of Laboratory Test|1
3003381|NCT00922207|10335127|P2|Overall Study|Abnormality of Laboratory Test|1
3003382|NCT00922207|10335128|P1|Overall Study|Abnormality of Laboratory Test|0
3003383|NCT00922207|10335126|P3|Overall Study|Withdrew Consent|2
3003384|NCT00922207|10335127|P2|Overall Study|Withdrew Consent|5
3003385|NCT00922207|10335128|P1|Overall Study|Withdrew Consent|2
3003386|NCT00922207|10335126|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
3003387|NCT00922207|10335127|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
3003388|NCT00922207|10335128|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
3003389|NCT00922207|10335126|P3|Overall Study|Violation of Selection Criteria at Entry|0
3003390|NCT00922207|10335127|P2|Overall Study|Violation of Selection Criteria at Entry|1
3003391|NCT00922207|10335128|P1|Overall Study|Violation of Selection Criteria at Entry|0
3003392|NCT00922207|10335126|P3|Overall Study|Insufficient Therapeutic Response|1
3003393|NCT00922207|10335127|P2|Overall Study|Insufficient Therapeutic Response|0
3003394|NCT00922207|10335128|P1|Overall Study|Insufficient Therapeutic Response|0
3003395|NCT00922207|10335126|P3|Overall Study|Adverse Event/Intercurrent Illness|0
3003396|NCT00922207|10335127|P2|Overall Study|Adverse Event/Intercurrent Illness|0
3003397|NCT00922207|10335128|P1|Overall Study|Adverse Event/Intercurrent Illness|3
3003398|NCT00922116|10335164|P1|Overall Study|Other|5
3003399|NCT00922116|10335164|P1|Overall Study|Withdrawal by Subject|4
3003400|NCT00922116|10335164|P1|Overall Study|Lost to Follow-up|1
3003401|NCT00922116|10335164|P1|Overall Study|Death|1
3003402|NCT00922116|10335164|P1|Overall Study|Adverse Event|4
3003403|NCT00921557|10335226|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
3003404|NCT00921557|10335227|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
3003405|NCT00921557|10335228|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
3003406|NCT00921557|10335226|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
3003407|NCT00921557|10335227|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
3003408|NCT00921557|10335228|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
3003409|NCT00921557|10335226|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
3003410|NCT00921557|10335227|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
3003411|NCT00921557|10335228|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
3003412|NCT00921557|10335226|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
3003413|NCT00921557|10335227|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
3003414|NCT00921557|10335228|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
3003415|NCT00921557|10335226|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
3003416|NCT00921557|10335227|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
3003417|NCT00921557|10335228|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
3003418|NCT00921024|10335330|P2|Overall Study|Withdrawal by Subject|3
3003419|NCT00921024|10335331|P1|Overall Study|Withdrawal by Subject|0
3003420|NCT00921024|10335330|P2|Overall Study|Received concomittant therapy|0
3003421|NCT00921024|10335331|P1|Overall Study|Received concomittant therapy|2
3003422|NCT00921024|10335330|P2|Overall Study|Lost to Follow-up|0
3003423|NCT00921024|10335331|P1|Overall Study|Lost to Follow-up|2
3003424|NCT00920907|10335341|P2|Maintenance Period|Adverse Event|1
3003425|NCT00920907|10335342|P1|Maintenance Period|Adverse Event|0
3003426|NCT00920907|10335341|P2|Maintenance Period|Withdrawal by Subject|0
3003427|NCT00920907|10335342|P1|Maintenance Period|Withdrawal by Subject|1
3003428|NCT00920907|10335341|P2|Maintenance Period|Death|1
3003429|NCT00920907|10335342|P1|Maintenance Period|Death|1
3003430|NCT00920907|10335341|P2|Maintenance Period|Study Drug Toxicity|2
3003431|NCT00920907|10335342|P1|Maintenance Period|Study Drug Toxicity|0
3003432|NCT00920907|10335341|P2|Maintenance Period|Administrative (study closure)|2
3003433|NCT00920907|10335342|P1|Maintenance Period|Administrative (study closure)|7
3003434|NCT00920907|10335341|P2|Maintenance Period|Disease Progression|7
3003435|NCT00920907|10335342|P1|Maintenance Period|Disease Progression|3
3003436|NCT00920907|10335341|P2|Induction Period|Withdrawal by Subject|1
3003437|NCT00920907|10335342|P1|Induction Period|Withdrawal by Subject|1
3003438|NCT00920907|10335341|P2|Induction Period|No longer meets study criteria|1
3003439|NCT00920907|10335342|P1|Induction Period|No longer meets study criteria|0
3003440|NCT00920907|10335341|P2|Induction Period|Study Drug Toxicity|6
3003441|NCT00920907|10335342|P1|Induction Period|Study Drug Toxicity|8
3003442|NCT00920907|10335341|P2|Induction Period|Disease Progression|11
3003443|NCT00920907|10335342|P1|Induction Period|Disease Progression|12
3003444|NCT00920907|10335341|P2|Induction Period|Death|1
3003445|NCT00920907|10335342|P1|Induction Period|Death|1
3003446|NCT00920907|10335341|P2|Induction Period|Adverse Event|2
3003447|NCT00920907|10335342|P1|Induction Period|Adverse Event|0
3003448|NCT00920855|10335383|P3|Overall Study|Response plateau; started maintenance|1
3003449|NCT00920855|10335384|P2|Overall Study|Response plateau; started maintenance|0
3003450|NCT00920855|10335385|P1|Overall Study|Response plateau; started maintenance|0
3003451|NCT00920855|10335383|P3|Overall Study|Noncompliance to study medication|1
3003452|NCT00920855|10335384|P2|Overall Study|Noncompliance to study medication|0
3003453|NCT00920855|10335385|P1|Overall Study|Noncompliance to study medication|0
3003454|NCT00920855|10335383|P3|Overall Study|Disease progression|10
3003455|NCT00920855|10335384|P2|Overall Study|Disease progression|1
3003456|NCT00920855|10335385|P1|Overall Study|Disease progression|2
3003457|NCT00920855|10335383|P3|Overall Study|Withdrawal by Subject|6
3003458|NCT00920855|10335384|P2|Overall Study|Withdrawal by Subject|1
3003459|NCT00920855|10335385|P1|Overall Study|Withdrawal by Subject|2
3003460|NCT00920855|10335383|P3|Overall Study|Adverse Event|4
3003461|NCT00920855|10335384|P2|Overall Study|Adverse Event|1
3003462|NCT00920855|10335385|P1|Overall Study|Adverse Event|1
3003463|NCT00920829|10335411|P4|Available for Analysis|Required more treatment|1
3003464|NCT00920829|10335412|P3|Available for Analysis|Required more treatment|0
3003465|NCT00920829|10335413|P2|Available for Analysis|Required more treatment|2
3003466|NCT00920829|10335414|P1|Available for Analysis|Required more treatment|0
3003467|NCT00920829|10335411|P4|Available for Analysis|Protocol Violation|0
3003468|NCT00920829|10335412|P3|Available for Analysis|Protocol Violation|1
3003469|NCT00920829|10335413|P2|Available for Analysis|Protocol Violation|0
3003470|NCT00920829|10335414|P1|Available for Analysis|Protocol Violation|0
3003471|NCT00920829|10335411|P4|Available for Analysis|Death|0
3003472|NCT00920829|10335412|P3|Available for Analysis|Death|0
3003473|NCT00920829|10335413|P2|Available for Analysis|Death|0
3003474|NCT00920829|10335414|P1|Available for Analysis|Death|1
3003475|NCT00920829|10335411|P4|Available for Analysis|Adverse Event|0
3003476|NCT00920829|10335412|P3|Available for Analysis|Adverse Event|1
3003477|NCT00920829|10335413|P2|Available for Analysis|Adverse Event|2
3003478|NCT00920829|10335414|P1|Available for Analysis|Adverse Event|1
3003479|NCT00920829|10335411|P4|Available for Analysis|Required Medical Treatment|0
3003480|NCT00920829|10335412|P3|Available for Analysis|Required Medical Treatment|2
3003481|NCT00920829|10335413|P2|Available for Analysis|Required Medical Treatment|1
3003482|NCT00920829|10335414|P1|Available for Analysis|Required Medical Treatment|0
3003483|NCT00920829|10335411|P4|Available for Analysis|Withdrawal by Subject|10
3003484|NCT00920829|10335412|P3|Available for Analysis|Withdrawal by Subject|6
3003485|NCT00920829|10335413|P2|Available for Analysis|Withdrawal by Subject|6
3003486|NCT00920829|10335414|P1|Available for Analysis|Withdrawal by Subject|6
3003487|NCT00920829|10335411|P4|Allocation|No post randomization data|2
3003488|NCT00920829|10335412|P3|Allocation|No post randomization data|0
3003489|NCT00920829|10335413|P2|Allocation|No post randomization data|1
3003490|NCT00920829|10335414|P1|Allocation|No post randomization data|3
3003491|NCT00920816|10335428|P4|Overall Study|Ongoing|36
3003492|NCT00920816|10335429|P3|Overall Study|Ongoing|70
3003493|NCT00920816|10335430|P2|Overall Study|Ongoing|56
3003494|NCT00920816|10335431|P1|Overall Study|Ongoing|106
3003495|NCT00920816|10335428|P4|Overall Study|Withdrawal by Subject|1
3003496|NCT00920816|10335429|P3|Overall Study|Withdrawal by Subject|1
3003497|NCT00920816|10335430|P2|Overall Study|Withdrawal by Subject|2
3003498|NCT00920816|10335431|P1|Overall Study|Withdrawal by Subject|7
3003499|NCT00920816|10335428|P4|Overall Study|Objective progression or relapse|0
3003500|NCT00920816|10335429|P3|Overall Study|Objective progression or relapse|2
3003501|NCT00920816|10335430|P2|Overall Study|Objective progression or relapse|0
3003502|NCT00920816|10335431|P1|Overall Study|Objective progression or relapse|0
3003503|NCT00920816|10335428|P4|Overall Study|Lost to Follow-up|4
3003504|NCT00920816|10335429|P3|Overall Study|Lost to Follow-up|3
3003505|NCT00920816|10335430|P2|Overall Study|Lost to Follow-up|2
3003506|NCT00920816|10335431|P1|Overall Study|Lost to Follow-up|1
3003507|NCT00920816|10335428|P4|Overall Study|Adverse Event|0
3003508|NCT00920816|10335429|P3|Overall Study|Adverse Event|1
3003509|NCT00920816|10335430|P2|Overall Study|Adverse Event|0
3003510|NCT00920816|10335431|P1|Overall Study|Adverse Event|1
3003511|NCT00920816|10335428|P4|Overall Study|Death|28
3003512|NCT00920816|10335429|P3|Overall Study|Death|58
3003513|NCT00920816|10335430|P2|Overall Study|Death|36
3003514|NCT00920816|10335431|P1|Overall Study|Death|77
3003515|NCT00920790|10335469|P1|Overall Study|aggravation of general condition|14
3003516|NCT00920699|10335481|P3|Overall Study|Lost to Follow-up|2
3003517|NCT00920699|10335482|P2|Overall Study|Lost to Follow-up|0
3003518|NCT00920699|10335483|P1|Overall Study|Lost to Follow-up|0
3003519|NCT00920699|10335481|P3|Overall Study|no longer met eligibility|0
3003520|NCT00920699|10335482|P2|Overall Study|no longer met eligibility|1
3003521|NCT00920699|10335483|P1|Overall Study|no longer met eligibility|0
3003522|NCT00920699|10335481|P3|Overall Study|Withdrawal by Subject|2
3003523|NCT00920699|10335482|P2|Overall Study|Withdrawal by Subject|0
3003524|NCT00920699|10335483|P1|Overall Study|Withdrawal by Subject|2
3003525|NCT00920686|10335500|P3|Overall Study|Study drug dosing criteria not met|12
3003526|NCT00920686|10335501|P2|Overall Study|Study drug dosing criteria not met|19
3003527|NCT00920686|10335502|P1|Overall Study|Study drug dosing criteria not met|17
3003528|NCT00920686|10335500|P3|Overall Study|Lost to Follow-up|1
3003529|NCT00920686|10335501|P2|Overall Study|Lost to Follow-up|3
3003530|NCT00920686|10335502|P1|Overall Study|Lost to Follow-up|2
3003531|NCT00920621|10335581|P4|Overall Study|Blood sample not collected|0
3003532|NCT00920621|10335582|P3|Overall Study|Blood sample not collected|0
3003533|NCT00920621|10335583|P2|Overall Study|Blood sample not collected|14
3003534|NCT00920621|10335584|P1|Overall Study|Blood sample not collected|22
3003535|NCT00920621|10335581|P4|Overall Study|Fetal/neonatal deaths|14
3003536|NCT00920621|10335582|P3|Overall Study|Fetal/neonatal deaths|16
3003537|NCT00920621|10335583|P2|Overall Study|Fetal/neonatal deaths|14
3003538|NCT00920621|10335584|P1|Overall Study|Fetal/neonatal deaths|16
3003539|NCT00920621|10335581|P4|Overall Study|Lost to Follow-up|21
3003540|NCT00920621|10335582|P3|Overall Study|Lost to Follow-up|19
3003541|NCT00920621|10335583|P2|Overall Study|Lost to Follow-up|17
3003542|NCT00920621|10335584|P1|Overall Study|Lost to Follow-up|16
3003543|NCT00920556|10335614|P1|Overall Study|Withdrawal by Subject|1
3003544|NCT00920556|10335614|P1|Overall Study|Physician Decision|7
3003545|NCT00920556|10335614|P1|Overall Study|Adverse Event|16
3003546|NCT00920426|10335663|P4|ITZ111451|Adverse Event|0
3003547|NCT00920426|10335664|P3|ITZ111451|Adverse Event|0
3003548|NCT00920426|10335665|P2|ITZ111451|Adverse Event|0
3003549|NCT00920426|10335666|P1|ITZ111451|Adverse Event|1
3003550|NCT00920218|10335786|P4|Overall Study|Other|0
3003551|NCT00920218|10335787|P3|Overall Study|Other|1
3003552|NCT00920218|10335788|P2|Overall Study|Other|0
3003553|NCT00920218|10335789|P1|Overall Study|Other|0
3003554|NCT00920218|10335786|P4|Overall Study|Transplant failed/malignancy recurrence|3
3003555|NCT00920218|10335787|P3|Overall Study|Transplant failed/malignancy recurrence|2
3003556|NCT00920218|10335788|P2|Overall Study|Transplant failed/malignancy recurrence|1
3003557|NCT00920218|10335789|P1|Overall Study|Transplant failed/malignancy recurrence|0
3003558|NCT00920218|10335786|P4|Overall Study|Lost to Follow-up|3
3003559|NCT00920218|10335787|P3|Overall Study|Lost to Follow-up|0
3003560|NCT00920218|10335788|P2|Overall Study|Lost to Follow-up|1
3003561|NCT00920218|10335789|P1|Overall Study|Lost to Follow-up|0
3003562|NCT00920218|10335786|P4|Overall Study|Migrated/moved from study area|0
3003563|NCT00920218|10335787|P3|Overall Study|Migrated/moved from study area|1
3003564|NCT00920218|10335788|P2|Overall Study|Migrated/moved from study area|0
3003565|NCT00920218|10335789|P1|Overall Study|Migrated/moved from study area|0
3003566|NCT00920218|10335786|P4|Overall Study|Withdrawal by Subject|0
3003567|NCT00920218|10335787|P3|Overall Study|Withdrawal by Subject|2
3003568|NCT00920218|10335788|P2|Overall Study|Withdrawal by Subject|3
3003569|NCT00920218|10335789|P1|Overall Study|Withdrawal by Subject|0
3003570|NCT00920218|10335786|P4|Overall Study|Serious Adverse Event|1
3003571|NCT00920218|10335787|P3|Overall Study|Serious Adverse Event|2
3003572|NCT00920218|10335788|P2|Overall Study|Serious Adverse Event|0
3003573|NCT00920218|10335789|P1|Overall Study|Serious Adverse Event|2
3003574|NCT00920140|10335892|P5|Phase 2|Withdrawal by Subject|1
3003575|NCT00920140|10335893|P4|Phase 2|Withdrawal by Subject|2
3003576|NCT00920140|10335894|P3|Phase 2|Withdrawal by Subject|4
3003577|NCT00920140|10335895|P2|Phase 2|Withdrawal by Subject|0
3003578|NCT00920140|10335896|P1|Phase 2|Withdrawal by Subject|0
3003579|NCT00920140|10335892|P5|Phase 2|Physician Decision|2
3003580|NCT00920140|10335893|P4|Phase 2|Physician Decision|3
3003581|NCT00920140|10335894|P3|Phase 2|Physician Decision|3
3003582|NCT00920140|10335895|P2|Phase 2|Physician Decision|0
3003583|NCT00920140|10335896|P1|Phase 2|Physician Decision|0
3003584|NCT00920140|10335892|P5|Phase 2|Lost to Follow-up|0
3003585|NCT00920140|10335893|P4|Phase 2|Lost to Follow-up|1
3003586|NCT00920140|10335894|P3|Phase 2|Lost to Follow-up|0
3003587|NCT00920140|10335895|P2|Phase 2|Lost to Follow-up|0
3003588|NCT00920140|10335896|P1|Phase 2|Lost to Follow-up|0
3003589|NCT00920140|10335892|P5|Phase 2|Lack of Efficacy|5
3003590|NCT00920140|10335893|P4|Phase 2|Lack of Efficacy|14
3003591|NCT00920140|10335894|P3|Phase 2|Lack of Efficacy|29
3003592|NCT00920140|10335895|P2|Phase 2|Lack of Efficacy|0
3003593|NCT00920140|10335896|P1|Phase 2|Lack of Efficacy|0
3003594|NCT00920140|10335892|P5|Phase 2|Adverse Event|3
3003595|NCT00920140|10335893|P4|Phase 2|Adverse Event|2
3003596|NCT00920140|10335894|P3|Phase 2|Adverse Event|14
3003597|NCT00920140|10335895|P2|Phase 2|Adverse Event|0
3003598|NCT00920140|10335896|P1|Phase 2|Adverse Event|0
3003599|NCT00920140|10335892|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
3003600|NCT00920140|10335893|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
3003601|NCT00920140|10335894|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
3003602|NCT00920140|10335895|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
3003603|NCT00920140|10335896|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
3003604|NCT00920140|10335892|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
3003605|NCT00920140|10335893|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
3003606|NCT00920140|10335894|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
3003607|NCT00920140|10335895|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
3003608|NCT00920140|10335896|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
3003609|NCT00920140|10335892|P5|Phase 1 (Dose Escalation)|Adverse Event|0
3003610|NCT00920140|10335893|P4|Phase 1 (Dose Escalation)|Adverse Event|0
3003611|NCT00920140|10335894|P3|Phase 1 (Dose Escalation)|Adverse Event|0
3003612|NCT00920140|10335895|P2|Phase 1 (Dose Escalation)|Adverse Event|3
3003613|NCT00920140|10335896|P1|Phase 1 (Dose Escalation)|Adverse Event|3
3003614|NCT00919893|10335958|P2|Overall Study|Protocol Violation|9
3003615|NCT00919893|10335959|P1|Overall Study|Protocol Violation|19
3003616|NCT00919867|10335971|P6|First Intervention|Physician Decision|1
3003617|NCT00919867|10335972|P5|First Intervention|Physician Decision|0
3003618|NCT00919867|10335973|P4|First Intervention|Physician Decision|0
3003619|NCT00919867|10335974|P3|First Intervention|Physician Decision|0
3003620|NCT00919867|10335975|P2|First Intervention|Physician Decision|0
3003621|NCT00919867|10335976|P1|First Intervention|Physician Decision|0
3003622|NCT00919867|10335971|P6|First Intervention|Withdrawal by Subject|0
3003623|NCT00919867|10335972|P5|First Intervention|Withdrawal by Subject|0
3003624|NCT00919867|10335973|P4|First Intervention|Withdrawal by Subject|0
3003625|NCT00919867|10335974|P3|First Intervention|Withdrawal by Subject|1
3003626|NCT00919867|10335975|P2|First Intervention|Withdrawal by Subject|0
3003627|NCT00919867|10335976|P1|First Intervention|Withdrawal by Subject|0
3003628|NCT00919854|10335997|P1|Overall Study|Adverse Event|1
3003629|NCT00919711|10336035|P2|Overall Study|Noncompliance|0
3003630|NCT00919711|10336036|P1|Overall Study|Noncompliance|1
3003631|NCT00919711|10336035|P2|Overall Study|Death|0
3003632|NCT00919711|10336036|P1|Overall Study|Death|1
3003633|NCT00919711|10336035|P2|Overall Study|Lost to Follow-up|0
3003634|NCT00919711|10336036|P1|Overall Study|Lost to Follow-up|2
3003635|NCT00919711|10336035|P2|Overall Study|Administrative Decision|1
3003636|NCT00919711|10336036|P1|Overall Study|Administrative Decision|0
3003637|NCT00919711|10336035|P2|Overall Study|Other|2
3003638|NCT00919711|10336036|P1|Overall Study|Other|1
3003639|NCT00919711|10336035|P2|Overall Study|Adverse Event|3
3003640|NCT00919711|10336036|P1|Overall Study|Adverse Event|13
3003641|NCT00919711|10336035|P2|Overall Study|Withdrawal by Subject|7
3003642|NCT00919711|10336036|P1|Overall Study|Withdrawal by Subject|15
3003643|NCT00919633|10336052|P4|Overall Study|Viral rebound outside protocol timepoint|0
3003644|NCT00919633|10336053|P3|Overall Study|Viral rebound outside protocol timepoint|1
3003645|NCT00919633|10336054|P2|Overall Study|Viral rebound outside protocol timepoint|0
3003646|NCT00919633|10336055|P1|Overall Study|Viral rebound outside protocol timepoint|0
3003647|NCT00919633|10336052|P4|Overall Study|Request of withdrawal w/o future contact|0
3003648|NCT00919633|10336053|P3|Overall Study|Request of withdrawal w/o future contact|1
3003649|NCT00919633|10336054|P2|Overall Study|Request of withdrawal w/o future contact|0
3003650|NCT00919633|10336055|P1|Overall Study|Request of withdrawal w/o future contact|0
3003651|NCT00919633|10336052|P4|Overall Study|Physician Decision|1
3003652|NCT00919633|10336053|P3|Overall Study|Physician Decision|0
3003653|NCT00919633|10336054|P2|Overall Study|Physician Decision|0
3003654|NCT00919633|10336055|P1|Overall Study|Physician Decision|0
3003655|NCT00919633|10336052|P4|Overall Study|Protocol Violation|1
3003656|NCT00919633|10336053|P3|Overall Study|Protocol Violation|0
3003657|NCT00919633|10336054|P2|Overall Study|Protocol Violation|0
3003658|NCT00919633|10336055|P1|Overall Study|Protocol Violation|0
3003659|NCT00919633|10336052|P4|Overall Study|Withdraw consent post transition to SOC|1
3003660|NCT00919633|10336053|P3|Overall Study|Withdraw consent post transition to SOC|1
3003661|NCT00919633|10336054|P2|Overall Study|Withdraw consent post transition to SOC|0
3003662|NCT00919633|10336055|P1|Overall Study|Withdraw consent post transition to SOC|0
3003663|NCT00919633|10336052|P4|Overall Study|Lost to Follow-up|2
3003664|NCT00919633|10336053|P3|Overall Study|Lost to Follow-up|0
3003665|NCT00919633|10336054|P2|Overall Study|Lost to Follow-up|1
3003666|NCT00919633|10336055|P1|Overall Study|Lost to Follow-up|3
3003667|NCT00919633|10336052|P4|Overall Study|Withdrawal by Subject|3
3003668|NCT00919633|10336053|P3|Overall Study|Withdrawal by Subject|4
3003669|NCT00919633|10336054|P2|Overall Study|Withdrawal by Subject|2
3003670|NCT00919633|10336055|P1|Overall Study|Withdrawal by Subject|1
3003671|NCT00919633|10336052|P4|Overall Study|Lack of Efficacy|3
3003672|NCT00919633|10336053|P3|Overall Study|Lack of Efficacy|2
3003673|NCT00919633|10336054|P2|Overall Study|Lack of Efficacy|3
3003674|NCT00919633|10336055|P1|Overall Study|Lack of Efficacy|17
3003675|NCT00919633|10336052|P4|Overall Study|Death|0
3003676|NCT00919633|10336053|P3|Overall Study|Death|2
3003677|NCT00919633|10336054|P2|Overall Study|Death|0
3003678|NCT00919633|10336055|P1|Overall Study|Death|0
3003679|NCT00919633|10336052|P4|Overall Study|Adverse Event|10
3003680|NCT00919633|10336053|P3|Overall Study|Adverse Event|12
3003681|NCT00919633|10336054|P2|Overall Study|Adverse Event|9
3003682|NCT00919633|10336055|P1|Overall Study|Adverse Event|1
3003683|NCT00919061|10336153|P1|Overall Study|Withdrawal by Subject|1
3003684|NCT00919061|10336153|P1|Overall Study|Adverse Event|1
3003685|NCT00918957|10336166|P2|Overall Study|Withdrawal by Subject|0
3003686|NCT00918957|10336167|P1|Overall Study|Withdrawal by Subject|1
3003687|NCT00918957|10336166|P2|Overall Study|Adverse Event|0
3003688|NCT00918957|10336167|P1|Overall Study|Adverse Event|2
3003689|NCT00918879|10336200|P2|Overall Study|Severe non-compliance to protocol|1
3003690|NCT00918879|10336201|P1|Overall Study|Severe non-compliance to protocol|1
3003691|NCT00918879|10336200|P2|Overall Study|Lost to Follow-up|1
3003692|NCT00918879|10336201|P1|Overall Study|Lost to Follow-up|1
3003693|NCT00918879|10336200|P2|Overall Study|Withdrawal by Subject|4
3003694|NCT00918879|10336201|P1|Overall Study|Withdrawal by Subject|4
3003695|NCT00918749|10336233|P3|Overall Study|No Study Medication Taken|0
3003696|NCT00918749|10336234|P2|Overall Study|No Study Medication Taken|0
3003697|NCT00918749|10336235|P1|Overall Study|No Study Medication Taken|1
3003698|NCT00918749|10336233|P3|Overall Study|Withdrawal by Subject|5
3003699|NCT00918749|10336234|P2|Overall Study|Withdrawal by Subject|3
3003700|NCT00918749|10336235|P1|Overall Study|Withdrawal by Subject|5
3003701|NCT00918749|10336233|P3|Overall Study|Lost to Follow-up|1
3003702|NCT00918749|10336234|P2|Overall Study|Lost to Follow-up|0
3003703|NCT00918749|10336235|P1|Overall Study|Lost to Follow-up|0
3003704|NCT00918749|10336233|P3|Overall Study|Adverse Event|1
3003705|NCT00918749|10336234|P2|Overall Study|Adverse Event|0
3003706|NCT00918749|10336235|P1|Overall Study|Adverse Event|1
3003707|NCT00918736|10336267|P1|Overall Study|Withdrawal by Subject|4
3003708|NCT00918684|10336280|P1|Treatment Phase|Withdrawal by Subject|8
3003709|NCT00918684|10336280|P1|Treatment Phase|Protocol Violation|1
3003710|NCT00918684|10336280|P1|Treatment Phase|Physician Decision|8
3003711|NCT00918684|10336280|P1|Treatment Phase|Lost to Follow-up|2
3003712|NCT00918684|10336280|P1|Treatment Phase|Lack of Efficacy|6
3003713|NCT00918684|10336280|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
3003714|NCT00918645|10336291|P1|Overall Study|Withdrawal by Subject|1
3003715|NCT00918580|10336297|P1|After 6-month FU to 1-year FU|Failed to Return|2
3003716|NCT00918580|10336297|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
3003717|NCT00918580|10336297|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
3003718|NCT00918580|10336297|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
3003719|NCT00918580|10336297|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
3003720|NCT00918580|10336297|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
3003721|NCT00918580|10336297|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
3003722|NCT00918567|10336317|P2|Overall Study|Adverse Event|0
3003723|NCT00918567|10336318|P1|Overall Study|Adverse Event|1
3003724|NCT00918567|10336317|P2|Overall Study|Withdrawal by Subject|1
3003725|NCT00918567|10336318|P1|Overall Study|Withdrawal by Subject|1
3003726|NCT00918567|10336317|P2|Overall Study|Lack of Efficacy|1
3003727|NCT00918567|10336318|P1|Overall Study|Lack of Efficacy|3
3003728|NCT00918463|10336344|P1|Overall Study|Lack of Efficacy|1
3003729|NCT00918463|10336344|P1|Overall Study|Death|1
3003730|NCT00918385|10336352|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
3003731|NCT00918385|10336353|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
3003732|NCT00918385|10336352|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
3003733|NCT00918385|10336353|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
3003734|NCT00918385|10336352|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
3003735|NCT00918385|10336353|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
3003736|NCT00918385|10336352|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
3003737|NCT00918385|10336353|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
3003738|NCT00918385|10336352|P2|Monotherapy|Complicating illness|0
3003739|NCT00918385|10336353|P1|Monotherapy|Complicating illness|1
3003740|NCT00918385|10336352|P2|Monotherapy|Adverse Event|6
3003741|NCT00918385|10336353|P1|Monotherapy|Adverse Event|1
3003742|NCT00918346|10336362|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
3003743|NCT00918346|10336363|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
3003744|NCT00918333|10336379|P2|Overall Study|Withdrawal by Subject|1
3003745|NCT00918333|10336380|P1|Overall Study|Withdrawal by Subject|0
3003746|NCT00918333|10336379|P2|Overall Study|Ineligible|0
3003747|NCT00918333|10336380|P1|Overall Study|Ineligible|1
3003748|NCT00918333|10336379|P2|Overall Study|Inadequate amount of drugs provided|4
3003749|NCT00918333|10336380|P1|Overall Study|Inadequate amount of drugs provided|1
3003750|NCT00918333|10336379|P2|Overall Study|Drug not taken per protocol|0
3003751|NCT00918333|10336380|P1|Overall Study|Drug not taken per protocol|1
3003752|NCT00918281|10336400|P1|Overall Study|Physician Decision|29
3003753|NCT00918255|10336410|P3|Overall Study|Investigator discretion|0
3003754|NCT00918255|10336411|P2|Overall Study|Investigator discretion|0
3003755|NCT00918255|10336412|P1|Overall Study|Investigator discretion|1
3003756|NCT00918255|10336410|P3|Overall Study|Non-compliance|0
3003757|NCT00918255|10336411|P2|Overall Study|Non-compliance|0
3003758|NCT00918255|10336412|P1|Overall Study|Non-compliance|1
3003759|NCT00918255|10336410|P3|Overall Study|Exceeded allowed number of interventions|1
3003760|NCT00918255|10336411|P2|Overall Study|Exceeded allowed number of interventions|0
3003761|NCT00918255|10336412|P1|Overall Study|Exceeded allowed number of interventions|0
3003762|NCT00918255|10336410|P3|Overall Study|Lost to Follow-up|2
3003763|NCT00918255|10336411|P2|Overall Study|Lost to Follow-up|0
3003764|NCT00918255|10336412|P1|Overall Study|Lost to Follow-up|1
3003765|NCT00918255|10336410|P3|Overall Study|Lack of Efficacy|0
3003766|NCT00918255|10336411|P2|Overall Study|Lack of Efficacy|0
3003767|NCT00918255|10336412|P1|Overall Study|Lack of Efficacy|1
3003768|NCT00918255|10336410|P3|Overall Study|Withdrawal by Subject|2
3003769|NCT00918255|10336411|P2|Overall Study|Withdrawal by Subject|0
3003770|NCT00918255|10336412|P1|Overall Study|Withdrawal by Subject|1
3003771|NCT00918255|10336410|P3|Overall Study|Adverse Event|0
3003772|NCT00918255|10336411|P2|Overall Study|Adverse Event|0
3003773|NCT00918255|10336412|P1|Overall Study|Adverse Event|1
3003774|NCT00918203|10336445|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
3003775|NCT00918203|10336446|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
3003776|NCT00918203|10336447|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
3003777|NCT00918203|10336445|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
3003778|NCT00918203|10336446|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
3003779|NCT00918203|10336447|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
3003780|NCT00918203|10336445|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
3003781|NCT00918203|10336446|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
3003782|NCT00918203|10336447|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
3003783|NCT00918203|10336445|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
3003784|NCT00918203|10336446|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
3003785|NCT00918203|10336447|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
3003786|NCT00918138|10336478|P2|Overall Study|Death|0
3003787|NCT00918138|10336479|P1|Overall Study|Death|1
3003788|NCT00918138|10336478|P2|Overall Study|Subject withdrew consent|1
3003789|NCT00918138|10336479|P1|Overall Study|Subject withdrew consent|1
3003790|NCT00917852|10336518|P1|Overall Study|Death|6
3003791|NCT00917644|10336536|P2|Period 2: Second Intervention|family emergency|0
3003792|NCT00917644|10336537|P1|Period 2: Second Intervention|family emergency|1
3003793|NCT00917644|10336536|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
3003794|NCT00917644|10336537|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
3003795|NCT00917644|10336536|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
3003796|NCT00917644|10336537|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
3003797|NCT00917579|10336551|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
3003798|NCT00917579|10336552|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
3003799|NCT00917579|10336551|P2|Washout >= 2 Weeks|Adverse Event|0
3003800|NCT00917579|10336552|P1|Washout >= 2 Weeks|Adverse Event|1
3003801|NCT00917553|10336568|P2|Overall Study|Lost to Follow-up|1
3003802|NCT00917553|10336569|P1|Overall Study|Lost to Follow-up|2
3003803|NCT00917501|10336585|P2|Overall Study|trouble swollowing capsules|1
3003804|NCT00917501|10336586|P1|Overall Study|trouble swollowing capsules|0
3003805|NCT00917501|10336585|P2|Overall Study|Lack of Efficacy|2
3003806|NCT00917501|10336586|P1|Overall Study|Lack of Efficacy|1
3003807|NCT00917501|10336585|P2|Overall Study|Withdrawal by Subject|1
3003808|NCT00917501|10336586|P1|Overall Study|Withdrawal by Subject|3
3003809|NCT00917501|10336585|P2|Overall Study|Lost to Follow-up|1
3003810|NCT00917501|10336586|P1|Overall Study|Lost to Follow-up|4
3003811|NCT00917462|10336592|P1|Overall Study|Clinical Deterioration|1
3003812|NCT00917384|10336602|P2|Overall Study|Withdrawal by Subject|2
3003813|NCT00917384|10336603|P1|Overall Study|Withdrawal by Subject|10
3003814|NCT00917384|10336602|P2|Overall Study|Lost to Follow-up|2
3003815|NCT00917384|10336603|P1|Overall Study|Lost to Follow-up|4
3003816|NCT00917267|10336627|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
3003817|NCT00917267|10336628|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
3003818|NCT00917267|10336627|P2|Overall Study|Sponsor Decision|5
3003819|NCT00917267|10336628|P1|Overall Study|Sponsor Decision|5
3003820|NCT00917267|10336627|P2|Overall Study|Entry Criteria Not Met|0
3003821|NCT00917267|10336628|P1|Overall Study|Entry Criteria Not Met|1
3003822|NCT00917267|10336627|P2|Overall Study|Lost to follow up|2
3003823|NCT00917267|10336628|P1|Overall Study|Lost to follow up|0
3003824|NCT00917267|10336627|P2|Overall Study|Withdrawal by Subject|12
3003825|NCT00917267|10336628|P1|Overall Study|Withdrawal by Subject|5
3003826|NCT00917267|10336627|P2|Overall Study|Protocol Violation|18
3003827|NCT00917267|10336628|P1|Overall Study|Protocol Violation|9
3003828|NCT00917267|10336627|P2|Overall Study|Physician Decision|4
3003829|NCT00917267|10336628|P1|Overall Study|Physician Decision|2
3003830|NCT00917267|10336627|P2|Overall Study|Adverse Event|36
3003831|NCT00917267|10336628|P1|Overall Study|Adverse Event|15
3003832|NCT00917124|10336656|P2|Overall Study|Protocol Violation|6
3003833|NCT00917124|10336657|P1|Overall Study|Protocol Violation|4
3003834|NCT00916929|10336667|P2|Overall Study|Device unable to process impedance data|7
3003835|NCT00916929|10336668|P1|Overall Study|Device unable to process impedance data|0
3003836|NCT00916929|10336667|P2|Overall Study|Moved to another state|1
3003837|NCT00916929|10336668|P1|Overall Study|Moved to another state|0
3003838|NCT00916929|10336667|P2|Overall Study|System explant|0
3003839|NCT00916929|10336668|P1|Overall Study|System explant|1
3003840|NCT00916929|10336667|P2|Overall Study|Transferred to hospice care|1
3003841|NCT00916929|10336668|P1|Overall Study|Transferred to hospice care|1
3003842|NCT00916929|10336667|P2|Overall Study|Left ventricular epicardial lead|2
3003843|NCT00916929|10336668|P1|Overall Study|Left ventricular epicardial lead|1
3003844|NCT00916929|10336667|P2|Overall Study|Withdrawal by Subject|5
3003845|NCT00916929|10336668|P1|Overall Study|Withdrawal by Subject|1
3003846|NCT00916929|10336667|P2|Overall Study|Death|10
3003847|NCT00916929|10336668|P1|Overall Study|Death|5
3003848|NCT00916929|10336667|P2|Overall Study|Lost to Follow-up|3
3003849|NCT00916929|10336668|P1|Overall Study|Lost to Follow-up|1
3003850|NCT00916721|10336678|P2|Overall Study|Protocol Violation|4
3003851|NCT00916721|10336679|P1|Overall Study|Protocol Violation|2
3003852|NCT00916721|10336678|P2|Overall Study|Withdrawal by Subject|2
3003853|NCT00916721|10336679|P1|Overall Study|Withdrawal by Subject|2
3003854|NCT00916721|10336678|P2|Overall Study|Adverse Event|3
3003855|NCT00916721|10336679|P1|Overall Study|Adverse Event|6
3003856|NCT00916721|10336678|P2|Overall Study|Lost to Follow-up|1
3003857|NCT00916721|10336679|P1|Overall Study|Lost to Follow-up|0
3003858|NCT00916617|10336702|P4|Overall Study|Other|2
3003859|NCT00916617|10336703|P3|Overall Study|Other|0
3003860|NCT00916617|10336704|P2|Overall Study|Other|0
3003861|NCT00916617|10336705|P1|Overall Study|Other|2
3003862|NCT00916617|10336702|P4|Overall Study|Lack of Efficacy|0
3003863|NCT00916617|10336703|P3|Overall Study|Lack of Efficacy|0
3003864|NCT00916617|10336704|P2|Overall Study|Lack of Efficacy|0
3003865|NCT00916617|10336705|P1|Overall Study|Lack of Efficacy|1
3003866|NCT00916617|10336702|P4|Overall Study|Lost to Follow-up|0
3003867|NCT00916617|10336703|P3|Overall Study|Lost to Follow-up|0
3003868|NCT00916617|10336704|P2|Overall Study|Lost to Follow-up|1
3003869|NCT00916617|10336705|P1|Overall Study|Lost to Follow-up|2
3003870|NCT00916617|10336702|P4|Overall Study|Discontinuation of Study by Sponsor|1
3003871|NCT00916617|10336703|P3|Overall Study|Discontinuation of Study by Sponsor|3
3003872|NCT00916617|10336704|P2|Overall Study|Discontinuation of Study by Sponsor|13
3003873|NCT00916617|10336705|P1|Overall Study|Discontinuation of Study by Sponsor|8
3003874|NCT00916617|10336702|P4|Overall Study|Physician Decision|0
3003875|NCT00916617|10336703|P3|Overall Study|Physician Decision|0
3003876|NCT00916617|10336704|P2|Overall Study|Physician Decision|1
3003877|NCT00916617|10336705|P1|Overall Study|Physician Decision|1
3003878|NCT00916617|10336702|P4|Overall Study|Caregiver Request|0
3003879|NCT00916617|10336703|P3|Overall Study|Caregiver Request|1
3003880|NCT00916617|10336704|P2|Overall Study|Caregiver Request|2
3003881|NCT00916617|10336705|P1|Overall Study|Caregiver Request|3
3003882|NCT00916617|10336702|P4|Overall Study|Withdrawal by Subject|1
3003883|NCT00916617|10336703|P3|Overall Study|Withdrawal by Subject|0
3003884|NCT00916617|10336704|P2|Overall Study|Withdrawal by Subject|2
3003885|NCT00916617|10336705|P1|Overall Study|Withdrawal by Subject|3
3003886|NCT00916617|10336702|P4|Overall Study|Adverse Event|3
3003887|NCT00916617|10336703|P3|Overall Study|Adverse Event|6
3003888|NCT00916617|10336704|P2|Overall Study|Adverse Event|2
3003889|NCT00916617|10336705|P1|Overall Study|Adverse Event|3
3003890|NCT00916578|10336719|P1|Overall Study|Insurance Denial|2
3003891|NCT00916578|10336719|P1|Overall Study|Withdrawal by Subject|3
3003892|NCT00916578|10336719|P1|Overall Study|Physician Decision|2
3003893|NCT00916383|10336748|P1|Overall Study|Protocol Violation|1
3003894|NCT00916383|10336748|P1|Overall Study|Death|1
3003895|NCT00916383|10336748|P1|Overall Study|Adverse Event|1
3003896|NCT00916370|10336776|P2|Overall Study|Physician Decision|1
3003897|NCT00916370|10336777|P1|Overall Study|Physician Decision|0
3003898|NCT00916370|10336776|P2|Overall Study|Withdrawal by Subject|0
3003899|NCT00916370|10336777|P1|Overall Study|Withdrawal by Subject|2
3003900|NCT00916370|10336776|P2|Overall Study|Death|1
3003901|NCT00916370|10336777|P1|Overall Study|Death|3
3003902|NCT00916357|10336951|P6|Period 2|Weight loss > 3 kilograms (kg)|0
3003903|NCT00916357|10336952|P5|Period 2|Weight loss > 3 kilograms (kg)|0
3003904|NCT00916357|10336953|P4|Period 2|Weight loss > 3 kilograms (kg)|1
3003905|NCT00916357|10336954|P3|Period 2|Weight loss > 3 kilograms (kg)|0
3003906|NCT00916357|10336955|P2|Period 2|Weight loss > 3 kilograms (kg)|0
3003907|NCT00916357|10336956|P1|Period 2|Weight loss > 3 kilograms (kg)|0
3003908|NCT00916357|10336951|P6|Period 1|Withdrawal by Subject|0
3003909|NCT00916357|10336952|P5|Period 1|Withdrawal by Subject|0
3003910|NCT00916357|10336953|P4|Period 1|Withdrawal by Subject|0
3003911|NCT00916357|10336954|P3|Period 1|Withdrawal by Subject|0
3003912|NCT00916357|10336955|P2|Period 1|Withdrawal by Subject|0
3003913|NCT00916357|10336956|P1|Period 1|Withdrawal by Subject|1
3003914|NCT00916344|10336994|P1|Overall Study|Drop-out|5
3003915|NCT00916344|10336994|P1|Overall Study|ICD upgrade|1
3003916|NCT00916344|10336994|P1|Overall Study|Death|2
3003917|NCT00916305|10337001|P2|Overall Study|Withdrawal by Subject|1
3003918|NCT00916305|10337002|P1|Overall Study|Withdrawal by Subject|0
3003919|NCT00916305|10337001|P2|Overall Study|Lost to Follow-up|27
3003920|NCT00916305|10337002|P1|Overall Study|Lost to Follow-up|21
3003921|NCT00916279|10337010|P1|Overall Study|Lost to Follow-up|2
3003922|NCT00916279|10337010|P1|Overall Study|Death|2
3003923|NCT00916149|10337021|P3|Overall Study|Unable to place scalp EEG leads|0
3003924|NCT00916149|10337022|P2|Overall Study|Unable to place scalp EEG leads|0
3003925|NCT00916149|10337023|P1|Overall Study|Unable to place scalp EEG leads|1
3003926|NCT00916149|10337021|P3|Overall Study|Lost to Follow-up|0
3003927|NCT00916149|10337022|P2|Overall Study|Lost to Follow-up|2
3003928|NCT00916149|10337023|P1|Overall Study|Lost to Follow-up|3
3003929|NCT00916058|10337110|P7|Phase 2|Screen Failure|3
3003930|NCT00916058|10337111|P6|Phase 2|Screen Failure|0
3003931|NCT00916058|10337112|P5|Phase 2|Screen Failure|0
3003932|NCT00916058|10337113|P4|Phase 2|Screen Failure|0
3003933|NCT00916058|10337114|P3|Phase 2|Screen Failure|0
3003934|NCT00916058|10337115|P2|Phase 2|Screen Failure|0
3003935|NCT00916058|10337116|P1|Phase 2|Screen Failure|0
3003936|NCT00916058|10337110|P7|Phase 1|Screen Failure|0
3003937|NCT00916058|10337111|P6|Phase 1|Screen Failure|1
3003938|NCT00916058|10337112|P5|Phase 1|Screen Failure|0
3003939|NCT00916058|10337113|P4|Phase 1|Screen Failure|0
3003940|NCT00916058|10337114|P3|Phase 1|Screen Failure|0
3003941|NCT00916058|10337115|P2|Phase 1|Screen Failure|0
3003942|NCT00916058|10337116|P1|Phase 1|Screen Failure|0
3003943|NCT00916006|10337179|P2|Overall Study|Protocol Violation|1
3003944|NCT00916006|10337180|P1|Overall Study|Protocol Violation|0
3003945|NCT00916006|10337179|P2|Overall Study|Withdrawal by Subject|5
3003946|NCT00916006|10337180|P1|Overall Study|Withdrawal by Subject|2
3003947|NCT00916006|10337179|P2|Overall Study|Adverse Event|1
3003948|NCT00916006|10337180|P1|Overall Study|Adverse Event|1
3003949|NCT00915876|10337232|P2|Overall Study|Adverse Event|1
3003950|NCT00915876|10337233|P1|Overall Study|Adverse Event|0
3003951|NCT00915772|10337269|P3|Overall Study|Any other reason|7
3003952|NCT00915772|10337270|P2|Overall Study|Any other reason|7
3003953|NCT00915772|10337271|P1|Overall Study|Any other reason|4
3003954|NCT00915772|10337269|P3|Overall Study|Refused to continue trial medication|4
3003955|NCT00915772|10337270|P2|Overall Study|Refused to continue trial medication|8
3003956|NCT00915772|10337271|P1|Overall Study|Refused to continue trial medication|6
3003957|NCT00915772|10337269|P3|Overall Study|Lack of Efficacy|3
3003958|NCT00915772|10337270|P2|Overall Study|Lack of Efficacy|15
3003959|NCT00915772|10337271|P1|Overall Study|Lack of Efficacy|9
3003960|NCT00915772|10337269|P3|Overall Study|Lost to Follow-up|2
3003961|NCT00915772|10337270|P2|Overall Study|Lost to Follow-up|2
3003962|NCT00915772|10337271|P1|Overall Study|Lost to Follow-up|1
3003963|NCT00915772|10337269|P3|Overall Study|Protocol Violation|2
3003964|NCT00915772|10337270|P2|Overall Study|Protocol Violation|1
3003965|NCT00915772|10337271|P1|Overall Study|Protocol Violation|4
3003966|NCT00915772|10337269|P3|Overall Study|Adverse Event|11
3003967|NCT00915772|10337270|P2|Overall Study|Adverse Event|13
3003968|NCT00915772|10337271|P1|Overall Study|Adverse Event|12
3003969|NCT00915551|10337370|P2|Overall Study|Withdrawal by Subject|1
3003970|NCT00915551|10337371|P1|Overall Study|Withdrawal by Subject|0
3003971|NCT00915525|10337381|P2|Overall Study|Patient Moved|9
3003972|NCT00915525|10337382|P1|Overall Study|Patient Moved|15
3003973|NCT00915525|10337381|P2|Overall Study|Non-Compliance|1
3003974|NCT00915525|10337382|P1|Overall Study|Non-Compliance|3
3003975|NCT00915525|10337381|P2|Overall Study|Study Burden|12
3003976|NCT00915525|10337382|P1|Overall Study|Study Burden|28
3003977|NCT00915525|10337381|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
3003978|NCT00915525|10337382|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
3003979|NCT00915525|10337381|P2|Overall Study|Site Closed|9
3003980|NCT00915525|10337382|P1|Overall Study|Site Closed|27
3003981|NCT00915525|10337381|P2|Overall Study|Other Reason|12
3003982|NCT00915525|10337382|P1|Overall Study|Other Reason|35
3003983|NCT00915525|10337381|P2|Overall Study|Missing|1
3003984|NCT00915525|10337382|P1|Overall Study|Missing|12
3003985|NCT00915525|10337381|P2|Overall Study|Adverse Event|13
3003986|NCT00915525|10337382|P1|Overall Study|Adverse Event|29
3003987|NCT00915525|10337381|P2|Overall Study|Lack of Efficacy|32
3003988|NCT00915525|10337382|P1|Overall Study|Lack of Efficacy|15
3003989|NCT00915525|10337381|P2|Overall Study|Pregnancy|0
3003990|NCT00915525|10337382|P1|Overall Study|Pregnancy|2
3003991|NCT00915525|10337381|P2|Overall Study|Lost to Follow-up|16
3003992|NCT00915525|10337382|P1|Overall Study|Lost to Follow-up|27
3003993|NCT00915525|10337381|P2|Overall Study|Withdrawal by Subject|21
3003994|NCT00915525|10337382|P1|Overall Study|Withdrawal by Subject|59
3003995|NCT00915525|10337381|P2|Overall Study|Protocol Violation|4
3003996|NCT00915525|10337382|P1|Overall Study|Protocol Violation|9
3003997|NCT00915473|10337496|P2|4-week Follow Up|Lost to Follow-up|5
3003998|NCT00915473|10337497|P1|4-week Follow Up|Lost to Follow-up|1
3003999|NCT00915473|10337496|P2|Screening|Withdrawal by Subject|0
3004000|NCT00915473|10337497|P1|Screening|Withdrawal by Subject|1
3004001|NCT00915356|10337514|P5|Overall Study|Withdrawal by Subject|0
3004002|NCT00915356|10337515|P4|Overall Study|Withdrawal by Subject|0
3004003|NCT00915356|10337516|P3|Overall Study|Withdrawal by Subject|0
3004004|NCT00915356|10337517|P2|Overall Study|Withdrawal by Subject|0
3004005|NCT00915356|10337518|P1|Overall Study|Withdrawal by Subject|1
3004006|NCT00915343|10337580|P3|Part B - Open Label Period|Did not attend the last visit|1
3004007|NCT00915343|10337581|P2|Part B - Open Label Period|Did not attend the last visit|0
3004008|NCT00915343|10337582|P1|Part B - Open Label Period|Did not attend the last visit|0
3004009|NCT00915343|10337580|P3|Part B - Open Label Period|Treatment switch|1
3004010|NCT00915343|10337581|P2|Part B - Open Label Period|Treatment switch|0
3004011|NCT00915343|10337582|P1|Part B - Open Label Period|Treatment switch|0
3004012|NCT00915278|10337667|P6|Overall Study|Admission to hospice|0
3004013|NCT00915278|10337668|P5|Overall Study|Admission to hospice|0
3004014|NCT00915278|10337669|P4|Overall Study|Admission to hospice|0
3004015|NCT00915278|10337670|P3|Overall Study|Admission to hospice|1
3004016|NCT00915278|10337671|P2|Overall Study|Admission to hospice|0
3004017|NCT00915278|10337672|P1|Overall Study|Admission to hospice|0
3004018|NCT00915278|10337667|P6|Overall Study|Infusion related AEs|2
3004019|NCT00915278|10337668|P5|Overall Study|Infusion related AEs|0
3004020|NCT00915278|10337669|P4|Overall Study|Infusion related AEs|0
3004021|NCT00915278|10337670|P3|Overall Study|Infusion related AEs|0
3004022|NCT00915278|10337671|P2|Overall Study|Infusion related AEs|0
3004023|NCT00915278|10337672|P1|Overall Study|Infusion related AEs|0
3004024|NCT00915278|10337667|P6|Overall Study|Progressive disease/clinical progression|2
3004025|NCT00915278|10337668|P5|Overall Study|Progressive disease/clinical progression|1
3004026|NCT00915278|10337669|P4|Overall Study|Progressive disease/clinical progression|3
3004027|NCT00915278|10337670|P3|Overall Study|Progressive disease/clinical progression|0
3004028|NCT00915278|10337671|P2|Overall Study|Progressive disease/clinical progression|0
3004029|NCT00915278|10337672|P1|Overall Study|Progressive disease/clinical progression|0
3004030|NCT00915278|10337667|P6|Overall Study|Adverse Event|0
3004031|NCT00915278|10337668|P5|Overall Study|Adverse Event|0
3004032|NCT00915278|10337669|P4|Overall Study|Adverse Event|0
3004033|NCT00915278|10337670|P3|Overall Study|Adverse Event|0
3004034|NCT00915278|10337671|P2|Overall Study|Adverse Event|1
3004035|NCT00915278|10337672|P1|Overall Study|Adverse Event|4
3004036|NCT00915278|10337667|P6|Overall Study|Withdrawal by Subject|4
3004037|NCT00915278|10337668|P5|Overall Study|Withdrawal by Subject|1
3004038|NCT00915278|10337669|P4|Overall Study|Withdrawal by Subject|0
3004039|NCT00915278|10337670|P3|Overall Study|Withdrawal by Subject|0
3004040|NCT00915278|10337671|P2|Overall Study|Withdrawal by Subject|1
3004041|NCT00915278|10337672|P1|Overall Study|Withdrawal by Subject|0
3004042|NCT00915278|10337667|P6|Overall Study|Lost to Follow-up|0
3004043|NCT00915278|10337668|P5|Overall Study|Lost to Follow-up|0
3004044|NCT00915278|10337669|P4|Overall Study|Lost to Follow-up|0
3004045|NCT00915278|10337670|P3|Overall Study|Lost to Follow-up|0
3004046|NCT00915278|10337671|P2|Overall Study|Lost to Follow-up|1
3004047|NCT00915278|10337672|P1|Overall Study|Lost to Follow-up|0
3004048|NCT00915278|10337667|P6|Overall Study|Death|0
3004049|NCT00915278|10337668|P5|Overall Study|Death|0
3004050|NCT00915278|10337669|P4|Overall Study|Death|0
3004051|NCT00915278|10337670|P3|Overall Study|Death|0
3004052|NCT00915278|10337671|P2|Overall Study|Death|0
3004053|NCT00915278|10337672|P1|Overall Study|Death|1
3004054|NCT00915018|10337833|P2|Overall Study|By Sponsor due to Protocol Amendment|105
3004055|NCT00915018|10337834|P1|Overall Study|By Sponsor due to Protocol Amendment|92
3004056|NCT00915018|10337833|P2|Overall Study|Withdrawal by Subject|27
3004057|NCT00915018|10337834|P1|Overall Study|Withdrawal by Subject|38
3004058|NCT00915018|10337833|P2|Overall Study|Lost to Follow-up|5
3004059|NCT00915018|10337834|P1|Overall Study|Lost to Follow-up|10
3004060|NCT00915018|10337833|P2|Overall Study|Death|70
3004061|NCT00915018|10337834|P1|Overall Study|Death|75
3004062|NCT00915005|10337850|P2|Overall Study|Insurance denial|15
3004063|NCT00915005|10337851|P1|Overall Study|Insurance denial|3
3004064|NCT00915005|10337850|P2|Overall Study|Patient preferred protons therapy|0
3004065|NCT00915005|10337851|P1|Overall Study|Patient preferred protons therapy|6
3004066|NCT00915005|10337850|P2|Overall Study|Withdrawal by Subject|4
3004067|NCT00915005|10337851|P1|Overall Study|Withdrawal by Subject|4
3004068|NCT00914966|10337859|P1|Step 2: 2000 Units|Withdrawal by Subject|1
3004069|NCT00914966|10337859|P1|Step 1: 1500 Units|Physician Decision|1
3004070|NCT00914966|10337859|P1|Step 1: 1500 Units|Withdrawal by Subject|1
3004071|NCT00914927|10337878|P7|Overall Study|Administrative/Other|0
3004072|NCT00914927|10337879|P6|Overall Study|Administrative/Other|0
3004073|NCT00914927|10337880|P5|Overall Study|Administrative/Other|1
3004074|NCT00914927|10337881|P4|Overall Study|Administrative/Other|0
3004075|NCT00914927|10337882|P3|Overall Study|Administrative/Other|0
3004076|NCT00914927|10337883|P2|Overall Study|Administrative/Other|1
3004077|NCT00914927|10337884|P1|Overall Study|Administrative/Other|2
3004078|NCT00914927|10337878|P7|Overall Study|Lost to Follow-up|0
3004079|NCT00914927|10337879|P6|Overall Study|Lost to Follow-up|0
3004080|NCT00914927|10337880|P5|Overall Study|Lost to Follow-up|0
3004081|NCT00914927|10337881|P4|Overall Study|Lost to Follow-up|1
3004082|NCT00914927|10337882|P3|Overall Study|Lost to Follow-up|0
3004083|NCT00914927|10337883|P2|Overall Study|Lost to Follow-up|0
3004084|NCT00914927|10337884|P1|Overall Study|Lost to Follow-up|0
3004085|NCT00914927|10337878|P7|Overall Study|Withdrawal by Subject|0
3004086|NCT00914927|10337879|P6|Overall Study|Withdrawal by Subject|0
3004087|NCT00914927|10337880|P5|Overall Study|Withdrawal by Subject|0
3004088|NCT00914927|10337881|P4|Overall Study|Withdrawal by Subject|1
3004089|NCT00914927|10337882|P3|Overall Study|Withdrawal by Subject|0
3004090|NCT00914927|10337883|P2|Overall Study|Withdrawal by Subject|1
3004091|NCT00914927|10337884|P1|Overall Study|Withdrawal by Subject|0
3004092|NCT00914927|10337878|P7|Overall Study|Adverse Event|0
3004093|NCT00914927|10337879|P6|Overall Study|Adverse Event|0
3004094|NCT00914927|10337880|P5|Overall Study|Adverse Event|1
3004095|NCT00914927|10337881|P4|Overall Study|Adverse Event|0
3004096|NCT00914927|10337882|P3|Overall Study|Adverse Event|0
3004097|NCT00914927|10337883|P2|Overall Study|Adverse Event|0
3004098|NCT00914927|10337884|P1|Overall Study|Adverse Event|0
3004099|NCT00914849|10338011|P2|Overall Study|Not eligible|1
3004100|NCT00914849|10338012|P1|Overall Study|Not eligible|0
3004101|NCT00914849|10338011|P2|Overall Study|Withdrawal by Subject|0
3004102|NCT00914849|10338012|P1|Overall Study|Withdrawal by Subject|1
3004103|NCT00914810|10338046|P2|Overall Study|Hospitalized and unable to follow up.|1
3004104|NCT00914810|10338047|P1|Overall Study|Hospitalized and unable to follow up.|0
3004105|NCT00914810|10338046|P2|Overall Study|Relocated out of state|0
3004106|NCT00914810|10338047|P1|Overall Study|Relocated out of state|1
3004107|NCT00914810|10338046|P2|Overall Study|Withdrawal by Subject|0
3004108|NCT00914810|10338047|P1|Overall Study|Withdrawal by Subject|1
3004109|NCT00914589|10338058|P3|Overall Study|Death|1
3004110|NCT00914589|10338059|P2|Overall Study|Death|1
3004111|NCT00914589|10338060|P1|Overall Study|Death|0
3004112|NCT00914589|10338058|P3|Overall Study|unclassified|7
3004113|NCT00914589|10338059|P2|Overall Study|unclassified|9
3004114|NCT00914589|10338060|P1|Overall Study|unclassified|16
3004115|NCT00914589|10338058|P3|Overall Study|Protocol Violation|3
3004116|NCT00914589|10338059|P2|Overall Study|Protocol Violation|6
3004117|NCT00914589|10338060|P1|Overall Study|Protocol Violation|8
3004118|NCT00914589|10338058|P3|Overall Study|Adverse Event|1
3004119|NCT00914589|10338059|P2|Overall Study|Adverse Event|0
3004120|NCT00914589|10338060|P1|Overall Study|Adverse Event|1
3004121|NCT00914459|10338086|P2|Overall Study|Parent/Legal guardian request|0
3004122|NCT00914459|10338087|P1|Overall Study|Parent/Legal guardian request|1
3004123|NCT00914459|10338086|P2|Overall Study|Protocol Violation|1
3004124|NCT00914459|10338087|P1|Overall Study|Protocol Violation|0
3004125|NCT00914316|10338117|P4|Phase 2|Withdrawal by Subject|0
3004126|NCT00914316|10338118|P3|Phase 2|Withdrawal by Subject|1
3004127|NCT00914316|10338119|P2|Phase 2|Withdrawal by Subject|0
3004128|NCT00914316|10338120|P1|Phase 2|Withdrawal by Subject|1
3004129|NCT00914316|10338117|P4|Phase 1|Adverse Event|0
3004130|NCT00914316|10338118|P3|Phase 1|Adverse Event|0
3004131|NCT00914316|10338119|P2|Phase 1|Adverse Event|0
3004132|NCT00914316|10338120|P1|Phase 1|Adverse Event|1
3004133|NCT00914316|10338117|P4|Phase 1|Withdrawal by Subject|0
3004134|NCT00914316|10338118|P3|Phase 1|Withdrawal by Subject|4
3004135|NCT00914316|10338119|P2|Phase 1|Withdrawal by Subject|2
3004136|NCT00914316|10338120|P1|Phase 1|Withdrawal by Subject|0
3004137|NCT00914316|10338117|P4|Phase 1|Physician Decision|2
3004138|NCT00914316|10338118|P3|Phase 1|Physician Decision|1
3004139|NCT00914316|10338119|P2|Phase 1|Physician Decision|0
3004140|NCT00914316|10338120|P1|Phase 1|Physician Decision|4
3004141|NCT00913978|10338192|P2|Overall Study|Surgeon choice|3
3004142|NCT00913978|10338193|P1|Overall Study|Surgeon choice|1
3004143|NCT00913835|10338210|P2|Lip Dox: Olaratumab Monotherapy|Other|3
3004144|NCT00913835|10338211|P1|Lip Dox: Olaratumab Monotherapy|Other|0
3004145|NCT00913835|10338210|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
3004146|NCT00913835|10338211|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
3004147|NCT00913835|10338210|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
3004148|NCT00913835|10338211|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
3004149|NCT00913835|10338210|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
3004150|NCT00913835|10338211|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
3004151|NCT00913835|10338210|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
3004152|NCT00913835|10338211|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
3004153|NCT00913770|10338250|P3|Overall Study|Refused|8
3004154|NCT00913770|10338251|P2|Overall Study|Refused|10
3004155|NCT00913770|10338252|P1|Overall Study|Refused|11
3004156|NCT00913770|10338250|P3|Overall Study|Unable to contact|13
3004157|NCT00913770|10338251|P2|Overall Study|Unable to contact|19
3004158|NCT00913770|10338252|P1|Overall Study|Unable to contact|24
3004159|NCT00913744|10338265|P2|Overall Study|Death|0
3004160|NCT00913744|10338266|P1|Overall Study|Death|1
3004161|NCT00913744|10338265|P2|Overall Study|Withdrawal by Subject|1
3004162|NCT00913744|10338266|P1|Overall Study|Withdrawal by Subject|2
3004163|NCT00913744|10338265|P2|Overall Study|Adverse Event|0
3004164|NCT00913744|10338266|P1|Overall Study|Adverse Event|2
3004165|NCT00913692|10338272|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
3004166|NCT00913692|10338272|P1|Screening (4 Months)|Not eligible after screening phase.|6
3004167|NCT00913692|10338272|P1|Screening (4 Months)|Physician Decision|3
3004168|NCT00913523|10338366|P3|Overall Study|Inadequate Number of Tampons Used|3
3004169|NCT00913523|10338367|P2|Overall Study|Inadequate Number of Tampons Used|2
3004170|NCT00913523|10338368|P1|Overall Study|Inadequate Number of Tampons Used|7
3004171|NCT00913523|10338366|P3|Overall Study|Pregnancy|0
3004172|NCT00913523|10338367|P2|Overall Study|Pregnancy|3
3004173|NCT00913523|10338368|P1|Overall Study|Pregnancy|1
3004174|NCT00913523|10338366|P3|Overall Study|Protocol Violation|8
3004175|NCT00913523|10338367|P2|Overall Study|Protocol Violation|8
3004176|NCT00913523|10338368|P1|Overall Study|Protocol Violation|5
3004177|NCT00913523|10338366|P3|Overall Study|Adverse Event|0
3004178|NCT00913523|10338367|P2|Overall Study|Adverse Event|0
3004179|NCT00913523|10338368|P1|Overall Study|Adverse Event|1
3004180|NCT00913523|10338366|P3|Overall Study|Lost to Follow-up|1
3004181|NCT00913523|10338367|P2|Overall Study|Lost to Follow-up|1
3004182|NCT00913523|10338368|P1|Overall Study|Lost to Follow-up|1
3004183|NCT00913523|10338366|P3|Overall Study|Withdrawal by Subject|2
3004184|NCT00913523|10338367|P2|Overall Study|Withdrawal by Subject|2
3004185|NCT00913523|10338368|P1|Overall Study|Withdrawal by Subject|3
3004186|NCT00913458|10338400|P7|Phase 3|Unsatisfactory Response per Investigator|4
3004187|NCT00913458|10338401|P6|Phase 3|Unsatisfactory Response per Investigator|11
3004188|NCT00913458|10338402|P5|Phase 3|Unsatisfactory Response per Investigator|14
3004189|NCT00913458|10338403|P4|Phase 3|Unsatisfactory Response per Investigator|0
3004190|NCT00913458|10338404|P3|Phase 3|Unsatisfactory Response per Investigator|0
3004191|NCT00913458|10338405|P2|Phase 3|Unsatisfactory Response per Investigator|0
3004192|NCT00913458|10338406|P1|Phase 3|Unsatisfactory Response per Investigator|0
3004193|NCT00913458|10338400|P7|Phase 3|Withdrawal by Subject|0
3004194|NCT00913458|10338401|P6|Phase 3|Withdrawal by Subject|2
3004195|NCT00913458|10338402|P5|Phase 3|Withdrawal by Subject|1
3004196|NCT00913458|10338403|P4|Phase 3|Withdrawal by Subject|0
3004197|NCT00913458|10338404|P3|Phase 3|Withdrawal by Subject|0
3004198|NCT00913458|10338405|P2|Phase 3|Withdrawal by Subject|0
3004199|NCT00913458|10338406|P1|Phase 3|Withdrawal by Subject|0
3004200|NCT00913458|10338400|P7|Phase 3|Non-Responder|3
3004201|NCT00913458|10338401|P6|Phase 3|Non-Responder|1
3004202|NCT00913458|10338402|P5|Phase 3|Non-Responder|0
3004203|NCT00913458|10338403|P4|Phase 3|Non-Responder|0
3004204|NCT00913458|10338404|P3|Phase 3|Non-Responder|0
3004205|NCT00913458|10338405|P2|Phase 3|Non-Responder|0
3004206|NCT00913458|10338406|P1|Phase 3|Non-Responder|0
3004207|NCT00913458|10338400|P7|Phase 3|Lost to Follow-up|0
3004208|NCT00913458|10338401|P6|Phase 3|Lost to Follow-up|0
3004209|NCT00913458|10338402|P5|Phase 3|Lost to Follow-up|2
3004210|NCT00913458|10338403|P4|Phase 3|Lost to Follow-up|0
3004211|NCT00913458|10338404|P3|Phase 3|Lost to Follow-up|0
3004212|NCT00913458|10338405|P2|Phase 3|Lost to Follow-up|0
3004213|NCT00913458|10338406|P1|Phase 3|Lost to Follow-up|0
3004214|NCT00913458|10338400|P7|Phase 3|Adverse Event|1
3004215|NCT00913458|10338401|P6|Phase 3|Adverse Event|4
3004216|NCT00913458|10338402|P5|Phase 3|Adverse Event|5
3004217|NCT00913458|10338403|P4|Phase 3|Adverse Event|0
3004218|NCT00913458|10338404|P3|Phase 3|Adverse Event|0
3004219|NCT00913458|10338405|P2|Phase 3|Adverse Event|0
3004220|NCT00913458|10338406|P1|Phase 3|Adverse Event|0
3004221|NCT00913458|10338400|P7|Phase 2|Unsatisfactory Response per Investigator|0
3004222|NCT00913458|10338401|P6|Phase 2|Unsatisfactory Response per Investigator|0
3004223|NCT00913458|10338402|P5|Phase 2|Unsatisfactory Response per Investigator|0
3004224|NCT00913458|10338403|P4|Phase 2|Unsatisfactory Response per Investigator|17
3004225|NCT00913458|10338404|P3|Phase 2|Unsatisfactory Response per Investigator|11
3004226|NCT00913458|10338405|P2|Phase 2|Unsatisfactory Response per Investigator|0
3004227|NCT00913458|10338406|P1|Phase 2|Unsatisfactory Response per Investigator|0
3004228|NCT00913458|10338400|P7|Phase 2|Protocol Violation|0
3004229|NCT00913458|10338401|P6|Phase 2|Protocol Violation|0
3004230|NCT00913458|10338402|P5|Phase 2|Protocol Violation|0
3004231|NCT00913458|10338403|P4|Phase 2|Protocol Violation|0
3004232|NCT00913458|10338404|P3|Phase 2|Protocol Violation|0
3004233|NCT00913458|10338405|P2|Phase 2|Protocol Violation|2
3004234|NCT00913458|10338406|P1|Phase 2|Protocol Violation|0
3004235|NCT00913458|10338400|P7|Phase 2|Lost to Follow-up|0
3004236|NCT00913458|10338401|P6|Phase 2|Lost to Follow-up|0
3004237|NCT00913458|10338402|P5|Phase 2|Lost to Follow-up|0
3004238|NCT00913458|10338403|P4|Phase 2|Lost to Follow-up|1
3004239|NCT00913458|10338404|P3|Phase 2|Lost to Follow-up|0
3004240|NCT00913458|10338405|P2|Phase 2|Lost to Follow-up|0
3004241|NCT00913458|10338406|P1|Phase 2|Lost to Follow-up|0
3004242|NCT00913458|10338400|P7|Phase 2|Adverse Event|0
3004243|NCT00913458|10338401|P6|Phase 2|Adverse Event|0
3004244|NCT00913458|10338402|P5|Phase 2|Adverse Event|0
3004245|NCT00913458|10338403|P4|Phase 2|Adverse Event|1
3004246|NCT00913458|10338404|P3|Phase 2|Adverse Event|0
3004247|NCT00913458|10338405|P2|Phase 2|Adverse Event|3
3004248|NCT00913458|10338406|P1|Phase 2|Adverse Event|0
3004249|NCT00913458|10338400|P7|Phase 2|Subject Request|0
3004250|NCT00913458|10338401|P6|Phase 2|Subject Request|0
3004251|NCT00913458|10338402|P5|Phase 2|Subject Request|0
3004252|NCT00913458|10338403|P4|Phase 2|Subject Request|2
3004253|NCT00913458|10338404|P3|Phase 2|Subject Request|1
3004254|NCT00913458|10338405|P2|Phase 2|Subject Request|0
3004255|NCT00913458|10338406|P1|Phase 2|Subject Request|0
3004256|NCT00913458|10338400|P7|Phase 2|Non-Responder|0
3004257|NCT00913458|10338401|P6|Phase 2|Non-Responder|0
3004258|NCT00913458|10338402|P5|Phase 2|Non-Responder|0
3004259|NCT00913458|10338403|P4|Phase 2|Non-Responder|12
3004260|NCT00913458|10338404|P3|Phase 2|Non-Responder|7
3004261|NCT00913458|10338405|P2|Phase 2|Non-Responder|5
3004262|NCT00913458|10338406|P1|Phase 2|Non-Responder|0
3004263|NCT00913458|10338400|P7|Phase 1|Unsatisfactory Response per Investigator|0
3004264|NCT00913458|10338401|P6|Phase 1|Unsatisfactory Response per Investigator|0
3004265|NCT00913458|10338402|P5|Phase 1|Unsatisfactory Response per Investigator|0
3004266|NCT00913458|10338403|P4|Phase 1|Unsatisfactory Response per Investigator|0
3004267|NCT00913458|10338404|P3|Phase 1|Unsatisfactory Response per Investigator|0
3004268|NCT00913458|10338405|P2|Phase 1|Unsatisfactory Response per Investigator|0
3004269|NCT00913458|10338406|P1|Phase 1|Unsatisfactory Response per Investigator|7
3004270|NCT00913458|10338400|P7|Phase 1|Sponsor|0
3004271|NCT00913458|10338401|P6|Phase 1|Sponsor|0
3004272|NCT00913458|10338402|P5|Phase 1|Sponsor|0
3004273|NCT00913458|10338403|P4|Phase 1|Sponsor|0
3004274|NCT00913458|10338404|P3|Phase 1|Sponsor|0
3004275|NCT00913458|10338405|P2|Phase 1|Sponsor|0
3004276|NCT00913458|10338406|P1|Phase 1|Sponsor|2
3004277|NCT00913458|10338400|P7|Phase 1|Protocol Violation|0
3004278|NCT00913458|10338401|P6|Phase 1|Protocol Violation|0
3004279|NCT00913458|10338402|P5|Phase 1|Protocol Violation|0
3004280|NCT00913458|10338403|P4|Phase 1|Protocol Violation|0
3004281|NCT00913458|10338404|P3|Phase 1|Protocol Violation|0
3004282|NCT00913458|10338405|P2|Phase 1|Protocol Violation|0
3004283|NCT00913458|10338406|P1|Phase 1|Protocol Violation|10
3004284|NCT00913458|10338400|P7|Phase 1|Lost to Follow-up|0
3004285|NCT00913458|10338401|P6|Phase 1|Lost to Follow-up|0
3004286|NCT00913458|10338402|P5|Phase 1|Lost to Follow-up|0
3004287|NCT00913458|10338403|P4|Phase 1|Lost to Follow-up|0
3004288|NCT00913458|10338404|P3|Phase 1|Lost to Follow-up|0
3004289|NCT00913458|10338405|P2|Phase 1|Lost to Follow-up|0
3004290|NCT00913458|10338406|P1|Phase 1|Lost to Follow-up|2
3004291|NCT00913458|10338400|P7|Phase 1|Adverse Event|0
3004292|NCT00913458|10338401|P6|Phase 1|Adverse Event|0
3004293|NCT00913458|10338402|P5|Phase 1|Adverse Event|0
3004294|NCT00913458|10338403|P4|Phase 1|Adverse Event|0
3004295|NCT00913458|10338404|P3|Phase 1|Adverse Event|0
3004296|NCT00913458|10338405|P2|Phase 1|Adverse Event|0
3004297|NCT00913458|10338406|P1|Phase 1|Adverse Event|20
3004298|NCT00913458|10338400|P7|Phase 1|Subject Request|0
3004299|NCT00913458|10338401|P6|Phase 1|Subject Request|0
3004300|NCT00913458|10338402|P5|Phase 1|Subject Request|0
3004301|NCT00913458|10338403|P4|Phase 1|Subject Request|0
3004302|NCT00913458|10338404|P3|Phase 1|Subject Request|0
3004303|NCT00913458|10338405|P2|Phase 1|Subject Request|0
3004304|NCT00913458|10338406|P1|Phase 1|Subject Request|17
3004305|NCT00913458|10338400|P7|Phase 1|Non-Responder|0
3004306|NCT00913458|10338401|P6|Phase 1|Non-Responder|0
3004307|NCT00913458|10338402|P5|Phase 1|Non-Responder|0
3004308|NCT00913458|10338403|P4|Phase 1|Non-Responder|0
3004309|NCT00913458|10338404|P3|Phase 1|Non-Responder|0
3004310|NCT00913458|10338405|P2|Phase 1|Non-Responder|0
3004311|NCT00913458|10338406|P1|Phase 1|Non-Responder|54
3004312|NCT00913380|10338499|P2|Clinical Outcomes|Lost to Follow-up|6
3004313|NCT00913380|10338500|P1|Clinical Outcomes|Lost to Follow-up|6
3004314|NCT00912964|10338566|P3|Overall Study|Randomized but never received study drug|0
3004315|NCT00912964|10338567|P2|Overall Study|Randomized but never received study drug|1
3004316|NCT00912964|10338568|P1|Overall Study|Randomized but never received study drug|0
3004317|NCT00912964|10338566|P3|Overall Study|Violation of exclusion criterion|2
3004318|NCT00912964|10338567|P2|Overall Study|Violation of exclusion criterion|0
3004319|NCT00912964|10338568|P1|Overall Study|Violation of exclusion criterion|0
3004320|NCT00912964|10338566|P3|Overall Study|Non-compliance with study procedures|0
3004321|NCT00912964|10338567|P2|Overall Study|Non-compliance with study procedures|0
3004322|NCT00912964|10338568|P1|Overall Study|Non-compliance with study procedures|2
3004323|NCT00912964|10338566|P3|Overall Study|Medical History|0
3004324|NCT00912964|10338567|P2|Overall Study|Medical History|0
3004325|NCT00912964|10338568|P1|Overall Study|Medical History|1
3004326|NCT00912964|10338566|P3|Overall Study|Taking exclusionary medications|8
3004327|NCT00912964|10338567|P2|Overall Study|Taking exclusionary medications|4
3004328|NCT00912964|10338568|P1|Overall Study|Taking exclusionary medications|7
3004329|NCT00912964|10338566|P3|Overall Study|Protocol Violation|8
3004330|NCT00912964|10338567|P2|Overall Study|Protocol Violation|3
3004331|NCT00912964|10338568|P1|Overall Study|Protocol Violation|5
3004332|NCT00912964|10338566|P3|Overall Study|Lost to Follow-up|3
3004333|NCT00912964|10338567|P2|Overall Study|Lost to Follow-up|3
3004334|NCT00912964|10338568|P1|Overall Study|Lost to Follow-up|4
3004335|NCT00912964|10338566|P3|Overall Study|Withdrawal by Subject|18
3004336|NCT00912964|10338567|P2|Overall Study|Withdrawal by Subject|12
3004337|NCT00912964|10338568|P1|Overall Study|Withdrawal by Subject|20
3004338|NCT00912964|10338566|P3|Overall Study|Lack of Efficacy|3
3004339|NCT00912964|10338567|P2|Overall Study|Lack of Efficacy|4
3004340|NCT00912964|10338568|P1|Overall Study|Lack of Efficacy|11
3004341|NCT00912964|10338566|P3|Overall Study|Adverse Event|12
3004342|NCT00912964|10338567|P2|Overall Study|Adverse Event|18
3004343|NCT00912964|10338568|P1|Overall Study|Adverse Event|15
3004344|NCT00912964|10338566|P3|Overall Study|Eligibility criterion not met|0
3004345|NCT00912964|10338567|P2|Overall Study|Eligibility criterion not met|1
3004346|NCT00912964|10338568|P1|Overall Study|Eligibility criterion not met|1
3004347|NCT00912912|10338711|P1|Overall Study|Disease Progression|3
3004348|NCT00912912|10338711|P1|Overall Study|Withdrawal by Subject|1
3004349|NCT00912808|10338717|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
3004350|NCT00912808|10338718|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
3004351|NCT00912808|10338717|P2|Second Intervention (6 Weeks)|Adverse Event|1
3004352|NCT00912808|10338718|P1|Second Intervention (6 Weeks)|Adverse Event|0
3004353|NCT00912808|10338717|P2|Washout|Withdrawal by Subject|1
3004354|NCT00912808|10338718|P1|Washout|Withdrawal by Subject|0
3004355|NCT00912808|10338717|P2|First Intervention (6 Weeks)|Adverse Event|1
3004356|NCT00912808|10338718|P1|First Intervention (6 Weeks)|Adverse Event|2
3004357|NCT00912782|10338743|P2|Overall Study|Relocated before study completion|1
3004358|NCT00912782|10338744|P1|Overall Study|Relocated before study completion|0
3004359|NCT00912782|10338743|P2|Overall Study|Did not receive vascular access type|2
3004360|NCT00912782|10338744|P1|Overall Study|Did not receive vascular access type|1
3004361|NCT00912782|10338743|P2|Overall Study|Lost to Follow-up|1
3004362|NCT00912782|10338744|P1|Overall Study|Lost to Follow-up|0
3004363|NCT00912782|10338743|P2|Overall Study|Death|1
3004364|NCT00912782|10338744|P1|Overall Study|Death|2
3004365|NCT00912743|10338754|P2|Overall Study|End of treatment form was not collected|0
3004366|NCT00912743|10338755|P1|Overall Study|End of treatment form was not collected|1
3004367|NCT00912743|10338754|P2|Overall Study|Toxicity|1
3004368|NCT00912743|10338755|P1|Overall Study|Toxicity|0
3004369|NCT00912743|10338754|P2|Overall Study|Lack of Efficacy|18
3004370|NCT00912743|10338755|P1|Overall Study|Lack of Efficacy|9
3004371|NCT00912743|10338754|P2|Overall Study|Adverse Event|1
3004372|NCT00912743|10338755|P1|Overall Study|Adverse Event|3
3004373|NCT00912509|10338767|P2|Overall Study|Lack of Efficacy|3
3004374|NCT00912509|10338768|P1|Overall Study|Lack of Efficacy|4
3004375|NCT00912509|10338767|P2|Overall Study|Lost to Follow-up|0
3004376|NCT00912509|10338768|P1|Overall Study|Lost to Follow-up|1
3004377|NCT00912405|10338776|P1|Overall Study|Lost to Follow-up|5
3004378|NCT00912340|10338786|P3|Overall Study|Protocol revised to remove arm|4
3004379|NCT00912340|10338787|P2|Overall Study|Protocol revised to remove arm|0
3004380|NCT00912340|10338788|P1|Overall Study|Protocol revised to remove arm|0
3004381|NCT00912340|10338786|P3|Overall Study|Adverse Event|0
3004382|NCT00912340|10338787|P2|Overall Study|Adverse Event|4
3004383|NCT00912340|10338788|P1|Overall Study|Adverse Event|2
3004384|NCT00912288|10338826|P2|Overall Study|Other|0
3004385|NCT00912288|10338827|P1|Overall Study|Other|1
3004386|NCT00912288|10338826|P2|Overall Study|Study terminated by sponsor|35
3004387|NCT00912288|10338827|P1|Overall Study|Study terminated by sponsor|34
3004388|NCT00912288|10338826|P2|Overall Study|Withdrawal by Subject|3
3004389|NCT00912288|10338827|P1|Overall Study|Withdrawal by Subject|3
3004390|NCT00912288|10338826|P2|Overall Study|Protocol Violation|0
3004391|NCT00912288|10338827|P1|Overall Study|Protocol Violation|1
3004392|NCT00912288|10338826|P2|Overall Study|Lost to Follow-up|0
3004393|NCT00912288|10338827|P1|Overall Study|Lost to Follow-up|1
3004394|NCT00912288|10338826|P2|Overall Study|Adverse Event|1
3004395|NCT00912288|10338827|P1|Overall Study|Adverse Event|1
3004396|NCT00912288|10338826|P2|Overall Study|Death|1
3004397|NCT00912288|10338827|P1|Overall Study|Death|0
3004398|NCT00912223|10338849|P1|Overall Study|Transformed disease|1
3004399|NCT00912223|10338849|P1|Overall Study|Not transplanted|1
3004400|NCT00912223|10338849|P1|Overall Study|Withdrawal by Subject|1
3004401|NCT00912093|10338880|P5|The Controlled Phase|Lost to Follow-up|1
3004402|NCT00912093|10338881|P4|The Controlled Phase|Lost to Follow-up|0
3004403|NCT00912093|10338882|P3|The Controlled Phase|Lost to Follow-up|0
3004404|NCT00912093|10338883|P2|The Controlled Phase|Lost to Follow-up|0
3004405|NCT00912093|10338884|P1|The Controlled Phase|Lost to Follow-up|0
3004406|NCT00912093|10338880|P5|The Controlled Phase|Medical Condition|0
3004407|NCT00912093|10338881|P4|The Controlled Phase|Medical Condition|0
3004408|NCT00912093|10338882|P3|The Controlled Phase|Medical Condition|0
3004409|NCT00912093|10338883|P2|The Controlled Phase|Medical Condition|1
3004410|NCT00912093|10338884|P1|The Controlled Phase|Medical Condition|0
3004411|NCT00912093|10338880|P5|The Controlled Phase|Death|0
3004412|NCT00912093|10338881|P4|The Controlled Phase|Death|0
3004413|NCT00912093|10338882|P3|The Controlled Phase|Death|0
3004414|NCT00912093|10338883|P2|The Controlled Phase|Death|1
3004415|NCT00912093|10338884|P1|The Controlled Phase|Death|0
3004416|NCT00912028|10338903|P5|Overall Study|Withdrawal by Subject|0
3004417|NCT00912028|10338904|P4|Overall Study|Withdrawal by Subject|0
3004418|NCT00912028|10338905|P3|Overall Study|Withdrawal by Subject|0
3004419|NCT00912028|10338906|P2|Overall Study|Withdrawal by Subject|0
3004420|NCT00912028|10338907|P1|Overall Study|Withdrawal by Subject|3
3004421|NCT00912028|10338903|P5|Overall Study|Lost to Follow-up|3
3004422|NCT00912028|10338904|P4|Overall Study|Lost to Follow-up|1
3004423|NCT00912028|10338905|P3|Overall Study|Lost to Follow-up|0
3004424|NCT00912028|10338906|P2|Overall Study|Lost to Follow-up|3
3004425|NCT00912028|10338907|P1|Overall Study|Lost to Follow-up|2
3004426|NCT00912015|10338936|P4|Overall Study|Adverse Event|1
3004427|NCT00912015|10338937|P3|Overall Study|Adverse Event|0
3004428|NCT00912015|10338938|P2|Overall Study|Adverse Event|0
3004429|NCT00912015|10338939|P1|Overall Study|Adverse Event|6
3004430|NCT00912015|10338936|P4|Overall Study|Protocol Violation|1
3004431|NCT00912015|10338937|P3|Overall Study|Protocol Violation|0
3004432|NCT00912015|10338938|P2|Overall Study|Protocol Violation|0
3004433|NCT00912015|10338939|P1|Overall Study|Protocol Violation|1
3004434|NCT00912015|10338936|P4|Overall Study|Withdrawal by Subject|0
3004435|NCT00912015|10338937|P3|Overall Study|Withdrawal by Subject|3
3004436|NCT00912015|10338938|P2|Overall Study|Withdrawal by Subject|8
3004437|NCT00912015|10338939|P1|Overall Study|Withdrawal by Subject|8
3004438|NCT00912015|10338936|P4|Overall Study|Lack of Efficacy|0
3004439|NCT00912015|10338937|P3|Overall Study|Lack of Efficacy|0
3004440|NCT00912015|10338938|P2|Overall Study|Lack of Efficacy|0
3004441|NCT00912015|10338939|P1|Overall Study|Lack of Efficacy|1
3004442|NCT00911989|10338955|P1|Overall Study|Adverse Event|1
3004443|NCT00911937|10338961|P2|Overall Study|Other|5
3004444|NCT00911937|10338962|P1|Overall Study|Other|9
3004445|NCT00911937|10338961|P2|Overall Study|Randomized but not treated|13
3004446|NCT00911937|10338962|P1|Overall Study|Randomized but not treated|13
3004447|NCT00911937|10338961|P2|Overall Study|Protocol Violation|23
3004448|NCT00911937|10338962|P1|Overall Study|Protocol Violation|14
3004449|NCT00911937|10338961|P2|Overall Study|Did not meet inclusion criteria|11
3004450|NCT00911937|10338962|P1|Overall Study|Did not meet inclusion criteria|9
3004451|NCT00911937|10338961|P2|Overall Study|Lack of Efficacy|6
3004452|NCT00911937|10338962|P1|Overall Study|Lack of Efficacy|11
3004453|NCT00911937|10338961|P2|Overall Study|Adverse Event|25
3004454|NCT00911937|10338962|P1|Overall Study|Adverse Event|11
3004455|NCT00911937|10338961|P2|Overall Study|Withdrawn due to pregnancy|0
3004456|NCT00911937|10338962|P1|Overall Study|Withdrawn due to pregnancy|1
3004457|NCT00911937|10338961|P2|Overall Study|Withdrawal by Subject|7
3004458|NCT00911937|10338962|P1|Overall Study|Withdrawal by Subject|10
3004459|NCT00911937|10338961|P2|Overall Study|Lost to Follow-up|5
3004460|NCT00911937|10338962|P1|Overall Study|Lost to Follow-up|8
3004461|NCT00911937|10338961|P2|Overall Study|Death|0
3004462|NCT00911937|10338962|P1|Overall Study|Death|1
3004463|NCT00911859|10339029|P3|Follow-up Period|Study terminated by sponsor|27
3004464|NCT00911859|10339030|P2|Follow-up Period|Study terminated by sponsor|33
3004465|NCT00911859|10339031|P1|Follow-up Period|Study terminated by sponsor|5
3004466|NCT00911859|10339029|P3|Follow-up Period|Withdrawal by Subject|4
3004467|NCT00911859|10339030|P2|Follow-up Period|Withdrawal by Subject|4
3004468|NCT00911859|10339031|P1|Follow-up Period|Withdrawal by Subject|0
3004469|NCT00911859|10339029|P3|Follow-up Period|Lost to Follow-up|0
3004470|NCT00911859|10339030|P2|Follow-up Period|Lost to Follow-up|1
3004471|NCT00911859|10339031|P1|Follow-up Period|Lost to Follow-up|1
3004472|NCT00911859|10339029|P3|Follow-up Period|Death|10
3004473|NCT00911859|10339030|P2|Follow-up Period|Death|8
3004474|NCT00911859|10339031|P1|Follow-up Period|Death|5
3004475|NCT00911859|10339029|P3|Maintainance Period|Withdrawal by Subject|3
3004476|NCT00911859|10339030|P2|Maintainance Period|Withdrawal by Subject|0
3004477|NCT00911859|10339031|P1|Maintainance Period|Withdrawal by Subject|0
3004478|NCT00911859|10339029|P3|Maintainance Period|Physician Decision|9
3004479|NCT00911859|10339030|P2|Maintainance Period|Physician Decision|0
3004480|NCT00911859|10339031|P1|Maintainance Period|Physician Decision|0
3004481|NCT00911859|10339029|P3|Maintainance Period|Lack of Efficacy|9
3004482|NCT00911859|10339030|P2|Maintainance Period|Lack of Efficacy|0
3004483|NCT00911859|10339031|P1|Maintainance Period|Lack of Efficacy|0
3004484|NCT00911859|10339029|P3|Treatment Period|Did not receive study treatment|0
3004485|NCT00911859|10339030|P2|Treatment Period|Did not receive study treatment|1
3004486|NCT00911859|10339031|P1|Treatment Period|Did not receive study treatment|0
3004487|NCT00911859|10339029|P3|Treatment Period|Withdrawal by Subject|5
3004488|NCT00911859|10339030|P2|Treatment Period|Withdrawal by Subject|4
3004489|NCT00911859|10339031|P1|Treatment Period|Withdrawal by Subject|0
3004490|NCT00911859|10339029|P3|Treatment Period|Physician Decision|3
3004491|NCT00911859|10339030|P2|Treatment Period|Physician Decision|3
3004492|NCT00911859|10339031|P1|Treatment Period|Physician Decision|3
3004493|NCT00911859|10339029|P3|Treatment Period|Lack of Efficacy|5
3004494|NCT00911859|10339030|P2|Treatment Period|Lack of Efficacy|7
3004495|NCT00911859|10339031|P1|Treatment Period|Lack of Efficacy|1
3004496|NCT00911859|10339029|P3|Treatment Period|Death|5
3004497|NCT00911859|10339030|P2|Treatment Period|Death|3
3004498|NCT00911859|10339031|P1|Treatment Period|Death|1
3004499|NCT00911859|10339029|P3|Treatment Period|Adverse Event|7
3004500|NCT00911859|10339030|P2|Treatment Period|Adverse Event|3
3004501|NCT00911859|10339031|P1|Treatment Period|Adverse Event|3
3004502|NCT00911820|10339057|P2|Overall Study|Withdraw before Receive Treatment|2
3004503|NCT00911820|10339058|P1|Overall Study|Withdraw before Receive Treatment|0
3004504|NCT00911820|10339057|P2|Overall Study|Pathology Not Confirmed|0
3004505|NCT00911820|10339058|P1|Overall Study|Pathology Not Confirmed|1
3004506|NCT00911820|10339057|P2|Overall Study|Still on Therapy|2
3004507|NCT00911820|10339058|P1|Overall Study|Still on Therapy|2
3004508|NCT00911820|10339057|P2|Overall Study|Pursue Radiation|0
3004509|NCT00911820|10339058|P1|Overall Study|Pursue Radiation|1
3004510|NCT00911820|10339057|P2|Overall Study|Pursue surgery|1
3004511|NCT00911820|10339058|P1|Overall Study|Pursue surgery|1
3004512|NCT00911820|10339057|P2|Overall Study|Death|2
3004513|NCT00911820|10339058|P1|Overall Study|Death|1
3004514|NCT00911820|10339057|P2|Overall Study|Withdrawal by Subject|4
3004515|NCT00911820|10339058|P1|Overall Study|Withdrawal by Subject|3
3004516|NCT00911820|10339057|P2|Overall Study|Decline in Performance Status|2
3004517|NCT00911820|10339058|P1|Overall Study|Decline in Performance Status|4
3004518|NCT00911820|10339057|P2|Overall Study|Physician Decision|9
3004519|NCT00911820|10339058|P1|Overall Study|Physician Decision|5
3004520|NCT00911820|10339057|P2|Overall Study|Clinical Progression|5
3004521|NCT00911820|10339058|P1|Overall Study|Clinical Progression|7
3004522|NCT00911820|10339057|P2|Overall Study|Adverse Event|8
3004523|NCT00911820|10339058|P1|Overall Study|Adverse Event|8
3004524|NCT00911820|10339057|P2|Overall Study|RECIST progression|8
3004525|NCT00911820|10339058|P1|Overall Study|RECIST progression|12
3004526|NCT00911807|10339075|P3|Overall Study|Organizational reasons|1
3004527|NCT00911807|10339076|P2|Overall Study|Organizational reasons|3
3004528|NCT00911807|10339077|P1|Overall Study|Organizational reasons|1
3004529|NCT00911807|10339075|P3|Overall Study|Withdrawal by Subject|7
3004530|NCT00911807|10339076|P2|Overall Study|Withdrawal by Subject|10
3004531|NCT00911807|10339077|P1|Overall Study|Withdrawal by Subject|8
3004532|NCT00911807|10339075|P3|Overall Study|Protocol Violation|9
3004533|NCT00911807|10339076|P2|Overall Study|Protocol Violation|4
3004534|NCT00911807|10339077|P1|Overall Study|Protocol Violation|6
3004535|NCT00911807|10339075|P3|Overall Study|Death|1
3004536|NCT00911807|10339076|P2|Overall Study|Death|0
3004537|NCT00911807|10339077|P1|Overall Study|Death|0
3004538|NCT00911807|10339075|P3|Overall Study|Adverse Event|5
3004539|NCT00911807|10339076|P2|Overall Study|Adverse Event|1
3004540|NCT00911807|10339077|P1|Overall Study|Adverse Event|2
3004541|NCT00911768|10339087|P2|Overall Study|Withdrawal by Subject|0
3004542|NCT00911768|10339088|P1|Overall Study|Withdrawal by Subject|1
3004543|NCT00911768|10339087|P2|Overall Study|Protocol Violation|4
3004544|NCT00911768|10339088|P1|Overall Study|Protocol Violation|5
3004545|NCT00911625|10339117|P2|Overall Study|Lost to Follow-up|0
3004546|NCT00911625|10339118|P1|Overall Study|Lost to Follow-up|7
3004547|NCT00911547|10339147|P4|Overall Study|Withdrawal by Subject|8
3004548|NCT00911547|10339148|P3|Overall Study|Withdrawal by Subject|4
3004549|NCT00911547|10339149|P2|Overall Study|Withdrawal by Subject|10
3004550|NCT00911547|10339150|P1|Overall Study|Withdrawal by Subject|3
3004551|NCT00911547|10339147|P4|Overall Study|Protocol Violation|1
3004552|NCT00911547|10339148|P3|Overall Study|Protocol Violation|5
3004553|NCT00911547|10339149|P2|Overall Study|Protocol Violation|5
3004554|NCT00911547|10339150|P1|Overall Study|Protocol Violation|0
3004555|NCT00911547|10339147|P4|Overall Study|Lost to Follow-up|1
3004556|NCT00911547|10339148|P3|Overall Study|Lost to Follow-up|2
3004557|NCT00911547|10339149|P2|Overall Study|Lost to Follow-up|0
3004558|NCT00911547|10339150|P1|Overall Study|Lost to Follow-up|0
3004559|NCT00911547|10339147|P4|Overall Study|Adverse Event|6
3004560|NCT00911547|10339148|P3|Overall Study|Adverse Event|11
3004561|NCT00911547|10339149|P2|Overall Study|Adverse Event|27
3004562|NCT00911547|10339150|P1|Overall Study|Adverse Event|8
3004563|NCT00911534|10339178|P2|Overall Study|Other|2
3004564|NCT00911534|10339179|P1|Overall Study|Other|2
3004565|NCT00911534|10339178|P2|Overall Study|Withdrawal of consent|4
3004566|NCT00911534|10339179|P1|Overall Study|Withdrawal of consent|1
3004567|NCT00911534|10339178|P2|Overall Study|Lack of Efficacy|1
3004568|NCT00911534|10339179|P1|Overall Study|Lack of Efficacy|4
3004569|NCT00911534|10339178|P2|Overall Study|Withdrawal by Subject|1
3004570|NCT00911534|10339179|P1|Overall Study|Withdrawal by Subject|2
3004571|NCT00911534|10339178|P2|Overall Study|Lost to Follow-up|4
3004572|NCT00911534|10339179|P1|Overall Study|Lost to Follow-up|2
3004573|NCT00911534|10339178|P2|Overall Study|Adverse Event|4
3004574|NCT00911534|10339179|P1|Overall Study|Adverse Event|4
3004575|NCT00911508|10339193|P2|Overall Study|Withdrawal by Subject|112
3004576|NCT00911508|10339194|P1|Overall Study|Withdrawal by Subject|79
3004577|NCT00911508|10339193|P2|Overall Study|Lost to Follow-up|18
3004578|NCT00911508|10339194|P1|Overall Study|Lost to Follow-up|27
3004579|NCT00911300|10339269|P2|Overall Study|Randomized; No Study Medication Received|2
3004580|NCT00911300|10339270|P1|Overall Study|Randomized; No Study Medication Received|0
3004581|NCT00911300|10339269|P2|Overall Study|Treatment Stopped by Mistake|1
3004582|NCT00911300|10339270|P1|Overall Study|Treatment Stopped by Mistake|0
3004583|NCT00911300|10339269|P2|Overall Study|Physician Decision|1
3004584|NCT00911300|10339270|P1|Overall Study|Physician Decision|0
3004585|NCT00911300|10339269|P2|Overall Study|Underlying Disease (Myocarditis)|1
3004586|NCT00911300|10339270|P1|Overall Study|Underlying Disease (Myocarditis)|0
3004587|NCT00911300|10339269|P2|Overall Study|Participant Refused Hospital Consulation|1
3004588|NCT00911300|10339270|P1|Overall Study|Participant Refused Hospital Consulation|0
3004589|NCT00911300|10339269|P2|Overall Study|International Normalized Ratio Too High|1
3004590|NCT00911300|10339270|P1|Overall Study|International Normalized Ratio Too High|0
3004591|NCT00911300|10339269|P2|Overall Study|Investigator's Decision; New AF Episode|1
3004592|NCT00911300|10339270|P1|Overall Study|Investigator's Decision; New AF Episode|0
3004593|NCT00911300|10339269|P2|Overall Study|Participant Could Not Stay in Hospital|1
3004594|NCT00911300|10339270|P1|Overall Study|Participant Could Not Stay in Hospital|0
3004595|NCT00911300|10339269|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
3004596|NCT00911300|10339270|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
3004597|NCT00911300|10339269|P2|Overall Study|Nurse Unavailable in Participant's City|0
3004598|NCT00911300|10339270|P1|Overall Study|Nurse Unavailable in Participant's City|1
3004599|NCT00911300|10339269|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
3004600|NCT00911300|10339270|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
3004601|NCT00911300|10339269|P2|Overall Study|Recurrent Tachyarrhythmia|1
3004602|NCT00911300|10339270|P1|Overall Study|Recurrent Tachyarrhythmia|1
3004603|NCT00911300|10339269|P2|Overall Study|Received Commercial Treatment|0
3004604|NCT00911300|10339270|P1|Overall Study|Received Commercial Treatment|1
3004605|NCT00911300|10339269|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
3004606|NCT00911300|10339270|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
3004607|NCT00911300|10339269|P2|Overall Study|Coronary Angiography Performed|0
3004608|NCT00911300|10339270|P1|Overall Study|Coronary Angiography Performed|1
3004609|NCT00911300|10339269|P2|Overall Study|Consent Withdrawn|12
3004610|NCT00911300|10339270|P1|Overall Study|Consent Withdrawn|4
3004611|NCT00911300|10339269|P2|Overall Study|Protocol Violation|2
3004612|NCT00911300|10339270|P1|Overall Study|Protocol Violation|3
3004613|NCT00911300|10339269|P2|Overall Study|Adverse Event|6
3004614|NCT00911300|10339270|P1|Overall Study|Adverse Event|14
3004615|NCT00911300|10339269|P2|Overall Study|Thrombus Persistant in Second TEE|7
3004616|NCT00911300|10339270|P1|Overall Study|Thrombus Persistant in Second TEE|3
3004617|NCT00911300|10339269|P2|Overall Study|Death|0
3004618|NCT00911300|10339270|P1|Overall Study|Death|1
3004619|NCT00911300|10339269|P2|Overall Study|Primary Endpoint Component Occurred|2
3004620|NCT00911300|10339270|P1|Overall Study|Primary Endpoint Component Occurred|1
3004621|NCT00911170|10339307|P2|Long Term Follow-Up|Death|121
3004622|NCT00911170|10339308|P1|Long Term Follow-Up|Death|116
3004623|NCT00911170|10339307|P2|Long Term Follow-Up|Lost to Follow-up|7
3004624|NCT00911170|10339308|P1|Long Term Follow-Up|Lost to Follow-up|8
3004625|NCT00911170|10339307|P2|Long Term Follow-Up|Physician Decision|4
3004626|NCT00911170|10339308|P1|Long Term Follow-Up|Physician Decision|5
3004627|NCT00911170|10339307|P2|Long Term Follow-Up|Withdrawal by Subject|21
3004628|NCT00911170|10339308|P1|Long Term Follow-Up|Withdrawal by Subject|20
3004629|NCT00911170|10339307|P2|Long Term Follow-Up|Continuing in study|269
3004630|NCT00911170|10339308|P1|Long Term Follow-Up|Continuing in study|274
3004631|NCT00911170|10339307|P2|Treatment Period|Death|9
3004632|NCT00911170|10339308|P1|Treatment Period|Death|6
3004633|NCT00911170|10339307|P2|Treatment Period|Lost to Follow-up|1
3004634|NCT00911170|10339308|P1|Treatment Period|Lost to Follow-up|0
3004635|NCT00911170|10339307|P2|Treatment Period|Physician Decision|5
3004636|NCT00911170|10339308|P1|Treatment Period|Physician Decision|5
3004637|NCT00911170|10339307|P2|Treatment Period|Disease progression|2
3004638|NCT00911170|10339308|P1|Treatment Period|Disease progression|0
3004639|NCT00911170|10339307|P2|Treatment Period|Withdrawal by Subject|4
3004640|NCT00911170|10339308|P1|Treatment Period|Withdrawal by Subject|4
3004641|NCT00911170|10339307|P2|Treatment Period|Adverse Event|10
3004642|NCT00911170|10339308|P1|Treatment Period|Adverse Event|9
3004643|NCT00911170|10339307|P2|Treatment Period|Protocol deviation|2
3004644|NCT00911170|10339308|P1|Treatment Period|Protocol deviation|1
3004645|NCT00911170|10339307|P2|Treatment Period|Ineligibility determined|3
3004646|NCT00911170|10339308|P1|Treatment Period|Ineligibility determined|1
3004647|NCT00911170|10339307|P2|Treatment Period|Randomized in error|1
3004648|NCT00911170|10339308|P1|Treatment Period|Randomized in error|1
3004649|NCT00911157|10339332|P2|Overall Study|Need to treat for lung cancer|0
3004650|NCT00911157|10339333|P1|Overall Study|Need to treat for lung cancer|1
3004651|NCT00911157|10339332|P2|Overall Study|Need for prohibited drug (heparin)|0
3004652|NCT00911157|10339333|P1|Overall Study|Need for prohibited drug (heparin)|1
3004653|NCT00911157|10339332|P2|Overall Study|Withdrawal by Subject|1
3004654|NCT00911157|10339333|P1|Overall Study|Withdrawal by Subject|1
3004655|NCT00911157|10339332|P2|Overall Study|Adverse Event|1
3004656|NCT00911157|10339333|P1|Overall Study|Adverse Event|4
3004657|NCT00911144|10339349|P2|Overall Study|Withdrawal by Subject|5
3004658|NCT00911144|10339350|P1|Overall Study|Withdrawal by Subject|16
3004659|NCT00910988|10339404|P4|Overall Study|Lost to Follow-up|0
3004660|NCT00910988|10339405|P3|Overall Study|Lost to Follow-up|3
3004661|NCT00910988|10339406|P2|Overall Study|Lost to Follow-up|4
3004662|NCT00910988|10339407|P1|Overall Study|Lost to Follow-up|2
3004663|NCT00910962|10339452|P3|Overall Study|Reached defined stopping criteria|17
3004664|NCT00910962|10339453|P2|Overall Study|Reached defined stopping criteria|14
3004665|NCT00910962|10339454|P1|Overall Study|Reached defined stopping criteria|12
3004666|NCT00910962|10339452|P3|Overall Study|Withdrawal by Subject|32
3004667|NCT00910962|10339453|P2|Overall Study|Withdrawal by Subject|32
3004668|NCT00910962|10339454|P1|Overall Study|Withdrawal by Subject|25
3004669|NCT00910962|10339452|P3|Overall Study|Physician Decision|6
3004670|NCT00910962|10339453|P2|Overall Study|Physician Decision|6
3004671|NCT00910962|10339454|P1|Overall Study|Physician Decision|0
3004672|NCT00910962|10339452|P3|Overall Study|Lost to Follow-up|1
3004673|NCT00910962|10339453|P2|Overall Study|Lost to Follow-up|3
3004674|NCT00910962|10339454|P1|Overall Study|Lost to Follow-up|0
3004675|NCT00910962|10339452|P3|Overall Study|Protocol Violation|3
3004676|NCT00910962|10339453|P2|Overall Study|Protocol Violation|3
3004677|NCT00910962|10339454|P1|Overall Study|Protocol Violation|1
3004678|NCT00910962|10339452|P3|Overall Study|Adverse Event|17
3004679|NCT00910962|10339453|P2|Overall Study|Adverse Event|20
3004680|NCT00910962|10339454|P1|Overall Study|Adverse Event|5
3004681|NCT00910910|10339546|P2|Overall Study|Untreated before cycle 1|2
3004682|NCT00910910|10339547|P1|Overall Study|Untreated before cycle 1|1
3004683|NCT00910910|10339546|P2|Overall Study|Other|32
3004684|NCT00910910|10339547|P1|Overall Study|Other|114
3004685|NCT00910910|10339546|P2|Overall Study|Completed 13 cycles of treatment|118
3004686|NCT00910910|10339547|P1|Overall Study|Completed 13 cycles of treatment|0
3004687|NCT00910910|10339546|P2|Overall Study|Protocol Violation|2
3004688|NCT00910910|10339547|P1|Overall Study|Protocol Violation|2
3004689|NCT00910910|10339546|P2|Overall Study|Death|3
3004690|NCT00910910|10339547|P1|Overall Study|Death|9
3004691|NCT00910910|10339546|P2|Overall Study|Lost to Follow-up|2
3004692|NCT00910910|10339547|P1|Overall Study|Lost to Follow-up|2
3004693|NCT00910910|10339546|P2|Overall Study|Withdrawal by Subject|5
3004694|NCT00910910|10339547|P1|Overall Study|Withdrawal by Subject|7
3004695|NCT00910910|10339546|P2|Overall Study|PD with histologic change|2
3004696|NCT00910910|10339547|P1|Overall Study|PD with histologic change|0
3004697|NCT00910910|10339546|P2|Overall Study|PD without histologic change|23
3004698|NCT00910910|10339547|P1|Overall Study|PD without histologic change|27
3004699|NCT00910910|10339546|P2|Overall Study|Adverse Event|35
3004700|NCT00910910|10339547|P1|Overall Study|Adverse Event|63
3004701|NCT00910871|10339583|P1|Overall Study|Undefined|1
3004702|NCT00910871|10339583|P1|Overall Study|Subject didn’t meet eligibility criteria|5
3004703|NCT00910871|10339583|P1|Overall Study|Withdrawal by Subject|12
3004704|NCT00910871|10339583|P1|Overall Study|Protocol Violation|11
3004705|NCT00910871|10339583|P1|Overall Study|Lost to Follow-up|8
3004706|NCT00910871|10339583|P1|Overall Study|Death|12
3004707|NCT00910871|10339583|P1|Overall Study|Adverse Event|5
3004708|NCT00910858|10339591|P3|Combined Treatment Phase|Other|1
3004709|NCT00910858|10339592|P2|Combined Treatment Phase|Other|2
3004710|NCT00910858|10339593|P1|Combined Treatment Phase|Other|0
3004711|NCT00910858|10339591|P3|Combined Treatment Phase|Protocol Violation|0
3004712|NCT00910858|10339592|P2|Combined Treatment Phase|Protocol Violation|0
3004713|NCT00910858|10339593|P1|Combined Treatment Phase|Protocol Violation|1
3004714|NCT00910858|10339591|P3|Combined Treatment Phase|Withdrawal by Subject|0
3004715|NCT00910858|10339592|P2|Combined Treatment Phase|Withdrawal by Subject|2
3004716|NCT00910858|10339593|P1|Combined Treatment Phase|Withdrawal by Subject|0
3004717|NCT00910858|10339591|P3|Combined Treatment Phase|Lack of therapeutic effect|3
3004718|NCT00910858|10339592|P2|Combined Treatment Phase|Lack of therapeutic effect|6
3004719|NCT00910858|10339593|P1|Combined Treatment Phase|Lack of therapeutic effect|8
3004720|NCT00910858|10339591|P3|Monotherapy Phase|Other|2
3004721|NCT00910858|10339592|P2|Monotherapy Phase|Other|4
3004722|NCT00910858|10339593|P1|Monotherapy Phase|Other|3
3004723|NCT00910858|10339591|P3|Monotherapy Phase|Protocol Violation|0
3004724|NCT00910858|10339592|P2|Monotherapy Phase|Protocol Violation|0
3004725|NCT00910858|10339593|P1|Monotherapy Phase|Protocol Violation|1
3004726|NCT00910858|10339591|P3|Monotherapy Phase|Withdrawal by Subject|1
3004727|NCT00910858|10339592|P2|Monotherapy Phase|Withdrawal by Subject|3
3004728|NCT00910858|10339593|P1|Monotherapy Phase|Withdrawal by Subject|1
3004729|NCT00910858|10339591|P3|Monotherapy Phase|Lack of therapeutic effect|4
3004730|NCT00910858|10339592|P2|Monotherapy Phase|Lack of therapeutic effect|6
3004731|NCT00910858|10339593|P1|Monotherapy Phase|Lack of therapeutic effect|9
3004732|NCT00910858|10339591|P3|Monotherapy Phase|Adverse Event|0
3004733|NCT00910858|10339592|P2|Monotherapy Phase|Adverse Event|2
3004734|NCT00910858|10339593|P1|Monotherapy Phase|Adverse Event|3
3004735|NCT00910858|10339591|P3|Pharmacokinetic Phase|Adverse Event|0
3004736|NCT00910858|10339592|P2|Pharmacokinetic Phase|Adverse Event|0
3004737|NCT00910858|10339593|P1|Pharmacokinetic Phase|Adverse Event|1
3004738|NCT00910728|10339638|P9|Overall Study|Adverse Event|1
3004739|NCT00910728|10339639|P8|Overall Study|Adverse Event|1
3004740|NCT00910728|10339640|P7|Overall Study|Adverse Event|2
3004741|NCT00910728|10339641|P6|Overall Study|Adverse Event|0
3004742|NCT00910728|10339642|P5|Overall Study|Adverse Event|0
3004743|NCT00910728|10339643|P4|Overall Study|Adverse Event|1
3004744|NCT00910728|10339644|P3|Overall Study|Adverse Event|1
3004745|NCT00910728|10339645|P2|Overall Study|Adverse Event|0
3004746|NCT00910728|10339646|P1|Overall Study|Adverse Event|2
3004747|NCT00910728|10339638|P9|Overall Study|(not specified)|0
3004748|NCT00910728|10339639|P8|Overall Study|(not specified)|0
3004749|NCT00910728|10339640|P7|Overall Study|(not specified)|0
3004750|NCT00910728|10339641|P6|Overall Study|(not specified)|0
3004751|NCT00910728|10339642|P5|Overall Study|(not specified)|1
3004752|NCT00910728|10339643|P4|Overall Study|(not specified)|0
3004753|NCT00910728|10339644|P3|Overall Study|(not specified)|1
3004754|NCT00910728|10339645|P2|Overall Study|(not specified)|0
3004755|NCT00910728|10339646|P1|Overall Study|(not specified)|2
3004756|NCT00910728|10339638|P9|Overall Study|Withdrawal by Subject|0
3004757|NCT00910728|10339639|P8|Overall Study|Withdrawal by Subject|0
3004758|NCT00910728|10339640|P7|Overall Study|Withdrawal by Subject|2
3004759|NCT00910728|10339641|P6|Overall Study|Withdrawal by Subject|1
3004760|NCT00910728|10339642|P5|Overall Study|Withdrawal by Subject|3
3004761|NCT00910728|10339643|P4|Overall Study|Withdrawal by Subject|0
3004762|NCT00910728|10339644|P3|Overall Study|Withdrawal by Subject|0
3004763|NCT00910728|10339645|P2|Overall Study|Withdrawal by Subject|0
3004764|NCT00910728|10339646|P1|Overall Study|Withdrawal by Subject|0
3004765|NCT00910728|10339638|P9|Overall Study|Lack of Efficacy|2
3004766|NCT00910728|10339639|P8|Overall Study|Lack of Efficacy|2
3004767|NCT00910728|10339640|P7|Overall Study|Lack of Efficacy|2
3004768|NCT00910728|10339641|P6|Overall Study|Lack of Efficacy|0
3004769|NCT00910728|10339642|P5|Overall Study|Lack of Efficacy|1
3004770|NCT00910728|10339643|P4|Overall Study|Lack of Efficacy|2
3004771|NCT00910728|10339644|P3|Overall Study|Lack of Efficacy|1
3004772|NCT00910728|10339645|P2|Overall Study|Lack of Efficacy|3
3004773|NCT00910728|10339646|P1|Overall Study|Lack of Efficacy|2
3004774|NCT00910715|10339768|P3|Overall Study|Lost to Follow-up|0
3004775|NCT00910715|10339769|P2|Overall Study|Lost to Follow-up|26
3004776|NCT00910715|10339770|P1|Overall Study|Lost to Follow-up|22
3004777|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
3004778|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
3004779|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
3004780|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
3004781|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
3004782|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
3004783|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
3004784|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
3004785|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Time Demands|0
3004786|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Time Demands|0
3004787|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Time Demands|1
3004788|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Time Demands|2
3004789|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
3004790|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
3004791|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
3004792|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
3004793|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
3004794|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
3004795|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
3004796|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
3004797|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
3004798|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
3004799|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
3004800|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
3004801|NCT00910689|10339784|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
3004802|NCT00910689|10339785|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
3004803|NCT00910689|10339786|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
3004804|NCT00910689|10339787|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
3004805|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
3004806|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
3004807|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
3004808|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
3004809|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
3004810|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
3004811|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
3004812|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
3004813|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
3004814|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
3004815|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
3004816|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
3004817|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
3004818|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
3004819|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
3004820|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
3004821|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
3004822|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
3004823|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
3004824|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
3004825|NCT00910689|10339784|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
3004826|NCT00910689|10339785|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
3004827|NCT00910689|10339786|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
3004828|NCT00910689|10339787|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
3004829|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Protocol Violation|0
3004830|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Protocol Violation|0
3004831|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Protocol Violation|0
3004832|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Protocol Violation|1
3004833|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Pregnancy|0
3004834|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Pregnancy|0
3004835|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Pregnancy|2
3004836|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Pregnancy|0
3004837|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
3004838|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
3004839|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
3004840|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
3004841|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
3004842|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
3004843|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
3004844|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
3004845|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Time Demands|8
3004846|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Time Demands|4
3004847|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Time Demands|0
3004848|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Time Demands|1
3004849|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Adverse Event|0
3004850|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Adverse Event|2
3004851|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Adverse Event|3
3004852|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Adverse Event|2
3004853|NCT00910689|10339784|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
3004854|NCT00910689|10339785|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
3004855|NCT00910689|10339786|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
3004856|NCT00910689|10339787|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
3004857|NCT00910689|10339784|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
3004858|NCT00910689|10339785|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
3004859|NCT00910689|10339786|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
3004860|NCT00910689|10339787|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
3004861|NCT00910663|10339819|P2|Period 1|Withdrawal by Subject|1
3004862|NCT00910663|10339820|P1|Period 1|Withdrawal by Subject|0
3004863|NCT00910624|10339834|P4|Follow-Up Phase|Administrative|0
3004864|NCT00910624|10339835|P3|Follow-Up Phase|Administrative|1
3004865|NCT00910624|10339836|P2|Follow-Up Phase|Administrative|1
3004866|NCT00910624|10339837|P1|Follow-Up Phase|Administrative|0
3004867|NCT00910624|10339834|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
3004868|NCT00910624|10339835|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
3004869|NCT00910624|10339836|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
3004870|NCT00910624|10339837|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
3004871|NCT00910624|10339834|P4|Follow-Up Phase|Withdrawal by Subject|0
3004872|NCT00910624|10339835|P3|Follow-Up Phase|Withdrawal by Subject|0
3004873|NCT00910624|10339836|P2|Follow-Up Phase|Withdrawal by Subject|0
3004874|NCT00910624|10339837|P1|Follow-Up Phase|Withdrawal by Subject|1
3004875|NCT00910624|10339834|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
3004876|NCT00910624|10339835|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
3004877|NCT00910624|10339836|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
3004878|NCT00910624|10339837|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
3004879|NCT00910624|10339834|P4|Follow-Up Phase|Lost to Follow-up|0
3004880|NCT00910624|10339835|P3|Follow-Up Phase|Lost to Follow-up|2
3004881|NCT00910624|10339836|P2|Follow-Up Phase|Lost to Follow-up|1
3004882|NCT00910624|10339837|P1|Follow-Up Phase|Lost to Follow-up|3
3004883|NCT00910624|10339834|P4|Follow-Up Phase|Adverse Event|0
3004884|NCT00910624|10339835|P3|Follow-Up Phase|Adverse Event|1
3004885|NCT00910624|10339836|P2|Follow-Up Phase|Adverse Event|0
3004886|NCT00910624|10339837|P1|Follow-Up Phase|Adverse Event|0
3004887|NCT00910624|10339834|P4|Treatment Phase|Non-Compliance With Protocol|0
3004888|NCT00910624|10339835|P3|Treatment Phase|Non-Compliance With Protocol|1
3004889|NCT00910624|10339836|P2|Treatment Phase|Non-Compliance With Protocol|1
3004890|NCT00910624|10339837|P1|Treatment Phase|Non-Compliance With Protocol|0
3004891|NCT00910624|10339834|P4|Treatment Phase|Withdrawal by Subject|0
3004892|NCT00910624|10339835|P3|Treatment Phase|Withdrawal by Subject|0
3004893|NCT00910624|10339836|P2|Treatment Phase|Withdrawal by Subject|1
3004894|NCT00910624|10339837|P1|Treatment Phase|Withdrawal by Subject|2
3004895|NCT00910624|10339834|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
3004896|NCT00910624|10339835|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
3004897|NCT00910624|10339836|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
3004898|NCT00910624|10339837|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
3004899|NCT00910624|10339834|P4|Treatment Phase|Lost to Follow-up|0
3004900|NCT00910624|10339835|P3|Treatment Phase|Lost to Follow-up|1
3004901|NCT00910624|10339836|P2|Treatment Phase|Lost to Follow-up|0
3004902|NCT00910624|10339837|P1|Treatment Phase|Lost to Follow-up|0
3004903|NCT00910624|10339834|P4|Treatment Phase|Treatment Failure|0
3004904|NCT00910624|10339835|P3|Treatment Phase|Treatment Failure|0
3004905|NCT00910624|10339836|P2|Treatment Phase|Treatment Failure|10
3004906|NCT00910624|10339837|P1|Treatment Phase|Treatment Failure|23
3004907|NCT00910624|10339834|P4|Treatment Phase|Adverse Event|0
3004908|NCT00910624|10339835|P3|Treatment Phase|Adverse Event|6
3004909|NCT00910624|10339836|P2|Treatment Phase|Adverse Event|6
3004910|NCT00910624|10339837|P1|Treatment Phase|Adverse Event|2
3004911|NCT00910299|10339864|P2|Overall Study|Didn't receive any study drug|1
3004912|NCT00910299|10339865|P1|Overall Study|Didn't receive any study drug|2
3004913|NCT00910299|10339864|P2|Overall Study|Sponsor Decision|60
3004914|NCT00910299|10339865|P1|Overall Study|Sponsor Decision|58
3004915|NCT00910299|10339864|P2|Overall Study|Withdrawal by Subject|13
3004916|NCT00910299|10339865|P1|Overall Study|Withdrawal by Subject|16
3004917|NCT00910273|10339877|P2|Overall Study|Lost to Follow-up|1
3004918|NCT00910273|10339878|P1|Overall Study|Lost to Follow-up|1
3004919|NCT00910273|10339877|P2|Overall Study|Protocol Violation|0
3004920|NCT00910273|10339878|P1|Overall Study|Protocol Violation|1
3004921|NCT00910273|10339877|P2|Overall Study|Discontinuation of study by sponsor|2
3004922|NCT00910273|10339878|P1|Overall Study|Discontinuation of study by sponsor|8
3004923|NCT00910273|10339877|P2|Overall Study|Withdrawal by Subject|0
3004924|NCT00910273|10339878|P1|Overall Study|Withdrawal by Subject|1
3004925|NCT00910273|10339877|P2|Overall Study|Adverse Event|1
3004926|NCT00910273|10339878|P1|Overall Study|Adverse Event|1
3004927|NCT00910273|10339877|P2|Overall Study|Lack of Efficacy|9
3004928|NCT00910273|10339878|P1|Overall Study|Lack of Efficacy|6
3004929|NCT00910247|10339928|P1|Overall Study|Not collected|4
3004930|NCT00910247|10339928|P1|Overall Study|Withdrawal by Subject|25
3004931|NCT00910247|10339928|P1|Overall Study|Protocol Violation|10
3004932|NCT00910247|10339928|P1|Overall Study|Physician Decision|3
3004933|NCT00910247|10339928|P1|Overall Study|Lost to Follow-up|10
3004934|NCT00910247|10339928|P1|Overall Study|Death|2
3004935|NCT00910247|10339928|P1|Overall Study|Adverse Event|15
3004936|NCT00910091|10339978|P2|Treatment and Survival|Adverse Event|0
3004937|NCT00910091|10339979|P1|Treatment and Survival|Adverse Event|1
3004938|NCT00910091|10339978|P2|Treatment and Survival|Withdrawal by Subject|4
3004939|NCT00910091|10339979|P1|Treatment and Survival|Withdrawal by Subject|3
3004940|NCT00910091|10339978|P2|Pre-assignment|Withdrawal by Subject|2
3004941|NCT00910091|10339979|P1|Pre-assignment|Withdrawal by Subject|0
3004942|NCT00910039|10340007|P1|Overall Study|Physician Decision|1
3004943|NCT00910000|10340024|P6|Overall Study|Withdrawal by Subject|0
3004944|NCT00910000|10340025|P5|Overall Study|Withdrawal by Subject|1
3004945|NCT00910000|10340026|P4|Overall Study|Withdrawal by Subject|0
3004946|NCT00910000|10340027|P3|Overall Study|Withdrawal by Subject|1
3004947|NCT00910000|10340028|P2|Overall Study|Withdrawal by Subject|0
3004948|NCT00910000|10340029|P1|Overall Study|Withdrawal by Subject|0
3004949|NCT00910000|10340024|P6|Overall Study|Adverse Event|1
3004950|NCT00910000|10340025|P5|Overall Study|Adverse Event|0
3004951|NCT00910000|10340026|P4|Overall Study|Adverse Event|2
3004952|NCT00910000|10340027|P3|Overall Study|Adverse Event|2
3004953|NCT00910000|10340028|P2|Overall Study|Adverse Event|3
3004954|NCT00910000|10340029|P1|Overall Study|Adverse Event|0
3004955|NCT00909870|10340047|P2|Overall Study|Other|5
3004956|NCT00909870|10340048|P1|Overall Study|Other|1
3004957|NCT00909870|10340047|P2|Overall Study|Physician Decision|2
3004958|NCT00909870|10340048|P1|Overall Study|Physician Decision|0
3004959|NCT00909870|10340047|P2|Overall Study|Lost to Follow-up|3
3004960|NCT00909870|10340048|P1|Overall Study|Lost to Follow-up|3
3004961|NCT00909870|10340047|P2|Overall Study|Withdrawal by Subject|8
3004962|NCT00909870|10340048|P1|Overall Study|Withdrawal by Subject|5
3004963|NCT00909870|10340047|P2|Overall Study|Protocol Violation|2
3004964|NCT00909870|10340048|P1|Overall Study|Protocol Violation|1
3004965|NCT00909870|10340047|P2|Overall Study|Adverse Event|7
3004966|NCT00909870|10340048|P1|Overall Study|Adverse Event|13
3004967|NCT00909857|10340060|P2|Overall Study|Did not receive study medication|24
3004968|NCT00909857|10340061|P1|Overall Study|Did not receive study medication|19
3004969|NCT00909857|10340060|P2|Overall Study|Other|0
3004970|NCT00909857|10340061|P1|Overall Study|Other|1
3004971|NCT00909857|10340060|P2|Overall Study|Pregnancy|0
3004972|NCT00909857|10340061|P1|Overall Study|Pregnancy|1
3004973|NCT00909857|10340060|P2|Overall Study|Protocol Violation|1
3004974|NCT00909857|10340061|P1|Overall Study|Protocol Violation|2
3004975|NCT00909857|10340060|P2|Overall Study|Lost to Follow-up|5
3004976|NCT00909857|10340061|P1|Overall Study|Lost to Follow-up|2
3004977|NCT00909857|10340060|P2|Overall Study|Adverse Event|5
3004978|NCT00909857|10340061|P1|Overall Study|Adverse Event|5
3004979|NCT00909857|10340060|P2|Overall Study|Withdrawal by Subject|10
3004980|NCT00909857|10340061|P1|Overall Study|Withdrawal by Subject|6
3004981|NCT00909844|10340201|P1|Overall Study|Lost to Follow-up|2
3004982|NCT00909844|10340201|P1|Overall Study|Withdrawal by Subject|1
3004983|NCT00909844|10340201|P1|Overall Study|Adverse Event|1
3004984|NCT00909792|10340219|P2|Period 2|Lost to Follow-up|1
3004985|NCT00909792|10340220|P1|Period 2|Lost to Follow-up|0
3004986|NCT00909792|10340219|P2|Period 2|Biomicroscopy|0
3004987|NCT00909792|10340220|P1|Period 2|Biomicroscopy|1
3004988|NCT00909792|10340219|P2|Period 1|Did not meet inclusion criteria|1
3004989|NCT00909792|10340220|P1|Period 1|Did not meet inclusion criteria|0
3004990|NCT00909779|10340228|P2|Overall Study|Randomized in error|1
3004991|NCT00909779|10340229|P1|Overall Study|Randomized in error|1
3004992|NCT00909779|10340228|P2|Overall Study|Noncompliance|1
3004993|NCT00909779|10340229|P1|Overall Study|Noncompliance|1
3004994|NCT00909779|10340228|P2|Overall Study|Medical Monitor Decision|0
3004995|NCT00909779|10340229|P1|Overall Study|Medical Monitor Decision|1
3004996|NCT00909779|10340228|P2|Overall Study|Site Ceasing Operation|2
3004997|NCT00909779|10340229|P1|Overall Study|Site Ceasing Operation|2
3004998|NCT00909779|10340228|P2|Overall Study|Withdrawal by Subject|80
3004999|NCT00909779|10340229|P1|Overall Study|Withdrawal by Subject|116
3005000|NCT00909779|10340228|P2|Overall Study|Protocol Violation|5
3005001|NCT00909779|10340229|P1|Overall Study|Protocol Violation|2
3005002|NCT00909779|10340228|P2|Overall Study|Physician Decision|2
3005003|NCT00909779|10340229|P1|Overall Study|Physician Decision|8
3005004|NCT00909779|10340228|P2|Overall Study|Lost to Follow-up|15
3005005|NCT00909779|10340229|P1|Overall Study|Lost to Follow-up|19
3005006|NCT00909779|10340228|P2|Overall Study|Lack of Efficacy|4
3005007|NCT00909779|10340229|P1|Overall Study|Lack of Efficacy|7
3005008|NCT00909779|10340228|P2|Overall Study|Adverse Event|55
3005009|NCT00909779|10340229|P1|Overall Study|Adverse Event|53
3005010|NCT00909753|10340253|P2|Period: Second Intervention|Protocol Violation|0
3005011|NCT00909753|10340254|P1|Period: Second Intervention|Protocol Violation|1
3005012|NCT00909753|10340253|P2|Period: Washout of 28 Days|Protocol Violation|3
3005013|NCT00909753|10340254|P1|Period: Washout of 28 Days|Protocol Violation|2
3005014|NCT00909727|10340274|P2|Overall Study|Prohibited Medication|0
3005015|NCT00909727|10340275|P1|Overall Study|Prohibited Medication|1
3005016|NCT00909727|10340274|P2|Overall Study|Withdrawal of Consent|0
3005017|NCT00909727|10340275|P1|Overall Study|Withdrawal of Consent|1
3005018|NCT00909727|10340274|P2|Overall Study|Wrong Genotype|0
3005019|NCT00909727|10340275|P1|Overall Study|Wrong Genotype|1
3005020|NCT00909727|10340274|P2|Overall Study|Adverse Event|0
3005021|NCT00909727|10340275|P1|Overall Study|Adverse Event|1
3005022|NCT00909610|10340298|P2|Period: Second Intervention|Adverse Event|0
3005023|NCT00909610|10340299|P1|Period: Second Intervention|Adverse Event|1
3005024|NCT00909610|10340298|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
3005025|NCT00909610|10340299|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
3005026|NCT00909610|10340298|P2|Period: First Intervention|Adverse Event|1
3005027|NCT00909610|10340299|P1|Period: First Intervention|Adverse Event|0
3005028|NCT00909532|10340460|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
3005029|NCT00909532|10340461|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
3005030|NCT00909532|10340460|P2|Overall Study|Wrong Genotype|0
3005031|NCT00909532|10340461|P1|Overall Study|Wrong Genotype|1
3005032|NCT00909532|10340460|P2|Overall Study|Physician Decision|0
3005033|NCT00909532|10340461|P1|Overall Study|Physician Decision|1
3005034|NCT00909532|10340460|P2|Overall Study|Noncompliance with Study Requirements|2
3005035|NCT00909532|10340461|P1|Overall Study|Noncompliance with Study Requirements|0
3005036|NCT00909532|10340460|P2|Overall Study|Withdrawal of Consent|1
3005037|NCT00909532|10340461|P1|Overall Study|Withdrawal of Consent|1
3005038|NCT00909532|10340460|P2|Overall Study|Prohibited Medication|1
3005039|NCT00909532|10340461|P1|Overall Study|Prohibited Medication|2
3005040|NCT00909532|10340460|P2|Overall Study|Pregnancy|1
3005041|NCT00909532|10340461|P1|Overall Study|Pregnancy|0
3005042|NCT00909532|10340460|P2|Overall Study|Adverse Event|1
3005043|NCT00909532|10340461|P1|Overall Study|Adverse Event|4
3005044|NCT00909480|10340479|P2|Overall Study|Unclassified|19
3005045|NCT00909480|10340480|P1|Overall Study|Unclassified|18
3005046|NCT00909480|10340479|P2|Overall Study|Withdrawal criteria|11
3005047|NCT00909480|10340480|P1|Overall Study|Withdrawal criteria|9
3005048|NCT00909480|10340479|P2|Overall Study|Protocol Violation|8
3005049|NCT00909480|10340480|P1|Overall Study|Protocol Violation|6
3005050|NCT00909480|10340479|P2|Overall Study|Adverse Event|3
3005051|NCT00909480|10340480|P1|Overall Study|Adverse Event|5
3005052|NCT00909428|10340515|P3|Overall Study|Lost to Follow-up|9
3005053|NCT00909428|10340516|P2|Overall Study|Lost to Follow-up|10
3005054|NCT00909428|10340517|P1|Overall Study|Lost to Follow-up|13
3005055|NCT00909389|10340524|P1|Overall Study|No Information|103
3005056|NCT00909389|10340524|P1|Overall Study|Lost to Follow-up|4
3005057|NCT00909389|10340524|P1|Overall Study|Poor Compliance|16
3005058|NCT00909389|10340524|P1|Overall Study|Death|4
3005059|NCT00909389|10340524|P1|Overall Study|Adverse Event|6
3005060|NCT00909363|10340531|P3|Overall Study|Lack of Efficacy|0
3005061|NCT00909363|10340532|P2|Overall Study|Lack of Efficacy|0
3005062|NCT00909363|10340533|P1|Overall Study|Lack of Efficacy|1
3005063|NCT00909363|10340531|P3|Overall Study|Withdrawal by Subject|0
3005064|NCT00909363|10340532|P2|Overall Study|Withdrawal by Subject|0
3005065|NCT00909363|10340533|P1|Overall Study|Withdrawal by Subject|1
3005066|NCT00909181|10340580|P3|Overall Study|Lost to Follow-up|33
3005067|NCT00909181|10340581|P2|Overall Study|Lost to Follow-up|18
3005068|NCT00909181|10340582|P1|Overall Study|Lost to Follow-up|39
3005069|NCT00909038|10340612|P1|Overall Study|Non-evaluable Subjects|230
3005070|NCT00909038|10340612|P1|Overall Study|Protocol Violation|187
3005071|NCT00908960|10340624|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
3005072|NCT00908960|10340625|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
3005073|NCT00908960|10340626|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
3005074|NCT00908895|10340670|P2|Overall Study|Adverse Event|1
3005075|NCT00908895|10340671|P1|Overall Study|Adverse Event|1
3005076|NCT00908895|10340670|P2|Overall Study|algodystrophy|2
3005077|NCT00908895|10340671|P1|Overall Study|algodystrophy|2
3005078|NCT00908895|10340670|P2|Overall Study|Lost to Follow-up|3
3005079|NCT00908895|10340671|P1|Overall Study|Lost to Follow-up|1
3005080|NCT00908596|10340772|P4|Overall Study|Withdrawal by Subject|1
3005081|NCT00908596|10340773|P3|Overall Study|Withdrawal by Subject|3
3005082|NCT00908596|10340774|P2|Overall Study|Withdrawal by Subject|1
3005083|NCT00908596|10340775|P1|Overall Study|Withdrawal by Subject|0
3005084|NCT00908596|10340772|P4|Overall Study|Protocol Violation|0
3005085|NCT00908596|10340773|P3|Overall Study|Protocol Violation|0
3005086|NCT00908596|10340774|P2|Overall Study|Protocol Violation|0
3005087|NCT00908596|10340775|P1|Overall Study|Protocol Violation|1
3005088|NCT00908596|10340772|P4|Overall Study|Death|32
3005089|NCT00908596|10340773|P3|Overall Study|Death|57
3005090|NCT00908596|10340774|P2|Overall Study|Death|5
3005091|NCT00908596|10340775|P1|Overall Study|Death|0
3005092|NCT00908596|10340772|P4|Overall Study|Lost to Follow-up|4
3005093|NCT00908596|10340773|P3|Overall Study|Lost to Follow-up|12
3005094|NCT00908596|10340774|P2|Overall Study|Lost to Follow-up|1
3005095|NCT00908596|10340775|P1|Overall Study|Lost to Follow-up|0
3005096|NCT00908596|10340772|P4|Overall Study|Other reasons|0
3005097|NCT00908596|10340773|P3|Overall Study|Other reasons|2
3005098|NCT00908596|10340774|P2|Overall Study|Other reasons|6
3005099|NCT00908596|10340775|P1|Overall Study|Other reasons|46
3005100|NCT00908583|10340805|P1|Phase 5|Adverse Event|3
3005101|NCT00908583|10340805|P1|Phase 4|Physician Decision|1
3005102|NCT00908583|10340805|P1|Phase 4|Adverse Event|1
3005103|NCT00908583|10340805|P1|Phase 3|Adverse Event|2
3005104|NCT00908583|10340805|P1|Phase 2|Adverse Event|1
3005105|NCT00908583|10340805|P1|Phase 2|Physician Decision|1
3005106|NCT00908583|10340805|P1|Phase 1|Adverse Event|4
3005107|NCT00908583|10340805|P1|Phase 1|Withdrawal by Subject|1
3005108|NCT00908544|10340825|P2|Overall Study|Unable to visit sutdy center|0
3005109|NCT00908544|10340826|P1|Overall Study|Unable to visit sutdy center|1
3005110|NCT00908544|10340825|P2|Overall Study|Relocation abroad|1
3005111|NCT00908544|10340826|P1|Overall Study|Relocation abroad|1
3005112|NCT00908544|10340825|P2|Overall Study|Pregnancy|0
3005113|NCT00908544|10340826|P1|Overall Study|Pregnancy|1
3005114|NCT00908544|10340825|P2|Overall Study|Lack of Efficacy|1
3005115|NCT00908544|10340826|P1|Overall Study|Lack of Efficacy|0
3005116|NCT00908544|10340825|P2|Overall Study|Withdrawal by Subject|4
3005117|NCT00908544|10340826|P1|Overall Study|Withdrawal by Subject|2
3005118|NCT00908375|10340885|P2|Overall Study|Lost to Follow-up|6
3005119|NCT00908375|10340886|P1|Overall Study|Lost to Follow-up|8
3005120|NCT00908375|10340885|P2|Overall Study|Withdrawal by Subject|4
3005121|NCT00908375|10340886|P1|Overall Study|Withdrawal by Subject|2
3005122|NCT00908349|10340896|P1|Overall Study|Various|6
3005123|NCT00908349|10340896|P1|Overall Study|Lost to Follow-up|5
3005124|NCT00908349|10340896|P1|Overall Study|Physician Decision|5
3005125|NCT00908349|10340896|P1|Overall Study|Withdrawal by Subject|9
3005126|NCT00908349|10340896|P1|Overall Study|Adverse Event|10
3005127|NCT00908310|10340900|P1|Overall Study|Other reasons|4
3005128|NCT00908310|10340900|P1|Overall Study|Screening failure|5
3005129|NCT00908310|10340900|P1|Overall Study|Lost to Follow-up|7
3005130|NCT00908310|10340900|P1|Overall Study|Withdrawal by Subject|7
3005131|NCT00908310|10340900|P1|Overall Study|Death|37
3005132|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
3005133|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
3005134|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
3005135|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
3005136|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Other|0
3005137|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Other|0
3005138|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Other|1
3005139|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Other|3
3005140|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
3005141|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
3005142|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
3005143|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
3005144|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
3005145|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
3005146|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
3005147|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
3005148|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
3005149|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
3005150|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
3005151|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
3005152|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Death|0
3005153|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Death|0
3005154|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Death|0
3005155|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Death|2
3005156|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
3005157|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
3005158|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
3005159|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
3005160|NCT00908232|10340904|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
3005161|NCT00908232|10340905|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
3005162|NCT00908232|10340906|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
3005163|NCT00908232|10340907|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
3005164|NCT00908232|10340904|P4|Cycle 1 to 4|Other|0
3005165|NCT00908232|10340905|P3|Cycle 1 to 4|Other|0
3005166|NCT00908232|10340906|P2|Cycle 1 to 4|Other|0
3005167|NCT00908232|10340907|P1|Cycle 1 to 4|Other|1
3005168|NCT00908232|10340904|P4|Cycle 1 to 4|Adverse Event|0
3005169|NCT00908232|10340905|P3|Cycle 1 to 4|Adverse Event|0
3005170|NCT00908232|10340906|P2|Cycle 1 to 4|Adverse Event|0
3005171|NCT00908232|10340907|P1|Cycle 1 to 4|Adverse Event|12
3005172|NCT00908232|10340904|P4|Cycle 1 to 4|Progressive Disease|0
3005173|NCT00908232|10340905|P3|Cycle 1 to 4|Progressive Disease|0
3005174|NCT00908232|10340906|P2|Cycle 1 to 4|Progressive Disease|0
3005175|NCT00908232|10340907|P1|Cycle 1 to 4|Progressive Disease|6
3005176|NCT00908232|10340904|P4|Cycle 1 to 4|Withdrawal by Subject|0
3005177|NCT00908232|10340905|P3|Cycle 1 to 4|Withdrawal by Subject|0
3005178|NCT00908232|10340906|P2|Cycle 1 to 4|Withdrawal by Subject|0
3005179|NCT00908232|10340907|P1|Cycle 1 to 4|Withdrawal by Subject|4
3005180|NCT00908232|10340904|P4|Cycle 1 to 4|Death|0
3005181|NCT00908232|10340905|P3|Cycle 1 to 4|Death|0
3005182|NCT00908232|10340906|P2|Cycle 1 to 4|Death|0
3005183|NCT00908232|10340907|P1|Cycle 1 to 4|Death|5
3005184|NCT00908141|10340925|P2|Overall Study|Withdrawal by Subject|1
3005185|NCT00908141|10340926|P1|Overall Study|Withdrawal by Subject|0
3005186|NCT00908115|10340943|P1|Overall Study|Other|14
3005187|NCT00908076|10340951|P2|Overall Study|Lack of Efficacy|1
3005188|NCT00908076|10340952|P1|Overall Study|Lack of Efficacy|1
3005189|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005190|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
3005191|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005192|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005193|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005194|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005195|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005196|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005197|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005198|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005199|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005200|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
3005201|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005202|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005203|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
3005204|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005205|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005206|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005207|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005208|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005209|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005210|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005211|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005212|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
3005213|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005214|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
3005215|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005216|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005217|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005218|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005219|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005220|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005221|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005222|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005223|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005224|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
3005225|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005226|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005227|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
3005228|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005229|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005230|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005231|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005232|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005233|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005234|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005235|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005236|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
3005237|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
3005238|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005239|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
3005240|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005241|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005242|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005243|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005244|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005245|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005246|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005247|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005248|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
3005249|NCT00908037|10340965|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
3005250|NCT00908037|10340966|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005251|NCT00908037|10340967|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005252|NCT00908037|10340968|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005253|NCT00908037|10340969|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005254|NCT00908037|10340970|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005255|NCT00908037|10340971|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005256|NCT00908037|10340972|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005257|NCT00908037|10340973|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005258|NCT00908037|10340974|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005259|NCT00908037|10340975|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005260|NCT00908037|10340976|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
3005261|NCT00908037|10340965|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005262|NCT00908037|10340966|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005263|NCT00908037|10340967|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005264|NCT00908037|10340968|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005265|NCT00908037|10340969|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005266|NCT00908037|10340970|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
3005267|NCT00908037|10340971|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005268|NCT00908037|10340972|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005269|NCT00908037|10340973|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
3005270|NCT00908037|10340974|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005271|NCT00908037|10340975|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005272|NCT00908037|10340976|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
3005273|NCT00908037|10340965|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005274|NCT00908037|10340966|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005275|NCT00908037|10340967|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005276|NCT00908037|10340968|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
3005277|NCT00908037|10340969|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005278|NCT00908037|10340970|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005279|NCT00908037|10340971|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005280|NCT00908037|10340972|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
3005281|NCT00908037|10340973|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005282|NCT00908037|10340974|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005283|NCT00908037|10340975|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005284|NCT00908037|10340976|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
3005285|NCT00908037|10340965|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005286|NCT00908037|10340966|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005287|NCT00908037|10340967|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005288|NCT00908037|10340968|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
3005289|NCT00908037|10340969|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005290|NCT00908037|10340970|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
3005291|NCT00908037|10340971|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005292|NCT00908037|10340972|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
3005293|NCT00908037|10340973|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005294|NCT00908037|10340974|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005295|NCT00908037|10340975|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005296|NCT00908037|10340976|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
3005297|NCT00908011|10341125|P2|Overall Study|Withdrawal by Subject|2
3005298|NCT00908011|10341126|P1|Overall Study|Withdrawal by Subject|2
3005299|NCT00907881|10341143|P1|Overall Study|Missing discontinuation information|15
3005300|NCT00907881|10341143|P1|Overall Study|Protocol Violation|1
3005301|NCT00907881|10341143|P1|Overall Study|Withdrawal by Subject|5
3005302|NCT00907881|10341143|P1|Overall Study|Noncompliance|5
3005303|NCT00907881|10341143|P1|Overall Study|Lost to Follow-up|59
3005304|NCT00907803|10341153|P3|Overall Study|Protocol Violation|0
3005305|NCT00907803|10341154|P2|Overall Study|Protocol Violation|1
3005306|NCT00907803|10341155|P1|Overall Study|Protocol Violation|0
3005307|NCT00907803|10341153|P3|Overall Study|Lost to Follow-up|0
3005308|NCT00907803|10341154|P2|Overall Study|Lost to Follow-up|1
3005309|NCT00907803|10341155|P1|Overall Study|Lost to Follow-up|0
3005310|NCT00907803|10341153|P3|Overall Study|Withdrawal by Subject|0
3005311|NCT00907803|10341154|P2|Overall Study|Withdrawal by Subject|1
3005312|NCT00907803|10341155|P1|Overall Study|Withdrawal by Subject|0
3005313|NCT00907803|10341153|P3|Overall Study|Adverse Event|0
3005314|NCT00907803|10341154|P2|Overall Study|Adverse Event|0
3005315|NCT00907803|10341155|P1|Overall Study|Adverse Event|2
3005316|NCT00907803|10341153|P3|Overall Study|Withdrawal of consent - long commute|0
3005317|NCT00907803|10341154|P2|Overall Study|Withdrawal of consent - long commute|0
3005318|NCT00907803|10341155|P1|Overall Study|Withdrawal of consent - long commute|1
3005319|NCT00907777|10341186|P2|Overall Study|Withdrawal by Subject|1
3005320|NCT00907777|10341187|P1|Overall Study|Withdrawal by Subject|0
3005321|NCT00907738|10341214|P5|Overall Study|Disease progression|2
3005322|NCT00907738|10341215|P4|Overall Study|Disease progression|4
3005323|NCT00907738|10341216|P3|Overall Study|Disease progression|6
3005324|NCT00907738|10341217|P2|Overall Study|Disease progression|1
3005325|NCT00907738|10341218|P1|Overall Study|Disease progression|8
3005326|NCT00907738|10341214|P5|Overall Study|not specified or withdrew consent|0
3005327|NCT00907738|10341215|P4|Overall Study|not specified or withdrew consent|0
3005328|NCT00907738|10341216|P3|Overall Study|not specified or withdrew consent|0
3005329|NCT00907738|10341217|P2|Overall Study|not specified or withdrew consent|0
3005330|NCT00907738|10341218|P1|Overall Study|not specified or withdrew consent|3
3005331|NCT00907738|10341214|P5|Overall Study|Adverse Event|0
3005332|NCT00907738|10341215|P4|Overall Study|Adverse Event|0
3005333|NCT00907738|10341216|P3|Overall Study|Adverse Event|1
3005334|NCT00907738|10341217|P2|Overall Study|Adverse Event|0
3005335|NCT00907738|10341218|P1|Overall Study|Adverse Event|2
3005336|NCT00907621|10341236|P2|Overall Study|intercurrent febrile illness|1
3005337|NCT00907621|10341237|P1|Overall Study|intercurrent febrile illness|1
3005338|NCT00907621|10341236|P2|Overall Study|Lost to Follow-up|3
3005339|NCT00907621|10341237|P1|Overall Study|Lost to Follow-up|6
3005340|NCT00907517|10341250|P5|Overall Study|Symptomatic Deterioration|1
3005341|NCT00907517|10341251|P4|Overall Study|Symptomatic Deterioration|0
3005342|NCT00907517|10341252|P3|Overall Study|Symptomatic Deterioration|0
3005343|NCT00907517|10341253|P2|Overall Study|Symptomatic Deterioration|0
3005344|NCT00907517|10341254|P1|Overall Study|Symptomatic Deterioration|0
3005345|NCT00907517|10341250|P5|Overall Study|Progressive Disease|4
3005346|NCT00907517|10341251|P4|Overall Study|Progressive Disease|4
3005347|NCT00907517|10341252|P3|Overall Study|Progressive Disease|4
3005348|NCT00907517|10341253|P2|Overall Study|Progressive Disease|3
3005349|NCT00907517|10341254|P1|Overall Study|Progressive Disease|3
3005350|NCT00907478|10341279|P3|Overall Study|Other|1
3005351|NCT00907478|10341280|P2|Overall Study|Other|0
3005352|NCT00907478|10341281|P1|Overall Study|Other|3
3005353|NCT00907478|10341279|P3|Overall Study|Lost to Follow-up|0
3005354|NCT00907478|10341280|P2|Overall Study|Lost to Follow-up|0
3005355|NCT00907478|10341281|P1|Overall Study|Lost to Follow-up|1
3005356|NCT00907478|10341279|P3|Overall Study|Pregnancy|1
3005357|NCT00907478|10341280|P2|Overall Study|Pregnancy|1
3005358|NCT00907478|10341281|P1|Overall Study|Pregnancy|0
3005359|NCT00907478|10341279|P3|Overall Study|Protocol-specified criteria|3
3005360|NCT00907478|10341280|P2|Overall Study|Protocol-specified criteria|2
3005361|NCT00907478|10341281|P1|Overall Study|Protocol-specified criteria|5
3005362|NCT00907478|10341279|P3|Overall Study|Death|1
3005363|NCT00907478|10341280|P2|Overall Study|Death|2
3005364|NCT00907478|10341281|P1|Overall Study|Death|4
3005365|NCT00907478|10341279|P3|Overall Study|Physician Decision|3
3005366|NCT00907478|10341280|P2|Overall Study|Physician Decision|0
3005367|NCT00907478|10341281|P1|Overall Study|Physician Decision|2
3005368|NCT00907478|10341279|P3|Overall Study|Requirement for alternative therapy|3
3005369|NCT00907478|10341280|P2|Overall Study|Requirement for alternative therapy|2
3005370|NCT00907478|10341281|P1|Overall Study|Requirement for alternative therapy|1
3005371|NCT00907478|10341279|P3|Overall Study|Withdrawal by Subject|6
3005372|NCT00907478|10341280|P2|Overall Study|Withdrawal by Subject|9
3005373|NCT00907478|10341281|P1|Overall Study|Withdrawal by Subject|8
3005374|NCT00907478|10341279|P3|Overall Study|Adverse Event|2
3005375|NCT00907478|10341280|P2|Overall Study|Adverse Event|1
3005376|NCT00907478|10341281|P1|Overall Study|Adverse Event|3
3005377|NCT00907478|10341279|P3|Overall Study|Noncompliance|1
3005378|NCT00907478|10341280|P2|Overall Study|Noncompliance|0
3005379|NCT00907478|10341281|P1|Overall Study|Noncompliance|0
3005380|NCT00907478|10341279|P3|Overall Study|Ineligibility determined|1
3005381|NCT00907478|10341280|P2|Overall Study|Ineligibility determined|0
3005382|NCT00907478|10341281|P1|Overall Study|Ineligibility determined|0
3005383|NCT00907374|10341331|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
3005384|NCT00907374|10341332|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
3005385|NCT00907335|10341346|P2|Overall Study|Lost to Follow-up|0
3005386|NCT00907335|10341347|P1|Overall Study|Lost to Follow-up|2
3005387|NCT00907335|10341346|P2|Overall Study|Adverse Event|1
3005388|NCT00907335|10341347|P1|Overall Study|Adverse Event|4
3005389|NCT00907335|10341346|P2|Overall Study|Withdrawal by Subject|0
3005390|NCT00907335|10341347|P1|Overall Study|Withdrawal by Subject|2
3005391|NCT00907296|10341373|P10|Overall Study|Lost to Follow-up|4
3005392|NCT00907296|10341374|P9|Overall Study|Lost to Follow-up|0
3005393|NCT00907296|10341375|P8|Overall Study|Lost to Follow-up|2
3005394|NCT00907296|10341376|P7|Overall Study|Lost to Follow-up|2
3005395|NCT00907296|10341377|P6|Overall Study|Lost to Follow-up|3
3005396|NCT00907296|10341378|P5|Overall Study|Lost to Follow-up|0
3005397|NCT00907296|10341379|P4|Overall Study|Lost to Follow-up|2
3005398|NCT00907296|10341380|P3|Overall Study|Lost to Follow-up|0
3005399|NCT00907296|10341381|P2|Overall Study|Lost to Follow-up|1
3005400|NCT00907296|10341382|P1|Overall Study|Lost to Follow-up|9
3005401|NCT00907296|10341373|P10|Overall Study|Withdrawal by Subject|2
3005402|NCT00907296|10341374|P9|Overall Study|Withdrawal by Subject|4
3005403|NCT00907296|10341375|P8|Overall Study|Withdrawal by Subject|2
3005404|NCT00907296|10341376|P7|Overall Study|Withdrawal by Subject|3
3005405|NCT00907296|10341377|P6|Overall Study|Withdrawal by Subject|5
3005406|NCT00907296|10341378|P5|Overall Study|Withdrawal by Subject|1
3005407|NCT00907296|10341379|P4|Overall Study|Withdrawal by Subject|1
3005408|NCT00907296|10341380|P3|Overall Study|Withdrawal by Subject|1
3005409|NCT00907296|10341381|P2|Overall Study|Withdrawal by Subject|2
3005410|NCT00907296|10341382|P1|Overall Study|Withdrawal by Subject|7
3005411|NCT00907296|10341373|P10|Overall Study|Adverse Event|1
3005412|NCT00907296|10341374|P9|Overall Study|Adverse Event|0
3005413|NCT00907296|10341375|P8|Overall Study|Adverse Event|0
3005414|NCT00907296|10341376|P7|Overall Study|Adverse Event|1
3005415|NCT00907296|10341377|P6|Overall Study|Adverse Event|0
3005416|NCT00907296|10341378|P5|Overall Study|Adverse Event|0
3005417|NCT00907296|10341379|P4|Overall Study|Adverse Event|0
3005418|NCT00907296|10341380|P3|Overall Study|Adverse Event|0
3005419|NCT00907296|10341381|P2|Overall Study|Adverse Event|0
3005420|NCT00907296|10341382|P1|Overall Study|Adverse Event|2
3005421|NCT00907296|10341373|P10|Overall Study|Noncompliance|0
3005422|NCT00907296|10341374|P9|Overall Study|Noncompliance|0
3005423|NCT00907296|10341375|P8|Overall Study|Noncompliance|2
3005424|NCT00907296|10341376|P7|Overall Study|Noncompliance|0
3005425|NCT00907296|10341377|P6|Overall Study|Noncompliance|1
3005426|NCT00907296|10341378|P5|Overall Study|Noncompliance|0
3005427|NCT00907296|10341379|P4|Overall Study|Noncompliance|0
3005428|NCT00907296|10341380|P3|Overall Study|Noncompliance|1
3005429|NCT00907296|10341381|P2|Overall Study|Noncompliance|1
3005430|NCT00907296|10341382|P1|Overall Study|Noncompliance|1
3005431|NCT00907296|10341373|P10|Overall Study|Protocol Deviation|0
3005432|NCT00907296|10341374|P9|Overall Study|Protocol Deviation|0
3005433|NCT00907296|10341375|P8|Overall Study|Protocol Deviation|0
3005434|NCT00907296|10341376|P7|Overall Study|Protocol Deviation|0
3005435|NCT00907296|10341377|P6|Overall Study|Protocol Deviation|0
3005436|NCT00907296|10341378|P5|Overall Study|Protocol Deviation|0
3005437|NCT00907296|10341379|P4|Overall Study|Protocol Deviation|0
3005438|NCT00907296|10341380|P3|Overall Study|Protocol Deviation|0
3005439|NCT00907296|10341381|P2|Overall Study|Protocol Deviation|1
3005440|NCT00907296|10341382|P1|Overall Study|Protocol Deviation|0
3005441|NCT00907296|10341373|P10|Overall Study|Ineligibility Determined|0
3005442|NCT00907296|10341374|P9|Overall Study|Ineligibility Determined|0
3005443|NCT00907296|10341375|P8|Overall Study|Ineligibility Determined|1
3005444|NCT00907296|10341376|P7|Overall Study|Ineligibility Determined|0
3005445|NCT00907296|10341377|P6|Overall Study|Ineligibility Determined|0
3005446|NCT00907296|10341378|P5|Overall Study|Ineligibility Determined|0
3005447|NCT00907296|10341379|P4|Overall Study|Ineligibility Determined|1
3005448|NCT00907296|10341380|P3|Overall Study|Ineligibility Determined|0
3005449|NCT00907296|10341381|P2|Overall Study|Ineligibility Determined|0
3005450|NCT00907296|10341382|P1|Overall Study|Ineligibility Determined|1
3005451|NCT00907257|10341436|P2|Overall Study|Personal Reasons|1
3005452|NCT00907257|10341437|P1|Overall Study|Personal Reasons|6
3005453|NCT00907257|10341436|P2|Overall Study|Moved|0
3005454|NCT00907257|10341437|P1|Overall Study|Moved|1
3005455|NCT00907257|10341436|P2|Overall Study|Per IRB-Subject became vulnerable|0
3005456|NCT00907257|10341437|P1|Overall Study|Per IRB-Subject became vulnerable|1
3005457|NCT00907257|10341436|P2|Overall Study|Withdrawal by Subject|2
3005458|NCT00907257|10341437|P1|Overall Study|Withdrawal by Subject|1
3005459|NCT00907257|10341436|P2|Overall Study|Lost to Follow-up|3
3005460|NCT00907257|10341437|P1|Overall Study|Lost to Follow-up|3
3005461|NCT00907257|10341436|P2|Overall Study|Protocol Violation|2
3005462|NCT00907257|10341437|P1|Overall Study|Protocol Violation|1
3005463|NCT00907257|10341436|P2|Overall Study|Adverse Event|4
3005464|NCT00907257|10341437|P1|Overall Study|Adverse Event|0
3005465|NCT00907153|10341459|P2|Overall Study|Withdrawal by Subject|3
3005466|NCT00907153|10341460|P1|Overall Study|Withdrawal by Subject|1
3005467|NCT00907153|10341459|P2|Overall Study|Lost to Follow-up|1
3005468|NCT00907153|10341460|P1|Overall Study|Lost to Follow-up|1
3005469|NCT00906971|10341521|P2|Overall Study|Lost to Follow-up|1
3005470|NCT00906971|10341522|P1|Overall Study|Lost to Follow-up|0
3005471|NCT00906971|10341521|P2|Overall Study|Withdrawal by Subject|2
3005472|NCT00906971|10341522|P1|Overall Study|Withdrawal by Subject|8
3005473|NCT00906945|10341535|P6|Overall Study|Physician Decision|1
3005474|NCT00906945|10341536|P5|Overall Study|Physician Decision|0
3005475|NCT00906945|10341537|P4|Overall Study|Physician Decision|0
3005476|NCT00906945|10341538|P3|Overall Study|Physician Decision|0
3005477|NCT00906945|10341539|P2|Overall Study|Physician Decision|0
3005478|NCT00906945|10341540|P1|Overall Study|Physician Decision|0
3005479|NCT00906945|10341535|P6|Overall Study|Found to be not eligible|1
3005480|NCT00906945|10341536|P5|Overall Study|Found to be not eligible|1
3005481|NCT00906945|10341537|P4|Overall Study|Found to be not eligible|1
3005482|NCT00906945|10341538|P3|Overall Study|Found to be not eligible|0
3005483|NCT00906945|10341539|P2|Overall Study|Found to be not eligible|0
3005484|NCT00906945|10341540|P1|Overall Study|Found to be not eligible|0
3005485|NCT00906698|10341600|P6|Overall Study|incl. non compliance, lost to follow-up|0
3005486|NCT00906698|10341601|P5|Overall Study|incl. non compliance, lost to follow-up|0
3005487|NCT00906698|10341602|P4|Overall Study|incl. non compliance, lost to follow-up|0
3005488|NCT00906698|10341603|P3|Overall Study|incl. non compliance, lost to follow-up|0
3005489|NCT00906698|10341604|P2|Overall Study|incl. non compliance, lost to follow-up|1
3005490|NCT00906698|10341605|P1|Overall Study|incl. non compliance, lost to follow-up|0
3005491|NCT00906698|10341600|P6|Overall Study|Withdrawal by Subject|0
3005492|NCT00906698|10341601|P5|Overall Study|Withdrawal by Subject|1
3005493|NCT00906698|10341602|P4|Overall Study|Withdrawal by Subject|0
3005494|NCT00906698|10341603|P3|Overall Study|Withdrawal by Subject|0
3005495|NCT00906698|10341604|P2|Overall Study|Withdrawal by Subject|0
3005496|NCT00906698|10341605|P1|Overall Study|Withdrawal by Subject|0
3005497|NCT00906698|10341600|P6|Overall Study|Disease progression|4
3005498|NCT00906698|10341601|P5|Overall Study|Disease progression|12
3005499|NCT00906698|10341602|P4|Overall Study|Disease progression|4
3005500|NCT00906698|10341603|P3|Overall Study|Disease progression|4
3005501|NCT00906698|10341604|P2|Overall Study|Disease progression|12
3005502|NCT00906698|10341605|P1|Overall Study|Disease progression|3
3005503|NCT00906698|10341600|P6|Overall Study|Adverse Event|1
3005504|NCT00906698|10341601|P5|Overall Study|Adverse Event|4
3005505|NCT00906698|10341602|P4|Overall Study|Adverse Event|0
3005506|NCT00906698|10341603|P3|Overall Study|Adverse Event|2
3005507|NCT00906698|10341604|P2|Overall Study|Adverse Event|0
3005508|NCT00906698|10341605|P1|Overall Study|Adverse Event|0
3005509|NCT00906698|10341600|P6|Overall Study|Dose-limiting toxicity (DLT)|0
3005510|NCT00906698|10341601|P5|Overall Study|Dose-limiting toxicity (DLT)|1
3005511|NCT00906698|10341602|P4|Overall Study|Dose-limiting toxicity (DLT)|0
3005512|NCT00906698|10341603|P3|Overall Study|Dose-limiting toxicity (DLT)|0
3005513|NCT00906698|10341604|P2|Overall Study|Dose-limiting toxicity (DLT)|6
3005514|NCT00906698|10341605|P1|Overall Study|Dose-limiting toxicity (DLT)|0
3005515|NCT00906399|10341707|P7|Year 2|Other|0
3005516|NCT00906399|10341708|P6|Year 2|Other|1
3005517|NCT00906399|10341709|P5|Year 2|Other|3
3005518|NCT00906399|10341710|P4|Year 2|Other|2
3005519|NCT00906399|10341711|P3|Year 2|Other|0
3005520|NCT00906399|10341712|P2|Year 2|Other|0
3005521|NCT00906399|10341713|P1|Year 2|Other|0
3005522|NCT00906399|10341707|P7|Year 2|Death|3
3005523|NCT00906399|10341708|P6|Year 2|Death|0
3005524|NCT00906399|10341709|P5|Year 2|Death|0
3005525|NCT00906399|10341710|P4|Year 2|Death|1
3005526|NCT00906399|10341711|P3|Year 2|Death|0
3005527|NCT00906399|10341712|P2|Year 2|Death|0
3005528|NCT00906399|10341713|P1|Year 2|Death|0
3005529|NCT00906399|10341707|P7|Year 2|Physician Decision|3
3005530|NCT00906399|10341708|P6|Year 2|Physician Decision|6
3005531|NCT00906399|10341709|P5|Year 2|Physician Decision|2
3005532|NCT00906399|10341710|P4|Year 2|Physician Decision|0
3005533|NCT00906399|10341711|P3|Year 2|Physician Decision|0
3005534|NCT00906399|10341712|P2|Year 2|Physician Decision|0
3005535|NCT00906399|10341713|P1|Year 2|Physician Decision|0
3005536|NCT00906399|10341707|P7|Year 2|Withdrawal by Subject|13
3005537|NCT00906399|10341708|P6|Year 2|Withdrawal by Subject|27
3005538|NCT00906399|10341709|P5|Year 2|Withdrawal by Subject|18
3005539|NCT00906399|10341710|P4|Year 2|Withdrawal by Subject|17
3005540|NCT00906399|10341711|P3|Year 2|Withdrawal by Subject|0
3005541|NCT00906399|10341712|P2|Year 2|Withdrawal by Subject|0
3005542|NCT00906399|10341713|P1|Year 2|Withdrawal by Subject|0
3005543|NCT00906399|10341707|P7|Year 2|Lost to Follow-up|4
3005544|NCT00906399|10341708|P6|Year 2|Lost to Follow-up|2
3005545|NCT00906399|10341709|P5|Year 2|Lost to Follow-up|4
3005546|NCT00906399|10341710|P4|Year 2|Lost to Follow-up|1
3005547|NCT00906399|10341711|P3|Year 2|Lost to Follow-up|0
3005548|NCT00906399|10341712|P2|Year 2|Lost to Follow-up|0
3005549|NCT00906399|10341713|P1|Year 2|Lost to Follow-up|0
3005550|NCT00906399|10341707|P7|Year 2|Adverse Event|6
3005551|NCT00906399|10341708|P6|Year 2|Adverse Event|11
3005552|NCT00906399|10341709|P5|Year 2|Adverse Event|8
3005553|NCT00906399|10341710|P4|Year 2|Adverse Event|9
3005554|NCT00906399|10341711|P3|Year 2|Adverse Event|0
3005555|NCT00906399|10341712|P2|Year 2|Adverse Event|0
3005556|NCT00906399|10341713|P1|Year 2|Adverse Event|0
3005557|NCT00906399|10341707|P7|Year 1|Other|0
3005558|NCT00906399|10341708|P6|Year 1|Other|0
3005559|NCT00906399|10341709|P5|Year 1|Other|0
3005560|NCT00906399|10341710|P4|Year 1|Other|0
3005561|NCT00906399|10341711|P3|Year 1|Other|7
3005562|NCT00906399|10341712|P2|Year 1|Other|2
3005563|NCT00906399|10341713|P1|Year 1|Other|4
3005564|NCT00906399|10341707|P7|Year 1|Death|0
3005565|NCT00906399|10341708|P6|Year 1|Death|0
3005566|NCT00906399|10341709|P5|Year 1|Death|0
3005567|NCT00906399|10341710|P4|Year 1|Death|0
3005568|NCT00906399|10341711|P3|Year 1|Death|1
3005569|NCT00906399|10341712|P2|Year 1|Death|1
3005570|NCT00906399|10341713|P1|Year 1|Death|2
3005571|NCT00906399|10341707|P7|Year 1|Physician Decision|0
3005572|NCT00906399|10341708|P6|Year 1|Physician Decision|0
3005573|NCT00906399|10341709|P5|Year 1|Physician Decision|0
3005574|NCT00906399|10341710|P4|Year 1|Physician Decision|0
3005575|NCT00906399|10341711|P3|Year 1|Physician Decision|3
3005576|NCT00906399|10341712|P2|Year 1|Physician Decision|1
3005577|NCT00906399|10341713|P1|Year 1|Physician Decision|0
3005578|NCT00906399|10341707|P7|Year 1|Withdrawal by Subject|0
3005579|NCT00906399|10341708|P6|Year 1|Withdrawal by Subject|0
3005580|NCT00906399|10341709|P5|Year 1|Withdrawal by Subject|0
3005581|NCT00906399|10341710|P4|Year 1|Withdrawal by Subject|0
3005582|NCT00906399|10341711|P3|Year 1|Withdrawal by Subject|36
3005583|NCT00906399|10341712|P2|Year 1|Withdrawal by Subject|32
3005584|NCT00906399|10341713|P1|Year 1|Withdrawal by Subject|30
3005585|NCT00906399|10341707|P7|Year 1|Lost to Follow-up|0
3005586|NCT00906399|10341708|P6|Year 1|Lost to Follow-up|0
3005587|NCT00906399|10341709|P5|Year 1|Lost to Follow-up|0
3005588|NCT00906399|10341710|P4|Year 1|Lost to Follow-up|0
3005589|NCT00906399|10341711|P3|Year 1|Lost to Follow-up|2
3005590|NCT00906399|10341712|P2|Year 1|Lost to Follow-up|4
3005591|NCT00906399|10341713|P1|Year 1|Lost to Follow-up|4
3005592|NCT00906399|10341707|P7|Year 1|Adverse Event|0
3005593|NCT00906399|10341708|P6|Year 1|Adverse Event|0
3005594|NCT00906399|10341709|P5|Year 1|Adverse Event|0
3005595|NCT00906399|10341710|P4|Year 1|Adverse Event|0
3005596|NCT00906399|10341711|P3|Year 1|Adverse Event|24
3005597|NCT00906399|10341712|P2|Year 1|Adverse Event|22
3005598|NCT00906399|10341713|P1|Year 1|Adverse Event|4
3005599|NCT00906399|10341707|P7|Year 1|Randomized But Not Treated|0
3005600|NCT00906399|10341708|P6|Year 1|Randomized But Not Treated|0
3005601|NCT00906399|10341709|P5|Year 1|Randomized But Not Treated|0
3005602|NCT00906399|10341710|P4|Year 1|Randomized But Not Treated|0
3005603|NCT00906399|10341711|P3|Year 1|Randomized But Not Treated|3
3005604|NCT00906399|10341712|P2|Year 1|Randomized But Not Treated|1
3005605|NCT00906399|10341713|P1|Year 1|Randomized But Not Treated|0
3005606|NCT00906373|10341736|P2|Overall Study|Still on treatment at cutoff date|2
3005607|NCT00906373|10341737|P1|Overall Study|Still on treatment at cutoff date|0
3005608|NCT00906373|10341736|P2|Overall Study|Other|1
3005609|NCT00906373|10341737|P1|Overall Study|Other|0
3005610|NCT00906373|10341736|P2|Overall Study|Withdrawal by Subject|5
3005611|NCT00906373|10341737|P1|Overall Study|Withdrawal by Subject|0
3005612|NCT00906347|10341776|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
3005613|NCT00906347|10341777|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
3005614|NCT00906347|10341776|P2|Received Study Drug|Refused study drug|0
3005615|NCT00906347|10341777|P1|Received Study Drug|Refused study drug|1
3005616|NCT00906347|10341776|P2|Received Study Drug|Nonreassuring fetal heart rate|1
3005617|NCT00906347|10341777|P1|Received Study Drug|Nonreassuring fetal heart rate|13
3005618|NCT00906347|10341776|P2|Received Study Drug|8 cm prior to initiation of study drug|30
3005619|NCT00906347|10341777|P1|Received Study Drug|8 cm prior to initiation of study drug|18
3005620|NCT00906282|10341797|P1|Preoperative Chemotherapy|Toxicity|1
3005621|NCT00906282|10341797|P1|Preoperative Chemotherapy|Progressive disease|6
3005622|NCT00906282|10341797|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
3005623|NCT00906282|10341797|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
3005624|NCT00906204|10341811|P2|Secondary Endpoints (Long-term Safety)|Death|1
3005625|NCT00906204|10341812|P1|Secondary Endpoints (Long-term Safety)|Death|0
3005626|NCT00906204|10341811|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
3005627|NCT00906204|10341812|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
3005628|NCT00906204|10341811|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
3005629|NCT00906204|10341812|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
3005630|NCT00906204|10341811|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
3005631|NCT00906204|10341812|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
3005632|NCT00906204|10341811|P2|Primary Endpoint (Early Safety)|Physician Decision|0
3005633|NCT00906204|10341812|P1|Primary Endpoint (Early Safety)|Physician Decision|1
3005634|NCT00906087|10341866|P1|Initial Washout|Physician Decision|1
3005635|NCT00906087|10341866|P1|Initial Washout|Withdrawal by Subject|1
3005636|NCT00906035|10341903|P3|Overall Study|Withdrawal by Subject|0
3005637|NCT00906035|10341904|P2|Overall Study|Withdrawal by Subject|3
3005638|NCT00906035|10341905|P1|Overall Study|Withdrawal by Subject|2
3005639|NCT00905840|10341919|P1|Overall Study|Adverse Event|1
3005640|NCT00905840|10341919|P1|Overall Study|Withdrawal by Subject|1
3005641|NCT00905840|10341919|P1|Overall Study|Death|3
3005642|NCT00905840|10341919|P1|Overall Study|Lost to Follow-up|11
3005643|NCT00905632|10341950|P7|Overall Study|Adverse Event|4
3005644|NCT00905632|10341951|P6|Overall Study|Adverse Event|1
3005645|NCT00905632|10341952|P5|Overall Study|Adverse Event|0
3005646|NCT00905632|10341953|P4|Overall Study|Adverse Event|0
3005647|NCT00905632|10341954|P3|Overall Study|Adverse Event|0
3005648|NCT00905632|10341955|P2|Overall Study|Adverse Event|0
3005649|NCT00905632|10341956|P1|Overall Study|Adverse Event|0
3005650|NCT00905606|10342094|P2|Washout|Withdrawal by Subject|0
3005651|NCT00905606|10342095|P1|Washout|Withdrawal by Subject|1
3005652|NCT00905606|10342094|P2|Period 1|Adverse Event|1
3005653|NCT00905606|10342095|P1|Period 1|Adverse Event|0
3005654|NCT00905567|10342120|P2|Washout|Withdrawal by Subject|1
3005655|NCT00905567|10342121|P1|Washout|Withdrawal by Subject|0
3005656|NCT00905489|10342153|P1|Optional Extension Phase (OEP)|Adverse Event|1
3005657|NCT00905489|10342153|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
3005658|NCT00905489|10342153|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
3005659|NCT00905437|10342202|P2|Overall Study|Other|6
3005660|NCT00905437|10342203|P1|Overall Study|Other|5
3005661|NCT00905437|10342202|P2|Overall Study|Withdrawal by Subject|1
3005662|NCT00905437|10342203|P1|Overall Study|Withdrawal by Subject|0
3005663|NCT00905437|10342202|P2|Overall Study|Lost to Follow-up|1
3005664|NCT00905437|10342203|P1|Overall Study|Lost to Follow-up|0
3005665|NCT00905437|10342202|P2|Overall Study|Adverse Event|2
3005666|NCT00905437|10342203|P1|Overall Study|Adverse Event|3
3005667|NCT00905424|10342223|P2|Overall Study|Non-adherence to visit schedule|1
3005668|NCT00905424|10342224|P1|Overall Study|Non-adherence to visit schedule|0
3005669|NCT00905424|10342223|P2|Overall Study|Positive urine drug screen|1
3005670|NCT00905424|10342224|P1|Overall Study|Positive urine drug screen|0
3005671|NCT00905424|10342223|P2|Overall Study|Sponsor decision|0
3005672|NCT00905424|10342224|P1|Overall Study|Sponsor decision|1
3005673|NCT00905424|10342223|P2|Overall Study|Non-compliance with study medication|0
3005674|NCT00905424|10342224|P1|Overall Study|Non-compliance with study medication|2
3005675|NCT00905424|10342223|P2|Overall Study|Adverse Event|2
3005676|NCT00905424|10342224|P1|Overall Study|Adverse Event|4
3005677|NCT00905424|10342223|P2|Overall Study|Withdrawal by Subject|2
3005678|NCT00905424|10342224|P1|Overall Study|Withdrawal by Subject|1
3005679|NCT00905424|10342223|P2|Overall Study|Lost to Follow-up|3
3005680|NCT00905424|10342224|P1|Overall Study|Lost to Follow-up|3
3005681|NCT00905359|10342266|P2|Overall Study|Withdrawal consent|6
3005682|NCT00905359|10342267|P1|Overall Study|Withdrawal consent|5
3005683|NCT00905359|10342266|P2|Overall Study|Death|0
3005684|NCT00905359|10342267|P1|Overall Study|Death|2
3005685|NCT00905359|10342266|P2|Overall Study|Lost to Follow-up|10
3005686|NCT00905359|10342267|P1|Overall Study|Lost to Follow-up|17
3005687|NCT00905346|10342303|P2|Period 1|Withdrawal by Subject|0
3005688|NCT00905346|10342304|P1|Period 1|Withdrawal by Subject|1
3005689|NCT00905307|10342318|P6|Overall Study|Lack of Efficacy|8
3005690|NCT00905307|10342319|P5|Overall Study|Lack of Efficacy|4
3005691|NCT00905307|10342320|P4|Overall Study|Lack of Efficacy|4
3005692|NCT00905307|10342321|P3|Overall Study|Lack of Efficacy|5
3005693|NCT00905307|10342322|P2|Overall Study|Lack of Efficacy|3
3005694|NCT00905307|10342323|P1|Overall Study|Lack of Efficacy|6
3005695|NCT00905307|10342318|P6|Overall Study|Protocol Violation|0
3005696|NCT00905307|10342319|P5|Overall Study|Protocol Violation|0
3005697|NCT00905307|10342320|P4|Overall Study|Protocol Violation|0
3005698|NCT00905307|10342321|P3|Overall Study|Protocol Violation|1
3005699|NCT00905307|10342322|P2|Overall Study|Protocol Violation|0
3005700|NCT00905307|10342323|P1|Overall Study|Protocol Violation|1
3005701|NCT00905307|10342318|P6|Overall Study|Withdrawal by Subject|13
3005702|NCT00905307|10342319|P5|Overall Study|Withdrawal by Subject|4
3005703|NCT00905307|10342320|P4|Overall Study|Withdrawal by Subject|11
3005704|NCT00905307|10342321|P3|Overall Study|Withdrawal by Subject|15
3005705|NCT00905307|10342322|P2|Overall Study|Withdrawal by Subject|13
3005706|NCT00905307|10342323|P1|Overall Study|Withdrawal by Subject|5
3005707|NCT00905307|10342318|P6|Overall Study|Adverse Event|5
3005708|NCT00905307|10342319|P5|Overall Study|Adverse Event|3
3005709|NCT00905307|10342320|P4|Overall Study|Adverse Event|11
3005710|NCT00905307|10342321|P3|Overall Study|Adverse Event|5
3005711|NCT00905307|10342322|P2|Overall Study|Adverse Event|4
3005712|NCT00905307|10342323|P1|Overall Study|Adverse Event|3
3005713|NCT00905307|10342318|P6|Overall Study|Lost to Follow-up|1
3005714|NCT00905307|10342319|P5|Overall Study|Lost to Follow-up|1
3005715|NCT00905307|10342320|P4|Overall Study|Lost to Follow-up|0
3005716|NCT00905307|10342321|P3|Overall Study|Lost to Follow-up|0
3005717|NCT00905307|10342322|P2|Overall Study|Lost to Follow-up|0
3005718|NCT00905307|10342323|P1|Overall Study|Lost to Follow-up|0
3005719|NCT00905307|10342318|P6|Overall Study|Switched to Open Label Rescue|15
3005720|NCT00905307|10342319|P5|Overall Study|Switched to Open Label Rescue|4
3005721|NCT00905307|10342320|P4|Overall Study|Switched to Open Label Rescue|11
3005722|NCT00905307|10342321|P3|Overall Study|Switched to Open Label Rescue|11
3005723|NCT00905307|10342322|P2|Overall Study|Switched to Open Label Rescue|17
3005724|NCT00905307|10342323|P1|Overall Study|Switched to Open Label Rescue|7
3005725|NCT00905255|10342418|P2|Overall Study|Familial and Personal Reasons|0
3005726|NCT00905255|10342419|P1|Overall Study|Familial and Personal Reasons|1
3005727|NCT00905255|10342418|P2|Overall Study|Withdrawal by Subject|4
3005728|NCT00905255|10342419|P1|Overall Study|Withdrawal by Subject|5
3005729|NCT00905255|10342418|P2|Overall Study|Adverse Event|5
3005730|NCT00905255|10342419|P1|Overall Study|Adverse Event|7
3005731|NCT00905164|10342437|P2|Period 1|Protocol Violation|1
3005732|NCT00905164|10342438|P1|Period 1|Protocol Violation|0
3005733|NCT00905034|10342485|P1|Overall Study|Withdrawal by Subject|1
3005734|NCT00905021|10342489|P1|Overall Study|Adverse Event|2
3005735|NCT00904982|10342507|P4|Overall Study|Withdrawal by Subject|0
3005736|NCT00904982|10342508|P3|Overall Study|Withdrawal by Subject|0
3005737|NCT00904982|10342509|P2|Overall Study|Withdrawal by Subject|0
3005738|NCT00904982|10342510|P1|Overall Study|Withdrawal by Subject|2
3005739|NCT00904969|10342520|P1|Overall Study|Case Aborted; Subject Exited|1
3005740|NCT00904969|10342520|P1|Overall Study|Additional Treatments|11
3005741|NCT00904969|10342520|P1|Overall Study|Withdrawal by Subject|3
3005742|NCT00904969|10342520|P1|Overall Study|Lost to Follow-up|4
3005743|NCT00904917|10342585|P4|Overall Study|Lost to Follow-up|2
3005744|NCT00904917|10342586|P3|Overall Study|Lost to Follow-up|2
3005745|NCT00904917|10342587|P2|Overall Study|Lost to Follow-up|2
3005746|NCT00904917|10342588|P1|Overall Study|Lost to Follow-up|2
3005747|NCT00904839|10342606|P3|Overall Study|Other than above|7
3005748|NCT00904839|10342607|P2|Overall Study|Other than above|9
3005749|NCT00904839|10342608|P1|Overall Study|Other than above|0
3005750|NCT00904839|10342606|P3|Overall Study|Not treated|1
3005751|NCT00904839|10342607|P2|Overall Study|Not treated|0
3005752|NCT00904839|10342608|P1|Overall Study|Not treated|1
3005753|NCT00904839|10342606|P3|Overall Study|Withdrawal by Subject|0
3005754|NCT00904839|10342607|P2|Overall Study|Withdrawal by Subject|2
3005755|NCT00904839|10342608|P1|Overall Study|Withdrawal by Subject|0
3005756|NCT00904839|10342606|P3|Overall Study|Lost to Follow-up|2
3005757|NCT00904839|10342607|P2|Overall Study|Lost to Follow-up|1
3005758|NCT00904839|10342608|P1|Overall Study|Lost to Follow-up|0
3005759|NCT00904839|10342606|P3|Overall Study|Protocol Violation|1
3005760|NCT00904839|10342607|P2|Overall Study|Protocol Violation|1
3005761|NCT00904839|10342608|P1|Overall Study|Protocol Violation|0
3005762|NCT00904839|10342606|P3|Overall Study|Adverse Event|4
3005763|NCT00904839|10342607|P2|Overall Study|Adverse Event|5
3005764|NCT00904839|10342608|P1|Overall Study|Adverse Event|0
3005765|NCT00904748|10342654|P6|Overall Study|Adverse Event|0
3005766|NCT00904748|10342655|P5|Overall Study|Adverse Event|1
3005767|NCT00904748|10342656|P4|Overall Study|Adverse Event|0
3005768|NCT00904748|10342657|P3|Overall Study|Adverse Event|0
3005769|NCT00904748|10342658|P2|Overall Study|Adverse Event|0
3005770|NCT00904748|10342659|P1|Overall Study|Adverse Event|0
3005771|NCT00904748|10342654|P6|Overall Study|Withdrawal by Subject|0
3005772|NCT00904748|10342655|P5|Overall Study|Withdrawal by Subject|0
3005773|NCT00904748|10342656|P4|Overall Study|Withdrawal by Subject|2
3005774|NCT00904748|10342657|P3|Overall Study|Withdrawal by Subject|1
3005775|NCT00904748|10342658|P2|Overall Study|Withdrawal by Subject|1
3005776|NCT00904748|10342659|P1|Overall Study|Withdrawal by Subject|1
3005777|NCT00904722|10342683|P1|Overall Study|Physician Decision|1
3005778|NCT00904670|10342688|P2|Open Label Phase|Lost to Follow-up|0
3005779|NCT00904670|10342689|P1|Open Label Phase|Lost to Follow-up|1
3005780|NCT00904670|10342688|P2|Open Label Phase|Lack of Efficacy|0
3005781|NCT00904670|10342689|P1|Open Label Phase|Lack of Efficacy|1
3005782|NCT00904670|10342688|P2|Open Label Phase|Adverse Event|0
3005783|NCT00904670|10342689|P1|Open Label Phase|Adverse Event|2
3005784|NCT00904670|10342688|P2|Open Label Phase|Withdrawal by Subject|0
3005785|NCT00904670|10342689|P1|Open Label Phase|Withdrawal by Subject|2
3005786|NCT00904371|10342759|P1|Overall Study|Continued with Tritace|1
3005787|NCT00904371|10342759|P1|Overall Study|Discontinued at target blood pressure|2
3005788|NCT00904371|10342759|P1|Overall Study|Lost to Follow-up|4
3005789|NCT00904371|10342759|P1|Overall Study|Adverse Event|2
3005790|NCT00904215|10342773|P1|Overall Study|Other|28
3005791|NCT00904215|10342773|P1|Overall Study|Withdrawal by Subject|9
3005792|NCT00904215|10342773|P1|Overall Study|Lost to Follow-up|63
3005793|NCT00904215|10342773|P1|Overall Study|Protocol Violation|10
3005794|NCT00904215|10342773|P1|Overall Study|Adverse Event|25
3005795|NCT00904150|10342787|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
3005796|NCT00904150|10342788|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
3005797|NCT00904150|10342787|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
3005798|NCT00904150|10342788|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
3005799|NCT00904033|10342810|P4|Overall Study|Unable to obtain final blood draw|2
3005800|NCT00904033|10342811|P3|Overall Study|Unable to obtain final blood draw|0
3005801|NCT00904033|10342812|P2|Overall Study|Unable to obtain final blood draw|0
3005802|NCT00904033|10342813|P1|Overall Study|Unable to obtain final blood draw|0
3005803|NCT00904033|10342810|P4|Overall Study|Physician Decision|0
3005804|NCT00904033|10342811|P3|Overall Study|Physician Decision|1
3005805|NCT00904033|10342812|P2|Overall Study|Physician Decision|0
3005806|NCT00904033|10342813|P1|Overall Study|Physician Decision|0
3005807|NCT00904033|10342810|P4|Overall Study|Withdrawal by Subject|0
3005808|NCT00904033|10342811|P3|Overall Study|Withdrawal by Subject|0
3005809|NCT00904033|10342812|P2|Overall Study|Withdrawal by Subject|1
3005810|NCT00904033|10342813|P1|Overall Study|Withdrawal by Subject|1
3005811|NCT00903968|10342878|P8|Overall Study|Lack of Efficacy|3
3005812|NCT00903968|10342879|P7|Overall Study|Lack of Efficacy|0
3005813|NCT00903968|10342880|P6|Overall Study|Lack of Efficacy|0
3005814|NCT00903968|10342881|P5|Overall Study|Lack of Efficacy|0
3005815|NCT00903968|10342882|P4|Overall Study|Lack of Efficacy|0
3005816|NCT00903968|10342883|P3|Overall Study|Lack of Efficacy|0
3005817|NCT00903968|10342884|P2|Overall Study|Lack of Efficacy|0
3005818|NCT00903968|10342885|P1|Overall Study|Lack of Efficacy|0
3005819|NCT00903968|10342878|P8|Overall Study|Progressive Disease|18
3005820|NCT00903968|10342879|P7|Overall Study|Progressive Disease|0
3005821|NCT00903968|10342880|P6|Overall Study|Progressive Disease|3
3005822|NCT00903968|10342881|P5|Overall Study|Progressive Disease|3
3005823|NCT00903968|10342882|P4|Overall Study|Progressive Disease|3
3005824|NCT00903968|10342883|P3|Overall Study|Progressive Disease|2
3005825|NCT00903968|10342884|P2|Overall Study|Progressive Disease|3
3005826|NCT00903968|10342885|P1|Overall Study|Progressive Disease|2
3005827|NCT00903968|10342878|P8|Overall Study|Physician Decision|0
3005828|NCT00903968|10342879|P7|Overall Study|Physician Decision|0
3005829|NCT00903968|10342880|P6|Overall Study|Physician Decision|1
3005830|NCT00903968|10342881|P5|Overall Study|Physician Decision|0
3005831|NCT00903968|10342882|P4|Overall Study|Physician Decision|0
3005832|NCT00903968|10342883|P3|Overall Study|Physician Decision|0
3005833|NCT00903968|10342884|P2|Overall Study|Physician Decision|0
3005834|NCT00903968|10342885|P1|Overall Study|Physician Decision|0
3005835|NCT00903968|10342878|P8|Overall Study|Non-Compliance|0
3005836|NCT00903968|10342879|P7|Overall Study|Non-Compliance|0
3005837|NCT00903968|10342880|P6|Overall Study|Non-Compliance|1
3005838|NCT00903968|10342881|P5|Overall Study|Non-Compliance|0
3005839|NCT00903968|10342882|P4|Overall Study|Non-Compliance|0
3005840|NCT00903968|10342883|P3|Overall Study|Non-Compliance|0
3005841|NCT00903968|10342884|P2|Overall Study|Non-Compliance|0
3005842|NCT00903968|10342885|P1|Overall Study|Non-Compliance|0
3005843|NCT00903968|10342878|P8|Overall Study|Withdrawal by Subject|4
3005844|NCT00903968|10342879|P7|Overall Study|Withdrawal by Subject|0
3005845|NCT00903968|10342880|P6|Overall Study|Withdrawal by Subject|1
3005846|NCT00903968|10342881|P5|Overall Study|Withdrawal by Subject|1
3005847|NCT00903968|10342882|P4|Overall Study|Withdrawal by Subject|0
3005848|NCT00903968|10342883|P3|Overall Study|Withdrawal by Subject|1
3005849|NCT00903968|10342884|P2|Overall Study|Withdrawal by Subject|0
3005850|NCT00903968|10342885|P1|Overall Study|Withdrawal by Subject|1
3005851|NCT00903968|10342878|P8|Overall Study|DLT|0
3005852|NCT00903968|10342879|P7|Overall Study|DLT|2
3005853|NCT00903968|10342880|P6|Overall Study|DLT|0
3005854|NCT00903968|10342881|P5|Overall Study|DLT|0
3005855|NCT00903968|10342882|P4|Overall Study|DLT|0
3005856|NCT00903968|10342883|P3|Overall Study|DLT|0
3005857|NCT00903968|10342884|P2|Overall Study|DLT|0
3005858|NCT00903968|10342885|P1|Overall Study|DLT|0
3005859|NCT00903968|10342878|P8|Overall Study|Adverse Event|8
3005860|NCT00903968|10342879|P7|Overall Study|Adverse Event|1
3005861|NCT00903968|10342880|P6|Overall Study|Adverse Event|0
3005862|NCT00903968|10342881|P5|Overall Study|Adverse Event|0
3005863|NCT00903968|10342882|P4|Overall Study|Adverse Event|0
3005864|NCT00903968|10342883|P3|Overall Study|Adverse Event|0
3005865|NCT00903968|10342884|P2|Overall Study|Adverse Event|0
3005866|NCT00903968|10342885|P1|Overall Study|Adverse Event|0
3005867|NCT00903929|10342915|P4|Overall Study|Adverse Event|1
3005868|NCT00903929|10342916|P3|Overall Study|Adverse Event|0
3005869|NCT00903929|10342917|P2|Overall Study|Adverse Event|0
3005870|NCT00903929|10342918|P1|Overall Study|Adverse Event|0
3005871|NCT00903929|10342915|P4|Overall Study|Withdrawal by Subject|2
3005872|NCT00903929|10342916|P3|Overall Study|Withdrawal by Subject|1
3005873|NCT00903929|10342917|P2|Overall Study|Withdrawal by Subject|0
3005874|NCT00903929|10342918|P1|Overall Study|Withdrawal by Subject|0
3005875|NCT00903877|10342924|P1|Overall Study|Participation put on hold|4
3005876|NCT00903877|10342924|P1|Overall Study|Lost to Follow-up|1
3005877|NCT00903877|10342924|P1|Overall Study|Adverse Event|2
3005878|NCT00903877|10342924|P1|Overall Study|Withdrawal by Subject|3
3005879|NCT00903877|10342924|P1|Overall Study|Did not meet study criteria|33
3005880|NCT00903786|10342928|P1|Overall Study|Reason other than lack of efficacy|4
3005881|NCT00903786|10342928|P1|Overall Study|Lack of Efficacy|5
3005882|NCT00903786|10342928|P1|Overall Study|Physician Decision|6
3005883|NCT00903760|10342938|P2|Overall Study|Off treatment for long period|1
3005884|NCT00903760|10342939|P1|Overall Study|Off treatment for long period|0
3005885|NCT00903760|10342938|P2|Overall Study|Withdrawal by Subject|2
3005886|NCT00903760|10342939|P1|Overall Study|Withdrawal by Subject|1
3005887|NCT00903760|10342938|P2|Overall Study|Lost to Follow-up|0
3005888|NCT00903760|10342939|P1|Overall Study|Lost to Follow-up|1
3005889|NCT00903760|10342938|P2|Overall Study|Death|1
3005890|NCT00903760|10342939|P1|Overall Study|Death|0
3005891|NCT00903760|10342938|P2|Overall Study|Physician Decision|2
3005892|NCT00903760|10342939|P1|Overall Study|Physician Decision|1
3005893|NCT00903760|10342938|P2|Overall Study|Stem Cell Transplant|4
3005894|NCT00903760|10342939|P1|Overall Study|Stem Cell Transplant|8
3005895|NCT00903760|10342938|P2|Overall Study|Disease Progression/Death|6
3005896|NCT00903760|10342939|P1|Overall Study|Disease Progression/Death|8
3005897|NCT00903695|10342949|P2|Overall Study|lung cancer|0
3005898|NCT00903695|10342950|P1|Overall Study|lung cancer|1
3005899|NCT00903695|10342949|P2|Overall Study|medical exclusion after 1st testing|0
3005900|NCT00903695|10342950|P1|Overall Study|medical exclusion after 1st testing|1
3005901|NCT00903682|10342972|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
3005902|NCT00903682|10342973|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
3005903|NCT00903682|10342972|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
3005904|NCT00903682|10342973|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
3005905|NCT00903682|10342972|P2|Overall Study|Subject Non-Compliant|0
3005906|NCT00903682|10342973|P1|Overall Study|Subject Non-Compliant|1
3005907|NCT00903682|10342972|P2|Overall Study|Subject Reached A Virologic Endpoint|1
3005908|NCT00903682|10342973|P1|Overall Study|Subject Reached A Virologic Endpoint|1
3005909|NCT00903682|10342972|P2|Overall Study|Pregnancy|1
3005910|NCT00903682|10342973|P1|Overall Study|Pregnancy|0
3005911|NCT00903682|10342972|P2|Overall Study|Withdrawal by Subject|0
3005912|NCT00903682|10342973|P1|Overall Study|Withdrawal by Subject|5
3005913|NCT00903682|10342972|P2|Overall Study|Lost to Follow-up|0
3005914|NCT00903682|10342973|P1|Overall Study|Lost to Follow-up|1
3005915|NCT00903682|10342972|P2|Overall Study|Adverse Event|13
3005916|NCT00903682|10342973|P1|Overall Study|Adverse Event|6
3005917|NCT00903630|10342994|P3|Phase 2|Adverse Event|1
3005918|NCT00903630|10342995|P2|Phase 2|Adverse Event|0
3005919|NCT00903630|10342996|P1|Phase 2|Adverse Event|0
3005920|NCT00903617|10343014|P4|Overall Study|Withdrawal by Subject|0
3005921|NCT00903617|10343015|P3|Overall Study|Withdrawal by Subject|3
3005922|NCT00903617|10343016|P2|Overall Study|Withdrawal by Subject|2
3005923|NCT00903617|10343017|P1|Overall Study|Withdrawal by Subject|1
3005924|NCT00903617|10343014|P4|Overall Study|Lost to Follow-up|1
3005925|NCT00903617|10343015|P3|Overall Study|Lost to Follow-up|1
3005926|NCT00903617|10343016|P2|Overall Study|Lost to Follow-up|0
3005927|NCT00903617|10343017|P1|Overall Study|Lost to Follow-up|2
3005928|NCT00903617|10343014|P4|Overall Study|Protocol-defined stopping criteria|0
3005929|NCT00903617|10343015|P3|Overall Study|Protocol-defined stopping criteria|0
3005930|NCT00903617|10343016|P2|Overall Study|Protocol-defined stopping criteria|2
3005931|NCT00903617|10343017|P1|Overall Study|Protocol-defined stopping criteria|0
3005932|NCT00903617|10343014|P4|Overall Study|Adverse Event|0
3005933|NCT00903617|10343015|P3|Overall Study|Adverse Event|1
3005934|NCT00903617|10343016|P2|Overall Study|Adverse Event|1
3005935|NCT00903617|10343017|P1|Overall Study|Adverse Event|0
3005936|NCT00903409|10343120|P2|Overall Study|Lost to Follow-up|6
3005937|NCT00903409|10343121|P1|Overall Study|Lost to Follow-up|2
3005938|NCT00903409|10343120|P2|Overall Study|Other|3
3005939|NCT00903409|10343121|P1|Overall Study|Other|2
3005940|NCT00903409|10343120|P2|Overall Study|Withdrawal by Subject|8
3005941|NCT00903409|10343121|P1|Overall Study|Withdrawal by Subject|8
3005942|NCT00903409|10343120|P2|Overall Study|Laboratory Abnormality|0
3005943|NCT00903409|10343121|P1|Overall Study|Laboratory Abnormality|2
3005944|NCT00903409|10343120|P2|Overall Study|Non-compliance with Protocol|1
3005945|NCT00903409|10343121|P1|Overall Study|Non-compliance with Protocol|1
3005946|NCT00903409|10343120|P2|Overall Study|Adverse Event|9
3005947|NCT00903409|10343121|P1|Overall Study|Adverse Event|11
3005948|NCT00903383|10343172|P4|Overall Study|Patient Decision|1
3005949|NCT00903383|10343173|P3|Overall Study|Patient Decision|0
3005950|NCT00903383|10343174|P2|Overall Study|Patient Decision|0
3005951|NCT00903383|10343175|P1|Overall Study|Patient Decision|0
3005952|NCT00903383|10343172|P4|Overall Study|Patient Decision - Lack of Efficacy|0
3005953|NCT00903383|10343173|P3|Overall Study|Patient Decision - Lack of Efficacy|0
3005954|NCT00903383|10343174|P2|Overall Study|Patient Decision - Lack of Efficacy|1
3005955|NCT00903383|10343175|P1|Overall Study|Patient Decision - Lack of Efficacy|0
3005956|NCT00903383|10343172|P4|Overall Study|Withdrawal by Subject|2
3005957|NCT00903383|10343173|P3|Overall Study|Withdrawal by Subject|0
3005958|NCT00903383|10343174|P2|Overall Study|Withdrawal by Subject|1
3005959|NCT00903383|10343175|P1|Overall Study|Withdrawal by Subject|4
3005960|NCT00903383|10343172|P4|Overall Study|Decision of Sponsor|0
3005961|NCT00903383|10343173|P3|Overall Study|Decision of Sponsor|0
3005962|NCT00903383|10343174|P2|Overall Study|Decision of Sponsor|0
3005963|NCT00903383|10343175|P1|Overall Study|Decision of Sponsor|1
3005964|NCT00903383|10343172|P4|Overall Study|Lost to Follow-up|1
3005965|NCT00903383|10343173|P3|Overall Study|Lost to Follow-up|0
3005966|NCT00903383|10343174|P2|Overall Study|Lost to Follow-up|0
3005967|NCT00903383|10343175|P1|Overall Study|Lost to Follow-up|0
3005968|NCT00903383|10343172|P4|Overall Study|Physician Decision|0
3005969|NCT00903383|10343173|P3|Overall Study|Physician Decision|0
3005970|NCT00903383|10343174|P2|Overall Study|Physician Decision|2
3005971|NCT00903383|10343175|P1|Overall Study|Physician Decision|1
3005972|NCT00903383|10343172|P4|Overall Study|Adverse Event|1
3005973|NCT00903383|10343173|P3|Overall Study|Adverse Event|3
3005974|NCT00903383|10343174|P2|Overall Study|Adverse Event|2
3005975|NCT00903383|10343175|P1|Overall Study|Adverse Event|1
3005976|NCT00903370|10343207|P2|Overall Study|Lost to Follow-up|8
3005977|NCT00903370|10343208|P1|Overall Study|Lost to Follow-up|6
3005978|NCT00903370|10343207|P2|Overall Study|Withdrawal by Subject|6
3005979|NCT00903370|10343208|P1|Overall Study|Withdrawal by Subject|9
3005980|NCT00903370|10343207|P2|Overall Study|Death|10
3005981|NCT00903370|10343208|P1|Overall Study|Death|13
3005982|NCT00903357|10343216|P2|Second Intervention|Lost to Follow-up|0
3005983|NCT00903357|10343217|P1|Second Intervention|Lost to Follow-up|1
3005984|NCT00903357|10343216|P2|Wash Out Period of 2 Weeks|Flu|1
3005985|NCT00903357|10343217|P1|Wash Out Period of 2 Weeks|Flu|0
3005986|NCT00903357|10343216|P2|First Intervention|Flu|1
3005987|NCT00903357|10343217|P1|First Intervention|Flu|0
3005988|NCT00903357|10343216|P2|First Intervention|Withdrawal by Subject|3
3005989|NCT00903357|10343217|P1|First Intervention|Withdrawal by Subject|5
3005990|NCT00903344|10343229|P2|Overall Study|Lost to Follow-up|0
3005991|NCT00903344|10343230|P1|Overall Study|Lost to Follow-up|3
3005992|NCT00903344|10343229|P2|Overall Study|Pregnancy|3
3005993|NCT00903344|10343230|P1|Overall Study|Pregnancy|2
3005994|NCT00903331|10343248|P2|Overall Study|Lung transplant|2
3005995|NCT00903331|10343249|P1|Overall Study|Lung transplant|0
3005996|NCT00903331|10343248|P2|Overall Study|Withdrawal of consent|8
3005997|NCT00903331|10343249|P1|Overall Study|Withdrawal of consent|1
3005998|NCT00903331|10343248|P2|Overall Study|Death|8
3005999|NCT00903331|10343249|P1|Overall Study|Death|4
3006000|NCT00903201|10343260|P3|Overall Study|Withdrawal by Subject|1
3006001|NCT00903201|10343261|P2|Overall Study|Withdrawal by Subject|0
3006002|NCT00903201|10343262|P1|Overall Study|Withdrawal by Subject|1
3006003|NCT00903201|10343260|P3|Overall Study|Physician Decision|1
3006004|NCT00903201|10343261|P2|Overall Study|Physician Decision|0
3006005|NCT00903201|10343262|P1|Overall Study|Physician Decision|1
3006006|NCT00903201|10343260|P3|Overall Study|Lost to Follow-up|0
3006007|NCT00903201|10343261|P2|Overall Study|Lost to Follow-up|1
3006008|NCT00903201|10343262|P1|Overall Study|Lost to Follow-up|0
3006009|NCT00903201|10343260|P3|Overall Study|Protocol Violation|0
3006010|NCT00903201|10343261|P2|Overall Study|Protocol Violation|1
3006011|NCT00903201|10343262|P1|Overall Study|Protocol Violation|2
3006012|NCT00903201|10343260|P3|Overall Study|Adverse Event|0
3006013|NCT00903201|10343261|P2|Overall Study|Adverse Event|4
3006014|NCT00903201|10343262|P1|Overall Study|Adverse Event|1
3006015|NCT00903175|10343320|P2|Period 2 - Second Line|Death|2
3006016|NCT00903175|10343321|P1|Period 2 - Second Line|Death|5
3006017|NCT00903175|10343320|P2|Period 2 - Second Line|Administrative problems|9
3006018|NCT00903175|10343321|P1|Period 2 - Second Line|Administrative problems|19
3006019|NCT00903175|10343320|P2|Period 2 - Second Line|Lost to Follow-up|0
3006020|NCT00903175|10343321|P1|Period 2 - Second Line|Lost to Follow-up|1
3006021|NCT00903175|10343320|P2|Period 2 - Second Line|Withdrawal by Subject|5
3006022|NCT00903175|10343321|P1|Period 2 - Second Line|Withdrawal by Subject|7
3006023|NCT00903175|10343320|P2|Period 2 - Second Line|Adverse Event|20
3006024|NCT00903175|10343321|P1|Period 2 - Second Line|Adverse Event|16
3006025|NCT00903175|10343320|P2|Period 2 - Second Line|Missing|0
3006026|NCT00903175|10343321|P1|Period 2 - Second Line|Missing|1
3006027|NCT00903175|10343320|P2|Period 1 - First Line|Death|10
3006028|NCT00903175|10343321|P1|Period 1 - First Line|Death|17
3006029|NCT00903175|10343320|P2|Period 1 - First Line|Administrative problems|13
3006030|NCT00903175|10343321|P1|Period 1 - First Line|Administrative problems|12
3006031|NCT00903175|10343320|P2|Period 1 - First Line|Withdrawal by Subject|12
3006032|NCT00903175|10343321|P1|Period 1 - First Line|Withdrawal by Subject|8
3006033|NCT00903175|10343320|P2|Period 1 - First Line|Protocol Violation|3
3006034|NCT00903175|10343321|P1|Period 1 - First Line|Protocol Violation|3
3006035|NCT00903175|10343320|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
3006036|NCT00903175|10343321|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
3006037|NCT00903175|10343320|P2|Period 1 - First Line|Abnormal lab value(s)|1
3006038|NCT00903175|10343321|P1|Period 1 - First Line|Abnormal lab value(s)|0
3006039|NCT00903175|10343320|P2|Period 1 - First Line|Adverse Event|50
3006040|NCT00903175|10343321|P1|Period 1 - First Line|Adverse Event|36
3006041|NCT00903032|10343359|P2|Overall Study|Lost to Follow-up|2
3006042|NCT00903032|10343360|P1|Overall Study|Lost to Follow-up|2
3006043|NCT00903032|10343359|P2|Overall Study|Withdrawal by Subject|3
3006044|NCT00903032|10343360|P1|Overall Study|Withdrawal by Subject|5
3006045|NCT00903006|10343370|P4|Overall Study|Progressive Disease|0
3006046|NCT00903006|10343371|P3|Overall Study|Progressive Disease|1
3006047|NCT00903006|10343372|P2|Overall Study|Progressive Disease|3
3006048|NCT00903006|10343373|P1|Overall Study|Progressive Disease|0
3006049|NCT00903006|10343370|P4|Overall Study|Withdrawal by Subject|0
3006050|NCT00903006|10343371|P3|Overall Study|Withdrawal by Subject|0
3006051|NCT00903006|10343372|P2|Overall Study|Withdrawal by Subject|0
3006052|NCT00903006|10343373|P1|Overall Study|Withdrawal by Subject|2
3006053|NCT00902850|10343385|P2|Overall Study|Physician Decision|2
3006054|NCT00902850|10343386|P1|Overall Study|Physician Decision|2
3006055|NCT00902746|10343392|P1|Overall Study|Physician Decision|2
3006056|NCT00902746|10343392|P1|Overall Study|Lost to Follow-up|3
3006057|NCT00902746|10343392|P1|Overall Study|Adverse Event|8
3006058|NCT00902746|10343392|P1|Overall Study|Withdrawal by Subject|16
3006059|NCT00902746|10343392|P1|Overall Study|Protocol Violation|7
3006060|NCT00902668|10343397|P1|Overall Study|Protocol stopped due to slow accrual.|3
3006061|NCT00902577|10343401|P1|Overall Study|FMISO production failure|2
3006062|NCT00902577|10343401|P1|Overall Study|Withdrawal by Subject|6
3006063|NCT00902564|10343430|P1|Overall Study|Withdrawal by Subject|2
3006064|NCT00902538|10343445|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
3006065|NCT00902538|10343446|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
3006066|NCT00902538|10343447|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
3006067|NCT00902538|10343448|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
3006068|NCT00902538|10343449|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
3006069|NCT00902538|10343450|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
3006070|NCT00902538|10343445|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
3006071|NCT00902538|10343446|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
3006072|NCT00902538|10343447|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
3006073|NCT00902538|10343448|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
3006074|NCT00902538|10343449|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
3006075|NCT00902538|10343450|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
3006076|NCT00902538|10343445|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
3006077|NCT00902538|10343446|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
3006078|NCT00902538|10343447|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
3006079|NCT00902538|10343448|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
3006080|NCT00902538|10343449|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
3006081|NCT00902538|10343450|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
3006082|NCT00902538|10343445|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
3006083|NCT00902538|10343446|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
3006084|NCT00902538|10343447|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
3006085|NCT00902538|10343448|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
3006086|NCT00902538|10343449|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
3006087|NCT00902538|10343450|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
3006088|NCT00902538|10343445|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
3006089|NCT00902538|10343446|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
3006090|NCT00902538|10343447|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
3006091|NCT00902538|10343448|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
3006092|NCT00902538|10343449|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
3006093|NCT00902538|10343450|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
3006094|NCT00902538|10343445|P6|3-Single-blind, Single Treatment|Protocol Violation|0
3006095|NCT00902538|10343446|P5|3-Single-blind, Single Treatment|Protocol Violation|0
3006096|NCT00902538|10343447|P4|3-Single-blind, Single Treatment|Protocol Violation|0
3006097|NCT00902538|10343448|P3|3-Single-blind, Single Treatment|Protocol Violation|0
3006098|NCT00902538|10343449|P2|3-Single-blind, Single Treatment|Protocol Violation|5
3006099|NCT00902538|10343450|P1|3-Single-blind, Single Treatment|Protocol Violation|0
3006100|NCT00902538|10343445|P6|3-Single-blind, Single Treatment|Adverse Event|0
3006101|NCT00902538|10343446|P5|3-Single-blind, Single Treatment|Adverse Event|0
3006102|NCT00902538|10343447|P4|3-Single-blind, Single Treatment|Adverse Event|0
3006103|NCT00902538|10343448|P3|3-Single-blind, Single Treatment|Adverse Event|0
3006104|NCT00902538|10343449|P2|3-Single-blind, Single Treatment|Adverse Event|5
3006105|NCT00902538|10343450|P1|3-Single-blind, Single Treatment|Adverse Event|0
3006106|NCT00902538|10343445|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
3006107|NCT00902538|10343446|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
3006108|NCT00902538|10343447|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
3006109|NCT00902538|10343448|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
3006110|NCT00902538|10343449|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
3006111|NCT00902538|10343450|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
3006112|NCT00902538|10343445|P6|2-Randomized Double-blind 3 Treatments|Other|0
3006113|NCT00902538|10343446|P5|2-Randomized Double-blind 3 Treatments|Other|0
3006114|NCT00902538|10343447|P4|2-Randomized Double-blind 3 Treatments|Other|0
3006115|NCT00902538|10343448|P3|2-Randomized Double-blind 3 Treatments|Other|0
3006116|NCT00902538|10343449|P2|2-Randomized Double-blind 3 Treatments|Other|1
3006117|NCT00902538|10343450|P1|2-Randomized Double-blind 3 Treatments|Other|2
3006118|NCT00902538|10343445|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
3006119|NCT00902538|10343446|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
3006120|NCT00902538|10343447|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
3006121|NCT00902538|10343448|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
3006122|NCT00902538|10343449|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
3006123|NCT00902538|10343450|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
3006124|NCT00902538|10343445|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
3006125|NCT00902538|10343446|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
3006126|NCT00902538|10343447|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
3006127|NCT00902538|10343448|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
3006128|NCT00902538|10343449|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
3006129|NCT00902538|10343450|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
3006130|NCT00902538|10343445|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
3006131|NCT00902538|10343446|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
3006132|NCT00902538|10343447|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
3006133|NCT00902538|10343448|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
3006134|NCT00902538|10343449|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
3006135|NCT00902538|10343450|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
3006136|NCT00902538|10343445|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
3006137|NCT00902538|10343446|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
3006138|NCT00902538|10343447|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
3006139|NCT00902538|10343448|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
3006140|NCT00902538|10343449|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
3006141|NCT00902538|10343450|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
3006142|NCT00902538|10343445|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
3006143|NCT00902538|10343446|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
3006144|NCT00902538|10343447|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
3006145|NCT00902538|10343448|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
3006146|NCT00902538|10343449|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
3006147|NCT00902538|10343450|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
3006148|NCT00902538|10343445|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
3006149|NCT00902538|10343446|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
3006150|NCT00902538|10343447|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
3006151|NCT00902538|10343448|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
3006152|NCT00902538|10343449|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
3006153|NCT00902538|10343450|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
3006154|NCT00902538|10343445|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
3006155|NCT00902538|10343446|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
3006156|NCT00902538|10343447|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
3006157|NCT00902538|10343448|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
3006158|NCT00902538|10343449|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
3006159|NCT00902538|10343450|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
3006160|NCT00902538|10343445|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
3006161|NCT00902538|10343446|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
3006162|NCT00902538|10343447|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
3006163|NCT00902538|10343448|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
3006164|NCT00902538|10343449|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
3006165|NCT00902538|10343450|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
3006166|NCT00902486|10343484|P6|Follow-up (After Week 24)|Lost to Follow-up|0
3006167|NCT00902486|10343485|P5|Follow-up (After Week 24)|Lost to Follow-up|0
3006168|NCT00902486|10343486|P4|Follow-up (After Week 24)|Lost to Follow-up|1
3006169|NCT00902486|10343487|P3|Follow-up (After Week 24)|Lost to Follow-up|0
3006170|NCT00902486|10343488|P2|Follow-up (After Week 24)|Lost to Follow-up|0
3006171|NCT00902486|10343489|P1|Follow-up (After Week 24)|Lost to Follow-up|0
3006172|NCT00902486|10343484|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
3006173|NCT00902486|10343485|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
3006174|NCT00902486|10343486|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
3006175|NCT00902486|10343487|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
3006176|NCT00902486|10343488|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
3006177|NCT00902486|10343489|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
3006178|NCT00902486|10343484|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
3006179|NCT00902486|10343485|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
3006180|NCT00902486|10343486|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
3006181|NCT00902486|10343487|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
3006182|NCT00902486|10343488|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
3006183|NCT00902486|10343489|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
3006184|NCT00902486|10343484|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
3006185|NCT00902486|10343485|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
3006186|NCT00902486|10343486|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
3006187|NCT00902486|10343487|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
3006188|NCT00902486|10343488|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
3006189|NCT00902486|10343489|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
3006190|NCT00902486|10343484|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
3006191|NCT00902486|10343485|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
3006192|NCT00902486|10343486|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
3006193|NCT00902486|10343487|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
3006194|NCT00902486|10343488|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
3006195|NCT00902486|10343489|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
3006196|NCT00902486|10343484|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
3006197|NCT00902486|10343485|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
3006198|NCT00902486|10343486|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
3006199|NCT00902486|10343487|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
3006200|NCT00902486|10343488|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
3006201|NCT00902486|10343489|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
3006202|NCT00902486|10343484|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
3006203|NCT00902486|10343485|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
3006204|NCT00902486|10343486|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
3006205|NCT00902486|10343487|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
3006206|NCT00902486|10343488|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
3006207|NCT00902486|10343489|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
3006208|NCT00902486|10343484|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
3006209|NCT00902486|10343485|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
3006210|NCT00902486|10343486|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
3006211|NCT00902486|10343487|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
3006212|NCT00902486|10343488|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
3006213|NCT00902486|10343489|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
3006214|NCT00902486|10343484|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
3006215|NCT00902486|10343485|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
3006216|NCT00902486|10343486|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
3006217|NCT00902486|10343487|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
3006218|NCT00902486|10343488|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
3006219|NCT00902486|10343489|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
3006220|NCT00902486|10343484|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
3006221|NCT00902486|10343485|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
3006222|NCT00902486|10343486|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
3006223|NCT00902486|10343487|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
3006224|NCT00902486|10343488|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
3006225|NCT00902486|10343489|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
3006226|NCT00902486|10343484|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
3006227|NCT00902486|10343485|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
3006228|NCT00902486|10343486|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
3006229|NCT00902486|10343487|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
3006230|NCT00902486|10343488|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
3006231|NCT00902486|10343489|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
3006232|NCT00902330|10343627|P2|Overall Study|No post baseline data|0
3006233|NCT00902330|10343628|P1|Overall Study|No post baseline data|1
3006234|NCT00902330|10343627|P2|Overall Study|Adverse Event|0
3006235|NCT00902330|10343628|P1|Overall Study|Adverse Event|1
3006236|NCT00902330|10343627|P2|Overall Study|Too overwhelmed by treatment|5
3006237|NCT00902330|10343628|P1|Overall Study|Too overwhelmed by treatment|2
3006238|NCT00902304|10343665|P3|Overall Study|includes pregnancy|2
3006239|NCT00902304|10343666|P2|Overall Study|includes pregnancy|9
3006240|NCT00902304|10343667|P1|Overall Study|includes pregnancy|3
3006241|NCT00902304|10343665|P3|Overall Study|Withdrawal by Subject|43
3006242|NCT00902304|10343666|P2|Overall Study|Withdrawal by Subject|22
3006243|NCT00902304|10343667|P1|Overall Study|Withdrawal by Subject|32
3006244|NCT00902304|10343665|P3|Overall Study|Protocol Violation|20
3006245|NCT00902304|10343666|P2|Overall Study|Protocol Violation|18
3006246|NCT00902304|10343667|P1|Overall Study|Protocol Violation|9
3006247|NCT00902304|10343665|P3|Overall Study|Lost to Follow-up|7
3006248|NCT00902304|10343666|P2|Overall Study|Lost to Follow-up|7
3006249|NCT00902304|10343667|P1|Overall Study|Lost to Follow-up|7
3006250|NCT00902304|10343665|P3|Overall Study|Investigator discretion|13
3006251|NCT00902304|10343666|P2|Overall Study|Investigator discretion|5
3006252|NCT00902304|10343667|P1|Overall Study|Investigator discretion|3
3006253|NCT00902304|10343665|P3|Overall Study|Adverse Event|25
3006254|NCT00902304|10343666|P2|Overall Study|Adverse Event|10
3006255|NCT00902304|10343667|P1|Overall Study|Adverse Event|4
3006256|NCT00902278|10343717|P5|Overall Study|Lost to Follow-up|1
3006257|NCT00902278|10343718|P4|Overall Study|Lost to Follow-up|0
3006258|NCT00902278|10343719|P3|Overall Study|Lost to Follow-up|3
3006259|NCT00902278|10343720|P2|Overall Study|Lost to Follow-up|2
3006260|NCT00902278|10343721|P1|Overall Study|Lost to Follow-up|3
3006261|NCT00902278|10343717|P5|Overall Study|Physician Decision|1
3006262|NCT00902278|10343718|P4|Overall Study|Physician Decision|0
3006263|NCT00902278|10343719|P3|Overall Study|Physician Decision|2
3006264|NCT00902278|10343720|P2|Overall Study|Physician Decision|0
3006265|NCT00902278|10343721|P1|Overall Study|Physician Decision|1
3006266|NCT00902265|10343738|P1|Overall Study|Protocol Violation|1
3006267|NCT00902265|10343738|P1|Overall Study|Lack of Efficacy|2
3006268|NCT00902265|10343738|P1|Overall Study|Adverse Event|2
3006269|NCT00902265|10343738|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
3006270|NCT00902174|10343762|P2|Overall Study|Administration problem|1
3006271|NCT00902174|10343763|P1|Overall Study|Administration problem|0
3006272|NCT00902174|10343762|P2|Overall Study|Protocol Violation|1
3006273|NCT00902174|10343763|P1|Overall Study|Protocol Violation|1
3006274|NCT00902174|10343762|P2|Overall Study|Abnormal labs|1
3006275|NCT00902174|10343763|P1|Overall Study|Abnormal labs|1
3006276|NCT00902174|10343762|P2|Overall Study|Withdrawal by Subject|1
3006277|NCT00902174|10343763|P1|Overall Study|Withdrawal by Subject|2
3006278|NCT00902174|10343762|P2|Overall Study|Death|2
3006279|NCT00902174|10343763|P1|Overall Study|Death|2
3006280|NCT00902174|10343762|P2|Overall Study|Lack of Efficacy|5
3006281|NCT00902174|10343763|P1|Overall Study|Lack of Efficacy|1
3006282|NCT00902174|10343762|P2|Overall Study|Adverse Event|7
3006283|NCT00902174|10343763|P1|Overall Study|Adverse Event|27
3006284|NCT00901927|10343838|P1|Overall Study|Withdrawal by Subject|2
3006285|NCT00901927|10343838|P1|Overall Study|Protocol Violation|3
3006286|NCT00901927|10343838|P1|Overall Study|Lack of Efficacy|1
3006287|NCT00901901|10343846|P2|Follow-up Period|Missing|80
3006288|NCT00901901|10343847|P1|Follow-up Period|Missing|94
3006289|NCT00901901|10343846|P2|Follow-up Period|Lost to Follow-up|8
3006290|NCT00901901|10343847|P1|Follow-up Period|Lost to Follow-up|12
3006291|NCT00901901|10343846|P2|Follow-up Period|Withdrawal by Subject|9
3006292|NCT00901901|10343847|P1|Follow-up Period|Withdrawal by Subject|6
3006293|NCT00901901|10343846|P2|Follow-up Period|Protocol driven decision point|36
3006294|NCT00901901|10343847|P1|Follow-up Period|Protocol driven decision point|47
3006295|NCT00901901|10343846|P2|Follow-up Period|Death|208
3006296|NCT00901901|10343847|P1|Follow-up Period|Death|181
3006297|NCT00901901|10343846|P2|Treatment Period|Transfer to treatment continuation study|2
3006298|NCT00901901|10343847|P1|Treatment Period|Transfer to treatment continuation study|5
3006299|NCT00901901|10343846|P2|Treatment Period|Switch to commercial drug|1
3006300|NCT00901901|10343847|P1|Treatment Period|Switch to commercial drug|1
3006301|NCT00901901|10343846|P2|Treatment Period|Protocol Violation|9
3006302|NCT00901901|10343847|P1|Treatment Period|Protocol Violation|5
3006303|NCT00901901|10343846|P2|Treatment Period|Study terminated by sponsor|0
3006304|NCT00901901|10343847|P1|Treatment Period|Study terminated by sponsor|2
3006305|NCT00901901|10343846|P2|Treatment Period|Protocol driven decision point|2
3006306|NCT00901901|10343847|P1|Treatment Period|Protocol driven decision point|0
3006307|NCT00901901|10343846|P2|Treatment Period|Never treated|3
3006308|NCT00901901|10343847|P1|Treatment Period|Never treated|0
3006309|NCT00901901|10343846|P2|Treatment Period|Missing|0
3006310|NCT00901901|10343847|P1|Treatment Period|Missing|1
3006311|NCT00901901|10343846|P2|Treatment Period|Noncompliance with study medication|1
3006312|NCT00901901|10343847|P1|Treatment Period|Noncompliance with study medication|4
3006313|NCT00901901|10343846|P2|Treatment Period|Lost to Follow-up|5
3006314|NCT00901901|10343847|P1|Treatment Period|Lost to Follow-up|3
3006315|NCT00901901|10343846|P2|Treatment Period|Physician Decision|2
3006316|NCT00901901|10343847|P1|Treatment Period|Physician Decision|2
3006317|NCT00901901|10343846|P2|Treatment Period|Withdrawal by Subject|24
3006318|NCT00901901|10343847|P1|Treatment Period|Withdrawal by Subject|26
3006319|NCT00901901|10343846|P2|Treatment Period|Adverse Event|128
3006320|NCT00901901|10343847|P1|Treatment Period|Adverse Event|120
3006321|NCT00901628|10343869|P2|Overall Study|peroneal nerve palsy|1
3006322|NCT00901628|10343870|P1|Overall Study|peroneal nerve palsy|0
3006323|NCT00901628|10343869|P2|Overall Study|disconnection of drain|1
3006324|NCT00901628|10343870|P1|Overall Study|disconnection of drain|0
3006325|NCT00901628|10343869|P2|Overall Study|disconnection of catheter|8
3006326|NCT00901628|10343870|P1|Overall Study|disconnection of catheter|4
3006327|NCT00901576|10343892|P6|Second Intervention|Physician Decision|0
3006328|NCT00901576|10343893|P5|Second Intervention|Physician Decision|0
3006329|NCT00901576|10343894|P4|Second Intervention|Physician Decision|0
3006330|NCT00901576|10343895|P3|Second Intervention|Physician Decision|0
3006331|NCT00901576|10343896|P2|Second Intervention|Physician Decision|0
3006332|NCT00901576|10343897|P1|Second Intervention|Physician Decision|1
3006333|NCT00901576|10343892|P6|Second Intervention|Withdrawal by Subject|1
3006334|NCT00901576|10343893|P5|Second Intervention|Withdrawal by Subject|0
3006335|NCT00901576|10343894|P4|Second Intervention|Withdrawal by Subject|1
3006336|NCT00901576|10343895|P3|Second Intervention|Withdrawal by Subject|0
3006337|NCT00901576|10343896|P2|Second Intervention|Withdrawal by Subject|0
3006338|NCT00901576|10343897|P1|Second Intervention|Withdrawal by Subject|0
3006339|NCT00901459|10343918|P1|Overall Study|Withdrawal by Subject|6
3006340|NCT00901342|10343929|P1|Overall Study|Withdrawal by Subject|9
3006341|NCT00901342|10343929|P1|Overall Study|Disease progression|1
3006342|NCT00901342|10343929|P1|Overall Study|Death|4
3006343|NCT00901342|10343929|P1|Overall Study|Adverse Event|1
3006344|NCT00901186|10343962|P2|Overall Study|Protocol deviations|4
3006345|NCT00901186|10343963|P1|Overall Study|Protocol deviations|5
3006346|NCT00901186|10343962|P2|Overall Study|Administration problems|1
3006347|NCT00901186|10343963|P1|Overall Study|Administration problems|0
3006348|NCT00901186|10343962|P2|Overall Study|Adverse Event|4
3006349|NCT00901186|10343963|P1|Overall Study|Adverse Event|2
3006350|NCT00901186|10343962|P2|Overall Study|Lost to Follow-up|0
3006351|NCT00901186|10343963|P1|Overall Study|Lost to Follow-up|2
3006352|NCT00901186|10343962|P2|Overall Study|Abnormal laboratory values|1
3006353|NCT00901186|10343963|P1|Overall Study|Abnormal laboratory values|0
3006354|NCT00901186|10343962|P2|Overall Study|Lack of Efficacy|1
3006355|NCT00901186|10343963|P1|Overall Study|Lack of Efficacy|0
3006356|NCT00900796|10344003|P1|Phase 2|Lost to Follow-up|5
3006357|NCT00900796|10344003|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
3006358|NCT00900796|10344003|P1|Phase 1|Missing information at Week 16|7
3006359|NCT00900796|10344003|P1|Phase 1|Lacked sufficient information|4
3006360|NCT00900757|10344013|P1|Overall Study|screen failure|19
3006361|NCT00900731|10344023|P2|Overall Study|Death|2
3006362|NCT00900731|10344024|P1|Overall Study|Death|0
3006363|NCT00900731|10344023|P2|Overall Study|Lack of Efficacy|3
3006364|NCT00900731|10344024|P1|Overall Study|Lack of Efficacy|1
3006365|NCT00900731|10344023|P2|Overall Study|Lost to Follow-up|3
3006366|NCT00900731|10344024|P1|Overall Study|Lost to Follow-up|2
3006367|NCT00900731|10344023|P2|Overall Study|Abnormal Laboratory Value(s)|4
3006368|NCT00900731|10344024|P1|Overall Study|Abnormal Laboratory Value(s)|2
3006369|NCT00900731|10344023|P2|Overall Study|Abnormal Test Procedure Result(s)|0
3006370|NCT00900731|10344024|P1|Overall Study|Abnormal Test Procedure Result(s)|3
3006371|NCT00900731|10344023|P2|Overall Study|Administrative Problems|4
3006372|NCT00900731|10344024|P1|Overall Study|Administrative Problems|5
3006373|NCT00900731|10344023|P2|Overall Study|Protocol Deviation|11
3006374|NCT00900731|10344024|P1|Overall Study|Protocol Deviation|8
3006375|NCT00900731|10344023|P2|Overall Study|Withdrawal by Subject|7
3006376|NCT00900731|10344024|P1|Overall Study|Withdrawal by Subject|8
3006377|NCT00900731|10344023|P2|Overall Study|Adverse Event|27
3006378|NCT00900731|10344024|P1|Overall Study|Adverse Event|31
3006379|NCT00900627|10344061|P6|Overall Study|Death|24
3006380|NCT00900627|10344062|P5|Overall Study|Death|28
3006381|NCT00900627|10344063|P4|Overall Study|Death|0
3006382|NCT00900627|10344064|P3|Overall Study|Death|0
3006383|NCT00900627|10344065|P2|Overall Study|Death|0
3006384|NCT00900627|10344066|P1|Overall Study|Death|0
3006385|NCT00900627|10344061|P6|Overall Study|Adverse Event|0
3006386|NCT00900627|10344062|P5|Overall Study|Adverse Event|0
3006387|NCT00900627|10344063|P4|Overall Study|Adverse Event|3
3006388|NCT00900627|10344064|P3|Overall Study|Adverse Event|0
3006389|NCT00900627|10344065|P2|Overall Study|Adverse Event|2
3006390|NCT00900627|10344066|P1|Overall Study|Adverse Event|1
3006391|NCT00900627|10344061|P6|Overall Study|Withdrawal by Subject|2
3006392|NCT00900627|10344062|P5|Overall Study|Withdrawal by Subject|1
3006393|NCT00900627|10344063|P4|Overall Study|Withdrawal by Subject|0
3006394|NCT00900627|10344064|P3|Overall Study|Withdrawal by Subject|1
3006395|NCT00900627|10344065|P2|Overall Study|Withdrawal by Subject|0
3006396|NCT00900627|10344066|P1|Overall Study|Withdrawal by Subject|1
3006397|NCT00900627|10344061|P6|Overall Study|Condition under investigation worsened|0
3006398|NCT00900627|10344062|P5|Overall Study|Condition under investigation worsened|0
3006399|NCT00900627|10344063|P4|Overall Study|Condition under investigation worsened|3
3006400|NCT00900627|10344064|P3|Overall Study|Condition under investigation worsened|5
3006401|NCT00900627|10344065|P2|Overall Study|Condition under investigation worsened|0
3006402|NCT00900627|10344066|P1|Overall Study|Condition under investigation worsened|4
3006403|NCT00900601|10344084|P1|Overall Study|Physician Decision|1
3006404|NCT00900159|10344103|P2|Second Intervention|disempanelled for inappropriate behavior|0
3006405|NCT00900159|10344104|P1|Second Intervention|disempanelled for inappropriate behavior|1
3006406|NCT00900146|10344123|P5|Intermediate: Period III|Administrative problems|163
3006407|NCT00900146|10344124|P4|Intermediate: Period III|Administrative problems|90
3006408|NCT00900146|10344125|P3|Intermediate: Period III|Administrative problems|84
3006409|NCT00900146|10344126|P2|Intermediate: Period III|Administrative problems|92
3006410|NCT00900146|10344127|P1|Intermediate: Period III|Administrative problems|85
3006411|NCT00900146|10344123|P5|Intermediate: Period III|Lost to Follow-up|1
3006412|NCT00900146|10344124|P4|Intermediate: Period III|Lost to Follow-up|0
3006413|NCT00900146|10344125|P3|Intermediate: Period III|Lost to Follow-up|0
3006414|NCT00900146|10344126|P2|Intermediate: Period III|Lost to Follow-up|0
3006415|NCT00900146|10344127|P1|Intermediate: Period III|Lost to Follow-up|2
3006416|NCT00900146|10344123|P5|Intermediate: Period III|Withdrawal by Subject|3
3006417|NCT00900146|10344124|P4|Intermediate: Period III|Withdrawal by Subject|0
3006418|NCT00900146|10344125|P3|Intermediate: Period III|Withdrawal by Subject|0
3006419|NCT00900146|10344126|P2|Intermediate: Period III|Withdrawal by Subject|1
3006420|NCT00900146|10344127|P1|Intermediate: Period III|Withdrawal by Subject|0
3006421|NCT00900146|10344123|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
3006422|NCT00900146|10344124|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
3006423|NCT00900146|10344125|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
3006424|NCT00900146|10344126|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
3006425|NCT00900146|10344127|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
3006426|NCT00900146|10344123|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
3006427|NCT00900146|10344124|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
3006428|NCT00900146|10344125|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
3006429|NCT00900146|10344126|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
3006430|NCT00900146|10344127|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
3006431|NCT00900146|10344123|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
3006432|NCT00900146|10344124|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
3006433|NCT00900146|10344125|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
3006434|NCT00900146|10344126|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
3006435|NCT00900146|10344127|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
3006436|NCT00900029|10344244|P5|Overall Study|Death|0
3006437|NCT00900029|10344245|P4|Overall Study|Death|1
3006438|NCT00900029|10344246|P3|Overall Study|Death|0
3006439|NCT00900029|10344247|P2|Overall Study|Death|0
3006440|NCT00900029|10344248|P1|Overall Study|Death|1
3006441|NCT00900029|10344244|P5|Overall Study|Adverse Event|1
3006442|NCT00900029|10344245|P4|Overall Study|Adverse Event|1
3006443|NCT00900029|10344246|P3|Overall Study|Adverse Event|1
3006444|NCT00900029|10344247|P2|Overall Study|Adverse Event|0
3006445|NCT00900029|10344248|P1|Overall Study|Adverse Event|0
3006446|NCT00900029|10344244|P5|Overall Study|Withdrawal by Subject|1
3006447|NCT00900029|10344245|P4|Overall Study|Withdrawal by Subject|1
3006448|NCT00900029|10344246|P3|Overall Study|Withdrawal by Subject|1
3006449|NCT00900029|10344247|P2|Overall Study|Withdrawal by Subject|2
3006450|NCT00900029|10344248|P1|Overall Study|Withdrawal by Subject|2
3006451|NCT00900029|10344244|P5|Overall Study|Lost to Follow-up|4
3006452|NCT00900029|10344245|P4|Overall Study|Lost to Follow-up|4
3006453|NCT00900029|10344246|P3|Overall Study|Lost to Follow-up|1
3006454|NCT00900029|10344247|P2|Overall Study|Lost to Follow-up|2
3006455|NCT00900029|10344248|P1|Overall Study|Lost to Follow-up|0
3006456|NCT00899847|10344265|P1|Overall Study|Lack of suitable allogeneic donor|2
3006457|NCT00899678|10344296|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
3006458|NCT00899678|10344297|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
3006459|NCT00899678|10344298|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
3006460|NCT00899678|10344296|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
3006461|NCT00899678|10344297|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
3006462|NCT00899678|10344298|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
3006463|NCT00899678|10344296|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
3006464|NCT00899678|10344297|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
3006465|NCT00899678|10344298|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
3006466|NCT00899678|10344296|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
3006467|NCT00899678|10344297|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
3006468|NCT00899678|10344298|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
3006469|NCT00899678|10344296|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
3006470|NCT00899678|10344297|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
3006471|NCT00899678|10344298|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
3006472|NCT00899678|10344296|P3|Induction Period (Weeks 0 to 6)|Other reason|0
3006473|NCT00899678|10344297|P2|Induction Period (Weeks 0 to 6)|Other reason|0
3006474|NCT00899678|10344298|P1|Induction Period (Weeks 0 to 6)|Other reason|1
3006475|NCT00899678|10344296|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
3006476|NCT00899678|10344297|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
3006477|NCT00899678|10344298|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
3006478|NCT00899678|10344296|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
3006479|NCT00899678|10344297|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
3006480|NCT00899678|10344298|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
3006481|NCT00899678|10344296|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
3006482|NCT00899678|10344297|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
3006483|NCT00899678|10344298|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
3006484|NCT00899548|10344348|P1|Overall Study|Physician Decision|3
3006485|NCT00899431|10344442|P3|Overall Study|Physician Decision|0
3006486|NCT00899431|10344443|P2|Overall Study|Physician Decision|0
3006487|NCT00899431|10344444|P1|Overall Study|Physician Decision|1
3006488|NCT00899392|10344457|P2|Overall Study|Subject didn't finish/partial pilot data|24
3006489|NCT00899392|10344458|P1|Overall Study|Subject didn't finish/partial pilot data|21
3006490|NCT00899379|10344475|P5|Overall Study|Inc/Exc Criteria Not Met|0
3006491|NCT00899379|10344476|P4|Overall Study|Inc/Exc Criteria Not Met|0
3006492|NCT00899379|10344477|P3|Overall Study|Inc/Exc Criteria Not Met|1
3006493|NCT00899379|10344478|P2|Overall Study|Inc/Exc Criteria Not Met|0
3006494|NCT00899379|10344479|P1|Overall Study|Inc/Exc Criteria Not Met|0
3006495|NCT00899379|10344475|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
3006496|NCT00899379|10344476|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
3006497|NCT00899379|10344477|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
3006498|NCT00899379|10344478|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
3006499|NCT00899379|10344479|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
3006500|NCT00899379|10344475|P5|Overall Study|No Attack Pretreatment|4
3006501|NCT00899379|10344476|P4|Overall Study|No Attack Pretreatment|6
3006502|NCT00899379|10344477|P3|Overall Study|No Attack Pretreatment|5
3006503|NCT00899379|10344478|P2|Overall Study|No Attack Pretreatment|5
3006504|NCT00899379|10344479|P1|Overall Study|No Attack Pretreatment|3
3006505|NCT00899379|10344475|P5|Overall Study|Abnormal Baseline ECG|0
3006506|NCT00899379|10344476|P4|Overall Study|Abnormal Baseline ECG|1
3006507|NCT00899379|10344477|P3|Overall Study|Abnormal Baseline ECG|1
3006508|NCT00899379|10344478|P2|Overall Study|Abnormal Baseline ECG|0
3006509|NCT00899379|10344479|P1|Overall Study|Abnormal Baseline ECG|0
3006510|NCT00899379|10344475|P5|Overall Study|Abnormal Prestudy Labs|2
3006511|NCT00899379|10344476|P4|Overall Study|Abnormal Prestudy Labs|0
3006512|NCT00899379|10344477|P3|Overall Study|Abnormal Prestudy Labs|0
3006513|NCT00899379|10344478|P2|Overall Study|Abnormal Prestudy Labs|0
3006514|NCT00899379|10344479|P1|Overall Study|Abnormal Prestudy Labs|0
3006515|NCT00899379|10344475|P5|Overall Study|Patient Uncooperative|0
3006516|NCT00899379|10344476|P4|Overall Study|Patient Uncooperative|1
3006517|NCT00899379|10344477|P3|Overall Study|Patient Uncooperative|0
3006518|NCT00899379|10344478|P2|Overall Study|Patient Uncooperative|0
3006519|NCT00899379|10344479|P1|Overall Study|Patient Uncooperative|0
3006520|NCT00899379|10344475|P5|Overall Study|Pregnancy|0
3006521|NCT00899379|10344476|P4|Overall Study|Pregnancy|0
3006522|NCT00899379|10344477|P3|Overall Study|Pregnancy|0
3006523|NCT00899379|10344478|P2|Overall Study|Pregnancy|0
3006524|NCT00899379|10344479|P1|Overall Study|Pregnancy|1
3006525|NCT00899379|10344475|P5|Overall Study|Withdrawal by Subject|2
3006526|NCT00899379|10344476|P4|Overall Study|Withdrawal by Subject|7
3006527|NCT00899379|10344477|P3|Overall Study|Withdrawal by Subject|4
3006528|NCT00899379|10344478|P2|Overall Study|Withdrawal by Subject|7
3006529|NCT00899379|10344479|P1|Overall Study|Withdrawal by Subject|4
3006530|NCT00899379|10344475|P5|Overall Study|Lost to Follow-up|5
3006531|NCT00899379|10344476|P4|Overall Study|Lost to Follow-up|2
3006532|NCT00899379|10344477|P3|Overall Study|Lost to Follow-up|0
3006533|NCT00899379|10344478|P2|Overall Study|Lost to Follow-up|1
3006534|NCT00899379|10344479|P1|Overall Study|Lost to Follow-up|3
3006535|NCT00899379|10344475|P5|Overall Study|Study Terminated|1
3006536|NCT00899379|10344476|P4|Overall Study|Study Terminated|3
3006537|NCT00899379|10344477|P3|Overall Study|Study Terminated|3
3006538|NCT00899379|10344478|P2|Overall Study|Study Terminated|0
3006539|NCT00899379|10344479|P1|Overall Study|Study Terminated|3
3006540|NCT00899379|10344475|P5|Overall Study|Not Completed/Entered Extn|3
3006541|NCT00899379|10344476|P4|Overall Study|Not Completed/Entered Extn|4
3006542|NCT00899379|10344477|P3|Overall Study|Not Completed/Entered Extn|6
3006543|NCT00899379|10344478|P2|Overall Study|Not Completed/Entered Extn|1
3006544|NCT00899379|10344479|P1|Overall Study|Not Completed/Entered Extn|5
3006545|NCT00899379|10344475|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
3006546|NCT00899379|10344476|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
3006547|NCT00899379|10344477|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
3006548|NCT00899379|10344478|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
3006549|NCT00899379|10344479|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
3006550|NCT00899379|10344475|P5|Overall Study|Abnormal Baseline ECG|0
3006551|NCT00899379|10344476|P4|Overall Study|Abnormal Baseline ECG|1
3006552|NCT00899379|10344477|P3|Overall Study|Abnormal Baseline ECG|0
3006553|NCT00899379|10344478|P2|Overall Study|Abnormal Baseline ECG|0
3006554|NCT00899379|10344479|P1|Overall Study|Abnormal Baseline ECG|0
3006555|NCT00899379|10344475|P5|Overall Study|Patient Uncooperative|2
3006556|NCT00899379|10344476|P4|Overall Study|Patient Uncooperative|1
3006557|NCT00899379|10344477|P3|Overall Study|Patient Uncooperative|0
3006558|NCT00899379|10344478|P2|Overall Study|Patient Uncooperative|1
3006559|NCT00899379|10344479|P1|Overall Study|Patient Uncooperative|0
3006560|NCT00899379|10344475|P5|Overall Study|Pregnancy|1
3006561|NCT00899379|10344476|P4|Overall Study|Pregnancy|0
3006562|NCT00899379|10344477|P3|Overall Study|Pregnancy|1
3006563|NCT00899379|10344478|P2|Overall Study|Pregnancy|0
3006564|NCT00899379|10344479|P1|Overall Study|Pregnancy|0
3006565|NCT00899379|10344475|P5|Overall Study|Withdrawal by Subject|6
3006566|NCT00899379|10344476|P4|Overall Study|Withdrawal by Subject|3
3006567|NCT00899379|10344477|P3|Overall Study|Withdrawal by Subject|2
3006568|NCT00899379|10344478|P2|Overall Study|Withdrawal by Subject|4
3006569|NCT00899379|10344479|P1|Overall Study|Withdrawal by Subject|2
3006570|NCT00899379|10344475|P5|Overall Study|Protocol Violation|0
3006571|NCT00899379|10344476|P4|Overall Study|Protocol Violation|1
3006572|NCT00899379|10344477|P3|Overall Study|Protocol Violation|1
3006573|NCT00899379|10344478|P2|Overall Study|Protocol Violation|0
3006574|NCT00899379|10344479|P1|Overall Study|Protocol Violation|0
3006575|NCT00899379|10344475|P5|Overall Study|Lost to Follow-up|2
3006576|NCT00899379|10344476|P4|Overall Study|Lost to Follow-up|6
3006577|NCT00899379|10344477|P3|Overall Study|Lost to Follow-up|0
3006578|NCT00899379|10344478|P2|Overall Study|Lost to Follow-up|3
3006579|NCT00899379|10344479|P1|Overall Study|Lost to Follow-up|9
3006580|NCT00899379|10344475|P5|Overall Study|Lack of Efficacy|1
3006581|NCT00899379|10344476|P4|Overall Study|Lack of Efficacy|0
3006582|NCT00899379|10344477|P3|Overall Study|Lack of Efficacy|3
3006583|NCT00899379|10344478|P2|Overall Study|Lack of Efficacy|4
3006584|NCT00899379|10344479|P1|Overall Study|Lack of Efficacy|0
3006585|NCT00899379|10344475|P5|Overall Study|Adverse Event|2
3006586|NCT00899379|10344476|P4|Overall Study|Adverse Event|1
3006587|NCT00899379|10344477|P3|Overall Study|Adverse Event|1
3006588|NCT00899379|10344478|P2|Overall Study|Adverse Event|2
3006589|NCT00899379|10344479|P1|Overall Study|Adverse Event|2
3006590|NCT00899353|10344491|P1|Overall Study|Withdrawal by Subject|2
3006591|NCT00899353|10344491|P1|Overall Study|Lost to Follow-up|1
3006592|NCT00899353|10344491|P1|Overall Study|Adverse Event|2
3006593|NCT00898807|10344527|P2|Overall Study|Death|1
3006594|NCT00898807|10344528|P1|Overall Study|Death|0
3006595|NCT00898807|10344527|P2|Overall Study|Lost to Follow-up|3
3006596|NCT00898807|10344528|P1|Overall Study|Lost to Follow-up|1
3006597|NCT00898807|10344527|P2|Overall Study|Family pressure to discontinue|2
3006598|NCT00898807|10344528|P1|Overall Study|Family pressure to discontinue|2
3006599|NCT00898807|10344527|P2|Overall Study|Withdrawal by Subject|3
3006600|NCT00898807|10344528|P1|Overall Study|Withdrawal by Subject|5
3006601|NCT00898677|10344544|P4|Overall Study|Not Treated: Other (Not Specified)|0
3006602|NCT00898677|10344545|P3|Overall Study|Not Treated: Other (Not Specified)|2
3006603|NCT00898677|10344546|P2|Overall Study|Not Treated: Other (Not Specified)|0
3006604|NCT00898677|10344547|P1|Overall Study|Not Treated: Other (Not Specified)|0
3006605|NCT00898677|10344544|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
3006606|NCT00898677|10344545|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
3006607|NCT00898677|10344546|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
3006608|NCT00898677|10344547|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
3006609|NCT00898677|10344544|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
3006610|NCT00898677|10344545|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
3006611|NCT00898677|10344546|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
3006612|NCT00898677|10344547|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
3006613|NCT00898677|10344544|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
3006614|NCT00898677|10344545|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
3006615|NCT00898677|10344546|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
3006616|NCT00898677|10344547|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
3006617|NCT00898677|10344544|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
3006618|NCT00898677|10344545|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
3006619|NCT00898677|10344546|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
3006620|NCT00898677|10344547|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
3006621|NCT00898677|10344544|P4|Overall Study|Not Treated: Patient uncooperative|0
3006622|NCT00898677|10344545|P3|Overall Study|Not Treated: Patient uncooperative|1
3006623|NCT00898677|10344546|P2|Overall Study|Not Treated: Patient uncooperative|3
3006624|NCT00898677|10344547|P1|Overall Study|Not Treated: Patient uncooperative|2
3006625|NCT00898677|10344544|P4|Overall Study|Not Treated: Withdraw by Subject|3
3006626|NCT00898677|10344545|P3|Overall Study|Not Treated: Withdraw by Subject|11
3006627|NCT00898677|10344546|P2|Overall Study|Not Treated: Withdraw by Subject|16
3006628|NCT00898677|10344547|P1|Overall Study|Not Treated: Withdraw by Subject|2
3006629|NCT00898677|10344544|P4|Overall Study|Not Treated: Protocol Violation|0
3006630|NCT00898677|10344545|P3|Overall Study|Not Treated: Protocol Violation|2
3006631|NCT00898677|10344546|P2|Overall Study|Not Treated: Protocol Violation|0
3006632|NCT00898677|10344547|P1|Overall Study|Not Treated: Protocol Violation|2
3006633|NCT00898677|10344544|P4|Overall Study|Not Treated: Pregnancy|0
3006634|NCT00898677|10344545|P3|Overall Study|Not Treated: Pregnancy|1
3006635|NCT00898677|10344546|P2|Overall Study|Not Treated: Pregnancy|0
3006636|NCT00898677|10344547|P1|Overall Study|Not Treated: Pregnancy|0
3006637|NCT00898677|10344544|P4|Overall Study|Not Treated: Lost to Follow-Up|2
3006638|NCT00898677|10344545|P3|Overall Study|Not Treated: Lost to Follow-Up|5
3006639|NCT00898677|10344546|P2|Overall Study|Not Treated: Lost to Follow-Up|5
3006640|NCT00898677|10344547|P1|Overall Study|Not Treated: Lost to Follow-Up|0
3006641|NCT00898677|10344544|P4|Overall Study|Not Treated: Adverse Event|0
3006642|NCT00898677|10344545|P3|Overall Study|Not Treated: Adverse Event|1
3006643|NCT00898677|10344546|P2|Overall Study|Not Treated: Adverse Event|2
3006644|NCT00898677|10344547|P1|Overall Study|Not Treated: Adverse Event|0
3006645|NCT00898677|10344544|P4|Overall Study|Withdrawal by Subject|1
3006646|NCT00898677|10344545|P3|Overall Study|Withdrawal by Subject|0
3006647|NCT00898677|10344546|P2|Overall Study|Withdrawal by Subject|0
3006648|NCT00898677|10344547|P1|Overall Study|Withdrawal by Subject|0
3006649|NCT00898677|10344544|P4|Overall Study|Protocol Violation|0
3006650|NCT00898677|10344545|P3|Overall Study|Protocol Violation|2
3006651|NCT00898677|10344546|P2|Overall Study|Protocol Violation|1
3006652|NCT00898677|10344547|P1|Overall Study|Protocol Violation|1
3006653|NCT00898677|10344544|P4|Overall Study|Lost to Follow-up|0
3006654|NCT00898677|10344545|P3|Overall Study|Lost to Follow-up|2
3006655|NCT00898677|10344546|P2|Overall Study|Lost to Follow-up|0
3006656|NCT00898677|10344547|P1|Overall Study|Lost to Follow-up|0
3006657|NCT00898677|10344544|P4|Overall Study|Adverse Event|0
3006658|NCT00898677|10344545|P3|Overall Study|Adverse Event|1
3006659|NCT00898677|10344546|P2|Overall Study|Adverse Event|0
3006660|NCT00898677|10344547|P1|Overall Study|Adverse Event|0
3006661|NCT00898443|10344585|P2|Overall Study|Withdrawal by Subject|0
3006662|NCT00898443|10344586|P1|Overall Study|Withdrawal by Subject|1
3006663|NCT00897949|10344601|P3|Overall Study|Did not take study drug|4
3006664|NCT00897949|10344602|P2|Overall Study|Did not take study drug|3
3006665|NCT00897949|10344603|P1|Overall Study|Did not take study drug|9
3006666|NCT00897949|10344601|P3|Overall Study|Lack of Migraine Attack|19
3006667|NCT00897949|10344602|P2|Overall Study|Lack of Migraine Attack|30
3006668|NCT00897949|10344603|P1|Overall Study|Lack of Migraine Attack|29
3006669|NCT00897949|10344601|P3|Overall Study|Need for Concom. Med.|1
3006670|NCT00897949|10344602|P2|Overall Study|Need for Concom. Med.|1
3006671|NCT00897949|10344603|P1|Overall Study|Need for Concom. Med.|0
3006672|NCT00897949|10344601|P3|Overall Study|Abnormal Baseline ECG|4
3006673|NCT00897949|10344602|P2|Overall Study|Abnormal Baseline ECG|2
3006674|NCT00897949|10344603|P1|Overall Study|Abnormal Baseline ECG|2
3006675|NCT00897949|10344601|P3|Overall Study|Abnormal Prestudy Labs|4
3006676|NCT00897949|10344602|P2|Overall Study|Abnormal Prestudy Labs|3
3006677|NCT00897949|10344603|P1|Overall Study|Abnormal Prestudy Labs|2
3006678|NCT00897949|10344601|P3|Overall Study|Withdrawal by Subject|17
3006679|NCT00897949|10344602|P2|Overall Study|Withdrawal by Subject|31
3006680|NCT00897949|10344603|P1|Overall Study|Withdrawal by Subject|24
3006681|NCT00897949|10344601|P3|Overall Study|Lost to Follow-up|17
3006682|NCT00897949|10344602|P2|Overall Study|Lost to Follow-up|23
3006683|NCT00897949|10344603|P1|Overall Study|Lost to Follow-up|30
3006684|NCT00897949|10344601|P3|Overall Study|Patient Uncoorperative|1
3006685|NCT00897949|10344602|P2|Overall Study|Patient Uncoorperative|2
3006686|NCT00897949|10344603|P1|Overall Study|Patient Uncoorperative|0
3006687|NCT00897949|10344601|P3|Overall Study|Withdrawal by Subject|0
3006688|NCT00897949|10344602|P2|Overall Study|Withdrawal by Subject|2
3006689|NCT00897949|10344603|P1|Overall Study|Withdrawal by Subject|1
3006690|NCT00897949|10344601|P3|Overall Study|Protocol Violation|1
3006691|NCT00897949|10344602|P2|Overall Study|Protocol Violation|3
3006692|NCT00897949|10344603|P1|Overall Study|Protocol Violation|6
3006693|NCT00897949|10344601|P3|Overall Study|Lost to Follow-up|1
3006694|NCT00897949|10344602|P2|Overall Study|Lost to Follow-up|2
3006695|NCT00897949|10344603|P1|Overall Study|Lost to Follow-up|0
3006696|NCT00897949|10344601|P3|Overall Study|Adverse Event|0
3006697|NCT00897949|10344602|P2|Overall Study|Adverse Event|1
3006698|NCT00897949|10344603|P1|Overall Study|Adverse Event|1
3006699|NCT00897715|10344637|P2|Overall Study|increased risk of infection|0
3006700|NCT00897715|10344638|P1|Overall Study|increased risk of infection|1
3006701|NCT00897715|10344637|P2|Overall Study|Physician Decision|0
3006702|NCT00897715|10344638|P1|Overall Study|Physician Decision|1
3006703|NCT00897715|10344637|P2|Overall Study|Lost to Follow-up|1
3006704|NCT00897715|10344638|P1|Overall Study|Lost to Follow-up|0
3006705|NCT00897390|10344663|P1|Overall Study|Did not Return for the Clinic Visit|2
3006706|NCT00897390|10344663|P1|Overall Study|Personal Reasons|1
3006707|NCT00897390|10344663|P1|Overall Study|No Longer Met Study Criteria|1
3006708|NCT00897390|10344663|P1|Overall Study|Adverse Event|2
3006709|NCT00897104|10344753|P3|Overall Study|Withdrawal by Subject|1
3006710|NCT00897104|10344754|P2|Overall Study|Withdrawal by Subject|0
3006711|NCT00897104|10344755|P1|Overall Study|Withdrawal by Subject|0
3006712|NCT00897104|10344753|P3|Overall Study|Protocol Violation|0
3006713|NCT00897104|10344754|P2|Overall Study|Protocol Violation|0
3006714|NCT00897104|10344755|P1|Overall Study|Protocol Violation|1
3006715|NCT00897104|10344753|P3|Overall Study|Other|0
3006716|NCT00897104|10344754|P2|Overall Study|Other|0
3006717|NCT00897104|10344755|P1|Overall Study|Other|3
3006718|NCT00897104|10344753|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
3006719|NCT00897104|10344754|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
3006720|NCT00897104|10344755|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
3006721|NCT00897104|10344753|P3|Overall Study|Lack of Migraine Attack|1
3006722|NCT00897104|10344754|P2|Overall Study|Lack of Migraine Attack|22
3006723|NCT00897104|10344755|P1|Overall Study|Lack of Migraine Attack|20
3006724|NCT00897104|10344753|P3|Overall Study|Need for Concom. Med.|1
3006725|NCT00897104|10344754|P2|Overall Study|Need for Concom. Med.|1
3006726|NCT00897104|10344755|P1|Overall Study|Need for Concom. Med.|0
3006727|NCT00897104|10344753|P3|Overall Study|Abnormal Baseline ECG|0
3006728|NCT00897104|10344754|P2|Overall Study|Abnormal Baseline ECG|2
3006729|NCT00897104|10344755|P1|Overall Study|Abnormal Baseline ECG|2
3006730|NCT00897104|10344753|P3|Overall Study|Abnormal Prestudy Labs|0
3006731|NCT00897104|10344754|P2|Overall Study|Abnormal Prestudy Labs|0
3006732|NCT00897104|10344755|P1|Overall Study|Abnormal Prestudy Labs|2
3006733|NCT00897104|10344753|P3|Overall Study|Withdrawal by Subject|3
3006734|NCT00897104|10344754|P2|Overall Study|Withdrawal by Subject|27
3006735|NCT00897104|10344755|P1|Overall Study|Withdrawal by Subject|23
3006736|NCT00897104|10344753|P3|Overall Study|Protocol Violation|0
3006737|NCT00897104|10344754|P2|Overall Study|Protocol Violation|1
3006738|NCT00897104|10344755|P1|Overall Study|Protocol Violation|0
3006739|NCT00897104|10344753|P3|Overall Study|Pregnancy|0
3006740|NCT00897104|10344754|P2|Overall Study|Pregnancy|1
3006741|NCT00897104|10344755|P1|Overall Study|Pregnancy|0
3006742|NCT00897104|10344753|P3|Overall Study|Lost to Follow-up|2
3006743|NCT00897104|10344754|P2|Overall Study|Lost to Follow-up|17
3006744|NCT00897104|10344755|P1|Overall Study|Lost to Follow-up|12
3006745|NCT00896649|10344790|P1|Overall Study|technical difficulties|2
3006746|NCT00896649|10344790|P1|Overall Study|missing documentation|1
3006747|NCT00896649|10344790|P1|Overall Study|Pregnancy|1
3006748|NCT00896649|10344790|P1|Overall Study|Physician Decision|1
3006749|NCT00896532|10344803|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006750|NCT00896532|10344804|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
3006751|NCT00896532|10344805|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006752|NCT00896532|10344806|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006753|NCT00896532|10344807|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006754|NCT00896532|10344808|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006755|NCT00896532|10344809|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006756|NCT00896532|10344810|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006757|NCT00896532|10344811|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006758|NCT00896532|10344812|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006759|NCT00896532|10344813|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006760|NCT00896532|10344814|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006761|NCT00896532|10344815|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006762|NCT00896532|10344816|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006763|NCT00896532|10344817|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006764|NCT00896532|10344818|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006765|NCT00896532|10344819|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006766|NCT00896532|10344820|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006767|NCT00896532|10344821|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006768|NCT00896532|10344822|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006769|NCT00896532|10344823|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006770|NCT00896532|10344824|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006771|NCT00896532|10344825|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
3006772|NCT00896532|10344803|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006773|NCT00896532|10344804|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
3006774|NCT00896532|10344805|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006775|NCT00896532|10344806|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006776|NCT00896532|10344807|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006777|NCT00896532|10344808|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006778|NCT00896532|10344809|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006779|NCT00896532|10344810|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006780|NCT00896532|10344811|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006781|NCT00896532|10344812|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006782|NCT00896532|10344813|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006783|NCT00896532|10344814|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006784|NCT00896532|10344815|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006785|NCT00896532|10344816|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006786|NCT00896532|10344817|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006787|NCT00896532|10344818|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006788|NCT00896532|10344819|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006789|NCT00896532|10344820|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006790|NCT00896532|10344821|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006791|NCT00896532|10344822|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006792|NCT00896532|10344823|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006793|NCT00896532|10344824|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006794|NCT00896532|10344825|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
3006795|NCT00896532|10344803|P23|Months 48-72: Follow-on Phase|Death|0
3006796|NCT00896532|10344804|P22|Months 48-72: Follow-on Phase|Death|0
3006797|NCT00896532|10344805|P21|Months 48-72: Follow-on Phase|Death|0
3006798|NCT00896532|10344806|P20|Months 48-72: Follow-on Phase|Death|0
3006799|NCT00896532|10344807|P19|Months 48-72: Follow-on Phase|Death|1
3006800|NCT00896532|10344808|P18|Months 48-72: Follow-on Phase|Death|0
3006801|NCT00896532|10344809|P17|Months 48-72: Follow-on Phase|Death|0
3006802|NCT00896532|10344810|P16|Months 48-72: Follow-on Phase|Death|0
3006803|NCT00896532|10344811|P15|Months 48-72: Follow-on Phase|Death|0
3006804|NCT00896532|10344812|P14|Months 48-72: Follow-on Phase|Death|0
3006805|NCT00896532|10344813|P13|Months 48-72: Follow-on Phase|Death|0
3006806|NCT00896532|10344814|P12|Months 48-72: Follow-on Phase|Death|0
3006807|NCT00896532|10344815|P11|Months 48-72: Follow-on Phase|Death|0
3006808|NCT00896532|10344816|P10|Months 48-72: Follow-on Phase|Death|0
3006809|NCT00896532|10344817|P9|Months 48-72: Follow-on Phase|Death|0
3006810|NCT00896532|10344818|P8|Months 48-72: Follow-on Phase|Death|0
3006811|NCT00896532|10344819|P7|Months 48-72: Follow-on Phase|Death|0
3006812|NCT00896532|10344820|P6|Months 48-72: Follow-on Phase|Death|0
3006813|NCT00896532|10344821|P5|Months 48-72: Follow-on Phase|Death|0
3006814|NCT00896532|10344822|P4|Months 48-72: Follow-on Phase|Death|0
3006815|NCT00896532|10344823|P3|Months 48-72: Follow-on Phase|Death|0
3006816|NCT00896532|10344824|P2|Months 48-72: Follow-on Phase|Death|0
3006817|NCT00896532|10344825|P1|Months 48-72: Follow-on Phase|Death|0
3006818|NCT00896532|10344803|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006819|NCT00896532|10344804|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006820|NCT00896532|10344805|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006821|NCT00896532|10344806|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006822|NCT00896532|10344807|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006823|NCT00896532|10344808|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006824|NCT00896532|10344809|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
3006825|NCT00896532|10344810|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006826|NCT00896532|10344811|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006827|NCT00896532|10344812|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006828|NCT00896532|10344813|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006829|NCT00896532|10344814|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006830|NCT00896532|10344815|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006831|NCT00896532|10344816|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006832|NCT00896532|10344817|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006833|NCT00896532|10344818|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006834|NCT00896532|10344819|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006835|NCT00896532|10344820|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006836|NCT00896532|10344821|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006837|NCT00896532|10344822|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006838|NCT00896532|10344823|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006839|NCT00896532|10344824|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006840|NCT00896532|10344825|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
3006841|NCT00896532|10344803|P23|Months 36-48: Romosozumab Retreatment|Other|0
3006842|NCT00896532|10344804|P22|Months 36-48: Romosozumab Retreatment|Other|0
3006843|NCT00896532|10344805|P21|Months 36-48: Romosozumab Retreatment|Other|0
3006844|NCT00896532|10344806|P20|Months 36-48: Romosozumab Retreatment|Other|0
3006845|NCT00896532|10344807|P19|Months 36-48: Romosozumab Retreatment|Other|0
3006846|NCT00896532|10344808|P18|Months 36-48: Romosozumab Retreatment|Other|1
3006847|NCT00896532|10344809|P17|Months 36-48: Romosozumab Retreatment|Other|0
3006848|NCT00896532|10344810|P16|Months 36-48: Romosozumab Retreatment|Other|0
3006849|NCT00896532|10344811|P15|Months 36-48: Romosozumab Retreatment|Other|0
3006850|NCT00896532|10344812|P14|Months 36-48: Romosozumab Retreatment|Other|0
3006851|NCT00896532|10344813|P13|Months 36-48: Romosozumab Retreatment|Other|0
3006852|NCT00896532|10344814|P12|Months 36-48: Romosozumab Retreatment|Other|0
3006853|NCT00896532|10344815|P11|Months 36-48: Romosozumab Retreatment|Other|0
3006854|NCT00896532|10344816|P10|Months 36-48: Romosozumab Retreatment|Other|0
3006855|NCT00896532|10344817|P9|Months 36-48: Romosozumab Retreatment|Other|0
3006856|NCT00896532|10344818|P8|Months 36-48: Romosozumab Retreatment|Other|0
3006857|NCT00896532|10344819|P7|Months 36-48: Romosozumab Retreatment|Other|0
3006858|NCT00896532|10344820|P6|Months 36-48: Romosozumab Retreatment|Other|0
3006859|NCT00896532|10344821|P5|Months 36-48: Romosozumab Retreatment|Other|0
3006860|NCT00896532|10344822|P4|Months 36-48: Romosozumab Retreatment|Other|0
3006861|NCT00896532|10344823|P3|Months 36-48: Romosozumab Retreatment|Other|0
3006862|NCT00896532|10344824|P2|Months 36-48: Romosozumab Retreatment|Other|0
3006863|NCT00896532|10344825|P1|Months 36-48: Romosozumab Retreatment|Other|0
3006864|NCT00896532|10344803|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006865|NCT00896532|10344804|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006866|NCT00896532|10344805|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006867|NCT00896532|10344806|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006868|NCT00896532|10344807|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006869|NCT00896532|10344808|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006870|NCT00896532|10344809|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
3006871|NCT00896532|10344810|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006872|NCT00896532|10344811|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006873|NCT00896532|10344812|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006874|NCT00896532|10344813|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006875|NCT00896532|10344814|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006876|NCT00896532|10344815|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006877|NCT00896532|10344816|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006878|NCT00896532|10344817|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006879|NCT00896532|10344818|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006880|NCT00896532|10344819|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006881|NCT00896532|10344820|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006882|NCT00896532|10344821|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006883|NCT00896532|10344822|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006884|NCT00896532|10344823|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006885|NCT00896532|10344824|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006886|NCT00896532|10344825|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
3006887|NCT00896532|10344803|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006888|NCT00896532|10344804|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006889|NCT00896532|10344805|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006890|NCT00896532|10344806|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006891|NCT00896532|10344807|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006892|NCT00896532|10344808|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
3006893|NCT00896532|10344809|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
3006894|NCT00896532|10344810|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
3006895|NCT00896532|10344811|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006896|NCT00896532|10344812|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006897|NCT00896532|10344813|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006898|NCT00896532|10344814|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006899|NCT00896532|10344815|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006900|NCT00896532|10344816|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006901|NCT00896532|10344817|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006902|NCT00896532|10344818|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006903|NCT00896532|10344819|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006904|NCT00896532|10344820|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006905|NCT00896532|10344821|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006906|NCT00896532|10344822|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006907|NCT00896532|10344823|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006908|NCT00896532|10344824|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006909|NCT00896532|10344825|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
3006910|NCT00896532|10344803|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006911|NCT00896532|10344804|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006912|NCT00896532|10344805|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006913|NCT00896532|10344806|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006914|NCT00896532|10344807|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006915|NCT00896532|10344808|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006916|NCT00896532|10344809|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
3006917|NCT00896532|10344810|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
3006918|NCT00896532|10344811|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006919|NCT00896532|10344812|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006920|NCT00896532|10344813|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006921|NCT00896532|10344814|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006922|NCT00896532|10344815|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006923|NCT00896532|10344816|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006924|NCT00896532|10344817|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006925|NCT00896532|10344818|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006926|NCT00896532|10344819|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006927|NCT00896532|10344820|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006928|NCT00896532|10344821|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006929|NCT00896532|10344822|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006930|NCT00896532|10344823|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006931|NCT00896532|10344824|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006932|NCT00896532|10344825|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
3006933|NCT00896532|10344803|P23|Months 24-36: Denosumab Extension Phase|Other|0
3006934|NCT00896532|10344804|P22|Months 24-36: Denosumab Extension Phase|Other|0
3006935|NCT00896532|10344805|P21|Months 24-36: Denosumab Extension Phase|Other|0
3006936|NCT00896532|10344806|P20|Months 24-36: Denosumab Extension Phase|Other|0
3006937|NCT00896532|10344807|P19|Months 24-36: Denosumab Extension Phase|Other|0
3006938|NCT00896532|10344808|P18|Months 24-36: Denosumab Extension Phase|Other|0
3006939|NCT00896532|10344809|P17|Months 24-36: Denosumab Extension Phase|Other|0
3006940|NCT00896532|10344810|P16|Months 24-36: Denosumab Extension Phase|Other|0
3006941|NCT00896532|10344811|P15|Months 24-36: Denosumab Extension Phase|Other|0
3006942|NCT00896532|10344812|P14|Months 24-36: Denosumab Extension Phase|Other|1
3006943|NCT00896532|10344813|P13|Months 24-36: Denosumab Extension Phase|Other|2
3006944|NCT00896532|10344814|P12|Months 24-36: Denosumab Extension Phase|Other|2
3006945|NCT00896532|10344815|P11|Months 24-36: Denosumab Extension Phase|Other|1
3006946|NCT00896532|10344816|P10|Months 24-36: Denosumab Extension Phase|Other|0
3006947|NCT00896532|10344817|P9|Months 24-36: Denosumab Extension Phase|Other|0
3006948|NCT00896532|10344818|P8|Months 24-36: Denosumab Extension Phase|Other|0
3006949|NCT00896532|10344819|P7|Months 24-36: Denosumab Extension Phase|Other|0
3006950|NCT00896532|10344820|P6|Months 24-36: Denosumab Extension Phase|Other|0
3006951|NCT00896532|10344821|P5|Months 24-36: Denosumab Extension Phase|Other|0
3006952|NCT00896532|10344822|P4|Months 24-36: Denosumab Extension Phase|Other|0
3006953|NCT00896532|10344823|P3|Months 24-36: Denosumab Extension Phase|Other|0
3006954|NCT00896532|10344824|P2|Months 24-36: Denosumab Extension Phase|Other|0
3006955|NCT00896532|10344825|P1|Months 24-36: Denosumab Extension Phase|Other|0
3006956|NCT00896532|10344803|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006957|NCT00896532|10344804|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006958|NCT00896532|10344805|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006959|NCT00896532|10344806|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006960|NCT00896532|10344807|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006961|NCT00896532|10344808|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006962|NCT00896532|10344809|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006963|NCT00896532|10344810|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006964|NCT00896532|10344811|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006965|NCT00896532|10344812|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
3006966|NCT00896532|10344813|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
3006967|NCT00896532|10344814|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006968|NCT00896532|10344815|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006969|NCT00896532|10344816|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006970|NCT00896532|10344817|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006971|NCT00896532|10344818|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006972|NCT00896532|10344819|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006973|NCT00896532|10344820|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006974|NCT00896532|10344821|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006975|NCT00896532|10344822|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006976|NCT00896532|10344823|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006977|NCT00896532|10344824|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006978|NCT00896532|10344825|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
3006979|NCT00896532|10344803|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006980|NCT00896532|10344804|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006981|NCT00896532|10344805|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006982|NCT00896532|10344806|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006983|NCT00896532|10344807|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006984|NCT00896532|10344808|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006985|NCT00896532|10344809|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006986|NCT00896532|10344810|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006987|NCT00896532|10344811|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006988|NCT00896532|10344812|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006989|NCT00896532|10344813|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
3006990|NCT00896532|10344814|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006991|NCT00896532|10344815|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
3006992|NCT00896532|10344816|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006993|NCT00896532|10344817|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006994|NCT00896532|10344818|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3007277|NCT00896168|10345189|P1|Overall Study|Other|1
3006995|NCT00896532|10344819|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006996|NCT00896532|10344820|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006997|NCT00896532|10344821|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006998|NCT00896532|10344822|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3006999|NCT00896532|10344823|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3007000|NCT00896532|10344824|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3007001|NCT00896532|10344825|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
3007002|NCT00896532|10344803|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007003|NCT00896532|10344804|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007004|NCT00896532|10344805|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007005|NCT00896532|10344806|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007006|NCT00896532|10344807|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007007|NCT00896532|10344808|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007008|NCT00896532|10344809|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007009|NCT00896532|10344810|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007010|NCT00896532|10344811|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007011|NCT00896532|10344812|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007012|NCT00896532|10344813|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
3007013|NCT00896532|10344814|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007014|NCT00896532|10344815|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007015|NCT00896532|10344816|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007016|NCT00896532|10344817|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007017|NCT00896532|10344818|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007018|NCT00896532|10344819|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007019|NCT00896532|10344820|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007020|NCT00896532|10344821|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007021|NCT00896532|10344822|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007022|NCT00896532|10344823|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007023|NCT00896532|10344824|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007024|NCT00896532|10344825|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
3007025|NCT00896532|10344803|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007026|NCT00896532|10344804|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007027|NCT00896532|10344805|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007028|NCT00896532|10344806|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007029|NCT00896532|10344807|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007030|NCT00896532|10344808|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007031|NCT00896532|10344809|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007032|NCT00896532|10344810|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007033|NCT00896532|10344811|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007034|NCT00896532|10344812|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007035|NCT00896532|10344813|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007036|NCT00896532|10344814|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007037|NCT00896532|10344815|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007038|NCT00896532|10344816|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007039|NCT00896532|10344817|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
3007040|NCT00896532|10344818|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007041|NCT00896532|10344819|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007042|NCT00896532|10344820|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007043|NCT00896532|10344821|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007044|NCT00896532|10344822|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007045|NCT00896532|10344823|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007046|NCT00896532|10344824|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007047|NCT00896532|10344825|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
3007048|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
3007049|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
3007050|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
3007051|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
3007052|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
3007053|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
3007054|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
3007055|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
3007056|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
3007057|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
3007058|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
3007059|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
3007060|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
3007061|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
3007062|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
3007063|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
3007064|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
3007065|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
3007066|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
3007067|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
3007068|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
3007069|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
3007070|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
3007071|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007072|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007073|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007074|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007075|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007076|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007077|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007078|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007079|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007080|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007081|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007082|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007083|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007084|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007085|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007086|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007087|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007088|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007089|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007090|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
3007091|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007092|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007093|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
3007094|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007095|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007096|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007097|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007098|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007099|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007100|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007101|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007102|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007103|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007104|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007105|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007106|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007107|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007108|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007109|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007110|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007111|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007112|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007113|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007114|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
3007115|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007116|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
3007117|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007118|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007119|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007120|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007121|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007122|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007123|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007124|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007125|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007126|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007127|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007128|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007129|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007130|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007131|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007132|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007133|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007134|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007135|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007136|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007137|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
3007138|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007139|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
3007140|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
3007141|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
3007142|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
3007143|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
3007144|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
3007145|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
3007146|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
3007147|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
3007148|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
3007149|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
3007150|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
3007151|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
3007152|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
3007153|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
3007154|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
3007155|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
3007156|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
3007157|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
3007158|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
3007159|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
3007160|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
3007161|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
3007162|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
3007163|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007164|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007165|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007166|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007167|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007168|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007169|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007170|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007171|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007172|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007173|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007174|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007175|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007176|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007177|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007178|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007179|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007180|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007181|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
3007182|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007183|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
3007184|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007185|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
3007186|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007187|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007188|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007189|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007190|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007191|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007192|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007193|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007194|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007195|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007196|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007197|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007198|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007199|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007200|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
3007201|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
3007202|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
3007203|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
3007204|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
3007205|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
3007206|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
3007207|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
3007208|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
3007209|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007210|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007211|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007212|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007213|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007214|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007215|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007216|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007217|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007218|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007219|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007220|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007221|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007222|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007223|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007224|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
3007225|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
3007226|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
3007227|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
3007228|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
3007229|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
3007230|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
3007231|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
3007232|NCT00896532|10344803|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007233|NCT00896532|10344804|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007234|NCT00896532|10344805|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007235|NCT00896532|10344806|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007236|NCT00896532|10344807|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007237|NCT00896532|10344808|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007238|NCT00896532|10344809|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007239|NCT00896532|10344810|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007240|NCT00896532|10344811|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007241|NCT00896532|10344812|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007242|NCT00896532|10344813|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007243|NCT00896532|10344814|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007244|NCT00896532|10344815|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007245|NCT00896532|10344816|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007246|NCT00896532|10344817|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007247|NCT00896532|10344818|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007248|NCT00896532|10344819|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007249|NCT00896532|10344820|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
3007250|NCT00896532|10344821|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007251|NCT00896532|10344822|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
3007252|NCT00896532|10344823|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007253|NCT00896532|10344824|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007254|NCT00896532|10344825|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
3007255|NCT00896480|10344952|P1|Overall Study|Disease progression/recurrence|21
3007256|NCT00896454|10345000|P1|Overall Study|Withdrawal by Subject|1
3007257|NCT00896454|10345000|P1|Overall Study|Ongoing in study|2
3007258|NCT00896454|10345000|P1|Overall Study|Requirement for alternative therapy|3
3007259|NCT00896454|10345000|P1|Overall Study|Other|4
3007260|NCT00896454|10345000|P1|Overall Study|Disease Progression|5
3007261|NCT00896454|10345000|P1|Overall Study|Adverse Event|8
3007262|NCT00896454|10345000|P1|Overall Study|Death|10
3007263|NCT00896363|10345039|P3|Overall Study|Withdrawal by Subject|5
3007264|NCT00896363|10345040|P2|Overall Study|Withdrawal by Subject|5
3007265|NCT00896363|10345041|P1|Overall Study|Withdrawal by Subject|3
3007266|NCT00896363|10345039|P3|Overall Study|Lack of Efficacy|1
3007267|NCT00896363|10345040|P2|Overall Study|Lack of Efficacy|2
3007268|NCT00896363|10345041|P1|Overall Study|Lack of Efficacy|0
3007269|NCT00896363|10345039|P3|Overall Study|Adverse Event|2
3007270|NCT00896363|10345040|P2|Overall Study|Adverse Event|4
3007271|NCT00896363|10345041|P1|Overall Study|Adverse Event|3
3007272|NCT00896337|10345093|P1|Overall Study|Lost to Follow-up|11
3007273|NCT00896337|10345093|P1|Overall Study|Withdrawal by Subject|7
3007274|NCT00896337|10345093|P1|Overall Study|Death|7
3007275|NCT00896233|10345175|P1|Overall Study|Claustrophobia during MRI|1
3007276|NCT00896168|10345188|P2|Overall Study|Other|1
3007278|NCT00896168|10345188|P2|Overall Study|Lost to Follow-up|1
3007279|NCT00896168|10345189|P1|Overall Study|Lost to Follow-up|1
3007280|NCT00896168|10345188|P2|Overall Study|Treatment failure|10
3007281|NCT00896168|10345189|P1|Overall Study|Treatment failure|8
3007282|NCT00896168|10345188|P2|Overall Study|Adverse Event|7
3007283|NCT00896168|10345189|P1|Overall Study|Adverse Event|4
3007284|NCT00896051|10345250|P2|Overall Study|Other|1
3007285|NCT00896051|10345251|P1|Overall Study|Other|1
3007286|NCT00896051|10345250|P2|Overall Study|Subject noncompliant|3
3007287|NCT00896051|10345251|P1|Overall Study|Subject noncompliant|1
3007288|NCT00896051|10345250|P2|Overall Study|Withdrawal by Subject|2
3007289|NCT00896051|10345251|P1|Overall Study|Withdrawal by Subject|3
3007290|NCT00896051|10345250|P2|Overall Study|Lost to Follow-up|2
3007291|NCT00896051|10345251|P1|Overall Study|Lost to Follow-up|3
3007292|NCT00896051|10345250|P2|Overall Study|Adverse Event|1
3007293|NCT00896051|10345251|P1|Overall Study|Adverse Event|2
3007294|NCT00895947|10345346|P2|Overall Study|Withdrawal by Subject|0
3007295|NCT00895947|10345347|P1|Overall Study|Withdrawal by Subject|2
3007296|NCT00895947|10345346|P2|Overall Study|Protocol Violation|2
3007297|NCT00895947|10345347|P1|Overall Study|Protocol Violation|4
3007298|NCT00895947|10345346|P2|Overall Study|Lost to Follow-up|4
3007299|NCT00895947|10345347|P1|Overall Study|Lost to Follow-up|3
3007300|NCT00895947|10345346|P2|Overall Study|Adverse Event|4
3007301|NCT00895947|10345347|P1|Overall Study|Adverse Event|3
3007302|NCT00895895|10345385|P5|Period 2|unsatisfactory response-efficacy|0
3007303|NCT00895895|10345386|P4|Period 2|unsatisfactory response-efficacy|0
3007304|NCT00895895|10345387|P3|Period 2|unsatisfactory response-efficacy|0
3007305|NCT00895895|10345388|P2|Period 2|unsatisfactory response-efficacy|1
3007306|NCT00895895|10345389|P1|Period 2|unsatisfactory response-efficacy|2
3007307|NCT00895895|10345385|P5|Period 2|Withdrawal by Subject|5
3007308|NCT00895895|10345386|P4|Period 2|Withdrawal by Subject|3
3007309|NCT00895895|10345387|P3|Period 2|Withdrawal by Subject|0
3007310|NCT00895895|10345388|P2|Period 2|Withdrawal by Subject|2
3007311|NCT00895895|10345389|P1|Period 2|Withdrawal by Subject|0
3007312|NCT00895895|10345385|P5|Period 2|Protocol Violation|1
3007313|NCT00895895|10345386|P4|Period 2|Protocol Violation|1
3007314|NCT00895895|10345387|P3|Period 2|Protocol Violation|1
3007315|NCT00895895|10345388|P2|Period 2|Protocol Violation|0
3007316|NCT00895895|10345389|P1|Period 2|Protocol Violation|1
3007317|NCT00895895|10345385|P5|Period 2|Other|1
3007318|NCT00895895|10345386|P4|Period 2|Other|1
3007319|NCT00895895|10345387|P3|Period 2|Other|3
3007320|NCT00895895|10345388|P2|Period 2|Other|1
3007321|NCT00895895|10345389|P1|Period 2|Other|1
3007322|NCT00895895|10345385|P5|Period 2|Lost to Follow-up|0
3007323|NCT00895895|10345386|P4|Period 2|Lost to Follow-up|1
3007324|NCT00895895|10345387|P3|Period 2|Lost to Follow-up|1
3007325|NCT00895895|10345388|P2|Period 2|Lost to Follow-up|2
3007326|NCT00895895|10345389|P1|Period 2|Lost to Follow-up|1
3007327|NCT00895895|10345385|P5|Period 2|investigator request|0
3007328|NCT00895895|10345386|P4|Period 2|investigator request|0
3007329|NCT00895895|10345387|P3|Period 2|investigator request|0
3007330|NCT00895895|10345388|P2|Period 2|investigator request|0
3007331|NCT00895895|10345389|P1|Period 2|investigator request|2
3007332|NCT00895895|10345385|P5|Period 2|failed to return|0
3007333|NCT00895895|10345386|P4|Period 2|failed to return|0
3007334|NCT00895895|10345387|P3|Period 2|failed to return|0
3007335|NCT00895895|10345388|P2|Period 2|failed to return|0
3007336|NCT00895895|10345389|P1|Period 2|failed to return|2
3007337|NCT00895895|10345385|P5|Period 2|discontinued by sponsor|37
3007338|NCT00895895|10345386|P4|Period 2|discontinued by sponsor|46
3007339|NCT00895895|10345387|P3|Period 2|discontinued by sponsor|38
3007340|NCT00895895|10345388|P2|Period 2|discontinued by sponsor|44
3007341|NCT00895895|10345389|P1|Period 2|discontinued by sponsor|44
3007342|NCT00895895|10345385|P5|Period 2|Death|0
3007343|NCT00895895|10345386|P4|Period 2|Death|0
3007344|NCT00895895|10345387|P3|Period 2|Death|1
3007345|NCT00895895|10345388|P2|Period 2|Death|0
3007346|NCT00895895|10345389|P1|Period 2|Death|0
3007347|NCT00895895|10345385|P5|Period 2|Adverse Event|5
3007348|NCT00895895|10345386|P4|Period 2|Adverse Event|2
3007349|NCT00895895|10345387|P3|Period 2|Adverse Event|5
3007350|NCT00895895|10345388|P2|Period 2|Adverse Event|3
3007351|NCT00895895|10345389|P1|Period 2|Adverse Event|3
3007352|NCT00895895|10345385|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
3007353|NCT00895895|10345386|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
3007354|NCT00895895|10345387|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
3007355|NCT00895895|10345388|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
3007356|NCT00895895|10345389|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
3007357|NCT00895895|10345385|P5|After Period 1, Prior to Period 2|Protocol Violation|1
3007358|NCT00895895|10345386|P4|After Period 1, Prior to Period 2|Protocol Violation|0
3007359|NCT00895895|10345387|P3|After Period 1, Prior to Period 2|Protocol Violation|0
3007360|NCT00895895|10345388|P2|After Period 1, Prior to Period 2|Protocol Violation|0
3007361|NCT00895895|10345389|P1|After Period 1, Prior to Period 2|Protocol Violation|0
3007362|NCT00895895|10345385|P5|After Period 1, Prior to Period 2|Other|0
3007363|NCT00895895|10345386|P4|After Period 1, Prior to Period 2|Other|0
3007364|NCT00895895|10345387|P3|After Period 1, Prior to Period 2|Other|1
3007365|NCT00895895|10345388|P2|After Period 1, Prior to Period 2|Other|0
3007366|NCT00895895|10345389|P1|After Period 1, Prior to Period 2|Other|0
3007458|NCT00895245|10345718|P1|Overall Study|Lack of Efficacy|6
3007367|NCT00895895|10345385|P5|After Period 1, Prior to Period 2|Adverse Event|0
3007368|NCT00895895|10345386|P4|After Period 1, Prior to Period 2|Adverse Event|0
3007369|NCT00895895|10345387|P3|After Period 1, Prior to Period 2|Adverse Event|1
3007370|NCT00895895|10345388|P2|After Period 1, Prior to Period 2|Adverse Event|0
3007371|NCT00895895|10345389|P1|After Period 1, Prior to Period 2|Adverse Event|0
3007372|NCT00895895|10345385|P5|Period 1|randomized and not treated|2
3007373|NCT00895895|10345386|P4|Period 1|randomized and not treated|1
3007374|NCT00895895|10345387|P3|Period 1|randomized and not treated|1
3007375|NCT00895895|10345388|P2|Period 1|randomized and not treated|3
3007376|NCT00895895|10345389|P1|Period 1|randomized and not treated|1
3007377|NCT00895895|10345385|P5|Period 1|unsatisfactory response-efficacy|0
3007378|NCT00895895|10345386|P4|Period 1|unsatisfactory response-efficacy|0
3007379|NCT00895895|10345387|P3|Period 1|unsatisfactory response-efficacy|0
3007380|NCT00895895|10345388|P2|Period 1|unsatisfactory response-efficacy|0
3007381|NCT00895895|10345389|P1|Period 1|unsatisfactory response-efficacy|2
3007382|NCT00895895|10345385|P5|Period 1|Withdrawal by Subject|4
3007383|NCT00895895|10345386|P4|Period 1|Withdrawal by Subject|2
3007384|NCT00895895|10345387|P3|Period 1|Withdrawal by Subject|8
3007385|NCT00895895|10345388|P2|Period 1|Withdrawal by Subject|6
3007386|NCT00895895|10345389|P1|Period 1|Withdrawal by Subject|6
3007387|NCT00895895|10345385|P5|Period 1|Protocol Violation|0
3007388|NCT00895895|10345386|P4|Period 1|Protocol Violation|0
3007389|NCT00895895|10345387|P3|Period 1|Protocol Violation|0
3007390|NCT00895895|10345388|P2|Period 1|Protocol Violation|1
3007391|NCT00895895|10345389|P1|Period 1|Protocol Violation|0
3007392|NCT00895895|10345385|P5|Period 1|Other|1
3007393|NCT00895895|10345386|P4|Period 1|Other|1
3007394|NCT00895895|10345387|P3|Period 1|Other|1
3007395|NCT00895895|10345388|P2|Period 1|Other|2
3007396|NCT00895895|10345389|P1|Period 1|Other|1
3007397|NCT00895895|10345385|P5|Period 1|Lost to Follow-up|3
3007398|NCT00895895|10345386|P4|Period 1|Lost to Follow-up|2
3007399|NCT00895895|10345387|P3|Period 1|Lost to Follow-up|3
3007400|NCT00895895|10345388|P2|Period 1|Lost to Follow-up|1
3007401|NCT00895895|10345389|P1|Period 1|Lost to Follow-up|2
3007402|NCT00895895|10345385|P5|Period 1|investigator request|0
3007403|NCT00895895|10345386|P4|Period 1|investigator request|0
3007404|NCT00895895|10345387|P3|Period 1|investigator request|0
3007405|NCT00895895|10345388|P2|Period 1|investigator request|1
3007406|NCT00895895|10345389|P1|Period 1|investigator request|0
3007407|NCT00895895|10345385|P5|Period 1|failed to return|1
3007408|NCT00895895|10345386|P4|Period 1|failed to return|0
3007409|NCT00895895|10345387|P3|Period 1|failed to return|1
3007410|NCT00895895|10345388|P2|Period 1|failed to return|0
3007411|NCT00895895|10345389|P1|Period 1|failed to return|0
3007412|NCT00895895|10345385|P5|Period 1|discontinued by sponsor|1
3007413|NCT00895895|10345386|P4|Period 1|discontinued by sponsor|1
3007414|NCT00895895|10345387|P3|Period 1|discontinued by sponsor|2
3007415|NCT00895895|10345388|P2|Period 1|discontinued by sponsor|1
3007416|NCT00895895|10345389|P1|Period 1|discontinued by sponsor|2
3007417|NCT00895895|10345385|P5|Period 1|Death|1
3007418|NCT00895895|10345386|P4|Period 1|Death|0
3007419|NCT00895895|10345387|P3|Period 1|Death|0
3007420|NCT00895895|10345388|P2|Period 1|Death|0
3007421|NCT00895895|10345389|P1|Period 1|Death|0
3007422|NCT00895895|10345385|P5|Period 1|Adverse Event|7
3007423|NCT00895895|10345386|P4|Period 1|Adverse Event|6
3007424|NCT00895895|10345387|P3|Period 1|Adverse Event|4
3007425|NCT00895895|10345388|P2|Period 1|Adverse Event|6
3007426|NCT00895895|10345389|P1|Period 1|Adverse Event|7
3007427|NCT00895843|10345503|P2|Overall Study|Protocol Violation|12
3007428|NCT00895843|10345504|P1|Overall Study|Protocol Violation|12
3007429|NCT00895661|10345551|P1|Overall Study|reason unknown|2
3007430|NCT00895661|10345551|P1|Overall Study|Death|1
3007431|NCT00895622|10345561|P3|Overall Study|Protocol Violation|4
3007432|NCT00895622|10345562|P2|Overall Study|Protocol Violation|4
3007433|NCT00895622|10345563|P1|Overall Study|Protocol Violation|5
3007434|NCT00895583|10345590|P2|Overall Study|Other|1
3007435|NCT00895583|10345591|P1|Overall Study|Other|0
3007436|NCT00895583|10345590|P2|Overall Study|Lack of Efficacy|0
3007437|NCT00895583|10345591|P1|Overall Study|Lack of Efficacy|5
3007438|NCT00895583|10345590|P2|Overall Study|Withdrawal by Subject|2
3007439|NCT00895583|10345591|P1|Overall Study|Withdrawal by Subject|4
3007440|NCT00895583|10345590|P2|Overall Study|Protocol Violation|0
3007441|NCT00895583|10345591|P1|Overall Study|Protocol Violation|1
3007442|NCT00895583|10345590|P2|Overall Study|Lost to Follow-up|3
3007443|NCT00895583|10345591|P1|Overall Study|Lost to Follow-up|1
3007444|NCT00895583|10345590|P2|Overall Study|Physician Decision|1
3007445|NCT00895583|10345591|P1|Overall Study|Physician Decision|3
3007446|NCT00895583|10345590|P2|Overall Study|Death|1
3007447|NCT00895583|10345591|P1|Overall Study|Death|2
3007448|NCT00895583|10345590|P2|Overall Study|Adverse Event|4
3007449|NCT00895583|10345591|P1|Overall Study|Adverse Event|28
3007450|NCT00895453|10345681|P3|Overall Study|Lost to Follow-up|23
3007451|NCT00895453|10345682|P2|Overall Study|Lost to Follow-up|25
3007452|NCT00895453|10345683|P1|Overall Study|Lost to Follow-up|25
3007453|NCT00895414|10345691|P2|First Intervention (14 Days)|Physician Decision|1
3007454|NCT00895414|10345692|P1|First Intervention (14 Days)|Physician Decision|0
3007455|NCT00895414|10345691|P2|First Intervention (14 Days)|Withdrawal by Subject|0
3007456|NCT00895414|10345692|P1|First Intervention (14 Days)|Withdrawal by Subject|1
3007457|NCT00895310|10345702|P1|Overall Study|Withdrawal by Subject|1
3007459|NCT00895154|10345796|P2|Overall Study|Withdrawal by Subject|1
3007460|NCT00895154|10345797|P1|Overall Study|Withdrawal by Subject|0
3007461|NCT00895154|10345796|P2|Overall Study|Lost to Follow-up|1
3007462|NCT00895154|10345797|P1|Overall Study|Lost to Follow-up|1
3007463|NCT00895037|10345832|P3|Overall Study|Death|1
3007464|NCT00895037|10345833|P2|Overall Study|Death|2
3007465|NCT00895037|10345834|P1|Overall Study|Death|0
3007466|NCT00895011|10345865|P3|Overall Study|schedule conflict|0
3007467|NCT00895011|10345866|P2|Overall Study|schedule conflict|0
3007468|NCT00895011|10345867|P1|Overall Study|schedule conflict|1
3007469|NCT00895011|10345865|P3|Overall Study|Adverse Event|2
3007470|NCT00895011|10345866|P2|Overall Study|Adverse Event|2
3007471|NCT00895011|10345867|P1|Overall Study|Adverse Event|1
3007472|NCT00895011|10345865|P3|Overall Study|Protocol Violation|3
3007473|NCT00895011|10345866|P2|Overall Study|Protocol Violation|1
3007474|NCT00895011|10345867|P1|Overall Study|Protocol Violation|3
3007475|NCT00895011|10345865|P3|Overall Study|Lost to Follow-up|1
3007476|NCT00895011|10345866|P2|Overall Study|Lost to Follow-up|4
3007477|NCT00895011|10345867|P1|Overall Study|Lost to Follow-up|5
3007478|NCT00895011|10345865|P3|Overall Study|Withdrawal by Subject|2
3007479|NCT00895011|10345866|P2|Overall Study|Withdrawal by Subject|7
3007480|NCT00895011|10345867|P1|Overall Study|Withdrawal by Subject|14
3007481|NCT00894933|10345881|P1|Overall Study|Did not meeting incl/excl criteria|1
3007482|NCT00894933|10345881|P1|Overall Study|Cancelled Procedure|1
3007483|NCT00894933|10345881|P1|Overall Study|Lost to Follow-up|2
3007484|NCT00894803|10345899|P2|Overall Study|Lost to Follow-up|1
3007485|NCT00894803|10345900|P1|Overall Study|Lost to Follow-up|0
3007486|NCT00894803|10345899|P2|Overall Study|Death|4
3007487|NCT00894803|10345900|P1|Overall Study|Death|20
3007488|NCT00894790|10345936|P2|Overall Study|Did not meet entrance criteria|0
3007489|NCT00894790|10345937|P1|Overall Study|Did not meet entrance criteria|1
3007490|NCT00894790|10345936|P2|Overall Study|Lost to Follow-up|1
3007491|NCT00894790|10345937|P1|Overall Study|Lost to Follow-up|0
3007492|NCT00894790|10345936|P2|Overall Study|Protocol Violation|1
3007493|NCT00894790|10345937|P1|Overall Study|Protocol Violation|0
3007494|NCT00894686|10345979|P1|Overall Study|Other|5
3007495|NCT00894686|10345979|P1|Overall Study|Physician Decision|1
3007496|NCT00894686|10345979|P1|Overall Study|Withdrawal by Subject|50
3007497|NCT00894647|10346003|P2|Overall Study|Other, not due to AE|2
3007498|NCT00894647|10346004|P1|Overall Study|Other, not due to AE|1
3007499|NCT00894647|10346003|P2|Overall Study|Non-compliance with study procedures|2
3007500|NCT00894647|10346004|P1|Overall Study|Non-compliance with study procedures|0
3007501|NCT00894647|10346003|P2|Overall Study|Lost to Follow-up|2
3007502|NCT00894647|10346004|P1|Overall Study|Lost to Follow-up|0
3007503|NCT00894647|10346003|P2|Overall Study|Withdrawal by Subject|4
3007504|NCT00894647|10346004|P1|Overall Study|Withdrawal by Subject|4
3007505|NCT00894647|10346003|P2|Overall Study|Adverse Event|4
3007506|NCT00894647|10346004|P1|Overall Study|Adverse Event|5
3007507|NCT00894556|10346017|P4|Treatment Phase|Lack of Qualifying Event|0
3007508|NCT00894556|10346018|P3|Treatment Phase|Lack of Qualifying Event|0
3007509|NCT00894556|10346019|P2|Treatment Phase|Lack of Qualifying Event|1
3007510|NCT00894556|10346020|P1|Treatment Phase|Lack of Qualifying Event|2
3007511|NCT00894556|10346017|P4|Treatment Phase|Lost to Follow-up|0
3007512|NCT00894556|10346018|P3|Treatment Phase|Lost to Follow-up|1
3007513|NCT00894556|10346019|P2|Treatment Phase|Lost to Follow-up|3
3007514|NCT00894556|10346020|P1|Treatment Phase|Lost to Follow-up|2
3007515|NCT00894556|10346017|P4|Baseline Phase|Did not meet Randomization Criteria|85
3007516|NCT00894556|10346018|P3|Baseline Phase|Did not meet Randomization Criteria|0
3007517|NCT00894556|10346019|P2|Baseline Phase|Did not meet Randomization Criteria|0
3007518|NCT00894556|10346020|P1|Baseline Phase|Did not meet Randomization Criteria|0
3007519|NCT00894543|10346031|P2|Week 4 to Week 8|No diary or lost or withdrew|2
3007520|NCT00894543|10346032|P1|Week 4 to Week 8|No diary or lost or withdrew|4
3007521|NCT00894543|10346031|P2|Baseline to Week 4|No diary or lost or withdrew|2
3007522|NCT00894543|10346032|P1|Baseline to Week 4|No diary or lost or withdrew|3
3007523|NCT00894413|10346098|P2|Overall Study|Withdrawal by Subject|4
3007524|NCT00894413|10346099|P1|Overall Study|Withdrawal by Subject|0
3007525|NCT00894413|10346098|P2|Overall Study|Adverse Event|2
3007526|NCT00894413|10346099|P1|Overall Study|Adverse Event|0
3007527|NCT00894413|10346098|P2|Overall Study|Physician Decision|2
3007528|NCT00894413|10346099|P1|Overall Study|Physician Decision|0
3007529|NCT00894387|10346107|P2|Overall Study|GCP non-compliance|2
3007530|NCT00894387|10346108|P1|Overall Study|GCP non-compliance|0
3007531|NCT00894387|10346107|P2|Overall Study|Mis-randomized|9
3007532|NCT00894387|10346108|P1|Overall Study|Mis-randomized|13
3007533|NCT00894387|10346107|P2|Overall Study|Other (Missing)|3
3007534|NCT00894387|10346108|P1|Overall Study|Other (Missing)|5
3007535|NCT00894387|10346107|P2|Overall Study|Patient's request|30
3007536|NCT00894387|10346108|P1|Overall Study|Patient's request|25
3007537|NCT00894387|10346107|P2|Overall Study|Protocol Deviation|0
3007538|NCT00894387|10346108|P1|Overall Study|Protocol Deviation|4
3007539|NCT00894387|10346107|P2|Overall Study|Death|76
3007540|NCT00894387|10346108|P1|Overall Study|Death|77
3007541|NCT00894387|10346107|P2|Overall Study|Administrative problems|2
3007542|NCT00894387|10346108|P1|Overall Study|Administrative problems|2
3007543|NCT00894387|10346107|P2|Overall Study|Lost to Follow-up|5
3007544|NCT00894387|10346108|P1|Overall Study|Lost to Follow-up|3
3007545|NCT00894387|10346107|P2|Overall Study|Unsatisfactory therapeutic effect|1
3007546|NCT00894387|10346108|P1|Overall Study|Unsatisfactory therapeutic effect|0
3007547|NCT00894387|10346107|P2|Overall Study|Abnormal Laboratory values|2
3007548|NCT00894387|10346108|P1|Overall Study|Abnormal Laboratory values|2
3007549|NCT00894387|10346107|P2|Overall Study|Adverse Event|45
3007550|NCT00894387|10346108|P1|Overall Study|Adverse Event|44
3007551|NCT00894361|10346128|P2|Overall Study|deaths and less than 2 yr followup|64
3007552|NCT00894361|10346129|P1|Overall Study|deaths and less than 2 yr followup|24
3007553|NCT00894322|10346138|P3|Overall Study|Withdrawal by Subject|0
3007554|NCT00894322|10346139|P2|Overall Study|Withdrawal by Subject|0
3007555|NCT00894322|10346140|P1|Overall Study|Withdrawal by Subject|1
3007556|NCT00894166|10346191|P8|Overall Study|Death|0
3007557|NCT00894166|10346192|P7|Overall Study|Death|0
3007558|NCT00894166|10346193|P6|Overall Study|Death|0
3007559|NCT00894166|10346194|P5|Overall Study|Death|0
3007560|NCT00894166|10346195|P4|Overall Study|Death|1
3007561|NCT00894166|10346196|P3|Overall Study|Death|0
3007562|NCT00894166|10346197|P2|Overall Study|Death|0
3007563|NCT00894166|10346198|P1|Overall Study|Death|0
3007564|NCT00894166|10346191|P8|Overall Study|Withdrew or Lost to Follow-Up|34
3007565|NCT00894166|10346192|P7|Overall Study|Withdrew or Lost to Follow-Up|16
3007566|NCT00894166|10346193|P6|Overall Study|Withdrew or Lost to Follow-Up|16
3007567|NCT00894166|10346194|P5|Overall Study|Withdrew or Lost to Follow-Up|24
3007568|NCT00894166|10346195|P4|Overall Study|Withdrew or Lost to Follow-Up|68
3007569|NCT00894166|10346196|P3|Overall Study|Withdrew or Lost to Follow-Up|62
3007570|NCT00894166|10346197|P2|Overall Study|Withdrew or Lost to Follow-Up|63
3007571|NCT00894166|10346198|P1|Overall Study|Withdrew or Lost to Follow-Up|61
3007572|NCT00893971|10346244|P1|Overall Study|Physician Decision|3
3007573|NCT00893789|10346362|P4|Overall Study|Lost to Follow-up|1
3007574|NCT00893789|10346363|P3|Overall Study|Lost to Follow-up|0
3007575|NCT00893789|10346364|P2|Overall Study|Lost to Follow-up|0
3007576|NCT00893789|10346365|P1|Overall Study|Lost to Follow-up|0
3007577|NCT00893789|10346362|P4|Overall Study|Protocol Violation|4
3007578|NCT00893789|10346363|P3|Overall Study|Protocol Violation|1
3007579|NCT00893789|10346364|P2|Overall Study|Protocol Violation|1
3007580|NCT00893789|10346365|P1|Overall Study|Protocol Violation|0
3007581|NCT00893789|10346362|P4|Overall Study|Adverse Event|5
3007582|NCT00893789|10346363|P3|Overall Study|Adverse Event|1
3007583|NCT00893789|10346364|P2|Overall Study|Adverse Event|2
3007584|NCT00893789|10346365|P1|Overall Study|Adverse Event|0
3007585|NCT00893789|10346362|P4|Overall Study|Taking Excluded Concomitant Medication|0
3007586|NCT00893789|10346363|P3|Overall Study|Taking Excluded Concomitant Medication|1
3007587|NCT00893789|10346364|P2|Overall Study|Taking Excluded Concomitant Medication|0
3007588|NCT00893789|10346365|P1|Overall Study|Taking Excluded Concomitant Medication|1
3007589|NCT00893789|10346362|P4|Overall Study|Noncompliance With Study Procedures|0
3007590|NCT00893789|10346363|P3|Overall Study|Noncompliance With Study Procedures|0
3007591|NCT00893789|10346364|P2|Overall Study|Noncompliance With Study Procedures|0
3007592|NCT00893789|10346365|P1|Overall Study|Noncompliance With Study Procedures|1
3007593|NCT00893789|10346362|P4|Overall Study|Noncompliance With Study Drug|2
3007594|NCT00893789|10346363|P3|Overall Study|Noncompliance With Study Drug|1
3007595|NCT00893789|10346364|P2|Overall Study|Noncompliance With Study Drug|0
3007596|NCT00893789|10346365|P1|Overall Study|Noncompliance With Study Drug|1
3007597|NCT00893789|10346362|P4|Overall Study|Withdrawal by Subject|1
3007598|NCT00893789|10346363|P3|Overall Study|Withdrawal by Subject|3
3007599|NCT00893789|10346364|P2|Overall Study|Withdrawal by Subject|1
3007600|NCT00893789|10346365|P1|Overall Study|Withdrawal by Subject|3
3007601|NCT00893763|10346449|P2|Overall Study|extubated|110
3007602|NCT00893763|10346450|P1|Overall Study|extubated|110
3007603|NCT00893737|10346458|P1|Overall Study|Lost to Follow-up|6
3007604|NCT00893737|10346458|P1|Overall Study|Withdrawal by Subject|2
3007605|NCT00893737|10346458|P1|Overall Study|Adverse Event|4
3007606|NCT00893464|10346472|P8|Overall Study|Did not complete therapy/experience PD|2
3007607|NCT00893464|10346473|P7|Overall Study|Did not complete therapy/experience PD|2
3007608|NCT00893464|10346474|P6|Overall Study|Did not complete therapy/experience PD|0
3007609|NCT00893464|10346475|P5|Overall Study|Did not complete therapy/experience PD|0
3007610|NCT00893464|10346476|P4|Overall Study|Did not complete therapy/experience PD|0
3007611|NCT00893464|10346477|P3|Overall Study|Did not complete therapy/experience PD|0
3007612|NCT00893464|10346478|P2|Overall Study|Did not complete therapy/experience PD|0
3007613|NCT00893464|10346479|P1|Overall Study|Did not complete therapy/experience PD|0
3007614|NCT00893113|10346606|P2|Overall Study|Withdrew Consent|7
3007615|NCT00893113|10346607|P1|Overall Study|Withdrew Consent|8
3007616|NCT00893113|10346606|P2|Overall Study|Early Termination|1
3007617|NCT00893113|10346607|P1|Overall Study|Early Termination|1
3007618|NCT00893113|10346606|P2|Overall Study|Lost to Follow-up|8
3007619|NCT00893113|10346607|P1|Overall Study|Lost to Follow-up|4
3007620|NCT00892957|10346637|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
3007621|NCT00892957|10346638|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
3007622|NCT00892957|10346637|P2|Between Postoperative Day 1 and Day 14|Death|2
3007623|NCT00892957|10346638|P1|Between Postoperative Day 1 and Day 14|Death|0
3007624|NCT00892775|10346726|P2|Overall Study|Lost to Follow-up|0
3007625|NCT00892775|10346727|P1|Overall Study|Lost to Follow-up|1
3007626|NCT00892775|10346726|P2|Overall Study|Withdrawal by Subject|1
3007627|NCT00892775|10346727|P1|Overall Study|Withdrawal by Subject|0
3007628|NCT00892775|10346726|P2|Overall Study|Migrated/ moved from study area|0
3007629|NCT00892775|10346727|P1|Overall Study|Migrated/ moved from study area|1
3007630|NCT00892775|10346726|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
3007631|NCT00892775|10346727|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
3007632|NCT00892775|10346726|P2|Overall Study|Subject difficulties with blood drawing|0
3007633|NCT00892775|10346727|P1|Overall Study|Subject difficulties with blood drawing|1
3007634|NCT00892775|10346726|P2|Overall Study|Protocol Violation|0
3007635|NCT00892775|10346727|P1|Overall Study|Protocol Violation|1
3007636|NCT00892723|10346754|P3|Overall Study|Withdrawal by Subject|1
3007637|NCT00892723|10346755|P2|Overall Study|Withdrawal by Subject|1
3007638|NCT00892723|10346756|P1|Overall Study|Withdrawal by Subject|1
3007639|NCT00892723|10346754|P3|Overall Study|Lost to Follow-up|1
3007640|NCT00892723|10346755|P2|Overall Study|Lost to Follow-up|3
3007641|NCT00892723|10346756|P1|Overall Study|Lost to Follow-up|1
3007642|NCT00892437|10346845|P2|Open-Label Extension Phase|Withdrew Consent|1
3007643|NCT00892437|10346846|P1|Open-Label Extension Phase|Withdrew Consent|3
3007644|NCT00892437|10346845|P2|Open-Label Extension Phase|Investigator's Discretion|0
3007645|NCT00892437|10346846|P1|Open-Label Extension Phase|Investigator's Discretion|1
3007646|NCT00892437|10346845|P2|Open-Label Extension Phase|Lost to Follow-up|1
3007647|NCT00892437|10346846|P1|Open-Label Extension Phase|Lost to Follow-up|3
3007648|NCT00892437|10346845|P2|Open-Label Extension Phase|Lack of Efficacy|0
3007649|NCT00892437|10346846|P1|Open-Label Extension Phase|Lack of Efficacy|1
3007650|NCT00892437|10346845|P2|Open-Label Extension Phase|Adverse Event|2
3007651|NCT00892437|10346846|P1|Open-Label Extension Phase|Adverse Event|4
3007652|NCT00892437|10346845|P2|Randomized Phase|Withdrew Consent|0
3007653|NCT00892437|10346846|P1|Randomized Phase|Withdrew Consent|1
3007654|NCT00892437|10346845|P2|Randomized Phase|Investigator’s Discretion|0
3007655|NCT00892437|10346846|P1|Randomized Phase|Investigator’s Discretion|1
3007656|NCT00892437|10346845|P2|Randomized Phase|Lost to Follow-up|3
3007657|NCT00892437|10346846|P1|Randomized Phase|Lost to Follow-up|1
3007658|NCT00892437|10346845|P2|Randomized Phase|Adverse Event|2
3007659|NCT00892437|10346846|P1|Randomized Phase|Adverse Event|2
3007660|NCT00892437|10346845|P2|Randomized Phase|Randomized but not treated|0
3007661|NCT00892437|10346846|P1|Randomized Phase|Randomized but not treated|6
3007662|NCT00892281|10346865|P2|Overall Study|Visit 4 date out of window|0
3007663|NCT00892281|10346866|P1|Overall Study|Visit 4 date out of window|1
3007664|NCT00892281|10346865|P2|Overall Study|Rash on hand|0
3007665|NCT00892281|10346866|P1|Overall Study|Rash on hand|1
3007666|NCT00892281|10346865|P2|Overall Study|Subject had history of drug abuse|0
3007667|NCT00892281|10346866|P1|Overall Study|Subject had history of drug abuse|1
3007668|NCT00892281|10346865|P2|Overall Study|Non-compliant with visits as scheduled|0
3007669|NCT00892281|10346866|P1|Overall Study|Non-compliant with visits as scheduled|1
3007670|NCT00892281|10346865|P2|Overall Study|Missed visits rescheduled out of window|0
3007671|NCT00892281|10346866|P1|Overall Study|Missed visits rescheduled out of window|1
3007672|NCT00892281|10346865|P2|Overall Study|Missed multiple visits|0
3007673|NCT00892281|10346866|P1|Overall Study|Missed multiple visits|1
3007674|NCT00892281|10346865|P2|Overall Study|No show Visit 2; prescription not filled|0
3007675|NCT00892281|10346866|P1|Overall Study|No show Visit 2; prescription not filled|1
3007676|NCT00892281|10346865|P2|Overall Study|Subject not seen by PI at final visit|0
3007677|NCT00892281|10346866|P1|Overall Study|Subject not seen by PI at final visit|1
3007678|NCT00892281|10346865|P2|Overall Study|Lack of efficacy of study product|0
3007679|NCT00892281|10346866|P1|Overall Study|Lack of efficacy of study product|2
3007680|NCT00892281|10346865|P2|Overall Study|Death in family|0
3007681|NCT00892281|10346866|P1|Overall Study|Death in family|1
3007682|NCT00892281|10346865|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
3007683|NCT00892281|10346866|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
3007684|NCT00892281|10346865|P2|Overall Study|Subject lost interest in program|1
3007685|NCT00892281|10346866|P1|Overall Study|Subject lost interest in program|0
3007686|NCT00892281|10346865|P2|Overall Study|PI complained of inadequate compensation|0
3007687|NCT00892281|10346866|P1|Overall Study|PI complained of inadequate compensation|3
3007688|NCT00892281|10346865|P2|Overall Study|Scheduled for knee replacement|1
3007689|NCT00892281|10346866|P1|Overall Study|Scheduled for knee replacement|0
3007690|NCT00892281|10346865|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
3007691|NCT00892281|10346866|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
3007692|NCT00892281|10346865|P2|Overall Study|Subject missed several visits/lost meds|0
3007693|NCT00892281|10346866|P1|Overall Study|Subject missed several visits/lost meds|1
3007694|NCT00892281|10346865|P2|Overall Study|Subject did not return for any visits|0
3007695|NCT00892281|10346866|P1|Overall Study|Subject did not return for any visits|1
3007696|NCT00892281|10346865|P2|Overall Study|Subject not good candidate for study|0
3007697|NCT00892281|10346866|P1|Overall Study|Subject not good candidate for study|1
3007698|NCT00892281|10346865|P2|Overall Study|Unable to redeem the drug voucher|0
3007699|NCT00892281|10346866|P1|Overall Study|Unable to redeem the drug voucher|1
3007700|NCT00892281|10346865|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
3007701|NCT00892281|10346866|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
3007702|NCT00892281|10346865|P2|Overall Study|Did not meet incl/excl criteria|0
3007703|NCT00892281|10346866|P1|Overall Study|Did not meet incl/excl criteria|1
3007704|NCT00892281|10346865|P2|Overall Study|Last visit not done - death in family|0
3007705|NCT00892281|10346866|P1|Overall Study|Last visit not done - death in family|1
3007706|NCT00892281|10346865|P2|Overall Study|Family emergency|0
3007707|NCT00892281|10346866|P1|Overall Study|Family emergency|1
3007708|NCT00892281|10346865|P2|Overall Study|Subject completed day after study closed|0
3007709|NCT00892281|10346866|P1|Overall Study|Subject completed day after study closed|1
3007710|NCT00892281|10346865|P2|Overall Study|Final visit completed 4 weeks late|1
3007711|NCT00892281|10346866|P1|Overall Study|Final visit completed 4 weeks late|0
3007712|NCT00892281|10346865|P2|Overall Study|Subject unable to keep follow-up visits|0
3007713|NCT00892281|10346866|P1|Overall Study|Subject unable to keep follow-up visits|1
3007714|NCT00892281|10346865|P2|Overall Study|Subject failed to return for final visit|0
3007715|NCT00892281|10346866|P1|Overall Study|Subject failed to return for final visit|2
3007716|NCT00892281|10346865|P2|Overall Study|Withdrawal by Subject|14
3007717|NCT00892281|10346866|P1|Overall Study|Withdrawal by Subject|86
3007718|NCT00892281|10346865|P2|Overall Study|Protocol Violation|2
3007719|NCT00892281|10346866|P1|Overall Study|Protocol Violation|7
3007720|NCT00892281|10346865|P2|Overall Study|Pregnancy|0
3007721|NCT00892281|10346866|P1|Overall Study|Pregnancy|1
3007722|NCT00892281|10346865|P2|Overall Study|Lost to Follow-up|8
3007723|NCT00892281|10346866|P1|Overall Study|Lost to Follow-up|81
3007724|NCT00892281|10346865|P2|Overall Study|Adverse Event|8
3007725|NCT00892281|10346866|P1|Overall Study|Adverse Event|65
3007726|NCT00892177|10346879|P6|Phase II|Withdrawal by Subject|1
3007727|NCT00892177|10346880|P5|Phase II|Withdrawal by Subject|4
3007728|NCT00892177|10346881|P4|Phase II|Withdrawal by Subject|0
3007729|NCT00892177|10346882|P3|Phase II|Withdrawal by Subject|0
3007730|NCT00892177|10346883|P2|Phase II|Withdrawal by Subject|0
3007731|NCT00892177|10346884|P1|Phase II|Withdrawal by Subject|0
3007732|NCT00892177|10346879|P6|Phase II|Ineligible|1
3007733|NCT00892177|10346880|P5|Phase II|Ineligible|1
3007734|NCT00892177|10346881|P4|Phase II|Ineligible|0
3007735|NCT00892177|10346882|P3|Phase II|Ineligible|0
3007736|NCT00892177|10346883|P2|Phase II|Ineligible|0
3007737|NCT00892177|10346884|P1|Phase II|Ineligible|0
3007738|NCT00892151|10346909|P1|Overall Study|Protocol Violation|1
3007739|NCT00892099|10346918|P3|Overall Study|Lost to Follow-up|1
3007740|NCT00892099|10346919|P2|Overall Study|Lost to Follow-up|0
3007741|NCT00892099|10346920|P1|Overall Study|Lost to Follow-up|0
3007742|NCT00892099|10346918|P3|Overall Study|investigator decision|1
3007743|NCT00892099|10346919|P2|Overall Study|investigator decision|0
3007744|NCT00892099|10346920|P1|Overall Study|investigator decision|0
3007745|NCT00892099|10346918|P3|Overall Study|kidney function recovered|0
3007746|NCT00892099|10346919|P2|Overall Study|kidney function recovered|1
3007747|NCT00892099|10346920|P1|Overall Study|kidney function recovered|0
3007748|NCT00892099|10346918|P3|Overall Study|no further details|1
3007749|NCT00892099|10346919|P2|Overall Study|no further details|0
3007750|NCT00892099|10346920|P1|Overall Study|no further details|1
3007751|NCT00892099|10346918|P3|Overall Study|Prolonged hospitalization|1
3007752|NCT00892099|10346919|P2|Overall Study|Prolonged hospitalization|0
3007753|NCT00892099|10346920|P1|Overall Study|Prolonged hospitalization|1
3007754|NCT00892099|10346918|P3|Overall Study|replocated|2
3007755|NCT00892099|10346919|P2|Overall Study|replocated|0
3007756|NCT00892099|10346920|P1|Overall Study|replocated|1
3007757|NCT00892099|10346918|P3|Overall Study|Adverse Event|0
3007758|NCT00892099|10346919|P2|Overall Study|Adverse Event|0
3007759|NCT00892099|10346920|P1|Overall Study|Adverse Event|1
3007760|NCT00892099|10346918|P3|Overall Study|Death|1
3007761|NCT00892099|10346919|P2|Overall Study|Death|0
3007762|NCT00892099|10346920|P1|Overall Study|Death|1
3007763|NCT00892047|10346945|P2|Overall Study|Lack of Efficacy|2
3007764|NCT00892047|10346946|P1|Overall Study|Lack of Efficacy|0
3007765|NCT00892047|10346945|P2|Overall Study|subject burden|3
3007766|NCT00892047|10346946|P1|Overall Study|subject burden|2
3007767|NCT00892047|10346945|P2|Overall Study|Adverse Event|2
3007768|NCT00892047|10346946|P1|Overall Study|Adverse Event|2
3007769|NCT00892008|10346962|P1|Overall Study|Adverse Event|37
3007770|NCT00892008|10346962|P1|Overall Study|Other|378
3007771|NCT00892008|10346962|P1|Overall Study|Lost to Follow-up|142
3007772|NCT00892008|10346962|P1|Overall Study|Lack of Efficacy|3
3007773|NCT00892008|10346962|P1|Overall Study|Death|5
3007774|NCT00891930|10347048|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
3007775|NCT00891930|10347048|P1|Part 2: Panitumumab + Ganitumab|Death|30
3007776|NCT00891930|10347048|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
3007777|NCT00891930|10347048|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
3007778|NCT00891930|10347048|P1|Part 1: Panitumumab +Irinotecan|Death|38
3007779|NCT00891904|10347069|P1|Overall Study|Adverse Event|1
3007780|NCT00891904|10347069|P1|Overall Study|Death|1
3007781|NCT00891839|10347095|P1|Overall Study|Disease progression|3
3007782|NCT00891839|10347095|P1|Overall Study|Withdrawal by Subject|2
3007783|NCT00891839|10347095|P1|Overall Study|Adverse Event|2
3007784|NCT00891813|10347104|P1|Overall Study|Protocol Violation|2
3007785|NCT00891813|10347104|P1|Overall Study|Patient Noncompliance|6
3007786|NCT00891813|10347104|P1|Overall Study|Withdrawal by Subject|1
3007787|NCT00891813|10347104|P1|Overall Study|Adverse Event|3
3007788|NCT00891774|10347110|P1|Overall Study|Protocol Violation|4
3007789|NCT00891774|10347110|P1|Overall Study|Withdrawal by Subject|2
3007790|NCT00891774|10347110|P1|Overall Study|Illness (Self/Mother)|3
3007791|NCT00891774|10347110|P1|Overall Study|Lost to Follow-up|5
3007792|NCT00891735|10347121|P4|Overall Study|Patient's decision to withdraw|8
3007793|NCT00891735|10347122|P3|Overall Study|Patient's decision to withdraw|4
3007794|NCT00891735|10347123|P2|Overall Study|Patient's decision to withdraw|9
3007795|NCT00891735|10347124|P1|Overall Study|Patient's decision to withdraw|4
3007796|NCT00891735|10347121|P4|Overall Study|Physician's decision to withdraw patient|0
3007797|NCT00891735|10347122|P3|Overall Study|Physician's decision to withdraw patient|0
3007798|NCT00891735|10347123|P2|Overall Study|Physician's decision to withdraw patient|0
3007799|NCT00891735|10347124|P1|Overall Study|Physician's decision to withdraw patient|1
3007800|NCT00891735|10347121|P4|Overall Study|Lost to Follow-up|2
3007801|NCT00891735|10347122|P3|Overall Study|Lost to Follow-up|2
3007802|NCT00891735|10347123|P2|Overall Study|Lost to Follow-up|2
3007803|NCT00891735|10347124|P1|Overall Study|Lost to Follow-up|2
3007804|NCT00891735|10347121|P4|Overall Study|Death|5
3007805|NCT00891735|10347122|P3|Overall Study|Death|4
3007806|NCT00891735|10347123|P2|Overall Study|Death|5
3007807|NCT00891735|10347124|P1|Overall Study|Death|8
3007808|NCT00891735|10347121|P4|Overall Study|Adverse Event|0
3007809|NCT00891735|10347122|P3|Overall Study|Adverse Event|2
3007810|NCT00891735|10347123|P2|Overall Study|Adverse Event|0
3007811|NCT00891735|10347124|P1|Overall Study|Adverse Event|2
3007812|NCT00891657|10347164|P2|Overall Study|Withdrawal by Subject|1
3007813|NCT00891657|10347165|P1|Overall Study|Withdrawal by Subject|1
3007814|NCT00891618|10347177|P1|Overall Study|Withdrawal by Subject|1
3007815|NCT00891527|10347181|P1|Overall Study|Withdrawal by Subject|2
3007816|NCT00891462|10347190|P3|Overall Study|Lost to Follow-up|0
3007817|NCT00891462|10347191|P2|Overall Study|Lost to Follow-up|2
3007818|NCT00891462|10347192|P1|Overall Study|Lost to Follow-up|0
3007819|NCT00891462|10347190|P3|Overall Study|Inclusion/exclusion criteria|2
3007820|NCT00891462|10347191|P2|Overall Study|Inclusion/exclusion criteria|2
3007821|NCT00891462|10347192|P1|Overall Study|Inclusion/exclusion criteria|0
3007822|NCT00891462|10347190|P3|Overall Study|Protocol Violation|3
3007823|NCT00891462|10347191|P2|Overall Study|Protocol Violation|1
3007824|NCT00891462|10347192|P1|Overall Study|Protocol Violation|2
3007825|NCT00891462|10347190|P3|Overall Study|Other Reason|3
3007826|NCT00891462|10347191|P2|Overall Study|Other Reason|5
3007827|NCT00891462|10347192|P1|Overall Study|Other Reason|2
3007828|NCT00891462|10347190|P3|Overall Study|COPD exacerbation|1
3007829|NCT00891462|10347191|P2|Overall Study|COPD exacerbation|4
3007830|NCT00891462|10347192|P1|Overall Study|COPD exacerbation|7
3007831|NCT00891462|10347190|P3|Overall Study|Lack of Efficacy|1
3007832|NCT00891462|10347191|P2|Overall Study|Lack of Efficacy|5
3007833|NCT00891462|10347192|P1|Overall Study|Lack of Efficacy|10
3007834|NCT00891462|10347190|P3|Overall Study|Adverse Event|7
3007835|NCT00891462|10347191|P2|Overall Study|Adverse Event|8
3007836|NCT00891462|10347192|P1|Overall Study|Adverse Event|7
3007837|NCT00891462|10347190|P3|Overall Study|Withdrawal by Subject|7
3007838|NCT00891462|10347191|P2|Overall Study|Withdrawal by Subject|6
3007839|NCT00891462|10347192|P1|Overall Study|Withdrawal by Subject|9
3007840|NCT00891371|10347214|P1|Treatment|Lost to Follow-up|1
3007841|NCT00891371|10347214|P1|Treatment|Death|1
3007842|NCT00891371|10347214|P1|Treatment|Adverse Event|2
3007843|NCT00891371|10347214|P1|Treatment|Lack of Efficacy|5
3007844|NCT00891371|10347214|P1|Pre-assignment|Consent withdrawal|1
3007845|NCT00891371|10347214|P1|Pre-assignment|Inclusion/exclusion|5
3007846|NCT00891293|10347236|P1|Overall Study|Sponsor termination|62
3007847|NCT00891293|10347236|P1|Overall Study|Subject withdrew consent|7
3007848|NCT00891293|10347236|P1|Overall Study|Lost to Follow-up|7
3007849|NCT00891293|10347236|P1|Overall Study|Laboratory abnormality|4
3007850|NCT00891293|10347236|P1|Overall Study|Protocol Violation|2
3007851|NCT00891293|10347236|P1|Overall Study|Adverse Event|2
3007852|NCT00891228|10347251|P3|Overall Study|Pregnancy|0
3007853|NCT00891228|10347252|P2|Overall Study|Pregnancy|1
3007854|NCT00891228|10347253|P1|Overall Study|Pregnancy|0
3007855|NCT00891228|10347251|P3|Overall Study|Lost to Follow-up|5
3007856|NCT00891228|10347252|P2|Overall Study|Lost to Follow-up|4
3007857|NCT00891228|10347253|P1|Overall Study|Lost to Follow-up|4
3007858|NCT00891228|10347251|P3|Overall Study|Physician Decision|0
3007859|NCT00891228|10347252|P2|Overall Study|Physician Decision|1
3007860|NCT00891228|10347253|P1|Overall Study|Physician Decision|2
3007861|NCT00891228|10347251|P3|Overall Study|Protocol Violation|2
3007862|NCT00891228|10347252|P2|Overall Study|Protocol Violation|1
3007863|NCT00891228|10347253|P1|Overall Study|Protocol Violation|3
3007864|NCT00891228|10347251|P3|Overall Study|Withdrawal by Subject|5
3007865|NCT00891228|10347252|P2|Overall Study|Withdrawal by Subject|4
3007866|NCT00891228|10347253|P1|Overall Study|Withdrawal by Subject|2
3007867|NCT00891228|10347251|P3|Overall Study|Adverse Event|3
3007868|NCT00891228|10347252|P2|Overall Study|Adverse Event|2
3007869|NCT00891228|10347253|P1|Overall Study|Adverse Event|0
3007870|NCT00891202|10347275|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
3007871|NCT00891202|10347276|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
3007872|NCT00891202|10347277|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
3007873|NCT00891202|10347278|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
3007874|NCT00891202|10347275|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
3007875|NCT00891202|10347276|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
3007876|NCT00891202|10347277|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
3007877|NCT00891202|10347278|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
3007878|NCT00891202|10347275|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
3007879|NCT00891202|10347276|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
3007880|NCT00891202|10347277|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
3007881|NCT00891202|10347278|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
3007882|NCT00891202|10347275|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
3007883|NCT00891202|10347276|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
3007884|NCT00891202|10347277|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
3007885|NCT00891202|10347278|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
3007886|NCT00891046|10347454|P5|Overall Study|Lost to Follow-up|1
3007887|NCT00891046|10347455|P4|Overall Study|Lost to Follow-up|0
3007888|NCT00891046|10347456|P3|Overall Study|Lost to Follow-up|0
3007889|NCT00891046|10347457|P2|Overall Study|Lost to Follow-up|0
3007890|NCT00891046|10347458|P1|Overall Study|Lost to Follow-up|0
3007891|NCT00891046|10347454|P5|Overall Study|Withdrawal by Subject|1
3007892|NCT00891046|10347455|P4|Overall Study|Withdrawal by Subject|1
3007893|NCT00891046|10347456|P3|Overall Study|Withdrawal by Subject|2
3007894|NCT00891046|10347457|P2|Overall Study|Withdrawal by Subject|1
3007895|NCT00891046|10347458|P1|Overall Study|Withdrawal by Subject|2
3007896|NCT00891046|10347454|P5|Overall Study|Adverse Event|14
3007897|NCT00891046|10347455|P4|Overall Study|Adverse Event|0
3007898|NCT00891046|10347456|P3|Overall Study|Adverse Event|2
3007899|NCT00891046|10347457|P2|Overall Study|Adverse Event|3
3007900|NCT00891046|10347458|P1|Overall Study|Adverse Event|4
3007901|NCT00891046|10347454|P5|Overall Study|Participant no longer required drug|1
3007902|NCT00891046|10347455|P4|Overall Study|Participant no longer required drug|0
3007903|NCT00891046|10347456|P3|Overall Study|Participant no longer required drug|0
3007904|NCT00891046|10347457|P2|Overall Study|Participant no longer required drug|2
3007905|NCT00891046|10347458|P1|Overall Study|Participant no longer required drug|0
3007906|NCT00891046|10347454|P5|Overall Study|Administrative problems|1
3007907|NCT00891046|10347455|P4|Overall Study|Administrative problems|0
3007908|NCT00891046|10347456|P3|Overall Study|Administrative problems|0
3007909|NCT00891046|10347457|P2|Overall Study|Administrative problems|0
3007910|NCT00891046|10347458|P1|Overall Study|Administrative problems|0
3007911|NCT00891046|10347454|P5|Overall Study|Unsatisfactory therapeutic effect|20
3007912|NCT00891046|10347455|P4|Overall Study|Unsatisfactory therapeutic effect|2
3007913|NCT00891046|10347456|P3|Overall Study|Unsatisfactory therapeutic effect|19
3007914|NCT00891046|10347457|P2|Overall Study|Unsatisfactory therapeutic effect|2
3007915|NCT00891046|10347458|P1|Overall Study|Unsatisfactory therapeutic effect|5
3007916|NCT00891046|10347454|P5|Overall Study|Protocol Violation|1
3007917|NCT00891046|10347455|P4|Overall Study|Protocol Violation|0
3007918|NCT00891046|10347456|P3|Overall Study|Protocol Violation|0
3007919|NCT00891046|10347457|P2|Overall Study|Protocol Violation|1
3007920|NCT00891046|10347458|P1|Overall Study|Protocol Violation|1
3007921|NCT00891020|10347534|P3|Long-term Extension Period|Administrative|2
3007922|NCT00891020|10347535|P2|Long-term Extension Period|Administrative|2
3007923|NCT00891020|10347536|P1|Long-term Extension Period|Administrative|1
3007924|NCT00891020|10347534|P3|Long-term Extension Period|Failure to return|3
3007925|NCT00891020|10347535|P2|Long-term Extension Period|Failure to return|2
3007926|NCT00891020|10347536|P1|Long-term Extension Period|Failure to return|0
3007927|NCT00891020|10347534|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
3007928|NCT00891020|10347535|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
3007929|NCT00891020|10347536|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
3007930|NCT00891020|10347534|P3|Long-term Extension Period|Protocol Violation|1
3007931|NCT00891020|10347535|P2|Long-term Extension Period|Protocol Violation|1
3007932|NCT00891020|10347536|P1|Long-term Extension Period|Protocol Violation|0
3007933|NCT00891020|10347534|P3|Long-term Extension Period|Insufficient therapeutic response|2
3007934|NCT00891020|10347535|P2|Long-term Extension Period|Insufficient therapeutic response|2
3007935|NCT00891020|10347536|P1|Long-term Extension Period|Insufficient therapeutic response|3
3007936|NCT00891020|10347534|P3|Long-term Extension Period|Death|1
3007937|NCT00891020|10347535|P2|Long-term Extension Period|Death|0
3007938|NCT00891020|10347536|P1|Long-term Extension Period|Death|0
3007939|NCT00891020|10347534|P3|Long-term Extension Period|Adverse Event|10
3007940|NCT00891020|10347535|P2|Long-term Extension Period|Adverse Event|11
3007941|NCT00891020|10347536|P1|Long-term Extension Period|Adverse Event|1
3007942|NCT00891020|10347534|P3|24 Week Treatment Period|Administrative/Other|1
3007943|NCT00891020|10347535|P2|24 Week Treatment Period|Administrative/Other|6
3007944|NCT00891020|10347536|P1|24 Week Treatment Period|Administrative/Other|5
3007945|NCT00891020|10347534|P3|24 Week Treatment Period|Withdrew consent|15
3007946|NCT00891020|10347535|P2|24 Week Treatment Period|Withdrew consent|3
3007947|NCT00891020|10347536|P1|24 Week Treatment Period|Withdrew consent|6
3007948|NCT00891020|10347534|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
3007949|NCT00891020|10347535|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
3007950|NCT00891020|10347536|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
3007951|NCT00891020|10347534|P3|24 Week Treatment Period|Other protocol violation|2
3007952|NCT00891020|10347535|P2|24 Week Treatment Period|Other protocol violation|1
3007953|NCT00891020|10347536|P1|24 Week Treatment Period|Other protocol violation|1
3007954|NCT00891020|10347534|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
3007955|NCT00891020|10347535|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
3007956|NCT00891020|10347536|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
3007957|NCT00891020|10347534|P3|24 Week Treatment Period|Failure to return|5
3007958|NCT00891020|10347535|P2|24 Week Treatment Period|Failure to return|5
3007959|NCT00891020|10347536|P1|24 Week Treatment Period|Failure to return|4
3007960|NCT00891020|10347534|P3|24 Week Treatment Period|Insufficient therapeutic response|15
3007961|NCT00891020|10347535|P2|24 Week Treatment Period|Insufficient therapeutic response|9
3007962|NCT00891020|10347536|P1|24 Week Treatment Period|Insufficient therapeutic response|6
3007963|NCT00891020|10347534|P3|24 Week Treatment Period|Death|0
3007964|NCT00891020|10347535|P2|24 Week Treatment Period|Death|2
3007965|NCT00891020|10347536|P1|24 Week Treatment Period|Death|0
3007966|NCT00891020|10347534|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
3007967|NCT00891020|10347535|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
3007968|NCT00891020|10347536|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
3007969|NCT00890929|10347600|P1|Overall Study|Physician Decision|1
3007970|NCT00890929|10347600|P1|Overall Study|Withdrawal by Subject|3
3007971|NCT00890929|10347600|P1|Overall Study|Death before treatment|2
3007972|NCT00890825|10347618|P2|Overall Study|Alive at data cut off (DCO)|14
3007973|NCT00890825|10347619|P1|Overall Study|Alive at data cut off (DCO)|13
3007974|NCT00890825|10347618|P2|Overall Study|Withdrawal by Subject|0
3007975|NCT00890825|10347619|P1|Overall Study|Withdrawal by Subject|1
3007976|NCT00890695|10347648|P2|Overall Study|Protocol Violation|0
3007977|NCT00890695|10347649|P1|Overall Study|Protocol Violation|1
3007978|NCT00890591|10347678|P1|Overall Study|Lack of Efficacy|20
3007979|NCT00890552|10347684|P1|On-treatment|Early prog disease/ death|10
3007980|NCT00890552|10347684|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
3007981|NCT00890409|10347693|P2|Overall Study|Lost to Follow-up|21
3007982|NCT00890409|10347694|P1|Overall Study|Lost to Follow-up|20
3007983|NCT00890201|10347704|P2|Overall Study|Protocol Violation|56
3007984|NCT00890201|10347705|P1|Overall Study|Protocol Violation|5
3007985|NCT00890097|10347723|P3|Overall Study|Protocol Deviation|1
3007986|NCT00890097|10347724|P2|Overall Study|Protocol Deviation|1
3007987|NCT00890097|10347725|P1|Overall Study|Protocol Deviation|1
3007988|NCT00890097|10347723|P3|Overall Study|Subject Moved|0
3007989|NCT00890097|10347724|P2|Overall Study|Subject Moved|4
3007990|NCT00890097|10347725|P1|Overall Study|Subject Moved|0
3007991|NCT00890097|10347723|P3|Overall Study|Transportation|0
3007992|NCT00890097|10347724|P2|Overall Study|Transportation|2
3007993|NCT00890097|10347725|P1|Overall Study|Transportation|0
3007994|NCT00890097|10347723|P3|Overall Study|Failed inclusion criteria|0
3007995|NCT00890097|10347724|P2|Overall Study|Failed inclusion criteria|4
3007996|NCT00890097|10347725|P1|Overall Study|Failed inclusion criteria|3
3007997|NCT00890097|10347723|P3|Overall Study|Randomization Error|0
3007998|NCT00890097|10347724|P2|Overall Study|Randomization Error|0
3007999|NCT00890097|10347725|P1|Overall Study|Randomization Error|2
3008000|NCT00890097|10347723|P3|Overall Study|Subject Decision|6
3008001|NCT00890097|10347724|P2|Overall Study|Subject Decision|2
3008002|NCT00890097|10347725|P1|Overall Study|Subject Decision|3
3008003|NCT00890097|10347723|P3|Overall Study|Did not attend final visit|0
3008004|NCT00890097|10347724|P2|Overall Study|Did not attend final visit|3
3008005|NCT00890097|10347725|P1|Overall Study|Did not attend final visit|2
3008006|NCT00890097|10347723|P3|Overall Study|Sponsor Decision|7
3008007|NCT00890097|10347724|P2|Overall Study|Sponsor Decision|11
3008008|NCT00890097|10347725|P1|Overall Study|Sponsor Decision|7
3008009|NCT00890097|10347723|P3|Overall Study|Noncompliance|4
3008010|NCT00890097|10347724|P2|Overall Study|Noncompliance|4
3008011|NCT00890097|10347725|P1|Overall Study|Noncompliance|0
3008012|NCT00890097|10347723|P3|Overall Study|Lost to Follow-up|5
3008013|NCT00890097|10347724|P2|Overall Study|Lost to Follow-up|5
3008014|NCT00890097|10347725|P1|Overall Study|Lost to Follow-up|5
3008015|NCT00890097|10347723|P3|Overall Study|Withdrew Consent|9
3008016|NCT00890097|10347724|P2|Overall Study|Withdrew Consent|6
3008017|NCT00890097|10347725|P1|Overall Study|Withdrew Consent|9
3008018|NCT00890097|10347723|P3|Overall Study|Decision Unrelated to an Adverse Event|17
3008019|NCT00890097|10347724|P2|Overall Study|Decision Unrelated to an Adverse Event|12
3008020|NCT00890097|10347725|P1|Overall Study|Decision Unrelated to an Adverse Event|15
3008021|NCT00890097|10347723|P3|Overall Study|Adverse Event|28
3008022|NCT00890097|10347724|P2|Overall Study|Adverse Event|32
3008023|NCT00890097|10347725|P1|Overall Study|Adverse Event|21
3008024|NCT00890084|10347733|P1|Overall Study|Lost to Follow-up|126
3008025|NCT00890084|10347733|P1|Overall Study|Adverse Event|16
3008026|NCT00889863|10347773|P2|Part II: Randomized Double Blind|Protocol deviation|1
3008027|NCT00889863|10347774|P1|Part II: Randomized Double Blind|Protocol deviation|0
3008028|NCT00889863|10347773|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
3008029|NCT00889863|10347774|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
3008030|NCT00889863|10347773|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
3008031|NCT00889863|10347774|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
3008032|NCT00889863|10347773|P2|Part II: Randomized Double Blind|Adverse Event|4
3008033|NCT00889863|10347774|P1|Part II: Randomized Double Blind|Adverse Event|0
3008034|NCT00889863|10347773|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
3008035|NCT00889863|10347774|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
3008036|NCT00889863|10347773|P2|Part I: Open Label|Adverse Event|0
3008037|NCT00889863|10347774|P1|Part I: Open Label|Adverse Event|4
3008038|NCT00889863|10347773|P2|Part I: Open Label|Death|0
3008039|NCT00889863|10347774|P1|Part I: Open Label|Death|1
3008040|NCT00889720|10347800|P1|Overall Study|Other|4
3008041|NCT00889720|10347800|P1|Overall Study|Withdrawal by Subject|4
3008042|NCT00889707|10347827|P2|Overall Study|Lack of Efficacy|5
3008043|NCT00889707|10347828|P1|Overall Study|Lack of Efficacy|2
3008044|NCT00889707|10347827|P2|Overall Study|Lost to Follow-up|2
3008045|NCT00889707|10347828|P1|Overall Study|Lost to Follow-up|0
3008046|NCT00889707|10347827|P2|Overall Study|Withdrawal by Subject|3
3008047|NCT00889707|10347828|P1|Overall Study|Withdrawal by Subject|4
3008048|NCT00889707|10347827|P2|Overall Study|Adverse Event|0
3008049|NCT00889707|10347828|P1|Overall Study|Adverse Event|1
3008050|NCT00889681|10347836|P1|Overall Study|Insurance disapproval|1
3008051|NCT00889681|10347836|P1|Overall Study|Not meeting qualification Criteria|2
3008052|NCT00889603|10347843|P1|Overall Study|Other|4
3008053|NCT00889603|10347843|P1|Overall Study|No longer willing to participant in stud|4
3008054|NCT00889603|10347843|P1|Overall Study|Lost to Follow-up|19
3008055|NCT00889603|10347843|P1|Overall Study|Death|3
3008056|NCT00889603|10347843|P1|Overall Study|Adverse Event|7
3008057|NCT00889421|10347865|P1|Overall Study|Lack of Efficacy|3
3008058|NCT00889265|10347906|P1|Overall Study|Protocol Violation|1
3008059|NCT00889265|10347906|P1|Overall Study|Lost to Follow-up|5
3008060|NCT00889265|10347906|P1|Overall Study|Adverse Event|1
3008061|NCT00889252|10347913|P2|Overall Study|Protocol Violation|0
3008062|NCT00889252|10347914|P1|Overall Study|Protocol Violation|2
3008063|NCT00889252|10347913|P2|Overall Study|Withdrawal by Subject|0
3008064|NCT00889252|10347914|P1|Overall Study|Withdrawal by Subject|3
3008065|NCT00889252|10347913|P2|Overall Study|Adverse Event|4
3008066|NCT00889252|10347914|P1|Overall Study|Adverse Event|2
3008067|NCT00889005|10347991|P2|Overall Study|Withdrawal by Subject|0
3008068|NCT00889005|10347992|P1|Overall Study|Withdrawal by Subject|4
3008069|NCT00889005|10347991|P2|Overall Study|Lost to Follow-up|2
3008070|NCT00889005|10347992|P1|Overall Study|Lost to Follow-up|4
3008071|NCT00888940|10348006|P2|Overall Study|Randomized Not Treated|13
3008072|NCT00888940|10348007|P1|Overall Study|Randomized Not Treated|11
3008073|NCT00888940|10348006|P2|Overall Study|Lost to Follow-up|5
3008074|NCT00888940|10348007|P1|Overall Study|Lost to Follow-up|5
3008075|NCT00888940|10348006|P2|Overall Study|Adverse Event|3
3008076|NCT00888940|10348007|P1|Overall Study|Adverse Event|12
3008077|NCT00888849|10348017|P2|Overall Study|Lost to Follow-up|2
3008078|NCT00888849|10348018|P1|Overall Study|Lost to Follow-up|1
3008079|NCT00888849|10348017|P2|Overall Study|Death|7
3008080|NCT00888849|10348018|P1|Overall Study|Death|4
3008081|NCT00888654|10348028|P1|Overall Study|Stopped meds due to headaches|1
3008082|NCT00888654|10348028|P1|Overall Study|Change in surg date|1
3008083|NCT00888654|10348028|P1|Overall Study|Inelig. due to contraindication of med|1
3008084|NCT00888654|10348028|P1|Overall Study|Withdrawal by Subject|1
3008085|NCT00888654|10348028|P1|Overall Study|Surgery aborted|2
3008086|NCT00888654|10348028|P1|Overall Study|Not enough oral meds before surgery|3
3008087|NCT00888654|10348028|P1|Overall Study|Problems swallowing oral meds.|1
3008088|NCT00888615|10348046|P1|Overall Study|No treatment|2
3008089|NCT00888433|10348066|P2|Overall Study|Missed Visit|1
3008090|NCT00888433|10348067|P1|Overall Study|Missed Visit|2
3008091|NCT00888433|10348066|P2|Overall Study|Withdrawal by Subject|2
3008092|NCT00888433|10348067|P1|Overall Study|Withdrawal by Subject|1
3008093|NCT00888381|10348075|P2|Overall Study|Lost to Follow-up|1
3008094|NCT00888381|10348076|P1|Overall Study|Lost to Follow-up|0
3008095|NCT00888355|10348096|P4|Overall Study|Withdrawal by Subject|3
3008096|NCT00888355|10348097|P3|Overall Study|Withdrawal by Subject|1
3008097|NCT00888355|10348098|P2|Overall Study|Withdrawal by Subject|3
3008098|NCT00888355|10348099|P1|Overall Study|Withdrawal by Subject|0
3008099|NCT00888355|10348096|P4|Overall Study|Protocol Violation|2
3008100|NCT00888355|10348097|P3|Overall Study|Protocol Violation|1
3008101|NCT00888355|10348098|P2|Overall Study|Protocol Violation|2
3008102|NCT00888355|10348099|P1|Overall Study|Protocol Violation|3
3008103|NCT00888355|10348096|P4|Overall Study|Lost to Follow-up|0
3008104|NCT00888355|10348097|P3|Overall Study|Lost to Follow-up|2
3008105|NCT00888355|10348098|P2|Overall Study|Lost to Follow-up|2
3008106|NCT00888355|10348099|P1|Overall Study|Lost to Follow-up|0
3008107|NCT00888355|10348096|P4|Overall Study|Lack of Efficacy|2
3008108|NCT00888355|10348097|P3|Overall Study|Lack of Efficacy|5
3008109|NCT00888355|10348098|P2|Overall Study|Lack of Efficacy|2
3008110|NCT00888355|10348099|P1|Overall Study|Lack of Efficacy|9
3008111|NCT00888355|10348096|P4|Overall Study|Adverse Event|3
3008112|NCT00888355|10348097|P3|Overall Study|Adverse Event|3
3008113|NCT00888355|10348098|P2|Overall Study|Adverse Event|0
3008114|NCT00888355|10348099|P1|Overall Study|Adverse Event|10
3008115|NCT00888329|10348155|P2|Overall Study|Physician Decision|9
3008116|NCT00888329|10348156|P1|Overall Study|Physician Decision|6
3008117|NCT00888238|10348162|P3|Washout Period After Period 2|Adverse Event|1
3008118|NCT00888238|10348163|P2|Washout Period After Period 2|Adverse Event|0
3008119|NCT00888238|10348164|P1|Washout Period After Period 2|Adverse Event|0
3008120|NCT00888173|10348172|P1|Overall Study|Ineligible: required test not done|1
3008121|NCT00888173|10348172|P1|Overall Study|Wrong Primary|1
3008122|NCT00888134|10348180|P1|Follow-up|being followed for long-term survival|1
3008123|NCT00888134|10348180|P1|Treatment With Study Drug|Withdrawal by Subject|1
3008124|NCT00887978|10348190|P2|Overall Study|Lost to Follow-up|1
3008125|NCT00887978|10348191|P1|Overall Study|Lost to Follow-up|0
3008126|NCT00887978|10348190|P2|Overall Study|Withdrawal by Subject|2
3008127|NCT00887978|10348191|P1|Overall Study|Withdrawal by Subject|1
3008128|NCT00887978|10348190|P2|Overall Study|Death|3
3008129|NCT00887978|10348191|P1|Overall Study|Death|2
3008130|NCT00887978|10348190|P2|Overall Study|Clinical Worsening|4
3008131|NCT00887978|10348191|P1|Overall Study|Clinical Worsening|4
3008132|NCT00887978|10348190|P2|Overall Study|Adverse Event|5
3008133|NCT00887978|10348191|P1|Overall Study|Adverse Event|18
3008134|NCT00887926|10348261|P4|Overall Study|Withdrawal by Subject|0
3008135|NCT00887926|10348262|P3|Overall Study|Withdrawal by Subject|0
3008136|NCT00887926|10348263|P2|Overall Study|Withdrawal by Subject|1
3008137|NCT00887926|10348264|P1|Overall Study|Withdrawal by Subject|0
3008138|NCT00887913|10348299|P1|Overall Study|Withdrawal by Subject|6
3008139|NCT00887822|10348307|P2|Overall Study|Randomized but not treated|1
3008140|NCT00887822|10348308|P1|Overall Study|Randomized but not treated|0
3008141|NCT00887822|10348307|P2|Overall Study|Protocol Violation|1
3008142|NCT00887822|10348308|P1|Overall Study|Protocol Violation|0
3008143|NCT00887822|10348307|P2|Overall Study|Death|3
3008144|NCT00887822|10348308|P1|Overall Study|Death|2
3008145|NCT00887822|10348307|P2|Overall Study|Administrative/Other than specified|4
3008146|NCT00887822|10348308|P1|Overall Study|Administrative/Other than specified|5
3008147|NCT00887822|10348307|P2|Overall Study|Refused treatment/Did not cooperate|10
3008148|NCT00887822|10348308|P1|Overall Study|Refused treatment/Did not cooperate|12
3008149|NCT00887822|10348307|P2|Overall Study|Failure to return|11
3008150|NCT00887822|10348308|P1|Overall Study|Failure to return|11
3008151|NCT00887822|10348307|P2|Overall Study|Adverse Event|17
3008152|NCT00887822|10348308|P1|Overall Study|Adverse Event|14
3008153|NCT00887822|10348307|P2|Overall Study|Insufficient therapeutic response|55
3008154|NCT00887822|10348308|P1|Overall Study|Insufficient therapeutic response|53
3008155|NCT00887809|10348340|P2|Overall Study|Death|0
3008156|NCT00887809|10348341|P1|Overall Study|Death|1
3008157|NCT00887809|10348340|P2|Overall Study|Patient Not Treated|0
3008158|NCT00887809|10348341|P1|Overall Study|Patient Not Treated|3
3008159|NCT00887744|10348347|P1|Overall Study|Various reasons|9
3008160|NCT00887744|10348347|P1|Overall Study|Withdrawal by Subject|18
3008161|NCT00887744|10348347|P1|Overall Study|Lost to Follow-up|3
3008162|NCT00887744|10348347|P1|Overall Study|Death|1
3008163|NCT00887744|10348347|P1|Overall Study|Adverse Event|3
3008164|NCT00887679|10348356|P1|Overall Study|Physician Decision|5
3008165|NCT00887679|10348356|P1|Overall Study|Lost to Follow-up|4
3008166|NCT00887679|10348356|P1|Overall Study|Withdrawal by Subject|1
3008167|NCT00887588|10348386|P2|Extension Period|Lost to Follow-up|0
3008168|NCT00887588|10348387|P1|Extension Period|Lost to Follow-up|1
3008169|NCT00887588|10348386|P2|Extension Period|Protocol deviation|0
3008170|NCT00887588|10348387|P1|Extension Period|Protocol deviation|1
3008171|NCT00887588|10348386|P2|Extension Period|Death|1
3008172|NCT00887588|10348387|P1|Extension Period|Death|0
3008173|NCT00887588|10348386|P2|Extension Period|Adverse Event|4
3008174|NCT00887588|10348387|P1|Extension Period|Adverse Event|4
3008175|NCT00887588|10348386|P2|Core Period|Adverse Event|11
3008176|NCT00887588|10348387|P1|Core Period|Adverse Event|9
3008177|NCT00887588|10348386|P2|Core Period|Withdrawal by Subject|8
3008178|NCT00887588|10348387|P1|Core Period|Withdrawal by Subject|6
3008179|NCT00887588|10348386|P2|Core Period|Lost to Follow-up|1
3008180|NCT00887588|10348387|P1|Core Period|Lost to Follow-up|3
3008181|NCT00887588|10348386|P2|Core Period|Death|1
3008182|NCT00887588|10348387|P1|Core Period|Death|1
3008183|NCT00887549|10348468|P1|Maintenance Therapy|Death due to adverse event|1
3008184|NCT00887549|10348468|P1|Maintenance Therapy|Progressive Disease|25
3008185|NCT00887549|10348468|P1|Maintenance Therapy|Physician Decision|1
3008186|NCT00887549|10348468|P1|Maintenance Therapy|Adverse Event|16
3008187|NCT00887549|10348468|P1|Induction Therapy|Death due to Study Drug Toxicity|1
3008188|NCT00887549|10348468|P1|Induction Therapy|Death due to Study Disease|4
3008189|NCT00887549|10348468|P1|Induction Therapy|Progressive Disease|13
3008190|NCT00887549|10348468|P1|Induction Therapy|Physician Decision|1
3008191|NCT00887549|10348468|P1|Induction Therapy|Adverse Event|8
3008192|NCT00887484|10348486|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
3008193|NCT00887484|10348486|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
3008194|NCT00887484|10348486|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
3008195|NCT00887354|10348574|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
3008196|NCT00887354|10348575|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
3008197|NCT00887354|10348574|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
3008198|NCT00887354|10348575|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
3008199|NCT00887354|10348574|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
3008200|NCT00887354|10348575|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
3008201|NCT00887354|10348574|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
3008202|NCT00887354|10348575|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
3008203|NCT00887354|10348574|P2|Open Label Phase (Week 26 to Week 78)|Death|2
3008204|NCT00887354|10348575|P1|Open Label Phase (Week 26 to Week 78)|Death|0
3008205|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
3008206|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
3008207|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
3008208|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
3008209|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
3008210|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
3008211|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
3008212|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
3008213|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
3008214|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
3008215|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
3008216|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
3008217|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
3008218|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
3008219|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
3008220|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
3008221|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
3008222|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
3008223|NCT00887354|10348574|P2|Treatment Phase (Week 0 to Week 26)|Death|1
3008224|NCT00887354|10348575|P1|Treatment Phase (Week 0 to Week 26)|Death|0
3008225|NCT00887341|10348595|P2|Overall Study|Lost to Follow-up|1
3008226|NCT00887341|10348596|P1|Overall Study|Lost to Follow-up|0
3008227|NCT00887341|10348595|P2|Overall Study|Adverse Event|1
3008228|NCT00887341|10348596|P1|Overall Study|Adverse Event|0
3008229|NCT00887341|10348595|P2|Overall Study|Withdrawal by Subject|1
3008230|NCT00887341|10348596|P1|Overall Study|Withdrawal by Subject|1
3008231|NCT00887341|10348595|P2|Overall Study|Refused treatment|0
3008232|NCT00887341|10348596|P1|Overall Study|Refused treatment|1
3008233|NCT00887315|10348632|P2|Overall Study|Study termination|4
3008234|NCT00887315|10348633|P1|Overall Study|Study termination|7
3008235|NCT00887289|10348641|P1|Overall Study|Other|20
3008236|NCT00887289|10348641|P1|Overall Study|Lost to Follow-up|8
3008237|NCT00887289|10348641|P1|Overall Study|Withdrawal by Subject|26
3008238|NCT00887289|10348641|P1|Overall Study|Adverse Event|27
3008239|NCT00887289|10348641|P1|Overall Study|Lack of Efficacy|14
3008240|NCT00887250|10348653|P3|Overall Study|Patient uncooperative|1
3008241|NCT00887250|10348654|P2|Overall Study|Patient uncooperative|0
3008242|NCT00887250|10348655|P1|Overall Study|Patient uncooperative|0
3008243|NCT00887250|10348653|P3|Overall Study|Withdrawal by Subject|2
3008244|NCT00887250|10348654|P2|Overall Study|Withdrawal by Subject|1
3008245|NCT00887250|10348655|P1|Overall Study|Withdrawal by Subject|2
3008246|NCT00887250|10348653|P3|Overall Study|Protocol Violation|1
3008247|NCT00887250|10348654|P2|Overall Study|Protocol Violation|2
3008248|NCT00887250|10348655|P1|Overall Study|Protocol Violation|2
3008249|NCT00887250|10348653|P3|Overall Study|Lost to Follow-up|1
3008250|NCT00887250|10348654|P2|Overall Study|Lost to Follow-up|3
3008251|NCT00887250|10348655|P1|Overall Study|Lost to Follow-up|2
3008252|NCT00887250|10348653|P3|Overall Study|Lack of Efficacy|1
3008253|NCT00887250|10348654|P2|Overall Study|Lack of Efficacy|6
3008254|NCT00887250|10348655|P1|Overall Study|Lack of Efficacy|9
3008255|NCT00887250|10348653|P3|Overall Study|Adverse Event|7
3008256|NCT00887250|10348654|P2|Overall Study|Adverse Event|0
3008257|NCT00887250|10348655|P1|Overall Study|Adverse Event|3
3008258|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
3008259|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
3008260|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
3008261|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
3008262|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
3008263|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
3008264|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Other|12
3008265|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Other|11
3008266|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Other|0
3008267|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
3008268|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
3008269|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
3008270|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
3008271|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
3008272|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
3008273|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
3008274|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
3008275|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
3008276|NCT00887224|10348678|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
3008277|NCT00887224|10348679|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
3008278|NCT00887224|10348680|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
3008279|NCT00887224|10348678|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
3008280|NCT00887224|10348679|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
3008281|NCT00887224|10348680|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
3008282|NCT00887224|10348678|P3|Double-blind (DB) Phase|Protocol Violation|5
3008283|NCT00887224|10348679|P2|Double-blind (DB) Phase|Protocol Violation|8
3008284|NCT00887224|10348680|P1|Double-blind (DB) Phase|Protocol Violation|0
3008285|NCT00887224|10348678|P3|Double-blind (DB) Phase|Other|0
3008286|NCT00887224|10348679|P2|Double-blind (DB) Phase|Other|2
3008287|NCT00887224|10348680|P1|Double-blind (DB) Phase|Other|0
3008288|NCT00887224|10348678|P3|Double-blind (DB) Phase|Lost to Follow-up|8
3008289|NCT00887224|10348679|P2|Double-blind (DB) Phase|Lost to Follow-up|8
3008290|NCT00887224|10348680|P1|Double-blind (DB) Phase|Lost to Follow-up|0
3008291|NCT00887224|10348678|P3|Double-blind (DB) Phase|Lack of Efficacy|33
3008292|NCT00887224|10348679|P2|Double-blind (DB) Phase|Lack of Efficacy|67
3008293|NCT00887224|10348680|P1|Double-blind (DB) Phase|Lack of Efficacy|0
3008294|NCT00887224|10348678|P3|Double-blind (DB) Phase|Failed to return|2
3008295|NCT00887224|10348679|P2|Double-blind (DB) Phase|Failed to return|2
3008296|NCT00887224|10348680|P1|Double-blind (DB) Phase|Failed to return|0
3008297|NCT00887224|10348678|P3|Double-blind (DB) Phase|Adverse Event|2
3008298|NCT00887224|10348679|P2|Double-blind (DB) Phase|Adverse Event|7
3008299|NCT00887224|10348680|P1|Double-blind (DB) Phase|Adverse Event|0
3008300|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
3008301|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
3008466|NCT00886821|10348808|P11|Stage 2|Adverse Event|0
3008302|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
3008303|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
3008304|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
3008305|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
3008306|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Other|0
3008307|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Other|0
3008308|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Other|30
3008309|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
3008310|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
3008311|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
3008312|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
3008313|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
3008314|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
3008315|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Failed to return|0
3008316|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Failed to return|0
3008317|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Failed to return|17
3008318|NCT00887224|10348678|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
3008319|NCT00887224|10348679|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
3008320|NCT00887224|10348680|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
3008321|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
3008322|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
3008323|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
3008324|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
3008325|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
3008326|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
3008327|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Other|0
3008328|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Other|0
3008329|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Other|1
3008330|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
3008331|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
3008332|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
3008333|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
3008334|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
3008335|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
3008336|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Failed to return|0
3008337|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Failed to return|0
3008338|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Failed to return|3
3008339|NCT00887224|10348678|P3|Open-label Stability (OLS) Phase|Adverse Event|0
3008340|NCT00887224|10348679|P2|Open-label Stability (OLS) Phase|Adverse Event|0
3008341|NCT00887224|10348680|P1|Open-label Stability (OLS) Phase|Adverse Event|22
3008342|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
3008343|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
3008344|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
3008345|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Protocol Violation|0
3008346|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Protocol Violation|0
3008347|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Protocol Violation|12
3008348|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Other|0
3008349|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Other|0
3008350|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Other|1
3008351|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
3008352|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
3008353|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
3008354|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
3008355|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
3008356|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
3008357|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Failed to return|0
3008358|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Failed to return|0
3008359|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Failed to return|6
3008360|NCT00887224|10348678|P3|Open-label Response (OLR) Phase|Adverse Event|0
3008361|NCT00887224|10348679|P2|Open-label Response (OLR) Phase|Adverse Event|0
3008362|NCT00887224|10348680|P1|Open-label Response (OLR) Phase|Adverse Event|46
3008363|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Other|19
3008364|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Other|0
3008365|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Other|0
3008366|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Progressive disease|20
3008367|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Progressive disease|0
3008368|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Progressive disease|0
3008369|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
3008370|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
3008371|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
3008372|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Adverse Event|9
3008373|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Adverse Event|0
3008374|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Adverse Event|0
3008375|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Ongoing|35
3008376|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Ongoing|0
3008377|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Ongoing|0
3008378|NCT00887198|10348707|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
3008379|NCT00887198|10348708|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
3008380|NCT00887198|10348709|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
3008381|NCT00887198|10348707|P3|Randomized Period|Randomized, Not treated|0
3008382|NCT00887198|10348708|P2|Randomized Period|Randomized, Not treated|2
3008383|NCT00887198|10348709|P1|Randomized Period|Randomized, Not treated|4
3008384|NCT00887198|10348707|P3|Randomized Period|Other|0
3008385|NCT00887198|10348708|P2|Randomized Period|Other|30
3008386|NCT00887198|10348709|P1|Randomized Period|Other|42
3008387|NCT00887198|10348707|P3|Randomized Period|Progressive disease|0
3008388|NCT00887198|10348708|P2|Randomized Period|Progressive disease|370
3008389|NCT00887198|10348709|P1|Randomized Period|Progressive disease|366
3008390|NCT00887198|10348707|P3|Randomized Period|Withdrawal by Subject|0
3008391|NCT00887198|10348708|P2|Randomized Period|Withdrawal by Subject|56
3008392|NCT00887198|10348709|P1|Randomized Period|Withdrawal by Subject|41
3008393|NCT00887198|10348707|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
3008394|NCT00887198|10348708|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
3008395|NCT00887198|10348709|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
3008396|NCT00887198|10348707|P3|Randomized Period|Lost to Follow-up|0
3008397|NCT00887198|10348708|P2|Randomized Period|Lost to Follow-up|0
3008398|NCT00887198|10348709|P1|Randomized Period|Lost to Follow-up|1
3008399|NCT00887198|10348707|P3|Randomized Period|Adverse Event|0
3008400|NCT00887198|10348708|P2|Randomized Period|Adverse Event|33
3008401|NCT00887198|10348709|P1|Randomized Period|Adverse Event|50
3008402|NCT00887198|10348707|P3|Randomized Period|Ongoing|0
3008403|NCT00887198|10348708|P2|Randomized Period|Ongoing|0
3008404|NCT00887198|10348709|P1|Randomized Period|Ongoing|42
3008405|NCT00887159|10348740|P3|Overall Study|Never started assigned therapy|4
3008406|NCT00887159|10348741|P2|Overall Study|Never started assigned therapy|3
3008407|NCT00887159|10348742|P1|Overall Study|Never started assigned therapy|3
3008408|NCT00887159|10348740|P3|Overall Study|Ineligible|0
3008409|NCT00887159|10348741|P2|Overall Study|Ineligible|1
3008410|NCT00887159|10348742|P1|Overall Study|Ineligible|5
3008411|NCT00887159|10348740|P3|Overall Study|Received more tx instead of observation|0
3008412|NCT00887159|10348741|P2|Overall Study|Received more tx instead of observation|0
3008413|NCT00887159|10348742|P1|Overall Study|Received more tx instead of observation|1
3008414|NCT00887159|10348740|P3|Overall Study|Pt had PD but was SD when re-measured|0
3008415|NCT00887159|10348741|P2|Overall Study|Pt had PD but was SD when re-measured|1
3008416|NCT00887159|10348742|P1|Overall Study|Pt had PD but was SD when re-measured|0
3008417|NCT00887159|10348740|P3|Overall Study|Treatment delayed|0
3008418|NCT00887159|10348741|P2|Overall Study|Treatment delayed|1
3008419|NCT00887159|10348742|P1|Overall Study|Treatment delayed|1
3008420|NCT00887159|10348740|P3|Overall Study|Sympomatic deterioration|0
3008421|NCT00887159|10348741|P2|Overall Study|Sympomatic deterioration|0
3008422|NCT00887159|10348742|P1|Overall Study|Sympomatic deterioration|1
3008423|NCT00887159|10348740|P3|Overall Study|Physician Decision|0
3008424|NCT00887159|10348741|P2|Overall Study|Physician Decision|1
3008425|NCT00887159|10348742|P1|Overall Study|Physician Decision|1
3008426|NCT00887159|10348740|P3|Overall Study|Alternative therapy|0
3008427|NCT00887159|10348741|P2|Overall Study|Alternative therapy|0
3008428|NCT00887159|10348742|P1|Overall Study|Alternative therapy|2
3008429|NCT00887159|10348740|P3|Overall Study|Withdrawal by Subject|2
3008430|NCT00887159|10348741|P2|Overall Study|Withdrawal by Subject|4
3008431|NCT00887159|10348742|P1|Overall Study|Withdrawal by Subject|4
3008432|NCT00887159|10348740|P3|Overall Study|Death|0
3008433|NCT00887159|10348741|P2|Overall Study|Death|2
3008434|NCT00887159|10348742|P1|Overall Study|Death|2
3008435|NCT00887159|10348740|P3|Overall Study|Adverse Event|17
3008436|NCT00887159|10348741|P2|Overall Study|Adverse Event|4
3008437|NCT00887159|10348742|P1|Overall Study|Adverse Event|3
3008438|NCT00887159|10348740|P3|Overall Study|Disease progression|33
3008439|NCT00887159|10348741|P2|Overall Study|Disease progression|39
3008440|NCT00887159|10348742|P1|Overall Study|Disease progression|6
3008441|NCT00887068|10348760|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
3008442|NCT00887068|10348761|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
3008443|NCT00887068|10348760|P2|Overall Study|Withdrawal by Subject|0
3008444|NCT00887068|10348761|P1|Overall Study|Withdrawal by Subject|2
3008445|NCT00886938|10348769|P1|Overall Study|Withdrawal by Subject|1
3008446|NCT00886938|10348769|P1|Overall Study|Adverse Event|1
3008447|NCT00886834|10348782|P2|Overall Study|Protocol Violation|3
3008448|NCT00886834|10348783|P1|Overall Study|Protocol Violation|0
3008449|NCT00886821|10348805|P14|Stage 2|Lost to Follow-up|1
3008450|NCT00886821|10348806|P13|Stage 2|Lost to Follow-up|2
3008451|NCT00886821|10348807|P12|Stage 2|Lost to Follow-up|0
3008452|NCT00886821|10348808|P11|Stage 2|Lost to Follow-up|0
3008453|NCT00886821|10348809|P10|Stage 2|Lost to Follow-up|0
3008454|NCT00886821|10348810|P9|Stage 2|Lost to Follow-up|0
3008455|NCT00886821|10348811|P8|Stage 2|Lost to Follow-up|0
3008456|NCT00886821|10348812|P7|Stage 2|Lost to Follow-up|0
3008457|NCT00886821|10348813|P6|Stage 2|Lost to Follow-up|0
3008458|NCT00886821|10348814|P5|Stage 2|Lost to Follow-up|0
3008459|NCT00886821|10348815|P4|Stage 2|Lost to Follow-up|0
3008460|NCT00886821|10348816|P3|Stage 2|Lost to Follow-up|0
3008461|NCT00886821|10348817|P2|Stage 2|Lost to Follow-up|0
3008462|NCT00886821|10348818|P1|Stage 2|Lost to Follow-up|0
3008463|NCT00886821|10348805|P14|Stage 2|Adverse Event|0
3008464|NCT00886821|10348806|P13|Stage 2|Adverse Event|3
3008465|NCT00886821|10348807|P12|Stage 2|Adverse Event|1
3008467|NCT00886821|10348809|P10|Stage 2|Adverse Event|0
3008468|NCT00886821|10348810|P9|Stage 2|Adverse Event|0
3008469|NCT00886821|10348811|P8|Stage 2|Adverse Event|0
3008470|NCT00886821|10348812|P7|Stage 2|Adverse Event|0
3008471|NCT00886821|10348813|P6|Stage 2|Adverse Event|0
3008472|NCT00886821|10348814|P5|Stage 2|Adverse Event|0
3008473|NCT00886821|10348815|P4|Stage 2|Adverse Event|0
3008474|NCT00886821|10348816|P3|Stage 2|Adverse Event|0
3008475|NCT00886821|10348817|P2|Stage 2|Adverse Event|0
3008476|NCT00886821|10348818|P1|Stage 2|Adverse Event|0
3008477|NCT00886795|10349043|P1|Overall Study|Lack of Efficacy|1
3008478|NCT00886769|10349050|P2|Overall Study|Unsatisfactory therapeutic effect|37
3008479|NCT00886769|10349051|P1|Overall Study|Unsatisfactory therapeutic effect|6
3008480|NCT00886743|10349075|P1|Overall Study|Other|1
3008481|NCT00886743|10349075|P1|Overall Study|Adverse Event|3
3008482|NCT00886639|10349113|P1|Overall Study|non-compliance|2
3008483|NCT00886639|10349113|P1|Overall Study|acute exacerbation|14
3008484|NCT00886613|10349127|P3|Overall Study|Subject withdrew consent (Part A)|2
3008485|NCT00886613|10349128|P2|Overall Study|Subject withdrew consent (Part A)|0
3008486|NCT00886613|10349129|P1|Overall Study|Subject withdrew consent (Part A)|0
3008487|NCT00886613|10349127|P3|Overall Study|Lost to follow-up (Part B)|1
3008488|NCT00886613|10349128|P2|Overall Study|Lost to follow-up (Part B)|0
3008489|NCT00886613|10349129|P1|Overall Study|Lost to follow-up (Part B)|1
3008490|NCT00886613|10349127|P3|Overall Study|Protocol deviation (Part B)|0
3008491|NCT00886613|10349128|P2|Overall Study|Protocol deviation (Part B)|0
3008492|NCT00886613|10349129|P1|Overall Study|Protocol deviation (Part B)|1
3008493|NCT00886600|10349151|P4|Combination Therapy Period|Protocol Violation|0
3008494|NCT00886600|10349152|P3|Combination Therapy Period|Protocol Violation|1
3008495|NCT00886600|10349153|P2|Combination Therapy Period|Protocol Violation|0
3008496|NCT00886600|10349154|P1|Combination Therapy Period|Protocol Violation|0
3008497|NCT00886600|10349151|P4|Combination Therapy Period|Adverse Event|0
3008498|NCT00886600|10349152|P3|Combination Therapy Period|Adverse Event|1
3008499|NCT00886600|10349153|P2|Combination Therapy Period|Adverse Event|0
3008500|NCT00886600|10349154|P1|Combination Therapy Period|Adverse Event|0
3008501|NCT00886600|10349151|P4|Double-blind Monotherapy|Withdrawal by Subject|0
3008502|NCT00886600|10349152|P3|Double-blind Monotherapy|Withdrawal by Subject|0
3008503|NCT00886600|10349153|P2|Double-blind Monotherapy|Withdrawal by Subject|0
3008504|NCT00886600|10349154|P1|Double-blind Monotherapy|Withdrawal by Subject|1
3008505|NCT00886600|10349151|P4|Double-blind Monotherapy|Protocol Violation|1
3008506|NCT00886600|10349152|P3|Double-blind Monotherapy|Protocol Violation|0
3008507|NCT00886600|10349153|P2|Double-blind Monotherapy|Protocol Violation|0
3008508|NCT00886600|10349154|P1|Double-blind Monotherapy|Protocol Violation|0
3008509|NCT00886600|10349151|P4|Double-blind Monotherapy|Adverse Event|1
3008510|NCT00886600|10349152|P3|Double-blind Monotherapy|Adverse Event|1
3008511|NCT00886600|10349153|P2|Double-blind Monotherapy|Adverse Event|1
3008512|NCT00886600|10349154|P1|Double-blind Monotherapy|Adverse Event|1
3008513|NCT00886587|10349178|P2|Overall Study|Withdrawal by Subject|1
3008514|NCT00886587|10349179|P1|Overall Study|Withdrawal by Subject|0
3008515|NCT00886587|10349178|P2|Overall Study|Protocol Violation|0
3008516|NCT00886587|10349179|P1|Overall Study|Protocol Violation|2
3008517|NCT00886587|10349178|P2|Overall Study|Adverse Event|1
3008518|NCT00886587|10349179|P1|Overall Study|Adverse Event|2
3008519|NCT00886483|10349193|P2|Overall Study|Distance to center, poor grades|0
3008520|NCT00886483|10349194|P1|Overall Study|Distance to center, poor grades|1
3008521|NCT00886483|10349193|P2|Overall Study|Pursue medications|2
3008522|NCT00886483|10349194|P1|Overall Study|Pursue medications|1
3008523|NCT00886483|10349193|P2|Overall Study|Lost to Follow-up|1
3008524|NCT00886483|10349194|P1|Overall Study|Lost to Follow-up|0
3008525|NCT00886340|10349212|P2|Overall Study|Withdrawal by Subject|7
3008526|NCT00886340|10349213|P1|Overall Study|Withdrawal by Subject|0
3008527|NCT00886288|10349221|P2|Overall Study|Lost to Follow-up|0
3008528|NCT00886288|10349222|P1|Overall Study|Lost to Follow-up|86
3008529|NCT00886288|10349221|P2|Overall Study|no respect of the 12 weeks period|227
3008530|NCT00886288|10349222|P1|Overall Study|no respect of the 12 weeks period|657
3008531|NCT00886119|10349278|P2|Period 1|Did not meet inclusion criteria|0
3008532|NCT00886119|10349279|P1|Period 1|Did not meet inclusion criteria|1
3008533|NCT00886015|10349287|P2|Overall Study|Death|2
3008534|NCT00886015|10349288|P1|Overall Study|Death|0
3008535|NCT00885846|10349307|P3|Overall Study|Withdrawal by Subject|2
3008536|NCT00885846|10349308|P2|Overall Study|Withdrawal by Subject|5
3008537|NCT00885846|10349309|P1|Overall Study|Withdrawal by Subject|2
3008538|NCT00885755|10349324|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
3008539|NCT00885755|10349325|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
3008540|NCT00885755|10349326|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
3008541|NCT00885755|10349324|P3|Part I: Trastuzumab+Taxane|Death|1
3008542|NCT00885755|10349325|P2|Part I: Trastuzumab+Taxane|Death|0
3008543|NCT00885755|10349326|P1|Part I: Trastuzumab+Taxane|Death|0
3008544|NCT00885755|10349324|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
3008545|NCT00885755|10349325|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
3008546|NCT00885755|10349326|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
3008547|NCT00885755|10349324|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
3008548|NCT00885755|10349325|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
3008549|NCT00885755|10349326|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
3008550|NCT00885755|10349324|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
3008551|NCT00885755|10349325|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
3008552|NCT00885755|10349326|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
3008553|NCT00885703|10349369|P7|Overall Study|Ineligible (no CM)|1
3008554|NCT00885703|10349370|P6|Overall Study|Ineligible (no CM)|3
3008555|NCT00885703|10349371|P5|Overall Study|Ineligible (no CM)|2
3008556|NCT00885703|10349372|P4|Overall Study|Ineligible (no CM)|1
3008557|NCT00885703|10349373|P3|Overall Study|Ineligible (no CM)|2
3008558|NCT00885703|10349374|P2|Overall Study|Ineligible (no CM)|3
3008559|NCT00885703|10349375|P1|Overall Study|Ineligible (no CM)|1
3008560|NCT00885703|10349369|P7|Overall Study|Withdrawal by Subject|1
3008561|NCT00885703|10349370|P6|Overall Study|Withdrawal by Subject|1
3008562|NCT00885703|10349371|P5|Overall Study|Withdrawal by Subject|3
3008563|NCT00885703|10349372|P4|Overall Study|Withdrawal by Subject|1
3008564|NCT00885703|10349373|P3|Overall Study|Withdrawal by Subject|0
3008565|NCT00885703|10349374|P2|Overall Study|Withdrawal by Subject|0
3008566|NCT00885703|10349375|P1|Overall Study|Withdrawal by Subject|0
3008567|NCT00885703|10349369|P7|Overall Study|Lost to Follow-up|0
3008568|NCT00885703|10349370|P6|Overall Study|Lost to Follow-up|1
3008569|NCT00885703|10349371|P5|Overall Study|Lost to Follow-up|0
3008570|NCT00885703|10349372|P4|Overall Study|Lost to Follow-up|0
3008571|NCT00885703|10349373|P3|Overall Study|Lost to Follow-up|1
3008572|NCT00885703|10349374|P2|Overall Study|Lost to Follow-up|0
3008573|NCT00885703|10349375|P1|Overall Study|Lost to Follow-up|0
3008574|NCT00885703|10349369|P7|Overall Study|Death|4
3008575|NCT00885703|10349370|P6|Overall Study|Death|8
3008576|NCT00885703|10349371|P5|Overall Study|Death|7
3008577|NCT00885703|10349372|P4|Overall Study|Death|7
3008578|NCT00885703|10349373|P3|Overall Study|Death|8
3008579|NCT00885703|10349374|P2|Overall Study|Death|7
3008580|NCT00885703|10349375|P1|Overall Study|Death|9
3008581|NCT00885677|10349433|P2|Overall Study|Inclusion/exclusion not met|27
3008582|NCT00885677|10349434|P1|Overall Study|Inclusion/exclusion not met|25
3008583|NCT00885677|10349433|P2|Overall Study|Heart transplantation|0
3008584|NCT00885677|10349434|P1|Overall Study|Heart transplantation|1
3008585|NCT00885677|10349433|P2|Overall Study|device/lead revision or replacement|6
3008586|NCT00885677|10349434|P1|Overall Study|device/lead revision or replacement|7
3008587|NCT00885677|10349433|P2|Overall Study|premature study closure|44
3008588|NCT00885677|10349434|P1|Overall Study|premature study closure|41
3008589|NCT00885677|10349433|P2|Overall Study|Protocol Violation|54
3008590|NCT00885677|10349434|P1|Overall Study|Protocol Violation|54
3008591|NCT00885677|10349433|P2|Overall Study|Lost to Follow-up|13
3008592|NCT00885677|10349434|P1|Overall Study|Lost to Follow-up|15
3008593|NCT00885677|10349433|P2|Overall Study|Death|34
3008594|NCT00885677|10349434|P1|Overall Study|Death|40
3008595|NCT00885534|10349450|P1|Overall Study|Patient deemed ineligible|1
3008596|NCT00885482|10349454|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
3008597|NCT00885482|10349454|P1|Overall Study|Death|1
3008598|NCT00885482|10349454|P1|Overall Study|Lack of Efficacy|1
3008599|NCT00885482|10349454|P1|Overall Study|Pregnancy|1
3008600|NCT00885378|10349460|P2|Overall Study|Protocol Violation|0
3008601|NCT00885378|10349461|P1|Overall Study|Protocol Violation|2
3008602|NCT00885378|10349460|P2|Overall Study|Poor/Noncompliance|2
3008603|NCT00885378|10349461|P1|Overall Study|Poor/Noncompliance|2
3008604|NCT00885378|10349460|P2|Overall Study|Lost to Follow-up|2
3008605|NCT00885378|10349461|P1|Overall Study|Lost to Follow-up|1
3008606|NCT00885378|10349460|P2|Overall Study|Withdrawal by Subject|2
3008607|NCT00885378|10349461|P1|Overall Study|Withdrawal by Subject|1
3008608|NCT00885378|10349460|P2|Overall Study|Lack of Efficacy|2
3008609|NCT00885378|10349461|P1|Overall Study|Lack of Efficacy|2
3008610|NCT00885365|10349491|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
3008611|NCT00885365|10349492|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
3008612|NCT00885365|10349491|P2|4 Weeks ON Treatment|Protocol Violation|2
3008613|NCT00885365|10349492|P1|4 Weeks ON Treatment|Protocol Violation|1
3008614|NCT00885365|10349491|P2|4 Weeks ON Treatment|Adverse Event|4
3008615|NCT00885365|10349492|P1|4 Weeks ON Treatment|Adverse Event|2
3008616|NCT00885352|10349528|P2|Overall Study|Lab abnormalities|1
3008617|NCT00885352|10349529|P1|Overall Study|Lab abnormalities|1
3008618|NCT00885352|10349528|P2|Overall Study|Excluded medication|2
3008619|NCT00885352|10349529|P1|Overall Study|Excluded medication|2
3008620|NCT00885352|10349528|P2|Overall Study|Contradiction to study medication|2
3008621|NCT00885352|10349529|P1|Overall Study|Contradiction to study medication|0
3008622|NCT00885352|10349528|P2|Overall Study|Withdrawal by Subject|5
3008623|NCT00885352|10349529|P1|Overall Study|Withdrawal by Subject|1
3008624|NCT00885352|10349528|P2|Overall Study|Protocol Violation|2
3008625|NCT00885352|10349529|P1|Overall Study|Protocol Violation|0
3008626|NCT00885352|10349528|P2|Overall Study|Physician Decision|3
3008627|NCT00885352|10349529|P1|Overall Study|Physician Decision|0
3008628|NCT00885352|10349528|P2|Overall Study|Lost to Follow-up|2
3008629|NCT00885352|10349529|P1|Overall Study|Lost to Follow-up|2
3008630|NCT00885352|10349528|P2|Overall Study|Adverse Event|3
3008631|NCT00885352|10349529|P1|Overall Study|Adverse Event|2
3008632|NCT00885170|10349541|P2|Overall Study|Withdrawal by Subject|13
3008633|NCT00885170|10349542|P1|Overall Study|Withdrawal by Subject|13
3008634|NCT00885170|10349541|P2|Overall Study|Protocol Violation|1
3008635|NCT00885170|10349542|P1|Overall Study|Protocol Violation|3
3008636|NCT00885170|10349541|P2|Overall Study|Physician Decision|1
3008637|NCT00885170|10349542|P1|Overall Study|Physician Decision|2
3008638|NCT00885170|10349541|P2|Overall Study|Lost to Follow-up|1
3008639|NCT00885170|10349542|P1|Overall Study|Lost to Follow-up|2
3008640|NCT00885170|10349541|P2|Overall Study|Excessive bone loss|3
3008641|NCT00885170|10349542|P1|Overall Study|Excessive bone loss|6
3008642|NCT00885170|10349541|P2|Overall Study|Adverse Event|4
3008643|NCT00885170|10349542|P1|Overall Study|Adverse Event|12
3008644|NCT00885118|10349601|P5|Overall Study|Other reason not defined above|0
3008645|NCT00885118|10349602|P4|Overall Study|Other reason not defined above|0
3008646|NCT00885118|10349603|P3|Overall Study|Other reason not defined above|1
3008647|NCT00885118|10349604|P2|Overall Study|Other reason not defined above|0
3008648|NCT00885118|10349605|P1|Overall Study|Other reason not defined above|0
3008649|NCT00885118|10349601|P5|Overall Study|Withdrawal by Subject|1
3008650|NCT00885118|10349602|P4|Overall Study|Withdrawal by Subject|0
3008651|NCT00885118|10349603|P3|Overall Study|Withdrawal by Subject|0
3008652|NCT00885118|10349604|P2|Overall Study|Withdrawal by Subject|0
3008653|NCT00885118|10349605|P1|Overall Study|Withdrawal by Subject|0
3008654|NCT00885118|10349601|P5|Overall Study|Adverse Event|0
3008655|NCT00885118|10349602|P4|Overall Study|Adverse Event|0
3008656|NCT00885118|10349603|P3|Overall Study|Adverse Event|0
3008657|NCT00885118|10349604|P2|Overall Study|Adverse Event|0
3008658|NCT00885118|10349605|P1|Overall Study|Adverse Event|1
3008659|NCT00885105|10349744|P2|Overall Study|Protocol Violation|2
3008660|NCT00885105|10349745|P1|Overall Study|Protocol Violation|0
3008661|NCT00885105|10349744|P2|Overall Study|Adverse Event|0
3008662|NCT00885105|10349745|P1|Overall Study|Adverse Event|1
3008663|NCT00885105|10349744|P2|Overall Study|Withdrawal by Subject|8
3008664|NCT00885105|10349745|P1|Overall Study|Withdrawal by Subject|0
3008665|NCT00884949|10349785|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
3008666|NCT00884949|10349785|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
3008667|NCT00884832|10349820|P2|Overall Study|Withdrawal by Subject|1
3008668|NCT00884832|10349821|P1|Overall Study|Withdrawal by Subject|0
3008669|NCT00884793|10349856|P1|Overall Study|Withdrawal by Subject|1
3008670|NCT00884741|10349875|P4|Randomization|Protocol Violation|8
3008671|NCT00884741|10349876|P3|Randomization|Protocol Violation|8
3008672|NCT00884741|10349877|P2|Randomization|Protocol Violation|0
3008673|NCT00884741|10349878|P1|Randomization|Protocol Violation|0
3008674|NCT00884741|10349875|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
3008675|NCT00884741|10349876|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
3008676|NCT00884741|10349877|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
3008677|NCT00884741|10349878|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
3008678|NCT00884741|10349875|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
3008679|NCT00884741|10349876|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
3008680|NCT00884741|10349877|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
3008681|NCT00884741|10349878|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
3008682|NCT00884741|10349875|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
3008683|NCT00884741|10349876|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
3008684|NCT00884741|10349877|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
3008685|NCT00884741|10349878|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
3008686|NCT00884741|10349875|P4|Step 2 Registration: Tissue Analysis|Death|0
3008687|NCT00884741|10349876|P3|Step 2 Registration: Tissue Analysis|Death|0
3008688|NCT00884741|10349877|P2|Step 2 Registration: Tissue Analysis|Death|1
3008689|NCT00884741|10349878|P1|Step 2 Registration: Tissue Analysis|Death|0
3008690|NCT00884741|10349875|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
3008691|NCT00884741|10349876|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
3008692|NCT00884741|10349877|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
3008693|NCT00884741|10349878|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
3008694|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
3008695|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
3008696|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
3008697|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
3008698|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Disease progression|0
3008699|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Disease progression|0
3008700|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Disease progression|0
3008701|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Disease progression|12
3008702|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
3008703|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
3008704|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
3008705|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
3008706|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
3008707|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
3008708|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
3008709|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
3008710|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Death|0
3008711|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Death|0
3008712|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Death|0
3008713|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Death|3
3008714|NCT00884741|10349875|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
3008715|NCT00884741|10349876|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
3008716|NCT00884741|10349877|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
3008717|NCT00884741|10349878|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
3008718|NCT00884390|10349928|P2|Overall Study|Other|1
3008719|NCT00884390|10349929|P1|Overall Study|Other|11
3008720|NCT00884390|10349928|P2|Overall Study|Discontinuation of Study by Sponsor|2
3008721|NCT00884390|10349929|P1|Overall Study|Discontinuation of Study by Sponsor|2
3008722|NCT00884390|10349928|P2|Overall Study|Withdrawal by Subject|1
3008723|NCT00884390|10349929|P1|Overall Study|Withdrawal by Subject|4
3008724|NCT00884390|10349928|P2|Overall Study|Protocol Violation|1
3008725|NCT00884390|10349929|P1|Overall Study|Protocol Violation|4
3008726|NCT00884390|10349928|P2|Overall Study|Physician Decision|1
3008727|NCT00884390|10349929|P1|Overall Study|Physician Decision|2
3008728|NCT00884390|10349928|P2|Overall Study|Lost to Follow-up|1
3008729|NCT00884390|10349929|P1|Overall Study|Lost to Follow-up|0
3008730|NCT00884390|10349928|P2|Overall Study|Adverse Event|1
3008731|NCT00884390|10349929|P1|Overall Study|Adverse Event|0
3008732|NCT00884377|10349947|P2|Overall Study|Physician Decision|1
3008733|NCT00884377|10349948|P1|Overall Study|Physician Decision|0
3008734|NCT00884377|10349947|P2|Overall Study|Could not confirm diagnosis|0
3008735|NCT00884377|10349948|P1|Overall Study|Could not confirm diagnosis|1
3008736|NCT00884377|10349947|P2|Overall Study|Withdrawal by Subject|0
3008737|NCT00884377|10349948|P1|Overall Study|Withdrawal by Subject|1
3008738|NCT00884325|10349970|P2|Overall Study|Not provided|0
3008739|NCT00884325|10349971|P1|Overall Study|Not provided|1
3008740|NCT00884325|10349970|P2|Overall Study|Withdrawal by Subject|1
3008741|NCT00884325|10349971|P1|Overall Study|Withdrawal by Subject|1
3008742|NCT00884325|10349970|P2|Overall Study|Lack of Efficacy|1
3008743|NCT00884325|10349971|P1|Overall Study|Lack of Efficacy|0
3008744|NCT00884325|10349970|P2|Overall Study|Lost to Follow-up|2
3008745|NCT00884325|10349971|P1|Overall Study|Lost to Follow-up|1
3008746|NCT00884312|10349981|P2|Overall Study|Did Not Receive Study Drug|1
3008747|NCT00884312|10349982|P1|Overall Study|Did Not Receive Study Drug|0
3008748|NCT00884312|10349981|P2|Overall Study|Other|4
3008749|NCT00884312|10349982|P1|Overall Study|Other|0
3008750|NCT00884312|10349981|P2|Overall Study|Physician Decision|1
3008751|NCT00884312|10349982|P1|Overall Study|Physician Decision|0
3008752|NCT00884312|10349981|P2|Overall Study|Withdrawal by Subject|6
3008753|NCT00884312|10349982|P1|Overall Study|Withdrawal by Subject|0
3008754|NCT00884312|10349981|P2|Overall Study|Fatal Adverse Event|4
3008755|NCT00884312|10349982|P1|Overall Study|Fatal Adverse Event|1
3008756|NCT00884312|10349981|P2|Overall Study|Non-fatal Adverse Event|0
3008757|NCT00884312|10349982|P1|Overall Study|Non-fatal Adverse Event|1
3008758|NCT00884312|10349981|P2|Overall Study|Fatal Progressive Disease|1
3008759|NCT00884312|10349982|P1|Overall Study|Fatal Progressive Disease|0
3008760|NCT00884312|10349981|P2|Overall Study|Non-fatal Progressive Disease|8
3008761|NCT00884312|10349982|P1|Overall Study|Non-fatal Progressive Disease|0
3008762|NCT00884286|10349998|P2|Overall Study|Comprised lung carcinoma|1
3008763|NCT00884286|10349999|P1|Overall Study|Comprised lung carcinoma|0
3008764|NCT00884286|10349998|P2|Overall Study|Not treated|1
3008765|NCT00884286|10349999|P1|Overall Study|Not treated|2
3008766|NCT00884286|10349998|P2|Overall Study|Thrombus in right auricle|0
3008767|NCT00884286|10349999|P1|Overall Study|Thrombus in right auricle|1
3008768|NCT00884286|10349998|P2|Overall Study|Septic shock|0
3008769|NCT00884286|10349999|P1|Overall Study|Septic shock|1
3008770|NCT00884286|10349998|P2|Overall Study|Physician Decision|0
3008771|NCT00884286|10349999|P1|Overall Study|Physician Decision|1
3008772|NCT00884286|10349998|P2|Overall Study|Death|2
3008773|NCT00884286|10349999|P1|Overall Study|Death|2
3008774|NCT00884286|10349998|P2|Overall Study|Toxicity|1
3008775|NCT00884286|10349999|P1|Overall Study|Toxicity|4
3008776|NCT00884286|10349998|P2|Overall Study|Progressive disease|28
3008777|NCT00884286|10349999|P1|Overall Study|Progressive disease|21
3008778|NCT00884273|10350013|P2|Overall Study|Practical reasons|0
3008779|NCT00884273|10350014|P1|Overall Study|Practical reasons|1
3008780|NCT00884273|10350013|P2|Overall Study|Protocol Violation|3
3008781|NCT00884273|10350014|P1|Overall Study|Protocol Violation|1
3008782|NCT00884273|10350013|P2|Overall Study|Adverse Event|2
3008783|NCT00884273|10350014|P1|Overall Study|Adverse Event|0
3008784|NCT00884221|10350040|P2|Overall Study|Cancellation of Cycle and Other Reason|13
3008785|NCT00884221|10350041|P1|Overall Study|Cancellation of Cycle and Other Reason|12
3008786|NCT00884221|10350040|P2|Overall Study|Protocol Violation|13
3008787|NCT00884221|10350041|P1|Overall Study|Protocol Violation|16
3008788|NCT00884221|10350040|P2|Overall Study|Adverse Event|3
3008789|NCT00884221|10350041|P1|Overall Study|Adverse Event|6
3008790|NCT00884221|10350040|P2|Overall Study|Withdrawal by Subject|3
3008791|NCT00884221|10350041|P1|Overall Study|Withdrawal by Subject|0
3008792|NCT00884117|10350077|P1|Overall Study|Other|12
3008793|NCT00884117|10350077|P1|Overall Study|Lost to Follow-up|143
3008794|NCT00884117|10350077|P1|Overall Study|Death|3
3008795|NCT00884117|10350077|P1|Overall Study|Withdrawal by Subject|89
3008796|NCT00884117|10350077|P1|Overall Study|Adverse Event|2
3008797|NCT00884039|10350148|P2|Overall Study|Lack of Efficacy|0
3008798|NCT00884039|10350149|P1|Overall Study|Lack of Efficacy|2
3008799|NCT00884039|10350148|P2|Overall Study|Withdrawal by Subject|1
3008800|NCT00884039|10350149|P1|Overall Study|Withdrawal by Subject|0
3008801|NCT00883779|10350157|P2|Off-study Phase|Other|21
3008802|NCT00883779|10350158|P1|Off-study Phase|Other|18
3008803|NCT00883779|10350157|P2|Off-study Phase|Failure to return|6
3008804|NCT00883779|10350158|P1|Off-study Phase|Failure to return|5
3008805|NCT00883779|10350157|P2|Off-study Phase|Refused treatment|1
3008806|NCT00883779|10350158|P1|Off-study Phase|Refused treatment|1
3008807|NCT00883779|10350157|P2|Off-study Phase|Death|174
3008808|NCT00883779|10350158|P1|Off-study Phase|Death|185
3008809|NCT00883779|10350157|P2|Post-Study Treatment Phase|Ongoing in the study|6
3008810|NCT00883779|10350158|P1|Post-Study Treatment Phase|Ongoing in the study|0
3008811|NCT00883779|10350157|P2|Post-Study Treatment Phase|Other|0
3008812|NCT00883779|10350158|P1|Post-Study Treatment Phase|Other|3
3008813|NCT00883779|10350157|P2|Post-Study Treatment Phase|Disease progression|122
3008814|NCT00883779|10350158|P1|Post-Study Treatment Phase|Disease progression|103
3008815|NCT00883779|10350157|P2|Post-Study Treatment Phase|Refused Treatment|0
3008816|NCT00883779|10350158|P1|Post-Study Treatment Phase|Refused Treatment|3
3008817|NCT00883779|10350157|P2|Post-Study Treatment Phase|Protocol Violation|1
3008818|NCT00883779|10350158|P1|Post-Study Treatment Phase|Protocol Violation|0
3008819|NCT00883779|10350157|P2|Post-Study Treatment Phase|Death|3
3008820|NCT00883779|10350158|P1|Post-Study Treatment Phase|Death|1
3008821|NCT00883779|10350157|P2|Post-Study Treatment Phase|Adverse Event|3
3008822|NCT00883779|10350158|P1|Post-Study Treatment Phase|Adverse Event|2
3008823|NCT00883779|10350157|P2|Primary Study Treatment Phase|Other|0
3008824|NCT00883779|10350158|P1|Primary Study Treatment Phase|Other|3
3008825|NCT00883779|10350157|P2|Primary Study Treatment Phase|Refused Treatment|4
3008826|NCT00883779|10350158|P1|Primary Study Treatment Phase|Refused Treatment|5
3008827|NCT00883779|10350157|P2|Primary Study Treatment Phase|Death|3
3008828|NCT00883779|10350158|P1|Primary Study Treatment Phase|Death|2
3008829|NCT00883779|10350157|P2|Primary Study Treatment Phase|Adverse Event|16
3008830|NCT00883779|10350158|P1|Primary Study Treatment Phase|Adverse Event|16
3008831|NCT00883779|10350157|P2|Primary Study Treatment Phase|Disease progression|59
3008832|NCT00883779|10350158|P1|Primary Study Treatment Phase|Disease progression|75
3008833|NCT00883779|10350157|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
3008834|NCT00883779|10350158|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
3008835|NCT00883753|10350194|P1|Overall Study|Administrative/Other|8
3008836|NCT00883753|10350194|P1|Overall Study|Investigator's decision|17
3008837|NCT00883753|10350194|P1|Overall Study|Withdrew consent|10
3008838|NCT00883753|10350194|P1|Overall Study|Refused treatment|4
3008839|NCT00883753|10350194|P1|Overall Study|Protocol Violation|2
3008840|NCT00883753|10350194|P1|Overall Study|Violation of selection criteria at entry|7
3008841|NCT00883753|10350194|P1|Overall Study|Lost to Follow-up|4
3008842|NCT00883753|10350194|P1|Overall Study|Insufficient therapeutic response|16
3008843|NCT00883753|10350194|P1|Overall Study|Death|2
3008844|NCT00883753|10350194|P1|Overall Study|Adverse Event|37
3008845|NCT00883740|10350234|P2|Second Intervention|No longer willing to participate|1
3008846|NCT00883740|10350235|P1|Second Intervention|No longer willing to participate|0
3008847|NCT00883740|10350234|P2|Second Intervention|Protocol Violation|0
3008848|NCT00883740|10350235|P1|Second Intervention|Protocol Violation|1
3008849|NCT00883740|10350234|P2|First Intervention|Adverse Event|2
3008850|NCT00883740|10350235|P1|First Intervention|Adverse Event|1
3008851|NCT00883740|10350234|P2|First Intervention|Protocol Violation|6
3008852|NCT00883740|10350235|P1|First Intervention|Protocol Violation|3
3008853|NCT00883740|10350234|P2|First Intervention|No longer willing to participate|0
3008854|NCT00883740|10350235|P1|First Intervention|No longer willing to participate|2
3008855|NCT00883740|10350234|P2|First Intervention|Lost to Follow-up|0
3008856|NCT00883740|10350235|P1|First Intervention|Lost to Follow-up|1
3008857|NCT00883558|10350279|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
3008858|NCT00883558|10350280|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
3008859|NCT00883558|10350281|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
3008860|NCT00883558|10350279|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
3008861|NCT00883558|10350280|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
3008862|NCT00883558|10350281|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
3008863|NCT00883558|10350279|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
3008864|NCT00883558|10350280|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
3008865|NCT00883558|10350281|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
3008866|NCT00883558|10350279|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
3008867|NCT00883558|10350280|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
3008868|NCT00883558|10350281|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
3008869|NCT00883558|10350279|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
3008870|NCT00883558|10350280|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
3008871|NCT00883558|10350281|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
3008872|NCT00883493|10350293|P2|Overall Study|Other|3
3008873|NCT00883493|10350294|P1|Overall Study|Other|5
3008874|NCT00883493|10350293|P2|Overall Study|Study specific disc. criteria|0
3008875|NCT00883493|10350294|P1|Overall Study|Study specific disc. criteria|2
3008876|NCT00883493|10350293|P2|Overall Study|Eligibility Criteria not fullfilled|6
3008877|NCT00883493|10350294|P1|Overall Study|Eligibility Criteria not fullfilled|6
3008878|NCT00883493|10350293|P2|Overall Study|Withdrawal by Subject|20
3008879|NCT00883493|10350294|P1|Overall Study|Withdrawal by Subject|11
3008880|NCT00883493|10350293|P2|Overall Study|Lost to Follow-up|6
3008881|NCT00883493|10350294|P1|Overall Study|Lost to Follow-up|7
3008882|NCT00883493|10350293|P2|Overall Study|Lack of Efficacy|3
3008883|NCT00883493|10350294|P1|Overall Study|Lack of Efficacy|4
3008884|NCT00883493|10350293|P2|Overall Study|Adverse Event|12
3008885|NCT00883493|10350294|P1|Overall Study|Adverse Event|11
3008886|NCT00883337|10350329|P3|Extension Treatment Period|Other than above|5
3008887|NCT00883337|10350330|P2|Extension Treatment Period|Other than above|9
3008888|NCT00883337|10350331|P1|Extension Treatment Period|Other than above|10
3008889|NCT00883337|10350329|P3|Extension Treatment Period|Lost to Follow-up|0
3008890|NCT00883337|10350330|P2|Extension Treatment Period|Lost to Follow-up|0
3008891|NCT00883337|10350331|P1|Extension Treatment Period|Lost to Follow-up|1
3008892|NCT00883337|10350329|P3|Extension Treatment Period|Poor compliance to protocol|1
3008893|NCT00883337|10350330|P2|Extension Treatment Period|Poor compliance to protocol|1
3008894|NCT00883337|10350331|P1|Extension Treatment Period|Poor compliance to protocol|1
3008895|NCT00883337|10350329|P3|Extension Treatment Period|Lack of Efficacy|8
3008896|NCT00883337|10350330|P2|Extension Treatment Period|Lack of Efficacy|8
3008897|NCT00883337|10350331|P1|Extension Treatment Period|Lack of Efficacy|8
3008898|NCT00883337|10350329|P3|Extension Treatment Period|Adverse Event|5
3008899|NCT00883337|10350330|P2|Extension Treatment Period|Adverse Event|5
3008900|NCT00883337|10350331|P1|Extension Treatment Period|Adverse Event|8
3008901|NCT00883337|10350329|P3|Core Treatment Period|Other than above|1
3008902|NCT00883337|10350330|P2|Core Treatment Period|Other than above|1
3008903|NCT00883337|10350331|P1|Core Treatment Period|Other than above|0
3008904|NCT00883337|10350329|P3|Core Treatment Period|Poor compliance to protocol|1
3008905|NCT00883337|10350330|P2|Core Treatment Period|Poor compliance to protocol|0
3008906|NCT00883337|10350331|P1|Core Treatment Period|Poor compliance to protocol|0
3008907|NCT00883337|10350329|P3|Core Treatment Period|Wish to be pregnant|1
3008908|NCT00883337|10350330|P2|Core Treatment Period|Wish to be pregnant|2
3008909|NCT00883337|10350331|P1|Core Treatment Period|Wish to be pregnant|1
3008910|NCT00883337|10350329|P3|Core Treatment Period|Withdrawal by Subject|6
3008911|NCT00883337|10350330|P2|Core Treatment Period|Withdrawal by Subject|2
3008912|NCT00883337|10350331|P1|Core Treatment Period|Withdrawal by Subject|2
3008913|NCT00883337|10350329|P3|Core Treatment Period|Lost to Follow-up|0
3008914|NCT00883337|10350330|P2|Core Treatment Period|Lost to Follow-up|1
3008915|NCT00883337|10350331|P1|Core Treatment Period|Lost to Follow-up|1
3008916|NCT00883337|10350329|P3|Core Treatment Period|Lack of Efficacy|2
3008917|NCT00883337|10350330|P2|Core Treatment Period|Lack of Efficacy|4
3008918|NCT00883337|10350331|P1|Core Treatment Period|Lack of Efficacy|7
3008919|NCT00883337|10350329|P3|Core Treatment Period|Adverse Event|22
3008920|NCT00883337|10350330|P2|Core Treatment Period|Adverse Event|12
3008921|NCT00883337|10350331|P1|Core Treatment Period|Adverse Event|9
3008922|NCT00883181|10350398|P1|Overall Study|Noncompliance|3
3008923|NCT00883181|10350398|P1|Overall Study|Protocol Deviation|3
3008924|NCT00883181|10350398|P1|Overall Study|Other|38
3008925|NCT00883181|10350398|P1|Overall Study|Death|31
3008926|NCT00883181|10350398|P1|Overall Study|Withdrawal by Subject|4
3008927|NCT00883181|10350398|P1|Overall Study|Administrative Reason|24
3008928|NCT00883181|10350398|P1|Overall Study|Disease Progression|94
3008929|NCT00883181|10350398|P1|Overall Study|Non-hematological Adverse Event|55
3008930|NCT00883181|10350398|P1|Overall Study|Hematological Adverse Event|26
3008931|NCT00883129|10350634|P2|Overall Study|Defined Treatment Failure|2
3008932|NCT00883129|10350635|P1|Overall Study|Defined Treatment Failure|0
3008933|NCT00883129|10350634|P2|Overall Study|Death|2
3008934|NCT00883129|10350635|P1|Overall Study|Death|1
3008935|NCT00883129|10350634|P2|Overall Study|Lost to Follow-up|2
3008936|NCT00883129|10350635|P1|Overall Study|Lost to Follow-up|1
3008937|NCT00883129|10350634|P2|Overall Study|Non-compliance|6
3008938|NCT00883129|10350635|P1|Overall Study|Non-compliance|3
3008939|NCT00883129|10350634|P2|Overall Study|Withdrawal by Subject|9
3008940|NCT00883129|10350635|P1|Overall Study|Withdrawal by Subject|8
3008941|NCT00883129|10350634|P2|Overall Study|Adverse Event|15
3008942|NCT00883129|10350635|P1|Overall Study|Adverse Event|7
3008943|NCT00883116|10350659|P2|Overall Study|No longer meets study criteria|2
3008944|NCT00883116|10350660|P1|Overall Study|No longer meets study criteria|2
3008945|NCT00883116|10350659|P2|Overall Study|Withdrawal by Subject|8
3008946|NCT00883116|10350660|P1|Overall Study|Withdrawal by Subject|14
3008947|NCT00883116|10350659|P2|Overall Study|Study drug toxicity|16
3008948|NCT00883116|10350660|P1|Overall Study|Study drug toxicity|36
3008949|NCT00883116|10350659|P2|Overall Study|Not identified|6
3008950|NCT00883116|10350660|P1|Overall Study|Not identified|3
3008951|NCT00883116|10350659|P2|Overall Study|Maximum clinical benefit|46
3008952|NCT00883116|10350660|P1|Overall Study|Maximum clinical benefit|13
3008953|NCT00883116|10350659|P2|Overall Study|Lost to Follow-up|1
3008954|NCT00883116|10350660|P1|Overall Study|Lost to Follow-up|0
3008955|NCT00883116|10350659|P2|Overall Study|Disease progression|128
3008956|NCT00883116|10350660|P1|Overall Study|Disease progression|130
3008957|NCT00883116|10350659|P2|Overall Study|Death|2
3008958|NCT00883116|10350660|P1|Overall Study|Death|6
3008959|NCT00883116|10350659|P2|Overall Study|Adverse event unrelated to study drug|10
3008960|NCT00883116|10350660|P1|Overall Study|Adverse event unrelated to study drug|5
3008961|NCT00883090|10350682|P1|Overall Study|Withdrawal by Subject|1
3008962|NCT00883090|10350682|P1|Overall Study|Sponsor's decision|1
3008963|NCT00883051|10350702|P5|Overall Study|Did not use study medication|17
3008964|NCT00883051|10350703|P4|Overall Study|Did not use study medication|29
3008965|NCT00883051|10350704|P3|Overall Study|Did not use study medication|29
3008966|NCT00883051|10350705|P2|Overall Study|Did not use study medication|22
3008967|NCT00883051|10350706|P1|Overall Study|Did not use study medication|24
3008968|NCT00883051|10350702|P5|Overall Study|Lost to Follow-up|1
3008969|NCT00883051|10350703|P4|Overall Study|Lost to Follow-up|0
3008970|NCT00883051|10350704|P3|Overall Study|Lost to Follow-up|0
3008971|NCT00883051|10350705|P2|Overall Study|Lost to Follow-up|0
3008972|NCT00883051|10350706|P1|Overall Study|Lost to Follow-up|0
3008973|NCT00882999|10350810|P7|Overall Study|Physician Decision|1
3008974|NCT00882999|10350811|P6|Overall Study|Physician Decision|1
3008975|NCT00882999|10350812|P5|Overall Study|Physician Decision|0
3008976|NCT00882999|10350813|P4|Overall Study|Physician Decision|0
3008977|NCT00882999|10350814|P3|Overall Study|Physician Decision|0
3008978|NCT00882999|10350815|P2|Overall Study|Physician Decision|0
3008979|NCT00882999|10350816|P1|Overall Study|Physician Decision|1
3008980|NCT00882999|10350810|P7|Overall Study|Lost to Follow-up|2
3008981|NCT00882999|10350811|P6|Overall Study|Lost to Follow-up|1
3008982|NCT00882999|10350812|P5|Overall Study|Lost to Follow-up|1
3008983|NCT00882999|10350813|P4|Overall Study|Lost to Follow-up|2
3008984|NCT00882999|10350814|P3|Overall Study|Lost to Follow-up|1
3008985|NCT00882999|10350815|P2|Overall Study|Lost to Follow-up|1
3008986|NCT00882999|10350816|P1|Overall Study|Lost to Follow-up|0
3008987|NCT00882999|10350810|P7|Overall Study|Withdrawal by Subject|5
3008988|NCT00882999|10350811|P6|Overall Study|Withdrawal by Subject|5
3008989|NCT00882999|10350812|P5|Overall Study|Withdrawal by Subject|6
3008990|NCT00882999|10350813|P4|Overall Study|Withdrawal by Subject|3
3008991|NCT00882999|10350814|P3|Overall Study|Withdrawal by Subject|3
3008992|NCT00882999|10350815|P2|Overall Study|Withdrawal by Subject|6
3008993|NCT00882999|10350816|P1|Overall Study|Withdrawal by Subject|7
3008994|NCT00882999|10350810|P7|Overall Study|Death|0
3008995|NCT00882999|10350811|P6|Overall Study|Death|0
3008996|NCT00882999|10350812|P5|Overall Study|Death|0
3008997|NCT00882999|10350813|P4|Overall Study|Death|0
3008998|NCT00882999|10350814|P3|Overall Study|Death|0
3008999|NCT00882999|10350815|P2|Overall Study|Death|1
3009000|NCT00882999|10350816|P1|Overall Study|Death|0
3009001|NCT00882999|10350810|P7|Overall Study|Adverse Event|0
3009002|NCT00882999|10350811|P6|Overall Study|Adverse Event|0
3009003|NCT00882999|10350812|P5|Overall Study|Adverse Event|1
3009004|NCT00882999|10350813|P4|Overall Study|Adverse Event|0
3009005|NCT00882999|10350814|P3|Overall Study|Adverse Event|0
3009006|NCT00882999|10350815|P2|Overall Study|Adverse Event|0
3009007|NCT00882999|10350816|P1|Overall Study|Adverse Event|0
3009008|NCT00882921|10350943|P1|Overall Study|Withdrawal Of Consent|1
3009009|NCT00882921|10350943|P1|Overall Study|Termination By Investigator|3
3009010|NCT00882921|10350943|P1|Overall Study|Lost to Follow-up|2
3009011|NCT00882921|10350943|P1|Overall Study|Other|3
3009012|NCT00882921|10350943|P1|Overall Study|Death|2
3009013|NCT00882908|10350953|P5|Overall Study|Study terminated in error|0
3009014|NCT00882908|10350954|P4|Overall Study|Study terminated in error|1
3009015|NCT00882908|10350955|P3|Overall Study|Study terminated in error|0
3009016|NCT00882908|10350956|P2|Overall Study|Study terminated in error|0
3009017|NCT00882908|10350957|P1|Overall Study|Study terminated in error|0
3009018|NCT00882908|10350953|P5|Overall Study|Subject reached a virologic endpoint|1
3009019|NCT00882908|10350954|P4|Overall Study|Subject reached a virologic endpoint|0
3009020|NCT00882908|10350955|P3|Overall Study|Subject reached a virologic endpoint|0
3009021|NCT00882908|10350956|P2|Overall Study|Subject reached a virologic endpoint|0
3009022|NCT00882908|10350957|P1|Overall Study|Subject reached a virologic endpoint|0
3009023|NCT00882908|10350953|P5|Overall Study|Withdrawal by Subject|2
3009024|NCT00882908|10350954|P4|Overall Study|Withdrawal by Subject|5
3009025|NCT00882908|10350955|P3|Overall Study|Withdrawal by Subject|3
3009026|NCT00882908|10350956|P2|Overall Study|Withdrawal by Subject|0
3009027|NCT00882908|10350957|P1|Overall Study|Withdrawal by Subject|0
3009028|NCT00882908|10350953|P5|Overall Study|Protocol Violation|0
3009029|NCT00882908|10350954|P4|Overall Study|Protocol Violation|0
3009030|NCT00882908|10350955|P3|Overall Study|Protocol Violation|0
3009031|NCT00882908|10350956|P2|Overall Study|Protocol Violation|1
3009032|NCT00882908|10350957|P1|Overall Study|Protocol Violation|0
3009033|NCT00882908|10350953|P5|Overall Study|Lost to Follow-up|2
3009034|NCT00882908|10350954|P4|Overall Study|Lost to Follow-up|1
3009035|NCT00882908|10350955|P3|Overall Study|Lost to Follow-up|3
3009036|NCT00882908|10350956|P2|Overall Study|Lost to Follow-up|5
3009037|NCT00882908|10350957|P1|Overall Study|Lost to Follow-up|3
3009038|NCT00882908|10350953|P5|Overall Study|Adverse Event|1
3009039|NCT00882908|10350954|P4|Overall Study|Adverse Event|0
3009040|NCT00882908|10350955|P3|Overall Study|Adverse Event|1
3009041|NCT00882908|10350956|P2|Overall Study|Adverse Event|0
3009042|NCT00882908|10350957|P1|Overall Study|Adverse Event|0
3009043|NCT00882713|10351063|P1|Overall Study|Other - Reasons|2
3009044|NCT00882713|10351063|P1|Overall Study|Failure to return|2
3009045|NCT00882713|10351063|P1|Overall Study|Insufficient therapeutic response|3
3009046|NCT00882713|10351063|P1|Overall Study|Blood transfusion|2
3009047|NCT00882713|10351063|P1|Overall Study|refused treatment/withdrew consent|4
3009048|NCT00882713|10351063|P1|Overall Study|Administrative reasons|4
3009049|NCT00882713|10351063|P1|Overall Study|Death|3
3009050|NCT00882713|10351063|P1|Overall Study|Adverse Event|2
3009051|NCT00882583|10351156|P2|Overall Study|Adverse Event|1
3009052|NCT00882583|10351157|P1|Overall Study|Adverse Event|0
3009053|NCT00882583|10351156|P2|Overall Study|Physician Decision|0
3009054|NCT00882583|10351157|P1|Overall Study|Physician Decision|1
3009055|NCT00882557|10351165|P2|Overall Study|Randomized Not Treated|1
3009056|NCT00882557|10351166|P1|Overall Study|Randomized Not Treated|0
3009057|NCT00882557|10351165|P2|Overall Study|Trouble with Vein Access|0
3009058|NCT00882557|10351166|P1|Overall Study|Trouble with Vein Access|1
3009059|NCT00882557|10351165|P2|Overall Study|Withdrawal by Subject|0
3009060|NCT00882557|10351166|P1|Overall Study|Withdrawal by Subject|1
3009061|NCT00882518|10351186|P2|Overall Study|Allocating random number by mistake|1
3009062|NCT00882518|10351187|P1|Overall Study|Allocating random number by mistake|0
3009063|NCT00882518|10351186|P2|Overall Study|Central lab closure for National day|0
3009064|NCT00882518|10351187|P1|Overall Study|Central lab closure for National day|1
3009065|NCT00882518|10351186|P2|Overall Study|Incorrect enrolment|2
3009066|NCT00882518|10351187|P1|Overall Study|Incorrect enrolment|4
3009067|NCT00882518|10351186|P2|Overall Study|Severe non-compliance to protocol|1
3009068|NCT00882518|10351187|P1|Overall Study|Severe non-compliance to protocol|3
3009069|NCT00882518|10351186|P2|Overall Study|Lack of Efficacy|9
3009070|NCT00882518|10351187|P1|Overall Study|Lack of Efficacy|12
3009071|NCT00882518|10351186|P2|Overall Study|Withdrawal by Subject|13
3009072|NCT00882518|10351187|P1|Overall Study|Withdrawal by Subject|9
3009073|NCT00882518|10351186|P2|Overall Study|Adverse Event|18
3009074|NCT00882518|10351187|P1|Overall Study|Adverse Event|9
3009075|NCT00882440|10351216|P7|Overall Study|Patient Uncooperative|0
3009076|NCT00882440|10351217|P6|Overall Study|Patient Uncooperative|0
3009077|NCT00882440|10351218|P5|Overall Study|Patient Uncooperative|1
3009078|NCT00882440|10351219|P4|Overall Study|Patient Uncooperative|0
3009079|NCT00882440|10351220|P3|Overall Study|Patient Uncooperative|0
3009080|NCT00882440|10351221|P2|Overall Study|Patient Uncooperative|0
3009081|NCT00882440|10351222|P1|Overall Study|Patient Uncooperative|2
3009082|NCT00882440|10351216|P7|Overall Study|Withdrawal by Subject|1
3009083|NCT00882440|10351217|P6|Overall Study|Withdrawal by Subject|0
3009084|NCT00882440|10351218|P5|Overall Study|Withdrawal by Subject|6
3009085|NCT00882440|10351219|P4|Overall Study|Withdrawal by Subject|0
3009086|NCT00882440|10351220|P3|Overall Study|Withdrawal by Subject|1
3009087|NCT00882440|10351221|P2|Overall Study|Withdrawal by Subject|1
3009088|NCT00882440|10351222|P1|Overall Study|Withdrawal by Subject|2
3009089|NCT00882440|10351216|P7|Overall Study|Protocol Violation|0
3009090|NCT00882440|10351217|P6|Overall Study|Protocol Violation|0
3009091|NCT00882440|10351218|P5|Overall Study|Protocol Violation|1
3009092|NCT00882440|10351219|P4|Overall Study|Protocol Violation|1
3009093|NCT00882440|10351220|P3|Overall Study|Protocol Violation|1
3009094|NCT00882440|10351221|P2|Overall Study|Protocol Violation|0
3009095|NCT00882440|10351222|P1|Overall Study|Protocol Violation|0
3009096|NCT00882440|10351216|P7|Overall Study|Lost to Follow-up|1
3009097|NCT00882440|10351217|P6|Overall Study|Lost to Follow-up|0
3009098|NCT00882440|10351218|P5|Overall Study|Lost to Follow-up|1
3009099|NCT00882440|10351219|P4|Overall Study|Lost to Follow-up|1
3009100|NCT00882440|10351220|P3|Overall Study|Lost to Follow-up|1
3009101|NCT00882440|10351221|P2|Overall Study|Lost to Follow-up|0
3009102|NCT00882440|10351222|P1|Overall Study|Lost to Follow-up|2
3009103|NCT00882440|10351216|P7|Overall Study|Lack of Efficacy|0
3009104|NCT00882440|10351217|P6|Overall Study|Lack of Efficacy|3
3009105|NCT00882440|10351218|P5|Overall Study|Lack of Efficacy|0
3009106|NCT00882440|10351219|P4|Overall Study|Lack of Efficacy|0
3009107|NCT00882440|10351220|P3|Overall Study|Lack of Efficacy|2
3009108|NCT00882440|10351221|P2|Overall Study|Lack of Efficacy|5
3009109|NCT00882440|10351222|P1|Overall Study|Lack of Efficacy|3
3009110|NCT00882440|10351216|P7|Overall Study|Adverse Event|2
3009111|NCT00882440|10351217|P6|Overall Study|Adverse Event|4
3009112|NCT00882440|10351218|P5|Overall Study|Adverse Event|1
3009113|NCT00882440|10351219|P4|Overall Study|Adverse Event|1
3009114|NCT00882440|10351220|P3|Overall Study|Adverse Event|2
3009115|NCT00882440|10351221|P2|Overall Study|Adverse Event|2
3009116|NCT00882440|10351222|P1|Overall Study|Adverse Event|2
3009117|NCT00882362|10351247|P2|Overall Study|change of residence or other commitments|0
3009118|NCT00882362|10351248|P1|Overall Study|change of residence or other commitments|5
3009119|NCT00882362|10351247|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
3009120|NCT00882362|10351248|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
3009121|NCT00882362|10351247|P2|Overall Study|Physician Decision|1
3009122|NCT00882362|10351248|P1|Overall Study|Physician Decision|5
3009123|NCT00882362|10351247|P2|Overall Study|Pregnancy|0
3009124|NCT00882362|10351248|P1|Overall Study|Pregnancy|1
3009125|NCT00882362|10351247|P2|Overall Study|Protocol Violation|2
3009126|NCT00882362|10351248|P1|Overall Study|Protocol Violation|7
3009127|NCT00882362|10351247|P2|Overall Study|Lack of Efficacy|0
3009128|NCT00882362|10351248|P1|Overall Study|Lack of Efficacy|3
3009129|NCT00882362|10351247|P2|Overall Study|Withdrawal by Subject|10
3009130|NCT00882362|10351248|P1|Overall Study|Withdrawal by Subject|13
3009131|NCT00882362|10351247|P2|Overall Study|Adverse Event|10
3009132|NCT00882362|10351248|P1|Overall Study|Adverse Event|13
3009133|NCT00882310|10351254|P1|Overall Study|Adverse Event|1
3009134|NCT00882310|10351254|P1|Overall Study|Progression of disease|4
3009135|NCT00882310|10351254|P1|Overall Study|Death|6
3009136|NCT00882310|10351254|P1|Overall Study|Never received treatment|1
3009137|NCT00882310|10351254|P1|Overall Study|Screen Failure|10
3009138|NCT00882115|10351267|P1|Overall Study|did not respond to DEP challe|6
3009139|NCT00882115|10351267|P1|Overall Study|Withdrawal by Subject|3
3009140|NCT00881959|10351277|P2|Overall Study|Lost to Follow-up|4
3009141|NCT00881959|10351278|P1|Overall Study|Lost to Follow-up|2
3009142|NCT00881894|10351286|P2|Overall Study|Other reasons for premature termination|2
3009143|NCT00881894|10351287|P1|Overall Study|Other reasons for premature termination|1
3009144|NCT00881894|10351286|P2|Overall Study|Consent withdrawn|1
3009145|NCT00881894|10351287|P1|Overall Study|Consent withdrawn|0
3009146|NCT00881868|10351319|P2|Overall Study|Protocol Violation|0
3009147|NCT00881868|10351320|P1|Overall Study|Protocol Violation|2
3009148|NCT00881868|10351319|P2|Overall Study|Physician Decision|0
3009149|NCT00881868|10351320|P1|Overall Study|Physician Decision|4
3009150|NCT00881868|10351319|P2|Overall Study|Lost to Follow-up|1
3009151|NCT00881868|10351320|P1|Overall Study|Lost to Follow-up|2
3009152|NCT00881868|10351319|P2|Overall Study|Adverse Event|1
3009153|NCT00881868|10351320|P1|Overall Study|Adverse Event|0
3009154|NCT00881751|10351334|P2|Overall Study|Withdrawal by Subject|2
3009155|NCT00881751|10351335|P1|Overall Study|Withdrawal by Subject|0
3009156|NCT00881751|10351334|P2|Overall Study|Adverse Event|2
3009157|NCT00881751|10351335|P1|Overall Study|Adverse Event|0
3009158|NCT00881751|10351334|P2|Overall Study|Physician Decision|1
3009159|NCT00881751|10351335|P1|Overall Study|Physician Decision|0
3009160|NCT00881712|10351350|P3|Overall Study|Withdrawal by Subject|0
3009161|NCT00881712|10351351|P2|Overall Study|Withdrawal by Subject|0
3009162|NCT00881712|10351352|P1|Overall Study|Withdrawal by Subject|1
3009163|NCT00881712|10351350|P3|Overall Study|Death|0
3009164|NCT00881712|10351351|P2|Overall Study|Death|0
3009165|NCT00881712|10351352|P1|Overall Study|Death|1
3009166|NCT00881621|10351385|P1|Overall Study|Physician Decision|34
3009167|NCT00881608|10351397|P1|Overall Study|Study prematurely terminated|11
3009168|NCT00881530|10351420|P6|Overall Study|Other reason not defined above|2
3009169|NCT00881530|10351421|P5|Overall Study|Other reason not defined above|0
3009170|NCT00881530|10351422|P4|Overall Study|Other reason not defined above|0
3009171|NCT00881530|10351423|P3|Overall Study|Other reason not defined above|2
3009172|NCT00881530|10351424|P2|Overall Study|Other reason not defined above|1
3009173|NCT00881530|10351425|P1|Overall Study|Other reason not defined above|1
3009174|NCT00881530|10351420|P6|Overall Study|Refused to continue medication|0
3009175|NCT00881530|10351421|P5|Overall Study|Refused to continue medication|0
3009176|NCT00881530|10351422|P4|Overall Study|Refused to continue medication|2
3009177|NCT00881530|10351423|P3|Overall Study|Refused to continue medication|1
3009178|NCT00881530|10351424|P2|Overall Study|Refused to continue medication|2
3009179|NCT00881530|10351425|P1|Overall Study|Refused to continue medication|7
3009180|NCT00881530|10351420|P6|Overall Study|Lost to Follow-up|0
3009181|NCT00881530|10351421|P5|Overall Study|Lost to Follow-up|1
3009182|NCT00881530|10351422|P4|Overall Study|Lost to Follow-up|3
3009183|NCT00881530|10351423|P3|Overall Study|Lost to Follow-up|1
3009184|NCT00881530|10351424|P2|Overall Study|Lost to Follow-up|1
3009185|NCT00881530|10351425|P1|Overall Study|Lost to Follow-up|0
3009186|NCT00881530|10351420|P6|Overall Study|Not compliant with the protocol|0
3009187|NCT00881530|10351421|P5|Overall Study|Not compliant with the protocol|2
3009188|NCT00881530|10351422|P4|Overall Study|Not compliant with the protocol|0
3009189|NCT00881530|10351423|P3|Overall Study|Not compliant with the protocol|0
3009190|NCT00881530|10351424|P2|Overall Study|Not compliant with the protocol|0
3009191|NCT00881530|10351425|P1|Overall Study|Not compliant with the protocol|0
3009192|NCT00881530|10351420|P6|Overall Study|Lack of Efficacy|1
3009193|NCT00881530|10351421|P5|Overall Study|Lack of Efficacy|1
3009194|NCT00881530|10351422|P4|Overall Study|Lack of Efficacy|0
3009195|NCT00881530|10351423|P3|Overall Study|Lack of Efficacy|0
3009196|NCT00881530|10351424|P2|Overall Study|Lack of Efficacy|0
3009197|NCT00881530|10351425|P1|Overall Study|Lack of Efficacy|1
3009198|NCT00881530|10351420|P6|Overall Study|Adverse Event|2
3009199|NCT00881530|10351421|P5|Overall Study|Adverse Event|10
3009200|NCT00881530|10351422|P4|Overall Study|Adverse Event|4
3009201|NCT00881530|10351423|P3|Overall Study|Adverse Event|1
3009202|NCT00881530|10351424|P2|Overall Study|Adverse Event|1
3009203|NCT00881530|10351425|P1|Overall Study|Adverse Event|5
3009204|NCT00881504|10351481|P1|Overall Study|Withdrawal by Subject|1
3009205|NCT00881361|10351501|P3|Overall Study|Ineligible|2
3009206|NCT00881361|10351502|P2|Overall Study|Ineligible|2
3009207|NCT00881361|10351503|P1|Overall Study|Ineligible|17
3009208|NCT00881361|10351501|P3|Overall Study|Terminated prior to surgery|0
3009209|NCT00881361|10351502|P2|Overall Study|Terminated prior to surgery|7
3009210|NCT00881361|10351503|P1|Overall Study|Terminated prior to surgery|27
3009211|NCT00881335|10351518|P2|Overall Study|Lost to Follow-up|2
3009212|NCT00881335|10351519|P1|Overall Study|Lost to Follow-up|3
3009213|NCT00881205|10351539|P2|Overall Study|Condition no longer requires drug|0
3009214|NCT00881205|10351540|P1|Overall Study|Condition no longer requires drug|1
3009215|NCT00881205|10351539|P2|Overall Study|Administrative problems|1
3009216|NCT00881205|10351540|P1|Overall Study|Administrative problems|1
3009217|NCT00881205|10351539|P2|Overall Study|Lost to Follow-up|1
3009218|NCT00881205|10351540|P1|Overall Study|Lost to Follow-up|0
3009219|NCT00881205|10351539|P2|Overall Study|Withdrawal by Subject|2
3009220|NCT00881205|10351540|P1|Overall Study|Withdrawal by Subject|1
3009221|NCT00881205|10351539|P2|Overall Study|Adverse Event|3
3009222|NCT00881205|10351540|P1|Overall Study|Adverse Event|8
3009223|NCT00880906|10351608|P2|Overall Study|Did not meet criteria following patholog|6
3009224|NCT00880906|10351609|P1|Overall Study|Did not meet criteria following patholog|12
3009225|NCT00880906|10351608|P2|Overall Study|Lost to Follow-up|1
3009226|NCT00880906|10351609|P1|Overall Study|Lost to Follow-up|0
3009227|NCT00880893|10351619|P2|Overall Study|Serious adverse event|0
3009228|NCT00880893|10351620|P1|Overall Study|Serious adverse event|3
3009229|NCT00880893|10351619|P2|Overall Study|Lost to Follow-up|33
3009230|NCT00880893|10351620|P1|Overall Study|Lost to Follow-up|76
3009231|NCT00880893|10351619|P2|Overall Study|Withdrawal by Subject|11
3009232|NCT00880893|10351620|P1|Overall Study|Withdrawal by Subject|15
3009233|NCT00880893|10351619|P2|Overall Study|Protocol Violation|1
3009234|NCT00880893|10351620|P1|Overall Study|Protocol Violation|13
3009235|NCT00880763|10351672|P4|Extension Period (Part 2)|Lack of Efficacy|1
3009236|NCT00880763|10351673|P3|Extension Period (Part 2)|Lack of Efficacy|0
3009237|NCT00880763|10351674|P2|Extension Period (Part 2)|Lack of Efficacy|0
3009238|NCT00880763|10351675|P1|Extension Period (Part 2)|Lack of Efficacy|0
3009239|NCT00880763|10351672|P4|Extension Period (Part 2)|Physician Decision|0
3009240|NCT00880763|10351673|P3|Extension Period (Part 2)|Physician Decision|1
3009241|NCT00880763|10351674|P2|Extension Period (Part 2)|Physician Decision|1
3009242|NCT00880763|10351675|P1|Extension Period (Part 2)|Physician Decision|0
3009243|NCT00880763|10351672|P4|Extension Period (Part 2)|Withdrawal by Subject|1
3009244|NCT00880763|10351673|P3|Extension Period (Part 2)|Withdrawal by Subject|1
3009245|NCT00880763|10351674|P2|Extension Period (Part 2)|Withdrawal by Subject|2
3009246|NCT00880763|10351675|P1|Extension Period (Part 2)|Withdrawal by Subject|0
3009247|NCT00880763|10351672|P4|Extension Period (Part 2)|Adverse Event|1
3009248|NCT00880763|10351673|P3|Extension Period (Part 2)|Adverse Event|1
3009249|NCT00880763|10351674|P2|Extension Period (Part 2)|Adverse Event|0
3009250|NCT00880763|10351675|P1|Extension Period (Part 2)|Adverse Event|0
3009251|NCT00880750|10351707|P2|Second Intervention|Unable to collect urine|0
3009252|NCT00880750|10351708|P1|Second Intervention|Unable to collect urine|1
3009253|NCT00880750|10351707|P2|Second Intervention|Protocol Violation|0
3009254|NCT00880750|10351708|P1|Second Intervention|Protocol Violation|1
3009255|NCT00880750|10351707|P2|Second Intervention|Withdrawal by Subject|2
3009256|NCT00880750|10351708|P1|Second Intervention|Withdrawal by Subject|2
3009257|NCT00880750|10351707|P2|First Intervention|Lost to Follow-up|0
3009258|NCT00880750|10351708|P1|First Intervention|Lost to Follow-up|2
3009259|NCT00880750|10351707|P2|First Intervention|Withdrawal by Subject|0
3009260|NCT00880750|10351708|P1|First Intervention|Withdrawal by Subject|2
3009261|NCT00880750|10351707|P2|First Intervention|Non-compliance with meals|1
3009262|NCT00880750|10351708|P1|First Intervention|Non-compliance with meals|0
3009263|NCT00880750|10351707|P2|First Intervention|Unable to collect urine|0
3009264|NCT00880750|10351708|P1|First Intervention|Unable to collect urine|4
3009265|NCT00880750|10351707|P2|First Intervention|Adverse Event|0
3009266|NCT00880750|10351708|P1|First Intervention|Adverse Event|1
3009267|NCT00880698|10351726|P4|Overall Study|Lost to Follow-up|1
3009268|NCT00880698|10351727|P3|Overall Study|Lost to Follow-up|0
3009269|NCT00880698|10351728|P2|Overall Study|Lost to Follow-up|3
3009270|NCT00880698|10351729|P1|Overall Study|Lost to Follow-up|1
3009271|NCT00880698|10351726|P4|Overall Study|Death|2
3009272|NCT00880698|10351727|P3|Overall Study|Death|1
3009273|NCT00880698|10351728|P2|Overall Study|Death|0
3009274|NCT00880698|10351729|P1|Overall Study|Death|0
3009275|NCT00880685|10351755|P1|Memantine 20mg|Withdrawal by Subject|1
3009276|NCT00880685|10351755|P1|Memantine 10mg|Lost to Follow-up|2
3009277|NCT00880620|10351767|P4|Overall Study|Other|2
3009278|NCT00880620|10351768|P3|Overall Study|Other|2
3009279|NCT00880620|10351769|P2|Overall Study|Other|1
3009280|NCT00880620|10351770|P1|Overall Study|Other|1
3009281|NCT00880620|10351767|P4|Overall Study|Noncompliance|1
3009282|NCT00880620|10351768|P3|Overall Study|Noncompliance|1
3009283|NCT00880620|10351769|P2|Overall Study|Noncompliance|0
3009284|NCT00880620|10351770|P1|Overall Study|Noncompliance|0
3009285|NCT00880620|10351767|P4|Overall Study|Withdrawal by Subject|3
3009286|NCT00880620|10351768|P3|Overall Study|Withdrawal by Subject|1
3009287|NCT00880620|10351769|P2|Overall Study|Withdrawal by Subject|3
3009288|NCT00880620|10351770|P1|Overall Study|Withdrawal by Subject|4
3009289|NCT00880620|10351767|P4|Overall Study|Protocol Violation|2
3009290|NCT00880620|10351768|P3|Overall Study|Protocol Violation|0
3009291|NCT00880620|10351769|P2|Overall Study|Protocol Violation|1
3009292|NCT00880620|10351770|P1|Overall Study|Protocol Violation|0
3009293|NCT00880620|10351767|P4|Overall Study|Lost to Follow-up|0
3009294|NCT00880620|10351768|P3|Overall Study|Lost to Follow-up|1
3009295|NCT00880620|10351769|P2|Overall Study|Lost to Follow-up|1
3009296|NCT00880620|10351770|P1|Overall Study|Lost to Follow-up|0
3009297|NCT00880620|10351767|P4|Overall Study|Lack of Efficacy|1
3009298|NCT00880620|10351768|P3|Overall Study|Lack of Efficacy|0
3009299|NCT00880620|10351769|P2|Overall Study|Lack of Efficacy|4
3009300|NCT00880620|10351770|P1|Overall Study|Lack of Efficacy|12
3009301|NCT00880620|10351767|P4|Overall Study|Death|0
3009302|NCT00880620|10351768|P3|Overall Study|Death|1
3009303|NCT00880620|10351769|P2|Overall Study|Death|0
3009304|NCT00880620|10351770|P1|Overall Study|Death|0
3009305|NCT00880620|10351767|P4|Overall Study|Adverse Event|15
3009306|NCT00880620|10351768|P3|Overall Study|Adverse Event|15
3009307|NCT00880620|10351769|P2|Overall Study|Adverse Event|5
3009308|NCT00880620|10351770|P1|Overall Study|Adverse Event|4
3009309|NCT00880607|10351786|P2|Overall Study|surgery did not extend past L1 level|0
3009310|NCT00880607|10351787|P1|Overall Study|surgery did not extend past L1 level|3
3009311|NCT00880607|10351786|P2|Overall Study|Protocol Violation|1
3009312|NCT00880607|10351787|P1|Overall Study|Protocol Violation|2
3009313|NCT00880607|10351786|P2|Overall Study|Physician Decision|2
3009314|NCT00880607|10351787|P1|Overall Study|Physician Decision|2
3009315|NCT00880568|10351819|P9|Overall Study|Withdrawal by Subject|0
3009316|NCT00880568|10351820|P8|Overall Study|Withdrawal by Subject|1
3009317|NCT00880568|10351821|P7|Overall Study|Withdrawal by Subject|0
3009318|NCT00880568|10351822|P6|Overall Study|Withdrawal by Subject|0
3009319|NCT00880568|10351823|P5|Overall Study|Withdrawal by Subject|0
3009320|NCT00880568|10351824|P4|Overall Study|Withdrawal by Subject|0
3009321|NCT00880568|10351825|P3|Overall Study|Withdrawal by Subject|0
3009322|NCT00880568|10351826|P2|Overall Study|Withdrawal by Subject|0
3009323|NCT00880568|10351827|P1|Overall Study|Withdrawal by Subject|0
3009324|NCT00880568|10351819|P9|Overall Study|Adverse Event|0
3009325|NCT00880568|10351820|P8|Overall Study|Adverse Event|1
3009326|NCT00880568|10351821|P7|Overall Study|Adverse Event|1
3009327|NCT00880568|10351822|P6|Overall Study|Adverse Event|0
3009328|NCT00880568|10351823|P5|Overall Study|Adverse Event|0
3009329|NCT00880568|10351824|P4|Overall Study|Adverse Event|0
3009330|NCT00880568|10351825|P3|Overall Study|Adverse Event|0
3009331|NCT00880568|10351826|P2|Overall Study|Adverse Event|0
3009332|NCT00880568|10351827|P1|Overall Study|Adverse Event|0
3009333|NCT00880568|10351819|P9|Overall Study|Disease progression|3
3009334|NCT00880568|10351820|P8|Overall Study|Disease progression|0
3009335|NCT00880568|10351821|P7|Overall Study|Disease progression|5
3009336|NCT00880568|10351822|P6|Overall Study|Disease progression|3
3009337|NCT00880568|10351823|P5|Overall Study|Disease progression|3
3009338|NCT00880568|10351824|P4|Overall Study|Disease progression|1
3009339|NCT00880568|10351825|P3|Overall Study|Disease progression|3
3009340|NCT00880568|10351826|P2|Overall Study|Disease progression|3
3009341|NCT00880568|10351827|P1|Overall Study|Disease progression|3
3009342|NCT00880555|10351873|P6|Overall Study|Lost to Follow-up|0
3009343|NCT00880555|10351874|P5|Overall Study|Lost to Follow-up|0
3009344|NCT00880555|10351875|P4|Overall Study|Lost to Follow-up|0
3009345|NCT00880555|10351876|P3|Overall Study|Lost to Follow-up|0
3009346|NCT00880555|10351877|P2|Overall Study|Lost to Follow-up|1
3009347|NCT00880555|10351878|P1|Overall Study|Lost to Follow-up|0
3009348|NCT00880555|10351873|P6|Overall Study|Death|1
3009349|NCT00880555|10351874|P5|Overall Study|Death|0
3009350|NCT00880555|10351875|P4|Overall Study|Death|0
3009351|NCT00880555|10351876|P3|Overall Study|Death|0
3009352|NCT00880555|10351877|P2|Overall Study|Death|0
3009353|NCT00880555|10351878|P1|Overall Study|Death|0
3009354|NCT00880555|10351873|P6|Overall Study|Lack of resources (hired rater)|0
3009355|NCT00880555|10351874|P5|Overall Study|Lack of resources (hired rater)|0
3009356|NCT00880555|10351875|P4|Overall Study|Lack of resources (hired rater)|0
3009357|NCT00880555|10351876|P3|Overall Study|Lack of resources (hired rater)|5
3009358|NCT00880555|10351877|P2|Overall Study|Lack of resources (hired rater)|7
3009359|NCT00880555|10351878|P1|Overall Study|Lack of resources (hired rater)|9
3009360|NCT00880555|10351873|P6|Overall Study|Withdrawal by Subject|0
3009361|NCT00880555|10351874|P5|Overall Study|Withdrawal by Subject|0
3009362|NCT00880555|10351875|P4|Overall Study|Withdrawal by Subject|0
3009363|NCT00880555|10351876|P3|Overall Study|Withdrawal by Subject|0
3009364|NCT00880555|10351877|P2|Overall Study|Withdrawal by Subject|1
3009365|NCT00880555|10351878|P1|Overall Study|Withdrawal by Subject|1
3009366|NCT00880555|10351873|P6|Overall Study|Physician Decision|0
3009367|NCT00880555|10351874|P5|Overall Study|Physician Decision|1
3009368|NCT00880555|10351875|P4|Overall Study|Physician Decision|2
3009369|NCT00880555|10351876|P3|Overall Study|Physician Decision|0
3009370|NCT00880555|10351877|P2|Overall Study|Physician Decision|8
3009371|NCT00880555|10351878|P1|Overall Study|Physician Decision|0
3009372|NCT00880542|10351889|P1|REP: Surgical Resection|progressive disease|1
3009373|NCT00880542|10351889|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
3009374|NCT00880542|10351889|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
3009375|NCT00880399|10351906|P3|Overall Study|Withdrawal by Subject|3
3009376|NCT00880399|10351907|P2|Overall Study|Withdrawal by Subject|3
3009377|NCT00880399|10351908|P1|Overall Study|Withdrawal by Subject|6
3009378|NCT00880399|10351906|P3|Overall Study|Physician Decision|3
3009379|NCT00880399|10351907|P2|Overall Study|Physician Decision|0
3009380|NCT00880399|10351908|P1|Overall Study|Physician Decision|5
3009381|NCT00880399|10351906|P3|Overall Study|Lost to Follow-up|3
3009382|NCT00880399|10351907|P2|Overall Study|Lost to Follow-up|5
3009383|NCT00880399|10351908|P1|Overall Study|Lost to Follow-up|8
3009384|NCT00880399|10351906|P3|Overall Study|Study closed/terminated|4
3009385|NCT00880399|10351907|P2|Overall Study|Study closed/terminated|7
3009386|NCT00880399|10351908|P1|Overall Study|Study closed/terminated|3
3009387|NCT00880399|10351906|P3|Overall Study|Protocol Violation|6
3009388|NCT00880399|10351907|P2|Overall Study|Protocol Violation|4
3009389|NCT00880399|10351908|P1|Overall Study|Protocol Violation|4
3009390|NCT00880399|10351906|P3|Overall Study|Lack of Efficacy|2
3009391|NCT00880399|10351907|P2|Overall Study|Lack of Efficacy|4
3009392|NCT00880399|10351908|P1|Overall Study|Lack of Efficacy|1
3009393|NCT00880399|10351906|P3|Overall Study|Adverse Event|5
3009394|NCT00880399|10351907|P2|Overall Study|Adverse Event|6
3009395|NCT00880399|10351908|P1|Overall Study|Adverse Event|4
3009396|NCT00880334|10351971|P2|Randomized Phase|Crossover Participants|37
3009397|NCT00880334|10351972|P1|Randomized Phase|Crossover Participants|0
3009398|NCT00880334|10351971|P2|Randomized Phase|Brain Metastasis|1
3009399|NCT00880334|10351972|P1|Randomized Phase|Brain Metastasis|0
3009400|NCT00880334|10351971|P2|Randomized Phase|Inadequate Labs|1
3009401|NCT00880334|10351972|P1|Randomized Phase|Inadequate Labs|1
3009402|NCT00880334|10351971|P2|Randomized Phase|Withdrawal by Subject|1
3009403|NCT00880334|10351972|P1|Randomized Phase|Withdrawal by Subject|2
3009404|NCT00880334|10351971|P2|Randomized Phase|Physician Decision|0
3009405|NCT00880334|10351972|P1|Randomized Phase|Physician Decision|1
3009406|NCT00880269|10351989|P2|Overall Study|Adverse Event|9
3009407|NCT00880269|10351990|P1|Overall Study|Adverse Event|10
3009408|NCT00880269|10351989|P2|Overall Study|Withdrawal by Subject|4
3009409|NCT00880269|10351990|P1|Overall Study|Withdrawal by Subject|3
3009410|NCT00880269|10351989|P2|Overall Study|Lost to Follow-up|1
3009411|NCT00880269|10351990|P1|Overall Study|Lost to Follow-up|0
3009412|NCT00880269|10351989|P2|Overall Study|Death|2
3009413|NCT00880269|10351990|P1|Overall Study|Death|4
3009414|NCT00880269|10351989|P2|Overall Study|New Cancer Therapy|0
3009415|NCT00880269|10351990|P1|Overall Study|New Cancer Therapy|1
3009416|NCT00880269|10351989|P2|Overall Study|Disease Progression|11
3009417|NCT00880269|10351990|P1|Overall Study|Disease Progression|13
3009418|NCT00880269|10351989|P2|Overall Study|Protocol Violation|0
3009419|NCT00880269|10351990|P1|Overall Study|Protocol Violation|1
3009420|NCT00880256|10352006|P1|Overall Study|Lost to Follow-up|28
3009421|NCT00880191|10352033|P2|Overall Study|Hospitalization/efficacy|1
3009422|NCT00880191|10352034|P1|Overall Study|Hospitalization/efficacy|1
3009423|NCT00880191|10352033|P2|Overall Study|Adverse Event|6
3009424|NCT00880191|10352034|P1|Overall Study|Adverse Event|8
3009425|NCT00880191|10352033|P2|Overall Study|Refused further treatment|1
3009426|NCT00880191|10352034|P1|Overall Study|Refused further treatment|4
3009427|NCT00880165|10352054|P2|Overall Study|Lost to follow|15
3009428|NCT00880165|10352055|P1|Overall Study|Lost to follow|9
3009429|NCT00880165|10352054|P2|Overall Study|Required BIPAP or oxygen treatment|4
3009430|NCT00880165|10352055|P1|Overall Study|Required BIPAP or oxygen treatment|12
3009431|NCT00880165|10352054|P2|Overall Study|Not diagnosed with OSA|8
3009432|NCT00880165|10352055|P1|Overall Study|Not diagnosed with OSA|14
3009433|NCT00880165|10352054|P2|Overall Study|Withdrawal by Subject|23
3009434|NCT00880165|10352055|P1|Overall Study|Withdrawal by Subject|27
3009435|NCT00880100|10352065|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
3009436|NCT00880100|10352065|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
3009437|NCT00880100|10352065|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
3009438|NCT00880087|10352078|P2|Overall Study|Lost to Follow-up|2
3009439|NCT00880087|10352079|P1|Overall Study|Lost to Follow-up|0
3009440|NCT00880048|10352094|P3|Overall Study|Study closed/terminated|6
3009441|NCT00880048|10352095|P2|Overall Study|Study closed/terminated|7
3009442|NCT00880048|10352096|P1|Overall Study|Study closed/terminated|9
3009443|NCT00880048|10352094|P3|Overall Study|Withdrawal by Subject|5
3009444|NCT00880048|10352095|P2|Overall Study|Withdrawal by Subject|8
3009445|NCT00880048|10352096|P1|Overall Study|Withdrawal by Subject|5
3009446|NCT00880048|10352094|P3|Overall Study|Physician Decision|7
3009447|NCT00880048|10352095|P2|Overall Study|Physician Decision|1
3009448|NCT00880048|10352096|P1|Overall Study|Physician Decision|1
3009449|NCT00880048|10352094|P3|Overall Study|Lost to Follow-up|5
3009450|NCT00880048|10352095|P2|Overall Study|Lost to Follow-up|6
3009451|NCT00880048|10352096|P1|Overall Study|Lost to Follow-up|6
3009452|NCT00880048|10352094|P3|Overall Study|Protocol Violation|5
3009453|NCT00880048|10352095|P2|Overall Study|Protocol Violation|6
3009454|NCT00880048|10352096|P1|Overall Study|Protocol Violation|4
3009455|NCT00880048|10352094|P3|Overall Study|Lack of Efficacy|2
3009456|NCT00880048|10352095|P2|Overall Study|Lack of Efficacy|2
3009457|NCT00880048|10352096|P1|Overall Study|Lack of Efficacy|1
3009458|NCT00880048|10352094|P3|Overall Study|Adverse Event|5
3009459|NCT00880048|10352095|P2|Overall Study|Adverse Event|3
3009460|NCT00880048|10352096|P1|Overall Study|Adverse Event|2
3009461|NCT00880009|10352163|P1|Overall Study|Protocol Violation|1
3009462|NCT00880009|10352163|P1|Overall Study|Withdrawal by Subject|1
3009463|NCT00880009|10352163|P1|Overall Study|Study terminated by sponsor|14
3009464|NCT00879996|10352187|P2|Overall Study|put on parole|0
3009465|NCT00879996|10352188|P1|Overall Study|put on parole|1
3009466|NCT00879996|10352187|P2|Overall Study|psychiatric problem|1
3009467|NCT00879996|10352188|P1|Overall Study|psychiatric problem|0
3009468|NCT00879996|10352187|P2|Overall Study|Physician Decision|2
3009469|NCT00879996|10352188|P1|Overall Study|Physician Decision|1
3009470|NCT00879996|10352187|P2|Overall Study|non-compliance|4
3009471|NCT00879996|10352188|P1|Overall Study|non-compliance|6
3009472|NCT00879996|10352187|P2|Overall Study|Lost to Follow-up|6
3009473|NCT00879996|10352188|P1|Overall Study|Lost to Follow-up|7
3009474|NCT00879970|10352203|P5|Period 2 Vitamin D Randomization|Death|0
3009475|NCT00879970|10352204|P4|Period 2 Vitamin D Randomization|Death|2
3009476|NCT00879970|10352205|P3|Period 2 Vitamin D Randomization|Death|0
3009477|NCT00879970|10352206|P2|Period 2 Vitamin D Randomization|Death|0
3009478|NCT00879970|10352207|P1|Period 2 Vitamin D Randomization|Death|0
3009479|NCT00879970|10352203|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
3009480|NCT00879970|10352204|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
3009481|NCT00879970|10352205|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
3009482|NCT00879970|10352206|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
3009483|NCT00879970|10352207|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
3009484|NCT00879970|10352203|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
3009485|NCT00879970|10352204|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
3009486|NCT00879970|10352205|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
3009487|NCT00879970|10352206|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
3009488|NCT00879970|10352207|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
3009489|NCT00879970|10352203|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
3009490|NCT00879970|10352204|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
3009491|NCT00879970|10352205|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
3009492|NCT00879970|10352206|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
3009493|NCT00879970|10352207|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
3009494|NCT00879970|10352203|P5|Period 1 TZD Randomization|Death|0
3009495|NCT00879970|10352204|P4|Period 1 TZD Randomization|Death|0
3009496|NCT00879970|10352205|P3|Period 1 TZD Randomization|Death|0
3009497|NCT00879970|10352206|P2|Period 1 TZD Randomization|Death|1
3009498|NCT00879970|10352207|P1|Period 1 TZD Randomization|Death|2
3009499|NCT00879970|10352203|P5|Period 1 TZD Randomization|Lost to Follow-up|0
3009500|NCT00879970|10352204|P4|Period 1 TZD Randomization|Lost to Follow-up|0
3009501|NCT00879970|10352205|P3|Period 1 TZD Randomization|Lost to Follow-up|1
3009502|NCT00879970|10352206|P2|Period 1 TZD Randomization|Lost to Follow-up|0
3009503|NCT00879970|10352207|P1|Period 1 TZD Randomization|Lost to Follow-up|1
3009504|NCT00879970|10352203|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
3009505|NCT00879970|10352204|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
3009506|NCT00879970|10352205|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
3009507|NCT00879970|10352206|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
3009508|NCT00879970|10352207|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
3009509|NCT00879879|10352289|P1|Overall Study|Physician Decision|1
3009510|NCT00879879|10352289|P1|Overall Study|Withdrawal by Subject|1
3009511|NCT00879879|10352289|P1|Overall Study|Death|1
3009512|NCT00879814|10352297|P4|Overall Study|Other|0
3009513|NCT00879814|10352298|P3|Overall Study|Other|1
3009514|NCT00879814|10352299|P2|Overall Study|Other|0
3009515|NCT00879814|10352300|P1|Overall Study|Other|0
3009516|NCT00879814|10352297|P4|Overall Study|Physician Decision|0
3009517|NCT00879814|10352298|P3|Overall Study|Physician Decision|1
3009518|NCT00879814|10352299|P2|Overall Study|Physician Decision|0
3009519|NCT00879814|10352300|P1|Overall Study|Physician Decision|0
3009520|NCT00879814|10352297|P4|Overall Study|Withdrawal by Subject|2
3009521|NCT00879814|10352298|P3|Overall Study|Withdrawal by Subject|1
3009522|NCT00879814|10352299|P2|Overall Study|Withdrawal by Subject|1
3009523|NCT00879814|10352300|P1|Overall Study|Withdrawal by Subject|3
3009524|NCT00879814|10352297|P4|Overall Study|Participant Failed to Return|1
3009525|NCT00879814|10352298|P3|Overall Study|Participant Failed to Return|0
3009526|NCT00879814|10352299|P2|Overall Study|Participant Failed to Return|0
3009527|NCT00879814|10352300|P1|Overall Study|Participant Failed to Return|0
3009528|NCT00879814|10352297|P4|Overall Study|Lost to Follow-up|2
3009529|NCT00879814|10352298|P3|Overall Study|Lost to Follow-up|0
3009530|NCT00879814|10352299|P2|Overall Study|Lost to Follow-up|0
3009531|NCT00879814|10352300|P1|Overall Study|Lost to Follow-up|1
3009532|NCT00879814|10352297|P4|Overall Study|Adverse Event|0
3009533|NCT00879814|10352298|P3|Overall Study|Adverse Event|0
3009534|NCT00879814|10352299|P2|Overall Study|Adverse Event|1
3009535|NCT00879814|10352300|P1|Overall Study|Adverse Event|0
3009536|NCT00879775|10352408|P2|Overall Study|Lost to Follow-up|1
3009537|NCT00879775|10352409|P1|Overall Study|Lost to Follow-up|2
3009538|NCT00879710|10352425|P4|Phase 1 - 6 Weeks|Adverse Event|0
3009539|NCT00879710|10352426|P3|Phase 1 - 6 Weeks|Adverse Event|1
3009540|NCT00879710|10352427|P2|Phase 1 - 6 Weeks|Adverse Event|0
3009541|NCT00879710|10352428|P1|Phase 1 - 6 Weeks|Adverse Event|0
3009542|NCT00879710|10352425|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
3009543|NCT00879710|10352426|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
3009544|NCT00879710|10352427|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
3009545|NCT00879710|10352428|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
3009546|NCT00879697|10352438|P2|Overall Study|Physician Decision|2
3009547|NCT00879697|10352439|P1|Overall Study|Physician Decision|2
3009548|NCT00879684|10352445|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
3009549|NCT00879684|10352446|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
3009550|NCT00879684|10352447|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
3009551|NCT00879684|10352448|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
3009552|NCT00879684|10352449|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
3009553|NCT00879684|10352450|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
3009554|NCT00879684|10352451|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
3009555|NCT00879684|10352445|P7|Stage 2: Expanded Cohort|Progressive Disease|11
3009556|NCT00879684|10352446|P6|Stage 2: Expanded Cohort|Progressive Disease|0
3009557|NCT00879684|10352447|P5|Stage 2: Expanded Cohort|Progressive Disease|0
3009558|NCT00879684|10352448|P4|Stage 2: Expanded Cohort|Progressive Disease|0
3009559|NCT00879684|10352449|P3|Stage 2: Expanded Cohort|Progressive Disease|0
3009560|NCT00879684|10352450|P2|Stage 2: Expanded Cohort|Progressive Disease|0
3009561|NCT00879684|10352451|P1|Stage 2: Expanded Cohort|Progressive Disease|0
3009562|NCT00879684|10352445|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
3009563|NCT00879684|10352446|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009564|NCT00879684|10352447|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009565|NCT00879684|10352448|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009566|NCT00879684|10352449|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009567|NCT00879684|10352450|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009568|NCT00879684|10352451|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
3009569|NCT00879684|10352445|P7|Stage 1: Dose Escalation|Death|0
3009570|NCT00879684|10352446|P6|Stage 1: Dose Escalation|Death|0
3009571|NCT00879684|10352447|P5|Stage 1: Dose Escalation|Death|0
3009572|NCT00879684|10352448|P4|Stage 1: Dose Escalation|Death|0
3009573|NCT00879684|10352449|P3|Stage 1: Dose Escalation|Death|1
3009574|NCT00879684|10352450|P2|Stage 1: Dose Escalation|Death|0
3009575|NCT00879684|10352451|P1|Stage 1: Dose Escalation|Death|0
3009576|NCT00879684|10352445|P7|Stage 1: Dose Escalation|Investigator declined participation|0
3009577|NCT00879684|10352446|P6|Stage 1: Dose Escalation|Investigator declined participation|0
3009578|NCT00879684|10352447|P5|Stage 1: Dose Escalation|Investigator declined participation|0
3009579|NCT00879684|10352448|P4|Stage 1: Dose Escalation|Investigator declined participation|2
3009580|NCT00879684|10352449|P3|Stage 1: Dose Escalation|Investigator declined participation|2
3009581|NCT00879684|10352450|P2|Stage 1: Dose Escalation|Investigator declined participation|0
3009582|NCT00879684|10352451|P1|Stage 1: Dose Escalation|Investigator declined participation|0
3009583|NCT00879684|10352445|P7|Stage 1: Dose Escalation|Progressive Disease|0
3009584|NCT00879684|10352446|P6|Stage 1: Dose Escalation|Progressive Disease|3
3009585|NCT00879684|10352447|P5|Stage 1: Dose Escalation|Progressive Disease|3
3009586|NCT00879684|10352448|P4|Stage 1: Dose Escalation|Progressive Disease|4
3009587|NCT00879684|10352449|P3|Stage 1: Dose Escalation|Progressive Disease|0
3009588|NCT00879684|10352450|P2|Stage 1: Dose Escalation|Progressive Disease|3
3009589|NCT00879684|10352451|P1|Stage 1: Dose Escalation|Progressive Disease|2
3009590|NCT00879684|10352445|P7|Stage 1: Dose Escalation|Adverse Event|0
3009591|NCT00879684|10352446|P6|Stage 1: Dose Escalation|Adverse Event|0
3009592|NCT00879684|10352447|P5|Stage 1: Dose Escalation|Adverse Event|0
3009593|NCT00879684|10352448|P4|Stage 1: Dose Escalation|Adverse Event|0
3009594|NCT00879684|10352449|P3|Stage 1: Dose Escalation|Adverse Event|0
3009595|NCT00879684|10352450|P2|Stage 1: Dose Escalation|Adverse Event|0
3009596|NCT00879684|10352451|P1|Stage 1: Dose Escalation|Adverse Event|1
3009597|NCT00879658|10352520|P7|Overall Study|misrandomized (never received study med)|0
3009598|NCT00879658|10352521|P6|Overall Study|misrandomized (never received study med)|0
3009599|NCT00879658|10352522|P5|Overall Study|misrandomized (never received study med)|0
3009600|NCT00879658|10352523|P4|Overall Study|misrandomized (never received study med)|1
3009601|NCT00879658|10352524|P3|Overall Study|misrandomized (never received study med)|0
3009602|NCT00879658|10352525|P2|Overall Study|misrandomized (never received study med)|0
3009603|NCT00879658|10352526|P1|Overall Study|misrandomized (never received study med)|0
3009604|NCT00879658|10352520|P7|Overall Study|Lack of Efficacy|0
3009605|NCT00879658|10352521|P6|Overall Study|Lack of Efficacy|0
3009606|NCT00879658|10352522|P5|Overall Study|Lack of Efficacy|0
3009607|NCT00879658|10352523|P4|Overall Study|Lack of Efficacy|0
3009608|NCT00879658|10352524|P3|Overall Study|Lack of Efficacy|2
3009609|NCT00879658|10352525|P2|Overall Study|Lack of Efficacy|0
3009610|NCT00879658|10352526|P1|Overall Study|Lack of Efficacy|0
3009611|NCT00879658|10352520|P7|Overall Study|Withdrawal by Subject|0
3009612|NCT00879658|10352521|P6|Overall Study|Withdrawal by Subject|1
3009613|NCT00879658|10352522|P5|Overall Study|Withdrawal by Subject|0
3009614|NCT00879658|10352523|P4|Overall Study|Withdrawal by Subject|0
3009615|NCT00879658|10352524|P3|Overall Study|Withdrawal by Subject|2
3009616|NCT00879658|10352525|P2|Overall Study|Withdrawal by Subject|0
3009617|NCT00879658|10352526|P1|Overall Study|Withdrawal by Subject|3
3009618|NCT00879658|10352520|P7|Overall Study|Protocol Violation|0
3009619|NCT00879658|10352521|P6|Overall Study|Protocol Violation|0
3009620|NCT00879658|10352522|P5|Overall Study|Protocol Violation|0
3009621|NCT00879658|10352523|P4|Overall Study|Protocol Violation|0
3009622|NCT00879658|10352524|P3|Overall Study|Protocol Violation|0
3009623|NCT00879658|10352525|P2|Overall Study|Protocol Violation|0
3009624|NCT00879658|10352526|P1|Overall Study|Protocol Violation|1
3009625|NCT00879658|10352520|P7|Overall Study|Adverse Event|0
3009626|NCT00879658|10352521|P6|Overall Study|Adverse Event|0
3009627|NCT00879658|10352522|P5|Overall Study|Adverse Event|2
3009628|NCT00879658|10352523|P4|Overall Study|Adverse Event|1
3009629|NCT00879658|10352524|P3|Overall Study|Adverse Event|3
3009630|NCT00879658|10352525|P2|Overall Study|Adverse Event|4
3009631|NCT00879658|10352526|P1|Overall Study|Adverse Event|6
3009632|NCT00879658|10352520|P7|Overall Study|Administrative problems|0
3009633|NCT00879658|10352521|P6|Overall Study|Administrative problems|0
3009634|NCT00879658|10352522|P5|Overall Study|Administrative problems|0
3009635|NCT00879658|10352523|P4|Overall Study|Administrative problems|1
3009636|NCT00879658|10352524|P3|Overall Study|Administrative problems|0
3009637|NCT00879658|10352525|P2|Overall Study|Administrative problems|1
3009638|NCT00879658|10352526|P1|Overall Study|Administrative problems|2
3009639|NCT00879658|10352520|P7|Overall Study|Abnormal laboratory value(s)|0
3009640|NCT00879658|10352521|P6|Overall Study|Abnormal laboratory value(s)|0
3009641|NCT00879658|10352522|P5|Overall Study|Abnormal laboratory value(s)|0
3009642|NCT00879658|10352523|P4|Overall Study|Abnormal laboratory value(s)|1
3009643|NCT00879658|10352524|P3|Overall Study|Abnormal laboratory value(s)|0
3009644|NCT00879658|10352525|P2|Overall Study|Abnormal laboratory value(s)|0
3009645|NCT00879658|10352526|P1|Overall Study|Abnormal laboratory value(s)|3
3009646|NCT00879645|10352612|P4|Overall Study|Adverse Event|0
3009647|NCT00879645|10352613|P3|Overall Study|Adverse Event|0
3009648|NCT00879645|10352614|P2|Overall Study|Adverse Event|0
3009649|NCT00879645|10352615|P1|Overall Study|Adverse Event|1
3009650|NCT00879411|10352642|P1|Overall Study|lost to follow-up (non-AE)|162
3009651|NCT00879398|10352648|P1|Overall Study|Other Reasons|171
3009652|NCT00879398|10352648|P1|Overall Study|Adverse Event|41
3009653|NCT00879398|10352648|P1|Overall Study|Lack of Efficacy|64
3009654|NCT00879398|10352648|P1|Overall Study|Visit Stop|399
3009655|NCT00879333|10352666|P2|Overall Study|Protocol Violation|1
3009656|NCT00879333|10352667|P1|Overall Study|Protocol Violation|1
3009657|NCT00879333|10352666|P2|Overall Study|Disease Progression|169
3009658|NCT00879333|10352667|P1|Overall Study|Disease Progression|292
3009659|NCT00879333|10352666|P2|Overall Study|Death|5
3009660|NCT00879333|10352667|P1|Overall Study|Death|16
3009661|NCT00879333|10352666|P2|Overall Study|Administrative Problems|0
3009662|NCT00879333|10352667|P1|Overall Study|Administrative Problems|2
3009663|NCT00879333|10352666|P2|Overall Study|Lost to Follow-up|1
3009664|NCT00879333|10352667|P1|Overall Study|Lost to Follow-up|2
3009665|NCT00879333|10352666|P2|Overall Study|Withdrawal by Subject|7
3009666|NCT00879333|10352667|P1|Overall Study|Withdrawal by Subject|20
3009667|NCT00879333|10352666|P2|Overall Study|Abnormal Laboratory Value|0
3009668|NCT00879333|10352667|P1|Overall Study|Abnormal Laboratory Value|1
3009669|NCT00879333|10352666|P2|Overall Study|Adverse Event|34
3009670|NCT00879333|10352667|P1|Overall Study|Adverse Event|94
3009671|NCT00879229|10352700|P2|Overall Study|Other|0
3009672|NCT00879229|10352701|P1|Overall Study|Other|1
3009673|NCT00879229|10352700|P2|Overall Study|Clinical status did not improve|0
3009674|NCT00879229|10352701|P1|Overall Study|Clinical status did not improve|1
3009675|NCT00879229|10352700|P2|Overall Study|Withdrawal by Subject|0
3009676|NCT00879229|10352701|P1|Overall Study|Withdrawal by Subject|1
3009677|NCT00879229|10352700|P2|Overall Study|Adverse Event|0
3009678|NCT00879229|10352701|P1|Overall Study|Adverse Event|2
3009679|NCT00879229|10352700|P2|Overall Study|Death|2
3009680|NCT00879229|10352701|P1|Overall Study|Death|4
3009681|NCT00879229|10352700|P2|Overall Study|Study terminated by Sponsor|12
3009682|NCT00879229|10352701|P1|Overall Study|Study terminated by Sponsor|13
3009683|NCT00878995|10352749|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
3009684|NCT00878995|10352750|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
3009685|NCT00878969|10352851|P3|Overall Study|Pregnancy|0
3009686|NCT00878969|10352852|P2|Overall Study|Pregnancy|1
3009687|NCT00878969|10352853|P1|Overall Study|Pregnancy|0
3009688|NCT00878969|10352851|P3|Overall Study|Death|2
3009689|NCT00878969|10352852|P2|Overall Study|Death|0
3009690|NCT00878969|10352853|P1|Overall Study|Death|0
3009691|NCT00878969|10352851|P3|Overall Study|Protocol Violation|0
3009692|NCT00878969|10352852|P2|Overall Study|Protocol Violation|0
3009693|NCT00878969|10352853|P1|Overall Study|Protocol Violation|2
3009694|NCT00878969|10352851|P3|Overall Study|Lost to Follow-up|0
3009695|NCT00878969|10352852|P2|Overall Study|Lost to Follow-up|1
3009696|NCT00878969|10352853|P1|Overall Study|Lost to Follow-up|2
3009697|NCT00878969|10352851|P3|Overall Study|Adverse Event|2
3009698|NCT00878969|10352852|P2|Overall Study|Adverse Event|1
3009699|NCT00878969|10352853|P1|Overall Study|Adverse Event|3
3009700|NCT00878969|10352851|P3|Overall Study|kidney transplant|2
3009701|NCT00878969|10352852|P2|Overall Study|kidney transplant|3
3009702|NCT00878969|10352853|P1|Overall Study|kidney transplant|2
3009703|NCT00878969|10352851|P3|Overall Study|Withdrawal by Subject|3
3009704|NCT00878969|10352852|P2|Overall Study|Withdrawal by Subject|6
3009705|NCT00878969|10352853|P1|Overall Study|Withdrawal by Subject|1
3009706|NCT00878969|10352851|P3|Overall Study|Physician Decision|2
3009707|NCT00878969|10352852|P2|Overall Study|Physician Decision|3
3009708|NCT00878969|10352853|P1|Overall Study|Physician Decision|5
3009709|NCT00878800|10352901|P5|Overall Study|Other|1
3009710|NCT00878800|10352902|P4|Overall Study|Other|0
3009711|NCT00878800|10352903|P3|Overall Study|Other|0
3009712|NCT00878800|10352904|P2|Overall Study|Other|1
3009713|NCT00878800|10352905|P1|Overall Study|Other|1
3009714|NCT00878800|10352901|P5|Overall Study|Death|0
3009715|NCT00878800|10352902|P4|Overall Study|Death|0
3009716|NCT00878800|10352903|P3|Overall Study|Death|1
3009717|NCT00878800|10352904|P2|Overall Study|Death|0
3009718|NCT00878800|10352905|P1|Overall Study|Death|0
3009719|NCT00878800|10352901|P5|Overall Study|Withdrew consent|1
3009720|NCT00878800|10352902|P4|Overall Study|Withdrew consent|1
3009721|NCT00878800|10352903|P3|Overall Study|Withdrew consent|0
3009722|NCT00878800|10352904|P2|Overall Study|Withdrew consent|1
3009723|NCT00878800|10352905|P1|Overall Study|Withdrew consent|1
3009724|NCT00878800|10352901|P5|Overall Study|Progressive disease|13
3009725|NCT00878800|10352902|P4|Overall Study|Progressive disease|5
3009726|NCT00878800|10352903|P3|Overall Study|Progressive disease|6
3009727|NCT00878800|10352904|P2|Overall Study|Progressive disease|5
3009728|NCT00878800|10352905|P1|Overall Study|Progressive disease|1
3009729|NCT00878800|10352901|P5|Overall Study|Adverse Event|1
3009730|NCT00878800|10352902|P4|Overall Study|Adverse Event|0
3009731|NCT00878800|10352903|P3|Overall Study|Adverse Event|2
3009732|NCT00878800|10352904|P2|Overall Study|Adverse Event|0
3009733|NCT00878800|10352905|P1|Overall Study|Adverse Event|0
3009734|NCT00878722|10352940|P8|Overall Study|Relapse|0
3009735|NCT00878722|10352941|P7|Overall Study|Relapse|0
3009736|NCT00878722|10352942|P6|Overall Study|Relapse|0
3009737|NCT00878722|10352943|P5|Overall Study|Relapse|0
3009738|NCT00878722|10352944|P4|Overall Study|Relapse|1
3009739|NCT00878722|10352945|P3|Overall Study|Relapse|0
3009740|NCT00878722|10352946|P2|Overall Study|Relapse|0
3009741|NCT00878722|10352947|P1|Overall Study|Relapse|0
3009742|NCT00878722|10352940|P8|Overall Study|Withdrawal by Subject|2
3009743|NCT00878722|10352941|P7|Overall Study|Withdrawal by Subject|0
3009744|NCT00878722|10352942|P6|Overall Study|Withdrawal by Subject|0
3009745|NCT00878722|10352943|P5|Overall Study|Withdrawal by Subject|0
3009746|NCT00878722|10352944|P4|Overall Study|Withdrawal by Subject|0
3009747|NCT00878722|10352945|P3|Overall Study|Withdrawal by Subject|0
3009748|NCT00878722|10352946|P2|Overall Study|Withdrawal by Subject|0
3009749|NCT00878722|10352947|P1|Overall Study|Withdrawal by Subject|0
3009750|NCT00878722|10352940|P8|Overall Study|Adverse Event|0
3009751|NCT00878722|10352941|P7|Overall Study|Adverse Event|2
3009752|NCT00878722|10352942|P6|Overall Study|Adverse Event|0
3009753|NCT00878722|10352943|P5|Overall Study|Adverse Event|0
3009754|NCT00878722|10352944|P4|Overall Study|Adverse Event|0
3009755|NCT00878722|10352945|P3|Overall Study|Adverse Event|0
3009756|NCT00878722|10352946|P2|Overall Study|Adverse Event|0
3009757|NCT00878722|10352947|P1|Overall Study|Adverse Event|0
3009758|NCT00878722|10352940|P8|Overall Study|Death|2
3009759|NCT00878722|10352941|P7|Overall Study|Death|0
3009760|NCT00878722|10352942|P6|Overall Study|Death|1
3009761|NCT00878722|10352943|P5|Overall Study|Death|0
3009762|NCT00878722|10352944|P4|Overall Study|Death|1
3009763|NCT00878722|10352945|P3|Overall Study|Death|0
3009764|NCT00878722|10352946|P2|Overall Study|Death|0
3009765|NCT00878722|10352947|P1|Overall Study|Death|0
3009766|NCT00878722|10352940|P8|Overall Study|Progressive disease|3
3009767|NCT00878722|10352941|P7|Overall Study|Progressive disease|4
3009768|NCT00878722|10352942|P6|Overall Study|Progressive disease|1
3009769|NCT00878722|10352943|P5|Overall Study|Progressive disease|7
3009770|NCT00878722|10352944|P4|Overall Study|Progressive disease|7
3009771|NCT00878722|10352945|P3|Overall Study|Progressive disease|3
3009772|NCT00878722|10352946|P2|Overall Study|Progressive disease|3
3009773|NCT00878722|10352947|P1|Overall Study|Progressive disease|3
3009774|NCT00878709|10353032|P2|Overall Study|Other Reasons|84
3009775|NCT00878709|10353033|P1|Overall Study|Other Reasons|93
3009776|NCT00878709|10353032|P2|Overall Study|Lost to Follow-up|33
3009777|NCT00878709|10353033|P1|Overall Study|Lost to Follow-up|35
3009778|NCT00878709|10353032|P2|Overall Study|Withdrawal by Subject|120
3009779|NCT00878709|10353033|P1|Overall Study|Withdrawal by Subject|197
3009780|NCT00878553|10353093|P5|PK Study|Withdrawal by Subject|0
3009781|NCT00878553|10353094|P4|PK Study|Withdrawal by Subject|1
3009782|NCT00878553|10353095|P3|PK Study|Withdrawal by Subject|0
3009783|NCT00878553|10353096|P2|PK Study|Withdrawal by Subject|0
3009784|NCT00878553|10353097|P1|PK Study|Withdrawal by Subject|0
3009785|NCT00878553|10353093|P5|Sleep Study|family emergency|0
3009786|NCT00878553|10353094|P4|Sleep Study|family emergency|0
3009787|NCT00878553|10353095|P3|Sleep Study|family emergency|0
3009788|NCT00878553|10353096|P2|Sleep Study|family emergency|0
3009789|NCT00878553|10353097|P1|Sleep Study|family emergency|1
3009790|NCT00878553|10353093|P5|Sleep Study|car accident|0
3009791|NCT00878553|10353094|P4|Sleep Study|car accident|0
3009792|NCT00878553|10353095|P3|Sleep Study|car accident|0
3009793|NCT00878553|10353096|P2|Sleep Study|car accident|0
3009794|NCT00878553|10353097|P1|Sleep Study|car accident|1
3009795|NCT00878553|10353093|P5|Sleep Study|Lost to Follow-up|0
3009796|NCT00878553|10353094|P4|Sleep Study|Lost to Follow-up|0
3009797|NCT00878553|10353095|P3|Sleep Study|Lost to Follow-up|0
3009798|NCT00878553|10353096|P2|Sleep Study|Lost to Follow-up|0
3009799|NCT00878553|10353097|P1|Sleep Study|Lost to Follow-up|1
3009800|NCT00878553|10353093|P5|Sleep Study|Withdrawal by Subject|0
3009801|NCT00878553|10353094|P4|Sleep Study|Withdrawal by Subject|0
3009802|NCT00878553|10353095|P3|Sleep Study|Withdrawal by Subject|0
3009803|NCT00878553|10353096|P2|Sleep Study|Withdrawal by Subject|0
3009804|NCT00878553|10353097|P1|Sleep Study|Withdrawal by Subject|2
3009805|NCT00878501|10353156|P3|Overall Study|Administrative|1
3009806|NCT00878501|10353157|P2|Overall Study|Administrative|0
3009807|NCT00878501|10353158|P1|Overall Study|Administrative|0
3009808|NCT00878501|10353156|P3|Overall Study|Mis-randomisation of patient|0
3009809|NCT00878501|10353157|P2|Overall Study|Mis-randomisation of patient|0
3009810|NCT00878501|10353158|P1|Overall Study|Mis-randomisation of patient|1
3009811|NCT00878501|10353156|P3|Overall Study|Intake of prohibited concom. medication|1
3009812|NCT00878501|10353157|P2|Overall Study|Intake of prohibited concom. medication|0
3009813|NCT00878501|10353158|P1|Overall Study|Intake of prohibited concom. medication|0
3009814|NCT00878501|10353156|P3|Overall Study|Incorrect enrolment|0
3009815|NCT00878501|10353157|P2|Overall Study|Incorrect enrolment|2
3009816|NCT00878501|10353158|P1|Overall Study|Incorrect enrolment|1
3009817|NCT00878501|10353156|P3|Overall Study|Protocol Violation|1
3009818|NCT00878501|10353157|P2|Overall Study|Protocol Violation|0
3009819|NCT00878501|10353158|P1|Overall Study|Protocol Violation|0
3009820|NCT00878501|10353156|P3|Overall Study|Withdrawal by Subject|2
3009821|NCT00878501|10353157|P2|Overall Study|Withdrawal by Subject|1
3009822|NCT00878501|10353158|P1|Overall Study|Withdrawal by Subject|2
3009823|NCT00878501|10353156|P3|Overall Study|Lack of Efficacy|0
3009824|NCT00878501|10353157|P2|Overall Study|Lack of Efficacy|1
3009825|NCT00878501|10353158|P1|Overall Study|Lack of Efficacy|2
3009826|NCT00878501|10353156|P3|Overall Study|Adverse Event|3
3009827|NCT00878501|10353157|P2|Overall Study|Adverse Event|3
3009828|NCT00878501|10353158|P1|Overall Study|Adverse Event|11
3009829|NCT00878215|10353207|P4|Overall Study|Determined to be ineligible|0
3009830|NCT00878215|10353208|P3|Overall Study|Determined to be ineligible|0
3009831|NCT00878215|10353209|P2|Overall Study|Determined to be ineligible|10
3009832|NCT00878215|10353210|P1|Overall Study|Determined to be ineligible|0
3009833|NCT00878189|10353222|P9|Overall Study|Objection Progression or Relapse|3
3009834|NCT00878189|10353223|P8|Overall Study|Objection Progression or Relapse|0
3009835|NCT00878189|10353224|P7|Overall Study|Objection Progression or Relapse|0
3009836|NCT00878189|10353225|P6|Overall Study|Objection Progression or Relapse|0
3009837|NCT00878189|10353226|P5|Overall Study|Objection Progression or Relapse|0
3009838|NCT00878189|10353227|P4|Overall Study|Objection Progression or Relapse|0
3009839|NCT00878189|10353228|P3|Overall Study|Objection Progression or Relapse|0
3009840|NCT00878189|10353229|P2|Overall Study|Objection Progression or Relapse|0
3009841|NCT00878189|10353230|P1|Overall Study|Objection Progression or Relapse|0
3009842|NCT00878189|10353222|P9|Overall Study|Lost to Follow-up|0
3009843|NCT00878189|10353223|P8|Overall Study|Lost to Follow-up|0
3009844|NCT00878189|10353224|P7|Overall Study|Lost to Follow-up|1
3009845|NCT00878189|10353225|P6|Overall Study|Lost to Follow-up|1
3009846|NCT00878189|10353226|P5|Overall Study|Lost to Follow-up|0
3009847|NCT00878189|10353227|P4|Overall Study|Lost to Follow-up|0
3009848|NCT00878189|10353228|P3|Overall Study|Lost to Follow-up|0
3009849|NCT00878189|10353229|P2|Overall Study|Lost to Follow-up|0
3009850|NCT00878189|10353230|P1|Overall Study|Lost to Follow-up|0
3009851|NCT00878189|10353222|P9|Overall Study|Other|4
3009852|NCT00878189|10353223|P8|Overall Study|Other|3
3009853|NCT00878189|10353224|P7|Overall Study|Other|15
3009854|NCT00878189|10353225|P6|Overall Study|Other|18
3009855|NCT00878189|10353226|P5|Overall Study|Other|4
3009856|NCT00878189|10353227|P4|Overall Study|Other|7
3009857|NCT00878189|10353228|P3|Overall Study|Other|4
3009858|NCT00878189|10353229|P2|Overall Study|Other|2
3009859|NCT00878189|10353230|P1|Overall Study|Other|3
3009860|NCT00878189|10353222|P9|Overall Study|Participant Refused to Follow-up|0
3009861|NCT00878189|10353223|P8|Overall Study|Participant Refused to Follow-up|0
3009862|NCT00878189|10353224|P7|Overall Study|Participant Refused to Follow-up|0
3009863|NCT00878189|10353225|P6|Overall Study|Participant Refused to Follow-up|4
3009864|NCT00878189|10353226|P5|Overall Study|Participant Refused to Follow-up|0
3009865|NCT00878189|10353227|P4|Overall Study|Participant Refused to Follow-up|0
3009866|NCT00878189|10353228|P3|Overall Study|Participant Refused to Follow-up|0
3009867|NCT00878189|10353229|P2|Overall Study|Participant Refused to Follow-up|0
3009868|NCT00878189|10353230|P1|Overall Study|Participant Refused to Follow-up|0
3009869|NCT00878189|10353222|P9|Overall Study|Death|1
3009870|NCT00878189|10353223|P8|Overall Study|Death|0
3009871|NCT00878189|10353224|P7|Overall Study|Death|0
3009872|NCT00878189|10353225|P6|Overall Study|Death|0
3009873|NCT00878189|10353226|P5|Overall Study|Death|0
3009874|NCT00878189|10353227|P4|Overall Study|Death|1
3009875|NCT00878189|10353228|P3|Overall Study|Death|0
3009876|NCT00878189|10353229|P2|Overall Study|Death|1
3009877|NCT00878189|10353230|P1|Overall Study|Death|0
3009878|NCT00877929|10353498|P2|Overall Study|Other reason (not specified)|6
3009879|NCT00877929|10353499|P1|Overall Study|Other reason (not specified)|2
3009880|NCT00877929|10353498|P2|Overall Study|Lack of Efficacy|1
3009881|NCT00877929|10353499|P1|Overall Study|Lack of Efficacy|0
3009882|NCT00877929|10353498|P2|Overall Study|Withdrawal by Subject|4
3009883|NCT00877929|10353499|P1|Overall Study|Withdrawal by Subject|4
3009884|NCT00877929|10353498|P2|Overall Study|Lost to Follow-up|1
3009885|NCT00877929|10353499|P1|Overall Study|Lost to Follow-up|0
3009886|NCT00877929|10353498|P2|Overall Study|Protocol Violation|3
3009887|NCT00877929|10353499|P1|Overall Study|Protocol Violation|3
3009888|NCT00877929|10353498|P2|Overall Study|Adverse Event|20
3009889|NCT00877929|10353499|P1|Overall Study|Adverse Event|11
3009890|NCT00877890|10353587|P2|Overall Study|Loss of Glucose Control|4
3009891|NCT00877890|10353588|P1|Overall Study|Loss of Glucose Control|3
3009892|NCT00877890|10353587|P2|Overall Study|Investigator Decision|2
3009893|NCT00877890|10353588|P1|Overall Study|Investigator Decision|0
3009894|NCT00877890|10353587|P2|Overall Study|Withdrawal of Consent|12
3009895|NCT00877890|10353588|P1|Overall Study|Withdrawal of Consent|6
3009896|NCT00877890|10353587|P2|Overall Study|Protocol Violation|1
3009897|NCT00877890|10353588|P1|Overall Study|Protocol Violation|0
3009898|NCT00877890|10353587|P2|Overall Study|Lost to Follow-up|5
3009899|NCT00877890|10353588|P1|Overall Study|Lost to Follow-up|5
3009900|NCT00877890|10353587|P2|Overall Study|Adverse Event|6
3009901|NCT00877890|10353588|P1|Overall Study|Adverse Event|6
3009902|NCT00877799|10353653|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
3009903|NCT00877799|10353654|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
3009904|NCT00877799|10353655|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
3009905|NCT00877799|10353656|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
3009906|NCT00877799|10353657|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
3009907|NCT00877799|10353653|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
3009908|NCT00877799|10353654|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
3009909|NCT00877799|10353655|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
3009910|NCT00877799|10353656|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
3009911|NCT00877799|10353657|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
3009912|NCT00877799|10353653|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
3009913|NCT00877799|10353654|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
3009914|NCT00877799|10353655|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
3009915|NCT00877799|10353656|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
3009916|NCT00877799|10353657|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
3009917|NCT00877799|10353653|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
3009918|NCT00877799|10353654|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
3009919|NCT00877799|10353655|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
3009920|NCT00877799|10353656|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
3009921|NCT00877799|10353657|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
3009922|NCT00877799|10353653|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
3009923|NCT00877799|10353654|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
3009924|NCT00877799|10353655|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
3009925|NCT00877799|10353656|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
3009926|NCT00877799|10353657|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
3009927|NCT00877773|10353672|P1|Overall Study|Disease Progression|44
3009928|NCT00877487|10353685|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
3009929|NCT00877487|10353686|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
3009930|NCT00877487|10353685|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
3009931|NCT00877487|10353686|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
3009932|NCT00877487|10353685|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
3009933|NCT00877487|10353686|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
3009934|NCT00877487|10353685|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
3009935|NCT00877487|10353686|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
3009936|NCT00877487|10353685|P2|Open-label Treatment Phase|Out of country for business|0
3009937|NCT00877487|10353686|P1|Open-label Treatment Phase|Out of country for business|1
3009938|NCT00877487|10353685|P2|Open-label Treatment Phase|Lost to Follow-up|0
3009939|NCT00877487|10353686|P1|Open-label Treatment Phase|Lost to Follow-up|1
3009940|NCT00877487|10353685|P2|Open-label Treatment Phase|Withdrawal by Subject|0
3009941|NCT00877487|10353686|P1|Open-label Treatment Phase|Withdrawal by Subject|1
3009942|NCT00877487|10353685|P2|Open-label Treatment Phase|Protocol Violation|0
3009943|NCT00877487|10353686|P1|Open-label Treatment Phase|Protocol Violation|3
3009944|NCT00877487|10353685|P2|Open-label Treatment Phase|Adverse Event|0
3009945|NCT00877487|10353686|P1|Open-label Treatment Phase|Adverse Event|1
3009946|NCT00877383|10353734|P2|Overall Study|Death|2
3009947|NCT00877383|10353735|P1|Overall Study|Death|1
3009948|NCT00877383|10353734|P2|Overall Study|Unsatisfactory therapeutic effect|0
3009949|NCT00877383|10353735|P1|Overall Study|Unsatisfactory therapeutic effect|1
3009950|NCT00877383|10353734|P2|Overall Study|Protocol deviation|6
3009951|NCT00877383|10353735|P1|Overall Study|Protocol deviation|2
3009952|NCT00877383|10353734|P2|Overall Study|Administrative problems|0
3009953|NCT00877383|10353735|P1|Overall Study|Administrative problems|2
3009954|NCT00877383|10353734|P2|Overall Study|Subject no longer requires study drug|0
3009955|NCT00877383|10353735|P1|Overall Study|Subject no longer requires study drug|2
3009956|NCT00877383|10353734|P2|Overall Study|Subject withdrew consent|12
3009957|NCT00877383|10353735|P1|Overall Study|Subject withdrew consent|3
3009958|NCT00877383|10353734|P2|Overall Study|Lost to Follow-up|3
3009959|NCT00877383|10353735|P1|Overall Study|Lost to Follow-up|5
3009960|NCT00877383|10353734|P2|Overall Study|Adverse Event|14
3009961|NCT00877383|10353735|P1|Overall Study|Adverse Event|13
3009962|NCT00877071|10353755|P1|Overall Study|disease progression|2
3009963|NCT00877032|10353788|P7|Overall Study|Did not meet entrance criteria|2
3009964|NCT00877032|10353789|P6|Overall Study|Did not meet entrance criteria|0
3009965|NCT00877032|10353790|P5|Overall Study|Did not meet entrance criteria|0
3009966|NCT00877032|10353791|P4|Overall Study|Did not meet entrance criteria|1
3009967|NCT00877032|10353792|P3|Overall Study|Did not meet entrance criteria|0
3009968|NCT00877032|10353793|P2|Overall Study|Did not meet entrance criteria|0
3009969|NCT00877032|10353794|P1|Overall Study|Did not meet entrance criteria|0
3009970|NCT00877006|10353895|P2|Long-Term Follow-up Period|Other|9
3009971|NCT00877006|10353896|P1|Long-Term Follow-up Period|Other|7
3009972|NCT00877006|10353895|P2|Long-Term Follow-up Period|Death|18
3009973|NCT00877006|10353896|P1|Long-Term Follow-up Period|Death|26
3009974|NCT00877006|10353895|P2|Long-Term Follow-up Period|Lost to Follow-up|9
3009975|NCT00877006|10353896|P1|Long-Term Follow-up Period|Lost to Follow-up|8
3009976|NCT00877006|10353895|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
3009977|NCT00877006|10353896|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
3009978|NCT00877006|10353895|P2|Treatment Period|Randomized but Not Treated|8
3009979|NCT00877006|10353896|P1|Treatment Period|Randomized but Not Treated|3
3009980|NCT00877006|10353895|P2|Treatment Period|Other|4
3009981|NCT00877006|10353896|P1|Treatment Period|Other|4
3009982|NCT00877006|10353895|P2|Treatment Period|Started New Treatment Regimen|5
3009983|NCT00877006|10353896|P1|Treatment Period|Started New Treatment Regimen|2
3009984|NCT00877006|10353895|P2|Treatment Period|Disease Progression|2
3009985|NCT00877006|10353896|P1|Treatment Period|Disease Progression|1
3009986|NCT00877006|10353895|P2|Treatment Period|Lost to Follow-up|1
3009987|NCT00877006|10353896|P1|Treatment Period|Lost to Follow-up|0
3009988|NCT00877006|10353895|P2|Treatment Period|Protocol Violation|0
3009989|NCT00877006|10353896|P1|Treatment Period|Protocol Violation|1
3009990|NCT00877006|10353895|P2|Treatment Period|Withdrawal by Subject|3
3009991|NCT00877006|10353896|P1|Treatment Period|Withdrawal by Subject|2
3009992|NCT00877006|10353895|P2|Treatment Period|Adverse Event|3
3009993|NCT00877006|10353896|P1|Treatment Period|Adverse Event|10
3009994|NCT00877006|10353895|P2|Treatment Period|Death|1
3009995|NCT00877006|10353896|P1|Treatment Period|Death|2
3009996|NCT00876928|10353972|P2|Overall Study|Hypokalemia-affects insulin secretion|0
3009997|NCT00876928|10353973|P1|Overall Study|Hypokalemia-affects insulin secretion|1
3009998|NCT00876928|10353972|P2|Overall Study|Lost to Follow-up|5
3009999|NCT00876928|10353973|P1|Overall Study|Lost to Follow-up|2
3010000|NCT00876733|10354010|P4|Overall Study|Data not available|1
3010001|NCT00876733|10354011|P3|Overall Study|Data not available|7
3010002|NCT00876733|10354012|P2|Overall Study|Data not available|3
3010003|NCT00876733|10354013|P1|Overall Study|Data not available|14
3010004|NCT00876733|10354010|P4|Overall Study|Lost to Follow-up|2
3010005|NCT00876733|10354011|P3|Overall Study|Lost to Follow-up|3
3010006|NCT00876733|10354012|P2|Overall Study|Lost to Follow-up|10
3010007|NCT00876733|10354013|P1|Overall Study|Lost to Follow-up|26
3010008|NCT00876733|10354010|P4|Overall Study|Lack of Efficacy|1
3010009|NCT00876733|10354011|P3|Overall Study|Lack of Efficacy|10
3010010|NCT00876733|10354012|P2|Overall Study|Lack of Efficacy|9
3010011|NCT00876733|10354013|P1|Overall Study|Lack of Efficacy|17
3010012|NCT00876733|10354010|P4|Overall Study|Adverse Event|3
3010013|NCT00876733|10354011|P3|Overall Study|Adverse Event|10
3010014|NCT00876733|10354012|P2|Overall Study|Adverse Event|20
3010015|NCT00876733|10354013|P1|Overall Study|Adverse Event|34
3010016|NCT00876694|10354121|P2|Overall Study|Death|0
3010017|NCT00876694|10354122|P1|Overall Study|Death|1
3010018|NCT00876694|10354121|P2|Overall Study|Administrative problems|1
3010019|NCT00876694|10354122|P1|Overall Study|Administrative problems|1
3010020|NCT00876694|10354121|P2|Overall Study|Abnormal test procedure result(s)|0
3010021|NCT00876694|10354122|P1|Overall Study|Abnormal test procedure result(s)|1
3010022|NCT00876694|10354121|P2|Overall Study|Unsatisfactory therapeutic effect|0
3010023|NCT00876694|10354122|P1|Overall Study|Unsatisfactory therapeutic effect|2
3010024|NCT00876694|10354121|P2|Overall Study|Subject withdrew consent|4
3010025|NCT00876694|10354122|P1|Overall Study|Subject withdrew consent|6
3010026|NCT00876694|10354121|P2|Overall Study|Adverse Event|7
3010027|NCT00876694|10354122|P1|Overall Study|Adverse Event|10
3010028|NCT00876460|10354148|P8|Mono Therapy Phase|Adverse Event|0
3010029|NCT00876460|10354149|P7|Mono Therapy Phase|Adverse Event|0
3010030|NCT00876460|10354150|P6|Mono Therapy Phase|Adverse Event|0
3010031|NCT00876460|10354151|P5|Mono Therapy Phase|Adverse Event|0
3010032|NCT00876460|10354152|P4|Mono Therapy Phase|Adverse Event|1
3010033|NCT00876460|10354153|P3|Mono Therapy Phase|Adverse Event|0
3010034|NCT00876460|10354154|P2|Mono Therapy Phase|Adverse Event|0
3010035|NCT00876460|10354155|P1|Mono Therapy Phase|Adverse Event|0
3010036|NCT00876460|10354148|P8|Mono Therapy Phase|Withdrawal by Subject|0
3010037|NCT00876460|10354149|P7|Mono Therapy Phase|Withdrawal by Subject|0
3010038|NCT00876460|10354150|P6|Mono Therapy Phase|Withdrawal by Subject|0
3010039|NCT00876460|10354151|P5|Mono Therapy Phase|Withdrawal by Subject|0
3010040|NCT00876460|10354152|P4|Mono Therapy Phase|Withdrawal by Subject|0
3010041|NCT00876460|10354153|P3|Mono Therapy Phase|Withdrawal by Subject|0
3010042|NCT00876460|10354154|P2|Mono Therapy Phase|Withdrawal by Subject|1
3010043|NCT00876460|10354155|P1|Mono Therapy Phase|Withdrawal by Subject|0
3010044|NCT00876460|10354148|P8|Mono Therapy Phase|Progressive disease|3
3010045|NCT00876460|10354149|P7|Mono Therapy Phase|Progressive disease|1
3010046|NCT00876460|10354150|P6|Mono Therapy Phase|Progressive disease|0
3010047|NCT00876460|10354151|P5|Mono Therapy Phase|Progressive disease|2
3010048|NCT00876460|10354152|P4|Mono Therapy Phase|Progressive disease|0
3010049|NCT00876460|10354153|P3|Mono Therapy Phase|Progressive disease|0
3010050|NCT00876460|10354154|P2|Mono Therapy Phase|Progressive disease|0
3010051|NCT00876460|10354155|P1|Mono Therapy Phase|Progressive disease|0
3010052|NCT00876460|10354148|P8|Combination Therapy Phase|Not treated|0
3010053|NCT00876460|10354149|P7|Combination Therapy Phase|Not treated|1
3010054|NCT00876460|10354150|P6|Combination Therapy Phase|Not treated|0
3010055|NCT00876460|10354151|P5|Combination Therapy Phase|Not treated|0
3010056|NCT00876460|10354152|P4|Combination Therapy Phase|Not treated|0
3010057|NCT00876460|10354153|P3|Combination Therapy Phase|Not treated|0
3010058|NCT00876460|10354154|P2|Combination Therapy Phase|Not treated|0
3010059|NCT00876460|10354155|P1|Combination Therapy Phase|Not treated|0
3010060|NCT00876460|10354148|P8|Combination Therapy Phase|Other reason not defined above|2
3010061|NCT00876460|10354149|P7|Combination Therapy Phase|Other reason not defined above|1
3010062|NCT00876460|10354150|P6|Combination Therapy Phase|Other reason not defined above|0
3010063|NCT00876460|10354151|P5|Combination Therapy Phase|Other reason not defined above|0
3010064|NCT00876460|10354152|P4|Combination Therapy Phase|Other reason not defined above|0
3010065|NCT00876460|10354153|P3|Combination Therapy Phase|Other reason not defined above|0
3010066|NCT00876460|10354154|P2|Combination Therapy Phase|Other reason not defined above|0
3010067|NCT00876460|10354155|P1|Combination Therapy Phase|Other reason not defined above|0
3010068|NCT00876460|10354148|P8|Combination Therapy Phase|Withdrawal by Subject|0
3010069|NCT00876460|10354149|P7|Combination Therapy Phase|Withdrawal by Subject|0
3010070|NCT00876460|10354150|P6|Combination Therapy Phase|Withdrawal by Subject|0
3010071|NCT00876460|10354151|P5|Combination Therapy Phase|Withdrawal by Subject|1
3010072|NCT00876460|10354152|P4|Combination Therapy Phase|Withdrawal by Subject|0
3010073|NCT00876460|10354153|P3|Combination Therapy Phase|Withdrawal by Subject|0
3010074|NCT00876460|10354154|P2|Combination Therapy Phase|Withdrawal by Subject|1
3010075|NCT00876460|10354155|P1|Combination Therapy Phase|Withdrawal by Subject|1
3010076|NCT00876460|10354148|P8|Combination Therapy Phase|Adverse Event|2
3010077|NCT00876460|10354149|P7|Combination Therapy Phase|Adverse Event|3
3010078|NCT00876460|10354150|P6|Combination Therapy Phase|Adverse Event|0
3010079|NCT00876460|10354151|P5|Combination Therapy Phase|Adverse Event|2
3010080|NCT00876460|10354152|P4|Combination Therapy Phase|Adverse Event|2
3010081|NCT00876460|10354153|P3|Combination Therapy Phase|Adverse Event|0
3010082|NCT00876460|10354154|P2|Combination Therapy Phase|Adverse Event|2
3010083|NCT00876460|10354155|P1|Combination Therapy Phase|Adverse Event|0
3010084|NCT00876460|10354148|P8|Combination Therapy Phase|Dose limiting toxicity|1
3010085|NCT00876460|10354149|P7|Combination Therapy Phase|Dose limiting toxicity|2
3010086|NCT00876460|10354150|P6|Combination Therapy Phase|Dose limiting toxicity|2
3010087|NCT00876460|10354151|P5|Combination Therapy Phase|Dose limiting toxicity|1
3010088|NCT00876460|10354152|P4|Combination Therapy Phase|Dose limiting toxicity|1
3010089|NCT00876460|10354153|P3|Combination Therapy Phase|Dose limiting toxicity|0
3010090|NCT00876460|10354154|P2|Combination Therapy Phase|Dose limiting toxicity|1
3010091|NCT00876460|10354155|P1|Combination Therapy Phase|Dose limiting toxicity|0
3010092|NCT00876460|10354148|P8|Combination Therapy Phase|Progressive disease|1
3010093|NCT00876460|10354149|P7|Combination Therapy Phase|Progressive disease|1
3010094|NCT00876460|10354150|P6|Combination Therapy Phase|Progressive disease|1
3010095|NCT00876460|10354151|P5|Combination Therapy Phase|Progressive disease|3
3010096|NCT00876460|10354152|P4|Combination Therapy Phase|Progressive disease|3
3010097|NCT00876460|10354153|P3|Combination Therapy Phase|Progressive disease|3
3010098|NCT00876460|10354154|P2|Combination Therapy Phase|Progressive disease|3
3010099|NCT00876460|10354155|P1|Combination Therapy Phase|Progressive disease|2
3010100|NCT00876447|10354227|P2|Overall Study|Adverse Event|8
3010101|NCT00876447|10354228|P1|Overall Study|Adverse Event|4
3010102|NCT00876447|10354227|P2|Overall Study|Lack of Efficacy|3
3010103|NCT00876447|10354228|P1|Overall Study|Lack of Efficacy|5
3010104|NCT00876447|10354227|P2|Overall Study|Pregnancy|2
3010105|NCT00876447|10354228|P1|Overall Study|Pregnancy|4
3010106|NCT00876447|10354227|P2|Overall Study|Lost to Follow-up|15
3010107|NCT00876447|10354228|P1|Overall Study|Lost to Follow-up|6
3010108|NCT00876447|10354227|P2|Overall Study|Personal reasons|28
3010109|NCT00876447|10354228|P1|Overall Study|Personal reasons|30
3010110|NCT00876447|10354227|P2|Overall Study|Protocol Violation|3
3010111|NCT00876447|10354228|P1|Overall Study|Protocol Violation|9
3010112|NCT00876447|10354227|P2|Overall Study|Site closure|14
3010113|NCT00876447|10354228|P1|Overall Study|Site closure|19
3010114|NCT00876447|10354227|P2|Overall Study|Other miscellaneous reasons|8
3010115|NCT00876447|10354228|P1|Overall Study|Other miscellaneous reasons|3
3010116|NCT00876395|10354288|P2|Overall Study|Death|0
3010117|NCT00876395|10354289|P1|Overall Study|Death|12
3010118|NCT00876395|10354288|P2|Overall Study|Administrative problems|23
3010119|NCT00876395|10354289|P1|Overall Study|Administrative problems|39
3010120|NCT00876395|10354288|P2|Overall Study|Lost to Follow-up|0
3010121|NCT00876395|10354289|P1|Overall Study|Lost to Follow-up|2
3010122|NCT00876395|10354288|P2|Overall Study|Withdrawal by Subject|33
3010123|NCT00876395|10354289|P1|Overall Study|Withdrawal by Subject|66
3010124|NCT00876395|10354288|P2|Overall Study|Protocol Violation|2
3010125|NCT00876395|10354289|P1|Overall Study|Protocol Violation|5
3010126|NCT00876395|10354288|P2|Overall Study|New cancer therapy|7
3010127|NCT00876395|10354289|P1|Overall Study|New cancer therapy|25
3010128|NCT00876395|10354288|P2|Overall Study|Disease progression|162
3010129|NCT00876395|10354289|P1|Overall Study|Disease progression|259
3010130|NCT00876395|10354288|P2|Overall Study|Abnormal test procedure result(s)|0
3010131|NCT00876395|10354289|P1|Overall Study|Abnormal test procedure result(s)|1
3010132|NCT00876395|10354288|P2|Overall Study|Adverse Event|11
3010133|NCT00876395|10354289|P1|Overall Study|Adverse Event|63
3010134|NCT00876395|10354288|P2|Overall Study|Untreated|1
3010135|NCT00876395|10354289|P1|Overall Study|Untreated|8
3010136|NCT00876343|10354330|P3|Overall Study|Change of residence or other commitments|3
3010137|NCT00876343|10354331|P2|Overall Study|Change of residence or other commitments|2
3010138|NCT00876343|10354332|P1|Overall Study|Change of residence or other commitments|2
3010139|NCT00876343|10354330|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
3010140|NCT00876343|10354331|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
3010141|NCT00876343|10354332|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
3010142|NCT00876343|10354330|P3|Overall Study|Physician Decision|1
3010143|NCT00876343|10354331|P2|Overall Study|Physician Decision|1
3010144|NCT00876343|10354332|P1|Overall Study|Physician Decision|0
3010145|NCT00876343|10354330|P3|Overall Study|Protocol Violation|1
3010146|NCT00876343|10354331|P2|Overall Study|Protocol Violation|1
3010147|NCT00876343|10354332|P1|Overall Study|Protocol Violation|4
3010148|NCT00876343|10354330|P3|Overall Study|Lack of Efficacy|1
3010149|NCT00876343|10354331|P2|Overall Study|Lack of Efficacy|0
3010150|NCT00876343|10354332|P1|Overall Study|Lack of Efficacy|0
3010151|NCT00876343|10354330|P3|Overall Study|Withdrawal by Subject|3
3010152|NCT00876343|10354331|P2|Overall Study|Withdrawal by Subject|4
3010153|NCT00876343|10354332|P1|Overall Study|Withdrawal by Subject|4
3010154|NCT00876343|10354330|P3|Overall Study|Adverse Event|2
3010155|NCT00876343|10354331|P2|Overall Study|Adverse Event|8
3010156|NCT00876343|10354332|P1|Overall Study|Adverse Event|7
3010157|NCT00876265|10354346|P1|Overall Study|Withdrawal by Subject|2
3010158|NCT00876265|10354346|P1|Overall Study|Lost to Follow-up|6
3010159|NCT00876265|10354346|P1|Overall Study|Miscellaneous reasons|4
3010160|NCT00876018|10354364|P3|Overall Study|Withdrew Consent due to Adverse Event|2
3010161|NCT00876018|10354365|P2|Overall Study|Withdrew Consent due to Adverse Event|4
3010162|NCT00876018|10354366|P1|Overall Study|Withdrew Consent due to Adverse Event|5
3010163|NCT00876018|10354364|P3|Overall Study|Lost to Follow-up|1
3010164|NCT00876018|10354365|P2|Overall Study|Lost to Follow-up|1
3010165|NCT00876018|10354366|P1|Overall Study|Lost to Follow-up|0
3010166|NCT00875979|10354421|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
3010167|NCT00875979|10354422|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
3010168|NCT00875979|10354421|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
3010169|NCT00875979|10354422|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
3010170|NCT00875979|10354421|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
3010171|NCT00875979|10354422|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
3010257|NCT00875420|10354754|P5|Overall Study|Adverse Event|0
3010172|NCT00875979|10354421|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
3010173|NCT00875979|10354422|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
3010174|NCT00875979|10354421|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
3010175|NCT00875979|10354422|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
3010176|NCT00875979|10354421|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
3010177|NCT00875979|10354422|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
3010178|NCT00875979|10354421|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
3010179|NCT00875979|10354422|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
3010180|NCT00875979|10354421|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
3010181|NCT00875979|10354422|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
3010182|NCT00875979|10354421|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
3010183|NCT00875979|10354422|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
3010184|NCT00875810|10354445|P1|Overall Study|Device explanted|1
3010185|NCT00875810|10354445|P1|Overall Study|Patient enroled but not implanted|2
3010186|NCT00875810|10354445|P1|Overall Study|Lost to Follow-up|39
3010187|NCT00875810|10354445|P1|Overall Study|Physician Decision|3
3010188|NCT00875810|10354445|P1|Overall Study|Withdrawal by Subject|1
3010189|NCT00875797|10354454|P2|Overall Study|Protocol Violation|3
3010190|NCT00875797|10354455|P1|Overall Study|Protocol Violation|6
3010191|NCT00875706|10354468|P3|Overall Study|Withdrawal by Subject|0
3010192|NCT00875706|10354469|P2|Overall Study|Withdrawal by Subject|0
3010193|NCT00875706|10354470|P1|Overall Study|Withdrawal by Subject|1
3010194|NCT00875667|10354489|P2|Overall Study|Randomized but no Study Drug Given|1
3010195|NCT00875667|10354490|P1|Overall Study|Randomized but no Study Drug Given|3
3010196|NCT00875667|10354489|P2|Overall Study|Miscellaneous|6
3010197|NCT00875667|10354490|P1|Overall Study|Miscellaneous|12
3010198|NCT00875667|10354489|P2|Overall Study|Disease Progression|49
3010199|NCT00875667|10354490|P1|Overall Study|Disease Progression|100
3010200|NCT00875667|10354489|P2|Overall Study|Protocol Violation|0
3010201|NCT00875667|10354490|P1|Overall Study|Protocol Violation|2
3010202|NCT00875667|10354489|P2|Overall Study|Death|2
3010203|NCT00875667|10354490|P1|Overall Study|Death|7
3010204|NCT00875667|10354489|P2|Overall Study|Withdrawal by Subject|5
3010205|NCT00875667|10354490|P1|Overall Study|Withdrawal by Subject|17
3010206|NCT00875667|10354489|P2|Overall Study|Adverse Event|10
3010207|NCT00875667|10354490|P1|Overall Study|Adverse Event|29
3010208|NCT00875615|10354625|P1|Overall Study|Withdrawal by Subject|1
3010209|NCT00875563|10354639|P1|Overall Study|Still be eligible for follow-up|7
3010210|NCT00875563|10354639|P1|Overall Study|No long-term (3-5 year) consent|6
3010211|NCT00875563|10354639|P1|Overall Study|Withdrawal by Subject|7
3010212|NCT00875563|10354639|P1|Overall Study|Death|4
3010213|NCT00875524|10354664|P2|Overall Study|Withdrawal by Subject|5
3010214|NCT00875524|10354665|P1|Overall Study|Withdrawal by Subject|3
3010215|NCT00875524|10354664|P2|Overall Study|Lost to Follow-up|0
3010216|NCT00875524|10354665|P1|Overall Study|Lost to Follow-up|1
3010217|NCT00875524|10354664|P2|Overall Study|Protocol Violation|0
3010218|NCT00875524|10354665|P1|Overall Study|Protocol Violation|4
3010219|NCT00875524|10354664|P2|Overall Study|Serious adverse event|1
3010220|NCT00875524|10354665|P1|Overall Study|Serious adverse event|0
3010221|NCT00875485|10354683|P2|Challenge Dose Epoch|Pregnancy|0
3010222|NCT00875485|10354684|P1|Challenge Dose Epoch|Pregnancy|1
3010223|NCT00875433|10354724|P1|Overall Study|Other|3
3010224|NCT00875433|10354724|P1|Overall Study|Withdrawal by Subject|2
3010225|NCT00875433|10354724|P1|Overall Study|Other Adverse Event|14
3010226|NCT00875433|10354724|P1|Overall Study|Progressive disease|41
3010227|NCT00875420|10354754|P5|Overall Study|Withdrawal by Subject|0
3010228|NCT00875420|10354755|P4|Overall Study|Withdrawal by Subject|0
3010229|NCT00875420|10354756|P3|Overall Study|Withdrawal by Subject|1
3010230|NCT00875420|10354757|P2|Overall Study|Withdrawal by Subject|0
3010231|NCT00875420|10354758|P1|Overall Study|Withdrawal by Subject|0
3010232|NCT00875420|10354754|P5|Overall Study|Sponsor decision|0
3010233|NCT00875420|10354755|P4|Overall Study|Sponsor decision|0
3010234|NCT00875420|10354756|P3|Overall Study|Sponsor decision|0
3010235|NCT00875420|10354757|P2|Overall Study|Sponsor decision|1
3010236|NCT00875420|10354758|P1|Overall Study|Sponsor decision|0
3010237|NCT00875420|10354754|P5|Overall Study|Prohibited medication|0
3010238|NCT00875420|10354755|P4|Overall Study|Prohibited medication|1
3010239|NCT00875420|10354756|P3|Overall Study|Prohibited medication|0
3010240|NCT00875420|10354757|P2|Overall Study|Prohibited medication|0
3010241|NCT00875420|10354758|P1|Overall Study|Prohibited medication|0
3010242|NCT00875420|10354754|P5|Overall Study|Personal reason|1
3010243|NCT00875420|10354755|P4|Overall Study|Personal reason|0
3010244|NCT00875420|10354756|P3|Overall Study|Personal reason|0
3010245|NCT00875420|10354757|P2|Overall Study|Personal reason|0
3010246|NCT00875420|10354758|P1|Overall Study|Personal reason|0
3010247|NCT00875420|10354754|P5|Overall Study|Lost to Follow-up|0
3010248|NCT00875420|10354755|P4|Overall Study|Lost to Follow-up|0
3010249|NCT00875420|10354756|P3|Overall Study|Lost to Follow-up|0
3010250|NCT00875420|10354757|P2|Overall Study|Lost to Follow-up|0
3010251|NCT00875420|10354758|P1|Overall Study|Lost to Follow-up|1
3010252|NCT00875420|10354754|P5|Overall Study|Inability to complete study procedures|1
3010253|NCT00875420|10354755|P4|Overall Study|Inability to complete study procedures|1
3010254|NCT00875420|10354756|P3|Overall Study|Inability to complete study procedures|1
3010255|NCT00875420|10354757|P2|Overall Study|Inability to complete study procedures|0
3010256|NCT00875420|10354758|P1|Overall Study|Inability to complete study procedures|1
3010258|NCT00875420|10354755|P4|Overall Study|Adverse Event|0
3010259|NCT00875420|10354756|P3|Overall Study|Adverse Event|1
3010260|NCT00875420|10354757|P2|Overall Study|Adverse Event|1
3010261|NCT00875420|10354758|P1|Overall Study|Adverse Event|0
3010262|NCT00875017|10354900|P6|Fourth Intervention|Inability to comply with fasting|1
3010263|NCT00875017|10354901|P5|Fourth Intervention|Inability to comply with fasting|0
3010264|NCT00875017|10354902|P4|Fourth Intervention|Inability to comply with fasting|0
3010265|NCT00875017|10354903|P3|Fourth Intervention|Inability to comply with fasting|0
3010266|NCT00875017|10354904|P2|Fourth Intervention|Inability to comply with fasting|0
3010267|NCT00875017|10354905|P1|Fourth Intervention|Inability to comply with fasting|0
3010268|NCT00875017|10354900|P6|Washout|Withdrawal by Subject|0
3010269|NCT00875017|10354901|P5|Washout|Withdrawal by Subject|1
3010270|NCT00875017|10354902|P4|Washout|Withdrawal by Subject|0
3010271|NCT00875017|10354903|P3|Washout|Withdrawal by Subject|0
3010272|NCT00875017|10354904|P2|Washout|Withdrawal by Subject|0
3010273|NCT00875017|10354905|P1|Washout|Withdrawal by Subject|0
3010274|NCT00875017|10354900|P6|Third Intervention|Adverse Event|0
3010275|NCT00875017|10354901|P5|Third Intervention|Adverse Event|0
3010276|NCT00875017|10354902|P4|Third Intervention|Adverse Event|0
3010277|NCT00875017|10354903|P3|Third Intervention|Adverse Event|1
3010278|NCT00875017|10354904|P2|Third Intervention|Adverse Event|1
3010279|NCT00875017|10354905|P1|Third Intervention|Adverse Event|0
3010280|NCT00875017|10354900|P6|Washout|Problems collecting rectal effluent|0
3010281|NCT00875017|10354901|P5|Washout|Problems collecting rectal effluent|0
3010282|NCT00875017|10354902|P4|Washout|Problems collecting rectal effluent|0
3010283|NCT00875017|10354903|P3|Washout|Problems collecting rectal effluent|0
3010284|NCT00875017|10354904|P2|Washout|Problems collecting rectal effluent|1
3010285|NCT00875017|10354905|P1|Washout|Problems collecting rectal effluent|0
3010286|NCT00875017|10354900|P6|Second Intervention|Adverse Event|0
3010287|NCT00875017|10354901|P5|Second Intervention|Adverse Event|0
3010288|NCT00875017|10354902|P4|Second Intervention|Adverse Event|1
3010289|NCT00875017|10354903|P3|Second Intervention|Adverse Event|0
3010290|NCT00875017|10354904|P2|Second Intervention|Adverse Event|0
3010291|NCT00875017|10354905|P1|Second Intervention|Adverse Event|0
3010292|NCT00875017|10354900|P6|Washout|Problem collecting rectal effluent|0
3010293|NCT00875017|10354901|P5|Washout|Problem collecting rectal effluent|0
3010294|NCT00875017|10354902|P4|Washout|Problem collecting rectal effluent|0
3010295|NCT00875017|10354903|P3|Washout|Problem collecting rectal effluent|1
3010296|NCT00875017|10354904|P2|Washout|Problem collecting rectal effluent|0
3010297|NCT00875017|10354905|P1|Washout|Problem collecting rectal effluent|0
3010298|NCT00875017|10354900|P6|First Intervention|Intolerance to nasogastric tube|0
3010299|NCT00875017|10354901|P5|First Intervention|Intolerance to nasogastric tube|1
3010300|NCT00875017|10354902|P4|First Intervention|Intolerance to nasogastric tube|0
3010301|NCT00875017|10354903|P3|First Intervention|Intolerance to nasogastric tube|0
3010302|NCT00875017|10354904|P2|First Intervention|Intolerance to nasogastric tube|0
3010303|NCT00875017|10354905|P1|First Intervention|Intolerance to nasogastric tube|0
3010304|NCT00875017|10354900|P6|First Intervention|Problems collecting rectal effluent|0
3010305|NCT00875017|10354901|P5|First Intervention|Problems collecting rectal effluent|0
3010306|NCT00875017|10354902|P4|First Intervention|Problems collecting rectal effluent|0
3010307|NCT00875017|10354903|P3|First Intervention|Problems collecting rectal effluent|0
3010308|NCT00875017|10354904|P2|First Intervention|Problems collecting rectal effluent|0
3010309|NCT00875017|10354905|P1|First Intervention|Problems collecting rectal effluent|1
3010310|NCT00875017|10354900|P6|First Intervention|Adverse Event|0
3010311|NCT00875017|10354901|P5|First Intervention|Adverse Event|0
3010312|NCT00875017|10354902|P4|First Intervention|Adverse Event|1
3010313|NCT00875017|10354903|P3|First Intervention|Adverse Event|0
3010314|NCT00875017|10354904|P2|First Intervention|Adverse Event|0
3010315|NCT00875017|10354905|P1|First Intervention|Adverse Event|0
3010316|NCT00875017|10354900|P6|First Intervention|Withdrawal by Subject|0
3010317|NCT00875017|10354901|P5|First Intervention|Withdrawal by Subject|0
3010318|NCT00875017|10354902|P4|First Intervention|Withdrawal by Subject|0
3010319|NCT00875017|10354903|P3|First Intervention|Withdrawal by Subject|1
3010320|NCT00875017|10354904|P2|First Intervention|Withdrawal by Subject|0
3010321|NCT00875017|10354905|P1|First Intervention|Withdrawal by Subject|1
3010322|NCT00874939|10354919|P1|Overall Study|Study terminated|4
3010323|NCT00874848|10354952|P2|Overall Study|Physician Decision|2
3010324|NCT00874848|10354953|P1|Overall Study|Physician Decision|0
3010325|NCT00874848|10354952|P2|Overall Study|Failure to comply with protocol|1
3010326|NCT00874848|10354953|P1|Overall Study|Failure to comply with protocol|0
3010327|NCT00874848|10354952|P2|Overall Study|Noncompliance|1
3010328|NCT00874848|10354953|P1|Overall Study|Noncompliance|1
3010329|NCT00874848|10354952|P2|Overall Study|Withdrawal by Subject|4
3010330|NCT00874848|10354953|P1|Overall Study|Withdrawal by Subject|7
3010331|NCT00874848|10354952|P2|Overall Study|Progressive neoplastic disease|18
3010332|NCT00874848|10354953|P1|Overall Study|Progressive neoplastic disease|38
3010333|NCT00874848|10354952|P2|Overall Study|Adverse Event|2
3010334|NCT00874848|10354953|P1|Overall Study|Adverse Event|13
3010335|NCT00874822|10354969|P1|Overall Study|excluded by criteria|8
3010336|NCT00874770|10354977|P4|Overall Study|Subject no Longer Meets Study Criteria|0
3010337|NCT00874770|10354978|P3|Overall Study|Subject no Longer Meets Study Criteria|0
3010338|NCT00874770|10354979|P2|Overall Study|Subject no Longer Meets Study Criteria|0
3010339|NCT00874770|10354980|P1|Overall Study|Subject no Longer Meets Study Criteria|1
3010340|NCT00874770|10354977|P4|Overall Study|Lost to Follow-up|1
3010341|NCT00874770|10354978|P3|Overall Study|Lost to Follow-up|0
3010342|NCT00874770|10354979|P2|Overall Study|Lost to Follow-up|0
3010343|NCT00874770|10354980|P1|Overall Study|Lost to Follow-up|1
3010344|NCT00874770|10354977|P4|Overall Study|Adverse Event|2
3010345|NCT00874770|10354978|P3|Overall Study|Adverse Event|4
3010346|NCT00874770|10354979|P2|Overall Study|Adverse Event|1
3010347|NCT00874770|10354980|P1|Overall Study|Adverse Event|1
3010348|NCT00874770|10354977|P4|Overall Study|Lack of Efficacy|2
3010349|NCT00874770|10354978|P3|Overall Study|Lack of Efficacy|0
3010350|NCT00874770|10354979|P2|Overall Study|Lack of Efficacy|0
3010351|NCT00874770|10354980|P1|Overall Study|Lack of Efficacy|2
3010352|NCT00874731|10355014|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
3010353|NCT00874731|10355015|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
3010354|NCT00874731|10355016|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
3010355|NCT00874731|10355014|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
3010356|NCT00874731|10355015|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
3010357|NCT00874731|10355016|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
3010358|NCT00874731|10355014|P3|Part 1, Day 1: Placebo|Disease Progression|0
3010359|NCT00874731|10355015|P2|Part 1, Day 1: Placebo|Disease Progression|0
3010360|NCT00874731|10355016|P1|Part 1, Day 1: Placebo|Disease Progression|1
3010361|NCT00874549|10355057|P4|Overall Study|Withdrawal by Subject|1
3010362|NCT00874549|10355058|P3|Overall Study|Withdrawal by Subject|0
3010363|NCT00874549|10355059|P2|Overall Study|Withdrawal by Subject|1
3010364|NCT00874549|10355060|P1|Overall Study|Withdrawal by Subject|0
3010365|NCT00874549|10355057|P4|Overall Study|Lost to Follow-up|0
3010366|NCT00874549|10355058|P3|Overall Study|Lost to Follow-up|1
3010367|NCT00874549|10355059|P2|Overall Study|Lost to Follow-up|0
3010368|NCT00874549|10355060|P1|Overall Study|Lost to Follow-up|0
3010369|NCT00874549|10355057|P4|Overall Study|Protocol Violation|1
3010370|NCT00874549|10355058|P3|Overall Study|Protocol Violation|2
3010371|NCT00874549|10355059|P2|Overall Study|Protocol Violation|0
3010372|NCT00874549|10355060|P1|Overall Study|Protocol Violation|1
3010373|NCT00874549|10355057|P4|Overall Study|Adverse Event|0
3010374|NCT00874549|10355058|P3|Overall Study|Adverse Event|1
3010375|NCT00874549|10355059|P2|Overall Study|Adverse Event|0
3010376|NCT00874549|10355060|P1|Overall Study|Adverse Event|0
3010377|NCT00874497|10355137|P2|Overall Study|Withdrawal by Subject|4
3010378|NCT00874497|10355138|P1|Overall Study|Withdrawal by Subject|5
3010379|NCT00874497|10355137|P2|Overall Study|Physician Decision|1
3010380|NCT00874497|10355138|P1|Overall Study|Physician Decision|1
3010381|NCT00874497|10355137|P2|Overall Study|Met Withdrawal Criteria|2
3010382|NCT00874497|10355138|P1|Overall Study|Met Withdrawal Criteria|4
3010383|NCT00874497|10355137|P2|Overall Study|Sponsor Discontinued Trial|3
3010384|NCT00874497|10355138|P1|Overall Study|Sponsor Discontinued Trial|7
3010385|NCT00874497|10355137|P2|Overall Study|Adverse Event|4
3010386|NCT00874497|10355138|P1|Overall Study|Adverse Event|9
3010387|NCT00874497|10355137|P2|Overall Study|Lost to Follow-up|4
3010388|NCT00874497|10355138|P1|Overall Study|Lost to Follow-up|2
3010389|NCT00874276|10355178|P2|Overall Study|Withdrawal by Subject|1
3010390|NCT00874276|10355179|P1|Overall Study|Withdrawal by Subject|1
3010391|NCT00874237|10355199|P6|Overall Study|Withdrawal by Subject|0
3010392|NCT00874237|10355200|P5|Overall Study|Withdrawal by Subject|0
3010393|NCT00874237|10355201|P4|Overall Study|Withdrawal by Subject|0
3010394|NCT00874237|10355202|P3|Overall Study|Withdrawal by Subject|1
3010395|NCT00874237|10355203|P2|Overall Study|Withdrawal by Subject|0
3010396|NCT00874237|10355204|P1|Overall Study|Withdrawal by Subject|0
3010397|NCT00874237|10355199|P6|Overall Study|Physician Decision|0
3010398|NCT00874237|10355200|P5|Overall Study|Physician Decision|0
3010399|NCT00874237|10355201|P4|Overall Study|Physician Decision|0
3010400|NCT00874237|10355202|P3|Overall Study|Physician Decision|0
3010401|NCT00874237|10355203|P2|Overall Study|Physician Decision|1
3010402|NCT00874237|10355204|P1|Overall Study|Physician Decision|0
3010403|NCT00874120|10355222|P2|Second Intervention|Protocol Violation|0
3010404|NCT00874120|10355223|P1|Second Intervention|Protocol Violation|1
3010405|NCT00874120|10355222|P2|Second Intervention|Withdrawal by Subject|0
3010406|NCT00874120|10355223|P1|Second Intervention|Withdrawal by Subject|1
3010407|NCT00874120|10355222|P2|First Intervention|positive drug test|0
3010408|NCT00874120|10355223|P1|First Intervention|positive drug test|1
3010409|NCT00874120|10355222|P2|First Intervention|Protocol Violation|0
3010410|NCT00874120|10355223|P1|First Intervention|Protocol Violation|3
3010411|NCT00874120|10355222|P2|First Intervention|Lost to Follow-up|1
3010412|NCT00874120|10355223|P1|First Intervention|Lost to Follow-up|0
3010413|NCT00874120|10355222|P2|First Intervention|Withdrawal by Subject|0
3010414|NCT00874120|10355223|P1|First Intervention|Withdrawal by Subject|2
3010415|NCT00874120|10355222|P2|First Intervention|Adverse Event|1
3010416|NCT00874120|10355223|P1|First Intervention|Adverse Event|0
3010417|NCT00874029|10355236|P1|Overall Study|Lost to Follow-up|5
3010418|NCT00874029|10355236|P1|Overall Study|Adverse Event|1
3010419|NCT00874029|10355236|P1|Overall Study|Physician Decision|1
3010420|NCT00874029|10355236|P1|Overall Study|Pregnancy|4
3010421|NCT00874029|10355236|P1|Overall Study|Withdrawal by Subject|10
3010422|NCT00873912|10355252|P2|Overall Study|Lost to Follow-up|0
3010423|NCT00873912|10355253|P1|Overall Study|Lost to Follow-up|2
3010424|NCT00873912|10355252|P2|Overall Study|Withdrawal by Subject|0
3010425|NCT00873912|10355253|P1|Overall Study|Withdrawal by Subject|1
3010426|NCT00873860|10355292|P4|Overall Study|Other|0
3010427|NCT00873860|10355293|P3|Overall Study|Other|1
3010428|NCT00873860|10355294|P2|Overall Study|Other|0
3010429|NCT00873860|10355295|P1|Overall Study|Other|1
3010430|NCT00873860|10355292|P4|Overall Study|Death|0
3010431|NCT00873860|10355293|P3|Overall Study|Death|0
3010432|NCT00873860|10355294|P2|Overall Study|Death|0
3010433|NCT00873860|10355295|P1|Overall Study|Death|1
3010434|NCT00873860|10355292|P4|Overall Study|Withdrawal by Subject|0
3010435|NCT00873860|10355293|P3|Overall Study|Withdrawal by Subject|2
3010436|NCT00873860|10355294|P2|Overall Study|Withdrawal by Subject|0
3010437|NCT00873860|10355295|P1|Overall Study|Withdrawal by Subject|1
3010438|NCT00873860|10355292|P4|Overall Study|Lost to Follow-up|1
3010439|NCT00873860|10355293|P3|Overall Study|Lost to Follow-up|0
3010440|NCT00873860|10355294|P2|Overall Study|Lost to Follow-up|0
3010441|NCT00873860|10355295|P1|Overall Study|Lost to Follow-up|1
3010442|NCT00873730|10355383|P2|Overall Study|Sponsor decision|0
3010443|NCT00873730|10355384|P1|Overall Study|Sponsor decision|1
3010444|NCT00873730|10355383|P2|Overall Study|Withdrawal by Subject|1
3010445|NCT00873730|10355384|P1|Overall Study|Withdrawal by Subject|0
3010446|NCT00873730|10355383|P2|Overall Study|Adverse Event|2
3010447|NCT00873730|10355384|P1|Overall Study|Adverse Event|0
3010448|NCT00873730|10355383|P2|Overall Study|Protocol Deviation|2
3010449|NCT00873730|10355384|P1|Overall Study|Protocol Deviation|5
3010450|NCT00873366|10355427|P1|Overall Study|Refused to continue DM-BT testing|3
3010451|NCT00873366|10355427|P1|Overall Study|Off tamoxifen due to side effects|2
3010452|NCT00873366|10355427|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
3010453|NCT00873119|10355452|P2|Overall Study|Not treated|0
3010454|NCT00873119|10355453|P1|Overall Study|Not treated|2
3010455|NCT00873119|10355452|P2|Overall Study|Other|5
3010456|NCT00873119|10355453|P1|Overall Study|Other|2
3010457|NCT00873119|10355452|P2|Overall Study|Death|1
3010458|NCT00873119|10355453|P1|Overall Study|Death|2
3010459|NCT00873119|10355452|P2|Overall Study|Progressive disease|18
3010460|NCT00873119|10355453|P1|Overall Study|Progressive disease|26
3010461|NCT00873119|10355452|P2|Overall Study|Adverse Event|0
3010462|NCT00873119|10355453|P1|Overall Study|Adverse Event|8
3010463|NCT00873119|10355452|P2|Overall Study|Patient request|2
3010464|NCT00873119|10355453|P1|Overall Study|Patient request|4
3010465|NCT00873093|10355474|P5|Overall Study|Ineligible|0
3010466|NCT00873093|10355475|P4|Overall Study|Ineligible|1
3010467|NCT00873093|10355476|P3|Overall Study|Ineligible|0
3010468|NCT00873093|10355477|P2|Overall Study|Ineligible|1
3010469|NCT00873093|10355478|P1|Overall Study|Ineligible|0
3010470|NCT00873093|10355474|P5|Overall Study|Withdrawal by Subject|0
3010471|NCT00873093|10355475|P4|Overall Study|Withdrawal by Subject|0
3010472|NCT00873093|10355476|P3|Overall Study|Withdrawal by Subject|4
3010473|NCT00873093|10355477|P2|Overall Study|Withdrawal by Subject|4
3010474|NCT00873093|10355478|P1|Overall Study|Withdrawal by Subject|1
3010475|NCT00873093|10355474|P5|Overall Study|Physician Decision|2
3010476|NCT00873093|10355475|P4|Overall Study|Physician Decision|10
3010477|NCT00873093|10355476|P3|Overall Study|Physician Decision|10
3010478|NCT00873093|10355477|P2|Overall Study|Physician Decision|17
3010479|NCT00873093|10355478|P1|Overall Study|Physician Decision|0
3010480|NCT00873093|10355474|P5|Overall Study|Death|0
3010481|NCT00873093|10355475|P4|Overall Study|Death|0
3010482|NCT00873093|10355476|P3|Overall Study|Death|2
3010483|NCT00873093|10355477|P2|Overall Study|Death|3
3010484|NCT00873093|10355478|P1|Overall Study|Death|0
3010485|NCT00873093|10355474|P5|Overall Study|Adverse Event|0
3010486|NCT00873093|10355475|P4|Overall Study|Adverse Event|0
3010487|NCT00873093|10355476|P3|Overall Study|Adverse Event|0
3010488|NCT00873093|10355477|P2|Overall Study|Adverse Event|2
3010489|NCT00873093|10355478|P1|Overall Study|Adverse Event|0
3010490|NCT00873041|10355535|P3|Extension Study|Administrative reasons|1
3010491|NCT00873041|10355536|P2|Extension Study|Administrative reasons|0
3010492|NCT00873041|10355537|P1|Extension Study|Administrative reasons|0
3010493|NCT00873041|10355535|P3|Extension Study|Adverse Event|1
3010494|NCT00873041|10355536|P2|Extension Study|Adverse Event|0
3010495|NCT00873041|10355537|P1|Extension Study|Adverse Event|1
3010496|NCT00873041|10355535|P3|Core Study|Protocol deviation|1
3010497|NCT00873041|10355536|P2|Core Study|Protocol deviation|0
3010498|NCT00873041|10355537|P1|Core Study|Protocol deviation|1
3010499|NCT00873041|10355535|P3|Core Study|Abnormal laboratory value|1
3010500|NCT00873041|10355536|P2|Core Study|Abnormal laboratory value|0
3010501|NCT00873041|10355537|P1|Core Study|Abnormal laboratory value|0
3010502|NCT00873041|10355535|P3|Core Study|Lost to Follow-up|0
3010503|NCT00873041|10355536|P2|Core Study|Lost to Follow-up|1
3010504|NCT00873041|10355537|P1|Core Study|Lost to Follow-up|3
3010505|NCT00873041|10355535|P3|Core Study|Withdrawal by Subject|2
3010506|NCT00873041|10355536|P2|Core Study|Withdrawal by Subject|2
3010507|NCT00873041|10355537|P1|Core Study|Withdrawal by Subject|1
3010508|NCT00873041|10355535|P3|Core Study|Adverse Event|1
3010509|NCT00873041|10355536|P2|Core Study|Adverse Event|3
3010510|NCT00873041|10355537|P1|Core Study|Adverse Event|2
3010511|NCT00873015|10355595|P4|Overall Study|Withdrawal by Subject|0
3010512|NCT00873015|10355596|P3|Overall Study|Withdrawal by Subject|0
3010513|NCT00873015|10355597|P2|Overall Study|Withdrawal by Subject|1
3010514|NCT00873015|10355598|P1|Overall Study|Withdrawal by Subject|0
3010515|NCT00872989|10355615|P2|Overall Study|Not protocol specified|8
3010516|NCT00872989|10355616|P1|Overall Study|Not protocol specified|3
3010517|NCT00872989|10355615|P2|Overall Study|Progression/relapse|35
3010518|NCT00872989|10355616|P1|Overall Study|Progression/relapse|47
3010519|NCT00872989|10355615|P2|Overall Study|Withdrawal by Subject|5
3010520|NCT00872989|10355616|P1|Overall Study|Withdrawal by Subject|8
3010521|NCT00872989|10355615|P2|Overall Study|Adverse Event|15
3010522|NCT00872989|10355616|P1|Overall Study|Adverse Event|7
3010523|NCT00872898|10355635|P2|Part Two - Double Blind|Other reasons|0
3010524|NCT00872898|10355636|P1|Part Two - Double Blind|Other reasons|2
3010525|NCT00872898|10355635|P2|Part Two - Double Blind|Lost to Follow-up|2
3010526|NCT00872898|10355636|P1|Part Two - Double Blind|Lost to Follow-up|0
3010527|NCT00872898|10355635|P2|Part Two - Double Blind|Withdrawal by Subject|1
3010528|NCT00872898|10355636|P1|Part Two - Double Blind|Withdrawal by Subject|3
3010529|NCT00872898|10355635|P2|Part Two - Double Blind|Protocol Violation|0
3010530|NCT00872898|10355636|P1|Part Two - Double Blind|Protocol Violation|1
3010531|NCT00872898|10355635|P2|Part Two - Double Blind|Lack of Efficacy|0
3010532|NCT00872898|10355636|P1|Part Two - Double Blind|Lack of Efficacy|1
3010533|NCT00872898|10355635|P2|Part Two - Double Blind|Adverse Event|3
3010534|NCT00872898|10355636|P1|Part Two - Double Blind|Adverse Event|4
3010535|NCT00872599|10355710|P2|Second Washout Period|Adverse Event|1
3010536|NCT00872599|10355711|P1|Second Washout Period|Adverse Event|1
3010537|NCT00872521|10355731|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
3010538|NCT00872521|10355732|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
3010539|NCT00872521|10355733|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
3010540|NCT00872521|10355731|P3|Completed 3-month Follow up|Physician Decision|0
3010541|NCT00872521|10355732|P2|Completed 3-month Follow up|Physician Decision|1
3010542|NCT00872521|10355733|P1|Completed 3-month Follow up|Physician Decision|0
3010543|NCT00872521|10355731|P3|Completed 3-month Follow up|Other|0
3010544|NCT00872521|10355732|P2|Completed 3-month Follow up|Other|2
3010545|NCT00872521|10355733|P1|Completed 3-month Follow up|Other|0
3010546|NCT00872521|10355731|P3|Primary Endpoint Analysis|Patient response missing|1
3010547|NCT00872521|10355732|P2|Primary Endpoint Analysis|Patient response missing|0
3010548|NCT00872521|10355733|P1|Primary Endpoint Analysis|Patient response missing|0
3010549|NCT00872521|10355731|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
3010550|NCT00872521|10355732|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
3010551|NCT00872521|10355733|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
3010552|NCT00872521|10355731|P3|Primary Endpoint Analysis|Patient choice|0
3010553|NCT00872521|10355732|P2|Primary Endpoint Analysis|Patient choice|1
3010554|NCT00872521|10355733|P1|Primary Endpoint Analysis|Patient choice|0
3010555|NCT00872521|10355731|P3|Primary Endpoint Analysis|Other|0
3010556|NCT00872521|10355732|P2|Primary Endpoint Analysis|Other|2
3010557|NCT00872521|10355733|P1|Primary Endpoint Analysis|Other|1
3010558|NCT00872521|10355731|P3|Completed PAD Induction|Death|0
3010559|NCT00872521|10355732|P2|Completed PAD Induction|Death|1
3010560|NCT00872521|10355733|P1|Completed PAD Induction|Death|1
3010561|NCT00872521|10355731|P3|Completed PAD Induction|Adverse Event|0
3010562|NCT00872521|10355732|P2|Completed PAD Induction|Adverse Event|0
3010563|NCT00872521|10355733|P1|Completed PAD Induction|Adverse Event|4
3010564|NCT00872521|10355731|P3|Completed PAD Induction|Disease progression|0
3010565|NCT00872521|10355732|P2|Completed PAD Induction|Disease progression|2
3010566|NCT00872521|10355733|P1|Completed PAD Induction|Disease progression|0
3010567|NCT00872521|10355731|P3|Completed PAD Induction|Patient choice|0
3010568|NCT00872521|10355732|P2|Completed PAD Induction|Patient choice|1
3010569|NCT00872521|10355733|P1|Completed PAD Induction|Patient choice|0
3010570|NCT00872170|10355804|P2|Overall Study|Adverse Event|0
3010571|NCT00872170|10355805|P1|Overall Study|Adverse Event|1
3010572|NCT00872001|10355835|P2|Overall Study|Administrative|15
3010573|NCT00872001|10355836|P1|Overall Study|Administrative|23
3010574|NCT00872001|10355835|P2|Overall Study|Did Not Meet Protocol Eligibility|36
3010575|NCT00872001|10355836|P1|Overall Study|Did Not Meet Protocol Eligibility|38
3010576|NCT00872001|10355835|P2|Overall Study|Protocol Violation|8
3010577|NCT00872001|10355836|P1|Overall Study|Protocol Violation|5
3010578|NCT00872001|10355835|P2|Overall Study|Withdrawal by Subject|30
3010579|NCT00872001|10355836|P1|Overall Study|Withdrawal by Subject|18
3010580|NCT00872001|10355835|P2|Overall Study|Lost to Follow-up|12
3010581|NCT00872001|10355836|P1|Overall Study|Lost to Follow-up|13
3010582|NCT00872001|10355835|P2|Overall Study|Protocol Defined Clinical Event|7
3010583|NCT00872001|10355836|P1|Overall Study|Protocol Defined Clinical Event|5
3010584|NCT00872001|10355835|P2|Overall Study|Adverse Event|23
3010585|NCT00872001|10355836|P1|Overall Study|Adverse Event|34
3010586|NCT00871975|10355844|P1|Overall Study|Motion artifact, tracing uninterpretable|5
3010587|NCT00871975|10355844|P1|Overall Study|Patient unable to void/insufficient vol|13
3010588|NCT00871975|10355844|P1|Overall Study|Catheters could not be inserted|1
3010589|NCT00871975|10355844|P1|Overall Study|Technical difficulty w155-1ith equipment|3
3010590|NCT00871871|10355850|P4|Part II|Protocol Violation|1
3010591|NCT00871871|10355851|P3|Part II|Protocol Violation|0
3010592|NCT00871871|10355852|P2|Part II|Protocol Violation|0
3010593|NCT00871871|10355853|P1|Part II|Protocol Violation|0
3010594|NCT00871871|10355850|P4|Part II|Adverse Event|2
3010595|NCT00871871|10355851|P3|Part II|Adverse Event|1
3010596|NCT00871871|10355852|P2|Part II|Adverse Event|0
3010597|NCT00871871|10355853|P1|Part II|Adverse Event|0
3010598|NCT00871871|10355850|P4|Part II|Withdrawal by Subject|1
3010599|NCT00871871|10355851|P3|Part II|Withdrawal by Subject|2
3010600|NCT00871871|10355852|P2|Part II|Withdrawal by Subject|0
3010601|NCT00871871|10355853|P1|Part II|Withdrawal by Subject|0
3010602|NCT00871871|10355850|P4|Part II|Lack of Efficacy|0
3010603|NCT00871871|10355851|P3|Part II|Lack of Efficacy|1
3010604|NCT00871871|10355852|P2|Part II|Lack of Efficacy|0
3010605|NCT00871871|10355853|P1|Part II|Lack of Efficacy|0
3010606|NCT00871871|10355850|P4|Part I|Laboratory abnormality|0
3010607|NCT00871871|10355851|P3|Part I|Laboratory abnormality|0
3010608|NCT00871871|10355852|P2|Part I|Laboratory abnormality|1
3010609|NCT00871871|10355853|P1|Part I|Laboratory abnormality|0
3010610|NCT00871871|10355850|P4|Part I|Withdrawal by Subject|0
3010611|NCT00871871|10355851|P3|Part I|Withdrawal by Subject|0
3010612|NCT00871871|10355852|P2|Part I|Withdrawal by Subject|0
3010613|NCT00871871|10355853|P1|Part I|Withdrawal by Subject|3
3010614|NCT00871871|10355850|P4|Part I|Adverse Event|0
3010615|NCT00871871|10355851|P3|Part I|Adverse Event|0
3010616|NCT00871871|10355852|P2|Part I|Adverse Event|2
3010617|NCT00871871|10355853|P1|Part I|Adverse Event|0
3010618|NCT00871780|10355890|P1|Overall Study|Physician Decision|1
3010619|NCT00871780|10355890|P1|Overall Study|Death|1
3010620|NCT00871780|10355890|P1|Overall Study|Voluntary Discontinuation|4
3010621|NCT00871780|10355890|P1|Overall Study|Adverse Event|6
3010622|NCT00871780|10355890|P1|Overall Study|Withdrawal by Subject|9
3010623|NCT00871780|10355890|P1|Overall Study|Enrolled But Not Treated|6
3010624|NCT00871741|10355910|P2|Overall Study|Premature study termination|7
3010625|NCT00871741|10355911|P1|Overall Study|Premature study termination|9
3010626|NCT00871728|10355925|P1|Overall Study|Withdrawal of Informed Consent|5
3010627|NCT00871728|10355925|P1|Overall Study|Participant Non-compliance|1
3010628|NCT00871728|10355925|P1|Overall Study|Failed to Visit Hospital|4
3010629|NCT00871728|10355925|P1|Overall Study|Lost to Follow-up|2
3010630|NCT00871728|10355925|P1|Overall Study|Protocol Violation|7
3010631|NCT00871728|10355925|P1|Overall Study|Adverse Event|1
3010632|NCT00871715|10355938|P3|Overall Study|Lost to Follow-up|9
3010633|NCT00871715|10355939|P2|Overall Study|Lost to Follow-up|6
3010634|NCT00871715|10355940|P1|Overall Study|Lost to Follow-up|3
3010635|NCT00871715|10355938|P3|Overall Study|Physician Decision|2
3010636|NCT00871715|10355939|P2|Overall Study|Physician Decision|0
3010637|NCT00871715|10355940|P1|Overall Study|Physician Decision|6
3010638|NCT00871715|10355938|P3|Overall Study|Withdrawal by Subject|15
3010639|NCT00871715|10355939|P2|Overall Study|Withdrawal by Subject|10
3010640|NCT00871715|10355940|P1|Overall Study|Withdrawal by Subject|6
3010641|NCT00871572|10356017|P4|Overall Study|Withdrawal by Subject|1
3010642|NCT00871572|10356018|P3|Overall Study|Withdrawal by Subject|3
3010643|NCT00871572|10356019|P2|Overall Study|Withdrawal by Subject|2
3010644|NCT00871572|10356020|P1|Overall Study|Withdrawal by Subject|1
3010645|NCT00871572|10356017|P4|Overall Study|Sponsor Decision|0
3010646|NCT00871572|10356018|P3|Overall Study|Sponsor Decision|0
3010647|NCT00871572|10356019|P2|Overall Study|Sponsor Decision|0
3010648|NCT00871572|10356020|P1|Overall Study|Sponsor Decision|1
3010649|NCT00871572|10356017|P4|Overall Study|Protocol Violation|1
3010650|NCT00871572|10356018|P3|Overall Study|Protocol Violation|1
3010651|NCT00871572|10356019|P2|Overall Study|Protocol Violation|0
3010652|NCT00871572|10356020|P1|Overall Study|Protocol Violation|0
3010653|NCT00871572|10356017|P4|Overall Study|Lost to Follow-up|1
3010654|NCT00871572|10356018|P3|Overall Study|Lost to Follow-up|0
3010655|NCT00871572|10356019|P2|Overall Study|Lost to Follow-up|1
3010656|NCT00871572|10356020|P1|Overall Study|Lost to Follow-up|0
3010657|NCT00871572|10356017|P4|Overall Study|Investigator Decision|1
3010658|NCT00871572|10356018|P3|Overall Study|Investigator Decision|0
3010659|NCT00871572|10356019|P2|Overall Study|Investigator Decision|1
3010660|NCT00871572|10356020|P1|Overall Study|Investigator Decision|0
3010661|NCT00871572|10356017|P4|Overall Study|Adverse Event|3
3010662|NCT00871572|10356018|P3|Overall Study|Adverse Event|0
3010663|NCT00871572|10356019|P2|Overall Study|Adverse Event|2
3010664|NCT00871572|10356020|P1|Overall Study|Adverse Event|0
3010665|NCT00871494|10356090|P1|Overall Study|Lost to Follow-up|1
3010666|NCT00871494|10356090|P1|Overall Study|Adverse Event|4
3010667|NCT00871494|10356090|P1|Overall Study|Lack of Efficacy|4
3010668|NCT00871494|10356090|P1|Overall Study|Protocol Violation|5
3010669|NCT00871429|10356097|P1|Overall Study|Questionnaire not completed|1
3010670|NCT00871429|10356097|P1|Overall Study|Withdrawal by Subject|17
3010671|NCT00871429|10356097|P1|Overall Study|Lost to Follow-up|6
3010672|NCT00871403|10356108|P3|Monotherapy Treatment Phase|Adverse Event|0
3010673|NCT00871403|10356109|P2|Monotherapy Treatment Phase|Adverse Event|4
3010674|NCT00871403|10356110|P1|Monotherapy Treatment Phase|Adverse Event|0
3010675|NCT00871403|10356108|P3|Monotherapy Treatment Phase|Disease Progression|1
3010676|NCT00871403|10356109|P2|Monotherapy Treatment Phase|Disease Progression|9
3010677|NCT00871403|10356110|P1|Monotherapy Treatment Phase|Disease Progression|0
3010678|NCT00871403|10356108|P3|Combination Treatment Phase|Physician Decision|3
3010679|NCT00871403|10356109|P2|Combination Treatment Phase|Physician Decision|1
3010680|NCT00871403|10356110|P1|Combination Treatment Phase|Physician Decision|0
3010681|NCT00871403|10356108|P3|Combination Treatment Phase|Withdrawal by Subject|1
3010682|NCT00871403|10356109|P2|Combination Treatment Phase|Withdrawal by Subject|3
3010683|NCT00871403|10356110|P1|Combination Treatment Phase|Withdrawal by Subject|0
3010684|NCT00871403|10356108|P3|Combination Treatment Phase|Disease Progression|5
3010685|NCT00871403|10356109|P2|Combination Treatment Phase|Disease Progression|8
3010686|NCT00871403|10356110|P1|Combination Treatment Phase|Disease Progression|0
3010687|NCT00871403|10356108|P3|Combination Treatment Phase|Adverse Event|2
3010688|NCT00871403|10356109|P2|Combination Treatment Phase|Adverse Event|17
3010689|NCT00871403|10356110|P1|Combination Treatment Phase|Adverse Event|0
3010690|NCT00871403|10356108|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
3010691|NCT00871403|10356109|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
3010692|NCT00871403|10356110|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
3010693|NCT00871403|10356108|P3|Combination Treatment Phase|Randomized but Not Treated|1
3010694|NCT00871403|10356109|P2|Combination Treatment Phase|Randomized but Not Treated|1
3010695|NCT00871403|10356110|P1|Combination Treatment Phase|Randomized but Not Treated|1
3010696|NCT00871377|10356123|P6|Third Intervention (10 Weeks)|Death|0
3010697|NCT00871377|10356124|P5|Third Intervention (10 Weeks)|Death|0
3010698|NCT00871377|10356125|P4|Third Intervention (10 Weeks)|Death|1
3010699|NCT00871377|10356126|P3|Third Intervention (10 Weeks)|Death|0
3010700|NCT00871377|10356127|P2|Third Intervention (10 Weeks)|Death|0
3010701|NCT00871377|10356128|P1|Third Intervention (10 Weeks)|Death|0
3010702|NCT00871377|10356123|P6|Washout (6 Weeks)|Withdrawal by Subject|1
3010703|NCT00871377|10356124|P5|Washout (6 Weeks)|Withdrawal by Subject|0
3010704|NCT00871377|10356125|P4|Washout (6 Weeks)|Withdrawal by Subject|0
3010705|NCT00871377|10356126|P3|Washout (6 Weeks)|Withdrawal by Subject|0
3010706|NCT00871377|10356127|P2|Washout (6 Weeks)|Withdrawal by Subject|0
3010707|NCT00871377|10356128|P1|Washout (6 Weeks)|Withdrawal by Subject|0
3010708|NCT00871377|10356123|P6|Washout (6 Weeks)|Withdrawal by Subject|0
3010709|NCT00871377|10356124|P5|Washout (6 Weeks)|Withdrawal by Subject|0
3010710|NCT00871377|10356125|P4|Washout (6 Weeks)|Withdrawal by Subject|0
3010711|NCT00871377|10356126|P3|Washout (6 Weeks)|Withdrawal by Subject|0
3010712|NCT00871377|10356127|P2|Washout (6 Weeks)|Withdrawal by Subject|0
3010713|NCT00871377|10356128|P1|Washout (6 Weeks)|Withdrawal by Subject|1
3010714|NCT00871377|10356123|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
3010715|NCT00871377|10356124|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
3010716|NCT00871377|10356125|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
3010717|NCT00871377|10356126|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
3010718|NCT00871377|10356127|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
3010719|NCT00871377|10356128|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
3010720|NCT00871377|10356123|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
3010721|NCT00871377|10356124|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
3010722|NCT00871377|10356125|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
3010723|NCT00871377|10356126|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
3010724|NCT00871377|10356127|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
3010725|NCT00871377|10356128|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
3010726|NCT00871351|10356139|P3|Overall Study|Adverse Event|0
3010727|NCT00871351|10356140|P2|Overall Study|Adverse Event|1
3010728|NCT00871351|10356141|P1|Overall Study|Adverse Event|3
3010729|NCT00871351|10356139|P3|Overall Study|Withdrawal by Subject|0
3010730|NCT00871351|10356140|P2|Overall Study|Withdrawal by Subject|0
3010731|NCT00871351|10356141|P1|Overall Study|Withdrawal by Subject|1
3010732|NCT00871338|10356163|P2|Prior to Booster|Lost to Follow-up|0
3010733|NCT00871338|10356164|P1|Prior to Booster|Lost to Follow-up|1
3010734|NCT00871338|10356163|P2|Prior to Booster|Withdrawal by Subject|3
3010735|NCT00871338|10356164|P1|Prior to Booster|Withdrawal by Subject|1
3010736|NCT00871234|10356253|P1|Overall Study|Lost to Follow-up|3
3010737|NCT00871234|10356253|P1|Overall Study|Adverse Event|2
3010738|NCT00871169|10356257|P1|Overall Study|Patient did not receive study treatment|2
3010739|NCT00871169|10356257|P1|Overall Study|Protocol Violation|1
3010740|NCT00871117|10356285|P2|Overall Study|Other|4
3010741|NCT00871117|10356286|P1|Overall Study|Other|0
3010742|NCT00871117|10356285|P2|Overall Study|Lost to Follow-up|6
3010743|NCT00871117|10356286|P1|Overall Study|Lost to Follow-up|5
3010744|NCT00871000|10356320|P2|Overall Study|Withdrawal by Subject|0
3010745|NCT00871000|10356321|P1|Overall Study|Withdrawal by Subject|1
3010746|NCT00870870|10356373|P4|Overall Study|Adverse Event|2
3010747|NCT00870870|10356374|P3|Overall Study|Adverse Event|2
3010748|NCT00870870|10356375|P2|Overall Study|Adverse Event|0
3010749|NCT00870870|10356376|P1|Overall Study|Adverse Event|0
3010750|NCT00870870|10356373|P4|Overall Study|Withdrawal by Subject|3
3010751|NCT00870870|10356374|P3|Overall Study|Withdrawal by Subject|1
3010752|NCT00870870|10356375|P2|Overall Study|Withdrawal by Subject|1
3010753|NCT00870870|10356376|P1|Overall Study|Withdrawal by Subject|0
3010754|NCT00870740|10356420|P6|Overall Study|Other|5
3010755|NCT00870740|10356421|P5|Overall Study|Other|3
3010756|NCT00870740|10356422|P4|Overall Study|Other|4
3010757|NCT00870740|10356423|P3|Overall Study|Other|2
3010758|NCT00870740|10356424|P2|Overall Study|Other|5
3010759|NCT00870740|10356425|P1|Overall Study|Other|2
3010760|NCT00870740|10356420|P6|Overall Study|Death|0
3010761|NCT00870740|10356421|P5|Overall Study|Death|1
3010762|NCT00870740|10356422|P4|Overall Study|Death|0
3010763|NCT00870740|10356423|P3|Overall Study|Death|0
3010764|NCT00870740|10356424|P2|Overall Study|Death|0
3010765|NCT00870740|10356425|P1|Overall Study|Death|0
3010766|NCT00870740|10356420|P6|Overall Study|Subject Non-compliance|1
3010767|NCT00870740|10356421|P5|Overall Study|Subject Non-compliance|0
3010768|NCT00870740|10356422|P4|Overall Study|Subject Non-compliance|0
3010769|NCT00870740|10356423|P3|Overall Study|Subject Non-compliance|0
3010770|NCT00870740|10356424|P2|Overall Study|Subject Non-compliance|0
3010771|NCT00870740|10356425|P1|Overall Study|Subject Non-compliance|0
3010772|NCT00870740|10356420|P6|Overall Study|Investigator Decision|0
3010773|NCT00870740|10356421|P5|Overall Study|Investigator Decision|0
3010774|NCT00870740|10356422|P4|Overall Study|Investigator Decision|0
3010775|NCT00870740|10356423|P3|Overall Study|Investigator Decision|1
3010776|NCT00870740|10356424|P2|Overall Study|Investigator Decision|0
3010777|NCT00870740|10356425|P1|Overall Study|Investigator Decision|2
3010778|NCT00870740|10356420|P6|Overall Study|Consent Withdrawn|5
3010779|NCT00870740|10356421|P5|Overall Study|Consent Withdrawn|6
3010780|NCT00870740|10356422|P4|Overall Study|Consent Withdrawn|6
3010781|NCT00870740|10356423|P3|Overall Study|Consent Withdrawn|4
3010782|NCT00870740|10356424|P2|Overall Study|Consent Withdrawn|3
3010783|NCT00870740|10356425|P1|Overall Study|Consent Withdrawn|6
3010784|NCT00870740|10356420|P6|Overall Study|Adverse Event|6
3010785|NCT00870740|10356421|P5|Overall Study|Adverse Event|1
3010786|NCT00870740|10356422|P4|Overall Study|Adverse Event|2
3010787|NCT00870740|10356423|P3|Overall Study|Adverse Event|3
3010788|NCT00870740|10356424|P2|Overall Study|Adverse Event|1
3010789|NCT00870740|10356425|P1|Overall Study|Adverse Event|2
3010790|NCT00870727|10356501|P2|Overall Study|Adverse Event|1
3010791|NCT00870727|10356502|P1|Overall Study|Adverse Event|0
3010792|NCT00870727|10356501|P2|Overall Study|Lack of Efficacy|3
3010793|NCT00870727|10356502|P1|Overall Study|Lack of Efficacy|1
3010794|NCT00870727|10356501|P2|Overall Study|Lost to Follow-up|1
3010795|NCT00870727|10356502|P1|Overall Study|Lost to Follow-up|0
3010796|NCT00870688|10356518|P1|Overall Study|Granules in the Stools|1
3010797|NCT00870688|10356518|P1|Overall Study|Death, Unrelated|1
3010798|NCT00870688|10356518|P1|Overall Study|Lost to Follow-up|2
3010799|NCT00870584|10356523|P2|Overall Study|Protocol Deviation|2
3010800|NCT00870584|10356524|P1|Overall Study|Protocol Deviation|2
3010801|NCT00870584|10356523|P2|Overall Study|Lost to Follow-up|1
3010802|NCT00870584|10356524|P1|Overall Study|Lost to Follow-up|5
3010803|NCT00870584|10356523|P2|Overall Study|Withdrawal by Subject|7
3010804|NCT00870584|10356524|P1|Overall Study|Withdrawal by Subject|6
3010805|NCT00870584|10356523|P2|Overall Study|Adverse Event|3
3010806|NCT00870584|10356524|P1|Overall Study|Adverse Event|3
3010807|NCT00870233|10356633|P1|Overall Study|Death|1
3010808|NCT00870233|10356633|P1|Overall Study|Incompatible internet browser|2
3010809|NCT00870233|10356633|P1|Overall Study|Did not undergo laparotomy|3
3010810|NCT00870233|10356633|P1|Overall Study|Withdrawal by Subject|18
3010811|NCT00870194|10356642|P2|Overall Study|Subject Decision|2
3010812|NCT00870194|10356643|P1|Overall Study|Subject Decision|7
3010813|NCT00870194|10356642|P2|Overall Study|Entry Criteria Not Met|2
3010814|NCT00870194|10356643|P1|Overall Study|Entry Criteria Not Met|1
3010815|NCT00870194|10356642|P2|Overall Study|Protocol Violation|3
3010816|NCT00870194|10356643|P1|Overall Study|Protocol Violation|3
3010817|NCT00870194|10356642|P2|Overall Study|Physician Decision|1
3010818|NCT00870194|10356643|P1|Overall Study|Physician Decision|3
3010819|NCT00870194|10356642|P2|Overall Study|Lost to Follow-up|0
3010820|NCT00870194|10356643|P1|Overall Study|Lost to Follow-up|2
3010821|NCT00870194|10356642|P2|Overall Study|Lack of Efficacy|1
3010822|NCT00870194|10356643|P1|Overall Study|Lack of Efficacy|0
3010823|NCT00870194|10356642|P2|Overall Study|Adverse Event|5
3010824|NCT00870194|10356643|P1|Overall Study|Adverse Event|10
3010825|NCT00870103|10356681|P1|Overall Study|Lost to Follow-up|2
3010826|NCT00870103|10356681|P1|Overall Study|Physician Decision|2
3010827|NCT00869999|10356686|P1|Overall Study|removed prior to starting therapy|1
3010828|NCT00869999|10356686|P1|Overall Study|Withdrawal by Subject|1
3010829|NCT00869960|10356692|P1|Overall Study|Lost to Follow-up|2
3010830|NCT00869778|10356741|P3|Overall Study|Unblinding|0
3010831|NCT00869778|10356742|P2|Overall Study|Unblinding|0
3010832|NCT00869778|10356743|P1|Overall Study|Unblinding|1
3010833|NCT00869778|10356741|P3|Overall Study|Protocol Violation|5
3010834|NCT00869778|10356742|P2|Overall Study|Protocol Violation|3
3010835|NCT00869778|10356743|P1|Overall Study|Protocol Violation|5
3010836|NCT00869778|10356741|P3|Overall Study|Pregnancy|0
3010837|NCT00869778|10356742|P2|Overall Study|Pregnancy|0
3010838|NCT00869778|10356743|P1|Overall Study|Pregnancy|1
3010839|NCT00869778|10356741|P3|Overall Study|Withdrawal by Subject|5
3010840|NCT00869778|10356742|P2|Overall Study|Withdrawal by Subject|4
3010841|NCT00869778|10356743|P1|Overall Study|Withdrawal by Subject|3
3010842|NCT00869778|10356741|P3|Overall Study|Adverse Event|0
3010843|NCT00869778|10356742|P2|Overall Study|Adverse Event|0
3010844|NCT00869778|10356743|P1|Overall Study|Adverse Event|2
3010845|NCT00869557|10356818|P2|Extension Phase|Withdrew Consent|0
3010846|NCT00869557|10356819|P1|Extension Phase|Withdrew Consent|2
3010847|NCT00869557|10356818|P2|Extension Phase|Investigator's Discretion|0
3010848|NCT00869557|10356819|P1|Extension Phase|Investigator's Discretion|2
3010849|NCT00869557|10356818|P2|Extension Phase|Lost to Follow-up|1
3010850|NCT00869557|10356819|P1|Extension Phase|Lost to Follow-up|3
3010851|NCT00869557|10356818|P2|Extension Phase|Lack of Efficacy|0
3010852|NCT00869557|10356819|P1|Extension Phase|Lack of Efficacy|1
3010853|NCT00869557|10356818|P2|Extension Phase|Adverse Event|2
3010854|NCT00869557|10356819|P1|Extension Phase|Adverse Event|2
3010855|NCT00869557|10356818|P2|Randomized Phase|Withdrew Consent|1
3010856|NCT00869557|10356819|P1|Randomized Phase|Withdrew Consent|0
3010857|NCT00869557|10356818|P2|Randomized Phase|Investigator's Discretion|0
3010858|NCT00869557|10356819|P1|Randomized Phase|Investigator's Discretion|1
3010859|NCT00869557|10356818|P2|Randomized Phase|Lost to Follow-up|1
3010860|NCT00869557|10356819|P1|Randomized Phase|Lost to Follow-up|2
3010861|NCT00869518|10356838|P2|Overall Study|Lost to Follow-up|1
3010862|NCT00869518|10356839|P1|Overall Study|Lost to Follow-up|1
3010863|NCT00869440|10356855|P4|Overall Study|Physician Decision|0
3010864|NCT00869440|10356856|P3|Overall Study|Physician Decision|0
3010865|NCT00869440|10356857|P2|Overall Study|Physician Decision|1
3010866|NCT00869440|10356858|P1|Overall Study|Physician Decision|1
3010867|NCT00869440|10356855|P4|Overall Study|Withdrawal by Subject|0
3010868|NCT00869440|10356856|P3|Overall Study|Withdrawal by Subject|0
3010869|NCT00869440|10356857|P2|Overall Study|Withdrawal by Subject|0
3010870|NCT00869440|10356858|P1|Overall Study|Withdrawal by Subject|1
3010871|NCT00869401|10356892|P5|Overall Study|Withdrawal by Subject|3
3010872|NCT00869401|10356893|P4|Overall Study|Withdrawal by Subject|5
3010873|NCT00869401|10356894|P3|Overall Study|Withdrawal by Subject|0
3010874|NCT00869401|10356895|P2|Overall Study|Withdrawal by Subject|0
3010875|NCT00869401|10356896|P1|Overall Study|Withdrawal by Subject|0
3010876|NCT00869362|10356925|P2|Overall Study|Lost to Follow-up|3
3010877|NCT00869362|10356926|P1|Overall Study|Lost to Follow-up|1
3010878|NCT00869362|10356925|P2|Overall Study|Death|2
3010879|NCT00869362|10356926|P1|Overall Study|Death|0
3010880|NCT00869323|10356947|P1|Maintenance Therapy|concurrent illness|1
3010881|NCT00869258|10356955|P1|Overall Study|Physician Decision|1
3010882|NCT00869128|10357020|P2|Overall Study|lack of Compliance|6
3010883|NCT00869128|10357021|P1|Overall Study|lack of Compliance|6
3010884|NCT00869089|10357025|P1|Overall Study|Screen Fail|1
3010885|NCT00869089|10357025|P1|Overall Study|Withdrawal by Subject|1
3010886|NCT00869089|10357025|P1|Overall Study|Lost to Follow-up|1
3010887|NCT00869050|10357029|P1|Overall Study|Screen Failure|3
3010888|NCT00869024|10357036|P2|Overall Study|Protocol Violation|1
3010889|NCT00869024|10357037|P1|Overall Study|Protocol Violation|0
3010890|NCT00869024|10357036|P2|Overall Study|Lost to Follow-up|1
3010891|NCT00869024|10357037|P1|Overall Study|Lost to Follow-up|0
3010892|NCT00869024|10357036|P2|Overall Study|Death|3
3010893|NCT00869024|10357037|P1|Overall Study|Death|2
3010894|NCT00868998|10357053|P1|Overall Study|Death|1
3010895|NCT00868998|10357053|P1|Overall Study|Progression of disease|2
3010896|NCT00868998|10357053|P1|Overall Study|Withdrawal by Subject|1
3010897|NCT00868998|10357053|P1|Overall Study|Screen Failure|1
3010898|NCT00868790|10357064|P14|Post-study|Excluded Medication|0
3010899|NCT00868790|10357065|P13|Post-study|Excluded Medication|0
3010900|NCT00868790|10357066|P12|Post-study|Excluded Medication|0
3010901|NCT00868790|10357067|P11|Post-study|Excluded Medication|0
3010902|NCT00868790|10357068|P10|Post-study|Excluded Medication|1
3010903|NCT00868790|10357069|P9|Post-study|Excluded Medication|0
3010904|NCT00868790|10357070|P8|Post-study|Excluded Medication|2
3010905|NCT00868790|10357071|P7|Post-study|Excluded Medication|0
3010906|NCT00868790|10357072|P6|Post-study|Excluded Medication|0
3010907|NCT00868790|10357073|P5|Post-study|Excluded Medication|0
3010908|NCT00868790|10357074|P4|Post-study|Excluded Medication|0
3010909|NCT00868790|10357075|P3|Post-study|Excluded Medication|0
3010910|NCT00868790|10357076|P2|Post-study|Excluded Medication|0
3010911|NCT00868790|10357077|P1|Post-study|Excluded Medication|0
3010912|NCT00868790|10357064|P14|Post-study|Withdrawal by Subject|0
3010913|NCT00868790|10357065|P13|Post-study|Withdrawal by Subject|0
3010914|NCT00868790|10357066|P12|Post-study|Withdrawal by Subject|0
3010915|NCT00868790|10357067|P11|Post-study|Withdrawal by Subject|0
3010916|NCT00868790|10357068|P10|Post-study|Withdrawal by Subject|0
3010917|NCT00868790|10357069|P9|Post-study|Withdrawal by Subject|0
3010918|NCT00868790|10357070|P8|Post-study|Withdrawal by Subject|0
3010919|NCT00868790|10357071|P7|Post-study|Withdrawal by Subject|0
3010920|NCT00868790|10357072|P6|Post-study|Withdrawal by Subject|0
3010921|NCT00868790|10357073|P5|Post-study|Withdrawal by Subject|1
3010922|NCT00868790|10357074|P4|Post-study|Withdrawal by Subject|0
3010923|NCT00868790|10357075|P3|Post-study|Withdrawal by Subject|0
3010924|NCT00868790|10357076|P2|Post-study|Withdrawal by Subject|0
3010925|NCT00868790|10357077|P1|Post-study|Withdrawal by Subject|0
3010926|NCT00868790|10357064|P14|Period 4|Abnormal ALT/AST|0
3010927|NCT00868790|10357065|P13|Period 4|Abnormal ALT/AST|0
3010928|NCT00868790|10357066|P12|Period 4|Abnormal ALT/AST|0
3010929|NCT00868790|10357067|P11|Period 4|Abnormal ALT/AST|0
3010930|NCT00868790|10357068|P10|Period 4|Abnormal ALT/AST|0
3010931|NCT00868790|10357069|P9|Period 4|Abnormal ALT/AST|0
3010932|NCT00868790|10357070|P8|Period 4|Abnormal ALT/AST|0
3010933|NCT00868790|10357071|P7|Period 4|Abnormal ALT/AST|0
3010934|NCT00868790|10357072|P6|Period 4|Abnormal ALT/AST|0
3010935|NCT00868790|10357073|P5|Period 4|Abnormal ALT/AST|0
3010936|NCT00868790|10357074|P4|Period 4|Abnormal ALT/AST|0
3010937|NCT00868790|10357075|P3|Period 4|Abnormal ALT/AST|1
3010938|NCT00868790|10357076|P2|Period 4|Abnormal ALT/AST|0
3010939|NCT00868790|10357077|P1|Period 4|Abnormal ALT/AST|0
3010940|NCT00868790|10357064|P14|Period 4|Study Terminated by Sponsor|1
3010941|NCT00868790|10357065|P13|Period 4|Study Terminated by Sponsor|0
3010942|NCT00868790|10357066|P12|Period 4|Study Terminated by Sponsor|1
3010943|NCT00868790|10357067|P11|Period 4|Study Terminated by Sponsor|2
3010944|NCT00868790|10357068|P10|Period 4|Study Terminated by Sponsor|0
3010945|NCT00868790|10357069|P9|Period 4|Study Terminated by Sponsor|2
3010946|NCT00868790|10357070|P8|Period 4|Study Terminated by Sponsor|1
3010947|NCT00868790|10357071|P7|Period 4|Study Terminated by Sponsor|0
3010948|NCT00868790|10357072|P6|Period 4|Study Terminated by Sponsor|0
3010949|NCT00868790|10357073|P5|Period 4|Study Terminated by Sponsor|0
3010950|NCT00868790|10357074|P4|Period 4|Study Terminated by Sponsor|0
3010951|NCT00868790|10357075|P3|Period 4|Study Terminated by Sponsor|0
3010952|NCT00868790|10357076|P2|Period 4|Study Terminated by Sponsor|0
3010953|NCT00868790|10357077|P1|Period 4|Study Terminated by Sponsor|2
3010954|NCT00868790|10357064|P14|Period 4|Lost to Follow-up|0
3010955|NCT00868790|10357065|P13|Period 4|Lost to Follow-up|0
3010956|NCT00868790|10357066|P12|Period 4|Lost to Follow-up|0
3010957|NCT00868790|10357067|P11|Period 4|Lost to Follow-up|0
3010958|NCT00868790|10357068|P10|Period 4|Lost to Follow-up|0
3010959|NCT00868790|10357069|P9|Period 4|Lost to Follow-up|0
3010960|NCT00868790|10357070|P8|Period 4|Lost to Follow-up|1
3010961|NCT00868790|10357071|P7|Period 4|Lost to Follow-up|0
3010962|NCT00868790|10357072|P6|Period 4|Lost to Follow-up|0
3010963|NCT00868790|10357073|P5|Period 4|Lost to Follow-up|0
3010964|NCT00868790|10357074|P4|Period 4|Lost to Follow-up|0
3010965|NCT00868790|10357075|P3|Period 4|Lost to Follow-up|0
3010966|NCT00868790|10357076|P2|Period 4|Lost to Follow-up|0
3010967|NCT00868790|10357077|P1|Period 4|Lost to Follow-up|0
3010968|NCT00868790|10357064|P14|Period 4|Adverse Event|0
3010969|NCT00868790|10357065|P13|Period 4|Adverse Event|1
3010970|NCT00868790|10357066|P12|Period 4|Adverse Event|0
3010971|NCT00868790|10357067|P11|Period 4|Adverse Event|1
3010972|NCT00868790|10357068|P10|Period 4|Adverse Event|0
3010973|NCT00868790|10357069|P9|Period 4|Adverse Event|0
3010974|NCT00868790|10357070|P8|Period 4|Adverse Event|1
3010975|NCT00868790|10357071|P7|Period 4|Adverse Event|0
3010976|NCT00868790|10357072|P6|Period 4|Adverse Event|0
3010977|NCT00868790|10357073|P5|Period 4|Adverse Event|0
3010978|NCT00868790|10357074|P4|Period 4|Adverse Event|0
3010979|NCT00868790|10357075|P3|Period 4|Adverse Event|0
3010980|NCT00868790|10357076|P2|Period 4|Adverse Event|0
3010981|NCT00868790|10357077|P1|Period 4|Adverse Event|0
3010982|NCT00868790|10357064|P14|Period 3|Study Terminated by Sponsor|0
3010983|NCT00868790|10357065|P13|Period 3|Study Terminated by Sponsor|0
3010984|NCT00868790|10357066|P12|Period 3|Study Terminated by Sponsor|0
3010985|NCT00868790|10357067|P11|Period 3|Study Terminated by Sponsor|0
3010986|NCT00868790|10357068|P10|Period 3|Study Terminated by Sponsor|0
3010987|NCT00868790|10357069|P9|Period 3|Study Terminated by Sponsor|0
3010988|NCT00868790|10357070|P8|Period 3|Study Terminated by Sponsor|0
3010989|NCT00868790|10357071|P7|Period 3|Study Terminated by Sponsor|0
3010990|NCT00868790|10357072|P6|Period 3|Study Terminated by Sponsor|0
3010991|NCT00868790|10357073|P5|Period 3|Study Terminated by Sponsor|0
3010992|NCT00868790|10357074|P4|Period 3|Study Terminated by Sponsor|1
3010993|NCT00868790|10357075|P3|Period 3|Study Terminated by Sponsor|0
3010994|NCT00868790|10357076|P2|Period 3|Study Terminated by Sponsor|0
3010995|NCT00868790|10357077|P1|Period 3|Study Terminated by Sponsor|0
3010996|NCT00868790|10357064|P14|Period 3|Protocol Violation|0
3010997|NCT00868790|10357065|P13|Period 3|Protocol Violation|0
3010998|NCT00868790|10357066|P12|Period 3|Protocol Violation|0
3010999|NCT00868790|10357067|P11|Period 3|Protocol Violation|1
3011000|NCT00868790|10357068|P10|Period 3|Protocol Violation|0
3011001|NCT00868790|10357069|P9|Period 3|Protocol Violation|0
3011002|NCT00868790|10357070|P8|Period 3|Protocol Violation|0
3011003|NCT00868790|10357071|P7|Period 3|Protocol Violation|0
3011004|NCT00868790|10357072|P6|Period 3|Protocol Violation|0
3011005|NCT00868790|10357073|P5|Period 3|Protocol Violation|0
3011006|NCT00868790|10357074|P4|Period 3|Protocol Violation|0
3011007|NCT00868790|10357075|P3|Period 3|Protocol Violation|0
3011008|NCT00868790|10357076|P2|Period 3|Protocol Violation|0
3011009|NCT00868790|10357077|P1|Period 3|Protocol Violation|0
3011010|NCT00868790|10357064|P14|Period 3|Adverse Event|0
3011011|NCT00868790|10357065|P13|Period 3|Adverse Event|0
3011012|NCT00868790|10357066|P12|Period 3|Adverse Event|0
3011013|NCT00868790|10357067|P11|Period 3|Adverse Event|0
3011014|NCT00868790|10357068|P10|Period 3|Adverse Event|1
3011015|NCT00868790|10357069|P9|Period 3|Adverse Event|0
3011016|NCT00868790|10357070|P8|Period 3|Adverse Event|0
3011017|NCT00868790|10357071|P7|Period 3|Adverse Event|0
3011018|NCT00868790|10357072|P6|Period 3|Adverse Event|0
3011019|NCT00868790|10357073|P5|Period 3|Adverse Event|0
3011020|NCT00868790|10357074|P4|Period 3|Adverse Event|0
3011021|NCT00868790|10357075|P3|Period 3|Adverse Event|0
3011022|NCT00868790|10357076|P2|Period 3|Adverse Event|0
3011023|NCT00868790|10357077|P1|Period 3|Adverse Event|0
3011024|NCT00868790|10357064|P14|Period 2|Withdrawal by Subject|1
3011025|NCT00868790|10357065|P13|Period 2|Withdrawal by Subject|0
3011026|NCT00868790|10357066|P12|Period 2|Withdrawal by Subject|0
3011027|NCT00868790|10357067|P11|Period 2|Withdrawal by Subject|0
3011028|NCT00868790|10357068|P10|Period 2|Withdrawal by Subject|0
3011029|NCT00868790|10357069|P9|Period 2|Withdrawal by Subject|1
3011030|NCT00868790|10357070|P8|Period 2|Withdrawal by Subject|0
3011031|NCT00868790|10357071|P7|Period 2|Withdrawal by Subject|0
3011032|NCT00868790|10357072|P6|Period 2|Withdrawal by Subject|0
3011033|NCT00868790|10357073|P5|Period 2|Withdrawal by Subject|0
3011034|NCT00868790|10357074|P4|Period 2|Withdrawal by Subject|0
3011035|NCT00868790|10357075|P3|Period 2|Withdrawal by Subject|0
3011036|NCT00868790|10357076|P2|Period 2|Withdrawal by Subject|0
3011037|NCT00868790|10357077|P1|Period 2|Withdrawal by Subject|0
3011038|NCT00868790|10357064|P14|Period 2|Lost to Follow-up|0
3011039|NCT00868790|10357065|P13|Period 2|Lost to Follow-up|0
3011040|NCT00868790|10357066|P12|Period 2|Lost to Follow-up|0
3011041|NCT00868790|10357067|P11|Period 2|Lost to Follow-up|0
3011042|NCT00868790|10357068|P10|Period 2|Lost to Follow-up|0
3011043|NCT00868790|10357069|P9|Period 2|Lost to Follow-up|0
3011044|NCT00868790|10357070|P8|Period 2|Lost to Follow-up|0
3011045|NCT00868790|10357071|P7|Period 2|Lost to Follow-up|0
3011046|NCT00868790|10357072|P6|Period 2|Lost to Follow-up|1
3011047|NCT00868790|10357073|P5|Period 2|Lost to Follow-up|0
3011048|NCT00868790|10357074|P4|Period 2|Lost to Follow-up|0
3011049|NCT00868790|10357075|P3|Period 2|Lost to Follow-up|0
3011050|NCT00868790|10357076|P2|Period 2|Lost to Follow-up|1
3011051|NCT00868790|10357077|P1|Period 2|Lost to Follow-up|0
3011052|NCT00868790|10357064|P14|Period 2|Adverse Event|0
3011053|NCT00868790|10357065|P13|Period 2|Adverse Event|0
3011054|NCT00868790|10357066|P12|Period 2|Adverse Event|0
3011055|NCT00868790|10357067|P11|Period 2|Adverse Event|0
3011056|NCT00868790|10357068|P10|Period 2|Adverse Event|0
3011057|NCT00868790|10357069|P9|Period 2|Adverse Event|1
3011058|NCT00868790|10357070|P8|Period 2|Adverse Event|0
3011059|NCT00868790|10357071|P7|Period 2|Adverse Event|0
3011060|NCT00868790|10357072|P6|Period 2|Adverse Event|0
3011061|NCT00868790|10357073|P5|Period 2|Adverse Event|0
3011062|NCT00868790|10357074|P4|Period 2|Adverse Event|0
3011063|NCT00868790|10357075|P3|Period 2|Adverse Event|0
3011064|NCT00868790|10357076|P2|Period 2|Adverse Event|0
3011065|NCT00868790|10357077|P1|Period 2|Adverse Event|0
3011066|NCT00868790|10357064|P14|Period 1|Lost to Follow-up|0
3011067|NCT00868790|10357065|P13|Period 1|Lost to Follow-up|0
3011068|NCT00868790|10357066|P12|Period 1|Lost to Follow-up|0
3011069|NCT00868790|10357067|P11|Period 1|Lost to Follow-up|0
3011070|NCT00868790|10357068|P10|Period 1|Lost to Follow-up|0
3011071|NCT00868790|10357069|P9|Period 1|Lost to Follow-up|0
3011072|NCT00868790|10357070|P8|Period 1|Lost to Follow-up|0
3011073|NCT00868790|10357071|P7|Period 1|Lost to Follow-up|0
3011074|NCT00868790|10357072|P6|Period 1|Lost to Follow-up|1
3011075|NCT00868790|10357073|P5|Period 1|Lost to Follow-up|0
3011076|NCT00868790|10357074|P4|Period 1|Lost to Follow-up|0
3011077|NCT00868790|10357075|P3|Period 1|Lost to Follow-up|0
3011078|NCT00868790|10357076|P2|Period 1|Lost to Follow-up|0
3011079|NCT00868790|10357077|P1|Period 1|Lost to Follow-up|0
3011080|NCT00868790|10357064|P14|Period 1|Abnormal Triglycerides|0
3011081|NCT00868790|10357065|P13|Period 1|Abnormal Triglycerides|0
3011082|NCT00868790|10357066|P12|Period 1|Abnormal Triglycerides|0
3011083|NCT00868790|10357067|P11|Period 1|Abnormal Triglycerides|0
3011084|NCT00868790|10357068|P10|Period 1|Abnormal Triglycerides|0
3011085|NCT00868790|10357069|P9|Period 1|Abnormal Triglycerides|0
3011086|NCT00868790|10357070|P8|Period 1|Abnormal Triglycerides|0
3011087|NCT00868790|10357071|P7|Period 1|Abnormal Triglycerides|0
3011088|NCT00868790|10357072|P6|Period 1|Abnormal Triglycerides|0
3011089|NCT00868790|10357073|P5|Period 1|Abnormal Triglycerides|1
3011090|NCT00868790|10357074|P4|Period 1|Abnormal Triglycerides|0
3011091|NCT00868790|10357075|P3|Period 1|Abnormal Triglycerides|0
3011092|NCT00868790|10357076|P2|Period 1|Abnormal Triglycerides|0
3011093|NCT00868790|10357077|P1|Period 1|Abnormal Triglycerides|0
3011094|NCT00868790|10357064|P14|Period 1|Withdrawal by Subject|1
3011095|NCT00868790|10357065|P13|Period 1|Withdrawal by Subject|0
3011096|NCT00868790|10357066|P12|Period 1|Withdrawal by Subject|0
3011097|NCT00868790|10357067|P11|Period 1|Withdrawal by Subject|0
3011098|NCT00868790|10357068|P10|Period 1|Withdrawal by Subject|0
3011099|NCT00868790|10357069|P9|Period 1|Withdrawal by Subject|0
3011100|NCT00868790|10357070|P8|Period 1|Withdrawal by Subject|0
3011101|NCT00868790|10357071|P7|Period 1|Withdrawal by Subject|0
3011102|NCT00868790|10357072|P6|Period 1|Withdrawal by Subject|0
3011103|NCT00868790|10357073|P5|Period 1|Withdrawal by Subject|0
3011104|NCT00868790|10357074|P4|Period 1|Withdrawal by Subject|0
3011105|NCT00868790|10357075|P3|Period 1|Withdrawal by Subject|0
3011106|NCT00868790|10357076|P2|Period 1|Withdrawal by Subject|1
3011107|NCT00868790|10357077|P1|Period 1|Withdrawal by Subject|0
3011108|NCT00868790|10357064|P14|Period 1|Protocol Violation|0
3011109|NCT00868790|10357065|P13|Period 1|Protocol Violation|0
3011110|NCT00868790|10357066|P12|Period 1|Protocol Violation|0
3011111|NCT00868790|10357067|P11|Period 1|Protocol Violation|0
3011112|NCT00868790|10357068|P10|Period 1|Protocol Violation|0
3011113|NCT00868790|10357069|P9|Period 1|Protocol Violation|0
3011114|NCT00868790|10357070|P8|Period 1|Protocol Violation|0
3011115|NCT00868790|10357071|P7|Period 1|Protocol Violation|0
3011116|NCT00868790|10357072|P6|Period 1|Protocol Violation|0
3011117|NCT00868790|10357073|P5|Period 1|Protocol Violation|0
3011118|NCT00868790|10357074|P4|Period 1|Protocol Violation|0
3011119|NCT00868790|10357075|P3|Period 1|Protocol Violation|0
3011120|NCT00868790|10357076|P2|Period 1|Protocol Violation|0
3011121|NCT00868790|10357077|P1|Period 1|Protocol Violation|1
3011122|NCT00868790|10357064|P14|Period 1|Adverse Event|1
3011123|NCT00868790|10357065|P13|Period 1|Adverse Event|0
3011124|NCT00868790|10357066|P12|Period 1|Adverse Event|0
3011125|NCT00868790|10357067|P11|Period 1|Adverse Event|0
3011126|NCT00868790|10357068|P10|Period 1|Adverse Event|0
3011127|NCT00868790|10357069|P9|Period 1|Adverse Event|1
3011128|NCT00868790|10357070|P8|Period 1|Adverse Event|3
3011129|NCT00868790|10357071|P7|Period 1|Adverse Event|0
3011130|NCT00868790|10357072|P6|Period 1|Adverse Event|0
3011131|NCT00868790|10357073|P5|Period 1|Adverse Event|0
3011132|NCT00868790|10357074|P4|Period 1|Adverse Event|0
3011133|NCT00868790|10357075|P3|Period 1|Adverse Event|0
3011134|NCT00868790|10357076|P2|Period 1|Adverse Event|0
3011135|NCT00868790|10357077|P1|Period 1|Adverse Event|1
3011136|NCT00868608|10357160|P3|Overall Study|Other - Unspecified|0
3011137|NCT00868608|10357161|P2|Overall Study|Other - Unspecified|0
3011138|NCT00868608|10357162|P1|Overall Study|Other - Unspecified|1
3011139|NCT00868608|10357160|P3|Overall Study|Death|4
3011140|NCT00868608|10357161|P2|Overall Study|Death|2
3011141|NCT00868608|10357162|P1|Overall Study|Death|16
3011142|NCT00868608|10357160|P3|Overall Study|Lost to Follow-up|1
3011143|NCT00868608|10357161|P2|Overall Study|Lost to Follow-up|0
3011144|NCT00868608|10357162|P1|Overall Study|Lost to Follow-up|3
3011145|NCT00868608|10357160|P3|Overall Study|Withdrawal by Subject|0
3011146|NCT00868608|10357161|P2|Overall Study|Withdrawal by Subject|1
3011147|NCT00868608|10357162|P1|Overall Study|Withdrawal by Subject|3
3011148|NCT00868530|10357186|P1|Overall Study|Lost to Follow-up|1
3011149|NCT00868530|10357186|P1|Overall Study|Adverse Event|3
3011150|NCT00868517|10357201|P3|Overall Study|Protocol Violation|0
3011151|NCT00868517|10357202|P2|Overall Study|Protocol Violation|1
3011152|NCT00868517|10357203|P1|Overall Study|Protocol Violation|1
3011153|NCT00868517|10357201|P3|Overall Study|Withdrawal by Subject|2
3011154|NCT00868517|10357202|P2|Overall Study|Withdrawal by Subject|3
3011155|NCT00868517|10357203|P1|Overall Study|Withdrawal by Subject|3
3011156|NCT00868439|10357241|P2|Overall Study|Withdrawal by Subject|1
3011157|NCT00868439|10357242|P1|Overall Study|Withdrawal by Subject|0
3011158|NCT00868439|10357241|P2|Overall Study|Physician Decision|0
3011159|NCT00868439|10357242|P1|Overall Study|Physician Decision|1
3011160|NCT00868439|10357241|P2|Overall Study|Protocol Violation|1
3011161|NCT00868439|10357242|P1|Overall Study|Protocol Violation|1
3011162|NCT00868439|10357241|P2|Overall Study|Death|1
3011163|NCT00868439|10357242|P1|Overall Study|Death|0
3011164|NCT00868439|10357241|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
3011165|NCT00868439|10357242|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
3011166|NCT00868439|10357241|P2|Overall Study|Adverse Event|3
3011167|NCT00868439|10357242|P1|Overall Study|Adverse Event|4
3011168|NCT00868296|10357299|P2|Overall Study|Withdrawal by Subject|1
3011169|NCT00868296|10357300|P1|Overall Study|Withdrawal by Subject|0
3011170|NCT00868296|10357299|P2|Overall Study|Adverse Event|2
3011171|NCT00868296|10357300|P1|Overall Study|Adverse Event|0
3011172|NCT00868231|10357308|P6|Treatment Period 3|Adverse Event|0
3011173|NCT00868231|10357309|P5|Treatment Period 3|Adverse Event|0
3011174|NCT00868231|10357310|P4|Treatment Period 3|Adverse Event|0
3011175|NCT00868231|10357311|P3|Treatment Period 3|Adverse Event|1
3011176|NCT00868231|10357312|P2|Treatment Period 3|Adverse Event|0
3011177|NCT00868231|10357313|P1|Treatment Period 3|Adverse Event|0
3011178|NCT00868231|10357308|P6|Treatment Period 2|Adverse Event|0
3011179|NCT00868231|10357309|P5|Treatment Period 2|Adverse Event|0
3011180|NCT00868231|10357310|P4|Treatment Period 2|Adverse Event|0
3011181|NCT00868231|10357311|P3|Treatment Period 2|Adverse Event|0
3011182|NCT00868231|10357312|P2|Treatment Period 2|Adverse Event|0
3011183|NCT00868231|10357313|P1|Treatment Period 2|Adverse Event|1
3011184|NCT00868231|10357308|P6|Treatment Period 1|Adverse Event|0
3011185|NCT00868231|10357309|P5|Treatment Period 1|Adverse Event|1
3011186|NCT00868231|10357310|P4|Treatment Period 1|Adverse Event|0
3011187|NCT00868231|10357311|P3|Treatment Period 1|Adverse Event|0
3011188|NCT00868231|10357312|P2|Treatment Period 1|Adverse Event|0
3011189|NCT00868231|10357313|P1|Treatment Period 1|Adverse Event|0
3011190|NCT00868192|10357379|P1|Overall Study|Ineligible|4
3011191|NCT00868166|10357396|P2|Overall Study|Non-compliance with IMP|1
3011192|NCT00868166|10357397|P1|Overall Study|Non-compliance with IMP|1
3011193|NCT00868166|10357396|P2|Overall Study|Lack of efficacy, logistics, unwell|10
3011194|NCT00868166|10357397|P1|Overall Study|Lack of efficacy, logistics, unwell|9
3011195|NCT00868166|10357396|P2|Overall Study|Adverse Event|10
3011196|NCT00868166|10357397|P1|Overall Study|Adverse Event|9
3011197|NCT00868166|10357396|P2|Overall Study|Lost to Follow-up|3
3011198|NCT00868166|10357397|P1|Overall Study|Lost to Follow-up|1
3011199|NCT00868166|10357396|P2|Overall Study|Protocol Violation|0
3011200|NCT00868166|10357397|P1|Overall Study|Protocol Violation|1
3011201|NCT00868166|10357396|P2|Overall Study|Withdrawal by Subject|25
3011202|NCT00868166|10357397|P1|Overall Study|Withdrawal by Subject|33
3011203|NCT00868166|10357396|P2|Overall Study|Death|65
3011204|NCT00868166|10357397|P1|Overall Study|Death|58
3011205|NCT00867815|10357459|P1|Overall Study|Lost to Follow-up|1
3011206|NCT00867568|10357470|P1|Overall Study|Withdrawal by Subject|1
3011207|NCT00867568|10357470|P1|Overall Study|Adverse Event|4
3011208|NCT00867568|10357470|P1|Overall Study|Lack of Efficacy|10
3011209|NCT00867503|10357487|P1|Overall Study|Withdrawal by Subject|1
3011210|NCT00867490|10357493|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
3011211|NCT00867490|10357493|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
3011212|NCT00867490|10357493|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
3011213|NCT00867490|10357493|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
3011214|NCT00867490|10357493|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
3011215|NCT00867360|10357535|P2|Overall Study|Physician Decision|1
3011216|NCT00867360|10357536|P1|Overall Study|Physician Decision|0
3011217|NCT00867360|10357535|P2|Overall Study|Withdrawal by Subject|0
3011218|NCT00867360|10357536|P1|Overall Study|Withdrawal by Subject|1
3011219|NCT00867334|10357548|P2|Overall Study|Physician Decision|0
3011220|NCT00867334|10357549|P1|Overall Study|Physician Decision|1
3011221|NCT00867334|10357548|P2|Overall Study|Withdrawal by Subject|0
3011222|NCT00867334|10357549|P1|Overall Study|Withdrawal by Subject|1
3011223|NCT00867334|10357548|P2|Overall Study|Withdrawal by Subject|1
3011224|NCT00867334|10357549|P1|Overall Study|Withdrawal by Subject|0
3011225|NCT00867308|10357585|P2|Overall Study|Withdrawal by Subject|2
3011226|NCT00867308|10357586|P1|Overall Study|Withdrawal by Subject|1
3011227|NCT00867308|10357585|P2|Overall Study|Lack of Efficacy|12
3011228|NCT00867308|10357586|P1|Overall Study|Lack of Efficacy|6
3011229|NCT00867308|10357585|P2|Overall Study|Adverse Event|4
3011230|NCT00867308|10357586|P1|Overall Study|Adverse Event|1
3011231|NCT00867308|10357585|P2|Overall Study|Death|0
3011232|NCT00867308|10357586|P1|Overall Study|Death|1
3011233|NCT00867165|10357605|P2|Overall Study|Withdrawal by Subject|0
3011234|NCT00867165|10357606|P1|Overall Study|Withdrawal by Subject|1
3011235|NCT00867165|10357605|P2|Overall Study|Adverse Event|0
3011236|NCT00867165|10357606|P1|Overall Study|Adverse Event|3
3011237|NCT00867113|10357754|P1|Post Treatment After Survival Follow-up|Administrative problems|4
3011238|NCT00867113|10357754|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
3011239|NCT00867113|10357754|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
3011240|NCT00867113|10357754|P1|Post Treatment After Survival Follow-up|Death|1
3011241|NCT00867113|10357754|P1|Treatment Period|Protocol Violation|4
3011242|NCT00867113|10357754|P1|Treatment Period|Disease progression/relapse|1
3011243|NCT00867113|10357754|P1|Treatment Period|Administrative problems|1
3011244|NCT00867113|10357754|P1|Treatment Period|Lost to Follow-up|3
3011245|NCT00867113|10357754|P1|Treatment Period|Withdrawal by Subject|19
3011246|NCT00867113|10357754|P1|Treatment Period|Death|2
3011247|NCT00867113|10357754|P1|Treatment Period|Adverse Event|15
3011248|NCT00867087|10357818|P1|Overall Study|Death|37
3011249|NCT00867087|10357818|P1|Overall Study|Withdrawal by Subject|4
3011250|NCT00867087|10357818|P1|Overall Study|Other|1
3011251|NCT00867035|10357834|P2|Baseline to 1 Week|Withdrawal by Subject|0
3011252|NCT00867035|10357835|P1|Baseline to 1 Week|Withdrawal by Subject|1
3011253|NCT00867035|10357834|P2|Baseline to 1 Hour|Withdrawal by Subject|1
3011254|NCT00867035|10357835|P1|Baseline to 1 Hour|Withdrawal by Subject|1
3011255|NCT00867009|10357861|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
3011256|NCT00867009|10357861|P1|Induction Period|Progressive Disease (PD)|25
3011257|NCT00867009|10357861|P1|Induction Period|Physician Decision|3
3011258|NCT00867009|10357861|P1|Induction Period|Withdrawal by Subject|8
3011259|NCT00867009|10357861|P1|Induction Period|Protocol Violation|1
3011260|NCT00867009|10357861|P1|Induction Period|Death due to Study Disease|4
3011261|NCT00867009|10357861|P1|Induction Period|Death due to serious adverse event|6
3011262|NCT00867009|10357861|P1|Induction Period|Serious Adverse Event|10
3011263|NCT00867009|10357861|P1|Induction Period|Nonserious Adverse Event|5
3011264|NCT00866918|10357870|P2|Overall Study|Secondary malignancy|0
3011265|NCT00866918|10357871|P1|Overall Study|Secondary malignancy|1
3011266|NCT00866918|10357870|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
3011267|NCT00866918|10357871|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
3011268|NCT00866918|10357870|P2|Overall Study|Ineligible|4
3011269|NCT00866918|10357871|P1|Overall Study|Ineligible|2
3011270|NCT00866918|10357870|P2|Overall Study|Physician Decision|2
3011271|NCT00866918|10357871|P1|Overall Study|Physician Decision|10
3011272|NCT00866918|10357870|P2|Overall Study|Lack of Efficacy|1
3011273|NCT00866918|10357871|P1|Overall Study|Lack of Efficacy|1
3011274|NCT00866918|10357870|P2|Overall Study|Death|5
3011275|NCT00866918|10357871|P1|Overall Study|Death|1
3011276|NCT00866814|10357905|P1|Overall Study|Moved to area without study site|1
3011277|NCT00866814|10357905|P1|Overall Study|Unable to meet follow-up requirements|2
3011278|NCT00866814|10357905|P1|Overall Study|No longer wished to participate|1
3011279|NCT00866814|10357905|P1|Overall Study|Death|1
3011280|NCT00866814|10357905|P1|Overall Study|Physician Decision|1
3011281|NCT00866814|10357905|P1|Overall Study|Adverse Event|2
3011282|NCT00866814|10357905|P1|Overall Study|Lost to Follow-up|12
3011283|NCT00866788|10357918|P4|Overall Study|Physician Decision|1
3011284|NCT00866788|10357919|P3|Overall Study|Physician Decision|1
3011285|NCT00866788|10357920|P2|Overall Study|Physician Decision|0
3011286|NCT00866788|10357921|P1|Overall Study|Physician Decision|0
3011287|NCT00866788|10357918|P4|Overall Study|Disease progression|0
3011288|NCT00866788|10357919|P3|Overall Study|Disease progression|1
3011289|NCT00866788|10357920|P2|Overall Study|Disease progression|1
3011290|NCT00866788|10357921|P1|Overall Study|Disease progression|3
3011291|NCT00866788|10357918|P4|Overall Study|Pregnancy|0
3011292|NCT00866788|10357919|P3|Overall Study|Pregnancy|0
3011293|NCT00866788|10357920|P2|Overall Study|Pregnancy|1
3011294|NCT00866788|10357921|P1|Overall Study|Pregnancy|0
3011295|NCT00866788|10357918|P4|Overall Study|Withdrawal by Subject|1
3011296|NCT00866788|10357919|P3|Overall Study|Withdrawal by Subject|0
3011297|NCT00866788|10357920|P2|Overall Study|Withdrawal by Subject|1
3011298|NCT00866788|10357921|P1|Overall Study|Withdrawal by Subject|2
3011299|NCT00866788|10357918|P4|Overall Study|Lost to Follow-up|2
3011300|NCT00866788|10357919|P3|Overall Study|Lost to Follow-up|0
3011301|NCT00866788|10357920|P2|Overall Study|Lost to Follow-up|1
3011302|NCT00866788|10357921|P1|Overall Study|Lost to Follow-up|1
3011303|NCT00866788|10357918|P4|Overall Study|Adverse Event|1
3011304|NCT00866788|10357919|P3|Overall Study|Adverse Event|0
3011305|NCT00866788|10357920|P2|Overall Study|Adverse Event|2
3011306|NCT00866788|10357921|P1|Overall Study|Adverse Event|0
3011307|NCT00866775|10357969|P2|Overall Study|discontinued due to communication error|1
3011308|NCT00866775|10357970|P1|Overall Study|discontinued due to communication error|0
3011309|NCT00866775|10357969|P2|Overall Study|met exit criteria|17
3011310|NCT00866775|10357970|P1|Overall Study|met exit criteria|23
3011311|NCT00866775|10357969|P2|Overall Study|Withdrawal by Subject|4
3011312|NCT00866775|10357970|P1|Overall Study|Withdrawal by Subject|4
3011313|NCT00866775|10357969|P2|Overall Study|Protocol Violation|4
3011314|NCT00866775|10357970|P1|Overall Study|Protocol Violation|3
3011315|NCT00866775|10357969|P2|Overall Study|Physician Decision|3
3011316|NCT00866775|10357970|P1|Overall Study|Physician Decision|0
3011317|NCT00866775|10357969|P2|Overall Study|Lost to Follow-up|4
3011318|NCT00866775|10357970|P1|Overall Study|Lost to Follow-up|0
3011319|NCT00866775|10357969|P2|Overall Study|Death|0
3011320|NCT00866775|10357970|P1|Overall Study|Death|1
3011321|NCT00866775|10357969|P2|Overall Study|Adverse Event|19
3011322|NCT00866775|10357970|P1|Overall Study|Adverse Event|5
3011323|NCT00866723|10358013|P1|Overall Study|Disease Progression|4
3011324|NCT00866723|10358013|P1|Overall Study|Withdrawal by Subject|1
3011325|NCT00866697|10358020|P2|Overall Study|Withdrawal by Subject|57
3011326|NCT00866697|10358021|P1|Overall Study|Withdrawal by Subject|33
3011327|NCT00866697|10358020|P2|Overall Study|Physician Decision|5
3011328|NCT00866697|10358021|P1|Overall Study|Physician Decision|3
3011329|NCT00866697|10358020|P2|Overall Study|Lost to Follow-up|28
3011330|NCT00866697|10358021|P1|Overall Study|Lost to Follow-up|22
3011331|NCT00866697|10358020|P2|Overall Study|Study closed/terminated|138
3011332|NCT00866697|10358021|P1|Overall Study|Study closed/terminated|156
3011333|NCT00866658|10358063|P2|Overall Study|Familial and Personal Reasons|5
3011334|NCT00866658|10358064|P1|Overall Study|Familial and Personal Reasons|4
3011335|NCT00866658|10358063|P2|Overall Study|Protocol Violation|1
3011336|NCT00866658|10358064|P1|Overall Study|Protocol Violation|1
3011337|NCT00866658|10358063|P2|Overall Study|Withdrawal by Subject|0
3011338|NCT00866658|10358064|P1|Overall Study|Withdrawal by Subject|1
3011339|NCT00866658|10358063|P2|Overall Study|Lack of Efficacy|1
3011340|NCT00866658|10358064|P1|Overall Study|Lack of Efficacy|2
3011341|NCT00866658|10358063|P2|Overall Study|Adverse Event|14
3011342|NCT00866658|10358064|P1|Overall Study|Adverse Event|5
3011343|NCT00866619|10358096|P4|Overall Study|Lost to Follow-up|425
3011344|NCT00866619|10358097|P3|Overall Study|Lost to Follow-up|568
3011345|NCT00866619|10358098|P2|Overall Study|Lost to Follow-up|830
3011346|NCT00866619|10358099|P1|Overall Study|Lost to Follow-up|1145
3011347|NCT00866619|10358096|P4|Overall Study|Withdrawal by Subject|144
3011348|NCT00866619|10358097|P3|Overall Study|Withdrawal by Subject|272
3011349|NCT00866619|10358098|P2|Overall Study|Withdrawal by Subject|295
3011350|NCT00866619|10358099|P1|Overall Study|Withdrawal by Subject|587
3011351|NCT00866619|10358096|P4|Overall Study|Protocol Violation|17
3011352|NCT00866619|10358097|P3|Overall Study|Protocol Violation|2
3011353|NCT00866619|10358098|P2|Overall Study|Protocol Violation|39
3011354|NCT00866619|10358099|P1|Overall Study|Protocol Violation|2
3011355|NCT00866619|10358096|P4|Overall Study|Adverse Event|44
3011356|NCT00866619|10358097|P3|Overall Study|Adverse Event|47
3011357|NCT00866619|10358098|P2|Overall Study|Adverse Event|106
3011358|NCT00866619|10358099|P1|Overall Study|Adverse Event|112
3011359|NCT00866606|10358419|P1|Overall Study|Adverse Event|1
3011360|NCT00866606|10358419|P1|Overall Study|Lost to Follow-up|3
3011361|NCT00866359|10358433|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
3011362|NCT00866359|10358434|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
3011363|NCT00866359|10358435|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
3011364|NCT00866359|10358436|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
3011365|NCT00866359|10358433|P4|Treatment Phase (Days 1 to 85)|Other|0
3011366|NCT00866359|10358434|P3|Treatment Phase (Days 1 to 85)|Other|0
3011367|NCT00866359|10358435|P2|Treatment Phase (Days 1 to 85)|Other|0
3011368|NCT00866359|10358436|P1|Treatment Phase (Days 1 to 85)|Other|1
3011369|NCT00866359|10358433|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
3011370|NCT00866359|10358434|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
3011371|NCT00866359|10358435|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
3011372|NCT00866359|10358436|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
3011373|NCT00866359|10358433|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
3011374|NCT00866359|10358434|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
3011375|NCT00866359|10358435|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
3011376|NCT00866359|10358436|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
3011377|NCT00866359|10358433|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
3011378|NCT00866359|10358434|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
3011379|NCT00866359|10358435|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
3011380|NCT00866359|10358436|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
3011381|NCT00866359|10358433|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
3011382|NCT00866359|10358434|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
3011383|NCT00866359|10358435|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
3011384|NCT00866359|10358436|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
3011385|NCT00866333|10358492|P3|Overall Study|Study Terminated by Sponsor|9
3011386|NCT00866333|10358493|P2|Overall Study|Study Terminated by Sponsor|5
3011387|NCT00866333|10358494|P1|Overall Study|Study Terminated by Sponsor|2
3011388|NCT00866333|10358492|P3|Overall Study|Reason not Specified|1
3011389|NCT00866333|10358493|P2|Overall Study|Reason not Specified|1
3011390|NCT00866333|10358494|P1|Overall Study|Reason not Specified|3
3011391|NCT00866333|10358492|P3|Overall Study|Withdrawal of consent|2
3011392|NCT00866333|10358493|P2|Overall Study|Withdrawal of consent|1
3011393|NCT00866333|10358494|P1|Overall Study|Withdrawal of consent|0
3011394|NCT00866320|10358511|P1|Overall Study|Death|2
3011395|NCT00866320|10358511|P1|Overall Study|Withdrawal by Subject|4
3011396|NCT00866307|10358518|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
3011397|NCT00866307|10358519|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
3011398|NCT00866307|10358520|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
3011399|NCT00866307|10358518|P3|Consolidation/Maintenance|Non-compliance|1
3011400|NCT00866307|10358519|P2|Consolidation/Maintenance|Non-compliance|0
3011401|NCT00866307|10358520|P1|Consolidation/Maintenance|Non-compliance|0
3011402|NCT00866307|10358518|P3|Consolidation/Maintenance|Therapy error|0
3011403|NCT00866307|10358519|P2|Consolidation/Maintenance|Therapy error|1
3011404|NCT00866307|10358520|P1|Consolidation/Maintenance|Therapy error|0
3011405|NCT00866307|10358518|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
3011406|NCT00866307|10358519|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
3011407|NCT00866307|10358520|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
3011408|NCT00866307|10358518|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
3011409|NCT00866307|10358519|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
3011410|NCT00866307|10358520|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
3011411|NCT00866307|10358518|P3|Consolidation/Maintenance|Withdrawal by Subject|1
3011412|NCT00866307|10358519|P2|Consolidation/Maintenance|Withdrawal by Subject|1
3011413|NCT00866307|10358520|P1|Consolidation/Maintenance|Withdrawal by Subject|0
3011414|NCT00866307|10358518|P3|Consolidation/Maintenance|Physician Decision|2
3011415|NCT00866307|10358519|P2|Consolidation/Maintenance|Physician Decision|3
3011416|NCT00866307|10358520|P1|Consolidation/Maintenance|Physician Decision|0
3011417|NCT00866307|10358518|P3|Consolidation/Maintenance|Death|1
3011418|NCT00866307|10358519|P2|Consolidation/Maintenance|Death|0
3011419|NCT00866307|10358520|P1|Consolidation/Maintenance|Death|0
3011420|NCT00866307|10358518|P3|Consolidation/Maintenance|Adverse Event|8
3011421|NCT00866307|10358519|P2|Consolidation/Maintenance|Adverse Event|0
3011422|NCT00866307|10358520|P1|Consolidation/Maintenance|Adverse Event|0
3011423|NCT00866307|10358518|P3|Induction|Study was closed at the time|0
3011424|NCT00866307|10358519|P2|Induction|Study was closed at the time|0
3011425|NCT00866307|10358520|P1|Induction|Study was closed at the time|1
3011426|NCT00866307|10358518|P3|Induction|Improper post-induction consent|0
3011427|NCT00866307|10358519|P2|Induction|Improper post-induction consent|0
3011428|NCT00866307|10358520|P1|Induction|Improper post-induction consent|2
3011429|NCT00866307|10358518|P3|Induction|Inadequate cytognetic samples th|0
3011430|NCT00866307|10358519|P2|Induction|Inadequate cytognetic samples th|0
3011431|NCT00866307|10358520|P1|Induction|Inadequate cytognetic samples th|1
3011432|NCT00866307|10358518|P3|Induction|Identification of Patients with Day 29 M|0
3011433|NCT00866307|10358519|P2|Induction|Identification of Patients with Day 29 M|0
3011434|NCT00866307|10358520|P1|Induction|Identification of Patients with Day 29 M|3
3011435|NCT00866307|10358518|P3|Induction|Progressive Disease|0
3011436|NCT00866307|10358519|P2|Induction|Progressive Disease|0
3011437|NCT00866307|10358520|P1|Induction|Progressive Disease|1
3011438|NCT00866307|10358518|P3|Induction|Physician Decision|0
3011439|NCT00866307|10358519|P2|Induction|Physician Decision|0
3011440|NCT00866307|10358520|P1|Induction|Physician Decision|5
3011441|NCT00866307|10358518|P3|Induction|Death|0
3011442|NCT00866307|10358519|P2|Induction|Death|0
3011443|NCT00866307|10358520|P1|Induction|Death|2
3011444|NCT00866307|10358518|P3|Induction|Adverse Event|0
3011445|NCT00866307|10358519|P2|Induction|Adverse Event|0
3011446|NCT00866307|10358520|P1|Induction|Adverse Event|5
3011447|NCT00866294|10358530|P3|Overall Study|Physician Decision|1
3011448|NCT00866294|10358531|P2|Overall Study|Physician Decision|2
3011449|NCT00866294|10358532|P1|Overall Study|Physician Decision|6
3011450|NCT00866294|10358530|P3|Overall Study|Lost to Follow-up|0
3011451|NCT00866294|10358531|P2|Overall Study|Lost to Follow-up|3
3011452|NCT00866294|10358532|P1|Overall Study|Lost to Follow-up|1
3011453|NCT00866294|10358530|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
3011454|NCT00866294|10358531|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
3011455|NCT00866294|10358532|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
3011456|NCT00866294|10358530|P3|Overall Study|Protocol Violation|0
3011457|NCT00866294|10358531|P2|Overall Study|Protocol Violation|0
3011458|NCT00866294|10358532|P1|Overall Study|Protocol Violation|2
3011459|NCT00866294|10358530|P3|Overall Study|Lack of Efficacy|0
3011460|NCT00866294|10358531|P2|Overall Study|Lack of Efficacy|1
3011461|NCT00866294|10358532|P1|Overall Study|Lack of Efficacy|7
3011462|NCT00866294|10358530|P3|Overall Study|Adverse Event|9
3011463|NCT00866294|10358531|P2|Overall Study|Adverse Event|13
3011464|NCT00866294|10358532|P1|Overall Study|Adverse Event|12
3011465|NCT00866281|10358561|P2|Overall Study|New cancer therapy|4
3011466|NCT00866281|10358562|P1|Overall Study|New cancer therapy|0
3011467|NCT00866281|10358561|P2|Overall Study|Disease progression|11
3011468|NCT00866281|10358562|P1|Overall Study|Disease progression|3
3011469|NCT00866281|10358561|P2|Overall Study|Withdrawal by participants|0
3011470|NCT00866281|10358562|P1|Overall Study|Withdrawal by participants|3
3011471|NCT00866281|10358561|P2|Overall Study|Adverse Event|0
3011472|NCT00866281|10358562|P1|Overall Study|Adverse Event|1
3011473|NCT00866177|10358578|P1|Overall Study|Not Treated|151
3011474|NCT00866177|10358578|P1|Overall Study|Withdrawal by Subject|1
3011475|NCT00866047|10358582|P1|Follow-up Period|Lost to Follow-up|5
3011476|NCT00866047|10358582|P1|Treatment Period|Withdrawal by Subject|5
3011477|NCT00866047|10358582|P1|Treatment Period|Physician Decision|14
3011478|NCT00866047|10358582|P1|Treatment Period|Adverse Event|16
3011479|NCT00866047|10358582|P1|Treatment Period|Progressive disease|13
3011480|NCT00865904|10358614|P5|Overall Study|Randomized but not Treated|1
3011481|NCT00865904|10358615|P4|Overall Study|Randomized but not Treated|1
3011482|NCT00865904|10358616|P3|Overall Study|Randomized but not Treated|0
3011483|NCT00865904|10358617|P2|Overall Study|Randomized but not Treated|0
3011484|NCT00865904|10358618|P1|Overall Study|Randomized but not Treated|2
3011485|NCT00865709|10358675|P2|Treatment|Surgery|3
3011486|NCT00865709|10358676|P1|Treatment|Surgery|8
3011487|NCT00865709|10358675|P2|Treatment|Physician Decision|2
3011488|NCT00865709|10358676|P1|Treatment|Physician Decision|3
3011489|NCT00865709|10358675|P2|Treatment|Withdrawal by Subject|7
3011490|NCT00865709|10358676|P1|Treatment|Withdrawal by Subject|10
3011491|NCT00865709|10358675|P2|Treatment|Adverse Event|6
3011492|NCT00865709|10358676|P1|Treatment|Adverse Event|9
3011493|NCT00865566|10358694|P2|Overall Study|HIV infection|7
3011494|NCT00865566|10358695|P1|Overall Study|HIV infection|5
3011495|NCT00865566|10358694|P2|Overall Study|Other; N=245 due to early study closure|139
3011496|NCT00865566|10358695|P1|Overall Study|Other; N=245 due to early study closure|154
3011497|NCT00865566|10358694|P2|Overall Study|Participant unable to adhere|42
3011498|NCT00865566|10358695|P1|Overall Study|Participant unable to adhere|27
3011499|NCT00865566|10358694|P2|Overall Study|Participant relocated|107
3011500|NCT00865566|10358695|P1|Overall Study|Participant relocated|78
3011501|NCT00865566|10358694|P2|Overall Study|Physician Decision|1
3011502|NCT00865566|10358695|P1|Overall Study|Physician Decision|0
3011503|NCT00865566|10358694|P2|Overall Study|Withdrawal by Subject|65
3011504|NCT00865566|10358695|P1|Overall Study|Withdrawal by Subject|45
3011505|NCT00865566|10358694|P2|Overall Study|Lost to Follow-up|315
3011506|NCT00865566|10358695|P1|Overall Study|Lost to Follow-up|314
3011507|NCT00865566|10358694|P2|Overall Study|Death|11
3011508|NCT00865566|10358695|P1|Overall Study|Death|1
3011509|NCT00865514|10358715|P1|Overall Study|Infusion cost exceeded funding|2
3011510|NCT00865345|10358720|P1|Overall Study|Withdrawal by Subject|2
3011511|NCT00865306|10358727|P2|Controlled Trial|Withdrawal by Subject|1
3011512|NCT00865306|10358728|P1|Controlled Trial|Withdrawal by Subject|0
3011513|NCT00865306|10358727|P2|Controlled Trial|Sought treatment for conduct disorder|0
3011514|NCT00865306|10358728|P1|Controlled Trial|Sought treatment for conduct disorder|1
3011515|NCT00865306|10358727|P2|Controlled Trial|Improved btw baseline and first session|0
3011516|NCT00865306|10358728|P1|Controlled Trial|Improved btw baseline and first session|1
3011517|NCT00865306|10358727|P2|Controlled Trial|Difficulty commuting|0
3011518|NCT00865306|10358728|P1|Controlled Trial|Difficulty commuting|2
3011519|NCT00865306|10358727|P2|Controlled Trial|Lost to Follow-up|1
3011520|NCT00865306|10358728|P1|Controlled Trial|Lost to Follow-up|1
3011521|NCT00865189|10358757|P2|Overall Study|Withdrawal by Subject|0
3011522|NCT00865189|10358758|P1|Overall Study|Withdrawal by Subject|1
3011523|NCT00865189|10358757|P2|Overall Study|Lost to Follow-up|6
3011524|NCT00865189|10358758|P1|Overall Study|Lost to Follow-up|6
3011525|NCT00865189|10358757|P2|Overall Study|Death|11
3011526|NCT00865189|10358758|P1|Overall Study|Death|4
3011527|NCT00865189|10358757|P2|Overall Study|Other|2
3011528|NCT00865189|10358758|P1|Overall Study|Other|1
3011529|NCT00865124|10358786|P3|Overall Study|Withdrawn consent|0
3011530|NCT00865124|10358787|P2|Overall Study|Withdrawn consent|0
3011531|NCT00865124|10358788|P1|Overall Study|Withdrawn consent|2
3011532|NCT00865124|10358786|P3|Overall Study|Physician Decision|0
3011533|NCT00865124|10358787|P2|Overall Study|Physician Decision|1
3011534|NCT00865124|10358788|P1|Overall Study|Physician Decision|2
3011535|NCT00865098|10358805|P1|Overall Study|Progressive disease|1
3011536|NCT00865046|10358817|P3|Overall Study|Withdrawal by Subject|0
3011537|NCT00865046|10358818|P2|Overall Study|Withdrawal by Subject|0
3011538|NCT00865046|10358819|P1|Overall Study|Withdrawal by Subject|5
3011539|NCT00865046|10358817|P3|Overall Study|Death|1
3011540|NCT00865046|10358818|P2|Overall Study|Death|1
3011541|NCT00865046|10358819|P1|Overall Study|Death|0
3011542|NCT00865046|10358817|P3|Overall Study|Lost to Follow-up|0
3011543|NCT00865046|10358818|P2|Overall Study|Lost to Follow-up|4
3011544|NCT00865046|10358819|P1|Overall Study|Lost to Follow-up|1
3011545|NCT00865020|10358829|P2|Overall Study|Randomized but discontinued|4
3011546|NCT00865020|10358830|P1|Overall Study|Randomized but discontinued|2
3011547|NCT00865020|10358829|P2|Overall Study|Death|1
3011548|NCT00865020|10358830|P1|Overall Study|Death|0
3011549|NCT00865020|10358829|P2|Overall Study|Abnormal laboratory value(s)|1
3011550|NCT00865020|10358830|P1|Overall Study|Abnormal laboratory value(s)|0
3011551|NCT00865020|10358829|P2|Overall Study|Administrative problems|2
3011552|NCT00865020|10358830|P1|Overall Study|Administrative problems|0
3011553|NCT00865020|10358829|P2|Overall Study|Protocol deviation|1
3011554|NCT00865020|10358830|P1|Overall Study|Protocol deviation|4
3011555|NCT00865020|10358829|P2|Overall Study|Lost to Follow-up|4
3011556|NCT00865020|10358830|P1|Overall Study|Lost to Follow-up|6
3011557|NCT00865020|10358829|P2|Overall Study|Abnormal test procedure result(s)|8
3011558|NCT00865020|10358830|P1|Overall Study|Abnormal test procedure result(s)|6
3011559|NCT00865020|10358829|P2|Overall Study|Adverse Event|14
3011560|NCT00865020|10358830|P1|Overall Study|Adverse Event|9
3011561|NCT00865020|10358829|P2|Overall Study|Withdrawal by Subject|16
3011562|NCT00865020|10358830|P1|Overall Study|Withdrawal by Subject|22
3011563|NCT00864916|10358846|P2|Overall Study|Withdrawal by Subject|0
3011564|NCT00864916|10358847|P1|Overall Study|Withdrawal by Subject|1
3011565|NCT00864916|10358846|P2|Overall Study|Protocol Violation|0
3011566|NCT00864916|10358847|P1|Overall Study|Protocol Violation|1
3011567|NCT00864916|10358846|P2|Overall Study|Lost to Follow-up|4
3011568|NCT00864916|10358847|P1|Overall Study|Lost to Follow-up|4
3011569|NCT00864851|10358856|P3|Overall Study|Patient uncooperative|0
3011570|NCT00864851|10358857|P2|Overall Study|Patient uncooperative|0
3011571|NCT00864851|10358858|P1|Overall Study|Patient uncooperative|1
3011572|NCT00864851|10358856|P3|Overall Study|Death|0
3011573|NCT00864851|10358857|P2|Overall Study|Death|0
3011574|NCT00864851|10358858|P1|Overall Study|Death|1
3011575|NCT00864851|10358856|P3|Overall Study|Physician Decision|0
3011576|NCT00864851|10358857|P2|Overall Study|Physician Decision|0
3011577|NCT00864851|10358858|P1|Overall Study|Physician Decision|1
3011578|NCT00864851|10358856|P3|Overall Study|Withdrawal by Subject|0
3011579|NCT00864851|10358857|P2|Overall Study|Withdrawal by Subject|1
3011580|NCT00864851|10358858|P1|Overall Study|Withdrawal by Subject|0
3011581|NCT00864721|10358892|P1|Overall Study|Adverse Event|21
3011582|NCT00864721|10358892|P1|Overall Study|Drug hold/delay more than 4 weeks|1
3011583|NCT00864721|10358892|P1|Overall Study|Hospitalized|1
3011584|NCT00864721|10358892|P1|Overall Study|Patient request|11
3011585|NCT00864682|10358912|P3|Overall Study|Protocol Violation|2
3011586|NCT00864682|10358913|P2|Overall Study|Protocol Violation|1
3011587|NCT00864682|10358914|P1|Overall Study|Protocol Violation|2
3011588|NCT00864513|10358953|P1|Overall Study|Withdrawal by Subject|3
3011589|NCT00864253|10359037|P2|Overall Study|Untreated|7
3011590|NCT00864253|10359038|P1|Overall Study|Untreated|7
3011591|NCT00864253|10359037|P2|Overall Study|Ongoing|3
3011592|NCT00864253|10359038|P1|Overall Study|Ongoing|2
3011593|NCT00864253|10359037|P2|Overall Study|Death|0
3011594|NCT00864253|10359038|P1|Overall Study|Death|1
3011595|NCT00864253|10359037|P2|Overall Study|Withdrawal by Subject|18
3011596|NCT00864253|10359038|P1|Overall Study|Withdrawal by Subject|18
3011597|NCT00864253|10359037|P2|Overall Study|Lost to Follow-up|1
3011598|NCT00864253|10359038|P1|Overall Study|Lost to Follow-up|1
3011599|NCT00864253|10359037|P2|Overall Study|Protocol Violation|2
3011600|NCT00864253|10359038|P1|Overall Study|Protocol Violation|0
3011601|NCT00864253|10359037|P2|Overall Study|Physician Decision|15
3011602|NCT00864253|10359038|P1|Overall Study|Physician Decision|11
3011603|NCT00864253|10359037|P2|Overall Study|Unrelated Adverse Event|1
3011604|NCT00864253|10359038|P1|Overall Study|Unrelated Adverse Event|3
3011605|NCT00864253|10359037|P2|Overall Study|Adverse Event|11
3011606|NCT00864253|10359038|P1|Overall Study|Adverse Event|56
3011607|NCT00864227|10359068|P1|Overall Study|Disease Relapse/Progression|3
3011608|NCT00864227|10359068|P1|Overall Study|Withdrawal by Subject|1
3011609|NCT00863928|10359129|P2|Overall Study|medication allergy|0
3011610|NCT00863928|10359130|P1|Overall Study|medication allergy|3
3011611|NCT00863928|10359129|P2|Overall Study|surgery cancellation|0
3011612|NCT00863928|10359130|P1|Overall Study|surgery cancellation|4
3011613|NCT00863928|10359129|P2|Overall Study|Withdrawal by Subject|0
3011614|NCT00863928|10359130|P1|Overall Study|Withdrawal by Subject|3
3011615|NCT00863928|10359129|P2|Overall Study|Protocol Violation|0
3011616|NCT00863928|10359130|P1|Overall Study|Protocol Violation|26
3011617|NCT00863798|10359139|P3|Overall Study|Randomized not treated|3
3011618|NCT00863798|10359140|P2|Overall Study|Randomized not treated|2
3011619|NCT00863798|10359141|P1|Overall Study|Randomized not treated|4
3011620|NCT00863798|10359139|P3|Overall Study|Withdrawal by Subject|4
3011621|NCT00863798|10359140|P2|Overall Study|Withdrawal by Subject|7
3011622|NCT00863798|10359141|P1|Overall Study|Withdrawal by Subject|8
3011623|NCT00863798|10359139|P3|Overall Study|Protocol Violation|1
3011624|NCT00863798|10359140|P2|Overall Study|Protocol Violation|1
3011625|NCT00863798|10359141|P1|Overall Study|Protocol Violation|0
3011626|NCT00863798|10359139|P3|Overall Study|Other|1
3011627|NCT00863798|10359140|P2|Overall Study|Other|3
3011628|NCT00863798|10359141|P1|Overall Study|Other|2
3011629|NCT00863798|10359139|P3|Overall Study|Lost to Follow-up|5
3011630|NCT00863798|10359140|P2|Overall Study|Lost to Follow-up|9
3011631|NCT00863798|10359141|P1|Overall Study|Lost to Follow-up|6
3011632|NCT00863798|10359139|P3|Overall Study|Lack of Efficacy|6
3011633|NCT00863798|10359140|P2|Overall Study|Lack of Efficacy|3
3011634|NCT00863798|10359141|P1|Overall Study|Lack of Efficacy|4
3011635|NCT00863798|10359139|P3|Overall Study|Investigator request|1
3011636|NCT00863798|10359140|P2|Overall Study|Investigator request|2
3011637|NCT00863798|10359141|P1|Overall Study|Investigator request|1
3011638|NCT00863798|10359139|P3|Overall Study|Participant failed to return|0
3011639|NCT00863798|10359140|P2|Overall Study|Participant failed to return|1
3011640|NCT00863798|10359141|P1|Overall Study|Participant failed to return|2
3011641|NCT00863798|10359139|P3|Overall Study|Adverse Event|4
3011642|NCT00863798|10359140|P2|Overall Study|Adverse Event|2
3011643|NCT00863798|10359141|P1|Overall Study|Adverse Event|5
3011644|NCT00863746|10359193|P2|Survival Follow up|Consent Withdrawn|8
3011645|NCT00863746|10359194|P1|Survival Follow up|Consent Withdrawn|7
3011646|NCT00863746|10359193|P2|Survival Follow up|Lost to Follow-up|1
3011647|NCT00863746|10359194|P1|Survival Follow up|Lost to Follow-up|2
3011648|NCT00863746|10359193|P2|Survival Follow up|Death|271
3011649|NCT00863746|10359194|P1|Survival Follow up|Death|244
3011650|NCT00863746|10359193|P2|Treatment|Other|0
3011651|NCT00863746|10359194|P1|Treatment|Other|1
3011652|NCT00863746|10359193|P2|Treatment|Protocol Violation|3
3011653|NCT00863746|10359194|P1|Treatment|Protocol Violation|5
3011654|NCT00863746|10359193|P2|Treatment|Lost to Follow-up|0
3011655|NCT00863746|10359194|P1|Treatment|Lost to Follow-up|1
3011656|NCT00863746|10359193|P2|Treatment|Consent withdrawn|14
3011657|NCT00863746|10359194|P1|Treatment|Consent withdrawn|15
3011658|NCT00863746|10359193|P2|Treatment|non-compliant with study medication|0
3011659|NCT00863746|10359194|P1|Treatment|non-compliant with study medication|4
3011660|NCT00863746|10359193|P2|Treatment|Adverse Event|16
3011661|NCT00863746|10359194|P1|Treatment|Adverse Event|41
3011662|NCT00863746|10359193|P2|Treatment|Not treated|2
3011663|NCT00863746|10359194|P1|Treatment|Not treated|4
3011664|NCT00863707|10359220|P2|Overall Study|Randomized, but drug not received|3
3011665|NCT00863707|10359221|P1|Overall Study|Randomized, but drug not received|4
3011666|NCT00863655|10359229|P2|Overall Study|Treatment completed as per protocol|1
3011667|NCT00863655|10359230|P1|Overall Study|Treatment completed as per protocol|5
3011668|NCT00863655|10359229|P2|Overall Study|Disease progression|221
3011669|NCT00863655|10359230|P1|Overall Study|Disease progression|364
3011670|NCT00863655|10359229|P2|Overall Study|New cancer therapy|1
3011671|NCT00863655|10359230|P1|Overall Study|New cancer therapy|5
3011672|NCT00863655|10359229|P2|Overall Study|Death|1
3011673|NCT00863655|10359230|P1|Overall Study|Death|7
3011674|NCT00863655|10359229|P2|Overall Study|Administrative problems|0
3011675|NCT00863655|10359230|P1|Overall Study|Administrative problems|1
3011676|NCT00863655|10359229|P2|Overall Study|Withdrawal by Subject|7
3011677|NCT00863655|10359230|P1|Overall Study|Withdrawal by Subject|47
3011678|NCT00863655|10359229|P2|Overall Study|Adverse Event|8
3011679|NCT00863655|10359230|P1|Overall Study|Adverse Event|52
3011680|NCT00863655|10359229|P2|Overall Study|Protocol Violation|0
3011681|NCT00863655|10359230|P1|Overall Study|Protocol Violation|4
3011682|NCT00863512|10359267|P2|Overall Study|Physician Decision|0
3011683|NCT00863512|10359268|P1|Overall Study|Physician Decision|1
3011684|NCT00863512|10359267|P2|Overall Study|Withdrawal by Subject|0
3011685|NCT00863512|10359268|P1|Overall Study|Withdrawal by Subject|11
3011686|NCT00863512|10359267|P2|Overall Study|Adverse Event|0
3011687|NCT00863512|10359268|P1|Overall Study|Adverse Event|2
3011688|NCT00863330|10359299|P1|Overall Study|study terminated early due to administra|6
3011689|NCT00863317|10359305|P2|Overall Study|Lost to Follow-up|9
3011690|NCT00863317|10359306|P1|Overall Study|Lost to Follow-up|8
3011691|NCT00863057|10359362|P4|Period 2 (Weeks 6-10)|Physician Decision|1
3011692|NCT00863057|10359363|P3|Period 2 (Weeks 6-10)|Physician Decision|0
3011693|NCT00863057|10359364|P2|Period 2 (Weeks 6-10)|Physician Decision|0
3011694|NCT00863057|10359365|P1|Period 2 (Weeks 6-10)|Physician Decision|0
3011695|NCT00863057|10359362|P4|Period 2 (Weeks 6-10)|Adverse Event|0
3011696|NCT00863057|10359363|P3|Period 2 (Weeks 6-10)|Adverse Event|1
3011697|NCT00863057|10359364|P2|Period 2 (Weeks 6-10)|Adverse Event|1
3011698|NCT00863057|10359365|P1|Period 2 (Weeks 6-10)|Adverse Event|0
3011699|NCT00863057|10359362|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
3011700|NCT00863057|10359363|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
3011701|NCT00863057|10359364|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
3011702|NCT00863057|10359365|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
3011703|NCT00863057|10359362|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
3011704|NCT00863057|10359363|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
3011705|NCT00863057|10359364|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
3011706|NCT00863057|10359365|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
3011707|NCT00862979|10359423|P2|Overall Study|Death|1
3011708|NCT00862979|10359424|P1|Overall Study|Death|0
3011709|NCT00862979|10359423|P2|Overall Study|Administrative problems|1
3011710|NCT00862979|10359424|P1|Overall Study|Administrative problems|0
3011711|NCT00862979|10359423|P2|Overall Study|Patient withdrew consent|1
3011712|NCT00862979|10359424|P1|Overall Study|Patient withdrew consent|2
3011713|NCT00862979|10359423|P2|Overall Study|Protocol Violation|1
3011714|NCT00862979|10359424|P1|Overall Study|Protocol Violation|0
3011715|NCT00862979|10359423|P2|Overall Study|Adverse Event|3
3011716|NCT00862979|10359424|P1|Overall Study|Adverse Event|6
3011717|NCT00862940|10359442|P2|Overall Study|Administrative or other reason(s)|3
3011718|NCT00862940|10359443|P1|Overall Study|Administrative or other reason(s)|4
3011719|NCT00862940|10359442|P2|Overall Study|Lost to Follow-up|1
3011720|NCT00862940|10359443|P1|Overall Study|Lost to Follow-up|0
3011721|NCT00862940|10359442|P2|Overall Study|Non-compliance|0
3011722|NCT00862940|10359443|P1|Overall Study|Non-compliance|4
3011723|NCT00862940|10359442|P2|Overall Study|Withdrawal by Subject|6
3011724|NCT00862940|10359443|P1|Overall Study|Withdrawal by Subject|4
3011725|NCT00862940|10359442|P2|Overall Study|Protocol Violation|5
3011726|NCT00862940|10359443|P1|Overall Study|Protocol Violation|2
3011727|NCT00862940|10359442|P2|Overall Study|Lack of Efficacy|3
3011728|NCT00862940|10359443|P1|Overall Study|Lack of Efficacy|1
3011729|NCT00862940|10359442|P2|Overall Study|Adverse Event|12
3011730|NCT00862940|10359443|P1|Overall Study|Adverse Event|15
3011731|NCT00862849|10359455|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
3011732|NCT00862849|10359456|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
3011733|NCT00862849|10359457|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
3011734|NCT00862849|10359458|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
3011735|NCT00862849|10359459|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
3011736|NCT00862849|10359460|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
3011737|NCT00862849|10359455|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
3011738|NCT00862849|10359456|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
3011739|NCT00862849|10359457|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
3011740|NCT00862849|10359458|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
3011741|NCT00862849|10359459|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
3011742|NCT00862849|10359460|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
3011743|NCT00862836|10359483|P1|Overall Study|Withdrawal by Subject|1
3011744|NCT00862823|10359494|P2|First Intervention|Withdrawal by Subject|1
3011745|NCT00862823|10359495|P1|First Intervention|Withdrawal by Subject|1
3011746|NCT00862719|10359544|P4|Overall Study|Veno-Occlusive Disease|0
3011747|NCT00862719|10359545|P3|Overall Study|Veno-Occlusive Disease|1
3011748|NCT00862719|10359546|P2|Overall Study|Veno-Occlusive Disease|0
3011749|NCT00862719|10359547|P1|Overall Study|Veno-Occlusive Disease|0
3011750|NCT00862719|10359544|P4|Overall Study|Engraftment failure|0
3011751|NCT00862719|10359545|P3|Overall Study|Engraftment failure|1
3011752|NCT00862719|10359546|P2|Overall Study|Engraftment failure|0
3011753|NCT00862719|10359547|P1|Overall Study|Engraftment failure|0
3011754|NCT00862719|10359544|P4|Overall Study|Death|1
3011755|NCT00862719|10359545|P3|Overall Study|Death|1
3011756|NCT00862719|10359546|P2|Overall Study|Death|6
3011757|NCT00862719|10359547|P1|Overall Study|Death|5
3011758|NCT00862719|10359544|P4|Overall Study|Disease Progression|0
3011759|NCT00862719|10359545|P3|Overall Study|Disease Progression|1
3011760|NCT00862719|10359546|P2|Overall Study|Disease Progression|0
3011761|NCT00862719|10359547|P1|Overall Study|Disease Progression|5
3011762|NCT00862654|10359570|P4|Overall Study|Included after end of inclusions|0
3011763|NCT00862654|10359571|P3|Overall Study|Included after end of inclusions|1
3011764|NCT00862654|10359572|P2|Overall Study|Included after end of inclusions|0
3011765|NCT00862654|10359573|P1|Overall Study|Included after end of inclusions|0
3011766|NCT00862654|10359570|P4|Overall Study|Never used study drugs|0
3011767|NCT00862654|10359571|P3|Overall Study|Never used study drugs|0
3011768|NCT00862654|10359572|P2|Overall Study|Never used study drugs|0
3011769|NCT00862654|10359573|P1|Overall Study|Never used study drugs|1
3011770|NCT00862654|10359570|P4|Overall Study|Familly constraint|0
3011771|NCT00862654|10359571|P3|Overall Study|Familly constraint|0
3011772|NCT00862654|10359572|P2|Overall Study|Familly constraint|1
3011773|NCT00862654|10359573|P1|Overall Study|Familly constraint|0
3011774|NCT00862654|10359570|P4|Overall Study|Subject mistake|0
3011775|NCT00862654|10359571|P3|Overall Study|Subject mistake|0
3011776|NCT00862654|10359572|P2|Overall Study|Subject mistake|1
3011777|NCT00862654|10359573|P1|Overall Study|Subject mistake|0
3011778|NCT00862654|10359570|P4|Overall Study|Withdrawal by Subject|3
3011779|NCT00862654|10359571|P3|Overall Study|Withdrawal by Subject|2
3011780|NCT00862654|10359572|P2|Overall Study|Withdrawal by Subject|2
3011781|NCT00862654|10359573|P1|Overall Study|Withdrawal by Subject|2
3011782|NCT00862654|10359570|P4|Overall Study|Pregnancy|0
3011783|NCT00862654|10359571|P3|Overall Study|Pregnancy|0
3011784|NCT00862654|10359572|P2|Overall Study|Pregnancy|1
3011785|NCT00862654|10359573|P1|Overall Study|Pregnancy|1
3011786|NCT00862654|10359570|P4|Overall Study|Adverse Event|0
3011787|NCT00862654|10359571|P3|Overall Study|Adverse Event|1
3011788|NCT00862654|10359572|P2|Overall Study|Adverse Event|1
3011789|NCT00862654|10359573|P1|Overall Study|Adverse Event|0
3011790|NCT00862654|10359570|P4|Overall Study|Lost to Follow-up|3
3011791|NCT00862654|10359571|P3|Overall Study|Lost to Follow-up|1
3011792|NCT00862654|10359572|P2|Overall Study|Lost to Follow-up|2
3011793|NCT00862654|10359573|P1|Overall Study|Lost to Follow-up|1
3011794|NCT00862654|10359570|P4|Overall Study|Lack of Efficacy|0
3011795|NCT00862654|10359571|P3|Overall Study|Lack of Efficacy|1
3011796|NCT00862654|10359572|P2|Overall Study|Lack of Efficacy|0
3011797|NCT00862654|10359573|P1|Overall Study|Lack of Efficacy|1
3011798|NCT00862641|10359587|P4|Overall Study|Randomized, but drug not received|4
3011799|NCT00862641|10359588|P3|Overall Study|Randomized, but drug not received|1
3011800|NCT00862641|10359589|P2|Overall Study|Randomized, but drug not received|4
3011801|NCT00862641|10359590|P1|Overall Study|Randomized, but drug not received|1
3011802|NCT00862459|10359684|P3|Overall Study|Administrative problems|0
3011803|NCT00862459|10359685|P2|Overall Study|Administrative problems|1
3011804|NCT00862459|10359686|P1|Overall Study|Administrative problems|0
3011805|NCT00862459|10359684|P3|Overall Study|Inclusion/exclusion criteria not met|0
3011806|NCT00862459|10359685|P2|Overall Study|Inclusion/exclusion criteria not met|1
3011807|NCT00862459|10359686|P1|Overall Study|Inclusion/exclusion criteria not met|0
3011808|NCT00862459|10359684|P3|Overall Study|Unable to hold still for imaging|0
3011809|NCT00862459|10359685|P2|Overall Study|Unable to hold still for imaging|1
3011810|NCT00862459|10359686|P1|Overall Study|Unable to hold still for imaging|0
3011811|NCT00862459|10359684|P3|Overall Study|Intravenous (IV) site problems|1
3011812|NCT00862459|10359685|P2|Overall Study|Intravenous (IV) site problems|0
3011813|NCT00862459|10359686|P1|Overall Study|Intravenous (IV) site problems|1
3011814|NCT00862459|10359684|P3|Overall Study|Operation|0
3011815|NCT00862459|10359685|P2|Overall Study|Operation|1
3011816|NCT00862459|10359686|P1|Overall Study|Operation|1
3011817|NCT00862459|10359684|P3|Overall Study|Personal reasons|0
3011818|NCT00862459|10359685|P2|Overall Study|Personal reasons|0
3011819|NCT00862459|10359686|P1|Overall Study|Personal reasons|1
3011820|NCT00862459|10359684|P3|Overall Study|Adverse Event|0
3011821|NCT00862459|10359685|P2|Overall Study|Adverse Event|1
3011822|NCT00862459|10359686|P1|Overall Study|Adverse Event|0
3011823|NCT00862459|10359684|P3|Overall Study|Withdrawal by Subject|3
3011824|NCT00862459|10359685|P2|Overall Study|Withdrawal by Subject|1
3011825|NCT00862459|10359686|P1|Overall Study|Withdrawal by Subject|1
3011826|NCT00862459|10359684|P3|Overall Study|Protocol Violation|0
3011827|NCT00862459|10359685|P2|Overall Study|Protocol Violation|0
3011828|NCT00862459|10359686|P1|Overall Study|Protocol Violation|1
3011829|NCT00862459|10359684|P3|Overall Study|Lost to Follow-up|2
3011830|NCT00862459|10359685|P2|Overall Study|Lost to Follow-up|2
3011831|NCT00862459|10359686|P1|Overall Study|Lost to Follow-up|1
3011832|NCT00862277|10359833|P3|Overall Study|Protocol Violation|5
3011833|NCT00862277|10359834|P2|Overall Study|Protocol Violation|2
3011834|NCT00862277|10359835|P1|Overall Study|Protocol Violation|1
3011835|NCT00862251|10359849|P3|Overall Study|Withdrawal by Subject|6
3011836|NCT00862251|10359850|P2|Overall Study|Withdrawal by Subject|2
3011837|NCT00862251|10359851|P1|Overall Study|Withdrawal by Subject|9
3011838|NCT00862251|10359849|P3|Overall Study|Protocol Violation|1
3011839|NCT00862251|10359850|P2|Overall Study|Protocol Violation|0
3011840|NCT00862251|10359851|P1|Overall Study|Protocol Violation|2
3011841|NCT00862251|10359849|P3|Overall Study|Lost to Follow-up|1
3011842|NCT00862251|10359850|P2|Overall Study|Lost to Follow-up|0
3011843|NCT00862251|10359851|P1|Overall Study|Lost to Follow-up|0
3011844|NCT00862251|10359849|P3|Overall Study|Adverse Event|1
3011845|NCT00862251|10359850|P2|Overall Study|Adverse Event|3
3011846|NCT00862251|10359851|P1|Overall Study|Adverse Event|8
3011847|NCT00862134|10359911|P2|Overall Study|Withdrew prior to dosing|0
3011848|NCT00862134|10359912|P1|Overall Study|Withdrew prior to dosing|2
3011849|NCT00862134|10359911|P2|Overall Study|Adverse Event|2
3011850|NCT00862134|10359912|P1|Overall Study|Adverse Event|2
3011851|NCT00862134|10359911|P2|Overall Study|Sponsor terminated study|7
3011852|NCT00862134|10359912|P1|Overall Study|Sponsor terminated study|5
3011853|NCT00862134|10359911|P2|Overall Study|Withdrawal by Subject|2
3011854|NCT00862134|10359912|P1|Overall Study|Withdrawal by Subject|1
3011855|NCT00862134|10359911|P2|Overall Study|Physician Decision|1
3011856|NCT00862134|10359912|P1|Overall Study|Physician Decision|0
3011857|NCT00862134|10359911|P2|Overall Study|Death|0
3011858|NCT00862134|10359912|P1|Overall Study|Death|1
3011859|NCT00862121|10359924|P2|Overall Study|Incorrect randomisation|1
3011860|NCT00862121|10359925|P1|Overall Study|Incorrect randomisation|0
3011861|NCT00862121|10359924|P2|Overall Study|Exclusion criterion violation|1
3011862|NCT00862121|10359925|P1|Overall Study|Exclusion criterion violation|0
3011863|NCT00862121|10359924|P2|Overall Study|Protocol Violation|1
3011864|NCT00862121|10359925|P1|Overall Study|Protocol Violation|0
3011865|NCT00862121|10359924|P2|Overall Study|Lack of Efficacy|3
3011866|NCT00862121|10359925|P1|Overall Study|Lack of Efficacy|0
3011867|NCT00862121|10359924|P2|Overall Study|Adverse Event|2
3011868|NCT00862121|10359925|P1|Overall Study|Adverse Event|1
3011869|NCT00862082|10359943|P2|Overall Study|Withdrawal by Subject|1
3011870|NCT00862082|10359944|P1|Overall Study|Withdrawal by Subject|0
3011871|NCT00862082|10359943|P2|Overall Study|Sponsor decision to terminate the study|0
3011872|NCT00862082|10359944|P1|Overall Study|Sponsor decision to terminate the study|5
3011873|NCT00861757|10359999|P4|Overall Study|Withdrawal by Subject|2
3011874|NCT00861757|10360000|P3|Overall Study|Withdrawal by Subject|5
3011875|NCT00861757|10360001|P2|Overall Study|Withdrawal by Subject|5
3011876|NCT00861757|10360002|P1|Overall Study|Withdrawal by Subject|1
3011877|NCT00861757|10359999|P4|Overall Study|Protocol Violation|1
3011878|NCT00861757|10360000|P3|Overall Study|Protocol Violation|4
3011879|NCT00861757|10360001|P2|Overall Study|Protocol Violation|2
3011880|NCT00861757|10360002|P1|Overall Study|Protocol Violation|2
3011881|NCT00861757|10359999|P4|Overall Study|Physician Decision|1
3011882|NCT00861757|10360000|P3|Overall Study|Physician Decision|0
3011883|NCT00861757|10360001|P2|Overall Study|Physician Decision|0
3011884|NCT00861757|10360002|P1|Overall Study|Physician Decision|0
3011885|NCT00861757|10359999|P4|Overall Study|Lost to Follow-up|1
3011886|NCT00861757|10360000|P3|Overall Study|Lost to Follow-up|1
3011887|NCT00861757|10360001|P2|Overall Study|Lost to Follow-up|0
3011888|NCT00861757|10360002|P1|Overall Study|Lost to Follow-up|1
3011889|NCT00861757|10359999|P4|Overall Study|Lack of Efficacy|1
3011890|NCT00861757|10360000|P3|Overall Study|Lack of Efficacy|0
3011891|NCT00861757|10360001|P2|Overall Study|Lack of Efficacy|1
3011892|NCT00861757|10360002|P1|Overall Study|Lack of Efficacy|3
3011893|NCT00861757|10359999|P4|Overall Study|Entry Criteria Not Met|1
3011894|NCT00861757|10360000|P3|Overall Study|Entry Criteria Not Met|1
3011895|NCT00861757|10360001|P2|Overall Study|Entry Criteria Not Met|2
3011896|NCT00861757|10360002|P1|Overall Study|Entry Criteria Not Met|1
3011897|NCT00861757|10359999|P4|Overall Study|Adverse Event|2
3011898|NCT00861757|10360000|P3|Overall Study|Adverse Event|7
3011899|NCT00861757|10360001|P2|Overall Study|Adverse Event|5
3011900|NCT00861757|10360002|P1|Overall Study|Adverse Event|1
3011901|NCT00861744|10360060|P4|Overall Study|Blood draws|1
3011902|NCT00861744|10360061|P3|Overall Study|Blood draws|0
3011903|NCT00861744|10360062|P2|Overall Study|Blood draws|0
3011904|NCT00861744|10360063|P1|Overall Study|Blood draws|0
3011905|NCT00861744|10360060|P4|Overall Study|Migration from study area|0
3011906|NCT00861744|10360061|P3|Overall Study|Migration from study area|1
3011907|NCT00861744|10360062|P2|Overall Study|Migration from study area|3
3011908|NCT00861744|10360063|P1|Overall Study|Migration from study area|0
3011909|NCT00861744|10360060|P4|Overall Study|Protocol Violation|0
3011910|NCT00861744|10360061|P3|Overall Study|Protocol Violation|0
3011911|NCT00861744|10360062|P2|Overall Study|Protocol Violation|1
3011912|NCT00861744|10360063|P1|Overall Study|Protocol Violation|0
3011913|NCT00861744|10360060|P4|Overall Study|Withdrawal by Subject|19
3011914|NCT00861744|10360061|P3|Overall Study|Withdrawal by Subject|6
3011915|NCT00861744|10360062|P2|Overall Study|Withdrawal by Subject|6
3011916|NCT00861744|10360063|P1|Overall Study|Withdrawal by Subject|10
3011917|NCT00861744|10360060|P4|Overall Study|Lost to Follow-up|12
3011918|NCT00861744|10360061|P3|Overall Study|Lost to Follow-up|17
3011919|NCT00861744|10360062|P2|Overall Study|Lost to Follow-up|19
3011920|NCT00861744|10360063|P1|Overall Study|Lost to Follow-up|7
3011921|NCT00861744|10360060|P4|Overall Study|Adverse Event|1
3011922|NCT00861744|10360061|P3|Overall Study|Adverse Event|0
3011923|NCT00861744|10360062|P2|Overall Study|Adverse Event|0
3011924|NCT00861744|10360063|P1|Overall Study|Adverse Event|0
3011925|NCT00861705|10360245|P4|Overall Study|Never Began Treatment|1
3011926|NCT00861705|10360246|P3|Overall Study|Never Began Treatment|0
3011927|NCT00861705|10360247|P2|Overall Study|Never Began Treatment|3
3011928|NCT00861705|10360248|P1|Overall Study|Never Began Treatment|7
3011929|NCT00861692|10360288|P1|Overall Study|Death|6
3011930|NCT00861614|10360300|P2|Overall Study|Other|22
3011931|NCT00861614|10360301|P1|Overall Study|Other|17
3011932|NCT00861614|10360300|P2|Overall Study|Withdrawal by Subject|35
3011933|NCT00861614|10360301|P1|Overall Study|Withdrawal by Subject|34
3011934|NCT00861614|10360300|P2|Overall Study|Adverse Event|23
3011935|NCT00861614|10360301|P1|Overall Study|Adverse Event|27
3011936|NCT00861614|10360300|P2|Overall Study|Death|19
3011937|NCT00861614|10360301|P1|Overall Study|Death|32
3011938|NCT00861614|10360300|P2|Overall Study|Study Drug Toxicity|6
3011939|NCT00861614|10360301|P1|Overall Study|Study Drug Toxicity|79
3011940|NCT00861614|10360300|P2|Overall Study|Disease Progression|263
3011941|NCT00861614|10360301|P1|Overall Study|Disease Progression|182
3011942|NCT00861471|10360386|P1|Overall Study|Physician Decision|2
3011943|NCT00861471|10360386|P1|Overall Study|treatment for lumbar laminectomy|1
3011944|NCT00861471|10360386|P1|Overall Study|Lack of Efficacy|3
3011945|NCT00861471|10360386|P1|Overall Study|Adverse Event|2
3011946|NCT00861471|10360386|P1|Overall Study|Withdrawal by Subject|1
3011947|NCT00861341|10360394|P1|Overall Study|Withdrawal by Subject|2
3011948|NCT00861198|10360403|P1|Overall Study|SpyGlass Failed|5
3011949|NCT00860951|10360420|P1|Overall Study|Lost to Follow-up|5
3011950|NCT00860951|10360420|P1|Overall Study|Withdrawal by Subject|2
3011951|NCT00860743|10360477|P2|Overall Study|Withdrawal by Subject|0
3011952|NCT00860743|10360478|P1|Overall Study|Withdrawal by Subject|3
3011953|NCT00860470|10360491|P2|Overall Study|Lost to Follow-up|39
3011954|NCT00860470|10360492|P1|Overall Study|Lost to Follow-up|34
3011955|NCT00860470|10360491|P2|Overall Study|Moved away|10
3011956|NCT00860470|10360492|P1|Overall Study|Moved away|8
3011957|NCT00860470|10360491|P2|Overall Study|Death|10
3011958|NCT00860470|10360492|P1|Overall Study|Death|6
3011959|NCT00860405|10360522|P2|Overall Study|Main reason: Follow-up data not complete|4
3011960|NCT00860405|10360523|P1|Overall Study|Main reason: Follow-up data not complete|5
3011961|NCT00860262|10360563|P3|Overall Study|Other|1
3011962|NCT00860262|10360564|P2|Overall Study|Other|3
3011963|NCT00860262|10360565|P1|Overall Study|Other|5
3011964|NCT00860262|10360563|P3|Overall Study|Lack of Efficacy|3
3011965|NCT00860262|10360564|P2|Overall Study|Lack of Efficacy|4
3011966|NCT00860262|10360565|P1|Overall Study|Lack of Efficacy|0
3011967|NCT00860262|10360563|P3|Overall Study|Withdrawal by Subject|6
3011968|NCT00860262|10360564|P2|Overall Study|Withdrawal by Subject|8
3011969|NCT00860262|10360565|P1|Overall Study|Withdrawal by Subject|4
3011970|NCT00860262|10360563|P3|Overall Study|Lost to Follow-up|1
3011971|NCT00860262|10360564|P2|Overall Study|Lost to Follow-up|0
3011972|NCT00860262|10360565|P1|Overall Study|Lost to Follow-up|2
3011973|NCT00860262|10360563|P3|Overall Study|Protocol Violation|0
3011974|NCT00860262|10360564|P2|Overall Study|Protocol Violation|1
3011975|NCT00860262|10360565|P1|Overall Study|Protocol Violation|0
3011976|NCT00860262|10360563|P3|Overall Study|Adverse Event|7
3011977|NCT00860262|10360564|P2|Overall Study|Adverse Event|6
3011978|NCT00860262|10360565|P1|Overall Study|Adverse Event|9
3011979|NCT00860249|10360678|P3|Overall Study|trial was terminated prior to completion|21
3011980|NCT00860249|10360679|P2|Overall Study|trial was terminated prior to completion|18
3011981|NCT00860249|10360680|P1|Overall Study|trial was terminated prior to completion|21
3011982|NCT00860158|10360700|P1|Overall Study|Study Terminated|1
3011983|NCT00860067|10360712|P3|Overall Study|Pregnancy|0
3011984|NCT00860067|10360713|P2|Overall Study|Pregnancy|0
3011985|NCT00860067|10360714|P1|Overall Study|Pregnancy|1
3011986|NCT00860067|10360712|P3|Overall Study|Withdrawal by Subject|0
3011987|NCT00860067|10360713|P2|Overall Study|Withdrawal by Subject|0
3011988|NCT00860067|10360714|P1|Overall Study|Withdrawal by Subject|4
3011989|NCT00860067|10360712|P3|Overall Study|Lost to Follow-up|9
3011990|NCT00860067|10360713|P2|Overall Study|Lost to Follow-up|9
3011991|NCT00860067|10360714|P1|Overall Study|Lost to Follow-up|46
3011992|NCT00860028|10360774|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
3011993|NCT00860028|10360775|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
3011994|NCT00859937|10360813|P2|Overall Study|Protocol Violation|0
3011995|NCT00859937|10360814|P1|Overall Study|Protocol Violation|1
3011996|NCT00859898|10360829|P3|Overall Study|non-specified|1
3011997|NCT00859898|10360830|P2|Overall Study|non-specified|1
3011998|NCT00859898|10360831|P1|Overall Study|non-specified|1
3011999|NCT00859898|10360829|P3|Overall Study|No longer meets criteria|0
3012000|NCT00859898|10360830|P2|Overall Study|No longer meets criteria|1
3012001|NCT00859898|10360831|P1|Overall Study|No longer meets criteria|0
3012002|NCT00859898|10360829|P3|Overall Study|poor/non-compliance|0
3012003|NCT00859898|10360830|P2|Overall Study|poor/non-compliance|0
3012004|NCT00859898|10360831|P1|Overall Study|poor/non-compliance|2
3012005|NCT00859898|10360829|P3|Overall Study|Lost to Follow-up|5
3012006|NCT00859898|10360830|P2|Overall Study|Lost to Follow-up|11
3012007|NCT00859898|10360831|P1|Overall Study|Lost to Follow-up|10
3012008|NCT00859898|10360829|P3|Overall Study|Death|1
3012009|NCT00859898|10360830|P2|Overall Study|Death|0
3012010|NCT00859898|10360831|P1|Overall Study|Death|0
3012011|NCT00859898|10360829|P3|Overall Study|Withdrawal by Subject|11
3012012|NCT00859898|10360830|P2|Overall Study|Withdrawal by Subject|8
3012013|NCT00859898|10360831|P1|Overall Study|Withdrawal by Subject|11
3012014|NCT00859898|10360829|P3|Overall Study|Adverse Event|8
3012015|NCT00859898|10360830|P2|Overall Study|Adverse Event|9
3012016|NCT00859898|10360831|P1|Overall Study|Adverse Event|4
3012017|NCT00859898|10360829|P3|Overall Study|Lack of Efficacy|1
3012018|NCT00859898|10360830|P2|Overall Study|Lack of Efficacy|1
3012019|NCT00859898|10360831|P1|Overall Study|Lack of Efficacy|0
3012020|NCT00859638|10360890|P2|Overall Study|Ill health|1
3012021|NCT00859638|10360891|P1|Overall Study|Ill health|1
3012022|NCT00859638|10360890|P2|Overall Study|Withdrawal by Subject|2
3012023|NCT00859638|10360891|P1|Overall Study|Withdrawal by Subject|3
3012024|NCT00859638|10360890|P2|Overall Study|Lost to Follow-up|1
3012025|NCT00859638|10360891|P1|Overall Study|Lost to Follow-up|6
3012026|NCT00859586|10360897|P1|Overall Study|Donors|4
3012027|NCT00859573|10360903|P2|Overall Study|Physician Decision|1
3012028|NCT00859573|10360904|P1|Overall Study|Physician Decision|1
3012029|NCT00859573|10360903|P2|Overall Study|Withdrawal by Subject|1
3012030|NCT00859573|10360904|P1|Overall Study|Withdrawal by Subject|4
3012031|NCT00859547|10360910|P1|Overall Study|Parent withdrew consent|1
3012032|NCT00859547|10360910|P1|Overall Study|Lost to Follow-up|1
3012033|NCT00859521|10360923|P2|Washout|Withdrawal by Subject|1
3012034|NCT00859521|10360924|P1|Washout|Withdrawal by Subject|0
3012035|NCT00859469|10360941|P1|Overall Study|Death|16
3012036|NCT00859469|10360941|P1|Overall Study|Withdrawal by Subject|1
3012037|NCT00859469|10360941|P1|Overall Study|Lack of Efficacy|9
3012038|NCT00859469|10360941|P1|Overall Study|Adverse Event|2
3012039|NCT00859456|10360947|P1|Overall Study|Non-compliance|3
3012040|NCT00859456|10360947|P1|Overall Study|Progressive disease|2
3012041|NCT00859456|10360947|P1|Overall Study|Adverse Event|3
3012042|NCT00859430|10360953|P2|First Intervention|Withdrawal by Subject|1
3012043|NCT00859430|10360954|P1|First Intervention|Withdrawal by Subject|0
3012044|NCT00859313|10360970|P1|Overall Study|staff error|1
3012045|NCT00859313|10360970|P1|Overall Study|Adverse Event|1
3012046|NCT00859313|10360970|P1|Overall Study|Lack of Efficacy|2
3012047|NCT00859222|10360977|P5|Overall Study|DLT|0
3012048|NCT00859222|10360978|P4|Overall Study|DLT|0
3012049|NCT00859222|10360979|P3|Overall Study|DLT|0
3012050|NCT00859222|10360980|P2|Overall Study|DLT|0
3012051|NCT00859222|10360981|P1|Overall Study|DLT|1
3012052|NCT00859222|10360977|P5|Overall Study|Adverse Event|15
3012053|NCT00859222|10360978|P4|Overall Study|Adverse Event|24
3012054|NCT00859222|10360979|P3|Overall Study|Adverse Event|6
3012055|NCT00859222|10360980|P2|Overall Study|Adverse Event|3
3012056|NCT00859222|10360981|P1|Overall Study|Adverse Event|2
3012057|NCT00859014|10361103|P1|Overall Study|Lost to Follow-up|1
3012058|NCT00859014|10361103|P1|Overall Study|Death|4
3012059|NCT00858988|10361110|P2|Analysis|Lactulose unable to be detected in urine|1
3012060|NCT00858988|10361111|P1|Analysis|Lactulose unable to be detected in urine|2
3012061|NCT00858845|10361127|P2|Overall Study|Patient underwent heart transplant.|1
3012062|NCT00858845|10361128|P1|Overall Study|Patient underwent heart transplant.|0
3012063|NCT00858832|10361140|P2|Overall Study|Adverse Event|1
3012064|NCT00858832|10361141|P1|Overall Study|Adverse Event|0
3012065|NCT00858832|10361140|P2|Overall Study|became ineligible: delivered vaginally|0
3012066|NCT00858832|10361141|P1|Overall Study|became ineligible: delivered vaginally|1
3012067|NCT00858780|10361147|P5|OL Re-Treatment (Failure to Week 48)|Other|1
3012068|NCT00858780|10361148|P4|OL Re-Treatment (Failure to Week 48)|Other|0
3012069|NCT00858780|10361149|P3|OL Re-Treatment (Failure to Week 48)|Other|0
3012070|NCT00858780|10361150|P2|OL Re-Treatment (Failure to Week 48)|Other|0
3012071|NCT00858780|10361151|P1|OL Re-Treatment (Failure to Week 48)|Other|0
3012072|NCT00858780|10361147|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
3012073|NCT00858780|10361148|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
3012074|NCT00858780|10361149|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
3012075|NCT00858780|10361150|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
3012076|NCT00858780|10361151|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
3012077|NCT00858780|10361147|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
3012078|NCT00858780|10361148|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
3012079|NCT00858780|10361149|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
3012080|NCT00858780|10361150|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
3012081|NCT00858780|10361151|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
3012082|NCT00858780|10361147|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
3012083|NCT00858780|10361148|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
3012084|NCT00858780|10361149|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
3012085|NCT00858780|10361150|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
3012086|NCT00858780|10361151|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
3012087|NCT00858780|10361147|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
3012088|NCT00858780|10361148|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
3012089|NCT00858780|10361149|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
3012090|NCT00858780|10361150|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
3012091|NCT00858780|10361151|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
3012092|NCT00858780|10361147|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
3012093|NCT00858780|10361148|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
3012094|NCT00858780|10361149|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
3012095|NCT00858780|10361150|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
3012096|NCT00858780|10361151|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
3012097|NCT00858702|10361226|P2|Overall Study|Withdrawal by Subject|0
3012098|NCT00858702|10361227|P1|Overall Study|Withdrawal by Subject|1
3012099|NCT00858702|10361226|P2|Overall Study|Other|1
3012100|NCT00858702|10361227|P1|Overall Study|Other|2
3012101|NCT00858702|10361226|P2|Overall Study|Protocol Violation|1
3012102|NCT00858702|10361227|P1|Overall Study|Protocol Violation|1
3012103|NCT00858702|10361226|P2|Overall Study|Lack of Efficacy|0
3012104|NCT00858702|10361227|P1|Overall Study|Lack of Efficacy|1
3012105|NCT00858637|10361242|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
3012106|NCT00858637|10361243|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
3012107|NCT00858637|10361244|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
3012108|NCT00858637|10361245|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
3012109|NCT00858637|10361246|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
3012110|NCT00858637|10361247|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
3012111|NCT00858637|10361242|P6|Placebo-controlled Withdrawal Phase|Death|0
3012112|NCT00858637|10361243|P5|Placebo-controlled Withdrawal Phase|Death|1
3012113|NCT00858637|10361244|P4|Placebo-controlled Withdrawal Phase|Death|0
3012114|NCT00858637|10361245|P3|Placebo-controlled Withdrawal Phase|Death|1
3012115|NCT00858637|10361246|P2|Placebo-controlled Withdrawal Phase|Death|0
3012116|NCT00858637|10361247|P1|Placebo-controlled Withdrawal Phase|Death|0
3012117|NCT00858637|10361242|P6|Active Comparison Phase|Other Reasons|0
3012118|NCT00858637|10361243|P5|Active Comparison Phase|Other Reasons|0
3012119|NCT00858637|10361244|P4|Active Comparison Phase|Other Reasons|1
3012120|NCT00858637|10361245|P3|Active Comparison Phase|Other Reasons|0
3012121|NCT00858637|10361246|P2|Active Comparison Phase|Other Reasons|0
3012122|NCT00858637|10361247|P1|Active Comparison Phase|Other Reasons|1
3012123|NCT00858637|10361242|P6|Active Comparison Phase|Withdrawal by Subject|0
3012124|NCT00858637|10361243|P5|Active Comparison Phase|Withdrawal by Subject|0
3012125|NCT00858637|10361244|P4|Active Comparison Phase|Withdrawal by Subject|6
3012126|NCT00858637|10361245|P3|Active Comparison Phase|Withdrawal by Subject|0
3012127|NCT00858637|10361246|P2|Active Comparison Phase|Withdrawal by Subject|0
3012128|NCT00858637|10361247|P1|Active Comparison Phase|Withdrawal by Subject|7
3012129|NCT00858637|10361242|P6|Active Comparison Phase|Physician Decision|0
3012130|NCT00858637|10361243|P5|Active Comparison Phase|Physician Decision|0
3012131|NCT00858637|10361244|P4|Active Comparison Phase|Physician Decision|1
3012132|NCT00858637|10361245|P3|Active Comparison Phase|Physician Decision|0
3012133|NCT00858637|10361246|P2|Active Comparison Phase|Physician Decision|0
3012134|NCT00858637|10361247|P1|Active Comparison Phase|Physician Decision|1
3012135|NCT00858637|10361242|P6|Active Comparison Phase|Death|0
3012136|NCT00858637|10361243|P5|Active Comparison Phase|Death|0
3012137|NCT00858637|10361244|P4|Active Comparison Phase|Death|1
3012138|NCT00858637|10361245|P3|Active Comparison Phase|Death|0
3012139|NCT00858637|10361246|P2|Active Comparison Phase|Death|0
3012140|NCT00858637|10361247|P1|Active Comparison Phase|Death|1
3012141|NCT00858637|10361242|P6|Active Comparison Phase|Adverse Event|0
3012142|NCT00858637|10361243|P5|Active Comparison Phase|Adverse Event|0
3012143|NCT00858637|10361244|P4|Active Comparison Phase|Adverse Event|9
3012144|NCT00858637|10361245|P3|Active Comparison Phase|Adverse Event|0
3012145|NCT00858637|10361246|P2|Active Comparison Phase|Adverse Event|0
3012146|NCT00858637|10361247|P1|Active Comparison Phase|Adverse Event|14
3012147|NCT00858442|10361288|P2|Compression:Start to Finish|Lost to Follow-up|3
3012148|NCT00858442|10361289|P1|Compression:Start to Finish|Lost to Follow-up|1
3012149|NCT00858403|10361299|P1|Overall Study|Disease Progression|1
3012150|NCT00858403|10361299|P1|Overall Study|Death|3
3012151|NCT00858403|10361299|P1|Overall Study|Withdrawal by Subject|1
3012152|NCT00858364|10361320|P2|Overall Study|Still on-study|247
3012153|NCT00858364|10361321|P1|Overall Study|Still on-study|114
3012154|NCT00858364|10361320|P2|Overall Study|Missing|1
3012155|NCT00858364|10361321|P1|Overall Study|Missing|1
3012156|NCT00858364|10361320|P2|Overall Study|Other|17
3012157|NCT00858364|10361321|P1|Overall Study|Other|9
3012158|NCT00858364|10361320|P2|Overall Study|Protocol Deviation|2
3012159|NCT00858364|10361321|P1|Overall Study|Protocol Deviation|0
3012160|NCT00858364|10361320|P2|Overall Study|Noncompliance|4
3012161|NCT00858364|10361321|P1|Overall Study|Noncompliance|3
3012162|NCT00858364|10361320|P2|Overall Study|Lost to Follow-up|54
3012163|NCT00858364|10361321|P1|Overall Study|Lost to Follow-up|24
3012164|NCT00858364|10361320|P2|Overall Study|Ineligibility Determined|10
3012165|NCT00858364|10361321|P1|Overall Study|Ineligibility Determined|1
3012166|NCT00858364|10361320|P2|Overall Study|Withdrawal by Subject|118
3012167|NCT00858364|10361321|P1|Overall Study|Withdrawal by Subject|44
3012168|NCT00858364|10361320|P2|Overall Study|Adverse Event|2
3012169|NCT00858364|10361321|P1|Overall Study|Adverse Event|5
3012170|NCT00858364|10361320|P2|Overall Study|Administrative Decision|2
3012171|NCT00858364|10361321|P1|Overall Study|Administrative Decision|3
3012172|NCT00858247|10361343|P2|Week 12 Follow-up|Withdrawal by Subject|1
3012173|NCT00858247|10361344|P1|Week 12 Follow-up|Withdrawal by Subject|0
3012174|NCT00858247|10361343|P2|Baseline Assessment|Protocol Violation|1
3012175|NCT00858247|10361344|P1|Baseline Assessment|Protocol Violation|0
3012176|NCT00858247|10361343|P2|Baseline Assessment|Poor IV access|0
3012177|NCT00858247|10361344|P1|Baseline Assessment|Poor IV access|1
3012178|NCT00858247|10361343|P2|Baseline Assessment|Withdrawal by Subject|1
3012179|NCT00858247|10361344|P1|Baseline Assessment|Withdrawal by Subject|1
3012180|NCT00858208|10361360|P1|Overall Study|Other|10
3012181|NCT00858208|10361360|P1|Overall Study|Participant refused|40
3012182|NCT00858208|10361360|P1|Overall Study|Lost to Follow-up|26
3012183|NCT00858208|10361360|P1|Overall Study|Adverse Event|3
3012184|NCT00858143|10361377|P1|Overall Study|Other|23
3012185|NCT00858143|10361377|P1|Overall Study|Death|7
3012186|NCT00858143|10361377|P1|Overall Study|Lack of Efficacy|4
3012187|NCT00858143|10361377|P1|Overall Study|Adverse Event|16
3012188|NCT00857948|10361489|P4|Overall Study|Protocol Violation|0
3012189|NCT00857948|10361490|P3|Overall Study|Protocol Violation|1
3012190|NCT00857948|10361491|P2|Overall Study|Protocol Violation|0
3012191|NCT00857948|10361492|P1|Overall Study|Protocol Violation|1
3012192|NCT00857948|10361489|P4|Overall Study|Withdrawal by Subject|0
3012193|NCT00857948|10361490|P3|Overall Study|Withdrawal by Subject|0
3012194|NCT00857948|10361491|P2|Overall Study|Withdrawal by Subject|0
3012195|NCT00857948|10361492|P1|Overall Study|Withdrawal by Subject|2
3012196|NCT00857896|10361514|P1|Baseline to Week 4|Withdrawal by Subject|1
3012197|NCT00857818|10361670|P2|Overall Study|Investigator decision|0
3012198|NCT00857818|10361671|P1|Overall Study|Investigator decision|1
3012199|NCT00857818|10361670|P2|Overall Study|Sponsor terminated study|4
3012200|NCT00857818|10361671|P1|Overall Study|Sponsor terminated study|6
3012201|NCT00857818|10361670|P2|Overall Study|Withdrawal by Subject|4
3012202|NCT00857818|10361671|P1|Overall Study|Withdrawal by Subject|0
3012203|NCT00857818|10361670|P2|Overall Study|Adverse Event|0
3012204|NCT00857818|10361671|P1|Overall Study|Adverse Event|3
3012205|NCT00857818|10361670|P2|Overall Study|Lack of Efficacy|0
3012206|NCT00857818|10361671|P1|Overall Study|Lack of Efficacy|1
3012207|NCT00857792|10361699|P1|Overall Study|inadequate image quality for analysis|12
3012208|NCT00857766|10361705|P2|Overall Study|Participant Withdrew Consent|4
3012209|NCT00857766|10361706|P1|Overall Study|Participant Withdrew Consent|4
3012210|NCT00857766|10361705|P2|Overall Study|Investigator Discretion|3
3012211|NCT00857766|10361706|P1|Overall Study|Investigator Discretion|2
3012212|NCT00857766|10361705|P2|Overall Study|Lost to Follow-up|0
3012213|NCT00857766|10361706|P1|Overall Study|Lost to Follow-up|1
3012214|NCT00857766|10361705|P2|Overall Study|Protocol Violation|11
3012215|NCT00857766|10361706|P1|Overall Study|Protocol Violation|11
3012216|NCT00857766|10361705|P2|Overall Study|Adverse Event|12
3012217|NCT00857766|10361706|P1|Overall Study|Adverse Event|13
3012218|NCT00857649|10361748|P2|Overall Study|Other Reasons|3
3012219|NCT00857649|10361749|P1|Overall Study|Other Reasons|1
3012220|NCT00857649|10361748|P2|Overall Study|Nursing Home Placement|9
3012221|NCT00857649|10361749|P1|Overall Study|Nursing Home Placement|2
3012222|NCT00857649|10361748|P2|Overall Study|Withdrawal of Consent|7
3012223|NCT00857649|10361749|P1|Overall Study|Withdrawal of Consent|10
3012224|NCT00857649|10361748|P2|Overall Study|Protocol Violation|2
3012225|NCT00857649|10361749|P1|Overall Study|Protocol Violation|2
3012226|NCT00857649|10361748|P2|Overall Study|Non-compliance|1
3012227|NCT00857649|10361749|P1|Overall Study|Non-compliance|1
3012228|NCT00857649|10361748|P2|Overall Study|Adverse Event|10
3012229|NCT00857649|10361749|P1|Overall Study|Adverse Event|15
3012230|NCT00857623|10361765|P2|Overall Study|Positive for HEP C|1
3012231|NCT00857623|10361766|P1|Overall Study|Positive for HEP C|0
3012232|NCT00857623|10361765|P2|Overall Study|Intake of prohibited medication|1
3012233|NCT00857623|10361766|P1|Overall Study|Intake of prohibited medication|0
3012234|NCT00857623|10361765|P2|Overall Study|Severe non-compliance to protocol|1
3012235|NCT00857623|10361766|P1|Overall Study|Severe non-compliance to protocol|1
3012236|NCT00857623|10361765|P2|Overall Study|Lack of Efficacy|1
3012237|NCT00857623|10361766|P1|Overall Study|Lack of Efficacy|1
3012238|NCT00857623|10361765|P2|Overall Study|Withdrawal by Subject|1
3012239|NCT00857623|10361766|P1|Overall Study|Withdrawal by Subject|2
3012240|NCT00857623|10361765|P2|Overall Study|Study-specific discontinuation criteria|3
3012241|NCT00857623|10361766|P1|Overall Study|Study-specific discontinuation criteria|5
3012242|NCT00857623|10361765|P2|Overall Study|Adverse Event|2
3012243|NCT00857623|10361766|P1|Overall Study|Adverse Event|5
3012244|NCT00857584|10361790|P2|Overall Study|Physician Decision|1
3012245|NCT00857584|10361791|P1|Overall Study|Physician Decision|1
3012246|NCT00857584|10361790|P2|Overall Study|Adverse Event|2
3012247|NCT00857584|10361791|P1|Overall Study|Adverse Event|2
3012248|NCT00857584|10361790|P2|Overall Study|Lack of Efficacy|2
3012249|NCT00857584|10361791|P1|Overall Study|Lack of Efficacy|1
3012250|NCT00857454|10361918|P1|Overall Study|MTE09 enrollment criteria not met|6
3012251|NCT00857454|10361918|P1|Overall Study|Total Testosterone <300 ng/dL|8
3012252|NCT00857454|10361918|P1|Overall Study|Total Testosterone >1050 ng/dL|1
3012253|NCT00857454|10361918|P1|Overall Study|Adverse Event|2
3012254|NCT00857454|10361918|P1|Overall Study|Lost to Follow-up|1
3012255|NCT00857454|10361918|P1|Overall Study|Withdrawal by Subject|2
3012256|NCT00857415|10361931|P2|Overall Study|Deceased with no autopsy|0
3012257|NCT00857415|10361932|P1|Overall Study|Deceased with no autopsy|2
3012258|NCT00857415|10361931|P2|Overall Study|Subject still living at end of study|0
3012259|NCT00857415|10361932|P1|Overall Study|Subject still living at end of study|110
3012260|NCT00857415|10361931|P2|Overall Study|Invalid image or not imaged|0
3012261|NCT00857415|10361932|P1|Overall Study|Invalid image or not imaged|3
3012262|NCT00857415|10361931|P2|Overall Study|Image acquisition failure|0
3012263|NCT00857415|10361932|P1|Overall Study|Image acquisition failure|2
3012264|NCT00857389|10361939|P1|Overall Study|Did not proceed to transplant|2
3012265|NCT00857311|10361953|P4|Overall Study|Lost to Follow-up|0
3012266|NCT00857311|10361954|P3|Overall Study|Lost to Follow-up|0
3012267|NCT00857311|10361955|P2|Overall Study|Lost to Follow-up|0
3012268|NCT00857311|10361956|P1|Overall Study|Lost to Follow-up|1
3012269|NCT00857285|10361968|P2|Overall Study|Randomization criteria not met|1
3012270|NCT00857285|10361969|P1|Overall Study|Randomization criteria not met|1
3012271|NCT00857285|10361968|P2|Overall Study|Withdrawal by Subject|0
3012272|NCT00857285|10361969|P1|Overall Study|Withdrawal by Subject|4
3012273|NCT00857285|10361968|P2|Overall Study|Protocol Violation|1
3012274|NCT00857285|10361969|P1|Overall Study|Protocol Violation|3
3012275|NCT00857285|10361968|P2|Overall Study|Lack of Efficacy|2
3012276|NCT00857285|10361969|P1|Overall Study|Lack of Efficacy|0
3012277|NCT00857285|10361968|P2|Overall Study|Adverse Event|2
3012278|NCT00857285|10361969|P1|Overall Study|Adverse Event|4
3012279|NCT00857259|10361985|P3|Overall Study|Protocol Violation|1
3012280|NCT00857259|10361986|P2|Overall Study|Protocol Violation|0
3012281|NCT00857259|10361987|P1|Overall Study|Protocol Violation|1
3012282|NCT00857246|10361997|P1|ChemoRT|Adverse Event|2
3012283|NCT00857246|10361997|P1|ChemoRT|Withdrawal by Subject|1
3012284|NCT00857246|10361997|P1|Surgery (Curative)|disease progression|6
3012285|NCT00857246|10361997|P1|Induction Regimen|Withdrawal by Subject|1
3012286|NCT00857246|10361997|P1|Induction Regimen|disease-related complications|1
3012287|NCT00857246|10361997|P1|Induction Regimen|Adverse Event|1
3012288|NCT00857233|10362007|P1|Overall Study|Other Reasons|2
3012289|NCT00857233|10362007|P1|Overall Study|Nursing Home Placement|14
3012290|NCT00857233|10362007|P1|Overall Study|Lost to Follow-up|4
3012291|NCT00857233|10362007|P1|Overall Study|Withdrawal of Consent|9
3012292|NCT00857233|10362007|P1|Overall Study|Non-compliance|1
3012293|NCT00857233|10362007|P1|Overall Study|Lack of Efficacy|1
3012294|NCT00857233|10362007|P1|Overall Study|Adverse Event|24
3012295|NCT00857220|10362016|P1|Overall Study|Miscellaneous|8
3012296|NCT00857220|10362016|P1|Overall Study|Site Closed|5
3012297|NCT00857220|10362016|P1|Overall Study|Clinical Hold|6
3012298|NCT00857220|10362016|P1|Overall Study|Withdrawal by Subject|67
3012299|NCT00857220|10362016|P1|Overall Study|Protocol Violation|16
3012300|NCT00857220|10362016|P1|Overall Study|Physician Decision|4
3012301|NCT00857220|10362016|P1|Overall Study|Lost to Follow-up|30
3012302|NCT00857220|10362016|P1|Overall Study|Lack of Efficacy|11
3012303|NCT00857220|10362016|P1|Overall Study|Death|1
3012304|NCT00857220|10362016|P1|Overall Study|Adverse Event|35
3012305|NCT00856999|10362033|P1|Overall Study|Withdrawal by Subject|5
3012306|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Unclassified|0
3012307|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Unclassified|0
3012308|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Unclassified|11
3012309|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Unclassified|2
3012310|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Unclassified|4
3012311|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
3012312|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
3012313|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
3012314|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
3012315|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
3012316|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
3012317|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
3012318|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
3012319|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
3012320|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
3012321|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
3012322|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
3012323|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
3012324|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
3012325|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
3012326|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Protocol Violation|0
3012327|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Protocol Violation|0
3012328|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Protocol Violation|5
3012329|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Protocol Violation|2
3012330|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Protocol Violation|6
3012331|NCT00856986|10362043|P5|Extension Period, Weeks 26-52|Adverse Event|0
3012332|NCT00856986|10362044|P4|Extension Period, Weeks 26-52|Adverse Event|0
3012333|NCT00856986|10362045|P3|Extension Period, Weeks 26-52|Adverse Event|10
3012334|NCT00856986|10362046|P2|Extension Period, Weeks 26-52|Adverse Event|3
3012335|NCT00856986|10362047|P1|Extension Period, Weeks 26-52|Adverse Event|3
3012336|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Unclassified|0
3012337|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Unclassified|0
3012338|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Unclassified|7
3012339|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Unclassified|6
3012340|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Unclassified|7
3012341|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
3012342|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
3012343|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
3012344|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
3012345|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
3012346|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
3012347|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
3012348|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
3012349|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
3012350|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
3012351|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
3012352|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
3012353|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
3012354|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
3012355|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
3012356|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Protocol Violation|0
3012357|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Protocol Violation|0
3012358|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Protocol Violation|7
3012359|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Protocol Violation|5
3012360|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Protocol Violation|4
3012361|NCT00856986|10362043|P5|Main Period, Weeks 0-26|Adverse Event|0
3012362|NCT00856986|10362044|P4|Main Period, Weeks 0-26|Adverse Event|0
3012363|NCT00856986|10362045|P3|Main Period, Weeks 0-26|Adverse Event|9
3012364|NCT00856986|10362046|P2|Main Period, Weeks 0-26|Adverse Event|4
3012365|NCT00856986|10362047|P1|Main Period, Weeks 0-26|Adverse Event|6
3012366|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Unclassified|0
3012367|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Unclassified|24
3012368|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Unclassified|0
3012369|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Unclassified|0
3012370|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Unclassified|0
3012371|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
3012372|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
3012373|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
3012374|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
3012375|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
3012376|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
3012377|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
3012378|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
3012379|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
3012380|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
3012381|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
3012382|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
3012383|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
3012384|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
3012385|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
3012386|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
3012387|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
3012388|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
3012389|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
3012390|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
3012391|NCT00856986|10362043|P5|Run-in Period, Weeks -12-0|Adverse Event|0
3012392|NCT00856986|10362044|P4|Run-in Period, Weeks -12-0|Adverse Event|92
3012393|NCT00856986|10362045|P3|Run-in Period, Weeks -12-0|Adverse Event|0
3012394|NCT00856986|10362046|P2|Run-in Period, Weeks -12-0|Adverse Event|0
3012395|NCT00856986|10362047|P1|Run-in Period, Weeks -12-0|Adverse Event|0
3012396|NCT00856973|10362217|P3|Overall Study|Other|13
3012397|NCT00856973|10362218|P2|Overall Study|Other|12
3012398|NCT00856973|10362219|P1|Overall Study|Other|11
3012399|NCT00856973|10362217|P3|Overall Study|Withdrawal by Subject|15
3012400|NCT00856973|10362218|P2|Overall Study|Withdrawal by Subject|16
3012401|NCT00856973|10362219|P1|Overall Study|Withdrawal by Subject|13
3012402|NCT00856973|10362217|P3|Overall Study|Protocol Violation|1
3012403|NCT00856973|10362218|P2|Overall Study|Protocol Violation|2
3012404|NCT00856973|10362219|P1|Overall Study|Protocol Violation|1
3012405|NCT00856973|10362217|P3|Overall Study|Physician Decision|1
3012406|NCT00856973|10362218|P2|Overall Study|Physician Decision|3
3012407|NCT00856973|10362219|P1|Overall Study|Physician Decision|0
3012408|NCT00856973|10362217|P3|Overall Study|Lost to Follow-up|5
3012409|NCT00856973|10362218|P2|Overall Study|Lost to Follow-up|3
3012410|NCT00856973|10362219|P1|Overall Study|Lost to Follow-up|6
3012411|NCT00856973|10362217|P3|Overall Study|Adverse Event|3
3012412|NCT00856973|10362218|P2|Overall Study|Adverse Event|5
3012413|NCT00856973|10362219|P1|Overall Study|Adverse Event|5
3012414|NCT00856908|10362299|P2|Overall Study|Lost to Follow-up|0
3012415|NCT00856908|10362300|P1|Overall Study|Lost to Follow-up|1
3012416|NCT00856856|10362325|P1|4-year Clinical Follow-up|Missed visit|1
3012417|NCT00856856|10362325|P1|2-year Clinical Follow-up|Lost to Follow-up|1
3012418|NCT00856843|10362524|P2|Overall Study|Lack of Efficacy|0
3012419|NCT00856843|10362525|P1|Overall Study|Lack of Efficacy|1
3012420|NCT00856843|10362524|P2|Overall Study|Withdrawal by Subject|5
3012421|NCT00856843|10362525|P1|Overall Study|Withdrawal by Subject|1
3012422|NCT00856830|10362561|P4|Irinotecan & Bendamustine|Physician Decision|1
3012423|NCT00856830|10362562|P3|Irinotecan & Bendamustine|Physician Decision|0
3012424|NCT00856830|10362563|P2|Irinotecan & Bendamustine|Physician Decision|0
3012425|NCT00856830|10362564|P1|Irinotecan & Bendamustine|Physician Decision|0
3012426|NCT00856830|10362561|P4|Irinotecan & Bendamustine|Death|2
3012427|NCT00856830|10362562|P3|Irinotecan & Bendamustine|Death|0
3012428|NCT00856830|10362563|P2|Irinotecan & Bendamustine|Death|0
3012429|NCT00856830|10362564|P1|Irinotecan & Bendamustine|Death|0
3012430|NCT00856778|10362575|P1|Overall Study|Lost to Follow-up|5
3012431|NCT00856778|10362575|P1|Overall Study|Study deviation|2
3012432|NCT00856778|10362575|P1|Overall Study|Withdrawal by Subject|10
3012433|NCT00856778|10362575|P1|Overall Study|Adverse Event|7
3012434|NCT00856661|10362618|P2|Overall Study|Physician Judgement|5
3012435|NCT00856661|10362619|P1|Overall Study|Physician Judgement|8
3012436|NCT00856661|10362618|P2|Overall Study|Lost to Follow-up|3
3012437|NCT00856661|10362619|P1|Overall Study|Lost to Follow-up|1
3012438|NCT00856661|10362618|P2|Overall Study|Withdrawal by Subject|2
3012439|NCT00856661|10362619|P1|Overall Study|Withdrawal by Subject|1
3012440|NCT00856661|10362618|P2|Overall Study|Protocol Violation|1
3012441|NCT00856661|10362619|P1|Overall Study|Protocol Violation|2
3012442|NCT00856661|10362618|P2|Overall Study|Death|18
3012443|NCT00856661|10362619|P1|Overall Study|Death|15
3012444|NCT00856635|10362633|P2|Overall Study|Discontinued at Randomization|2
3012445|NCT00856635|10362634|P1|Overall Study|Discontinued at Randomization|2
3012446|NCT00856635|10362633|P2|Overall Study|Other|0
3012447|NCT00856635|10362634|P1|Overall Study|Other|1
3012448|NCT00856635|10362633|P2|Overall Study|Serious Adverse Event|0
3012449|NCT00856635|10362634|P1|Overall Study|Serious Adverse Event|1
3012450|NCT00856635|10362633|P2|Overall Study|Withdrawal by Subject|1
3012451|NCT00856635|10362634|P1|Overall Study|Withdrawal by Subject|3
3012452|NCT00856635|10362633|P2|Overall Study|Pregnancy|0
3012453|NCT00856635|10362634|P1|Overall Study|Pregnancy|1
3012454|NCT00856635|10362633|P2|Overall Study|Lost to Follow-up|5
3012455|NCT00856635|10362634|P1|Overall Study|Lost to Follow-up|2
3012456|NCT00856609|10362644|P2|Overall Study|Adverse Event|0
3012457|NCT00856609|10362645|P1|Overall Study|Adverse Event|1
3012458|NCT00856583|10362657|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
3012459|NCT00856583|10362658|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
3012460|NCT00856583|10362657|P2|Overall Study|Other|104
3012461|NCT00856583|10362658|P1|Overall Study|Other|92
3012462|NCT00856583|10362657|P2|Overall Study|Pregnancy|5
3012463|NCT00856583|10362658|P1|Overall Study|Pregnancy|14
3012464|NCT00856583|10362657|P2|Overall Study|Physician Decision|82
3012465|NCT00856583|10362658|P1|Overall Study|Physician Decision|59
3012466|NCT00856583|10362657|P2|Overall Study|Withdrawal by Subject|919
3012467|NCT00856583|10362658|P1|Overall Study|Withdrawal by Subject|1092
3012468|NCT00856583|10362657|P2|Overall Study|Non-compliance|262
3012469|NCT00856583|10362658|P1|Overall Study|Non-compliance|305
3012470|NCT00856583|10362657|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
3012471|NCT00856583|10362658|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
3012472|NCT00856583|10362657|P2|Overall Study|Serious Adverse Event (SAE)|65
3012473|NCT00856583|10362658|P1|Overall Study|Serious Adverse Event (SAE)|99
3012474|NCT00856583|10362657|P2|Overall Study|Lack of Efficacy|377
3012475|NCT00856583|10362658|P1|Overall Study|Lack of Efficacy|389
3012476|NCT00856557|10362688|P2|Overall Study|No patients with contextual flags|16
3012477|NCT00856557|10362689|P1|Overall Study|No patients with contextual flags|12
3012478|NCT00856544|10362703|P4|Overall Study|Withdrawal by Subject|1
3012479|NCT00856544|10362704|P3|Overall Study|Withdrawal by Subject|0
3012480|NCT00856544|10362705|P2|Overall Study|Withdrawal by Subject|5
3012481|NCT00856544|10362706|P1|Overall Study|Withdrawal by Subject|8
3012482|NCT00856544|10362703|P4|Overall Study|Lost to Follow-up|0
3012483|NCT00856544|10362704|P3|Overall Study|Lost to Follow-up|2
3012484|NCT00856544|10362705|P2|Overall Study|Lost to Follow-up|2
3012485|NCT00856544|10362706|P1|Overall Study|Lost to Follow-up|1
3012486|NCT00856544|10362703|P4|Overall Study|Other|6
3012487|NCT00856544|10362704|P3|Overall Study|Other|1
3012488|NCT00856544|10362705|P2|Overall Study|Other|16
3012489|NCT00856544|10362706|P1|Overall Study|Other|9
3012490|NCT00856544|10362703|P4|Overall Study|Lack of Efficacy|3
3012491|NCT00856544|10362704|P3|Overall Study|Lack of Efficacy|3
3012492|NCT00856544|10362705|P2|Overall Study|Lack of Efficacy|12
3012493|NCT00856544|10362706|P1|Overall Study|Lack of Efficacy|16
3012494|NCT00856544|10362703|P4|Overall Study|Adverse Event|3
3012495|NCT00856544|10362704|P3|Overall Study|Adverse Event|2
3012496|NCT00856544|10362705|P2|Overall Study|Adverse Event|29
3012497|NCT00856544|10362706|P1|Overall Study|Adverse Event|20
3012498|NCT00856544|10362703|P4|Overall Study|Death|0
3012499|NCT00856544|10362704|P3|Overall Study|Death|0
3012500|NCT00856544|10362705|P2|Overall Study|Death|2
3012501|NCT00856544|10362706|P1|Overall Study|Death|0
3012502|NCT00856544|10362703|P4|Overall Study|Randomized but not treated|0
3012503|NCT00856544|10362704|P3|Overall Study|Randomized but not treated|0
3012504|NCT00856544|10362705|P2|Overall Study|Randomized but not treated|0
3012505|NCT00856544|10362706|P1|Overall Study|Randomized but not treated|3
3012506|NCT00856518|10362885|P2|Overall Study|Lost to Follow-up|2
3012507|NCT00856518|10362886|P1|Overall Study|Lost to Follow-up|4
3012508|NCT00856492|10362899|P3|Overall Study|Ineligible or withdrew consent|2
3012509|NCT00856492|10362900|P2|Overall Study|Ineligible or withdrew consent|1
3012510|NCT00856492|10362901|P1|Overall Study|Ineligible or withdrew consent|1
3012511|NCT00856388|10362923|P1|Overall Study|Other|1
3012512|NCT00856349|10362934|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
3012513|NCT00856349|10362934|P1|Overall Study|Site closure|78
3012514|NCT00856349|10362934|P1|Overall Study|Device explant|33
3012515|NCT00856349|10362934|P1|Overall Study|Subject relocation|104
3012516|NCT00856349|10362934|P1|Overall Study|Physician Decision|13
3012517|NCT00856349|10362934|P1|Overall Study|Protocol Violation|38
3012518|NCT00856349|10362934|P1|Overall Study|Lost to Follow-up|91
3012519|NCT00856349|10362934|P1|Overall Study|Withdrawal by Subject|116
3012520|NCT00856349|10362934|P1|Overall Study|Death|418
3012521|NCT00856323|10362943|P1|Overall Study|Withdrawal by Subject|2
3012522|NCT00856297|10362955|P5|Overall Study|Unable to classify|0
3012523|NCT00856297|10362956|P4|Overall Study|Unable to classify|0
3012524|NCT00856297|10362957|P3|Overall Study|Unable to classify|0
3012525|NCT00856297|10362958|P2|Overall Study|Unable to classify|0
3012526|NCT00856297|10362959|P1|Overall Study|Unable to classify|2
3012527|NCT00856284|10362992|P3|Overall Study|Randomized in error|1
3012528|NCT00856284|10362993|P2|Overall Study|Randomized in error|0
3012529|NCT00856284|10362994|P1|Overall Study|Randomized in error|0
3012530|NCT00856284|10362992|P3|Overall Study|Other|14
3012531|NCT00856284|10362993|P2|Overall Study|Other|17
3012532|NCT00856284|10362994|P1|Overall Study|Other|15
3012533|NCT00856284|10362992|P3|Overall Study|Investigator discretion|10
3012534|NCT00856284|10362993|P2|Overall Study|Investigator discretion|8
3012535|NCT00856284|10362994|P1|Overall Study|Investigator discretion|9
3012536|NCT00856284|10362992|P3|Overall Study|Pregnancy|0
3012537|NCT00856284|10362993|P2|Overall Study|Pregnancy|2
3012538|NCT00856284|10362994|P1|Overall Study|Pregnancy|1
3012539|NCT00856284|10362992|P3|Overall Study|Voluntary withdrawal|62
3012540|NCT00856284|10362993|P2|Overall Study|Voluntary withdrawal|52
3012541|NCT00856284|10362994|P1|Overall Study|Voluntary withdrawal|48
3012542|NCT00856284|10362992|P3|Overall Study|Lost to Follow-up|28
3012543|NCT00856284|10362993|P2|Overall Study|Lost to Follow-up|22
3012544|NCT00856284|10362994|P1|Overall Study|Lost to Follow-up|20
3012545|NCT00856284|10362992|P3|Overall Study|Major protocol deviation|15
3012546|NCT00856284|10362993|P2|Overall Study|Major protocol deviation|16
3012547|NCT00856284|10362994|P1|Overall Study|Major protocol deviation|24
3012548|NCT00856284|10362992|P3|Overall Study|Adverse Event|82
3012549|NCT00856284|10362993|P2|Overall Study|Adverse Event|74
3012550|NCT00856284|10362994|P1|Overall Study|Adverse Event|60
3012551|NCT00856284|10362992|P3|Overall Study|Hyperglycemic rescue|235
3012552|NCT00856284|10362993|P2|Overall Study|Hyperglycemic rescue|201
3012553|NCT00856284|10362994|P1|Overall Study|Hyperglycemic rescue|231
3012554|NCT00856245|10363020|P1|Overall Study|Was not transplanted|5
3012555|NCT00856206|10363043|P2|Overall Study|Other than specified above|10
3012556|NCT00856206|10363044|P1|Overall Study|Other than specified above|3
3012557|NCT00856206|10363043|P2|Overall Study|Decision by the Sponsor|8
3012558|NCT00856206|10363044|P1|Overall Study|Decision by the Sponsor|4
3012559|NCT00856206|10363043|P2|Overall Study|Death|2
3012560|NCT00856206|10363044|P1|Overall Study|Death|2
3012561|NCT00856206|10363043|P2|Overall Study|Lost to Follow-up|39
3012562|NCT00856206|10363044|P1|Overall Study|Lost to Follow-up|13
3012563|NCT00856206|10363043|P2|Overall Study|Withdrawal by Subject|36
3012564|NCT00856206|10363044|P1|Overall Study|Withdrawal by Subject|15
3012565|NCT00856206|10363043|P2|Overall Study|Lack of Efficacy|2
3012566|NCT00856206|10363044|P1|Overall Study|Lack of Efficacy|1
3012567|NCT00856206|10363043|P2|Overall Study|Adverse Event|46
3012568|NCT00856206|10363044|P1|Overall Study|Adverse Event|10
3012569|NCT00856206|10363043|P2|Overall Study|Protocol Violation|18
3012570|NCT00856206|10363044|P1|Overall Study|Protocol Violation|6
3012571|NCT00856193|10363058|P2|Period 2|Lost to Follow-up|1
3012572|NCT00856193|10363059|P1|Period 2|Lost to Follow-up|0
3012573|NCT00856193|10363058|P2|Period 2|Abnormal test procedure results|1
3012574|NCT00856193|10363059|P1|Period 2|Abnormal test procedure results|0
3012575|NCT00856180|10363071|P1|Overall Study|Progressive Disease|16
3012576|NCT00856180|10363071|P1|Overall Study|Adverse Event|4
3012577|NCT00855959|10363096|P1|Overall Study|Incorrect enrolment|1
3012578|NCT00855959|10363096|P1|Overall Study|Pregnancy|1
3012579|NCT00855959|10363096|P1|Overall Study|Withdrawal by Subject|3
3012580|NCT00855959|10363096|P1|Overall Study|Lost to Follow-up|2
3012581|NCT00855959|10363096|P1|Overall Study|Adverse Event|2
3012582|NCT00855933|10363113|P2|Overall Study|Withdrawal by Subject|1
3012583|NCT00855933|10363114|P1|Overall Study|Withdrawal by Subject|0
3012584|NCT00855920|10363123|P3|Overall Study|Other than specified above|1
3012585|NCT00855920|10363124|P2|Overall Study|Other than specified above|1
3012586|NCT00855920|10363125|P1|Overall Study|Other than specified above|1
3012587|NCT00855920|10363123|P3|Overall Study|Decision by the sponsor|1
3012588|NCT00855920|10363124|P2|Overall Study|Decision by the sponsor|1
3012589|NCT00855920|10363125|P1|Overall Study|Decision by the sponsor|0
3012590|NCT00855920|10363123|P3|Overall Study|Death|0
3012591|NCT00855920|10363124|P2|Overall Study|Death|1
3012592|NCT00855920|10363125|P1|Overall Study|Death|0
3012593|NCT00855920|10363123|P3|Overall Study|Lost to Follow-up|2
3012594|NCT00855920|10363124|P2|Overall Study|Lost to Follow-up|0
3012595|NCT00855920|10363125|P1|Overall Study|Lost to Follow-up|1
3012596|NCT00855920|10363123|P3|Overall Study|Withdrawal by Subject|2
3012597|NCT00855920|10363124|P2|Overall Study|Withdrawal by Subject|3
3012598|NCT00855920|10363125|P1|Overall Study|Withdrawal by Subject|2
3012599|NCT00855920|10363123|P3|Overall Study|Lack of Efficacy|2
3012600|NCT00855920|10363124|P2|Overall Study|Lack of Efficacy|2
3012601|NCT00855920|10363125|P1|Overall Study|Lack of Efficacy|2
3012602|NCT00855920|10363123|P3|Overall Study|Adverse Event|1
3012603|NCT00855920|10363124|P2|Overall Study|Adverse Event|1
3012604|NCT00855920|10363125|P1|Overall Study|Adverse Event|2
3012605|NCT00855920|10363123|P3|Overall Study|Protocol Violation|2
3012606|NCT00855920|10363124|P2|Overall Study|Protocol Violation|0
3012607|NCT00855920|10363125|P1|Overall Study|Protocol Violation|0
3012608|NCT00855894|10363142|P1|Overall Study|Disease progression|1
3012609|NCT00855894|10363142|P1|Overall Study|Patient's decision|1
3012610|NCT00855894|10363142|P1|Overall Study|Death|31
3012611|NCT00855816|10363165|P2|Overall Study|Became ineligible|1
3012612|NCT00855816|10363166|P1|Overall Study|Became ineligible|0
3012613|NCT00855816|10363165|P2|Overall Study|Death|0
3012614|NCT00855816|10363166|P1|Overall Study|Death|1
3012615|NCT00855816|10363165|P2|Overall Study|Lost to Follow-up|5
3012616|NCT00855816|10363166|P1|Overall Study|Lost to Follow-up|3
3012617|NCT00855816|10363165|P2|Overall Study|Withdrawal by Subject|15
3012618|NCT00855816|10363166|P1|Overall Study|Withdrawal by Subject|22
3012619|NCT00855738|10363172|P1|Overall Study|Death|1
3012620|NCT00855738|10363172|P1|Overall Study|Subject Defaulted|1
3012621|NCT00855738|10363172|P1|Overall Study|Adverse Event|1
3012622|NCT00855738|10363172|P1|Overall Study|Lost to Follow-up|2
3012623|NCT00855595|10363200|P2|Overall Study|patient left country|1
3012624|NCT00855595|10363201|P1|Overall Study|patient left country|0
3012625|NCT00855595|10363200|P2|Overall Study|patient moved out of state|0
3012626|NCT00855595|10363201|P1|Overall Study|patient moved out of state|1
3012627|NCT00855595|10363200|P2|Overall Study|Adverse Event|1
3012628|NCT00855595|10363201|P1|Overall Study|Adverse Event|1
3012629|NCT00855595|10363200|P2|Overall Study|Lost to Follow-up|3
3012630|NCT00855595|10363201|P1|Overall Study|Lost to Follow-up|3
3012631|NCT00855595|10363200|P2|Overall Study|Withdrawal by Subject|2
3012632|NCT00855595|10363201|P1|Overall Study|Withdrawal by Subject|1
3012633|NCT00855582|10363240|P3|Overall Study|Withdrawal by Subject|8
3012634|NCT00855582|10363241|P2|Overall Study|Withdrawal by Subject|4
3012635|NCT00855582|10363242|P1|Overall Study|Withdrawal by Subject|7
3012636|NCT00855582|10363240|P3|Overall Study|Entry Criteria Not Met|3
3012637|NCT00855582|10363241|P2|Overall Study|Entry Criteria Not Met|6
3012638|NCT00855582|10363242|P1|Overall Study|Entry Criteria Not Met|8
3012639|NCT00855582|10363240|P3|Overall Study|Protocol Violation|6
3012640|NCT00855582|10363241|P2|Overall Study|Protocol Violation|2
3012641|NCT00855582|10363242|P1|Overall Study|Protocol Violation|6
3012642|NCT00855582|10363240|P3|Overall Study|Physician Decision|1
3012643|NCT00855582|10363241|P2|Overall Study|Physician Decision|0
3012644|NCT00855582|10363242|P1|Overall Study|Physician Decision|0
3012645|NCT00855582|10363240|P3|Overall Study|Lost to Follow-up|1
3012646|NCT00855582|10363241|P2|Overall Study|Lost to Follow-up|3
3012647|NCT00855582|10363242|P1|Overall Study|Lost to Follow-up|1
3012648|NCT00855582|10363240|P3|Overall Study|Lack of Efficacy|8
3012649|NCT00855582|10363241|P2|Overall Study|Lack of Efficacy|3
3012650|NCT00855582|10363242|P1|Overall Study|Lack of Efficacy|1
3012651|NCT00855582|10363240|P3|Overall Study|Death|0
3012652|NCT00855582|10363241|P2|Overall Study|Death|0
3012653|NCT00855582|10363242|P1|Overall Study|Death|1
3012654|NCT00855582|10363240|P3|Overall Study|Adverse Event|3
3012655|NCT00855582|10363241|P2|Overall Study|Adverse Event|6
3012656|NCT00855582|10363242|P1|Overall Study|Adverse Event|2
3012657|NCT00855465|10363331|P2|Follow-up Period (FUP)|Missing|0
3012658|NCT00855465|10363332|P1|Follow-up Period (FUP)|Missing|1
3012659|NCT00855465|10363331|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
3012660|NCT00855465|10363332|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
3012661|NCT00855465|10363331|P2|Follow-up Period (FUP)|Lost to Follow-up|0
3012662|NCT00855465|10363332|P1|Follow-up Period (FUP)|Lost to Follow-up|3
3012663|NCT00855465|10363331|P2|Follow-up Period (FUP)|Death|1
3012664|NCT00855465|10363332|P1|Follow-up Period (FUP)|Death|0
3012665|NCT00855465|10363331|P2|Follow-up Period (FUP)|Adverse Event|1
3012666|NCT00855465|10363332|P1|Follow-up Period (FUP)|Adverse Event|0
3012667|NCT00855465|10363331|P2|Treatment Period|Not treated|0
3012668|NCT00855465|10363332|P1|Treatment Period|Not treated|1
3012669|NCT00855465|10363331|P2|Treatment Period|Withdrawal by Subject|0
3012670|NCT00855465|10363332|P1|Treatment Period|Withdrawal by Subject|2
3012671|NCT00855465|10363331|P2|Treatment Period|Protocol Violation|0
3012672|NCT00855465|10363332|P1|Treatment Period|Protocol Violation|2
3012673|NCT00855465|10363331|P2|Treatment Period|Non-compliance|0
3012674|NCT00855465|10363332|P1|Treatment Period|Non-compliance|1
3012675|NCT00855465|10363331|P2|Treatment Period|Lack of Efficacy|1
3012676|NCT00855465|10363332|P1|Treatment Period|Lack of Efficacy|2
3012677|NCT00855465|10363331|P2|Treatment Period|Death|2
3012678|NCT00855465|10363332|P1|Treatment Period|Death|2
3012679|NCT00855465|10363331|P2|Treatment Period|Adverse Event|2
3012680|NCT00855465|10363332|P1|Treatment Period|Adverse Event|4
3012681|NCT00855439|10363422|P2|Overall Study|Pregnancy|0
3012682|NCT00855439|10363423|P1|Overall Study|Pregnancy|1
3012683|NCT00855439|10363422|P2|Overall Study|Withdrawal by Subject|0
3012684|NCT00855439|10363423|P1|Overall Study|Withdrawal by Subject|2
3012685|NCT00855335|10363481|P5|Overall Study|Other|1
3012686|NCT00855335|10363482|P4|Overall Study|Other|5
3012687|NCT00855335|10363483|P3|Overall Study|Other|2
3012688|NCT00855335|10363484|P2|Overall Study|Other|1
3012689|NCT00855335|10363485|P1|Overall Study|Other|2
3012690|NCT00855335|10363481|P5|Overall Study|Physician Decision|0
3012691|NCT00855335|10363482|P4|Overall Study|Physician Decision|0
3012692|NCT00855335|10363483|P3|Overall Study|Physician Decision|0
3012693|NCT00855335|10363484|P2|Overall Study|Physician Decision|1
3012694|NCT00855335|10363485|P1|Overall Study|Physician Decision|1
3012695|NCT00855335|10363481|P5|Overall Study|Adverse Event|0
3012696|NCT00855335|10363482|P4|Overall Study|Adverse Event|0
3012697|NCT00855335|10363483|P3|Overall Study|Adverse Event|0
3012698|NCT00855335|10363484|P2|Overall Study|Adverse Event|0
3012699|NCT00855335|10363485|P1|Overall Study|Adverse Event|2
3012700|NCT00855335|10363481|P5|Overall Study|Withdrawal by Subject|0
3012701|NCT00855335|10363482|P4|Overall Study|Withdrawal by Subject|1
3012702|NCT00855335|10363483|P3|Overall Study|Withdrawal by Subject|0
3012703|NCT00855335|10363484|P2|Overall Study|Withdrawal by Subject|0
3012704|NCT00855335|10363485|P1|Overall Study|Withdrawal by Subject|0
3012705|NCT00855335|10363481|P5|Overall Study|Lost to Follow-up|0
3012706|NCT00855335|10363482|P4|Overall Study|Lost to Follow-up|1
3012707|NCT00855335|10363483|P3|Overall Study|Lost to Follow-up|3
3012708|NCT00855335|10363484|P2|Overall Study|Lost to Follow-up|0
3012709|NCT00855335|10363485|P1|Overall Study|Lost to Follow-up|0
3012710|NCT00855309|10363572|P2|Overall Study|patient never recieved drug|0
3012711|NCT00855309|10363573|P1|Overall Study|patient never recieved drug|1
3012712|NCT00855218|10363581|P2|Overall Study|Clinical endpoint reached|13
3012713|NCT00855218|10363582|P1|Overall Study|Clinical endpoint reached|10
3012714|NCT00855218|10363581|P2|Overall Study|Progression measurement proven|15
3012715|NCT00855218|10363582|P1|Overall Study|Progression measurement proven|7
3012716|NCT00855218|10363581|P2|Overall Study|Second malignancy|1
3012717|NCT00855218|10363582|P1|Overall Study|Second malignancy|0
3012718|NCT00855218|10363581|P2|Overall Study|Untreatable disease progression|67
3012719|NCT00855218|10363582|P1|Overall Study|Untreatable disease progression|54
3012720|NCT00855218|10363581|P2|Overall Study|Still treated with study medication|1
3012721|NCT00855218|10363582|P1|Overall Study|Still treated with study medication|0
3012722|NCT00855218|10363581|P2|Overall Study|technical problems|1
3012723|NCT00855218|10363582|P1|Overall Study|technical problems|2
3012724|NCT00855218|10363581|P2|Overall Study|patient convenience|0
3012725|NCT00855218|10363582|P1|Overall Study|patient convenience|2
3012726|NCT00855218|10363581|P2|Overall Study|non-compliant with study drug|1
3012727|NCT00855218|10363582|P1|Overall Study|non-compliant with study drug|3
3012728|NCT00855218|10363581|P2|Overall Study|Protocol Violation|9
3012729|NCT00855218|10363582|P1|Overall Study|Protocol Violation|5
3012730|NCT00855218|10363581|P2|Overall Study|Lost to Follow-up|1
3012731|NCT00855218|10363582|P1|Overall Study|Lost to Follow-up|0
3012732|NCT00855218|10363581|P2|Overall Study|Physician Decision|11
3012733|NCT00855218|10363582|P1|Overall Study|Physician Decision|18
3012734|NCT00855218|10363581|P2|Overall Study|Withdrawal by Subject|6
3012735|NCT00855218|10363582|P1|Overall Study|Withdrawal by Subject|10
3012736|NCT00855218|10363581|P2|Overall Study|Adverse Event|27
3012737|NCT00855218|10363582|P1|Overall Study|Adverse Event|43
3012738|NCT00855166|10363600|P2|Overall Study|Subject no longer meets study criteria|1
3012739|NCT00855166|10363601|P1|Overall Study|Subject no longer meets study criteria|1
3012740|NCT00855166|10363600|P2|Overall Study|Administrative reasons by sponsor|0
3012741|NCT00855166|10363601|P1|Overall Study|Administrative reasons by sponsor|1
3012742|NCT00855166|10363600|P2|Overall Study|Poor/non-compliance|0
3012743|NCT00855166|10363601|P1|Overall Study|Poor/non-compliance|2
3012744|NCT00855166|10363600|P2|Overall Study|Withdrawal by Subject|4
3012745|NCT00855166|10363601|P1|Overall Study|Withdrawal by Subject|1
3012746|NCT00855166|10363600|P2|Overall Study|Death|1
3012747|NCT00855166|10363601|P1|Overall Study|Death|0
3012748|NCT00855166|10363600|P2|Overall Study|Adverse Event|2
3012749|NCT00855166|10363601|P1|Overall Study|Adverse Event|0
3012750|NCT00855062|10363621|P2|Step2|Initiation of antiretroviral therapy/ART|1
3012751|NCT00855062|10363622|P1|Step2|Initiation of antiretroviral therapy/ART|0
3012752|NCT00855062|10363621|P2|Step2|Adverse Event|3
3012753|NCT00855062|10363622|P1|Step2|Adverse Event|0
3012754|NCT00855062|10363621|P2|Step2|Early Study Closure|2
3012755|NCT00855062|10363622|P1|Step2|Early Study Closure|6
3012756|NCT00855062|10363621|P2|Step1|Withdrawal by Subject|3
3012757|NCT00855062|10363622|P1|Step1|Withdrawal by Subject|2
3012758|NCT00855062|10363621|P2|Step1|Pregnancy|0
3012759|NCT00855062|10363622|P1|Step1|Pregnancy|1
3012760|NCT00855062|10363621|P2|Step1|Protocol Violation|0
3012761|NCT00855062|10363622|P1|Step1|Protocol Violation|1
3012762|NCT00855062|10363621|P2|Step1|Adverse Event|1
3012763|NCT00855062|10363622|P1|Step1|Adverse Event|1
3012764|NCT00855062|10363621|P2|Step1|Early Study Closure|7
3012765|NCT00855062|10363622|P1|Step1|Early Study Closure|5
3012766|NCT00854906|10363671|P1|Overall Study|One person had no ocular history|1
3012767|NCT00854724|10363680|P2|Second Intervention|Physician Decision|1
3012768|NCT00854724|10363681|P1|Second Intervention|Physician Decision|0
3012769|NCT00854724|10363680|P2|Second Intervention|Protocol Violation|0
3012770|NCT00854724|10363681|P1|Second Intervention|Protocol Violation|1
3012771|NCT00854724|10363680|P2|Washout|Withdrawal by Subject|1
3012772|NCT00854724|10363681|P1|Washout|Withdrawal by Subject|0
3012773|NCT00854724|10363680|P2|Washout|Protocol Violation|0
3012774|NCT00854724|10363681|P1|Washout|Protocol Violation|1
3012775|NCT00854724|10363680|P2|First Intervention|Withdrawal by Subject|1
3012776|NCT00854724|10363681|P1|First Intervention|Withdrawal by Subject|1
3012777|NCT00854620|10363687|P1|Overall Study|Adverse Event|1
3012778|NCT00854607|10363691|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
3012779|NCT00854581|10363739|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
3012780|NCT00854581|10363739|P1|Induction (Up to Day 21)|Physician Decision|1
3012781|NCT00854581|10363739|P1|Induction (Up to Day 21)|Death|1
3012782|NCT00854581|10363739|P1|Induction (Up to Day 21)|Lack of Efficacy|4
3012783|NCT00854373|10363754|P2|Overall Study|Forgot to take study drug|1
3012784|NCT00854373|10363755|P1|Overall Study|Forgot to take study drug|1
3012785|NCT00854373|10363754|P2|Overall Study|Withdrawal by Subject|3
3012786|NCT00854373|10363755|P1|Overall Study|Withdrawal by Subject|1
3012787|NCT00854360|10363769|P4|Overall Study|Other|3
3012788|NCT00854360|10363770|P3|Overall Study|Other|0
3012789|NCT00854360|10363771|P2|Overall Study|Other|0
3012790|NCT00854360|10363772|P1|Overall Study|Other|0
3012791|NCT00854360|10363769|P4|Overall Study|Lack of Efficacy|0
3012792|NCT00854360|10363770|P3|Overall Study|Lack of Efficacy|0
3012793|NCT00854360|10363771|P2|Overall Study|Lack of Efficacy|1
3012794|NCT00854360|10363772|P1|Overall Study|Lack of Efficacy|2
3012795|NCT00854360|10363769|P4|Overall Study|Pregnancy|0
3012796|NCT00854360|10363770|P3|Overall Study|Pregnancy|0
3012797|NCT00854360|10363771|P2|Overall Study|Pregnancy|1
3012798|NCT00854360|10363772|P1|Overall Study|Pregnancy|0
3012799|NCT00854360|10363769|P4|Overall Study|Withdrawal by Subject|1
3012800|NCT00854360|10363770|P3|Overall Study|Withdrawal by Subject|0
3012801|NCT00854360|10363771|P2|Overall Study|Withdrawal by Subject|0
3012802|NCT00854360|10363772|P1|Overall Study|Withdrawal by Subject|0
3012803|NCT00854360|10363769|P4|Overall Study|Adverse Event|6
3012804|NCT00854360|10363770|P3|Overall Study|Adverse Event|2
3012805|NCT00854360|10363771|P2|Overall Study|Adverse Event|1
3012806|NCT00854360|10363772|P1|Overall Study|Adverse Event|0
3012807|NCT00854308|10363804|P2|Overall Study|Sponsor's decision to terminate study|1
3012808|NCT00854308|10363805|P1|Overall Study|Sponsor's decision to terminate study|0
3012809|NCT00854308|10363804|P2|Overall Study|Withdrawal by Subject|2
3012810|NCT00854308|10363805|P1|Overall Study|Withdrawal by Subject|4
3012811|NCT00854308|10363804|P2|Overall Study|Physician Decision|6
3012812|NCT00854308|10363805|P1|Overall Study|Physician Decision|6
3012813|NCT00854308|10363804|P2|Overall Study|Death|5
3012814|NCT00854308|10363805|P1|Overall Study|Death|2
3012815|NCT00854308|10363804|P2|Overall Study|Adverse Event|3
3012816|NCT00854308|10363805|P1|Overall Study|Adverse Event|8
3012817|NCT00854308|10363804|P2|Overall Study|Disease progression|50
3012818|NCT00854308|10363805|P1|Overall Study|Disease progression|42
3012819|NCT00854113|10363830|P11|Overall Study|Withdrawal by Subject|0
3012820|NCT00854113|10363831|P10|Overall Study|Withdrawal by Subject|0
3012821|NCT00854113|10363832|P9|Overall Study|Withdrawal by Subject|1
3012822|NCT00854113|10363833|P8|Overall Study|Withdrawal by Subject|1
3012823|NCT00854113|10363834|P7|Overall Study|Withdrawal by Subject|0
3012824|NCT00854113|10363835|P6|Overall Study|Withdrawal by Subject|0
3012825|NCT00854113|10363836|P5|Overall Study|Withdrawal by Subject|0
3012826|NCT00854113|10363837|P4|Overall Study|Withdrawal by Subject|0
3012827|NCT00854113|10363838|P3|Overall Study|Withdrawal by Subject|0
3012828|NCT00854113|10363839|P2|Overall Study|Withdrawal by Subject|0
3012829|NCT00854113|10363840|P1|Overall Study|Withdrawal by Subject|0
3012830|NCT00854113|10363830|P11|Overall Study|Adverse Event|0
3012831|NCT00854113|10363831|P10|Overall Study|Adverse Event|0
3012832|NCT00854113|10363832|P9|Overall Study|Adverse Event|0
3012833|NCT00854113|10363833|P8|Overall Study|Adverse Event|2
3012834|NCT00854113|10363834|P7|Overall Study|Adverse Event|0
3012835|NCT00854113|10363835|P6|Overall Study|Adverse Event|0
3012836|NCT00854113|10363836|P5|Overall Study|Adverse Event|0
3012837|NCT00854113|10363837|P4|Overall Study|Adverse Event|0
3012838|NCT00854113|10363838|P3|Overall Study|Adverse Event|0
3012839|NCT00854113|10363839|P2|Overall Study|Adverse Event|0
3012840|NCT00854113|10363840|P1|Overall Study|Adverse Event|0
3012841|NCT00854100|10363944|P3|Overall Study|Adverse Event|2
3012842|NCT00854100|10363945|P2|Overall Study|Adverse Event|1
3012843|NCT00854100|10363946|P1|Overall Study|Adverse Event|2
3012844|NCT00854100|10363944|P3|Overall Study|Protocol Violation|3
3012845|NCT00854100|10363945|P2|Overall Study|Protocol Violation|4
3012846|NCT00854100|10363946|P1|Overall Study|Protocol Violation|2
3012847|NCT00854100|10363944|P3|Overall Study|Withdrawal by Subject|2
3012848|NCT00854100|10363945|P2|Overall Study|Withdrawal by Subject|1
3012849|NCT00854100|10363946|P1|Overall Study|Withdrawal by Subject|3
3012850|NCT00854100|10363944|P3|Overall Study|Lost to Follow-up|3
3012851|NCT00854100|10363945|P2|Overall Study|Lost to Follow-up|0
3012852|NCT00854100|10363946|P1|Overall Study|Lost to Follow-up|2
3012853|NCT00854100|10363944|P3|Overall Study|Inability to complete the study visits|1
3012854|NCT00854100|10363945|P2|Overall Study|Inability to complete the study visits|0
3012855|NCT00854100|10363946|P1|Overall Study|Inability to complete the study visits|0
3012856|NCT00853970|10363979|P2|Overall Study|Cancelled surgery|2
3012857|NCT00853970|10363980|P1|Overall Study|Cancelled surgery|4
3012858|NCT00853970|10363979|P2|Overall Study|Withdrawal by Subject|1
3012859|NCT00853970|10363980|P1|Overall Study|Withdrawal by Subject|2
3012860|NCT00853957|10363990|P2|Overall Study|Protocol deviation|3
3012861|NCT00853957|10363991|P1|Overall Study|Protocol deviation|0
3012862|NCT00853957|10363990|P2|Overall Study|Lost to Follow-up|6
3012863|NCT00853957|10363991|P1|Overall Study|Lost to Follow-up|1
3012864|NCT00853957|10363990|P2|Overall Study|Subject withdrew consent|5
3012865|NCT00853957|10363991|P1|Overall Study|Subject withdrew consent|4
3012866|NCT00853957|10363990|P2|Overall Study|Unsatisfactory therapeutic effect|2
3012867|NCT00853957|10363991|P1|Overall Study|Unsatisfactory therapeutic effect|0
3012868|NCT00853957|10363990|P2|Overall Study|Adverse Event|3
3012869|NCT00853957|10363991|P1|Overall Study|Adverse Event|9
3012870|NCT00853905|10364009|P2|Overall Study|never had surgery|0
3012871|NCT00853905|10364010|P1|Overall Study|never had surgery|1
3012872|NCT00853905|10364009|P2|Overall Study|Withdrawal by Subject|1
3012873|NCT00853905|10364010|P1|Overall Study|Withdrawal by Subject|0
3012874|NCT00853905|10364009|P2|Overall Study|Lost to Follow-up|3
3012875|NCT00853905|10364010|P1|Overall Study|Lost to Follow-up|1
3012876|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Death|6
3012877|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Death|1
3012878|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Administrative problems|56
3012879|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Administrative problems|45
3012880|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
3012881|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
3012882|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
3012883|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
3012884|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
3012885|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
3012886|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
3012887|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
3012888|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
3012889|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
3012890|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
3012891|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
3012892|NCT00853827|10364042|P2|Double Blind Period (103 Weeks)|Adverse Event|14
3012893|NCT00853827|10364043|P1|Double Blind Period (103 Weeks)|Adverse Event|25
3012894|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Protocol Violation|0
3012895|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Protocol Violation|12
3012896|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
3012897|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
3012898|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
3012899|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
3012900|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
3012901|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
3012902|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
3012903|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
3012904|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Adverse Event|0
3012905|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Adverse Event|9
3012906|NCT00853827|10364042|P2|Single Blind Period (1 Week)|Other|0
3012907|NCT00853827|10364043|P1|Single Blind Period (1 Week)|Other|4
3012908|NCT00853762|10364059|P4|Overall Study|Randomised but not Treated|0
3012909|NCT00853762|10364060|P3|Overall Study|Randomised but not Treated|2
3012910|NCT00853762|10364061|P2|Overall Study|Randomised but not Treated|2
3012911|NCT00853762|10364062|P1|Overall Study|Randomised but not Treated|0
3012912|NCT00853762|10364059|P4|Overall Study|Other|0
3012913|NCT00853762|10364060|P3|Overall Study|Other|0
3012914|NCT00853762|10364061|P2|Overall Study|Other|2
3012915|NCT00853762|10364062|P1|Overall Study|Other|0
3012916|NCT00853762|10364059|P4|Overall Study|Withdrawal by Subject|0
3012917|NCT00853762|10364060|P3|Overall Study|Withdrawal by Subject|1
3012918|NCT00853762|10364061|P2|Overall Study|Withdrawal by Subject|0
3012919|NCT00853762|10364062|P1|Overall Study|Withdrawal by Subject|0
3012920|NCT00853762|10364059|P4|Overall Study|Protocol Violation|1
3012921|NCT00853762|10364060|P3|Overall Study|Protocol Violation|0
3012922|NCT00853762|10364061|P2|Overall Study|Protocol Violation|0
3012923|NCT00853762|10364062|P1|Overall Study|Protocol Violation|0
3012924|NCT00853762|10364059|P4|Overall Study|Premature Termination|21
3012925|NCT00853762|10364060|P3|Overall Study|Premature Termination|14
3012926|NCT00853762|10364061|P2|Overall Study|Premature Termination|15
3012927|NCT00853762|10364062|P1|Overall Study|Premature Termination|16
3012928|NCT00853749|10364130|P2|Overall Study|Lost to Follow-up|1
3012929|NCT00853749|10364131|P1|Overall Study|Lost to Follow-up|0
3012930|NCT00853723|10364152|P3|Overall Study|Protocol Violation|1
3012931|NCT00853723|10364153|P2|Overall Study|Protocol Violation|2
3012932|NCT00853723|10364154|P1|Overall Study|Protocol Violation|1
3012933|NCT00853723|10364152|P3|Overall Study|Withdrawal by Subject|0
3012934|NCT00853723|10364153|P2|Overall Study|Withdrawal by Subject|1
3012935|NCT00853723|10364154|P1|Overall Study|Withdrawal by Subject|2
3012936|NCT00853723|10364152|P3|Overall Study|Adverse Event|1
3012937|NCT00853723|10364153|P2|Overall Study|Adverse Event|4
3012938|NCT00853723|10364154|P1|Overall Study|Adverse Event|3
3012939|NCT00853658|10364208|P3|Overall Study|Missing study completion information|6
3012940|NCT00853658|10364209|P2|Overall Study|Missing study completion information|4
3012941|NCT00853658|10364210|P1|Overall Study|Missing study completion information|5
3012942|NCT00853658|10364208|P3|Overall Study|Patient's request|11
3012943|NCT00853658|10364209|P2|Overall Study|Patient's request|17
3012944|NCT00853658|10364210|P1|Overall Study|Patient's request|21
3012945|NCT00853658|10364208|P3|Overall Study|Vital Status at study end N/A|10
3012946|NCT00853658|10364209|P2|Overall Study|Vital Status at study end N/A|10
3012947|NCT00853658|10364210|P1|Overall Study|Vital Status at study end N/A|8
3012948|NCT00853658|10364208|P3|Overall Study|Vital Status unknown at study end|0
3012949|NCT00853658|10364209|P2|Overall Study|Vital Status unknown at study end|1
3012950|NCT00853658|10364210|P1|Overall Study|Vital Status unknown at study end|1
3012951|NCT00853658|10364208|P3|Overall Study|Vital Status known (alive) at study end|3
3012952|NCT00853658|10364209|P2|Overall Study|Vital Status known (alive) at study end|3
3012953|NCT00853658|10364210|P1|Overall Study|Vital Status known (alive) at study end|2
3012954|NCT00853658|10364208|P3|Overall Study|IRB request|2
3012955|NCT00853658|10364209|P2|Overall Study|IRB request|0
3012956|NCT00853658|10364210|P1|Overall Study|IRB request|0
3012957|NCT00853658|10364208|P3|Overall Study|H.A. Request|19
3012958|NCT00853658|10364209|P2|Overall Study|H.A. Request|23
3012959|NCT00853658|10364210|P1|Overall Study|H.A. Request|26
3012960|NCT00853658|10364208|P3|Overall Study|Lost to Follow-up|11
3012961|NCT00853658|10364209|P2|Overall Study|Lost to Follow-up|6
3012962|NCT00853658|10364210|P1|Overall Study|Lost to Follow-up|11
3012963|NCT00853658|10364208|P3|Overall Study|Death|753
3012964|NCT00853658|10364209|P2|Overall Study|Death|768
3012965|NCT00853658|10364210|P1|Overall Study|Death|713
3012966|NCT00853593|10364230|P1|Overall Study|Implant not attempted|4
3012967|NCT00853593|10364230|P1|Overall Study|Model 4396 lead not attempted|29
3012968|NCT00853593|10364230|P1|Overall Study|Subjects did not receive a 4396 lead|12
3012969|NCT00853580|10364257|P2|Overall Study|Commenced contraindicated therapy|2
3012970|NCT00853580|10364258|P1|Overall Study|Commenced contraindicated therapy|0
3012971|NCT00853580|10364257|P2|Overall Study|Withdrawal by Subject|8
3012972|NCT00853580|10364258|P1|Overall Study|Withdrawal by Subject|2
3012973|NCT00853580|10364257|P2|Overall Study|Protocol Violation|1
3012974|NCT00853580|10364258|P1|Overall Study|Protocol Violation|2
3012975|NCT00853580|10364257|P2|Overall Study|Lost to Follow-up|5
3012976|NCT00853580|10364258|P1|Overall Study|Lost to Follow-up|3
3012977|NCT00853567|10364305|P1|Overall Study|Study prematurely terminated|71
3012978|NCT00853489|10364315|P2|Overall Study|Lost to Follow-up|2
3012979|NCT00853489|10364316|P1|Overall Study|Lost to Follow-up|5
3012980|NCT00853385|10364331|P5|Overall Study|Other|12
3012981|NCT00853385|10364332|P4|Overall Study|Other|4
3012982|NCT00853385|10364333|P3|Overall Study|Other|4
3012983|NCT00853385|10364334|P2|Overall Study|Other|9
3012984|NCT00853385|10364335|P1|Overall Study|Other|18
3012985|NCT00853385|10364331|P5|Overall Study|Withdrawal by Subject|1
3012986|NCT00853385|10364332|P4|Overall Study|Withdrawal by Subject|1
3012987|NCT00853385|10364333|P3|Overall Study|Withdrawal by Subject|0
3012988|NCT00853385|10364334|P2|Overall Study|Withdrawal by Subject|2
3012989|NCT00853385|10364335|P1|Overall Study|Withdrawal by Subject|4
3012990|NCT00853385|10364331|P5|Overall Study|Lost to Follow-up|0
3012991|NCT00853385|10364332|P4|Overall Study|Lost to Follow-up|0
3012992|NCT00853385|10364333|P3|Overall Study|Lost to Follow-up|0
3012993|NCT00853385|10364334|P2|Overall Study|Lost to Follow-up|1
3012994|NCT00853385|10364335|P1|Overall Study|Lost to Follow-up|2
3012995|NCT00853385|10364331|P5|Overall Study|Lack of Efficacy|6
3012996|NCT00853385|10364332|P4|Overall Study|Lack of Efficacy|3
3012997|NCT00853385|10364333|P3|Overall Study|Lack of Efficacy|3
3012998|NCT00853385|10364334|P2|Overall Study|Lack of Efficacy|7
3012999|NCT00853385|10364335|P1|Overall Study|Lack of Efficacy|6
3013000|NCT00853385|10364331|P5|Overall Study|Adverse Event|22
3013001|NCT00853385|10364332|P4|Overall Study|Adverse Event|5
3013002|NCT00853385|10364333|P3|Overall Study|Adverse Event|2
3013003|NCT00853385|10364334|P2|Overall Study|Adverse Event|24
3013004|NCT00853385|10364335|P1|Overall Study|Adverse Event|24
3013005|NCT00853385|10364331|P5|Overall Study|Death|1
3013006|NCT00853385|10364332|P4|Overall Study|Death|0
3013007|NCT00853385|10364333|P3|Overall Study|Death|0
3013008|NCT00853385|10364334|P2|Overall Study|Death|0
3013009|NCT00853385|10364335|P1|Overall Study|Death|0
3013010|NCT00853307|10364563|P2|Overall Study|Reason Not Specified|1
3013011|NCT00853307|10364564|P1|Overall Study|Reason Not Specified|0
3013012|NCT00853307|10364563|P2|Overall Study|Withdrawal by Subject|2
3013013|NCT00853307|10364564|P1|Overall Study|Withdrawal by Subject|1
3013014|NCT00853307|10364563|P2|Overall Study|Adverse Event|2
3013015|NCT00853307|10364564|P1|Overall Study|Adverse Event|1
3013016|NCT00853242|10364591|P7|Overall Study|Other|2
3013017|NCT00853242|10364592|P6|Overall Study|Other|1
3013018|NCT00853242|10364593|P5|Overall Study|Other|0
3013019|NCT00853242|10364594|P4|Overall Study|Other|0
3013020|NCT00853242|10364595|P3|Overall Study|Other|2
3013021|NCT00853242|10364596|P2|Overall Study|Other|0
3013022|NCT00853242|10364597|P1|Overall Study|Other|2
3013023|NCT00853242|10364591|P7|Overall Study|Withdrawal by Subject|2
3013024|NCT00853242|10364592|P6|Overall Study|Withdrawal by Subject|0
3013025|NCT00853242|10364593|P5|Overall Study|Withdrawal by Subject|0
3013026|NCT00853242|10364594|P4|Overall Study|Withdrawal by Subject|4
3013027|NCT00853242|10364595|P3|Overall Study|Withdrawal by Subject|0
3013028|NCT00853242|10364596|P2|Overall Study|Withdrawal by Subject|2
3013029|NCT00853242|10364597|P1|Overall Study|Withdrawal by Subject|1
3013030|NCT00853242|10364591|P7|Overall Study|Noncompliant|0
3013031|NCT00853242|10364592|P6|Overall Study|Noncompliant|0
3013032|NCT00853242|10364593|P5|Overall Study|Noncompliant|1
3013033|NCT00853242|10364594|P4|Overall Study|Noncompliant|0
3013034|NCT00853242|10364595|P3|Overall Study|Noncompliant|0
3013035|NCT00853242|10364596|P2|Overall Study|Noncompliant|0
3013036|NCT00853242|10364597|P1|Overall Study|Noncompliant|0
3013037|NCT00853242|10364591|P7|Overall Study|Adverse Event|1
3013038|NCT00853242|10364592|P6|Overall Study|Adverse Event|1
3013039|NCT00853242|10364593|P5|Overall Study|Adverse Event|3
3013040|NCT00853242|10364594|P4|Overall Study|Adverse Event|0
3013041|NCT00853242|10364595|P3|Overall Study|Adverse Event|1
3013042|NCT00853242|10364596|P2|Overall Study|Adverse Event|1
3013043|NCT00853242|10364597|P1|Overall Study|Adverse Event|0
3013044|NCT00853229|10364639|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
3013045|NCT00853229|10364640|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
3013046|NCT00853151|10364650|P4|Overall Study|Sponsor Decision|0
3013047|NCT00853151|10364651|P3|Overall Study|Sponsor Decision|0
3013048|NCT00853151|10364652|P2|Overall Study|Sponsor Decision|3
3013049|NCT00853151|10364653|P1|Overall Study|Sponsor Decision|0
3013050|NCT00853151|10364650|P4|Overall Study|Physician Decision|0
3013051|NCT00853151|10364651|P3|Overall Study|Physician Decision|1
3013052|NCT00853151|10364652|P2|Overall Study|Physician Decision|2
3013053|NCT00853151|10364653|P1|Overall Study|Physician Decision|0
3013054|NCT00853151|10364650|P4|Overall Study|Withdrawal by Subject|1
3013055|NCT00853151|10364651|P3|Overall Study|Withdrawal by Subject|2
3013056|NCT00853151|10364652|P2|Overall Study|Withdrawal by Subject|4
3013057|NCT00853151|10364653|P1|Overall Study|Withdrawal by Subject|5
3013058|NCT00853151|10364650|P4|Overall Study|Protocol Violation|1
3013059|NCT00853151|10364651|P3|Overall Study|Protocol Violation|0
3013060|NCT00853151|10364652|P2|Overall Study|Protocol Violation|0
3013061|NCT00853151|10364653|P1|Overall Study|Protocol Violation|0
3013062|NCT00853151|10364650|P4|Overall Study|Death|1
3013063|NCT00853151|10364651|P3|Overall Study|Death|0
3013064|NCT00853151|10364652|P2|Overall Study|Death|0
3013065|NCT00853151|10364653|P1|Overall Study|Death|1
3013066|NCT00853151|10364650|P4|Overall Study|Lost to Follow-up|0
3013067|NCT00853151|10364651|P3|Overall Study|Lost to Follow-up|3
3013068|NCT00853151|10364652|P2|Overall Study|Lost to Follow-up|0
3013069|NCT00853151|10364653|P1|Overall Study|Lost to Follow-up|2
3013070|NCT00853151|10364650|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3013071|NCT00853151|10364651|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3013072|NCT00853151|10364652|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3013073|NCT00853151|10364653|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
3013074|NCT00853151|10364650|P4|Overall Study|Adverse Event|0
3013075|NCT00853151|10364651|P3|Overall Study|Adverse Event|2
3013076|NCT00853151|10364652|P2|Overall Study|Adverse Event|4
3013077|NCT00853151|10364653|P1|Overall Study|Adverse Event|1
3013078|NCT00853125|10364795|P1|Overall Study|Study participant's donor was CMV +|1
3013079|NCT00853112|10364807|P7|Overall Study|Randomized but not treated|1
3013080|NCT00853112|10364808|P6|Overall Study|Randomized but not treated|0
3013081|NCT00853112|10364809|P5|Overall Study|Randomized but not treated|0
3013082|NCT00853112|10364810|P4|Overall Study|Randomized but not treated|2
3013083|NCT00853112|10364811|P3|Overall Study|Randomized but not treated|0
3013084|NCT00853112|10364812|P2|Overall Study|Randomized but not treated|1
3013085|NCT00853112|10364813|P1|Overall Study|Randomized but not treated|0
3013086|NCT00853099|10364923|P4|Double-blind + Open-label Periods|Other|6
3013087|NCT00853099|10364924|P3|Double-blind + Open-label Periods|Other|0
3013088|NCT00853099|10364925|P2|Double-blind + Open-label Periods|Other|0
3013089|NCT00853099|10364926|P1|Double-blind + Open-label Periods|Other|0
3013090|NCT00853099|10364923|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
3013091|NCT00853099|10364924|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
3013092|NCT00853099|10364925|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
3013093|NCT00853099|10364926|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
3013094|NCT00853099|10364923|P4|Double-blind + Open-label Periods|Adverse Event|47
3013095|NCT00853099|10364924|P3|Double-blind + Open-label Periods|Adverse Event|0
3013096|NCT00853099|10364925|P2|Double-blind + Open-label Periods|Adverse Event|0
3013097|NCT00853099|10364926|P1|Double-blind + Open-label Periods|Adverse Event|0
3013098|NCT00853099|10364923|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
3013099|NCT00853099|10364924|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
3013100|NCT00853099|10364925|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
3013101|NCT00853099|10364926|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
3013102|NCT00853099|10364923|P4|Double-blind Period|Mistreated with rescue study drug|0
3013103|NCT00853099|10364924|P3|Double-blind Period|Mistreated with rescue study drug|1
3013104|NCT00853099|10364925|P2|Double-blind Period|Mistreated with rescue study drug|0
3013105|NCT00853099|10364926|P1|Double-blind Period|Mistreated with rescue study drug|0
3013106|NCT00853099|10364923|P4|Double-blind Period|Other|0
3013107|NCT00853099|10364924|P3|Double-blind Period|Other|1
3013108|NCT00853099|10364925|P2|Double-blind Period|Other|0
3013109|NCT00853099|10364926|P1|Double-blind Period|Other|0
3013110|NCT00853099|10364923|P4|Double-blind Period|Lack of Efficacy|0
3013111|NCT00853099|10364924|P3|Double-blind Period|Lack of Efficacy|16
3013112|NCT00853099|10364925|P2|Double-blind Period|Lack of Efficacy|17
3013113|NCT00853099|10364926|P1|Double-blind Period|Lack of Efficacy|14
3013114|NCT00853099|10364923|P4|Double-blind Period|Withdrawal by Subject|0
3013115|NCT00853099|10364924|P3|Double-blind Period|Withdrawal by Subject|0
3013116|NCT00853099|10364925|P2|Double-blind Period|Withdrawal by Subject|3
3013117|NCT00853099|10364926|P1|Double-blind Period|Withdrawal by Subject|2
3013118|NCT00853099|10364923|P4|Double-blind Period|Adverse Event|0
3013119|NCT00853099|10364924|P3|Double-blind Period|Adverse Event|13
3013120|NCT00853099|10364925|P2|Double-blind Period|Adverse Event|9
3013121|NCT00853099|10364926|P1|Double-blind Period|Adverse Event|7
3013122|NCT00853073|10364968|P2|Overall Study|Withdrawal by Subject|2
3013123|NCT00853073|10364969|P1|Overall Study|Withdrawal by Subject|3
3013124|NCT00853047|10364982|P6|Open-Label Extension Phase|Reason Not Specified|6
3013125|NCT00853047|10364983|P5|Open-Label Extension Phase|Reason Not Specified|0
3013126|NCT00853047|10364984|P4|Open-Label Extension Phase|Reason Not Specified|0
3013127|NCT00853047|10364985|P3|Open-Label Extension Phase|Reason Not Specified|0
3013128|NCT00853047|10364986|P2|Open-Label Extension Phase|Reason Not Specified|0
3013129|NCT00853047|10364987|P1|Open-Label Extension Phase|Reason Not Specified|0
3013130|NCT00853047|10364982|P6|Open-Label Extension Phase|Investigator Decision|1
3013131|NCT00853047|10364983|P5|Open-Label Extension Phase|Investigator Decision|0
3013132|NCT00853047|10364984|P4|Open-Label Extension Phase|Investigator Decision|0
3013133|NCT00853047|10364985|P3|Open-Label Extension Phase|Investigator Decision|0
3013134|NCT00853047|10364986|P2|Open-Label Extension Phase|Investigator Decision|0
3013135|NCT00853047|10364987|P1|Open-Label Extension Phase|Investigator Decision|0
3013136|NCT00853047|10364982|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
3013137|NCT00853047|10364983|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
3013138|NCT00853047|10364984|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
3013139|NCT00853047|10364985|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
3013140|NCT00853047|10364986|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
3013141|NCT00853047|10364987|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
3013142|NCT00853047|10364982|P6|Open-Label Extension Phase|Lost to Follow-up|1
3013143|NCT00853047|10364983|P5|Open-Label Extension Phase|Lost to Follow-up|0
3013144|NCT00853047|10364984|P4|Open-Label Extension Phase|Lost to Follow-up|0
3013145|NCT00853047|10364985|P3|Open-Label Extension Phase|Lost to Follow-up|0
3013146|NCT00853047|10364986|P2|Open-Label Extension Phase|Lost to Follow-up|0
3013147|NCT00853047|10364987|P1|Open-Label Extension Phase|Lost to Follow-up|0
3013148|NCT00853047|10364982|P6|Open-Label Extension Phase|Participant Request|7
3013149|NCT00853047|10364983|P5|Open-Label Extension Phase|Participant Request|0
3013150|NCT00853047|10364984|P4|Open-Label Extension Phase|Participant Request|0
3013151|NCT00853047|10364985|P3|Open-Label Extension Phase|Participant Request|0
3013152|NCT00853047|10364986|P2|Open-Label Extension Phase|Participant Request|0
3013153|NCT00853047|10364987|P1|Open-Label Extension Phase|Participant Request|0
3013154|NCT00853047|10364982|P6|Core Phase|Participant Request|0
3013155|NCT00853047|10364983|P5|Core Phase|Participant Request|0
3013156|NCT00853047|10364984|P4|Core Phase|Participant Request|1
3013157|NCT00853047|10364985|P3|Core Phase|Participant Request|0
3013158|NCT00853047|10364986|P2|Core Phase|Participant Request|0
3013159|NCT00853047|10364987|P1|Core Phase|Participant Request|0
3013160|NCT00853021|10365053|P1|Overall Study|Death|1
3013161|NCT00853021|10365053|P1|Overall Study|Withdrawal by Subject|2
3013162|NCT00853021|10365053|P1|Overall Study|Adverse Event|2
3013163|NCT00852995|10365065|P5|Overall Study|Moved Out of Area|0
3013164|NCT00852995|10365066|P4|Overall Study|Moved Out of Area|0
3013165|NCT00852995|10365067|P3|Overall Study|Moved Out of Area|0
3013166|NCT00852995|10365068|P2|Overall Study|Moved Out of Area|0
3013167|NCT00852995|10365069|P1|Overall Study|Moved Out of Area|1
3013168|NCT00852995|10365065|P5|Overall Study|Protocol Violation|1
3013169|NCT00852995|10365066|P4|Overall Study|Protocol Violation|0
3013170|NCT00852995|10365067|P3|Overall Study|Protocol Violation|0
3013171|NCT00852995|10365068|P2|Overall Study|Protocol Violation|0
3013172|NCT00852995|10365069|P1|Overall Study|Protocol Violation|0
3013173|NCT00852995|10365065|P5|Overall Study|Physician Decision|0
3013174|NCT00852995|10365066|P4|Overall Study|Physician Decision|0
3013175|NCT00852995|10365067|P3|Overall Study|Physician Decision|0
3013176|NCT00852995|10365068|P2|Overall Study|Physician Decision|0
3013177|NCT00852995|10365069|P1|Overall Study|Physician Decision|1
3013178|NCT00852995|10365065|P5|Overall Study|Progressive Disease|1
3013179|NCT00852995|10365066|P4|Overall Study|Progressive Disease|2
3013180|NCT00852995|10365067|P3|Overall Study|Progressive Disease|0
3013181|NCT00852995|10365068|P2|Overall Study|Progressive Disease|0
3013182|NCT00852995|10365069|P1|Overall Study|Progressive Disease|1
3013183|NCT00852995|10365065|P5|Overall Study|Non-Compliance|0
3013184|NCT00852995|10365066|P4|Overall Study|Non-Compliance|2
3013185|NCT00852995|10365067|P3|Overall Study|Non-Compliance|0
3013186|NCT00852995|10365068|P2|Overall Study|Non-Compliance|0
3013187|NCT00852995|10365069|P1|Overall Study|Non-Compliance|0
3013188|NCT00852995|10365065|P5|Overall Study|Withdrawal by Subject|2
3013189|NCT00852995|10365066|P4|Overall Study|Withdrawal by Subject|1
3013190|NCT00852995|10365067|P3|Overall Study|Withdrawal by Subject|0
3013191|NCT00852995|10365068|P2|Overall Study|Withdrawal by Subject|0
3013192|NCT00852995|10365069|P1|Overall Study|Withdrawal by Subject|4
3013193|NCT00852995|10365065|P5|Overall Study|Lost to Follow-up|0
3013194|NCT00852995|10365066|P4|Overall Study|Lost to Follow-up|0
3013195|NCT00852995|10365067|P3|Overall Study|Lost to Follow-up|1
3013196|NCT00852995|10365068|P2|Overall Study|Lost to Follow-up|1
3013197|NCT00852995|10365069|P1|Overall Study|Lost to Follow-up|0
3013198|NCT00852995|10365065|P5|Overall Study|Adverse Event|0
3013199|NCT00852995|10365066|P4|Overall Study|Adverse Event|0
3013200|NCT00852995|10365067|P3|Overall Study|Adverse Event|4
3013201|NCT00852995|10365068|P2|Overall Study|Adverse Event|0
3013202|NCT00852995|10365069|P1|Overall Study|Adverse Event|1
3013203|NCT00852969|10365113|P2|Overall Study|Lost to Follow-up|1
3013204|NCT00852969|10365114|P1|Overall Study|Lost to Follow-up|0
3013205|NCT00852969|10365113|P2|Overall Study|Adverse Event|1
3013206|NCT00852969|10365114|P1|Overall Study|Adverse Event|0
3013207|NCT00852930|10365125|P3|Overall Study|Physician Decision|1
3013208|NCT00852930|10365126|P2|Overall Study|Physician Decision|0
3013209|NCT00852930|10365127|P1|Overall Study|Physician Decision|0
3013210|NCT00852930|10365125|P3|Overall Study|Withdrawal by Subject|1
3013211|NCT00852930|10365126|P2|Overall Study|Withdrawal by Subject|1
3013212|NCT00852930|10365127|P1|Overall Study|Withdrawal by Subject|1
3013213|NCT00852917|10365148|P4|Overall Study|Death|1
3013214|NCT00852917|10365149|P3|Overall Study|Death|0
3013215|NCT00852917|10365150|P2|Overall Study|Death|0
3013216|NCT00852917|10365151|P1|Overall Study|Death|0
3013217|NCT00852917|10365148|P4|Overall Study|Physician Decision|19
3013218|NCT00852917|10365149|P3|Overall Study|Physician Decision|2
3013219|NCT00852917|10365150|P2|Overall Study|Physician Decision|7
3013220|NCT00852917|10365151|P1|Overall Study|Physician Decision|6
3013221|NCT00852917|10365148|P4|Overall Study|Withdrawal by Subject|9
3013222|NCT00852917|10365149|P3|Overall Study|Withdrawal by Subject|10
3013223|NCT00852917|10365150|P2|Overall Study|Withdrawal by Subject|8
3013224|NCT00852917|10365151|P1|Overall Study|Withdrawal by Subject|4
3013225|NCT00852917|10365148|P4|Overall Study|Lack of Efficacy|47
3013226|NCT00852917|10365149|P3|Overall Study|Lack of Efficacy|11
3013227|NCT00852917|10365150|P2|Overall Study|Lack of Efficacy|11
3013228|NCT00852917|10365151|P1|Overall Study|Lack of Efficacy|21
3013229|NCT00852917|10365148|P4|Overall Study|Adverse Event|17
3013230|NCT00852917|10365149|P3|Overall Study|Adverse Event|35
3013231|NCT00852917|10365150|P2|Overall Study|Adverse Event|20
3013232|NCT00852917|10365151|P1|Overall Study|Adverse Event|13
3013233|NCT00852540|10365279|P2|Overall Study|Did Not Receive Study Drug|3
3013234|NCT00852540|10365280|P1|Overall Study|Did Not Receive Study Drug|3
3013235|NCT00852540|10365279|P2|Overall Study|Withdrawal by Subject|1
3013236|NCT00852540|10365280|P1|Overall Study|Withdrawal by Subject|3
3013237|NCT00852540|10365279|P2|Overall Study|Investigator Discretion|3
3013238|NCT00852540|10365280|P1|Overall Study|Investigator Discretion|2
3013239|NCT00852540|10365279|P2|Overall Study|Lost to Follow-up|3
3013240|NCT00852540|10365280|P1|Overall Study|Lost to Follow-up|2
3013241|NCT00852540|10365279|P2|Overall Study|Protocol Violation|2
3013242|NCT00852540|10365280|P1|Overall Study|Protocol Violation|1
3013243|NCT00852540|10365279|P2|Overall Study|Lack of Efficacy|3
3013244|NCT00852540|10365280|P1|Overall Study|Lack of Efficacy|15
3013245|NCT00852540|10365279|P2|Overall Study|Adverse Event|3
3013246|NCT00852540|10365280|P1|Overall Study|Adverse Event|10
3013247|NCT00852475|10365314|P2|Overall Study|Lost to Follow-up|4
3013248|NCT00852475|10365315|P1|Overall Study|Lost to Follow-up|3
3013249|NCT00852397|10365326|P3|Overall Study|Protocol Violation|1
3013250|NCT00852397|10365327|P2|Overall Study|Protocol Violation|0
3013251|NCT00852397|10365328|P1|Overall Study|Protocol Violation|0
3013252|NCT00852397|10365326|P3|Overall Study|Difficulty in study site visit|0
3013253|NCT00852397|10365327|P2|Overall Study|Difficulty in study site visit|0
3013254|NCT00852397|10365328|P1|Overall Study|Difficulty in study site visit|1
3013255|NCT00852397|10365326|P3|Overall Study|Study terminated by sponsor|6
3013256|NCT00852397|10365327|P2|Overall Study|Study terminated by sponsor|1
3013257|NCT00852397|10365328|P1|Overall Study|Study terminated by sponsor|2
3013258|NCT00852397|10365326|P3|Overall Study|Withdrawal by Subject|2
3013259|NCT00852397|10365327|P2|Overall Study|Withdrawal by Subject|1
3013260|NCT00852397|10365328|P1|Overall Study|Withdrawal by Subject|4
3013261|NCT00852397|10365326|P3|Overall Study|Death|1
3013262|NCT00852397|10365327|P2|Overall Study|Death|0
3013263|NCT00852397|10365328|P1|Overall Study|Death|0
3013264|NCT00852397|10365326|P3|Overall Study|Adverse Event|4
3013265|NCT00852397|10365327|P2|Overall Study|Adverse Event|6
3013266|NCT00852397|10365328|P1|Overall Study|Adverse Event|4
3013267|NCT00852241|10365357|P1|Overall Study|Physician Decision|18
3013268|NCT00852202|10365364|P3|Overall Study|pregnancy,moving away and surgery|2
3013269|NCT00852202|10365365|P2|Overall Study|pregnancy,moving away and surgery|0
3013270|NCT00852202|10365366|P1|Overall Study|pregnancy,moving away and surgery|1
3013271|NCT00852202|10365364|P3|Overall Study|Lost to Follow-up|6
3013272|NCT00852202|10365365|P2|Overall Study|Lost to Follow-up|5
3013273|NCT00852202|10365366|P1|Overall Study|Lost to Follow-up|5
3013274|NCT00852202|10365364|P3|Overall Study|Withdrawal by Subject|2
3013275|NCT00852202|10365365|P2|Overall Study|Withdrawal by Subject|1
3013276|NCT00852202|10365366|P1|Overall Study|Withdrawal by Subject|3
3013277|NCT00852202|10365364|P3|Overall Study|Protocol Violation|7
3013278|NCT00852202|10365365|P2|Overall Study|Protocol Violation|2
3013279|NCT00852202|10365366|P1|Overall Study|Protocol Violation|2
3013280|NCT00852202|10365364|P3|Overall Study|Lack of Efficacy|2
3013281|NCT00852202|10365365|P2|Overall Study|Lack of Efficacy|1
3013282|NCT00852202|10365366|P1|Overall Study|Lack of Efficacy|4
3013283|NCT00852202|10365364|P3|Overall Study|Adverse Event|7
3013284|NCT00852202|10365365|P2|Overall Study|Adverse Event|3
3013285|NCT00852202|10365366|P1|Overall Study|Adverse Event|2
3013286|NCT00851903|10365408|P1|Overall Study|Withdrawal by Subject|2
3013287|NCT00851890|10365422|P4|Overall Study|Lost to Follow-up|1
3013288|NCT00851890|10365423|P3|Overall Study|Lost to Follow-up|0
3013289|NCT00851890|10365424|P2|Overall Study|Lost to Follow-up|1
3013290|NCT00851890|10365425|P1|Overall Study|Lost to Follow-up|0
3013291|NCT00851877|10365482|P3|Phase II|Withdrawal by Subject|3
3013292|NCT00851877|10365483|P2|Phase II|Withdrawal by Subject|0
3013293|NCT00851877|10365484|P1|Phase II|Withdrawal by Subject|0
3013294|NCT00851877|10365482|P3|Phase I-1|Death|0
3013295|NCT00851877|10365483|P2|Phase I-1|Death|0
3013296|NCT00851877|10365484|P1|Phase I-1|Death|1
3013297|NCT00851799|10365494|P3|Overall Study|Completed protocol due to pregnancy|1
3013298|NCT00851799|10365495|P2|Overall Study|Completed protocol due to pregnancy|0
3013299|NCT00851799|10365496|P1|Overall Study|Completed protocol due to pregnancy|0
3013300|NCT00851799|10365494|P3|Overall Study|Severe Debilitation|0
3013301|NCT00851799|10365495|P2|Overall Study|Severe Debilitation|1
3013302|NCT00851799|10365496|P1|Overall Study|Severe Debilitation|0
3013303|NCT00851799|10365494|P3|Overall Study|Withdrew consent prior study completion|1
3013304|NCT00851799|10365495|P2|Overall Study|Withdrew consent prior study completion|2
3013305|NCT00851799|10365496|P1|Overall Study|Withdrew consent prior study completion|1
3013306|NCT00851799|10365494|P3|Overall Study|Not willing to adhere to requirements|2
3013307|NCT00851799|10365495|P2|Overall Study|Not willing to adhere to requirements|2
3013308|NCT00851799|10365496|P1|Overall Study|Not willing to adhere to requirements|1
3013309|NCT00851799|10365494|P3|Overall Study|Not able to get to clinic|9
3013310|NCT00851799|10365495|P2|Overall Study|Not able to get to clinic|5
3013311|NCT00851799|10365496|P1|Overall Study|Not able to get to clinic|8
3013312|NCT00851799|10365494|P3|Overall Study|Lost to Follow-up|10
3013313|NCT00851799|10365495|P2|Overall Study|Lost to Follow-up|3
3013314|NCT00851799|10365496|P1|Overall Study|Lost to Follow-up|5
3013315|NCT00851799|10365494|P3|Overall Study|Death|1
3013316|NCT00851799|10365495|P2|Overall Study|Death|0
3013317|NCT00851799|10365496|P1|Overall Study|Death|1
3013318|NCT00851786|10365584|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
3013319|NCT00851786|10365585|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
3013320|NCT00851786|10365584|P2|Overall Study|Site Closure|0
3013321|NCT00851786|10365585|P1|Overall Study|Site Closure|1
3013322|NCT00851786|10365584|P2|Overall Study|Incarceration|0
3013323|NCT00851786|10365585|P1|Overall Study|Incarceration|1
3013324|NCT00851786|10365584|P2|Overall Study|Lost to Follow-up|0
3013325|NCT00851786|10365585|P1|Overall Study|Lost to Follow-up|1
3013326|NCT00851786|10365584|P2|Overall Study|Protocol Violation|1
3013327|NCT00851786|10365585|P1|Overall Study|Protocol Violation|0
3013328|NCT00851786|10365584|P2|Overall Study|Withdrawal by Subject|1
3013329|NCT00851786|10365585|P1|Overall Study|Withdrawal by Subject|0
3013330|NCT00851747|10365598|P3|Overall Study|Physician Decision|6
3013331|NCT00851747|10365599|P2|Overall Study|Physician Decision|6
3013332|NCT00851747|10365600|P1|Overall Study|Physician Decision|6
3013333|NCT00851721|10365609|P2|Overall Study|Adverse Event|1
3013334|NCT00851721|10365610|P1|Overall Study|Adverse Event|0
3013335|NCT00851721|10365609|P2|Overall Study|Death|0
3013336|NCT00851721|10365610|P1|Overall Study|Death|1
3013337|NCT00851721|10365609|P2|Overall Study|planned surgery|0
3013338|NCT00851721|10365610|P1|Overall Study|planned surgery|1
3013339|NCT00851682|10365700|P2|Overall Study|screen failure|0
3013340|NCT00851682|10365701|P1|Overall Study|screen failure|5
3013341|NCT00851643|10365715|P6|Extension Study (Up to 36 Months)|Moved|1
3013342|NCT00851643|10365716|P5|Extension Study (Up to 36 Months)|Moved|0
3013343|NCT00851643|10365717|P4|Extension Study (Up to 36 Months)|Moved|1
3013344|NCT00851643|10365718|P3|Extension Study (Up to 36 Months)|Moved|1
3013345|NCT00851643|10365719|P2|Extension Study (Up to 36 Months)|Moved|2
3013346|NCT00851643|10365720|P1|Extension Study (Up to 36 Months)|Moved|0
3013347|NCT00851643|10365715|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
3013348|NCT00851643|10365716|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
3013349|NCT00851643|10365717|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
3013350|NCT00851643|10365718|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
3013351|NCT00851643|10365719|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
3013352|NCT00851643|10365720|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
3013353|NCT00851643|10365715|P6|Base Study (Up to 12 Months)|Other|1
3013354|NCT00851643|10365716|P5|Base Study (Up to 12 Months)|Other|0
3013355|NCT00851643|10365717|P4|Base Study (Up to 12 Months)|Other|0
3013356|NCT00851643|10365718|P3|Base Study (Up to 12 Months)|Other|0
3013357|NCT00851643|10365719|P2|Base Study (Up to 12 Months)|Other|0
3013358|NCT00851643|10365720|P1|Base Study (Up to 12 Months)|Other|0
3013359|NCT00851643|10365715|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
3013360|NCT00851643|10365716|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
3013361|NCT00851643|10365717|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
3013362|NCT00851643|10365718|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
3013363|NCT00851643|10365719|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
3013364|NCT00851643|10365720|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
3013365|NCT00851630|10365741|P2|Overall Study|Clinical failure|1
3013366|NCT00851630|10365742|P1|Overall Study|Clinical failure|0
3013367|NCT00851630|10365741|P2|Overall Study|Death|1
3013368|NCT00851630|10365742|P1|Overall Study|Death|2
3013369|NCT00851591|10365756|P2|Overall Study|Withdrawal by Subject|0
3013370|NCT00851591|10365757|P1|Overall Study|Withdrawal by Subject|2
3013371|NCT00851552|10365763|P1|Overall Study|Disease Progression|4
3013372|NCT00851552|10365763|P1|Overall Study|Adverse Event|1
3013373|NCT00851552|10365763|P1|Overall Study|Death|2
3013374|NCT00851318|10365793|P4|Overall Study|Physician Decision|1
3013375|NCT00851318|10365794|P3|Overall Study|Physician Decision|1
3013376|NCT00851318|10365795|P2|Overall Study|Physician Decision|0
3013377|NCT00851318|10365796|P1|Overall Study|Physician Decision|0
3013378|NCT00851318|10365793|P4|Overall Study|Non-compliance with Study Procedures|0
3013379|NCT00851318|10365794|P3|Overall Study|Non-compliance with Study Procedures|1
3013380|NCT00851318|10365795|P2|Overall Study|Non-compliance with Study Procedures|0
3013381|NCT00851318|10365796|P1|Overall Study|Non-compliance with Study Procedures|2
3013382|NCT00851318|10365793|P4|Overall Study|Lack of Efficacy|2
3013383|NCT00851318|10365794|P3|Overall Study|Lack of Efficacy|4
3013384|NCT00851318|10365795|P2|Overall Study|Lack of Efficacy|2
3013385|NCT00851318|10365796|P1|Overall Study|Lack of Efficacy|8
3013386|NCT00851318|10365793|P4|Overall Study|Pregnancy|1
3013387|NCT00851318|10365794|P3|Overall Study|Pregnancy|1
3013388|NCT00851318|10365795|P2|Overall Study|Pregnancy|0
3013389|NCT00851318|10365796|P1|Overall Study|Pregnancy|0
3013390|NCT00851318|10365793|P4|Overall Study|Adverse Event|12
3013391|NCT00851318|10365794|P3|Overall Study|Adverse Event|9
3013392|NCT00851318|10365795|P2|Overall Study|Adverse Event|2
3013393|NCT00851318|10365796|P1|Overall Study|Adverse Event|13
3013394|NCT00851318|10365793|P4|Overall Study|Withdrawal by Subject|3
3013395|NCT00851318|10365794|P3|Overall Study|Withdrawal by Subject|5
3013396|NCT00851318|10365795|P2|Overall Study|Withdrawal by Subject|1
3013397|NCT00851318|10365796|P1|Overall Study|Withdrawal by Subject|7
3013398|NCT00851253|10365832|P2|Overall Study|Disease Progression|0
3013399|NCT00851253|10365833|P1|Overall Study|Disease Progression|1
3013400|NCT00851084|10365843|P2|Overall Study|Other|1
3013401|NCT00851084|10365844|P1|Overall Study|Other|7
3013402|NCT00851084|10365843|P2|Overall Study|Metastatic surgery|6
3013403|NCT00851084|10365844|P1|Overall Study|Metastatic surgery|6
3013404|NCT00851084|10365843|P2|Overall Study|Withdrawal by Subject|12
3013405|NCT00851084|10365844|P1|Overall Study|Withdrawal by Subject|11
3013406|NCT00851084|10365843|P2|Overall Study|Consent withdrawn|2
3013407|NCT00851084|10365844|P1|Overall Study|Consent withdrawn|0
3013408|NCT00851084|10365843|P2|Overall Study|Physician Decision|14
3013409|NCT00851084|10365844|P1|Overall Study|Physician Decision|13
3013410|NCT00851084|10365843|P2|Overall Study|Poor compliance to protocol|1
3013411|NCT00851084|10365844|P1|Overall Study|Poor compliance to protocol|1
3013412|NCT00851084|10365843|P2|Overall Study|Disease progression|47
3013413|NCT00851084|10365844|P1|Overall Study|Disease progression|52
3013414|NCT00851084|10365843|P2|Overall Study|Adverse Event|36
3013415|NCT00851084|10365844|P1|Overall Study|Adverse Event|26
3013416|NCT00851084|10365843|P2|Overall Study|Randomized but not treated|0
3013417|NCT00851084|10365844|P1|Overall Study|Randomized but not treated|1
3013418|NCT00850993|10365872|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
3013419|NCT00850993|10365873|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
3013420|NCT00850993|10365874|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
3013421|NCT00850993|10365875|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
3013422|NCT00850759|10365904|P4|Overall Study|Lost to Follow-up|3
3013423|NCT00850759|10365905|P3|Overall Study|Lost to Follow-up|5
3013424|NCT00850759|10365906|P2|Overall Study|Lost to Follow-up|5
3013425|NCT00850759|10365907|P1|Overall Study|Lost to Follow-up|7
3013426|NCT00850564|10365988|P1|Overall Study|Withdrawal by Subject|2
3013427|NCT00850538|10365993|P1|Overall Study|Protocol Violation|2
3013428|NCT00850538|10365993|P1|Overall Study|radiology error|2
3013429|NCT00850538|10365993|P1|Overall Study|Withdrawal by Subject|3
3013430|NCT00850538|10365993|P1|Overall Study|specimen unusable|7
3013431|NCT00850538|10365993|P1|Overall Study|specimen missed due to scheduling error|14
3013432|NCT00850538|10365993|P1|Overall Study|unable/unwilling to complete MRI|13
3013433|NCT00850499|10365999|P2|Overall Study|Lack of Efficacy|1
3013434|NCT00850499|10366000|P1|Overall Study|Lack of Efficacy|0
3013435|NCT00850499|10365999|P2|Overall Study|Adverse Event|1
3013436|NCT00850499|10366000|P1|Overall Study|Adverse Event|3
3013437|NCT00850460|10366014|P2|Overall Study|Lost to Follow-up|4
3013438|NCT00850460|10366015|P1|Overall Study|Lost to Follow-up|4
3013439|NCT00850395|10366029|P1|Overall Study|Other|5
3013440|NCT00850395|10366029|P1|Overall Study|Insufficient clinical response|3
3013441|NCT00850395|10366029|P1|Overall Study|Adverse Event|1
3013442|NCT00850395|10366029|P1|Overall Study|Death|1
3013443|NCT00850343|10366049|P4|Overall Study|Physician Decision|1
3013444|NCT00850343|10366050|P3|Overall Study|Physician Decision|1
3013445|NCT00850343|10366051|P2|Overall Study|Physician Decision|1
3013446|NCT00850343|10366052|P1|Overall Study|Physician Decision|2
3013447|NCT00850343|10366049|P4|Overall Study|Non-compliance with Study Procedures|1
3013448|NCT00850343|10366050|P3|Overall Study|Non-compliance with Study Procedures|1
3013449|NCT00850343|10366051|P2|Overall Study|Non-compliance with Study Procedures|0
3013450|NCT00850343|10366052|P1|Overall Study|Non-compliance with Study Procedures|1
3013451|NCT00850343|10366049|P4|Overall Study|Lack of Efficacy|2
3013452|NCT00850343|10366050|P3|Overall Study|Lack of Efficacy|3
3013453|NCT00850343|10366051|P2|Overall Study|Lack of Efficacy|0
3013454|NCT00850343|10366052|P1|Overall Study|Lack of Efficacy|17
3013455|NCT00850343|10366049|P4|Overall Study|Pregnancy|1
3013456|NCT00850343|10366050|P3|Overall Study|Pregnancy|0
3013457|NCT00850343|10366051|P2|Overall Study|Pregnancy|0
3013458|NCT00850343|10366052|P1|Overall Study|Pregnancy|0
3013459|NCT00850343|10366049|P4|Overall Study|Adverse Event|6
3013460|NCT00850343|10366050|P3|Overall Study|Adverse Event|6
3013461|NCT00850343|10366051|P2|Overall Study|Adverse Event|2
3013462|NCT00850343|10366052|P1|Overall Study|Adverse Event|15
3013463|NCT00850343|10366049|P4|Overall Study|Withdrawal by Subject|2
3013464|NCT00850343|10366050|P3|Overall Study|Withdrawal by Subject|3
3013465|NCT00850343|10366051|P2|Overall Study|Withdrawal by Subject|0
3013466|NCT00850343|10366052|P1|Overall Study|Withdrawal by Subject|11
3013467|NCT00850200|10366082|P1|Overall Study|Withdrawal by Subject|1
3013468|NCT00850200|10366082|P1|Overall Study|Did not recieve treatment|2
3013469|NCT00850200|10366082|P1|Overall Study|Physician Decision|2
3013470|NCT00850174|10366092|P2|Second Intervention|Withdrawal by Subject|0
3013471|NCT00850174|10366093|P1|Second Intervention|Withdrawal by Subject|1
3013472|NCT00850174|10366092|P2|Washout: One Week|Withdrawal by Subject|2
3013473|NCT00850174|10366093|P1|Washout: One Week|Withdrawal by Subject|0
3013474|NCT00850135|10366107|P1|Overall Study|Physician Decision|1
3013475|NCT00850070|10366126|P2|Overall Study|Adverse Event|0
3013476|NCT00850070|10366127|P1|Overall Study|Adverse Event|2
3013477|NCT00850070|10366126|P2|Overall Study|Lack of Efficacy|1
3013478|NCT00850070|10366127|P1|Overall Study|Lack of Efficacy|1
3013479|NCT00849940|10366156|P1|Overall Study|Physician Decision|4
3013480|NCT00849901|10366167|P3|Extension Phase|Lack of Efficacy|1
3013481|NCT00849901|10366168|P2|Extension Phase|Lack of Efficacy|4
3013482|NCT00849901|10366169|P1|Extension Phase|Lack of Efficacy|2
3013483|NCT00849901|10366167|P3|Extension Phase|Physician Decision|0
3013484|NCT00849901|10366168|P2|Extension Phase|Physician Decision|2
3013485|NCT00849901|10366169|P1|Extension Phase|Physician Decision|1
3013486|NCT00849901|10366167|P3|Extension Phase|Parent or Caregiver Decision|4
3013487|NCT00849901|10366168|P2|Extension Phase|Parent or Caregiver Decision|4
3013488|NCT00849901|10366169|P1|Extension Phase|Parent or Caregiver Decision|10
3013489|NCT00849901|10366167|P3|Extension Phase|Withdrawal by Subject|3
3013490|NCT00849901|10366168|P2|Extension Phase|Withdrawal by Subject|6
3013491|NCT00849901|10366169|P1|Extension Phase|Withdrawal by Subject|7
3013492|NCT00849901|10366167|P3|Extension Phase|Protocol Violation|4
3013493|NCT00849901|10366168|P2|Extension Phase|Protocol Violation|2
3013494|NCT00849901|10366169|P1|Extension Phase|Protocol Violation|2
3013495|NCT00849901|10366167|P3|Extension Phase|Lost to Follow-up|1
3013496|NCT00849901|10366168|P2|Extension Phase|Lost to Follow-up|0
3013497|NCT00849901|10366169|P1|Extension Phase|Lost to Follow-up|3
3013498|NCT00849901|10366167|P3|Extension Phase|Adverse Event|4
3013499|NCT00849901|10366168|P2|Extension Phase|Adverse Event|8
3013500|NCT00849901|10366169|P1|Extension Phase|Adverse Event|2
3013501|NCT00849901|10366167|P3|Acute Treatment Phase|Lack of Efficacy|2
3013502|NCT00849901|10366168|P2|Acute Treatment Phase|Lack of Efficacy|3
3013503|NCT00849901|10366169|P1|Acute Treatment Phase|Lack of Efficacy|2
3013504|NCT00849901|10366167|P3|Acute Treatment Phase|Sponsor Decision|0
3013505|NCT00849901|10366168|P2|Acute Treatment Phase|Sponsor Decision|0
3013506|NCT00849901|10366169|P1|Acute Treatment Phase|Sponsor Decision|1
3013507|NCT00849901|10366167|P3|Acute Treatment Phase|Physician Decision|1
3013508|NCT00849901|10366168|P2|Acute Treatment Phase|Physician Decision|1
3013509|NCT00849901|10366169|P1|Acute Treatment Phase|Physician Decision|1
3013510|NCT00849901|10366167|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
3013511|NCT00849901|10366168|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
3013512|NCT00849901|10366169|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
3013513|NCT00849901|10366167|P3|Acute Treatment Phase|Withdrawal by Subject|4
3013514|NCT00849901|10366168|P2|Acute Treatment Phase|Withdrawal by Subject|10
3013515|NCT00849901|10366169|P1|Acute Treatment Phase|Withdrawal by Subject|4
3013516|NCT00849901|10366167|P3|Acute Treatment Phase|Protocol Violation|1
3013517|NCT00849901|10366168|P2|Acute Treatment Phase|Protocol Violation|2
3013518|NCT00849901|10366169|P1|Acute Treatment Phase|Protocol Violation|0
3013519|NCT00849901|10366167|P3|Acute Treatment Phase|Lost to Follow-up|1
3013520|NCT00849901|10366168|P2|Acute Treatment Phase|Lost to Follow-up|4
3013521|NCT00849901|10366169|P1|Acute Treatment Phase|Lost to Follow-up|2
3013522|NCT00849901|10366167|P3|Acute Treatment Phase|Adverse Event|3
3013523|NCT00849901|10366168|P2|Acute Treatment Phase|Adverse Event|1
3013524|NCT00849901|10366169|P1|Acute Treatment Phase|Adverse Event|9
3013525|NCT00849875|10366216|P1|Overall Study|Lost to Follow-up|2
3013526|NCT00849875|10366216|P1|Overall Study|Others|6
3013527|NCT00849875|10366216|P1|Overall Study|Ongoing (unknown completion status)|11
3013528|NCT00849875|10366216|P1|Overall Study|Death|28
3013529|NCT00849797|10366313|P2|Washout: One Week|Withdrawal by Subject|2
3013530|NCT00849797|10366314|P1|Washout: One Week|Withdrawal by Subject|0
3013531|NCT00849797|10366313|P2|First Intervention|Adverse Event|1
3013532|NCT00849797|10366314|P1|First Intervention|Adverse Event|0
3013533|NCT00849797|10366313|P2|First Intervention|bad veins|0
3013534|NCT00849797|10366314|P1|First Intervention|bad veins|1
3013535|NCT00849693|10366332|P4|Extension Phase|Lack of Efficacy|1
3013536|NCT00849693|10366333|P3|Extension Phase|Lack of Efficacy|2
3013537|NCT00849693|10366334|P2|Extension Phase|Lack of Efficacy|2
3013538|NCT00849693|10366335|P1|Extension Phase|Lack of Efficacy|2
3013539|NCT00849693|10366332|P4|Extension Phase|Sponsor decision|1
3013540|NCT00849693|10366333|P3|Extension Phase|Sponsor decision|0
3013541|NCT00849693|10366334|P2|Extension Phase|Sponsor decision|0
3013542|NCT00849693|10366335|P1|Extension Phase|Sponsor decision|1
3013543|NCT00849693|10366332|P4|Extension Phase|Physician Decision|0
3013544|NCT00849693|10366333|P3|Extension Phase|Physician Decision|2
3013545|NCT00849693|10366334|P2|Extension Phase|Physician Decision|1
3013546|NCT00849693|10366335|P1|Extension Phase|Physician Decision|1
3013547|NCT00849693|10366332|P4|Extension Phase|Parent or caregiver decision|5
3013548|NCT00849693|10366333|P3|Extension Phase|Parent or caregiver decision|10
3013549|NCT00849693|10366334|P2|Extension Phase|Parent or caregiver decision|4
3013550|NCT00849693|10366335|P1|Extension Phase|Parent or caregiver decision|9
3013551|NCT00849693|10366332|P4|Extension Phase|Withdrawal by Subject|15
3013552|NCT00849693|10366333|P3|Extension Phase|Withdrawal by Subject|10
3013553|NCT00849693|10366334|P2|Extension Phase|Withdrawal by Subject|9
3013554|NCT00849693|10366335|P1|Extension Phase|Withdrawal by Subject|6
3013555|NCT00849693|10366332|P4|Extension Phase|Protocol Violation|3
3013556|NCT00849693|10366333|P3|Extension Phase|Protocol Violation|2
3013557|NCT00849693|10366334|P2|Extension Phase|Protocol Violation|3
3013558|NCT00849693|10366335|P1|Extension Phase|Protocol Violation|0
3013559|NCT00849693|10366332|P4|Extension Phase|Lost to Follow-up|6
3013560|NCT00849693|10366333|P3|Extension Phase|Lost to Follow-up|6
3013561|NCT00849693|10366334|P2|Extension Phase|Lost to Follow-up|5
3013562|NCT00849693|10366335|P1|Extension Phase|Lost to Follow-up|7
3013563|NCT00849693|10366332|P4|Extension Phase|Adverse Event|7
3013564|NCT00849693|10366333|P3|Extension Phase|Adverse Event|3
3013565|NCT00849693|10366334|P2|Extension Phase|Adverse Event|6
3013566|NCT00849693|10366335|P1|Extension Phase|Adverse Event|4
3013567|NCT00849693|10366332|P4|Acute Treatment Phase|Lack of Efficacy|2
3013568|NCT00849693|10366333|P3|Acute Treatment Phase|Lack of Efficacy|1
3013569|NCT00849693|10366334|P2|Acute Treatment Phase|Lack of Efficacy|3
3013570|NCT00849693|10366335|P1|Acute Treatment Phase|Lack of Efficacy|1
3013571|NCT00849693|10366332|P4|Acute Treatment Phase|Sponsor decision|0
3013572|NCT00849693|10366333|P3|Acute Treatment Phase|Sponsor decision|1
3013573|NCT00849693|10366334|P2|Acute Treatment Phase|Sponsor decision|0
3013574|NCT00849693|10366335|P1|Acute Treatment Phase|Sponsor decision|0
3013575|NCT00849693|10366332|P4|Acute Treatment Phase|Physician Decision|1
3013576|NCT00849693|10366333|P3|Acute Treatment Phase|Physician Decision|2
3013577|NCT00849693|10366334|P2|Acute Treatment Phase|Physician Decision|1
3013578|NCT00849693|10366335|P1|Acute Treatment Phase|Physician Decision|2
3013579|NCT00849693|10366332|P4|Acute Treatment Phase|Parent or caregiver decision|7
3013580|NCT00849693|10366333|P3|Acute Treatment Phase|Parent or caregiver decision|7
3013581|NCT00849693|10366334|P2|Acute Treatment Phase|Parent or caregiver decision|6
3013582|NCT00849693|10366335|P1|Acute Treatment Phase|Parent or caregiver decision|7
3013583|NCT00849693|10366332|P4|Acute Treatment Phase|Withdrawal by Subject|8
3013584|NCT00849693|10366333|P3|Acute Treatment Phase|Withdrawal by Subject|3
3013585|NCT00849693|10366334|P2|Acute Treatment Phase|Withdrawal by Subject|5
3013586|NCT00849693|10366335|P1|Acute Treatment Phase|Withdrawal by Subject|5
3013587|NCT00849693|10366332|P4|Acute Treatment Phase|Protocol Violation|6
3013588|NCT00849693|10366333|P3|Acute Treatment Phase|Protocol Violation|2
3013589|NCT00849693|10366334|P2|Acute Treatment Phase|Protocol Violation|5
3013590|NCT00849693|10366335|P1|Acute Treatment Phase|Protocol Violation|1
3013591|NCT00849693|10366332|P4|Acute Treatment Phase|Lost to Follow-up|9
3013592|NCT00849693|10366333|P3|Acute Treatment Phase|Lost to Follow-up|11
3013593|NCT00849693|10366334|P2|Acute Treatment Phase|Lost to Follow-up|8
3013594|NCT00849693|10366335|P1|Acute Treatment Phase|Lost to Follow-up|5
3013595|NCT00849693|10366332|P4|Acute Treatment Phase|Adverse Event|4
3013596|NCT00849693|10366333|P3|Acute Treatment Phase|Adverse Event|6
3013597|NCT00849693|10366334|P2|Acute Treatment Phase|Adverse Event|7
3013598|NCT00849693|10366335|P1|Acute Treatment Phase|Adverse Event|12
3013599|NCT00849680|10366402|P8|Overall Study|Subject unable to comply with protocol|0
3013600|NCT00849680|10366403|P7|Overall Study|Subject unable to comply with protocol|0
3013601|NCT00849680|10366404|P6|Overall Study|Subject unable to comply with protocol|0
3013602|NCT00849680|10366405|P5|Overall Study|Subject unable to comply with protocol|0
3013603|NCT00849680|10366406|P4|Overall Study|Subject unable to comply with protocol|0
3013604|NCT00849680|10366407|P3|Overall Study|Subject unable to comply with protocol|0
3013605|NCT00849680|10366408|P2|Overall Study|Subject unable to comply with protocol|0
3013606|NCT00849680|10366409|P1|Overall Study|Subject unable to comply with protocol|1
3013607|NCT00849680|10366402|P8|Overall Study|Withdrawal by Subject|1
3013608|NCT00849680|10366403|P7|Overall Study|Withdrawal by Subject|1
3013609|NCT00849680|10366404|P6|Overall Study|Withdrawal by Subject|2
3013610|NCT00849680|10366405|P5|Overall Study|Withdrawal by Subject|2
3013611|NCT00849680|10366406|P4|Overall Study|Withdrawal by Subject|2
3013612|NCT00849680|10366407|P3|Overall Study|Withdrawal by Subject|0
3013613|NCT00849680|10366408|P2|Overall Study|Withdrawal by Subject|0
3013614|NCT00849680|10366409|P1|Overall Study|Withdrawal by Subject|2
3013615|NCT00849680|10366402|P8|Overall Study|Subject moved|2
3013616|NCT00849680|10366403|P7|Overall Study|Subject moved|2
3013617|NCT00849680|10366404|P6|Overall Study|Subject moved|2
3013618|NCT00849680|10366405|P5|Overall Study|Subject moved|0
3013619|NCT00849680|10366406|P4|Overall Study|Subject moved|1
3013620|NCT00849680|10366407|P3|Overall Study|Subject moved|3
3013621|NCT00849680|10366408|P2|Overall Study|Subject moved|0
3013622|NCT00849680|10366409|P1|Overall Study|Subject moved|1
3013623|NCT00849680|10366402|P8|Overall Study|Lost to Follow-up|5
3013624|NCT00849680|10366403|P7|Overall Study|Lost to Follow-up|12
3013625|NCT00849680|10366404|P6|Overall Study|Lost to Follow-up|11
3013626|NCT00849680|10366405|P5|Overall Study|Lost to Follow-up|8
3013627|NCT00849680|10366406|P4|Overall Study|Lost to Follow-up|11
3013628|NCT00849680|10366407|P3|Overall Study|Lost to Follow-up|12
3013629|NCT00849680|10366408|P2|Overall Study|Lost to Follow-up|3
3013630|NCT00849680|10366409|P1|Overall Study|Lost to Follow-up|7
3013631|NCT00849680|10366402|P8|Overall Study|Adverse Event|0
3013632|NCT00849680|10366403|P7|Overall Study|Adverse Event|2
3013633|NCT00849680|10366404|P6|Overall Study|Adverse Event|0
3013634|NCT00849680|10366405|P5|Overall Study|Adverse Event|0
3013635|NCT00849680|10366406|P4|Overall Study|Adverse Event|0
3013636|NCT00849680|10366407|P3|Overall Study|Adverse Event|0
3013637|NCT00849680|10366408|P2|Overall Study|Adverse Event|0
3013638|NCT00849680|10366409|P1|Overall Study|Adverse Event|0
3013639|NCT00849524|10366451|P1|Overall Study|Lack of Efficacy|3
3013640|NCT00849472|10366468|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
3013641|NCT00849472|10366468|P1|Pazopanib Postsurgery Treatment|Moved|1
3013642|NCT00849472|10366468|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
3013643|NCT00849472|10366468|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
3013644|NCT00849472|10366468|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
3013645|NCT00849472|10366468|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
3013646|NCT00849472|10366468|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
3013647|NCT00849472|10366468|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
3013648|NCT00849472|10366468|P1|Weekly Paclitaxel|Physician Decision|3
3013649|NCT00849472|10366468|P1|Weekly Paclitaxel|Withdrawal by Subject|1
3013650|NCT00849472|10366468|P1|Weekly Paclitaxel|Adverse Event|11
3013651|NCT00849472|10366468|P1|Weekly Paclitaxel|Disease Progression|1
3013652|NCT00849472|10366468|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
3013653|NCT00849472|10366468|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
3013654|NCT00849472|10366468|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
3013655|NCT00849472|10366468|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
3013656|NCT00849472|10366468|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
3013657|NCT00849381|10366482|P1|Overall Study|Other|4
3013658|NCT00849381|10366482|P1|Overall Study|Withdrawal by Subject|6
3013659|NCT00849381|10366482|P1|Overall Study|Protocol Violation|5
3013660|NCT00849381|10366482|P1|Overall Study|Lost to Follow-up|129
3013661|NCT00849381|10366482|P1|Overall Study|Adverse Event|1
3013662|NCT00849290|10366488|P1|Overall Study|Disease Progression|20
3013663|NCT00849290|10366488|P1|Overall Study|Protocol Violation|5
3013664|NCT00849290|10366488|P1|Overall Study|Lost to Follow-up|2
3013665|NCT00849290|10366488|P1|Overall Study|Withdrawal by Subject|11
3013666|NCT00849290|10366488|P1|Overall Study|Death|14
3013667|NCT00849290|10366488|P1|Overall Study|Adverse Event|3
3013668|NCT00849212|10366499|P1|Overall Study|Miscellaneous|1
3013669|NCT00849212|10366499|P1|Overall Study|Adverse Event|2
3013670|NCT00849212|10366499|P1|Overall Study|Withdrawal by Subject|3
3013671|NCT00849212|10366499|P1|Overall Study|Lack of Efficacy|1
3013672|NCT00849186|10366504|P1|Overall Study|Other|1
3013673|NCT00849186|10366504|P1|Overall Study|not treated|6
3013674|NCT00849186|10366504|P1|Overall Study|Withdrawal by Subject|1
3013675|NCT00849186|10366504|P1|Overall Study|Adverse Event|2
3013676|NCT00849147|10366510|P1|Overall Study|Disease Relapse/Progression|2
3013677|NCT00849147|10366510|P1|Overall Study|Protocol Violation|2
3013678|NCT00849147|10366510|P1|Overall Study|Withdrawal by Subject|1
3013679|NCT00849108|10366543|P2|Cohort 2 Efficacy|Other|9
3013680|NCT00849108|10366544|P1|Cohort 2 Efficacy|Other|0
3013681|NCT00849108|10366543|P2|Cohort 2 Efficacy|Adverse Event|1
3013682|NCT00849108|10366544|P1|Cohort 2 Efficacy|Adverse Event|0
3013683|NCT00849108|10366543|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
3013684|NCT00849108|10366544|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
3013685|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
3013686|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
3013687|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
3013688|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
3013689|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
3013690|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
3013691|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
3013692|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
3013693|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
3013694|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
3013695|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
3013696|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
3013697|NCT00849056|10366554|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
3013698|NCT00849056|10366555|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
3013699|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
3013700|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
3013701|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
3013702|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
3013703|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
3013704|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
3013705|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
3013706|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
3013707|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
3013708|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
3013709|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
3013710|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
3013711|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
3013712|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
3013713|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
3013714|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
3013715|NCT00849056|10366554|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
3013716|NCT00849056|10366555|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
3013717|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
3013718|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
3013719|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
3013720|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
3013721|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
3013722|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
3013723|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Physician Decision|1
3013724|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Physician Decision|1
3013725|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Physician Decision|0
3013726|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
3013727|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
3013728|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
3013729|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
3013730|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
3013731|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
3013732|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
3013733|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
3013734|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
3013735|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Noncompliance|0
3013736|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Noncompliance|1
3013737|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Noncompliance|2
3013738|NCT00849017|10366580|P3|Follow-up Period (8 Weeks)|Adverse Event|0
3013739|NCT00849017|10366581|P2|Follow-up Period (8 Weeks)|Adverse Event|0
3013740|NCT00849017|10366582|P1|Follow-up Period (8 Weeks)|Adverse Event|1
3013741|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
3013742|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
3013743|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
3013744|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Pregnancy|1
3013745|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Pregnancy|0
3013746|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Pregnancy|1
3013747|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
3013748|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
3013749|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
3013750|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
3013751|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
3013752|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
3013753|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
3013754|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
3013755|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
3013756|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
3013757|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
3013758|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
3013759|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Physician Decision|1
3013760|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Physician Decision|2
3013761|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Physician Decision|0
3013762|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
3013763|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
3013764|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
3013765|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
3013766|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
3013767|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
3013768|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Noncompliance|4
3013769|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Noncompliance|3
3013770|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Noncompliance|3
3013771|NCT00849017|10366580|P3|Treatment Period (156 Weeks)|Adverse Event|15
3013772|NCT00849017|10366581|P2|Treatment Period (156 Weeks)|Adverse Event|6
3013773|NCT00849017|10366582|P1|Treatment Period (156 Weeks)|Adverse Event|5
3013774|NCT00848965|10366625|P1|Overall Study|Withdrawal by Subject|1
3013775|NCT00848965|10366625|P1|Overall Study|Adverse Event|1
3013776|NCT00848926|10366667|P1|Follow-up Period|Other|2
3013777|NCT00848926|10366667|P1|Follow-up Period|Withdrawal by Subject|3
3013778|NCT00848926|10366667|P1|Follow-up Period|Lost to Follow-up|7
3013779|NCT00848926|10366667|P1|Treatment Period|Withdrawal by Subject|7
3013780|NCT00848926|10366667|P1|Treatment Period|Physician Decision|12
3013781|NCT00848926|10366667|P1|Treatment Period|Adverse Event|20
3013782|NCT00848926|10366667|P1|Treatment Period|Progressive disease|45
3013783|NCT00848718|10366717|P13|Overall Study|Progressive disease during treatment|2
3013784|NCT00848718|10366718|P12|Overall Study|Progressive disease during treatment|0
3013785|NCT00848718|10366719|P11|Overall Study|Progressive disease during treatment|0
3013786|NCT00848718|10366720|P10|Overall Study|Progressive disease during treatment|0
3013787|NCT00848718|10366721|P9|Overall Study|Progressive disease during treatment|0
3013788|NCT00848718|10366722|P8|Overall Study|Progressive disease during treatment|2
3013789|NCT00848718|10366723|P7|Overall Study|Progressive disease during treatment|0
3013790|NCT00848718|10366724|P6|Overall Study|Progressive disease during treatment|0
3013791|NCT00848718|10366725|P5|Overall Study|Progressive disease during treatment|0
3013792|NCT00848718|10366726|P4|Overall Study|Progressive disease during treatment|0
3013793|NCT00848718|10366727|P3|Overall Study|Progressive disease during treatment|3
3013794|NCT00848718|10366728|P2|Overall Study|Progressive disease during treatment|0
3013795|NCT00848718|10366729|P1|Overall Study|Progressive disease during treatment|3
3013796|NCT00848718|10366717|P13|Overall Study|Withdrawal by Subject|0
3013797|NCT00848718|10366718|P12|Overall Study|Withdrawal by Subject|0
3013798|NCT00848718|10366719|P11|Overall Study|Withdrawal by Subject|1
3013799|NCT00848718|10366720|P10|Overall Study|Withdrawal by Subject|0
3013800|NCT00848718|10366721|P9|Overall Study|Withdrawal by Subject|0
3013801|NCT00848718|10366722|P8|Overall Study|Withdrawal by Subject|0
3013802|NCT00848718|10366723|P7|Overall Study|Withdrawal by Subject|0
3013803|NCT00848718|10366724|P6|Overall Study|Withdrawal by Subject|0
3013804|NCT00848718|10366725|P5|Overall Study|Withdrawal by Subject|0
3013805|NCT00848718|10366726|P4|Overall Study|Withdrawal by Subject|1
3013806|NCT00848718|10366727|P3|Overall Study|Withdrawal by Subject|0
3013807|NCT00848718|10366728|P2|Overall Study|Withdrawal by Subject|0
3013808|NCT00848718|10366729|P1|Overall Study|Withdrawal by Subject|1
3013809|NCT00848718|10366717|P13|Overall Study|Protocol Violation|1
3013810|NCT00848718|10366718|P12|Overall Study|Protocol Violation|0
3013811|NCT00848718|10366719|P11|Overall Study|Protocol Violation|0
3013812|NCT00848718|10366720|P10|Overall Study|Protocol Violation|0
3013813|NCT00848718|10366721|P9|Overall Study|Protocol Violation|0
3013814|NCT00848718|10366722|P8|Overall Study|Protocol Violation|1
3013815|NCT00848718|10366723|P7|Overall Study|Protocol Violation|0
3013816|NCT00848718|10366724|P6|Overall Study|Protocol Violation|0
3013817|NCT00848718|10366725|P5|Overall Study|Protocol Violation|0
3013818|NCT00848718|10366726|P4|Overall Study|Protocol Violation|0
3013819|NCT00848718|10366727|P3|Overall Study|Protocol Violation|0
3013820|NCT00848718|10366728|P2|Overall Study|Protocol Violation|1
3013821|NCT00848718|10366729|P1|Overall Study|Protocol Violation|0
3013822|NCT00848718|10366717|P13|Overall Study|Progressive disease before treatment|2
3013823|NCT00848718|10366718|P12|Overall Study|Progressive disease before treatment|6
3013824|NCT00848718|10366719|P11|Overall Study|Progressive disease before treatment|3
3013825|NCT00848718|10366720|P10|Overall Study|Progressive disease before treatment|7
3013826|NCT00848718|10366721|P9|Overall Study|Progressive disease before treatment|2
3013827|NCT00848718|10366722|P8|Overall Study|Progressive disease before treatment|1
3013828|NCT00848718|10366723|P7|Overall Study|Progressive disease before treatment|2
3013829|NCT00848718|10366724|P6|Overall Study|Progressive disease before treatment|4
3013830|NCT00848718|10366725|P5|Overall Study|Progressive disease before treatment|4
3013831|NCT00848718|10366726|P4|Overall Study|Progressive disease before treatment|3
3013832|NCT00848718|10366727|P3|Overall Study|Progressive disease before treatment|1
3013833|NCT00848718|10366728|P2|Overall Study|Progressive disease before treatment|5
3013834|NCT00848718|10366729|P1|Overall Study|Progressive disease before treatment|1
3013835|NCT00848718|10366717|P13|Overall Study|Physician Decision|1
3013836|NCT00848718|10366718|P12|Overall Study|Physician Decision|0
3013837|NCT00848718|10366719|P11|Overall Study|Physician Decision|0
3013838|NCT00848718|10366720|P10|Overall Study|Physician Decision|2
3013839|NCT00848718|10366721|P9|Overall Study|Physician Decision|1
3013840|NCT00848718|10366722|P8|Overall Study|Physician Decision|0
3013841|NCT00848718|10366723|P7|Overall Study|Physician Decision|0
3013842|NCT00848718|10366724|P6|Overall Study|Physician Decision|1
3013843|NCT00848718|10366725|P5|Overall Study|Physician Decision|1
3013844|NCT00848718|10366726|P4|Overall Study|Physician Decision|0
3013845|NCT00848718|10366727|P3|Overall Study|Physician Decision|0
3013846|NCT00848718|10366728|P2|Overall Study|Physician Decision|1
3013847|NCT00848718|10366729|P1|Overall Study|Physician Decision|0
3013848|NCT00848718|10366717|P13|Overall Study|Lack of Efficacy|0
3013849|NCT00848718|10366718|P12|Overall Study|Lack of Efficacy|0
3013850|NCT00848718|10366719|P11|Overall Study|Lack of Efficacy|0
3013851|NCT00848718|10366720|P10|Overall Study|Lack of Efficacy|0
3013852|NCT00848718|10366721|P9|Overall Study|Lack of Efficacy|0
3013853|NCT00848718|10366722|P8|Overall Study|Lack of Efficacy|0
3013854|NCT00848718|10366723|P7|Overall Study|Lack of Efficacy|1
3013855|NCT00848718|10366724|P6|Overall Study|Lack of Efficacy|0
3013856|NCT00848718|10366725|P5|Overall Study|Lack of Efficacy|0
3013857|NCT00848718|10366726|P4|Overall Study|Lack of Efficacy|0
3013858|NCT00848718|10366727|P3|Overall Study|Lack of Efficacy|1
3013859|NCT00848718|10366728|P2|Overall Study|Lack of Efficacy|0
3013860|NCT00848718|10366729|P1|Overall Study|Lack of Efficacy|0
3013861|NCT00848718|10366717|P13|Overall Study|Adverse Event|2
3013862|NCT00848718|10366718|P12|Overall Study|Adverse Event|0
3013863|NCT00848718|10366719|P11|Overall Study|Adverse Event|0
3013864|NCT00848718|10366720|P10|Overall Study|Adverse Event|0
3013865|NCT00848718|10366721|P9|Overall Study|Adverse Event|1
3013866|NCT00848718|10366722|P8|Overall Study|Adverse Event|1
3013867|NCT00848718|10366723|P7|Overall Study|Adverse Event|0
3013868|NCT00848718|10366724|P6|Overall Study|Adverse Event|0
3013869|NCT00848718|10366725|P5|Overall Study|Adverse Event|1
3013870|NCT00848718|10366726|P4|Overall Study|Adverse Event|1
3013871|NCT00848718|10366727|P3|Overall Study|Adverse Event|1
3013872|NCT00848718|10366728|P2|Overall Study|Adverse Event|2
3013873|NCT00848718|10366729|P1|Overall Study|Adverse Event|2
3013874|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Other|6
3013875|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Other|5
3013876|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
3013877|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
3013878|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
3013879|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
3013880|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
3013881|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
3013882|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
3013883|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
3013884|NCT00848549|10366830|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
3013885|NCT00848549|10366831|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
3013886|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
3013887|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
3013888|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Other|3
3013889|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Other|4
3013890|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
3013891|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
3013892|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
3013893|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
3013894|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
3013895|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
3013896|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
3013897|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
3013983|NCT00848211|10367177|P3|Overall Study|Adverse Event|0
3013898|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
3013899|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
3013900|NCT00848549|10366830|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
3013901|NCT00848549|10366831|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
3013902|NCT00848536|10366849|P2|Overall Study|Patient Moved|2
3013903|NCT00848536|10366850|P1|Overall Study|Patient Moved|0
3013904|NCT00848536|10366849|P2|Overall Study|Inadequate Control of IOP|1
3013905|NCT00848536|10366850|P1|Overall Study|Inadequate Control of IOP|1
3013906|NCT00848536|10366849|P2|Overall Study|Noncompliance|0
3013907|NCT00848536|10366850|P1|Overall Study|Noncompliance|1
3013908|NCT00848536|10366849|P2|Overall Study|Protocol Violation|1
3013909|NCT00848536|10366850|P1|Overall Study|Protocol Violation|0
3013910|NCT00848536|10366849|P2|Overall Study|Withdrawal by Subject|1
3013911|NCT00848536|10366850|P1|Overall Study|Withdrawal by Subject|0
3013912|NCT00848536|10366849|P2|Overall Study|Adverse Event|2
3013913|NCT00848536|10366850|P1|Overall Study|Adverse Event|2
3013914|NCT00848497|10366915|P2|Overall Study|Withdrawal by Subject|1
3013915|NCT00848497|10366916|P1|Overall Study|Withdrawal by Subject|0
3013916|NCT00848497|10366915|P2|Overall Study|Screen failure|0
3013917|NCT00848497|10366916|P1|Overall Study|Screen failure|2
3013918|NCT00848484|10366930|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
3013919|NCT00848484|10366931|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
3013920|NCT00848484|10366930|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
3013921|NCT00848484|10366931|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
3013922|NCT00848484|10366930|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
3013923|NCT00848484|10366931|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
3013924|NCT00848484|10366930|P2|First Intervention (Treatment Period 1)|Physician Decision|1
3013925|NCT00848484|10366931|P1|First Intervention (Treatment Period 1)|Physician Decision|0
3013926|NCT00848484|10366930|P2|First Intervention (Treatment Period 1)|Adverse Event|1
3013927|NCT00848484|10366931|P1|First Intervention (Treatment Period 1)|Adverse Event|2
3013928|NCT00848393|10366950|P3|Overall Study|surgical complications unrelated to stud|2
3013929|NCT00848393|10366951|P2|Overall Study|surgical complications unrelated to stud|0
3013930|NCT00848393|10366952|P1|Overall Study|surgical complications unrelated to stud|0
3013931|NCT00848393|10366950|P3|Overall Study|Protocol Violation|1
3013932|NCT00848393|10366951|P2|Overall Study|Protocol Violation|0
3013933|NCT00848393|10366952|P1|Overall Study|Protocol Violation|0
3013934|NCT00848354|10366991|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
3013935|NCT00848354|10366992|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
3013936|NCT00848354|10366991|P2|Phase 2 Year 2|Subject Request|1
3013937|NCT00848354|10366992|P1|Phase 2 Year 2|Subject Request|1
3013938|NCT00848354|10366991|P2|Phase 2 Year 2|Protocol Violation|1
3013939|NCT00848354|10366992|P1|Phase 2 Year 2|Protocol Violation|1
3013940|NCT00848354|10366991|P2|Phase 2 Year 2|Unspecified Reason|0
3013941|NCT00848354|10366992|P1|Phase 2 Year 2|Unspecified Reason|1
3013942|NCT00848354|10366991|P2|Phase 2 Year 2|Lost to Follow-up|3
3013943|NCT00848354|10366992|P1|Phase 2 Year 2|Lost to Follow-up|1
3013944|NCT00848354|10366991|P2|Phase 2 Year 2|Failed to return|0
3013945|NCT00848354|10366992|P1|Phase 2 Year 2|Failed to return|3
3013946|NCT00848354|10366991|P2|Phase 2 Year 2|Death|0
3013947|NCT00848354|10366992|P1|Phase 2 Year 2|Death|2
3013948|NCT00848354|10366991|P2|Phase 2 Year 2|Adverse Event|2
3013949|NCT00848354|10366992|P1|Phase 2 Year 2|Adverse Event|12
3013950|NCT00848354|10366991|P2|Phase 2 Year 1|Subject Request|2
3013951|NCT00848354|10366992|P1|Phase 2 Year 1|Subject Request|1
3013952|NCT00848354|10366991|P2|Phase 2 Year 1|Protocol Violation|1
3013953|NCT00848354|10366992|P1|Phase 2 Year 1|Protocol Violation|4
3013954|NCT00848354|10366991|P2|Phase 2 Year 1|Unspecified Reason|0
3013955|NCT00848354|10366992|P1|Phase 2 Year 1|Unspecified Reason|3
3013956|NCT00848354|10366991|P2|Phase 2 Year 1|Lost to Follow-up|0
3013957|NCT00848354|10366992|P1|Phase 2 Year 1|Lost to Follow-up|1
3013958|NCT00848354|10366991|P2|Phase 2 Year 1|Failed to Return|1
3013959|NCT00848354|10366992|P1|Phase 2 Year 1|Failed to Return|1
3013960|NCT00848354|10366991|P2|Phase 2 Year 1|Death|0
3013961|NCT00848354|10366992|P1|Phase 2 Year 1|Death|1
3013962|NCT00848354|10366991|P2|Phase 2 Year 1|Adverse Event|2
3013963|NCT00848354|10366992|P1|Phase 2 Year 1|Adverse Event|7
3013964|NCT00848354|10366991|P2|Phase 1|Lack of Efficacy|1
3013965|NCT00848354|10366992|P1|Phase 1|Lack of Efficacy|0
3013966|NCT00848354|10366991|P2|Phase 1|Withdrawal by Subject|4
3013967|NCT00848354|10366992|P1|Phase 1|Withdrawal by Subject|2
3013968|NCT00848354|10366991|P2|Phase 1|Protocol Violation|1
3013969|NCT00848354|10366992|P1|Phase 1|Protocol Violation|1
3013970|NCT00848354|10366991|P2|Phase 1|Unspecified Reason|1
3013971|NCT00848354|10366992|P1|Phase 1|Unspecified Reason|1
3013972|NCT00848354|10366991|P2|Phase 1|Lost to Follow-up|1
3013973|NCT00848354|10366992|P1|Phase 1|Lost to Follow-up|1
3013974|NCT00848354|10366991|P2|Phase 1|Failed to return|1
3013975|NCT00848354|10366992|P1|Phase 1|Failed to return|0
3013976|NCT00848354|10366991|P2|Phase 1|Discontinuation of study by sponsor|1
3013977|NCT00848354|10366992|P1|Phase 1|Discontinuation of study by sponsor|2
3013978|NCT00848354|10366991|P2|Phase 1|Adverse Event|4
3013979|NCT00848354|10366992|P1|Phase 1|Adverse Event|5
3013980|NCT00848250|10367144|P2|Overall Study|surgery was completed without cardiopulm|1
3013981|NCT00848250|10367145|P1|Overall Study|surgery was completed without cardiopulm|0
3013982|NCT00848211|10367176|P4|Overall Study|Adverse Event|0
3013984|NCT00848211|10367178|P2|Overall Study|Adverse Event|0
3013985|NCT00848211|10367179|P1|Overall Study|Adverse Event|0
3013986|NCT00848211|10367176|P4|Overall Study|Protocol Violation|0
3013987|NCT00848211|10367177|P3|Overall Study|Protocol Violation|1
3013988|NCT00848211|10367178|P2|Overall Study|Protocol Violation|1
3013989|NCT00848211|10367179|P1|Overall Study|Protocol Violation|0
3013990|NCT00848198|10367197|P1|Overall Study|Incomplete Case Report Forms|15
3013991|NCT00848120|10367262|P1|Overall Study|Adverse Event|1
3013992|NCT00848107|10367274|P1|Overall Study|Pregnancy|1
3013993|NCT00848107|10367274|P1|Overall Study|Death|1
3013994|NCT00848107|10367274|P1|Overall Study|Adverse Event|9
3013995|NCT00848107|10367274|P1|Overall Study|Withdrawal by Subject|8
3013996|NCT00848107|10367274|P1|Overall Study|Lost to Follow-up|2
3013997|NCT00848081|10367284|P2|Overall Study|Withdrawal by Subject|3
3013998|NCT00848081|10367285|P1|Overall Study|Withdrawal by Subject|5
3013999|NCT00848081|10367284|P2|Overall Study|Physician Decision|3
3014000|NCT00848081|10367285|P1|Overall Study|Physician Decision|0
3014001|NCT00848081|10367284|P2|Overall Study|Lost to Follow-up|0
3014002|NCT00848081|10367285|P1|Overall Study|Lost to Follow-up|1
3014003|NCT00848081|10367284|P2|Overall Study|Protocol Violation|5
3014004|NCT00848081|10367285|P1|Overall Study|Protocol Violation|8
3014005|NCT00848081|10367284|P2|Overall Study|Adverse Event|7
3014006|NCT00848081|10367285|P1|Overall Study|Adverse Event|6
3014007|NCT00848042|10367302|P3|Overall Study|Other Therapy|0
3014008|NCT00848042|10367303|P2|Overall Study|Other Therapy|0
3014009|NCT00848042|10367304|P1|Overall Study|Other Therapy|3
3014010|NCT00848042|10367302|P3|Overall Study|Death|0
3014011|NCT00848042|10367303|P2|Overall Study|Death|2
3014012|NCT00848042|10367304|P1|Overall Study|Death|1
3014013|NCT00847912|10367340|P2|Overall Study|Withdrawal by Subject|6
3014014|NCT00847912|10367341|P1|Overall Study|Withdrawal by Subject|3
3014015|NCT00847912|10367340|P2|Overall Study|Protocol Violation|7
3014016|NCT00847912|10367341|P1|Overall Study|Protocol Violation|6
3014017|NCT00847886|10367351|P2|Overall Study|Adverse Event|1
3014018|NCT00847886|10367352|P1|Overall Study|Adverse Event|0
3014019|NCT00847808|10367378|P1|Overall Study|Participant Took Excluded Medication|1
3014020|NCT00847808|10367378|P1|Overall Study|Participant Reported Lack of Efficacy|1
3014021|NCT00847808|10367378|P1|Overall Study|Withdrawal by Subject|4
3014022|NCT00847808|10367378|P1|Overall Study|Lost to Follow-up|1
3014023|NCT00847808|10367378|P1|Overall Study|Protocol Violation|1
3014024|NCT00847808|10367378|P1|Overall Study|Adverse Event|7
3014025|NCT00847730|10367395|P1|Overall Study|Multiple interruptions in therapy|8
3014026|NCT00847704|10367399|P1|Overall Study|Withdrawal by Subject|1
3014027|NCT00847665|10367410|P2|Overall Study|Withdrawal by Subject|0
3014028|NCT00847665|10367411|P1|Overall Study|Withdrawal by Subject|1
3014029|NCT00847626|10367434|P11|Overall Study|Other|3
3014030|NCT00847626|10367435|P10|Overall Study|Other|1
3014031|NCT00847626|10367436|P9|Overall Study|Other|1
3014032|NCT00847626|10367437|P8|Overall Study|Other|3
3014033|NCT00847626|10367438|P7|Overall Study|Other|2
3014034|NCT00847626|10367439|P6|Overall Study|Other|2
3014035|NCT00847626|10367440|P5|Overall Study|Other|2
3014036|NCT00847626|10367441|P4|Overall Study|Other|1
3014037|NCT00847626|10367442|P3|Overall Study|Other|4
3014038|NCT00847626|10367443|P2|Overall Study|Other|5
3014039|NCT00847626|10367444|P1|Overall Study|Other|1
3014040|NCT00847626|10367434|P11|Overall Study|Lack of Efficacy|7
3014041|NCT00847626|10367435|P10|Overall Study|Lack of Efficacy|1
3014042|NCT00847626|10367436|P9|Overall Study|Lack of Efficacy|5
3014043|NCT00847626|10367437|P8|Overall Study|Lack of Efficacy|2
3014044|NCT00847626|10367438|P7|Overall Study|Lack of Efficacy|6
3014045|NCT00847626|10367439|P6|Overall Study|Lack of Efficacy|0
3014046|NCT00847626|10367440|P5|Overall Study|Lack of Efficacy|2
3014047|NCT00847626|10367441|P4|Overall Study|Lack of Efficacy|1
3014048|NCT00847626|10367442|P3|Overall Study|Lack of Efficacy|0
3014049|NCT00847626|10367443|P2|Overall Study|Lack of Efficacy|1
3014050|NCT00847626|10367444|P1|Overall Study|Lack of Efficacy|3
3014051|NCT00847626|10367434|P11|Overall Study|Withdrawal by Subject|2
3014052|NCT00847626|10367435|P10|Overall Study|Withdrawal by Subject|5
3014053|NCT00847626|10367436|P9|Overall Study|Withdrawal by Subject|4
3014054|NCT00847626|10367437|P8|Overall Study|Withdrawal by Subject|4
3014055|NCT00847626|10367438|P7|Overall Study|Withdrawal by Subject|8
3014056|NCT00847626|10367439|P6|Overall Study|Withdrawal by Subject|9
3014057|NCT00847626|10367440|P5|Overall Study|Withdrawal by Subject|12
3014058|NCT00847626|10367441|P4|Overall Study|Withdrawal by Subject|8
3014059|NCT00847626|10367442|P3|Overall Study|Withdrawal by Subject|3
3014060|NCT00847626|10367443|P2|Overall Study|Withdrawal by Subject|5
3014061|NCT00847626|10367444|P1|Overall Study|Withdrawal by Subject|5
3014062|NCT00847626|10367434|P11|Overall Study|Lost to Follow-up|1
3014063|NCT00847626|10367435|P10|Overall Study|Lost to Follow-up|0
3014064|NCT00847626|10367436|P9|Overall Study|Lost to Follow-up|1
3014065|NCT00847626|10367437|P8|Overall Study|Lost to Follow-up|3
3014066|NCT00847626|10367438|P7|Overall Study|Lost to Follow-up|1
3014067|NCT00847626|10367439|P6|Overall Study|Lost to Follow-up|3
3014068|NCT00847626|10367440|P5|Overall Study|Lost to Follow-up|0
3014069|NCT00847626|10367441|P4|Overall Study|Lost to Follow-up|1
3014070|NCT00847626|10367442|P3|Overall Study|Lost to Follow-up|1
3014071|NCT00847626|10367443|P2|Overall Study|Lost to Follow-up|1
3014072|NCT00847626|10367444|P1|Overall Study|Lost to Follow-up|0
3014073|NCT00847626|10367434|P11|Overall Study|Protocol Violation|1
3014074|NCT00847626|10367435|P10|Overall Study|Protocol Violation|1
3014075|NCT00847626|10367436|P9|Overall Study|Protocol Violation|0
3014076|NCT00847626|10367437|P8|Overall Study|Protocol Violation|1
3014077|NCT00847626|10367438|P7|Overall Study|Protocol Violation|1
3014078|NCT00847626|10367439|P6|Overall Study|Protocol Violation|1
3014079|NCT00847626|10367440|P5|Overall Study|Protocol Violation|1
3014080|NCT00847626|10367441|P4|Overall Study|Protocol Violation|1
3014081|NCT00847626|10367442|P3|Overall Study|Protocol Violation|2
3014082|NCT00847626|10367443|P2|Overall Study|Protocol Violation|1
3014083|NCT00847626|10367444|P1|Overall Study|Protocol Violation|2
3014084|NCT00847626|10367434|P11|Overall Study|Adverse Event|6
3014085|NCT00847626|10367435|P10|Overall Study|Adverse Event|6
3014086|NCT00847626|10367436|P9|Overall Study|Adverse Event|3
3014087|NCT00847626|10367437|P8|Overall Study|Adverse Event|6
3014088|NCT00847626|10367438|P7|Overall Study|Adverse Event|4
3014089|NCT00847626|10367439|P6|Overall Study|Adverse Event|22
3014090|NCT00847626|10367440|P5|Overall Study|Adverse Event|11
3014091|NCT00847626|10367441|P4|Overall Study|Adverse Event|19
3014092|NCT00847626|10367442|P3|Overall Study|Adverse Event|6
3014093|NCT00847626|10367443|P2|Overall Study|Adverse Event|10
3014094|NCT00847626|10367444|P1|Overall Study|Adverse Event|10
3014095|NCT00847613|10367643|P4|Overall Study|Other|0
3014096|NCT00847613|10367644|P3|Overall Study|Other|2
3014097|NCT00847613|10367645|P2|Overall Study|Other|1
3014098|NCT00847613|10367646|P1|Overall Study|Other|1
3014099|NCT00847613|10367643|P4|Overall Study|Randomized, but not treated|0
3014100|NCT00847613|10367644|P3|Overall Study|Randomized, but not treated|0
3014101|NCT00847613|10367645|P2|Overall Study|Randomized, but not treated|3
3014102|NCT00847613|10367646|P1|Overall Study|Randomized, but not treated|0
3014103|NCT00847613|10367643|P4|Overall Study|Sponsor request|0
3014104|NCT00847613|10367644|P3|Overall Study|Sponsor request|0
3014105|NCT00847613|10367645|P2|Overall Study|Sponsor request|1
3014106|NCT00847613|10367646|P1|Overall Study|Sponsor request|0
3014107|NCT00847613|10367643|P4|Overall Study|Participant moved|0
3014108|NCT00847613|10367644|P3|Overall Study|Participant moved|0
3014109|NCT00847613|10367645|P2|Overall Study|Participant moved|1
3014110|NCT00847613|10367646|P1|Overall Study|Participant moved|4
3014111|NCT00847613|10367643|P4|Overall Study|Withdrawal by Subject|2
3014112|NCT00847613|10367644|P3|Overall Study|Withdrawal by Subject|2
3014113|NCT00847613|10367645|P2|Overall Study|Withdrawal by Subject|11
3014114|NCT00847613|10367646|P1|Overall Study|Withdrawal by Subject|8
3014115|NCT00847613|10367643|P4|Overall Study|Site closure|1
3014116|NCT00847613|10367644|P3|Overall Study|Site closure|0
3014117|NCT00847613|10367645|P2|Overall Study|Site closure|0
3014118|NCT00847613|10367646|P1|Overall Study|Site closure|1
3014119|NCT00847613|10367643|P4|Overall Study|Pregnancy|0
3014120|NCT00847613|10367644|P3|Overall Study|Pregnancy|0
3014121|NCT00847613|10367645|P2|Overall Study|Pregnancy|1
3014122|NCT00847613|10367646|P1|Overall Study|Pregnancy|1
3014123|NCT00847613|10367643|P4|Overall Study|Protocol Violation|1
3014124|NCT00847613|10367644|P3|Overall Study|Protocol Violation|3
3014125|NCT00847613|10367645|P2|Overall Study|Protocol Violation|6
3014126|NCT00847613|10367646|P1|Overall Study|Protocol Violation|6
3014127|NCT00847613|10367643|P4|Overall Study|Lost to Follow-up|3
3014128|NCT00847613|10367644|P3|Overall Study|Lost to Follow-up|0
3014129|NCT00847613|10367645|P2|Overall Study|Lost to Follow-up|0
3014130|NCT00847613|10367646|P1|Overall Study|Lost to Follow-up|5
3014131|NCT00847613|10367643|P4|Overall Study|Study terminated by Sponsor|1
3014132|NCT00847613|10367644|P3|Overall Study|Study terminated by Sponsor|2
3014133|NCT00847613|10367645|P2|Overall Study|Study terminated by Sponsor|0
3014134|NCT00847613|10367646|P1|Overall Study|Study terminated by Sponsor|1
3014135|NCT00847613|10367643|P4|Overall Study|Lack of Efficacy|1
3014136|NCT00847613|10367644|P3|Overall Study|Lack of Efficacy|3
3014137|NCT00847613|10367645|P2|Overall Study|Lack of Efficacy|3
3014138|NCT00847613|10367646|P1|Overall Study|Lack of Efficacy|7
3014139|NCT00847613|10367643|P4|Overall Study|Adverse Event|6
3014140|NCT00847613|10367644|P3|Overall Study|Adverse Event|5
3014141|NCT00847613|10367645|P2|Overall Study|Adverse Event|26
3014142|NCT00847613|10367646|P1|Overall Study|Adverse Event|36
3014143|NCT00847613|10367643|P4|Overall Study|Death|0
3014144|NCT00847613|10367644|P3|Overall Study|Death|0
3014145|NCT00847613|10367645|P2|Overall Study|Death|1
3014146|NCT00847613|10367646|P1|Overall Study|Death|1
3014147|NCT00847613|10367643|P4|Overall Study|Ongoing at cut-off date|64
3014148|NCT00847613|10367644|P3|Overall Study|Ongoing at cut-off date|64
3014149|NCT00847613|10367645|P2|Overall Study|Ongoing at cut-off date|265
3014150|NCT00847613|10367646|P1|Overall Study|Ongoing at cut-off date|250
3014151|NCT00847561|10367897|P2|Overall Study|Unable to schedule|1
3014152|NCT00847561|10367898|P1|Overall Study|Unable to schedule|9
3014153|NCT00847561|10367897|P2|Overall Study|Withdrawal by Subject|3
3014154|NCT00847561|10367898|P1|Overall Study|Withdrawal by Subject|4
3014155|NCT00847535|10367904|P3|Overall Study|Lost to Follow-up|0
3014156|NCT00847535|10367905|P2|Overall Study|Lost to Follow-up|1
3014157|NCT00847535|10367906|P1|Overall Study|Lost to Follow-up|0
3014158|NCT00847535|10367904|P3|Overall Study|Withdrawal by Subject|1
3014159|NCT00847535|10367905|P2|Overall Study|Withdrawal by Subject|1
3014160|NCT00847535|10367906|P1|Overall Study|Withdrawal by Subject|2
3014161|NCT00847405|10367925|P2|Washout of 7 Days|Withdrawal by Subject|0
3014162|NCT00847405|10367926|P1|Washout of 7 Days|Withdrawal by Subject|1
3014163|NCT00847405|10367925|P2|First Intervention|Adverse Event|1
3014164|NCT00847405|10367926|P1|First Intervention|Adverse Event|0
3014165|NCT00847301|10367934|P1|Overall Study|Other reason not defined above|1
3014166|NCT00847301|10367934|P1|Overall Study|No prescription after hospital discharge|1
3014167|NCT00847301|10367934|P1|Overall Study|Lost to Follow-up|1
3014168|NCT00847301|10367934|P1|Overall Study|Switch to other anticoagulants|16
3014169|NCT00847301|10367934|P1|Overall Study|Adverse Event|35
3014170|NCT00847197|10367982|P2|Overall Study|Withdrawal by Subject|1
3014171|NCT00847197|10367983|P1|Overall Study|Withdrawal by Subject|3
3014172|NCT00847197|10367982|P2|Overall Study|Protocol Violation|1
3014173|NCT00847197|10367983|P1|Overall Study|Protocol Violation|0
3014174|NCT00847197|10367982|P2|Overall Study|Adverse Event|3
3014175|NCT00847197|10367983|P1|Overall Study|Adverse Event|21
3014176|NCT00847145|10368007|P8|Overall Study|Protocol Violation|1
3014177|NCT00847145|10368008|P7|Overall Study|Protocol Violation|0
3014178|NCT00847145|10368009|P6|Overall Study|Protocol Violation|0
3014179|NCT00847145|10368010|P5|Overall Study|Protocol Violation|1
3014180|NCT00847145|10368011|P4|Overall Study|Protocol Violation|0
3014181|NCT00847145|10368012|P3|Overall Study|Protocol Violation|3
3014182|NCT00847145|10368013|P2|Overall Study|Protocol Violation|0
3014183|NCT00847145|10368014|P1|Overall Study|Protocol Violation|0
3014184|NCT00847145|10368007|P8|Overall Study|Inappropriate enrollment|0
3014185|NCT00847145|10368008|P7|Overall Study|Inappropriate enrollment|0
3014186|NCT00847145|10368009|P6|Overall Study|Inappropriate enrollment|0
3014187|NCT00847145|10368010|P5|Overall Study|Inappropriate enrollment|1
3014188|NCT00847145|10368011|P4|Overall Study|Inappropriate enrollment|0
3014189|NCT00847145|10368012|P3|Overall Study|Inappropriate enrollment|0
3014190|NCT00847145|10368013|P2|Overall Study|Inappropriate enrollment|0
3014191|NCT00847145|10368014|P1|Overall Study|Inappropriate enrollment|0
3014192|NCT00847145|10368007|P8|Overall Study|Lost to Follow-up|2
3014193|NCT00847145|10368008|P7|Overall Study|Lost to Follow-up|8
3014194|NCT00847145|10368009|P6|Overall Study|Lost to Follow-up|4
3014195|NCT00847145|10368010|P5|Overall Study|Lost to Follow-up|4
3014196|NCT00847145|10368011|P4|Overall Study|Lost to Follow-up|0
3014197|NCT00847145|10368012|P3|Overall Study|Lost to Follow-up|1
3014198|NCT00847145|10368013|P2|Overall Study|Lost to Follow-up|1
3014199|NCT00847145|10368014|P1|Overall Study|Lost to Follow-up|3
3014200|NCT00847145|10368007|P8|Overall Study|Withdrawal by Subject|1
3014201|NCT00847145|10368008|P7|Overall Study|Withdrawal by Subject|1
3014202|NCT00847145|10368009|P6|Overall Study|Withdrawal by Subject|0
3014203|NCT00847145|10368010|P5|Overall Study|Withdrawal by Subject|0
3014204|NCT00847145|10368011|P4|Overall Study|Withdrawal by Subject|1
3014205|NCT00847145|10368012|P3|Overall Study|Withdrawal by Subject|6
3014206|NCT00847145|10368013|P2|Overall Study|Withdrawal by Subject|4
3014207|NCT00847145|10368014|P1|Overall Study|Withdrawal by Subject|3
3014208|NCT00847145|10368007|P8|Overall Study|AE or Death|0
3014209|NCT00847145|10368008|P7|Overall Study|AE or Death|0
3014210|NCT00847145|10368009|P6|Overall Study|AE or Death|0
3014211|NCT00847145|10368010|P5|Overall Study|AE or Death|0
3014212|NCT00847145|10368011|P4|Overall Study|AE or Death|0
3014213|NCT00847145|10368012|P3|Overall Study|AE or Death|1
3014214|NCT00847145|10368013|P2|Overall Study|AE or Death|1
3014215|NCT00847145|10368014|P1|Overall Study|AE or Death|0
3014216|NCT00847132|10368064|P2|Overall Study|Death|1
3014217|NCT00847132|10368065|P1|Overall Study|Death|1
3014218|NCT00847015|10368073|P1|Overall Study|partial cystectomy vs radical cystectomy|1
3014219|NCT00847015|10368073|P1|Overall Study|declined any surgery|1
3014220|NCT00847015|10368073|P1|Overall Study|Withdrawal by Subject|1
3014221|NCT00846846|10368101|P1|Overall Study|Withdrawal by Subject|19
3014222|NCT00846846|10368101|P1|Overall Study|Death|56
3014223|NCT00846807|10368106|P1|Overall Study|Other|60
3014224|NCT00846807|10368106|P1|Overall Study|No prescription after hospital discharge|56
3014225|NCT00846807|10368106|P1|Overall Study|Switch to other anticoagulants|89
3014226|NCT00846807|10368106|P1|Overall Study|Non compliant with European label|7
3014227|NCT00846807|10368106|P1|Overall Study|Withdrawal by Subject|56
3014228|NCT00846807|10368106|P1|Overall Study|Lost to Follow-up|94
3014229|NCT00846807|10368106|P1|Overall Study|Adverse Event|270
3014230|NCT00846768|10368114|P4|Overall Study|Adverse Event|0
3014231|NCT00846768|10368115|P3|Overall Study|Adverse Event|0
3014232|NCT00846768|10368116|P2|Overall Study|Adverse Event|1
3014233|NCT00846768|10368117|P1|Overall Study|Adverse Event|0
3014234|NCT00846742|10368187|P1|Overall Study|Withdrawal by Subject|1
3014235|NCT00846586|10368214|P2|Overall Study|Unsatisfactory therapeutic effect|1
3014236|NCT00846586|10368215|P1|Overall Study|Unsatisfactory therapeutic effect|0
3014237|NCT00846586|10368214|P2|Overall Study|Lost to Follow-up|4
3014238|NCT00846586|10368215|P1|Overall Study|Lost to Follow-up|1
3014239|NCT00846586|10368214|P2|Overall Study|Abnormal test procedure result(s)|0
3014240|NCT00846586|10368215|P1|Overall Study|Abnormal test procedure result(s)|1
3014241|NCT00846586|10368214|P2|Overall Study|Protocol deviation|6
3014242|NCT00846586|10368215|P1|Overall Study|Protocol deviation|2
3014243|NCT00846586|10368214|P2|Overall Study|Death|0
3014244|NCT00846586|10368215|P1|Overall Study|Death|2
3014245|NCT00846586|10368214|P2|Overall Study|Administrative problems|4
3014246|NCT00846586|10368215|P1|Overall Study|Administrative problems|5
3014247|NCT00846586|10368214|P2|Overall Study|Subject withdrew consent|10
3014248|NCT00846586|10368215|P1|Overall Study|Subject withdrew consent|8
3014249|NCT00846586|10368214|P2|Overall Study|Adverse Event|10
3014250|NCT00846586|10368215|P1|Overall Study|Adverse Event|20
3014251|NCT00846521|10368249|P1|Overall Study|Protocol Violation|1
3014252|NCT00846521|10368249|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
3014253|NCT00846521|10368249|P1|Overall Study|Withdrawal by Subject|5
3014254|NCT00846495|10368256|P2|Overall Study|Physician Decision|0
3014255|NCT00846495|10368257|P1|Overall Study|Physician Decision|1
3014256|NCT00846495|10368256|P2|Overall Study|Lack of Efficacy|2
3014257|NCT00846495|10368257|P1|Overall Study|Lack of Efficacy|1
3014258|NCT00846495|10368256|P2|Overall Study|Adverse Event|1
3014259|NCT00846495|10368257|P1|Overall Study|Adverse Event|5
3014260|NCT00846495|10368256|P2|Overall Study|Lost to Follow-up|0
3014261|NCT00846495|10368257|P1|Overall Study|Lost to Follow-up|1
3014262|NCT00846391|10368280|P3|Overall Study|Study Terminated by Sponsor|2
3014263|NCT00846391|10368281|P2|Overall Study|Study Terminated by Sponsor|2
3014264|NCT00846391|10368282|P1|Overall Study|Study Terminated by Sponsor|1
3014265|NCT00846391|10368280|P3|Overall Study|Physician Decision|1
3014266|NCT00846391|10368281|P2|Overall Study|Physician Decision|0
3014267|NCT00846391|10368282|P1|Overall Study|Physician Decision|0
3014268|NCT00846365|10368293|P3|Overall Study|Other|6
3014269|NCT00846365|10368294|P2|Overall Study|Other|1
3014270|NCT00846365|10368295|P1|Overall Study|Other|9
3014271|NCT00846365|10368293|P3|Overall Study|Lack of Efficacy|2
3014272|NCT00846365|10368294|P2|Overall Study|Lack of Efficacy|1
3014273|NCT00846365|10368295|P1|Overall Study|Lack of Efficacy|1
3014274|NCT00846365|10368293|P3|Overall Study|Pregnancy|0
3014275|NCT00846365|10368294|P2|Overall Study|Pregnancy|0
3014276|NCT00846365|10368295|P1|Overall Study|Pregnancy|1
3014277|NCT00846365|10368293|P3|Overall Study|Withdrawal by Subject|9
3014278|NCT00846365|10368294|P2|Overall Study|Withdrawal by Subject|11
3014279|NCT00846365|10368295|P1|Overall Study|Withdrawal by Subject|11
3014280|NCT00846365|10368293|P3|Overall Study|Lost to Follow-up|5
3014281|NCT00846365|10368294|P2|Overall Study|Lost to Follow-up|2
3014282|NCT00846365|10368295|P1|Overall Study|Lost to Follow-up|8
3014283|NCT00846365|10368293|P3|Overall Study|Protocol Violation|0
3014284|NCT00846365|10368294|P2|Overall Study|Protocol Violation|4
3014285|NCT00846365|10368295|P1|Overall Study|Protocol Violation|5
3014286|NCT00846365|10368293|P3|Overall Study|Adverse Event|11
3014287|NCT00846365|10368294|P2|Overall Study|Adverse Event|30
3014288|NCT00846365|10368295|P1|Overall Study|Adverse Event|20
3014289|NCT00846053|10368376|P2|Overall Study|Physician Decision|0
3014290|NCT00846053|10368377|P1|Overall Study|Physician Decision|3
3014291|NCT00846027|10368385|P1|Overall Study|Subject Not Treated|7
3014292|NCT00846027|10368385|P1|Overall Study|Protocol Violation|2
3014293|NCT00846027|10368385|P1|Overall Study|Investigator Discretion|29
3014294|NCT00846027|10368385|P1|Overall Study|Patient Decision|7
3014295|NCT00846027|10368385|P1|Overall Study|Toxicity|12
3014296|NCT00846027|10368385|P1|Overall Study|Disease Progression|30
3014297|NCT00846027|10368385|P1|Overall Study|Death|3
3014298|NCT00845897|10368408|P3|Overall Study|Too ill to participate|0
3014299|NCT00845897|10368409|P2|Overall Study|Too ill to participate|1
3014300|NCT00845897|10368410|P1|Overall Study|Too ill to participate|0
3014301|NCT00845897|10368408|P3|Overall Study|Ulcer did not heal|1
3014302|NCT00845897|10368409|P2|Overall Study|Ulcer did not heal|0
3014303|NCT00845897|10368410|P1|Overall Study|Ulcer did not heal|1
3014304|NCT00845897|10368408|P3|Overall Study|Withdrawal by Subject|2
3014305|NCT00845897|10368409|P2|Overall Study|Withdrawal by Subject|3
3014306|NCT00845897|10368410|P1|Overall Study|Withdrawal by Subject|0
3014307|NCT00845897|10368408|P3|Overall Study|Lost to Follow-up|0
3014308|NCT00845897|10368409|P2|Overall Study|Lost to Follow-up|1
3014309|NCT00845897|10368410|P1|Overall Study|Lost to Follow-up|1
3014310|NCT00845858|10368424|P3|Overall Study|not eligible|2
3014311|NCT00845858|10368425|P2|Overall Study|not eligible|3
3014312|NCT00845858|10368426|P1|Overall Study|not eligible|0
3014313|NCT00845858|10368424|P3|Overall Study|Protocol Violation|1
3014314|NCT00845858|10368425|P2|Overall Study|Protocol Violation|0
3014315|NCT00845858|10368426|P1|Overall Study|Protocol Violation|0
3014316|NCT00845858|10368424|P3|Overall Study|Adverse Event|4
3014317|NCT00845858|10368425|P2|Overall Study|Adverse Event|8
3014318|NCT00845858|10368426|P1|Overall Study|Adverse Event|3
3014319|NCT00845858|10368424|P3|Overall Study|Withdrawal by Subject|1
3014320|NCT00845858|10368425|P2|Overall Study|Withdrawal by Subject|1
3014321|NCT00845858|10368426|P1|Overall Study|Withdrawal by Subject|5
3014322|NCT00845845|10368439|P2|Overall Study|Lost to Follow-up|4
3014323|NCT00845845|10368440|P1|Overall Study|Lost to Follow-up|0
3014324|NCT00845832|10368451|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
3014325|NCT00845832|10368452|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
3014326|NCT00845832|10368453|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
3014327|NCT00845832|10368451|P3|Safety Follow-Up|Withdrawal by Subject|0
3014328|NCT00845832|10368452|P2|Safety Follow-Up|Withdrawal by Subject|0
3014329|NCT00845832|10368453|P1|Safety Follow-Up|Withdrawal by Subject|1
3014330|NCT00845832|10368451|P3|Treatment Period|Protocol Violation|0
3014331|NCT00845832|10368452|P2|Treatment Period|Protocol Violation|1
3014332|NCT00845832|10368453|P1|Treatment Period|Protocol Violation|1
3014333|NCT00845832|10368451|P3|Treatment Period|Adverse Event|0
3014334|NCT00845832|10368452|P2|Treatment Period|Adverse Event|2
3014335|NCT00845832|10368453|P1|Treatment Period|Adverse Event|0
3014336|NCT00845728|10368499|P2|Overall Study|Withdrawal by Subject|108
3014337|NCT00845728|10368500|P1|Overall Study|Withdrawal by Subject|105
3014338|NCT00845728|10368499|P2|Overall Study|Adverse Event|96
3014339|NCT00845728|10368500|P1|Overall Study|Adverse Event|101
3014340|NCT00845728|10368499|P2|Overall Study|Lack of Efficacy|39
3014341|NCT00845728|10368500|P1|Overall Study|Lack of Efficacy|51
3014342|NCT00845728|10368499|P2|Overall Study|Protocol Violation|24
3014343|NCT00845728|10368500|P1|Overall Study|Protocol Violation|36
3014344|NCT00845728|10368499|P2|Overall Study|Administrative Problems|26
3014345|NCT00845728|10368500|P1|Overall Study|Administrative Problems|34
3014346|NCT00845728|10368499|P2|Overall Study|Death|26
3014347|NCT00845728|10368500|P1|Overall Study|Death|24
3014348|NCT00845728|10368499|P2|Overall Study|Lost to Follow-up|13
3014349|NCT00845728|10368500|P1|Overall Study|Lost to Follow-up|22
3014350|NCT00845728|10368499|P2|Overall Study|Abnormal test procedure result (s)|2
3014351|NCT00845728|10368500|P1|Overall Study|Abnormal test procedure result (s)|7
3014352|NCT00845728|10368499|P2|Overall Study|Patient's inability to use the device|6
3014353|NCT00845728|10368500|P1|Overall Study|Patient's inability to use the device|4
3014354|NCT00845728|10368499|P2|Overall Study|Abnormal laboratory value (s)|2
3014355|NCT00845728|10368500|P1|Overall Study|Abnormal laboratory value (s)|2
3014356|NCT00845676|10368514|P1|Overall Study|Adverse Event|1
3014357|NCT00845676|10368514|P1|Overall Study|Virologic breakthrough at week 20|1
3014358|NCT00845650|10368577|P6|Overall Study|Unable to access IV line|0
3014359|NCT00845650|10368578|P5|Overall Study|Unable to access IV line|0
3014360|NCT00845650|10368579|P4|Overall Study|Unable to access IV line|0
3014361|NCT00845650|10368580|P3|Overall Study|Unable to access IV line|0
3014362|NCT00845650|10368581|P2|Overall Study|Unable to access IV line|0
3014363|NCT00845650|10368582|P1|Overall Study|Unable to access IV line|1
3014364|NCT00845650|10368577|P6|Overall Study|Sponsor hold on dosing|1
3014365|NCT00845650|10368578|P5|Overall Study|Sponsor hold on dosing|1
3014366|NCT00845650|10368579|P4|Overall Study|Sponsor hold on dosing|0
3014367|NCT00845650|10368580|P3|Overall Study|Sponsor hold on dosing|0
3014368|NCT00845650|10368581|P2|Overall Study|Sponsor hold on dosing|0
3014369|NCT00845650|10368582|P1|Overall Study|Sponsor hold on dosing|0
3014370|NCT00845650|10368577|P6|Overall Study|Lost to Follow-up|1
3014371|NCT00845650|10368578|P5|Overall Study|Lost to Follow-up|0
3014372|NCT00845650|10368579|P4|Overall Study|Lost to Follow-up|1
3014373|NCT00845650|10368580|P3|Overall Study|Lost to Follow-up|3
3014374|NCT00845650|10368581|P2|Overall Study|Lost to Follow-up|0
3014375|NCT00845650|10368582|P1|Overall Study|Lost to Follow-up|0
3014376|NCT00845650|10368577|P6|Overall Study|Withdrawal by Subject|0
3014377|NCT00845650|10368578|P5|Overall Study|Withdrawal by Subject|2
3014378|NCT00845650|10368579|P4|Overall Study|Withdrawal by Subject|0
3014379|NCT00845650|10368580|P3|Overall Study|Withdrawal by Subject|0
3014380|NCT00845650|10368581|P2|Overall Study|Withdrawal by Subject|0
3014381|NCT00845650|10368582|P1|Overall Study|Withdrawal by Subject|0
3014382|NCT00845520|10368620|P3|Overall Study|Adverse Event|1
3014383|NCT00845520|10368621|P2|Overall Study|Adverse Event|0
3014384|NCT00845520|10368622|P1|Overall Study|Adverse Event|0
3014385|NCT00845520|10368620|P3|Overall Study|Lost to Follow-up|0
3014386|NCT00845520|10368621|P2|Overall Study|Lost to Follow-up|0
3014387|NCT00845520|10368622|P1|Overall Study|Lost to Follow-up|1
3014388|NCT00845520|10368620|P3|Overall Study|Death|0
3014389|NCT00845520|10368621|P2|Overall Study|Death|2
3014390|NCT00845520|10368622|P1|Overall Study|Death|1
3014391|NCT00845429|10368659|P3|Overall Study|Serious adverse event|1
3014392|NCT00845429|10368660|P2|Overall Study|Serious adverse event|0
3014393|NCT00845429|10368661|P1|Overall Study|Serious adverse event|0
3014394|NCT00845429|10368659|P3|Overall Study|Withdrawal by Subject|2
3014395|NCT00845429|10368660|P2|Overall Study|Withdrawal by Subject|2
3014396|NCT00845429|10368661|P1|Overall Study|Withdrawal by Subject|2
3014397|NCT00845429|10368659|P3|Overall Study|Lost to Follow-up|10
3014398|NCT00845429|10368660|P2|Overall Study|Lost to Follow-up|9
3014399|NCT00845429|10368661|P1|Overall Study|Lost to Follow-up|7
3014400|NCT00845429|10368659|P3|Overall Study|Protocol Violation|7
3014401|NCT00845429|10368660|P2|Overall Study|Protocol Violation|4
3014402|NCT00845429|10368661|P1|Overall Study|Protocol Violation|5
3014403|NCT00845182|10368696|P3|Overall Study|Physician Decision|1
3014404|NCT00845182|10368697|P2|Overall Study|Physician Decision|0
3014405|NCT00845182|10368698|P1|Overall Study|Physician Decision|0
3014406|NCT00845182|10368696|P3|Overall Study|Adverse Event|1
3014407|NCT00845182|10368697|P2|Overall Study|Adverse Event|1
3014408|NCT00845182|10368698|P1|Overall Study|Adverse Event|0
3014409|NCT00845182|10368696|P3|Overall Study|Lost to Follow-up|4
3014410|NCT00845182|10368697|P2|Overall Study|Lost to Follow-up|3
3014411|NCT00845182|10368698|P1|Overall Study|Lost to Follow-up|3
3014412|NCT00845065|10368723|P2|Overall Study|Non-Medical Reasons|11
3014413|NCT00845065|10368724|P1|Overall Study|Non-Medical Reasons|1
3014414|NCT00845065|10368723|P2|Overall Study|Lack of Efficacy|21
3014415|NCT00845065|10368724|P1|Overall Study|Lack of Efficacy|43
3014416|NCT00845065|10368723|P2|Overall Study|Adverse Event|23
3014417|NCT00845065|10368724|P1|Overall Study|Adverse Event|3
3014418|NCT00844896|10368792|P2|Overall Study|Parents did not have time to complete|1
3014419|NCT00844896|10368793|P1|Overall Study|Parents did not have time to complete|0
3014420|NCT00844896|10368792|P2|Overall Study|Lost to Follow-up|16
3014421|NCT00844896|10368793|P1|Overall Study|Lost to Follow-up|12
3014422|NCT00844883|10368815|P1|Overall Study|Bridged to resection|1
3014423|NCT00844883|10368815|P1|Overall Study|Bridged to liver transplant|3
3014424|NCT00844857|10368827|P2|Overall Study|Good Clinical Practice Violations|11
3014425|NCT00844857|10368828|P1|Overall Study|Good Clinical Practice Violations|21
3014426|NCT00844857|10368827|P2|Overall Study|Did Not Take Study Drug|1
3014427|NCT00844857|10368828|P1|Overall Study|Did Not Take Study Drug|3
3014428|NCT00844857|10368827|P2|Overall Study|Lost to Follow-up|3
3014429|NCT00844857|10368828|P1|Overall Study|Lost to Follow-up|2
3014430|NCT00844857|10368827|P2|Overall Study|Entry Criteria Not Met|1
3014431|NCT00844857|10368828|P1|Overall Study|Entry Criteria Not Met|0
3014432|NCT00844857|10368827|P2|Overall Study|Clinical Relapse|1
3014433|NCT00844857|10368828|P1|Overall Study|Clinical Relapse|0
3014434|NCT00844857|10368827|P2|Overall Study|Lack of Efficacy|5
3014435|NCT00844857|10368828|P1|Overall Study|Lack of Efficacy|5
3014436|NCT00844857|10368827|P2|Overall Study|Protocol Violation|0
3014437|NCT00844857|10368828|P1|Overall Study|Protocol Violation|6
3014438|NCT00844857|10368827|P2|Overall Study|Withdrawal by Subject|7
3014439|NCT00844857|10368828|P1|Overall Study|Withdrawal by Subject|8
3014440|NCT00844857|10368827|P2|Overall Study|Parent/Caregiver Decision|2
3014441|NCT00844857|10368828|P1|Overall Study|Parent/Caregiver Decision|6
3014442|NCT00844857|10368827|P2|Overall Study|Physician Decision|0
3014443|NCT00844857|10368828|P1|Overall Study|Physician Decision|2
3014444|NCT00844857|10368827|P2|Overall Study|Sponsor Decision|1
3014445|NCT00844857|10368828|P1|Overall Study|Sponsor Decision|1
3014446|NCT00844857|10368827|P2|Overall Study|Adverse Event|5
3014447|NCT00844857|10368828|P1|Overall Study|Adverse Event|24
3014448|NCT00844844|10368872|P1|Post Treatment Period|Withdrawal by Subject|1
3014449|NCT00844844|10368872|P1|Extension Treatment Period|Adverse Event|2
3014450|NCT00844844|10368872|P1|Treatment Period (26 Weeks)|Protocol Violation|1
3014451|NCT00844844|10368872|P1|Treatment Period (26 Weeks)|Adverse Event|1
3014452|NCT00844831|10368886|P1|Overall Study|Physician Decision|1
3014453|NCT00844831|10368886|P1|Overall Study|Adverse Event|1
3014454|NCT00844831|10368886|P1|Overall Study|Withdrawal by Subject|4
3014455|NCT00844805|10368896|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
3014456|NCT00844805|10368897|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
3014457|NCT00844805|10368898|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
3014458|NCT00844805|10368899|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
3014459|NCT00844805|10368896|P4|Follow-Up Phase|Relapse/Recurrence|4
3014460|NCT00844805|10368897|P3|Follow-Up Phase|Relapse/Recurrence|2
3014461|NCT00844805|10368898|P2|Follow-Up Phase|Relapse/Recurrence|0
3014462|NCT00844805|10368899|P1|Follow-Up Phase|Relapse/Recurrence|0
3014463|NCT00844805|10368896|P4|Follow-Up Phase|Noncompliance With Protocol|1
3014464|NCT00844805|10368897|P3|Follow-Up Phase|Noncompliance With Protocol|0
3014465|NCT00844805|10368898|P2|Follow-Up Phase|Noncompliance With Protocol|0
3014466|NCT00844805|10368899|P1|Follow-Up Phase|Noncompliance With Protocol|0
3014467|NCT00844805|10368896|P4|Follow-Up Phase|Withdrawal by Subject|3
3014468|NCT00844805|10368897|P3|Follow-Up Phase|Withdrawal by Subject|6
3014469|NCT00844805|10368898|P2|Follow-Up Phase|Withdrawal by Subject|0
3014470|NCT00844805|10368899|P1|Follow-Up Phase|Withdrawal by Subject|0
3014471|NCT00844805|10368896|P4|Follow-Up Phase|Adverse Event|0
3014472|NCT00844805|10368897|P3|Follow-Up Phase|Adverse Event|1
3014473|NCT00844805|10368898|P2|Follow-Up Phase|Adverse Event|0
3014474|NCT00844805|10368899|P1|Follow-Up Phase|Adverse Event|0
3014475|NCT00844805|10368896|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
3014476|NCT00844805|10368897|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
3014477|NCT00844805|10368898|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
3014478|NCT00844805|10368899|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
3014479|NCT00844805|10368896|P4|Treatment Phase|Noncompliance With Protocol|0
3014480|NCT00844805|10368897|P3|Treatment Phase|Noncompliance With Protocol|0
3014481|NCT00844805|10368898|P2|Treatment Phase|Noncompliance With Protocol|0
3014482|NCT00844805|10368899|P1|Treatment Phase|Noncompliance With Protocol|1
3014483|NCT00844805|10368896|P4|Treatment Phase|Withdrawal by Subject|0
3014484|NCT00844805|10368897|P3|Treatment Phase|Withdrawal by Subject|0
3014485|NCT00844805|10368898|P2|Treatment Phase|Withdrawal by Subject|4
3014486|NCT00844805|10368899|P1|Treatment Phase|Withdrawal by Subject|3
3014487|NCT00844805|10368896|P4|Treatment Phase|Adverse Event|0
3014488|NCT00844805|10368897|P3|Treatment Phase|Adverse Event|0
3014489|NCT00844805|10368898|P2|Treatment Phase|Adverse Event|1
3014490|NCT00844805|10368899|P1|Treatment Phase|Adverse Event|5
3014491|NCT00844753|10368943|P4|Overall Study|Withdrawal by Subject|3
3014492|NCT00844753|10368944|P3|Overall Study|Withdrawal by Subject|0
3014493|NCT00844753|10368945|P2|Overall Study|Withdrawal by Subject|0
3014494|NCT00844753|10368946|P1|Overall Study|Withdrawal by Subject|1
3014495|NCT00844753|10368943|P4|Overall Study|could not swallow medication|0
3014496|NCT00844753|10368944|P3|Overall Study|could not swallow medication|0
3014497|NCT00844753|10368945|P2|Overall Study|could not swallow medication|0
3014498|NCT00844753|10368946|P1|Overall Study|could not swallow medication|2
3014499|NCT00844753|10368943|P4|Overall Study|Lost to Follow-up|1
3014500|NCT00844753|10368944|P3|Overall Study|Lost to Follow-up|0
3014501|NCT00844753|10368945|P2|Overall Study|Lost to Follow-up|1
3014502|NCT00844753|10368946|P1|Overall Study|Lost to Follow-up|1
3014503|NCT00844753|10368943|P4|Overall Study|Adverse Event|5
3014504|NCT00844753|10368944|P3|Overall Study|Adverse Event|5
3014505|NCT00844753|10368945|P2|Overall Study|Adverse Event|2
3014506|NCT00844753|10368946|P1|Overall Study|Adverse Event|3
3014507|NCT00844753|10368943|P4|Overall Study|Lack of Efficacy|2
3014508|NCT00844753|10368944|P3|Overall Study|Lack of Efficacy|2
3014509|NCT00844753|10368945|P2|Overall Study|Lack of Efficacy|0
3014510|NCT00844753|10368946|P1|Overall Study|Lack of Efficacy|1
3014511|NCT00844649|10368964|P2|Overall Study|Withdrew prior to starting treatment|27
3014512|NCT00844649|10368965|P1|Overall Study|Withdrew prior to starting treatment|11
3014513|NCT00844649|10368964|P2|Overall Study|Other|10
3014514|NCT00844649|10368965|P1|Overall Study|Other|7
3014515|NCT00844649|10368964|P2|Overall Study|Withdrawal by Subject|39
3014516|NCT00844649|10368965|P1|Overall Study|Withdrawal by Subject|28
3014517|NCT00844649|10368964|P2|Overall Study|Protocol Violation|6
3014518|NCT00844649|10368965|P1|Overall Study|Protocol Violation|10
3014519|NCT00844649|10368964|P2|Overall Study|Physician Decision|18
3014520|NCT00844649|10368965|P1|Overall Study|Physician Decision|25
3014521|NCT00844649|10368964|P2|Overall Study|Adverse Event|73
3014522|NCT00844649|10368965|P1|Overall Study|Adverse Event|128
3014523|NCT00844649|10368964|P2|Overall Study|Progressive Disease|245
3014524|NCT00844649|10368965|P1|Overall Study|Progressive Disease|196
3014525|NCT00844597|10368989|P6|Overall Study|Adverse Event|0
3014526|NCT00844597|10368990|P5|Overall Study|Adverse Event|0
3014527|NCT00844597|10368991|P4|Overall Study|Adverse Event|1
3014528|NCT00844597|10368992|P3|Overall Study|Adverse Event|0
3014529|NCT00844597|10368993|P2|Overall Study|Adverse Event|0
3014530|NCT00844597|10368994|P1|Overall Study|Adverse Event|0
3014531|NCT00844558|10369014|P2|Overall Study|Physician Decision|0
3014532|NCT00844558|10369015|P1|Overall Study|Physician Decision|1
3014533|NCT00844558|10369014|P2|Overall Study|Lost to Follow-up|1
3014534|NCT00844558|10369015|P1|Overall Study|Lost to Follow-up|0
3014535|NCT00844558|10369014|P2|Overall Study|Protocol Violation|1
3014536|NCT00844558|10369015|P1|Overall Study|Protocol Violation|1
3014537|NCT00844558|10369014|P2|Overall Study|Death|0
3014538|NCT00844558|10369015|P1|Overall Study|Death|1
3014539|NCT00844558|10369014|P2|Overall Study|Withdrawal by Subject|2
3014540|NCT00844558|10369015|P1|Overall Study|Withdrawal by Subject|9
3014541|NCT00844545|10369031|P1|Post Treatment Period|Withdrawal by Subject|1
3014542|NCT00844545|10369031|P1|Extension Treatment Period|Adverse Event|2
3014543|NCT00844545|10369031|P1|Treatment Period (26 Weeks)|Protocol Violation|1
3014544|NCT00844545|10369031|P1|Treatment Period (26 Weeks)|Adverse Event|1
3014545|NCT00844532|10369045|P1|Overall Study|Lost to Follow-up|7
3014546|NCT00844532|10369045|P1|Overall Study|Withdrawal by Subject|16
3014547|NCT00844532|10369045|P1|Overall Study|Death|16
3014548|NCT00844519|10369131|P2|Overall Study|Adverse Event|0
3014549|NCT00844519|10369132|P1|Overall Study|Adverse Event|1
3014550|NCT00844519|10369131|P2|Overall Study|Withdrawal by Subject|1
3014551|NCT00844519|10369132|P1|Overall Study|Withdrawal by Subject|1
3014552|NCT00844480|10369140|P2|Overall Study|Withdrawal by Subject|3
3014553|NCT00844480|10369141|P1|Overall Study|Withdrawal by Subject|2
3014554|NCT00844428|10369149|P1|Post Treatment Period (Patients Who Disc|Death|1
3014555|NCT00844428|10369149|P1|Extension Treatment Period|Death|1
3014556|NCT00844428|10369149|P1|Screening Period|Screen Failure|3
3014557|NCT00844415|10369165|P1|Overall Study|Withdrawal by Subject|1
3014558|NCT00844376|10369179|P2|Period 1: First Intervention|Withdrawal by Subject|0
3014559|NCT00844376|10369180|P1|Period 1: First Intervention|Withdrawal by Subject|1
3014560|NCT00844194|10369204|P2|Overall Study|Other reason (not specified)|0
3014561|NCT00844194|10369205|P1|Overall Study|Other reason (not specified)|1
3014562|NCT00844194|10369204|P2|Overall Study|Lack of Efficacy|0
3014563|NCT00844194|10369205|P1|Overall Study|Lack of Efficacy|3
3014564|NCT00844194|10369204|P2|Overall Study|Withdrawal by Subject|1
3014565|NCT00844194|10369205|P1|Overall Study|Withdrawal by Subject|2
3014566|NCT00844194|10369204|P2|Overall Study|Lost to Follow-up|1
3014567|NCT00844194|10369205|P1|Overall Study|Lost to Follow-up|1
3014568|NCT00844194|10369204|P2|Overall Study|Protocol Violation|1
3014569|NCT00844194|10369205|P1|Overall Study|Protocol Violation|1
3014570|NCT00844194|10369204|P2|Overall Study|Adverse Event|5
3014571|NCT00844194|10369205|P1|Overall Study|Adverse Event|17
3014572|NCT00843856|10369460|P2|Overall Study|Lost to Follow-up|2
3014573|NCT00843856|10369461|P1|Overall Study|Lost to Follow-up|1
3014574|NCT00843843|10369471|P2|Overall Study|Protocol Violation|1
3014575|NCT00843843|10369472|P1|Overall Study|Protocol Violation|1
3014576|NCT00843843|10369471|P2|Overall Study|Physician Decision|1
3014577|NCT00843843|10369472|P1|Overall Study|Physician Decision|1
3014578|NCT00843778|10369485|P1|Overall Study|Withdrawal by Subject|4
3014579|NCT00843778|10369485|P1|Overall Study|Loss of efficacy|2
3014580|NCT00843778|10369485|P1|Overall Study|Lack of Efficacy|14
3014581|NCT00843778|10369485|P1|Overall Study|Adverse Event|15
3014582|NCT00843635|10369530|P3|Overall Study|Adverse Event|0
3014583|NCT00843635|10369531|P2|Overall Study|Adverse Event|2
3014584|NCT00843635|10369532|P1|Overall Study|Adverse Event|2
3014585|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
3014586|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
3014587|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
3014588|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
3014589|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
3014590|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
3014591|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
3014592|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
3014593|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
3014594|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
3014595|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Death|1
3014596|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Death|0
3014597|NCT00843518|10369561|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
3014598|NCT00843518|10369562|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
3014599|NCT00843492|10369592|P2|Overall Study|Deep-vein Thrombosis|0
3014600|NCT00843492|10369593|P1|Overall Study|Deep-vein Thrombosis|1
3014601|NCT00843492|10369592|P2|Overall Study|Visit Not Performed|0
3014602|NCT00843492|10369593|P1|Overall Study|Visit Not Performed|1
3014603|NCT00843492|10369592|P2|Overall Study|Orthopedic Surgery|2
3014604|NCT00843492|10369593|P1|Overall Study|Orthopedic Surgery|0
3014605|NCT00843492|10369592|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
3014606|NCT00843492|10369593|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
3014607|NCT00843492|10369592|P2|Overall Study|Immobilization Stopped|0
3014608|NCT00843492|10369593|P1|Overall Study|Immobilization Stopped|1
3014609|NCT00843492|10369592|P2|Overall Study|Withdrawal by Subject|4
3014610|NCT00843492|10369593|P1|Overall Study|Withdrawal by Subject|0
3014611|NCT00843492|10369592|P2|Overall Study|Lost to Follow-up|4
3014612|NCT00843492|10369593|P1|Overall Study|Lost to Follow-up|4
3014613|NCT00843492|10369592|P2|Overall Study|Adverse Event|3
3014614|NCT00843492|10369593|P1|Overall Study|Adverse Event|0
3014615|NCT00843284|10369664|P1|Overall Study|Death|3
3014616|NCT00843284|10369664|P1|Overall Study|Withdrawal by Subject|4
3014617|NCT00843284|10369664|P1|Overall Study|Other|10
3014618|NCT00843284|10369664|P1|Overall Study|Lost to Follow-up|11
3014619|NCT00843284|10369664|P1|Overall Study|Lack of Efficacy|5
3014620|NCT00843284|10369664|P1|Overall Study|Adverse Event|39
3014621|NCT00843193|10369674|P2|Overall Study|Withdrawal by Subject|3
3014622|NCT00843193|10369675|P1|Overall Study|Withdrawal by Subject|3
3014623|NCT00843193|10369674|P2|Overall Study|Physician Decision|1
3014624|NCT00843193|10369675|P1|Overall Study|Physician Decision|0
3014625|NCT00843193|10369674|P2|Overall Study|Lost to Follow-up|0
3014626|NCT00843193|10369675|P1|Overall Study|Lost to Follow-up|1
3014627|NCT00843193|10369674|P2|Overall Study|Protocol Violation|2
3014628|NCT00843193|10369675|P1|Overall Study|Protocol Violation|1
3014629|NCT00843193|10369674|P2|Overall Study|Lack of Efficacy|1
3014630|NCT00843193|10369675|P1|Overall Study|Lack of Efficacy|1
3014631|NCT00843193|10369674|P2|Overall Study|Adverse Event|4
3014632|NCT00843193|10369675|P1|Overall Study|Adverse Event|2
3014633|NCT00843167|10369726|P2|Treatment Period|Withdrawal by Subject|3
3014634|NCT00843167|10369727|P1|Treatment Period|Withdrawal by Subject|2
3014635|NCT00843167|10369726|P2|Treatment Period|Adverse Event|5
3014636|NCT00843167|10369727|P1|Treatment Period|Adverse Event|1
3014637|NCT00843115|10369740|P1|Overall Study|Syndrome De Glissement|1
3014638|NCT00843115|10369740|P1|Overall Study|week 12 not done|1
3014639|NCT00843115|10369740|P1|Overall Study|hospitalized due to deterioration|1
3014640|NCT00843115|10369740|P1|Overall Study|patient never took the medication|1
3014641|NCT00843115|10369740|P1|Overall Study|patient took for 2 days then stopped|1
3014642|NCT00843115|10369740|P1|Overall Study|Family discontinued meds|1
3014643|NCT00843115|10369740|P1|Overall Study|Physician Decision|1
3014644|NCT00843115|10369740|P1|Overall Study|Does not meet entrance criteria|1
3014645|NCT00843115|10369740|P1|Overall Study|Patient forgot to take meds|1
3014646|NCT00843115|10369740|P1|Overall Study|Family does not want continuation|1
3014647|NCT00843115|10369740|P1|Overall Study|Family wanted meds stopped|1
3014648|NCT00843115|10369740|P1|Overall Study|Withdrawal by Subject|17
3014649|NCT00843115|10369740|P1|Overall Study|Lost to Follow-up|4
3014650|NCT00843115|10369740|P1|Overall Study|Adverse Event|30
3014651|NCT00843115|10369740|P1|Overall Study|Death|4
3014652|NCT00843024|10369796|P6|Double-blind Treatment Phase|Lack of Efficacy|0
3014653|NCT00843024|10369797|P5|Double-blind Treatment Phase|Lack of Efficacy|1
3014654|NCT00843024|10369798|P4|Double-blind Treatment Phase|Lack of Efficacy|0
3014655|NCT00843024|10369799|P3|Double-blind Treatment Phase|Lack of Efficacy|0
3014656|NCT00843024|10369800|P2|Double-blind Treatment Phase|Lack of Efficacy|0
3014657|NCT00843024|10369801|P1|Double-blind Treatment Phase|Lack of Efficacy|0
3014658|NCT00843024|10369796|P6|Double-blind Treatment Phase|Adverse Event|1
3014659|NCT00843024|10369797|P5|Double-blind Treatment Phase|Adverse Event|1
3014660|NCT00843024|10369798|P4|Double-blind Treatment Phase|Adverse Event|0
3014661|NCT00843024|10369799|P3|Double-blind Treatment Phase|Adverse Event|0
3014662|NCT00843024|10369800|P2|Double-blind Treatment Phase|Adverse Event|0
3014663|NCT00843024|10369801|P1|Double-blind Treatment Phase|Adverse Event|0
3014664|NCT00843024|10369796|P6|Double-blind Treatment Phase|Physician Decision|1
3014665|NCT00843024|10369797|P5|Double-blind Treatment Phase|Physician Decision|1
3014666|NCT00843024|10369798|P4|Double-blind Treatment Phase|Physician Decision|3
3014667|NCT00843024|10369799|P3|Double-blind Treatment Phase|Physician Decision|0
3014668|NCT00843024|10369800|P2|Double-blind Treatment Phase|Physician Decision|0
3014669|NCT00843024|10369801|P1|Double-blind Treatment Phase|Physician Decision|0
3014670|NCT00843024|10369796|P6|Double-blind Treatment Phase|Protocol Violation|3
3014671|NCT00843024|10369797|P5|Double-blind Treatment Phase|Protocol Violation|0
3014672|NCT00843024|10369798|P4|Double-blind Treatment Phase|Protocol Violation|0
3014673|NCT00843024|10369799|P3|Double-blind Treatment Phase|Protocol Violation|3
3014674|NCT00843024|10369800|P2|Double-blind Treatment Phase|Protocol Violation|0
3014675|NCT00843024|10369801|P1|Double-blind Treatment Phase|Protocol Violation|0
3014676|NCT00843024|10369796|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
3014677|NCT00843024|10369797|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
3014678|NCT00843024|10369798|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
3014679|NCT00843024|10369799|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
3014680|NCT00843024|10369800|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
3014681|NCT00843024|10369801|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
3014682|NCT00843024|10369796|P6|Double-blind Treatment Phase|Lost to Follow-up|4
3014758|NCT00842829|10369886|P1|Continuation Period|Lack of Efficacy|0
3014683|NCT00843024|10369797|P5|Double-blind Treatment Phase|Lost to Follow-up|4
3014684|NCT00843024|10369798|P4|Double-blind Treatment Phase|Lost to Follow-up|4
3014685|NCT00843024|10369799|P3|Double-blind Treatment Phase|Lost to Follow-up|8
3014686|NCT00843024|10369800|P2|Double-blind Treatment Phase|Lost to Follow-up|0
3014687|NCT00843024|10369801|P1|Double-blind Treatment Phase|Lost to Follow-up|0
3014688|NCT00843024|10369796|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
3014689|NCT00843024|10369797|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
3014690|NCT00843024|10369798|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
3014691|NCT00843024|10369799|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
3014692|NCT00843024|10369800|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
3014693|NCT00843024|10369801|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
3014694|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Other|0
3014695|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Other|0
3014696|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Other|0
3014697|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Other|0
3014698|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Other|1
3014699|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Other|0
3014700|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
3014701|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
3014702|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
3014703|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
3014704|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
3014705|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
3014706|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
3014707|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
3014708|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
3014709|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
3014710|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
3014711|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
3014712|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
3014713|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
3014714|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
3014715|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
3014716|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
3014717|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
3014718|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
3014719|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
3014720|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
3014721|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
3014722|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
3014723|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
3014724|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
3014725|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
3014726|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
3014727|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
3014728|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
3014729|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
3014730|NCT00843024|10369796|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
3014731|NCT00843024|10369797|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
3014732|NCT00843024|10369798|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
3014733|NCT00843024|10369799|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
3014734|NCT00843024|10369800|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
3014735|NCT00843024|10369801|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
3014736|NCT00842985|10369866|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
3014737|NCT00842985|10369866|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
3014738|NCT00842985|10369866|P1|First Intervention|Protocol Violation|3
3014739|NCT00842985|10369866|P1|First Intervention|Withdrawal by Subject|3
3014740|NCT00842985|10369866|P1|Screening|Did not meet entrance requirements|27
3014741|NCT00842829|10369884|P3|Continuation Period|Non-compliance to study drug|1
3014742|NCT00842829|10369885|P2|Continuation Period|Non-compliance to study drug|0
3014743|NCT00842829|10369886|P1|Continuation Period|Non-compliance to study drug|0
3014744|NCT00842829|10369884|P3|Continuation Period|Non-compliance to study procedures|2
3014745|NCT00842829|10369885|P2|Continuation Period|Non-compliance to study procedures|0
3014746|NCT00842829|10369886|P1|Continuation Period|Non-compliance to study procedures|0
3014747|NCT00842829|10369884|P3|Continuation Period|Other|7
3014748|NCT00842829|10369885|P2|Continuation Period|Other|0
3014749|NCT00842829|10369886|P1|Continuation Period|Other|0
3014750|NCT00842829|10369884|P3|Continuation Period|Withdrawal by Subject|10
3014751|NCT00842829|10369885|P2|Continuation Period|Withdrawal by Subject|0
3014752|NCT00842829|10369886|P1|Continuation Period|Withdrawal by Subject|0
3014753|NCT00842829|10369884|P3|Continuation Period|Unstable persistent cancer pain|3
3014754|NCT00842829|10369885|P2|Continuation Period|Unstable persistent cancer pain|0
3014755|NCT00842829|10369886|P1|Continuation Period|Unstable persistent cancer pain|0
3014756|NCT00842829|10369884|P3|Continuation Period|Lack of Efficacy|6
3014757|NCT00842829|10369885|P2|Continuation Period|Lack of Efficacy|0
3014759|NCT00842829|10369884|P3|Continuation Period|Adverse Event|32
3014760|NCT00842829|10369885|P2|Continuation Period|Adverse Event|0
3014761|NCT00842829|10369886|P1|Continuation Period|Adverse Event|0
3014762|NCT00842829|10369884|P3|Treatment Period|Unclear completion status|1
3014763|NCT00842829|10369885|P2|Treatment Period|Unclear completion status|0
3014764|NCT00842829|10369886|P1|Treatment Period|Unclear completion status|0
3014765|NCT00842829|10369884|P3|Treatment Period|Non-compliance to study procedures|4
3014766|NCT00842829|10369885|P2|Treatment Period|Non-compliance to study procedures|0
3014767|NCT00842829|10369886|P1|Treatment Period|Non-compliance to study procedures|0
3014768|NCT00842829|10369884|P3|Treatment Period|Other|18
3014769|NCT00842829|10369885|P2|Treatment Period|Other|0
3014770|NCT00842829|10369886|P1|Treatment Period|Other|0
3014771|NCT00842829|10369884|P3|Treatment Period|Protocol Violation|2
3014772|NCT00842829|10369885|P2|Treatment Period|Protocol Violation|0
3014773|NCT00842829|10369886|P1|Treatment Period|Protocol Violation|0
3014774|NCT00842829|10369884|P3|Treatment Period|Consistently >4 BTP episodes daily|1
3014775|NCT00842829|10369885|P2|Treatment Period|Consistently >4 BTP episodes daily|0
3014776|NCT00842829|10369886|P1|Treatment Period|Consistently >4 BTP episodes daily|0
3014777|NCT00842829|10369884|P3|Treatment Period|Withdrawal by Subject|11
3014778|NCT00842829|10369885|P2|Treatment Period|Withdrawal by Subject|0
3014779|NCT00842829|10369886|P1|Treatment Period|Withdrawal by Subject|0
3014780|NCT00842829|10369884|P3|Treatment Period|Unstable persistent cancer pain|5
3014781|NCT00842829|10369885|P2|Treatment Period|Unstable persistent cancer pain|0
3014782|NCT00842829|10369886|P1|Treatment Period|Unstable persistent cancer pain|0
3014783|NCT00842829|10369884|P3|Treatment Period|Lack of Efficacy|6
3014784|NCT00842829|10369885|P2|Treatment Period|Lack of Efficacy|0
3014785|NCT00842829|10369886|P1|Treatment Period|Lack of Efficacy|0
3014786|NCT00842829|10369884|P3|Treatment Period|Adverse Event|15
3014787|NCT00842829|10369885|P2|Treatment Period|Adverse Event|0
3014788|NCT00842829|10369886|P1|Treatment Period|Adverse Event|0
3014789|NCT00842829|10369884|P3|Dose Titration Period|Non-compliance to study drug|0
3014790|NCT00842829|10369885|P2|Dose Titration Period|Non-compliance to study drug|1
3014791|NCT00842829|10369886|P1|Dose Titration Period|Non-compliance to study drug|2
3014792|NCT00842829|10369884|P3|Dose Titration Period|Non-compliance to study procedures|0
3014793|NCT00842829|10369885|P2|Dose Titration Period|Non-compliance to study procedures|1
3014794|NCT00842829|10369886|P1|Dose Titration Period|Non-compliance to study procedures|1
3014795|NCT00842829|10369884|P3|Dose Titration Period|Other|0
3014796|NCT00842829|10369885|P2|Dose Titration Period|Other|4
3014797|NCT00842829|10369886|P1|Dose Titration Period|Other|5
3014798|NCT00842829|10369884|P3|Dose Titration Period|Withdrawal by Subject|0
3014799|NCT00842829|10369885|P2|Dose Titration Period|Withdrawal by Subject|6
3014800|NCT00842829|10369886|P1|Dose Titration Period|Withdrawal by Subject|2
3014801|NCT00842829|10369884|P3|Dose Titration Period|Unstable persistent cancer pain|0
3014802|NCT00842829|10369885|P2|Dose Titration Period|Unstable persistent cancer pain|0
3014803|NCT00842829|10369886|P1|Dose Titration Period|Unstable persistent cancer pain|1
3014804|NCT00842829|10369884|P3|Dose Titration Period|Lack of Efficacy|0
3014805|NCT00842829|10369885|P2|Dose Titration Period|Lack of Efficacy|1
3014806|NCT00842829|10369886|P1|Dose Titration Period|Lack of Efficacy|4
3014807|NCT00842829|10369884|P3|Dose Titration Period|Adverse Event|0
3014808|NCT00842829|10369885|P2|Dose Titration Period|Adverse Event|10
3014809|NCT00842829|10369886|P1|Dose Titration Period|Adverse Event|11
3014810|NCT00842712|10369945|P7|Randomized Part|Ongoing at cut-off date|2
3014811|NCT00842712|10369946|P6|Randomized Part|Ongoing at cut-off date|0
3014812|NCT00842712|10369947|P5|Randomized Part|Ongoing at cut-off date|0
3014813|NCT00842712|10369948|P4|Randomized Part|Ongoing at cut-off date|0
3014814|NCT00842712|10369949|P3|Randomized Part|Ongoing at cut-off date|0
3014815|NCT00842712|10369950|P2|Randomized Part|Ongoing at cut-off date|0
3014816|NCT00842712|10369951|P1|Randomized Part|Ongoing at cut-off date|0
3014817|NCT00842712|10369945|P7|Randomized Part|Randomized but not treated|4
3014818|NCT00842712|10369946|P6|Randomized Part|Randomized but not treated|1
3014819|NCT00842712|10369947|P5|Randomized Part|Randomized but not treated|0
3014820|NCT00842712|10369948|P4|Randomized Part|Randomized but not treated|0
3014821|NCT00842712|10369949|P3|Randomized Part|Randomized but not treated|0
3014822|NCT00842712|10369950|P2|Randomized Part|Randomized but not treated|0
3014823|NCT00842712|10369951|P1|Randomized Part|Randomized but not treated|0
3014824|NCT00842712|10369945|P7|Safety Run-in Part|Progressive disease|0
3014825|NCT00842712|10369946|P6|Safety Run-in Part|Progressive disease|0
3014826|NCT00842712|10369947|P5|Safety Run-in Part|Progressive disease|0
3014827|NCT00842712|10369948|P4|Safety Run-in Part|Progressive disease|1
3014828|NCT00842712|10369949|P3|Safety Run-in Part|Progressive disease|0
3014829|NCT00842712|10369950|P2|Safety Run-in Part|Progressive disease|1
3014830|NCT00842712|10369951|P1|Safety Run-in Part|Progressive disease|3
3014831|NCT00842712|10369945|P7|Safety Run-in Part|Adverse Event|0
3014832|NCT00842712|10369946|P6|Safety Run-in Part|Adverse Event|0
3014833|NCT00842712|10369947|P5|Safety Run-in Part|Adverse Event|0
3014834|NCT00842712|10369948|P4|Safety Run-in Part|Adverse Event|0
3014835|NCT00842712|10369949|P3|Safety Run-in Part|Adverse Event|0
3014836|NCT00842712|10369950|P2|Safety Run-in Part|Adverse Event|1
3014837|NCT00842712|10369951|P1|Safety Run-in Part|Adverse Event|0
3014838|NCT00842543|10370008|P4|Overall Study|Withdrawal by Subject|4
3014839|NCT00842543|10370009|P3|Overall Study|Withdrawal by Subject|3
3014840|NCT00842543|10370010|P2|Overall Study|Withdrawal by Subject|0
3014841|NCT00842543|10370011|P1|Overall Study|Withdrawal by Subject|2
3014842|NCT00842530|10370025|P2|Overall Study|Withdrawal by Subject|28
3014843|NCT00842530|10370026|P1|Overall Study|Withdrawal by Subject|73
3014844|NCT00842530|10370025|P2|Overall Study|Lost to Follow-up|8
3014845|NCT00842530|10370026|P1|Overall Study|Lost to Follow-up|6
3014846|NCT00842530|10370025|P2|Overall Study|Protocol Violation|14
3014847|NCT00842530|10370026|P1|Overall Study|Protocol Violation|32
3014848|NCT00842530|10370025|P2|Overall Study|Other adverse event|1
3014849|NCT00842530|10370026|P1|Overall Study|Other adverse event|6
3014850|NCT00842530|10370025|P2|Overall Study|Serious adverse event|6
3014851|NCT00842530|10370026|P1|Overall Study|Serious adverse event|0
3014852|NCT00842361|10370056|P2|Overall Study|Unclassified|2
3014853|NCT00842361|10370057|P1|Overall Study|Unclassified|0
3014854|NCT00842361|10370056|P2|Overall Study|Protocol Violation|0
3014855|NCT00842361|10370057|P1|Overall Study|Protocol Violation|1
3014856|NCT00842348|10370077|P2|Study 729|Surgical resection|0
3014857|NCT00842348|10370078|P1|Study 729|Surgical resection|1
3014858|NCT00842348|10370077|P2|Study 729|Sponsor's decision|0
3014859|NCT00842348|10370078|P1|Study 729|Sponsor's decision|1
3014860|NCT00842348|10370077|P2|Study 729|Due to non-availability of IP|1
3014861|NCT00842348|10370078|P1|Study 729|Due to non-availability of IP|0
3014862|NCT00842348|10370077|P2|Study 729|Due to Sponsor stopping the study|1
3014863|NCT00842348|10370078|P1|Study 729|Due to Sponsor stopping the study|1
3014864|NCT00842348|10370077|P2|Study 729|Withdrawal by Subject|4
3014865|NCT00842348|10370078|P1|Study 729|Withdrawal by Subject|2
3014866|NCT00842348|10370077|P2|Study 729|Protocol Violation|1
3014867|NCT00842348|10370078|P1|Study 729|Protocol Violation|1
3014868|NCT00842348|10370077|P2|Study 729|Adverse Event|1
3014869|NCT00842348|10370078|P1|Study 729|Adverse Event|1
3014870|NCT00842348|10370077|P2|Study 729|Disease progression/death|30
3014871|NCT00842348|10370078|P1|Study 729|Disease progression/death|19
3014872|NCT00842348|10370077|P2|Patients Randomised in Study 726|Did not enter Study 729|56
3014873|NCT00842348|10370078|P1|Patients Randomised in Study 726|Did not enter Study 729|59
3014874|NCT00842309|10370097|P2|Overall Study|Withdrawal by Subject|1
3014875|NCT00842309|10370098|P1|Overall Study|Withdrawal by Subject|3
3014876|NCT00842257|10370132|P1|Overall Study|Adverse Event|1
3014877|NCT00842244|10370139|P1|Overall Study|Other|17
3014878|NCT00842244|10370139|P1|Overall Study|Withdrawal by Subject|1
3014879|NCT00842244|10370139|P1|Overall Study|Death|3
3014880|NCT00842153|10370166|P2|Overall Study|Lost to Follow-up|2
3014881|NCT00842153|10370167|P1|Overall Study|Lost to Follow-up|1
3014882|NCT00842153|10370166|P2|Overall Study|Adverse Event|1
3014883|NCT00842153|10370167|P1|Overall Study|Adverse Event|0
3014884|NCT00841906|10370242|P2|Overall Study|Withdrawal by Subject|0
3014885|NCT00841906|10370243|P1|Overall Study|Withdrawal by Subject|2
3014886|NCT00841815|10370268|P2|Washout|Withdrawal by Subject|1
3014887|NCT00841815|10370269|P1|Washout|Withdrawal by Subject|0
3014888|NCT00841776|10370279|P2|Overall Study|Withdrawal by Subject|1
3014889|NCT00841776|10370280|P1|Overall Study|Withdrawal by Subject|0
3014890|NCT00841776|10370279|P2|Overall Study|Lost to Follow-up|1
3014891|NCT00841776|10370280|P1|Overall Study|Lost to Follow-up|2
3014892|NCT00841776|10370279|P2|Overall Study|Lack of Efficacy|1
3014893|NCT00841776|10370280|P1|Overall Study|Lack of Efficacy|0
3014894|NCT00841763|10370298|P4|Overall Study|Unable to Classify|0
3014895|NCT00841763|10370299|P3|Overall Study|Unable to Classify|0
3014896|NCT00841763|10370300|P2|Overall Study|Unable to Classify|1
3014897|NCT00841763|10370301|P1|Overall Study|Unable to Classify|7
3014898|NCT00841763|10370298|P4|Overall Study|Administrative Reasons|0
3014899|NCT00841763|10370299|P3|Overall Study|Administrative Reasons|0
3014900|NCT00841763|10370300|P2|Overall Study|Administrative Reasons|1
3014901|NCT00841763|10370301|P1|Overall Study|Administrative Reasons|3
3014902|NCT00841763|10370298|P4|Overall Study|Protocol Violation|0
3014903|NCT00841763|10370299|P3|Overall Study|Protocol Violation|1
3014904|NCT00841763|10370300|P2|Overall Study|Protocol Violation|3
3014905|NCT00841763|10370301|P1|Overall Study|Protocol Violation|20
3014906|NCT00841763|10370298|P4|Overall Study|Lost to Follow-up|0
3014907|NCT00841763|10370299|P3|Overall Study|Lost to Follow-up|0
3014908|NCT00841763|10370300|P2|Overall Study|Lost to Follow-up|25
3014909|NCT00841763|10370301|P1|Overall Study|Lost to Follow-up|63
3014910|NCT00841763|10370298|P4|Overall Study|Adverse Event|2
3014911|NCT00841763|10370299|P3|Overall Study|Adverse Event|3
3014912|NCT00841763|10370300|P2|Overall Study|Adverse Event|10
3014913|NCT00841763|10370301|P1|Overall Study|Adverse Event|9
3014914|NCT00841763|10370298|P4|Overall Study|Withdrawal by Subject|1
3014915|NCT00841763|10370299|P3|Overall Study|Withdrawal by Subject|4
3014916|NCT00841763|10370300|P2|Overall Study|Withdrawal by Subject|17
3014917|NCT00841763|10370301|P1|Overall Study|Withdrawal by Subject|60
3014918|NCT00841698|10370363|P2|First Intervention|Withdrawal by Subject|0
3014919|NCT00841698|10370364|P1|First Intervention|Withdrawal by Subject|1
3014920|NCT00841672|10370374|P2|Overall Study|Protocol Deviation|1
3014921|NCT00841672|10370375|P1|Overall Study|Protocol Deviation|0
3014922|NCT00841672|10370374|P2|Overall Study|Misrandomized|0
3014923|NCT00841672|10370375|P1|Overall Study|Misrandomized|1
3014924|NCT00841672|10370374|P2|Overall Study|Administrative problems|9
3014925|NCT00841672|10370375|P1|Overall Study|Administrative problems|9
3014926|NCT00841672|10370374|P2|Overall Study|Lost to Follow-up|1
3014927|NCT00841672|10370375|P1|Overall Study|Lost to Follow-up|1
3014928|NCT00841672|10370374|P2|Overall Study|Subject withdrew consent|4
3014929|NCT00841672|10370375|P1|Overall Study|Subject withdrew consent|2
3014930|NCT00841672|10370374|P2|Overall Study|Abnormal test procedure result(s)|1
3014931|NCT00841672|10370375|P1|Overall Study|Abnormal test procedure result(s)|0
3014932|NCT00841672|10370374|P2|Overall Study|Adverse Event|16
3014933|NCT00841672|10370375|P1|Overall Study|Adverse Event|7
3014934|NCT00841659|10370391|P2|Washout: 2 Weeks|Protocol Violation|0
3014935|NCT00841659|10370392|P1|Washout: 2 Weeks|Protocol Violation|1
3014936|NCT00841568|10370400|P1|Overall Study|Creatinine over the withdrawal criteria|1
3014937|NCT00841568|10370400|P1|Overall Study|Withdrawal by Subject|2
3014938|NCT00841568|10370400|P1|Overall Study|Death|1
3014939|NCT00841568|10370400|P1|Overall Study|Adverse Event|1
3014940|NCT00841542|10370428|P2|Period 1|Adverse Event|0
3014941|NCT00841542|10370429|P1|Period 1|Adverse Event|1
3014942|NCT00841321|10370444|P2|Overall Study|Adverse Event|2
3014943|NCT00841321|10370445|P1|Overall Study|Adverse Event|0
3014944|NCT00841321|10370444|P2|Overall Study|Lost to Follow-up|1
3014945|NCT00841321|10370445|P1|Overall Study|Lost to Follow-up|1
3014946|NCT00841100|10370492|P1|Phase 1 (28 Days)|Participant non-compliance|2
3014947|NCT00841100|10370492|P1|Phase 1 (28 Days)|Adverse Event|1
3014948|NCT00841035|10370517|P1|Phase 1 Overall Study|Physician Decision|13
3014949|NCT00840996|10370524|P2|Overall Study|Withdrawal by Subject|0
3014950|NCT00840996|10370525|P1|Overall Study|Withdrawal by Subject|1
3014951|NCT00840879|10370545|P2|Second Intervention|Withdrawal by Subject|0
3014952|NCT00840879|10370546|P1|Second Intervention|Withdrawal by Subject|1
3014953|NCT00840827|10370582|P1|Overall Study|Physician Decision|1
3014954|NCT00840827|10370582|P1|Overall Study|Lack of Efficacy|4
3014955|NCT00840827|10370582|P1|Overall Study|Adverse Event|1
3014956|NCT00840658|10370599|P4|Overall Study|Lost to Follow-up|1
3014957|NCT00840658|10370600|P3|Overall Study|Lost to Follow-up|2
3014958|NCT00840658|10370601|P2|Overall Study|Lost to Follow-up|1
3014959|NCT00840658|10370602|P1|Overall Study|Lost to Follow-up|3
3014960|NCT00840658|10370599|P4|Overall Study|Death|3
3014961|NCT00840658|10370600|P3|Overall Study|Death|3
3014962|NCT00840658|10370601|P2|Overall Study|Death|2
3014963|NCT00840658|10370602|P1|Overall Study|Death|2
3014964|NCT00840632|10370620|P2|Washout|Withdrawal by Subject|1
3014965|NCT00840632|10370621|P1|Washout|Withdrawal by Subject|1
3014966|NCT00840632|10370620|P2|First Intervention|Withdrawal by Subject|1
3014967|NCT00840632|10370621|P1|First Intervention|Withdrawal by Subject|0
3014968|NCT00840463|10370648|P2|Overall Study|Adverse Event|0
3014969|NCT00840463|10370649|P1|Overall Study|Adverse Event|1
3014970|NCT00840450|10370663|P1|Overall Study|Lack of Efficacy|2
3014971|NCT00840450|10370663|P1|Overall Study|Adverse Event|1
3014972|NCT00840411|10370671|P2|Washout|Withdrawal by Subject|0
3014973|NCT00840411|10370672|P1|Washout|Withdrawal by Subject|1
3014974|NCT00840411|10370671|P2|First Intervention|Adverse Event|0
3014975|NCT00840411|10370672|P1|First Intervention|Adverse Event|1
3014976|NCT00840294|10370686|P2|Overall Study|Illness|1
3014977|NCT00840294|10370687|P1|Overall Study|Illness|0
3014978|NCT00840294|10370686|P2|Overall Study|Protocol Violation|3
3014979|NCT00840294|10370687|P1|Overall Study|Protocol Violation|1
3014980|NCT00840294|10370686|P2|Overall Study|Withdrawal by Subject|1
3014981|NCT00840294|10370687|P1|Overall Study|Withdrawal by Subject|2
3014982|NCT00840216|10370708|P2|Washout: 7 Days|Withdrawal by Subject|0
3014983|NCT00840216|10370709|P1|Washout: 7 Days|Withdrawal by Subject|1
3014984|NCT00840203|10370719|P2|Washout|Protocol Violation|0
3014985|NCT00840203|10370720|P1|Washout|Protocol Violation|1
3014986|NCT00840203|10370719|P2|First Intervention|Protocol Violation|1
3014987|NCT00840203|10370720|P1|First Intervention|Protocol Violation|1
3014988|NCT00840177|10370737|P3|Overall Study|Did not start treatment|1
3014989|NCT00840177|10370738|P2|Overall Study|Did not start treatment|0
3014990|NCT00840177|10370739|P1|Overall Study|Did not start treatment|0
3014991|NCT00840177|10370737|P3|Overall Study|Ineligible|3
3014992|NCT00840177|10370738|P2|Overall Study|Ineligible|0
3014993|NCT00840177|10370739|P1|Overall Study|Ineligible|0
3014994|NCT00840177|10370737|P3|Overall Study|not protocol specified|0
3014995|NCT00840177|10370738|P2|Overall Study|not protocol specified|3
3014996|NCT00840177|10370739|P1|Overall Study|not protocol specified|6
3014997|NCT00840177|10370737|P3|Overall Study|Death|5
3014998|NCT00840177|10370738|P2|Overall Study|Death|5
3014999|NCT00840177|10370739|P1|Overall Study|Death|4
3015000|NCT00840177|10370737|P3|Overall Study|Progression/relapse|0
3015001|NCT00840177|10370738|P2|Overall Study|Progression/relapse|0
3015002|NCT00840177|10370739|P1|Overall Study|Progression/relapse|2
3015003|NCT00840177|10370737|P3|Overall Study|Refusal unrelated to adverse events|1
3015004|NCT00840177|10370738|P2|Overall Study|Refusal unrelated to adverse events|0
3015005|NCT00840177|10370739|P1|Overall Study|Refusal unrelated to adverse events|1
3015006|NCT00840177|10370737|P3|Overall Study|Adverse Event|1
3015007|NCT00840177|10370738|P2|Overall Study|Adverse Event|1
3015008|NCT00840177|10370739|P1|Overall Study|Adverse Event|5
3015009|NCT00840086|10370773|P1|Overall Study|Lost to Follow-up|1
3015010|NCT00840086|10370773|P1|Overall Study|Protocol Violation|2
3015011|NCT00840086|10370773|P1|Overall Study|Adverse Event|1
3015012|NCT00840073|10370782|P2|Second Intervention|Missed 72 hour blood draw|1
3015013|NCT00840073|10370783|P1|Second Intervention|Missed 72 hour blood draw|1
3015014|NCT00840060|10370797|P2|Overall Study|Change in emotional/behavioral status|1
3015015|NCT00840060|10370798|P1|Overall Study|Change in emotional/behavioral status|0
3015016|NCT00840060|10370797|P2|Overall Study|Withdrawal by Subject|0
3015017|NCT00840060|10370798|P1|Overall Study|Withdrawal by Subject|1
3015018|NCT00840034|10370808|P2|Taper Phase|Withdrawal by Subject|1
3015019|NCT00840034|10370809|P1|Taper Phase|Withdrawal by Subject|1
3015020|NCT00840034|10370808|P2|Taper Phase|Lost to Follow-up|1
3015021|NCT00840034|10370809|P1|Taper Phase|Lost to Follow-up|1
3015022|NCT00840034|10370808|P2|Taper Phase|Adverse Event|0
3015023|NCT00840034|10370809|P1|Taper Phase|Adverse Event|1
3015024|NCT00840034|10370808|P2|Acute Treatment Phase|Withdrawal by Subject|11
3015025|NCT00840034|10370809|P1|Acute Treatment Phase|Withdrawal by Subject|6
3015026|NCT00840034|10370808|P2|Acute Treatment Phase|Protocol Violation|4
3015027|NCT00840034|10370809|P1|Acute Treatment Phase|Protocol Violation|2
3015028|NCT00840034|10370808|P2|Acute Treatment Phase|Physician Decision|1
3015029|NCT00840034|10370809|P1|Acute Treatment Phase|Physician Decision|0
3015030|NCT00840034|10370808|P2|Acute Treatment Phase|Lost to Follow-up|12
3015031|NCT00840034|10370809|P1|Acute Treatment Phase|Lost to Follow-up|5
3015032|NCT00840034|10370808|P2|Acute Treatment Phase|Lack of Efficacy|0
3015033|NCT00840034|10370809|P1|Acute Treatment Phase|Lack of Efficacy|2
3015034|NCT00840034|10370808|P2|Acute Treatment Phase|Adverse Event|8
3015035|NCT00840034|10370809|P1|Acute Treatment Phase|Adverse Event|6
3015036|NCT00839956|10370862|P1|Overall Study|Withdrawal by Subject|3
3015037|NCT00839956|10370862|P1|Overall Study|Physician Decision|1
3015038|NCT00839956|10370862|P1|Overall Study|Lack of Efficacy|6
3015039|NCT00839956|10370862|P1|Overall Study|Adverse Event|2
3015040|NCT00839917|10370882|P2|Overall Study|Did not receive vaccine|1
3015041|NCT00839917|10370883|P1|Overall Study|Did not receive vaccine|0
3015042|NCT00839917|10370882|P2|Overall Study|Lost to Follow-up|0
3015043|NCT00839917|10370883|P1|Overall Study|Lost to Follow-up|1
3015044|NCT00839852|10370919|P1|Overall Study|Pregnancy|1
3015045|NCT00839852|10370919|P1|Overall Study|Lack of Compliance While in Jail|1
3015046|NCT00839852|10370919|P1|Overall Study|Lost to Follow-up|7
3015047|NCT00839852|10370919|P1|Overall Study|Withdrawal of Consent|16
3015048|NCT00839852|10370919|P1|Overall Study|Protocol Violation|9
3015049|NCT00839852|10370919|P1|Overall Study|Insufficient Therapeutic Response|3
3015050|NCT00839852|10370919|P1|Overall Study|Adverse Event|10
3015051|NCT00839800|10370926|P2|Overall Study|Severe Non-Compliance to Protocol|7
3015052|NCT00839800|10370927|P1|Overall Study|Severe Non-Compliance to Protocol|7
3015053|NCT00839800|10370926|P2|Overall Study|Other|14
3015054|NCT00839800|10370927|P1|Overall Study|Other|8
3015055|NCT00839800|10370926|P2|Overall Study|Safety Reasons|1
3015056|NCT00839800|10370927|P1|Overall Study|Safety Reasons|2
3015057|NCT00839800|10370926|P2|Overall Study|Study-Specific Discontinuation Criteria|13
3015058|NCT00839800|10370927|P1|Overall Study|Study-Specific Discontinuation Criteria|6
3015059|NCT00839800|10370926|P2|Overall Study|Incorrect Enrolment|3
3015060|NCT00839800|10370927|P1|Overall Study|Incorrect Enrolment|3
3015061|NCT00839800|10370926|P2|Overall Study|Withdrawal by Subject|34
3015062|NCT00839800|10370927|P1|Overall Study|Withdrawal by Subject|28
3015063|NCT00839800|10370926|P2|Overall Study|Lost to Follow-up|26
3015064|NCT00839800|10370927|P1|Overall Study|Lost to Follow-up|31
3015065|NCT00839800|10370926|P2|Overall Study|Adverse Event|12
3015066|NCT00839800|10370927|P1|Overall Study|Adverse Event|8
3015067|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
3015068|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
3015069|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
3015070|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
3015071|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
3015072|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
3015073|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
3015074|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
3015075|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
3015076|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
3015077|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
3015078|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
3015079|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
3015080|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
3015081|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
3015082|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
3015083|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
3015084|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
3015085|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
3015086|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
3015087|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
3015088|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
3015089|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
3015090|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
3015091|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
3015092|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
3015093|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
3015094|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
3015095|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
3015096|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
3015097|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
3015098|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
3015099|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
3015100|NCT00839527|10370973|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
3015101|NCT00839527|10370974|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
3015102|NCT00839527|10370975|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
3015103|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
3015104|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
3015105|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
3015106|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
3015107|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
3015108|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
3015109|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
3015110|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
3015111|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
3015112|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
3015113|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
3015114|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
3015115|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Missing|0
3015116|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Missing|1
3015117|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Missing|0
3015118|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
3015119|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
3015120|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
3015121|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
3015122|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
3015123|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
3015124|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
3015125|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
3015126|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
3015127|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
3015128|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
3015129|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
3015130|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
3015131|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
3015132|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
3015133|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
3015134|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
3015135|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
3015136|NCT00839527|10370973|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
3015137|NCT00839527|10370974|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
3015138|NCT00839527|10370975|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
3015139|NCT00839436|10371010|P3|Overall Study|Study drug no longer available|1
3015140|NCT00839436|10371011|P2|Overall Study|Study drug no longer available|0
3015141|NCT00839436|10371012|P1|Overall Study|Study drug no longer available|0
3015142|NCT00839436|10371010|P3|Overall Study|Withdrawal by Subject|0
3015143|NCT00839436|10371011|P2|Overall Study|Withdrawal by Subject|1
3015144|NCT00839436|10371012|P1|Overall Study|Withdrawal by Subject|0
3015145|NCT00839436|10371010|P3|Overall Study|Developed exclusionary condition|0
3015146|NCT00839436|10371011|P2|Overall Study|Developed exclusionary condition|0
3015147|NCT00839436|10371012|P1|Overall Study|Developed exclusionary condition|1
3015148|NCT00839423|10371024|P4|Overall Study|Administrative or other reasons|0
3015149|NCT00839423|10371025|P3|Overall Study|Administrative or other reasons|1
3015150|NCT00839423|10371026|P2|Overall Study|Administrative or other reasons|0
3015151|NCT00839423|10371027|P1|Overall Study|Administrative or other reasons|3
3015152|NCT00839423|10371024|P4|Overall Study|Lost to Follow-up|0
3015153|NCT00839423|10371025|P3|Overall Study|Lost to Follow-up|1
3015154|NCT00839423|10371026|P2|Overall Study|Lost to Follow-up|0
3015155|NCT00839423|10371027|P1|Overall Study|Lost to Follow-up|1
3015156|NCT00839423|10371024|P4|Overall Study|Withdrawal of consent|1
3015157|NCT00839423|10371025|P3|Overall Study|Withdrawal of consent|4
3015158|NCT00839423|10371026|P2|Overall Study|Withdrawal of consent|0
3015159|NCT00839423|10371027|P1|Overall Study|Withdrawal of consent|4
3015160|NCT00839423|10371024|P4|Overall Study|Protocol Violation|0
3015161|NCT00839423|10371025|P3|Overall Study|Protocol Violation|2
3015162|NCT00839423|10371026|P2|Overall Study|Protocol Violation|1
3015163|NCT00839423|10371027|P1|Overall Study|Protocol Violation|0
3015164|NCT00839423|10371024|P4|Overall Study|Non-compliance|1
3015165|NCT00839423|10371025|P3|Overall Study|Non-compliance|0
3015166|NCT00839423|10371026|P2|Overall Study|Non-compliance|0
3015167|NCT00839423|10371027|P1|Overall Study|Non-compliance|0
3015168|NCT00839423|10371024|P4|Overall Study|Lack of Efficacy|2
3015169|NCT00839423|10371025|P3|Overall Study|Lack of Efficacy|3
3015170|NCT00839423|10371026|P2|Overall Study|Lack of Efficacy|6
3015171|NCT00839423|10371027|P1|Overall Study|Lack of Efficacy|6
3015172|NCT00839423|10371024|P4|Overall Study|Adverse Event|16
3015173|NCT00839423|10371025|P3|Overall Study|Adverse Event|7
3015174|NCT00839423|10371026|P2|Overall Study|Adverse Event|3
3015175|NCT00839423|10371027|P1|Overall Study|Adverse Event|4
3015176|NCT00839332|10371068|P3|Phase 2|Lost to Follow-up|1
3015177|NCT00839332|10371069|P2|Phase 2|Lost to Follow-up|0
3015178|NCT00839332|10371070|P1|Phase 2|Lost to Follow-up|0
3015179|NCT00839332|10371068|P3|Phase 2|Physician Decision|1
3015180|NCT00839332|10371069|P2|Phase 2|Physician Decision|4
3015181|NCT00839332|10371070|P1|Phase 2|Physician Decision|0
3015182|NCT00839332|10371068|P3|Phase 2|Withdrawal by Subject|8
3015183|NCT00839332|10371069|P2|Phase 2|Withdrawal by Subject|5
3015184|NCT00839332|10371070|P1|Phase 2|Withdrawal by Subject|0
3015185|NCT00839332|10371068|P3|Phase 2|Death|2
3015186|NCT00839332|10371069|P2|Phase 2|Death|4
3015187|NCT00839332|10371070|P1|Phase 2|Death|0
3015188|NCT00839332|10371068|P3|Phase 2|Adverse Event|6
3015189|NCT00839332|10371069|P2|Phase 2|Adverse Event|8
3015190|NCT00839332|10371070|P1|Phase 2|Adverse Event|0
3015191|NCT00839332|10371068|P3|Phase 2|Disease Progression|21
3015192|NCT00839332|10371069|P2|Phase 2|Disease Progression|46
3015193|NCT00839332|10371070|P1|Phase 2|Disease Progression|0
3015194|NCT00839332|10371068|P3|Phase 2|Protocol Violation|0
3015195|NCT00839332|10371069|P2|Phase 2|Protocol Violation|1
3015196|NCT00839332|10371070|P1|Phase 2|Protocol Violation|0
3015197|NCT00839332|10371068|P3|Phase 1|Physician Decision|0
3015198|NCT00839332|10371069|P2|Phase 1|Physician Decision|0
3015199|NCT00839332|10371070|P1|Phase 1|Physician Decision|2
3015200|NCT00839332|10371068|P3|Phase 1|Withdrawal by Subject|0
3015201|NCT00839332|10371069|P2|Phase 1|Withdrawal by Subject|0
3015202|NCT00839332|10371070|P1|Phase 1|Withdrawal by Subject|4
3015203|NCT00839332|10371068|P3|Phase 1|Adverse Event|0
3015204|NCT00839332|10371069|P2|Phase 1|Adverse Event|0
3015205|NCT00839332|10371070|P1|Phase 1|Adverse Event|6
3015206|NCT00839332|10371068|P3|Phase 1|Disease Progression|0
3015207|NCT00839332|10371069|P2|Phase 1|Disease Progression|0
3015208|NCT00839332|10371070|P1|Phase 1|Disease Progression|38
3015209|NCT00839306|10371131|P2|Overall Study|Other|18
3015210|NCT00839306|10371132|P1|Overall Study|Other|6
3015211|NCT00839306|10371131|P2|Overall Study|Lack of Efficacy|4
3015212|NCT00839306|10371132|P1|Overall Study|Lack of Efficacy|5
3015213|NCT00839306|10371131|P2|Overall Study|Withdrawal by Subject|7
3015214|NCT00839306|10371132|P1|Overall Study|Withdrawal by Subject|5
3015215|NCT00839306|10371131|P2|Overall Study|Lost to Follow-up|9
3015216|NCT00839306|10371132|P1|Overall Study|Lost to Follow-up|6
3015217|NCT00839306|10371131|P2|Overall Study|Adverse Event|5
3015218|NCT00839306|10371132|P1|Overall Study|Adverse Event|3
3015219|NCT00839098|10371230|P3|Overall Study|Withdrawal by Subject|7
3015220|NCT00839098|10371231|P2|Overall Study|Withdrawal by Subject|1
3015221|NCT00839098|10371232|P1|Overall Study|Withdrawal by Subject|2
3015222|NCT00839072|10371258|P2|Second Intervention Period|Withdrawal by Subject|0
3015223|NCT00839072|10371259|P1|Second Intervention Period|Withdrawal by Subject|1
3015224|NCT00839072|10371258|P2|First Intervention Period|Adverse Event|1
3015225|NCT00839072|10371259|P1|First Intervention Period|Adverse Event|1
3015226|NCT00839072|10371258|P2|First Intervention Period|Withdrawal by Subject|0
3015227|NCT00839072|10371259|P1|First Intervention Period|Withdrawal by Subject|1
3015228|NCT00838929|10371303|P3|Overall Study|Disease progression|1
3015229|NCT00838929|10371304|P2|Overall Study|Disease progression|2
3015230|NCT00838929|10371305|P1|Overall Study|Disease progression|0
3015231|NCT00838929|10371303|P3|Overall Study|Protocol Violation|0
3015232|NCT00838929|10371304|P2|Overall Study|Protocol Violation|1
3015233|NCT00838929|10371305|P1|Overall Study|Protocol Violation|0
3015234|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Missing|0
3015235|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Missing|3
3015236|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
3015237|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
3015238|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
3015239|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
3015240|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Physician Decision|0
3015241|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Physician Decision|2
3015242|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
3015243|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
3015244|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
3015245|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
3015246|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
3015247|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
3015248|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Noncompliance|5
3015249|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Noncompliance|6
3015250|NCT00838916|10371313|P2|Follow-up Period (8 Weeks)|Adverse Event|5
3015251|NCT00838916|10371314|P1|Follow-up Period (8 Weeks)|Adverse Event|10
3015252|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Pregnancy|0
3015253|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Pregnancy|2
3015254|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Missing|1
3015255|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Missing|3
3015256|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
3015257|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
3015258|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Physician Decision|1
3015259|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Physician Decision|6
3015260|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
3015261|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
3015262|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
3015263|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
3015264|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
3015265|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
3015266|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Noncompliance|14
3015267|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Noncompliance|21
3015268|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Protocol Violation|3
3015269|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Protocol Violation|12
3015270|NCT00838916|10371313|P2|Treatment Period (156 Weeks)|Adverse Event|11
3015271|NCT00838916|10371314|P1|Treatment Period (156 Weeks)|Adverse Event|50
3015272|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Missing|1
3015273|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Missing|1
3015274|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Missing|2
3015275|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Missing|1
3015276|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
3015277|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
3015278|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
3015279|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
3015280|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
3015281|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
3015282|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
3015283|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
3015284|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
3015285|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
3015286|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
3015287|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
3015288|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
3015289|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
3015290|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
3015291|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
3015292|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Physician Decision|1
3015293|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Physician Decision|1
3015294|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Physician Decision|1
3015295|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Physician Decision|1
3015296|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
3015297|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
3015298|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
3015299|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
3015300|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
3015301|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
3015302|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
3015303|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
3015304|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
3015305|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
3015306|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
3015307|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
3015308|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Noncompliance|5
3015309|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Noncompliance|5
3015310|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Noncompliance|8
3015311|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Noncompliance|2
3015312|NCT00838903|10371343|P4|Follow-up Period (8 Weeks)|Adverse Event|1
3015313|NCT00838903|10371344|P3|Follow-up Period (8 Weeks)|Adverse Event|3
3015314|NCT00838903|10371345|P2|Follow-up Period (8 Weeks)|Adverse Event|0
3015315|NCT00838903|10371346|P1|Follow-up Period (8 Weeks)|Adverse Event|0
3015316|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
3015317|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
3015318|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
3015319|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
3015320|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
3015321|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
3015322|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
3015323|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
3015324|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
3015325|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
3015326|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
3015327|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
3015328|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Site closed|0
3015329|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Site closed|1
3015330|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Site closed|0
3015331|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Site closed|0
3015332|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
3015333|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
3015334|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
3015335|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
3015336|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Pregnancy|0
3015337|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Pregnancy|1
3015338|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Pregnancy|0
3015339|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Pregnancy|0
3015340|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
3015341|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
3015342|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
3015343|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
3015344|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
3015345|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
3015346|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
3015347|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
3015348|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
3015349|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
3015350|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
3015351|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
3015352|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
3015353|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
3015354|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
3015355|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
3015356|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Physician Decision|2
3015357|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Physician Decision|1
3015358|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Physician Decision|2
3015359|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Physician Decision|1
3015360|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
3015361|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
3015362|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
3015363|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
3015364|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
3015365|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
3015366|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
3015367|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
3015368|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
3015369|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
3015370|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
3015371|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
3015372|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Noncompliance|6
3015373|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Noncompliance|12
3015374|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Noncompliance|13
3015375|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Noncompliance|9
3015376|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Protocol Violation|5
3015377|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Protocol Violation|6
3015378|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Protocol Violation|6
3015379|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Protocol Violation|1
3015380|NCT00838903|10371343|P4|Treatment Period (156 Weeks)|Adverse Event|25
3015381|NCT00838903|10371344|P3|Treatment Period (156 Weeks)|Adverse Event|17
3015382|NCT00838903|10371345|P2|Treatment Period (156 Weeks)|Adverse Event|13
3015383|NCT00838903|10371346|P1|Treatment Period (156 Weeks)|Adverse Event|5
3015384|NCT00838682|10371401|P2|Overall Study|Withdrawal by Subject|1
3015385|NCT00838682|10371402|P1|Overall Study|Withdrawal by Subject|0
3015386|NCT00838682|10371401|P2|Overall Study|Protocol Violation|1
3015387|NCT00838682|10371402|P1|Overall Study|Protocol Violation|0
3015388|NCT00838682|10371401|P2|Overall Study|detection of exclusion criteria|3
3015389|NCT00838682|10371402|P1|Overall Study|detection of exclusion criteria|4
3015390|NCT00838682|10371401|P2|Overall Study|Lost to Follow-up|14
3015391|NCT00838682|10371402|P1|Overall Study|Lost to Follow-up|21
3015392|NCT00838630|10371420|P2|Washout: 7 Days|Protocol Violation|0
3015393|NCT00838630|10371421|P1|Washout: 7 Days|Protocol Violation|1
3015394|NCT00838630|10371420|P2|First Intervention|Adverse Event|0
3015395|NCT00838630|10371421|P1|First Intervention|Adverse Event|1
3015396|NCT00838578|10371429|P1|Overall Study|Protocol Violation|2
3015397|NCT00838565|10371443|P6|Overall Study|Randomized but not Treated|0
3015398|NCT00838565|10371444|P5|Overall Study|Randomized but not Treated|0
3015399|NCT00838565|10371445|P4|Overall Study|Randomized but not Treated|0
3015400|NCT00838565|10371446|P3|Overall Study|Randomized but not Treated|0
3015401|NCT00838565|10371447|P2|Overall Study|Randomized but not Treated|1
3015402|NCT00838565|10371448|P1|Overall Study|Randomized but not Treated|0
3015403|NCT00838565|10371443|P6|Overall Study|Other|0
3015404|NCT00838565|10371444|P5|Overall Study|Other|0
3015405|NCT00838565|10371445|P4|Overall Study|Other|0
3015406|NCT00838565|10371446|P3|Overall Study|Other|0
3015407|NCT00838565|10371447|P2|Overall Study|Other|2
3015408|NCT00838565|10371448|P1|Overall Study|Other|0
3015409|NCT00838565|10371443|P6|Overall Study|Withdrawal by Subject|2
3015410|NCT00838565|10371444|P5|Overall Study|Withdrawal by Subject|0
3015411|NCT00838565|10371445|P4|Overall Study|Withdrawal by Subject|0
3015412|NCT00838565|10371446|P3|Overall Study|Withdrawal by Subject|1
3015413|NCT00838565|10371447|P2|Overall Study|Withdrawal by Subject|0
3015414|NCT00838565|10371448|P1|Overall Study|Withdrawal by Subject|0
3015415|NCT00838539|10371553|P12|Overall Study|Symptomatic Deterioration|0
3015416|NCT00838539|10371554|P11|Overall Study|Symptomatic Deterioration|0
3015417|NCT00838539|10371555|P10|Overall Study|Symptomatic Deterioration|1
3015418|NCT00838539|10371556|P9|Overall Study|Symptomatic Deterioration|0
3015419|NCT00838539|10371557|P8|Overall Study|Symptomatic Deterioration|0
3015420|NCT00838539|10371558|P7|Overall Study|Symptomatic Deterioration|0
3015421|NCT00838539|10371559|P6|Overall Study|Symptomatic Deterioration|1
3015422|NCT00838539|10371560|P5|Overall Study|Symptomatic Deterioration|0
3015423|NCT00838539|10371561|P4|Overall Study|Symptomatic Deterioration|1
3015424|NCT00838539|10371562|P3|Overall Study|Symptomatic Deterioration|1
3015425|NCT00838539|10371563|P2|Overall Study|Symptomatic Deterioration|0
3015426|NCT00838539|10371564|P1|Overall Study|Symptomatic Deterioration|0
3015427|NCT00838539|10371553|P12|Overall Study|Clinical Progression|0
3015428|NCT00838539|10371554|P11|Overall Study|Clinical Progression|0
3015429|NCT00838539|10371555|P10|Overall Study|Clinical Progression|0
3015430|NCT00838539|10371556|P9|Overall Study|Clinical Progression|0
3015431|NCT00838539|10371557|P8|Overall Study|Clinical Progression|0
3015432|NCT00838539|10371558|P7|Overall Study|Clinical Progression|1
3015433|NCT00838539|10371559|P6|Overall Study|Clinical Progression|0
3015434|NCT00838539|10371560|P5|Overall Study|Clinical Progression|0
3015435|NCT00838539|10371561|P4|Overall Study|Clinical Progression|0
3015436|NCT00838539|10371562|P3|Overall Study|Clinical Progression|0
3015437|NCT00838539|10371563|P2|Overall Study|Clinical Progression|0
3015438|NCT00838539|10371564|P1|Overall Study|Clinical Progression|0
3015439|NCT00838539|10371553|P12|Overall Study|Physician Decision|0
3015440|NCT00838539|10371554|P11|Overall Study|Physician Decision|0
3015441|NCT00838539|10371555|P10|Overall Study|Physician Decision|0
3015442|NCT00838539|10371556|P9|Overall Study|Physician Decision|1
3015443|NCT00838539|10371557|P8|Overall Study|Physician Decision|0
3015444|NCT00838539|10371558|P7|Overall Study|Physician Decision|0
3015445|NCT00838539|10371559|P6|Overall Study|Physician Decision|0
3015446|NCT00838539|10371560|P5|Overall Study|Physician Decision|0
3015447|NCT00838539|10371561|P4|Overall Study|Physician Decision|0
3015448|NCT00838539|10371562|P3|Overall Study|Physician Decision|0
3015449|NCT00838539|10371563|P2|Overall Study|Physician Decision|0
3015450|NCT00838539|10371564|P1|Overall Study|Physician Decision|0
3015451|NCT00838539|10371553|P12|Overall Study|Death|0
3015452|NCT00838539|10371554|P11|Overall Study|Death|0
3015453|NCT00838539|10371555|P10|Overall Study|Death|0
3015454|NCT00838539|10371556|P9|Overall Study|Death|0
3015455|NCT00838539|10371557|P8|Overall Study|Death|0
3015456|NCT00838539|10371558|P7|Overall Study|Death|1
3015457|NCT00838539|10371559|P6|Overall Study|Death|0
3015458|NCT00838539|10371560|P5|Overall Study|Death|0
3015459|NCT00838539|10371561|P4|Overall Study|Death|0
3015460|NCT00838539|10371562|P3|Overall Study|Death|0
3015461|NCT00838539|10371563|P2|Overall Study|Death|0
3015462|NCT00838539|10371564|P1|Overall Study|Death|0
3015463|NCT00838539|10371553|P12|Overall Study|Withdrawal by Subject|0
3015464|NCT00838539|10371554|P11|Overall Study|Withdrawal by Subject|2
3015465|NCT00838539|10371555|P10|Overall Study|Withdrawal by Subject|1
3015466|NCT00838539|10371556|P9|Overall Study|Withdrawal by Subject|0
3015467|NCT00838539|10371557|P8|Overall Study|Withdrawal by Subject|0
3015468|NCT00838539|10371558|P7|Overall Study|Withdrawal by Subject|0
3015469|NCT00838539|10371559|P6|Overall Study|Withdrawal by Subject|0
3015470|NCT00838539|10371560|P5|Overall Study|Withdrawal by Subject|0
3015471|NCT00838539|10371561|P4|Overall Study|Withdrawal by Subject|0
3015472|NCT00838539|10371562|P3|Overall Study|Withdrawal by Subject|0
3015473|NCT00838539|10371563|P2|Overall Study|Withdrawal by Subject|1
3015474|NCT00838539|10371564|P1|Overall Study|Withdrawal by Subject|0
3015475|NCT00838539|10371553|P12|Overall Study|Adverse Event|0
3015476|NCT00838539|10371554|P11|Overall Study|Adverse Event|2
3015477|NCT00838539|10371555|P10|Overall Study|Adverse Event|1
3015478|NCT00838539|10371556|P9|Overall Study|Adverse Event|0
3015479|NCT00838539|10371557|P8|Overall Study|Adverse Event|2
3015480|NCT00838539|10371558|P7|Overall Study|Adverse Event|0
3015481|NCT00838539|10371559|P6|Overall Study|Adverse Event|1
3015482|NCT00838539|10371560|P5|Overall Study|Adverse Event|2
3015483|NCT00838539|10371561|P4|Overall Study|Adverse Event|1
3015484|NCT00838539|10371562|P3|Overall Study|Adverse Event|1
3015485|NCT00838539|10371563|P2|Overall Study|Adverse Event|1
3015486|NCT00838539|10371564|P1|Overall Study|Adverse Event|1
3015487|NCT00838539|10371553|P12|Overall Study|Disease Progression|4
3015488|NCT00838539|10371554|P11|Overall Study|Disease Progression|1
3015489|NCT00838539|10371555|P10|Overall Study|Disease Progression|5
3015490|NCT00838539|10371556|P9|Overall Study|Disease Progression|4
3015491|NCT00838539|10371557|P8|Overall Study|Disease Progression|4
3015492|NCT00838539|10371558|P7|Overall Study|Disease Progression|3
3015493|NCT00838539|10371559|P6|Overall Study|Disease Progression|2
3015494|NCT00838539|10371560|P5|Overall Study|Disease Progression|4
3015495|NCT00838539|10371561|P4|Overall Study|Disease Progression|2
3015496|NCT00838539|10371562|P3|Overall Study|Disease Progression|3
3015497|NCT00838539|10371563|P2|Overall Study|Disease Progression|4
3015498|NCT00838539|10371564|P1|Overall Study|Disease Progression|2
3015499|NCT00838526|10371614|P2|Overall Study|Other|7
3015500|NCT00838526|10371615|P1|Overall Study|Other|11
3015501|NCT00838526|10371614|P2|Overall Study|Lack of Efficacy|3
3015502|NCT00838526|10371615|P1|Overall Study|Lack of Efficacy|2
3015503|NCT00838526|10371614|P2|Overall Study|Withdrawal by Subject|5
3015504|NCT00838526|10371615|P1|Overall Study|Withdrawal by Subject|4
3015505|NCT00838526|10371614|P2|Overall Study|Lost to Follow-up|12
3015506|NCT00838526|10371615|P1|Overall Study|Lost to Follow-up|4
3015507|NCT00838526|10371614|P2|Overall Study|Adverse Event|12
3015508|NCT00838526|10371615|P1|Overall Study|Adverse Event|3
3015509|NCT00838513|10371623|P1|Post Treatment Period (Patients Who Disc|Death|1
3015510|NCT00838513|10371623|P1|Extension Treatment Period|Death|1
3015511|NCT00838513|10371623|P1|Screening Period|Screen Failure|3
3015512|NCT00838331|10371639|P1|Aged Blood Transfusion|Withdrawal by Subject|9
3015513|NCT00838279|10371645|P2|Washout|Withdrawal by Subject|1
3015514|NCT00838279|10371646|P1|Washout|Withdrawal by Subject|0
3015515|NCT00838279|10371645|P2|Washout|Protocol Violation|0
3015516|NCT00838279|10371646|P1|Washout|Protocol Violation|1
3015517|NCT00838201|10371656|P2|Overall Study|Death|13
3015518|NCT00838201|10371657|P1|Overall Study|Death|11
3015519|NCT00838201|10371656|P2|Overall Study|Adverse Event|9
3015520|NCT00838201|10371657|P1|Overall Study|Adverse Event|5
3015521|NCT00838201|10371656|P2|Overall Study|Lost to Follow-up|3
3015522|NCT00838201|10371657|P1|Overall Study|Lost to Follow-up|4
3015523|NCT00838201|10371656|P2|Overall Study|Consent withdrawn|19
3015524|NCT00838201|10371657|P1|Overall Study|Consent withdrawn|16
3015525|NCT00838201|10371656|P2|Overall Study|Disease progression|3
3015526|NCT00838201|10371657|P1|Overall Study|Disease progression|3
3015527|NCT00838201|10371656|P2|Overall Study|Administrative decision|2
3015528|NCT00838201|10371657|P1|Overall Study|Administrative decision|1
3015529|NCT00838201|10371656|P2|Overall Study|Noncompliance|1
3015530|NCT00838201|10371657|P1|Overall Study|Noncompliance|0
3015531|NCT00838201|10371656|P2|Overall Study|Investigator decision, or other reasons|3
3015532|NCT00838201|10371657|P1|Overall Study|Investigator decision, or other reasons|2
3015533|NCT00838110|10371725|P4|Overall Study|Randomized but not treated|0
3015534|NCT00838110|10371726|P3|Overall Study|Randomized but not treated|0
3015535|NCT00838110|10371727|P2|Overall Study|Randomized but not treated|1
3015536|NCT00838110|10371728|P1|Overall Study|Randomized but not treated|0
3015537|NCT00838110|10371725|P4|Overall Study|Did not meet eligibility criteria|2
3015538|NCT00838110|10371726|P3|Overall Study|Did not meet eligibility criteria|1
3015539|NCT00838110|10371727|P2|Overall Study|Did not meet eligibility criteria|0
3015540|NCT00838110|10371728|P1|Overall Study|Did not meet eligibility criteria|0
3015541|NCT00838110|10371725|P4|Overall Study|Lost to Follow-up|0
3015542|NCT00838110|10371726|P3|Overall Study|Lost to Follow-up|0
3015543|NCT00838110|10371727|P2|Overall Study|Lost to Follow-up|0
3015544|NCT00838110|10371728|P1|Overall Study|Lost to Follow-up|3
3015545|NCT00838110|10371725|P4|Overall Study|Protocol Violation|1
3015546|NCT00838110|10371726|P3|Overall Study|Protocol Violation|1
3015547|NCT00838110|10371727|P2|Overall Study|Protocol Violation|2
3015548|NCT00838110|10371728|P1|Overall Study|Protocol Violation|0
3015549|NCT00838110|10371725|P4|Overall Study|Other|2
3015550|NCT00838110|10371726|P3|Overall Study|Other|3
3015551|NCT00838110|10371727|P2|Overall Study|Other|3
3015552|NCT00838110|10371728|P1|Overall Study|Other|3
3015553|NCT00838110|10371725|P4|Overall Study|Withdrawal by Subject|4
3015554|NCT00838110|10371726|P3|Overall Study|Withdrawal by Subject|3
3015555|NCT00838110|10371727|P2|Overall Study|Withdrawal by Subject|6
3015556|NCT00838110|10371728|P1|Overall Study|Withdrawal by Subject|5
3015557|NCT00838110|10371725|P4|Overall Study|Adverse Event|7
3015558|NCT00838110|10371726|P3|Overall Study|Adverse Event|8
3015559|NCT00838110|10371727|P2|Overall Study|Adverse Event|10
3015560|NCT00838110|10371728|P1|Overall Study|Adverse Event|11
3015561|NCT00838110|10371725|P4|Overall Study|Death|2
3015562|NCT00838110|10371726|P3|Overall Study|Death|1
3015563|NCT00838110|10371727|P2|Overall Study|Death|0
3015564|NCT00838110|10371728|P1|Overall Study|Death|0
3015565|NCT00838097|10371748|P1|Overall Study|Protocol-specified criteria|142
3015566|NCT00838097|10371748|P1|Overall Study|Death|6
3015567|NCT00838097|10371748|P1|Overall Study|Lost to Follow-up|11
3015568|NCT00838097|10371748|P1|Overall Study|Physician Decision|4
3015569|NCT00838097|10371748|P1|Overall Study|Requirement for alternative therapy|2
3015570|NCT00838097|10371748|P1|Overall Study|Withdrawal by Subject|3
3015571|NCT00838097|10371748|P1|Overall Study|Adverse Event|2
3015572|NCT00838097|10371748|P1|Overall Study|Ineligibility determined|6
3015573|NCT00837967|10371756|P2|Washout Period of 7 - 14 Days|Adverse Event|0
3015574|NCT00837967|10371757|P1|Washout Period of 7 - 14 Days|Adverse Event|2
3015575|NCT00837876|10371783|P1|Overall Study|disease progression|24
3015576|NCT00837876|10371783|P1|Overall Study|Withdrawal by Subject|3
3015577|NCT00837876|10371783|P1|Overall Study|Physician Decision|1
3015578|NCT00837876|10371783|P1|Overall Study|Adverse Event|7
3015579|NCT00837876|10371783|P1|Overall Study|Death|2
3015580|NCT00837811|10371805|P3|Overall Study|Sponsor Decision|0
3015581|NCT00837811|10371806|P2|Overall Study|Sponsor Decision|2
3015582|NCT00837811|10371807|P1|Overall Study|Sponsor Decision|0
3015583|NCT00837811|10371805|P3|Overall Study|Withdrawal by Subject|0
3015584|NCT00837811|10371806|P2|Overall Study|Withdrawal by Subject|9
3015585|NCT00837811|10371807|P1|Overall Study|Withdrawal by Subject|1
3015586|NCT00837811|10371805|P3|Overall Study|Physician Decision|1
3015587|NCT00837811|10371806|P2|Overall Study|Physician Decision|2
3015588|NCT00837811|10371807|P1|Overall Study|Physician Decision|0
3015589|NCT00837811|10371805|P3|Overall Study|Lost to Follow-up|0
3015590|NCT00837811|10371806|P2|Overall Study|Lost to Follow-up|3
3015591|NCT00837811|10371807|P1|Overall Study|Lost to Follow-up|1
3015592|NCT00837811|10371805|P3|Overall Study|Lack of Efficacy|0
3015593|NCT00837811|10371806|P2|Overall Study|Lack of Efficacy|11
3015594|NCT00837811|10371807|P1|Overall Study|Lack of Efficacy|0
3015595|NCT00837811|10371805|P3|Overall Study|Death|0
3015596|NCT00837811|10371806|P2|Overall Study|Death|1
3015597|NCT00837811|10371807|P1|Overall Study|Death|1
3015598|NCT00837811|10371805|P3|Overall Study|Adverse Event|0
3015599|NCT00837811|10371806|P2|Overall Study|Adverse Event|6
3015600|NCT00837811|10371807|P1|Overall Study|Adverse Event|4
3015601|NCT00837759|10371892|P1|Overall Study|Lost to Follow-up|1
3015602|NCT00837759|10371892|P1|Overall Study|Protocol Violation|3
3015603|NCT00837694|10371907|P6|Overall Study|Lost to Follow-up|1
3015604|NCT00837694|10371908|P5|Overall Study|Lost to Follow-up|1
3015605|NCT00837694|10371909|P4|Overall Study|Lost to Follow-up|1
3015606|NCT00837694|10371910|P3|Overall Study|Lost to Follow-up|2
3015607|NCT00837694|10371911|P2|Overall Study|Lost to Follow-up|0
3015608|NCT00837694|10371912|P1|Overall Study|Lost to Follow-up|2
3015609|NCT00837616|10371928|P2|Overall Study|Withdrawal by Subject|1
3015610|NCT00837616|10371929|P1|Overall Study|Withdrawal by Subject|0
3015611|NCT00837577|10371968|P2|Open-label Period|Other Reason|1
3015612|NCT00837577|10371969|P1|Open-label Period|Other Reason|1
3015613|NCT00837577|10371968|P2|Open-label Period|Withdrawal by Subject|2
3015614|NCT00837577|10371969|P1|Open-label Period|Withdrawal by Subject|1
3015615|NCT00837577|10371968|P2|Open-label Period|Lack of Efficacy|3
3015616|NCT00837577|10371969|P1|Open-label Period|Lack of Efficacy|4
3015617|NCT00837577|10371968|P2|Open-label Period|Laboratory Adverse Event|1
3015618|NCT00837577|10371969|P1|Open-label Period|Laboratory Adverse Event|0
3015619|NCT00837577|10371968|P2|Open-label Period|Clinical Adverse Event|2
3015620|NCT00837577|10371969|P1|Open-label Period|Clinical Adverse Event|2
3015621|NCT00837577|10371968|P2|Double-blind Period|Withdrawal by Subject|0
3015622|NCT00837577|10371969|P1|Double-blind Period|Withdrawal by Subject|1
3015623|NCT00837577|10371968|P2|Double-blind Period|Clinical Adverse Event|0
3015624|NCT00837577|10371969|P1|Double-blind Period|Clinical Adverse Event|1
3015625|NCT00837486|10371989|P2|Long-term Follow-up Phase - Open Label|Death|0
3015626|NCT00837486|10371990|P1|Long-term Follow-up Phase - Open Label|Death|1
3015627|NCT00837486|10371989|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
3015628|NCT00837486|10371990|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
3015629|NCT00837486|10371989|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
3015630|NCT00837486|10371990|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
3015631|NCT00837486|10371989|P2|Blinded-treatment Phase|Physician Decision|0
3015632|NCT00837486|10371990|P1|Blinded-treatment Phase|Physician Decision|1
3015633|NCT00837473|10372002|P1|Overall Study|Withdrawal by Subject|2
3015634|NCT00837473|10372002|P1|Overall Study|Lost to Follow-up|1
3015635|NCT00837434|10372022|P2|Overall Study|Unable to obtain study drug|0
3015636|NCT00837434|10372023|P1|Overall Study|Unable to obtain study drug|1
3015637|NCT00837434|10372022|P2|Overall Study|Baseline assessments not done in time|0
3015638|NCT00837434|10372023|P1|Overall Study|Baseline assessments not done in time|1
3015639|NCT00837434|10372022|P2|Overall Study|Noncompliant|0
3015640|NCT00837434|10372023|P1|Overall Study|Noncompliant|2
3015641|NCT00837434|10372022|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
3015642|NCT00837434|10372023|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
3015643|NCT00837434|10372022|P2|Overall Study|Lost to Follow-up|1
3015644|NCT00837434|10372023|P1|Overall Study|Lost to Follow-up|1
3015645|NCT00837434|10372022|P2|Overall Study|Physician Decision|0
3015646|NCT00837434|10372023|P1|Overall Study|Physician Decision|3
3015647|NCT00837330|10372043|P2|Overall Study|Lost to Follow-up|3
3015648|NCT00837330|10372044|P1|Overall Study|Lost to Follow-up|1
3015649|NCT00837213|10372067|P2|Overall Study|not stated|1
3015650|NCT00837213|10372068|P1|Overall Study|not stated|1
3015651|NCT00837213|10372067|P2|Overall Study|Withdrawal by Subject|2
3015652|NCT00837213|10372068|P1|Overall Study|Withdrawal by Subject|2
3015653|NCT00837213|10372067|P2|Overall Study|Lost to Follow-up|2
3015654|NCT00837213|10372068|P1|Overall Study|Lost to Follow-up|3
3015655|NCT00837161|10372094|P1|Overall Study|refused hysterectomy|2
3015656|NCT00837148|10372102|P1|Overall Study|Death|1
3015657|NCT00837148|10372102|P1|Overall Study|Adverse Event|1
3015658|NCT00837096|10372108|P2|Overall Study|Not reported|8
3015659|NCT00837096|10372109|P1|Overall Study|Not reported|9
3015660|NCT00837096|10372108|P2|Overall Study|Physician Decision|1
3015661|NCT00837096|10372109|P1|Overall Study|Physician Decision|1
3015662|NCT00836953|10372121|P1|Overall Study|Lost to Follow-up|1
3015663|NCT00836953|10372121|P1|Overall Study|Withdrawal by Subject|1
3015664|NCT00836927|10372132|P5|Overall Study|Withdrawal by Subject|0
3015665|NCT00836927|10372133|P4|Overall Study|Withdrawal by Subject|0
3015666|NCT00836927|10372134|P3|Overall Study|Withdrawal by Subject|0
3015667|NCT00836927|10372135|P2|Overall Study|Withdrawal by Subject|0
3015668|NCT00836927|10372136|P1|Overall Study|Withdrawal by Subject|1
3015669|NCT00836927|10372132|P5|Overall Study|Progressive disease|1
3015670|NCT00836927|10372133|P4|Overall Study|Progressive disease|1
3015671|NCT00836927|10372134|P3|Overall Study|Progressive disease|0
3015672|NCT00836927|10372135|P2|Overall Study|Progressive disease|0
3015673|NCT00836927|10372136|P1|Overall Study|Progressive disease|2
3015674|NCT00836901|10372172|P2|First Intervention|Withdrawal by Subject|0
3015675|NCT00836901|10372173|P1|First Intervention|Withdrawal by Subject|1
3015676|NCT00836875|10372189|P2|Overall Study|Withdrawal by Subject|1
3015677|NCT00836875|10372190|P1|Overall Study|Withdrawal by Subject|0
3015678|NCT00836875|10372189|P2|Overall Study|Death|2
3015679|NCT00836875|10372190|P1|Overall Study|Death|3
3015680|NCT00836810|10372206|P2|Overall Study|New diagnosis|0
3015681|NCT00836810|10372207|P1|Overall Study|New diagnosis|1
3015682|NCT00836745|10372229|P1|Overall Study|Other|2
3015683|NCT00836745|10372229|P1|Overall Study|Objective progression or relapse|4
3015684|NCT00836745|10372229|P1|Overall Study|Adverse Event|3
3015685|NCT00836745|10372229|P1|Overall Study|Lost to Follow-up|10
3015686|NCT00836745|10372229|P1|Overall Study|Death|2
3015687|NCT00836706|10372243|P2|Washout: 7 Days|Withdrawal by Subject|1
3015688|NCT00836706|10372244|P1|Washout: 7 Days|Withdrawal by Subject|0
3015689|NCT00836693|10372254|P2|Overall Study|Lost to Follow-up|0
3015690|NCT00836693|10372255|P1|Overall Study|Lost to Follow-up|1
3015691|NCT00836693|10372254|P2|Overall Study|Protocol Violation|0
3015692|NCT00836693|10372255|P1|Overall Study|Protocol Violation|1
3015693|NCT00836693|10372254|P2|Overall Study|Withdrawal by Subject|4
3015694|NCT00836693|10372255|P1|Overall Study|Withdrawal by Subject|9
3015695|NCT00836693|10372254|P2|Overall Study|Physician Decision|0
3015696|NCT00836693|10372255|P1|Overall Study|Physician Decision|2
3015697|NCT00836693|10372254|P2|Overall Study|Sponsor Decision|1
3015698|NCT00836693|10372255|P1|Overall Study|Sponsor Decision|0
3015699|NCT00836693|10372254|P2|Overall Study|Adverse Event|1
3015700|NCT00836693|10372255|P1|Overall Study|Adverse Event|4
3015701|NCT00836589|10372305|P1|Overall Study|Withdrawal by Subject or Physician|591
3015702|NCT00836589|10372305|P1|Overall Study|Death|429
3015703|NCT00836589|10372305|P1|Overall Study|Lost to Follow-up|246
3015704|NCT00836498|10372338|P2|Overall Study|Withdrawal by Subject|1
3015705|NCT00836498|10372339|P1|Overall Study|Withdrawal by Subject|2
3015706|NCT00836498|10372338|P2|Overall Study|Lost to Follow-up|0
3015707|NCT00836498|10372339|P1|Overall Study|Lost to Follow-up|1
3015708|NCT00836498|10372338|P2|Overall Study|Adverse Event|0
3015709|NCT00836498|10372339|P1|Overall Study|Adverse Event|1
3015710|NCT00836472|10372371|P2|Washout|Withdrawal by Subject|1
3015711|NCT00836472|10372372|P1|Washout|Withdrawal by Subject|1
3015712|NCT00836472|10372371|P2|Washout|Adverse Event|2
3015713|NCT00836472|10372372|P1|Washout|Adverse Event|1
3015714|NCT00836277|10372449|P1|Overall Study|Not evaluable for response|6
3015715|NCT00836095|10372459|P2|Overall Study|Physician Decision|3
3015716|NCT00836095|10372460|P1|Overall Study|Physician Decision|0
3015717|NCT00836056|10372470|P2|First Intervention|Adverse Event|0
3015718|NCT00836056|10372471|P1|First Intervention|Adverse Event|1
3015719|NCT00835991|10372500|P2|Washout|Withdrawal by Subject|1
3015720|NCT00835991|10372501|P1|Washout|Withdrawal by Subject|3
3015721|NCT00835991|10372500|P2|Washout|Protocol Violation|2
3015722|NCT00835991|10372501|P1|Washout|Protocol Violation|0
3015723|NCT00835991|10372500|P2|First Intervention|Adverse Event|1
3015724|NCT00835991|10372501|P1|First Intervention|Adverse Event|0
3015725|NCT00835978|10372519|P4|Overall Study|Study terminated by sponsor|0
3015726|NCT00835978|10372520|P3|Overall Study|Study terminated by sponsor|30
3015727|NCT00835978|10372521|P2|Overall Study|Study terminated by sponsor|8
3015728|NCT00835978|10372522|P1|Overall Study|Study terminated by sponsor|12
3015729|NCT00835978|10372519|P4|Overall Study|Withdrawal by Subject|5
3015730|NCT00835978|10372520|P3|Overall Study|Withdrawal by Subject|0
3015731|NCT00835978|10372521|P2|Overall Study|Withdrawal by Subject|3
3015732|NCT00835978|10372522|P1|Overall Study|Withdrawal by Subject|0
3015733|NCT00835978|10372519|P4|Overall Study|Adverse Event|0
3015734|NCT00835978|10372520|P3|Overall Study|Adverse Event|1
3015735|NCT00835978|10372521|P2|Overall Study|Adverse Event|0
3015736|NCT00835978|10372522|P1|Overall Study|Adverse Event|1
3015737|NCT00835978|10372519|P4|Overall Study|Objective progression or relapse|0
3015738|NCT00835978|10372520|P3|Overall Study|Objective progression or relapse|1
3015739|NCT00835978|10372521|P2|Overall Study|Objective progression or relapse|0
3015740|NCT00835978|10372522|P1|Overall Study|Objective progression or relapse|2
3015741|NCT00835978|10372519|P4|Overall Study|Other|0
3015742|NCT00835978|10372520|P3|Overall Study|Other|8
3015743|NCT00835978|10372521|P2|Overall Study|Other|1
3015744|NCT00835978|10372522|P1|Overall Study|Other|5
3015745|NCT00835978|10372519|P4|Overall Study|Lost to Follow-up|1
3015746|NCT00835978|10372520|P3|Overall Study|Lost to Follow-up|2
3015747|NCT00835978|10372521|P2|Overall Study|Lost to Follow-up|4
3015748|NCT00835978|10372522|P1|Overall Study|Lost to Follow-up|3
3015749|NCT00835978|10372519|P4|Overall Study|Death|4
3015750|NCT00835978|10372520|P3|Overall Study|Death|49
3015751|NCT00835978|10372521|P2|Overall Study|Death|40
3015752|NCT00835978|10372522|P1|Overall Study|Death|33
3015753|NCT00835796|10372633|P2|First Intervention|Withdrawal by Subject|1
3015754|NCT00835796|10372634|P1|First Intervention|Withdrawal by Subject|0
3015755|NCT00835731|10372644|P2|Overall Study|Physician Decision|1
3015756|NCT00835731|10372645|P1|Overall Study|Physician Decision|1
3015757|NCT00835731|10372644|P2|Overall Study|Withdrawal by Subject|0
3015758|NCT00835731|10372645|P1|Overall Study|Withdrawal by Subject|1
3015759|NCT00835705|10372665|P2|Second Intervention|Difficulty with vein|0
3015760|NCT00835705|10372666|P1|Second Intervention|Difficulty with vein|1
3015761|NCT00835705|10372665|P2|First Intervention|Difficulty with vein|0
3015762|NCT00835705|10372666|P1|First Intervention|Difficulty with vein|1
3015763|NCT00835692|10372682|P2|First Intervention|Withdrawal by Subject|0
3015764|NCT00835692|10372683|P1|First Intervention|Withdrawal by Subject|1
3015765|NCT00835679|10372695|P4|Overall Study|Withdrawal by Subject|0
3015766|NCT00835679|10372696|P3|Overall Study|Withdrawal by Subject|0
3015767|NCT00835679|10372697|P2|Overall Study|Withdrawal by Subject|0
3015768|NCT00835679|10372698|P1|Overall Study|Withdrawal by Subject|1
3015769|NCT00835666|10372722|P2|Washout|Withdrawal by Subject|0
3015770|NCT00835666|10372723|P1|Washout|Withdrawal by Subject|1
3015771|NCT00835666|10372722|P2|Washout|Protocol Violation|0
3015772|NCT00835666|10372723|P1|Washout|Protocol Violation|1
3015773|NCT00835640|10372733|P2|Second Intervention|Protocol Violation|0
3015774|NCT00835640|10372734|P1|Second Intervention|Protocol Violation|1
3015775|NCT00835575|10372766|P2|Washout of 14 Days|Withdrawal by Subject|0
3015776|NCT00835575|10372767|P1|Washout of 14 Days|Withdrawal by Subject|1
3015777|NCT00835549|10372777|P2|Washout of 7 Days|Withdrawal by Subject|0
3015778|NCT00835549|10372778|P1|Washout of 7 Days|Withdrawal by Subject|2
3015779|NCT00835536|10372788|P2|Washout of 5 Weeks|Withdrawal by Subject|0
3015780|NCT00835536|10372789|P1|Washout of 5 Weeks|Withdrawal by Subject|1
3015781|NCT00835406|10372850|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
3015782|NCT00835406|10372851|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
3015783|NCT00835406|10372850|P2|Period: First Intervention|Withdrawal by Subject|0
3015784|NCT00835406|10372851|P1|Period: First Intervention|Withdrawal by Subject|2
3015785|NCT00835406|10372850|P2|Period: First Intervention|Adverse Event|1
3015786|NCT00835406|10372851|P1|Period: First Intervention|Adverse Event|0
3015787|NCT00835380|10372857|P1|Overall Study|Withdrawal by Subject|2
3015788|NCT00835367|10372864|P2|Second Intervention|Adverse Event|1
3015789|NCT00835367|10372865|P1|Second Intervention|Adverse Event|1
3015790|NCT00835367|10372864|P2|Washout|Withdrawal by Subject|0
3015791|NCT00835367|10372865|P1|Washout|Withdrawal by Subject|1
3015792|NCT00835367|10372864|P2|Washout|Adverse Event|0
3015793|NCT00835367|10372865|P1|Washout|Adverse Event|2
3015794|NCT00835354|10372887|P2|First Intervention|Adverse Event|1
3015795|NCT00835354|10372888|P1|First Intervention|Adverse Event|0
3015796|NCT00835341|10372898|P2|Overall Study|Lost to Follow-up|12
3015797|NCT00835341|10372899|P1|Overall Study|Lost to Follow-up|3
3015798|NCT00835263|10372962|P2|Second Intervention|Adverse Event|0
3015799|NCT00835263|10372963|P1|Second Intervention|Adverse Event|1
3015800|NCT00835237|10372973|P2|Overall Study|Withdrawal by Subject|0
3015801|NCT00835237|10372974|P1|Overall Study|Withdrawal by Subject|2
3015802|NCT00835237|10372973|P2|Overall Study|Lost to Follow-up|0
3015803|NCT00835237|10372974|P1|Overall Study|Lost to Follow-up|4
3015804|NCT00835211|10373014|P2|Washout: 7 Days|Withdrawal by Subject|0
3015805|NCT00835211|10373015|P1|Washout: 7 Days|Withdrawal by Subject|1
3015806|NCT00835211|10373014|P2|Washout: 7 Days|Adverse Event|1
3015807|NCT00835211|10373015|P1|Washout: 7 Days|Adverse Event|2
3015808|NCT00835211|10373014|P2|First Intervention|Withdrawal by Subject|1
3015809|NCT00835211|10373015|P1|First Intervention|Withdrawal by Subject|0
3015810|NCT00835172|10373061|P2|Washout|Protocol Violation|1
3015811|NCT00835172|10373062|P1|Washout|Protocol Violation|0
3015812|NCT00835120|10373088|P1|Overall Study|Withdrawal by Subject|2
3015813|NCT00835120|10373088|P1|Overall Study|Adverse Event|2
3015814|NCT00835120|10373088|P1|Overall Study|Lost to Follow-up|3
3015815|NCT00835120|10373088|P1|Overall Study|Lack of Efficacy|1
3015816|NCT00835081|10373098|P2|Washout of 7 Days|Withdrawal by Subject|0
3015817|NCT00835081|10373099|P1|Washout of 7 Days|Withdrawal by Subject|1
3015818|NCT00835068|10373109|P2|Overall Study|Withdrawal by Subject|0
3015819|NCT00835068|10373110|P1|Overall Study|Withdrawal by Subject|1
3015820|NCT00835068|10373109|P2|Overall Study|Other|0
3015821|NCT00835068|10373110|P1|Overall Study|Other|8
3015822|NCT00835068|10373109|P2|Overall Study|Adverse Event|1
3015823|NCT00835068|10373110|P1|Overall Study|Adverse Event|0
3015824|NCT00835068|10373109|P2|Overall Study|Death|0
3015825|NCT00835068|10373110|P1|Overall Study|Death|1
3015826|NCT00835042|10373130|P2|Washout of 21 Days|Withdrawal by Subject|2
3015827|NCT00835042|10373131|P1|Washout of 21 Days|Withdrawal by Subject|0
3015828|NCT00835042|10373130|P2|First Intervention|Adverse Event|2
3015829|NCT00835042|10373131|P1|First Intervention|Adverse Event|1
3015830|NCT00835042|10373130|P2|First Intervention|Withdrawal by Subject|0
3015831|NCT00835042|10373131|P1|First Intervention|Withdrawal by Subject|3
3015832|NCT00834912|10373217|P6|Treatment Period 2|Withdrawal by Subject|0
3015833|NCT00834912|10373218|P5|Treatment Period 2|Withdrawal by Subject|1
3015834|NCT00834912|10373219|P4|Treatment Period 2|Withdrawal by Subject|0
3015835|NCT00834912|10373220|P3|Treatment Period 2|Withdrawal by Subject|1
3015836|NCT00834912|10373221|P2|Treatment Period 2|Withdrawal by Subject|0
3015837|NCT00834912|10373222|P1|Treatment Period 2|Withdrawal by Subject|0
3015838|NCT00834912|10373217|P6|Treatment Period 1|Adverse Event|0
3015839|NCT00834912|10373218|P5|Treatment Period 1|Adverse Event|0
3015840|NCT00834912|10373219|P4|Treatment Period 1|Adverse Event|1
3015841|NCT00834912|10373220|P3|Treatment Period 1|Adverse Event|0
3015842|NCT00834912|10373221|P2|Treatment Period 1|Adverse Event|1
3015843|NCT00834912|10373222|P1|Treatment Period 1|Adverse Event|0
3015844|NCT00834899|10373244|P2|Overall Study|Withdrawal by Subject|1
3015845|NCT00834899|10373245|P1|Overall Study|Withdrawal by Subject|1
3015846|NCT00834873|10373284|P2|First Intervention|Adverse Event|1
3015847|NCT00834873|10373285|P1|First Intervention|Adverse Event|0
3015848|NCT00834834|10373295|P2|Overall Study|Withdrawal by Subject|3
3015849|NCT00834834|10373296|P1|Overall Study|Withdrawal by Subject|4
3015850|NCT00834795|10373331|P2|Second Intervention|Adverse Event|0
3015851|NCT00834795|10373332|P1|Second Intervention|Adverse Event|1
3015852|NCT00834795|10373331|P2|Washout: 7 Days|Withdrawal by Subject|1
3015853|NCT00834795|10373332|P1|Washout: 7 Days|Withdrawal by Subject|0
3015854|NCT00834756|10373342|P2|Washout: 21 Days|Withdrawal by Subject|0
3015855|NCT00834756|10373343|P1|Washout: 21 Days|Withdrawal by Subject|1
3015856|NCT00834756|10373342|P2|First Intervention|Adverse Event|0
3015857|NCT00834756|10373343|P1|First Intervention|Adverse Event|1
3015858|NCT00834743|10373353|P2|Second Intervention|Withdrawal by Subject|0
3015859|NCT00834743|10373354|P1|Second Intervention|Withdrawal by Subject|1
3015860|NCT00834717|10373364|P2|First Intervention|Withdrawal by Subject|1
3015861|NCT00834717|10373365|P1|First Intervention|Withdrawal by Subject|0
3015862|NCT00834717|10373364|P2|First Intervention|Adverse Event|0
3015863|NCT00834717|10373365|P1|First Intervention|Adverse Event|1
3015864|NCT00834639|10373396|P2|Second Intervention|Physician Decision|2
3015865|NCT00834639|10373397|P1|Second Intervention|Physician Decision|0
3015866|NCT00834613|10373414|P2|First Intervention|Protocol Violation|0
3015867|NCT00834613|10373415|P1|First Intervention|Protocol Violation|1
3015868|NCT00834587|10373425|P2|Washout: 7 Days|Withdrawal by Subject|0
3015869|NCT00834587|10373426|P1|Washout: 7 Days|Withdrawal by Subject|1
3015870|NCT00834522|10373475|P2|Washout|Withdrawal by Subject|1
3015871|NCT00834522|10373476|P1|Washout|Withdrawal by Subject|2
3015872|NCT00834522|10373475|P2|Washout|Adverse Event|0
3015873|NCT00834522|10373476|P1|Washout|Adverse Event|1
3015874|NCT00834444|10373499|P2|Second Intervention|Adverse Event|0
3015875|NCT00834444|10373500|P1|Second Intervention|Adverse Event|1
3015876|NCT00834444|10373499|P2|Washout of 7 Days|Withdrawal by Subject|1
3015877|NCT00834444|10373500|P1|Washout of 7 Days|Withdrawal by Subject|0
3015878|NCT00834444|10373499|P2|First Intervention|Intolerance to Venopuncture|1
3015879|NCT00834444|10373500|P1|First Intervention|Intolerance to Venopuncture|0
3015880|NCT00834444|10373499|P2|First Intervention|Adverse Event|0
3015881|NCT00834444|10373500|P1|First Intervention|Adverse Event|1
3015882|NCT00834431|10373510|P2|Washout of 7 Days|Withdrawal by Subject|1
3015883|NCT00834431|10373511|P1|Washout of 7 Days|Withdrawal by Subject|0
3015884|NCT00834431|10373510|P2|First Intervention|Adverse Event|1
3015885|NCT00834431|10373511|P1|First Intervention|Adverse Event|0
3015886|NCT00834418|10373521|P2|Overall Study|Adverse Event|2
3015887|NCT00834418|10373522|P1|Overall Study|Adverse Event|0
3015888|NCT00834366|10373539|P2|Treatment Period 1|Adverse Event|1
3015889|NCT00834366|10373540|P1|Treatment Period 1|Adverse Event|1
3015890|NCT00834340|10373556|P2|Washout|Withdrawal by Subject|0
3015891|NCT00834340|10373557|P1|Washout|Withdrawal by Subject|1
3015892|NCT00834340|10373556|P2|Washout|Adverse Event|0
3015893|NCT00834340|10373557|P1|Washout|Adverse Event|1
3015894|NCT00834249|10373601|P2|Second Intervention|Adverse Event|0
3015895|NCT00834249|10373602|P1|Second Intervention|Adverse Event|1
3015896|NCT00834249|10373601|P2|Washout: 7 Days|Withdrawal by Subject|1
3015897|NCT00834249|10373602|P1|Washout: 7 Days|Withdrawal by Subject|1
3015898|NCT00834080|10373698|P1|Overall Study|Subject Relocated|1
3015899|NCT00834080|10373698|P1|Overall Study|Physician Decision|1
3015900|NCT00834080|10373698|P1|Overall Study|Other - False positive tests of the UDS|1
3015901|NCT00834080|10373698|P1|Overall Study|Other - Pregnancy|1
3015902|NCT00834080|10373698|P1|Overall Study|Withdrawal by Subject|5
3015903|NCT00834080|10373698|P1|Overall Study|Lost to Follow-up|7
3015904|NCT00834080|10373698|P1|Overall Study|Adverse Event|7
3015905|NCT00834067|10373704|P2|Washout of 21 Days|Protocol Violation|1
3015906|NCT00834067|10373705|P1|Washout of 21 Days|Protocol Violation|0
3015907|NCT00834041|10373727|P2|Overall Study|Lost to Follow-up|1
3015908|NCT00834041|10373728|P1|Overall Study|Lost to Follow-up|0
3015909|NCT00834041|10373727|P2|Overall Study|Withdrawal by Subject|0
3015910|NCT00834041|10373728|P1|Overall Study|Withdrawal by Subject|1
3015911|NCT00833989|10373746|P4|Overall Study|Withdrawal by Subject|1
3015912|NCT00833989|10373747|P3|Overall Study|Withdrawal by Subject|1
3015913|NCT00833989|10373748|P2|Overall Study|Withdrawal by Subject|0
3015914|NCT00833989|10373749|P1|Overall Study|Withdrawal by Subject|3
3015915|NCT00833989|10373746|P4|Overall Study|Physician Decision|1
3015916|NCT00833989|10373747|P3|Overall Study|Physician Decision|0
3015917|NCT00833989|10373748|P2|Overall Study|Physician Decision|0
3015918|NCT00833989|10373749|P1|Overall Study|Physician Decision|0
3015919|NCT00833976|10373853|P1|Overall Study|Physician Decision|1
3015920|NCT00833976|10373853|P1|Overall Study|Did not meet eligibility criteria|41
3015921|NCT00833976|10373853|P1|Overall Study|Lost to Follow-up|4
3015922|NCT00833976|10373853|P1|Overall Study|Withdrawal by Subject|5
3015923|NCT00833937|10373861|P2|Washout|Withdrawal by Subject|0
3015924|NCT00833937|10373862|P1|Washout|Withdrawal by Subject|1
3015925|NCT00833924|10373870|P1|Overall Study|In study follow-up|71
3015926|NCT00833924|10373870|P1|Overall Study|Withdrawal by Subject|13
3015927|NCT00833924|10373870|P1|Overall Study|Lost to Follow-up|2
3015928|NCT00833924|10373870|P1|Overall Study|Conversion|2
3015929|NCT00833924|10373870|P1|Overall Study|Death|21
3015930|NCT00833911|10373875|P1|Maintenance Phase II|Lack of Efficacy|1
3015931|NCT00833911|10373875|P1|Maintenance Phase II|Withdrawal by Subject|1
3015932|NCT00833911|10373875|P1|Maintenance Phase II|Physician Decision|2
3015933|NCT00833911|10373875|P1|Maintenance Phase II|Adverse Event|6
3015934|NCT00833911|10373875|P1|Maintenance Phase I|Lack of Efficacy|4
3015935|NCT00833911|10373875|P1|Maintenance Phase I|Physician Decision|10
3015936|NCT00833911|10373875|P1|Maintenance Phase I|Withdrawal by Subject|11
3015937|NCT00833911|10373875|P1|Maintenance Phase I|Adverse Event|73
3015938|NCT00833911|10373875|P1|Titration|Withdrawal by Subject|3
3015939|NCT00833911|10373875|P1|Titration|Adverse Event|18
3015940|NCT00833898|10373885|P2|Overall Study|Patient did not receive transplant|2
3015941|NCT00833898|10373886|P1|Overall Study|Patient did not receive transplant|0
3015942|NCT00833898|10373885|P2|Overall Study|Lost to Follow-up|7
3015943|NCT00833898|10373886|P1|Overall Study|Lost to Follow-up|7
3015944|NCT00833898|10373885|P2|Overall Study|Withdrawal by Subject|27
3015945|NCT00833898|10373886|P1|Overall Study|Withdrawal by Subject|33
3015946|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
3015947|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
3015948|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
3015949|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
3015950|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
3015951|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
3015952|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Other|3
3015953|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Other|4
3015954|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Other|0
3015955|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Other|0
3015956|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Other|0
3015957|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Other|0
3015958|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
3015959|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
3015960|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
3015961|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
3015962|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
3015963|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
3015964|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
3015965|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
3015966|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015967|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015968|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015969|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015970|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Death|9
3015971|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Death|8
3015972|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Death|0
3015973|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Death|0
3015974|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Death|0
3015975|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Death|0
3015976|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
3015977|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
3015978|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
3015979|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
3015980|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
3015981|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
3015982|NCT00833833|10373945|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
3015983|NCT00833833|10373946|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
3015984|NCT00833833|10373947|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
3015985|NCT00833833|10373948|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
3015986|NCT00833833|10373949|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
3015987|NCT00833833|10373950|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
3015988|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Other|0
3015989|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Other|0
3015990|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Other|1
3015991|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Other|0
3015992|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Other|3
3015993|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Other|1
3015994|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015995|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015996|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015997|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
3015998|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
3015999|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
3016000|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Death|0
3016001|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Death|0
3016002|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Death|0
3016003|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Death|2
3016004|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Death|1
3016005|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Death|0
3016006|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
3016007|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
3016008|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
3016009|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
3016010|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
3016011|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
3016012|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
3016013|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
3016014|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
3016015|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
3016016|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
3016017|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
3016018|NCT00833833|10373945|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
3016019|NCT00833833|10373946|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
3016020|NCT00833833|10373947|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
3016021|NCT00833833|10373948|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
3016022|NCT00833833|10373949|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
3016023|NCT00833833|10373950|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
3016024|NCT00833794|10373990|P2|Double-blind Phase|Administrative reason|3
3016025|NCT00833794|10373991|P1|Double-blind Phase|Administrative reason|1
3016026|NCT00833794|10373990|P2|Double-blind Phase|Physician Decision|7
3016027|NCT00833794|10373991|P1|Double-blind Phase|Physician Decision|4
3016028|NCT00833794|10373990|P2|Double-blind Phase|Withdrawal by Subject|6
3016029|NCT00833794|10373991|P1|Double-blind Phase|Withdrawal by Subject|23
3016030|NCT00833794|10373990|P2|Double-blind Phase|Lack of Efficacy|22
3016031|NCT00833794|10373991|P1|Double-blind Phase|Lack of Efficacy|34
3016032|NCT00833794|10373990|P2|Double-blind Phase|Adverse Event|11
3016033|NCT00833794|10373991|P1|Double-blind Phase|Adverse Event|44
3016034|NCT00833794|10373990|P2|Open-label Phase|enrolled in error (immediately D/C)|0
3016035|NCT00833794|10373991|P1|Open-label Phase|enrolled in error (immediately D/C)|1
3016036|NCT00833794|10373990|P2|Open-label Phase|Did not complete wash-out period|0
3016037|NCT00833794|10373991|P1|Open-label Phase|Did not complete wash-out period|12
3016038|NCT00833794|10373990|P2|Open-label Phase|Protocol Violation|0
3016039|NCT00833794|10373991|P1|Open-label Phase|Protocol Violation|47
3016040|NCT00833794|10373990|P2|Open-label Phase|Administrative reason|0
3016041|NCT00833794|10373991|P1|Open-label Phase|Administrative reason|1
3016042|NCT00833794|10373990|P2|Open-label Phase|Physician Decision|0
3016043|NCT00833794|10373991|P1|Open-label Phase|Physician Decision|20
3016044|NCT00833794|10373990|P2|Open-label Phase|Withdrawal by Subject|0
3016045|NCT00833794|10373991|P1|Open-label Phase|Withdrawal by Subject|48
3016046|NCT00833794|10373990|P2|Open-label Phase|Lack of Efficacy|0
3016047|NCT00833794|10373991|P1|Open-label Phase|Lack of Efficacy|28
3016048|NCT00833794|10373990|P2|Open-label Phase|Adverse Event|0
3016049|NCT00833794|10373991|P1|Open-label Phase|Adverse Event|225
3016050|NCT00833755|10374035|P4|Overall Study|Subject had scheduling issues|0
3016051|NCT00833755|10374036|P3|Overall Study|Subject had scheduling issues|0
3016052|NCT00833755|10374037|P2|Overall Study|Subject had scheduling issues|1
3016053|NCT00833755|10374038|P1|Overall Study|Subject had scheduling issues|0
3016054|NCT00833755|10374035|P4|Overall Study|Physician Decision|6
3016055|NCT00833755|10374036|P3|Overall Study|Physician Decision|2
3016056|NCT00833755|10374037|P2|Overall Study|Physician Decision|4
3016057|NCT00833755|10374038|P1|Overall Study|Physician Decision|4
3016058|NCT00833703|10374058|P2|Overall Study|Parent(s)/guardian(s)'s request|1
3016059|NCT00833703|10374059|P1|Overall Study|Parent(s)/guardian(s)'s request|0
3016060|NCT00833690|10374072|P3|Overall Study|Discontinued study drug|0
3016061|NCT00833690|10374073|P2|Overall Study|Discontinued study drug|2
3016062|NCT00833690|10374074|P1|Overall Study|Discontinued study drug|3
3016063|NCT00833690|10374072|P3|Overall Study|Withdrawal by Subject|0
3016064|NCT00833690|10374073|P2|Overall Study|Withdrawal by Subject|0
3016065|NCT00833690|10374074|P1|Overall Study|Withdrawal by Subject|1
3016066|NCT00833638|10374210|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
3016067|NCT00833638|10374211|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
3016068|NCT00833638|10374212|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
3016069|NCT00833638|10374210|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
3016070|NCT00833638|10374211|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
3016071|NCT00833638|10374212|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
3016072|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
3016073|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
3016074|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
3016075|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
3016076|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
3016077|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
3016078|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
3016079|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
3016080|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
3016081|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
3016082|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
3016083|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
3016084|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
3016085|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
3016086|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
3016087|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
3016088|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
3016089|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
3016090|NCT00833638|10374210|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
3016091|NCT00833638|10374211|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
3016092|NCT00833638|10374212|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
3016093|NCT00833560|10374263|P1|Overall Study|Other|5
3016094|NCT00833560|10374263|P1|Overall Study|Pregression of other disease|1
3016095|NCT00833560|10374263|P1|Overall Study|Death|2
3016096|NCT00833560|10374263|P1|Overall Study|Lack of Efficacy|4
3016097|NCT00833560|10374263|P1|Overall Study|Protocol Violation|6
3016098|NCT00833560|10374263|P1|Overall Study|Adverse Event|11
3016099|NCT00833560|10374263|P1|Overall Study|Toxicity|13
3016100|NCT00833547|10374272|P2|Overall Study|Withdrawal by Subject|2
3016101|NCT00833547|10374273|P1|Overall Study|Withdrawal by Subject|2
3016102|NCT00833482|10374294|P6|Days 21-30|Withdrawal by Subject|0
3016103|NCT00833482|10374295|P5|Days 21-30|Withdrawal by Subject|1
3016104|NCT00833482|10374296|P4|Days 21-30|Withdrawal by Subject|0
3016105|NCT00833482|10374297|P3|Days 21-30|Withdrawal by Subject|0
3016106|NCT00833482|10374298|P2|Days 21-30|Withdrawal by Subject|0
3016107|NCT00833482|10374299|P1|Days 21-30|Withdrawal by Subject|0
3016108|NCT00833482|10374294|P6|Days 21-30|Adverse Event|0
3016109|NCT00833482|10374295|P5|Days 21-30|Adverse Event|0
3016110|NCT00833482|10374296|P4|Days 21-30|Adverse Event|0
3016111|NCT00833482|10374297|P3|Days 21-30|Adverse Event|1
3016112|NCT00833482|10374298|P2|Days 21-30|Adverse Event|0
3016113|NCT00833482|10374299|P1|Days 21-30|Adverse Event|0
3016114|NCT00833482|10374294|P6|Days 11-20|Withdrawal by Subject|0
3016115|NCT00833482|10374295|P5|Days 11-20|Withdrawal by Subject|0
3016116|NCT00833482|10374296|P4|Days 11-20|Withdrawal by Subject|0
3016117|NCT00833482|10374297|P3|Days 11-20|Withdrawal by Subject|0
3016118|NCT00833482|10374298|P2|Days 11-20|Withdrawal by Subject|1
3016119|NCT00833482|10374299|P1|Days 11-20|Withdrawal by Subject|0
3016120|NCT00833482|10374294|P6|Days 11-20|Adverse Event|0
3016121|NCT00833482|10374295|P5|Days 11-20|Adverse Event|0
3016122|NCT00833482|10374296|P4|Days 11-20|Adverse Event|0
3016123|NCT00833482|10374297|P3|Days 11-20|Adverse Event|0
3016124|NCT00833482|10374298|P2|Days 11-20|Adverse Event|2
3016125|NCT00833482|10374299|P1|Days 11-20|Adverse Event|0
3016126|NCT00833469|10374355|P1|Overall Study|Lost to Follow-up|1
3016127|NCT00833469|10374355|P1|Overall Study|Withdrawal by Subject|1
3016128|NCT00833417|10374378|P2|Overall Study|Reason Not Specified|1
3016129|NCT00833417|10374379|P1|Overall Study|Reason Not Specified|0
3016130|NCT00833417|10374378|P2|Overall Study|Disease Progression|17
3016131|NCT00833417|10374379|P1|Overall Study|Disease Progression|18
3016132|NCT00833417|10374378|P2|Overall Study|Sponsor Decision to Terminate Study|2
3016133|NCT00833417|10374379|P1|Overall Study|Sponsor Decision to Terminate Study|1
3016134|NCT00833417|10374378|P2|Overall Study|Patient Decision to Withdraw|23
3016135|NCT00833417|10374379|P1|Overall Study|Patient Decision to Withdraw|4
3016136|NCT00833417|10374378|P2|Overall Study|Physician Decision to Withdraw Patient|7
3016137|NCT00833417|10374379|P1|Overall Study|Physician Decision to Withdraw Patient|3
3016138|NCT00833417|10374378|P2|Overall Study|Lost to Follow-up|2
3016139|NCT00833417|10374379|P1|Overall Study|Lost to Follow-up|1
3016140|NCT00833417|10374378|P2|Overall Study|Death|3
3016141|NCT00833417|10374379|P1|Overall Study|Death|1
3016142|NCT00833417|10374378|P2|Overall Study|Adverse Event|16
3016143|NCT00833417|10374379|P1|Overall Study|Adverse Event|5
3016144|NCT00833261|10374403|P1|Overall Study|Withdrawal by Subject|4
3016145|NCT00833248|10374410|P2|Overall Study|Withdrawal by Subject|1
3016146|NCT00833248|10374411|P1|Overall Study|Withdrawal by Subject|0
3016147|NCT00833248|10374410|P2|Overall Study|Protocol Violation|2
3016148|NCT00833248|10374411|P1|Overall Study|Protocol Violation|1
3016149|NCT00833248|10374410|P2|Overall Study|Adverse Event|0
3016150|NCT00833248|10374411|P1|Overall Study|Adverse Event|3
3016151|NCT00833105|10374433|P1|Overall Study|Adverse Event|2
3016152|NCT00833105|10374433|P1|Overall Study|Withdrawal by Subject|1
3016153|NCT00833092|10374451|P2|Overall Study|constipation|1
3016154|NCT00833092|10374452|P1|Overall Study|constipation|0
3016155|NCT00833092|10374451|P2|Overall Study|Diarrhea|2
3016156|NCT00833092|10374452|P1|Overall Study|Diarrhea|0
3016157|NCT00833092|10374451|P2|Overall Study|Protocol Violation|1
3016158|NCT00833092|10374452|P1|Overall Study|Protocol Violation|2
3016159|NCT00833092|10374451|P2|Overall Study|Withdrawal by Subject|3
3016160|NCT00833092|10374452|P1|Overall Study|Withdrawal by Subject|2
3016161|NCT00833053|10374460|P2|Overall Study|Protocol Violation|1
3016162|NCT00833053|10374461|P1|Overall Study|Protocol Violation|2
3016163|NCT00833053|10374460|P2|Overall Study|Withdrawal by Subject|1
3016164|NCT00833053|10374461|P1|Overall Study|Withdrawal by Subject|0
3016165|NCT00833053|10374460|P2|Overall Study|Treatment Failure|1
3016166|NCT00833053|10374461|P1|Overall Study|Treatment Failure|3
3016167|NCT00833053|10374460|P2|Overall Study|Adverse Event|0
3016168|NCT00833053|10374461|P1|Overall Study|Adverse Event|4
3016169|NCT00833040|10374479|P6|Overall Study|Adverse Event|1
3016170|NCT00833040|10374480|P5|Overall Study|Adverse Event|0
3016171|NCT00833040|10374481|P4|Overall Study|Adverse Event|0
3016172|NCT00833040|10374482|P3|Overall Study|Adverse Event|0
3016173|NCT00833040|10374483|P2|Overall Study|Adverse Event|0
3016174|NCT00833040|10374484|P1|Overall Study|Adverse Event|0
3016175|NCT00833027|10374489|P1|Overall Study|Missing|10
3016176|NCT00833027|10374489|P1|Overall Study|Withdrawal by Subject|16
3016177|NCT00833027|10374489|P1|Overall Study|Protocol Violation|115
3016178|NCT00833027|10374489|P1|Overall Study|Lost to Follow-up|24
3016179|NCT00833027|10374489|P1|Overall Study|Lack of Efficacy|12
3016180|NCT00833027|10374489|P1|Overall Study|Death|1
3016181|NCT00833027|10374489|P1|Overall Study|Adverse Event|33
3016182|NCT00832975|10374494|P1|Overall Study|Other reasons|14
3016183|NCT00832975|10374494|P1|Overall Study|Withdrawal by Subject|3
3016184|NCT00832975|10374494|P1|Overall Study|Physician Decision|4
3016185|NCT00832975|10374494|P1|Overall Study|Death|5
3016186|NCT00832975|10374494|P1|Overall Study|Protocol Violation|6
3016187|NCT00832975|10374494|P1|Overall Study|Lost to Follow-up|7
3016188|NCT00832819|10374508|P3|Overall Study|Protocol Violation|1
3016189|NCT00832819|10374509|P2|Overall Study|Protocol Violation|0
3016190|NCT00832819|10374510|P1|Overall Study|Protocol Violation|0
3016191|NCT00832819|10374508|P3|Overall Study|Adverse Event|0
3016192|NCT00832819|10374509|P2|Overall Study|Adverse Event|1
3016193|NCT00832819|10374510|P1|Overall Study|Adverse Event|0
3016194|NCT00832780|10374516|P1|Overall Study|Physician Decision|1
3016195|NCT00832780|10374516|P1|Overall Study|other complicating condition|2
3016196|NCT00832780|10374516|P1|Overall Study|no reason given|2
3016197|NCT00832780|10374516|P1|Overall Study|Lost to Follow-up|4
3016198|NCT00832780|10374516|P1|Overall Study|Death|16
3016199|NCT00832650|10374558|P3|Overall Study|Randomized but not treated|1
3016200|NCT00832650|10374559|P2|Overall Study|Randomized but not treated|0
3016201|NCT00832650|10374560|P1|Overall Study|Randomized but not treated|0
3016202|NCT00832624|10374600|P1|Overall Study|Study Terminated|10
3016203|NCT00832585|10374610|P1|Overall Study|Lost to Follow-up|1
3016204|NCT00832585|10374610|P1|Overall Study|Withdrawal by Subject|1
3016205|NCT00832455|10374635|P1|Overall Study|Patient moved|1
3016206|NCT00832455|10374635|P1|Overall Study|No improvement|3
3016207|NCT00832455|10374635|P1|Overall Study|Parent dissatisfied|1
3016208|NCT00832455|10374635|P1|Overall Study|Parent misunderstood study|1
3016209|NCT00832455|10374635|P1|Overall Study|Stopped Medication|4
3016210|NCT00832455|10374635|P1|Overall Study|Screening Failure|2
3016211|NCT00832455|10374635|P1|Overall Study|Withdrawal by Subject|17
3016212|NCT00832455|10374635|P1|Overall Study|Protocol Violation|4
3016213|NCT00832455|10374635|P1|Overall Study|Lost to Follow-up|26
3016214|NCT00832455|10374635|P1|Overall Study|Adverse Event|13
3016215|NCT00832416|10374659|P4|Overall Study|Death|0
3016216|NCT00832416|10374660|P3|Overall Study|Death|0
3016217|NCT00832416|10374661|P2|Overall Study|Death|0
3016218|NCT00832416|10374662|P1|Overall Study|Death|1
3016219|NCT00832416|10374659|P4|Overall Study|Adverse Event|10
3016220|NCT00832416|10374660|P3|Overall Study|Adverse Event|41
3016221|NCT00832416|10374661|P2|Overall Study|Adverse Event|19
3016222|NCT00832416|10374662|P1|Overall Study|Adverse Event|21
3016223|NCT00832416|10374659|P4|Overall Study|Administrative|1
3016224|NCT00832416|10374660|P3|Overall Study|Administrative|0
3016225|NCT00832416|10374661|P2|Overall Study|Administrative|0
3016226|NCT00832416|10374662|P1|Overall Study|Administrative|0
3016227|NCT00832416|10374659|P4|Overall Study|Physician Decision|10
3016228|NCT00832416|10374660|P3|Overall Study|Physician Decision|5
3016229|NCT00832416|10374661|P2|Overall Study|Physician Decision|12
3016230|NCT00832416|10374662|P1|Overall Study|Physician Decision|2
3016231|NCT00832416|10374659|P4|Overall Study|Withdrawal by Subject|10
3016232|NCT00832416|10374660|P3|Overall Study|Withdrawal by Subject|2
3016233|NCT00832416|10374661|P2|Overall Study|Withdrawal by Subject|7
3016234|NCT00832416|10374662|P1|Overall Study|Withdrawal by Subject|5
3016235|NCT00832416|10374659|P4|Overall Study|Lack of Efficacy|52
3016236|NCT00832416|10374660|P3|Overall Study|Lack of Efficacy|13
3016237|NCT00832416|10374661|P2|Overall Study|Lack of Efficacy|15
3016238|NCT00832416|10374662|P1|Overall Study|Lack of Efficacy|17
3016239|NCT00832377|10374713|P1|Overall Study|Protocol Violation|1
3016240|NCT00832117|10374759|P1|Overall Study|Disease Progression|11
3016241|NCT00832117|10374759|P1|Overall Study|Death|1
3016242|NCT00832091|10374778|P2|Overall Study|Prohibited Medication|0
3016243|NCT00832091|10374779|P1|Overall Study|Prohibited Medication|1
3016244|NCT00832091|10374778|P2|Overall Study|Withdrawal by Subject|1
3016245|NCT00832091|10374779|P1|Overall Study|Withdrawal by Subject|2
3016246|NCT00832091|10374778|P2|Overall Study|Protocol Violation|0
3016247|NCT00832091|10374779|P1|Overall Study|Protocol Violation|1
3016248|NCT00832091|10374778|P2|Overall Study|Adverse Event|1
3016249|NCT00832091|10374779|P1|Overall Study|Adverse Event|1
3016250|NCT00832078|10374787|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
3016251|NCT00832078|10374788|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
3016252|NCT00832078|10374787|P2|Test Day 1-2 Period|Lack of Efficacy|2
3016253|NCT00832078|10374788|P1|Test Day 1-2 Period|Lack of Efficacy|0
3016254|NCT00832000|10374794|P2|Overall Study|No calls to IVR in period 2|0
3016255|NCT00832000|10374795|P1|Overall Study|No calls to IVR in period 2|2
3016256|NCT00832000|10374794|P2|Overall Study|No calls to IVR in either period|1
3016257|NCT00832000|10374795|P1|Overall Study|No calls to IVR in either period|1
3016258|NCT00832000|10374794|P2|Overall Study|Withdrawal by Subject|0
3016259|NCT00832000|10374795|P1|Overall Study|Withdrawal by Subject|1
3016260|NCT00832000|10374794|P2|Overall Study|Adverse Event|0
3016261|NCT00832000|10374795|P1|Overall Study|Adverse Event|2
3016262|NCT00831844|10374856|P10|Overall Study|Ineligible|0
3016263|NCT00831844|10374857|P9|Overall Study|Ineligible|0
3016264|NCT00831844|10374858|P8|Overall Study|Ineligible|0
3016265|NCT00831844|10374859|P7|Overall Study|Ineligible|0
3016266|NCT00831844|10374860|P6|Overall Study|Ineligible|0
3016267|NCT00831844|10374861|P5|Overall Study|Ineligible|1
3016268|NCT00831844|10374862|P4|Overall Study|Ineligible|0
3016269|NCT00831844|10374863|P3|Overall Study|Ineligible|1
3016270|NCT00831844|10374864|P2|Overall Study|Ineligible|1
3016271|NCT00831844|10374865|P1|Overall Study|Ineligible|0
3016272|NCT00831844|10374856|P10|Overall Study|Withdrawal by Subject|0
3016273|NCT00831844|10374857|P9|Overall Study|Withdrawal by Subject|1
3016274|NCT00831844|10374858|P8|Overall Study|Withdrawal by Subject|1
3016275|NCT00831844|10374859|P7|Overall Study|Withdrawal by Subject|0
3016276|NCT00831844|10374860|P6|Overall Study|Withdrawal by Subject|0
3016277|NCT00831844|10374861|P5|Overall Study|Withdrawal by Subject|0
3016278|NCT00831844|10374862|P4|Overall Study|Withdrawal by Subject|0
3016279|NCT00831844|10374863|P3|Overall Study|Withdrawal by Subject|1
3016280|NCT00831844|10374864|P2|Overall Study|Withdrawal by Subject|0
3016281|NCT00831844|10374865|P1|Overall Study|Withdrawal by Subject|0
3016282|NCT00831844|10374856|P10|Overall Study|Physician Decision|0
3016283|NCT00831844|10374857|P9|Overall Study|Physician Decision|1
3016284|NCT00831844|10374858|P8|Overall Study|Physician Decision|0
3016285|NCT00831844|10374859|P7|Overall Study|Physician Decision|0
3016286|NCT00831844|10374860|P6|Overall Study|Physician Decision|1
3016287|NCT00831844|10374861|P5|Overall Study|Physician Decision|1
3016288|NCT00831844|10374862|P4|Overall Study|Physician Decision|1
3016289|NCT00831844|10374863|P3|Overall Study|Physician Decision|3
3016290|NCT00831844|10374864|P2|Overall Study|Physician Decision|1
3016291|NCT00831844|10374865|P1|Overall Study|Physician Decision|0
3016292|NCT00831844|10374856|P10|Overall Study|Lack of Efficacy|0
3016293|NCT00831844|10374857|P9|Overall Study|Lack of Efficacy|7
3016294|NCT00831844|10374858|P8|Overall Study|Lack of Efficacy|9
3016295|NCT00831844|10374859|P7|Overall Study|Lack of Efficacy|8
3016296|NCT00831844|10374860|P6|Overall Study|Lack of Efficacy|17
3016297|NCT00831844|10374861|P5|Overall Study|Lack of Efficacy|11
3016298|NCT00831844|10374862|P4|Overall Study|Lack of Efficacy|8
3016299|NCT00831844|10374863|P3|Overall Study|Lack of Efficacy|15
3016300|NCT00831844|10374864|P2|Overall Study|Lack of Efficacy|10
3016301|NCT00831844|10374865|P1|Overall Study|Lack of Efficacy|8
3016302|NCT00831844|10374856|P10|Overall Study|Death|0
3016303|NCT00831844|10374857|P9|Overall Study|Death|0
3016304|NCT00831844|10374858|P8|Overall Study|Death|0
3016305|NCT00831844|10374859|P7|Overall Study|Death|0
3016306|NCT00831844|10374860|P6|Overall Study|Death|0
3016307|NCT00831844|10374861|P5|Overall Study|Death|0
3016308|NCT00831844|10374862|P4|Overall Study|Death|1
3016309|NCT00831844|10374863|P3|Overall Study|Death|0
3016310|NCT00831844|10374864|P2|Overall Study|Death|0
3016311|NCT00831844|10374865|P1|Overall Study|Death|0
3016312|NCT00831844|10374856|P10|Overall Study|Adverse Event|0
3016313|NCT00831844|10374857|P9|Overall Study|Adverse Event|0
3016314|NCT00831844|10374858|P8|Overall Study|Adverse Event|0
3016315|NCT00831844|10374859|P7|Overall Study|Adverse Event|2
3016316|NCT00831844|10374860|P6|Overall Study|Adverse Event|1
3016317|NCT00831844|10374861|P5|Overall Study|Adverse Event|1
3016318|NCT00831844|10374862|P4|Overall Study|Adverse Event|0
3016319|NCT00831844|10374863|P3|Overall Study|Adverse Event|0
3016320|NCT00831844|10374864|P2|Overall Study|Adverse Event|0
3016321|NCT00831844|10374865|P1|Overall Study|Adverse Event|2
3016322|NCT00831792|10374887|P1|Overall Study|Lack of Efficacy|1
3016323|NCT00831792|10374887|P1|Overall Study|Death|1
3016324|NCT00831792|10374887|P1|Overall Study|Adverse Event|1
3016325|NCT00831792|10374887|P1|Overall Study|Not Eligible|3
3016326|NCT00831779|10374893|P2|Overall Study|No longer met criteria|1
3016327|NCT00831779|10374894|P1|Overall Study|No longer met criteria|0
3016328|NCT00831779|10374893|P2|Overall Study|Lost to Follow-up|0
3016329|NCT00831779|10374894|P1|Overall Study|Lost to Follow-up|1
3016330|NCT00831701|10374931|P2|Overall Study|Lost to Follow-up|3
3016331|NCT00831701|10374932|P1|Overall Study|Lost to Follow-up|1
3016332|NCT00831701|10374931|P2|Overall Study|Stone expulsion before first medication|2
3016333|NCT00831701|10374932|P1|Overall Study|Stone expulsion before first medication|2
3016334|NCT00831701|10374931|P2|Overall Study|Withdrawal by Subject|0
3016335|NCT00831701|10374932|P1|Overall Study|Withdrawal by Subject|2
3016336|NCT00831493|10374961|P1|Overall Study|Intractable nausea and vomiting|1
3016337|NCT00831441|10374971|P2|Follow Up (30 Days)|missing end of study status|1
3016338|NCT00831441|10374972|P1|Follow Up (30 Days)|missing end of study status|0
3016339|NCT00831441|10374971|P2|Follow Up (30 Days)|non-specified|26
3016340|NCT00831441|10374972|P1|Follow Up (30 Days)|non-specified|16
3016341|NCT00831441|10374971|P2|Follow Up (30 Days)|Death|86
3016342|NCT00831441|10374972|P1|Follow Up (30 Days)|Death|63
3016343|NCT00831441|10374971|P2|Follow Up (30 Days)|Lost to Follow-up|27
3016344|NCT00831441|10374972|P1|Follow Up (30 Days)|Lost to Follow-up|13
3016345|NCT00831441|10374971|P2|Follow Up (30 Days)|Withdrawal by Subject|34
3016346|NCT00831441|10374972|P1|Follow Up (30 Days)|Withdrawal by Subject|41
3016347|NCT00831441|10374971|P2|Randomized|non-specified|266
3016348|NCT00831441|10374972|P1|Randomized|non-specified|276
3016349|NCT00831441|10374971|P2|Randomized|poor/non-compliance|38
3016350|NCT00831441|10374972|P1|Randomized|poor/non-compliance|30
3016351|NCT00831441|10374971|P2|Randomized|Administrative reason by sponsor|2671
3016352|NCT00831441|10374972|P1|Randomized|Administrative reason by sponsor|2780
3016353|NCT00831441|10374971|P2|Randomized|Lost to Follow-up|35
3016354|NCT00831441|10374972|P1|Randomized|Lost to Follow-up|26
3016355|NCT00831441|10374971|P2|Randomized|Withdrawal by Subject|212
3016356|NCT00831441|10374972|P1|Randomized|Withdrawal by Subject|178
3016357|NCT00831441|10374971|P2|Randomized|No longer met criteria|19
3016358|NCT00831441|10374972|P1|Randomized|No longer met criteria|13
3016359|NCT00831441|10374971|P2|Randomized|Physician Decision|35
3016360|NCT00831441|10374972|P1|Randomized|Physician Decision|26
3016361|NCT00831441|10374971|P2|Randomized|Elective procedure|25
3016362|NCT00831441|10374972|P1|Randomized|Elective procedure|26
3016363|NCT00831441|10374971|P2|Randomized|Emergency procedure|2
3016364|NCT00831441|10374972|P1|Randomized|Emergency procedure|2
3016365|NCT00831441|10374971|P2|Randomized|Adverse Event|321
3016366|NCT00831441|10374972|P1|Randomized|Adverse Event|248
3016367|NCT00831441|10374971|P2|Randomized|Death|81
3016368|NCT00831441|10374972|P1|Randomized|Death|82
3016369|NCT00831415|10375004|P1|Overall Study|Death|1
3016370|NCT00831415|10375004|P1|Overall Study|Unsatisfactory response - Efficacy|4
3016371|NCT00831415|10375004|P1|Overall Study|Withdrawal by Subject|35
3016372|NCT00831415|10375004|P1|Overall Study|Protocol Violation|3
3016373|NCT00831415|10375004|P1|Overall Study|Lost to Follow-up|9
3016374|NCT00831415|10375004|P1|Overall Study|Physician Decision|6
3016375|NCT00831415|10375004|P1|Overall Study|Failed to return|3
3016376|NCT00831415|10375004|P1|Overall Study|Adverse Event|14
3016377|NCT00831389|10375013|P2|Overall Study|Withdrawal by Subject|1
3016378|NCT00831389|10375014|P1|Overall Study|Withdrawal by Subject|0
3016379|NCT00831311|10375040|P2|Overall Study|Withdrawal by Subject|4
3016380|NCT00831311|10375041|P1|Overall Study|Withdrawal by Subject|6
3016381|NCT00831311|10375040|P2|Overall Study|Physician Decision|1
3016382|NCT00831311|10375041|P1|Overall Study|Physician Decision|0
3016383|NCT00831311|10375040|P2|Overall Study|Lost to Follow-up|0
3016384|NCT00831311|10375041|P1|Overall Study|Lost to Follow-up|3
3016385|NCT00831311|10375040|P2|Overall Study|Definitive Contraindication|3
3016386|NCT00831311|10375041|P1|Overall Study|Definitive Contraindication|3
3016387|NCT00831233|10375078|P2|Overall Study|Selection Criteria Not Met|0
3016388|NCT00831233|10375079|P1|Overall Study|Selection Criteria Not Met|2
3016389|NCT00831233|10375078|P2|Overall Study|Protocol Violation|0
3016390|NCT00831233|10375079|P1|Overall Study|Protocol Violation|1
3016391|NCT00831233|10375078|P2|Overall Study|Adverse Event|1
3016392|NCT00831233|10375079|P1|Overall Study|Adverse Event|0
3016393|NCT00831181|10375103|P1|Overall Study|Adverse Event|12
3016394|NCT00831129|10375116|P2|Overall Study|9 lost to follow-up reasons uknown|9
3016395|NCT00831129|10375117|P1|Overall Study|9 lost to follow-up reasons uknown|0
3016396|NCT00831129|10375116|P2|Overall Study|Adverse Event|1
3016397|NCT00831129|10375117|P1|Overall Study|Adverse Event|0
3016398|NCT00830960|10375159|P6|Overall Study|No study drug received|7
3016399|NCT00830960|10375160|P5|Overall Study|No study drug received|5
3016400|NCT00830960|10375161|P4|Overall Study|No study drug received|3
3016401|NCT00830960|10375162|P3|Overall Study|No study drug received|4
3016402|NCT00830960|10375163|P2|Overall Study|No study drug received|2
3016403|NCT00830960|10375164|P1|Overall Study|No study drug received|7
3016404|NCT00830960|10375159|P6|Overall Study|Sponsor Decision|7
3016405|NCT00830960|10375160|P5|Overall Study|Sponsor Decision|5
3016406|NCT00830960|10375161|P4|Overall Study|Sponsor Decision|4
3016407|NCT00830960|10375162|P3|Overall Study|Sponsor Decision|3
3016408|NCT00830960|10375163|P2|Overall Study|Sponsor Decision|2
3016409|NCT00830960|10375164|P1|Overall Study|Sponsor Decision|1
3016410|NCT00830960|10375159|P6|Overall Study|Withdrawal by Subject|21
3016411|NCT00830960|10375160|P5|Overall Study|Withdrawal by Subject|16
3016412|NCT00830960|10375161|P4|Overall Study|Withdrawal by Subject|23
3016413|NCT00830960|10375162|P3|Overall Study|Withdrawal by Subject|18
3016414|NCT00830960|10375163|P2|Overall Study|Withdrawal by Subject|19
3016415|NCT00830960|10375164|P1|Overall Study|Withdrawal by Subject|19
3016416|NCT00830960|10375159|P6|Overall Study|Lost to Follow-up|1
3016417|NCT00830960|10375160|P5|Overall Study|Lost to Follow-up|0
3016418|NCT00830960|10375161|P4|Overall Study|Lost to Follow-up|0
3016419|NCT00830960|10375162|P3|Overall Study|Lost to Follow-up|1
3016420|NCT00830960|10375163|P2|Overall Study|Lost to Follow-up|1
3016421|NCT00830960|10375164|P1|Overall Study|Lost to Follow-up|1
3016422|NCT00830960|10375159|P6|Overall Study|Death|1
3016423|NCT00830960|10375160|P5|Overall Study|Death|6
3016424|NCT00830960|10375161|P4|Overall Study|Death|2
3016425|NCT00830960|10375162|P3|Overall Study|Death|3
3016426|NCT00830960|10375163|P2|Overall Study|Death|4
3016427|NCT00830960|10375164|P1|Overall Study|Death|5
3016428|NCT00830947|10375280|P2|Overall Study|Lost to Follow-up|4
3016429|NCT00830947|10375281|P1|Overall Study|Lost to Follow-up|4
3016430|NCT00830869|10375299|P12|Period 2: Part 2|Other|0
3016431|NCT00830869|10375300|P11|Period 2: Part 2|Other|0
3016432|NCT00830869|10375301|P10|Period 2: Part 2|Other|1
3016433|NCT00830869|10375302|P9|Period 2: Part 2|Other|0
3016434|NCT00830869|10375303|P8|Period 2: Part 2|Other|0
3016435|NCT00830869|10375304|P7|Period 2: Part 2|Other|0
3016436|NCT00830869|10375305|P6|Period 2: Part 2|Other|0
3016437|NCT00830869|10375306|P5|Period 2: Part 2|Other|0
3016438|NCT00830869|10375307|P4|Period 2: Part 2|Other|0
3016439|NCT00830869|10375308|P3|Period 2: Part 2|Other|0
3016440|NCT00830869|10375309|P2|Period 2: Part 2|Other|0
3016441|NCT00830869|10375310|P1|Period 2: Part 2|Other|0
3016442|NCT00830869|10375299|P12|Period 2: Part 2|Progressive disease|15
3016443|NCT00830869|10375300|P11|Period 2: Part 2|Progressive disease|8
3016444|NCT00830869|10375301|P10|Period 2: Part 2|Progressive disease|12
3016445|NCT00830869|10375302|P9|Period 2: Part 2|Progressive disease|11
3016446|NCT00830869|10375303|P8|Period 2: Part 2|Progressive disease|14
3016447|NCT00830869|10375304|P7|Period 2: Part 2|Progressive disease|0
3016448|NCT00830869|10375305|P6|Period 2: Part 2|Progressive disease|0
3016449|NCT00830869|10375306|P5|Period 2: Part 2|Progressive disease|0
3016450|NCT00830869|10375307|P4|Period 2: Part 2|Progressive disease|0
3016451|NCT00830869|10375308|P3|Period 2: Part 2|Progressive disease|0
3016452|NCT00830869|10375309|P2|Period 2: Part 2|Progressive disease|0
3016453|NCT00830869|10375310|P1|Period 2: Part 2|Progressive disease|0
3016454|NCT00830869|10375299|P12|Period 2: Part 2|Symptomatic Deterioration|4
3016455|NCT00830869|10375300|P11|Period 2: Part 2|Symptomatic Deterioration|1
3016456|NCT00830869|10375301|P10|Period 2: Part 2|Symptomatic Deterioration|3
3016457|NCT00830869|10375302|P9|Period 2: Part 2|Symptomatic Deterioration|6
3016458|NCT00830869|10375303|P8|Period 2: Part 2|Symptomatic Deterioration|0
3016459|NCT00830869|10375304|P7|Period 2: Part 2|Symptomatic Deterioration|0
3016460|NCT00830869|10375305|P6|Period 2: Part 2|Symptomatic Deterioration|0
3016461|NCT00830869|10375306|P5|Period 2: Part 2|Symptomatic Deterioration|0
3016462|NCT00830869|10375307|P4|Period 2: Part 2|Symptomatic Deterioration|0
3016463|NCT00830869|10375308|P3|Period 2: Part 2|Symptomatic Deterioration|0
3016464|NCT00830869|10375309|P2|Period 2: Part 2|Symptomatic Deterioration|0
3016465|NCT00830869|10375310|P1|Period 2: Part 2|Symptomatic Deterioration|0
3016466|NCT00830869|10375299|P12|Period 2: Part 2|Adverse Event|0
3016467|NCT00830869|10375300|P11|Period 2: Part 2|Adverse Event|2
3016468|NCT00830869|10375301|P10|Period 2: Part 2|Adverse Event|2
3016469|NCT00830869|10375302|P9|Period 2: Part 2|Adverse Event|3
3016470|NCT00830869|10375303|P8|Period 2: Part 2|Adverse Event|4
3016471|NCT00830869|10375304|P7|Period 2: Part 2|Adverse Event|0
3016472|NCT00830869|10375305|P6|Period 2: Part 2|Adverse Event|0
3016473|NCT00830869|10375306|P5|Period 2: Part 2|Adverse Event|0
3016474|NCT00830869|10375307|P4|Period 2: Part 2|Adverse Event|0
3016475|NCT00830869|10375308|P3|Period 2: Part 2|Adverse Event|0
3016476|NCT00830869|10375309|P2|Period 2: Part 2|Adverse Event|0
3016477|NCT00830869|10375310|P1|Period 2: Part 2|Adverse Event|0
3016478|NCT00830869|10375299|P12|Period 2: Part 2|Withdrawal by Subject|1
3016479|NCT00830869|10375300|P11|Period 2: Part 2|Withdrawal by Subject|0
3016480|NCT00830869|10375301|P10|Period 2: Part 2|Withdrawal by Subject|1
3016481|NCT00830869|10375302|P9|Period 2: Part 2|Withdrawal by Subject|2
3016482|NCT00830869|10375303|P8|Period 2: Part 2|Withdrawal by Subject|1
3016483|NCT00830869|10375304|P7|Period 2: Part 2|Withdrawal by Subject|0
3016484|NCT00830869|10375305|P6|Period 2: Part 2|Withdrawal by Subject|0
3016485|NCT00830869|10375306|P5|Period 2: Part 2|Withdrawal by Subject|0
3016486|NCT00830869|10375307|P4|Period 2: Part 2|Withdrawal by Subject|0
3016487|NCT00830869|10375308|P3|Period 2: Part 2|Withdrawal by Subject|0
3016488|NCT00830869|10375309|P2|Period 2: Part 2|Withdrawal by Subject|0
3016489|NCT00830869|10375310|P1|Period 2: Part 2|Withdrawal by Subject|0
3016490|NCT00830869|10375299|P12|Period 2: Part 2|Protocol Violation|0
3016491|NCT00830869|10375300|P11|Period 2: Part 2|Protocol Violation|0
3016492|NCT00830869|10375301|P10|Period 2: Part 2|Protocol Violation|1
3016493|NCT00830869|10375302|P9|Period 2: Part 2|Protocol Violation|0
3016494|NCT00830869|10375303|P8|Period 2: Part 2|Protocol Violation|1
3016495|NCT00830869|10375304|P7|Period 2: Part 2|Protocol Violation|0
3016496|NCT00830869|10375305|P6|Period 2: Part 2|Protocol Violation|0
3016497|NCT00830869|10375306|P5|Period 2: Part 2|Protocol Violation|0
3016498|NCT00830869|10375307|P4|Period 2: Part 2|Protocol Violation|0
3016499|NCT00830869|10375308|P3|Period 2: Part 2|Protocol Violation|0
3016500|NCT00830869|10375309|P2|Period 2: Part 2|Protocol Violation|0
3016501|NCT00830869|10375310|P1|Period 2: Part 2|Protocol Violation|0
3016502|NCT00830869|10375299|P12|Period 1: Part 1|Progressive disease|0
3016503|NCT00830869|10375300|P11|Period 1: Part 1|Progressive disease|0
3016504|NCT00830869|10375301|P10|Period 1: Part 1|Progressive disease|0
3016505|NCT00830869|10375302|P9|Period 1: Part 1|Progressive disease|0
3016506|NCT00830869|10375303|P8|Period 1: Part 1|Progressive disease|0
3016507|NCT00830869|10375304|P7|Period 1: Part 1|Progressive disease|1
3016508|NCT00830869|10375305|P6|Period 1: Part 1|Progressive disease|4
3016509|NCT00830869|10375306|P5|Period 1: Part 1|Progressive disease|4
3016510|NCT00830869|10375307|P4|Period 1: Part 1|Progressive disease|6
3016511|NCT00830869|10375308|P3|Period 1: Part 1|Progressive disease|1
3016512|NCT00830869|10375309|P2|Period 1: Part 1|Progressive disease|0
3016513|NCT00830869|10375310|P1|Period 1: Part 1|Progressive disease|1
3016514|NCT00830869|10375299|P12|Period 1: Part 1|Adverse Event|0
3016515|NCT00830869|10375300|P11|Period 1: Part 1|Adverse Event|0
3016516|NCT00830869|10375301|P10|Period 1: Part 1|Adverse Event|0
3016517|NCT00830869|10375302|P9|Period 1: Part 1|Adverse Event|0
3016518|NCT00830869|10375303|P8|Period 1: Part 1|Adverse Event|0
3016519|NCT00830869|10375304|P7|Period 1: Part 1|Adverse Event|1
3016520|NCT00830869|10375305|P6|Period 1: Part 1|Adverse Event|1
3016521|NCT00830869|10375306|P5|Period 1: Part 1|Adverse Event|0
3016522|NCT00830869|10375307|P4|Period 1: Part 1|Adverse Event|0
3016523|NCT00830869|10375308|P3|Period 1: Part 1|Adverse Event|0
3016524|NCT00830869|10375309|P2|Period 1: Part 1|Adverse Event|0
3016525|NCT00830869|10375310|P1|Period 1: Part 1|Adverse Event|0
3016526|NCT00830869|10375299|P12|Period 1: Part 1|Withdrawal by Subject|0
3016527|NCT00830869|10375300|P11|Period 1: Part 1|Withdrawal by Subject|0
3016528|NCT00830869|10375301|P10|Period 1: Part 1|Withdrawal by Subject|0
3016529|NCT00830869|10375302|P9|Period 1: Part 1|Withdrawal by Subject|0
3016530|NCT00830869|10375303|P8|Period 1: Part 1|Withdrawal by Subject|0
3016531|NCT00830869|10375304|P7|Period 1: Part 1|Withdrawal by Subject|0
3016532|NCT00830869|10375305|P6|Period 1: Part 1|Withdrawal by Subject|0
3016533|NCT00830869|10375306|P5|Period 1: Part 1|Withdrawal by Subject|0
3016534|NCT00830869|10375307|P4|Period 1: Part 1|Withdrawal by Subject|0
3016535|NCT00830869|10375308|P3|Period 1: Part 1|Withdrawal by Subject|0
3016536|NCT00830869|10375309|P2|Period 1: Part 1|Withdrawal by Subject|1
3016537|NCT00830869|10375310|P1|Period 1: Part 1|Withdrawal by Subject|0
3016538|NCT00830869|10375299|P12|Period 1: Part 1|Symptomatic deterioration|0
3016539|NCT00830869|10375300|P11|Period 1: Part 1|Symptomatic deterioration|0
3016540|NCT00830869|10375301|P10|Period 1: Part 1|Symptomatic deterioration|0
3016541|NCT00830869|10375302|P9|Period 1: Part 1|Symptomatic deterioration|0
3016542|NCT00830869|10375303|P8|Period 1: Part 1|Symptomatic deterioration|0
3016543|NCT00830869|10375304|P7|Period 1: Part 1|Symptomatic deterioration|1
3016544|NCT00830869|10375305|P6|Period 1: Part 1|Symptomatic deterioration|1
3016545|NCT00830869|10375306|P5|Period 1: Part 1|Symptomatic deterioration|0
3016546|NCT00830869|10375307|P4|Period 1: Part 1|Symptomatic deterioration|1
3016547|NCT00830869|10375308|P3|Period 1: Part 1|Symptomatic deterioration|0
3016548|NCT00830869|10375309|P2|Period 1: Part 1|Symptomatic deterioration|0
3016549|NCT00830869|10375310|P1|Period 1: Part 1|Symptomatic deterioration|0
3016550|NCT00830804|10375446|P1|Overall Study|Unwilling to adhere to study requirement|1
3016551|NCT00830804|10375446|P1|Overall Study|Consent withdrawn|2
3016552|NCT00830804|10375446|P1|Overall Study|Unable to get to clinic|7
3016553|NCT00830804|10375446|P1|Overall Study|Death|1
3016554|NCT00830804|10375446|P1|Overall Study|Lost to Follow-up|4
3016555|NCT00830765|10375526|P2|Overall Study|Protocol Violation|2
3016556|NCT00830765|10375527|P1|Overall Study|Protocol Violation|3
3016557|NCT00830518|10375560|P2|Overall Study|Reason not Specified|1
3016558|NCT00830518|10375561|P1|Overall Study|Reason not Specified|8
3016559|NCT00830518|10375560|P2|Overall Study|Withdrawal by Patient|0
3016560|NCT00830518|10375561|P1|Overall Study|Withdrawal by Patient|2
3016561|NCT00830518|10375560|P2|Overall Study|Adverse Event|1
3016562|NCT00830518|10375561|P1|Overall Study|Adverse Event|14
3016563|NCT00830518|10375560|P2|Overall Study|Symptomatic Deterioration|1
3016564|NCT00830518|10375561|P1|Overall Study|Symptomatic Deterioration|4
3016565|NCT00830518|10375560|P2|Overall Study|Progressive Disease|8
3016566|NCT00830518|10375561|P1|Overall Study|Progressive Disease|18
3016567|NCT00830440|10375580|P2|Overall Study|Adverse Event|0
3016568|NCT00830440|10375581|P1|Overall Study|Adverse Event|2
3016569|NCT00830440|10375580|P2|Overall Study|unsuccessful procedure|0
3016570|NCT00830440|10375581|P1|Overall Study|unsuccessful procedure|4
3016571|NCT00830440|10375580|P2|Overall Study|Withdrawal by Subject|0
3016572|NCT00830440|10375581|P1|Overall Study|Withdrawal by Subject|1
3016573|NCT00830440|10375580|P2|Overall Study|Protocol Violation|0
3016574|NCT00830440|10375581|P1|Overall Study|Protocol Violation|1
3016575|NCT00830375|10375596|P1|Overall Study|Lost to Follow-up|1
3016576|NCT00830336|10375611|P2|Washout: 21 Days|Withdrawal by Subject|0
3016577|NCT00830336|10375612|P1|Washout: 21 Days|Withdrawal by Subject|1
3016578|NCT00830258|10375639|P2|Washout: 7 Days|Protocol Violation|0
3016579|NCT00830258|10375640|P1|Washout: 7 Days|Protocol Violation|1
3016580|NCT00830258|10375639|P2|First Intervention|Adverse Event|0
3016581|NCT00830258|10375640|P1|First Intervention|Adverse Event|1
3016582|NCT00830219|10375659|P2|Washout of 7 Days|Withdrawal by Subject|1
3016583|NCT00830219|10375660|P1|Washout of 7 Days|Withdrawal by Subject|1
3016584|NCT00830206|10375670|P2|Washout: 21 Days|Withdrawal by Subject|1
3016585|NCT00830206|10375671|P1|Washout: 21 Days|Withdrawal by Subject|1
3016586|NCT00830167|10375681|P2|Overall Study|Other|2
3016587|NCT00830167|10375682|P1|Overall Study|Other|2
3016588|NCT00830167|10375681|P2|Overall Study|Protocol Violation|1
3016589|NCT00830167|10375682|P1|Overall Study|Protocol Violation|0
3016590|NCT00830167|10375681|P2|Overall Study|Lost to Follow-up|1
3016591|NCT00830167|10375682|P1|Overall Study|Lost to Follow-up|0
3016592|NCT00830167|10375681|P2|Overall Study|Withdrawal by Subject|0
3016593|NCT00830167|10375682|P1|Overall Study|Withdrawal by Subject|2
3016594|NCT00830167|10375681|P2|Overall Study|Not meeting entrance criteria|5
3016595|NCT00830167|10375682|P1|Overall Study|Not meeting entrance criteria|2
3016596|NCT00830167|10375681|P2|Overall Study|Adverse Event|24
3016597|NCT00830167|10375682|P1|Overall Study|Adverse Event|8
3016598|NCT00830167|10375681|P2|Overall Study|Lack of Efficacy|10
3016599|NCT00830167|10375682|P1|Overall Study|Lack of Efficacy|26
3016600|NCT00830128|10375752|P1|Overall Study|Operating a vehicle|1
3016601|NCT00830128|10375752|P1|Overall Study|Work obligation|1
3016602|NCT00830128|10375752|P1|Overall Study|Relocation|1
3016603|NCT00830128|10375752|P1|Overall Study|Family obligation|1
3016604|NCT00830128|10375752|P1|Overall Study|Withdrawal by Subject|2
3016605|NCT00830128|10375752|P1|Overall Study|Protocol Violation|1
3016606|NCT00830128|10375752|P1|Overall Study|Lack of Efficacy|7
3016607|NCT00830128|10375752|P1|Overall Study|Adverse Event|5
3016608|NCT00830115|10375767|P1|Overall Study|Improvement/recovery|1
3016609|NCT00830115|10375767|P1|Overall Study|Adverse Event|2
3016610|NCT00830037|10375794|P2|Overall Study|Active when terminated by DSMB|14
3016611|NCT00830037|10375795|P1|Overall Study|Active when terminated by DSMB|15
3016612|NCT00830037|10375794|P2|Overall Study|Lost to Follow-up|2
3016613|NCT00830037|10375795|P1|Overall Study|Lost to Follow-up|1
3016614|NCT00830037|10375794|P2|Overall Study|Withdrawal by Subject|3
3016615|NCT00830037|10375795|P1|Overall Study|Withdrawal by Subject|2
3016616|NCT00830024|10375805|P2|Washout: 7 Days|Withdrawal by Subject|0
3016617|NCT00830024|10375806|P1|Washout: 7 Days|Withdrawal by Subject|1
3016618|NCT00829998|10375816|P2|Washout|Adverse Event|1
3016619|NCT00829998|10375817|P1|Washout|Adverse Event|0
3016620|NCT00829933|10375846|P4|Overall Study|withdrew before treatment started|9
3016621|NCT00829933|10375847|P3|Overall Study|withdrew before treatment started|2
3016622|NCT00829933|10375848|P2|Overall Study|withdrew before treatment started|1
3016623|NCT00829933|10375849|P1|Overall Study|withdrew before treatment started|5
3016624|NCT00829933|10375846|P4|Overall Study|Protocol Violation|0
3016625|NCT00829933|10375847|P3|Overall Study|Protocol Violation|0
3016626|NCT00829933|10375848|P2|Overall Study|Protocol Violation|1
3016627|NCT00829933|10375849|P1|Overall Study|Protocol Violation|2
3016628|NCT00829933|10375846|P4|Overall Study|Pregnancy|2
3016629|NCT00829933|10375847|P3|Overall Study|Pregnancy|0
3016630|NCT00829933|10375848|P2|Overall Study|Pregnancy|0
3016631|NCT00829933|10375849|P1|Overall Study|Pregnancy|0
3016632|NCT00829933|10375846|P4|Overall Study|Physician Decision|1
3016633|NCT00829933|10375847|P3|Overall Study|Physician Decision|8
3016634|NCT00829933|10375848|P2|Overall Study|Physician Decision|7
3016635|NCT00829933|10375849|P1|Overall Study|Physician Decision|5
3016636|NCT00829933|10375846|P4|Overall Study|Lack of Efficacy|0
3016637|NCT00829933|10375847|P3|Overall Study|Lack of Efficacy|0
3016638|NCT00829933|10375848|P2|Overall Study|Lack of Efficacy|1
3016639|NCT00829933|10375849|P1|Overall Study|Lack of Efficacy|0
3016640|NCT00829933|10375846|P4|Overall Study|Death|1
3016641|NCT00829933|10375847|P3|Overall Study|Death|1
3016642|NCT00829933|10375848|P2|Overall Study|Death|0
3016643|NCT00829933|10375849|P1|Overall Study|Death|0
3016644|NCT00829933|10375846|P4|Overall Study|Adverse Event|1
3016645|NCT00829933|10375847|P3|Overall Study|Adverse Event|2
3016646|NCT00829933|10375848|P2|Overall Study|Adverse Event|3
3016647|NCT00829933|10375849|P1|Overall Study|Adverse Event|2
3016648|NCT00829868|10375861|P2|Washout|Physician Decision|0
3016649|NCT00829868|10375862|P1|Washout|Physician Decision|1
3016650|NCT00829829|10375873|P3|Overall Study|Other than specified above|1
3016651|NCT00829829|10375874|P2|Overall Study|Other than specified above|2
3016652|NCT00829829|10375875|P1|Overall Study|Other than specified above|2
3016653|NCT00829829|10375873|P3|Overall Study|Lost to Follow-up|3
3016654|NCT00829829|10375874|P2|Overall Study|Lost to Follow-up|3
3016655|NCT00829829|10375875|P1|Overall Study|Lost to Follow-up|7
3016656|NCT00829829|10375873|P3|Overall Study|Decision by the Sponsor|2
3016657|NCT00829829|10375874|P2|Overall Study|Decision by the Sponsor|0
3016658|NCT00829829|10375875|P1|Overall Study|Decision by the Sponsor|1
3016659|NCT00829829|10375873|P3|Overall Study|Withdrawal by Subject|2
3016660|NCT00829829|10375874|P2|Overall Study|Withdrawal by Subject|4
3016661|NCT00829829|10375875|P1|Overall Study|Withdrawal by Subject|8
3016662|NCT00829829|10375873|P3|Overall Study|Adverse Event|3
3016663|NCT00829829|10375874|P2|Overall Study|Adverse Event|4
3016664|NCT00829829|10375875|P1|Overall Study|Adverse Event|4
3016665|NCT00829829|10375873|P3|Overall Study|Protocol Violation|0
3016666|NCT00829829|10375874|P2|Overall Study|Protocol Violation|3
3016667|NCT00829829|10375875|P1|Overall Study|Protocol Violation|0
3016668|NCT00829790|10375900|P2|Washout of 14 Days|Withdrawal by Subject|1
3016669|NCT00829790|10375901|P1|Washout of 14 Days|Withdrawal by Subject|0
3016670|NCT00829764|10375911|P2|First Intervention|Withdrawal by Subject|1
3016671|NCT00829764|10375912|P1|First Intervention|Withdrawal by Subject|1
3016672|NCT00829764|10375911|P2|First Intervention|Adverse Event|0
3016673|NCT00829764|10375912|P1|First Intervention|Adverse Event|1
3016674|NCT00829712|10375938|P2|Washout of 7 Days|Withdrawal by Subject|1
3016675|NCT00829712|10375939|P1|Washout of 7 Days|Withdrawal by Subject|0
3016676|NCT00829673|10375958|P2|Washout of 7 Days|Withdrawal by Subject|0
3016677|NCT00829673|10375959|P1|Washout of 7 Days|Withdrawal by Subject|1
3016678|NCT00829621|10375969|P2|Overall Study|Lost to Follow-up|4
3016679|NCT00829621|10375970|P1|Overall Study|Lost to Follow-up|3
3016680|NCT00829621|10375969|P2|Overall Study|Death|0
3016681|NCT00829621|10375970|P1|Overall Study|Death|1
3016682|NCT00829530|10375978|P2|Second Intervention|Intolerance to Venopuncture|0
3016683|NCT00829530|10375979|P1|Second Intervention|Intolerance to Venopuncture|1
3016684|NCT00829530|10375978|P2|First Intervention|Intolerance to Venopuncture|1
3016685|NCT00829530|10375979|P1|First Intervention|Intolerance to Venopuncture|0
3016686|NCT00829530|10375978|P2|First Intervention|Adverse Event|1
3016687|NCT00829530|10375979|P1|First Intervention|Adverse Event|0
3016688|NCT00829504|10375993|P2|Second Intervention|Physician Decision|0
3016689|NCT00829504|10375994|P1|Second Intervention|Physician Decision|1
3016690|NCT00829504|10375993|P2|Washout of 7 Days|Withdrawal by Subject|0
3016691|NCT00829504|10375994|P1|Washout of 7 Days|Withdrawal by Subject|1
3016692|NCT00829504|10375993|P2|First Intervention|Adverse Event|0
3016693|NCT00829504|10375994|P1|First Intervention|Adverse Event|1
3016694|NCT00829452|10376004|P2|Second Intervention|Physician Decision|1
3016695|NCT00829452|10376005|P1|Second Intervention|Physician Decision|0
3016696|NCT00829452|10376004|P2|Washout of 42 Days|Withdrawal by Subject|1
3016697|NCT00829452|10376005|P1|Washout of 42 Days|Withdrawal by Subject|0
3016698|NCT00829452|10376004|P2|First Intervention|Withdrawal by Subject|1
3016699|NCT00829452|10376005|P1|First Intervention|Withdrawal by Subject|0
3016700|NCT00829439|10376017|P4|Overall Study|Adverse Event|0
3016701|NCT00829439|10376018|P3|Overall Study|Adverse Event|1
3016702|NCT00829439|10376019|P2|Overall Study|Adverse Event|0
3016703|NCT00829439|10376020|P1|Overall Study|Adverse Event|0
3016704|NCT00829426|10376026|P2|Washout: 7 Days|Withdrawal by Subject|0
3016705|NCT00829426|10376027|P1|Washout: 7 Days|Withdrawal by Subject|1
3016706|NCT00829413|10376035|P1|Overall Study|Indeterminate diagnosis from truth stand|3
3016707|NCT00829413|10376035|P1|Overall Study|Technically inadequate truth standard|2
3016708|NCT00829413|10376035|P1|Overall Study|No truth standard procedure available|9
3016709|NCT00829413|10376035|P1|Overall Study|Training Patients|67
3016710|NCT00829413|10376035|P1|Overall Study|No study drug admimnistered|13
3016711|NCT00829387|10376084|P2|Overall Study|Disqualified by PI|0
3016712|NCT00829387|10376085|P1|Overall Study|Disqualified by PI|1
3016713|NCT00829387|10376084|P2|Overall Study|Withdrawal by Subject|3
3016714|NCT00829387|10376085|P1|Overall Study|Withdrawal by Subject|2
3016715|NCT00829309|10376103|P2|Washout: 7 Days|Protocol Violation|0
3016716|NCT00829309|10376104|P1|Washout: 7 Days|Protocol Violation|1
3016717|NCT00829296|10376114|P2|Overall Study|Adverse Event|4
3016718|NCT00829296|10376115|P1|Overall Study|Adverse Event|5
3016719|NCT00829283|10376129|P2|Overall Study|Lost to Follow-up|25
3016720|NCT00829283|10376130|P1|Overall Study|Lost to Follow-up|7
3016721|NCT00829244|10376140|P2|Overall Study|No embryo cleavage|2
3016722|NCT00829244|10376141|P1|Overall Study|No embryo cleavage|0
3016723|NCT00829244|10376140|P2|Overall Study|All embryos discarded|3
3016724|NCT00829244|10376141|P1|Overall Study|All embryos discarded|0
3016725|NCT00829244|10376140|P2|Overall Study|No fertilization|2
3016726|NCT00829244|10376141|P1|Overall Study|No fertilization|2
3016727|NCT00829244|10376140|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
3016728|NCT00829244|10376141|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
3016729|NCT00829244|10376140|P2|Overall Study|Lack of ovarian response to stimulation|5
3016730|NCT00829244|10376141|P1|Overall Study|Lack of ovarian response to stimulation|9
3016731|NCT00829244|10376140|P2|Overall Study|Protocol Violation|0
3016732|NCT00829244|10376141|P1|Overall Study|Protocol Violation|1
3016733|NCT00829244|10376140|P2|Overall Study|Adverse Event|3
3016734|NCT00829244|10376141|P1|Overall Study|Adverse Event|1
3016735|NCT00829179|10376171|P1|Overall Study|Withdrawal by Subject|1
3016736|NCT00829166|10376177|P2|Overall Study|Reason Not Specified|3
3016737|NCT00829166|10376178|P1|Overall Study|Reason Not Specified|3
3016738|NCT00829166|10376177|P2|Overall Study|Sponsor’s Decision|98
3016739|NCT00829166|10376178|P1|Overall Study|Sponsor’s Decision|137
3016740|NCT00829166|10376177|P2|Overall Study|Subject's Decision|55
3016741|NCT00829166|10376178|P1|Overall Study|Subject's Decision|41
3016742|NCT00829166|10376177|P2|Overall Study|Physician's Decision|3
3016743|NCT00829166|10376178|P1|Overall Study|Physician's Decision|4
3016744|NCT00829166|10376177|P2|Overall Study|Lost to Follow-up|4
3016745|NCT00829166|10376178|P1|Overall Study|Lost to Follow-up|5
3016746|NCT00829166|10376177|P2|Overall Study|Death|333
3016747|NCT00829166|10376178|P1|Overall Study|Death|305
3016748|NCT00829010|10376241|P5|Overall Study|Migrated/Moved from study area|0
3016749|NCT00829010|10376242|P4|Overall Study|Migrated/Moved from study area|5
3016750|NCT00829010|10376243|P3|Overall Study|Migrated/Moved from study area|0
3016751|NCT00829010|10376244|P2|Overall Study|Migrated/Moved from study area|4
3016752|NCT00829010|10376245|P1|Overall Study|Migrated/Moved from study area|3
3016753|NCT00829010|10376241|P5|Overall Study|Fatality|0
3016754|NCT00829010|10376242|P4|Overall Study|Fatality|3
3016755|NCT00829010|10376243|P3|Overall Study|Fatality|0
3016756|NCT00829010|10376244|P2|Overall Study|Fatality|4
3016757|NCT00829010|10376245|P1|Overall Study|Fatality|5
3016758|NCT00829010|10376241|P5|Overall Study|Lost to Follow-up|0
3016759|NCT00829010|10376242|P4|Overall Study|Lost to Follow-up|0
3016760|NCT00829010|10376243|P3|Overall Study|Lost to Follow-up|2
3016761|NCT00829010|10376244|P2|Overall Study|Lost to Follow-up|0
3016762|NCT00829010|10376245|P1|Overall Study|Lost to Follow-up|1
3016763|NCT00829010|10376241|P5|Overall Study|Withdrawal by Subject|2
3016764|NCT00829010|10376242|P4|Overall Study|Withdrawal by Subject|0
3016765|NCT00829010|10376243|P3|Overall Study|Withdrawal by Subject|1
3016766|NCT00829010|10376244|P2|Overall Study|Withdrawal by Subject|1
3016767|NCT00829010|10376245|P1|Overall Study|Withdrawal by Subject|0
3016768|NCT00829010|10376241|P5|Overall Study|Adverse Event|0
3016769|NCT00829010|10376242|P4|Overall Study|Adverse Event|0
3016770|NCT00829010|10376243|P3|Overall Study|Adverse Event|0
3016771|NCT00829010|10376244|P2|Overall Study|Adverse Event|0
3016772|NCT00829010|10376245|P1|Overall Study|Adverse Event|1
3016773|NCT00828984|10376410|P3|Overall Study|ConMed|1
3016774|NCT00828984|10376411|P2|Overall Study|ConMed|1
3016775|NCT00828984|10376412|P1|Overall Study|ConMed|1
3016776|NCT00828984|10376410|P3|Overall Study|Noncompliant|3
3016777|NCT00828984|10376411|P2|Overall Study|Noncompliant|2
3016778|NCT00828984|10376412|P1|Overall Study|Noncompliant|1
3016779|NCT00828984|10376410|P3|Overall Study|Medical Contraindication|0
3016780|NCT00828984|10376411|P2|Overall Study|Medical Contraindication|1
3016781|NCT00828984|10376412|P1|Overall Study|Medical Contraindication|0
3016782|NCT00828984|10376410|P3|Overall Study|Ineligable|0
3016783|NCT00828984|10376411|P2|Overall Study|Ineligable|2
3016784|NCT00828984|10376412|P1|Overall Study|Ineligable|1
3016785|NCT00828984|10376410|P3|Overall Study|Withdrawal by Subject|4
3016786|NCT00828984|10376411|P2|Overall Study|Withdrawal by Subject|4
3016787|NCT00828984|10376412|P1|Overall Study|Withdrawal by Subject|4
3016788|NCT00828984|10376410|P3|Overall Study|Lost to Follow-up|1
3016789|NCT00828984|10376411|P2|Overall Study|Lost to Follow-up|3
3016790|NCT00828984|10376412|P1|Overall Study|Lost to Follow-up|5
3016791|NCT00828984|10376410|P3|Overall Study|Adverse Event|0
3016792|NCT00828984|10376411|P2|Overall Study|Adverse Event|3
3016793|NCT00828984|10376412|P1|Overall Study|Adverse Event|2
3016794|NCT00828945|10376435|P1|Overall Study|Other|36
3016795|NCT00828945|10376435|P1|Overall Study|Participant was missing|1
3016796|NCT00828945|10376435|P1|Overall Study|Death|4
3016797|NCT00828750|10376467|P1|Overall Study|Normal PC Remained While No Treatment|1
3016798|NCT00828750|10376467|P1|Overall Study|Lack of Efficacy|3
3016799|NCT00828711|10376481|P3|Overall Study|Lost to Follow-up|0
3016800|NCT00828711|10376482|P2|Overall Study|Lost to Follow-up|0
3016801|NCT00828711|10376483|P1|Overall Study|Lost to Follow-up|1
3016802|NCT00828672|10376514|P2|Post-surgery (<30 Days)|No central review materials|1
3016803|NCT00828672|10376515|P1|Post-surgery (<30 Days)|No central review materials|0
3016804|NCT00828672|10376514|P2|Study Treatment|Complete response, no surgery|1
3016805|NCT00828672|10376515|P1|Study Treatment|Complete response, no surgery|1
3016806|NCT00828672|10376514|P2|Study Treatment|Adverse Event|1
3016807|NCT00828672|10376515|P1|Study Treatment|Adverse Event|0
3016808|NCT00828672|10376514|P2|Study Treatment|Lost to Follow-up|0
3016809|NCT00828672|10376515|P1|Study Treatment|Lost to Follow-up|1
3016810|NCT00828568|10376536|P3|Treated - Received at Least One Dose|Protocol Violation|3
3016811|NCT00828568|10376537|P2|Treated - Received at Least One Dose|Protocol Violation|5
3016812|NCT00828568|10376538|P1|Treated - Received at Least One Dose|Protocol Violation|9
3016813|NCT00828568|10376536|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
3016814|NCT00828568|10376537|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
3016815|NCT00828568|10376538|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
3016816|NCT00828568|10376536|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
3016817|NCT00828568|10376537|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
3016818|NCT00828568|10376538|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
3016819|NCT00828568|10376536|P3|Treated - Received at Least One Dose|Adverse Event|1
3016820|NCT00828568|10376537|P2|Treated - Received at Least One Dose|Adverse Event|8
3016821|NCT00828568|10376538|P1|Treated - Received at Least One Dose|Adverse Event|11
3016822|NCT00828568|10376536|P3|Randomized|Withdrawal by Subject|2
3016823|NCT00828568|10376537|P2|Randomized|Withdrawal by Subject|0
3016824|NCT00828568|10376538|P1|Randomized|Withdrawal by Subject|1
3016825|NCT00828516|10376560|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
3016826|NCT00828464|10376565|P1|Overall Study|Withdrawal by Subject|1
3016827|NCT00828451|10376582|P1|Overall Study|Deterioration in clinical status|1
3016828|NCT00828451|10376582|P1|Overall Study|Withdrawal by Subject|1
3016829|NCT00828451|10376582|P1|Overall Study|Lack of intravenous line|7
3016830|NCT00828451|10376582|P1|Overall Study|Death|2
3016831|NCT00828321|10376608|P2|Second Intervention|Protocol Violation|1
3016832|NCT00828321|10376609|P1|Second Intervention|Protocol Violation|0
3016833|NCT00828321|10376608|P2|Washout of 42 Days|Withdrawal by Subject|0
3016834|NCT00828321|10376609|P1|Washout of 42 Days|Withdrawal by Subject|2
3016835|NCT00828204|10376638|P2|Extension Study|Physician Decision|2
3016836|NCT00828204|10376639|P1|Extension Study|Physician Decision|0
3016837|NCT00828204|10376638|P2|Extension Study|Lost to Follow-up|1
3016838|NCT00828204|10376639|P1|Extension Study|Lost to Follow-up|0
3016839|NCT00828204|10376638|P2|Main Study: After Study Restart|Noncompliance|1
3016840|NCT00828204|10376639|P1|Main Study: After Study Restart|Noncompliance|0
3016841|NCT00828204|10376638|P2|Main Study: After Study Restart|Adverse Event|2
3016842|NCT00828204|10376639|P1|Main Study: After Study Restart|Adverse Event|0
3016843|NCT00828204|10376638|P2|Main Study: Prior to Study Suspension|Study Suspension|0
3016844|NCT00828204|10376639|P1|Main Study: Prior to Study Suspension|Study Suspension|11
3016845|NCT00828204|10376638|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
3016846|NCT00828204|10376639|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
3016847|NCT00828204|10376638|P2|Main Study: Prior to Study Suspension|Adverse Event|0
3016848|NCT00828204|10376639|P1|Main Study: Prior to Study Suspension|Adverse Event|1
3016849|NCT00828139|10376686|P4|Overall Study|Other|2
3016850|NCT00828139|10376687|P3|Overall Study|Other|5
3016851|NCT00828139|10376688|P2|Overall Study|Other|2
3016852|NCT00828139|10376689|P1|Overall Study|Other|4
3016853|NCT00828139|10376686|P4|Overall Study|Disease Progression|39
3016854|NCT00828139|10376687|P3|Overall Study|Disease Progression|35
3016855|NCT00828139|10376688|P2|Overall Study|Disease Progression|33
3016856|NCT00828139|10376689|P1|Overall Study|Disease Progression|24
3016857|NCT00828139|10376686|P4|Overall Study|Refusal unrelated to toxicity|3
3016858|NCT00828139|10376687|P3|Overall Study|Refusal unrelated to toxicity|5
3016859|NCT00828139|10376688|P2|Overall Study|Refusal unrelated to toxicity|4
3016860|NCT00828139|10376689|P1|Overall Study|Refusal unrelated to toxicity|3
3016861|NCT00828139|10376686|P4|Overall Study|Death|2
3016862|NCT00828139|10376687|P3|Overall Study|Death|0
3016863|NCT00828139|10376688|P2|Overall Study|Death|1
3016864|NCT00828139|10376689|P1|Overall Study|Death|2
3016865|NCT00828139|10376686|P4|Overall Study|Adverse Event|5
3016866|NCT00828139|10376687|P3|Overall Study|Adverse Event|10
3016867|NCT00828139|10376688|P2|Overall Study|Adverse Event|1
3016868|NCT00828139|10376689|P1|Overall Study|Adverse Event|8
3016869|NCT00828113|10376709|P2|Overall Study|Lost to Follow-up|5
3016870|NCT00828113|10376710|P1|Overall Study|Lost to Follow-up|3
3016871|NCT00828113|10376709|P2|Overall Study|Withdrawal by Subject|26
3016872|NCT00828113|10376710|P1|Overall Study|Withdrawal by Subject|27
3016873|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Other|1
3016874|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Complicating disease|2
3016875|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
3016876|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Death|1
3016877|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Adverse Event|13
3016878|NCT00828009|10376748|P1|Step 2 - Maintenance Therapy|Progressive disease|12
3016879|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
3016880|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
3016881|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
3016882|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
3016883|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
3016884|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
3016885|NCT00828009|10376748|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
3016886|NCT00827931|10376791|P2|Overall Study|Other|0
3016887|NCT00827931|10376792|P1|Overall Study|Other|1
3016888|NCT00827931|10376791|P2|Overall Study|Withdrawal by Subject|1
3016889|NCT00827931|10376792|P1|Overall Study|Withdrawal by Subject|0
3016890|NCT00827931|10376791|P2|Overall Study|Lost to Follow-up|0
3016891|NCT00827931|10376792|P1|Overall Study|Lost to Follow-up|1
3016892|NCT00827931|10376791|P2|Overall Study|Adverse Event|0
3016893|NCT00827931|10376792|P1|Overall Study|Adverse Event|1
3016894|NCT00827931|10376791|P2|Overall Study|Death|5
3016895|NCT00827931|10376792|P1|Overall Study|Death|3
3016896|NCT00827918|10376813|P3|Overall Study|Withdrawal by Subject|6
3016897|NCT00827918|10376814|P2|Overall Study|Withdrawal by Subject|2
3016898|NCT00827918|10376815|P1|Overall Study|Withdrawal by Subject|6
3016899|NCT00827918|10376813|P3|Overall Study|Protocol Violation|0
3016900|NCT00827918|10376814|P2|Overall Study|Protocol Violation|1
3016901|NCT00827918|10376815|P1|Overall Study|Protocol Violation|0
3016902|NCT00827918|10376813|P3|Overall Study|Progressive Disease|0
3016903|NCT00827918|10376814|P2|Overall Study|Progressive Disease|1
3016904|NCT00827918|10376815|P1|Overall Study|Progressive Disease|1
3016905|NCT00827918|10376813|P3|Overall Study|Pregnancy|0
3016906|NCT00827918|10376814|P2|Overall Study|Pregnancy|1
3016907|NCT00827918|10376815|P1|Overall Study|Pregnancy|0
3016908|NCT00827918|10376813|P3|Overall Study|Physician Decision|0
3016909|NCT00827918|10376814|P2|Overall Study|Physician Decision|0
3016910|NCT00827918|10376815|P1|Overall Study|Physician Decision|1
3016911|NCT00827918|10376813|P3|Overall Study|Lack of Efficacy|15
3016912|NCT00827918|10376814|P2|Overall Study|Lack of Efficacy|4
3016913|NCT00827918|10376815|P1|Overall Study|Lack of Efficacy|16
3016914|NCT00827918|10376813|P3|Overall Study|Adverse Event|0
3016915|NCT00827918|10376814|P2|Overall Study|Adverse Event|0
3016916|NCT00827918|10376815|P1|Overall Study|Adverse Event|4
3016917|NCT00827827|10376843|P2|Overall Study|Burned with water at home|0
3016918|NCT00827827|10376844|P1|Overall Study|Burned with water at home|1
3016919|NCT00827827|10376843|P2|Overall Study|Transportation issues|0
3016920|NCT00827827|10376844|P1|Overall Study|Transportation issues|1
3016921|NCT00827827|10376843|P2|Overall Study|Gout|0
3016922|NCT00827827|10376844|P1|Overall Study|Gout|1
3016923|NCT00827827|10376843|P2|Overall Study|Another cerebrovascular accident (CVA)|0
3016924|NCT00827827|10376844|P1|Overall Study|Another cerebrovascular accident (CVA)|1
3016925|NCT00827827|10376843|P2|Overall Study|Fall at home- hospitalization|0
3016926|NCT00827827|10376844|P1|Overall Study|Fall at home- hospitalization|1
3016927|NCT00827827|10376843|P2|Overall Study|Lost to Follow-up|0
3016928|NCT00827827|10376844|P1|Overall Study|Lost to Follow-up|3
3016929|NCT00827632|10376888|P2|Overall Study|Early withdrawal|11
3016930|NCT00827632|10376889|P1|Overall Study|Early withdrawal|14
3016931|NCT00827632|10376888|P2|Overall Study|Lost to Follow-up|12
3016932|NCT00827632|10376889|P1|Overall Study|Lost to Follow-up|8
3016933|NCT00827606|10376901|P2|Overall Study|Adverse Event|2
3016934|NCT00827606|10376902|P1|Overall Study|Adverse Event|4
3016935|NCT00827606|10376901|P2|Overall Study|LDL below 2.59 mmol/L|12
3016936|NCT00827606|10376902|P1|Overall Study|LDL below 2.59 mmol/L|4
3016937|NCT00827606|10376901|P2|Overall Study|Other|13
3016938|NCT00827606|10376902|P1|Overall Study|Other|5
3016939|NCT00827606|10376901|P2|Overall Study|Pregnancy|1
3016940|NCT00827606|10376902|P1|Overall Study|Pregnancy|0
3016941|NCT00827606|10376901|P2|Overall Study|Withdrawal by Subject|6
3016942|NCT00827606|10376902|P1|Overall Study|Withdrawal by Subject|7
3016943|NCT00827606|10376901|P2|Overall Study|Lost to Follow-up|1
3016944|NCT00827606|10376902|P1|Overall Study|Lost to Follow-up|3
3016945|NCT00827606|10376901|P2|Overall Study|Protocol Violation|3
3016946|NCT00827606|10376902|P1|Overall Study|Protocol Violation|4
3016947|NCT00827567|10376963|P1|Overall Study|Progression of Disease/Screen Failure|4
3016948|NCT00827541|10376969|P2|Overall Study|Lack of effectiveness|0
3016949|NCT00827541|10376970|P1|Overall Study|Lack of effectiveness|1
3016950|NCT00827541|10376969|P2|Overall Study|Pathogen not susceptible|0
3016951|NCT00827541|10376970|P1|Overall Study|Pathogen not susceptible|1
3016952|NCT00827541|10376969|P2|Overall Study|Other|3
3016953|NCT00827541|10376970|P1|Overall Study|Other|1
3016954|NCT00827541|10376969|P2|Overall Study|Exitus|8
3016955|NCT00827541|10376970|P1|Overall Study|Exitus|1
3016956|NCT00827502|10376982|P1|Overall Study|Withdrawal by Subject|5
3016957|NCT00827502|10376982|P1|Overall Study|Lost to Follow-up|4
3016958|NCT00827502|10376982|P1|Overall Study|Adverse Event|1
3016959|NCT00827502|10376982|P1|Overall Study|randomized but not treated|11
3016960|NCT00827372|10376988|P1|Overall Study|Lack of Efficacy|3
3016961|NCT00827372|10376988|P1|Overall Study|Adverse Event|5
3016962|NCT00827242|10377003|P2|Overall Study|Lack of Efficacy|0
3016963|NCT00827242|10377004|P1|Overall Study|Lack of Efficacy|1
3016964|NCT00827242|10377003|P2|Overall Study|Death|0
3016965|NCT00827242|10377004|P1|Overall Study|Death|1
3016966|NCT00827242|10377003|P2|Overall Study|Physician Decision|0
3016967|NCT00827242|10377004|P1|Overall Study|Physician Decision|2
3016968|NCT00827242|10377003|P2|Overall Study|Entry Criteria Not Met|1
3016969|NCT00827242|10377004|P1|Overall Study|Entry Criteria Not Met|4
3016970|NCT00827242|10377003|P2|Overall Study|Adverse Event Excluding Death|1
3016971|NCT00827242|10377004|P1|Overall Study|Adverse Event Excluding Death|2
3016972|NCT00827242|10377003|P2|Overall Study|Lost to Follow-up|3
3016973|NCT00827242|10377004|P1|Overall Study|Lost to Follow-up|0
3016974|NCT00827242|10377003|P2|Overall Study|Protocol Violation|3
3016975|NCT00827242|10377004|P1|Overall Study|Protocol Violation|1
3016976|NCT00827242|10377003|P2|Overall Study|Withdrawal by Subject|4
3016977|NCT00827242|10377004|P1|Overall Study|Withdrawal by Subject|2
3016978|NCT00827112|10377042|P2|Overall Study|Other|3
3016979|NCT00827112|10377043|P1|Overall Study|Other|1
3016980|NCT00827112|10377042|P2|Overall Study|Randomized but not treated|3
3016981|NCT00827112|10377043|P1|Overall Study|Randomized but not treated|5
3016982|NCT00827112|10377042|P2|Overall Study|Withdrawal by Subject|1
3016983|NCT00827112|10377043|P1|Overall Study|Withdrawal by Subject|2
3016984|NCT00827112|10377042|P2|Overall Study|Protocol Violation|2
3016985|NCT00827112|10377043|P1|Overall Study|Protocol Violation|0
3016986|NCT00827112|10377042|P2|Overall Study|Pregnancy|1
3016987|NCT00827112|10377043|P1|Overall Study|Pregnancy|0
3016988|NCT00827112|10377042|P2|Overall Study|Lost to Follow-up|2
3016989|NCT00827112|10377043|P1|Overall Study|Lost to Follow-up|3
3016990|NCT00827112|10377042|P2|Overall Study|Lack of Efficacy|0
3016991|NCT00827112|10377043|P1|Overall Study|Lack of Efficacy|2
3016992|NCT00827112|10377042|P2|Overall Study|Adverse Event|0
3016993|NCT00827112|10377043|P1|Overall Study|Adverse Event|2
3016994|NCT00826943|10377096|P6|Overall Study|Withdrawal by Subject|0
3016995|NCT00826943|10377097|P5|Overall Study|Withdrawal by Subject|1
3016996|NCT00826943|10377098|P4|Overall Study|Withdrawal by Subject|0
3016997|NCT00826943|10377099|P3|Overall Study|Withdrawal by Subject|0
3016998|NCT00826943|10377100|P2|Overall Study|Withdrawal by Subject|0
3016999|NCT00826943|10377101|P1|Overall Study|Withdrawal by Subject|0
3017000|NCT00826748|10377122|P3|Overall Study|Samples Did Not pass QC|1
3017001|NCT00826748|10377123|P2|Overall Study|Samples Did Not pass QC|0
3017002|NCT00826748|10377124|P1|Overall Study|Samples Did Not pass QC|0
3017003|NCT00826748|10377122|P3|Overall Study|Physician Decision|1
3017004|NCT00826748|10377123|P2|Overall Study|Physician Decision|0
3017005|NCT00826748|10377124|P1|Overall Study|Physician Decision|0
3017006|NCT00826748|10377122|P3|Overall Study|Withdrawal by Subject|2
3017007|NCT00826748|10377123|P2|Overall Study|Withdrawal by Subject|0
3017008|NCT00826748|10377124|P1|Overall Study|Withdrawal by Subject|0
3017009|NCT00826618|10377132|P1|Overall Study|Withdrawal by Subject|1
3017010|NCT00826540|10377136|P1|Overall Study|Withdrawal by Subject|1
3017011|NCT00826540|10377136|P1|Overall Study|ineligible|3
3017012|NCT00826449|10377142|P1|Overall Study|Withdrawal by Subject|1
3017013|NCT00826449|10377142|P1|Overall Study|Disease Progression|4
3017014|NCT00826280|10377151|P3|Overall Study|One or more non-interpretable scan|1
3017015|NCT00826280|10377152|P2|Overall Study|One or more non-interpretable scan|1
3017016|NCT00826280|10377153|P1|Overall Study|One or more non-interpretable scan|0
3017017|NCT00826280|10377151|P3|Overall Study|Machine Failure|0
3017018|NCT00826280|10377152|P2|Overall Study|Machine Failure|1
3017019|NCT00826280|10377153|P1|Overall Study|Machine Failure|1
3017020|NCT00826280|10377151|P3|Overall Study|Interpretation Failure|0
3017021|NCT00826280|10377152|P2|Overall Study|Interpretation Failure|0
3017022|NCT00826280|10377153|P1|Overall Study|Interpretation Failure|1
3017023|NCT00826280|10377151|P3|Overall Study|Reversible ischemic defect not present|44
3017024|NCT00826280|10377152|P2|Overall Study|Reversible ischemic defect not present|40
3017025|NCT00826280|10377153|P1|Overall Study|Reversible ischemic defect not present|43
3017026|NCT00826280|10377151|P3|Overall Study|Sponsor discontinued subject or study|0
3017027|NCT00826280|10377152|P2|Overall Study|Sponsor discontinued subject or study|0
3017028|NCT00826280|10377153|P1|Overall Study|Sponsor discontinued subject or study|1
3017029|NCT00826280|10377151|P3|Overall Study|Lost to Follow-up|0
3017030|NCT00826280|10377152|P2|Overall Study|Lost to Follow-up|1
3017031|NCT00826280|10377153|P1|Overall Study|Lost to Follow-up|0
3017032|NCT00826280|10377151|P3|Overall Study|Adverse Event|0
3017033|NCT00826280|10377152|P2|Overall Study|Adverse Event|3
3017034|NCT00826280|10377153|P1|Overall Study|Adverse Event|1
3017035|NCT00826280|10377151|P3|Overall Study|Randomized but drug not received|1
3017036|NCT00826280|10377152|P2|Overall Study|Randomized but drug not received|0
3017037|NCT00826280|10377153|P1|Overall Study|Randomized but drug not received|1
3017038|NCT00826267|10377182|P3|Overall Study|Other Adverse Event|0
3017039|NCT00826267|10377183|P2|Overall Study|Other Adverse Event|0
3017040|NCT00826267|10377184|P1|Overall Study|Other Adverse Event|1
3017041|NCT00826241|10377202|P1|Overall Study|Pt opt not to proceed w/trmt|1
3017042|NCT00826241|10377202|P1|Overall Study|Pt unable to proceed to registration|1
3017043|NCT00826241|10377202|P1|Overall Study|Screen failure|2
3017044|NCT00826241|10377202|P1|Overall Study|Could not obtain records|1
3017045|NCT00826241|10377202|P1|Overall Study|Lost to Follow-up|9
3017046|NCT00826241|10377202|P1|Overall Study|Patient refused follow-up|3
3017047|NCT00826241|10377202|P1|Overall Study|Progression of disease|1
3017048|NCT00826241|10377202|P1|Overall Study|Non-compliance|1
3017049|NCT00826241|10377202|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
3017050|NCT00826241|10377202|P1|Overall Study|Death|4
3017051|NCT00826241|10377202|P1|Overall Study|Withdrew consent|2
3017052|NCT00826241|10377202|P1|Overall Study|Withdrawal from Follow-up|1
3017053|NCT00826228|10377208|P1|Overall Study|Withdrawal by Subject|1
3017054|NCT00826176|10377230|P2|Overall Study|Administrative|0
3017055|NCT00826176|10377231|P1|Overall Study|Administrative|9
3017056|NCT00826176|10377230|P2|Overall Study|Subject Withdrew Consent|0
3017057|NCT00826176|10377231|P1|Overall Study|Subject Withdrew Consent|3
3017058|NCT00826176|10377230|P2|Overall Study|Lost to Follow-up|0
3017059|NCT00826176|10377231|P1|Overall Study|Lost to Follow-up|1
3017060|NCT00826111|10377280|P2|Overall Study|Physician Decision|1
3017061|NCT00826111|10377281|P1|Overall Study|Physician Decision|1
3017062|NCT00826111|10377280|P2|Overall Study|Withdrawal by Subject|0
3017063|NCT00826111|10377281|P1|Overall Study|Withdrawal by Subject|5
3017064|NCT00826111|10377280|P2|Overall Study|Protocol Violation|0
3017065|NCT00826111|10377281|P1|Overall Study|Protocol Violation|1
3017066|NCT00826111|10377280|P2|Overall Study|Lost to Follow-up|1
3017067|NCT00826111|10377281|P1|Overall Study|Lost to Follow-up|0
3017068|NCT00825994|10377316|P1|Overall Study|Placebo Responder at V2|1
3017069|NCT00825994|10377316|P1|Overall Study|Protocol Violation|1
3017070|NCT00825994|10377316|P1|Overall Study|Lost to Follow-up|1
3017071|NCT00825994|10377316|P1|Overall Study|Withdrawal by Subject|2
3017072|NCT00825916|10377324|P3|Overall Study|Lost to Follow-up|1
3017073|NCT00825916|10377325|P2|Overall Study|Lost to Follow-up|2
3017074|NCT00825916|10377326|P1|Overall Study|Lost to Follow-up|4
3017075|NCT00825825|10377367|P6|Third Medication Period (14 Days)|poor data quality|0
3017076|NCT00825825|10377368|P5|Third Medication Period (14 Days)|poor data quality|0
3017077|NCT00825825|10377369|P4|Third Medication Period (14 Days)|poor data quality|0
3017078|NCT00825825|10377370|P3|Third Medication Period (14 Days)|poor data quality|0
3017079|NCT00825825|10377371|P2|Third Medication Period (14 Days)|poor data quality|1
3017080|NCT00825825|10377372|P1|Third Medication Period (14 Days)|poor data quality|0
3017081|NCT00825825|10377367|P6|Third Medication Period (14 Days)|Protocol Violation|2
3017082|NCT00825825|10377368|P5|Third Medication Period (14 Days)|Protocol Violation|0
3017083|NCT00825825|10377369|P4|Third Medication Period (14 Days)|Protocol Violation|0
3017084|NCT00825825|10377370|P3|Third Medication Period (14 Days)|Protocol Violation|0
3017085|NCT00825825|10377371|P2|Third Medication Period (14 Days)|Protocol Violation|0
3017086|NCT00825825|10377372|P1|Third Medication Period (14 Days)|Protocol Violation|0
3017087|NCT00825825|10377367|P6|Third Medication Period (14 Days)|Adverse Event|0
3017088|NCT00825825|10377368|P5|Third Medication Period (14 Days)|Adverse Event|0
3017089|NCT00825825|10377369|P4|Third Medication Period (14 Days)|Adverse Event|0
3017090|NCT00825825|10377370|P3|Third Medication Period (14 Days)|Adverse Event|0
3017091|NCT00825825|10377371|P2|Third Medication Period (14 Days)|Adverse Event|1
3017092|NCT00825825|10377372|P1|Third Medication Period (14 Days)|Adverse Event|0
3017093|NCT00825825|10377367|P6|Second Medication Period (14 Days)|Protocol Violation|0
3017094|NCT00825825|10377368|P5|Second Medication Period (14 Days)|Protocol Violation|1
3017095|NCT00825825|10377369|P4|Second Medication Period (14 Days)|Protocol Violation|0
3017096|NCT00825825|10377370|P3|Second Medication Period (14 Days)|Protocol Violation|0
3017097|NCT00825825|10377371|P2|Second Medication Period (14 Days)|Protocol Violation|0
3017098|NCT00825825|10377372|P1|Second Medication Period (14 Days)|Protocol Violation|1
3017099|NCT00825825|10377367|P6|Second Medication Period (14 Days)|Physician Decision|0
3017100|NCT00825825|10377368|P5|Second Medication Period (14 Days)|Physician Decision|0
3017101|NCT00825825|10377369|P4|Second Medication Period (14 Days)|Physician Decision|2
3017102|NCT00825825|10377370|P3|Second Medication Period (14 Days)|Physician Decision|0
3017103|NCT00825825|10377371|P2|Second Medication Period (14 Days)|Physician Decision|0
3017104|NCT00825825|10377372|P1|Second Medication Period (14 Days)|Physician Decision|1
3017105|NCT00825825|10377367|P6|First Medication Period (14 Days)|Physician Decision|1
3017106|NCT00825825|10377368|P5|First Medication Period (14 Days)|Physician Decision|0
3017107|NCT00825825|10377369|P4|First Medication Period (14 Days)|Physician Decision|0
3017108|NCT00825825|10377370|P3|First Medication Period (14 Days)|Physician Decision|1
3017109|NCT00825825|10377371|P2|First Medication Period (14 Days)|Physician Decision|0
3017110|NCT00825825|10377372|P1|First Medication Period (14 Days)|Physician Decision|2
3017111|NCT00825825|10377367|P6|First Medication Period (14 Days)|Adverse Event|1
3017112|NCT00825825|10377368|P5|First Medication Period (14 Days)|Adverse Event|0
3017113|NCT00825825|10377369|P4|First Medication Period (14 Days)|Adverse Event|0
3017114|NCT00825825|10377370|P3|First Medication Period (14 Days)|Adverse Event|0
3017115|NCT00825825|10377371|P2|First Medication Period (14 Days)|Adverse Event|0
3017116|NCT00825825|10377372|P1|First Medication Period (14 Days)|Adverse Event|1
3017117|NCT00825812|10377388|P4|Overall Study|Administrative|5
3017118|NCT00825812|10377389|P3|Overall Study|Administrative|3
3017119|NCT00825812|10377390|P2|Overall Study|Administrative|1
3017120|NCT00825812|10377391|P1|Overall Study|Administrative|0
3017121|NCT00825812|10377388|P4|Overall Study|Non-compliance with protocol|1
3017122|NCT00825812|10377389|P3|Overall Study|Non-compliance with protocol|0
3017123|NCT00825812|10377390|P2|Overall Study|Non-compliance with protocol|0
3017124|NCT00825812|10377391|P1|Overall Study|Non-compliance with protocol|0
3017125|NCT00825812|10377388|P4|Overall Study|Subject withdrew consent|2
3017126|NCT00825812|10377389|P3|Overall Study|Subject withdrew consent|3
3017127|NCT00825812|10377390|P2|Overall Study|Subject withdrew consent|0
3017128|NCT00825812|10377391|P1|Overall Study|Subject withdrew consent|0
3017129|NCT00825812|10377388|P4|Overall Study|Adverse Event|1
3017130|NCT00825812|10377389|P3|Overall Study|Adverse Event|0
3017131|NCT00825812|10377390|P2|Overall Study|Adverse Event|0
3017132|NCT00825812|10377391|P1|Overall Study|Adverse Event|0
3017133|NCT00825812|10377388|P4|Overall Study|Never entered follow up|1
3017134|NCT00825812|10377389|P3|Overall Study|Never entered follow up|0
3017135|NCT00825812|10377390|P2|Overall Study|Never entered follow up|0
3017136|NCT00825812|10377391|P1|Overall Study|Never entered follow up|0
3017137|NCT00825682|10377438|P2|Overall Study|personal reasons/ inconvenience|5
3017138|NCT00825682|10377439|P1|Overall Study|personal reasons/ inconvenience|13
3017139|NCT00825305|10377530|P2|Overall Study|Can not be classified|1
3017140|NCT00825305|10377531|P1|Overall Study|Can not be classified|0
3017141|NCT00825305|10377530|P2|Overall Study|Protocol Violation|9
3017142|NCT00825305|10377531|P1|Overall Study|Protocol Violation|9
3017143|NCT00825305|10377530|P2|Overall Study|Inappropriate inclusion|0
3017144|NCT00825305|10377531|P1|Overall Study|Inappropriate inclusion|1
3017145|NCT00825305|10377530|P2|Overall Study|Withdrawal by Subject|12
3017146|NCT00825305|10377531|P1|Overall Study|Withdrawal by Subject|6
3017147|NCT00825305|10377530|P2|Overall Study|Adverse Event|1
3017148|NCT00825305|10377531|P1|Overall Study|Adverse Event|1
3017149|NCT00825175|10377571|P2|Overall Study|Withdrawal by Subject|5
3017150|NCT00825175|10377572|P1|Overall Study|Withdrawal by Subject|0
3017151|NCT00825162|10377581|P3|Overall Study|Unable to attend the study visit|0
3017152|NCT00825162|10377582|P2|Overall Study|Unable to attend the study visit|2
3017153|NCT00825162|10377583|P1|Overall Study|Unable to attend the study visit|5
3017154|NCT00825162|10377581|P3|Overall Study|Move away from the study area|0
3017155|NCT00825162|10377582|P2|Overall Study|Move away from the study area|0
3017156|NCT00825162|10377583|P1|Overall Study|Move away from the study area|1
3017157|NCT00825162|10377581|P3|Overall Study|Physician Decision|0
3017158|NCT00825162|10377582|P2|Overall Study|Physician Decision|0
3017159|NCT00825162|10377583|P1|Overall Study|Physician Decision|2
3017160|NCT00825162|10377581|P3|Overall Study|Lost to Follow-up|3
3017161|NCT00825162|10377582|P2|Overall Study|Lost to Follow-up|6
3017162|NCT00825162|10377583|P1|Overall Study|Lost to Follow-up|9
3017163|NCT00825162|10377581|P3|Overall Study|Withdrawal by Subject|3
3017164|NCT00825162|10377582|P2|Overall Study|Withdrawal by Subject|13
3017165|NCT00825162|10377583|P1|Overall Study|Withdrawal by Subject|11
3017166|NCT00824993|10377609|P2|Overall Study|Death|3
3017167|NCT00824993|10377610|P1|Overall Study|Death|0
3017168|NCT00824993|10377609|P2|Overall Study|Insurance Issue|1
3017169|NCT00824993|10377610|P1|Overall Study|Insurance Issue|2
3017170|NCT00824993|10377609|P2|Overall Study|Non-Compliant|1
3017171|NCT00824993|10377610|P1|Overall Study|Non-Compliant|2
3017172|NCT00824993|10377609|P2|Overall Study|Rapid Bone Loss|1
3017173|NCT00824993|10377610|P1|Overall Study|Rapid Bone Loss|0
3017174|NCT00824993|10377609|P2|Overall Study|Malignancy Relapse|10
3017175|NCT00824993|10377610|P1|Overall Study|Malignancy Relapse|9
3017176|NCT00824993|10377609|P2|Overall Study|Withdrawal by Subject|1
3017177|NCT00824993|10377610|P1|Overall Study|Withdrawal by Subject|1
3017178|NCT00824850|10377618|P2|Overall Study|Withdrawal by Subject|1
3017179|NCT00824850|10377619|P1|Overall Study|Withdrawal by Subject|0
3017180|NCT00824772|10377672|P1|Overall Study|Withdrawal by Subject|8
3017181|NCT00824720|10377692|P3|Overall Study|Protocol Violation|1
3017182|NCT00824720|10377693|P2|Overall Study|Protocol Violation|0
3017183|NCT00824720|10377694|P1|Overall Study|Protocol Violation|0
3017184|NCT00824720|10377692|P3|Overall Study|failed plug insertion|0
3017185|NCT00824720|10377693|P2|Overall Study|failed plug insertion|1
3017186|NCT00824720|10377694|P1|Overall Study|failed plug insertion|3
3017187|NCT00824655|10377710|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
3017188|NCT00824655|10377711|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
3017189|NCT00824655|10377710|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
3017190|NCT00824655|10377711|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
3017191|NCT00824616|10377731|P2|Overall Study|Withdrawal by Subject|1
3017192|NCT00824616|10377732|P1|Overall Study|Withdrawal by Subject|1
3017193|NCT00824616|10377731|P2|Overall Study|Lost to Follow-up|1
3017194|NCT00824616|10377732|P1|Overall Study|Lost to Follow-up|0
3017195|NCT00824616|10377731|P2|Overall Study|Lack of Efficacy|1
3017196|NCT00824616|10377732|P1|Overall Study|Lack of Efficacy|2
3017197|NCT00824616|10377731|P2|Overall Study|Hyperglycemia|1
3017198|NCT00824616|10377732|P1|Overall Study|Hyperglycemia|1
3017199|NCT00824616|10377731|P2|Overall Study|Creatinine/Creatinine Clearance|2
3017200|NCT00824616|10377732|P1|Overall Study|Creatinine/Creatinine Clearance|0
3017201|NCT00824616|10377731|P2|Overall Study|Adverse Event|1
3017202|NCT00824616|10377732|P1|Overall Study|Adverse Event|2
3017203|NCT00824564|10377742|P2|Overall Study|Randomized, but not treated|0
3017204|NCT00824564|10377743|P1|Overall Study|Randomized, but not treated|1
3017205|NCT00824564|10377742|P2|Overall Study|Other|2
3017206|NCT00824564|10377743|P1|Overall Study|Other|1
3017207|NCT00824564|10377742|P2|Overall Study|Withdrawal by Subject|1
3017208|NCT00824564|10377743|P1|Overall Study|Withdrawal by Subject|1
3017209|NCT00824564|10377742|P2|Overall Study|Lost to Follow-up|7
3017210|NCT00824564|10377743|P1|Overall Study|Lost to Follow-up|5
3017211|NCT00824473|10377822|P2|Overall Study|Other|1
3017212|NCT00824473|10377823|P1|Overall Study|Other|1
3017213|NCT00824473|10377822|P2|Overall Study|Withdrawal by Subject|3
3017214|NCT00824473|10377823|P1|Overall Study|Withdrawal by Subject|2
3017215|NCT00824473|10377822|P2|Overall Study|Non-Compliance|2
3017216|NCT00824473|10377823|P1|Overall Study|Non-Compliance|4
3017217|NCT00824473|10377822|P2|Overall Study|Protocol Violation|0
3017218|NCT00824473|10377823|P1|Overall Study|Protocol Violation|2
3017219|NCT00824473|10377822|P2|Overall Study|Lack of Efficacy|2
3017220|NCT00824473|10377823|P1|Overall Study|Lack of Efficacy|2
3017221|NCT00824473|10377822|P2|Overall Study|Adverse Event|5
3017222|NCT00824473|10377823|P1|Overall Study|Adverse Event|4
3017223|NCT00824421|10377904|P3|Overall Study|Other|0
3017224|NCT00824421|10377905|P2|Overall Study|Other|1
3017225|NCT00824421|10377906|P1|Overall Study|Other|0
3017226|NCT00824421|10377904|P3|Overall Study|Randomized but not Treated|0
3017227|NCT00824421|10377905|P2|Overall Study|Randomized but not Treated|1
3017228|NCT00824421|10377906|P1|Overall Study|Randomized but not Treated|1
3017229|NCT00824421|10377904|P3|Overall Study|Withdrawal by Subject|3
3017230|NCT00824421|10377905|P2|Overall Study|Withdrawal by Subject|3
3017231|NCT00824421|10377906|P1|Overall Study|Withdrawal by Subject|2
3017232|NCT00824421|10377904|P3|Overall Study|Pregnancy|1
3017233|NCT00824421|10377905|P2|Overall Study|Pregnancy|0
3017234|NCT00824421|10377906|P1|Overall Study|Pregnancy|1
3017235|NCT00824421|10377904|P3|Overall Study|Lost to Follow-up|0
3017236|NCT00824421|10377905|P2|Overall Study|Lost to Follow-up|3
3017237|NCT00824421|10377906|P1|Overall Study|Lost to Follow-up|2
3017238|NCT00824421|10377904|P3|Overall Study|Lack of Efficacy|4
3017239|NCT00824421|10377905|P2|Overall Study|Lack of Efficacy|7
3017240|NCT00824421|10377906|P1|Overall Study|Lack of Efficacy|5
3017241|NCT00824421|10377904|P3|Overall Study|Death|0
3017242|NCT00824421|10377905|P2|Overall Study|Death|1
3017243|NCT00824421|10377906|P1|Overall Study|Death|0
3017244|NCT00824421|10377904|P3|Overall Study|Adverse Event|6
3017245|NCT00824421|10377905|P2|Overall Study|Adverse Event|6
3017246|NCT00824421|10377906|P1|Overall Study|Adverse Event|6
3017247|NCT00824408|10377957|P5|Randomized Phase|Other reason not defined above|4
3017248|NCT00824408|10377958|P4|Randomized Phase|Other reason not defined above|2
3017249|NCT00824408|10377959|P3|Randomized Phase|Other reason not defined above|4
3017250|NCT00824408|10377960|P2|Randomized Phase|Other reason not defined above|0
3017251|NCT00824408|10377961|P1|Randomized Phase|Other reason not defined above|0
3017252|NCT00824408|10377957|P5|Randomized Phase|Refused to continue medication|2
3017253|NCT00824408|10377958|P4|Randomized Phase|Refused to continue medication|2
3017254|NCT00824408|10377959|P3|Randomized Phase|Refused to continue medication|2
3017255|NCT00824408|10377960|P2|Randomized Phase|Refused to continue medication|0
3017256|NCT00824408|10377961|P1|Randomized Phase|Refused to continue medication|0
3017257|NCT00824408|10377957|P5|Randomized Phase|Adverse Event|5
3017258|NCT00824408|10377958|P4|Randomized Phase|Adverse Event|5
3017259|NCT00824408|10377959|P3|Randomized Phase|Adverse Event|4
3017260|NCT00824408|10377960|P2|Randomized Phase|Adverse Event|0
3017261|NCT00824408|10377961|P1|Randomized Phase|Adverse Event|0
3017262|NCT00824408|10377957|P5|Randomized Phase|Progressive disease|34
3017263|NCT00824408|10377958|P4|Randomized Phase|Progressive disease|36
3017264|NCT00824408|10377959|P3|Randomized Phase|Progressive disease|25
3017265|NCT00824408|10377960|P2|Randomized Phase|Progressive disease|0
3017266|NCT00824408|10377961|P1|Randomized Phase|Progressive disease|0
3017267|NCT00824408|10377957|P5|Randomized Phase|Not treated|1
3017268|NCT00824408|10377958|P4|Randomized Phase|Not treated|1
3017269|NCT00824408|10377959|P3|Randomized Phase|Not treated|1
3017270|NCT00824408|10377960|P2|Randomized Phase|Not treated|0
3017271|NCT00824408|10377961|P1|Randomized Phase|Not treated|0
3017272|NCT00824408|10377957|P5|Run-in Phase|Other reason not defined above|0
3017273|NCT00824408|10377958|P4|Run-in Phase|Other reason not defined above|0
3017274|NCT00824408|10377959|P3|Run-in Phase|Other reason not defined above|0
3017275|NCT00824408|10377960|P2|Run-in Phase|Other reason not defined above|1
3017276|NCT00824408|10377961|P1|Run-in Phase|Other reason not defined above|0
3017277|NCT00824408|10377957|P5|Run-in Phase|Refused to continue medication|0
3017278|NCT00824408|10377958|P4|Run-in Phase|Refused to continue medication|0
3017279|NCT00824408|10377959|P3|Run-in Phase|Refused to continue medication|0
3017280|NCT00824408|10377960|P2|Run-in Phase|Refused to continue medication|0
3017281|NCT00824408|10377961|P1|Run-in Phase|Refused to continue medication|1
3017282|NCT00824408|10377957|P5|Run-in Phase|Adverse Event|0
3017283|NCT00824408|10377958|P4|Run-in Phase|Adverse Event|0
3017284|NCT00824408|10377959|P3|Run-in Phase|Adverse Event|0
3017285|NCT00824408|10377960|P2|Run-in Phase|Adverse Event|1
3017286|NCT00824408|10377961|P1|Run-in Phase|Adverse Event|1
3017287|NCT00824408|10377957|P5|Run-in Phase|Progressive disease|0
3017288|NCT00824408|10377958|P4|Run-in Phase|Progressive disease|0
3017289|NCT00824408|10377959|P3|Run-in Phase|Progressive disease|0
3017290|NCT00824408|10377960|P2|Run-in Phase|Progressive disease|4
3017291|NCT00824408|10377961|P1|Run-in Phase|Progressive disease|4
3017292|NCT00824382|10378013|P4|Overall Study|Investigator's decision|0
3017293|NCT00824382|10378014|P3|Overall Study|Investigator's decision|2
3017294|NCT00824382|10378015|P2|Overall Study|Investigator's decision|1
3017295|NCT00824382|10378016|P1|Overall Study|Investigator's decision|0
3017296|NCT00824382|10378013|P4|Overall Study|Protocol Violation|1
3017297|NCT00824382|10378014|P3|Overall Study|Protocol Violation|0
3017298|NCT00824382|10378015|P2|Overall Study|Protocol Violation|0
3017299|NCT00824382|10378016|P1|Overall Study|Protocol Violation|1
3017300|NCT00824382|10378013|P4|Overall Study|Adverse Event|4
3017301|NCT00824382|10378014|P3|Overall Study|Adverse Event|1
3017302|NCT00824382|10378015|P2|Overall Study|Adverse Event|1
3017303|NCT00824382|10378016|P1|Overall Study|Adverse Event|4
3017304|NCT00824369|10378092|P6|Overall Study|Lost to Follow-up|0
3017305|NCT00824369|10378093|P5|Overall Study|Lost to Follow-up|1
3017306|NCT00824369|10378094|P4|Overall Study|Lost to Follow-up|0
3017307|NCT00824369|10378095|P3|Overall Study|Lost to Follow-up|0
3017308|NCT00824369|10378096|P2|Overall Study|Lost to Follow-up|0
3017309|NCT00824369|10378097|P1|Overall Study|Lost to Follow-up|0
3017310|NCT00824369|10378092|P6|Overall Study|Nolonger willing to participate in study|1
3017311|NCT00824369|10378093|P5|Overall Study|Nolonger willing to participate in study|0
3017312|NCT00824369|10378094|P4|Overall Study|Nolonger willing to participate in study|2
3017313|NCT00824369|10378095|P3|Overall Study|Nolonger willing to participate in study|1
3017314|NCT00824369|10378096|P2|Overall Study|Nolonger willing to participate in study|0
3017315|NCT00824369|10378097|P1|Overall Study|Nolonger willing to participate in study|1
3017316|NCT00824291|10378137|P2|Overall Study|Participant on prohibited medication|0
3017317|NCT00824291|10378138|P1|Overall Study|Participant on prohibited medication|1
3017318|NCT00824291|10378137|P2|Overall Study|Lack of Efficacy|8
3017319|NCT00824291|10378138|P1|Overall Study|Lack of Efficacy|7
3017320|NCT00824291|10378137|P2|Overall Study|Withdrawal by Subject|8
3017321|NCT00824291|10378138|P1|Overall Study|Withdrawal by Subject|14
3017322|NCT00824291|10378137|P2|Overall Study|Protocol Violation|1
3017323|NCT00824291|10378138|P1|Overall Study|Protocol Violation|4
3017324|NCT00824291|10378137|P2|Overall Study|Non-compliance|1
3017325|NCT00824291|10378138|P1|Overall Study|Non-compliance|1
3017326|NCT00824291|10378137|P2|Overall Study|Lost to Follow-up|9
3017327|NCT00824291|10378138|P1|Overall Study|Lost to Follow-up|11
3017328|NCT00824291|10378137|P2|Overall Study|Discontinuation of Study by Sponsor|2
3017329|NCT00824291|10378138|P1|Overall Study|Discontinuation of Study by Sponsor|1
3017330|NCT00824291|10378137|P2|Overall Study|Adverse Event|6
3017331|NCT00824291|10378138|P1|Overall Study|Adverse Event|15
3017332|NCT00824265|10378160|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
3017333|NCT00824265|10378161|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
3017334|NCT00824265|10378160|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
3017335|NCT00824265|10378161|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
3017336|NCT00824265|10378160|P2|Treatment Phase|Withdrawal by Subject|15
3017337|NCT00824265|10378161|P1|Treatment Phase|Withdrawal by Subject|6
3017338|NCT00824265|10378160|P2|Treatment Phase|Physician Decision|12
3017339|NCT00824265|10378161|P1|Treatment Phase|Physician Decision|6
3017340|NCT00824265|10378160|P2|Treatment Phase|Lost to Follow-up|1
3017341|NCT00824265|10378161|P1|Treatment Phase|Lost to Follow-up|1
3017342|NCT00824265|10378160|P2|Treatment Phase|Protocol Violation|0
3017343|NCT00824265|10378161|P1|Treatment Phase|Protocol Violation|1
3017344|NCT00824265|10378160|P2|Treatment Phase|Adverse Event,non-fatal|52
3017345|NCT00824265|10378161|P1|Treatment Phase|Adverse Event,non-fatal|50
3017346|NCT00824161|10378222|P1|Overall Study|Screen Failure|1
3017347|NCT00824161|10378222|P1|Overall Study|Withdrawal by Subject|1
3017348|NCT00824005|10378288|P2|Overall Study|Lost to Follow-up|1
3017349|NCT00824005|10378289|P1|Overall Study|Lost to Follow-up|0
3017350|NCT00824005|10378288|P2|Overall Study|Death|1
3017351|NCT00824005|10378289|P1|Overall Study|Death|0
3017352|NCT00823979|10378324|P3|Overall Study|Study Terminated by Sponsor|7
3017353|NCT00823979|10378325|P2|Overall Study|Study Terminated by Sponsor|5
3017354|NCT00823979|10378326|P1|Overall Study|Study Terminated by Sponsor|5
3017355|NCT00823979|10378324|P3|Overall Study|Randomized but not Treated|1
3017356|NCT00823979|10378325|P2|Overall Study|Randomized but not Treated|3
3017357|NCT00823979|10378326|P1|Overall Study|Randomized but not Treated|4
3017358|NCT00823979|10378324|P3|Overall Study|Other|1
3017359|NCT00823979|10378325|P2|Overall Study|Other|0
3017360|NCT00823979|10378326|P1|Overall Study|Other|2
3017361|NCT00823979|10378324|P3|Overall Study|Adverse Event|4
3017362|NCT00823979|10378325|P2|Overall Study|Adverse Event|2
3017363|NCT00823979|10378326|P1|Overall Study|Adverse Event|0
3017364|NCT00823979|10378324|P3|Overall Study|Pregnancy|0
3017365|NCT00823979|10378325|P2|Overall Study|Pregnancy|1
3017366|NCT00823979|10378326|P1|Overall Study|Pregnancy|0
3017367|NCT00823979|10378324|P3|Overall Study|Protocol Violation|0
3017368|NCT00823979|10378325|P2|Overall Study|Protocol Violation|1
3017369|NCT00823979|10378326|P1|Overall Study|Protocol Violation|1
3017370|NCT00823979|10378324|P3|Overall Study|Withdrawal by Subject|2
3017371|NCT00823979|10378325|P2|Overall Study|Withdrawal by Subject|3
3017372|NCT00823979|10378326|P1|Overall Study|Withdrawal by Subject|2
3017373|NCT00823979|10378324|P3|Overall Study|Lost to Follow-up|0
3017374|NCT00823979|10378325|P2|Overall Study|Lost to Follow-up|1
3017375|NCT00823979|10378326|P1|Overall Study|Lost to Follow-up|2
3017376|NCT00823979|10378324|P3|Overall Study|Lack of Efficacy|9
3017377|NCT00823979|10378325|P2|Overall Study|Lack of Efficacy|16
3017378|NCT00823979|10378326|P1|Overall Study|Lack of Efficacy|13
3017379|NCT00823901|10378371|P2|Overall Study|Lost to Follow-up|1
3017380|NCT00823901|10378372|P1|Overall Study|Lost to Follow-up|2
3017381|NCT00823901|10378371|P2|Overall Study|Lack of Efficacy|0
3017382|NCT00823901|10378372|P1|Overall Study|Lack of Efficacy|1
3017383|NCT00823901|10378371|P2|Overall Study|Adverse Event|1
3017384|NCT00823901|10378372|P1|Overall Study|Adverse Event|1
3017385|NCT00823836|10378380|P2|Long-term Phase|Withdrawal by Subject|1
3017386|NCT00823836|10378381|P1|Long-term Phase|Withdrawal by Subject|1
3017387|NCT00823836|10378380|P2|Long-term Phase|Physician Decision|2
3017388|NCT00823836|10378381|P1|Long-term Phase|Physician Decision|1
3017389|NCT00823836|10378380|P2|Long-term Phase|Adverse Event|2
3017390|NCT00823836|10378381|P1|Long-term Phase|Adverse Event|3
3017391|NCT00823836|10378380|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
3017392|NCT00823836|10378381|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
3017393|NCT00823836|10378380|P2|NV and PR/XR Switching Phases|Physician Decision|2
3017394|NCT00823836|10378381|P1|NV and PR/XR Switching Phases|Physician Decision|5
3017395|NCT00823836|10378380|P2|NV and PR/XR Switching Phases|Protocol Violation|1
3017396|NCT00823836|10378381|P1|NV and PR/XR Switching Phases|Protocol Violation|1
3017397|NCT00823836|10378380|P2|NV and PR/XR Switching Phases|Adverse Event|21
3017398|NCT00823836|10378381|P1|NV and PR/XR Switching Phases|Adverse Event|22
3017399|NCT00823823|10378487|P2|Overall Study|Protocol Violation|5
3017400|NCT00823823|10378488|P1|Overall Study|Protocol Violation|5
3017401|NCT00823823|10378487|P2|Overall Study|Lost to Follow-up|1
3017402|NCT00823823|10378488|P1|Overall Study|Lost to Follow-up|3
3017403|NCT00823719|10378512|P2|Overall Study|Disease Progression|4
3017404|NCT00823719|10378513|P1|Overall Study|Disease Progression|4
3017405|NCT00823719|10378512|P2|Overall Study|Withdrawal by Subject|1
3017406|NCT00823719|10378513|P1|Overall Study|Withdrawal by Subject|0
3017407|NCT00823719|10378512|P2|Overall Study|Physician Decision|4
3017408|NCT00823719|10378513|P1|Overall Study|Physician Decision|1
3017409|NCT00823719|10378512|P2|Overall Study|Adverse Event|2
3017410|NCT00823719|10378513|P1|Overall Study|Adverse Event|1
3017411|NCT00823615|10378566|P2|Period 2|Time/Job Conflict|2
3017412|NCT00823615|10378567|P1|Period 2|Time/Job Conflict|1
3017413|NCT00823615|10378566|P2|Period 2|Lost to Follow-up|0
3017414|NCT00823615|10378567|P1|Period 2|Lost to Follow-up|2
3017415|NCT00823472|10378577|P2|Overall Study|Physician Decision|28
3017416|NCT00823472|10378578|P1|Overall Study|Physician Decision|24
3017417|NCT00823264|10378605|P2|Overall Study|Protocol Violation|0
3017418|NCT00823264|10378606|P1|Overall Study|Protocol Violation|2
3017419|NCT00823212|10378614|P2|Overall Study|Missed 12-month visit|21
3017420|NCT00823212|10378615|P1|Overall Study|Missed 12-month visit|21
3017421|NCT00823212|10378614|P2|Overall Study|Incarcerated|1
3017422|NCT00823212|10378615|P1|Overall Study|Incarcerated|0
3017423|NCT00823212|10378614|P2|Overall Study|Withdrawal by Subject|1
3017424|NCT00823212|10378615|P1|Overall Study|Withdrawal by Subject|6
3017425|NCT00823212|10378614|P2|Overall Study|Death|10
3017426|NCT00823212|10378615|P1|Overall Study|Death|8
3017427|NCT00823199|10378697|P1|Overall Study|Withdrawal by Subject|2
3017428|NCT00823134|10378703|P1|Overall Study|Invalid measurement|1
3017429|NCT00822926|10378776|P2|Second Injection Visit|Withdrawal by Subject|1
3017430|NCT00822926|10378777|P1|Second Injection Visit|Withdrawal by Subject|0
3017431|NCT00822926|10378776|P2|Second Injection Visit|Lost to Follow-up|0
3017432|NCT00822926|10378777|P1|Second Injection Visit|Lost to Follow-up|1
3017433|NCT00822900|10378791|P2|Overall Study|Became a ward of the state|1
3017434|NCT00822900|10378792|P1|Overall Study|Became a ward of the state|2
3017435|NCT00822900|10378791|P2|Overall Study|Death|69
3017436|NCT00822900|10378792|P1|Overall Study|Death|83
3017437|NCT00822900|10378791|P2|Overall Study|Lost to Follow-up|9
3017438|NCT00822900|10378792|P1|Overall Study|Lost to Follow-up|9
3017439|NCT00822900|10378791|P2|Overall Study|Withdrawal by Subject|14
3017440|NCT00822900|10378792|P1|Overall Study|Withdrawal by Subject|14
3017441|NCT00822692|10378839|P2|Overall Study|Lost to Follow-up|25
3017442|NCT00822692|10378840|P1|Overall Study|Lost to Follow-up|17
3017443|NCT00822237|10378978|P2|Dose 2 Vaccination|Lost to Follow-up|9
3017444|NCT00822237|10378979|P1|Dose 2 Vaccination|Lost to Follow-up|2
3017445|NCT00822237|10378978|P2|Dose 2 Vaccination|Withdrawal by Subject|2
3017446|NCT00822237|10378979|P1|Dose 2 Vaccination|Withdrawal by Subject|2
3017447|NCT00822237|10378978|P2|Dose 1 Vaccination|Lost to Follow-up|12
3017448|NCT00822237|10378979|P1|Dose 1 Vaccination|Lost to Follow-up|9
3017449|NCT00822237|10378978|P2|Dose 1 Vaccination|Withdrawal by Subject|14
3017450|NCT00822237|10378979|P1|Dose 1 Vaccination|Withdrawal by Subject|13
3017451|NCT00822237|10378978|P2|Dose 1 Vaccination|Not vaccinated|0
3017452|NCT00822237|10378979|P1|Dose 1 Vaccination|Not vaccinated|3
3017453|NCT00822172|10379060|P2|Overall Study|Other|1
3017454|NCT00822172|10379061|P1|Overall Study|Other|0
3017455|NCT00822172|10379060|P2|Overall Study|site closed|1
3017456|NCT00822172|10379061|P1|Overall Study|site closed|0
3017457|NCT00822172|10379060|P2|Overall Study|Withdrawal by Subject|4
3017458|NCT00822172|10379061|P1|Overall Study|Withdrawal by Subject|1
3017459|NCT00822172|10379060|P2|Overall Study|Lost to Follow-up|1
3017460|NCT00822172|10379061|P1|Overall Study|Lost to Follow-up|3
3017461|NCT00822172|10379060|P2|Overall Study|Death|0
3017462|NCT00822172|10379061|P1|Overall Study|Death|1
3017463|NCT00822172|10379060|P2|Overall Study|Adverse Event|12
3017464|NCT00822172|10379061|P1|Overall Study|Adverse Event|10
3017465|NCT00822120|10379081|P6|PET-directed Therapy|Protocol Violation|0
3017466|NCT00822120|10379082|P5|PET-directed Therapy|Protocol Violation|0
3017467|NCT00822120|10379083|P4|PET-directed Therapy|Protocol Violation|6
3017468|NCT00822120|10379084|P3|PET-directed Therapy|Protocol Violation|0
3017469|NCT00822120|10379085|P2|PET-directed Therapy|Protocol Violation|0
3017470|NCT00822120|10379086|P1|PET-directed Therapy|Protocol Violation|0
3017471|NCT00822120|10379081|P6|PET-directed Therapy|Death|0
3017472|NCT00822120|10379082|P5|PET-directed Therapy|Death|0
3017473|NCT00822120|10379083|P4|PET-directed Therapy|Death|2
3017474|NCT00822120|10379084|P3|PET-directed Therapy|Death|0
3017475|NCT00822120|10379085|P2|PET-directed Therapy|Death|0
3017476|NCT00822120|10379086|P1|PET-directed Therapy|Death|0
3017477|NCT00822120|10379081|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
3017478|NCT00822120|10379082|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
3017479|NCT00822120|10379083|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
3017480|NCT00822120|10379084|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
3017481|NCT00822120|10379085|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
3017482|NCT00822120|10379086|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
3017483|NCT00822120|10379081|P6|PET-directed Therapy|Adverse Event|0
3017484|NCT00822120|10379082|P5|PET-directed Therapy|Adverse Event|0
3017485|NCT00822120|10379083|P4|PET-directed Therapy|Adverse Event|1
3017486|NCT00822120|10379084|P3|PET-directed Therapy|Adverse Event|0
3017487|NCT00822120|10379085|P2|PET-directed Therapy|Adverse Event|0
3017488|NCT00822120|10379086|P1|PET-directed Therapy|Adverse Event|0
3017489|NCT00822120|10379081|P6|Initial Registration|Ineligible|0
3017490|NCT00822120|10379082|P5|Initial Registration|Ineligible|0
3017491|NCT00822120|10379083|P4|Initial Registration|Ineligible|0
3017492|NCT00822120|10379084|P3|Initial Registration|Ineligible|0
3017493|NCT00822120|10379085|P2|Initial Registration|Ineligible|1
3017494|NCT00822120|10379086|P1|Initial Registration|Ineligible|22
3017495|NCT00822120|10379081|P6|Initial Registration|Reasons not Protocol Specified|0
3017496|NCT00822120|10379082|P5|Initial Registration|Reasons not Protocol Specified|0
3017497|NCT00822120|10379083|P4|Initial Registration|Reasons not Protocol Specified|0
3017498|NCT00822120|10379084|P3|Initial Registration|Reasons not Protocol Specified|0
3017499|NCT00822120|10379085|P2|Initial Registration|Reasons not Protocol Specified|0
3017500|NCT00822120|10379086|P1|Initial Registration|Reasons not Protocol Specified|2
3017501|NCT00822120|10379081|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
3017502|NCT00822120|10379082|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
3017503|NCT00822120|10379083|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
3017504|NCT00822120|10379084|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
3017505|NCT00822120|10379085|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
3017506|NCT00822120|10379086|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
3017507|NCT00822120|10379081|P6|Initial Registration|Adverse Event|0
3017508|NCT00822120|10379082|P5|Initial Registration|Adverse Event|0
3017509|NCT00822120|10379083|P4|Initial Registration|Adverse Event|0
3017510|NCT00822120|10379084|P3|Initial Registration|Adverse Event|0
3017511|NCT00822120|10379085|P2|Initial Registration|Adverse Event|0
3017512|NCT00822120|10379086|P1|Initial Registration|Adverse Event|1
3017513|NCT00821873|10379152|P1|Overall Study|Lost to Follow-up|4
3017514|NCT00821678|10379182|P2|Overall Study|Death|2
3017515|NCT00821678|10379183|P1|Overall Study|Death|0
3017516|NCT00821678|10379182|P2|Overall Study|Lost to Follow-up|12
3017517|NCT00821678|10379183|P1|Overall Study|Lost to Follow-up|13
3017518|NCT00821678|10379182|P2|Overall Study|Withdrawal by Subject|0
3017519|NCT00821678|10379183|P1|Overall Study|Withdrawal by Subject|8
3017520|NCT00821587|10379218|P2|Overall Study|Physician Decision|1
3017521|NCT00821587|10379219|P1|Overall Study|Physician Decision|0
3017522|NCT00821509|10379228|P3|Overall Study|Withdrawal by Subject|34
3017523|NCT00821509|10379229|P2|Overall Study|Withdrawal by Subject|11
3017524|NCT00821509|10379230|P1|Overall Study|Withdrawal by Subject|12
3017525|NCT00821431|10379243|P2|Overall Study|Physician Decision|1
3017526|NCT00821431|10379244|P1|Overall Study|Physician Decision|0
3017527|NCT00821431|10379243|P2|Overall Study|Protocol Violation|1
3017528|NCT00821431|10379244|P1|Overall Study|Protocol Violation|3
3017529|NCT00821431|10379243|P2|Overall Study|Lost to Follow-up|0
3017530|NCT00821431|10379244|P1|Overall Study|Lost to Follow-up|1
3017531|NCT00821431|10379243|P2|Overall Study|Withdrawal by Subject|0
3017532|NCT00821431|10379244|P1|Overall Study|Withdrawal by Subject|5
3017533|NCT00821431|10379243|P2|Overall Study|Adverse Event|3
3017534|NCT00821431|10379244|P1|Overall Study|Adverse Event|6
3017535|NCT00821327|10379252|P1|Overall Study|Other/Unknown|5
3017536|NCT00821327|10379252|P1|Overall Study|Disease Progression|13
3017537|NCT00821327|10379252|P1|Overall Study|Sponsor Request|1
3017538|NCT00821327|10379252|P1|Overall Study|Investigator Request|2
3017539|NCT00821327|10379252|P1|Overall Study|Patient Request|1
3017540|NCT00821327|10379252|P1|Overall Study|Adverse Event|13
3017541|NCT00821236|10379261|P1|Overall Study|Lost to Follow-up|3
3017542|NCT00821093|10379301|P2|Overall Study|Administrative problems|2
3017543|NCT00821093|10379302|P1|Overall Study|Administrative problems|1
3017544|NCT00821093|10379301|P2|Overall Study|Abnormal test procedure result(s)|1
3017545|NCT00821093|10379302|P1|Overall Study|Abnormal test procedure result(s)|1
3017546|NCT00821093|10379301|P2|Overall Study|Death|1
3017547|NCT00821093|10379302|P1|Overall Study|Death|2
3017548|NCT00821093|10379301|P2|Overall Study|Lack of Efficacy|2
3017549|NCT00821093|10379302|P1|Overall Study|Lack of Efficacy|2
3017550|NCT00821093|10379301|P2|Overall Study|Abnormal laboratory value(s)|0
3017551|NCT00821093|10379302|P1|Overall Study|Abnormal laboratory value(s)|2
3017552|NCT00821093|10379301|P2|Overall Study|Protocol deviation|6
3017553|NCT00821093|10379302|P1|Overall Study|Protocol deviation|3
3017554|NCT00821093|10379301|P2|Overall Study|Lost to Follow-up|3
3017555|NCT00821093|10379302|P1|Overall Study|Lost to Follow-up|9
3017556|NCT00821093|10379301|P2|Overall Study|Withdrawal by Subject|13
3017557|NCT00821093|10379302|P1|Overall Study|Withdrawal by Subject|9
3017558|NCT00821093|10379301|P2|Overall Study|Adverse Event|12
3017559|NCT00821093|10379302|P1|Overall Study|Adverse Event|20
3017560|NCT00821015|10379321|P1|Overall Study|Lost to Follow-up|12
3017561|NCT00820898|10379332|P1|Overall Study|Inelgible - wrong primary site|1
3017562|NCT00820755|10379346|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
3017563|NCT00820755|10379347|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
3017564|NCT00820755|10379348|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
3017565|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Other|0
3017566|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Other|0
3017567|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Other|11
3017568|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
3017569|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
3017570|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
3017571|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Progressive disease|0
3017572|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Progressive disease|0
3017573|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Progressive disease|114
3017574|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
3017575|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
3017576|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
3017577|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
3017578|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
3017579|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
3017580|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
3017581|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
3017582|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
3017583|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Death|0
3017584|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Death|0
3017585|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Death|28
3017586|NCT00820755|10379346|P3|Period 1: Combination Therapy Phase|Adverse Event|0
3017587|NCT00820755|10379347|P2|Period 1: Combination Therapy Phase|Adverse Event|0
3017588|NCT00820755|10379348|P1|Period 1: Combination Therapy Phase|Adverse Event|77
3017589|NCT00820248|10379441|P2|Overall Study|No treated|1
3017590|NCT00820248|10379442|P1|Overall Study|No treated|4
3017591|NCT00820222|10379474|P2|Overall Study|Unkown|7
3017592|NCT00820222|10379475|P1|Overall Study|Unkown|11
3017593|NCT00820222|10379474|P2|Overall Study|Sponsor Terminated Study|65
3017594|NCT00820222|10379475|P1|Overall Study|Sponsor Terminated Study|43
3017595|NCT00820222|10379474|P2|Overall Study|Physician Decision|88
3017596|NCT00820222|10379475|P1|Overall Study|Physician Decision|93
3017597|NCT00820222|10379474|P2|Overall Study|Withdrawal by Subject|21
3017598|NCT00820222|10379475|P1|Overall Study|Withdrawal by Subject|19
3017599|NCT00820222|10379474|P2|Overall Study|Lost to Follow-up|9
3017600|NCT00820222|10379475|P1|Overall Study|Lost to Follow-up|10
3017601|NCT00820170|10379506|P5|Overall Study|Progressive Disease|2
3017602|NCT00820170|10379507|P4|Overall Study|Progressive Disease|0
3017603|NCT00820170|10379508|P3|Overall Study|Progressive Disease|0
3017604|NCT00820170|10379509|P2|Overall Study|Progressive Disease|0
3017605|NCT00820170|10379510|P1|Overall Study|Progressive Disease|0
3017606|NCT00820170|10379506|P5|Overall Study|Adverse Event|2
3017607|NCT00820170|10379507|P4|Overall Study|Adverse Event|0
3017608|NCT00820170|10379508|P3|Overall Study|Adverse Event|0
3017609|NCT00820170|10379509|P2|Overall Study|Adverse Event|0
3017610|NCT00820170|10379510|P1|Overall Study|Adverse Event|0
3017611|NCT00820027|10379562|P4|Overall Study|Withdrawal by Subject|6
3017612|NCT00820027|10379563|P3|Overall Study|Withdrawal by Subject|4
3017613|NCT00820027|10379564|P2|Overall Study|Withdrawal by Subject|4
3017614|NCT00820027|10379565|P1|Overall Study|Withdrawal by Subject|6
3017615|NCT00820027|10379562|P4|Overall Study|Protocol Violation|0
3017616|NCT00820027|10379563|P3|Overall Study|Protocol Violation|4
3017617|NCT00820027|10379564|P2|Overall Study|Protocol Violation|0
3017618|NCT00820027|10379565|P1|Overall Study|Protocol Violation|3
3017619|NCT00820027|10379562|P4|Overall Study|Physician Decision|0
3017620|NCT00820027|10379563|P3|Overall Study|Physician Decision|1
3017621|NCT00820027|10379564|P2|Overall Study|Physician Decision|1
3017622|NCT00820027|10379565|P1|Overall Study|Physician Decision|0
3017623|NCT00820027|10379562|P4|Overall Study|Lack of Efficacy|2
3017624|NCT00820027|10379563|P3|Overall Study|Lack of Efficacy|2
3017625|NCT00820027|10379564|P2|Overall Study|Lack of Efficacy|1
3017626|NCT00820027|10379565|P1|Overall Study|Lack of Efficacy|2
3017627|NCT00820027|10379562|P4|Overall Study|Adverse Event|5
3017628|NCT00820027|10379563|P3|Overall Study|Adverse Event|10
3017629|NCT00820027|10379564|P2|Overall Study|Adverse Event|8
3017630|NCT00820027|10379565|P1|Overall Study|Adverse Event|15
3017631|NCT00819910|10379607|P4|Overall Study|Lost to Follow-up|0
3017632|NCT00819910|10379608|P3|Overall Study|Lost to Follow-up|0
3017633|NCT00819910|10379609|P2|Overall Study|Lost to Follow-up|0
3017634|NCT00819910|10379610|P1|Overall Study|Lost to Follow-up|1
3017635|NCT00819910|10379607|P4|Overall Study|Withdrawal by Subject|0
3017636|NCT00819910|10379608|P3|Overall Study|Withdrawal by Subject|1
3017637|NCT00819910|10379609|P2|Overall Study|Withdrawal by Subject|1
3017638|NCT00819910|10379610|P1|Overall Study|Withdrawal by Subject|1
3017639|NCT00819910|10379607|P4|Overall Study|Adverse Event|1
3017640|NCT00819910|10379608|P3|Overall Study|Adverse Event|2
3017641|NCT00819910|10379609|P2|Overall Study|Adverse Event|0
3017642|NCT00819910|10379610|P1|Overall Study|Adverse Event|0
3017643|NCT00819832|10379642|P6|Overall Study|Sponsor Termination of Study|0
3017644|NCT00819832|10379643|P5|Overall Study|Sponsor Termination of Study|0
3017645|NCT00819832|10379644|P4|Overall Study|Sponsor Termination of Study|0
3017646|NCT00819832|10379645|P3|Overall Study|Sponsor Termination of Study|0
3017647|NCT00819832|10379646|P2|Overall Study|Sponsor Termination of Study|0
3017648|NCT00819832|10379647|P1|Overall Study|Sponsor Termination of Study|3
3017649|NCT00819780|10379668|P2|Overall Study|Still in treatment|17
3017650|NCT00819780|10379669|P1|Overall Study|Still in treatment|25
3017651|NCT00819780|10379668|P2|Overall Study|Did not receive study drug|4
3017652|NCT00819780|10379669|P1|Overall Study|Did not receive study drug|3
3017653|NCT00819767|10379703|P2|Overall Study|Unsatisfactory therapeutic effect|2
3017654|NCT00819767|10379704|P1|Overall Study|Unsatisfactory therapeutic effect|1
3017655|NCT00819741|10379716|P2|Overall Study|Reasons unknown|3
3017656|NCT00819741|10379717|P1|Overall Study|Reasons unknown|3
3017657|NCT00819741|10379716|P2|Overall Study|Unclassified|0
3017658|NCT00819741|10379717|P1|Overall Study|Unclassified|6
3017659|NCT00819741|10379716|P2|Overall Study|Withdrawal by Subject|2
3017660|NCT00819741|10379717|P1|Overall Study|Withdrawal by Subject|2
3017661|NCT00819741|10379716|P2|Overall Study|Protocol Violation|4
3017662|NCT00819741|10379717|P1|Overall Study|Protocol Violation|3
3017663|NCT00819741|10379716|P2|Overall Study|Lost to Follow-up|1
3017664|NCT00819741|10379717|P1|Overall Study|Lost to Follow-up|3
3017665|NCT00819741|10379716|P2|Overall Study|Lack of Efficacy|2
3017666|NCT00819741|10379717|P1|Overall Study|Lack of Efficacy|0
3017667|NCT00819741|10379716|P2|Overall Study|Adverse Event|2
3017668|NCT00819741|10379717|P1|Overall Study|Adverse Event|5
3017669|NCT00819585|10379771|P11|Extension Study|Death|0
3017670|NCT00819585|10379772|P10|Extension Study|Death|0
3017671|NCT00819585|10379773|P9|Extension Study|Death|2
3017672|NCT00819585|10379774|P8|Extension Study|Death|0
3017673|NCT00819585|10379775|P7|Extension Study|Death|0
3017674|NCT00819585|10379776|P6|Extension Study|Death|0
3017675|NCT00819585|10379777|P5|Extension Study|Death|0
3017676|NCT00819585|10379778|P4|Extension Study|Death|0
3017677|NCT00819585|10379779|P3|Extension Study|Death|0
3017678|NCT00819585|10379780|P2|Extension Study|Death|0
3017679|NCT00819585|10379781|P1|Extension Study|Death|0
3017680|NCT00819585|10379771|P11|Extension Study|Lost to Follow-up|1
3017681|NCT00819585|10379772|P10|Extension Study|Lost to Follow-up|1
3017682|NCT00819585|10379773|P9|Extension Study|Lost to Follow-up|2
3017683|NCT00819585|10379774|P8|Extension Study|Lost to Follow-up|0
3017684|NCT00819585|10379775|P7|Extension Study|Lost to Follow-up|0
3017685|NCT00819585|10379776|P6|Extension Study|Lost to Follow-up|0
3017686|NCT00819585|10379777|P5|Extension Study|Lost to Follow-up|0
3017687|NCT00819585|10379778|P4|Extension Study|Lost to Follow-up|0
3017688|NCT00819585|10379779|P3|Extension Study|Lost to Follow-up|0
3017689|NCT00819585|10379780|P2|Extension Study|Lost to Follow-up|0
3017690|NCT00819585|10379781|P1|Extension Study|Lost to Follow-up|0
3017691|NCT00819585|10379771|P11|Extension Study|Subject Withdrew Consent|1
3017692|NCT00819585|10379772|P10|Extension Study|Subject Withdrew Consent|0
3017693|NCT00819585|10379773|P9|Extension Study|Subject Withdrew Consent|3
3017694|NCT00819585|10379774|P8|Extension Study|Subject Withdrew Consent|0
3017695|NCT00819585|10379775|P7|Extension Study|Subject Withdrew Consent|0
3017696|NCT00819585|10379776|P6|Extension Study|Subject Withdrew Consent|0
3017697|NCT00819585|10379777|P5|Extension Study|Subject Withdrew Consent|0
3017698|NCT00819585|10379778|P4|Extension Study|Subject Withdrew Consent|0
3017699|NCT00819585|10379779|P3|Extension Study|Subject Withdrew Consent|0
3017700|NCT00819585|10379780|P2|Extension Study|Subject Withdrew Consent|0
3017701|NCT00819585|10379781|P1|Extension Study|Subject Withdrew Consent|0
3017702|NCT00819585|10379771|P11|Extension Study|Abnormal Laboratory Value(s)|0
3017703|NCT00819585|10379772|P10|Extension Study|Abnormal Laboratory Value(s)|0
3017704|NCT00819585|10379773|P9|Extension Study|Abnormal Laboratory Value(s)|1
3017705|NCT00819585|10379774|P8|Extension Study|Abnormal Laboratory Value(s)|0
3017706|NCT00819585|10379775|P7|Extension Study|Abnormal Laboratory Value(s)|0
3017707|NCT00819585|10379776|P6|Extension Study|Abnormal Laboratory Value(s)|0
3017708|NCT00819585|10379777|P5|Extension Study|Abnormal Laboratory Value(s)|0
3017709|NCT00819585|10379778|P4|Extension Study|Abnormal Laboratory Value(s)|0
3017710|NCT00819585|10379779|P3|Extension Study|Abnormal Laboratory Value(s)|0
3017711|NCT00819585|10379780|P2|Extension Study|Abnormal Laboratory Value(s)|0
3017712|NCT00819585|10379781|P1|Extension Study|Abnormal Laboratory Value(s)|0
3017713|NCT00819585|10379771|P11|Core Study|Protocol Violation|0
3017714|NCT00819585|10379772|P10|Core Study|Protocol Violation|0
3017715|NCT00819585|10379773|P9|Core Study|Protocol Violation|0
3017716|NCT00819585|10379774|P8|Core Study|Protocol Violation|0
3017717|NCT00819585|10379775|P7|Core Study|Protocol Violation|3
3017718|NCT00819585|10379776|P6|Core Study|Protocol Violation|1
3017719|NCT00819585|10379777|P5|Core Study|Protocol Violation|0
3017720|NCT00819585|10379778|P4|Core Study|Protocol Violation|0
3017721|NCT00819585|10379779|P3|Core Study|Protocol Violation|1
3017722|NCT00819585|10379780|P2|Core Study|Protocol Violation|0
3017723|NCT00819585|10379781|P1|Core Study|Protocol Violation|0
3017724|NCT00819585|10379771|P11|Core Study|Death|0
3017725|NCT00819585|10379772|P10|Core Study|Death|0
3017726|NCT00819585|10379773|P9|Core Study|Death|0
3017727|NCT00819585|10379774|P8|Core Study|Death|0
3017728|NCT00819585|10379775|P7|Core Study|Death|1
3017729|NCT00819585|10379776|P6|Core Study|Death|0
3017730|NCT00819585|10379777|P5|Core Study|Death|0
3017731|NCT00819585|10379778|P4|Core Study|Death|0
3017732|NCT00819585|10379779|P3|Core Study|Death|0
3017733|NCT00819585|10379780|P2|Core Study|Death|0
3017734|NCT00819585|10379781|P1|Core Study|Death|0
3017735|NCT00819585|10379771|P11|Core Study|Administrative Problems|0
3017736|NCT00819585|10379772|P10|Core Study|Administrative Problems|0
3017737|NCT00819585|10379773|P9|Core Study|Administrative Problems|0
3017738|NCT00819585|10379774|P8|Core Study|Administrative Problems|0
3017739|NCT00819585|10379775|P7|Core Study|Administrative Problems|2
3017740|NCT00819585|10379776|P6|Core Study|Administrative Problems|0
3017741|NCT00819585|10379777|P5|Core Study|Administrative Problems|0
3017742|NCT00819585|10379778|P4|Core Study|Administrative Problems|0
3017743|NCT00819585|10379779|P3|Core Study|Administrative Problems|0
3017744|NCT00819585|10379780|P2|Core Study|Administrative Problems|0
3017745|NCT00819585|10379781|P1|Core Study|Administrative Problems|0
3017746|NCT00819585|10379771|P11|Core Study|Lost to Follow-up|0
3017747|NCT00819585|10379772|P10|Core Study|Lost to Follow-up|0
3017748|NCT00819585|10379773|P9|Core Study|Lost to Follow-up|0
3017749|NCT00819585|10379774|P8|Core Study|Lost to Follow-up|0
3017750|NCT00819585|10379775|P7|Core Study|Lost to Follow-up|1
3017751|NCT00819585|10379776|P6|Core Study|Lost to Follow-up|1
3017752|NCT00819585|10379777|P5|Core Study|Lost to Follow-up|1
3017753|NCT00819585|10379778|P4|Core Study|Lost to Follow-up|0
3017754|NCT00819585|10379779|P3|Core Study|Lost to Follow-up|2
3017755|NCT00819585|10379780|P2|Core Study|Lost to Follow-up|1
3017756|NCT00819585|10379781|P1|Core Study|Lost to Follow-up|2
3017757|NCT00819585|10379771|P11|Core Study|Subject Withdrew Consent|0
3017758|NCT00819585|10379772|P10|Core Study|Subject Withdrew Consent|0
3017759|NCT00819585|10379773|P9|Core Study|Subject Withdrew Consent|0
3017760|NCT00819585|10379774|P8|Core Study|Subject Withdrew Consent|0
3017761|NCT00819585|10379775|P7|Core Study|Subject Withdrew Consent|3
3017762|NCT00819585|10379776|P6|Core Study|Subject Withdrew Consent|0
3017763|NCT00819585|10379777|P5|Core Study|Subject Withdrew Consent|0
3017764|NCT00819585|10379778|P4|Core Study|Subject Withdrew Consent|1
3017765|NCT00819585|10379779|P3|Core Study|Subject Withdrew Consent|2
3017766|NCT00819585|10379780|P2|Core Study|Subject Withdrew Consent|3
3017767|NCT00819585|10379781|P1|Core Study|Subject Withdrew Consent|0
3017768|NCT00819585|10379771|P11|Core Study|Subject No Longer Requires Study Drug|0
3017769|NCT00819585|10379772|P10|Core Study|Subject No Longer Requires Study Drug|0
3017770|NCT00819585|10379773|P9|Core Study|Subject No Longer Requires Study Drug|0
3017771|NCT00819585|10379774|P8|Core Study|Subject No Longer Requires Study Drug|0
3017772|NCT00819585|10379775|P7|Core Study|Subject No Longer Requires Study Drug|0
3017773|NCT00819585|10379776|P6|Core Study|Subject No Longer Requires Study Drug|0
3017774|NCT00819585|10379777|P5|Core Study|Subject No Longer Requires Study Drug|1
3017775|NCT00819585|10379778|P4|Core Study|Subject No Longer Requires Study Drug|0
3017776|NCT00819585|10379779|P3|Core Study|Subject No Longer Requires Study Drug|0
3017777|NCT00819585|10379780|P2|Core Study|Subject No Longer Requires Study Drug|0
3017778|NCT00819585|10379781|P1|Core Study|Subject No Longer Requires Study Drug|0
3017779|NCT00819585|10379771|P11|Core Study|Unsatisfactory Therapeutic Effect|0
3017780|NCT00819585|10379772|P10|Core Study|Unsatisfactory Therapeutic Effect|0
3017781|NCT00819585|10379773|P9|Core Study|Unsatisfactory Therapeutic Effect|0
3017782|NCT00819585|10379774|P8|Core Study|Unsatisfactory Therapeutic Effect|0
3017783|NCT00819585|10379775|P7|Core Study|Unsatisfactory Therapeutic Effect|1
3017784|NCT00819585|10379776|P6|Core Study|Unsatisfactory Therapeutic Effect|0
3017785|NCT00819585|10379777|P5|Core Study|Unsatisfactory Therapeutic Effect|0
3017786|NCT00819585|10379778|P4|Core Study|Unsatisfactory Therapeutic Effect|0
3017787|NCT00819585|10379779|P3|Core Study|Unsatisfactory Therapeutic Effect|0
3017788|NCT00819585|10379780|P2|Core Study|Unsatisfactory Therapeutic Effect|1
3017789|NCT00819585|10379781|P1|Core Study|Unsatisfactory Therapeutic Effect|0
3017790|NCT00819585|10379771|P11|Core Study|Abnormal Laboratory Value(s)|0
3017791|NCT00819585|10379772|P10|Core Study|Abnormal Laboratory Value(s)|0
3017792|NCT00819585|10379773|P9|Core Study|Abnormal Laboratory Value(s)|0
3017793|NCT00819585|10379774|P8|Core Study|Abnormal Laboratory Value(s)|0
3017794|NCT00819585|10379775|P7|Core Study|Abnormal Laboratory Value(s)|0
3017795|NCT00819585|10379776|P6|Core Study|Abnormal Laboratory Value(s)|0
3017796|NCT00819585|10379777|P5|Core Study|Abnormal Laboratory Value(s)|0
3017797|NCT00819585|10379778|P4|Core Study|Abnormal Laboratory Value(s)|0
3017798|NCT00819585|10379779|P3|Core Study|Abnormal Laboratory Value(s)|0
3017799|NCT00819585|10379780|P2|Core Study|Abnormal Laboratory Value(s)|0
3017800|NCT00819585|10379781|P1|Core Study|Abnormal Laboratory Value(s)|2
3017801|NCT00819585|10379771|P11|Core Study|Adverse Event|0
3017802|NCT00819585|10379772|P10|Core Study|Adverse Event|0
3017803|NCT00819585|10379773|P9|Core Study|Adverse Event|0
3017804|NCT00819585|10379774|P8|Core Study|Adverse Event|0
3017805|NCT00819585|10379775|P7|Core Study|Adverse Event|2
3017806|NCT00819585|10379776|P6|Core Study|Adverse Event|0
3017807|NCT00819585|10379777|P5|Core Study|Adverse Event|1
3017808|NCT00819585|10379778|P4|Core Study|Adverse Event|4
3017809|NCT00819585|10379779|P3|Core Study|Adverse Event|1
3017810|NCT00819585|10379780|P2|Core Study|Adverse Event|1
3017811|NCT00819585|10379781|P1|Core Study|Adverse Event|2
3017812|NCT00819390|10379872|P4|Overall Study|Adverse Event|0
3017813|NCT00819390|10379873|P3|Overall Study|Adverse Event|1
3017814|NCT00819390|10379874|P2|Overall Study|Adverse Event|0
3017815|NCT00819390|10379875|P1|Overall Study|Adverse Event|0
3017816|NCT00819390|10379872|P4|Overall Study|Withdrawal by Subject|0
3017817|NCT00819390|10379873|P3|Overall Study|Withdrawal by Subject|0
3017818|NCT00819390|10379874|P2|Overall Study|Withdrawal by Subject|0
3017819|NCT00819390|10379875|P1|Overall Study|Withdrawal by Subject|2
3017820|NCT00819390|10379872|P4|Overall Study|Lost to Follow-up|0
3017821|NCT00819390|10379873|P3|Overall Study|Lost to Follow-up|0
3017822|NCT00819390|10379874|P2|Overall Study|Lost to Follow-up|1
3017823|NCT00819390|10379875|P1|Overall Study|Lost to Follow-up|1
3017824|NCT00819247|10380011|P3|Overall Study|Other|0
3017825|NCT00819247|10380012|P2|Overall Study|Other|0
3017826|NCT00819247|10380013|P1|Overall Study|Other|1
3017827|NCT00819247|10380011|P3|Overall Study|Bad prostate-specific antigen response|0
3017828|NCT00819247|10380012|P2|Overall Study|Bad prostate-specific antigen response|2
3017829|NCT00819247|10380013|P1|Overall Study|Bad prostate-specific antigen response|3
3017830|NCT00819247|10380011|P3|Overall Study|Mistakenly withdrawn|0
3017831|NCT00819247|10380012|P2|Overall Study|Mistakenly withdrawn|1
3017832|NCT00819247|10380013|P1|Overall Study|Mistakenly withdrawn|0
3017833|NCT00819247|10380011|P3|Overall Study|Protocol Violation|1
3017834|NCT00819247|10380012|P2|Overall Study|Protocol Violation|0
3017835|NCT00819247|10380013|P1|Overall Study|Protocol Violation|1
3017836|NCT00819247|10380011|P3|Overall Study|Withdrawal by Subject|0
3017837|NCT00819247|10380012|P2|Overall Study|Withdrawal by Subject|0
3017838|NCT00819247|10380013|P1|Overall Study|Withdrawal by Subject|1
3017839|NCT00819247|10380011|P3|Overall Study|Insufficient testosterone response|10
3017840|NCT00819247|10380012|P2|Overall Study|Insufficient testosterone response|8
3017841|NCT00819247|10380013|P1|Overall Study|Insufficient testosterone response|5
3017842|NCT00819247|10380011|P3|Overall Study|Adverse Event|3
3017843|NCT00819247|10380012|P2|Overall Study|Adverse Event|5
3017844|NCT00819247|10380013|P1|Overall Study|Adverse Event|0
3017845|NCT00819234|10380039|P10|Overall Study|Lost to Follow-up|2
3017846|NCT00819234|10380040|P9|Overall Study|Lost to Follow-up|1
3017847|NCT00819234|10380041|P8|Overall Study|Lost to Follow-up|1
3017848|NCT00819234|10380042|P7|Overall Study|Lost to Follow-up|1
3017849|NCT00819234|10380043|P6|Overall Study|Lost to Follow-up|1
3017850|NCT00819234|10380044|P5|Overall Study|Lost to Follow-up|1
3017851|NCT00819234|10380045|P4|Overall Study|Lost to Follow-up|2
3017852|NCT00819234|10380046|P3|Overall Study|Lost to Follow-up|0
3017853|NCT00819234|10380047|P2|Overall Study|Lost to Follow-up|2
3017854|NCT00819234|10380048|P1|Overall Study|Lost to Follow-up|2
3017855|NCT00819234|10380039|P10|Overall Study|Protocol Violation|0
3017856|NCT00819234|10380040|P9|Overall Study|Protocol Violation|0
3017857|NCT00819234|10380041|P8|Overall Study|Protocol Violation|0
3017858|NCT00819234|10380042|P7|Overall Study|Protocol Violation|0
3017859|NCT00819234|10380043|P6|Overall Study|Protocol Violation|0
3017860|NCT00819234|10380044|P5|Overall Study|Protocol Violation|0
3017861|NCT00819234|10380045|P4|Overall Study|Protocol Violation|0
3017862|NCT00819234|10380046|P3|Overall Study|Protocol Violation|1
3017863|NCT00819234|10380047|P2|Overall Study|Protocol Violation|0
3017864|NCT00819234|10380048|P1|Overall Study|Protocol Violation|0
3017865|NCT00819234|10380039|P10|Overall Study|Physician Decision|2
3017866|NCT00819234|10380040|P9|Overall Study|Physician Decision|0
3017867|NCT00819234|10380041|P8|Overall Study|Physician Decision|0
3017868|NCT00819234|10380042|P7|Overall Study|Physician Decision|0
3017869|NCT00819234|10380043|P6|Overall Study|Physician Decision|0
3017870|NCT00819234|10380044|P5|Overall Study|Physician Decision|0
3017871|NCT00819234|10380045|P4|Overall Study|Physician Decision|1
3017872|NCT00819234|10380046|P3|Overall Study|Physician Decision|0
3017873|NCT00819234|10380047|P2|Overall Study|Physician Decision|0
3017874|NCT00819234|10380048|P1|Overall Study|Physician Decision|0
3017875|NCT00819234|10380039|P10|Overall Study|Adverse Event|0
3017876|NCT00819234|10380040|P9|Overall Study|Adverse Event|0
3017877|NCT00819234|10380041|P8|Overall Study|Adverse Event|0
3017878|NCT00819234|10380042|P7|Overall Study|Adverse Event|0
3017879|NCT00819234|10380043|P6|Overall Study|Adverse Event|2
3017880|NCT00819234|10380044|P5|Overall Study|Adverse Event|0
3017881|NCT00819234|10380045|P4|Overall Study|Adverse Event|0
3017882|NCT00819234|10380046|P3|Overall Study|Adverse Event|1
3017883|NCT00819234|10380047|P2|Overall Study|Adverse Event|0
3017884|NCT00819234|10380048|P1|Overall Study|Adverse Event|0
3017885|NCT00819234|10380039|P10|Overall Study|Withdrawal by Subject|3
3017886|NCT00819234|10380040|P9|Overall Study|Withdrawal by Subject|5
3017887|NCT00819234|10380041|P8|Overall Study|Withdrawal by Subject|8
3017888|NCT00819234|10380042|P7|Overall Study|Withdrawal by Subject|4
3017889|NCT00819234|10380043|P6|Overall Study|Withdrawal by Subject|4
3017890|NCT00819234|10380044|P5|Overall Study|Withdrawal by Subject|0
3017891|NCT00819234|10380045|P4|Overall Study|Withdrawal by Subject|3
3017892|NCT00819234|10380046|P3|Overall Study|Withdrawal by Subject|6
3017893|NCT00819234|10380047|P2|Overall Study|Withdrawal by Subject|13
3017894|NCT00819234|10380048|P1|Overall Study|Withdrawal by Subject|8
3017895|NCT00819156|10380247|P6|Overall Study|Prostate-specific antigen progression|0
3017896|NCT00819156|10380248|P5|Overall Study|Prostate-specific antigen progression|1
3017897|NCT00819156|10380249|P4|Overall Study|Prostate-specific antigen progression|0
3017898|NCT00819156|10380250|P3|Overall Study|Prostate-specific antigen progression|0
3017899|NCT00819156|10380251|P2|Overall Study|Prostate-specific antigen progression|0
3017900|NCT00819156|10380252|P1|Overall Study|Prostate-specific antigen progression|0
3017901|NCT00819156|10380247|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
3017902|NCT00819156|10380248|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
3017903|NCT00819156|10380249|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
3017904|NCT00819156|10380250|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
3017905|NCT00819156|10380251|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
3017906|NCT00819156|10380252|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
3017907|NCT00819156|10380247|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
3017908|NCT00819156|10380248|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
3017909|NCT00819156|10380249|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
3017910|NCT00819156|10380250|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
3017911|NCT00819156|10380251|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
3017912|NCT00819156|10380252|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
3017913|NCT00819156|10380247|P6|Overall Study|Lost to Follow-up|2
3017914|NCT00819156|10380248|P5|Overall Study|Lost to Follow-up|0
3017915|NCT00819156|10380249|P4|Overall Study|Lost to Follow-up|0
3017916|NCT00819156|10380250|P3|Overall Study|Lost to Follow-up|0
3017917|NCT00819156|10380251|P2|Overall Study|Lost to Follow-up|1
3017918|NCT00819156|10380252|P1|Overall Study|Lost to Follow-up|0
3017919|NCT00819156|10380247|P6|Overall Study|Protocol Violation|1
3017920|NCT00819156|10380248|P5|Overall Study|Protocol Violation|0
3017921|NCT00819156|10380249|P4|Overall Study|Protocol Violation|0
3017922|NCT00819156|10380250|P3|Overall Study|Protocol Violation|1
3017923|NCT00819156|10380251|P2|Overall Study|Protocol Violation|0
3017924|NCT00819156|10380252|P1|Overall Study|Protocol Violation|1
3017925|NCT00819156|10380247|P6|Overall Study|Withdrawal by Subject|0
3017926|NCT00819156|10380248|P5|Overall Study|Withdrawal by Subject|1
3017927|NCT00819156|10380249|P4|Overall Study|Withdrawal by Subject|0
3017928|NCT00819156|10380250|P3|Overall Study|Withdrawal by Subject|2
3017929|NCT00819156|10380251|P2|Overall Study|Withdrawal by Subject|3
3017930|NCT00819156|10380252|P1|Overall Study|Withdrawal by Subject|0
3017931|NCT00819156|10380247|P6|Overall Study|Adverse Event|3
3017932|NCT00819156|10380248|P5|Overall Study|Adverse Event|2
3017933|NCT00819156|10380249|P4|Overall Study|Adverse Event|1
3017934|NCT00819156|10380250|P3|Overall Study|Adverse Event|2
3017935|NCT00819156|10380251|P2|Overall Study|Adverse Event|4
3017936|NCT00819156|10380252|P1|Overall Study|Adverse Event|1
3017937|NCT00819091|10380342|P2|Overall Study|Other|2
3017938|NCT00819091|10380343|P1|Overall Study|Other|1
3017939|NCT00819091|10380342|P2|Overall Study|Withdrawal by Subject|2
3017940|NCT00819091|10380343|P1|Overall Study|Withdrawal by Subject|1
3017941|NCT00819091|10380342|P2|Overall Study|Lost to Follow-up|0
3017942|NCT00819091|10380343|P1|Overall Study|Lost to Follow-up|2
3017943|NCT00819091|10380342|P2|Overall Study|Protocol Violation|1
3017944|NCT00819091|10380343|P1|Overall Study|Protocol Violation|0
3017945|NCT00819091|10380342|P2|Overall Study|Adverse Event|5
3017946|NCT00819091|10380343|P1|Overall Study|Adverse Event|3
3017947|NCT00819052|10380369|P2|Overall Study|Death or events leading to death|0
3017948|NCT00819052|10380370|P1|Overall Study|Death or events leading to death|1
3017949|NCT00819052|10380369|P2|Overall Study|Pregnancy|2
3017950|NCT00819052|10380370|P1|Overall Study|Pregnancy|1
3017951|NCT00819052|10380369|P2|Overall Study|Lack of Efficacy|1
3017952|NCT00819052|10380370|P1|Overall Study|Lack of Efficacy|1
3017953|NCT00819052|10380369|P2|Overall Study|Withdrawal by Subject|2
3017954|NCT00819052|10380370|P1|Overall Study|Withdrawal by Subject|1
3017955|NCT00819052|10380369|P2|Overall Study|Lost to Follow-up|2
3017956|NCT00819052|10380370|P1|Overall Study|Lost to Follow-up|1
3017957|NCT00819052|10380369|P2|Overall Study|Protocol Violation|2
3017958|NCT00819052|10380370|P1|Overall Study|Protocol Violation|1
3017959|NCT00819052|10380369|P2|Overall Study|Adverse Event|5
3017960|NCT00819052|10380370|P1|Overall Study|Adverse Event|0
3017961|NCT00819039|10380485|P3|Overall Study|Protocol Violation|0
3017962|NCT00819039|10380486|P2|Overall Study|Protocol Violation|0
3017963|NCT00819039|10380487|P1|Overall Study|Protocol Violation|1
3017964|NCT00819039|10380485|P3|Overall Study|Physician Decision|1
3017965|NCT00819039|10380486|P2|Overall Study|Physician Decision|0
3017966|NCT00819039|10380487|P1|Overall Study|Physician Decision|1
3017967|NCT00819013|10380517|P4|Overall Study|Death|1
3017968|NCT00819013|10380518|P3|Overall Study|Death|0
3017969|NCT00819013|10380519|P2|Overall Study|Death|0
3017970|NCT00819013|10380520|P1|Overall Study|Death|0
3017971|NCT00819013|10380517|P4|Overall Study|Lost to Follow-up|2
3017972|NCT00819013|10380518|P3|Overall Study|Lost to Follow-up|1
3017973|NCT00819013|10380519|P2|Overall Study|Lost to Follow-up|0
3017974|NCT00819013|10380520|P1|Overall Study|Lost to Follow-up|0
3017975|NCT00819013|10380517|P4|Overall Study|Withdrawal by Subject|0
3017976|NCT00819013|10380518|P3|Overall Study|Withdrawal by Subject|1
3017977|NCT00819013|10380519|P2|Overall Study|Withdrawal by Subject|0
3017978|NCT00819013|10380520|P1|Overall Study|Withdrawal by Subject|1
3017979|NCT00819013|10380517|P4|Overall Study|Adverse Event|0
3017980|NCT00819013|10380518|P3|Overall Study|Adverse Event|1
3017981|NCT00819013|10380519|P2|Overall Study|Adverse Event|0
3017982|NCT00819013|10380520|P1|Overall Study|Adverse Event|0
3017983|NCT00819013|10380517|P4|Overall Study|Not meeting continuing study eligibility|1
3017984|NCT00819013|10380518|P3|Overall Study|Not meeting continuing study eligibility|2
3017985|NCT00819013|10380519|P2|Overall Study|Not meeting continuing study eligibility|1
3017986|NCT00819013|10380520|P1|Overall Study|Not meeting continuing study eligibility|2
3017987|NCT00818883|10380586|P2|Overall Study|Other|7
3017988|NCT00818883|10380587|P1|Overall Study|Other|2
3017989|NCT00818883|10380586|P2|Overall Study|Lack of Efficacy|2
3017990|NCT00818883|10380587|P1|Overall Study|Lack of Efficacy|0
3017991|NCT00818883|10380586|P2|Overall Study|Withdrawal by Subject|14
3017992|NCT00818883|10380587|P1|Overall Study|Withdrawal by Subject|16
3017993|NCT00818883|10380586|P2|Overall Study|Lost to Follow-up|2
3017994|NCT00818883|10380587|P1|Overall Study|Lost to Follow-up|3
3017995|NCT00818883|10380586|P2|Overall Study|Protocol Violation|2
3017996|NCT00818883|10380587|P1|Overall Study|Protocol Violation|2
3017997|NCT00818883|10380586|P2|Overall Study|Adverse Event|19
3017998|NCT00818883|10380587|P1|Overall Study|Adverse Event|28
3017999|NCT00818779|10380634|P2|Overall Study|Adverse Event|1
3018000|NCT00818779|10380635|P1|Overall Study|Adverse Event|4
3018001|NCT00818779|10380634|P2|Overall Study|Lost to Follow-up|0
3018002|NCT00818779|10380635|P1|Overall Study|Lost to Follow-up|1
3018003|NCT00818779|10380634|P2|Overall Study|Protocol Violation|0
3018004|NCT00818779|10380635|P1|Overall Study|Protocol Violation|1
3018005|NCT00818766|10380651|P2|Overall Study|Did not Receive Allocated Intervention|0
3018006|NCT00818766|10380652|P1|Overall Study|Did not Receive Allocated Intervention|3
3018007|NCT00818766|10380651|P2|Overall Study|Death|0
3018008|NCT00818766|10380652|P1|Overall Study|Death|1
3018009|NCT00818766|10380651|P2|Overall Study|Could not be Contacted on Day 28|10
3018010|NCT00818766|10380652|P1|Overall Study|Could not be Contacted on Day 28|11
3018011|NCT00818753|10380681|P3|Overall Study|Randomised and not treated|0
3018012|NCT00818753|10380682|P2|Overall Study|Randomised and not treated|0
3018013|NCT00818753|10380683|P1|Overall Study|Randomised and not treated|2
3018014|NCT00818753|10380681|P3|Overall Study|Other reason (not specified)|1
3018015|NCT00818753|10380682|P2|Overall Study|Other reason (not specified)|0
3018016|NCT00818753|10380683|P1|Overall Study|Other reason (not specified)|0
3018017|NCT00818753|10380681|P3|Overall Study|Protocol Violation|0
3018018|NCT00818753|10380682|P2|Overall Study|Protocol Violation|0
3018019|NCT00818753|10380683|P1|Overall Study|Protocol Violation|1
3018020|NCT00818662|10380707|P4|Overall Study|Admitted to long term nursing care|0
3018021|NCT00818662|10380708|P3|Overall Study|Admitted to long term nursing care|0
3018022|NCT00818662|10380709|P2|Overall Study|Admitted to long term nursing care|1
3018023|NCT00818662|10380710|P1|Overall Study|Admitted to long term nursing care|0
3018024|NCT00818662|10380707|P4|Overall Study|Study partner decision|1
3018025|NCT00818662|10380708|P3|Overall Study|Study partner decision|0
3018026|NCT00818662|10380709|P2|Overall Study|Study partner decision|0
3018027|NCT00818662|10380710|P1|Overall Study|Study partner decision|0
3018028|NCT00818662|10380707|P4|Overall Study|Change in living situation|1
3018029|NCT00818662|10380708|P3|Overall Study|Change in living situation|0
3018030|NCT00818662|10380709|P2|Overall Study|Change in living situation|0
3018031|NCT00818662|10380710|P1|Overall Study|Change in living situation|0
3018032|NCT00818662|10380707|P4|Overall Study|Declined move to another study site|0
3018033|NCT00818662|10380708|P3|Overall Study|Declined move to another study site|0
3018034|NCT00818662|10380709|P2|Overall Study|Declined move to another study site|0
3018035|NCT00818662|10380710|P1|Overall Study|Declined move to another study site|1
3018036|NCT00818662|10380707|P4|Overall Study|Moving out of state|1
3018037|NCT00818662|10380708|P3|Overall Study|Moving out of state|0
3018038|NCT00818662|10380709|P2|Overall Study|Moving out of state|0
3018039|NCT00818662|10380710|P1|Overall Study|Moving out of state|0
3018040|NCT00818662|10380707|P4|Overall Study|Caregiver to pursue other treatment|0
3018041|NCT00818662|10380708|P3|Overall Study|Caregiver to pursue other treatment|0
3018042|NCT00818662|10380709|P2|Overall Study|Caregiver to pursue other treatment|1
3018043|NCT00818662|10380710|P1|Overall Study|Caregiver to pursue other treatment|0
3018044|NCT00818662|10380707|P4|Overall Study|Participant's health declined|1
3018045|NCT00818662|10380708|P3|Overall Study|Participant's health declined|0
3018046|NCT00818662|10380709|P2|Overall Study|Participant's health declined|0
3018047|NCT00818662|10380710|P1|Overall Study|Participant's health declined|0
3018048|NCT00818662|10380707|P4|Overall Study|Study Partner Unwilling or Unable|1
3018049|NCT00818662|10380708|P3|Overall Study|Study Partner Unwilling or Unable|1
3018050|NCT00818662|10380709|P2|Overall Study|Study Partner Unwilling or Unable|2
3018051|NCT00818662|10380710|P1|Overall Study|Study Partner Unwilling or Unable|3
3018052|NCT00818662|10380707|P4|Overall Study|Safety Risk|1
3018053|NCT00818662|10380708|P3|Overall Study|Safety Risk|0
3018054|NCT00818662|10380709|P2|Overall Study|Safety Risk|1
3018055|NCT00818662|10380710|P1|Overall Study|Safety Risk|1
3018056|NCT00818662|10380707|P4|Overall Study|Requires a Prohibited Medication|0
3018057|NCT00818662|10380708|P3|Overall Study|Requires a Prohibited Medication|0
3018058|NCT00818662|10380709|P2|Overall Study|Requires a Prohibited Medication|0
3018059|NCT00818662|10380710|P1|Overall Study|Requires a Prohibited Medication|1
3018060|NCT00818662|10380707|P4|Overall Study|Protocol Violation|0
3018061|NCT00818662|10380708|P3|Overall Study|Protocol Violation|0
3018062|NCT00818662|10380709|P2|Overall Study|Protocol Violation|1
3018063|NCT00818662|10380710|P1|Overall Study|Protocol Violation|1
3018064|NCT00818662|10380707|P4|Overall Study|Unwilling or Unable to Participate|4
3018065|NCT00818662|10380708|P3|Overall Study|Unwilling or Unable to Participate|2
3018066|NCT00818662|10380709|P2|Overall Study|Unwilling or Unable to Participate|6
3018067|NCT00818662|10380710|P1|Overall Study|Unwilling or Unable to Participate|4
3018068|NCT00818662|10380707|P4|Overall Study|Lost to Follow-up|1
3018069|NCT00818662|10380708|P3|Overall Study|Lost to Follow-up|0
3018070|NCT00818662|10380709|P2|Overall Study|Lost to Follow-up|0
3018071|NCT00818662|10380710|P1|Overall Study|Lost to Follow-up|0
3018072|NCT00818662|10380707|P4|Overall Study|Physician Decision|0
3018073|NCT00818662|10380708|P3|Overall Study|Physician Decision|0
3018074|NCT00818662|10380709|P2|Overall Study|Physician Decision|0
3018075|NCT00818662|10380710|P1|Overall Study|Physician Decision|1
3018076|NCT00818662|10380707|P4|Overall Study|Death|0
3018077|NCT00818662|10380708|P3|Overall Study|Death|0
3018078|NCT00818662|10380709|P2|Overall Study|Death|3
3018079|NCT00818662|10380710|P1|Overall Study|Death|1
3018080|NCT00818662|10380707|P4|Overall Study|Withdrawal by Subject|2
3018081|NCT00818662|10380708|P3|Overall Study|Withdrawal by Subject|2
3018082|NCT00818662|10380709|P2|Overall Study|Withdrawal by Subject|4
3018083|NCT00818662|10380710|P1|Overall Study|Withdrawal by Subject|5
3018084|NCT00818662|10380707|P4|Overall Study|Adverse Event|3
3018085|NCT00818662|10380708|P3|Overall Study|Adverse Event|4
3018086|NCT00818662|10380709|P2|Overall Study|Adverse Event|14
3018087|NCT00818662|10380710|P1|Overall Study|Adverse Event|5
3018088|NCT00818649|10380796|P1|Overall Study|Adverse Event|1
3018089|NCT00818649|10380796|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
3018090|NCT00818649|10380796|P1|Overall Study|Declining performance status|2
3018091|NCT00818623|10380810|P8|Overall Study|Disease progression|0
3018092|NCT00818623|10380811|P7|Overall Study|Disease progression|1
3018093|NCT00818623|10380812|P6|Overall Study|Disease progression|0
3018094|NCT00818623|10380813|P5|Overall Study|Disease progression|0
3018095|NCT00818623|10380814|P4|Overall Study|Disease progression|0
3018096|NCT00818623|10380815|P3|Overall Study|Disease progression|0
3018097|NCT00818623|10380816|P2|Overall Study|Disease progression|0
3018098|NCT00818623|10380817|P1|Overall Study|Disease progression|0
3018099|NCT00818623|10380810|P8|Overall Study|Lack of trial drug at site|0
3018100|NCT00818623|10380811|P7|Overall Study|Lack of trial drug at site|1
3018101|NCT00818623|10380812|P6|Overall Study|Lack of trial drug at site|0
3018102|NCT00818623|10380813|P5|Overall Study|Lack of trial drug at site|2
3018103|NCT00818623|10380814|P4|Overall Study|Lack of trial drug at site|0
3018104|NCT00818623|10380815|P3|Overall Study|Lack of trial drug at site|0
3018105|NCT00818623|10380816|P2|Overall Study|Lack of trial drug at site|0
3018106|NCT00818623|10380817|P1|Overall Study|Lack of trial drug at site|0
3018107|NCT00818623|10380810|P8|Overall Study|Need of additional treatment|0
3018108|NCT00818623|10380811|P7|Overall Study|Need of additional treatment|0
3018109|NCT00818623|10380812|P6|Overall Study|Need of additional treatment|0
3018110|NCT00818623|10380813|P5|Overall Study|Need of additional treatment|1
3018111|NCT00818623|10380814|P4|Overall Study|Need of additional treatment|0
3018112|NCT00818623|10380815|P3|Overall Study|Need of additional treatment|0
3018113|NCT00818623|10380816|P2|Overall Study|Need of additional treatment|0
3018114|NCT00818623|10380817|P1|Overall Study|Need of additional treatment|0
3018115|NCT00818623|10380810|P8|Overall Study|Protocol Violation|0
3018116|NCT00818623|10380811|P7|Overall Study|Protocol Violation|1
3018117|NCT00818623|10380812|P6|Overall Study|Protocol Violation|0
3018118|NCT00818623|10380813|P5|Overall Study|Protocol Violation|1
3018119|NCT00818623|10380814|P4|Overall Study|Protocol Violation|0
3018120|NCT00818623|10380815|P3|Overall Study|Protocol Violation|0
3018121|NCT00818623|10380816|P2|Overall Study|Protocol Violation|0
3018122|NCT00818623|10380817|P1|Overall Study|Protocol Violation|1
3018123|NCT00818623|10380810|P8|Overall Study|Withdrawal by Subject|1
3018124|NCT00818623|10380811|P7|Overall Study|Withdrawal by Subject|1
3018125|NCT00818623|10380812|P6|Overall Study|Withdrawal by Subject|1
3018126|NCT00818623|10380813|P5|Overall Study|Withdrawal by Subject|0
3018127|NCT00818623|10380814|P4|Overall Study|Withdrawal by Subject|0
3018128|NCT00818623|10380815|P3|Overall Study|Withdrawal by Subject|1
3018129|NCT00818623|10380816|P2|Overall Study|Withdrawal by Subject|1
3018130|NCT00818623|10380817|P1|Overall Study|Withdrawal by Subject|0
3018131|NCT00818623|10380810|P8|Overall Study|Bad prostate specific antigen response|0
3018132|NCT00818623|10380811|P7|Overall Study|Bad prostate specific antigen response|0
3018133|NCT00818623|10380812|P6|Overall Study|Bad prostate specific antigen response|1
3018134|NCT00818623|10380813|P5|Overall Study|Bad prostate specific antigen response|0
3018135|NCT00818623|10380814|P4|Overall Study|Bad prostate specific antigen response|5
3018136|NCT00818623|10380815|P3|Overall Study|Bad prostate specific antigen response|2
3018137|NCT00818623|10380816|P2|Overall Study|Bad prostate specific antigen response|3
3018138|NCT00818623|10380817|P1|Overall Study|Bad prostate specific antigen response|0
3018139|NCT00818623|10380810|P8|Overall Study|Adverse Event|0
3018140|NCT00818623|10380811|P7|Overall Study|Adverse Event|0
3018141|NCT00818623|10380812|P6|Overall Study|Adverse Event|1
3018142|NCT00818623|10380813|P5|Overall Study|Adverse Event|0
3018143|NCT00818623|10380814|P4|Overall Study|Adverse Event|0
3018144|NCT00818623|10380815|P3|Overall Study|Adverse Event|1
3018145|NCT00818623|10380816|P2|Overall Study|Adverse Event|0
3018146|NCT00818623|10380817|P1|Overall Study|Adverse Event|1
3018147|NCT00818519|10380893|P2|Overall Study|participant will leave for long tme|0
3018148|NCT00818519|10380894|P1|Overall Study|participant will leave for long tme|1
3018149|NCT00818519|10380893|P2|Overall Study|participant recovered completely|0
3018150|NCT00818519|10380894|P1|Overall Study|participant recovered completely|1
3018151|NCT00818519|10380893|P2|Overall Study|Withdrawal by Subject|9
3018152|NCT00818519|10380894|P1|Overall Study|Withdrawal by Subject|4
3018153|NCT00818519|10380893|P2|Overall Study|Pregnancy|1
3018154|NCT00818519|10380894|P1|Overall Study|Pregnancy|0
3018155|NCT00818519|10380893|P2|Overall Study|Protocol Violation|1
3018156|NCT00818519|10380894|P1|Overall Study|Protocol Violation|2
3018157|NCT00818519|10380893|P2|Overall Study|Lost to Follow-up|6
3018158|NCT00818519|10380894|P1|Overall Study|Lost to Follow-up|4
3018159|NCT00818519|10380893|P2|Overall Study|Adverse Event|2
3018160|NCT00818519|10380894|P1|Overall Study|Adverse Event|2
3018161|NCT00818454|10380924|P4|Treatment Period 3|Adverse Event|1
3018162|NCT00818454|10380925|P3|Treatment Period 3|Adverse Event|0
3018163|NCT00818454|10380926|P2|Treatment Period 3|Adverse Event|0
3018164|NCT00818454|10380927|P1|Treatment Period 3|Adverse Event|0
3018165|NCT00818454|10380924|P4|Treatment Period 2|Other|0
3018166|NCT00818454|10380925|P3|Treatment Period 2|Other|0
3018167|NCT00818454|10380926|P2|Treatment Period 2|Other|1
3018168|NCT00818454|10380927|P1|Treatment Period 2|Other|2
3018169|NCT00818454|10380924|P4|Washout Period of 1 Week|Other|0
3018170|NCT00818454|10380925|P3|Washout Period of 1 Week|Other|0
3018171|NCT00818454|10380926|P2|Washout Period of 1 Week|Other|2
3018172|NCT00818454|10380927|P1|Washout Period of 1 Week|Other|1
3018173|NCT00818454|10380924|P4|Washout Period of 1 Week|Protocol Violation|0
3018174|NCT00818454|10380925|P3|Washout Period of 1 Week|Protocol Violation|0
3018175|NCT00818454|10380926|P2|Washout Period of 1 Week|Protocol Violation|0
3018176|NCT00818454|10380927|P1|Washout Period of 1 Week|Protocol Violation|2
3018177|NCT00818454|10380924|P4|Washout Period of 1 Week|Adverse Event|0
3018178|NCT00818454|10380925|P3|Washout Period of 1 Week|Adverse Event|0
3018179|NCT00818454|10380926|P2|Washout Period of 1 Week|Adverse Event|1
3018180|NCT00818454|10380927|P1|Washout Period of 1 Week|Adverse Event|1
3018181|NCT00818454|10380924|P4|Treatment Period 1|Other|0
3018182|NCT00818454|10380925|P3|Treatment Period 1|Other|0
3018183|NCT00818454|10380926|P2|Treatment Period 1|Other|0
3018184|NCT00818454|10380927|P1|Treatment Period 1|Other|3
3018185|NCT00818454|10380924|P4|Treatment Period 1|Adverse Event|0
3018186|NCT00818454|10380925|P3|Treatment Period 1|Adverse Event|0
3018187|NCT00818454|10380926|P2|Treatment Period 1|Adverse Event|1
3018188|NCT00818454|10380927|P1|Treatment Period 1|Adverse Event|0
3018189|NCT00818441|10380955|P2|Overall Study|Study terminated by sponsor|2
3018190|NCT00818441|10380956|P1|Overall Study|Study terminated by sponsor|11
3018191|NCT00818441|10380955|P2|Overall Study|Adverse Event|1
3018192|NCT00818441|10380956|P1|Overall Study|Adverse Event|0
3018193|NCT00818441|10380955|P2|Overall Study|Withdrawal by Subject|0
3018194|NCT00818441|10380956|P1|Overall Study|Withdrawal by Subject|2
3018195|NCT00818441|10380955|P2|Overall Study|Lost to Follow-up|1
3018196|NCT00818441|10380956|P1|Overall Study|Lost to Follow-up|2
3018197|NCT00818441|10380955|P2|Overall Study|Other|0
3018198|NCT00818441|10380956|P1|Overall Study|Other|5
3018199|NCT00818441|10380955|P2|Overall Study|Death|26
3018200|NCT00818441|10380956|P1|Overall Study|Death|69
3018201|NCT00818389|10380978|P2|Overall Study|Adverse Event|1
3018202|NCT00818389|10380979|P1|Overall Study|Adverse Event|0
3018203|NCT00818389|10380978|P2|Overall Study|Withdrawal by Subject|2
3018204|NCT00818389|10380979|P1|Overall Study|Withdrawal by Subject|2
3018205|NCT00818389|10380978|P2|Overall Study|ALS Disease Progression|0
3018206|NCT00818389|10380979|P1|Overall Study|ALS Disease Progression|1
3018207|NCT00818389|10380978|P2|Overall Study|Death|3
3018208|NCT00818389|10380979|P1|Overall Study|Death|1
3018209|NCT00818259|10381014|P9|Part V|Adverse Event|0
3018210|NCT00818259|10381015|P8|Part V|Adverse Event|1
3018211|NCT00818259|10381016|P7|Part V|Adverse Event|0
3018212|NCT00818259|10381017|P6|Part V|Adverse Event|0
3018213|NCT00818259|10381018|P5|Part V|Adverse Event|0
3018214|NCT00818259|10381019|P4|Part V|Adverse Event|0
3018215|NCT00818259|10381020|P3|Part V|Adverse Event|0
3018216|NCT00818259|10381021|P2|Part V|Adverse Event|0
3018217|NCT00818259|10381022|P1|Part V|Adverse Event|0
3018218|NCT00818259|10381014|P9|Part IV|Physician Decision|0
3018219|NCT00818259|10381015|P8|Part IV|Physician Decision|0
3018220|NCT00818259|10381016|P7|Part IV|Physician Decision|0
3018221|NCT00818259|10381017|P6|Part IV|Physician Decision|1
3018222|NCT00818259|10381018|P5|Part IV|Physician Decision|0
3018223|NCT00818259|10381019|P4|Part IV|Physician Decision|0
3018224|NCT00818259|10381020|P3|Part IV|Physician Decision|0
3018225|NCT00818259|10381021|P2|Part IV|Physician Decision|0
3018226|NCT00818259|10381022|P1|Part IV|Physician Decision|0
3018227|NCT00818259|10381014|P9|Part II|Not Treated|0
3018228|NCT00818259|10381015|P8|Part II|Not Treated|0
3018229|NCT00818259|10381016|P7|Part II|Not Treated|0
3018230|NCT00818259|10381017|P6|Part II|Not Treated|0
3018231|NCT00818259|10381018|P5|Part II|Not Treated|0
3018232|NCT00818259|10381019|P4|Part II|Not Treated|1
3018233|NCT00818259|10381020|P3|Part II|Not Treated|0
3018234|NCT00818259|10381021|P2|Part II|Not Treated|0
3018235|NCT00818259|10381022|P1|Part II|Not Treated|0
3018236|NCT00818259|10381014|P9|Part II|Lack of Efficacy|0
3018237|NCT00818259|10381015|P8|Part II|Lack of Efficacy|0
3018238|NCT00818259|10381016|P7|Part II|Lack of Efficacy|0
3018239|NCT00818259|10381017|P6|Part II|Lack of Efficacy|0
3018240|NCT00818259|10381018|P5|Part II|Lack of Efficacy|0
3018241|NCT00818259|10381019|P4|Part II|Lack of Efficacy|1
3018242|NCT00818259|10381020|P3|Part II|Lack of Efficacy|0
3018243|NCT00818259|10381021|P2|Part II|Lack of Efficacy|0
3018244|NCT00818259|10381022|P1|Part II|Lack of Efficacy|0
3018245|NCT00818259|10381014|P9|Part II|Physician Decision|0
3018246|NCT00818259|10381015|P8|Part II|Physician Decision|0
3018247|NCT00818259|10381016|P7|Part II|Physician Decision|0
3018248|NCT00818259|10381017|P6|Part II|Physician Decision|0
3018249|NCT00818259|10381018|P5|Part II|Physician Decision|0
3018250|NCT00818259|10381019|P4|Part II|Physician Decision|0
3018251|NCT00818259|10381020|P3|Part II|Physician Decision|1
3018252|NCT00818259|10381021|P2|Part II|Physician Decision|0
3018253|NCT00818259|10381022|P1|Part II|Physician Decision|0
3018254|NCT00818259|10381014|P9|Part I|Withdrawal by Subject|0
3018255|NCT00818259|10381015|P8|Part I|Withdrawal by Subject|0
3018256|NCT00818259|10381016|P7|Part I|Withdrawal by Subject|0
3018257|NCT00818259|10381017|P6|Part I|Withdrawal by Subject|0
3018258|NCT00818259|10381018|P5|Part I|Withdrawal by Subject|0
3018259|NCT00818259|10381019|P4|Part I|Withdrawal by Subject|0
3018260|NCT00818259|10381020|P3|Part I|Withdrawal by Subject|0
3018261|NCT00818259|10381021|P2|Part I|Withdrawal by Subject|0
3018262|NCT00818259|10381022|P1|Part I|Withdrawal by Subject|1
3018263|NCT00818246|10381094|P1|Overall Study|Impossible to match pictures|5
3018264|NCT00818207|10381103|P2|Overall Study|Death|5
3018265|NCT00818207|10381104|P1|Overall Study|Death|3
3018266|NCT00818207|10381103|P2|Overall Study|Withdrawal by Subject|104
3018267|NCT00818207|10381104|P1|Overall Study|Withdrawal by Subject|42
3018268|NCT00818207|10381103|P2|Overall Study|Multiple reasons|12
3018269|NCT00818207|10381104|P1|Overall Study|Multiple reasons|11
3018270|NCT00818207|10381103|P2|Overall Study|Lost to Follow-up|146
3018271|NCT00818207|10381104|P1|Overall Study|Lost to Follow-up|160
3018272|NCT00818207|10381103|P2|Overall Study|Adverse Event|0
3018273|NCT00818207|10381104|P1|Overall Study|Adverse Event|6
3018274|NCT00818168|10381118|P1|Overall Study|Participant Moved|2
3018275|NCT00818168|10381118|P1|Overall Study|Reason for Non-completion Not reported|6
3018276|NCT00818168|10381118|P1|Overall Study|Adverse Event|19
3018277|NCT00818168|10381118|P1|Overall Study|Lost to Follow-up|7
3018278|NCT00818168|10381118|P1|Overall Study|Withdrawal by Subject|16
3018279|NCT00818168|10381118|P1|Overall Study|Pregnancy|2
3018280|NCT00818168|10381118|P1|Overall Study|Lack of Efficacy|18
3018281|NCT00817778|10381158|P2|Overall Study|Poor venous access|0
3018282|NCT00817778|10381159|P1|Overall Study|Poor venous access|1
3018283|NCT00817778|10381158|P2|Overall Study|Study-specific discontinuation criteria|1
3018284|NCT00817778|10381159|P1|Overall Study|Study-specific discontinuation criteria|0
3018285|NCT00817778|10381158|P2|Overall Study|Protocol Violation|1
3018286|NCT00817778|10381159|P1|Overall Study|Protocol Violation|0
3018287|NCT00817778|10381158|P2|Overall Study|Withdrawal by Subject|1
3018288|NCT00817778|10381159|P1|Overall Study|Withdrawal by Subject|1
3018289|NCT00817778|10381158|P2|Overall Study|Adverse Event|0
3018290|NCT00817778|10381159|P1|Overall Study|Adverse Event|1
3018291|NCT00817531|10381188|P1|Overall Study|Lack of Efficacy|1
3018292|NCT00817531|10381188|P1|Overall Study|Adverse Event|1
3018293|NCT00817479|10381194|P2|Overall Study|Physician Decision|1
3018294|NCT00817479|10381195|P1|Overall Study|Physician Decision|1
3018295|NCT00817336|10381205|P2|Overall Study|Withdrawal by Subject|1
3018296|NCT00817336|10381206|P1|Overall Study|Withdrawal by Subject|1
3018297|NCT00817206|10381232|P2|Overall Study|Physician Decision|0
3018298|NCT00817206|10381233|P1|Overall Study|Physician Decision|2
3018299|NCT00817206|10381232|P2|Overall Study|Withdrawal by Subject|3
3018300|NCT00817206|10381233|P1|Overall Study|Withdrawal by Subject|7
3018301|NCT00817206|10381232|P2|Overall Study|Death|0
3018302|NCT00817206|10381233|P1|Overall Study|Death|2
3018303|NCT00817206|10381232|P2|Overall Study|Lost to Follow-up|1
3018304|NCT00817206|10381233|P1|Overall Study|Lost to Follow-up|0
3018305|NCT00817206|10381232|P2|Overall Study|Protocol Violation|2
3018306|NCT00817206|10381233|P1|Overall Study|Protocol Violation|0
3018307|NCT00817206|10381232|P2|Overall Study|Adverse Event|3
3018308|NCT00817206|10381233|P1|Overall Study|Adverse Event|10
3018309|NCT00817089|10381243|P4|Second Alcohol Challenge|Lost to Follow-up|0
3018310|NCT00817089|10381244|P3|Second Alcohol Challenge|Lost to Follow-up|0
3018311|NCT00817089|10381245|P2|Second Alcohol Challenge|Lost to Follow-up|1
3018312|NCT00817089|10381246|P1|Second Alcohol Challenge|Lost to Follow-up|0
3018313|NCT00817089|10381243|P4|First Alcohol Challenge|Lost to Follow-up|1
3018314|NCT00817089|10381244|P3|First Alcohol Challenge|Lost to Follow-up|0
3018315|NCT00817089|10381245|P2|First Alcohol Challenge|Lost to Follow-up|0
3018316|NCT00817089|10381246|P1|First Alcohol Challenge|Lost to Follow-up|0
3018317|NCT00817063|10381262|P2|Overall Study|Abnormality of Laboratory Test|1
3018318|NCT00817063|10381263|P1|Overall Study|Abnormality of Laboratory Test|2
3018319|NCT00817063|10381262|P2|Overall Study|Administrative|4
3018320|NCT00817063|10381263|P1|Overall Study|Administrative|10
3018321|NCT00817063|10381262|P2|Overall Study|Early Improvement|4
3018322|NCT00817063|10381263|P1|Overall Study|Early Improvement|19
3018323|NCT00817063|10381262|P2|Overall Study|Withdrawal by Subject|37
3018324|NCT00817063|10381263|P1|Overall Study|Withdrawal by Subject|17
3018325|NCT00817063|10381262|P2|Overall Study|Protocol Violation|8
3018326|NCT00817063|10381263|P1|Overall Study|Protocol Violation|3
3018327|NCT00817063|10381262|P2|Overall Study|Violation of Selection at Entry|4
3018328|NCT00817063|10381263|P1|Overall Study|Violation of Selection at Entry|7
3018329|NCT00817063|10381262|P2|Overall Study|Failure to Return|12
3018330|NCT00817063|10381263|P1|Overall Study|Failure to Return|13
3018331|NCT00817063|10381262|P2|Overall Study|Lack of Efficacy|86
3018332|NCT00817063|10381263|P1|Overall Study|Lack of Efficacy|33
3018333|NCT00817063|10381262|P2|Overall Study|Death|1
3018334|NCT00817063|10381263|P1|Overall Study|Death|1
3018335|NCT00817063|10381262|P2|Overall Study|Adverse Event|13
3018336|NCT00817063|10381263|P1|Overall Study|Adverse Event|32
3018337|NCT00816595|10381391|P2|Overall Study|Withdrawal by Subject|0
3018338|NCT00816595|10381392|P1|Overall Study|Withdrawal by Subject|2
3018339|NCT00816556|10381405|P3|Overall Study|Lost to Follow-up|1
3018340|NCT00816556|10381406|P2|Overall Study|Lost to Follow-up|0
3018341|NCT00816556|10381407|P1|Overall Study|Lost to Follow-up|0
3018342|NCT00816556|10381405|P3|Overall Study|Withdrawal by Subject|1
3018343|NCT00816556|10381406|P2|Overall Study|Withdrawal by Subject|1
3018344|NCT00816556|10381407|P1|Overall Study|Withdrawal by Subject|1
3018345|NCT00816556|10381405|P3|Overall Study|Adverse Event|1
3018346|NCT00816556|10381406|P2|Overall Study|Adverse Event|1
3018347|NCT00816556|10381407|P1|Overall Study|Adverse Event|1
3018348|NCT00816400|10381430|P9|Overall Study|In hospice care at the end of the study|0
3018349|NCT00816400|10381431|P8|Overall Study|In hospice care at the end of the study|0
3018350|NCT00816400|10381432|P7|Overall Study|In hospice care at the end of the study|0
3018351|NCT00816400|10381433|P6|Overall Study|In hospice care at the end of the study|0
3018352|NCT00816400|10381434|P5|Overall Study|In hospice care at the end of the study|0
3018353|NCT00816400|10381435|P4|Overall Study|In hospice care at the end of the study|0
3018354|NCT00816400|10381436|P3|Overall Study|In hospice care at the end of the study|2
3018355|NCT00816400|10381437|P2|Overall Study|In hospice care at the end of the study|0
3018356|NCT00816400|10381438|P1|Overall Study|In hospice care at the end of the study|0
3018357|NCT00816400|10381430|P9|Overall Study|Death|6
3018358|NCT00816400|10381431|P8|Overall Study|Death|5
3018359|NCT00816400|10381432|P7|Overall Study|Death|2
3018360|NCT00816400|10381433|P6|Overall Study|Death|3
3018361|NCT00816400|10381434|P5|Overall Study|Death|2
3018362|NCT00816400|10381435|P4|Overall Study|Death|3
3018363|NCT00816400|10381436|P3|Overall Study|Death|3
3018364|NCT00816400|10381437|P2|Overall Study|Death|3
3018365|NCT00816400|10381438|P1|Overall Study|Death|2
3018366|NCT00816361|10381629|P9|Overall Study|Other|1
3018367|NCT00816361|10381630|P8|Overall Study|Other|0
3018368|NCT00816361|10381631|P7|Overall Study|Other|0
3018369|NCT00816361|10381632|P6|Overall Study|Other|0
3018370|NCT00816361|10381633|P5|Overall Study|Other|0
3018371|NCT00816361|10381634|P4|Overall Study|Other|0
3018372|NCT00816361|10381635|P3|Overall Study|Other|0
3018373|NCT00816361|10381636|P2|Overall Study|Other|0
3018374|NCT00816361|10381637|P1|Overall Study|Other|0
3018375|NCT00816361|10381629|P9|Overall Study|Death|8
3018376|NCT00816361|10381630|P8|Overall Study|Death|7
3018377|NCT00816361|10381631|P7|Overall Study|Death|3
3018378|NCT00816361|10381632|P6|Overall Study|Death|1
3018379|NCT00816361|10381633|P5|Overall Study|Death|1
3018380|NCT00816361|10381634|P4|Overall Study|Death|3
3018381|NCT00816361|10381635|P3|Overall Study|Death|3
3018382|NCT00816361|10381636|P2|Overall Study|Death|3
3018383|NCT00816361|10381637|P1|Overall Study|Death|4
3018384|NCT00816361|10381629|P9|Overall Study|Withdrawal by Subject|1
3018385|NCT00816361|10381630|P8|Overall Study|Withdrawal by Subject|2
3018386|NCT00816361|10381631|P7|Overall Study|Withdrawal by Subject|0
3018387|NCT00816361|10381632|P6|Overall Study|Withdrawal by Subject|2
3018388|NCT00816361|10381633|P5|Overall Study|Withdrawal by Subject|1
3018389|NCT00816361|10381634|P4|Overall Study|Withdrawal by Subject|0
3018390|NCT00816361|10381635|P3|Overall Study|Withdrawal by Subject|0
3018391|NCT00816361|10381636|P2|Overall Study|Withdrawal by Subject|0
3018392|NCT00816361|10381637|P1|Overall Study|Withdrawal by Subject|0
3018393|NCT00816166|10381796|P2|Overall Study|Death|2
3018394|NCT00816166|10381797|P1|Overall Study|Death|4
3018395|NCT00816166|10381796|P2|Overall Study|Lost to Follow-up|10
3018396|NCT00816166|10381797|P1|Overall Study|Lost to Follow-up|6
3018397|NCT00816036|10381829|P2|Overall Study|Withdrawal by Subject|23
3018398|NCT00816036|10381830|P1|Overall Study|Withdrawal by Subject|54
3018399|NCT00816036|10381829|P2|Overall Study|Lost to Follow-up|57
3018400|NCT00816036|10381830|P1|Overall Study|Lost to Follow-up|75
3018401|NCT00816036|10381829|P2|Overall Study|Death|28
3018402|NCT00816036|10381830|P1|Overall Study|Death|47
3018403|NCT00816023|10381844|P4|Overall Study|Randomized Not Treated|11
3018404|NCT00816023|10381845|P3|Overall Study|Randomized Not Treated|6
3018405|NCT00816023|10381846|P2|Overall Study|Randomized Not Treated|4
3018406|NCT00816023|10381847|P1|Overall Study|Randomized Not Treated|6
3018407|NCT00816023|10381844|P4|Overall Study|assessments complete prior to window|1
3018408|NCT00816023|10381845|P3|Overall Study|assessments complete prior to window|2
3018409|NCT00816023|10381846|P2|Overall Study|assessments complete prior to window|1
3018410|NCT00816023|10381847|P1|Overall Study|assessments complete prior to window|1
3018411|NCT00816023|10381844|P4|Overall Study|Physician Decision|0
3018412|NCT00816023|10381845|P3|Overall Study|Physician Decision|1
3018413|NCT00816023|10381846|P2|Overall Study|Physician Decision|0
3018414|NCT00816023|10381847|P1|Overall Study|Physician Decision|0
3018415|NCT00816023|10381844|P4|Overall Study|Withdrawal by Subject|0
3018416|NCT00816023|10381845|P3|Overall Study|Withdrawal by Subject|0
3018417|NCT00816023|10381846|P2|Overall Study|Withdrawal by Subject|0
3018418|NCT00816023|10381847|P1|Overall Study|Withdrawal by Subject|1
3018419|NCT00816023|10381844|P4|Overall Study|Lost to Follow-up|0
3018420|NCT00816023|10381845|P3|Overall Study|Lost to Follow-up|0
3018421|NCT00816023|10381846|P2|Overall Study|Lost to Follow-up|1
3018422|NCT00816023|10381847|P1|Overall Study|Lost to Follow-up|1
3018423|NCT00815919|10381884|P1|Overall Study|Lack of Efficacy|2
3018424|NCT00815919|10381884|P1|Overall Study|AML Relapse|1
3018425|NCT00815919|10381884|P1|Overall Study|Unrelated Fungal Infection|1
3018426|NCT00815659|10381927|P1|Overall Study|Protocol Violation|1
3018427|NCT00815659|10381927|P1|Overall Study|Lost to Follow-up|4
3018428|NCT00815659|10381927|P1|Overall Study|Withdrawal by Subject|9
3018429|NCT00815659|10381927|P1|Overall Study|Adverse Event|9
3018430|NCT00815633|10381970|P1|Overall Study|study terminated|1
3018431|NCT00815516|10381977|P2|Overall Study|Physician Decision|0
3018432|NCT00815516|10381978|P1|Overall Study|Physician Decision|1
3018433|NCT00815516|10381977|P2|Overall Study|Death|1
3018434|NCT00815516|10381978|P1|Overall Study|Death|3
3018435|NCT00815308|10382043|P1|Overall Study|Protocol Violation|6
3018436|NCT00815308|10382043|P1|Overall Study|Withdrawal by Subject|0
3018437|NCT00815308|10382043|P1|Overall Study|Adverse Event|4
3018438|NCT00815295|10382052|P3|Overall Study|Cetuximab hypersensitivity reaction|3
3018439|NCT00815295|10382053|P2|Overall Study|Cetuximab hypersensitivity reaction|1
3018440|NCT00815295|10382054|P1|Overall Study|Cetuximab hypersensitivity reaction|0
3018441|NCT00815191|10382066|P2|Overall Study|Protocol Violation|1
3018442|NCT00815191|10382067|P1|Overall Study|Protocol Violation|1
3018443|NCT00814983|10382104|P2|Overall Study|Graft failure|0
3018444|NCT00814983|10382105|P1|Overall Study|Graft failure|1
3018445|NCT00814983|10382104|P2|Overall Study|Withdrawal by Subject|0
3018446|NCT00814983|10382105|P1|Overall Study|Withdrawal by Subject|1
3018447|NCT00814983|10382104|P2|Overall Study|Screen failure|0
3018448|NCT00814983|10382105|P1|Overall Study|Screen failure|1
3018449|NCT00814892|10382136|P1|Overall Study|Study Termination|1
3018450|NCT00814892|10382136|P1|Overall Study|Disease Progression|1
3018451|NCT00814879|10382148|P2|By Week 48|Death|1
3018452|NCT00814879|10382149|P1|By Week 48|Death|0
3018453|NCT00814879|10382148|P2|By Week 48|Lost to Follow-up|2
3018454|NCT00814879|10382149|P1|By Week 48|Lost to Follow-up|2
3018455|NCT00814879|10382148|P2|By Week 24|Incarceration|1
3018456|NCT00814879|10382149|P1|By Week 24|Incarceration|0
3018457|NCT00814879|10382148|P2|By Week 24|Cancer Diagnosis|0
3018458|NCT00814879|10382149|P1|By Week 24|Cancer Diagnosis|1
3018459|NCT00814801|10382168|P3|Overall Study|Other|4
3018460|NCT00814801|10382169|P2|Overall Study|Other|6
3018461|NCT00814801|10382170|P1|Overall Study|Other|2
3018462|NCT00814801|10382168|P3|Overall Study|Non-compliance|1
3018463|NCT00814801|10382169|P2|Overall Study|Non-compliance|1
3018464|NCT00814801|10382170|P1|Overall Study|Non-compliance|0
3018465|NCT00814801|10382168|P3|Overall Study|Missing or change of caregiver|4
3018466|NCT00814801|10382169|P2|Overall Study|Missing or change of caregiver|2
3018467|NCT00814801|10382170|P1|Overall Study|Missing or change of caregiver|6
3018468|NCT00814801|10382168|P3|Overall Study|Change of patients for CIBIC plus-J|0
3018469|NCT00814801|10382169|P2|Overall Study|Change of patients for CIBIC plus-J|1
3018470|NCT00814801|10382170|P1|Overall Study|Change of patients for CIBIC plus-J|1
3018471|NCT00814801|10382168|P3|Overall Study|Inappropriate as a subject|1
3018472|NCT00814801|10382169|P2|Overall Study|Inappropriate as a subject|1
3018473|NCT00814801|10382170|P1|Overall Study|Inappropriate as a subject|1
3018474|NCT00814801|10382168|P3|Overall Study|Withdrawal by Subject|14
3018475|NCT00814801|10382169|P2|Overall Study|Withdrawal by Subject|11
3018476|NCT00814801|10382170|P1|Overall Study|Withdrawal by Subject|9
3018477|NCT00814801|10382168|P3|Overall Study|Adverse Event|19
3018478|NCT00814801|10382169|P2|Overall Study|Adverse Event|16
3018479|NCT00814801|10382170|P1|Overall Study|Adverse Event|15
3018480|NCT00814710|10382209|P2|Overall Study|Lost to Follow-up|3
3018481|NCT00814710|10382210|P1|Overall Study|Lost to Follow-up|7
3018482|NCT00814710|10382209|P2|Overall Study|Adverse Event|0
3018483|NCT00814710|10382210|P1|Overall Study|Adverse Event|1
3018484|NCT00814658|10382278|P2|Overall Study|Adverse Event|3
3018485|NCT00814658|10382279|P1|Overall Study|Adverse Event|3
3018486|NCT00814658|10382278|P2|Overall Study|Physician Decision|0
3018487|NCT00814658|10382279|P1|Overall Study|Physician Decision|1
3018488|NCT00814658|10382278|P2|Overall Study|Lost to Follow-up|1
3018489|NCT00814658|10382279|P1|Overall Study|Lost to Follow-up|0
3018490|NCT00814632|10382345|P1|Overall Study|Lack of Efficacy|2
3018491|NCT00814580|10382351|P2|Overall Study|Did Not Take Drug|2
3018492|NCT00814580|10382352|P1|Overall Study|Did Not Take Drug|2
3018493|NCT00814580|10382351|P2|Overall Study|Other|3
3018494|NCT00814580|10382352|P1|Overall Study|Other|1
3018495|NCT00814580|10382351|P2|Overall Study|Withdrawal by Subject|2
3018496|NCT00814580|10382352|P1|Overall Study|Withdrawal by Subject|2
3018497|NCT00814580|10382351|P2|Overall Study|Protocol Violation|0
3018498|NCT00814580|10382352|P1|Overall Study|Protocol Violation|2
3018499|NCT00814580|10382351|P2|Overall Study|Lack of Efficacy|25
3018500|NCT00814580|10382352|P1|Overall Study|Lack of Efficacy|18
3018501|NCT00814580|10382351|P2|Overall Study|Adverse Event|15
3018502|NCT00814580|10382352|P1|Overall Study|Adverse Event|6
3018503|NCT00814502|10382482|P2|Overall Study|Withdrawal by Subject|2
3018504|NCT00814502|10382483|P1|Overall Study|Withdrawal by Subject|0
3018505|NCT00814502|10382482|P2|Overall Study|Adverse Event|0
3018506|NCT00814502|10382483|P1|Overall Study|Adverse Event|1
3018507|NCT00814489|10382496|P3|Overall Study|Other|1
3018508|NCT00814489|10382497|P2|Overall Study|Other|0
3018509|NCT00814489|10382498|P1|Overall Study|Other|2
3018510|NCT00814463|10382530|P1|Overall Study|Lost to Follow-up|1
3018511|NCT00814346|10382543|P2|Open Phase (17 Months)|Not otherwise specified|0
3018512|NCT00814346|10382544|P1|Open Phase (17 Months)|Not otherwise specified|1
3018513|NCT00814346|10382543|P2|Open Phase (17 Months)|Lost to Follow-up|0
3018514|NCT00814346|10382544|P1|Open Phase (17 Months)|Lost to Follow-up|2
3018515|NCT00814346|10382543|P2|Open Phase (17 Months)|Consent|0
3018516|NCT00814346|10382544|P1|Open Phase (17 Months)|Consent|2
3018517|NCT00814346|10382543|P2|Open Phase (17 Months)|Adverse Event|0
3018518|NCT00814346|10382544|P1|Open Phase (17 Months)|Adverse Event|5
3018519|NCT00814346|10382543|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
3018520|NCT00814346|10382544|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
3018521|NCT00814346|10382543|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
3018522|NCT00814346|10382544|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
3018523|NCT00814333|10382610|P2|Enrollment|Lost to Follow-up|0
3018524|NCT00814333|10382611|P1|Enrollment|Lost to Follow-up|1
3018525|NCT00814320|10382619|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
3018526|NCT00814320|10382620|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
3018527|NCT00814320|10382619|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
3018528|NCT00814320|10382620|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
3018529|NCT00814320|10382619|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
3018530|NCT00814320|10382620|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
3018531|NCT00814320|10382619|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
3018532|NCT00814320|10382620|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
3018533|NCT00814320|10382619|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
3018534|NCT00814320|10382620|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
3018535|NCT00814320|10382619|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
3018536|NCT00814320|10382620|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
3018537|NCT00814320|10382619|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
3018538|NCT00814320|10382620|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
3018539|NCT00814320|10382619|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
3018540|NCT00814320|10382620|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
3018541|NCT00814320|10382619|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
3018542|NCT00814320|10382620|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
3018543|NCT00814320|10382619|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
3018544|NCT00814320|10382620|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
3018545|NCT00814307|10382752|P4|Overall Study|Death|0
3018546|NCT00814307|10382753|P3|Overall Study|Death|0
3018547|NCT00814307|10382754|P2|Overall Study|Death|1
3018548|NCT00814307|10382755|P1|Overall Study|Death|0
3018549|NCT00814307|10382752|P4|Overall Study|Withdrawal by Subject|2
3018550|NCT00814307|10382753|P3|Overall Study|Withdrawal by Subject|0
3018551|NCT00814307|10382754|P2|Overall Study|Withdrawal by Subject|6
3018552|NCT00814307|10382755|P1|Overall Study|Withdrawal by Subject|4
3018553|NCT00814307|10382752|P4|Overall Study|Protocol Violation|1
3018554|NCT00814307|10382753|P3|Overall Study|Protocol Violation|1
3018555|NCT00814307|10382754|P2|Overall Study|Protocol Violation|8
3018556|NCT00814307|10382755|P1|Overall Study|Protocol Violation|2
3018557|NCT00814307|10382752|P4|Overall Study|Other|1
3018558|NCT00814307|10382753|P3|Overall Study|Other|0
3018559|NCT00814307|10382754|P2|Overall Study|Other|2
3018560|NCT00814307|10382755|P1|Overall Study|Other|1
3018561|NCT00814307|10382752|P4|Overall Study|Lack of Efficacy|4
3018562|NCT00814307|10382753|P3|Overall Study|Lack of Efficacy|3
3018563|NCT00814307|10382754|P2|Overall Study|Lack of Efficacy|1
3018564|NCT00814307|10382755|P1|Overall Study|Lack of Efficacy|1
3018565|NCT00814307|10382752|P4|Overall Study|Adverse Event|2
3018566|NCT00814307|10382753|P3|Overall Study|Adverse Event|3
3018567|NCT00814307|10382754|P2|Overall Study|Adverse Event|9
3018568|NCT00814307|10382755|P1|Overall Study|Adverse Event|3
3018569|NCT00814307|10382752|P4|Overall Study|Randomized but not treated|0
3018570|NCT00814307|10382753|P3|Overall Study|Randomized but not treated|0
3018571|NCT00814307|10382754|P2|Overall Study|Randomized but not treated|0
3018572|NCT00814307|10382755|P1|Overall Study|Randomized but not treated|1
3018573|NCT00814164|10382951|P1|Overall Study|Death|5
3018574|NCT00814164|10382951|P1|Overall Study|not stated|7
3018575|NCT00814164|10382951|P1|Overall Study|Progression|7
3018576|NCT00813995|10382985|P2|Overall Study|Withdrawal by Subject|5
3018577|NCT00813995|10382986|P1|Overall Study|Withdrawal by Subject|0
3018578|NCT00813995|10382985|P2|Overall Study|Subject moved|0
3018579|NCT00813995|10382986|P1|Overall Study|Subject moved|4
3018580|NCT00813995|10382985|P2|Overall Study|Protocol Violation|2
3018581|NCT00813995|10382986|P1|Overall Study|Protocol Violation|3
3018582|NCT00813995|10382985|P2|Overall Study|Other reason|2
3018583|NCT00813995|10382986|P1|Overall Study|Other reason|2
3018584|NCT00813995|10382985|P2|Overall Study|Lost to Follow-up|2
3018585|NCT00813995|10382986|P1|Overall Study|Lost to Follow-up|4
3018586|NCT00813995|10382985|P2|Overall Study|Lack of Efficacy|0
3018587|NCT00813995|10382986|P1|Overall Study|Lack of Efficacy|1
3018588|NCT00813995|10382985|P2|Overall Study|Laboratory adverse event|2
3018589|NCT00813995|10382986|P1|Overall Study|Laboratory adverse event|0
3018590|NCT00813995|10382985|P2|Overall Study|Clinical adverse event|3
3018591|NCT00813995|10382986|P1|Overall Study|Clinical adverse event|9
3018592|NCT00813943|10383009|P3|Overall Study|Ongoing at cut-off date|3
3018593|NCT00813943|10383010|P2|Overall Study|Ongoing at cut-off date|5
3018594|NCT00813943|10383011|P1|Overall Study|Ongoing at cut-off date|5
3018595|NCT00813917|10383041|P2|Overall Study|Lost to Follow-up|1
3018596|NCT00813917|10383042|P1|Overall Study|Lost to Follow-up|3
3018597|NCT00813917|10383041|P2|Overall Study|Withdrawal by Subject|4
3018598|NCT00813917|10383042|P1|Overall Study|Withdrawal by Subject|3
3018599|NCT00813917|10383041|P2|Overall Study|Adverse Event|1
3018600|NCT00813917|10383042|P1|Overall Study|Adverse Event|0
3018601|NCT00813904|10383048|P1|Overall Study|Death|1
3018602|NCT00813865|10383054|P1|Overall Study|Withdrawal by Subject|1
3018603|NCT00813865|10383054|P1|Overall Study|Lost to Follow-up|3
3018604|NCT00813865|10383054|P1|Overall Study|Failure to Respond|3
3018605|NCT00813813|10383062|P2|Overall Study|Other|1
3018606|NCT00813813|10383063|P1|Overall Study|Other|0
3018607|NCT00813813|10383062|P2|Overall Study|Lost to Follow-up|7
3018608|NCT00813813|10383063|P1|Overall Study|Lost to Follow-up|2
3018609|NCT00813813|10383062|P2|Overall Study|Withdrawal by Subject|1
3018610|NCT00813813|10383063|P1|Overall Study|Withdrawal by Subject|1
3018611|NCT00813800|10383079|P1|Overall Study|Physician Decision|1
3018612|NCT00813800|10383079|P1|Overall Study|Worsening of depression|2
3018613|NCT00813800|10383079|P1|Overall Study|Adverse Event|1
3018614|NCT00813800|10383079|P1|Overall Study|Screen Failure after Consent|2
3018615|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
3018616|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
3018617|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
3018618|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
3018619|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
3018620|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
3018621|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
3018622|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
3018623|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
3018624|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
3018625|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
3018626|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
3018627|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
3018628|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
3018629|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
3018630|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
3018631|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
3018632|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
3018633|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
3018634|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
3018635|NCT00813761|10383087|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
3018636|NCT00813761|10383088|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
3018637|NCT00813761|10383089|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
3018638|NCT00813761|10383090|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
3018639|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
3018640|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
3018641|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
3018642|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
3018643|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
3018644|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
3018645|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
3018646|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
3018647|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
3018648|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
3018649|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
3018650|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
3018651|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
3018652|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
3018653|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
3018654|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
3018655|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
3018656|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
3018657|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
3018658|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
3018659|NCT00813761|10383087|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
3018660|NCT00813761|10383088|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
3018661|NCT00813761|10383089|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
3018662|NCT00813761|10383090|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
3018663|NCT00813748|10383140|P2|Skin Test Substudy|Physician Decision|1
3018664|NCT00813748|10383141|P1|Skin Test Substudy|Physician Decision|0
3018665|NCT00813709|10383170|P6|Open Label Period|Other|6
3018666|NCT00813709|10383171|P5|Open Label Period|Other|5
3018667|NCT00813709|10383172|P4|Open Label Period|Other|11
3018668|NCT00813709|10383173|P3|Open Label Period|Other|0
3018669|NCT00813709|10383174|P2|Open Label Period|Other|0
3018670|NCT00813709|10383175|P1|Open Label Period|Other|0
3018671|NCT00813709|10383170|P6|Open Label Period|Randomized but not treated|1
3018672|NCT00813709|10383171|P5|Open Label Period|Randomized but not treated|0
3018673|NCT00813709|10383172|P4|Open Label Period|Randomized but not treated|1
3018674|NCT00813709|10383173|P3|Open Label Period|Randomized but not treated|0
3018675|NCT00813709|10383174|P2|Open Label Period|Randomized but not treated|0
3018676|NCT00813709|10383175|P1|Open Label Period|Randomized but not treated|0
3018677|NCT00813709|10383170|P6|Open Label Period|Lack of Efficacy|1
3018678|NCT00813709|10383171|P5|Open Label Period|Lack of Efficacy|1
3018679|NCT00813709|10383172|P4|Open Label Period|Lack of Efficacy|3
3018680|NCT00813709|10383173|P3|Open Label Period|Lack of Efficacy|0
3018681|NCT00813709|10383174|P2|Open Label Period|Lack of Efficacy|0
3018682|NCT00813709|10383175|P1|Open Label Period|Lack of Efficacy|0
3018683|NCT00813709|10383170|P6|Open Label Period|Adverse Event|3
3018684|NCT00813709|10383171|P5|Open Label Period|Adverse Event|4
3018685|NCT00813709|10383172|P4|Open Label Period|Adverse Event|5
3018686|NCT00813709|10383173|P3|Open Label Period|Adverse Event|0
3018687|NCT00813709|10383174|P2|Open Label Period|Adverse Event|0
3018688|NCT00813709|10383175|P1|Open Label Period|Adverse Event|0
3018689|NCT00813709|10383170|P6|Double Blind Period|Other|0
3018690|NCT00813709|10383171|P5|Double Blind Period|Other|0
3018691|NCT00813709|10383172|P4|Double Blind Period|Other|0
3018692|NCT00813709|10383173|P3|Double Blind Period|Other|6
3018693|NCT00813709|10383174|P2|Double Blind Period|Other|9
3018694|NCT00813709|10383175|P1|Double Blind Period|Other|14
3018695|NCT00813709|10383170|P6|Double Blind Period|Randomized but not treated|0
3018696|NCT00813709|10383171|P5|Double Blind Period|Randomized but not treated|0
3018697|NCT00813709|10383172|P4|Double Blind Period|Randomized but not treated|0
3018698|NCT00813709|10383173|P3|Double Blind Period|Randomized but not treated|1
3018699|NCT00813709|10383174|P2|Double Blind Period|Randomized but not treated|3
3018700|NCT00813709|10383175|P1|Double Blind Period|Randomized but not treated|1
3018701|NCT00813709|10383170|P6|Double Blind Period|Switched to open label phase|0
3018702|NCT00813709|10383171|P5|Double Blind Period|Switched to open label phase|0
3018703|NCT00813709|10383172|P4|Double Blind Period|Switched to open label phase|0
3018704|NCT00813709|10383173|P3|Double Blind Period|Switched to open label phase|18
3018705|NCT00813709|10383174|P2|Double Blind Period|Switched to open label phase|26
3018706|NCT00813709|10383175|P1|Double Blind Period|Switched to open label phase|9
3018707|NCT00813709|10383170|P6|Double Blind Period|Lost to Follow-up|0
3018708|NCT00813709|10383171|P5|Double Blind Period|Lost to Follow-up|0
3018709|NCT00813709|10383172|P4|Double Blind Period|Lost to Follow-up|0
3018710|NCT00813709|10383173|P3|Double Blind Period|Lost to Follow-up|2
3018711|NCT00813709|10383174|P2|Double Blind Period|Lost to Follow-up|2
3018712|NCT00813709|10383175|P1|Double Blind Period|Lost to Follow-up|3
3018713|NCT00813709|10383170|P6|Double Blind Period|Adverse Event|0
3018714|NCT00813709|10383171|P5|Double Blind Period|Adverse Event|0
3018715|NCT00813709|10383172|P4|Double Blind Period|Adverse Event|0
3018716|NCT00813709|10383173|P3|Double Blind Period|Adverse Event|4
3018717|NCT00813709|10383174|P2|Double Blind Period|Adverse Event|1
3018718|NCT00813709|10383175|P1|Double Blind Period|Adverse Event|4
3018719|NCT00813592|10383255|P1|Overall Study|Disease assessment was not completed per|2
3018720|NCT00813488|10383264|P2|Open-label Extension|Other|0
3018721|NCT00813488|10383265|P1|Open-label Extension|Other|1
3018722|NCT00813488|10383264|P2|Open-label Extension|Non-compliance study procedures|1
3018723|NCT00813488|10383265|P1|Open-label Extension|Non-compliance study procedures|2
3018724|NCT00813488|10383264|P2|Open-label Extension|Non-compliance study medication|0
3018725|NCT00813488|10383265|P1|Open-label Extension|Non-compliance study medication|4
3018726|NCT00813488|10383264|P2|Open-label Extension|Protocol Violation|2
3018727|NCT00813488|10383265|P1|Open-label Extension|Protocol Violation|1
3018728|NCT00813488|10383264|P2|Open-label Extension|Withdrawal by Subject|2
3018729|NCT00813488|10383265|P1|Open-label Extension|Withdrawal by Subject|0
3018730|NCT00813488|10383264|P2|Open-label Extension|Lack of Efficacy|0
3018731|NCT00813488|10383265|P1|Open-label Extension|Lack of Efficacy|3
3018732|NCT00813488|10383264|P2|Open-label Extension|Adverse Event|2
3018733|NCT00813488|10383265|P1|Open-label Extension|Adverse Event|1
3018734|NCT00813488|10383264|P2|Double-blind Treatment Period 2|Other|0
3018735|NCT00813488|10383265|P1|Double-blind Treatment Period 2|Other|1
3018736|NCT00813488|10383264|P2|Double-blind Treatment Period 2|Protocol Violation|0
3018737|NCT00813488|10383265|P1|Double-blind Treatment Period 2|Protocol Violation|2
3018738|NCT00813488|10383264|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
3018739|NCT00813488|10383265|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
3018740|NCT00813488|10383264|P2|Double-blind Treatment Period 2|Adverse Event|0
3018741|NCT00813488|10383265|P1|Double-blind Treatment Period 2|Adverse Event|1
3018742|NCT00813488|10383264|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
3018743|NCT00813488|10383265|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
3018744|NCT00813488|10383264|P2|Double-blind Treatment Period 1|Protocol Violation|2
3018745|NCT00813488|10383265|P1|Double-blind Treatment Period 1|Protocol Violation|0
3018746|NCT00813488|10383264|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
3018747|NCT00813488|10383265|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
3018748|NCT00813488|10383264|P2|Double-blind Treatment Period 1|Adverse Event|1
3018749|NCT00813488|10383265|P1|Double-blind Treatment Period 1|Adverse Event|1
3018750|NCT00813488|10383264|P2|Titration Period 2|Non-compliance with study procedures|1
3018751|NCT00813488|10383265|P1|Titration Period 2|Non-compliance with study procedures|2
3018752|NCT00813488|10383264|P2|Titration Period 2|Lost to Follow-up|0
3018753|NCT00813488|10383265|P1|Titration Period 2|Lost to Follow-up|1
3018754|NCT00813488|10383264|P2|Titration Period 2|Protocol Violation|2
3018755|NCT00813488|10383265|P1|Titration Period 2|Protocol Violation|3
3018756|NCT00813488|10383264|P2|Titration Period 2|Lack of Efficacy|4
3018757|NCT00813488|10383265|P1|Titration Period 2|Lack of Efficacy|8
3018758|NCT00813488|10383264|P2|Titration Period 2|Adverse Event|3
3018759|NCT00813488|10383265|P1|Titration Period 2|Adverse Event|2
3018760|NCT00813488|10383264|P2|Titration Period 1|Technical Difficulties|1
3018761|NCT00813488|10383265|P1|Titration Period 1|Technical Difficulties|0
3018762|NCT00813488|10383264|P2|Titration Period 1|Non-compliance to study procedures|2
3018763|NCT00813488|10383265|P1|Titration Period 1|Non-compliance to study procedures|2
3018764|NCT00813488|10383264|P2|Titration Period 1|Non-compliance to study medication|1
3018765|NCT00813488|10383265|P1|Titration Period 1|Non-compliance to study medication|4
3018766|NCT00813488|10383264|P2|Titration Period 1|Protocol Violation|3
3018767|NCT00813488|10383265|P1|Titration Period 1|Protocol Violation|4
3018768|NCT00813488|10383264|P2|Titration Period 1|Withdrawal by Subject|2
3018769|NCT00813488|10383265|P1|Titration Period 1|Withdrawal by Subject|2
3018770|NCT00813488|10383264|P2|Titration Period 1|Lack of Efficacy|7
3018771|NCT00813488|10383265|P1|Titration Period 1|Lack of Efficacy|9
3018772|NCT00813488|10383264|P2|Titration Period 1|Adverse Event|1
3018773|NCT00813488|10383265|P1|Titration Period 1|Adverse Event|6
3018774|NCT00813150|10383395|P2|Long Term Follow-up|Progression/Relapse|24
3018775|NCT00813150|10383396|P1|Long Term Follow-up|Progression/Relapse|22
3018776|NCT00813150|10383395|P2|Long Term Follow-up|Lost to Follow-up|0
3018777|NCT00813150|10383396|P1|Long Term Follow-up|Lost to Follow-up|2
3018778|NCT00813150|10383395|P2|Long Term Follow-up|Other|3
3018779|NCT00813150|10383396|P1|Long Term Follow-up|Other|0
3018780|NCT00813150|10383395|P2|Long Term Follow-up|Death|4
3018781|NCT00813150|10383396|P1|Long Term Follow-up|Death|0
3018782|NCT00813150|10383395|P2|Treatment Period|Data not available|2
3018783|NCT00813150|10383396|P1|Treatment Period|Data not available|1
3018784|NCT00813150|10383395|P2|Treatment Period|Reason not specified|4
3018785|NCT00813150|10383396|P1|Treatment Period|Reason not specified|3
3018786|NCT00813150|10383395|P2|Treatment Period|Non compliance|1
3018787|NCT00813150|10383396|P1|Treatment Period|Non compliance|0
3018788|NCT00813150|10383395|P2|Treatment Period|Withdrawal by Subject|3
3018789|NCT00813150|10383396|P1|Treatment Period|Withdrawal by Subject|5
3018790|NCT00813150|10383395|P2|Treatment Period|Protocol Violation|4
3018791|NCT00813150|10383396|P1|Treatment Period|Protocol Violation|3
3018792|NCT00813150|10383395|P2|Treatment Period|Stable disease|2
3018793|NCT00813150|10383396|P1|Treatment Period|Stable disease|1
3018794|NCT00813150|10383395|P2|Treatment Period|Complete response|1
3018795|NCT00813150|10383396|P1|Treatment Period|Complete response|0
3018796|NCT00813150|10383395|P2|Treatment Period|Progressive disease|0
3018797|NCT00813150|10383396|P1|Treatment Period|Progressive disease|1
3018798|NCT00813150|10383395|P2|Treatment Period|Death|0
3018799|NCT00813150|10383396|P1|Treatment Period|Death|2
3018800|NCT00813150|10383395|P2|Treatment Period|Adverse Event|15
3018801|NCT00813150|10383396|P1|Treatment Period|Adverse Event|16
3018802|NCT00813098|10383420|P3|Overall Study|Withdrew Consent|0
3018803|NCT00813098|10383421|P2|Overall Study|Withdrew Consent|1
3018804|NCT00813098|10383422|P1|Overall Study|Withdrew Consent|0
3018805|NCT00813098|10383420|P3|Overall Study|Principal Investigator decision|0
3018806|NCT00813098|10383421|P2|Overall Study|Principal Investigator decision|1
3018807|NCT00813098|10383422|P1|Overall Study|Principal Investigator decision|0
3018808|NCT00813098|10383420|P3|Overall Study|Protocol Violation|1
3018809|NCT00813098|10383421|P2|Overall Study|Protocol Violation|0
3018810|NCT00813098|10383422|P1|Overall Study|Protocol Violation|0
3018811|NCT00813098|10383420|P3|Overall Study|Lost to Follow-up|0
3018812|NCT00813098|10383421|P2|Overall Study|Lost to Follow-up|1
3018813|NCT00813098|10383422|P1|Overall Study|Lost to Follow-up|0
3018814|NCT00813098|10383420|P3|Overall Study|Inability to complete study procedures|0
3018815|NCT00813098|10383421|P2|Overall Study|Inability to complete study procedures|0
3018816|NCT00813098|10383422|P1|Overall Study|Inability to complete study procedures|1
3018817|NCT00813098|10383420|P3|Overall Study|Withdrawal by Subject|0
3018818|NCT00813098|10383421|P2|Overall Study|Withdrawal by Subject|1
3018819|NCT00813098|10383422|P1|Overall Study|Withdrawal by Subject|0
3018820|NCT00813098|10383420|P3|Overall Study|Adverse Event|1
3018821|NCT00813098|10383421|P2|Overall Study|Adverse Event|4
3018822|NCT00813098|10383422|P1|Overall Study|Adverse Event|2
3018823|NCT00812981|10383447|P2|Overall Study|Other|1
3018824|NCT00812981|10383448|P1|Overall Study|Other|0
3018825|NCT00812968|10383486|P1|Overall Study|Study closed due to marketing approval|3
3018826|NCT00812968|10383486|P1|Overall Study|No further treatment required|1
3018827|NCT00812968|10383486|P1|Overall Study|Disease progression|1
3018828|NCT00812968|10383486|P1|Overall Study|Relapse after erythroid response|6
3018829|NCT00812955|10383521|P4|Overall Study|randomized in error|0
3018830|NCT00812955|10383522|P3|Overall Study|randomized in error|1
3018831|NCT00812955|10383523|P2|Overall Study|randomized in error|0
3018832|NCT00812955|10383524|P1|Overall Study|randomized in error|0
3018833|NCT00812955|10383521|P4|Overall Study|Withdrawal by Subject|2
3018834|NCT00812955|10383522|P3|Overall Study|Withdrawal by Subject|1
3018835|NCT00812955|10383523|P2|Overall Study|Withdrawal by Subject|0
3018836|NCT00812955|10383524|P1|Overall Study|Withdrawal by Subject|1
3018837|NCT00812955|10383521|P4|Overall Study|Lost to Follow-up|2
3018838|NCT00812955|10383522|P3|Overall Study|Lost to Follow-up|1
3018839|NCT00812955|10383523|P2|Overall Study|Lost to Follow-up|1
3018840|NCT00812955|10383524|P1|Overall Study|Lost to Follow-up|2
3018841|NCT00812955|10383521|P4|Overall Study|Adverse Event|4
3018842|NCT00812955|10383522|P3|Overall Study|Adverse Event|3
3018843|NCT00812955|10383523|P2|Overall Study|Adverse Event|6
3018844|NCT00812955|10383524|P1|Overall Study|Adverse Event|7
3018845|NCT00812929|10383544|P10|Washout Period 3 (7 Days)|Adverse Event|0
3018846|NCT00812929|10383545|P9|Washout Period 3 (7 Days)|Adverse Event|0
3018847|NCT00812929|10383546|P8|Washout Period 3 (7 Days)|Adverse Event|0
3018848|NCT00812929|10383547|P7|Washout Period 3 (7 Days)|Adverse Event|0
3018849|NCT00812929|10383548|P6|Washout Period 3 (7 Days)|Adverse Event|1
3018850|NCT00812929|10383549|P5|Washout Period 3 (7 Days)|Adverse Event|0
3018851|NCT00812929|10383550|P4|Washout Period 3 (7 Days)|Adverse Event|0
3018852|NCT00812929|10383551|P3|Washout Period 3 (7 Days)|Adverse Event|0
3018853|NCT00812929|10383552|P2|Washout Period 3 (7 Days)|Adverse Event|0
3018854|NCT00812929|10383553|P1|Washout Period 3 (7 Days)|Adverse Event|0
3018855|NCT00812929|10383544|P10|Washout Period 2 (7 Days)|Physician Decision|1
3018856|NCT00812929|10383545|P9|Washout Period 2 (7 Days)|Physician Decision|0
3018857|NCT00812929|10383546|P8|Washout Period 2 (7 Days)|Physician Decision|0
3018858|NCT00812929|10383547|P7|Washout Period 2 (7 Days)|Physician Decision|0
3018859|NCT00812929|10383548|P6|Washout Period 2 (7 Days)|Physician Decision|0
3018860|NCT00812929|10383549|P5|Washout Period 2 (7 Days)|Physician Decision|0
3018861|NCT00812929|10383550|P4|Washout Period 2 (7 Days)|Physician Decision|0
3018862|NCT00812929|10383551|P3|Washout Period 2 (7 Days)|Physician Decision|0
3018863|NCT00812929|10383552|P2|Washout Period 2 (7 Days)|Physician Decision|0
3018864|NCT00812929|10383553|P1|Washout Period 2 (7 Days)|Physician Decision|0
3018865|NCT00812929|10383544|P10|Washout Period 1 (7 Days)|Physician Decision|0
3018866|NCT00812929|10383545|P9|Washout Period 1 (7 Days)|Physician Decision|0
3018867|NCT00812929|10383546|P8|Washout Period 1 (7 Days)|Physician Decision|0
3018868|NCT00812929|10383547|P7|Washout Period 1 (7 Days)|Physician Decision|0
3018869|NCT00812929|10383548|P6|Washout Period 1 (7 Days)|Physician Decision|0
3018870|NCT00812929|10383549|P5|Washout Period 1 (7 Days)|Physician Decision|0
3018871|NCT00812929|10383550|P4|Washout Period 1 (7 Days)|Physician Decision|0
3018872|NCT00812929|10383551|P3|Washout Period 1 (7 Days)|Physician Decision|1
3018873|NCT00812929|10383552|P2|Washout Period 1 (7 Days)|Physician Decision|0
3018874|NCT00812929|10383553|P1|Washout Period 1 (7 Days)|Physician Decision|0
3018875|NCT00812812|10383708|P2|Overall Study|Withdrawal by Subject|2
3018876|NCT00812812|10383709|P1|Overall Study|Withdrawal by Subject|0
3018877|NCT00812812|10383708|P2|Overall Study|Lost to Follow-up|1
3018878|NCT00812812|10383709|P1|Overall Study|Lost to Follow-up|0
3018879|NCT00812812|10383708|P2|Overall Study|Lack of Efficacy|0
3018880|NCT00812812|10383709|P1|Overall Study|Lack of Efficacy|1
3018881|NCT00812812|10383708|P2|Overall Study|Adverse Event|1
3018882|NCT00812812|10383709|P1|Overall Study|Adverse Event|2
3018883|NCT00812708|10383722|P1|Overall Study|Signed consent but later withdrew|3
3018884|NCT00812708|10383722|P1|Overall Study|Surgery cancelled due to uveitis|1
3018885|NCT00812708|10383722|P1|Overall Study|Switched to another study|1
3018886|NCT00812708|10383722|P1|Overall Study|Lack of medical insurance|1
3018887|NCT00812708|10383722|P1|Overall Study|Device could not be implanted|2
3018888|NCT00812565|10383750|P8|Overall Study|Reason Not Specified|0
3018889|NCT00812565|10383751|P7|Overall Study|Reason Not Specified|0
3018890|NCT00812565|10383752|P6|Overall Study|Reason Not Specified|1
3018891|NCT00812565|10383753|P5|Overall Study|Reason Not Specified|0
3018892|NCT00812565|10383754|P4|Overall Study|Reason Not Specified|0
3018893|NCT00812565|10383755|P3|Overall Study|Reason Not Specified|0
3018894|NCT00812565|10383756|P2|Overall Study|Reason Not Specified|0
3018895|NCT00812565|10383757|P1|Overall Study|Reason Not Specified|0
3018896|NCT00812565|10383750|P8|Overall Study|Withdrawal of Consent|0
3018897|NCT00812565|10383751|P7|Overall Study|Withdrawal of Consent|0
3018898|NCT00812565|10383752|P6|Overall Study|Withdrawal of Consent|0
3018899|NCT00812565|10383753|P5|Overall Study|Withdrawal of Consent|1
3018900|NCT00812565|10383754|P4|Overall Study|Withdrawal of Consent|0
3018901|NCT00812565|10383755|P3|Overall Study|Withdrawal of Consent|0
3018902|NCT00812565|10383756|P2|Overall Study|Withdrawal of Consent|0
3018903|NCT00812565|10383757|P1|Overall Study|Withdrawal of Consent|1
3018904|NCT00812565|10383750|P8|Overall Study|Did Not Come to Study Visit|0
3018905|NCT00812565|10383751|P7|Overall Study|Did Not Come to Study Visit|0
3018906|NCT00812565|10383752|P6|Overall Study|Did Not Come to Study Visit|0
3018907|NCT00812565|10383753|P5|Overall Study|Did Not Come to Study Visit|0
3018908|NCT00812565|10383754|P4|Overall Study|Did Not Come to Study Visit|0
3018909|NCT00812565|10383755|P3|Overall Study|Did Not Come to Study Visit|0
3018910|NCT00812565|10383756|P2|Overall Study|Did Not Come to Study Visit|0
3018911|NCT00812565|10383757|P1|Overall Study|Did Not Come to Study Visit|1
3018912|NCT00812565|10383750|P8|Overall Study|Adverse Event|1
3018913|NCT00812565|10383751|P7|Overall Study|Adverse Event|0
3018914|NCT00812565|10383752|P6|Overall Study|Adverse Event|0
3018915|NCT00812565|10383753|P5|Overall Study|Adverse Event|0
3018916|NCT00812565|10383754|P4|Overall Study|Adverse Event|2
3018917|NCT00812565|10383755|P3|Overall Study|Adverse Event|0
3018918|NCT00812565|10383756|P2|Overall Study|Adverse Event|0
3018919|NCT00812565|10383757|P1|Overall Study|Adverse Event|0
3018920|NCT00812565|10383750|P8|Overall Study|Did Not Receive Study Medication|0
3018921|NCT00812565|10383751|P7|Overall Study|Did Not Receive Study Medication|0
3018922|NCT00812565|10383752|P6|Overall Study|Did Not Receive Study Medication|0
3018923|NCT00812565|10383753|P5|Overall Study|Did Not Receive Study Medication|0
3018924|NCT00812565|10383754|P4|Overall Study|Did Not Receive Study Medication|0
3018925|NCT00812565|10383755|P3|Overall Study|Did Not Receive Study Medication|0
3018926|NCT00812565|10383756|P2|Overall Study|Did Not Receive Study Medication|1
3018927|NCT00812565|10383757|P1|Overall Study|Did Not Receive Study Medication|1
3018928|NCT00812487|10383881|P2|Overall Study|Protocol Violation|1
3018929|NCT00812487|10383882|P1|Overall Study|Protocol Violation|0
3018930|NCT00812487|10383881|P2|Overall Study|Transfer to ICU prior to intervention|0
3018931|NCT00812487|10383882|P1|Overall Study|Transfer to ICU prior to intervention|1
3018932|NCT00812487|10383881|P2|Overall Study|Withdrawal by Subject|2
3018933|NCT00812487|10383882|P1|Overall Study|Withdrawal by Subject|3
3018934|NCT00812487|10383881|P2|Overall Study|Lost to Follow-up|0
3018935|NCT00812487|10383882|P1|Overall Study|Lost to Follow-up|2
3018936|NCT00812461|10383908|P2|All Treated Patients|Other Reason|21
3018937|NCT00812461|10383909|P1|All Treated Patients|Other Reason|13
3018938|NCT00812461|10383908|P2|All Treated Patients|Lost to Follow-up|14
3018939|NCT00812461|10383909|P1|All Treated Patients|Lost to Follow-up|11
3018940|NCT00812461|10383908|P2|All Treated Patients|Withdrawal by Subject|54
3018941|NCT00812461|10383909|P1|All Treated Patients|Withdrawal by Subject|45
3018942|NCT00812461|10383908|P2|All Treated Patients|Protocol Violation|27
3018943|NCT00812461|10383909|P1|All Treated Patients|Protocol Violation|36
3018944|NCT00812461|10383908|P2|All Treated Patients|Non-compliance|9
3018945|NCT00812461|10383909|P1|All Treated Patients|Non-compliance|6
3018946|NCT00812461|10383908|P2|All Treated Patients|Lack of Efficacy|7
3018947|NCT00812461|10383909|P1|All Treated Patients|Lack of Efficacy|13
3018948|NCT00812461|10383908|P2|All Treated Patients|Adverse Event|15
3018949|NCT00812461|10383909|P1|All Treated Patients|Adverse Event|8
3018950|NCT00812461|10383908|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
3018951|NCT00812461|10383909|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
3018952|NCT00812331|10383932|P5|Overall Study|Adverse Event|0
3018953|NCT00812331|10383933|P4|Overall Study|Adverse Event|0
3018954|NCT00812331|10383934|P3|Overall Study|Adverse Event|0
3018955|NCT00812331|10383935|P2|Overall Study|Adverse Event|0
3018956|NCT00812331|10383936|P1|Overall Study|Adverse Event|1
3018957|NCT00812253|10384011|P2|Overall Study|Lost to Follow-up|0
3018958|NCT00812253|10384012|P1|Overall Study|Lost to Follow-up|2
3018959|NCT00812253|10384011|P2|Overall Study|Protocol Violation|1
3018960|NCT00812253|10384012|P1|Overall Study|Protocol Violation|1
3018961|NCT00812253|10384011|P2|Overall Study|Withdrawal by Subject|2
3018962|NCT00812253|10384012|P1|Overall Study|Withdrawal by Subject|3
3018963|NCT00812097|10384037|P4|Overall Study|Unknown reasons and patient/doctor moves|5
3018964|NCT00812097|10384038|P3|Overall Study|Unknown reasons and patient/doctor moves|15
3018965|NCT00812097|10384039|P2|Overall Study|Unknown reasons and patient/doctor moves|24
3018966|NCT00812097|10384040|P1|Overall Study|Unknown reasons and patient/doctor moves|111
3018967|NCT00812097|10384037|P4|Overall Study|Explantation of study device(s)|20
3018968|NCT00812097|10384038|P3|Overall Study|Explantation of study device(s)|14
3018969|NCT00812097|10384039|P2|Overall Study|Explantation of study device(s)|29
3018970|NCT00812097|10384040|P1|Overall Study|Explantation of study device(s)|27
3018971|NCT00812097|10384037|P4|Overall Study|Lost to Follow-up|5
3018972|NCT00812097|10384038|P3|Overall Study|Lost to Follow-up|17
3018973|NCT00812097|10384039|P2|Overall Study|Lost to Follow-up|14
3018974|NCT00812097|10384040|P1|Overall Study|Lost to Follow-up|90
3018975|NCT00812097|10384037|P4|Overall Study|Withdrawal by Subject|2
3018976|NCT00812097|10384038|P3|Overall Study|Withdrawal by Subject|8
3018977|NCT00812097|10384039|P2|Overall Study|Withdrawal by Subject|12
3018978|NCT00812097|10384040|P1|Overall Study|Withdrawal by Subject|14
3018979|NCT00812097|10384037|P4|Overall Study|Death|3
3018980|NCT00812097|10384038|P3|Overall Study|Death|3
3018981|NCT00812097|10384039|P2|Overall Study|Death|10
3018982|NCT00812097|10384040|P1|Overall Study|Death|3
3018983|NCT00812006|10384069|P3|Overall Study|Lack of Qualifying Event|2
3018984|NCT00812006|10384070|P2|Overall Study|Lack of Qualifying Event|2
3018985|NCT00812006|10384071|P1|Overall Study|Lack of Qualifying Event|4
3018986|NCT00812006|10384069|P3|Overall Study|Withdrawal by Subject|1
3018987|NCT00812006|10384070|P2|Overall Study|Withdrawal by Subject|1
3018988|NCT00812006|10384071|P1|Overall Study|Withdrawal by Subject|2
3018989|NCT00812006|10384069|P3|Overall Study|Physician Decision|1
3018990|NCT00812006|10384070|P2|Overall Study|Physician Decision|0
3018991|NCT00812006|10384071|P1|Overall Study|Physician Decision|0
3018992|NCT00812006|10384069|P3|Overall Study|Lost to Follow-up|2
3018993|NCT00812006|10384070|P2|Overall Study|Lost to Follow-up|0
3018994|NCT00812006|10384071|P1|Overall Study|Lost to Follow-up|0
3018995|NCT00811954|10384088|P3|Overall Study|Complete Protocol: No follow-up|1
3018996|NCT00811954|10384089|P2|Overall Study|Complete Protocol: No follow-up|0
3018997|NCT00811954|10384090|P1|Overall Study|Complete Protocol: No follow-up|0
3018998|NCT00811954|10384088|P3|Overall Study|Severe Debilitation|1
3018999|NCT00811954|10384089|P2|Overall Study|Severe Debilitation|0
3019000|NCT00811954|10384090|P1|Overall Study|Severe Debilitation|2
3019001|NCT00811954|10384088|P3|Overall Study|Site Closure|1
3019002|NCT00811954|10384089|P2|Overall Study|Site Closure|0
3019003|NCT00811954|10384090|P1|Overall Study|Site Closure|4
3019004|NCT00811954|10384088|P3|Overall Study|Withdraw consent prior study completion|5
3019005|NCT00811954|10384089|P2|Overall Study|Withdraw consent prior study completion|6
3019006|NCT00811954|10384090|P1|Overall Study|Withdraw consent prior study completion|4
3019007|NCT00811954|10384088|P3|Overall Study|Not willing to adhere to requirements|16
3019008|NCT00811954|10384089|P2|Overall Study|Not willing to adhere to requirements|2
3019009|NCT00811954|10384090|P1|Overall Study|Not willing to adhere to requirements|12
3019010|NCT00811954|10384088|P3|Overall Study|Not able to get to clinic|30
3019011|NCT00811954|10384089|P2|Overall Study|Not able to get to clinic|35
3019012|NCT00811954|10384090|P1|Overall Study|Not able to get to clinic|28
3019013|NCT00811954|10384088|P3|Overall Study|Lost to Follow-up|34
3019014|NCT00811954|10384089|P2|Overall Study|Lost to Follow-up|23
3019015|NCT00811954|10384090|P1|Overall Study|Lost to Follow-up|29
3019016|NCT00811954|10384088|P3|Overall Study|Death|13
3019017|NCT00811954|10384089|P2|Overall Study|Death|6
3019018|NCT00811954|10384090|P1|Overall Study|Death|10
3019019|NCT00811941|10384154|P2|All Treated Patients|Other Reason|14
3019020|NCT00811941|10384155|P1|All Treated Patients|Other Reason|4
3019021|NCT00811941|10384154|P2|All Treated Patients|Lost to Follow-up|12
3019022|NCT00811941|10384155|P1|All Treated Patients|Lost to Follow-up|3
3019023|NCT00811941|10384154|P2|All Treated Patients|Withdrawal by Subject|94
3019024|NCT00811941|10384155|P1|All Treated Patients|Withdrawal by Subject|35
3019025|NCT00811941|10384154|P2|All Treated Patients|Protocol Violation|17
3019026|NCT00811941|10384155|P1|All Treated Patients|Protocol Violation|5
3019027|NCT00811941|10384154|P2|All Treated Patients|Non-compliance|8
3019028|NCT00811941|10384155|P1|All Treated Patients|Non-compliance|1
3019029|NCT00811941|10384154|P2|All Treated Patients|Lack of Efficacy|3
3019030|NCT00811941|10384155|P1|All Treated Patients|Lack of Efficacy|2
3019031|NCT00811941|10384154|P2|All Treated Patients|Adverse Event|43
3019032|NCT00811941|10384155|P1|All Treated Patients|Adverse Event|2
3019033|NCT00811941|10384154|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
3019034|NCT00811941|10384155|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
3019035|NCT00811928|10384193|P2|Overall Study|Poor Compliance|5
3019036|NCT00811928|10384194|P1|Overall Study|Poor Compliance|2
3019037|NCT00811928|10384193|P2|Overall Study|Investigator Decision|1
3019038|NCT00811928|10384194|P1|Overall Study|Investigator Decision|2
3019039|NCT00811928|10384193|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
3019040|NCT00811928|10384194|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
3019041|NCT00811928|10384193|P2|Overall Study|Did Not Take Study Drug|0
3019042|NCT00811928|10384194|P1|Overall Study|Did Not Take Study Drug|3
3019043|NCT00811928|10384193|P2|Overall Study|Withdrawal by Subject|12
3019044|NCT00811928|10384194|P1|Overall Study|Withdrawal by Subject|18
3019045|NCT00811928|10384193|P2|Overall Study|AEs and SAEs Including Death|11
3019046|NCT00811928|10384194|P1|Overall Study|AEs and SAEs Including Death|7
3019047|NCT00811733|10384238|P2|Overall Study|Withdrawal by Subject|2
3019048|NCT00811733|10384239|P1|Overall Study|Withdrawal by Subject|1
3019049|NCT00811733|10384238|P2|Overall Study|Investigator Discretion|8
3019050|NCT00811733|10384239|P1|Overall Study|Investigator Discretion|10
3019051|NCT00811720|10384287|P2|All Treated Patients|Other Reason|4
3019052|NCT00811720|10384288|P1|All Treated Patients|Other Reason|7
3019053|NCT00811720|10384287|P2|All Treated Patients|Lost to Follow-up|16
3019054|NCT00811720|10384288|P1|All Treated Patients|Lost to Follow-up|10
3019055|NCT00811720|10384287|P2|All Treated Patients|Withdrawal by Subject|34
3019056|NCT00811720|10384288|P1|All Treated Patients|Withdrawal by Subject|28
3019057|NCT00811720|10384287|P2|All Treated Patients|Protocol Violation|16
3019058|NCT00811720|10384288|P1|All Treated Patients|Protocol Violation|9
3019059|NCT00811720|10384287|P2|All Treated Patients|Non-compliance|14
3019060|NCT00811720|10384288|P1|All Treated Patients|Non-compliance|0
3019061|NCT00811720|10384287|P2|All Treated Patients|Lack of Efficacy|18
3019062|NCT00811720|10384288|P1|All Treated Patients|Lack of Efficacy|22
3019063|NCT00811720|10384287|P2|All Treated Patients|Adverse Event|62
3019064|NCT00811720|10384288|P1|All Treated Patients|Adverse Event|20
3019065|NCT00811720|10384287|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
3019066|NCT00811720|10384288|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
3019067|NCT00811655|10384306|P1|Overall Study|Physician Decision|1
3019068|NCT00811642|10384318|P1|Overall Study|Cumulative use of antifungal agent|2
3019069|NCT00811642|10384318|P1|Overall Study|Withdrawal by Subject|7
3019070|NCT00811642|10384318|P1|Overall Study|Death|2
3019071|NCT00811642|10384318|P1|Overall Study|Protocol Violation|1
3019072|NCT00811642|10384318|P1|Overall Study|Adverse Event|3
3019073|NCT00811577|10384334|P2|Overall Study|Withdrawal by Subject|0
3019074|NCT00811577|10384335|P1|Overall Study|Withdrawal by Subject|3
3019075|NCT00811577|10384334|P2|Overall Study|Lost to Follow-up|1
3019076|NCT00811577|10384335|P1|Overall Study|Lost to Follow-up|7
3019077|NCT00811473|10384395|P2|Overall Study|Safety Reasons|0
3019078|NCT00811473|10384396|P1|Overall Study|Safety Reasons|1
3019079|NCT00811473|10384395|P2|Overall Study|Incorrect Enrollment|0
3019080|NCT00811473|10384396|P1|Overall Study|Incorrect Enrollment|1
3019081|NCT00811473|10384395|P2|Overall Study|Other 2|1
3019082|NCT00811473|10384396|P1|Overall Study|Other 2|4
3019083|NCT00811473|10384395|P2|Overall Study|Condition under investigation worsened|3
3019084|NCT00811473|10384396|P1|Overall Study|Condition under investigation worsened|1
3019085|NCT00811473|10384395|P2|Overall Study|Lack of therapeutic response|1
3019086|NCT00811473|10384396|P1|Overall Study|Lack of therapeutic response|4
3019087|NCT00811473|10384395|P2|Overall Study|Severe non-compliance to protocol|4
3019088|NCT00811473|10384396|P1|Overall Study|Severe non-compliance to protocol|2
3019089|NCT00811473|10384395|P2|Overall Study|Withdrawal by Subject|4
3019090|NCT00811473|10384396|P1|Overall Study|Withdrawal by Subject|2
3019091|NCT00811473|10384395|P2|Overall Study|Lost to Follow-up|1
3019092|NCT00811473|10384396|P1|Overall Study|Lost to Follow-up|5
3019093|NCT00811473|10384395|P2|Overall Study|Adverse Event|12
3019094|NCT00811473|10384396|P1|Overall Study|Adverse Event|3
3019095|NCT00811395|10384427|P6|Extension Treatment|Other than above|0
3019096|NCT00811395|10384428|P5|Extension Treatment|Other than above|0
3019097|NCT00811395|10384429|P4|Extension Treatment|Other than above|0
3019098|NCT00811395|10384430|P3|Extension Treatment|Other than above|1
3019099|NCT00811395|10384431|P2|Extension Treatment|Other than above|0
3019100|NCT00811395|10384432|P1|Extension Treatment|Other than above|0
3019101|NCT00811395|10384427|P6|Extension Treatment|Participant did not wish to continue|1
3019102|NCT00811395|10384428|P5|Extension Treatment|Participant did not wish to continue|0
3019103|NCT00811395|10384429|P4|Extension Treatment|Participant did not wish to continue|1
3019104|NCT00811395|10384430|P3|Extension Treatment|Participant did not wish to continue|0
3019105|NCT00811395|10384431|P2|Extension Treatment|Participant did not wish to continue|3
3019106|NCT00811395|10384432|P1|Extension Treatment|Participant did not wish to continue|0
3019107|NCT00811395|10384427|P6|Extension Treatment|Progressive disease|0
3019108|NCT00811395|10384428|P5|Extension Treatment|Progressive disease|0
3019109|NCT00811395|10384429|P4|Extension Treatment|Progressive disease|0
3019110|NCT00811395|10384430|P3|Extension Treatment|Progressive disease|0
3019111|NCT00811395|10384431|P2|Extension Treatment|Progressive disease|1
3019112|NCT00811395|10384432|P1|Extension Treatment|Progressive disease|1
3019113|NCT00811395|10384427|P6|Extension Treatment|Adverse Event|1
3019114|NCT00811395|10384428|P5|Extension Treatment|Adverse Event|0
3019115|NCT00811395|10384429|P4|Extension Treatment|Adverse Event|2
3019116|NCT00811395|10384430|P3|Extension Treatment|Adverse Event|2
3019117|NCT00811395|10384431|P2|Extension Treatment|Adverse Event|2
3019118|NCT00811395|10384432|P1|Extension Treatment|Adverse Event|1
3019119|NCT00811252|10384538|P3|Overall Study|Administrative or Other Reasons|2
3019120|NCT00811252|10384539|P2|Overall Study|Administrative or Other Reasons|3
3019121|NCT00811252|10384540|P1|Overall Study|Administrative or Other Reasons|0
3019122|NCT00811252|10384538|P3|Overall Study|Lost to Follow-up|2
3019123|NCT00811252|10384539|P2|Overall Study|Lost to Follow-up|0
3019124|NCT00811252|10384540|P1|Overall Study|Lost to Follow-up|0
3019125|NCT00811252|10384538|P3|Overall Study|Withdrawal of Consent|2
3019126|NCT00811252|10384539|P2|Overall Study|Withdrawal of Consent|2
3019127|NCT00811252|10384540|P1|Overall Study|Withdrawal of Consent|1
3019128|NCT00811252|10384538|P3|Overall Study|Protocol Violation|2
3019129|NCT00811252|10384539|P2|Overall Study|Protocol Violation|3
3019130|NCT00811252|10384540|P1|Overall Study|Protocol Violation|3
3019131|NCT00811252|10384538|P3|Overall Study|Lack of Efficacy|0
3019132|NCT00811252|10384539|P2|Overall Study|Lack of Efficacy|2
3019133|NCT00811252|10384540|P1|Overall Study|Lack of Efficacy|7
3019134|NCT00811252|10384538|P3|Overall Study|Adverse Event|15
3019135|NCT00811252|10384539|P2|Overall Study|Adverse Event|10
3019136|NCT00811252|10384540|P1|Overall Study|Adverse Event|6
3019137|NCT00811187|10384586|P2|Overall Study|Unable to place device / procedure abort|3
3019138|NCT00811187|10384587|P1|Overall Study|Unable to place device / procedure abort|3
3019139|NCT00811174|10384593|P1|Overall Study|Sponsors Decision|1
3019140|NCT00811174|10384593|P1|Overall Study|Protocol Violation|2
3019141|NCT00811135|10384604|P1|Overall Study|Ongoing|59
3019142|NCT00811135|10384604|P1|Overall Study|Administrative/Other Unspecified|11
3019143|NCT00811135|10384604|P1|Overall Study|Withdrawal by Subject|3
3019144|NCT00811135|10384604|P1|Overall Study|Refused Treatment|1
3019145|NCT00811135|10384604|P1|Overall Study|Violation of Selection Criteria|1
3019146|NCT00811135|10384604|P1|Overall Study|Protocol Violation|2
3019147|NCT00811135|10384604|P1|Overall Study|Death|3
3019148|NCT00811135|10384604|P1|Overall Study|Adverse Event/Intercurrent Illness|8
3019149|NCT00811070|10384622|P6|Overall Study|Physician Decision|1
3019150|NCT00811070|10384623|P5|Overall Study|Physician Decision|0
3019151|NCT00811070|10384624|P4|Overall Study|Physician Decision|0
3019152|NCT00811070|10384625|P3|Overall Study|Physician Decision|0
3019153|NCT00811070|10384626|P2|Overall Study|Physician Decision|0
3019154|NCT00811070|10384627|P1|Overall Study|Physician Decision|0
3019155|NCT00811070|10384622|P6|Overall Study|Withdrawal by Subject|0
3019156|NCT00811070|10384623|P5|Overall Study|Withdrawal by Subject|0
3019157|NCT00811070|10384624|P4|Overall Study|Withdrawal by Subject|0
3019158|NCT00811070|10384625|P3|Overall Study|Withdrawal by Subject|0
3019159|NCT00811070|10384626|P2|Overall Study|Withdrawal by Subject|1
3019160|NCT00811070|10384627|P1|Overall Study|Withdrawal by Subject|0
3019161|NCT00811070|10384622|P6|Overall Study|Other|0
3019162|NCT00811070|10384623|P5|Overall Study|Other|0
3019163|NCT00811070|10384624|P4|Overall Study|Other|0
3019164|NCT00811070|10384625|P3|Overall Study|Other|0
3019165|NCT00811070|10384626|P2|Overall Study|Other|0
3019166|NCT00811070|10384627|P1|Overall Study|Other|1
3019167|NCT00811070|10384622|P6|Overall Study|Death|0
3019168|NCT00811070|10384623|P5|Overall Study|Death|5
3019169|NCT00811070|10384624|P4|Overall Study|Death|2
3019170|NCT00811070|10384625|P3|Overall Study|Death|0
3019171|NCT00811070|10384626|P2|Overall Study|Death|0
3019172|NCT00811070|10384627|P1|Overall Study|Death|0
3019173|NCT00811057|10384687|P3|Overall Study|Protocol Violation|10
3019174|NCT00811057|10384688|P2|Overall Study|Protocol Violation|10
3019175|NCT00811057|10384689|P1|Overall Study|Protocol Violation|5
3019176|NCT00811018|10384700|P1|Overall Study|Other|26
3019177|NCT00811018|10384700|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
3019178|NCT00811018|10384700|P1|Overall Study|Withdrawal by Subject|70
3019179|NCT00811018|10384700|P1|Overall Study|Sponsor Decision|450
3019180|NCT00811018|10384700|P1|Overall Study|Pregnancy|6
3019181|NCT00811018|10384700|P1|Overall Study|Lost to Follow-up|19
3019182|NCT00811018|10384700|P1|Overall Study|Investigator Decision|57
3019183|NCT00811018|10384700|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
3019184|NCT00811018|10384700|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
3019185|NCT00811018|10384700|P1|Overall Study|Death|147
3019186|NCT00811018|10384700|P1|Overall Study|Adverse Event|79
3019187|NCT00811018|10384700|P1|Overall Study|Additional Chronic Treatment|31
3019188|NCT00810901|10384718|P2|Overall Study|Lost to Follow-up|58
3019189|NCT00810901|10384719|P1|Overall Study|Lost to Follow-up|88
3019190|NCT00810810|10384765|P4|Overall Study|Physician Decision|5
3019191|NCT00810810|10384766|P3|Overall Study|Physician Decision|1
3019192|NCT00810810|10384767|P2|Overall Study|Physician Decision|3
3019193|NCT00810810|10384768|P1|Overall Study|Physician Decision|0
3019194|NCT00810810|10384765|P4|Overall Study|Withdrawal by Subject|8
3019195|NCT00810810|10384766|P3|Overall Study|Withdrawal by Subject|10
3019196|NCT00810810|10384767|P2|Overall Study|Withdrawal by Subject|8
3019197|NCT00810810|10384768|P1|Overall Study|Withdrawal by Subject|0
3019198|NCT00810693|10384816|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
3019199|NCT00810693|10384817|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
3019200|NCT00810693|10384818|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
3019201|NCT00810693|10384816|P3|Follow-up Period (FUP)|Protocol Violation|0
3019202|NCT00810693|10384817|P2|Follow-up Period (FUP)|Protocol Violation|1
3019203|NCT00810693|10384818|P1|Follow-up Period (FUP)|Protocol Violation|0
3019204|NCT00810693|10384816|P3|Follow-up Period (FUP)|Lost to Follow-up|2
3019205|NCT00810693|10384817|P2|Follow-up Period (FUP)|Lost to Follow-up|0
3019206|NCT00810693|10384818|P1|Follow-up Period (FUP)|Lost to Follow-up|1
3019207|NCT00810693|10384816|P3|Follow-up Period (FUP)|Death|1
3019208|NCT00810693|10384817|P2|Follow-up Period (FUP)|Death|0
3019209|NCT00810693|10384818|P1|Follow-up Period (FUP)|Death|2
3019210|NCT00810693|10384816|P3|Follow-up Period (FUP)|Adverse Event|1
3019211|NCT00810693|10384817|P2|Follow-up Period (FUP)|Adverse Event|1
3019212|NCT00810693|10384818|P1|Follow-up Period (FUP)|Adverse Event|3
3019213|NCT00810693|10384816|P3|Treatment Period|Not treated|1
3019214|NCT00810693|10384817|P2|Treatment Period|Not treated|1
3019215|NCT00810693|10384818|P1|Treatment Period|Not treated|0
3019216|NCT00810693|10384816|P3|Treatment Period|Withdrawal by Subject|3
3019217|NCT00810693|10384817|P2|Treatment Period|Withdrawal by Subject|2
3019218|NCT00810693|10384818|P1|Treatment Period|Withdrawal by Subject|6
3019219|NCT00810693|10384816|P3|Treatment Period|Protocol Violation|2
3019220|NCT00810693|10384817|P2|Treatment Period|Protocol Violation|2
3019221|NCT00810693|10384818|P1|Treatment Period|Protocol Violation|1
3019222|NCT00810693|10384816|P3|Treatment Period|Non-compliance|0
3019223|NCT00810693|10384817|P2|Treatment Period|Non-compliance|0
3019224|NCT00810693|10384818|P1|Treatment Period|Non-compliance|1
3019225|NCT00810693|10384816|P3|Treatment Period|Lost to Follow-up|0
3019226|NCT00810693|10384817|P2|Treatment Period|Lost to Follow-up|0
3019227|NCT00810693|10384818|P1|Treatment Period|Lost to Follow-up|1
3019228|NCT00810693|10384816|P3|Treatment Period|Lack of Efficacy|1
3019229|NCT00810693|10384817|P2|Treatment Period|Lack of Efficacy|0
3019230|NCT00810693|10384818|P1|Treatment Period|Lack of Efficacy|0
3019231|NCT00810693|10384816|P3|Treatment Period|Death|2
3019232|NCT00810693|10384817|P2|Treatment Period|Death|1
3019233|NCT00810693|10384818|P1|Treatment Period|Death|0
3019234|NCT00810693|10384816|P3|Treatment Period|Adverse Event|7
3019235|NCT00810693|10384817|P2|Treatment Period|Adverse Event|1
3019236|NCT00810693|10384818|P1|Treatment Period|Adverse Event|8
3019237|NCT00810641|10384850|P3|Overall Study|Withdrawal by Subject|2
3019238|NCT00810641|10384851|P2|Overall Study|Withdrawal by Subject|1
3019239|NCT00810641|10384852|P1|Overall Study|Withdrawal by Subject|0
3019240|NCT00810615|10384862|P2|Overall Study|Withdrawal by Subject|1
3019241|NCT00810615|10384863|P1|Overall Study|Withdrawal by Subject|1
3019242|NCT00810602|10384913|P2|Overall Study|Withdrawal by Subject|3
3019243|NCT00810602|10384914|P1|Overall Study|Withdrawal by Subject|8
3019244|NCT00810511|10384927|P2|Overall Study|deposits on contact lens|1
3019245|NCT00810511|10384928|P1|Overall Study|deposits on contact lens|0
3019246|NCT00810511|10384927|P2|Overall Study|Lost to Follow-up|0
3019247|NCT00810511|10384928|P1|Overall Study|Lost to Follow-up|1
3019248|NCT00810511|10384927|P2|Overall Study|death in the family|1
3019249|NCT00810511|10384928|P1|Overall Study|death in the family|0
3019250|NCT00810511|10384927|P2|Overall Study|Lack of Efficacy|1
3019251|NCT00810511|10384928|P1|Overall Study|Lack of Efficacy|9
3019252|NCT00810511|10384927|P2|Overall Study|Protocol Violation|1
3019253|NCT00810511|10384928|P1|Overall Study|Protocol Violation|0
3019254|NCT00810407|10384946|P1|Overall Study|No Visit After First Day of Treatment|3
3019255|NCT00810407|10384946|P1|Overall Study|Protocol Violation|3
3019256|NCT00810394|10384958|P1|Overall Study|Withdrawal by Subject|3
3019257|NCT00810368|10384966|P2|Overall Study|Lack of Efficacy|0
3019258|NCT00810368|10384967|P1|Overall Study|Lack of Efficacy|2
3019259|NCT00810368|10384966|P2|Overall Study|Lost to Follow-up|2
3019260|NCT00810368|10384967|P1|Overall Study|Lost to Follow-up|4
3019261|NCT00810355|10384988|P3|Overall Study|Withdrawal by Subject|0
3019262|NCT00810355|10384989|P2|Overall Study|Withdrawal by Subject|0
3019263|NCT00810355|10384990|P1|Overall Study|Withdrawal by Subject|1
3019264|NCT00810355|10384988|P3|Overall Study|Lost to Follow-up|11
3019265|NCT00810355|10384989|P2|Overall Study|Lost to Follow-up|17
3019266|NCT00810355|10384990|P1|Overall Study|Lost to Follow-up|13
3019267|NCT00810342|10385006|P2|12-month Followup|Lost to Follow-up|1
3019268|NCT00810342|10385007|P1|12-month Followup|Lost to Follow-up|3
3019269|NCT00810342|10385006|P2|12-month Followup|Pregnancy|10
3019270|NCT00810342|10385007|P1|12-month Followup|Pregnancy|9
3019271|NCT00810342|10385006|P2|6-month Follow-up|Pregnancy|2
3019272|NCT00810342|10385007|P1|6-month Follow-up|Pregnancy|6
3019273|NCT00810342|10385006|P2|6-month Follow-up|Lost to Follow-up|6
3019274|NCT00810342|10385007|P1|6-month Follow-up|Lost to Follow-up|18
3019275|NCT00810342|10385006|P2|Month 1 Follow-up|Pregnancy|0
3019276|NCT00810342|10385007|P1|Month 1 Follow-up|Pregnancy|1
3019277|NCT00810342|10385006|P2|Month 1 Follow-up|Lost to Follow-up|2
3019278|NCT00810342|10385007|P1|Month 1 Follow-up|Lost to Follow-up|4
3019279|NCT00810277|10385040|P1|Overall Study|Adverse Event|1
3019280|NCT00810264|10385053|P1|Overall Study|Death|641
3019281|NCT00810264|10385053|P1|Overall Study|Withdrawal by subject or physician|721
3019282|NCT00810264|10385053|P1|Overall Study|Lost to Follow-up|191
3019283|NCT00810199|10385080|P2|Overall Study|Did not receive study drug|1
3019284|NCT00810199|10385081|P1|Overall Study|Did not receive study drug|2
3019285|NCT00810199|10385080|P2|Overall Study|Failure to return|4
3019286|NCT00810199|10385081|P1|Overall Study|Failure to return|1
3019287|NCT00810199|10385080|P2|Overall Study|Protocol Violation|6
3019288|NCT00810199|10385081|P1|Overall Study|Protocol Violation|2
3019289|NCT00810199|10385080|P2|Overall Study|Administrative/Other|6
3019290|NCT00810199|10385081|P1|Overall Study|Administrative/Other|5
3019291|NCT00810199|10385080|P2|Overall Study|Refused treatment/Did not cooperate|7
3019292|NCT00810199|10385081|P1|Overall Study|Refused treatment/Did not cooperate|7
3019293|NCT00810199|10385080|P2|Overall Study|Insufficient therapeutic response|14
3019294|NCT00810199|10385081|P1|Overall Study|Insufficient therapeutic response|5
3019295|NCT00810199|10385080|P2|Overall Study|Withdrew consent|12
3019296|NCT00810199|10385081|P1|Overall Study|Withdrew consent|9
3019297|NCT00810199|10385080|P2|Overall Study|Death|6
3019298|NCT00810199|10385081|P1|Overall Study|Death|4
3019299|NCT00810199|10385080|P2|Overall Study|Adverse Event|26
3019300|NCT00810199|10385081|P1|Overall Study|Adverse Event|24
3019301|NCT00810108|10385159|P2|Overall Study|Withdrawal by Subject|0
3019302|NCT00810108|10385160|P1|Overall Study|Withdrawal by Subject|1
3019303|NCT00810082|10385174|P2|Overall Study|Lost to Follow-up|4
3019304|NCT00810082|10385175|P1|Overall Study|Lost to Follow-up|0
3019305|NCT00810069|10385183|P3|Double-Blind Period II|Protocol Violation|6
3019306|NCT00810069|10385184|P2|Double-Blind Period II|Protocol Violation|7
3019307|NCT00810069|10385185|P1|Double-Blind Period II|Protocol Violation|0
3019308|NCT00810069|10385183|P3|Double-Blind Period II|Clinical relapse|0
3019309|NCT00810069|10385184|P2|Double-Blind Period II|Clinical relapse|3
3019310|NCT00810069|10385185|P1|Double-Blind Period II|Clinical relapse|0
3019311|NCT00810069|10385183|P3|Double-Blind Period II|Protocol entry criterion not met|1
3019312|NCT00810069|10385184|P2|Double-Blind Period II|Protocol entry criterion not met|0
3019313|NCT00810069|10385185|P1|Double-Blind Period II|Protocol entry criterion not met|0
3019314|NCT00810069|10385183|P3|Double-Blind Period II|Withdrawal by Subject|35
3019315|NCT00810069|10385184|P2|Double-Blind Period II|Withdrawal by Subject|21
3019316|NCT00810069|10385185|P1|Double-Blind Period II|Withdrawal by Subject|0
3019317|NCT00810069|10385183|P3|Double-Blind Period II|Physician Decision|1
3019318|NCT00810069|10385184|P2|Double-Blind Period II|Physician Decision|0
3019319|NCT00810069|10385185|P1|Double-Blind Period II|Physician Decision|0
3019320|NCT00810069|10385183|P3|Double-Blind Period II|Lost to Follow-up|9
3019321|NCT00810069|10385184|P2|Double-Blind Period II|Lost to Follow-up|9
3019322|NCT00810069|10385185|P1|Double-Blind Period II|Lost to Follow-up|0
3019323|NCT00810069|10385183|P3|Double-Blind Period II|Lack of Efficacy|12
3019324|NCT00810069|10385184|P2|Double-Blind Period II|Lack of Efficacy|7
3019325|NCT00810069|10385185|P1|Double-Blind Period II|Lack of Efficacy|0
3019326|NCT00810069|10385183|P3|Double-Blind Period II|Adverse Event|8
3019327|NCT00810069|10385184|P2|Double-Blind Period II|Adverse Event|9
3019328|NCT00810069|10385185|P1|Double-Blind Period II|Adverse Event|0
3019329|NCT00810069|10385183|P3|Lead-in Period I|Randomization criteria not met|0
3019330|NCT00810069|10385184|P2|Lead-in Period I|Randomization criteria not met|0
3019331|NCT00810069|10385185|P1|Lead-in Period I|Randomization criteria not met|158
3019332|NCT00810069|10385183|P3|Lead-in Period I|Protocol entry criterion not met|0
3019333|NCT00810069|10385184|P2|Lead-in Period I|Protocol entry criterion not met|0
3019334|NCT00810069|10385185|P1|Lead-in Period I|Protocol entry criterion not met|5
3019335|NCT00810069|10385183|P3|Lead-in Period I|Withdrawal by Subject|0
3019336|NCT00810069|10385184|P2|Lead-in Period I|Withdrawal by Subject|0
3019337|NCT00810069|10385185|P1|Lead-in Period I|Withdrawal by Subject|46
3019338|NCT00810069|10385183|P3|Lead-in Period I|Protocol Violation|0
3019339|NCT00810069|10385184|P2|Lead-in Period I|Protocol Violation|0
3019340|NCT00810069|10385185|P1|Lead-in Period I|Protocol Violation|1
3019341|NCT00810069|10385183|P3|Lead-in Period I|Physician Decision|0
3019342|NCT00810069|10385184|P2|Lead-in Period I|Physician Decision|0
3019343|NCT00810069|10385185|P1|Lead-in Period I|Physician Decision|1
3019344|NCT00810069|10385183|P3|Lead-in Period I|Lost to Follow-up|0
3019345|NCT00810069|10385184|P2|Lead-in Period I|Lost to Follow-up|0
3019346|NCT00810069|10385185|P1|Lead-in Period I|Lost to Follow-up|19
3019347|NCT00810069|10385183|P3|Lead-in Period I|Lack of Efficacy|0
3019348|NCT00810069|10385184|P2|Lead-in Period I|Lack of Efficacy|0
3019349|NCT00810069|10385185|P1|Lead-in Period I|Lack of Efficacy|1
3019350|NCT00810069|10385183|P3|Lead-in Period I|Adverse Event|0
3019351|NCT00810069|10385184|P2|Lead-in Period I|Adverse Event|0
3019352|NCT00810069|10385185|P1|Lead-in Period I|Adverse Event|43
3019353|NCT00810043|10385230|P3|Overall Study|No longer met enrollment criteria|3
3019354|NCT00810043|10385231|P2|Overall Study|No longer met enrollment criteria|0
3019355|NCT00810043|10385232|P1|Overall Study|No longer met enrollment criteria|0
3019356|NCT00810043|10385230|P3|Overall Study|Non-medical problem|1
3019357|NCT00810043|10385231|P2|Overall Study|Non-medical problem|0
3019358|NCT00810043|10385232|P1|Overall Study|Non-medical problem|0
3019359|NCT00810043|10385230|P3|Overall Study|Unrelated medical problem|0
3019360|NCT00810043|10385231|P2|Overall Study|Unrelated medical problem|1
3019361|NCT00810043|10385232|P1|Overall Study|Unrelated medical problem|0
3019362|NCT00810043|10385230|P3|Overall Study|Death|0
3019363|NCT00810043|10385231|P2|Overall Study|Death|0
3019364|NCT00810043|10385232|P1|Overall Study|Death|2
3019365|NCT00810043|10385230|P3|Overall Study|Physician Decision|2
3019366|NCT00810043|10385231|P2|Overall Study|Physician Decision|0
3019367|NCT00810043|10385232|P1|Overall Study|Physician Decision|0
3019368|NCT00810043|10385230|P3|Overall Study|Lost to Follow-up|0
3019369|NCT00810043|10385231|P2|Overall Study|Lost to Follow-up|0
3019370|NCT00810043|10385232|P1|Overall Study|Lost to Follow-up|1
3019371|NCT00810043|10385230|P3|Overall Study|Withdrawal by Subject|2
3019372|NCT00810043|10385231|P2|Overall Study|Withdrawal by Subject|0
3019373|NCT00810043|10385232|P1|Overall Study|Withdrawal by Subject|1
3019374|NCT00809965|10385254|P3|Overall Study|Other Reason|189
3019375|NCT00809965|10385255|P2|Overall Study|Other Reason|170
3019376|NCT00809965|10385256|P1|Overall Study|Other Reason|167
3019377|NCT00809965|10385254|P3|Overall Study|Withdrawal by Subject|441
3019378|NCT00809965|10385255|P2|Overall Study|Withdrawal by Subject|448
3019379|NCT00809965|10385256|P1|Overall Study|Withdrawal by Subject|405
3019380|NCT00809965|10385254|P3|Overall Study|Lost to Follow-up|18
3019381|NCT00809965|10385255|P2|Overall Study|Lost to Follow-up|10
3019382|NCT00809965|10385256|P1|Overall Study|Lost to Follow-up|17
3019383|NCT00809965|10385254|P3|Overall Study|Death|196
3019384|NCT00809965|10385255|P2|Overall Study|Death|147
3019385|NCT00809965|10385256|P1|Overall Study|Death|194
3019386|NCT00809926|10385278|P2|Overall Study|Protocol deviation|2
3019387|NCT00809926|10385279|P1|Overall Study|Protocol deviation|0
3019388|NCT00809926|10385278|P2|Overall Study|Administrative Problems|1
3019389|NCT00809926|10385279|P1|Overall Study|Administrative Problems|0
3019390|NCT00809926|10385278|P2|Overall Study|Lost to Follow-up|1
3019391|NCT00809926|10385279|P1|Overall Study|Lost to Follow-up|2
3019392|NCT00809926|10385278|P2|Overall Study|Patient withdrew consent|6
3019393|NCT00809926|10385279|P1|Overall Study|Patient withdrew consent|8
3019394|NCT00809926|10385278|P2|Overall Study|Unsatisfactory therapeutic effect|3
3019395|NCT00809926|10385279|P1|Overall Study|Unsatisfactory therapeutic effect|3
3019396|NCT00809926|10385278|P2|Overall Study|Adverse Event|10
3019397|NCT00809926|10385279|P1|Overall Study|Adverse Event|18
3019398|NCT00809835|10385333|P4|Overall Study|Withdrawal by Subject|0
3019399|NCT00809835|10385334|P3|Overall Study|Withdrawal by Subject|1
3019400|NCT00809835|10385335|P2|Overall Study|Withdrawal by Subject|1
3019401|NCT00809835|10385336|P1|Overall Study|Withdrawal by Subject|1
3019402|NCT00809835|10385333|P4|Overall Study|Lost to Follow-up|2
3019403|NCT00809835|10385334|P3|Overall Study|Lost to Follow-up|10
3019404|NCT00809835|10385335|P2|Overall Study|Lost to Follow-up|6
3019405|NCT00809835|10385336|P1|Overall Study|Lost to Follow-up|7
3019406|NCT00809757|10385366|P3|Overall Study|Noncompliance with Medication|1
3019407|NCT00809757|10385367|P2|Overall Study|Noncompliance with Medication|0
3019408|NCT00809757|10385368|P1|Overall Study|Noncompliance with Medication|0
3019409|NCT00809757|10385366|P3|Overall Study|Subject Uncooperative|2
3019410|NCT00809757|10385367|P2|Overall Study|Subject Uncooperative|0
3019411|NCT00809757|10385368|P1|Overall Study|Subject Uncooperative|1
3019412|NCT00809757|10385366|P3|Overall Study|Withdrawal by Subject|3
3019413|NCT00809757|10385367|P2|Overall Study|Withdrawal by Subject|1
3019414|NCT00809757|10385368|P1|Overall Study|Withdrawal by Subject|2
3019415|NCT00809757|10385366|P3|Overall Study|Protocol Violation|1
3019416|NCT00809757|10385367|P2|Overall Study|Protocol Violation|1
3019417|NCT00809757|10385368|P1|Overall Study|Protocol Violation|1
3019418|NCT00809757|10385366|P3|Overall Study|Lost to Follow-up|1
3019419|NCT00809757|10385367|P2|Overall Study|Lost to Follow-up|0
3019420|NCT00809757|10385368|P1|Overall Study|Lost to Follow-up|0
3019421|NCT00809757|10385366|P3|Overall Study|Adverse Event|3
3019422|NCT00809757|10385367|P2|Overall Study|Adverse Event|3
3019423|NCT00809757|10385368|P1|Overall Study|Adverse Event|2
3019424|NCT00809614|10385453|P2|Overall Study|Withdrawal by Subject|1
3019425|NCT00809614|10385454|P1|Overall Study|Withdrawal by Subject|1
3019426|NCT00809614|10385453|P2|Overall Study|Lack of Efficacy|3
3019427|NCT00809614|10385454|P1|Overall Study|Lack of Efficacy|2
3019428|NCT00809471|10385498|P3|Overall Study|Requirement for restricted medication|0
3019429|NCT00809471|10385499|P2|Overall Study|Requirement for restricted medication|1
3019430|NCT00809471|10385500|P1|Overall Study|Requirement for restricted medication|1
3019431|NCT00809471|10385498|P3|Overall Study|Adverse Event|2
3019432|NCT00809471|10385499|P2|Overall Study|Adverse Event|2
3019433|NCT00809471|10385500|P1|Overall Study|Adverse Event|0
3019434|NCT00809471|10385498|P3|Overall Study|Lost to Follow-up|9
3019435|NCT00809471|10385499|P2|Overall Study|Lost to Follow-up|2
3019436|NCT00809471|10385500|P1|Overall Study|Lost to Follow-up|4
3019437|NCT00809471|10385498|P3|Overall Study|Protocol non-compliance|6
3019438|NCT00809471|10385499|P2|Overall Study|Protocol non-compliance|15
3019439|NCT00809471|10385500|P1|Overall Study|Protocol non-compliance|15
3019440|NCT00809445|10385530|P3|6 Month Follow-up|Withdrew consent|1
3019441|NCT00809445|10385531|P2|6 Month Follow-up|Withdrew consent|0
3019442|NCT00809445|10385532|P1|6 Month Follow-up|Withdrew consent|0
3019443|NCT00809445|10385530|P3|6 Month Follow-up|Incarcerated|8
3019444|NCT00809445|10385531|P2|6 Month Follow-up|Incarcerated|8
3019445|NCT00809445|10385532|P1|6 Month Follow-up|Incarcerated|6
3019446|NCT00809445|10385530|P3|6 Month Follow-up|Death|1
3019447|NCT00809445|10385531|P2|6 Month Follow-up|Death|1
3019448|NCT00809445|10385532|P1|6 Month Follow-up|Death|2
3019449|NCT00809445|10385530|P3|6 Month Follow-up|Lost contact|14
3019450|NCT00809445|10385531|P2|6 Month Follow-up|Lost contact|14
3019451|NCT00809445|10385532|P1|6 Month Follow-up|Lost contact|16
3019452|NCT00809445|10385530|P3|1 Month Follow-up|Incarcerated|1
3019453|NCT00809445|10385531|P2|1 Month Follow-up|Incarcerated|0
3019454|NCT00809445|10385532|P1|1 Month Follow-up|Incarcerated|0
3019455|NCT00809445|10385530|P3|1 Month Follow-up|Death|1
3019456|NCT00809445|10385531|P2|1 Month Follow-up|Death|1
3019457|NCT00809445|10385532|P1|1 Month Follow-up|Death|0
3019458|NCT00809445|10385530|P3|1 Month Follow-up|Withdrew consent|1
3019459|NCT00809445|10385531|P2|1 Month Follow-up|Withdrew consent|1
3019460|NCT00809445|10385532|P1|1 Month Follow-up|Withdrew consent|1
3019461|NCT00809445|10385530|P3|1 Month Follow-up|Lost contact|1
3019462|NCT00809445|10385531|P2|1 Month Follow-up|Lost contact|2
3019463|NCT00809445|10385532|P1|1 Month Follow-up|Lost contact|1
3019464|NCT00809341|10385551|P2|Overall Study|Physician Decision|1
3019465|NCT00809341|10385552|P1|Overall Study|Physician Decision|0
3019466|NCT00809328|10385560|P1|Overall Study|Withdrawal by Subject|2
3019467|NCT00809328|10385560|P1|Overall Study|Protocol Violation|3
3019468|NCT00809328|10385560|P1|Overall Study|Adverse Event|6
3019469|NCT00809328|10385560|P1|Overall Study|Lack of Efficacy|18
3019470|NCT00809159|10385582|P6|Part 1 and 2|Withdrawal by Subject|1
3019471|NCT00809159|10385583|P5|Part 1 and 2|Withdrawal by Subject|0
3019472|NCT00809159|10385584|P4|Part 1 and 2|Withdrawal by Subject|0
3019473|NCT00809159|10385585|P3|Part 1 and 2|Withdrawal by Subject|4
3019474|NCT00809159|10385586|P2|Part 1 and 2|Withdrawal by Subject|0
3019475|NCT00809159|10385587|P1|Part 1 and 2|Withdrawal by Subject|0
3019476|NCT00809159|10385582|P6|Part 1 and 2|Lost to Follow-up|0
3019477|NCT00809159|10385583|P5|Part 1 and 2|Lost to Follow-up|0
3019478|NCT00809159|10385584|P4|Part 1 and 2|Lost to Follow-up|1
3019479|NCT00809159|10385585|P3|Part 1 and 2|Lost to Follow-up|1
3019480|NCT00809159|10385586|P2|Part 1 and 2|Lost to Follow-up|0
3019481|NCT00809159|10385587|P1|Part 1 and 2|Lost to Follow-up|0
3019482|NCT00809159|10385582|P6|Part 1 and 2|Adverse Event|1
3019483|NCT00809159|10385583|P5|Part 1 and 2|Adverse Event|1
3019484|NCT00809159|10385584|P4|Part 1 and 2|Adverse Event|0
3019485|NCT00809159|10385585|P3|Part 1 and 2|Adverse Event|1
3019486|NCT00809159|10385586|P2|Part 1 and 2|Adverse Event|0
3019487|NCT00809159|10385587|P1|Part 1 and 2|Adverse Event|0
3019488|NCT00809159|10385582|P6|Part 1 and 2|Administrative problems|0
3019489|NCT00809159|10385583|P5|Part 1 and 2|Administrative problems|0
3019490|NCT00809159|10385584|P4|Part 1 and 2|Administrative problems|1
3019491|NCT00809159|10385585|P3|Part 1 and 2|Administrative problems|0
3019492|NCT00809159|10385586|P2|Part 1 and 2|Administrative problems|0
3019493|NCT00809159|10385587|P1|Part 1 and 2|Administrative problems|0
3019494|NCT00809159|10385582|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
3019495|NCT00809159|10385583|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
3019496|NCT00809159|10385584|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
3019497|NCT00809159|10385585|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
3019498|NCT00809159|10385586|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
3019499|NCT00809159|10385587|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
3019500|NCT00809159|10385582|P6|Part 1|Unsatisfactory therapeutic effect|0
3019501|NCT00809159|10385583|P5|Part 1|Unsatisfactory therapeutic effect|0
3019502|NCT00809159|10385584|P4|Part 1|Unsatisfactory therapeutic effect|0
3019503|NCT00809159|10385585|P3|Part 1|Unsatisfactory therapeutic effect|0
3019504|NCT00809159|10385586|P2|Part 1|Unsatisfactory therapeutic effect|1
3019505|NCT00809159|10385587|P1|Part 1|Unsatisfactory therapeutic effect|3
3019506|NCT00809159|10385582|P6|Part 1|Withdrawal by Subject|0
3019507|NCT00809159|10385583|P5|Part 1|Withdrawal by Subject|0
3019508|NCT00809159|10385584|P4|Part 1|Withdrawal by Subject|0
3019509|NCT00809159|10385585|P3|Part 1|Withdrawal by Subject|0
3019510|NCT00809159|10385586|P2|Part 1|Withdrawal by Subject|1
3019511|NCT00809159|10385587|P1|Part 1|Withdrawal by Subject|3
3019512|NCT00809159|10385582|P6|Part 1|Lost to Follow-up|0
3019513|NCT00809159|10385583|P5|Part 1|Lost to Follow-up|0
3019514|NCT00809159|10385584|P4|Part 1|Lost to Follow-up|0
3019515|NCT00809159|10385585|P3|Part 1|Lost to Follow-up|0
3019516|NCT00809159|10385586|P2|Part 1|Lost to Follow-up|0
3019517|NCT00809159|10385587|P1|Part 1|Lost to Follow-up|1
3019518|NCT00809159|10385582|P6|Part 1|Adverse Event|0
3019519|NCT00809159|10385583|P5|Part 1|Adverse Event|0
3019520|NCT00809159|10385584|P4|Part 1|Adverse Event|0
3019521|NCT00809159|10385585|P3|Part 1|Adverse Event|0
3019522|NCT00809159|10385586|P2|Part 1|Adverse Event|1
3019523|NCT00809159|10385587|P1|Part 1|Adverse Event|1
3019524|NCT00809133|10385692|P14|Overall Study|Other not mentioned above|0
3019525|NCT00809133|10385693|P13|Overall Study|Other not mentioned above|0
3019526|NCT00809133|10385694|P12|Overall Study|Other not mentioned above|0
3019527|NCT00809133|10385695|P11|Overall Study|Other not mentioned above|0
3019528|NCT00809133|10385696|P10|Overall Study|Other not mentioned above|0
3019529|NCT00809133|10385697|P9|Overall Study|Other not mentioned above|0
3019530|NCT00809133|10385698|P8|Overall Study|Other not mentioned above|0
3019531|NCT00809133|10385699|P7|Overall Study|Other not mentioned above|0
3019532|NCT00809133|10385700|P6|Overall Study|Other not mentioned above|1
3019533|NCT00809133|10385701|P5|Overall Study|Other not mentioned above|0
3019534|NCT00809133|10385702|P4|Overall Study|Other not mentioned above|0
3019535|NCT00809133|10385703|P3|Overall Study|Other not mentioned above|0
3019536|NCT00809133|10385704|P2|Overall Study|Other not mentioned above|1
3019537|NCT00809133|10385705|P1|Overall Study|Other not mentioned above|0
3019538|NCT00809133|10385692|P14|Overall Study|Consent withdrawn|0
3019539|NCT00809133|10385693|P13|Overall Study|Consent withdrawn|0
3019540|NCT00809133|10385694|P12|Overall Study|Consent withdrawn|0
3019541|NCT00809133|10385695|P11|Overall Study|Consent withdrawn|0
3019542|NCT00809133|10385696|P10|Overall Study|Consent withdrawn|0
3019543|NCT00809133|10385697|P9|Overall Study|Consent withdrawn|0
3019544|NCT00809133|10385698|P8|Overall Study|Consent withdrawn|0
3019545|NCT00809133|10385699|P7|Overall Study|Consent withdrawn|0
3019546|NCT00809133|10385700|P6|Overall Study|Consent withdrawn|0
3019547|NCT00809133|10385701|P5|Overall Study|Consent withdrawn|1
3019548|NCT00809133|10385702|P4|Overall Study|Consent withdrawn|0
3019549|NCT00809133|10385703|P3|Overall Study|Consent withdrawn|0
3019550|NCT00809133|10385704|P2|Overall Study|Consent withdrawn|0
3019551|NCT00809133|10385705|P1|Overall Study|Consent withdrawn|0
3019552|NCT00809133|10385692|P14|Overall Study|Lost to Follow-up|0
3019553|NCT00809133|10385693|P13|Overall Study|Lost to Follow-up|0
3019554|NCT00809133|10385694|P12|Overall Study|Lost to Follow-up|0
3019555|NCT00809133|10385695|P11|Overall Study|Lost to Follow-up|0
3019556|NCT00809133|10385696|P10|Overall Study|Lost to Follow-up|0
3019557|NCT00809133|10385697|P9|Overall Study|Lost to Follow-up|0
3019558|NCT00809133|10385698|P8|Overall Study|Lost to Follow-up|0
3019559|NCT00809133|10385699|P7|Overall Study|Lost to Follow-up|0
3019560|NCT00809133|10385700|P6|Overall Study|Lost to Follow-up|1
3019561|NCT00809133|10385701|P5|Overall Study|Lost to Follow-up|0
3019562|NCT00809133|10385702|P4|Overall Study|Lost to Follow-up|0
3019563|NCT00809133|10385703|P3|Overall Study|Lost to Follow-up|0
3019564|NCT00809133|10385704|P2|Overall Study|Lost to Follow-up|0
3019565|NCT00809133|10385705|P1|Overall Study|Lost to Follow-up|0
3019566|NCT00809133|10385692|P14|Overall Study|Other adverse event|1
3019567|NCT00809133|10385693|P13|Overall Study|Other adverse event|0
3019568|NCT00809133|10385694|P12|Overall Study|Other adverse event|1
3019569|NCT00809133|10385695|P11|Overall Study|Other adverse event|1
3019570|NCT00809133|10385696|P10|Overall Study|Other adverse event|0
3019571|NCT00809133|10385697|P9|Overall Study|Other adverse event|0
3019572|NCT00809133|10385698|P8|Overall Study|Other adverse event|4
3019573|NCT00809133|10385699|P7|Overall Study|Other adverse event|2
3019574|NCT00809133|10385700|P6|Overall Study|Other adverse event|3
3019575|NCT00809133|10385701|P5|Overall Study|Other adverse event|0
3019576|NCT00809133|10385702|P4|Overall Study|Other adverse event|0
3019577|NCT00809133|10385703|P3|Overall Study|Other adverse event|1
3019578|NCT00809133|10385704|P2|Overall Study|Other adverse event|1
3019579|NCT00809133|10385705|P1|Overall Study|Other adverse event|1
3019580|NCT00809133|10385692|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
3019581|NCT00809133|10385693|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
3019582|NCT00809133|10385694|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
3019583|NCT00809133|10385695|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
3019584|NCT00809133|10385696|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
3019585|NCT00809133|10385697|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
3019586|NCT00809133|10385698|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
3019587|NCT00809133|10385699|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
3019588|NCT00809133|10385700|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
3019589|NCT00809133|10385701|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
3019590|NCT00809133|10385702|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
3019591|NCT00809133|10385703|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
3019592|NCT00809133|10385704|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
3019593|NCT00809133|10385705|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
3019594|NCT00809133|10385692|P14|Overall Study|Progressive disease|4
3019595|NCT00809133|10385693|P13|Overall Study|Progressive disease|5
3019596|NCT00809133|10385694|P12|Overall Study|Progressive disease|7
3019597|NCT00809133|10385695|P11|Overall Study|Progressive disease|5
3019598|NCT00809133|10385696|P10|Overall Study|Progressive disease|9
3019599|NCT00809133|10385697|P9|Overall Study|Progressive disease|3
3019600|NCT00809133|10385698|P8|Overall Study|Progressive disease|3
3019601|NCT00809133|10385699|P7|Overall Study|Progressive disease|3
3019602|NCT00809133|10385700|P6|Overall Study|Progressive disease|1
3019603|NCT00809133|10385701|P5|Overall Study|Progressive disease|4
3019604|NCT00809133|10385702|P4|Overall Study|Progressive disease|3
3019605|NCT00809133|10385703|P3|Overall Study|Progressive disease|5
3019606|NCT00809133|10385704|P2|Overall Study|Progressive disease|5
3019607|NCT00809133|10385705|P1|Overall Study|Progressive disease|2
3019608|NCT00809094|10385859|P2|Overall Study|Lost to Follow-up|1
3019609|NCT00809094|10385860|P1|Overall Study|Lost to Follow-up|0
3019610|NCT00808899|10385905|P1|Overall Study|Physician Decision|3
3019611|NCT00808899|10385905|P1|Overall Study|Death|1
3019612|NCT00808808|10385919|P3|Overall Study|Employee was not vaccinated.|2255
3019613|NCT00808808|10385920|P2|Overall Study|Employee was not vaccinated.|2268
3019614|NCT00808808|10385921|P1|Overall Study|Employee was not vaccinated.|2686
3019615|NCT00808808|10385919|P3|Overall Study|Vaccinated; survey not completed|302
3019616|NCT00808808|10385920|P2|Overall Study|Vaccinated; survey not completed|169
3019617|NCT00808808|10385921|P1|Overall Study|Vaccinated; survey not completed|131
3019618|NCT00808665|10385956|P2|Overall Study|Medication stopped by resident|1
3019619|NCT00808665|10385957|P1|Overall Study|Medication stopped by resident|0
3019620|NCT00808665|10385956|P2|Overall Study|Physician Decision|1
3019621|NCT00808665|10385957|P1|Overall Study|Physician Decision|3
3019622|NCT00808665|10385956|P2|Overall Study|required an additional procedure|1
3019623|NCT00808665|10385957|P1|Overall Study|required an additional procedure|0
3019624|NCT00808665|10385956|P2|Overall Study|surgery cancelled|0
3019625|NCT00808665|10385957|P1|Overall Study|surgery cancelled|1
3019626|NCT00808665|10385956|P2|Overall Study|only required minimally invasive surgery|0
3019627|NCT00808665|10385957|P1|Overall Study|only required minimally invasive surgery|1
3019628|NCT00808665|10385956|P2|Overall Study|Withdrawal by Subject|0
3019629|NCT00808665|10385957|P1|Overall Study|Withdrawal by Subject|1
3019630|NCT00808639|10385963|P1|Overall Study|Disease progression before surgery.|1
3019631|NCT00808509|10385971|P2|Randomized Phase|Patient refused rescue therapy|3
3019632|NCT00808509|10385972|P1|Randomized Phase|Patient refused rescue therapy|0
3019633|NCT00808509|10385971|P2|Randomized Phase|Reduced methotrexate dose|2
3019634|NCT00808509|10385972|P1|Randomized Phase|Reduced methotrexate dose|1
3019635|NCT00808509|10385971|P2|Randomized Phase|Did not meet eligibility criteria|0
3019636|NCT00808509|10385972|P1|Randomized Phase|Did not meet eligibility criteria|1
3019637|NCT00808483|10386070|P2|From 5 Months to 12 Months|Lack of Efficacy|0
3019638|NCT00808483|10386071|P1|From 5 Months to 12 Months|Lack of Efficacy|1
3019639|NCT00808483|10386070|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
3019640|NCT00808483|10386071|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
3019641|NCT00808483|10386070|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
3019642|NCT00808483|10386071|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
3019643|NCT00808444|10386108|P2|Overall Study|Lost to Follow-up|1
3019644|NCT00808444|10386109|P1|Overall Study|Lost to Follow-up|0
3019645|NCT00808444|10386108|P2|Overall Study|Withdrawal by Subject|0
3019646|NCT00808444|10386109|P1|Overall Study|Withdrawal by Subject|1
3019647|NCT00808249|10386184|P4|Overall Study|All other reasons|1
3019648|NCT00808249|10386185|P3|Overall Study|All other reasons|3
3019649|NCT00808249|10386186|P2|Overall Study|All other reasons|1
3019650|NCT00808249|10386187|P1|Overall Study|All other reasons|2
3019651|NCT00808249|10386184|P4|Overall Study|study specific discontinuation criteria|0
3019652|NCT00808249|10386185|P3|Overall Study|study specific discontinuation criteria|1
3019653|NCT00808249|10386186|P2|Overall Study|study specific discontinuation criteria|0
3019654|NCT00808249|10386187|P1|Overall Study|study specific discontinuation criteria|1
3019655|NCT00808249|10386184|P4|Overall Study|Lack of Efficacy|0
3019656|NCT00808249|10386185|P3|Overall Study|Lack of Efficacy|0
3019657|NCT00808249|10386186|P2|Overall Study|Lack of Efficacy|1
3019658|NCT00808249|10386187|P1|Overall Study|Lack of Efficacy|1
3019659|NCT00808249|10386184|P4|Overall Study|Protocol Violation|0
3019660|NCT00808249|10386185|P3|Overall Study|Protocol Violation|3
3019661|NCT00808249|10386186|P2|Overall Study|Protocol Violation|3
3019662|NCT00808249|10386187|P1|Overall Study|Protocol Violation|3
3019663|NCT00808249|10386184|P4|Overall Study|Withdrawal by Subject|4
3019664|NCT00808249|10386185|P3|Overall Study|Withdrawal by Subject|2
3019665|NCT00808249|10386186|P2|Overall Study|Withdrawal by Subject|0
3019666|NCT00808249|10386187|P1|Overall Study|Withdrawal by Subject|4
3019667|NCT00808249|10386184|P4|Overall Study|Lost to Follow-up|5
3019668|NCT00808249|10386185|P3|Overall Study|Lost to Follow-up|3
3019669|NCT00808249|10386186|P2|Overall Study|Lost to Follow-up|3
3019670|NCT00808249|10386187|P1|Overall Study|Lost to Follow-up|2
3019671|NCT00808249|10386184|P4|Overall Study|Adverse Event|6
3019672|NCT00808249|10386185|P3|Overall Study|Adverse Event|10
3019673|NCT00808249|10386186|P2|Overall Study|Adverse Event|7
3019674|NCT00808249|10386187|P1|Overall Study|Adverse Event|4
3019675|NCT00808236|10386215|P2|Overall Study|Death|30
3019676|NCT00808236|10386216|P1|Overall Study|Death|18
3019677|NCT00808236|10386215|P2|Overall Study|Physician Decision|1
3019678|NCT00808236|10386216|P1|Overall Study|Physician Decision|0
3019679|NCT00808236|10386215|P2|Overall Study|Lost to Follow-up|1
3019680|NCT00808236|10386216|P1|Overall Study|Lost to Follow-up|1
3019681|NCT00808236|10386215|P2|Overall Study|Pre-defined exclusion|3
3019682|NCT00808236|10386216|P1|Overall Study|Pre-defined exclusion|13
3019683|NCT00808236|10386215|P2|Overall Study|Was not resuscitated|56
3019684|NCT00808236|10386216|P1|Overall Study|Was not resuscitated|50
3019685|NCT00808132|10386249|P5|Overall Study|Unsatisfactory response|12
3019686|NCT00808132|10386250|P4|Overall Study|Unsatisfactory response|4
3019687|NCT00808132|10386251|P3|Overall Study|Unsatisfactory response|6
3019688|NCT00808132|10386252|P2|Overall Study|Unsatisfactory response|6
3019689|NCT00808132|10386253|P1|Overall Study|Unsatisfactory response|5
3019690|NCT00808132|10386249|P5|Overall Study|Randomized, but not treated|9
3019691|NCT00808132|10386250|P4|Overall Study|Randomized, but not treated|8
3019692|NCT00808132|10386251|P3|Overall Study|Randomized, but not treated|9
3019693|NCT00808132|10386252|P2|Overall Study|Randomized, but not treated|7
3019694|NCT00808132|10386253|P1|Overall Study|Randomized, but not treated|10
3019695|NCT00808132|10386249|P5|Overall Study|Other|15
3019696|NCT00808132|10386250|P4|Overall Study|Other|2
3019697|NCT00808132|10386251|P3|Overall Study|Other|6
3019698|NCT00808132|10386252|P2|Overall Study|Other|4
3019699|NCT00808132|10386253|P1|Overall Study|Other|6
3019700|NCT00808132|10386249|P5|Overall Study|Withdrawal by Subject|16
3019701|NCT00808132|10386250|P4|Overall Study|Withdrawal by Subject|7
3019702|NCT00808132|10386251|P3|Overall Study|Withdrawal by Subject|2
3019703|NCT00808132|10386252|P2|Overall Study|Withdrawal by Subject|18
3019704|NCT00808132|10386253|P1|Overall Study|Withdrawal by Subject|27
3019705|NCT00808132|10386249|P5|Overall Study|Protocol Violation|5
3019706|NCT00808132|10386250|P4|Overall Study|Protocol Violation|9
3019707|NCT00808132|10386251|P3|Overall Study|Protocol Violation|4
3019708|NCT00808132|10386252|P2|Overall Study|Protocol Violation|9
3019709|NCT00808132|10386253|P1|Overall Study|Protocol Violation|8
3019710|NCT00808132|10386249|P5|Overall Study|Lost to Follow-up|9
3019711|NCT00808132|10386250|P4|Overall Study|Lost to Follow-up|8
3019712|NCT00808132|10386251|P3|Overall Study|Lost to Follow-up|11
3019713|NCT00808132|10386252|P2|Overall Study|Lost to Follow-up|10
3019714|NCT00808132|10386253|P1|Overall Study|Lost to Follow-up|8
3019715|NCT00808132|10386249|P5|Overall Study|Physician Decision|0
3019716|NCT00808132|10386250|P4|Overall Study|Physician Decision|0
3019717|NCT00808132|10386251|P3|Overall Study|Physician Decision|0
3019718|NCT00808132|10386252|P2|Overall Study|Physician Decision|1
3019719|NCT00808132|10386253|P1|Overall Study|Physician Decision|0
3019720|NCT00808132|10386249|P5|Overall Study|Death|1
3019721|NCT00808132|10386250|P4|Overall Study|Death|0
3019722|NCT00808132|10386251|P3|Overall Study|Death|0
3019723|NCT00808132|10386252|P2|Overall Study|Death|0
3019724|NCT00808132|10386253|P1|Overall Study|Death|0
3019725|NCT00808132|10386249|P5|Overall Study|Adverse Event|33
3019726|NCT00808132|10386250|P4|Overall Study|Adverse Event|31
3019727|NCT00808132|10386251|P3|Overall Study|Adverse Event|16
3019728|NCT00808132|10386252|P2|Overall Study|Adverse Event|33
3019729|NCT00808132|10386253|P1|Overall Study|Adverse Event|34
3019730|NCT00808080|10386325|P1|Overall Study|Patients Became Ineligible for infusion|6
3019731|NCT00808067|10386332|P2|Overall Study|Excluded from analysis|19
3019732|NCT00808067|10386333|P1|Overall Study|Excluded from analysis|13
3019733|NCT00808067|10386332|P2|Overall Study|Other reason not defined above|5
3019734|NCT00808067|10386333|P1|Overall Study|Other reason not defined above|5
3019735|NCT00808067|10386332|P2|Overall Study|Site closed for cause|19
3019736|NCT00808067|10386333|P1|Overall Study|Site closed for cause|19
3019737|NCT00808067|10386332|P2|Overall Study|Patient elected|9
3019738|NCT00808067|10386333|P1|Overall Study|Patient elected|7
3019739|NCT00808067|10386332|P2|Overall Study|Protocol Violation|11
3019740|NCT00808067|10386333|P1|Overall Study|Protocol Violation|3
3019741|NCT00808067|10386332|P2|Overall Study|Physician Decision|38
3019742|NCT00808067|10386333|P1|Overall Study|Physician Decision|47
3019743|NCT00808067|10386332|P2|Overall Study|Site closed|3
3019744|NCT00808067|10386333|P1|Overall Study|Site closed|4
3019745|NCT00808067|10386332|P2|Overall Study|Withdrawal by Subject|25
3019746|NCT00808067|10386333|P1|Overall Study|Withdrawal by Subject|21
3019747|NCT00808067|10386332|P2|Overall Study|Procedure|7
3019748|NCT00808067|10386333|P1|Overall Study|Procedure|6
3019749|NCT00808067|10386332|P2|Overall Study|Death|1
3019750|NCT00808067|10386333|P1|Overall Study|Death|1
3019751|NCT00808067|10386332|P2|Overall Study|Missing|0
3019752|NCT00808067|10386333|P1|Overall Study|Missing|1
3019753|NCT00808067|10386332|P2|Overall Study|Patient refused to take study medication|76
3019754|NCT00808067|10386333|P1|Overall Study|Patient refused to take study medication|65
3019755|NCT00808067|10386332|P2|Overall Study|Elevated LFT results|3
3019756|NCT00808067|10386333|P1|Overall Study|Elevated LFT results|7
3019757|NCT00808067|10386332|P2|Overall Study|Reduced creatinine clearance|55
3019758|NCT00808067|10386333|P1|Overall Study|Reduced creatinine clearance|53
3019759|NCT00808067|10386332|P2|Overall Study|Hospitalization due to surgery|40
3019760|NCT00808067|10386333|P1|Overall Study|Hospitalization due to surgery|37
3019761|NCT00808067|10386332|P2|Overall Study|Hospitalization (not including surgery)|17
3019762|NCT00808067|10386333|P1|Overall Study|Hospitalization (not including surgery)|18
3019763|NCT00808067|10386332|P2|Overall Study|Adverse Event|121
3019764|NCT00808067|10386333|P1|Overall Study|Adverse Event|111
3019765|NCT00808067|10386332|P2|Overall Study|Outcome event - other|25
3019766|NCT00808067|10386333|P1|Overall Study|Outcome event - other|33
3019767|NCT00808067|10386332|P2|Overall Study|Major/minor bleed|44
3019768|NCT00808067|10386333|P1|Overall Study|Major/minor bleed|30
3019769|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
3019770|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
3019771|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
3019772|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
3019773|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Death|0
3019774|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Death|1
3019775|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Death|0
3019776|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Death|0
3019777|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
3019778|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
3019779|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
3019780|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
3019781|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Other|1
3019782|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Other|1
3019783|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Other|0
3019784|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Other|0
3019785|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
3019786|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
3019787|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
3019788|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
3019789|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
3019790|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
3019791|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
3019792|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
3019793|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
3019794|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
3019795|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
3019796|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
3019797|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
3019798|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
3019799|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
3019800|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
3019801|NCT00808028|10386369|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
3019802|NCT00808028|10386370|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
3019803|NCT00808028|10386371|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
3019804|NCT00808028|10386372|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
3019805|NCT00808028|10386369|P4|Stage 1 (6 Months)|Protocol Violation|1
3019806|NCT00808028|10386370|P3|Stage 1 (6 Months)|Protocol Violation|0
3019807|NCT00808028|10386371|P2|Stage 1 (6 Months)|Protocol Violation|0
3019808|NCT00808028|10386372|P1|Stage 1 (6 Months)|Protocol Violation|0
3019809|NCT00808028|10386369|P4|Stage 1 (6 Months)|Lost to Follow-up|0
3019810|NCT00808028|10386370|P3|Stage 1 (6 Months)|Lost to Follow-up|1
3019811|NCT00808028|10386371|P2|Stage 1 (6 Months)|Lost to Follow-up|0
3019812|NCT00808028|10386372|P1|Stage 1 (6 Months)|Lost to Follow-up|1
3019813|NCT00808028|10386369|P4|Stage 1 (6 Months)|Adverse Event|2
3019814|NCT00808028|10386370|P3|Stage 1 (6 Months)|Adverse Event|1
3019815|NCT00808028|10386371|P2|Stage 1 (6 Months)|Adverse Event|0
3019816|NCT00808028|10386372|P1|Stage 1 (6 Months)|Adverse Event|0
3019817|NCT00808028|10386369|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
3019818|NCT00808028|10386370|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
3019819|NCT00808028|10386371|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
3019820|NCT00808028|10386372|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
3019821|NCT00808028|10386369|P4|Stage 1 (6 Months)|Other|4
3019822|NCT00808028|10386370|P3|Stage 1 (6 Months)|Other|2
3019823|NCT00808028|10386371|P2|Stage 1 (6 Months)|Other|0
3019824|NCT00808028|10386372|P1|Stage 1 (6 Months)|Other|1
3019825|NCT00808028|10386369|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
3019826|NCT00808028|10386370|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
3019827|NCT00808028|10386371|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
3019828|NCT00808028|10386372|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
3019829|NCT00808015|10386408|P1|Overall Study|Enrolled but not treated|4
3019830|NCT00808015|10386408|P1|Overall Study|Other|25
3019831|NCT00808015|10386408|P1|Overall Study|Adverse Event|22
3019832|NCT00808015|10386408|P1|Overall Study|Participants not willing to participate|158
3019833|NCT00808015|10386408|P1|Overall Study|Lost to Follow-up|76
3019834|NCT00808015|10386408|P1|Overall Study|Lack of Efficacy|58
3019835|NCT00808015|10386408|P1|Overall Study|Death|1
3019836|NCT00807937|10386437|P4|Overall Study|All other reasons (not provided)|1
3019837|NCT00807937|10386438|P3|Overall Study|All other reasons (not provided)|0
3019838|NCT00807937|10386439|P2|Overall Study|All other reasons (not provided)|4
3019839|NCT00807937|10386440|P1|Overall Study|All other reasons (not provided)|2
3019840|NCT00807937|10386437|P4|Overall Study|Intake of prohibited medicine|0
3019841|NCT00807937|10386438|P3|Overall Study|Intake of prohibited medicine|2
3019842|NCT00807937|10386439|P2|Overall Study|Intake of prohibited medicine|0
3019843|NCT00807937|10386440|P1|Overall Study|Intake of prohibited medicine|0
3019844|NCT00807937|10386437|P4|Overall Study|Lack of Efficacy|2
3019845|NCT00807937|10386438|P3|Overall Study|Lack of Efficacy|1
3019846|NCT00807937|10386439|P2|Overall Study|Lack of Efficacy|0
3019847|NCT00807937|10386440|P1|Overall Study|Lack of Efficacy|0
3019848|NCT00807937|10386437|P4|Overall Study|Lost to Follow-up|1
3019849|NCT00807937|10386438|P3|Overall Study|Lost to Follow-up|2
3019850|NCT00807937|10386439|P2|Overall Study|Lost to Follow-up|0
3019851|NCT00807937|10386440|P1|Overall Study|Lost to Follow-up|4
3019852|NCT00807937|10386437|P4|Overall Study|Withdrawal by Subject|4
3019853|NCT00807937|10386438|P3|Overall Study|Withdrawal by Subject|1
3019854|NCT00807937|10386439|P2|Overall Study|Withdrawal by Subject|4
3019855|NCT00807937|10386440|P1|Overall Study|Withdrawal by Subject|5
3019856|NCT00807937|10386437|P4|Overall Study|Protocol Violation|3
3019857|NCT00807937|10386438|P3|Overall Study|Protocol Violation|3
3019858|NCT00807937|10386439|P2|Overall Study|Protocol Violation|5
3019859|NCT00807937|10386440|P1|Overall Study|Protocol Violation|4
3019860|NCT00807937|10386437|P4|Overall Study|Adverse Event|4
3019861|NCT00807937|10386438|P3|Overall Study|Adverse Event|5
3019862|NCT00807937|10386439|P2|Overall Study|Adverse Event|12
3019863|NCT00807937|10386440|P1|Overall Study|Adverse Event|12
3019864|NCT00807885|10386475|P9|Overall Study|Lost to Follow-up|0
3019865|NCT00807885|10386476|P8|Overall Study|Lost to Follow-up|0
3019866|NCT00807885|10386477|P7|Overall Study|Lost to Follow-up|0
3019867|NCT00807885|10386478|P6|Overall Study|Lost to Follow-up|1
3019868|NCT00807885|10386479|P5|Overall Study|Lost to Follow-up|0
3019869|NCT00807885|10386480|P4|Overall Study|Lost to Follow-up|0
3019870|NCT00807885|10386481|P3|Overall Study|Lost to Follow-up|0
3019871|NCT00807885|10386482|P2|Overall Study|Lost to Follow-up|0
3019872|NCT00807885|10386483|P1|Overall Study|Lost to Follow-up|0
3019873|NCT00807846|10386532|P2|Overall Study|Other|2
3019874|NCT00807846|10386533|P1|Overall Study|Other|1
3019875|NCT00807846|10386532|P2|Overall Study|Withdrawal by Subject|1
3019876|NCT00807846|10386533|P1|Overall Study|Withdrawal by Subject|2
3019877|NCT00807846|10386532|P2|Overall Study|Protocol Violation|1
3019878|NCT00807846|10386533|P1|Overall Study|Protocol Violation|2
3019879|NCT00807846|10386532|P2|Overall Study|Lack of Efficacy|0
3019880|NCT00807846|10386533|P1|Overall Study|Lack of Efficacy|2
3019881|NCT00807846|10386532|P2|Overall Study|Adverse Event|0
3019882|NCT00807846|10386533|P1|Overall Study|Adverse Event|5
3019883|NCT00807742|10386586|P2|Overall Study|Lost to Follow-up|51
3019884|NCT00807742|10386587|P1|Overall Study|Lost to Follow-up|35
3019885|NCT00807742|10386586|P2|Overall Study|Withdrawal by Subject|1
3019886|NCT00807742|10386587|P1|Overall Study|Withdrawal by Subject|2
3019887|NCT00807742|10386586|P2|Overall Study|Death|2
3019888|NCT00807742|10386587|P1|Overall Study|Death|9
3019889|NCT00807599|10386646|P3|Overall Study|Withdrawal by Subject|1
3019890|NCT00807599|10386647|P2|Overall Study|Withdrawal by Subject|0
3019891|NCT00807599|10386648|P1|Overall Study|Withdrawal by Subject|0
3019892|NCT00807599|10386646|P3|Overall Study|Inadequate response to induction|9
3019893|NCT00807599|10386647|P2|Overall Study|Inadequate response to induction|0
3019894|NCT00807599|10386648|P1|Overall Study|Inadequate response to induction|0
3019895|NCT00807599|10386646|P3|Overall Study|Adverse Event|5
3019896|NCT00807599|10386647|P2|Overall Study|Adverse Event|0
3019897|NCT00807599|10386648|P1|Overall Study|Adverse Event|0
3019898|NCT00807599|10386646|P3|Overall Study|Not treated on protocol study|2
3019899|NCT00807599|10386647|P2|Overall Study|Not treated on protocol study|0
3019900|NCT00807599|10386648|P1|Overall Study|Not treated on protocol study|0
3019901|NCT00807573|10386675|P1|Overall Study|Adverse Event|1
3019902|NCT00807573|10386675|P1|Overall Study|Withdrawal by Subject|1
3019903|NCT00807495|10386721|P5|Overall Study|Reason Not Specified|3
3019904|NCT00807495|10386722|P4|Overall Study|Reason Not Specified|0
3019905|NCT00807495|10386723|P3|Overall Study|Reason Not Specified|2
3019906|NCT00807495|10386724|P2|Overall Study|Reason Not Specified|3
3019907|NCT00807495|10386725|P1|Overall Study|Reason Not Specified|0
3019908|NCT00807495|10386721|P5|Overall Study|Withdrawal by Patient|0
3019909|NCT00807495|10386722|P4|Overall Study|Withdrawal by Patient|0
3019910|NCT00807495|10386723|P3|Overall Study|Withdrawal by Patient|1
3019911|NCT00807495|10386724|P2|Overall Study|Withdrawal by Patient|0
3019912|NCT00807495|10386725|P1|Overall Study|Withdrawal by Patient|2
3019913|NCT00807495|10386721|P5|Overall Study|Adverse Event|2
3019914|NCT00807495|10386722|P4|Overall Study|Adverse Event|1
3019915|NCT00807495|10386723|P3|Overall Study|Adverse Event|1
3019916|NCT00807495|10386724|P2|Overall Study|Adverse Event|3
3019917|NCT00807495|10386725|P1|Overall Study|Adverse Event|6
3019918|NCT00807365|10386771|P1|Overall Study|Study Terminated|5
3019919|NCT00807248|10386779|P4|Overall Study|Other Reason|0
3019920|NCT00807248|10386780|P3|Overall Study|Other Reason|2
3019921|NCT00807248|10386781|P2|Overall Study|Other Reason|0
3019922|NCT00807248|10386782|P1|Overall Study|Other Reason|0
3019923|NCT00807248|10386779|P4|Overall Study|Lost to Follow-up|0
3019924|NCT00807248|10386780|P3|Overall Study|Lost to Follow-up|0
3019925|NCT00807248|10386781|P2|Overall Study|Lost to Follow-up|0
3019926|NCT00807248|10386782|P1|Overall Study|Lost to Follow-up|1
3019927|NCT00807248|10386779|P4|Overall Study|Withdrawal of Consent|5
3019928|NCT00807248|10386780|P3|Overall Study|Withdrawal of Consent|5
3019929|NCT00807248|10386781|P2|Overall Study|Withdrawal of Consent|5
3019930|NCT00807248|10386782|P1|Overall Study|Withdrawal of Consent|5
3019931|NCT00807248|10386779|P4|Overall Study|Protocol Violation|0
3019932|NCT00807248|10386780|P3|Overall Study|Protocol Violation|1
3019933|NCT00807248|10386781|P2|Overall Study|Protocol Violation|1
3019934|NCT00807248|10386782|P1|Overall Study|Protocol Violation|0
3019935|NCT00807248|10386779|P4|Overall Study|Lack of Efficacy|3
3019936|NCT00807248|10386780|P3|Overall Study|Lack of Efficacy|8
3019937|NCT00807248|10386781|P2|Overall Study|Lack of Efficacy|4
3019938|NCT00807248|10386782|P1|Overall Study|Lack of Efficacy|14
3019939|NCT00807248|10386779|P4|Overall Study|Adverse Event|6
3019940|NCT00807248|10386780|P3|Overall Study|Adverse Event|2
3019941|NCT00807248|10386781|P2|Overall Study|Adverse Event|2
3019942|NCT00807248|10386782|P1|Overall Study|Adverse Event|1
3019943|NCT00807235|10386826|P2|Overall Study|Adverse Event|0
3019944|NCT00807235|10386827|P1|Overall Study|Adverse Event|1
3019945|NCT00807092|10386872|P2|Overall Study|CGMS data collection failed|1
3019946|NCT00807092|10386873|P1|Overall Study|CGMS data collection failed|0
3019947|NCT00807092|10386872|P2|Overall Study|Withdrawal by Subject|0
3019948|NCT00807092|10386873|P1|Overall Study|Withdrawal by Subject|1
3019949|NCT00807092|10386872|P2|Overall Study|Protocol Violation|2
3019950|NCT00807092|10386873|P1|Overall Study|Protocol Violation|0
3019951|NCT00807092|10386872|P2|Overall Study|Adverse Event|1
3019952|NCT00807092|10386873|P1|Overall Study|Adverse Event|0
3019953|NCT00807040|10386903|P2|Overall Study|Lost to Follow-up|6
3019954|NCT00807040|10386904|P1|Overall Study|Lost to Follow-up|4
3019955|NCT00807040|10386903|P2|Overall Study|Withdrawal by Subject|6
3019956|NCT00807040|10386904|P1|Overall Study|Withdrawal by Subject|8
3019957|NCT00807040|10386903|P2|Overall Study|Death|29
3019958|NCT00807040|10386904|P1|Overall Study|Death|24
3019959|NCT00807014|10386914|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
3019960|NCT00807014|10386915|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
3019961|NCT00807014|10386914|P2|Overall Study|Recovery|0
3019962|NCT00807014|10386915|P1|Overall Study|Recovery|1
3019963|NCT00807014|10386914|P2|Overall Study|Lost to Follow-up|7
3019964|NCT00807014|10386915|P1|Overall Study|Lost to Follow-up|9
3019965|NCT00807014|10386914|P2|Overall Study|Adverse Event|2
3019966|NCT00807014|10386915|P1|Overall Study|Adverse Event|0
3019967|NCT00807014|10386914|P2|Overall Study|Protocol Violation|8
3019968|NCT00807014|10386915|P1|Overall Study|Protocol Violation|2
3019969|NCT00807014|10386914|P2|Overall Study|Participant Considered Disease Not Cured|7
3019970|NCT00807014|10386915|P1|Overall Study|Participant Considered Disease Not Cured|2
3019971|NCT00807014|10386914|P2|Overall Study|Participant Considered Disease Cured|2
3019972|NCT00807014|10386915|P1|Overall Study|Participant Considered Disease Cured|13
3019973|NCT00807001|10386946|P5|Overall Study|Non-compliance|0
3019974|NCT00807001|10386947|P4|Overall Study|Non-compliance|0
3019975|NCT00807001|10386948|P3|Overall Study|Non-compliance|0
3019976|NCT00807001|10386949|P2|Overall Study|Non-compliance|1
3019977|NCT00807001|10386950|P1|Overall Study|Non-compliance|0
3019978|NCT00806988|10386969|P2|Overall Study|Lost to Follow-up|19
3019979|NCT00806988|10386970|P1|Overall Study|Lost to Follow-up|4
3019980|NCT00806988|10386969|P2|Overall Study|Withdrawal by Subject|8
3019981|NCT00806988|10386970|P1|Overall Study|Withdrawal by Subject|8
3019982|NCT00806988|10386969|P2|Overall Study|Death|16
3019983|NCT00806988|10386970|P1|Overall Study|Death|15
3019984|NCT00806819|10386980|P2|Overall Study|Reasons other than stated above|41
3019985|NCT00806819|10386981|P1|Overall Study|Reasons other than stated above|25
3019986|NCT00806819|10386980|P2|Overall Study|Not treated|3
3019987|NCT00806819|10386981|P1|Overall Study|Not treated|6
3019988|NCT00806819|10386980|P2|Overall Study|Withdrawal by Subject|29
3019989|NCT00806819|10386981|P1|Overall Study|Withdrawal by Subject|32
3019990|NCT00806819|10386980|P2|Overall Study|Lost to Follow-up|0
3019991|NCT00806819|10386981|P1|Overall Study|Lost to Follow-up|1
3019992|NCT00806819|10386980|P2|Overall Study|Protocol Violation|4
3019993|NCT00806819|10386981|P1|Overall Study|Protocol Violation|9
3019994|NCT00806819|10386980|P2|Overall Study|Other AE|40
3019995|NCT00806819|10386981|P1|Overall Study|Other AE|38
3019996|NCT00806819|10386980|P2|Overall Study|Worsening or AE of underlying disease|25
3019997|NCT00806819|10386981|P1|Overall Study|Worsening or AE of underlying disease|18
3019998|NCT00806819|10386980|P2|Overall Study|progressive disease (modified RECIST )|216
3019999|NCT00806819|10386981|P1|Overall Study|progressive disease (modified RECIST )|217
3020000|NCT00806624|10387050|P3|Overall Study|discontinued before start of treatment|1
3020001|NCT00806624|10387051|P2|Overall Study|discontinued before start of treatment|0
3020002|NCT00806624|10387052|P1|Overall Study|discontinued before start of treatment|0
3020003|NCT00806624|10387050|P3|Overall Study|Withdrawal by Subject|3
3020004|NCT00806624|10387051|P2|Overall Study|Withdrawal by Subject|3
3020005|NCT00806624|10387052|P1|Overall Study|Withdrawal by Subject|6
3020006|NCT00806624|10387050|P3|Overall Study|Lost to Follow-up|1
3020007|NCT00806624|10387051|P2|Overall Study|Lost to Follow-up|0
3020008|NCT00806624|10387052|P1|Overall Study|Lost to Follow-up|1
3020009|NCT00806624|10387050|P3|Overall Study|Death|1
3020010|NCT00806624|10387051|P2|Overall Study|Death|1
3020011|NCT00806624|10387052|P1|Overall Study|Death|0
3020012|NCT00806624|10387050|P3|Overall Study|Adverse Event|0
3020013|NCT00806624|10387051|P2|Overall Study|Adverse Event|8
3020014|NCT00806624|10387052|P1|Overall Study|Adverse Event|2
3020015|NCT00806585|10387069|P5|Overall Study|Completion status unknown|12
3020016|NCT00806585|10387070|P4|Overall Study|Completion status unknown|4
3020017|NCT00806585|10387071|P3|Overall Study|Completion status unknown|12
3020018|NCT00806585|10387072|P2|Overall Study|Completion status unknown|14
3020019|NCT00806585|10387073|P1|Overall Study|Completion status unknown|15
3020020|NCT00806585|10387069|P5|Overall Study|Withdrawal by Subject|11
3020021|NCT00806585|10387070|P4|Overall Study|Withdrawal by Subject|3
3020022|NCT00806585|10387071|P3|Overall Study|Withdrawal by Subject|9
3020023|NCT00806585|10387072|P2|Overall Study|Withdrawal by Subject|8
3020024|NCT00806585|10387073|P1|Overall Study|Withdrawal by Subject|10
3020025|NCT00806585|10387069|P5|Overall Study|Adverse Event|2
3020026|NCT00806585|10387070|P4|Overall Study|Adverse Event|4
3020027|NCT00806585|10387071|P3|Overall Study|Adverse Event|3
3020028|NCT00806585|10387072|P2|Overall Study|Adverse Event|5
3020029|NCT00806585|10387073|P1|Overall Study|Adverse Event|1
3020030|NCT00806585|10387069|P5|Overall Study|Lack of Efficacy|0
3020031|NCT00806585|10387070|P4|Overall Study|Lack of Efficacy|0
3020032|NCT00806585|10387071|P3|Overall Study|Lack of Efficacy|0
3020033|NCT00806585|10387072|P2|Overall Study|Lack of Efficacy|0
3020034|NCT00806585|10387073|P1|Overall Study|Lack of Efficacy|1
3020035|NCT00806585|10387069|P5|Overall Study|Lost to Follow-up|5
3020036|NCT00806585|10387070|P4|Overall Study|Lost to Follow-up|2
3020037|NCT00806585|10387071|P3|Overall Study|Lost to Follow-up|2
3020038|NCT00806585|10387072|P2|Overall Study|Lost to Follow-up|1
3020039|NCT00806585|10387073|P1|Overall Study|Lost to Follow-up|2
3020040|NCT00806585|10387069|P5|Overall Study|Physician Decision|1
3020041|NCT00806585|10387070|P4|Overall Study|Physician Decision|0
3020042|NCT00806585|10387071|P3|Overall Study|Physician Decision|3
3020043|NCT00806585|10387072|P2|Overall Study|Physician Decision|2
3020044|NCT00806585|10387073|P1|Overall Study|Physician Decision|0
3020045|NCT00806585|10387069|P5|Overall Study|Protocol Violation|0
3020046|NCT00806585|10387070|P4|Overall Study|Protocol Violation|0
3020047|NCT00806585|10387071|P3|Overall Study|Protocol Violation|2
3020048|NCT00806585|10387072|P2|Overall Study|Protocol Violation|1
3020049|NCT00806585|10387073|P1|Overall Study|Protocol Violation|3
3020050|NCT00806585|10387069|P5|Overall Study|Study terminated by Sponsor|0
3020051|NCT00806585|10387070|P4|Overall Study|Study terminated by Sponsor|2
3020052|NCT00806585|10387071|P3|Overall Study|Study terminated by Sponsor|1
3020053|NCT00806585|10387072|P2|Overall Study|Study terminated by Sponsor|0
3020054|NCT00806585|10387073|P1|Overall Study|Study terminated by Sponsor|0
3020055|NCT00806546|10387105|P1|Overall Study|Various|42
3020056|NCT00806546|10387105|P1|Overall Study|Protocol Violation|49
3020057|NCT00806546|10387105|P1|Overall Study|Withdrawal by Subject|75
3020058|NCT00806546|10387105|P1|Overall Study|Adverse Event|74
3020059|NCT00806546|10387105|P1|Overall Study|Lost to Follow-up|32
3020060|NCT00806546|10387105|P1|Overall Study|Enrolled, not treated|35
3020061|NCT00806494|10387109|P1|Overall Study|Withdrawal by Subject|5
3020062|NCT00806494|10387109|P1|Overall Study|Other|30
3020063|NCT00806494|10387109|P1|Overall Study|Lost to Follow-up|10
3020064|NCT00806494|10387109|P1|Overall Study|Lack of Efficacy|6
3020065|NCT00806494|10387109|P1|Overall Study|Adverse Event|29
3020066|NCT00806442|10387133|P2|Overall Study|Withdrawal by Subject|5
3020067|NCT00806442|10387134|P1|Overall Study|Withdrawal by Subject|1
3020068|NCT00806442|10387133|P2|Overall Study|Lost to Follow-up|2
3020069|NCT00806442|10387134|P1|Overall Study|Lost to Follow-up|3
3020070|NCT00806416|10387156|P4|Period 1 - Part II|Withdrawal by Subject|2
3020071|NCT00806416|10387157|P3|Period 1 - Part II|Withdrawal by Subject|0
3020072|NCT00806416|10387158|P2|Period 1 - Part II|Withdrawal by Subject|0
3020073|NCT00806416|10387159|P1|Period 1 - Part II|Withdrawal by Subject|0
3020074|NCT00806416|10387156|P4|Period 1 - Part I|Withdrawal by Subject|0
3020075|NCT00806416|10387157|P3|Period 1 - Part I|Withdrawal by Subject|0
3020076|NCT00806416|10387158|P2|Period 1 - Part I|Withdrawal by Subject|1
3020077|NCT00806416|10387159|P1|Period 1 - Part I|Withdrawal by Subject|3
3020078|NCT00806416|10387156|P4|Period 1 - Part I|Lost to Follow-up|0
3020079|NCT00806416|10387157|P3|Period 1 - Part I|Lost to Follow-up|0
3020080|NCT00806416|10387158|P2|Period 1 - Part I|Lost to Follow-up|2
3020081|NCT00806416|10387159|P1|Period 1 - Part I|Lost to Follow-up|0
3020082|NCT00806416|10387156|P4|Period 1 - Part I|Adverse Event|0
3020083|NCT00806416|10387157|P3|Period 1 - Part I|Adverse Event|0
3020084|NCT00806416|10387158|P2|Period 1 - Part I|Adverse Event|1
3020085|NCT00806416|10387159|P1|Period 1 - Part I|Adverse Event|0
3020086|NCT00806403|10387172|P2|Overall Study|Death|3
3020087|NCT00806403|10387173|P1|Overall Study|Death|4
3020088|NCT00806351|10387196|P2|Overall Study|Death|4
3020089|NCT00806351|10387197|P1|Overall Study|Death|5
3020090|NCT00806286|10387231|P3|Overall Study|Due to a variety of reasons|1
3020091|NCT00806286|10387232|P2|Overall Study|Due to a variety of reasons|2
3020092|NCT00806286|10387233|P1|Overall Study|Due to a variety of reasons|7
3020093|NCT00806286|10387231|P3|Overall Study|Physician Decision|0
3020094|NCT00806286|10387232|P2|Overall Study|Physician Decision|2
3020095|NCT00806286|10387233|P1|Overall Study|Physician Decision|2
3020096|NCT00806286|10387231|P3|Overall Study|Withdrawal by Subject|1
3020097|NCT00806286|10387232|P2|Overall Study|Withdrawal by Subject|3
3020098|NCT00806286|10387233|P1|Overall Study|Withdrawal by Subject|8
3020099|NCT00806286|10387231|P3|Overall Study|Lost to Follow-up|0
3020100|NCT00806286|10387232|P2|Overall Study|Lost to Follow-up|1
3020101|NCT00806286|10387233|P1|Overall Study|Lost to Follow-up|0
3020102|NCT00806286|10387231|P3|Overall Study|Death|0
3020103|NCT00806286|10387232|P2|Overall Study|Death|6
3020104|NCT00806286|10387233|P1|Overall Study|Death|1
3020105|NCT00806286|10387231|P3|Overall Study|Disease progression|1
3020106|NCT00806286|10387232|P2|Overall Study|Disease progression|38
3020107|NCT00806286|10387233|P1|Overall Study|Disease progression|31
3020108|NCT00806286|10387231|P3|Overall Study|Adverse Event|0
3020109|NCT00806286|10387232|P2|Overall Study|Adverse Event|2
3020110|NCT00806286|10387233|P1|Overall Study|Adverse Event|5
3020111|NCT00806260|10387255|P6|Period 3|Pregnancy|0
3020112|NCT00806260|10387256|P5|Period 3|Pregnancy|0
3020113|NCT00806260|10387257|P4|Period 3|Pregnancy|0
3020114|NCT00806260|10387258|P3|Period 3|Pregnancy|0
3020115|NCT00806260|10387259|P2|Period 3|Pregnancy|0
3020116|NCT00806260|10387260|P1|Period 3|Pregnancy|1
3020117|NCT00806260|10387255|P6|Period 3|Protocol Violation|0
3020118|NCT00806260|10387256|P5|Period 3|Protocol Violation|0
3020119|NCT00806260|10387257|P4|Period 3|Protocol Violation|0
3020120|NCT00806260|10387258|P3|Period 3|Protocol Violation|1
3020121|NCT00806260|10387259|P2|Period 3|Protocol Violation|1
3020122|NCT00806260|10387260|P1|Period 3|Protocol Violation|0
3020123|NCT00806260|10387255|P6|Period 2|sponsor request|0
3020124|NCT00806260|10387256|P5|Period 2|sponsor request|0
3020125|NCT00806260|10387257|P4|Period 2|sponsor request|1
3020126|NCT00806260|10387258|P3|Period 2|sponsor request|1
3020127|NCT00806260|10387259|P2|Period 2|sponsor request|0
3020128|NCT00806260|10387260|P1|Period 2|sponsor request|0
3020129|NCT00806260|10387255|P6|Period 2|Need to take concomitant medication|0
3020130|NCT00806260|10387256|P5|Period 2|Need to take concomitant medication|0
3020131|NCT00806260|10387257|P4|Period 2|Need to take concomitant medication|0
3020132|NCT00806260|10387258|P3|Period 2|Need to take concomitant medication|0
3020133|NCT00806260|10387259|P2|Period 2|Need to take concomitant medication|0
3020134|NCT00806260|10387260|P1|Period 2|Need to take concomitant medication|1
3020135|NCT00806260|10387255|P6|Period 2|Protocol Violation|0
3020136|NCT00806260|10387256|P5|Period 2|Protocol Violation|0
3020137|NCT00806260|10387257|P4|Period 2|Protocol Violation|0
3020138|NCT00806260|10387258|P3|Period 2|Protocol Violation|1
3020139|NCT00806260|10387259|P2|Period 2|Protocol Violation|0
3020140|NCT00806260|10387260|P1|Period 2|Protocol Violation|1
3020141|NCT00806260|10387255|P6|Period 2|Adverse Event|0
3020142|NCT00806260|10387256|P5|Period 2|Adverse Event|0
3020143|NCT00806260|10387257|P4|Period 2|Adverse Event|1
3020144|NCT00806260|10387258|P3|Period 2|Adverse Event|0
3020145|NCT00806260|10387259|P2|Period 2|Adverse Event|0
3020146|NCT00806260|10387260|P1|Period 2|Adverse Event|0
3020147|NCT00806260|10387255|P6|Period 1 (1 Day)|Adverse Event|0
3020148|NCT00806260|10387256|P5|Period 1 (1 Day)|Adverse Event|3
3020149|NCT00806260|10387257|P4|Period 1 (1 Day)|Adverse Event|0
3020150|NCT00806260|10387258|P3|Period 1 (1 Day)|Adverse Event|0
3020151|NCT00806260|10387259|P2|Period 1 (1 Day)|Adverse Event|0
3020152|NCT00806260|10387260|P1|Period 1 (1 Day)|Adverse Event|0
3020153|NCT00806195|10387305|P4|Overall Study|Protocol Violation|9
3020154|NCT00806195|10387306|P3|Overall Study|Protocol Violation|26
3020155|NCT00806195|10387307|P2|Overall Study|Protocol Violation|24
3020156|NCT00806195|10387308|P1|Overall Study|Protocol Violation|34
3020157|NCT00806195|10387305|P4|Overall Study|Administrative Reason|26
3020158|NCT00806195|10387306|P3|Overall Study|Administrative Reason|66
3020159|NCT00806195|10387307|P2|Overall Study|Administrative Reason|35
3020160|NCT00806195|10387308|P1|Overall Study|Administrative Reason|113
3020161|NCT00806195|10387305|P4|Overall Study|Inappropriate Enrollment|0
3020162|NCT00806195|10387306|P3|Overall Study|Inappropriate Enrollment|0
3020163|NCT00806195|10387307|P2|Overall Study|Inappropriate Enrollment|1
3020164|NCT00806195|10387308|P1|Overall Study|Inappropriate Enrollment|0
3020165|NCT00806195|10387305|P4|Overall Study|Lost to Follow-up|34
3020166|NCT00806195|10387306|P3|Overall Study|Lost to Follow-up|90
3020167|NCT00806195|10387307|P2|Overall Study|Lost to Follow-up|66
3020168|NCT00806195|10387308|P1|Overall Study|Lost to Follow-up|217
3020169|NCT00806195|10387305|P4|Overall Study|Withdrawal by Subject|35
3020170|NCT00806195|10387306|P3|Overall Study|Withdrawal by Subject|76
3020171|NCT00806195|10387307|P2|Overall Study|Withdrawal by Subject|31
3020172|NCT00806195|10387308|P1|Overall Study|Withdrawal by Subject|119
3020173|NCT00806195|10387305|P4|Overall Study|Adverse Event|2
3020174|NCT00806195|10387306|P3|Overall Study|Adverse Event|11
3020175|NCT00806195|10387307|P2|Overall Study|Adverse Event|5
3020176|NCT00806195|10387308|P1|Overall Study|Adverse Event|25
3020177|NCT00806195|10387305|P4|Overall Study|Death|0
3020178|NCT00806195|10387306|P3|Overall Study|Death|1
3020179|NCT00806195|10387307|P2|Overall Study|Death|0
3020180|NCT00806195|10387308|P1|Overall Study|Death|6
3020181|NCT00806026|10387339|P6|Overall Study|Adverse Event|9
3020182|NCT00806026|10387340|P5|Overall Study|Adverse Event|9
3020183|NCT00806026|10387341|P4|Overall Study|Adverse Event|17
3020184|NCT00806026|10387342|P3|Overall Study|Adverse Event|44
3020185|NCT00806026|10387343|P2|Overall Study|Adverse Event|35
3020186|NCT00806026|10387344|P1|Overall Study|Adverse Event|52
3020187|NCT00806026|10387339|P6|Overall Study|Protocol Violation|3
3020188|NCT00806026|10387340|P5|Overall Study|Protocol Violation|2
3020189|NCT00806026|10387341|P4|Overall Study|Protocol Violation|0
3020190|NCT00806026|10387342|P3|Overall Study|Protocol Violation|9
3020191|NCT00806026|10387343|P2|Overall Study|Protocol Violation|9
3020192|NCT00806026|10387344|P1|Overall Study|Protocol Violation|6
3020193|NCT00806026|10387339|P6|Overall Study|Other|4
3020194|NCT00806026|10387340|P5|Overall Study|Other|0
3020195|NCT00806026|10387341|P4|Overall Study|Other|2
3020196|NCT00806026|10387342|P3|Overall Study|Other|8
3020197|NCT00806026|10387343|P2|Overall Study|Other|6
3020198|NCT00806026|10387344|P1|Overall Study|Other|3
3020199|NCT00806026|10387339|P6|Overall Study|Withdrawal by Subject|3
3020200|NCT00806026|10387340|P5|Overall Study|Withdrawal by Subject|5
3020201|NCT00806026|10387341|P4|Overall Study|Withdrawal by Subject|2
3020202|NCT00806026|10387342|P3|Overall Study|Withdrawal by Subject|9
3020203|NCT00806026|10387343|P2|Overall Study|Withdrawal by Subject|17
3020204|NCT00806026|10387344|P1|Overall Study|Withdrawal by Subject|14
3020205|NCT00806026|10387339|P6|Overall Study|Lost to Follow-up|6
3020206|NCT00806026|10387340|P5|Overall Study|Lost to Follow-up|6
3020207|NCT00806026|10387341|P4|Overall Study|Lost to Follow-up|2
3020208|NCT00806026|10387342|P3|Overall Study|Lost to Follow-up|8
3020209|NCT00806026|10387343|P2|Overall Study|Lost to Follow-up|15
3020210|NCT00806026|10387344|P1|Overall Study|Lost to Follow-up|8
3020211|NCT00806026|10387339|P6|Overall Study|Lack of Efficacy|7
3020212|NCT00806026|10387340|P5|Overall Study|Lack of Efficacy|8
3020213|NCT00806026|10387341|P4|Overall Study|Lack of Efficacy|4
3020214|NCT00806026|10387342|P3|Overall Study|Lack of Efficacy|13
3020215|NCT00806026|10387343|P2|Overall Study|Lack of Efficacy|18
3020216|NCT00806026|10387344|P1|Overall Study|Lack of Efficacy|5
3020217|NCT00806026|10387339|P6|Overall Study|Did not meet entrance criteria|0
3020218|NCT00806026|10387340|P5|Overall Study|Did not meet entrance criteria|0
3020219|NCT00806026|10387341|P4|Overall Study|Did not meet entrance criteria|1
3020220|NCT00806026|10387342|P3|Overall Study|Did not meet entrance criteria|2
3020221|NCT00806026|10387343|P2|Overall Study|Did not meet entrance criteria|1
3020222|NCT00806026|10387344|P1|Overall Study|Did not meet entrance criteria|4
3020223|NCT00806026|10387339|P6|Overall Study|Death|0
3020224|NCT00806026|10387340|P5|Overall Study|Death|0
3020225|NCT00806026|10387341|P4|Overall Study|Death|1
3020226|NCT00806026|10387342|P3|Overall Study|Death|0
3020227|NCT00806026|10387343|P2|Overall Study|Death|0
3020228|NCT00806026|10387344|P1|Overall Study|Death|0
3020229|NCT00805961|10387439|P1|Maintenance Treatment|Withdrawn Consent|1
3020230|NCT00805961|10387439|P1|Maintenance Treatment|Symptomatic Deterioration|2
3020231|NCT00805961|10387439|P1|Maintenance Treatment|Withdrawal by Subject|5
3020232|NCT00805961|10387439|P1|Maintenance Treatment|Adverse Event|6
3020233|NCT00805961|10387439|P1|Maintenance Treatment|Intercurrent Illness|7
3020234|NCT00805961|10387439|P1|Maintenance Treatment|Lack of Efficacy|13
3020235|NCT00805961|10387439|P1|Treatment-Free Interval|Lack of Efficacy|1
3020236|NCT00805961|10387439|P1|Treatment-Free Interval|Physician Decision|1
3020237|NCT00805961|10387439|P1|Treatment-Free Interval|Intercurrent Illness|2
3020238|NCT00805961|10387439|P1|Treatment-Free Interval|Adverse Event|3
3020239|NCT00805961|10387439|P1|Modality Therapy|Disease Progression|2
3020240|NCT00805961|10387439|P1|Modality Therapy|Adverse Event|1
3020241|NCT00805961|10387439|P1|Modality Therapy|Withdrawal by Subject|1
3020242|NCT00805935|10387463|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
3020243|NCT00805935|10387464|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
3020244|NCT00805935|10387465|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
3020245|NCT00805935|10387466|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
3020246|NCT00805935|10387463|P4|Overall Study|Ectopic pregnancy|0
3020247|NCT00805935|10387464|P3|Overall Study|Ectopic pregnancy|1
3020248|NCT00805935|10387465|P2|Overall Study|Ectopic pregnancy|0
3020249|NCT00805935|10387466|P1|Overall Study|Ectopic pregnancy|0
3020250|NCT00805935|10387463|P4|Overall Study|Chemical pregnancy|2
3020251|NCT00805935|10387464|P3|Overall Study|Chemical pregnancy|3
3020252|NCT00805935|10387465|P2|Overall Study|Chemical pregnancy|5
3020253|NCT00805935|10387466|P1|Overall Study|Chemical pregnancy|0
3020254|NCT00805935|10387463|P4|Overall Study|Biochemical pregnancy|0
3020255|NCT00805935|10387464|P3|Overall Study|Biochemical pregnancy|0
3020256|NCT00805935|10387465|P2|Overall Study|Biochemical pregnancy|1
3020257|NCT00805935|10387466|P1|Overall Study|Biochemical pregnancy|0
3020258|NCT00805935|10387463|P4|Overall Study|Pregnancy loss/miscarriage|0
3020259|NCT00805935|10387464|P3|Overall Study|Pregnancy loss/miscarriage|0
3020260|NCT00805935|10387465|P2|Overall Study|Pregnancy loss/miscarriage|0
3020261|NCT00805935|10387466|P1|Overall Study|Pregnancy loss/miscarriage|2
3020262|NCT00805935|10387463|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
3020263|NCT00805935|10387464|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
3020264|NCT00805935|10387465|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
3020265|NCT00805935|10387466|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
3020266|NCT00805935|10387463|P4|Overall Study|No positive serum pregnancy|5
3020267|NCT00805935|10387464|P3|Overall Study|No positive serum pregnancy|6
3020268|NCT00805935|10387465|P2|Overall Study|No positive serum pregnancy|7
3020269|NCT00805935|10387466|P1|Overall Study|No positive serum pregnancy|8
3020270|NCT00805935|10387463|P4|Overall Study|Lost to Follow-up|0
3020271|NCT00805935|10387464|P3|Overall Study|Lost to Follow-up|0
3020272|NCT00805935|10387465|P2|Overall Study|Lost to Follow-up|0
3020273|NCT00805935|10387466|P1|Overall Study|Lost to Follow-up|1
3020274|NCT00805935|10387463|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
3020275|NCT00805935|10387464|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
3020276|NCT00805935|10387465|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
3020277|NCT00805935|10387466|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
3020278|NCT00805935|10387463|P4|Overall Study|Cycle cancellation for risk of OHSS|0
3020279|NCT00805935|10387464|P3|Overall Study|Cycle cancellation for risk of OHSS|1
3020280|NCT00805935|10387465|P2|Overall Study|Cycle cancellation for risk of OHSS|0
3020281|NCT00805935|10387466|P1|Overall Study|Cycle cancellation for risk of OHSS|1
3020282|NCT00805935|10387463|P4|Overall Study|Cycle cancelled|0
3020283|NCT00805935|10387464|P3|Overall Study|Cycle cancelled|2
3020284|NCT00805935|10387465|P2|Overall Study|Cycle cancelled|0
3020285|NCT00805935|10387466|P1|Overall Study|Cycle cancelled|0
3020286|NCT00805935|10387463|P4|Overall Study|Stimulation Failure|2
3020287|NCT00805935|10387464|P3|Overall Study|Stimulation Failure|2
3020288|NCT00805935|10387465|P2|Overall Study|Stimulation Failure|5
3020289|NCT00805935|10387466|P1|Overall Study|Stimulation Failure|1
3020290|NCT00805792|10387533|P1|Overall Study|Lost to Follow-up|2
3020291|NCT00805792|10387533|P1|Overall Study|Death|3
3020292|NCT00805766|10387541|P1|Increased Dose Period|Withdrawal by Subject|1
3020293|NCT00805766|10387541|P1|Increased Dose Period|Pregnancy|1
3020294|NCT00805766|10387541|P1|Increased Dose Period|Lack of Efficacy|7
3020295|NCT00805766|10387541|P1|Increased Dose Period|Adverse Event|4
3020296|NCT00805766|10387541|P1|Screening Period|Responder|2
3020297|NCT00805766|10387541|P1|Screening Period|Pregnancy|1
3020298|NCT00805766|10387541|P1|Screening Period|Lack of Efficacy|2
3020299|NCT00805766|10387541|P1|Screening Period|Adverse Event|1
3020300|NCT00805740|10387555|P2|Overall Study|Randomized, but not treated|0
3020301|NCT00805740|10387556|P1|Overall Study|Randomized, but not treated|2
3020302|NCT00805740|10387555|P2|Overall Study|Lost to Follow-up|0
3020303|NCT00805740|10387556|P1|Overall Study|Lost to Follow-up|1
3020304|NCT00805740|10387555|P2|Overall Study|Withdrawal by Subject|0
3020305|NCT00805740|10387556|P1|Overall Study|Withdrawal by Subject|1
3020306|NCT00805740|10387555|P2|Overall Study|Death|4
3020307|NCT00805740|10387556|P1|Overall Study|Death|7
3020308|NCT00805675|10387581|P3|Overall Study|Adverse Event|1
3020309|NCT00805675|10387582|P2|Overall Study|Adverse Event|0
3020310|NCT00805675|10387583|P1|Overall Study|Adverse Event|0
3020311|NCT00805545|10387617|P2|Overall Study|Protocol Violation|1
3020312|NCT00805545|10387618|P1|Overall Study|Protocol Violation|3
3020313|NCT00805545|10387617|P2|Overall Study|Protocol Violation|2
3020314|NCT00805545|10387618|P1|Overall Study|Protocol Violation|3
3020315|NCT00805532|10387626|P2|Overall Study|invalid data|1
3020316|NCT00805532|10387627|P1|Overall Study|invalid data|0
3020317|NCT00805480|10387661|P4|Overall Study|Adverse Event|0
3020318|NCT00805480|10387662|P3|Overall Study|Adverse Event|1
3020319|NCT00805480|10387663|P2|Overall Study|Adverse Event|0
3020320|NCT00805480|10387664|P1|Overall Study|Adverse Event|0
3020321|NCT00805480|10387661|P4|Overall Study|Lost to Follow-up|0
3020322|NCT00805480|10387662|P3|Overall Study|Lost to Follow-up|0
3020323|NCT00805480|10387663|P2|Overall Study|Lost to Follow-up|2
3020324|NCT00805480|10387664|P1|Overall Study|Lost to Follow-up|1
3020325|NCT00805480|10387661|P4|Overall Study|Withdrawal by Subject|5
3020326|NCT00805480|10387662|P3|Overall Study|Withdrawal by Subject|11
3020327|NCT00805480|10387663|P2|Overall Study|Withdrawal by Subject|5
3020328|NCT00805480|10387664|P1|Overall Study|Withdrawal by Subject|13
3020329|NCT00805467|10387693|P4|Overall Study|Not reported|7
3020330|NCT00805467|10387694|P3|Overall Study|Not reported|3
3020331|NCT00805467|10387695|P2|Overall Study|Not reported|0
3020332|NCT00805467|10387696|P1|Overall Study|Not reported|0
3020333|NCT00805467|10387693|P4|Overall Study|Physician Decision|6
3020334|NCT00805467|10387694|P3|Overall Study|Physician Decision|2
3020335|NCT00805467|10387695|P2|Overall Study|Physician Decision|1
3020336|NCT00805467|10387696|P1|Overall Study|Physician Decision|0
3020337|NCT00805467|10387693|P4|Overall Study|Death|5
3020338|NCT00805467|10387694|P3|Overall Study|Death|7
3020339|NCT00805467|10387695|P2|Overall Study|Death|2
3020340|NCT00805467|10387696|P1|Overall Study|Death|0
3020341|NCT00805467|10387693|P4|Overall Study|Adverse Event|57
3020342|NCT00805467|10387694|P3|Overall Study|Adverse Event|26
3020343|NCT00805467|10387695|P2|Overall Study|Adverse Event|13
3020344|NCT00805467|10387696|P1|Overall Study|Adverse Event|0
3020345|NCT00805467|10387693|P4|Overall Study|Protocol Violation|5
3020346|NCT00805467|10387694|P3|Overall Study|Protocol Violation|0
3020347|NCT00805467|10387695|P2|Overall Study|Protocol Violation|3
3020348|NCT00805467|10387696|P1|Overall Study|Protocol Violation|0
3020349|NCT00805467|10387693|P4|Overall Study|Withdrawal by Subject|50
3020350|NCT00805467|10387694|P3|Overall Study|Withdrawal by Subject|45
3020351|NCT00805467|10387695|P2|Overall Study|Withdrawal by Subject|6
3020352|NCT00805467|10387696|P1|Overall Study|Withdrawal by Subject|0
3020353|NCT00805467|10387693|P4|Overall Study|Lost to Follow-up|21
3020354|NCT00805467|10387694|P3|Overall Study|Lost to Follow-up|7
3020355|NCT00805467|10387695|P2|Overall Study|Lost to Follow-up|1
3020356|NCT00805467|10387696|P1|Overall Study|Lost to Follow-up|0
3020357|NCT00805467|10387693|P4|Overall Study|Lack of Efficacy|86
3020358|NCT00805467|10387694|P3|Overall Study|Lack of Efficacy|13
3020359|NCT00805467|10387695|P2|Overall Study|Lack of Efficacy|8
3020360|NCT00805467|10387696|P1|Overall Study|Lack of Efficacy|0
3020361|NCT00805441|10387716|P2|Overall Study|Acute Alcohol Withdrawal|1
3020362|NCT00805441|10387717|P1|Overall Study|Acute Alcohol Withdrawal|0
3020363|NCT00805441|10387716|P2|Overall Study|Physician Decision|1
3020364|NCT00805441|10387717|P1|Overall Study|Physician Decision|0
3020365|NCT00805441|10387716|P2|Overall Study|Withdrawal by Subject|9
3020366|NCT00805441|10387717|P1|Overall Study|Withdrawal by Subject|15
3020367|NCT00805441|10387716|P2|Overall Study|Lost to Follow-up|13
3020368|NCT00805441|10387717|P1|Overall Study|Lost to Follow-up|10
3020369|NCT00805441|10387716|P2|Overall Study|Protocol Violation|8
3020370|NCT00805441|10387717|P1|Overall Study|Protocol Violation|4
3020371|NCT00805441|10387716|P2|Overall Study|Lack of Efficacy|2
3020372|NCT00805441|10387717|P1|Overall Study|Lack of Efficacy|0
3020373|NCT00805441|10387716|P2|Overall Study|Adverse Event|2
3020374|NCT00805441|10387717|P1|Overall Study|Adverse Event|5
3020375|NCT00805389|10387752|P5|Overall Study|Withdrawal by Subject|4
3020376|NCT00805389|10387753|P4|Overall Study|Withdrawal by Subject|5
3020377|NCT00805389|10387754|P3|Overall Study|Withdrawal by Subject|4
3020378|NCT00805389|10387755|P2|Overall Study|Withdrawal by Subject|2
3020379|NCT00805389|10387756|P1|Overall Study|Withdrawal by Subject|3
3020380|NCT00805389|10387752|P5|Overall Study|Protocol Violation|0
3020381|NCT00805389|10387753|P4|Overall Study|Protocol Violation|0
3020382|NCT00805389|10387754|P3|Overall Study|Protocol Violation|1
3020383|NCT00805389|10387755|P2|Overall Study|Protocol Violation|0
3020384|NCT00805389|10387756|P1|Overall Study|Protocol Violation|0
3020385|NCT00805389|10387752|P5|Overall Study|Lost to Follow-up|9
3020386|NCT00805389|10387753|P4|Overall Study|Lost to Follow-up|10
3020387|NCT00805389|10387754|P3|Overall Study|Lost to Follow-up|6
3020388|NCT00805389|10387755|P2|Overall Study|Lost to Follow-up|3
3020389|NCT00805389|10387756|P1|Overall Study|Lost to Follow-up|4
3020390|NCT00805389|10387752|P5|Overall Study|Adverse Event|0
3020391|NCT00805389|10387753|P4|Overall Study|Adverse Event|2
3020392|NCT00805389|10387754|P3|Overall Study|Adverse Event|1
3020393|NCT00805389|10387755|P2|Overall Study|Adverse Event|0
3020394|NCT00805389|10387756|P1|Overall Study|Adverse Event|0
3020395|NCT00805285|10388003|P1|Overall Study|Lack of Efficacy|1
3020396|NCT00805207|10388020|P9|Overall Study|Withdrawal by Subject|0
3020397|NCT00805207|10388021|P8|Overall Study|Withdrawal by Subject|0
3020398|NCT00805207|10388022|P7|Overall Study|Withdrawal by Subject|0
3020399|NCT00805207|10388023|P6|Overall Study|Withdrawal by Subject|2
3020400|NCT00805207|10388024|P5|Overall Study|Withdrawal by Subject|1
3020401|NCT00805207|10388025|P4|Overall Study|Withdrawal by Subject|0
3020402|NCT00805207|10388026|P3|Overall Study|Withdrawal by Subject|0
3020403|NCT00805207|10388027|P2|Overall Study|Withdrawal by Subject|1
3020404|NCT00805207|10388028|P1|Overall Study|Withdrawal by Subject|0
3020405|NCT00805207|10388020|P9|Overall Study|Physician Decision|0
3020406|NCT00805207|10388021|P8|Overall Study|Physician Decision|0
3020407|NCT00805207|10388022|P7|Overall Study|Physician Decision|0
3020408|NCT00805207|10388023|P6|Overall Study|Physician Decision|1
3020409|NCT00805207|10388024|P5|Overall Study|Physician Decision|0
3020410|NCT00805207|10388025|P4|Overall Study|Physician Decision|0
3020411|NCT00805207|10388026|P3|Overall Study|Physician Decision|0
3020412|NCT00805207|10388027|P2|Overall Study|Physician Decision|1
3020413|NCT00805207|10388028|P1|Overall Study|Physician Decision|0
3020414|NCT00805207|10388020|P9|Overall Study|Protocol Violation|0
3020415|NCT00805207|10388021|P8|Overall Study|Protocol Violation|0
3020416|NCT00805207|10388022|P7|Overall Study|Protocol Violation|0
3020417|NCT00805207|10388023|P6|Overall Study|Protocol Violation|0
3020418|NCT00805207|10388024|P5|Overall Study|Protocol Violation|0
3020419|NCT00805207|10388025|P4|Overall Study|Protocol Violation|0
3020420|NCT00805207|10388026|P3|Overall Study|Protocol Violation|1
3020421|NCT00805207|10388027|P2|Overall Study|Protocol Violation|0
3020422|NCT00805207|10388028|P1|Overall Study|Protocol Violation|0
3020423|NCT00805194|10388086|P2|Overall Study|Reasons other than stated above|16
3020424|NCT00805194|10388087|P1|Overall Study|Reasons other than stated above|20
3020425|NCT00805194|10388086|P2|Overall Study|Not treated|4
3020426|NCT00805194|10388087|P1|Overall Study|Not treated|3
3020427|NCT00805194|10388086|P2|Overall Study|Withdrawal by Subject|42
3020428|NCT00805194|10388087|P1|Overall Study|Withdrawal by Subject|60
3020429|NCT00805194|10388086|P2|Overall Study|Lost to Follow-up|5
3020430|NCT00805194|10388087|P1|Overall Study|Lost to Follow-up|5
3020431|NCT00805194|10388086|P2|Overall Study|Protocol Violation|9
3020432|NCT00805194|10388087|P1|Overall Study|Protocol Violation|9
3020433|NCT00805194|10388086|P2|Overall Study|Other AE|73
3020434|NCT00805194|10388087|P1|Overall Study|Other AE|84
3020435|NCT00805194|10388086|P2|Overall Study|Worsening or AE of underlying disease|70
3020436|NCT00805194|10388087|P1|Overall Study|Worsening or AE of underlying disease|64
3020437|NCT00805194|10388086|P2|Overall Study|Progressive disease (modified RECIST)|435
3020438|NCT00805194|10388087|P1|Overall Study|Progressive disease (modified RECIST)|404
3020439|NCT00805142|10388121|P2|Maintenance Period|Other|1
3020440|NCT00805142|10388122|P1|Maintenance Period|Other|0
3020441|NCT00805142|10388121|P2|Maintenance Period|Adverse Event|1
3020442|NCT00805142|10388122|P1|Maintenance Period|Adverse Event|0
3020443|NCT00805142|10388121|P2|Titration Period|Other|3
3020444|NCT00805142|10388122|P1|Titration Period|Other|0
3020445|NCT00805142|10388121|P2|Titration Period|Withdrawal of consent|1
3020446|NCT00805142|10388122|P1|Titration Period|Withdrawal of consent|0
3020447|NCT00805142|10388121|P2|Titration Period|Disease Progression|1
3020448|NCT00805142|10388122|P1|Titration Period|Disease Progression|2
3020449|NCT00805142|10388121|P2|Titration Period|Lost to Follow-up|1
3020450|NCT00805142|10388122|P1|Titration Period|Lost to Follow-up|0
3020451|NCT00805142|10388121|P2|Titration Period|Lack of Efficacy|1
3020452|NCT00805142|10388122|P1|Titration Period|Lack of Efficacy|1
3020453|NCT00805142|10388121|P2|Titration Period|Adverse Event|3
3020454|NCT00805142|10388122|P1|Titration Period|Adverse Event|3
3020455|NCT00805025|10388155|P1|Overall Study|Physician Decision|1
3020456|NCT00805025|10388155|P1|Overall Study|Withdrawal by Subject|2
3020457|NCT00805025|10388155|P1|Overall Study|Adverse Event|4
3020458|NCT00805025|10388155|P1|Overall Study|Screened but not enrolled/treated|42
3020459|NCT00804986|10388184|P6|Overall Study|Physician Decision|0
3020460|NCT00804986|10388185|P5|Overall Study|Physician Decision|0
3020461|NCT00804986|10388186|P4|Overall Study|Physician Decision|0
3020462|NCT00804986|10388187|P3|Overall Study|Physician Decision|0
3020463|NCT00804986|10388188|P2|Overall Study|Physician Decision|0
3020464|NCT00804986|10388189|P1|Overall Study|Physician Decision|1
3020465|NCT00804986|10388184|P6|Overall Study|Sponsor Decision|0
3020466|NCT00804986|10388185|P5|Overall Study|Sponsor Decision|0
3020467|NCT00804986|10388186|P4|Overall Study|Sponsor Decision|0
3020468|NCT00804986|10388187|P3|Overall Study|Sponsor Decision|0
3020469|NCT00804986|10388188|P2|Overall Study|Sponsor Decision|1
3020470|NCT00804986|10388189|P1|Overall Study|Sponsor Decision|0
3020471|NCT00804986|10388184|P6|Overall Study|Inclusion/Exclusion criteria not met|1
3020472|NCT00804986|10388185|P5|Overall Study|Inclusion/Exclusion criteria not met|0
3020473|NCT00804986|10388186|P4|Overall Study|Inclusion/Exclusion criteria not met|1
3020474|NCT00804986|10388187|P3|Overall Study|Inclusion/Exclusion criteria not met|0
3020475|NCT00804986|10388188|P2|Overall Study|Inclusion/Exclusion criteria not met|2
3020476|NCT00804986|10388189|P1|Overall Study|Inclusion/Exclusion criteria not met|0
3020477|NCT00804986|10388184|P6|Overall Study|Withdrawal by Subject|3
3020478|NCT00804986|10388185|P5|Overall Study|Withdrawal by Subject|5
3020479|NCT00804986|10388186|P4|Overall Study|Withdrawal by Subject|3
3020480|NCT00804986|10388187|P3|Overall Study|Withdrawal by Subject|0
3020481|NCT00804986|10388188|P2|Overall Study|Withdrawal by Subject|3
3020482|NCT00804986|10388189|P1|Overall Study|Withdrawal by Subject|0
3020483|NCT00804986|10388184|P6|Overall Study|Protocol Violation|0
3020484|NCT00804986|10388185|P5|Overall Study|Protocol Violation|0
3020485|NCT00804986|10388186|P4|Overall Study|Protocol Violation|1
3020486|NCT00804986|10388187|P3|Overall Study|Protocol Violation|0
3020487|NCT00804986|10388188|P2|Overall Study|Protocol Violation|1
3020488|NCT00804986|10388189|P1|Overall Study|Protocol Violation|0
3020489|NCT00804986|10388184|P6|Overall Study|Lost to Follow-up|3
3020490|NCT00804986|10388185|P5|Overall Study|Lost to Follow-up|1
3020491|NCT00804986|10388186|P4|Overall Study|Lost to Follow-up|1
3020492|NCT00804986|10388187|P3|Overall Study|Lost to Follow-up|0
3020493|NCT00804986|10388188|P2|Overall Study|Lost to Follow-up|0
3020494|NCT00804986|10388189|P1|Overall Study|Lost to Follow-up|0
3020495|NCT00804986|10388184|P6|Overall Study|Lack of Efficacy|3
3020496|NCT00804986|10388185|P5|Overall Study|Lack of Efficacy|0
3020497|NCT00804986|10388186|P4|Overall Study|Lack of Efficacy|1
3020498|NCT00804986|10388187|P3|Overall Study|Lack of Efficacy|0
3020499|NCT00804986|10388188|P2|Overall Study|Lack of Efficacy|0
3020500|NCT00804986|10388189|P1|Overall Study|Lack of Efficacy|0
3020501|NCT00804986|10388184|P6|Overall Study|Adverse Event|0
3020502|NCT00804986|10388185|P5|Overall Study|Adverse Event|3
3020503|NCT00804986|10388186|P4|Overall Study|Adverse Event|1
3020504|NCT00804986|10388187|P3|Overall Study|Adverse Event|2
3020505|NCT00804986|10388188|P2|Overall Study|Adverse Event|1
3020506|NCT00804986|10388189|P1|Overall Study|Adverse Event|0
3020507|NCT00804908|10388324|P3|Overall Study|Other|114
3020508|NCT00804908|10388325|P2|Overall Study|Other|116
3020509|NCT00804908|10388326|P1|Overall Study|Other|115
3020510|NCT00804843|10388357|P2|Overall Study|Withdrawal by Subject|2
3020511|NCT00804843|10388358|P1|Overall Study|Withdrawal by Subject|1
3020512|NCT00804843|10388357|P2|Overall Study|Adverse Event|5
3020513|NCT00804843|10388358|P1|Overall Study|Adverse Event|8
3020514|NCT00804843|10388357|P2|Overall Study|Protocol Violation|0
3020515|NCT00804843|10388358|P1|Overall Study|Protocol Violation|1
3020516|NCT00804687|10388376|P6|Period 5: Treatment Period|Positive drug test|0
3020517|NCT00804687|10388377|P5|Period 5: Treatment Period|Positive drug test|0
3020518|NCT00804687|10388378|P4|Period 5: Treatment Period|Positive drug test|0
3020519|NCT00804687|10388379|P3|Period 5: Treatment Period|Positive drug test|0
3020520|NCT00804687|10388380|P2|Period 5: Treatment Period|Positive drug test|0
3020521|NCT00804687|10388381|P1|Period 5: Treatment Period|Positive drug test|1
3020522|NCT00804687|10388376|P6|Period 5: Treatment Period|Positive drugs of abuse|0
3020523|NCT00804687|10388377|P5|Period 5: Treatment Period|Positive drugs of abuse|0
3020524|NCT00804687|10388378|P4|Period 5: Treatment Period|Positive drugs of abuse|0
3020525|NCT00804687|10388379|P3|Period 5: Treatment Period|Positive drugs of abuse|1
3020526|NCT00804687|10388380|P2|Period 5: Treatment Period|Positive drugs of abuse|0
3020527|NCT00804687|10388381|P1|Period 5: Treatment Period|Positive drugs of abuse|0
3020528|NCT00804687|10388376|P6|Period 5: Treatment Period|Withdrawal by Subject|0
3020529|NCT00804687|10388377|P5|Period 5: Treatment Period|Withdrawal by Subject|1
3020530|NCT00804687|10388378|P4|Period 5: Treatment Period|Withdrawal by Subject|0
3020531|NCT00804687|10388379|P3|Period 5: Treatment Period|Withdrawal by Subject|0
3020706|NCT00803179|10388977|P1|Overall Study|Lost to Follow-up|3
3020532|NCT00804687|10388380|P2|Period 5: Treatment Period|Withdrawal by Subject|0
3020533|NCT00804687|10388381|P1|Period 5: Treatment Period|Withdrawal by Subject|0
3020534|NCT00804687|10388376|P6|Period 3: Treatment Period|Positive Drug screen|0
3020535|NCT00804687|10388377|P5|Period 3: Treatment Period|Positive Drug screen|0
3020536|NCT00804687|10388378|P4|Period 3: Treatment Period|Positive Drug screen|1
3020537|NCT00804687|10388379|P3|Period 3: Treatment Period|Positive Drug screen|0
3020538|NCT00804687|10388380|P2|Period 3: Treatment Period|Positive Drug screen|0
3020539|NCT00804687|10388381|P1|Period 3: Treatment Period|Positive Drug screen|0
3020540|NCT00804570|10388460|P2|Overall Study|Withdrawal by Subject|38
3020541|NCT00804570|10388461|P1|Overall Study|Withdrawal by Subject|21
3020542|NCT00804570|10388460|P2|Overall Study|Sponsor decision|4
3020543|NCT00804570|10388461|P1|Overall Study|Sponsor decision|1
3020544|NCT00804570|10388460|P2|Overall Study|Physician Decision|2
3020545|NCT00804570|10388461|P1|Overall Study|Physician Decision|1
3020546|NCT00804570|10388460|P2|Overall Study|Protocol Violation|16
3020547|NCT00804570|10388461|P1|Overall Study|Protocol Violation|12
3020548|NCT00804570|10388460|P2|Overall Study|Entry criteria not met|5
3020549|NCT00804570|10388461|P1|Overall Study|Entry criteria not met|5
3020550|NCT00804570|10388460|P2|Overall Study|Lost to Follow-up|21
3020551|NCT00804570|10388461|P1|Overall Study|Lost to Follow-up|18
3020552|NCT00804570|10388460|P2|Overall Study|Lack of Efficacy|1
3020553|NCT00804570|10388461|P1|Overall Study|Lack of Efficacy|0
3020554|NCT00804570|10388460|P2|Overall Study|Adverse Event|7
3020555|NCT00804570|10388461|P1|Overall Study|Adverse Event|14
3020556|NCT00804193|10388535|P3|Overall Study|Withdrawal by Subject|2
3020557|NCT00804193|10388536|P2|Overall Study|Withdrawal by Subject|1
3020558|NCT00804193|10388537|P1|Overall Study|Withdrawal by Subject|3
3020559|NCT00804193|10388535|P3|Overall Study|Lost to Follow-up|4
3020560|NCT00804193|10388536|P2|Overall Study|Lost to Follow-up|3
3020561|NCT00804193|10388537|P1|Overall Study|Lost to Follow-up|3
3020562|NCT00804193|10388535|P3|Overall Study|Protocol Violation|2
3020563|NCT00804193|10388536|P2|Overall Study|Protocol Violation|8
3020564|NCT00804193|10388537|P1|Overall Study|Protocol Violation|0
3020565|NCT00804193|10388535|P3|Overall Study|Lack of Efficacy|3
3020566|NCT00804193|10388536|P2|Overall Study|Lack of Efficacy|1
3020567|NCT00804193|10388537|P1|Overall Study|Lack of Efficacy|1
3020568|NCT00804193|10388535|P3|Overall Study|Adverse Event|2
3020569|NCT00804193|10388536|P2|Overall Study|Adverse Event|0
3020570|NCT00804193|10388537|P1|Overall Study|Adverse Event|0
3020571|NCT00804193|10388535|P3|Overall Study|Lack of baseline fungus|19
3020572|NCT00804193|10388536|P2|Overall Study|Lack of baseline fungus|31
3020573|NCT00804193|10388537|P1|Overall Study|Lack of baseline fungus|32
3020574|NCT00804141|10388551|P1|Overall Study|Enrolled but not treated|6
3020575|NCT00804141|10388551|P1|Overall Study|Other than specified|30
3020576|NCT00804141|10388551|P1|Overall Study|Lack of Efficacy|46
3020577|NCT00804141|10388551|P1|Overall Study|Withdrawal by Subject|131
3020578|NCT00804141|10388551|P1|Overall Study|Protocol Violation|85
3020579|NCT00804141|10388551|P1|Overall Study|Investigator request|8
3020580|NCT00804141|10388551|P1|Overall Study|Failed to return|96
3020581|NCT00804141|10388551|P1|Overall Study|Death|4
3020582|NCT00804141|10388551|P1|Overall Study|Adverse Event|157
3020583|NCT00803790|10388591|P4|Period 2|Positive Drug Screen or Personal Reasons|0
3020584|NCT00803790|10388592|P3|Period 2|Positive Drug Screen or Personal Reasons|0
3020585|NCT00803790|10388593|P2|Period 2|Positive Drug Screen or Personal Reasons|0
3020586|NCT00803790|10388594|P1|Period 2|Positive Drug Screen or Personal Reasons|1
3020587|NCT00803790|10388591|P4|Period 2|Withdrawal by Subject|0
3020588|NCT00803790|10388592|P3|Period 2|Withdrawal by Subject|0
3020589|NCT00803790|10388593|P2|Period 2|Withdrawal by Subject|0
3020590|NCT00803790|10388594|P1|Period 2|Withdrawal by Subject|1
3020591|NCT00803790|10388591|P4|Period 2|Adverse Event|1
3020592|NCT00803790|10388592|P3|Period 2|Adverse Event|1
3020593|NCT00803790|10388593|P2|Period 2|Adverse Event|0
3020594|NCT00803790|10388594|P1|Period 2|Adverse Event|0
3020595|NCT00803790|10388591|P4|Period 1|Protocol Violation|0
3020596|NCT00803790|10388592|P3|Period 1|Protocol Violation|1
3020597|NCT00803790|10388593|P2|Period 1|Protocol Violation|0
3020598|NCT00803790|10388594|P1|Period 1|Protocol Violation|0
3020599|NCT00803790|10388591|P4|Period 1|positive drug screen or personal reasons|4
3020600|NCT00803790|10388592|P3|Period 1|positive drug screen or personal reasons|0
3020601|NCT00803790|10388593|P2|Period 1|positive drug screen or personal reasons|3
3020602|NCT00803790|10388594|P1|Period 1|positive drug screen or personal reasons|0
3020603|NCT00803790|10388591|P4|Period 1|Withdrawal by Subject|0
3020604|NCT00803790|10388592|P3|Period 1|Withdrawal by Subject|0
3020605|NCT00803790|10388593|P2|Period 1|Withdrawal by Subject|6
3020606|NCT00803790|10388594|P1|Period 1|Withdrawal by Subject|8
3020607|NCT00803790|10388591|P4|Period 1|Lost to Follow-up|0
3020608|NCT00803790|10388592|P3|Period 1|Lost to Follow-up|0
3020609|NCT00803790|10388593|P2|Period 1|Lost to Follow-up|2
3020610|NCT00803790|10388594|P1|Period 1|Lost to Follow-up|1
3020611|NCT00803790|10388591|P4|Period 1|Adverse Event|0
3020612|NCT00803790|10388592|P3|Period 1|Adverse Event|0
3020613|NCT00803790|10388593|P2|Period 1|Adverse Event|1
3020614|NCT00803790|10388594|P1|Period 1|Adverse Event|0
3020615|NCT00803738|10388634|P2|Overall Study|Positive Results for STD or abnormal PAP|8
3020616|NCT00803738|10388635|P1|Overall Study|Positive Results for STD or abnormal PAP|2
3020617|NCT00803738|10388634|P2|Overall Study|Negative Baseline Culture of Candida|63
3020618|NCT00803738|10388635|P1|Overall Study|Negative Baseline Culture of Candida|56
3020619|NCT00803738|10388634|P2|Overall Study|Lack of Efficacy|16
3020620|NCT00803738|10388635|P1|Overall Study|Lack of Efficacy|10
3020621|NCT00803738|10388634|P2|Overall Study|Withdrawal by Subject|4
3020622|NCT00803738|10388635|P1|Overall Study|Withdrawal by Subject|1
3020623|NCT00803738|10388634|P2|Overall Study|Protocol Violation|10
3020624|NCT00803738|10388635|P1|Overall Study|Protocol Violation|18
3020625|NCT00803738|10388634|P2|Overall Study|Lost to Follow-up|4
3020626|NCT00803738|10388635|P1|Overall Study|Lost to Follow-up|4
3020627|NCT00803738|10388634|P2|Overall Study|Adverse Event|5
3020628|NCT00803738|10388635|P1|Overall Study|Adverse Event|3
3020629|NCT00803712|10388647|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
3020630|NCT00803712|10388648|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
3020631|NCT00803712|10388647|P2|Overall Study|Administrative decision|3
3020632|NCT00803712|10388648|P1|Overall Study|Administrative decision|2
3020633|NCT00803712|10388647|P2|Overall Study|Protocol criteria (renal transplant)|8
3020634|NCT00803712|10388648|P1|Overall Study|Protocol criteria (renal transplant)|12
3020635|NCT00803712|10388647|P2|Overall Study|Protocol criteria (other)|2
3020636|NCT00803712|10388648|P1|Overall Study|Protocol criteria (other)|0
3020637|NCT00803712|10388647|P2|Overall Study|"Other in electronic Case Report Form"|1
3020638|NCT00803712|10388648|P1|Overall Study|"Other in electronic Case Report Form"|0
3020639|NCT00803712|10388647|P2|Overall Study|Withdrawal by Subject|4
3020640|NCT00803712|10388648|P1|Overall Study|Withdrawal by Subject|2
3020641|NCT00803712|10388647|P2|Overall Study|Lost to Follow-up|1
3020642|NCT00803712|10388648|P1|Overall Study|Lost to Follow-up|3
3020643|NCT00803712|10388647|P2|Overall Study|Death|7
3020644|NCT00803712|10388648|P1|Overall Study|Death|8
3020645|NCT00803712|10388647|P2|Overall Study|Adverse Event|0
3020646|NCT00803712|10388648|P1|Overall Study|Adverse Event|5
3020647|NCT00803712|10388647|P2|Overall Study|Noncompliance|0
3020648|NCT00803712|10388648|P1|Overall Study|Noncompliance|3
3020649|NCT00803634|10388747|P2|Overall Study|Death|2
3020650|NCT00803634|10388748|P1|Overall Study|Death|3
3020651|NCT00803634|10388747|P2|Overall Study|Lost to Follow-up|3
3020652|NCT00803634|10388748|P1|Overall Study|Lost to Follow-up|2
3020653|NCT00803634|10388747|P2|Overall Study|Withdrew Consent|0
3020654|NCT00803634|10388748|P1|Overall Study|Withdrew Consent|1
3020655|NCT00803595|10388777|P3|Overall Study|Withdrawal by Subject|3
3020656|NCT00803595|10388778|P2|Overall Study|Withdrawal by Subject|2
3020657|NCT00803595|10388779|P1|Overall Study|Withdrawal by Subject|5
3020658|NCT00803595|10388777|P3|Overall Study|Protocol Violation|12
3020659|NCT00803595|10388778|P2|Overall Study|Protocol Violation|2
3020660|NCT00803595|10388779|P1|Overall Study|Protocol Violation|7
3020661|NCT00803595|10388777|P3|Overall Study|Adverse Event|1
3020662|NCT00803595|10388778|P2|Overall Study|Adverse Event|4
3020663|NCT00803595|10388779|P1|Overall Study|Adverse Event|3
3020664|NCT00803569|10388790|P1|Overall Study|Noncompliance|1
3020665|NCT00803569|10388790|P1|Overall Study|Progressive Disease|3
3020666|NCT00803452|10388824|P2|Overall Study|Lost to Follow-up|3
3020667|NCT00803452|10388825|P1|Overall Study|Lost to Follow-up|0
3020668|NCT00803452|10388824|P2|Overall Study|Adverse Event|2
3020669|NCT00803452|10388825|P1|Overall Study|Adverse Event|0
3020670|NCT00803361|10388863|P2|Overall Study|Withdrawal by Subject|6
3020671|NCT00803361|10388864|P1|Overall Study|Withdrawal by Subject|5
3020672|NCT00803361|10388863|P2|Overall Study|Protocol Violation|4
3020673|NCT00803361|10388864|P1|Overall Study|Protocol Violation|2
3020674|NCT00803361|10388863|P2|Overall Study|Physician Decision|0
3020675|NCT00803361|10388864|P1|Overall Study|Physician Decision|1
3020676|NCT00803361|10388863|P2|Overall Study|Lost to Follow-up|2
3020677|NCT00803361|10388864|P1|Overall Study|Lost to Follow-up|1
3020678|NCT00803361|10388863|P2|Overall Study|Lack of Efficacy|13
3020679|NCT00803361|10388864|P1|Overall Study|Lack of Efficacy|4
3020680|NCT00803361|10388863|P2|Overall Study|Adverse Event|3
3020681|NCT00803361|10388864|P1|Overall Study|Adverse Event|13
3020682|NCT00803270|10388911|P2|Overall Study|Lost to Follow-up|2
3020683|NCT00803270|10388912|P1|Overall Study|Lost to Follow-up|1
3020684|NCT00803244|10388922|P2|Overall Study|Any other reason not above-mentioned|10
3020685|NCT00803244|10388923|P1|Overall Study|Any other reason not above-mentioned|4
3020686|NCT00803244|10388922|P2|Overall Study|Withdrawal by Subject|3
3020687|NCT00803244|10388923|P1|Overall Study|Withdrawal by Subject|2
3020688|NCT00803244|10388922|P2|Overall Study|Adverse Event|2
3020689|NCT00803244|10388923|P1|Overall Study|Adverse Event|1
3020690|NCT00803205|10388933|P2|Overall Study|Sponsor Decision|1
3020691|NCT00803205|10388934|P1|Overall Study|Sponsor Decision|0
3020692|NCT00803205|10388933|P2|Overall Study|Acquired a Lung Infection|1
3020693|NCT00803205|10388934|P1|Overall Study|Acquired a Lung Infection|0
3020694|NCT00803205|10388933|P2|Overall Study|Medical Monitor Decision|0
3020695|NCT00803205|10388934|P1|Overall Study|Medical Monitor Decision|1
3020696|NCT00803205|10388933|P2|Overall Study|Protocol Violation|1
3020697|NCT00803205|10388934|P1|Overall Study|Protocol Violation|1
3020698|NCT00803205|10388933|P2|Overall Study|Physician Decision|0
3020699|NCT00803205|10388934|P1|Overall Study|Physician Decision|1
3020700|NCT00803205|10388933|P2|Overall Study|Withdrawal by Subject|9
3020701|NCT00803205|10388934|P1|Overall Study|Withdrawal by Subject|9
3020702|NCT00803205|10388933|P2|Overall Study|Lost to Follow-up|0
3020703|NCT00803205|10388934|P1|Overall Study|Lost to Follow-up|1
3020704|NCT00803205|10388933|P2|Overall Study|Adverse Event|2
3020705|NCT00803205|10388934|P1|Overall Study|Adverse Event|7
3020707|NCT00803101|10388996|P2|Overall Study|Patient did not have surgery|1
3020708|NCT00803101|10388997|P1|Overall Study|Patient did not have surgery|1
3020709|NCT00803101|10388996|P2|Overall Study|Patient did not attend scheduled visit|1
3020710|NCT00803101|10388997|P1|Overall Study|Patient did not attend scheduled visit|2
3020711|NCT00803101|10388996|P2|Overall Study|Patient died outside SAE report period|0
3020712|NCT00803101|10388997|P1|Overall Study|Patient died outside SAE report period|1
3020713|NCT00803101|10388996|P2|Overall Study|Surgery finished outside protocol window|1
3020714|NCT00803101|10388997|P1|Overall Study|Surgery finished outside protocol window|1
3020715|NCT00803101|10388996|P2|Overall Study|Protocol Violation|7
3020716|NCT00803101|10388997|P1|Overall Study|Protocol Violation|1
3020717|NCT00803101|10388996|P2|Overall Study|Lost to Follow-up|2
3020718|NCT00803101|10388997|P1|Overall Study|Lost to Follow-up|2
3020719|NCT00803101|10388996|P2|Overall Study|Withdrawal by Subject|4
3020720|NCT00803101|10388997|P1|Overall Study|Withdrawal by Subject|6
3020721|NCT00803101|10388996|P2|Overall Study|Death / Serious Adverse Event|6
3020722|NCT00803101|10388997|P1|Overall Study|Death / Serious Adverse Event|4
3020723|NCT00803049|10389048|P4|Overall Study|Other than Specified Above|5
3020724|NCT00803049|10389049|P3|Overall Study|Other than Specified Above|2
3020725|NCT00803049|10389050|P2|Overall Study|Other than Specified Above|9
3020726|NCT00803049|10389051|P1|Overall Study|Other than Specified Above|3
3020727|NCT00803049|10389048|P4|Overall Study|Randomized and Not Treated|2
3020728|NCT00803049|10389049|P3|Overall Study|Randomized and Not Treated|0
3020729|NCT00803049|10389050|P2|Overall Study|Randomized and Not Treated|0
3020730|NCT00803049|10389051|P1|Overall Study|Randomized and Not Treated|0
3020731|NCT00803049|10389048|P4|Overall Study|Protocol Violation|0
3020732|NCT00803049|10389049|P3|Overall Study|Protocol Violation|1
3020733|NCT00803049|10389050|P2|Overall Study|Protocol Violation|1
3020734|NCT00803049|10389051|P1|Overall Study|Protocol Violation|0
3020735|NCT00803049|10389048|P4|Overall Study|Withdrawal by Subject|44
3020736|NCT00803049|10389049|P3|Overall Study|Withdrawal by Subject|16
3020737|NCT00803049|10389050|P2|Overall Study|Withdrawal by Subject|43
3020738|NCT00803049|10389051|P1|Overall Study|Withdrawal by Subject|19
3020739|NCT00803049|10389048|P4|Overall Study|Progressive Disease|6
3020740|NCT00803049|10389049|P3|Overall Study|Progressive Disease|6
3020741|NCT00803049|10389050|P2|Overall Study|Progressive Disease|10
3020742|NCT00803049|10389051|P1|Overall Study|Progressive Disease|6
3020743|NCT00803049|10389048|P4|Overall Study|Death|2
3020744|NCT00803049|10389049|P3|Overall Study|Death|0
3020745|NCT00803049|10389050|P2|Overall Study|Death|1
3020746|NCT00803049|10389051|P1|Overall Study|Death|2
3020747|NCT00803049|10389048|P4|Overall Study|Lost to Follow-up|3
3020748|NCT00803049|10389049|P3|Overall Study|Lost to Follow-up|0
3020749|NCT00803049|10389050|P2|Overall Study|Lost to Follow-up|2
3020750|NCT00803049|10389051|P1|Overall Study|Lost to Follow-up|0
3020751|NCT00803049|10389048|P4|Overall Study|Lack of Efficacy|13
3020752|NCT00803049|10389049|P3|Overall Study|Lack of Efficacy|6
3020753|NCT00803049|10389050|P2|Overall Study|Lack of Efficacy|19
3020754|NCT00803049|10389051|P1|Overall Study|Lack of Efficacy|10
3020755|NCT00803049|10389048|P4|Overall Study|Adverse Event|27
3020756|NCT00803049|10389049|P3|Overall Study|Adverse Event|13
3020757|NCT00803049|10389050|P2|Overall Study|Adverse Event|33
3020758|NCT00803049|10389051|P1|Overall Study|Adverse Event|21
3020759|NCT00803023|10389085|P4|Overall Study|Lack of Efficacy|1
3020760|NCT00803023|10389086|P3|Overall Study|Lack of Efficacy|1
3020761|NCT00803023|10389087|P2|Overall Study|Lack of Efficacy|1
3020762|NCT00803023|10389088|P1|Overall Study|Lack of Efficacy|0
3020763|NCT00803023|10389085|P4|Overall Study|Lost to Follow-up|1
3020764|NCT00803023|10389086|P3|Overall Study|Lost to Follow-up|2
3020765|NCT00803023|10389087|P2|Overall Study|Lost to Follow-up|1
3020766|NCT00803023|10389088|P1|Overall Study|Lost to Follow-up|0
3020767|NCT00803023|10389085|P4|Overall Study|Withdrawal by Subject|0
3020768|NCT00803023|10389086|P3|Overall Study|Withdrawal by Subject|0
3020769|NCT00803023|10389087|P2|Overall Study|Withdrawal by Subject|2
3020770|NCT00803023|10389088|P1|Overall Study|Withdrawal by Subject|0
3020771|NCT00803023|10389085|P4|Overall Study|Adverse Event|6
3020772|NCT00803023|10389086|P3|Overall Study|Adverse Event|8
3020773|NCT00803023|10389087|P2|Overall Study|Adverse Event|4
3020774|NCT00803023|10389088|P1|Overall Study|Adverse Event|5
3020775|NCT00802945|10389126|P2|Overall Study|Terminated by sponsor|12
3020776|NCT00802945|10389127|P1|Overall Study|Terminated by sponsor|8
3020777|NCT00802945|10389126|P2|Overall Study|Death|23
3020778|NCT00802945|10389127|P1|Overall Study|Death|27
3020779|NCT00802893|10389158|P1|Overall Study|study terminated|3
3020780|NCT00802867|10389182|P1|Overall Study|Withdrawal by Subject|1
3020781|NCT00802867|10389182|P1|Overall Study|Protocol Violation|6
3020782|NCT00802867|10389182|P1|Overall Study|Lost to Follow-up|6
3020783|NCT00802841|10389205|P2|Overall Study|Treatment duration completed|76
3020784|NCT00802841|10389206|P1|Overall Study|Treatment duration completed|66
3020785|NCT00802841|10389205|P2|Overall Study|Protocol deviation|6
3020786|NCT00802841|10389206|P1|Overall Study|Protocol deviation|2
3020787|NCT00802841|10389205|P2|Overall Study|Withdrawal by Subject|5
3020788|NCT00802841|10389206|P1|Overall Study|Withdrawal by Subject|9
3020789|NCT00802841|10389205|P2|Overall Study|Disease progression|3
3020790|NCT00802841|10389206|P1|Overall Study|Disease progression|7
3020791|NCT00802841|10389205|P2|Overall Study|Adverse Event|2
3020792|NCT00802841|10389206|P1|Overall Study|Adverse Event|8
3020793|NCT00802841|10389205|P2|Overall Study|Death|2
3020794|NCT00802841|10389206|P1|Overall Study|Death|1
3020795|NCT00802841|10389205|P2|Overall Study|Lost to Follow-up|1
3020796|NCT00802841|10389206|P1|Overall Study|Lost to Follow-up|2
3020797|NCT00802841|10389205|P2|Overall Study|Administrative problems|0
3020798|NCT00802841|10389206|P1|Overall Study|Administrative problems|1
3020799|NCT00802737|10389231|P3|Overall Study|Participant too Unwell|0
3020800|NCT00802737|10389232|P2|Overall Study|Participant too Unwell|2
3020801|NCT00802737|10389233|P1|Overall Study|Participant too Unwell|0
3020802|NCT00802737|10389231|P3|Overall Study|Ongoing CLL-Treatment|0
3020803|NCT00802737|10389232|P2|Overall Study|Ongoing CLL-Treatment|1
3020804|NCT00802737|10389233|P1|Overall Study|Ongoing CLL-Treatment|0
3020805|NCT00802737|10389231|P3|Overall Study|Received Prohibited Therapy|0
3020806|NCT00802737|10389232|P2|Overall Study|Received Prohibited Therapy|0
3020807|NCT00802737|10389233|P1|Overall Study|Received Prohibited Therapy|1
3020808|NCT00802737|10389231|P3|Overall Study|Adverse Event|0
3020809|NCT00802737|10389232|P2|Overall Study|Adverse Event|0
3020810|NCT00802737|10389233|P1|Overall Study|Adverse Event|1
3020811|NCT00802737|10389231|P3|Overall Study|Death|1
3020812|NCT00802737|10389232|P2|Overall Study|Death|5
3020813|NCT00802737|10389233|P1|Overall Study|Death|6
3020814|NCT00802737|10389231|P3|Overall Study|Withdrawn due to Disease Progression|0
3020815|NCT00802737|10389232|P2|Overall Study|Withdrawn due to Disease Progression|3
3020816|NCT00802737|10389233|P1|Overall Study|Withdrawn due to Disease Progression|9
3020817|NCT00802672|10389293|P3|Overall Study|other|2
3020818|NCT00802672|10389294|P2|Overall Study|other|1
3020819|NCT00802672|10389295|P1|Overall Study|other|3
3020820|NCT00802672|10389293|P3|Overall Study|Withdrawal by Subject|2
3020821|NCT00802672|10389294|P2|Overall Study|Withdrawal by Subject|1
3020822|NCT00802672|10389295|P1|Overall Study|Withdrawal by Subject|1
3020823|NCT00802672|10389293|P3|Overall Study|Lost to Follow-up|3
3020824|NCT00802672|10389294|P2|Overall Study|Lost to Follow-up|5
3020825|NCT00802672|10389295|P1|Overall Study|Lost to Follow-up|5
3020826|NCT00802672|10389293|P3|Overall Study|Protocol Violation|1
3020827|NCT00802672|10389294|P2|Overall Study|Protocol Violation|1
3020828|NCT00802672|10389295|P1|Overall Study|Protocol Violation|2
3020829|NCT00802672|10389293|P3|Overall Study|Adverse Event|1
3020830|NCT00802672|10389294|P2|Overall Study|Adverse Event|1
3020831|NCT00802672|10389295|P1|Overall Study|Adverse Event|1
3020832|NCT00802672|10389293|P3|Overall Study|Lack of fungal pathogen at baseline|25
3020833|NCT00802672|10389294|P2|Overall Study|Lack of fungal pathogen at baseline|43
3020834|NCT00802672|10389295|P1|Overall Study|Lack of fungal pathogen at baseline|56
3020835|NCT00802659|10389313|P4|Overall Study|Physician Decision|0
3020836|NCT00802659|10389314|P3|Overall Study|Physician Decision|0
3020837|NCT00802659|10389315|P2|Overall Study|Physician Decision|1
3020838|NCT00802659|10389316|P1|Overall Study|Physician Decision|0
3020839|NCT00802529|10389355|P2|Overall Study|Lost to Follow-up|1
3020840|NCT00802529|10389356|P1|Overall Study|Lost to Follow-up|0
3020841|NCT00802464|10389395|P4|Month 8 - Month 14|Lost to Follow-up|0
3020842|NCT00802464|10389396|P3|Month 8 - Month 14|Lost to Follow-up|1
3020843|NCT00802464|10389397|P2|Month 8 - Month 14|Lost to Follow-up|0
3020844|NCT00802464|10389398|P1|Month 8 - Month 14|Lost to Follow-up|0
3020845|NCT00802464|10389395|P4|Month 8 - Month 14|Withdrawal by Subject|0
3020846|NCT00802464|10389396|P3|Month 8 - Month 14|Withdrawal by Subject|0
3020847|NCT00802464|10389397|P2|Month 8 - Month 14|Withdrawal by Subject|1
3020848|NCT00802464|10389398|P1|Month 8 - Month 14|Withdrawal by Subject|1
3020849|NCT00802464|10389395|P4|Month 8 - Month 14|Adverse Event|0
3020850|NCT00802464|10389396|P3|Month 8 - Month 14|Adverse Event|0
3020851|NCT00802464|10389397|P2|Month 8 - Month 14|Adverse Event|1
3020852|NCT00802464|10389398|P1|Month 8 - Month 14|Adverse Event|0
3020853|NCT00802464|10389395|P4|Month 0 - Month 8|Other|0
3020854|NCT00802464|10389396|P3|Month 0 - Month 8|Other|1
3020855|NCT00802464|10389397|P2|Month 0 - Month 8|Other|0
3020856|NCT00802464|10389398|P1|Month 0 - Month 8|Other|0
3020857|NCT00802464|10389395|P4|Month 0 - Month 8|Lost to Follow-up|2
3020858|NCT00802464|10389396|P3|Month 0 - Month 8|Lost to Follow-up|2
3020859|NCT00802464|10389397|P2|Month 0 - Month 8|Lost to Follow-up|1
3020860|NCT00802464|10389398|P1|Month 0 - Month 8|Lost to Follow-up|0
3020861|NCT00802464|10389395|P4|Month 0 - Month 8|Withdrawal by Subject|5
3020862|NCT00802464|10389396|P3|Month 0 - Month 8|Withdrawal by Subject|2
3020863|NCT00802464|10389397|P2|Month 0 - Month 8|Withdrawal by Subject|1
3020864|NCT00802464|10389398|P1|Month 0 - Month 8|Withdrawal by Subject|0
3020865|NCT00802464|10389395|P4|Month 0 - Month 8|Protocol Violation|0
3020866|NCT00802464|10389396|P3|Month 0 - Month 8|Protocol Violation|1
3020867|NCT00802464|10389397|P2|Month 0 - Month 8|Protocol Violation|0
3020868|NCT00802464|10389398|P1|Month 0 - Month 8|Protocol Violation|0
3020869|NCT00802464|10389395|P4|Month 0 - Month 8|Adverse Event|2
3020870|NCT00802464|10389396|P3|Month 0 - Month 8|Adverse Event|1
3020871|NCT00802464|10389397|P2|Month 0 - Month 8|Adverse Event|1
3020872|NCT00802464|10389398|P1|Month 0 - Month 8|Adverse Event|0
3020873|NCT00802438|10389484|P1|Overall Study|Physician Decision|1
3020874|NCT00802438|10389484|P1|Overall Study|Withdrawal by Subject|7
3020875|NCT00802438|10389484|P1|Overall Study|Screen Failure|20
3020876|NCT00802360|10389504|P4|Overall Study|Other|3
3020877|NCT00802360|10389505|P3|Overall Study|Other|6
3020878|NCT00802360|10389506|P2|Overall Study|Other|3
3020879|NCT00802360|10389507|P1|Overall Study|Other|2
3020880|NCT00802360|10389504|P4|Overall Study|Pregnancy loss/miscarriage|3
3020881|NCT00802360|10389505|P3|Overall Study|Pregnancy loss/miscarriage|0
3020882|NCT00802360|10389506|P2|Overall Study|Pregnancy loss/miscarriage|2
3020883|NCT00802360|10389507|P1|Overall Study|Pregnancy loss/miscarriage|0
3020884|NCT00802360|10389504|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
3020885|NCT00802360|10389505|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
3020886|NCT00802360|10389506|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
3020887|NCT00802360|10389507|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
3020888|NCT00802360|10389504|P4|Overall Study|No positive serum pregnancy|10
3020889|NCT00802360|10389505|P3|Overall Study|No positive serum pregnancy|14
3020890|NCT00802360|10389506|P2|Overall Study|No positive serum pregnancy|20
3020891|NCT00802360|10389507|P1|Overall Study|No positive serum pregnancy|17
3020892|NCT00802360|10389504|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
3020893|NCT00802360|10389505|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
3020894|NCT00802360|10389506|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
3020895|NCT00802360|10389507|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
3020896|NCT00802360|10389504|P4|Overall Study|Cycle cancelled|1
3020897|NCT00802360|10389505|P3|Overall Study|Cycle cancelled|1
3020898|NCT00802360|10389506|P2|Overall Study|Cycle cancelled|1
3020899|NCT00802360|10389507|P1|Overall Study|Cycle cancelled|0
3020900|NCT00802360|10389504|P4|Overall Study|Inadequate number of oocytes retrieved|1
3020901|NCT00802360|10389505|P3|Overall Study|Inadequate number of oocytes retrieved|0
3020902|NCT00802360|10389506|P2|Overall Study|Inadequate number of oocytes retrieved|0
3020903|NCT00802360|10389507|P1|Overall Study|Inadequate number of oocytes retrieved|0
3020904|NCT00802360|10389504|P4|Overall Study|Stimulation failure|3
3020905|NCT00802360|10389505|P3|Overall Study|Stimulation failure|3
3020906|NCT00802360|10389506|P2|Overall Study|Stimulation failure|0
3020907|NCT00802360|10389507|P1|Overall Study|Stimulation failure|4
3020908|NCT00802178|10389574|P1|Overall Study|Patients wish and other reason|1
3020909|NCT00802178|10389574|P1|Overall Study|IT and patient wish|8
3020910|NCT00802178|10389574|P1|Overall Study|Lack of efficacy and patient wish|1
3020911|NCT00802178|10389574|P1|Overall Study|Other|32
3020912|NCT00802178|10389574|P1|Overall Study|Withdrawal by Subject|18
3020913|NCT00802178|10389574|P1|Overall Study|Insufficient tolerability (IT)|17
3020914|NCT00802178|10389574|P1|Overall Study|Lack of Efficacy|36
3020915|NCT00802074|10389622|P6|Overall Study|Withdrawal by Subject|0
3020916|NCT00802074|10389623|P5|Overall Study|Withdrawal by Subject|0
3020917|NCT00802074|10389624|P4|Overall Study|Withdrawal by Subject|0
3020918|NCT00802074|10389625|P3|Overall Study|Withdrawal by Subject|0
3020919|NCT00802074|10389626|P2|Overall Study|Withdrawal by Subject|0
3020920|NCT00802074|10389627|P1|Overall Study|Withdrawal by Subject|1
3020921|NCT00802074|10389622|P6|Overall Study|Adverse Event|0
3020922|NCT00802074|10389623|P5|Overall Study|Adverse Event|0
3020923|NCT00802074|10389624|P4|Overall Study|Adverse Event|0
3020924|NCT00802074|10389625|P3|Overall Study|Adverse Event|1
3020925|NCT00802074|10389626|P2|Overall Study|Adverse Event|1
3020926|NCT00802074|10389627|P1|Overall Study|Adverse Event|1
3020927|NCT00801983|10389661|P2|Period 2|Withdrawal by Subject|1
3020928|NCT00801983|10389662|P1|Period 2|Withdrawal by Subject|2
3020929|NCT00801983|10389661|P2|Period 1|Withdrawal by Subject|8
3020930|NCT00801983|10389662|P1|Period 1|Withdrawal by Subject|2
3020931|NCT00801983|10389661|P2|Period 1|Lost to Follow-up|0
3020932|NCT00801983|10389662|P1|Period 1|Lost to Follow-up|2
3020933|NCT00801892|10389677|P2|Sham Crossover Period|Lost to Follow-up|2
3020934|NCT00801892|10389678|P1|Sham Crossover Period|Lost to Follow-up|0
3020935|NCT00801892|10389677|P2|Main Study Period|Withdrawal by Subject|1
3020936|NCT00801892|10389678|P1|Main Study Period|Withdrawal by Subject|0
3020937|NCT00801632|10389725|P1|Overall Study|Re-transplant|1
3020938|NCT00801242|10389803|P1|Overall Study|Miscellaneous reasons|20
3020939|NCT00801242|10389803|P1|Overall Study|Lost to Follow-up|1
3020940|NCT00801242|10389803|P1|Overall Study|Physician Decision|3
3020941|NCT00801242|10389803|P1|Overall Study|Protocol Violation|5
3020942|NCT00801242|10389803|P1|Overall Study|Withdrawal by Subject|13
3020943|NCT00801242|10389803|P1|Overall Study|Adverse Event|10
3020944|NCT00801229|10389816|P2|Received Study Drug/Placebo|Adverse Event|1
3020945|NCT00801229|10389817|P1|Received Study Drug/Placebo|Adverse Event|1
3020946|NCT00801229|10389816|P2|Received Study Drug/Placebo|Lost to Follow-up|1
3020947|NCT00801229|10389817|P1|Received Study Drug/Placebo|Lost to Follow-up|0
3020948|NCT00801229|10389816|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
3020949|NCT00801229|10389817|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
3020950|NCT00801229|10389816|P2|Received Study Drug/Placebo|Simulator sickness|1
3020951|NCT00801229|10389817|P1|Received Study Drug/Placebo|Simulator sickness|1
3020952|NCT00801229|10389816|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
3020953|NCT00801229|10389817|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
3020954|NCT00801229|10389816|P2|Received Study Drug/Placebo|Elevated SGOT level|0
3020955|NCT00801229|10389817|P1|Received Study Drug/Placebo|Elevated SGOT level|1
3020956|NCT00801229|10389816|P2|Signed Consent|Found Ineligible|1
3020957|NCT00801229|10389817|P1|Signed Consent|Found Ineligible|1
3020958|NCT00801229|10389816|P2|Signed Consent|Withdrawal by Subject|2
3020959|NCT00801229|10389817|P1|Signed Consent|Withdrawal by Subject|2
3020960|NCT00801099|10389852|P1|Overall Study|Lost to Follow-up|101
3020961|NCT00800982|10389858|P2|Overall Study|Patient moved out of state|0
3020962|NCT00800982|10389859|P1|Overall Study|Patient moved out of state|1
3020963|NCT00800982|10389858|P2|Overall Study|Withdrawal by Subject|1
3020964|NCT00800982|10389859|P1|Overall Study|Withdrawal by Subject|0
3020965|NCT00800982|10389858|P2|Overall Study|Lost to Follow-up|2
3020966|NCT00800982|10389859|P1|Overall Study|Lost to Follow-up|1
3020967|NCT00800735|10389885|P1|Overall Study|Withdrew Consent|3
3020968|NCT00800735|10389885|P1|Overall Study|Violation of Selection Criteria at Entry|7
3020969|NCT00800735|10389885|P1|Overall Study|Insufficient Therapeutic Response|2
3020970|NCT00800735|10389885|P1|Overall Study|Administrative/Other|2
3020971|NCT00800683|10389891|P2|Overall Study|Other|2
3020972|NCT00800683|10389892|P1|Overall Study|Other|1
3020973|NCT00800683|10389891|P2|Overall Study|Lack of Efficacy|1
3020974|NCT00800683|10389892|P1|Overall Study|Lack of Efficacy|1
3020975|NCT00800683|10389891|P2|Overall Study|Withdrawal by Subject|7
3020976|NCT00800683|10389892|P1|Overall Study|Withdrawal by Subject|1
3020977|NCT00800683|10389891|P2|Overall Study|Lost to Follow-up|1
3020978|NCT00800683|10389892|P1|Overall Study|Lost to Follow-up|3
3020979|NCT00800683|10389891|P2|Overall Study|Adverse Event|8
3020980|NCT00800683|10389892|P1|Overall Study|Adverse Event|11
3020981|NCT00800540|10389938|P2|Period 2: 6 Weeks|Adverse Event|1
3020982|NCT00800540|10389939|P1|Period 2: 6 Weeks|Adverse Event|0
3020983|NCT00800540|10389938|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
3020984|NCT00800540|10389939|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
3020985|NCT00800540|10389938|P2|Period One: 6 Weeks|Noncompliance|0
3020986|NCT00800540|10389939|P1|Period One: 6 Weeks|Noncompliance|1
3020987|NCT00800436|10389974|P7|Overall Study|Withdrawal by Subject|0
3020988|NCT00800436|10389975|P6|Overall Study|Withdrawal by Subject|0
3020989|NCT00800436|10389976|P5|Overall Study|Withdrawal by Subject|0
3020990|NCT00800436|10389977|P4|Overall Study|Withdrawal by Subject|1
3020991|NCT00800436|10389978|P3|Overall Study|Withdrawal by Subject|1
3020992|NCT00800436|10389979|P2|Overall Study|Withdrawal by Subject|0
3020993|NCT00800436|10389980|P1|Overall Study|Withdrawal by Subject|0
3020994|NCT00800384|10390026|P2|Overall Study|Lost to Follow-up|26
3020995|NCT00800384|10390027|P1|Overall Study|Lost to Follow-up|17
3020996|NCT00800384|10390026|P2|Overall Study|Withdrawal by Subject|17
3020997|NCT00800384|10390027|P1|Overall Study|Withdrawal by Subject|24
3020998|NCT00800202|10390065|P2|Overall Study|Disease Progression|18
3020999|NCT00800202|10390066|P1|Overall Study|Disease Progression|54
3021000|NCT00800202|10390065|P2|Overall Study|Other|0
3021001|NCT00800202|10390066|P1|Overall Study|Other|5
3021002|NCT00800202|10390065|P2|Overall Study|Death|0
3021003|NCT00800202|10390066|P1|Overall Study|Death|1
3021004|NCT00800202|10390065|P2|Overall Study|Adverse Event|6
3021005|NCT00800202|10390066|P1|Overall Study|Adverse Event|7
3021006|NCT00799903|10390086|P2|Overall Study|Lost to Follow-up|80
3021007|NCT00799903|10390087|P1|Overall Study|Lost to Follow-up|69
3021008|NCT00799903|10390086|P2|Overall Study|Withdrawal by Subject|175
3021009|NCT00799903|10390087|P1|Overall Study|Withdrawal by Subject|179
3021010|NCT00799903|10390086|P2|Overall Study|Investigator Site Closed|23
3021011|NCT00799903|10390087|P1|Overall Study|Investigator Site Closed|25
3021012|NCT00799825|10390107|P1|Overall Study|Pregnancy|3
3021013|NCT00799825|10390107|P1|Overall Study|Lost to Follow-up|38
3021014|NCT00799825|10390107|P1|Overall Study|Withdrawal by Subject|6
3021015|NCT00799825|10390107|P1|Overall Study|Adverse Event|1
3021016|NCT00799708|10390147|P3|Overall Study|non-compliance|0
3021017|NCT00799708|10390148|P2|Overall Study|non-compliance|0
3021018|NCT00799708|10390149|P1|Overall Study|non-compliance|1
3021019|NCT00799617|10390172|P2|Anemia Trial|Withdrawal by Subject|3
3021020|NCT00799617|10390173|P1|Anemia Trial|Withdrawal by Subject|3
3021021|NCT00799617|10390172|P2|Cognitive Function Trial|Lost to Follow-up|1
3021022|NCT00799617|10390173|P1|Cognitive Function Trial|Lost to Follow-up|0
3021023|NCT00799617|10390172|P2|Bone Trial|Month 12 scan not available|16
3021024|NCT00799617|10390173|P1|Bone Trial|Month 12 scan not available|6
3021025|NCT00799617|10390172|P2|Cardiovascular Trial|Baseline scan not analyzable|2
3021026|NCT00799617|10390173|P1|Cardiovascular Trial|Baseline scan not analyzable|0
3021027|NCT00799617|10390172|P2|Cardiovascular Trial|Month 12 scan not available|15
3021028|NCT00799617|10390173|P1|Cardiovascular Trial|Month 12 scan not available|15
3021029|NCT00799617|10390172|P2|Vitality Trial|Lost to Follow-up|22
3021030|NCT00799617|10390173|P1|Vitality Trial|Lost to Follow-up|7
3021031|NCT00799617|10390172|P2|Physical Function Trial|Lost to Follow-up|11
3021032|NCT00799617|10390173|P1|Physical Function Trial|Lost to Follow-up|6
3021033|NCT00799617|10390172|P2|Sexual Funtion Trial|No Baseline Data|7
3021034|NCT00799617|10390173|P1|Sexual Funtion Trial|No Baseline Data|4
3021035|NCT00799617|10390172|P2|Sexual Funtion Trial|Lost to Follow-up|14
3021036|NCT00799617|10390173|P1|Sexual Funtion Trial|Lost to Follow-up|12
3021037|NCT00799617|10390172|P2|Main Testosterone Trial|Lost to Follow-up|20
3021038|NCT00799617|10390173|P1|Main Testosterone Trial|Lost to Follow-up|18
3021039|NCT00799617|10390172|P2|Main Testosterone Trial|Randomized in error|1
3021040|NCT00799617|10390173|P1|Main Testosterone Trial|Randomized in error|1
3021041|NCT00799591|10390280|P1|Overall Study|Infectious origin not probable|1
3021042|NCT00799591|10390280|P1|Overall Study|Antibiotic changed, no apparent reason|1
3021043|NCT00799591|10390280|P1|Overall Study|Persistance of fever undetermined origin|1
3021044|NCT00799591|10390280|P1|Overall Study|Resistance germ and technical failure|2
3021045|NCT00799591|10390280|P1|Overall Study|New infection|4
3021046|NCT00799591|10390280|P1|Overall Study|Resistant germ|11
3021047|NCT00799591|10390280|P1|Overall Study|Technical failure|12
3021048|NCT00799591|10390280|P1|Overall Study|Death|14
3021049|NCT00799591|10390280|P1|Overall Study|De-escalation of doses|20
3021050|NCT00799487|10390298|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
3021051|NCT00799487|10390299|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
3021052|NCT00799487|10390300|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
3021053|NCT00799487|10390298|P3|Double-Blind Assessment Period|Subject was out of the state|1
3021054|NCT00799487|10390299|P2|Double-Blind Assessment Period|Subject was out of the state|0
3021055|NCT00799487|10390300|P1|Double-Blind Assessment Period|Subject was out of the state|0
3021056|NCT00799487|10390298|P3|Double-Blind Assessment Period|Lost to Follow-up|1
3021057|NCT00799487|10390299|P2|Double-Blind Assessment Period|Lost to Follow-up|0
3021058|NCT00799487|10390300|P1|Double-Blind Assessment Period|Lost to Follow-up|0
3021059|NCT00799487|10390298|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
3021060|NCT00799487|10390299|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
3021061|NCT00799487|10390300|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
3021062|NCT00799487|10390298|P3|Dose Adjustment Period|Missed laboratory day 1|0
3021063|NCT00799487|10390299|P2|Dose Adjustment Period|Missed laboratory day 1|0
3021064|NCT00799487|10390300|P1|Dose Adjustment Period|Missed laboratory day 1|1
3021065|NCT00799487|10390298|P3|Dose Adjustment Period|Child too young (exclusion)|0
3021066|NCT00799487|10390299|P2|Dose Adjustment Period|Child too young (exclusion)|0
3021067|NCT00799487|10390300|P1|Dose Adjustment Period|Child too young (exclusion)|1
3021068|NCT00799487|10390298|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
3021069|NCT00799487|10390299|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
3021070|NCT00799487|10390300|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
3021071|NCT00799487|10390298|P3|Dose Adjustment Period|Withdrawal by Subject|0
3021072|NCT00799487|10390299|P2|Dose Adjustment Period|Withdrawal by Subject|0
3021073|NCT00799487|10390300|P1|Dose Adjustment Period|Withdrawal by Subject|3
3021074|NCT00799487|10390298|P3|Dose Adjustment Period|Investigator Discretion|0
3021075|NCT00799487|10390299|P2|Dose Adjustment Period|Investigator Discretion|0
3021076|NCT00799487|10390300|P1|Dose Adjustment Period|Investigator Discretion|2
3021077|NCT00799487|10390298|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
3021078|NCT00799487|10390299|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
3021079|NCT00799487|10390300|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
3021080|NCT00799487|10390298|P3|Dose Adjustment Period|Adverse Event|0
3021081|NCT00799487|10390299|P2|Dose Adjustment Period|Adverse Event|0
3021082|NCT00799487|10390300|P1|Dose Adjustment Period|Adverse Event|2
3021083|NCT00799487|10390298|P3|Dose Adjustment Period|Lost to Follow-up|0
3021084|NCT00799487|10390299|P2|Dose Adjustment Period|Lost to Follow-up|0
3021085|NCT00799487|10390300|P1|Dose Adjustment Period|Lost to Follow-up|1
3021086|NCT00799422|10390395|P6|First Week of Wear|Adverse Event|0
3021087|NCT00799422|10390396|P5|First Week of Wear|Adverse Event|0
3021088|NCT00799422|10390397|P4|First Week of Wear|Adverse Event|1
3021089|NCT00799422|10390398|P3|First Week of Wear|Adverse Event|0
3021090|NCT00799422|10390399|P2|First Week of Wear|Adverse Event|0
3021091|NCT00799422|10390400|P1|First Week of Wear|Adverse Event|0
3021092|NCT00799422|10390395|P6|First Week of Wear|Lost to Follow-up|0
3021093|NCT00799422|10390396|P5|First Week of Wear|Lost to Follow-up|0
3021094|NCT00799422|10390397|P4|First Week of Wear|Lost to Follow-up|0
3021095|NCT00799422|10390398|P3|First Week of Wear|Lost to Follow-up|1
3021096|NCT00799422|10390399|P2|First Week of Wear|Lost to Follow-up|0
3021097|NCT00799422|10390400|P1|First Week of Wear|Lost to Follow-up|0
3021098|NCT00799409|10390417|P3|Overall Study|medication compliance|0
3021099|NCT00799409|10390418|P2|Overall Study|medication compliance|0
3021100|NCT00799409|10390419|P1|Overall Study|medication compliance|1
3021101|NCT00799409|10390417|P3|Overall Study|Did not attend lab school day 1|0
3021102|NCT00799409|10390418|P2|Overall Study|Did not attend lab school day 1|0
3021103|NCT00799409|10390419|P1|Overall Study|Did not attend lab school day 1|1
3021104|NCT00799409|10390417|P3|Overall Study|Failure to follow study protocol)|0
3021105|NCT00799409|10390418|P2|Overall Study|Failure to follow study protocol)|0
3021106|NCT00799409|10390419|P1|Overall Study|Failure to follow study protocol)|1
3021107|NCT00799409|10390417|P3|Overall Study|Optimal Dose Not Achieved|0
3021108|NCT00799409|10390418|P2|Overall Study|Optimal Dose Not Achieved|0
3021109|NCT00799409|10390419|P1|Overall Study|Optimal Dose Not Achieved|2
3021110|NCT00799409|10390417|P3|Overall Study|Lost to Follow-up|0
3021111|NCT00799409|10390418|P2|Overall Study|Lost to Follow-up|0
3021112|NCT00799409|10390419|P1|Overall Study|Lost to Follow-up|1
3021113|NCT00799409|10390417|P3|Overall Study|Withdrawal by Subject|0
3021114|NCT00799409|10390418|P2|Overall Study|Withdrawal by Subject|0
3021115|NCT00799409|10390419|P1|Overall Study|Withdrawal by Subject|1
3021116|NCT00799396|10390499|P1|Clopidogrel Plus Aspirin|Physician Decision|4
3021117|NCT00799396|10390499|P1|Clopidogrel Plus Aspirin|Adverse Event|2
3021118|NCT00799396|10390499|P1|Clopidogrel Treatment|Withdrawal by Subject|2
3021119|NCT00799396|10390499|P1|Clopidogrel Treatment|Physician Decision|5
3021120|NCT00799396|10390499|P1|Clopidogrel Treatment|Adverse Event|6
3021121|NCT00799383|10390506|P2|Overall Study|Withdrawal by Subject|1
3021122|NCT00799383|10390507|P1|Overall Study|Withdrawal by Subject|0
3021123|NCT00799383|10390506|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
3021124|NCT00799383|10390507|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
3021125|NCT00799383|10390506|P2|Overall Study|Lost to Follow-up|2
3021126|NCT00799383|10390507|P1|Overall Study|Lost to Follow-up|1
3021127|NCT00799383|10390506|P2|Overall Study|Adverse Event|1
3021128|NCT00799383|10390507|P1|Overall Study|Adverse Event|0
3021129|NCT00799383|10390506|P2|Overall Study|Protocol Violation|1
3021130|NCT00799383|10390507|P1|Overall Study|Protocol Violation|1
3021131|NCT00799266|10390536|P2|Overall Study|Subject withdrew consent|0
3021132|NCT00799266|10390537|P1|Overall Study|Subject withdrew consent|3
3021133|NCT00799266|10390536|P2|Overall Study|Adverse Event|1
3021134|NCT00799266|10390537|P1|Overall Study|Adverse Event|0
3021135|NCT00798967|10390577|P2|Overall Study|Randomized in error by site|0
3021136|NCT00798967|10390578|P1|Overall Study|Randomized in error by site|1
3021137|NCT00798967|10390577|P2|Overall Study|Physician Decision|0
3021138|NCT00798967|10390578|P1|Overall Study|Physician Decision|1
3021139|NCT00798967|10390577|P2|Overall Study|Withdrawal by Subject|1
3021140|NCT00798967|10390578|P1|Overall Study|Withdrawal by Subject|0
3021141|NCT00798967|10390577|P2|Overall Study|Adverse Event|3
3021142|NCT00798967|10390578|P1|Overall Study|Adverse Event|2
3021143|NCT00798889|10390586|P1|Overall Study|Enrolled, Not treated|3
3021144|NCT00798889|10390586|P1|Overall Study|Decision of Sponsor|11
3021145|NCT00798889|10390586|P1|Overall Study|Lack of Efficacy|213
3021146|NCT00798889|10390586|P1|Overall Study|Lost to Follow-up|1
3021147|NCT00798889|10390586|P1|Overall Study|Withdrawal by Subject|31
3021148|NCT00798889|10390586|P1|Overall Study|Protocol Violation|2
3021149|NCT00798889|10390586|P1|Overall Study|Adverse Event|53
3021150|NCT00798759|10390592|P2|Overall Study|Other|1
3021151|NCT00798759|10390593|P1|Overall Study|Other|0
3021152|NCT00798759|10390592|P2|Overall Study|Protocol Violation|8
3021153|NCT00798759|10390593|P1|Overall Study|Protocol Violation|4
3021154|NCT00798759|10390592|P2|Overall Study|Lost to Follow-up|1
3021155|NCT00798759|10390593|P1|Overall Study|Lost to Follow-up|1
3021156|NCT00798759|10390592|P2|Overall Study|Adverse Event|3
3021157|NCT00798759|10390593|P1|Overall Study|Adverse Event|3
3021158|NCT00798707|10390611|P3|Overall Study|Randomized not treated|1
3021159|NCT00798707|10390612|P2|Overall Study|Randomized not treated|5
3021160|NCT00798707|10390613|P1|Overall Study|Randomized not treated|4
3021161|NCT00798707|10390611|P3|Overall Study|Withdrawal by Subject|2
3021162|NCT00798707|10390612|P2|Overall Study|Withdrawal by Subject|8
3021163|NCT00798707|10390613|P1|Overall Study|Withdrawal by Subject|3
3021164|NCT00798707|10390611|P3|Overall Study|Protocol Violation|2
3021165|NCT00798707|10390612|P2|Overall Study|Protocol Violation|0
3021166|NCT00798707|10390613|P1|Overall Study|Protocol Violation|4
3021167|NCT00798707|10390611|P3|Overall Study|Other|0
3021168|NCT00798707|10390612|P2|Overall Study|Other|1
3021169|NCT00798707|10390613|P1|Overall Study|Other|0
3021170|NCT00798707|10390611|P3|Overall Study|Lost to Follow-up|6
3021171|NCT00798707|10390612|P2|Overall Study|Lost to Follow-up|6
3021172|NCT00798707|10390613|P1|Overall Study|Lost to Follow-up|5
3021173|NCT00798707|10390611|P3|Overall Study|Lack of Efficacy|1
3021174|NCT00798707|10390612|P2|Overall Study|Lack of Efficacy|2
3021175|NCT00798707|10390613|P1|Overall Study|Lack of Efficacy|2
3021176|NCT00798707|10390611|P3|Overall Study|Investigator|2
3021177|NCT00798707|10390612|P2|Overall Study|Investigator|1
3021178|NCT00798707|10390613|P1|Overall Study|Investigator|0
3021179|NCT00798707|10390611|P3|Overall Study|Failed to return|0
3021180|NCT00798707|10390612|P2|Overall Study|Failed to return|2
3021181|NCT00798707|10390613|P1|Overall Study|Failed to return|2
3021182|NCT00798707|10390611|P3|Overall Study|Adverse Event|8
3021183|NCT00798707|10390612|P2|Overall Study|Adverse Event|8
3021184|NCT00798707|10390613|P1|Overall Study|Adverse Event|6
3021185|NCT00798694|10390665|P2|Overall Study|Physician Decision|0
3021186|NCT00798694|10390666|P1|Overall Study|Physician Decision|1
3021187|NCT00798694|10390665|P2|Overall Study|Lost to Follow-up|1
3021188|NCT00798694|10390666|P1|Overall Study|Lost to Follow-up|1
3021189|NCT00798655|10390690|P1|Overall Study|Did not receive at least one dose of pan|2
3021190|NCT00798603|10390695|P1|Overall Study|Lack of insurance coverage|1
3021191|NCT00798603|10390695|P1|Overall Study|Physician Decision|1
3021192|NCT00798603|10390695|P1|Overall Study|Adverse Event|22
3021193|NCT00798603|10390695|P1|Overall Study|Withdrawal by Subject|10
3021194|NCT00798603|10390695|P1|Overall Study|Still on treatment as of 11/6/2012|1
3021195|NCT00798590|10390717|P2|Overall Study|P.I, Left institution. Study terminated|8
3021196|NCT00798590|10390718|P1|Overall Study|P.I, Left institution. Study terminated|11
3021197|NCT00798434|10390752|P2|Open-Label|Not Treated|1
3021198|NCT00798434|10390753|P1|Open-Label|Not Treated|0
3021199|NCT00798434|10390752|P2|Open-Label|Other|2
3021200|NCT00798434|10390753|P1|Open-Label|Other|1
3021201|NCT00798434|10390752|P2|Open-Label|Protocol Violation|0
3021202|NCT00798434|10390753|P1|Open-Label|Protocol Violation|1
3021203|NCT00798434|10390752|P2|Open-Label|Withdrawal by Subject|7
3021204|NCT00798434|10390753|P1|Open-Label|Withdrawal by Subject|2
3021205|NCT00798434|10390752|P2|Open-Label|Lack of Efficacy|11
3021206|NCT00798434|10390753|P1|Open-Label|Lack of Efficacy|5
3021207|NCT00798434|10390752|P2|Open-Label|Adverse Event|11
3021208|NCT00798434|10390753|P1|Open-Label|Adverse Event|33
3021209|NCT00798434|10390752|P2|Double-Blind|Not Treated|6
3021210|NCT00798434|10390753|P1|Double-Blind|Not Treated|3
3021211|NCT00798434|10390752|P2|Double-Blind|Other|0
3021212|NCT00798434|10390753|P1|Double-Blind|Other|1
3021213|NCT00798434|10390752|P2|Double-Blind|Did Not Meet Entrance Criteria|1
3021214|NCT00798434|10390753|P1|Double-Blind|Did Not Meet Entrance Criteria|2
3021215|NCT00798434|10390752|P2|Double-Blind|Protocol Violation|4
3021216|NCT00798434|10390753|P1|Double-Blind|Protocol Violation|1
3021217|NCT00798434|10390752|P2|Double-Blind|Withdrawal by Subject|14
3021218|NCT00798434|10390753|P1|Double-Blind|Withdrawal by Subject|17
3021219|NCT00798434|10390752|P2|Double-Blind|Lack of Efficacy|12
3021220|NCT00798434|10390753|P1|Double-Blind|Lack of Efficacy|8
3021221|NCT00798434|10390752|P2|Double-Blind|Lost to Follow-up|0
3021222|NCT00798434|10390753|P1|Double-Blind|Lost to Follow-up|1
3021223|NCT00798434|10390752|P2|Double-Blind|Death|1
3021224|NCT00798434|10390753|P1|Double-Blind|Death|0
3021225|NCT00798434|10390752|P2|Double-Blind|Adverse Event|46
3021226|NCT00798434|10390753|P1|Double-Blind|Adverse Event|22
3021227|NCT00798369|10390839|P6|Overall Study|Adminstrative problems|1
3021228|NCT00798369|10390840|P5|Overall Study|Adminstrative problems|0
3021229|NCT00798369|10390841|P4|Overall Study|Adminstrative problems|0
3021230|NCT00798369|10390842|P3|Overall Study|Adminstrative problems|0
3021231|NCT00798369|10390843|P2|Overall Study|Adminstrative problems|0
3021232|NCT00798369|10390844|P1|Overall Study|Adminstrative problems|0
3021233|NCT00798369|10390839|P6|Overall Study|Lost to Follow-up|0
3021234|NCT00798369|10390840|P5|Overall Study|Lost to Follow-up|1
3021235|NCT00798369|10390841|P4|Overall Study|Lost to Follow-up|0
3021236|NCT00798369|10390842|P3|Overall Study|Lost to Follow-up|1
3021237|NCT00798369|10390843|P2|Overall Study|Lost to Follow-up|1
3021238|NCT00798369|10390844|P1|Overall Study|Lost to Follow-up|1
3021239|NCT00798369|10390839|P6|Overall Study|Subject withdrew consent|2
3021240|NCT00798369|10390840|P5|Overall Study|Subject withdrew consent|0
3021241|NCT00798369|10390841|P4|Overall Study|Subject withdrew consent|1
3021242|NCT00798369|10390842|P3|Overall Study|Subject withdrew consent|1
3021243|NCT00798369|10390843|P2|Overall Study|Subject withdrew consent|0
3021244|NCT00798369|10390844|P1|Overall Study|Subject withdrew consent|0
3021245|NCT00798317|10390891|P2|Overall Study|Death|0
3021246|NCT00798317|10390892|P1|Overall Study|Death|1
3021247|NCT00798317|10390891|P2|Overall Study|Adverse Event|0
3021248|NCT00798317|10390892|P1|Overall Study|Adverse Event|2
3021249|NCT00798317|10390891|P2|Overall Study|Lost to Follow-up|2
3021250|NCT00798317|10390892|P1|Overall Study|Lost to Follow-up|2
3021251|NCT00798317|10390891|P2|Overall Study|Withdrawal by Subject|4
3021252|NCT00798317|10390892|P1|Overall Study|Withdrawal by Subject|5
3021253|NCT00798317|10390891|P2|Overall Study|Physician Decision|1
3021254|NCT00798317|10390892|P1|Overall Study|Physician Decision|0
3021255|NCT00798304|10390903|P3|Overall Study|Discontinuation by Sponsor|9
3021256|NCT00798304|10390904|P2|Overall Study|Discontinuation by Sponsor|21
3021257|NCT00798304|10390905|P1|Overall Study|Discontinuation by Sponsor|14
3021258|NCT00798304|10390903|P3|Overall Study|Adverse Event|1
3021259|NCT00798304|10390904|P2|Overall Study|Adverse Event|1
3021260|NCT00798304|10390905|P1|Overall Study|Adverse Event|0
3021261|NCT00798174|10390931|P2|Overall Study|Inability to sedate for DFT testing|0
3021262|NCT00798174|10390932|P1|Overall Study|Inability to sedate for DFT testing|1
3021263|NCT00798174|10390931|P2|Overall Study|inability to implant azygos coil|3
3021264|NCT00798174|10390932|P1|Overall Study|inability to implant azygos coil|3
3021265|NCT00798161|10390943|P7|Overall Study|Other reason (incl. lack of efficacy)|5
3021266|NCT00798161|10390944|P6|Overall Study|Other reason (incl. lack of efficacy)|4
3021267|NCT00798161|10390945|P5|Overall Study|Other reason (incl. lack of efficacy)|2
3021268|NCT00798161|10390946|P4|Overall Study|Other reason (incl. lack of efficacy)|5
3021269|NCT00798161|10390947|P3|Overall Study|Other reason (incl. lack of efficacy)|3
3021270|NCT00798161|10390948|P2|Overall Study|Other reason (incl. lack of efficacy)|5
3021271|NCT00798161|10390949|P1|Overall Study|Other reason (incl. lack of efficacy)|7
3021272|NCT00798161|10390943|P7|Overall Study|Withdrawal by Subject|1
3021273|NCT00798161|10390944|P6|Overall Study|Withdrawal by Subject|3
3021274|NCT00798161|10390945|P5|Overall Study|Withdrawal by Subject|2
3021275|NCT00798161|10390946|P4|Overall Study|Withdrawal by Subject|4
3021276|NCT00798161|10390947|P3|Overall Study|Withdrawal by Subject|5
3021277|NCT00798161|10390948|P2|Overall Study|Withdrawal by Subject|4
3021278|NCT00798161|10390949|P1|Overall Study|Withdrawal by Subject|5
3021279|NCT00798161|10390943|P7|Overall Study|Lost to Follow-up|0
3021280|NCT00798161|10390944|P6|Overall Study|Lost to Follow-up|0
3021281|NCT00798161|10390945|P5|Overall Study|Lost to Follow-up|4
3021282|NCT00798161|10390946|P4|Overall Study|Lost to Follow-up|3
3021283|NCT00798161|10390947|P3|Overall Study|Lost to Follow-up|4
3021284|NCT00798161|10390948|P2|Overall Study|Lost to Follow-up|3
3021285|NCT00798161|10390949|P1|Overall Study|Lost to Follow-up|1
3021286|NCT00798161|10390943|P7|Overall Study|Protocol Violation|0
3021287|NCT00798161|10390944|P6|Overall Study|Protocol Violation|2
3021288|NCT00798161|10390945|P5|Overall Study|Protocol Violation|3
3021289|NCT00798161|10390946|P4|Overall Study|Protocol Violation|3
3021290|NCT00798161|10390947|P3|Overall Study|Protocol Violation|3
3021291|NCT00798161|10390948|P2|Overall Study|Protocol Violation|1
3021292|NCT00798161|10390949|P1|Overall Study|Protocol Violation|2
3021293|NCT00798161|10390943|P7|Overall Study|Adverse Event|4
3021294|NCT00798161|10390944|P6|Overall Study|Adverse Event|2
3021295|NCT00798161|10390945|P5|Overall Study|Adverse Event|5
3021296|NCT00798161|10390946|P4|Overall Study|Adverse Event|6
3021297|NCT00798161|10390947|P3|Overall Study|Adverse Event|6
3021298|NCT00798161|10390948|P2|Overall Study|Adverse Event|4
3021299|NCT00798161|10390949|P1|Overall Study|Adverse Event|3
3021300|NCT00798135|10391056|P1|Overall Study|Physician Decision|1
3021301|NCT00798135|10391056|P1|Overall Study|Disease progression, refractory|1
3021302|NCT00798135|10391056|P1|Overall Study|Disease progression, relapse|11
3021303|NCT00798096|10391062|P1|Overall Study|Ongoing|2
3021304|NCT00797966|10391090|P6|Phase A+|Protocol deviation|4
3021305|NCT00797966|10391091|P5|Phase A+|Protocol deviation|0
3021306|NCT00797966|10391092|P4|Phase A+|Protocol deviation|0
3021307|NCT00797966|10391093|P3|Phase A+|Protocol deviation|0
3021308|NCT00797966|10391094|P2|Phase A+|Protocol deviation|0
3021309|NCT00797966|10391095|P1|Phase A+|Protocol deviation|0
3021310|NCT00797966|10391090|P6|Phase A+|Adverse Event|4
3021311|NCT00797966|10391091|P5|Phase A+|Adverse Event|0
3021312|NCT00797966|10391092|P4|Phase A+|Adverse Event|0
3021313|NCT00797966|10391093|P3|Phase A+|Adverse Event|0
3021314|NCT00797966|10391094|P2|Phase A+|Adverse Event|0
3021315|NCT00797966|10391095|P1|Phase A+|Adverse Event|0
3021316|NCT00797966|10391090|P6|Phase A+|Withdrawal by Subject|6
3021317|NCT00797966|10391091|P5|Phase A+|Withdrawal by Subject|0
3021318|NCT00797966|10391092|P4|Phase A+|Withdrawal by Subject|0
3021319|NCT00797966|10391093|P3|Phase A+|Withdrawal by Subject|0
3021320|NCT00797966|10391094|P2|Phase A+|Withdrawal by Subject|0
3021321|NCT00797966|10391095|P1|Phase A+|Withdrawal by Subject|0
3021322|NCT00797966|10391090|P6|Phase A+|Met withdrawal criteria|5
3021323|NCT00797966|10391091|P5|Phase A+|Met withdrawal criteria|0
3021324|NCT00797966|10391092|P4|Phase A+|Met withdrawal criteria|0
3021325|NCT00797966|10391093|P3|Phase A+|Met withdrawal criteria|0
3021326|NCT00797966|10391094|P2|Phase A+|Met withdrawal criteria|0
3021327|NCT00797966|10391095|P1|Phase A+|Met withdrawal criteria|0
3021328|NCT00797966|10391090|P6|Phase A+|Lost to Follow-up|9
3021329|NCT00797966|10391091|P5|Phase A+|Lost to Follow-up|0
3021330|NCT00797966|10391092|P4|Phase A+|Lost to Follow-up|0
3021331|NCT00797966|10391093|P3|Phase A+|Lost to Follow-up|0
3021332|NCT00797966|10391094|P2|Phase A+|Lost to Follow-up|0
3021333|NCT00797966|10391095|P1|Phase A+|Lost to Follow-up|0
3021334|NCT00797966|10391090|P6|Phase B|Lack of Efficacy|0
3021335|NCT00797966|10391091|P5|Phase B|Lack of Efficacy|0
3021336|NCT00797966|10391092|P4|Phase B|Lack of Efficacy|4
3021337|NCT00797966|10391093|P3|Phase B|Lack of Efficacy|1
3021338|NCT00797966|10391094|P2|Phase B|Lack of Efficacy|1
3021339|NCT00797966|10391095|P1|Phase B|Lack of Efficacy|0
3021340|NCT00797966|10391090|P6|Phase B|Protocol Deviation|0
3021341|NCT00797966|10391091|P5|Phase B|Protocol Deviation|0
3021342|NCT00797966|10391092|P4|Phase B|Protocol Deviation|6
3021343|NCT00797966|10391093|P3|Phase B|Protocol Deviation|2
3021344|NCT00797966|10391094|P2|Phase B|Protocol Deviation|8
3021345|NCT00797966|10391095|P1|Phase B|Protocol Deviation|4
3021346|NCT00797966|10391090|P6|Phase B|Withdrawal by Subject|0
3021347|NCT00797966|10391091|P5|Phase B|Withdrawal by Subject|0
3021348|NCT00797966|10391092|P4|Phase B|Withdrawal by Subject|3
3021349|NCT00797966|10391093|P3|Phase B|Withdrawal by Subject|3
3021350|NCT00797966|10391094|P2|Phase B|Withdrawal by Subject|4
3021351|NCT00797966|10391095|P1|Phase B|Withdrawal by Subject|1
3021352|NCT00797966|10391090|P6|Phase B|Physician Decision|0
3021353|NCT00797966|10391091|P5|Phase B|Physician Decision|0
3021354|NCT00797966|10391092|P4|Phase B|Physician Decision|1
3021355|NCT00797966|10391093|P3|Phase B|Physician Decision|3
3021356|NCT00797966|10391094|P2|Phase B|Physician Decision|0
3021357|NCT00797966|10391095|P1|Phase B|Physician Decision|1
3021358|NCT00797966|10391090|P6|Phase B|Met Withdrawal Criteria|0
3021359|NCT00797966|10391091|P5|Phase B|Met Withdrawal Criteria|0
3021360|NCT00797966|10391092|P4|Phase B|Met Withdrawal Criteria|1
3021361|NCT00797966|10391093|P3|Phase B|Met Withdrawal Criteria|6
3021362|NCT00797966|10391094|P2|Phase B|Met Withdrawal Criteria|3
3021363|NCT00797966|10391095|P1|Phase B|Met Withdrawal Criteria|3
3021364|NCT00797966|10391090|P6|Phase B|Adverse Event|0
3021365|NCT00797966|10391091|P5|Phase B|Adverse Event|0
3021366|NCT00797966|10391092|P4|Phase B|Adverse Event|1
3021367|NCT00797966|10391093|P3|Phase B|Adverse Event|3
3021368|NCT00797966|10391094|P2|Phase B|Adverse Event|1
3021369|NCT00797966|10391095|P1|Phase B|Adverse Event|2
3021370|NCT00797966|10391090|P6|Phase B|Lost to Follow-up|0
3021371|NCT00797966|10391091|P5|Phase B|Lost to Follow-up|0
3021372|NCT00797966|10391092|P4|Phase B|Lost to Follow-up|0
3021373|NCT00797966|10391093|P3|Phase B|Lost to Follow-up|3
3021374|NCT00797966|10391094|P2|Phase B|Lost to Follow-up|1
3021375|NCT00797966|10391095|P1|Phase B|Lost to Follow-up|0
3021376|NCT00797966|10391090|P6|Phase A|Protocol deviation|0
3021377|NCT00797966|10391091|P5|Phase A|Protocol deviation|56
3021378|NCT00797966|10391092|P4|Phase A|Protocol deviation|0
3021379|NCT00797966|10391093|P3|Phase A|Protocol deviation|0
3021380|NCT00797966|10391094|P2|Phase A|Protocol deviation|0
3021381|NCT00797966|10391095|P1|Phase A|Protocol deviation|0
3021382|NCT00797966|10391090|P6|Phase A|Withdrawal by Subject|0
3021383|NCT00797966|10391091|P5|Phase A|Withdrawal by Subject|33
3021384|NCT00797966|10391092|P4|Phase A|Withdrawal by Subject|0
3021385|NCT00797966|10391093|P3|Phase A|Withdrawal by Subject|0
3021386|NCT00797966|10391094|P2|Phase A|Withdrawal by Subject|0
3021387|NCT00797966|10391095|P1|Phase A|Withdrawal by Subject|0
3021388|NCT00797966|10391090|P6|Phase A|Physician Decision|0
3021389|NCT00797966|10391091|P5|Phase A|Physician Decision|13
3021390|NCT00797966|10391092|P4|Phase A|Physician Decision|0
3021391|NCT00797966|10391093|P3|Phase A|Physician Decision|0
3021392|NCT00797966|10391094|P2|Phase A|Physician Decision|0
3021393|NCT00797966|10391095|P1|Phase A|Physician Decision|0
3021394|NCT00797966|10391090|P6|Phase A|Met withdrawal criteria|0
3021395|NCT00797966|10391091|P5|Phase A|Met withdrawal criteria|4
3021396|NCT00797966|10391092|P4|Phase A|Met withdrawal criteria|0
3021397|NCT00797966|10391093|P3|Phase A|Met withdrawal criteria|0
3021398|NCT00797966|10391094|P2|Phase A|Met withdrawal criteria|0
3021399|NCT00797966|10391095|P1|Phase A|Met withdrawal criteria|0
3021400|NCT00797966|10391090|P6|Phase A|Adverse Event|0
3021401|NCT00797966|10391091|P5|Phase A|Adverse Event|46
3021402|NCT00797966|10391092|P4|Phase A|Adverse Event|0
3021403|NCT00797966|10391093|P3|Phase A|Adverse Event|0
3021404|NCT00797966|10391094|P2|Phase A|Adverse Event|0
3021405|NCT00797966|10391095|P1|Phase A|Adverse Event|0
3021406|NCT00797966|10391090|P6|Phase A|Lost to Follow-up|0
3021407|NCT00797966|10391091|P5|Phase A|Lost to Follow-up|33
3021408|NCT00797966|10391092|P4|Phase A|Lost to Follow-up|0
3021409|NCT00797966|10391093|P3|Phase A|Lost to Follow-up|0
3021410|NCT00797966|10391094|P2|Phase A|Lost to Follow-up|0
3021411|NCT00797966|10391095|P1|Phase A|Lost to Follow-up|0
3021412|NCT00797862|10391160|P3|Overall Study|Mis-randomized|1
3021413|NCT00797862|10391161|P2|Overall Study|Mis-randomized|3
3021414|NCT00797862|10391162|P1|Overall Study|Mis-randomized|3
3021415|NCT00797862|10391160|P3|Overall Study|Protocol Violation|8
3021416|NCT00797862|10391161|P2|Overall Study|Protocol Violation|6
3021417|NCT00797862|10391162|P1|Overall Study|Protocol Violation|4
3021418|NCT00797862|10391160|P3|Overall Study|Administrative Problem|0
3021419|NCT00797862|10391161|P2|Overall Study|Administrative Problem|0
3021420|NCT00797862|10391162|P1|Overall Study|Administrative Problem|4
3021421|NCT00797862|10391160|P3|Overall Study|Lost to Follow-up|5
3021422|NCT00797862|10391161|P2|Overall Study|Lost to Follow-up|0
3021423|NCT00797862|10391162|P1|Overall Study|Lost to Follow-up|11
3021424|NCT00797862|10391160|P3|Overall Study|Withdrawal by Subject|7
3021425|NCT00797862|10391161|P2|Overall Study|Withdrawal by Subject|7
3021426|NCT00797862|10391162|P1|Overall Study|Withdrawal by Subject|14
3021427|NCT00797862|10391160|P3|Overall Study|No longer required study medication|0
3021428|NCT00797862|10391161|P2|Overall Study|No longer required study medication|0
3021429|NCT00797862|10391162|P1|Overall Study|No longer required study medication|1
3021430|NCT00797862|10391160|P3|Overall Study|Lack of Efficacy|6
3021431|NCT00797862|10391161|P2|Overall Study|Lack of Efficacy|7
3021432|NCT00797862|10391162|P1|Overall Study|Lack of Efficacy|1
3021433|NCT00797862|10391160|P3|Overall Study|Abnormal Test Procedure Result|1
3021434|NCT00797862|10391161|P2|Overall Study|Abnormal Test Procedure Result|1
3021435|NCT00797862|10391162|P1|Overall Study|Abnormal Test Procedure Result|0
3021436|NCT00797862|10391160|P3|Overall Study|Adverse Event|58
3021437|NCT00797862|10391161|P2|Overall Study|Adverse Event|44
3021438|NCT00797862|10391162|P1|Overall Study|Adverse Event|86
3021439|NCT00797823|10391191|P3|First Period (Initial Randomization)|Physician Decision|0
3021440|NCT00797823|10391192|P2|First Period (Initial Randomization)|Physician Decision|0
3021441|NCT00797823|10391193|P1|First Period (Initial Randomization)|Physician Decision|1
3021442|NCT00797732|10391215|P3|Overall Study|Refused to Participate|123
3021443|NCT00797732|10391216|P2|Overall Study|Refused to Participate|0
3021444|NCT00797732|10391217|P1|Overall Study|Refused to Participate|0
3021445|NCT00797732|10391215|P3|Overall Study|Excluded due to time constraints|24
3021446|NCT00797732|10391216|P2|Overall Study|Excluded due to time constraints|0
3021447|NCT00797732|10391217|P1|Overall Study|Excluded due to time constraints|0
3021448|NCT00797732|10391215|P3|Overall Study|Not meet inclusion criteria|7
3021449|NCT00797732|10391216|P2|Overall Study|Not meet inclusion criteria|0
3021450|NCT00797732|10391217|P1|Overall Study|Not meet inclusion criteria|0
3021451|NCT00797732|10391215|P3|Overall Study|Death|0
3021452|NCT00797732|10391216|P2|Overall Study|Death|0
3021453|NCT00797732|10391217|P1|Overall Study|Death|1
3021454|NCT00797732|10391215|P3|Overall Study|Lost to Follow-up|0
3021455|NCT00797732|10391216|P2|Overall Study|Lost to Follow-up|0
3021456|NCT00797732|10391217|P1|Overall Study|Lost to Follow-up|1
3021457|NCT00797732|10391215|P3|Overall Study|Withdrawal by Subject|0
3021458|NCT00797732|10391216|P2|Overall Study|Withdrawal by Subject|3
3021459|NCT00797732|10391217|P1|Overall Study|Withdrawal by Subject|3
3021460|NCT00797667|10391232|P3|Overall Study|Adverse Event|8
3021461|NCT00797667|10391233|P2|Overall Study|Adverse Event|8
3021462|NCT00797667|10391234|P1|Overall Study|Adverse Event|19
3021463|NCT00797667|10391232|P3|Overall Study|Withdrawal by Subject|2
3021464|NCT00797667|10391233|P2|Overall Study|Withdrawal by Subject|14
3021465|NCT00797667|10391234|P1|Overall Study|Withdrawal by Subject|9
3021466|NCT00797667|10391232|P3|Overall Study|Study Terminated by Sponsor|115
3021467|NCT00797667|10391233|P2|Overall Study|Study Terminated by Sponsor|216
3021468|NCT00797667|10391234|P1|Overall Study|Study Terminated by Sponsor|217
3021469|NCT00797667|10391232|P3|Overall Study|Protocol Violation|0
3021470|NCT00797667|10391233|P2|Overall Study|Protocol Violation|7
3021471|NCT00797667|10391234|P1|Overall Study|Protocol Violation|2
3021472|NCT00797667|10391232|P3|Overall Study|Pregnancy|0
3021473|NCT00797667|10391233|P2|Overall Study|Pregnancy|0
3021474|NCT00797667|10391234|P1|Overall Study|Pregnancy|2
3021475|NCT00797667|10391232|P3|Overall Study|Physician Decision|0
3021476|NCT00797667|10391233|P2|Overall Study|Physician Decision|1
3021477|NCT00797667|10391234|P1|Overall Study|Physician Decision|3
3021478|NCT00797667|10391232|P3|Overall Study|Lost to Follow-up|2
3021479|NCT00797667|10391233|P2|Overall Study|Lost to Follow-up|12
3021480|NCT00797667|10391234|P1|Overall Study|Lost to Follow-up|8
3021481|NCT00797667|10391232|P3|Overall Study|Lack of Efficacy|0
3021482|NCT00797667|10391233|P2|Overall Study|Lack of Efficacy|1
3021483|NCT00797667|10391234|P1|Overall Study|Lack of Efficacy|0
3021484|NCT00797563|10391260|P1|Overall Study|Adverse Event|1
3021485|NCT00797511|10391266|P1|Overall Study|Withdrawal by Subject|1
3021486|NCT00797316|10391284|P2|Overall Study|Unsatisfactory therapeutic effect|13
3021487|NCT00797316|10391285|P1|Overall Study|Unsatisfactory therapeutic effect|0
3021488|NCT00797316|10391284|P2|Overall Study|Patient withdrew consent|6
3021489|NCT00797316|10391285|P1|Overall Study|Patient withdrew consent|12
3021490|NCT00797316|10391284|P2|Overall Study|Protocol Deviation|2
3021491|NCT00797316|10391285|P1|Overall Study|Protocol Deviation|1
3021492|NCT00797316|10391284|P2|Overall Study|Lost to Follow-up|8
3021493|NCT00797316|10391285|P1|Overall Study|Lost to Follow-up|4
3021494|NCT00797316|10391284|P2|Overall Study|Adverse Event|3
3021495|NCT00797316|10391285|P1|Overall Study|Adverse Event|5
3021496|NCT00797316|10391284|P2|Overall Study|Administrative problems|0
3021497|NCT00797316|10391285|P1|Overall Study|Administrative problems|1
3021498|NCT00797225|10391314|P8|Weeks 13 to 24|Sponsor Decision|0
3021499|NCT00797225|10391315|P7|Weeks 13 to 24|Sponsor Decision|1
3021500|NCT00797225|10391316|P6|Weeks 13 to 24|Sponsor Decision|0
3021501|NCT00797225|10391317|P5|Weeks 13 to 24|Sponsor Decision|0
3021502|NCT00797225|10391318|P4|Weeks 13 to 24|Sponsor Decision|0
3021503|NCT00797225|10391319|P3|Weeks 13 to 24|Sponsor Decision|0
3021504|NCT00797225|10391320|P2|Weeks 13 to 24|Sponsor Decision|0
3021505|NCT00797225|10391321|P1|Weeks 13 to 24|Sponsor Decision|0
3021506|NCT00797225|10391314|P8|Weeks 13 to 24|Adverse Event|0
3021507|NCT00797225|10391315|P7|Weeks 13 to 24|Adverse Event|1
3021508|NCT00797225|10391316|P6|Weeks 13 to 24|Adverse Event|0
3021509|NCT00797225|10391317|P5|Weeks 13 to 24|Adverse Event|0
3021510|NCT00797225|10391318|P4|Weeks 13 to 24|Adverse Event|0
3021511|NCT00797225|10391319|P3|Weeks 13 to 24|Adverse Event|0
3021512|NCT00797225|10391320|P2|Weeks 13 to 24|Adverse Event|1
3021513|NCT00797225|10391321|P1|Weeks 13 to 24|Adverse Event|0
3021514|NCT00797225|10391314|P8|Weeks 13 to 24|Lost to Follow-up|0
3021515|NCT00797225|10391315|P7|Weeks 13 to 24|Lost to Follow-up|0
3021516|NCT00797225|10391316|P6|Weeks 13 to 24|Lost to Follow-up|0
3021517|NCT00797225|10391317|P5|Weeks 13 to 24|Lost to Follow-up|1
3021518|NCT00797225|10391318|P4|Weeks 13 to 24|Lost to Follow-up|0
3021519|NCT00797225|10391319|P3|Weeks 13 to 24|Lost to Follow-up|1
3021520|NCT00797225|10391320|P2|Weeks 13 to 24|Lost to Follow-up|0
3021521|NCT00797225|10391321|P1|Weeks 13 to 24|Lost to Follow-up|0
3021522|NCT00797225|10391314|P8|Weeks 13 to 24|Withdrawal by Subject|0
3021523|NCT00797225|10391315|P7|Weeks 13 to 24|Withdrawal by Subject|0
3021524|NCT00797225|10391316|P6|Weeks 13 to 24|Withdrawal by Subject|0
3021525|NCT00797225|10391317|P5|Weeks 13 to 24|Withdrawal by Subject|0
3021526|NCT00797225|10391318|P4|Weeks 13 to 24|Withdrawal by Subject|0
3021527|NCT00797225|10391319|P3|Weeks 13 to 24|Withdrawal by Subject|1
3021528|NCT00797225|10391320|P2|Weeks 13 to 24|Withdrawal by Subject|1
3021529|NCT00797225|10391321|P1|Weeks 13 to 24|Withdrawal by Subject|0
3021530|NCT00797225|10391314|P8|Weeks 13 to 24|Non-compliance|0
3021531|NCT00797225|10391315|P7|Weeks 13 to 24|Non-compliance|0
3021532|NCT00797225|10391316|P6|Weeks 13 to 24|Non-compliance|0
3021533|NCT00797225|10391317|P5|Weeks 13 to 24|Non-compliance|0
3021534|NCT00797225|10391318|P4|Weeks 13 to 24|Non-compliance|0
3021535|NCT00797225|10391319|P3|Weeks 13 to 24|Non-compliance|0
3021536|NCT00797225|10391320|P2|Weeks 13 to 24|Non-compliance|2
3021537|NCT00797225|10391321|P1|Weeks 13 to 24|Non-compliance|0
3021538|NCT00797225|10391314|P8|Weeks 1 to 12|Sponsor Decision|0
3021539|NCT00797225|10391315|P7|Weeks 1 to 12|Sponsor Decision|0
3021540|NCT00797225|10391316|P6|Weeks 1 to 12|Sponsor Decision|0
3021541|NCT00797225|10391317|P5|Weeks 1 to 12|Sponsor Decision|0
3021542|NCT00797225|10391318|P4|Weeks 1 to 12|Sponsor Decision|0
3021543|NCT00797225|10391319|P3|Weeks 1 to 12|Sponsor Decision|0
3021544|NCT00797225|10391320|P2|Weeks 1 to 12|Sponsor Decision|0
3021545|NCT00797225|10391321|P1|Weeks 1 to 12|Sponsor Decision|1
3021546|NCT00797225|10391314|P8|Weeks 1 to 12|Lack of Efficacy|0
3021547|NCT00797225|10391315|P7|Weeks 1 to 12|Lack of Efficacy|0
3021548|NCT00797225|10391316|P6|Weeks 1 to 12|Lack of Efficacy|0
3021549|NCT00797225|10391317|P5|Weeks 1 to 12|Lack of Efficacy|0
3021550|NCT00797225|10391318|P4|Weeks 1 to 12|Lack of Efficacy|0
3021551|NCT00797225|10391319|P3|Weeks 1 to 12|Lack of Efficacy|0
3021552|NCT00797225|10391320|P2|Weeks 1 to 12|Lack of Efficacy|0
3021553|NCT00797225|10391321|P1|Weeks 1 to 12|Lack of Efficacy|1
3021554|NCT00797225|10391314|P8|Weeks 1 to 12|Non-compliance|0
3021555|NCT00797225|10391315|P7|Weeks 1 to 12|Non-compliance|0
3021556|NCT00797225|10391316|P6|Weeks 1 to 12|Non-compliance|0
3021557|NCT00797225|10391317|P5|Weeks 1 to 12|Non-compliance|0
3021558|NCT00797225|10391318|P4|Weeks 1 to 12|Non-compliance|0
3021559|NCT00797225|10391319|P3|Weeks 1 to 12|Non-compliance|0
3021560|NCT00797225|10391320|P2|Weeks 1 to 12|Non-compliance|1
3021561|NCT00797225|10391321|P1|Weeks 1 to 12|Non-compliance|0
3021562|NCT00797225|10391314|P8|Weeks 1 to 12|Adverse Event|0
3021563|NCT00797225|10391315|P7|Weeks 1 to 12|Adverse Event|0
3021564|NCT00797225|10391316|P6|Weeks 1 to 12|Adverse Event|0
3021565|NCT00797225|10391317|P5|Weeks 1 to 12|Adverse Event|0
3021566|NCT00797225|10391318|P4|Weeks 1 to 12|Adverse Event|0
3021567|NCT00797225|10391319|P3|Weeks 1 to 12|Adverse Event|1
3021568|NCT00797225|10391320|P2|Weeks 1 to 12|Adverse Event|0
3021569|NCT00797225|10391321|P1|Weeks 1 to 12|Adverse Event|0
3021570|NCT00797108|10391438|P3|Overall Study|Randomized but not Treated|0
3021571|NCT00797108|10391439|P2|Overall Study|Randomized but not Treated|0
3021572|NCT00797108|10391440|P1|Overall Study|Randomized but not Treated|2
3021573|NCT00797108|10391438|P3|Overall Study|Other|2
3021574|NCT00797108|10391439|P2|Overall Study|Other|0
3021575|NCT00797108|10391440|P1|Overall Study|Other|0
3021576|NCT00797108|10391438|P3|Overall Study|Lack of Efficacy|1
3021577|NCT00797108|10391439|P2|Overall Study|Lack of Efficacy|0
3021578|NCT00797108|10391440|P1|Overall Study|Lack of Efficacy|1
3021579|NCT00797108|10391438|P3|Overall Study|Global Deterioration of Health Status|0
3021580|NCT00797108|10391439|P2|Overall Study|Global Deterioration of Health Status|1
3021581|NCT00797108|10391440|P1|Overall Study|Global Deterioration of Health Status|0
3021582|NCT00797108|10391438|P3|Overall Study|Did Not Meet Entrance Criteria|0
3021583|NCT00797108|10391439|P2|Overall Study|Did Not Meet Entrance Criteria|1
3021584|NCT00797108|10391440|P1|Overall Study|Did Not Meet Entrance Criteria|0
3021585|NCT00797108|10391438|P3|Overall Study|Adverse Event|3
3021586|NCT00797108|10391439|P2|Overall Study|Adverse Event|0
3021587|NCT00797108|10391440|P1|Overall Study|Adverse Event|1
3021588|NCT00796991|10391475|P3|Overall Study|Withdrawal by Subject|1
3021589|NCT00796991|10391476|P2|Overall Study|Withdrawal by Subject|0
3021590|NCT00796991|10391477|P1|Overall Study|Withdrawal by Subject|0
3021591|NCT00796991|10391475|P3|Overall Study|Study Drug Toxicity|5
3021592|NCT00796991|10391476|P2|Overall Study|Study Drug Toxicity|3
3021593|NCT00796991|10391477|P1|Overall Study|Study Drug Toxicity|3
3021594|NCT00796991|10391475|P3|Overall Study|Disease Progression|7
3021595|NCT00796991|10391476|P2|Overall Study|Disease Progression|9
3021596|NCT00796991|10391477|P1|Overall Study|Disease Progression|10
3021597|NCT00796991|10391475|P3|Overall Study|Death|0
3021598|NCT00796991|10391476|P2|Overall Study|Death|0
3021599|NCT00796991|10391477|P1|Overall Study|Death|2
3021600|NCT00796991|10391475|P3|Overall Study|Adverse Event|1
3021601|NCT00796991|10391476|P2|Overall Study|Adverse Event|0
3021602|NCT00796991|10391477|P1|Overall Study|Adverse Event|0
3021603|NCT00796861|10391584|P1|Overall Study|Death|2
3021604|NCT00796861|10391584|P1|Overall Study|Withdrawal by Subject|2
3021605|NCT00796822|10391590|P2|Overall Study|Adverse Event|0
3021606|NCT00796822|10391591|P1|Overall Study|Adverse Event|1
3021607|NCT00796822|10391590|P2|Overall Study|Lost to Follow-up|0
3021608|NCT00796822|10391591|P1|Overall Study|Lost to Follow-up|2
3021609|NCT00796757|10391599|P1|Overall Study|Other|7
3021610|NCT00796757|10391599|P1|Overall Study|Investigator's decision|2
3021611|NCT00796757|10391599|P1|Overall Study|Participant noncompliance|1
3021612|NCT00796757|10391599|P1|Overall Study|Protocol Violation|1
3021613|NCT00796757|10391599|P1|Overall Study|Death|61
3021614|NCT00796757|10391599|P1|Overall Study|Withdrawal by Subject|14
3021615|NCT00796718|10391633|P1|Overall Study|Withdrawal by Informed Consent|1
3021616|NCT00796718|10391633|P1|Overall Study|Lost to Follow-up|5
3021617|NCT00796718|10391633|P1|Overall Study|Exclusion Criteria|1
3021618|NCT00796718|10391633|P1|Overall Study|Adverse Event|2
3021619|NCT00796666|10391685|P2|Overall Study|Randomized and not treated|0
3021620|NCT00796666|10391686|P1|Overall Study|Randomized and not treated|1
3021621|NCT00796666|10391685|P2|Overall Study|Terminated by sponsor|55
3021622|NCT00796666|10391686|P1|Overall Study|Terminated by sponsor|53
3021623|NCT00796666|10391685|P2|Overall Study|Other|0
3021624|NCT00796666|10391686|P1|Overall Study|Other|1
3021625|NCT00796666|10391685|P2|Overall Study|Protocol Violation|0
3021626|NCT00796666|10391686|P1|Overall Study|Protocol Violation|1
3021627|NCT00796666|10391685|P2|Overall Study|Adverse Event|5
3021628|NCT00796666|10391686|P1|Overall Study|Adverse Event|7
3021629|NCT00796666|10391685|P2|Overall Study|Withdrawal by Subject|0
3021630|NCT00796666|10391686|P1|Overall Study|Withdrawal by Subject|2
3021631|NCT00796666|10391685|P2|Overall Study|Death|4
3021632|NCT00796666|10391686|P1|Overall Study|Death|2
3021633|NCT00796653|10391720|P4|Overall Study|Other reason not described above|4
3021634|NCT00796653|10391721|P3|Overall Study|Other reason not described above|7
3021635|NCT00796653|10391722|P2|Overall Study|Other reason not described above|9
3021636|NCT00796653|10391723|P1|Overall Study|Other reason not described above|4
3021637|NCT00796653|10391720|P4|Overall Study|Non compliance with protocol|2
3021638|NCT00796653|10391721|P3|Overall Study|Non compliance with protocol|0
3021639|NCT00796653|10391722|P2|Overall Study|Non compliance with protocol|2
3021640|NCT00796653|10391723|P1|Overall Study|Non compliance with protocol|2
3021641|NCT00796653|10391720|P4|Overall Study|Lack of Efficacy|2
3021642|NCT00796653|10391721|P3|Overall Study|Lack of Efficacy|3
3021643|NCT00796653|10391722|P2|Overall Study|Lack of Efficacy|1
3021644|NCT00796653|10391723|P1|Overall Study|Lack of Efficacy|8
3021645|NCT00796653|10391720|P4|Overall Study|Withdrawal by Subject|13
3021646|NCT00796653|10391721|P3|Overall Study|Withdrawal by Subject|8
3021647|NCT00796653|10391722|P2|Overall Study|Withdrawal by Subject|8
3021648|NCT00796653|10391723|P1|Overall Study|Withdrawal by Subject|16
3021649|NCT00796653|10391720|P4|Overall Study|Lost to Follow-up|3
3021650|NCT00796653|10391721|P3|Overall Study|Lost to Follow-up|2
3021651|NCT00796653|10391722|P2|Overall Study|Lost to Follow-up|1
3021652|NCT00796653|10391723|P1|Overall Study|Lost to Follow-up|2
3021653|NCT00796653|10391720|P4|Overall Study|Adverse Event|16
3021654|NCT00796653|10391721|P3|Overall Study|Adverse Event|16
3021655|NCT00796653|10391722|P2|Overall Study|Adverse Event|16
3021656|NCT00796653|10391723|P1|Overall Study|Adverse Event|19
3021657|NCT00796614|10392008|P4|Overall Study|Other than stated|0
3021658|NCT00796614|10392009|P3|Overall Study|Other than stated|0
3021659|NCT00796614|10392010|P2|Overall Study|Other than stated|0
3021660|NCT00796614|10392011|P1|Overall Study|Other than stated|1
3021661|NCT00796614|10392008|P4|Overall Study|Withdrawal by Subject|1
3021662|NCT00796614|10392009|P3|Overall Study|Withdrawal by Subject|0
3021663|NCT00796614|10392010|P2|Overall Study|Withdrawal by Subject|0
3021664|NCT00796614|10392011|P1|Overall Study|Withdrawal by Subject|1
3021665|NCT00796614|10392008|P4|Overall Study|Lost to Follow-up|0
3021666|NCT00796614|10392009|P3|Overall Study|Lost to Follow-up|1
3021667|NCT00796614|10392010|P2|Overall Study|Lost to Follow-up|2
3021668|NCT00796614|10392011|P1|Overall Study|Lost to Follow-up|2
3021669|NCT00796614|10392008|P4|Overall Study|Protocol Violation|0
3021670|NCT00796614|10392009|P3|Overall Study|Protocol Violation|2
3021671|NCT00796614|10392010|P2|Overall Study|Protocol Violation|0
3021672|NCT00796614|10392011|P1|Overall Study|Protocol Violation|0
3021673|NCT00796614|10392008|P4|Overall Study|Adverse Event|0
3021674|NCT00796614|10392009|P3|Overall Study|Adverse Event|0
3021675|NCT00796614|10392010|P2|Overall Study|Adverse Event|2
3021676|NCT00796614|10392011|P1|Overall Study|Adverse Event|1
3021677|NCT00796562|10392053|P1|Overall Study|Death|49
3021678|NCT00796549|10392062|P1|Overall Study|Progressive disease|56
3021679|NCT00796549|10392062|P1|Overall Study|Other|2
3021680|NCT00796549|10392062|P1|Overall Study|not entered|149
3021681|NCT00796549|10392062|P1|Overall Study|Adverse Event|11
3021682|NCT00796523|10392079|P2|Overall Study|Lost to Follow-up|7
3021683|NCT00796523|10392080|P1|Overall Study|Lost to Follow-up|9
3021684|NCT00796510|10392090|P2|Overall Study|Study Terminated|0
3021685|NCT00796510|10392091|P1|Overall Study|Study Terminated|2
3021686|NCT00796510|10392090|P2|Overall Study|Death|0
3021687|NCT00796510|10392091|P1|Overall Study|Death|1
3021688|NCT00796445|10392103|P2|Overall Study|Withdrawal by Subject|9
3021689|NCT00796445|10392104|P1|Overall Study|Withdrawal by Subject|18
3021690|NCT00796445|10392103|P2|Overall Study|Other|7
3021691|NCT00796445|10392104|P1|Overall Study|Other|10
3021692|NCT00796445|10392103|P2|Overall Study|Disease progression/recurrence|268
3021693|NCT00796445|10392104|P1|Overall Study|Disease progression/recurrence|537
3021694|NCT00796445|10392103|P2|Overall Study|Adverse event, non-fatal|0
3021695|NCT00796445|10392104|P1|Overall Study|Adverse event, non-fatal|4
3021696|NCT00796445|10392103|P2|Overall Study|Adverse event, serious fatal|5
3021697|NCT00796445|10392104|P1|Overall Study|Adverse event, serious fatal|10
3021698|NCT00796445|10392103|P2|Overall Study|Protocol Violation|3
3021699|NCT00796445|10392104|P1|Overall Study|Protocol Violation|5
3021700|NCT00796419|10392156|P2|Overall Study|Death|1
3021701|NCT00796419|10392157|P1|Overall Study|Death|0
3021702|NCT00796367|10392170|P3|Overall Study|other|3
3021703|NCT00796367|10392171|P2|Overall Study|other|4
3021704|NCT00796367|10392172|P1|Overall Study|other|2
3021705|NCT00796367|10392170|P3|Overall Study|Requirement for restricted medication|2
3021706|NCT00796367|10392171|P2|Overall Study|Requirement for restricted medication|0
3021707|NCT00796367|10392172|P1|Overall Study|Requirement for restricted medication|2
3021708|NCT00796367|10392170|P3|Overall Study|Pregnancy|1
3021709|NCT00796367|10392171|P2|Overall Study|Pregnancy|0
3021710|NCT00796367|10392172|P1|Overall Study|Pregnancy|1
3021711|NCT00796367|10392170|P3|Overall Study|non compliance|1
3021712|NCT00796367|10392171|P2|Overall Study|non compliance|1
3021713|NCT00796367|10392172|P1|Overall Study|non compliance|3
3021714|NCT00796367|10392170|P3|Overall Study|Lack of Efficacy|0
3021715|NCT00796367|10392171|P2|Overall Study|Lack of Efficacy|1
3021716|NCT00796367|10392172|P1|Overall Study|Lack of Efficacy|2
3021717|NCT00796367|10392170|P3|Overall Study|Withdrawal by Subject|12
3021718|NCT00796367|10392171|P2|Overall Study|Withdrawal by Subject|11
3021719|NCT00796367|10392172|P1|Overall Study|Withdrawal by Subject|9
3021720|NCT00796367|10392170|P3|Overall Study|Lost to Follow-up|21
3021721|NCT00796367|10392171|P2|Overall Study|Lost to Follow-up|4
3021722|NCT00796367|10392172|P1|Overall Study|Lost to Follow-up|5
3021723|NCT00796367|10392170|P3|Overall Study|Adverse Event|7
3021724|NCT00796367|10392171|P2|Overall Study|Adverse Event|4
3021725|NCT00796367|10392172|P1|Overall Study|Adverse Event|6
3021726|NCT00796328|10392183|P1|Overall Study|experienced hypotension requiring tx|6
3021727|NCT00796315|10392187|P3|Overall Study|Protocol Violation|0
3021728|NCT00796315|10392188|P2|Overall Study|Protocol Violation|1
3021729|NCT00796315|10392189|P1|Overall Study|Protocol Violation|0
3021730|NCT00796224|10392217|P2|Overall Study|Protocol Violation|1
3021731|NCT00796224|10392218|P1|Overall Study|Protocol Violation|0
3021732|NCT00796224|10392217|P2|Overall Study|Adverse Event|0
3021733|NCT00796224|10392218|P1|Overall Study|Adverse Event|1
3021734|NCT00796120|10392238|P2|Overall Study|Randomized but not treated|3
3021735|NCT00796120|10392239|P1|Overall Study|Randomized but not treated|0
3021736|NCT00796120|10392238|P2|Overall Study|Physician Decision|17
3021737|NCT00796120|10392239|P1|Overall Study|Physician Decision|16
3021738|NCT00796120|10392238|P2|Overall Study|Other|17
3021739|NCT00796120|10392239|P1|Overall Study|Other|6
3021740|NCT00796120|10392238|P2|Overall Study|Participant refusal|4
3021741|NCT00796120|10392239|P1|Overall Study|Participant refusal|3
3021742|NCT00796120|10392238|P2|Overall Study|Progressive disease|13
3021743|NCT00796120|10392239|P1|Overall Study|Progressive disease|22
3021744|NCT00796120|10392238|P2|Overall Study|Adverse Event|6
3021745|NCT00796120|10392239|P1|Overall Study|Adverse Event|11
3021746|NCT00796120|10392238|P2|Overall Study|Death|0
3021747|NCT00796120|10392239|P1|Overall Study|Death|3
3021748|NCT00796003|10392255|P2|Overall Study|Participants Not treated|2
3021749|NCT00796003|10392256|P1|Overall Study|Participants Not treated|0
3021750|NCT00796003|10392255|P2|Overall Study|Other|1
3021751|NCT00796003|10392256|P1|Overall Study|Other|0
3021752|NCT00796003|10392255|P2|Overall Study|Withdrawal by Subject|1
3021753|NCT00796003|10392256|P1|Overall Study|Withdrawal by Subject|0
3021754|NCT00796003|10392255|P2|Overall Study|Physician Decision|4
3021755|NCT00796003|10392256|P1|Overall Study|Physician Decision|0
3021756|NCT00796003|10392255|P2|Overall Study|Specified organ function not met|1
3021757|NCT00796003|10392256|P1|Overall Study|Specified organ function not met|0
3021758|NCT00796003|10392255|P2|Overall Study|Adverse Event|7
3021759|NCT00796003|10392256|P1|Overall Study|Adverse Event|1
3021760|NCT00796003|10392255|P2|Overall Study|Disease Progression|13
3021761|NCT00796003|10392256|P1|Overall Study|Disease Progression|2
3021762|NCT00795951|10392277|P1|Overall Study|Withdrawal by Subject|1
3021763|NCT00795951|10392277|P1|Overall Study|Lost to Follow-up|1
3021764|NCT00795886|10392370|P1|Overall Study|Death|10
3021765|NCT00795821|10392378|P2|Taper Phase|Withdrawal by Subject|0
3021766|NCT00795821|10392379|P1|Taper Phase|Withdrawal by Subject|4
3021767|NCT00795821|10392378|P2|Taper Phase|Physician Decision|0
3021768|NCT00795821|10392379|P1|Taper Phase|Physician Decision|2
3021769|NCT00795821|10392378|P2|Taper Phase|Lost to Follow-up|0
3021770|NCT00795821|10392379|P1|Taper Phase|Lost to Follow-up|1
3021771|NCT00795821|10392378|P2|Taper Phase|Adverse Event|0
3021772|NCT00795821|10392379|P1|Taper Phase|Adverse Event|2
3021773|NCT00795821|10392378|P2|Long-term Extension Phase|Withdrawal by Subject|25
3021774|NCT00795821|10392379|P1|Long-term Extension Phase|Withdrawal by Subject|25
3021775|NCT00795821|10392378|P2|Long-term Extension Phase|Protocol Violation|5
3021776|NCT00795821|10392379|P1|Long-term Extension Phase|Protocol Violation|3
3021777|NCT00795821|10392378|P2|Long-term Extension Phase|Physician Decision|2
3021778|NCT00795821|10392379|P1|Long-term Extension Phase|Physician Decision|1
3021779|NCT00795821|10392378|P2|Long-term Extension Phase|Lost to Follow-up|16
3021780|NCT00795821|10392379|P1|Long-term Extension Phase|Lost to Follow-up|20
3021781|NCT00795821|10392378|P2|Long-term Extension Phase|Lack of Efficacy|12
3021782|NCT00795821|10392379|P1|Long-term Extension Phase|Lack of Efficacy|16
3021783|NCT00795821|10392378|P2|Long-term Extension Phase|Adverse Event|32
3021784|NCT00795821|10392379|P1|Long-term Extension Phase|Adverse Event|25
3021785|NCT00795821|10392378|P2|Acute Treatment Phase|Withdrawal by Subject|10
3021786|NCT00795821|10392379|P1|Acute Treatment Phase|Withdrawal by Subject|16
3021787|NCT00795821|10392378|P2|Acute Treatment Phase|Protocol Violation|2
3021788|NCT00795821|10392379|P1|Acute Treatment Phase|Protocol Violation|1
3021789|NCT00795821|10392378|P2|Acute Treatment Phase|Physician Decision|1
3021790|NCT00795821|10392379|P1|Acute Treatment Phase|Physician Decision|1
3021791|NCT00795821|10392378|P2|Acute Treatment Phase|Lost to Follow-up|12
3021792|NCT00795821|10392379|P1|Acute Treatment Phase|Lost to Follow-up|9
3021793|NCT00795821|10392378|P2|Acute Treatment Phase|Lack of Efficacy|2
3021794|NCT00795821|10392379|P1|Acute Treatment Phase|Lack of Efficacy|5
3021795|NCT00795821|10392378|P2|Acute Treatment Phase|Death|0
3021796|NCT00795821|10392379|P1|Acute Treatment Phase|Death|1
3021797|NCT00795821|10392378|P2|Acute Treatment Phase|Adverse Event|4
3021798|NCT00795821|10392379|P1|Acute Treatment Phase|Adverse Event|23
3021799|NCT00795717|10392454|P2|Phase II|too busy|1
3021800|NCT00795717|10392455|P1|Phase II|too busy|0
3021801|NCT00795717|10392454|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
3021802|NCT00795717|10392455|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
3021803|NCT00795717|10392454|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
3021804|NCT00795717|10392455|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
3021805|NCT00795717|10392454|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
3021806|NCT00795717|10392455|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
3021807|NCT00795704|10392467|P2|Overall Study|Adverse Event|1
3021808|NCT00795704|10392468|P1|Overall Study|Adverse Event|1
3021809|NCT00795704|10392467|P2|Overall Study|Withdrawal by Subject|2
3021810|NCT00795704|10392468|P1|Overall Study|Withdrawal by Subject|3
3021811|NCT00795639|10392488|P2|Overall Study|Randomized and not treated|1
3021812|NCT00795639|10392489|P1|Overall Study|Randomized and not treated|0
3021813|NCT00795639|10392488|P2|Overall Study|Terminated by sponsor|12
3021814|NCT00795639|10392489|P1|Overall Study|Terminated by sponsor|13
3021815|NCT00795639|10392488|P2|Overall Study|Other|2
3021816|NCT00795639|10392489|P1|Overall Study|Other|0
3021817|NCT00795639|10392488|P2|Overall Study|Adverse Event|2
3021818|NCT00795639|10392489|P1|Overall Study|Adverse Event|5
3021819|NCT00795639|10392488|P2|Overall Study|Pregnancy|0
3021820|NCT00795639|10392489|P1|Overall Study|Pregnancy|1
3021821|NCT00795639|10392488|P2|Overall Study|Withdrawal by Subject|3
3021822|NCT00795639|10392489|P1|Overall Study|Withdrawal by Subject|1
3021823|NCT00795639|10392488|P2|Overall Study|Death|6
3021824|NCT00795639|10392489|P1|Overall Study|Death|1
3021825|NCT00795600|10392501|P2|Overall Study|Unclassified|1
3021826|NCT00795600|10392502|P1|Overall Study|Unclassified|1
3021827|NCT00795600|10392501|P2|Overall Study|Withdrawal by Subject|0
3021828|NCT00795600|10392502|P1|Overall Study|Withdrawal by Subject|1
3021829|NCT00795600|10392501|P2|Overall Study|Protocol Violation|2
3021830|NCT00795600|10392502|P1|Overall Study|Protocol Violation|1
3021831|NCT00795600|10392501|P2|Overall Study|Adverse Event|1
3021832|NCT00795600|10392502|P1|Overall Study|Adverse Event|1
3021833|NCT00795535|10392622|P1|Overall Study|incomplete data and technical problems|20
3021834|NCT00795509|10392629|P1|Overall Study|Protocol Violation|31
3021835|NCT00795184|10392698|P2|Overall Study|Tissue sampling incomplete/conclusive|13
3021836|NCT00795184|10392699|P1|Overall Study|Tissue sampling incomplete/conclusive|8
3021837|NCT00795132|10392760|P1|Overall Study|Relapse|2
3021838|NCT00795132|10392760|P1|Overall Study|Death|1
3021839|NCT00794963|10392787|P2|Overall Study|Withdrawal by Subject|4
3021840|NCT00794963|10392788|P1|Overall Study|Withdrawal by Subject|1
3021841|NCT00794950|10392794|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
3021842|NCT00794950|10392794|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
3021843|NCT00794950|10392794|P1|Beginning Sunitinib Treatment|Physician Decision|5
3021844|NCT00794950|10392794|P1|Beginning Sunitinib Treatment|cystectomy|5
3021845|NCT00794950|10392794|P1|BCG Induction|Adverse Event|1
3021846|NCT00794950|10392794|P1|BCG Induction|noncompliant w. BCG|1
3021847|NCT00794950|10392794|P1|BCG Induction|ineligible|3
3021848|NCT00794950|10392794|P1|BCG Induction|Withdrawal by Subject|2
3021849|NCT00794924|10392803|P2|Overall Study|Adverse Event|2
3021850|NCT00794924|10392804|P1|Overall Study|Adverse Event|6
3021851|NCT00794924|10392803|P2|Overall Study|Withdrawal by Subject|60
3021852|NCT00794924|10392804|P1|Overall Study|Withdrawal by Subject|48
3021853|NCT00794924|10392803|P2|Overall Study|Lost to Follow-up|8
3021854|NCT00794924|10392804|P1|Overall Study|Lost to Follow-up|6
3021855|NCT00794820|10392808|P1|Overall Study|Ineligible/Screen Failure|1
3021856|NCT00794820|10392808|P1|Overall Study|Resistant Disease|2
3021857|NCT00794820|10392808|P1|Overall Study|Secondary Malignancies|2
3021858|NCT00794820|10392808|P1|Overall Study|Adverse Event|11
3021859|NCT00794677|10392816|P2|First Intervention|Withdrawal by Subject|0
3021860|NCT00794677|10392817|P1|First Intervention|Withdrawal by Subject|2
3021861|NCT00794664|10392839|P2|Follow-up Period|Protocol non-compliance|1
3021862|NCT00794664|10392840|P1|Follow-up Period|Protocol non-compliance|0
3021863|NCT00794664|10392839|P2|Follow-up Period|Withdrawal by Subject|2
3021864|NCT00794664|10392840|P1|Follow-up Period|Withdrawal by Subject|0
3021865|NCT00794664|10392839|P2|Follow-up Period|Other|2
3021866|NCT00794664|10392840|P1|Follow-up Period|Other|1
3021867|NCT00794664|10392839|P2|Treatment Period|Adverse Event|8
3021868|NCT00794664|10392840|P1|Treatment Period|Adverse Event|1
3021869|NCT00794664|10392839|P2|Treatment Period|Other|1
3021870|NCT00794664|10392840|P1|Treatment Period|Other|0
3021871|NCT00794664|10392839|P2|Treatment Period|Protocol non-compliance|1
3021872|NCT00794664|10392840|P1|Treatment Period|Protocol non-compliance|0
3021873|NCT00794664|10392839|P2|Treatment Period|Withdrawal by Subject|2
3021874|NCT00794664|10392840|P1|Treatment Period|Withdrawal by Subject|0
3021875|NCT00794573|10392886|P2|Overall Study|Lost to Follow-up|33
3021876|NCT00794573|10392887|P1|Overall Study|Lost to Follow-up|26
3021877|NCT00794573|10392886|P2|Overall Study|Withdrawal by Subject|12
3021878|NCT00794573|10392887|P1|Overall Study|Withdrawal by Subject|9
3021879|NCT00794573|10392886|P2|Overall Study|Death|0
3021880|NCT00794573|10392887|P1|Overall Study|Death|3
3021881|NCT00794365|10392956|P1|Overall Study|Lack of Efficacy|3
3021882|NCT00794365|10392956|P1|Overall Study|Adverse Event|10
3021883|NCT00794365|10392956|P1|Overall Study|Poor Compliance|11
3021884|NCT00794365|10392956|P1|Overall Study|Other|17
3021885|NCT00794365|10392956|P1|Overall Study|Lost to Follow-up|38
3021886|NCT00794196|10392977|P2|Overall Study|Lost to Follow-up|23
3021887|NCT00794196|10392978|P1|Overall Study|Lost to Follow-up|5
3021888|NCT00794157|10392998|P3|Overall Study|Protocol deviation|1
3021889|NCT00794157|10392999|P2|Overall Study|Protocol deviation|1
3021890|NCT00794157|10393000|P1|Overall Study|Protocol deviation|0
3021891|NCT00794157|10392998|P3|Overall Study|Abnormal test procedure result(s)|0
3021892|NCT00794157|10392999|P2|Overall Study|Abnormal test procedure result(s)|1
3021893|NCT00794157|10393000|P1|Overall Study|Abnormal test procedure result(s)|0
3021894|NCT00794157|10392998|P3|Overall Study|Administrative problems|4
3021895|NCT00794157|10392999|P2|Overall Study|Administrative problems|7
3021896|NCT00794157|10393000|P1|Overall Study|Administrative problems|1
3021897|NCT00794157|10392998|P3|Overall Study|Unsatisfactory therapeutic effect|2
3021898|NCT00794157|10392999|P2|Overall Study|Unsatisfactory therapeutic effect|0
3021899|NCT00794157|10393000|P1|Overall Study|Unsatisfactory therapeutic effect|1
3021900|NCT00794157|10392998|P3|Overall Study|Lost to Follow-up|1
3021901|NCT00794157|10392999|P2|Overall Study|Lost to Follow-up|0
3021902|NCT00794157|10393000|P1|Overall Study|Lost to Follow-up|2
3021903|NCT00794157|10392998|P3|Overall Study|Subject withdrew consent|3
3021904|NCT00794157|10392999|P2|Overall Study|Subject withdrew consent|0
3021905|NCT00794157|10393000|P1|Overall Study|Subject withdrew consent|2
3021906|NCT00794157|10392998|P3|Overall Study|Adverse Event|8
3021907|NCT00794157|10392999|P2|Overall Study|Adverse Event|1
3021908|NCT00794157|10393000|P1|Overall Study|Adverse Event|4
3021909|NCT00794118|10393029|P1|Overall Study|Changed hospital center|2
3021910|NCT00794118|10393029|P1|Overall Study|Withdrawal by Subject|9
3021911|NCT00794118|10393029|P1|Overall Study|Lost to Follow-up|16
3021912|NCT00794040|10393089|P2|Overall Study|Physician Decision|1
3021913|NCT00794040|10393090|P1|Overall Study|Physician Decision|0
3021914|NCT00794040|10393089|P2|Overall Study|Withdrawal by Subject|4
3021915|NCT00794040|10393090|P1|Overall Study|Withdrawal by Subject|3
3021916|NCT00793910|10393106|P2|Overall Study|Withdrawal by Subject|1
3021917|NCT00793910|10393107|P1|Overall Study|Withdrawal by Subject|0
3021918|NCT00793910|10393106|P2|Overall Study|decided to undergo LASIK instead of PRK|1
3021919|NCT00793910|10393107|P1|Overall Study|decided to undergo LASIK instead of PRK|2
3021920|NCT00793910|10393106|P2|Overall Study|ineligible based on entry criteria|3
3021921|NCT00793910|10393107|P1|Overall Study|ineligible based on entry criteria|2
3021922|NCT00793910|10393106|P2|Overall Study|did not pick up medications|1
3021923|NCT00793910|10393107|P1|Overall Study|did not pick up medications|1
3021924|NCT00793910|10393106|P2|Overall Study|discarded study pills|1
3021925|NCT00793910|10393107|P1|Overall Study|discarded study pills|0
3021926|NCT00793871|10393121|P1|Overall Study|Study terminated by the Sponsor|7
3021927|NCT00793871|10393121|P1|Overall Study|Lost to Follow-up|3
3021928|NCT00793871|10393121|P1|Overall Study|Death|50
3021929|NCT00793819|10393135|P2|Overall Study|Lost to Follow-up|1
3021930|NCT00793819|10393136|P1|Overall Study|Lost to Follow-up|1
3021931|NCT00793819|10393135|P2|Overall Study|Withdrawal by Subject|3
3021932|NCT00793819|10393136|P1|Overall Study|Withdrawal by Subject|4
3021933|NCT00793819|10393135|P2|Overall Study|Lack of Efficacy|1
3021934|NCT00793819|10393136|P1|Overall Study|Lack of Efficacy|1
3021935|NCT00793819|10393135|P2|Overall Study|Adverse Event|4
3021936|NCT00793819|10393136|P1|Overall Study|Adverse Event|8
3021937|NCT00793793|10393154|P12|Overall Study|reason not specified|4
3021938|NCT00793793|10393155|P11|Overall Study|reason not specified|2
3021939|NCT00793793|10393156|P10|Overall Study|reason not specified|6
3021940|NCT00793793|10393157|P9|Overall Study|reason not specified|7
3021941|NCT00793793|10393158|P8|Overall Study|reason not specified|0
3021942|NCT00793793|10393159|P7|Overall Study|reason not specified|2
3021943|NCT00793793|10393160|P6|Overall Study|reason not specified|1
3021944|NCT00793793|10393161|P5|Overall Study|reason not specified|1
3021945|NCT00793793|10393162|P4|Overall Study|reason not specified|1
3021946|NCT00793793|10393163|P3|Overall Study|reason not specified|0
3021947|NCT00793793|10393164|P2|Overall Study|reason not specified|1
3021948|NCT00793793|10393165|P1|Overall Study|reason not specified|0
3021949|NCT00793793|10393154|P12|Overall Study|Withdrawal by Subject|0
3021950|NCT00793793|10393155|P11|Overall Study|Withdrawal by Subject|0
3021951|NCT00793793|10393156|P10|Overall Study|Withdrawal by Subject|0
3021952|NCT00793793|10393157|P9|Overall Study|Withdrawal by Subject|1
3021953|NCT00793793|10393158|P8|Overall Study|Withdrawal by Subject|0
3021954|NCT00793793|10393159|P7|Overall Study|Withdrawal by Subject|0
3021955|NCT00793793|10393160|P6|Overall Study|Withdrawal by Subject|0
3021956|NCT00793793|10393161|P5|Overall Study|Withdrawal by Subject|1
3021957|NCT00793793|10393162|P4|Overall Study|Withdrawal by Subject|0
3021958|NCT00793793|10393163|P3|Overall Study|Withdrawal by Subject|0
3021959|NCT00793793|10393164|P2|Overall Study|Withdrawal by Subject|0
3021960|NCT00793793|10393165|P1|Overall Study|Withdrawal by Subject|0
3021961|NCT00793793|10393154|P12|Overall Study|Lost to Follow-up|0
3021962|NCT00793793|10393155|P11|Overall Study|Lost to Follow-up|1
3021963|NCT00793793|10393156|P10|Overall Study|Lost to Follow-up|3
3021964|NCT00793793|10393157|P9|Overall Study|Lost to Follow-up|1
3021965|NCT00793793|10393158|P8|Overall Study|Lost to Follow-up|0
3021966|NCT00793793|10393159|P7|Overall Study|Lost to Follow-up|0
3021967|NCT00793793|10393160|P6|Overall Study|Lost to Follow-up|0
3021968|NCT00793793|10393161|P5|Overall Study|Lost to Follow-up|0
3021969|NCT00793793|10393162|P4|Overall Study|Lost to Follow-up|0
3021970|NCT00793793|10393163|P3|Overall Study|Lost to Follow-up|1
3021971|NCT00793793|10393164|P2|Overall Study|Lost to Follow-up|0
3021972|NCT00793793|10393165|P1|Overall Study|Lost to Follow-up|0
3021973|NCT00793793|10393154|P12|Overall Study|Protocol Violation|0
3021974|NCT00793793|10393155|P11|Overall Study|Protocol Violation|0
3021975|NCT00793793|10393156|P10|Overall Study|Protocol Violation|0
3021976|NCT00793793|10393157|P9|Overall Study|Protocol Violation|0
3021977|NCT00793793|10393158|P8|Overall Study|Protocol Violation|0
3021978|NCT00793793|10393159|P7|Overall Study|Protocol Violation|0
3021979|NCT00793793|10393160|P6|Overall Study|Protocol Violation|0
3021980|NCT00793793|10393161|P5|Overall Study|Protocol Violation|0
3021981|NCT00793793|10393162|P4|Overall Study|Protocol Violation|1
3021982|NCT00793793|10393163|P3|Overall Study|Protocol Violation|0
3021983|NCT00793793|10393164|P2|Overall Study|Protocol Violation|0
3021984|NCT00793793|10393165|P1|Overall Study|Protocol Violation|0
3021985|NCT00793793|10393154|P12|Overall Study|Adverse Event|2
3021986|NCT00793793|10393155|P11|Overall Study|Adverse Event|0
3021987|NCT00793793|10393156|P10|Overall Study|Adverse Event|0
3021988|NCT00793793|10393157|P9|Overall Study|Adverse Event|0
3021989|NCT00793793|10393158|P8|Overall Study|Adverse Event|0
3021990|NCT00793793|10393159|P7|Overall Study|Adverse Event|2
3021991|NCT00793793|10393160|P6|Overall Study|Adverse Event|1
3021992|NCT00793793|10393161|P5|Overall Study|Adverse Event|0
3021993|NCT00793793|10393162|P4|Overall Study|Adverse Event|1
3021994|NCT00793793|10393163|P3|Overall Study|Adverse Event|1
3021995|NCT00793793|10393164|P2|Overall Study|Adverse Event|0
3021996|NCT00793793|10393165|P1|Overall Study|Adverse Event|0
3021997|NCT00793780|10393540|P2|Overall Study|Withdrawal by Subject|1
3021998|NCT00793780|10393541|P1|Overall Study|Withdrawal by Subject|2
3021999|NCT00793624|10393572|P4|Overall Study|Other reason not described above|3
3022000|NCT00793624|10393573|P3|Overall Study|Other reason not described above|6
3022001|NCT00793624|10393574|P2|Overall Study|Other reason not described above|4
3022002|NCT00793624|10393575|P1|Overall Study|Other reason not described above|6
3022003|NCT00793624|10393572|P4|Overall Study|Non compliance with protocol|3
3022004|NCT00793624|10393573|P3|Overall Study|Non compliance with protocol|2
3022005|NCT00793624|10393574|P2|Overall Study|Non compliance with protocol|3
3022006|NCT00793624|10393575|P1|Overall Study|Non compliance with protocol|2
3022007|NCT00793624|10393572|P4|Overall Study|Lack of Efficacy|3
3022008|NCT00793624|10393573|P3|Overall Study|Lack of Efficacy|1
3022009|NCT00793624|10393574|P2|Overall Study|Lack of Efficacy|2
3022010|NCT00793624|10393575|P1|Overall Study|Lack of Efficacy|9
3022011|NCT00793624|10393572|P4|Overall Study|Withdrawal by Subject|14
3022012|NCT00793624|10393573|P3|Overall Study|Withdrawal by Subject|11
3022013|NCT00793624|10393574|P2|Overall Study|Withdrawal by Subject|9
3022014|NCT00793624|10393575|P1|Overall Study|Withdrawal by Subject|20
3022015|NCT00793624|10393572|P4|Overall Study|Lost to Follow-up|0
3022016|NCT00793624|10393573|P3|Overall Study|Lost to Follow-up|4
3022017|NCT00793624|10393574|P2|Overall Study|Lost to Follow-up|2
3022018|NCT00793624|10393575|P1|Overall Study|Lost to Follow-up|2
3022019|NCT00793624|10393572|P4|Overall Study|Adverse Event|20
3022020|NCT00793624|10393573|P3|Overall Study|Adverse Event|15
3022021|NCT00793624|10393574|P2|Overall Study|Adverse Event|16
3022022|NCT00793624|10393575|P1|Overall Study|Adverse Event|18
3022023|NCT00793585|10393856|P2|Overall Study|Protocol Violation|2
3022024|NCT00793585|10393857|P1|Overall Study|Protocol Violation|1
3022025|NCT00793585|10393856|P2|Overall Study|Adverse Event|1
3022026|NCT00793585|10393857|P1|Overall Study|Adverse Event|1
3022027|NCT00793546|10393876|P2|Overall Study|Other|0
3022028|NCT00793546|10393877|P1|Overall Study|Other|1
3022029|NCT00793546|10393876|P2|Overall Study|Study Terminated by Sponsor|27
3022030|NCT00793546|10393877|P1|Overall Study|Study Terminated by Sponsor|8
3022031|NCT00793546|10393876|P2|Overall Study|Withdrawal by Subject|1
3022032|NCT00793546|10393877|P1|Overall Study|Withdrawal by Subject|1
3022033|NCT00793546|10393876|P2|Overall Study|Lost to Follow-up|0
3022034|NCT00793546|10393877|P1|Overall Study|Lost to Follow-up|1
3022035|NCT00793546|10393876|P2|Overall Study|Death|0
3022036|NCT00793546|10393877|P1|Overall Study|Death|3
3022037|NCT00793403|10393927|P1|Overall Study|Other|73
3022038|NCT00793325|10393974|P1|Overall Study|Lost to Follow-up|1
3022039|NCT00793325|10393974|P1|Overall Study|Protocol Violation|18
3022040|NCT00793182|10394000|P2|Overall Study|Adverse Event|1
3022041|NCT00793182|10394001|P1|Overall Study|Adverse Event|0
3022042|NCT00793104|10394011|P1|Overall Study|Lost to Follow-up|1
3022043|NCT00792948|10394019|P1|Overall Study|Protocol Violation|1
3022044|NCT00792948|10394019|P1|Overall Study|Physician Decision|11
3022045|NCT00792948|10394019|P1|Overall Study|Insurance denial - not treated|1
3022046|NCT00792948|10394019|P1|Overall Study|Ineligible|2
3022047|NCT00792948|10394019|P1|Overall Study|Withdrawal by Subject|3
3022048|NCT00792948|10394019|P1|Overall Study|Death|4
3022049|NCT00792948|10394019|P1|Overall Study|Adverse Event|6
3022050|NCT00792935|10394030|P2|Overall Study|Withdrawal by Subject|1
3022051|NCT00792935|10394031|P1|Overall Study|Withdrawal by Subject|0
3022052|NCT00792935|10394030|P2|Overall Study|Protocol Violation|0
3022053|NCT00792935|10394031|P1|Overall Study|Protocol Violation|2
3022054|NCT00792935|10394030|P2|Overall Study|Lost to Follow-up|1
3022055|NCT00792935|10394031|P1|Overall Study|Lost to Follow-up|0
3022056|NCT00792935|10394030|P2|Overall Study|Adverse Event|1
3022057|NCT00792935|10394031|P1|Overall Study|Adverse Event|2
3022058|NCT00792909|10394063|P3|Overall Study|Withdrawal by Subject|0
3022059|NCT00792909|10394064|P2|Overall Study|Withdrawal by Subject|1
3022060|NCT00792909|10394065|P1|Overall Study|Withdrawal by Subject|0
3022061|NCT00792805|10394121|P3|Overall Study|Protocol deviation|1
3022062|NCT00792805|10394122|P2|Overall Study|Protocol deviation|1
3022063|NCT00792805|10394123|P1|Overall Study|Protocol deviation|0
3022064|NCT00792805|10394121|P3|Overall Study|Abnormal laboratory value(s)|1
3022065|NCT00792805|10394122|P2|Overall Study|Abnormal laboratory value(s)|0
3022066|NCT00792805|10394123|P1|Overall Study|Abnormal laboratory value(s)|0
3022067|NCT00792805|10394121|P3|Overall Study|Lost to Follow-up|6
3022068|NCT00792805|10394122|P2|Overall Study|Lost to Follow-up|1
3022069|NCT00792805|10394123|P1|Overall Study|Lost to Follow-up|1
3022070|NCT00792805|10394121|P3|Overall Study|Unsatisfactory therapeutic effect|6
3022071|NCT00792805|10394122|P2|Overall Study|Unsatisfactory therapeutic effect|6
3022072|NCT00792805|10394123|P1|Overall Study|Unsatisfactory therapeutic effect|1
3022073|NCT00792805|10394121|P3|Overall Study|Abnormal test procedure result(s)|0
3022074|NCT00792805|10394122|P2|Overall Study|Abnormal test procedure result(s)|2
3022075|NCT00792805|10394123|P1|Overall Study|Abnormal test procedure result(s)|1
3022076|NCT00792805|10394121|P3|Overall Study|Administrative problems|4
3022077|NCT00792805|10394122|P2|Overall Study|Administrative problems|0
3022078|NCT00792805|10394123|P1|Overall Study|Administrative problems|2
3022079|NCT00792805|10394121|P3|Overall Study|Subject withdrew consent|5
3022080|NCT00792805|10394122|P2|Overall Study|Subject withdrew consent|6
3022081|NCT00792805|10394123|P1|Overall Study|Subject withdrew consent|5
3022082|NCT00792805|10394121|P3|Overall Study|Adverse Event|10
3022083|NCT00792805|10394122|P2|Overall Study|Adverse Event|10
3022084|NCT00792805|10394123|P1|Overall Study|Adverse Event|12
3022085|NCT00792701|10394133|P2|Overall Study|Not protocol specified|0
3022086|NCT00792701|10394134|P1|Overall Study|Not protocol specified|17
3022087|NCT00792701|10394133|P2|Overall Study|Withdrawal by Subject|19
3022088|NCT00792701|10394134|P1|Overall Study|Withdrawal by Subject|1
3022089|NCT00792701|10394133|P2|Overall Study|Ineligible|3
3022090|NCT00792701|10394134|P1|Overall Study|Ineligible|1
3022091|NCT00792701|10394133|P2|Overall Study|Adverse Event|22
3022092|NCT00792701|10394134|P1|Overall Study|Adverse Event|0
3022093|NCT00792636|10394164|P3|Overall Study|Investigator Discretion|2
3022094|NCT00792636|10394165|P2|Overall Study|Investigator Discretion|0
3022095|NCT00792636|10394166|P1|Overall Study|Investigator Discretion|2
3022096|NCT00792636|10394164|P3|Overall Study|Adverse Event|3
3022097|NCT00792636|10394165|P2|Overall Study|Adverse Event|2
3022098|NCT00792636|10394166|P1|Overall Study|Adverse Event|4
3022099|NCT00792636|10394164|P3|Overall Study|Lack of Efficacy|13
3022100|NCT00792636|10394165|P2|Overall Study|Lack of Efficacy|4
3022101|NCT00792636|10394166|P1|Overall Study|Lack of Efficacy|3
3022102|NCT00792636|10394164|P3|Overall Study|Withdrew Consent|9
3022103|NCT00792636|10394165|P2|Overall Study|Withdrew Consent|13
3022104|NCT00792636|10394166|P1|Overall Study|Withdrew Consent|10
3022105|NCT00792636|10394164|P3|Overall Study|Lost to Follow-up|14
3022106|NCT00792636|10394165|P2|Overall Study|Lost to Follow-up|19
3022107|NCT00792636|10394166|P1|Overall Study|Lost to Follow-up|13
3022108|NCT00792636|10394164|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
3022109|NCT00792636|10394165|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
3022110|NCT00792636|10394166|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
3022111|NCT00792636|10394164|P3|Overall Study|Protocol Violation|20
3022112|NCT00792636|10394165|P2|Overall Study|Protocol Violation|23
3022113|NCT00792636|10394166|P1|Overall Study|Protocol Violation|17
3022114|NCT00792623|10394203|P1|Overall Study|Withdrawal by Subject|5
3022115|NCT00792623|10394203|P1|Overall Study|Adverse Event|2
3022116|NCT00792571|10394220|P1|Overall Study|Other|4
3022117|NCT00792571|10394220|P1|Overall Study|Withdrawal by Subject|1
3022118|NCT00792571|10394220|P1|Overall Study|Adverse Event|4
3022119|NCT00792571|10394220|P1|Overall Study|Death|1
3022120|NCT00792298|10394240|P8|Treatment Period 2|Withdrawal by Subject|2
3022121|NCT00792298|10394241|P7|Treatment Period 2|Withdrawal by Subject|0
3022122|NCT00792298|10394242|P6|Treatment Period 2|Withdrawal by Subject|0
3022123|NCT00792298|10394243|P5|Treatment Period 2|Withdrawal by Subject|1
3022124|NCT00792298|10394244|P4|Treatment Period 2|Withdrawal by Subject|2
3022125|NCT00792298|10394245|P3|Treatment Period 2|Withdrawal by Subject|0
3022126|NCT00792298|10394246|P2|Treatment Period 2|Withdrawal by Subject|1
3022127|NCT00792298|10394247|P1|Treatment Period 2|Withdrawal by Subject|1
3022128|NCT00792298|10394240|P8|Treatment Period 2|Pregnancy|0
3022129|NCT00792298|10394241|P7|Treatment Period 2|Pregnancy|0
3022130|NCT00792298|10394242|P6|Treatment Period 2|Pregnancy|0
3022131|NCT00792298|10394243|P5|Treatment Period 2|Pregnancy|0
3022132|NCT00792298|10394244|P4|Treatment Period 2|Pregnancy|0
3022133|NCT00792298|10394245|P3|Treatment Period 2|Pregnancy|1
3022134|NCT00792298|10394246|P2|Treatment Period 2|Pregnancy|0
3022135|NCT00792298|10394247|P1|Treatment Period 2|Pregnancy|0
3022136|NCT00792298|10394240|P8|Treatment Period 2|Physician Decision|0
3022137|NCT00792298|10394241|P7|Treatment Period 2|Physician Decision|1
3022138|NCT00792298|10394242|P6|Treatment Period 2|Physician Decision|0
3022139|NCT00792298|10394243|P5|Treatment Period 2|Physician Decision|0
3022140|NCT00792298|10394244|P4|Treatment Period 2|Physician Decision|0
3022141|NCT00792298|10394245|P3|Treatment Period 2|Physician Decision|0
3022142|NCT00792298|10394246|P2|Treatment Period 2|Physician Decision|0
3022143|NCT00792298|10394247|P1|Treatment Period 2|Physician Decision|0
3022144|NCT00792298|10394240|P8|Treatment Period 2|Lack of Efficacy|0
3022145|NCT00792298|10394241|P7|Treatment Period 2|Lack of Efficacy|0
3022146|NCT00792298|10394242|P6|Treatment Period 2|Lack of Efficacy|0
3022147|NCT00792298|10394243|P5|Treatment Period 2|Lack of Efficacy|1
3022148|NCT00792298|10394244|P4|Treatment Period 2|Lack of Efficacy|0
3022149|NCT00792298|10394245|P3|Treatment Period 2|Lack of Efficacy|0
3022150|NCT00792298|10394246|P2|Treatment Period 2|Lack of Efficacy|0
3022151|NCT00792298|10394247|P1|Treatment Period 2|Lack of Efficacy|0
3022152|NCT00792298|10394240|P8|Washout|Withdrawal by Subject|0
3022153|NCT00792298|10394241|P7|Washout|Withdrawal by Subject|0
3022154|NCT00792298|10394242|P6|Washout|Withdrawal by Subject|1
3022155|NCT00792298|10394243|P5|Washout|Withdrawal by Subject|0
3022156|NCT00792298|10394244|P4|Washout|Withdrawal by Subject|0
3022157|NCT00792298|10394245|P3|Washout|Withdrawal by Subject|1
3022158|NCT00792298|10394246|P2|Washout|Withdrawal by Subject|0
3022159|NCT00792298|10394247|P1|Washout|Withdrawal by Subject|0
3022160|NCT00792298|10394240|P8|Washout|Adverse Event|0
3022161|NCT00792298|10394241|P7|Washout|Adverse Event|0
3022162|NCT00792298|10394242|P6|Washout|Adverse Event|1
3022163|NCT00792298|10394243|P5|Washout|Adverse Event|0
3022164|NCT00792298|10394244|P4|Washout|Adverse Event|0
3022165|NCT00792298|10394245|P3|Washout|Adverse Event|0
3022166|NCT00792298|10394246|P2|Washout|Adverse Event|0
3022167|NCT00792298|10394247|P1|Washout|Adverse Event|0
3022168|NCT00792298|10394240|P8|Treatment Period 1|Protocol Violation|1
3022169|NCT00792298|10394241|P7|Treatment Period 1|Protocol Violation|0
3022170|NCT00792298|10394242|P6|Treatment Period 1|Protocol Violation|0
3022171|NCT00792298|10394243|P5|Treatment Period 1|Protocol Violation|0
3022172|NCT00792298|10394244|P4|Treatment Period 1|Protocol Violation|0
3022173|NCT00792298|10394245|P3|Treatment Period 1|Protocol Violation|0
3022174|NCT00792298|10394246|P2|Treatment Period 1|Protocol Violation|0
3022175|NCT00792298|10394247|P1|Treatment Period 1|Protocol Violation|0
3022176|NCT00792298|10394240|P8|Treatment Period 1|Physician Decision|0
3022177|NCT00792298|10394241|P7|Treatment Period 1|Physician Decision|1
3022178|NCT00792298|10394242|P6|Treatment Period 1|Physician Decision|0
3022179|NCT00792298|10394243|P5|Treatment Period 1|Physician Decision|0
3022180|NCT00792298|10394244|P4|Treatment Period 1|Physician Decision|1
3022181|NCT00792298|10394245|P3|Treatment Period 1|Physician Decision|0
3022182|NCT00792298|10394246|P2|Treatment Period 1|Physician Decision|0
3022183|NCT00792298|10394247|P1|Treatment Period 1|Physician Decision|0
3022184|NCT00792298|10394240|P8|Treatment Period 1|Lost to Follow-up|0
3022185|NCT00792298|10394241|P7|Treatment Period 1|Lost to Follow-up|1
3022186|NCT00792298|10394242|P6|Treatment Period 1|Lost to Follow-up|0
3022187|NCT00792298|10394243|P5|Treatment Period 1|Lost to Follow-up|0
3022188|NCT00792298|10394244|P4|Treatment Period 1|Lost to Follow-up|0
3022189|NCT00792298|10394245|P3|Treatment Period 1|Lost to Follow-up|0
3022190|NCT00792298|10394246|P2|Treatment Period 1|Lost to Follow-up|0
3022191|NCT00792298|10394247|P1|Treatment Period 1|Lost to Follow-up|0
3022192|NCT00792298|10394240|P8|Treatment Period 1|Withdrawal by Subject|0
3022193|NCT00792298|10394241|P7|Treatment Period 1|Withdrawal by Subject|1
3022194|NCT00792298|10394242|P6|Treatment Period 1|Withdrawal by Subject|2
3022195|NCT00792298|10394243|P5|Treatment Period 1|Withdrawal by Subject|0
3022196|NCT00792298|10394244|P4|Treatment Period 1|Withdrawal by Subject|2
3022197|NCT00792298|10394245|P3|Treatment Period 1|Withdrawal by Subject|1
3022198|NCT00792298|10394246|P2|Treatment Period 1|Withdrawal by Subject|0
3022199|NCT00792298|10394247|P1|Treatment Period 1|Withdrawal by Subject|1
3022200|NCT00792298|10394240|P8|Treatment Period 1|Lack of Efficacy|0
3022201|NCT00792298|10394241|P7|Treatment Period 1|Lack of Efficacy|0
3022202|NCT00792298|10394242|P6|Treatment Period 1|Lack of Efficacy|0
3022203|NCT00792298|10394243|P5|Treatment Period 1|Lack of Efficacy|0
3022204|NCT00792298|10394244|P4|Treatment Period 1|Lack of Efficacy|0
3022205|NCT00792298|10394245|P3|Treatment Period 1|Lack of Efficacy|1
3022206|NCT00792298|10394246|P2|Treatment Period 1|Lack of Efficacy|0
3022207|NCT00792298|10394247|P1|Treatment Period 1|Lack of Efficacy|0
3022208|NCT00792298|10394240|P8|Treatment Period 1|Adverse Event|0
3022209|NCT00792298|10394241|P7|Treatment Period 1|Adverse Event|1
3022210|NCT00792298|10394242|P6|Treatment Period 1|Adverse Event|1
3022211|NCT00792298|10394243|P5|Treatment Period 1|Adverse Event|0
3022212|NCT00792298|10394244|P4|Treatment Period 1|Adverse Event|1
3022213|NCT00792298|10394245|P3|Treatment Period 1|Adverse Event|0
3022214|NCT00792298|10394246|P2|Treatment Period 1|Adverse Event|1
3022215|NCT00792298|10394247|P1|Treatment Period 1|Adverse Event|0
3022216|NCT00792259|10394277|P3|Overall Study|Poor Quality Scans|0
3022217|NCT00792259|10394278|P2|Overall Study|Poor Quality Scans|0
3022218|NCT00792259|10394279|P1|Overall Study|Poor Quality Scans|1
3022219|NCT00792116|10394289|P2|Overall Study|Discontnued intervention|0
3022220|NCT00792116|10394290|P1|Overall Study|Discontnued intervention|1
3022221|NCT00792116|10394289|P2|Overall Study|Lost to Follow-up|1
3022222|NCT00792116|10394290|P1|Overall Study|Lost to Follow-up|0
3022223|NCT00792103|10394300|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
3022224|NCT00792103|10394300|P1|Overall Study|Protocol Violation|10
3022225|NCT00792103|10394300|P1|Overall Study|Withdrawal by Subject|52
3022226|NCT00792103|10394300|P1|Overall Study|Adverse Event|25
3022227|NCT00792103|10394300|P1|Overall Study|Lost to Follow-up|17
3022228|NCT00792103|10394300|P1|Overall Study|Enrolled, not treated|15
3022229|NCT00791999|10394312|P4|Overall Study|Reason other than those above|0
3022230|NCT00791999|10394313|P3|Overall Study|Reason other than those above|1
3022231|NCT00791999|10394314|P2|Overall Study|Reason other than those above|0
3022232|NCT00791999|10394315|P1|Overall Study|Reason other than those above|1
3022233|NCT00791999|10394312|P4|Overall Study|Lack of Efficacy|2
3022234|NCT00791999|10394313|P3|Overall Study|Lack of Efficacy|0
3022235|NCT00791999|10394314|P2|Overall Study|Lack of Efficacy|1
3022236|NCT00791999|10394315|P1|Overall Study|Lack of Efficacy|0
3022237|NCT00791999|10394312|P4|Overall Study|Adverse Event|3
3022238|NCT00791999|10394313|P3|Overall Study|Adverse Event|7
3022239|NCT00791999|10394314|P2|Overall Study|Adverse Event|3
3022240|NCT00791999|10394315|P1|Overall Study|Adverse Event|3
3022241|NCT00791999|10394312|P4|Overall Study|Protocol Violation|0
3022242|NCT00791999|10394313|P3|Overall Study|Protocol Violation|1
3022243|NCT00791999|10394314|P2|Overall Study|Protocol Violation|0
3022244|NCT00791999|10394315|P1|Overall Study|Protocol Violation|3
3022245|NCT00791999|10394312|P4|Overall Study|Withdrawal by Subject|2
3022246|NCT00791999|10394313|P3|Overall Study|Withdrawal by Subject|0
3022247|NCT00791999|10394314|P2|Overall Study|Withdrawal by Subject|1
3022248|NCT00791999|10394315|P1|Overall Study|Withdrawal by Subject|0
3022249|NCT00791999|10394312|P4|Overall Study|Protocol planed withdrawal|45
3022250|NCT00791999|10394313|P3|Overall Study|Protocol planed withdrawal|11
3022251|NCT00791999|10394314|P2|Overall Study|Protocol planed withdrawal|11
3022252|NCT00791999|10394315|P1|Overall Study|Protocol planed withdrawal|14
3022253|NCT00791934|10394340|P1|Overall Study|Did not consent for extended follow-up|13
3022254|NCT00791934|10394340|P1|Overall Study|Withdrawal by Subject|2
3022255|NCT00791921|10394350|P2|Overall Study|Reason other than those above|1
3022256|NCT00791921|10394351|P1|Overall Study|Reason other than those above|0
3022257|NCT00791921|10394350|P2|Overall Study|Lack of study drug administration|1
3022258|NCT00791921|10394351|P1|Overall Study|Lack of study drug administration|1
3022259|NCT00791921|10394350|P2|Overall Study|Lack of Efficacy|2
3022260|NCT00791921|10394351|P1|Overall Study|Lack of Efficacy|0
3022261|NCT00791921|10394350|P2|Overall Study|Adverse Event|2
3022262|NCT00791921|10394351|P1|Overall Study|Adverse Event|8
3022263|NCT00791921|10394350|P2|Overall Study|Withdrawal by Subject|2
3022264|NCT00791921|10394351|P1|Overall Study|Withdrawal by Subject|1
3022265|NCT00791921|10394350|P2|Overall Study|Protocol planed|88
3022266|NCT00791921|10394351|P1|Overall Study|Protocol planed|24
3022267|NCT00791778|10394382|P2|Follow-up|Lost to Follow-up|1
3022268|NCT00791778|10394383|P1|Follow-up|Lost to Follow-up|2
3022269|NCT00791778|10394382|P2|Follow-up|Withdrawal by Subject|0
3022270|NCT00791778|10394383|P1|Follow-up|Withdrawal by Subject|3
3022271|NCT00791778|10394382|P2|Double-blind Treatment|Non-compliant with study medication|0
3022272|NCT00791778|10394383|P1|Double-blind Treatment|Non-compliant with study medication|2
3022273|NCT00791778|10394382|P2|Double-blind Treatment|Withdrawal by Subject|9
3022274|NCT00791778|10394383|P1|Double-blind Treatment|Withdrawal by Subject|20
3022275|NCT00791778|10394382|P2|Double-blind Treatment|Protocol Violation|4
3022276|NCT00791778|10394383|P1|Double-blind Treatment|Protocol Violation|0
3022277|NCT00791778|10394382|P2|Double-blind Treatment|Physician Decision|26
3022278|NCT00791778|10394383|P1|Double-blind Treatment|Physician Decision|6
3022279|NCT00791778|10394382|P2|Double-blind Treatment|Adverse Event|9
3022280|NCT00791778|10394383|P1|Double-blind Treatment|Adverse Event|49
3022281|NCT00791765|10394437|P2|Weeks 13 to 24|Other|1
3022282|NCT00791765|10394438|P1|Weeks 13 to 24|Other|0
3022283|NCT00791765|10394437|P2|Weeks 13 to 24|Lost to Follow-up|2
3022284|NCT00791765|10394438|P1|Weeks 13 to 24|Lost to Follow-up|1
3022285|NCT00791765|10394437|P2|Weeks 13 to 24|Disease progression|1
3022286|NCT00791765|10394438|P1|Weeks 13 to 24|Disease progression|0
3022287|NCT00791765|10394437|P2|Weeks 13 to 24|Withdrawal by Subject|1
3022288|NCT00791765|10394438|P1|Weeks 13 to 24|Withdrawal by Subject|2
3022289|NCT00791765|10394437|P2|Weeks 13 to 24|Adverse Event|3
3022290|NCT00791765|10394438|P1|Weeks 13 to 24|Adverse Event|0
3022291|NCT00791765|10394437|P2|Weeks 13 to 24|Protocol deviation|0
3022292|NCT00791765|10394438|P1|Weeks 13 to 24|Protocol deviation|2
3022293|NCT00791765|10394437|P2|Weeks 1 to 12|Ineligibility determined|3
3022294|NCT00791765|10394438|P1|Weeks 1 to 12|Ineligibility determined|0
3022295|NCT00791765|10394437|P2|Weeks 1 to 12|Disease progression|0
3022296|NCT00791765|10394438|P1|Weeks 1 to 12|Disease progression|3
3022297|NCT00791765|10394437|P2|Weeks 1 to 12|Physician Decision|0
3022298|NCT00791765|10394438|P1|Weeks 1 to 12|Physician Decision|1
3022299|NCT00791765|10394437|P2|Weeks 1 to 12|Withdrawal by Subject|0
3022300|NCT00791765|10394438|P1|Weeks 1 to 12|Withdrawal by Subject|3
3022301|NCT00791765|10394437|P2|Weeks 1 to 12|Lost to Follow-up|0
3022302|NCT00791765|10394438|P1|Weeks 1 to 12|Lost to Follow-up|1
3022303|NCT00791765|10394437|P2|Weeks 1 to 12|Adverse Event|1
3022304|NCT00791765|10394438|P1|Weeks 1 to 12|Adverse Event|0
3022305|NCT00791700|10394453|P4|Overall Study|Adverse Event|1
3022306|NCT00791700|10394454|P3|Overall Study|Adverse Event|1
3022307|NCT00791700|10394455|P2|Overall Study|Adverse Event|0
3022308|NCT00791700|10394456|P1|Overall Study|Adverse Event|0
3022309|NCT00791700|10394453|P4|Overall Study|Lost to Follow-up|6
3022310|NCT00791700|10394454|P3|Overall Study|Lost to Follow-up|4
3022311|NCT00791700|10394455|P2|Overall Study|Lost to Follow-up|3
3022312|NCT00791700|10394456|P1|Overall Study|Lost to Follow-up|4
3022313|NCT00791700|10394453|P4|Overall Study|Death|1
3022314|NCT00791700|10394454|P3|Overall Study|Death|0
3022315|NCT00791700|10394455|P2|Overall Study|Death|0
3022316|NCT00791700|10394456|P1|Overall Study|Death|0
3022317|NCT00791700|10394453|P4|Overall Study|Other|1
3022318|NCT00791700|10394454|P3|Overall Study|Other|0
3022319|NCT00791700|10394455|P2|Overall Study|Other|1
3022320|NCT00791700|10394456|P1|Overall Study|Other|0
3022321|NCT00791700|10394453|P4|Overall Study|Withdrawn due to pregnancy|1
3022322|NCT00791700|10394454|P3|Overall Study|Withdrawn due to pregnancy|0
3022323|NCT00791700|10394455|P2|Overall Study|Withdrawn due to pregnancy|0
3022324|NCT00791700|10394456|P1|Overall Study|Withdrawn due to pregnancy|0
3022325|NCT00791700|10394453|P4|Overall Study|Non-compliance with study treatment|4
3022326|NCT00791700|10394454|P3|Overall Study|Non-compliance with study treatment|0
3022327|NCT00791700|10394455|P2|Overall Study|Non-compliance with study treatment|2
3022328|NCT00791700|10394456|P1|Overall Study|Non-compliance with study treatment|0
3022329|NCT00791700|10394453|P4|Overall Study|No longer willing to participate|8
3022330|NCT00791700|10394454|P3|Overall Study|No longer willing to participate|0
3022331|NCT00791700|10394455|P2|Overall Study|No longer willing to participate|1
3022332|NCT00791700|10394456|P1|Overall Study|No longer willing to participate|1
3022333|NCT00791700|10394453|P4|Overall Study|Insufficient clinical response|8
3022334|NCT00791700|10394454|P3|Overall Study|Insufficient clinical response|1
3022335|NCT00791700|10394455|P2|Overall Study|Insufficient clinical response|4
3022336|NCT00791700|10394456|P1|Overall Study|Insufficient clinical response|1
3022337|NCT00791661|10394544|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
3022338|NCT00791661|10394545|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
3022339|NCT00791661|10394546|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
3022340|NCT00791661|10394544|P3|7 Day Wash-out|Adverse Event|1
3022341|NCT00791661|10394545|P2|7 Day Wash-out|Adverse Event|0
3022342|NCT00791661|10394546|P1|7 Day Wash-out|Adverse Event|0
3022343|NCT00791648|10394639|P2|Overall Study|Withdrawal by Subject|1
3022344|NCT00791648|10394640|P1|Overall Study|Withdrawal by Subject|0
3022345|NCT00791648|10394639|P2|Overall Study|Physician Decision|1
3022346|NCT00791648|10394640|P1|Overall Study|Physician Decision|0
3022347|NCT00791557|10394676|P1|Overall Study|Adverse Event|1
3022348|NCT00791518|10394680|P1|Overall Study|Protocol Violation|93
3022349|NCT00791492|10394708|P2|Overall Study|Liver transplantation|1
3022350|NCT00791492|10394709|P1|Overall Study|Liver transplantation|5
3022351|NCT00791492|10394708|P2|Overall Study|Withdrawal by Subject|2
3022352|NCT00791492|10394709|P1|Overall Study|Withdrawal by Subject|1
3022353|NCT00791479|10394757|P6|Overall Study|Withdrawal by Subject|1
3022354|NCT00791479|10394758|P5|Overall Study|Withdrawal by Subject|0
3022355|NCT00791479|10394759|P4|Overall Study|Withdrawal by Subject|1
3022356|NCT00791479|10394760|P3|Overall Study|Withdrawal by Subject|0
3022357|NCT00791479|10394761|P2|Overall Study|Withdrawal by Subject|0
3022358|NCT00791479|10394762|P1|Overall Study|Withdrawal by Subject|0
3022359|NCT00791479|10394757|P6|Overall Study|Protocol Violation|0
3022360|NCT00791479|10394758|P5|Overall Study|Protocol Violation|0
3022361|NCT00791479|10394759|P4|Overall Study|Protocol Violation|1
3022362|NCT00791479|10394760|P3|Overall Study|Protocol Violation|0
3022363|NCT00791479|10394761|P2|Overall Study|Protocol Violation|1
3022364|NCT00791479|10394762|P1|Overall Study|Protocol Violation|2
3022365|NCT00791479|10394757|P6|Overall Study|Lost to Follow-up|1
3022366|NCT00791479|10394758|P5|Overall Study|Lost to Follow-up|0
3022367|NCT00791479|10394759|P4|Overall Study|Lost to Follow-up|0
3022368|NCT00791479|10394760|P3|Overall Study|Lost to Follow-up|0
3022369|NCT00791479|10394761|P2|Overall Study|Lost to Follow-up|1
3022370|NCT00791479|10394762|P1|Overall Study|Lost to Follow-up|0
3022371|NCT00791479|10394757|P6|Overall Study|Adverse Event|1
3022372|NCT00791479|10394758|P5|Overall Study|Adverse Event|0
3022373|NCT00791479|10394759|P4|Overall Study|Adverse Event|2
3022374|NCT00791479|10394760|P3|Overall Study|Adverse Event|0
3022375|NCT00791479|10394761|P2|Overall Study|Adverse Event|1
3022376|NCT00791479|10394762|P1|Overall Study|Adverse Event|0
3022377|NCT00791479|10394757|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
3022378|NCT00791479|10394758|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
3022379|NCT00791479|10394759|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
3022380|NCT00791479|10394760|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
3022381|NCT00791479|10394761|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
3022382|NCT00791479|10394762|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
3022383|NCT00791388|10394861|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
3022384|NCT00791388|10394862|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
3022385|NCT00791388|10394863|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
3022386|NCT00791388|10394864|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
3022387|NCT00791388|10394865|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
3022388|NCT00791388|10394861|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
3022389|NCT00791388|10394862|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
3022390|NCT00791388|10394863|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
3022391|NCT00791388|10394864|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
3022392|NCT00791388|10394865|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
3022393|NCT00791388|10394861|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
3022394|NCT00791388|10394862|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
3022395|NCT00791388|10394863|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
3022396|NCT00791388|10394864|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
3022397|NCT00791388|10394865|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
3022398|NCT00791258|10394907|P1|Overall Study|Lack of Efficacy|1
3022399|NCT00791258|10394907|P1|Overall Study|Subject required restricted medication|1
3022400|NCT00791258|10394907|P1|Overall Study|Subject incarcerated|1
3022401|NCT00791258|10394907|P1|Overall Study|non-compliance|3
3022402|NCT00791258|10394907|P1|Overall Study|subject left area|2
3022403|NCT00791258|10394907|P1|Overall Study|Did not take medication for >3 days|1
3022404|NCT00791258|10394907|P1|Overall Study|Withdrawal by Subject|40
3022405|NCT00791258|10394907|P1|Overall Study|Protocol Violation|109
3022406|NCT00791258|10394907|P1|Overall Study|Lost to Follow-up|18
3022407|NCT00791258|10394907|P1|Overall Study|Adverse Event|87
3022408|NCT00791128|10394969|P1|Overall Study|abdominal tumor, unrelated to device|1
3022409|NCT00791128|10394969|P1|Overall Study|non-compliance by subject|2
3022410|NCT00791128|10394969|P1|Overall Study|Device migration|2
3022411|NCT00791128|10394969|P1|Overall Study|Adverse Event|4
3022412|NCT00791076|10395000|P1|Overall Study|Study was terminated,PI left institution|8
3022413|NCT00790933|10395020|P5|Overall Study|Reason Not Specified|9
3022414|NCT00790933|10395021|P4|Overall Study|Reason Not Specified|1
3022415|NCT00790933|10395022|P3|Overall Study|Reason Not Specified|4
3022416|NCT00790933|10395023|P2|Overall Study|Reason Not Specified|16
3022417|NCT00790933|10395024|P1|Overall Study|Reason Not Specified|8
3022418|NCT00790933|10395020|P5|Overall Study|Lost to Follow-up|15
3022419|NCT00790933|10395021|P4|Overall Study|Lost to Follow-up|1
3022420|NCT00790933|10395022|P3|Overall Study|Lost to Follow-up|10
3022421|NCT00790933|10395023|P2|Overall Study|Lost to Follow-up|31
3022422|NCT00790933|10395024|P1|Overall Study|Lost to Follow-up|13
3022423|NCT00790933|10395020|P5|Overall Study|Withdrawal by Subject|50
3022424|NCT00790933|10395021|P4|Overall Study|Withdrawal by Subject|6
3022425|NCT00790933|10395022|P3|Overall Study|Withdrawal by Subject|52
3022426|NCT00790933|10395023|P2|Overall Study|Withdrawal by Subject|120
3022427|NCT00790933|10395024|P1|Overall Study|Withdrawal by Subject|123
3022428|NCT00790933|10395020|P5|Overall Study|Study Terminated by Sponsor|0
3022429|NCT00790933|10395021|P4|Overall Study|Study Terminated by Sponsor|0
3022430|NCT00790933|10395022|P3|Overall Study|Study Terminated by Sponsor|1
3022431|NCT00790933|10395023|P2|Overall Study|Study Terminated by Sponsor|0
3022432|NCT00790933|10395024|P1|Overall Study|Study Terminated by Sponsor|0
3022433|NCT00790933|10395020|P5|Overall Study|Lack of Efficacy|121
3022434|NCT00790933|10395021|P4|Overall Study|Lack of Efficacy|1
3022435|NCT00790933|10395022|P3|Overall Study|Lack of Efficacy|130
3022436|NCT00790933|10395023|P2|Overall Study|Lack of Efficacy|176
3022437|NCT00790933|10395024|P1|Overall Study|Lack of Efficacy|192
3022438|NCT00790933|10395020|P5|Overall Study|Protocol Violation(s)|12
3022439|NCT00790933|10395021|P4|Overall Study|Protocol Violation(s)|0
3022440|NCT00790933|10395022|P3|Overall Study|Protocol Violation(s)|7
3022441|NCT00790933|10395023|P2|Overall Study|Protocol Violation(s)|18
3022442|NCT00790933|10395024|P1|Overall Study|Protocol Violation(s)|8
3022443|NCT00790933|10395020|P5|Overall Study|Adverse Event|69
3022444|NCT00790933|10395021|P4|Overall Study|Adverse Event|5
3022445|NCT00790933|10395022|P3|Overall Study|Adverse Event|65
3022446|NCT00790933|10395023|P2|Overall Study|Adverse Event|119
3022447|NCT00790933|10395024|P1|Overall Study|Adverse Event|94
3022448|NCT00790907|10395555|P3|Overall Study|Did Not Receive Study Drug|0
3022449|NCT00790907|10395556|P2|Overall Study|Did Not Receive Study Drug|0
3022450|NCT00790907|10395557|P1|Overall Study|Did Not Receive Study Drug|10
3022451|NCT00790907|10395555|P3|Overall Study|Verbatim Reason on the Case Report Form|29
3022452|NCT00790907|10395556|P2|Overall Study|Verbatim Reason on the Case Report Form|20
3022453|NCT00790907|10395557|P1|Overall Study|Verbatim Reason on the Case Report Form|74
3022454|NCT00790907|10395555|P3|Overall Study|Qualifying Condition Not Present|16
3022455|NCT00790907|10395556|P2|Overall Study|Qualifying Condition Not Present|14
3022456|NCT00790907|10395557|P1|Overall Study|Qualifying Condition Not Present|29
3022457|NCT00790907|10395555|P3|Overall Study|Required Protocol-prohibited Therapy|7
3022458|NCT00790907|10395556|P2|Overall Study|Required Protocol-prohibited Therapy|5
3022459|NCT00790907|10395557|P1|Overall Study|Required Protocol-prohibited Therapy|17
3022460|NCT00790907|10395555|P3|Overall Study|Bleeding Event|21
3022461|NCT00790907|10395556|P2|Overall Study|Bleeding Event|16
3022462|NCT00790907|10395557|P1|Overall Study|Bleeding Event|11
3022463|NCT00790907|10395555|P3|Overall Study|Withdrawal by Subject|5
3022464|NCT00790907|10395556|P2|Overall Study|Withdrawal by Subject|7
3022465|NCT00790907|10395557|P1|Overall Study|Withdrawal by Subject|1
3022466|NCT00790907|10395555|P3|Overall Study|Physician Decision|255
3022467|NCT00790907|10395556|P2|Overall Study|Physician Decision|271
3022468|NCT00790907|10395557|P1|Overall Study|Physician Decision|304
3022469|NCT00790907|10395555|P3|Overall Study|Adverse Event|6
3022470|NCT00790907|10395556|P2|Overall Study|Adverse Event|7
3022471|NCT00790907|10395557|P1|Overall Study|Adverse Event|9
3022472|NCT00790868|10395580|P2|Overall Study|Lost to Follow-up|12
3022473|NCT00790868|10395581|P1|Overall Study|Lost to Follow-up|2
3022474|NCT00790868|10395580|P2|Overall Study|Withdrawal by Subject|5
3022475|NCT00790868|10395581|P1|Overall Study|Withdrawal by Subject|4
3022476|NCT00790842|10395603|P11|Expansion Cohort|Study Closure|0
3022477|NCT00790842|10395604|P10|Expansion Cohort|Study Closure|0
3022478|NCT00790842|10395605|P9|Expansion Cohort|Study Closure|0
3022479|NCT00790842|10395606|P8|Expansion Cohort|Study Closure|0
3022480|NCT00790842|10395607|P7|Expansion Cohort|Study Closure|0
3022481|NCT00790842|10395608|P6|Expansion Cohort|Study Closure|0
3022482|NCT00790842|10395609|P5|Expansion Cohort|Study Closure|0
3022483|NCT00790842|10395610|P4|Expansion Cohort|Study Closure|0
3022484|NCT00790842|10395611|P3|Expansion Cohort|Study Closure|1
3022485|NCT00790842|10395612|P2|Expansion Cohort|Study Closure|0
3022486|NCT00790842|10395613|P1|Expansion Cohort|Study Closure|0
3022487|NCT00790842|10395603|P11|Expansion Cohort|Withdrawal by Subject|0
3022488|NCT00790842|10395604|P10|Expansion Cohort|Withdrawal by Subject|0
3022489|NCT00790842|10395605|P9|Expansion Cohort|Withdrawal by Subject|0
3022490|NCT00790842|10395606|P8|Expansion Cohort|Withdrawal by Subject|0
3022491|NCT00790842|10395607|P7|Expansion Cohort|Withdrawal by Subject|0
3022492|NCT00790842|10395608|P6|Expansion Cohort|Withdrawal by Subject|0
3022493|NCT00790842|10395609|P5|Expansion Cohort|Withdrawal by Subject|0
3022494|NCT00790842|10395610|P4|Expansion Cohort|Withdrawal by Subject|0
3022495|NCT00790842|10395611|P3|Expansion Cohort|Withdrawal by Subject|3
3022496|NCT00790842|10395612|P2|Expansion Cohort|Withdrawal by Subject|0
3022497|NCT00790842|10395613|P1|Expansion Cohort|Withdrawal by Subject|0
3022498|NCT00790842|10395603|P11|Expansion Cohort|Physician Decision|0
3022499|NCT00790842|10395604|P10|Expansion Cohort|Physician Decision|0
3022500|NCT00790842|10395605|P9|Expansion Cohort|Physician Decision|0
3022501|NCT00790842|10395606|P8|Expansion Cohort|Physician Decision|0
3022502|NCT00790842|10395607|P7|Expansion Cohort|Physician Decision|0
3022503|NCT00790842|10395608|P6|Expansion Cohort|Physician Decision|0
3022504|NCT00790842|10395609|P5|Expansion Cohort|Physician Decision|0
3022505|NCT00790842|10395610|P4|Expansion Cohort|Physician Decision|0
3022506|NCT00790842|10395611|P3|Expansion Cohort|Physician Decision|1
3022507|NCT00790842|10395612|P2|Expansion Cohort|Physician Decision|0
3022508|NCT00790842|10395613|P1|Expansion Cohort|Physician Decision|0
3022509|NCT00790842|10395603|P11|Expansion Cohort|Death|0
3022510|NCT00790842|10395604|P10|Expansion Cohort|Death|0
3022511|NCT00790842|10395605|P9|Expansion Cohort|Death|0
3022512|NCT00790842|10395606|P8|Expansion Cohort|Death|0
3022513|NCT00790842|10395607|P7|Expansion Cohort|Death|0
3022514|NCT00790842|10395608|P6|Expansion Cohort|Death|0
3022515|NCT00790842|10395609|P5|Expansion Cohort|Death|0
3022516|NCT00790842|10395610|P4|Expansion Cohort|Death|0
3022517|NCT00790842|10395611|P3|Expansion Cohort|Death|2
3022518|NCT00790842|10395612|P2|Expansion Cohort|Death|0
3022519|NCT00790842|10395613|P1|Expansion Cohort|Death|0
3022520|NCT00790842|10395603|P11|Expansion Cohort|Adverse Event|0
3022521|NCT00790842|10395604|P10|Expansion Cohort|Adverse Event|0
3022522|NCT00790842|10395605|P9|Expansion Cohort|Adverse Event|0
3022523|NCT00790842|10395606|P8|Expansion Cohort|Adverse Event|0
3022524|NCT00790842|10395607|P7|Expansion Cohort|Adverse Event|1
3022525|NCT00790842|10395608|P6|Expansion Cohort|Adverse Event|0
3022526|NCT00790842|10395609|P5|Expansion Cohort|Adverse Event|0
3022527|NCT00790842|10395610|P4|Expansion Cohort|Adverse Event|0
3022528|NCT00790842|10395611|P3|Expansion Cohort|Adverse Event|0
3022529|NCT00790842|10395612|P2|Expansion Cohort|Adverse Event|0
3022530|NCT00790842|10395613|P1|Expansion Cohort|Adverse Event|0
3022531|NCT00790842|10395603|P11|Dose Level 4|Withdrawal by Subject|1
3022532|NCT00790842|10395604|P10|Dose Level 4|Withdrawal by Subject|0
3022533|NCT00790842|10395605|P9|Dose Level 4|Withdrawal by Subject|0
3022534|NCT00790842|10395606|P8|Dose Level 4|Withdrawal by Subject|0
3022535|NCT00790842|10395607|P7|Dose Level 4|Withdrawal by Subject|0
3022536|NCT00790842|10395608|P6|Dose Level 4|Withdrawal by Subject|0
3022537|NCT00790842|10395609|P5|Dose Level 4|Withdrawal by Subject|0
3022538|NCT00790842|10395610|P4|Dose Level 4|Withdrawal by Subject|0
3022539|NCT00790842|10395611|P3|Dose Level 4|Withdrawal by Subject|0
3022540|NCT00790842|10395612|P2|Dose Level 4|Withdrawal by Subject|0
3022541|NCT00790842|10395613|P1|Dose Level 4|Withdrawal by Subject|0
3022542|NCT00790842|10395603|P11|Dose Level 4|Physician Decision|1
3022543|NCT00790842|10395604|P10|Dose Level 4|Physician Decision|0
3022544|NCT00790842|10395605|P9|Dose Level 4|Physician Decision|0
3022545|NCT00790842|10395606|P8|Dose Level 4|Physician Decision|0
3022546|NCT00790842|10395607|P7|Dose Level 4|Physician Decision|1
3022547|NCT00790842|10395608|P6|Dose Level 4|Physician Decision|0
3022548|NCT00790842|10395609|P5|Dose Level 4|Physician Decision|0
3022549|NCT00790842|10395610|P4|Dose Level 4|Physician Decision|0
3022550|NCT00790842|10395611|P3|Dose Level 4|Physician Decision|0
3022551|NCT00790842|10395612|P2|Dose Level 4|Physician Decision|0
3022552|NCT00790842|10395613|P1|Dose Level 4|Physician Decision|0
3022553|NCT00790842|10395603|P11|Dose Level 4|Adverse Event|0
3022554|NCT00790842|10395604|P10|Dose Level 4|Adverse Event|0
3022555|NCT00790842|10395605|P9|Dose Level 4|Adverse Event|0
3022556|NCT00790842|10395606|P8|Dose Level 4|Adverse Event|0
3022557|NCT00790842|10395607|P7|Dose Level 4|Adverse Event|1
3022558|NCT00790842|10395608|P6|Dose Level 4|Adverse Event|0
3022559|NCT00790842|10395609|P5|Dose Level 4|Adverse Event|0
3022560|NCT00790842|10395610|P4|Dose Level 4|Adverse Event|0
3022561|NCT00790842|10395611|P3|Dose Level 4|Adverse Event|0
3022562|NCT00790842|10395612|P2|Dose Level 4|Adverse Event|0
3022563|NCT00790842|10395613|P1|Dose Level 4|Adverse Event|0
3022564|NCT00790842|10395603|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022565|NCT00790842|10395604|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022566|NCT00790842|10395605|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022567|NCT00790842|10395606|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022568|NCT00790842|10395607|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022569|NCT00790842|10395608|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022570|NCT00790842|10395609|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022571|NCT00790842|10395610|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022572|NCT00790842|10395611|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
3022573|NCT00790842|10395612|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022574|NCT00790842|10395613|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
3022575|NCT00790842|10395603|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022576|NCT00790842|10395604|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022577|NCT00790842|10395605|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022578|NCT00790842|10395606|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022579|NCT00790842|10395607|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022580|NCT00790842|10395608|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
3022581|NCT00790842|10395609|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022582|NCT00790842|10395610|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022583|NCT00790842|10395611|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022584|NCT00790842|10395612|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022585|NCT00790842|10395613|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
3022586|NCT00790842|10395603|P11|Dose Level 3|Withdrawal by Subject|0
3022587|NCT00790842|10395604|P10|Dose Level 3|Withdrawal by Subject|2
3022588|NCT00790842|10395605|P9|Dose Level 3|Withdrawal by Subject|0
3022589|NCT00790842|10395606|P8|Dose Level 3|Withdrawal by Subject|0
3022590|NCT00790842|10395607|P7|Dose Level 3|Withdrawal by Subject|0
3022591|NCT00790842|10395608|P6|Dose Level 3|Withdrawal by Subject|0
3022592|NCT00790842|10395609|P5|Dose Level 3|Withdrawal by Subject|0
3022593|NCT00790842|10395610|P4|Dose Level 3|Withdrawal by Subject|0
3022594|NCT00790842|10395611|P3|Dose Level 3|Withdrawal by Subject|3
3022595|NCT00790842|10395612|P2|Dose Level 3|Withdrawal by Subject|0
3022596|NCT00790842|10395613|P1|Dose Level 3|Withdrawal by Subject|0
3022597|NCT00790842|10395603|P11|Dose Level 3|Adverse Event|0
3022598|NCT00790842|10395604|P10|Dose Level 3|Adverse Event|0
3022599|NCT00790842|10395605|P9|Dose Level 3|Adverse Event|0
3022600|NCT00790842|10395606|P8|Dose Level 3|Adverse Event|0
3022601|NCT00790842|10395607|P7|Dose Level 3|Adverse Event|0
3022602|NCT00790842|10395608|P6|Dose Level 3|Adverse Event|0
3022603|NCT00790842|10395609|P5|Dose Level 3|Adverse Event|0
3022604|NCT00790842|10395610|P4|Dose Level 3|Adverse Event|0
3022605|NCT00790842|10395611|P3|Dose Level 3|Adverse Event|1
3022606|NCT00790842|10395612|P2|Dose Level 3|Adverse Event|0
3022607|NCT00790842|10395613|P1|Dose Level 3|Adverse Event|0
3022608|NCT00790842|10395603|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022609|NCT00790842|10395604|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022610|NCT00790842|10395605|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
3022611|NCT00790842|10395606|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022612|NCT00790842|10395607|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022613|NCT00790842|10395608|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022614|NCT00790842|10395609|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022615|NCT00790842|10395610|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022616|NCT00790842|10395611|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022617|NCT00790842|10395612|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022618|NCT00790842|10395613|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
3022619|NCT00790842|10395603|P11|Dose Level 2|Withdrawal by Subject|0
3022620|NCT00790842|10395604|P10|Dose Level 2|Withdrawal by Subject|0
3022621|NCT00790842|10395605|P9|Dose Level 2|Withdrawal by Subject|0
3022622|NCT00790842|10395606|P8|Dose Level 2|Withdrawal by Subject|0
3022623|NCT00790842|10395607|P7|Dose Level 2|Withdrawal by Subject|0
3022624|NCT00790842|10395608|P6|Dose Level 2|Withdrawal by Subject|0
3022625|NCT00790842|10395609|P5|Dose Level 2|Withdrawal by Subject|0
3022626|NCT00790842|10395610|P4|Dose Level 2|Withdrawal by Subject|0
3022627|NCT00790842|10395611|P3|Dose Level 2|Withdrawal by Subject|0
3022628|NCT00790842|10395612|P2|Dose Level 2|Withdrawal by Subject|1
3022629|NCT00790842|10395613|P1|Dose Level 2|Withdrawal by Subject|0
3022630|NCT00790842|10395603|P11|Dose Level 2|Physician Decision|0
3022631|NCT00790842|10395604|P10|Dose Level 2|Physician Decision|0
3022632|NCT00790842|10395605|P9|Dose Level 2|Physician Decision|0
3022633|NCT00790842|10395606|P8|Dose Level 2|Physician Decision|0
3022634|NCT00790842|10395607|P7|Dose Level 2|Physician Decision|0
3022635|NCT00790842|10395608|P6|Dose Level 2|Physician Decision|0
3022636|NCT00790842|10395609|P5|Dose Level 2|Physician Decision|0
3022637|NCT00790842|10395610|P4|Dose Level 2|Physician Decision|0
3022638|NCT00790842|10395611|P3|Dose Level 2|Physician Decision|0
3022639|NCT00790842|10395612|P2|Dose Level 2|Physician Decision|1
3022640|NCT00790842|10395613|P1|Dose Level 2|Physician Decision|0
3022641|NCT00790842|10395603|P11|Dose Level 2|Death|0
3022642|NCT00790842|10395604|P10|Dose Level 2|Death|0
3022643|NCT00790842|10395605|P9|Dose Level 2|Death|0
3022644|NCT00790842|10395606|P8|Dose Level 2|Death|0
3022645|NCT00790842|10395607|P7|Dose Level 2|Death|0
3022646|NCT00790842|10395608|P6|Dose Level 2|Death|0
3022647|NCT00790842|10395609|P5|Dose Level 2|Death|1
3022648|NCT00790842|10395610|P4|Dose Level 2|Death|0
3022649|NCT00790842|10395611|P3|Dose Level 2|Death|0
3022650|NCT00790842|10395612|P2|Dose Level 2|Death|1
3022651|NCT00790842|10395613|P1|Dose Level 2|Death|0
3022652|NCT00790842|10395603|P11|Dose Level 1|Withdrawal by Subject|0
3022653|NCT00790842|10395604|P10|Dose Level 1|Withdrawal by Subject|0
3022654|NCT00790842|10395605|P9|Dose Level 1|Withdrawal by Subject|0
3022655|NCT00790842|10395606|P8|Dose Level 1|Withdrawal by Subject|0
3022656|NCT00790842|10395607|P7|Dose Level 1|Withdrawal by Subject|0
3022657|NCT00790842|10395608|P6|Dose Level 1|Withdrawal by Subject|0
3022658|NCT00790842|10395609|P5|Dose Level 1|Withdrawal by Subject|0
3022659|NCT00790842|10395610|P4|Dose Level 1|Withdrawal by Subject|0
3022660|NCT00790842|10395611|P3|Dose Level 1|Withdrawal by Subject|0
3022661|NCT00790842|10395612|P2|Dose Level 1|Withdrawal by Subject|0
3022662|NCT00790842|10395613|P1|Dose Level 1|Withdrawal by Subject|1
3022663|NCT00790842|10395603|P11|Dose Level 1|Physician Decision|0
3022664|NCT00790842|10395604|P10|Dose Level 1|Physician Decision|0
3022665|NCT00790842|10395605|P9|Dose Level 1|Physician Decision|0
3022666|NCT00790842|10395606|P8|Dose Level 1|Physician Decision|1
3022667|NCT00790842|10395607|P7|Dose Level 1|Physician Decision|0
3022668|NCT00790842|10395608|P6|Dose Level 1|Physician Decision|0
3022669|NCT00790842|10395609|P5|Dose Level 1|Physician Decision|0
3022670|NCT00790842|10395610|P4|Dose Level 1|Physician Decision|0
3022671|NCT00790842|10395611|P3|Dose Level 1|Physician Decision|0
3022672|NCT00790842|10395612|P2|Dose Level 1|Physician Decision|0
3022673|NCT00790842|10395613|P1|Dose Level 1|Physician Decision|1
3022674|NCT00790842|10395603|P11|Dose Level 1|Adverse Event|0
3022675|NCT00790842|10395604|P10|Dose Level 1|Adverse Event|0
3022676|NCT00790842|10395605|P9|Dose Level 1|Adverse Event|0
3022677|NCT00790842|10395606|P8|Dose Level 1|Adverse Event|1
3022678|NCT00790842|10395607|P7|Dose Level 1|Adverse Event|0
3022679|NCT00790842|10395608|P6|Dose Level 1|Adverse Event|0
3022680|NCT00790842|10395609|P5|Dose Level 1|Adverse Event|0
3022681|NCT00790842|10395610|P4|Dose Level 1|Adverse Event|2
3022682|NCT00790842|10395611|P3|Dose Level 1|Adverse Event|0
3022683|NCT00790842|10395612|P2|Dose Level 1|Adverse Event|0
3022684|NCT00790842|10395613|P1|Dose Level 1|Adverse Event|1
3022685|NCT00790790|10395681|P3|Study Period 2: Therapy Phase|Physician Decision|0
3022686|NCT00790790|10395682|P2|Study Period 2: Therapy Phase|Physician Decision|1
3022687|NCT00790790|10395683|P1|Study Period 2: Therapy Phase|Physician Decision|0
3022688|NCT00790790|10395681|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
3022689|NCT00790790|10395682|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
3022690|NCT00790790|10395683|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
3022691|NCT00790790|10395681|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
3022692|NCT00790790|10395682|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
3022693|NCT00790790|10395683|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
3022694|NCT00790790|10395681|P3|Study Period 2: Therapy Phase|Protocol Violation|0
3022695|NCT00790790|10395682|P2|Study Period 2: Therapy Phase|Protocol Violation|1
3022696|NCT00790790|10395683|P1|Study Period 2: Therapy Phase|Protocol Violation|1
3022697|NCT00790790|10395681|P3|Study Period 2: Therapy Phase|Adverse Event|16
3022698|NCT00790790|10395682|P2|Study Period 2: Therapy Phase|Adverse Event|16
3022699|NCT00790790|10395683|P1|Study Period 2: Therapy Phase|Adverse Event|3
3022700|NCT00790751|10395760|P4|Overall Study|Physician Decision|1
3022701|NCT00790751|10395761|P3|Overall Study|Physician Decision|0
3022702|NCT00790751|10395762|P2|Overall Study|Physician Decision|0
3022703|NCT00790751|10395763|P1|Overall Study|Physician Decision|0
3022704|NCT00790751|10395760|P4|Overall Study|Death|0
3022705|NCT00790751|10395761|P3|Overall Study|Death|1
3022706|NCT00790751|10395762|P2|Overall Study|Death|0
3022707|NCT00790751|10395763|P1|Overall Study|Death|0
3022708|NCT00790751|10395760|P4|Overall Study|Requirement for restricted medication|0
3022709|NCT00790751|10395761|P3|Overall Study|Requirement for restricted medication|0
3022710|NCT00790751|10395762|P2|Overall Study|Requirement for restricted medication|2
3022711|NCT00790751|10395763|P1|Overall Study|Requirement for restricted medication|0
3022712|NCT00790751|10395760|P4|Overall Study|Adverse Event|4
3022713|NCT00790751|10395761|P3|Overall Study|Adverse Event|5
3022714|NCT00790751|10395762|P2|Overall Study|Adverse Event|3
3022715|NCT00790751|10395763|P1|Overall Study|Adverse Event|5
3022716|NCT00790751|10395760|P4|Overall Study|Lost to Follow-up|5
3022717|NCT00790751|10395761|P3|Overall Study|Lost to Follow-up|4
3022718|NCT00790751|10395762|P2|Overall Study|Lost to Follow-up|9
3022719|NCT00790751|10395763|P1|Overall Study|Lost to Follow-up|4
3022720|NCT00790751|10395760|P4|Overall Study|Protocol non-compliance|11
3022721|NCT00790751|10395761|P3|Overall Study|Protocol non-compliance|10
3022722|NCT00790751|10395762|P2|Overall Study|Protocol non-compliance|16
3022723|NCT00790751|10395763|P1|Overall Study|Protocol non-compliance|16
3022724|NCT00790647|10395811|P1|Overall Study|Adverse Event|1
3022725|NCT00790569|10395821|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
3022726|NCT00790569|10395822|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
3022727|NCT00790569|10395823|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
3022728|NCT00790569|10395821|P3|End of Treatment (6 Month Interview)|Incarcerated|3
3022729|NCT00790569|10395822|P2|End of Treatment (6 Month Interview)|Incarcerated|0
3022730|NCT00790569|10395823|P1|End of Treatment (6 Month Interview)|Incarcerated|0
3022731|NCT00790569|10395821|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
3022732|NCT00790569|10395822|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
3022733|NCT00790569|10395823|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
3022734|NCT00790569|10395821|P3|End of Treatment (6 Month Interview)|Hospitalized|0
3022735|NCT00790569|10395822|P2|End of Treatment (6 Month Interview)|Hospitalized|0
3022736|NCT00790569|10395823|P1|End of Treatment (6 Month Interview)|Hospitalized|2
3022737|NCT00790569|10395821|P3|End of Treatment (6 Month Interview)|Death|1
3022738|NCT00790569|10395822|P2|End of Treatment (6 Month Interview)|Death|2
3022739|NCT00790569|10395823|P1|End of Treatment (6 Month Interview)|Death|0
3022740|NCT00790569|10395821|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
3022741|NCT00790569|10395822|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
3022742|NCT00790569|10395823|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
3022743|NCT00790556|10395864|P2|Treatment Period 1|Withdrawal by Subject|0
3022744|NCT00790556|10395865|P1|Treatment Period 1|Withdrawal by Subject|1
3022745|NCT00790556|10395864|P2|Treatment Period 1|Physician Decision|0
3022746|NCT00790556|10395865|P1|Treatment Period 1|Physician Decision|1
3022747|NCT00790452|10395877|P2|Overall Study|Drug supply issue|0
3022748|NCT00790452|10395878|P1|Overall Study|Drug supply issue|1
3022749|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|New treatment|0
3022750|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|New treatment|2
3022751|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
3022752|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
3022753|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Disease progression|0
3022754|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Disease progression|5
3022755|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Death|0
3022756|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Death|1
3022757|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Administrative problems|0
3022758|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Administrative problems|2
3022759|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
3022760|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
3022761|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
3022762|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
3022763|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
3022764|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
3022765|NCT00790400|10395886|P2|Everolimus Period (Core or Extension)|Adverse Event|0
3022766|NCT00790400|10395887|P1|Everolimus Period (Core or Extension)|Adverse Event|9
3022767|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Death|0
3022768|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Death|1
3022769|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Administrative problems|0
3022770|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Administrative problems|1
3022771|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
3022772|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
3022773|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
3022774|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
3022775|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Adverse Event|4
3022776|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Adverse Event|2
3022777|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Progressive disease|9
3022778|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Progressive disease|0
3022779|NCT00790400|10395886|P2|Double-blind Period (Core Phase)|Protocol Violation|0
3022780|NCT00790400|10395887|P1|Double-blind Period (Core Phase)|Protocol Violation|1
3022781|NCT00790296|10395977|P2|Overall Study|Adverse Event|1
3022782|NCT00790296|10395978|P1|Overall Study|Adverse Event|0
3022783|NCT00790296|10395977|P2|Overall Study|Did not meet study eligibility criteria|1
3022784|NCT00790296|10395978|P1|Overall Study|Did not meet study eligibility criteria|1
3022785|NCT00790218|10396000|P3|Overall Study|Death|0
3022786|NCT00790218|10396001|P2|Overall Study|Death|0
3022787|NCT00790218|10396002|P1|Overall Study|Death|1
3022788|NCT00790205|10396012|P2|Overall Study|Withdrawal by Subject|363
3022789|NCT00790205|10396013|P1|Overall Study|Withdrawal by Subject|299
3022790|NCT00790205|10396012|P2|Overall Study|Lost to Follow-up|71
3022791|NCT00790205|10396013|P1|Overall Study|Lost to Follow-up|61
3022792|NCT00790088|10396074|P1|Overall Study|Physician Decision|4
3022793|NCT00790088|10396074|P1|Overall Study|Lost to Follow-up|7
3022794|NCT00790088|10396074|P1|Overall Study|Withdrawal by Subject|17
3022795|NCT00790088|10396074|P1|Overall Study|Protocol Violation|11
3022796|NCT00790036|10396120|P2|Overall Study|Subject/guardian decision|7
3022797|NCT00790036|10396121|P1|Overall Study|Subject/guardian decision|20
3022798|NCT00790036|10396120|P2|Overall Study|Withdrawal by Subject|7
3022799|NCT00790036|10396121|P1|Overall Study|Withdrawal by Subject|18
3022800|NCT00790036|10396120|P2|Overall Study|Protocol Violation|2
3022801|NCT00790036|10396121|P1|Overall Study|Protocol Violation|10
3022802|NCT00790036|10396120|P2|Overall Study|Lost to Follow-up|2
3022803|NCT00790036|10396121|P1|Overall Study|Lost to Follow-up|1
3022804|NCT00790036|10396120|P2|Overall Study|Disease progression|48
3022805|NCT00790036|10396121|P1|Overall Study|Disease progression|24
3022806|NCT00790036|10396120|P2|Overall Study|Death|0
3022807|NCT00790036|10396121|P1|Overall Study|Death|1
3022808|NCT00790036|10396120|P2|Overall Study|Adverse Event|44
3022809|NCT00790036|10396121|P1|Overall Study|Adverse Event|113
3022810|NCT00790036|10396120|P2|Overall Study|Administrative problems|9
3022811|NCT00790036|10396121|P1|Overall Study|Administrative problems|5
3022812|NCT00790036|10396120|P2|Overall Study|Abnormal lab values|2
3022813|NCT00790036|10396121|P1|Overall Study|Abnormal lab values|3
3022814|NCT00790023|10396135|P3|Overall Study|Other|8
3022815|NCT00790023|10396136|P2|Overall Study|Other|5
3022816|NCT00790023|10396137|P1|Overall Study|Other|5
3022817|NCT00790023|10396135|P3|Overall Study|Lost to Follow-up|1
3022818|NCT00790023|10396136|P2|Overall Study|Lost to Follow-up|0
3022819|NCT00790023|10396137|P1|Overall Study|Lost to Follow-up|0
3022820|NCT00790023|10396135|P3|Overall Study|Withdrawal by Subject|6
3022821|NCT00790023|10396136|P2|Overall Study|Withdrawal by Subject|0
3022822|NCT00790023|10396137|P1|Overall Study|Withdrawal by Subject|2
3022823|NCT00790023|10396135|P3|Overall Study|Protocol Violation|2
3022824|NCT00790023|10396136|P2|Overall Study|Protocol Violation|4
3022825|NCT00790023|10396137|P1|Overall Study|Protocol Violation|2
3022826|NCT00790023|10396135|P3|Overall Study|Adverse Event|4
3022827|NCT00790023|10396136|P2|Overall Study|Adverse Event|1
3022828|NCT00790023|10396137|P1|Overall Study|Adverse Event|2
3022829|NCT00789958|10396236|P1|Overall Study|Not eligible/not analyzable|26
3022830|NCT00789958|10396236|P1|Overall Study|not protocol specified|1
3022831|NCT00789958|10396236|P1|Overall Study|Progression|3
3022832|NCT00789958|10396236|P1|Overall Study|Withdrawal by Subject|4
3022833|NCT00789958|10396236|P1|Overall Study|Adverse Event|3
3022834|NCT00789880|10396255|P6|Overall Study|Withdrawal by Subject|0
3022835|NCT00789880|10396256|P5|Overall Study|Withdrawal by Subject|2
3022836|NCT00789880|10396257|P4|Overall Study|Withdrawal by Subject|0
3022837|NCT00789880|10396258|P3|Overall Study|Withdrawal by Subject|0
3022838|NCT00789880|10396259|P2|Overall Study|Withdrawal by Subject|0
3022839|NCT00789880|10396260|P1|Overall Study|Withdrawal by Subject|1
3022840|NCT00789880|10396255|P6|Overall Study|Protocol Violation|0
3022841|NCT00789880|10396256|P5|Overall Study|Protocol Violation|0
3022842|NCT00789880|10396257|P4|Overall Study|Protocol Violation|1
3022843|NCT00789880|10396258|P3|Overall Study|Protocol Violation|0
3022844|NCT00789880|10396259|P2|Overall Study|Protocol Violation|1
3022845|NCT00789880|10396260|P1|Overall Study|Protocol Violation|0
3022846|NCT00789880|10396255|P6|Overall Study|Adverse Event|0
3022847|NCT00789880|10396256|P5|Overall Study|Adverse Event|1
3022848|NCT00789880|10396257|P4|Overall Study|Adverse Event|0
3022849|NCT00789880|10396258|P3|Overall Study|Adverse Event|0
3022850|NCT00789880|10396259|P2|Overall Study|Adverse Event|0
3022851|NCT00789880|10396260|P1|Overall Study|Adverse Event|0
3022852|NCT00789854|10396317|P3|Overall Study|Other|5
3022853|NCT00789854|10396318|P2|Overall Study|Other|0
3022854|NCT00789854|10396319|P1|Overall Study|Other|6
3022855|NCT00789854|10396317|P3|Overall Study|Safety reasons|2
3022856|NCT00789854|10396318|P2|Overall Study|Safety reasons|0
3022857|NCT00789854|10396319|P1|Overall Study|Safety reasons|0
3022858|NCT00789854|10396317|P3|Overall Study|Severe non-compliance to the protocol|0
3022859|NCT00789854|10396318|P2|Overall Study|Severe non-compliance to the protocol|0
3022860|NCT00789854|10396319|P1|Overall Study|Severe non-compliance to the protocol|3
3022861|NCT00789854|10396317|P3|Overall Study|Eligibility criteria not fulfilled|1
3022862|NCT00789854|10396318|P2|Overall Study|Eligibility criteria not fulfilled|5
3022863|NCT00789854|10396319|P1|Overall Study|Eligibility criteria not fulfilled|2
3022864|NCT00789854|10396317|P3|Overall Study|Withdrawal by Subject|17
3022865|NCT00789854|10396318|P2|Overall Study|Withdrawal by Subject|6
3022866|NCT00789854|10396319|P1|Overall Study|Withdrawal by Subject|9
3022867|NCT00789854|10396317|P3|Overall Study|Lost to Follow-up|4
3022868|NCT00789854|10396318|P2|Overall Study|Lost to Follow-up|1
3022869|NCT00789854|10396319|P1|Overall Study|Lost to Follow-up|1
3022870|NCT00789854|10396317|P3|Overall Study|Adverse Event|18
3022871|NCT00789854|10396318|P2|Overall Study|Adverse Event|23
3022872|NCT00789854|10396319|P1|Overall Study|Adverse Event|28
3022873|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
3022874|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
3022875|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Disease progression|0
3022876|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Disease progression|1
3022877|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Death|0
3022878|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Death|1
3022879|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Administrative problems|0
3022880|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Administrative problems|7
3022881|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
3022882|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
3022883|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
3022884|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
3022885|NCT00789828|10396416|P2|Open-label Extension Period (4 Years)|Adverse Event|0
3022886|NCT00789828|10396417|P1|Open-label Extension Period (4 Years)|Adverse Event|10
3022887|NCT00789828|10396416|P2|Core Period (48 Weeks)|Lost to Follow-up|1
3022888|NCT00789828|10396417|P1|Core Period (48 Weeks)|Lost to Follow-up|0
3022889|NCT00789828|10396416|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
3022890|NCT00789828|10396417|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
3022891|NCT00789828|10396416|P2|Core Period (48 Weeks)|Administrative problems|1
3022892|NCT00789828|10396417|P1|Core Period (48 Weeks)|Administrative problems|0
3022893|NCT00789815|10396451|P2|Overall Study|Intubation due to massive bleeding|0
3022894|NCT00789815|10396452|P1|Overall Study|Intubation due to massive bleeding|1
3022895|NCT00789815|10396451|P2|Overall Study|Protocol Violation|1
3022896|NCT00789815|10396452|P1|Overall Study|Protocol Violation|6
3022897|NCT00789737|10396562|P2|Overall Study|Other|7
3022898|NCT00789737|10396563|P1|Overall Study|Other|11
3022899|NCT00789737|10396562|P2|Overall Study|hyperglycemia that met protocol-specifie|4
3022900|NCT00789737|10396563|P1|Overall Study|hyperglycemia that met protocol-specifie|0
3022901|NCT00789737|10396562|P2|Overall Study|Lack of Efficacy|0
3022902|NCT00789737|10396563|P1|Overall Study|Lack of Efficacy|3
3022903|NCT00789737|10396562|P2|Overall Study|Protocol Violation|0
3022904|NCT00789737|10396563|P1|Overall Study|Protocol Violation|3
3022905|NCT00789737|10396562|P2|Overall Study|Adverse Event|8
3022906|NCT00789737|10396563|P1|Overall Study|Adverse Event|8
3022907|NCT00789737|10396562|P2|Overall Study|Lost to Follow-up|14
3022908|NCT00789737|10396563|P1|Overall Study|Lost to Follow-up|10
3022909|NCT00789737|10396562|P2|Overall Study|Withdrawal by Subject|22
3022910|NCT00789737|10396563|P1|Overall Study|Withdrawal by Subject|13
3022911|NCT00789698|10396606|P4|Overall Study|Administrative|1
3022912|NCT00789698|10396607|P3|Overall Study|Administrative|3
3022913|NCT00789698|10396608|P2|Overall Study|Administrative|3
3022914|NCT00789698|10396609|P1|Overall Study|Administrative|0
3022915|NCT00789698|10396606|P4|Overall Study|Withdrawal by Subject|19
3022916|NCT00789698|10396607|P3|Overall Study|Withdrawal by Subject|12
3022917|NCT00789698|10396608|P2|Overall Study|Withdrawal by Subject|15
3022918|NCT00789698|10396609|P1|Overall Study|Withdrawal by Subject|14
3022919|NCT00789698|10396606|P4|Overall Study|Protocol Violation|1
3022920|NCT00789698|10396607|P3|Overall Study|Protocol Violation|2
3022921|NCT00789698|10396608|P2|Overall Study|Protocol Violation|1
3022922|NCT00789698|10396609|P1|Overall Study|Protocol Violation|6
3022923|NCT00789698|10396606|P4|Overall Study|Lost to Follow-up|9
3022924|NCT00789698|10396607|P3|Overall Study|Lost to Follow-up|2
3022925|NCT00789698|10396608|P2|Overall Study|Lost to Follow-up|5
3022926|NCT00789698|10396609|P1|Overall Study|Lost to Follow-up|5
3022927|NCT00789698|10396606|P4|Overall Study|Adverse Event|4
3022928|NCT00789698|10396607|P3|Overall Study|Adverse Event|3
3022929|NCT00789698|10396608|P2|Overall Study|Adverse Event|5
3022930|NCT00789698|10396609|P1|Overall Study|Adverse Event|5
3022931|NCT00789698|10396606|P4|Overall Study|Lack of Efficacy|18
3022932|NCT00789698|10396607|P3|Overall Study|Lack of Efficacy|5
3022933|NCT00789698|10396608|P2|Overall Study|Lack of Efficacy|4
3022934|NCT00789698|10396609|P1|Overall Study|Lack of Efficacy|10
3022935|NCT00789581|10396664|P2|Adjuvant Therapy|Other|1
3022936|NCT00789581|10396665|P1|Adjuvant Therapy|Other|0
3022937|NCT00789581|10396664|P2|Adjuvant Therapy|Protocol Violation|1
3022938|NCT00789581|10396665|P1|Adjuvant Therapy|Protocol Violation|1
3022939|NCT00789581|10396664|P2|Adjuvant Therapy|Intercurrent Illness|3
3022940|NCT00789581|10396665|P1|Adjuvant Therapy|Intercurrent Illness|1
3022941|NCT00789581|10396664|P2|Adjuvant Therapy|Disease recurrence|1
3022942|NCT00789581|10396665|P1|Adjuvant Therapy|Disease recurrence|2
3022943|NCT00789581|10396664|P2|Adjuvant Therapy|Withdrawal by Subject|5
3022944|NCT00789581|10396665|P1|Adjuvant Therapy|Withdrawal by Subject|14
3022945|NCT00789581|10396664|P2|Adjuvant Therapy|Adverse Event|44
3022946|NCT00789581|10396665|P1|Adjuvant Therapy|Adverse Event|20
3022947|NCT00789581|10396664|P2|Adjuvant Therapy|Never treated|2
3022948|NCT00789581|10396665|P1|Adjuvant Therapy|Never treated|2
3022949|NCT00789581|10396664|P2|AC Therapy|Other|2
3022950|NCT00789581|10396665|P1|AC Therapy|Other|0
3022951|NCT00789581|10396664|P2|AC Therapy|Never Treated|4
3022952|NCT00789581|10396665|P1|AC Therapy|Never Treated|1
3022953|NCT00789581|10396664|P2|AC Therapy|Intercurrent Illness|0
3022954|NCT00789581|10396665|P1|AC Therapy|Intercurrent Illness|1
3022955|NCT00789581|10396664|P2|AC Therapy|Disease recurrence|1
3022956|NCT00789581|10396665|P1|AC Therapy|Disease recurrence|3
3022957|NCT00789581|10396664|P2|AC Therapy|Withdrawal by Subject|7
3022958|NCT00789581|10396665|P1|AC Therapy|Withdrawal by Subject|4
3022959|NCT00789581|10396664|P2|AC Therapy|Adverse Event|3
3022960|NCT00789581|10396665|P1|AC Therapy|Adverse Event|2
3022961|NCT00789555|10396676|P3|Overall Study|Protocol Violation|13
3022962|NCT00789555|10396677|P2|Overall Study|Protocol Violation|9
3022963|NCT00789555|10396678|P1|Overall Study|Protocol Violation|6
3022964|NCT00789555|10396676|P3|Overall Study|Treatment failure|12
3022965|NCT00789555|10396677|P2|Overall Study|Treatment failure|8
3022966|NCT00789555|10396678|P1|Overall Study|Treatment failure|11
3022967|NCT00789555|10396676|P3|Overall Study|Patient decision unnrelated to adv event|26
3022968|NCT00789555|10396677|P2|Overall Study|Patient decision unnrelated to adv event|29
3022969|NCT00789555|10396678|P1|Overall Study|Patient decision unnrelated to adv event|38
3022970|NCT00789555|10396676|P3|Overall Study|Lost to Follow-up|18
3022971|NCT00789555|10396677|P2|Overall Study|Lost to Follow-up|10
3022972|NCT00789555|10396678|P1|Overall Study|Lost to Follow-up|9
3022973|NCT00789555|10396676|P3|Overall Study|Adverse Event|10
3022974|NCT00789555|10396677|P2|Overall Study|Adverse Event|7
3022975|NCT00789555|10396678|P1|Overall Study|Adverse Event|17
3022976|NCT00789555|10396676|P3|Overall Study|Protocol Amendment|80
3022977|NCT00789555|10396677|P2|Overall Study|Protocol Amendment|76
3022978|NCT00789555|10396678|P1|Overall Study|Protocol Amendment|78
3022979|NCT00789529|10396703|P2|Overall Study|Other Reason|0
3022980|NCT00789529|10396704|P1|Overall Study|Other Reason|1
3022981|NCT00789529|10396703|P2|Overall Study|Withdrawal by Subject|1
3022982|NCT00789529|10396704|P1|Overall Study|Withdrawal by Subject|0
3022983|NCT00789477|10396717|P5|Overall Study|Other|0
3022984|NCT00789477|10396718|P4|Overall Study|Other|3
3022985|NCT00789477|10396719|P3|Overall Study|Other|1
3022986|NCT00789477|10396720|P2|Overall Study|Other|0
3022987|NCT00789477|10396721|P1|Overall Study|Other|2
3022988|NCT00789477|10396717|P5|Overall Study|Lack of Efficacy|0
3022989|NCT00789477|10396718|P4|Overall Study|Lack of Efficacy|0
3022990|NCT00789477|10396719|P3|Overall Study|Lack of Efficacy|0
3022991|NCT00789477|10396720|P2|Overall Study|Lack of Efficacy|0
3022992|NCT00789477|10396721|P1|Overall Study|Lack of Efficacy|2
3022993|NCT00789477|10396717|P5|Overall Study|Lost to Follow-up|4
3022994|NCT00789477|10396718|P4|Overall Study|Lost to Follow-up|2
3022995|NCT00789477|10396719|P3|Overall Study|Lost to Follow-up|4
3022996|NCT00789477|10396720|P2|Overall Study|Lost to Follow-up|1
3022997|NCT00789477|10396721|P1|Overall Study|Lost to Follow-up|0
3022998|NCT00789477|10396717|P5|Overall Study|Death|0
3022999|NCT00789477|10396718|P4|Overall Study|Death|2
3023000|NCT00789477|10396719|P3|Overall Study|Death|2
3023001|NCT00789477|10396720|P2|Overall Study|Death|1
3023002|NCT00789477|10396721|P1|Overall Study|Death|1
3023003|NCT00789477|10396717|P5|Overall Study|Adverse Event|0
3023004|NCT00789477|10396718|P4|Overall Study|Adverse Event|0
3023005|NCT00789477|10396719|P3|Overall Study|Adverse Event|1
3023006|NCT00789477|10396720|P2|Overall Study|Adverse Event|3
3023007|NCT00789477|10396721|P1|Overall Study|Adverse Event|3
3023008|NCT00789477|10396717|P5|Overall Study|Protocol Violation|0
3023009|NCT00789477|10396718|P4|Overall Study|Protocol Violation|1
3023010|NCT00789477|10396719|P3|Overall Study|Protocol Violation|0
3023011|NCT00789477|10396720|P2|Overall Study|Protocol Violation|0
3023012|NCT00789477|10396721|P1|Overall Study|Protocol Violation|1
3023013|NCT00789477|10396717|P5|Overall Study|Withdrawal by Subject|3
3023014|NCT00789477|10396718|P4|Overall Study|Withdrawal by Subject|2
3023015|NCT00789477|10396719|P3|Overall Study|Withdrawal by Subject|3
3023016|NCT00789477|10396720|P2|Overall Study|Withdrawal by Subject|1
3023017|NCT00789477|10396721|P1|Overall Study|Withdrawal by Subject|2
3023018|NCT00789373|10396766|P3|Maintenance|Participants On-Going at Data Cut-Off|0
3023019|NCT00789373|10396767|P2|Maintenance|Participants On-Going at Data Cut-Off|4
3023020|NCT00789373|10396768|P1|Maintenance|Participants On-Going at Data Cut-Off|0
3023021|NCT00789373|10396766|P3|Maintenance|Sponsor Decision|2
3023022|NCT00789373|10396767|P2|Maintenance|Sponsor Decision|0
3023023|NCT00789373|10396768|P1|Maintenance|Sponsor Decision|0
3023024|NCT00789373|10396766|P3|Maintenance|Withdrawal by Subject|8
3023025|NCT00789373|10396767|P2|Maintenance|Withdrawal by Subject|21
3023026|NCT00789373|10396768|P1|Maintenance|Withdrawal by Subject|0
3023027|NCT00789373|10396766|P3|Maintenance|Progressive Disease|152
3023028|NCT00789373|10396767|P2|Maintenance|Progressive Disease|253
3023029|NCT00789373|10396768|P1|Maintenance|Progressive Disease|0
3023030|NCT00789373|10396766|P3|Maintenance|Lost to Follow-up|0
3023031|NCT00789373|10396767|P2|Maintenance|Lost to Follow-up|2
3023032|NCT00789373|10396768|P1|Maintenance|Lost to Follow-up|0
3023033|NCT00789373|10396766|P3|Maintenance|Protocol entry criteria not met|0
3023034|NCT00789373|10396767|P2|Maintenance|Protocol entry criteria not met|2
3023035|NCT00789373|10396768|P1|Maintenance|Protocol entry criteria not met|0
3023036|NCT00789373|10396766|P3|Maintenance|Investigator Decision|2
3023037|NCT00789373|10396767|P2|Maintenance|Investigator Decision|4
3023038|NCT00789373|10396768|P1|Maintenance|Investigator Decision|0
3023039|NCT00789373|10396766|P3|Maintenance|Death due to toxicity|2
3023040|NCT00789373|10396767|P2|Maintenance|Death due to toxicity|1
3023041|NCT00789373|10396768|P1|Maintenance|Death due to toxicity|0
3023042|NCT00789373|10396766|P3|Maintenance|Death due to adverse event|1
3023043|NCT00789373|10396767|P2|Maintenance|Death due to adverse event|4
3023044|NCT00789373|10396768|P1|Maintenance|Death due to adverse event|0
3023045|NCT00789373|10396766|P3|Maintenance|Death due to study disease|1
3023046|NCT00789373|10396767|P2|Maintenance|Death due to study disease|3
3023047|NCT00789373|10396768|P1|Maintenance|Death due to study disease|0
3023048|NCT00789373|10396766|P3|Maintenance|Adverse Event|12
3023049|NCT00789373|10396767|P2|Maintenance|Adverse Event|65
3023050|NCT00789373|10396768|P1|Maintenance|Adverse Event|0
3023051|NCT00789373|10396766|P3|Induction|Withdrawal by Subject|0
3023052|NCT00789373|10396767|P2|Induction|Withdrawal by Subject|0
3023053|NCT00789373|10396768|P1|Induction|Withdrawal by Subject|37
3023054|NCT00789373|10396766|P3|Induction|Progressive Disease|0
3023055|NCT00789373|10396767|P2|Induction|Progressive Disease|0
3023056|NCT00789373|10396768|P1|Induction|Progressive Disease|220
3023057|NCT00789373|10396766|P3|Induction|Protocol Violation|0
3023058|NCT00789373|10396767|P2|Induction|Protocol Violation|0
3023059|NCT00789373|10396768|P1|Induction|Protocol Violation|1
3023060|NCT00789373|10396766|P3|Induction|Lost to Follow-up|0
3023061|NCT00789373|10396767|P2|Induction|Lost to Follow-up|0
3023062|NCT00789373|10396768|P1|Induction|Lost to Follow-up|6
3023063|NCT00789373|10396766|P3|Induction|Protocol entry criteria not met|0
3023064|NCT00789373|10396767|P2|Induction|Protocol entry criteria not met|0
3023065|NCT00789373|10396768|P1|Induction|Protocol entry criteria not met|9
3023066|NCT00789373|10396766|P3|Induction|Investigator decision|0
3023067|NCT00789373|10396767|P2|Induction|Investigator decision|0
3023068|NCT00789373|10396768|P1|Induction|Investigator decision|7
3023069|NCT00789373|10396766|P3|Induction|Death due to procedure|0
3023070|NCT00789373|10396767|P2|Induction|Death due to procedure|0
3023071|NCT00789373|10396768|P1|Induction|Death due to procedure|1
3023072|NCT00789373|10396766|P3|Induction|Death due to toxicity|0
3023073|NCT00789373|10396767|P2|Induction|Death due to toxicity|0
3023074|NCT00789373|10396768|P1|Induction|Death due to toxicity|11
3023075|NCT00789373|10396766|P3|Induction|Death due to adverse event|0
3023076|NCT00789373|10396767|P2|Induction|Death due to adverse event|0
3023077|NCT00789373|10396768|P1|Induction|Death due to adverse event|19
3023078|NCT00789373|10396766|P3|Induction|Death Due to study disease|0
3023079|NCT00789373|10396767|P2|Induction|Death Due to study disease|0
3023080|NCT00789373|10396768|P1|Induction|Death Due to study disease|24
3023081|NCT00789373|10396766|P3|Induction|Adverse Event|0
3023082|NCT00789373|10396767|P2|Induction|Adverse Event|0
3023083|NCT00789373|10396768|P1|Induction|Adverse Event|64
3023084|NCT00789360|10396795|P2|Overall Study|Protocol Violation|1
3023085|NCT00789360|10396796|P1|Overall Study|Protocol Violation|3
3023086|NCT00789321|10396806|P2|Overall Study|Adverse Event|1
3023087|NCT00789321|10396807|P1|Overall Study|Adverse Event|0
3023088|NCT00789191|10396829|P2|Overall Study|Unclassified|3
3023089|NCT00789191|10396830|P1|Overall Study|Unclassified|5
3023090|NCT00789191|10396829|P2|Overall Study|Withdrawal Criteria|4
3023091|NCT00789191|10396830|P1|Overall Study|Withdrawal Criteria|2
3023092|NCT00789191|10396829|P2|Overall Study|Protocol Violation|3
3023093|NCT00789191|10396830|P1|Overall Study|Protocol Violation|5
3023094|NCT00789191|10396829|P2|Overall Study|Lack of Efficacy|5
3023095|NCT00789191|10396830|P1|Overall Study|Lack of Efficacy|0
3023096|NCT00789191|10396829|P2|Overall Study|Adverse Event|4
3023097|NCT00789191|10396830|P1|Overall Study|Adverse Event|2
3023098|NCT00789035|10396887|P5|Overall Study|Other reason not defined above|1
3023099|NCT00789035|10396888|P4|Overall Study|Other reason not defined above|0
3023100|NCT00789035|10396889|P3|Overall Study|Other reason not defined above|1
3023101|NCT00789035|10396890|P2|Overall Study|Other reason not defined above|3
3023102|NCT00789035|10396891|P1|Overall Study|Other reason not defined above|2
3023103|NCT00789035|10396887|P5|Overall Study|Withdrawal by Subject|0
3023104|NCT00789035|10396888|P4|Overall Study|Withdrawal by Subject|0
3023105|NCT00789035|10396889|P3|Overall Study|Withdrawal by Subject|0
3023106|NCT00789035|10396890|P2|Overall Study|Withdrawal by Subject|2
3023107|NCT00789035|10396891|P1|Overall Study|Withdrawal by Subject|0
3023108|NCT00789035|10396887|P5|Overall Study|Protocol Violation|0
3023109|NCT00789035|10396888|P4|Overall Study|Protocol Violation|0
3023110|NCT00789035|10396889|P3|Overall Study|Protocol Violation|0
3023111|NCT00789035|10396890|P2|Overall Study|Protocol Violation|0
3023112|NCT00789035|10396891|P1|Overall Study|Protocol Violation|1
3023113|NCT00789035|10396887|P5|Overall Study|Lack of Efficacy|2
3023114|NCT00789035|10396888|P4|Overall Study|Lack of Efficacy|0
3023115|NCT00789035|10396889|P3|Overall Study|Lack of Efficacy|0
3023116|NCT00789035|10396890|P2|Overall Study|Lack of Efficacy|0
3023117|NCT00789035|10396891|P1|Overall Study|Lack of Efficacy|3
3023118|NCT00789035|10396887|P5|Overall Study|Adverse Event|3
3023119|NCT00789035|10396888|P4|Overall Study|Adverse Event|1
3023120|NCT00789035|10396889|P3|Overall Study|Adverse Event|0
3023121|NCT00789035|10396890|P2|Overall Study|Adverse Event|2
3023122|NCT00789035|10396891|P1|Overall Study|Adverse Event|0
3023123|NCT00788957|10396950|P6|Part 3|On-study at time of data cut-off|0
3023124|NCT00788957|10396951|P5|Part 3|On-study at time of data cut-off|1
3023125|NCT00788957|10396952|P4|Part 3|On-study at time of data cut-off|0
3023126|NCT00788957|10396953|P3|Part 3|On-study at time of data cut-off|0
3023127|NCT00788957|10396954|P2|Part 3|On-study at time of data cut-off|0
3023128|NCT00788957|10396955|P1|Part 3|On-study at time of data cut-off|0
3023129|NCT00788957|10396950|P6|Part 3|Death|9
3023130|NCT00788957|10396951|P5|Part 3|Death|8
3023131|NCT00788957|10396952|P4|Part 3|Death|0
3023132|NCT00788957|10396953|P3|Part 3|Death|0
3023133|NCT00788957|10396954|P2|Part 3|Death|0
3023134|NCT00788957|10396955|P1|Part 3|Death|0
3023135|NCT00788957|10396950|P6|Part 3|Withdrawal by Subject|2
3023136|NCT00788957|10396951|P5|Part 3|Withdrawal by Subject|0
3023137|NCT00788957|10396952|P4|Part 3|Withdrawal by Subject|0
3023138|NCT00788957|10396953|P3|Part 3|Withdrawal by Subject|0
3023139|NCT00788957|10396954|P2|Part 3|Withdrawal by Subject|0
3023140|NCT00788957|10396955|P1|Part 3|Withdrawal by Subject|0
3023141|NCT00788957|10396950|P6|Part 2|On-study at time of data cut-off|0
3023142|NCT00788957|10396951|P5|Part 2|On-study at time of data cut-off|0
3023143|NCT00788957|10396952|P4|Part 2|On-study at time of data cut-off|1
3023144|NCT00788957|10396953|P3|Part 2|On-study at time of data cut-off|1
3023145|NCT00788957|10396954|P2|Part 2|On-study at time of data cut-off|1
3023146|NCT00788957|10396955|P1|Part 2|On-study at time of data cut-off|0
3023147|NCT00788957|10396950|P6|Part 2|Lost to Follow-up|0
3023148|NCT00788957|10396951|P5|Part 2|Lost to Follow-up|0
3023149|NCT00788957|10396952|P4|Part 2|Lost to Follow-up|0
3023150|NCT00788957|10396953|P3|Part 2|Lost to Follow-up|3
3023151|NCT00788957|10396954|P2|Part 2|Lost to Follow-up|0
3023152|NCT00788957|10396955|P1|Part 2|Lost to Follow-up|0
3023153|NCT00788957|10396950|P6|Part 2|Death|0
3023154|NCT00788957|10396951|P5|Part 2|Death|0
3023155|NCT00788957|10396952|P4|Part 2|Death|37
3023156|NCT00788957|10396953|P3|Part 2|Death|35
3023157|NCT00788957|10396954|P2|Part 2|Death|32
3023158|NCT00788957|10396955|P1|Part 2|Death|0
3023159|NCT00788957|10396950|P6|Part 2|Withdrawal by Subject|0
3023160|NCT00788957|10396951|P5|Part 2|Withdrawal by Subject|0
3023161|NCT00788957|10396952|P4|Part 2|Withdrawal by Subject|3
3023162|NCT00788957|10396953|P3|Part 2|Withdrawal by Subject|5
3023163|NCT00788957|10396954|P2|Part 2|Withdrawal by Subject|9
3023164|NCT00788957|10396955|P1|Part 2|Withdrawal by Subject|0
3023165|NCT00788957|10396950|P6|Part 1|Lost to Follow-up|0
3023166|NCT00788957|10396951|P5|Part 1|Lost to Follow-up|0
3023167|NCT00788957|10396952|P4|Part 1|Lost to Follow-up|0
3023168|NCT00788957|10396953|P3|Part 1|Lost to Follow-up|0
3023169|NCT00788957|10396954|P2|Part 1|Lost to Follow-up|0
3023170|NCT00788957|10396955|P1|Part 1|Lost to Follow-up|1
3023171|NCT00788957|10396950|P6|Part 1|Death|0
3023172|NCT00788957|10396951|P5|Part 1|Death|0
3023173|NCT00788957|10396952|P4|Part 1|Death|0
3023174|NCT00788957|10396953|P3|Part 1|Death|0
3023175|NCT00788957|10396954|P2|Part 1|Death|0
3023176|NCT00788957|10396955|P1|Part 1|Death|8
3023177|NCT00788827|10397028|P1|Overall Study|Lack of Efficacy|2
3023178|NCT00788775|10397042|P2|Overall Study|Patient's measurable disease resected.|0
3023179|NCT00788775|10397043|P1|Overall Study|Patient's measurable disease resected.|1
3023180|NCT00788775|10397042|P2|Overall Study|Patient Non-Compliance|0
3023181|NCT00788775|10397043|P1|Overall Study|Patient Non-Compliance|1
3023182|NCT00788775|10397042|P2|Overall Study|Withdrawal by Subject|2
3023183|NCT00788775|10397043|P1|Overall Study|Withdrawal by Subject|0
3023184|NCT00788775|10397042|P2|Overall Study|Progressive Disease|6
3023185|NCT00788775|10397043|P1|Overall Study|Progressive Disease|8
3023186|NCT00788710|10397058|P3|Overall Study|Withdrawal by Subject|0
3023187|NCT00788710|10397059|P2|Overall Study|Withdrawal by Subject|2
3023188|NCT00788710|10397060|P1|Overall Study|Withdrawal by Subject|2
3023189|NCT00788710|10397058|P3|Overall Study|Protocol Violation|1
3023190|NCT00788710|10397059|P2|Overall Study|Protocol Violation|1
3023191|NCT00788710|10397060|P1|Overall Study|Protocol Violation|0
3023192|NCT00788710|10397058|P3|Overall Study|Physician Decision|0
3023193|NCT00788710|10397059|P2|Overall Study|Physician Decision|1
3023194|NCT00788710|10397060|P1|Overall Study|Physician Decision|2
3023195|NCT00788710|10397058|P3|Overall Study|Lost to Follow-up|0
3023196|NCT00788710|10397059|P2|Overall Study|Lost to Follow-up|1
3023197|NCT00788710|10397060|P1|Overall Study|Lost to Follow-up|0
3023198|NCT00788710|10397058|P3|Overall Study|Lack of Efficacy|1
3023199|NCT00788710|10397059|P2|Overall Study|Lack of Efficacy|0
3023200|NCT00788710|10397060|P1|Overall Study|Lack of Efficacy|0
3023201|NCT00788710|10397058|P3|Overall Study|Adverse Event|4
3023202|NCT00788710|10397059|P2|Overall Study|Adverse Event|3
3023203|NCT00788710|10397060|P1|Overall Study|Adverse Event|1
3023204|NCT00788697|10397074|P1|Overall Study|Indeterminate diagnosis from truth stand|17
3023205|NCT00788697|10397074|P1|Overall Study|Technically inadequate truth standard|1
3023206|NCT00788697|10397074|P1|Overall Study|no truth standard procedure available|5
3023207|NCT00788697|10397074|P1|Overall Study|Training Patients|74
3023208|NCT00788697|10397074|P1|Overall Study|No study drug administered|12
3023209|NCT00788593|10397121|P3|Second Intervention Period|Other|1
3023210|NCT00788593|10397122|P2|Second Intervention Period|Other|0
3023211|NCT00788593|10397123|P1|Second Intervention Period|Other|0
3023212|NCT00788593|10397121|P3|Second Intervention Period|Lost to Follow-up|0
3023213|NCT00788593|10397122|P2|Second Intervention Period|Lost to Follow-up|1
3023214|NCT00788593|10397123|P1|Second Intervention Period|Lost to Follow-up|0
3023215|NCT00788593|10397121|P3|First Intervention Period|Adverse Event|0
3023216|NCT00788593|10397122|P2|First Intervention Period|Adverse Event|1
3023217|NCT00788593|10397123|P1|First Intervention Period|Adverse Event|0
3023218|NCT00788593|10397121|P3|Placebo Run-in Phase|Protocol Violation|0
3023219|NCT00788593|10397122|P2|Placebo Run-in Phase|Protocol Violation|0
3023220|NCT00788593|10397123|P1|Placebo Run-in Phase|Protocol Violation|2
3023221|NCT00788593|10397121|P3|Placebo Run-in Phase|Withdrawal by Subject|0
3023222|NCT00788593|10397122|P2|Placebo Run-in Phase|Withdrawal by Subject|0
3023223|NCT00788593|10397123|P1|Placebo Run-in Phase|Withdrawal by Subject|2
3023224|NCT00788593|10397121|P3|Placebo Run-in Phase|Adverse Event|0
3023225|NCT00788593|10397122|P2|Placebo Run-in Phase|Adverse Event|0
3023226|NCT00788593|10397123|P1|Placebo Run-in Phase|Adverse Event|2
3023227|NCT00788372|10397140|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
3023228|NCT00788372|10397140|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
3023229|NCT00788372|10397140|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
3023230|NCT00788372|10397140|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
3023231|NCT00788372|10397140|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
3023232|NCT00788372|10397140|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
3023233|NCT00788372|10397140|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
3023234|NCT00788151|10397169|P2|Overall Study|Enrolled but not treated|1
3023235|NCT00788151|10397170|P1|Overall Study|Enrolled but not treated|1
3023236|NCT00788151|10397169|P2|Overall Study|Withdrawal by Subject|6
3023237|NCT00788151|10397170|P1|Overall Study|Withdrawal by Subject|13
3023238|NCT00788151|10397169|P2|Overall Study|Protocol Violation|1
3023239|NCT00788151|10397170|P1|Overall Study|Protocol Violation|0
3023240|NCT00788151|10397169|P2|Overall Study|Other adverse event|2
3023241|NCT00788151|10397170|P1|Overall Study|Other adverse event|0
3023242|NCT00788073|10397214|P2|Placebo Then STX209|Protocol Violation|1
3023243|NCT00788073|10397215|P1|Placebo Then STX209|Protocol Violation|0
3023244|NCT00788073|10397214|P2|Placebo Then STX209|Adverse Event|0
3023245|NCT00788073|10397215|P1|Placebo Then STX209|Adverse Event|2
3023246|NCT00788073|10397214|P2|STX209 Then Placebo|unable to return due to travel|1
3023247|NCT00788073|10397215|P1|STX209 Then Placebo|unable to return due to travel|0
3023248|NCT00788073|10397214|P2|STX209 Then Placebo|Withdrawal by Subject|1
3023249|NCT00788073|10397215|P1|STX209 Then Placebo|Withdrawal by Subject|0
3023250|NCT00788073|10397214|P2|STX209 Then Placebo|Lost to Follow-up|1
3023251|NCT00788073|10397215|P1|STX209 Then Placebo|Lost to Follow-up|0
3023252|NCT00788073|10397214|P2|STX209 Then Placebo|Adverse Event|0
3023253|NCT00788073|10397215|P1|STX209 Then Placebo|Adverse Event|1
3023254|NCT00787930|10397240|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
3023255|NCT00787917|10397255|P2|Open Label|Administrative problems|0
3023256|NCT00787917|10397256|P1|Open Label|Administrative problems|3
3023257|NCT00787917|10397255|P2|Open Label|Unsatisfactory therapeutic effect|0
3023258|NCT00787917|10397256|P1|Open Label|Unsatisfactory therapeutic effect|1
3023259|NCT00787917|10397255|P2|Blinded Treatment|Administrative problems|2
3023260|NCT00787917|10397256|P1|Blinded Treatment|Administrative problems|3
3023261|NCT00787917|10397255|P2|Blinded Treatment|Lack of Efficacy|0
3023262|NCT00787917|10397256|P1|Blinded Treatment|Lack of Efficacy|1
3023263|NCT00787917|10397255|P2|Blinded Treatment|Adverse Event|0
3023264|NCT00787917|10397256|P1|Blinded Treatment|Adverse Event|1
3023265|NCT00787891|10397286|P2|Maintenance Double-blind Phase (Part 2)|Other|2
3023266|NCT00787891|10397287|P1|Maintenance Double-blind Phase (Part 2)|Other|5
3023267|NCT00787891|10397286|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
3023268|NCT00787891|10397287|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
3023269|NCT00787891|10397286|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
3023270|NCT00787891|10397287|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
3023271|NCT00787891|10397286|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
3023272|NCT00787891|10397287|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
3023273|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Other|2
3023274|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Other|0
3023275|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
3023276|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
3023277|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
3023278|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
3023279|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
3023280|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
3023281|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
3023282|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
3023283|NCT00787891|10397286|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
3023284|NCT00787891|10397287|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
3023285|NCT00787839|10397314|P1|Overall Study|Failure to have the OGTT was most common|404
3023286|NCT00787800|10397337|P2|Overall Study|Death|2
3023287|NCT00787800|10397338|P1|Overall Study|Death|0
3023288|NCT00787800|10397337|P2|Overall Study|Withdrawal by Subject|5
3023289|NCT00787800|10397338|P1|Overall Study|Withdrawal by Subject|3
3023290|NCT00787787|10397354|P1|Overall Study|Adverse Event|3
3023291|NCT00787787|10397354|P1|Overall Study|Lack of Efficacy|4
3023292|NCT00787644|10397382|P2|Overall Study|Withdrawal by Subject|1
3023293|NCT00787644|10397383|P1|Overall Study|Withdrawal by Subject|1
3023294|NCT00787644|10397382|P2|Overall Study|Lost to Follow-up|1
3023295|NCT00787644|10397383|P1|Overall Study|Lost to Follow-up|1
3023296|NCT00787605|10397404|P2|Overall Study|Lack of Efficacy|9
3023297|NCT00787605|10397405|P1|Overall Study|Lack of Efficacy|13
3023298|NCT00787605|10397404|P2|Overall Study|Withdrawal by Subject|13
3023299|NCT00787605|10397405|P1|Overall Study|Withdrawal by Subject|6
3023300|NCT00787605|10397404|P2|Overall Study|Protocol Violation|3
3023301|NCT00787605|10397405|P1|Overall Study|Protocol Violation|7
3023302|NCT00787605|10397404|P2|Overall Study|Lost to Follow-up|6
3023303|NCT00787605|10397405|P1|Overall Study|Lost to Follow-up|3
3023304|NCT00787605|10397404|P2|Overall Study|Adverse Event|25
3023305|NCT00787605|10397405|P1|Overall Study|Adverse Event|14
3023306|NCT00787605|10397404|P2|Overall Study|Administrative Problems|0
3023307|NCT00787605|10397405|P1|Overall Study|Administrative Problems|3
3023308|NCT00787566|10397424|P3|Overall Study|AE related to chemotherapy|0
3023309|NCT00787566|10397425|P2|Overall Study|AE related to chemotherapy|1
3023310|NCT00787566|10397426|P1|Overall Study|AE related to chemotherapy|0
3023311|NCT00787527|10397434|P1|Overall Study|Toxicity|3
3023312|NCT00787319|10397451|P1|Overall Study|Inactive disease|5
3023313|NCT00787319|10397451|P1|Overall Study|Stabilized disease findings|3
3023314|NCT00787319|10397451|P1|Overall Study|No health insurance reimbursement|2
3023315|NCT00787319|10397451|P1|Overall Study|Unresponsiveness to visit invitation|1
3023316|NCT00787319|10397451|P1|Overall Study|Budget exhausted/exceeded|1
3023317|NCT00787319|10397451|P1|Overall Study|Lack of Efficacy|1
3023318|NCT00787319|10397451|P1|Overall Study|Objective progression or relapse|30
3023319|NCT00787319|10397451|P1|Overall Study|Adverse Event|3
3023320|NCT00787319|10397451|P1|Overall Study|Withdrawal by Subject|15
3023321|NCT00787319|10397451|P1|Overall Study|Lost to Follow-up|2
3023322|NCT00787267|10397463|P1|Overall Study|Withdrawal by Subject|1
3023323|NCT00787267|10397463|P1|Overall Study|No Reason Provided|1
3023324|NCT00787267|10397463|P1|Overall Study|Screen failure/Ineligible|10
3023325|NCT00787254|10397473|P2|Overall Study|Physician Decision|8
3023326|NCT00787254|10397474|P1|Overall Study|Physician Decision|4
3023327|NCT00787254|10397473|P2|Overall Study|Institution closed|0
3023328|NCT00787254|10397474|P1|Overall Study|Institution closed|1
3023329|NCT00787254|10397473|P2|Overall Study|NSAIDs discontinuation|2
3023330|NCT00787254|10397474|P1|Overall Study|NSAIDs discontinuation|1
3023331|NCT00787254|10397473|P2|Overall Study|Lack of Efficacy|15
3023332|NCT00787254|10397474|P1|Overall Study|Lack of Efficacy|4
3023333|NCT00787254|10397473|P2|Overall Study|Withdrawal by Subject|11
3023334|NCT00787254|10397474|P1|Overall Study|Withdrawal by Subject|16
3023335|NCT00787254|10397473|P2|Overall Study|Protocol Violation|23
3023336|NCT00787254|10397474|P1|Overall Study|Protocol Violation|26
3023337|NCT00787254|10397473|P2|Overall Study|Adverse Event|23
3023338|NCT00787254|10397474|P1|Overall Study|Adverse Event|24
3023339|NCT00787202|10397598|P5|Overall Study|Randomized, not treated|0
3023340|NCT00787202|10397599|P4|Overall Study|Randomized, not treated|0
3023341|NCT00787202|10397600|P3|Overall Study|Randomized, not treated|0
3023342|NCT00787202|10397601|P2|Overall Study|Randomized, not treated|0
3023343|NCT00787202|10397602|P1|Overall Study|Randomized, not treated|1
3023344|NCT00787202|10397598|P5|Overall Study|Protocol Violation|1
3023345|NCT00787202|10397599|P4|Overall Study|Protocol Violation|0
3023346|NCT00787202|10397600|P3|Overall Study|Protocol Violation|0
3023347|NCT00787202|10397601|P2|Overall Study|Protocol Violation|1
3023348|NCT00787202|10397602|P1|Overall Study|Protocol Violation|2
3023349|NCT00787202|10397598|P5|Overall Study|Withdrawal by Subject|0
3023350|NCT00787202|10397599|P4|Overall Study|Withdrawal by Subject|0
3023351|NCT00787202|10397600|P3|Overall Study|Withdrawal by Subject|2
3023352|NCT00787202|10397601|P2|Overall Study|Withdrawal by Subject|2
3023353|NCT00787202|10397602|P1|Overall Study|Withdrawal by Subject|2
3023354|NCT00787202|10397598|P5|Overall Study|Lost to Follow-up|0
3023355|NCT00787202|10397599|P4|Overall Study|Lost to Follow-up|0
3023356|NCT00787202|10397600|P3|Overall Study|Lost to Follow-up|0
3023357|NCT00787202|10397601|P2|Overall Study|Lost to Follow-up|0
3023358|NCT00787202|10397602|P1|Overall Study|Lost to Follow-up|1
3023359|NCT00787202|10397598|P5|Overall Study|Lack of Efficacy|1
3023360|NCT00787202|10397599|P4|Overall Study|Lack of Efficacy|2
3023361|NCT00787202|10397600|P3|Overall Study|Lack of Efficacy|5
3023362|NCT00787202|10397601|P2|Overall Study|Lack of Efficacy|6
3023363|NCT00787202|10397602|P1|Overall Study|Lack of Efficacy|5
3023364|NCT00787202|10397598|P5|Overall Study|Adverse Event|2
3023365|NCT00787202|10397599|P4|Overall Study|Adverse Event|0
3023366|NCT00787202|10397600|P3|Overall Study|Adverse Event|0
3023367|NCT00787202|10397601|P2|Overall Study|Adverse Event|2
3023368|NCT00787202|10397602|P1|Overall Study|Adverse Event|3
3023369|NCT00787189|10397655|P2|Overall Study|Lost to Follow-up|2
3023370|NCT00787189|10397656|P1|Overall Study|Lost to Follow-up|2
3023371|NCT00787150|10397665|P3|Overall Study|Dosing incorrect study durg|0
3023372|NCT00787150|10397666|P2|Overall Study|Dosing incorrect study durg|0
3023373|NCT00787150|10397667|P1|Overall Study|Dosing incorrect study durg|2
3023374|NCT00787150|10397665|P3|Overall Study|Withdrawal by Subject|0
3023375|NCT00787150|10397666|P2|Overall Study|Withdrawal by Subject|1
3023376|NCT00787150|10397667|P1|Overall Study|Withdrawal by Subject|2
3023377|NCT00787150|10397665|P3|Overall Study|Physician Decision|1
3023378|NCT00787150|10397666|P2|Overall Study|Physician Decision|2
3023379|NCT00787150|10397667|P1|Overall Study|Physician Decision|1
3023380|NCT00787150|10397665|P3|Overall Study|Adverse Event|4
3023381|NCT00787150|10397666|P2|Overall Study|Adverse Event|4
3023382|NCT00787150|10397667|P1|Overall Study|Adverse Event|4
3023383|NCT00787137|10397712|P3|Overall Study|Study Termination|1
3023384|NCT00787137|10397713|P2|Overall Study|Study Termination|0
3023385|NCT00787137|10397714|P1|Overall Study|Study Termination|0
3023386|NCT00786864|10397789|P2|Overall Study|Sustained serious back injury|0
3023387|NCT00786864|10397790|P1|Overall Study|Sustained serious back injury|1
3023388|NCT00786864|10397789|P2|Overall Study|Lost to Follow-up|1
3023389|NCT00786864|10397790|P1|Overall Study|Lost to Follow-up|0
3023390|NCT00786838|10397802|P1|Overall Study|Withdrawal by Subject|4
3023391|NCT00786838|10397802|P1|Overall Study|Progressive disease|31
3023392|NCT00786838|10397802|P1|Overall Study|Adverse Event|6
3023393|NCT00786838|10397802|P1|Overall Study|Death|4
3023394|NCT00786838|10397802|P1|Overall Study|Physician Decision|4
3023395|NCT00786799|10397838|P2|Overall Study|Lost to Follow-up|1
3023396|NCT00786799|10397839|P1|Overall Study|Lost to Follow-up|1
3023397|NCT00786565|10397869|P1|Post Surgery|Adapt AO implanted posterior side up|1
3023398|NCT00786565|10397869|P1|Post Surgery|Abnormal macular pucker|1
3023399|NCT00786565|10397869|P1|Enrollment Prior to Surgery|Protocol Violation|3
3023400|NCT00786565|10397869|P1|Enrollment Prior to Surgery|Site Closed|3
3023401|NCT00786474|10397926|P2|Overall Study|Other|4
3023402|NCT00786474|10397927|P1|Overall Study|Other|4
3023403|NCT00786474|10397926|P2|Overall Study|Physician Decision|1
3023404|NCT00786474|10397927|P1|Overall Study|Physician Decision|2
3023405|NCT00786474|10397926|P2|Overall Study|Lost to Follow-up|3
3023406|NCT00786474|10397927|P1|Overall Study|Lost to Follow-up|3
3023407|NCT00786474|10397926|P2|Overall Study|Withdrawal by Subject|31
3023408|NCT00786474|10397927|P1|Overall Study|Withdrawal by Subject|23
3023409|NCT00786474|10397926|P2|Overall Study|Death|4
3023410|NCT00786474|10397927|P1|Overall Study|Death|5
3023411|NCT00786422|10397939|P1|Follow-up Period|End-of-study done up to 4 days early|2
3023412|NCT00786422|10397939|P1|Follow-up Period|Death|1
3023413|NCT00786422|10397939|P1|Rivaroxaban Treatment|Adverse Event|2
3023414|NCT00786422|10397939|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
3023415|NCT00786422|10397939|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
3023416|NCT00786422|10397939|P1|Rivaroxaban Treatment|Physician Decision|1
3023417|NCT00786422|10397939|P1|Rivaroxaban Treatment|Lack of Efficacy|1
3023418|NCT00786422|10397939|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
3023419|NCT00786422|10397939|P1|Rivaroxaban Treatment|Death|2
3023420|NCT00786409|10397955|P1|Overall Study|Lost to Follow-up|1
3023421|NCT00786409|10397955|P1|Overall Study|Pregnancy|2
3023422|NCT00786409|10397955|P1|Overall Study|Adverse Event|2
3023423|NCT00786409|10397955|P1|Overall Study|Withdrawal by Subject|2
3023424|NCT00786188|10397972|P2|Overall Study|Withdrawal by Subject|0
3023425|NCT00786188|10397973|P1|Overall Study|Withdrawal by Subject|2
3023426|NCT00786188|10397972|P2|Overall Study|Adverse Event|1
3023427|NCT00786188|10397973|P1|Overall Study|Adverse Event|3
3023428|NCT00786032|10397999|P1|Overall Study|Did not complete in the timeframe|6
3023429|NCT00786032|10397999|P1|Overall Study|Withdrawal by Subject|14
3023430|NCT00786032|10397999|P1|Overall Study|Death|4
3023431|NCT00785980|10398020|P1|7 Day Washout Period|Protocol Violation|3
3023432|NCT00785928|10398038|P7|Treatment Phase|Withdrawal by Subject|0
3023433|NCT00785928|10398039|P6|Treatment Phase|Withdrawal by Subject|0
3023434|NCT00785928|10398040|P5|Treatment Phase|Withdrawal by Subject|1
3023435|NCT00785928|10398041|P4|Treatment Phase|Withdrawal by Subject|0
3023436|NCT00785928|10398042|P3|Treatment Phase|Withdrawal by Subject|0
3023437|NCT00785928|10398043|P2|Treatment Phase|Withdrawal by Subject|2
3023438|NCT00785928|10398044|P1|Treatment Phase|Withdrawal by Subject|1
3023439|NCT00785928|10398038|P7|Treatment Phase|Sponsor Decision|1
3023440|NCT00785928|10398039|P6|Treatment Phase|Sponsor Decision|0
3023441|NCT00785928|10398040|P5|Treatment Phase|Sponsor Decision|0
3023442|NCT00785928|10398041|P4|Treatment Phase|Sponsor Decision|0
3023443|NCT00785928|10398042|P3|Treatment Phase|Sponsor Decision|0
3023444|NCT00785928|10398043|P2|Treatment Phase|Sponsor Decision|0
3023445|NCT00785928|10398044|P1|Treatment Phase|Sponsor Decision|1
3023446|NCT00785928|10398038|P7|Treatment Phase|Physician Decision|0
3023447|NCT00785928|10398039|P6|Treatment Phase|Physician Decision|0
3023448|NCT00785928|10398040|P5|Treatment Phase|Physician Decision|1
3023449|NCT00785928|10398041|P4|Treatment Phase|Physician Decision|0
3023450|NCT00785928|10398042|P3|Treatment Phase|Physician Decision|0
3023451|NCT00785928|10398043|P2|Treatment Phase|Physician Decision|0
3023452|NCT00785928|10398044|P1|Treatment Phase|Physician Decision|0
3023453|NCT00785928|10398038|P7|Treatment Phase|Lack of Efficacy|0
3023454|NCT00785928|10398039|P6|Treatment Phase|Lack of Efficacy|0
3023455|NCT00785928|10398040|P5|Treatment Phase|Lack of Efficacy|0
3023456|NCT00785928|10398041|P4|Treatment Phase|Lack of Efficacy|0
3023457|NCT00785928|10398042|P3|Treatment Phase|Lack of Efficacy|1
3023458|NCT00785928|10398043|P2|Treatment Phase|Lack of Efficacy|1
3023459|NCT00785928|10398044|P1|Treatment Phase|Lack of Efficacy|0
3023460|NCT00785928|10398038|P7|Treatment Phase|Inadequate Response|0
3023461|NCT00785928|10398039|P6|Treatment Phase|Inadequate Response|0
3023462|NCT00785928|10398040|P5|Treatment Phase|Inadequate Response|0
3023463|NCT00785928|10398041|P4|Treatment Phase|Inadequate Response|0
3023464|NCT00785928|10398042|P3|Treatment Phase|Inadequate Response|0
3023465|NCT00785928|10398043|P2|Treatment Phase|Inadequate Response|1
3023466|NCT00785928|10398044|P1|Treatment Phase|Inadequate Response|0
3023467|NCT00785928|10398038|P7|Treatment Phase|Adverse Event|2
3023468|NCT00785928|10398039|P6|Treatment Phase|Adverse Event|0
3023469|NCT00785928|10398040|P5|Treatment Phase|Adverse Event|0
3023470|NCT00785928|10398041|P4|Treatment Phase|Adverse Event|0
3023471|NCT00785928|10398042|P3|Treatment Phase|Adverse Event|2
3023472|NCT00785928|10398043|P2|Treatment Phase|Adverse Event|1
3023473|NCT00785928|10398044|P1|Treatment Phase|Adverse Event|1
3023474|NCT00785785|10398191|P2|Optional Extension Phase|Study terminated by sponsor|37
3023475|NCT00785785|10398192|P1|Optional Extension Phase|Study terminated by sponsor|3
3023476|NCT00785785|10398191|P2|Optional Extension Phase|Protocol deviation|2
3023477|NCT00785785|10398192|P1|Optional Extension Phase|Protocol deviation|0
3023478|NCT00785785|10398191|P2|Optional Extension Phase|Disease progression|70
3023479|NCT00785785|10398192|P1|Optional Extension Phase|Disease progression|22
3023480|NCT00785785|10398191|P2|Optional Extension Phase|Death|5
3023481|NCT00785785|10398192|P1|Optional Extension Phase|Death|1
3023482|NCT00785785|10398191|P2|Optional Extension Phase|Administrative problems|0
3023483|NCT00785785|10398192|P1|Optional Extension Phase|Administrative problems|2
3023484|NCT00785785|10398191|P2|Optional Extension Phase|Lost to Follow-up|0
3023485|NCT00785785|10398192|P1|Optional Extension Phase|Lost to Follow-up|1
3023486|NCT00785785|10398191|P2|Optional Extension Phase|Withdrawal by Subject|6
3023487|NCT00785785|10398192|P1|Optional Extension Phase|Withdrawal by Subject|6
3023488|NCT00785785|10398191|P2|Optional Extension Phase|Adverse Event|5
3023489|NCT00785785|10398192|P1|Optional Extension Phase|Adverse Event|4
3023490|NCT00785785|10398191|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
3023491|NCT00785785|10398192|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
3023492|NCT00785785|10398191|P2|Core Phase up to 36 Months|Protocol deviation|6
3023493|NCT00785785|10398192|P1|Core Phase up to 36 Months|Protocol deviation|5
3023494|NCT00785785|10398191|P2|Core Phase up to 36 Months|Disease progression|119
3023495|NCT00785785|10398192|P1|Core Phase up to 36 Months|Disease progression|139
3023496|NCT00785785|10398191|P2|Core Phase up to 36 Months|Death|8
3023497|NCT00785785|10398192|P1|Core Phase up to 36 Months|Death|5
3023498|NCT00785785|10398191|P2|Core Phase up to 36 Months|Administrative problems|3
3023499|NCT00785785|10398192|P1|Core Phase up to 36 Months|Administrative problems|3
3023500|NCT00785785|10398191|P2|Core Phase up to 36 Months|Lost to Follow-up|7
3023501|NCT00785785|10398192|P1|Core Phase up to 36 Months|Lost to Follow-up|3
3023502|NCT00785785|10398191|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
3023503|NCT00785785|10398192|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
3023504|NCT00785785|10398191|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
3023505|NCT00785785|10398192|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
3023506|NCT00785785|10398191|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
3023507|NCT00785785|10398192|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
3023508|NCT00785785|10398191|P2|Core Phase up to 36 Months|Adverse Event|21
3023509|NCT00785785|10398192|P1|Core Phase up to 36 Months|Adverse Event|31
3023510|NCT00785785|10398191|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
3023511|NCT00785785|10398192|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
3023512|NCT00785707|10398206|P1|Overall Study|Lost to Follow-up|7
3023513|NCT00785629|10398215|P4|Overall Study|Withdrawal by Subject|2
3023514|NCT00785629|10398216|P3|Overall Study|Withdrawal by Subject|2
3023515|NCT00785629|10398217|P2|Overall Study|Withdrawal by Subject|1
3023516|NCT00785629|10398218|P1|Overall Study|Withdrawal by Subject|0
3023517|NCT00785629|10398215|P4|Overall Study|administrative decision|4
3023518|NCT00785629|10398216|P3|Overall Study|administrative decision|3
3023519|NCT00785629|10398217|P2|Overall Study|administrative decision|1
3023520|NCT00785629|10398218|P1|Overall Study|administrative decision|5
3023521|NCT00785629|10398215|P4|Overall Study|Protocol Violation|5
3023522|NCT00785629|10398216|P3|Overall Study|Protocol Violation|4
3023523|NCT00785629|10398217|P2|Overall Study|Protocol Violation|2
3023524|NCT00785629|10398218|P1|Overall Study|Protocol Violation|1
3023525|NCT00785629|10398215|P4|Overall Study|Adverse Event|5
3023526|NCT00785629|10398216|P3|Overall Study|Adverse Event|1
3023527|NCT00785629|10398217|P2|Overall Study|Adverse Event|1
3023528|NCT00785629|10398218|P1|Overall Study|Adverse Event|2
3023529|NCT00785577|10398231|P5|Study Period 3: 1-Week Washout Phase|Death|1
3023530|NCT00785577|10398232|P4|Study Period 3: 1-Week Washout Phase|Death|0
3023531|NCT00785577|10398233|P3|Study Period 3: 1-Week Washout Phase|Death|0
3023532|NCT00785577|10398234|P2|Study Period 3: 1-Week Washout Phase|Death|0
3023533|NCT00785577|10398235|P1|Study Period 3: 1-Week Washout Phase|Death|0
3023534|NCT00785577|10398231|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
3023535|NCT00785577|10398232|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
3023536|NCT00785577|10398233|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
3023537|NCT00785577|10398234|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
3023538|NCT00785577|10398235|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
3023539|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
3023540|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
3023541|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
3023542|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
3023543|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
3023544|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
3023545|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
3023546|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
3023547|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
3023548|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
3023549|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
3023550|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
3023551|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
3023552|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
3023553|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
3023554|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Protocol Violation|1
3023555|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Protocol Violation|0
3023556|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Protocol Violation|1
3023557|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Protocol Violation|1
3023558|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Protocol Violation|1
3023559|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Physician Decision|0
3023560|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Physician Decision|0
3023561|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Physician Decision|0
3023562|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Physician Decision|0
3023563|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Physician Decision|1
3023564|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
3023565|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
3023566|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
3023567|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
3023568|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
3023569|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
3023570|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
3023571|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
3023572|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
3023573|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
3023574|NCT00785577|10398231|P5|Study Period 2: Therapy Phase|Adverse Event|17
3023575|NCT00785577|10398232|P4|Study Period 2: Therapy Phase|Adverse Event|10
3023576|NCT00785577|10398233|P3|Study Period 2: Therapy Phase|Adverse Event|14
3023577|NCT00785577|10398234|P2|Study Period 2: Therapy Phase|Adverse Event|7
3023578|NCT00785577|10398235|P1|Study Period 2: Therapy Phase|Adverse Event|5
3023579|NCT00785538|10398375|P4|Treatment Period|Withdrawal by Subject|1
3023580|NCT00785538|10398376|P3|Treatment Period|Withdrawal by Subject|0
3023581|NCT00785538|10398377|P2|Treatment Period|Withdrawal by Subject|0
3023582|NCT00785538|10398378|P1|Treatment Period|Withdrawal by Subject|0
3023583|NCT00785538|10398375|P4|Treatment Period|Adverse Event|0
3023584|NCT00785538|10398376|P3|Treatment Period|Adverse Event|2
3023585|NCT00785538|10398377|P2|Treatment Period|Adverse Event|2
3023586|NCT00785538|10398378|P1|Treatment Period|Adverse Event|1
3023587|NCT00785512|10398426|P2|Overall Study|Lack of compliance|1
3023588|NCT00785512|10398427|P1|Overall Study|Lack of compliance|0
3023589|NCT00785512|10398426|P2|Overall Study|Physician Decision|0
3023590|NCT00785512|10398427|P1|Overall Study|Physician Decision|0
3023591|NCT00785512|10398426|P2|Overall Study|IVRS Programing Error|0
3023592|NCT00785512|10398427|P1|Overall Study|IVRS Programing Error|0
3023593|NCT00785512|10398426|P2|Overall Study|Precedure Refused|0
3023594|NCT00785512|10398427|P1|Overall Study|Precedure Refused|0
3023595|NCT00785512|10398426|P2|Overall Study|Lost to Follow-up|0
3023596|NCT00785512|10398427|P1|Overall Study|Lost to Follow-up|3
3023597|NCT00785512|10398426|P2|Overall Study|Withdrawal by Subject|1
3023598|NCT00785512|10398427|P1|Overall Study|Withdrawal by Subject|0
3023599|NCT00785512|10398426|P2|Overall Study|Lack of Efficacy|2
3023600|NCT00785512|10398427|P1|Overall Study|Lack of Efficacy|0
3023601|NCT00785512|10398426|P2|Overall Study|Adverse Event|0
3023602|NCT00785512|10398427|P1|Overall Study|Adverse Event|0
3023603|NCT00785512|10398426|P2|Overall Study|Inclusion/Exclusion not meet|0
3023604|NCT00785512|10398427|P1|Overall Study|Inclusion/Exclusion not meet|0
3023605|NCT00785486|10398436|P1|Midazolam Alone|Withdrawal by Subject|1
3023606|NCT00785356|10398460|P1|Overall Study|Study prematurely terminated|8
3023607|NCT00785291|10398471|P3|Overall Study|Other Medical Reasons|15
3023608|NCT00785291|10398472|P2|Overall Study|Other Medical Reasons|25
3023609|NCT00785291|10398473|P1|Overall Study|Other Medical Reasons|29
3023610|NCT00785291|10398471|P3|Overall Study|Complicating illness|4
3023611|NCT00785291|10398472|P2|Overall Study|Complicating illness|4
3023612|NCT00785291|10398473|P1|Overall Study|Complicating illness|6
3023613|NCT00785291|10398471|P3|Overall Study|Alternative Therapy|7
3023614|NCT00785291|10398472|P2|Overall Study|Alternative Therapy|6
3023615|NCT00785291|10398473|P1|Overall Study|Alternative Therapy|12
3023616|NCT00785291|10398471|P3|Overall Study|Withdrawal by Subject|17
3023617|NCT00785291|10398472|P2|Overall Study|Withdrawal by Subject|36
3023618|NCT00785291|10398473|P1|Overall Study|Withdrawal by Subject|35
3023619|NCT00785291|10398471|P3|Overall Study|Death|3
3023620|NCT00785291|10398472|P2|Overall Study|Death|4
3023621|NCT00785291|10398473|P1|Overall Study|Death|7
3023622|NCT00785291|10398471|P3|Overall Study|Adverse Event|56
3023623|NCT00785291|10398472|P2|Overall Study|Adverse Event|70
3023624|NCT00785291|10398473|P1|Overall Study|Adverse Event|39
3023625|NCT00785291|10398471|P3|Overall Study|Never began treatment|4
3023626|NCT00785291|10398472|P2|Overall Study|Never began treatment|4
3023627|NCT00785291|10398473|P1|Overall Study|Never began treatment|8
3023628|NCT00785213|10398493|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
3023629|NCT00785213|10398493|P1|Quinine Sulfate Alone|Adverse Event|4
3023630|NCT00785044|10398504|P1|Overall Study|Withdrawal by Subject|1
3023631|NCT00785044|10398504|P1|Overall Study|Lost to Follow-up|266
3023632|NCT00785044|10398504|P1|Overall Study|Death|77
3023633|NCT00785044|10398504|P1|Overall Study|Dosed at non-participating sites|152
3023634|NCT00784979|10398509|P1|Overall Study|incomplete data|6
3023635|NCT00784927|10398513|P1|Overall Study|Ineligible|1
3023636|NCT00784927|10398513|P1|Overall Study|Protocol Violation|1
3023637|NCT00784927|10398513|P1|Overall Study|Cancel Prior to Initiating Treatment|1
3023638|NCT00784875|10398525|P4|Period D|Lost to Follow-up|1
3023639|NCT00784875|10398526|P3|Period D|Lost to Follow-up|1
3023640|NCT00784875|10398527|P2|Period D|Lost to Follow-up|0
3023641|NCT00784875|10398528|P1|Period D|Lost to Follow-up|1
3023642|NCT00784875|10398525|P4|Period D|Sponsor Decision|0
3023643|NCT00784875|10398526|P3|Period D|Sponsor Decision|1
3023644|NCT00784875|10398527|P2|Period D|Sponsor Decision|1
3023645|NCT00784875|10398528|P1|Period D|Sponsor Decision|1
3023646|NCT00784875|10398525|P4|Period D|Physician Decision|0
3023647|NCT00784875|10398526|P3|Period D|Physician Decision|0
3023648|NCT00784875|10398527|P2|Period D|Physician Decision|1
3023649|NCT00784875|10398528|P1|Period D|Physician Decision|0
3023650|NCT00784875|10398525|P4|Period D|Withdrawal by Subject|0
3023651|NCT00784875|10398526|P3|Period D|Withdrawal by Subject|2
3023652|NCT00784875|10398527|P2|Period D|Withdrawal by Subject|0
3023653|NCT00784875|10398528|P1|Period D|Withdrawal by Subject|2
3023654|NCT00784875|10398525|P4|Period D|Protocol Violation|0
3023655|NCT00784875|10398526|P3|Period D|Protocol Violation|0
3023656|NCT00784875|10398527|P2|Period D|Protocol Violation|0
3023657|NCT00784875|10398528|P1|Period D|Protocol Violation|1
3023658|NCT00784875|10398525|P4|Period D|Adverse Event|0
3023659|NCT00784875|10398526|P3|Period D|Adverse Event|2
3023660|NCT00784875|10398527|P2|Period D|Adverse Event|2
3023661|NCT00784875|10398528|P1|Period D|Adverse Event|0
3023662|NCT00784875|10398525|P4|Period C|Sponsor Decision|2
3023663|NCT00784875|10398526|P3|Period C|Sponsor Decision|4
3023664|NCT00784875|10398527|P2|Period C|Sponsor Decision|5
3023665|NCT00784875|10398528|P1|Period C|Sponsor Decision|5
3023666|NCT00784875|10398525|P4|Period C|Physician Decision|1
3023667|NCT00784875|10398526|P3|Period C|Physician Decision|1
3023668|NCT00784875|10398527|P2|Period C|Physician Decision|0
3023669|NCT00784875|10398528|P1|Period C|Physician Decision|0
3023670|NCT00784875|10398525|P4|Period C|Withdrawal by Subject|0
3023671|NCT00784875|10398526|P3|Period C|Withdrawal by Subject|2
3023672|NCT00784875|10398527|P2|Period C|Withdrawal by Subject|1
3023673|NCT00784875|10398528|P1|Period C|Withdrawal by Subject|1
3023674|NCT00784875|10398525|P4|Period C|Lack of Efficacy|0
3023675|NCT00784875|10398526|P3|Period C|Lack of Efficacy|1
3023676|NCT00784875|10398527|P2|Period C|Lack of Efficacy|0
3023677|NCT00784875|10398528|P1|Period C|Lack of Efficacy|0
3023678|NCT00784875|10398525|P4|Period C|Protocol Violation|2
3023679|NCT00784875|10398526|P3|Period C|Protocol Violation|1
3023680|NCT00784875|10398527|P2|Period C|Protocol Violation|0
3023681|NCT00784875|10398528|P1|Period C|Protocol Violation|0
3023682|NCT00784875|10398525|P4|Period C|Adverse Event|2
3023683|NCT00784875|10398526|P3|Period C|Adverse Event|4
3023684|NCT00784875|10398527|P2|Period C|Adverse Event|0
3023685|NCT00784875|10398528|P1|Period C|Adverse Event|1
3023686|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
3023687|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
3023688|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
3023689|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
3023690|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
3023691|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
3023692|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
3023693|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
3023694|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Physician Decision|0
3023695|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Physician Decision|1
3023696|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Physician Decision|0
3023697|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Physician Decision|0
3023698|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
3023699|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
3023700|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
3023701|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
3023702|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
3023703|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
3023704|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
3023705|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
3023706|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Protocol Violation|3
3023707|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Protocol Violation|2
3023708|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Protocol Violation|1
3023709|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Protocol Violation|1
3023710|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Adverse Event|1
3023711|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Adverse Event|2
3023712|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Adverse Event|3
3023713|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Adverse Event|0
3023714|NCT00784875|10398525|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
3023715|NCT00784875|10398526|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
3023716|NCT00784875|10398527|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
3023717|NCT00784875|10398528|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
3023718|NCT00784875|10398525|P4|Period A - Baseline|Lost to Follow-up|2
3023719|NCT00784875|10398526|P3|Period A - Baseline|Lost to Follow-up|0
3023720|NCT00784875|10398527|P2|Period A - Baseline|Lost to Follow-up|0
3023721|NCT00784875|10398528|P1|Period A - Baseline|Lost to Follow-up|0
3023722|NCT00784875|10398525|P4|Period A - Baseline|Sponsor Decision|113
3023723|NCT00784875|10398526|P3|Period A - Baseline|Sponsor Decision|0
3023724|NCT00784875|10398527|P2|Period A - Baseline|Sponsor Decision|0
3023725|NCT00784875|10398528|P1|Period A - Baseline|Sponsor Decision|0
3023726|NCT00784875|10398525|P4|Period A - Baseline|Physician Decision|2
3023727|NCT00784875|10398526|P3|Period A - Baseline|Physician Decision|0
3023728|NCT00784875|10398527|P2|Period A - Baseline|Physician Decision|0
3023729|NCT00784875|10398528|P1|Period A - Baseline|Physician Decision|0
3023730|NCT00784875|10398525|P4|Period A - Baseline|Withdrawal by Subject|27
3023731|NCT00784875|10398526|P3|Period A - Baseline|Withdrawal by Subject|0
3023732|NCT00784875|10398527|P2|Period A - Baseline|Withdrawal by Subject|0
3023733|NCT00784875|10398528|P1|Period A - Baseline|Withdrawal by Subject|0
3023734|NCT00784875|10398525|P4|Period A - Baseline|Protocol Violation|25
3023735|NCT00784875|10398526|P3|Period A - Baseline|Protocol Violation|0
3023736|NCT00784875|10398527|P2|Period A - Baseline|Protocol Violation|0
3023737|NCT00784875|10398528|P1|Period A - Baseline|Protocol Violation|0
3023738|NCT00784875|10398525|P4|Period A - Baseline|Adverse Event|8
3023739|NCT00784875|10398526|P3|Period A - Baseline|Adverse Event|0
3023740|NCT00784875|10398527|P2|Period A - Baseline|Adverse Event|0
3023741|NCT00784875|10398528|P1|Period A - Baseline|Adverse Event|0
3023742|NCT00784875|10398525|P4|Period A - Baseline|Entry Criteria Not Met|5
3023743|NCT00784875|10398526|P3|Period A - Baseline|Entry Criteria Not Met|0
3023744|NCT00784875|10398527|P2|Period A - Baseline|Entry Criteria Not Met|0
3023745|NCT00784875|10398528|P1|Period A - Baseline|Entry Criteria Not Met|0
3023746|NCT00784836|10398648|P1|Overall Study|Early Study Termination|3
3023747|NCT00784810|10398655|P2|Overall Study|Lost to Follow-up|1
3023748|NCT00784810|10398656|P1|Overall Study|Lost to Follow-up|1
3023749|NCT00784810|10398655|P2|Overall Study|Administrative|8
3023750|NCT00784810|10398656|P1|Overall Study|Administrative|5
3023751|NCT00784810|10398655|P2|Overall Study|Withdrawal by Subject|9
3023752|NCT00784810|10398656|P1|Overall Study|Withdrawal by Subject|11
3023753|NCT00784810|10398655|P2|Overall Study|Lack of Efficacy|11
3023754|NCT00784810|10398656|P1|Overall Study|Lack of Efficacy|14
3023755|NCT00784810|10398655|P2|Overall Study|Adverse Event|20
3023756|NCT00784810|10398656|P1|Overall Study|Adverse Event|32
3023757|NCT00784784|10398666|P2|Overall Study|Withdrawal by Subject|2
3023758|NCT00784784|10398667|P1|Overall Study|Withdrawal by Subject|2
3023759|NCT00784758|10398677|P2|Overall Study|Adverse Event|0
3023760|NCT00784758|10398678|P1|Overall Study|Adverse Event|1
3023761|NCT00784758|10398677|P2|Overall Study|Withdrawal by Subject|0
3023762|NCT00784758|10398678|P1|Overall Study|Withdrawal by Subject|3
3023763|NCT00784719|10398727|P7|Overall Study|Withdrawal by Subject|1
3023764|NCT00784719|10398728|P6|Overall Study|Withdrawal by Subject|0
3023765|NCT00784719|10398729|P5|Overall Study|Withdrawal by Subject|2
3023766|NCT00784719|10398730|P4|Overall Study|Withdrawal by Subject|0
3023767|NCT00784719|10398731|P3|Overall Study|Withdrawal by Subject|0
3023768|NCT00784719|10398732|P2|Overall Study|Withdrawal by Subject|0
3023769|NCT00784719|10398733|P1|Overall Study|Withdrawal by Subject|1
3023770|NCT00784719|10398727|P7|Overall Study|Other|3
3023771|NCT00784719|10398728|P6|Overall Study|Other|1
3023772|NCT00784719|10398729|P5|Overall Study|Other|2
3023773|NCT00784719|10398730|P4|Overall Study|Other|0
3023774|NCT00784719|10398731|P3|Overall Study|Other|1
3023775|NCT00784719|10398732|P2|Overall Study|Other|1
3023776|NCT00784719|10398733|P1|Overall Study|Other|2
3023777|NCT00784719|10398727|P7|Overall Study|Lost to Follow-up|0
3023778|NCT00784719|10398728|P6|Overall Study|Lost to Follow-up|1
3023779|NCT00784719|10398729|P5|Overall Study|Lost to Follow-up|1
3023780|NCT00784719|10398730|P4|Overall Study|Lost to Follow-up|0
3023781|NCT00784719|10398731|P3|Overall Study|Lost to Follow-up|0
3023782|NCT00784719|10398732|P2|Overall Study|Lost to Follow-up|0
3023783|NCT00784719|10398733|P1|Overall Study|Lost to Follow-up|0
3023784|NCT00784719|10398727|P7|Overall Study|Adverse Event|1
3023785|NCT00784719|10398728|P6|Overall Study|Adverse Event|1
3023786|NCT00784719|10398729|P5|Overall Study|Adverse Event|1
3023787|NCT00784719|10398730|P4|Overall Study|Adverse Event|0
3023788|NCT00784719|10398731|P3|Overall Study|Adverse Event|0
3023789|NCT00784719|10398732|P2|Overall Study|Adverse Event|2
3023790|NCT00784719|10398733|P1|Overall Study|Adverse Event|0
3023791|NCT00784654|10398903|P3|Randomized Withdrawal Period|Family reasons|1
3023792|NCT00784654|10398904|P2|Randomized Withdrawal Period|Family reasons|0
3023793|NCT00784654|10398905|P1|Randomized Withdrawal Period|Family reasons|0
3023794|NCT00784654|10398903|P3|Randomized Withdrawal Period|Did not complete a visit|0
3023795|NCT00784654|10398904|P2|Randomized Withdrawal Period|Did not complete a visit|1
3023796|NCT00784654|10398905|P1|Randomized Withdrawal Period|Did not complete a visit|0
3023797|NCT00784654|10398903|P3|Randomized Withdrawal Period|Adverse Event|1
3023798|NCT00784654|10398904|P2|Randomized Withdrawal Period|Adverse Event|1
3023799|NCT00784654|10398905|P1|Randomized Withdrawal Period|Adverse Event|0
3023800|NCT00784654|10398903|P3|Randomized Withdrawal Period|Protocol Violation|1
3023801|NCT00784654|10398904|P2|Randomized Withdrawal Period|Protocol Violation|2
3023802|NCT00784654|10398905|P1|Randomized Withdrawal Period|Protocol Violation|0
3023803|NCT00784654|10398903|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
3023804|NCT00784654|10398904|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
3023805|NCT00784654|10398905|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
3023806|NCT00784654|10398903|P3|Randomized Withdrawal Period|Lack of Efficacy|18
3023807|NCT00784654|10398904|P2|Randomized Withdrawal Period|Lack of Efficacy|5
3023808|NCT00784654|10398905|P1|Randomized Withdrawal Period|Lack of Efficacy|0
3023809|NCT00784654|10398903|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
3023810|NCT00784654|10398904|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
3023811|NCT00784654|10398905|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
3023812|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
3023813|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
3023814|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
3023815|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
3023816|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
3023817|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
3023818|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
3023819|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
3023820|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
3023821|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
3023822|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
3023823|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
3023909|NCT00784277|10399080|P4|ER Treatment|Withdrawal by Subject|0
3023824|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
3023825|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
3023826|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
3023827|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
3023828|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
3023829|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
3023830|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
3023831|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
3023832|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
3023833|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
3023834|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
3023835|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
3023836|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
3023837|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
3023838|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
3023839|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
3023840|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
3023841|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
3023842|NCT00784654|10398903|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
3023843|NCT00784654|10398904|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
3023844|NCT00784654|10398905|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
3023845|NCT00784563|10398940|P3|Year 3|Adverse Event|1
3023846|NCT00784563|10398941|P2|Year 3|Adverse Event|0
3023847|NCT00784563|10398942|P1|Year 3|Adverse Event|0
3023848|NCT00784563|10398940|P3|Year 3|Withdrawal by Subject|2
3023849|NCT00784563|10398941|P2|Year 3|Withdrawal by Subject|0
3023850|NCT00784563|10398942|P1|Year 3|Withdrawal by Subject|0
3023851|NCT00784563|10398940|P3|Years 1 & 2|Adverse Event|0
3023852|NCT00784563|10398941|P2|Years 1 & 2|Adverse Event|3
3023853|NCT00784563|10398942|P1|Years 1 & 2|Adverse Event|0
3023854|NCT00784563|10398940|P3|Years 1 & 2|Withdrawal by Subject|0
3023855|NCT00784563|10398941|P2|Years 1 & 2|Withdrawal by Subject|2
3023856|NCT00784563|10398942|P1|Years 1 & 2|Withdrawal by Subject|3
3023857|NCT00784550|10398960|P2|Overall Study|Withdrawal by Subject|13
3023858|NCT00784550|10398961|P1|Overall Study|Withdrawal by Subject|4
3023859|NCT00784550|10398960|P2|Overall Study|Physician Decision|3
3023860|NCT00784550|10398961|P1|Overall Study|Physician Decision|2
3023861|NCT00784550|10398960|P2|Overall Study|Lost to Follow-up|5
3023862|NCT00784550|10398961|P1|Overall Study|Lost to Follow-up|8
3023863|NCT00784550|10398960|P2|Overall Study|Protocol Violation|10
3023864|NCT00784550|10398961|P1|Overall Study|Protocol Violation|10
3023865|NCT00784550|10398960|P2|Overall Study|Lack of Efficacy|1
3023866|NCT00784550|10398961|P1|Overall Study|Lack of Efficacy|0
3023867|NCT00784550|10398960|P2|Overall Study|Adverse Event|10
3023868|NCT00784550|10398961|P1|Overall Study|Adverse Event|12
3023869|NCT00784459|10398987|P2|Overall Study|Adverse Event|2
3023870|NCT00784459|10398988|P1|Overall Study|Adverse Event|0
3023871|NCT00784368|10398999|P3|Overall Study|Withdrawal of informed consent|0
3023872|NCT00784368|10399000|P2|Overall Study|Withdrawal of informed consent|1
3023873|NCT00784368|10399001|P1|Overall Study|Withdrawal of informed consent|0
3023874|NCT00784368|10398999|P3|Overall Study|Worsening of symptoms|0
3023875|NCT00784368|10399000|P2|Overall Study|Worsening of symptoms|1
3023876|NCT00784368|10399001|P1|Overall Study|Worsening of symptoms|0
3023877|NCT00784368|10398999|P3|Overall Study|Worsening of complications|1
3023878|NCT00784368|10399000|P2|Overall Study|Worsening of complications|0
3023879|NCT00784368|10399001|P1|Overall Study|Worsening of complications|0
3023880|NCT00784368|10398999|P3|Overall Study|Diagnosis of fever|1
3023881|NCT00784368|10399000|P2|Overall Study|Diagnosis of fever|0
3023882|NCT00784368|10399001|P1|Overall Study|Diagnosis of fever|0
3023883|NCT00784368|10398999|P3|Overall Study|Adverse Event|2
3023884|NCT00784368|10399000|P2|Overall Study|Adverse Event|9
3023885|NCT00784368|10399001|P1|Overall Study|Adverse Event|6
3023886|NCT00784368|10398999|P3|Overall Study|Lack of Efficacy|1
3023887|NCT00784368|10399000|P2|Overall Study|Lack of Efficacy|0
3023888|NCT00784368|10399001|P1|Overall Study|Lack of Efficacy|2
3023889|NCT00784368|10398999|P3|Overall Study|Physician Decision|6
3023890|NCT00784368|10399000|P2|Overall Study|Physician Decision|0
3023891|NCT00784368|10399001|P1|Overall Study|Physician Decision|0
3023892|NCT00784277|10399077|P7|ER Treatment|Other|2
3023893|NCT00784277|10399078|P6|ER Treatment|Other|3
3023894|NCT00784277|10399079|P5|ER Treatment|Other|1
3023895|NCT00784277|10399080|P4|ER Treatment|Other|0
3023896|NCT00784277|10399081|P3|ER Treatment|Other|0
3023897|NCT00784277|10399082|P2|ER Treatment|Other|0
3023898|NCT00784277|10399083|P1|ER Treatment|Other|0
3023899|NCT00784277|10399077|P7|ER Treatment|Study Medication Non-Compliant|3
3023900|NCT00784277|10399078|P6|ER Treatment|Study Medication Non-Compliant|3
3023901|NCT00784277|10399079|P5|ER Treatment|Study Medication Non-Compliant|2
3023902|NCT00784277|10399080|P4|ER Treatment|Study Medication Non-Compliant|0
3023903|NCT00784277|10399081|P3|ER Treatment|Study Medication Non-Compliant|0
3023904|NCT00784277|10399082|P2|ER Treatment|Study Medication Non-Compliant|0
3023905|NCT00784277|10399083|P1|ER Treatment|Study Medication Non-Compliant|0
3023906|NCT00784277|10399077|P7|ER Treatment|Withdrawal by Subject|3
3023907|NCT00784277|10399078|P6|ER Treatment|Withdrawal by Subject|5
3023908|NCT00784277|10399079|P5|ER Treatment|Withdrawal by Subject|2
3023910|NCT00784277|10399081|P3|ER Treatment|Withdrawal by Subject|0
3023911|NCT00784277|10399082|P2|ER Treatment|Withdrawal by Subject|0
3023912|NCT00784277|10399083|P1|ER Treatment|Withdrawal by Subject|0
3023913|NCT00784277|10399077|P7|ER Treatment|Lost to Follow-up|0
3023914|NCT00784277|10399078|P6|ER Treatment|Lost to Follow-up|2
3023915|NCT00784277|10399079|P5|ER Treatment|Lost to Follow-up|0
3023916|NCT00784277|10399080|P4|ER Treatment|Lost to Follow-up|0
3023917|NCT00784277|10399081|P3|ER Treatment|Lost to Follow-up|0
3023918|NCT00784277|10399082|P2|ER Treatment|Lost to Follow-up|0
3023919|NCT00784277|10399083|P1|ER Treatment|Lost to Follow-up|0
3023920|NCT00784277|10399077|P7|ER Treatment|Lack of Efficacy|0
3023921|NCT00784277|10399078|P6|ER Treatment|Lack of Efficacy|4
3023922|NCT00784277|10399079|P5|ER Treatment|Lack of Efficacy|3
3023923|NCT00784277|10399080|P4|ER Treatment|Lack of Efficacy|0
3023924|NCT00784277|10399081|P3|ER Treatment|Lack of Efficacy|0
3023925|NCT00784277|10399082|P2|ER Treatment|Lack of Efficacy|0
3023926|NCT00784277|10399083|P1|ER Treatment|Lack of Efficacy|0
3023927|NCT00784277|10399077|P7|ER Treatment|Adverse Event|7
3023928|NCT00784277|10399078|P6|ER Treatment|Adverse Event|7
3023929|NCT00784277|10399079|P5|ER Treatment|Adverse Event|1
3023930|NCT00784277|10399080|P4|ER Treatment|Adverse Event|0
3023931|NCT00784277|10399081|P3|ER Treatment|Adverse Event|0
3023932|NCT00784277|10399082|P2|ER Treatment|Adverse Event|0
3023933|NCT00784277|10399083|P1|ER Treatment|Adverse Event|0
3023934|NCT00784277|10399077|P7|IR Treatment|Other|0
3023935|NCT00784277|10399078|P6|IR Treatment|Other|0
3023936|NCT00784277|10399079|P5|IR Treatment|Other|0
3023937|NCT00784277|10399080|P4|IR Treatment|Other|2
3023938|NCT00784277|10399081|P3|IR Treatment|Other|3
3023939|NCT00784277|10399082|P2|IR Treatment|Other|3
3023940|NCT00784277|10399083|P1|IR Treatment|Other|2
3023941|NCT00784277|10399077|P7|IR Treatment|Resolution Of Pain|0
3023942|NCT00784277|10399078|P6|IR Treatment|Resolution Of Pain|0
3023943|NCT00784277|10399079|P5|IR Treatment|Resolution Of Pain|0
3023944|NCT00784277|10399080|P4|IR Treatment|Resolution Of Pain|0
3023945|NCT00784277|10399081|P3|IR Treatment|Resolution Of Pain|0
3023946|NCT00784277|10399082|P2|IR Treatment|Resolution Of Pain|1
3023947|NCT00784277|10399083|P1|IR Treatment|Resolution Of Pain|0
3023948|NCT00784277|10399077|P7|IR Treatment|Withdrawal by Subject|0
3023949|NCT00784277|10399078|P6|IR Treatment|Withdrawal by Subject|0
3023950|NCT00784277|10399079|P5|IR Treatment|Withdrawal by Subject|0
3023951|NCT00784277|10399080|P4|IR Treatment|Withdrawal by Subject|6
3023952|NCT00784277|10399081|P3|IR Treatment|Withdrawal by Subject|4
3023953|NCT00784277|10399082|P2|IR Treatment|Withdrawal by Subject|1
3023954|NCT00784277|10399083|P1|IR Treatment|Withdrawal by Subject|5
3023955|NCT00784277|10399077|P7|IR Treatment|Lost to Follow-up|0
3023956|NCT00784277|10399078|P6|IR Treatment|Lost to Follow-up|0
3023957|NCT00784277|10399079|P5|IR Treatment|Lost to Follow-up|0
3023958|NCT00784277|10399080|P4|IR Treatment|Lost to Follow-up|0
3023959|NCT00784277|10399081|P3|IR Treatment|Lost to Follow-up|1
3023960|NCT00784277|10399082|P2|IR Treatment|Lost to Follow-up|0
3023961|NCT00784277|10399083|P1|IR Treatment|Lost to Follow-up|1
3023962|NCT00784277|10399077|P7|IR Treatment|Lack of Efficacy|0
3023963|NCT00784277|10399078|P6|IR Treatment|Lack of Efficacy|0
3023964|NCT00784277|10399079|P5|IR Treatment|Lack of Efficacy|0
3023965|NCT00784277|10399080|P4|IR Treatment|Lack of Efficacy|0
3023966|NCT00784277|10399081|P3|IR Treatment|Lack of Efficacy|1
3023967|NCT00784277|10399082|P2|IR Treatment|Lack of Efficacy|4
3023968|NCT00784277|10399083|P1|IR Treatment|Lack of Efficacy|4
3023969|NCT00784277|10399077|P7|IR Treatment|Adverse Event|0
3023970|NCT00784277|10399078|P6|IR Treatment|Adverse Event|0
3023971|NCT00784277|10399079|P5|IR Treatment|Adverse Event|0
3023972|NCT00784277|10399080|P4|IR Treatment|Adverse Event|35
3023973|NCT00784277|10399081|P3|IR Treatment|Adverse Event|19
3023974|NCT00784277|10399082|P2|IR Treatment|Adverse Event|8
3023975|NCT00784277|10399083|P1|IR Treatment|Adverse Event|4
3023976|NCT00784238|10399100|P1|Overall Study|Other|14
3023977|NCT00784238|10399100|P1|Overall Study|Withdrawal by Subject|26
3023978|NCT00784238|10399100|P1|Overall Study|Pregnancy|1
3023979|NCT00784238|10399100|P1|Overall Study|Lost to Follow-up|29
3023980|NCT00784238|10399100|P1|Overall Study|Lack of Efficacy|33
3023981|NCT00784238|10399100|P1|Overall Study|Death|2
3023982|NCT00784238|10399100|P1|Overall Study|Adverse Event|14
3023983|NCT00784147|10399172|P2|Overall Study|Death|0
3023984|NCT00784147|10399173|P1|Overall Study|Death|2
3023985|NCT00784147|10399172|P2|Overall Study|Protocol Violation|1
3023986|NCT00784147|10399173|P1|Overall Study|Protocol Violation|1
3023987|NCT00784147|10399172|P2|Overall Study|Physician Decision|1
3023988|NCT00784147|10399173|P1|Overall Study|Physician Decision|2
3023989|NCT00784147|10399172|P2|Overall Study|Withdrawal by Subject|3
3023990|NCT00784147|10399173|P1|Overall Study|Withdrawal by Subject|1
3023991|NCT00784147|10399172|P2|Overall Study|Lost to Follow-up|4
3023992|NCT00784147|10399173|P1|Overall Study|Lost to Follow-up|2
3023993|NCT00784134|10399193|P2|Overall Study|Lost to Follow-up|6
3023994|NCT00784134|10399194|P1|Overall Study|Lost to Follow-up|3
3023995|NCT00784043|10399317|P2|Overall Study|Protocol Terminated|1
3023996|NCT00784043|10399318|P1|Overall Study|Protocol Terminated|23
3023997|NCT00784043|10399317|P2|Overall Study|Withdrawal by Subject|5
3023998|NCT00784043|10399318|P1|Overall Study|Withdrawal by Subject|8
3023999|NCT00783835|10399353|P1|Overall Study|Participant not Adherent|3
3024000|NCT00783835|10399353|P1|Overall Study|Lost to Follow-up|1
3024001|NCT00783835|10399353|P1|Overall Study|Withdrawal by Subject|2
3024002|NCT00783835|10399353|P1|Overall Study|Medical Criteria|1
3024003|NCT00783835|10399353|P1|Overall Study|Adverse Event|3
3024004|NCT00783796|10399365|P1|Overall Study|Received commercial XIENCE V stent|1
3024005|NCT00783796|10399365|P1|Overall Study|Received non-XIENCE V stent|1
3024006|NCT00783796|10399365|P1|Overall Study|Did not receive any stent|4
3024007|NCT00783718|10399470|P7|Maintenance Phase|Lost to Follow-up|2
3024008|NCT00783718|10399471|P6|Maintenance Phase|Lost to Follow-up|0
3024009|NCT00783718|10399472|P5|Maintenance Phase|Lost to Follow-up|2
3024010|NCT00783718|10399473|P4|Maintenance Phase|Lost to Follow-up|0
3024011|NCT00783718|10399474|P3|Maintenance Phase|Lost to Follow-up|0
3024012|NCT00783718|10399475|P2|Maintenance Phase|Lost to Follow-up|0
3024013|NCT00783718|10399476|P1|Maintenance Phase|Lost to Follow-up|3
3024014|NCT00783718|10399470|P7|Maintenance Phase|Withdrawal by Subject|20
3024015|NCT00783718|10399471|P6|Maintenance Phase|Withdrawal by Subject|2
3024016|NCT00783718|10399472|P5|Maintenance Phase|Withdrawal by Subject|5
3024017|NCT00783718|10399473|P4|Maintenance Phase|Withdrawal by Subject|2
3024018|NCT00783718|10399474|P3|Maintenance Phase|Withdrawal by Subject|0
3024019|NCT00783718|10399475|P2|Maintenance Phase|Withdrawal by Subject|0
3024020|NCT00783718|10399476|P1|Maintenance Phase|Withdrawal by Subject|6
3024021|NCT00783718|10399470|P7|Maintenance Phase|Lack of Efficacy|155
3024022|NCT00783718|10399471|P6|Maintenance Phase|Lack of Efficacy|33
3024023|NCT00783718|10399472|P5|Maintenance Phase|Lack of Efficacy|31
3024024|NCT00783718|10399473|P4|Maintenance Phase|Lack of Efficacy|61
3024025|NCT00783718|10399474|P3|Maintenance Phase|Lack of Efficacy|0
3024026|NCT00783718|10399475|P2|Maintenance Phase|Lack of Efficacy|0
3024027|NCT00783718|10399476|P1|Maintenance Phase|Lack of Efficacy|83
3024028|NCT00783718|10399470|P7|Maintenance Phase|Protocol Violation|2
3024029|NCT00783718|10399471|P6|Maintenance Phase|Protocol Violation|0
3024030|NCT00783718|10399472|P5|Maintenance Phase|Protocol Violation|0
3024031|NCT00783718|10399473|P4|Maintenance Phase|Protocol Violation|0
3024032|NCT00783718|10399474|P3|Maintenance Phase|Protocol Violation|0
3024033|NCT00783718|10399475|P2|Maintenance Phase|Protocol Violation|0
3024034|NCT00783718|10399476|P1|Maintenance Phase|Protocol Violation|1
3024035|NCT00783718|10399470|P7|Maintenance Phase|Adverse Event|16
3024036|NCT00783718|10399471|P6|Maintenance Phase|Adverse Event|6
3024037|NCT00783718|10399472|P5|Maintenance Phase|Adverse Event|7
3024038|NCT00783718|10399473|P4|Maintenance Phase|Adverse Event|15
3024039|NCT00783718|10399474|P3|Maintenance Phase|Adverse Event|0
3024040|NCT00783718|10399475|P2|Maintenance Phase|Adverse Event|0
3024041|NCT00783718|10399476|P1|Maintenance Phase|Adverse Event|12
3024042|NCT00783718|10399470|P7|Induction Phase|Lost to Follow-up|0
3024043|NCT00783718|10399471|P6|Induction Phase|Lost to Follow-up|0
3024044|NCT00783718|10399472|P5|Induction Phase|Lost to Follow-up|0
3024045|NCT00783718|10399473|P4|Induction Phase|Lost to Follow-up|0
3024046|NCT00783718|10399474|P3|Induction Phase|Lost to Follow-up|1
3024047|NCT00783718|10399475|P2|Induction Phase|Lost to Follow-up|0
3024048|NCT00783718|10399476|P1|Induction Phase|Lost to Follow-up|1
3024049|NCT00783718|10399470|P7|Induction Phase|Withdrawal by Subject|0
3024050|NCT00783718|10399471|P6|Induction Phase|Withdrawal by Subject|0
3024051|NCT00783718|10399472|P5|Induction Phase|Withdrawal by Subject|0
3024052|NCT00783718|10399473|P4|Induction Phase|Withdrawal by Subject|0
3024053|NCT00783718|10399474|P3|Induction Phase|Withdrawal by Subject|8
3024054|NCT00783718|10399475|P2|Induction Phase|Withdrawal by Subject|4
3024055|NCT00783718|10399476|P1|Induction Phase|Withdrawal by Subject|3
3024056|NCT00783718|10399470|P7|Induction Phase|Lack of Efficacy|0
3024057|NCT00783718|10399471|P6|Induction Phase|Lack of Efficacy|0
3024058|NCT00783718|10399472|P5|Induction Phase|Lack of Efficacy|0
3024059|NCT00783718|10399473|P4|Induction Phase|Lack of Efficacy|0
3024060|NCT00783718|10399474|P3|Induction Phase|Lack of Efficacy|14
3024061|NCT00783718|10399475|P2|Induction Phase|Lack of Efficacy|2
3024062|NCT00783718|10399476|P1|Induction Phase|Lack of Efficacy|5
3024063|NCT00783718|10399470|P7|Induction Phase|Protocol Violation|0
3024064|NCT00783718|10399471|P6|Induction Phase|Protocol Violation|0
3024065|NCT00783718|10399472|P5|Induction Phase|Protocol Violation|0
3024066|NCT00783718|10399473|P4|Induction Phase|Protocol Violation|0
3024067|NCT00783718|10399474|P3|Induction Phase|Protocol Violation|6
3024068|NCT00783718|10399475|P2|Induction Phase|Protocol Violation|1
3024069|NCT00783718|10399476|P1|Induction Phase|Protocol Violation|1
3024070|NCT00783718|10399470|P7|Induction Phase|Adverse Event|0
3024071|NCT00783718|10399471|P6|Induction Phase|Adverse Event|0
3024072|NCT00783718|10399472|P5|Induction Phase|Adverse Event|0
3024073|NCT00783718|10399473|P4|Induction Phase|Adverse Event|0
3024074|NCT00783718|10399474|P3|Induction Phase|Adverse Event|7
3024075|NCT00783718|10399475|P2|Induction Phase|Adverse Event|0
3024076|NCT00783718|10399476|P1|Induction Phase|Adverse Event|4
3024077|NCT00783705|10399504|P2|Overall Study|Lost to Follow-up|3
3024078|NCT00783705|10399505|P1|Overall Study|Lost to Follow-up|1
3024079|NCT00783705|10399504|P2|Overall Study|Withdrawal by Subject|2
3024080|NCT00783705|10399505|P1|Overall Study|Withdrawal by Subject|3
3024081|NCT00783705|10399504|P2|Overall Study|Adverse Event|0
3024082|NCT00783705|10399505|P1|Overall Study|Adverse Event|2
3024083|NCT00783692|10399552|P7|Maintenance Phase|Other|1
3024084|NCT00783692|10399553|P6|Maintenance Phase|Other|1
3024085|NCT00783692|10399554|P5|Maintenance Phase|Other|0
3024086|NCT00783692|10399555|P4|Maintenance Phase|Other|1
3024087|NCT00783692|10399556|P3|Maintenance Phase|Other|0
3024088|NCT00783692|10399557|P2|Maintenance Phase|Other|0
3024089|NCT00783692|10399558|P1|Maintenance Phase|Other|0
3024090|NCT00783692|10399552|P7|Maintenance Phase|Lost to Follow-up|5
3024091|NCT00783692|10399553|P6|Maintenance Phase|Lost to Follow-up|2
3024092|NCT00783692|10399554|P5|Maintenance Phase|Lost to Follow-up|3
3024093|NCT00783692|10399555|P4|Maintenance Phase|Lost to Follow-up|1
3024094|NCT00783692|10399556|P3|Maintenance Phase|Lost to Follow-up|0
3024095|NCT00783692|10399557|P2|Maintenance Phase|Lost to Follow-up|0
3024096|NCT00783692|10399558|P1|Maintenance Phase|Lost to Follow-up|2
3024097|NCT00783692|10399552|P7|Maintenance Phase|Withdrawal by Subject|24
3024098|NCT00783692|10399553|P6|Maintenance Phase|Withdrawal by Subject|9
3024099|NCT00783692|10399554|P5|Maintenance Phase|Withdrawal by Subject|6
3024100|NCT00783692|10399555|P4|Maintenance Phase|Withdrawal by Subject|7
3024101|NCT00783692|10399556|P3|Maintenance Phase|Withdrawal by Subject|0
3024102|NCT00783692|10399557|P2|Maintenance Phase|Withdrawal by Subject|0
3024103|NCT00783692|10399558|P1|Maintenance Phase|Withdrawal by Subject|7
3024104|NCT00783692|10399552|P7|Maintenance Phase|Lack of Efficacy|177
3024105|NCT00783692|10399553|P6|Maintenance Phase|Lack of Efficacy|48
3024106|NCT00783692|10399554|P5|Maintenance Phase|Lack of Efficacy|58
3024107|NCT00783692|10399555|P4|Maintenance Phase|Lack of Efficacy|64
3024108|NCT00783692|10399556|P3|Maintenance Phase|Lack of Efficacy|0
3024109|NCT00783692|10399557|P2|Maintenance Phase|Lack of Efficacy|0
3024110|NCT00783692|10399558|P1|Maintenance Phase|Lack of Efficacy|79
3024111|NCT00783692|10399552|P7|Maintenance Phase|Protocol Violation|4
3024112|NCT00783692|10399553|P6|Maintenance Phase|Protocol Violation|3
3024113|NCT00783692|10399554|P5|Maintenance Phase|Protocol Violation|2
3024114|NCT00783692|10399555|P4|Maintenance Phase|Protocol Violation|1
3024115|NCT00783692|10399556|P3|Maintenance Phase|Protocol Violation|0
3024116|NCT00783692|10399557|P2|Maintenance Phase|Protocol Violation|0
3024117|NCT00783692|10399558|P1|Maintenance Phase|Protocol Violation|0
3024118|NCT00783692|10399552|P7|Maintenance Phase|Adverse Event|38
3024119|NCT00783692|10399553|P6|Maintenance Phase|Adverse Event|9
3024120|NCT00783692|10399554|P5|Maintenance Phase|Adverse Event|12
3024121|NCT00783692|10399555|P4|Maintenance Phase|Adverse Event|15
3024122|NCT00783692|10399556|P3|Maintenance Phase|Adverse Event|0
3024123|NCT00783692|10399557|P2|Maintenance Phase|Adverse Event|0
3024124|NCT00783692|10399558|P1|Maintenance Phase|Adverse Event|7
3024125|NCT00783692|10399552|P7|Induction Phase|Other|0
3024126|NCT00783692|10399553|P6|Induction Phase|Other|0
3024127|NCT00783692|10399554|P5|Induction Phase|Other|0
3024128|NCT00783692|10399555|P4|Induction Phase|Other|0
3024129|NCT00783692|10399556|P3|Induction Phase|Other|2
3024130|NCT00783692|10399557|P2|Induction Phase|Other|0
3024131|NCT00783692|10399558|P1|Induction Phase|Other|0
3024132|NCT00783692|10399552|P7|Induction Phase|Lost to Follow-up|0
3024133|NCT00783692|10399553|P6|Induction Phase|Lost to Follow-up|0
3024134|NCT00783692|10399554|P5|Induction Phase|Lost to Follow-up|0
3024135|NCT00783692|10399555|P4|Induction Phase|Lost to Follow-up|0
3024136|NCT00783692|10399556|P3|Induction Phase|Lost to Follow-up|3
3024137|NCT00783692|10399557|P2|Induction Phase|Lost to Follow-up|0
3024138|NCT00783692|10399558|P1|Induction Phase|Lost to Follow-up|0
3024139|NCT00783692|10399552|P7|Induction Phase|Withdrawal by Subject|0
3024140|NCT00783692|10399553|P6|Induction Phase|Withdrawal by Subject|0
3024141|NCT00783692|10399554|P5|Induction Phase|Withdrawal by Subject|0
3024142|NCT00783692|10399555|P4|Induction Phase|Withdrawal by Subject|0
3024143|NCT00783692|10399556|P3|Induction Phase|Withdrawal by Subject|16
3024144|NCT00783692|10399557|P2|Induction Phase|Withdrawal by Subject|9
3024145|NCT00783692|10399558|P1|Induction Phase|Withdrawal by Subject|3
3024146|NCT00783692|10399552|P7|Induction Phase|Lack of Efficacy|0
3024147|NCT00783692|10399553|P6|Induction Phase|Lack of Efficacy|0
3024148|NCT00783692|10399554|P5|Induction Phase|Lack of Efficacy|0
3024149|NCT00783692|10399555|P4|Induction Phase|Lack of Efficacy|0
3024150|NCT00783692|10399556|P3|Induction Phase|Lack of Efficacy|28
3024151|NCT00783692|10399557|P2|Induction Phase|Lack of Efficacy|3
3024152|NCT00783692|10399558|P1|Induction Phase|Lack of Efficacy|1
3024153|NCT00783692|10399552|P7|Induction Phase|Protocol Violation|0
3024154|NCT00783692|10399553|P6|Induction Phase|Protocol Violation|0
3024155|NCT00783692|10399554|P5|Induction Phase|Protocol Violation|0
3024156|NCT00783692|10399555|P4|Induction Phase|Protocol Violation|0
3024157|NCT00783692|10399556|P3|Induction Phase|Protocol Violation|1
3024158|NCT00783692|10399557|P2|Induction Phase|Protocol Violation|0
3024159|NCT00783692|10399558|P1|Induction Phase|Protocol Violation|0
3024160|NCT00783692|10399552|P7|Induction Phase|Adverse Event|0
3024161|NCT00783692|10399553|P6|Induction Phase|Adverse Event|0
3024162|NCT00783692|10399554|P5|Induction Phase|Adverse Event|0
3024163|NCT00783692|10399555|P4|Induction Phase|Adverse Event|0
3024164|NCT00783692|10399556|P3|Induction Phase|Adverse Event|24
3024165|NCT00783692|10399557|P2|Induction Phase|Adverse Event|9
3024166|NCT00783692|10399558|P1|Induction Phase|Adverse Event|7
3024167|NCT00783432|10399604|P2|Overall Study|Protocol Violation|9
3024168|NCT00783432|10399605|P1|Overall Study|Protocol Violation|6
3024169|NCT00783432|10399604|P2|Overall Study|subject moved|5
3024170|NCT00783432|10399605|P1|Overall Study|subject moved|3
3024171|NCT00783432|10399604|P2|Overall Study|Withdrawal by Subject|20
3024172|NCT00783432|10399605|P1|Overall Study|Withdrawal by Subject|23
3024173|NCT00783432|10399604|P2|Overall Study|Lost to Follow-up|6
3024174|NCT00783432|10399605|P1|Overall Study|Lost to Follow-up|11
3024175|NCT00783432|10399604|P2|Overall Study|Lack of Efficacy|21
3024176|NCT00783432|10399605|P1|Overall Study|Lack of Efficacy|20
3024177|NCT00783432|10399604|P2|Overall Study|Adverse Event|17
3024178|NCT00783432|10399605|P1|Overall Study|Adverse Event|22
3024179|NCT00783302|10399615|P1|Overall Study|Withdrawal by Subject|3
3024180|NCT00783302|10399615|P1|Overall Study|Physician Decision|1
3024181|NCT00783302|10399615|P1|Overall Study|Protocol Violation|3
3024182|NCT00783302|10399615|P1|Overall Study|Technical Problems|11
3024183|NCT00783302|10399615|P1|Overall Study|Lost to Follow-up|17
3024184|NCT00783289|10399637|P4|Overall Study|Protocol Violation|0
3024185|NCT00783289|10399638|P3|Overall Study|Protocol Violation|0
3024186|NCT00783289|10399639|P2|Overall Study|Protocol Violation|1
3024187|NCT00783289|10399640|P1|Overall Study|Protocol Violation|0
3024188|NCT00783263|10399670|P4|Overall Study|Withdrawal by Subject|2
3024189|NCT00783263|10399671|P3|Overall Study|Withdrawal by Subject|1
3024190|NCT00783263|10399672|P2|Overall Study|Withdrawal by Subject|1
3024191|NCT00783263|10399673|P1|Overall Study|Withdrawal by Subject|0
3024192|NCT00783263|10399670|P4|Overall Study|Lost to Follow-up|0
3024193|NCT00783263|10399671|P3|Overall Study|Lost to Follow-up|0
3024194|NCT00783263|10399672|P2|Overall Study|Lost to Follow-up|1
3024195|NCT00783263|10399673|P1|Overall Study|Lost to Follow-up|1
3024196|NCT00783263|10399670|P4|Overall Study|Adverse Event|1
3024197|NCT00783263|10399671|P3|Overall Study|Adverse Event|2
3024198|NCT00783263|10399672|P2|Overall Study|Adverse Event|0
3024199|NCT00783263|10399673|P1|Overall Study|Adverse Event|3
3024200|NCT00783224|10399703|P4|Overall Study|Inappropriate as a study subject|1
3024201|NCT00783224|10399704|P3|Overall Study|Inappropriate as a study subject|0
3024202|NCT00783224|10399705|P2|Overall Study|Inappropriate as a study subject|0
3024203|NCT00783224|10399706|P1|Overall Study|Inappropriate as a study subject|0
3024204|NCT00783224|10399703|P4|Overall Study|Discarded the Investigational Drug Used|1
3024205|NCT00783224|10399704|P3|Overall Study|Discarded the Investigational Drug Used|0
3024206|NCT00783224|10399705|P2|Overall Study|Discarded the Investigational Drug Used|0
3024207|NCT00783224|10399706|P1|Overall Study|Discarded the Investigational Drug Used|0
3024208|NCT00783224|10399703|P4|Overall Study|Adverse Event|0
3024209|NCT00783224|10399704|P3|Overall Study|Adverse Event|1
3024210|NCT00783224|10399705|P2|Overall Study|Adverse Event|0
3024211|NCT00783224|10399706|P1|Overall Study|Adverse Event|0
3024212|NCT00783198|10399718|P3|Overall Study|Administrative|2
3024213|NCT00783198|10399719|P2|Overall Study|Administrative|1
3024214|NCT00783198|10399720|P1|Overall Study|Administrative|2
3024215|NCT00783198|10399718|P3|Overall Study|Did not meet protocol eligibility|0
3024216|NCT00783198|10399719|P2|Overall Study|Did not meet protocol eligibility|1
3024217|NCT00783198|10399720|P1|Overall Study|Did not meet protocol eligibility|0
3024218|NCT00783198|10399718|P3|Overall Study|Noncompliance with protocol|10
3024219|NCT00783198|10399719|P2|Overall Study|Noncompliance with protocol|7
3024220|NCT00783198|10399720|P1|Overall Study|Noncompliance with protocol|7
3024221|NCT00783198|10399718|P3|Overall Study|Withdrawal by Subject|20
3024222|NCT00783198|10399719|P2|Overall Study|Withdrawal by Subject|14
3024223|NCT00783198|10399720|P1|Overall Study|Withdrawal by Subject|22
3024224|NCT00783198|10399718|P3|Overall Study|Lost to Follow-up|7
3024225|NCT00783198|10399719|P2|Overall Study|Lost to Follow-up|1
3024226|NCT00783198|10399720|P1|Overall Study|Lost to Follow-up|11
3024227|NCT00783198|10399718|P3|Overall Study|Adverse Event|3
3024228|NCT00783198|10399719|P2|Overall Study|Adverse Event|19
3024229|NCT00783198|10399720|P1|Overall Study|Adverse Event|15
3024230|NCT00783094|10399743|P3|Open-Label Extension Period|Lack of Efficacy|0
3024231|NCT00783094|10399744|P2|Open-Label Extension Period|Lack of Efficacy|4
3024232|NCT00783094|10399745|P1|Open-Label Extension Period|Lack of Efficacy|1
3024233|NCT00783094|10399743|P3|Open-Label Extension Period|Physician Decision|3
3024234|NCT00783094|10399744|P2|Open-Label Extension Period|Physician Decision|2
3024235|NCT00783094|10399745|P1|Open-Label Extension Period|Physician Decision|4
3024236|NCT00783094|10399743|P3|Open-Label Extension Period|Withdrawal by Subject|3
3024237|NCT00783094|10399744|P2|Open-Label Extension Period|Withdrawal by Subject|1
3024238|NCT00783094|10399745|P1|Open-Label Extension Period|Withdrawal by Subject|1
3024239|NCT00783094|10399743|P3|Open-Label Extension Period|Protocol Violation|7
3024240|NCT00783094|10399744|P2|Open-Label Extension Period|Protocol Violation|5
3024241|NCT00783094|10399745|P1|Open-Label Extension Period|Protocol Violation|4
3024242|NCT00783094|10399743|P3|Open-Label Extension Period|Death|1
3024243|NCT00783094|10399744|P2|Open-Label Extension Period|Death|0
3024244|NCT00783094|10399745|P1|Open-Label Extension Period|Death|0
3024245|NCT00783094|10399743|P3|Open-Label Extension Period|Adverse Event|16
3024246|NCT00783094|10399744|P2|Open-Label Extension Period|Adverse Event|7
3024247|NCT00783094|10399745|P1|Open-Label Extension Period|Adverse Event|12
3024248|NCT00783094|10399743|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
3024249|NCT00783094|10399744|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
3024250|NCT00783094|10399745|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
3024251|NCT00783094|10399743|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
3024252|NCT00783094|10399744|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
3024253|NCT00783094|10399745|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
3024254|NCT00783094|10399743|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
3024255|NCT00783094|10399744|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
3024256|NCT00783094|10399745|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
3024257|NCT00783094|10399743|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
3024258|NCT00783094|10399744|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
3024259|NCT00783094|10399745|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
3024260|NCT00783094|10399743|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
3024261|NCT00783094|10399744|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
3024262|NCT00783094|10399745|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
3024263|NCT00782834|10399821|P1|Treatment Phase|fibrous tumor not GIST|1
3024264|NCT00782795|10399861|P2|Overall Study|Withdrawal by Subject|2
3024265|NCT00782795|10399862|P1|Overall Study|Withdrawal by Subject|1
3024266|NCT00782717|10399902|P2|Overall Study|Exited in error|2
3024267|NCT00782717|10399903|P1|Overall Study|Exited in error|0
3024268|NCT00782717|10399902|P2|Overall Study|Did not meet entrance criteria|3
3024269|NCT00782717|10399903|P1|Overall Study|Did not meet entrance criteria|1
3024270|NCT00782717|10399902|P2|Overall Study|Enrollment close prior to surgery|0
3024271|NCT00782717|10399903|P1|Overall Study|Enrollment close prior to surgery|1
3024272|NCT00782717|10399902|P2|Overall Study|Treatment failure|14
3024273|NCT00782717|10399903|P1|Overall Study|Treatment failure|3
3024274|NCT00782717|10399902|P2|Overall Study|Noncompliance|1
3024275|NCT00782717|10399903|P1|Overall Study|Noncompliance|2
3024276|NCT00782717|10399902|P2|Overall Study|Patient decision unrelated to AE|3
3024277|NCT00782717|10399903|P1|Overall Study|Patient decision unrelated to AE|6
3024278|NCT00782717|10399902|P2|Overall Study|Adverse Event|5
3024279|NCT00782717|10399903|P1|Overall Study|Adverse Event|2
3024280|NCT00782626|10399930|P1|Overall Study|Other Complicating Disease|1
3024281|NCT00782626|10399930|P1|Overall Study|Progressive Disease|5
3024282|NCT00782626|10399930|P1|Overall Study|Adverse Event|1
3024283|NCT00782509|10399937|P3|Overall Study|Lack of Efficacy|2
3024284|NCT00782509|10399938|P2|Overall Study|Lack of Efficacy|5
3024285|NCT00782509|10399939|P1|Overall Study|Lack of Efficacy|10
3024286|NCT00782509|10399937|P3|Overall Study|Other reasons not stated above|3
3024287|NCT00782509|10399938|P2|Overall Study|Other reasons not stated above|2
3024288|NCT00782509|10399939|P1|Overall Study|Other reasons not stated above|5
3024289|NCT00782509|10399937|P3|Overall Study|Non compliance with protocol|0
3024290|NCT00782509|10399938|P2|Overall Study|Non compliance with protocol|0
3024291|NCT00782509|10399939|P1|Overall Study|Non compliance with protocol|2
3024292|NCT00782509|10399937|P3|Overall Study|Withdrawal by Subject|8
3024293|NCT00782509|10399938|P2|Overall Study|Withdrawal by Subject|5
3024294|NCT00782509|10399939|P1|Overall Study|Withdrawal by Subject|3
3024295|NCT00782509|10399937|P3|Overall Study|Lost to Follow-up|3
3024296|NCT00782509|10399938|P2|Overall Study|Lost to Follow-up|2
3024297|NCT00782509|10399939|P1|Overall Study|Lost to Follow-up|1
3024298|NCT00782509|10399937|P3|Overall Study|Adverse Event|20
3024299|NCT00782509|10399938|P2|Overall Study|Adverse Event|10
3024300|NCT00782509|10399939|P1|Overall Study|Adverse Event|20
3024301|NCT00782496|10400132|P2|Overall Study|Lost to Follow-up|15
3024302|NCT00782496|10400133|P1|Overall Study|Lost to Follow-up|14
3024303|NCT00782483|10400140|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
3024304|NCT00782418|10400144|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
3024305|NCT00782418|10400145|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
3024306|NCT00782418|10400146|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
3024307|NCT00782418|10400147|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
3024308|NCT00782418|10400148|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
3024309|NCT00782418|10400149|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
3024310|NCT00782418|10400150|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
3024311|NCT00782418|10400144|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024312|NCT00782418|10400145|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024313|NCT00782418|10400146|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024314|NCT00782418|10400147|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024315|NCT00782418|10400148|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024316|NCT00782418|10400149|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
3024317|NCT00782418|10400150|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
3024318|NCT00782340|10400187|P3|Open Label Titration|Randomized in error|0
3024319|NCT00782340|10400188|P2|Open Label Titration|Randomized in error|0
3024320|NCT00782340|10400189|P1|Open Label Titration|Randomized in error|6
3024321|NCT00782340|10400187|P3|Open Label Titration|Lost to Follow-up|0
3024322|NCT00782340|10400188|P2|Open Label Titration|Lost to Follow-up|0
3024323|NCT00782340|10400189|P1|Open Label Titration|Lost to Follow-up|5
3024324|NCT00782340|10400187|P3|Open Label Titration|Did not meet responder criteria|0
3024325|NCT00782340|10400188|P2|Open Label Titration|Did not meet responder criteria|0
3024326|NCT00782340|10400189|P1|Open Label Titration|Did not meet responder criteria|2
3024327|NCT00782340|10400187|P3|Open Label Titration|Enrollment capped|0
3024328|NCT00782340|10400188|P2|Open Label Titration|Enrollment capped|0
3024329|NCT00782340|10400189|P1|Open Label Titration|Enrollment capped|16
3024330|NCT00782340|10400187|P3|Open Label Titration|Withdrawal by Subject|0
3024331|NCT00782340|10400188|P2|Open Label Titration|Withdrawal by Subject|0
3024332|NCT00782340|10400189|P1|Open Label Titration|Withdrawal by Subject|5
3024333|NCT00782340|10400187|P3|Open Label Titration|Protocol Violation|0
3024334|NCT00782340|10400188|P2|Open Label Titration|Protocol Violation|0
3024335|NCT00782340|10400189|P1|Open Label Titration|Protocol Violation|5
3024336|NCT00782340|10400187|P3|Open Label Titration|Treatment failure|0
3024337|NCT00782340|10400188|P2|Open Label Titration|Treatment failure|0
3024338|NCT00782340|10400189|P1|Open Label Titration|Treatment failure|50
3024339|NCT00782340|10400187|P3|Open Label Titration|Adverse Event|0
3024340|NCT00782340|10400188|P2|Open Label Titration|Adverse Event|0
3024341|NCT00782340|10400189|P1|Open Label Titration|Adverse Event|12
3024342|NCT00782275|10400259|P1|Overall Study|Other|3
3024343|NCT00782275|10400259|P1|Overall Study|Not started treatment|1
3024344|NCT00782275|10400259|P1|Overall Study|Physician Decision|4
3024345|NCT00782275|10400259|P1|Overall Study|Progressive Disease|21
3024346|NCT00782275|10400259|P1|Overall Study|Withdrawal by Subject|1
3024347|NCT00782275|10400259|P1|Overall Study|Adverse Event|11
3024348|NCT00782210|10400268|P3|Overall Study|Other reason not described above|3
3024349|NCT00782210|10400269|P2|Overall Study|Other reason not described above|2
3024350|NCT00782210|10400270|P1|Overall Study|Other reason not described above|3
3024351|NCT00782210|10400268|P3|Overall Study|Lack of Efficacy|1
3024352|NCT00782210|10400269|P2|Overall Study|Lack of Efficacy|4
3024353|NCT00782210|10400270|P1|Overall Study|Lack of Efficacy|13
3024354|NCT00782210|10400268|P3|Overall Study|Non compliance with protocol|2
3024355|NCT00782210|10400269|P2|Overall Study|Non compliance with protocol|3
3024356|NCT00782210|10400270|P1|Overall Study|Non compliance with protocol|0
3024357|NCT00782210|10400268|P3|Overall Study|Withdrawal by Subject|11
3024358|NCT00782210|10400269|P2|Overall Study|Withdrawal by Subject|8
3024359|NCT00782210|10400270|P1|Overall Study|Withdrawal by Subject|11
3024360|NCT00782210|10400268|P3|Overall Study|Lost to Follow-up|2
3024361|NCT00782210|10400269|P2|Overall Study|Lost to Follow-up|1
3024362|NCT00782210|10400270|P1|Overall Study|Lost to Follow-up|2
3024363|NCT00782210|10400268|P3|Overall Study|Adverse Event|16
3024364|NCT00782210|10400269|P2|Overall Study|Adverse Event|17
3024365|NCT00782210|10400270|P1|Overall Study|Adverse Event|21
3024366|NCT00782184|10400463|P2|Overall Study|Withdrawal by Subject|2
3024367|NCT00782184|10400464|P1|Overall Study|Withdrawal by Subject|3
3024368|NCT00782184|10400463|P2|Overall Study|Protocol Violation|1
3024369|NCT00782184|10400464|P1|Overall Study|Protocol Violation|0
3024370|NCT00782184|10400463|P2|Overall Study|Adverse Event|2
3024371|NCT00782184|10400464|P1|Overall Study|Adverse Event|1
3024372|NCT00782171|10400501|P2|Overall Study|not eligible|6
3024373|NCT00782171|10400502|P1|Overall Study|not eligible|8
3024374|NCT00782171|10400501|P2|Overall Study|others|9
3024375|NCT00782171|10400502|P1|Overall Study|others|7
3024376|NCT00782171|10400501|P2|Overall Study|complications|1
3024377|NCT00782171|10400502|P1|Overall Study|complications|3
3024378|NCT00782171|10400501|P2|Overall Study|Withdrawal by Subject|1
3024379|NCT00782171|10400502|P1|Overall Study|Withdrawal by Subject|2
3024380|NCT00782171|10400501|P2|Overall Study|Lost to Follow-up|2
3024381|NCT00782171|10400502|P1|Overall Study|Lost to Follow-up|2
3024382|NCT00782067|10400534|P1|Overall Study|Protocol deviation|2
3024383|NCT00782067|10400534|P1|Overall Study|Disease progression|43
3024384|NCT00782067|10400534|P1|Overall Study|Death|9
3024385|NCT00782067|10400534|P1|Overall Study|Administrative problems|14
3024386|NCT00782067|10400534|P1|Overall Study|Lost to Follow-up|2
3024387|NCT00782067|10400534|P1|Overall Study|Subject withdrew consent|11
3024388|NCT00782067|10400534|P1|Overall Study|Adverse Event|35
3024389|NCT00781963|10400546|P2|Overall Study|Refused follow-up|0
3024390|NCT00781963|10400547|P1|Overall Study|Refused follow-up|9
3024391|NCT00781963|10400546|P2|Overall Study|Withdrawal by Subject|1
3024392|NCT00781963|10400547|P1|Overall Study|Withdrawal by Subject|3
3024393|NCT00781963|10400546|P2|Overall Study|Lost to Follow-up|1
3024394|NCT00781963|10400547|P1|Overall Study|Lost to Follow-up|2
3024395|NCT00781963|10400546|P2|Overall Study|Death|0
3024396|NCT00781963|10400547|P1|Overall Study|Death|3
3024397|NCT00781937|10400576|P2|Follow up Period (Week 56-68)|Unclassified|4
3024398|NCT00781937|10400577|P1|Follow up Period (Week 56-68)|Unclassified|5
3024399|NCT00781937|10400576|P2|Follow up Period (Week 56-68)|Protocol Violation|1
3024400|NCT00781937|10400577|P1|Follow up Period (Week 56-68)|Protocol Violation|1
3024401|NCT00781937|10400576|P2|Main Trial Period Through Week 56|Unclassified|15
3024402|NCT00781937|10400577|P1|Main Trial Period Through Week 56|Unclassified|10
3024403|NCT00781937|10400576|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
3024404|NCT00781937|10400577|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
3024405|NCT00781937|10400576|P2|Main Trial Period Through Week 56|Protocol Violation|5
3024406|NCT00781937|10400577|P1|Main Trial Period Through Week 56|Protocol Violation|8
3024407|NCT00781937|10400576|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
3024408|NCT00781937|10400577|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
3024409|NCT00781937|10400576|P2|Main Trial Period Through Week 56|Adverse Event|18
3024410|NCT00781937|10400577|P1|Main Trial Period Through Week 56|Adverse Event|18
3024411|NCT00781911|10400635|P2|Overall Study|Sponsor Decision|0
3024412|NCT00781911|10400636|P1|Overall Study|Sponsor Decision|1
3024413|NCT00781911|10400635|P2|Overall Study|Physician Decision|2
3024414|NCT00781911|10400636|P1|Overall Study|Physician Decision|0
3024415|NCT00781911|10400635|P2|Overall Study|Withdrawal by Subject|2
3024416|NCT00781911|10400636|P1|Overall Study|Withdrawal by Subject|1
3024417|NCT00781911|10400635|P2|Overall Study|Adverse Event|4
3024418|NCT00781911|10400636|P1|Overall Study|Adverse Event|4
3024419|NCT00781859|10400673|P2|Overall Study|Death|0
3024420|NCT00781859|10400674|P1|Overall Study|Death|3
3024421|NCT00781859|10400673|P2|Overall Study|Lost to Follow-up|3
3024422|NCT00781859|10400674|P1|Overall Study|Lost to Follow-up|6
3024423|NCT00781859|10400673|P2|Overall Study|Withdrawal by Subject|4
3024424|NCT00781859|10400674|P1|Overall Study|Withdrawal by Subject|8
3024425|NCT00781859|10400673|P2|Overall Study|Adverse Event|2
3024426|NCT00781859|10400674|P1|Overall Study|Adverse Event|2
3024427|NCT00781768|10400684|P2|Overall Study|Not transplanted.|2
3024428|NCT00781768|10400685|P1|Overall Study|Not transplanted.|0
3024429|NCT00781599|10400693|P2|Overall Study|Lost to Follow-up|4
3024430|NCT00781599|10400694|P1|Overall Study|Lost to Follow-up|7
3024431|NCT00781456|10400719|P2|Overall Study|Other Reason, Unknown|1
3024432|NCT00781456|10400720|P1|Overall Study|Other Reason, Unknown|0
3024433|NCT00781456|10400719|P2|Overall Study|Lost to Follow-up|5
3024434|NCT00781456|10400720|P1|Overall Study|Lost to Follow-up|10
3024435|NCT00781456|10400719|P2|Overall Study|Noncompliance With Protocol|1
3024436|NCT00781456|10400720|P1|Overall Study|Noncompliance With Protocol|1
3024437|NCT00781456|10400719|P2|Overall Study|Protocol Violation|1
3024438|NCT00781456|10400720|P1|Overall Study|Protocol Violation|4
3024439|NCT00781456|10400719|P2|Overall Study|Withdrawal by Subject|5
3024440|NCT00781456|10400720|P1|Overall Study|Withdrawal by Subject|3
3024441|NCT00781456|10400719|P2|Overall Study|Adverse Event|3
3024442|NCT00781456|10400720|P1|Overall Study|Adverse Event|3
3024443|NCT00781391|10400743|P3|Overall Study|Lost to Follow-up|1
3024444|NCT00781391|10400744|P2|Overall Study|Lost to Follow-up|0
3024445|NCT00781391|10400745|P1|Overall Study|Lost to Follow-up|0
3024446|NCT00781391|10400743|P3|Overall Study|Withdrawal by Subject|25
3024447|NCT00781391|10400744|P2|Overall Study|Withdrawal by Subject|37
3024448|NCT00781391|10400745|P1|Overall Study|Withdrawal by Subject|47
3024449|NCT00781391|10400743|P3|Overall Study|Death|706
3024450|NCT00781391|10400744|P2|Overall Study|Death|730
3024451|NCT00781391|10400745|P1|Overall Study|Death|789
3024452|NCT00781391|10400743|P3|Overall Study|Protocol Violation|20
3024453|NCT00781391|10400744|P2|Overall Study|Protocol Violation|17
3024454|NCT00781391|10400745|P1|Overall Study|Protocol Violation|19
3024455|NCT00781391|10400743|P3|Overall Study|never received study drug|32
3024456|NCT00781391|10400744|P2|Overall Study|never received study drug|23
3024457|NCT00781391|10400745|P1|Overall Study|never received study drug|24
3024458|NCT00781365|10400779|P2|Overall Study|Language barrier|0
3024459|NCT00781365|10400780|P1|Overall Study|Language barrier|1
3024460|NCT00781365|10400779|P2|Overall Study|Did Not Attend Visit|28
3024461|NCT00781365|10400780|P1|Overall Study|Did Not Attend Visit|20
3024462|NCT00781365|10400779|P2|Overall Study|Withdrawal by Subject|8
3024463|NCT00781365|10400780|P1|Overall Study|Withdrawal by Subject|13
3024464|NCT00781326|10400790|P1|Phase I|Physician Decision|2
3024465|NCT00781326|10400790|P1|Phase I|Withdrawal by Subject|1
3024466|NCT00781326|10400790|P1|Phase I|Adverse Event|1
3024467|NCT00781274|10400794|P1|Overall Study|Withdrawal by Subject|2
3024468|NCT00780910|10400826|P1|Overall Study|Adverse Event|2
3024469|NCT00780559|10400888|P2|Overall Study|Death|0
3024470|NCT00780559|10400889|P1|Overall Study|Death|1
3024471|NCT00780559|10400888|P2|Overall Study|Lost to Follow-up|7
3024472|NCT00780559|10400889|P1|Overall Study|Lost to Follow-up|2
3024473|NCT00780416|10400957|P2|Overall Study|Withdrawal by Subject|6
3024474|NCT00780416|10400958|P1|Overall Study|Withdrawal by Subject|8
3024475|NCT00780416|10400957|P2|Overall Study|Protocol Violation|0
3024476|NCT00780416|10400958|P1|Overall Study|Protocol Violation|1
3024477|NCT00780416|10400957|P2|Overall Study|Physician Decision|3
3024478|NCT00780416|10400958|P1|Overall Study|Physician Decision|3
3024479|NCT00780273|10401003|P1|Overall Study|Lost to Follow-up|1
3024480|NCT00780273|10401003|P1|Overall Study|Death|1
3024481|NCT00780143|10401026|P1|Overall Study|Adverse Event|1
3024482|NCT00780143|10401026|P1|Overall Study|Toxicity|1
3024483|NCT00780143|10401026|P1|Overall Study|Progressive disease|1
3024484|NCT00779909|10401057|P4|Overall Study|Withdrawal by Subject|0
3024485|NCT00779909|10401058|P3|Overall Study|Withdrawal by Subject|0
3024486|NCT00779909|10401059|P2|Overall Study|Withdrawal by Subject|1
3024487|NCT00779909|10401060|P1|Overall Study|Withdrawal by Subject|0
3024488|NCT00779909|10401057|P4|Overall Study|Lost to Follow-up|1
3024489|NCT00779909|10401058|P3|Overall Study|Lost to Follow-up|0
3024490|NCT00779909|10401059|P2|Overall Study|Lost to Follow-up|0
3024491|NCT00779909|10401060|P1|Overall Study|Lost to Follow-up|1
3024492|NCT00779857|10401124|P1|Overall Study|Missed Visit|2
3024493|NCT00779857|10401124|P1|Overall Study|Withdrawal by Subject|3
3024494|NCT00779857|10401124|P1|Overall Study|Death|1
3024495|NCT00779779|10401129|P1|Overall Study|Lost to Follow-up|5
3024496|NCT00779779|10401129|P1|Overall Study|Withdrawal by Subject|4
3024497|NCT00779779|10401129|P1|Overall Study|Protocol Violation|14
3024498|NCT00779779|10401129|P1|Overall Study|Adverse Event|1
3024499|NCT00779766|10401138|P2|Month 72|Other|1
3024500|NCT00779766|10401139|P1|Month 72|Other|0
3024501|NCT00779766|10401138|P2|Month 72|Lost to Follow-up|8
3024502|NCT00779766|10401139|P1|Month 72|Lost to Follow-up|6
3024503|NCT00779766|10401138|P2|Month 72|Migrated/moved from study area|109
3024504|NCT00779766|10401139|P1|Month 72|Migrated/moved from study area|124
3024505|NCT00779766|10401138|P2|Month 72|Withdrawal by Subject|71
3024506|NCT00779766|10401139|P1|Month 72|Withdrawal by Subject|55
3024507|NCT00779766|10401138|P2|Month 48|Other|0
3024508|NCT00779766|10401139|P1|Month 48|Other|1
3024509|NCT00779766|10401138|P2|Month 48|Lost to Follow-up|30
3024510|NCT00779766|10401139|P1|Month 48|Lost to Follow-up|29
3024511|NCT00779766|10401138|P2|Month 48|Migrated/moved from study area|75
3024512|NCT00779766|10401139|P1|Month 48|Migrated/moved from study area|76
3024513|NCT00779766|10401138|P2|Month 48|Withdrawal by Subject|63
3024514|NCT00779766|10401139|P1|Month 48|Withdrawal by Subject|68
3024515|NCT00779766|10401138|P2|Month 24|Other|27
3024516|NCT00779766|10401139|P1|Month 24|Other|18
3024517|NCT00779766|10401138|P2|Month 24|Lost to Follow-up|9
3024518|NCT00779766|10401139|P1|Month 24|Lost to Follow-up|9
3024519|NCT00779766|10401138|P2|Month 24|Migrated/moved from study area|162
3024520|NCT00779766|10401139|P1|Month 24|Migrated/moved from study area|138
3024521|NCT00779766|10401138|P2|Month 24|Withdrawal by Subject|127
3024522|NCT00779766|10401139|P1|Month 24|Withdrawal by Subject|159
3024523|NCT00779766|10401138|P2|Month 24|Protocol Violation|1
3024524|NCT00779766|10401139|P1|Month 24|Protocol Violation|3
3024525|NCT00779766|10401138|P2|Month 24|Adverse Event|3
3024526|NCT00779766|10401139|P1|Month 24|Adverse Event|3
3024527|NCT00779766|10401138|P2|Month 24|Serious Adverse Event|3
3024528|NCT00779766|10401139|P1|Month 24|Serious Adverse Event|2
3024529|NCT00779675|10401227|P1|Extended Treatment Period|Lost to Follow-up|6
3024530|NCT00779675|10401227|P1|Extended Treatment Period|Protocol defined clinical event|1
3024531|NCT00779675|10401227|P1|Extended Treatment Period|Treatment Failure|11
3024532|NCT00779675|10401227|P1|Extended Treatment Period|Adverse Event|6
3024533|NCT00779675|10401227|P1|Extended Treatment Period|Protocol Violation|13
3024534|NCT00779675|10401227|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
3024535|NCT00779675|10401227|P1|Treatment Period|Administrative|3
3024536|NCT00779675|10401227|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
3024537|NCT00779675|10401227|P1|Treatment Period|Protocol Violation|54
3024538|NCT00779675|10401227|P1|Treatment Period|Withdrawal by Subject|46
3024539|NCT00779675|10401227|P1|Treatment Period|Lost to Follow-up|23
3024540|NCT00779675|10401227|P1|Treatment Period|Transferred to Another Study|38
3024541|NCT00779675|10401227|P1|Treatment Period|Treatment Failure|80
3024542|NCT00779675|10401227|P1|Treatment Period|Adverse Event|87
3024543|NCT00779584|10401255|P9|Overall Study|Ongoing in Study|0
3024544|NCT00779584|10401256|P8|Overall Study|Ongoing in Study|0
3024545|NCT00779584|10401257|P7|Overall Study|Ongoing in Study|0
3024546|NCT00779584|10401258|P6|Overall Study|Ongoing in Study|1
3024547|NCT00779584|10401259|P5|Overall Study|Ongoing in Study|1
3024548|NCT00779584|10401260|P4|Overall Study|Ongoing in Study|0
3024549|NCT00779584|10401261|P3|Overall Study|Ongoing in Study|0
3024550|NCT00779584|10401262|P2|Overall Study|Ongoing in Study|0
3024551|NCT00779584|10401263|P1|Overall Study|Ongoing in Study|0
3024552|NCT00779584|10401255|P9|Overall Study|Symptomatic Deterioration|0
3024553|NCT00779584|10401256|P8|Overall Study|Symptomatic Deterioration|0
3024554|NCT00779584|10401257|P7|Overall Study|Symptomatic Deterioration|1
3024555|NCT00779584|10401258|P6|Overall Study|Symptomatic Deterioration|1
3024556|NCT00779584|10401259|P5|Overall Study|Symptomatic Deterioration|0
3024557|NCT00779584|10401260|P4|Overall Study|Symptomatic Deterioration|0
3024558|NCT00779584|10401261|P3|Overall Study|Symptomatic Deterioration|1
3024559|NCT00779584|10401262|P2|Overall Study|Symptomatic Deterioration|1
3024560|NCT00779584|10401263|P1|Overall Study|Symptomatic Deterioration|1
3024561|NCT00779584|10401255|P9|Overall Study|Adverse Event|1
3024562|NCT00779584|10401256|P8|Overall Study|Adverse Event|1
3024563|NCT00779584|10401257|P7|Overall Study|Adverse Event|2
3024564|NCT00779584|10401258|P6|Overall Study|Adverse Event|0
3024565|NCT00779584|10401259|P5|Overall Study|Adverse Event|0
3024566|NCT00779584|10401260|P4|Overall Study|Adverse Event|0
3024567|NCT00779584|10401261|P3|Overall Study|Adverse Event|2
3024568|NCT00779584|10401262|P2|Overall Study|Adverse Event|0
3024569|NCT00779584|10401263|P1|Overall Study|Adverse Event|1
3024570|NCT00779584|10401255|P9|Overall Study|Progression of Disease|1
3024571|NCT00779584|10401256|P8|Overall Study|Progression of Disease|2
3024572|NCT00779584|10401257|P7|Overall Study|Progression of Disease|4
3024573|NCT00779584|10401258|P6|Overall Study|Progression of Disease|1
3024574|NCT00779584|10401259|P5|Overall Study|Progression of Disease|5
3024575|NCT00779584|10401260|P4|Overall Study|Progression of Disease|6
3024576|NCT00779584|10401261|P3|Overall Study|Progression of Disease|2
3024577|NCT00779584|10401262|P2|Overall Study|Progression of Disease|1
3024578|NCT00779584|10401263|P1|Overall Study|Progression of Disease|0
3024579|NCT00779584|10401255|P9|Overall Study|Lost to Follow-up|0
3024580|NCT00779584|10401256|P8|Overall Study|Lost to Follow-up|0
3024581|NCT00779584|10401257|P7|Overall Study|Lost to Follow-up|0
3024582|NCT00779584|10401258|P6|Overall Study|Lost to Follow-up|0
3024583|NCT00779584|10401259|P5|Overall Study|Lost to Follow-up|1
3024584|NCT00779584|10401260|P4|Overall Study|Lost to Follow-up|0
3024585|NCT00779584|10401261|P3|Overall Study|Lost to Follow-up|0
3024586|NCT00779584|10401262|P2|Overall Study|Lost to Follow-up|0
3024587|NCT00779584|10401263|P1|Overall Study|Lost to Follow-up|0
3024588|NCT00779584|10401255|P9|Overall Study|Withdrawal by Subject|0
3024589|NCT00779584|10401256|P8|Overall Study|Withdrawal by Subject|0
3024590|NCT00779584|10401257|P7|Overall Study|Withdrawal by Subject|1
3024591|NCT00779584|10401258|P6|Overall Study|Withdrawal by Subject|2
3024592|NCT00779584|10401259|P5|Overall Study|Withdrawal by Subject|0
3024593|NCT00779584|10401260|P4|Overall Study|Withdrawal by Subject|0
3024594|NCT00779584|10401261|P3|Overall Study|Withdrawal by Subject|2
3024595|NCT00779584|10401262|P2|Overall Study|Withdrawal by Subject|1
3024596|NCT00779584|10401263|P1|Overall Study|Withdrawal by Subject|1
3024597|NCT00779584|10401255|P9|Overall Study|Protocol Violation|0
3024598|NCT00779584|10401256|P8|Overall Study|Protocol Violation|0
3024599|NCT00779584|10401257|P7|Overall Study|Protocol Violation|0
3024600|NCT00779584|10401258|P6|Overall Study|Protocol Violation|1
3024601|NCT00779584|10401259|P5|Overall Study|Protocol Violation|0
3024602|NCT00779584|10401260|P4|Overall Study|Protocol Violation|0
3024603|NCT00779584|10401261|P3|Overall Study|Protocol Violation|0
3024604|NCT00779584|10401262|P2|Overall Study|Protocol Violation|0
3024605|NCT00779584|10401263|P1|Overall Study|Protocol Violation|0
3024606|NCT00779506|10401354|P1|Overall Study|Lost to Follow-up|1
3024607|NCT00779506|10401354|P1|Overall Study|Withdrawal by Subject|6
3024608|NCT00779506|10401354|P1|Overall Study|Protocol Violation|5
3024609|NCT00779506|10401354|P1|Overall Study|Lack of Efficacy|11
3024610|NCT00779506|10401354|P1|Overall Study|Adverse Event|4
3024611|NCT00779506|10401354|P1|Overall Study|Screening Failed|2
3024612|NCT00779467|10401368|P4|Overall Study|unavailable research staff|1
3024613|NCT00779467|10401369|P3|Overall Study|unavailable research staff|0
3024614|NCT00779467|10401370|P2|Overall Study|unavailable research staff|0
3024615|NCT00779467|10401371|P1|Overall Study|unavailable research staff|0
3024616|NCT00779467|10401368|P4|Overall Study|technical issue|1
3024617|NCT00779467|10401369|P3|Overall Study|technical issue|2
3024618|NCT00779467|10401370|P2|Overall Study|technical issue|0
3024619|NCT00779467|10401371|P1|Overall Study|technical issue|0
3024620|NCT00779467|10401368|P4|Overall Study|missing data|4
3024621|NCT00779467|10401369|P3|Overall Study|missing data|1
3024622|NCT00779467|10401370|P2|Overall Study|missing data|0
3024623|NCT00779467|10401371|P1|Overall Study|missing data|1
3024624|NCT00779467|10401368|P4|Overall Study|failed inclusion criteria|2
3024625|NCT00779467|10401369|P3|Overall Study|failed inclusion criteria|1
3024626|NCT00779467|10401370|P2|Overall Study|failed inclusion criteria|3
3024627|NCT00779467|10401371|P1|Overall Study|failed inclusion criteria|3
3024628|NCT00779467|10401368|P4|Overall Study|Lack of Efficacy|11
3024629|NCT00779467|10401369|P3|Overall Study|Lack of Efficacy|6
3024630|NCT00779467|10401370|P2|Overall Study|Lack of Efficacy|2
3024631|NCT00779467|10401371|P1|Overall Study|Lack of Efficacy|11
3024632|NCT00779402|10401411|P2|Long-term Follow-up|Completed Protocol Visits|2
3024633|NCT00779402|10401412|P1|Long-term Follow-up|Completed Protocol Visits|6
3024634|NCT00779402|10401411|P2|Long-term Follow-up|Closure of Study|4
3024635|NCT00779402|10401412|P1|Long-term Follow-up|Closure of Study|8
3024636|NCT00779402|10401411|P2|Long-term Follow-up|Other|0
3024637|NCT00779402|10401412|P1|Long-term Follow-up|Other|5
3024638|NCT00779402|10401411|P2|Long-term Follow-up|Patient refused to continue|0
3024639|NCT00779402|10401412|P1|Long-term Follow-up|Patient refused to continue|2
3024640|NCT00779402|10401411|P2|Surveillance Phase|Completed Protocol Visits|2
3024641|NCT00779402|10401412|P1|Surveillance Phase|Completed Protocol Visits|3
3024642|NCT00779402|10401411|P2|Surveillance Phase|Closure of study|6
3024643|NCT00779402|10401412|P1|Surveillance Phase|Closure of study|5
3024644|NCT00779402|10401411|P2|Surveillance Phase|Withdrawal by Subject|1
3024645|NCT00779402|10401412|P1|Surveillance Phase|Withdrawal by Subject|4
3024646|NCT00779402|10401411|P2|Surveillance Phase|Other|5
3024647|NCT00779402|10401412|P1|Surveillance Phase|Other|5
3024648|NCT00779402|10401411|P2|Surveillance Phase|Intercurrent Illness|0
3024649|NCT00779402|10401412|P1|Surveillance Phase|Intercurrent Illness|2
3024650|NCT00779402|10401411|P2|Surveillance Phase|Death|1
3024651|NCT00779402|10401412|P1|Surveillance Phase|Death|0
3024652|NCT00779402|10401411|P2|Surveillance Phase|Lost to Follow-up|1
3024653|NCT00779402|10401412|P1|Surveillance Phase|Lost to Follow-up|2
3024654|NCT00779402|10401411|P2|Surveillance Phase|Patient refused to continue|14
3024655|NCT00779402|10401412|P1|Surveillance Phase|Patient refused to continue|22
3024656|NCT00779402|10401411|P2|Surveillance Phase|Protocol Violation|1
3024657|NCT00779402|10401412|P1|Surveillance Phase|Protocol Violation|0
3024658|NCT00779402|10401411|P2|Treatment Phase 1|Completed Protocol Visits|6
3024659|NCT00779402|10401412|P1|Treatment Phase 1|Completed Protocol Visits|3
3024660|NCT00779402|10401411|P2|Treatment Phase 1|Closure of Study|2
3024661|NCT00779402|10401412|P1|Treatment Phase 1|Closure of Study|3
3024662|NCT00779402|10401411|P2|Treatment Phase 1|Other|2
3024663|NCT00779402|10401412|P1|Treatment Phase 1|Other|4
3024664|NCT00779402|10401411|P2|Treatment Phase 1|Withdrawal by Subject|0
3024665|NCT00779402|10401412|P1|Treatment Phase 1|Withdrawal by Subject|1
3024666|NCT00779402|10401411|P2|Treatment Phase 1|Intercurrent Illness|1
3024667|NCT00779402|10401412|P1|Treatment Phase 1|Intercurrent Illness|1
3024668|NCT00779402|10401411|P2|Treatment Phase 1|Death|1
3024669|NCT00779402|10401412|P1|Treatment Phase 1|Death|0
3024670|NCT00779402|10401411|P2|Treatment Phase 1|Lost to Follow-up|1
3024671|NCT00779402|10401412|P1|Treatment Phase 1|Lost to Follow-up|0
3024672|NCT00779402|10401411|P2|Treatment Phase 1|Patient Refused to Continue|2
3024673|NCT00779402|10401412|P1|Treatment Phase 1|Patient Refused to Continue|17
3024674|NCT00779402|10401411|P2|Treatment Phase 1|Protocol Violation|0
3024675|NCT00779402|10401412|P1|Treatment Phase 1|Protocol Violation|1
3024676|NCT00779402|10401411|P2|Treatment Phase 1|Adverse Event|0
3024677|NCT00779402|10401412|P1|Treatment Phase 1|Adverse Event|2
3024678|NCT00779402|10401411|P2|Treatment Phase 1|Disease Progression|0
3024679|NCT00779402|10401412|P1|Treatment Phase 1|Disease Progression|1
3024680|NCT00779259|10401455|P1|Quinine Alone|Adverse Event|2
3024681|NCT00779246|10401476|P2|Overall Study|Missing sufficient data for analysis|53
3024682|NCT00779246|10401477|P1|Overall Study|Missing sufficient data for analysis|33
3024683|NCT00779142|10401496|P1|Overall Study|Screen Failures|3
3024684|NCT00779038|10401510|P1|Overall Study|Study Prematurely Terminated|13
3024685|NCT00779025|10401519|P1|Overall Study|Withdrawal by Subject|1
3024686|NCT00778999|10401530|P2|Overall Study|Did not receive recFSH|20
3024687|NCT00778999|10401531|P1|Overall Study|Did not receive recFSH|14
3024688|NCT00778999|10401530|P2|Overall Study|Discontinuation: no embryo transfer|14
3024689|NCT00778999|10401531|P1|Overall Study|Discontinuation: no embryo transfer|14
3024690|NCT00778921|10401540|P3|Overall Study|Not treated|2
3024691|NCT00778921|10401541|P2|Overall Study|Not treated|2
3024692|NCT00778921|10401542|P1|Overall Study|Not treated|0
3024693|NCT00778921|10401540|P3|Overall Study|Protocol Violation|2
3024694|NCT00778921|10401541|P2|Overall Study|Protocol Violation|0
3024695|NCT00778921|10401542|P1|Overall Study|Protocol Violation|3
3024696|NCT00778921|10401540|P3|Overall Study|Administrative Problems|0
3024697|NCT00778921|10401541|P2|Overall Study|Administrative Problems|2
3024698|NCT00778921|10401542|P1|Overall Study|Administrative Problems|1
3024699|NCT00778921|10401540|P3|Overall Study|Lost to Follow-up|1
3024700|NCT00778921|10401541|P2|Overall Study|Lost to Follow-up|2
3024701|NCT00778921|10401542|P1|Overall Study|Lost to Follow-up|0
3024702|NCT00778921|10401540|P3|Overall Study|Patient withdrew request|6
3024703|NCT00778921|10401541|P2|Overall Study|Patient withdrew request|1
3024704|NCT00778921|10401542|P1|Overall Study|Patient withdrew request|3
3024705|NCT00778921|10401540|P3|Overall Study|Patient No Longer Requires Study Drug|0
3024706|NCT00778921|10401541|P2|Overall Study|Patient No Longer Requires Study Drug|1
3024707|NCT00778921|10401542|P1|Overall Study|Patient No Longer Requires Study Drug|0
3024708|NCT00778921|10401540|P3|Overall Study|Unsatisfactory therapeutic response|1
3024709|NCT00778921|10401541|P2|Overall Study|Unsatisfactory therapeutic response|1
3024710|NCT00778921|10401542|P1|Overall Study|Unsatisfactory therapeutic response|1
3024711|NCT00778921|10401540|P3|Overall Study|Abnormal Test Procedure Result(s)|2
3024712|NCT00778921|10401541|P2|Overall Study|Abnormal Test Procedure Result(s)|0
3024713|NCT00778921|10401542|P1|Overall Study|Abnormal Test Procedure Result(s)|0
3024714|NCT00778921|10401540|P3|Overall Study|Abnormal Laboratory Value(s)|0
3024715|NCT00778921|10401541|P2|Overall Study|Abnormal Laboratory Value(s)|0
3024716|NCT00778921|10401542|P1|Overall Study|Abnormal Laboratory Value(s)|1
3024717|NCT00778921|10401540|P3|Overall Study|Adverse Event|14
3024718|NCT00778921|10401541|P2|Overall Study|Adverse Event|10
3024719|NCT00778921|10401542|P1|Overall Study|Adverse Event|9
3024720|NCT00778895|10401559|P3|ESFU Phase|Other|0
3024721|NCT00778895|10401560|P2|ESFU Phase|Other|0
3024722|NCT00778895|10401561|P1|ESFU Phase|Other|2
3024723|NCT00778895|10401559|P3|ESFU Phase|Lost to Follow-up|2
3024724|NCT00778895|10401560|P2|ESFU Phase|Lost to Follow-up|7
3024725|NCT00778895|10401561|P1|ESFU Phase|Lost to Follow-up|6
3024726|NCT00778895|10401559|P3|ESFU Phase|Withdrawal by Subject|0
3024727|NCT00778895|10401560|P2|ESFU Phase|Withdrawal by Subject|4
3024728|NCT00778895|10401561|P1|ESFU Phase|Withdrawal by Subject|1
3024729|NCT00778895|10401559|P3|ESFU Phase|Adverse Event|0
3024730|NCT00778895|10401560|P2|ESFU Phase|Adverse Event|1
3024731|NCT00778895|10401561|P1|ESFU Phase|Adverse Event|2
3024732|NCT00778895|10401559|P3|Active Phase|Other|0
3024733|NCT00778895|10401560|P2|Active Phase|Other|0
3024734|NCT00778895|10401561|P1|Active Phase|Other|2
3024735|NCT00778895|10401559|P3|Active Phase|Lost to Follow-up|0
3024736|NCT00778895|10401560|P2|Active Phase|Lost to Follow-up|1
3024737|NCT00778895|10401561|P1|Active Phase|Lost to Follow-up|1
3024738|NCT00778895|10401559|P3|Active Phase|Withdrawal by Subject|0
3024739|NCT00778895|10401560|P2|Active Phase|Withdrawal by Subject|4
3024740|NCT00778895|10401561|P1|Active Phase|Withdrawal by Subject|1
3024741|NCT00778895|10401559|P3|Active Phase|Adverse Event|0
3024742|NCT00778895|10401560|P2|Active Phase|Adverse Event|1
3024743|NCT00778895|10401561|P1|Active Phase|Adverse Event|3
3024744|NCT00778830|10401605|P2|Overall Study|Ongoing at data cut-off|1
3024745|NCT00778830|10401606|P1|Overall Study|Ongoing at data cut-off|0
3024746|NCT00778817|10401618|P1|Overall Study|Withdrawal by Subject|2
3024747|NCT00778817|10401618|P1|Overall Study|Adverse Event|2
3024748|NCT00778622|10401645|P3|Overall Study|Other|1
3024749|NCT00778622|10401646|P2|Overall Study|Other|0
3024750|NCT00778622|10401647|P1|Overall Study|Other|1
3024751|NCT00778622|10401645|P3|Overall Study|immigration|0
3024752|NCT00778622|10401646|P2|Overall Study|immigration|0
3024753|NCT00778622|10401647|P1|Overall Study|immigration|1
3024754|NCT00778622|10401645|P3|Overall Study|Lack of Efficacy|0
3024755|NCT00778622|10401646|P2|Overall Study|Lack of Efficacy|0
3024756|NCT00778622|10401647|P1|Overall Study|Lack of Efficacy|2
3024757|NCT00778622|10401645|P3|Overall Study|Protocol Violation|0
3024758|NCT00778622|10401646|P2|Overall Study|Protocol Violation|3
3024759|NCT00778622|10401647|P1|Overall Study|Protocol Violation|0
3024760|NCT00778622|10401645|P3|Overall Study|Lost to Follow-up|2
3024761|NCT00778622|10401646|P2|Overall Study|Lost to Follow-up|3
3024762|NCT00778622|10401647|P1|Overall Study|Lost to Follow-up|3
3024763|NCT00778622|10401645|P3|Overall Study|Withdrawal by Subject|5
3024764|NCT00778622|10401646|P2|Overall Study|Withdrawal by Subject|5
3024765|NCT00778622|10401647|P1|Overall Study|Withdrawal by Subject|4
3024766|NCT00778622|10401645|P3|Overall Study|Adverse Event|7
3024767|NCT00778622|10401646|P2|Overall Study|Adverse Event|4
3024768|NCT00778622|10401647|P1|Overall Study|Adverse Event|5
3024769|NCT00778375|10401700|P1|Overall Study|Ineligible|3
3024770|NCT00778336|10401714|P4|3 Month Follow Up|Death|0
3024771|NCT00778336|10401715|P3|3 Month Follow Up|Death|2
3024772|NCT00778336|10401716|P2|3 Month Follow Up|Death|3
3024773|NCT00778336|10401717|P1|3 Month Follow Up|Death|8
3024774|NCT00778336|10401714|P4|3 Month Follow Up|Lost to Follow-up|0
3024775|NCT00778336|10401715|P3|3 Month Follow Up|Lost to Follow-up|3
3024776|NCT00778336|10401716|P2|3 Month Follow Up|Lost to Follow-up|20
3024777|NCT00778336|10401717|P1|3 Month Follow Up|Lost to Follow-up|15
3024778|NCT00778336|10401714|P4|Index Procedure-Discharge|Death|0
3024779|NCT00778336|10401715|P3|Index Procedure-Discharge|Death|2
3024780|NCT00778336|10401716|P2|Index Procedure-Discharge|Death|3
3024781|NCT00778336|10401717|P1|Index Procedure-Discharge|Death|6
3024782|NCT00778258|10401755|P9|Overall Study|Other|0
3024783|NCT00778258|10401756|P8|Overall Study|Other|0
3024784|NCT00778258|10401757|P7|Overall Study|Other|1
3024785|NCT00778258|10401758|P6|Overall Study|Other|0
3024786|NCT00778258|10401759|P5|Overall Study|Other|0
3024787|NCT00778258|10401760|P4|Overall Study|Other|0
3024788|NCT00778258|10401761|P3|Overall Study|Other|0
3024789|NCT00778258|10401762|P2|Overall Study|Other|0
3024790|NCT00778258|10401763|P1|Overall Study|Other|0
3024791|NCT00778258|10401755|P9|Overall Study|Non-compliance|0
3024792|NCT00778258|10401756|P8|Overall Study|Non-compliance|0
3024793|NCT00778258|10401757|P7|Overall Study|Non-compliance|0
3024794|NCT00778258|10401758|P6|Overall Study|Non-compliance|0
3024795|NCT00778258|10401759|P5|Overall Study|Non-compliance|0
3024796|NCT00778258|10401760|P4|Overall Study|Non-compliance|1
3024797|NCT00778258|10401761|P3|Overall Study|Non-compliance|0
3024798|NCT00778258|10401762|P2|Overall Study|Non-compliance|0
3024799|NCT00778258|10401763|P1|Overall Study|Non-compliance|0
3024800|NCT00778258|10401755|P9|Overall Study|New Contraindication|0
3024801|NCT00778258|10401756|P8|Overall Study|New Contraindication|1
3024802|NCT00778258|10401757|P7|Overall Study|New Contraindication|0
3024803|NCT00778258|10401758|P6|Overall Study|New Contraindication|0
3024804|NCT00778258|10401759|P5|Overall Study|New Contraindication|0
3024805|NCT00778258|10401760|P4|Overall Study|New Contraindication|0
3024806|NCT00778258|10401761|P3|Overall Study|New Contraindication|0
3024807|NCT00778258|10401762|P2|Overall Study|New Contraindication|0
3024808|NCT00778258|10401763|P1|Overall Study|New Contraindication|0
3024809|NCT00778258|10401755|P9|Overall Study|Withdrawal by Subject|4
3024810|NCT00778258|10401756|P8|Overall Study|Withdrawal by Subject|12
3024811|NCT00778258|10401757|P7|Overall Study|Withdrawal by Subject|12
3024812|NCT00778258|10401758|P6|Overall Study|Withdrawal by Subject|6
3024813|NCT00778258|10401759|P5|Overall Study|Withdrawal by Subject|0
3024814|NCT00778258|10401760|P4|Overall Study|Withdrawal by Subject|2
3024815|NCT00778258|10401761|P3|Overall Study|Withdrawal by Subject|8
3024816|NCT00778258|10401762|P2|Overall Study|Withdrawal by Subject|2
3024817|NCT00778258|10401763|P1|Overall Study|Withdrawal by Subject|6
3024818|NCT00778258|10401755|P9|Overall Study|Lost to Follow-up|0
3024819|NCT00778258|10401756|P8|Overall Study|Lost to Follow-up|2
3024820|NCT00778258|10401757|P7|Overall Study|Lost to Follow-up|2
3024821|NCT00778258|10401758|P6|Overall Study|Lost to Follow-up|3
3024822|NCT00778258|10401759|P5|Overall Study|Lost to Follow-up|0
3024823|NCT00778258|10401760|P4|Overall Study|Lost to Follow-up|0
3024824|NCT00778258|10401761|P3|Overall Study|Lost to Follow-up|2
3024825|NCT00778258|10401762|P2|Overall Study|Lost to Follow-up|0
3024826|NCT00778258|10401763|P1|Overall Study|Lost to Follow-up|0
3024827|NCT00778258|10401755|P9|Overall Study|Adverse Event|0
3024828|NCT00778258|10401756|P8|Overall Study|Adverse Event|0
3024829|NCT00778258|10401757|P7|Overall Study|Adverse Event|0
3024830|NCT00778258|10401758|P6|Overall Study|Adverse Event|1
3024831|NCT00778258|10401759|P5|Overall Study|Adverse Event|0
3024832|NCT00778258|10401760|P4|Overall Study|Adverse Event|0
3024833|NCT00778258|10401761|P3|Overall Study|Adverse Event|0
3024834|NCT00778258|10401762|P2|Overall Study|Adverse Event|0
3024835|NCT00778258|10401763|P1|Overall Study|Adverse Event|1
3024836|NCT00778102|10401830|P2|Overall Study|Administrative Reason|10
3024837|NCT00778102|10401831|P1|Overall Study|Administrative Reason|7
3024838|NCT00778102|10401830|P2|Overall Study|Withdrawal by Subject|1
3024839|NCT00778102|10401831|P1|Overall Study|Withdrawal by Subject|1
3024840|NCT00778102|10401830|P2|Overall Study|Refused Treatment|3
3024841|NCT00778102|10401831|P1|Overall Study|Refused Treatment|2
3024842|NCT00778102|10401830|P2|Overall Study|Protocol Violation|1
3024843|NCT00778102|10401831|P1|Overall Study|Protocol Violation|0
3024844|NCT00778102|10401830|P2|Overall Study|Violation of Selection Criteria|1
3024845|NCT00778102|10401831|P1|Overall Study|Violation of Selection Criteria|1
3024846|NCT00778102|10401830|P2|Overall Study|Lost to Follow-up|0
3024847|NCT00778102|10401831|P1|Overall Study|Lost to Follow-up|1
3024848|NCT00778102|10401830|P2|Overall Study|Death|1
3024849|NCT00778102|10401831|P1|Overall Study|Death|1
3024850|NCT00778102|10401830|P2|Overall Study|Adverse Event|5
3024851|NCT00778102|10401831|P1|Overall Study|Adverse Event|8
3024852|NCT00777946|10401866|P3|Overall Study|Randomized in error|0
3024853|NCT00777946|10401867|P2|Overall Study|Randomized in error|1
3024854|NCT00777946|10401868|P1|Overall Study|Randomized in error|1
3024855|NCT00777946|10401866|P3|Overall Study|Protocol deviation|1
3024856|NCT00777946|10401867|P2|Overall Study|Protocol deviation|1
3024857|NCT00777946|10401868|P1|Overall Study|Protocol deviation|2
3024858|NCT00777946|10401866|P3|Overall Study|Lost to Follow-up|0
3024859|NCT00777946|10401867|P2|Overall Study|Lost to Follow-up|1
3024860|NCT00777946|10401868|P1|Overall Study|Lost to Follow-up|3
3024861|NCT00777946|10401866|P3|Overall Study|Patient withdrew consent|3
3024862|NCT00777946|10401867|P2|Overall Study|Patient withdrew consent|2
3024863|NCT00777946|10401868|P1|Overall Study|Patient withdrew consent|3
3024864|NCT00777946|10401866|P3|Overall Study|Condition no longer required study drug|0
3024865|NCT00777946|10401867|P2|Overall Study|Condition no longer required study drug|0
3024866|NCT00777946|10401868|P1|Overall Study|Condition no longer required study drug|1
3024867|NCT00777946|10401866|P3|Overall Study|Lack of Efficacy|9
3024868|NCT00777946|10401867|P2|Overall Study|Lack of Efficacy|0
3024869|NCT00777946|10401868|P1|Overall Study|Lack of Efficacy|0
3024870|NCT00777946|10401866|P3|Overall Study|Adverse Event|3
3024871|NCT00777946|10401867|P2|Overall Study|Adverse Event|1
3024872|NCT00777946|10401868|P1|Overall Study|Adverse Event|11
3024873|NCT00777803|10401903|P2|Overall Study|Non-compliance|2
3024874|NCT00777803|10401904|P1|Overall Study|Non-compliance|2
3024875|NCT00777803|10401903|P2|Overall Study|Adverse Event|0
3024876|NCT00777803|10401904|P1|Overall Study|Adverse Event|1
3024877|NCT00777803|10401903|P2|Overall Study|Lost to Follow-up|5
3024878|NCT00777803|10401904|P1|Overall Study|Lost to Follow-up|12
3024879|NCT00777608|10401983|P2|Overall Study|Investigator Decision|2
3024880|NCT00777608|10401984|P1|Overall Study|Investigator Decision|1
3024881|NCT00777608|10401983|P2|Overall Study|Protocol Violation|0
3024882|NCT00777608|10401984|P1|Overall Study|Protocol Violation|1
3024883|NCT00777608|10401983|P2|Overall Study|Withdrawal by Subject|3
3024884|NCT00777608|10401984|P1|Overall Study|Withdrawal by Subject|1
3024885|NCT00777608|10401983|P2|Overall Study|Lost to Follow-up|1
3024886|NCT00777608|10401984|P1|Overall Study|Lost to Follow-up|1
3024887|NCT00777556|10401994|P1|Overall Study|Did not complete all 3 follow-up visits|20
3024888|NCT00777556|10401994|P1|Overall Study|Dispensed but did not use product|12
3024889|NCT00777556|10401994|P1|Overall Study|Inappropriate self-selection|34
3024890|NCT00777491|10402003|P2|Overall Study|Did not receive any protocol treatment|0
3024891|NCT00777491|10402004|P1|Overall Study|Did not receive any protocol treatment|2
3024892|NCT00777491|10402003|P2|Overall Study|Protocol Violation|2
3024893|NCT00777491|10402004|P1|Overall Study|Protocol Violation|0
3024894|NCT00777296|10402037|P4|Overall Study|CRF form not completed|0
3024895|NCT00777296|10402038|P3|Overall Study|CRF form not completed|2
3024896|NCT00777296|10402039|P2|Overall Study|CRF form not completed|0
3024897|NCT00777296|10402040|P1|Overall Study|CRF form not completed|0
3024898|NCT00777296|10402037|P4|Overall Study|Withdrawal by Subject|0
3024899|NCT00777296|10402038|P3|Overall Study|Withdrawal by Subject|0
3024900|NCT00777296|10402039|P2|Overall Study|Withdrawal by Subject|0
3024901|NCT00777296|10402040|P1|Overall Study|Withdrawal by Subject|1
3024902|NCT00777296|10402037|P4|Overall Study|Adverse Event|1
3024903|NCT00777296|10402038|P3|Overall Study|Adverse Event|0
3024904|NCT00777296|10402039|P2|Overall Study|Adverse Event|1
3024905|NCT00777296|10402040|P1|Overall Study|Adverse Event|0
3024906|NCT00777257|10402082|P3|Overall Study|Withdrawal by Subject|5
3024907|NCT00777257|10402083|P2|Overall Study|Withdrawal by Subject|6
3024908|NCT00777257|10402084|P1|Overall Study|Withdrawal by Subject|3
3024909|NCT00777257|10402082|P3|Overall Study|Protocol Violation|2
3024910|NCT00777257|10402083|P2|Overall Study|Protocol Violation|2
3024911|NCT00777257|10402084|P1|Overall Study|Protocol Violation|2
3024912|NCT00777257|10402082|P3|Overall Study|Lost to Follow-up|2
3024913|NCT00777257|10402083|P2|Overall Study|Lost to Follow-up|3
3024914|NCT00777257|10402084|P1|Overall Study|Lost to Follow-up|3
3024915|NCT00777257|10402082|P3|Overall Study|Adverse Event|0
3024916|NCT00777257|10402083|P2|Overall Study|Adverse Event|1
3024917|NCT00777257|10402084|P1|Overall Study|Adverse Event|3
3024918|NCT00777205|10402103|P2|Overall Study|Protocol Violation|56
3024919|NCT00777205|10402104|P1|Overall Study|Protocol Violation|0
3024920|NCT00777205|10402103|P2|Overall Study|Death|2
3024921|NCT00777205|10402104|P1|Overall Study|Death|0
3024922|NCT00777205|10402103|P2|Overall Study|Withdrawal by Subject|4
3024923|NCT00777205|10402104|P1|Overall Study|Withdrawal by Subject|6
3024924|NCT00777205|10402103|P2|Overall Study|Lost to Follow-up|9
3024925|NCT00777205|10402104|P1|Overall Study|Lost to Follow-up|25
3024926|NCT00777153|10402138|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
3024927|NCT00777153|10402139|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
3024928|NCT00777153|10402140|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
3024929|NCT00777153|10402138|P3|Overall Study|Withdrawal by Subject|3
3024930|NCT00777153|10402139|P2|Overall Study|Withdrawal by Subject|4
3024931|NCT00777153|10402140|P1|Overall Study|Withdrawal by Subject|3
3024932|NCT00777153|10402138|P3|Overall Study|Death|33
3024933|NCT00777153|10402139|P2|Overall Study|Death|73
3024934|NCT00777153|10402140|P1|Overall Study|Death|85
3024935|NCT00777153|10402138|P3|Overall Study|Lost to Follow-up|0
3024936|NCT00777153|10402139|P2|Overall Study|Lost to Follow-up|1
3024937|NCT00777153|10402140|P1|Overall Study|Lost to Follow-up|1
3024938|NCT00777101|10402165|P2|Overall Study|Failed to Return|1
3024939|NCT00777101|10402166|P1|Overall Study|Failed to Return|0
3024940|NCT00777101|10402165|P2|Overall Study|Discontinuation of Study by Sponsor|0
3024941|NCT00777101|10402166|P1|Overall Study|Discontinuation of Study by Sponsor|1
3024942|NCT00777101|10402165|P2|Overall Study|Lost to Follow-up|1
3024943|NCT00777101|10402166|P1|Overall Study|Lost to Follow-up|2
3024944|NCT00777101|10402165|P2|Overall Study|Withdrawal by Subject|6
3024945|NCT00777101|10402166|P1|Overall Study|Withdrawal by Subject|11
3024946|NCT00777101|10402165|P2|Overall Study|Death|43
3024947|NCT00777101|10402166|P1|Overall Study|Death|48
3024948|NCT00777088|10402184|P1|Overall Study|PED Treatment not attempted|1
3024949|NCT00777049|10402209|P2|Overall Study|No treatment (elevated liver enzymes)|1
3024950|NCT00777049|10402210|P1|Overall Study|No treatment (elevated liver enzymes)|0
3024951|NCT00777049|10402209|P2|Overall Study|Withdrawal by Subject|0
3024952|NCT00777049|10402210|P1|Overall Study|Withdrawal by Subject|1
3024953|NCT00777036|10402219|P3|Follow-Up|Death|0
3024954|NCT00777036|10402220|P2|Follow-Up|Death|8
3024955|NCT00777036|10402221|P1|Follow-Up|Death|1
3024956|NCT00777036|10402219|P3|Follow-Up|Withdrawal by Subject|4
3024957|NCT00777036|10402220|P2|Follow-Up|Withdrawal by Subject|0
3024958|NCT00777036|10402221|P1|Follow-Up|Withdrawal by Subject|1
3024959|NCT00777036|10402219|P3|Follow-Up|Reason Not Specified|0
3024960|NCT00777036|10402220|P2|Follow-Up|Reason Not Specified|0
3024961|NCT00777036|10402221|P1|Follow-Up|Reason Not Specified|2
3024962|NCT00777036|10402219|P3|Follow-Up|Lost to Follow-up|0
3024963|NCT00777036|10402220|P2|Follow-Up|Lost to Follow-up|0
3024964|NCT00777036|10402221|P1|Follow-Up|Lost to Follow-up|1
3024965|NCT00777036|10402219|P3|On Treatment|Progressive Disease|6
3024966|NCT00777036|10402220|P2|On Treatment|Progressive Disease|4
3024967|NCT00777036|10402221|P1|On Treatment|Progressive Disease|5
3024968|NCT00777036|10402219|P3|On Treatment|Study Drug Toxicity|1
3024969|NCT00777036|10402220|P2|On Treatment|Study Drug Toxicity|0
3024970|NCT00777036|10402221|P1|On Treatment|Study Drug Toxicity|0
3024971|NCT00777036|10402219|P3|On Treatment|Death|0
3024972|NCT00777036|10402220|P2|On Treatment|Death|2
3024973|NCT00777036|10402221|P1|On Treatment|Death|0
3024974|NCT00777036|10402219|P3|On Treatment|Withdrawal by Subject|3
3024975|NCT00777036|10402220|P2|On Treatment|Withdrawal by Subject|2
3024976|NCT00777036|10402221|P1|On Treatment|Withdrawal by Subject|3
3024977|NCT00777036|10402219|P3|On Treatment|Maximum Clinical Benefit|1
3024978|NCT00777036|10402220|P2|On Treatment|Maximum Clinical Benefit|0
3024979|NCT00777036|10402221|P1|On Treatment|Maximum Clinical Benefit|2
3024980|NCT00777036|10402219|P3|On Treatment|Non-compliance with Study Drug|0
3024981|NCT00777036|10402220|P2|On Treatment|Non-compliance with Study Drug|0
3024982|NCT00777036|10402221|P1|On Treatment|Non-compliance with Study Drug|1
3024983|NCT00777036|10402219|P3|On Treatment|Failure to Meet Study Criteria|0
3024984|NCT00777036|10402220|P2|On Treatment|Failure to Meet Study Criteria|1
3024985|NCT00777036|10402221|P1|On Treatment|Failure to Meet Study Criteria|0
3024986|NCT00777036|10402219|P3|On Treatment|Reason Not Specified|12
3024987|NCT00777036|10402220|P2|On Treatment|Reason Not Specified|7
3024988|NCT00777036|10402221|P1|On Treatment|Reason Not Specified|4
3024989|NCT00777023|10402317|P3|Overall Study|Last dose date unknown|1
3024990|NCT00777023|10402318|P2|Overall Study|Last dose date unknown|3
3024991|NCT00777023|10402319|P1|Overall Study|Last dose date unknown|3
3024992|NCT00777023|10402317|P3|Overall Study|Reasons not specified|2
3024993|NCT00777023|10402318|P2|Overall Study|Reasons not specified|4
3024994|NCT00777023|10402319|P1|Overall Study|Reasons not specified|4
3024995|NCT00777023|10402317|P3|Overall Study|Missing data|0
3024996|NCT00777023|10402318|P2|Overall Study|Missing data|1
3024997|NCT00777023|10402319|P1|Overall Study|Missing data|1
3024998|NCT00777023|10402317|P3|Overall Study|Withdrawal by Subject|8
3024999|NCT00777023|10402318|P2|Overall Study|Withdrawal by Subject|7
3025000|NCT00777023|10402319|P1|Overall Study|Withdrawal by Subject|7
3025001|NCT00777023|10402317|P3|Overall Study|Death|0
3025002|NCT00777023|10402318|P2|Overall Study|Death|1
3025003|NCT00777023|10402319|P1|Overall Study|Death|0
3025004|NCT00777023|10402317|P3|Overall Study|Lost to Follow-up|3
3025005|NCT00777023|10402318|P2|Overall Study|Lost to Follow-up|3
3025006|NCT00777023|10402319|P1|Overall Study|Lost to Follow-up|2
3025007|NCT00777023|10402317|P3|Overall Study|Protocol Violation|1
3025008|NCT00777023|10402318|P2|Overall Study|Protocol Violation|1
3025009|NCT00777023|10402319|P1|Overall Study|Protocol Violation|2
3025010|NCT00777023|10402317|P3|Overall Study|Lack of Efficacy|14
3025011|NCT00777023|10402318|P2|Overall Study|Lack of Efficacy|0
3025012|NCT00777023|10402319|P1|Overall Study|Lack of Efficacy|1
3025013|NCT00777023|10402317|P3|Overall Study|Adverse Event|8
3025014|NCT00777023|10402318|P2|Overall Study|Adverse Event|21
3025015|NCT00777023|10402319|P1|Overall Study|Adverse Event|15
3025016|NCT00776997|10402336|P1|Overall Study|Adverse Event|2
3025017|NCT00776984|10402345|P2|Overall Study|Other|9
3025018|NCT00776984|10402346|P1|Overall Study|Other|5
3025019|NCT00776984|10402345|P2|Overall Study|Lack of Efficacy|1
3025020|NCT00776984|10402346|P1|Overall Study|Lack of Efficacy|0
3025021|NCT00776984|10402345|P2|Overall Study|Withdrawal by Subject|7
3025022|NCT00776984|10402346|P1|Overall Study|Withdrawal by Subject|12
3025023|NCT00776984|10402345|P2|Overall Study|Lost to Follow-up|0
3025024|NCT00776984|10402346|P1|Overall Study|Lost to Follow-up|2
3025025|NCT00776984|10402345|P2|Overall Study|Protocol Violation|2
3025026|NCT00776984|10402346|P1|Overall Study|Protocol Violation|4
3025027|NCT00776984|10402345|P2|Overall Study|Adverse Event|2
3025028|NCT00776984|10402346|P1|Overall Study|Adverse Event|8
3025029|NCT00776919|10402420|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
3025030|NCT00776919|10402421|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
3025031|NCT00776919|10402422|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
3025032|NCT00776919|10402423|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
3025033|NCT00776919|10402420|P4|Overall Study|Protocol Violation|1
3025034|NCT00776919|10402421|P3|Overall Study|Protocol Violation|0
3025035|NCT00776919|10402422|P2|Overall Study|Protocol Violation|2
3025036|NCT00776919|10402423|P1|Overall Study|Protocol Violation|1
3025037|NCT00776919|10402420|P4|Overall Study|Adverse Event|2
3025038|NCT00776919|10402421|P3|Overall Study|Adverse Event|2
3025039|NCT00776919|10402422|P2|Overall Study|Adverse Event|0
3025040|NCT00776919|10402423|P1|Overall Study|Adverse Event|1
3025041|NCT00776919|10402420|P4|Overall Study|Lost to Follow-up|8
3025042|NCT00776919|10402421|P3|Overall Study|Lost to Follow-up|11
3025043|NCT00776919|10402422|P2|Overall Study|Lost to Follow-up|12
3025044|NCT00776919|10402423|P1|Overall Study|Lost to Follow-up|8
3025045|NCT00776919|10402420|P4|Overall Study|Withdrawal by Subject|26
3025046|NCT00776919|10402421|P3|Overall Study|Withdrawal by Subject|15
3025047|NCT00776919|10402422|P2|Overall Study|Withdrawal by Subject|14
3025048|NCT00776919|10402423|P1|Overall Study|Withdrawal by Subject|16
3025049|NCT00776789|10402487|P2|Overall Study|Poor quality video|1
3025050|NCT00776789|10402488|P1|Overall Study|Poor quality video|1
3025051|NCT00776789|10402487|P2|Overall Study|Consent refusal|2
3025052|NCT00776789|10402488|P1|Overall Study|Consent refusal|2
3025053|NCT00776659|10402500|P1|Overall Study|Study Terminated by Sponsor|1
3025054|NCT00776659|10402500|P1|Overall Study|Withdrawal by Subject|10
3025055|NCT00776659|10402500|P1|Overall Study|Lost to Follow-up|15
3025056|NCT00776555|10402527|P2|Overall Study|Study terminated|0
3025057|NCT00776555|10402528|P1|Overall Study|Study terminated|3
3025058|NCT00776230|10402546|P3|Overall Study|Subject missed Visit 4|0
3025059|NCT00776230|10402547|P2|Overall Study|Subject missed Visit 4|1
3025060|NCT00776230|10402548|P1|Overall Study|Subject missed Visit 4|0
3025061|NCT00776230|10402546|P3|Overall Study|Withdrawal by Subject|0
3025062|NCT00776230|10402547|P2|Overall Study|Withdrawal by Subject|1
3025063|NCT00776230|10402548|P1|Overall Study|Withdrawal by Subject|0
3025064|NCT00776230|10402546|P3|Overall Study|Not vaccinated at Day 0|0
3025065|NCT00776230|10402547|P2|Overall Study|Not vaccinated at Day 0|0
3025066|NCT00776230|10402548|P1|Overall Study|Not vaccinated at Day 0|1
3025067|NCT00776230|10402546|P3|Overall Study|Lost to Follow-up|5
3025068|NCT00776230|10402547|P2|Overall Study|Lost to Follow-up|1
3025069|NCT00776230|10402548|P1|Overall Study|Lost to Follow-up|2
3025070|NCT00776100|10402558|P2|Overall Study|Disease Progression|0
3025071|NCT00776100|10402559|P1|Overall Study|Disease Progression|1
3025072|NCT00776009|10402581|P6|Period 3: Third Intervention|Withdrawal by Subject|0
3025073|NCT00776009|10402582|P5|Period 3: Third Intervention|Withdrawal by Subject|0
3025074|NCT00776009|10402583|P4|Period 3: Third Intervention|Withdrawal by Subject|0
3025075|NCT00776009|10402584|P3|Period 3: Third Intervention|Withdrawal by Subject|0
3025076|NCT00776009|10402585|P2|Period 3: Third Intervention|Withdrawal by Subject|0
3025077|NCT00776009|10402586|P1|Period 3: Third Intervention|Withdrawal by Subject|1
3025078|NCT00776009|10402581|P6|Period 2: Second Intervention|Protocol Violation|0
3025079|NCT00776009|10402582|P5|Period 2: Second Intervention|Protocol Violation|0
3025080|NCT00776009|10402583|P4|Period 2: Second Intervention|Protocol Violation|0
3025081|NCT00776009|10402584|P3|Period 2: Second Intervention|Protocol Violation|1
3025082|NCT00776009|10402585|P2|Period 2: Second Intervention|Protocol Violation|0
3025083|NCT00776009|10402586|P1|Period 2: Second Intervention|Protocol Violation|1
3025084|NCT00776009|10402581|P6|Period 2: Second Intervention|Withdrawal by Subject|1
3025085|NCT00776009|10402582|P5|Period 2: Second Intervention|Withdrawal by Subject|0
3025086|NCT00776009|10402583|P4|Period 2: Second Intervention|Withdrawal by Subject|0
3025087|NCT00776009|10402584|P3|Period 2: Second Intervention|Withdrawal by Subject|0
3025088|NCT00776009|10402585|P2|Period 2: Second Intervention|Withdrawal by Subject|0
3025089|NCT00776009|10402586|P1|Period 2: Second Intervention|Withdrawal by Subject|0
3025090|NCT00776009|10402581|P6|Period 1: First Intervention|Protocol Violation|0
3025091|NCT00776009|10402582|P5|Period 1: First Intervention|Protocol Violation|1
3025092|NCT00776009|10402583|P4|Period 1: First Intervention|Protocol Violation|0
3025093|NCT00776009|10402584|P3|Period 1: First Intervention|Protocol Violation|0
3025094|NCT00776009|10402585|P2|Period 1: First Intervention|Protocol Violation|1
3025095|NCT00776009|10402586|P1|Period 1: First Intervention|Protocol Violation|0
3025096|NCT00776009|10402581|P6|Period 1: First Intervention|Withdrawal by Subject|0
3025097|NCT00776009|10402582|P5|Period 1: First Intervention|Withdrawal by Subject|1
3025098|NCT00776009|10402583|P4|Period 1: First Intervention|Withdrawal by Subject|0
3025099|NCT00776009|10402584|P3|Period 1: First Intervention|Withdrawal by Subject|1
3025100|NCT00776009|10402585|P2|Period 1: First Intervention|Withdrawal by Subject|0
3025101|NCT00776009|10402586|P1|Period 1: First Intervention|Withdrawal by Subject|0
3025102|NCT00775983|10402608|P2|Overall Study|Protocol Violation|2
3025103|NCT00775983|10402609|P1|Overall Study|Protocol Violation|1
3025104|NCT00775606|10402735|P2|Overall Study|Study sponsor terminated funding|0
3025105|NCT00775606|10402736|P1|Overall Study|Study sponsor terminated funding|3
3025106|NCT00775593|10402746|P1|Overall Study|Death|1
3025107|NCT00775593|10402746|P1|Overall Study|Unmet eligibility criteria|6
3025108|NCT00775528|10402753|P1|Overall Study|Protocol Violation|1
3025109|NCT00775463|10402762|P2|Overall Study|Lack of Efficacy|1
3025110|NCT00775463|10402763|P1|Overall Study|Lack of Efficacy|1
3025111|NCT00775463|10402762|P2|Overall Study|Lost to Follow-up|0
3025112|NCT00775463|10402763|P1|Overall Study|Lost to Follow-up|1
3025113|NCT00775463|10402762|P2|Overall Study|Protocol Violation|2
3025114|NCT00775463|10402763|P1|Overall Study|Protocol Violation|2
3025115|NCT00775463|10402762|P2|Overall Study|Adverse Event|9
3025116|NCT00775463|10402763|P1|Overall Study|Adverse Event|7
3025117|NCT00775463|10402762|P2|Overall Study|Withdrawal by Subject|1
3025118|NCT00775463|10402763|P1|Overall Study|Withdrawal by Subject|0
3025119|NCT00775450|10402800|P5|Overall Study|Withdrawal by Subject|1
3025120|NCT00775450|10402801|P4|Overall Study|Withdrawal by Subject|0
3025121|NCT00775450|10402802|P3|Overall Study|Withdrawal by Subject|0
3025122|NCT00775450|10402803|P2|Overall Study|Withdrawal by Subject|0
3025123|NCT00775450|10402804|P1|Overall Study|Withdrawal by Subject|1
3025124|NCT00775450|10402800|P5|Overall Study|Protocol Violation|1
3025125|NCT00775450|10402801|P4|Overall Study|Protocol Violation|0
3025126|NCT00775450|10402802|P3|Overall Study|Protocol Violation|0
3025127|NCT00775450|10402803|P2|Overall Study|Protocol Violation|0
3025128|NCT00775450|10402804|P1|Overall Study|Protocol Violation|0
3025129|NCT00775450|10402800|P5|Overall Study|Serious Adverse Event|0
3025130|NCT00775450|10402801|P4|Overall Study|Serious Adverse Event|0
3025131|NCT00775450|10402802|P3|Overall Study|Serious Adverse Event|0
3025132|NCT00775450|10402803|P2|Overall Study|Serious Adverse Event|0
3025133|NCT00775450|10402804|P1|Overall Study|Serious Adverse Event|2
3025134|NCT00775437|10402831|P1|Overall Study|Lost to Follow-up|1
3025135|NCT00775437|10402831|P1|Overall Study|Withdrawal by Subject|3
3025136|NCT00775437|10402831|P1|Overall Study|Loss of efficacy|2
3025137|NCT00775203|10402906|P2|Overall Study|Physician Decision|1
3025138|NCT00775203|10402907|P1|Overall Study|Physician Decision|0
3025139|NCT00775203|10402906|P2|Overall Study|Entered other study|0
3025140|NCT00775203|10402907|P1|Overall Study|Entered other study|1
3025141|NCT00775203|10402906|P2|Overall Study|Protocol Violation|1
3025142|NCT00775203|10402907|P1|Overall Study|Protocol Violation|0
3025143|NCT00775203|10402906|P2|Overall Study|Noncompliance|2
3025144|NCT00775203|10402907|P1|Overall Study|Noncompliance|4
3025145|NCT00775203|10402906|P2|Overall Study|Administrative reason|0
3025146|NCT00775203|10402907|P1|Overall Study|Administrative reason|2
3025147|NCT00775203|10402906|P2|Overall Study|Lost to Follow-up|15
3025148|NCT00775203|10402907|P1|Overall Study|Lost to Follow-up|11
3025149|NCT00775203|10402906|P2|Overall Study|Withdrawal by Subject|9
3025150|NCT00775203|10402907|P1|Overall Study|Withdrawal by Subject|11
3025151|NCT00775203|10402906|P2|Overall Study|Lack of Efficacy|9
3025152|NCT00775203|10402907|P1|Overall Study|Lack of Efficacy|8
3025153|NCT00775203|10402906|P2|Overall Study|Adverse Event|6
3025154|NCT00775203|10402907|P1|Overall Study|Adverse Event|25
3025155|NCT00775190|10402941|P2|Overall Study|Protocol Violation|0
3025156|NCT00775190|10402942|P1|Overall Study|Protocol Violation|1
3025157|NCT00775190|10402941|P2|Overall Study|Withdrawal by Subject|2
3025158|NCT00775190|10402942|P1|Overall Study|Withdrawal by Subject|1
3025159|NCT00775190|10402941|P2|Overall Study|Lost to Follow-up|3
3025160|NCT00775190|10402942|P1|Overall Study|Lost to Follow-up|2
3025161|NCT00775138|10402968|P4|Overall Study|Adverse Event|0
3025162|NCT00775138|10402969|P3|Overall Study|Adverse Event|1
3025163|NCT00775138|10402970|P2|Overall Study|Adverse Event|0
3025164|NCT00775138|10402971|P1|Overall Study|Adverse Event|0
3025165|NCT00775138|10402968|P4|Overall Study|Withdrawal by Subject|2
3025166|NCT00775138|10402969|P3|Overall Study|Withdrawal by Subject|2
3025167|NCT00775138|10402970|P2|Overall Study|Withdrawal by Subject|0
3025168|NCT00775138|10402971|P1|Overall Study|Withdrawal by Subject|0
3025169|NCT00775021|10403017|P2|Second Intervention|Adverse Event|1
3025170|NCT00775021|10403018|P1|Second Intervention|Adverse Event|0
3025171|NCT00775021|10403017|P2|First Intervention|Lost to Follow-up|0
3025172|NCT00775021|10403018|P1|First Intervention|Lost to Follow-up|1
3025173|NCT00774995|10403036|P4|Overall Study|Protocol Violation|0
3025174|NCT00774995|10403037|P3|Overall Study|Protocol Violation|1
3025175|NCT00774995|10403038|P2|Overall Study|Protocol Violation|0
3025176|NCT00774995|10403039|P1|Overall Study|Protocol Violation|0
3025177|NCT00774930|10403079|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
3025178|NCT00774930|10403080|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
3025179|NCT00774930|10403079|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
3025180|NCT00774930|10403080|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
3025181|NCT00774930|10403079|P2|LTOLE Phase|Disease Progression|5
3025182|NCT00774930|10403080|P1|LTOLE Phase|Disease Progression|2
3025183|NCT00774930|10403079|P2|LTOLE Phase|Sponsor decision|1
3025184|NCT00774930|10403080|P1|LTOLE Phase|Sponsor decision|2
3025185|NCT00774930|10403079|P2|LTOLE Phase|Physician Decision|1
3025186|NCT00774930|10403080|P1|LTOLE Phase|Physician Decision|4
3025187|NCT00774930|10403079|P2|LTOLE Phase|Subject decision|5
3025188|NCT00774930|10403080|P1|LTOLE Phase|Subject decision|0
3025189|NCT00774930|10403079|P2|LTOLE Phase|Adverse Event|3
3025190|NCT00774930|10403080|P1|LTOLE Phase|Adverse Event|7
3025191|NCT00774930|10403079|P2|IOL Phase|Brain radiation|1
3025192|NCT00774930|10403080|P1|IOL Phase|Brain radiation|0
3025193|NCT00774930|10403079|P2|IOL Phase|Other|0
3025194|NCT00774930|10403080|P1|IOL Phase|Other|1
3025195|NCT00774930|10403079|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
3025196|NCT00774930|10403080|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
3025197|NCT00774930|10403079|P2|IOL Phase|Subject Consumed Prohibited Medication|0
3025198|NCT00774930|10403080|P1|IOL Phase|Subject Consumed Prohibited Medication|1
3025199|NCT00774930|10403079|P2|IOL Phase|Disease Progression|1
3025200|NCT00774930|10403080|P1|IOL Phase|Disease Progression|2
3025201|NCT00774930|10403079|P2|IOL Phase|Sponsor Decision|0
3025202|NCT00774930|10403080|P1|IOL Phase|Sponsor Decision|1
3025203|NCT00774930|10403079|P2|IOL Phase|Physician Decision|2
3025204|NCT00774930|10403080|P1|IOL Phase|Physician Decision|3
3025205|NCT00774930|10403079|P2|IOL Phase|Subject Decision|3
3025206|NCT00774930|10403080|P1|IOL Phase|Subject Decision|4
3025207|NCT00774930|10403079|P2|IOL Phase|Adverse Event|1
3025208|NCT00774930|10403080|P1|IOL Phase|Adverse Event|1
3025209|NCT00774930|10403079|P2|DB Phase|Started Nonprotocol Radiation therapy|1
3025210|NCT00774930|10403080|P1|DB Phase|Started Nonprotocol Radiation therapy|0
3025211|NCT00774930|10403079|P2|DB Phase|Disease Progression|1
3025212|NCT00774930|10403080|P1|DB Phase|Disease Progression|1
3025213|NCT00774930|10403079|P2|DB Phase|Sponsor Decision|1
3025214|NCT00774930|10403080|P1|DB Phase|Sponsor Decision|0
3025215|NCT00774930|10403079|P2|DB Phase|Subject Decision|5
3025216|NCT00774930|10403080|P1|DB Phase|Subject Decision|1
3025217|NCT00774930|10403079|P2|DB Phase|Adverse Event|2
3025218|NCT00774930|10403080|P1|DB Phase|Adverse Event|1
3025219|NCT00774930|10403079|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
3025220|NCT00774930|10403080|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
3025221|NCT00774852|10403108|P2|Overall Study|Subject received prohibited medication|0
3025222|NCT00774852|10403109|P1|Overall Study|Subject received prohibited medication|1
3025223|NCT00774852|10403108|P2|Overall Study|Protocol Violation|0
3025224|NCT00774852|10403109|P1|Overall Study|Protocol Violation|1
3025225|NCT00774852|10403108|P2|Overall Study|Subject non-compliance|1
3025226|NCT00774852|10403109|P1|Overall Study|Subject non-compliance|0
3025227|NCT00774852|10403108|P2|Overall Study|Non-responder|11
3025228|NCT00774852|10403109|P1|Overall Study|Non-responder|15
3025229|NCT00774852|10403108|P2|Overall Study|Withdrawal by Subject|2
3025230|NCT00774852|10403109|P1|Overall Study|Withdrawal by Subject|2
3025231|NCT00774852|10403108|P2|Overall Study|Pregnancy|2
3025232|NCT00774852|10403109|P1|Overall Study|Pregnancy|1
3025233|NCT00774852|10403108|P2|Overall Study|Physician Decision|6
3025234|NCT00774852|10403109|P1|Overall Study|Physician Decision|2
3025235|NCT00774852|10403108|P2|Overall Study|Lost to Follow-up|5
3025236|NCT00774852|10403109|P1|Overall Study|Lost to Follow-up|9
3025237|NCT00774852|10403108|P2|Overall Study|Lack of Efficacy|7
3025238|NCT00774852|10403109|P1|Overall Study|Lack of Efficacy|3
3025239|NCT00774852|10403108|P2|Overall Study|Death|1
3025240|NCT00774852|10403109|P1|Overall Study|Death|2
3025241|NCT00774852|10403108|P2|Overall Study|Adverse Event|6
3025242|NCT00774852|10403109|P1|Overall Study|Adverse Event|9
3025243|NCT00774800|10403157|P1|Intervention 4|Withdrawal by Subject|1
3025244|NCT00774787|10403179|P1|Overall Study|Lost to Follow-up|1
3025245|NCT00774748|10403186|P1|Overall Study|Lost to Follow-up|3
3025246|NCT00774397|10403212|P7|Overall Study|Other than those stated above|1
3025247|NCT00774397|10403213|P6|Overall Study|Other than those stated above|0
3025248|NCT00774397|10403214|P5|Overall Study|Other than those stated above|2
3025249|NCT00774397|10403215|P4|Overall Study|Other than those stated above|2
3025250|NCT00774397|10403216|P3|Overall Study|Other than those stated above|3
3025251|NCT00774397|10403217|P2|Overall Study|Other than those stated above|1
3025252|NCT00774397|10403218|P1|Overall Study|Other than those stated above|1
3025253|NCT00774397|10403212|P7|Overall Study|Not treated|1
3025254|NCT00774397|10403213|P6|Overall Study|Not treated|0
3025255|NCT00774397|10403214|P5|Overall Study|Not treated|1
3025256|NCT00774397|10403215|P4|Overall Study|Not treated|0
3025257|NCT00774397|10403216|P3|Overall Study|Not treated|0
3025258|NCT00774397|10403217|P2|Overall Study|Not treated|0
3025259|NCT00774397|10403218|P1|Overall Study|Not treated|0
3025260|NCT00774397|10403212|P7|Overall Study|Refused to continue trial medication|3
3025261|NCT00774397|10403213|P6|Overall Study|Refused to continue trial medication|2
3025262|NCT00774397|10403214|P5|Overall Study|Refused to continue trial medication|6
3025263|NCT00774397|10403215|P4|Overall Study|Refused to continue trial medication|2
3025264|NCT00774397|10403216|P3|Overall Study|Refused to continue trial medication|2
3025265|NCT00774397|10403217|P2|Overall Study|Refused to continue trial medication|3
3025266|NCT00774397|10403218|P1|Overall Study|Refused to continue trial medication|1
3025267|NCT00774397|10403212|P7|Overall Study|Lost to Follow-up|0
3025268|NCT00774397|10403213|P6|Overall Study|Lost to Follow-up|1
3025269|NCT00774397|10403214|P5|Overall Study|Lost to Follow-up|0
3025270|NCT00774397|10403215|P4|Overall Study|Lost to Follow-up|1
3025271|NCT00774397|10403216|P3|Overall Study|Lost to Follow-up|1
3025272|NCT00774397|10403217|P2|Overall Study|Lost to Follow-up|1
3025273|NCT00774397|10403218|P1|Overall Study|Lost to Follow-up|0
3025274|NCT00774397|10403212|P7|Overall Study|Protocol Violation|0
3025275|NCT00774397|10403213|P6|Overall Study|Protocol Violation|1
3025276|NCT00774397|10403214|P5|Overall Study|Protocol Violation|2
3025277|NCT00774397|10403215|P4|Overall Study|Protocol Violation|1
3025278|NCT00774397|10403216|P3|Overall Study|Protocol Violation|3
3025279|NCT00774397|10403217|P2|Overall Study|Protocol Violation|1
3025280|NCT00774397|10403218|P1|Overall Study|Protocol Violation|0
3025281|NCT00774397|10403212|P7|Overall Study|Lack of Efficacy|9
3025282|NCT00774397|10403213|P6|Overall Study|Lack of Efficacy|15
3025283|NCT00774397|10403214|P5|Overall Study|Lack of Efficacy|27
3025284|NCT00774397|10403215|P4|Overall Study|Lack of Efficacy|3
3025285|NCT00774397|10403216|P3|Overall Study|Lack of Efficacy|5
3025286|NCT00774397|10403217|P2|Overall Study|Lack of Efficacy|4
3025287|NCT00774397|10403218|P1|Overall Study|Lack of Efficacy|11
3025288|NCT00774397|10403212|P7|Overall Study|Adverse Event|16
3025289|NCT00774397|10403213|P6|Overall Study|Adverse Event|3
3025290|NCT00774397|10403214|P5|Overall Study|Adverse Event|8
3025291|NCT00774397|10403215|P4|Overall Study|Adverse Event|8
3025292|NCT00774397|10403216|P3|Overall Study|Adverse Event|16
3025293|NCT00774397|10403217|P2|Overall Study|Adverse Event|3
3025294|NCT00774397|10403218|P1|Overall Study|Adverse Event|1
3025295|NCT00774306|10403454|P4|Overall Study|Death|0
3025296|NCT00774306|10403455|P3|Overall Study|Death|0
3025297|NCT00774306|10403456|P2|Overall Study|Death|1
3025298|NCT00774306|10403457|P1|Overall Study|Death|1
3025299|NCT00774306|10403454|P4|Overall Study|Lost to Follow-up|5
3025300|NCT00774306|10403455|P3|Overall Study|Lost to Follow-up|4
3025301|NCT00774306|10403456|P2|Overall Study|Lost to Follow-up|0
3025302|NCT00774306|10403457|P1|Overall Study|Lost to Follow-up|6
3025303|NCT00774306|10403454|P4|Overall Study|Withdrawal by Subject|0
3025304|NCT00774306|10403455|P3|Overall Study|Withdrawal by Subject|1
3025305|NCT00774306|10403456|P2|Overall Study|Withdrawal by Subject|1
3025306|NCT00774306|10403457|P1|Overall Study|Withdrawal by Subject|6
3025307|NCT00774306|10403454|P4|Overall Study|Protocol Violation|0
3025308|NCT00774306|10403455|P3|Overall Study|Protocol Violation|3
3025309|NCT00774306|10403456|P2|Overall Study|Protocol Violation|0
3025310|NCT00774306|10403457|P1|Overall Study|Protocol Violation|2
3025311|NCT00774306|10403454|P4|Overall Study|Adverse Event|0
3025312|NCT00774306|10403455|P3|Overall Study|Adverse Event|0
3025313|NCT00774306|10403456|P2|Overall Study|Adverse Event|0
3025314|NCT00774306|10403457|P1|Overall Study|Adverse Event|3
3025315|NCT00774046|10403538|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
3025316|NCT00774046|10403538|P1|Enrollment|Desired other therapy/refused|28
3025317|NCT00774046|10403538|P1|Screening|Not eligible|56
3025318|NCT00773968|10403548|P1|Overall Study|Other|8
3025319|NCT00773968|10403548|P1|Overall Study|Screen Failure|17
3025320|NCT00773968|10403548|P1|Overall Study|Withdrawal by Subject|11
3025321|NCT00773968|10403548|P1|Overall Study|Protocol Violation|1
3025322|NCT00773968|10403548|P1|Overall Study|Lack of Efficacy|3
3025323|NCT00773968|10403548|P1|Overall Study|Failure to Return|2
3025324|NCT00773968|10403548|P1|Overall Study|Death|1
3025325|NCT00773968|10403548|P1|Overall Study|Adverse Event|2
3025326|NCT00773734|10403579|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
3025327|NCT00773734|10403580|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
3025328|NCT00773734|10403581|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
3025329|NCT00773734|10403582|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
3025330|NCT00773734|10403583|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
3025331|NCT00773734|10403584|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
3025332|NCT00773734|10403579|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
3025333|NCT00773734|10403580|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
3025334|NCT00773734|10403581|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
3025335|NCT00773734|10403582|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
3025336|NCT00773734|10403583|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
3025337|NCT00773734|10403584|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
3025338|NCT00773734|10403579|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
3025339|NCT00773734|10403580|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
3025340|NCT00773734|10403581|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
3025341|NCT00773734|10403582|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
3025342|NCT00773734|10403583|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
3025343|NCT00773734|10403584|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
3025344|NCT00773734|10403579|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
3025345|NCT00773734|10403580|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
3025346|NCT00773734|10403581|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
3025347|NCT00773734|10403582|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
3025348|NCT00773734|10403583|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
3025349|NCT00773734|10403584|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
3025350|NCT00773734|10403579|P6|Extension: Active Treatment Week 24-52|Other|1
3025351|NCT00773734|10403580|P5|Extension: Active Treatment Week 24-52|Other|0
3025352|NCT00773734|10403581|P4|Extension: Active Treatment Week 24-52|Other|2
3025353|NCT00773734|10403582|P3|Extension: Active Treatment Week 24-52|Other|1
3025354|NCT00773734|10403583|P2|Extension: Active Treatment Week 24-52|Other|0
3025355|NCT00773734|10403584|P1|Extension: Active Treatment Week 24-52|Other|0
3025356|NCT00773734|10403579|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
3025357|NCT00773734|10403580|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
3025358|NCT00773734|10403581|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
3025359|NCT00773734|10403582|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
3025360|NCT00773734|10403583|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
3025361|NCT00773734|10403584|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
3025362|NCT00773734|10403579|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
3025363|NCT00773734|10403580|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
3025364|NCT00773734|10403581|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
3025365|NCT00773734|10403582|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
3025366|NCT00773734|10403583|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
3025367|NCT00773734|10403584|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
3025368|NCT00773734|10403579|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
3025369|NCT00773734|10403580|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
3025370|NCT00773734|10403581|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
3025371|NCT00773734|10403582|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
3025372|NCT00773734|10403583|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
3025373|NCT00773734|10403584|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
3025374|NCT00773734|10403579|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
3025375|NCT00773734|10403580|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
3025376|NCT00773734|10403581|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
3025377|NCT00773734|10403582|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
3025378|NCT00773734|10403583|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
3025379|NCT00773734|10403584|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
3025380|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Other|0
3025381|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Other|0
3025382|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Other|0
3025383|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Other|0
3025384|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Other|1
3025385|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Other|0
3025386|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
3025387|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
3025388|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
3025389|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
3025461|NCT00773513|10404153|P1|Overall Study|Reason Not Specified|159
3025390|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
3025391|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
3025392|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
3025393|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
3025394|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
3025395|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
3025396|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
3025397|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
3025398|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
3025399|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
3025400|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
3025401|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
3025402|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
3025403|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
3025404|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
3025405|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
3025406|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
3025407|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
3025408|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
3025409|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
3025410|NCT00773734|10403579|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
3025411|NCT00773734|10403580|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
3025412|NCT00773734|10403581|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
3025413|NCT00773734|10403582|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
3025414|NCT00773734|10403583|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
3025415|NCT00773734|10403584|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
3025416|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
3025417|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
3025418|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
3025419|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
3025420|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
3025421|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
3025422|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
3025423|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
3025424|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
3025425|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
3025426|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
3025427|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
3025428|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
3025429|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
3025430|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
3025431|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
3025432|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
3025433|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
3025434|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
3025435|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
3025436|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
3025437|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
3025438|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
3025439|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
3025440|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
3025441|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
3025442|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
3025443|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
3025444|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
3025445|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
3025446|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
3025447|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
3025448|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
3025449|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
3025450|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
3025451|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
3025452|NCT00773734|10403579|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
3025453|NCT00773734|10403580|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
3025454|NCT00773734|10403581|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
3025455|NCT00773734|10403582|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
3025456|NCT00773734|10403583|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
3025457|NCT00773734|10403584|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
3025458|NCT00773513|10404152|P2|Overall Study|Death|545
3025459|NCT00773513|10404153|P1|Overall Study|Death|531
3025460|NCT00773513|10404152|P2|Overall Study|Reason Not Specified|126
3025462|NCT00773513|10404152|P2|Overall Study|Insufficient Therapeutic Response|18
3025463|NCT00773513|10404153|P1|Overall Study|Insufficient Therapeutic Response|1
3025464|NCT00773513|10404152|P2|Overall Study|Failure to Return|8
3025465|NCT00773513|10404153|P1|Overall Study|Failure to Return|22
3025466|NCT00773513|10404152|P2|Overall Study|Refused Treatment / Did not Cooperate|32
3025467|NCT00773513|10404153|P1|Overall Study|Refused Treatment / Did not Cooperate|26
3025468|NCT00773513|10404152|P2|Overall Study|Withdrew Consent|69
3025469|NCT00773513|10404153|P1|Overall Study|Withdrew Consent|68
3025470|NCT00773513|10404152|P2|Overall Study|Adverse Event / Intercurrent Illness|48
3025471|NCT00773513|10404153|P1|Overall Study|Adverse Event / Intercurrent Illness|40
3025472|NCT00773513|10404152|P2|Overall Study|Renal Transplant|263
3025473|NCT00773513|10404153|P1|Overall Study|Renal Transplant|254
3025474|NCT00773461|10404182|P2|Overall Study|Withdrawal by Subject|1
3025475|NCT00773461|10404183|P1|Overall Study|Withdrawal by Subject|4
3025476|NCT00773461|10404182|P2|Overall Study|Adverse Event|3
3025477|NCT00773461|10404183|P1|Overall Study|Adverse Event|1
3025478|NCT00773383|10404237|P1|Overall Study|No study dose received|1
3025479|NCT00773383|10404237|P1|Overall Study|Other|2
3025480|NCT00773383|10404237|P1|Overall Study|Progression of Disease|23
3025481|NCT00773383|10404237|P1|Overall Study|Death|1
3025482|NCT00773383|10404237|P1|Overall Study|Adverse Event|4
3025483|NCT00773279|10404272|P2|Period 2|Unclassified|2
3025484|NCT00773279|10404273|P1|Period 2|Unclassified|2
3025485|NCT00773279|10404272|P2|Period 2|Protocol Violation|3
3025486|NCT00773279|10404273|P1|Period 2|Protocol Violation|0
3025487|NCT00773279|10404272|P2|Period 2|Lack of Efficacy|0
3025488|NCT00773279|10404273|P1|Period 2|Lack of Efficacy|1
3025489|NCT00773279|10404272|P2|Period 2|Adverse Event|1
3025490|NCT00773279|10404273|P1|Period 2|Adverse Event|0
3025491|NCT00773279|10404272|P2|Period 1|Unclassified|1
3025492|NCT00773279|10404273|P1|Period 1|Unclassified|5
3025493|NCT00773279|10404272|P2|Period 1|Lack of Efficacy|2
3025494|NCT00773279|10404273|P1|Period 1|Lack of Efficacy|0
3025495|NCT00773279|10404272|P2|Period 1|Adverse Event|1
3025496|NCT00773279|10404273|P1|Period 1|Adverse Event|2
3025497|NCT00773253|10404294|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
3025498|NCT00773253|10404295|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
3025499|NCT00773175|10404305|P2|Overall Study|Consent Withdrawn|2
3025500|NCT00773175|10404306|P1|Overall Study|Consent Withdrawn|0
3025501|NCT00773175|10404305|P2|Overall Study|Adverse Event|0
3025502|NCT00773175|10404306|P1|Overall Study|Adverse Event|2
3025503|NCT00773136|10404398|P1|Overall Study|Physician Decision|2
3025504|NCT00773097|10404403|P1|Overall Study|Physician Decision|6
3025505|NCT00773097|10404403|P1|Overall Study|Withdrawal by Subject|1
3025506|NCT00772967|10404409|P6|Crossover Treatment 3|Adverse Event|0
3025507|NCT00772967|10404410|P5|Crossover Treatment 3|Adverse Event|1
3025508|NCT00772967|10404411|P4|Crossover Treatment 3|Adverse Event|0
3025509|NCT00772967|10404412|P3|Crossover Treatment 3|Adverse Event|0
3025510|NCT00772967|10404413|P2|Crossover Treatment 3|Adverse Event|0
3025511|NCT00772967|10404414|P1|Crossover Treatment 3|Adverse Event|0
3025512|NCT00772967|10404409|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
3025513|NCT00772967|10404410|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
3025514|NCT00772967|10404411|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
3025515|NCT00772967|10404412|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
3025516|NCT00772967|10404413|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
3025517|NCT00772967|10404414|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
3025518|NCT00772967|10404409|P6|Crossover Treatment 1|Adverse Event (Pain)|0
3025519|NCT00772967|10404410|P5|Crossover Treatment 1|Adverse Event (Pain)|0
3025520|NCT00772967|10404411|P4|Crossover Treatment 1|Adverse Event (Pain)|1
3025521|NCT00772967|10404412|P3|Crossover Treatment 1|Adverse Event (Pain)|0
3025522|NCT00772967|10404413|P2|Crossover Treatment 1|Adverse Event (Pain)|0
3025523|NCT00772967|10404414|P1|Crossover Treatment 1|Adverse Event (Pain)|0
3025524|NCT00772954|10404434|P3|Overall Study|Adverse Event|1
3025525|NCT00772954|10404435|P2|Overall Study|Adverse Event|0
3025526|NCT00772954|10404436|P1|Overall Study|Adverse Event|0
3025527|NCT00772941|10404444|P1|Overall Study|GPSP Violation|90
3025528|NCT00772941|10404444|P1|Overall Study|Poor Compliance|7
3025529|NCT00772941|10404444|P1|Overall Study|Missed Visits|374
3025530|NCT00772941|10404444|P1|Overall Study|Study not completed|16
3025531|NCT00772941|10404444|P1|Overall Study|CRFs not available|195
3025532|NCT00772928|10404475|P2|Overall Study|Did not receive vaccine|1
3025533|NCT00772928|10404476|P1|Overall Study|Did not receive vaccine|0
3025534|NCT00772928|10404475|P2|Overall Study|Withdrawal by Subject|22
3025535|NCT00772928|10404476|P1|Overall Study|Withdrawal by Subject|25
3025536|NCT00772928|10404475|P2|Overall Study|Protocol Violation|12
3025537|NCT00772928|10404476|P1|Overall Study|Protocol Violation|10
3025538|NCT00772928|10404475|P2|Overall Study|Lost to Follow-up|6
3025539|NCT00772928|10404476|P1|Overall Study|Lost to Follow-up|9
3025540|NCT00772889|10404497|P3|Overall Study|Lost to Follow-up|7
3025541|NCT00772889|10404498|P2|Overall Study|Lost to Follow-up|6
3025542|NCT00772889|10404499|P1|Overall Study|Lost to Follow-up|6
3025543|NCT00772889|10404497|P3|Overall Study|Withdrawal by Subject|9
3025544|NCT00772889|10404498|P2|Overall Study|Withdrawal by Subject|8
3025545|NCT00772889|10404499|P1|Overall Study|Withdrawal by Subject|9
3025546|NCT00772889|10404497|P3|Overall Study|Adverse Event|0
3025547|NCT00772889|10404498|P2|Overall Study|Adverse Event|4
3025548|NCT00772889|10404499|P1|Overall Study|Adverse Event|7
3025549|NCT00772707|10404557|P1|Overall Study|Withdrawn|3
3025550|NCT00772668|10404562|P1|Overall Study|Physician Decision|3
3025551|NCT00772629|10404571|P2|Overall Study|Subject was not vaccinated|0
3025552|NCT00772629|10404572|P1|Overall Study|Subject was not vaccinated|1
3025553|NCT00772603|10404581|P3|Overall Study|Other|2
3025554|NCT00772603|10404582|P2|Overall Study|Other|0
3025555|NCT00772603|10404583|P1|Overall Study|Other|2
3025556|NCT00772603|10404581|P3|Overall Study|Physician Decision|1
3025557|NCT00772603|10404582|P2|Overall Study|Physician Decision|0
3025558|NCT00772603|10404583|P1|Overall Study|Physician Decision|0
3025559|NCT00772603|10404581|P3|Overall Study|Lost to Follow-up|2
3025560|NCT00772603|10404582|P2|Overall Study|Lost to Follow-up|5
3025561|NCT00772603|10404583|P1|Overall Study|Lost to Follow-up|1
3025562|NCT00772603|10404581|P3|Overall Study|Protocol Violation|1
3025563|NCT00772603|10404582|P2|Overall Study|Protocol Violation|1
3025564|NCT00772603|10404583|P1|Overall Study|Protocol Violation|0
3025565|NCT00772603|10404581|P3|Overall Study|Subject Non-compliance|4
3025566|NCT00772603|10404582|P2|Overall Study|Subject Non-compliance|6
3025567|NCT00772603|10404583|P1|Overall Study|Subject Non-compliance|1
3025568|NCT00772603|10404581|P3|Overall Study|Adverse Event|10
3025569|NCT00772603|10404582|P2|Overall Study|Adverse Event|18
3025570|NCT00772603|10404583|P1|Overall Study|Adverse Event|37
3025571|NCT00772603|10404581|P3|Overall Study|Withdrawal by Subject|6
3025572|NCT00772603|10404582|P2|Overall Study|Withdrawal by Subject|10
3025573|NCT00772603|10404583|P1|Overall Study|Withdrawal by Subject|11
3025574|NCT00772577|10404622|P2|Overall Study|Protocol Deviation|2
3025575|NCT00772577|10404623|P1|Overall Study|Protocol Deviation|3
3025576|NCT00772577|10404622|P2|Overall Study|Administrative problems|1
3025577|NCT00772577|10404623|P1|Overall Study|Administrative problems|2
3025578|NCT00772577|10404622|P2|Overall Study|Lost to Follow-up|3
3025579|NCT00772577|10404623|P1|Overall Study|Lost to Follow-up|4
3025580|NCT00772577|10404622|P2|Overall Study|Patient withdrew consent|5
3025581|NCT00772577|10404623|P1|Overall Study|Patient withdrew consent|8
3025582|NCT00772577|10404622|P2|Overall Study|Unsatisfactory therapeutic effect|8
3025583|NCT00772577|10404623|P1|Overall Study|Unsatisfactory therapeutic effect|0
3025584|NCT00772577|10404622|P2|Overall Study|Abnormal laboratory values|1
3025585|NCT00772577|10404623|P1|Overall Study|Abnormal laboratory values|0
3025586|NCT00772577|10404622|P2|Overall Study|Adverse Event|3
3025587|NCT00772577|10404623|P1|Overall Study|Adverse Event|6
3025588|NCT00772538|10404639|P2|Overall Study|Other|7
3025589|NCT00772538|10404640|P1|Overall Study|Other|7
3025590|NCT00772538|10404639|P2|Overall Study|Lack of Efficacy|1
3025591|NCT00772538|10404640|P1|Overall Study|Lack of Efficacy|0
3025592|NCT00772538|10404639|P2|Overall Study|Withdrawal by Subject|8
3025593|NCT00772538|10404640|P1|Overall Study|Withdrawal by Subject|3
3025594|NCT00772538|10404639|P2|Overall Study|Lost to Follow-up|1
3025595|NCT00772538|10404640|P1|Overall Study|Lost to Follow-up|1
3025596|NCT00772538|10404639|P2|Overall Study|Protocol Violation|3
3025597|NCT00772538|10404640|P1|Overall Study|Protocol Violation|3
3025598|NCT00772538|10404639|P2|Overall Study|Adverse Event|6
3025599|NCT00772538|10404640|P1|Overall Study|Adverse Event|6
3025600|NCT00772447|10404712|P2|Overall Study|all others|2
3025601|NCT00772447|10404713|P1|Overall Study|all others|2
3025602|NCT00772447|10404712|P2|Overall Study|Protocol Violation|1
3025603|NCT00772447|10404713|P1|Overall Study|Protocol Violation|0
3025604|NCT00772447|10404712|P2|Overall Study|incorrect enrolment|4
3025605|NCT00772447|10404713|P1|Overall Study|incorrect enrolment|3
3025606|NCT00772447|10404712|P2|Overall Study|Lost to Follow-up|4
3025607|NCT00772447|10404713|P1|Overall Study|Lost to Follow-up|2
3025608|NCT00772447|10404712|P2|Overall Study|Physician Decision|8
3025609|NCT00772447|10404713|P1|Overall Study|Physician Decision|4
3025610|NCT00772447|10404712|P2|Overall Study|Withdrawal by Subject|5
3025611|NCT00772447|10404713|P1|Overall Study|Withdrawal by Subject|9
3025612|NCT00772382|10404741|P1|Overall Study|Other Reasons|10
3025613|NCT00772382|10404741|P1|Overall Study|Withdrawal by Subject|10
3025614|NCT00772382|10404741|P1|Overall Study|Protocol Violation|1
3025615|NCT00772382|10404741|P1|Overall Study|Physician Decision|5
3025616|NCT00772382|10404741|P1|Overall Study|Lack of Efficacy|4
3025617|NCT00772382|10404741|P1|Overall Study|Death|6
3025618|NCT00772382|10404741|P1|Overall Study|Adverse Event|19
3025619|NCT00772369|10404746|P1|Overall Study|Did not return record release form|1
3025620|NCT00772148|10404757|P2|Maintenance Phase (Week 52)|Administrative/other|2
3025621|NCT00772148|10404758|P1|Maintenance Phase (Week 52)|Administrative/other|1
3025622|NCT00772148|10404757|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
3025623|NCT00772148|10404758|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
3025624|NCT00772148|10404757|P2|Maintenance Phase (Week 52)|Adverse Event|0
3025625|NCT00772148|10404758|P1|Maintenance Phase (Week 52)|Adverse Event|1
3025626|NCT00772148|10404757|P2|Maintenance Phase (Week 52)|Death|2
3025627|NCT00772148|10404758|P1|Maintenance Phase (Week 52)|Death|2
3025628|NCT00772148|10404757|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
3025629|NCT00772148|10404758|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
3025630|NCT00772148|10404757|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
3025631|NCT00772148|10404758|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
3025632|NCT00772148|10404757|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
3025633|NCT00772148|10404758|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
3025634|NCT00772109|10404778|P4|Overall Study|Withdrawal by Subject|16
3025635|NCT00772109|10404779|P3|Overall Study|Withdrawal by Subject|6
3025636|NCT00772109|10404780|P2|Overall Study|Withdrawal by Subject|8
3025637|NCT00772109|10404781|P1|Overall Study|Withdrawal by Subject|8
3025638|NCT00772109|10404778|P4|Overall Study|Lost to Follow-up|9
3025639|NCT00772109|10404779|P3|Overall Study|Lost to Follow-up|5
3025640|NCT00772109|10404780|P2|Overall Study|Lost to Follow-up|3
3025641|NCT00772109|10404781|P1|Overall Study|Lost to Follow-up|7
3025642|NCT00772109|10404778|P4|Overall Study|Protocol Violation|6
3025643|NCT00772109|10404779|P3|Overall Study|Protocol Violation|7
3025644|NCT00772109|10404780|P2|Overall Study|Protocol Violation|8
3025645|NCT00772109|10404781|P1|Overall Study|Protocol Violation|5
3025646|NCT00772109|10404778|P4|Overall Study|Serious adverse event|0
3025647|NCT00772109|10404779|P3|Overall Study|Serious adverse event|1
3025648|NCT00772109|10404780|P2|Overall Study|Serious adverse event|0
3025649|NCT00772109|10404781|P1|Overall Study|Serious adverse event|1
3025650|NCT00772070|10404805|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
3025651|NCT00772070|10404806|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
3025652|NCT00772070|10404805|P2|Overall Study|Withdrawal by Subject|2
3025653|NCT00772070|10404806|P1|Overall Study|Withdrawal by Subject|0
3025654|NCT00772070|10404805|P2|Overall Study|Lost to Follow-up|8
3025655|NCT00772070|10404806|P1|Overall Study|Lost to Follow-up|0
3025656|NCT00772031|10404818|P2|Overall Study|Lost to Follow-up|33
3025657|NCT00772031|10404819|P1|Overall Study|Lost to Follow-up|20
3025658|NCT00772031|10404818|P2|Overall Study|Early termination of trial|10
3025659|NCT00772031|10404819|P1|Overall Study|Early termination of trial|12
3025660|NCT00772005|10404845|P4|Overall Study|Non-compliance with drug administration|1
3025661|NCT00772005|10404846|P3|Overall Study|Non-compliance with drug administration|1
3025662|NCT00772005|10404847|P2|Overall Study|Non-compliance with drug administration|0
3025663|NCT00772005|10404848|P1|Overall Study|Non-compliance with drug administration|3
3025664|NCT00772005|10404845|P4|Overall Study|Non-compliance with study procedures|1
3025665|NCT00772005|10404846|P3|Overall Study|Non-compliance with study procedures|0
3025666|NCT00772005|10404847|P2|Overall Study|Non-compliance with study procedures|1
3025667|NCT00772005|10404848|P1|Overall Study|Non-compliance with study procedures|1
3025668|NCT00772005|10404845|P4|Overall Study|Lost to Follow-up|3
3025669|NCT00772005|10404846|P3|Overall Study|Lost to Follow-up|6
3025670|NCT00772005|10404847|P2|Overall Study|Lost to Follow-up|3
3025671|NCT00772005|10404848|P1|Overall Study|Lost to Follow-up|7
3025672|NCT00772005|10404845|P4|Overall Study|Protocol Violation|6
3025673|NCT00772005|10404846|P3|Overall Study|Protocol Violation|1
3025674|NCT00772005|10404847|P2|Overall Study|Protocol Violation|4
3025675|NCT00772005|10404848|P1|Overall Study|Protocol Violation|2
3025676|NCT00772005|10404845|P4|Overall Study|Withdrawal by Subject|2
3025677|NCT00772005|10404846|P3|Overall Study|Withdrawal by Subject|10
3025678|NCT00772005|10404847|P2|Overall Study|Withdrawal by Subject|7
3025679|NCT00772005|10404848|P1|Overall Study|Withdrawal by Subject|3
3025680|NCT00772005|10404845|P4|Overall Study|Lack of Efficacy|0
3025681|NCT00772005|10404846|P3|Overall Study|Lack of Efficacy|0
3025682|NCT00772005|10404847|P2|Overall Study|Lack of Efficacy|1
3025683|NCT00772005|10404848|P1|Overall Study|Lack of Efficacy|0
3025684|NCT00772005|10404845|P4|Overall Study|Adverse Event|13
3025685|NCT00772005|10404846|P3|Overall Study|Adverse Event|10
3025686|NCT00772005|10404847|P2|Overall Study|Adverse Event|14
3025687|NCT00772005|10404848|P1|Overall Study|Adverse Event|9
3025688|NCT00771953|10405536|P2|Overall Study|Withdrawal by Subject|3
3025689|NCT00771953|10405537|P1|Overall Study|Withdrawal by Subject|0
3025690|NCT00771953|10405536|P2|Overall Study|Other complicating disease|0
3025691|NCT00771953|10405537|P1|Overall Study|Other complicating disease|1
3025692|NCT00771953|10405536|P2|Overall Study|Sponsor decision|0
3025693|NCT00771953|10405537|P1|Overall Study|Sponsor decision|1
3025694|NCT00771953|10405536|P2|Overall Study|Progression before active Tx|2
3025695|NCT00771953|10405537|P1|Overall Study|Progression before active Tx|1
3025696|NCT00771953|10405536|P2|Overall Study|Death|2
3025697|NCT00771953|10405537|P1|Overall Study|Death|2
3025698|NCT00771953|10405536|P2|Overall Study|Adverse Event|3
3025699|NCT00771953|10405537|P1|Overall Study|Adverse Event|5
3025700|NCT00771927|10405547|P2|Overall Study|Other reason|27
3025701|NCT00771927|10405548|P1|Overall Study|Other reason|23
3025702|NCT00771927|10405547|P2|Overall Study|Withdrawal by Subject|17
3025703|NCT00771927|10405548|P1|Overall Study|Withdrawal by Subject|16
3025704|NCT00771927|10405547|P2|Overall Study|Lost to Follow-up|46
3025705|NCT00771927|10405548|P1|Overall Study|Lost to Follow-up|46
3025706|NCT00771927|10405547|P2|Overall Study|Lack of Efficacy|42
3025707|NCT00771927|10405548|P1|Overall Study|Lack of Efficacy|70
3025708|NCT00771927|10405547|P2|Overall Study|Adverse Event|105
3025709|NCT00771927|10405548|P1|Overall Study|Adverse Event|100
3025710|NCT00771914|10405560|P4|Overall Study|Lost to Follow-up|1
3025711|NCT00771914|10405561|P3|Overall Study|Lost to Follow-up|0
3025712|NCT00771914|10405562|P2|Overall Study|Lost to Follow-up|0
3025713|NCT00771914|10405563|P1|Overall Study|Lost to Follow-up|0
3025714|NCT00771914|10405560|P4|Overall Study|Physician Decision|1
3025715|NCT00771914|10405561|P3|Overall Study|Physician Decision|0
3025716|NCT00771914|10405562|P2|Overall Study|Physician Decision|0
3025717|NCT00771914|10405563|P1|Overall Study|Physician Decision|0
3025718|NCT00771901|10405576|P3|Overall Study|Dissat w/# of study medication (40/day)|4
3025719|NCT00771901|10405577|P2|Overall Study|Dissat w/# of study medication (40/day)|0
3025720|NCT00771901|10405578|P1|Overall Study|Dissat w/# of study medication (40/day)|0
3025721|NCT00771849|10405625|P2|Overall Study|Not vaccinated|1
3025722|NCT00771849|10405626|P1|Overall Study|Not vaccinated|0
3025723|NCT00771849|10405625|P2|Overall Study|Withdrawal by Subject|1
3025724|NCT00771849|10405626|P1|Overall Study|Withdrawal by Subject|1
3025725|NCT00771849|10405625|P2|Overall Study|Lost to Follow-up|2
3025726|NCT00771849|10405626|P1|Overall Study|Lost to Follow-up|1
3025727|NCT00771810|10405637|P3|Overall Study|Other|1
3025728|NCT00771810|10405638|P2|Overall Study|Other|0
3025729|NCT00771810|10405639|P1|Overall Study|Other|0
3025730|NCT00771810|10405637|P3|Overall Study|Withdrawal by Subject|0
3025731|NCT00771810|10405638|P2|Overall Study|Withdrawal by Subject|2
3025732|NCT00771810|10405639|P1|Overall Study|Withdrawal by Subject|1
3025733|NCT00771810|10405637|P3|Overall Study|Protocol Violation|1
3025734|NCT00771810|10405638|P2|Overall Study|Protocol Violation|1
3025735|NCT00771810|10405639|P1|Overall Study|Protocol Violation|0
3025736|NCT00771810|10405637|P3|Overall Study|Physician Decision|2
3025737|NCT00771810|10405638|P2|Overall Study|Physician Decision|2
3025738|NCT00771810|10405639|P1|Overall Study|Physician Decision|1
3025739|NCT00771810|10405637|P3|Overall Study|Lost to Follow-up|1
3025740|NCT00771810|10405638|P2|Overall Study|Lost to Follow-up|0
3025741|NCT00771810|10405639|P1|Overall Study|Lost to Follow-up|0
3025742|NCT00771810|10405637|P3|Overall Study|Adverse Event|2
3025743|NCT00771810|10405638|P2|Overall Study|Adverse Event|0
3025744|NCT00771810|10405639|P1|Overall Study|Adverse Event|3
3025745|NCT00771758|10405677|P3|Overall Study|Other|0
3025746|NCT00771758|10405678|P2|Overall Study|Other|2
3025747|NCT00771758|10405679|P1|Overall Study|Other|3
3025748|NCT00771758|10405677|P3|Overall Study|Withdrawal by Subject|0
3025749|NCT00771758|10405678|P2|Overall Study|Withdrawal by Subject|0
3025750|NCT00771758|10405679|P1|Overall Study|Withdrawal by Subject|1
3025751|NCT00771758|10405677|P3|Overall Study|Protocol Violation|0
3025752|NCT00771758|10405678|P2|Overall Study|Protocol Violation|0
3025753|NCT00771758|10405679|P1|Overall Study|Protocol Violation|1
3025754|NCT00771758|10405677|P3|Overall Study|Lost to Follow-up|0
3025755|NCT00771758|10405678|P2|Overall Study|Lost to Follow-up|0
3025756|NCT00771758|10405679|P1|Overall Study|Lost to Follow-up|1
3025757|NCT00771758|10405677|P3|Overall Study|Lack of Efficacy|1
3025758|NCT00771758|10405678|P2|Overall Study|Lack of Efficacy|2
3025759|NCT00771758|10405679|P1|Overall Study|Lack of Efficacy|0
3025760|NCT00771758|10405677|P3|Overall Study|Adverse Event|1
3025761|NCT00771758|10405678|P2|Overall Study|Adverse Event|8
3025762|NCT00771758|10405679|P1|Overall Study|Adverse Event|2
3025763|NCT00771667|10405840|P10|Maintenance Phase|Other|3
3025764|NCT00771667|10405841|P9|Maintenance Phase|Other|3
3025765|NCT00771667|10405842|P8|Maintenance Phase|Other|2
3025766|NCT00771667|10405843|P7|Maintenance Phase|Other|2
3025767|NCT00771667|10405844|P6|Maintenance Phase|Other|1
3025768|NCT00771667|10405845|P5|Maintenance Phase|Other|0
3025769|NCT00771667|10405846|P4|Maintenance Phase|Other|0
3025770|NCT00771667|10405847|P3|Maintenance Phase|Other|0
3025771|NCT00771667|10405848|P2|Maintenance Phase|Other|0
3025772|NCT00771667|10405849|P1|Maintenance Phase|Other|0
3025773|NCT00771667|10405840|P10|Maintenance Phase|Lack of Efficacy|7
3025774|NCT00771667|10405841|P9|Maintenance Phase|Lack of Efficacy|11
3025775|NCT00771667|10405842|P8|Maintenance Phase|Lack of Efficacy|2
3025776|NCT00771667|10405843|P7|Maintenance Phase|Lack of Efficacy|3
3025777|NCT00771667|10405844|P6|Maintenance Phase|Lack of Efficacy|3
3025778|NCT00771667|10405845|P5|Maintenance Phase|Lack of Efficacy|1
3025779|NCT00771667|10405846|P4|Maintenance Phase|Lack of Efficacy|0
3025780|NCT00771667|10405847|P3|Maintenance Phase|Lack of Efficacy|0
3025781|NCT00771667|10405848|P2|Maintenance Phase|Lack of Efficacy|0
3025782|NCT00771667|10405849|P1|Maintenance Phase|Lack of Efficacy|0
3025783|NCT00771667|10405840|P10|Maintenance Phase|Adverse Event|7
3025784|NCT00771667|10405841|P9|Maintenance Phase|Adverse Event|8
3025785|NCT00771667|10405842|P8|Maintenance Phase|Adverse Event|1
3025786|NCT00771667|10405843|P7|Maintenance Phase|Adverse Event|5
3025787|NCT00771667|10405844|P6|Maintenance Phase|Adverse Event|3
3025788|NCT00771667|10405845|P5|Maintenance Phase|Adverse Event|1
3025789|NCT00771667|10405846|P4|Maintenance Phase|Adverse Event|0
3025790|NCT00771667|10405847|P3|Maintenance Phase|Adverse Event|0
3025791|NCT00771667|10405848|P2|Maintenance Phase|Adverse Event|0
3025792|NCT00771667|10405849|P1|Maintenance Phase|Adverse Event|0
3025793|NCT00771667|10405840|P10|Induction Phase|Other|0
3025794|NCT00771667|10405841|P9|Induction Phase|Other|0
3025795|NCT00771667|10405842|P8|Induction Phase|Other|0
3025796|NCT00771667|10405843|P7|Induction Phase|Other|0
3025797|NCT00771667|10405844|P6|Induction Phase|Other|0
3025798|NCT00771667|10405845|P5|Induction Phase|Other|0
3025799|NCT00771667|10405846|P4|Induction Phase|Other|4
3025800|NCT00771667|10405847|P3|Induction Phase|Other|3
3025801|NCT00771667|10405848|P2|Induction Phase|Other|6
3025802|NCT00771667|10405849|P1|Induction Phase|Other|4
3025803|NCT00771667|10405840|P10|Induction Phase|Lost to Follow-up|0
3025804|NCT00771667|10405841|P9|Induction Phase|Lost to Follow-up|0
3025805|NCT00771667|10405842|P8|Induction Phase|Lost to Follow-up|0
3025806|NCT00771667|10405843|P7|Induction Phase|Lost to Follow-up|0
3025807|NCT00771667|10405844|P6|Induction Phase|Lost to Follow-up|0
3025808|NCT00771667|10405845|P5|Induction Phase|Lost to Follow-up|0
3025809|NCT00771667|10405846|P4|Induction Phase|Lost to Follow-up|0
3025810|NCT00771667|10405847|P3|Induction Phase|Lost to Follow-up|1
3025811|NCT00771667|10405848|P2|Induction Phase|Lost to Follow-up|0
3025812|NCT00771667|10405849|P1|Induction Phase|Lost to Follow-up|1
3025813|NCT00771667|10405840|P10|Induction Phase|Lack of Efficacy|0
3025814|NCT00771667|10405841|P9|Induction Phase|Lack of Efficacy|0
3025815|NCT00771667|10405842|P8|Induction Phase|Lack of Efficacy|0
3025816|NCT00771667|10405843|P7|Induction Phase|Lack of Efficacy|0
3025817|NCT00771667|10405844|P6|Induction Phase|Lack of Efficacy|0
3025818|NCT00771667|10405845|P5|Induction Phase|Lack of Efficacy|0
3025819|NCT00771667|10405846|P4|Induction Phase|Lack of Efficacy|3
3025820|NCT00771667|10405847|P3|Induction Phase|Lack of Efficacy|4
3025821|NCT00771667|10405848|P2|Induction Phase|Lack of Efficacy|2
3025822|NCT00771667|10405849|P1|Induction Phase|Lack of Efficacy|9
3025823|NCT00771667|10405840|P10|Induction Phase|Adverse Event|0
3025824|NCT00771667|10405841|P9|Induction Phase|Adverse Event|0
3025825|NCT00771667|10405842|P8|Induction Phase|Adverse Event|0
3025826|NCT00771667|10405843|P7|Induction Phase|Adverse Event|0
3025827|NCT00771667|10405844|P6|Induction Phase|Adverse Event|0
3025828|NCT00771667|10405845|P5|Induction Phase|Adverse Event|0
3025829|NCT00771667|10405846|P4|Induction Phase|Adverse Event|1
3025830|NCT00771667|10405847|P3|Induction Phase|Adverse Event|4
3025831|NCT00771667|10405848|P2|Induction Phase|Adverse Event|2
3025832|NCT00771667|10405849|P1|Induction Phase|Adverse Event|5
3025833|NCT00771615|10405894|P9|Overall Study|Lost to Follow-up|0
3025834|NCT00771615|10405895|P8|Overall Study|Lost to Follow-up|0
3025835|NCT00771615|10405896|P7|Overall Study|Lost to Follow-up|1
3025836|NCT00771615|10405897|P6|Overall Study|Lost to Follow-up|1
3025837|NCT00771615|10405898|P5|Overall Study|Lost to Follow-up|0
3025838|NCT00771615|10405899|P4|Overall Study|Lost to Follow-up|1
3025839|NCT00771615|10405900|P3|Overall Study|Lost to Follow-up|1
3025840|NCT00771615|10405901|P2|Overall Study|Lost to Follow-up|1
3025841|NCT00771615|10405902|P1|Overall Study|Lost to Follow-up|1
3025842|NCT00771615|10405894|P9|Overall Study|Withdrawal by Subject|0
3025843|NCT00771615|10405895|P8|Overall Study|Withdrawal by Subject|1
3025844|NCT00771615|10405896|P7|Overall Study|Withdrawal by Subject|0
3025845|NCT00771615|10405897|P6|Overall Study|Withdrawal by Subject|0
3025846|NCT00771615|10405898|P5|Overall Study|Withdrawal by Subject|0
3025847|NCT00771615|10405899|P4|Overall Study|Withdrawal by Subject|0
3025848|NCT00771615|10405900|P3|Overall Study|Withdrawal by Subject|0
3025849|NCT00771615|10405901|P2|Overall Study|Withdrawal by Subject|1
3025850|NCT00771615|10405902|P1|Overall Study|Withdrawal by Subject|0
3025851|NCT00771472|10406163|P2|Overall Study|Protocol Violation|0
3025852|NCT00771472|10406164|P1|Overall Study|Protocol Violation|1
3025853|NCT00771472|10406163|P2|Overall Study|Progressive Disease|1
3025854|NCT00771472|10406164|P1|Overall Study|Progressive Disease|3
3025855|NCT00771472|10406163|P2|Overall Study|Physician Decision|3
3025856|NCT00771472|10406164|P1|Overall Study|Physician Decision|2
3025857|NCT00771316|10406184|P2|Overall Study|Discontinued due to early termination|0
3025858|NCT00771316|10406185|P1|Overall Study|Discontinued due to early termination|1
3025859|NCT00771316|10406184|P2|Overall Study|Patient withdrew consent|0
3025860|NCT00771316|10406185|P1|Overall Study|Patient withdrew consent|1
3025861|NCT00771316|10406184|P2|Overall Study|Adverse Event|1
3025862|NCT00771316|10406185|P1|Overall Study|Adverse Event|0
3025863|NCT00770991|10406237|P2|Overall Study|Pregnancy|0
3025864|NCT00770991|10406238|P1|Overall Study|Pregnancy|1
3025865|NCT00770991|10406237|P2|Overall Study|Adverse Event|5
3025866|NCT00770991|10406238|P1|Overall Study|Adverse Event|1
3025867|NCT00770991|10406237|P2|Overall Study|Withdrawal by Subject|0
3025868|NCT00770991|10406238|P1|Overall Study|Withdrawal by Subject|1
3025869|NCT00770991|10406237|P2|Overall Study|Physician Decision|0
3025870|NCT00770991|10406238|P1|Overall Study|Physician Decision|2
3025871|NCT00770965|10406254|P4|Excluded Set|Withdrawal by Subject|3
3025872|NCT00770965|10406255|P3|Excluded Set|Withdrawal by Subject|2
3025873|NCT00770965|10406256|P2|Excluded Set|Withdrawal by Subject|1
3025874|NCT00770965|10406257|P1|Excluded Set|Withdrawal by Subject|1
3025875|NCT00770965|10406254|P4|Excluded Set|Administrative problems|10
3025876|NCT00770965|10406255|P3|Excluded Set|Administrative problems|12
3025877|NCT00770965|10406256|P2|Excluded Set|Administrative problems|12
3025878|NCT00770965|10406257|P1|Excluded Set|Administrative problems|14
3025879|NCT00770965|10406254|P4|Safety Set|Protocol deviation|0
3025880|NCT00770965|10406255|P3|Safety Set|Protocol deviation|1
3025881|NCT00770965|10406256|P2|Safety Set|Protocol deviation|0
3025882|NCT00770965|10406257|P1|Safety Set|Protocol deviation|0
3025883|NCT00770965|10406254|P4|Safety Set|Withdrawal by Subject|1
3025884|NCT00770965|10406255|P3|Safety Set|Withdrawal by Subject|0
3025885|NCT00770965|10406256|P2|Safety Set|Withdrawal by Subject|0
3025886|NCT00770965|10406257|P1|Safety Set|Withdrawal by Subject|0
3025887|NCT00770913|10406278|P3|Overall Study|Incorrect drug was allocated|0
3025888|NCT00770913|10406279|P2|Overall Study|Incorrect drug was allocated|0
3025889|NCT00770913|10406280|P1|Overall Study|Incorrect drug was allocated|1
3025890|NCT00770913|10406278|P3|Overall Study|Protocol Violation|1
3025891|NCT00770913|10406279|P2|Overall Study|Protocol Violation|0
3025892|NCT00770913|10406280|P1|Overall Study|Protocol Violation|3
3025893|NCT00770913|10406278|P3|Overall Study|Physician Decision|1
3025894|NCT00770913|10406279|P2|Overall Study|Physician Decision|1
3025895|NCT00770913|10406280|P1|Overall Study|Physician Decision|0
3025896|NCT00770913|10406278|P3|Overall Study|Refusal to continue participation|5
3025897|NCT00770913|10406279|P2|Overall Study|Refusal to continue participation|4
3025898|NCT00770913|10406280|P1|Overall Study|Refusal to continue participation|6
3025899|NCT00770913|10406278|P3|Overall Study|Adverse Event|6
3025900|NCT00770913|10406279|P2|Overall Study|Adverse Event|3
3025901|NCT00770913|10406280|P1|Overall Study|Adverse Event|1
3025902|NCT00770809|10406313|P3|Overall Study|Other Medical Reasons|3
3025903|NCT00770809|10406314|P2|Overall Study|Other Medical Reasons|4
3025904|NCT00770809|10406315|P1|Overall Study|Other Medical Reasons|2
3025905|NCT00770809|10406313|P3|Overall Study|Complicating illness|1
3025906|NCT00770809|10406314|P2|Overall Study|Complicating illness|0
3025907|NCT00770809|10406315|P1|Overall Study|Complicating illness|0
3025908|NCT00770809|10406313|P3|Overall Study|Progression|0
3025909|NCT00770809|10406314|P2|Overall Study|Progression|2
3025910|NCT00770809|10406315|P1|Overall Study|Progression|2
3025911|NCT00770809|10406313|P3|Overall Study|Withdrawal by Subject|7
3025912|NCT00770809|10406314|P2|Overall Study|Withdrawal by Subject|3
3025913|NCT00770809|10406315|P1|Overall Study|Withdrawal by Subject|3
3025914|NCT00770809|10406313|P3|Overall Study|Death|0
3025915|NCT00770809|10406314|P2|Overall Study|Death|0
3025916|NCT00770809|10406315|P1|Overall Study|Death|1
3025917|NCT00770809|10406313|P3|Overall Study|Adverse Event|12
3025918|NCT00770809|10406314|P2|Overall Study|Adverse Event|1
3025919|NCT00770809|10406315|P1|Overall Study|Adverse Event|9
3025920|NCT00770770|10406325|P2|Overall Study|Study Terminated|0
3025921|NCT00770770|10406326|P1|Overall Study|Study Terminated|8
3025922|NCT00770770|10406325|P2|Overall Study|Death|1
3025923|NCT00770770|10406326|P1|Overall Study|Death|0
3025924|NCT00770770|10406325|P2|Overall Study|Withdrawal by Subject|0
3025925|NCT00770770|10406326|P1|Overall Study|Withdrawal by Subject|1
3025926|NCT00770770|10406325|P2|Overall Study|Lost to Follow-up|0
3025927|NCT00770770|10406326|P1|Overall Study|Lost to Follow-up|1
3025928|NCT00770692|10406344|P4|Overall Study|Investigator judgment|1
3025929|NCT00770692|10406345|P3|Overall Study|Investigator judgment|1
3025930|NCT00770692|10406346|P2|Overall Study|Investigator judgment|0
3025931|NCT00770692|10406347|P1|Overall Study|Investigator judgment|2
3025932|NCT00770692|10406344|P4|Overall Study|Adverse Event|4
3025933|NCT00770692|10406345|P3|Overall Study|Adverse Event|4
3025934|NCT00770692|10406346|P2|Overall Study|Adverse Event|0
3025935|NCT00770692|10406347|P1|Overall Study|Adverse Event|3
3025936|NCT00770692|10406344|P4|Overall Study|Withdrawal by Subject|6
3025937|NCT00770692|10406345|P3|Overall Study|Withdrawal by Subject|9
3025938|NCT00770692|10406346|P2|Overall Study|Withdrawal by Subject|9
3025939|NCT00770692|10406347|P1|Overall Study|Withdrawal by Subject|7
3025940|NCT00770679|10406373|P1|Overall Study|Follow-up LDL measurement not collected|3
3025941|NCT00770679|10406373|P1|Overall Study|Lost to Follow-up|3
3025942|NCT00770653|10406381|P2|Overall Study|Physician Decision|0
3025943|NCT00770653|10406382|P1|Overall Study|Physician Decision|1
3025944|NCT00770653|10406381|P2|Overall Study|Lost to Follow-up|2
3025945|NCT00770653|10406382|P1|Overall Study|Lost to Follow-up|1
3025946|NCT00770653|10406381|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
3025947|NCT00770653|10406382|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
3025948|NCT00770653|10406381|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
3025949|NCT00770653|10406382|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
3025950|NCT00770653|10406381|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
3025951|NCT00770653|10406382|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
3025952|NCT00770653|10406381|P2|Overall Study|Lack of Compliance|4
3025953|NCT00770653|10406382|P1|Overall Study|Lack of Compliance|1
3025954|NCT00770653|10406381|P2|Overall Study|Withdrawal by Subject|7
3025955|NCT00770653|10406382|P1|Overall Study|Withdrawal by Subject|4
3025956|NCT00770653|10406381|P2|Overall Study|Protocol Violation|6
3025957|NCT00770653|10406382|P1|Overall Study|Protocol Violation|8
3025958|NCT00770653|10406381|P2|Overall Study|Adverse Event|5
3025959|NCT00770653|10406382|P1|Overall Study|Adverse Event|13
3025960|NCT00770588|10406452|P2|Overall Study|Withdrawal by Subject|1
3025961|NCT00770588|10406453|P1|Overall Study|Withdrawal by Subject|1
3025962|NCT00770588|10406452|P2|Overall Study|Lost to Follow-up|1
3025963|NCT00770588|10406453|P1|Overall Study|Lost to Follow-up|1
3025964|NCT00770588|10406452|P2|Overall Study|Death caused by progression of disease|91
3025965|NCT00770588|10406453|P1|Overall Study|Death caused by progression of disease|70
3025966|NCT00770588|10406452|P2|Overall Study|Adverse Event|2
3025967|NCT00770588|10406453|P1|Overall Study|Adverse Event|9
3025968|NCT00770562|10406469|P2|Overall Study|Did not take treatment|1
3025969|NCT00770562|10406470|P1|Overall Study|Did not take treatment|1
3025970|NCT00770510|10406481|P1|Overall Study|Withdrawal by Subject|2
3025971|NCT00770510|10406481|P1|Overall Study|Pregnancy|1
3025972|NCT00770510|10406481|P1|Overall Study|Lost to Follow-up|2
3025973|NCT00770484|10406520|P2|Overall Study|Withdrawal by Subject|0
3025974|NCT00770484|10406521|P1|Overall Study|Withdrawal by Subject|1
3025975|NCT00770432|10406529|P2|Overall Study|Non-compliance|1
3025976|NCT00770432|10406530|P1|Overall Study|Non-compliance|0
3025977|NCT00770432|10406529|P2|Overall Study|Other|6
3025978|NCT00770432|10406530|P1|Overall Study|Other|4
3025979|NCT00770367|10406538|P2|Second Intervention|Lost to Follow-up|0
3025980|NCT00770367|10406539|P1|Second Intervention|Lost to Follow-up|2
3025981|NCT00770367|10406538|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
3025982|NCT00770367|10406539|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
3025983|NCT00770367|10406538|P2|First Intervention|Withdrawal by Subject|2
3025984|NCT00770367|10406539|P1|First Intervention|Withdrawal by Subject|0
3025985|NCT00770341|10406550|P3|Overall Study|Not treated|0
3025986|NCT00770341|10406551|P2|Overall Study|Not treated|0
3025987|NCT00770341|10406552|P1|Overall Study|Not treated|1
3025988|NCT00770341|10406550|P3|Overall Study|Other|0
3025989|NCT00770341|10406551|P2|Overall Study|Other|0
3025990|NCT00770341|10406552|P1|Overall Study|Other|1
3025991|NCT00770341|10406550|P3|Overall Study|Lack of Efficacy|1
3025992|NCT00770341|10406551|P2|Overall Study|Lack of Efficacy|0
3025993|NCT00770341|10406552|P1|Overall Study|Lack of Efficacy|3
3025994|NCT00770341|10406550|P3|Overall Study|Laboratory adverse event|0
3025995|NCT00770341|10406551|P2|Overall Study|Laboratory adverse event|3
3025996|NCT00770341|10406552|P1|Overall Study|Laboratory adverse event|3
3025997|NCT00770341|10406550|P3|Overall Study|Clinical Adverse Event|2
3025998|NCT00770341|10406551|P2|Overall Study|Clinical Adverse Event|1
3025999|NCT00770341|10406552|P1|Overall Study|Clinical Adverse Event|3
3026000|NCT00770341|10406550|P3|Overall Study|Withdrawal by Subject|0
3026001|NCT00770341|10406551|P2|Overall Study|Withdrawal by Subject|1
3026002|NCT00770341|10406552|P1|Overall Study|Withdrawal by Subject|0
3026003|NCT00770341|10406550|P3|Overall Study|Did not meet eligibility criteria|0
3026004|NCT00770341|10406551|P2|Overall Study|Did not meet eligibility criteria|0
3026005|NCT00770341|10406552|P1|Overall Study|Did not meet eligibility criteria|1
3026006|NCT00770328|10406578|P2|Overall Study|Lost to Follow-up|2
3026007|NCT00770328|10406579|P1|Overall Study|Lost to Follow-up|2
3026008|NCT00770328|10406578|P2|Overall Study|Adverse Event|2
3026009|NCT00770328|10406579|P1|Overall Study|Adverse Event|11
3026010|NCT00770315|10406595|P4|Overall Study|Noncompliance with Protocol|9
3026011|NCT00770315|10406596|P3|Overall Study|Noncompliance with Protocol|7
3026012|NCT00770315|10406597|P2|Overall Study|Noncompliance with Protocol|4
3026013|NCT00770315|10406598|P1|Overall Study|Noncompliance with Protocol|7
3026014|NCT00770315|10406595|P4|Overall Study|Withdrawal by Subject|20
3026015|NCT00770315|10406596|P3|Overall Study|Withdrawal by Subject|24
3026016|NCT00770315|10406597|P2|Overall Study|Withdrawal by Subject|17
3026017|NCT00770315|10406598|P1|Overall Study|Withdrawal by Subject|13
3026018|NCT00770315|10406595|P4|Overall Study|Lost to Follow-up|3
3026019|NCT00770315|10406596|P3|Overall Study|Lost to Follow-up|10
3026020|NCT00770315|10406597|P2|Overall Study|Lost to Follow-up|5
3026021|NCT00770315|10406598|P1|Overall Study|Lost to Follow-up|9
3026022|NCT00770315|10406595|P4|Overall Study|Adverse Event|6
3026023|NCT00770315|10406596|P3|Overall Study|Adverse Event|16
3026024|NCT00770315|10406597|P2|Overall Study|Adverse Event|17
3026025|NCT00770315|10406598|P1|Overall Study|Adverse Event|11
3026026|NCT00770289|10406624|P1|Overall Study|Other|6
3026027|NCT00770224|10406633|P2|Step 2: Maintenance|Ineligible|2
3026028|NCT00770224|10406634|P1|Step 2: Maintenance|Ineligible|0
3026029|NCT00770224|10406633|P2|Step 2: Maintenance|Other reason not protocol specified|7
3026030|NCT00770224|10406634|P1|Step 2: Maintenance|Other reason not protocol specified|0
3026031|NCT00770224|10406633|P2|Step 2: Maintenance|Death|2
3026032|NCT00770224|10406634|P1|Step 2: Maintenance|Death|0
3026033|NCT00770224|10406633|P2|Step 2: Maintenance|Progression/relapse|1
3026034|NCT00770224|10406634|P1|Step 2: Maintenance|Progression/relapse|0
3026035|NCT00770224|10406633|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
3026036|NCT00770224|10406634|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
3026037|NCT00770224|10406633|P2|Step 2: Maintenance|Adverse Event|10
3026038|NCT00770224|10406634|P1|Step 2: Maintenance|Adverse Event|0
3026039|NCT00770224|10406633|P2|Step 1: Induction|No protocol treatment given|0
3026040|NCT00770224|10406634|P1|Step 1: Induction|No protocol treatment given|1
3026041|NCT00770224|10406633|P2|Step 1: Induction|Ineligible|0
3026042|NCT00770224|10406634|P1|Step 1: Induction|Ineligible|2
3026043|NCT00770224|10406633|P2|Step 1: Induction|Other reason not protocol specified|0
3026044|NCT00770224|10406634|P1|Step 1: Induction|Other reason not protocol specified|2
3026045|NCT00770224|10406633|P2|Step 1: Induction|Refusal unrelated to adverse event|0
3026046|NCT00770224|10406634|P1|Step 1: Induction|Refusal unrelated to adverse event|6
3026047|NCT00770224|10406633|P2|Step 1: Induction|Adverse Event|0
3026048|NCT00770224|10406634|P1|Step 1: Induction|Adverse Event|3
3026049|NCT00770211|10406646|P2|Overall Study|Withdrawal by Subject|2
3026050|NCT00770211|10406647|P1|Overall Study|Withdrawal by Subject|0
3026051|NCT00770211|10406646|P2|Overall Study|Lost to Follow-up|0
3026052|NCT00770211|10406647|P1|Overall Study|Lost to Follow-up|1
3026053|NCT00770146|10406663|P2|Follow-up Period|Other|5
3026054|NCT00770146|10406664|P1|Follow-up Period|Other|4
3026055|NCT00770146|10406663|P2|Follow-up Period|Adverse Event|2
3026056|NCT00770146|10406664|P1|Follow-up Period|Adverse Event|0
3026057|NCT00770146|10406663|P2|Follow-up Period|Withdrawal by Subject|13
3026058|NCT00770146|10406664|P1|Follow-up Period|Withdrawal by Subject|7
3026059|NCT00770146|10406663|P2|Treatment Period|Protocol non-compliance|1
3026060|NCT00770146|10406664|P1|Treatment Period|Protocol non-compliance|0
3026061|NCT00770146|10406663|P2|Treatment Period|Other|5
3026062|NCT00770146|10406664|P1|Treatment Period|Other|1
3026063|NCT00770146|10406663|P2|Treatment Period|Adverse Event|26
3026064|NCT00770146|10406664|P1|Treatment Period|Adverse Event|2
3026065|NCT00770146|10406663|P2|Treatment Period|Withdrawal by Subject|13
3026066|NCT00770146|10406664|P1|Treatment Period|Withdrawal by Subject|6
3026067|NCT00770120|10406708|P1|Overall Study|Reason under Review|1
3026068|NCT00770120|10406708|P1|Overall Study|Never Received Treatment/Not Analyzable|1
3026069|NCT00770120|10406708|P1|Overall Study|Ineligible|1
3026070|NCT00770120|10406708|P1|Overall Study|Withdrawal by Subject|2
3026071|NCT00770120|10406708|P1|Overall Study|Death|3
3026072|NCT00770120|10406708|P1|Overall Study|Not Protocol Specified|11
3026073|NCT00770120|10406708|P1|Overall Study|Adverse Event|11
3026074|NCT00770120|10406708|P1|Overall Study|Progression|31
3026075|NCT00770029|10406717|P2|Overall Study|Adverse Event|0
3026076|NCT00770029|10406718|P1|Overall Study|Adverse Event|1
3026077|NCT00770029|10406717|P2|Overall Study|Withdrawal by Subject|3
3026078|NCT00770029|10406718|P1|Overall Study|Withdrawal by Subject|3
3026079|NCT00770029|10406717|P2|Overall Study|Lost to Follow-up|0
3026080|NCT00770029|10406718|P1|Overall Study|Lost to Follow-up|2
3026081|NCT00769860|10406734|P2|Overall Study|Withdrawal by Subject|0
3026082|NCT00769860|10406735|P1|Overall Study|Withdrawal by Subject|2
3026083|NCT00769704|10406763|P2|Overall Study|Other|2
3026084|NCT00769704|10406764|P1|Overall Study|Other|1
3026085|NCT00769704|10406763|P2|Overall Study|Withdrawal by Subject|5
3026086|NCT00769704|10406764|P1|Overall Study|Withdrawal by Subject|12
3026087|NCT00769704|10406763|P2|Overall Study|Death|190
3026088|NCT00769704|10406764|P1|Overall Study|Death|95
3026089|NCT00769704|10406763|P2|Overall Study|Lost to Follow-up|2
3026090|NCT00769704|10406764|P1|Overall Study|Lost to Follow-up|3
3026091|NCT00769561|10406814|P2|Overall Study|Lost to Follow-up|3
3026092|NCT00769561|10406815|P1|Overall Study|Lost to Follow-up|1
3026093|NCT00769561|10406814|P2|Overall Study|Withdrawal by Subject|2
3026094|NCT00769561|10406815|P1|Overall Study|Withdrawal by Subject|2
3026095|NCT00769483|10406841|P6|Overall Study|Withdrawal by Subject|0
3026096|NCT00769483|10406842|P5|Overall Study|Withdrawal by Subject|1
3026097|NCT00769483|10406843|P4|Overall Study|Withdrawal by Subject|0
3026098|NCT00769483|10406844|P3|Overall Study|Withdrawal by Subject|0
3026099|NCT00769483|10406845|P2|Overall Study|Withdrawal by Subject|1
3026100|NCT00769483|10406846|P1|Overall Study|Withdrawal by Subject|0
3026101|NCT00769184|10406918|P2|No Treatment (6 Weeks)|Adverse Event|1
3026102|NCT00769184|10406919|P1|No Treatment (6 Weeks)|Adverse Event|1
3026103|NCT00769184|10406918|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
3026104|NCT00769184|10406919|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
3026105|NCT00769184|10406918|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
3026106|NCT00769184|10406919|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
3026107|NCT00769132|10406927|P4|Period 4|Withdrawal by Subject|0
3026108|NCT00769132|10406928|P3|Period 4|Withdrawal by Subject|0
3026109|NCT00769132|10406929|P2|Period 4|Withdrawal by Subject|1
3026110|NCT00769132|10406930|P1|Period 4|Withdrawal by Subject|0
3026111|NCT00769132|10406927|P4|Period 3|Withdrawal by Subject|0
3026112|NCT00769132|10406928|P3|Period 3|Withdrawal by Subject|0
3026113|NCT00769132|10406929|P2|Period 3|Withdrawal by Subject|0
3026114|NCT00769132|10406930|P1|Period 3|Withdrawal by Subject|1
3026115|NCT00769132|10406927|P4|Period 2|Withdrawal by Subject|1
3026116|NCT00769132|10406928|P3|Period 2|Withdrawal by Subject|0
3026117|NCT00769132|10406929|P2|Period 2|Withdrawal by Subject|0
3026118|NCT00769132|10406930|P1|Period 2|Withdrawal by Subject|0
3026119|NCT00769132|10406927|P4|Period 1|Adverse Event|1
3026120|NCT00769132|10406928|P3|Period 1|Adverse Event|0
3026121|NCT00769132|10406929|P2|Period 1|Adverse Event|0
3026122|NCT00769132|10406930|P1|Period 1|Adverse Event|1
3026123|NCT00769119|10406946|P2|Overall Study|Disallowed medication|0
3026124|NCT00769119|10406947|P1|Overall Study|Disallowed medication|1
3026125|NCT00769119|10406946|P2|Overall Study|Adverse Event|1
3026126|NCT00769119|10406947|P1|Overall Study|Adverse Event|1
3026127|NCT00769119|10406946|P2|Overall Study|Voluntary discontinuation|2
3026128|NCT00769119|10406947|P1|Overall Study|Voluntary discontinuation|0
3026129|NCT00769067|10406993|P2|Overall Study|Withdrawal by Subject|1
3026130|NCT00769067|10406994|P1|Overall Study|Withdrawal by Subject|0
3026131|NCT00769067|10406993|P2|Overall Study|Other|3
3026132|NCT00769067|10406994|P1|Overall Study|Other|1
3026133|NCT00769067|10406993|P2|Overall Study|Study terminated by sponsor|3
3026134|NCT00769067|10406994|P1|Overall Study|Study terminated by sponsor|1
3026135|NCT00769067|10406993|P2|Overall Study|Lost to Follow-up|1
3026136|NCT00769067|10406994|P1|Overall Study|Lost to Follow-up|3
3026137|NCT00769067|10406993|P2|Overall Study|Death|86
3026138|NCT00769067|10406994|P1|Overall Study|Death|89
3026139|NCT00768989|10407042|P2|On or After Week 36|Sponsor Termination|26
3026140|NCT00768989|10407043|P1|On or After Week 36|Sponsor Termination|45
3026141|NCT00768989|10407042|P2|On or After Week 36|Did not attend termination visit|0
3026142|NCT00768989|10407043|P1|On or After Week 36|Did not attend termination visit|2
3026143|NCT00768989|10407042|P2|On or After Week 36|Protocol Violation|0
3026144|NCT00768989|10407043|P1|On or After Week 36|Protocol Violation|1
3026145|NCT00768989|10407042|P2|On or After Week 36|Poor Compliance|0
3026146|NCT00768989|10407043|P1|On or After Week 36|Poor Compliance|1
3026147|NCT00768989|10407042|P2|On or After Week 36|Lost to Follow-up|0
3026148|NCT00768989|10407043|P1|On or After Week 36|Lost to Follow-up|1
3026149|NCT00768989|10407042|P2|On or After Week 36|Adverse Event|1
3026150|NCT00768989|10407043|P1|On or After Week 36|Adverse Event|0
3026151|NCT00768989|10407042|P2|On or After Week 36|Lack of Efficacy|0
3026152|NCT00768989|10407043|P1|On or After Week 36|Lack of Efficacy|1
3026153|NCT00768989|10407042|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
3026154|NCT00768989|10407043|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
3026155|NCT00768989|10407042|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
3026156|NCT00768989|10407043|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
3026157|NCT00768989|10407042|P2|Week 24 to Prior to Week 36|Adverse Event|0
3026158|NCT00768989|10407043|P1|Week 24 to Prior to Week 36|Adverse Event|1
3026159|NCT00768989|10407042|P2|Prior to Week 24|Protocol Violation|2
3026160|NCT00768989|10407043|P1|Prior to Week 24|Protocol Violation|0
3026161|NCT00768989|10407042|P2|Prior to Week 24|Lost to Follow-up|1
3026162|NCT00768989|10407043|P1|Prior to Week 24|Lost to Follow-up|0
3026163|NCT00768989|10407042|P2|Prior to Week 24|Adverse Event|0
3026164|NCT00768989|10407043|P1|Prior to Week 24|Adverse Event|3
3026165|NCT00768989|10407042|P2|Prior to Week 24|Withdrawal by Subject|0
3026166|NCT00768989|10407043|P1|Prior to Week 24|Withdrawal by Subject|1
3026167|NCT00768898|10407091|P1|Overall Study|Headache|1
3026168|NCT00768898|10407091|P1|Overall Study|Unrelated injury|1
3026169|NCT00768755|10407115|P4|Phase 2|Randomized but not treated|2
3026170|NCT00768755|10407116|P3|Phase 2|Randomized but not treated|0
3026171|NCT00768755|10407117|P2|Phase 2|Randomized but not treated|0
3026172|NCT00768755|10407118|P1|Phase 2|Randomized but not treated|0
3026173|NCT00768755|10407115|P4|Phase 2|Study Terminated by Sponsor|14
3026174|NCT00768755|10407116|P3|Phase 2|Study Terminated by Sponsor|7
3026175|NCT00768755|10407117|P2|Phase 2|Study Terminated by Sponsor|13
3026176|NCT00768755|10407118|P1|Phase 2|Study Terminated by Sponsor|0
3026177|NCT00768755|10407115|P4|Phase 2|Other|4
3026178|NCT00768755|10407116|P3|Phase 2|Other|2
3026179|NCT00768755|10407117|P2|Phase 2|Other|1
3026180|NCT00768755|10407118|P1|Phase 2|Other|0
3026181|NCT00768755|10407115|P4|Phase 2|Withdrawal by Subject|1
3026182|NCT00768755|10407116|P3|Phase 2|Withdrawal by Subject|0
3026183|NCT00768755|10407117|P2|Phase 2|Withdrawal by Subject|1
3026184|NCT00768755|10407118|P1|Phase 2|Withdrawal by Subject|0
3026185|NCT00768755|10407115|P4|Phase 2|Lost to Follow-up|4
3026186|NCT00768755|10407116|P3|Phase 2|Lost to Follow-up|1
3026187|NCT00768755|10407117|P2|Phase 2|Lost to Follow-up|1
3026188|NCT00768755|10407118|P1|Phase 2|Lost to Follow-up|0
3026189|NCT00768755|10407115|P4|Phase 2|Protocol Violation|1
3026190|NCT00768755|10407116|P3|Phase 2|Protocol Violation|0
3026191|NCT00768755|10407117|P2|Phase 2|Protocol Violation|2
3026192|NCT00768755|10407118|P1|Phase 2|Protocol Violation|0
3026193|NCT00768755|10407115|P4|Phase 2|Death|31
3026194|NCT00768755|10407116|P3|Phase 2|Death|48
3026195|NCT00768755|10407117|P2|Phase 2|Death|37
3026196|NCT00768755|10407118|P1|Phase 2|Death|0
3026197|NCT00768755|10407115|P4|Phase 1|Other|0
3026198|NCT00768755|10407116|P3|Phase 1|Other|0
3026199|NCT00768755|10407117|P2|Phase 1|Other|0
3026200|NCT00768755|10407118|P1|Phase 1|Other|4
3026201|NCT00768755|10407115|P4|Phase 1|Death|0
3026202|NCT00768755|10407116|P3|Phase 1|Death|0
3026203|NCT00768755|10407117|P2|Phase 1|Death|0
3026204|NCT00768755|10407118|P1|Phase 1|Death|6
3026205|NCT00768651|10407166|P1|Overall Study|Withdrawal by Subject|1
3026206|NCT00768560|10407205|P6|Intervention Set 1|Adverse Event|0
3026207|NCT00768560|10407206|P5|Intervention Set 1|Adverse Event|0
3026208|NCT00768560|10407207|P4|Intervention Set 1|Adverse Event|0
3026209|NCT00768560|10407208|P3|Intervention Set 1|Adverse Event|0
3026210|NCT00768560|10407209|P2|Intervention Set 1|Adverse Event|1
3026211|NCT00768560|10407210|P1|Intervention Set 1|Adverse Event|0
3026212|NCT00768469|10407247|P2|Overall Study|Withdrawal by Subject|1
3026213|NCT00768469|10407248|P1|Overall Study|Withdrawal by Subject|0
3026214|NCT00768469|10407247|P2|Overall Study|Disease Progression|4
3026215|NCT00768469|10407248|P1|Overall Study|Disease Progression|3
3026216|NCT00768469|10407247|P2|Overall Study|Adverse Event|2
3026217|NCT00768469|10407248|P1|Overall Study|Adverse Event|0
3026218|NCT00768430|10407263|P2|7 Day Endpoint|Withdrawal by Subject|3
3026219|NCT00768430|10407264|P1|7 Day Endpoint|Withdrawal by Subject|2
3026220|NCT00768300|10407272|P2|Overall Study|Missing data|0
3026221|NCT00768300|10407273|P1|Overall Study|Missing data|1
3026222|NCT00768300|10407272|P2|Overall Study|Treated but never dosed with Study drug|0
3026223|NCT00768300|10407273|P1|Overall Study|Treated but never dosed with Study drug|1
3026224|NCT00768300|10407272|P2|Overall Study|Began prohibited concomitant medication|1
3026225|NCT00768300|10407273|P1|Overall Study|Began prohibited concomitant medication|0
3026226|NCT00768300|10407272|P2|Overall Study|Lost to Follow-up|1
3026227|NCT00768300|10407273|P1|Overall Study|Lost to Follow-up|0
3026228|NCT00768300|10407272|P2|Overall Study|Received lung transplant|1
3026229|NCT00768300|10407273|P1|Overall Study|Received lung transplant|1
3026230|NCT00768300|10407272|P2|Overall Study|Screen failure following randomization|0
3026231|NCT00768300|10407273|P1|Overall Study|Screen failure following randomization|1
3026232|NCT00768300|10407272|P2|Overall Study|Subject moved to pursue lung transplant|1
3026233|NCT00768300|10407273|P1|Overall Study|Subject moved to pursue lung transplant|1
3026234|NCT00768300|10407272|P2|Overall Study|Death|5
3026235|NCT00768300|10407273|P1|Overall Study|Death|21
3026236|NCT00768300|10407272|P2|Overall Study|Study discontinued by Sponsor|140
3026237|NCT00768300|10407273|P1|Overall Study|Study discontinued by Sponsor|271
3026238|NCT00768300|10407272|P2|Overall Study|Physician Decision|3
3026239|NCT00768300|10407273|P1|Overall Study|Physician Decision|2
3026240|NCT00768300|10407272|P2|Overall Study|Withdrawal by Subject|7
3026241|NCT00768300|10407273|P1|Overall Study|Withdrawal by Subject|13
3026242|NCT00768300|10407272|P2|Overall Study|Protocol Violation|1
3026243|NCT00768300|10407273|P1|Overall Study|Protocol Violation|6
3026244|NCT00768300|10407272|P2|Overall Study|Adverse Event|2
3026245|NCT00768300|10407273|P1|Overall Study|Adverse Event|10
3026246|NCT00768300|10407272|P2|Overall Study|Randomized but not treated|1
3026247|NCT00768300|10407273|P1|Overall Study|Randomized but not treated|1
3026248|NCT00768248|10407357|P2|Overall Study|Research coordinator didn't collect data|1
3026249|NCT00768248|10407358|P1|Overall Study|Research coordinator didn't collect data|1
3026250|NCT00768222|10407374|P2|Overall Study|Protocol Violation|2
3026251|NCT00768222|10407375|P1|Overall Study|Protocol Violation|0
3026252|NCT00768222|10407374|P2|Overall Study|Withdrawal by Subject|1
3026253|NCT00768222|10407375|P1|Overall Study|Withdrawal by Subject|3
3026254|NCT00768222|10407374|P2|Overall Study|Lost to Follow-up|1
3026255|NCT00768222|10407375|P1|Overall Study|Lost to Follow-up|1
3026256|NCT00768144|10407397|P1|Overall Study|Pt Withdrew Consent|1
3026257|NCT00768144|10407397|P1|Overall Study|Patient or MD Decision to End Treatment|1
3026258|NCT00768144|10407397|P1|Overall Study|Progressive Disease|21
3026259|NCT00768144|10407397|P1|Overall Study|Adverse Event|13
3026260|NCT00768066|10407410|P3|Overall Study|Did not receive study product injection.|0
3026261|NCT00768066|10407411|P2|Overall Study|Did not receive study product injection.|3
3026262|NCT00768066|10407412|P1|Overall Study|Did not receive study product injection.|3
3026263|NCT00768053|10407444|P1|Overall Study|Lost to Follow-up|1
3026264|NCT00768053|10407444|P1|Overall Study|Adverse Event|10
3026265|NCT00768040|10407475|P2|Overall Study|Abnormal laboratory value|1
3026266|NCT00768040|10407476|P1|Overall Study|Abnormal laboratory value|1
3026267|NCT00768040|10407475|P2|Overall Study|Adverse Event|2
3026268|NCT00768040|10407476|P1|Overall Study|Adverse Event|3
3026269|NCT00767819|10407485|P3|Overall Study|Lost to Follow-up|0
3026270|NCT00767819|10407486|P2|Overall Study|Lost to Follow-up|0
3026271|NCT00767819|10407487|P1|Overall Study|Lost to Follow-up|1
3026272|NCT00767819|10407485|P3|Overall Study|Abnormal lab values|0
3026273|NCT00767819|10407486|P2|Overall Study|Abnormal lab values|0
3026274|NCT00767819|10407487|P1|Overall Study|Abnormal lab values|1
3026275|NCT00767819|10407485|P3|Overall Study|Adverse Event|0
3026276|NCT00767819|10407486|P2|Overall Study|Adverse Event|0
3026277|NCT00767819|10407487|P1|Overall Study|Adverse Event|2
3026278|NCT00767819|10407485|P3|Overall Study|Death|0
3026279|NCT00767819|10407486|P2|Overall Study|Death|3
3026280|NCT00767819|10407487|P1|Overall Study|Death|2
3026281|NCT00767819|10407485|P3|Overall Study|Administrative problems|0
3026282|NCT00767819|10407486|P2|Overall Study|Administrative problems|1
3026283|NCT00767819|10407487|P1|Overall Study|Administrative problems|0
3026284|NCT00767819|10407485|P3|Overall Study|Withdrawal by Subject|0
3026285|NCT00767819|10407486|P2|Overall Study|Withdrawal by Subject|1
3026286|NCT00767819|10407487|P1|Overall Study|Withdrawal by Subject|1
3026287|NCT00767819|10407485|P3|Overall Study|Unsatisfactory therapeutic effect|0
3026288|NCT00767819|10407486|P2|Overall Study|Unsatisfactory therapeutic effect|14
3026289|NCT00767819|10407487|P1|Overall Study|Unsatisfactory therapeutic effect|18
3026290|NCT00767806|10407512|P2|Overall Study|Sponsor Decision|1
3026291|NCT00767806|10407513|P1|Overall Study|Sponsor Decision|0
3026292|NCT00767806|10407512|P2|Overall Study|Entry Criteria Not Met|1
3026293|NCT00767806|10407513|P1|Overall Study|Entry Criteria Not Met|1
3026294|NCT00767806|10407512|P2|Overall Study|Lost to Follow-up|4
3026295|NCT00767806|10407513|P1|Overall Study|Lost to Follow-up|1
3026296|NCT00767806|10407512|P2|Overall Study|Physician Decision|3
3026297|NCT00767806|10407513|P1|Overall Study|Physician Decision|4
3026298|NCT00767806|10407512|P2|Overall Study|Lack of Efficacy|9
3026299|NCT00767806|10407513|P1|Overall Study|Lack of Efficacy|1
3026300|NCT00767806|10407512|P2|Overall Study|Protocol Violation|5
3026301|NCT00767806|10407513|P1|Overall Study|Protocol Violation|6
3026302|NCT00767806|10407512|P2|Overall Study|Withdrawal by Subject|13
3026303|NCT00767806|10407513|P1|Overall Study|Withdrawal by Subject|8
3026304|NCT00767806|10407512|P2|Overall Study|Adverse Event|11
3026305|NCT00767806|10407513|P1|Overall Study|Adverse Event|30
3026306|NCT00767676|10407590|P1|Overall Study|Investigator error|54
3026307|NCT00767520|10407613|P2|Overall Study|Randomized in error and Never treated|2
3026308|NCT00767520|10407614|P1|Overall Study|Randomized in error and Never treated|0
3026309|NCT00767520|10407613|P2|Overall Study|Participants still on treatment|15
3026310|NCT00767520|10407614|P1|Overall Study|Participants still on treatment|11
3026311|NCT00767455|10407667|P1|Overall Study|Investigator error|19
3026312|NCT00767325|10407701|P1|Overall Study|Missed visit due to family reasons|1
3026313|NCT00767325|10407701|P1|Overall Study|No longer met study criteria|2
3026314|NCT00767325|10407701|P1|Overall Study|Lost to Follow-up|3
3026315|NCT00767325|10407701|P1|Overall Study|Adverse Event|7
3026316|NCT00767325|10407701|P1|Overall Study|Lack of Efficacy|2
3026317|NCT00767104|10407712|P2|Overall Study|Lost to Follow-up|2
3026318|NCT00767104|10407713|P1|Overall Study|Lost to Follow-up|1
3026319|NCT00767039|10407723|P2|Overall Study|Death|2
3026320|NCT00767039|10407724|P1|Overall Study|Death|5
3026321|NCT00767000|10407755|P5|Optional 104-week Extension|Study terminated by sponsor|4
3026322|NCT00767000|10407756|P4|Optional 104-week Extension|Study terminated by sponsor|2
3026323|NCT00767000|10407757|P3|Optional 104-week Extension|Study terminated by sponsor|7
3026324|NCT00767000|10407758|P2|Optional 104-week Extension|Study terminated by sponsor|3
3026325|NCT00767000|10407759|P1|Optional 104-week Extension|Study terminated by sponsor|7
3026326|NCT00767000|10407755|P5|54-week Study|Reason not reported|0
3026327|NCT00767000|10407756|P4|54-week Study|Reason not reported|1
3026328|NCT00767000|10407757|P3|54-week Study|Reason not reported|0
3026329|NCT00767000|10407758|P2|54-week Study|Reason not reported|0
3026330|NCT00767000|10407759|P1|54-week Study|Reason not reported|0
3026331|NCT00767000|10407755|P5|54-week Study|Study terminated by sponsor|194
3026332|NCT00767000|10407756|P4|54-week Study|Study terminated by sponsor|196
3026333|NCT00767000|10407757|P3|54-week Study|Study terminated by sponsor|89
3026334|NCT00767000|10407758|P2|54-week Study|Study terminated by sponsor|102
3026335|NCT00767000|10407759|P1|54-week Study|Study terminated by sponsor|90
3026336|NCT00767000|10407755|P5|54-week Study|Withdrawal by Subject|13
3026337|NCT00767000|10407756|P4|54-week Study|Withdrawal by Subject|11
3026338|NCT00767000|10407757|P3|54-week Study|Withdrawal by Subject|5
3026339|NCT00767000|10407758|P2|54-week Study|Withdrawal by Subject|3
3026340|NCT00767000|10407759|P1|54-week Study|Withdrawal by Subject|2
3026341|NCT00767000|10407755|P5|54-week Study|Protocol Violation|0
3026342|NCT00767000|10407756|P4|54-week Study|Protocol Violation|2
3026343|NCT00767000|10407757|P3|54-week Study|Protocol Violation|1
3026344|NCT00767000|10407758|P2|54-week Study|Protocol Violation|0
3026345|NCT00767000|10407759|P1|54-week Study|Protocol Violation|0
3026346|NCT00767000|10407755|P5|54-week Study|Progressive disease|0
3026347|NCT00767000|10407756|P4|54-week Study|Progressive disease|0
3026348|NCT00767000|10407757|P3|54-week Study|Progressive disease|1
3026349|NCT00767000|10407758|P2|54-week Study|Progressive disease|0
3026350|NCT00767000|10407759|P1|54-week Study|Progressive disease|0
3026351|NCT00767000|10407755|P5|54-week Study|Physician Decision|1
3026352|NCT00767000|10407756|P4|54-week Study|Physician Decision|1
3026353|NCT00767000|10407757|P3|54-week Study|Physician Decision|1
3026354|NCT00767000|10407758|P2|54-week Study|Physician Decision|0
3026355|NCT00767000|10407759|P1|54-week Study|Physician Decision|4
3026356|NCT00767000|10407755|P5|54-week Study|Lost to Follow-up|2
3026357|NCT00767000|10407756|P4|54-week Study|Lost to Follow-up|4
3026358|NCT00767000|10407757|P3|54-week Study|Lost to Follow-up|1
3026359|NCT00767000|10407758|P2|54-week Study|Lost to Follow-up|0
3026360|NCT00767000|10407759|P1|54-week Study|Lost to Follow-up|4
3026361|NCT00767000|10407755|P5|54-week Study|Lack of Efficacy|5
3026362|NCT00767000|10407756|P4|54-week Study|Lack of Efficacy|0
3026363|NCT00767000|10407757|P3|54-week Study|Lack of Efficacy|1
3026364|NCT00767000|10407758|P2|54-week Study|Lack of Efficacy|0
3026365|NCT00767000|10407759|P1|54-week Study|Lack of Efficacy|2
3026366|NCT00767000|10407755|P5|54-week Study|Interruption of study medication|0
3026367|NCT00767000|10407756|P4|54-week Study|Interruption of study medication|0
3026368|NCT00767000|10407757|P3|54-week Study|Interruption of study medication|1
3026369|NCT00767000|10407758|P2|54-week Study|Interruption of study medication|0
3026370|NCT00767000|10407759|P1|54-week Study|Interruption of study medication|0
3026371|NCT00767000|10407755|P5|54-week Study|Hypoglycemia|0
3026372|NCT00767000|10407756|P4|54-week Study|Hypoglycemia|0
3026373|NCT00767000|10407757|P3|54-week Study|Hypoglycemia|0
3026374|NCT00767000|10407758|P2|54-week Study|Hypoglycemia|1
3026375|NCT00767000|10407759|P1|54-week Study|Hypoglycemia|0
3026376|NCT00767000|10407755|P5|54-week Study|Hyperglycemia|1
3026377|NCT00767000|10407756|P4|54-week Study|Hyperglycemia|0
3026378|NCT00767000|10407757|P3|54-week Study|Hyperglycemia|1
3026379|NCT00767000|10407758|P2|54-week Study|Hyperglycemia|0
3026380|NCT00767000|10407759|P1|54-week Study|Hyperglycemia|0
3026381|NCT00767000|10407755|P5|54-week Study|Creaninine/creatinine clearance|4
3026382|NCT00767000|10407756|P4|54-week Study|Creaninine/creatinine clearance|2
3026383|NCT00767000|10407757|P3|54-week Study|Creaninine/creatinine clearance|2
3026384|NCT00767000|10407758|P2|54-week Study|Creaninine/creatinine clearance|1
3026385|NCT00767000|10407759|P1|54-week Study|Creaninine/creatinine clearance|2
3026386|NCT00767000|10407755|P5|54-week Study|Adverse Event|4
3026387|NCT00767000|10407756|P4|54-week Study|Adverse Event|8
3026388|NCT00767000|10407757|P3|54-week Study|Adverse Event|6
3026389|NCT00767000|10407758|P2|54-week Study|Adverse Event|6
3026390|NCT00767000|10407759|P1|54-week Study|Adverse Event|4
3026391|NCT00766831|10407801|P1|Overall Study|Other|28
3026392|NCT00766831|10407801|P1|Overall Study|Non cooperation by participants|14
3026393|NCT00766831|10407801|P1|Overall Study|Withdrawal of consent|26
3026394|NCT00766831|10407801|P1|Overall Study|Physician Decision|5
3026395|NCT00766831|10407801|P1|Overall Study|Protocol Violation|15
3026396|NCT00766831|10407801|P1|Overall Study|Adverse Event|20
3026397|NCT00766831|10407801|P1|Overall Study|Lost to Follow-up|3
3026398|NCT00766831|10407801|P1|Overall Study|Withdrawal by Subject|4
3026399|NCT00766675|10407831|P1|Overall Study|Insufficient therapy|1
3026400|NCT00766675|10407831|P1|Overall Study|Receive other anti-neoplastic treatment|1
3026401|NCT00766675|10407831|P1|Overall Study|Participant took prohibited medication|1
3026402|NCT00766675|10407831|P1|Overall Study|Protocol Violation|8
3026403|NCT00766675|10407831|P1|Overall Study|Withdrawal by Subject|11
3026404|NCT00766675|10407831|P1|Overall Study|Lost to Follow-up|2
3026405|NCT00766675|10407831|P1|Overall Study|Adverse Event|16
3026406|NCT00766636|10407858|P2|Overall Study|Disease Progression|0
3026407|NCT00766636|10407859|P1|Overall Study|Disease Progression|1
3026408|NCT00766636|10407858|P2|Overall Study|Adverse Event|0
3026409|NCT00766636|10407859|P1|Overall Study|Adverse Event|1
3026410|NCT00766636|10407858|P2|Overall Study|Incomplete Treatment|1
3026411|NCT00766636|10407859|P1|Overall Study|Incomplete Treatment|0
3026412|NCT00766636|10407858|P2|Overall Study|Withdrawal by Subject|1
3026413|NCT00766636|10407859|P1|Overall Study|Withdrawal by Subject|1
3026414|NCT00766597|10407865|P1|Overall Study|Without CCR5-tropic virus|5
3026415|NCT00766597|10407865|P1|Overall Study|Unexpected closure of study|4
3026416|NCT00766532|10407877|P1|Overall Study|Protocol Violation|2
3026417|NCT00766506|10407883|P2|Overall Study|Other|2
3026418|NCT00766506|10407884|P1|Overall Study|Other|2
3026419|NCT00766506|10407883|P2|Overall Study|Use rescue medication after 3 hours|0
3026420|NCT00766506|10407884|P1|Overall Study|Use rescue medication after 3 hours|3
3026421|NCT00766493|10407908|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
3026422|NCT00766493|10407908|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
3026423|NCT00766493|10407908|P1|30 Days Post-Procedure|Discontinued|7
3026424|NCT00766467|10407918|P2|Overall Study|Physician Decision|0
3026425|NCT00766467|10407919|P1|Overall Study|Physician Decision|1
3026426|NCT00766467|10407918|P2|Overall Study|Tumor Progression on Study|1
3026427|NCT00766467|10407919|P1|Overall Study|Tumor Progression on Study|0
3026428|NCT00766467|10407918|P2|Overall Study|Protocol Violation|4
3026429|NCT00766467|10407919|P1|Overall Study|Protocol Violation|2
3026430|NCT00766467|10407918|P2|Overall Study|Adverse Event|1
3026431|NCT00766467|10407919|P1|Overall Study|Adverse Event|1
3026432|NCT00766467|10407918|P2|Overall Study|Withdrawal by Subject|2
3026433|NCT00766467|10407919|P1|Overall Study|Withdrawal by Subject|7
3026434|NCT00766415|10407931|P2|Overall Study|Withdrawal by Subject|1
3026435|NCT00766415|10407932|P1|Overall Study|Withdrawal by Subject|0
3026436|NCT00766376|10407980|P1|Overall Study|Withdrawal by Subject|27
3026437|NCT00766363|10407989|P4|Overall Study|Adverse Event Prior to Randomization|0
3026438|NCT00766363|10407990|P3|Overall Study|Adverse Event Prior to Randomization|0
3026439|NCT00766363|10407991|P2|Overall Study|Adverse Event Prior to Randomization|1
3026440|NCT00766363|10407992|P1|Overall Study|Adverse Event Prior to Randomization|0
3026441|NCT00766363|10407989|P4|Overall Study|Withdrawal by Subject|0
3026442|NCT00766363|10407990|P3|Overall Study|Withdrawal by Subject|0
3026443|NCT00766363|10407991|P2|Overall Study|Withdrawal by Subject|0
3026444|NCT00766363|10407992|P1|Overall Study|Withdrawal by Subject|1
3026445|NCT00766090|10408038|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026446|NCT00766090|10408039|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026447|NCT00766090|10408040|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026448|NCT00766090|10408041|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026449|NCT00766090|10408042|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026450|NCT00766090|10408043|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026451|NCT00766090|10408044|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026452|NCT00766090|10408045|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
3026453|NCT00766090|10408046|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026454|NCT00766090|10408047|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026455|NCT00766090|10408048|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026456|NCT00766090|10408049|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
3026457|NCT00766090|10408038|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
3026458|NCT00766090|10408039|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026459|NCT00766090|10408040|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026460|NCT00766090|10408041|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026461|NCT00766090|10408042|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026462|NCT00766090|10408043|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026463|NCT00766090|10408044|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026464|NCT00766090|10408045|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026465|NCT00766090|10408046|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
3026466|NCT00766090|10408047|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026467|NCT00766090|10408048|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
3026468|NCT00766090|10408049|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
3026469|NCT00766090|10408038|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
3026470|NCT00766090|10408039|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
3026471|NCT00766090|10408040|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
3026472|NCT00766090|10408041|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
3026473|NCT00766090|10408042|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
3026474|NCT00766090|10408043|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
3026475|NCT00766090|10408044|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
3026476|NCT00766090|10408045|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
3026477|NCT00766090|10408046|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
3026478|NCT00766090|10408047|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
3026479|NCT00766090|10408048|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
3026480|NCT00766090|10408049|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
3026481|NCT00766090|10408038|P12|Washout Period 2 (14 Days)|Physician Decision|0
3026482|NCT00766090|10408039|P11|Washout Period 2 (14 Days)|Physician Decision|0
3026483|NCT00766090|10408040|P10|Washout Period 2 (14 Days)|Physician Decision|0
3026484|NCT00766090|10408041|P9|Washout Period 2 (14 Days)|Physician Decision|0
3026485|NCT00766090|10408042|P8|Washout Period 2 (14 Days)|Physician Decision|0
3026486|NCT00766090|10408043|P7|Washout Period 2 (14 Days)|Physician Decision|0
3026487|NCT00766090|10408044|P6|Washout Period 2 (14 Days)|Physician Decision|0
3026488|NCT00766090|10408045|P5|Washout Period 2 (14 Days)|Physician Decision|0
3026489|NCT00766090|10408046|P4|Washout Period 2 (14 Days)|Physician Decision|0
3026490|NCT00766090|10408047|P3|Washout Period 2 (14 Days)|Physician Decision|1
3026491|NCT00766090|10408048|P2|Washout Period 2 (14 Days)|Physician Decision|0
3026492|NCT00766090|10408049|P1|Washout Period 2 (14 Days)|Physician Decision|0
3026493|NCT00766090|10408038|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026494|NCT00766090|10408039|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026495|NCT00766090|10408040|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026496|NCT00766090|10408041|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026497|NCT00766090|10408042|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026498|NCT00766090|10408043|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026499|NCT00766090|10408044|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026500|NCT00766090|10408045|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026501|NCT00766090|10408046|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026502|NCT00766090|10408047|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
3026503|NCT00766090|10408048|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026504|NCT00766090|10408049|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
3026505|NCT00766090|10408038|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026506|NCT00766090|10408039|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026507|NCT00766090|10408040|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026508|NCT00766090|10408041|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026509|NCT00766090|10408042|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026510|NCT00766090|10408043|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026511|NCT00766090|10408044|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026512|NCT00766090|10408045|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
3026513|NCT00766090|10408046|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026514|NCT00766090|10408047|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026515|NCT00766090|10408048|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026516|NCT00766090|10408049|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
3026517|NCT00766090|10408038|P12|Washout Period 1 (14 Days)|Protocol Violation|0
3026518|NCT00766090|10408039|P11|Washout Period 1 (14 Days)|Protocol Violation|0
3026519|NCT00766090|10408040|P10|Washout Period 1 (14 Days)|Protocol Violation|0
3026520|NCT00766090|10408041|P9|Washout Period 1 (14 Days)|Protocol Violation|0
3026521|NCT00766090|10408042|P8|Washout Period 1 (14 Days)|Protocol Violation|0
3026522|NCT00766090|10408043|P7|Washout Period 1 (14 Days)|Protocol Violation|0
3026523|NCT00766090|10408044|P6|Washout Period 1 (14 Days)|Protocol Violation|0
3026524|NCT00766090|10408045|P5|Washout Period 1 (14 Days)|Protocol Violation|0
3026525|NCT00766090|10408046|P4|Washout Period 1 (14 Days)|Protocol Violation|0
3026526|NCT00766090|10408047|P3|Washout Period 1 (14 Days)|Protocol Violation|1
3026527|NCT00766090|10408048|P2|Washout Period 1 (14 Days)|Protocol Violation|0
3026528|NCT00766090|10408049|P1|Washout Period 1 (14 Days)|Protocol Violation|0
3026529|NCT00766090|10408038|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026530|NCT00766090|10408039|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026531|NCT00766090|10408040|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026532|NCT00766090|10408041|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026533|NCT00766090|10408042|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026534|NCT00766090|10408043|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026535|NCT00766090|10408044|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026536|NCT00766090|10408045|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026537|NCT00766090|10408046|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
3026538|NCT00766090|10408047|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026539|NCT00766090|10408048|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
3026540|NCT00766090|10408049|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
3026541|NCT00766090|10408038|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026542|NCT00766090|10408039|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026543|NCT00766090|10408040|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026544|NCT00766090|10408041|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026545|NCT00766090|10408042|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026546|NCT00766090|10408043|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026547|NCT00766090|10408044|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026548|NCT00766090|10408045|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026549|NCT00766090|10408046|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026550|NCT00766090|10408047|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026551|NCT00766090|10408048|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
3026552|NCT00766090|10408049|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
3026553|NCT00766090|10408038|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026554|NCT00766090|10408039|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026555|NCT00766090|10408040|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026556|NCT00766090|10408041|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
3026557|NCT00766090|10408042|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026558|NCT00766090|10408043|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026559|NCT00766090|10408044|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026560|NCT00766090|10408045|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026561|NCT00766090|10408046|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026562|NCT00766090|10408047|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026563|NCT00766090|10408048|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026564|NCT00766090|10408049|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
3026565|NCT00766051|10408090|P2|Overall Study|Withdrawal by Subject|0
3026566|NCT00766051|10408091|P1|Overall Study|Withdrawal by Subject|2
3026567|NCT00766038|10408103|P2|Overall Study|Lost to Follow-up|14
3026568|NCT00766038|10408104|P1|Overall Study|Lost to Follow-up|15
3026569|NCT00765999|10408120|P1|Overall Study|Other Miscellaneous Reasons|51
3026570|NCT00765999|10408120|P1|Overall Study|Study Terminated by Sponsor|2
3026571|NCT00765999|10408120|P1|Overall Study|Lost to Follow-up|131
3026572|NCT00765999|10408120|P1|Overall Study|Consent Withdrawn|202
3026573|NCT00765999|10408120|P1|Overall Study|Protocol Violation|95
3026574|NCT00765999|10408120|P1|Overall Study|Insufficient Therapeutic Response|100
3026575|NCT00765999|10408120|P1|Overall Study|Adverse Event|203
3026576|NCT00765882|10408147|P3|Overall Study|Other Reason|2
3026577|NCT00765882|10408148|P2|Overall Study|Other Reason|1
3026578|NCT00765882|10408149|P1|Overall Study|Other Reason|3
3026579|NCT00765882|10408147|P3|Overall Study|Lost to Follow-up|6
3026580|NCT00765882|10408148|P2|Overall Study|Lost to Follow-up|9
3026581|NCT00765882|10408149|P1|Overall Study|Lost to Follow-up|1
3026582|NCT00765882|10408147|P3|Overall Study|Withdrawal by Subject|6
3026583|NCT00765882|10408148|P2|Overall Study|Withdrawal by Subject|6
3026584|NCT00765882|10408149|P1|Overall Study|Withdrawal by Subject|2
3026585|NCT00765882|10408147|P3|Overall Study|Protocol Violation|1
3026586|NCT00765882|10408148|P2|Overall Study|Protocol Violation|3
3026587|NCT00765882|10408149|P1|Overall Study|Protocol Violation|4
3026588|NCT00765882|10408147|P3|Overall Study|Lack of Efficacy|1
3026589|NCT00765882|10408148|P2|Overall Study|Lack of Efficacy|0
3026590|NCT00765882|10408149|P1|Overall Study|Lack of Efficacy|4
3026591|NCT00765882|10408147|P3|Overall Study|Adverse Event|20
3026592|NCT00765882|10408148|P2|Overall Study|Adverse Event|21
3026593|NCT00765882|10408149|P1|Overall Study|Adverse Event|10
3026594|NCT00765843|10408181|P3|Overall Study|Adverse Event|1
3026595|NCT00765843|10408182|P2|Overall Study|Adverse Event|0
3026596|NCT00765843|10408183|P1|Overall Study|Adverse Event|0
3026597|NCT00765843|10408181|P3|Overall Study|did not return to receive intervention|0
3026598|NCT00765843|10408182|P2|Overall Study|did not return to receive intervention|1
3026599|NCT00765843|10408183|P1|Overall Study|did not return to receive intervention|0
3026600|NCT00765843|10408181|P3|Overall Study|Lost to Follow-up|2
3026601|NCT00765843|10408182|P2|Overall Study|Lost to Follow-up|3
3026602|NCT00765843|10408183|P1|Overall Study|Lost to Follow-up|1
3026603|NCT00765817|10408193|P2|Overall Study|Subject decision|11
3026604|NCT00765817|10408194|P1|Overall Study|Subject decision|7
3026605|NCT00765817|10408193|P2|Overall Study|Protocol Violation|1
3026606|NCT00765817|10408194|P1|Overall Study|Protocol Violation|1
3026607|NCT00765817|10408193|P2|Overall Study|Physician Decision|1
3026608|NCT00765817|10408194|P1|Overall Study|Physician Decision|2
3026609|NCT00765817|10408193|P2|Overall Study|Lost to Follow-up|3
3026610|NCT00765817|10408194|P1|Overall Study|Lost to Follow-up|1
3026611|NCT00765817|10408193|P2|Overall Study|Loss of glucose control|2
3026612|NCT00765817|10408194|P1|Overall Study|Loss of glucose control|0
3026613|NCT00765817|10408193|P2|Overall Study|Entry criteria not met|2
3026614|NCT00765817|10408194|P1|Overall Study|Entry criteria not met|2
3026615|NCT00765817|10408193|P2|Overall Study|Death|1
3026616|NCT00765817|10408194|P1|Overall Study|Death|0
3026617|NCT00765817|10408193|P2|Overall Study|Adverse Event|1
3026618|NCT00765817|10408194|P1|Overall Study|Adverse Event|13
3026619|NCT00765726|10408242|P1|Overall Study|Discontinuation of study by sponsor|8
3026620|NCT00765726|10408242|P1|Overall Study|Withdrawal by Subject|1
3026621|NCT00765674|10408250|P4|Overall Study|Randomized in Error - No Study Drug|1
3026622|NCT00765674|10408251|P3|Overall Study|Randomized in Error - No Study Drug|0
3026623|NCT00765674|10408252|P2|Overall Study|Randomized in Error - No Study Drug|1
3026624|NCT00765674|10408253|P1|Overall Study|Randomized in Error - No Study Drug|0
3026625|NCT00765674|10408250|P4|Overall Study|Lost to Follow-up|1
3026626|NCT00765674|10408251|P3|Overall Study|Lost to Follow-up|2
3026627|NCT00765674|10408252|P2|Overall Study|Lost to Follow-up|6
3026628|NCT00765674|10408253|P1|Overall Study|Lost to Follow-up|4
3026629|NCT00765674|10408250|P4|Overall Study|Withdrawal by Subject|8
3026630|NCT00765674|10408251|P3|Overall Study|Withdrawal by Subject|3
3026631|NCT00765674|10408252|P2|Overall Study|Withdrawal by Subject|7
3026632|NCT00765674|10408253|P1|Overall Study|Withdrawal by Subject|5
3026633|NCT00765674|10408250|P4|Overall Study|Protocol Violation|0
3026634|NCT00765674|10408251|P3|Overall Study|Protocol Violation|1
3026635|NCT00765674|10408252|P2|Overall Study|Protocol Violation|0
3026636|NCT00765674|10408253|P1|Overall Study|Protocol Violation|2
3026637|NCT00765674|10408250|P4|Overall Study|Lack of Efficacy|2
3026638|NCT00765674|10408251|P3|Overall Study|Lack of Efficacy|1
3026639|NCT00765674|10408252|P2|Overall Study|Lack of Efficacy|3
3026640|NCT00765674|10408253|P1|Overall Study|Lack of Efficacy|2
3026641|NCT00765674|10408250|P4|Overall Study|Abnormal Test Procedure Result(s)|2
3026642|NCT00765674|10408251|P3|Overall Study|Abnormal Test Procedure Result(s)|1
3026643|NCT00765674|10408252|P2|Overall Study|Abnormal Test Procedure Result(s)|3
3026644|NCT00765674|10408253|P1|Overall Study|Abnormal Test Procedure Result(s)|1
3026645|NCT00765674|10408250|P4|Overall Study|Abnormal Laboratory Value(s)|0
3026646|NCT00765674|10408251|P3|Overall Study|Abnormal Laboratory Value(s)|1
3026647|NCT00765674|10408252|P2|Overall Study|Abnormal Laboratory Value(s)|0
3026648|NCT00765674|10408253|P1|Overall Study|Abnormal Laboratory Value(s)|0
3026649|NCT00765674|10408250|P4|Overall Study|Adverse Event|11
3026650|NCT00765674|10408251|P3|Overall Study|Adverse Event|8
3026651|NCT00765674|10408252|P2|Overall Study|Adverse Event|2
3026652|NCT00765674|10408253|P1|Overall Study|Adverse Event|7
3026653|NCT00765388|10408320|P2|Period 1|Hip operation|1
3026654|NCT00765388|10408321|P1|Period 1|Hip operation|0
3026655|NCT00765388|10408320|P2|Period 1|Herpes Zoster|1
3026656|NCT00765388|10408321|P1|Period 1|Herpes Zoster|0
3026657|NCT00765388|10408320|P2|Period 1|Lost to Follow-up|1
3026658|NCT00765388|10408321|P1|Period 1|Lost to Follow-up|0
3026659|NCT00765388|10408320|P2|Period 1|Lack of Efficacy|2
3026660|NCT00765388|10408321|P1|Period 1|Lack of Efficacy|1
3026661|NCT00765362|10408355|P1|Overall Study|Lost to Follow-up|95
3026662|NCT00765362|10408355|P1|Overall Study|Withdrawal by Subject|13
3026663|NCT00765362|10408355|P1|Overall Study|Protocol Violation|18
3026664|NCT00765362|10408355|P1|Overall Study|Adverse Event|2
3026665|NCT00765362|10408355|P1|Overall Study|Death|9
3026666|NCT00765336|10408363|P2|Overall Study|Adverse Event|1
3026667|NCT00765336|10408364|P1|Overall Study|Adverse Event|2
3026668|NCT00765336|10408363|P2|Overall Study|Lost to Follow-up|9
3026669|NCT00765336|10408364|P1|Overall Study|Lost to Follow-up|7
3026670|NCT00765336|10408363|P2|Overall Study|Withdrawal by Subject|4
3026671|NCT00765336|10408364|P1|Overall Study|Withdrawal by Subject|6
3026672|NCT00765336|10408363|P2|Overall Study|Protocol Violation|2
3026673|NCT00765336|10408364|P1|Overall Study|Protocol Violation|4
3026674|NCT00765245|10408372|P2|Overall Study|Death|0
3026675|NCT00765245|10408373|P1|Overall Study|Death|1
3026676|NCT00765245|10408372|P2|Overall Study|Physician Decision|0
3026677|NCT00765245|10408373|P1|Overall Study|Physician Decision|1
3026678|NCT00765245|10408372|P2|Overall Study|Adverse Event|0
3026679|NCT00765245|10408373|P1|Overall Study|Adverse Event|5
3026680|NCT00765245|10408372|P2|Overall Study|Withdrawal by Subject|0
3026681|NCT00765245|10408373|P1|Overall Study|Withdrawal by Subject|3
3026682|NCT00765245|10408372|P2|Overall Study|disease progression|2
3026683|NCT00765245|10408373|P1|Overall Study|disease progression|3
3026684|NCT00765102|10408419|P1|Overall Study|Protocol Violation|1
3026685|NCT00765102|10408419|P1|Overall Study|Withdrawal by Subject|2
3026686|NCT00765102|10408419|P1|Overall Study|Physician Decision|4
3026687|NCT00765102|10408419|P1|Overall Study|Adverse Event|6
3026688|NCT00765102|10408419|P1|Overall Study|Progressive disease|18
3026689|NCT00765076|10408444|P3|Overall Study|Withdrawal by Subject|1
3026690|NCT00765076|10408445|P2|Overall Study|Withdrawal by Subject|0
3026691|NCT00765076|10408446|P1|Overall Study|Withdrawal by Subject|0
3026692|NCT00765076|10408444|P3|Overall Study|Adverse Event|0
3026693|NCT00765076|10408445|P2|Overall Study|Adverse Event|0
3026694|NCT00765076|10408446|P1|Overall Study|Adverse Event|1
3026695|NCT00765063|10408499|P1|Overall Study|Adverse Event|4
3026696|NCT00765063|10408499|P1|Overall Study|Protocol Violation|6
3026697|NCT00765063|10408499|P1|Overall Study|Other|16
3026698|NCT00765063|10408499|P1|Overall Study|Withdrawal by Subject|1
3026699|NCT00765063|10408499|P1|Overall Study|Lack of Efficacy|5
3026700|NCT00765037|10408515|P1|Overall Study|Adverse Event|1
3026701|NCT00765037|10408515|P1|Overall Study|Lost to Follow-up|5
3026702|NCT00764946|10408522|P3|Overall Study|Never Treated|1
3026703|NCT00764946|10408523|P2|Overall Study|Never Treated|1
3026704|NCT00764946|10408524|P1|Overall Study|Never Treated|1
3026705|NCT00764946|10408522|P3|Overall Study|Withdrawal by Subject|2
3026706|NCT00764946|10408523|P2|Overall Study|Withdrawal by Subject|6
3026707|NCT00764946|10408524|P1|Overall Study|Withdrawal by Subject|3
3026708|NCT00764946|10408522|P3|Overall Study|Adverse Event|1
3026709|NCT00764946|10408523|P2|Overall Study|Adverse Event|2
3026710|NCT00764946|10408524|P1|Overall Study|Adverse Event|3
3026711|NCT00764946|10408522|P3|Overall Study|Physician Decision|0
3026712|NCT00764946|10408523|P2|Overall Study|Physician Decision|4
3026713|NCT00764946|10408524|P1|Overall Study|Physician Decision|2
3026714|NCT00764946|10408522|P3|Overall Study|Lost to Follow-up|0
3026715|NCT00764946|10408523|P2|Overall Study|Lost to Follow-up|4
3026716|NCT00764946|10408524|P1|Overall Study|Lost to Follow-up|3
3026717|NCT00764946|10408522|P3|Overall Study|Lack of Efficacy|0
3026718|NCT00764946|10408523|P2|Overall Study|Lack of Efficacy|0
3026719|NCT00764946|10408524|P1|Overall Study|Lack of Efficacy|1
3026720|NCT00764881|10408552|P2|Overall Study|no treatment or no observation|2
3026721|NCT00764881|10408553|P1|Overall Study|no treatment or no observation|2
3026722|NCT00764881|10408552|P2|Overall Study|Possibly noncompliant (study drug)|2
3026723|NCT00764881|10408553|P1|Overall Study|Possibly noncompliant (study drug)|0
3026724|NCT00764881|10408552|P2|Overall Study|Carcinoma detected|0
3026725|NCT00764881|10408553|P1|Overall Study|Carcinoma detected|1
3026726|NCT00764881|10408552|P2|Overall Study|Wished to become pregnant|0
3026727|NCT00764881|10408553|P1|Overall Study|Wished to become pregnant|1
3026728|NCT00764881|10408552|P2|Overall Study|Accidentally discontinued study drug|0
3026729|NCT00764881|10408553|P1|Overall Study|Accidentally discontinued study drug|1
3026730|NCT00764881|10408552|P2|Overall Study|Noncompliant|0
3026731|NCT00764881|10408553|P1|Overall Study|Noncompliant|1
3026732|NCT00764881|10408552|P2|Overall Study|Lost to Follow-up|0
3026733|NCT00764881|10408553|P1|Overall Study|Lost to Follow-up|2
3026734|NCT00764881|10408552|P2|Overall Study|Protocol Violation|2
3026735|NCT00764881|10408553|P1|Overall Study|Protocol Violation|2
3026736|NCT00764881|10408552|P2|Overall Study|Withdrawal by Subject|3
3026737|NCT00764881|10408553|P1|Overall Study|Withdrawal by Subject|1
3026738|NCT00764881|10408552|P2|Overall Study|Adverse Event|1
3026739|NCT00764881|10408553|P1|Overall Study|Adverse Event|5
3026740|NCT00764868|10408777|P1|Overall Study|Sponsor requested withdrawal|1
3026741|NCT00764868|10408777|P1|Overall Study|Positive drug screen|2
3026742|NCT00764868|10408777|P1|Overall Study|Met an exclusion criteria|1
3026743|NCT00764868|10408777|P1|Overall Study|Subject sent to boarding school|1
3026744|NCT00764868|10408777|P1|Overall Study|Misuse and compliance of study drug|1
3026745|NCT00764868|10408777|P1|Overall Study|Out of town|1
3026746|NCT00764868|10408777|P1|Overall Study|Prohibited medication|1
3026747|NCT00764868|10408777|P1|Overall Study|Pregnancy|3
3026748|NCT00764868|10408777|P1|Overall Study|Subject moved|7
3026749|NCT00764868|10408777|P1|Overall Study|Lack of Efficacy|5
3026750|NCT00764868|10408777|P1|Overall Study|Lost to Follow-up|25
3026751|NCT00764868|10408777|P1|Overall Study|Non-compliance|16
3026752|NCT00764868|10408777|P1|Overall Study|Withdrawal by Subject|31
3026753|NCT00764868|10408777|P1|Overall Study|Adverse Event|18
3026754|NCT00764790|10408786|P3|Overall Study|Lost to Follow-up|23
3026755|NCT00764790|10408787|P2|Overall Study|Lost to Follow-up|29
3026756|NCT00764790|10408788|P1|Overall Study|Lost to Follow-up|28
3026757|NCT00764790|10408786|P3|Overall Study|Withdrawal by Subject|6
3026758|NCT00764790|10408787|P2|Overall Study|Withdrawal by Subject|12
3026759|NCT00764790|10408788|P1|Overall Study|Withdrawal by Subject|10
3026760|NCT00764790|10408786|P3|Overall Study|Protocol Violation|1
3026761|NCT00764790|10408787|P2|Overall Study|Protocol Violation|0
3026762|NCT00764790|10408788|P1|Overall Study|Protocol Violation|0
3026763|NCT00764751|10408822|P2|Overall Study|Psoriasis flare up on the scalp|0
3026764|NCT00764751|10408823|P1|Overall Study|Psoriasis flare up on the scalp|1
3026765|NCT00764751|10408822|P2|Overall Study|Adverse Event|1
3026766|NCT00764751|10408823|P1|Overall Study|Adverse Event|1
3026767|NCT00764699|10408857|P1|Overall Study|PI left and study terminated|3
3026768|NCT00764673|10408861|P1|Overall Study|Revision of Device|2
3026769|NCT00764673|10408861|P1|Overall Study|Withdrawal by Subject|6
3026770|NCT00764673|10408861|P1|Overall Study|Lost to Follow-up|3
3026771|NCT00764673|10408861|P1|Overall Study|Death|1
3026772|NCT00764660|10408871|P2|Overall Study|Did Not Meet Protocol Eligibility|0
3026773|NCT00764660|10408872|P1|Overall Study|Did Not Meet Protocol Eligibility|1
3026774|NCT00764660|10408871|P2|Overall Study|Noncompliance With Protocol|1
3026775|NCT00764660|10408872|P1|Overall Study|Noncompliance With Protocol|5
3026776|NCT00764660|10408871|P2|Overall Study|Withdrawal by Subject|3
3026777|NCT00764660|10408872|P1|Overall Study|Withdrawal by Subject|7
3026778|NCT00764660|10408871|P2|Overall Study|Lost to Follow-up|4
3026779|NCT00764660|10408872|P1|Overall Study|Lost to Follow-up|3
3026780|NCT00764660|10408871|P2|Overall Study|Adverse Event|3
3026781|NCT00764660|10408872|P1|Overall Study|Adverse Event|6
3026782|NCT00764517|10408906|P2|Overall Study|Physician Decision|0
3026783|NCT00764517|10408907|P1|Overall Study|Physician Decision|3
3026784|NCT00764517|10408906|P2|Overall Study|Death|11
3026785|NCT00764517|10408907|P1|Overall Study|Death|3
3026786|NCT00764517|10408906|P2|Overall Study|Adverse Event|3
3026787|NCT00764517|10408907|P1|Overall Study|Adverse Event|9
3026788|NCT00764504|10408928|P3|Overall Study|Lost to Follow-up|72
3026789|NCT00764504|10408929|P2|Overall Study|Lost to Follow-up|34
3026790|NCT00764504|10408930|P1|Overall Study|Lost to Follow-up|40
3026791|NCT00764504|10408928|P3|Overall Study|Withdrawal by Subject|4
3026792|NCT00764504|10408929|P2|Overall Study|Withdrawal by Subject|7
3026793|NCT00764504|10408930|P1|Overall Study|Withdrawal by Subject|1
3026794|NCT00764504|10408928|P3|Overall Study|Physician Decision|0
3026795|NCT00764504|10408929|P2|Overall Study|Physician Decision|0
3026796|NCT00764504|10408930|P1|Overall Study|Physician Decision|1
3026797|NCT00764504|10408928|P3|Overall Study|Revision of Device|14
3026798|NCT00764504|10408929|P2|Overall Study|Revision of Device|23
3026799|NCT00764504|10408930|P1|Overall Study|Revision of Device|12
3026800|NCT00764504|10408928|P3|Overall Study|Death|13
3026801|NCT00764504|10408929|P2|Overall Study|Death|6
3026802|NCT00764504|10408930|P1|Overall Study|Death|12
3026803|NCT00764478|10408959|P3|Overall Study|Protocol Violation|1
3026804|NCT00764478|10408960|P2|Overall Study|Protocol Violation|1
3026805|NCT00764478|10408961|P1|Overall Study|Protocol Violation|0
3026806|NCT00764478|10408959|P3|Overall Study|Lost to Follow-up|5
3026807|NCT00764478|10408960|P2|Overall Study|Lost to Follow-up|8
3026808|NCT00764478|10408961|P1|Overall Study|Lost to Follow-up|7
3026809|NCT00764478|10408959|P3|Overall Study|Withdrawal by Subject|1
3026810|NCT00764478|10408960|P2|Overall Study|Withdrawal by Subject|12
3026811|NCT00764478|10408961|P1|Overall Study|Withdrawal by Subject|7
3026812|NCT00764478|10408959|P3|Overall Study|Adverse Event|1
3026813|NCT00764478|10408960|P2|Overall Study|Adverse Event|1
3026814|NCT00764478|10408961|P1|Overall Study|Adverse Event|1
3026815|NCT00764465|10409041|P6|Overall Study|Withdrawal by Subject|0
3026816|NCT00764465|10409042|P5|Overall Study|Withdrawal by Subject|0
3026817|NCT00764465|10409043|P4|Overall Study|Withdrawal by Subject|0
3026818|NCT00764465|10409044|P3|Overall Study|Withdrawal by Subject|1
3026819|NCT00764465|10409045|P2|Overall Study|Withdrawal by Subject|1
3026820|NCT00764465|10409046|P1|Overall Study|Withdrawal by Subject|0
3026821|NCT00764465|10409041|P6|Overall Study|Adverse Event|1
3026822|NCT00764465|10409042|P5|Overall Study|Adverse Event|1
3026823|NCT00764465|10409043|P4|Overall Study|Adverse Event|1
3026824|NCT00764465|10409044|P3|Overall Study|Adverse Event|0
3026825|NCT00764465|10409045|P2|Overall Study|Adverse Event|0
3026826|NCT00764465|10409046|P1|Overall Study|Adverse Event|2
3026827|NCT00764361|10409074|P2|Overall Study|Adverse Event|1
3026828|NCT00764361|10409075|P1|Overall Study|Adverse Event|0
3026829|NCT00764361|10409074|P2|Overall Study|Withdrawal by Subject|3
3026830|NCT00764361|10409075|P1|Overall Study|Withdrawal by Subject|2
3026831|NCT00764322|10409083|P1|Overall Study|No CYP2D6 genotyping|9
3026832|NCT00764322|10409083|P1|Overall Study|Withdrawal by Subject|11
3026833|NCT00763971|10409110|P3|Overall Study|Participation in 489-326 required|0
3026834|NCT00763971|10409111|P2|Overall Study|Participation in 489-326 required|0
3026835|NCT00763971|10409112|P1|Overall Study|Participation in 489-326 required|1
3026836|NCT00763971|10409110|P3|Overall Study|Performed final visit on phone|0
3026837|NCT00763971|10409111|P2|Overall Study|Performed final visit on phone|1
3026838|NCT00763971|10409112|P1|Overall Study|Performed final visit on phone|0
3026839|NCT00763971|10409110|P3|Overall Study|Lack of availability|0
3026840|NCT00763971|10409111|P2|Overall Study|Lack of availability|1
3026841|NCT00763971|10409112|P1|Overall Study|Lack of availability|0
3026842|NCT00763971|10409110|P3|Overall Study|Subject wanted dose reduction|0
3026843|NCT00763971|10409111|P2|Overall Study|Subject wanted dose reduction|1
3026844|NCT00763971|10409112|P1|Overall Study|Subject wanted dose reduction|0
3026845|NCT00763971|10409110|P3|Overall Study|Moved to another country|0
3026846|NCT00763971|10409111|P2|Overall Study|Moved to another country|1
3026847|NCT00763971|10409112|P1|Overall Study|Moved to another country|0
3026848|NCT00763971|10409110|P3|Overall Study|Medical monitor decision|1
3026849|NCT00763971|10409111|P2|Overall Study|Medical monitor decision|0
3026850|NCT00763971|10409112|P1|Overall Study|Medical monitor decision|0
3026851|NCT00763971|10409110|P3|Overall Study|Randomization error|1
3026852|NCT00763971|10409111|P2|Overall Study|Randomization error|0
3026853|NCT00763971|10409112|P1|Overall Study|Randomization error|0
3026854|NCT00763971|10409110|P3|Overall Study|Due to holiday season|1
3026855|NCT00763971|10409111|P2|Overall Study|Due to holiday season|0
3026856|NCT00763971|10409112|P1|Overall Study|Due to holiday season|2
3026857|NCT00763971|10409110|P3|Overall Study|Sponsor decision|0
3026858|NCT00763971|10409111|P2|Overall Study|Sponsor decision|0
3026859|NCT00763971|10409112|P1|Overall Study|Sponsor decision|1
3026860|NCT00763971|10409110|P3|Overall Study|Exclusion criteria met|0
3026861|NCT00763971|10409111|P2|Overall Study|Exclusion criteria met|0
3026862|NCT00763971|10409112|P1|Overall Study|Exclusion criteria met|1
3026863|NCT00763971|10409110|P3|Overall Study|Personal reason|0
3026864|NCT00763971|10409111|P2|Overall Study|Personal reason|0
3026865|NCT00763971|10409112|P1|Overall Study|Personal reason|3
3026866|NCT00763971|10409110|P3|Overall Study|Unable to swallow capsule|1
3026867|NCT00763971|10409111|P2|Overall Study|Unable to swallow capsule|1
3026868|NCT00763971|10409112|P1|Overall Study|Unable to swallow capsule|2
3026869|NCT00763971|10409110|P3|Overall Study|Lack of Efficacy|54
3026870|NCT00763971|10409111|P2|Overall Study|Lack of Efficacy|22
3026871|NCT00763971|10409112|P1|Overall Study|Lack of Efficacy|11
3026872|NCT00763971|10409110|P3|Overall Study|Lost to Follow-up|0
3026873|NCT00763971|10409111|P2|Overall Study|Lost to Follow-up|1
3026874|NCT00763971|10409112|P1|Overall Study|Lost to Follow-up|0
3026875|NCT00763971|10409110|P3|Overall Study|Withdrawal by Subject|5
3026876|NCT00763971|10409111|P2|Overall Study|Withdrawal by Subject|5
3026877|NCT00763971|10409112|P1|Overall Study|Withdrawal by Subject|4
3026878|NCT00763971|10409110|P3|Overall Study|Protocol Violation|2
3026879|NCT00763971|10409111|P2|Overall Study|Protocol Violation|3
3026880|NCT00763971|10409112|P1|Overall Study|Protocol Violation|3
3026881|NCT00763971|10409110|P3|Overall Study|Adverse Event|4
3026882|NCT00763971|10409111|P2|Overall Study|Adverse Event|2
3026883|NCT00763971|10409112|P1|Overall Study|Adverse Event|5
3026884|NCT00763958|10409143|P2|Overall Study|Believed they were receiving placebo|5
3026885|NCT00763958|10409144|P1|Overall Study|Believed they were receiving placebo|0
3026886|NCT00763958|10409143|P2|Overall Study|Lost to Follow-up|2
3026887|NCT00763958|10409144|P1|Overall Study|Lost to Follow-up|10
3026888|NCT00763958|10409143|P2|Overall Study|did not meet final criteria|4
3026889|NCT00763958|10409144|P1|Overall Study|did not meet final criteria|4
3026890|NCT00763815|10409279|P2|Overall Study|Sponsor's Decision|1
3026891|NCT00763815|10409280|P1|Overall Study|Sponsor's Decision|0
3026892|NCT00763815|10409279|P2|Overall Study|Protocol Violation|5
3026893|NCT00763815|10409280|P1|Overall Study|Protocol Violation|2
3026894|NCT00763815|10409279|P2|Overall Study|Withdrawal by Subject|12
3026895|NCT00763815|10409280|P1|Overall Study|Withdrawal by Subject|7
3026896|NCT00763815|10409279|P2|Overall Study|Physician Decision|0
3026897|NCT00763815|10409280|P1|Overall Study|Physician Decision|1
3026898|NCT00763815|10409279|P2|Overall Study|Familial and Personal Reasons|16
3026899|NCT00763815|10409280|P1|Overall Study|Familial and Personal Reasons|9
3026900|NCT00763815|10409279|P2|Overall Study|Early Termination|0
3026901|NCT00763815|10409280|P1|Overall Study|Early Termination|1
3026902|NCT00763815|10409279|P2|Overall Study|Lost to Follow-up|4
3026903|NCT00763815|10409280|P1|Overall Study|Lost to Follow-up|2
3026904|NCT00763815|10409279|P2|Overall Study|Poor Compliance to Protocol|6
3026905|NCT00763815|10409280|P1|Overall Study|Poor Compliance to Protocol|6
3026906|NCT00763815|10409279|P2|Overall Study|Lack of Efficacy|11
3026907|NCT00763815|10409280|P1|Overall Study|Lack of Efficacy|10
3026908|NCT00763815|10409279|P2|Overall Study|Adverse Event|29
3026909|NCT00763815|10409280|P1|Overall Study|Adverse Event|14
3026910|NCT00763698|10409308|P1|Overall Study|Withdrawal by Subject|1
3026911|NCT00763698|10409308|P1|Overall Study|Death|4
3026912|NCT00763698|10409308|P1|Overall Study|Unsuccessful Implant|5
3026913|NCT00763451|10409325|P4|Overall Study|Study Site Reason|1
3026914|NCT00763451|10409326|P3|Overall Study|Study Site Reason|1
3026915|NCT00763451|10409327|P2|Overall Study|Study Site Reason|1
3026916|NCT00763451|10409328|P1|Overall Study|Study Site Reason|0
3026917|NCT00763451|10409325|P4|Overall Study|Randomized but not Treated|0
3026918|NCT00763451|10409326|P3|Overall Study|Randomized but not Treated|0
3026919|NCT00763451|10409327|P2|Overall Study|Randomized but not Treated|1
3026920|NCT00763451|10409328|P1|Overall Study|Randomized but not Treated|1
3026921|NCT00763451|10409325|P4|Overall Study|Familial and Personal Reasons|4
3026922|NCT00763451|10409326|P3|Overall Study|Familial and Personal Reasons|5
3026923|NCT00763451|10409327|P2|Overall Study|Familial and Personal Reasons|3
3026924|NCT00763451|10409328|P1|Overall Study|Familial and Personal Reasons|5
3026925|NCT00763451|10409325|P4|Overall Study|Poor Compliance to Protocol|2
3026926|NCT00763451|10409326|P3|Overall Study|Poor Compliance to Protocol|2
3026927|NCT00763451|10409327|P2|Overall Study|Poor Compliance to Protocol|1
3026928|NCT00763451|10409328|P1|Overall Study|Poor Compliance to Protocol|1
3026929|NCT00763451|10409325|P4|Overall Study|Protocol Violation|0
3026930|NCT00763451|10409326|P3|Overall Study|Protocol Violation|1
3026931|NCT00763451|10409327|P2|Overall Study|Protocol Violation|0
3026932|NCT00763451|10409328|P1|Overall Study|Protocol Violation|0
3026933|NCT00763451|10409325|P4|Overall Study|Withdrawal by Subject|7
3026934|NCT00763451|10409326|P3|Overall Study|Withdrawal by Subject|9
3026935|NCT00763451|10409327|P2|Overall Study|Withdrawal by Subject|6
3026936|NCT00763451|10409328|P1|Overall Study|Withdrawal by Subject|1
3026937|NCT00763451|10409325|P4|Overall Study|Lack of Efficacy|2
3026938|NCT00763451|10409326|P3|Overall Study|Lack of Efficacy|3
3026939|NCT00763451|10409327|P2|Overall Study|Lack of Efficacy|4
3026940|NCT00763451|10409328|P1|Overall Study|Lack of Efficacy|1
3026941|NCT00763451|10409325|P4|Overall Study|Adverse Event|14
3026942|NCT00763451|10409326|P3|Overall Study|Adverse Event|19
3026943|NCT00763451|10409327|P2|Overall Study|Adverse Event|6
3026944|NCT00763451|10409328|P1|Overall Study|Adverse Event|4
3026945|NCT00763386|10409387|P2|Overall Study|Study Prosthesis Removed|0
3026946|NCT00763386|10409388|P1|Overall Study|Study Prosthesis Removed|1
3026947|NCT00763386|10409387|P2|Overall Study|CRF missing|1
3026948|NCT00763386|10409388|P1|Overall Study|CRF missing|0
3026949|NCT00763386|10409387|P2|Overall Study|Withdrawal by Subject|1
3026950|NCT00763386|10409388|P1|Overall Study|Withdrawal by Subject|0
3026951|NCT00763386|10409387|P2|Overall Study|Lost to Follow-up|3
3026952|NCT00763386|10409388|P1|Overall Study|Lost to Follow-up|3
3026953|NCT00763386|10409387|P2|Overall Study|Death|2
3026954|NCT00763386|10409388|P1|Overall Study|Death|1
3026955|NCT00763386|10409387|P2|Overall Study|Adverse Event|33
3026956|NCT00763386|10409388|P1|Overall Study|Adverse Event|43
3026957|NCT00763321|10409421|P3|Double-blind Period|Other|3
3026958|NCT00763321|10409422|P2|Double-blind Period|Other|2
3026959|NCT00763321|10409423|P1|Double-blind Period|Other|0
3026960|NCT00763321|10409421|P3|Double-blind Period|Withdrawal by Subject|3
3026961|NCT00763321|10409422|P2|Double-blind Period|Withdrawal by Subject|2
3026962|NCT00763321|10409423|P1|Double-blind Period|Withdrawal by Subject|0
3026963|NCT00763321|10409421|P3|Double-blind Period|Lost to Follow-up|2
3026964|NCT00763321|10409422|P2|Double-blind Period|Lost to Follow-up|4
3026965|NCT00763321|10409423|P1|Double-blind Period|Lost to Follow-up|0
3026966|NCT00763321|10409421|P3|Double-blind Period|Adverse Event|4
3026967|NCT00763321|10409422|P2|Double-blind Period|Adverse Event|4
3026968|NCT00763321|10409423|P1|Double-blind Period|Adverse Event|0
3026969|NCT00763321|10409421|P3|Double-blind Period|Lack of Efficacy|17
3026970|NCT00763321|10409422|P2|Double-blind Period|Lack of Efficacy|9
3026971|NCT00763321|10409423|P1|Double-blind Period|Lack of Efficacy|0
3026972|NCT00763321|10409421|P3|Open-label Period|Other|0
3026973|NCT00763321|10409422|P2|Open-label Period|Other|0
3026974|NCT00763321|10409423|P1|Open-label Period|Other|4
3026975|NCT00763321|10409421|P3|Open-label Period|Lack of Efficacy|0
3026976|NCT00763321|10409422|P2|Open-label Period|Lack of Efficacy|0
3026977|NCT00763321|10409423|P1|Open-label Period|Lack of Efficacy|2
3026978|NCT00763321|10409421|P3|Open-label Period|Did not meet DB randomization criteria|0
3026979|NCT00763321|10409422|P2|Open-label Period|Did not meet DB randomization criteria|0
3026980|NCT00763321|10409423|P1|Open-label Period|Did not meet DB randomization criteria|5
3026981|NCT00763321|10409421|P3|Open-label Period|Subject noncompliant|0
3026982|NCT00763321|10409422|P2|Open-label Period|Subject noncompliant|0
3026983|NCT00763321|10409423|P1|Open-label Period|Subject noncompliant|7
3026984|NCT00763321|10409421|P3|Open-label Period|Withdrawal by Subject|0
3026985|NCT00763321|10409422|P2|Open-label Period|Withdrawal by Subject|0
3026986|NCT00763321|10409423|P1|Open-label Period|Withdrawal by Subject|7
3026987|NCT00763321|10409421|P3|Open-label Period|Lost to Follow-up|0
3026988|NCT00763321|10409422|P2|Open-label Period|Lost to Follow-up|0
3026989|NCT00763321|10409423|P1|Open-label Period|Lost to Follow-up|14
3026990|NCT00763321|10409421|P3|Open-label Period|Adverse Event|0
3026991|NCT00763321|10409422|P2|Open-label Period|Adverse Event|0
3026992|NCT00763321|10409423|P1|Open-label Period|Adverse Event|24
3026993|NCT00763282|10409434|P2|Overall Study|Lost to Follow-up|26
3026994|NCT00763282|10409435|P1|Overall Study|Lost to Follow-up|22
3026995|NCT00763282|10409434|P2|Overall Study|Death|3
3026996|NCT00763282|10409435|P1|Overall Study|Death|4
3026997|NCT00763282|10409434|P2|Overall Study|Withdrawal by Subject|5
3026998|NCT00763282|10409435|P1|Overall Study|Withdrawal by Subject|6
3026999|NCT00763269|10409451|P2|Overall Study|Lost to Follow-up|13
3027000|NCT00763269|10409452|P1|Overall Study|Lost to Follow-up|12
3027001|NCT00763256|10409466|P2|Overall Study|Didn't return for appointments|10
3027002|NCT00763256|10409467|P1|Overall Study|Didn't return for appointments|7
3027003|NCT00763139|10409503|P2|Overall Study|med change not allowed by protocol|0
3027004|NCT00763139|10409504|P1|Overall Study|med change not allowed by protocol|1
3027005|NCT00763139|10409503|P2|Overall Study|Withdrawal by Subject|1
3027006|NCT00763139|10409504|P1|Overall Study|Withdrawal by Subject|0
3027007|NCT00763139|10409503|P2|Overall Study|Adverse Event|2
3027008|NCT00763139|10409504|P1|Overall Study|Adverse Event|4
3027009|NCT00763035|10409566|P2|Second Intervention|Physician Decision|0
3027010|NCT00763035|10409567|P1|Second Intervention|Physician Decision|2
3027011|NCT00763035|10409566|P2|Second Intervention|Adverse Event|0
3027012|NCT00763035|10409567|P1|Second Intervention|Adverse Event|1
3027013|NCT00763035|10409566|P2|First Intervention|Adverse Event|1
3027014|NCT00763035|10409567|P1|First Intervention|Adverse Event|0
3027015|NCT00763035|10409566|P2|First Intervention|Did not meeting inclusion/exclusion|0
3027016|NCT00763035|10409567|P1|First Intervention|Did not meeting inclusion/exclusion|1
3027017|NCT00763009|10409585|P1|Overall Study|Coronary Anatomy unsuitable|1
3027018|NCT00762996|10409590|P4|Period One|Withdrawal by Subject|0
3027019|NCT00762996|10409591|P3|Period One|Withdrawal by Subject|1
3027020|NCT00762996|10409592|P2|Period One|Withdrawal by Subject|0
3027021|NCT00762996|10409593|P1|Period One|Withdrawal by Subject|0
3027022|NCT00762996|10409590|P4|Period One|Adverse Event|0
3027023|NCT00762996|10409591|P3|Period One|Adverse Event|1
3027024|NCT00762996|10409592|P2|Period One|Adverse Event|0
3027025|NCT00762996|10409593|P1|Period One|Adverse Event|0
3027026|NCT00762996|10409590|P4|Period One|ineligible|1
3027027|NCT00762996|10409591|P3|Period One|ineligible|1
3027028|NCT00762996|10409592|P2|Period One|ineligible|0
3027029|NCT00762996|10409593|P1|Period One|ineligible|0
3027030|NCT00762996|10409590|P4|Period One|Protocol Violation|0
3027031|NCT00762996|10409591|P3|Period One|Protocol Violation|1
3027032|NCT00762996|10409592|P2|Period One|Protocol Violation|0
3027033|NCT00762996|10409593|P1|Period One|Protocol Violation|0
3027034|NCT00762970|10409606|P3|Overall Study|Difficulty of handling lens|0
3027035|NCT00762970|10409607|P2|Overall Study|Difficulty of handling lens|2
3027036|NCT00762970|10409608|P1|Overall Study|Difficulty of handling lens|1
3027037|NCT00762970|10409606|P3|Overall Study|Lost to Follow-up|0
3027038|NCT00762970|10409607|P2|Overall Study|Lost to Follow-up|2
3027039|NCT00762970|10409608|P1|Overall Study|Lost to Follow-up|1
3027040|NCT00762970|10409606|P3|Overall Study|Protocol Violation|1
3027041|NCT00762970|10409607|P2|Overall Study|Protocol Violation|1
3027042|NCT00762970|10409608|P1|Overall Study|Protocol Violation|3
3027043|NCT00762970|10409606|P3|Overall Study|Withdrawal by Subject|0
3027044|NCT00762970|10409607|P2|Overall Study|Withdrawal by Subject|4
3027045|NCT00762970|10409608|P1|Overall Study|Withdrawal by Subject|7
3027046|NCT00762892|10409626|P2|Overall Study|Incarceration|0
3027047|NCT00762892|10409627|P1|Overall Study|Incarceration|1
3027048|NCT00762892|10409626|P2|Overall Study|Pregnancy|0
3027049|NCT00762892|10409627|P1|Overall Study|Pregnancy|1
3027050|NCT00762892|10409626|P2|Overall Study|Death|0
3027051|NCT00762892|10409627|P1|Overall Study|Death|1
3027052|NCT00762892|10409626|P2|Overall Study|Withdrawal by Subject|1
3027053|NCT00762892|10409627|P1|Overall Study|Withdrawal by Subject|0
3027054|NCT00762892|10409626|P2|Overall Study|Lost to Follow-up|5
3027055|NCT00762892|10409627|P1|Overall Study|Lost to Follow-up|2
3027056|NCT00762788|10409656|P6|Overall Study|Lost to Follow-up|21
3027057|NCT00762788|10409657|P5|Overall Study|Lost to Follow-up|13
3027058|NCT00762788|10409658|P4|Overall Study|Lost to Follow-up|26
3027059|NCT00762788|10409659|P3|Overall Study|Lost to Follow-up|21
3027060|NCT00762788|10409660|P2|Overall Study|Lost to Follow-up|37
3027061|NCT00762788|10409661|P1|Overall Study|Lost to Follow-up|26
3027062|NCT00762762|10409683|P2|Overall Study|Did not report for appointments|10
3027063|NCT00762762|10409684|P1|Overall Study|Did not report for appointments|8
3027064|NCT00762723|10409701|P3|Overall Study|Study Terminated slow enrollement|3
3027065|NCT00762723|10409702|P2|Overall Study|Study Terminated slow enrollement|5
3027066|NCT00762723|10409703|P1|Overall Study|Study Terminated slow enrollement|5
3027067|NCT00762606|10409867|P2|Overall Study|Lost to Follow-up|13
3027068|NCT00762606|10409868|P1|Overall Study|Lost to Follow-up|18
3027069|NCT00762502|10409913|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
3027070|NCT00762502|10409914|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
3027071|NCT00762502|10409915|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
3027072|NCT00762502|10409913|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
3027073|NCT00762502|10409914|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
3027074|NCT00762502|10409915|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
3027075|NCT00762502|10409913|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
3027076|NCT00762502|10409914|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
3027077|NCT00762502|10409915|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
3027078|NCT00762476|10409929|P2|Overall Study|Seasonal allergies|0
3027079|NCT00762476|10409930|P1|Overall Study|Seasonal allergies|1
3027080|NCT00762476|10409929|P2|Overall Study|non-compliance with study visits|2
3027081|NCT00762476|10409930|P1|Overall Study|non-compliance with study visits|0
3027082|NCT00762476|10409929|P2|Overall Study|antibiotic use|1
3027083|NCT00762476|10409930|P1|Overall Study|antibiotic use|0
3027084|NCT00762476|10409929|P2|Overall Study|Withdrawal by Subject|12
3027085|NCT00762476|10409930|P1|Overall Study|Withdrawal by Subject|6
3027086|NCT00762476|10409929|P2|Overall Study|Physician Decision|14
3027087|NCT00762476|10409930|P1|Overall Study|Physician Decision|2
3027088|NCT00762476|10409929|P2|Overall Study|Protocol Violation|6
3027089|NCT00762476|10409930|P1|Overall Study|Protocol Violation|5
3027090|NCT00762476|10409929|P2|Overall Study|Lost to Follow-up|0
3027091|NCT00762476|10409930|P1|Overall Study|Lost to Follow-up|2
3027092|NCT00762476|10409929|P2|Overall Study|Adverse Event|1
3027093|NCT00762476|10409930|P1|Overall Study|Adverse Event|7
3027094|NCT00762463|10409942|P4|Extension Phase (Week 6 to Week 12)|Other|1
3027095|NCT00762463|10409943|P3|Extension Phase (Week 6 to Week 12)|Other|0
3027096|NCT00762463|10409944|P2|Extension Phase (Week 6 to Week 12)|Other|0
3027097|NCT00762463|10409945|P1|Extension Phase (Week 6 to Week 12)|Other|0
3027098|NCT00762463|10409942|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
3027099|NCT00762463|10409943|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
3027100|NCT00762463|10409944|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
3027101|NCT00762463|10409945|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
3027102|NCT00762463|10409942|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
3027103|NCT00762463|10409943|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
3027104|NCT00762463|10409944|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
3027183|NCT00762359|10410208|P2|Overall Study|Physician Decision|3
3027105|NCT00762463|10409945|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
3027106|NCT00762463|10409942|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
3027107|NCT00762463|10409943|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
3027108|NCT00762463|10409944|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
3027109|NCT00762463|10409945|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
3027110|NCT00762463|10409942|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
3027111|NCT00762463|10409943|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
3027112|NCT00762463|10409944|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
3027113|NCT00762463|10409945|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
3027114|NCT00762463|10409942|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
3027115|NCT00762463|10409943|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
3027116|NCT00762463|10409944|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
3027117|NCT00762463|10409945|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
3027118|NCT00762463|10409942|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
3027119|NCT00762463|10409943|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
3027120|NCT00762463|10409944|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
3027121|NCT00762463|10409945|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
3027122|NCT00762463|10409942|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
3027123|NCT00762463|10409943|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
3027124|NCT00762463|10409944|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
3027125|NCT00762463|10409945|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
3027126|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
3027127|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
3027128|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
3027129|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
3027130|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
3027131|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
3027132|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
3027133|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
3027134|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
3027135|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
3027136|NCT00762411|10410051|P2|Safety Follow Up (SFU)-Optional|Death|8
3027137|NCT00762411|10410052|P1|Safety Follow Up (SFU)-Optional|Death|1
3027138|NCT00762411|10410051|P2|Delayed Start|Caregiver Decision|1
3027139|NCT00762411|10410052|P1|Delayed Start|Caregiver Decision|1
3027140|NCT00762411|10410051|P2|Delayed Start|Sponsor Decision|20
3027141|NCT00762411|10410052|P1|Delayed Start|Sponsor Decision|16
3027142|NCT00762411|10410051|P2|Delayed Start|Protocol Violation|1
3027143|NCT00762411|10410052|P1|Delayed Start|Protocol Violation|0
3027144|NCT00762411|10410051|P2|Delayed Start|Adverse Event|4
3027145|NCT00762411|10410052|P1|Delayed Start|Adverse Event|0
3027146|NCT00762411|10410051|P2|Initial Treatment|Entry Criteria Exclusion|1
3027147|NCT00762411|10410052|P1|Initial Treatment|Entry Criteria Exclusion|0
3027148|NCT00762411|10410051|P2|Initial Treatment|Abnormal Lab/ECG Result|4
3027149|NCT00762411|10410052|P1|Initial Treatment|Abnormal Lab/ECG Result|6
3027150|NCT00762411|10410051|P2|Initial Treatment|Caregiver Decision|16
3027151|NCT00762411|10410052|P1|Initial Treatment|Caregiver Decision|21
3027152|NCT00762411|10410051|P2|Initial Treatment|Lost to Follow-up|0
3027153|NCT00762411|10410052|P1|Initial Treatment|Lost to Follow-up|5
3027154|NCT00762411|10410051|P2|Initial Treatment|Sponsor Decision|401
3027155|NCT00762411|10410052|P1|Initial Treatment|Sponsor Decision|293
3027156|NCT00762411|10410051|P2|Initial Treatment|Physician Decision|0
3027157|NCT00762411|10410052|P1|Initial Treatment|Physician Decision|1
3027158|NCT00762411|10410051|P2|Initial Treatment|Withdrawal by Subject|52
3027159|NCT00762411|10410052|P1|Initial Treatment|Withdrawal by Subject|65
3027160|NCT00762411|10410051|P2|Initial Treatment|Protocol Violation|1
3027161|NCT00762411|10410052|P1|Initial Treatment|Protocol Violation|4
3027162|NCT00762411|10410051|P2|Initial Treatment|Adverse Event|40
3027163|NCT00762411|10410052|P1|Initial Treatment|Adverse Event|132
3027164|NCT00762411|10410051|P2|Initial Treatment|Death|6
3027165|NCT00762411|10410052|P1|Initial Treatment|Death|7
3027166|NCT00762385|10410116|P2|Second Intervention|Protocol Violation|3
3027167|NCT00762385|10410117|P1|Second Intervention|Protocol Violation|3
3027168|NCT00762385|10410116|P2|First Intervention|Protocol Violation|1
3027169|NCT00762385|10410117|P1|First Intervention|Protocol Violation|0
3027170|NCT00762385|10410116|P2|First Intervention|Ineligible|0
3027171|NCT00762385|10410117|P1|First Intervention|Ineligible|1
3027172|NCT00762385|10410116|P2|First Intervention|Lost to Follow-up|2
3027173|NCT00762385|10410117|P1|First Intervention|Lost to Follow-up|0
3027174|NCT00762385|10410116|P2|First Intervention|Lens Issue|1
3027175|NCT00762385|10410117|P1|First Intervention|Lens Issue|1
3027176|NCT00762372|10410130|P3|Overall Study|Adverse Event|0
3027177|NCT00762372|10410131|P2|Overall Study|Adverse Event|0
3027178|NCT00762372|10410132|P1|Overall Study|Adverse Event|1
3027179|NCT00762359|10410208|P2|Overall Study|Withdrew consent|0
3027180|NCT00762359|10410209|P1|Overall Study|Withdrew consent|1
3027181|NCT00762359|10410208|P2|Overall Study|Removal|1
3027182|NCT00762359|10410209|P1|Overall Study|Removal|0
3027184|NCT00762359|10410209|P1|Overall Study|Physician Decision|2
3027185|NCT00762359|10410208|P2|Overall Study|Institution closed|3
3027186|NCT00762359|10410209|P1|Overall Study|Institution closed|2
3027187|NCT00762359|10410208|P2|Overall Study|Lack of Efficacy|4
3027188|NCT00762359|10410209|P1|Overall Study|Lack of Efficacy|0
3027189|NCT00762359|10410208|P2|Overall Study|Withdrawal by Subject|10
3027190|NCT00762359|10410209|P1|Overall Study|Withdrawal by Subject|13
3027191|NCT00762359|10410208|P2|Overall Study|Protocol Violation|13
3027192|NCT00762359|10410209|P1|Overall Study|Protocol Violation|21
3027193|NCT00762359|10410208|P2|Overall Study|Adverse Event|23
3027194|NCT00762359|10410209|P1|Overall Study|Adverse Event|20
3027195|NCT00762268|10410326|P2|Overall Study|Withdrawal by Subject|3
3027196|NCT00762268|10410327|P1|Overall Study|Withdrawal by Subject|3
3027197|NCT00762229|10410339|P2|Overall Study|did not recveive intervention|1
3027198|NCT00762229|10410340|P1|Overall Study|did not recveive intervention|0
3027199|NCT00762229|10410339|P2|Overall Study|Lost to Follow-up|1
3027200|NCT00762229|10410340|P1|Overall Study|Lost to Follow-up|1
3027201|NCT00762164|10410437|P2|Overall Study|Withdrawal by Subject|1
3027202|NCT00762164|10410438|P1|Overall Study|Withdrawal by Subject|0
3027203|NCT00762164|10410437|P2|Overall Study|Discontinued medication|0
3027204|NCT00762164|10410438|P1|Overall Study|Discontinued medication|2
3027205|NCT00762164|10410437|P2|Overall Study|Lost to Follow-up|1
3027206|NCT00762164|10410438|P1|Overall Study|Lost to Follow-up|1
3027207|NCT00762086|10410448|P2|Overall Study|Ineligible to participate in the study|0
3027208|NCT00762086|10410449|P1|Overall Study|Ineligible to participate in the study|1
3027209|NCT00762086|10410448|P2|Overall Study|Withdrawal by Subject|2
3027210|NCT00762086|10410449|P1|Overall Study|Withdrawal by Subject|2
3027211|NCT00762086|10410448|P2|Overall Study|Non compliance|0
3027212|NCT00762086|10410449|P1|Overall Study|Non compliance|1
3027213|NCT00762086|10410448|P2|Overall Study|Lost to Follow-up|2
3027214|NCT00762086|10410449|P1|Overall Study|Lost to Follow-up|0
3027215|NCT00762086|10410448|P2|Overall Study|Adverse Event|0
3027216|NCT00762086|10410449|P1|Overall Study|Adverse Event|2
3027217|NCT00762073|10410459|P4|Overall Study|Not on treatment for >/= 77 days|0
3027218|NCT00762073|10410460|P3|Overall Study|Not on treatment for >/= 77 days|0
3027219|NCT00762073|10410461|P2|Overall Study|Not on treatment for >/= 77 days|0
3027220|NCT00762073|10410462|P1|Overall Study|Not on treatment for >/= 77 days|1
3027221|NCT00762073|10410459|P4|Overall Study|Withdrawal by Subject|1
3027222|NCT00762073|10410460|P3|Overall Study|Withdrawal by Subject|1
3027223|NCT00762073|10410461|P2|Overall Study|Withdrawal by Subject|2
3027224|NCT00762073|10410462|P1|Overall Study|Withdrawal by Subject|1
3027225|NCT00762073|10410459|P4|Overall Study|Significant Subject Noncompliance|1
3027226|NCT00762073|10410460|P3|Overall Study|Significant Subject Noncompliance|0
3027227|NCT00762073|10410461|P2|Overall Study|Significant Subject Noncompliance|1
3027228|NCT00762073|10410462|P1|Overall Study|Significant Subject Noncompliance|0
3027229|NCT00762073|10410459|P4|Overall Study|Adverse Event|1
3027230|NCT00762073|10410460|P3|Overall Study|Adverse Event|1
3027231|NCT00762073|10410461|P2|Overall Study|Adverse Event|0
3027232|NCT00762073|10410462|P1|Overall Study|Adverse Event|1
3027233|NCT00762073|10410459|P4|Overall Study|Lack of Efficacy|0
3027234|NCT00762073|10410460|P3|Overall Study|Lack of Efficacy|0
3027235|NCT00762073|10410461|P2|Overall Study|Lack of Efficacy|1
3027236|NCT00762073|10410462|P1|Overall Study|Lack of Efficacy|1
3027237|NCT00762034|10410526|P2|Maintenance Period|Other|1
3027238|NCT00762034|10410527|P1|Maintenance Period|Other|1
3027239|NCT00762034|10410526|P2|Maintenance Period|Death due to study disease|3
3027240|NCT00762034|10410527|P1|Maintenance Period|Death due to study disease|3
3027241|NCT00762034|10410526|P2|Maintenance Period|Death not due to study disease|5
3027242|NCT00762034|10410527|P1|Maintenance Period|Death not due to study disease|2
3027243|NCT00762034|10410526|P2|Maintenance Period|Withdrawal by Subject|14
3027244|NCT00762034|10410527|P1|Maintenance Period|Withdrawal by Subject|34
3027245|NCT00762034|10410526|P2|Maintenance Period|Physician Decision|20
3027246|NCT00762034|10410527|P1|Maintenance Period|Physician Decision|25
3027247|NCT00762034|10410526|P2|Maintenance Period|Progressive Disease|224
3027248|NCT00762034|10410527|P1|Maintenance Period|Progressive Disease|186
3027249|NCT00762034|10410526|P2|Maintenance Period|Adverse Event|26
3027250|NCT00762034|10410527|P1|Maintenance Period|Adverse Event|42
3027251|NCT00762034|10410526|P2|Maintenance Period|Entry Criterion Not Met|2
3027252|NCT00762034|10410527|P1|Maintenance Period|Entry Criterion Not Met|0
3027253|NCT00762034|10410526|P2|Maintenance Period|Protocol Violation|3
3027254|NCT00762034|10410527|P1|Maintenance Period|Protocol Violation|1
3027255|NCT00762034|10410526|P2|Induction Period|Deaths Due to Study Disease|9
3027256|NCT00762034|10410527|P1|Induction Period|Deaths Due to Study Disease|9
3027257|NCT00762034|10410526|P2|Induction Period|Deaths Not Due to Study Disease|14
3027258|NCT00762034|10410527|P1|Induction Period|Deaths Not Due to Study Disease|19
3027259|NCT00762034|10410526|P2|Induction Period|Withdrawal by Subject|19
3027260|NCT00762034|10410527|P1|Induction Period|Withdrawal by Subject|15
3027261|NCT00762034|10410526|P2|Induction Period|Physician Decision|20
3027262|NCT00762034|10410527|P1|Induction Period|Physician Decision|21
3027263|NCT00762034|10410526|P2|Induction Period|Progressive Disease|55
3027264|NCT00762034|10410527|P1|Induction Period|Progressive Disease|73
3027265|NCT00762034|10410526|P2|Induction Period|Lost to Follow-up|1
3027266|NCT00762034|10410527|P1|Induction Period|Lost to Follow-up|1
3027267|NCT00762034|10410526|P2|Induction Period|Adverse Event|38
3027268|NCT00762034|10410527|P1|Induction Period|Adverse Event|27
3027269|NCT00762034|10410526|P2|Induction Period|Entry Criterion Not Met|11
3027270|NCT00762034|10410527|P1|Induction Period|Entry Criterion Not Met|12
3027271|NCT00762034|10410526|P2|Induction Period|Protocol Violation|2
3027272|NCT00762034|10410527|P1|Induction Period|Protocol Violation|1
3027273|NCT00761969|10410599|P2|Overall Study|Lost to Follow-up|93
3027274|NCT00761969|10410600|P1|Overall Study|Lost to Follow-up|88
3027275|NCT00761969|10410599|P2|Overall Study|Death|47
3027276|NCT00761969|10410600|P1|Overall Study|Death|112
3027277|NCT00761956|10410610|P2|Overall Study|Adverse Event|34
3027278|NCT00761956|10410611|P1|Overall Study|Adverse Event|26
3027279|NCT00761956|10410610|P2|Overall Study|Death|1
3027280|NCT00761956|10410611|P1|Overall Study|Death|0
3027281|NCT00761956|10410610|P2|Overall Study|Withdrawal by Subject|8
3027282|NCT00761956|10410611|P1|Overall Study|Withdrawal by Subject|3
3027283|NCT00761956|10410610|P2|Overall Study|Lost to Follow-up|11
3027284|NCT00761956|10410611|P1|Overall Study|Lost to Follow-up|6
3027285|NCT00761891|10410638|P1|Overall Study|Withdrawal by Subject|10
3027286|NCT00761865|10410645|P2|Overall Study|Lost to Follow-up|7
3027287|NCT00761865|10410646|P1|Overall Study|Lost to Follow-up|8
3027288|NCT00761774|10410667|P1|Overall Study|IP stopped by hospital physician|1
3027289|NCT00761774|10410667|P1|Overall Study|Subject IP non-compliance|1
3027290|NCT00761774|10410667|P1|Overall Study|Coordinator leaving site|1
3027291|NCT00761774|10410667|P1|Overall Study|Patient moved out of study area|1
3027292|NCT00761774|10410667|P1|Overall Study|Investigator clinical judgement|1
3027293|NCT00761774|10410667|P1|Overall Study|Sponsor decision|1
3027294|NCT00761774|10410667|P1|Overall Study|Medical decision to read SUSAR reports|1
3027295|NCT00761774|10410667|P1|Overall Study|Reclassification of seizures|1
3027296|NCT00761774|10410667|P1|Overall Study|End of study|2
3027297|NCT00761774|10410667|P1|Overall Study|Non-compliance|4
3027298|NCT00761774|10410667|P1|Overall Study|Withdrawal by Subject|9
3027299|NCT00761774|10410667|P1|Overall Study|Lost to Follow-up|2
3027300|NCT00761774|10410667|P1|Overall Study|Lack of Efficacy|37
3027301|NCT00761774|10410667|P1|Overall Study|Adverse Event|17
3027302|NCT00761761|10410678|P2|Overall Study|Withdrawal by Subject|0
3027303|NCT00761761|10410679|P1|Overall Study|Withdrawal by Subject|3
3027304|NCT00761761|10410678|P2|Overall Study|Lost to Follow-up|1
3027305|NCT00761761|10410679|P1|Overall Study|Lost to Follow-up|3
3027306|NCT00761748|10410691|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
3027307|NCT00761748|10410692|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
3027308|NCT00761748|10410691|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
3027309|NCT00761748|10410692|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
3027310|NCT00761735|10410698|P1|Overall Study|Administrative|1
3027311|NCT00761735|10410698|P1|Overall Study|Non-compliance with protocol|1
3027312|NCT00761735|10410698|P1|Overall Study|Withdrawal by Subject|6
3027313|NCT00761735|10410698|P1|Overall Study|Lost to Follow-up|6
3027314|NCT00761631|10410714|P6|Overall Study|Other|1
3027315|NCT00761631|10410715|P5|Overall Study|Other|1
3027316|NCT00761631|10410716|P4|Overall Study|Other|0
3027317|NCT00761631|10410717|P3|Overall Study|Other|0
3027318|NCT00761631|10410718|P2|Overall Study|Other|0
3027319|NCT00761631|10410719|P1|Overall Study|Other|0
3027320|NCT00761631|10410714|P6|Overall Study|Physician Decision|0
3027321|NCT00761631|10410715|P5|Overall Study|Physician Decision|0
3027322|NCT00761631|10410716|P4|Overall Study|Physician Decision|0
3027323|NCT00761631|10410717|P3|Overall Study|Physician Decision|0
3027324|NCT00761631|10410718|P2|Overall Study|Physician Decision|0
3027325|NCT00761631|10410719|P1|Overall Study|Physician Decision|1
3027326|NCT00761631|10410714|P6|Overall Study|Failed to return|2
3027327|NCT00761631|10410715|P5|Overall Study|Failed to return|5
3027328|NCT00761631|10410716|P4|Overall Study|Failed to return|1
3027329|NCT00761631|10410717|P3|Overall Study|Failed to return|1
3027330|NCT00761631|10410718|P2|Overall Study|Failed to return|0
3027331|NCT00761631|10410719|P1|Overall Study|Failed to return|1
3027332|NCT00761631|10410714|P6|Overall Study|Randomized, not treated|0
3027333|NCT00761631|10410715|P5|Overall Study|Randomized, not treated|0
3027334|NCT00761631|10410716|P4|Overall Study|Randomized, not treated|0
3027335|NCT00761631|10410717|P3|Overall Study|Randomized, not treated|0
3027336|NCT00761631|10410718|P2|Overall Study|Randomized, not treated|0
3027337|NCT00761631|10410719|P1|Overall Study|Randomized, not treated|1
3027338|NCT00761631|10410714|P6|Overall Study|Protocol Violation|1
3027339|NCT00761631|10410715|P5|Overall Study|Protocol Violation|5
3027340|NCT00761631|10410716|P4|Overall Study|Protocol Violation|1
3027341|NCT00761631|10410717|P3|Overall Study|Protocol Violation|0
3027342|NCT00761631|10410718|P2|Overall Study|Protocol Violation|0
3027343|NCT00761631|10410719|P1|Overall Study|Protocol Violation|2
3027344|NCT00761631|10410714|P6|Overall Study|Lost to Follow-up|1
3027345|NCT00761631|10410715|P5|Overall Study|Lost to Follow-up|6
3027346|NCT00761631|10410716|P4|Overall Study|Lost to Follow-up|1
3027347|NCT00761631|10410717|P3|Overall Study|Lost to Follow-up|7
3027348|NCT00761631|10410718|P2|Overall Study|Lost to Follow-up|4
3027349|NCT00761631|10410719|P1|Overall Study|Lost to Follow-up|2
3027350|NCT00761631|10410714|P6|Overall Study|Parent/legal guardian request|0
3027351|NCT00761631|10410715|P5|Overall Study|Parent/legal guardian request|5
3027352|NCT00761631|10410716|P4|Overall Study|Parent/legal guardian request|0
3027353|NCT00761631|10410717|P3|Overall Study|Parent/legal guardian request|8
3027354|NCT00761631|10410718|P2|Overall Study|Parent/legal guardian request|3
3027355|NCT00761631|10410719|P1|Overall Study|Parent/legal guardian request|8
3027356|NCT00761605|10410754|P1|Overall Study|Other|21
3027357|NCT00761605|10410754|P1|Overall Study|Withdrawal by Subject|37
3027358|NCT00761605|10410754|P1|Overall Study|Lost to Follow-up|29
3027359|NCT00761605|10410754|P1|Overall Study|Lack of Efficacy|26
3027360|NCT00761605|10410754|P1|Overall Study|Death|2
3027361|NCT00761605|10410754|P1|Overall Study|Adverse Event|26
3027362|NCT00761579|10410798|P1|Overall Study|Intake of prohibited concomitant drug|1
3027363|NCT00761579|10410798|P1|Overall Study|Lost survey form|1
3027364|NCT00761579|10410798|P1|Overall Study|Aggravation of symptoms by changing drug|1
3027365|NCT00761579|10410798|P1|Overall Study|Aggravation of depression|1
3027366|NCT00761579|10410798|P1|Overall Study|Drug overdose|1
3027367|NCT00761579|10410798|P1|Overall Study|Protocol deviation|1
3027368|NCT00761579|10410798|P1|Overall Study|Lack of compliance|2
3027369|NCT00761579|10410798|P1|Overall Study|Withdrawal by Subject|34
3027370|NCT00761579|10410798|P1|Overall Study|Pregnancy|1
3027371|NCT00761579|10410798|P1|Overall Study|Lost to Follow-up|16
3027372|NCT00761579|10410798|P1|Overall Study|Lack of Efficacy|21
3027373|NCT00761579|10410798|P1|Overall Study|Death|2
3027374|NCT00761579|10410798|P1|Overall Study|Adverse Event|10
3027375|NCT00761527|10410831|P1|Overall Study|Unknown reason|2
3027376|NCT00761527|10410831|P1|Overall Study|Lost to Follow-up|9
3027377|NCT00761527|10410831|P1|Overall Study|Poor Compliance|8
3027378|NCT00761527|10410831|P1|Overall Study|Adverse Event|3
3027379|NCT00761514|10410838|P1|Overall Study|Unable to pay for medications|1
3027380|NCT00761514|10410838|P1|Overall Study|Problem complying with study visit|1
3027381|NCT00761514|10410838|P1|Overall Study|Health insurance didn't cover study drug|1
3027382|NCT00761514|10410838|P1|Overall Study|Lost to Follow-up|1
3027383|NCT00761514|10410838|P1|Overall Study|Withdrawal by Subject|2
3027384|NCT00761514|10410838|P1|Overall Study|Adverse Event|1
3027385|NCT00761462|10410845|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
3027386|NCT00761462|10410846|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
3027387|NCT00761462|10410845|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
3027388|NCT00761462|10410846|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
3027389|NCT00761462|10410845|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
3027390|NCT00761462|10410846|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
3027391|NCT00761462|10410845|P2|Treatment|Subjects never received study medication|12
3027392|NCT00761462|10410846|P1|Treatment|Subjects never received study medication|23
3027393|NCT00761319|10410860|P2|Overall Study|Missing|0
3027394|NCT00761319|10410861|P1|Overall Study|Missing|1
3027395|NCT00761319|10410860|P2|Overall Study|Nonspecified|2
3027396|NCT00761319|10410861|P1|Overall Study|Nonspecified|2
3027397|NCT00761319|10410860|P2|Overall Study|Lost to Follow-up|1
3027398|NCT00761319|10410861|P1|Overall Study|Lost to Follow-up|1
3027399|NCT00761319|10410860|P2|Overall Study|Noncompliance|3
3027400|NCT00761319|10410861|P1|Overall Study|Noncompliance|4
3027401|NCT00761319|10410860|P2|Overall Study|Withdrawal by Subject|7
3027402|NCT00761319|10410861|P1|Overall Study|Withdrawal by Subject|8
3027403|NCT00761319|10410860|P2|Overall Study|Adverse Event|7
3027404|NCT00761319|10410861|P1|Overall Study|Adverse Event|11
3027405|NCT00761319|10410860|P2|Overall Study|Protocol Violation|14
3027406|NCT00761319|10410861|P1|Overall Study|Protocol Violation|21
3027407|NCT00761306|10410869|P1|Overall Study|Administrative or Other Reasons|5
3027408|NCT00761306|10410869|P1|Overall Study|Lost to Follow-up|1
3027409|NCT00761306|10410869|P1|Overall Study|Withdrawal of Consent|3
3027410|NCT00761306|10410869|P1|Overall Study|Protocol Violation|2
3027411|NCT00761306|10410869|P1|Overall Study|Lack of Efficacy|4
3027412|NCT00761306|10410869|P1|Overall Study|Adverse Event|5
3027413|NCT00761280|10410880|P2|First Dose to End of Study|Lost to Follow-up|1
3027414|NCT00761280|10410881|P1|First Dose to End of Study|Lost to Follow-up|0
3027415|NCT00761280|10410880|P2|First Dose to End of Study|Death|0
3027416|NCT00761280|10410881|P1|First Dose to End of Study|Death|1
3027417|NCT00761280|10410880|P2|First Dose to End of Study|Sponsor decision|2
3027418|NCT00761280|10410881|P1|First Dose to End of Study|Sponsor decision|1
3027419|NCT00761280|10410880|P2|First Dose to End of Study|Progressive disease|3
3027420|NCT00761280|10410881|P1|First Dose to End of Study|Progressive disease|5
3027421|NCT00761280|10410880|P2|First Dose to End of Study|End of trial|5
3027422|NCT00761280|10410881|P1|First Dose to End of Study|End of trial|5
3027423|NCT00761280|10410880|P2|Randomization to First Dose|Other|0
3027424|NCT00761280|10410881|P1|Randomization to First Dose|Other|1
3027425|NCT00761280|10410880|P2|Randomization to First Dose|Sponsor decision|0
3027426|NCT00761280|10410881|P1|Randomization to First Dose|Sponsor decision|1
3027427|NCT00761280|10410880|P2|Randomization to First Dose|Withdrawal by Subject|2
3027428|NCT00761280|10410881|P1|Randomization to First Dose|Withdrawal by Subject|0
3027429|NCT00761267|10410912|P3|Overall Study|Withdrawal by Subject|0
3027430|NCT00761267|10410913|P2|Overall Study|Withdrawal by Subject|1
3027431|NCT00761267|10410914|P1|Overall Study|Withdrawal by Subject|0
3027432|NCT00761267|10410912|P3|Overall Study|Randomized but not treated|0
3027433|NCT00761267|10410913|P2|Overall Study|Randomized but not treated|1
3027434|NCT00761267|10410914|P1|Overall Study|Randomized but not treated|1
3027435|NCT00761267|10410912|P3|Overall Study|Lost to Follow-up|1
3027436|NCT00761267|10410913|P2|Overall Study|Lost to Follow-up|0
3027437|NCT00761267|10410914|P1|Overall Study|Lost to Follow-up|0
3027438|NCT00761267|10410912|P3|Overall Study|Death|5
3027439|NCT00761267|10410913|P2|Overall Study|Death|2
3027440|NCT00761267|10410914|P1|Overall Study|Death|1
3027441|NCT00761215|10410965|P3|Overall Study|Bacteremia|0
3027442|NCT00761215|10410966|P2|Overall Study|Bacteremia|0
3027443|NCT00761215|10410967|P1|Overall Study|Bacteremia|1
3027444|NCT00761215|10410965|P3|Overall Study|Withdrawal by Subject|0
3027445|NCT00761215|10410966|P2|Overall Study|Withdrawal by Subject|0
3027446|NCT00761215|10410967|P1|Overall Study|Withdrawal by Subject|1
3027447|NCT00761215|10410965|P3|Overall Study|Lost to Follow-up|6
3027448|NCT00761215|10410966|P2|Overall Study|Lost to Follow-up|3
3027449|NCT00761215|10410967|P1|Overall Study|Lost to Follow-up|6
3027450|NCT00761215|10410965|P3|Overall Study|Randomized but didn't receive drug|2
3027451|NCT00761215|10410966|P2|Overall Study|Randomized but didn't receive drug|1
3027452|NCT00761215|10410967|P1|Overall Study|Randomized but didn't receive drug|1
3027453|NCT00761189|10411009|P1|Overall Study|Other|13
3027454|NCT00761189|10411009|P1|Overall Study|Withdrawal by Subject|49
3027455|NCT00761189|10411009|P1|Overall Study|Lost to Follow-up|36
3027456|NCT00761189|10411009|P1|Overall Study|Lack of Efficacy|45
3027457|NCT00761189|10411009|P1|Overall Study|Adverse Event|42
3027458|NCT00761176|10411026|P2|Overall Study|Withdrawal by Subject|1
3027459|NCT00761176|10411027|P1|Overall Study|Withdrawal by Subject|1
3027460|NCT00761176|10411026|P2|Overall Study|Death|0
3027461|NCT00761176|10411027|P1|Overall Study|Death|1
3027462|NCT00761150|10411036|P3|Double-blind Period|Other|3
3027463|NCT00761150|10411037|P2|Double-blind Period|Other|3
3027464|NCT00761150|10411038|P1|Double-blind Period|Other|0
3027465|NCT00761150|10411036|P3|Double-blind Period|Noncompliance|0
3027466|NCT00761150|10411037|P2|Double-blind Period|Noncompliance|1
3027467|NCT00761150|10411038|P1|Double-blind Period|Noncompliance|0
3027468|NCT00761150|10411036|P3|Double-blind Period|Did not meet DB randomization criteria|1
3027469|NCT00761150|10411037|P2|Double-blind Period|Did not meet DB randomization criteria|0
3027470|NCT00761150|10411038|P1|Double-blind Period|Did not meet DB randomization criteria|0
3027471|NCT00761150|10411036|P3|Double-blind Period|Lost to Follow-up|1
3027472|NCT00761150|10411037|P2|Double-blind Period|Lost to Follow-up|2
3027473|NCT00761150|10411038|P1|Double-blind Period|Lost to Follow-up|0
3027474|NCT00761150|10411036|P3|Double-blind Period|Withdrawal by Subject|2
3027475|NCT00761150|10411037|P2|Double-blind Period|Withdrawal by Subject|3
3027476|NCT00761150|10411038|P1|Double-blind Period|Withdrawal by Subject|0
3027477|NCT00761150|10411036|P3|Double-blind Period|Adverse Event|3
3027478|NCT00761150|10411037|P2|Double-blind Period|Adverse Event|3
3027479|NCT00761150|10411038|P1|Double-blind Period|Adverse Event|0
3027480|NCT00761150|10411036|P3|Double-blind Period|Lack of Efficacy|19
3027481|NCT00761150|10411037|P2|Double-blind Period|Lack of Efficacy|2
3027482|NCT00761150|10411038|P1|Double-blind Period|Lack of Efficacy|0
3027483|NCT00761150|10411036|P3|Open-label Period|Other|0
3027484|NCT00761150|10411037|P2|Open-label Period|Other|0
3027485|NCT00761150|10411038|P1|Open-label Period|Other|5
3027486|NCT00761150|10411036|P3|Open-label Period|Noncompliance|0
3027487|NCT00761150|10411037|P2|Open-label Period|Noncompliance|0
3027488|NCT00761150|10411038|P1|Open-label Period|Noncompliance|2
3027489|NCT00761150|10411036|P3|Open-label Period|Withdrawal by Subject|0
3027490|NCT00761150|10411037|P2|Open-label Period|Withdrawal by Subject|0
3027491|NCT00761150|10411038|P1|Open-label Period|Withdrawal by Subject|5
3027492|NCT00761150|10411036|P3|Open-label Period|Lack of Efficacy|0
3027493|NCT00761150|10411037|P2|Open-label Period|Lack of Efficacy|0
3027494|NCT00761150|10411038|P1|Open-label Period|Lack of Efficacy|4
3027495|NCT00761150|10411036|P3|Open-label Period|Lost to Follow-up|0
3027496|NCT00761150|10411037|P2|Open-label Period|Lost to Follow-up|0
3027497|NCT00761150|10411038|P1|Open-label Period|Lost to Follow-up|7
3027498|NCT00761150|10411036|P3|Open-label Period|Did not meet DB randomization criteria|0
3027499|NCT00761150|10411037|P2|Open-label Period|Did not meet DB randomization criteria|0
3027500|NCT00761150|10411038|P1|Open-label Period|Did not meet DB randomization criteria|11
3027501|NCT00761150|10411036|P3|Open-label Period|Adverse Event|0
3027502|NCT00761150|10411037|P2|Open-label Period|Adverse Event|0
3027503|NCT00761150|10411038|P1|Open-label Period|Adverse Event|36
3027504|NCT00760877|10411110|P2|Overall Study|Treatment failure|0
3027505|NCT00760877|10411111|P1|Overall Study|Treatment failure|1
3027506|NCT00760877|10411110|P2|Overall Study|Participants transferred to AMN107A2408|1
3027507|NCT00760877|10411111|P1|Overall Study|Participants transferred to AMN107A2408|11
3027508|NCT00760877|10411110|P2|Overall Study|Physician Decision|2
3027509|NCT00760877|10411111|P1|Overall Study|Physician Decision|1
3027510|NCT00760877|10411110|P2|Overall Study|Participant not eligible to cross-over|1
3027511|NCT00760877|10411111|P1|Overall Study|Participant not eligible to cross-over|0
3027512|NCT00760877|10411110|P2|Overall Study|Participant diagnosed with AML|1
3027513|NCT00760877|10411111|P1|Overall Study|Participant diagnosed with AML|0
3027514|NCT00760877|10411110|P2|Overall Study|Adverse Event|12
3027515|NCT00760877|10411111|P1|Overall Study|Adverse Event|19
3027516|NCT00760877|10411110|P2|Overall Study|Withdrawal by Subject|3
3027517|NCT00760877|10411111|P1|Overall Study|Withdrawal by Subject|7
3027518|NCT00760877|10411110|P2|Overall Study|Death|1
3027519|NCT00760877|10411111|P1|Overall Study|Death|2
3027520|NCT00760877|10411110|P2|Overall Study|Pregnancy|4
3027521|NCT00760877|10411111|P1|Overall Study|Pregnancy|1
3027522|NCT00760877|10411110|P2|Overall Study|Non-compliance with protocol treatment|1
3027523|NCT00760877|10411111|P1|Overall Study|Non-compliance with protocol treatment|2
3027524|NCT00760877|10411110|P2|Overall Study|Protocol Violation|0
3027525|NCT00760877|10411111|P1|Overall Study|Protocol Violation|1
3027526|NCT00760838|10411129|P2|Overall Study|Withdrawal by Subject|1
3027527|NCT00760838|10411130|P1|Overall Study|Withdrawal by Subject|1
3027528|NCT00760838|10411129|P2|Overall Study|Lost to Follow-up|0
3027529|NCT00760838|10411130|P1|Overall Study|Lost to Follow-up|2
3027530|NCT00760838|10411129|P2|Overall Study|Lack of Efficacy|0
3027531|NCT00760838|10411130|P1|Overall Study|Lack of Efficacy|1
3027532|NCT00760838|10411129|P2|Overall Study|Adverse Event|1
3027533|NCT00760838|10411130|P1|Overall Study|Adverse Event|1
3027534|NCT00760747|10411148|P2|Study Period III|Physician Decision|1
3027535|NCT00760747|10411149|P1|Study Period III|Physician Decision|0
3027536|NCT00760747|10411148|P2|Study Period III|Protocol Violation|1
3027537|NCT00760747|10411149|P1|Study Period III|Protocol Violation|1
3027538|NCT00760747|10411148|P2|Study Period III|Parent/Caregiver Decision|1
3027539|NCT00760747|10411149|P1|Study Period III|Parent/Caregiver Decision|0
3027540|NCT00760747|10411148|P2|Study Period III|Lack of Efficacy|0
3027541|NCT00760747|10411149|P1|Study Period III|Lack of Efficacy|1
3027542|NCT00760747|10411148|P2|Study Period III|Adverse Event|0
3027543|NCT00760747|10411149|P1|Study Period III|Adverse Event|1
3027544|NCT00760747|10411148|P2|Study Period II|No drug administered|1
3027545|NCT00760747|10411149|P1|Study Period II|No drug administered|0
3027546|NCT00760747|10411148|P2|Study Period II|Withdrawal by Subject|0
3027547|NCT00760747|10411149|P1|Study Period II|Withdrawal by Subject|1
3027548|NCT00760747|10411148|P2|Study Period II|Protocol Violation|3
3027549|NCT00760747|10411149|P1|Study Period II|Protocol Violation|6
3027550|NCT00760747|10411148|P2|Study Period II|Parent/Caregiver Decision|0
3027551|NCT00760747|10411149|P1|Study Period II|Parent/Caregiver Decision|3
3027552|NCT00760747|10411148|P2|Study Period II|Lack of Efficacy|6
3027553|NCT00760747|10411149|P1|Study Period II|Lack of Efficacy|0
3027554|NCT00760747|10411148|P2|Study Period II|Adverse Event|4
3027555|NCT00760747|10411149|P1|Study Period II|Adverse Event|3
3027556|NCT00760669|10411177|P1|Overall Study|Took drug before entering in contract|5
3027557|NCT00760669|10411177|P1|Overall Study|Participants with overlapping cases|1
3027558|NCT00760669|10411177|P1|Overall Study|Participants missing efficacy assessment|6
3027559|NCT00760669|10411177|P1|Overall Study|Not assessed for overall improvement|18
3027560|NCT00760617|10411194|P3|Overall Study|Lost to Follow-up|5
3027561|NCT00760617|10411195|P2|Overall Study|Lost to Follow-up|0
3027562|NCT00760617|10411196|P1|Overall Study|Lost to Follow-up|0
3027563|NCT00760617|10411194|P3|Overall Study|Adverse Event|0
3027564|NCT00760617|10411195|P2|Overall Study|Adverse Event|2
3027565|NCT00760617|10411196|P1|Overall Study|Adverse Event|5
3027566|NCT00760552|10411310|P2|Overall Study|Lost to Follow-up|10
3027567|NCT00760552|10411311|P1|Overall Study|Lost to Follow-up|11
3027568|NCT00760552|10411310|P2|Overall Study|Death|0
3027569|NCT00760552|10411311|P1|Overall Study|Death|2
3027570|NCT00760513|10411347|P2|Overall Study|Withdrawal by Subject|7
3027571|NCT00760513|10411348|P1|Overall Study|Withdrawal by Subject|5
3027572|NCT00760487|10411358|P1|Overall Study|Unilateral implantation|3
3027573|NCT00760474|10411364|P2|Period 2 (P2)|Adverse Event|1
3027574|NCT00760474|10411365|P1|Period 2 (P2)|Adverse Event|0
3027575|NCT00760474|10411364|P2|Period 2 (P2)|Lost to Follow-up|0
3027576|NCT00760474|10411365|P1|Period 2 (P2)|Lost to Follow-up|1
3027577|NCT00760474|10411364|P2|Placebo Washout Period|Other|1
3027578|NCT00760474|10411365|P1|Placebo Washout Period|Other|0
3027579|NCT00760474|10411364|P2|Period 1 (P1)|Discontinued then re-entered|1
3027580|NCT00760474|10411365|P1|Period 1 (P1)|Discontinued then re-entered|1
3027581|NCT00760383|10411422|P2|Overall Study|moved away; withdrew; medical reasons|7
3027582|NCT00760383|10411423|P1|Overall Study|moved away; withdrew; medical reasons|5
3027583|NCT00760266|10411435|P2|Overall Study|Administrative Problems|1
3027584|NCT00760266|10411436|P1|Overall Study|Administrative Problems|0
3027585|NCT00760266|10411435|P2|Overall Study|Lost to Follow-up|1
3027586|NCT00760266|10411436|P1|Overall Study|Lost to Follow-up|2
3027587|NCT00760266|10411435|P2|Overall Study|Patient withdrew consent|3
3027588|NCT00760266|10411436|P1|Overall Study|Patient withdrew consent|3
3027589|NCT00760266|10411435|P2|Overall Study|Protocol deviation|4
3027590|NCT00760266|10411436|P1|Overall Study|Protocol deviation|2
3027591|NCT00760266|10411435|P2|Overall Study|Lack of Efficacy|2
3027592|NCT00760266|10411436|P1|Overall Study|Lack of Efficacy|2
3027593|NCT00760266|10411435|P2|Overall Study|Abnormal test procedure result(s)|0
3027594|NCT00760266|10411436|P1|Overall Study|Abnormal test procedure result(s)|1
3027595|NCT00760266|10411435|P2|Overall Study|Abnormal laboratory value(s)|0
3027596|NCT00760266|10411436|P1|Overall Study|Abnormal laboratory value(s)|1
3027597|NCT00760266|10411435|P2|Overall Study|Adverse Event|7
3027598|NCT00760266|10411436|P1|Overall Study|Adverse Event|13
3027599|NCT00760214|10411453|P3|Overall Study|Other|6
3027600|NCT00760214|10411454|P2|Overall Study|Other|4
3027601|NCT00760214|10411455|P1|Overall Study|Other|3
3027602|NCT00760214|10411453|P3|Overall Study|Physician Decision|1
3027603|NCT00760214|10411454|P2|Overall Study|Physician Decision|1
3027604|NCT00760214|10411455|P1|Overall Study|Physician Decision|1
3027605|NCT00760214|10411453|P3|Overall Study|Pregnancy|1
3027606|NCT00760214|10411454|P2|Overall Study|Pregnancy|0
3027607|NCT00760214|10411455|P1|Overall Study|Pregnancy|0
3027608|NCT00760214|10411453|P3|Overall Study|Lack of Efficacy|4
3027609|NCT00760214|10411454|P2|Overall Study|Lack of Efficacy|2
3027610|NCT00760214|10411455|P1|Overall Study|Lack of Efficacy|3
3027611|NCT00760214|10411453|P3|Overall Study|Withdrawal by Subject|13
3027612|NCT00760214|10411454|P2|Overall Study|Withdrawal by Subject|14
3027613|NCT00760214|10411455|P1|Overall Study|Withdrawal by Subject|12
3027614|NCT00760214|10411453|P3|Overall Study|Lost to Follow-up|1
3027615|NCT00760214|10411454|P2|Overall Study|Lost to Follow-up|0
3027616|NCT00760214|10411455|P1|Overall Study|Lost to Follow-up|0
3027617|NCT00760214|10411453|P3|Overall Study|Protocol Violation|3
3027618|NCT00760214|10411454|P2|Overall Study|Protocol Violation|0
3027619|NCT00760214|10411455|P1|Overall Study|Protocol Violation|3
3027620|NCT00760214|10411453|P3|Overall Study|Adverse Event|12
3027621|NCT00760214|10411454|P2|Overall Study|Adverse Event|9
3027622|NCT00760214|10411455|P1|Overall Study|Adverse Event|8
3027623|NCT00760084|10411496|P1|Overall Study|Progressive Disease|3
3027624|NCT00760084|10411496|P1|Overall Study|Withdrawal by Subject|2
3027625|NCT00760084|10411496|P1|Overall Study|Physician Decision|5
3027626|NCT00759954|10411539|P2|Overall Study|Adverse Event|2
3027627|NCT00759954|10411540|P1|Overall Study|Adverse Event|1
3027628|NCT00759954|10411539|P2|Overall Study|Personal reason|0
3027629|NCT00759954|10411540|P1|Overall Study|Personal reason|1
3027630|NCT00759941|10411554|P2|Overall Study|Exited in error by site|1
3027631|NCT00759941|10411555|P1|Overall Study|Exited in error by site|1
3027632|NCT00759941|10411554|P2|Overall Study|Adverse Event|0
3027633|NCT00759941|10411555|P1|Overall Study|Adverse Event|1
3027634|NCT00759941|10411554|P2|Overall Study|Use of medication|0
3027635|NCT00759941|10411555|P1|Overall Study|Use of medication|1
3027636|NCT00759915|10411569|P2|Overall Study|Adverse Event|1
3027637|NCT00759915|10411570|P1|Overall Study|Adverse Event|0
3027638|NCT00759915|10411569|P2|Overall Study|Withdrawal by Subject|0
3027639|NCT00759915|10411570|P1|Overall Study|Withdrawal by Subject|1
3027640|NCT00759902|10411584|P2|Overall Study|Adverse Event|1
3027641|NCT00759902|10411585|P1|Overall Study|Adverse Event|0
3027642|NCT00759863|10411599|P2|Overall Study|Death, moved, or lost contact|18
3027643|NCT00759863|10411600|P1|Overall Study|Death, moved, or lost contact|20
3027644|NCT00759785|10411621|P2|Overall Study|Withdrawal by Subject|1
3027645|NCT00759785|10411622|P1|Overall Study|Withdrawal by Subject|0
3027646|NCT00759785|10411621|P2|Overall Study|Physician Decision|1
3027647|NCT00759785|10411622|P1|Overall Study|Physician Decision|0
3027648|NCT00759785|10411621|P2|Overall Study|Protocol Violation|0
3027649|NCT00759785|10411622|P1|Overall Study|Protocol Violation|1
3027650|NCT00759785|10411621|P2|Overall Study|Participant sample lost|1
3027651|NCT00759785|10411622|P1|Overall Study|Participant sample lost|0
3027652|NCT00759785|10411621|P2|Overall Study|Participant sample not evaluable|2
3027653|NCT00759785|10411622|P1|Overall Study|Participant sample not evaluable|11
3027654|NCT00759759|10411645|P2|Overall Study|Withdrawal by Subject|1
3027655|NCT00759759|10411646|P1|Overall Study|Withdrawal by Subject|2
3027656|NCT00759759|10411645|P2|Overall Study|Didn't receive drug in period 2|0
3027657|NCT00759759|10411646|P1|Overall Study|Didn't receive drug in period 2|1
3027658|NCT00759759|10411645|P2|Overall Study|didn't return for period 2|0
3027659|NCT00759759|10411646|P1|Overall Study|didn't return for period 2|1
3027660|NCT00759681|10411664|P2|Overall Study|Lost to Follow-up|5
3027661|NCT00759681|10411665|P1|Overall Study|Lost to Follow-up|8
3027662|NCT00759681|10411664|P2|Overall Study|Death|5
3027663|NCT00759681|10411665|P1|Overall Study|Death|2
3027664|NCT00759655|10411692|P1|Overall Study|Termination of the study by sponsor|1
3027665|NCT00759564|10411720|P5|Washout Period (at Least 14 Days)|Adverse Event|1
3027666|NCT00759564|10411721|P4|Washout Period (at Least 14 Days)|Adverse Event|0
3027667|NCT00759564|10411722|P3|Washout Period (at Least 14 Days)|Adverse Event|0
3027668|NCT00759564|10411723|P2|Washout Period (at Least 14 Days)|Adverse Event|0
3027669|NCT00759564|10411724|P1|Washout Period (at Least 14 Days)|Adverse Event|0
3027670|NCT00759395|10411901|P2|Overall Study|Lack of Efficacy|2
3027671|NCT00759395|10411902|P1|Overall Study|Lack of Efficacy|0
3027672|NCT00759395|10411901|P2|Overall Study|Withdrawal by Subject|0
3027673|NCT00759395|10411902|P1|Overall Study|Withdrawal by Subject|1
3027674|NCT00759395|10411901|P2|Overall Study|Adverse Event|0
3027675|NCT00759395|10411902|P1|Overall Study|Adverse Event|1
3027676|NCT00759356|10411918|P2|Overall Study|Subject was unable to return|0
3027677|NCT00759356|10411919|P1|Overall Study|Subject was unable to return|1
3027678|NCT00759356|10411918|P2|Overall Study|Withdrawal by Subject|2
3027679|NCT00759356|10411919|P1|Overall Study|Withdrawal by Subject|0
3027680|NCT00759356|10411918|P2|Overall Study|Adverse Event|1
3027681|NCT00759356|10411919|P1|Overall Study|Adverse Event|0
3027682|NCT00759174|10411999|P2|Overall Study|Other|2
3027683|NCT00759174|10412000|P1|Overall Study|Other|0
3027684|NCT00759148|10412024|P2|Overall Study|Reason not given|0
3027685|NCT00759148|10412025|P1|Overall Study|Reason not given|1
3027686|NCT00759148|10412024|P2|Overall Study|Treatment Failure|10
3027687|NCT00759148|10412025|P1|Overall Study|Treatment Failure|6
3027688|NCT00759148|10412024|P2|Overall Study|Lost to Follow-up|9
3027689|NCT00759148|10412025|P1|Overall Study|Lost to Follow-up|3
3027690|NCT00759148|10412024|P2|Overall Study|Withdrawal by Subject|7
3027691|NCT00759148|10412025|P1|Overall Study|Withdrawal by Subject|3
3027692|NCT00759148|10412024|P2|Overall Study|Adverse Event|6
3027693|NCT00759148|10412025|P1|Overall Study|Adverse Event|1
3027694|NCT00759109|10412035|P2|Overall Study|Lost during study|0
3027695|NCT00759109|10412036|P1|Overall Study|Lost during study|1
3027696|NCT00759109|10412035|P2|Overall Study|Participant had a liver transplant|1
3027697|NCT00759109|10412036|P1|Overall Study|Participant had a liver transplant|0
3027698|NCT00759109|10412035|P2|Overall Study|Participant moved to a different city|1
3027699|NCT00759109|10412036|P1|Overall Study|Participant moved to a different city|0
3027700|NCT00759109|10412035|P2|Overall Study|HCV RNA negative|0
3027701|NCT00759109|10412036|P1|Overall Study|HCV RNA negative|1
3027702|NCT00759109|10412035|P2|Overall Study|Started new therapy|6
3027703|NCT00759109|10412036|P1|Overall Study|Started new therapy|2
3027704|NCT00759109|10412035|P2|Overall Study|Lost to Follow-up|6
3027705|NCT00759109|10412036|P1|Overall Study|Lost to Follow-up|4
3027706|NCT00759109|10412035|P2|Overall Study|Death|3
3027707|NCT00759109|10412036|P1|Overall Study|Death|4
3027708|NCT00759109|10412035|P2|Overall Study|Withdrawal by Subject|5
3027709|NCT00759109|10412036|P1|Overall Study|Withdrawal by Subject|9
3027710|NCT00759109|10412035|P2|Overall Study|Inability to comply|1
3027711|NCT00759109|10412036|P1|Overall Study|Inability to comply|1
3027712|NCT00759109|10412035|P2|Overall Study|Adverse Event|12
3027713|NCT00759109|10412036|P1|Overall Study|Adverse Event|17
3027714|NCT00759031|10412058|P2|First Intervention (1 Day)|Screening failure|0
3027715|NCT00759031|10412059|P1|First Intervention (1 Day)|Screening failure|1
3027716|NCT00759031|10412058|P2|First Intervention (1 Day)|Withdrawal by Subject|1
3027717|NCT00759031|10412059|P1|First Intervention (1 Day)|Withdrawal by Subject|0
3027718|NCT00759031|10412058|P2|First Intervention (1 Day)|Physician Decision|0
3027719|NCT00759031|10412059|P1|First Intervention (1 Day)|Physician Decision|1
3027720|NCT00758771|10412112|P2|Overall Study|Did not meet eligibility criteria|4
3027721|NCT00758771|10412113|P1|Overall Study|Did not meet eligibility criteria|2
3027722|NCT00758771|10412112|P2|Overall Study|Withdrawal by Subject|1
3027723|NCT00758771|10412113|P1|Overall Study|Withdrawal by Subject|1
3027724|NCT00758706|10412171|P2|Overall Study|Adverse Event|4
3027725|NCT00758706|10412172|P1|Overall Study|Adverse Event|4
3027726|NCT00758680|10412208|P10|Overall Study|Withdrawal by Subject|0
3027727|NCT00758680|10412209|P9|Overall Study|Withdrawal by Subject|1
3027728|NCT00758680|10412210|P8|Overall Study|Withdrawal by Subject|0
3027729|NCT00758680|10412211|P7|Overall Study|Withdrawal by Subject|1
3027730|NCT00758680|10412212|P6|Overall Study|Withdrawal by Subject|0
3027731|NCT00758680|10412213|P5|Overall Study|Withdrawal by Subject|0
3027732|NCT00758680|10412214|P4|Overall Study|Withdrawal by Subject|0
3027733|NCT00758680|10412215|P3|Overall Study|Withdrawal by Subject|0
3027734|NCT00758680|10412216|P2|Overall Study|Withdrawal by Subject|0
3027735|NCT00758680|10412217|P1|Overall Study|Withdrawal by Subject|0
3027736|NCT00758680|10412208|P10|Overall Study|Laboratory Adverse Event|0
3027737|NCT00758680|10412209|P9|Overall Study|Laboratory Adverse Event|1
3027738|NCT00758680|10412210|P8|Overall Study|Laboratory Adverse Event|0
3027739|NCT00758680|10412211|P7|Overall Study|Laboratory Adverse Event|0
3027740|NCT00758680|10412212|P6|Overall Study|Laboratory Adverse Event|0
3027741|NCT00758680|10412213|P5|Overall Study|Laboratory Adverse Event|0
3027742|NCT00758680|10412214|P4|Overall Study|Laboratory Adverse Event|0
3027743|NCT00758680|10412215|P3|Overall Study|Laboratory Adverse Event|0
3027744|NCT00758680|10412216|P2|Overall Study|Laboratory Adverse Event|0
3027745|NCT00758680|10412217|P1|Overall Study|Laboratory Adverse Event|0
3027746|NCT00758680|10412208|P10|Overall Study|Adverse Event|1
3027747|NCT00758680|10412209|P9|Overall Study|Adverse Event|0
3027748|NCT00758680|10412210|P8|Overall Study|Adverse Event|1
3027749|NCT00758680|10412211|P7|Overall Study|Adverse Event|0
3027750|NCT00758680|10412212|P6|Overall Study|Adverse Event|0
3027751|NCT00758680|10412213|P5|Overall Study|Adverse Event|0
3027752|NCT00758680|10412214|P4|Overall Study|Adverse Event|0
3027753|NCT00758680|10412215|P3|Overall Study|Adverse Event|0
3027754|NCT00758680|10412216|P2|Overall Study|Adverse Event|0
3027755|NCT00758680|10412217|P1|Overall Study|Adverse Event|0
3027756|NCT00758602|10412270|P2|Overall Study|Reason not specified|3
3027757|NCT00758602|10412271|P1|Overall Study|Reason not specified|3
3027758|NCT00758602|10412270|P2|Overall Study|Death|1
3027759|NCT00758602|10412271|P1|Overall Study|Death|0
3027760|NCT00758602|10412270|P2|Overall Study|Protocol Violation|2
3027761|NCT00758602|10412271|P1|Overall Study|Protocol Violation|0
3027762|NCT00758602|10412270|P2|Overall Study|Withdrawal by Subject|3
3027763|NCT00758602|10412271|P1|Overall Study|Withdrawal by Subject|1
3027764|NCT00758602|10412270|P2|Overall Study|Lost to Follow-up|3
3027765|NCT00758602|10412271|P1|Overall Study|Lost to Follow-up|4
3027766|NCT00758602|10412270|P2|Overall Study|Adverse Event|10
3027767|NCT00758602|10412271|P1|Overall Study|Adverse Event|11
3027768|NCT00758589|10412297|P4|Overall Study|Palm stopped to work|1
3027769|NCT00758589|10412298|P3|Overall Study|Palm stopped to work|0
3027770|NCT00758589|10412299|P2|Overall Study|Palm stopped to work|0
3027771|NCT00758589|10412300|P1|Overall Study|Palm stopped to work|0
3027772|NCT00758589|10412297|P4|Overall Study|Withdrawal by Subject|1
3027773|NCT00758589|10412298|P3|Overall Study|Withdrawal by Subject|1
3027774|NCT00758589|10412299|P2|Overall Study|Withdrawal by Subject|1
3027775|NCT00758589|10412300|P1|Overall Study|Withdrawal by Subject|0
3027776|NCT00758589|10412297|P4|Overall Study|Adverse Event|4
3027777|NCT00758589|10412298|P3|Overall Study|Adverse Event|5
3027778|NCT00758589|10412299|P2|Overall Study|Adverse Event|2
3027779|NCT00758589|10412300|P1|Overall Study|Adverse Event|3
3027780|NCT00758498|10412393|P3|Overall Study|Noncompliance to study procedures|1
3027781|NCT00758498|10412394|P2|Overall Study|Noncompliance to study procedures|0
3027782|NCT00758498|10412395|P1|Overall Study|Noncompliance to study procedures|0
3027783|NCT00758498|10412393|P3|Overall Study|Withdrawal by Subject|1
3027784|NCT00758498|10412394|P2|Overall Study|Withdrawal by Subject|0
3027785|NCT00758498|10412395|P1|Overall Study|Withdrawal by Subject|0
3027786|NCT00758498|10412393|P3|Overall Study|Subject legally detained out of state|0
3027787|NCT00758498|10412394|P2|Overall Study|Subject legally detained out of state|0
3027788|NCT00758498|10412395|P1|Overall Study|Subject legally detained out of state|1
3027789|NCT00758498|10412393|P3|Overall Study|Adverse Event|3
3027790|NCT00758498|10412394|P2|Overall Study|Adverse Event|2
3027791|NCT00758498|10412395|P1|Overall Study|Adverse Event|2
3027792|NCT00758485|10412480|P2|Overall Study|Not Treated|2
3027793|NCT00758485|10412481|P1|Overall Study|Not Treated|1
3027794|NCT00758485|10412480|P2|Overall Study|Lost to Follow-up|1
3027795|NCT00758485|10412481|P1|Overall Study|Lost to Follow-up|0
3027796|NCT00758459|10412493|P2|Overall Study|Withdrawal by Subject|1
3027797|NCT00758459|10412494|P1|Overall Study|Withdrawal by Subject|0
3027798|NCT00758459|10412493|P2|Overall Study|Protocol Violation|1
3027799|NCT00758459|10412494|P1|Overall Study|Protocol Violation|0
3027800|NCT00758459|10412493|P2|Overall Study|Adverse Event|2
3027801|NCT00758459|10412494|P1|Overall Study|Adverse Event|3
3027802|NCT00758394|10412539|P4|3rd Intervention|Lost to Follow-up|1
3027803|NCT00758394|10412540|P3|3rd Intervention|Lost to Follow-up|0
3027804|NCT00758394|10412541|P2|3rd Intervention|Lost to Follow-up|0
3027805|NCT00758394|10412542|P1|3rd Intervention|Lost to Follow-up|1
3027806|NCT00758394|10412539|P4|2nd Intervention Order|Lost to Follow-up|0
3027807|NCT00758394|10412540|P3|2nd Intervention Order|Lost to Follow-up|0
3027808|NCT00758394|10412541|P2|2nd Intervention Order|Lost to Follow-up|1
3027809|NCT00758394|10412542|P1|2nd Intervention Order|Lost to Follow-up|0
3027810|NCT00758264|10412571|P3|Active Phase|Other|4
3027811|NCT00758264|10412572|P2|Active Phase|Other|0
3027812|NCT00758264|10412573|P1|Active Phase|Other|0
3027813|NCT00758264|10412571|P3|Active Phase|Lost to Follow-up|0
3027814|NCT00758264|10412572|P2|Active Phase|Lost to Follow-up|0
3027815|NCT00758264|10412573|P1|Active Phase|Lost to Follow-up|1
3027816|NCT00758264|10412571|P3|Active Phase|Withdrawal by Subject|1
3027817|NCT00758264|10412572|P2|Active Phase|Withdrawal by Subject|0
3027818|NCT00758264|10412573|P1|Active Phase|Withdrawal by Subject|0
3027819|NCT00758160|10412632|P1|Overall Study|Withdrawal by Subject|8
3027820|NCT00758160|10412632|P1|Overall Study|Protocol Violation|12
3027821|NCT00758160|10412632|P1|Overall Study|Lost to Follow-up|14
3027822|NCT00758160|10412632|P1|Overall Study|Lack of Efficacy|10
3027823|NCT00758160|10412632|P1|Overall Study|Adverse Event|15
3027824|NCT00758160|10412632|P1|Overall Study|Administration Problems|3
3027825|NCT00758160|10412632|P1|Overall Study|No Longer Requires Study Medication|4
3027826|NCT00758069|10412653|P3|Overall Study|Incorrect Study Drug|0
3027827|NCT00758069|10412654|P2|Overall Study|Incorrect Study Drug|0
3027828|NCT00758069|10412655|P1|Overall Study|Incorrect Study Drug|1
3027829|NCT00758069|10412653|P3|Overall Study|Lack of Efficacy|1
3027830|NCT00758069|10412654|P2|Overall Study|Lack of Efficacy|0
3027831|NCT00758069|10412655|P1|Overall Study|Lack of Efficacy|0
3027832|NCT00758043|10412670|P4|Overall Study|Other Reasons|5
3027833|NCT00758043|10412671|P3|Overall Study|Other Reasons|0
3027834|NCT00758043|10412672|P2|Overall Study|Other Reasons|1
3027835|NCT00758043|10412673|P1|Overall Study|Other Reasons|0
3027836|NCT00758043|10412670|P4|Overall Study|Non-Compliant With study Drug|1
3027837|NCT00758043|10412671|P3|Overall Study|Non-Compliant With study Drug|0
3027838|NCT00758043|10412672|P2|Overall Study|Non-Compliant With study Drug|0
3027839|NCT00758043|10412673|P1|Overall Study|Non-Compliant With study Drug|0
3027840|NCT00758043|10412670|P4|Overall Study|Required Prohibited Medication|3
3027841|NCT00758043|10412671|P3|Overall Study|Required Prohibited Medication|1
3027842|NCT00758043|10412672|P2|Overall Study|Required Prohibited Medication|0
3027843|NCT00758043|10412673|P1|Overall Study|Required Prohibited Medication|0
3027844|NCT00758043|10412670|P4|Overall Study|Withdrawal by Subject|4
3027845|NCT00758043|10412671|P3|Overall Study|Withdrawal by Subject|1
3027846|NCT00758043|10412672|P2|Overall Study|Withdrawal by Subject|1
3027847|NCT00758043|10412673|P1|Overall Study|Withdrawal by Subject|0
3027848|NCT00758043|10412670|P4|Overall Study|Lost to Follow-up|5
3027849|NCT00758043|10412671|P3|Overall Study|Lost to Follow-up|2
3027850|NCT00758043|10412672|P2|Overall Study|Lost to Follow-up|2
3027851|NCT00758043|10412673|P1|Overall Study|Lost to Follow-up|0
3027852|NCT00758043|10412670|P4|Overall Study|Refused Further Treatment|8
3027853|NCT00758043|10412671|P3|Overall Study|Refused Further Treatment|5
3027854|NCT00758043|10412672|P2|Overall Study|Refused Further Treatment|11
3027855|NCT00758043|10412673|P1|Overall Study|Refused Further Treatment|0
3027856|NCT00758043|10412670|P4|Overall Study|Lack of Efficacy|12
3027857|NCT00758043|10412671|P3|Overall Study|Lack of Efficacy|18
3027858|NCT00758043|10412672|P2|Overall Study|Lack of Efficacy|6
3027859|NCT00758043|10412673|P1|Overall Study|Lack of Efficacy|0
3027860|NCT00758043|10412670|P4|Overall Study|Adverse Event|62
3027861|NCT00758043|10412671|P3|Overall Study|Adverse Event|12
3027862|NCT00758043|10412672|P2|Overall Study|Adverse Event|20
3027863|NCT00758043|10412673|P1|Overall Study|Adverse Event|1
3027864|NCT00757848|10412701|P2|Overall Study|Incorrect enrolment|0
3027865|NCT00757848|10412702|P1|Overall Study|Incorrect enrolment|1
3027866|NCT00757848|10412701|P2|Overall Study|Adverse Event|2
3027867|NCT00757848|10412702|P1|Overall Study|Adverse Event|1
3027868|NCT00757848|10412701|P2|Overall Study|Voluntary discontinuation|0
3027869|NCT00757848|10412702|P1|Overall Study|Voluntary discontinuation|1
3027870|NCT00757783|10412771|P2|Overall Study|Other|2
3027871|NCT00757783|10412772|P1|Overall Study|Other|1
3027872|NCT00757783|10412771|P2|Overall Study|Withdrawal by Subject|1
3027873|NCT00757783|10412772|P1|Overall Study|Withdrawal by Subject|2
3027874|NCT00757783|10412771|P2|Overall Study|Protocol Violation|0
3027875|NCT00757783|10412772|P1|Overall Study|Protocol Violation|1
3027876|NCT00757783|10412771|P2|Overall Study|Lost to Follow-up|1
3027877|NCT00757783|10412772|P1|Overall Study|Lost to Follow-up|1
3027878|NCT00757783|10412771|P2|Overall Study|Adverse Event|2
3027879|NCT00757783|10412772|P1|Overall Study|Adverse Event|0
3027880|NCT00757705|10412808|P1|Overall Study|Other|18
3027881|NCT00757705|10412808|P1|Overall Study|Non-compliant|9
3027882|NCT00757705|10412808|P1|Overall Study|Ineligible to continue|8
3027883|NCT00757705|10412808|P1|Overall Study|Insufficient Response|26
3027884|NCT00757705|10412808|P1|Overall Study|Withdrawal by Subject|25
3027885|NCT00757705|10412808|P1|Overall Study|Lost to Follow-up|16
3027886|NCT00757705|10412808|P1|Overall Study|Adverse Event|19
3027887|NCT00757627|10412837|P1|Overall Study|Other|1
3027888|NCT00757627|10412837|P1|Overall Study|Withdrawal by Subject|27
3027889|NCT00757627|10412837|P1|Overall Study|Lost to Follow-up|28
3027890|NCT00757627|10412837|P1|Overall Study|Lack of Efficacy|10
3027891|NCT00757627|10412837|P1|Overall Study|Adverse Event|15
3027892|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Other|0
3027893|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Other|1
3027894|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
3027895|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
3027896|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
3027897|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
3027898|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
3027899|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
3027900|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
3027901|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
3027902|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
3027903|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
3027904|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
3027905|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
3027906|NCT00757588|10412972|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
3027907|NCT00757588|10412973|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
3027908|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Other|1
3027909|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Other|0
3027910|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
3027911|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
3027912|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
3027913|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
3027914|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
3027915|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
3027916|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Death|0
3027917|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Death|1
3027918|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
3027919|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
3027920|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
3027921|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
3027922|NCT00757588|10412972|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
3027923|NCT00757588|10412973|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
3027924|NCT00757237|10413014|P2|Overall Study|Other|2
3027925|NCT00757237|10413015|P1|Overall Study|Other|0
3027926|NCT00757237|10413014|P2|Overall Study|Safety or Tolerability|5
3027927|NCT00757237|10413015|P1|Overall Study|Safety or Tolerability|3
3027928|NCT00757237|10413014|P2|Overall Study|Withdrawal by Subject|12
3027929|NCT00757237|10413015|P1|Overall Study|Withdrawal by Subject|8
3027930|NCT00757237|10413014|P2|Overall Study|Physician Decision|3
3027931|NCT00757237|10413015|P1|Overall Study|Physician Decision|2
3027932|NCT00757237|10413014|P2|Overall Study|Protocol Violation|2
3027933|NCT00757237|10413015|P1|Overall Study|Protocol Violation|0
3027934|NCT00757237|10413014|P2|Overall Study|Lost to Follow-up|1
3027935|NCT00757237|10413015|P1|Overall Study|Lost to Follow-up|0
3027936|NCT00757172|10413043|P1|Overall Study|Progression|4
3027937|NCT00757172|10413043|P1|Overall Study|Physician Decision|3
3027938|NCT00757172|10413043|P1|Overall Study|Withdrawal by Subject|4
3027939|NCT00757003|10413051|P1|Overall Study|Not implanted|1
3027940|NCT00757003|10413051|P1|Overall Study|Surgically explanted|2
3027941|NCT00757003|10413051|P1|Overall Study|Withdrawal by Subject|4
3027942|NCT00757003|10413051|P1|Overall Study|Lost to Follow-up|9
3027943|NCT00757003|10413051|P1|Overall Study|Death|33
3027944|NCT00756938|10413098|P4|Optional Extension|Adverse Event|1
3027945|NCT00756938|10413099|P3|Optional Extension|Adverse Event|0
3027946|NCT00756938|10413100|P2|Optional Extension|Adverse Event|0
3027947|NCT00756938|10413101|P1|Optional Extension|Adverse Event|0
3027948|NCT00756938|10413098|P4|Optional Extension|Withdrawal by Subject|10
3027949|NCT00756938|10413099|P3|Optional Extension|Withdrawal by Subject|0
3027950|NCT00756938|10413100|P2|Optional Extension|Withdrawal by Subject|0
3027951|NCT00756938|10413101|P1|Optional Extension|Withdrawal by Subject|0
3027952|NCT00756938|10413098|P4|Optional Extension|Protocol Violation|1
3027953|NCT00756938|10413099|P3|Optional Extension|Protocol Violation|0
3027954|NCT00756938|10413100|P2|Optional Extension|Protocol Violation|0
3027955|NCT00756938|10413101|P1|Optional Extension|Protocol Violation|0
3027956|NCT00756938|10413098|P4|Optional Extension|Lost to Follow-up|1
3027957|NCT00756938|10413099|P3|Optional Extension|Lost to Follow-up|0
3027958|NCT00756938|10413100|P2|Optional Extension|Lost to Follow-up|0
3027959|NCT00756938|10413101|P1|Optional Extension|Lost to Follow-up|0
3027960|NCT00756938|10413098|P4|Optional Extension|Physician Decision|3
3027961|NCT00756938|10413099|P3|Optional Extension|Physician Decision|0
3027962|NCT00756938|10413100|P2|Optional Extension|Physician Decision|0
3027963|NCT00756938|10413101|P1|Optional Extension|Physician Decision|0
3027964|NCT00756938|10413098|P4|Optional Extension|Protocol-specific criteria met|9
3027965|NCT00756938|10413099|P3|Optional Extension|Protocol-specific criteria met|0
3027966|NCT00756938|10413100|P2|Optional Extension|Protocol-specific criteria met|0
3027967|NCT00756938|10413101|P1|Optional Extension|Protocol-specific criteria met|0
3027968|NCT00756938|10413098|P4|Optional Extension|End of Study|11
3027969|NCT00756938|10413099|P3|Optional Extension|End of Study|0
3027970|NCT00756938|10413100|P2|Optional Extension|End of Study|0
3027971|NCT00756938|10413101|P1|Optional Extension|End of Study|0
3027972|NCT00756938|10413098|P4|Optional Extension|Lack of Efficacy|1
3027973|NCT00756938|10413099|P3|Optional Extension|Lack of Efficacy|0
3027974|NCT00756938|10413100|P2|Optional Extension|Lack of Efficacy|0
3027975|NCT00756938|10413101|P1|Optional Extension|Lack of Efficacy|0
3027976|NCT00756938|10413098|P4|12-week Base Study|Lost to Follow-up|0
3027977|NCT00756938|10413099|P3|12-week Base Study|Lost to Follow-up|0
3027978|NCT00756938|10413100|P2|12-week Base Study|Lost to Follow-up|0
3027979|NCT00756938|10413101|P1|12-week Base Study|Lost to Follow-up|1
3027980|NCT00756938|10413098|P4|12-week Base Study|Protocol Violation|0
3027981|NCT00756938|10413099|P3|12-week Base Study|Protocol Violation|1
3027982|NCT00756938|10413100|P2|12-week Base Study|Protocol Violation|0
3027983|NCT00756938|10413101|P1|12-week Base Study|Protocol Violation|0
3027984|NCT00756938|10413098|P4|12-week Base Study|Protocol-specific Criteria Met|0
3027985|NCT00756938|10413099|P3|12-week Base Study|Protocol-specific Criteria Met|1
3027986|NCT00756938|10413100|P2|12-week Base Study|Protocol-specific Criteria Met|0
3027987|NCT00756938|10413101|P1|12-week Base Study|Protocol-specific Criteria Met|1
3027988|NCT00756886|10413129|P2|Overall Study|Ineligible|4
3027989|NCT00756886|10413130|P1|Overall Study|Ineligible|9
3027990|NCT00756886|10413129|P2|Overall Study|Lack of Efficacy|0
3027991|NCT00756886|10413130|P1|Overall Study|Lack of Efficacy|1
3027992|NCT00756886|10413129|P2|Overall Study|Adverse Event|3
3027993|NCT00756886|10413130|P1|Overall Study|Adverse Event|0
3027994|NCT00756886|10413129|P2|Overall Study|Lost to Follow-up|0
3027995|NCT00756886|10413130|P1|Overall Study|Lost to Follow-up|1
3027996|NCT00756730|10413138|P2|Overall Study|persistent low-level viremmia|1
3027997|NCT00756730|10413139|P1|Overall Study|persistent low-level viremmia|0
3027998|NCT00756730|10413138|P2|Overall Study|discontinued due to rash prior to week 4|1
3027999|NCT00756730|10413139|P1|Overall Study|discontinued due to rash prior to week 4|0
3028000|NCT00756717|10413159|P1|Overall Study|Withdrawal by Subject|2
3028001|NCT00756574|10413279|P2|Overall Study|Lost to Follow-up|4
3028002|NCT00756574|10413280|P1|Overall Study|Lost to Follow-up|4
3028003|NCT00756574|10413279|P2|Overall Study|Withdrawal by Subject|7
3028004|NCT00756574|10413280|P1|Overall Study|Withdrawal by Subject|9
3028005|NCT00756470|10413324|P1|Overall Study|Adverse Event|4
3028006|NCT00756470|10413324|P1|Overall Study|Withdrawal by Subject|1
3028007|NCT00756457|10413331|P2|Overall Study|Lost to Follow-up|2
3028008|NCT00756457|10413332|P1|Overall Study|Lost to Follow-up|1
3028009|NCT00756444|10413362|P2|Overall Study|Ineligibility Determined|0
3028010|NCT00756444|10413363|P1|Overall Study|Ineligibility Determined|1
3028011|NCT00756444|10413362|P2|Overall Study|Disease Progression|7
3028012|NCT00756444|10413363|P1|Overall Study|Disease Progression|2
3028013|NCT00756444|10413362|P2|Overall Study|Death|4
3028014|NCT00756444|10413363|P1|Overall Study|Death|5
3028015|NCT00756444|10413362|P2|Overall Study|Lost to Follow-up|1
3028016|NCT00756444|10413363|P1|Overall Study|Lost to Follow-up|0
3028017|NCT00756444|10413362|P2|Overall Study|Withdrawal by Subject|8
3028018|NCT00756444|10413363|P1|Overall Study|Withdrawal by Subject|6
3028019|NCT00756444|10413362|P2|Overall Study|Adverse Event|1
3028020|NCT00756444|10413363|P1|Overall Study|Adverse Event|1
3028021|NCT00756314|10413374|P2|Overall Study|Lost to Follow-up|59
3028022|NCT00756314|10413375|P1|Overall Study|Lost to Follow-up|2
3028023|NCT00756275|10413391|P2|Overall Study|Withdrawal by Subject|7
3028024|NCT00756275|10413392|P1|Overall Study|Withdrawal by Subject|4
3028025|NCT00756275|10413391|P2|Overall Study|Lost to Follow-up|21
3028026|NCT00756275|10413392|P1|Overall Study|Lost to Follow-up|25
3028027|NCT00756002|10413456|P2|Double-Blind Treatment Period|Other|2
3028028|NCT00756002|10413457|P1|Double-Blind Treatment Period|Other|2
3028029|NCT00756002|10413456|P2|Double-Blind Treatment Period|Protocol Violation|5
3028030|NCT00756002|10413457|P1|Double-Blind Treatment Period|Protocol Violation|6
3028031|NCT00756002|10413456|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
3028032|NCT00756002|10413457|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
3028033|NCT00756002|10413456|P2|Double-Blind Treatment Period|Lost to Follow-up|1
3028034|NCT00756002|10413457|P1|Double-Blind Treatment Period|Lost to Follow-up|0
3028035|NCT00756002|10413456|P2|Double-Blind Treatment Period|Lack of Efficacy|1
3028036|NCT00756002|10413457|P1|Double-Blind Treatment Period|Lack of Efficacy|1
3028037|NCT00755937|10413551|P1|Observational Follow-up|Lost to Follow-up|148
3028038|NCT00755937|10413551|P1|Recruitment|Unknown if infliximab received|164
3028039|NCT00755846|10413578|P6|Overall Study|Participant Non-compliance|0
3028040|NCT00755846|10413579|P5|Overall Study|Participant Non-compliance|1
3028041|NCT00755846|10413580|P4|Overall Study|Participant Non-compliance|0
3028042|NCT00755846|10413581|P3|Overall Study|Participant Non-compliance|0
3028043|NCT00755846|10413582|P2|Overall Study|Participant Non-compliance|0
3028044|NCT00755846|10413583|P1|Overall Study|Participant Non-compliance|0
3028045|NCT00755846|10413578|P6|Overall Study|Administrative Error|0
3028046|NCT00755846|10413579|P5|Overall Study|Administrative Error|0
3028047|NCT00755846|10413580|P4|Overall Study|Administrative Error|0
3028048|NCT00755846|10413581|P3|Overall Study|Administrative Error|0
3028049|NCT00755846|10413582|P2|Overall Study|Administrative Error|1
3028050|NCT00755846|10413583|P1|Overall Study|Administrative Error|0
3028051|NCT00755846|10413578|P6|Overall Study|Physician Decision|1
3028052|NCT00755846|10413579|P5|Overall Study|Physician Decision|0
3028053|NCT00755846|10413580|P4|Overall Study|Physician Decision|1
3028054|NCT00755846|10413581|P3|Overall Study|Physician Decision|0
3028055|NCT00755846|10413582|P2|Overall Study|Physician Decision|3
3028056|NCT00755846|10413583|P1|Overall Study|Physician Decision|1
3028057|NCT00755846|10413578|P6|Overall Study|Hyperglycemic Rescue|7
3028058|NCT00755846|10413579|P5|Overall Study|Hyperglycemic Rescue|8
3028059|NCT00755846|10413580|P4|Overall Study|Hyperglycemic Rescue|8
3028060|NCT00755846|10413581|P3|Overall Study|Hyperglycemic Rescue|5
3028061|NCT00755846|10413582|P2|Overall Study|Hyperglycemic Rescue|7
3028062|NCT00755846|10413583|P1|Overall Study|Hyperglycemic Rescue|21
3028063|NCT00755846|10413578|P6|Overall Study|Withdrawal by Subject|1
3028064|NCT00755846|10413579|P5|Overall Study|Withdrawal by Subject|0
3028065|NCT00755846|10413580|P4|Overall Study|Withdrawal by Subject|2
3028066|NCT00755846|10413581|P3|Overall Study|Withdrawal by Subject|5
3028067|NCT00755846|10413582|P2|Overall Study|Withdrawal by Subject|3
3028068|NCT00755846|10413583|P1|Overall Study|Withdrawal by Subject|2
3028069|NCT00755846|10413578|P6|Overall Study|Lost to Follow-up|2
3028070|NCT00755846|10413579|P5|Overall Study|Lost to Follow-up|4
3028071|NCT00755846|10413580|P4|Overall Study|Lost to Follow-up|0
3028072|NCT00755846|10413581|P3|Overall Study|Lost to Follow-up|1
3028073|NCT00755846|10413582|P2|Overall Study|Lost to Follow-up|2
3028074|NCT00755846|10413583|P1|Overall Study|Lost to Follow-up|0
3028075|NCT00755846|10413578|P6|Overall Study|Protocol Violation|1
3028076|NCT00755846|10413579|P5|Overall Study|Protocol Violation|1
3028077|NCT00755846|10413580|P4|Overall Study|Protocol Violation|1
3028078|NCT00755846|10413581|P3|Overall Study|Protocol Violation|1
3028079|NCT00755846|10413582|P2|Overall Study|Protocol Violation|1
3028080|NCT00755846|10413583|P1|Overall Study|Protocol Violation|1
3028081|NCT00755846|10413578|P6|Overall Study|Adverse Event|2
3028082|NCT00755846|10413579|P5|Overall Study|Adverse Event|3
3028083|NCT00755846|10413580|P4|Overall Study|Adverse Event|1
3028084|NCT00755846|10413581|P3|Overall Study|Adverse Event|0
3028085|NCT00755846|10413582|P2|Overall Study|Adverse Event|0
3028086|NCT00755846|10413583|P1|Overall Study|Adverse Event|0
3028087|NCT00755807|10413683|P2|Open-label Extension Phase|Sponsor Decision|1
3028088|NCT00755807|10413684|P1|Open-label Extension Phase|Sponsor Decision|0
3028089|NCT00755807|10413683|P2|Open-label Extension Phase|Lost to Follow-up|0
3028090|NCT00755807|10413684|P1|Open-label Extension Phase|Lost to Follow-up|2
3028091|NCT00755807|10413683|P2|Open-label Extension Phase|Withdrawal by Subject|3
3028092|NCT00755807|10413684|P1|Open-label Extension Phase|Withdrawal by Subject|1
3028093|NCT00755807|10413683|P2|Open-label Extension Phase|Lack of Efficacy|3
3028094|NCT00755807|10413684|P1|Open-label Extension Phase|Lack of Efficacy|3
3028095|NCT00755807|10413683|P2|Open-label Extension Phase|Protocol Violation|2
3028096|NCT00755807|10413684|P1|Open-label Extension Phase|Protocol Violation|5
3028097|NCT00755807|10413683|P2|Open-label Extension Phase|Adverse Event|7
3028098|NCT00755807|10413684|P1|Open-label Extension Phase|Adverse Event|7
3028099|NCT00755807|10413683|P2|Acute Phase|Physician Decision|1
3028100|NCT00755807|10413684|P1|Acute Phase|Physician Decision|0
3028101|NCT00755807|10413683|P2|Acute Phase|Lack of Efficacy|1
3028102|NCT00755807|10413684|P1|Acute Phase|Lack of Efficacy|0
3028103|NCT00755807|10413683|P2|Acute Phase|Withdrawal by Subject|2
3028104|NCT00755807|10413684|P1|Acute Phase|Withdrawal by Subject|1
3028105|NCT00755807|10413683|P2|Acute Phase|Protocol Violation|3
3028106|NCT00755807|10413684|P1|Acute Phase|Protocol Violation|1
3028107|NCT00755807|10413683|P2|Acute Phase|Adverse Event|5
3028108|NCT00755807|10413684|P1|Acute Phase|Adverse Event|16
3028109|NCT00755716|10413764|P3|Overall Study|work schedule issues|1
3028110|NCT00755716|10413765|P2|Overall Study|work schedule issues|1
3028111|NCT00755716|10413766|P1|Overall Study|work schedule issues|0
3028112|NCT00755716|10413764|P3|Overall Study|Lost to Follow-up|1
3028113|NCT00755716|10413765|P2|Overall Study|Lost to Follow-up|3
3028114|NCT00755716|10413766|P1|Overall Study|Lost to Follow-up|5
3028115|NCT00755716|10413764|P3|Overall Study|Lack of Efficacy|0
3028116|NCT00755716|10413765|P2|Overall Study|Lack of Efficacy|0
3028117|NCT00755716|10413766|P1|Overall Study|Lack of Efficacy|2
3028118|NCT00755716|10413764|P3|Overall Study|Adverse Event|1
3028119|NCT00755716|10413765|P2|Overall Study|Adverse Event|4
3028120|NCT00755716|10413766|P1|Overall Study|Adverse Event|1
3028121|NCT00755417|10413780|P3|Overall Study|Not specified or missing data|12
3028122|NCT00755417|10413781|P2|Overall Study|Not specified or missing data|18
3028123|NCT00755417|10413782|P1|Overall Study|Not specified or missing data|9
3028124|NCT00755417|10413780|P3|Overall Study|Withdrawal by Subject|12
3028125|NCT00755417|10413781|P2|Overall Study|Withdrawal by Subject|12
3028126|NCT00755417|10413782|P1|Overall Study|Withdrawal by Subject|12
3028127|NCT00755417|10413780|P3|Overall Study|Lost to Follow-up|1
3028128|NCT00755417|10413781|P2|Overall Study|Lost to Follow-up|0
3028129|NCT00755417|10413782|P1|Overall Study|Lost to Follow-up|3
3028130|NCT00755417|10413780|P3|Overall Study|Protocol Violation|1
3028131|NCT00755417|10413781|P2|Overall Study|Protocol Violation|1
3028132|NCT00755417|10413782|P1|Overall Study|Protocol Violation|2
3028133|NCT00755417|10413780|P3|Overall Study|Lack of Efficacy|9
3028134|NCT00755417|10413781|P2|Overall Study|Lack of Efficacy|4
3028135|NCT00755417|10413782|P1|Overall Study|Lack of Efficacy|8
3028136|NCT00755417|10413780|P3|Overall Study|Adverse Event|7
3028137|NCT00755417|10413781|P2|Overall Study|Adverse Event|20
3028138|NCT00755417|10413782|P1|Overall Study|Adverse Event|28
3028139|NCT00755326|10413801|P2|Overall Study|Lost to Follow-up|3
3028140|NCT00755326|10413802|P1|Overall Study|Lost to Follow-up|2
3028141|NCT00755222|10413852|P2|Overall Study|Protocol Violation|0
3028142|NCT00755222|10413853|P1|Overall Study|Protocol Violation|2
3028143|NCT00755222|10413852|P2|Overall Study|Adverse Event|0
3028144|NCT00755222|10413853|P1|Overall Study|Adverse Event|2
3028145|NCT00755222|10413852|P2|Overall Study|Withdrawal by Subject|2
3028146|NCT00755222|10413853|P1|Overall Study|Withdrawal by Subject|4
3028147|NCT00755196|10413867|P1|Overall Study|Lack of Efficiency|1
3028148|NCT00755196|10413867|P1|Overall Study|Lost to Follow-up|1
3028149|NCT00755105|10413888|P3|Overall Study|Withdrawal by Subject|4
3028150|NCT00755105|10413889|P2|Overall Study|Withdrawal by Subject|11
3028151|NCT00755105|10413890|P1|Overall Study|Withdrawal by Subject|9
3028152|NCT00755079|10413900|P2|Overall Study|Withdrawal by Subject|2
3028153|NCT00755079|10413901|P1|Overall Study|Withdrawal by Subject|0
3028154|NCT00755079|10413900|P2|Overall Study|Adverse Event|1
3028155|NCT00755079|10413901|P1|Overall Study|Adverse Event|0
3028156|NCT00755079|10413900|P2|Overall Study|Lost to Follow-up|3
3028157|NCT00755079|10413901|P1|Overall Study|Lost to Follow-up|1
3028158|NCT00754936|10413920|P1|Overall Study|Inter-current medical events|3
3028159|NCT00754936|10413920|P1|Overall Study|Side Effects|3
3028160|NCT00754936|10413920|P1|Overall Study|Withdrawal by Subject|2
3028161|NCT00754936|10413920|P1|Overall Study|Physician Decision|1
3028162|NCT00754936|10413920|P1|Overall Study|Lost to Follow-up|3
3028163|NCT00754793|10413960|P2|Overall Study|voluntary withdrawn from study|1
3028164|NCT00754793|10413961|P1|Overall Study|voluntary withdrawn from study|0
3028165|NCT00754741|10413979|P3|Overall Study|Died or disenrolled|54
3028166|NCT00754741|10413980|P2|Overall Study|Died or disenrolled|69
3028167|NCT00754741|10413981|P1|Overall Study|Died or disenrolled|57
3028168|NCT00754650|10414028|P1|Overall Study|Disease Progression|2
3028169|NCT00754624|10414033|P1|Overall Study|Lost to Follow-up|3
3028170|NCT00754624|10414033|P1|Overall Study|Various|12
3028171|NCT00754624|10414033|P1|Overall Study|Withdrawal by Subject|28
3028172|NCT00754624|10414033|P1|Overall Study|Protocol Violation|1
3028173|NCT00754624|10414033|P1|Overall Study|Physician Decision|8
3028174|NCT00754624|10414033|P1|Overall Study|Death|1
3028175|NCT00754624|10414033|P1|Overall Study|Adverse Event|16
3028176|NCT00754572|10414043|P1|Overall Study|Lost to Follow-up|1
3028177|NCT00754572|10414043|P1|Overall Study|Administrative Reason|3
3028178|NCT00754572|10414043|P1|Overall Study|Death|1
3028179|NCT00754572|10414043|P1|Overall Study|Lack of Efficacy|2
3028180|NCT00754572|10414043|P1|Overall Study|Withdrawal by Subject|3
3028181|NCT00754572|10414043|P1|Overall Study|Protocol Violation|3
3028182|NCT00754572|10414043|P1|Overall Study|Other|39
3028183|NCT00754572|10414043|P1|Overall Study|Adverse Event|19
3028184|NCT00754559|10414070|P1|Overall Study|Withdrawal by Subject|3
3028185|NCT00754559|10414070|P1|Overall Study|Other|5
3028186|NCT00754559|10414070|P1|Overall Study|Administrative reason|1
3028187|NCT00754559|10414070|P1|Overall Study|Lost to Follow-up|2
3028188|NCT00754559|10414070|P1|Overall Study|Lack of Efficacy|10
3028189|NCT00754559|10414070|P1|Overall Study|Protocol Violation|11
3028190|NCT00754559|10414070|P1|Overall Study|Adverse Event|15
3028191|NCT00754442|10414170|P2|Overall Study|Withdrawal by Subject|3
3028192|NCT00754442|10414171|P1|Overall Study|Withdrawal by Subject|5
3028193|NCT00754390|10414178|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
3028194|NCT00754390|10414178|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
3028195|NCT00754390|10414178|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
3028196|NCT00754390|10414178|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
3028197|NCT00754338|10414200|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
3028198|NCT00754338|10414201|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
3028199|NCT00754338|10414202|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
3028200|NCT00754338|10414203|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
3028201|NCT00754338|10414200|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
3028202|NCT00754338|10414201|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
3028203|NCT00754338|10414202|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
3028204|NCT00754338|10414203|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
3028205|NCT00754325|10414235|P2|Initial Treatment|Disease Progression|35
3028206|NCT00754325|10414236|P1|Initial Treatment|Disease Progression|35
3028207|NCT00754325|10414235|P2|Initial Treatment|Sponsor Request|1
3028208|NCT00754325|10414236|P1|Initial Treatment|Sponsor Request|0
3028209|NCT00754325|10414235|P2|Initial Treatment|Physician Decision|0
3028210|NCT00754325|10414236|P1|Initial Treatment|Physician Decision|2
3028211|NCT00754325|10414235|P2|Initial Treatment|Withdrawal by Subject|2
3028212|NCT00754325|10414236|P1|Initial Treatment|Withdrawal by Subject|2
3028213|NCT00754325|10414235|P2|Initial Treatment|Adverse Event|6
3028214|NCT00754325|10414236|P1|Initial Treatment|Adverse Event|7
3028215|NCT00754325|10414235|P2|Initial Treatment|Continuing Active Treatment|5
3028216|NCT00754325|10414236|P1|Initial Treatment|Continuing Active Treatment|4
3028217|NCT00754234|10414289|P1|Overall Study|Withdrawal by Subject|3
3028218|NCT00754065|10414375|P2|Overall Study|Reason not specified or unknown, etc.|27
3028219|NCT00754065|10414376|P1|Overall Study|Reason not specified or unknown, etc.|21
3028220|NCT00754065|10414375|P2|Overall Study|Pregnancy|0
3028221|NCT00754065|10414376|P1|Overall Study|Pregnancy|6
3028222|NCT00754065|10414375|P2|Overall Study|Withdrawal by Subject|5
3028223|NCT00754065|10414376|P1|Overall Study|Withdrawal by Subject|4
3028224|NCT00754065|10414375|P2|Overall Study|Protocol Violation|10
3028225|NCT00754065|10414376|P1|Overall Study|Protocol Violation|12
3028226|NCT00754065|10414375|P2|Overall Study|Lost to Follow-up|11
3028227|NCT00754065|10414376|P1|Overall Study|Lost to Follow-up|7
3028228|NCT00754065|10414375|P2|Overall Study|Adverse Event|25
3028229|NCT00754065|10414376|P1|Overall Study|Adverse Event|19
3028230|NCT00754065|10414375|P2|Overall Study|Never received treatment|2
3028231|NCT00754065|10414376|P1|Overall Study|Never received treatment|12
3028232|NCT00754052|10414616|P2|Overall Study|Study terminated by Sponsor|3
3028233|NCT00754052|10414617|P1|Overall Study|Study terminated by Sponsor|5
3028234|NCT00754013|10414631|P2|Overall Study|didn't return after study termed|4
3028235|NCT00754013|10414632|P1|Overall Study|didn't return after study termed|3
3028236|NCT00754013|10414631|P2|Overall Study|Lost to Follow-up|1
3028237|NCT00754013|10414632|P1|Overall Study|Lost to Follow-up|1
3028238|NCT00753922|10414669|P4|Overall Study|Discontinuation Due to Explantation|4
3028239|NCT00753922|10414670|P3|Overall Study|Discontinuation Due to Explantation|14
3028240|NCT00753922|10414671|P2|Overall Study|Discontinuation Due to Explantation|14
3028241|NCT00753922|10414672|P1|Overall Study|Discontinuation Due to Explantation|14
3028242|NCT00753922|10414669|P4|Overall Study|Death|1
3028243|NCT00753922|10414670|P3|Overall Study|Death|2
3028244|NCT00753922|10414671|P2|Overall Study|Death|23
3028245|NCT00753922|10414672|P1|Overall Study|Death|2
3028246|NCT00753922|10414669|P4|Overall Study|Patients Not Completing Visit|0
3028247|NCT00753922|10414670|P3|Overall Study|Patients Not Completing Visit|1
3028248|NCT00753922|10414671|P2|Overall Study|Patients Not Completing Visit|0
3028249|NCT00753922|10414672|P1|Overall Study|Patients Not Completing Visit|11
3028250|NCT00753922|10414669|P4|Overall Study|Patient Non-compliance|11
3028251|NCT00753922|10414670|P3|Overall Study|Patient Non-compliance|14
3028252|NCT00753922|10414671|P2|Overall Study|Patient Non-compliance|22
3028253|NCT00753922|10414672|P1|Overall Study|Patient Non-compliance|55
3028254|NCT00753922|10414669|P4|Overall Study|Withdrawal by Subject|2
3028255|NCT00753922|10414670|P3|Overall Study|Withdrawal by Subject|4
3028256|NCT00753922|10414671|P2|Overall Study|Withdrawal by Subject|11
3028257|NCT00753922|10414672|P1|Overall Study|Withdrawal by Subject|9
3028258|NCT00753922|10414669|P4|Overall Study|Lost to Follow-up|5
3028259|NCT00753922|10414670|P3|Overall Study|Lost to Follow-up|28
3028260|NCT00753922|10414671|P2|Overall Study|Lost to Follow-up|24
3028261|NCT00753922|10414672|P1|Overall Study|Lost to Follow-up|155
3028262|NCT00753896|10414702|P1|Overall Study|Entry Criteria Not Met|4
3028263|NCT00753896|10414702|P1|Overall Study|Withdrawal by Subject|4
3028264|NCT00753896|10414702|P1|Overall Study|Protocol Violation|1
3028265|NCT00753896|10414702|P1|Overall Study|Lost to Follow-up|2
3028266|NCT00753896|10414702|P1|Overall Study|Death|1
3028267|NCT00753896|10414702|P1|Overall Study|Adverse Event|4
3028268|NCT00753766|10414718|P2|Overall Study|Physician Decision|0
3028269|NCT00753766|10414719|P1|Overall Study|Physician Decision|1
3028270|NCT00753714|10414741|P2|Overall Study|Other|5
3028271|NCT00753714|10414742|P1|Overall Study|Other|7
3028272|NCT00753714|10414741|P2|Overall Study|Death|3
3028273|NCT00753714|10414742|P1|Overall Study|Death|3
3028274|NCT00753714|10414741|P2|Overall Study|Withdrawal by Subject|1
3028275|NCT00753714|10414742|P1|Overall Study|Withdrawal by Subject|2
3028276|NCT00753714|10414741|P2|Overall Study|Lost to Follow-up|1
3028277|NCT00753714|10414742|P1|Overall Study|Lost to Follow-up|0
3028278|NCT00753714|10414741|P2|Overall Study|Protocol Violation|0
3028279|NCT00753714|10414742|P1|Overall Study|Protocol Violation|1
3028280|NCT00753714|10414741|P2|Overall Study|Adverse Event|18
3028281|NCT00753714|10414742|P1|Overall Study|Adverse Event|26
3028282|NCT00753714|10414741|P2|Overall Study|Lack of Efficacy|34
3028283|NCT00753714|10414742|P1|Overall Study|Lack of Efficacy|21
3028284|NCT00753688|10414758|P2|Overall Study|Adverse Event|1
3028285|NCT00753688|10414759|P1|Overall Study|Adverse Event|0
3028286|NCT00753688|10414758|P2|Overall Study|Ongoing - in Follow-up|31
3028287|NCT00753688|10414759|P1|Overall Study|Ongoing - in Follow-up|15
3028288|NCT00753688|10414758|P2|Overall Study|Participant Withdrew Consent|2
3028289|NCT00753688|10414759|P1|Overall Study|Participant Withdrew Consent|2
3028290|NCT00753688|10414758|P2|Overall Study|Missing|9
3028291|NCT00753688|10414759|P1|Overall Study|Missing|4
3028292|NCT00753688|10414758|P2|Overall Study|Death|203
3028293|NCT00753688|10414759|P1|Overall Study|Death|102
3028294|NCT00753675|10414788|P3|Overall Study|Lost to Follow-up|0
3028295|NCT00753675|10414789|P2|Overall Study|Lost to Follow-up|0
3028296|NCT00753675|10414790|P1|Overall Study|Lost to Follow-up|1
3028297|NCT00753675|10414788|P3|Overall Study|Withdrawal by Subject|0
3028298|NCT00753675|10414789|P2|Overall Study|Withdrawal by Subject|1
3028299|NCT00753675|10414790|P1|Overall Study|Withdrawal by Subject|0
3028300|NCT00753675|10414788|P3|Overall Study|Objective progression of disease|35
3028301|NCT00753675|10414789|P2|Overall Study|Objective progression of disease|35
3028302|NCT00753675|10414790|P1|Overall Study|Objective progression of disease|35
3028303|NCT00753675|10414788|P3|Overall Study|Adverse Event|4
3028304|NCT00753675|10414789|P2|Overall Study|Adverse Event|9
3028305|NCT00753675|10414790|P1|Overall Study|Adverse Event|11
3028306|NCT00753675|10414788|P3|Overall Study|Death|4
3028307|NCT00753675|10414789|P2|Overall Study|Death|2
3028308|NCT00753675|10414790|P1|Overall Study|Death|1
3028309|NCT00753675|10414788|P3|Overall Study|other reason|13
3028310|NCT00753675|10414789|P2|Overall Study|other reason|12
3028311|NCT00753675|10414790|P1|Overall Study|other reason|11
3028312|NCT00753649|10414812|P2|Overall Study|Protocol Violation|0
3028313|NCT00753649|10414813|P1|Overall Study|Protocol Violation|2
3028314|NCT00753649|10414812|P2|Overall Study|Lost to follow-up-complete vaccination|0
3028315|NCT00753649|10414813|P1|Overall Study|Lost to follow-up-complete vaccination|1
3028316|NCT00753649|10414812|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
3028317|NCT00753649|10414813|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
3028318|NCT00753649|10414812|P2|Overall Study|Migrated/moved from study area|0
3028319|NCT00753649|10414813|P1|Overall Study|Migrated/moved from study area|1
3028320|NCT00753623|10414845|P2|Phase II (14 Days)|Physician Decision|1
3028321|NCT00753623|10414846|P1|Phase II (14 Days)|Physician Decision|0
3028322|NCT00753623|10414845|P2|Washout (7 Days)|Physician Decision|0
3028323|NCT00753623|10414846|P1|Washout (7 Days)|Physician Decision|1
3028324|NCT00753623|10414845|P2|Phase I (14 Days)|Adverse Event|1
3028325|NCT00753623|10414846|P1|Phase I (14 Days)|Adverse Event|0
3028326|NCT00753623|10414845|P2|Phase I (14 Days)|Physician Decision|2
3028327|NCT00753623|10414846|P1|Phase I (14 Days)|Physician Decision|1
3028328|NCT00753623|10414845|P2|Phase I (14 Days)|Withdrawal by Subject|1
3028329|NCT00753623|10414846|P1|Phase I (14 Days)|Withdrawal by Subject|1
3028330|NCT00753545|10414854|P2|Overall Study|Voluntary Discontinuation of Patient|3
3028331|NCT00753545|10414855|P1|Overall Study|Voluntary Discontinuation of Patient|7
3028332|NCT00753545|10414854|P2|Overall Study|Protocol Violation|0
3028333|NCT00753545|10414855|P1|Overall Study|Protocol Violation|1
3028334|NCT00753545|10414854|P2|Overall Study|Lost to Follow-up|3
3028335|NCT00753545|10414855|P1|Overall Study|Lost to Follow-up|2
3028336|NCT00753545|10414854|P2|Overall Study|Death|112
3028337|NCT00753545|10414855|P1|Overall Study|Death|98
3028338|NCT00753519|10414893|P2|Overall Study|Withdrawal by Subject|2
3028339|NCT00753519|10414894|P1|Overall Study|Withdrawal by Subject|0
3028340|NCT00753506|10414916|P2|Overall Study|Other reason|1
3028341|NCT00753506|10414917|P1|Overall Study|Other reason|1
3028342|NCT00753506|10414916|P2|Overall Study|Lost to Follow-up|0
3028343|NCT00753506|10414917|P1|Overall Study|Lost to Follow-up|2
3028344|NCT00753506|10414916|P2|Overall Study|Withdrawal by Subject|1
3028345|NCT00753506|10414917|P1|Overall Study|Withdrawal by Subject|4
3028346|NCT00753454|10414923|P1|Overall Study|Investigator Decision|1
3028347|NCT00753454|10414923|P1|Overall Study|Withdrawal by Subject|5
3028348|NCT00753454|10414923|P1|Overall Study|Lost to Follow-up|3
3028349|NCT00753454|10414923|P1|Overall Study|Lack of Efficacy|1
3028350|NCT00753454|10414923|P1|Overall Study|Adverse Event|4
3028351|NCT00753415|10414957|P10|Part B|Disease progression|1
3028352|NCT00753415|10414958|P9|Part B|Disease progression|2
3028353|NCT00753415|10414959|P8|Part B|Disease progression|0
3028354|NCT00753415|10414960|P7|Part B|Disease progression|0
3028355|NCT00753415|10414961|P6|Part B|Disease progression|0
3028356|NCT00753415|10414962|P5|Part B|Disease progression|0
3028357|NCT00753415|10414963|P4|Part B|Disease progression|0
3028358|NCT00753415|10414964|P3|Part B|Disease progression|0
3028359|NCT00753415|10414965|P2|Part B|Disease progression|0
3028360|NCT00753415|10414966|P1|Part B|Disease progression|0
3028361|NCT00753415|10414957|P10|Part B|Lost to Follow-up|0
3028362|NCT00753415|10414958|P9|Part B|Lost to Follow-up|1
3028363|NCT00753415|10414959|P8|Part B|Lost to Follow-up|1
3028364|NCT00753415|10414960|P7|Part B|Lost to Follow-up|0
3028365|NCT00753415|10414961|P6|Part B|Lost to Follow-up|0
3028366|NCT00753415|10414962|P5|Part B|Lost to Follow-up|0
3028367|NCT00753415|10414963|P4|Part B|Lost to Follow-up|0
3028368|NCT00753415|10414964|P3|Part B|Lost to Follow-up|0
3028369|NCT00753415|10414965|P2|Part B|Lost to Follow-up|0
3028370|NCT00753415|10414966|P1|Part B|Lost to Follow-up|0
3028371|NCT00753415|10414957|P10|Part A|Withdrawal by Subject|0
3028372|NCT00753415|10414958|P9|Part A|Withdrawal by Subject|0
3028373|NCT00753415|10414959|P8|Part A|Withdrawal by Subject|0
3028374|NCT00753415|10414960|P7|Part A|Withdrawal by Subject|0
3028375|NCT00753415|10414961|P6|Part A|Withdrawal by Subject|0
3028376|NCT00753415|10414962|P5|Part A|Withdrawal by Subject|0
3028377|NCT00753415|10414963|P4|Part A|Withdrawal by Subject|0
3028378|NCT00753415|10414964|P3|Part A|Withdrawal by Subject|1
3028379|NCT00753415|10414965|P2|Part A|Withdrawal by Subject|0
3028380|NCT00753415|10414966|P1|Part A|Withdrawal by Subject|0
3028381|NCT00753415|10414957|P10|Part A|Disease progression|0
3028382|NCT00753415|10414958|P9|Part A|Disease progression|0
3028383|NCT00753415|10414959|P8|Part A|Disease progression|0
3028384|NCT00753415|10414960|P7|Part A|Disease progression|0
3028385|NCT00753415|10414961|P6|Part A|Disease progression|0
3028386|NCT00753415|10414962|P5|Part A|Disease progression|0
3028387|NCT00753415|10414963|P4|Part A|Disease progression|2
3028388|NCT00753415|10414964|P3|Part A|Disease progression|1
3028389|NCT00753415|10414965|P2|Part A|Disease progression|0
3028390|NCT00753415|10414966|P1|Part A|Disease progression|1
3028391|NCT00753272|10415056|P2|Overall Study|Other|1088
3028392|NCT00753272|10415057|P1|Overall Study|Other|1104
3028393|NCT00753272|10415056|P2|Overall Study|Lost to Follow-up|497
3028394|NCT00753272|10415057|P1|Overall Study|Lost to Follow-up|491
3028395|NCT00753272|10415056|P2|Overall Study|Withdrawal by Subject|2407
3028396|NCT00753272|10415057|P1|Overall Study|Withdrawal by Subject|2481
3028397|NCT00753272|10415056|P2|Overall Study|Protocol Violation|46
3028398|NCT00753272|10415057|P1|Overall Study|Protocol Violation|28
3028399|NCT00753272|10415056|P2|Overall Study|Adverse Event|869
3028400|NCT00753272|10415057|P1|Overall Study|Adverse Event|878
3028401|NCT00753012|10415141|P2|Overall Study|Confounded endpoint data|0
3028402|NCT00753012|10415142|P1|Overall Study|Confounded endpoint data|1
3028403|NCT00753012|10415141|P2|Overall Study|Lost to Follow-up|0
3028404|NCT00753012|10415142|P1|Overall Study|Lost to Follow-up|4
3028405|NCT00753012|10415141|P2|Overall Study|Withdrawal by Subject|1
3028406|NCT00753012|10415142|P1|Overall Study|Withdrawal by Subject|0
3028407|NCT00753012|10415141|P2|Overall Study|Adverse Event|0
3028408|NCT00753012|10415142|P1|Overall Study|Adverse Event|2
3028409|NCT00753012|10415141|P2|Overall Study|Ineligible, abnormal cardiac histo|0
3028410|NCT00753012|10415142|P1|Overall Study|Ineligible, abnormal cardiac histo|1
3028411|NCT00752986|10415155|P3|Overall Study|Protocol Violation|0
3028412|NCT00752986|10415156|P2|Overall Study|Protocol Violation|0
3028413|NCT00752986|10415157|P1|Overall Study|Protocol Violation|3
3028414|NCT00752986|10415155|P3|Overall Study|Withdrawal by Subject|2
3028415|NCT00752986|10415156|P2|Overall Study|Withdrawal by Subject|1
3028416|NCT00752986|10415157|P1|Overall Study|Withdrawal by Subject|2
3028417|NCT00752895|10415197|P2|Overall Study|Withdrawal by Subject|3
3028418|NCT00752895|10415198|P1|Overall Study|Withdrawal by Subject|8
3028419|NCT00752791|10415206|P1|Overall Study|Protocol deviation|1
3028420|NCT00752791|10415206|P1|Overall Study|Switched to hemodialysis|2
3028421|NCT00752791|10415206|P1|Overall Study|Renal transplant|3
3028422|NCT00752791|10415206|P1|Overall Study|Death|1
3028423|NCT00752791|10415206|P1|Overall Study|Physician Decision|1
3028424|NCT00752791|10415206|P1|Overall Study|Withdrawal by Subject|1
3028425|NCT00752791|10415206|P1|Overall Study|Adverse Event|7
3028426|NCT00752726|10415218|P2|Overall Study|Other Reason|2
3028427|NCT00752726|10415219|P1|Overall Study|Other Reason|1
3028428|NCT00752726|10415218|P2|Overall Study|Withdrawal by Subject|10
3028429|NCT00752726|10415219|P1|Overall Study|Withdrawal by Subject|5
3028430|NCT00752726|10415218|P2|Overall Study|Adverse Event|0
3028431|NCT00752726|10415219|P1|Overall Study|Adverse Event|3
3028432|NCT00752726|10415218|P2|Overall Study|Lost to Follow-up|1
3028433|NCT00752726|10415219|P1|Overall Study|Lost to Follow-up|2
3028434|NCT00752622|10415244|P1|Interventional Phase|Premature Study Termination|5
3028435|NCT00752622|10415244|P1|Interventional Phase|Physician Decision|1
3028436|NCT00752622|10415244|P1|Interventional Phase|Non-responder|2
3028437|NCT00752622|10415244|P1|Observational Phase|Other|2
3028438|NCT00752622|10415244|P1|Observational Phase|Adverse Event|1
3028439|NCT00752622|10415244|P1|Observational Phase|Withdrawal by Subject|2
3028440|NCT00752622|10415244|P1|Observational Phase|Non-responder|2
3028441|NCT00752622|10415244|P1|Observational Phase|Premature Study Termination|36
3028442|NCT00752622|10415244|P1|Induction Phase|Premature study termination|14
3028443|NCT00752622|10415244|P1|Induction Phase|Withdrawal by Subject|1
3028444|NCT00752622|10415244|P1|Induction Phase|Non-responder|14
3028445|NCT00752622|10415244|P1|Induction Phase|Other|3
3028446|NCT00752622|10415244|P1|Induction Phase|Adverse Event|3
3028447|NCT00752609|10415257|P2|Overall Study|Received Aranesp in error|0
3028448|NCT00752609|10415258|P1|Overall Study|Received Aranesp in error|1
3028449|NCT00752609|10415257|P2|Overall Study|Met exclusion criteria|0
3028450|NCT00752609|10415258|P1|Overall Study|Met exclusion criteria|1
3028451|NCT00752609|10415257|P2|Overall Study|Death|0
3028452|NCT00752609|10415258|P1|Overall Study|Death|1
3028453|NCT00752609|10415257|P2|Overall Study|Physician Decision|0
3028454|NCT00752609|10415258|P1|Overall Study|Physician Decision|1
3028455|NCT00752609|10415257|P2|Overall Study|Withdrawal by Subject|0
3028456|NCT00752609|10415258|P1|Overall Study|Withdrawal by Subject|3
3028457|NCT00752609|10415257|P2|Overall Study|Adverse Event|2
3028458|NCT00752609|10415258|P1|Overall Study|Adverse Event|2
3028459|NCT00752557|10415280|P3|Overall Study|Lost to Follow-up|1
3028460|NCT00752557|10415281|P2|Overall Study|Lost to Follow-up|0
3028461|NCT00752557|10415282|P1|Overall Study|Lost to Follow-up|1
3028462|NCT00752557|10415280|P3|Overall Study|Unspecified resaons|2
3028463|NCT00752557|10415281|P2|Overall Study|Unspecified resaons|2
3028464|NCT00752557|10415282|P1|Overall Study|Unspecified resaons|0
3028465|NCT00752557|10415280|P3|Overall Study|Withdrawal by Subject|3
3028466|NCT00752557|10415281|P2|Overall Study|Withdrawal by Subject|3
3028467|NCT00752557|10415282|P1|Overall Study|Withdrawal by Subject|4
3028468|NCT00752232|10415314|P7|Overall Study|Caregiver could not attend the subject|0
3028469|NCT00752232|10415315|P6|Overall Study|Caregiver could not attend the subject|0
3028470|NCT00752232|10415316|P5|Overall Study|Caregiver could not attend the subject|1
3028471|NCT00752232|10415317|P4|Overall Study|Caregiver could not attend the subject|0
3028472|NCT00752232|10415318|P3|Overall Study|Caregiver could not attend the subject|0
3028473|NCT00752232|10415319|P2|Overall Study|Caregiver could not attend the subject|0
3028474|NCT00752232|10415320|P1|Overall Study|Caregiver could not attend the subject|0
3028475|NCT00752232|10415314|P7|Overall Study|Group home admission|0
3028476|NCT00752232|10415315|P6|Overall Study|Group home admission|0
3028477|NCT00752232|10415316|P5|Overall Study|Group home admission|0
3028478|NCT00752232|10415317|P4|Overall Study|Group home admission|1
3028479|NCT00752232|10415318|P3|Overall Study|Group home admission|0
3028480|NCT00752232|10415319|P2|Overall Study|Group home admission|0
3028481|NCT00752232|10415320|P1|Overall Study|Group home admission|0
3028482|NCT00752232|10415314|P7|Overall Study|Subject request|0
3028483|NCT00752232|10415315|P6|Overall Study|Subject request|0
3028484|NCT00752232|10415316|P5|Overall Study|Subject request|0
3028485|NCT00752232|10415317|P4|Overall Study|Subject request|0
3028486|NCT00752232|10415318|P3|Overall Study|Subject request|1
3028487|NCT00752232|10415319|P2|Overall Study|Subject request|0
3028488|NCT00752232|10415320|P1|Overall Study|Subject request|0
3028489|NCT00752232|10415314|P7|Overall Study|Investigator request|0
3028490|NCT00752232|10415315|P6|Overall Study|Investigator request|0
3028491|NCT00752232|10415316|P5|Overall Study|Investigator request|1
3028492|NCT00752232|10415317|P4|Overall Study|Investigator request|0
3028493|NCT00752232|10415318|P3|Overall Study|Investigator request|0
3028494|NCT00752232|10415319|P2|Overall Study|Investigator request|0
3028495|NCT00752232|10415320|P1|Overall Study|Investigator request|0
3028496|NCT00752232|10415314|P7|Overall Study|Caregiver request|0
3028497|NCT00752232|10415315|P6|Overall Study|Caregiver request|0
3028498|NCT00752232|10415316|P5|Overall Study|Caregiver request|1
3028499|NCT00752232|10415317|P4|Overall Study|Caregiver request|0
3028500|NCT00752232|10415318|P3|Overall Study|Caregiver request|0
3028501|NCT00752232|10415319|P2|Overall Study|Caregiver request|0
3028502|NCT00752232|10415320|P1|Overall Study|Caregiver request|2
3028503|NCT00752232|10415314|P7|Overall Study|Protocol Violation|0
3028504|NCT00752232|10415315|P6|Overall Study|Protocol Violation|1
3028505|NCT00752232|10415316|P5|Overall Study|Protocol Violation|0
3028506|NCT00752232|10415317|P4|Overall Study|Protocol Violation|0
3028507|NCT00752232|10415318|P3|Overall Study|Protocol Violation|0
3028508|NCT00752232|10415319|P2|Overall Study|Protocol Violation|0
3028509|NCT00752232|10415320|P1|Overall Study|Protocol Violation|0
3028510|NCT00752219|10415394|P2|Overall Study|Other|0
3028511|NCT00752219|10415395|P1|Overall Study|Other|3
3028512|NCT00752219|10415394|P2|Overall Study|Randomized but not treated|0
3028513|NCT00752219|10415395|P1|Overall Study|Randomized but not treated|1
3028514|NCT00752219|10415394|P2|Overall Study|Lost to Follow-up|2
3028515|NCT00752219|10415395|P1|Overall Study|Lost to Follow-up|1
3028516|NCT00752219|10415394|P2|Overall Study|Protocol deviation|0
3028517|NCT00752219|10415395|P1|Overall Study|Protocol deviation|1
3028518|NCT00752219|10415394|P2|Overall Study|Adverse Event|3
3028519|NCT00752219|10415395|P1|Overall Study|Adverse Event|5
3028520|NCT00752219|10415394|P2|Overall Study|Clinical failure|1
3028521|NCT00752219|10415395|P1|Overall Study|Clinical failure|0
3028522|NCT00752206|10415421|P2|Overall Study|Pregnancy|0
3028523|NCT00752206|10415422|P1|Overall Study|Pregnancy|1
3028524|NCT00752206|10415421|P2|Overall Study|Disease progression|11
3028525|NCT00752206|10415422|P1|Overall Study|Disease progression|8
3028526|NCT00752128|10415440|P1|Overall Study|Withdrawal by Subject|4
3028527|NCT00752089|10415454|P1|Overall Study|Cannot continue the study|1
3028528|NCT00752089|10415454|P1|Overall Study|Not capable of wearing partial denture|1
3028529|NCT00752089|10415454|P1|Overall Study|Could not attend visit 9|1
3028530|NCT00752089|10415454|P1|Overall Study|Protocol Deviation|2
3028531|NCT00752089|10415454|P1|Overall Study|Adverse Event|1
3028532|NCT00751998|10415468|P1|Overall Study|Withdrawal by Subject|2
3028533|NCT00751998|10415468|P1|Overall Study|Death|11
3028534|NCT00751998|10415468|P1|Overall Study|Lost to Follow-up|7
3028535|NCT00751933|10415487|P4|Overall Study|Physician Decision|1
3028536|NCT00751933|10415488|P3|Overall Study|Physician Decision|1
3028537|NCT00751933|10415489|P2|Overall Study|Physician Decision|0
3028538|NCT00751933|10415490|P1|Overall Study|Physician Decision|0
3028539|NCT00751933|10415487|P4|Overall Study|Withdrawal by Subject|0
3028540|NCT00751933|10415488|P3|Overall Study|Withdrawal by Subject|0
3028541|NCT00751933|10415489|P2|Overall Study|Withdrawal by Subject|1
3028542|NCT00751933|10415490|P1|Overall Study|Withdrawal by Subject|0
3028543|NCT00751881|10415498|P3|Extension Study Period|Other than specified above|18
3028544|NCT00751881|10415499|P2|Extension Study Period|Other than specified above|30
3028545|NCT00751881|10415500|P1|Extension Study Period|Other than specified above|26
3028546|NCT00751881|10415498|P3|Extension Study Period|Poor Compliance to Protocol|1
3028547|NCT00751881|10415499|P2|Extension Study Period|Poor Compliance to Protocol|2
3028548|NCT00751881|10415500|P1|Extension Study Period|Poor Compliance to Protocol|3
3028549|NCT00751881|10415498|P3|Extension Study Period|Lost to Follow-up|6
3028550|NCT00751881|10415499|P2|Extension Study Period|Lost to Follow-up|9
3028551|NCT00751881|10415500|P1|Extension Study Period|Lost to Follow-up|4
3028552|NCT00751881|10415498|P3|Extension Study Period|Lack of Efficacy|20
3028553|NCT00751881|10415499|P2|Extension Study Period|Lack of Efficacy|10
3028554|NCT00751881|10415500|P1|Extension Study Period|Lack of Efficacy|14
3028555|NCT00751881|10415498|P3|Extension Study Period|Adverse Event|21
3028556|NCT00751881|10415499|P2|Extension Study Period|Adverse Event|20
3028557|NCT00751881|10415500|P1|Extension Study Period|Adverse Event|18
3028558|NCT00751881|10415498|P3|Core Treatment Period|Other:participant's decision/unspecified|16
3028559|NCT00751881|10415499|P2|Core Treatment Period|Other:participant's decision/unspecified|22
3028560|NCT00751881|10415500|P1|Core Treatment Period|Other:participant's decision/unspecified|19
3028561|NCT00751881|10415498|P3|Core Treatment Period|Other: tolerability complaints|0
3028562|NCT00751881|10415499|P2|Core Treatment Period|Other: tolerability complaints|0
3028563|NCT00751881|10415500|P1|Core Treatment Period|Other: tolerability complaints|2
3028564|NCT00751881|10415498|P3|Core Treatment Period|Other: MS treatment change|4
3028565|NCT00751881|10415499|P2|Core Treatment Period|Other: MS treatment change|4
3028566|NCT00751881|10415500|P1|Core Treatment Period|Other: MS treatment change|6
3028567|NCT00751881|10415498|P3|Core Treatment Period|Other: personal/family constraints|10
3028568|NCT00751881|10415499|P2|Core Treatment Period|Other: personal/family constraints|7
3028569|NCT00751881|10415500|P1|Core Treatment Period|Other: personal/family constraints|6
3028570|NCT00751881|10415498|P3|Core Treatment Period|Other: wish to parent|4
3028571|NCT00751881|10415499|P2|Core Treatment Period|Other: wish to parent|7
3028572|NCT00751881|10415500|P1|Core Treatment Period|Other: wish to parent|5
3028573|NCT00751881|10415498|P3|Core Treatment Period|Other: protocol deviation|7
3028574|NCT00751881|10415499|P2|Core Treatment Period|Other: protocol deviation|3
3028575|NCT00751881|10415500|P1|Core Treatment Period|Other: protocol deviation|3
3028576|NCT00751881|10415498|P3|Core Treatment Period|Lost to Follow-up|3
3028577|NCT00751881|10415499|P2|Core Treatment Period|Lost to Follow-up|4
3028578|NCT00751881|10415500|P1|Core Treatment Period|Lost to Follow-up|6
3028579|NCT00751881|10415498|P3|Core Treatment Period|Poor compliance to protocol|4
3028580|NCT00751881|10415499|P2|Core Treatment Period|Poor compliance to protocol|3
3028581|NCT00751881|10415500|P1|Core Treatment Period|Poor compliance to protocol|15
3028582|NCT00751881|10415498|P3|Core Treatment Period|Lack of Efficacy|20
3028583|NCT00751881|10415499|P2|Core Treatment Period|Lack of Efficacy|30
3028584|NCT00751881|10415500|P1|Core Treatment Period|Lack of Efficacy|37
3028585|NCT00751881|10415498|P3|Core Treatment Period|Adverse Event|58
3028586|NCT00751881|10415499|P2|Core Treatment Period|Adverse Event|54
3028587|NCT00751881|10415500|P1|Core Treatment Period|Adverse Event|26
3028588|NCT00751881|10415498|P3|Core Treatment Period|Not treated|2
3028589|NCT00751881|10415499|P2|Core Treatment Period|Not treated|1
3028590|NCT00751881|10415500|P1|Core Treatment Period|Not treated|1
3028591|NCT00751790|10415547|P1|Overall Study|Withdrawal by Subject|1
3028592|NCT00751790|10415547|P1|Overall Study|Death|3
3028593|NCT00751790|10415547|P1|Overall Study|Lost to Follow-up|1
3028594|NCT00751621|10415578|P1|Overall Study|Poor adherence to asthma treatment|1
3028595|NCT00751621|10415578|P1|Overall Study|Subject moved to another country|1
3028596|NCT00751621|10415578|P1|Overall Study|Withdrawal by Subject|1
3028597|NCT00751621|10415578|P1|Overall Study|Adverse Event|1
3028598|NCT00751400|10415612|P1|Overall Study|Lost to Follow-up|10
3028599|NCT00751348|10415627|P2|Overall Study|Migration from study area|0
3028600|NCT00751348|10415628|P1|Overall Study|Migration from study area|1
3028601|NCT00751348|10415627|P2|Overall Study|Withdrawal by Subject|2
3028602|NCT00751348|10415628|P1|Overall Study|Withdrawal by Subject|5
3028603|NCT00751296|10415650|P1|Overall Study|Adverse Event|2
3028604|NCT00751140|10415678|P1|Overall Study|benign angioma excluded from analysis|1
3028605|NCT00751114|10415688|P2|Overall Study|Move to another city|0
3028606|NCT00751114|10415689|P1|Overall Study|Move to another city|1
3028607|NCT00751114|10415688|P2|Overall Study|Out of country for 2 months|0
3028608|NCT00751114|10415689|P1|Overall Study|Out of country for 2 months|1
3028609|NCT00751114|10415688|P2|Overall Study|Not Treated|1
3028610|NCT00751114|10415689|P1|Overall Study|Not Treated|13
3028611|NCT00751114|10415688|P2|Overall Study|Lack of Efficacy|7
3028612|NCT00751114|10415689|P1|Overall Study|Lack of Efficacy|0
3028613|NCT00751114|10415688|P2|Overall Study|Lost to Follow-up|7
3028614|NCT00751114|10415689|P1|Overall Study|Lost to Follow-up|4
3028615|NCT00751114|10415688|P2|Overall Study|Withdrawal by Subject|4
3028616|NCT00751114|10415689|P1|Overall Study|Withdrawal by Subject|9
3028617|NCT00751114|10415688|P2|Overall Study|Protocol Violation|9
3028618|NCT00751114|10415689|P1|Overall Study|Protocol Violation|8
3028619|NCT00751114|10415688|P2|Overall Study|Adverse Event|4
3028620|NCT00751114|10415689|P1|Overall Study|Adverse Event|2
3028621|NCT00751036|10415714|P2|Overall Study|Missing end of Treatment Page|3
3028622|NCT00751036|10415715|P1|Overall Study|Missing end of Treatment Page|2
3028623|NCT00751036|10415714|P2|Overall Study|Protocol Violation|0
3028624|NCT00751036|10415715|P1|Overall Study|Protocol Violation|1
3028625|NCT00751036|10415714|P2|Overall Study|Lost to Follow-up|1
3028626|NCT00751036|10415715|P1|Overall Study|Lost to Follow-up|0
3028627|NCT00751036|10415714|P2|Overall Study|Death|3
3028628|NCT00751036|10415715|P1|Overall Study|Death|3
3028629|NCT00751036|10415714|P2|Overall Study|Withdrawal by Subject|2
3028630|NCT00751036|10415715|P1|Overall Study|Withdrawal by Subject|5
3028631|NCT00751036|10415714|P2|Overall Study|Administrative Problems|4
3028632|NCT00751036|10415715|P1|Overall Study|Administrative Problems|3
3028633|NCT00751036|10415714|P2|Overall Study|Adverse Event|4
3028634|NCT00751036|10415715|P1|Overall Study|Adverse Event|6
3028635|NCT00751036|10415714|P2|Overall Study|Disease Progression|29
3028636|NCT00751036|10415715|P1|Overall Study|Disease Progression|28
3028637|NCT00751023|10415729|P2|Overall Study|Lost to Follow-up|7
3028638|NCT00751023|10415730|P1|Overall Study|Lost to Follow-up|11
3028639|NCT00750919|10415750|P1|Overall Study|Other|36
3028640|NCT00750919|10415750|P1|Overall Study|Could not cooperate, unrelated to trial|4
3028641|NCT00750919|10415750|P1|Overall Study|Lack of Efficacy|8
3028642|NCT00750919|10415750|P1|Overall Study|Withdrawal by Subject|1
3028643|NCT00750919|10415750|P1|Overall Study|Adverse Event|9
3028644|NCT00750893|10415758|P1|Overall Study|Other|17
3028645|NCT00750893|10415758|P1|Overall Study|Lost to Follow-up|510
3028646|NCT00750893|10415758|P1|Overall Study|Withdrawal by Subject|10
3028647|NCT00750893|10415758|P1|Overall Study|Adverse Event|5
3028648|NCT00750880|10415770|P1|Overall Study|Administrative|11
3028649|NCT00750880|10415770|P1|Overall Study|Physician Decision|20
3028650|NCT00750880|10415770|P1|Overall Study|Withdrawal by Subject|33
3028651|NCT00750880|10415770|P1|Overall Study|Protocol Violation|15
3028652|NCT00750880|10415770|P1|Overall Study|Lost to Follow-up|10
3028653|NCT00750880|10415770|P1|Overall Study|Lack of Efficacy|46
3028654|NCT00750880|10415770|P1|Overall Study|Death|4
3028655|NCT00750880|10415770|P1|Overall Study|Adverse Event|76
3028656|NCT00750867|10415793|P1|Overall Study|Adverse Event|2
3028657|NCT00750737|10415814|P2|Overall Study|Withdrawal by Subject|3
3028658|NCT00750737|10415815|P1|Overall Study|Withdrawal by Subject|3
3028659|NCT00750438|10415830|P2|Overall Study|Withdrawal by Subject|1
3028660|NCT00750438|10415831|P1|Overall Study|Withdrawal by Subject|1
3028661|NCT00750438|10415830|P2|Overall Study|Physician Decision|2
3028662|NCT00750438|10415831|P1|Overall Study|Physician Decision|2
3028663|NCT00750438|10415830|P2|Overall Study|Protocol Violation|1
3028664|NCT00750438|10415831|P1|Overall Study|Protocol Violation|4
3028665|NCT00750308|10415897|P12|Third Treatment|Withdrawal by Subject|0
3028666|NCT00750308|10415898|P11|Third Treatment|Withdrawal by Subject|0
3028667|NCT00750308|10415899|P10|Third Treatment|Withdrawal by Subject|0
3028668|NCT00750308|10415900|P9|Third Treatment|Withdrawal by Subject|0
3028669|NCT00750308|10415901|P8|Third Treatment|Withdrawal by Subject|0
3028670|NCT00750308|10415902|P7|Third Treatment|Withdrawal by Subject|0
3028671|NCT00750308|10415903|P6|Third Treatment|Withdrawal by Subject|0
3028672|NCT00750308|10415904|P5|Third Treatment|Withdrawal by Subject|0
3028673|NCT00750308|10415905|P4|Third Treatment|Withdrawal by Subject|0
3028674|NCT00750308|10415906|P3|Third Treatment|Withdrawal by Subject|0
3028675|NCT00750308|10415907|P2|Third Treatment|Withdrawal by Subject|1
3028676|NCT00750308|10415908|P1|Third Treatment|Withdrawal by Subject|0
3028677|NCT00750308|10415897|P12|Second Treatment|Withdrawal by Subject|0
3028678|NCT00750308|10415898|P11|Second Treatment|Withdrawal by Subject|0
3028679|NCT00750308|10415899|P10|Second Treatment|Withdrawal by Subject|0
3028680|NCT00750308|10415900|P9|Second Treatment|Withdrawal by Subject|0
3028681|NCT00750308|10415901|P8|Second Treatment|Withdrawal by Subject|0
3028682|NCT00750308|10415902|P7|Second Treatment|Withdrawal by Subject|0
3028683|NCT00750308|10415903|P6|Second Treatment|Withdrawal by Subject|0
3028684|NCT00750308|10415904|P5|Second Treatment|Withdrawal by Subject|1
3028685|NCT00750308|10415905|P4|Second Treatment|Withdrawal by Subject|0
3028686|NCT00750308|10415906|P3|Second Treatment|Withdrawal by Subject|0
3028687|NCT00750308|10415907|P2|Second Treatment|Withdrawal by Subject|0
3028688|NCT00750308|10415908|P1|Second Treatment|Withdrawal by Subject|0
3028689|NCT00750308|10415897|P12|Second Treatment|Adverse Event|0
3028690|NCT00750308|10415898|P11|Second Treatment|Adverse Event|0
3028691|NCT00750308|10415899|P10|Second Treatment|Adverse Event|0
3028692|NCT00750308|10415900|P9|Second Treatment|Adverse Event|1
3028693|NCT00750308|10415901|P8|Second Treatment|Adverse Event|0
3028694|NCT00750308|10415902|P7|Second Treatment|Adverse Event|0
3028695|NCT00750308|10415903|P6|Second Treatment|Adverse Event|1
3028696|NCT00750308|10415904|P5|Second Treatment|Adverse Event|0
3028697|NCT00750308|10415905|P4|Second Treatment|Adverse Event|0
3028698|NCT00750308|10415906|P3|Second Treatment|Adverse Event|0
3028699|NCT00750308|10415907|P2|Second Treatment|Adverse Event|0
3028700|NCT00750308|10415908|P1|Second Treatment|Adverse Event|0
3028701|NCT00750308|10415897|P12|First Treatment|Withdrawal by Subject|0
3028702|NCT00750308|10415898|P11|First Treatment|Withdrawal by Subject|0
3028703|NCT00750308|10415899|P10|First Treatment|Withdrawal by Subject|0
3028704|NCT00750308|10415900|P9|First Treatment|Withdrawal by Subject|0
3028705|NCT00750308|10415901|P8|First Treatment|Withdrawal by Subject|1
3028706|NCT00750308|10415902|P7|First Treatment|Withdrawal by Subject|0
3028707|NCT00750308|10415903|P6|First Treatment|Withdrawal by Subject|0
3028708|NCT00750308|10415904|P5|First Treatment|Withdrawal by Subject|0
3028709|NCT00750308|10415905|P4|First Treatment|Withdrawal by Subject|1
3028710|NCT00750308|10415906|P3|First Treatment|Withdrawal by Subject|0
3028711|NCT00750308|10415907|P2|First Treatment|Withdrawal by Subject|0
3028712|NCT00750308|10415908|P1|First Treatment|Withdrawal by Subject|0
3028713|NCT00750308|10415897|P12|First Treatment|Adverse Event|1
3028714|NCT00750308|10415898|P11|First Treatment|Adverse Event|1
3028715|NCT00750308|10415899|P10|First Treatment|Adverse Event|0
3028716|NCT00750308|10415900|P9|First Treatment|Adverse Event|0
3028717|NCT00750308|10415901|P8|First Treatment|Adverse Event|0
3028718|NCT00750308|10415902|P7|First Treatment|Adverse Event|0
3028719|NCT00750308|10415903|P6|First Treatment|Adverse Event|0
3028720|NCT00750308|10415904|P5|First Treatment|Adverse Event|0
3028721|NCT00750308|10415905|P4|First Treatment|Adverse Event|0
3028722|NCT00750308|10415906|P3|First Treatment|Adverse Event|0
3028723|NCT00750308|10415907|P2|First Treatment|Adverse Event|1
3028724|NCT00750308|10415908|P1|First Treatment|Adverse Event|0
3028725|NCT00750269|10415958|P5|Overall Study|Fiducials could not be placed|1
3028726|NCT00750269|10415959|P4|Overall Study|Fiducials could not be placed|0
3028727|NCT00750269|10415960|P3|Overall Study|Fiducials could not be placed|0
3028728|NCT00750269|10415961|P2|Overall Study|Fiducials could not be placed|0
3028729|NCT00750269|10415962|P1|Overall Study|Fiducials could not be placed|0
3028730|NCT00750269|10415958|P5|Overall Study|SBRT plan could not be drawn|1
3028731|NCT00750269|10415959|P4|Overall Study|SBRT plan could not be drawn|0
3028732|NCT00750269|10415960|P3|Overall Study|SBRT plan could not be drawn|0
3028733|NCT00750269|10415961|P2|Overall Study|SBRT plan could not be drawn|0
3028734|NCT00750269|10415962|P1|Overall Study|SBRT plan could not be drawn|0
3028735|NCT00750269|10415958|P5|Overall Study|Site error|0
3028736|NCT00750269|10415959|P4|Overall Study|Site error|1
3028737|NCT00750269|10415960|P3|Overall Study|Site error|0
3028738|NCT00750269|10415961|P2|Overall Study|Site error|0
3028739|NCT00750269|10415962|P1|Overall Study|Site error|0
3028740|NCT00750269|10415958|P5|Overall Study|Patient too large for positioning|0
3028741|NCT00750269|10415959|P4|Overall Study|Patient too large for positioning|0
3028742|NCT00750269|10415960|P3|Overall Study|Patient too large for positioning|1
3028743|NCT00750269|10415961|P2|Overall Study|Patient too large for positioning|0
3028744|NCT00750269|10415962|P1|Overall Study|Patient too large for positioning|0
3028745|NCT00750269|10415958|P5|Overall Study|Physician Decision|2
3028746|NCT00750269|10415959|P4|Overall Study|Physician Decision|0
3028747|NCT00750269|10415960|P3|Overall Study|Physician Decision|0
3028748|NCT00750269|10415961|P2|Overall Study|Physician Decision|0
3028749|NCT00750269|10415962|P1|Overall Study|Physician Decision|0
3028750|NCT00750269|10415958|P5|Overall Study|Withdrawal by Subject|2
3028751|NCT00750269|10415959|P4|Overall Study|Withdrawal by Subject|2
3028752|NCT00750269|10415960|P3|Overall Study|Withdrawal by Subject|2
3028753|NCT00750269|10415961|P2|Overall Study|Withdrawal by Subject|0
3028754|NCT00750269|10415962|P1|Overall Study|Withdrawal by Subject|0
3028755|NCT00750269|10415958|P5|Overall Study|Protocol Violation|4
3028756|NCT00750269|10415959|P4|Overall Study|Protocol Violation|2
3028757|NCT00750269|10415960|P3|Overall Study|Protocol Violation|1
3028758|NCT00750269|10415961|P2|Overall Study|Protocol Violation|1
3028759|NCT00750269|10415962|P1|Overall Study|Protocol Violation|0
3028760|NCT00750204|10416009|P2|Overall Study|study halted prematurely|1
3028761|NCT00750204|10416010|P1|Overall Study|study halted prematurely|1
3028762|NCT00750152|10416040|P2|Overall Study|Other|8
3028763|NCT00750152|10416041|P1|Overall Study|Other|7
3028764|NCT00750152|10416040|P2|Overall Study|Termination by sponsor|0
3028765|NCT00750152|10416041|P1|Overall Study|Termination by sponsor|1
3028766|NCT00750152|10416040|P2|Overall Study|Non-compliance|1
3028767|NCT00750152|10416041|P1|Overall Study|Non-compliance|0
3028768|NCT00750152|10416040|P2|Overall Study|Physician Decision|1
3028769|NCT00750152|10416041|P1|Overall Study|Physician Decision|1
3028770|NCT00750152|10416040|P2|Overall Study|Withdrawal by Subject|3
3028771|NCT00750152|10416041|P1|Overall Study|Withdrawal by Subject|3
3028772|NCT00750152|10416040|P2|Overall Study|Lost to Follow-up|13
3028773|NCT00750152|10416041|P1|Overall Study|Lost to Follow-up|8
3028774|NCT00750152|10416040|P2|Overall Study|Adverse Event|1
3028775|NCT00750152|10416041|P1|Overall Study|Adverse Event|2
3028776|NCT00750139|10416053|P4|Overall Study|Non-specific|33
3028777|NCT00750139|10416054|P3|Overall Study|Non-specific|79
3028778|NCT00750139|10416055|P2|Overall Study|Non-specific|42
3028779|NCT00750139|10416056|P1|Overall Study|Non-specific|62
3028780|NCT00750139|10416053|P4|Overall Study|Termination by sponsor|1
3028781|NCT00750139|10416054|P3|Overall Study|Termination by sponsor|0
3028782|NCT00750139|10416055|P2|Overall Study|Termination by sponsor|0
3028783|NCT00750139|10416056|P1|Overall Study|Termination by sponsor|4
3028784|NCT00750139|10416053|P4|Overall Study|Non-compliance|3
3028785|NCT00750139|10416054|P3|Overall Study|Non-compliance|1
3028786|NCT00750139|10416055|P2|Overall Study|Non-compliance|0
3028787|NCT00750139|10416056|P1|Overall Study|Non-compliance|1
3028788|NCT00750139|10416053|P4|Overall Study|Physician Decision|0
3028789|NCT00750139|10416054|P3|Overall Study|Physician Decision|0
3028790|NCT00750139|10416055|P2|Overall Study|Physician Decision|1
3028791|NCT00750139|10416056|P1|Overall Study|Physician Decision|1
3028792|NCT00750139|10416053|P4|Overall Study|Withdrawal by Subject|2
3028793|NCT00750139|10416054|P3|Overall Study|Withdrawal by Subject|6
3028794|NCT00750139|10416055|P2|Overall Study|Withdrawal by Subject|2
3028795|NCT00750139|10416056|P1|Overall Study|Withdrawal by Subject|3
3028796|NCT00750139|10416053|P4|Overall Study|Lost to Follow-up|6
3028797|NCT00750139|10416054|P3|Overall Study|Lost to Follow-up|15
3028798|NCT00750139|10416055|P2|Overall Study|Lost to Follow-up|12
3028799|NCT00750139|10416056|P1|Overall Study|Lost to Follow-up|17
3028800|NCT00750139|10416053|P4|Overall Study|Adverse Event|1
3028801|NCT00750139|10416054|P3|Overall Study|Adverse Event|0
3028802|NCT00750139|10416055|P2|Overall Study|Adverse Event|2
3028803|NCT00750139|10416056|P1|Overall Study|Adverse Event|1
3028804|NCT00750061|10416072|P2|Overall Study|Physician Decision|1
3028805|NCT00750061|10416073|P1|Overall Study|Physician Decision|0
3028806|NCT00750061|10416072|P2|Overall Study|Withdrawal by Subject|1
3028807|NCT00750061|10416073|P1|Overall Study|Withdrawal by Subject|0
3028808|NCT00750061|10416072|P2|Overall Study|Adverse Event|0
3028809|NCT00750061|10416073|P1|Overall Study|Adverse Event|2
3028810|NCT00749996|10416083|P2|Overall Study|Death|0
3028811|NCT00749996|10416084|P1|Overall Study|Death|1
3028812|NCT00749996|10416083|P2|Overall Study|Adverse Event|0
3028813|NCT00749996|10416084|P1|Overall Study|Adverse Event|1
3028814|NCT00749996|10416083|P2|Overall Study|Pregnancy|2
3028815|NCT00749996|10416084|P1|Overall Study|Pregnancy|0
3028816|NCT00749996|10416083|P2|Overall Study|Physician Decision|0
3028817|NCT00749996|10416084|P1|Overall Study|Physician Decision|2
3028818|NCT00749996|10416083|P2|Overall Study|Protocol Violation|3
3028819|NCT00749996|10416084|P1|Overall Study|Protocol Violation|2
3028820|NCT00749996|10416083|P2|Overall Study|Withdrawal by Subject|4
3028821|NCT00749996|10416084|P1|Overall Study|Withdrawal by Subject|5
3028822|NCT00749996|10416083|P2|Overall Study|Lost to Follow-up|4
3028823|NCT00749996|10416084|P1|Overall Study|Lost to Follow-up|7
3028824|NCT00749944|10416107|P2|Overall Study|Withdrawal by Subject|0
3028825|NCT00749944|10416108|P1|Overall Study|Withdrawal by Subject|2
3028826|NCT00749944|10416107|P2|Overall Study|Other|0
3028827|NCT00749944|10416108|P1|Overall Study|Other|1
3028828|NCT00749944|10416107|P2|Overall Study|Lost to Follow-up|1
3028829|NCT00749944|10416108|P1|Overall Study|Lost to Follow-up|2
3028830|NCT00749775|10416219|P1|Overall Study|No drug administration|3
3028831|NCT00749775|10416219|P1|Overall Study|No visit after first day of treatment|44
3028832|NCT00749775|10416219|P1|Overall Study|Lost to Follow-up|36
3028833|NCT00749775|10416219|P1|Overall Study|Protocol Violation|24
3028834|NCT00749684|10416235|P1|Overall Study|Missing|9
3028835|NCT00749684|10416235|P1|Overall Study|AE+discontinuation on participants wish|1
3028836|NCT00749684|10416235|P1|Overall Study|Therapy according to protocol + AE|2
3028837|NCT00749684|10416235|P1|Overall Study|Progressive Desease|31
3028838|NCT00749684|10416235|P1|Overall Study|Not Documented|1
3028839|NCT00749684|10416235|P1|Overall Study|Participant's Wish|10
3028840|NCT00749684|10416235|P1|Overall Study|Adverse Event|27
3028841|NCT00749684|10416235|P1|Overall Study|Death|1
3028842|NCT00749580|10416274|P2|Overall Study|Adverse Event|1
3028843|NCT00749580|10416275|P1|Overall Study|Adverse Event|0
3028844|NCT00749580|10416274|P2|Overall Study|Lost to Follow-up|8
3028845|NCT00749580|10416275|P1|Overall Study|Lost to Follow-up|4
3028846|NCT00749463|10416309|P3|Overall Study|Withdrawal by Subject|0
3028847|NCT00749463|10416310|P2|Overall Study|Withdrawal by Subject|0
3028848|NCT00749463|10416311|P1|Overall Study|Withdrawal by Subject|1
3028849|NCT00749463|10416309|P3|Overall Study|Adverse Event|1
3028850|NCT00749463|10416310|P2|Overall Study|Adverse Event|4
3028851|NCT00749463|10416311|P1|Overall Study|Adverse Event|0
3028852|NCT00749398|10416337|P1|Overall Study|Unknown reason|1
3028853|NCT00749398|10416337|P1|Overall Study|Reason not specified|2
3028854|NCT00749398|10416337|P1|Overall Study|Lost to Follow-up|11
3028855|NCT00749398|10416337|P1|Overall Study|Withdrawal by Subject|17
3028856|NCT00749398|10416337|P1|Overall Study|Serious adverse event|11
3028857|NCT00749398|10416337|P1|Overall Study|Adverse Event|4
3028858|NCT00749398|10416337|P1|Overall Study|Lack of Efficacy|7
3028859|NCT00749203|10416380|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
3028860|NCT00749203|10416381|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
3028861|NCT00749203|10416380|P2|Second Infusion at 2 Weeks|Protocol Violation|1
3028862|NCT00749203|10416381|P1|Second Infusion at 2 Weeks|Protocol Violation|0
3028863|NCT00749203|10416380|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
3028864|NCT00749203|10416381|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
3028865|NCT00749203|10416380|P2|no Infusion at Week 1|delayed-onset sedation|1
3028866|NCT00749203|10416381|P1|no Infusion at Week 1|delayed-onset sedation|0
3028867|NCT00749203|10416380|P2|no Infusion at Week 1|Withdrawal by Subject|1
3028868|NCT00749203|10416381|P1|no Infusion at Week 1|Withdrawal by Subject|0
3028869|NCT00749203|10416380|P2|no Infusion at Week 1|Lost to Follow-up|1
3028870|NCT00749203|10416381|P1|no Infusion at Week 1|Lost to Follow-up|0
3028871|NCT00749190|10416402|P7|Overall Study|Other reason not defined above|0
3028872|NCT00749190|10416403|P6|Overall Study|Other reason not defined above|0
3028873|NCT00749190|10416404|P5|Overall Study|Other reason not defined above|0
3028874|NCT00749190|10416405|P4|Overall Study|Other reason not defined above|1
3028875|NCT00749190|10416406|P3|Overall Study|Other reason not defined above|0
3028876|NCT00749190|10416407|P2|Overall Study|Other reason not defined above|0
3028877|NCT00749190|10416408|P1|Overall Study|Other reason not defined above|0
3028878|NCT00749190|10416402|P7|Overall Study|Protocol Violation|1
3028879|NCT00749190|10416403|P6|Overall Study|Protocol Violation|0
3028880|NCT00749190|10416404|P5|Overall Study|Protocol Violation|0
3028881|NCT00749190|10416405|P4|Overall Study|Protocol Violation|0
3028882|NCT00749190|10416406|P3|Overall Study|Protocol Violation|0
3028883|NCT00749190|10416407|P2|Overall Study|Protocol Violation|1
3028884|NCT00749190|10416408|P1|Overall Study|Protocol Violation|0
3028885|NCT00749190|10416402|P7|Overall Study|Withdrawal by Subject|0
3028886|NCT00749190|10416403|P6|Overall Study|Withdrawal by Subject|1
3028887|NCT00749190|10416404|P5|Overall Study|Withdrawal by Subject|0
3028888|NCT00749190|10416405|P4|Overall Study|Withdrawal by Subject|0
3028889|NCT00749190|10416406|P3|Overall Study|Withdrawal by Subject|0
3028890|NCT00749190|10416407|P2|Overall Study|Withdrawal by Subject|1
3028891|NCT00749190|10416408|P1|Overall Study|Withdrawal by Subject|2
3028892|NCT00749190|10416402|P7|Overall Study|Lack of Efficacy|0
3028893|NCT00749190|10416403|P6|Overall Study|Lack of Efficacy|1
3028894|NCT00749190|10416404|P5|Overall Study|Lack of Efficacy|0
3028895|NCT00749190|10416405|P4|Overall Study|Lack of Efficacy|0
3028896|NCT00749190|10416406|P3|Overall Study|Lack of Efficacy|1
3028897|NCT00749190|10416407|P2|Overall Study|Lack of Efficacy|1
3028898|NCT00749190|10416408|P1|Overall Study|Lack of Efficacy|3
3028899|NCT00749190|10416402|P7|Overall Study|Adverse Event|0
3028900|NCT00749190|10416403|P6|Overall Study|Adverse Event|3
3028901|NCT00749190|10416404|P5|Overall Study|Adverse Event|0
3028902|NCT00749190|10416405|P4|Overall Study|Adverse Event|4
3028903|NCT00749190|10416406|P3|Overall Study|Adverse Event|0
3028904|NCT00749190|10416407|P2|Overall Study|Adverse Event|2
3028905|NCT00749190|10416408|P1|Overall Study|Adverse Event|0
3028906|NCT00748969|10416517|P2|Overall Study|Withdrawal by Subject|1
3028907|NCT00748969|10416518|P1|Overall Study|Withdrawal by Subject|0
3028908|NCT00748969|10416517|P2|Overall Study|Withdrawal by Subject|0
3028909|NCT00748969|10416518|P1|Overall Study|Withdrawal by Subject|1
3028910|NCT00748709|10416568|P1|Overall Study|Other Reasons|1
3028911|NCT00748709|10416568|P1|Overall Study|Withdrawal by Subject|1
3028912|NCT00748709|10416568|P1|Overall Study|Other Adverse Event|1
3028913|NCT00748709|10416568|P1|Overall Study|Drug reducing Toxity|2
3028914|NCT00748709|10416568|P1|Overall Study|Progressive disease|15
3028915|NCT00748566|10416611|P1|Overall Study|Other|9
3028916|NCT00748566|10416611|P1|Overall Study|Study terminated by sponsor|5
3028917|NCT00748566|10416611|P1|Overall Study|Withdrawal by Subject|22
3028918|NCT00748566|10416611|P1|Overall Study|Protocol Violation|13
3028919|NCT00748566|10416611|P1|Overall Study|Lost to Follow-up|1
3028920|NCT00748566|10416611|P1|Overall Study|Lack of Efficacy|12
3028921|NCT00748566|10416611|P1|Overall Study|Death|1
3028922|NCT00748566|10416611|P1|Overall Study|Adverse Event|49
3028923|NCT00748553|10416641|P2|Overall Study|noncompliance|0
3028924|NCT00748553|10416642|P1|Overall Study|noncompliance|1
3028925|NCT00748553|10416641|P2|Overall Study|disease progression|0
3028926|NCT00748553|10416642|P1|Overall Study|disease progression|2
3028927|NCT00748553|10416641|P2|Overall Study|Adverse Event|1
3028928|NCT00748553|10416642|P1|Overall Study|Adverse Event|0
3028929|NCT00748540|10416649|P1|Overall Study|Physician Decision|1
3028930|NCT00748241|10416675|P1|Overall Study|Death|2
3028931|NCT00748241|10416675|P1|Overall Study|Lost to Follow-up|5
3028932|NCT00748241|10416675|P1|Overall Study|Implant failure|1
3028933|NCT00748189|10416685|P2|Overall Study|Study terminated by Sponsor|79
3028934|NCT00748189|10416686|P1|Overall Study|Study terminated by Sponsor|70
3028935|NCT00748189|10416685|P2|Overall Study|Lost to Follow-up|15
3028936|NCT00748189|10416686|P1|Overall Study|Lost to Follow-up|8
3028937|NCT00748189|10416685|P2|Overall Study|Physician Decision|5
3028938|NCT00748189|10416686|P1|Overall Study|Physician Decision|16
3028939|NCT00748189|10416685|P2|Overall Study|Withdrawal by Subject|29
3028940|NCT00748189|10416686|P1|Overall Study|Withdrawal by Subject|23
3028941|NCT00748189|10416685|P2|Overall Study|Death|84
3028942|NCT00748189|10416686|P1|Overall Study|Death|99
3028943|NCT00748098|10416741|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
3028944|NCT00748098|10416742|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
3028945|NCT00748098|10416741|P2|Second Treatment Intervention Period|Lost to Follow-up|1
3028946|NCT00748098|10416742|P1|Second Treatment Intervention Period|Lost to Follow-up|1
3028947|NCT00748098|10416741|P2|Second Treatment Intervention Period|Adverse Event|1
3028948|NCT00748098|10416742|P1|Second Treatment Intervention Period|Adverse Event|4
3028949|NCT00748098|10416741|P2|1-Week Washout Period|Withdrawal by Subject|0
3028950|NCT00748098|10416742|P1|1-Week Washout Period|Withdrawal by Subject|2
3028951|NCT00748098|10416741|P2|1-Week Washout Period|Adverse Event|1
3028952|NCT00748098|10416742|P1|1-Week Washout Period|Adverse Event|0
3028953|NCT00748098|10416741|P2|First Taper Period|Protocol Stopping Criteria Met|1
3028954|NCT00748098|10416742|P1|First Taper Period|Protocol Stopping Criteria Met|0
3028955|NCT00748098|10416741|P2|First Taper Period|Withdrawal by Subject|0
3028956|NCT00748098|10416742|P1|First Taper Period|Withdrawal by Subject|2
3028957|NCT00748098|10416741|P2|First Taper Period|Protocol Violation|0
3028958|NCT00748098|10416742|P1|First Taper Period|Protocol Violation|1
3028959|NCT00748098|10416741|P2|First Treatment Intervention Period|Withdrawal by Subject|0
3028960|NCT00748098|10416742|P1|First Treatment Intervention Period|Withdrawal by Subject|2
3028961|NCT00748098|10416741|P2|First Treatment Intervention Period|Lost to Follow-up|0
3028962|NCT00748098|10416742|P1|First Treatment Intervention Period|Lost to Follow-up|1
3028963|NCT00748098|10416741|P2|First Treatment Intervention Period|Protocol Violation|0
3028964|NCT00748098|10416742|P1|First Treatment Intervention Period|Protocol Violation|1
3028965|NCT00748098|10416741|P2|First Treatment Intervention Period|Adverse Event|1
3028966|NCT00748098|10416742|P1|First Treatment Intervention Period|Adverse Event|1
3028967|NCT00747812|10416823|P2|Overall Study|Research Site Staff Relocation|3
3028968|NCT00747812|10416824|P1|Overall Study|Research Site Staff Relocation|5
3028969|NCT00747643|10416862|P2|Overall Study|Withdrawal by Subject|27
3028970|NCT00747643|10416863|P1|Overall Study|Withdrawal by Subject|36
3028971|NCT00747617|10416877|P2|Overall Study|Lost to Follow-up|1
3028972|NCT00747617|10416878|P1|Overall Study|Lost to Follow-up|3
3028973|NCT00747565|10416888|P2|Overall Study|Lost to Follow-up|1
3028974|NCT00747565|10416889|P1|Overall Study|Lost to Follow-up|4
3028975|NCT00747565|10416888|P2|Overall Study|Withdrawal by Subject|6
3028976|NCT00747565|10416889|P1|Overall Study|Withdrawal by Subject|10
3028977|NCT00747474|10416902|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028978|NCT00747474|10416903|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028979|NCT00747474|10416904|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028980|NCT00747474|10416905|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028981|NCT00747474|10416906|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
3028982|NCT00747474|10416907|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028983|NCT00747474|10416908|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028984|NCT00747474|10416909|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028985|NCT00747474|10416910|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028986|NCT00747474|10416911|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028987|NCT00747474|10416912|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028988|NCT00747474|10416913|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
3028989|NCT00747461|10416939|P1|Overall Study|study terminated by sponsor|5
3028990|NCT00747435|10416944|P1|Overall Study|Still undergoing follow up|1
3028991|NCT00747435|10416944|P1|Overall Study|Withdrawal by Subject|3
3028992|NCT00747435|10416944|P1|Overall Study|Lost to Follow-up|2
3028993|NCT00747344|10416954|P4|After Controlled Period|Adverse Event|1
3028994|NCT00747344|10416955|P3|After Controlled Period|Adverse Event|0
3028995|NCT00747344|10416956|P2|After Controlled Period|Adverse Event|0
3028996|NCT00747344|10416957|P1|After Controlled Period|Adverse Event|0
3028997|NCT00747344|10416954|P4|Controlled Period|Other|0
3028998|NCT00747344|10416955|P3|Controlled Period|Other|0
3028999|NCT00747344|10416956|P2|Controlled Period|Other|3
3029000|NCT00747344|10416957|P1|Controlled Period|Other|0
3029001|NCT00747344|10416954|P4|Controlled Period|Lack of Efficacy|0
3029002|NCT00747344|10416955|P3|Controlled Period|Lack of Efficacy|0
3029003|NCT00747344|10416956|P2|Controlled Period|Lack of Efficacy|1
3029004|NCT00747344|10416957|P1|Controlled Period|Lack of Efficacy|2
3029005|NCT00747344|10416954|P4|Controlled Period|Adverse Event|0
3029006|NCT00747344|10416955|P3|Controlled Period|Adverse Event|0
3029007|NCT00747344|10416956|P2|Controlled Period|Adverse Event|0
3029008|NCT00747344|10416957|P1|Controlled Period|Adverse Event|3
3029009|NCT00747227|10416971|P2|Overall Study|Illness|1
3029010|NCT00747227|10416972|P1|Overall Study|Illness|1
3029011|NCT00747227|10416971|P2|Overall Study|Lost to Follow-up|2
3029012|NCT00747227|10416972|P1|Overall Study|Lost to Follow-up|1
3029013|NCT00747227|10416971|P2|Overall Study|Withdrawal by Subject|0
3029014|NCT00747227|10416972|P1|Overall Study|Withdrawal by Subject|1
3029015|NCT00747227|10416971|P2|Overall Study|Death|1
3029016|NCT00747227|10416972|P1|Overall Study|Death|3
3029017|NCT00747149|10417001|P2|Overall Study|Not reported|4
3029018|NCT00747149|10417002|P1|Overall Study|Not reported|1
3029019|NCT00747149|10417001|P2|Overall Study|Severe non-compliance to protocol|1
3029020|NCT00747149|10417002|P1|Overall Study|Severe non-compliance to protocol|0
3029021|NCT00747149|10417001|P2|Overall Study|Incorrect enrollment|6
3029022|NCT00747149|10417002|P1|Overall Study|Incorrect enrollment|0
3029023|NCT00747149|10417001|P2|Overall Study|Did not receive treatment|1
3029024|NCT00747149|10417002|P1|Overall Study|Did not receive treatment|0
3029025|NCT00747149|10417001|P2|Overall Study|Withdrawal by Subject|6
3029026|NCT00747149|10417002|P1|Overall Study|Withdrawal by Subject|0
3029027|NCT00747149|10417001|P2|Overall Study|Lost to Follow-up|10
3029028|NCT00747149|10417002|P1|Overall Study|Lost to Follow-up|0
3029029|NCT00747149|10417001|P2|Overall Study|Adverse Event|15
3029030|NCT00747149|10417002|P1|Overall Study|Adverse Event|0
3029031|NCT00747006|10417017|P3|Overall Study|Physician Decision|1
3029032|NCT00747006|10417018|P2|Overall Study|Physician Decision|0
3029033|NCT00747006|10417019|P1|Overall Study|Physician Decision|2
3029034|NCT00747006|10417017|P3|Overall Study|Lost to Follow-up|0
3029035|NCT00747006|10417018|P2|Overall Study|Lost to Follow-up|1
3029036|NCT00747006|10417019|P1|Overall Study|Lost to Follow-up|0
3029037|NCT00747006|10417017|P3|Overall Study|Adverse Event|0
3029038|NCT00747006|10417018|P2|Overall Study|Adverse Event|0
3029039|NCT00747006|10417019|P1|Overall Study|Adverse Event|1
3029040|NCT00746941|10417097|P4|Overall Study|Adverse Event|1
3029041|NCT00746941|10417098|P3|Overall Study|Adverse Event|0
3029042|NCT00746941|10417099|P2|Overall Study|Adverse Event|0
3029043|NCT00746941|10417100|P1|Overall Study|Adverse Event|0
3029044|NCT00746941|10417097|P4|Overall Study|Other, reason not provided|4
3029045|NCT00746941|10417098|P3|Overall Study|Other, reason not provided|0
3029046|NCT00746941|10417099|P2|Overall Study|Other, reason not provided|4
3029047|NCT00746941|10417100|P1|Overall Study|Other, reason not provided|2
3029048|NCT00746941|10417097|P4|Overall Study|Withdrawal by Subject|2
3029049|NCT00746941|10417098|P3|Overall Study|Withdrawal by Subject|0
3029050|NCT00746941|10417099|P2|Overall Study|Withdrawal by Subject|0
3029051|NCT00746941|10417100|P1|Overall Study|Withdrawal by Subject|3
3029052|NCT00746941|10417097|P4|Overall Study|Physician Decision|0
3029053|NCT00746941|10417098|P3|Overall Study|Physician Decision|2
3029054|NCT00746941|10417099|P2|Overall Study|Physician Decision|0
3029055|NCT00746941|10417100|P1|Overall Study|Physician Decision|0
3029056|NCT00746941|10417097|P4|Overall Study|Death|6
3029057|NCT00746941|10417098|P3|Overall Study|Death|0
3029058|NCT00746941|10417099|P2|Overall Study|Death|0
3029059|NCT00746941|10417100|P1|Overall Study|Death|2
3029060|NCT00746798|10417158|P4|Overall Study|Participant unable to return for visit|0
3029061|NCT00746798|10417159|P3|Overall Study|Participant unable to return for visit|0
3029062|NCT00746798|10417160|P2|Overall Study|Participant unable to return for visit|0
3029063|NCT00746798|10417161|P1|Overall Study|Participant unable to return for visit|1
3029064|NCT00746798|10417158|P4|Overall Study|Death|0
3029065|NCT00746798|10417159|P3|Overall Study|Death|2
3029066|NCT00746798|10417160|P2|Overall Study|Death|0
3029067|NCT00746798|10417161|P1|Overall Study|Death|0
3029068|NCT00746798|10417158|P4|Overall Study|Withdrawal by Subject|0
3029069|NCT00746798|10417159|P3|Overall Study|Withdrawal by Subject|1
3029070|NCT00746798|10417160|P2|Overall Study|Withdrawal by Subject|1
3029071|NCT00746798|10417161|P1|Overall Study|Withdrawal by Subject|0
3029072|NCT00746798|10417158|P4|Overall Study|Protocol Violation|0
3029073|NCT00746798|10417159|P3|Overall Study|Protocol Violation|0
3029074|NCT00746798|10417160|P2|Overall Study|Protocol Violation|1
3029075|NCT00746798|10417161|P1|Overall Study|Protocol Violation|0
3029076|NCT00746785|10417186|P3|Overall Study|Lost to Follow-up|27
3029077|NCT00746785|10417187|P2|Overall Study|Lost to Follow-up|25
3029078|NCT00746785|10417188|P1|Overall Study|Lost to Follow-up|29
3029079|NCT00746733|10417196|P2|Third Intervention|Withdrawal by Subject|1
3029080|NCT00746733|10417197|P1|Third Intervention|Withdrawal by Subject|1
3029081|NCT00746733|10417196|P2|Second Intervention|Adverse Event|0
3029082|NCT00746733|10417197|P1|Second Intervention|Adverse Event|1
3029083|NCT00746590|10417281|P1|Overall Study|Death|1
3029084|NCT00746564|10417285|P1|Overall Study|Required Pacemaker/ICD Implant|2
3029085|NCT00746551|10417300|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
3029086|NCT00746551|10417301|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
3029087|NCT00746551|10417300|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
3029088|NCT00746551|10417301|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
3029089|NCT00746551|10417300|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
3029090|NCT00746551|10417301|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
3029091|NCT00746356|10417352|P2|Overall Study|Patient relocated|0
3029092|NCT00746356|10417353|P1|Overall Study|Patient relocated|1
3029093|NCT00746356|10417352|P2|Overall Study|Removal of Device|1
3029094|NCT00746356|10417353|P1|Overall Study|Removal of Device|0
3029095|NCT00746356|10417352|P2|Overall Study|Lost to Follow-up|0
3029096|NCT00746356|10417353|P1|Overall Study|Lost to Follow-up|1
3029097|NCT00746356|10417352|P2|Overall Study|Death|3
3029098|NCT00746356|10417353|P1|Overall Study|Death|7
3029099|NCT00746356|10417352|P2|Overall Study|Withdrawal by Subject|3
3029100|NCT00746356|10417353|P1|Overall Study|Withdrawal by Subject|2
3029101|NCT00746330|10417365|P4|Period 1|Abnormal test procedure result|0
3029102|NCT00746330|10417366|P3|Period 1|Abnormal test procedure result|1
3029103|NCT00746330|10417367|P2|Period 1|Abnormal test procedure result|0
3029104|NCT00746330|10417368|P1|Period 1|Abnormal test procedure result|0
3029105|NCT00746252|10417398|P2|Overall Study|weight gain >7.5 %|2
3029106|NCT00746252|10417399|P1|Overall Study|weight gain >7.5 %|1
3029107|NCT00746096|10417434|P2|Overall Study|No study drug treatment|1
3029108|NCT00746096|10417435|P1|Overall Study|No study drug treatment|1
3029109|NCT00746096|10417434|P2|Overall Study|Protocol Violation|0
3029110|NCT00746096|10417435|P1|Overall Study|Protocol Violation|1
3029111|NCT00746096|10417434|P2|Overall Study|Lost to Follow-up|1
3029112|NCT00746096|10417435|P1|Overall Study|Lost to Follow-up|2
3029113|NCT00746096|10417434|P2|Overall Study|Withdrawal by Subject|1
3029114|NCT00746096|10417435|P1|Overall Study|Withdrawal by Subject|5
3029115|NCT00746096|10417434|P2|Overall Study|Adverse Event|0
3029116|NCT00746096|10417435|P1|Overall Study|Adverse Event|1
3029117|NCT00745901|10417466|P2|Overall Study|Patient didn't take any study medication|3
3029118|NCT00745901|10417467|P1|Overall Study|Patient didn't take any study medication|7
3029119|NCT00745901|10417466|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
3029120|NCT00745901|10417467|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
3029121|NCT00745901|10417466|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
3029122|NCT00745901|10417467|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
3029123|NCT00745901|10417466|P2|Overall Study|Patient's next menses did not start with|0
3029124|NCT00745901|10417467|P1|Overall Study|Patient's next menses did not start with|1
3029125|NCT00745901|10417466|P2|Overall Study|Lack of compliance|2
3029126|NCT00745901|10417467|P1|Overall Study|Lack of compliance|2
3029127|NCT00745901|10417466|P2|Overall Study|Pregnancy|4
3029128|NCT00745901|10417467|P1|Overall Study|Pregnancy|2
3029129|NCT00745901|10417466|P2|Overall Study|Lost to Follow-up|4
3029130|NCT00745901|10417467|P1|Overall Study|Lost to Follow-up|7
3029131|NCT00745901|10417466|P2|Overall Study|Withdrawal by Subject|0
3029132|NCT00745901|10417467|P1|Overall Study|Withdrawal by Subject|1
3029133|NCT00745901|10417466|P2|Overall Study|Protocol Violation|1
3029134|NCT00745901|10417467|P1|Overall Study|Protocol Violation|0
3029135|NCT00745901|10417466|P2|Overall Study|Adverse Event|4
3029136|NCT00745901|10417467|P1|Overall Study|Adverse Event|3
3029137|NCT00745875|10417513|P2|Overall Study|Continuing study treatment|4
3029138|NCT00745875|10417514|P1|Overall Study|Continuing study treatment|4
3029139|NCT00745849|10417522|P2|Second Intervention|Lost to Follow-up|1
3029140|NCT00745849|10417523|P1|Second Intervention|Lost to Follow-up|2
3029141|NCT00745849|10417522|P2|First Intervention|Lost to Follow-up|1
3029142|NCT00745849|10417523|P1|First Intervention|Lost to Follow-up|1
3029143|NCT00745849|10417522|P2|First Intervention|Withdrawal by Subject|1
3029144|NCT00745849|10417523|P1|First Intervention|Withdrawal by Subject|0
3029145|NCT00745823|10417531|P2|Overall Study|Study Terminated by Sponsor|349
3029146|NCT00745823|10417532|P1|Overall Study|Study Terminated by Sponsor|326
3029147|NCT00745823|10417531|P2|Overall Study|Withdrawal by Subject|8
3029148|NCT00745823|10417532|P1|Overall Study|Withdrawal by Subject|14
3029149|NCT00745823|10417531|P2|Overall Study|Pregnancy|4
3029150|NCT00745823|10417532|P1|Overall Study|Pregnancy|0
3029151|NCT00745823|10417531|P2|Overall Study|Physician Decision|5
3029152|NCT00745823|10417532|P1|Overall Study|Physician Decision|10
3029153|NCT00745823|10417531|P2|Overall Study|Lost to Follow-up|11
3029154|NCT00745823|10417532|P1|Overall Study|Lost to Follow-up|10
3029155|NCT00745823|10417531|P2|Overall Study|Lack of Efficacy|6
3029156|NCT00745823|10417532|P1|Overall Study|Lack of Efficacy|20
3029157|NCT00745823|10417531|P2|Overall Study|Adverse Event|3
3029158|NCT00745823|10417532|P1|Overall Study|Adverse Event|5
3029159|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
3029160|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
3029161|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
3029162|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
3029163|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
3029164|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
3029165|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Death|1
3029166|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Death|0
3029167|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Death|0
3029168|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Death|0
3029169|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Death|0
3029170|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Death|0
3029171|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
3029172|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
3029333|NCT00744497|10417984|P1|Overall Study|Not defined|19
3029173|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
3029174|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
3029175|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
3029176|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
3029177|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
3029178|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
3029179|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
3029180|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
3029181|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
3029182|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
3029183|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
3029184|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
3029185|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
3029186|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
3029187|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
3029188|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
3029189|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
3029190|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
3029191|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
3029192|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
3029193|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
3029194|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
3029195|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
3029196|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
3029197|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
3029198|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
3029199|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
3029200|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
3029201|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
3029202|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
3029203|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
3029204|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
3029205|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
3029206|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
3029207|NCT00745615|10417560|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
3029208|NCT00745615|10417561|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
3029209|NCT00745615|10417562|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
3029210|NCT00745615|10417563|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
3029211|NCT00745615|10417564|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
3029212|NCT00745615|10417565|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
3029213|NCT00745615|10417560|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
3029214|NCT00745615|10417561|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
3029215|NCT00745615|10417562|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
3029216|NCT00745615|10417563|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
3029217|NCT00745615|10417564|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
3029218|NCT00745615|10417565|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
3029219|NCT00745615|10417560|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
3029220|NCT00745615|10417561|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
3029221|NCT00745615|10417562|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
3029222|NCT00745615|10417563|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
3029223|NCT00745615|10417564|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
3029224|NCT00745615|10417565|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
3029225|NCT00745615|10417560|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
3029226|NCT00745615|10417561|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
3029227|NCT00745615|10417562|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
3029228|NCT00745615|10417563|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
3029229|NCT00745615|10417564|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
3029230|NCT00745615|10417565|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
3029231|NCT00745615|10417560|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
3029232|NCT00745615|10417561|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
3029233|NCT00745615|10417562|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
3029234|NCT00745615|10417563|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
3029235|NCT00745615|10417564|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
3029236|NCT00745615|10417565|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
3029237|NCT00745615|10417560|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
3029238|NCT00745615|10417561|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
3029239|NCT00745615|10417562|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
3029240|NCT00745615|10417563|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
3029241|NCT00745615|10417564|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
3029242|NCT00745615|10417565|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
3029243|NCT00745498|10417614|P3|Overall Study|Edophthalmitis after preoperative IVB|0
3029244|NCT00745498|10417615|P2|Overall Study|Edophthalmitis after preoperative IVB|0
3029245|NCT00745498|10417616|P1|Overall Study|Edophthalmitis after preoperative IVB|1
3029246|NCT00745498|10417614|P3|Overall Study|Non-PDR related VH|1
3029247|NCT00745498|10417615|P2|Overall Study|Non-PDR related VH|1
3029248|NCT00745498|10417616|P1|Overall Study|Non-PDR related VH|0
3029249|NCT00745498|10417614|P3|Overall Study|Injection of intravitreal silicone oil o|4
3029250|NCT00745498|10417615|P2|Overall Study|Injection of intravitreal silicone oil o|4
3029251|NCT00745498|10417616|P1|Overall Study|Injection of intravitreal silicone oil o|3
3029252|NCT00745498|10417614|P3|Overall Study|Lost to Follow-up|3
3029253|NCT00745498|10417615|P2|Overall Study|Lost to Follow-up|1
3029254|NCT00745498|10417616|P1|Overall Study|Lost to Follow-up|1
3029255|NCT00745420|10417630|P1|Overall Study|Ineligible|1
3029256|NCT00745368|10417647|P1|Overall Study|Unable to provide sample|3
3029257|NCT00745251|10417669|P2|Overall Study|Withdrawal by Subject|1
3029258|NCT00745251|10417670|P1|Overall Study|Withdrawal by Subject|1
3029259|NCT00745251|10417669|P2|Overall Study|Adverse Event|2
3029260|NCT00745251|10417670|P1|Overall Study|Adverse Event|1
3029261|NCT00745121|10417680|P2|Overall Study|Withdrawal by Subject|2
3029262|NCT00745121|10417681|P1|Overall Study|Withdrawal by Subject|4
3029263|NCT00745121|10417680|P2|Overall Study|Lost to Follow-up|0
3029264|NCT00745121|10417681|P1|Overall Study|Lost to Follow-up|1
3029265|NCT00745121|10417680|P2|Overall Study|Adverse Event|0
3029266|NCT00745121|10417681|P1|Overall Study|Adverse Event|1
3029267|NCT00745121|10417680|P2|Overall Study|Death|0
3029268|NCT00745121|10417681|P1|Overall Study|Death|3
3029269|NCT00745095|10417693|P6|Overall Study|Ineligible due to GFR criteria|28
3029270|NCT00745095|10417694|P5|Overall Study|Ineligible due to GFR criteria|30
3029271|NCT00745095|10417695|P4|Overall Study|Ineligible due to GFR criteria|3
3029272|NCT00745095|10417696|P3|Overall Study|Ineligible due to GFR criteria|3
3029273|NCT00745095|10417697|P2|Overall Study|Ineligible due to GFR criteria|2
3029274|NCT00745095|10417698|P1|Overall Study|Ineligible due to GFR criteria|0
3029275|NCT00745095|10417693|P6|Overall Study|Declined to participate|95
3029276|NCT00745095|10417694|P5|Overall Study|Declined to participate|92
3029277|NCT00745095|10417695|P4|Overall Study|Declined to participate|0
3029278|NCT00745095|10417696|P3|Overall Study|Declined to participate|0
3029279|NCT00745095|10417697|P2|Overall Study|Declined to participate|0
3029280|NCT00745095|10417698|P1|Overall Study|Declined to participate|1
3029281|NCT00744978|10417729|P2|Period 2|Adverse Event|1
3029282|NCT00744978|10417730|P1|Period 2|Adverse Event|0
3029283|NCT00744978|10417729|P2|Period 1|Randomized but not Treated|1
3029284|NCT00744978|10417730|P1|Period 1|Randomized but not Treated|1
3029285|NCT00744978|10417729|P2|Period 1|Adverse Event|0
3029286|NCT00744978|10417730|P1|Period 1|Adverse Event|4
3029287|NCT00744978|10417729|P2|Period 1|Other|2
3029288|NCT00744978|10417730|P1|Period 1|Other|0
3029289|NCT00744978|10417729|P2|Period 1|Withdrawal by Subject|2
3029290|NCT00744978|10417730|P1|Period 1|Withdrawal by Subject|0
3029291|NCT00744978|10417729|P2|Period 1|Lost to Follow-up|0
3029292|NCT00744978|10417730|P1|Period 1|Lost to Follow-up|1
3029293|NCT00744939|10417811|P1|Overall Study|incorrect race|1
3029294|NCT00744939|10417811|P1|Overall Study|coma|1
3029295|NCT00744939|10417811|P1|Overall Study|Failed inclusion/exclusion criteria|19
3029296|NCT00744939|10417811|P1|Overall Study|Did not receive Magnevist|7
3029297|NCT00744939|10417811|P1|Overall Study|Medical history exclusionary|1
3029298|NCT00744939|10417811|P1|Overall Study|Lost to Follow-up|12
3029299|NCT00744939|10417811|P1|Overall Study|distance|4
3029300|NCT00744939|10417811|P1|Overall Study|Death|24
3029301|NCT00744939|10417811|P1|Overall Study|Protocol Violation|13
3029302|NCT00744939|10417811|P1|Overall Study|Withdrawal by Subject|9
3029303|NCT00744874|10417847|P1|Overall Study|Unable to accomodate schedule|1
3029304|NCT00744874|10417847|P1|Overall Study|Study Device not available at procedure|1
3029305|NCT00744874|10417847|P1|Overall Study|Withdrawal by Subject|1
3029306|NCT00744874|10417847|P1|Overall Study|Lost to Follow-up|1
3029307|NCT00744757|10417872|P1|Overall Study|Adverse Event|2
3029308|NCT00744757|10417872|P1|Overall Study|Death|6
3029309|NCT00744757|10417872|P1|Overall Study|Withdrawal by Subject|1
3029310|NCT00744757|10417872|P1|Overall Study|Physician Decision|5
3029311|NCT00744757|10417872|P1|Overall Study|Objective disease progression|7
3029312|NCT00744653|10417897|P1|Overall Study|Physician Decision|3
3029313|NCT00744653|10417897|P1|Overall Study|Lost to Follow-up|1
3029314|NCT00744653|10417897|P1|Overall Study|Death|1
3029315|NCT00744653|10417897|P1|Overall Study|antineoplastic treatment|11
3029316|NCT00744627|10417905|P2|Overall Study|Other|0
3029317|NCT00744627|10417906|P1|Overall Study|Other|1
3029318|NCT00744627|10417905|P2|Overall Study|Lost to Follow-up|1
3029319|NCT00744627|10417906|P1|Overall Study|Lost to Follow-up|2
3029320|NCT00744627|10417905|P2|Overall Study|Voluntary Withdrawal|6
3029321|NCT00744627|10417906|P1|Overall Study|Voluntary Withdrawal|9
3029322|NCT00744627|10417905|P2|Overall Study|Protocol Deviations|2
3029323|NCT00744627|10417906|P1|Overall Study|Protocol Deviations|0
3029324|NCT00744627|10417905|P2|Overall Study|Noncompliance|1
3029325|NCT00744627|10417906|P1|Overall Study|Noncompliance|0
3029326|NCT00744627|10417905|P2|Overall Study|Lack of Efficacy|3
3029327|NCT00744627|10417906|P1|Overall Study|Lack of Efficacy|7
3029328|NCT00744627|10417905|P2|Overall Study|Adverse Event|9
3029329|NCT00744627|10417906|P1|Overall Study|Adverse Event|6
3029330|NCT00744523|10417962|P2|30 Days After the Procedure|Insufficient follow-up|5
3029331|NCT00744523|10417963|P1|30 Days After the Procedure|Insufficient follow-up|0
3029332|NCT00744497|10417983|P2|Overall Study|Not defined|13
3029334|NCT00744497|10417983|P2|Overall Study|Maximum clinical benefit|142
3029335|NCT00744497|10417984|P1|Overall Study|Maximum clinical benefit|141
3029336|NCT00744497|10417983|P2|Overall Study|Patient requested to stop study drug|80
3029337|NCT00744497|10417984|P1|Overall Study|Patient requested to stop study drug|65
3029338|NCT00744497|10417983|P2|Overall Study|Adverse event unrelated to study drug|122
3029339|NCT00744497|10417984|P1|Overall Study|Adverse event unrelated to study drug|78
3029340|NCT00744497|10417983|P2|Overall Study|Study drug toxicity|141
3029341|NCT00744497|10417984|P1|Overall Study|Study drug toxicity|68
3029342|NCT00744497|10417983|P2|Overall Study|Disease progression|219
3029343|NCT00744497|10417984|P1|Overall Study|Disease progression|312
3029344|NCT00744497|10417983|P2|Overall Study|Administrative Reason By Sponsor|8
3029345|NCT00744497|10417984|P1|Overall Study|Administrative Reason By Sponsor|25
3029346|NCT00744497|10417983|P2|Overall Study|No longer meets study criteria|3
3029347|NCT00744497|10417984|P1|Overall Study|No longer meets study criteria|7
3029348|NCT00744497|10417983|P2|Overall Study|Poor compliance/noncompliance|5
3029349|NCT00744497|10417984|P1|Overall Study|Poor compliance/noncompliance|9
3029350|NCT00744497|10417983|P2|Overall Study|Lost to Follow-up|2
3029351|NCT00744497|10417984|P1|Overall Study|Lost to Follow-up|4
3029352|NCT00744497|10417983|P2|Overall Study|Death|9
3029353|NCT00744497|10417984|P1|Overall Study|Death|11
3029354|NCT00744497|10417983|P2|Overall Study|Withdrawal by Subject|18
3029355|NCT00744497|10417984|P1|Overall Study|Withdrawal by Subject|21
3029356|NCT00744328|10418044|P3|Overall Study|Found ineligible after randomization|1
3029357|NCT00744328|10418045|P2|Overall Study|Found ineligible after randomization|0
3029358|NCT00744328|10418046|P1|Overall Study|Found ineligible after randomization|0
3029359|NCT00744328|10418044|P3|Overall Study|Withdrawal by Subject|4
3029360|NCT00744328|10418045|P2|Overall Study|Withdrawal by Subject|3
3029361|NCT00744328|10418046|P1|Overall Study|Withdrawal by Subject|5
3029362|NCT00744328|10418044|P3|Overall Study|Lost to Follow-up|3
3029363|NCT00744328|10418045|P2|Overall Study|Lost to Follow-up|5
3029364|NCT00744328|10418046|P1|Overall Study|Lost to Follow-up|2
3029365|NCT00744263|10418059|P2|Overall Study|Other|2
3029366|NCT00744263|10418060|P1|Overall Study|Other|2
3029367|NCT00744263|10418059|P2|Overall Study|Adverse Event|0
3029368|NCT00744263|10418060|P1|Overall Study|Adverse Event|1
3029369|NCT00744263|10418059|P2|Overall Study|Protocol Violation|5
3029370|NCT00744263|10418060|P1|Overall Study|Protocol Violation|3
3029371|NCT00744263|10418059|P2|Overall Study|Physician Decision|23
3029372|NCT00744263|10418060|P1|Overall Study|Physician Decision|20
3029373|NCT00744263|10418059|P2|Overall Study|Withdrawal by Subject|150
3029374|NCT00744263|10418060|P1|Overall Study|Withdrawal by Subject|166
3029375|NCT00744263|10418059|P2|Overall Study|Lost to Follow-up|2135
3029376|NCT00744263|10418060|P1|Overall Study|Lost to Follow-up|2038
3029377|NCT00744263|10418059|P2|Overall Study|Death|3005
3029378|NCT00744263|10418060|P1|Overall Study|Death|3006
3029379|NCT00744237|10418083|P3|Overall Study|Adverse Event|5
3029380|NCT00744237|10418084|P2|Overall Study|Adverse Event|13
3029381|NCT00744237|10418085|P1|Overall Study|Adverse Event|9
3029382|NCT00744237|10418083|P3|Overall Study|Administrative. Site Closed|1
3029383|NCT00744237|10418084|P2|Overall Study|Administrative. Site Closed|1
3029384|NCT00744237|10418085|P1|Overall Study|Administrative. Site Closed|1
3029385|NCT00744237|10418083|P3|Overall Study|Poor Compliance|0
3029386|NCT00744237|10418084|P2|Overall Study|Poor Compliance|2
3029387|NCT00744237|10418085|P1|Overall Study|Poor Compliance|0
3029388|NCT00744237|10418083|P3|Overall Study|Prohibited Concomitant Medication|1
3029389|NCT00744237|10418084|P2|Overall Study|Prohibited Concomitant Medication|0
3029390|NCT00744237|10418085|P1|Overall Study|Prohibited Concomitant Medication|0
3029391|NCT00744237|10418083|P3|Overall Study|Study Drug Error|0
3029392|NCT00744237|10418084|P2|Overall Study|Study Drug Error|0
3029393|NCT00744237|10418085|P1|Overall Study|Study Drug Error|1
3029394|NCT00744237|10418083|P3|Overall Study|Dosing Error|1
3029395|NCT00744237|10418084|P2|Overall Study|Dosing Error|0
3029396|NCT00744237|10418085|P1|Overall Study|Dosing Error|1
3029397|NCT00744237|10418083|P3|Overall Study|Inclusion/Exclusion criteria not met|0
3029398|NCT00744237|10418084|P2|Overall Study|Inclusion/Exclusion criteria not met|0
3029399|NCT00744237|10418085|P1|Overall Study|Inclusion/Exclusion criteria not met|1
3029400|NCT00744237|10418083|P3|Overall Study|Protocol Violation|3
3029401|NCT00744237|10418084|P2|Overall Study|Protocol Violation|4
3029402|NCT00744237|10418085|P1|Overall Study|Protocol Violation|3
3029403|NCT00744237|10418083|P3|Overall Study|Lost to Follow-up|1
3029404|NCT00744237|10418084|P2|Overall Study|Lost to Follow-up|1
3029405|NCT00744237|10418085|P1|Overall Study|Lost to Follow-up|1
3029406|NCT00744237|10418083|P3|Overall Study|Withdrawal by Subject|3
3029407|NCT00744237|10418084|P2|Overall Study|Withdrawal by Subject|5
3029408|NCT00744237|10418085|P1|Overall Study|Withdrawal by Subject|9
3029409|NCT00744237|10418083|P3|Overall Study|Lack of Efficacy|0
3029410|NCT00744237|10418084|P2|Overall Study|Lack of Efficacy|1
3029411|NCT00744237|10418085|P1|Overall Study|Lack of Efficacy|1
3029412|NCT00744055|10418119|P2|Overall Study|Lost to Follow-up|1
3029413|NCT00744055|10418120|P1|Overall Study|Lost to Follow-up|0
3029414|NCT00744055|10418119|P2|Overall Study|Protocol Violation|1
3029415|NCT00744055|10418120|P1|Overall Study|Protocol Violation|1
3029416|NCT00744055|10418119|P2|Overall Study|Physician Decision|2
3029417|NCT00744055|10418120|P1|Overall Study|Physician Decision|0
3029418|NCT00744055|10418119|P2|Overall Study|Lack of Efficacy|1
3029419|NCT00744055|10418120|P1|Overall Study|Lack of Efficacy|0
3029420|NCT00744055|10418119|P2|Overall Study|Withdrawal by Subject|9
3029421|NCT00744055|10418120|P1|Overall Study|Withdrawal by Subject|6
3029422|NCT00744042|10418128|P1|Overall Study|Withdrawal by Subject|1
3029423|NCT00743652|10418174|P5|Overall Study|Lost to Follow-up|0
3029424|NCT00743652|10418175|P4|Overall Study|Lost to Follow-up|0
3029425|NCT00743652|10418176|P3|Overall Study|Lost to Follow-up|0
3029426|NCT00743652|10418177|P2|Overall Study|Lost to Follow-up|0
3029427|NCT00743652|10418178|P1|Overall Study|Lost to Follow-up|1
3029428|NCT00743652|10418174|P5|Overall Study|Other|0
3029429|NCT00743652|10418175|P4|Overall Study|Other|0
3029430|NCT00743652|10418176|P3|Overall Study|Other|0
3029431|NCT00743652|10418177|P2|Overall Study|Other|1
3029432|NCT00743652|10418178|P1|Overall Study|Other|1
3029433|NCT00743652|10418174|P5|Overall Study|Investigator Request|0
3029434|NCT00743652|10418175|P4|Overall Study|Investigator Request|2
3029435|NCT00743652|10418176|P3|Overall Study|Investigator Request|0
3029436|NCT00743652|10418177|P2|Overall Study|Investigator Request|0
3029437|NCT00743652|10418178|P1|Overall Study|Investigator Request|0
3029438|NCT00743652|10418174|P5|Overall Study|Death|0
3029439|NCT00743652|10418175|P4|Overall Study|Death|0
3029440|NCT00743652|10418176|P3|Overall Study|Death|0
3029441|NCT00743652|10418177|P2|Overall Study|Death|0
3029442|NCT00743652|10418178|P1|Overall Study|Death|2
3029443|NCT00743652|10418174|P5|Overall Study|Adverse Event|0
3029444|NCT00743652|10418175|P4|Overall Study|Adverse Event|0
3029445|NCT00743652|10418176|P3|Overall Study|Adverse Event|0
3029446|NCT00743652|10418177|P2|Overall Study|Adverse Event|0
3029447|NCT00743652|10418178|P1|Overall Study|Adverse Event|3
3029448|NCT00743652|10418174|P5|Overall Study|Parent/Legal Guardian Request|0
3029449|NCT00743652|10418175|P4|Overall Study|Parent/Legal Guardian Request|2
3029450|NCT00743652|10418176|P3|Overall Study|Parent/Legal Guardian Request|2
3029451|NCT00743652|10418177|P2|Overall Study|Parent/Legal Guardian Request|2
3029452|NCT00743652|10418178|P1|Overall Study|Parent/Legal Guardian Request|3
3029453|NCT00743509|10418262|P1|Overall Study|Withdrawal by Subject|2
3029454|NCT00743483|10418267|P1|Treatment Period|Adverse Event|1
3029455|NCT00743483|10418267|P1|Baseline Period|Physician Decision|1
3029456|NCT00743444|10418271|P2|Washout Period|Adverse Event|1
3029457|NCT00743444|10418272|P1|Washout Period|Adverse Event|0
3029458|NCT00743444|10418271|P2|First Intervention|Catheter placement problems|1
3029459|NCT00743444|10418272|P1|First Intervention|Catheter placement problems|0
3029460|NCT00743431|10418281|P1|Overall Study|No documentation available|13
3029461|NCT00743431|10418281|P1|Overall Study|Reason for discontinuation not specified|29
3029462|NCT00743431|10418281|P1|Overall Study|Death|9
3029463|NCT00743431|10418281|P1|Overall Study|Withdrawal by Subject|13
3029464|NCT00743431|10418281|P1|Overall Study|Tumor progression|56
3029465|NCT00743431|10418281|P1|Overall Study|Toxicity|6
3029466|NCT00743366|10418285|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
3029467|NCT00743366|10418286|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
3029468|NCT00743340|10418292|P1|Overall Study|Participant Relocated|1
3029469|NCT00743340|10418292|P1|Overall Study|Rolled over to other Gilead Study|23
3029470|NCT00743340|10418292|P1|Overall Study|Pregnancy|1
3029471|NCT00743340|10418292|P1|Overall Study|Virologic failure|8
3029472|NCT00743340|10418292|P1|Overall Study|Protocol Violation|1
3029473|NCT00743340|10418292|P1|Overall Study|Withdrawal from the Study|5
3029474|NCT00743340|10418292|P1|Overall Study|Lost to Follow-up|1
3029475|NCT00743340|10418292|P1|Overall Study|Study medication non-compliance|1
3029476|NCT00743288|10418296|P7|Overall Study|Worsening of condition (Not PD)|0
3029477|NCT00743288|10418297|P6|Overall Study|Worsening of condition (Not PD)|0
3029478|NCT00743288|10418298|P5|Overall Study|Worsening of condition (Not PD)|0
3029479|NCT00743288|10418299|P4|Overall Study|Worsening of condition (Not PD)|1
3029480|NCT00743288|10418300|P3|Overall Study|Worsening of condition (Not PD)|1
3029481|NCT00743288|10418301|P2|Overall Study|Worsening of condition (Not PD)|2
3029482|NCT00743288|10418302|P1|Overall Study|Worsening of condition (Not PD)|0
3029483|NCT00743288|10418296|P7|Overall Study|Progressive disease (PD)|6
3029484|NCT00743288|10418297|P6|Overall Study|Progressive disease (PD)|3
3029485|NCT00743288|10418298|P5|Overall Study|Progressive disease (PD)|5
3029486|NCT00743288|10418299|P4|Overall Study|Progressive disease (PD)|4
3029487|NCT00743288|10418300|P3|Overall Study|Progressive disease (PD)|1
3029488|NCT00743288|10418301|P2|Overall Study|Progressive disease (PD)|0
3029489|NCT00743288|10418302|P1|Overall Study|Progressive disease (PD)|2
3029490|NCT00743288|10418296|P7|Overall Study|Withdrawal by Subject|1
3029491|NCT00743288|10418297|P6|Overall Study|Withdrawal by Subject|1
3029492|NCT00743288|10418298|P5|Overall Study|Withdrawal by Subject|0
3029493|NCT00743288|10418299|P4|Overall Study|Withdrawal by Subject|0
3029494|NCT00743288|10418300|P3|Overall Study|Withdrawal by Subject|1
3029495|NCT00743288|10418301|P2|Overall Study|Withdrawal by Subject|0
3029496|NCT00743288|10418302|P1|Overall Study|Withdrawal by Subject|0
3029497|NCT00743288|10418296|P7|Overall Study|Adverse Event|2
3029498|NCT00743288|10418297|P6|Overall Study|Adverse Event|1
3029499|NCT00743288|10418298|P5|Overall Study|Adverse Event|1
3029500|NCT00743288|10418299|P4|Overall Study|Adverse Event|2
3029501|NCT00743288|10418300|P3|Overall Study|Adverse Event|2
3029502|NCT00743288|10418301|P2|Overall Study|Adverse Event|1
3029503|NCT00743288|10418302|P1|Overall Study|Adverse Event|1
3029504|NCT00743275|10418316|P2|Overall Study|Protocol Violation|1
3029505|NCT00743275|10418317|P1|Overall Study|Protocol Violation|0
3029506|NCT00743249|10418337|P2|Overall Study|Unsuccessful insertion of stent|1
3029507|NCT00743249|10418338|P1|Overall Study|Unsuccessful insertion of stent|2
3029508|NCT00743249|10418337|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
3029509|NCT00743249|10418338|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
3029510|NCT00743249|10418337|P2|Overall Study|Adverse Event|4
3029511|NCT00743249|10418338|P1|Overall Study|Adverse Event|0
3029512|NCT00743197|10418348|P2|Overall Study|Study terminated due to departure of PI.|2
3029513|NCT00743197|10418349|P1|Overall Study|Study terminated due to departure of PI.|1
3029514|NCT00743145|10418355|P1|Overall Study|Pregnancy|1
3029515|NCT00743145|10418355|P1|Overall Study|Adverse Event|2
3029516|NCT00743145|10418355|P1|Overall Study|Withdrawal by Subject|1
3029517|NCT00743119|10418369|P1|Overall Study|Withdrawal by Subject|1
3029518|NCT00743119|10418369|P1|Overall Study|unreliable|3
3029519|NCT00743106|10418383|P2|Overall Study|Met intraoperative exclusion criterion|5
3029520|NCT00743106|10418384|P1|Overall Study|Met intraoperative exclusion criterion|8
3029521|NCT00742924|10418411|P4|Overall Study|Withdrawal by Subject|0
3029522|NCT00742924|10418412|P3|Overall Study|Withdrawal by Subject|1
3029523|NCT00742924|10418413|P2|Overall Study|Withdrawal by Subject|1
3029524|NCT00742924|10418414|P1|Overall Study|Withdrawal by Subject|0
3029525|NCT00742924|10418411|P4|Overall Study|Physician Decision|1
3029526|NCT00742924|10418412|P3|Overall Study|Physician Decision|0
3029527|NCT00742924|10418413|P2|Overall Study|Physician Decision|0
3029528|NCT00742924|10418414|P1|Overall Study|Physician Decision|0
3029529|NCT00742924|10418411|P4|Overall Study|Lack of Efficacy|4
3029530|NCT00742924|10418412|P3|Overall Study|Lack of Efficacy|2
3029531|NCT00742924|10418413|P2|Overall Study|Lack of Efficacy|1
3029532|NCT00742924|10418414|P1|Overall Study|Lack of Efficacy|5
3029533|NCT00742924|10418411|P4|Overall Study|Adverse Event|1
3029534|NCT00742924|10418412|P3|Overall Study|Adverse Event|1
3029535|NCT00742924|10418413|P2|Overall Study|Adverse Event|0
3029536|NCT00742924|10418414|P1|Overall Study|Adverse Event|0
3029537|NCT00742885|10418426|P2|Overall Study|Lost to Follow-up|0
3029538|NCT00742885|10418427|P1|Overall Study|Lost to Follow-up|1
3029539|NCT00742859|10418486|P4|Overall Study|Site error|1
3029540|NCT00742859|10418487|P3|Overall Study|Site error|1
3029541|NCT00742859|10418488|P2|Overall Study|Site error|0
3029542|NCT00742859|10418489|P1|Overall Study|Site error|0
3029543|NCT00742859|10418486|P4|Overall Study|Sponsor request patient out of town|1
3029544|NCT00742859|10418487|P3|Overall Study|Sponsor request patient out of town|1
3029545|NCT00742859|10418488|P2|Overall Study|Sponsor request patient out of town|0
3029546|NCT00742859|10418489|P1|Overall Study|Sponsor request patient out of town|0
3029547|NCT00742859|10418486|P4|Overall Study|Sponsor req visit schedule noncompliance|1
3029548|NCT00742859|10418487|P3|Overall Study|Sponsor req visit schedule noncompliance|0
3029549|NCT00742859|10418488|P2|Overall Study|Sponsor req visit schedule noncompliance|0
3029550|NCT00742859|10418489|P1|Overall Study|Sponsor req visit schedule noncompliance|0
3029551|NCT00742859|10418486|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
3029552|NCT00742859|10418487|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
3029553|NCT00742859|10418488|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
3029554|NCT00742859|10418489|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
3029555|NCT00742859|10418486|P4|Overall Study|Endpoint|2
3029556|NCT00742859|10418487|P3|Overall Study|Endpoint|1
3029557|NCT00742859|10418488|P2|Overall Study|Endpoint|1
3029558|NCT00742859|10418489|P1|Overall Study|Endpoint|0
3029559|NCT00742859|10418486|P4|Overall Study|Withdrawal by Subject|1
3029560|NCT00742859|10418487|P3|Overall Study|Withdrawal by Subject|4
3029561|NCT00742859|10418488|P2|Overall Study|Withdrawal by Subject|2
3029562|NCT00742859|10418489|P1|Overall Study|Withdrawal by Subject|4
3029563|NCT00742859|10418486|P4|Overall Study|Physician Decision|0
3029564|NCT00742859|10418487|P3|Overall Study|Physician Decision|0
3029565|NCT00742859|10418488|P2|Overall Study|Physician Decision|2
3029566|NCT00742859|10418489|P1|Overall Study|Physician Decision|1
3029567|NCT00742859|10418486|P4|Overall Study|Death|1
3029568|NCT00742859|10418487|P3|Overall Study|Death|0
3029569|NCT00742859|10418488|P2|Overall Study|Death|0
3029570|NCT00742859|10418489|P1|Overall Study|Death|1
3029571|NCT00742859|10418486|P4|Overall Study|Adverse Event|1
3029572|NCT00742859|10418487|P3|Overall Study|Adverse Event|3
3029573|NCT00742859|10418488|P2|Overall Study|Adverse Event|6
3029574|NCT00742859|10418489|P1|Overall Study|Adverse Event|5
3029575|NCT00742781|10418503|P1|Overall Study|Withdrawal by Subject|3
3029576|NCT00742625|10418512|P1|Consolidation|Non protocol therapy|13
3029577|NCT00742625|10418512|P1|Consolidation|Refused|1
3029578|NCT00742625|10418512|P1|Consolidation|Death|1
3029579|NCT00742625|10418512|P1|Consolidation|Adverse Event|1
3029580|NCT00742625|10418512|P1|Consolidation|Progression|5
3029581|NCT00742625|10418512|P1|Remission Induction|Other, not specified|5
3029582|NCT00742625|10418512|P1|Remission Induction|Non protocol treatment|17
3029583|NCT00742625|10418512|P1|Remission Induction|Refusal|5
3029584|NCT00742625|10418512|P1|Remission Induction|Death|10
3029585|NCT00742625|10418512|P1|Remission Induction|Adverse Event|3
3029586|NCT00742625|10418512|P1|Remission Induction|Failed induction|8
3029587|NCT00742625|10418512|P1|Remission Induction|Progression|6
3029588|NCT00742560|10418537|P5|Overall Study|MIssing|1
3029589|NCT00742560|10418538|P4|Overall Study|MIssing|0
3029590|NCT00742560|10418539|P3|Overall Study|MIssing|0
3029591|NCT00742560|10418540|P2|Overall Study|MIssing|0
3029592|NCT00742560|10418541|P1|Overall Study|MIssing|0
3029593|NCT00742560|10418537|P5|Overall Study|Other|9
3029594|NCT00742560|10418538|P4|Overall Study|Other|9
3029595|NCT00742560|10418539|P3|Overall Study|Other|8
3029596|NCT00742560|10418540|P2|Overall Study|Other|1
3029597|NCT00742560|10418541|P1|Overall Study|Other|0
3029598|NCT00742560|10418537|P5|Overall Study|New Multiple Myeloma Therapy|4
3029599|NCT00742560|10418538|P4|Overall Study|New Multiple Myeloma Therapy|3
3029600|NCT00742560|10418539|P3|Overall Study|New Multiple Myeloma Therapy|2
3029601|NCT00742560|10418540|P2|Overall Study|New Multiple Myeloma Therapy|0
3029602|NCT00742560|10418541|P1|Overall Study|New Multiple Myeloma Therapy|1
3029603|NCT00742560|10418537|P5|Overall Study|Disease Progression|16
3029604|NCT00742560|10418538|P4|Overall Study|Disease Progression|17
3029605|NCT00742560|10418539|P3|Overall Study|Disease Progression|5
3029606|NCT00742560|10418540|P2|Overall Study|Disease Progression|0
3029607|NCT00742560|10418541|P1|Overall Study|Disease Progression|1
3029608|NCT00742560|10418537|P5|Overall Study|Investigator's Decision|0
3029609|NCT00742560|10418538|P4|Overall Study|Investigator's Decision|1
3029610|NCT00742560|10418539|P3|Overall Study|Investigator's Decision|4
3029611|NCT00742560|10418540|P2|Overall Study|Investigator's Decision|0
3029612|NCT00742560|10418541|P1|Overall Study|Investigator's Decision|0
3029613|NCT00742560|10418537|P5|Overall Study|Subject's Decision|3
3029614|NCT00742560|10418538|P4|Overall Study|Subject's Decision|3
3029615|NCT00742560|10418539|P3|Overall Study|Subject's Decision|2
3029616|NCT00742560|10418540|P2|Overall Study|Subject's Decision|0
3029617|NCT00742560|10418541|P1|Overall Study|Subject's Decision|1
3029618|NCT00742560|10418537|P5|Overall Study|Death|3
3029619|NCT00742560|10418538|P4|Overall Study|Death|2
3029620|NCT00742560|10418539|P3|Overall Study|Death|0
3029621|NCT00742560|10418540|P2|Overall Study|Death|2
3029622|NCT00742560|10418541|P1|Overall Study|Death|0
3029623|NCT00742560|10418537|P5|Overall Study|Adverse Event|1
3029624|NCT00742560|10418538|P4|Overall Study|Adverse Event|1
3029625|NCT00742560|10418539|P3|Overall Study|Adverse Event|1
3029626|NCT00742560|10418540|P2|Overall Study|Adverse Event|0
3029627|NCT00742560|10418541|P1|Overall Study|Adverse Event|0
3029628|NCT00742508|10418615|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
3029629|NCT00742508|10418616|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
3029630|NCT00742508|10418615|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
3029631|NCT00742508|10418616|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
3029632|NCT00742508|10418615|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
3029633|NCT00742508|10418616|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
3029634|NCT00742508|10418615|P2|8-Week Primary Evaluation Period|Protocol Violation|0
3029635|NCT00742508|10418616|P1|8-Week Primary Evaluation Period|Protocol Violation|1
3029636|NCT00742508|10418615|P2|8-Week Primary Evaluation Period|Adverse Event|4
3029637|NCT00742508|10418616|P1|8-Week Primary Evaluation Period|Adverse Event|2
3029638|NCT00742417|10418689|P2|Intensive Period|Adverse Event|0
3029639|NCT00742417|10418690|P1|Intensive Period|Adverse Event|2
3029640|NCT00742417|10418689|P2|Intensive Period|Withdrawal by Subject|1
3029641|NCT00742417|10418690|P1|Intensive Period|Withdrawal by Subject|1
3029642|NCT00742417|10418689|P2|Randomized|Physician Decision|0
3029643|NCT00742417|10418690|P1|Randomized|Physician Decision|1
3029644|NCT00742417|10418689|P2|Randomized|Withdrawal by Subject|0
3029645|NCT00742417|10418690|P1|Randomized|Withdrawal by Subject|1
3029646|NCT00742417|10418689|P2|Randomized|Withdrawal by legal representative|1
3029647|NCT00742417|10418690|P1|Randomized|Withdrawal by legal representative|0
3029648|NCT00742391|10418714|P2|Overall Study|Protocol Violation|0
3029649|NCT00742391|10418715|P1|Overall Study|Protocol Violation|1
3029650|NCT00742391|10418714|P2|Overall Study|Lost to Follow-up|0
3029651|NCT00742391|10418715|P1|Overall Study|Lost to Follow-up|1
3029652|NCT00742391|10418714|P2|Overall Study|Adverse Event|1
3029653|NCT00742391|10418715|P1|Overall Study|Adverse Event|2
3029654|NCT00742326|10418725|P2|Overall Study|Physician Decision|1
3029655|NCT00742326|10418726|P1|Overall Study|Physician Decision|0
3029656|NCT00742274|10418745|P2|Overall Study|Removed for medical reasons|1
3029657|NCT00742274|10418746|P1|Overall Study|Removed for medical reasons|1
3029658|NCT00742274|10418745|P2|Overall Study|Withdrawal by Subject|2
3029659|NCT00742274|10418746|P1|Overall Study|Withdrawal by Subject|1
3029660|NCT00742274|10418745|P2|Overall Study|Death|0
3029661|NCT00742274|10418746|P1|Overall Study|Death|1
3029662|NCT00742235|10418754|P2|Overall Study|Lost to Follow-up|31
3029663|NCT00742235|10418755|P1|Overall Study|Lost to Follow-up|0
3029664|NCT00742209|10418768|P5|Overall Study|Investigator Discretion|1
3029665|NCT00742209|10418769|P4|Overall Study|Investigator Discretion|1
3029666|NCT00742209|10418770|P3|Overall Study|Investigator Discretion|5
3029667|NCT00742209|10418771|P2|Overall Study|Investigator Discretion|0
3029668|NCT00742209|10418772|P1|Overall Study|Investigator Discretion|0
3029669|NCT00742209|10418768|P5|Overall Study|Lack of Efficacy|1
3029670|NCT00742209|10418769|P4|Overall Study|Lack of Efficacy|3
3029671|NCT00742209|10418770|P3|Overall Study|Lack of Efficacy|1
3029672|NCT00742209|10418771|P2|Overall Study|Lack of Efficacy|1
3029673|NCT00742209|10418772|P1|Overall Study|Lack of Efficacy|6
3029674|NCT00742209|10418768|P5|Overall Study|Lost to Follow-up|3
3029675|NCT00742209|10418769|P4|Overall Study|Lost to Follow-up|5
3029676|NCT00742209|10418770|P3|Overall Study|Lost to Follow-up|5
3029677|NCT00742209|10418771|P2|Overall Study|Lost to Follow-up|4
3029678|NCT00742209|10418772|P1|Overall Study|Lost to Follow-up|3
3029679|NCT00742209|10418768|P5|Overall Study|Protocol Violation|3
3029680|NCT00742209|10418769|P4|Overall Study|Protocol Violation|5
3029681|NCT00742209|10418770|P3|Overall Study|Protocol Violation|4
3029682|NCT00742209|10418771|P2|Overall Study|Protocol Violation|5
3029683|NCT00742209|10418772|P1|Overall Study|Protocol Violation|6
3029684|NCT00742209|10418768|P5|Overall Study|Participant Withdrew Consent|4
3029685|NCT00742209|10418769|P4|Overall Study|Participant Withdrew Consent|7
3029686|NCT00742209|10418770|P3|Overall Study|Participant Withdrew Consent|14
3029687|NCT00742209|10418771|P2|Overall Study|Participant Withdrew Consent|4
3029688|NCT00742209|10418772|P1|Overall Study|Participant Withdrew Consent|8
3029689|NCT00742209|10418768|P5|Overall Study|Adverse Event|13
3029690|NCT00742209|10418769|P4|Overall Study|Adverse Event|16
3029691|NCT00742209|10418770|P3|Overall Study|Adverse Event|17
3029692|NCT00742209|10418771|P2|Overall Study|Adverse Event|4
3029693|NCT00742209|10418772|P1|Overall Study|Adverse Event|11
3029694|NCT00742183|10418875|P2|Overall Study|Lack of Efficacy|3
3029695|NCT00742183|10418876|P1|Overall Study|Lack of Efficacy|0
3029696|NCT00742183|10418875|P2|Overall Study|Withdrawal by Subject|0
3029697|NCT00742183|10418876|P1|Overall Study|Withdrawal by Subject|1
3029698|NCT00742183|10418875|P2|Overall Study|Required skin-graft|1
3029699|NCT00742183|10418876|P1|Overall Study|Required skin-graft|1
3029700|NCT00742183|10418875|P2|Overall Study|Lost to Follow-up|4
3029701|NCT00742183|10418876|P1|Overall Study|Lost to Follow-up|4
3029702|NCT00742183|10418875|P2|Overall Study|Physician Decision|2
3029703|NCT00742183|10418876|P1|Overall Study|Physician Decision|0
3029704|NCT00742183|10418875|P2|Overall Study|Death|0
3029705|NCT00742183|10418876|P1|Overall Study|Death|1
3029706|NCT00742183|10418875|P2|Overall Study|Adverse Event|2
3029707|NCT00742183|10418876|P1|Overall Study|Adverse Event|2
3029708|NCT00742079|10418895|P2|Overall Study|Lost to Follow-up|1
3029709|NCT00742079|10418896|P1|Overall Study|Lost to Follow-up|0
3029710|NCT00742001|10418917|P3|Overall Study|Withdrawn; health exclusion (flu)|1
3029711|NCT00742001|10418918|P2|Overall Study|Withdrawn; health exclusion (flu)|0
3029712|NCT00742001|10418919|P1|Overall Study|Withdrawn; health exclusion (flu)|0
3029713|NCT00741988|10418935|P2|Overall Study|Lack of Efficacy|0
3029714|NCT00741988|10418936|P1|Overall Study|Lack of Efficacy|2
3029715|NCT00741988|10418935|P2|Overall Study|Adverse Event|4
3029716|NCT00741988|10418936|P1|Overall Study|Adverse Event|2
3029717|NCT00741936|10418948|P2|Overall Study|Low compliance|0
3029718|NCT00741936|10418949|P1|Overall Study|Low compliance|3
3029719|NCT00741936|10418948|P2|Overall Study|Lack of Efficacy|2
3029720|NCT00741936|10418949|P1|Overall Study|Lack of Efficacy|0
3029721|NCT00741936|10418948|P2|Overall Study|Protocol Violation|0
3029722|NCT00741936|10418949|P1|Overall Study|Protocol Violation|2
3029723|NCT00741936|10418948|P2|Overall Study|Pregnancy|1
3029724|NCT00741936|10418949|P1|Overall Study|Pregnancy|0
3029725|NCT00741936|10418948|P2|Overall Study|Adverse Event|4
3029726|NCT00741936|10418949|P1|Overall Study|Adverse Event|3
3029727|NCT00741936|10418948|P2|Overall Study|Lost to Follow-up|1
3029728|NCT00741936|10418949|P1|Overall Study|Lost to Follow-up|1
3029729|NCT00741819|10418984|P1|Overall Study|Disease progression|1
3029730|NCT00741819|10418984|P1|Overall Study|Death|1
3029731|NCT00741819|10418984|P1|Overall Study|Withdrawal by Subject|3
3029732|NCT00741819|10418984|P1|Overall Study|Adverse Event|3
3029733|NCT00741611|10418998|P3|Overall Study|Withdrawal by Subject|2
3029734|NCT00741611|10418999|P2|Overall Study|Withdrawal by Subject|2
3029735|NCT00741611|10419000|P1|Overall Study|Withdrawal by Subject|0
3029736|NCT00741611|10418998|P3|Overall Study|Death|1
3029737|NCT00741611|10418999|P2|Overall Study|Death|0
3029738|NCT00741611|10419000|P1|Overall Study|Death|0
3029739|NCT00741598|10419019|P2|Overall Study|Withdrawal by Subject|2
3029740|NCT00741598|10419020|P1|Overall Study|Withdrawal by Subject|3
3029741|NCT00741598|10419019|P2|Overall Study|Pregnancy|0
3029742|NCT00741598|10419020|P1|Overall Study|Pregnancy|1
3029743|NCT00741598|10419019|P2|Overall Study|Physician Decision|1
3029744|NCT00741598|10419020|P1|Overall Study|Physician Decision|1
3029745|NCT00741598|10419019|P2|Overall Study|Lack of Efficacy|2
3029746|NCT00741598|10419020|P1|Overall Study|Lack of Efficacy|1
3029747|NCT00741598|10419019|P2|Overall Study|Lost to Follow-up|4
3029748|NCT00741598|10419020|P1|Overall Study|Lost to Follow-up|3
3029749|NCT00741338|10419066|P2|Overall Study|Adverse Event|1
3029750|NCT00741338|10419067|P1|Overall Study|Adverse Event|0
3029751|NCT00741286|10419077|P2|Overall Study|Primary Outcome|1
3029752|NCT00741286|10419078|P1|Overall Study|Primary Outcome|1
3029753|NCT00741286|10419077|P2|Overall Study|Protocol Violation|2
3029754|NCT00741286|10419078|P1|Overall Study|Protocol Violation|3
3029755|NCT00741286|10419077|P2|Overall Study|Adverse Event|6
3029756|NCT00741286|10419078|P1|Overall Study|Adverse Event|1
3029757|NCT00741286|10419077|P2|Overall Study|Lost to Follow-up|10
3029758|NCT00741286|10419078|P1|Overall Study|Lost to Follow-up|15
3029759|NCT00741260|10419112|P7|Overall Study|Other|1
3029760|NCT00741260|10419113|P6|Overall Study|Other|3
3029761|NCT00741260|10419114|P5|Overall Study|Other|1
3029762|NCT00741260|10419115|P4|Overall Study|Other|2
3029763|NCT00741260|10419116|P3|Overall Study|Other|1
3029764|NCT00741260|10419117|P2|Overall Study|Other|1
3029765|NCT00741260|10419118|P1|Overall Study|Other|2
3029766|NCT00741260|10419112|P7|Overall Study|Physician Decision|0
3029767|NCT00741260|10419113|P6|Overall Study|Physician Decision|0
3029768|NCT00741260|10419114|P5|Overall Study|Physician Decision|0
3029769|NCT00741260|10419115|P4|Overall Study|Physician Decision|0
3029770|NCT00741260|10419116|P3|Overall Study|Physician Decision|0
3029771|NCT00741260|10419117|P2|Overall Study|Physician Decision|1
3029772|NCT00741260|10419118|P1|Overall Study|Physician Decision|1
3029773|NCT00741260|10419112|P7|Overall Study|Withdrawal by Subject|1
3029774|NCT00741260|10419113|P6|Overall Study|Withdrawal by Subject|3
3029775|NCT00741260|10419114|P5|Overall Study|Withdrawal by Subject|1
3029776|NCT00741260|10419115|P4|Overall Study|Withdrawal by Subject|0
3029777|NCT00741260|10419116|P3|Overall Study|Withdrawal by Subject|0
3029778|NCT00741260|10419117|P2|Overall Study|Withdrawal by Subject|0
3029779|NCT00741260|10419118|P1|Overall Study|Withdrawal by Subject|0
3029780|NCT00741260|10419112|P7|Overall Study|Death|1
3029781|NCT00741260|10419113|P6|Overall Study|Death|2
3029782|NCT00741260|10419114|P5|Overall Study|Death|2
3029783|NCT00741260|10419115|P4|Overall Study|Death|1
3029784|NCT00741260|10419116|P3|Overall Study|Death|0
3029785|NCT00741260|10419117|P2|Overall Study|Death|1
3029786|NCT00741260|10419118|P1|Overall Study|Death|0
3029787|NCT00741260|10419112|P7|Overall Study|Disease Progression|4
3029788|NCT00741260|10419113|P6|Overall Study|Disease Progression|37
3029789|NCT00741260|10419114|P5|Overall Study|Disease Progression|5
3029790|NCT00741260|10419115|P4|Overall Study|Disease Progression|3
3029791|NCT00741260|10419116|P3|Overall Study|Disease Progression|3
3029792|NCT00741260|10419117|P2|Overall Study|Disease Progression|5
3029793|NCT00741260|10419118|P1|Overall Study|Disease Progression|3
3029794|NCT00741091|10419167|P1|Overall Study|Missed Visit|22
3029795|NCT00741091|10419167|P1|Overall Study|Withdrawal by Subject|6
3029796|NCT00741091|10419167|P1|Overall Study|Lost to Follow-up|16
3029797|NCT00741091|10419167|P1|Overall Study|Death|13
3029798|NCT00741039|10419177|P2|Overall Study|Patient non-compliance|0
3029799|NCT00741039|10419178|P1|Overall Study|Patient non-compliance|2
3029800|NCT00741013|10419215|P3|Overall Study|Discovered failed screen after enrolled|0
3029801|NCT00741013|10419216|P2|Overall Study|Discovered failed screen after enrolled|2
3029802|NCT00741013|10419217|P1|Overall Study|Discovered failed screen after enrolled|0
3029803|NCT00741013|10419215|P3|Overall Study|Withdrawal by Subject|1
3029804|NCT00741013|10419216|P2|Overall Study|Withdrawal by Subject|0
3029805|NCT00741013|10419217|P1|Overall Study|Withdrawal by Subject|0
3029806|NCT00741013|10419215|P3|Overall Study|Adverse Event|0
3029807|NCT00741013|10419216|P2|Overall Study|Adverse Event|0
3029808|NCT00741013|10419217|P1|Overall Study|Adverse Event|1
3029809|NCT00740870|10419228|P1|Overall Study|Further testing contraindicated implant|17
3029810|NCT00740870|10419228|P1|Overall Study|Not Catheterized|4
3029811|NCT00740857|10419243|P3|Overall Study|Withdrawal by Subject|0
3029812|NCT00740857|10419244|P2|Overall Study|Withdrawal by Subject|0
3029813|NCT00740857|10419245|P1|Overall Study|Withdrawal by Subject|1
3029814|NCT00740792|10419300|P4|Overall Study|administrative|2
3029815|NCT00740792|10419301|P3|Overall Study|administrative|8
3029816|NCT00740792|10419302|P2|Overall Study|administrative|3
3029817|NCT00740792|10419303|P1|Overall Study|administrative|3
3029818|NCT00740792|10419300|P4|Overall Study|Withdrawal by Subject|0
3029819|NCT00740792|10419301|P3|Overall Study|Withdrawal by Subject|0
3029820|NCT00740792|10419302|P2|Overall Study|Withdrawal by Subject|1
3029821|NCT00740792|10419303|P1|Overall Study|Withdrawal by Subject|1
3029822|NCT00740792|10419300|P4|Overall Study|Protocol Violation|2
3029823|NCT00740792|10419301|P3|Overall Study|Protocol Violation|0
3029824|NCT00740792|10419302|P2|Overall Study|Protocol Violation|1
3029825|NCT00740792|10419303|P1|Overall Study|Protocol Violation|0
3029826|NCT00740792|10419300|P4|Overall Study|Lost to Follow-up|0
3029827|NCT00740792|10419301|P3|Overall Study|Lost to Follow-up|0
3029828|NCT00740792|10419302|P2|Overall Study|Lost to Follow-up|1
3029829|NCT00740792|10419303|P1|Overall Study|Lost to Follow-up|2
3029830|NCT00740792|10419300|P4|Overall Study|Lack of Efficacy|3
3029831|NCT00740792|10419301|P3|Overall Study|Lack of Efficacy|0
3029832|NCT00740792|10419302|P2|Overall Study|Lack of Efficacy|1
3029833|NCT00740792|10419303|P1|Overall Study|Lack of Efficacy|1
3029834|NCT00740792|10419300|P4|Overall Study|Adverse Event|3
3029835|NCT00740792|10419301|P3|Overall Study|Adverse Event|1
3029836|NCT00740792|10419302|P2|Overall Study|Adverse Event|1
3029837|NCT00740792|10419303|P1|Overall Study|Adverse Event|3
3029838|NCT00740779|10419324|P3|Overall Study|Lost to Follow-up|5
3029839|NCT00740779|10419325|P2|Overall Study|Lost to Follow-up|3
3029840|NCT00740779|10419326|P1|Overall Study|Lost to Follow-up|2
3029841|NCT00740779|10419324|P3|Overall Study|Withdrawal by Subject|2
3029842|NCT00740779|10419325|P2|Overall Study|Withdrawal by Subject|4
3029843|NCT00740779|10419326|P1|Overall Study|Withdrawal by Subject|2
3029844|NCT00740779|10419324|P3|Overall Study|Lack of Efficacy|2
3029845|NCT00740779|10419325|P2|Overall Study|Lack of Efficacy|0
3029846|NCT00740779|10419326|P1|Overall Study|Lack of Efficacy|0
3029847|NCT00740779|10419324|P3|Overall Study|Protocol Violation|1
3029848|NCT00740779|10419325|P2|Overall Study|Protocol Violation|1
3029849|NCT00740779|10419326|P1|Overall Study|Protocol Violation|1
3029850|NCT00740779|10419324|P3|Overall Study|Adverse Event|3
3029851|NCT00740779|10419325|P2|Overall Study|Adverse Event|6
3029852|NCT00740779|10419326|P1|Overall Study|Adverse Event|4
3029853|NCT00740714|10419343|P3|Overall Study|Withdrawal by Subject|29
3029854|NCT00740714|10419344|P2|Overall Study|Withdrawal by Subject|19
3029855|NCT00740714|10419345|P1|Overall Study|Withdrawal by Subject|17
3029856|NCT00740636|10419421|P2|Overall Study|Death|0
3029857|NCT00740636|10419422|P1|Overall Study|Death|1
3029858|NCT00740636|10419421|P2|Overall Study|Progressive Disease|0
3029859|NCT00740636|10419422|P1|Overall Study|Progressive Disease|1
3029860|NCT00740636|10419421|P2|Overall Study|Patient Not Treated|1
3029861|NCT00740636|10419422|P1|Overall Study|Patient Not Treated|0
3029862|NCT00740636|10419421|P2|Overall Study|Patient Ineligible|1
3029863|NCT00740636|10419422|P1|Overall Study|Patient Ineligible|0
3029864|NCT00740636|10419421|P2|Overall Study|Adverse Event|2
3029865|NCT00740636|10419422|P1|Overall Study|Adverse Event|0
3029866|NCT00740597|10419428|P1|Overall Study|insurance would not cover treatment|1
3029867|NCT00740584|10419432|P1|Overall Study|Withdrawal by Subject|1
3029868|NCT00740480|10419437|P1|Overall Study|Physician Decision|1
3029869|NCT00740480|10419437|P1|Overall Study|Adverse Event|1
3029870|NCT00740220|10419462|P1|Overall Study|screen failures (non-COPD patients)|9
3029871|NCT00740051|10419487|P2|Overall Study|Other reason (not specified)|1
3029872|NCT00740051|10419488|P1|Overall Study|Other reason (not specified)|4
3029873|NCT00740051|10419487|P2|Overall Study|Withdrawal by Subject|8
3029874|NCT00740051|10419488|P1|Overall Study|Withdrawal by Subject|6
3029875|NCT00740051|10419487|P2|Overall Study|Lost to Follow-up|8
3029876|NCT00740051|10419488|P1|Overall Study|Lost to Follow-up|3
3029877|NCT00740051|10419487|P2|Overall Study|Protocol Violation|6
3029878|NCT00740051|10419488|P1|Overall Study|Protocol Violation|2
3029879|NCT00740051|10419487|P2|Overall Study|Adverse Event|4
3029880|NCT00740051|10419488|P1|Overall Study|Adverse Event|1
3029881|NCT00740051|10419487|P2|Overall Study|Lack of Efficacy|5
3029882|NCT00740051|10419488|P1|Overall Study|Lack of Efficacy|2
3029883|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029884|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029885|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
3029886|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029887|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029888|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029889|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029890|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
3029891|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
3029892|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
3029893|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
3029894|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
3029895|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
3029896|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
3029897|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
3029898|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
3029899|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
3029900|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
3029901|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029902|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029903|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
3029904|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029905|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029906|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029907|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029908|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029909|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
3029910|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
3029911|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
3029912|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
3029913|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
3029914|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
3029915|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
3029916|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
3029917|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
3029918|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
3029919|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
3029920|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
3029921|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
3029922|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
3029923|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
3029924|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
3029925|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
3029926|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
3029927|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
3029928|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029929|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029930|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029931|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029932|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029933|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029934|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
3029935|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029936|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
3029937|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
3029938|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
3029939|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
3029940|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
3029941|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
3029942|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
3029943|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
3029944|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
3029945|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
3029946|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029947|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029948|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029949|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029950|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029951|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029952|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
3029953|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
3029954|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
3029955|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029956|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
3029957|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029958|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029959|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
3029960|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029961|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029962|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029963|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
3029964|NCT00739973|10419591|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
3029965|NCT00739973|10419592|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
3029966|NCT00739973|10419593|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
3029967|NCT00739973|10419594|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
3029968|NCT00739973|10419595|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
3029969|NCT00739973|10419596|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
3029970|NCT00739973|10419597|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
3029971|NCT00739973|10419598|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
3029972|NCT00739973|10419599|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
3029973|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029974|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029975|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029976|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029977|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029978|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029979|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029980|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
3029981|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
3029982|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029983|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029984|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029985|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029986|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029987|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029988|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029989|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
3029990|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
3029991|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029992|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029993|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029994|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029995|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029996|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029997|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029998|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
3029999|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
3030000|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030001|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030002|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030003|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030004|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030005|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030006|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030007|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
3030008|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
3030009|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030010|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030011|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030012|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030013|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030014|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030015|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030016|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
3030017|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
3030018|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030019|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030020|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030021|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030022|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030023|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030024|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030025|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
3030026|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
3030027|NCT00739973|10419591|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030028|NCT00739973|10419592|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030029|NCT00739973|10419593|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030030|NCT00739973|10419594|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030031|NCT00739973|10419595|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030032|NCT00739973|10419596|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030033|NCT00739973|10419597|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030034|NCT00739973|10419598|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
3030035|NCT00739973|10419599|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
3030036|NCT00739934|10419690|P1|Voriconazole Oral|Other|3
3030037|NCT00739934|10419690|P1|Voriconazole IV|Adverse Event|6
3030038|NCT00739908|10419712|P2|Overall Study|Relocation|1
3030039|NCT00739908|10419713|P1|Overall Study|Relocation|0
3030040|NCT00739908|10419712|P2|Overall Study|Lack of Efficacy|1
3030041|NCT00739908|10419713|P1|Overall Study|Lack of Efficacy|0
3030042|NCT00739908|10419712|P2|Overall Study|Non-Compliance With Study Medication|3
3030043|NCT00739908|10419713|P1|Overall Study|Non-Compliance With Study Medication|0
3030044|NCT00739908|10419712|P2|Overall Study|Non-Compliance With Study Procedures|3
3030045|NCT00739908|10419713|P1|Overall Study|Non-Compliance With Study Procedures|2
3030046|NCT00739908|10419712|P2|Overall Study|Lost to Follow-up|9
3030047|NCT00739908|10419713|P1|Overall Study|Lost to Follow-up|14
3030048|NCT00739908|10419712|P2|Overall Study|Withdrawal by Subject|2
3030049|NCT00739908|10419713|P1|Overall Study|Withdrawal by Subject|4
3030050|NCT00739908|10419712|P2|Overall Study|Adverse Event|6
3030051|NCT00739908|10419713|P1|Overall Study|Adverse Event|5
3030052|NCT00739882|10419733|P2|Open-label Period|Other|5
3030053|NCT00739882|10419734|P1|Open-label Period|Other|9
3030054|NCT00739882|10419733|P2|Open-label Period|Adverse Event|0
3030055|NCT00739882|10419734|P1|Open-label Period|Adverse Event|1
3030056|NCT00739882|10419733|P2|Double-blind Period|Other|8
3030057|NCT00739882|10419734|P1|Double-blind Period|Other|16
3030058|NCT00739882|10419733|P2|Double-blind Period|Lack of Efficacy|1
3030059|NCT00739882|10419734|P1|Double-blind Period|Lack of Efficacy|1
3030060|NCT00739882|10419733|P2|Double-blind Period|Protocol Violation|0
3030061|NCT00739882|10419734|P1|Double-blind Period|Protocol Violation|1
3030062|NCT00739882|10419733|P2|Double-blind Period|Adverse Event|2
3030063|NCT00739882|10419734|P1|Double-blind Period|Adverse Event|1
3030064|NCT00739674|10419795|P2|Overall Study|Erectile dysfunction|1
3030065|NCT00739674|10419796|P1|Overall Study|Erectile dysfunction|0
3030066|NCT00739674|10419795|P2|Overall Study|Home monitoring off meds|0
3030067|NCT00739674|10419796|P1|Overall Study|Home monitoring off meds|1
3030068|NCT00739674|10419795|P2|Overall Study|Unable to attend visit|1
3030069|NCT00739674|10419796|P1|Overall Study|Unable to attend visit|3
3030070|NCT00739674|10419795|P2|Overall Study|Non compliant|0
3030071|NCT00739674|10419796|P1|Overall Study|Non compliant|4
3030072|NCT00739674|10419795|P2|Overall Study|Patient moved|2
3030073|NCT00739674|10419796|P1|Overall Study|Patient moved|3
3030074|NCT00739674|10419795|P2|Overall Study|Clinic closed|4
3030075|NCT00739674|10419796|P1|Overall Study|Clinic closed|6
3030076|NCT00739674|10419795|P2|Overall Study|Reason missing|0
3030077|NCT00739674|10419796|P1|Overall Study|Reason missing|2
3030078|NCT00739674|10419795|P2|Overall Study|Withdrawal by Subject|9
3030079|NCT00739674|10419796|P1|Overall Study|Withdrawal by Subject|9
3030080|NCT00739674|10419795|P2|Overall Study|Protocol Violation|5
3030081|NCT00739674|10419796|P1|Overall Study|Protocol Violation|5
3030082|NCT00739674|10419795|P2|Overall Study|Lost to Follow-up|30
3030083|NCT00739674|10419796|P1|Overall Study|Lost to Follow-up|52
3030084|NCT00739674|10419795|P2|Overall Study|Lack of Efficacy|0
3030085|NCT00739674|10419796|P1|Overall Study|Lack of Efficacy|1
3030086|NCT00739674|10419795|P2|Overall Study|Death|0
3030087|NCT00739674|10419796|P1|Overall Study|Death|1
3030088|NCT00739674|10419795|P2|Overall Study|Adverse Event|13
3030089|NCT00739674|10419796|P1|Overall Study|Adverse Event|22
3030090|NCT00739674|10419795|P2|Overall Study|Dietician consultation >30 days|9
3030091|NCT00739674|10419796|P1|Overall Study|Dietician consultation >30 days|1
3030092|NCT00739674|10419795|P2|Overall Study|No follow-up data|18
3030093|NCT00739674|10419796|P1|Overall Study|No follow-up data|33
3030094|NCT00739674|10419795|P2|Overall Study|Site 212 removal|13
3030095|NCT00739674|10419796|P1|Overall Study|Site 212 removal|19
3030096|NCT00739674|10419795|P2|Overall Study|Screening failures|17
3030097|NCT00739674|10419796|P1|Overall Study|Screening failures|19
3030098|NCT00739661|10419824|P2|Overall Study|Reason for discontinuation not available|1
3030099|NCT00739661|10419825|P1|Overall Study|Reason for discontinuation not available|1
3030100|NCT00739661|10419824|P2|Overall Study|Disease progression, radiographic|37
3030101|NCT00739661|10419825|P1|Overall Study|Disease progression, radiographic|33
3030102|NCT00739661|10419824|P2|Overall Study|Patient decision to withdraw|4
3030103|NCT00739661|10419825|P1|Overall Study|Patient decision to withdraw|9
3030104|NCT00739661|10419824|P2|Overall Study|Physician decision to withdraw patient|0
3030105|NCT00739661|10419825|P1|Overall Study|Physician decision to withdraw patient|1
3030106|NCT00739661|10419824|P2|Overall Study|Adverse Event|0
3030107|NCT00739661|10419825|P1|Overall Study|Adverse Event|2
3030108|NCT00739648|10419837|P2|Overall Study|Do not know|6
3030109|NCT00739648|10419838|P1|Overall Study|Do not know|4
3030110|NCT00739648|10419837|P2|Overall Study|Death|0
3030111|NCT00739648|10419838|P1|Overall Study|Death|2
3030112|NCT00739648|10419837|P2|Overall Study|Lost to Follow-up|7
3030113|NCT00739648|10419838|P1|Overall Study|Lost to Follow-up|4
3030114|NCT00739648|10419837|P2|Overall Study|Withdrawal by Subject|25
3030115|NCT00739648|10419838|P1|Overall Study|Withdrawal by Subject|13
3030116|NCT00739648|10419837|P2|Overall Study|Adverse Event|15
3030117|NCT00739648|10419838|P1|Overall Study|Adverse Event|3
3030118|NCT00739596|10419852|P2|Overall Study|Protocol Deviation|1
3030119|NCT00739596|10419853|P1|Overall Study|Protocol Deviation|1
3030120|NCT00739596|10419852|P2|Overall Study|Lost to Follow-up|2
3030121|NCT00739596|10419853|P1|Overall Study|Lost to Follow-up|0
3030122|NCT00739596|10419852|P2|Overall Study|Patient Withdrew Consent|8
3030123|NCT00739596|10419853|P1|Overall Study|Patient Withdrew Consent|8
3030124|NCT00739596|10419852|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
3030125|NCT00739596|10419853|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
3030126|NCT00739596|10419852|P2|Overall Study|Adverse Event|6
3030127|NCT00739596|10419853|P1|Overall Study|Adverse Event|12
3030128|NCT00739310|10419895|P1|Overall Study|Lost to Follow-up|2
3030129|NCT00739310|10419895|P1|Overall Study|Withdrawal by Subject|1
3030130|NCT00739310|10419895|P1|Overall Study|Poor adherance to prescribed therapy|4
3030131|NCT00739297|10419900|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
3030132|NCT00739297|10419901|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
3030133|NCT00739297|10419902|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
3030134|NCT00739297|10419903|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
3030135|NCT00739297|10419904|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
3030136|NCT00739297|10419905|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
3030137|NCT00739297|10419906|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
3030138|NCT00739297|10419900|P7|First Washout Period of 4-7 Days|Adverse Event|2
3030139|NCT00739297|10419901|P6|First Washout Period of 4-7 Days|Adverse Event|0
3030140|NCT00739297|10419902|P5|First Washout Period of 4-7 Days|Adverse Event|0
3030141|NCT00739297|10419903|P4|First Washout Period of 4-7 Days|Adverse Event|2
3030142|NCT00739297|10419904|P3|First Washout Period of 4-7 Days|Adverse Event|0
3030143|NCT00739297|10419905|P2|First Washout Period of 4-7 Days|Adverse Event|0
3030144|NCT00739297|10419906|P1|First Washout Period of 4-7 Days|Adverse Event|0
3030145|NCT00739102|10419934|P1|Overall Study|Withdrawal by Subject|10
3030146|NCT00739102|10419934|P1|Overall Study|Death|5
3030147|NCT00739063|10419950|P1|Overall Study|Screen failures|8
3030148|NCT00738894|10419995|P2|Overall Study|Death|0
3030149|NCT00738894|10419996|P1|Overall Study|Death|2
3030150|NCT00738894|10419995|P2|Overall Study|Physician Decision|5
3030151|NCT00738894|10419996|P1|Overall Study|Physician Decision|4
3030152|NCT00738894|10419995|P2|Overall Study|Withdrawal by Subject|15
3030153|NCT00738894|10419996|P1|Overall Study|Withdrawal by Subject|10
3030154|NCT00738894|10419995|P2|Overall Study|Lost to Follow-up|13
3030155|NCT00738894|10419996|P1|Overall Study|Lost to Follow-up|23
3030156|NCT00738881|10420009|P2|Overall Study|Withdrawal by Subject|2
3030157|NCT00738881|10420010|P1|Overall Study|Withdrawal by Subject|0
3030158|NCT00738699|10420024|P2|Overall Study|Other|0
3030159|NCT00738699|10420025|P1|Overall Study|Other|2
3030160|NCT00738699|10420024|P2|Overall Study|Discontinuation of study by Sponsor|72
3030161|NCT00738699|10420025|P1|Overall Study|Discontinuation of study by Sponsor|123
3030162|NCT00738699|10420024|P2|Overall Study|Death|68
3030163|NCT00738699|10420025|P1|Overall Study|Death|144
3030164|NCT00738699|10420024|P2|Overall Study|Lost to Follow-up|0
3030165|NCT00738699|10420025|P1|Overall Study|Lost to Follow-up|1
3030166|NCT00738699|10420024|P2|Overall Study|Withdrawal by Subject|0
3030167|NCT00738699|10420025|P1|Overall Study|Withdrawal by Subject|5
3030168|NCT00738673|10420043|P2|Overall Study|Withdrawal by Subject|1
3030169|NCT00738673|10420044|P1|Overall Study|Withdrawal by Subject|3
3030170|NCT00738673|10420043|P2|Overall Study|Protocol Violation|2
3030171|NCT00738673|10420044|P1|Overall Study|Protocol Violation|1
3030172|NCT00738673|10420043|P2|Overall Study|Lack of Efficacy|8
3030173|NCT00738673|10420044|P1|Overall Study|Lack of Efficacy|19
3030174|NCT00738673|10420043|P2|Overall Study|Adverse Event|0
3030175|NCT00738673|10420044|P1|Overall Study|Adverse Event|1
3030176|NCT00738530|10420082|P2|Overall Study|Withdrawal by Subject|8
3030177|NCT00738530|10420083|P1|Overall Study|Withdrawal by Subject|6
3030178|NCT00738530|10420082|P2|Overall Study|Lost to Follow-up|6
3030179|NCT00738530|10420083|P1|Overall Study|Lost to Follow-up|8
3030180|NCT00738530|10420082|P2|Overall Study|Death|224
3030181|NCT00738530|10420083|P1|Overall Study|Death|220
3030182|NCT00738400|10420118|P2|Overall Study|Non-compliant with study medication|1
3030183|NCT00738400|10420119|P1|Overall Study|Non-compliant with study medication|0
3030184|NCT00738400|10420118|P2|Overall Study|Protocol Violation|0
3030185|NCT00738400|10420119|P1|Overall Study|Protocol Violation|1
3030186|NCT00738400|10420118|P2|Overall Study|Lost to Follow-up|3
3030187|NCT00738400|10420119|P1|Overall Study|Lost to Follow-up|0
3030188|NCT00738400|10420118|P2|Overall Study|Lack of Efficacy|1
3030189|NCT00738400|10420119|P1|Overall Study|Lack of Efficacy|0
3030190|NCT00738400|10420118|P2|Overall Study|Withdrawal by Subject|1
3030191|NCT00738400|10420119|P1|Overall Study|Withdrawal by Subject|0
3030192|NCT00738400|10420118|P2|Overall Study|Adverse Event|1
3030193|NCT00738400|10420119|P1|Overall Study|Adverse Event|3
3030194|NCT00738374|10420140|P4|Maintenance Treatment/Observation Phase|Other|0
3030195|NCT00738374|10420141|P3|Maintenance Treatment/Observation Phase|Other|0
3030196|NCT00738374|10420142|P2|Maintenance Treatment/Observation Phase|Other|1
3030197|NCT00738374|10420143|P1|Maintenance Treatment/Observation Phase|Other|0
3030198|NCT00738374|10420140|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
3030199|NCT00738374|10420141|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
3030200|NCT00738374|10420142|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
3030201|NCT00738374|10420143|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
3030202|NCT00738374|10420140|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
3030203|NCT00738374|10420141|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
3030204|NCT00738374|10420142|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
3030205|NCT00738374|10420143|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
3030206|NCT00738374|10420140|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
3030207|NCT00738374|10420141|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
3030208|NCT00738374|10420142|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
3030209|NCT00738374|10420143|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
3030210|NCT00738374|10420140|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
3030211|NCT00738374|10420141|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
3030212|NCT00738374|10420142|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
3030213|NCT00738374|10420143|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
3030214|NCT00738374|10420140|P4|Induction Treatment Phase|Withdrawal by Subject|0
3030215|NCT00738374|10420141|P3|Induction Treatment Phase|Withdrawal by Subject|0
3030216|NCT00738374|10420142|P2|Induction Treatment Phase|Withdrawal by Subject|0
3030217|NCT00738374|10420143|P1|Induction Treatment Phase|Withdrawal by Subject|1
3030218|NCT00738374|10420140|P4|Induction Treatment Phase|Non-compliance|0
3030219|NCT00738374|10420141|P3|Induction Treatment Phase|Non-compliance|0
3030220|NCT00738374|10420142|P2|Induction Treatment Phase|Non-compliance|0
3030221|NCT00738374|10420143|P1|Induction Treatment Phase|Non-compliance|1
3030222|NCT00738374|10420140|P4|Induction Treatment Phase|Protocol Violation|0
3030223|NCT00738374|10420141|P3|Induction Treatment Phase|Protocol Violation|0
3030224|NCT00738374|10420142|P2|Induction Treatment Phase|Protocol Violation|0
3030225|NCT00738374|10420143|P1|Induction Treatment Phase|Protocol Violation|2
3030226|NCT00738374|10420140|P4|Induction Treatment Phase|Physician Decision|0
3030227|NCT00738374|10420141|P3|Induction Treatment Phase|Physician Decision|0
3030228|NCT00738374|10420142|P2|Induction Treatment Phase|Physician Decision|0
3030229|NCT00738374|10420143|P1|Induction Treatment Phase|Physician Decision|2
3030230|NCT00738374|10420140|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
3030231|NCT00738374|10420141|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
3030232|NCT00738374|10420142|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
3030233|NCT00738374|10420143|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
3030234|NCT00738374|10420140|P4|Induction Treatment Phase|Adverse Event|0
3030235|NCT00738374|10420141|P3|Induction Treatment Phase|Adverse Event|0
3030236|NCT00738374|10420142|P2|Induction Treatment Phase|Adverse Event|0
3030237|NCT00738374|10420143|P1|Induction Treatment Phase|Adverse Event|14
3030238|NCT00738283|10420181|P1|Overall Study|Discharge home prior to end of study|1
3030239|NCT00738283|10420181|P1|Overall Study|Transfer to another facility|2
3030240|NCT00738283|10420181|P1|Overall Study|Death|1
3030241|NCT00738101|10420185|P1|Overall Study|Repeat enrollment|1
3030242|NCT00738101|10420185|P1|Overall Study|Death|1
3030243|NCT00738101|10420185|P1|Overall Study|Physician Decision|5
3030244|NCT00738062|10420200|P3|Open-Label Extension|Study Terminated|0
3030245|NCT00738062|10420201|P2|Open-Label Extension|Study Terminated|0
3030246|NCT00738062|10420202|P1|Open-Label Extension|Study Terminated|2
3030247|NCT00738062|10420200|P3|Open-Label Extension|Protocol Violation|0
3030248|NCT00738062|10420201|P2|Open-Label Extension|Protocol Violation|0
3030249|NCT00738062|10420202|P1|Open-Label Extension|Protocol Violation|1
3030250|NCT00738062|10420200|P3|Open-Label Extension|Withdrawal by Subject|0
3030251|NCT00738062|10420201|P2|Open-Label Extension|Withdrawal by Subject|0
3030252|NCT00738062|10420202|P1|Open-Label Extension|Withdrawal by Subject|6
3030253|NCT00738062|10420200|P3|Open-Label Extension|Lack of Efficacy|0
3030254|NCT00738062|10420201|P2|Open-Label Extension|Lack of Efficacy|0
3030255|NCT00738062|10420202|P1|Open-Label Extension|Lack of Efficacy|2
3030256|NCT00738062|10420200|P3|Open-Label Extension|Physician Decision|0
3030257|NCT00738062|10420201|P2|Open-Label Extension|Physician Decision|0
3030258|NCT00738062|10420202|P1|Open-Label Extension|Physician Decision|1
3030259|NCT00738062|10420200|P3|Open-Label Extension|Adverse Event|0
3030260|NCT00738062|10420201|P2|Open-Label Extension|Adverse Event|0
3030261|NCT00738062|10420202|P1|Open-Label Extension|Adverse Event|5
3030262|NCT00738062|10420200|P3|Open Label Treatment|Investigator Decision|0
3030263|NCT00738062|10420201|P2|Open Label Treatment|Investigator Decision|0
3030264|NCT00738062|10420202|P1|Open Label Treatment|Investigator Decision|1
3030265|NCT00738062|10420200|P3|Open Label Treatment|Withdrawal by Subject|0
3030266|NCT00738062|10420201|P2|Open Label Treatment|Withdrawal by Subject|0
3030267|NCT00738062|10420202|P1|Open Label Treatment|Withdrawal by Subject|9
3030268|NCT00738062|10420200|P3|Open Label Treatment|Protocol Violation|0
3030269|NCT00738062|10420201|P2|Open Label Treatment|Protocol Violation|0
3030270|NCT00738062|10420202|P1|Open Label Treatment|Protocol Violation|2
3030271|NCT00738062|10420200|P3|Open Label Treatment|Adverse Event|0
3030272|NCT00738062|10420201|P2|Open Label Treatment|Adverse Event|0
3030273|NCT00738062|10420202|P1|Open Label Treatment|Adverse Event|11
3030274|NCT00738062|10420200|P3|Open Label Treatment|Lack of Efficacy|0
3030275|NCT00738062|10420201|P2|Open Label Treatment|Lack of Efficacy|0
3030276|NCT00738062|10420202|P1|Open Label Treatment|Lack of Efficacy|5
3030277|NCT00737711|10420264|P1|Overall Study|Other|5
3030278|NCT00737711|10420264|P1|Overall Study|Blood transfusion|6
3030279|NCT00737711|10420264|P1|Overall Study|Withdrawal by Subject|5
3030280|NCT00737711|10420264|P1|Overall Study|Protocol Violation|1
3030281|NCT00737711|10420264|P1|Overall Study|Failure to return|4
3030282|NCT00737711|10420264|P1|Overall Study|Death|8
3030283|NCT00737711|10420264|P1|Overall Study|Adverse Event|2
3030284|NCT00737698|10420298|P3|Overall Study|Death|1
3030285|NCT00737698|10420299|P2|Overall Study|Death|0
3030286|NCT00737698|10420300|P1|Overall Study|Death|0
3030287|NCT00737698|10420298|P3|Overall Study|Withdrawal by Subject|3
3030288|NCT00737698|10420299|P2|Overall Study|Withdrawal by Subject|5
3030289|NCT00737698|10420300|P1|Overall Study|Withdrawal by Subject|6
3030290|NCT00737672|10420310|P2|Overall Study|Physician Decision|2
3030291|NCT00737672|10420311|P1|Overall Study|Physician Decision|0
3030292|NCT00737672|10420310|P2|Overall Study|Miscellaneous|1
3030293|NCT00737672|10420311|P1|Overall Study|Miscellaneous|7
3030294|NCT00737672|10420310|P2|Overall Study|Lost to Follow-up|0
3030295|NCT00737672|10420311|P1|Overall Study|Lost to Follow-up|1
3030296|NCT00737672|10420310|P2|Overall Study|Withdrawal by Subject|2
3030297|NCT00737672|10420311|P1|Overall Study|Withdrawal by Subject|1
3030298|NCT00737672|10420310|P2|Overall Study|Death|22
3030299|NCT00737672|10420311|P1|Overall Study|Death|23
3030300|NCT00737672|10420310|P2|Overall Study|Graft Abandonment|56
3030301|NCT00737672|10420311|P1|Overall Study|Graft Abandonment|48
3030302|NCT00737633|10420349|P2|Overall Study|protocol non-compliance|1
3030303|NCT00737633|10420350|P1|Overall Study|protocol non-compliance|0
3030304|NCT00737633|10420349|P2|Overall Study|Lost to Follow-up|1
3030305|NCT00737633|10420350|P1|Overall Study|Lost to Follow-up|0
3030306|NCT00737633|10420349|P2|Overall Study|Study terminated by sponsor|55
3030307|NCT00737633|10420350|P1|Overall Study|Study terminated by sponsor|44
3030308|NCT00737568|10420373|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
3030309|NCT00737568|10420374|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
3030310|NCT00737568|10420373|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
3030311|NCT00737568|10420374|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
3030312|NCT00737568|10420373|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
3030313|NCT00737568|10420374|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
3030314|NCT00737568|10420373|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
3030315|NCT00737568|10420374|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
3030316|NCT00737568|10420373|P2|Treatment Period Through Week 240|Protocol Violation|3
3030317|NCT00737568|10420374|P1|Treatment Period Through Week 240|Protocol Violation|2
3030318|NCT00737568|10420373|P2|Treatment Period Through Week 240|Lost to Follow-up|3
3030319|NCT00737568|10420374|P1|Treatment Period Through Week 240|Lost to Follow-up|3
3030320|NCT00737568|10420373|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
3030321|NCT00737568|10420374|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
3030322|NCT00737568|10420373|P2|Treatment Period Through Week 240|Withdrew Consent|6
3030323|NCT00737568|10420374|P1|Treatment Period Through Week 240|Withdrew Consent|5
3030324|NCT00737568|10420373|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
3030325|NCT00737568|10420374|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
3030326|NCT00737529|10420404|P1|Overall Study|Other|4
3030327|NCT00737529|10420404|P1|Overall Study|Protocol Violation|1
3030328|NCT00737529|10420404|P1|Overall Study|Death|4
3030329|NCT00737529|10420404|P1|Overall Study|Withdrawal by Subject|5
3030330|NCT00737529|10420404|P1|Overall Study|Adverse Event|24
3030331|NCT00737529|10420404|P1|Overall Study|Disease Progression|95
3030332|NCT00737477|10420418|P1|Overall Study|Other|4
3030333|NCT00737477|10420418|P1|Overall Study|Renal Transplantation|10
3030334|NCT00737477|10420418|P1|Overall Study|Withdrawal by Subject|1
3030335|NCT00737477|10420418|P1|Overall Study|Treatment Refusal|1
3030336|NCT00737477|10420418|P1|Overall Study|Death|9
3030337|NCT00737477|10420418|P1|Overall Study|Adverse Event|9
3030338|NCT00737464|10420434|P1|Overall Study|Other reasons|4
3030339|NCT00737464|10420434|P1|Overall Study|Refused Treatment / Withdrew Consent|6
3030340|NCT00737464|10420434|P1|Overall Study|Other - Failure to Return|1
3030341|NCT00737464|10420434|P1|Overall Study|Death|6
3030342|NCT00737464|10420434|P1|Overall Study|Adverse Event|1
3030343|NCT00737438|10420455|P1|Overall Study|Patient ineligible|1
3030344|NCT00737438|10420455|P1|Overall Study|Withdrawal by Subject|2
3030345|NCT00737282|10420468|P1|Overall Study|Study prematurely terminated|175
3030346|NCT00737100|10420511|P3|Overall Study|Reason discontinued not explained above|1
3030347|NCT00737100|10420512|P2|Overall Study|Reason discontinued not explained above|1
3030348|NCT00737100|10420513|P1|Overall Study|Reason discontinued not explained above|1
3030349|NCT00737100|10420511|P3|Overall Study|Withdrawal by Subject|3
3030350|NCT00737100|10420512|P2|Overall Study|Withdrawal by Subject|0
3030351|NCT00737100|10420513|P1|Overall Study|Withdrawal by Subject|0
3030352|NCT00737100|10420511|P3|Overall Study|Lost to Follow-up|0
3030353|NCT00737100|10420512|P2|Overall Study|Lost to Follow-up|1
3030354|NCT00737100|10420513|P1|Overall Study|Lost to Follow-up|0
3030355|NCT00737100|10420511|P3|Overall Study|Adverse Event|3
3030356|NCT00737100|10420512|P2|Overall Study|Adverse Event|5
3030357|NCT00737100|10420513|P1|Overall Study|Adverse Event|6
3030358|NCT00737061|10420557|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
3030359|NCT00737061|10420557|P1|1 Year Wearing Period|Discontinued reilance|3
3030360|NCT00737061|10420557|P1|1 Year Wearing Period|Withdrawal by Subject|2
3030361|NCT00737061|10420557|P1|1 Year Wearing Period|Lost to Follow-up|11
3030362|NCT00737061|10420557|P1|Waiting Period|Elected surgical tubal ligation|5
3030363|NCT00737061|10420557|P1|Waiting Period|Alternative contraception failure|3
3030364|NCT00737061|10420557|P1|Waiting Period|Deemed patent following HSG|26
3030365|NCT00737061|10420557|P1|Waiting Period|Bilateral placement failure|34
3030366|NCT00737061|10420557|P1|Waiting Period|Withdrawal by Subject|1
3030367|NCT00737061|10420557|P1|Waiting Period|Lost to Follow-up|6
3030368|NCT00737048|10420574|P3|Overall Study|Worsening of the symptoms|3
3030369|NCT00737048|10420575|P2|Overall Study|Worsening of the symptoms|5
3030370|NCT00737048|10420576|P1|Overall Study|Worsening of the symptoms|3
3030371|NCT00737048|10420574|P3|Overall Study|Adverse Event|0
3030372|NCT00737048|10420575|P2|Overall Study|Adverse Event|1
3030373|NCT00737048|10420576|P1|Overall Study|Adverse Event|0
3030374|NCT00737048|10420574|P3|Overall Study|Physician Decision|1
3030375|NCT00737048|10420575|P2|Overall Study|Physician Decision|0
3030376|NCT00737048|10420576|P1|Overall Study|Physician Decision|0
3030377|NCT00736996|10420620|P3|Overall Study|Lost to Follow-up|2
3030378|NCT00736996|10420621|P2|Overall Study|Lost to Follow-up|9
3030379|NCT00736996|10420622|P1|Overall Study|Lost to Follow-up|1
3030380|NCT00736957|10420636|P1|Overall Study|Physician Decision|5
3030381|NCT00736957|10420636|P1|Overall Study|not eligible for Treatment Period I|22
3030382|NCT00736957|10420636|P1|Overall Study|did not attend hospital appointments|1
3030383|NCT00736957|10420636|P1|Overall Study|violation of eligibility criteria|2
3030384|NCT00736957|10420636|P1|Overall Study|Withdrawal by Subject|49
3030385|NCT00736957|10420636|P1|Overall Study|Adverse Event|43
3030386|NCT00736944|10420646|P1|Definitive Treatment|Physician Decision|1
3030387|NCT00736944|10420646|P1|Induction|Death|1
3030388|NCT00736879|10420677|P4|Follow up Period - No Drug Treatment|non-specified|0
3030389|NCT00736879|10420678|P3|Follow up Period - No Drug Treatment|non-specified|0
3030390|NCT00736879|10420679|P2|Follow up Period - No Drug Treatment|non-specified|2
3030391|NCT00736879|10420680|P1|Follow up Period - No Drug Treatment|non-specified|1
3030392|NCT00736879|10420677|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
3030393|NCT00736879|10420678|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
3030394|NCT00736879|10420679|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
3030395|NCT00736879|10420680|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
3030396|NCT00736879|10420677|P4|Double Blind Treatment Period|non-specified|0
3030397|NCT00736879|10420678|P3|Double Blind Treatment Period|non-specified|0
3030398|NCT00736879|10420679|P2|Double Blind Treatment Period|non-specified|1
3030399|NCT00736879|10420680|P1|Double Blind Treatment Period|non-specified|0
3030400|NCT00736879|10420677|P4|Double Blind Treatment Period|No longer met criteria|0
3030401|NCT00736879|10420678|P3|Double Blind Treatment Period|No longer met criteria|0
3030402|NCT00736879|10420679|P2|Double Blind Treatment Period|No longer met criteria|1
3030403|NCT00736879|10420680|P1|Double Blind Treatment Period|No longer met criteria|0
3030404|NCT00736879|10420677|P4|Double Blind Treatment Period|Poor non-compliance|1
3030405|NCT00736879|10420678|P3|Double Blind Treatment Period|Poor non-compliance|1
3030406|NCT00736879|10420679|P2|Double Blind Treatment Period|Poor non-compliance|0
3030407|NCT00736879|10420680|P1|Double Blind Treatment Period|Poor non-compliance|0
3030408|NCT00736879|10420677|P4|Double Blind Treatment Period|Lost to Follow-up|1
3030409|NCT00736879|10420678|P3|Double Blind Treatment Period|Lost to Follow-up|2
3030410|NCT00736879|10420679|P2|Double Blind Treatment Period|Lost to Follow-up|0
3030411|NCT00736879|10420680|P1|Double Blind Treatment Period|Lost to Follow-up|0
3030412|NCT00736879|10420677|P4|Double Blind Treatment Period|Withdrawal by Subject|3
3030413|NCT00736879|10420678|P3|Double Blind Treatment Period|Withdrawal by Subject|3
3030414|NCT00736879|10420679|P2|Double Blind Treatment Period|Withdrawal by Subject|1
3030415|NCT00736879|10420680|P1|Double Blind Treatment Period|Withdrawal by Subject|2
3030416|NCT00736879|10420677|P4|Double Blind Treatment Period|Adverse Event|0
3030417|NCT00736879|10420678|P3|Double Blind Treatment Period|Adverse Event|1
3030418|NCT00736879|10420679|P2|Double Blind Treatment Period|Adverse Event|1
3030419|NCT00736879|10420680|P1|Double Blind Treatment Period|Adverse Event|0
3030420|NCT00736879|10420677|P4|Double Blind Treatment Period|Lack of Efficacy|0
3030421|NCT00736879|10420678|P3|Double Blind Treatment Period|Lack of Efficacy|0
3030422|NCT00736879|10420679|P2|Double Blind Treatment Period|Lack of Efficacy|0
3030423|NCT00736879|10420680|P1|Double Blind Treatment Period|Lack of Efficacy|1
3030424|NCT00736853|10420734|P3|Double-Blind Period|Ineligible to participate the study|0
3030425|NCT00736853|10420735|P2|Double-Blind Period|Ineligible to participate the study|1
3030426|NCT00736853|10420736|P1|Double-Blind Period|Ineligible to participate the study|0
3030427|NCT00736853|10420734|P3|Double-Blind Period|Withdrawal by Subject|4
3030428|NCT00736853|10420735|P2|Double-Blind Period|Withdrawal by Subject|1
3030429|NCT00736853|10420736|P1|Double-Blind Period|Withdrawal by Subject|0
3030430|NCT00736853|10420734|P3|Double-Blind Period|Adverse Event|2
3030431|NCT00736853|10420735|P2|Double-Blind Period|Adverse Event|3
3030432|NCT00736853|10420736|P1|Double-Blind Period|Adverse Event|0
3030433|NCT00736853|10420734|P3|Double-Blind Period|Lack of Efficacy|42
3030434|NCT00736853|10420735|P2|Double-Blind Period|Lack of Efficacy|19
3030435|NCT00736853|10420736|P1|Double-Blind Period|Lack of Efficacy|0
3030436|NCT00736853|10420734|P3|Open-Label Period|Unable to attend hospital appointments|0
3030437|NCT00736853|10420735|P2|Open-Label Period|Unable to attend hospital appointments|0
3030438|NCT00736853|10420736|P1|Open-Label Period|Unable to attend hospital appointments|1
3030439|NCT00736853|10420734|P3|Open-Label Period|Failed to meet the transfer criteria|0
3030440|NCT00736853|10420735|P2|Open-Label Period|Failed to meet the transfer criteria|0
3030441|NCT00736853|10420736|P1|Open-Label Period|Failed to meet the transfer criteria|40
3030442|NCT00736853|10420734|P3|Open-Label Period|Started but not treated|0
3030443|NCT00736853|10420735|P2|Open-Label Period|Started but not treated|0
3030444|NCT00736853|10420736|P1|Open-Label Period|Started but not treated|42
3030445|NCT00736853|10420734|P3|Open-Label Period|Withdrawal by Subject|0
3030446|NCT00736853|10420735|P2|Open-Label Period|Withdrawal by Subject|0
3030447|NCT00736853|10420736|P1|Open-Label Period|Withdrawal by Subject|16
3030448|NCT00736853|10420734|P3|Open-Label Period|Adverse Event|0
3030449|NCT00736853|10420735|P2|Open-Label Period|Adverse Event|0
3030450|NCT00736853|10420736|P1|Open-Label Period|Adverse Event|31
3030451|NCT00736853|10420734|P3|Open-Label Period|Physician Decision|0
3030452|NCT00736853|10420735|P2|Open-Label Period|Physician Decision|0
3030453|NCT00736853|10420736|P1|Open-Label Period|Physician Decision|2
3030454|NCT00736840|10420776|P1|Overall Study|Lost to Follow-up|13
3030455|NCT00736723|10420783|P2|Overall Study|Withdrawal by Subject|3
3030456|NCT00736723|10420784|P1|Overall Study|Withdrawal by Subject|4
3030457|NCT00736645|10420794|P4|Overall Study|Adverse Event|0
3030458|NCT00736645|10420795|P3|Overall Study|Adverse Event|0
3030459|NCT00736645|10420796|P2|Overall Study|Adverse Event|2
3030460|NCT00736645|10420797|P1|Overall Study|Adverse Event|0
3030461|NCT00736502|10420847|P1|Overall Study|Lost to Follow-up|27
3030462|NCT00736502|10420847|P1|Overall Study|Lack of Efficacy|16
3030463|NCT00736502|10420847|P1|Overall Study|Adverse Event|22
3030464|NCT00736489|10420853|P6|Period 1|Withdrawal by Subject|1
3030465|NCT00736489|10420854|P5|Period 1|Withdrawal by Subject|0
3030466|NCT00736489|10420855|P4|Period 1|Withdrawal by Subject|0
3030467|NCT00736489|10420856|P3|Period 1|Withdrawal by Subject|0
3030468|NCT00736489|10420857|P2|Period 1|Withdrawal by Subject|0
3030469|NCT00736489|10420858|P1|Period 1|Withdrawal by Subject|0
3030470|NCT00736489|10420853|P6|Period 1|Lost to Follow-up|0
3030471|NCT00736489|10420854|P5|Period 1|Lost to Follow-up|0
3030472|NCT00736489|10420855|P4|Period 1|Lost to Follow-up|0
3030473|NCT00736489|10420856|P3|Period 1|Lost to Follow-up|0
3030474|NCT00736489|10420857|P2|Period 1|Lost to Follow-up|0
3030475|NCT00736489|10420858|P1|Period 1|Lost to Follow-up|1
3030476|NCT00736476|10421012|P2|Overall Study|Adverse Event|0
3030477|NCT00736476|10421013|P1|Overall Study|Adverse Event|1
3030478|NCT00736450|10421033|P1|Overall Study|Physician Decision|1
3030479|NCT00736450|10421033|P1|Overall Study|Withdrawal by Subject|5
3030480|NCT00736450|10421033|P1|Overall Study|Not ABC gene eligible|19
3030481|NCT00736385|10421041|P2|Overall Study|Adverse Event|1
3030482|NCT00736385|10421042|P1|Overall Study|Adverse Event|0
3030483|NCT00736385|10421041|P2|Overall Study|Withdrawal by Subject|2
3030484|NCT00736385|10421042|P1|Overall Study|Withdrawal by Subject|2
3030485|NCT00736333|10421054|P1|Overall Study|Other|4
3030486|NCT00736333|10421054|P1|Overall Study|Death|7
3030487|NCT00736333|10421054|P1|Overall Study|Withdrawal by Subject|10
3030488|NCT00736333|10421054|P1|Overall Study|Toxicity|6
3030489|NCT00736333|10421054|P1|Overall Study|Tumor Progression|75
3030490|NCT00736333|10421054|P1|Overall Study|Data Missing|2
3030491|NCT00736333|10421054|P1|Overall Study|Did Not Receive Drug or Not Documented|7
3030492|NCT00736255|10421065|P2|Overall Study|Non-compliance|1
3030493|NCT00736255|10421066|P1|Overall Study|Non-compliance|1
3030494|NCT00736255|10421065|P2|Overall Study|Physician Decision|0
3030495|NCT00736255|10421066|P1|Overall Study|Physician Decision|1
3030496|NCT00736255|10421065|P2|Overall Study|Adverse Event|0
3030497|NCT00736255|10421066|P1|Overall Study|Adverse Event|1
3030498|NCT00736190|10421113|P1|Overall Study|Adverse Event|1
3030499|NCT00736190|10421113|P1|Overall Study|Withdrawal by Subject|1
3030500|NCT00736190|10421113|P1|Overall Study|Pregnancy|1
3030501|NCT00736099|10421143|P2|Overall Study|Other reason|10
3030502|NCT00736099|10421144|P1|Overall Study|Other reason|43
3030503|NCT00736099|10421143|P2|Overall Study|Lack of Efficacy|8
3030504|NCT00736099|10421144|P1|Overall Study|Lack of Efficacy|15
3030505|NCT00736099|10421143|P2|Overall Study|Withdrawal by Subject|13
3030506|NCT00736099|10421144|P1|Overall Study|Withdrawal by Subject|42
3030507|NCT00736099|10421143|P2|Overall Study|Lost to Follow-up|5
3030508|NCT00736099|10421144|P1|Overall Study|Lost to Follow-up|12
3030509|NCT00736099|10421143|P2|Overall Study|Protocol Violation|4
3030510|NCT00736099|10421144|P1|Overall Study|Protocol Violation|10
3030511|NCT00736099|10421143|P2|Overall Study|Adverse Event|18
3030512|NCT00736099|10421144|P1|Overall Study|Adverse Event|61
3030513|NCT00736034|10421253|P1|Overall Study|Adverse Event|2
3030514|NCT00735943|10421261|P1|Overall Study|Adverse Event|1
3030515|NCT00735943|10421261|P1|Overall Study|Lost to Follow-up|1
3030516|NCT00735904|10421286|P1|Overall Study|Other|8
3030517|NCT00735904|10421286|P1|Overall Study|Study Terminated by Sponsor|5
3030518|NCT00735904|10421286|P1|Overall Study|Withdrawal by Subject|1
3030519|NCT00735904|10421286|P1|Overall Study|Protocol Violation|1
3030520|NCT00735904|10421286|P1|Overall Study|Death|20
3030521|NCT00735904|10421286|P1|Overall Study|Adverse Event|3
3030522|NCT00735878|10421296|P3|Phase I- Dose Determination|Withdrawal by Subject|1
3030523|NCT00735878|10421297|P2|Phase I- Dose Determination|Withdrawal by Subject|0
3030524|NCT00735878|10421298|P1|Phase I- Dose Determination|Withdrawal by Subject|0
3030525|NCT00735709|10421377|P4|Overall Study|Excluded medication|1
3030526|NCT00735709|10421378|P3|Overall Study|Excluded medication|0
3030527|NCT00735709|10421379|P2|Overall Study|Excluded medication|0
3030528|NCT00735709|10421380|P1|Overall Study|Excluded medication|1
3030529|NCT00735709|10421377|P4|Overall Study|Lost to Follow-up|1
3030530|NCT00735709|10421378|P3|Overall Study|Lost to Follow-up|1
3030531|NCT00735709|10421379|P2|Overall Study|Lost to Follow-up|1
3030532|NCT00735709|10421380|P1|Overall Study|Lost to Follow-up|0
3030533|NCT00735709|10421377|P4|Overall Study|Voluntary Withdrawal|7
3030534|NCT00735709|10421378|P3|Overall Study|Voluntary Withdrawal|5
3030535|NCT00735709|10421379|P2|Overall Study|Voluntary Withdrawal|3
3030536|NCT00735709|10421380|P1|Overall Study|Voluntary Withdrawal|1
3030537|NCT00735709|10421377|P4|Overall Study|Protocol deviations|1
3030538|NCT00735709|10421378|P3|Overall Study|Protocol deviations|1
3030539|NCT00735709|10421379|P2|Overall Study|Protocol deviations|2
3030540|NCT00735709|10421380|P1|Overall Study|Protocol deviations|1
3030541|NCT00735709|10421377|P4|Overall Study|Noncompliance|0
3030542|NCT00735709|10421378|P3|Overall Study|Noncompliance|1
3030543|NCT00735709|10421379|P2|Overall Study|Noncompliance|0
3030544|NCT00735709|10421380|P1|Overall Study|Noncompliance|0
3030545|NCT00735709|10421377|P4|Overall Study|Lack of Efficacy|3
3030546|NCT00735709|10421378|P3|Overall Study|Lack of Efficacy|2
3030547|NCT00735709|10421379|P2|Overall Study|Lack of Efficacy|4
3030548|NCT00735709|10421380|P1|Overall Study|Lack of Efficacy|8
3030549|NCT00735709|10421377|P4|Overall Study|Adverse Event|5
3030550|NCT00735709|10421378|P3|Overall Study|Adverse Event|1
3030551|NCT00735709|10421379|P2|Overall Study|Adverse Event|3
3030552|NCT00735709|10421380|P1|Overall Study|Adverse Event|2
3030553|NCT00735696|10421490|P1|Overall Study|Enrolled but never Treated|1
3030554|NCT00735696|10421490|P1|Overall Study|Withdrawal by Subject|1
3030555|NCT00735644|10421518|P5|Overall Study|Withdrawal by Subject|0
3030556|NCT00735644|10421519|P4|Overall Study|Withdrawal by Subject|1
3030557|NCT00735644|10421520|P3|Overall Study|Withdrawal by Subject|1
3030558|NCT00735644|10421521|P2|Overall Study|Withdrawal by Subject|1
3030559|NCT00735644|10421522|P1|Overall Study|Withdrawal by Subject|0
3030560|NCT00735644|10421518|P5|Overall Study|Did not receive study vaccine|0
3030561|NCT00735644|10421519|P4|Overall Study|Did not receive study vaccine|0
3030562|NCT00735644|10421520|P3|Overall Study|Did not receive study vaccine|0
3030563|NCT00735644|10421521|P2|Overall Study|Did not receive study vaccine|1
3030564|NCT00735644|10421522|P1|Overall Study|Did not receive study vaccine|0
3030565|NCT00735553|10421566|P1|Overall Study|Study prematurely terminated|77
3030566|NCT00735475|10421576|P2|Overall Study|Withdrawal by Subject|5
3030567|NCT00735475|10421577|P1|Overall Study|Withdrawal by Subject|4
3030568|NCT00735475|10421576|P2|Overall Study|Physician Decision|1
3030569|NCT00735475|10421577|P1|Overall Study|Physician Decision|0
3030570|NCT00735475|10421576|P2|Overall Study|Lost to Follow-up|3
3030571|NCT00735475|10421577|P1|Overall Study|Lost to Follow-up|3
3030572|NCT00735475|10421576|P2|Overall Study|Death|1
3030573|NCT00735475|10421577|P1|Overall Study|Death|1
3030574|NCT00735475|10421576|P2|Overall Study|Adverse Event|1
3030575|NCT00735475|10421577|P1|Overall Study|Adverse Event|0
3030576|NCT00735397|10421637|P1|Overall Study|Administrative/Other|502
3030577|NCT00735397|10421637|P1|Overall Study|Inadequate therapeutic effect|202
3030578|NCT00735397|10421637|P1|Overall Study|Participant choice|252
3030579|NCT00735397|10421637|P1|Overall Study|Lost to Follow-up|33
3030580|NCT00735397|10421637|P1|Overall Study|Adverse Event|194
3030581|NCT00735371|10421651|P4|Overall Study|Exclusion criteria|0
3030582|NCT00735371|10421652|P3|Overall Study|Exclusion criteria|0
3030583|NCT00735371|10421653|P2|Overall Study|Exclusion criteria|0
3030584|NCT00735371|10421654|P1|Overall Study|Exclusion criteria|1
3030585|NCT00735371|10421651|P4|Overall Study|Prior Vyvanse Exposure|0
3030586|NCT00735371|10421652|P3|Overall Study|Prior Vyvanse Exposure|0
3030587|NCT00735371|10421653|P2|Overall Study|Prior Vyvanse Exposure|1
3030588|NCT00735371|10421654|P1|Overall Study|Prior Vyvanse Exposure|1
3030589|NCT00735371|10421651|P4|Overall Study|Protocol Violation|0
3030590|NCT00735371|10421652|P3|Overall Study|Protocol Violation|2
3030591|NCT00735371|10421653|P2|Overall Study|Protocol Violation|1
3030592|NCT00735371|10421654|P1|Overall Study|Protocol Violation|0
3030593|NCT00735371|10421651|P4|Overall Study|Sponsor Decision|1
3030594|NCT00735371|10421652|P3|Overall Study|Sponsor Decision|0
3030595|NCT00735371|10421653|P2|Overall Study|Sponsor Decision|1
3030596|NCT00735371|10421654|P1|Overall Study|Sponsor Decision|3
3030597|NCT00735371|10421651|P4|Overall Study|Lack of Efficacy|4
3030598|NCT00735371|10421652|P3|Overall Study|Lack of Efficacy|0
3030599|NCT00735371|10421653|P2|Overall Study|Lack of Efficacy|2
3030600|NCT00735371|10421654|P1|Overall Study|Lack of Efficacy|4
3030601|NCT00735371|10421651|P4|Overall Study|Lost to Follow-up|1
3030602|NCT00735371|10421652|P3|Overall Study|Lost to Follow-up|3
3030603|NCT00735371|10421653|P2|Overall Study|Lost to Follow-up|1
3030604|NCT00735371|10421654|P1|Overall Study|Lost to Follow-up|1
3030605|NCT00735371|10421651|P4|Overall Study|Withdrawal by Subject|0
3030606|NCT00735371|10421652|P3|Overall Study|Withdrawal by Subject|2
3030607|NCT00735371|10421653|P2|Overall Study|Withdrawal by Subject|2
3030608|NCT00735371|10421654|P1|Overall Study|Withdrawal by Subject|0
3030609|NCT00735371|10421651|P4|Overall Study|Protocol Violation|3
3030610|NCT00735371|10421652|P3|Overall Study|Protocol Violation|0
3030611|NCT00735371|10421653|P2|Overall Study|Protocol Violation|2
3030612|NCT00735371|10421654|P1|Overall Study|Protocol Violation|2
3030613|NCT00735371|10421651|P4|Overall Study|Adverse Event|1
3030614|NCT00735371|10421652|P3|Overall Study|Adverse Event|4
3030615|NCT00735371|10421653|P2|Overall Study|Adverse Event|3
3030616|NCT00735371|10421654|P1|Overall Study|Adverse Event|3
3030617|NCT00735254|10421682|P4|Overall Study|Protocol Violation|0
3030618|NCT00735254|10421683|P3|Overall Study|Protocol Violation|1
3030619|NCT00735254|10421684|P2|Overall Study|Protocol Violation|1
3030620|NCT00735254|10421685|P1|Overall Study|Protocol Violation|1
3030621|NCT00735072|10421697|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
3030622|NCT00735072|10421698|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
3030623|NCT00735072|10421697|P2|Overall Study|interrupted study med during ARV change|0
3030624|NCT00735072|10421698|P1|Overall Study|interrupted study med during ARV change|1
3030625|NCT00735007|10421704|P1|Overall Study|Protocol Violation|1
3030626|NCT00735007|10421704|P1|Overall Study|Adverse Event|4
3030627|NCT00734994|10421729|P1|Overall Study|Withdrawal by Subject|1
3030628|NCT00734929|10421749|P2|Overall Study|No intervention/ screen fail|3
3030629|NCT00734929|10421750|P1|Overall Study|No intervention/ screen fail|5
3030630|NCT00734929|10421749|P2|Overall Study|Lost to Follow-up|2
3030631|NCT00734929|10421750|P1|Overall Study|Lost to Follow-up|1
3030632|NCT00734851|10421807|P1|Overall Study|Physician Decision|18
3030633|NCT00734851|10421807|P1|Overall Study|Lost to Follow-up|1
3030634|NCT00734851|10421807|P1|Overall Study|Withdrawal by Subject|2
3030635|NCT00734747|10421828|P1|6 Month Follow-up|Did not meet inclusion criteria|3
3030636|NCT00734747|10421828|P1|SRS Procedure|No staples placed|3
3030637|NCT00734656|10421842|P4|Lab Session 4|Withdrawal by Subject|1
3030638|NCT00734656|10421843|P3|Lab Session 4|Withdrawal by Subject|0
3030639|NCT00734656|10421844|P2|Lab Session 4|Withdrawal by Subject|0
3030640|NCT00734656|10421845|P1|Lab Session 4|Withdrawal by Subject|0
3030641|NCT00734656|10421842|P4|Washout 3|Withdrawal by Subject|1
3030642|NCT00734656|10421843|P3|Washout 3|Withdrawal by Subject|0
3030643|NCT00734656|10421844|P2|Washout 3|Withdrawal by Subject|0
3030644|NCT00734656|10421845|P1|Washout 3|Withdrawal by Subject|1
3030645|NCT00734656|10421842|P4|Washout 2|Withdrawal by Subject|0
3030646|NCT00734656|10421843|P3|Washout 2|Withdrawal by Subject|1
3030647|NCT00734656|10421844|P2|Washout 2|Withdrawal by Subject|1
3030648|NCT00734656|10421845|P1|Washout 2|Withdrawal by Subject|1
3030649|NCT00734656|10421842|P4|Lab Session 2|Withdrawal by Subject|1
3030650|NCT00734656|10421843|P3|Lab Session 2|Withdrawal by Subject|0
3030651|NCT00734656|10421844|P2|Lab Session 2|Withdrawal by Subject|0
3030652|NCT00734656|10421845|P1|Lab Session 2|Withdrawal by Subject|1
3030653|NCT00734656|10421842|P4|Washout 1|Withdrawal by Subject|3
3030654|NCT00734656|10421843|P3|Washout 1|Withdrawal by Subject|2
3030655|NCT00734656|10421844|P2|Washout 1|Withdrawal by Subject|5
3030656|NCT00734656|10421845|P1|Washout 1|Withdrawal by Subject|1
3030657|NCT00734656|10421842|P4|Lab Session 1|Withdrawal by Subject|0
3030658|NCT00734656|10421843|P3|Lab Session 1|Withdrawal by Subject|0
3030659|NCT00734656|10421844|P2|Lab Session 1|Withdrawal by Subject|0
3030660|NCT00734656|10421845|P1|Lab Session 1|Withdrawal by Subject|2
3030661|NCT00734630|10421869|P2|Overall Study|Poor Compliance|1
3030662|NCT00734630|10421870|P1|Overall Study|Poor Compliance|1
3030663|NCT00734630|10421869|P2|Overall Study|Tested Positive for Illegal Drug Use|1
3030664|NCT00734630|10421870|P1|Overall Study|Tested Positive for Illegal Drug Use|1
3030665|NCT00734630|10421869|P2|Overall Study|Randomized in Error|1
3030666|NCT00734630|10421870|P1|Overall Study|Randomized in Error|0
3030667|NCT00734630|10421869|P2|Overall Study|Adverse Event|6
3030668|NCT00734630|10421870|P1|Overall Study|Adverse Event|3
3030669|NCT00734630|10421869|P2|Overall Study|Inclusion/Exclusion criteria not met|1
3030670|NCT00734630|10421870|P1|Overall Study|Inclusion/Exclusion criteria not met|0
3030671|NCT00734630|10421869|P2|Overall Study|Protocol Violation|3
3030672|NCT00734630|10421870|P1|Overall Study|Protocol Violation|0
3030673|NCT00734630|10421869|P2|Overall Study|Lost to Follow-up|7
3030674|NCT00734630|10421870|P1|Overall Study|Lost to Follow-up|13
3030675|NCT00734630|10421869|P2|Overall Study|Withdrawal by Subject|9
3030676|NCT00734630|10421870|P1|Overall Study|Withdrawal by Subject|7
3030677|NCT00734630|10421869|P2|Overall Study|Lack of Efficacy|4
3030678|NCT00734630|10421870|P1|Overall Study|Lack of Efficacy|4
3030679|NCT00734617|10421880|P2|Overall Study|Withdrawal by Subject|95
3030680|NCT00734617|10421881|P1|Overall Study|Withdrawal by Subject|103
3030681|NCT00734617|10421880|P2|Overall Study|Adverse Event|7
3030682|NCT00734617|10421881|P1|Overall Study|Adverse Event|4
3030683|NCT00734604|10421893|P6|Overall Study|Lack of Efficacy|0
3030684|NCT00734604|10421894|P5|Overall Study|Lack of Efficacy|0
3030685|NCT00734604|10421895|P4|Overall Study|Lack of Efficacy|0
3030686|NCT00734604|10421896|P3|Overall Study|Lack of Efficacy|1
3030687|NCT00734604|10421897|P2|Overall Study|Lack of Efficacy|1
3030688|NCT00734604|10421898|P1|Overall Study|Lack of Efficacy|0
3030689|NCT00734604|10421893|P6|Overall Study|Withdrawal by Subject|1
3030690|NCT00734604|10421894|P5|Overall Study|Withdrawal by Subject|2
3030691|NCT00734604|10421895|P4|Overall Study|Withdrawal by Subject|1
3030692|NCT00734604|10421896|P3|Overall Study|Withdrawal by Subject|0
3030693|NCT00734604|10421897|P2|Overall Study|Withdrawal by Subject|2
3030694|NCT00734604|10421898|P1|Overall Study|Withdrawal by Subject|0
3030695|NCT00734604|10421893|P6|Overall Study|Sponsor Decision|0
3030696|NCT00734604|10421894|P5|Overall Study|Sponsor Decision|2
3030697|NCT00734604|10421895|P4|Overall Study|Sponsor Decision|0
3030698|NCT00734604|10421896|P3|Overall Study|Sponsor Decision|1
3030699|NCT00734604|10421897|P2|Overall Study|Sponsor Decision|2
3030700|NCT00734604|10421898|P1|Overall Study|Sponsor Decision|1
3030701|NCT00734604|10421893|P6|Overall Study|Protocol Violation|0
3030702|NCT00734604|10421894|P5|Overall Study|Protocol Violation|1
3030703|NCT00734604|10421895|P4|Overall Study|Protocol Violation|0
3030704|NCT00734604|10421896|P3|Overall Study|Protocol Violation|0
3030705|NCT00734604|10421897|P2|Overall Study|Protocol Violation|2
3030706|NCT00734604|10421898|P1|Overall Study|Protocol Violation|0
3030707|NCT00734604|10421893|P6|Overall Study|Physician Decision|0
3030708|NCT00734604|10421894|P5|Overall Study|Physician Decision|0
3030709|NCT00734604|10421895|P4|Overall Study|Physician Decision|0
3030710|NCT00734604|10421896|P3|Overall Study|Physician Decision|1
3030711|NCT00734604|10421897|P2|Overall Study|Physician Decision|1
3030712|NCT00734604|10421898|P1|Overall Study|Physician Decision|0
3030713|NCT00734604|10421893|P6|Overall Study|Lost to Follow-up|3
3030714|NCT00734604|10421894|P5|Overall Study|Lost to Follow-up|2
3030715|NCT00734604|10421895|P4|Overall Study|Lost to Follow-up|4
3030716|NCT00734604|10421896|P3|Overall Study|Lost to Follow-up|2
3030717|NCT00734604|10421897|P2|Overall Study|Lost to Follow-up|2
3030718|NCT00734604|10421898|P1|Overall Study|Lost to Follow-up|1
3030719|NCT00734604|10421893|P6|Overall Study|Serious Adverse Event|1
3030720|NCT00734604|10421894|P5|Overall Study|Serious Adverse Event|0
3030721|NCT00734604|10421895|P4|Overall Study|Serious Adverse Event|2
3030722|NCT00734604|10421896|P3|Overall Study|Serious Adverse Event|1
3030723|NCT00734604|10421897|P2|Overall Study|Serious Adverse Event|0
3030724|NCT00734604|10421898|P1|Overall Study|Serious Adverse Event|1
3030725|NCT00734604|10421893|P6|Overall Study|Adverse Event|1
3030726|NCT00734604|10421894|P5|Overall Study|Adverse Event|1
3030727|NCT00734604|10421895|P4|Overall Study|Adverse Event|2
3030728|NCT00734604|10421896|P3|Overall Study|Adverse Event|0
3030729|NCT00734604|10421897|P2|Overall Study|Adverse Event|2
3030730|NCT00734604|10421898|P1|Overall Study|Adverse Event|0
3030731|NCT00734591|10421948|P2|Prospective Period|Other|2
3030732|NCT00734591|10421949|P1|Prospective Period|Other|2
3030733|NCT00734591|10421948|P2|Prospective Period|Study Terminated|0
3030734|NCT00734591|10421949|P1|Prospective Period|Study Terminated|1
3030735|NCT00734591|10421948|P2|Prospective Period|Lost to Follow-up|33
3030736|NCT00734591|10421949|P1|Prospective Period|Lost to Follow-up|37
3030737|NCT00734591|10421948|P2|Prospective Period|Withdrawal by Subject|9
3030738|NCT00734591|10421949|P1|Prospective Period|Withdrawal by Subject|11
3030739|NCT00734591|10421948|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
3030740|NCT00734591|10421949|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
3030741|NCT00734591|10421948|P2|Screening for Prospective Period|Site did not participate|1488
3030742|NCT00734591|10421949|P1|Screening for Prospective Period|Site did not participate|1604
3030743|NCT00734578|10421964|P3|Overall Study|Exclusion criteria|0
3030744|NCT00734578|10421965|P2|Overall Study|Exclusion criteria|0
3030745|NCT00734578|10421966|P1|Overall Study|Exclusion criteria|1
3030746|NCT00734578|10421964|P3|Overall Study|Randomized in error|0
3030747|NCT00734578|10421965|P2|Overall Study|Randomized in error|0
3030748|NCT00734578|10421966|P1|Overall Study|Randomized in error|1
3030749|NCT00734578|10421964|P3|Overall Study|Lack of Efficacy|5
3030750|NCT00734578|10421965|P2|Overall Study|Lack of Efficacy|2
3030751|NCT00734578|10421966|P1|Overall Study|Lack of Efficacy|3
3030752|NCT00734578|10421964|P3|Overall Study|Lost to Follow-up|5
3030753|NCT00734578|10421965|P2|Overall Study|Lost to Follow-up|3
3030754|NCT00734578|10421966|P1|Overall Study|Lost to Follow-up|9
3030755|NCT00734578|10421964|P3|Overall Study|Withdrawal by Subject|11
3030756|NCT00734578|10421965|P2|Overall Study|Withdrawal by Subject|8
3030757|NCT00734578|10421966|P1|Overall Study|Withdrawal by Subject|7
3030758|NCT00734578|10421964|P3|Overall Study|Protocol Violation|3
3030759|NCT00734578|10421965|P2|Overall Study|Protocol Violation|6
3030760|NCT00734578|10421966|P1|Overall Study|Protocol Violation|8
3030761|NCT00734578|10421964|P3|Overall Study|Adverse Event|1
3030762|NCT00734578|10421965|P2|Overall Study|Adverse Event|6
3030763|NCT00734578|10421966|P1|Overall Study|Adverse Event|4
3030764|NCT00734539|10422000|P2|Main Study|Enrolled in error; ineligible|0
3030765|NCT00734539|10422001|P1|Main Study|Enrolled in error; ineligible|1
3030766|NCT00734539|10422000|P2|Main Study|Withdrawal by Subject|3
3030767|NCT00734539|10422001|P1|Main Study|Withdrawal by Subject|1
3030768|NCT00734539|10422000|P2|Main Study|Physician Decision|0
3030769|NCT00734539|10422001|P1|Main Study|Physician Decision|2
3030770|NCT00734539|10422000|P2|Main Study|Death|32
3030771|NCT00734539|10422001|P1|Main Study|Death|33
3030772|NCT00734474|10422043|P9|Overall Study|Lack of Efficacy|6
3030773|NCT00734474|10422044|P8|Overall Study|Lack of Efficacy|4
3030774|NCT00734474|10422045|P7|Overall Study|Lack of Efficacy|0
3030775|NCT00734474|10422046|P6|Overall Study|Lack of Efficacy|0
3030776|NCT00734474|10422047|P5|Overall Study|Lack of Efficacy|0
3030777|NCT00734474|10422048|P4|Overall Study|Lack of Efficacy|0
3030778|NCT00734474|10422049|P3|Overall Study|Lack of Efficacy|4
3030779|NCT00734474|10422050|P2|Overall Study|Lack of Efficacy|0
3030780|NCT00734474|10422051|P1|Overall Study|Lack of Efficacy|0
3030781|NCT00734474|10422043|P9|Overall Study|Death|1
3030782|NCT00734474|10422044|P8|Overall Study|Death|2
3030783|NCT00734474|10422045|P7|Overall Study|Death|0
3030784|NCT00734474|10422046|P6|Overall Study|Death|0
3030785|NCT00734474|10422047|P5|Overall Study|Death|0
3030786|NCT00734474|10422048|P4|Overall Study|Death|0
3030787|NCT00734474|10422049|P3|Overall Study|Death|1
3030788|NCT00734474|10422050|P2|Overall Study|Death|0
3030789|NCT00734474|10422051|P1|Overall Study|Death|0
3030790|NCT00734474|10422043|P9|Overall Study|Sponsor Decision|0
3030791|NCT00734474|10422044|P8|Overall Study|Sponsor Decision|0
3030792|NCT00734474|10422045|P7|Overall Study|Sponsor Decision|0
3030793|NCT00734474|10422046|P6|Overall Study|Sponsor Decision|0
3030794|NCT00734474|10422047|P5|Overall Study|Sponsor Decision|2
3030795|NCT00734474|10422048|P4|Overall Study|Sponsor Decision|0
3030796|NCT00734474|10422049|P3|Overall Study|Sponsor Decision|0
3030797|NCT00734474|10422050|P2|Overall Study|Sponsor Decision|0
3030798|NCT00734474|10422051|P1|Overall Study|Sponsor Decision|0
3030799|NCT00734474|10422043|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
3030800|NCT00734474|10422044|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
3030801|NCT00734474|10422045|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
3030802|NCT00734474|10422046|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
3030803|NCT00734474|10422047|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
3030804|NCT00734474|10422048|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
3030805|NCT00734474|10422049|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
3030806|NCT00734474|10422050|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
3030807|NCT00734474|10422051|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
3030808|NCT00734474|10422043|P9|Overall Study|Protocol Violation|1
3030809|NCT00734474|10422044|P8|Overall Study|Protocol Violation|3
3030810|NCT00734474|10422045|P7|Overall Study|Protocol Violation|0
3030811|NCT00734474|10422046|P6|Overall Study|Protocol Violation|0
3030812|NCT00734474|10422047|P5|Overall Study|Protocol Violation|3
3030813|NCT00734474|10422048|P4|Overall Study|Protocol Violation|0
3030814|NCT00734474|10422049|P3|Overall Study|Protocol Violation|4
3030815|NCT00734474|10422050|P2|Overall Study|Protocol Violation|0
3030816|NCT00734474|10422051|P1|Overall Study|Protocol Violation|0
3030817|NCT00734474|10422043|P9|Overall Study|Adverse Event|39
3030818|NCT00734474|10422044|P8|Overall Study|Adverse Event|65
3030819|NCT00734474|10422045|P7|Overall Study|Adverse Event|1
3030820|NCT00734474|10422046|P6|Overall Study|Adverse Event|0
3030821|NCT00734474|10422047|P5|Overall Study|Adverse Event|64
3030822|NCT00734474|10422048|P4|Overall Study|Adverse Event|1
3030823|NCT00734474|10422049|P3|Overall Study|Adverse Event|63
3030824|NCT00734474|10422050|P2|Overall Study|Adverse Event|4
3030825|NCT00734474|10422051|P1|Overall Study|Adverse Event|4
3030826|NCT00734474|10422043|P9|Overall Study|Physician Decision|9
3030827|NCT00734474|10422044|P8|Overall Study|Physician Decision|9
3030828|NCT00734474|10422045|P7|Overall Study|Physician Decision|0
3030829|NCT00734474|10422046|P6|Overall Study|Physician Decision|0
3030830|NCT00734474|10422047|P5|Overall Study|Physician Decision|11
3030831|NCT00734474|10422048|P4|Overall Study|Physician Decision|1
3030832|NCT00734474|10422049|P3|Overall Study|Physician Decision|4
3030833|NCT00734474|10422050|P2|Overall Study|Physician Decision|0
3030834|NCT00734474|10422051|P1|Overall Study|Physician Decision|0
3030835|NCT00734474|10422043|P9|Overall Study|Withdrawal by Subject|21
3030836|NCT00734474|10422044|P8|Overall Study|Withdrawal by Subject|36
3030837|NCT00734474|10422045|P7|Overall Study|Withdrawal by Subject|0
3030838|NCT00734474|10422046|P6|Overall Study|Withdrawal by Subject|2
3030839|NCT00734474|10422047|P5|Overall Study|Withdrawal by Subject|24
3030840|NCT00734474|10422048|P4|Overall Study|Withdrawal by Subject|0
3030841|NCT00734474|10422049|P3|Overall Study|Withdrawal by Subject|18
3030842|NCT00734474|10422050|P2|Overall Study|Withdrawal by Subject|1
3030843|NCT00734474|10422051|P1|Overall Study|Withdrawal by Subject|2
3030844|NCT00734474|10422043|P9|Overall Study|Lost to Follow-up|4
3030845|NCT00734474|10422044|P8|Overall Study|Lost to Follow-up|9
3030846|NCT00734474|10422045|P7|Overall Study|Lost to Follow-up|0
3030847|NCT00734474|10422046|P6|Overall Study|Lost to Follow-up|1
3030848|NCT00734474|10422047|P5|Overall Study|Lost to Follow-up|11
3030849|NCT00734474|10422048|P4|Overall Study|Lost to Follow-up|0
3030850|NCT00734474|10422049|P3|Overall Study|Lost to Follow-up|13
3030851|NCT00734474|10422050|P2|Overall Study|Lost to Follow-up|0
3030852|NCT00734474|10422051|P1|Overall Study|Lost to Follow-up|1
3030853|NCT00734474|10422043|P9|Overall Study|Entry Criteria Not Met|1
3030854|NCT00734474|10422044|P8|Overall Study|Entry Criteria Not Met|1
3030855|NCT00734474|10422045|P7|Overall Study|Entry Criteria Not Met|0
3030856|NCT00734474|10422046|P6|Overall Study|Entry Criteria Not Met|1
3030857|NCT00734474|10422047|P5|Overall Study|Entry Criteria Not Met|3
3030858|NCT00734474|10422048|P4|Overall Study|Entry Criteria Not Met|0
3030859|NCT00734474|10422049|P3|Overall Study|Entry Criteria Not Met|5
3030860|NCT00734474|10422050|P2|Overall Study|Entry Criteria Not Met|0
3030861|NCT00734474|10422051|P1|Overall Study|Entry Criteria Not Met|0
3030862|NCT00734214|10422341|P2|Overall Study|MD withdrawal|0
3030863|NCT00734214|10422342|P1|Overall Study|MD withdrawal|1
3030864|NCT00734214|10422341|P2|Overall Study|Withdrawal by Subject|4
3030865|NCT00734214|10422342|P1|Overall Study|Withdrawal by Subject|3
3030866|NCT00734162|10422352|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
3030867|NCT00734162|10422353|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
3030868|NCT00734162|10422354|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
3030869|NCT00734162|10422355|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
3030870|NCT00734162|10422352|P4|Open-Label Phase|Lost to Follow-up|1
3030871|NCT00734162|10422353|P3|Open-Label Phase|Lost to Follow-up|0
3030872|NCT00734162|10422354|P2|Open-Label Phase|Lost to Follow-up|2
3030873|NCT00734162|10422355|P1|Open-Label Phase|Lost to Follow-up|1
3030874|NCT00734162|10422352|P4|Open-Label Phase|Withdrew Consent|1
3030875|NCT00734162|10422353|P3|Open-Label Phase|Withdrew Consent|1
3030876|NCT00734162|10422354|P2|Open-Label Phase|Withdrew Consent|0
3030877|NCT00734162|10422355|P1|Open-Label Phase|Withdrew Consent|1
3030878|NCT00734162|10422352|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
3030879|NCT00734162|10422353|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
3030880|NCT00734162|10422354|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
3030881|NCT00734162|10422355|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
3030882|NCT00734162|10422352|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
3030883|NCT00734162|10422353|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
3030884|NCT00734162|10422354|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
3030885|NCT00734162|10422355|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
3030886|NCT00734162|10422352|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
3030887|NCT00734162|10422353|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
3030888|NCT00734162|10422354|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
3030889|NCT00734162|10422355|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
3030890|NCT00734149|10422579|P1|Overall Study|Withdrawal by Subject|1
3030891|NCT00734097|10422586|P1|Open Label|Protocol Violation|4
3030892|NCT00734097|10422586|P1|Open Label|Withdrawal by Subject|5
3030893|NCT00734097|10422586|P1|Open Label|Lost to Follow-up|7
3030894|NCT00734097|10422586|P1|Screening|Unconfirmed pregnancy|1
3030895|NCT00734097|10422586|P1|Screening|Lost to Follow-up|2
3030896|NCT00734097|10422586|P1|Screening|Withdrawal by Subject|5
3030897|NCT00734097|10422586|P1|Screening|Protocol Violation|12
3030898|NCT00734071|10422603|P2|Overall Study|Other|2
3030899|NCT00734071|10422604|P1|Overall Study|Other|1
3030900|NCT00734071|10422603|P2|Overall Study|Lost to Follow-up|8
3030901|NCT00734071|10422604|P1|Overall Study|Lost to Follow-up|16
3030902|NCT00734071|10422603|P2|Overall Study|Voluntary Withdrawal|7
3030903|NCT00734071|10422604|P1|Overall Study|Voluntary Withdrawal|9
3030904|NCT00734071|10422603|P2|Overall Study|Protocol Deviations|4
3030905|NCT00734071|10422604|P1|Overall Study|Protocol Deviations|3
3030906|NCT00734071|10422603|P2|Overall Study|Noncompliance|2
3030907|NCT00734071|10422604|P1|Overall Study|Noncompliance|2
3030908|NCT00734071|10422603|P2|Overall Study|Lack of Efficacy|1
3030909|NCT00734071|10422604|P1|Overall Study|Lack of Efficacy|3
3030910|NCT00734071|10422603|P2|Overall Study|Adverse Event|3
3030911|NCT00734071|10422604|P1|Overall Study|Adverse Event|4
3030912|NCT00734032|10422662|P4|Overall Study|Adverse Event|0
3030913|NCT00734032|10422663|P3|Overall Study|Adverse Event|0
3030914|NCT00734032|10422664|P2|Overall Study|Adverse Event|1
3030915|NCT00734032|10422665|P1|Overall Study|Adverse Event|0
3030916|NCT00733980|10422721|P2|Overall Study|Withdrawal by Subject|2
3030917|NCT00733980|10422722|P1|Overall Study|Withdrawal by Subject|6
3030918|NCT00733980|10422721|P2|Overall Study|Physician Decision|3
3030919|NCT00733980|10422722|P1|Overall Study|Physician Decision|2
3030920|NCT00733980|10422721|P2|Overall Study|Lost to Follow-up|11
3030921|NCT00733980|10422722|P1|Overall Study|Lost to Follow-up|6
3030922|NCT00733980|10422721|P2|Overall Study|Protocol defined stopping criteria reach|1
3030923|NCT00733980|10422722|P1|Overall Study|Protocol defined stopping criteria reach|1
3030924|NCT00733980|10422721|P2|Overall Study|Protocol Violation|1
3030925|NCT00733980|10422722|P1|Overall Study|Protocol Violation|2
3030926|NCT00733980|10422721|P2|Overall Study|Lack of Efficacy|1
3030927|NCT00733980|10422722|P1|Overall Study|Lack of Efficacy|0
3030928|NCT00733980|10422721|P2|Overall Study|Adverse Event|2
3030929|NCT00733980|10422722|P1|Overall Study|Adverse Event|5
3030930|NCT00733954|10422766|P2|Overall Study|Withdrawal by Subject|0
3030931|NCT00733954|10422767|P1|Overall Study|Withdrawal by Subject|2
3030932|NCT00733954|10422766|P2|Overall Study|Protocol Violation|0
3030933|NCT00733954|10422767|P1|Overall Study|Protocol Violation|1
3030934|NCT00733954|10422766|P2|Overall Study|Lost to Follow-up|2
3030935|NCT00733954|10422767|P1|Overall Study|Lost to Follow-up|5
3030936|NCT00733824|10422814|P5|Phase I|Withdrawal by Subject|0
3030937|NCT00733824|10422815|P4|Phase I|Withdrawal by Subject|0
3030938|NCT00733824|10422816|P3|Phase I|Withdrawal by Subject|0
3030939|NCT00733824|10422817|P2|Phase I|Withdrawal by Subject|0
3030940|NCT00733824|10422818|P1|Phase I|Withdrawal by Subject|1
3030941|NCT00733746|10422837|P1|Overall Study|Ineligible|5
3030942|NCT00733499|10422852|P2|10 Year Followup|missing, unable to locate|2
3030943|NCT00733499|10422853|P1|10 Year Followup|missing, unable to locate|0
3030944|NCT00733499|10422852|P2|10 Year Followup|Withdrawal by Subject|5
3030945|NCT00733499|10422853|P1|10 Year Followup|Withdrawal by Subject|5
3030946|NCT00733499|10422852|P2|10 Year Followup|Lost to Follow-up|2
3030947|NCT00733499|10422853|P1|10 Year Followup|Lost to Follow-up|3
3030948|NCT00733499|10422852|P2|10 Year Followup|Adverse Event|3
3030949|NCT00733499|10422853|P1|10 Year Followup|Adverse Event|3
3030950|NCT00733499|10422852|P2|10 Year Followup|Death|7
3030951|NCT00733499|10422853|P1|10 Year Followup|Death|9
3030952|NCT00733499|10422852|P2|5 Year Followup|Withdrawal by Subject|1
3030953|NCT00733499|10422853|P1|5 Year Followup|Withdrawal by Subject|4
3030954|NCT00733499|10422852|P2|5 Year Followup|missing, unable to locate|1
3030955|NCT00733499|10422853|P1|5 Year Followup|missing, unable to locate|0
3030956|NCT00733499|10422852|P2|5 Year Followup|Death|19
3030957|NCT00733499|10422853|P1|5 Year Followup|Death|13
3030958|NCT00733499|10422852|P2|5 Year Followup|Lost to Follow-up|0
3030959|NCT00733499|10422853|P1|5 Year Followup|Lost to Follow-up|2
3030960|NCT00733499|10422852|P2|5 Year Followup|Revision of Study Implant|1
3030961|NCT00733499|10422853|P1|5 Year Followup|Revision of Study Implant|0
3030962|NCT00733499|10422852|P2|5 Year Followup|Non device related AE|1
3030963|NCT00733499|10422853|P1|5 Year Followup|Non device related AE|0
3030964|NCT00733499|10422852|P2|5 Year Followup|Adverse Event|2
3030965|NCT00733499|10422853|P1|5 Year Followup|Adverse Event|2
3030966|NCT00733499|10422852|P2|24 Months Follow-up|Death|1
3030967|NCT00733499|10422853|P1|24 Months Follow-up|Death|0
3030968|NCT00733499|10422852|P2|12 Months Follow-up|Death|1
3030969|NCT00733499|10422853|P1|12 Months Follow-up|Death|2
3030970|NCT00733499|10422852|P2|6 Months Follow-up|Adverse Event|1
3030971|NCT00733499|10422853|P1|6 Months Follow-up|Adverse Event|0
3030972|NCT00733499|10422852|P2|6 Months Follow-up|Death|2
3030973|NCT00733499|10422853|P1|6 Months Follow-up|Death|0
3030974|NCT00733499|10422852|P2|3 Months Follow-up|Death|2
3030975|NCT00733499|10422853|P1|3 Months Follow-up|Death|1
3030976|NCT00733499|10422852|P2|Pre-operative|Protocol Violation|1
3030977|NCT00733499|10422853|P1|Pre-operative|Protocol Violation|0
3030978|NCT00733421|10422913|P2|Overall Study|Withdrawal by Subject|1
3030979|NCT00733421|10422914|P1|Overall Study|Withdrawal by Subject|1
3030980|NCT00733408|10422936|P1|Overall Study|Adverse Event|4
3030981|NCT00733369|10422948|P2|Overall Study|Protocol Violation|4
3030982|NCT00733369|10422949|P1|Overall Study|Protocol Violation|4
3030983|NCT00733369|10422948|P2|Overall Study|Adverse Event|4
3030984|NCT00733369|10422949|P1|Overall Study|Adverse Event|4
3030985|NCT00733369|10422948|P2|Overall Study|Lost to Follow-up|1
3030986|NCT00733369|10422949|P1|Overall Study|Lost to Follow-up|2
3030987|NCT00733304|10423248|P3|Overall Study|Withdrawal by Subject|0
3030988|NCT00733304|10423249|P2|Overall Study|Withdrawal by Subject|1
3030989|NCT00733304|10423250|P1|Overall Study|Withdrawal by Subject|1
3030990|NCT00733304|10423248|P3|Overall Study|Physician Decision|3
3030991|NCT00733304|10423249|P2|Overall Study|Physician Decision|1
3030992|NCT00733304|10423250|P1|Overall Study|Physician Decision|3
3030993|NCT00733304|10423248|P3|Overall Study|Lost to Follow-up|0
3030994|NCT00733304|10423249|P2|Overall Study|Lost to Follow-up|1
3030995|NCT00733304|10423250|P1|Overall Study|Lost to Follow-up|0
3030996|NCT00733304|10423248|P3|Overall Study|Lack of Efficacy|2
3030997|NCT00733304|10423249|P2|Overall Study|Lack of Efficacy|0
3030998|NCT00733304|10423250|P1|Overall Study|Lack of Efficacy|0
3030999|NCT00733304|10423248|P3|Overall Study|Adverse Event|0
3031000|NCT00733304|10423249|P2|Overall Study|Adverse Event|0
3031001|NCT00733304|10423250|P1|Overall Study|Adverse Event|3
3031002|NCT00733291|10423332|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
3031003|NCT00733291|10423333|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
3031004|NCT00733291|10423334|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
3031005|NCT00733291|10423335|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
3031006|NCT00733226|10423364|P2|Overall Study|moved to another place|0
3031007|NCT00733226|10423365|P1|Overall Study|moved to another place|2
3031008|NCT00733226|10423364|P2|Overall Study|Lost to Follow-up|0
3031009|NCT00733226|10423365|P1|Overall Study|Lost to Follow-up|2
3031010|NCT00733226|10423364|P2|Overall Study|Withdrawal by Subject|0
3031011|NCT00733226|10423365|P1|Overall Study|Withdrawal by Subject|1
3031012|NCT00733005|10423414|P2|Overall Study|Protocol Violation|0
3031013|NCT00733005|10423415|P1|Overall Study|Protocol Violation|2
3031014|NCT00733005|10423414|P2|Overall Study|Withdrawal by Subject|1
3031015|NCT00733005|10423415|P1|Overall Study|Withdrawal by Subject|0
3031016|NCT00733005|10423414|P2|Overall Study|Treatment Failure|1
3031017|NCT00733005|10423415|P1|Overall Study|Treatment Failure|0
3031018|NCT00733005|10423414|P2|Overall Study|Adverse Event|1
3031019|NCT00733005|10423415|P1|Overall Study|Adverse Event|0
3031020|NCT00732992|10423425|P2|Overall Study|Withdrawal by Subject|0
3031021|NCT00732992|10423426|P1|Overall Study|Withdrawal by Subject|1
3031022|NCT00732992|10423425|P2|Overall Study|Global Deterioration of Health Status|0
3031023|NCT00732992|10423426|P1|Overall Study|Global Deterioration of Health Status|1
3031024|NCT00732992|10423425|P2|Overall Study|Objective Progression or Relapse|5
3031025|NCT00732992|10423426|P1|Overall Study|Objective Progression or Relapse|3
3031026|NCT00732992|10423425|P2|Overall Study|Adverse Event|1
3031027|NCT00732992|10423426|P1|Overall Study|Adverse Event|1
3031028|NCT00732940|10423445|P2|Overall Study|Lost to Follow-up|0
3031029|NCT00732940|10423446|P1|Overall Study|Lost to Follow-up|1
3031030|NCT00732940|10423445|P2|Overall Study|Adverse Event|1
3031031|NCT00732940|10423446|P1|Overall Study|Adverse Event|0
3031032|NCT00732940|10423445|P2|Overall Study|Withdrawal by Subject|2
3031033|NCT00732940|10423446|P1|Overall Study|Withdrawal by Subject|1
3031034|NCT00732875|10423527|P1|Overall Study|Lack of Efficacy|13
3031035|NCT00732875|10423527|P1|Overall Study|Withdrawal by Subject|6
3031036|NCT00732875|10423527|P1|Overall Study|Adverse Event|16
3031037|NCT00732758|10423535|P2|Overall Study|Lost to Follow-up|16
3031038|NCT00732758|10423536|P1|Overall Study|Lost to Follow-up|8
3031039|NCT00732641|10423576|P2|Overall Study|Other|5
3031040|NCT00732641|10423577|P1|Overall Study|Other|18
3031041|NCT00732641|10423576|P2|Overall Study|Unable to Complete|1
3031042|NCT00732641|10423577|P1|Overall Study|Unable to Complete|1
3031043|NCT00732641|10423576|P2|Overall Study|Withdrawal by Subject|2
3031044|NCT00732641|10423577|P1|Overall Study|Withdrawal by Subject|4
3031045|NCT00732641|10423576|P2|Overall Study|Physician Decision|0
3031046|NCT00732641|10423577|P1|Overall Study|Physician Decision|6
3031047|NCT00732641|10423576|P2|Overall Study|Serious Adverse Events|3
3031048|NCT00732641|10423577|P1|Overall Study|Serious Adverse Events|12
3031049|NCT00732641|10423576|P2|Overall Study|Relapse or Progressive Disease|101
3031050|NCT00732641|10423577|P1|Overall Study|Relapse or Progressive Disease|65
3031051|NCT00732615|10423597|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
3031052|NCT00732615|10423598|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
3031053|NCT00732615|10423597|P2|Overall Study|Physician Decision|0
3031054|NCT00732615|10423598|P1|Overall Study|Physician Decision|3
3031055|NCT00732615|10423597|P2|Overall Study|Adverse Event|2
3031056|NCT00732615|10423598|P1|Overall Study|Adverse Event|0
3031057|NCT00732615|10423597|P2|Overall Study|Lost to Follow-up|1
3031058|NCT00732615|10423598|P1|Overall Study|Lost to Follow-up|0
3031059|NCT00732615|10423597|P2|Overall Study|Withdrawal by Subject|1
3031060|NCT00732615|10423598|P1|Overall Study|Withdrawal by Subject|3
3031061|NCT00732498|10423610|P1|Overall Study|Physician Decision|3
3031062|NCT00732498|10423610|P1|Overall Study|Adverse Event|2
3031063|NCT00732498|10423610|P1|Overall Study|Ineligible|1
3031064|NCT00732472|10423621|P4|Overall Study|Withdrawal by Subject|1
3031065|NCT00732472|10423622|P3|Overall Study|Withdrawal by Subject|0
3031066|NCT00732472|10423623|P2|Overall Study|Withdrawal by Subject|2
3031067|NCT00732472|10423624|P1|Overall Study|Withdrawal by Subject|0
3031068|NCT00732472|10423621|P4|Overall Study|Protocol Violation|1
3031069|NCT00732472|10423622|P3|Overall Study|Protocol Violation|0
3031070|NCT00732472|10423623|P2|Overall Study|Protocol Violation|0
3031071|NCT00732472|10423624|P1|Overall Study|Protocol Violation|0
3031072|NCT00732472|10423621|P4|Overall Study|Adverse Event|1
3031073|NCT00732472|10423622|P3|Overall Study|Adverse Event|1
3031074|NCT00732472|10423623|P2|Overall Study|Adverse Event|1
3031075|NCT00732472|10423624|P1|Overall Study|Adverse Event|0
3031076|NCT00732381|10423724|P2|Overall Study|Treatment Failure|1
3031077|NCT00732381|10423725|P1|Overall Study|Treatment Failure|1
3031078|NCT00732381|10423724|P2|Overall Study|Adverse Event|0
3031079|NCT00732381|10423725|P1|Overall Study|Adverse Event|1
3031080|NCT00732303|10423733|P1|Overall Study|Study Terminated|2
3031081|NCT00732251|10423739|P1|Overall Study|Early Term due to Site Closure|1
3031082|NCT00732251|10423739|P1|Overall Study|Withdrawal by Subject|3
3031083|NCT00732251|10423739|P1|Overall Study|Lost to Follow-up|3
3031084|NCT00732238|10423747|P2|Overall Study|Asymptomatic bacteriuria|0
3031085|NCT00732238|10423748|P1|Overall Study|Asymptomatic bacteriuria|1
3031086|NCT00732238|10423747|P2|Overall Study|Bacteremia|1
3031087|NCT00732238|10423748|P1|Overall Study|Bacteremia|4
3031088|NCT00732199|10423849|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
3031089|NCT00732199|10423850|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
3031090|NCT00732199|10423849|P2|Overall Study|Withdrawal by Subject|18
3031091|NCT00732199|10423850|P1|Overall Study|Withdrawal by Subject|25
3031092|NCT00732160|10423865|P4|Overall Study|scheduling|1
3031093|NCT00732160|10423866|P3|Overall Study|scheduling|2
3031094|NCT00732160|10423867|P2|Overall Study|scheduling|4
3031095|NCT00732160|10423868|P1|Overall Study|scheduling|4
3031096|NCT00732160|10423865|P4|Overall Study|Adverse Event|1
3031097|NCT00732160|10423866|P3|Overall Study|Adverse Event|1
3031098|NCT00732160|10423867|P2|Overall Study|Adverse Event|0
3031099|NCT00732160|10423868|P1|Overall Study|Adverse Event|1
3031100|NCT00732069|10423882|P6|Washout After First Study Drug|Adverse Event|0
3031101|NCT00732069|10423883|P5|Washout After First Study Drug|Adverse Event|0
3031102|NCT00732069|10423884|P4|Washout After First Study Drug|Adverse Event|0
3031103|NCT00732069|10423885|P3|Washout After First Study Drug|Adverse Event|0
3031104|NCT00732069|10423886|P2|Washout After First Study Drug|Adverse Event|0
3031105|NCT00732069|10423887|P1|Washout After First Study Drug|Adverse Event|1
3031106|NCT00731939|10423905|P1|Overall Study|Did not meet enrollment criteria|2
3031107|NCT00731939|10423905|P1|Overall Study|Withdrawal by Subject|2
3031108|NCT00731939|10423905|P1|Overall Study|Not implanted with study device|9
3031109|NCT00731939|10423905|P1|Overall Study|Lost to Follow-up|15
3031110|NCT00731939|10423905|P1|Overall Study|Adverse Event|6
3031111|NCT00731822|10423982|P2|Overall Study|Lost to Follow-up|0
3031112|NCT00731822|10423983|P1|Overall Study|Lost to Follow-up|1
3031113|NCT00731822|10423982|P2|Overall Study|Protocol Violation|0
3031114|NCT00731822|10423983|P1|Overall Study|Protocol Violation|1
3031115|NCT00731822|10423982|P2|Overall Study|Adverse Event|1
3031116|NCT00731822|10423983|P1|Overall Study|Adverse Event|2
3031117|NCT00731783|10423997|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
3031118|NCT00731783|10423998|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
3031119|NCT00731783|10423997|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
3031120|NCT00731783|10423998|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
3031121|NCT00731783|10423997|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
3031122|NCT00731783|10423998|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
3031123|NCT00731783|10423997|P2|One Month Follow-Up Visit|Lost to Follow-up|22
3031124|NCT00731783|10423998|P1|One Month Follow-Up Visit|Lost to Follow-up|14
3031125|NCT00731731|10424032|P3|Overall Study|Cancel prior to treatment|2
3031126|NCT00731731|10424033|P2|Overall Study|Cancel prior to treatment|0
3031127|NCT00731731|10424034|P1|Overall Study|Cancel prior to treatment|0
3031128|NCT00731731|10424032|P3|Overall Study|Protocol Violation|1
3031129|NCT00731731|10424033|P2|Overall Study|Protocol Violation|0
3031130|NCT00731731|10424034|P1|Overall Study|Protocol Violation|0
3031131|NCT00731692|10424052|P3|Extension Phase|Adverse Event|15
3031132|NCT00731692|10424053|P2|Extension Phase|Adverse Event|1
3031133|NCT00731692|10424054|P1|Extension Phase|Adverse Event|1
3031134|NCT00731692|10424052|P3|Extension Phase|Withdrawal by Subject|3
3031135|NCT00731692|10424053|P2|Extension Phase|Withdrawal by Subject|5
3031136|NCT00731692|10424054|P1|Extension Phase|Withdrawal by Subject|4
3031137|NCT00731692|10424052|P3|Extension Phase|Lost to Follow-up|4
3031138|NCT00731692|10424053|P2|Extension Phase|Lost to Follow-up|1
3031139|NCT00731692|10424054|P1|Extension Phase|Lost to Follow-up|0
3031140|NCT00731692|10424052|P3|Extension Phase|Abnormal lab values|1
3031141|NCT00731692|10424053|P2|Extension Phase|Abnormal lab values|0
3031142|NCT00731692|10424054|P1|Extension Phase|Abnormal lab values|0
3031143|NCT00731692|10424052|P3|Extension Phase|Abnormal test procedure|1
3031144|NCT00731692|10424053|P2|Extension Phase|Abnormal test procedure|0
3031145|NCT00731692|10424054|P1|Extension Phase|Abnormal test procedure|0
3031146|NCT00731692|10424052|P3|Extension Phase|Admin Problems: Terminated # patients|277
3031147|NCT00731692|10424053|P2|Extension Phase|Admin Problems: Terminated # patients|189
3031148|NCT00731692|10424054|P1|Extension Phase|Admin Problems: Terminated # patients|69
3031149|NCT00731692|10424052|P3|Core Study (36 Months)|Withdrawal by Subject|46
3031150|NCT00731692|10424053|P2|Core Study (36 Months)|Withdrawal by Subject|32
3031151|NCT00731692|10424054|P1|Core Study (36 Months)|Withdrawal by Subject|12
3031152|NCT00731692|10424052|P3|Core Study (36 Months)|Adverse Event|29
3031153|NCT00731692|10424053|P2|Core Study (36 Months)|Adverse Event|28
3031154|NCT00731692|10424054|P1|Core Study (36 Months)|Adverse Event|25
3031155|NCT00731692|10424052|P3|Core Study (36 Months)|Abnormal Lab values|5
3031156|NCT00731692|10424053|P2|Core Study (36 Months)|Abnormal Lab values|19
3031157|NCT00731692|10424054|P1|Core Study (36 Months)|Abnormal Lab values|6
3031158|NCT00731692|10424052|P3|Core Study (36 Months)|Protocol Violation|8
3031159|NCT00731692|10424053|P2|Core Study (36 Months)|Protocol Violation|5
3031160|NCT00731692|10424054|P1|Core Study (36 Months)|Protocol Violation|4
3031161|NCT00731692|10424052|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
3031162|NCT00731692|10424053|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
3031163|NCT00731692|10424054|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
3031164|NCT00731692|10424052|P3|Core Study (36 Months)|Administrative|6
3031165|NCT00731692|10424053|P2|Core Study (36 Months)|Administrative|2
3031166|NCT00731692|10424054|P1|Core Study (36 Months)|Administrative|2
3031167|NCT00731692|10424052|P3|Core Study (36 Months)|Lost to Follow-up|3
3031168|NCT00731692|10424053|P2|Core Study (36 Months)|Lost to Follow-up|3
3031169|NCT00731692|10424054|P1|Core Study (36 Months)|Lost to Follow-up|1
3031170|NCT00731692|10424052|P3|Core Study (36 Months)|Death|2
3031171|NCT00731692|10424053|P2|Core Study (36 Months)|Death|1
3031172|NCT00731692|10424054|P1|Core Study (36 Months)|Death|2
3031173|NCT00731692|10424052|P3|Core Study (36 Months)|Physician Decision|2
3031174|NCT00731692|10424053|P2|Core Study (36 Months)|Physician Decision|0
3031175|NCT00731692|10424054|P1|Core Study (36 Months)|Physician Decision|1
3031176|NCT00731692|10424052|P3|Core Study (36 Months)|Lack of Efficacy|64
3031177|NCT00731692|10424053|P2|Core Study (36 Months)|Lack of Efficacy|23
3031178|NCT00731692|10424054|P1|Core Study (36 Months)|Lack of Efficacy|11
3031179|NCT00731679|10424100|P2|Overall Study|Pregnancy|1
3031180|NCT00731679|10424101|P1|Overall Study|Pregnancy|0
3031181|NCT00731679|10424100|P2|Overall Study|Noncompliance|1
3031182|NCT00731679|10424101|P1|Overall Study|Noncompliance|0
3031183|NCT00731679|10424100|P2|Overall Study|Lost to Follow-up|8
3031184|NCT00731679|10424101|P1|Overall Study|Lost to Follow-up|7
3031185|NCT00731679|10424100|P2|Overall Study|Withdrawal by Subject|8
3031186|NCT00731679|10424101|P1|Overall Study|Withdrawal by Subject|8
3031187|NCT00731679|10424100|P2|Overall Study|Adverse Event|8
3031188|NCT00731679|10424101|P1|Overall Study|Adverse Event|7
3031189|NCT00731666|10424109|P1|Overall Study|Withdrawal by Subject|2
3031190|NCT00731666|10424109|P1|Overall Study|Lost to Follow-up|8
3031191|NCT00731666|10424109|P1|Overall Study|Adverse Event|2
3031192|NCT00731549|10424145|P1|Overall Study|Lack of efficacy without AE|6
3031193|NCT00731549|10424145|P1|Overall Study|Lack of efficacy with AE|37
3031194|NCT00731549|10424145|P1|Overall Study|Adverse Event|31
3031195|NCT00731549|10424145|P1|Overall Study|Protocol deviation|1
3031196|NCT00731549|10424145|P1|Overall Study|Withdrawal by Subject|89
3031197|NCT00731549|10424145|P1|Overall Study|Physician Decision|16
3031198|NCT00731549|10424145|P1|Overall Study|Met withdrawal criteria|24
3031199|NCT00731549|10424145|P1|Overall Study|Lost to Follow-up|19
3031200|NCT00731133|10424185|P1|Overall Study|Withdrawal by Subject|10
3031201|NCT00731120|10424193|P3|Overall Study|Other|1
3031202|NCT00731120|10424194|P2|Overall Study|Other|0
3031203|NCT00731120|10424195|P1|Overall Study|Other|4
3031204|NCT00731120|10424193|P3|Overall Study|Lost to Follow-up|17
3031205|NCT00731120|10424194|P2|Overall Study|Lost to Follow-up|15
3031206|NCT00731120|10424195|P1|Overall Study|Lost to Follow-up|10
3031207|NCT00731120|10424193|P3|Overall Study|Withdrawal of Consent|4
3031208|NCT00731120|10424194|P2|Overall Study|Withdrawal of Consent|8
3031209|NCT00731120|10424195|P1|Overall Study|Withdrawal of Consent|13
3031210|NCT00731120|10424193|P3|Overall Study|Protocol Deviations|1
3031211|NCT00731120|10424194|P2|Overall Study|Protocol Deviations|6
3031212|NCT00731120|10424195|P1|Overall Study|Protocol Deviations|1
3031213|NCT00731120|10424193|P3|Overall Study|Noncompliance with Study Drug|1
3031214|NCT00731120|10424194|P2|Overall Study|Noncompliance with Study Drug|3
3031215|NCT00731120|10424195|P1|Overall Study|Noncompliance with Study Drug|3
3031216|NCT00731120|10424193|P3|Overall Study|Lack of Efficacy|4
3031217|NCT00731120|10424194|P2|Overall Study|Lack of Efficacy|5
3031218|NCT00731120|10424195|P1|Overall Study|Lack of Efficacy|4
3031219|NCT00731120|10424193|P3|Overall Study|Adverse Event|8
3031220|NCT00731120|10424194|P2|Overall Study|Adverse Event|6
3031221|NCT00731120|10424195|P1|Overall Study|Adverse Event|7
3031222|NCT00731042|10424312|P2|Second Intervention|Did not meet inclusion criteria|2
3031223|NCT00731042|10424313|P1|Second Intervention|Did not meet inclusion criteria|0
3031224|NCT00730925|10424324|P1|Overall Study|Other|1
3031225|NCT00730925|10424324|P1|Overall Study|Switch to combination therapy|8
3031226|NCT00730925|10424324|P1|Overall Study|Withdrawal by Subject|1
3031227|NCT00730925|10424324|P1|Overall Study|Protocol Violation|1
3031228|NCT00730925|10424324|P1|Overall Study|Other Averse Event|7
3031229|NCT00730925|10424324|P1|Overall Study|Dose reducing Event|2
3031230|NCT00730925|10424324|P1|Overall Study|Progressive Disease|21
3031231|NCT00730912|10424334|P3|Overall Study|Discontinued|1
3031232|NCT00730912|10424335|P2|Overall Study|Discontinued|0
3031233|NCT00730912|10424336|P1|Overall Study|Discontinued|0
3031234|NCT00730886|10424349|P2|Overall Study|Physician Decision|0
3031235|NCT00730886|10424350|P1|Overall Study|Physician Decision|1
3031236|NCT00730886|10424349|P2|Overall Study|Lost to Follow-up|0
3031237|NCT00730886|10424350|P1|Overall Study|Lost to Follow-up|1
3031238|NCT00730847|10424374|P1|Overall Study|Other|24
3031239|NCT00730847|10424374|P1|Overall Study|Unknown completion status|21
3031240|NCT00730847|10424374|P1|Overall Study|Lost to Follow-up|67
3031241|NCT00730847|10424374|P1|Overall Study|Withdrawal by Subject|16
3031242|NCT00730847|10424374|P1|Overall Study|Protocol Violation|2
3031243|NCT00730847|10424374|P1|Overall Study|Adverse Event|1
3031244|NCT00730756|10424383|P2|Overall Study|Withdrew Consent|1
3031245|NCT00730756|10424384|P1|Overall Study|Withdrew Consent|0
3031246|NCT00730756|10424383|P2|Overall Study|Lost to Follow-up|1
3031247|NCT00730756|10424384|P1|Overall Study|Lost to Follow-up|0
3031248|NCT00730756|10424383|P2|Overall Study|Protocol Deviation|2
3031249|NCT00730756|10424384|P1|Overall Study|Protocol Deviation|1
3031250|NCT00730756|10424383|P2|Overall Study|Lack of Efficacy|1
3031251|NCT00730756|10424384|P1|Overall Study|Lack of Efficacy|1
3031252|NCT00730756|10424383|P2|Overall Study|Adverse Event|0
3031253|NCT00730756|10424384|P1|Overall Study|Adverse Event|2
3031254|NCT00730691|10424418|P5|Overall Study|Other|2
3031255|NCT00730691|10424419|P4|Overall Study|Other|2
3031256|NCT00730691|10424420|P3|Overall Study|Other|1
3031257|NCT00730691|10424421|P2|Overall Study|Other|1
3031258|NCT00730691|10424422|P1|Overall Study|Other|1
3031259|NCT00730691|10424418|P5|Overall Study|Lost to Follow-up|13
3031260|NCT00730691|10424419|P4|Overall Study|Lost to Follow-up|15
3031261|NCT00730691|10424420|P3|Overall Study|Lost to Follow-up|13
3031262|NCT00730691|10424421|P2|Overall Study|Lost to Follow-up|8
3031263|NCT00730691|10424422|P1|Overall Study|Lost to Follow-up|11
3031264|NCT00730691|10424418|P5|Overall Study|Withdrawal of Consent|3
3031265|NCT00730691|10424419|P4|Overall Study|Withdrawal of Consent|6
3031266|NCT00730691|10424420|P3|Overall Study|Withdrawal of Consent|3
3031267|NCT00730691|10424421|P2|Overall Study|Withdrawal of Consent|9
3031268|NCT00730691|10424422|P1|Overall Study|Withdrawal of Consent|7
3031269|NCT00730691|10424418|P5|Overall Study|Protocol Deviations|5
3031270|NCT00730691|10424419|P4|Overall Study|Protocol Deviations|7
3031271|NCT00730691|10424420|P3|Overall Study|Protocol Deviations|3
3031272|NCT00730691|10424421|P2|Overall Study|Protocol Deviations|5
3031273|NCT00730691|10424422|P1|Overall Study|Protocol Deviations|3
3031274|NCT00730691|10424418|P5|Overall Study|Non-compliance with Study Drug|3
3031275|NCT00730691|10424419|P4|Overall Study|Non-compliance with Study Drug|3
3031276|NCT00730691|10424420|P3|Overall Study|Non-compliance with Study Drug|6
3031277|NCT00730691|10424421|P2|Overall Study|Non-compliance with Study Drug|1
3031278|NCT00730691|10424422|P1|Overall Study|Non-compliance with Study Drug|6
3031279|NCT00730691|10424418|P5|Overall Study|Lack of Efficacy|1
3031280|NCT00730691|10424419|P4|Overall Study|Lack of Efficacy|1
3031281|NCT00730691|10424420|P3|Overall Study|Lack of Efficacy|2
3031282|NCT00730691|10424421|P2|Overall Study|Lack of Efficacy|4
3031283|NCT00730691|10424422|P1|Overall Study|Lack of Efficacy|4
3031284|NCT00730691|10424418|P5|Overall Study|Adverse Event|23
3031285|NCT00730691|10424419|P4|Overall Study|Adverse Event|11
3031286|NCT00730691|10424420|P3|Overall Study|Adverse Event|11
3031287|NCT00730691|10424421|P2|Overall Study|Adverse Event|8
3031288|NCT00730691|10424422|P1|Overall Study|Adverse Event|4
3031289|NCT00730639|10424514|P5|Overall Study|Treatment on-going|4
3031290|NCT00730639|10424515|P4|Overall Study|Treatment on-going|4
3031291|NCT00730639|10424516|P3|Overall Study|Treatment on-going|5
3031292|NCT00730639|10424517|P2|Overall Study|Treatment on-going|5
3031293|NCT00730639|10424518|P1|Overall Study|Treatment on-going|2
3031294|NCT00730639|10424514|P5|Overall Study|Withdrawal by Subject|4
3031295|NCT00730639|10424515|P4|Overall Study|Withdrawal by Subject|3
3031296|NCT00730639|10424516|P3|Overall Study|Withdrawal by Subject|6
3031297|NCT00730639|10424517|P2|Overall Study|Withdrawal by Subject|0
3031298|NCT00730639|10424518|P1|Overall Study|Withdrawal by Subject|0
3031299|NCT00730639|10424514|P5|Overall Study|Protocol Violation|0
3031300|NCT00730639|10424515|P4|Overall Study|Protocol Violation|0
3031301|NCT00730639|10424516|P3|Overall Study|Protocol Violation|1
3031302|NCT00730639|10424517|P2|Overall Study|Protocol Violation|0
3031303|NCT00730639|10424518|P1|Overall Study|Protocol Violation|0
3031304|NCT00730639|10424514|P5|Overall Study|non-specified|3
3031305|NCT00730639|10424515|P4|Overall Study|non-specified|2
3031306|NCT00730639|10424516|P3|Overall Study|non-specified|4
3031307|NCT00730639|10424517|P2|Overall Study|non-specified|0
3031308|NCT00730639|10424518|P1|Overall Study|non-specified|0
3031309|NCT00730639|10424514|P5|Overall Study|Disease Progression|88
3031310|NCT00730639|10424515|P4|Overall Study|Disease Progression|32
3031311|NCT00730639|10424516|P3|Overall Study|Disease Progression|48
3031312|NCT00730639|10424517|P2|Overall Study|Disease Progression|13
3031313|NCT00730639|10424518|P1|Overall Study|Disease Progression|12
3031314|NCT00730639|10424514|P5|Overall Study|Death|2
3031315|NCT00730639|10424515|P4|Overall Study|Death|0
3031316|NCT00730639|10424516|P3|Overall Study|Death|0
3031317|NCT00730639|10424517|P2|Overall Study|Death|0
3031318|NCT00730639|10424518|P1|Overall Study|Death|0
3031319|NCT00730639|10424514|P5|Overall Study|Completed Maximum Cycles|6
3031320|NCT00730639|10424515|P4|Overall Study|Completed Maximum Cycles|3
3031321|NCT00730639|10424516|P3|Overall Study|Completed Maximum Cycles|11
3031322|NCT00730639|10424517|P2|Overall Study|Completed Maximum Cycles|0
3031323|NCT00730639|10424518|P1|Overall Study|Completed Maximum Cycles|0
3031324|NCT00730639|10424514|P5|Overall Study|Complete Response|1
3031325|NCT00730639|10424515|P4|Overall Study|Complete Response|2
3031326|NCT00730639|10424516|P3|Overall Study|Complete Response|2
3031327|NCT00730639|10424517|P2|Overall Study|Complete Response|0
3031328|NCT00730639|10424518|P1|Overall Study|Complete Response|0
3031329|NCT00730639|10424514|P5|Overall Study|Adverse Event|23
3031330|NCT00730639|10424515|P4|Overall Study|Adverse Event|8
3031331|NCT00730639|10424516|P3|Overall Study|Adverse Event|9
3031332|NCT00730639|10424517|P2|Overall Study|Adverse Event|0
3031333|NCT00730639|10424518|P1|Overall Study|Adverse Event|3
3031334|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
3031335|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
3031336|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
3031337|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
3031338|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
3031339|NCT00730405|10424595|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
3031340|NCT00730405|10424596|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
3031341|NCT00730405|10424597|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
3031342|NCT00730405|10424598|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
3031343|NCT00730405|10424599|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
3031344|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Other Protocol violation|0
3031345|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Other Protocol violation|0
3031346|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Other Protocol violation|1
3031347|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Other Protocol violation|0
3031348|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Other Protocol violation|0
3031349|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Mis-randomized|0
3031350|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Mis-randomized|0
3031351|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Mis-randomized|0
3031352|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Mis-randomized|1
3031353|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Mis-randomized|0
3031354|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
3031355|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
3031356|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
3031357|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
3031358|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
3031359|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
3031360|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
3031361|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
3031362|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
3031363|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
3031364|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Missing|0
3031365|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Missing|0
3031366|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Missing|2
3031367|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Missing|0
3031368|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Missing|0
3031369|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Non-compliance|0
3031370|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Non-compliance|0
3031371|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Non-compliance|2
3031372|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Non-compliance|0
3031373|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Non-compliance|1
3031374|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Use of restricted medication|0
3031375|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Use of restricted medication|0
3031376|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Use of restricted medication|0
3031377|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Use of restricted medication|1
3031378|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Use of restricted medication|0
3031379|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
3031380|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
3031381|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
3031382|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
3031383|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
3031384|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
3031385|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
3031386|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
3031387|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
3031388|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
3031389|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
3031390|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
3031391|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
3031392|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
3031393|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
3031394|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
3031395|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
3031396|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
3031397|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
3031398|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
3031399|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
3031400|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
3031401|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
3031402|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
3031403|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
3031404|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
3031405|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
3031406|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
3031407|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
3031408|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
3031409|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
3031410|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
3031411|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
3031412|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
3031413|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
3031414|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Did not met eligibility|0
3031415|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Did not met eligibility|0
3031416|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Did not met eligibility|1
3031417|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Did not met eligibility|0
3031418|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Did not met eligibility|0
3031419|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Change of location|0
3031420|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Change of location|1
3031421|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Change of location|0
3031422|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Change of location|1
3031423|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Change of location|1
3031424|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Death|0
3031425|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Death|1
3031426|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Death|0
3031427|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Death|1
3031428|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Death|0
3031429|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
3031430|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
3031431|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
3031432|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
3031433|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
3031434|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
3031435|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
3031436|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
3031437|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
3031438|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
3031439|NCT00730405|10424595|P5|Overall Study-follow-up Phase|Adverse Event|4
3031440|NCT00730405|10424596|P4|Overall Study-follow-up Phase|Adverse Event|3
3031441|NCT00730405|10424597|P3|Overall Study-follow-up Phase|Adverse Event|2
3031442|NCT00730405|10424598|P2|Overall Study-follow-up Phase|Adverse Event|6
3031443|NCT00730405|10424599|P1|Overall Study-follow-up Phase|Adverse Event|2
3031444|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
3031445|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
3031446|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
3031447|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
3031448|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
3031449|NCT00730405|10424595|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
3031450|NCT00730405|10424596|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
3031451|NCT00730405|10424597|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
3031452|NCT00730405|10424598|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
3031453|NCT00730405|10424599|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
3031454|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Pregnancy|0
3031455|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Pregnancy|0
3031456|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Pregnancy|0
3031457|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Pregnancy|1
3031458|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Pregnancy|0
3031459|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Change of location|0
3031460|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Change of location|1
3031461|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Change of location|0
3031462|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Change of location|0
3031463|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Change of location|0
3031464|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
3031465|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
3031466|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
3031467|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
3031468|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
3031469|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
3031470|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
3031471|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
3031472|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
3031473|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
3031474|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Study drug interrupted|0
3031475|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Study drug interrupted|0
3031476|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Study drug interrupted|0
3031477|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Study drug interrupted|1
3031478|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Study drug interrupted|0
3031479|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Misrandomized|0
3031480|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Misrandomized|0
3031481|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Misrandomized|0
3031482|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Misrandomized|1
3031483|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Misrandomized|0
3031484|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
3031485|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
3031486|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
3031487|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
3031488|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
3031489|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
3031490|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
3031491|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
3031492|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
3031493|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
3031494|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
3031495|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
3031496|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
3031497|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
3031498|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
3031499|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
3031500|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
3031501|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
3031502|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
3031503|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
3031504|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
3031505|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
3031506|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
3031507|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
3031508|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
3031509|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Did not met eligibility|0
3031510|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Did not met eligibility|0
3031511|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Did not met eligibility|1
3031512|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Did not met eligibility|0
3031513|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Did not met eligibility|0
3031514|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
3031515|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
3031516|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
3031517|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
3031518|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
3031519|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
3031520|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
3031521|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
3031522|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
3031523|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
3031524|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
3031525|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
3031526|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
3031527|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
3031528|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
3031529|NCT00730405|10424595|P5|Overall Study-Treatment Phase|Adverse Event|4
3031530|NCT00730405|10424596|P4|Overall Study-Treatment Phase|Adverse Event|8
3031531|NCT00730405|10424597|P3|Overall Study-Treatment Phase|Adverse Event|4
3031532|NCT00730405|10424598|P2|Overall Study-Treatment Phase|Adverse Event|10
3031533|NCT00730405|10424599|P1|Overall Study-Treatment Phase|Adverse Event|5
3031534|NCT00730327|10424646|P2|Overall Study|Subject withdrew (reason not specified)|7
3031535|NCT00730327|10424647|P1|Overall Study|Subject withdrew (reason not specified)|2
3031536|NCT00730327|10424646|P2|Overall Study|Withdrawal by Subject|13
3031537|NCT00730327|10424647|P1|Overall Study|Withdrawal by Subject|3
3031538|NCT00730327|10424646|P2|Overall Study|Adverse Event|1
3031539|NCT00730327|10424647|P1|Overall Study|Adverse Event|8
3031540|NCT00730327|10424646|P2|Overall Study|Lost to Follow-up|16
3031541|NCT00730327|10424647|P1|Overall Study|Lost to Follow-up|14
3031542|NCT00730275|10424672|P4|Overall Study|Withdrawal by Subject|1
3031543|NCT00730275|10424673|P3|Overall Study|Withdrawal by Subject|0
3031544|NCT00730275|10424674|P2|Overall Study|Withdrawal by Subject|0
3031545|NCT00730275|10424675|P1|Overall Study|Withdrawal by Subject|0
3031546|NCT00730236|10424701|P1|Overall Study|Non-compliance|1
3031547|NCT00730236|10424701|P1|Overall Study|Withdrawal by Subject|1
3031548|NCT00730236|10424701|P1|Overall Study|Adverse Event|4
3031549|NCT00730171|10424716|P1|Overall Study|Other|61
3031550|NCT00730171|10424716|P1|Overall Study|Insufficient Therapeutic Response|141
3031551|NCT00730171|10424716|P1|Overall Study|Lost to Follow-up|121
3031552|NCT00730171|10424716|P1|Overall Study|Withdrawal by Subject|202
3031553|NCT00730171|10424716|P1|Overall Study|Protocol Violation|48
3031554|NCT00730171|10424716|P1|Overall Study|Adverse Event|193
3031555|NCT00730171|10424716|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
3031556|NCT00730158|10424726|P2|Overall Study|Withdrawal by Subject|1
3031557|NCT00730158|10424727|P1|Overall Study|Withdrawal by Subject|1
3031558|NCT00730132|10424765|P1|Overall Study|Death|1
3031559|NCT00730132|10424765|P1|Overall Study|Protocol Violation|154
3031560|NCT00730041|10424783|P2|Overall Study|Lost to Follow-up|2
3031561|NCT00730041|10424784|P1|Overall Study|Lost to Follow-up|0
3031562|NCT00730028|10424807|P5|Overall Study|Randomization Error|2
3031563|NCT00730028|10424808|P4|Overall Study|Randomization Error|0
3031564|NCT00730028|10424809|P3|Overall Study|Randomization Error|0
3031565|NCT00730028|10424810|P2|Overall Study|Randomization Error|0
3031566|NCT00730028|10424811|P1|Overall Study|Randomization Error|1
3031567|NCT00730028|10424807|P5|Overall Study|Treatment Failure|1
3031568|NCT00730028|10424808|P4|Overall Study|Treatment Failure|0
3031569|NCT00730028|10424809|P3|Overall Study|Treatment Failure|0
3031570|NCT00730028|10424810|P2|Overall Study|Treatment Failure|5
3031571|NCT00730028|10424811|P1|Overall Study|Treatment Failure|5
3031572|NCT00730028|10424807|P5|Overall Study|Physician Decision|2
3031573|NCT00730028|10424808|P4|Overall Study|Physician Decision|3
3031574|NCT00730028|10424809|P3|Overall Study|Physician Decision|2
3031575|NCT00730028|10424810|P2|Overall Study|Physician Decision|3
3031576|NCT00730028|10424811|P1|Overall Study|Physician Decision|3
3031577|NCT00730028|10424807|P5|Overall Study|Withdrawal by Subject|9
3031578|NCT00730028|10424808|P4|Overall Study|Withdrawal by Subject|5
3031579|NCT00730028|10424809|P3|Overall Study|Withdrawal by Subject|4
3031580|NCT00730028|10424810|P2|Overall Study|Withdrawal by Subject|5
3031581|NCT00730028|10424811|P1|Overall Study|Withdrawal by Subject|9
3031582|NCT00730028|10424807|P5|Overall Study|Protocol Violation|0
3031583|NCT00730028|10424808|P4|Overall Study|Protocol Violation|2
3031584|NCT00730028|10424809|P3|Overall Study|Protocol Violation|1
3031585|NCT00730028|10424810|P2|Overall Study|Protocol Violation|1
3031586|NCT00730028|10424811|P1|Overall Study|Protocol Violation|6
3031587|NCT00730028|10424807|P5|Overall Study|Lost to Follow-up|25
3031588|NCT00730028|10424808|P4|Overall Study|Lost to Follow-up|26
3031589|NCT00730028|10424809|P3|Overall Study|Lost to Follow-up|22
3031590|NCT00730028|10424810|P2|Overall Study|Lost to Follow-up|26
3031591|NCT00730028|10424811|P1|Overall Study|Lost to Follow-up|13
3031592|NCT00730028|10424807|P5|Overall Study|Adverse Event|43
3031593|NCT00730028|10424808|P4|Overall Study|Adverse Event|20
3031594|NCT00730028|10424809|P3|Overall Study|Adverse Event|16
3031595|NCT00730028|10424810|P2|Overall Study|Adverse Event|26
3031596|NCT00730028|10424811|P1|Overall Study|Adverse Event|23
3031597|NCT00730015|10424861|P3|Overall Study|Other Reason|1
3031598|NCT00730015|10424862|P2|Overall Study|Other Reason|0
3031599|NCT00730015|10424863|P1|Overall Study|Other Reason|1
3031600|NCT00730015|10424861|P3|Overall Study|Lack of Efficacy|8
3031601|NCT00730015|10424862|P2|Overall Study|Lack of Efficacy|2
3031602|NCT00730015|10424863|P1|Overall Study|Lack of Efficacy|1
3031603|NCT00730015|10424861|P3|Overall Study|Lost to Follow-up|3
3031604|NCT00730015|10424862|P2|Overall Study|Lost to Follow-up|10
3031605|NCT00730015|10424863|P1|Overall Study|Lost to Follow-up|4
3031606|NCT00730015|10424861|P3|Overall Study|Withdrawal by Subject|8
3031607|NCT00730015|10424862|P2|Overall Study|Withdrawal by Subject|12
3031608|NCT00730015|10424863|P1|Overall Study|Withdrawal by Subject|12
3031609|NCT00730015|10424861|P3|Overall Study|Protocol Violation|4
3031610|NCT00730015|10424862|P2|Overall Study|Protocol Violation|6
3031611|NCT00730015|10424863|P1|Overall Study|Protocol Violation|2
3031612|NCT00730015|10424861|P3|Overall Study|Adverse Event|8
3031613|NCT00730015|10424862|P2|Overall Study|Adverse Event|10
3031614|NCT00730015|10424863|P1|Overall Study|Adverse Event|11
3031615|NCT00729937|10424903|P6|Overall Study|Incarcerated|0
3031616|NCT00729937|10424904|P5|Overall Study|Incarcerated|0
3031617|NCT00729937|10424905|P4|Overall Study|Incarcerated|1
3031618|NCT00729937|10424906|P3|Overall Study|Incarcerated|1
3031619|NCT00729937|10424907|P2|Overall Study|Incarcerated|2
3031620|NCT00729937|10424908|P1|Overall Study|Incarcerated|0
3031621|NCT00729937|10424903|P6|Overall Study|Did not meet eligibility criteria|0
3031622|NCT00729937|10424904|P5|Overall Study|Did not meet eligibility criteria|0
3031623|NCT00729937|10424905|P4|Overall Study|Did not meet eligibility criteria|0
3031624|NCT00729937|10424906|P3|Overall Study|Did not meet eligibility criteria|0
3031625|NCT00729937|10424907|P2|Overall Study|Did not meet eligibility criteria|1
3031626|NCT00729937|10424908|P1|Overall Study|Did not meet eligibility criteria|2
3031627|NCT00729937|10424903|P6|Overall Study|Randomized but not treated|3
3031628|NCT00729937|10424904|P5|Overall Study|Randomized but not treated|1
3031629|NCT00729937|10424905|P4|Overall Study|Randomized but not treated|0
3031630|NCT00729937|10424906|P3|Overall Study|Randomized but not treated|1
3031631|NCT00729937|10424907|P2|Overall Study|Randomized but not treated|6
3031632|NCT00729937|10424908|P1|Overall Study|Randomized but not treated|12
3031633|NCT00729937|10424903|P6|Overall Study|Withdrawal by Subject|2
3031634|NCT00729937|10424904|P5|Overall Study|Withdrawal by Subject|4
3031635|NCT00729937|10424905|P4|Overall Study|Withdrawal by Subject|0
3031636|NCT00729937|10424906|P3|Overall Study|Withdrawal by Subject|6
3031637|NCT00729937|10424907|P2|Overall Study|Withdrawal by Subject|5
3031638|NCT00729937|10424908|P1|Overall Study|Withdrawal by Subject|3
3031639|NCT00729937|10424903|P6|Overall Study|Death|1
3031640|NCT00729937|10424904|P5|Overall Study|Death|0
3031641|NCT00729937|10424905|P4|Overall Study|Death|0
3031642|NCT00729937|10424906|P3|Overall Study|Death|1
3031643|NCT00729937|10424907|P2|Overall Study|Death|0
3031644|NCT00729937|10424908|P1|Overall Study|Death|1
3031645|NCT00729937|10424903|P6|Overall Study|Physician Decision|8
3031646|NCT00729937|10424904|P5|Overall Study|Physician Decision|5
3031647|NCT00729937|10424905|P4|Overall Study|Physician Decision|0
3031648|NCT00729937|10424906|P3|Overall Study|Physician Decision|2
3031649|NCT00729937|10424907|P2|Overall Study|Physician Decision|16
3031650|NCT00729937|10424908|P1|Overall Study|Physician Decision|7
3031651|NCT00729937|10424903|P6|Overall Study|Lost to Follow-up|23
3031652|NCT00729937|10424904|P5|Overall Study|Lost to Follow-up|18
3031653|NCT00729937|10424905|P4|Overall Study|Lost to Follow-up|33
3031654|NCT00729937|10424906|P3|Overall Study|Lost to Follow-up|18
3031655|NCT00729937|10424907|P2|Overall Study|Lost to Follow-up|58
3031656|NCT00729937|10424908|P1|Overall Study|Lost to Follow-up|49
3031657|NCT00729859|10425112|P3|Overall Study|Withdrawal by Subject|0
3031658|NCT00729859|10425113|P2|Overall Study|Withdrawal by Subject|1
3031659|NCT00729859|10425114|P1|Overall Study|Withdrawal by Subject|0
3031660|NCT00729859|10425112|P3|Overall Study|Adverse Event|0
3031661|NCT00729859|10425113|P2|Overall Study|Adverse Event|1
3031662|NCT00729859|10425114|P1|Overall Study|Adverse Event|0
3031663|NCT00729833|10425158|P4|Overall Study|Unspecified Reasons|1
3031664|NCT00729833|10425159|P3|Overall Study|Unspecified Reasons|5
3031665|NCT00729833|10425160|P2|Overall Study|Unspecified Reasons|5
3031666|NCT00729833|10425161|P1|Overall Study|Unspecified Reasons|11
3031667|NCT00729833|10425158|P4|Overall Study|Withdrawal by Subject|0
3031668|NCT00729833|10425159|P3|Overall Study|Withdrawal by Subject|3
3031669|NCT00729833|10425160|P2|Overall Study|Withdrawal by Subject|1
3031670|NCT00729833|10425161|P1|Overall Study|Withdrawal by Subject|3
3031671|NCT00729833|10425158|P4|Overall Study|Lost to Follow-up|0
3031672|NCT00729833|10425159|P3|Overall Study|Lost to Follow-up|0
3031673|NCT00729833|10425160|P2|Overall Study|Lost to Follow-up|0
3031674|NCT00729833|10425161|P1|Overall Study|Lost to Follow-up|1
3031675|NCT00729833|10425158|P4|Overall Study|Study Terminated by Sponsor|0
3031676|NCT00729833|10425159|P3|Overall Study|Study Terminated by Sponsor|1
3031677|NCT00729833|10425160|P2|Overall Study|Study Terminated by Sponsor|0
3031678|NCT00729833|10425161|P1|Overall Study|Study Terminated by Sponsor|0
3031679|NCT00729833|10425158|P4|Overall Study|Death|5
3031680|NCT00729833|10425159|P3|Overall Study|Death|3
3031681|NCT00729833|10425160|P2|Overall Study|Death|1
3031682|NCT00729833|10425161|P1|Overall Study|Death|5
3031683|NCT00729690|10425219|P3|Overall Study|IT Catheter Malfunction|2
3031684|NCT00729690|10425220|P2|Overall Study|IT Catheter Malfunction|2
3031685|NCT00729690|10425221|P1|Overall Study|IT Catheter Malfunction|0
3031686|NCT00729651|10425251|P2|Overall Study|Subject’s private reason|0
3031687|NCT00729651|10425252|P1|Overall Study|Subject’s private reason|2
3031688|NCT00729651|10425251|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
3031689|NCT00729651|10425252|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
3031690|NCT00729651|10425251|P2|Overall Study|Adverse Event|3
3031691|NCT00729651|10425252|P1|Overall Study|Adverse Event|7
3031692|NCT00729651|10425251|P2|Overall Study|Protocol Violation|1
3031693|NCT00729651|10425252|P1|Overall Study|Protocol Violation|0
3031694|NCT00729651|10425251|P2|Overall Study|Lost to Follow-up|4
3031695|NCT00729651|10425252|P1|Overall Study|Lost to Follow-up|5
3031696|NCT00729651|10425251|P2|Overall Study|Withdrawal by Subject|6
3031697|NCT00729651|10425252|P1|Overall Study|Withdrawal by Subject|5
3031698|NCT00729612|10425264|P1|Overall Study|Non evaluable for response|10
3031699|NCT00729586|10425273|P2|Overall Study|never treated|0
3031700|NCT00729586|10425274|P1|Overall Study|never treated|1
3031701|NCT00729586|10425273|P2|Overall Study|Ineligible|1
3031702|NCT00729586|10425274|P1|Overall Study|Ineligible|0
3031703|NCT00729560|10425287|P1|Overall Study|Withdrawal by Subject|3
3031704|NCT00729469|10425313|P2|Overall Study|Other-Not mentioned|4
3031705|NCT00729469|10425314|P1|Overall Study|Other-Not mentioned|9
3031706|NCT00729469|10425313|P2|Overall Study|Withdrawal by Subject|8
3031707|NCT00729469|10425314|P1|Overall Study|Withdrawal by Subject|19
3031708|NCT00729469|10425313|P2|Overall Study|Protocol Violation|1
3031709|NCT00729469|10425314|P1|Overall Study|Protocol Violation|2
3031710|NCT00729469|10425313|P2|Overall Study|Lost to Follow-up|9
3031711|NCT00729469|10425314|P1|Overall Study|Lost to Follow-up|9
3031712|NCT00729469|10425313|P2|Overall Study|Adverse Event|25
3031713|NCT00729469|10425314|P1|Overall Study|Adverse Event|14
3031714|NCT00729378|10425367|P2|36-months|Lost to Follow-up|6
3031715|NCT00729378|10425368|P1|36-months|Lost to Follow-up|15
3031716|NCT00729378|10425367|P2|24-months|Lost to Follow-up|51
3031717|NCT00729378|10425368|P1|24-months|Lost to Follow-up|72
3031718|NCT00729378|10425367|P2|12-months|Lost to Follow-up|65
3031719|NCT00729378|10425368|P1|12-months|Lost to Follow-up|100
3031720|NCT00729378|10425367|P2|Baseline|Withdrawal by Subject|59
3031721|NCT00729378|10425368|P1|Baseline|Withdrawal by Subject|66
3031722|NCT00729378|10425367|P2|Baseline|Did not complete study measurements|33
3031723|NCT00729378|10425368|P1|Baseline|Did not complete study measurements|72
3031724|NCT00729365|10425567|P3|Overall Study|Physician Decision|7
3031725|NCT00729365|10425568|P2|Overall Study|Physician Decision|6
3031726|NCT00729365|10425569|P1|Overall Study|Physician Decision|33
3031727|NCT00729326|10425582|P2|Overall Study|Sponsor Decision|2
3031728|NCT00729326|10425583|P1|Overall Study|Sponsor Decision|1
3031729|NCT00729326|10425582|P2|Overall Study|Subject Decision|4
3031730|NCT00729326|10425583|P1|Overall Study|Subject Decision|4
3031731|NCT00729326|10425582|P2|Overall Study|Protocol Violation|2
3031732|NCT00729326|10425583|P1|Overall Study|Protocol Violation|3
3031733|NCT00729326|10425582|P2|Overall Study|Physician Decision|1
3031734|NCT00729326|10425583|P1|Overall Study|Physician Decision|0
3031735|NCT00729326|10425582|P2|Overall Study|Lost to Follow-up|0
3031736|NCT00729326|10425583|P1|Overall Study|Lost to Follow-up|2
3031737|NCT00729248|10425625|P1|Overall Study|Physician Decision|2
3031738|NCT00729183|10425632|P2|Overall Study|Withdrawal by Subject|7
3031739|NCT00729183|10425633|P1|Overall Study|Withdrawal by Subject|9
3031740|NCT00729183|10425632|P2|Overall Study|Protocol Violation|0
3031741|NCT00729183|10425633|P1|Overall Study|Protocol Violation|1
3031742|NCT00729183|10425632|P2|Overall Study|Physician Decision|1
3031743|NCT00729183|10425633|P1|Overall Study|Physician Decision|1
3031744|NCT00729183|10425632|P2|Overall Study|Lost to Follow-up|1
3031745|NCT00729183|10425633|P1|Overall Study|Lost to Follow-up|3
3031746|NCT00729183|10425632|P2|Overall Study|Lack of Efficacy|1
3031747|NCT00729183|10425633|P1|Overall Study|Lack of Efficacy|0
3031748|NCT00729183|10425632|P2|Overall Study|Adverse Event|5
3031749|NCT00729183|10425633|P1|Overall Study|Adverse Event|11
3031750|NCT00729157|10425665|P1|Overall Study|Withdrawal by Subject|1
3031751|NCT00728988|10425708|P2|Overall Study|Withdrawal by Subject|6
3031752|NCT00728988|10425709|P1|Overall Study|Withdrawal by Subject|2
3031753|NCT00728988|10425708|P2|Overall Study|Other|77
3031754|NCT00728988|10425709|P1|Overall Study|Other|85
3031755|NCT00728988|10425708|P2|Overall Study|Adverse Event|2
3031756|NCT00728988|10425709|P1|Overall Study|Adverse Event|3
3031757|NCT00728988|10425708|P2|Overall Study|Death|1
3031758|NCT00728988|10425709|P1|Overall Study|Death|1
3031759|NCT00728988|10425708|P2|Overall Study|Not Treated|2
3031760|NCT00728988|10425709|P1|Overall Study|Not Treated|2
3031761|NCT00728962|10425727|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
3031762|NCT00728962|10425727|P1|Permanent Prosthesis Placement|Adverse Event|3
3031763|NCT00728962|10425727|P1|Implant Placement Surgery|Protocol Violation|1
3031764|NCT00728962|10425727|P1|Implant Placement Surgery|Lost to Follow-up|1
3031765|NCT00728962|10425727|P1|Implant Placement Surgery|Adverse Event|8
3031766|NCT00728949|10425733|P2|Overall Study|On treatment at cutoff date|0
3031767|NCT00728949|10425734|P1|Overall Study|On treatment at cutoff date|1
3031768|NCT00728949|10425733|P2|Overall Study|Abnormal Lab Results|2
3031769|NCT00728949|10425734|P1|Overall Study|Abnormal Lab Results|0
3031770|NCT00728949|10425733|P2|Overall Study|Withdrawal by Subject|2
3031771|NCT00728949|10425734|P1|Overall Study|Withdrawal by Subject|2
3031772|NCT00728949|10425733|P2|Overall Study|Adverse Event|0
3031773|NCT00728949|10425734|P1|Overall Study|Adverse Event|8
3031774|NCT00728936|10425759|P7|Overall Study|Withdrawal by Subject|0
3031775|NCT00728936|10425760|P6|Overall Study|Withdrawal by Subject|1
3031776|NCT00728936|10425761|P5|Overall Study|Withdrawal by Subject|0
3031777|NCT00728936|10425762|P4|Overall Study|Withdrawal by Subject|0
3031778|NCT00728936|10425763|P3|Overall Study|Withdrawal by Subject|0
3031779|NCT00728936|10425764|P2|Overall Study|Withdrawal by Subject|0
3031780|NCT00728936|10425765|P1|Overall Study|Withdrawal by Subject|0
3031781|NCT00728884|10425798|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
3031782|NCT00728884|10425798|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
3031783|NCT00728754|10425834|P2|One Year Post Placement Follow-up|Adverse Event|0
3031784|NCT00728754|10425835|P1|One Year Post Placement Follow-up|Adverse Event|1
3031785|NCT00728754|10425834|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
3031786|NCT00728754|10425835|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
3031787|NCT00728754|10425834|P2|Permanent Prosthesis Placement|Adverse Event|1
3031788|NCT00728754|10425835|P1|Permanent Prosthesis Placement|Adverse Event|1
3031789|NCT00728689|10425864|P2|Washout Period (Days 4 - 10)|Death in family|0
3031790|NCT00728689|10425865|P1|Washout Period (Days 4 - 10)|Death in family|1
3031791|NCT00728494|10425894|P2|Overall Study|No data available|1
3031792|NCT00728494|10425895|P1|Overall Study|No data available|0
3031793|NCT00728494|10425894|P2|Overall Study|Lack of Efficacy|4
3031794|NCT00728494|10425895|P1|Overall Study|Lack of Efficacy|2
3031795|NCT00728494|10425894|P2|Overall Study|Withdrawal by Subject|2
3031796|NCT00728494|10425895|P1|Overall Study|Withdrawal by Subject|0
3031797|NCT00728494|10425894|P2|Overall Study|Adverse Event|0
3031798|NCT00728494|10425895|P1|Overall Study|Adverse Event|7
3031799|NCT00728481|10425913|P2|Overall Study|Incorrectly assigned to opposite arm|0
3031800|NCT00728481|10425914|P1|Overall Study|Incorrectly assigned to opposite arm|1
3031801|NCT00728481|10425913|P2|Overall Study|Study medication non-compliance|2
3031802|NCT00728481|10425914|P1|Overall Study|Study medication non-compliance|0
3031803|NCT00728481|10425913|P2|Overall Study|Adverse Event|1
3031804|NCT00728481|10425914|P1|Overall Study|Adverse Event|0
3031805|NCT00728481|10425913|P2|Overall Study|Withdrawal by Subject|1
3031806|NCT00728481|10425914|P1|Overall Study|Withdrawal by Subject|0
3031807|NCT00728468|10425930|P1|Overall Study|Study terminated by sponsor|1
3031808|NCT00728468|10425930|P1|Overall Study|Objective progression or relapse|9
3031809|NCT00728468|10425930|P1|Overall Study|Protocol Violation|4
3031810|NCT00728468|10425930|P1|Overall Study|Death|1
3031811|NCT00728468|10425930|P1|Overall Study|Enrolled but not treated|1
3031812|NCT00728416|10425954|P2|Overall Study|Withdrawal by Subject|0
3031813|NCT00728416|10425955|P1|Overall Study|Withdrawal by Subject|1
3031814|NCT00728416|10425954|P2|Overall Study|Treatment Failure|1
3031815|NCT00728416|10425955|P1|Overall Study|Treatment Failure|0
3031816|NCT00728416|10425954|P2|Overall Study|Adverse Event|1
3031817|NCT00728416|10425955|P1|Overall Study|Adverse Event|1
3031818|NCT00728182|10425971|P2|Overall Study|Protocol Noncompliance|1
3031819|NCT00728182|10425972|P1|Overall Study|Protocol Noncompliance|0
3031820|NCT00728182|10425971|P2|Overall Study|Death|2
3031821|NCT00728182|10425972|P1|Overall Study|Death|0
3031822|NCT00728182|10425971|P2|Overall Study|Lost to Follow-up|0
3031823|NCT00728182|10425972|P1|Overall Study|Lost to Follow-up|2
3031824|NCT00728182|10425971|P2|Overall Study|Adverse Event|0
3031825|NCT00728182|10425972|P1|Overall Study|Adverse Event|1
3031826|NCT00728130|10426000|P1|Overall Study|Physician Decision|1
3031827|NCT00728130|10426000|P1|Overall Study|Paperwork not completed in time|1
3031828|NCT00728130|10426000|P1|Overall Study|Withdrawal by Subject|1
3031829|NCT00727961|10426005|P1|Overall Study|Progression|30
3031830|NCT00727961|10426005|P1|Overall Study|Patient's refusal|2
3031831|NCT00727961|10426005|P1|Overall Study|Adverse Event|4
3031832|NCT00727961|10426005|P1|Overall Study|Lost to Follow-up|1
3031833|NCT00727909|10426015|P4|Overall Study|Death|0
3031834|NCT00727909|10426016|P3|Overall Study|Death|1
3031835|NCT00727909|10426017|P2|Overall Study|Death|0
3031836|NCT00727909|10426018|P1|Overall Study|Death|0
3031837|NCT00727909|10426015|P4|Overall Study|Withdrawal by Subject|5
3031838|NCT00727909|10426016|P3|Overall Study|Withdrawal by Subject|8
3031839|NCT00727909|10426017|P2|Overall Study|Withdrawal by Subject|11
3031840|NCT00727909|10426018|P1|Overall Study|Withdrawal by Subject|5
3031841|NCT00727844|10426115|P4|Initial Randomization|Physician Decision|0
3031842|NCT00727844|10426116|P3|Initial Randomization|Physician Decision|0
3031843|NCT00727844|10426117|P2|Initial Randomization|Physician Decision|0
3031844|NCT00727844|10426118|P1|Initial Randomization|Physician Decision|2
3031845|NCT00727714|10426132|P1|Overall Study|Lost to Follow-up|2
3031846|NCT00727649|10426142|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
3031847|NCT00727649|10426143|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
3031848|NCT00727649|10426142|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
3031849|NCT00727649|10426143|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
3031850|NCT00727649|10426142|P2|Second Intervention (4-weeks)|Death|0
3031851|NCT00727649|10426143|P1|Second Intervention (4-weeks)|Death|1
3031852|NCT00727649|10426142|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
3031853|NCT00727649|10426143|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
3031854|NCT00727649|10426142|P2|Wash-out (2-weeks)|Lost to Follow-up|1
3031855|NCT00727649|10426143|P1|Wash-out (2-weeks)|Lost to Follow-up|3
3031856|NCT00727649|10426142|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
3031857|NCT00727649|10426143|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
3031858|NCT00727649|10426142|P2|First Intervention (4-weeks)|Lost to Follow-up|2
3031859|NCT00727649|10426143|P1|First Intervention (4-weeks)|Lost to Follow-up|1
3031860|NCT00727571|10426185|P4|Overall Study|Other|0
3031861|NCT00727571|10426186|P3|Overall Study|Other|6
3031862|NCT00727571|10426187|P2|Overall Study|Other|4
3031863|NCT00727571|10426188|P1|Overall Study|Other|0
3031864|NCT00727571|10426185|P4|Overall Study|AE not leading to hospitalization|0
3031865|NCT00727571|10426186|P3|Overall Study|AE not leading to hospitalization|2
3031866|NCT00727571|10426187|P2|Overall Study|AE not leading to hospitalization|0
3031867|NCT00727571|10426188|P1|Overall Study|AE not leading to hospitalization|0
3031868|NCT00727571|10426185|P4|Overall Study|Hospitalization|1
3031869|NCT00727571|10426186|P3|Overall Study|Hospitalization|0
3031870|NCT00727571|10426187|P2|Overall Study|Hospitalization|1
3031871|NCT00727571|10426188|P1|Overall Study|Hospitalization|0
3031872|NCT00727571|10426185|P4|Overall Study|Dismissed from nursing home|0
3031873|NCT00727571|10426186|P3|Overall Study|Dismissed from nursing home|5
3031874|NCT00727571|10426187|P2|Overall Study|Dismissed from nursing home|9
3031875|NCT00727571|10426188|P1|Overall Study|Dismissed from nursing home|0
3031876|NCT00727571|10426185|P4|Overall Study|Subject Non Compliance|4
3031877|NCT00727571|10426186|P3|Overall Study|Subject Non Compliance|0
3031878|NCT00727571|10426187|P2|Overall Study|Subject Non Compliance|6
3031879|NCT00727571|10426188|P1|Overall Study|Subject Non Compliance|0
3031880|NCT00727571|10426185|P4|Overall Study|Withdrawal by Subject|0
3031881|NCT00727571|10426186|P3|Overall Study|Withdrawal by Subject|11
3031882|NCT00727571|10426187|P2|Overall Study|Withdrawal by Subject|10
3031883|NCT00727571|10426188|P1|Overall Study|Withdrawal by Subject|0
3031884|NCT00727571|10426185|P4|Overall Study|Physician Decision|0
3031885|NCT00727571|10426186|P3|Overall Study|Physician Decision|0
3031886|NCT00727571|10426187|P2|Overall Study|Physician Decision|5
3031887|NCT00727571|10426188|P1|Overall Study|Physician Decision|0
3031888|NCT00727571|10426185|P4|Overall Study|Death|1
3031889|NCT00727571|10426186|P3|Overall Study|Death|5
3031890|NCT00727571|10426187|P2|Overall Study|Death|19
3031891|NCT00727571|10426188|P1|Overall Study|Death|0
3031892|NCT00727571|10426185|P4|Overall Study|Ineligibility determined|0
3031893|NCT00727571|10426186|P3|Overall Study|Ineligibility determined|1
3031894|NCT00727571|10426187|P2|Overall Study|Ineligibility determined|1
3031895|NCT00727571|10426188|P1|Overall Study|Ineligibility determined|1
3031896|NCT00727558|10426215|P2|Overall Study|Lost to Follow-up|0
3031897|NCT00727558|10426216|P1|Overall Study|Lost to Follow-up|1
3031898|NCT00727558|10426215|P2|Overall Study|Subject unable to return for follow-up|1
3031899|NCT00727558|10426216|P1|Overall Study|Subject unable to return for follow-up|1
3031900|NCT00727558|10426215|P2|Overall Study|Adverse Event|1
3031901|NCT00727558|10426216|P1|Overall Study|Adverse Event|0
3031902|NCT00727558|10426215|P2|Overall Study|Lens issue|1
3031903|NCT00727558|10426216|P1|Overall Study|Lens issue|0
3031904|NCT00727532|10426234|P1|Overall Study|Withdrawal by Subject|1
3031905|NCT00727532|10426234|P1|Overall Study|Adverse Event|1
3031906|NCT00727506|10426246|P6|Overall Study|Other reason not described above|1
3031907|NCT00727506|10426247|P5|Overall Study|Other reason not described above|1
3031908|NCT00727506|10426248|P4|Overall Study|Other reason not described above|4
3031909|NCT00727506|10426249|P3|Overall Study|Other reason not described above|1
3031910|NCT00727506|10426250|P2|Overall Study|Other reason not described above|0
3031911|NCT00727506|10426251|P1|Overall Study|Other reason not described above|0
3031912|NCT00727506|10426246|P6|Overall Study|Refused to continue medication|2
3031913|NCT00727506|10426247|P5|Overall Study|Refused to continue medication|1
3031914|NCT00727506|10426248|P4|Overall Study|Refused to continue medication|3
3031915|NCT00727506|10426249|P3|Overall Study|Refused to continue medication|2
3031916|NCT00727506|10426250|P2|Overall Study|Refused to continue medication|1
3031917|NCT00727506|10426251|P1|Overall Study|Refused to continue medication|0
3031918|NCT00727506|10426246|P6|Overall Study|Progressive disease|28
3031919|NCT00727506|10426247|P5|Overall Study|Progressive disease|38
3031920|NCT00727506|10426248|P4|Overall Study|Progressive disease|28
3031921|NCT00727506|10426249|P3|Overall Study|Progressive disease|9
3031922|NCT00727506|10426250|P2|Overall Study|Progressive disease|7
3031923|NCT00727506|10426251|P1|Overall Study|Progressive disease|4
3031924|NCT00727506|10426246|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
3031925|NCT00727506|10426247|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
3031926|NCT00727506|10426248|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
3031927|NCT00727506|10426249|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
3031928|NCT00727506|10426250|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
3031929|NCT00727506|10426251|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
3031930|NCT00727506|10426246|P6|Overall Study|Adverse Event|8
3031931|NCT00727506|10426247|P5|Overall Study|Adverse Event|1
3031932|NCT00727506|10426248|P4|Overall Study|Adverse Event|4
3031933|NCT00727506|10426249|P3|Overall Study|Adverse Event|4
3031934|NCT00727506|10426250|P2|Overall Study|Adverse Event|0
3031935|NCT00727506|10426251|P1|Overall Study|Adverse Event|0
3031936|NCT00727441|10426347|P3|Overall Study|Withdrawal by Subject|0
3031937|NCT00727441|10426348|P2|Overall Study|Withdrawal by Subject|1
3031938|NCT00727441|10426349|P1|Overall Study|Withdrawal by Subject|0
3031939|NCT00727441|10426347|P3|Overall Study|Physician Decision|0
3031940|NCT00727441|10426348|P2|Overall Study|Physician Decision|1
3031941|NCT00727441|10426349|P1|Overall Study|Physician Decision|0
3031942|NCT00727441|10426347|P3|Overall Study|Death|1
3031943|NCT00727441|10426348|P2|Overall Study|Death|1
3031944|NCT00727441|10426349|P1|Overall Study|Death|0
3031945|NCT00727441|10426347|P3|Overall Study|Eligibility|7
3031946|NCT00727441|10426348|P2|Overall Study|Eligibility|5
3031947|NCT00727441|10426349|P1|Overall Study|Eligibility|7
3031948|NCT00727441|10426347|P3|Overall Study|Disease Progression|17
3031949|NCT00727441|10426348|P2|Overall Study|Disease Progression|14
3031950|NCT00727441|10426349|P1|Overall Study|Disease Progression|11
3031951|NCT00727415|10426369|P1|Phase I|Dose Limiting Toxicity|2
3031952|NCT00727402|10426378|P1|Overall Study|Physician Decision|116
3031953|NCT00727311|10426407|P1|Overall Study|Multiple reasons|39
3031954|NCT00727311|10426407|P1|Overall Study|Other|97
3031955|NCT00727311|10426407|P1|Overall Study|Withdrawal by Subject|77
3031956|NCT00727311|10426407|P1|Overall Study|Lost to Follow-up|73
3031957|NCT00727311|10426407|P1|Overall Study|Lack of Efficacy|242
3031958|NCT00727311|10426407|P1|Overall Study|Adverse Event|58
3031959|NCT00727311|10426407|P1|Overall Study|Missing end of therapy data|205
3031960|NCT00727311|10426407|P1|Overall Study|Did not receive drug|316
3031961|NCT00727272|10426420|P3|Washout Period B|Withdrawal by Subject|1
3031962|NCT00727272|10426421|P2|Washout Period B|Withdrawal by Subject|0
3031963|NCT00727272|10426422|P1|Washout Period B|Withdrawal by Subject|0
3031964|NCT00727272|10426420|P3|Washout Period A|Adverse Event|1
3031965|NCT00727272|10426421|P2|Washout Period A|Adverse Event|0
3031966|NCT00727272|10426422|P1|Washout Period A|Adverse Event|0
3031967|NCT00727259|10426439|P1|Overall Study|Not all questionnaires completed|1055
3031968|NCT00727246|10426448|P4|Overall Study|withdrawn|0
3031969|NCT00727246|10426449|P3|Overall Study|withdrawn|1
3031970|NCT00727246|10426450|P2|Overall Study|withdrawn|0
3031971|NCT00727246|10426451|P1|Overall Study|withdrawn|0
3031972|NCT00727246|10426448|P4|Overall Study|incidental finding|1
3031973|NCT00727246|10426449|P3|Overall Study|incidental finding|0
3031974|NCT00727246|10426450|P2|Overall Study|incidental finding|0
3031975|NCT00727246|10426451|P1|Overall Study|incidental finding|0
3031976|NCT00727246|10426448|P4|Overall Study|could not complete MRI|1
3031977|NCT00727246|10426449|P3|Overall Study|could not complete MRI|0
3031978|NCT00727246|10426450|P2|Overall Study|could not complete MRI|1
3031979|NCT00727246|10426451|P1|Overall Study|could not complete MRI|0
3031980|NCT00727194|10426474|P3|Treatment Period 2|Lack of Efficacy|0
3031981|NCT00727194|10426475|P2|Treatment Period 2|Lack of Efficacy|1
3031982|NCT00727194|10426476|P1|Treatment Period 2|Lack of Efficacy|0
3031983|NCT00727194|10426474|P3|Screening Period|History of thymoma|1
3031984|NCT00727194|10426475|P2|Screening Period|History of thymoma|0
3031985|NCT00727194|10426476|P1|Screening Period|History of thymoma|0
3031986|NCT00727194|10426474|P3|Screening Period|Severe infections|2
3031987|NCT00727194|10426475|P2|Screening Period|Severe infections|0
3031988|NCT00727194|10426476|P1|Screening Period|Severe infections|0
3031989|NCT00727194|10426474|P3|Screening Period|Not stable on concomitant MG therapy|2
3031990|NCT00727194|10426475|P2|Screening Period|Not stable on concomitant MG therapy|0
3031991|NCT00727194|10426476|P1|Screening Period|Not stable on concomitant MG therapy|0
3031992|NCT00727194|10426474|P3|Screening Period|Lacked AChR antibodies|5
3031993|NCT00727194|10426475|P2|Screening Period|Lacked AChR antibodies|0
3031994|NCT00727194|10426476|P1|Screening Period|Lacked AChR antibodies|0
3031995|NCT00727194|10426474|P3|Screening Period|Low QMG scores|6
3031996|NCT00727194|10426475|P2|Screening Period|Low QMG scores|0
3031997|NCT00727194|10426476|P1|Screening Period|Low QMG scores|0
3031998|NCT00727025|10426548|P1|Overall Study|Physician Decision|23
3031999|NCT00726999|10426560|P2|Overall Study|Protocol Violation|0
3032000|NCT00726999|10426561|P1|Overall Study|Protocol Violation|1
3032001|NCT00726999|10426560|P2|Overall Study|Withdrawal by Subject|0
3032002|NCT00726999|10426561|P1|Overall Study|Withdrawal by Subject|2
3032003|NCT00726999|10426560|P2|Overall Study|Physician Decision|1
3032004|NCT00726999|10426561|P1|Overall Study|Physician Decision|0
3032005|NCT00726986|10426573|P1|Maintenance Phase|Lack of Efficacy|2
3032006|NCT00726986|10426573|P1|Maintenance Phase|Adverse Event|1
3032007|NCT00726986|10426573|P1|Induction Phase|Secondary Disease|2
3032008|NCT00726986|10426573|P1|Induction Phase|Lack of Efficacy|5
3032009|NCT00726986|10426573|P1|Induction Phase|Death|2
3032010|NCT00726986|10426573|P1|Induction Phase|Withdrawal by Subject|2
3032011|NCT00726986|10426573|P1|Induction Phase|Adverse Event|4
3032012|NCT00726895|10426580|P2|Washout Period of 7 Days|Withdrawal by Subject|1
3032013|NCT00726895|10426581|P1|Washout Period of 7 Days|Withdrawal by Subject|0
3032014|NCT00726882|10426594|P1|Overall Study|Other|10
3032015|NCT00726882|10426594|P1|Overall Study|Lost to Follow-up|7
3032016|NCT00726882|10426594|P1|Overall Study|Withdrawal by Subject|5
3032017|NCT00726752|10426609|P1|Overall Study|Lack of Efficacy|6
3032018|NCT00726661|10426671|P2|Overall Study|Other|35
3032019|NCT00726661|10426672|P1|Overall Study|Other|47
3032020|NCT00726661|10426671|P2|Overall Study|Physician Decision|13
3032021|NCT00726661|10426672|P1|Overall Study|Physician Decision|25
3032022|NCT00726661|10426671|P2|Overall Study|Death|159
3032023|NCT00726661|10426672|P1|Overall Study|Death|475
3032024|NCT00726661|10426671|P2|Overall Study|Trial terminated by sponsor|187
3032025|NCT00726661|10426672|P1|Overall Study|Trial terminated by sponsor|214
3032026|NCT00726661|10426671|P2|Overall Study|Withdrawal by Subject|13
3032027|NCT00726661|10426672|P1|Overall Study|Withdrawal by Subject|17
3032028|NCT00726661|10426671|P2|Overall Study|Lost to Follow-up|11
3032029|NCT00726661|10426672|P1|Overall Study|Lost to Follow-up|36
3032030|NCT00726622|10426689|P2|Overall Study|Metastasis|0
3032031|NCT00726622|10426690|P1|Overall Study|Metastasis|2
3032032|NCT00726622|10426689|P2|Overall Study|Physician Decision|1
3032033|NCT00726622|10426690|P1|Overall Study|Physician Decision|0
3032034|NCT00726622|10426689|P2|Overall Study|Withdrawal by Subject|2
3032035|NCT00726622|10426690|P1|Overall Study|Withdrawal by Subject|16
3032036|NCT00726609|10426708|P1|Overall Study|Other|3
3032037|NCT00726609|10426708|P1|Overall Study|Missing|42
3032038|NCT00726609|10426708|P1|Overall Study|Other|16
3032039|NCT00726609|10426708|P1|Overall Study|Lack of Efficacy|25
3032040|NCT00726609|10426708|P1|Overall Study|Withdrawal by Subject|2
3032041|NCT00726609|10426708|P1|Overall Study|Adverse Event|10
3032042|NCT00726557|10426712|P1|Overall Study|Inclusion criteria not met|15
3032043|NCT00726557|10426712|P1|Overall Study|Treatment less than 3 months|17
3032044|NCT00726557|10426712|P1|Overall Study|No follow-up documentation available|55
3032045|NCT00726557|10426712|P1|Overall Study|No end of treatment documentation|37
3032046|NCT00726557|10426712|P1|Overall Study|Screening failure|4
3032047|NCT00726453|10426719|P2|38 mm Length Group|Death|3
3032048|NCT00726453|10426720|P1|38 mm Length Group|Death|0
3032049|NCT00726453|10426719|P2|Primary Enrollment Group|Withdrawal by Subject|0
3032050|NCT00726453|10426720|P1|Primary Enrollment Group|Withdrawal by Subject|13
3032051|NCT00726453|10426719|P2|Primary Enrollment Group|Death|0
3032052|NCT00726453|10426720|P1|Primary Enrollment Group|Death|18
3032053|NCT00726323|10426748|P2|Overall Study|Metastatic lesions inferred cyst|1
3032054|NCT00726323|10426749|P1|Overall Study|Metastatic lesions inferred cyst|0
3032055|NCT00726323|10426748|P2|Overall Study|Participant wished to discontinue|1
3032056|NCT00726323|10426749|P1|Overall Study|Participant wished to discontinue|0
3032057|NCT00726323|10426748|P2|Overall Study|Death|0
3032058|NCT00726323|10426749|P1|Overall Study|Death|1
3032059|NCT00726323|10426748|P2|Overall Study|Adverse Event|9
3032060|NCT00726323|10426749|P1|Overall Study|Adverse Event|9
3032061|NCT00726323|10426748|P2|Overall Study|Clinical progression|3
3032062|NCT00726323|10426749|P1|Overall Study|Clinical progression|0
3032063|NCT00726323|10426748|P2|Overall Study|Progressive disease|16
3032064|NCT00726323|10426749|P1|Overall Study|Progressive disease|23
3032065|NCT00726323|10426748|P2|Overall Study|Physician Decision|0
3032066|NCT00726323|10426749|P1|Overall Study|Physician Decision|1
3032067|NCT00726323|10426748|P2|Overall Study|Withdrawal by Subject|1
3032068|NCT00726323|10426749|P1|Overall Study|Withdrawal by Subject|3
3032069|NCT00726232|10426779|P8|Expansion Phase|Unspecified reason|0
3032070|NCT00726232|10426780|P7|Expansion Phase|Unspecified reason|1
3032071|NCT00726232|10426781|P6|Expansion Phase|Unspecified reason|0
3032072|NCT00726232|10426782|P5|Expansion Phase|Unspecified reason|0
3032073|NCT00726232|10426783|P4|Expansion Phase|Unspecified reason|0
3032074|NCT00726232|10426784|P3|Expansion Phase|Unspecified reason|0
3032075|NCT00726232|10426785|P2|Expansion Phase|Unspecified reason|0
3032076|NCT00726232|10426786|P1|Expansion Phase|Unspecified reason|0
3032077|NCT00726232|10426779|P8|Expansion Phase|Per Investigator: lack of response|7
3032078|NCT00726232|10426780|P7|Expansion Phase|Per Investigator: lack of response|1
3032079|NCT00726232|10426781|P6|Expansion Phase|Per Investigator: lack of response|0
3032080|NCT00726232|10426782|P5|Expansion Phase|Per Investigator: lack of response|0
3032081|NCT00726232|10426783|P4|Expansion Phase|Per Investigator: lack of response|0
3032082|NCT00726232|10426784|P3|Expansion Phase|Per Investigator: lack of response|0
3032083|NCT00726232|10426785|P2|Expansion Phase|Per Investigator: lack of response|0
3032084|NCT00726232|10426786|P1|Expansion Phase|Per Investigator: lack of response|0
3032085|NCT00726232|10426779|P8|Expansion Phase|Termination of the trial by sponsor|16
3032086|NCT00726232|10426780|P7|Expansion Phase|Termination of the trial by sponsor|10
3032087|NCT00726232|10426781|P6|Expansion Phase|Termination of the trial by sponsor|0
3032088|NCT00726232|10426782|P5|Expansion Phase|Termination of the trial by sponsor|0
3032089|NCT00726232|10426783|P4|Expansion Phase|Termination of the trial by sponsor|0
3032090|NCT00726232|10426784|P3|Expansion Phase|Termination of the trial by sponsor|0
3032091|NCT00726232|10426785|P2|Expansion Phase|Termination of the trial by sponsor|0
3032092|NCT00726232|10426786|P1|Expansion Phase|Termination of the trial by sponsor|0
3032093|NCT00726232|10426779|P8|Expansion Phase|Disease progression|0
3032094|NCT00726232|10426780|P7|Expansion Phase|Disease progression|4
3032095|NCT00726232|10426781|P6|Expansion Phase|Disease progression|0
3032096|NCT00726232|10426782|P5|Expansion Phase|Disease progression|0
3032097|NCT00726232|10426783|P4|Expansion Phase|Disease progression|0
3032098|NCT00726232|10426784|P3|Expansion Phase|Disease progression|0
3032099|NCT00726232|10426785|P2|Expansion Phase|Disease progression|0
3032100|NCT00726232|10426786|P1|Expansion Phase|Disease progression|0
3032101|NCT00726232|10426779|P8|Expansion Phase|Withdrawal by Subject|3
3032102|NCT00726232|10426780|P7|Expansion Phase|Withdrawal by Subject|2
3032103|NCT00726232|10426781|P6|Expansion Phase|Withdrawal by Subject|0
3032104|NCT00726232|10426782|P5|Expansion Phase|Withdrawal by Subject|0
3032105|NCT00726232|10426783|P4|Expansion Phase|Withdrawal by Subject|0
3032106|NCT00726232|10426784|P3|Expansion Phase|Withdrawal by Subject|0
3032107|NCT00726232|10426785|P2|Expansion Phase|Withdrawal by Subject|0
3032108|NCT00726232|10426786|P1|Expansion Phase|Withdrawal by Subject|0
3032109|NCT00726232|10426779|P8|Expansion Phase|Adverse Event|11
3032110|NCT00726232|10426780|P7|Expansion Phase|Adverse Event|6
3032111|NCT00726232|10426781|P6|Expansion Phase|Adverse Event|0
3032112|NCT00726232|10426782|P5|Expansion Phase|Adverse Event|0
3032113|NCT00726232|10426783|P4|Expansion Phase|Adverse Event|0
3032114|NCT00726232|10426784|P3|Expansion Phase|Adverse Event|0
3032115|NCT00726232|10426785|P2|Expansion Phase|Adverse Event|0
3032116|NCT00726232|10426786|P1|Expansion Phase|Adverse Event|0
3032117|NCT00726232|10426779|P8|Expansion Phase|Death|1
3032118|NCT00726232|10426780|P7|Expansion Phase|Death|0
3032119|NCT00726232|10426781|P6|Expansion Phase|Death|0
3032120|NCT00726232|10426782|P5|Expansion Phase|Death|0
3032121|NCT00726232|10426783|P4|Expansion Phase|Death|0
3032122|NCT00726232|10426784|P3|Expansion Phase|Death|0
3032123|NCT00726232|10426785|P2|Expansion Phase|Death|0
3032124|NCT00726232|10426786|P1|Expansion Phase|Death|0
3032125|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Unspecified reason|0
3032126|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Unspecified reason|0
3032127|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Unspecified reason|0
3032128|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Unspecified reason|0
3032129|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Unspecified reason|0
3032130|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Unspecified reason|0
3032131|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Unspecified reason|0
3032132|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Unspecified reason|1
3032133|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
3032134|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
3032135|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
3032136|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
3032137|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
3032138|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
3032139|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
3032140|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
3032141|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
3032142|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
3032143|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
3032144|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
3032145|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
3032146|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
3032147|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
3032148|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
3032149|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Disease progression|0
3032150|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Disease progression|0
3032151|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Disease progression|0
3032152|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Disease progression|0
3032153|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Disease progression|0
3032154|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Disease progression|0
3032155|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Disease progression|1
3032156|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Disease progression|3
3032157|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
3032158|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
3032159|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
3032160|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
3032161|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
3032162|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
3032163|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
3032164|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
3032165|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Adverse Event|0
3032166|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Adverse Event|0
3032167|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Adverse Event|3
3032168|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Adverse Event|7
3032169|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Adverse Event|1
3032170|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Adverse Event|2
3032171|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Adverse Event|2
3032172|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Adverse Event|2
3032173|NCT00726232|10426779|P8|Initial Phase (Dose-finding)|Death|0
3032174|NCT00726232|10426780|P7|Initial Phase (Dose-finding)|Death|0
3032175|NCT00726232|10426781|P6|Initial Phase (Dose-finding)|Death|0
3032176|NCT00726232|10426782|P5|Initial Phase (Dose-finding)|Death|1
3032177|NCT00726232|10426783|P4|Initial Phase (Dose-finding)|Death|0
3032178|NCT00726232|10426784|P3|Initial Phase (Dose-finding)|Death|0
3032179|NCT00726232|10426785|P2|Initial Phase (Dose-finding)|Death|0
3032180|NCT00726232|10426786|P1|Initial Phase (Dose-finding)|Death|0
3032181|NCT00726063|10426838|P2|Overall Study|Adverse Event|7
3032182|NCT00726063|10426839|P1|Overall Study|Adverse Event|9
3032183|NCT00725985|10426853|P12|LTFU (No Cladribine Treatment)|Other|14
3032184|NCT00725985|10426854|P11|LTFU (No Cladribine Treatment)|Other|36
3032185|NCT00725985|10426855|P10|LTFU (No Cladribine Treatment)|Other|34
3032186|NCT00725985|10426856|P9|LTFU (No Cladribine Treatment)|Other|0
3032187|NCT00725985|10426857|P8|LTFU (No Cladribine Treatment)|Other|0
3032188|NCT00725985|10426858|P7|LTFU (No Cladribine Treatment)|Other|0
3032189|NCT00725985|10426859|P6|LTFU (No Cladribine Treatment)|Other|0
3032190|NCT00725985|10426860|P5|LTFU (No Cladribine Treatment)|Other|0
3032191|NCT00725985|10426861|P4|LTFU (No Cladribine Treatment)|Other|0
3032192|NCT00725985|10426862|P3|LTFU (No Cladribine Treatment)|Other|0
3032193|NCT00725985|10426863|P2|LTFU (No Cladribine Treatment)|Other|0
3032194|NCT00725985|10426864|P1|LTFU (No Cladribine Treatment)|Other|0
3032195|NCT00725985|10426853|P12|LTFU (With Cladribine Treatment)|Other|0
3032196|NCT00725985|10426854|P11|LTFU (With Cladribine Treatment)|Other|0
3032197|NCT00725985|10426855|P10|LTFU (With Cladribine Treatment)|Other|0
3032198|NCT00725985|10426856|P9|LTFU (With Cladribine Treatment)|Other|16
3032199|NCT00725985|10426857|P8|LTFU (With Cladribine Treatment)|Other|8
3032200|NCT00725985|10426858|P7|LTFU (With Cladribine Treatment)|Other|9
3032201|NCT00725985|10426859|P6|LTFU (With Cladribine Treatment)|Other|0
3032202|NCT00725985|10426860|P5|LTFU (With Cladribine Treatment)|Other|0
3032203|NCT00725985|10426861|P4|LTFU (With Cladribine Treatment)|Other|0
3032204|NCT00725985|10426862|P3|LTFU (With Cladribine Treatment)|Other|0
3032205|NCT00725985|10426863|P2|LTFU (With Cladribine Treatment)|Other|0
3032206|NCT00725985|10426864|P1|LTFU (With Cladribine Treatment)|Other|0
3032207|NCT00725985|10426853|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032208|NCT00725985|10426854|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032209|NCT00725985|10426855|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032210|NCT00725985|10426856|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
3032211|NCT00725985|10426857|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032212|NCT00725985|10426858|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032213|NCT00725985|10426859|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032214|NCT00725985|10426860|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032215|NCT00725985|10426861|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032216|NCT00725985|10426862|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032217|NCT00725985|10426863|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032218|NCT00725985|10426864|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
3032219|NCT00725985|10426853|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
3032220|NCT00725985|10426854|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
3032221|NCT00725985|10426855|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
3032222|NCT00725985|10426856|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
3032223|NCT00725985|10426857|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
3032224|NCT00725985|10426858|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
3032225|NCT00725985|10426859|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
3032226|NCT00725985|10426860|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
3032227|NCT00725985|10426861|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
3032228|NCT00725985|10426862|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
3032229|NCT00725985|10426863|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
3032230|NCT00725985|10426864|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
3032231|NCT00725985|10426853|P12|OLMP|Other|0
3032232|NCT00725985|10426854|P11|OLMP|Other|0
3032233|NCT00725985|10426855|P10|OLMP|Other|0
3032234|NCT00725985|10426856|P9|OLMP|Other|0
3032235|NCT00725985|10426857|P8|OLMP|Other|0
3032236|NCT00725985|10426858|P7|OLMP|Other|0
3032237|NCT00725985|10426859|P6|OLMP|Other|44
3032238|NCT00725985|10426860|P5|OLMP|Other|20
3032239|NCT00725985|10426861|P4|OLMP|Other|15
3032240|NCT00725985|10426862|P3|OLMP|Other|0
3032241|NCT00725985|10426863|P2|OLMP|Other|0
3032242|NCT00725985|10426864|P1|OLMP|Other|0
3032243|NCT00725985|10426853|P12|OLMP|Disease progression|0
3032244|NCT00725985|10426854|P11|OLMP|Disease progression|0
3032245|NCT00725985|10426855|P10|OLMP|Disease progression|0
3032246|NCT00725985|10426856|P9|OLMP|Disease progression|0
3032247|NCT00725985|10426857|P8|OLMP|Disease progression|0
3032248|NCT00725985|10426858|P7|OLMP|Disease progression|0
3032249|NCT00725985|10426859|P6|OLMP|Disease progression|4
3032250|NCT00725985|10426860|P5|OLMP|Disease progression|0
3032251|NCT00725985|10426861|P4|OLMP|Disease progression|0
3032252|NCT00725985|10426862|P3|OLMP|Disease progression|0
3032253|NCT00725985|10426863|P2|OLMP|Disease progression|0
3032254|NCT00725985|10426864|P1|OLMP|Disease progression|0
3032255|NCT00725985|10426853|P12|OLMP|Lost to Follow-up|0
3032256|NCT00725985|10426854|P11|OLMP|Lost to Follow-up|0
3032257|NCT00725985|10426855|P10|OLMP|Lost to Follow-up|0
3032258|NCT00725985|10426856|P9|OLMP|Lost to Follow-up|0
3032259|NCT00725985|10426857|P8|OLMP|Lost to Follow-up|0
3032260|NCT00725985|10426858|P7|OLMP|Lost to Follow-up|0
3032261|NCT00725985|10426859|P6|OLMP|Lost to Follow-up|0
3032262|NCT00725985|10426860|P5|OLMP|Lost to Follow-up|0
3032263|NCT00725985|10426861|P4|OLMP|Lost to Follow-up|1
3032264|NCT00725985|10426862|P3|OLMP|Lost to Follow-up|0
3032265|NCT00725985|10426863|P2|OLMP|Lost to Follow-up|0
3032266|NCT00725985|10426864|P1|OLMP|Lost to Follow-up|0
3032267|NCT00725985|10426853|P12|OLMP|Death|0
3032268|NCT00725985|10426854|P11|OLMP|Death|0
3032269|NCT00725985|10426855|P10|OLMP|Death|0
3032270|NCT00725985|10426856|P9|OLMP|Death|0
3032271|NCT00725985|10426857|P8|OLMP|Death|0
3032272|NCT00725985|10426858|P7|OLMP|Death|0
3032273|NCT00725985|10426859|P6|OLMP|Death|0
3032274|NCT00725985|10426860|P5|OLMP|Death|1
3032275|NCT00725985|10426861|P4|OLMP|Death|0
3032276|NCT00725985|10426862|P3|OLMP|Death|0
3032277|NCT00725985|10426863|P2|OLMP|Death|0
3032278|NCT00725985|10426864|P1|OLMP|Death|0
3032279|NCT00725985|10426853|P12|OLMP|Adverse Event|0
3032280|NCT00725985|10426854|P11|OLMP|Adverse Event|0
3032281|NCT00725985|10426855|P10|OLMP|Adverse Event|0
3032282|NCT00725985|10426856|P9|OLMP|Adverse Event|0
3032283|NCT00725985|10426857|P8|OLMP|Adverse Event|0
3032284|NCT00725985|10426858|P7|OLMP|Adverse Event|0
3032285|NCT00725985|10426859|P6|OLMP|Adverse Event|5
3032286|NCT00725985|10426860|P5|OLMP|Adverse Event|2
3032287|NCT00725985|10426861|P4|OLMP|Adverse Event|2
3032288|NCT00725985|10426862|P3|OLMP|Adverse Event|0
3032289|NCT00725985|10426863|P2|OLMP|Adverse Event|0
3032290|NCT00725985|10426864|P1|OLMP|Adverse Event|0
3032291|NCT00725985|10426853|P12|ITP (Up to 96 Weeks)|Other|0
3032292|NCT00725985|10426854|P11|ITP (Up to 96 Weeks)|Other|0
3032293|NCT00725985|10426855|P10|ITP (Up to 96 Weeks)|Other|0
3032294|NCT00725985|10426856|P9|ITP (Up to 96 Weeks)|Other|0
3032295|NCT00725985|10426857|P8|ITP (Up to 96 Weeks)|Other|0
3032296|NCT00725985|10426858|P7|ITP (Up to 96 Weeks)|Other|0
3032297|NCT00725985|10426859|P6|ITP (Up to 96 Weeks)|Other|0
3032298|NCT00725985|10426860|P5|ITP (Up to 96 Weeks)|Other|0
3032299|NCT00725985|10426861|P4|ITP (Up to 96 Weeks)|Other|0
3032300|NCT00725985|10426862|P3|ITP (Up to 96 Weeks)|Other|24
3032301|NCT00725985|10426863|P2|ITP (Up to 96 Weeks)|Other|38
3032302|NCT00725985|10426864|P1|ITP (Up to 96 Weeks)|Other|50
3032303|NCT00725985|10426853|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032304|NCT00725985|10426854|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032305|NCT00725985|10426855|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032306|NCT00725985|10426856|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032307|NCT00725985|10426857|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032308|NCT00725985|10426858|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032309|NCT00725985|10426859|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032310|NCT00725985|10426860|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032311|NCT00725985|10426861|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
3032312|NCT00725985|10426862|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
3032313|NCT00725985|10426863|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
3032314|NCT00725985|10426864|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
3032315|NCT00725985|10426853|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032316|NCT00725985|10426854|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032317|NCT00725985|10426855|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032318|NCT00725985|10426856|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032319|NCT00725985|10426857|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032320|NCT00725985|10426858|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032321|NCT00725985|10426859|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032322|NCT00725985|10426860|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032323|NCT00725985|10426861|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032324|NCT00725985|10426862|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032325|NCT00725985|10426863|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
3032326|NCT00725985|10426864|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
3032327|NCT00725985|10426853|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032328|NCT00725985|10426854|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032329|NCT00725985|10426855|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032330|NCT00725985|10426856|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032331|NCT00725985|10426857|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032332|NCT00725985|10426858|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032333|NCT00725985|10426859|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032334|NCT00725985|10426860|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032335|NCT00725985|10426861|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032336|NCT00725985|10426862|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
3032337|NCT00725985|10426863|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032338|NCT00725985|10426864|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
3032339|NCT00725985|10426853|P12|ITP (Up to 96 Weeks)|Adverse Event|0
3032340|NCT00725985|10426854|P11|ITP (Up to 96 Weeks)|Adverse Event|0
3032341|NCT00725985|10426855|P10|ITP (Up to 96 Weeks)|Adverse Event|0
3032342|NCT00725985|10426856|P9|ITP (Up to 96 Weeks)|Adverse Event|0
3032343|NCT00725985|10426857|P8|ITP (Up to 96 Weeks)|Adverse Event|0
3032344|NCT00725985|10426858|P7|ITP (Up to 96 Weeks)|Adverse Event|0
3032345|NCT00725985|10426859|P6|ITP (Up to 96 Weeks)|Adverse Event|0
3032346|NCT00725985|10426860|P5|ITP (Up to 96 Weeks)|Adverse Event|0
3032347|NCT00725985|10426861|P4|ITP (Up to 96 Weeks)|Adverse Event|0
3032348|NCT00725985|10426862|P3|ITP (Up to 96 Weeks)|Adverse Event|5
3032349|NCT00725985|10426863|P2|ITP (Up to 96 Weeks)|Adverse Event|10
3032350|NCT00725985|10426864|P1|ITP (Up to 96 Weeks)|Adverse Event|20
3032351|NCT00725920|10426901|P2|Overall Study|Lack of Efficacy|6
3032352|NCT00725920|10426902|P1|Overall Study|Lack of Efficacy|3
3032353|NCT00725842|10426908|P1|Overall Study|No Visit 1 data|1
3032354|NCT00725842|10426908|P1|Overall Study|Inclusion criterion not met|1
3032355|NCT00725842|10426908|P1|Overall Study|Consent date prior to study start date|5
3032356|NCT00725842|10426908|P1|Overall Study|Positive HCV-RNA at Visit 2|13
3032357|NCT00725842|10426908|P1|Overall Study|Death|1
3032358|NCT00725842|10426908|P1|Overall Study|Lost to Follow-up|19
3032359|NCT00725764|10426915|P1|Overall Study|Decline in performance status|1
3032360|NCT00725764|10426915|P1|Overall Study|Participant non compliant with protocol|1
3032361|NCT00725764|10426915|P1|Overall Study|Death|1
3032362|NCT00725764|10426915|P1|Overall Study|Lost to Follow-up|1
3032363|NCT00725764|10426915|P1|Overall Study|Progressive Disease|7
3032364|NCT00725764|10426915|P1|Overall Study|Physician Decision|1
3032365|NCT00725764|10426915|P1|Overall Study|Withdrawal by Subject|2
3032366|NCT00725725|10426948|P3|Overall Study|Protocol Violation|0
3032367|NCT00725725|10426949|P2|Overall Study|Protocol Violation|1
3032368|NCT00725725|10426950|P1|Overall Study|Protocol Violation|0
3032369|NCT00725725|10426948|P3|Overall Study|Withdrawal by Subject|1
3032370|NCT00725725|10426949|P2|Overall Study|Withdrawal by Subject|0
3032371|NCT00725725|10426950|P1|Overall Study|Withdrawal by Subject|1
3032372|NCT00725725|10426948|P3|Overall Study|Lost to Follow-up|2
3032373|NCT00725725|10426949|P2|Overall Study|Lost to Follow-up|0
3032374|NCT00725725|10426950|P1|Overall Study|Lost to Follow-up|2
3032375|NCT00725725|10426948|P3|Overall Study|Adverse Event|2
3032376|NCT00725725|10426949|P2|Overall Study|Adverse Event|3
3032377|NCT00725725|10426950|P1|Overall Study|Adverse Event|1
3032378|NCT00725712|10426993|P2|Overall Study|Hospitalized, unable to continue|1
3032379|NCT00725712|10426994|P1|Overall Study|Hospitalized, unable to continue|0
3032380|NCT00725712|10426993|P2|Overall Study|Other: Death|0
3032381|NCT00725712|10426994|P1|Overall Study|Other: Death|1
3032382|NCT00725712|10426993|P2|Overall Study|Death|0
3032383|NCT00725712|10426994|P1|Overall Study|Death|2
3032384|NCT00725712|10426993|P2|Overall Study|Adverse Event|5
3032385|NCT00725712|10426994|P1|Overall Study|Adverse Event|5
3032386|NCT00725712|10426993|P2|Overall Study|Clinical progression not based on RECIST|3
3032387|NCT00725712|10426994|P1|Overall Study|Clinical progression not based on RECIST|0
3032388|NCT00725712|10426993|P2|Overall Study|Progressive disease|16
3032389|NCT00725712|10426994|P1|Overall Study|Progressive disease|37
3032390|NCT00725712|10426993|P2|Overall Study|Protocol Violation|0
3032391|NCT00725712|10426994|P1|Overall Study|Protocol Violation|1
3032392|NCT00725712|10426993|P2|Overall Study|Withdrawal by Subject|1
3032393|NCT00725712|10426994|P1|Overall Study|Withdrawal by Subject|2
3032394|NCT00725621|10427030|P1|Overall Study|Reason not specified|55
3032395|NCT00725621|10427030|P1|Overall Study|Prepared for elective surgery|1
3032396|NCT00725621|10427030|P1|Overall Study|Switched to other drug|1
3032397|NCT00725621|10427030|P1|Overall Study|Switched to other study|1
3032398|NCT00725621|10427030|P1|Overall Study|Continued treatment by other physician|6
3032399|NCT00725621|10427030|P1|Overall Study|Non-compliance|8
3032400|NCT00725621|10427030|P1|Overall Study|Lost to Follow-up|52
3032401|NCT00725621|10427030|P1|Overall Study|Physician Decision|19
3032402|NCT00725621|10427030|P1|Overall Study|Withdrawal by Subject|57
3032403|NCT00725621|10427030|P1|Overall Study|Lack of Efficacy|46
3032404|NCT00725621|10427030|P1|Overall Study|Adverse Event|25
3032405|NCT00725608|10427053|P1|Overall Study|Other|7
3032406|NCT00725608|10427053|P1|Overall Study|Individual reasons|86
3032407|NCT00725608|10427053|P1|Overall Study|Adverse Event|14
3032408|NCT00725608|10427053|P1|Overall Study|Lost to Follow-up|60
3032409|NCT00725543|10427059|P1|Overall Study|Other|119
3032410|NCT00725543|10427059|P1|Overall Study|Non-compliance|2
3032411|NCT00725543|10427059|P1|Overall Study|Lost to Follow-up|4
3032412|NCT00725543|10427059|P1|Overall Study|Physician Decision|5
3032413|NCT00725543|10427059|P1|Overall Study|Withdrawal by Subject|10
3032414|NCT00725543|10427059|P1|Overall Study|Lack of Efficacy|3
3032415|NCT00725543|10427059|P1|Overall Study|Adverse Event|10
3032416|NCT00725491|10427084|P2|Overall Study|No/too few embryos/ bad quality embryos|2
3032417|NCT00725491|10427085|P1|Overall Study|No/too few embryos/ bad quality embryos|3
3032418|NCT00725491|10427084|P2|Overall Study|Fertilization failure|1
3032419|NCT00725491|10427085|P1|Overall Study|Fertilization failure|0
3032420|NCT00725491|10427084|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
3032421|NCT00725491|10427085|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
3032422|NCT00725491|10427084|P2|Overall Study|Risk for hyperstimulation|9
3032423|NCT00725491|10427085|P1|Overall Study|Risk for hyperstimulation|2
3032424|NCT00725491|10427084|P2|Overall Study|Pregnancy|3
3032425|NCT00725491|10427085|P1|Overall Study|Pregnancy|0
3032426|NCT00725491|10427084|P2|Overall Study|Adverse Event|2
3032427|NCT00725491|10427085|P1|Overall Study|Adverse Event|3
3032428|NCT00725452|10427091|P1|Overall Study|Lost to Follow-up|1
3032429|NCT00725452|10427091|P1|Overall Study|Withdrawal by Subject|3
3032430|NCT00725452|10427091|P1|Overall Study|Physician Decision|1
3032431|NCT00725452|10427091|P1|Overall Study|Reason not specified|1
3032432|NCT00725452|10427091|P1|Overall Study|Lack of Efficacy|2
3032433|NCT00725452|10427091|P1|Overall Study|Adverse Event|3
3032434|NCT00725322|10427110|P2|Washout (28 Days)|Protocol Violation|1
3032435|NCT00725322|10427111|P1|Washout (28 Days)|Protocol Violation|0
3032436|NCT00725322|10427110|P2|Washout (28 Days)|Withdrawal by Subject|0
3032437|NCT00725322|10427111|P1|Washout (28 Days)|Withdrawal by Subject|2
3032438|NCT00725296|10427119|P1|Overall Study|Other|38
3032439|NCT00725296|10427119|P1|Overall Study|Lost to Follow-up|1
3032440|NCT00725296|10427119|P1|Overall Study|Non-Compliance|2
3032441|NCT00725296|10427119|P1|Overall Study|Withdrawal by Subject|3
3032442|NCT00725296|10427119|P1|Overall Study|Lack of Efficacy|7
3032443|NCT00725296|10427119|P1|Overall Study|Adverse Event|11
3032444|NCT00725283|10427128|P1|Overall Study|Withdrawal by Subject|10
3032445|NCT00725283|10427128|P1|Overall Study|Other|6
3032446|NCT00725283|10427128|P1|Overall Study|Death|5
3032447|NCT00725283|10427128|P1|Overall Study|Missing Code|3
3032448|NCT00725205|10427149|P1|Overall Study|Treatment Failure|41
3032449|NCT00725205|10427149|P1|Overall Study|Protocol Defined Clinical Event|1
3032450|NCT00725205|10427149|P1|Overall Study|Other|8
3032451|NCT00725205|10427149|P1|Overall Study|Non-compliance With Protocol|14
3032452|NCT00725205|10427149|P1|Overall Study|Investigator Discontinued|1
3032453|NCT00725205|10427149|P1|Overall Study|Adverse Event|22
3032454|NCT00725101|10427162|P1|Overall Study|not specified/no reason given|11
3032455|NCT00725101|10427162|P1|Overall Study|Withdrawal by Subject|127
3032456|NCT00725101|10427162|P1|Overall Study|Protocol Violation|1
3032457|NCT00725101|10427162|P1|Overall Study|Lost to Follow-up|353
3032458|NCT00725101|10427162|P1|Overall Study|Death|3
3032459|NCT00725075|10427185|P3|Overall Study|Other|0
3032460|NCT00725075|10427186|P2|Overall Study|Other|0
3032461|NCT00725075|10427187|P1|Overall Study|Other|1
3032462|NCT00725075|10427185|P3|Overall Study|Inclusion/Exclusion Criteria|1
3032463|NCT00725075|10427186|P2|Overall Study|Inclusion/Exclusion Criteria|0
3032464|NCT00725075|10427187|P1|Overall Study|Inclusion/Exclusion Criteria|1
3032465|NCT00725075|10427185|P3|Overall Study|Worsening of Disease|2
3032466|NCT00725075|10427186|P2|Overall Study|Worsening of Disease|1
3032467|NCT00725075|10427187|P1|Overall Study|Worsening of Disease|2
3032468|NCT00725075|10427185|P3|Overall Study|Adverse Event|1
3032469|NCT00725075|10427186|P2|Overall Study|Adverse Event|1
3032470|NCT00725075|10427187|P1|Overall Study|Adverse Event|2
3032471|NCT00725075|10427185|P3|Overall Study|Withdrawal by Subject|4
3032472|NCT00725075|10427186|P2|Overall Study|Withdrawal by Subject|5
3032473|NCT00725075|10427187|P1|Overall Study|Withdrawal by Subject|4
3032474|NCT00725075|10427185|P3|Overall Study|Lost to Follow-up|0
3032475|NCT00725075|10427186|P2|Overall Study|Lost to Follow-up|0
3032476|NCT00725075|10427187|P1|Overall Study|Lost to Follow-up|1
3032477|NCT00725075|10427185|P3|Overall Study|Protocol Violation|1
3032478|NCT00725075|10427186|P2|Overall Study|Protocol Violation|0
3032479|NCT00725075|10427187|P1|Overall Study|Protocol Violation|0
3032480|NCT00725075|10427185|P3|Overall Study|Use of Excluded Medication|0
3032481|NCT00725075|10427186|P2|Overall Study|Use of Excluded Medication|1
3032482|NCT00725075|10427187|P1|Overall Study|Use of Excluded Medication|0
3032483|NCT00725010|10427240|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
3032484|NCT00725010|10427240|P1|Overall Study|No further documentation|1
3032485|NCT00725010|10427240|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
3032486|NCT00725010|10427240|P1|Overall Study|Hepatopathy probably not Temodal-related|1
3032487|NCT00725010|10427240|P1|Overall Study|Lost to Follow-up|1
3032488|NCT00725010|10427240|P1|Overall Study|Death|1
3032489|NCT00725010|10427240|P1|Overall Study|Withdrawal by Subject|2
3032490|NCT00725010|10427240|P1|Overall Study|Tumor Progression|7
3032491|NCT00725010|10427240|P1|Overall Study|Toxicity|9
3032492|NCT00724971|10427273|P1|Overall Study|Withdrawal by Subject|1
3032493|NCT00724971|10427273|P1|Overall Study|Adverse Event|5
3032494|NCT00724958|10427288|P1|Overall Study|No documentation for end of therapy|13
3032495|NCT00724958|10427288|P1|Overall Study|Other Reason|76
3032496|NCT00724958|10427288|P1|Overall Study|Remission|7
3032497|NCT00724958|10427288|P1|Overall Study|No Response|18
3032498|NCT00724958|10427288|P1|Overall Study|Loss of Response|40
3032499|NCT00724958|10427288|P1|Overall Study|Adverse Event|28
3032500|NCT00724945|10427297|P2|Period 2|lens physiology issue|0
3032501|NCT00724945|10427298|P1|Period 2|lens physiology issue|1
3032502|NCT00724945|10427297|P2|Period 2|lens comfort issue|0
3032503|NCT00724945|10427298|P1|Period 2|lens comfort issue|3
3032504|NCT00724945|10427297|P2|Period 1|Lost to Follow-up|0
3032505|NCT00724945|10427298|P1|Period 1|Lost to Follow-up|1
3032506|NCT00724945|10427297|P2|Period 1|Adverse Event|1
3032507|NCT00724945|10427298|P1|Period 1|Adverse Event|1
3032508|NCT00724945|10427297|P2|Period 1|non-compliance|0
3032509|NCT00724945|10427298|P1|Period 1|non-compliance|1
3032510|NCT00724932|10427310|P2|Overall Study|Not treated|3
3032511|NCT00724932|10427311|P1|Overall Study|Not treated|4
3032512|NCT00724932|10427310|P2|Overall Study|Lost to Follow-up|0
3032513|NCT00724932|10427311|P1|Overall Study|Lost to Follow-up|1
3032514|NCT00724893|10427382|P2|Overall Study|Unknown, missing data|1
3032515|NCT00724893|10427383|P1|Overall Study|Unknown, missing data|1
3032516|NCT00724893|10427382|P2|Overall Study|Lost to Follow-up|52
3032517|NCT00724893|10427383|P1|Overall Study|Lost to Follow-up|0
3032518|NCT00724893|10427382|P2|Overall Study|Assigned shorter treatment|2
3032519|NCT00724893|10427383|P1|Overall Study|Assigned shorter treatment|0
3032520|NCT00724893|10427382|P2|Overall Study|Financial reasons|2
3032521|NCT00724893|10427383|P1|Overall Study|Financial reasons|0
3032522|NCT00724893|10427382|P2|Overall Study|Substance abuse|3
3032523|NCT00724893|10427383|P1|Overall Study|Substance abuse|0
3032524|NCT00724893|10427382|P2|Overall Study|Incarceration|9
3032525|NCT00724893|10427383|P1|Overall Study|Incarceration|0
3032526|NCT00724893|10427382|P2|Overall Study|Geographic reasons|11
3032527|NCT00724893|10427383|P1|Overall Study|Geographic reasons|0
3032528|NCT00724893|10427382|P2|Overall Study|Patient choice|26
3032529|NCT00724893|10427383|P1|Overall Study|Patient choice|0
3032530|NCT00724893|10427382|P2|Overall Study|Reason not specified|7
3032531|NCT00724893|10427383|P1|Overall Study|Reason not specified|193
3032532|NCT00724893|10427382|P2|Overall Study|Lack of virologic response|202
3032533|NCT00724893|10427383|P1|Overall Study|Lack of virologic response|94
3032534|NCT00724893|10427382|P2|Overall Study|Withdrawal by Subject|1
3032535|NCT00724893|10427383|P1|Overall Study|Withdrawal by Subject|0
3032536|NCT00724893|10427382|P2|Overall Study|Adverse Event|142
3032537|NCT00724893|10427383|P1|Overall Study|Adverse Event|76
3032538|NCT00724867|10427451|P1|Overall Study|Elected to exit due to site closure|2
3032539|NCT00724867|10427451|P1|Overall Study|Subject moved out of state|1
3032540|NCT00724867|10427451|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
3032541|NCT00724867|10427451|P1|Overall Study|Subject incarcerated|1
3032542|NCT00724867|10427451|P1|Overall Study|Sponsor decision to end study|14
3032543|NCT00724867|10427451|P1|Overall Study|Withdrawal by Subject|31
3032544|NCT00724867|10427451|P1|Overall Study|Protocol Violation|1
3032545|NCT00724867|10427451|P1|Overall Study|Physician Decision|17
3032546|NCT00724867|10427451|P1|Overall Study|Non-compliance with study drug|6
3032547|NCT00724867|10427451|P1|Overall Study|Lost to Follow-up|12
3032548|NCT00724867|10427451|P1|Overall Study|Lack of Efficacy|14
3032549|NCT00724867|10427451|P1|Overall Study|Adverse Event|25
3032550|NCT00724854|10427491|P2|Overall Study|Adverse event + lack of efficacy|1
3032551|NCT00724854|10427492|P1|Overall Study|Adverse event + lack of efficacy|2
3032552|NCT00724854|10427491|P2|Overall Study|Withdrawal by Subject|0
3032553|NCT00724854|10427492|P1|Overall Study|Withdrawal by Subject|5
3032554|NCT00724854|10427491|P2|Overall Study|Change of treatment|0
3032555|NCT00724854|10427492|P1|Overall Study|Change of treatment|7
3032556|NCT00724854|10427491|P2|Overall Study|Death|0
3032557|NCT00724854|10427492|P1|Overall Study|Death|11
3032558|NCT00724854|10427491|P2|Overall Study|Other|3
3032559|NCT00724854|10427492|P1|Overall Study|Other|42
3032560|NCT00724854|10427491|P2|Overall Study|Adverse Event|4
3032561|NCT00724854|10427492|P1|Overall Study|Adverse Event|62
3032562|NCT00724854|10427491|P2|Overall Study|Lost to Follow-up|10
3032563|NCT00724854|10427492|P1|Overall Study|Lost to Follow-up|87
3032564|NCT00724854|10427491|P2|Overall Study|Lack of Efficacy|13
3032565|NCT00724854|10427492|P1|Overall Study|Lack of Efficacy|187
3032566|NCT00724815|10427509|P2|Overall Study|Other Various|5
3032567|NCT00724815|10427510|P1|Overall Study|Other Various|3
3032568|NCT00724815|10427509|P2|Overall Study|Lost to Follow-up|1
3032569|NCT00724815|10427510|P1|Overall Study|Lost to Follow-up|4
3032570|NCT00724815|10427509|P2|Overall Study|Adverse Event|3
3032571|NCT00724815|10427510|P1|Overall Study|Adverse Event|5
3032572|NCT00724815|10427509|P2|Overall Study|Randomized, not treated|30
3032573|NCT00724815|10427510|P1|Overall Study|Randomized, not treated|31
3032574|NCT00724711|10427543|P2|Overall Study|Protocol Violation|0
3032575|NCT00724711|10427544|P1|Overall Study|Protocol Violation|1
3032576|NCT00724711|10427543|P2|Overall Study|Lost to Follow-up|5
3032577|NCT00724711|10427544|P1|Overall Study|Lost to Follow-up|4
3032578|NCT00724711|10427543|P2|Overall Study|Withdrawal by Subject|4
3032579|NCT00724711|10427544|P1|Overall Study|Withdrawal by Subject|5
3032580|NCT00724711|10427543|P2|Overall Study|Physician Decision|3
3032581|NCT00724711|10427544|P1|Overall Study|Physician Decision|0
3032582|NCT00724711|10427543|P2|Overall Study|Lack of Efficacy|1
3032583|NCT00724711|10427544|P1|Overall Study|Lack of Efficacy|0
3032584|NCT00724711|10427543|P2|Overall Study|Pregnancy|1
3032585|NCT00724711|10427544|P1|Overall Study|Pregnancy|0
3032586|NCT00724711|10427543|P2|Overall Study|Adverse Event|3
3032587|NCT00724711|10427544|P1|Overall Study|Adverse Event|7
3032588|NCT00724698|10427576|P1|Overall Study|No Info|25
3032589|NCT00724698|10427576|P1|Overall Study|Lost to Follow-up|36
3032590|NCT00724698|10427576|P1|Overall Study|Poor Compliance|16
3032591|NCT00724698|10427576|P1|Overall Study|Failure of Therapy|4
3032592|NCT00724698|10427576|P1|Overall Study|Adverse Event|9
3032593|NCT00724503|10427629|P2|Overall Study|Not otherwise specified|7
3032594|NCT00724503|10427630|P1|Overall Study|Not otherwise specified|4
3032595|NCT00724503|10427629|P2|Overall Study|Adverse Event|0
3032596|NCT00724503|10427630|P1|Overall Study|Adverse Event|1
3032597|NCT00724503|10427629|P2|Overall Study|Death|182
3032598|NCT00724503|10427630|P1|Overall Study|Death|190
3032599|NCT00724503|10427629|P2|Overall Study|Withdrawal by Subject|23
3032600|NCT00724503|10427630|P1|Overall Study|Withdrawal by Subject|11
3032601|NCT00724503|10427629|P2|Overall Study|Lost to Follow-up|8
3032602|NCT00724503|10427630|P1|Overall Study|Lost to Follow-up|4
3032603|NCT00724451|10427654|P1|Overall Study|Investigator + Participant Decision|13
3032604|NCT00724451|10427654|P1|Overall Study|Withdrawal by Subject|45
3032605|NCT00724451|10427654|P1|Overall Study|Physician Decision|116
3032606|NCT00724451|10427654|P1|Overall Study|Unknown; No Data Sources Available|9
3032607|NCT00724451|10427654|P1|Overall Study|Never Started Treatment|89
3032608|NCT00724451|10427654|P1|Overall Study|Participant Refused Treatment|89
3032609|NCT00724451|10427654|P1|Overall Study|Not Eligible for Treatment|431
3032610|NCT00724451|10427654|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
3032611|NCT00724451|10427654|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
3032612|NCT00724373|10427660|P1|Overall Study|Tolerability|23
3032613|NCT00724373|10427660|P1|Overall Study|Drug Relapse|1
3032614|NCT00724373|10427660|P1|Overall Study|Acute HCV infection|1
3032615|NCT00724373|10427660|P1|Overall Study|Viral Relapse|1
3032616|NCT00724373|10427660|P1|Overall Study|Only to have 24 week regimen|1
3032617|NCT00724373|10427660|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
3032618|NCT00724373|10427660|P1|Overall Study|Participant moved away|1
3032619|NCT00724373|10427660|P1|Overall Study|HCV RNA negative after 4 weeks|9
3032620|NCT00724373|10427660|P1|Overall Study|Non-compliance|2
3032621|NCT00724373|10427660|P1|Overall Study|Lost to Follow-up|7
3032622|NCT00724373|10427660|P1|Overall Study|Lack of Efficacy|82
3032623|NCT00724373|10427660|P1|Overall Study|Adverse Event|41
3032624|NCT00724282|10427677|P1|Overall Study|Physician Decision|1
3032625|NCT00724282|10427677|P1|Overall Study|Withdrawal by Subject|3
3032626|NCT00724243|10427681|P1|Overall Study|Adverse Event|5
3032627|NCT00724243|10427681|P1|Overall Study|Lack of Efficacy|10
3032628|NCT00724152|10427691|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
3032629|NCT00724152|10427692|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
3032630|NCT00724152|10427693|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
3032631|NCT00724152|10427691|P3|Two-arm Study Period|Withdrawal by Subject|0
3032632|NCT00724152|10427692|P2|Two-arm Study Period|Withdrawal by Subject|2
3032633|NCT00724152|10427693|P1|Two-arm Study Period|Withdrawal by Subject|3
3032634|NCT00724126|10427710|P2|Overall Study|Subject had to leave vicinity of site|1
3032635|NCT00724126|10427711|P1|Overall Study|Subject had to leave vicinity of site|0
3032636|NCT00724126|10427710|P2|Overall Study|Subject randomized although ineligible|1
3032637|NCT00724126|10427711|P1|Overall Study|Subject randomized although ineligible|1
3032638|NCT00724126|10427710|P2|Overall Study|Noncompliance|1
3032639|NCT00724126|10427711|P1|Overall Study|Noncompliance|2
3032640|NCT00724126|10427710|P2|Overall Study|Lost to Follow-up|6
3032641|NCT00724126|10427711|P1|Overall Study|Lost to Follow-up|6
3032642|NCT00724126|10427710|P2|Overall Study|Withdrawal by Subject|6
3032643|NCT00724126|10427711|P1|Overall Study|Withdrawal by Subject|8
3032644|NCT00724126|10427710|P2|Overall Study|Adverse Event|0
3032645|NCT00724126|10427711|P1|Overall Study|Adverse Event|2
3032646|NCT00724061|10427719|P1|Dose Escalation Phase|Disease Progression|3
3032647|NCT00724061|10427719|P1|Dose Escalation Phase|Adverse Event|2
3032648|NCT00723957|10427739|P2|Overall Study|Never received treatment|3
3032649|NCT00723957|10427740|P1|Overall Study|Never received treatment|3
3032650|NCT00723957|10427739|P2|Overall Study|Reason not analyzed|0
3032651|NCT00723957|10427740|P1|Overall Study|Reason not analyzed|1
3032652|NCT00723957|10427739|P2|Overall Study|Withdrawal by Subject|5
3032653|NCT00723957|10427740|P1|Overall Study|Withdrawal by Subject|7
3032654|NCT00723957|10427739|P2|Overall Study|Study drug toxicity|6
3032655|NCT00723957|10427740|P1|Overall Study|Study drug toxicity|4
3032656|NCT00723957|10427739|P2|Overall Study|Investigator decision|1
3032657|NCT00723957|10427740|P1|Overall Study|Investigator decision|1
3032658|NCT00723957|10427739|P2|Overall Study|Maximum clinical benefit|5
3032659|NCT00723957|10427740|P1|Overall Study|Maximum clinical benefit|4
3032660|NCT00723957|10427739|P2|Overall Study|Disease progression|25
3032661|NCT00723957|10427740|P1|Overall Study|Disease progression|27
3032662|NCT00723957|10427739|P2|Overall Study|Death|4
3032663|NCT00723957|10427740|P1|Overall Study|Death|3
3032664|NCT00723957|10427739|P2|Overall Study|Adverse event unrelated to study drug|4
3032665|NCT00723957|10427740|P1|Overall Study|Adverse event unrelated to study drug|1
3032666|NCT00723944|10427764|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
3032667|NCT00723944|10427765|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
3032668|NCT00723944|10427764|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
3032669|NCT00723944|10427765|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
3032670|NCT00723944|10427764|P2|Permanent Prosthesis Placement|Adverse Event|7
3032671|NCT00723944|10427765|P1|Permanent Prosthesis Placement|Adverse Event|1
3032672|NCT00723892|10427778|P2|Overall Study|Drug addiction|0
3032673|NCT00723892|10427779|P1|Overall Study|Drug addiction|1
3032674|NCT00723892|10427778|P2|Overall Study|Intercurrent infection|0
3032675|NCT00723892|10427779|P1|Overall Study|Intercurrent infection|2
3032676|NCT00723892|10427778|P2|Overall Study|Alcohol abuse|1
3032677|NCT00723892|10427779|P1|Overall Study|Alcohol abuse|0
3032678|NCT00723892|10427778|P2|Overall Study|Weight loss|3
3032679|NCT00723892|10427779|P1|Overall Study|Weight loss|1
3032680|NCT00723892|10427778|P2|Overall Study|Study end|3
3032681|NCT00723892|10427779|P1|Overall Study|Study end|1
3032682|NCT00723892|10427778|P2|Overall Study|Other|3
3032683|NCT00723892|10427779|P1|Overall Study|Other|6
3032684|NCT00723892|10427778|P2|Overall Study|Multiple reasons|12
3032685|NCT00723892|10427779|P1|Overall Study|Multiple reasons|17
3032686|NCT00723892|10427778|P2|Overall Study|Bad tolerance|5
3032687|NCT00723892|10427779|P1|Overall Study|Bad tolerance|5
3032688|NCT00723892|10427778|P2|Overall Study|End planned|7
3032689|NCT00723892|10427779|P1|Overall Study|End planned|11
3032690|NCT00723892|10427778|P2|Overall Study|Withdrawal by Subject|9
3032691|NCT00723892|10427779|P1|Overall Study|Withdrawal by Subject|6
3032692|NCT00723892|10427778|P2|Overall Study|Virological criterion|9
3032693|NCT00723892|10427779|P1|Overall Study|Virological criterion|24
3032694|NCT00723892|10427778|P2|Overall Study|Participant not tracked|35
3032695|NCT00723892|10427779|P1|Overall Study|Participant not tracked|33
3032696|NCT00723840|10427786|P1|Overall Study|Unspecified reason|2
3032697|NCT00723840|10427786|P1|Overall Study|Other Medical Event|2
3032698|NCT00723840|10427786|P1|Overall Study|Serious Adverse Events|3
3032699|NCT00723840|10427786|P1|Overall Study|Withdrawal by Subject|55
3032700|NCT00723840|10427786|P1|Overall Study|Failure to return|18
3032701|NCT00723840|10427786|P1|Overall Study|Lost to Follow-up|2
3032702|NCT00723801|10427807|P2|Overall Study|Protocol Violation|1
3032703|NCT00723801|10427808|P1|Overall Study|Protocol Violation|2
3032704|NCT00723801|10427807|P2|Overall Study|Lost to Follow-up|2
3032705|NCT00723801|10427808|P1|Overall Study|Lost to Follow-up|1
3032706|NCT00723710|10427833|P1|Overall Study|Physician Decision|2
3032707|NCT00723710|10427833|P1|Overall Study|Withdrawal by Subject|36
3032708|NCT00723710|10427833|P1|Overall Study|Adverse Event|88
3032709|NCT00723710|10427833|P1|Overall Study|Disease progression|48
3032710|NCT00723697|10427837|P1|Overall Study|Other exclusion criteria applied|6
3032711|NCT00723697|10427837|P1|Overall Study|Missing Informed Consent Form|10
3032712|NCT00723697|10427837|P1|Overall Study|Physician questionnaires not received|2
3032713|NCT00723606|10427858|P2|Overall Study|Withdrawal by Subject|2
3032714|NCT00723606|10427859|P1|Overall Study|Withdrawal by Subject|0
3032715|NCT00723606|10427858|P2|Overall Study|Other|0
3032716|NCT00723606|10427859|P1|Overall Study|Other|2
3032717|NCT00723606|10427858|P2|Overall Study|Adverse Event|5
3032718|NCT00723606|10427859|P1|Overall Study|Adverse Event|2
3032719|NCT00723554|10427879|P1|Overall Study|Non-compliance|1
3032720|NCT00723554|10427879|P1|Overall Study|Lost to Follow-up|1
3032721|NCT00723554|10427879|P1|Overall Study|Other|3
3032722|NCT00723554|10427879|P1|Overall Study|Withdrawal of consent|3
3032723|NCT00723554|10427879|P1|Overall Study|Inhaled medication other than iloprost|4
3032724|NCT00723554|10427879|P1|Overall Study|Investigator's judgement|5
3032725|NCT00723554|10427879|P1|Overall Study|Adverse Event|12
3032726|NCT00723528|10427929|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
3032727|NCT00723528|10427930|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032728|NCT00723528|10427931|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032729|NCT00723528|10427932|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032730|NCT00723528|10427933|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032731|NCT00723528|10427934|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032732|NCT00723528|10427935|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
3032733|NCT00723528|10427929|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
3032734|NCT00723528|10427930|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032735|NCT00723528|10427931|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032736|NCT00723528|10427932|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032737|NCT00723528|10427933|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032738|NCT00723528|10427934|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032739|NCT00723528|10427935|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
3032740|NCT00723528|10427929|P7|Period 2: After Controlled Period|Adverse Event|1
3032741|NCT00723528|10427930|P6|Period 2: After Controlled Period|Adverse Event|0
3032742|NCT00723528|10427931|P5|Period 2: After Controlled Period|Adverse Event|1
3032743|NCT00723528|10427932|P4|Period 2: After Controlled Period|Adverse Event|0
3032744|NCT00723528|10427933|P3|Period 2: After Controlled Period|Adverse Event|0
3032745|NCT00723528|10427934|P2|Period 2: After Controlled Period|Adverse Event|0
3032746|NCT00723528|10427935|P1|Period 2: After Controlled Period|Adverse Event|0
3032747|NCT00723528|10427929|P7|Period 2: After Controlled Period|Other|0
3032748|NCT00723528|10427930|P6|Period 2: After Controlled Period|Other|4
3032749|NCT00723528|10427931|P5|Period 2: After Controlled Period|Other|1
3032750|NCT00723528|10427932|P4|Period 2: After Controlled Period|Other|0
3032751|NCT00723528|10427933|P3|Period 2: After Controlled Period|Other|0
3032752|NCT00723528|10427934|P2|Period 2: After Controlled Period|Other|0
3032753|NCT00723528|10427935|P1|Period 2: After Controlled Period|Other|0
3032754|NCT00723528|10427929|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032755|NCT00723528|10427930|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
3032756|NCT00723528|10427931|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032757|NCT00723528|10427932|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032758|NCT00723528|10427933|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032759|NCT00723528|10427934|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032760|NCT00723528|10427935|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
3032761|NCT00723528|10427929|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
3032762|NCT00723528|10427930|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
3032763|NCT00723528|10427931|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
3032764|NCT00723528|10427932|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
3032765|NCT00723528|10427933|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
3032766|NCT00723528|10427934|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
3032767|NCT00723528|10427935|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
3032768|NCT00723528|10427929|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
3032769|NCT00723528|10427930|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
3032770|NCT00723528|10427931|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
3032771|NCT00723528|10427932|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
3032772|NCT00723528|10427933|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
3032773|NCT00723528|10427934|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
3032774|NCT00723528|10427935|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
3032775|NCT00723528|10427929|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032776|NCT00723528|10427930|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032777|NCT00723528|10427931|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032778|NCT00723528|10427932|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032779|NCT00723528|10427933|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
3032780|NCT00723528|10427934|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032781|NCT00723528|10427935|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
3032782|NCT00723528|10427929|P7|Period 1: Controlled Period (CP)|Physician Decision|0
3032783|NCT00723528|10427930|P6|Period 1: Controlled Period (CP)|Physician Decision|0
3032784|NCT00723528|10427931|P5|Period 1: Controlled Period (CP)|Physician Decision|0
3032785|NCT00723528|10427932|P4|Period 1: Controlled Period (CP)|Physician Decision|0
3032786|NCT00723528|10427933|P3|Period 1: Controlled Period (CP)|Physician Decision|1
3032787|NCT00723528|10427934|P2|Period 1: Controlled Period (CP)|Physician Decision|0
3032788|NCT00723528|10427935|P1|Period 1: Controlled Period (CP)|Physician Decision|0
3032789|NCT00723528|10427929|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032790|NCT00723528|10427930|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032791|NCT00723528|10427931|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032792|NCT00723528|10427932|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032793|NCT00723528|10427933|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032880|NCT00723398|10428078|P3|Overall Study|Protocol Violation|5
3032794|NCT00723528|10427934|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
3032795|NCT00723528|10427935|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
3032796|NCT00723528|10427929|P7|Period 1: Controlled Period (CP)|Adverse Event|0
3032797|NCT00723528|10427930|P6|Period 1: Controlled Period (CP)|Adverse Event|0
3032798|NCT00723528|10427931|P5|Period 1: Controlled Period (CP)|Adverse Event|0
3032799|NCT00723528|10427932|P4|Period 1: Controlled Period (CP)|Adverse Event|0
3032800|NCT00723528|10427933|P3|Period 1: Controlled Period (CP)|Adverse Event|1
3032801|NCT00723528|10427934|P2|Period 1: Controlled Period (CP)|Adverse Event|0
3032802|NCT00723528|10427935|P1|Period 1: Controlled Period (CP)|Adverse Event|0
3032803|NCT00723489|10427997|P4|Overall Study|Samples Collected Out of Window|0
3032804|NCT00723489|10427998|P3|Overall Study|Samples Collected Out of Window|0
3032805|NCT00723489|10427999|P2|Overall Study|Samples Collected Out of Window|3
3032806|NCT00723489|10428000|P1|Overall Study|Samples Collected Out of Window|0
3032807|NCT00723489|10427997|P4|Overall Study|Prohibited Medication|1
3032808|NCT00723489|10427998|P3|Overall Study|Prohibited Medication|0
3032809|NCT00723489|10427999|P2|Overall Study|Prohibited Medication|0
3032810|NCT00723489|10428000|P1|Overall Study|Prohibited Medication|0
3032811|NCT00723489|10427997|P4|Overall Study|Seropositive at baseline|0
3032812|NCT00723489|10427998|P3|Overall Study|Seropositive at baseline|0
3032813|NCT00723489|10427999|P2|Overall Study|Seropositive at baseline|0
3032814|NCT00723489|10428000|P1|Overall Study|Seropositive at baseline|1
3032815|NCT00723489|10427997|P4|Overall Study|Withdrawal by Subject|1
3032816|NCT00723489|10427998|P3|Overall Study|Withdrawal by Subject|0
3032817|NCT00723489|10427999|P2|Overall Study|Withdrawal by Subject|0
3032818|NCT00723489|10428000|P1|Overall Study|Withdrawal by Subject|0
3032819|NCT00723489|10427997|P4|Overall Study|Pregnancy|1
3032820|NCT00723489|10427998|P3|Overall Study|Pregnancy|0
3032821|NCT00723489|10427999|P2|Overall Study|Pregnancy|0
3032822|NCT00723489|10428000|P1|Overall Study|Pregnancy|0
3032823|NCT00723489|10427997|P4|Overall Study|Physician Decision|0
3032824|NCT00723489|10427998|P3|Overall Study|Physician Decision|0
3032825|NCT00723489|10427999|P2|Overall Study|Physician Decision|1
3032826|NCT00723489|10428000|P1|Overall Study|Physician Decision|0
3032827|NCT00723450|10428028|P3|Randomized Phase|Withdrawal by Subject|22
3032828|NCT00723450|10428029|P2|Randomized Phase|Withdrawal by Subject|14
3032829|NCT00723450|10428030|P1|Randomized Phase|Withdrawal by Subject|0
3032830|NCT00723450|10428028|P3|Randomized Phase|Physician Decision|1
3032831|NCT00723450|10428029|P2|Randomized Phase|Physician Decision|3
3032832|NCT00723450|10428030|P1|Randomized Phase|Physician Decision|0
3032833|NCT00723450|10428028|P3|Randomized Phase|Lost to Follow-up|3
3032834|NCT00723450|10428029|P2|Randomized Phase|Lost to Follow-up|2
3032835|NCT00723450|10428030|P1|Randomized Phase|Lost to Follow-up|0
3032836|NCT00723450|10428028|P3|Randomized Phase|Protocol Violation|13
3032837|NCT00723450|10428029|P2|Randomized Phase|Protocol Violation|9
3032838|NCT00723450|10428030|P1|Randomized Phase|Protocol Violation|0
3032839|NCT00723450|10428028|P3|Randomized Phase|Lack of Efficacy|11
3032840|NCT00723450|10428029|P2|Randomized Phase|Lack of Efficacy|11
3032841|NCT00723450|10428030|P1|Randomized Phase|Lack of Efficacy|0
3032842|NCT00723450|10428028|P3|Randomized Phase|Adverse Event|17
3032843|NCT00723450|10428029|P2|Randomized Phase|Adverse Event|26
3032844|NCT00723450|10428030|P1|Randomized Phase|Adverse Event|0
3032845|NCT00723450|10428028|P3|Open-Label Phase|Withdrawal by Subject|0
3032846|NCT00723450|10428029|P2|Open-Label Phase|Withdrawal by Subject|0
3032847|NCT00723450|10428030|P1|Open-Label Phase|Withdrawal by Subject|37
3032848|NCT00723450|10428028|P3|Open-Label Phase|Physician Decision|0
3032849|NCT00723450|10428029|P2|Open-Label Phase|Physician Decision|0
3032850|NCT00723450|10428030|P1|Open-Label Phase|Physician Decision|2
3032851|NCT00723450|10428028|P3|Open-Label Phase|Lost to Follow-up|0
3032852|NCT00723450|10428029|P2|Open-Label Phase|Lost to Follow-up|0
3032853|NCT00723450|10428030|P1|Open-Label Phase|Lost to Follow-up|7
3032854|NCT00723450|10428028|P3|Open-Label Phase|Protocol Violation|0
3032855|NCT00723450|10428029|P2|Open-Label Phase|Protocol Violation|0
3032856|NCT00723450|10428030|P1|Open-Label Phase|Protocol Violation|35
3032857|NCT00723450|10428028|P3|Open-Label Phase|Lack of Efficacy|0
3032858|NCT00723450|10428029|P2|Open-Label Phase|Lack of Efficacy|0
3032859|NCT00723450|10428030|P1|Open-Label Phase|Lack of Efficacy|18
3032860|NCT00723450|10428028|P3|Open-Label Phase|Adverse Event|0
3032861|NCT00723450|10428029|P2|Open-Label Phase|Adverse Event|0
3032862|NCT00723450|10428030|P1|Open-Label Phase|Adverse Event|26
3032863|NCT00723398|10428076|P5|Overall Study|Lost to Follow-up|0
3032864|NCT00723398|10428077|P4|Overall Study|Lost to Follow-up|0
3032865|NCT00723398|10428078|P3|Overall Study|Lost to Follow-up|0
3032866|NCT00723398|10428079|P2|Overall Study|Lost to Follow-up|1
3032867|NCT00723398|10428080|P1|Overall Study|Lost to Follow-up|0
3032868|NCT00723398|10428076|P5|Overall Study|Adverse Event|4
3032869|NCT00723398|10428077|P4|Overall Study|Adverse Event|1
3032870|NCT00723398|10428078|P3|Overall Study|Adverse Event|3
3032871|NCT00723398|10428079|P2|Overall Study|Adverse Event|5
3032872|NCT00723398|10428080|P1|Overall Study|Adverse Event|0
3032873|NCT00723398|10428076|P5|Overall Study|Physician Decision|1
3032874|NCT00723398|10428077|P4|Overall Study|Physician Decision|0
3032875|NCT00723398|10428078|P3|Overall Study|Physician Decision|5
3032876|NCT00723398|10428079|P2|Overall Study|Physician Decision|2
3032877|NCT00723398|10428080|P1|Overall Study|Physician Decision|2
3032878|NCT00723398|10428076|P5|Overall Study|Protocol Violation|0
3032879|NCT00723398|10428077|P4|Overall Study|Protocol Violation|0
3032881|NCT00723398|10428079|P2|Overall Study|Protocol Violation|1
3032882|NCT00723398|10428080|P1|Overall Study|Protocol Violation|2
3032883|NCT00723398|10428076|P5|Overall Study|Withdrawal by Subject|4
3032884|NCT00723398|10428077|P4|Overall Study|Withdrawal by Subject|4
3032885|NCT00723398|10428078|P3|Overall Study|Withdrawal by Subject|4
3032886|NCT00723398|10428079|P2|Overall Study|Withdrawal by Subject|6
3032887|NCT00723398|10428080|P1|Overall Study|Withdrawal by Subject|2
3032888|NCT00723294|10428142|P1|Overall Study|No treatment due to probe failure|1
3032889|NCT00723294|10428142|P1|Overall Study|Withdrawal by Subject|1
3032890|NCT00723294|10428142|P1|Overall Study|Benign lesion|1
3032891|NCT00723294|10428142|P1|Overall Study|Treated by non-credentialed surgeon|1
3032892|NCT00723294|10428142|P1|Overall Study|Treated prior to registration|1
3032893|NCT00723294|10428142|P1|Overall Study|Did not undergo surgery|1
3032894|NCT00723294|10428142|P1|Overall Study|No cryoabalation|2
3032895|NCT00723294|10428142|P1|Overall Study|1.0-Tesla MRI|1
3032896|NCT00723294|10428142|P1|Overall Study|No MRI tumor enhancement|1
3032897|NCT00723294|10428142|P1|Overall Study|>25% intraductal component|1
3032898|NCT00723294|10428142|P1|Overall Study|Lobular histology|2
3032899|NCT00723255|10428147|P1|Overall Study|Ineligible: Wrong Primary|2
3032900|NCT00723255|10428147|P1|Overall Study|Ineligible: Second primary|1
3032901|NCT00723255|10428147|P1|Overall Study|Ineligible: Inadequate pathology|1
3032902|NCT00723229|10428174|P2|First Intervention|Lost to Follow-up|3
3032903|NCT00723229|10428175|P1|First Intervention|Lost to Follow-up|7
3032904|NCT00723203|10428187|P1|Overall Study|Withdrawal by Subject|3
3032905|NCT00723190|10428191|P1|Overall Study|Other-Not included in safety population|2
3032906|NCT00723190|10428191|P1|Overall Study|Other-Premature Discontinuation|9
3032907|NCT00723190|10428191|P1|Overall Study|Protocol Violation|15
3032908|NCT00723190|10428191|P1|Overall Study|Lack of Efficacy|16
3032909|NCT00723190|10428191|P1|Overall Study|Adverse Event|18
3032910|NCT00723190|10428191|P1|Overall Study|Lost to Follow-up|37
3032911|NCT00723190|10428191|P1|Overall Study|Withdrawal by Subject|45
3032912|NCT00723125|10428224|P2|Overall Study|Adverse Event|0
3032913|NCT00723125|10428225|P1|Overall Study|Adverse Event|2
3032914|NCT00723125|10428224|P2|Overall Study|Withdrawal by Subject|6
3032915|NCT00723125|10428225|P1|Overall Study|Withdrawal by Subject|15
3032916|NCT00723125|10428224|P2|Overall Study|Met Dx|0
3032917|NCT00723125|10428225|P1|Overall Study|Met Dx|1
3032918|NCT00723021|10428274|P5|Intervention Period 4|Adverse Event|1
3032919|NCT00723021|10428275|P4|Intervention Period 4|Adverse Event|0
3032920|NCT00723021|10428276|P3|Intervention Period 4|Adverse Event|0
3032921|NCT00723021|10428277|P2|Intervention Period 4|Adverse Event|0
3032922|NCT00723021|10428278|P1|Intervention Period 4|Adverse Event|0
3032923|NCT00723008|10428332|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
3032924|NCT00723008|10428333|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
3032925|NCT00723008|10428332|P2|4-Week Unblinded Treatment|Adverse Event|0
3032926|NCT00723008|10428333|P1|4-Week Unblinded Treatment|Adverse Event|1
3032927|NCT00723008|10428332|P2|4-Week Double Blinded|Lost to Follow-up|3
3032928|NCT00723008|10428333|P1|4-Week Double Blinded|Lost to Follow-up|4
3032929|NCT00723008|10428332|P2|4-Week Double Blinded|Withdrawal by Subject|1
3032930|NCT00723008|10428333|P1|4-Week Double Blinded|Withdrawal by Subject|1
3032931|NCT00723008|10428332|P2|4-Week Double Blinded|Lack of Efficacy|1
3032932|NCT00723008|10428333|P1|4-Week Double Blinded|Lack of Efficacy|0
3032933|NCT00723008|10428332|P2|Enrollment|Lost to Follow-up|0
3032934|NCT00723008|10428333|P1|Enrollment|Lost to Follow-up|1
3032935|NCT00722800|10428365|P2|Overall Study|Physician Decision|0
3032936|NCT00722800|10428366|P1|Overall Study|Physician Decision|1
3032937|NCT00722800|10428365|P2|Overall Study|Withdrawal by Subject|0
3032938|NCT00722800|10428366|P1|Overall Study|Withdrawal by Subject|1
3032939|NCT00722761|10428378|P2|Overall Study|Withdrawal by Subject|2
3032940|NCT00722761|10428379|P1|Overall Study|Withdrawal by Subject|5
3032941|NCT00722761|10428378|P2|Overall Study|Lost to Follow-up|4
3032942|NCT00722761|10428379|P1|Overall Study|Lost to Follow-up|1
3032943|NCT00722423|10428436|P2|Overall Study|Protocol Violation|1
3032944|NCT00722423|10428437|P1|Overall Study|Protocol Violation|0
3032945|NCT00722371|10428452|P7|Overall Study|Withdrawal by Subject|26
3032946|NCT00722371|10428453|P6|Overall Study|Withdrawal by Subject|18
3032947|NCT00722371|10428454|P5|Overall Study|Withdrawal by Subject|19
3032948|NCT00722371|10428455|P4|Overall Study|Withdrawal by Subject|23
3032949|NCT00722371|10428456|P3|Overall Study|Withdrawal by Subject|19
3032950|NCT00722371|10428457|P2|Overall Study|Withdrawal by Subject|27
3032951|NCT00722371|10428458|P1|Overall Study|Withdrawal by Subject|18
3032952|NCT00722371|10428452|P7|Overall Study|Protocol Violation|1
3032953|NCT00722371|10428453|P6|Overall Study|Protocol Violation|2
3032954|NCT00722371|10428454|P5|Overall Study|Protocol Violation|4
3032955|NCT00722371|10428455|P4|Overall Study|Protocol Violation|1
3032956|NCT00722371|10428456|P3|Overall Study|Protocol Violation|0
3032957|NCT00722371|10428457|P2|Overall Study|Protocol Violation|1
3032958|NCT00722371|10428458|P1|Overall Study|Protocol Violation|6
3032959|NCT00722371|10428452|P7|Overall Study|Pregnancy|0
3032960|NCT00722371|10428453|P6|Overall Study|Pregnancy|1
3032961|NCT00722371|10428454|P5|Overall Study|Pregnancy|0
3032962|NCT00722371|10428455|P4|Overall Study|Pregnancy|0
3032963|NCT00722371|10428456|P3|Overall Study|Pregnancy|0
3032964|NCT00722371|10428457|P2|Overall Study|Pregnancy|1
3032965|NCT00722371|10428458|P1|Overall Study|Pregnancy|1
3032966|NCT00722371|10428452|P7|Overall Study|Physician Decision|4
3032967|NCT00722371|10428453|P6|Overall Study|Physician Decision|3
3032968|NCT00722371|10428454|P5|Overall Study|Physician Decision|2
3032969|NCT00722371|10428455|P4|Overall Study|Physician Decision|5
3032970|NCT00722371|10428456|P3|Overall Study|Physician Decision|2
3032971|NCT00722371|10428457|P2|Overall Study|Physician Decision|2
3032972|NCT00722371|10428458|P1|Overall Study|Physician Decision|5
3032973|NCT00722371|10428452|P7|Overall Study|Lost to Follow-up|13
3032974|NCT00722371|10428453|P6|Overall Study|Lost to Follow-up|16
3032975|NCT00722371|10428454|P5|Overall Study|Lost to Follow-up|8
3032976|NCT00722371|10428455|P4|Overall Study|Lost to Follow-up|13
3032977|NCT00722371|10428456|P3|Overall Study|Lost to Follow-up|21
3032978|NCT00722371|10428457|P2|Overall Study|Lost to Follow-up|14
3032979|NCT00722371|10428458|P1|Overall Study|Lost to Follow-up|11
3032980|NCT00722371|10428452|P7|Overall Study|Lack of Efficacy|0
3032981|NCT00722371|10428453|P6|Overall Study|Lack of Efficacy|3
3032982|NCT00722371|10428454|P5|Overall Study|Lack of Efficacy|2
3032983|NCT00722371|10428455|P4|Overall Study|Lack of Efficacy|6
3032984|NCT00722371|10428456|P3|Overall Study|Lack of Efficacy|6
3032985|NCT00722371|10428457|P2|Overall Study|Lack of Efficacy|6
3032986|NCT00722371|10428458|P1|Overall Study|Lack of Efficacy|4
3032987|NCT00722371|10428452|P7|Overall Study|Hypoglycemia|0
3032988|NCT00722371|10428453|P6|Overall Study|Hypoglycemia|0
3032989|NCT00722371|10428454|P5|Overall Study|Hypoglycemia|0
3032990|NCT00722371|10428455|P4|Overall Study|Hypoglycemia|0
3032991|NCT00722371|10428456|P3|Overall Study|Hypoglycemia|0
3032992|NCT00722371|10428457|P2|Overall Study|Hypoglycemia|0
3032993|NCT00722371|10428458|P1|Overall Study|Hypoglycemia|1
3032994|NCT00722371|10428452|P7|Overall Study|Hyperglycemia|1
3032995|NCT00722371|10428453|P6|Overall Study|Hyperglycemia|1
3032996|NCT00722371|10428454|P5|Overall Study|Hyperglycemia|5
3032997|NCT00722371|10428455|P4|Overall Study|Hyperglycemia|2
3032998|NCT00722371|10428456|P3|Overall Study|Hyperglycemia|4
3032999|NCT00722371|10428457|P2|Overall Study|Hyperglycemia|6
3033000|NCT00722371|10428458|P1|Overall Study|Hyperglycemia|2
3033001|NCT00722371|10428452|P7|Overall Study|Excluded medication|1
3033002|NCT00722371|10428453|P6|Overall Study|Excluded medication|0
3033003|NCT00722371|10428454|P5|Overall Study|Excluded medication|0
3033004|NCT00722371|10428455|P4|Overall Study|Excluded medication|0
3033005|NCT00722371|10428456|P3|Overall Study|Excluded medication|1
3033006|NCT00722371|10428457|P2|Overall Study|Excluded medication|1
3033007|NCT00722371|10428458|P1|Overall Study|Excluded medication|0
3033008|NCT00722371|10428452|P7|Overall Study|Creatinine / Creatinine clearance|1
3033009|NCT00722371|10428453|P6|Overall Study|Creatinine / Creatinine clearance|1
3033010|NCT00722371|10428454|P5|Overall Study|Creatinine / Creatinine clearance|2
3033011|NCT00722371|10428455|P4|Overall Study|Creatinine / Creatinine clearance|3
3033012|NCT00722371|10428456|P3|Overall Study|Creatinine / Creatinine clearance|2
3033013|NCT00722371|10428457|P2|Overall Study|Creatinine / Creatinine clearance|1
3033014|NCT00722371|10428458|P1|Overall Study|Creatinine / Creatinine clearance|2
3033015|NCT00722371|10428452|P7|Overall Study|Contraindication|0
3033016|NCT00722371|10428453|P6|Overall Study|Contraindication|0
3033017|NCT00722371|10428454|P5|Overall Study|Contraindication|0
3033018|NCT00722371|10428455|P4|Overall Study|Contraindication|0
3033019|NCT00722371|10428456|P3|Overall Study|Contraindication|1
3033020|NCT00722371|10428457|P2|Overall Study|Contraindication|0
3033021|NCT00722371|10428458|P1|Overall Study|Contraindication|0
3033022|NCT00722371|10428452|P7|Overall Study|Adverse Event|4
3033023|NCT00722371|10428453|P6|Overall Study|Adverse Event|8
3033024|NCT00722371|10428454|P5|Overall Study|Adverse Event|6
3033025|NCT00722371|10428455|P4|Overall Study|Adverse Event|10
3033026|NCT00722371|10428456|P3|Overall Study|Adverse Event|9
3033027|NCT00722371|10428457|P2|Overall Study|Adverse Event|13
3033028|NCT00722371|10428458|P1|Overall Study|Adverse Event|6
3033029|NCT00722137|10428511|P2|Overall Study|Randomized But Not Treated|3
3033030|NCT00722137|10428512|P1|Overall Study|Randomized But Not Treated|2
3033031|NCT00722137|10428511|P2|Overall Study|Other Reason Unknown|4
3033032|NCT00722137|10428512|P1|Overall Study|Other Reason Unknown|3
3033033|NCT00722137|10428511|P2|Overall Study|Withdrawal by Subject|9
3033034|NCT00722137|10428512|P1|Overall Study|Withdrawal by Subject|6
3033035|NCT00722137|10428511|P2|Overall Study|Death|7
3033036|NCT00722137|10428512|P1|Overall Study|Death|12
3033037|NCT00722137|10428511|P2|Overall Study|Adverse Event|21
3033038|NCT00722137|10428512|P1|Overall Study|Adverse Event|17
3033039|NCT00722137|10428511|P2|Overall Study|Overt Disease Progression|4
3033040|NCT00722137|10428512|P1|Overall Study|Overt Disease Progression|5
3033041|NCT00721968|10428590|P2|Overall Study|Lost to Follow-up|0
3033042|NCT00721968|10428591|P1|Overall Study|Lost to Follow-up|2
3033043|NCT00721955|10428602|P3|Overall Study|Adverse Event|2
3033044|NCT00721955|10428603|P2|Overall Study|Adverse Event|0
3033045|NCT00721955|10428604|P1|Overall Study|Adverse Event|0
3033046|NCT00721799|10428618|P1|Overall Study|withdraw by subject after scan 1|1
3033047|NCT00721799|10428618|P1|Overall Study|Withdrawal by Subject|7
3033048|NCT00721734|10428658|P5|Overall Study|Other|0
3033049|NCT00721734|10428659|P4|Overall Study|Other|1
3033050|NCT00721734|10428660|P3|Overall Study|Other|0
3033051|NCT00721734|10428661|P2|Overall Study|Other|0
3033052|NCT00721734|10428662|P1|Overall Study|Other|0
3033053|NCT00721734|10428658|P5|Overall Study|Withdrawal by Subject|1
3033054|NCT00721734|10428659|P4|Overall Study|Withdrawal by Subject|0
3033055|NCT00721734|10428660|P3|Overall Study|Withdrawal by Subject|0
3033056|NCT00721734|10428661|P2|Overall Study|Withdrawal by Subject|1
3033057|NCT00721734|10428662|P1|Overall Study|Withdrawal by Subject|2
3033058|NCT00721734|10428658|P5|Overall Study|Adverse Event|3
3033059|NCT00721734|10428659|P4|Overall Study|Adverse Event|0
3033060|NCT00721734|10428660|P3|Overall Study|Adverse Event|4
3033061|NCT00721734|10428661|P2|Overall Study|Adverse Event|1
3033062|NCT00721734|10428662|P1|Overall Study|Adverse Event|3
3033063|NCT00721734|10428658|P5|Overall Study|Progressive Disease|2
3033064|NCT00721734|10428659|P4|Overall Study|Progressive Disease|5
3033065|NCT00721734|10428660|P3|Overall Study|Progressive Disease|4
3033066|NCT00721734|10428661|P2|Overall Study|Progressive Disease|10
3033067|NCT00721734|10428662|P1|Overall Study|Progressive Disease|3
3033068|NCT00721630|10428774|P1|Overall Study|Participant found to be ineligible|1
3033069|NCT00721578|10428803|P2|Overall Study|Withdrawal by Subject|1
3033070|NCT00721578|10428804|P1|Overall Study|Withdrawal by Subject|1
3033071|NCT00721578|10428803|P2|Overall Study|Death|1
3033072|NCT00721578|10428804|P1|Overall Study|Death|1
3033073|NCT00721409|10428859|P3|Overall Study|Objective progression or relapse|62
3033074|NCT00721409|10428860|P2|Overall Study|Objective progression or relapse|55
3033075|NCT00721409|10428861|P1|Overall Study|Objective progression or relapse|8
3033076|NCT00721409|10428859|P3|Overall Study|Withdrawal by Subject|5
3033077|NCT00721409|10428860|P2|Overall Study|Withdrawal by Subject|6
3033078|NCT00721409|10428861|P1|Overall Study|Withdrawal by Subject|1
3033079|NCT00721409|10428859|P3|Overall Study|Lost to Follow-up|1
3033080|NCT00721409|10428860|P2|Overall Study|Lost to Follow-up|0
3033081|NCT00721409|10428861|P1|Overall Study|Lost to Follow-up|0
3033082|NCT00721409|10428859|P3|Overall Study|Adverse Event|2
3033083|NCT00721409|10428860|P2|Overall Study|Adverse Event|13
3033084|NCT00721409|10428861|P1|Overall Study|Adverse Event|0
3033085|NCT00721409|10428859|P3|Overall Study|Reason not specified|2
3033086|NCT00721409|10428860|P2|Overall Study|Reason not specified|0
3033087|NCT00721409|10428861|P1|Overall Study|Reason not specified|1
3033088|NCT00721409|10428859|P3|Overall Study|Randomized not Treated|4
3033089|NCT00721409|10428860|P2|Overall Study|Randomized not Treated|1
3033090|NCT00721409|10428861|P1|Overall Study|Randomized not Treated|0
3033091|NCT00721409|10428859|P3|Overall Study|Death|0
3033092|NCT00721409|10428860|P2|Overall Study|Death|1
3033093|NCT00721409|10428861|P1|Overall Study|Death|0
3033094|NCT00721409|10428859|P3|Overall Study|Global deterioration of health status|3
3033095|NCT00721409|10428860|P2|Overall Study|Global deterioration of health status|6
3033096|NCT00721409|10428861|P1|Overall Study|Global deterioration of health status|2
3033097|NCT00721396|10428988|P4|Overall Study|Administrative reason|0
3033098|NCT00721396|10428989|P3|Overall Study|Administrative reason|1
3033099|NCT00721396|10428990|P2|Overall Study|Administrative reason|0
3033100|NCT00721396|10428991|P1|Overall Study|Administrative reason|3
3033101|NCT00721396|10428988|P4|Overall Study|Inappropriate enrollment|0
3033102|NCT00721396|10428989|P3|Overall Study|Inappropriate enrollment|0
3033103|NCT00721396|10428990|P2|Overall Study|Inappropriate enrollment|2
3033104|NCT00721396|10428991|P1|Overall Study|Inappropriate enrollment|0
3033105|NCT00721396|10428988|P4|Overall Study|Protocol Violation|0
3033106|NCT00721396|10428989|P3|Overall Study|Protocol Violation|1
3033107|NCT00721396|10428990|P2|Overall Study|Protocol Violation|3
3033108|NCT00721396|10428991|P1|Overall Study|Protocol Violation|4
3033109|NCT00721396|10428988|P4|Overall Study|Lost to Follow-up|3
3033110|NCT00721396|10428989|P3|Overall Study|Lost to Follow-up|3
3033111|NCT00721396|10428990|P2|Overall Study|Lost to Follow-up|9
3033112|NCT00721396|10428991|P1|Overall Study|Lost to Follow-up|7
3033113|NCT00721396|10428988|P4|Overall Study|Withdrawal by Subject|7
3033114|NCT00721396|10428989|P3|Overall Study|Withdrawal by Subject|3
3033115|NCT00721396|10428990|P2|Overall Study|Withdrawal by Subject|15
3033116|NCT00721396|10428991|P1|Overall Study|Withdrawal by Subject|12
3033117|NCT00721396|10428988|P4|Overall Study|Adverse Event|0
3033118|NCT00721396|10428989|P3|Overall Study|Adverse Event|2
3033119|NCT00721396|10428990|P2|Overall Study|Adverse Event|7
3033120|NCT00721396|10428991|P1|Overall Study|Adverse Event|4
3033121|NCT00721279|10429042|P2|Overall Study|Other|16
3033122|NCT00721279|10429043|P1|Overall Study|Other|12
3033123|NCT00721279|10429042|P2|Overall Study|Withdrawal by Subject|3
3033124|NCT00721279|10429043|P1|Overall Study|Withdrawal by Subject|13
3033125|NCT00721279|10429042|P2|Overall Study|Tolerability insufficient|2
3033126|NCT00721279|10429043|P1|Overall Study|Tolerability insufficient|5
3033127|NCT00721279|10429042|P2|Overall Study|Lack of Efficacy|3
3033128|NCT00721279|10429043|P1|Overall Study|Lack of Efficacy|6
3033129|NCT00721227|10429071|P2|Overall Study|Noncompliance with scheduled visits.|0
3033130|NCT00721227|10429072|P1|Overall Study|Noncompliance with scheduled visits.|1
3033131|NCT00721227|10429071|P2|Overall Study|Lost to Follow-up|0
3033132|NCT00721227|10429072|P1|Overall Study|Lost to Follow-up|3
3033133|NCT00721214|10429082|P1|Overall Study|Death|3
3033134|NCT00721214|10429082|P1|Overall Study|Chose another center for transplant|1
3033135|NCT00721149|10429132|P1|Overall Study|Physician Decision|1
3033136|NCT00721123|10429166|P1|Overall Study|Withdrawal by Subject|5
3033137|NCT00721123|10429166|P1|Overall Study|Failure to Return|9
3033138|NCT00721123|10429166|P1|Overall Study|Refused Treatment|41
3033139|NCT00721123|10429166|P1|Overall Study|Protocol Violation|1
3033140|NCT00721123|10429166|P1|Overall Study|Insufficient Therapeutic Response|21
3033141|NCT00721123|10429166|P1|Overall Study|Death|10
3033142|NCT00721123|10429166|P1|Overall Study|Adverse Event|96
3033143|NCT00721110|10429244|P4|Overall Study|vertical incision|0
3033144|NCT00721110|10429245|P3|Overall Study|vertical incision|1
3033145|NCT00721110|10429246|P2|Overall Study|vertical incision|0
3033146|NCT00721110|10429247|P1|Overall Study|vertical incision|0
3033147|NCT00721110|10429244|P4|Overall Study|Ultram use|0
3033148|NCT00721110|10429245|P3|Overall Study|Ultram use|0
3033149|NCT00721110|10429246|P2|Overall Study|Ultram use|0
3033150|NCT00721110|10429247|P1|Overall Study|Ultram use|1
3033151|NCT00720941|10429275|P2|Overall Study|Ongoing|23
3033152|NCT00720941|10429276|P1|Overall Study|Ongoing|34
3033153|NCT00720941|10429275|P2|Overall Study|Withdrawal by Subject|35
3033154|NCT00720941|10429276|P1|Overall Study|Withdrawal by Subject|27
3033155|NCT00720941|10429275|P2|Overall Study|Physician Decision|5
3033156|NCT00720941|10429276|P1|Overall Study|Physician Decision|1
3033157|NCT00720941|10429275|P2|Overall Study|Lost to Follow-up|15
3033158|NCT00720941|10429276|P1|Overall Study|Lost to Follow-up|17
3033159|NCT00720941|10429275|P2|Overall Study|Protocol Violation|2
3033160|NCT00720941|10429276|P1|Overall Study|Protocol Violation|0
3033161|NCT00720941|10429275|P2|Overall Study|Death|335
3033162|NCT00720941|10429276|P1|Overall Study|Death|334
3033163|NCT00720876|10429316|P1|Overall Study|found to be ineligible after starting tx|2
3033164|NCT00720798|10429322|P1|Overall Study|Reason not Specified|83
3033165|NCT00720798|10429322|P1|Overall Study|Failure to Return|46
3033166|NCT00720798|10429322|P1|Overall Study|Refused Treatment|151
3033167|NCT00720798|10429322|P1|Overall Study|Protocol Violation|4
3033168|NCT00720798|10429322|P1|Overall Study|Insufficient Therapeutic Response|129
3033169|NCT00720798|10429322|P1|Overall Study|Death|39
3033170|NCT00720798|10429322|P1|Overall Study|Adverse Event|304
3033171|NCT00720759|10429345|P4|Overall Study|Lost to Follow-up|0
3033172|NCT00720759|10429346|P3|Overall Study|Lost to Follow-up|1
3033173|NCT00720759|10429347|P2|Overall Study|Lost to Follow-up|1
3033174|NCT00720759|10429348|P1|Overall Study|Lost to Follow-up|0
3033175|NCT00720499|10429368|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
3033176|NCT00720499|10429369|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
3033177|NCT00720499|10429368|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
3033178|NCT00720499|10429369|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
3033179|NCT00720499|10429368|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
3033180|NCT00720499|10429369|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
3033181|NCT00720434|10429462|P4|Open-Label Period (Week 5-72)|Other|2
3033182|NCT00720434|10429463|P3|Open-Label Period (Week 5-72)|Other|3
3033183|NCT00720434|10429464|P2|Open-Label Period (Week 5-72)|Other|3
3033184|NCT00720434|10429465|P1|Open-Label Period (Week 5-72)|Other|4
3033185|NCT00720434|10429462|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
3033186|NCT00720434|10429463|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
3033187|NCT00720434|10429464|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
3033188|NCT00720434|10429465|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
3033189|NCT00720434|10429462|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
3033190|NCT00720434|10429463|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
3033191|NCT00720434|10429464|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
3033192|NCT00720434|10429465|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
3033193|NCT00720434|10429462|P4|Open-Label Period (Week 5-72)|Adverse Event|2
3033194|NCT00720434|10429463|P3|Open-Label Period (Week 5-72)|Adverse Event|0
3033195|NCT00720434|10429464|P2|Open-Label Period (Week 5-72)|Adverse Event|0
3033196|NCT00720434|10429465|P1|Open-Label Period (Week 5-72)|Adverse Event|0
3033197|NCT00720434|10429462|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
3033198|NCT00720434|10429463|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
3033199|NCT00720434|10429464|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
3033200|NCT00720434|10429465|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
3033201|NCT00720382|10429489|P2|Overall Study|administrative|5
3033202|NCT00720382|10429490|P1|Overall Study|administrative|14
3033203|NCT00720382|10429489|P2|Overall Study|Lost to Follow-up|14
3033204|NCT00720382|10429490|P1|Overall Study|Lost to Follow-up|28
3033205|NCT00720382|10429489|P2|Overall Study|Withdrawal by Subject|11
3033206|NCT00720382|10429490|P1|Overall Study|Withdrawal by Subject|47
3033207|NCT00720382|10429489|P2|Overall Study|Non-Compliance|5
3033208|NCT00720382|10429490|P1|Overall Study|Non-Compliance|15
3033209|NCT00720382|10429489|P2|Overall Study|Lack of Efficacy|7
3033210|NCT00720382|10429490|P1|Overall Study|Lack of Efficacy|18
3033211|NCT00720382|10429489|P2|Overall Study|Adverse Event|17
3033212|NCT00720382|10429490|P1|Overall Study|Adverse Event|54
3033213|NCT00720356|10429509|P1|Follow up Until Death|Alive at last data collection|4
3033214|NCT00720356|10429509|P1|Follow up Until Death|Withdrawal by Subject|1
3033215|NCT00720356|10429509|P1|Went on to be Treated Cycle 3|Physician Decision|1
3033216|NCT00720356|10429509|P1|Went on to be Treated Cycle 3|Adverse Event|1
3033217|NCT00720356|10429509|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
3033218|NCT00720356|10429509|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
3033219|NCT00720356|10429509|P1|Registration to Study|Determined to have methylated MGMT|67
3033220|NCT00720343|10429523|P1|Overall Study|No data|3
3033221|NCT00720343|10429523|P1|Overall Study|Physician Decision|3
3033222|NCT00720278|10429557|P3|Overall Study|eligibility criteria violation|1
3033223|NCT00720278|10429558|P2|Overall Study|eligibility criteria violation|0
3033224|NCT00720278|10429559|P1|Overall Study|eligibility criteria violation|1
3033225|NCT00720278|10429557|P3|Overall Study|Non-compliance|0
3033226|NCT00720278|10429558|P2|Overall Study|Non-compliance|0
3033227|NCT00720278|10429559|P1|Overall Study|Non-compliance|1
3033228|NCT00720278|10429557|P3|Overall Study|Lost to Follow-up|1
3033229|NCT00720278|10429558|P2|Overall Study|Lost to Follow-up|0
3033230|NCT00720278|10429559|P1|Overall Study|Lost to Follow-up|0
3033231|NCT00720278|10429557|P3|Overall Study|Withdrawal by Subject|0
3033232|NCT00720278|10429558|P2|Overall Study|Withdrawal by Subject|1
3033233|NCT00720278|10429559|P1|Overall Study|Withdrawal by Subject|0
3033234|NCT00720278|10429557|P3|Overall Study|Adverse Event|4
3033235|NCT00720278|10429558|P2|Overall Study|Adverse Event|3
3033236|NCT00720278|10429559|P1|Overall Study|Adverse Event|5
3033237|NCT00720226|10429581|P2|Overall Study|Withdrawal by Subject|4
3033238|NCT00720226|10429582|P1|Overall Study|Withdrawal by Subject|7
3033239|NCT00720213|10429590|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
3033240|NCT00720213|10429591|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
3033241|NCT00720213|10429592|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
3033242|NCT00720122|10429630|P1|Overall Study|Withdrawal by Subject|7
3033243|NCT00720122|10429630|P1|Overall Study|Physician Decision|1
3033244|NCT00720122|10429630|P1|Overall Study|Lost to Follow-up|1
3033245|NCT00720109|10429634|P3|Risk Stratification Period|Development of second malignant neoplasm|0
3033246|NCT00720109|10429635|P2|Risk Stratification Period|Development of second malignant neoplasm|1
3033247|NCT00720109|10429636|P1|Risk Stratification Period|Development of second malignant neoplasm|0
3033248|NCT00720109|10429634|P3|Risk Stratification Period|Disease progression or relapse|0
3033249|NCT00720109|10429635|P2|Risk Stratification Period|Disease progression or relapse|2
3033250|NCT00720109|10429636|P1|Risk Stratification Period|Disease progression or relapse|0
3033251|NCT00720109|10429634|P3|Risk Stratification Period|Bone marrow transplant|7
3033252|NCT00720109|10429635|P2|Risk Stratification Period|Bone marrow transplant|9
3033253|NCT00720109|10429636|P1|Risk Stratification Period|Bone marrow transplant|0
3033254|NCT00720109|10429634|P3|Risk Stratification Period|Physician Decision|1
3033255|NCT00720109|10429635|P2|Risk Stratification Period|Physician Decision|2
3033256|NCT00720109|10429636|P1|Risk Stratification Period|Physician Decision|0
3033257|NCT00720109|10429634|P3|Risk Stratification Period|Adverse Event|0
3033258|NCT00720109|10429635|P2|Risk Stratification Period|Adverse Event|1
3033259|NCT00720109|10429636|P1|Risk Stratification Period|Adverse Event|0
3033260|NCT00720109|10429634|P3|Induction Period|Physician Decision|0
3033261|NCT00720109|10429635|P2|Induction Period|Physician Decision|0
3033262|NCT00720109|10429636|P1|Induction Period|Physician Decision|1
3033263|NCT00720109|10429634|P3|Induction Period|Bone Marrow Transplant|0
3033264|NCT00720109|10429635|P2|Induction Period|Bone Marrow Transplant|0
3033265|NCT00720109|10429636|P1|Induction Period|Bone Marrow Transplant|2
3033266|NCT00720109|10429634|P3|Induction Period|Did not meet eligibility criteria|0
3033267|NCT00720109|10429635|P2|Induction Period|Did not meet eligibility criteria|0
3033268|NCT00720109|10429636|P1|Induction Period|Did not meet eligibility criteria|3
3033269|NCT00720096|10429656|P2|Overall Study|Withdrawal by Subject|2
3033270|NCT00720096|10429657|P1|Overall Study|Withdrawal by Subject|0
3033271|NCT00720083|10429669|P2|Overall Study|Ineligible|2
3033272|NCT00720083|10429670|P1|Overall Study|Ineligible|1
3033273|NCT00720057|10429678|P2|Overall Study|Withdrawal by Subject|1
3033274|NCT00720057|10429679|P1|Overall Study|Withdrawal by Subject|0
3033275|NCT00720057|10429678|P2|Overall Study|Protocol Violation|0
3033276|NCT00720057|10429679|P1|Overall Study|Protocol Violation|1
3033277|NCT00720057|10429678|P2|Overall Study|Lost to Follow-up|2
3033278|NCT00720057|10429679|P1|Overall Study|Lost to Follow-up|0
3033279|NCT00719953|10429695|P1|Overall Study|Adverse Event|4
3033280|NCT00719901|10429708|P1|Overall Study|Availability of Study Drug|1
3033281|NCT00719901|10429708|P1|Overall Study|Disease Progression|3
3033282|NCT00719901|10429708|P1|Overall Study|Alternate Treatment|1
3033283|NCT00719901|10429708|P1|Overall Study|Withdrawal by Subject|1
3033284|NCT00719901|10429708|P1|Overall Study|Adverse Event|5
3033285|NCT00719862|10429720|P2|Overall Study|Other|3
3033286|NCT00719862|10429721|P1|Overall Study|Other|2
3033287|NCT00719862|10429720|P2|Overall Study|Lost to Follow-up|1
3033288|NCT00719862|10429721|P1|Overall Study|Lost to Follow-up|0
3033289|NCT00719862|10429720|P2|Overall Study|Withdrawal by Subject|0
3033290|NCT00719862|10429721|P1|Overall Study|Withdrawal by Subject|1
3033291|NCT00719862|10429720|P2|Overall Study|Non-Compliance|0
3033292|NCT00719862|10429721|P1|Overall Study|Non-Compliance|1
3033293|NCT00719862|10429720|P2|Overall Study|Lack of Efficacy|0
3033294|NCT00719862|10429721|P1|Overall Study|Lack of Efficacy|3
3033295|NCT00719862|10429720|P2|Overall Study|Adverse Event|2
3033296|NCT00719862|10429721|P1|Overall Study|Adverse Event|1
3033297|NCT00719849|10429739|P2|Overall Study|Death|1
3033298|NCT00719849|10429740|P1|Overall Study|Death|0
3033299|NCT00719810|10429779|P3|Overall Study|Withdrawal by Subject|2
3033300|NCT00719810|10429780|P2|Overall Study|Withdrawal by Subject|1
3033301|NCT00719810|10429781|P1|Overall Study|Withdrawal by Subject|1
3033302|NCT00719810|10429779|P3|Overall Study|Physician Decision|0
3033303|NCT00719810|10429780|P2|Overall Study|Physician Decision|1
3033304|NCT00719810|10429781|P1|Overall Study|Physician Decision|0
3033305|NCT00719810|10429779|P3|Overall Study|Lost to Follow-up|3
3033306|NCT00719810|10429780|P2|Overall Study|Lost to Follow-up|0
3033307|NCT00719810|10429781|P1|Overall Study|Lost to Follow-up|2
3033308|NCT00719810|10429779|P3|Overall Study|Adverse Event|3
3033309|NCT00719810|10429780|P2|Overall Study|Adverse Event|2
3033310|NCT00719810|10429781|P1|Overall Study|Adverse Event|0
3033311|NCT00719732|10429792|P1|Overall Study|Illness not associated with device|1
3033312|NCT00719732|10429792|P1|Overall Study|Unilateral (not bilateral) implantation|1
3033313|NCT00719732|10429792|P1|Overall Study|Lost to Follow-up|20
3033314|NCT00719706|10429798|P2|Overall Study|Protocol Violation|0
3033315|NCT00719706|10429799|P1|Overall Study|Protocol Violation|3
3033316|NCT00719706|10429798|P2|Overall Study|Withdrawal by Subject|2
3033317|NCT00719706|10429799|P1|Overall Study|Withdrawal by Subject|1
3033318|NCT00719706|10429798|P2|Overall Study|Adverse Event|4
3033319|NCT00719706|10429799|P1|Overall Study|Adverse Event|5
3033320|NCT00719680|10429813|P1|Overall Study|Withdrawal by Subject|3
3033321|NCT00719680|10429813|P1|Overall Study|Lost to Follow-up|1
3033322|NCT00719680|10429813|P1|Overall Study|Adverse Event|1
3033323|NCT00719563|10429869|P2|Overall Study|Lost to Follow-up|3
3033324|NCT00719563|10429870|P1|Overall Study|Lost to Follow-up|5
3033325|NCT00719563|10429869|P2|Overall Study|Noncompliant|1
3033326|NCT00719563|10429870|P1|Overall Study|Noncompliant|1
3033327|NCT00719563|10429869|P2|Overall Study|Unknown reasons|6
3033328|NCT00719563|10429870|P1|Overall Study|Unknown reasons|4
3033329|NCT00719563|10429869|P2|Overall Study|Personal reasons|7
3033330|NCT00719563|10429870|P1|Overall Study|Personal reasons|6
3033331|NCT00719563|10429869|P2|Overall Study|Lack of Efficacy|7
3033332|NCT00719563|10429870|P1|Overall Study|Lack of Efficacy|3
3033333|NCT00719563|10429869|P2|Overall Study|Medical condition changed|5
3033334|NCT00719563|10429870|P1|Overall Study|Medical condition changed|3
3033335|NCT00719563|10429869|P2|Overall Study|Adverse Event|13
3033336|NCT00719563|10429870|P1|Overall Study|Adverse Event|16
3033337|NCT00719537|10429902|P2|Overall Study|Lost to Follow-up|1
3033338|NCT00719537|10429903|P1|Overall Study|Lost to Follow-up|0
3033339|NCT00719537|10429902|P2|Overall Study|Withdrawal by Subject|0
3033340|NCT00719537|10429903|P1|Overall Study|Withdrawal by Subject|1
3033341|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Various Reasons|25
3033342|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
3033343|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
3033344|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
3033345|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Disease progression|3
3033346|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Death|6
3033347|NCT00719472|10429909|P1|Received Cycle 2 Treatment|Adverse Event|12
3033348|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Various Reasons|13
3033349|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
3033350|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
3033351|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
3033352|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Death|5
3033353|NCT00719472|10429909|P1|Received Cycle 1 Treatment|Adverse Event|8
3033354|NCT00719472|10429909|P1|Enrolled in Study|Various Reasons|17
3033355|NCT00719472|10429909|P1|Enrolled in Study|Subject decision to withdraw|8
3033356|NCT00719472|10429909|P1|Enrolled in Study|Physician decision to withdraw patient|1
3033357|NCT00719355|10429920|P2|Overall Study|Moved|1
3033358|NCT00719355|10429921|P1|Overall Study|Moved|0
3033359|NCT00719355|10429920|P2|Overall Study|Compliance|6
3033360|NCT00719355|10429921|P1|Overall Study|Compliance|4
3033361|NCT00719355|10429920|P2|Overall Study|Medical|5
3033362|NCT00719355|10429921|P1|Overall Study|Medical|14
3033363|NCT00719355|10429920|P2|Overall Study|Death|1
3033364|NCT00719355|10429921|P1|Overall Study|Death|0
3033365|NCT00719264|10429950|P2|Overall Study|Disease Progression|107
3033366|NCT00719264|10429951|P1|Overall Study|Disease Progression|104
3033367|NCT00719264|10429950|P2|Overall Study|New Cancer Therapy|2
3033368|NCT00719264|10429951|P1|Overall Study|New Cancer Therapy|4
3033369|NCT00719264|10429950|P2|Overall Study|Protocol Deviation|3
3033370|NCT00719264|10429951|P1|Overall Study|Protocol Deviation|1
3033371|NCT00719264|10429950|P2|Overall Study|Withdrawal by Subject|7
3033372|NCT00719264|10429951|P1|Overall Study|Withdrawal by Subject|12
3033373|NCT00719264|10429950|P2|Overall Study|Lost to Follow-up|1
3033374|NCT00719264|10429951|P1|Overall Study|Lost to Follow-up|1
3033375|NCT00719264|10429950|P2|Overall Study|Administrative Problems|4
3033376|NCT00719264|10429951|P1|Overall Study|Administrative Problems|6
3033377|NCT00719264|10429950|P2|Overall Study|Death|10
3033378|NCT00719264|10429951|P1|Overall Study|Death|13
3033379|NCT00719264|10429950|P2|Overall Study|Adverse Event|49
3033380|NCT00719264|10429951|P1|Overall Study|Adverse Event|41
3033381|NCT00719212|10429970|P1|Overall Study|Withdrawal by Subject|1
3033382|NCT00719212|10429970|P1|Overall Study|Lost to Follow-up|2
3033383|NCT00719212|10429970|P1|Overall Study|Death|41
3033384|NCT00719043|10430018|P7|Overall Study|Withdrawal by Subject|14
3033385|NCT00719043|10430019|P6|Overall Study|Withdrawal by Subject|18
3033386|NCT00719043|10430020|P5|Overall Study|Withdrawal by Subject|16
3033387|NCT00719043|10430021|P4|Overall Study|Withdrawal by Subject|10
3033388|NCT00719043|10430022|P3|Overall Study|Withdrawal by Subject|9
3033389|NCT00719043|10430023|P2|Overall Study|Withdrawal by Subject|14
3033390|NCT00719043|10430024|P1|Overall Study|Withdrawal by Subject|12
3033391|NCT00719043|10430018|P7|Overall Study|Other|1
3033392|NCT00719043|10430019|P6|Overall Study|Other|2
3033393|NCT00719043|10430020|P5|Overall Study|Other|0
3033394|NCT00719043|10430021|P4|Overall Study|Other|2
3033395|NCT00719043|10430022|P3|Overall Study|Other|1
3033396|NCT00719043|10430023|P2|Overall Study|Other|0
3033397|NCT00719043|10430024|P1|Overall Study|Other|1
3033398|NCT00719043|10430018|P7|Overall Study|Protocol Violation|0
3033399|NCT00719043|10430019|P6|Overall Study|Protocol Violation|1
3033400|NCT00719043|10430020|P5|Overall Study|Protocol Violation|0
3033401|NCT00719043|10430021|P4|Overall Study|Protocol Violation|0
3033402|NCT00719043|10430022|P3|Overall Study|Protocol Violation|0
3033403|NCT00719043|10430023|P2|Overall Study|Protocol Violation|0
3033404|NCT00719043|10430024|P1|Overall Study|Protocol Violation|0
3033405|NCT00719043|10430018|P7|Overall Study|Lost to Follow-up|9
3033406|NCT00719043|10430019|P6|Overall Study|Lost to Follow-up|9
3033407|NCT00719043|10430020|P5|Overall Study|Lost to Follow-up|10
3033408|NCT00719043|10430021|P4|Overall Study|Lost to Follow-up|9
3033409|NCT00719043|10430022|P3|Overall Study|Lost to Follow-up|8
3033410|NCT00719043|10430023|P2|Overall Study|Lost to Follow-up|10
3033411|NCT00719043|10430024|P1|Overall Study|Lost to Follow-up|14
3033412|NCT00719043|10430018|P7|Overall Study|Adverse Event|4
3033413|NCT00719043|10430019|P6|Overall Study|Adverse Event|4
3033414|NCT00719043|10430020|P5|Overall Study|Adverse Event|1
3033415|NCT00719043|10430021|P4|Overall Study|Adverse Event|2
3033416|NCT00719043|10430022|P3|Overall Study|Adverse Event|2
3033417|NCT00719043|10430023|P2|Overall Study|Adverse Event|1
3033418|NCT00719043|10430024|P1|Overall Study|Adverse Event|5
3033419|NCT00718887|10430148|P2|Overall Study|Not identified|7
3033420|NCT00718887|10430149|P1|Overall Study|Not identified|2
3033421|NCT00718887|10430148|P2|Overall Study|Withdrawal by Subject|2
3033422|NCT00718887|10430149|P1|Overall Study|Withdrawal by Subject|3
3033423|NCT00718861|10430173|P2|Overall Study|Death|5
3033424|NCT00718861|10430174|P1|Overall Study|Death|1
3033425|NCT00718861|10430173|P2|Overall Study|Administrative Problems|1
3033426|NCT00718861|10430174|P1|Overall Study|Administrative Problems|1
3033427|NCT00718861|10430173|P2|Overall Study|Lost to Follow-up|1
3033428|NCT00718861|10430174|P1|Overall Study|Lost to Follow-up|2
3033429|NCT00718861|10430173|P2|Overall Study|Adverse Event|1
3033430|NCT00718861|10430174|P1|Overall Study|Adverse Event|2
3033431|NCT00718861|10430173|P2|Overall Study|Withdrawal by Subject|10
3033432|NCT00718861|10430174|P1|Overall Study|Withdrawal by Subject|15
3033433|NCT00718809|10430202|P2|Overall Study|Noncompliance|0
3033434|NCT00718809|10430203|P1|Overall Study|Noncompliance|1
3033435|NCT00718809|10430202|P2|Overall Study|Lost to Follow-up|0
3033436|NCT00718809|10430203|P1|Overall Study|Lost to Follow-up|1
3033437|NCT00718809|10430202|P2|Overall Study|Withdrawal by Subject|1
3033438|NCT00718809|10430203|P1|Overall Study|Withdrawal by Subject|0
3033439|NCT00718809|10430202|P2|Overall Study|Adverse Event|1
3033440|NCT00718809|10430203|P1|Overall Study|Adverse Event|1
3033441|NCT00718809|10430202|P2|Overall Study|Disease progression|7
3033442|NCT00718809|10430203|P1|Overall Study|Disease progression|9
3033443|NCT00718770|10430217|P1|Overall Study|Adverse Event|1
3033444|NCT00718770|10430217|P1|Overall Study|Lack of Efficacy|1
3033445|NCT00718770|10430217|P1|Overall Study|Adverse Event|1
3033446|NCT00718770|10430217|P1|Overall Study|Lack of Efficacy|1
3033447|NCT00718770|10430217|P1|Overall Study|Adverse Event|1
3033448|NCT00718770|10430217|P1|Overall Study|Lack of Efficacy|1
3033449|NCT00718770|10430217|P1|Overall Study|Lack of Efficacy|1
3033450|NCT00718770|10430217|P1|Overall Study|Adverse Event|1
3033451|NCT00718718|10430228|P10|Week 12 to End of Study|Other|0
3033452|NCT00718718|10430229|P9|Week 12 to End of Study|Other|0
3033453|NCT00718718|10430230|P8|Week 12 to End of Study|Other|0
3033454|NCT00718718|10430231|P7|Week 12 to End of Study|Other|1
3033455|NCT00718718|10430232|P6|Week 12 to End of Study|Other|0
3033456|NCT00718718|10430233|P5|Week 12 to End of Study|Other|0
3033457|NCT00718718|10430234|P4|Week 12 to End of Study|Other|1
3033458|NCT00718718|10430235|P3|Week 12 to End of Study|Other|0
3033459|NCT00718718|10430236|P2|Week 12 to End of Study|Other|1
3033460|NCT00718718|10430237|P1|Week 12 to End of Study|Other|0
3033461|NCT00718718|10430228|P10|Week 12 to End of Study|Lost to Follow-up|0
3033462|NCT00718718|10430229|P9|Week 12 to End of Study|Lost to Follow-up|1
3033463|NCT00718718|10430230|P8|Week 12 to End of Study|Lost to Follow-up|0
3033464|NCT00718718|10430231|P7|Week 12 to End of Study|Lost to Follow-up|0
3033465|NCT00718718|10430232|P6|Week 12 to End of Study|Lost to Follow-up|0
3033466|NCT00718718|10430233|P5|Week 12 to End of Study|Lost to Follow-up|0
3033467|NCT00718718|10430234|P4|Week 12 to End of Study|Lost to Follow-up|0
3033468|NCT00718718|10430235|P3|Week 12 to End of Study|Lost to Follow-up|0
3033469|NCT00718718|10430236|P2|Week 12 to End of Study|Lost to Follow-up|0
3033470|NCT00718718|10430237|P1|Week 12 to End of Study|Lost to Follow-up|0
3033471|NCT00718718|10430228|P10|Week 12 to End of Study|Withdrawal by Subject|0
3033472|NCT00718718|10430229|P9|Week 12 to End of Study|Withdrawal by Subject|0
3033473|NCT00718718|10430230|P8|Week 12 to End of Study|Withdrawal by Subject|0
3033474|NCT00718718|10430231|P7|Week 12 to End of Study|Withdrawal by Subject|1
3033475|NCT00718718|10430232|P6|Week 12 to End of Study|Withdrawal by Subject|2
3033476|NCT00718718|10430233|P5|Week 12 to End of Study|Withdrawal by Subject|0
3033477|NCT00718718|10430234|P4|Week 12 to End of Study|Withdrawal by Subject|0
3033478|NCT00718718|10430235|P3|Week 12 to End of Study|Withdrawal by Subject|0
3033479|NCT00718718|10430236|P2|Week 12 to End of Study|Withdrawal by Subject|0
3033480|NCT00718718|10430237|P1|Week 12 to End of Study|Withdrawal by Subject|0
3033481|NCT00718718|10430228|P10|Week 12 to End of Study|Death|0
3033482|NCT00718718|10430229|P9|Week 12 to End of Study|Death|0
3033483|NCT00718718|10430230|P8|Week 12 to End of Study|Death|0
3033484|NCT00718718|10430231|P7|Week 12 to End of Study|Death|0
3033485|NCT00718718|10430232|P6|Week 12 to End of Study|Death|1
3033486|NCT00718718|10430233|P5|Week 12 to End of Study|Death|0
3033487|NCT00718718|10430234|P4|Week 12 to End of Study|Death|0
3033488|NCT00718718|10430235|P3|Week 12 to End of Study|Death|0
3033489|NCT00718718|10430236|P2|Week 12 to End of Study|Death|0
3033490|NCT00718718|10430237|P1|Week 12 to End of Study|Death|0
3033491|NCT00718718|10430228|P10|Week 12 to End of Study|Adverse Event|0
3033492|NCT00718718|10430229|P9|Week 12 to End of Study|Adverse Event|0
3033493|NCT00718718|10430230|P8|Week 12 to End of Study|Adverse Event|1
3033494|NCT00718718|10430231|P7|Week 12 to End of Study|Adverse Event|0
3033495|NCT00718718|10430232|P6|Week 12 to End of Study|Adverse Event|0
3033496|NCT00718718|10430233|P5|Week 12 to End of Study|Adverse Event|0
3033497|NCT00718718|10430234|P4|Week 12 to End of Study|Adverse Event|0
3033498|NCT00718718|10430235|P3|Week 12 to End of Study|Adverse Event|0
3033499|NCT00718718|10430236|P2|Week 12 to End of Study|Adverse Event|0
3033500|NCT00718718|10430237|P1|Week 12 to End of Study|Adverse Event|0
3033501|NCT00718718|10430228|P10|Prior to Week 12|Other|0
3033502|NCT00718718|10430229|P9|Prior to Week 12|Other|0
3033503|NCT00718718|10430230|P8|Prior to Week 12|Other|0
3033504|NCT00718718|10430231|P7|Prior to Week 12|Other|0
3033505|NCT00718718|10430232|P6|Prior to Week 12|Other|0
3033506|NCT00718718|10430233|P5|Prior to Week 12|Other|0
3033507|NCT00718718|10430234|P4|Prior to Week 12|Other|0
3033508|NCT00718718|10430235|P3|Prior to Week 12|Other|1
3033509|NCT00718718|10430236|P2|Prior to Week 12|Other|0
3033510|NCT00718718|10430237|P1|Prior to Week 12|Other|1
3033511|NCT00718718|10430228|P10|Prior to Week 12|Withdrawal by Subject|0
3033512|NCT00718718|10430229|P9|Prior to Week 12|Withdrawal by Subject|1
3033513|NCT00718718|10430230|P8|Prior to Week 12|Withdrawal by Subject|1
3033514|NCT00718718|10430231|P7|Prior to Week 12|Withdrawal by Subject|1
3033515|NCT00718718|10430232|P6|Prior to Week 12|Withdrawal by Subject|0
3033516|NCT00718718|10430233|P5|Prior to Week 12|Withdrawal by Subject|3
3033517|NCT00718718|10430234|P4|Prior to Week 12|Withdrawal by Subject|0
3033518|NCT00718718|10430235|P3|Prior to Week 12|Withdrawal by Subject|0
3033519|NCT00718718|10430236|P2|Prior to Week 12|Withdrawal by Subject|0
3033520|NCT00718718|10430237|P1|Prior to Week 12|Withdrawal by Subject|0
3033521|NCT00718718|10430228|P10|Prior to Week 12|Adverse Event|0
3033522|NCT00718718|10430229|P9|Prior to Week 12|Adverse Event|1
3033523|NCT00718718|10430230|P8|Prior to Week 12|Adverse Event|1
3033524|NCT00718718|10430231|P7|Prior to Week 12|Adverse Event|0
3033525|NCT00718718|10430232|P6|Prior to Week 12|Adverse Event|0
3033526|NCT00718718|10430233|P5|Prior to Week 12|Adverse Event|0
3033527|NCT00718718|10430234|P4|Prior to Week 12|Adverse Event|0
3033528|NCT00718718|10430235|P3|Prior to Week 12|Adverse Event|0
3033529|NCT00718718|10430236|P2|Prior to Week 12|Adverse Event|0
3033530|NCT00718718|10430237|P1|Prior to Week 12|Adverse Event|0
3033531|NCT00718666|10430280|P3|Booster Phase Year 5|Lost to Follow-up|4
3033532|NCT00718666|10430281|P2|Booster Phase Year 5|Lost to Follow-up|0
3033533|NCT00718666|10430282|P1|Booster Phase Year 5|Lost to Follow-up|1
3033534|NCT00718666|10430280|P3|Booster Phase Year 5|Withdrawal by Subject|1
3033535|NCT00718666|10430281|P2|Booster Phase Year 5|Withdrawal by Subject|0
3033536|NCT00718666|10430282|P1|Booster Phase Year 5|Withdrawal by Subject|0
3033537|NCT00718666|10430280|P3|Booster Phase Year 5|Declined v-4 serology|0
3033538|NCT00718666|10430281|P2|Booster Phase Year 5|Declined v-4 serology|0
3033539|NCT00718666|10430282|P1|Booster Phase Year 5|Declined v-4 serology|1
3033540|NCT00718666|10430280|P3|Booster Phase Year 5|No active participation request|1
3033541|NCT00718666|10430281|P2|Booster Phase Year 5|No active participation request|0
3033542|NCT00718666|10430282|P1|Booster Phase Year 5|No active participation request|0
3033543|NCT00718640|10430366|P1|Overall Study|Unresolved toxicity after 2 weeks|2
3033544|NCT00718640|10430366|P1|Overall Study|Death|1
3033545|NCT00718640|10430366|P1|Overall Study|Adverse Event|4
3033546|NCT00718549|10430378|P3|Maintenance/ Observation Phase|Relapse|2
3033547|NCT00718549|10430379|P2|Maintenance/ Observation Phase|Relapse|3
3033548|NCT00718549|10430380|P1|Maintenance/ Observation Phase|Relapse|0
3033549|NCT00718549|10430378|P3|Maintenance/ Observation Phase|Progression|14
3033550|NCT00718549|10430379|P2|Maintenance/ Observation Phase|Progression|5
3033551|NCT00718549|10430380|P1|Maintenance/ Observation Phase|Progression|0
3033552|NCT00718549|10430378|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
3033553|NCT00718549|10430379|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
3033554|NCT00718549|10430380|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
3033555|NCT00718549|10430378|P3|Maintenance/ Observation Phase|Death|2
3033556|NCT00718549|10430379|P2|Maintenance/ Observation Phase|Death|1
3033557|NCT00718549|10430380|P1|Maintenance/ Observation Phase|Death|0
3033558|NCT00718549|10430378|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
3033559|NCT00718549|10430379|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
3033560|NCT00718549|10430380|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
3033561|NCT00718549|10430378|P3|Induction Phase|Early Termination - No Additional Info|0
3033562|NCT00718549|10430379|P2|Induction Phase|Early Termination - No Additional Info|0
3033563|NCT00718549|10430380|P1|Induction Phase|Early Termination - No Additional Info|59
3033564|NCT00718549|10430378|P3|Induction Phase|Eligibility Criteria Violation|0
3033565|NCT00718549|10430379|P2|Induction Phase|Eligibility Criteria Violation|0
3033566|NCT00718549|10430380|P1|Induction Phase|Eligibility Criteria Violation|2
3033567|NCT00718549|10430378|P3|Induction Phase|Disease Progression|0
3033568|NCT00718549|10430379|P2|Induction Phase|Disease Progression|0
3033569|NCT00718549|10430380|P1|Induction Phase|Disease Progression|1
3033570|NCT00718523|10430405|P2|Overall Study|Death|17
3033571|NCT00718523|10430406|P1|Overall Study|Death|13
3033572|NCT00718523|10430405|P2|Overall Study|Withdrawal by Subject|7
3033573|NCT00718523|10430406|P1|Overall Study|Withdrawal by Subject|5
3033574|NCT00718510|10430418|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
3033575|NCT00718510|10430419|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
3033576|NCT00718510|10430418|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
3033577|NCT00718510|10430419|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
3033578|NCT00718328|10430431|P2|Overall Study|Lost to Follow-up|0
3033579|NCT00718328|10430432|P1|Overall Study|Lost to Follow-up|1
3033580|NCT00718315|10430441|P3|Overall Study|Use of ATB and Corticoids|2
3033581|NCT00718315|10430442|P2|Overall Study|Use of ATB and Corticoids|1
3033582|NCT00718315|10430443|P1|Overall Study|Use of ATB and Corticoids|0
3033583|NCT00718315|10430441|P3|Overall Study|Other|1
3033584|NCT00718315|10430442|P2|Overall Study|Other|0
3033585|NCT00718315|10430443|P1|Overall Study|Other|0
3033586|NCT00718315|10430441|P3|Overall Study|Disease progression|1
3033587|NCT00718315|10430442|P2|Overall Study|Disease progression|1
3033588|NCT00718315|10430443|P1|Overall Study|Disease progression|0
3033589|NCT00718315|10430441|P3|Overall Study|Use of Minocyclin|1
3033590|NCT00718315|10430442|P2|Overall Study|Use of Minocyclin|1
3033591|NCT00718315|10430443|P1|Overall Study|Use of Minocyclin|1
3033592|NCT00718315|10430441|P3|Overall Study|Erlotinib dose decreased|1
3033593|NCT00718315|10430442|P2|Overall Study|Erlotinib dose decreased|3
3033594|NCT00718315|10430443|P1|Overall Study|Erlotinib dose decreased|4
3033595|NCT00718315|10430441|P3|Overall Study|Protocol Violation|3
3033596|NCT00718315|10430442|P2|Overall Study|Protocol Violation|5
3033597|NCT00718315|10430443|P1|Overall Study|Protocol Violation|5
3033598|NCT00718315|10430441|P3|Overall Study|Lost to Follow-up|4
3033599|NCT00718315|10430442|P2|Overall Study|Lost to Follow-up|3
3033600|NCT00718315|10430443|P1|Overall Study|Lost to Follow-up|2
3033601|NCT00718315|10430441|P3|Overall Study|Death|5
3033602|NCT00718315|10430442|P2|Overall Study|Death|6
3033603|NCT00718315|10430443|P1|Overall Study|Death|6
3033604|NCT00718315|10430441|P3|Overall Study|Adverse Event|3
3033605|NCT00718315|10430442|P2|Overall Study|Adverse Event|2
3033606|NCT00718315|10430443|P1|Overall Study|Adverse Event|1
3033607|NCT00718237|10430494|P2|Overall Study|Withdrawal by Subject|10
3033608|NCT00718237|10430495|P1|Overall Study|Withdrawal by Subject|9
3033609|NCT00718237|10430494|P2|Overall Study|Physician Decision|0
3033610|NCT00718237|10430495|P1|Overall Study|Physician Decision|1
3033611|NCT00718237|10430494|P2|Overall Study|Lost to Follow-up|2
3033612|NCT00718237|10430495|P1|Overall Study|Lost to Follow-up|2
3033613|NCT00718237|10430494|P2|Overall Study|Adverse Event|3
3033614|NCT00718237|10430495|P1|Overall Study|Adverse Event|1
3033615|NCT00718159|10430512|P7|Overall Study|Investigator Decision|1
3033616|NCT00718159|10430513|P6|Overall Study|Investigator Decision|1
3033617|NCT00718159|10430514|P5|Overall Study|Investigator Decision|0
3033618|NCT00718159|10430515|P4|Overall Study|Investigator Decision|0
3033619|NCT00718159|10430516|P3|Overall Study|Investigator Decision|0
3033620|NCT00718159|10430517|P2|Overall Study|Investigator Decision|0
3033621|NCT00718159|10430518|P1|Overall Study|Investigator Decision|0
3033622|NCT00718159|10430512|P7|Overall Study|Death due to Study Drug Toxicity|0
3033623|NCT00718159|10430513|P6|Overall Study|Death due to Study Drug Toxicity|0
3033624|NCT00718159|10430514|P5|Overall Study|Death due to Study Drug Toxicity|0
3033625|NCT00718159|10430515|P4|Overall Study|Death due to Study Drug Toxicity|2
3033626|NCT00718159|10430516|P3|Overall Study|Death due to Study Drug Toxicity|1
3033627|NCT00718159|10430517|P2|Overall Study|Death due to Study Drug Toxicity|0
3033628|NCT00718159|10430518|P1|Overall Study|Death due to Study Drug Toxicity|0
3033629|NCT00718159|10430512|P7|Overall Study|Death due to Adverse Event|0
3033630|NCT00718159|10430513|P6|Overall Study|Death due to Adverse Event|0
3033631|NCT00718159|10430514|P5|Overall Study|Death due to Adverse Event|2
3033632|NCT00718159|10430515|P4|Overall Study|Death due to Adverse Event|2
3033633|NCT00718159|10430516|P3|Overall Study|Death due to Adverse Event|0
3033634|NCT00718159|10430517|P2|Overall Study|Death due to Adverse Event|0
3033635|NCT00718159|10430518|P1|Overall Study|Death due to Adverse Event|0
3033636|NCT00718159|10430512|P7|Overall Study|Progressive Disease|0
3033637|NCT00718159|10430513|P6|Overall Study|Progressive Disease|0
3033638|NCT00718159|10430514|P5|Overall Study|Progressive Disease|6
3033639|NCT00718159|10430515|P4|Overall Study|Progressive Disease|0
3033640|NCT00718159|10430516|P3|Overall Study|Progressive Disease|2
3033641|NCT00718159|10430517|P2|Overall Study|Progressive Disease|3
3033642|NCT00718159|10430518|P1|Overall Study|Progressive Disease|3
3033643|NCT00718081|10430575|P3|Overall Study|Lack of Efficacy|21
3033644|NCT00718081|10430576|P2|Overall Study|Lack of Efficacy|3
3033645|NCT00718081|10430577|P1|Overall Study|Lack of Efficacy|7
3033646|NCT00718081|10430575|P3|Overall Study|Adverse Event|0
3033647|NCT00718081|10430576|P2|Overall Study|Adverse Event|1
3033648|NCT00718081|10430577|P1|Overall Study|Adverse Event|0
3033649|NCT00718042|10430594|P6|Donor Follow-up|Lost to Follow-up|0
3033650|NCT00718042|10430595|P5|Donor Follow-up|Lost to Follow-up|19
3033651|NCT00718042|10430596|P4|Donor Follow-up|Lost to Follow-up|0
3033652|NCT00718042|10430597|P3|Donor Follow-up|Lost to Follow-up|0
3033653|NCT00718042|10430598|P2|Donor Follow-up|Lost to Follow-up|0
3033654|NCT00718042|10430599|P1|Donor Follow-up|Lost to Follow-up|13
3033655|NCT00718042|10430594|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
3033656|NCT00718042|10430595|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
3033657|NCT00718042|10430596|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
3033658|NCT00718042|10430597|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
3033659|NCT00718042|10430598|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
3033660|NCT00718042|10430599|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
3033661|NCT00718042|10430594|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
3033662|NCT00718042|10430595|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
3033663|NCT00718042|10430596|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
3033664|NCT00718042|10430597|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
3033665|NCT00718042|10430598|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
3033666|NCT00718042|10430599|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
3033667|NCT00718042|10430594|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
3033668|NCT00718042|10430595|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
3033669|NCT00718042|10430596|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
3033670|NCT00718042|10430597|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
3033671|NCT00718042|10430598|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
3033672|NCT00718042|10430599|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
3033673|NCT00718042|10430594|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
3033674|NCT00718042|10430595|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
3033675|NCT00718042|10430596|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
3033676|NCT00718042|10430597|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
3033677|NCT00718042|10430598|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
3033678|NCT00718042|10430599|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
3033679|NCT00717886|10430655|P1|Overall Study|Treatment Failure|1
3033680|NCT00717886|10430655|P1|Overall Study|Withdrawal by Subject|3
3033681|NCT00717860|10430670|P2|Overall Study|Withdrew consent|3
3033682|NCT00717860|10430671|P1|Overall Study|Withdrew consent|7
3033683|NCT00717860|10430670|P2|Overall Study|Discontinued for other reason|1
3033684|NCT00717860|10430671|P1|Overall Study|Discontinued for other reason|6
3033685|NCT00717860|10430670|P2|Overall Study|Lack of Efficacy|13
3033686|NCT00717860|10430671|P1|Overall Study|Lack of Efficacy|7
3033687|NCT00717860|10430670|P2|Overall Study|Laboratory adverse experience|2
3033688|NCT00717860|10430671|P1|Overall Study|Laboratory adverse experience|2
3033689|NCT00717860|10430670|P2|Overall Study|Clinical adverse experience|9
3033690|NCT00717860|10430671|P1|Overall Study|Clinical adverse experience|5
3033691|NCT00717756|10430681|P1|Overall Study|Withdrawal by Subject|1
3033692|NCT00717522|10430694|P1|Overall Study|Death|1
3033693|NCT00717522|10430694|P1|Overall Study|Adverse Event|1
3033694|NCT00717522|10430694|P1|Overall Study|Disease Progression|5
3033695|NCT00717366|10430730|P2|Extension Period (52 Weeks)|Withdrew consent|1
3033696|NCT00717366|10430731|P1|Extension Period (52 Weeks)|Withdrew consent|1
3033697|NCT00717366|10430730|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
3033698|NCT00717366|10430731|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
3033699|NCT00717366|10430730|P2|Extension Period (52 Weeks)|Renal transplant|13
3033700|NCT00717366|10430731|P1|Extension Period (52 Weeks)|Renal transplant|3
3033701|NCT00717366|10430730|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
3033702|NCT00717366|10430731|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
3033703|NCT00717366|10430730|P2|Core Study Period (20 Weeks)|Death|1
3033704|NCT00717366|10430731|P1|Core Study Period (20 Weeks)|Death|0
3033705|NCT00717366|10430730|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
3033706|NCT00717366|10430731|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
3033707|NCT00717366|10430730|P2|Core Study Period (20 Weeks)|Renal transplant|9
3033708|NCT00717366|10430731|P1|Core Study Period (20 Weeks)|Renal transplant|4
3033709|NCT00717314|10430755|P2|Overall Study|Withdrawal by Subject|3
3033710|NCT00717314|10430756|P1|Overall Study|Withdrawal by Subject|1
3033711|NCT00717314|10430755|P2|Overall Study|Lost to Follow-up|5
3033712|NCT00717314|10430756|P1|Overall Study|Lost to Follow-up|1
3033713|NCT00717314|10430755|P2|Overall Study|Protocol Violation|0
3033714|NCT00717314|10430756|P1|Overall Study|Protocol Violation|1
3033715|NCT00717314|10430755|P2|Overall Study|Adverse Event|2
3033716|NCT00717314|10430756|P1|Overall Study|Adverse Event|3
3033717|NCT00717275|10430793|P1|Overall Study|Premature study termination.|3
3033718|NCT00717249|10430799|P2|Overall Study|Headaches|0
3033719|NCT00717249|10430800|P1|Overall Study|Headaches|1
3033720|NCT00717249|10430799|P2|Overall Study|Subject relocated|0
3033721|NCT00717249|10430800|P1|Overall Study|Subject relocated|1
3033722|NCT00717249|10430799|P2|Overall Study|Diagnosed with Multiple Scletosis|0
3033723|NCT00717249|10430800|P1|Overall Study|Diagnosed with Multiple Scletosis|1
3033724|NCT00717249|10430799|P2|Overall Study|Diagnosed with Diabetes|0
3033725|NCT00717249|10430800|P1|Overall Study|Diagnosed with Diabetes|1
3033726|NCT00717249|10430799|P2|Overall Study|Gastric Surgery|1
3033727|NCT00717249|10430800|P1|Overall Study|Gastric Surgery|0
3033728|NCT00717249|10430799|P2|Overall Study|Unsatisfactory Physiological Response|1
3033729|NCT00717249|10430800|P1|Overall Study|Unsatisfactory Physiological Response|0
3033730|NCT00717249|10430799|P2|Overall Study|Subject became Ineligible|1
3033731|NCT00717249|10430800|P1|Overall Study|Subject became Ineligible|1
3033732|NCT00717249|10430799|P2|Overall Study|Protocol Violation|2
3033733|NCT00717249|10430800|P1|Overall Study|Protocol Violation|0
3033734|NCT00717249|10430799|P2|Overall Study|Pregnancy|3
3033735|NCT00717249|10430800|P1|Overall Study|Pregnancy|6
3033736|NCT00717249|10430799|P2|Overall Study|Withdrawal by Subject|2
3033737|NCT00717249|10430800|P1|Overall Study|Withdrawal by Subject|1
3033738|NCT00717249|10430799|P2|Overall Study|Lost to Follow-up|0
3033739|NCT00717249|10430800|P1|Overall Study|Lost to Follow-up|2
3033740|NCT00717249|10430799|P2|Overall Study|Adverse Event|2
3033741|NCT00717249|10430800|P1|Overall Study|Adverse Event|4
3033742|NCT00717249|10430799|P2|Overall Study|Unsatisfactory visual Response|2
3033743|NCT00717249|10430800|P1|Overall Study|Unsatisfactory visual Response|0
3033744|NCT00717249|10430799|P2|Overall Study|Lens Discomfort|1
3033745|NCT00717249|10430800|P1|Overall Study|Lens Discomfort|4
3033746|NCT00717236|10430814|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
3033747|NCT00717236|10430815|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
3033748|NCT00717236|10430814|P2|Open-Label Period|Other: Completion Accidently Performed|0
3033749|NCT00717236|10430815|P1|Open-Label Period|Other: Completion Accidently Performed|1
3033750|NCT00717236|10430814|P2|Open-Label Period|Other: Administration of Golimumab|0
3033751|NCT00717236|10430815|P1|Open-Label Period|Other: Administration of Golimumab|1
3033752|NCT00717236|10430814|P2|Open-Label Period|Other: Cataract Surgery|0
3033753|NCT00717236|10430815|P1|Open-Label Period|Other: Cataract Surgery|1
3033754|NCT00717236|10430814|P2|Open-Label Period|Other: Sponsor Request|0
3033755|NCT00717236|10430815|P1|Open-Label Period|Other: Sponsor Request|3
3033756|NCT00717236|10430814|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
3033757|NCT00717236|10430815|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
3033758|NCT00717236|10430814|P2|Open-Label Period|Other: Investigator Decision|0
3033759|NCT00717236|10430815|P1|Open-Label Period|Other: Investigator Decision|1
3033760|NCT00717236|10430814|P2|Open-Label Period|Other: Moved|0
3033761|NCT00717236|10430815|P1|Open-Label Period|Other: Moved|1
3033762|NCT00717236|10430814|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
3033763|NCT00717236|10430815|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
3033764|NCT00717236|10430814|P2|Open-Label Period|Other: Lack of Compliance|1
3033765|NCT00717236|10430815|P1|Open-Label Period|Other: Lack of Compliance|1
3033766|NCT00717236|10430814|P2|Open-Label Period|Other: Peripheral Neuropathy|1
3033767|NCT00717236|10430815|P1|Open-Label Period|Other: Peripheral Neuropathy|0
3033768|NCT00717236|10430814|P2|Open-Label Period|Loss of Efficacy|1
3033769|NCT00717236|10430815|P1|Open-Label Period|Loss of Efficacy|6
3033770|NCT00717236|10430814|P2|Open-Label Period|Withdrawal by Subject|2
3033771|NCT00717236|10430815|P1|Open-Label Period|Withdrawal by Subject|20
3033772|NCT00717236|10430814|P2|Open-Label Period|Lost to Follow-up|4
3033773|NCT00717236|10430815|P1|Open-Label Period|Lost to Follow-up|28
3033774|NCT00717236|10430814|P2|Open-Label Period|Lack of Efficacy|8
3033775|NCT00717236|10430815|P1|Open-Label Period|Lack of Efficacy|30
3033776|NCT00717236|10430814|P2|Open-Label Period|Adverse Event|4
3033777|NCT00717236|10430815|P1|Open-Label Period|Adverse Event|29
3033778|NCT00717236|10430814|P2|Double-Blind Period|Other: Investigator Decision|1
3033779|NCT00717236|10430815|P1|Double-Blind Period|Other: Investigator Decision|0
3033780|NCT00717236|10430814|P2|Double-Blind Period|Other: Transportation problems|1
3033781|NCT00717236|10430815|P1|Double-Blind Period|Other: Transportation problems|0
3033782|NCT00717236|10430814|P2|Double-Blind Period|Other: Prohibited medication taken|2
3033783|NCT00717236|10430815|P1|Double-Blind Period|Other: Prohibited medication taken|2
3033784|NCT00717236|10430814|P2|Double-Blind Period|Other: Stopped taking DMARD|0
3033785|NCT00717236|10430815|P1|Double-Blind Period|Other: Stopped taking DMARD|1
3033786|NCT00717236|10430814|P2|Double-Blind Period|Other: Subject moved|1
3033787|NCT00717236|10430815|P1|Double-Blind Period|Other: Subject moved|1
3033788|NCT00717236|10430814|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
3033789|NCT00717236|10430815|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
3033790|NCT00717236|10430814|P2|Double-Blind Period|Other: Inappropriate randomization|0
3033791|NCT00717236|10430815|P1|Double-Blind Period|Other: Inappropriate randomization|1
3033792|NCT00717236|10430814|P2|Double-Blind Period|Other: Sponsor request|0
3033793|NCT00717236|10430815|P1|Double-Blind Period|Other: Sponsor request|1
3033794|NCT00717236|10430814|P2|Double-Blind Period|Other: History of cancer|0
3033795|NCT00717236|10430815|P1|Double-Blind Period|Other: History of cancer|1
3033796|NCT00717236|10430814|P2|Double-Blind Period|Other: History of adenoid grown|0
3033797|NCT00717236|10430815|P1|Double-Blind Period|Other: History of adenoid grown|1
3033798|NCT00717236|10430814|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
3033799|NCT00717236|10430815|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
3033800|NCT00717236|10430814|P2|Double-Blind Period|Other: subject withdrew consent|1
3033801|NCT00717236|10430815|P1|Double-Blind Period|Other: subject withdrew consent|1
3033802|NCT00717236|10430814|P2|Double-Blind Period|Other: Screening failure|0
3033803|NCT00717236|10430815|P1|Double-Blind Period|Other: Screening failure|1
3033804|NCT00717236|10430814|P2|Double-Blind Period|Other: Site withdrew|0
3033805|NCT00717236|10430815|P1|Double-Blind Period|Other: Site withdrew|2
3033806|NCT00717236|10430814|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
3033807|NCT00717236|10430815|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
3033808|NCT00717236|10430814|P2|Double-Blind Period|Other: Protocol Violation|0
3033809|NCT00717236|10430815|P1|Double-Blind Period|Other: Protocol Violation|2
3033810|NCT00717236|10430814|P2|Double-Blind Period|Other: Pregnancy|0
3033811|NCT00717236|10430815|P1|Double-Blind Period|Other: Pregnancy|1
3033812|NCT00717236|10430814|P2|Double-Blind Period|Other: Death|0
3033813|NCT00717236|10430815|P1|Double-Blind Period|Other: Death|1
3033814|NCT00717236|10430814|P2|Double-Blind Period|Loss of efficacy|0
3033815|NCT00717236|10430815|P1|Double-Blind Period|Loss of efficacy|3
3033816|NCT00717236|10430814|P2|Double-Blind Period|Withdrawal by Subject|2
3033817|NCT00717236|10430815|P1|Double-Blind Period|Withdrawal by Subject|10
3033818|NCT00717236|10430814|P2|Double-Blind Period|Lost to Follow-up|5
3033819|NCT00717236|10430815|P1|Double-Blind Period|Lost to Follow-up|3
3033820|NCT00717236|10430814|P2|Double-Blind Period|Lack of Efficacy|6
3033821|NCT00717236|10430815|P1|Double-Blind Period|Lack of Efficacy|6
3033822|NCT00717236|10430814|P2|Double-Blind Period|Adverse Event|6
3033823|NCT00717236|10430815|P1|Double-Blind Period|Adverse Event|33
3033824|NCT00717197|10430884|P1|Overall Study|Physician Decision|1
3033825|NCT00717197|10430884|P1|Overall Study|Tumor Progression|1
3033826|NCT00717197|10430884|P1|Overall Study|Unable to purchase study drug|5
3033827|NCT00717093|10430890|P2|Overall Study|Randomized but not treated|0
3033828|NCT00717093|10430891|P1|Overall Study|Randomized but not treated|1
3033829|NCT00717093|10430890|P2|Overall Study|Other|1
3033830|NCT00717093|10430891|P1|Overall Study|Other|0
3033831|NCT00717093|10430890|P2|Overall Study|Withdrawal by Subject|19
3033832|NCT00717093|10430891|P1|Overall Study|Withdrawal by Subject|12
3033833|NCT00717093|10430890|P2|Overall Study|Lost to Follow-up|6
3033834|NCT00717093|10430891|P1|Overall Study|Lost to Follow-up|9
3033835|NCT00717093|10430890|P2|Overall Study|Lack of Efficacy|13
3033836|NCT00717093|10430891|P1|Overall Study|Lack of Efficacy|3
3033837|NCT00717093|10430890|P2|Overall Study|Adverse Event|9
3033838|NCT00717093|10430891|P1|Overall Study|Adverse Event|19
3033839|NCT00717067|10430908|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
3033840|NCT00717067|10430909|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
3033841|NCT00717067|10430910|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
3033842|NCT00717067|10430911|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
3033843|NCT00717067|10430912|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
3033844|NCT00716976|10431019|P2|Overall Study|Ineligibles|2
3033845|NCT00716976|10431020|P1|Overall Study|Ineligibles|4
3033846|NCT00716976|10431019|P2|Overall Study|Radiation during protocol|0
3033847|NCT00716976|10431020|P1|Overall Study|Radiation during protocol|1
3033848|NCT00716976|10431019|P2|Overall Study|Premature discontinuation cisplatin|4
3033849|NCT00716976|10431020|P1|Overall Study|Premature discontinuation cisplatin|5
3033850|NCT00716976|10431019|P2|Overall Study|Withdrawal by Subject|1
3033851|NCT00716976|10431020|P1|Overall Study|Withdrawal by Subject|5
3033852|NCT00716976|10431019|P2|Overall Study|Physician Decision|2
3033853|NCT00716976|10431020|P1|Overall Study|Physician Decision|2
3033854|NCT00716976|10431019|P2|Overall Study|Death|0
3033855|NCT00716976|10431020|P1|Overall Study|Death|1
3033856|NCT00716976|10431019|P2|Overall Study|Adverse Event|0
3033857|NCT00716976|10431020|P1|Overall Study|Adverse Event|2
3033858|NCT00716859|10431060|P2|Overall Study|Not treated|1
3033859|NCT00716859|10431061|P1|Overall Study|Not treated|1
3033860|NCT00716859|10431060|P2|Overall Study|Withdrawal by Subject|3
3033861|NCT00716859|10431061|P1|Overall Study|Withdrawal by Subject|1
3033862|NCT00716859|10431060|P2|Overall Study|Lack of Efficacy|0
3033863|NCT00716859|10431061|P1|Overall Study|Lack of Efficacy|3
3033864|NCT00716859|10431060|P2|Overall Study|Adverse Event|1
3033865|NCT00716859|10431061|P1|Overall Study|Adverse Event|4
3033866|NCT00716625|10431146|P1|Overall Study|Safety was not Assessable|1
3033867|NCT00716482|10431171|P1|Overall Study|inclusion/exclusion criteria not met|25
3033868|NCT00716482|10431171|P1|Overall Study|technical/machine error|28
3033869|NCT00716482|10431171|P1|Overall Study|no pathology obtained|10
3033870|NCT00716482|10431171|P1|Overall Study|Inadequate acquisition or analysis|50
3033871|NCT00716482|10431171|P1|Overall Study|Lost to Follow-up|6
3033872|NCT00716456|10431184|P3|Overall Study|Adverse Event|0
3033873|NCT00716456|10431185|P2|Overall Study|Adverse Event|2
3033874|NCT00716456|10431186|P1|Overall Study|Adverse Event|0
3033875|NCT00716417|10431237|P10|Overall Study|On patient request due to toxicities|0
3033876|NCT00716417|10431238|P9|Overall Study|On patient request due to toxicities|0
3033877|NCT00716417|10431239|P8|Overall Study|On patient request due to toxicities|1
3033878|NCT00716417|10431240|P7|Overall Study|On patient request due to toxicities|0
3033879|NCT00716417|10431241|P6|Overall Study|On patient request due to toxicities|0
3033880|NCT00716417|10431242|P5|Overall Study|On patient request due to toxicities|0
3033881|NCT00716417|10431243|P4|Overall Study|On patient request due to toxicities|0
3033882|NCT00716417|10431244|P3|Overall Study|On patient request due to toxicities|0
3033883|NCT00716417|10431245|P2|Overall Study|On patient request due to toxicities|0
3033884|NCT00716417|10431246|P1|Overall Study|On patient request due to toxicities|0
3033885|NCT00716417|10431237|P10|Overall Study|Dose limiting toxicity (DLT)|0
3033886|NCT00716417|10431238|P9|Overall Study|Dose limiting toxicity (DLT)|0
3033887|NCT00716417|10431239|P8|Overall Study|Dose limiting toxicity (DLT)|0
3033888|NCT00716417|10431240|P7|Overall Study|Dose limiting toxicity (DLT)|0
3033889|NCT00716417|10431241|P6|Overall Study|Dose limiting toxicity (DLT)|0
3033890|NCT00716417|10431242|P5|Overall Study|Dose limiting toxicity (DLT)|1
3033891|NCT00716417|10431243|P4|Overall Study|Dose limiting toxicity (DLT)|0
3033892|NCT00716417|10431244|P3|Overall Study|Dose limiting toxicity (DLT)|0
3033893|NCT00716417|10431245|P2|Overall Study|Dose limiting toxicity (DLT)|0
3033894|NCT00716417|10431246|P1|Overall Study|Dose limiting toxicity (DLT)|0
3033895|NCT00716417|10431237|P10|Overall Study|Progressive disease|0
3033896|NCT00716417|10431238|P9|Overall Study|Progressive disease|5
3033897|NCT00716417|10431239|P8|Overall Study|Progressive disease|1
3033898|NCT00716417|10431240|P7|Overall Study|Progressive disease|3
3033899|NCT00716417|10431241|P6|Overall Study|Progressive disease|3
3033900|NCT00716417|10431242|P5|Overall Study|Progressive disease|0
3033901|NCT00716417|10431243|P4|Overall Study|Progressive disease|8
3033902|NCT00716417|10431244|P3|Overall Study|Progressive disease|3
3033903|NCT00716417|10431245|P2|Overall Study|Progressive disease|5
3033904|NCT00716417|10431246|P1|Overall Study|Progressive disease|3
3033905|NCT00716417|10431237|P10|Overall Study|Withdrawal by Subject|0
3033906|NCT00716417|10431238|P9|Overall Study|Withdrawal by Subject|0
3033907|NCT00716417|10431239|P8|Overall Study|Withdrawal by Subject|0
3033908|NCT00716417|10431240|P7|Overall Study|Withdrawal by Subject|1
3033909|NCT00716417|10431241|P6|Overall Study|Withdrawal by Subject|0
3033910|NCT00716417|10431242|P5|Overall Study|Withdrawal by Subject|0
3033911|NCT00716417|10431243|P4|Overall Study|Withdrawal by Subject|2
3033912|NCT00716417|10431244|P3|Overall Study|Withdrawal by Subject|0
3033913|NCT00716417|10431245|P2|Overall Study|Withdrawal by Subject|1
3033914|NCT00716417|10431246|P1|Overall Study|Withdrawal by Subject|0
3033915|NCT00716417|10431237|P10|Overall Study|Adverse Event|3
3033916|NCT00716417|10431238|P9|Overall Study|Adverse Event|0
3033917|NCT00716417|10431239|P8|Overall Study|Adverse Event|1
3033918|NCT00716417|10431240|P7|Overall Study|Adverse Event|3
3033919|NCT00716417|10431241|P6|Overall Study|Adverse Event|0
3033920|NCT00716417|10431242|P5|Overall Study|Adverse Event|0
3033921|NCT00716417|10431243|P4|Overall Study|Adverse Event|1
3033922|NCT00716417|10431244|P3|Overall Study|Adverse Event|2
3033923|NCT00716417|10431245|P2|Overall Study|Adverse Event|0
3033924|NCT00716417|10431246|P1|Overall Study|Adverse Event|0
3033925|NCT00716274|10431293|P6|Study Period III (16-Weeks)|Adverse Event|0
3033926|NCT00716274|10431294|P5|Study Period III (16-Weeks)|Adverse Event|1
3033927|NCT00716274|10431295|P4|Study Period III (16-Weeks)|Adverse Event|0
3033928|NCT00716274|10431296|P3|Study Period III (16-Weeks)|Adverse Event|0
3033929|NCT00716274|10431297|P2|Study Period III (16-Weeks)|Adverse Event|0
3033930|NCT00716274|10431298|P1|Study Period III (16-Weeks)|Adverse Event|0
3033931|NCT00716274|10431293|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
3033932|NCT00716274|10431294|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
3033933|NCT00716274|10431295|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
3033934|NCT00716274|10431296|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
3033935|NCT00716274|10431297|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
3033936|NCT00716274|10431298|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
3033937|NCT00716274|10431293|P6|Study Period III (16-Weeks)|Physician Decision|0
3033938|NCT00716274|10431294|P5|Study Period III (16-Weeks)|Physician Decision|1
3033939|NCT00716274|10431295|P4|Study Period III (16-Weeks)|Physician Decision|0
3033940|NCT00716274|10431296|P3|Study Period III (16-Weeks)|Physician Decision|0
3033941|NCT00716274|10431297|P2|Study Period III (16-Weeks)|Physician Decision|0
3033942|NCT00716274|10431298|P1|Study Period III (16-Weeks)|Physician Decision|0
3033943|NCT00716274|10431293|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
3033944|NCT00716274|10431294|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
3033945|NCT00716274|10431295|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
3033946|NCT00716274|10431296|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
3033947|NCT00716274|10431297|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
3033948|NCT00716274|10431298|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
3033949|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
3033950|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
3033951|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
3033952|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
3033953|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
3033954|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
3033955|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
3033956|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
3033957|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
3033958|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
3033959|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
3033960|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
3033961|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Physician Decision|1
3033962|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Physician Decision|0
3033963|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Physician Decision|0
3033964|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Physician Decision|0
3033965|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Physician Decision|1
3033966|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Physician Decision|3
3033967|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
3033968|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
3033969|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
3033970|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
3033971|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
3033972|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
3033973|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Protocol Violation|1
3033974|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Protocol Violation|0
3033975|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Protocol Violation|0
3033976|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Protocol Violation|0
3033977|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Protocol Violation|3
3033978|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Protocol Violation|0
3033979|NCT00716274|10431293|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
3033980|NCT00716274|10431294|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
3033981|NCT00716274|10431295|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
3033982|NCT00716274|10431296|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
3033983|NCT00716274|10431297|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
3033984|NCT00716274|10431298|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
3033985|NCT00716144|10431432|P4|Overall Study|Clinical Depression|0
3033986|NCT00716144|10431433|P3|Overall Study|Clinical Depression|0
3033987|NCT00716144|10431434|P2|Overall Study|Clinical Depression|1
3033988|NCT00716144|10431435|P1|Overall Study|Clinical Depression|0
3033989|NCT00716144|10431432|P4|Overall Study|Adverse event: left foot pain|0
3033990|NCT00716144|10431433|P3|Overall Study|Adverse event: left foot pain|0
3033991|NCT00716144|10431434|P2|Overall Study|Adverse event: left foot pain|1
3033992|NCT00716144|10431435|P1|Overall Study|Adverse event: left foot pain|0
3033993|NCT00716144|10431432|P4|Overall Study|Withdrew consent, allowed use of data|0
3033994|NCT00716144|10431433|P3|Overall Study|Withdrew consent, allowed use of data|1
3033995|NCT00716144|10431434|P2|Overall Study|Withdrew consent, allowed use of data|0
3033996|NCT00716144|10431435|P1|Overall Study|Withdrew consent, allowed use of data|0
3033997|NCT00716144|10431432|P4|Overall Study|Intercurrent illness|0
3033998|NCT00716144|10431433|P3|Overall Study|Intercurrent illness|1
3033999|NCT00716144|10431434|P2|Overall Study|Intercurrent illness|0
3034000|NCT00716144|10431435|P1|Overall Study|Intercurrent illness|0
3034001|NCT00716144|10431432|P4|Overall Study|Physician Decision|2
3034002|NCT00716144|10431433|P3|Overall Study|Physician Decision|2
3034003|NCT00716144|10431434|P2|Overall Study|Physician Decision|1
3034004|NCT00716144|10431435|P1|Overall Study|Physician Decision|0
3034005|NCT00716144|10431432|P4|Overall Study|Protocol Violation|0
3034006|NCT00716144|10431433|P3|Overall Study|Protocol Violation|1
3034007|NCT00716144|10431434|P2|Overall Study|Protocol Violation|0
3034008|NCT00716144|10431435|P1|Overall Study|Protocol Violation|2
3034009|NCT00716144|10431432|P4|Overall Study|Non-compliance|0
3034010|NCT00716144|10431433|P3|Overall Study|Non-compliance|0
3034011|NCT00716144|10431434|P2|Overall Study|Non-compliance|0
3034012|NCT00716144|10431435|P1|Overall Study|Non-compliance|1
3034013|NCT00716144|10431432|P4|Overall Study|Adverse Event|2
3034014|NCT00716144|10431433|P3|Overall Study|Adverse Event|0
3034015|NCT00716144|10431434|P2|Overall Study|Adverse Event|0
3034016|NCT00716144|10431435|P1|Overall Study|Adverse Event|0
3034017|NCT00716144|10431432|P4|Overall Study|Lost to Follow-up|2
3034018|NCT00716144|10431433|P3|Overall Study|Lost to Follow-up|1
3034019|NCT00716144|10431434|P2|Overall Study|Lost to Follow-up|2
3034020|NCT00716144|10431435|P1|Overall Study|Lost to Follow-up|2
3034021|NCT00716144|10431432|P4|Overall Study|Withdrawal by Subject|6
3034022|NCT00716144|10431433|P3|Overall Study|Withdrawal by Subject|6
3034023|NCT00716144|10431434|P2|Overall Study|Withdrawal by Subject|2
3034024|NCT00716144|10431435|P1|Overall Study|Withdrawal by Subject|4
3034025|NCT00716092|10431460|P3|Overall Study|Other incl. Lack of Efficacy|0
3034026|NCT00716092|10431461|P2|Overall Study|Other incl. Lack of Efficacy|1
3034027|NCT00716092|10431462|P1|Overall Study|Other incl. Lack of Efficacy|2
3034028|NCT00715949|10431515|P1|Overall Study|could not finish first test|4
3034029|NCT00715910|10431523|P6|Booster and ESFU Phase|Other|0
3034030|NCT00715910|10431524|P5|Booster and ESFU Phase|Other|1
3034031|NCT00715910|10431525|P4|Booster and ESFU Phase|Other|5
3034032|NCT00715910|10431526|P3|Booster and ESFU Phase|Other|0
3034033|NCT00715910|10431527|P2|Booster and ESFU Phase|Other|0
3034034|NCT00715910|10431528|P1|Booster and ESFU Phase|Other|0
3034035|NCT00715910|10431523|P6|Booster and ESFU Phase|Lost to Follow-up|13
3034036|NCT00715910|10431524|P5|Booster and ESFU Phase|Lost to Follow-up|1
3034037|NCT00715910|10431525|P4|Booster and ESFU Phase|Lost to Follow-up|6
3034038|NCT00715910|10431526|P3|Booster and ESFU Phase|Lost to Follow-up|0
3034039|NCT00715910|10431527|P2|Booster and ESFU Phase|Lost to Follow-up|0
3034040|NCT00715910|10431528|P1|Booster and ESFU Phase|Lost to Follow-up|0
3034041|NCT00715793|10431647|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
3034042|NCT00715793|10431648|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
3034043|NCT00715793|10431647|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
3034044|NCT00715793|10431648|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
3034045|NCT00715676|10431709|P3|Overall Study|Elevated Blood Glucose|0
3034046|NCT00715676|10431710|P2|Overall Study|Elevated Blood Glucose|1
3034047|NCT00715676|10431711|P1|Overall Study|Elevated Blood Glucose|0
3034048|NCT00715676|10431709|P3|Overall Study|Use of Exclusionary Medication|1
3034049|NCT00715676|10431710|P2|Overall Study|Use of Exclusionary Medication|0
3034050|NCT00715676|10431711|P1|Overall Study|Use of Exclusionary Medication|0
3034051|NCT00715676|10431709|P3|Overall Study|Did Not Meet Entry Criteria|1
3034052|NCT00715676|10431710|P2|Overall Study|Did Not Meet Entry Criteria|0
3034053|NCT00715676|10431711|P1|Overall Study|Did Not Meet Entry Criteria|0
3034054|NCT00715676|10431709|P3|Overall Study|Terminated by Sponsor|0
3034055|NCT00715676|10431710|P2|Overall Study|Terminated by Sponsor|0
3034056|NCT00715676|10431711|P1|Overall Study|Terminated by Sponsor|1
3034057|NCT00715676|10431709|P3|Overall Study|Lost to Follow-up|1
3034058|NCT00715676|10431710|P2|Overall Study|Lost to Follow-up|2
3034059|NCT00715676|10431711|P1|Overall Study|Lost to Follow-up|1
3034060|NCT00715676|10431709|P3|Overall Study|Withdrawal by Subject|8
3034061|NCT00715676|10431710|P2|Overall Study|Withdrawal by Subject|3
3034062|NCT00715676|10431711|P1|Overall Study|Withdrawal by Subject|1
3034063|NCT00715676|10431709|P3|Overall Study|Adverse Event|21
3034064|NCT00715676|10431710|P2|Overall Study|Adverse Event|5
3034065|NCT00715676|10431711|P1|Overall Study|Adverse Event|3
3034066|NCT00715624|10431754|P2|Overall Study|Other|1
3034067|NCT00715624|10431755|P1|Overall Study|Other|0
3034068|NCT00715624|10431754|P2|Overall Study|Incorrect randomization (not treated)|1
3034069|NCT00715624|10431755|P1|Overall Study|Incorrect randomization (not treated)|0
3034070|NCT00715624|10431754|P2|Overall Study|Sponsor decision|4
3034071|NCT00715624|10431755|P1|Overall Study|Sponsor decision|0
3034072|NCT00715624|10431754|P2|Overall Study|Poor compliance|13
3034073|NCT00715624|10431755|P1|Overall Study|Poor compliance|6
3034074|NCT00715624|10431754|P2|Overall Study|Familial and personal reasons|22
3034075|NCT00715624|10431755|P1|Overall Study|Familial and personal reasons|10
3034076|NCT00715624|10431754|P2|Overall Study|Withdrawal by Subject|25
3034077|NCT00715624|10431755|P1|Overall Study|Withdrawal by Subject|11
3034078|NCT00715624|10431754|P2|Overall Study|Protocol Violation|0
3034079|NCT00715624|10431755|P1|Overall Study|Protocol Violation|1
3034080|NCT00715624|10431754|P2|Overall Study|Lost to Follow-up|2
3034081|NCT00715624|10431755|P1|Overall Study|Lost to Follow-up|1
3034082|NCT00715624|10431754|P2|Overall Study|Lack of Efficacy|11
3034083|NCT00715624|10431755|P1|Overall Study|Lack of Efficacy|11
3034084|NCT00715624|10431754|P2|Overall Study|Adverse Event|37
3034085|NCT00715624|10431755|P1|Overall Study|Adverse Event|12
3034086|NCT00715559|10431783|P1|Overall Study|medication not tolerated - nausea|1
3034087|NCT00715520|10431793|P3|Overall Study|Withdrawal by Subject|1
3034088|NCT00715520|10431794|P2|Overall Study|Withdrawal by Subject|0
3034089|NCT00715520|10431795|P1|Overall Study|Withdrawal by Subject|2
3034090|NCT00715520|10431793|P3|Overall Study|Screen failure|1
3034091|NCT00715520|10431794|P2|Overall Study|Screen failure|1
3034092|NCT00715520|10431795|P1|Overall Study|Screen failure|8
3034093|NCT00715429|10431810|P2|Overall Study|Did not complete the study diary|1
3034094|NCT00715429|10431811|P1|Overall Study|Did not complete the study diary|0
3034095|NCT00715403|10431826|P7|Overall Study|Other reason not defined above|0
3034096|NCT00715403|10431827|P6|Overall Study|Other reason not defined above|1
3034097|NCT00715403|10431828|P5|Overall Study|Other reason not defined above|1
3034098|NCT00715403|10431829|P4|Overall Study|Other reason not defined above|0
3034099|NCT00715403|10431830|P3|Overall Study|Other reason not defined above|1
3034100|NCT00715403|10431831|P2|Overall Study|Other reason not defined above|0
3034101|NCT00715403|10431832|P1|Overall Study|Other reason not defined above|0
3034102|NCT00715403|10431826|P7|Overall Study|Protocol Violation|0
3034103|NCT00715403|10431827|P6|Overall Study|Protocol Violation|1
3034104|NCT00715403|10431828|P5|Overall Study|Protocol Violation|0
3034105|NCT00715403|10431829|P4|Overall Study|Protocol Violation|0
3034106|NCT00715403|10431830|P3|Overall Study|Protocol Violation|0
3034107|NCT00715403|10431831|P2|Overall Study|Protocol Violation|0
3034108|NCT00715403|10431832|P1|Overall Study|Protocol Violation|0
3034109|NCT00715403|10431826|P7|Overall Study|Other Adverse Event than DLT|0
3034110|NCT00715403|10431827|P6|Overall Study|Other Adverse Event than DLT|2
3034111|NCT00715403|10431828|P5|Overall Study|Other Adverse Event than DLT|0
3034112|NCT00715403|10431829|P4|Overall Study|Other Adverse Event than DLT|0
3034113|NCT00715403|10431830|P3|Overall Study|Other Adverse Event than DLT|0
3034114|NCT00715403|10431831|P2|Overall Study|Other Adverse Event than DLT|0
3034115|NCT00715403|10431832|P1|Overall Study|Other Adverse Event than DLT|1
3034116|NCT00715403|10431826|P7|Overall Study|Dose limiting Toxicity (DLT)|0
3034117|NCT00715403|10431827|P6|Overall Study|Dose limiting Toxicity (DLT)|1
3034118|NCT00715403|10431828|P5|Overall Study|Dose limiting Toxicity (DLT)|0
3034119|NCT00715403|10431829|P4|Overall Study|Dose limiting Toxicity (DLT)|0
3034120|NCT00715403|10431830|P3|Overall Study|Dose limiting Toxicity (DLT)|0
3034121|NCT00715403|10431831|P2|Overall Study|Dose limiting Toxicity (DLT)|0
3034122|NCT00715403|10431832|P1|Overall Study|Dose limiting Toxicity (DLT)|0
3034123|NCT00715403|10431826|P7|Overall Study|Progressive disease|1
3034124|NCT00715403|10431827|P6|Overall Study|Progressive disease|14
3034125|NCT00715403|10431828|P5|Overall Study|Progressive disease|5
3034126|NCT00715403|10431829|P4|Overall Study|Progressive disease|9
3034127|NCT00715403|10431830|P3|Overall Study|Progressive disease|3
3034128|NCT00715403|10431831|P2|Overall Study|Progressive disease|1
3034129|NCT00715403|10431832|P1|Overall Study|Progressive disease|0
3034130|NCT00715299|10431971|P1|Overall Study|failed the pre-screen exercise test|2
3034131|NCT00715299|10431971|P1|Overall Study|Adverse Event|3
3034132|NCT00715299|10431971|P1|Overall Study|Withdrawal by Subject|1
3034133|NCT00715208|10431977|P2|Overall Study|Lack of Efficacy|2
3034134|NCT00715208|10431978|P1|Overall Study|Lack of Efficacy|0
3034135|NCT00715208|10431977|P2|Overall Study|Adverse Event|6
3034136|NCT00715208|10431978|P1|Overall Study|Adverse Event|0
3034137|NCT00715208|10431977|P2|Overall Study|Withdrawal by Subject|1
3034138|NCT00715208|10431978|P1|Overall Study|Withdrawal by Subject|1
3034139|NCT00715117|10431994|P2|Overall Study|Crohn's flare and rescue with steroids|1
3034140|NCT00715117|10431995|P1|Overall Study|Crohn's flare and rescue with steroids|0
3034141|NCT00715078|10432063|P3|Overall Study|Unable to start due to disease prog.|1
3034142|NCT00715078|10432064|P2|Overall Study|Unable to start due to disease prog.|0
3034143|NCT00715078|10432065|P1|Overall Study|Unable to start due to disease prog.|0
3034144|NCT00715078|10432063|P3|Overall Study|Withdrawal by Subject|1
3034145|NCT00715078|10432064|P2|Overall Study|Withdrawal by Subject|0
3034146|NCT00715078|10432065|P1|Overall Study|Withdrawal by Subject|1
3034147|NCT00715078|10432063|P3|Overall Study|Death|36
3034148|NCT00715078|10432064|P2|Overall Study|Death|36
3034149|NCT00715078|10432065|P1|Overall Study|Death|29
3034150|NCT00715026|10432073|P1|Overall Study|Surgery done on non-study consented hip|1
3034151|NCT00715026|10432073|P1|Overall Study|Protocol Violation|1
3034152|NCT00715026|10432073|P1|Overall Study|Lost to Follow-up|3
3034153|NCT00715026|10432073|P1|Overall Study|Withdrawal by Subject|5
3034154|NCT00714948|10432078|P1|Overall Study|Adverse Event|2
3034155|NCT00714870|10432084|P2|Overall Study|did not attend minimum of 4 sessions|0
3034156|NCT00714870|10432085|P1|Overall Study|did not attend minimum of 4 sessions|4
3034157|NCT00714870|10432084|P2|Overall Study|patient unable to come b/c back pain|0
3034158|NCT00714870|10432085|P1|Overall Study|patient unable to come b/c back pain|1
3034159|NCT00714870|10432084|P2|Overall Study|Lost to Follow-up|5
3034160|NCT00714870|10432085|P1|Overall Study|Lost to Follow-up|22
3034161|NCT00714714|10432109|P1|Overall Study|Adverse Event|1
3034162|NCT00714688|10432118|P3|Overall Study|Other|5
3034163|NCT00714688|10432119|P2|Overall Study|Other|6
3034164|NCT00714688|10432120|P1|Overall Study|Other|1
3034165|NCT00714688|10432118|P3|Overall Study|Sponsor's Decision|0
3034166|NCT00714688|10432119|P2|Overall Study|Sponsor's Decision|2
3034167|NCT00714688|10432120|P1|Overall Study|Sponsor's Decision|0
3034168|NCT00714688|10432118|P3|Overall Study|Ineligible to Continue the Study|1
3034169|NCT00714688|10432119|P2|Overall Study|Ineligible to Continue the Study|1
3034170|NCT00714688|10432120|P1|Overall Study|Ineligible to Continue the Study|0
3034171|NCT00714688|10432118|P3|Overall Study|Subject Non-compliant|5
3034172|NCT00714688|10432119|P2|Overall Study|Subject Non-compliant|5
3034173|NCT00714688|10432120|P1|Overall Study|Subject Non-compliant|3
3034174|NCT00714688|10432118|P3|Overall Study|Adverse Event|19
3034175|NCT00714688|10432119|P2|Overall Study|Adverse Event|15
3034176|NCT00714688|10432120|P1|Overall Study|Adverse Event|2
3034177|NCT00714688|10432118|P3|Overall Study|Lost to Follow-up|0
3034178|NCT00714688|10432119|P2|Overall Study|Lost to Follow-up|2
3034179|NCT00714688|10432120|P1|Overall Study|Lost to Follow-up|5
3034180|NCT00714688|10432118|P3|Overall Study|Withdrawal by Subject|3
3034181|NCT00714688|10432119|P2|Overall Study|Withdrawal by Subject|3
3034182|NCT00714688|10432120|P1|Overall Study|Withdrawal by Subject|4
3034183|NCT00714688|10432118|P3|Overall Study|Lack of Efficacy|4
3034184|NCT00714688|10432119|P2|Overall Study|Lack of Efficacy|1
3034185|NCT00714688|10432120|P1|Overall Study|Lack of Efficacy|14
3034186|NCT00714493|10432162|P1|Overall Study|OTHER|2
3034187|NCT00714493|10432162|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
3034188|NCT00714493|10432162|P1|Overall Study|Protocol Violation|12
3034189|NCT00714493|10432162|P1|Overall Study|Lost to Follow-up|3
3034190|NCT00714493|10432162|P1|Overall Study|Lack of Efficacy|10
3034191|NCT00714493|10432162|P1|Overall Study|Death|3
3034192|NCT00714493|10432162|P1|Overall Study|Adverse Event|11
3034193|NCT00714415|10432174|P2|Overall Study|Death|0
3034194|NCT00714415|10432175|P1|Overall Study|Death|1
3034195|NCT00714415|10432174|P2|Overall Study|Lack of Efficacy|0
3034196|NCT00714415|10432175|P1|Overall Study|Lack of Efficacy|1
3034197|NCT00714285|10432225|P4|Overall Study|Migrated/moved from study area|0
3034198|NCT00714285|10432226|P3|Overall Study|Migrated/moved from study area|0
3034199|NCT00714285|10432227|P2|Overall Study|Migrated/moved from study area|1
3034200|NCT00714285|10432228|P1|Overall Study|Migrated/moved from study area|0
3034201|NCT00714285|10432225|P4|Overall Study|Lost to Follow-up|1
3034202|NCT00714285|10432226|P3|Overall Study|Lost to Follow-up|0
3034203|NCT00714285|10432227|P2|Overall Study|Lost to Follow-up|2
3034204|NCT00714285|10432228|P1|Overall Study|Lost to Follow-up|0
3034205|NCT00714259|10432278|P1|Overall Study|Death|2
3034206|NCT00714168|10432324|P2|Overall Study|Non-study medical condition|2
3034207|NCT00714168|10432325|P1|Overall Study|Non-study medical condition|3
3034208|NCT00714168|10432324|P2|Overall Study|Relocation|3
3034209|NCT00714168|10432325|P1|Overall Study|Relocation|4
3034210|NCT00714168|10432324|P2|Overall Study|Lost to Follow-up|50
3034211|NCT00714168|10432325|P1|Overall Study|Lost to Follow-up|32
3034212|NCT00714168|10432324|P2|Overall Study|Pregnancy|4
3034213|NCT00714168|10432325|P1|Overall Study|Pregnancy|5
3034214|NCT00714051|10432341|P2|Overall Study|Death|1
3034215|NCT00714051|10432342|P1|Overall Study|Death|0
3034216|NCT00714051|10432341|P2|Overall Study|Withdrawal by Subject|0
3034217|NCT00714051|10432342|P1|Overall Study|Withdrawal by Subject|1
3034218|NCT00713830|10432350|P2|Overall Study|Sponsor Decision|10
3034219|NCT00713830|10432351|P1|Overall Study|Sponsor Decision|4
3034220|NCT00713830|10432350|P2|Overall Study|Familial and Personal Reasons|34
3034221|NCT00713830|10432351|P1|Overall Study|Familial and Personal Reasons|9
3034222|NCT00713830|10432350|P2|Overall Study|Poor Compliance to Protocol|14
3034223|NCT00713830|10432351|P1|Overall Study|Poor Compliance to Protocol|7
3034224|NCT00713830|10432350|P2|Overall Study|Withdrawal by Subject|23
3034225|NCT00713830|10432351|P1|Overall Study|Withdrawal by Subject|13
3034226|NCT00713830|10432350|P2|Overall Study|Lost to Follow-up|9
3034227|NCT00713830|10432351|P1|Overall Study|Lost to Follow-up|2
3034228|NCT00713830|10432350|P2|Overall Study|Lack of Efficacy|16
3034229|NCT00713830|10432351|P1|Overall Study|Lack of Efficacy|24
3034230|NCT00713830|10432350|P2|Overall Study|Adverse Event|71
3034231|NCT00713830|10432351|P1|Overall Study|Adverse Event|23
3034232|NCT00713700|10432408|P1|Overall Study|Withdrawal by Subject|1
3034233|NCT00713700|10432408|P1|Overall Study|Lost to Follow-up|3
3034234|NCT00713648|10432434|P1|Overall Study|Development of antibodies|3
3034235|NCT00713648|10432434|P1|Overall Study|According to Protocol|2
3034236|NCT00713648|10432434|P1|Overall Study|Unclassified|2
3034237|NCT00713648|10432434|P1|Overall Study|Adverse Event|1
3034238|NCT00713609|10432447|P6|Overall Study|Protocol Violation|0
3034239|NCT00713609|10432448|P5|Overall Study|Protocol Violation|2
3034240|NCT00713609|10432449|P4|Overall Study|Protocol Violation|1
3034241|NCT00713609|10432450|P3|Overall Study|Protocol Violation|1
3034242|NCT00713609|10432451|P2|Overall Study|Protocol Violation|3
3034243|NCT00713609|10432452|P1|Overall Study|Protocol Violation|6
3034244|NCT00713609|10432447|P6|Overall Study|Withdrawal by Subject|7
3034245|NCT00713609|10432448|P5|Overall Study|Withdrawal by Subject|5
3034246|NCT00713609|10432449|P4|Overall Study|Withdrawal by Subject|1
3034247|NCT00713609|10432450|P3|Overall Study|Withdrawal by Subject|5
3034248|NCT00713609|10432451|P2|Overall Study|Withdrawal by Subject|1
3034249|NCT00713609|10432452|P1|Overall Study|Withdrawal by Subject|6
3034250|NCT00713609|10432447|P6|Overall Study|Non-Compliance with Study Treatment|0
3034251|NCT00713609|10432448|P5|Overall Study|Non-Compliance with Study Treatment|1
3034252|NCT00713609|10432449|P4|Overall Study|Non-Compliance with Study Treatment|0
3034253|NCT00713609|10432450|P3|Overall Study|Non-Compliance with Study Treatment|2
3034254|NCT00713609|10432451|P2|Overall Study|Non-Compliance with Study Treatment|1
3034255|NCT00713609|10432452|P1|Overall Study|Non-Compliance with Study Treatment|1
3034256|NCT00713609|10432447|P6|Overall Study|Lack of Efficacy|0
3034257|NCT00713609|10432448|P5|Overall Study|Lack of Efficacy|1
3034258|NCT00713609|10432449|P4|Overall Study|Lack of Efficacy|0
3034259|NCT00713609|10432450|P3|Overall Study|Lack of Efficacy|0
3034260|NCT00713609|10432451|P2|Overall Study|Lack of Efficacy|3
3034261|NCT00713609|10432452|P1|Overall Study|Lack of Efficacy|1
3034262|NCT00713609|10432447|P6|Overall Study|Lost to Follow-up|0
3034263|NCT00713609|10432448|P5|Overall Study|Lost to Follow-up|7
3034264|NCT00713609|10432449|P4|Overall Study|Lost to Follow-up|5
3034265|NCT00713609|10432450|P3|Overall Study|Lost to Follow-up|5
3034266|NCT00713609|10432451|P2|Overall Study|Lost to Follow-up|7
3034267|NCT00713609|10432452|P1|Overall Study|Lost to Follow-up|5
3034268|NCT00713609|10432447|P6|Overall Study|Adverse Event|1
3034269|NCT00713609|10432448|P5|Overall Study|Adverse Event|3
3034270|NCT00713609|10432449|P4|Overall Study|Adverse Event|2
3034271|NCT00713609|10432450|P3|Overall Study|Adverse Event|2
3034272|NCT00713609|10432451|P2|Overall Study|Adverse Event|0
3034273|NCT00713609|10432452|P1|Overall Study|Adverse Event|2
3034274|NCT00713596|10432487|P3|Overall Study|Study was terminated|2
3034275|NCT00713596|10432488|P2|Overall Study|Study was terminated|3
3034276|NCT00713596|10432489|P1|Overall Study|Study was terminated|2
3034277|NCT00713544|10432515|P6|Overall Study|Hepatotoxicity - not an AE|0
3034278|NCT00713544|10432516|P5|Overall Study|Hepatotoxicity - not an AE|1
3034279|NCT00713544|10432517|P4|Overall Study|Hepatotoxicity - not an AE|0
3034280|NCT00713544|10432518|P3|Overall Study|Hepatotoxicity - not an AE|0
3034281|NCT00713544|10432519|P2|Overall Study|Hepatotoxicity - not an AE|0
3034282|NCT00713544|10432520|P1|Overall Study|Hepatotoxicity - not an AE|0
3034283|NCT00713544|10432515|P6|Overall Study|Incorrect enrollment|0
3034284|NCT00713544|10432516|P5|Overall Study|Incorrect enrollment|0
3034285|NCT00713544|10432517|P4|Overall Study|Incorrect enrollment|0
3034286|NCT00713544|10432518|P3|Overall Study|Incorrect enrollment|0
3034287|NCT00713544|10432519|P2|Overall Study|Incorrect enrollment|1
3034288|NCT00713544|10432520|P1|Overall Study|Incorrect enrollment|0
3034289|NCT00713544|10432515|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
3034290|NCT00713544|10432516|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
3034291|NCT00713544|10432517|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
3034292|NCT00713544|10432518|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
3034293|NCT00713544|10432519|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
3034294|NCT00713544|10432520|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
3034295|NCT00713544|10432515|P6|Overall Study|Lost to Follow-up|0
3034296|NCT00713544|10432516|P5|Overall Study|Lost to Follow-up|0
3034297|NCT00713544|10432517|P4|Overall Study|Lost to Follow-up|0
3034298|NCT00713544|10432518|P3|Overall Study|Lost to Follow-up|1
3034299|NCT00713544|10432519|P2|Overall Study|Lost to Follow-up|0
3034300|NCT00713544|10432520|P1|Overall Study|Lost to Follow-up|0
3034301|NCT00713544|10432515|P6|Overall Study|Lack of Efficacy|0
3034302|NCT00713544|10432516|P5|Overall Study|Lack of Efficacy|1
3034303|NCT00713544|10432517|P4|Overall Study|Lack of Efficacy|1
3034304|NCT00713544|10432518|P3|Overall Study|Lack of Efficacy|0
3034305|NCT00713544|10432519|P2|Overall Study|Lack of Efficacy|1
3034306|NCT00713544|10432520|P1|Overall Study|Lack of Efficacy|0
3034307|NCT00713544|10432515|P6|Overall Study|Physician Decision|2
3034308|NCT00713544|10432516|P5|Overall Study|Physician Decision|0
3034309|NCT00713544|10432517|P4|Overall Study|Physician Decision|0
3034310|NCT00713544|10432518|P3|Overall Study|Physician Decision|0
3034311|NCT00713544|10432519|P2|Overall Study|Physician Decision|0
3034312|NCT00713544|10432520|P1|Overall Study|Physician Decision|0
3034313|NCT00713544|10432515|P6|Overall Study|Protocol Violation|1
3034314|NCT00713544|10432516|P5|Overall Study|Protocol Violation|0
3034315|NCT00713544|10432517|P4|Overall Study|Protocol Violation|0
3034316|NCT00713544|10432518|P3|Overall Study|Protocol Violation|0
3034317|NCT00713544|10432519|P2|Overall Study|Protocol Violation|0
3034318|NCT00713544|10432520|P1|Overall Study|Protocol Violation|0
3034319|NCT00713544|10432515|P6|Overall Study|Withdrawal by Subject|1
3034320|NCT00713544|10432516|P5|Overall Study|Withdrawal by Subject|3
3034321|NCT00713544|10432517|P4|Overall Study|Withdrawal by Subject|2
3034322|NCT00713544|10432518|P3|Overall Study|Withdrawal by Subject|3
3034323|NCT00713544|10432519|P2|Overall Study|Withdrawal by Subject|0
3034324|NCT00713544|10432520|P1|Overall Study|Withdrawal by Subject|2
3034325|NCT00713544|10432515|P6|Overall Study|Adverse Event|5
3034326|NCT00713544|10432516|P5|Overall Study|Adverse Event|3
3034327|NCT00713544|10432517|P4|Overall Study|Adverse Event|7
3034328|NCT00713544|10432518|P3|Overall Study|Adverse Event|7
3034329|NCT00713544|10432519|P2|Overall Study|Adverse Event|3
3034330|NCT00713544|10432520|P1|Overall Study|Adverse Event|5
3034331|NCT00713349|10432571|P1|Overall Study|Protocol Violation|1
3034332|NCT00713323|10432577|P1|Overall Study|Treatment that may interact with Sativex|1
3034333|NCT00713323|10432577|P1|Overall Study|Subject travelling to Dominica Republic|1
3034334|NCT00713323|10432577|P1|Overall Study|Subject travelling to USA|1
3034335|NCT00713323|10432577|P1|Overall Study|Pain resolved|1
3034336|NCT00713323|10432577|P1|Overall Study|Non-compliance|1
3034337|NCT00713323|10432577|P1|Overall Study|Pain free|1
3034338|NCT00713323|10432577|P1|Overall Study|Surgery cured allodynic pain|1
3034339|NCT00713323|10432577|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
3034340|NCT00713323|10432577|P1|Overall Study|Low creatine clearance at screening|1
3034341|NCT00713323|10432577|P1|Overall Study|Lack of Efficacy|36
3034342|NCT00713323|10432577|P1|Overall Study|Lost to Follow-up|11
3034343|NCT00713323|10432577|P1|Overall Study|Withdrawal by Subject|15
3034344|NCT00713323|10432577|P1|Overall Study|Adverse Event|75
3034345|NCT00713310|10432590|P2|Overall Study|Withdrawal by Subject|2
3034346|NCT00713310|10432591|P1|Overall Study|Withdrawal by Subject|0
3034347|NCT00713310|10432590|P2|Overall Study|Lack of Efficacy|2
3034348|NCT00713310|10432591|P1|Overall Study|Lack of Efficacy|0
3034349|NCT00713310|10432590|P2|Overall Study|Adverse Event|2
3034350|NCT00713310|10432591|P1|Overall Study|Adverse Event|5
3034351|NCT00713258|10432601|P2|Overall Study|Other|1
3034352|NCT00713258|10432602|P1|Overall Study|Other|1
3034353|NCT00713258|10432601|P2|Overall Study|Non-Compliance|1
3034354|NCT00713258|10432602|P1|Overall Study|Non-Compliance|2
3034355|NCT00713258|10432601|P2|Overall Study|Adverse Event|4
3034356|NCT00713258|10432602|P1|Overall Study|Adverse Event|2
3034357|NCT00713219|10432610|P1|Overall Study|Protocol Violation|1
3034358|NCT00713219|10432610|P1|Overall Study|Death|1
3034359|NCT00713206|10432616|P2|Overall Study|Adverse Event|1
3034360|NCT00713206|10432617|P1|Overall Study|Adverse Event|2
3034361|NCT00713206|10432616|P2|Overall Study|Lost to Follow-up|2
3034362|NCT00713206|10432617|P1|Overall Study|Lost to Follow-up|5
3034363|NCT00712985|10432623|P1|Overall Study|Lack of Efficacy|3
3034364|NCT00712985|10432623|P1|Overall Study|1 patient moved out of state|1
3034365|NCT00712985|10432623|P1|Overall Study|1 withdrew prior to start of drug|1
3034366|NCT00712959|10432629|P2|Overall Study|Withdrawal by Subject|0
3034367|NCT00712959|10432630|P1|Overall Study|Withdrawal by Subject|3
3034368|NCT00712959|10432629|P2|Overall Study|Lost to Follow-up|2
3034369|NCT00712959|10432630|P1|Overall Study|Lost to Follow-up|13
3034370|NCT00712959|10432629|P2|Overall Study|Protocol Violation|1
3034371|NCT00712959|10432630|P1|Overall Study|Protocol Violation|3
3034372|NCT00712933|10432648|P1|Overall Study|Withdrawal by Subject|151
3034373|NCT00712933|10432648|P1|Overall Study|Protocol Violation|4
3034374|NCT00712933|10432648|P1|Overall Study|Physician Decision|36
3034375|NCT00712933|10432648|P1|Overall Study|Participant received medication|1
3034376|NCT00712933|10432648|P1|Overall Study|Not committed to contraception|1
3034377|NCT00712933|10432648|P1|Overall Study|Other Physician decision|1
3034378|NCT00712933|10432648|P1|Overall Study|Death of patient|1
3034379|NCT00712933|10432648|P1|Overall Study|Participant travelled overseas|2
3034380|NCT00712933|10432648|P1|Overall Study|Participant hospitalized|1
3034381|NCT00712933|10432648|P1|Overall Study|Involved in Clinical research|3
3034382|NCT00712933|10432648|P1|Overall Study|Hip replacement surgery|1
3034383|NCT00712933|10432648|P1|Overall Study|Withdrew consent|4
3034384|NCT00712933|10432648|P1|Overall Study|Sponsor decision|14
3034385|NCT00712933|10432648|P1|Overall Study|Other Pregnancy|37
3034386|NCT00712933|10432648|P1|Overall Study|Non-compliance with study drug|13
3034387|NCT00712933|10432648|P1|Overall Study|Lost to Follow-up|22
3034388|NCT00712933|10432648|P1|Overall Study|Lack of Efficacy|6
3034389|NCT00712933|10432648|P1|Overall Study|Adverse Event|69
3034390|NCT00712920|10432678|P3|Overall Study|Non-compliance|0
3034391|NCT00712920|10432679|P2|Overall Study|Non-compliance|0
3034392|NCT00712920|10432680|P1|Overall Study|Non-compliance|3
3034393|NCT00712920|10432678|P3|Overall Study|Other|3
3034394|NCT00712920|10432679|P2|Overall Study|Other|7
3034395|NCT00712920|10432680|P1|Overall Study|Other|5
3034396|NCT00712920|10432678|P3|Overall Study|Lack of Efficacy|1
3034397|NCT00712920|10432679|P2|Overall Study|Lack of Efficacy|0
3034398|NCT00712920|10432680|P1|Overall Study|Lack of Efficacy|1
3034399|NCT00712920|10432678|P3|Overall Study|Lost to Follow-up|0
3034400|NCT00712920|10432679|P2|Overall Study|Lost to Follow-up|4
3034401|NCT00712920|10432680|P1|Overall Study|Lost to Follow-up|1
3034402|NCT00712920|10432678|P3|Overall Study|Withdrawal by Subject|1
3034403|NCT00712920|10432679|P2|Overall Study|Withdrawal by Subject|2
3034404|NCT00712920|10432680|P1|Overall Study|Withdrawal by Subject|4
3034405|NCT00712920|10432678|P3|Overall Study|Adverse Event|7
3034406|NCT00712920|10432679|P2|Overall Study|Adverse Event|4
3034407|NCT00712920|10432680|P1|Overall Study|Adverse Event|3
3034408|NCT00712725|10432708|P8|Overall Study|Protocol Specified Criteria|1
3034409|NCT00712725|10432709|P7|Overall Study|Protocol Specified Criteria|2
3034410|NCT00712725|10432710|P6|Overall Study|Protocol Specified Criteria|0
3034411|NCT00712725|10432711|P5|Overall Study|Protocol Specified Criteria|1
3034412|NCT00712725|10432712|P4|Overall Study|Protocol Specified Criteria|2
3034413|NCT00712725|10432713|P3|Overall Study|Protocol Specified Criteria|1
3034414|NCT00712725|10432714|P2|Overall Study|Protocol Specified Criteria|0
3034415|NCT00712725|10432715|P1|Overall Study|Protocol Specified Criteria|3
3034416|NCT00712725|10432708|P8|Overall Study|Lack of Qualifying Event|6
3034417|NCT00712725|10432709|P7|Overall Study|Lack of Qualifying Event|11
3034418|NCT00712725|10432710|P6|Overall Study|Lack of Qualifying Event|13
3034419|NCT00712725|10432711|P5|Overall Study|Lack of Qualifying Event|11
3034420|NCT00712725|10432712|P4|Overall Study|Lack of Qualifying Event|8
3034421|NCT00712725|10432713|P3|Overall Study|Lack of Qualifying Event|6
3034422|NCT00712725|10432714|P2|Overall Study|Lack of Qualifying Event|2
3034423|NCT00712725|10432715|P1|Overall Study|Lack of Qualifying Event|16
3034424|NCT00712725|10432708|P8|Overall Study|Withdrawal by Subject|2
3034425|NCT00712725|10432709|P7|Overall Study|Withdrawal by Subject|1
3034426|NCT00712725|10432710|P6|Overall Study|Withdrawal by Subject|1
3034427|NCT00712725|10432711|P5|Overall Study|Withdrawal by Subject|1
3034428|NCT00712725|10432712|P4|Overall Study|Withdrawal by Subject|2
3034429|NCT00712725|10432713|P3|Overall Study|Withdrawal by Subject|1
3034430|NCT00712725|10432714|P2|Overall Study|Withdrawal by Subject|1
3034431|NCT00712725|10432715|P1|Overall Study|Withdrawal by Subject|2
3034432|NCT00712725|10432708|P8|Overall Study|Protocol Violation|1
3034433|NCT00712725|10432709|P7|Overall Study|Protocol Violation|1
3034434|NCT00712725|10432710|P6|Overall Study|Protocol Violation|0
3034435|NCT00712725|10432711|P5|Overall Study|Protocol Violation|2
3034436|NCT00712725|10432712|P4|Overall Study|Protocol Violation|3
3034437|NCT00712725|10432713|P3|Overall Study|Protocol Violation|1
3034438|NCT00712725|10432714|P2|Overall Study|Protocol Violation|0
3034439|NCT00712725|10432715|P1|Overall Study|Protocol Violation|2
3034440|NCT00712725|10432708|P8|Overall Study|Pregnancy|0
3034441|NCT00712725|10432709|P7|Overall Study|Pregnancy|2
3034442|NCT00712725|10432710|P6|Overall Study|Pregnancy|0
3034443|NCT00712725|10432711|P5|Overall Study|Pregnancy|1
3034444|NCT00712725|10432712|P4|Overall Study|Pregnancy|0
3034445|NCT00712725|10432713|P3|Overall Study|Pregnancy|0
3034446|NCT00712725|10432714|P2|Overall Study|Pregnancy|1
3034447|NCT00712725|10432715|P1|Overall Study|Pregnancy|0
3034448|NCT00712725|10432708|P8|Overall Study|Physician Decision|0
3034449|NCT00712725|10432709|P7|Overall Study|Physician Decision|2
3034450|NCT00712725|10432710|P6|Overall Study|Physician Decision|0
3034451|NCT00712725|10432711|P5|Overall Study|Physician Decision|1
3034452|NCT00712725|10432712|P4|Overall Study|Physician Decision|0
3034453|NCT00712725|10432713|P3|Overall Study|Physician Decision|0
3034454|NCT00712725|10432714|P2|Overall Study|Physician Decision|0
3034455|NCT00712725|10432715|P1|Overall Study|Physician Decision|2
3034456|NCT00712725|10432708|P8|Overall Study|Lost to Follow-up|1
3034457|NCT00712725|10432709|P7|Overall Study|Lost to Follow-up|3
3034458|NCT00712725|10432710|P6|Overall Study|Lost to Follow-up|2
3034459|NCT00712725|10432711|P5|Overall Study|Lost to Follow-up|2
3034460|NCT00712725|10432712|P4|Overall Study|Lost to Follow-up|1
3034461|NCT00712725|10432713|P3|Overall Study|Lost to Follow-up|1
3034462|NCT00712725|10432714|P2|Overall Study|Lost to Follow-up|2
3034463|NCT00712725|10432715|P1|Overall Study|Lost to Follow-up|3
3034464|NCT00712725|10432708|P8|Overall Study|Adverse Event|0
3034465|NCT00712725|10432709|P7|Overall Study|Adverse Event|0
3034466|NCT00712725|10432710|P6|Overall Study|Adverse Event|0
3034467|NCT00712725|10432711|P5|Overall Study|Adverse Event|0
3034468|NCT00712725|10432712|P4|Overall Study|Adverse Event|1
3034469|NCT00712725|10432713|P3|Overall Study|Adverse Event|0
3034470|NCT00712725|10432714|P2|Overall Study|Adverse Event|0
3034471|NCT00712725|10432715|P1|Overall Study|Adverse Event|1
3034472|NCT00712673|10432776|P4|Overall Study|Protocol Violation|0
3034473|NCT00712673|10432777|P3|Overall Study|Protocol Violation|2
3034474|NCT00712673|10432778|P2|Overall Study|Protocol Violation|0
3034475|NCT00712673|10432779|P1|Overall Study|Protocol Violation|0
3034476|NCT00712673|10432776|P4|Overall Study|Investigator's Decision|0
3034477|NCT00712673|10432777|P3|Overall Study|Investigator's Decision|0
3034478|NCT00712673|10432778|P2|Overall Study|Investigator's Decision|0
3034479|NCT00712673|10432779|P1|Overall Study|Investigator's Decision|1
3034480|NCT00712673|10432776|P4|Overall Study|Familial and Personal Reasons|2
3034481|NCT00712673|10432777|P3|Overall Study|Familial and Personal Reasons|5
3034482|NCT00712673|10432778|P2|Overall Study|Familial and Personal Reasons|0
3034483|NCT00712673|10432779|P1|Overall Study|Familial and Personal Reasons|5
3034484|NCT00712673|10432776|P4|Overall Study|Withdrawal by Subject|20
3034485|NCT00712673|10432777|P3|Overall Study|Withdrawal by Subject|15
3034486|NCT00712673|10432778|P2|Overall Study|Withdrawal by Subject|7
3034487|NCT00712673|10432779|P1|Overall Study|Withdrawal by Subject|6
3034488|NCT00712673|10432776|P4|Overall Study|Lost to Follow-up|0
3034489|NCT00712673|10432777|P3|Overall Study|Lost to Follow-up|2
3034490|NCT00712673|10432778|P2|Overall Study|Lost to Follow-up|0
3034491|NCT00712673|10432779|P1|Overall Study|Lost to Follow-up|1
3034492|NCT00712673|10432776|P4|Overall Study|Poor Compliance to Protocol|16
3034493|NCT00712673|10432777|P3|Overall Study|Poor Compliance to Protocol|4
3034494|NCT00712673|10432778|P2|Overall Study|Poor Compliance to Protocol|3
3034495|NCT00712673|10432779|P1|Overall Study|Poor Compliance to Protocol|3
3034496|NCT00712673|10432776|P4|Overall Study|Lack of Efficacy|6
3034497|NCT00712673|10432777|P3|Overall Study|Lack of Efficacy|8
3034498|NCT00712673|10432778|P2|Overall Study|Lack of Efficacy|8
3034499|NCT00712673|10432779|P1|Overall Study|Lack of Efficacy|2
3034500|NCT00712673|10432776|P4|Overall Study|Adverse Event|26
3034501|NCT00712673|10432777|P3|Overall Study|Adverse Event|21
3034502|NCT00712673|10432778|P2|Overall Study|Adverse Event|3
3034503|NCT00712673|10432779|P1|Overall Study|Adverse Event|3
3034504|NCT00712543|10432843|P2|Day 8-14|Lost to Follow-up|2
3034505|NCT00712543|10432844|P1|Day 8-14|Lost to Follow-up|0
3034506|NCT00712348|10432878|P1|Overall Study|Withdrawal by Subject|1
3034507|NCT00712335|10432890|P5|Overall Study|Other Reason|0
3034508|NCT00712335|10432891|P4|Overall Study|Other Reason|0
3034509|NCT00712335|10432892|P3|Overall Study|Other Reason|1
3034510|NCT00712335|10432893|P2|Overall Study|Other Reason|3
3034511|NCT00712335|10432894|P1|Overall Study|Other Reason|0
3034512|NCT00712335|10432890|P5|Overall Study|Lack of Efficacy|0
3034513|NCT00712335|10432891|P4|Overall Study|Lack of Efficacy|1
3034514|NCT00712335|10432892|P3|Overall Study|Lack of Efficacy|1
3034515|NCT00712335|10432893|P2|Overall Study|Lack of Efficacy|0
3034516|NCT00712335|10432894|P1|Overall Study|Lack of Efficacy|0
3034517|NCT00712335|10432890|P5|Overall Study|Protocol Violation|0
3034518|NCT00712335|10432891|P4|Overall Study|Protocol Violation|0
3034519|NCT00712335|10432892|P3|Overall Study|Protocol Violation|1
3034520|NCT00712335|10432893|P2|Overall Study|Protocol Violation|2
3034521|NCT00712335|10432894|P1|Overall Study|Protocol Violation|1
3034522|NCT00712335|10432890|P5|Overall Study|Lost to Follow-up|0
3034523|NCT00712335|10432891|P4|Overall Study|Lost to Follow-up|1
3034524|NCT00712335|10432892|P3|Overall Study|Lost to Follow-up|0
3034525|NCT00712335|10432893|P2|Overall Study|Lost to Follow-up|5
3034526|NCT00712335|10432894|P1|Overall Study|Lost to Follow-up|2
3034527|NCT00712335|10432890|P5|Overall Study|Withdrawal by Subject|0
3034528|NCT00712335|10432891|P4|Overall Study|Withdrawal by Subject|3
3034529|NCT00712335|10432892|P3|Overall Study|Withdrawal by Subject|2
3034530|NCT00712335|10432893|P2|Overall Study|Withdrawal by Subject|7
3034531|NCT00712335|10432894|P1|Overall Study|Withdrawal by Subject|0
3034532|NCT00712270|10432939|P1|Overall Study|Screen Failure|3
3034533|NCT00712270|10432939|P1|Overall Study|Withdrawal by Subject|11
3034534|NCT00712166|10433003|P2|Overall Study|Noncompliance|1
3034535|NCT00712166|10433004|P1|Overall Study|Noncompliance|0
3034536|NCT00712010|10433047|P1|Washout (7 Days)|Withdrawal by Subject|1
3034537|NCT00711971|10433086|P3|Overall Study|Lost to Follow-up|1
3034538|NCT00711971|10433087|P2|Overall Study|Lost to Follow-up|4
3034539|NCT00711971|10433088|P1|Overall Study|Lost to Follow-up|3
3034540|NCT00711958|10433122|P2|Overall Study|Progression of disease|0
3034541|NCT00711958|10433123|P1|Overall Study|Progression of disease|1
3034542|NCT00711958|10433122|P2|Overall Study|Death|5
3034543|NCT00711958|10433123|P1|Overall Study|Death|10
3034544|NCT00711958|10433122|P2|Overall Study|Lost to Follow-up|2
3034545|NCT00711958|10433123|P1|Overall Study|Lost to Follow-up|2
3034546|NCT00711958|10433122|P2|Overall Study|Protocol Violation|0
3034547|NCT00711958|10433123|P1|Overall Study|Protocol Violation|1
3034548|NCT00711958|10433122|P2|Overall Study|Adverse Event|7
3034549|NCT00711958|10433123|P1|Overall Study|Adverse Event|9
3034550|NCT00711958|10433122|P2|Overall Study|Clinical deterioration|0
3034551|NCT00711958|10433123|P1|Overall Study|Clinical deterioration|1
3034552|NCT00711958|10433122|P2|Overall Study|Lack of Efficacy|1
3034553|NCT00711958|10433123|P1|Overall Study|Lack of Efficacy|3
3034554|NCT00711958|10433122|P2|Overall Study|Withdrawal by Subject|8
3034555|NCT00711958|10433123|P1|Overall Study|Withdrawal by Subject|6
3034556|NCT00711880|10433131|P2|Overall Study|Lack of Efficacy|5
3034557|NCT00711880|10433132|P1|Overall Study|Lack of Efficacy|1
3034558|NCT00711880|10433131|P2|Overall Study|Patient non-compliance|0
3034559|NCT00711880|10433132|P1|Overall Study|Patient non-compliance|1
3034560|NCT00711880|10433131|P2|Overall Study|Adverse Event|2
3034561|NCT00711880|10433132|P1|Overall Study|Adverse Event|11
3034562|NCT00711802|10433194|P8|Overall Study|Reason not reported|0
3034563|NCT00711802|10433195|P7|Overall Study|Reason not reported|1
3034564|NCT00711802|10433196|P6|Overall Study|Reason not reported|0
3034565|NCT00711802|10433197|P5|Overall Study|Reason not reported|1
3034566|NCT00711802|10433198|P4|Overall Study|Reason not reported|0
3034567|NCT00711802|10433199|P3|Overall Study|Reason not reported|1
3034568|NCT00711802|10433200|P2|Overall Study|Reason not reported|1
3034569|NCT00711802|10433201|P1|Overall Study|Reason not reported|0
3034570|NCT00711802|10433194|P8|Overall Study|Lost to Follow-up|2
3034571|NCT00711802|10433195|P7|Overall Study|Lost to Follow-up|4
3034572|NCT00711802|10433196|P6|Overall Study|Lost to Follow-up|6
3034573|NCT00711802|10433197|P5|Overall Study|Lost to Follow-up|10
3034574|NCT00711802|10433198|P4|Overall Study|Lost to Follow-up|1
3034575|NCT00711802|10433199|P3|Overall Study|Lost to Follow-up|3
3034576|NCT00711802|10433200|P2|Overall Study|Lost to Follow-up|0
3034577|NCT00711802|10433201|P1|Overall Study|Lost to Follow-up|0
3034578|NCT00711802|10433194|P8|Overall Study|Withdrawal by Subject|0
3034579|NCT00711802|10433195|P7|Overall Study|Withdrawal by Subject|0
3034580|NCT00711802|10433196|P6|Overall Study|Withdrawal by Subject|0
3034581|NCT00711802|10433197|P5|Overall Study|Withdrawal by Subject|0
3034582|NCT00711802|10433198|P4|Overall Study|Withdrawal by Subject|1
3034583|NCT00711802|10433199|P3|Overall Study|Withdrawal by Subject|0
3034584|NCT00711802|10433200|P2|Overall Study|Withdrawal by Subject|1
3034585|NCT00711802|10433201|P1|Overall Study|Withdrawal by Subject|0
3034586|NCT00711802|10433194|P8|Overall Study|Physician Decision|0
3034587|NCT00711802|10433195|P7|Overall Study|Physician Decision|0
3034588|NCT00711802|10433196|P6|Overall Study|Physician Decision|0
3034589|NCT00711802|10433197|P5|Overall Study|Physician Decision|0
3034590|NCT00711802|10433198|P4|Overall Study|Physician Decision|0
3034591|NCT00711802|10433199|P3|Overall Study|Physician Decision|0
3034592|NCT00711802|10433200|P2|Overall Study|Physician Decision|2
3034593|NCT00711802|10433201|P1|Overall Study|Physician Decision|0
3034594|NCT00711802|10433194|P8|Overall Study|Protocol Violation|0
3034595|NCT00711802|10433195|P7|Overall Study|Protocol Violation|0
3034596|NCT00711802|10433196|P6|Overall Study|Protocol Violation|0
3034597|NCT00711802|10433197|P5|Overall Study|Protocol Violation|0
3034598|NCT00711802|10433198|P4|Overall Study|Protocol Violation|1
3034599|NCT00711802|10433199|P3|Overall Study|Protocol Violation|0
3034600|NCT00711802|10433200|P2|Overall Study|Protocol Violation|0
3034601|NCT00711802|10433201|P1|Overall Study|Protocol Violation|0
3034602|NCT00711802|10433194|P8|Overall Study|Microbiological failure|0
3034603|NCT00711802|10433195|P7|Overall Study|Microbiological failure|0
3034604|NCT00711802|10433196|P6|Overall Study|Microbiological failure|1
3034605|NCT00711802|10433197|P5|Overall Study|Microbiological failure|0
3034606|NCT00711802|10433198|P4|Overall Study|Microbiological failure|0
3034607|NCT00711802|10433199|P3|Overall Study|Microbiological failure|0
3034608|NCT00711802|10433200|P2|Overall Study|Microbiological failure|1
3034609|NCT00711802|10433201|P1|Overall Study|Microbiological failure|0
3034610|NCT00711802|10433194|P8|Overall Study|Adverse Event|0
3034611|NCT00711802|10433195|P7|Overall Study|Adverse Event|0
3034612|NCT00711802|10433196|P6|Overall Study|Adverse Event|1
3034613|NCT00711802|10433197|P5|Overall Study|Adverse Event|1
3034614|NCT00711802|10433198|P4|Overall Study|Adverse Event|0
3034615|NCT00711802|10433199|P3|Overall Study|Adverse Event|0
3034616|NCT00711802|10433200|P2|Overall Study|Adverse Event|0
3034617|NCT00711802|10433201|P1|Overall Study|Adverse Event|0
3034618|NCT00711802|10433194|P8|Overall Study|Not treated (no further detail)|0
3034619|NCT00711802|10433195|P7|Overall Study|Not treated (no further detail)|0
3034620|NCT00711802|10433196|P6|Overall Study|Not treated (no further detail)|0
3034621|NCT00711802|10433197|P5|Overall Study|Not treated (no further detail)|2
3034622|NCT00711802|10433198|P4|Overall Study|Not treated (no further detail)|0
3034623|NCT00711802|10433199|P3|Overall Study|Not treated (no further detail)|2
3034624|NCT00711802|10433200|P2|Overall Study|Not treated (no further detail)|1
3034625|NCT00711802|10433201|P1|Overall Study|Not treated (no further detail)|2
3034626|NCT00711646|10433244|P2|Overall Study|patient non-compliance|0
3034627|NCT00711646|10433245|P1|Overall Study|patient non-compliance|1
3034628|NCT00711646|10433244|P2|Overall Study|administrative decision|1
3034629|NCT00711646|10433245|P1|Overall Study|administrative decision|0
3034630|NCT00711646|10433244|P2|Overall Study|Lost to Follow-up|0
3034631|NCT00711646|10433245|P1|Overall Study|Lost to Follow-up|1
3034632|NCT00711646|10433244|P2|Overall Study|Protocol Violation|1
3034633|NCT00711646|10433245|P1|Overall Study|Protocol Violation|0
3034634|NCT00711646|10433244|P2|Overall Study|Withdrawal by Subject|0
3034635|NCT00711646|10433245|P1|Overall Study|Withdrawal by Subject|4
3034636|NCT00711646|10433244|P2|Overall Study|Adverse Event|1
3034637|NCT00711646|10433245|P1|Overall Study|Adverse Event|6
3034638|NCT00711594|10433267|P4|Overall Study|Withdrawal by Subject|2
3034639|NCT00711594|10433268|P3|Overall Study|Withdrawal by Subject|0
3034640|NCT00711594|10433269|P2|Overall Study|Withdrawal by Subject|1
3034641|NCT00711594|10433270|P1|Overall Study|Withdrawal by Subject|0
3034642|NCT00711594|10433267|P4|Overall Study|Other Adverse Event|16
3034643|NCT00711594|10433268|P3|Overall Study|Other Adverse Event|0
3034644|NCT00711594|10433269|P2|Overall Study|Other Adverse Event|0
3034645|NCT00711594|10433270|P1|Overall Study|Other Adverse Event|1
3034646|NCT00711594|10433267|P4|Overall Study|Progressive disease|44
3034647|NCT00711594|10433268|P3|Overall Study|Progressive disease|6
3034648|NCT00711594|10433269|P2|Overall Study|Progressive disease|2
3034649|NCT00711594|10433270|P1|Overall Study|Progressive disease|2
3034650|NCT00711555|10433307|P1|Overall Study|Adverse Event|3
3034651|NCT00711529|10433316|P2|Overall Study|Withdrawal by Subject|6
3034652|NCT00711529|10433317|P1|Overall Study|Withdrawal by Subject|2
3034653|NCT00711529|10433316|P2|Overall Study|Protocol Violation|0
3034654|NCT00711529|10433317|P1|Overall Study|Protocol Violation|2
3034655|NCT00711516|10433341|P2|Overall Study|Protocol Violation|1
3034656|NCT00711516|10433342|P1|Overall Study|Protocol Violation|0
3034657|NCT00711516|10433341|P2|Overall Study|Withdrawal by Subject|1
3034658|NCT00711516|10433342|P1|Overall Study|Withdrawal by Subject|0
3034659|NCT00711516|10433341|P2|Overall Study|Adverse Event|1
3034660|NCT00711516|10433342|P1|Overall Study|Adverse Event|1
3034661|NCT00711477|10433449|P2|Overall Study|Noncompliance|1
3034662|NCT00711477|10433450|P1|Overall Study|Noncompliance|0
3034663|NCT00711477|10433449|P2|Overall Study|Lost to Follow-up|1
3034664|NCT00711477|10433450|P1|Overall Study|Lost to Follow-up|0
3034665|NCT00711477|10433449|P2|Overall Study|Adverse Event|1
3034666|NCT00711477|10433450|P1|Overall Study|Adverse Event|3
3034667|NCT00711425|10433496|P1|Overall Study|Lost to Follow-up|1
3034668|NCT00711425|10433496|P1|Overall Study|Death|2
3034669|NCT00711425|10433496|P1|Overall Study|Protocol Violation|1
3034670|NCT00711412|10433502|P1|Survival Follow up Until Death|Other|12
3034671|NCT00711412|10433502|P1|Evaluation for Response and Surgery|Death|1
3034672|NCT00711412|10433502|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
3034673|NCT00711412|10433502|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
3034674|NCT00711412|10433502|P1|Evaluation for Response and Surgery|Progressive Disease|2
3034675|NCT00711412|10433502|P1|Combination Treatment|Progressive Disease|1
3034676|NCT00711412|10433502|P1|Evaluated for Combination Treatment|Progressive disease|2
3034677|NCT00711412|10433502|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
3034678|NCT00711412|10433502|P1|Evaluated for Combination Treatment|Death|1
3034679|NCT00711412|10433502|P1|Evaluated for Combination Treatment|Adverse Event|2
3034680|NCT00711412|10433502|P1|Induction Treatment|Other|1
3034681|NCT00711412|10433502|P1|Induction Treatment|Adverse Event|1
3034682|NCT00711412|10433502|P1|Induction Treatment|Death|2
3034683|NCT00711243|10433580|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
3034684|NCT00711243|10433581|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
3034685|NCT00711243|10433582|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
3034686|NCT00711243|10433583|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
3034687|NCT00711243|10433584|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
3034688|NCT00711243|10433585|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
3034689|NCT00711243|10433580|P6|Treated Cycle 5 After First Response|Decline in performance status|1
3034690|NCT00711243|10433581|P5|Treated Cycle 5 After First Response|Decline in performance status|0
3034691|NCT00711243|10433582|P4|Treated Cycle 5 After First Response|Decline in performance status|0
3034692|NCT00711243|10433583|P3|Treated Cycle 5 After First Response|Decline in performance status|0
3034693|NCT00711243|10433584|P2|Treated Cycle 5 After First Response|Decline in performance status|0
3034694|NCT00711243|10433585|P1|Treated Cycle 5 After First Response|Decline in performance status|0
3034695|NCT00711243|10433580|P6|Treated Cycle 5 After First Response|Death|2
3034696|NCT00711243|10433581|P5|Treated Cycle 5 After First Response|Death|0
3034697|NCT00711243|10433582|P4|Treated Cycle 5 After First Response|Death|0
3034698|NCT00711243|10433583|P3|Treated Cycle 5 After First Response|Death|0
3034699|NCT00711243|10433584|P2|Treated Cycle 5 After First Response|Death|0
3034700|NCT00711243|10433585|P1|Treated Cycle 5 After First Response|Death|0
3034701|NCT00711243|10433580|P6|Treated Cycle 5 After First Response|Progressive disease|1
3034702|NCT00711243|10433581|P5|Treated Cycle 5 After First Response|Progressive disease|1
3034703|NCT00711243|10433582|P4|Treated Cycle 5 After First Response|Progressive disease|0
3034704|NCT00711243|10433583|P3|Treated Cycle 5 After First Response|Progressive disease|0
3034705|NCT00711243|10433584|P2|Treated Cycle 5 After First Response|Progressive disease|2
3034706|NCT00711243|10433585|P1|Treated Cycle 5 After First Response|Progressive disease|1
3034707|NCT00711243|10433580|P6|Reached First Response/4 Cycles|Progressive disease|0
3034708|NCT00711243|10433581|P5|Reached First Response/4 Cycles|Progressive disease|0
3034709|NCT00711243|10433582|P4|Reached First Response/4 Cycles|Progressive disease|1
3034710|NCT00711243|10433583|P3|Reached First Response/4 Cycles|Progressive disease|0
3034711|NCT00711243|10433584|P2|Reached First Response/4 Cycles|Progressive disease|0
3034712|NCT00711243|10433585|P1|Reached First Response/4 Cycles|Progressive disease|0
3034713|NCT00711243|10433580|P6|Reached First Response/4 Cycles|Death|2
3034714|NCT00711243|10433581|P5|Reached First Response/4 Cycles|Death|0
3034715|NCT00711243|10433582|P4|Reached First Response/4 Cycles|Death|0
3034716|NCT00711243|10433583|P3|Reached First Response/4 Cycles|Death|0
3034717|NCT00711243|10433584|P2|Reached First Response/4 Cycles|Death|0
3034718|NCT00711243|10433585|P1|Reached First Response/4 Cycles|Death|0
3034719|NCT00711243|10433580|P6|Registed and Started Treatment|Withdrawal by Subject|1
3034720|NCT00711243|10433581|P5|Registed and Started Treatment|Withdrawal by Subject|0
3034721|NCT00711243|10433582|P4|Registed and Started Treatment|Withdrawal by Subject|0
3034722|NCT00711243|10433583|P3|Registed and Started Treatment|Withdrawal by Subject|0
3034723|NCT00711243|10433584|P2|Registed and Started Treatment|Withdrawal by Subject|0
3034724|NCT00711243|10433585|P1|Registed and Started Treatment|Withdrawal by Subject|0
3034725|NCT00711191|10433608|P3|Overall Study|Withdrawal by Subject|3
3034726|NCT00711191|10433609|P2|Overall Study|Withdrawal by Subject|1
3034727|NCT00711191|10433610|P1|Overall Study|Withdrawal by Subject|0
3034728|NCT00711191|10433608|P3|Overall Study|Objective progression or relapse|7
3034729|NCT00711191|10433609|P2|Overall Study|Objective progression or relapse|3
3034730|NCT00711191|10433610|P1|Overall Study|Objective progression or relapse|2
3034731|NCT00711191|10433608|P3|Overall Study|Adverse Event|2
3034732|NCT00711191|10433609|P2|Overall Study|Adverse Event|1
3034733|NCT00711191|10433610|P1|Overall Study|Adverse Event|1
3034734|NCT00711113|10433647|P1|Overall Study|Implant lost|2
3034735|NCT00711113|10433647|P1|Overall Study|Lost to Follow-up|9
3034736|NCT00711100|10433653|P1|Overall Study|Withdrawal by Subject|8
3034737|NCT00711100|10433653|P1|Overall Study|Lack of Efficacy|5
3034738|NCT00711087|10433671|P2|Overall Study|Lost to Follow-up|0
3034739|NCT00711087|10433672|P1|Overall Study|Lost to Follow-up|1
3034740|NCT00711009|10433684|P2|Overall Study|Dose adjustment|0
3034741|NCT00711009|10433685|P1|Overall Study|Dose adjustment|1
3034742|NCT00711009|10433684|P2|Overall Study|Site closing|1
3034743|NCT00711009|10433685|P1|Overall Study|Site closing|0
3034744|NCT00711009|10433684|P2|Overall Study|Pregnancy|0
3034745|NCT00711009|10433685|P1|Overall Study|Pregnancy|1
3034746|NCT00711009|10433684|P2|Overall Study|Virologic Failure|1
3034747|NCT00711009|10433685|P1|Overall Study|Virologic Failure|2
3034748|NCT00711009|10433684|P2|Overall Study|Participant Noncompliant|1
3034749|NCT00711009|10433685|P1|Overall Study|Participant Noncompliant|0
3034750|NCT00711009|10433684|P2|Overall Study|Lost to Follow-up|9
3034751|NCT00711009|10433685|P1|Overall Study|Lost to Follow-up|3
3034752|NCT00711009|10433684|P2|Overall Study|Withdrawal by Subject|2
3034753|NCT00711009|10433685|P1|Overall Study|Withdrawal by Subject|4
3034754|NCT00711009|10433684|P2|Overall Study|Adverse Event/HIV-Related Event|5
3034755|NCT00711009|10433685|P1|Overall Study|Adverse Event/HIV-Related Event|4
3034756|NCT00710970|10433866|P1|Overall Study|Never took drug|2
3034757|NCT00710970|10433866|P1|Overall Study|Lost to Follow-up|8
3034758|NCT00710879|10433893|P2|Overall Study|Protocol Violation|3
3034759|NCT00710879|10433894|P1|Overall Study|Protocol Violation|0
3034760|NCT00710879|10433893|P2|Overall Study|Lost to Follow-up|1
3034761|NCT00710879|10433894|P1|Overall Study|Lost to Follow-up|2
3034762|NCT00710866|10433906|P2|Overall Study|Failed to meet eligibility|1
3034763|NCT00710866|10433907|P1|Overall Study|Failed to meet eligibility|1
3034764|NCT00710866|10433906|P2|Overall Study|Lost to Follow-up|0
3034765|NCT00710866|10433907|P1|Overall Study|Lost to Follow-up|1
3034766|NCT00710866|10433906|P2|Overall Study|Withdrawal by Subject|1
3034767|NCT00710866|10433907|P1|Overall Study|Withdrawal by Subject|2
3034768|NCT00710866|10433906|P2|Overall Study|Protocol Violation|4
3034769|NCT00710866|10433907|P1|Overall Study|Protocol Violation|5
3034770|NCT00710762|10433953|P2|Overall Study|Reason other than listed above|2
3034771|NCT00710762|10433954|P1|Overall Study|Reason other than listed above|2
3034772|NCT00710762|10433953|P2|Overall Study|Lost to Follow-up|0
3034773|NCT00710762|10433954|P1|Overall Study|Lost to Follow-up|1
3034774|NCT00710762|10433953|P2|Overall Study|Other Adverse Event|7
3034775|NCT00710762|10433954|P1|Overall Study|Other Adverse Event|7
3034776|NCT00710762|10433953|P2|Overall Study|Adverse Event other disease worsening|1
3034777|NCT00710762|10433954|P1|Overall Study|Adverse Event other disease worsening|2
3034778|NCT00710762|10433953|P2|Overall Study|Progressive disease|30
3034779|NCT00710762|10433954|P1|Overall Study|Progressive disease|27
3034780|NCT00710749|10433970|P2|First Intervention|Withdrawal by Subject|0
3034781|NCT00710749|10433971|P1|First Intervention|Withdrawal by Subject|1
3034782|NCT00710684|10433982|P3|Overall Study|Did not continue after week 24|16
3034783|NCT00710684|10433983|P2|Overall Study|Did not continue after week 24|21
3034784|NCT00710684|10433984|P1|Overall Study|Did not continue after week 24|25
3034785|NCT00710684|10433982|P3|Overall Study|Missing|0
3034786|NCT00710684|10433983|P2|Overall Study|Missing|0
3034787|NCT00710684|10433984|P1|Overall Study|Missing|1
3034788|NCT00710684|10433982|P3|Overall Study|Withdrawal by Subject|11
3034789|NCT00710684|10433983|P2|Overall Study|Withdrawal by Subject|18
3034790|NCT00710684|10433984|P1|Overall Study|Withdrawal by Subject|24
3034791|NCT00710684|10433982|P3|Overall Study|Physician Decision|4
3034792|NCT00710684|10433983|P2|Overall Study|Physician Decision|2
3034793|NCT00710684|10433984|P1|Overall Study|Physician Decision|0
3034794|NCT00710684|10433982|P3|Overall Study|Lost to Follow-up|7
3034795|NCT00710684|10433983|P2|Overall Study|Lost to Follow-up|6
3034796|NCT00710684|10433984|P1|Overall Study|Lost to Follow-up|4
3034797|NCT00710684|10433982|P3|Overall Study|Protocol Violation|5
3034798|NCT00710684|10433983|P2|Overall Study|Protocol Violation|5
3034799|NCT00710684|10433984|P1|Overall Study|Protocol Violation|5
3034800|NCT00710684|10433982|P3|Overall Study|Lack of Efficacy|5
3034801|NCT00710684|10433983|P2|Overall Study|Lack of Efficacy|3
3034802|NCT00710684|10433984|P1|Overall Study|Lack of Efficacy|4
3034803|NCT00710684|10433982|P3|Overall Study|Adverse Event|16
3034804|NCT00710684|10433983|P2|Overall Study|Adverse Event|19
3034805|NCT00710684|10433984|P1|Overall Study|Adverse Event|11
3034806|NCT00710606|10434041|P2|Overall Study|Adverse Event|2
3034807|NCT00710606|10434042|P1|Overall Study|Adverse Event|0
3034808|NCT00710593|10434054|P2|Overall Study|Prem disc vaccine, completed all visits|2
3034809|NCT00710593|10434055|P1|Overall Study|Prem disc vaccine, completed all visits|6
3034810|NCT00710593|10434054|P2|Overall Study|Protocol Violation|1
3034811|NCT00710593|10434055|P1|Overall Study|Protocol Violation|1
3034812|NCT00710593|10434054|P2|Overall Study|Failure to adhere or complete study eval|1
3034813|NCT00710593|10434055|P1|Overall Study|Failure to adhere or complete study eval|1
3034814|NCT00710593|10434054|P2|Overall Study|Moved out of area|0
3034815|NCT00710593|10434055|P1|Overall Study|Moved out of area|1
3034816|NCT00710593|10434054|P2|Overall Study|Lost to Follow-up|1
3034817|NCT00710593|10434055|P1|Overall Study|Lost to Follow-up|3
3034818|NCT00710593|10434054|P2|Overall Study|Unable to complete Wk 48 within window|0
3034819|NCT00710593|10434055|P1|Overall Study|Unable to complete Wk 48 within window|2
3034820|NCT00710593|10434054|P2|Overall Study|Incarceration|0
3034821|NCT00710593|10434055|P1|Overall Study|Incarceration|1
3034822|NCT00710554|10434098|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
3034823|NCT00710554|10434099|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
3034824|NCT00710554|10434098|P2|Overall Study|Lack of Efficacy|12
3034825|NCT00710554|10434099|P1|Overall Study|Lack of Efficacy|11
3034826|NCT00710554|10434098|P2|Overall Study|Lost to Follow-up|1
3034827|NCT00710554|10434099|P1|Overall Study|Lost to Follow-up|7
3034828|NCT00710554|10434098|P2|Overall Study|Withdrawal by Subject|3
3034829|NCT00710554|10434099|P1|Overall Study|Withdrawal by Subject|7
3034830|NCT00710554|10434098|P2|Overall Study|Adverse Event|7
3034831|NCT00710554|10434099|P1|Overall Study|Adverse Event|24
3034832|NCT00710424|10434127|P2|Overall Study|Felt good so stopped treatment|1
3034833|NCT00710424|10434128|P1|Overall Study|Felt good so stopped treatment|0
3034834|NCT00710424|10434127|P2|Overall Study|Subject preferred paracetamol|1
3034835|NCT00710424|10434128|P1|Overall Study|Subject preferred paracetamol|0
3034836|NCT00710424|10434127|P2|Overall Study|Ceased treatment due to travel|0
3034837|NCT00710424|10434128|P1|Overall Study|Ceased treatment due to travel|1
3034838|NCT00710424|10434127|P2|Overall Study|Subject thought medication changed|0
3034839|NCT00710424|10434128|P1|Overall Study|Subject thought medication changed|1
3034840|NCT00710424|10434127|P2|Overall Study|Did not meet entry criteria at visit 1|0
3034841|NCT00710424|10434128|P1|Overall Study|Did not meet entry criteria at visit 1|1
3034842|NCT00710424|10434127|P2|Overall Study|Non-compliance with stable analgesia|0
3034843|NCT00710424|10434128|P1|Overall Study|Non-compliance with stable analgesia|1
3034844|NCT00710424|10434127|P2|Overall Study|Refused medication, no side effects|0
3034845|NCT00710424|10434128|P1|Overall Study|Refused medication, no side effects|1
3034846|NCT00710424|10434127|P2|Overall Study|Lost to Follow-up|1
3034847|NCT00710424|10434128|P1|Overall Study|Lost to Follow-up|0
3034848|NCT00710424|10434127|P2|Overall Study|Withdrawal by Subject|3
3034849|NCT00710424|10434128|P1|Overall Study|Withdrawal by Subject|5
3034850|NCT00710424|10434127|P2|Overall Study|Lack of Efficacy|5
3034851|NCT00710424|10434128|P1|Overall Study|Lack of Efficacy|4
3034852|NCT00710424|10434127|P2|Overall Study|Adverse Event|12
3034853|NCT00710424|10434128|P1|Overall Study|Adverse Event|30
3034854|NCT00710385|10434152|P1|Overall Study|Undisclosed excessive methadone use|1
3034855|NCT00710385|10434152|P1|Overall Study|Physician Decision|1
3034856|NCT00710385|10434152|P1|Overall Study|Undisclosed back pain|1
3034857|NCT00710385|10434152|P1|Overall Study|Withdrawal by Subject|1
3034858|NCT00710385|10434152|P1|Overall Study|Did not qualify|1
3034859|NCT00710034|10434197|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
3034860|NCT00710034|10434198|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
3034861|NCT00710034|10434197|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
3034862|NCT00710034|10434198|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
3034863|NCT00710034|10434197|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
3034864|NCT00710034|10434198|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
3034865|NCT00710034|10434197|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
3034866|NCT00710034|10434198|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
3034867|NCT00710034|10434197|P2|Completed 12 Weeks of Treatment|Adverse Event|1
3034868|NCT00710034|10434198|P1|Completed 12 Weeks of Treatment|Adverse Event|0
3034869|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Physician Decision|0
3034870|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Physician Decision|1
3034871|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
3034872|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
3034873|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
3034874|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
3034875|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
3034876|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
3034877|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
3034878|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
3034879|NCT00710034|10434197|P2|Completed 6 Weeks of Treatment|Adverse Event|12
3034880|NCT00710034|10434198|P1|Completed 6 Weeks of Treatment|Adverse Event|5
3034881|NCT00710021|10434215|P3|Overall Study|Physician Decision|0
3034882|NCT00710021|10434216|P2|Overall Study|Physician Decision|1
3034883|NCT00710021|10434217|P1|Overall Study|Physician Decision|0
3034884|NCT00710021|10434215|P3|Overall Study|Subject misrandomized|1
3034885|NCT00710021|10434216|P2|Overall Study|Subject misrandomized|1
3034886|NCT00710021|10434217|P1|Overall Study|Subject misrandomized|0
3034887|NCT00710021|10434215|P3|Overall Study|Subject's Decision|0
3034888|NCT00710021|10434216|P2|Overall Study|Subject's Decision|1
3034889|NCT00710021|10434217|P1|Overall Study|Subject's Decision|0
3034890|NCT00710021|10434215|P3|Overall Study|Lost to Follow-up|0
3034891|NCT00710021|10434216|P2|Overall Study|Lost to Follow-up|0
3034892|NCT00710021|10434217|P1|Overall Study|Lost to Follow-up|1
3034893|NCT00709995|10434332|P2|Overall Study|Withdrawal by Subject|3
3034894|NCT00709995|10434333|P1|Overall Study|Withdrawal by Subject|1
3034895|NCT00709995|10434332|P2|Overall Study|Adverse Event|2
3034896|NCT00709995|10434333|P1|Overall Study|Adverse Event|4
3034897|NCT00709956|10434351|P2|Overall Study|Inclusion/exclusion criteria violation|3
3034898|NCT00709956|10434352|P1|Overall Study|Inclusion/exclusion criteria violation|2
3034899|NCT00709956|10434351|P2|Overall Study|Withdrawal by Subject|1
3034900|NCT00709956|10434352|P1|Overall Study|Withdrawal by Subject|1
3034901|NCT00709852|10434382|P2|Period 2|No 72-hour follow-up|0
3034902|NCT00709852|10434383|P1|Period 2|No 72-hour follow-up|3
3034903|NCT00709852|10434382|P2|Period 2|Lost to Follow-up|0
3034904|NCT00709852|10434383|P1|Period 2|Lost to Follow-up|1
3034905|NCT00709852|10434382|P2|Period 2|Adverse Event|1
3034906|NCT00709852|10434383|P1|Period 2|Adverse Event|1
3034907|NCT00709852|10434382|P2|Period 2|Protocol Violation|1
3034908|NCT00709852|10434383|P1|Period 2|Protocol Violation|4
3034909|NCT00709852|10434382|P2|Period 1|Lost to Follow-up|0
3034910|NCT00709852|10434383|P1|Period 1|Lost to Follow-up|1
3034911|NCT00709852|10434382|P2|Period 1|Defective scanner|1
3034912|NCT00709852|10434383|P1|Period 1|Defective scanner|0
3034913|NCT00709852|10434382|P2|Period 1|Protocol Violation|0
3034914|NCT00709852|10434383|P1|Period 1|Protocol Violation|1
3034915|NCT00709852|10434382|P2|Period 1|Withdrawal by Subject|2
3034916|NCT00709852|10434383|P1|Period 1|Withdrawal by Subject|4
3034917|NCT00709852|10434382|P2|Period 1|Adverse Event|0
3034918|NCT00709852|10434383|P1|Period 1|Adverse Event|2
3034919|NCT00709761|10434547|P1|Overall Study|Lost to Follow-up|2
3034920|NCT00709761|10434547|P1|Overall Study|study closed/terminated|17
3034921|NCT00709761|10434547|P1|Overall Study|Withdrawal by Subject|8
3034922|NCT00709735|10434558|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
3034923|NCT00709735|10434559|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
3034924|NCT00709735|10434558|P2|Overall Study|Relapse into Opioid Abuse|1
3034925|NCT00709735|10434559|P1|Overall Study|Relapse into Opioid Abuse|0
3034926|NCT00709735|10434558|P2|Overall Study|Lost to Follow-up|1
3034927|NCT00709735|10434559|P1|Overall Study|Lost to Follow-up|1
3034928|NCT00709722|10434567|P1|Overall Study|Adverse Event|1
3034929|NCT00709618|10434582|P1|Overall Study|Study Closed/Terminated|25
3034930|NCT00709618|10434582|P1|Overall Study|Lost to Follow-up|1
3034931|NCT00709618|10434582|P1|Overall Study|Withdrawal by Subject|4
3034932|NCT00709592|10434594|P2|Overall Study|Unable to proceed to transplant|1
3034933|NCT00709592|10434595|P1|Overall Study|Unable to proceed to transplant|0
3034934|NCT00709319|10434617|P1|Overall Study|Withdrawal by Subject|2
3034935|NCT00709319|10434617|P1|Overall Study|Death|4
3034936|NCT00709228|10434646|P1|Overall Study|Non-compliance|5
3034937|NCT00709228|10434646|P1|Overall Study|Lost to Follow-up|6
3034938|NCT00709228|10434646|P1|Overall Study|Disease progression|1
3034939|NCT00709228|10434646|P1|Overall Study|Discontinued follow-up|5
3034940|NCT00709228|10434646|P1|Overall Study|Did not enter follow-up|4
3034941|NCT00709228|10434646|P1|Overall Study|Discontinued treatment|14
3034942|NCT00709228|10434646|P1|Overall Study|Adverse events|2
3034943|NCT00709228|10434646|P1|Overall Study|Eligibility criteria not met|281
3034944|NCT00709228|10434646|P1|Overall Study|Not treated|14
3034945|NCT00709202|10434652|P2|Overall Study|Withdrawal by Subject|6
3034946|NCT00709202|10434653|P1|Overall Study|Withdrawal by Subject|6
3034947|NCT00709124|10434681|P2|Overall Study|encephalopathy; can't do assessment|0
3034948|NCT00709124|10434682|P1|Overall Study|encephalopathy; can't do assessment|1
3034949|NCT00709124|10434681|P2|Overall Study|Death|1
3034950|NCT00709124|10434682|P1|Overall Study|Death|3
3034951|NCT00709111|10434716|P1|Overall Study|Unable to attend clinic visits|1
3034952|NCT00709111|10434716|P1|Overall Study|Withdrawal by Subject|1
3034953|NCT00709098|10434757|P3|Open-label Period|Lost to Follow-up|1
3034954|NCT00709098|10434758|P2|Open-label Period|Lost to Follow-up|0
3034955|NCT00709098|10434759|P1|Open-label Period|Lost to Follow-up|0
3034956|NCT00709098|10434757|P3|Open-label Period|Death|1
3034957|NCT00709098|10434758|P2|Open-label Period|Death|0
3034958|NCT00709098|10434759|P1|Open-label Period|Death|0
3034959|NCT00709098|10434757|P3|Open-label Period|Administrative reason|5
3034960|NCT00709098|10434758|P2|Open-label Period|Administrative reason|0
3034961|NCT00709098|10434759|P1|Open-label Period|Administrative reason|0
3034962|NCT00709098|10434757|P3|Open-label Period|Withdrawal of consent|7
3034963|NCT00709098|10434758|P2|Open-label Period|Withdrawal of consent|0
3034964|NCT00709098|10434759|P1|Open-label Period|Withdrawal of consent|0
3034965|NCT00709098|10434757|P3|Double-blind Period|Lost to Follow-up|0
3034966|NCT00709098|10434758|P2|Double-blind Period|Lost to Follow-up|1
3034967|NCT00709098|10434759|P1|Double-blind Period|Lost to Follow-up|1
3034968|NCT00709098|10434757|P3|Double-blind Period|Death|0
3034969|NCT00709098|10434758|P2|Double-blind Period|Death|1
3034970|NCT00709098|10434759|P1|Double-blind Period|Death|1
3034971|NCT00709098|10434757|P3|Double-blind Period|Administrative reason|0
3034972|NCT00709098|10434758|P2|Double-blind Period|Administrative reason|3
3034973|NCT00709098|10434759|P1|Double-blind Period|Administrative reason|1
3034974|NCT00709098|10434757|P3|Double-blind Period|Withdrawal of consent|0
3034975|NCT00709098|10434758|P2|Double-blind Period|Withdrawal of consent|3
3034976|NCT00709098|10434759|P1|Double-blind Period|Withdrawal of consent|3
3034977|NCT00709059|10434778|P1|Overall Study|Serious side effects|11
3034978|NCT00709059|10434778|P1|Overall Study|Side effects|20
3034979|NCT00709059|10434778|P1|Overall Study|Disease complication|3
3034980|NCT00709059|10434778|P1|Overall Study|Physician Decision|7
3034981|NCT00709059|10434778|P1|Overall Study|Withdrawal by Subject|19
3034982|NCT00709059|10434778|P1|Overall Study|Lost to Follow-up|34
3034983|NCT00708734|10434825|P1|Overall Study|leg fracture|1
3034984|NCT00708734|10434825|P1|Overall Study|vertigo|1
3034985|NCT00708734|10434825|P1|Overall Study|knee replacement|1
3034986|NCT00708734|10434825|P1|Overall Study|leg injury|1
3034987|NCT00708734|10434825|P1|Overall Study|moved|1
3034988|NCT00708734|10434825|P1|Overall Study|scheduling conflict|2
3034989|NCT00708708|10434845|P1|Overall Study|Missing values|392
3034990|NCT00708708|10434845|P1|Overall Study|Adverse Event|3
3034991|NCT00708708|10434845|P1|Overall Study|Pregnancy|3
3034992|NCT00708708|10434845|P1|Overall Study|Lack of compliance|3
3034993|NCT00708708|10434845|P1|Overall Study|Lack of effectiveness|4
3034994|NCT00708708|10434845|P1|Overall Study|Administrative reasons|7
3034995|NCT00708708|10434845|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
3034996|NCT00708708|10434845|P1|Overall Study|Good effectiveness|9
3034997|NCT00708708|10434845|P1|Overall Study|Other unspecified|11
3034998|NCT00708708|10434845|P1|Overall Study|Another therapy along with Enbrel|15
3034999|NCT00708708|10434845|P1|Overall Study|Intolerance|42
3035000|NCT00708708|10434845|P1|Overall Study|Withdrawal by Subject|51
3035001|NCT00708708|10434845|P1|Overall Study|Lost to Follow-up|52
3035002|NCT00708708|10434845|P1|Overall Study|Another therapy instead of Enbrel|141
3035003|NCT00708682|10434893|P1|Toddler Dose|Failed to Return|4
3035004|NCT00708682|10434893|P1|Toddler Dose|Lost to Follow-up|3
3035005|NCT00708682|10434893|P1|Toddler Dose|Parent/Legal Guardian Request|1
3035006|NCT00708682|10434893|P1|After Infant Series|Parent/Legal Guardian Request|1
3035007|NCT00708682|10434893|P1|Infant Series|Other|19
3035008|NCT00708682|10434893|P1|Infant Series|Failed to return|2
3035009|NCT00708682|10434893|P1|Infant Series|Parent/legal guardian request|6
3035010|NCT00708682|10434893|P1|Infant Series|Protocol Violation|1
3035011|NCT00708682|10434893|P1|Infant Series|Lost to Follow-up|4
3035012|NCT00708682|10434893|P1|Infant Series|Adverse Event|1
3035013|NCT00708643|10434914|P2|Overall Study|Adverse Event|1
3035014|NCT00708643|10434915|P1|Overall Study|Adverse Event|0
3035015|NCT00708552|10434935|P4|Overall Study|Withdrawal by Subject|10
3035016|NCT00708552|10434936|P3|Overall Study|Withdrawal by Subject|8
3035017|NCT00708552|10434937|P2|Overall Study|Withdrawal by Subject|7
3035018|NCT00708552|10434938|P1|Overall Study|Withdrawal by Subject|12
3035019|NCT00708552|10434935|P4|Overall Study|Physician Decision|0
3035020|NCT00708552|10434936|P3|Overall Study|Physician Decision|0
3035021|NCT00708552|10434937|P2|Overall Study|Physician Decision|2
3035022|NCT00708552|10434938|P1|Overall Study|Physician Decision|1
3035023|NCT00708552|10434935|P4|Overall Study|Lost to Follow-up|1
3035024|NCT00708552|10434936|P3|Overall Study|Lost to Follow-up|0
3035025|NCT00708552|10434937|P2|Overall Study|Lost to Follow-up|2
3035026|NCT00708552|10434938|P1|Overall Study|Lost to Follow-up|4
3035027|NCT00708552|10434935|P4|Overall Study|Protocol Violation|4
3035028|NCT00708552|10434936|P3|Overall Study|Protocol Violation|2
3035029|NCT00708552|10434937|P2|Overall Study|Protocol Violation|0
3035030|NCT00708552|10434938|P1|Overall Study|Protocol Violation|0
3035031|NCT00708552|10434935|P4|Overall Study|Lack of Efficacy|0
3035032|NCT00708552|10434936|P3|Overall Study|Lack of Efficacy|1
3035033|NCT00708552|10434937|P2|Overall Study|Lack of Efficacy|4
3035034|NCT00708552|10434938|P1|Overall Study|Lack of Efficacy|0
3035035|NCT00708552|10434935|P4|Overall Study|Adverse Event|6
3035036|NCT00708552|10434936|P3|Overall Study|Adverse Event|4
3035037|NCT00708552|10434937|P2|Overall Study|Adverse Event|3
3035038|NCT00708552|10434938|P1|Overall Study|Adverse Event|10
3035039|NCT00708500|10435100|P3|FOLLOWUP|Non-compliance with protocol|1
3035040|NCT00708500|10435101|P2|FOLLOWUP|Non-compliance with protocol|0
3035041|NCT00708500|10435102|P1|FOLLOWUP|Non-compliance with protocol|5
3035042|NCT00708500|10435100|P3|FOLLOWUP|Subject withdrew consent|5
3035043|NCT00708500|10435101|P2|FOLLOWUP|Subject withdrew consent|4
3035044|NCT00708500|10435102|P1|FOLLOWUP|Subject withdrew consent|31
3035045|NCT00708500|10435100|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
3035046|NCT00708500|10435101|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
3035047|NCT00708500|10435102|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
3035048|NCT00708500|10435100|P3|FOLLOWUP|Lost to Follow-up|4
3035049|NCT00708500|10435101|P2|FOLLOWUP|Lost to Follow-up|6
3035050|NCT00708500|10435102|P1|FOLLOWUP|Lost to Follow-up|1
3035051|NCT00708500|10435100|P3|FOLLOWUP|Adverse Event|0
3035052|NCT00708500|10435101|P2|FOLLOWUP|Adverse Event|1
3035053|NCT00708500|10435102|P1|FOLLOWUP|Adverse Event|0
3035054|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
3035055|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
3035056|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
3035057|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
3035058|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
3035059|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
3035060|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
3035061|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
3035062|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
3035063|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
3035064|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
3035065|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
3035066|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
3035067|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
3035068|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
3035069|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
3035070|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
3035071|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
3035072|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
3035073|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
3035074|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
3035075|NCT00708500|10435100|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
3035076|NCT00708500|10435101|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
3035077|NCT00708500|10435102|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
3035078|NCT00708500|10435100|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
3035079|NCT00708500|10435101|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
3035080|NCT00708500|10435102|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
3035081|NCT00708500|10435100|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
3035082|NCT00708500|10435101|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
3035083|NCT00708500|10435102|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
3035084|NCT00708500|10435100|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
3035085|NCT00708500|10435101|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
3035086|NCT00708500|10435102|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
3035087|NCT00708500|10435100|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
3035088|NCT00708500|10435101|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
3035089|NCT00708500|10435102|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
3035090|NCT00708500|10435100|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
3035091|NCT00708500|10435101|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
3035092|NCT00708500|10435102|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
3035093|NCT00708461|10435121|P2|Overall Study|left workforce|180
3035094|NCT00708461|10435122|P1|Overall Study|left workforce|115
3035095|NCT00708461|10435121|P2|Overall Study|Withdrawal by Subject|9
3035096|NCT00708461|10435122|P1|Overall Study|Withdrawal by Subject|8
3035097|NCT00708461|10435121|P2|Overall Study|Lost to Follow-up|11
3035098|NCT00708461|10435122|P1|Overall Study|Lost to Follow-up|18
3035099|NCT00708435|10435130|P2|Overall Study|Refused hospitalization|0
3035100|NCT00708435|10435131|P1|Overall Study|Refused hospitalization|1
3035101|NCT00708435|10435130|P2|Overall Study|Intervention by primary care physician|0
3035102|NCT00708435|10435131|P1|Overall Study|Intervention by primary care physician|1
3035103|NCT00708435|10435130|P2|Overall Study|Protocol Violation|1
3035104|NCT00708435|10435131|P1|Overall Study|Protocol Violation|0
3035105|NCT00708435|10435130|P2|Overall Study|Adverse Event|0
3035106|NCT00708435|10435131|P1|Overall Study|Adverse Event|1
3035107|NCT00708435|10435130|P2|Overall Study|Withdrawal by Subject|7
3035108|NCT00708435|10435131|P1|Overall Study|Withdrawal by Subject|3
3035109|NCT00708435|10435130|P2|Overall Study|Lost to Follow-up|4
3035110|NCT00708435|10435131|P1|Overall Study|Lost to Follow-up|9
3035111|NCT00708435|10435130|P2|Overall Study|Death / Serious Adverse Event|5
3035112|NCT00708435|10435131|P1|Overall Study|Death / Serious Adverse Event|10
3035113|NCT00708422|10435158|P2|Overall Study|Withdrawal by Subject|0
3035114|NCT00708422|10435159|P1|Overall Study|Withdrawal by Subject|1
3035115|NCT00708422|10435158|P2|Overall Study|Adverse Event|1
3035116|NCT00708422|10435159|P1|Overall Study|Adverse Event|3
3035117|NCT00708305|10435167|P4|Period 3|Other Reason|0
3035118|NCT00708305|10435168|P3|Period 3|Other Reason|0
3035119|NCT00708305|10435169|P2|Period 3|Other Reason|0
3035120|NCT00708305|10435170|P1|Period 3|Other Reason|1
3035121|NCT00708305|10435167|P4|Period 3|Protocol Violation|0
3035122|NCT00708305|10435168|P3|Period 3|Protocol Violation|0
3035123|NCT00708305|10435169|P2|Period 3|Protocol Violation|2
3035124|NCT00708305|10435170|P1|Period 3|Protocol Violation|0
3035125|NCT00708305|10435167|P4|Period 2|Other Reason|1
3035126|NCT00708305|10435168|P3|Period 2|Other Reason|0
3035127|NCT00708305|10435169|P2|Period 2|Other Reason|0
3035128|NCT00708305|10435170|P1|Period 2|Other Reason|1
3035129|NCT00708305|10435167|P4|Period 2|Protocol Violation|0
3035130|NCT00708305|10435168|P3|Period 2|Protocol Violation|0
3035131|NCT00708305|10435169|P2|Period 2|Protocol Violation|1
3035132|NCT00708305|10435170|P1|Period 2|Protocol Violation|0
3035133|NCT00708305|10435167|P4|Period 2|Lost to Follow-up|0
3035134|NCT00708305|10435168|P3|Period 2|Lost to Follow-up|0
3035135|NCT00708305|10435169|P2|Period 2|Lost to Follow-up|1
3035136|NCT00708305|10435170|P1|Period 2|Lost to Follow-up|0
3035137|NCT00708305|10435167|P4|Period 1|Other Reason|2
3035138|NCT00708305|10435168|P3|Period 1|Other Reason|0
3035139|NCT00708305|10435169|P2|Period 1|Other Reason|0
3035140|NCT00708305|10435170|P1|Period 1|Other Reason|0
3035141|NCT00708305|10435167|P4|Period 1|Protocol Violation|0
3035142|NCT00708305|10435168|P3|Period 1|Protocol Violation|1
3035143|NCT00708305|10435169|P2|Period 1|Protocol Violation|0
3035144|NCT00708305|10435170|P1|Period 1|Protocol Violation|1
3035145|NCT00708227|10435206|P4|Overall Study|Withdrawal by Subject|1
3035146|NCT00708227|10435207|P3|Overall Study|Withdrawal by Subject|0
3035147|NCT00708227|10435208|P2|Overall Study|Withdrawal by Subject|2
3035148|NCT00708227|10435209|P1|Overall Study|Withdrawal by Subject|1
3035149|NCT00708227|10435206|P4|Overall Study|Physician Decision|2
3035150|NCT00708227|10435207|P3|Overall Study|Physician Decision|1
3035151|NCT00708227|10435208|P2|Overall Study|Physician Decision|3
3035152|NCT00708227|10435209|P1|Overall Study|Physician Decision|0
3035153|NCT00708214|10435242|P3|Overall Study|Progressive Disease|5
3035154|NCT00708214|10435243|P2|Overall Study|Progressive Disease|6
3035155|NCT00708214|10435244|P1|Overall Study|Progressive Disease|4
3035156|NCT00708214|10435242|P3|Overall Study|Other|1
3035157|NCT00708214|10435243|P2|Overall Study|Other|1
3035158|NCT00708214|10435244|P1|Overall Study|Other|0
3035159|NCT00708214|10435242|P3|Overall Study|Other Adverse Event|2
3035160|NCT00708214|10435243|P2|Overall Study|Other Adverse Event|6
3035161|NCT00708214|10435244|P1|Overall Study|Other Adverse Event|3
3035162|NCT00708201|10435287|P2|Overall Study|Protocol Violation|1
3035163|NCT00708201|10435288|P1|Overall Study|Protocol Violation|0
3035164|NCT00708201|10435287|P2|Overall Study|Lost to Follow-up|0
3035165|NCT00708201|10435288|P1|Overall Study|Lost to Follow-up|2
3035166|NCT00708201|10435287|P2|Overall Study|Withdrawal by Subject|1
3035167|NCT00708201|10435288|P1|Overall Study|Withdrawal by Subject|1
3035168|NCT00708201|10435287|P2|Overall Study|Adverse Event|4
3035169|NCT00708201|10435288|P1|Overall Study|Adverse Event|4
3035170|NCT00708175|10435312|P2|Overall Study|BMD loss >7%|3
3035171|NCT00708175|10435313|P1|Overall Study|BMD loss >7%|2
3035172|NCT00708175|10435312|P2|Overall Study|Withdrawal by Subject|7
3035173|NCT00708175|10435313|P1|Overall Study|Withdrawal by Subject|5
3035174|NCT00708175|10435312|P2|Overall Study|Lost to Follow-up|3
3035175|NCT00708175|10435313|P1|Overall Study|Lost to Follow-up|5
3035176|NCT00708175|10435312|P2|Overall Study|Protocol Violation|3
3035177|NCT00708175|10435313|P1|Overall Study|Protocol Violation|2
3035178|NCT00708175|10435312|P2|Overall Study|Adverse Event|5
3035179|NCT00708175|10435313|P1|Overall Study|Adverse Event|4
3035180|NCT00708162|10435329|P2|Open-Label Phase|Other|0
3035181|NCT00708162|10435330|P1|Open-Label Phase|Other|1
3035182|NCT00708162|10435329|P2|Open-Label Phase|Adverse Event|2
3035183|NCT00708162|10435330|P1|Open-Label Phase|Adverse Event|1
3035184|NCT00708162|10435329|P2|Open-Label Phase|Death|1
3035185|NCT00708162|10435330|P1|Open-Label Phase|Death|3
3035186|NCT00708162|10435329|P2|Open-Label Phase|Investigator's Discretion|2
3035187|NCT00708162|10435330|P1|Open-Label Phase|Investigator's Discretion|3
3035188|NCT00708162|10435329|P2|Open-Label Phase|Lack of Efficacy|4
3035189|NCT00708162|10435330|P1|Open-Label Phase|Lack of Efficacy|7
3035190|NCT00708162|10435329|P2|Open-Label Phase|Participant Noncompliance|7
3035191|NCT00708162|10435330|P1|Open-Label Phase|Participant Noncompliance|7
3035192|NCT00708162|10435329|P2|Open-Label Phase|Withdrew Consent|6
3035193|NCT00708162|10435330|P1|Open-Label Phase|Withdrew Consent|12
3035194|NCT00708162|10435329|P2|Open-Label Phase|Lost to Follow-up|8
3035195|NCT00708162|10435330|P1|Open-Label Phase|Lost to Follow-up|10
3035196|NCT00708162|10435329|P2|Randomized Phase|Pregnancy|0
3035197|NCT00708162|10435330|P1|Randomized Phase|Pregnancy|3
3035198|NCT00708162|10435329|P2|Randomized Phase|Death|9
3035199|NCT00708162|10435330|P1|Randomized Phase|Death|2
3035200|NCT00708162|10435329|P2|Randomized Phase|Investigator’s Discretion|10
3035201|NCT00708162|10435330|P1|Randomized Phase|Investigator’s Discretion|7
3035202|NCT00708162|10435329|P2|Randomized Phase|Adverse Event|12
3035203|NCT00708162|10435330|P1|Randomized Phase|Adverse Event|8
3035204|NCT00708162|10435329|P2|Randomized Phase|Protocol Violation|11
3035205|NCT00708162|10435330|P1|Randomized Phase|Protocol Violation|10
3035206|NCT00708162|10435329|P2|Randomized Phase|Lack of Efficacy|19
3035207|NCT00708162|10435330|P1|Randomized Phase|Lack of Efficacy|14
3035208|NCT00708162|10435329|P2|Randomized Phase|Withdrew Consent|22
3035209|NCT00708162|10435330|P1|Randomized Phase|Withdrew Consent|31
3035210|NCT00708162|10435329|P2|Randomized Phase|Lost to Follow-up|34
3035211|NCT00708162|10435330|P1|Randomized Phase|Lost to Follow-up|34
3035212|NCT00708162|10435329|P2|Randomized Phase|Participant Noncompliance|32
3035213|NCT00708162|10435330|P1|Randomized Phase|Participant Noncompliance|40
3035214|NCT00708162|10435329|P2|Randomized Phase|Randomized but Not Treated|5
3035215|NCT00708162|10435330|P1|Randomized Phase|Randomized but Not Treated|7
3035216|NCT00708123|10435371|P5|Period 4|Protocol Violation|0
3035217|NCT00708123|10435372|P4|Period 4|Protocol Violation|0
3035218|NCT00708123|10435373|P3|Period 4|Protocol Violation|0
3035219|NCT00708123|10435374|P2|Period 4|Protocol Violation|1
3035220|NCT00708123|10435375|P1|Period 4|Protocol Violation|0
3035221|NCT00708123|10435371|P5|Period 3|Lost to Follow-up|0
3035222|NCT00708123|10435372|P4|Period 3|Lost to Follow-up|1
3035223|NCT00708123|10435373|P3|Period 3|Lost to Follow-up|1
3035224|NCT00708123|10435374|P2|Period 3|Lost to Follow-up|0
3035225|NCT00708123|10435375|P1|Period 3|Lost to Follow-up|0
3035226|NCT00708123|10435371|P5|Period 2|Other Reason|0
3035227|NCT00708123|10435372|P4|Period 2|Other Reason|0
3035228|NCT00708123|10435373|P3|Period 2|Other Reason|0
3035229|NCT00708123|10435374|P2|Period 2|Other Reason|0
3035230|NCT00708123|10435375|P1|Period 2|Other Reason|1
3035231|NCT00708123|10435371|P5|Period 2|Protocol Violation|0
3035232|NCT00708123|10435372|P4|Period 2|Protocol Violation|1
3035233|NCT00708123|10435373|P3|Period 2|Protocol Violation|0
3035234|NCT00708123|10435374|P2|Period 2|Protocol Violation|0
3035235|NCT00708123|10435375|P1|Period 2|Protocol Violation|0
3035236|NCT00708123|10435371|P5|Period 1|Adverse Event|0
3035237|NCT00708123|10435372|P4|Period 1|Adverse Event|0
3035238|NCT00708123|10435373|P3|Period 1|Adverse Event|1
3035239|NCT00708123|10435374|P2|Period 1|Adverse Event|0
3035240|NCT00708123|10435375|P1|Period 1|Adverse Event|0
3035241|NCT00708123|10435371|P5|Period 1|Protocol Violation|0
3035242|NCT00708123|10435372|P4|Period 1|Protocol Violation|1
3035243|NCT00708123|10435373|P3|Period 1|Protocol Violation|0
3035244|NCT00708123|10435374|P2|Period 1|Protocol Violation|1
3035245|NCT00708123|10435375|P1|Period 1|Protocol Violation|0
3035246|NCT00708097|10435508|P5|Period 2|Protocol Violation|0
3035247|NCT00708097|10435509|P4|Period 2|Protocol Violation|1
3035248|NCT00708097|10435510|P3|Period 2|Protocol Violation|1
3035249|NCT00708097|10435511|P2|Period 2|Protocol Violation|1
3035250|NCT00708097|10435512|P1|Period 2|Protocol Violation|0
3035251|NCT00708097|10435508|P5|Period 1|Other Reason|1
3035252|NCT00708097|10435509|P4|Period 1|Other Reason|0
3035253|NCT00708097|10435510|P3|Period 1|Other Reason|0
3035254|NCT00708097|10435511|P2|Period 1|Other Reason|0
3035255|NCT00708097|10435512|P1|Period 1|Other Reason|0
3035256|NCT00708097|10435508|P5|Period 1|Protocol Violation|0
3035257|NCT00708097|10435509|P4|Period 1|Protocol Violation|2
3035258|NCT00708097|10435510|P3|Period 1|Protocol Violation|0
3035259|NCT00708097|10435511|P2|Period 1|Protocol Violation|1
3035260|NCT00708097|10435512|P1|Period 1|Protocol Violation|0
3035261|NCT00708032|10435622|P2|Overall Study|Withdrawal by Subject|1
3035262|NCT00708032|10435623|P1|Overall Study|Withdrawal by Subject|0
3035263|NCT00708032|10435622|P2|Overall Study|Protocol Violation|1
3035264|NCT00708032|10435623|P1|Overall Study|Protocol Violation|4
3035265|NCT00708032|10435622|P2|Overall Study|Did not meet protocol criteria|2
3035266|NCT00708032|10435623|P1|Overall Study|Did not meet protocol criteria|1
3035267|NCT00708032|10435622|P2|Overall Study|Visit out of range at month 12|1
3035268|NCT00708032|10435623|P1|Overall Study|Visit out of range at month 12|4
3035269|NCT00708032|10435622|P2|Overall Study|Poor vision|6
3035270|NCT00708032|10435623|P1|Overall Study|Poor vision|0
3035271|NCT00708032|10435622|P2|Overall Study|Pregnancy|1
3035272|NCT00708032|10435623|P1|Overall Study|Pregnancy|0
3035273|NCT00708032|10435622|P2|Overall Study|Lost to Follow-up|2
3035274|NCT00708032|10435623|P1|Overall Study|Lost to Follow-up|1
3035275|NCT00708032|10435622|P2|Overall Study|Adverse Event|2
3035276|NCT00708032|10435623|P1|Overall Study|Adverse Event|0
3035277|NCT00707993|10435650|P2|Overall Study|Other|0
3035278|NCT00707993|10435651|P1|Overall Study|Other|2
3035279|NCT00707993|10435650|P2|Overall Study|Hyperglycemic Rescue|47
3035280|NCT00707993|10435651|P1|Overall Study|Hyperglycemic Rescue|55
3035281|NCT00707993|10435650|P2|Overall Study|Withdrawal by Subject|16
3035282|NCT00707993|10435651|P1|Overall Study|Withdrawal by Subject|12
3035283|NCT00707993|10435650|P2|Overall Study|Lost to Follow-up|4
3035284|NCT00707993|10435651|P1|Overall Study|Lost to Follow-up|0
3035285|NCT00707993|10435650|P2|Overall Study|Protocol Violation|7
3035286|NCT00707993|10435651|P1|Overall Study|Protocol Violation|4
3035287|NCT00707993|10435650|P2|Overall Study|Adverse Event|20
3035288|NCT00707993|10435651|P1|Overall Study|Adverse Event|16
3035289|NCT00707980|10435693|P1|Overall Study|Other|39
3035290|NCT00707980|10435693|P1|Overall Study|Lost to Follow-up|59
3035291|NCT00707980|10435693|P1|Overall Study|Withdrawal of Consent|81
3035292|NCT00707980|10435693|P1|Overall Study|Protocol Deviations|19
3035293|NCT00707980|10435693|P1|Overall Study|Non-Compliance with Study Drug|28
3035294|NCT00707980|10435693|P1|Overall Study|Lack of Efficacy|35
3035295|NCT00707980|10435693|P1|Overall Study|Adverse Event|49
3035296|NCT00707954|10435777|P5|Overall Study|Physician Decision|1
3035297|NCT00707954|10435778|P4|Overall Study|Physician Decision|0
3035298|NCT00707954|10435779|P3|Overall Study|Physician Decision|0
3035299|NCT00707954|10435780|P2|Overall Study|Physician Decision|0
3035300|NCT00707954|10435781|P1|Overall Study|Physician Decision|0
3035301|NCT00707746|10435822|P2|Treatment Period|Ineligibility|1
3035302|NCT00707746|10435823|P1|Treatment Period|Ineligibility|0
3035303|NCT00707746|10435822|P2|Treatment Period|Adverse Event|4
3035304|NCT00707746|10435823|P1|Treatment Period|Adverse Event|2
3035305|NCT00707577|10435884|P2|Overall Study|Pregnancy|1
3035306|NCT00707577|10435885|P1|Overall Study|Pregnancy|4
3035307|NCT00707577|10435884|P2|Overall Study|Left employment|10
3035308|NCT00707577|10435885|P1|Overall Study|Left employment|13
3035309|NCT00707577|10435884|P2|Overall Study|Lost to Follow-up|25
3035310|NCT00707577|10435885|P1|Overall Study|Lost to Follow-up|34
3035311|NCT00707577|10435884|P2|Overall Study|Withdrawal by Subject|2
3035312|NCT00707577|10435885|P1|Overall Study|Withdrawal by Subject|3
3035313|NCT00707486|10435891|P1|Overall Study|Withdrawal by Subject|1
3035314|NCT00707434|10435927|P1|Overall Study|Adverse Event|1
3035315|NCT00707239|10435938|P3|Overall Study|Other|5
3035316|NCT00707239|10435939|P2|Overall Study|Other|3
3035317|NCT00707239|10435940|P1|Overall Study|Other|8
3035318|NCT00707239|10435938|P3|Overall Study|Randomized, but not treated|1
3035319|NCT00707239|10435939|P2|Overall Study|Randomized, but not treated|1
3035320|NCT00707239|10435940|P1|Overall Study|Randomized, but not treated|1
3035321|NCT00707239|10435938|P3|Overall Study|Lack of Efficacy|0
3035322|NCT00707239|10435939|P2|Overall Study|Lack of Efficacy|2
3035323|NCT00707239|10435940|P1|Overall Study|Lack of Efficacy|1
3035324|NCT00707239|10435938|P3|Overall Study|Protocol Violation|1
3035325|NCT00707239|10435939|P2|Overall Study|Protocol Violation|0
3035326|NCT00707239|10435940|P1|Overall Study|Protocol Violation|0
3035327|NCT00707239|10435938|P3|Overall Study|Physician Decision|2
3035328|NCT00707239|10435939|P2|Overall Study|Physician Decision|1
3035329|NCT00707239|10435940|P1|Overall Study|Physician Decision|1
3035330|NCT00707239|10435938|P3|Overall Study|Death|3
3035331|NCT00707239|10435939|P2|Overall Study|Death|1
3035332|NCT00707239|10435940|P1|Overall Study|Death|3
3035333|NCT00707239|10435938|P3|Overall Study|Adverse Event|2
3035334|NCT00707239|10435939|P2|Overall Study|Adverse Event|3
3035335|NCT00707239|10435940|P1|Overall Study|Adverse Event|5
3035336|NCT00707174|10435988|P2|Overall Study|Withdrawal by Subject|1
3035337|NCT00707174|10435989|P1|Overall Study|Withdrawal by Subject|4
3035338|NCT00707174|10435988|P2|Overall Study|Adverse Event|6
3035339|NCT00707174|10435989|P1|Overall Study|Adverse Event|1
3035340|NCT00707161|10435995|P1|Overall Study|Physician Decision|6
3035341|NCT00707057|10436001|P2|Overall Study|Dosed incorrectly|1
3035342|NCT00707057|10436002|P1|Overall Study|Dosed incorrectly|0
3035343|NCT00707057|10436001|P2|Overall Study|Withdrawal by Subject|3
3035344|NCT00707057|10436002|P1|Overall Study|Withdrawal by Subject|8
3035345|NCT00707031|10436036|P2|Overall Study|Sponsor Decision|8
3035346|NCT00707031|10436037|P1|Overall Study|Sponsor Decision|9
3035347|NCT00707031|10436036|P2|Overall Study|Serious Noncompliance|3
3035348|NCT00707031|10436037|P1|Overall Study|Serious Noncompliance|2
3035349|NCT00707031|10436036|P2|Overall Study|Familial or Personal Reasons|15
3035350|NCT00707031|10436037|P1|Overall Study|Familial or Personal Reasons|12
3035351|NCT00707031|10436036|P2|Overall Study|Poor Compliance to Protocol|13
3035352|NCT00707031|10436037|P1|Overall Study|Poor Compliance to Protocol|7
3035353|NCT00707031|10436036|P2|Overall Study|Withdrawal by Subject|8
3035354|NCT00707031|10436037|P1|Overall Study|Withdrawal by Subject|7
3035355|NCT00707031|10436036|P2|Overall Study|Protocol Violation|0
3035356|NCT00707031|10436037|P1|Overall Study|Protocol Violation|1
3035357|NCT00707031|10436036|P2|Overall Study|Lost to Follow-up|1
3035358|NCT00707031|10436037|P1|Overall Study|Lost to Follow-up|2
3035359|NCT00707031|10436036|P2|Overall Study|Lack of Efficacy|6
3035360|NCT00707031|10436037|P1|Overall Study|Lack of Efficacy|19
3035361|NCT00707031|10436036|P2|Overall Study|Adverse Event|45
3035362|NCT00707031|10436037|P1|Overall Study|Adverse Event|45
3035363|NCT00706992|10436066|P7|Overall Study|Disease progression before treatment|0
3035364|NCT00706992|10436067|P6|Overall Study|Disease progression before treatment|0
3035365|NCT00706992|10436068|P5|Overall Study|Disease progression before treatment|1
3035366|NCT00706992|10436069|P4|Overall Study|Disease progression before treatment|0
3035367|NCT00706992|10436070|P3|Overall Study|Disease progression before treatment|0
3035368|NCT00706992|10436071|P2|Overall Study|Disease progression before treatment|0
3035369|NCT00706992|10436072|P1|Overall Study|Disease progression before treatment|0
3035370|NCT00706992|10436066|P7|Overall Study|Study termination|3
3035371|NCT00706992|10436067|P6|Overall Study|Study termination|2
3035372|NCT00706992|10436068|P5|Overall Study|Study termination|3
3035373|NCT00706992|10436069|P4|Overall Study|Study termination|2
3035374|NCT00706992|10436070|P3|Overall Study|Study termination|6
3035375|NCT00706992|10436071|P2|Overall Study|Study termination|5
3035376|NCT00706992|10436072|P1|Overall Study|Study termination|5
3035377|NCT00706966|10436104|P1|Overall Study|Adverse Event|1
3035378|NCT00706914|10436140|P3|Overall Study|Protocol Violation|1
3035379|NCT00706914|10436141|P2|Overall Study|Protocol Violation|1
3035380|NCT00706914|10436142|P1|Overall Study|Protocol Violation|3
3035381|NCT00706914|10436140|P3|Overall Study|Adverse Event|0
3035382|NCT00706914|10436141|P2|Overall Study|Adverse Event|2
3035383|NCT00706914|10436142|P1|Overall Study|Adverse Event|2
3035384|NCT00706914|10436140|P3|Overall Study|Lost to Follow-up|0
3035385|NCT00706914|10436141|P2|Overall Study|Lost to Follow-up|0
3035386|NCT00706914|10436142|P1|Overall Study|Lost to Follow-up|1
3035387|NCT00706914|10436140|P3|Overall Study|Lack of Efficacy|0
3035388|NCT00706914|10436141|P2|Overall Study|Lack of Efficacy|1
3035389|NCT00706914|10436142|P1|Overall Study|Lack of Efficacy|0
3035390|NCT00706901|10436165|P3|Overall Study|Death|0
3035391|NCT00706901|10436166|P2|Overall Study|Death|0
3035392|NCT00706901|10436167|P1|Overall Study|Death|1
3035393|NCT00706901|10436165|P3|Overall Study|In Jail|1
3035394|NCT00706901|10436166|P2|Overall Study|In Jail|0
3035395|NCT00706901|10436167|P1|Overall Study|In Jail|1
3035396|NCT00706901|10436165|P3|Overall Study|Withdrawal by Subject|5
3035397|NCT00706901|10436166|P2|Overall Study|Withdrawal by Subject|2
3035398|NCT00706901|10436167|P1|Overall Study|Withdrawal by Subject|4
3035399|NCT00706901|10436165|P3|Overall Study|Lost to Follow-up|2
3035400|NCT00706901|10436166|P2|Overall Study|Lost to Follow-up|3
3035401|NCT00706901|10436167|P1|Overall Study|Lost to Follow-up|2
3035402|NCT00706849|10436192|P2|Follow-up Period|Protocol non-compliance|1
3035403|NCT00706849|10436193|P1|Follow-up Period|Protocol non-compliance|0
3035404|NCT00706849|10436192|P2|Follow-up Period|Withdrawal by Subject|2
3035405|NCT00706849|10436193|P1|Follow-up Period|Withdrawal by Subject|0
3035406|NCT00706849|10436192|P2|Treatment Period|Other|1
3035407|NCT00706849|10436193|P1|Treatment Period|Other|0
3035408|NCT00706849|10436192|P2|Treatment Period|Adverse Event|9
3035409|NCT00706849|10436193|P1|Treatment Period|Adverse Event|0
3035410|NCT00706797|10436271|P2|Overall Study|Other|0
3035411|NCT00706797|10436272|P1|Overall Study|Other|1
3035412|NCT00706797|10436271|P2|Overall Study|Lost to Follow-up|2
3035413|NCT00706797|10436272|P1|Overall Study|Lost to Follow-up|1
3035414|NCT00706797|10436271|P2|Overall Study|Protocol Violation|2
3035415|NCT00706797|10436272|P1|Overall Study|Protocol Violation|3
3035416|NCT00706797|10436271|P2|Overall Study|Discontinuation of study by sponsor|63
3035417|NCT00706797|10436272|P1|Overall Study|Discontinuation of study by sponsor|52
3035418|NCT00706797|10436271|P2|Overall Study|Death|0
3035419|NCT00706797|10436272|P1|Overall Study|Death|1
3035420|NCT00706797|10436271|P2|Overall Study|Withdrawal by Subject|1
3035421|NCT00706797|10436272|P1|Overall Study|Withdrawal by Subject|8
3035422|NCT00706797|10436271|P2|Overall Study|Adverse Event|3
3035423|NCT00706797|10436272|P1|Overall Study|Adverse Event|0
3035424|NCT00706797|10436271|P2|Overall Study|Lack of Efficacy|0
3035425|NCT00706797|10436272|P1|Overall Study|Lack of Efficacy|3
3035426|NCT00706706|10436341|P1|Overall Study|Study endpoint had reached|45
3035427|NCT00706706|10436341|P1|Overall Study|Lost to Follow-up|7
3035428|NCT00706706|10436341|P1|Overall Study|Death|53
3035429|NCT00706654|10436351|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
3035430|NCT00706654|10436352|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
3035431|NCT00706654|10436353|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
3035432|NCT00706654|10436354|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
3035433|NCT00706654|10436351|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
3035434|NCT00706654|10436352|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
3035435|NCT00706654|10436353|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
3035436|NCT00706654|10436354|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
3035437|NCT00706654|10436351|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
3035438|NCT00706654|10436352|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
3035439|NCT00706654|10436353|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
3035440|NCT00706654|10436354|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
3035441|NCT00706654|10436351|P4|Depot Maintenance Phase|Protocol Deviation|1
3035442|NCT00706654|10436352|P3|Depot Maintenance Phase|Protocol Deviation|3
3035443|NCT00706654|10436353|P2|Depot Maintenance Phase|Protocol Deviation|2
3035444|NCT00706654|10436354|P1|Depot Maintenance Phase|Protocol Deviation|0
3035445|NCT00706654|10436351|P4|Depot Maintenance Phase|Withdrew Consent|14
3035446|NCT00706654|10436352|P3|Depot Maintenance Phase|Withdrew Consent|29
3035447|NCT00706654|10436353|P2|Depot Maintenance Phase|Withdrew Consent|21
3035448|NCT00706654|10436354|P1|Depot Maintenance Phase|Withdrew Consent|0
3035449|NCT00706654|10436351|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
3035450|NCT00706654|10436352|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
3035451|NCT00706654|10436353|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
3035452|NCT00706654|10436354|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
3035453|NCT00706654|10436351|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
3035454|NCT00706654|10436352|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
3035455|NCT00706654|10436353|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
3035456|NCT00706654|10436354|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
3035457|NCT00706654|10436351|P4|Depot Maintenance Phase|Lost to Follow-up|6
3035458|NCT00706654|10436352|P3|Depot Maintenance Phase|Lost to Follow-up|10
3035459|NCT00706654|10436353|P2|Depot Maintenance Phase|Lost to Follow-up|4
3035460|NCT00706654|10436354|P1|Depot Maintenance Phase|Lost to Follow-up|0
3035461|NCT00706654|10436351|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035462|NCT00706654|10436352|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035463|NCT00706654|10436353|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035464|NCT00706654|10436354|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
3035465|NCT00706654|10436351|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035466|NCT00706654|10436352|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035467|NCT00706654|10436353|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035468|NCT00706654|10436354|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
3035469|NCT00706654|10436351|P4|Oral Stabilization Phase|Adverse Event|0
3035470|NCT00706654|10436352|P3|Oral Stabilization Phase|Adverse Event|0
3035471|NCT00706654|10436353|P2|Oral Stabilization Phase|Adverse Event|0
3035472|NCT00706654|10436354|P1|Oral Stabilization Phase|Adverse Event|21
3035473|NCT00706654|10436351|P4|Oral Stabilization Phase|Protocol Deviation|0
3035474|NCT00706654|10436352|P3|Oral Stabilization Phase|Protocol Deviation|0
3035475|NCT00706654|10436353|P2|Oral Stabilization Phase|Protocol Deviation|0
3035476|NCT00706654|10436354|P1|Oral Stabilization Phase|Protocol Deviation|2
3035477|NCT00706654|10436351|P4|Oral Stabilization Phase|Withdrew consent|0
3035478|NCT00706654|10436352|P3|Oral Stabilization Phase|Withdrew consent|0
3035479|NCT00706654|10436353|P2|Oral Stabilization Phase|Withdrew consent|0
3035480|NCT00706654|10436354|P1|Oral Stabilization Phase|Withdrew consent|55
3035481|NCT00706654|10436351|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
3035482|NCT00706654|10436352|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
3035483|NCT00706654|10436353|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
3035484|NCT00706654|10436354|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
3035485|NCT00706654|10436351|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
3035486|NCT00706654|10436352|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
3035487|NCT00706654|10436353|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
3035488|NCT00706654|10436354|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
3035489|NCT00706654|10436351|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
3035490|NCT00706654|10436352|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
3035491|NCT00706654|10436353|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
3035492|NCT00706654|10436354|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
3035493|NCT00706654|10436351|P4|Oral Stabilization Phase|Lost to Follow-up|0
3035494|NCT00706654|10436352|P3|Oral Stabilization Phase|Lost to Follow-up|0
3035495|NCT00706654|10436353|P2|Oral Stabilization Phase|Lost to Follow-up|0
3035496|NCT00706654|10436354|P1|Oral Stabilization Phase|Lost to Follow-up|17
3035497|NCT00706654|10436351|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
3035498|NCT00706654|10436352|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
3035499|NCT00706654|10436353|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
3035500|NCT00706654|10436354|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
3035501|NCT00706654|10436351|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
3035502|NCT00706654|10436352|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
3035503|NCT00706654|10436353|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
3035504|NCT00706654|10436354|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
3035505|NCT00706654|10436351|P4|Conversion Phase|Adverse Event|0
3035506|NCT00706654|10436352|P3|Conversion Phase|Adverse Event|0
3035507|NCT00706654|10436353|P2|Conversion Phase|Adverse Event|0
3035508|NCT00706654|10436354|P1|Conversion Phase|Adverse Event|18
3035509|NCT00706654|10436351|P4|Conversion Phase|Withdrew Consent|0
3035510|NCT00706654|10436352|P3|Conversion Phase|Withdrew Consent|0
3035511|NCT00706654|10436353|P2|Conversion Phase|Withdrew Consent|0
3035512|NCT00706654|10436354|P1|Conversion Phase|Withdrew Consent|38
3035513|NCT00706654|10436351|P4|Conversion Phase|Withdrawn by Investigator|0
3035514|NCT00706654|10436352|P3|Conversion Phase|Withdrawn by Investigator|0
3035515|NCT00706654|10436353|P2|Conversion Phase|Withdrawn by Investigator|0
3035516|NCT00706654|10436354|P1|Conversion Phase|Withdrawn by Investigator|14
3035517|NCT00706654|10436351|P4|Conversion Phase|Met Withdrawal Criteria|0
3035518|NCT00706654|10436352|P3|Conversion Phase|Met Withdrawal Criteria|0
3035519|NCT00706654|10436353|P2|Conversion Phase|Met Withdrawal Criteria|0
3035520|NCT00706654|10436354|P1|Conversion Phase|Met Withdrawal Criteria|2
3035521|NCT00706654|10436351|P4|Conversion Phase|Sponsor Discontinued Trial|0
3035522|NCT00706654|10436352|P3|Conversion Phase|Sponsor Discontinued Trial|0
3035523|NCT00706654|10436353|P2|Conversion Phase|Sponsor Discontinued Trial|0
3035524|NCT00706654|10436354|P1|Conversion Phase|Sponsor Discontinued Trial|8
3035525|NCT00706654|10436351|P4|Conversion Phase|Lost to Follow-up|0
3035526|NCT00706654|10436352|P3|Conversion Phase|Lost to Follow-up|0
3035527|NCT00706654|10436353|P2|Conversion Phase|Lost to Follow-up|0
3035528|NCT00706654|10436354|P1|Conversion Phase|Lost to Follow-up|4
3035529|NCT00706641|10436373|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
3035530|NCT00706641|10436373|P1|Dasatinib Administration|Ineligible after start of therapy|1
3035531|NCT00706641|10436373|P1|Dasatinib Administration|Withdrawal by Subject|1
3035532|NCT00706628|10436387|P4|Overall Study|Not treated|0
3035533|NCT00706628|10436388|P3|Overall Study|Not treated|0
3035534|NCT00706628|10436389|P2|Overall Study|Not treated|1
3035535|NCT00706628|10436390|P1|Overall Study|Not treated|1
3035536|NCT00706628|10436387|P4|Overall Study|Other than those stated above|0
3035537|NCT00706628|10436388|P3|Overall Study|Other than those stated above|0
3035538|NCT00706628|10436389|P2|Overall Study|Other than those stated above|0
3035539|NCT00706628|10436390|P1|Overall Study|Other than those stated above|4
3035540|NCT00706628|10436387|P4|Overall Study|Progressive disease|1
3035541|NCT00706628|10436388|P3|Overall Study|Progressive disease|8
3035542|NCT00706628|10436389|P2|Overall Study|Progressive disease|13
3035543|NCT00706628|10436390|P1|Overall Study|Progressive disease|20
3035544|NCT00706628|10436387|P4|Overall Study|Consent withdrawn|0
3035545|NCT00706628|10436388|P3|Overall Study|Consent withdrawn|3
3035546|NCT00706628|10436389|P2|Overall Study|Consent withdrawn|1
3035547|NCT00706628|10436390|P1|Overall Study|Consent withdrawn|6
3035548|NCT00706628|10436387|P4|Overall Study|Non compliant with protocol|0
3035549|NCT00706628|10436388|P3|Overall Study|Non compliant with protocol|0
3035550|NCT00706628|10436389|P2|Overall Study|Non compliant with protocol|1
3035551|NCT00706628|10436390|P1|Overall Study|Non compliant with protocol|0
3035552|NCT00706628|10436387|P4|Overall Study|Other Adverse Event|2
3035553|NCT00706628|10436388|P3|Overall Study|Other Adverse Event|5
3035554|NCT00706628|10436389|P2|Overall Study|Other Adverse Event|5
3035555|NCT00706628|10436390|P1|Overall Study|Other Adverse Event|16
3035556|NCT00706511|10436495|P4|Overall Study|Withdrawal by Subject|0
3035557|NCT00706511|10436496|P3|Overall Study|Withdrawal by Subject|0
3035558|NCT00706511|10436497|P2|Overall Study|Withdrawal by Subject|0
3035559|NCT00706511|10436498|P1|Overall Study|Withdrawal by Subject|1
3035560|NCT00706433|10436589|P4|Overall Study|new job|1
3035561|NCT00706433|10436590|P3|Overall Study|new job|0
3035562|NCT00706433|10436591|P2|Overall Study|new job|0
3035563|NCT00706433|10436592|P1|Overall Study|new job|0
3035564|NCT00706433|10436589|P4|Overall Study|Protocol Violation|0
3035565|NCT00706433|10436590|P3|Overall Study|Protocol Violation|0
3035566|NCT00706433|10436591|P2|Overall Study|Protocol Violation|0
3035567|NCT00706433|10436592|P1|Overall Study|Protocol Violation|1
3035568|NCT00706433|10436589|P4|Overall Study|Adverse Event|0
3035569|NCT00706433|10436590|P3|Overall Study|Adverse Event|1
3035570|NCT00706433|10436591|P2|Overall Study|Adverse Event|0
3035571|NCT00706433|10436592|P1|Overall Study|Adverse Event|0
3035572|NCT00706433|10436589|P4|Overall Study|Withdrawal by Subject|1
3035573|NCT00706433|10436590|P3|Overall Study|Withdrawal by Subject|3
3035574|NCT00706433|10436591|P2|Overall Study|Withdrawal by Subject|2
3035575|NCT00706433|10436592|P1|Overall Study|Withdrawal by Subject|1
3035576|NCT00706433|10436589|P4|Overall Study|Lost to Follow-up|0
3035577|NCT00706433|10436590|P3|Overall Study|Lost to Follow-up|6
3035578|NCT00706433|10436591|P2|Overall Study|Lost to Follow-up|1
3035579|NCT00706433|10436592|P1|Overall Study|Lost to Follow-up|3
3035580|NCT00706355|10436919|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
3035581|NCT00706355|10436920|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
3035582|NCT00706355|10436921|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
3035583|NCT00706355|10436922|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
3035584|NCT00706355|10436919|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
3035585|NCT00706355|10436920|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
3035586|NCT00706355|10436921|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
3035587|NCT00706355|10436922|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
3035588|NCT00706355|10436919|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
3035589|NCT00706355|10436920|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
3035590|NCT00706355|10436921|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
3035591|NCT00706355|10436922|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
3035592|NCT00706355|10436919|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
3035593|NCT00706355|10436920|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
3035594|NCT00706355|10436921|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
3035595|NCT00706355|10436922|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
3035596|NCT00706355|10436919|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
3035597|NCT00706355|10436920|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
3035598|NCT00706355|10436921|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
3035599|NCT00706355|10436922|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
3035600|NCT00706355|10436919|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
3035601|NCT00706355|10436920|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
3035602|NCT00706355|10436921|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
3035603|NCT00706355|10436922|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
3035604|NCT00706355|10436919|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
3035605|NCT00706355|10436920|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
3035606|NCT00706355|10436921|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
3035607|NCT00706355|10436922|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
3035608|NCT00706355|10436919|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
3035609|NCT00706355|10436920|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
3035610|NCT00706355|10436921|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
3035611|NCT00706355|10436922|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
3035612|NCT00706355|10436919|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
3035613|NCT00706355|10436920|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
3035614|NCT00706355|10436921|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
3035615|NCT00706355|10436922|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
3035616|NCT00706342|10436974|P1|Overall Study|WIthdrawal of consent|1
3035617|NCT00706342|10436974|P1|Overall Study|Ongoing|6
3035618|NCT00706342|10436974|P1|Overall Study|Non-responder Week 12|1
3035619|NCT00706342|10436974|P1|Overall Study|Investigator discretion|2
3035620|NCT00706342|10436974|P1|Overall Study|Withdrew from the study on his own.|1
3035621|NCT00706342|10436974|P1|Overall Study|Death|1
3035622|NCT00706342|10436974|P1|Overall Study|Withdrawn due to failure to respond|1
3035623|NCT00706342|10436974|P1|Overall Study|Not responding to treatment|2
3035624|NCT00706342|10436974|P1|Overall Study|Adverse Event|3
3035625|NCT00706238|10436987|P1|Overall Study|Other|1
3035626|NCT00706238|10436987|P1|Overall Study|Disease progression|4
3035627|NCT00706134|10437004|P4|Overall Study|Did not meet study criteria|0
3035628|NCT00706134|10437005|P3|Overall Study|Did not meet study criteria|0
3035629|NCT00706134|10437006|P2|Overall Study|Did not meet study criteria|0
3035630|NCT00706134|10437007|P1|Overall Study|Did not meet study criteria|2
3035631|NCT00706134|10437004|P4|Overall Study|Unsatisfactory therapeutic effect|5
3035632|NCT00706134|10437005|P3|Overall Study|Unsatisfactory therapeutic effect|3
3035633|NCT00706134|10437006|P2|Overall Study|Unsatisfactory therapeutic effect|3
3035634|NCT00706134|10437007|P1|Overall Study|Unsatisfactory therapeutic effect|9
3035635|NCT00706134|10437004|P4|Overall Study|Withdrawal by Subject|0
3035636|NCT00706134|10437005|P3|Overall Study|Withdrawal by Subject|1
3035637|NCT00706134|10437006|P2|Overall Study|Withdrawal by Subject|2
3035638|NCT00706134|10437007|P1|Overall Study|Withdrawal by Subject|1
3035639|NCT00706134|10437004|P4|Overall Study|Protocol Violation|3
3035640|NCT00706134|10437005|P3|Overall Study|Protocol Violation|0
3035641|NCT00706134|10437006|P2|Overall Study|Protocol Violation|6
3035642|NCT00706134|10437007|P1|Overall Study|Protocol Violation|0
3035643|NCT00706134|10437004|P4|Overall Study|Lost to Follow-up|0
3035644|NCT00706134|10437005|P3|Overall Study|Lost to Follow-up|0
3035645|NCT00706134|10437006|P2|Overall Study|Lost to Follow-up|1
3035646|NCT00706134|10437007|P1|Overall Study|Lost to Follow-up|0
3035647|NCT00706134|10437004|P4|Overall Study|Adverse Event|3
3035648|NCT00706134|10437005|P3|Overall Study|Adverse Event|2
3035649|NCT00706134|10437006|P2|Overall Study|Adverse Event|7
3035650|NCT00706134|10437007|P1|Overall Study|Adverse Event|8
3035651|NCT00706095|10437073|P3|Overall Study|Withdrawal by Subject|0
3035652|NCT00706095|10437074|P2|Overall Study|Withdrawal by Subject|0
3035653|NCT00706095|10437075|P1|Overall Study|Withdrawal by Subject|1
3035654|NCT00706095|10437073|P3|Overall Study|Clinical Progression|2
3035655|NCT00706095|10437074|P2|Overall Study|Clinical Progression|2
3035656|NCT00706095|10437075|P1|Overall Study|Clinical Progression|1
3035657|NCT00706095|10437073|P3|Overall Study|Progressive Disease|3
3035658|NCT00706095|10437074|P2|Overall Study|Progressive Disease|5
3035659|NCT00706095|10437075|P1|Overall Study|Progressive Disease|4
3035660|NCT00706030|10437093|P4|Overall Study|Death|0
3035661|NCT00706030|10437094|P3|Overall Study|Death|1
3035662|NCT00706030|10437095|P2|Overall Study|Death|0
3035663|NCT00706030|10437096|P1|Overall Study|Death|0
3035664|NCT00706030|10437093|P4|Overall Study|No treatment received|1
3035665|NCT00706030|10437094|P3|Overall Study|No treatment received|0
3035666|NCT00706030|10437095|P2|Overall Study|No treatment received|0
3035667|NCT00706030|10437096|P1|Overall Study|No treatment received|0
3035668|NCT00706030|10437093|P4|Overall Study|Symptomatic Deterioration|0
3035669|NCT00706030|10437094|P3|Overall Study|Symptomatic Deterioration|1
3035670|NCT00706030|10437095|P2|Overall Study|Symptomatic Deterioration|0
3035671|NCT00706030|10437096|P1|Overall Study|Symptomatic Deterioration|0
3035672|NCT00706030|10437093|P4|Overall Study|Failed to return|0
3035673|NCT00706030|10437094|P3|Overall Study|Failed to return|1
3035674|NCT00706030|10437095|P2|Overall Study|Failed to return|0
3035675|NCT00706030|10437096|P1|Overall Study|Failed to return|0
3035676|NCT00706030|10437093|P4|Overall Study|Protocol Violation|1
3035677|NCT00706030|10437094|P3|Overall Study|Protocol Violation|1
3035678|NCT00706030|10437095|P2|Overall Study|Protocol Violation|0
3035679|NCT00706030|10437096|P1|Overall Study|Protocol Violation|0
3035680|NCT00706030|10437093|P4|Overall Study|Not recorded|0
3035681|NCT00706030|10437094|P3|Overall Study|Not recorded|2
3035682|NCT00706030|10437095|P2|Overall Study|Not recorded|0
3035683|NCT00706030|10437096|P1|Overall Study|Not recorded|0
3035684|NCT00706030|10437093|P4|Overall Study|Physician Decision|0
3035685|NCT00706030|10437094|P3|Overall Study|Physician Decision|2
3035686|NCT00706030|10437095|P2|Overall Study|Physician Decision|0
3035687|NCT00706030|10437096|P1|Overall Study|Physician Decision|0
3035688|NCT00706030|10437093|P4|Overall Study|Withdrawal by Subject|0
3035689|NCT00706030|10437094|P3|Overall Study|Withdrawal by Subject|2
3035690|NCT00706030|10437095|P2|Overall Study|Withdrawal by Subject|0
3035691|NCT00706030|10437096|P1|Overall Study|Withdrawal by Subject|1
3035692|NCT00706030|10437093|P4|Overall Study|Adverse Event|2
3035693|NCT00706030|10437094|P3|Overall Study|Adverse Event|4
3035694|NCT00706030|10437095|P2|Overall Study|Adverse Event|0
3035695|NCT00706030|10437096|P1|Overall Study|Adverse Event|1
3035696|NCT00706030|10437093|P4|Overall Study|Disease Progression|12
3035697|NCT00706030|10437094|P3|Overall Study|Disease Progression|46
3035698|NCT00706030|10437095|P2|Overall Study|Disease Progression|6
3035699|NCT00706030|10437096|P1|Overall Study|Disease Progression|4
3035700|NCT00706004|10437111|P1|Overall Study|Did not meet eligibility criteria|2
3035701|NCT00705939|10437139|P3|Overall Study|Physician Decision|0
3035702|NCT00705939|10437140|P2|Overall Study|Physician Decision|1
3035703|NCT00705939|10437141|P1|Overall Study|Physician Decision|0
3035704|NCT00705939|10437139|P3|Overall Study|Withdrawal by Subject|3
3035705|NCT00705939|10437140|P2|Overall Study|Withdrawal by Subject|1
3035706|NCT00705939|10437141|P1|Overall Study|Withdrawal by Subject|0
3035707|NCT00705939|10437139|P3|Overall Study|Protocol Violation|1
3035708|NCT00705939|10437140|P2|Overall Study|Protocol Violation|0
3035709|NCT00705939|10437141|P1|Overall Study|Protocol Violation|0
3035710|NCT00705783|10437195|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
3035711|NCT00705783|10437196|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
3035712|NCT00705783|10437197|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
3035713|NCT00705783|10437195|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
3035714|NCT00705783|10437196|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
3035715|NCT00705783|10437197|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
3035716|NCT00705783|10437195|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
3035717|NCT00705783|10437196|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
3035718|NCT00705783|10437197|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
3035719|NCT00705783|10437195|P3|Depot Maintenance Phase|Protocol Deviation|0
3035720|NCT00705783|10437196|P2|Depot Maintenance Phase|Protocol Deviation|2
3035721|NCT00705783|10437197|P1|Depot Maintenance Phase|Protocol Deviation|0
3035722|NCT00705783|10437195|P3|Depot Maintenance Phase|Withdrew Consent|4
3035723|NCT00705783|10437196|P2|Depot Maintenance Phase|Withdrew Consent|14
3035724|NCT00705783|10437197|P1|Depot Maintenance Phase|Withdrew Consent|0
3035725|NCT00705783|10437195|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
3035726|NCT00705783|10437196|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
3035727|NCT00705783|10437197|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
3035728|NCT00705783|10437195|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
3035729|NCT00705783|10437196|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
3035730|NCT00705783|10437197|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
3035731|NCT00705783|10437195|P3|Depot Maintenance Phase|Lost to Follow-up|3
3035732|NCT00705783|10437196|P2|Depot Maintenance Phase|Lost to Follow-up|5
3035733|NCT00705783|10437197|P1|Depot Maintenance Phase|Lost to Follow-up|0
3035734|NCT00705783|10437195|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
3035735|NCT00705783|10437196|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
3035736|NCT00705783|10437197|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
3035737|NCT00705783|10437195|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035738|NCT00705783|10437196|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035739|NCT00705783|10437197|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
3035740|NCT00705783|10437195|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035741|NCT00705783|10437196|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035742|NCT00705783|10437197|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
3035743|NCT00705783|10437195|P3|Depot Stabilization Phase|Adverse Event|0
3035744|NCT00705783|10437196|P2|Depot Stabilization Phase|Adverse Event|0
3035745|NCT00705783|10437197|P1|Depot Stabilization Phase|Adverse Event|17
3035746|NCT00705783|10437195|P3|Depot Stabilization Phase|Withdrew Consent|0
3035747|NCT00705783|10437196|P2|Depot Stabilization Phase|Withdrew Consent|0
3035748|NCT00705783|10437197|P1|Depot Stabilization Phase|Withdrew Consent|29
3035749|NCT00705783|10437195|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
3035750|NCT00705783|10437196|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
3035751|NCT00705783|10437197|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
3035752|NCT00705783|10437195|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
3035753|NCT00705783|10437196|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
3035754|NCT00705783|10437197|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
3035755|NCT00705783|10437195|P3|Depot Stabilization Phase|Lost to Follow-up|0
3035756|NCT00705783|10437196|P2|Depot Stabilization Phase|Lost to Follow-up|0
3035757|NCT00705783|10437197|P1|Depot Stabilization Phase|Lost to Follow-up|11
3035758|NCT00705783|10437195|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
3035759|NCT00705783|10437196|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
3035760|NCT00705783|10437197|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
3035761|NCT00705783|10437195|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035762|NCT00705783|10437196|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
3035763|NCT00705783|10437197|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
3035764|NCT00705783|10437195|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035765|NCT00705783|10437196|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
3035766|NCT00705783|10437197|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
3035767|NCT00705783|10437195|P3|Oral Stabilization Phase|Adverse Event|0
3035768|NCT00705783|10437196|P2|Oral Stabilization Phase|Adverse Event|0
3035769|NCT00705783|10437197|P1|Oral Stabilization Phase|Adverse Event|14
3035770|NCT00705783|10437195|P3|Oral Stabilization Phase|Withdrew Consent|0
3035771|NCT00705783|10437196|P2|Oral Stabilization Phase|Withdrew Consent|0
3035772|NCT00705783|10437197|P1|Oral Stabilization Phase|Withdrew Consent|29
3035773|NCT00705783|10437195|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
3035774|NCT00705783|10437196|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
3035775|NCT00705783|10437197|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
3035776|NCT00705783|10437195|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
3035777|NCT00705783|10437196|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
3035778|NCT00705783|10437197|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
3035779|NCT00705783|10437195|P3|Oral Stabilization Phase|Lost to Follow-up|0
3035780|NCT00705783|10437196|P2|Oral Stabilization Phase|Lost to Follow-up|0
3035781|NCT00705783|10437197|P1|Oral Stabilization Phase|Lost to Follow-up|7
3035782|NCT00705783|10437195|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
3035783|NCT00705783|10437196|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
3035784|NCT00705783|10437197|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
3035785|NCT00705783|10437195|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
3035786|NCT00705783|10437196|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
3035787|NCT00705783|10437197|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
3035788|NCT00705783|10437195|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
3035789|NCT00705783|10437196|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
3035790|NCT00705783|10437197|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
3035791|NCT00705783|10437195|P3|Conversion Phase|Adverse Event|0
3035792|NCT00705783|10437196|P2|Conversion Phase|Adverse Event|0
3035793|NCT00705783|10437197|P1|Conversion Phase|Adverse Event|11
3035794|NCT00705783|10437195|P3|Conversion Phase|Protocol Deviation|0
3035795|NCT00705783|10437196|P2|Conversion Phase|Protocol Deviation|0
3035796|NCT00705783|10437197|P1|Conversion Phase|Protocol Deviation|2
3035797|NCT00705783|10437195|P3|Conversion Phase|Withdrew Consent|0
3035798|NCT00705783|10437196|P2|Conversion Phase|Withdrew Consent|0
3035799|NCT00705783|10437197|P1|Conversion Phase|Withdrew Consent|24
3035800|NCT00705783|10437195|P3|Conversion Phase|Withdrawn by Investigator|0
3035801|NCT00705783|10437196|P2|Conversion Phase|Withdrawn by Investigator|0
3035802|NCT00705783|10437197|P1|Conversion Phase|Withdrawn by Investigator|4
3035803|NCT00705783|10437195|P3|Conversion Phase|Met Withdrawal Criteria|0
3035804|NCT00705783|10437196|P2|Conversion Phase|Met Withdrawal Criteria|0
3035805|NCT00705783|10437197|P1|Conversion Phase|Met Withdrawal Criteria|4
3035806|NCT00705783|10437195|P3|Conversion Phase|Lost to Follow-up|0
3035807|NCT00705783|10437196|P2|Conversion Phase|Lost to Follow-up|0
3035808|NCT00705783|10437197|P1|Conversion Phase|Lost to Follow-up|13
3035809|NCT00705783|10437195|P3|Conversion Phase|Sponsor Discontinued Study|0
3035810|NCT00705783|10437196|P2|Conversion Phase|Sponsor Discontinued Study|0
3035811|NCT00705783|10437197|P1|Conversion Phase|Sponsor Discontinued Study|54
3035812|NCT00705757|10437227|P3|Overall Study|Withdrawal by Subject|2
3035813|NCT00705757|10437228|P2|Overall Study|Withdrawal by Subject|1
3035814|NCT00705757|10437229|P1|Overall Study|Withdrawal by Subject|1
3035815|NCT00705757|10437227|P3|Overall Study|Lost to Follow-up|6
3035816|NCT00705757|10437228|P2|Overall Study|Lost to Follow-up|6
3035817|NCT00705757|10437229|P1|Overall Study|Lost to Follow-up|7
3035818|NCT00705757|10437227|P3|Overall Study|Lack of Efficacy|3
3035819|NCT00705757|10437228|P2|Overall Study|Lack of Efficacy|1
3035820|NCT00705757|10437229|P1|Overall Study|Lack of Efficacy|5
3035821|NCT00705718|10437239|P2|Overall Study|Follow up not done|4
3035822|NCT00705718|10437240|P1|Overall Study|Follow up not done|1
3035823|NCT00705718|10437239|P2|Overall Study|Not due for Visit|12
3035824|NCT00705718|10437240|P1|Overall Study|Not due for Visit|0
3035825|NCT00705718|10437239|P2|Overall Study|Death|6
3035826|NCT00705718|10437240|P1|Overall Study|Death|6
3035827|NCT00705679|10437261|P5|Overall Study|Withdrawal by Subject|33
3035828|NCT00705679|10437262|P4|Overall Study|Withdrawal by Subject|47
3035829|NCT00705679|10437263|P3|Overall Study|Withdrawal by Subject|68
3035830|NCT00705679|10437264|P2|Overall Study|Withdrawal by Subject|77
3035831|NCT00705679|10437265|P1|Overall Study|Withdrawal by Subject|32
3035832|NCT00705679|10437261|P5|Overall Study|Physician Decision|0
3035833|NCT00705679|10437262|P4|Overall Study|Physician Decision|1
3035834|NCT00705679|10437263|P3|Overall Study|Physician Decision|0
3035835|NCT00705679|10437264|P2|Overall Study|Physician Decision|1
3035836|NCT00705679|10437265|P1|Overall Study|Physician Decision|0
3035837|NCT00705679|10437261|P5|Overall Study|Lost to Follow-up|35
3035838|NCT00705679|10437262|P4|Overall Study|Lost to Follow-up|30
3035839|NCT00705679|10437263|P3|Overall Study|Lost to Follow-up|44
3035840|NCT00705679|10437264|P2|Overall Study|Lost to Follow-up|60
3035841|NCT00705679|10437265|P1|Overall Study|Lost to Follow-up|32
3035842|NCT00705679|10437261|P5|Overall Study|Death|1
3035843|NCT00705679|10437262|P4|Overall Study|Death|2
3035844|NCT00705679|10437263|P3|Overall Study|Death|3
3035845|NCT00705679|10437264|P2|Overall Study|Death|0
3035846|NCT00705679|10437265|P1|Overall Study|Death|0
3035847|NCT00705679|10437261|P5|Overall Study|Adverse Event|0
3035848|NCT00705679|10437262|P4|Overall Study|Adverse Event|0
3035849|NCT00705679|10437263|P3|Overall Study|Adverse Event|0
3035850|NCT00705679|10437264|P2|Overall Study|Adverse Event|1
3035851|NCT00705679|10437265|P1|Overall Study|Adverse Event|1
3035852|NCT00705666|10437300|P1|Overall Study|Untreated|5
3035853|NCT00705666|10437300|P1|Overall Study|Lack of data|3
3035854|NCT00705666|10437300|P1|Overall Study|Other|2
3035855|NCT00705666|10437300|P1|Overall Study|Other|12
3035856|NCT00705666|10437300|P1|Overall Study|Adverse Event|4
3035857|NCT00705666|10437300|P1|Overall Study|Death|1
3035858|NCT00705666|10437300|P1|Overall Study|Lost to Follow-up|5
3035859|NCT00705666|10437300|P1|Overall Study|Physician Decision|7
3035860|NCT00705666|10437300|P1|Overall Study|Withdrawal by Subject|21
3035861|NCT00705666|10437300|P1|Overall Study|No post-treatment questionnaire|279
3035862|NCT00705614|10437311|P2|Switch to Remicade|Administrative Reason|9
3035863|NCT00705614|10437312|P1|Switch to Remicade|Administrative Reason|0
3035864|NCT00705614|10437311|P2|Switch to Remicade|Withdrawal by Subject|12
3035865|NCT00705614|10437312|P1|Switch to Remicade|Withdrawal by Subject|0
3035866|NCT00705614|10437311|P2|Switch to Remicade|Lost to Follow-up|23
3035867|NCT00705614|10437312|P1|Switch to Remicade|Lost to Follow-up|0
3035868|NCT00705614|10437311|P2|Switch to Remicade|Adverse Event|5
3035869|NCT00705614|10437312|P1|Switch to Remicade|Adverse Event|0
3035870|NCT00705614|10437311|P2|Initial Intervention|Status completion unknown|0
3035871|NCT00705614|10437312|P1|Initial Intervention|Status completion unknown|3
3035872|NCT00705614|10437311|P2|Initial Intervention|Administrative Reason|38
3035873|NCT00705614|10437312|P1|Initial Intervention|Administrative Reason|51
3035874|NCT00705614|10437311|P2|Initial Intervention|Withdrawal by Subject|71
3035875|NCT00705614|10437312|P1|Initial Intervention|Withdrawal by Subject|114
3035876|NCT00705614|10437311|P2|Initial Intervention|Lost to Follow-up|191
3035877|NCT00705614|10437312|P1|Initial Intervention|Lost to Follow-up|310
3035878|NCT00705614|10437311|P2|Initial Intervention|Adverse Event|21
3035879|NCT00705614|10437312|P1|Initial Intervention|Adverse Event|40
3035880|NCT00705575|10437361|P2|Overall Study|Withdrawal by Subject|10
3035881|NCT00705575|10437362|P1|Overall Study|Withdrawal by Subject|5
3035882|NCT00705575|10437361|P2|Overall Study|Protocol Violation|2
3035883|NCT00705575|10437362|P1|Overall Study|Protocol Violation|2
3035884|NCT00705575|10437361|P2|Overall Study|Lost to Follow-up|4
3035885|NCT00705575|10437362|P1|Overall Study|Lost to Follow-up|3
3035886|NCT00705575|10437361|P2|Overall Study|Adverse Event|15
3035887|NCT00705575|10437362|P1|Overall Study|Adverse Event|11
3035888|NCT00705575|10437361|P2|Overall Study|Abnormal test procedure result(s)|12
3035889|NCT00705575|10437362|P1|Overall Study|Abnormal test procedure result(s)|2
3035890|NCT00705575|10437361|P2|Overall Study|Abnormal laboratory value(s)|3
3035891|NCT00705575|10437362|P1|Overall Study|Abnormal laboratory value(s)|0
3035892|NCT00705536|10437376|P4|Start Period 1|Withdrawal by Subject|1
3035893|NCT00705536|10437377|P3|Start Period 1|Withdrawal by Subject|0
3035894|NCT00705536|10437378|P2|Start Period 1|Withdrawal by Subject|0
3035895|NCT00705536|10437379|P1|Start Period 1|Withdrawal by Subject|0
3035896|NCT00705523|10437440|P2|Overall Study|Lost to Follow-up|3
3035897|NCT00705523|10437441|P1|Overall Study|Lost to Follow-up|2
3035898|NCT00705484|10437451|P2|Overall Study|Administrative|59
3035899|NCT00705484|10437452|P1|Overall Study|Administrative|89
3035900|NCT00705484|10437451|P2|Overall Study|Withdrawal by Subject|72
3035901|NCT00705484|10437452|P1|Overall Study|Withdrawal by Subject|96
3035902|NCT00705484|10437451|P2|Overall Study|Lost to Follow-up|250
3035903|NCT00705484|10437452|P1|Overall Study|Lost to Follow-up|169
3035904|NCT00705484|10437451|P2|Overall Study|Adverse Event|27
3035905|NCT00705484|10437452|P1|Overall Study|Adverse Event|28
3035906|NCT00705432|10437466|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
3035907|NCT00705432|10437467|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
3035908|NCT00705432|10437468|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
3035909|NCT00705432|10437469|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
3035910|NCT00705432|10437470|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
3035911|NCT00705432|10437471|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
3035912|NCT00705432|10437466|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
3035913|NCT00705432|10437467|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
3035914|NCT00705432|10437468|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
3035915|NCT00705432|10437469|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
3035916|NCT00705432|10437470|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
3035917|NCT00705432|10437471|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
3035918|NCT00705432|10437466|P6|Treatment Period|Non medical reason|7
3035919|NCT00705432|10437467|P5|Treatment Period|Non medical reason|7
3035920|NCT00705432|10437468|P4|Treatment Period|Non medical reason|4
3035921|NCT00705432|10437469|P3|Treatment Period|Non medical reason|37
3035922|NCT00705432|10437470|P2|Treatment Period|Non medical reason|32
3035923|NCT00705432|10437471|P1|Treatment Period|Non medical reason|26
3035924|NCT00705432|10437466|P6|Treatment Period|Treatment failure|14
3035925|NCT00705432|10437467|P5|Treatment Period|Treatment failure|13
3035926|NCT00705432|10437468|P4|Treatment Period|Treatment failure|25
3035927|NCT00705432|10437469|P3|Treatment Period|Treatment failure|33
3035928|NCT00705432|10437470|P2|Treatment Period|Treatment failure|42
3035929|NCT00705432|10437471|P1|Treatment Period|Treatment failure|92
3035930|NCT00705432|10437466|P6|Treatment Period|Adverse Event|9
3035931|NCT00705432|10437467|P5|Treatment Period|Adverse Event|8
3035932|NCT00705432|10437468|P4|Treatment Period|Adverse Event|12
3035933|NCT00705432|10437469|P3|Treatment Period|Adverse Event|51
3035934|NCT00705432|10437470|P2|Treatment Period|Adverse Event|37
3035935|NCT00705432|10437471|P1|Treatment Period|Adverse Event|45
3035936|NCT00705406|10437508|P2|Overall Study|Did not receive study drug|2
3035937|NCT00705406|10437509|P1|Overall Study|Did not receive study drug|1
3035938|NCT00705406|10437508|P2|Overall Study|Lost to Follow-up|3
3035939|NCT00705406|10437509|P1|Overall Study|Lost to Follow-up|3
3035940|NCT00705367|10437533|P2|Long-term Extension Period|Administrative reason by sponsor|0
3035941|NCT00705367|10437534|P1|Long-term Extension Period|Administrative reason by sponsor|3
3035942|NCT00705367|10437533|P2|Long-term Extension Period|No longer met study criteria|0
3035943|NCT00705367|10437534|P1|Long-term Extension Period|No longer met study criteria|1
3035944|NCT00705367|10437533|P2|Long-term Extension Period|Lack of Efficacy|0
3035945|NCT00705367|10437534|P1|Long-term Extension Period|Lack of Efficacy|1
3035946|NCT00705367|10437533|P2|Long-term Extension Period|Withdrawal by Subject|0
3035947|NCT00705367|10437534|P1|Long-term Extension Period|Withdrawal by Subject|2
3035948|NCT00705367|10437533|P2|Long-term Extension Period|Adverse Event|0
3035949|NCT00705367|10437534|P1|Long-term Extension Period|Adverse Event|2
3035950|NCT00705341|10437561|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
3035951|NCT00705341|10437562|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
3035952|NCT00705341|10437563|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
3035953|NCT00705341|10437564|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
3035954|NCT00705341|10437561|P4|Phase 2: Trial|Withdrawal by Subject|4
3035955|NCT00705341|10437562|P3|Phase 2: Trial|Withdrawal by Subject|6
3035956|NCT00705341|10437563|P2|Phase 2: Trial|Withdrawal by Subject|0
3035957|NCT00705341|10437564|P1|Phase 2: Trial|Withdrawal by Subject|0
3035958|NCT00705289|10437572|P1|Overall Study|Subject or treating physician's choice|131
3035959|NCT00705263|10437596|P1|Overall Study|Withdrawal by Subject|2
3035960|NCT00705250|10437600|P1|Overall Study|Patient died in car accident|1
3035961|NCT00705250|10437600|P1|Overall Study|Withdrawal by Subject|1
3035962|NCT00705224|10437604|P1|Overall Study|Lost to Follow-up|5
3035963|NCT00705224|10437604|P1|Overall Study|Withdrawal by Subject|3
3035964|NCT00705224|10437604|P1|Overall Study|Lack of Efficacy|2
3035965|NCT00705224|10437604|P1|Overall Study|Adverse Event|1
3035966|NCT00705159|10437620|P4|Overall Study|Screen Failure|1
3035967|NCT00705159|10437621|P3|Overall Study|Screen Failure|0
3035968|NCT00705159|10437622|P2|Overall Study|Screen Failure|0
3035969|NCT00705159|10437623|P1|Overall Study|Screen Failure|0
3035970|NCT00705159|10437620|P4|Overall Study|Lost to Follow-up|2
3035971|NCT00705159|10437621|P3|Overall Study|Lost to Follow-up|3
3035972|NCT00705159|10437622|P2|Overall Study|Lost to Follow-up|0
3035973|NCT00705159|10437623|P1|Overall Study|Lost to Follow-up|0
3035974|NCT00705159|10437620|P4|Overall Study|Adverse Event|0
3035975|NCT00705159|10437621|P3|Overall Study|Adverse Event|1
3035976|NCT00705159|10437622|P2|Overall Study|Adverse Event|0
3035977|NCT00705159|10437623|P1|Overall Study|Adverse Event|0
3035978|NCT00705159|10437620|P4|Overall Study|Protocol Violation|0
3035979|NCT00705159|10437621|P3|Overall Study|Protocol Violation|0
3035980|NCT00705159|10437622|P2|Overall Study|Protocol Violation|1
3035981|NCT00705159|10437623|P1|Overall Study|Protocol Violation|0
3035982|NCT00705159|10437620|P4|Overall Study|Withdrawal by Subject|1
3035983|NCT00705159|10437621|P3|Overall Study|Withdrawal by Subject|1
3035984|NCT00705159|10437622|P2|Overall Study|Withdrawal by Subject|1
3035985|NCT00705159|10437623|P1|Overall Study|Withdrawal by Subject|0
3035986|NCT00705146|10437643|P2|Overall Study|Lost to Follow-up|1
3035987|NCT00705146|10437644|P1|Overall Study|Lost to Follow-up|1
3035988|NCT00705016|10437673|P3|Overall Study|Other|6
3035989|NCT00705016|10437674|P2|Overall Study|Other|6
3035990|NCT00705016|10437675|P1|Overall Study|Other|9
3035991|NCT00705016|10437673|P3|Overall Study|Symptomatic Deterioration|1
3035992|NCT00705016|10437674|P2|Overall Study|Symptomatic Deterioration|1
3035993|NCT00705016|10437675|P1|Overall Study|Symptomatic Deterioration|3
3035994|NCT00705016|10437673|P3|Overall Study|Progressive Disease|33
3035995|NCT00705016|10437674|P2|Overall Study|Progressive Disease|29
3035996|NCT00705016|10437675|P1|Overall Study|Progressive Disease|33
3035997|NCT00705016|10437673|P3|Overall Study|Withdrawal by Subject|2
3035998|NCT00705016|10437674|P2|Overall Study|Withdrawal by Subject|3
3035999|NCT00705016|10437675|P1|Overall Study|Withdrawal by Subject|4
3036000|NCT00705016|10437673|P3|Overall Study|Protocol Violation|1
3036001|NCT00705016|10437674|P2|Overall Study|Protocol Violation|1
3036002|NCT00705016|10437675|P1|Overall Study|Protocol Violation|0
3036003|NCT00705016|10437673|P3|Overall Study|Death|5
3036004|NCT00705016|10437674|P2|Overall Study|Death|7
3036005|NCT00705016|10437675|P1|Overall Study|Death|5
3036006|NCT00705016|10437673|P3|Overall Study|Adverse Event|10
3036007|NCT00705016|10437674|P2|Overall Study|Adverse Event|11
3036008|NCT00705016|10437675|P1|Overall Study|Adverse Event|6
3036009|NCT00704964|10437726|P1|Overall Study|Not completed on time|328
3036010|NCT00704808|10437787|P1|Overall Study|Treatment change|1
3036011|NCT00704808|10437787|P1|Overall Study|Lost to Follow-up|1
3036012|NCT00704808|10437787|P1|Overall Study|Adverse Event|1
3036013|NCT00704808|10437787|P1|Overall Study|Early therapy discontinuation|16
3036014|NCT00704808|10437787|P1|Overall Study|Patient's decision|11
3036015|NCT00704808|10437787|P1|Overall Study|Tumor progression|80
3036016|NCT00704808|10437787|P1|Overall Study|Death|7
3036017|NCT00704808|10437787|P1|Overall Study|Discontinued prior to starting treatment|14
3036018|NCT00704730|10437798|P2|Overall Study|Withdrawal by Subject|13
3036019|NCT00704730|10437799|P1|Overall Study|Withdrawal by Subject|9
3036020|NCT00704730|10437798|P2|Overall Study|data unavailable|0
3036021|NCT00704730|10437799|P1|Overall Study|data unavailable|1
3036022|NCT00704730|10437798|P2|Overall Study|Disease progression per PI|67
3036023|NCT00704730|10437799|P1|Overall Study|Disease progression per PI|58
3036024|NCT00704730|10437798|P2|Overall Study|Did not receive drug|2
3036025|NCT00704730|10437799|P1|Overall Study|Did not receive drug|5
3036026|NCT00704730|10437798|P2|Overall Study|Physician Decision|0
3036027|NCT00704730|10437799|P1|Overall Study|Physician Decision|2
3036028|NCT00704730|10437798|P2|Overall Study|Death|5
3036029|NCT00704730|10437799|P1|Overall Study|Death|11
3036030|NCT00704730|10437798|P2|Overall Study|Adverse Event|9
3036031|NCT00704730|10437799|P1|Overall Study|Adverse Event|35
3036032|NCT00704535|10437819|P1|Overall Study|Completed status not on Case Report Form|124
3036033|NCT00704535|10437819|P1|Overall Study|Protocol Violation|10
3036034|NCT00704535|10437819|P1|Overall Study|Lost to Follow-up|8
3036035|NCT00704535|10437819|P1|Overall Study|Death|2
3036036|NCT00704535|10437819|P1|Overall Study|Adverse Event|2
3036037|NCT00704522|10437832|P2|Overall Study|No information on therapy end|2
3036038|NCT00704522|10437833|P1|Overall Study|No information on therapy end|27
3036039|NCT00704522|10437832|P2|Overall Study|Undefined causes|7
3036040|NCT00704522|10437833|P1|Overall Study|Undefined causes|9
3036041|NCT00704522|10437832|P2|Overall Study|Adverse Event|1
3036042|NCT00704522|10437833|P1|Overall Study|Adverse Event|9
3036043|NCT00704522|10437832|P2|Overall Study|Withdrawal by Subject|8
3036044|NCT00704522|10437833|P1|Overall Study|Withdrawal by Subject|17
3036045|NCT00704522|10437832|P2|Overall Study|Failure to appear again at hospital|10
3036046|NCT00704522|10437833|P1|Overall Study|Failure to appear again at hospital|56
3036047|NCT00704522|10437832|P2|Overall Study|Lack of Efficacy|17
3036048|NCT00704522|10437833|P1|Overall Study|Lack of Efficacy|65
3036049|NCT00704418|10437853|P2|Overall Study|Over-enrolled/surgery postponed|6
3036050|NCT00704418|10437854|P1|Overall Study|Over-enrolled/surgery postponed|3
3036051|NCT00704418|10437853|P2|Overall Study|Withdrawal by Subject|0
3036052|NCT00704418|10437854|P1|Overall Study|Withdrawal by Subject|2
3036053|NCT00704405|10437867|P5|Overall Study (C Population)|Lost to Follow-up|0
3036054|NCT00704405|10437868|P4|Overall Study (C Population)|Lost to Follow-up|0
3036055|NCT00704405|10437869|P3|Overall Study (C Population)|Lost to Follow-up|0
3036056|NCT00704405|10437870|P2|Overall Study (C Population)|Lost to Follow-up|2
3036057|NCT00704405|10437871|P1|Overall Study (C Population)|Lost to Follow-up|0
3036058|NCT00704405|10437867|P5|Overall Study (C Population)|Withdrawal by Subject|0
3036059|NCT00704405|10437868|P4|Overall Study (C Population)|Withdrawal by Subject|1
3036060|NCT00704405|10437869|P3|Overall Study (C Population)|Withdrawal by Subject|1
3036061|NCT00704405|10437870|P2|Overall Study (C Population)|Withdrawal by Subject|1
3036062|NCT00704405|10437871|P1|Overall Study (C Population)|Withdrawal by Subject|1
3036063|NCT00704405|10437867|P5|Overall Study (NC Population)|Other|1
3036064|NCT00704405|10437868|P4|Overall Study (NC Population)|Other|0
3036065|NCT00704405|10437869|P3|Overall Study (NC Population)|Other|0
3036066|NCT00704405|10437870|P2|Overall Study (NC Population)|Other|0
3036067|NCT00704405|10437871|P1|Overall Study (NC Population)|Other|0
3036068|NCT00704405|10437867|P5|Overall Study (NC Population)|Withdrawal by Subject|2
3036069|NCT00704405|10437868|P4|Overall Study (NC Population)|Withdrawal by Subject|2
3036070|NCT00704405|10437869|P3|Overall Study (NC Population)|Withdrawal by Subject|2
3036071|NCT00704405|10437870|P2|Overall Study (NC Population)|Withdrawal by Subject|3
3036072|NCT00704405|10437871|P1|Overall Study (NC Population)|Withdrawal by Subject|2
3036073|NCT00704405|10437867|P5|Overall Study (NC Population)|Lost to Follow-up|2
3036074|NCT00704405|10437868|P4|Overall Study (NC Population)|Lost to Follow-up|2
3036075|NCT00704405|10437869|P3|Overall Study (NC Population)|Lost to Follow-up|1
3036076|NCT00704405|10437870|P2|Overall Study (NC Population)|Lost to Follow-up|1
3036077|NCT00704405|10437871|P1|Overall Study (NC Population)|Lost to Follow-up|2
3036078|NCT00704405|10437867|P5|Overall Study (NC Population)|Adverse Event|0
3036079|NCT00704405|10437868|P4|Overall Study (NC Population)|Adverse Event|0
3036080|NCT00704405|10437869|P3|Overall Study (NC Population)|Adverse Event|0
3036081|NCT00704405|10437870|P2|Overall Study (NC Population)|Adverse Event|0
3036082|NCT00704405|10437871|P1|Overall Study (NC Population)|Adverse Event|1
3036083|NCT00704340|10437929|P2|Overall Study|Death|1
3036084|NCT00704340|10437930|P1|Overall Study|Death|0
3036085|NCT00704340|10437929|P2|Overall Study|Lost to Follow-up|1
3036086|NCT00704340|10437930|P1|Overall Study|Lost to Follow-up|2
3036087|NCT00704184|10437945|P5|Open-Label Treatment|Withdrawal by Subject|0
3036088|NCT00704184|10437946|P4|Open-Label Treatment|Withdrawal by Subject|3
3036089|NCT00704184|10437947|P3|Open-Label Treatment|Withdrawal by Subject|0
3036090|NCT00704184|10437948|P2|Open-Label Treatment|Withdrawal by Subject|0
3036091|NCT00704184|10437949|P1|Open-Label Treatment|Withdrawal by Subject|1
3036092|NCT00704184|10437945|P5|Open-Label Treatment|Physician Decision|1
3036093|NCT00704184|10437946|P4|Open-Label Treatment|Physician Decision|0
3036094|NCT00704184|10437947|P3|Open-Label Treatment|Physician Decision|0
3036095|NCT00704184|10437948|P2|Open-Label Treatment|Physician Decision|0
3036096|NCT00704184|10437949|P1|Open-Label Treatment|Physician Decision|0
3036097|NCT00704184|10437945|P5|Open-Label Treatment|Lack of Efficacy|1
3036098|NCT00704184|10437946|P4|Open-Label Treatment|Lack of Efficacy|2
3036099|NCT00704184|10437947|P3|Open-Label Treatment|Lack of Efficacy|2
3036100|NCT00704184|10437948|P2|Open-Label Treatment|Lack of Efficacy|2
3036101|NCT00704184|10437949|P1|Open-Label Treatment|Lack of Efficacy|0
3036102|NCT00704184|10437945|P5|Open-Label Treatment|Adverse Event|1
3036103|NCT00704184|10437946|P4|Open-Label Treatment|Adverse Event|0
3036104|NCT00704184|10437947|P3|Open-Label Treatment|Adverse Event|2
3036105|NCT00704184|10437948|P2|Open-Label Treatment|Adverse Event|0
3036106|NCT00704184|10437949|P1|Open-Label Treatment|Adverse Event|0
3036107|NCT00704184|10437945|P5|Double-Blind Treatment|Withdrawal by Subject|0
3036108|NCT00704184|10437946|P4|Double-Blind Treatment|Withdrawal by Subject|0
3036109|NCT00704184|10437947|P3|Double-Blind Treatment|Withdrawal by Subject|0
3036110|NCT00704184|10437948|P2|Double-Blind Treatment|Withdrawal by Subject|0
3036111|NCT00704184|10437949|P1|Double-Blind Treatment|Withdrawal by Subject|1
3036112|NCT00704171|10437988|P2|Overall Study|Withdrawal by Subject|0
3036113|NCT00704171|10437989|P1|Overall Study|Withdrawal by Subject|1
3036114|NCT00704132|10438007|P2|Overall Study|Withdrawal by Subject|1
3036115|NCT00704132|10438008|P1|Overall Study|Withdrawal by Subject|0
3036116|NCT00704132|10438007|P2|Overall Study|Lack of Efficacy|1
3036117|NCT00704132|10438008|P1|Overall Study|Lack of Efficacy|0
3036118|NCT00704132|10438007|P2|Overall Study|Clinical Adverse Experience|0
3036119|NCT00704132|10438008|P1|Overall Study|Clinical Adverse Experience|1
3036120|NCT00703963|10438036|P2|Overall Study|Physician Decision|1
3036121|NCT00703963|10438037|P1|Overall Study|Physician Decision|0
3036122|NCT00703963|10438036|P2|Overall Study|Withdrawal by Subject|13
3036123|NCT00703963|10438037|P1|Overall Study|Withdrawal by Subject|7
3036124|NCT00703924|10438058|P2|Overall Study|Withdrawal by Subject|1
3036125|NCT00703924|10438059|P1|Overall Study|Withdrawal by Subject|1
3036126|NCT00703911|10438075|P1|Overall Study|Withdrawal by Subject|2
3036127|NCT00703911|10438075|P1|Overall Study|Lost to Follow-up|1
3036128|NCT00703911|10438075|P1|Overall Study|Physician Decision|6
3036129|NCT00703911|10438075|P1|Overall Study|Death|1
3036130|NCT00703846|10438108|P1|Overall Study|Did Not Receive Study Drug|2
3036131|NCT00703846|10438108|P1|Overall Study|Other|14
3036132|NCT00703846|10438108|P1|Overall Study|Death|1
3036133|NCT00703846|10438108|P1|Overall Study|Withdrawal by Subject|40
3036134|NCT00703846|10438108|P1|Overall Study|Noncompliance with Study Treatment|2
3036135|NCT00703846|10438108|P1|Overall Study|Lack of Efficacy|15
3036136|NCT00703846|10438108|P1|Overall Study|Lost to Follow-up|55
3036137|NCT00703846|10438108|P1|Overall Study|Adverse Event|8
3036138|NCT00703820|10438124|P2|Overall Study|Withdrawal by Subject|1
3036139|NCT00703820|10438125|P1|Overall Study|Withdrawal by Subject|2
3036140|NCT00703820|10438124|P2|Overall Study|Physician Decision|5
3036141|NCT00703820|10438125|P1|Overall Study|Physician Decision|4
3036142|NCT00703820|10438124|P2|Overall Study|Received non-protocol therapy|0
3036143|NCT00703820|10438125|P1|Overall Study|Received non-protocol therapy|1
3036144|NCT00703820|10438124|P2|Overall Study|Lack of Efficacy|11
3036145|NCT00703820|10438125|P1|Overall Study|Lack of Efficacy|11
3036146|NCT00703820|10438124|P2|Overall Study|Death|0
3036147|NCT00703820|10438125|P1|Overall Study|Death|5
3036148|NCT00703820|10438124|P2|Overall Study|Adverse Event|17
3036149|NCT00703820|10438125|P1|Overall Study|Adverse Event|12
3036150|NCT00703781|10438134|P2|Overall Study|Cancelled surgery|0
3036151|NCT00703781|10438135|P1|Overall Study|Cancelled surgery|1
3036152|NCT00703781|10438134|P2|Overall Study|Withdrawal by Subject|2
3036153|NCT00703781|10438135|P1|Overall Study|Withdrawal by Subject|1
3036154|NCT00703677|10438180|P1|Overall Study|Dropout-withdrawal not related to drug|3
3036155|NCT00703534|10438220|P2|Overall Study|Severe Non Compliance|5
3036156|NCT00703534|10438221|P1|Overall Study|Severe Non Compliance|1
3036157|NCT00703534|10438220|P2|Overall Study|Lost to Follow-up|4
3036158|NCT00703534|10438221|P1|Overall Study|Lost to Follow-up|1
3036159|NCT00703534|10438220|P2|Overall Study|Incorrect Enrollment|6
3036160|NCT00703534|10438221|P1|Overall Study|Incorrect Enrollment|6
3036161|NCT00703534|10438220|P2|Overall Study|Withdrawal by Subject|7
3036162|NCT00703534|10438221|P1|Overall Study|Withdrawal by Subject|8
3036163|NCT00703534|10438220|P2|Overall Study|Adverse Event|3
3036164|NCT00703534|10438221|P1|Overall Study|Adverse Event|14
3036165|NCT00703326|10438293|P2|Overall Study|Withdrawal by Subject|20
3036166|NCT00703326|10438294|P1|Overall Study|Withdrawal by Subject|42
3036167|NCT00703326|10438293|P2|Overall Study|Lost to Follow-up|8
3036168|NCT00703326|10438294|P1|Overall Study|Lost to Follow-up|25
3036169|NCT00703326|10438293|P2|Overall Study|Still on study|197
3036170|NCT00703326|10438294|P1|Overall Study|Still on study|380
3036171|NCT00703157|10438326|P2|Overall Study|source data permanently lost/ other|1
3036172|NCT00703157|10438327|P1|Overall Study|source data permanently lost/ other|4
3036173|NCT00703157|10438326|P2|Overall Study|Lost to Follow-up|1
3036174|NCT00703157|10438327|P1|Overall Study|Lost to Follow-up|0
3036175|NCT00703118|10438361|P3|Overall Study|Other|1
3036176|NCT00703118|10438362|P2|Overall Study|Other|0
3036177|NCT00703118|10438363|P1|Overall Study|Other|0
3036178|NCT00703118|10438361|P3|Overall Study|Withdrawal by Subject|13
3036179|NCT00703118|10438362|P2|Overall Study|Withdrawal by Subject|7
3036180|NCT00703118|10438363|P1|Overall Study|Withdrawal by Subject|8
3036181|NCT00703118|10438361|P3|Overall Study|Lost to Follow-up|4
3036182|NCT00703118|10438362|P2|Overall Study|Lost to Follow-up|4
3036183|NCT00703118|10438363|P1|Overall Study|Lost to Follow-up|6
3036184|NCT00703118|10438361|P3|Overall Study|Subject Ineligible To Continue The Trial|2
3036185|NCT00703118|10438362|P2|Overall Study|Subject Ineligible To Continue The Trial|3
3036186|NCT00703118|10438363|P1|Overall Study|Subject Ineligible To Continue The Trial|6
3036187|NCT00703118|10438361|P3|Overall Study|Adverse Event|2
3036188|NCT00703118|10438362|P2|Overall Study|Adverse Event|2
3036189|NCT00703118|10438363|P1|Overall Study|Adverse Event|1
3036190|NCT00703092|10438394|P1|Overall Study|Withdrawal by Subject|2
3036191|NCT00703014|10438602|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
3036192|NCT00703014|10438603|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
3036193|NCT00703014|10438604|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
3036194|NCT00703014|10438605|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
3036195|NCT00703014|10438602|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
3036196|NCT00703014|10438603|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
3036197|NCT00703014|10438604|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
3036198|NCT00703014|10438605|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
3036199|NCT00702962|10438625|P2|Overall Study|Hospitalized for other health disorder|0
3036200|NCT00702962|10438626|P1|Overall Study|Hospitalized for other health disorder|1
3036201|NCT00702962|10438625|P2|Overall Study|Progressive disease|1
3036202|NCT00702962|10438626|P1|Overall Study|Progressive disease|0
3036203|NCT00702949|10438637|P3|Overall Study|Other Medical Reason/unknown|3
3036204|NCT00702949|10438638|P2|Overall Study|Other Medical Reason/unknown|1
3036205|NCT00702949|10438639|P1|Overall Study|Other Medical Reason/unknown|1
3036206|NCT00702949|10438637|P3|Overall Study|Adverse Event|3
3036207|NCT00702949|10438638|P2|Overall Study|Adverse Event|6
3036208|NCT00702949|10438639|P1|Overall Study|Adverse Event|1
3036209|NCT00702949|10438637|P3|Overall Study|Refusal|2
3036210|NCT00702949|10438638|P2|Overall Study|Refusal|2
3036211|NCT00702949|10438639|P1|Overall Study|Refusal|3
3036212|NCT00702923|10438664|P1|Overall Study|Adverse Event|1
3036213|NCT00702845|10438687|P2|Overall Study|Not randomized|1
3036214|NCT00702845|10438688|P1|Overall Study|Not randomized|0
3036215|NCT00702845|10438687|P2|Overall Study|Patient's decision|1
3036216|NCT00702845|10438688|P1|Overall Study|Patient's decision|2
3036217|NCT00702845|10438687|P2|Overall Study|No or abnormal fertilization|2
3036218|NCT00702845|10438688|P1|Overall Study|No or abnormal fertilization|4
3036219|NCT00702845|10438687|P2|Overall Study|No/too few/bad quality embryos retrieved|1
3036220|NCT00702845|10438688|P1|Overall Study|No/too few/bad quality embryos retrieved|7
3036221|NCT00702845|10438687|P2|Overall Study|Insufficient ovarian response|0
3036222|NCT00702845|10438688|P1|Overall Study|Insufficient ovarian response|1
3036223|NCT00702845|10438687|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
3036224|NCT00702845|10438688|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
3036225|NCT00702845|10438687|P2|Overall Study|Too high ovarian response|1
3036226|NCT00702845|10438688|P1|Overall Study|Too high ovarian response|5
3036227|NCT00702845|10438687|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
3036228|NCT00702845|10438688|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
3036229|NCT00702715|10438750|P2|Overall Study|Lost to Follow-up|0
3036230|NCT00702715|10438751|P1|Overall Study|Lost to Follow-up|1
3036231|NCT00702702|10438764|P1|Overall Study|Study prematurely terminated|56
3036232|NCT00702689|10438772|P1|Overall Study|Adverse Event|1
3036233|NCT00702689|10438772|P1|Overall Study|Recurrent malignancy|1
3036234|NCT00702689|10438772|P1|Overall Study|Withdrawal by Subject|4
3036235|NCT00702650|10438783|P1|Overall Study|Adverse Event|3
3036236|NCT00702650|10438783|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
3036237|NCT00702650|10438783|P1|Overall Study|Sponsor Request|1
3036238|NCT00702650|10438783|P1|Overall Study|Non-Compliance with Site Directives|1
3036239|NCT00702650|10438783|P1|Overall Study|Lost to Follow-up|2
3036240|NCT00702650|10438783|P1|Overall Study|Non-Compliance of Study Drug|3
3036241|NCT00702650|10438783|P1|Overall Study|Withdrawal by Subject|9
3036242|NCT00702520|10438845|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
3036243|NCT00702520|10438846|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
3036244|NCT00702520|10438847|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
3036245|NCT00702520|10438848|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
3036246|NCT00702520|10438845|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
3036247|NCT00702520|10438846|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
3036248|NCT00702520|10438847|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
3036249|NCT00702520|10438848|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
3036250|NCT00702520|10438845|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
3036251|NCT00702520|10438846|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
3036252|NCT00702520|10438847|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
3036253|NCT00702520|10438848|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
3036254|NCT00702507|10438864|P1|Follow-up Phase|Late Enrollment|1
3036255|NCT00702507|10438864|P1|Follow-up Phase|Lost to Follow-up|23
3036256|NCT00702507|10438864|P1|Follow-up Phase|Protocol Violation|2
3036257|NCT00702507|10438864|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
3036258|NCT00702507|10438864|P1|Initial Treatment Phase|Negative Candida Culture|34
3036259|NCT00702507|10438864|P1|Initial Treatment Phase|Lost to Follow-up|2
3036260|NCT00702507|10438864|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
3036261|NCT00702507|10438864|P1|Initial Treatment Phase|Adverse Event|2
3036262|NCT00702403|10438901|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
3036263|NCT00702403|10438901|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
3036264|NCT00702403|10438901|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
3036265|NCT00702403|10438901|P1|From Engraftment to Study Completion|Suicide|1
3036266|NCT00702403|10438901|P1|From Engraftment to Study Completion|Liver GVHD|1
3036267|NCT00702403|10438901|P1|From Engraftment to Study Completion|Adenocarcinoma|1
3036268|NCT00702403|10438901|P1|From Engraftment to Study Completion|Non-compliance|2
3036269|NCT00702403|10438901|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
3036270|NCT00702403|10438901|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
3036271|NCT00702403|10438901|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
3036272|NCT00702403|10438901|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
3036273|NCT00702403|10438901|P1|From Consent to Engraftment|Myocardial infarction|1
3036274|NCT00702403|10438901|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
3036275|NCT00702403|10438901|P1|From Consent to Engraftment|Critically ill|2
3036276|NCT00702403|10438901|P1|From Consent to Engraftment|Progressive leukemia|6
3036277|NCT00702325|10438955|P2|Overall Study|Incorrectly Discontinued|1
3036278|NCT00702325|10438956|P1|Overall Study|Incorrectly Discontinued|0
3036279|NCT00702325|10438955|P2|Overall Study|Withdrew consent|1
3036280|NCT00702325|10438956|P1|Overall Study|Withdrew consent|0
3036281|NCT00702325|10438955|P2|Overall Study|Didn't follow study medication dosage|2
3036282|NCT00702325|10438956|P1|Overall Study|Didn't follow study medication dosage|0
3036283|NCT00702325|10438955|P2|Overall Study|Termination due to lab results|0
3036284|NCT00702325|10438956|P1|Overall Study|Termination due to lab results|1
3036285|NCT00702325|10438955|P2|Overall Study|Severe noncompliance to protocol|3
3036286|NCT00702325|10438956|P1|Overall Study|Severe noncompliance to protocol|3
3036287|NCT00702325|10438955|P2|Overall Study|Developed study discontinuation criteria|28
3036288|NCT00702325|10438956|P1|Overall Study|Developed study discontinuation criteria|18
3036289|NCT00702325|10438955|P2|Overall Study|Incorrect enrollment|7
3036290|NCT00702325|10438956|P1|Overall Study|Incorrect enrollment|5
3036291|NCT00702325|10438955|P2|Overall Study|Lost to Follow-up|4
3036292|NCT00702325|10438956|P1|Overall Study|Lost to Follow-up|3
3036293|NCT00702325|10438955|P2|Overall Study|Withdrawal by Subject|7
3036294|NCT00702325|10438956|P1|Overall Study|Withdrawal by Subject|7
3036295|NCT00702325|10438955|P2|Overall Study|Adverse Event|0
3036296|NCT00702325|10438956|P1|Overall Study|Adverse Event|1
3036297|NCT00702221|10439052|P2|Overall Study|Adverse Event|3
3036298|NCT00702221|10439053|P1|Overall Study|Adverse Event|4
3036299|NCT00702208|10439059|P1|Overall Study|Unsatisfactory colposcopy|2
3036300|NCT00702208|10439059|P1|Overall Study|Did not self-lavage|1
3036301|NCT00702208|10439059|P1|Overall Study|Lost to Follow-up|28
3036302|NCT00702143|10439068|P3|Overall Study|Lost to Follow-up|1
3036303|NCT00702143|10439069|P2|Overall Study|Lost to Follow-up|0
3036304|NCT00702143|10439070|P1|Overall Study|Lost to Follow-up|0
3036305|NCT00701805|10439119|P4|Overall Study|Resumption criteria were not met|0
3036306|NCT00701805|10439120|P3|Overall Study|Resumption criteria were not met|0
3036307|NCT00701805|10439121|P2|Overall Study|Resumption criteria were not met|1
3036308|NCT00701805|10439122|P1|Overall Study|Resumption criteria were not met|0
3036309|NCT00701805|10439119|P4|Overall Study|Difficult to travel to dialysis site|0
3036310|NCT00701805|10439120|P3|Overall Study|Difficult to travel to dialysis site|1
3036311|NCT00701805|10439121|P2|Overall Study|Difficult to travel to dialysis site|0
3036312|NCT00701805|10439122|P1|Overall Study|Difficult to travel to dialysis site|0
3036313|NCT00701805|10439119|P4|Overall Study|Physician decision, change of therapy|1
3036314|NCT00701805|10439120|P3|Overall Study|Physician decision, change of therapy|0
3036315|NCT00701805|10439121|P2|Overall Study|Physician decision, change of therapy|0
3036316|NCT00701805|10439122|P1|Overall Study|Physician decision, change of therapy|0
3036317|NCT00701805|10439119|P4|Overall Study|Admitted to hospital for 2 weeks|0
3036318|NCT00701805|10439120|P3|Overall Study|Admitted to hospital for 2 weeks|1
3036319|NCT00701805|10439121|P2|Overall Study|Admitted to hospital for 2 weeks|0
3036320|NCT00701805|10439122|P1|Overall Study|Admitted to hospital for 2 weeks|0
3036321|NCT00701805|10439119|P4|Overall Study|Missed 7 consecutive doses|0
3036322|NCT00701805|10439120|P3|Overall Study|Missed 7 consecutive doses|0
3036323|NCT00701805|10439121|P2|Overall Study|Missed 7 consecutive doses|1
3036324|NCT00701805|10439122|P1|Overall Study|Missed 7 consecutive doses|0
3036325|NCT00701805|10439119|P4|Overall Study|Adverse Event|0
3036326|NCT00701805|10439120|P3|Overall Study|Adverse Event|1
3036327|NCT00701805|10439121|P2|Overall Study|Adverse Event|1
3036328|NCT00701805|10439122|P1|Overall Study|Adverse Event|0
3036329|NCT00701805|10439119|P4|Overall Study|Withdrawal by Subject|3
3036330|NCT00701805|10439120|P3|Overall Study|Withdrawal by Subject|4
3036331|NCT00701805|10439121|P2|Overall Study|Withdrawal by Subject|1
3036332|NCT00701805|10439122|P1|Overall Study|Withdrawal by Subject|3
3036333|NCT00701779|10439172|P1|Overall Study|Withdrawal by Subject|2
3036334|NCT00701779|10439172|P1|Overall Study|Lost to Follow-up|1
3036335|NCT00701779|10439172|P1|Overall Study|Adverse Event|6
3036336|NCT00701727|10439184|P2|Second Treatment Period|Withdrawal by Subject|0
3036337|NCT00701727|10439185|P1|Second Treatment Period|Withdrawal by Subject|2
3036338|NCT00701727|10439184|P2|First Treatment Period|Lost to Follow-up|1
3036339|NCT00701727|10439185|P1|First Treatment Period|Lost to Follow-up|0
3036340|NCT00701727|10439184|P2|First Treatment Period|sponsor decision|1
3036341|NCT00701727|10439185|P1|First Treatment Period|sponsor decision|0
3036342|NCT00701727|10439184|P2|First Treatment Period|Withdrawal by Subject|0
3036343|NCT00701727|10439185|P1|First Treatment Period|Withdrawal by Subject|1
3036344|NCT00701727|10439184|P2|First Treatment Period|Adverse Event|0
3036345|NCT00701727|10439185|P1|First Treatment Period|Adverse Event|0
3036346|NCT00701662|10439231|P1|Overall Study|Lack of Efficacy|1
3036347|NCT00701558|10439256|P1|Overall Study|Lost to Follow-up|8
3036348|NCT00701558|10439256|P1|Overall Study|Death|7
3036349|NCT00701441|10439264|P2|Overall Study|failure in cpap compliance|4
3036350|NCT00701441|10439265|P1|Overall Study|failure in cpap compliance|0
3036351|NCT00701415|10439277|P2|Overall Study|Social/family issues and needle phobia|0
3036352|NCT00701415|10439278|P1|Overall Study|Social/family issues and needle phobia|1
3036353|NCT00701415|10439277|P2|Overall Study|Adverse Event|1
3036354|NCT00701415|10439278|P1|Overall Study|Adverse Event|0
3036355|NCT00701363|10439313|P4|Treatment Phase 2|Withdrawal by Subject|0
3036356|NCT00701363|10439314|P3|Treatment Phase 2|Withdrawal by Subject|1
3036357|NCT00701363|10439315|P2|Treatment Phase 2|Withdrawal by Subject|0
3036358|NCT00701363|10439316|P1|Treatment Phase 2|Withdrawal by Subject|0
3036359|NCT00701363|10439313|P4|Treatment Phase 2|Adverse Event|0
3036360|NCT00701363|10439314|P3|Treatment Phase 2|Adverse Event|1
3036361|NCT00701363|10439315|P2|Treatment Phase 2|Adverse Event|0
3036362|NCT00701363|10439316|P1|Treatment Phase 2|Adverse Event|0
3036363|NCT00701363|10439313|P4|Treatment Phase 1|Lack of Efficacy|0
3036364|NCT00701363|10439314|P3|Treatment Phase 1|Lack of Efficacy|0
3036365|NCT00701363|10439315|P2|Treatment Phase 1|Lack of Efficacy|0
3036366|NCT00701363|10439316|P1|Treatment Phase 1|Lack of Efficacy|1
3036367|NCT00701363|10439313|P4|Treatment Phase 1|Withdrawal by Subject|0
3036368|NCT00701363|10439314|P3|Treatment Phase 1|Withdrawal by Subject|0
3036369|NCT00701363|10439315|P2|Treatment Phase 1|Withdrawal by Subject|0
3036370|NCT00701363|10439316|P1|Treatment Phase 1|Withdrawal by Subject|5
3036371|NCT00701363|10439313|P4|Treatment Phase 1|Protocol Violation|0
3036372|NCT00701363|10439314|P3|Treatment Phase 1|Protocol Violation|0
3036373|NCT00701363|10439315|P2|Treatment Phase 1|Protocol Violation|0
3036374|NCT00701363|10439316|P1|Treatment Phase 1|Protocol Violation|1
3036375|NCT00701363|10439313|P4|Treatment Phase 1|Adverse Event|0
3036376|NCT00701363|10439314|P3|Treatment Phase 1|Adverse Event|0
3036377|NCT00701363|10439315|P2|Treatment Phase 1|Adverse Event|0
3036378|NCT00701363|10439316|P1|Treatment Phase 1|Adverse Event|7
3036379|NCT00701363|10439313|P4|Treatment Phase 1|Does not meet entry Criteria|0
3036380|NCT00701363|10439314|P3|Treatment Phase 1|Does not meet entry Criteria|0
3036381|NCT00701363|10439315|P2|Treatment Phase 1|Does not meet entry Criteria|0
3036382|NCT00701363|10439316|P1|Treatment Phase 1|Does not meet entry Criteria|1
3036383|NCT00701363|10439313|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
3036384|NCT00701363|10439314|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
3036385|NCT00701363|10439315|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
3036386|NCT00701363|10439316|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
3036387|NCT00701311|10439356|P1|Overall Study|Withdrawal by Subject|2
3036388|NCT00701311|10439356|P1|Overall Study|Adverse Event|3
3036389|NCT00701311|10439356|P1|Overall Study|Lack of Efficacy|3
3036390|NCT00701129|10439360|P1|Overall Study|Death|2
3036391|NCT00701103|10439382|P11|Overall Study|Other|0
3036392|NCT00701103|10439383|P10|Overall Study|Other|1
3036393|NCT00701103|10439384|P9|Overall Study|Other|1
3036394|NCT00701103|10439385|P8|Overall Study|Other|0
3036395|NCT00701103|10439386|P7|Overall Study|Other|0
3036396|NCT00701103|10439387|P6|Overall Study|Other|0
3036397|NCT00701103|10439388|P5|Overall Study|Other|0
3036398|NCT00701103|10439389|P4|Overall Study|Other|0
3036399|NCT00701103|10439390|P3|Overall Study|Other|0
3036400|NCT00701103|10439391|P2|Overall Study|Other|0
3036401|NCT00701103|10439392|P1|Overall Study|Other|0
3036402|NCT00701103|10439382|P11|Overall Study|Withdrawal by Subject|0
3036403|NCT00701103|10439383|P10|Overall Study|Withdrawal by Subject|0
3036404|NCT00701103|10439384|P9|Overall Study|Withdrawal by Subject|0
3036405|NCT00701103|10439385|P8|Overall Study|Withdrawal by Subject|0
3036406|NCT00701103|10439386|P7|Overall Study|Withdrawal by Subject|0
3036407|NCT00701103|10439387|P6|Overall Study|Withdrawal by Subject|0
3036408|NCT00701103|10439388|P5|Overall Study|Withdrawal by Subject|0
3036409|NCT00701103|10439389|P4|Overall Study|Withdrawal by Subject|0
3036410|NCT00701103|10439390|P3|Overall Study|Withdrawal by Subject|1
3036411|NCT00701103|10439391|P2|Overall Study|Withdrawal by Subject|1
3036412|NCT00701103|10439392|P1|Overall Study|Withdrawal by Subject|0
3036413|NCT00701103|10439382|P11|Overall Study|Progressive Disease|11
3036414|NCT00701103|10439383|P10|Overall Study|Progressive Disease|8
3036415|NCT00701103|10439384|P9|Overall Study|Progressive Disease|8
3036416|NCT00701103|10439385|P8|Overall Study|Progressive Disease|7
3036417|NCT00701103|10439386|P7|Overall Study|Progressive Disease|7
3036418|NCT00701103|10439387|P6|Overall Study|Progressive Disease|5
3036419|NCT00701103|10439388|P5|Overall Study|Progressive Disease|6
3036420|NCT00701103|10439389|P4|Overall Study|Progressive Disease|5
3036421|NCT00701103|10439390|P3|Overall Study|Progressive Disease|6
3036422|NCT00701103|10439391|P2|Overall Study|Progressive Disease|2
3036423|NCT00701103|10439392|P1|Overall Study|Progressive Disease|5
3036424|NCT00701103|10439382|P11|Overall Study|Adverse Event|0
3036425|NCT00701103|10439383|P10|Overall Study|Adverse Event|2
3036426|NCT00701103|10439384|P9|Overall Study|Adverse Event|0
3036427|NCT00701103|10439385|P8|Overall Study|Adverse Event|0
3036428|NCT00701103|10439386|P7|Overall Study|Adverse Event|1
3036429|NCT00701103|10439387|P6|Overall Study|Adverse Event|1
3036430|NCT00701103|10439388|P5|Overall Study|Adverse Event|0
3036431|NCT00701103|10439389|P4|Overall Study|Adverse Event|1
3036432|NCT00701103|10439390|P3|Overall Study|Adverse Event|1
3036433|NCT00701103|10439391|P2|Overall Study|Adverse Event|0
3036434|NCT00701103|10439392|P1|Overall Study|Adverse Event|0
3036435|NCT00701090|10439498|P2|Overall Study|Other|12
3036436|NCT00701090|10439499|P1|Overall Study|Other|7
3036437|NCT00701090|10439498|P2|Overall Study|Withdrawal by Subject|16
3036438|NCT00701090|10439499|P1|Overall Study|Withdrawal by Subject|11
3036439|NCT00701090|10439498|P2|Overall Study|Protocol Violation|3
3036440|NCT00701090|10439499|P1|Overall Study|Protocol Violation|2
3036441|NCT00701090|10439498|P2|Overall Study|Physician Decision|4
3036442|NCT00701090|10439499|P1|Overall Study|Physician Decision|3
3036443|NCT00701090|10439498|P2|Overall Study|Lost to Follow-up|9
3036444|NCT00701090|10439499|P1|Overall Study|Lost to Follow-up|9
3036445|NCT00701090|10439498|P2|Overall Study|Lack of Efficacy|4
3036446|NCT00701090|10439499|P1|Overall Study|Lack of Efficacy|5
3036447|NCT00701090|10439498|P2|Overall Study|Death|1
3036448|NCT00701090|10439499|P1|Overall Study|Death|0
3036449|NCT00701090|10439498|P2|Overall Study|Adverse Event|2
3036450|NCT00701090|10439499|P1|Overall Study|Adverse Event|11
3036451|NCT00701064|10439517|P2|Overall Study|initiated other PTSD treatment|2
3036452|NCT00701064|10439518|P1|Overall Study|initiated other PTSD treatment|2
3036453|NCT00701064|10439517|P2|Overall Study|Withdrawal by Subject|1
3036454|NCT00701064|10439518|P1|Overall Study|Withdrawal by Subject|1
3036455|NCT00701064|10439517|P2|Overall Study|Protocol Violation|1
3036456|NCT00701064|10439518|P1|Overall Study|Protocol Violation|1
3036457|NCT00701051|10439530|P3|Exercise Intervention|time conflict; non-study related illness|3
3036458|NCT00701051|10439531|P2|Exercise Intervention|time conflict; non-study related illness|5
3036459|NCT00701051|10439532|P1|Exercise Intervention|time conflict; non-study related illness|0
3036460|NCT00701051|10439530|P3|Screening|Time conflicts|0
3036461|NCT00701051|10439531|P2|Screening|Time conflicts|0
3036462|NCT00701051|10439532|P1|Screening|Time conflicts|19
3036463|NCT00701051|10439530|P3|Screening|Failed Screening|0
3036464|NCT00701051|10439531|P2|Screening|Failed Screening|0
3036465|NCT00701051|10439532|P1|Screening|Failed Screening|40
3036466|NCT00701038|10439550|P2|Overall Study|study amended pilot group of patients|4
3036467|NCT00701038|10439551|P1|Overall Study|study amended pilot group of patients|4
3036468|NCT00700999|10439559|P2|Overall Study|Withdrawal by Subject|1
3036469|NCT00700999|10439560|P1|Overall Study|Withdrawal by Subject|8
3036470|NCT00700999|10439559|P2|Overall Study|Excluded - did not meet study criteria|1
3036471|NCT00700999|10439560|P1|Overall Study|Excluded - did not meet study criteria|0
3036472|NCT00700999|10439559|P2|Overall Study|Lost to Follow-up|7
3036473|NCT00700999|10439560|P1|Overall Study|Lost to Follow-up|7
3036474|NCT00700882|10439575|P1|Overall Study|No KIT mutation|51
3036475|NCT00700882|10439575|P1|Overall Study|Ineligible|2
3036476|NCT00700882|10439575|P1|Overall Study|Never received treatment|6
3036477|NCT00700817|10439584|P5|Week 52-78 (Extension Period 2)|Unclassified|1
3036478|NCT00700817|10439585|P4|Week 52-78 (Extension Period 2)|Unclassified|0
3036479|NCT00700817|10439586|P3|Week 52-78 (Extension Period 2)|Unclassified|0
3036480|NCT00700817|10439587|P2|Week 52-78 (Extension Period 2)|Unclassified|4
3036481|NCT00700817|10439588|P1|Week 52-78 (Extension Period 2)|Unclassified|2
3036482|NCT00700817|10439584|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
3036483|NCT00700817|10439585|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
3036484|NCT00700817|10439586|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
3036485|NCT00700817|10439587|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
3036486|NCT00700817|10439588|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
3036487|NCT00700817|10439584|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
3036488|NCT00700817|10439585|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
3036489|NCT00700817|10439586|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
3036490|NCT00700817|10439587|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
3036491|NCT00700817|10439588|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
3036492|NCT00700817|10439584|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
3036493|NCT00700817|10439585|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
3036494|NCT00700817|10439586|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
3036495|NCT00700817|10439587|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
3036496|NCT00700817|10439588|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
3036497|NCT00700817|10439584|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
3036498|NCT00700817|10439585|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
3036499|NCT00700817|10439586|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
3036500|NCT00700817|10439587|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
3036501|NCT00700817|10439588|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
3036502|NCT00700817|10439584|P5|Week 26-52 (Extension Period 1)|Unclassified|0
3036503|NCT00700817|10439585|P4|Week 26-52 (Extension Period 1)|Unclassified|0
3036504|NCT00700817|10439586|P3|Week 26-52 (Extension Period 1)|Unclassified|1
3036505|NCT00700817|10439587|P2|Week 26-52 (Extension Period 1)|Unclassified|3
3036506|NCT00700817|10439588|P1|Week 26-52 (Extension Period 1)|Unclassified|4
3036507|NCT00700817|10439584|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
3036508|NCT00700817|10439585|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
3036509|NCT00700817|10439586|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
3036510|NCT00700817|10439587|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
3036511|NCT00700817|10439588|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
3036512|NCT00700817|10439584|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
3036513|NCT00700817|10439585|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
3036514|NCT00700817|10439586|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
3036515|NCT00700817|10439587|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
3036516|NCT00700817|10439588|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
3036517|NCT00700817|10439584|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
3036518|NCT00700817|10439585|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
3036519|NCT00700817|10439586|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
3036520|NCT00700817|10439587|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
3036521|NCT00700817|10439588|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
3036522|NCT00700817|10439584|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
3036523|NCT00700817|10439585|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
3036524|NCT00700817|10439586|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
3036525|NCT00700817|10439587|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
3036526|NCT00700817|10439588|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
3036527|NCT00700817|10439584|P5|Week 0-26 (Main Period)|Unclassified|0
3036528|NCT00700817|10439585|P4|Week 0-26 (Main Period)|Unclassified|0
3036529|NCT00700817|10439586|P3|Week 0-26 (Main Period)|Unclassified|8
3036530|NCT00700817|10439587|P2|Week 0-26 (Main Period)|Unclassified|4
3036531|NCT00700817|10439588|P1|Week 0-26 (Main Period)|Unclassified|14
3036532|NCT00700817|10439584|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
3036533|NCT00700817|10439585|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
3036534|NCT00700817|10439586|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
3036535|NCT00700817|10439587|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
3036536|NCT00700817|10439588|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
3036537|NCT00700817|10439584|P5|Week 0-26 (Main Period)|Protocol Violation|0
3036538|NCT00700817|10439585|P4|Week 0-26 (Main Period)|Protocol Violation|0
3036539|NCT00700817|10439586|P3|Week 0-26 (Main Period)|Protocol Violation|4
3036540|NCT00700817|10439587|P2|Week 0-26 (Main Period)|Protocol Violation|4
3036541|NCT00700817|10439588|P1|Week 0-26 (Main Period)|Protocol Violation|14
3036542|NCT00700817|10439584|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
3036543|NCT00700817|10439585|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
3036544|NCT00700817|10439586|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
3036545|NCT00700817|10439587|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
3036546|NCT00700817|10439588|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
3036547|NCT00700817|10439584|P5|Week 0-26 (Main Period)|Adverse Event|0
3036548|NCT00700817|10439585|P4|Week 0-26 (Main Period)|Adverse Event|0
3036549|NCT00700817|10439586|P3|Week 0-26 (Main Period)|Adverse Event|4
3036550|NCT00700817|10439587|P2|Week 0-26 (Main Period)|Adverse Event|15
3036551|NCT00700817|10439588|P1|Week 0-26 (Main Period)|Adverse Event|14
3036552|NCT00700804|10439970|P2|Overall Study|Loose Stools|1
3036553|NCT00700804|10439971|P1|Overall Study|Loose Stools|1
3036554|NCT00700804|10439970|P2|Overall Study|Protocol Violation|1
3036555|NCT00700804|10439971|P1|Overall Study|Protocol Violation|1
3036556|NCT00700804|10439970|P2|Overall Study|Withdrawal by Subject|2
3036557|NCT00700804|10439971|P1|Overall Study|Withdrawal by Subject|1
3036558|NCT00700752|10439979|P2|First Intervention|Withdrawal by Subject|2
3036559|NCT00700752|10439980|P1|First Intervention|Withdrawal by Subject|0
3036560|NCT00700739|10439988|P2|Overall Study|Lost to Follow-up|4
3036561|NCT00700739|10439989|P1|Overall Study|Lost to Follow-up|4
3036562|NCT00700713|10440028|P3|Overall Study|Withdrawal by Subject|1
3036563|NCT00700713|10440029|P2|Overall Study|Withdrawal by Subject|0
3036564|NCT00700713|10440030|P1|Overall Study|Withdrawal by Subject|0
3036565|NCT00700713|10440028|P3|Overall Study|Protocol Violation|1
3036566|NCT00700713|10440029|P2|Overall Study|Protocol Violation|0
3036567|NCT00700713|10440030|P1|Overall Study|Protocol Violation|1
3036568|NCT00700635|10440047|P3|Overall Study|Withdrawal by Subject|1
3036569|NCT00700635|10440048|P2|Overall Study|Withdrawal by Subject|3
3036570|NCT00700635|10440049|P1|Overall Study|Withdrawal by Subject|7
3036571|NCT00700635|10440047|P3|Overall Study|Protocol Violation|0
3036572|NCT00700635|10440048|P2|Overall Study|Protocol Violation|2
3036573|NCT00700635|10440049|P1|Overall Study|Protocol Violation|2
3036574|NCT00700635|10440047|P3|Overall Study|Lost to Follow-up|0
3036575|NCT00700635|10440048|P2|Overall Study|Lost to Follow-up|3
3036576|NCT00700635|10440049|P1|Overall Study|Lost to Follow-up|1
3036577|NCT00700635|10440047|P3|Overall Study|Adverse Event|0
3036578|NCT00700635|10440048|P2|Overall Study|Adverse Event|0
3036579|NCT00700635|10440049|P1|Overall Study|Adverse Event|1
3036580|NCT00700622|10440071|P2|Overall Study|Other|1
3036581|NCT00700622|10440072|P1|Overall Study|Other|3
3036582|NCT00700622|10440071|P2|Overall Study|Withdrawal by Subject|1
3036583|NCT00700622|10440072|P1|Overall Study|Withdrawal by Subject|4
3036584|NCT00700622|10440071|P2|Overall Study|Protocol Violation|1
3036585|NCT00700622|10440072|P1|Overall Study|Protocol Violation|0
3036586|NCT00700622|10440071|P2|Overall Study|Physician Decision|1
3036587|NCT00700622|10440072|P1|Overall Study|Physician Decision|2
3036588|NCT00700622|10440071|P2|Overall Study|Lost to Follow-up|1
3036589|NCT00700622|10440072|P1|Overall Study|Lost to Follow-up|0
3036590|NCT00700622|10440071|P2|Overall Study|Adverse Event|0
3036591|NCT00700622|10440072|P1|Overall Study|Adverse Event|4
3036592|NCT00700570|10440080|P2|Overall Study|Withdrawal by Subject|6
3036593|NCT00700570|10440081|P1|Overall Study|Withdrawal by Subject|1
3036594|NCT00700570|10440080|P2|Overall Study|Disease Progression|11
3036595|NCT00700570|10440081|P1|Overall Study|Disease Progression|8
3036596|NCT00700570|10440080|P2|Overall Study|Discretion of Investigator or Sponsor|3
3036597|NCT00700570|10440081|P1|Overall Study|Discretion of Investigator or Sponsor|0
3036598|NCT00700570|10440080|P2|Overall Study|Adverse Event|6
3036599|NCT00700570|10440081|P1|Overall Study|Adverse Event|2
3036600|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
3036601|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
3036602|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
3036603|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
3036604|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
3036605|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
3036606|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
3036607|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
3036608|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
3036609|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
3036610|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
3036611|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
3036612|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
3036613|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
3036614|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
3036615|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
3036616|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
3036617|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
3036618|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
3036619|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
3036620|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
3036621|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
3036622|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
3036623|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
3036624|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
3036625|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
3036626|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
3036627|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
3036628|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
3036629|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
3036630|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
3036631|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
3036632|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
3036633|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
3036634|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
3036635|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Death|1
3036636|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Death|0
3036637|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Death|0
3036638|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Death|0
3036639|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Death|0
3036640|NCT00700427|10440097|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
3036641|NCT00700427|10440098|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
3036642|NCT00700427|10440099|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
3036643|NCT00700427|10440100|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
3036644|NCT00700427|10440101|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
3036645|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Death|0
3036646|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Death|0
3036647|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Death|1
3036648|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Death|0
3036649|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Death|0
3036650|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
3036651|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
3036652|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
3036653|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
3036654|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
3036655|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
3036656|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
3036657|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
3036658|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
3036659|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
3036660|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
3036661|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
3036662|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
3036663|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
3036664|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
3036665|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
3036666|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
3036667|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
3036668|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
3036669|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
3036670|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
3036671|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
3036672|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
3036673|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
3036674|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
3036675|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
3036676|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
3036677|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
3036678|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
3036679|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
3036680|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
3036681|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
3036682|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
3036683|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
3036684|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
3036685|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
3036686|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
3036687|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
3036688|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
3036689|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
3036690|NCT00700427|10440097|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
3036691|NCT00700427|10440098|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
3036692|NCT00700427|10440099|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
3036693|NCT00700427|10440100|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
3036694|NCT00700427|10440101|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
3036695|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
3036696|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
3036697|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
3036698|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
3036699|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
3036700|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
3036701|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
3036702|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
3036703|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
3036704|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
3036705|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
3036706|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
3036707|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
3036708|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
3036709|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
3036710|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
3036711|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
3036712|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
3036713|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
3036714|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
3036715|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
3036716|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
3036717|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
3036718|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
3036719|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
3036720|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
3036721|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
3036722|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
3036723|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
3036724|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
3036725|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
3036726|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
3036727|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
3036728|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
3036729|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
3036730|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
3036731|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
3036732|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
3036733|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
3036734|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
3036735|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
3036736|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
3036737|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
3036738|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
3036739|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
3036740|NCT00700427|10440097|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
3036741|NCT00700427|10440098|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
3036742|NCT00700427|10440099|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
3036743|NCT00700427|10440100|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
3036744|NCT00700427|10440101|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
3036745|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
3036746|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
3036747|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
3036748|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
3036749|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
3036750|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
3036751|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
3036752|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
3036753|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
3036754|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
3036755|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
3036756|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
3036757|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
3036758|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
3036759|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
3036760|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
3036761|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
3036762|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
3036763|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
3036764|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
3036765|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
3036766|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
3036767|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
3036768|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
3036769|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
3036770|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
3036771|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
3036772|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
3036773|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
3036774|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
3036775|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
3036776|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
3036777|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
3036778|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
3036779|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
3036780|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
3036781|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
3036782|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
3036783|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
3036784|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
3036785|NCT00700427|10440097|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
3036786|NCT00700427|10440098|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
3036787|NCT00700427|10440099|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
3036788|NCT00700427|10440100|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
3036789|NCT00700427|10440101|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
3036790|NCT00700401|10440123|P1|Overall Study|Withdrawal by Subject|2
3036791|NCT00700401|10440123|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
3036792|NCT00700401|10440123|P1|Overall Study|Treatment never started|1
3036793|NCT00700401|10440123|P1|Overall Study|Lost to Follow-up|1
3036794|NCT00700401|10440123|P1|Overall Study|Refused Treatment|2
3036795|NCT00700401|10440123|P1|Overall Study|Adverse Event|5
3036796|NCT00700401|10440123|P1|Overall Study|Detectable HCV RNA after Week 4|82
3036797|NCT00700310|10440147|P4|Overall Study|Randomized, Not Treated|2
3036798|NCT00700310|10440148|P3|Overall Study|Randomized, Not Treated|2
3036799|NCT00700310|10440149|P2|Overall Study|Randomized, Not Treated|0
3036800|NCT00700310|10440150|P1|Overall Study|Randomized, Not Treated|2
3036801|NCT00700310|10440147|P4|Overall Study|Administrative/Other|3
3036802|NCT00700310|10440148|P3|Overall Study|Administrative/Other|1
3036803|NCT00700310|10440149|P2|Overall Study|Administrative/Other|3
3036804|NCT00700310|10440150|P1|Overall Study|Administrative/Other|1
3036805|NCT00700310|10440147|P4|Overall Study|Lack of Efficacy|1
3036806|NCT00700310|10440148|P3|Overall Study|Lack of Efficacy|0
3036807|NCT00700310|10440149|P2|Overall Study|Lack of Efficacy|3
3036808|NCT00700310|10440150|P1|Overall Study|Lack of Efficacy|0
3036809|NCT00700310|10440147|P4|Overall Study|Withdrawal by Subject|8
3036810|NCT00700310|10440148|P3|Overall Study|Withdrawal by Subject|8
3036811|NCT00700310|10440149|P2|Overall Study|Withdrawal by Subject|9
3036812|NCT00700310|10440150|P1|Overall Study|Withdrawal by Subject|8
3036813|NCT00700310|10440147|P4|Overall Study|Lost to Follow-up|1
3036814|NCT00700310|10440148|P3|Overall Study|Lost to Follow-up|0
3036815|NCT00700310|10440149|P2|Overall Study|Lost to Follow-up|1
3036816|NCT00700310|10440150|P1|Overall Study|Lost to Follow-up|4
3036817|NCT00700310|10440147|P4|Overall Study|Adverse Event|11
3036818|NCT00700310|10440148|P3|Overall Study|Adverse Event|5
3036819|NCT00700310|10440149|P2|Overall Study|Adverse Event|10
3036820|NCT00700310|10440150|P1|Overall Study|Adverse Event|6
3036821|NCT00700271|10440170|P2|Overall Study|Lost to Follow-up|2
3036822|NCT00700271|10440171|P1|Overall Study|Lost to Follow-up|2
3036823|NCT00700271|10440170|P2|Overall Study|Withdrawal by Subject|4
3036824|NCT00700271|10440171|P1|Overall Study|Withdrawal by Subject|6
3036825|NCT00700271|10440170|P2|Overall Study|Administrative Reasons|0
3036826|NCT00700271|10440171|P1|Overall Study|Administrative Reasons|1
3036827|NCT00700271|10440170|P2|Overall Study|Protocol Violation|0
3036828|NCT00700271|10440171|P1|Overall Study|Protocol Violation|1
3036829|NCT00700271|10440170|P2|Overall Study|Adverse Event|6
3036830|NCT00700271|10440171|P1|Overall Study|Adverse Event|4
3036831|NCT00700180|10440199|P2|Overall Study|Lost to Follow-up|5
3036832|NCT00700180|10440200|P1|Overall Study|Lost to Follow-up|4
3036833|NCT00700180|10440199|P2|Overall Study|Alive in follow-up|27
3036834|NCT00700180|10440200|P1|Overall Study|Alive in follow-up|46
3036835|NCT00700180|10440199|P2|Overall Study|Alive on treatment|3
3036836|NCT00700180|10440200|P1|Overall Study|Alive on treatment|5
3036837|NCT00700180|10440199|P2|Overall Study|Death|114
3036838|NCT00700180|10440200|P1|Overall Study|Death|99
3036839|NCT00700115|10440229|P2|Overall Study|Lost to Follow-up|1
3036840|NCT00700115|10440230|P1|Overall Study|Lost to Follow-up|0
3036841|NCT00700115|10440229|P2|Overall Study|Withdrawal by Subject|0
3036842|NCT00700115|10440230|P1|Overall Study|Withdrawal by Subject|1
3036843|NCT00700102|10440240|P2|Overall Study|Lost to Follow-up|10
3036844|NCT00700102|10440241|P1|Overall Study|Lost to Follow-up|8
3036845|NCT00700102|10440240|P2|Overall Study|Died|385
3036846|NCT00700102|10440241|P1|Overall Study|Died|394
3036847|NCT00700011|10440380|P2|Overall Study|Death|1
3036848|NCT00700011|10440381|P1|Overall Study|Death|0
3036849|NCT00699998|10440397|P4|Overall Study|Lost to Follow-up|1
3036850|NCT00699998|10440398|P3|Overall Study|Lost to Follow-up|3
3036851|NCT00699998|10440399|P2|Overall Study|Lost to Follow-up|1
3036852|NCT00699998|10440400|P1|Overall Study|Lost to Follow-up|2
3036853|NCT00699998|10440397|P4|Overall Study|Physician Decision|1
3036854|NCT00699998|10440398|P3|Overall Study|Physician Decision|1
3036855|NCT00699998|10440399|P2|Overall Study|Physician Decision|2
3036856|NCT00699998|10440400|P1|Overall Study|Physician Decision|3
3036857|NCT00699998|10440397|P4|Overall Study|Withdrawal by Subject|80
3036858|NCT00699998|10440398|P3|Overall Study|Withdrawal by Subject|202
3036859|NCT00699998|10440399|P2|Overall Study|Withdrawal by Subject|83
3036860|NCT00699998|10440400|P1|Overall Study|Withdrawal by Subject|194
3036861|NCT00699972|10440445|P3|Overall Study|Randomized, Not Treated|1
3036862|NCT00699972|10440446|P2|Overall Study|Randomized, Not Treated|0
3036863|NCT00699972|10440447|P1|Overall Study|Randomized, Not Treated|1
3036864|NCT00699972|10440445|P3|Overall Study|Administrative/Other|4
3036865|NCT00699972|10440446|P2|Overall Study|Administrative/Other|1
3036866|NCT00699972|10440447|P1|Overall Study|Administrative/Other|3
3036867|NCT00699972|10440445|P3|Overall Study|Lack of Efficacy|2
3036868|NCT00699972|10440446|P2|Overall Study|Lack of Efficacy|0
3036869|NCT00699972|10440447|P1|Overall Study|Lack of Efficacy|2
3036870|NCT00699972|10440445|P3|Overall Study|Withdrawal by Subject|4
3036871|NCT00699972|10440446|P2|Overall Study|Withdrawal by Subject|7
3036872|NCT00699972|10440447|P1|Overall Study|Withdrawal by Subject|3
3036873|NCT00699972|10440445|P3|Overall Study|Lost to Follow-up|0
3036874|NCT00699972|10440446|P2|Overall Study|Lost to Follow-up|2
3036875|NCT00699972|10440447|P1|Overall Study|Lost to Follow-up|0
3036876|NCT00699972|10440445|P3|Overall Study|Adverse Event|24
3036877|NCT00699972|10440446|P2|Overall Study|Adverse Event|9
3036878|NCT00699972|10440447|P1|Overall Study|Adverse Event|7
3036879|NCT00699907|10440464|P3|Overall Study|No usable sample|8
3036880|NCT00699907|10440465|P2|Overall Study|No usable sample|9
3036881|NCT00699907|10440466|P1|Overall Study|No usable sample|0
3036882|NCT00699907|10440464|P3|Overall Study|Withdrawal by Subject|0
3036883|NCT00699907|10440465|P2|Overall Study|Withdrawal by Subject|1
3036884|NCT00699907|10440466|P1|Overall Study|Withdrawal by Subject|2
3036885|NCT00699842|10440501|P3|Overall Study|Death|0
3036886|NCT00699842|10440502|P2|Overall Study|Death|1
3036887|NCT00699842|10440503|P1|Overall Study|Death|0
3036888|NCT00699816|10440516|P2|Overall Study|Protocol Violation|3
3036889|NCT00699816|10440517|P1|Overall Study|Protocol Violation|1
3036890|NCT00699751|10440535|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
3036891|NCT00699751|10440536|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
3036892|NCT00699751|10440535|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
3036893|NCT00699751|10440536|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
3036894|NCT00699751|10440535|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
3036895|NCT00699751|10440536|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
3036896|NCT00699751|10440535|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
3036897|NCT00699751|10440536|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
3036898|NCT00699751|10440535|P2|Period 1: Without/Before Drug Switch|Other|20
3036899|NCT00699751|10440536|P1|Period 1: Without/Before Drug Switch|Other|30
3036900|NCT00699751|10440535|P2|Period 1: Without/Before Drug Switch|Subject Request|23
3036901|NCT00699751|10440536|P1|Period 1: Without/Before Drug Switch|Subject Request|43
3036902|NCT00699751|10440535|P2|Period 1: Without/Before Drug Switch|Death|29
3036903|NCT00699751|10440536|P1|Period 1: Without/Before Drug Switch|Death|28
3036904|NCT00699751|10440535|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
3036905|NCT00699751|10440536|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
3036906|NCT00699699|10440621|P1|Overall Study|Individual different reasons|21
3036907|NCT00699699|10440621|P1|Overall Study|Adverse Event|36
3036908|NCT00699660|10440630|P2|Overall Study|missing reports and recording failures|6
3036909|NCT00699660|10440631|P1|Overall Study|missing reports and recording failures|10
3036910|NCT00699660|10440630|P2|Overall Study|Lost to Follow-up|2
3036911|NCT00699660|10440631|P1|Overall Study|Lost to Follow-up|4
3036912|NCT00699608|10440643|P6|Second Intervention|Withdrawal by Subject|0
3036913|NCT00699608|10440644|P5|Second Intervention|Withdrawal by Subject|0
3036914|NCT00699608|10440645|P4|Second Intervention|Withdrawal by Subject|1
3036915|NCT00699608|10440646|P3|Second Intervention|Withdrawal by Subject|0
3036916|NCT00699608|10440647|P2|Second Intervention|Withdrawal by Subject|0
3036917|NCT00699608|10440648|P1|Second Intervention|Withdrawal by Subject|0
3036918|NCT00699608|10440643|P6|Second Intervention|Adverse Event|0
3036919|NCT00699608|10440644|P5|Second Intervention|Adverse Event|0
3036920|NCT00699608|10440645|P4|Second Intervention|Adverse Event|0
3036921|NCT00699608|10440646|P3|Second Intervention|Adverse Event|1
3036922|NCT00699608|10440647|P2|Second Intervention|Adverse Event|0
3036923|NCT00699608|10440648|P1|Second Intervention|Adverse Event|0
3036924|NCT00699608|10440643|P6|First Intervention|Protocol Violation|0
3036925|NCT00699608|10440644|P5|First Intervention|Protocol Violation|1
3036926|NCT00699608|10440645|P4|First Intervention|Protocol Violation|0
3036927|NCT00699608|10440646|P3|First Intervention|Protocol Violation|0
3036928|NCT00699608|10440647|P2|First Intervention|Protocol Violation|0
3036929|NCT00699608|10440648|P1|First Intervention|Protocol Violation|0
3036930|NCT00699608|10440643|P6|First Intervention|Withdrawal by Subject|0
3036931|NCT00699608|10440644|P5|First Intervention|Withdrawal by Subject|0
3036932|NCT00699608|10440645|P4|First Intervention|Withdrawal by Subject|0
3036933|NCT00699608|10440646|P3|First Intervention|Withdrawal by Subject|1
3036934|NCT00699608|10440647|P2|First Intervention|Withdrawal by Subject|0
3036935|NCT00699608|10440648|P1|First Intervention|Withdrawal by Subject|0
3036936|NCT00699582|10440701|P3|Overall Study|Randomized, Not Treated|0
3036937|NCT00699582|10440702|P2|Overall Study|Randomized, Not Treated|1
3036938|NCT00699582|10440703|P1|Overall Study|Randomized, Not Treated|2
3036939|NCT00699582|10440701|P3|Overall Study|Administrative/Other|0
3036940|NCT00699582|10440702|P2|Overall Study|Administrative/Other|3
3036941|NCT00699582|10440703|P1|Overall Study|Administrative/Other|4
3036942|NCT00699582|10440701|P3|Overall Study|Progressive Disease|0
3036943|NCT00699582|10440702|P2|Overall Study|Progressive Disease|0
3036944|NCT00699582|10440703|P1|Overall Study|Progressive Disease|1
3036945|NCT00699582|10440701|P3|Overall Study|Lack of Efficacy|1
3036946|NCT00699582|10440702|P2|Overall Study|Lack of Efficacy|0
3036947|NCT00699582|10440703|P1|Overall Study|Lack of Efficacy|1
3036948|NCT00699582|10440701|P3|Overall Study|Withdrawal by Subject|4
3036949|NCT00699582|10440702|P2|Overall Study|Withdrawal by Subject|7
3036950|NCT00699582|10440703|P1|Overall Study|Withdrawal by Subject|6
3036951|NCT00699582|10440701|P3|Overall Study|Adverse Event|23
3036952|NCT00699582|10440702|P2|Overall Study|Adverse Event|11
3036953|NCT00699582|10440703|P1|Overall Study|Adverse Event|4
3036954|NCT00699413|10440758|P2|Overall Study|Study terminated by sponsor|2
3036955|NCT00699413|10440759|P1|Overall Study|Study terminated by sponsor|4
3036956|NCT00699413|10440758|P2|Overall Study|Withdrawal by Subject|2
3036957|NCT00699413|10440759|P1|Overall Study|Withdrawal by Subject|0
3036958|NCT00699374|10440813|P2|Overall Study|Died 28 days after last dose|9
3036959|NCT00699374|10440814|P1|Overall Study|Died 28 days after last dose|5
3036960|NCT00699374|10440813|P2|Overall Study|Randomized but not treated|2
3036961|NCT00699374|10440814|P1|Overall Study|Randomized but not treated|4
3036962|NCT00699374|10440813|P2|Overall Study|Study terminated by sponsor|28
3036963|NCT00699374|10440814|P1|Overall Study|Study terminated by sponsor|13
3036964|NCT00699374|10440813|P2|Overall Study|Protocol Violation|6
3036965|NCT00699374|10440814|P1|Overall Study|Protocol Violation|2
3036966|NCT00699374|10440813|P2|Overall Study|Other|15
3036967|NCT00699374|10440814|P1|Overall Study|Other|18
3036968|NCT00699374|10440813|P2|Overall Study|Objective progression or relapse|277
3036969|NCT00699374|10440814|P1|Overall Study|Objective progression or relapse|281
3036970|NCT00699374|10440813|P2|Overall Study|Withdrawal by Subject|44
3036971|NCT00699374|10440814|P1|Overall Study|Withdrawal by Subject|34
3036972|NCT00699374|10440813|P2|Overall Study|Lost to Follow-up|5
3036973|NCT00699374|10440814|P1|Overall Study|Lost to Follow-up|3
3036974|NCT00699374|10440813|P2|Overall Study|Global deterioration of health status|8
3036975|NCT00699374|10440814|P1|Overall Study|Global deterioration of health status|7
3036976|NCT00699374|10440813|P2|Overall Study|Adverse Event|67
3036977|NCT00699374|10440814|P1|Overall Study|Adverse Event|70
3036978|NCT00699374|10440813|P2|Overall Study|Death|83
3036979|NCT00699374|10440814|P1|Overall Study|Death|93
3036980|NCT00699348|10440826|P1|Overall Study|Other|5
3036981|NCT00699348|10440826|P1|Overall Study|Renal transplantation|10
3036982|NCT00699348|10440826|P1|Overall Study|Blood transfusion|24
3036983|NCT00699348|10440826|P1|Overall Study|Failure to return|1
3036984|NCT00699348|10440826|P1|Overall Study|Lack of Efficacy|8
3036985|NCT00699348|10440826|P1|Overall Study|Protocol Violation|10
3036986|NCT00699348|10440826|P1|Overall Study|Withdrawal by Subject|11
3036987|NCT00699348|10440826|P1|Overall Study|Adverse Event|15
3036988|NCT00699348|10440826|P1|Overall Study|Death|6
3036989|NCT00699335|10440835|P1|Overall Study|Missing data|52
3036990|NCT00699335|10440835|P1|Overall Study|Combination of multiple reasons|176
3036991|NCT00699283|10440868|P2|Overall Study|AE of unknown type|0
3036992|NCT00699283|10440869|P1|Overall Study|AE of unknown type|1
3036993|NCT00699283|10440868|P2|Overall Study|AE, non-serious non-fatal|1
3036994|NCT00699283|10440869|P1|Overall Study|AE, non-serious non-fatal|8
3036995|NCT00699283|10440868|P2|Overall Study|SAE, non-fatal|1
3036996|NCT00699283|10440869|P1|Overall Study|SAE, non-fatal|1
3036997|NCT00699283|10440868|P2|Overall Study|Other Reason|1
3036998|NCT00699283|10440869|P1|Overall Study|Other Reason|5
3036999|NCT00699283|10440868|P2|Overall Study|Withdrawal by Subject|0
3037000|NCT00699283|10440869|P1|Overall Study|Withdrawal by Subject|1
3037001|NCT00699283|10440868|P2|Overall Study|Lost to Follow-up|0
3037002|NCT00699283|10440869|P1|Overall Study|Lost to Follow-up|2
3037003|NCT00699283|10440868|P2|Overall Study|Lack of Efficacy|5
3037004|NCT00699283|10440869|P1|Overall Study|Lack of Efficacy|15
3037005|NCT00699192|10440882|P3|Overall Study|Protocol Violation|0
3037006|NCT00699192|10440883|P2|Overall Study|Protocol Violation|2
3037007|NCT00699192|10440884|P1|Overall Study|Protocol Violation|2
3037008|NCT00699192|10440882|P3|Overall Study|Administrative problems|1
3037009|NCT00699192|10440883|P2|Overall Study|Administrative problems|3
3037010|NCT00699192|10440884|P1|Overall Study|Administrative problems|1
3037011|NCT00699192|10440882|P3|Overall Study|Withdrawal by Subject|4
3037012|NCT00699192|10440883|P2|Overall Study|Withdrawal by Subject|2
3037013|NCT00699192|10440884|P1|Overall Study|Withdrawal by Subject|3
3037014|NCT00699192|10440882|P3|Overall Study|Lack of Efficacy|1
3037015|NCT00699192|10440883|P2|Overall Study|Lack of Efficacy|0
3037016|NCT00699192|10440884|P1|Overall Study|Lack of Efficacy|0
3037017|NCT00699192|10440882|P3|Overall Study|Abnormal test procedure result(s)|1
3037018|NCT00699192|10440883|P2|Overall Study|Abnormal test procedure result(s)|0
3037019|NCT00699192|10440884|P1|Overall Study|Abnormal test procedure result(s)|0
3037020|NCT00699192|10440882|P3|Overall Study|Adverse Event|3
3037021|NCT00699192|10440883|P2|Overall Study|Adverse Event|4
3037022|NCT00699192|10440884|P1|Overall Study|Adverse Event|9
3037023|NCT00699192|10440882|P3|Overall Study|Missing|1
3037024|NCT00699192|10440883|P2|Overall Study|Missing|1
3037025|NCT00699192|10440884|P1|Overall Study|Missing|1
3037026|NCT00699153|10440906|P2|Overall Study|Travel Problem|0
3037027|NCT00699153|10440907|P1|Overall Study|Travel Problem|1
3037028|NCT00699153|10440906|P2|Overall Study|Protocol Violation|0
3037029|NCT00699153|10440907|P1|Overall Study|Protocol Violation|1
3037030|NCT00699153|10440906|P2|Overall Study|Adverse Event|2
3037031|NCT00699153|10440907|P1|Overall Study|Adverse Event|0
3037032|NCT00699153|10440906|P2|Overall Study|Lost to Follow-up|0
3037033|NCT00699153|10440907|P1|Overall Study|Lost to Follow-up|1
3037034|NCT00698997|10440942|P2|Overall Study|Withdrawal by Subject|27
3037035|NCT00698997|10440943|P1|Overall Study|Withdrawal by Subject|7
3037036|NCT00698997|10440942|P2|Overall Study|Lost to Follow-up|0
3037037|NCT00698997|10440943|P1|Overall Study|Lost to Follow-up|3
3037038|NCT00698932|10440957|P2|Overall Study|Death|0
3037039|NCT00698932|10440958|P1|Overall Study|Death|1
3037040|NCT00698932|10440957|P2|Overall Study|Safety reasons|2
3037041|NCT00698932|10440958|P1|Overall Study|Safety reasons|0
3037042|NCT00698932|10440957|P2|Overall Study|Severe non-compliance to protocol|2
3037043|NCT00698932|10440958|P1|Overall Study|Severe non-compliance to protocol|1
3037044|NCT00698932|10440957|P2|Overall Study|Lost to Follow-up|1
3037045|NCT00698932|10440958|P1|Overall Study|Lost to Follow-up|6
3037046|NCT00698932|10440957|P2|Overall Study|Withdrawal by Subject|23
3037047|NCT00698932|10440958|P1|Overall Study|Withdrawal by Subject|11
3037048|NCT00698932|10440957|P2|Overall Study|Study specific discontinuation criteria|4
3037049|NCT00698932|10440958|P1|Overall Study|Study specific discontinuation criteria|3
3037050|NCT00698932|10440957|P2|Overall Study|Incorrect enrollment|2
3037051|NCT00698932|10440958|P1|Overall Study|Incorrect enrollment|0
3037052|NCT00698932|10440957|P2|Overall Study|Adverse Event|2
3037053|NCT00698932|10440958|P1|Overall Study|Adverse Event|0
3037054|NCT00698841|10440984|P1|Overall Study|Other|2
3037055|NCT00698841|10440984|P1|Overall Study|Study drug toxicity|2
3037056|NCT00698841|10440984|P1|Overall Study|Failure to meet eligibility criteria|2
3037057|NCT00698841|10440984|P1|Overall Study|Disease progression|7
3037058|NCT00698841|10440984|P1|Overall Study|Adverse Event|3
3037059|NCT00698841|10440984|P1|Overall Study|Withdrawal by Subject|2
3037060|NCT00698815|10440998|P3|Overall Study|Did not receive protocol treatment|2
3037061|NCT00698815|10440999|P2|Overall Study|Did not receive protocol treatment|2
3037062|NCT00698815|10441000|P1|Overall Study|Did not receive protocol treatment|1
3037063|NCT00698815|10440998|P3|Overall Study|MD discretion|2
3037064|NCT00698815|10440999|P2|Overall Study|MD discretion|7
3037065|NCT00698815|10441000|P1|Overall Study|MD discretion|2
3037066|NCT00698815|10440998|P3|Overall Study|Withdrawal by Subject|2
3037067|NCT00698815|10440999|P2|Overall Study|Withdrawal by Subject|3
3037068|NCT00698815|10441000|P1|Overall Study|Withdrawal by Subject|6
3037069|NCT00698815|10440998|P3|Overall Study|Death|4
3037070|NCT00698815|10440999|P2|Overall Study|Death|2
3037071|NCT00698815|10441000|P1|Overall Study|Death|1
3037072|NCT00698685|10441017|P1|Overall Study|Off study pre transplant by clinic MD|1
3037073|NCT00698685|10441017|P1|Overall Study|Sister withdrew as donor|1
3037074|NCT00698646|10441025|P3|Overall Study|Administrative problems|1
3037075|NCT00698646|10441026|P2|Overall Study|Administrative problems|0
3037076|NCT00698646|10441027|P1|Overall Study|Administrative problems|1
3037077|NCT00698646|10441025|P3|Overall Study|Lost to Follow-up|2
3037078|NCT00698646|10441026|P2|Overall Study|Lost to Follow-up|0
3037079|NCT00698646|10441027|P1|Overall Study|Lost to Follow-up|0
3037080|NCT00698646|10441025|P3|Overall Study|Withdrawal by Subject|8
3037081|NCT00698646|10441026|P2|Overall Study|Withdrawal by Subject|11
3037082|NCT00698646|10441027|P1|Overall Study|Withdrawal by Subject|10
3037083|NCT00698646|10441025|P3|Overall Study|Protocol Deviation|3
3037084|NCT00698646|10441026|P2|Overall Study|Protocol Deviation|2
3037085|NCT00698646|10441027|P1|Overall Study|Protocol Deviation|6
3037086|NCT00698646|10441025|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
3037087|NCT00698646|10441026|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
3037088|NCT00698646|10441027|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
3037089|NCT00698646|10441025|P3|Overall Study|Adverse Event|8
3037090|NCT00698646|10441026|P2|Overall Study|Adverse Event|7
3037091|NCT00698646|10441027|P1|Overall Study|Adverse Event|8
3037092|NCT00698581|10441052|P2|Overall Study|AE of unknown type|0
3037093|NCT00698581|10441053|P1|Overall Study|AE of unknown type|1
3037094|NCT00698581|10441052|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
3037095|NCT00698581|10441053|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
3037096|NCT00698581|10441052|P2|Overall Study|AE, non-serious non-fatal|0
3037097|NCT00698581|10441053|P1|Overall Study|AE, non-serious non-fatal|4
3037098|NCT00698581|10441052|P2|Overall Study|SAE, non-fatal|0
3037099|NCT00698581|10441053|P1|Overall Study|SAE, non-fatal|1
3037100|NCT00698581|10441052|P2|Overall Study|Other reason|1
3037101|NCT00698581|10441053|P1|Overall Study|Other reason|9
3037102|NCT00698581|10441052|P2|Overall Study|Withdrawal by Subject|0
3037103|NCT00698581|10441053|P1|Overall Study|Withdrawal by Subject|6
3037104|NCT00698581|10441052|P2|Overall Study|Lack of Efficacy|11
3037105|NCT00698581|10441053|P1|Overall Study|Lack of Efficacy|23
3037106|NCT00698516|10441064|P1|Overall Study|Withdrawal by Subject|3
3037107|NCT00698516|10441064|P1|Overall Study|Study Termination|2
3037108|NCT00698451|10441082|P1|Overall Study|Disease progression|3
3037109|NCT00698451|10441082|P1|Overall Study|Withdrawal by Subject|6
3037110|NCT00698451|10441082|P1|Overall Study|Protocol Violation|6
3037111|NCT00698451|10441082|P1|Overall Study|Physician Decision|2
3037112|NCT00698451|10441082|P1|Overall Study|Adverse Event|22
3037113|NCT00698204|10441089|P2|Overall Study|Withdrawal by Subject|0
3037114|NCT00698204|10441090|P1|Overall Study|Withdrawal by Subject|1
3037115|NCT00698009|10441150|P1|Overall Study|Withdrawal by Subject|1
3037116|NCT00697827|10441156|P2|Overall Study|enrolled but not treated|1
3037117|NCT00697827|10441157|P1|Overall Study|enrolled but not treated|2
3037118|NCT00697788|10441184|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037119|NCT00697788|10441185|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037120|NCT00697788|10441186|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037121|NCT00697788|10441187|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
3037122|NCT00697788|10441188|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037123|NCT00697788|10441189|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037124|NCT00697788|10441190|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037125|NCT00697788|10441191|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
3037126|NCT00697788|10441184|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037127|NCT00697788|10441185|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037128|NCT00697788|10441186|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037129|NCT00697788|10441187|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037130|NCT00697788|10441188|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037131|NCT00697788|10441189|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037132|NCT00697788|10441190|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
3037133|NCT00697788|10441191|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
3037134|NCT00697619|10441246|P2|Overall Study|Adverse Event|6
3037135|NCT00697619|10441247|P1|Overall Study|Adverse Event|4
3037136|NCT00697619|10441246|P2|Overall Study|Lack of Efficacy|2
3037137|NCT00697619|10441247|P1|Overall Study|Lack of Efficacy|2
3037138|NCT00697593|10441253|P1|Overall Study|Suspension of the study by sponsor|12
3037139|NCT00697593|10441253|P1|Overall Study|Lack of Efficacy|3
3037140|NCT00697593|10441253|P1|Overall Study|Protocol Violation|1
3037141|NCT00697593|10441253|P1|Overall Study|Adverse Event|3
3037142|NCT00697515|10441297|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
3037143|NCT00697515|10441298|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
3037144|NCT00697515|10441297|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
3037145|NCT00697515|10441298|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
3037146|NCT00697515|10441297|P2|First Intervention (Crossover Period)|Adverse Event|2
3037147|NCT00697515|10441298|P1|First Intervention (Crossover Period)|Adverse Event|0
3037148|NCT00697515|10441297|P2|First Intervention (Crossover Period)|Natural disaster|9
3037149|NCT00697515|10441298|P1|First Intervention (Crossover Period)|Natural disaster|8
3037150|NCT00697515|10441297|P2|Dose Optimization Period|elevated QTc|0
3037151|NCT00697515|10441298|P1|Dose Optimization Period|elevated QTc|1
3037152|NCT00697515|10441297|P2|Dose Optimization Period|called to active duty|0
3037153|NCT00697515|10441298|P1|Dose Optimization Period|called to active duty|1
3037154|NCT00697515|10441297|P2|Dose Optimization Period|sponsor request|0
3037155|NCT00697515|10441298|P1|Dose Optimization Period|sponsor request|2
3037156|NCT00697515|10441297|P2|Dose Optimization Period|Lost to Follow-up|0
3037157|NCT00697515|10441298|P1|Dose Optimization Period|Lost to Follow-up|2
3037158|NCT00697515|10441297|P2|Dose Optimization Period|Withdrawal by Subject|0
3037159|NCT00697515|10441298|P1|Dose Optimization Period|Withdrawal by Subject|5
3037160|NCT00697515|10441297|P2|Dose Optimization Period|Adverse Event|0
3037161|NCT00697515|10441298|P1|Dose Optimization Period|Adverse Event|4
3037162|NCT00697463|10441326|P1|Overall Study|Withdrawal by Subject|1
3037163|NCT00697346|10441333|P3|Overall Study|Reason not Specified|1
3037164|NCT00697346|10441334|P2|Overall Study|Reason not Specified|0
3037165|NCT00697346|10441335|P1|Overall Study|Reason not Specified|3
3037166|NCT00697346|10441333|P3|Overall Study|Withdrawal by Subject|0
3037167|NCT00697346|10441334|P2|Overall Study|Withdrawal by Subject|2
3037168|NCT00697346|10441335|P1|Overall Study|Withdrawal by Subject|2
3037169|NCT00697346|10441333|P3|Overall Study|Symptomatic Deterioration|0
3037170|NCT00697346|10441334|P2|Overall Study|Symptomatic Deterioration|1
3037171|NCT00697346|10441335|P1|Overall Study|Symptomatic Deterioration|0
3037172|NCT00697346|10441333|P3|Overall Study|Progressive Disease|0
3037173|NCT00697346|10441334|P2|Overall Study|Progressive Disease|18
3037174|NCT00697346|10441335|P1|Overall Study|Progressive Disease|19
3037175|NCT00697346|10441333|P3|Overall Study|Adverse Event|0
3037176|NCT00697346|10441334|P2|Overall Study|Adverse Event|5
3037177|NCT00697346|10441335|P1|Overall Study|Adverse Event|4
3037178|NCT00697255|10441443|P2|Stage 1b|Insufficient ovarian response|1
3037179|NCT00697255|10441444|P1|Stage 1b|Insufficient ovarian response|0
3037180|NCT00697255|10441443|P2|Stage 1b|Not growing of dominant follicle|1
3037181|NCT00697255|10441444|P1|Stage 1b|Not growing of dominant follicle|0
3037182|NCT00697255|10441443|P2|Stage 1a|Not growing of dominant follicle|0
3037183|NCT00697255|10441444|P1|Stage 1a|Not growing of dominant follicle|1
3037184|NCT00697255|10441443|P2|Stage 1a|Multifollicular growth|0
3037185|NCT00697255|10441444|P1|Stage 1a|Multifollicular growth|1
3037186|NCT00697255|10441443|P2|Stage 1a|Insufficient ovarian response|0
3037187|NCT00697255|10441444|P1|Stage 1a|Insufficient ovarian response|1
3037188|NCT00697112|10441532|P1|Overall Study|Did not meet inclusion criteria|1
3037189|NCT00697112|10441532|P1|Overall Study|Lost to Follow-up|1
3037190|NCT00697112|10441532|P1|Overall Study|Adverse Event|8
3037191|NCT00697073|10441556|P1|Overall Study|non compliance and other|6
3037192|NCT00697073|10441556|P1|Overall Study|Pregnancy|1
3037193|NCT00697073|10441556|P1|Overall Study|Withdrawal by Subject|2
3037194|NCT00696878|10441560|P1|Overall Study|Other reason (not specified)|55
3037195|NCT00696878|10441560|P1|Overall Study|Trial stopped|32
3037196|NCT00696878|10441560|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
3037197|NCT00696878|10441560|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
3037198|NCT00696878|10441560|P1|Overall Study|Withdrawal by Subject|87
3037199|NCT00696878|10441560|P1|Overall Study|Adverse Event|8
3037200|NCT00696800|10441634|P2|Overall Study|Not treated|2
3037201|NCT00696800|10441635|P1|Overall Study|Not treated|1
3037202|NCT00696800|10441634|P2|Overall Study|Other Reasons|3
3037203|NCT00696800|10441635|P1|Overall Study|Other Reasons|5
3037204|NCT00696800|10441634|P2|Overall Study|No/too few/bad quality embryos|18
3037205|NCT00696800|10441635|P1|Overall Study|No/too few/bad quality embryos|24
3037206|NCT00696800|10441634|P2|Overall Study|No/abnormal fertilization|13
3037207|NCT00696800|10441635|P1|Overall Study|No/abnormal fertilization|11
3037208|NCT00696800|10441634|P2|Overall Study|No/too few/bad quality oocytes|3
3037209|NCT00696800|10441635|P1|Overall Study|No/too few/bad quality oocytes|4
3037210|NCT00696800|10441634|P2|Overall Study|Too high ovarian response|1
3037211|NCT00696800|10441635|P1|Overall Study|Too high ovarian response|6
3037212|NCT00696800|10441634|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
3037213|NCT00696800|10441635|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
3037214|NCT00696800|10441634|P2|Overall Study|Insufficient ovarian response|1
3037215|NCT00696800|10441635|P1|Overall Study|Insufficient ovarian response|4
3037216|NCT00696800|10441634|P2|Overall Study|Insufficient ovarian response on Day 8|1
3037217|NCT00696800|10441635|P1|Overall Study|Insufficient ovarian response on Day 8|4
3037218|NCT00696800|10441634|P2|Overall Study|Insufficient compliance with medication|1
3037219|NCT00696800|10441635|P1|Overall Study|Insufficient compliance with medication|2
3037220|NCT00696800|10441634|P2|Overall Study|Adverse Event|3
3037221|NCT00696800|10441635|P1|Overall Study|Adverse Event|16
3037222|NCT00696787|10441688|P3|Overall Study|Failed to return|1
3037223|NCT00696787|10441689|P2|Overall Study|Failed to return|3
3037224|NCT00696787|10441690|P1|Overall Study|Failed to return|1
3037225|NCT00696787|10441688|P3|Overall Study|Withdrawal by Subject|2
3037226|NCT00696787|10441689|P2|Overall Study|Withdrawal by Subject|3
3037227|NCT00696787|10441690|P1|Overall Study|Withdrawal by Subject|0
3037228|NCT00696787|10441688|P3|Overall Study|Lost to Follow-up|3
3037229|NCT00696787|10441689|P2|Overall Study|Lost to Follow-up|0
3037230|NCT00696787|10441690|P1|Overall Study|Lost to Follow-up|4
3037231|NCT00696787|10441688|P3|Overall Study|Lack of Efficacy|0
3037232|NCT00696787|10441689|P2|Overall Study|Lack of Efficacy|1
3037233|NCT00696787|10441690|P1|Overall Study|Lack of Efficacy|0
3037234|NCT00696787|10441688|P3|Overall Study|Discontinuation by Sponsor|14
3037235|NCT00696787|10441689|P2|Overall Study|Discontinuation by Sponsor|13
3037236|NCT00696787|10441690|P1|Overall Study|Discontinuation by Sponsor|9
3037237|NCT00696787|10441688|P3|Overall Study|Adverse Event|6
3037238|NCT00696787|10441689|P2|Overall Study|Adverse Event|0
3037239|NCT00696787|10441690|P1|Overall Study|Adverse Event|1
3037240|NCT00696774|10441704|P3|Period III|Lack of Efficacy|0
3037241|NCT00696774|10441705|P2|Period III|Lack of Efficacy|2
3037242|NCT00696774|10441706|P1|Period III|Lack of Efficacy|0
3037243|NCT00696774|10441704|P3|Period III|Sponsor Decision|0
3037244|NCT00696774|10441705|P2|Period III|Sponsor Decision|0
3037245|NCT00696774|10441706|P1|Period III|Sponsor Decision|2
3037246|NCT00696774|10441704|P3|Period III|Withdrawal by Subject|0
3037247|NCT00696774|10441705|P2|Period III|Withdrawal by Subject|2
3037248|NCT00696774|10441706|P1|Period III|Withdrawal by Subject|1
3037249|NCT00696774|10441704|P3|Period III|Protocol Violation|0
3037250|NCT00696774|10441705|P2|Period III|Protocol Violation|1
3037251|NCT00696774|10441706|P1|Period III|Protocol Violation|1
3037252|NCT00696774|10441704|P3|Period III|Lost to Follow-up|0
3037253|NCT00696774|10441705|P2|Period III|Lost to Follow-up|1
3037254|NCT00696774|10441706|P1|Period III|Lost to Follow-up|2
3037255|NCT00696774|10441704|P3|Period III|Adverse Event|0
3037256|NCT00696774|10441705|P2|Period III|Adverse Event|1
3037257|NCT00696774|10441706|P1|Period III|Adverse Event|1
3037258|NCT00696774|10441704|P3|Period II|Lack of Efficacy|2
3037259|NCT00696774|10441705|P2|Period II|Lack of Efficacy|0
3037260|NCT00696774|10441706|P1|Period II|Lack of Efficacy|0
3037261|NCT00696774|10441704|P3|Period II|Sponsor Decision|0
3037262|NCT00696774|10441705|P2|Period II|Sponsor Decision|0
3037263|NCT00696774|10441706|P1|Period II|Sponsor Decision|0
3037264|NCT00696774|10441704|P3|Period II|Withdrawal by Subject|4
3037265|NCT00696774|10441705|P2|Period II|Withdrawal by Subject|0
3037266|NCT00696774|10441706|P1|Period II|Withdrawal by Subject|0
3037267|NCT00696774|10441704|P3|Period II|Protocol Violation|11
3037268|NCT00696774|10441705|P2|Period II|Protocol Violation|0
3037269|NCT00696774|10441706|P1|Period II|Protocol Violation|0
3037270|NCT00696774|10441704|P3|Period II|Lost to Follow-up|4
3037271|NCT00696774|10441705|P2|Period II|Lost to Follow-up|0
3037272|NCT00696774|10441706|P1|Period II|Lost to Follow-up|0
3037273|NCT00696774|10441704|P3|Period II|Adverse Event|15
3037274|NCT00696774|10441705|P2|Period II|Adverse Event|0
3037275|NCT00696774|10441706|P1|Period II|Adverse Event|0
3037276|NCT00696709|10441766|P5|Overall Study|Adverse Event|0
3037277|NCT00696709|10441767|P4|Overall Study|Adverse Event|1
3037278|NCT00696709|10441768|P3|Overall Study|Adverse Event|0
3037279|NCT00696709|10441769|P2|Overall Study|Adverse Event|0
3037280|NCT00696709|10441770|P1|Overall Study|Adverse Event|0
3037281|NCT00696709|10441766|P5|Overall Study|Lost to Follow-up|0
3037282|NCT00696709|10441767|P4|Overall Study|Lost to Follow-up|0
3037283|NCT00696709|10441768|P3|Overall Study|Lost to Follow-up|0
3037284|NCT00696709|10441769|P2|Overall Study|Lost to Follow-up|1
3037285|NCT00696709|10441770|P1|Overall Study|Lost to Follow-up|1
3037286|NCT00696709|10441766|P5|Overall Study|Protocol Violation|0
3037287|NCT00696709|10441767|P4|Overall Study|Protocol Violation|0
3037288|NCT00696709|10441768|P3|Overall Study|Protocol Violation|0
3037289|NCT00696709|10441769|P2|Overall Study|Protocol Violation|0
3037290|NCT00696709|10441770|P1|Overall Study|Protocol Violation|1
3037291|NCT00696709|10441766|P5|Overall Study|Withdrawal by Subject|3
3037292|NCT00696709|10441767|P4|Overall Study|Withdrawal by Subject|4
3037293|NCT00696709|10441768|P3|Overall Study|Withdrawal by Subject|1
3037294|NCT00696709|10441769|P2|Overall Study|Withdrawal by Subject|2
3037295|NCT00696709|10441770|P1|Overall Study|Withdrawal by Subject|1
3037296|NCT00696696|10441806|P1|Overall Study|Death|3
3037297|NCT00696696|10441806|P1|Overall Study|Physician Decision|2
3037298|NCT00696696|10441806|P1|Overall Study|Withdrawal by Subject|8
3037299|NCT00696696|10441806|P1|Overall Study|Adverse Event|5
3037300|NCT00696657|10441821|P9|Overall Study|Adverse Event|5
3037301|NCT00696657|10441822|P8|Overall Study|Adverse Event|2
3037302|NCT00696657|10441823|P7|Overall Study|Adverse Event|14
3037303|NCT00696657|10441824|P6|Overall Study|Adverse Event|9
3037304|NCT00696657|10441825|P5|Overall Study|Adverse Event|6
3037305|NCT00696657|10441826|P4|Overall Study|Adverse Event|7
3037306|NCT00696657|10441827|P3|Overall Study|Adverse Event|3
3037307|NCT00696657|10441828|P2|Overall Study|Adverse Event|0
3037308|NCT00696657|10441829|P1|Overall Study|Adverse Event|0
3037309|NCT00696657|10441821|P9|Overall Study|Unclassified|1
3037310|NCT00696657|10441822|P8|Overall Study|Unclassified|0
3037311|NCT00696657|10441823|P7|Overall Study|Unclassified|0
3037312|NCT00696657|10441824|P6|Overall Study|Unclassified|2
3037313|NCT00696657|10441825|P5|Overall Study|Unclassified|4
3037314|NCT00696657|10441826|P4|Overall Study|Unclassified|2
3037315|NCT00696657|10441827|P3|Overall Study|Unclassified|3
3037316|NCT00696657|10441828|P2|Overall Study|Unclassified|1
3037317|NCT00696657|10441829|P1|Overall Study|Unclassified|0
3037318|NCT00696657|10441821|P9|Overall Study|Withdrawal criteria|2
3037319|NCT00696657|10441822|P8|Overall Study|Withdrawal criteria|1
3037320|NCT00696657|10441823|P7|Overall Study|Withdrawal criteria|1
3037321|NCT00696657|10441824|P6|Overall Study|Withdrawal criteria|0
3037322|NCT00696657|10441825|P5|Overall Study|Withdrawal criteria|0
3037323|NCT00696657|10441826|P4|Overall Study|Withdrawal criteria|2
3037324|NCT00696657|10441827|P3|Overall Study|Withdrawal criteria|2
3037325|NCT00696657|10441828|P2|Overall Study|Withdrawal criteria|3
3037326|NCT00696657|10441829|P1|Overall Study|Withdrawal criteria|1
3037327|NCT00696657|10441821|P9|Overall Study|Lack of Efficacy|0
3037328|NCT00696657|10441822|P8|Overall Study|Lack of Efficacy|0
3037329|NCT00696657|10441823|P7|Overall Study|Lack of Efficacy|0
3037330|NCT00696657|10441824|P6|Overall Study|Lack of Efficacy|0
3037331|NCT00696657|10441825|P5|Overall Study|Lack of Efficacy|0
3037332|NCT00696657|10441826|P4|Overall Study|Lack of Efficacy|0
3037333|NCT00696657|10441827|P3|Overall Study|Lack of Efficacy|0
3037334|NCT00696657|10441828|P2|Overall Study|Lack of Efficacy|1
3037335|NCT00696657|10441829|P1|Overall Study|Lack of Efficacy|0
3037336|NCT00696657|10441821|P9|Overall Study|Protocol Violation|1
3037337|NCT00696657|10441822|P8|Overall Study|Protocol Violation|0
3037338|NCT00696657|10441823|P7|Overall Study|Protocol Violation|0
3037339|NCT00696657|10441824|P6|Overall Study|Protocol Violation|1
3037340|NCT00696657|10441825|P5|Overall Study|Protocol Violation|0
3037341|NCT00696657|10441826|P4|Overall Study|Protocol Violation|0
3037342|NCT00696657|10441827|P3|Overall Study|Protocol Violation|0
3037343|NCT00696657|10441828|P2|Overall Study|Protocol Violation|0
3037344|NCT00696657|10441829|P1|Overall Study|Protocol Violation|0
3037345|NCT00696436|10442198|P5|Overall Study|Missing|0
3037346|NCT00696436|10442199|P4|Overall Study|Missing|0
3037347|NCT00696436|10442200|P3|Overall Study|Missing|1
3037348|NCT00696436|10442201|P2|Overall Study|Missing|1
3037349|NCT00696436|10442202|P1|Overall Study|Missing|0
3037350|NCT00696436|10442198|P5|Overall Study|Administrative Decision|0
3037351|NCT00696436|10442199|P4|Overall Study|Administrative Decision|0
3037352|NCT00696436|10442200|P3|Overall Study|Administrative Decision|0
3037353|NCT00696436|10442201|P2|Overall Study|Administrative Decision|0
3037354|NCT00696436|10442202|P1|Overall Study|Administrative Decision|1
3037355|NCT00696436|10442198|P5|Overall Study|Participant Non-compliance|0
3037356|NCT00696436|10442199|P4|Overall Study|Participant Non-compliance|2
3037357|NCT00696436|10442200|P3|Overall Study|Participant Non-compliance|1
3037358|NCT00696436|10442201|P2|Overall Study|Participant Non-compliance|0
3037359|NCT00696436|10442202|P1|Overall Study|Participant Non-compliance|0
3037360|NCT00696436|10442198|P5|Overall Study|Administrative Error|0
3037361|NCT00696436|10442199|P4|Overall Study|Administrative Error|0
3037362|NCT00696436|10442200|P3|Overall Study|Administrative Error|2
3037363|NCT00696436|10442201|P2|Overall Study|Administrative Error|0
3037364|NCT00696436|10442202|P1|Overall Study|Administrative Error|2
3037365|NCT00696436|10442198|P5|Overall Study|Participant Unavailability|0
3037366|NCT00696436|10442199|P4|Overall Study|Participant Unavailability|1
3037367|NCT00696436|10442200|P3|Overall Study|Participant Unavailability|2
3037368|NCT00696436|10442201|P2|Overall Study|Participant Unavailability|0
3037369|NCT00696436|10442202|P1|Overall Study|Participant Unavailability|2
3037370|NCT00696436|10442198|P5|Overall Study|Lack of Efficacy|4
3037371|NCT00696436|10442199|P4|Overall Study|Lack of Efficacy|2
3037372|NCT00696436|10442200|P3|Overall Study|Lack of Efficacy|5
3037373|NCT00696436|10442201|P2|Overall Study|Lack of Efficacy|1
3037374|NCT00696436|10442202|P1|Overall Study|Lack of Efficacy|3
3037375|NCT00696436|10442198|P5|Overall Study|Withdrawal by Subject|1
3037376|NCT00696436|10442199|P4|Overall Study|Withdrawal by Subject|7
3037377|NCT00696436|10442200|P3|Overall Study|Withdrawal by Subject|5
3037378|NCT00696436|10442201|P2|Overall Study|Withdrawal by Subject|11
3037379|NCT00696436|10442202|P1|Overall Study|Withdrawal by Subject|4
3037380|NCT00696436|10442198|P5|Overall Study|Lost to Follow-up|3
3037381|NCT00696436|10442199|P4|Overall Study|Lost to Follow-up|4
3037382|NCT00696436|10442200|P3|Overall Study|Lost to Follow-up|2
3037383|NCT00696436|10442201|P2|Overall Study|Lost to Follow-up|6
3037384|NCT00696436|10442202|P1|Overall Study|Lost to Follow-up|1
3037385|NCT00696436|10442198|P5|Overall Study|Protocol Violation|1
3037386|NCT00696436|10442199|P4|Overall Study|Protocol Violation|0
3037387|NCT00696436|10442200|P3|Overall Study|Protocol Violation|2
3037388|NCT00696436|10442201|P2|Overall Study|Protocol Violation|2
3037389|NCT00696436|10442202|P1|Overall Study|Protocol Violation|3
3037390|NCT00696436|10442198|P5|Overall Study|Adverse Event|4
3037391|NCT00696436|10442199|P4|Overall Study|Adverse Event|6
3037392|NCT00696436|10442200|P3|Overall Study|Adverse Event|8
3037393|NCT00696436|10442201|P2|Overall Study|Adverse Event|9
3037394|NCT00696436|10442202|P1|Overall Study|Adverse Event|7
3037395|NCT00696423|10442286|P2|Overall Study|Lost to Follow-up|5
3037396|NCT00696423|10442287|P1|Overall Study|Lost to Follow-up|0
3037397|NCT00696410|10442319|P2|Overall Study|Physician Decision|0
3037398|NCT00696410|10442320|P1|Overall Study|Physician Decision|3
3037399|NCT00696410|10442319|P2|Overall Study|Withdrawal by Subject|0
3037400|NCT00696410|10442320|P1|Overall Study|Withdrawal by Subject|8
3037401|NCT00696410|10442319|P2|Overall Study|Lost to Follow-up|0
3037402|NCT00696410|10442320|P1|Overall Study|Lost to Follow-up|2
3037403|NCT00696384|10442334|P3|Double Blind Phase|Physician Decision|0
3037404|NCT00696384|10442335|P2|Double Blind Phase|Physician Decision|2
3037405|NCT00696384|10442336|P1|Double Blind Phase|Physician Decision|0
3037406|NCT00696384|10442334|P3|Double Blind Phase|Lack of Efficacy|0
3037407|NCT00696384|10442335|P2|Double Blind Phase|Lack of Efficacy|1
3037408|NCT00696384|10442336|P1|Double Blind Phase|Lack of Efficacy|0
3037409|NCT00696384|10442334|P3|Double Blind Phase|Withdrawal by Subject|3
3037410|NCT00696384|10442335|P2|Double Blind Phase|Withdrawal by Subject|4
3037411|NCT00696384|10442336|P1|Double Blind Phase|Withdrawal by Subject|0
3037412|NCT00696384|10442334|P3|Double Blind Phase|Lost to Follow-up|1
3037413|NCT00696384|10442335|P2|Double Blind Phase|Lost to Follow-up|2
3037414|NCT00696384|10442336|P1|Double Blind Phase|Lost to Follow-up|0
3037415|NCT00696384|10442334|P3|Double Blind Phase|Adverse Event|2
3037416|NCT00696384|10442335|P2|Double Blind Phase|Adverse Event|2
3037417|NCT00696384|10442336|P1|Double Blind Phase|Adverse Event|0
3037418|NCT00696384|10442334|P3|Open Label Phase|Physician Decision|0
3037419|NCT00696384|10442335|P2|Open Label Phase|Physician Decision|0
3037420|NCT00696384|10442336|P1|Open Label Phase|Physician Decision|4
3037421|NCT00696384|10442334|P3|Open Label Phase|Lack of Efficacy|0
3037422|NCT00696384|10442335|P2|Open Label Phase|Lack of Efficacy|0
3037423|NCT00696384|10442336|P1|Open Label Phase|Lack of Efficacy|3
3037424|NCT00696384|10442334|P3|Open Label Phase|Other|0
3037425|NCT00696384|10442335|P2|Open Label Phase|Other|0
3037426|NCT00696384|10442336|P1|Open Label Phase|Other|6
3037427|NCT00696384|10442334|P3|Open Label Phase|Withdrawal by Subject|0
3037428|NCT00696384|10442335|P2|Open Label Phase|Withdrawal by Subject|0
3037429|NCT00696384|10442336|P1|Open Label Phase|Withdrawal by Subject|37
3037430|NCT00696384|10442334|P3|Open Label Phase|Lost to Follow-up|0
3037431|NCT00696384|10442335|P2|Open Label Phase|Lost to Follow-up|0
3037432|NCT00696384|10442336|P1|Open Label Phase|Lost to Follow-up|24
3037433|NCT00696384|10442334|P3|Open Label Phase|Protocol Violation|0
3037434|NCT00696384|10442335|P2|Open Label Phase|Protocol Violation|0
3037435|NCT00696384|10442336|P1|Open Label Phase|Protocol Violation|18
3037436|NCT00696384|10442334|P3|Open Label Phase|Adverse Event|0
3037437|NCT00696384|10442335|P2|Open Label Phase|Adverse Event|0
3037438|NCT00696384|10442336|P1|Open Label Phase|Adverse Event|27
3037439|NCT00696241|10442360|P5|Overall Study|Other|1
3037440|NCT00696241|10442361|P4|Overall Study|Other|2
3037441|NCT00696241|10442362|P3|Overall Study|Other|5
3037442|NCT00696241|10442363|P2|Overall Study|Other|1
3037443|NCT00696241|10442364|P1|Overall Study|Other|6
3037444|NCT00696241|10442360|P5|Overall Study|Lack of Efficacy|3
3037445|NCT00696241|10442361|P4|Overall Study|Lack of Efficacy|5
3037446|NCT00696241|10442362|P3|Overall Study|Lack of Efficacy|4
3037447|NCT00696241|10442363|P2|Overall Study|Lack of Efficacy|5
3037448|NCT00696241|10442364|P1|Overall Study|Lack of Efficacy|1
3037449|NCT00696241|10442360|P5|Overall Study|Withdrawal by Subject|0
3037450|NCT00696241|10442361|P4|Overall Study|Withdrawal by Subject|1
3037451|NCT00696241|10442362|P3|Overall Study|Withdrawal by Subject|6
3037452|NCT00696241|10442363|P2|Overall Study|Withdrawal by Subject|8
3037453|NCT00696241|10442364|P1|Overall Study|Withdrawal by Subject|4
3037454|NCT00696241|10442360|P5|Overall Study|Lost to Follow-up|0
3037455|NCT00696241|10442361|P4|Overall Study|Lost to Follow-up|2
3037456|NCT00696241|10442362|P3|Overall Study|Lost to Follow-up|1
3037457|NCT00696241|10442363|P2|Overall Study|Lost to Follow-up|4
3037458|NCT00696241|10442364|P1|Overall Study|Lost to Follow-up|1
3037459|NCT00696241|10442360|P5|Overall Study|Protocol Violation|3
3037460|NCT00696241|10442361|P4|Overall Study|Protocol Violation|0
3037461|NCT00696241|10442362|P3|Overall Study|Protocol Violation|2
3037462|NCT00696241|10442363|P2|Overall Study|Protocol Violation|1
3037463|NCT00696241|10442364|P1|Overall Study|Protocol Violation|1
3037464|NCT00696241|10442360|P5|Overall Study|Adverse Event|5
3037465|NCT00696241|10442361|P4|Overall Study|Adverse Event|4
3037466|NCT00696241|10442362|P3|Overall Study|Adverse Event|6
3037467|NCT00696241|10442363|P2|Overall Study|Adverse Event|3
3037468|NCT00696241|10442364|P1|Overall Study|Adverse Event|11
3037469|NCT00696137|10442446|P1|Overall Study|Withdrawal by Subject|2
3037470|NCT00696072|10442452|P2|Overall Study|Non-specified|2
3037471|NCT00696072|10442453|P1|Overall Study|Non-specified|1
3037472|NCT00696072|10442452|P2|Overall Study|Disease Progression|30
3037473|NCT00696072|10442453|P1|Overall Study|Disease Progression|32
3037474|NCT00696072|10442452|P2|Overall Study|Sponsor Request|1
3037475|NCT00696072|10442453|P1|Overall Study|Sponsor Request|0
3037476|NCT00696072|10442452|P2|Overall Study|Investigator Request|4
3037477|NCT00696072|10442453|P1|Overall Study|Investigator Request|1
3037478|NCT00696072|10442452|P2|Overall Study|Patient Request|7
3037479|NCT00696072|10442453|P1|Overall Study|Patient Request|3
3037480|NCT00696072|10442452|P2|Overall Study|Adverse Event|6
3037481|NCT00696072|10442453|P1|Overall Study|Adverse Event|10
3037482|NCT00696072|10442452|P2|Overall Study|continuing active treatment|13
3037483|NCT00696072|10442453|P1|Overall Study|continuing active treatment|10
3037484|NCT00696020|10442474|P4|Overall Study|Other not stated above|1
3037485|NCT00696020|10442475|P3|Overall Study|Other not stated above|1
3037486|NCT00696020|10442476|P2|Overall Study|Other not stated above|0
3037487|NCT00696020|10442477|P1|Overall Study|Other not stated above|0
3037488|NCT00696020|10442474|P4|Overall Study|Withdrawal by Subject|1
3037489|NCT00696020|10442475|P3|Overall Study|Withdrawal by Subject|0
3037490|NCT00696020|10442476|P2|Overall Study|Withdrawal by Subject|1
3037491|NCT00696020|10442477|P1|Overall Study|Withdrawal by Subject|0
3037492|NCT00696020|10442474|P4|Overall Study|Protocol Violation|1
3037493|NCT00696020|10442475|P3|Overall Study|Protocol Violation|0
3037494|NCT00696020|10442476|P2|Overall Study|Protocol Violation|0
3037495|NCT00696020|10442477|P1|Overall Study|Protocol Violation|0
3037496|NCT00696020|10442474|P4|Overall Study|Lack of Efficacy|0
3037497|NCT00696020|10442475|P3|Overall Study|Lack of Efficacy|0
3037498|NCT00696020|10442476|P2|Overall Study|Lack of Efficacy|0
3037499|NCT00696020|10442477|P1|Overall Study|Lack of Efficacy|1
3037500|NCT00696020|10442474|P4|Overall Study|Adverse Event|1
3037501|NCT00696020|10442475|P3|Overall Study|Adverse Event|2
3037502|NCT00696020|10442476|P2|Overall Study|Adverse Event|1
3037503|NCT00696020|10442477|P1|Overall Study|Adverse Event|3
3037504|NCT00695955|10442585|P1|Cohort 2|Other|5
3037505|NCT00695955|10442585|P1|Cohort 2|Lack of Efficacy|4
3037506|NCT00695955|10442585|P1|Cohort 2|Withdrawal by Subject|28
3037507|NCT00695955|10442585|P1|Cohort 2|Lost to Follow-up|38
3037508|NCT00695955|10442585|P1|Cohort 2|Protocol Violation|5
3037509|NCT00695955|10442585|P1|Cohort 2|Adverse Event|24
3037510|NCT00695955|10442585|P1|Cohort 1|Other|16
3037511|NCT00695955|10442585|P1|Cohort 1|Lack of Efficacy|3
3037512|NCT00695955|10442585|P1|Cohort 1|Withdrawal by Subject|25
3037513|NCT00695955|10442585|P1|Cohort 1|Lost to Follow-up|30
3037514|NCT00695955|10442585|P1|Cohort 1|Protocol Violation|2
3037515|NCT00695955|10442585|P1|Cohort 1|Adverse Event|26
3037516|NCT00695903|10442597|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
3037517|NCT00695903|10442598|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
3037518|NCT00695903|10442597|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
3037519|NCT00695903|10442598|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
3037520|NCT00695903|10442597|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
3037521|NCT00695903|10442598|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
3037522|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
3037523|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
3037524|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
3037525|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
3037526|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
3037527|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
3037528|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
3037529|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
3037530|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
3037531|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
3037532|NCT00695903|10442597|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
3037533|NCT00695903|10442598|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
3037534|NCT00695864|10442610|P1|Placebo|Physician Decision|4
3037535|NCT00695864|10442610|P1|Placebo|Withdrawal by Subject|1
3037536|NCT00695669|10442620|P4|Overall Study|Lost to Follow-up|4
3037537|NCT00695669|10442621|P3|Overall Study|Lost to Follow-up|1
3037538|NCT00695669|10442622|P2|Overall Study|Lost to Follow-up|4
3037539|NCT00695669|10442623|P1|Overall Study|Lost to Follow-up|4
3037540|NCT00695669|10442620|P4|Overall Study|Adverse Event|0
3037541|NCT00695669|10442621|P3|Overall Study|Adverse Event|2
3037542|NCT00695669|10442622|P2|Overall Study|Adverse Event|0
3037543|NCT00695669|10442623|P1|Overall Study|Adverse Event|0
3037544|NCT00695565|10442708|P2|Overall Study|Subject did not follow instructions|1
3037545|NCT00695565|10442709|P1|Overall Study|Subject did not follow instructions|1
3037546|NCT00695565|10442708|P2|Overall Study|Lack of Efficacy|1
3037547|NCT00695565|10442709|P1|Overall Study|Lack of Efficacy|1
3037548|NCT00695565|10442708|P2|Overall Study|Withdrawal by Subject|1
3037549|NCT00695565|10442709|P1|Overall Study|Withdrawal by Subject|1
3037550|NCT00695565|10442708|P2|Overall Study|Protocol Violation|1
3037551|NCT00695565|10442709|P1|Overall Study|Protocol Violation|3
3037552|NCT00695565|10442708|P2|Overall Study|Adverse Event|1
3037553|NCT00695565|10442709|P1|Overall Study|Adverse Event|3
3037554|NCT00695565|10442708|P2|Overall Study|Lost to Follow-up|4
3037555|NCT00695565|10442709|P1|Overall Study|Lost to Follow-up|4
3037556|NCT00695396|10442782|P3|Overall Study|Withdrawal by Subject|0
3037557|NCT00695396|10442783|P2|Overall Study|Withdrawal by Subject|2
3037558|NCT00695396|10442784|P1|Overall Study|Withdrawal by Subject|2
3037559|NCT00695396|10442782|P3|Overall Study|Study Closed Prematurely|8
3037560|NCT00695396|10442783|P2|Overall Study|Study Closed Prematurely|6
3037561|NCT00695396|10442784|P1|Overall Study|Study Closed Prematurely|5
3037562|NCT00695318|10442800|P2|Overall Study|Study Terminated|0
3037563|NCT00695318|10442801|P1|Overall Study|Study Terminated|1
3037564|NCT00695318|10442800|P2|Overall Study|Death|1
3037565|NCT00695318|10442801|P1|Overall Study|Death|1
3037566|NCT00695318|10442800|P2|Overall Study|Withdrawal by Subject|0
3037567|NCT00695318|10442801|P1|Overall Study|Withdrawal by Subject|2
3037568|NCT00695318|10442800|P2|Overall Study|Lost to Follow-up|0
3037569|NCT00695318|10442801|P1|Overall Study|Lost to Follow-up|1
3037570|NCT00695136|10442826|P1|Overall Study|unrelated adverse event|1
3037571|NCT00695136|10442826|P1|Overall Study|Withdrawal by Subject|1
3037572|NCT00695019|10442842|P3|Overall Study|Various|4
3037573|NCT00695019|10442843|P2|Overall Study|Various|5
3037574|NCT00695019|10442844|P1|Overall Study|Various|4
3037575|NCT00695019|10442842|P3|Overall Study|Lack of Efficacy|1
3037576|NCT00695019|10442843|P2|Overall Study|Lack of Efficacy|0
3037577|NCT00695019|10442844|P1|Overall Study|Lack of Efficacy|0
3037578|NCT00695019|10442842|P3|Overall Study|Protocol Violation|1
3037579|NCT00695019|10442843|P2|Overall Study|Protocol Violation|3
3037580|NCT00695019|10442844|P1|Overall Study|Protocol Violation|1
3037581|NCT00695019|10442842|P3|Overall Study|Withdrawal by Subject|4
3037582|NCT00695019|10442843|P2|Overall Study|Withdrawal by Subject|6
3037583|NCT00695019|10442844|P1|Overall Study|Withdrawal by Subject|8
3037584|NCT00694707|10442878|P5|Overall Study|Notification of Past Head Injury|0
3037585|NCT00694707|10442879|P4|Overall Study|Notification of Past Head Injury|1
3037586|NCT00694707|10442880|P3|Overall Study|Notification of Past Head Injury|0
3037587|NCT00694707|10442881|P2|Overall Study|Notification of Past Head Injury|0
3037588|NCT00694707|10442882|P1|Overall Study|Notification of Past Head Injury|0
3037589|NCT00694707|10442878|P5|Overall Study|Administrative Reasons|0
3037590|NCT00694707|10442879|P4|Overall Study|Administrative Reasons|2
3037591|NCT00694707|10442880|P3|Overall Study|Administrative Reasons|0
3037592|NCT00694707|10442881|P2|Overall Study|Administrative Reasons|1
3037593|NCT00694707|10442882|P1|Overall Study|Administrative Reasons|0
3037594|NCT00694707|10442878|P5|Overall Study|Arrest by Police|0
3037595|NCT00694707|10442879|P4|Overall Study|Arrest by Police|0
3037596|NCT00694707|10442880|P3|Overall Study|Arrest by Police|0
3037597|NCT00694707|10442881|P2|Overall Study|Arrest by Police|1
3037598|NCT00694707|10442882|P1|Overall Study|Arrest by Police|0
3037599|NCT00694707|10442878|P5|Overall Study|Death in the Family|0
3037600|NCT00694707|10442879|P4|Overall Study|Death in the Family|0
3037601|NCT00694707|10442880|P3|Overall Study|Death in the Family|0
3037602|NCT00694707|10442881|P2|Overall Study|Death in the Family|0
3037603|NCT00694707|10442882|P1|Overall Study|Death in the Family|1
3037604|NCT00694707|10442878|P5|Overall Study|Jeopardizing Parole Status|0
3037605|NCT00694707|10442879|P4|Overall Study|Jeopardizing Parole Status|0
3037606|NCT00694707|10442880|P3|Overall Study|Jeopardizing Parole Status|0
3037607|NCT00694707|10442881|P2|Overall Study|Jeopardizing Parole Status|0
3037608|NCT00694707|10442882|P1|Overall Study|Jeopardizing Parole Status|1
3037609|NCT00694707|10442878|P5|Overall Study|Lost to Follow-up|0
3037610|NCT00694707|10442879|P4|Overall Study|Lost to Follow-up|0
3037611|NCT00694707|10442880|P3|Overall Study|Lost to Follow-up|2
3037612|NCT00694707|10442881|P2|Overall Study|Lost to Follow-up|1
3037613|NCT00694707|10442882|P1|Overall Study|Lost to Follow-up|0
3037614|NCT00694707|10442878|P5|Overall Study|Withdrawal of Consent|15
3037615|NCT00694707|10442879|P4|Overall Study|Withdrawal of Consent|16
3037616|NCT00694707|10442880|P3|Overall Study|Withdrawal of Consent|22
3037617|NCT00694707|10442881|P2|Overall Study|Withdrawal of Consent|18
3037618|NCT00694707|10442882|P1|Overall Study|Withdrawal of Consent|14
3037619|NCT00694707|10442878|P5|Overall Study|Protocol Violation|1
3037620|NCT00694707|10442879|P4|Overall Study|Protocol Violation|3
3037621|NCT00694707|10442880|P3|Overall Study|Protocol Violation|1
3037622|NCT00694707|10442881|P2|Overall Study|Protocol Violation|2
3037623|NCT00694707|10442882|P1|Overall Study|Protocol Violation|1
3037624|NCT00694707|10442878|P5|Overall Study|Insufficient Therapeutic Response|10
3037625|NCT00694707|10442879|P4|Overall Study|Insufficient Therapeutic Response|15
3037626|NCT00694707|10442880|P3|Overall Study|Insufficient Therapeutic Response|17
3037627|NCT00694707|10442881|P2|Overall Study|Insufficient Therapeutic Response|18
3037628|NCT00694707|10442882|P1|Overall Study|Insufficient Therapeutic Response|33
3037629|NCT00694707|10442878|P5|Overall Study|Adverse Event|13
3037630|NCT00694707|10442879|P4|Overall Study|Adverse Event|12
3037631|NCT00694707|10442880|P3|Overall Study|Adverse Event|8
3037632|NCT00694707|10442881|P2|Overall Study|Adverse Event|14
3037633|NCT00694707|10442882|P1|Overall Study|Adverse Event|22
3037634|NCT00694707|10442878|P5|Overall Study|Did Not Receive Treatment|1
3037635|NCT00694707|10442879|P4|Overall Study|Did Not Receive Treatment|1
3037636|NCT00694707|10442880|P3|Overall Study|Did Not Receive Treatment|1
3037637|NCT00694707|10442881|P2|Overall Study|Did Not Receive Treatment|0
3037638|NCT00694707|10442882|P1|Overall Study|Did Not Receive Treatment|0
3037639|NCT00694551|10442911|P3|Overall Study|Disease Progression|1
3037640|NCT00694551|10442912|P2|Overall Study|Disease Progression|0
3037641|NCT00694551|10442913|P1|Overall Study|Disease Progression|1
3037642|NCT00694369|10442942|P5|Overall Study|Withdrawal by Subject|2
3037643|NCT00694369|10442943|P4|Overall Study|Withdrawal by Subject|1
3037644|NCT00694369|10442944|P3|Overall Study|Withdrawal by Subject|1
3037645|NCT00694369|10442945|P2|Overall Study|Withdrawal by Subject|1
3037646|NCT00694369|10442946|P1|Overall Study|Withdrawal by Subject|1
3037647|NCT00694369|10442942|P5|Overall Study|Protocol Violation|0
3037648|NCT00694369|10442943|P4|Overall Study|Protocol Violation|0
3037649|NCT00694369|10442944|P3|Overall Study|Protocol Violation|0
3037650|NCT00694369|10442945|P2|Overall Study|Protocol Violation|1
3037651|NCT00694369|10442946|P1|Overall Study|Protocol Violation|0
3037652|NCT00694369|10442942|P5|Overall Study|Physician Decision|1
3037653|NCT00694369|10442943|P4|Overall Study|Physician Decision|0
3037654|NCT00694369|10442944|P3|Overall Study|Physician Decision|0
3037655|NCT00694369|10442945|P2|Overall Study|Physician Decision|0
3037656|NCT00694369|10442946|P1|Overall Study|Physician Decision|0
3037657|NCT00694369|10442942|P5|Overall Study|Lost to Follow-up|0
3037658|NCT00694369|10442943|P4|Overall Study|Lost to Follow-up|1
3037659|NCT00694369|10442944|P3|Overall Study|Lost to Follow-up|1
3037660|NCT00694369|10442945|P2|Overall Study|Lost to Follow-up|0
3037661|NCT00694369|10442946|P1|Overall Study|Lost to Follow-up|0
3037662|NCT00694369|10442942|P5|Overall Study|Adverse Event|3
3037663|NCT00694369|10442943|P4|Overall Study|Adverse Event|1
3037664|NCT00694369|10442944|P3|Overall Study|Adverse Event|0
3037665|NCT00694369|10442945|P2|Overall Study|Adverse Event|1
3037666|NCT00694369|10442946|P1|Overall Study|Adverse Event|0
3037667|NCT00694356|10442966|P3|Overall Study|Progressive Disease|6
3037668|NCT00694356|10442967|P2|Overall Study|Progressive Disease|6
3037669|NCT00694356|10442968|P1|Overall Study|Progressive Disease|2
3037670|NCT00694356|10442966|P3|Overall Study|Adverse Event|0
3037671|NCT00694356|10442967|P2|Overall Study|Adverse Event|0
3037672|NCT00694356|10442968|P1|Overall Study|Adverse Event|1
3037673|NCT00694304|10443003|P1|Overall Study|Administrative or Other Reasons|32
3037674|NCT00694304|10443003|P1|Overall Study|Lost to Follow-up|15
3037675|NCT00694304|10443003|P1|Overall Study|Withdrawal of Consent|61
3037676|NCT00694304|10443003|P1|Overall Study|Protocol Violation|6
3037677|NCT00694304|10443003|P1|Overall Study|Non-compliance With Study Product|16
3037678|NCT00694304|10443003|P1|Overall Study|Lack of Efficacy|35
3037679|NCT00694304|10443003|P1|Overall Study|Adverse Event|42
3037680|NCT00694161|10443016|P1|Part 2 (After Week 6 up to Month 12)|Death|1
3037681|NCT00694161|10443016|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
3037682|NCT00694161|10443016|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
3037683|NCT00694122|10443055|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
3037684|NCT00694122|10443056|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
3037685|NCT00694122|10443055|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
3037686|NCT00694122|10443056|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
3037687|NCT00694122|10443055|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
3037688|NCT00694122|10443056|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
3037689|NCT00694109|10443072|P1|Overall Study|Consented but no additional treatment|3
3037690|NCT00694109|10443072|P1|Overall Study|Other|2
3037691|NCT00694109|10443072|P1|Overall Study|Enrolled but not treated|1
3037692|NCT00694109|10443072|P1|Overall Study|Pregnancy|1
3037693|NCT00694109|10443072|P1|Overall Study|Withdrawal by Subject|13
3037694|NCT00694109|10443072|P1|Overall Study|Lack of Efficacy|2
3037695|NCT00694109|10443072|P1|Overall Study|Not consent of more 2 years of treatment|18
3037696|NCT00694109|10443072|P1|Overall Study|Adverse Event|74
3037697|NCT00694109|10443072|P1|Overall Study|Physician Decision|3
3037698|NCT00694096|10443096|P1|Overall Study|Withdrawal by Subject|5
3037699|NCT00693784|10443136|P1|Overall Study|Withdrawal by Subject|2
3037700|NCT00693784|10443136|P1|Overall Study|Lost to Follow-up|2
3037701|NCT00693706|10443149|P2|Overall Study|Protocol Violation|1
3037702|NCT00693706|10443150|P1|Overall Study|Protocol Violation|0
3037703|NCT00693693|10443177|P3|Overall Study|Lost to Follow-up|2
3037704|NCT00693693|10443178|P2|Overall Study|Lost to Follow-up|1
3037705|NCT00693693|10443179|P1|Overall Study|Lost to Follow-up|1
3037706|NCT00693472|10443238|P4|Part 2|Withdrew - reason unrelated to treatment|2
3037707|NCT00693472|10443239|P3|Part 2|Withdrew - reason unrelated to treatment|1
3037708|NCT00693472|10443240|P2|Part 2|Withdrew - reason unrelated to treatment|0
3037709|NCT00693472|10443241|P1|Part 2|Withdrew - reason unrelated to treatment|0
3037710|NCT00693472|10443238|P4|Part 2|Adverse Event|0
3037711|NCT00693472|10443239|P3|Part 2|Adverse Event|1
3037712|NCT00693472|10443240|P2|Part 2|Adverse Event|0
3037713|NCT00693472|10443241|P1|Part 2|Adverse Event|0
3037714|NCT00693472|10443238|P4|Part 1|Withdrew - reason unrelated to treatment|0
3037715|NCT00693472|10443239|P3|Part 1|Withdrew - reason unrelated to treatment|0
3037716|NCT00693472|10443240|P2|Part 1|Withdrew - reason unrelated to treatment|2
3037717|NCT00693472|10443241|P1|Part 1|Withdrew - reason unrelated to treatment|5
3037718|NCT00693472|10443238|P4|Part 1|Lost to Follow-up|0
3037719|NCT00693472|10443239|P3|Part 1|Lost to Follow-up|0
3037720|NCT00693472|10443240|P2|Part 1|Lost to Follow-up|1
3037721|NCT00693472|10443241|P1|Part 1|Lost to Follow-up|0
3037722|NCT00693472|10443238|P4|Part 1|Adverse Event|0
3037723|NCT00693472|10443239|P3|Part 1|Adverse Event|0
3037724|NCT00693472|10443240|P2|Part 1|Adverse Event|1
3037725|NCT00693472|10443241|P1|Part 1|Adverse Event|1
3037726|NCT00693420|10443261|P2|Overall Study|Personal Reasons|4
3037727|NCT00693420|10443262|P1|Overall Study|Personal Reasons|1
3037728|NCT00693420|10443261|P2|Overall Study|Sponsor Request - Conflict of Interest|2
3037729|NCT00693420|10443262|P1|Overall Study|Sponsor Request - Conflict of Interest|0
3037730|NCT00693420|10443261|P2|Overall Study|Protocol Violation|2
3037731|NCT00693420|10443262|P1|Overall Study|Protocol Violation|0
3037732|NCT00693420|10443261|P2|Overall Study|Withdrawal by Subject|0
3037733|NCT00693420|10443262|P1|Overall Study|Withdrawal by Subject|1
3037734|NCT00693420|10443261|P2|Overall Study|Lost to Follow-up|3
3037735|NCT00693420|10443262|P1|Overall Study|Lost to Follow-up|0
3037736|NCT00693420|10443261|P2|Overall Study|Adverse Event|4
3037737|NCT00693420|10443262|P1|Overall Study|Adverse Event|4
3037738|NCT00693225|10443301|P2|Overall Study|Adverse Event|3
3037739|NCT00693225|10443302|P1|Overall Study|Adverse Event|1
3037740|NCT00693225|10443301|P2|Overall Study|Lost to Follow-up|2
3037741|NCT00693225|10443302|P1|Overall Study|Lost to Follow-up|1
3037742|NCT00693017|10443325|P2|Overall Study|Death|1
3037743|NCT00693017|10443326|P1|Overall Study|Death|0
3037744|NCT00693017|10443325|P2|Overall Study|Sponsor Decision|1
3037745|NCT00693017|10443326|P1|Overall Study|Sponsor Decision|2
3037746|NCT00692913|10443336|P2|Overall Study|Withdrawal by Subject|20
3037747|NCT00692913|10443337|P1|Overall Study|Withdrawal by Subject|15
3037748|NCT00692913|10443336|P2|Overall Study|Protocol Violation|1
3037749|NCT00692913|10443337|P1|Overall Study|Protocol Violation|1
3037750|NCT00692913|10443336|P2|Overall Study|Physician Decision|0
3037751|NCT00692913|10443337|P1|Overall Study|Physician Decision|2
3037752|NCT00692913|10443336|P2|Overall Study|Lost to Follow-up|5
3037753|NCT00692913|10443337|P1|Overall Study|Lost to Follow-up|3
3037754|NCT00692913|10443336|P2|Overall Study|Adverse Event|4
3037755|NCT00692913|10443337|P1|Overall Study|Adverse Event|8
3037756|NCT00692770|10443359|P2|Overall Study|Randomized but not treated|4
3037757|NCT00692770|10443360|P1|Overall Study|Randomized but not treated|3
3037758|NCT00692770|10443359|P2|Overall Study|Study terminated by sponsor|2
3037759|NCT00692770|10443360|P1|Overall Study|Study terminated by sponsor|2
3037760|NCT00692770|10443359|P2|Overall Study|Clinical endpoint reached|43
3037761|NCT00692770|10443360|P1|Overall Study|Clinical endpoint reached|16
3037762|NCT00692770|10443359|P2|Overall Study|Radiological and clinical progression|8
3037763|NCT00692770|10443360|P1|Overall Study|Radiological and clinical progression|8
3037764|NCT00692770|10443359|P2|Overall Study|Completed all planned assessments|101
3037765|NCT00692770|10443360|P1|Overall Study|Completed all planned assessments|79
3037766|NCT00692770|10443359|P2|Overall Study|Protocol driven decision point|7
3037767|NCT00692770|10443360|P1|Overall Study|Protocol driven decision point|3
3037768|NCT00692770|10443359|P2|Overall Study|Disease progression, recurrence/relapse|279
3037769|NCT00692770|10443360|P1|Overall Study|Disease progression, recurrence/relapse|170
3037770|NCT00692770|10443359|P2|Overall Study|Physician decision not protocol driven|14
3037771|NCT00692770|10443360|P1|Overall Study|Physician decision not protocol driven|10
3037772|NCT00692770|10443359|P2|Overall Study|Progression by clinical judgment|3
3037773|NCT00692770|10443360|P1|Overall Study|Progression by clinical judgment|2
3037774|NCT00692770|10443359|P2|Overall Study|Non-compliant with study medication|5
3037775|NCT00692770|10443360|P1|Overall Study|Non-compliant with study medication|11
3037776|NCT00692770|10443359|P2|Overall Study|Lost to Follow-up|3
3037777|NCT00692770|10443360|P1|Overall Study|Lost to Follow-up|7
3037778|NCT00692770|10443359|P2|Overall Study|Death|5
3037779|NCT00692770|10443360|P1|Overall Study|Death|10
3037780|NCT00692770|10443359|P2|Overall Study|Adverse Event|41
3037781|NCT00692770|10443360|P1|Overall Study|Adverse Event|136
3037782|NCT00692770|10443359|P2|Overall Study|Withdrawal by Subject|36
3037783|NCT00692770|10443360|P1|Overall Study|Withdrawal by Subject|97
3037784|NCT00692770|10443359|P2|Overall Study|Protocol Violation|7
3037785|NCT00692770|10443360|P1|Overall Study|Protocol Violation|2
3037786|NCT00692406|10443406|P1|Overall Study|PI dropped, bad data|57
3037787|NCT00692237|10443468|P2|Overall Study|Adverse Event|1
3037788|NCT00692237|10443469|P1|Overall Study|Adverse Event|0
3037789|NCT00692237|10443468|P2|Overall Study|Withdrawal by Subject|3
3037790|NCT00692237|10443469|P1|Overall Study|Withdrawal by Subject|1
3037791|NCT00692003|10443556|P2|Overall Study|Sponsor Decision|1
3037792|NCT00692003|10443557|P1|Overall Study|Sponsor Decision|5
3037793|NCT00691938|10443572|P7|Overall Study|QTc prolongation|0
3037794|NCT00691938|10443573|P6|Overall Study|QTc prolongation|0
3037795|NCT00691938|10443574|P5|Overall Study|QTc prolongation|0
3037796|NCT00691938|10443575|P4|Overall Study|QTc prolongation|0
3037797|NCT00691938|10443576|P3|Overall Study|QTc prolongation|0
3037798|NCT00691938|10443577|P2|Overall Study|QTc prolongation|0
3037799|NCT00691938|10443578|P1|Overall Study|QTc prolongation|1
3037800|NCT00691704|10443645|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
3037801|NCT00691704|10443645|P1|Two Years of Maintenance Therapy|Physician Decision|4
3037802|NCT00691704|10443645|P1|Two Years of Maintenance Therapy|Disease Progression|8
3037803|NCT00691704|10443645|P1|Induction Therapy|Active Hepatitis|1
3037804|NCT00691704|10443645|P1|Induction Therapy|Disease Progression|1
3037805|NCT00691483|10443693|P2|Overall Study|Randomized by not treated|1
3037806|NCT00691483|10443694|P1|Overall Study|Randomized by not treated|7
3037807|NCT00691483|10443693|P2|Overall Study|Other known cause|1
3037808|NCT00691483|10443694|P1|Overall Study|Other known cause|6
3037809|NCT00691483|10443693|P2|Overall Study|Withdrawal by Subject|7
3037810|NCT00691483|10443694|P1|Overall Study|Withdrawal by Subject|24
3037811|NCT00691483|10443693|P2|Overall Study|Lost to Follow-up|10
3037812|NCT00691483|10443694|P1|Overall Study|Lost to Follow-up|17
3037813|NCT00691483|10443693|P2|Overall Study|Adverse Event|6
3037814|NCT00691483|10443694|P1|Overall Study|Adverse Event|14
3037815|NCT00691301|10443737|P1|Overall Study|Did not initiate study treatment|1
3037816|NCT00691301|10443737|P1|Overall Study|other reason|3
3037817|NCT00691301|10443737|P1|Overall Study|Concurrent illness|2
3037818|NCT00691301|10443737|P1|Overall Study|Withdrawal by Subject|4
3037819|NCT00691301|10443737|P1|Overall Study|Lack of Efficacy|32
3037820|NCT00691301|10443737|P1|Overall Study|Death|2
3037821|NCT00691301|10443737|P1|Overall Study|Adverse Event|10
3037822|NCT00691210|10443757|P8|Overall Study|Lack of Efficacy|0
3037823|NCT00691210|10443758|P7|Overall Study|Lack of Efficacy|0
3037824|NCT00691210|10443759|P6|Overall Study|Lack of Efficacy|1
3037825|NCT00691210|10443760|P5|Overall Study|Lack of Efficacy|0
3037826|NCT00691210|10443761|P4|Overall Study|Lack of Efficacy|1
3037827|NCT00691210|10443762|P3|Overall Study|Lack of Efficacy|0
3037828|NCT00691210|10443763|P2|Overall Study|Lack of Efficacy|0
3037829|NCT00691210|10443764|P1|Overall Study|Lack of Efficacy|0
3037830|NCT00691210|10443757|P8|Overall Study|Progression of Disease|0
3037831|NCT00691210|10443758|P7|Overall Study|Progression of Disease|0
3037832|NCT00691210|10443759|P6|Overall Study|Progression of Disease|0
3037833|NCT00691210|10443760|P5|Overall Study|Progression of Disease|0
3037834|NCT00691210|10443761|P4|Overall Study|Progression of Disease|2
3037835|NCT00691210|10443762|P3|Overall Study|Progression of Disease|0
3037836|NCT00691210|10443763|P2|Overall Study|Progression of Disease|0
3037837|NCT00691210|10443764|P1|Overall Study|Progression of Disease|0
3037838|NCT00691132|10443799|P2|Overall Study|Withdrawal by Subject|10
3037839|NCT00691132|10443800|P1|Overall Study|Withdrawal by Subject|10
3037840|NCT00691132|10443799|P2|Overall Study|Adverse Event|3
3037841|NCT00691132|10443800|P1|Overall Study|Adverse Event|2
3037842|NCT00691093|10443819|P1|Overall Study|Ongoing at Date of Cut-Off|4
3037843|NCT00691093|10443819|P1|Overall Study|Lack of Efficacy|1
3037844|NCT00691093|10443819|P1|Overall Study|Lost to Follow-up|1
3037845|NCT00691093|10443819|P1|Overall Study|Adverse Event|1
3037846|NCT00691054|10443853|P1|Overall Study|Withdrawal by Subject|1
3037847|NCT00691028|10443865|P4|Double-blind Period|not come to a hospital.|0
3037848|NCT00691028|10443866|P3|Double-blind Period|not come to a hospital.|0
3037849|NCT00691028|10443867|P2|Double-blind Period|not come to a hospital.|1
3037850|NCT00691028|10443868|P1|Double-blind Period|not come to a hospital.|0
3037851|NCT00691028|10443865|P4|Double-blind Period|Withdrawal by Subject|0
3037852|NCT00691028|10443866|P3|Double-blind Period|Withdrawal by Subject|1
3037853|NCT00691028|10443867|P2|Double-blind Period|Withdrawal by Subject|0
3037854|NCT00691028|10443868|P1|Double-blind Period|Withdrawal by Subject|1
3037855|NCT00691028|10443865|P4|Double-blind Period|Lack of Efficacy|0
3037856|NCT00691028|10443866|P3|Double-blind Period|Lack of Efficacy|2
3037857|NCT00691028|10443867|P2|Double-blind Period|Lack of Efficacy|3
3037858|NCT00691028|10443868|P1|Double-blind Period|Lack of Efficacy|4
3037859|NCT00691028|10443865|P4|Double-blind Period|Adverse Event|0
3037860|NCT00691028|10443866|P3|Double-blind Period|Adverse Event|6
3037861|NCT00691028|10443867|P2|Double-blind Period|Adverse Event|9
3037862|NCT00691028|10443868|P1|Double-blind Period|Adverse Event|8
3037863|NCT00691028|10443865|P4|Open-label Period|not come to a hospital|1
3037864|NCT00691028|10443866|P3|Open-label Period|not come to a hospital|0
3037865|NCT00691028|10443867|P2|Open-label Period|not come to a hospital|0
3037866|NCT00691028|10443868|P1|Open-label Period|not come to a hospital|0
3037867|NCT00691028|10443865|P4|Open-label Period|Withdrawal by Subject|3
3037868|NCT00691028|10443866|P3|Open-label Period|Withdrawal by Subject|0
3037869|NCT00691028|10443867|P2|Open-label Period|Withdrawal by Subject|0
3037870|NCT00691028|10443868|P1|Open-label Period|Withdrawal by Subject|0
3037871|NCT00691028|10443865|P4|Open-label Period|Adverse Event|16
3037872|NCT00691028|10443866|P3|Open-label Period|Adverse Event|0
3037873|NCT00691028|10443867|P2|Open-label Period|Adverse Event|0
3037874|NCT00691028|10443868|P1|Open-label Period|Adverse Event|0
3037875|NCT00691015|10443901|P1|Overall Study|Refused further treatment|1
3037876|NCT00690898|10443916|P1|TREATMENT|Other (not otherwise specified)|1
3037877|NCT00690898|10443916|P1|TREATMENT|Withdrawal by Subject|4
3037878|NCT00690898|10443916|P1|TREATMENT|Lack of Efficacy|18
3037879|NCT00690898|10443916|P1|TREATMENT|Adverse Event|3
3037880|NCT00690898|10443916|P1|SCREENING|Screen failure|18
3037881|NCT00690820|10443936|P2|Period 1|Withdrawal by Subject|1
3037882|NCT00690820|10443937|P1|Period 1|Withdrawal by Subject|0
3037883|NCT00690794|10443959|P2|Overall Study|Other not specified|3
3037884|NCT00690794|10443960|P1|Overall Study|Other not specified|1
3037885|NCT00690794|10443959|P2|Overall Study|Noncompliance|2
3037886|NCT00690794|10443960|P1|Overall Study|Noncompliance|1
3037887|NCT00690794|10443959|P2|Overall Study|Protocol Violation|7
3037888|NCT00690794|10443960|P1|Overall Study|Protocol Violation|6
3037889|NCT00690794|10443959|P2|Overall Study|Withdrawal by Subject|9
3037890|NCT00690794|10443960|P1|Overall Study|Withdrawal by Subject|0
3037891|NCT00690794|10443959|P2|Overall Study|Lost to Follow-up|4
3037892|NCT00690794|10443960|P1|Overall Study|Lost to Follow-up|1
3037893|NCT00690794|10443959|P2|Overall Study|Adverse Event|10
3037894|NCT00690794|10443960|P1|Overall Study|Adverse Event|12
3037895|NCT00690755|10443975|P7|Overall Study|Physician Decision|0
3037896|NCT00690755|10443976|P6|Overall Study|Physician Decision|4
3037897|NCT00690755|10443977|P5|Overall Study|Physician Decision|0
3037898|NCT00690755|10443978|P4|Overall Study|Physician Decision|5
3037899|NCT00690755|10443979|P3|Overall Study|Physician Decision|46
3037900|NCT00690755|10443980|P2|Overall Study|Physician Decision|0
3037901|NCT00690755|10443981|P1|Overall Study|Physician Decision|2
3037902|NCT00690612|10443997|P1|Overall Study|Withdrawal by Subject|2
3037903|NCT00690612|10443997|P1|Overall Study|Adverse Event|1
3037904|NCT00690573|10444002|P1|Overall Study|Withdrawal by Subject|1
3037905|NCT00690573|10444002|P1|Overall Study|Lack of Efficacy|8
3037906|NCT00690482|10444021|P2|Overall Study|withdrew consent at rand.day|1
3037907|NCT00690482|10444022|P1|Overall Study|withdrew consent at rand.day|0
3037908|NCT00690482|10444021|P2|Overall Study|Intake of prohibited medicine|0
3037909|NCT00690482|10444022|P1|Overall Study|Intake of prohibited medicine|1
3037910|NCT00690482|10444021|P2|Overall Study|Study-specific discontinuation criteria|0
3037911|NCT00690482|10444022|P1|Overall Study|Study-specific discontinuation criteria|1
3037912|NCT00690482|10444021|P2|Overall Study|Incorrect enrolment|1
3037913|NCT00690482|10444022|P1|Overall Study|Incorrect enrolment|0
3037914|NCT00690482|10444021|P2|Overall Study|Adverse Event|1
3037915|NCT00690482|10444022|P1|Overall Study|Adverse Event|2
3037916|NCT00690443|10444056|P2|Overall Study|Adverse Event|2
3037917|NCT00690443|10444057|P1|Overall Study|Adverse Event|1
3037918|NCT00690430|10444067|P3|Extension Phase|Early Termination|3
3037919|NCT00690430|10444068|P2|Extension Phase|Early Termination|1
3037920|NCT00690430|10444069|P1|Extension Phase|Early Termination|10
3037921|NCT00690430|10444067|P3|Extension Phase|Withdrawal by Subject|2
3037922|NCT00690430|10444068|P2|Extension Phase|Withdrawal by Subject|0
3037923|NCT00690430|10444069|P1|Extension Phase|Withdrawal by Subject|0
3037924|NCT00690430|10444067|P3|Extension Phase|Death|1
3037925|NCT00690430|10444068|P2|Extension Phase|Death|1
3037926|NCT00690430|10444069|P1|Extension Phase|Death|1
3037927|NCT00690430|10444067|P3|Extension Phase|Adverse Event|2
3037928|NCT00690430|10444068|P2|Extension Phase|Adverse Event|1
3037929|NCT00690430|10444069|P1|Extension Phase|Adverse Event|2
3037930|NCT00690430|10444067|P3|Extension Phase|Administrative Problems|1
3037931|NCT00690430|10444068|P2|Extension Phase|Administrative Problems|1
3037932|NCT00690430|10444069|P1|Extension Phase|Administrative Problems|0
3037933|NCT00690430|10444067|P3|Extension Phase|Abnormal test procedure results|0
3037934|NCT00690430|10444068|P2|Extension Phase|Abnormal test procedure results|0
3037935|NCT00690430|10444069|P1|Extension Phase|Abnormal test procedure results|1
3037936|NCT00690430|10444067|P3|Extension Phase|Abnormal Lab Values|0
3037937|NCT00690430|10444068|P2|Extension Phase|Abnormal Lab Values|0
3037938|NCT00690430|10444069|P1|Extension Phase|Abnormal Lab Values|1
3037939|NCT00690430|10444067|P3|Extension Phase|Lack of Efficacy|4
3037940|NCT00690430|10444068|P2|Extension Phase|Lack of Efficacy|1
3037941|NCT00690430|10444069|P1|Extension Phase|Lack of Efficacy|3
3037942|NCT00690430|10444067|P3|Core Phase|Early Termination|0
3037943|NCT00690430|10444068|P2|Core Phase|Early Termination|5
3037944|NCT00690430|10444069|P1|Core Phase|Early Termination|0
3037945|NCT00690430|10444067|P3|Core Phase|Administrative Problems|0
3037946|NCT00690430|10444068|P2|Core Phase|Administrative Problems|1
3037947|NCT00690430|10444069|P1|Core Phase|Administrative Problems|0
3037948|NCT00690430|10444067|P3|Core Phase|Lack of Efficacy|0
3037949|NCT00690430|10444068|P2|Core Phase|Lack of Efficacy|10
3037950|NCT00690430|10444069|P1|Core Phase|Lack of Efficacy|8
3037951|NCT00690430|10444067|P3|Core Phase|Subject no longer requires study drug|0
3037952|NCT00690430|10444068|P2|Core Phase|Subject no longer requires study drug|0
3037953|NCT00690430|10444069|P1|Core Phase|Subject no longer requires study drug|1
3037954|NCT00690430|10444067|P3|Core Phase|Withdrawal by Subject|0
3037955|NCT00690430|10444068|P2|Core Phase|Withdrawal by Subject|3
3037956|NCT00690430|10444069|P1|Core Phase|Withdrawal by Subject|3
3037957|NCT00690430|10444067|P3|Core Phase|Protocol Violation|0
3037958|NCT00690430|10444068|P2|Core Phase|Protocol Violation|0
3037959|NCT00690430|10444069|P1|Core Phase|Protocol Violation|1
3037960|NCT00690430|10444067|P3|Core Phase|Death|0
3037961|NCT00690430|10444068|P2|Core Phase|Death|2
3037962|NCT00690430|10444069|P1|Core Phase|Death|0
3037963|NCT00690430|10444067|P3|Core Phase|Adverse Event|0
3037964|NCT00690430|10444068|P2|Core Phase|Adverse Event|1
3037965|NCT00690430|10444069|P1|Core Phase|Adverse Event|5
3037966|NCT00690430|10444067|P3|Core Phase|Abnormal Laboratory value|0
3037967|NCT00690430|10444068|P2|Core Phase|Abnormal Laboratory value|1
3037968|NCT00690430|10444069|P1|Core Phase|Abnormal Laboratory value|0
3037969|NCT00690378|10444098|P2|Overall Study|Social problem|0
3037970|NCT00690378|10444099|P1|Overall Study|Social problem|1
3037971|NCT00690378|10444098|P2|Overall Study|Did not meet inc/exc criteria|11
3037972|NCT00690378|10444099|P1|Overall Study|Did not meet inc/exc criteria|13
3037973|NCT00690378|10444098|P2|Overall Study|Lost to Follow-up|3
3037974|NCT00690378|10444099|P1|Overall Study|Lost to Follow-up|2
3037975|NCT00690378|10444098|P2|Overall Study|Protocol Violation|0
3037976|NCT00690378|10444099|P1|Overall Study|Protocol Violation|1
3037977|NCT00690378|10444098|P2|Overall Study|Withdrawal by Subject|0
3037978|NCT00690378|10444099|P1|Overall Study|Withdrawal by Subject|2
3037979|NCT00690378|10444098|P2|Overall Study|Adverse Event|0
3037980|NCT00690378|10444099|P1|Overall Study|Adverse Event|1
3037981|NCT00689936|10444196|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
3037982|NCT00689936|10444197|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
3037983|NCT00689936|10444198|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
3037984|NCT00689936|10444196|P3|Active Treatment Phase|Miscellaneous|47
3037985|NCT00689936|10444197|P2|Active Treatment Phase|Miscellaneous|34
3037986|NCT00689936|10444198|P1|Active Treatment Phase|Miscellaneous|52
3037987|NCT00689936|10444196|P3|Active Treatment Phase|Study Close Out|21
3037988|NCT00689936|10444197|P2|Active Treatment Phase|Study Close Out|26
3037989|NCT00689936|10444198|P1|Active Treatment Phase|Study Close Out|64
3037990|NCT00689936|10444196|P3|Active Treatment Phase|Protocol Violation|4
3037991|NCT00689936|10444197|P2|Active Treatment Phase|Protocol Violation|2
3037992|NCT00689936|10444198|P1|Active Treatment Phase|Protocol Violation|2
3037993|NCT00689936|10444196|P3|Active Treatment Phase|Lost to Follow-up|2
3037994|NCT00689936|10444197|P2|Active Treatment Phase|Lost to Follow-up|2
3037995|NCT00689936|10444198|P1|Active Treatment Phase|Lost to Follow-up|0
3037996|NCT00689936|10444196|P3|Active Treatment Phase|Death|37
3037997|NCT00689936|10444197|P2|Active Treatment Phase|Death|28
3037998|NCT00689936|10444198|P1|Active Treatment Phase|Death|60
3037999|NCT00689936|10444196|P3|Active Treatment Phase|Withdrawal by Subject|21
3038000|NCT00689936|10444197|P2|Active Treatment Phase|Withdrawal by Subject|16
3038001|NCT00689936|10444198|P1|Active Treatment Phase|Withdrawal by Subject|16
3038002|NCT00689936|10444196|P3|Active Treatment Phase|Disease Progression|339
3038003|NCT00689936|10444197|P2|Active Treatment Phase|Disease Progression|362
3038004|NCT00689936|10444198|P1|Active Treatment Phase|Disease Progression|273
3038005|NCT00689936|10444196|P3|Active Treatment Phase|Adverse Event|76
3038006|NCT00689936|10444197|P2|Active Treatment Phase|Adverse Event|71
3038007|NCT00689936|10444198|P1|Active Treatment Phase|Adverse Event|68
3038008|NCT00689871|10444347|P4|Overall Study|Physician Decision|0
3038009|NCT00689871|10444348|P3|Overall Study|Physician Decision|1
3038010|NCT00689871|10444349|P2|Overall Study|Physician Decision|1
3038011|NCT00689871|10444350|P1|Overall Study|Physician Decision|2
3038012|NCT00689871|10444347|P4|Overall Study|Death|2
3038013|NCT00689871|10444348|P3|Overall Study|Death|2
3038014|NCT00689871|10444349|P2|Overall Study|Death|10
3038015|NCT00689871|10444350|P1|Overall Study|Death|1
3038016|NCT00689871|10444347|P4|Overall Study|Withdrawal by Subject|1
3038017|NCT00689871|10444348|P3|Overall Study|Withdrawal by Subject|4
3038018|NCT00689871|10444349|P2|Overall Study|Withdrawal by Subject|3
3038019|NCT00689871|10444350|P1|Overall Study|Withdrawal by Subject|13
3038020|NCT00689871|10444347|P4|Overall Study|Explanted of All Study Devices|3
3038021|NCT00689871|10444348|P3|Overall Study|Explanted of All Study Devices|29
3038022|NCT00689871|10444349|P2|Overall Study|Explanted of All Study Devices|25
3038023|NCT00689871|10444350|P1|Overall Study|Explanted of All Study Devices|36
3038024|NCT00689871|10444347|P4|Overall Study|Lost to Follow-up|1
3038025|NCT00689871|10444348|P3|Overall Study|Lost to Follow-up|37
3038026|NCT00689871|10444349|P2|Overall Study|Lost to Follow-up|13
3038027|NCT00689871|10444350|P1|Overall Study|Lost to Follow-up|123
3038028|NCT00689793|10444377|P2|Overall Study|Lost to Follow-up|5
3038029|NCT00689793|10444378|P1|Overall Study|Lost to Follow-up|4
3038030|NCT00689728|10444397|P3|Optional Follow-Up|Withdrawal by Subject|3
3038031|NCT00689728|10444398|P2|Optional Follow-Up|Withdrawal by Subject|4
3038032|NCT00689728|10444399|P1|Optional Follow-Up|Withdrawal by Subject|2
3038033|NCT00689728|10444397|P3|Optional Follow-Up|Protocol Violation|1
3038034|NCT00689728|10444398|P2|Optional Follow-Up|Protocol Violation|0
3038035|NCT00689728|10444399|P1|Optional Follow-Up|Protocol Violation|0
3038036|NCT00689728|10444397|P3|Optional Follow-Up|Lost to Follow-up|1
3038037|NCT00689728|10444398|P2|Optional Follow-Up|Lost to Follow-up|1
3038038|NCT00689728|10444399|P1|Optional Follow-Up|Lost to Follow-up|0
3038039|NCT00689728|10444397|P3|Optional Follow-Up|Lack of Efficacy|1
3038040|NCT00689728|10444398|P2|Optional Follow-Up|Lack of Efficacy|1
3038041|NCT00689728|10444399|P1|Optional Follow-Up|Lack of Efficacy|0
3038042|NCT00689728|10444397|P3|Optional Follow-Up|Adverse Event|0
3038043|NCT00689728|10444398|P2|Optional Follow-Up|Adverse Event|0
3038044|NCT00689728|10444399|P1|Optional Follow-Up|Adverse Event|1
3038045|NCT00689728|10444397|P3|Rescue|Withdrawal by Subject|1
3038046|NCT00689728|10444398|P2|Rescue|Withdrawal by Subject|1
3038047|NCT00689728|10444399|P1|Rescue|Withdrawal by Subject|1
3038048|NCT00689728|10444397|P3|Rescue|Adverse Event|0
3038049|NCT00689728|10444398|P2|Rescue|Adverse Event|1
3038050|NCT00689728|10444399|P1|Rescue|Adverse Event|0
3038051|NCT00689728|10444397|P3|Double-Blind Treatment|Lack of Efficacy|2
3038052|NCT00689728|10444398|P2|Double-Blind Treatment|Lack of Efficacy|1
3038053|NCT00689728|10444399|P1|Double-Blind Treatment|Lack of Efficacy|0
3038054|NCT00689728|10444397|P3|Double-Blind Treatment|Withdrawal by Subject|2
3038055|NCT00689728|10444398|P2|Double-Blind Treatment|Withdrawal by Subject|3
3038056|NCT00689728|10444399|P1|Double-Blind Treatment|Withdrawal by Subject|3
3038057|NCT00689728|10444397|P3|Double-Blind Treatment|Protocol Violation|1
3038058|NCT00689728|10444398|P2|Double-Blind Treatment|Protocol Violation|0
3038059|NCT00689728|10444399|P1|Double-Blind Treatment|Protocol Violation|0
3038060|NCT00689728|10444397|P3|Double-Blind Treatment|Adverse Event|0
3038061|NCT00689728|10444398|P2|Double-Blind Treatment|Adverse Event|0
3038062|NCT00689728|10444399|P1|Double-Blind Treatment|Adverse Event|1
3038063|NCT00689611|10444482|P2|Overall Study|Lost to Follow-up|28
3038064|NCT00689611|10444483|P1|Overall Study|Lost to Follow-up|27
3038065|NCT00689611|10444482|P2|Overall Study|Withdrawal by Subject|9
3038066|NCT00689611|10444483|P1|Overall Study|Withdrawal by Subject|8
3038067|NCT00689611|10444482|P2|Overall Study|Death|9
3038068|NCT00689611|10444483|P1|Overall Study|Death|6
3038069|NCT00689481|10444493|P2|Overall Study|Subject early term, left on vacation|1
3038070|NCT00689481|10444494|P1|Overall Study|Subject early term, left on vacation|0
3038071|NCT00689481|10444493|P2|Overall Study|Excluded medication started during study|1
3038072|NCT00689481|10444494|P1|Overall Study|Excluded medication started during study|0
3038073|NCT00689481|10444493|P2|Overall Study|Withdrawal by Subject|4
3038074|NCT00689481|10444494|P1|Overall Study|Withdrawal by Subject|8
3038075|NCT00689481|10444493|P2|Overall Study|Non-compliance with study treatment|1
3038076|NCT00689481|10444494|P1|Overall Study|Non-compliance with study treatment|1
3038077|NCT00689481|10444493|P2|Overall Study|Lack of Efficacy|3
3038078|NCT00689481|10444494|P1|Overall Study|Lack of Efficacy|4
3038079|NCT00689481|10444493|P2|Overall Study|Lost to Follow-up|3
3038080|NCT00689481|10444494|P1|Overall Study|Lost to Follow-up|4
3038081|NCT00689481|10444493|P2|Overall Study|Adverse Event|1
3038082|NCT00689481|10444494|P1|Overall Study|Adverse Event|7
3038083|NCT00689390|10444512|P2|Overall Study|Administrative|0
3038084|NCT00689390|10444513|P1|Overall Study|Administrative|37
3038085|NCT00689390|10444512|P2|Overall Study|Did Not Meet Protocol Eligibility|0
3038086|NCT00689390|10444513|P1|Overall Study|Did Not Meet Protocol Eligibility|1
3038087|NCT00689390|10444512|P2|Overall Study|Non-Compliance With Protocol|0
3038088|NCT00689390|10444513|P1|Overall Study|Non-Compliance With Protocol|21
3038089|NCT00689390|10444512|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
3038090|NCT00689390|10444513|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
3038091|NCT00689390|10444512|P2|Overall Study|Withdrawal by Subject|3
3038092|NCT00689390|10444513|P1|Overall Study|Withdrawal by Subject|117
3038093|NCT00689390|10444512|P2|Overall Study|Lost to Follow-up|7
3038094|NCT00689390|10444513|P1|Overall Study|Lost to Follow-up|179
3038095|NCT00689390|10444512|P2|Overall Study|Adverse Event|0
3038096|NCT00689390|10444513|P1|Overall Study|Adverse Event|19
3038097|NCT00689351|10444531|P2|After Infant Series|Parent/legal guardian request|0
3038098|NCT00689351|10444532|P1|After Infant Series|Parent/legal guardian request|1
3038099|NCT00689351|10444531|P2|Infant Series of Dosing|Lost to Follow-up|1
3038100|NCT00689351|10444532|P1|Infant Series of Dosing|Lost to Follow-up|0
3038101|NCT00689351|10444531|P2|Infant Series of Dosing|Adverse Event|0
3038102|NCT00689351|10444532|P1|Infant Series of Dosing|Adverse Event|1
3038103|NCT00689351|10444531|P2|Infant Series of Dosing|Parent/legal guardian request|0
3038104|NCT00689351|10444532|P1|Infant Series of Dosing|Parent/legal guardian request|5
3038105|NCT00689338|10444564|P1|Overall Study|Protocol Violation|15
3038106|NCT00689338|10444564|P1|Overall Study|Withdrawal by Subject|3
3038107|NCT00689338|10444564|P1|Overall Study|Lost to Follow-up|5
3038108|NCT00689338|10444564|P1|Overall Study|Did not Meet Entrance Criteria|27
3038109|NCT00689338|10444564|P1|Overall Study|Other|8
3038110|NCT00689338|10444564|P1|Overall Study|Lack of Efficacy|6
3038111|NCT00689338|10444564|P1|Overall Study|Insufficient Clinical Response|1
3038112|NCT00689338|10444564|P1|Overall Study|Adverse Event|13
3038113|NCT00689338|10444564|P1|Overall Study|Death|65
3038114|NCT00689299|10444577|P3|Overall Study|Protocol Violation|0
3038115|NCT00689299|10444578|P2|Overall Study|Protocol Violation|0
3038116|NCT00689299|10444579|P1|Overall Study|Protocol Violation|1
3038117|NCT00689299|10444577|P3|Overall Study|Withdrawal by Subject|3
3038118|NCT00689299|10444578|P2|Overall Study|Withdrawal by Subject|1
3038119|NCT00689299|10444579|P1|Overall Study|Withdrawal by Subject|4
3038120|NCT00689299|10444577|P3|Overall Study|Lost to Follow-up|1
3038121|NCT00689299|10444578|P2|Overall Study|Lost to Follow-up|1
3038122|NCT00689299|10444579|P1|Overall Study|Lost to Follow-up|0
3038123|NCT00689299|10444577|P3|Overall Study|Adverse Event|1
3038124|NCT00689299|10444578|P2|Overall Study|Adverse Event|1
3038125|NCT00689299|10444579|P1|Overall Study|Adverse Event|2
3038126|NCT00689221|10444608|P2|Overall Study|Ongoing at cut-off date|36
3038127|NCT00689221|10444609|P1|Overall Study|Ongoing at cut-off date|39
3038128|NCT00689117|10444638|P4|Overall Study|Dispensing Error|0
3038129|NCT00689117|10444639|P3|Overall Study|Dispensing Error|0
3038130|NCT00689117|10444640|P2|Overall Study|Dispensing Error|1
3038131|NCT00689117|10444641|P1|Overall Study|Dispensing Error|0
3038132|NCT00689117|10444638|P4|Overall Study|Personal Reason|0
3038133|NCT00689117|10444639|P3|Overall Study|Personal Reason|0
3038134|NCT00689117|10444640|P2|Overall Study|Personal Reason|1
3038135|NCT00689117|10444641|P1|Overall Study|Personal Reason|0
3038136|NCT00689117|10444638|P4|Overall Study|Patient Withdrew from Study|1
3038137|NCT00689117|10444639|P3|Overall Study|Patient Withdrew from Study|0
3038138|NCT00689117|10444640|P2|Overall Study|Patient Withdrew from Study|0
3038139|NCT00689117|10444641|P1|Overall Study|Patient Withdrew from Study|0
3038140|NCT00689117|10444638|P4|Overall Study|Transportation|0
3038141|NCT00689117|10444639|P3|Overall Study|Transportation|0
3038142|NCT00689117|10444640|P2|Overall Study|Transportation|0
3038143|NCT00689117|10444641|P1|Overall Study|Transportation|1
3038144|NCT00689117|10444638|P4|Overall Study|Fear of Birth Defects|0
3038145|NCT00689117|10444639|P3|Overall Study|Fear of Birth Defects|1
3038146|NCT00689117|10444640|P2|Overall Study|Fear of Birth Defects|0
3038147|NCT00689117|10444641|P1|Overall Study|Fear of Birth Defects|0
3038148|NCT00689117|10444638|P4|Overall Study|Incarceration|0
3038149|NCT00689117|10444639|P3|Overall Study|Incarceration|0
3038150|NCT00689117|10444640|P2|Overall Study|Incarceration|0
3038151|NCT00689117|10444641|P1|Overall Study|Incarceration|2
3038152|NCT00689117|10444638|P4|Overall Study|Pregnancy|2
3038153|NCT00689117|10444639|P3|Overall Study|Pregnancy|0
3038154|NCT00689117|10444640|P2|Overall Study|Pregnancy|2
3038155|NCT00689117|10444641|P1|Overall Study|Pregnancy|0
3038156|NCT00689117|10444638|P4|Overall Study|Use of Prohibitive Medication|0
3038157|NCT00689117|10444639|P3|Overall Study|Use of Prohibitive Medication|3
3038158|NCT00689117|10444640|P2|Overall Study|Use of Prohibitive Medication|1
3038159|NCT00689117|10444641|P1|Overall Study|Use of Prohibitive Medication|2
3038160|NCT00689117|10444638|P4|Overall Study|Change/Discontinuation of Birth Control|0
3038161|NCT00689117|10444639|P3|Overall Study|Change/Discontinuation of Birth Control|1
3038162|NCT00689117|10444640|P2|Overall Study|Change/Discontinuation of Birth Control|1
3038163|NCT00689117|10444641|P1|Overall Study|Change/Discontinuation of Birth Control|1
3038164|NCT00689117|10444638|P4|Overall Study|Non-compliance with Treatment Regimen|0
3038165|NCT00689117|10444639|P3|Overall Study|Non-compliance with Treatment Regimen|0
3038166|NCT00689117|10444640|P2|Overall Study|Non-compliance with Treatment Regimen|1
3038167|NCT00689117|10444641|P1|Overall Study|Non-compliance with Treatment Regimen|0
3038168|NCT00689117|10444638|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3038169|NCT00689117|10444639|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3038170|NCT00689117|10444640|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
3038171|NCT00689117|10444641|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
3038172|NCT00689117|10444638|P4|Overall Study|Unable to Comply with Visit Schedule|1
3038173|NCT00689117|10444639|P3|Overall Study|Unable to Comply with Visit Schedule|1
3038174|NCT00689117|10444640|P2|Overall Study|Unable to Comply with Visit Schedule|0
3038175|NCT00689117|10444641|P1|Overall Study|Unable to Comply with Visit Schedule|0
3038176|NCT00689117|10444638|P4|Overall Study|Withdrawal by Subject|13
3038177|NCT00689117|10444639|P3|Overall Study|Withdrawal by Subject|26
3038178|NCT00689117|10444640|P2|Overall Study|Withdrawal by Subject|18
3038179|NCT00689117|10444641|P1|Overall Study|Withdrawal by Subject|19
3038180|NCT00689117|10444638|P4|Overall Study|Non-Compliance with Study Treatment|1
3038181|NCT00689117|10444639|P3|Overall Study|Non-Compliance with Study Treatment|3
3038182|NCT00689117|10444640|P2|Overall Study|Non-Compliance with Study Treatment|3
3038183|NCT00689117|10444641|P1|Overall Study|Non-Compliance with Study Treatment|3
3038184|NCT00689117|10444638|P4|Overall Study|Lack of Efficacy|2
3038185|NCT00689117|10444639|P3|Overall Study|Lack of Efficacy|2
3038186|NCT00689117|10444640|P2|Overall Study|Lack of Efficacy|2
3038187|NCT00689117|10444641|P1|Overall Study|Lack of Efficacy|1
3038188|NCT00689117|10444638|P4|Overall Study|Lost to Follow-up|11
3038189|NCT00689117|10444639|P3|Overall Study|Lost to Follow-up|17
3038190|NCT00689117|10444640|P2|Overall Study|Lost to Follow-up|19
3038191|NCT00689117|10444641|P1|Overall Study|Lost to Follow-up|26
3038192|NCT00689117|10444638|P4|Overall Study|Adverse Event|0
3038193|NCT00689117|10444639|P3|Overall Study|Adverse Event|5
3038194|NCT00689117|10444640|P2|Overall Study|Adverse Event|0
3038195|NCT00689117|10444641|P1|Overall Study|Adverse Event|6
3038196|NCT00689104|10444671|P4|Overall Study|Non-compliance with study procedures|0
3038197|NCT00689104|10444672|P3|Overall Study|Non-compliance with study procedures|1
3038198|NCT00689104|10444673|P2|Overall Study|Non-compliance with study procedures|0
3038199|NCT00689104|10444674|P1|Overall Study|Non-compliance with study procedures|0
3038200|NCT00689104|10444671|P4|Overall Study|Physician Decision|0
3038201|NCT00689104|10444672|P3|Overall Study|Physician Decision|0
3038202|NCT00689104|10444673|P2|Overall Study|Physician Decision|0
3038203|NCT00689104|10444674|P1|Overall Study|Physician Decision|1
3038204|NCT00689104|10444671|P4|Overall Study|Randomized but never received study drug|0
3038205|NCT00689104|10444672|P3|Overall Study|Randomized but never received study drug|1
3038206|NCT00689104|10444673|P2|Overall Study|Randomized but never received study drug|1
3038207|NCT00689104|10444674|P1|Overall Study|Randomized but never received study drug|2
3038208|NCT00689104|10444671|P4|Overall Study|Protocol Violation|3
3038209|NCT00689104|10444672|P3|Overall Study|Protocol Violation|5
3038210|NCT00689104|10444673|P2|Overall Study|Protocol Violation|3
3038211|NCT00689104|10444674|P1|Overall Study|Protocol Violation|2
3038212|NCT00689104|10444671|P4|Overall Study|Lost to Follow-up|5
3038213|NCT00689104|10444672|P3|Overall Study|Lost to Follow-up|2
3038214|NCT00689104|10444673|P2|Overall Study|Lost to Follow-up|3
3038215|NCT00689104|10444674|P1|Overall Study|Lost to Follow-up|4
3038216|NCT00689104|10444671|P4|Overall Study|Withdrawal by Subject|11
3038217|NCT00689104|10444672|P3|Overall Study|Withdrawal by Subject|18
3038218|NCT00689104|10444673|P2|Overall Study|Withdrawal by Subject|11
3038219|NCT00689104|10444674|P1|Overall Study|Withdrawal by Subject|12
3038220|NCT00689104|10444671|P4|Overall Study|Lack of Efficacy|3
3038221|NCT00689104|10444672|P3|Overall Study|Lack of Efficacy|2
3038222|NCT00689104|10444673|P2|Overall Study|Lack of Efficacy|6
3038223|NCT00689104|10444674|P1|Overall Study|Lack of Efficacy|5
3038224|NCT00689104|10444671|P4|Overall Study|Adverse Event|24
3038225|NCT00689104|10444672|P3|Overall Study|Adverse Event|16
3038226|NCT00689104|10444673|P2|Overall Study|Adverse Event|25
3038227|NCT00689104|10444674|P1|Overall Study|Adverse Event|13
3038228|NCT00689104|10444671|P4|Overall Study|Eligibility criterion not met|4
3038229|NCT00689104|10444672|P3|Overall Study|Eligibility criterion not met|0
3038230|NCT00689104|10444673|P2|Overall Study|Eligibility criterion not met|8
3038231|NCT00689104|10444674|P1|Overall Study|Eligibility criterion not met|5
3038232|NCT00689052|10444880|P2|Overall Study|Early termination of the trial|24
3038233|NCT00689052|10444881|P1|Overall Study|Early termination of the trial|22
3038234|NCT00689052|10444880|P2|Overall Study|Withdrawal by Subject|0
3038235|NCT00689052|10444881|P1|Overall Study|Withdrawal by Subject|2
3038236|NCT00689052|10444880|P2|Overall Study|Lost to Follow-up|0
3038237|NCT00689052|10444881|P1|Overall Study|Lost to Follow-up|2
3038238|NCT00689052|10444880|P2|Overall Study|Protocol Violation|0
3038239|NCT00689052|10444881|P1|Overall Study|Protocol Violation|1
3038240|NCT00689052|10444880|P2|Overall Study|Adverse Event|6
3038241|NCT00689052|10444881|P1|Overall Study|Adverse Event|4
3038242|NCT00689026|10444913|P2|Overall Study|Withdrawal by Subject|6
3038243|NCT00689026|10444914|P1|Overall Study|Withdrawal by Subject|13
3038244|NCT00688870|10444927|P2|Infant Series|Parent or legal guardian request|0
3038245|NCT00688870|10444928|P1|Infant Series|Parent or legal guardian request|4
3038246|NCT00688844|10444960|P1|Overall Study|Lost to Follow-up|10
3038247|NCT00688753|10444970|P1|Overall Study|Lost to Follow-up|3
3038248|NCT00688753|10444970|P1|Overall Study|Protocol Violation|1
3038249|NCT00688753|10444970|P1|Overall Study|Adverse Event|20
3038250|NCT00688753|10444970|P1|Overall Study|Withdrawal by Subject|3
3038251|NCT00688753|10444970|P1|Overall Study|Death|9
3038252|NCT00688753|10444970|P1|Overall Study|Missing|1
3038253|NCT00688753|10444970|P1|Overall Study|Disease progression|55
3038254|NCT00688740|10444981|P2|Overall Study|Violation of Inclusion Criteria|3
3038255|NCT00688740|10444982|P1|Overall Study|Violation of Inclusion Criteria|1
3038256|NCT00688740|10444981|P2|Overall Study|Breast Cancer Relapse|4
3038257|NCT00688740|10444982|P1|Overall Study|Breast Cancer Relapse|1
3038258|NCT00688740|10444981|P2|Overall Study|Consent Withdrawn|17
3038259|NCT00688740|10444982|P1|Overall Study|Consent Withdrawn|17
3038260|NCT00688740|10444981|P2|Overall Study|Lost to Follow-up|1
3038261|NCT00688740|10444982|P1|Overall Study|Lost to Follow-up|0
3038262|NCT00688740|10444981|P2|Overall Study|Death|2
3038263|NCT00688740|10444982|P1|Overall Study|Death|2
3038264|NCT00688740|10444981|P2|Overall Study|Adverse Event|8
3038265|NCT00688740|10444982|P1|Overall Study|Adverse Event|45
3038266|NCT00688701|10444995|P4|Overall Study|Poor compliance to protocol|0
3038267|NCT00688701|10444996|P3|Overall Study|Poor compliance to protocol|1
3038268|NCT00688701|10444997|P2|Overall Study|Poor compliance to protocol|1
3038269|NCT00688701|10444998|P1|Overall Study|Poor compliance to protocol|0
3038270|NCT00688701|10444995|P4|Overall Study|Withdrawal by Subject|8
3038271|NCT00688701|10444996|P3|Overall Study|Withdrawal by Subject|4
3038272|NCT00688701|10444997|P2|Overall Study|Withdrawal by Subject|3
3038273|NCT00688701|10444998|P1|Overall Study|Withdrawal by Subject|3
3038274|NCT00688701|10444995|P4|Overall Study|Lack of Efficacy|0
3038275|NCT00688701|10444996|P3|Overall Study|Lack of Efficacy|0
3038276|NCT00688701|10444997|P2|Overall Study|Lack of Efficacy|1
3038277|NCT00688701|10444998|P1|Overall Study|Lack of Efficacy|0
3038278|NCT00688701|10444995|P4|Overall Study|Adverse Event|3
3038279|NCT00688701|10444996|P3|Overall Study|Adverse Event|5
3038280|NCT00688701|10444997|P2|Overall Study|Adverse Event|0
3038281|NCT00688701|10444998|P1|Overall Study|Adverse Event|1
3038282|NCT00688688|10445039|P3|Overall Study|Violation of exclusion criterion|0
3038283|NCT00688688|10445040|P2|Overall Study|Violation of exclusion criterion|1
3038284|NCT00688688|10445041|P1|Overall Study|Violation of exclusion criterion|0
3038285|NCT00688688|10445039|P3|Overall Study|Site closure|0
3038286|NCT00688688|10445040|P2|Overall Study|Site closure|1
3038287|NCT00688688|10445041|P1|Overall Study|Site closure|0
3038288|NCT00688688|10445039|P3|Overall Study|Taking exclusionary medications|0
3038289|NCT00688688|10445040|P2|Overall Study|Taking exclusionary medications|0
3038290|NCT00688688|10445041|P1|Overall Study|Taking exclusionary medications|1
3038291|NCT00688688|10445039|P3|Overall Study|Non-compliance with study procedures|4
3038292|NCT00688688|10445040|P2|Overall Study|Non-compliance with study procedures|3
3038293|NCT00688688|10445041|P1|Overall Study|Non-compliance with study procedures|5
3038294|NCT00688688|10445039|P3|Overall Study|Randomized but never received study drug|0
3038295|NCT00688688|10445040|P2|Overall Study|Randomized but never received study drug|0
3038296|NCT00688688|10445041|P1|Overall Study|Randomized but never received study drug|1
3038297|NCT00688688|10445039|P3|Overall Study|Protocol Violation|11
3038298|NCT00688688|10445040|P2|Overall Study|Protocol Violation|9
3038299|NCT00688688|10445041|P1|Overall Study|Protocol Violation|6
3038300|NCT00688688|10445039|P3|Overall Study|Lost to Follow-up|7
3038301|NCT00688688|10445040|P2|Overall Study|Lost to Follow-up|7
3038302|NCT00688688|10445041|P1|Overall Study|Lost to Follow-up|14
3038303|NCT00688688|10445039|P3|Overall Study|Withdrawal by Subject|65
3038304|NCT00688688|10445040|P2|Overall Study|Withdrawal by Subject|75
3038305|NCT00688688|10445041|P1|Overall Study|Withdrawal by Subject|66
3038306|NCT00688688|10445039|P3|Overall Study|Lack of Efficacy|45
3038307|NCT00688688|10445040|P2|Overall Study|Lack of Efficacy|25
3038308|NCT00688688|10445041|P1|Overall Study|Lack of Efficacy|34
3038309|NCT00688688|10445039|P3|Overall Study|Adverse Event|50
3038310|NCT00688688|10445040|P2|Overall Study|Adverse Event|51
3038311|NCT00688688|10445041|P1|Overall Study|Adverse Event|52
3038312|NCT00688688|10445039|P3|Overall Study|Eligibility criterion not met|10
3038313|NCT00688688|10445040|P2|Overall Study|Eligibility criterion not met|7
3038314|NCT00688688|10445041|P1|Overall Study|Eligibility criterion not met|7
3038315|NCT00688636|10445143|P2|Overall Study|Adverse Event|1
3038316|NCT00688636|10445144|P1|Overall Study|Adverse Event|2
3038317|NCT00688623|10445158|P1|Overall Study|Protocol Violation|2
3038318|NCT00688623|10445158|P1|Overall Study|disease progression|23
3038319|NCT00688623|10445158|P1|Overall Study|Death|3
3038320|NCT00688623|10445158|P1|Overall Study|Withdrawal by Subject|4
3038321|NCT00688623|10445158|P1|Overall Study|abnormal lab value|1
3038322|NCT00688623|10445158|P1|Overall Study|Adverse Event|22
3038323|NCT00688597|10445172|P3|Overall Study|Physician Decision|0
3038324|NCT00688597|10445173|P2|Overall Study|Physician Decision|0
3038325|NCT00688597|10445174|P1|Overall Study|Physician Decision|1
3038326|NCT00688597|10445172|P3|Overall Study|Adverse Event|0
3038327|NCT00688597|10445173|P2|Overall Study|Adverse Event|0
3038328|NCT00688597|10445174|P1|Overall Study|Adverse Event|2
3038329|NCT00688545|10445187|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
3038330|NCT00688545|10445188|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
3038331|NCT00688545|10445187|P2|Overall Study|Withdrawal by Subject|3
3038332|NCT00688545|10445188|P1|Overall Study|Withdrawal by Subject|2
3038333|NCT00688545|10445187|P2|Overall Study|Insurance/cost of drug|1
3038334|NCT00688545|10445188|P1|Overall Study|Insurance/cost of drug|0
3038335|NCT00688545|10445187|P2|Overall Study|Lost to Follow-up|4
3038336|NCT00688545|10445188|P1|Overall Study|Lost to Follow-up|1
3038337|NCT00688519|10445198|P2|Overall Study|Pregnancy|1
3038338|NCT00688519|10445199|P1|Overall Study|Pregnancy|0
3038339|NCT00688519|10445198|P2|Overall Study|Subject moved out of area|0
3038340|NCT00688519|10445199|P1|Overall Study|Subject moved out of area|1
3038341|NCT00688519|10445198|P2|Overall Study|Investigator decision|0
3038342|NCT00688519|10445199|P1|Overall Study|Investigator decision|1
3038343|NCT00688519|10445198|P2|Overall Study|Subject moved out of state|0
3038344|NCT00688519|10445199|P1|Overall Study|Subject moved out of state|1
3038345|NCT00688519|10445198|P2|Overall Study|Non-compliance|1
3038346|NCT00688519|10445199|P1|Overall Study|Non-compliance|0
3038347|NCT00688519|10445198|P2|Overall Study|Prohibited medication|0
3038348|NCT00688519|10445199|P1|Overall Study|Prohibited medication|1
3038349|NCT00688519|10445198|P2|Overall Study|Withdrawal by Subject|6
3038350|NCT00688519|10445199|P1|Overall Study|Withdrawal by Subject|7
3038351|NCT00688519|10445198|P2|Overall Study|Lack of Efficacy|1
3038352|NCT00688519|10445199|P1|Overall Study|Lack of Efficacy|3
3038353|NCT00688519|10445198|P2|Overall Study|Lost to Follow-up|3
3038354|NCT00688519|10445199|P1|Overall Study|Lost to Follow-up|3
3038355|NCT00688519|10445198|P2|Overall Study|Adverse Event|3
3038356|NCT00688519|10445199|P1|Overall Study|Adverse Event|2
3038357|NCT00688467|10445217|P2|Treatment Period 2|Adverse Event|1
3038358|NCT00688467|10445218|P1|Treatment Period 2|Adverse Event|0
3038359|NCT00688467|10445217|P2|Treatment Period 2|Protocol Violation|1
3038360|NCT00688467|10445218|P1|Treatment Period 2|Protocol Violation|0
3038361|NCT00688467|10445217|P2|Treatment Period 1|Did not meet protocol eligibility|1
3038362|NCT00688467|10445218|P1|Treatment Period 1|Did not meet protocol eligibility|0
3038363|NCT00688467|10445217|P2|Treatment Period 1|Adverse Event|1
3038364|NCT00688467|10445218|P1|Treatment Period 1|Adverse Event|2
3038365|NCT00688376|10445250|P2|Blinded Extension Phase|Other|0
3038366|NCT00688376|10445251|P1|Blinded Extension Phase|Other|1
3038367|NCT00688376|10445250|P2|Blinded Extension Phase|Physician Decision|0
3038368|NCT00688376|10445251|P1|Blinded Extension Phase|Physician Decision|1
3038369|NCT00688376|10445250|P2|Blinded Extension Phase|Withdrawal by Subject|1
3038370|NCT00688376|10445251|P1|Blinded Extension Phase|Withdrawal by Subject|0
3038371|NCT00688376|10445250|P2|Blinded Extension Phase|Adverse Event|4
3038372|NCT00688376|10445251|P1|Blinded Extension Phase|Adverse Event|3
3038373|NCT00688376|10445250|P2|Double-Blind Phase|Not treated|1
3038374|NCT00688376|10445251|P1|Double-Blind Phase|Not treated|0
3038375|NCT00688376|10445250|P2|Double-Blind Phase|Withdrawal by Subject|0
3038376|NCT00688376|10445251|P1|Double-Blind Phase|Withdrawal by Subject|1
3038377|NCT00688376|10445250|P2|Double-Blind Phase|Protocol Violation|2
3038378|NCT00688376|10445251|P1|Double-Blind Phase|Protocol Violation|1
3038379|NCT00688376|10445250|P2|Double-Blind Phase|Adverse Event|4
3038380|NCT00688376|10445251|P1|Double-Blind Phase|Adverse Event|4
3038381|NCT00688324|10445265|P1|Overall Study|Lost to Follow-up|1
3038382|NCT00688324|10445265|P1|Overall Study|Physician Decision|5
3038383|NCT00688324|10445265|P1|Overall Study|Withdrawal by Subject|2
3038384|NCT00688259|10445310|P2|Overall Study|Hospitalized at Follow-up|1
3038385|NCT00688259|10445311|P1|Overall Study|Hospitalized at Follow-up|0
3038386|NCT00688259|10445310|P2|Overall Study|Declined Interview|3
3038387|NCT00688259|10445311|P1|Overall Study|Declined Interview|2
3038388|NCT00688259|10445310|P2|Overall Study|Withdrawal by Subject|0
3038389|NCT00688259|10445311|P1|Overall Study|Withdrawal by Subject|2
3038390|NCT00688259|10445310|P2|Overall Study|Physician Decision|0
3038391|NCT00688259|10445311|P1|Overall Study|Physician Decision|1
3038392|NCT00688259|10445310|P2|Overall Study|Lost to Follow-up|4
3038393|NCT00688259|10445311|P1|Overall Study|Lost to Follow-up|2
3038394|NCT00688155|10445331|P4|Overall Study|Withdrawal by Subject|1
3038395|NCT00688155|10445332|P3|Overall Study|Withdrawal by Subject|1
3038396|NCT00688155|10445333|P2|Overall Study|Withdrawal by Subject|2
3038397|NCT00688155|10445334|P1|Overall Study|Withdrawal by Subject|2
3038398|NCT00688103|10445354|P2|Overall Study|complex reasons|9
3038399|NCT00688103|10445355|P1|Overall Study|complex reasons|11
3038400|NCT00688103|10445354|P2|Overall Study|Withdrawal by Subject|2
3038401|NCT00688103|10445355|P1|Overall Study|Withdrawal by Subject|4
3038402|NCT00688103|10445354|P2|Overall Study|Lack of Efficacy|1
3038403|NCT00688103|10445355|P1|Overall Study|Lack of Efficacy|11
3038404|NCT00688103|10445354|P2|Overall Study|Adverse Event|1
3038405|NCT00688103|10445355|P1|Overall Study|Adverse Event|4
3038406|NCT00688064|10445367|P2|Overall Study|Any other reasons|3
3038407|NCT00688064|10445368|P1|Overall Study|Any other reasons|1
3038408|NCT00688064|10445367|P2|Overall Study|Pregnancy|0
3038409|NCT00688064|10445368|P1|Overall Study|Pregnancy|1
3038410|NCT00688064|10445367|P2|Overall Study|Lack of Efficacy|1
3038411|NCT00688064|10445368|P1|Overall Study|Lack of Efficacy|0
3038412|NCT00688064|10445367|P2|Overall Study|Lost to Follow-up|10
3038413|NCT00688064|10445368|P1|Overall Study|Lost to Follow-up|10
3038414|NCT00688064|10445367|P2|Overall Study|Withdrawal by Subject|7
3038415|NCT00688064|10445368|P1|Overall Study|Withdrawal by Subject|7
3038416|NCT00688064|10445367|P2|Overall Study|Adverse Event|4
3038417|NCT00688064|10445368|P1|Overall Study|Adverse Event|2
3038418|NCT00688064|10445367|P2|Overall Study|Protocol Violation|1
3038419|NCT00688064|10445368|P1|Overall Study|Protocol Violation|0
3038420|NCT00687973|10445384|P2|Overall Study|Withdrawal by Subject|3
3038421|NCT00687973|10445385|P1|Overall Study|Withdrawal by Subject|3
3038422|NCT00687973|10445384|P2|Overall Study|Administrative Reasons|2
3038423|NCT00687973|10445385|P1|Overall Study|Administrative Reasons|0
3038424|NCT00687973|10445384|P2|Overall Study|Protocol Violation|2
3038425|NCT00687973|10445385|P1|Overall Study|Protocol Violation|1
3038426|NCT00687973|10445384|P2|Overall Study|Lack of Efficacy|3
3038427|NCT00687973|10445385|P1|Overall Study|Lack of Efficacy|2
3038428|NCT00687973|10445384|P2|Overall Study|Adverse Event|28
3038429|NCT00687973|10445385|P1|Overall Study|Adverse Event|18
3038430|NCT00687804|10445447|P3|Open-Label Extension Study|Death|3
3038431|NCT00687804|10445448|P2|Open-Label Extension Study|Death|3
3038432|NCT00687804|10445449|P1|Open-Label Extension Study|Death|2
3038433|NCT00687804|10445447|P3|Open-Label Extension Study|Administrative problems|0
3038434|NCT00687804|10445448|P2|Open-Label Extension Study|Administrative problems|1
3038435|NCT00687804|10445449|P1|Open-Label Extension Study|Administrative problems|1
3038436|NCT00687804|10445447|P3|Open-Label Extension Study|Lost to Follow-up|2
3038437|NCT00687804|10445448|P2|Open-Label Extension Study|Lost to Follow-up|1
3038438|NCT00687804|10445449|P1|Open-Label Extension Study|Lost to Follow-up|2
3038439|NCT00687804|10445447|P3|Open-Label Extension Study|Subject withdrew consent|4
3038440|NCT00687804|10445448|P2|Open-Label Extension Study|Subject withdrew consent|4
3038441|NCT00687804|10445449|P1|Open-Label Extension Study|Subject withdrew consent|3
3038442|NCT00687804|10445447|P3|Open-Label Extension Study|Adverse Event|2
3038443|NCT00687804|10445448|P2|Open-Label Extension Study|Adverse Event|2
3038444|NCT00687804|10445449|P1|Open-Label Extension Study|Adverse Event|2
3038445|NCT00687804|10445447|P3|Core Study|Protocol Violation|0
3038446|NCT00687804|10445448|P2|Core Study|Protocol Violation|1
3038447|NCT00687804|10445449|P1|Core Study|Protocol Violation|1
3038448|NCT00687804|10445447|P3|Core Study|Death|2
3038449|NCT00687804|10445448|P2|Core Study|Death|2
3038450|NCT00687804|10445449|P1|Core Study|Death|2
3038451|NCT00687804|10445447|P3|Core Study|Lost to Follow-up|0
3038452|NCT00687804|10445448|P2|Core Study|Lost to Follow-up|1
3038453|NCT00687804|10445449|P1|Core Study|Lost to Follow-up|0
3038454|NCT00687804|10445447|P3|Core Study|Withdrawal by Subject|7
3038455|NCT00687804|10445448|P2|Core Study|Withdrawal by Subject|7
3038456|NCT00687804|10445449|P1|Core Study|Withdrawal by Subject|4
3038457|NCT00687804|10445447|P3|Core Study|Lack of Efficacy|1
3038458|NCT00687804|10445448|P2|Core Study|Lack of Efficacy|1
3038459|NCT00687804|10445449|P1|Core Study|Lack of Efficacy|1
3038460|NCT00687804|10445447|P3|Core Study|Abnormal laboratory value(s)|0
3038461|NCT00687804|10445448|P2|Core Study|Abnormal laboratory value(s)|0
3038462|NCT00687804|10445449|P1|Core Study|Abnormal laboratory value(s)|1
3038463|NCT00687804|10445447|P3|Core Study|Adverse Event|3
3038464|NCT00687804|10445448|P2|Core Study|Adverse Event|3
3038465|NCT00687804|10445449|P1|Core Study|Adverse Event|5
3038466|NCT00687739|10445496|P4|Overall Study|Adverse Event|0
3038467|NCT00687739|10445497|P3|Overall Study|Adverse Event|1
3038468|NCT00687739|10445498|P2|Overall Study|Adverse Event|1
3038469|NCT00687739|10445499|P1|Overall Study|Adverse Event|0
3038470|NCT00687739|10445496|P4|Overall Study|Lost to Follow-up|2
3038471|NCT00687739|10445497|P3|Overall Study|Lost to Follow-up|1
3038472|NCT00687739|10445498|P2|Overall Study|Lost to Follow-up|2
3038473|NCT00687739|10445499|P1|Overall Study|Lost to Follow-up|2
3038474|NCT00687609|10445541|P1|Overall Study|Withdrawal by Subject|2
3038475|NCT00687609|10445541|P1|Overall Study|Physician Decision|1
3038476|NCT00687531|10445564|P1|Overall Study|Lost to Follow-up|26
3038477|NCT00687531|10445564|P1|Overall Study|Adverse Event|5
3038478|NCT00687531|10445564|P1|Overall Study|Did not meet protocol eligibility|104
3038479|NCT00687440|10445587|P1|Overall Study|Missing|1
3038480|NCT00687440|10445587|P1|Overall Study|Other|1
3038481|NCT00687440|10445587|P1|Overall Study|Death|2
3038482|NCT00687440|10445587|P1|Overall Study|Lack of Efficacy|2
3038483|NCT00687440|10445587|P1|Overall Study|Lost to Follow-up|3
3038484|NCT00687440|10445587|P1|Overall Study|Adverse Event|3
3038485|NCT00687401|10445591|P1|Overall Study|For reasons different from those above|4
3038486|NCT00687401|10445591|P1|Overall Study|Did not return for visit|3
3038487|NCT00687401|10445591|P1|Overall Study|Withdrawal by Subject|4
3038488|NCT00687401|10445591|P1|Overall Study|Lack of Efficacy|6
3038489|NCT00687401|10445591|P1|Overall Study|Adverse Event|6
3038490|NCT00687401|10445591|P1|Overall Study|Protocol Violation|7
3038491|NCT00687362|10445596|P1|Overall Study|Withdrawal by Subject|1
3038492|NCT00687362|10445596|P1|Overall Study|Protocol Violation|2
3038493|NCT00687323|10445600|P1|Overall Study|Screen failure|148
3038494|NCT00687323|10445600|P1|Overall Study|Excluded from efficacy evaluations|6
3038495|NCT00687323|10445600|P1|Overall Study|Withdrawal by Subject|1
3038496|NCT00687323|10445600|P1|Overall Study|Death|25
3038497|NCT00687297|10445616|P2|Induction|Other|1
3038498|NCT00687297|10445617|P1|Induction|Other|0
3038499|NCT00687297|10445616|P2|Induction|Physician Decision|2
3038500|NCT00687297|10445617|P1|Induction|Physician Decision|0
3038501|NCT00687297|10445616|P2|Induction|Patient Noncompliance|0
3038502|NCT00687297|10445617|P1|Induction|Patient Noncompliance|1
3038503|NCT00687297|10445616|P2|Induction|Ineligible|1
3038504|NCT00687297|10445617|P1|Induction|Ineligible|0
3038505|NCT00687297|10445616|P2|Induction|Lack of Efficacy|21
3038506|NCT00687297|10445617|P1|Induction|Lack of Efficacy|17
3038507|NCT00687297|10445616|P2|Induction|Death|11
3038508|NCT00687297|10445617|P1|Induction|Death|7
3038509|NCT00687297|10445616|P2|Induction|Adverse Event|15
3038510|NCT00687297|10445617|P1|Induction|Adverse Event|16
3038511|NCT00687297|10445616|P2|Induction|Withdrawal by Subject|4
3038512|NCT00687297|10445617|P1|Induction|Withdrawal by Subject|4
3038513|NCT00687297|10445616|P2|Randomization|Withdrew before treatment, ineligible|1
3038514|NCT00687297|10445617|P1|Randomization|Withdrew before treatment, ineligible|1
3038515|NCT00687297|10445616|P2|Randomization|Withdrawal by Subject|0
3038516|NCT00687297|10445617|P1|Randomization|Withdrawal by Subject|2
3038517|NCT00687271|10445631|P4|Overall Study|Withdrawal by Subject|0
3038518|NCT00687271|10445632|P3|Overall Study|Withdrawal by Subject|3
3038519|NCT00687271|10445633|P2|Overall Study|Withdrawal by Subject|1
3038520|NCT00687271|10445634|P1|Overall Study|Withdrawal by Subject|0
3038521|NCT00687271|10445631|P4|Overall Study|Protocol Violation|0
3038522|NCT00687271|10445632|P3|Overall Study|Protocol Violation|1
3038523|NCT00687271|10445633|P2|Overall Study|Protocol Violation|1
3038524|NCT00687271|10445634|P1|Overall Study|Protocol Violation|2
3038525|NCT00687271|10445631|P4|Overall Study|Lost to Follow-up|0
3038526|NCT00687271|10445632|P3|Overall Study|Lost to Follow-up|0
3038527|NCT00687271|10445633|P2|Overall Study|Lost to Follow-up|1
3038528|NCT00687271|10445634|P1|Overall Study|Lost to Follow-up|0
3038529|NCT00687271|10445631|P4|Overall Study|Adverse Event|0
3038530|NCT00687271|10445632|P3|Overall Study|Adverse Event|1
3038531|NCT00687271|10445633|P2|Overall Study|Adverse Event|3
3038532|NCT00687271|10445634|P1|Overall Study|Adverse Event|1
3038533|NCT00687219|10445672|P1|Overall Study|Lack of Efficacy|1
3038534|NCT00687219|10445672|P1|Overall Study|Withdrawal by Subject|1
3038535|NCT00687219|10445672|P1|Overall Study|HCV-RNA positive conversion|34
3038536|NCT00687219|10445672|P1|Overall Study|Discontinuance criteria met|7
3038537|NCT00687219|10445672|P1|Overall Study|Adverse Event|8
3038538|NCT00687193|10445684|P6|Overall Study|Protocol Violation|0
3038539|NCT00687193|10445685|P5|Overall Study|Protocol Violation|2
3038540|NCT00687193|10445686|P4|Overall Study|Protocol Violation|1
3038541|NCT00687193|10445687|P3|Overall Study|Protocol Violation|0
3038542|NCT00687193|10445688|P2|Overall Study|Protocol Violation|2
3038543|NCT00687193|10445689|P1|Overall Study|Protocol Violation|1
3038544|NCT00687193|10445684|P6|Overall Study|Lack of Efficacy|2
3038545|NCT00687193|10445685|P5|Overall Study|Lack of Efficacy|0
3038546|NCT00687193|10445686|P4|Overall Study|Lack of Efficacy|0
3038547|NCT00687193|10445687|P3|Overall Study|Lack of Efficacy|0
3038548|NCT00687193|10445688|P2|Overall Study|Lack of Efficacy|1
3038549|NCT00687193|10445689|P1|Overall Study|Lack of Efficacy|1
3038550|NCT00687193|10445684|P6|Overall Study|Adverse Event|2
3038551|NCT00687193|10445685|P5|Overall Study|Adverse Event|0
3038552|NCT00687193|10445686|P4|Overall Study|Adverse Event|3
3038553|NCT00687193|10445687|P3|Overall Study|Adverse Event|2
3038554|NCT00687193|10445688|P2|Overall Study|Adverse Event|1
3038555|NCT00687193|10445689|P1|Overall Study|Adverse Event|0
3038556|NCT00686998|10445899|P3|Overall Study|Safety Reasons|0
3038557|NCT00686998|10445900|P2|Overall Study|Safety Reasons|0
3038558|NCT00686998|10445901|P1|Overall Study|Safety Reasons|1
3038559|NCT00686998|10445899|P3|Overall Study|Other|1
3038560|NCT00686998|10445900|P2|Overall Study|Other|0
3038561|NCT00686998|10445901|P1|Overall Study|Other|0
3038562|NCT00686998|10445899|P3|Overall Study|Lack of Efficacy|0
3038563|NCT00686998|10445900|P2|Overall Study|Lack of Efficacy|5
3038564|NCT00686998|10445901|P1|Overall Study|Lack of Efficacy|7
3038565|NCT00686998|10445899|P3|Overall Study|Withdrawal by Subject|2
3038566|NCT00686998|10445900|P2|Overall Study|Withdrawal by Subject|1
3038567|NCT00686998|10445901|P1|Overall Study|Withdrawal by Subject|2
3038568|NCT00686998|10445899|P3|Overall Study|Adverse Event|1
3038569|NCT00686998|10445900|P2|Overall Study|Adverse Event|2
3038570|NCT00686998|10445901|P1|Overall Study|Adverse Event|3
3038571|NCT00686972|10445909|P1|Overall Study|P.I, Left institution. Study terminated|51
3038572|NCT00686959|10445915|P2|Overall Study|Participants censored (no death events)|117
3038573|NCT00686959|10445916|P1|Overall Study|Participants censored (no death events)|124
3038574|NCT00686920|10445936|P2|Overall Study|Principal Investigator Decision|0
3038575|NCT00686920|10445937|P1|Overall Study|Principal Investigator Decision|2
3038576|NCT00686920|10445936|P2|Overall Study|Noncompliance|0
3038577|NCT00686920|10445937|P1|Overall Study|Noncompliance|9
3038578|NCT00686920|10445936|P2|Overall Study|Transferred to Nursing Home|0
3038579|NCT00686920|10445937|P1|Overall Study|Transferred to Nursing Home|1
3038580|NCT00686920|10445936|P2|Overall Study|Moved to Another State|0
3038581|NCT00686920|10445937|P1|Overall Study|Moved to Another State|1
3038582|NCT00686920|10445936|P2|Overall Study|Lost to Follow-up|3
3038583|NCT00686920|10445937|P1|Overall Study|Lost to Follow-up|15
3038584|NCT00686920|10445936|P2|Overall Study|Personal Reason|1
3038585|NCT00686920|10445937|P1|Overall Study|Personal Reason|0
3038586|NCT00686920|10445936|P2|Overall Study|Adverse Event|2
3038587|NCT00686920|10445937|P1|Overall Study|Adverse Event|10
3038588|NCT00686920|10445936|P2|Overall Study|Protocol Violation|1
3038589|NCT00686920|10445937|P1|Overall Study|Protocol Violation|2
3038590|NCT00686920|10445936|P2|Overall Study|Withdrawal by Subject|5
3038591|NCT00686920|10445937|P1|Overall Study|Withdrawal by Subject|23
3038592|NCT00686920|10445936|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
3038593|NCT00686920|10445937|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
3038594|NCT00686920|10445936|P2|Overall Study|Liver Transplant|8
3038595|NCT00686920|10445937|P1|Overall Study|Liver Transplant|23
3038596|NCT00686920|10445936|P2|Overall Study|Death|14
3038597|NCT00686920|10445937|P1|Overall Study|Death|45
3038598|NCT00686894|10445949|P1|Overall Study|Protocol Violation|4
3038599|NCT00686894|10445949|P1|Overall Study|Relapse|2
3038600|NCT00686881|10445955|P2|Overall Study|Never received study drug|6
3038601|NCT00686881|10445956|P1|Overall Study|Never received study drug|2
3038602|NCT00686881|10445955|P2|Overall Study|Study discontinuation|32
3038603|NCT00686881|10445956|P1|Overall Study|Study discontinuation|35
3038604|NCT00686881|10445955|P2|Overall Study|Irregular visits|0
3038605|NCT00686881|10445956|P1|Overall Study|Irregular visits|1
3038606|NCT00686881|10445955|P2|Overall Study|Did not meet protocol eligibility|0
3038607|NCT00686881|10445956|P1|Overall Study|Did not meet protocol eligibility|1
3038608|NCT00686881|10445955|P2|Overall Study|Circumstances of site|1
3038609|NCT00686881|10445956|P1|Overall Study|Circumstances of site|1
3038610|NCT00686881|10445955|P2|Overall Study|Physician Decision|0
3038611|NCT00686881|10445956|P1|Overall Study|Physician Decision|1
3038612|NCT00686881|10445955|P2|Overall Study|Lack of Efficacy|3
3038613|NCT00686881|10445956|P1|Overall Study|Lack of Efficacy|4
3038614|NCT00686881|10445955|P2|Overall Study|Onset of malignant tumor|11
3038615|NCT00686881|10445956|P1|Overall Study|Onset of malignant tumor|11
3038616|NCT00686881|10445955|P2|Overall Study|Met discontinuation criteria|0
3038617|NCT00686881|10445956|P1|Overall Study|Met discontinuation criteria|5
3038618|NCT00686881|10445955|P2|Overall Study|Treatment-related adverse event|9
3038619|NCT00686881|10445956|P1|Overall Study|Treatment-related adverse event|10
3038620|NCT00686881|10445955|P2|Overall Study|Lost to Follow-up|1
3038621|NCT00686881|10445956|P1|Overall Study|Lost to Follow-up|0
3038622|NCT00686881|10445955|P2|Overall Study|Withdrawal by Subject|18
3038623|NCT00686881|10445956|P1|Overall Study|Withdrawal by Subject|11
3038624|NCT00686855|10445968|P2|Overall Study|Progressive GVHD|1
3038625|NCT00686855|10445969|P1|Overall Study|Progressive GVHD|0
3038626|NCT00686855|10445968|P2|Overall Study|Lost to Follow-up|0
3038627|NCT00686855|10445969|P1|Overall Study|Lost to Follow-up|1
3038628|NCT00686790|10445995|P1|Overall Study|Lost to Follow-up|12
3038629|NCT00686790|10445995|P1|Overall Study|Death|1
3038630|NCT00686790|10445995|P1|Overall Study|Withdrawal by Subject|1
3038631|NCT00686790|10445995|P1|Overall Study|Adverse Event|2
3038632|NCT00686777|10446003|P1|Overall Study|No Visit|1
3038633|NCT00686777|10446003|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
3038634|NCT00686777|10446003|P1|Overall Study|Withdrawal by Subject|2
3038635|NCT00686777|10446003|P1|Overall Study|Pregnancy|1
3038636|NCT00686777|10446003|P1|Overall Study|Adverse Event|2
3038637|NCT00686725|10446011|P2|Overall Study|Other|3
3038638|NCT00686725|10446012|P1|Overall Study|Other|1
3038639|NCT00686725|10446011|P2|Overall Study|Protocol Violation|3
3038640|NCT00686725|10446012|P1|Overall Study|Protocol Violation|1
3038641|NCT00686725|10446011|P2|Overall Study|Withdrawal by Subject|4
3038642|NCT00686725|10446012|P1|Overall Study|Withdrawal by Subject|13
3038643|NCT00686725|10446011|P2|Overall Study|Death|3
3038644|NCT00686725|10446012|P1|Overall Study|Death|6
3038645|NCT00686725|10446011|P2|Overall Study|Lost to Follow-up|5
3038646|NCT00686725|10446012|P1|Overall Study|Lost to Follow-up|7
3038647|NCT00686725|10446011|P2|Overall Study|Progressive Disease|23
3038648|NCT00686725|10446012|P1|Overall Study|Progressive Disease|17
3038649|NCT00686725|10446011|P2|Overall Study|Adverse Event|1
3038650|NCT00686725|10446012|P1|Overall Study|Adverse Event|1
3038651|NCT00686712|10446037|P3|Overall Study|Adverse Event|0
3038652|NCT00686712|10446038|P2|Overall Study|Adverse Event|1
3038653|NCT00686712|10446039|P1|Overall Study|Adverse Event|1
3038654|NCT00686712|10446037|P3|Overall Study|Lost to Follow-up|3
3038655|NCT00686712|10446038|P2|Overall Study|Lost to Follow-up|2
3038656|NCT00686712|10446039|P1|Overall Study|Lost to Follow-up|1
3038657|NCT00686712|10446037|P3|Overall Study|Protocol Violation|10
3038658|NCT00686712|10446038|P2|Overall Study|Protocol Violation|8
3038659|NCT00686712|10446039|P1|Overall Study|Protocol Violation|8
3038660|NCT00686699|10446067|P2|Treatment Period 1|Adverse Event|2
3038661|NCT00686699|10446068|P1|Treatment Period 1|Adverse Event|0
3038662|NCT00686686|10446092|P1|Overall Study|Lost to Follow-up|3
3038663|NCT00686686|10446092|P1|Overall Study|Adverse Event|2
3038664|NCT00686686|10446092|P1|Overall Study|Non-compliance|1
3038665|NCT00686647|10446100|P1|Overall Study|Death|1
3038666|NCT00686647|10446100|P1|Overall Study|Lost to Follow-up|1
3038667|NCT00686634|10446106|P1|Overall Study|Protocol Violation|6
3038668|NCT00686595|10446113|P1|Overall Study|Poor Compliance|1
3038669|NCT00686595|10446113|P1|Overall Study|Lack of Efficacy|1
3038670|NCT00686595|10446113|P1|Overall Study|Lost to Follow-up|1
3038671|NCT00686595|10446113|P1|Overall Study|Protocol Violation|1
3038672|NCT00686595|10446113|P1|Overall Study|Adverse Event|3
3038673|NCT00686543|10446173|P4|Overall Study|Protocol Violation|1
3038674|NCT00686543|10446174|P3|Overall Study|Protocol Violation|2
3038675|NCT00686543|10446175|P2|Overall Study|Protocol Violation|0
3038676|NCT00686543|10446176|P1|Overall Study|Protocol Violation|3
3038677|NCT00686543|10446173|P4|Overall Study|Withdrawal by Subject|0
3038678|NCT00686543|10446174|P3|Overall Study|Withdrawal by Subject|0
3038679|NCT00686543|10446175|P2|Overall Study|Withdrawal by Subject|0
3038680|NCT00686543|10446176|P1|Overall Study|Withdrawal by Subject|2
3038681|NCT00686543|10446173|P4|Overall Study|Adverse Event|2
3038682|NCT00686543|10446174|P3|Overall Study|Adverse Event|3
3038683|NCT00686543|10446175|P2|Overall Study|Adverse Event|1
3038684|NCT00686543|10446176|P1|Overall Study|Adverse Event|9
3038685|NCT00686517|10446197|P3|Treatment|Protocol Violation|0
3038686|NCT00686517|10446198|P2|Treatment|Protocol Violation|1
3038687|NCT00686517|10446199|P1|Treatment|Protocol Violation|2
3038688|NCT00686517|10446197|P3|Treatment|Poor Protocol Compliance|0
3038689|NCT00686517|10446198|P2|Treatment|Poor Protocol Compliance|0
3038690|NCT00686517|10446199|P1|Treatment|Poor Protocol Compliance|1
3038691|NCT00686517|10446197|P3|Treatment|Adverse Event|0
3038692|NCT00686517|10446198|P2|Treatment|Adverse Event|0
3038693|NCT00686517|10446199|P1|Treatment|Adverse Event|2
3038694|NCT00686517|10446197|P3|Treatment|Serious Adverse Event|1
3038695|NCT00686517|10446198|P2|Treatment|Serious Adverse Event|2
3038696|NCT00686517|10446199|P1|Treatment|Serious Adverse Event|1
3038697|NCT00686374|10446222|P1|Overall Study|Other, not specified|4
3038698|NCT00686374|10446222|P1|Overall Study|Missing reason|33
3038699|NCT00686374|10446222|P1|Overall Study|Lost to Follow-up|1
3038700|NCT00686374|10446222|P1|Overall Study|Withdrew consent|5
3038701|NCT00686374|10446222|P1|Overall Study|Adverse Event|8
3038702|NCT00686374|10446222|P1|Overall Study|Lack of Efficacy|10
3038703|NCT00686335|10446233|P1|Run-in Period|violation of inclusion/exclusion criteri|3
3038704|NCT00686335|10446233|P1|Run-in Period|asthma exacerbation|1
3038705|NCT00686335|10446233|P1|Run-in Period|Adverse Event|1
3038706|NCT00686205|10446277|P2|Overall Study|Specimens not confirmed HIV positive|981
3038707|NCT00686205|10446278|P1|Overall Study|Specimens not confirmed HIV positive|0
3038708|NCT00686205|10446277|P2|Overall Study|Specimen handling procedure altered|0
3038709|NCT00686205|10446278|P1|Overall Study|Specimen handling procedure altered|5878
3038710|NCT00686205|10446277|P2|Overall Study|Withdrawal by Subject|0
3038711|NCT00686205|10446278|P1|Overall Study|Withdrawal by Subject|2
3038712|NCT00686205|10446277|P2|Overall Study|Protocol Violation|0
3038713|NCT00686205|10446278|P1|Overall Study|Protocol Violation|127
3038714|NCT00686166|10446284|P1|Overall Study|Did not begin protocol therapy|4
3038715|NCT00686166|10446284|P1|Overall Study|Ineligible|5
3038716|NCT00686166|10446284|P1|Overall Study|Not Protocol Specified|1
3038717|NCT00686166|10446284|P1|Overall Study|Death|1
3038718|NCT00686166|10446284|P1|Overall Study|Progression/Relapse|1
3038719|NCT00686166|10446284|P1|Overall Study|Withdrawal by Subject|1
3038720|NCT00686166|10446284|P1|Overall Study|Adverse Event|7
3038721|NCT00686127|10446296|P2|Overall Study|Withdrawal by Subject|6
3038722|NCT00686127|10446297|P1|Overall Study|Withdrawal by Subject|14
3038723|NCT00686075|10446313|P10|Overall Study|Other|1
3038724|NCT00686075|10446314|P9|Overall Study|Other|0
3038725|NCT00686075|10446315|P8|Overall Study|Other|0
3038726|NCT00686075|10446316|P7|Overall Study|Other|0
3038727|NCT00686075|10446317|P6|Overall Study|Other|0
3038728|NCT00686075|10446318|P5|Overall Study|Other|0
3038729|NCT00686075|10446319|P4|Overall Study|Other|0
3038730|NCT00686075|10446320|P3|Overall Study|Other|0
3038731|NCT00686075|10446321|P2|Overall Study|Other|1
3038732|NCT00686075|10446322|P1|Overall Study|Other|1
3038733|NCT00686075|10446313|P10|Overall Study|Lost to Follow-up|3
3038734|NCT00686075|10446314|P9|Overall Study|Lost to Follow-up|2
3038735|NCT00686075|10446315|P8|Overall Study|Lost to Follow-up|0
3038736|NCT00686075|10446316|P7|Overall Study|Lost to Follow-up|0
3038737|NCT00686075|10446317|P6|Overall Study|Lost to Follow-up|3
3038738|NCT00686075|10446318|P5|Overall Study|Lost to Follow-up|3
3038739|NCT00686075|10446319|P4|Overall Study|Lost to Follow-up|2
3038740|NCT00686075|10446320|P3|Overall Study|Lost to Follow-up|3
3038741|NCT00686075|10446321|P2|Overall Study|Lost to Follow-up|6
3038742|NCT00686075|10446322|P1|Overall Study|Lost to Follow-up|3
3038743|NCT00686075|10446313|P10|Overall Study|Withdrawal by Subject|6
3038744|NCT00686075|10446314|P9|Overall Study|Withdrawal by Subject|4
3038745|NCT00686075|10446315|P8|Overall Study|Withdrawal by Subject|2
3038746|NCT00686075|10446316|P7|Overall Study|Withdrawal by Subject|0
3038747|NCT00686075|10446317|P6|Overall Study|Withdrawal by Subject|0
3038748|NCT00686075|10446318|P5|Overall Study|Withdrawal by Subject|1
3038749|NCT00686075|10446319|P4|Overall Study|Withdrawal by Subject|7
3038750|NCT00686075|10446320|P3|Overall Study|Withdrawal by Subject|3
3038751|NCT00686075|10446321|P2|Overall Study|Withdrawal by Subject|3
3038752|NCT00686075|10446322|P1|Overall Study|Withdrawal by Subject|4
3038753|NCT00686036|10446516|P2|Overall Study|Other reasons not identified|4
3038754|NCT00686036|10446517|P1|Overall Study|Other reasons not identified|0
3038755|NCT00686036|10446516|P2|Overall Study|PSA ≥ 10ng/mL|0
3038756|NCT00686036|10446517|P1|Overall Study|PSA ≥ 10ng/mL|1
3038757|NCT00686036|10446516|P2|Overall Study|Study terminated by AstraZeneca|1
3038758|NCT00686036|10446517|P1|Overall Study|Study terminated by AstraZeneca|2
3038759|NCT00686036|10446516|P2|Overall Study|Withdrawal by Subject|1
3038760|NCT00686036|10446517|P1|Overall Study|Withdrawal by Subject|3
3038761|NCT00686036|10446516|P2|Overall Study|Adverse Event|0
3038762|NCT00686036|10446517|P1|Overall Study|Adverse Event|3
3038763|NCT00685945|10446529|P1|L-NMMA + Bradykinin|Physician Decision|1
3038764|NCT00685802|10446564|P2|Washout Period of 7 Days|Withdrawal by Subject|1
3038765|NCT00685802|10446565|P1|Washout Period of 7 Days|Withdrawal by Subject|0
3038766|NCT00685802|10446564|P2|Washout Period of 7 Days|Protocol Violation|0
3038767|NCT00685802|10446565|P1|Washout Period of 7 Days|Protocol Violation|2
3038768|NCT00685763|10446575|P1|Overall Study|Protocol Violation|1
3038769|NCT00685763|10446575|P1|Overall Study|Intercurrent death-incomplete treatment|1
3038770|NCT00685750|10446586|P7|Overall Study|Eligibility criteria not fulfilled|0
3038771|NCT00685750|10446587|P6|Overall Study|Eligibility criteria not fulfilled|0
3038772|NCT00685750|10446588|P5|Overall Study|Eligibility criteria not fulfilled|0
3038773|NCT00685750|10446589|P4|Overall Study|Eligibility criteria not fulfilled|0
3038774|NCT00685750|10446590|P3|Overall Study|Eligibility criteria not fulfilled|1
3038775|NCT00685750|10446591|P2|Overall Study|Eligibility criteria not fulfilled|0
3038776|NCT00685750|10446592|P1|Overall Study|Eligibility criteria not fulfilled|0
3038777|NCT00685750|10446586|P7|Overall Study|Patient didn't receive the treatment|1
3038778|NCT00685750|10446587|P6|Overall Study|Patient didn't receive the treatment|0
3038779|NCT00685750|10446588|P5|Overall Study|Patient didn't receive the treatment|0
3038780|NCT00685750|10446589|P4|Overall Study|Patient didn't receive the treatment|0
3038781|NCT00685750|10446590|P3|Overall Study|Patient didn't receive the treatment|0
3038782|NCT00685750|10446591|P2|Overall Study|Patient didn't receive the treatment|0
3038783|NCT00685750|10446592|P1|Overall Study|Patient didn't receive the treatment|0
3038784|NCT00685750|10446586|P7|Overall Study|Tumor sampling failure|0
3038785|NCT00685750|10446587|P6|Overall Study|Tumor sampling failure|0
3038786|NCT00685750|10446588|P5|Overall Study|Tumor sampling failure|0
3038787|NCT00685750|10446589|P4|Overall Study|Tumor sampling failure|0
3038788|NCT00685750|10446590|P3|Overall Study|Tumor sampling failure|1
3038789|NCT00685750|10446591|P2|Overall Study|Tumor sampling failure|0
3038790|NCT00685750|10446592|P1|Overall Study|Tumor sampling failure|0
3038791|NCT00685698|10446620|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
3038792|NCT00685698|10446620|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
3038793|NCT00685698|10446620|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
3038794|NCT00685698|10446620|P1|Overall Study|Adverse Event|3
3038795|NCT00685698|10446620|P1|Overall Study|Protocol Violation|6
3038796|NCT00685698|10446620|P1|Overall Study|Withdrawal by Subject|1
3038797|NCT00685685|10446655|P2|Washout Period of 7 Days|Withdrawal by Subject|1
3038798|NCT00685685|10446656|P1|Washout Period of 7 Days|Withdrawal by Subject|0
3038799|NCT00685685|10446655|P2|Washout Period of 7 Days|Adverse Event|0
3038800|NCT00685685|10446656|P1|Washout Period of 7 Days|Adverse Event|2
3038801|NCT00685399|10446809|P8|Extension|Adverse Event|0
3038802|NCT00685399|10446810|P7|Extension|Adverse Event|0
3038803|NCT00685399|10446811|P6|Extension|Adverse Event|0
3038804|NCT00685399|10446812|P5|Extension|Adverse Event|0
3038805|NCT00685399|10446813|P4|Extension|Adverse Event|2
3038806|NCT00685399|10446814|P3|Extension|Adverse Event|0
3038807|NCT00685399|10446815|P2|Extension|Adverse Event|0
3038808|NCT00685399|10446816|P1|Extension|Adverse Event|0
3038809|NCT00685399|10446809|P8|Extension|Lack of Efficacy|0
3038810|NCT00685399|10446810|P7|Extension|Lack of Efficacy|0
3038811|NCT00685399|10446811|P6|Extension|Lack of Efficacy|0
3038812|NCT00685399|10446812|P5|Extension|Lack of Efficacy|0
3038813|NCT00685399|10446813|P4|Extension|Lack of Efficacy|2
3038814|NCT00685399|10446814|P3|Extension|Lack of Efficacy|0
3038815|NCT00685399|10446815|P2|Extension|Lack of Efficacy|0
3038816|NCT00685399|10446816|P1|Extension|Lack of Efficacy|0
3038817|NCT00685399|10446809|P8|Extension|Protocol Violation|0
3038818|NCT00685399|10446810|P7|Extension|Protocol Violation|0
3038819|NCT00685399|10446811|P6|Extension|Protocol Violation|0
3038820|NCT00685399|10446812|P5|Extension|Protocol Violation|0
3038821|NCT00685399|10446813|P4|Extension|Protocol Violation|1
3038822|NCT00685399|10446814|P3|Extension|Protocol Violation|0
3038823|NCT00685399|10446815|P2|Extension|Protocol Violation|0
3038824|NCT00685399|10446816|P1|Extension|Protocol Violation|0
3038825|NCT00685399|10446809|P8|Extension|Withdrawal by Subject|0
3038826|NCT00685399|10446810|P7|Extension|Withdrawal by Subject|0
3038827|NCT00685399|10446811|P6|Extension|Withdrawal by Subject|0
3038828|NCT00685399|10446812|P5|Extension|Withdrawal by Subject|0
3038829|NCT00685399|10446813|P4|Extension|Withdrawal by Subject|1
3038830|NCT00685399|10446814|P3|Extension|Withdrawal by Subject|0
3038831|NCT00685399|10446815|P2|Extension|Withdrawal by Subject|0
3038832|NCT00685399|10446816|P1|Extension|Withdrawal by Subject|0
3038833|NCT00685399|10446809|P8|Extension|Administrative Issues|0
3038834|NCT00685399|10446810|P7|Extension|Administrative Issues|0
3038835|NCT00685399|10446811|P6|Extension|Administrative Issues|0
3038836|NCT00685399|10446812|P5|Extension|Administrative Issues|0
3038837|NCT00685399|10446813|P4|Extension|Administrative Issues|1
3038838|NCT00685399|10446814|P3|Extension|Administrative Issues|0
3038839|NCT00685399|10446815|P2|Extension|Administrative Issues|0
3038840|NCT00685399|10446816|P1|Extension|Administrative Issues|0
3038841|NCT00685399|10446809|P8|Treatment Period 2|Lack of Efficacy|0
3038842|NCT00685399|10446810|P7|Treatment Period 2|Lack of Efficacy|0
3038843|NCT00685399|10446811|P6|Treatment Period 2|Lack of Efficacy|1
3038844|NCT00685399|10446812|P5|Treatment Period 2|Lack of Efficacy|0
3038845|NCT00685399|10446813|P4|Treatment Period 2|Lack of Efficacy|0
3038846|NCT00685399|10446814|P3|Treatment Period 2|Lack of Efficacy|2
3038847|NCT00685399|10446815|P2|Treatment Period 2|Lack of Efficacy|10
3038848|NCT00685399|10446816|P1|Treatment Period 2|Lack of Efficacy|0
3038849|NCT00685399|10446809|P8|Treatment Period 2|Adverse Event|0
3038850|NCT00685399|10446810|P7|Treatment Period 2|Adverse Event|0
3038851|NCT00685399|10446811|P6|Treatment Period 2|Adverse Event|1
3038852|NCT00685399|10446812|P5|Treatment Period 2|Adverse Event|0
3038853|NCT00685399|10446813|P4|Treatment Period 2|Adverse Event|0
3038854|NCT00685399|10446814|P3|Treatment Period 2|Adverse Event|0
3038855|NCT00685399|10446815|P2|Treatment Period 2|Adverse Event|0
3038856|NCT00685399|10446816|P1|Treatment Period 2|Adverse Event|0
3038857|NCT00685399|10446809|P8|Treatment Period 2|Withdrawal by Subject|2
3038858|NCT00685399|10446810|P7|Treatment Period 2|Withdrawal by Subject|0
3038859|NCT00685399|10446811|P6|Treatment Period 2|Withdrawal by Subject|0
3038860|NCT00685399|10446812|P5|Treatment Period 2|Withdrawal by Subject|0
3038861|NCT00685399|10446813|P4|Treatment Period 2|Withdrawal by Subject|0
3038862|NCT00685399|10446814|P3|Treatment Period 2|Withdrawal by Subject|0
3038863|NCT00685399|10446815|P2|Treatment Period 2|Withdrawal by Subject|0
3038864|NCT00685399|10446816|P1|Treatment Period 2|Withdrawal by Subject|0
3038865|NCT00685399|10446809|P8|Treatment Period 2|Administrative Problems|0
3038866|NCT00685399|10446810|P7|Treatment Period 2|Administrative Problems|0
3038867|NCT00685399|10446811|P6|Treatment Period 2|Administrative Problems|0
3038868|NCT00685399|10446812|P5|Treatment Period 2|Administrative Problems|0
3038869|NCT00685399|10446813|P4|Treatment Period 2|Administrative Problems|0
3038870|NCT00685399|10446814|P3|Treatment Period 2|Administrative Problems|1
3038871|NCT00685399|10446815|P2|Treatment Period 2|Administrative Problems|2
3038872|NCT00685399|10446816|P1|Treatment Period 2|Administrative Problems|0
3038873|NCT00685399|10446809|P8|Treatment Period 1|Lack of Efficacy|0
3038874|NCT00685399|10446810|P7|Treatment Period 1|Lack of Efficacy|0
3038875|NCT00685399|10446811|P6|Treatment Period 1|Lack of Efficacy|0
3038876|NCT00685399|10446812|P5|Treatment Period 1|Lack of Efficacy|0
3038877|NCT00685399|10446813|P4|Treatment Period 1|Lack of Efficacy|0
3038878|NCT00685399|10446814|P3|Treatment Period 1|Lack of Efficacy|0
3038879|NCT00685399|10446815|P2|Treatment Period 1|Lack of Efficacy|0
3038880|NCT00685399|10446816|P1|Treatment Period 1|Lack of Efficacy|1
3038881|NCT00685399|10446809|P8|Treatment Period 1|Administrative|0
3038882|NCT00685399|10446810|P7|Treatment Period 1|Administrative|0
3038883|NCT00685399|10446811|P6|Treatment Period 1|Administrative|0
3038884|NCT00685399|10446812|P5|Treatment Period 1|Administrative|0
3038885|NCT00685399|10446813|P4|Treatment Period 1|Administrative|0
3038886|NCT00685399|10446814|P3|Treatment Period 1|Administrative|0
3038887|NCT00685399|10446815|P2|Treatment Period 1|Administrative|0
3038888|NCT00685399|10446816|P1|Treatment Period 1|Administrative|2
3038889|NCT00685399|10446809|P8|Treatment Period 1|Protocol Violation|0
3038890|NCT00685399|10446810|P7|Treatment Period 1|Protocol Violation|0
3038891|NCT00685399|10446811|P6|Treatment Period 1|Protocol Violation|0
3038892|NCT00685399|10446812|P5|Treatment Period 1|Protocol Violation|0
3038893|NCT00685399|10446813|P4|Treatment Period 1|Protocol Violation|0
3038894|NCT00685399|10446814|P3|Treatment Period 1|Protocol Violation|0
3038895|NCT00685399|10446815|P2|Treatment Period 1|Protocol Violation|0
3038896|NCT00685399|10446816|P1|Treatment Period 1|Protocol Violation|1
3038897|NCT00685399|10446809|P8|Treatment Period 1|Withdrawal by Subject|0
3038898|NCT00685399|10446810|P7|Treatment Period 1|Withdrawal by Subject|0
3038899|NCT00685399|10446811|P6|Treatment Period 1|Withdrawal by Subject|0
3038900|NCT00685399|10446812|P5|Treatment Period 1|Withdrawal by Subject|0
3038901|NCT00685399|10446813|P4|Treatment Period 1|Withdrawal by Subject|0
3038902|NCT00685399|10446814|P3|Treatment Period 1|Withdrawal by Subject|0
3038903|NCT00685399|10446815|P2|Treatment Period 1|Withdrawal by Subject|0
3038904|NCT00685399|10446816|P1|Treatment Period 1|Withdrawal by Subject|2
3038905|NCT00685373|10446849|P1|Overall Study|Protocol Violation|1
3038906|NCT00685373|10446849|P1|Overall Study|Lost to Follow-up|2
3038907|NCT00685373|10446849|P1|Overall Study|Condition no longer requires study drug|1
3038908|NCT00685373|10446849|P1|Overall Study|Lack of Efficacy|3
3038909|NCT00685373|10446849|P1|Overall Study|Withdrawal by Subject|5
3038910|NCT00685373|10446849|P1|Overall Study|Adverse Event|3
3038911|NCT00685334|10446858|P2|Overall Study|Chose to enter hospital|1
3038912|NCT00685334|10446859|P1|Overall Study|Chose to enter hospital|1
3038913|NCT00685334|10446858|P2|Overall Study|Lost to Follow-up|0
3038914|NCT00685334|10446859|P1|Overall Study|Lost to Follow-up|4
3038915|NCT00685334|10446858|P2|Overall Study|Withdrawal by Subject|6
3038916|NCT00685334|10446859|P1|Overall Study|Withdrawal by Subject|5
3038917|NCT00685178|10446884|P4|Overall Study|Pregnancy|1
3038918|NCT00685178|10446885|P3|Overall Study|Pregnancy|0
3038919|NCT00685178|10446886|P2|Overall Study|Pregnancy|0
3038920|NCT00685178|10446887|P1|Overall Study|Pregnancy|0
3038921|NCT00685178|10446884|P4|Overall Study|administrative (disciplinary) discharge|2
3038922|NCT00685178|10446885|P3|Overall Study|administrative (disciplinary) discharge|0
3038923|NCT00685178|10446886|P2|Overall Study|administrative (disciplinary) discharge|1
3038924|NCT00685178|10446887|P1|Overall Study|administrative (disciplinary) discharge|0
3038925|NCT00685178|10446884|P4|Overall Study|incarcerated|0
3038926|NCT00685178|10446885|P3|Overall Study|incarcerated|7
3038927|NCT00685178|10446886|P2|Overall Study|incarcerated|3
3038928|NCT00685178|10446887|P1|Overall Study|incarcerated|1
3038929|NCT00685178|10446884|P4|Overall Study|voluntary study discharge|1
3038930|NCT00685178|10446885|P3|Overall Study|voluntary study discharge|1
3038931|NCT00685178|10446886|P2|Overall Study|voluntary study discharge|5
3038932|NCT00685178|10446887|P1|Overall Study|voluntary study discharge|4
3038933|NCT00685178|10446884|P4|Overall Study|missed 3 consecutive methadone clin days|6
3038934|NCT00685178|10446885|P3|Overall Study|missed 3 consecutive methadone clin days|2
3038935|NCT00685178|10446886|P2|Overall Study|missed 3 consecutive methadone clin days|5
3038936|NCT00685178|10446887|P1|Overall Study|missed 3 consecutive methadone clin days|7
3038937|NCT00685178|10446884|P4|Overall Study|Adverse Event|4
3038938|NCT00685178|10446885|P3|Overall Study|Adverse Event|2
3038939|NCT00685178|10446886|P2|Overall Study|Adverse Event|5
3038940|NCT00685178|10446887|P1|Overall Study|Adverse Event|1
3038941|NCT00685165|10446901|P2|Washout Period of 14 Days|Adverse Event|0
3038942|NCT00685165|10446902|P1|Washout Period of 14 Days|Adverse Event|1
3038943|NCT00685035|10446921|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
3038944|NCT00685035|10446922|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
3038945|NCT00684996|10446946|P1|Overall Study|Other reasons not protocol specified|1
3038946|NCT00684996|10446946|P1|Overall Study|Progression/relapse|2
3038947|NCT00684996|10446946|P1|Overall Study|Refusal unrelated to adverse event|1
3038948|NCT00684996|10446946|P1|Overall Study|Adverse Event|1
3038949|NCT00684814|10446978|P2|Second Intervention|Adverse Event|0
3038950|NCT00684814|10446979|P1|Second Intervention|Adverse Event|1
3038951|NCT00684814|10446978|P2|Washout Period of 7 Days|Withdrawal by Subject|2
3038952|NCT00684814|10446979|P1|Washout Period of 7 Days|Withdrawal by Subject|1
3038953|NCT00684814|10446978|P2|Washout Period of 7 Days|Adverse Event|2
3038954|NCT00684814|10446979|P1|Washout Period of 7 Days|Adverse Event|1
3038955|NCT00684762|10447031|P2|Washout Period of 7 Days|Withdrawal by Subject|2
3038956|NCT00684762|10447032|P1|Washout Period of 7 Days|Withdrawal by Subject|2
3038957|NCT00684671|10447060|P3|Overall Study|Alcoholic dependance|0
3038958|NCT00684671|10447061|P2|Overall Study|Alcoholic dependance|0
3038959|NCT00684671|10447062|P1|Overall Study|Alcoholic dependance|1
3038960|NCT00684671|10447060|P3|Overall Study|Lost to Follow-up|0
3038961|NCT00684671|10447061|P2|Overall Study|Lost to Follow-up|0
3038962|NCT00684671|10447062|P1|Overall Study|Lost to Follow-up|1
3038963|NCT00684671|10447060|P3|Overall Study|Adverse Event|0
3038964|NCT00684671|10447061|P2|Overall Study|Adverse Event|0
3038965|NCT00684671|10447062|P1|Overall Study|Adverse Event|1
3038966|NCT00684645|10447091|P1|Overall Study|Other|15
3038967|NCT00684645|10447091|P1|Overall Study|Lost to Follow-up|3
3038968|NCT00684645|10447091|P1|Overall Study|Adverse Event|27
3038969|NCT00684645|10447091|P1|Overall Study|Progressive disease|67
3038970|NCT00684645|10447091|P1|Overall Study|Death|2
3038971|NCT00684593|10447111|P2|Overall Study|Adverse Event|2
3038972|NCT00684593|10447112|P1|Overall Study|Adverse Event|0
3038973|NCT00684567|10447124|P1|Monotherapy Period|Progression of primary disease|11
3038974|NCT00684567|10447124|P1|Monotherapy Period|Death|1
3038975|NCT00684567|10447124|P1|Monotherapy Period|Adverse Event|2
3038976|NCT00684567|10447124|P1|Concomitant Radiotherapy Period|Adverse Event|2
3038977|NCT00684515|10447157|P3|Overall Study|Protocol-Defined Clinical Event|0
3038978|NCT00684515|10447158|P2|Overall Study|Protocol-Defined Clinical Event|0
3038979|NCT00684515|10447159|P1|Overall Study|Protocol-Defined Clinical Event|1
3038980|NCT00684515|10447157|P3|Overall Study|Adverse Event|1
3038981|NCT00684515|10447158|P2|Overall Study|Adverse Event|3
3038982|NCT00684515|10447159|P1|Overall Study|Adverse Event|3
3038983|NCT00684424|10447182|P1|Overall Study|Other|2
3038984|NCT00684424|10447182|P1|Overall Study|Lost to Follow-up|2
3038985|NCT00684424|10447182|P1|Overall Study|Adverse Event|1
3038986|NCT00684411|10447197|P1|Overall Study|Adverse Event|1
3038987|NCT00684411|10447197|P1|Overall Study|Disease Progression|10
3038988|NCT00684411|10447197|P1|Overall Study|New Primary Cancer|1
3038989|NCT00684307|10447219|P5|Overall Study|Criteria from the CSR|3
3038990|NCT00684307|10447220|P4|Overall Study|Criteria from the CSR|3
3038991|NCT00684307|10447221|P3|Overall Study|Criteria from the CSR|1
3038992|NCT00684307|10447222|P2|Overall Study|Criteria from the CSR|0
3038993|NCT00684307|10447223|P1|Overall Study|Criteria from the CSR|0
3038994|NCT00684307|10447219|P5|Overall Study|Participant not willing to continue|8
3038995|NCT00684307|10447220|P4|Overall Study|Participant not willing to continue|5
3038996|NCT00684307|10447221|P3|Overall Study|Participant not willing to continue|11
3038997|NCT00684307|10447222|P2|Overall Study|Participant not willing to continue|10
3038998|NCT00684307|10447223|P1|Overall Study|Participant not willing to continue|7
3038999|NCT00684307|10447219|P5|Overall Study|Severe non compliance to protocol|2
3039000|NCT00684307|10447220|P4|Overall Study|Severe non compliance to protocol|1
3039001|NCT00684307|10447221|P3|Overall Study|Severe non compliance to protocol|0
3039002|NCT00684307|10447222|P2|Overall Study|Severe non compliance to protocol|0
3039003|NCT00684307|10447223|P1|Overall Study|Severe non compliance to protocol|1
3039004|NCT00684307|10447219|P5|Overall Study|Interupted IP for more than 7 days|3
3039005|NCT00684307|10447220|P4|Overall Study|Interupted IP for more than 7 days|3
3039006|NCT00684307|10447221|P3|Overall Study|Interupted IP for more than 7 days|1
3039007|NCT00684307|10447222|P2|Overall Study|Interupted IP for more than 7 days|4
3039008|NCT00684307|10447223|P1|Overall Study|Interupted IP for more than 7 days|0
3039009|NCT00684307|10447219|P5|Overall Study|Incorrect enrolment or randomization|0
3039010|NCT00684307|10447220|P4|Overall Study|Incorrect enrolment or randomization|0
3039011|NCT00684307|10447221|P3|Overall Study|Incorrect enrolment or randomization|0
3039012|NCT00684307|10447222|P2|Overall Study|Incorrect enrolment or randomization|0
3039013|NCT00684307|10447223|P1|Overall Study|Incorrect enrolment or randomization|4
3039014|NCT00684307|10447219|P5|Overall Study|Fullfillment of exclusion criteria|1
3039015|NCT00684307|10447220|P4|Overall Study|Fullfillment of exclusion criteria|3
3039016|NCT00684307|10447221|P3|Overall Study|Fullfillment of exclusion criteria|0
3039017|NCT00684307|10447222|P2|Overall Study|Fullfillment of exclusion criteria|0
3039018|NCT00684307|10447223|P1|Overall Study|Fullfillment of exclusion criteria|1
3039019|NCT00684307|10447219|P5|Overall Study|Development of increasing Liver Function|0
3039020|NCT00684307|10447220|P4|Overall Study|Development of increasing Liver Function|1
3039021|NCT00684307|10447221|P3|Overall Study|Development of increasing Liver Function|0
3039022|NCT00684307|10447222|P2|Overall Study|Development of increasing Liver Function|2
3039023|NCT00684307|10447223|P1|Overall Study|Development of increasing Liver Function|0
3039024|NCT00684307|10447219|P5|Overall Study|Adverse Event|8
3039025|NCT00684307|10447220|P4|Overall Study|Adverse Event|16
3039026|NCT00684307|10447221|P3|Overall Study|Adverse Event|15
3039027|NCT00684307|10447222|P2|Overall Study|Adverse Event|6
3039028|NCT00684307|10447223|P1|Overall Study|Adverse Event|11
3039029|NCT00684203|10447305|P6|Overall Study|Did not meet protocol eligibility|0
3039030|NCT00684203|10447306|P5|Overall Study|Did not meet protocol eligibility|0
3039031|NCT00684203|10447307|P4|Overall Study|Did not meet protocol eligibility|0
3039032|NCT00684203|10447308|P3|Overall Study|Did not meet protocol eligibility|0
3039033|NCT00684203|10447309|P2|Overall Study|Did not meet protocol eligibility|1
3039034|NCT00684203|10447310|P1|Overall Study|Did not meet protocol eligibility|0
3039035|NCT00684203|10447305|P6|Overall Study|Withdrawal by Subject|0
3039036|NCT00684203|10447306|P5|Overall Study|Withdrawal by Subject|0
3039037|NCT00684203|10447307|P4|Overall Study|Withdrawal by Subject|0
3039038|NCT00684203|10447308|P3|Overall Study|Withdrawal by Subject|1
3039039|NCT00684203|10447309|P2|Overall Study|Withdrawal by Subject|2
3039040|NCT00684203|10447310|P1|Overall Study|Withdrawal by Subject|0
3039041|NCT00684203|10447305|P6|Overall Study|Protocol-defined clinical event|0
3039042|NCT00684203|10447306|P5|Overall Study|Protocol-defined clinical event|0
3039043|NCT00684203|10447307|P4|Overall Study|Protocol-defined clinical event|0
3039044|NCT00684203|10447308|P3|Overall Study|Protocol-defined clinical event|0
3039045|NCT00684203|10447309|P2|Overall Study|Protocol-defined clinical event|1
3039046|NCT00684203|10447310|P1|Overall Study|Protocol-defined clinical event|3
3039047|NCT00684203|10447305|P6|Overall Study|Adverse Event|0
3039048|NCT00684203|10447306|P5|Overall Study|Adverse Event|0
3039049|NCT00684203|10447307|P4|Overall Study|Adverse Event|0
3039050|NCT00684203|10447308|P3|Overall Study|Adverse Event|8
3039051|NCT00684203|10447309|P2|Overall Study|Adverse Event|4
3039052|NCT00684203|10447310|P1|Overall Study|Adverse Event|6
3039053|NCT00684177|10447371|P2|Overall Study|Other|2
3039054|NCT00684177|10447372|P1|Overall Study|Other|1
3039055|NCT00684177|10447371|P2|Overall Study|Withdrawal by Subject|2
3039056|NCT00684177|10447372|P1|Overall Study|Withdrawal by Subject|1
3039057|NCT00684177|10447371|P2|Overall Study|Physician Decision|0
3039058|NCT00684177|10447372|P1|Overall Study|Physician Decision|2
3039059|NCT00684177|10447371|P2|Overall Study|Lost to Follow-up|1
3039060|NCT00684177|10447372|P1|Overall Study|Lost to Follow-up|2
3039061|NCT00684177|10447371|P2|Overall Study|Protocol Violation|0
3039062|NCT00684177|10447372|P1|Overall Study|Protocol Violation|1
3039063|NCT00684177|10447371|P2|Overall Study|Lack of Efficacy|15
3039064|NCT00684177|10447372|P1|Overall Study|Lack of Efficacy|10
3039065|NCT00684177|10447371|P2|Overall Study|Adverse Event|3
3039066|NCT00684177|10447372|P1|Overall Study|Adverse Event|4
3039067|NCT00684073|10447407|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
3039068|NCT00684073|10447407|P1|Selection|request of the sponsor|1
3039069|NCT00684073|10447407|P1|Selection|Lost to Follow-up|1
3039070|NCT00684073|10447407|P1|Selection|noncompliance|1
3039071|NCT00684073|10447407|P1|Selection|Death|1
3039072|NCT00684073|10447407|P1|Selection|Selection/non-selection criteria|3
3039073|NCT00684060|10447417|P2|Overall Study|Death|1
3039074|NCT00684060|10447418|P1|Overall Study|Death|0
3039075|NCT00684060|10447417|P2|Overall Study|Unable to collect MRI|2
3039076|NCT00684060|10447418|P1|Overall Study|Unable to collect MRI|1
3039077|NCT00684060|10447417|P2|Overall Study|New stenosis identified|0
3039078|NCT00684060|10447418|P1|Overall Study|New stenosis identified|1
3039079|NCT00684060|10447417|P2|Overall Study|Lost to Follow-up|0
3039080|NCT00684060|10447418|P1|Overall Study|Lost to Follow-up|1
3039081|NCT00684021|10447457|P4|Overall Study|Death|0
3039082|NCT00684021|10447458|P3|Overall Study|Death|0
3039083|NCT00684021|10447459|P2|Overall Study|Death|0
3039084|NCT00684021|10447460|P1|Overall Study|Death|1
3039085|NCT00684021|10447457|P4|Overall Study|MRI not performed|2
3039086|NCT00684021|10447458|P3|Overall Study|MRI not performed|1
3039087|NCT00684021|10447459|P2|Overall Study|MRI not performed|1
3039088|NCT00684021|10447460|P1|Overall Study|MRI not performed|0
3039089|NCT00684021|10447457|P4|Overall Study|MRI Contraindicated|0
3039090|NCT00684021|10447458|P3|Overall Study|MRI Contraindicated|1
3039091|NCT00684021|10447459|P2|Overall Study|MRI Contraindicated|1
3039092|NCT00684021|10447460|P1|Overall Study|MRI Contraindicated|1
3039093|NCT00683917|10447521|P1|Overall Study|Study prematurely terminated|10
3039094|NCT00683904|10447531|P2|Dose Level 2|Adverse Event|2
3039095|NCT00683904|10447532|P1|Dose Level 2|Adverse Event|0
3039096|NCT00683904|10447531|P2|Dose Level 1|Adverse Event|0
3039097|NCT00683904|10447532|P1|Dose Level 1|Adverse Event|1
3039098|NCT00683904|10447531|P2|Dose Level 1|Disease progression|0
3039099|NCT00683904|10447532|P1|Dose Level 1|Disease progression|2
3039100|NCT00683878|10447568|P3|Overall Study|Non-compliance, not met criteria etc.|0
3039101|NCT00683878|10447569|P2|Overall Study|Non-compliance, not met criteria etc.|2
3039102|NCT00683878|10447570|P1|Overall Study|Non-compliance, not met criteria etc.|3
3039103|NCT00683878|10447568|P3|Overall Study|Lost to Follow-up|4
3039104|NCT00683878|10447569|P2|Overall Study|Lost to Follow-up|2
3039105|NCT00683878|10447570|P1|Overall Study|Lost to Follow-up|4
3039106|NCT00683878|10447568|P3|Overall Study|Death|0
3039107|NCT00683878|10447569|P2|Overall Study|Death|1
3039108|NCT00683878|10447570|P1|Overall Study|Death|0
3039109|NCT00683878|10447568|P3|Overall Study|Withdrawal by Subject|6
3039110|NCT00683878|10447569|P2|Overall Study|Withdrawal by Subject|8
3039111|NCT00683878|10447570|P1|Overall Study|Withdrawal by Subject|9
3039112|NCT00683878|10447568|P3|Overall Study|Adverse Event|3
3039113|NCT00683878|10447569|P2|Overall Study|Adverse Event|3
3039114|NCT00683878|10447570|P1|Overall Study|Adverse Event|4
3039115|NCT00683878|10447568|P3|Overall Study|Lack of Efficacy|1
3039116|NCT00683878|10447569|P2|Overall Study|Lack of Efficacy|0
3039117|NCT00683878|10447570|P1|Overall Study|Lack of Efficacy|3
3039118|NCT00683800|10447644|P2|Overall Study|Randomized, not treated|33
3039119|NCT00683800|10447645|P1|Overall Study|Randomized, not treated|35
3039120|NCT00683800|10447644|P2|Overall Study|Lack of Efficacy|104
3039121|NCT00683800|10447645|P1|Overall Study|Lack of Efficacy|61
3039122|NCT00683800|10447644|P2|Overall Study|Withdrawal by Subject|64
3039123|NCT00683800|10447645|P1|Overall Study|Withdrawal by Subject|66
3039124|NCT00683800|10447644|P2|Overall Study|Protocol Violation|16
3039125|NCT00683800|10447645|P1|Overall Study|Protocol Violation|13
3039126|NCT00683800|10447644|P2|Overall Study|Other|2
3039127|NCT00683800|10447645|P1|Overall Study|Other|5
3039128|NCT00683800|10447644|P2|Overall Study|Lost to Follow-up|44
3039129|NCT00683800|10447645|P1|Overall Study|Lost to Follow-up|57
3039130|NCT00683800|10447644|P2|Overall Study|Death|1
3039131|NCT00683800|10447645|P1|Overall Study|Death|0
3039132|NCT00683800|10447644|P2|Overall Study|Adverse Event|102
3039133|NCT00683800|10447645|P1|Overall Study|Adverse Event|195
3039134|NCT00683787|10447712|P3|Overall Study|Adverse Event|2
3039135|NCT00683787|10447713|P2|Overall Study|Adverse Event|0
3039136|NCT00683787|10447714|P1|Overall Study|Adverse Event|0
3039137|NCT00683787|10447712|P3|Overall Study|Progression|0
3039138|NCT00683787|10447713|P2|Overall Study|Progression|3
3039139|NCT00683787|10447714|P1|Overall Study|Progression|3
3039140|NCT00683774|10447733|P2|Overall Study|Physician Decision|0
3039141|NCT00683774|10447734|P1|Overall Study|Physician Decision|3
3039142|NCT00683774|10447733|P2|Overall Study|Withdrawal by Subject|1
3039143|NCT00683774|10447734|P1|Overall Study|Withdrawal by Subject|0
3039144|NCT00683696|10447744|P2|Overall Study|Death|30
3039145|NCT00683696|10447745|P1|Overall Study|Death|46
3039146|NCT00683696|10447744|P2|Overall Study|Vital status follow-up only|3
3039147|NCT00683696|10447745|P1|Overall Study|Vital status follow-up only|3
3039148|NCT00683696|10447744|P2|Overall Study|Lost to Follow-up|6
3039149|NCT00683696|10447745|P1|Overall Study|Lost to Follow-up|5
3039150|NCT00683696|10447744|P2|Overall Study|Withdrawn prior to study closure|28
3039151|NCT00683696|10447745|P1|Overall Study|Withdrawn prior to study closure|13
3039152|NCT00683696|10447744|P2|Overall Study|Withdrawn due to study closure|338
3039153|NCT00683696|10447745|P1|Overall Study|Withdrawn due to study closure|337
3039154|NCT00683657|10447764|P2|Overall Study|Subject Withdrew Consent|0
3039155|NCT00683657|10447765|P1|Overall Study|Subject Withdrew Consent|1
3039156|NCT00683657|10447764|P2|Overall Study|Adverse Event|1
3039157|NCT00683657|10447765|P1|Overall Study|Adverse Event|0
3039158|NCT00683644|10447781|P2|Overall Study|Low copper, other health problems,|6
3039159|NCT00683644|10447782|P1|Overall Study|Low copper, other health problems,|7
3039160|NCT00683644|10447781|P2|Overall Study|Adverse Event|2
3039161|NCT00683644|10447782|P1|Overall Study|Adverse Event|1
3039162|NCT00683644|10447781|P2|Overall Study|Lost to Follow-up|4
3039163|NCT00683644|10447782|P1|Overall Study|Lost to Follow-up|1
3039164|NCT00683644|10447781|P2|Overall Study|Withdrawal by Subject|2
3039165|NCT00683644|10447782|P1|Overall Study|Withdrawal by Subject|4
3039166|NCT00683618|10447795|P3|Extension Treatment Period|Protocol Violation|0
3039167|NCT00683618|10447796|P2|Extension Treatment Period|Protocol Violation|0
3039168|NCT00683618|10447797|P1|Extension Treatment Period|Protocol Violation|1
3039169|NCT00683618|10447795|P3|Extension Treatment Period|Adverse Event|0
3039170|NCT00683618|10447796|P2|Extension Treatment Period|Adverse Event|0
3039171|NCT00683618|10447797|P1|Extension Treatment Period|Adverse Event|1
3039172|NCT00683618|10447795|P3|Extension Treatment Period|Withdrawal by Subject|0
3039173|NCT00683618|10447796|P2|Extension Treatment Period|Withdrawal by Subject|0
3039174|NCT00683618|10447797|P1|Extension Treatment Period|Withdrawal by Subject|1
3039175|NCT00683618|10447795|P3|Randomised Treatment Period|Reason not provided|2
3039176|NCT00683618|10447796|P2|Randomised Treatment Period|Reason not provided|0
3039177|NCT00683618|10447797|P1|Randomised Treatment Period|Reason not provided|0
3039178|NCT00683618|10447795|P3|Randomised Treatment Period|Adverse Event|2
3039179|NCT00683618|10447796|P2|Randomised Treatment Period|Adverse Event|0
3039180|NCT00683618|10447797|P1|Randomised Treatment Period|Adverse Event|2
3039181|NCT00683618|10447795|P3|Randomised Treatment Period|Protocol Violation|0
3039182|NCT00683618|10447796|P2|Randomised Treatment Period|Protocol Violation|1
3039183|NCT00683618|10447797|P1|Randomised Treatment Period|Protocol Violation|0
3039184|NCT00683618|10447795|P3|Randomised Treatment Period|Withdrawal by Subject|2
3039185|NCT00683618|10447796|P2|Randomised Treatment Period|Withdrawal by Subject|1
3039186|NCT00683618|10447797|P1|Randomised Treatment Period|Withdrawal by Subject|4
3039187|NCT00683592|10447847|P2|Overall Study|Other|1
3039188|NCT00683592|10447848|P1|Overall Study|Other|1
3039189|NCT00683592|10447847|P2|Overall Study|Non-compliance|5
3039190|NCT00683592|10447848|P1|Overall Study|Non-compliance|3
3039191|NCT00683592|10447847|P2|Overall Study|Physician Decision|1
3039192|NCT00683592|10447848|P1|Overall Study|Physician Decision|0
3039193|NCT00683592|10447847|P2|Overall Study|Lack of Efficacy|7
3039194|NCT00683592|10447848|P1|Overall Study|Lack of Efficacy|3
3039195|NCT00683592|10447847|P2|Overall Study|Lost to Follow-up|17
3039196|NCT00683592|10447848|P1|Overall Study|Lost to Follow-up|17
3039197|NCT00683592|10447847|P2|Overall Study|Withdrawal by Subject|11
3039198|NCT00683592|10447848|P1|Overall Study|Withdrawal by Subject|11
3039199|NCT00683592|10447847|P2|Overall Study|Adverse Event|4
3039200|NCT00683592|10447848|P1|Overall Study|Adverse Event|12
3039201|NCT00683475|10447866|P2|Overall Study|Never Treated: Progressive Disease|0
3039202|NCT00683475|10447867|P1|Overall Study|Never Treated: Progressive Disease|1
3039203|NCT00683475|10447866|P2|Overall Study|Never Treated: Adverse Event|3
3039204|NCT00683475|10447867|P1|Overall Study|Never Treated: Adverse Event|2
3039205|NCT00683475|10447866|P2|Overall Study|Withdrawal by Subject|0
3039206|NCT00683475|10447867|P1|Overall Study|Withdrawal by Subject|1
3039207|NCT00683449|10447902|P5|Overall Study|Lost to Follow-up|0
3039208|NCT00683449|10447903|P4|Overall Study|Lost to Follow-up|0
3039209|NCT00683449|10447904|P3|Overall Study|Lost to Follow-up|0
3039210|NCT00683449|10447905|P2|Overall Study|Lost to Follow-up|1
3039211|NCT00683449|10447906|P1|Overall Study|Lost to Follow-up|0
3039212|NCT00683384|10447932|P1|Overall Study|Adverse Event|1
3039213|NCT00683384|10447932|P1|Overall Study|Death|1
3039214|NCT00683293|10447942|P2|Overall Study|Withdrawal by Subject|3
3039215|NCT00683293|10447943|P1|Overall Study|Withdrawal by Subject|2
3039216|NCT00682929|10448006|P3|Overall Study|lag in DEA renewal|0
3039217|NCT00682929|10448007|P2|Overall Study|lag in DEA renewal|0
3039218|NCT00682929|10448008|P1|Overall Study|lag in DEA renewal|1
3039219|NCT00682929|10448006|P3|Overall Study|dosing compliance < 80%|0
3039220|NCT00682929|10448007|P2|Overall Study|dosing compliance < 80%|2
3039221|NCT00682929|10448008|P1|Overall Study|dosing compliance < 80%|0
3039222|NCT00682929|10448006|P3|Overall Study|Withdrawal by Subject|1
3039223|NCT00682929|10448007|P2|Overall Study|Withdrawal by Subject|2
3039224|NCT00682929|10448008|P1|Overall Study|Withdrawal by Subject|1
3039225|NCT00682929|10448006|P3|Overall Study|Adverse Event|1
3039226|NCT00682929|10448007|P2|Overall Study|Adverse Event|1
3039227|NCT00682929|10448008|P1|Overall Study|Adverse Event|4
3039228|NCT00682890|10448177|P2|Overall Study|heavy menstrual bleeding|0
3039229|NCT00682890|10448178|P1|Overall Study|heavy menstrual bleeding|1
3039230|NCT00682890|10448177|P2|Overall Study|subject moved away|1
3039231|NCT00682890|10448178|P1|Overall Study|subject moved away|0
3039232|NCT00682890|10448177|P2|Overall Study|Lost to Follow-up|1
3039233|NCT00682890|10448178|P1|Overall Study|Lost to Follow-up|1
3039234|NCT00682786|10448220|P2|Overall Study|Did not receive irinotecan|1
3039235|NCT00682786|10448221|P1|Overall Study|Did not receive irinotecan|0
3039236|NCT00682786|10448220|P2|Overall Study|Withdrawal by Subject|2
3039237|NCT00682786|10448221|P1|Overall Study|Withdrawal by Subject|2
3039238|NCT00682643|10448270|P2|Overall Study|Did Not Receive Study Drug|1
3039239|NCT00682643|10448271|P1|Overall Study|Did Not Receive Study Drug|1
3039240|NCT00682643|10448270|P2|Overall Study|Withdrawal by Subject|53
3039241|NCT00682643|10448271|P1|Overall Study|Withdrawal by Subject|19
3039242|NCT00682643|10448270|P2|Overall Study|Physician Decision|6
3039243|NCT00682643|10448271|P1|Overall Study|Physician Decision|2
3039244|NCT00682643|10448270|P2|Overall Study|Lost to Follow-up|6
3039245|NCT00682643|10448271|P1|Overall Study|Lost to Follow-up|1
3039246|NCT00682643|10448270|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
3039247|NCT00682643|10448271|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
3039248|NCT00682643|10448270|P2|Overall Study|Protocol Violation|76
3039249|NCT00682643|10448271|P1|Overall Study|Protocol Violation|38
3039250|NCT00682643|10448270|P2|Overall Study|Lack of Efficacy|0
3039251|NCT00682643|10448271|P1|Overall Study|Lack of Efficacy|2
3039252|NCT00682643|10448270|P2|Overall Study|Adverse Event|23
3039253|NCT00682643|10448271|P1|Overall Study|Adverse Event|12
3039254|NCT00682539|10448345|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
3039255|NCT00682539|10448346|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
3039256|NCT00682539|10448347|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
3039257|NCT00682539|10448345|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
3039258|NCT00682539|10448346|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
3039259|NCT00682539|10448347|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
3039260|NCT00682461|10448360|P2|Overall Study|Withdrawal by Subject|19
3039261|NCT00682461|10448361|P1|Overall Study|Withdrawal by Subject|12
3039262|NCT00682461|10448360|P2|Overall Study|Lost to Follow-up|5
3039263|NCT00682461|10448361|P1|Overall Study|Lost to Follow-up|8
3039264|NCT00682461|10448360|P2|Overall Study|Adverse Event|7
3039265|NCT00682461|10448361|P1|Overall Study|Adverse Event|5
3039266|NCT00682435|10448375|P1|Overall Study|Erroneously enrolled twice|2
3039267|NCT00682435|10448375|P1|Overall Study|Insufficient data|5
3039268|NCT00681863|10448408|P1|Overall Study|Other|18
3039269|NCT00681863|10448408|P1|Overall Study|Lack of Efficacy|2
3039270|NCT00681863|10448408|P1|Overall Study|Lost to Follow-up|2
3039271|NCT00681863|10448408|P1|Overall Study|Adverse Event|1
3039272|NCT00681824|10448456|P3|Overall Study|Death|0
3039273|NCT00681824|10448457|P2|Overall Study|Death|1
3039274|NCT00681824|10448458|P1|Overall Study|Death|0
3039275|NCT00681824|10448456|P3|Overall Study|scheduling conflict|0
3039276|NCT00681824|10448457|P2|Overall Study|scheduling conflict|0
3039277|NCT00681824|10448458|P1|Overall Study|scheduling conflict|1
3039278|NCT00681824|10448456|P3|Overall Study|withdrawn by investigator|1
3039279|NCT00681824|10448457|P2|Overall Study|withdrawn by investigator|0
3039280|NCT00681824|10448458|P1|Overall Study|withdrawn by investigator|0
3039281|NCT00681811|10448476|P2|Overall Study|Non-compliance|1
3039282|NCT00681811|10448477|P1|Overall Study|Non-compliance|0
3039283|NCT00681811|10448476|P2|Overall Study|Withdrawal by Subject|2
3039284|NCT00681811|10448477|P1|Overall Study|Withdrawal by Subject|2
3039285|NCT00681811|10448476|P2|Overall Study|Adverse Event|1
3039286|NCT00681811|10448477|P1|Overall Study|Adverse Event|1
3039287|NCT00681668|10448505|P1|Overall Study|Withdrawal by Subject|1
3039288|NCT00681668|10448505|P1|Overall Study|Protocol Violation|1
3039289|NCT00681629|10448514|P2|Overall Study|Adverse Event|0
3039290|NCT00681629|10448515|P1|Overall Study|Adverse Event|1
3039291|NCT00681629|10448514|P2|Overall Study|Study termination|2
3039292|NCT00681629|10448515|P1|Overall Study|Study termination|4
3039293|NCT00681590|10448561|P2|Overall Study|Withdrawal by Subject|12
3039294|NCT00681590|10448562|P1|Overall Study|Withdrawal by Subject|2
3039295|NCT00681564|10448572|P2|Overall Study|Death|1
3039296|NCT00681564|10448573|P1|Overall Study|Death|0
3039297|NCT00681564|10448572|P2|Overall Study|Withdrawal by Subject|1
3039298|NCT00681564|10448573|P1|Overall Study|Withdrawal by Subject|0
3039299|NCT00681564|10448572|P2|Overall Study|Lost to Follow-up|6
3039300|NCT00681564|10448573|P1|Overall Study|Lost to Follow-up|6
3039301|NCT00681187|10448665|P2|Overall Study|Adverse Event|1
3039302|NCT00681187|10448666|P1|Overall Study|Adverse Event|0
3039303|NCT00681187|10448665|P2|Overall Study|Death|1
3039304|NCT00681187|10448666|P1|Overall Study|Death|0
3039305|NCT00681187|10448665|P2|Overall Study|Withdrawal by Subject|0
3039306|NCT00681187|10448666|P1|Overall Study|Withdrawal by Subject|1
3039307|NCT00681109|10448701|P3|Overall Study|Lost to Follow-up|0
3039308|NCT00681109|10448702|P2|Overall Study|Lost to Follow-up|6
3039309|NCT00681109|10448703|P1|Overall Study|Lost to Follow-up|2
3039310|NCT00680992|10448744|P3|Overall Study|Ineligibility Determined|0
3039311|NCT00680992|10448745|P2|Overall Study|Ineligibility Determined|1
3039312|NCT00680992|10448746|P1|Overall Study|Ineligibility Determined|0
3039313|NCT00680992|10448744|P3|Overall Study|Death|0
3039314|NCT00680992|10448745|P2|Overall Study|Death|1
3039315|NCT00680992|10448746|P1|Overall Study|Death|5
3039316|NCT00680992|10448744|P3|Overall Study|Pregnancy|1
3039317|NCT00680992|10448745|P2|Overall Study|Pregnancy|0
3039318|NCT00680992|10448746|P1|Overall Study|Pregnancy|5
3039319|NCT00680992|10448744|P3|Overall Study|Requirement for Alternative Therapy|0
3039320|NCT00680992|10448745|P2|Overall Study|Requirement for Alternative Therapy|2
3039321|NCT00680992|10448746|P1|Overall Study|Requirement for Alternative Therapy|8
3039322|NCT00680992|10448744|P3|Overall Study|Noncompliance|0
3039323|NCT00680992|10448745|P2|Overall Study|Noncompliance|6
3039324|NCT00680992|10448746|P1|Overall Study|Noncompliance|4
3039325|NCT00680992|10448744|P3|Overall Study|Lost to Follow-up|0
3039326|NCT00680992|10448745|P2|Overall Study|Lost to Follow-up|14
3039327|NCT00680992|10448746|P1|Overall Study|Lost to Follow-up|12
3039328|NCT00680992|10448744|P3|Overall Study|Disease Progression|0
3039329|NCT00680992|10448745|P2|Overall Study|Disease Progression|9
3039330|NCT00680992|10448746|P1|Overall Study|Disease Progression|21
3039331|NCT00680992|10448744|P3|Overall Study|Other|1
3039332|NCT00680992|10448745|P2|Overall Study|Other|14
3039333|NCT00680992|10448746|P1|Overall Study|Other|19
3039334|NCT00680992|10448744|P3|Overall Study|Adverse Event|1
3039335|NCT00680992|10448745|P2|Overall Study|Adverse Event|19
3039336|NCT00680992|10448746|P1|Overall Study|Adverse Event|21
3039337|NCT00680992|10448744|P3|Overall Study|Withdrawal by Subject|1
3039338|NCT00680992|10448745|P2|Overall Study|Withdrawal by Subject|11
3039339|NCT00680992|10448746|P1|Overall Study|Withdrawal by Subject|33
3039340|NCT00680992|10448744|P3|Overall Study|End of Trial|3
3039341|NCT00680992|10448745|P2|Overall Study|End of Trial|12
3039342|NCT00680992|10448746|P1|Overall Study|End of Trial|32
3039343|NCT00680992|10448744|P3|Overall Study|Administrative Decision|5
3039344|NCT00680992|10448745|P2|Overall Study|Administrative Decision|42
3039345|NCT00680992|10448746|P1|Overall Study|Administrative Decision|83
3039346|NCT00680992|10448744|P3|Overall Study|Complete Resection (as per protocol)|0
3039347|NCT00680992|10448745|P2|Overall Study|Complete Resection (as per protocol)|121
3039348|NCT00680992|10448746|P1|Overall Study|Complete Resection (as per protocol)|25
3039349|NCT00680914|10448780|P2|Overall Study|serious adverse event (SAE)|1
3039350|NCT00680914|10448781|P1|Overall Study|serious adverse event (SAE)|0
3039351|NCT00680914|10448780|P2|Overall Study|Lost to Follow-up|0
3039352|NCT00680914|10448781|P1|Overall Study|Lost to Follow-up|4
3039353|NCT00680914|10448780|P2|Overall Study|Consent withdrawal|3
3039354|NCT00680914|10448781|P1|Overall Study|Consent withdrawal|6
3039355|NCT00680901|10448815|P2|Overall Study|Ongoing: In Follow Up|41
3039356|NCT00680901|10448816|P1|Overall Study|Ongoing: In Follow Up|45
3039357|NCT00680901|10448815|P2|Overall Study|Ongoing: On Study Treatment|13
3039358|NCT00680901|10448816|P1|Overall Study|Ongoing: On Study Treatment|16
3039359|NCT00680901|10448815|P2|Overall Study|Physician Decision|1
3039360|NCT00680901|10448816|P1|Overall Study|Physician Decision|0
3039361|NCT00680901|10448815|P2|Overall Study|Withdrawal by Subject|13
3039362|NCT00680901|10448816|P1|Overall Study|Withdrawal by Subject|4
3039363|NCT00680901|10448815|P2|Overall Study|Lost to Follow-up|8
3039364|NCT00680901|10448816|P1|Overall Study|Lost to Follow-up|8
3039365|NCT00680836|10448854|P2|Overall Study|Physician Decision|1
3039366|NCT00680836|10448855|P1|Overall Study|Physician Decision|2
3039367|NCT00680836|10448854|P2|Overall Study|Lost to Follow-up|1
3039368|NCT00680836|10448855|P1|Overall Study|Lost to Follow-up|3
3039369|NCT00680836|10448854|P2|Overall Study|Withdrawal by Subject|0
3039370|NCT00680836|10448855|P1|Overall Study|Withdrawal by Subject|3
3039371|NCT00680771|10448909|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
3039372|NCT00680771|10448910|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
3039373|NCT00680771|10448909|P2|Overall Study|Sleep Apnea suspected after PSG|0
3039374|NCT00680771|10448910|P1|Overall Study|Sleep Apnea suspected after PSG|1
3039375|NCT00680771|10448909|P2|Overall Study|Withdrawal by Subject|0
3039376|NCT00680771|10448910|P1|Overall Study|Withdrawal by Subject|1
3039377|NCT00680745|10448920|P4|Overall Study|False Treatment|0
3039378|NCT00680745|10448921|P3|Overall Study|False Treatment|3
3039379|NCT00680745|10448922|P2|Overall Study|False Treatment|1
3039380|NCT00680745|10448923|P1|Overall Study|False Treatment|0
3039381|NCT00680745|10448920|P4|Overall Study|Subject No Longer Meets Study Criteria|2
3039382|NCT00680745|10448921|P3|Overall Study|Subject No Longer Meets Study Criteria|0
3039383|NCT00680745|10448922|P2|Overall Study|Subject No Longer Meets Study Criteria|2
3039384|NCT00680745|10448923|P1|Overall Study|Subject No Longer Meets Study Criteria|0
3039385|NCT00680745|10448920|P4|Overall Study|Poor/Non-compliance|0
3039386|NCT00680745|10448921|P3|Overall Study|Poor/Non-compliance|0
3039387|NCT00680745|10448922|P2|Overall Study|Poor/Non-compliance|3
3039388|NCT00680745|10448923|P1|Overall Study|Poor/Non-compliance|0
3039389|NCT00680745|10448920|P4|Overall Study|Adverse Event|3
3039390|NCT00680745|10448921|P3|Overall Study|Adverse Event|3
3039391|NCT00680745|10448922|P2|Overall Study|Adverse Event|3
3039392|NCT00680745|10448923|P1|Overall Study|Adverse Event|5
3039393|NCT00680745|10448920|P4|Overall Study|Death|0
3039394|NCT00680745|10448921|P3|Overall Study|Death|1
3039395|NCT00680745|10448922|P2|Overall Study|Death|0
3039396|NCT00680745|10448923|P1|Overall Study|Death|1
3039397|NCT00680745|10448920|P4|Overall Study|Lost to Follow-up|0
3039398|NCT00680745|10448921|P3|Overall Study|Lost to Follow-up|1
3039399|NCT00680745|10448922|P2|Overall Study|Lost to Follow-up|1
3039400|NCT00680745|10448923|P1|Overall Study|Lost to Follow-up|0
3039401|NCT00680745|10448920|P4|Overall Study|Withdrawal by Subject|8
3039402|NCT00680745|10448921|P3|Overall Study|Withdrawal by Subject|2
3039403|NCT00680745|10448922|P2|Overall Study|Withdrawal by Subject|3
3039404|NCT00680745|10448923|P1|Overall Study|Withdrawal by Subject|8
3039405|NCT00680407|10448997|P3|Overall Study|Withdrawal by Subject|2
3039406|NCT00680407|10448998|P2|Overall Study|Withdrawal by Subject|2
3039407|NCT00680407|10448999|P1|Overall Study|Withdrawal by Subject|5
3039408|NCT00680407|10448997|P3|Overall Study|Lost to Follow-up|1
3039409|NCT00680407|10448998|P2|Overall Study|Lost to Follow-up|3
3039410|NCT00680407|10448999|P1|Overall Study|Lost to Follow-up|3
3039411|NCT00680368|10449013|P1|Overall Study|not supervised, not eligible|15
3039412|NCT00680186|10449041|P2|Overall Study|Other|1
3039413|NCT00680186|10449042|P1|Overall Study|Other|4
3039414|NCT00680186|10449041|P2|Overall Study|Withdrawal by Subject|39
3039415|NCT00680186|10449042|P1|Overall Study|Withdrawal by Subject|32
3039416|NCT00680186|10449041|P2|Overall Study|Lost to Follow-up|6
3039417|NCT00680186|10449042|P1|Overall Study|Lost to Follow-up|11
3039418|NCT00680186|10449041|P2|Overall Study|Protocol Violation|26
3039419|NCT00680186|10449042|P1|Overall Study|Protocol Violation|31
3039420|NCT00680186|10449041|P2|Overall Study|Adverse Event|44
3039421|NCT00680186|10449042|P1|Overall Study|Adverse Event|47
3039422|NCT00680121|10449068|P2|Overall Study|Lost to Follow-up|23
3039423|NCT00680121|10449069|P1|Overall Study|Lost to Follow-up|27
3039424|NCT00680056|10449083|P2|Second Intervention|Protocol Violation|1
3039425|NCT00680056|10449084|P1|Second Intervention|Protocol Violation|3
3039426|NCT00680056|10449083|P2|First Intervention|Mainly Exacerbation of COPD|2
3039427|NCT00680056|10449084|P1|First Intervention|Mainly Exacerbation of COPD|1
3039428|NCT00680043|10449095|P3|Overall Study|Renal Transplant|4
3039429|NCT00680043|10449096|P2|Overall Study|Renal Transplant|0
3039430|NCT00680043|10449097|P1|Overall Study|Renal Transplant|1
3039431|NCT00680043|10449095|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
3039432|NCT00680043|10449096|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
3039433|NCT00680043|10449097|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
3039434|NCT00680043|10449095|P3|Overall Study|Withdrawal by Subject|0
3039435|NCT00680043|10449096|P2|Overall Study|Withdrawal by Subject|0
3039436|NCT00680043|10449097|P1|Overall Study|Withdrawal by Subject|1
3039437|NCT00680017|10449113|P2|Overall Study|Lost to Follow-up|0
3039438|NCT00680017|10449114|P1|Overall Study|Lost to Follow-up|2
3039439|NCT00680017|10449113|P2|Overall Study|Withdrawal by Subject|5
3039440|NCT00680017|10449114|P1|Overall Study|Withdrawal by Subject|2
3039441|NCT00680017|10449113|P2|Overall Study|Adverse Event|7
3039442|NCT00680017|10449114|P1|Overall Study|Adverse Event|13
3039443|NCT00679939|10449133|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
3039444|NCT00679939|10449134|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
3039445|NCT00679939|10449133|P2|24-Week Open-Label (OL) Period|Physician Decision|0
3039446|NCT00679939|10449134|P1|24-Week Open-Label (OL) Period|Physician Decision|1
3039447|NCT00679939|10449133|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
3039448|NCT00679939|10449134|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
3039449|NCT00679939|10449133|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
3039450|NCT00679939|10449134|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
3039451|NCT00679939|10449133|P2|24-Week Open-Label (OL) Period|Adverse Event|1
3039452|NCT00679939|10449134|P1|24-Week Open-Label (OL) Period|Adverse Event|0
3039453|NCT00679939|10449133|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
3039454|NCT00679939|10449134|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
3039455|NCT00679939|10449133|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
3039456|NCT00679939|10449134|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
3039457|NCT00679939|10449133|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
3039458|NCT00679939|10449134|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
3039459|NCT00679939|10449133|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
3039460|NCT00679939|10449134|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
3039461|NCT00679939|10449133|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
3039462|NCT00679939|10449134|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
3039463|NCT00679913|10449285|P2|Overall Study|Protocol Violation|13
3039464|NCT00679913|10449286|P1|Overall Study|Protocol Violation|18
3039465|NCT00679783|10449301|P7|Overall Study|Ongoing at data cut-off|0
3039466|NCT00679783|10449302|P6|Overall Study|Ongoing at data cut-off|0
3039467|NCT00679783|10449303|P5|Overall Study|Ongoing at data cut-off|1
3039468|NCT00679783|10449304|P4|Overall Study|Ongoing at data cut-off|9
3039469|NCT00679783|10449305|P3|Overall Study|Ongoing at data cut-off|0
3039470|NCT00679783|10449306|P2|Overall Study|Ongoing at data cut-off|2
3039471|NCT00679783|10449307|P1|Overall Study|Ongoing at data cut-off|2
3039472|NCT00679783|10449301|P7|Overall Study|Not Captured|0
3039473|NCT00679783|10449302|P6|Overall Study|Not Captured|0
3039474|NCT00679783|10449303|P5|Overall Study|Not Captured|0
3039475|NCT00679783|10449304|P4|Overall Study|Not Captured|5
3039476|NCT00679783|10449305|P3|Overall Study|Not Captured|0
3039477|NCT00679783|10449306|P2|Overall Study|Not Captured|0
3039478|NCT00679783|10449307|P1|Overall Study|Not Captured|0
3039479|NCT00679783|10449301|P7|Overall Study|Withdrawal by Subject|0
3039480|NCT00679783|10449302|P6|Overall Study|Withdrawal by Subject|0
3039481|NCT00679783|10449303|P5|Overall Study|Withdrawal by Subject|0
3039482|NCT00679783|10449304|P4|Overall Study|Withdrawal by Subject|1
3039483|NCT00679783|10449305|P3|Overall Study|Withdrawal by Subject|1
3039484|NCT00679783|10449306|P2|Overall Study|Withdrawal by Subject|0
3039485|NCT00679783|10449307|P1|Overall Study|Withdrawal by Subject|0
3039486|NCT00679783|10449301|P7|Overall Study|Lack of Efficacy|0
3039487|NCT00679783|10449302|P6|Overall Study|Lack of Efficacy|0
3039488|NCT00679783|10449303|P5|Overall Study|Lack of Efficacy|0
3039489|NCT00679783|10449304|P4|Overall Study|Lack of Efficacy|2
3039490|NCT00679783|10449305|P3|Overall Study|Lack of Efficacy|0
3039491|NCT00679783|10449306|P2|Overall Study|Lack of Efficacy|1
3039492|NCT00679783|10449307|P1|Overall Study|Lack of Efficacy|0
3039493|NCT00679783|10449301|P7|Overall Study|Adverse Event|1
3039494|NCT00679783|10449302|P6|Overall Study|Adverse Event|0
3039495|NCT00679783|10449303|P5|Overall Study|Adverse Event|0
3039496|NCT00679783|10449304|P4|Overall Study|Adverse Event|3
3039497|NCT00679783|10449305|P3|Overall Study|Adverse Event|0
3039498|NCT00679783|10449306|P2|Overall Study|Adverse Event|0
3039499|NCT00679783|10449307|P1|Overall Study|Adverse Event|0
3039500|NCT00679627|10449360|P2|Overall Study|Early Study Closure|405
3039501|NCT00679627|10449361|P1|Overall Study|Early Study Closure|425
3039502|NCT00679627|10449360|P2|Overall Study|Lost to Follow-up|26
3039503|NCT00679627|10449361|P1|Overall Study|Lost to Follow-up|22
3039504|NCT00679627|10449360|P2|Overall Study|Withdrawal by Subject|172
3039505|NCT00679627|10449361|P1|Overall Study|Withdrawal by Subject|168
3039506|NCT00679627|10449360|P2|Overall Study|Adverse Event|53
3039507|NCT00679627|10449361|P1|Overall Study|Adverse Event|43
3039508|NCT00679627|10449360|P2|Overall Study|Death|29
3039509|NCT00679627|10449361|P1|Overall Study|Death|41
3039510|NCT00679549|10449385|P2|Overall Study|missing outcome echocardiograms|5
3039511|NCT00679549|10449386|P1|Overall Study|missing outcome echocardiograms|4
3039512|NCT00679549|10449385|P2|Overall Study|dropout|4
3039513|NCT00679549|10449386|P1|Overall Study|dropout|2
3039514|NCT00679432|10449396|P4|Overall Study|Randomization error, return to prior Rx|0
3039515|NCT00679432|10449397|P3|Overall Study|Randomization error, return to prior Rx|3
3039516|NCT00679432|10449398|P2|Overall Study|Randomization error, return to prior Rx|0
3039517|NCT00679432|10449399|P1|Overall Study|Randomization error, return to prior Rx|0
3039518|NCT00679432|10449396|P4|Overall Study|Infectious colitis, normal histology|3
3039519|NCT00679432|10449397|P3|Overall Study|Infectious colitis, normal histology|8
3039520|NCT00679432|10449398|P2|Overall Study|Infectious colitis, normal histology|4
3039521|NCT00679432|10449399|P1|Overall Study|Infectious colitis, normal histology|5
3039522|NCT00679432|10449396|P4|Overall Study|Lack of Efficacy|8
3039523|NCT00679432|10449397|P3|Overall Study|Lack of Efficacy|14
3039524|NCT00679432|10449398|P2|Overall Study|Lack of Efficacy|9
3039525|NCT00679432|10449399|P1|Overall Study|Lack of Efficacy|13
3039526|NCT00679432|10449396|P4|Overall Study|Sponsor decision|0
3039527|NCT00679432|10449397|P3|Overall Study|Sponsor decision|0
3039528|NCT00679432|10449398|P2|Overall Study|Sponsor decision|0
3039529|NCT00679432|10449399|P1|Overall Study|Sponsor decision|1
3039530|NCT00679432|10449396|P4|Overall Study|Physician Decision|2
3039531|NCT00679432|10449397|P3|Overall Study|Physician Decision|2
3039532|NCT00679432|10449398|P2|Overall Study|Physician Decision|2
3039533|NCT00679432|10449399|P1|Overall Study|Physician Decision|3
3039534|NCT00679432|10449396|P4|Overall Study|Lost to Follow-up|2
3039535|NCT00679432|10449397|P3|Overall Study|Lost to Follow-up|4
3039536|NCT00679432|10449398|P2|Overall Study|Lost to Follow-up|5
3039537|NCT00679432|10449399|P1|Overall Study|Lost to Follow-up|1
3039538|NCT00679432|10449396|P4|Overall Study|Withdrawal by Subject|9
3039539|NCT00679432|10449397|P3|Overall Study|Withdrawal by Subject|10
3039540|NCT00679432|10449398|P2|Overall Study|Withdrawal by Subject|11
3039541|NCT00679432|10449399|P1|Overall Study|Withdrawal by Subject|8
3039542|NCT00679432|10449396|P4|Overall Study|Protocol Violation|1
3039543|NCT00679432|10449397|P3|Overall Study|Protocol Violation|2
3039544|NCT00679432|10449398|P2|Overall Study|Protocol Violation|1
3039545|NCT00679432|10449399|P1|Overall Study|Protocol Violation|1
3039546|NCT00679432|10449396|P4|Overall Study|Adverse Event|7
3039547|NCT00679432|10449397|P3|Overall Study|Adverse Event|10
3039548|NCT00679432|10449398|P2|Overall Study|Adverse Event|6
3039549|NCT00679432|10449399|P1|Overall Study|Adverse Event|5
3039550|NCT00679367|10449442|P1|Overall Study|Withdrawal by Subject|1
3039551|NCT00679367|10449442|P1|Overall Study|Lack of Efficacy|3
3039552|NCT00679367|10449442|P1|Overall Study|inability to swallow oral drugs|1
3039553|NCT00679367|10449442|P1|Overall Study|Adverse Event|7
3039554|NCT00679354|10449448|P1|Overall Study|Ineligible|1
3039555|NCT00679354|10449448|P1|Overall Study|Physician Decision|4
3039556|NCT00679354|10449448|P1|Overall Study|Lack of Efficacy|22
3039557|NCT00679354|10449448|P1|Overall Study|Death|3
3039558|NCT00679341|10449466|P2|Overall Study|Physician/patient decision to withdraw|6
3039559|NCT00679341|10449467|P1|Overall Study|Physician/patient decision to withdraw|0
3039560|NCT00679341|10449466|P2|Overall Study|Not treated|2
3039561|NCT00679341|10449467|P1|Overall Study|Not treated|0
3039562|NCT00679341|10449466|P2|Overall Study|Physician Decision|0
3039563|NCT00679341|10449467|P1|Overall Study|Physician Decision|1
3039564|NCT00679341|10449466|P2|Overall Study|Other|0
3039565|NCT00679341|10449467|P1|Overall Study|Other|1
3039566|NCT00679341|10449466|P2|Overall Study|Death|1
3039567|NCT00679341|10449467|P1|Overall Study|Death|1
3039568|NCT00679341|10449466|P2|Overall Study|Subject/guardian decision to discontinue|0
3039569|NCT00679341|10449467|P1|Overall Study|Subject/guardian decision to discontinue|3
3039570|NCT00679341|10449466|P2|Overall Study|Adverse Event|6
3039571|NCT00679341|10449467|P1|Overall Study|Adverse Event|5
3039572|NCT00679341|10449466|P2|Overall Study|Disease progression|36
3039573|NCT00679341|10449467|P1|Overall Study|Disease progression|42
3039574|NCT00679302|10449487|P2|Overall Study|Lost to Follow-up|4
3039575|NCT00679302|10449488|P1|Overall Study|Lost to Follow-up|8
3039576|NCT00679289|10449499|P3|Overall Study|Physician Decision|1
3039577|NCT00679289|10449500|P2|Overall Study|Physician Decision|0
3039578|NCT00679289|10449501|P1|Overall Study|Physician Decision|1
3039579|NCT00679289|10449499|P3|Overall Study|Adverse Event|3
3039580|NCT00679289|10449500|P2|Overall Study|Adverse Event|0
3039581|NCT00679289|10449501|P1|Overall Study|Adverse Event|0
3039582|NCT00679289|10449499|P3|Overall Study|Withdrawal by Subject|1
3039583|NCT00679289|10449500|P2|Overall Study|Withdrawal by Subject|1
3039584|NCT00679289|10449501|P1|Overall Study|Withdrawal by Subject|0
3039585|NCT00679289|10449499|P3|Overall Study|Progressive disease|18
3039586|NCT00679289|10449500|P2|Overall Study|Progressive disease|5
3039587|NCT00679289|10449501|P1|Overall Study|Progressive disease|4
3039588|NCT00679263|10449523|P3|Visit 2/Dose 1|subject not compliance|0
3039589|NCT00679263|10449524|P2|Visit 2/Dose 1|subject not compliance|1
3039590|NCT00679263|10449525|P1|Visit 2/Dose 1|subject not compliance|1
3039591|NCT00679263|10449523|P3|Visit 2/Dose 1|Adverse Event|0
3039592|NCT00679263|10449524|P2|Visit 2/Dose 1|Adverse Event|0
3039593|NCT00679263|10449525|P1|Visit 2/Dose 1|Adverse Event|1
3039594|NCT00679211|10449536|P1|Overall Study|Other|1
3039595|NCT00679211|10449536|P1|Overall Study|Transferred to extension study TDM4529g|12
3039596|NCT00679211|10449536|P1|Overall Study|Refused to undergo protocol procedures|1
3039597|NCT00679211|10449536|P1|Overall Study|Physician Decision|5
3039598|NCT00679211|10449536|P1|Overall Study|Withdrawal by Subject|2
3039599|NCT00679211|10449536|P1|Overall Study|Adverse Event|7
3039600|NCT00679211|10449536|P1|Overall Study|Progressive disease|82
3039601|NCT00679172|10449553|P5|Overall Study|Other not specified|0
3039602|NCT00679172|10449554|P4|Overall Study|Other not specified|0
3039603|NCT00679172|10449555|P3|Overall Study|Other not specified|1
3039604|NCT00679172|10449556|P2|Overall Study|Other not specified|0
3039605|NCT00679172|10449557|P1|Overall Study|Other not specified|0
3039606|NCT00679172|10449553|P5|Overall Study|Non-compliance|0
3039607|NCT00679172|10449554|P4|Overall Study|Non-compliance|1
3039608|NCT00679172|10449555|P3|Overall Study|Non-compliance|0
3039609|NCT00679172|10449556|P2|Overall Study|Non-compliance|1
3039610|NCT00679172|10449557|P1|Overall Study|Non-compliance|1
3039611|NCT00679081|10449620|P1|Overall Study|Lost to Follow-up|1
3039612|NCT00679055|10449630|P2|Overall Study|Study Terminated|1
3039613|NCT00679055|10449631|P1|Overall Study|Study Terminated|2
3039614|NCT00679055|10449630|P2|Overall Study|Other|3
3039615|NCT00679055|10449631|P1|Overall Study|Other|0
3039616|NCT00679055|10449630|P2|Overall Study|Adverse Event|1
3039617|NCT00679055|10449631|P1|Overall Study|Adverse Event|0
3039618|NCT00679029|10449641|P1|Overall Study|Lost to Follow-up|1
3039619|NCT00679029|10449641|P1|Overall Study|Withdrawal by Subject|1
3039620|NCT00679029|10449641|P1|Overall Study|Adverse Event|3
3039621|NCT00678899|10449648|P1|Overall Study|Adverse Event|1
3039622|NCT00678886|10449657|P4|Overall Study|Other|0
3039623|NCT00678886|10449658|P3|Overall Study|Other|1
3039624|NCT00678886|10449659|P2|Overall Study|Other|0
3039625|NCT00678886|10449660|P1|Overall Study|Other|0
3039626|NCT00678886|10449657|P4|Overall Study|Lost to Follow-up|2
3039627|NCT00678886|10449658|P3|Overall Study|Lost to Follow-up|3
3039628|NCT00678886|10449659|P2|Overall Study|Lost to Follow-up|0
3039629|NCT00678886|10449660|P1|Overall Study|Lost to Follow-up|0
3039630|NCT00678886|10449657|P4|Overall Study|Physician Decision|1
3039631|NCT00678886|10449658|P3|Overall Study|Physician Decision|1
3039632|NCT00678886|10449659|P2|Overall Study|Physician Decision|0
3039633|NCT00678886|10449660|P1|Overall Study|Physician Decision|0
3039634|NCT00678886|10449657|P4|Overall Study|Withdrawal by Subject|6
3039635|NCT00678886|10449658|P3|Overall Study|Withdrawal by Subject|4
3039636|NCT00678886|10449659|P2|Overall Study|Withdrawal by Subject|0
3039637|NCT00678886|10449660|P1|Overall Study|Withdrawal by Subject|0
3039638|NCT00678795|10449729|P2|Overall Study|Lack of Efficacy|1
3039639|NCT00678795|10449730|P1|Overall Study|Lack of Efficacy|1
3039640|NCT00678795|10449729|P2|Overall Study|Lost to Follow-up|1
3039641|NCT00678795|10449730|P1|Overall Study|Lost to Follow-up|0
3039642|NCT00678795|10449729|P2|Overall Study|Protocol Violation|1
3039643|NCT00678795|10449730|P1|Overall Study|Protocol Violation|0
3039644|NCT00678795|10449729|P2|Overall Study|Withdrawal by Subject|0
3039645|NCT00678795|10449730|P1|Overall Study|Withdrawal by Subject|3
3039646|NCT00678795|10449729|P2|Overall Study|Adverse Event|3
3039647|NCT00678795|10449730|P1|Overall Study|Adverse Event|7
3039648|NCT00678691|10449752|P2|Overall Study|Adverse Event|4
3039649|NCT00678691|10449753|P1|Overall Study|Adverse Event|6
3039650|NCT00678652|10449763|P4|Overall Study|Relocation|0
3039651|NCT00678652|10449764|P3|Overall Study|Relocation|0
3039652|NCT00678652|10449765|P2|Overall Study|Relocation|0
3039653|NCT00678652|10449766|P1|Overall Study|Relocation|1
3039654|NCT00678652|10449763|P4|Overall Study|Pregnancy|0
3039655|NCT00678652|10449764|P3|Overall Study|Pregnancy|1
3039656|NCT00678652|10449765|P2|Overall Study|Pregnancy|0
3039657|NCT00678652|10449766|P1|Overall Study|Pregnancy|0
3039658|NCT00678652|10449763|P4|Overall Study|Protocol Violation|0
3039659|NCT00678652|10449764|P3|Overall Study|Protocol Violation|0
3039660|NCT00678652|10449765|P2|Overall Study|Protocol Violation|0
3039661|NCT00678652|10449766|P1|Overall Study|Protocol Violation|2
3039662|NCT00678639|10449790|P2|Overall Study|Lost to Follow-up at 30 days|0
3039663|NCT00678639|10449791|P1|Overall Study|Lost to Follow-up at 30 days|2
3039664|NCT00678587|10449806|P2|Overall Study|Withdrew Consent|3
3039665|NCT00678587|10449807|P1|Overall Study|Withdrew Consent|8
3039666|NCT00678587|10449806|P2|Overall Study|Investigator Discretion|6
3039667|NCT00678587|10449807|P1|Overall Study|Investigator Discretion|2
3039668|NCT00678587|10449806|P2|Overall Study|Lost to Follow-up|5
3039669|NCT00678587|10449807|P1|Overall Study|Lost to Follow-up|3
3039670|NCT00678587|10449806|P2|Overall Study|Study Closed/Terminated|0
3039671|NCT00678587|10449807|P1|Overall Study|Study Closed/Terminated|1
3039672|NCT00678587|10449806|P2|Overall Study|Protocol Violation|1
3039673|NCT00678587|10449807|P1|Overall Study|Protocol Violation|2
3039674|NCT00678587|10449806|P2|Overall Study|Lack of Efficacy|0
3039675|NCT00678587|10449807|P1|Overall Study|Lack of Efficacy|1
3039676|NCT00678587|10449806|P2|Overall Study|Adverse Event|3
3039677|NCT00678587|10449807|P1|Overall Study|Adverse Event|3
3039678|NCT00678392|10449901|P2|Overall Study|Other|53
3039679|NCT00678392|10449902|P1|Overall Study|Other|56
3039680|NCT00678392|10449901|P2|Overall Study|Randomized But Not Treated|7
3039681|NCT00678392|10449902|P1|Overall Study|Randomized But Not Treated|2
3039682|NCT00678392|10449901|P2|Overall Study|Withdrawal by Subject|4
3039683|NCT00678392|10449902|P1|Overall Study|Withdrawal by Subject|4
3039684|NCT00678392|10449901|P2|Overall Study|Sponsor's Decision|2
3039685|NCT00678392|10449902|P1|Overall Study|Sponsor's Decision|1
3039686|NCT00678392|10449901|P2|Overall Study|Objective Progression or Relapse|8
3039687|NCT00678392|10449902|P1|Overall Study|Objective Progression or Relapse|3
3039688|NCT00678392|10449901|P2|Overall Study|Lost to Follow-up|13
3039689|NCT00678392|10449902|P1|Overall Study|Lost to Follow-up|15
3039690|NCT00678392|10449901|P2|Overall Study|Death|269
3039691|NCT00678392|10449902|P1|Overall Study|Death|280
3039692|NCT00678392|10449901|P2|Overall Study|Adverse Event|6
3039693|NCT00678392|10449902|P1|Overall Study|Adverse Event|0
3039694|NCT00678379|10449937|P3|Overall Study|Incomplete Data|3
3039695|NCT00678379|10449938|P2|Overall Study|Incomplete Data|3
3039696|NCT00678379|10449939|P1|Overall Study|Incomplete Data|4
3039697|NCT00678379|10449937|P3|Overall Study|Injection performed after tonsillectomy|1
3039698|NCT00678379|10449938|P2|Overall Study|Injection performed after tonsillectomy|0
3039699|NCT00678379|10449939|P1|Overall Study|Injection performed after tonsillectomy|2
3039700|NCT00678301|10449967|P2|Overall Study|Lost to Follow-up|1
3039701|NCT00678301|10449968|P1|Overall Study|Lost to Follow-up|3
3039702|NCT00678301|10449967|P2|Overall Study|Withdrawal by Subject|0
3039703|NCT00678301|10449968|P1|Overall Study|Withdrawal by Subject|4
3039704|NCT00678301|10449967|P2|Overall Study|Adverse Event|0
3039705|NCT00678301|10449968|P1|Overall Study|Adverse Event|1
3039706|NCT00678301|10449967|P2|Overall Study|Non-compliance with study procedures|1
3039707|NCT00678301|10449968|P1|Overall Study|Non-compliance with study procedures|0
3039708|NCT00678288|10450026|P2|Overall Study|Disease progression/recurrence/relapse|1
3039709|NCT00678288|10450027|P1|Overall Study|Disease progression/recurrence/relapse|6
3039710|NCT00678288|10450026|P2|Overall Study|Reason not reported|0
3039711|NCT00678288|10450027|P1|Overall Study|Reason not reported|1
3039712|NCT00678288|10450026|P2|Overall Study|Switch to commercial drug|1
3039713|NCT00678288|10450027|P1|Overall Study|Switch to commercial drug|0
3039714|NCT00678288|10450026|P2|Overall Study|Not compliant with study medication|1
3039715|NCT00678288|10450027|P1|Overall Study|Not compliant with study medication|0
3039716|NCT00678288|10450026|P2|Overall Study|Study terminated by the sponsor|0
3039717|NCT00678288|10450027|P1|Overall Study|Study terminated by the sponsor|2
3039718|NCT00678288|10450026|P2|Overall Study|Withdrawal by Subject|1
3039719|NCT00678288|10450027|P1|Overall Study|Withdrawal by Subject|1
3039720|NCT00678288|10450026|P2|Overall Study|Adverse Event|2
3039721|NCT00678288|10450027|P1|Overall Study|Adverse Event|0
3039722|NCT00678210|10450082|P4|Overall Study|Other|0
3039723|NCT00678210|10450083|P3|Overall Study|Other|1
3039724|NCT00678210|10450084|P2|Overall Study|Other|0
3039725|NCT00678210|10450085|P1|Overall Study|Other|1
3039726|NCT00678210|10450082|P4|Overall Study|Withdrawal by Subject|7
3039727|NCT00678210|10450083|P3|Overall Study|Withdrawal by Subject|1
3039728|NCT00678210|10450084|P2|Overall Study|Withdrawal by Subject|4
3039729|NCT00678210|10450085|P1|Overall Study|Withdrawal by Subject|3
3039730|NCT00678210|10450082|P4|Overall Study|Lost to Follow-up|1
3039731|NCT00678210|10450083|P3|Overall Study|Lost to Follow-up|0
3039732|NCT00678210|10450084|P2|Overall Study|Lost to Follow-up|2
3039733|NCT00678210|10450085|P1|Overall Study|Lost to Follow-up|4
3039734|NCT00678210|10450082|P4|Overall Study|Lack of Efficacy|9
3039735|NCT00678210|10450083|P3|Overall Study|Lack of Efficacy|1
3039736|NCT00678210|10450084|P2|Overall Study|Lack of Efficacy|3
3039737|NCT00678210|10450085|P1|Overall Study|Lack of Efficacy|2
3039738|NCT00678210|10450082|P4|Overall Study|Adverse Event|3
3039739|NCT00678210|10450083|P3|Overall Study|Adverse Event|3
3039740|NCT00678210|10450084|P2|Overall Study|Adverse Event|2
3039741|NCT00678210|10450085|P1|Overall Study|Adverse Event|1
3039742|NCT00678080|10450121|P2|Overall Study|Withdrawal by Subject|1
3039743|NCT00678080|10450122|P1|Overall Study|Withdrawal by Subject|0
3039744|NCT00678080|10450121|P2|Overall Study|Lost to Follow-up|0
3039745|NCT00678080|10450122|P1|Overall Study|Lost to Follow-up|1
3039746|NCT00678080|10450121|P2|Overall Study|Physician Decision|0
3039747|NCT00678080|10450122|P1|Overall Study|Physician Decision|2
3039748|NCT00678041|10450148|P2|Overall Study|Physician Decision|5
3039749|NCT00678041|10450149|P1|Overall Study|Physician Decision|5
3039750|NCT00677833|10450202|P4|Overall Study|Lost to Follow-up|0
3039751|NCT00677833|10450203|P3|Overall Study|Lost to Follow-up|1
3039752|NCT00677833|10450204|P2|Overall Study|Lost to Follow-up|0
3039753|NCT00677833|10450205|P1|Overall Study|Lost to Follow-up|0
3039754|NCT00677833|10450202|P4|Overall Study|Withdrawal by Subject|3
3039755|NCT00677833|10450203|P3|Overall Study|Withdrawal by Subject|1
3039756|NCT00677833|10450204|P2|Overall Study|Withdrawal by Subject|0
3039757|NCT00677833|10450205|P1|Overall Study|Withdrawal by Subject|4
3039758|NCT00677820|10450255|P2|Overall Study|Lost to Follow-up|0
3039759|NCT00677820|10450256|P1|Overall Study|Lost to Follow-up|1
3039760|NCT00677807|10450277|P3|Overall Study|Protocol Deviation|0
3039761|NCT00677807|10450278|P2|Overall Study|Protocol Deviation|3
3039762|NCT00677807|10450279|P1|Overall Study|Protocol Deviation|1
3039763|NCT00677807|10450277|P3|Overall Study|Death|1
3039764|NCT00677807|10450278|P2|Overall Study|Death|1
3039765|NCT00677807|10450279|P1|Overall Study|Death|0
3039766|NCT00677807|10450277|P3|Overall Study|Administrative problems|2
3039767|NCT00677807|10450278|P2|Overall Study|Administrative problems|1
3039768|NCT00677807|10450279|P1|Overall Study|Administrative problems|1
3039769|NCT00677807|10450277|P3|Overall Study|Lost to Follow-up|2
3039770|NCT00677807|10450278|P2|Overall Study|Lost to Follow-up|2
3039771|NCT00677807|10450279|P1|Overall Study|Lost to Follow-up|2
3039772|NCT00677807|10450277|P3|Overall Study|Withdrawal by Subject|6
3039773|NCT00677807|10450278|P2|Overall Study|Withdrawal by Subject|3
3039774|NCT00677807|10450279|P1|Overall Study|Withdrawal by Subject|10
3039775|NCT00677807|10450277|P3|Overall Study|Participant no longer needs study drug|1
3039776|NCT00677807|10450278|P2|Overall Study|Participant no longer needs study drug|0
3039777|NCT00677807|10450279|P1|Overall Study|Participant no longer needs study drug|0
3039778|NCT00677807|10450277|P3|Overall Study|Lack of Efficacy|2
3039779|NCT00677807|10450278|P2|Overall Study|Lack of Efficacy|0
3039780|NCT00677807|10450279|P1|Overall Study|Lack of Efficacy|0
3039781|NCT00677807|10450277|P3|Overall Study|Adverse Event|6
3039782|NCT00677807|10450278|P2|Overall Study|Adverse Event|1
3039783|NCT00677807|10450279|P1|Overall Study|Adverse Event|4
3039784|NCT00677534|10450325|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
3039785|NCT00677534|10450325|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
3039786|NCT00677534|10450325|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
3039787|NCT00677365|10450333|P4|Overall Study|Other reason|1
3039788|NCT00677365|10450334|P3|Overall Study|Other reason|0
3039789|NCT00677365|10450335|P2|Overall Study|Other reason|0
3039790|NCT00677365|10450336|P1|Overall Study|Other reason|0
3039791|NCT00677365|10450333|P4|Overall Study|Withdrawal by Subject|0
3039792|NCT00677365|10450334|P3|Overall Study|Withdrawal by Subject|1
3039793|NCT00677365|10450335|P2|Overall Study|Withdrawal by Subject|0
3039794|NCT00677365|10450336|P1|Overall Study|Withdrawal by Subject|0
3039795|NCT00677365|10450333|P4|Overall Study|Adverse Event|2
3039796|NCT00677365|10450334|P3|Overall Study|Adverse Event|1
3039797|NCT00677365|10450335|P2|Overall Study|Adverse Event|1
3039798|NCT00677365|10450336|P1|Overall Study|Adverse Event|2
3039799|NCT00677352|10450368|P2|Tapering Phase|Job transfer|1
3039800|NCT00677352|10450369|P1|Tapering Phase|Job transfer|0
3039801|NCT00677352|10450368|P2|Tapering Phase|Pregnancy|1
3039802|NCT00677352|10450369|P1|Tapering Phase|Pregnancy|0
3039803|NCT00677352|10450368|P2|Tapering Phase|Withdrawal by Subject|3
3039804|NCT00677352|10450369|P1|Tapering Phase|Withdrawal by Subject|5
3039805|NCT00677352|10450368|P2|Tapering Phase|Adverse Event|5
3039806|NCT00677352|10450369|P1|Tapering Phase|Adverse Event|1
3039807|NCT00677352|10450368|P2|Treatment Phase|Not treated|2
3039808|NCT00677352|10450369|P1|Treatment Phase|Not treated|0
3039809|NCT00677352|10450368|P2|Treatment Phase|Transference or work related matter|5
3039810|NCT00677352|10450369|P1|Treatment Phase|Transference or work related matter|0
3039811|NCT00677352|10450368|P2|Treatment Phase|Protocol Violation|1
3039812|NCT00677352|10450369|P1|Treatment Phase|Protocol Violation|1
3039813|NCT00677352|10450368|P2|Treatment Phase|Pregnancy|1
3039814|NCT00677352|10450369|P1|Treatment Phase|Pregnancy|0
3039815|NCT00677352|10450368|P2|Treatment Phase|Physician Decision|0
3039816|NCT00677352|10450369|P1|Treatment Phase|Physician Decision|1
3039817|NCT00677352|10450368|P2|Treatment Phase|Withdrawal by Subject|7
3039818|NCT00677352|10450369|P1|Treatment Phase|Withdrawal by Subject|7
3039819|NCT00677352|10450368|P2|Treatment Phase|Lost to Follow-up|1
3039820|NCT00677352|10450369|P1|Treatment Phase|Lost to Follow-up|0
3039821|NCT00677352|10450368|P2|Treatment Phase|Lack of Efficacy|3
3039822|NCT00677352|10450369|P1|Treatment Phase|Lack of Efficacy|2
3039823|NCT00677352|10450368|P2|Treatment Phase|Adverse Event|22
3039824|NCT00677352|10450369|P1|Treatment Phase|Adverse Event|14
3039825|NCT00677235|10450389|P2|Overall Study|Adverse Experience|0
3039826|NCT00677235|10450390|P1|Overall Study|Adverse Experience|1
3039827|NCT00677235|10450389|P2|Overall Study|Death|36
3039828|NCT00677235|10450390|P1|Overall Study|Death|37
3039829|NCT00677235|10450389|P2|Overall Study|Lost to Follow-up|1
3039830|NCT00677235|10450390|P1|Overall Study|Lost to Follow-up|2
3039831|NCT00677235|10450389|P2|Overall Study|Withdrawal by Subject|1
3039832|NCT00677235|10450390|P1|Overall Study|Withdrawal by Subject|1
3039833|NCT00677092|10450430|P1|Overall Study|Death Prior to Receiving Treatment|1
3039834|NCT00677092|10450430|P1|Overall Study|Withdrawal by Subject|3
3039835|NCT00677092|10450430|P1|Overall Study|Lost to Follow-up|1
3039836|NCT00677092|10450430|P1|Overall Study|Adverse Event|1
3039837|NCT00677014|10450447|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
3039838|NCT00677014|10450448|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
3039839|NCT00677014|10450449|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
3039840|NCT00677014|10450447|P3|Overall Study|Death|7
3039841|NCT00677014|10450448|P2|Overall Study|Death|15
3039842|NCT00677014|10450449|P1|Overall Study|Death|6
3039843|NCT00677014|10450447|P3|Overall Study|Lost to Follow-up|24
3039844|NCT00677014|10450448|P2|Overall Study|Lost to Follow-up|12
3039845|NCT00677014|10450449|P1|Overall Study|Lost to Follow-up|20
3039846|NCT00676715|10450502|P4|Overall Study|Participants Ongoing|24
3039847|NCT00676715|10450503|P3|Overall Study|Participants Ongoing|17
3039848|NCT00676715|10450504|P2|Overall Study|Participants Ongoing|29
3039849|NCT00676715|10450505|P1|Overall Study|Participants Ongoing|29
3039850|NCT00676715|10450502|P4|Overall Study|Adverse Event|0
3039851|NCT00676715|10450503|P3|Overall Study|Adverse Event|2
3039852|NCT00676715|10450504|P2|Overall Study|Adverse Event|1
3039853|NCT00676715|10450505|P1|Overall Study|Adverse Event|0
3039854|NCT00676715|10450502|P4|Overall Study|Death|0
3039855|NCT00676715|10450503|P3|Overall Study|Death|1
3039856|NCT00676715|10450504|P2|Overall Study|Death|1
3039857|NCT00676715|10450505|P1|Overall Study|Death|1
3039858|NCT00676715|10450502|P4|Overall Study|Lost to Follow-up|3
3039859|NCT00676715|10450503|P3|Overall Study|Lost to Follow-up|7
3039860|NCT00676715|10450504|P2|Overall Study|Lost to Follow-up|1
3039861|NCT00676715|10450505|P1|Overall Study|Lost to Follow-up|1
3039862|NCT00676715|10450502|P4|Overall Study|Other|3
3039863|NCT00676715|10450503|P3|Overall Study|Other|4
3039864|NCT00676715|10450504|P2|Overall Study|Other|6
3039865|NCT00676715|10450505|P1|Overall Study|Other|2
3039866|NCT00676715|10450502|P4|Overall Study|Withdrawal by Subject|10
3039867|NCT00676715|10450503|P3|Overall Study|Withdrawal by Subject|10
3039868|NCT00676715|10450504|P2|Overall Study|Withdrawal by Subject|9
3039869|NCT00676715|10450505|P1|Overall Study|Withdrawal by Subject|7
3039870|NCT00676689|10450535|P1|Overall Study|Continuing FU|49
3039871|NCT00676689|10450535|P1|Overall Study|Withdrawal by Subject|3
3039872|NCT00676689|10450535|P1|Overall Study|Physician Decision|1
3039873|NCT00676689|10450535|P1|Overall Study|Lost to Follow-up|4
3039874|NCT00676689|10450535|P1|Overall Study|Death|2
3039875|NCT00676689|10450535|P1|Overall Study|Screen Failure|2
3039876|NCT00676663|10450547|P2|Overall Study|Lost to Follow-up|3
3039877|NCT00676663|10450548|P1|Overall Study|Lost to Follow-up|1
3039878|NCT00676663|10450547|P2|Overall Study|Withdrew Consent|8
3039879|NCT00676663|10450548|P1|Overall Study|Withdrew Consent|1
3039880|NCT00676663|10450547|P2|Overall Study|Death|27
3039881|NCT00676663|10450548|P1|Overall Study|Death|43
3039882|NCT00676650|10450564|P2|Overall Study|Randomized but not treated|4
3039883|NCT00676650|10450565|P1|Overall Study|Randomized but not treated|3
3039884|NCT00676650|10450564|P2|Overall Study|Withdrawal by Subject|24
3039885|NCT00676650|10450565|P1|Overall Study|Withdrawal by Subject|48
3039886|NCT00676650|10450564|P2|Overall Study|Study terminated by sponsor|43
3039887|NCT00676650|10450565|P1|Overall Study|Study terminated by sponsor|57
3039888|NCT00676650|10450564|P2|Overall Study|Protocol Violation|1
3039889|NCT00676650|10450565|P1|Overall Study|Protocol Violation|3
3039890|NCT00676650|10450564|P2|Overall Study|Other|10
3039891|NCT00676650|10450565|P1|Overall Study|Other|14
3039892|NCT00676650|10450564|P2|Overall Study|Objective progression or relapse|140
3039893|NCT00676650|10450565|P1|Overall Study|Objective progression or relapse|189
3039894|NCT00676650|10450564|P2|Overall Study|Lost to Follow-up|1
3039895|NCT00676650|10450565|P1|Overall Study|Lost to Follow-up|0
3039896|NCT00676650|10450564|P2|Overall Study|Global deterioration of health status|31
3039897|NCT00676650|10450565|P1|Overall Study|Global deterioration of health status|66
3039898|NCT00676650|10450564|P2|Overall Study|Adverse Event|21
3039899|NCT00676650|10450565|P1|Overall Study|Adverse Event|159
3039900|NCT00676650|10450564|P2|Overall Study|Death|14
3039901|NCT00676650|10450565|P1|Overall Study|Death|45
3039902|NCT00676520|10450607|P1|Overall Study|Other Reason|18
3039903|NCT00676520|10450607|P1|Overall Study|Ineligible for Randomization to DAPT|209
3039904|NCT00676520|10450607|P1|Overall Study|Physician Decision|20
3039905|NCT00676520|10450607|P1|Overall Study|Death|159
3039906|NCT00676520|10450607|P1|Overall Study|Lost to Follow-up|162
3039907|NCT00676520|10450607|P1|Overall Study|Withdrawal by Subject|163
3039908|NCT00676494|10450664|P1|Overall Study|Withdrawal by Subject|6
3039909|NCT00676494|10450664|P1|Overall Study|Missed Visit|8
3039910|NCT00676403|10450681|P6|Overall Study|Withdrawal by Subject|1
3039911|NCT00676403|10450682|P5|Overall Study|Withdrawal by Subject|0
3039912|NCT00676403|10450683|P4|Overall Study|Withdrawal by Subject|0
3039913|NCT00676403|10450684|P3|Overall Study|Withdrawal by Subject|0
3039914|NCT00676403|10450685|P2|Overall Study|Withdrawal by Subject|0
3039915|NCT00676403|10450686|P1|Overall Study|Withdrawal by Subject|0
3039916|NCT00676403|10450681|P6|Overall Study|Reason Unspecified|1
3039917|NCT00676403|10450682|P5|Overall Study|Reason Unspecified|0
3039918|NCT00676403|10450683|P4|Overall Study|Reason Unspecified|0
3039919|NCT00676403|10450684|P3|Overall Study|Reason Unspecified|1
3039920|NCT00676403|10450685|P2|Overall Study|Reason Unspecified|0
3039921|NCT00676403|10450686|P1|Overall Study|Reason Unspecified|1
3039922|NCT00676403|10450681|P6|Overall Study|Lost to Follow-up|1
3039923|NCT00676403|10450682|P5|Overall Study|Lost to Follow-up|0
3039924|NCT00676403|10450683|P4|Overall Study|Lost to Follow-up|0
3039925|NCT00676403|10450684|P3|Overall Study|Lost to Follow-up|0
3039926|NCT00676403|10450685|P2|Overall Study|Lost to Follow-up|0
3039927|NCT00676403|10450686|P1|Overall Study|Lost to Follow-up|0
3039928|NCT00676403|10450681|P6|Overall Study|Adverse Event|2
3039929|NCT00676403|10450682|P5|Overall Study|Adverse Event|1
3039930|NCT00676403|10450683|P4|Overall Study|Adverse Event|5
3039931|NCT00676403|10450684|P3|Overall Study|Adverse Event|0
3039932|NCT00676403|10450685|P2|Overall Study|Adverse Event|2
3039933|NCT00676403|10450686|P1|Overall Study|Adverse Event|1
3039934|NCT00676338|10450829|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
3039935|NCT00676338|10450830|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
3039936|NCT00676338|10450831|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
3039937|NCT00676338|10450832|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
3039938|NCT00676338|10450829|P4|Overall Study|Entry Criteria Not Met|1
3039939|NCT00676338|10450830|P3|Overall Study|Entry Criteria Not Met|1
3039940|NCT00676338|10450831|P2|Overall Study|Entry Criteria Not Met|2
3039941|NCT00676338|10450832|P1|Overall Study|Entry Criteria Not Met|0
3039942|NCT00676338|10450829|P4|Overall Study|Withdrawal by Subject|6
3039943|NCT00676338|10450830|P3|Overall Study|Withdrawal by Subject|12
3039944|NCT00676338|10450831|P2|Overall Study|Withdrawal by Subject|9
3039945|NCT00676338|10450832|P1|Overall Study|Withdrawal by Subject|17
3039946|NCT00676338|10450829|P4|Overall Study|Protocol Violation|5
3039947|NCT00676338|10450830|P3|Overall Study|Protocol Violation|2
3039948|NCT00676338|10450831|P2|Overall Study|Protocol Violation|9
3039949|NCT00676338|10450832|P1|Overall Study|Protocol Violation|5
3039950|NCT00676338|10450829|P4|Overall Study|Physician Decision|3
3039951|NCT00676338|10450830|P3|Overall Study|Physician Decision|2
3039952|NCT00676338|10450831|P2|Overall Study|Physician Decision|3
3039953|NCT00676338|10450832|P1|Overall Study|Physician Decision|3
3039954|NCT00676338|10450829|P4|Overall Study|Lost to Follow-up|4
3039955|NCT00676338|10450830|P3|Overall Study|Lost to Follow-up|3
3039956|NCT00676338|10450831|P2|Overall Study|Lost to Follow-up|1
3039957|NCT00676338|10450832|P1|Overall Study|Lost to Follow-up|4
3039958|NCT00676338|10450829|P4|Overall Study|Adverse Event|1
3039959|NCT00676338|10450830|P3|Overall Study|Adverse Event|5
3039960|NCT00676338|10450831|P2|Overall Study|Adverse Event|6
3039961|NCT00676338|10450832|P1|Overall Study|Adverse Event|6
3039962|NCT00676208|10450884|P2|Overall Study|Incomplete data|4
3039963|NCT00676208|10450885|P1|Overall Study|Incomplete data|2
3039964|NCT00676208|10450884|P2|Overall Study|Lost to Follow-up|2
3039965|NCT00676208|10450885|P1|Overall Study|Lost to Follow-up|0
3039966|NCT00676195|10450893|P1|Overall Study|Physician Decision|1
3039967|NCT00676195|10450893|P1|Overall Study|Adverse Event|1
3039968|NCT00676195|10450893|P1|Overall Study|Lost to Follow-up|1
3039969|NCT00676143|10450918|P2|Overall Study|Vasogenic edema recurrence|3
3039970|NCT00676143|10450919|P1|Overall Study|Vasogenic edema recurrence|1
3039971|NCT00676143|10450918|P2|Overall Study|Participant participation unknown|4
3039972|NCT00676143|10450919|P1|Overall Study|Participant participation unknown|1
3039973|NCT00676143|10450918|P2|Overall Study|Other|20
3039974|NCT00676143|10450919|P1|Overall Study|Other|11
3039975|NCT00676143|10450918|P2|Overall Study|Loss of caregiver|3
3039976|NCT00676143|10450919|P1|Overall Study|Loss of caregiver|5
3039977|NCT00676143|10450918|P2|Overall Study|Failed to return|1
3039978|NCT00676143|10450919|P1|Overall Study|Failed to return|2
3039979|NCT00676143|10450918|P2|Overall Study|Discontinuation of study by sponsor|88
3039980|NCT00676143|10450919|P1|Overall Study|Discontinuation of study by sponsor|65
3039981|NCT00676143|10450918|P2|Overall Study|Withdrawal by Subject|42
3039982|NCT00676143|10450919|P1|Overall Study|Withdrawal by Subject|24
3039983|NCT00676143|10450918|P2|Overall Study|Protocol Violation|8
3039984|NCT00676143|10450919|P1|Overall Study|Protocol Violation|4
3039985|NCT00676143|10450918|P2|Overall Study|Physician Decision|8
3039986|NCT00676143|10450919|P1|Overall Study|Physician Decision|5
3039987|NCT00676143|10450918|P2|Overall Study|Lost to Follow-up|13
3039988|NCT00676143|10450919|P1|Overall Study|Lost to Follow-up|0
3039989|NCT00676143|10450918|P2|Overall Study|Lack of Efficacy|6
3039990|NCT00676143|10450919|P1|Overall Study|Lack of Efficacy|0
3039991|NCT00676143|10450918|P2|Overall Study|Death|4
3039992|NCT00676143|10450919|P1|Overall Study|Death|4
3039993|NCT00676143|10450918|P2|Overall Study|Adverse Event|60
3039994|NCT00676143|10450919|P1|Overall Study|Adverse Event|34
3039995|NCT00676130|10450959|P2|Overall Study|Withdrawal by Subject|1
3039996|NCT00676130|10450960|P1|Overall Study|Withdrawal by Subject|0
3039997|NCT00676130|10450959|P2|Overall Study|Found ineligible|2
3039998|NCT00676130|10450960|P1|Overall Study|Found ineligible|3
3039999|NCT00676130|10450959|P2|Overall Study|Lost to Follow-up|1
3040000|NCT00676130|10450960|P1|Overall Study|Lost to Follow-up|0
3040001|NCT00676091|10450970|P2|Toddler Dose|Parent or legal guardian request|0
3040002|NCT00676091|10450971|P1|Toddler Dose|Parent or legal guardian request|1
3040003|NCT00676091|10450970|P2|Toddler Dose|Failed to return|0
3040004|NCT00676091|10450971|P1|Toddler Dose|Failed to return|2
3040005|NCT00676091|10450970|P2|After Infant Series|Failed to return|1
3040006|NCT00676091|10450971|P1|After Infant Series|Failed to return|1
3040007|NCT00676091|10450970|P2|After Infant Series|Protocol Violation|1
3040008|NCT00676091|10450971|P1|After Infant Series|Protocol Violation|0
3040009|NCT00676091|10450970|P2|After Infant Series|Adverse Event|1
3040010|NCT00676091|10450971|P1|After Infant Series|Adverse Event|0
3040011|NCT00676091|10450970|P2|Infant Series|Died prior to receiving 7vPnC|1
3040012|NCT00676091|10450971|P1|Infant Series|Died prior to receiving 7vPnC|0
3040013|NCT00676091|10450970|P2|Infant Series|Lost to Follow-up|0
3040014|NCT00676091|10450971|P1|Infant Series|Lost to Follow-up|1
3040015|NCT00676091|10450970|P2|Infant Series|Failed to return|3
3040016|NCT00676091|10450971|P1|Infant Series|Failed to return|1
3040017|NCT00676091|10450970|P2|Infant Series|Adverse Event|3
3040018|NCT00676091|10450971|P1|Infant Series|Adverse Event|2
3040019|NCT00676091|10450970|P2|Infant Series|Protocol Violation|3
3040020|NCT00676091|10450971|P1|Infant Series|Protocol Violation|6
3040021|NCT00676091|10450970|P2|Infant Series|Parent or legal guardian request|8
3040022|NCT00676091|10450971|P1|Infant Series|Parent or legal guardian request|10
3040023|NCT00676052|10451028|P6|Overall Study|Withdrawal by Subject|0
3040024|NCT00676052|10451029|P5|Overall Study|Withdrawal by Subject|0
3040025|NCT00676052|10451030|P4|Overall Study|Withdrawal by Subject|0
3040026|NCT00676052|10451031|P3|Overall Study|Withdrawal by Subject|1
3040027|NCT00676052|10451032|P2|Overall Study|Withdrawal by Subject|0
3040028|NCT00676052|10451033|P1|Overall Study|Withdrawal by Subject|1
3040029|NCT00676052|10451028|P6|Overall Study|Physician Decision|1
3040030|NCT00676052|10451029|P5|Overall Study|Physician Decision|0
3040031|NCT00676052|10451030|P4|Overall Study|Physician Decision|0
3040032|NCT00676052|10451031|P3|Overall Study|Physician Decision|1
3040033|NCT00676052|10451032|P2|Overall Study|Physician Decision|1
3040034|NCT00676052|10451033|P1|Overall Study|Physician Decision|1
3040035|NCT00676052|10451028|P6|Overall Study|Lost to Follow-up|0
3040036|NCT00676052|10451029|P5|Overall Study|Lost to Follow-up|1
3040037|NCT00676052|10451030|P4|Overall Study|Lost to Follow-up|0
3040038|NCT00676052|10451031|P3|Overall Study|Lost to Follow-up|0
3040039|NCT00676052|10451032|P2|Overall Study|Lost to Follow-up|0
3040040|NCT00676052|10451033|P1|Overall Study|Lost to Follow-up|0
3040041|NCT00676052|10451028|P6|Overall Study|Protocol Violation|2
3040042|NCT00676052|10451029|P5|Overall Study|Protocol Violation|1
3040043|NCT00676052|10451030|P4|Overall Study|Protocol Violation|2
3040044|NCT00676052|10451031|P3|Overall Study|Protocol Violation|2
3040045|NCT00676052|10451032|P2|Overall Study|Protocol Violation|3
3040046|NCT00676052|10451033|P1|Overall Study|Protocol Violation|5
3040047|NCT00676052|10451028|P6|Overall Study|Lack of Efficacy|1
3040048|NCT00676052|10451029|P5|Overall Study|Lack of Efficacy|2
3040049|NCT00676052|10451030|P4|Overall Study|Lack of Efficacy|1
3040050|NCT00676052|10451031|P3|Overall Study|Lack of Efficacy|1
3040051|NCT00676052|10451032|P2|Overall Study|Lack of Efficacy|2
3040052|NCT00676052|10451033|P1|Overall Study|Lack of Efficacy|2
3040053|NCT00676052|10451028|P6|Overall Study|Adverse Event|2
3040054|NCT00676052|10451029|P5|Overall Study|Adverse Event|2
3040055|NCT00676052|10451030|P4|Overall Study|Adverse Event|2
3040056|NCT00676052|10451031|P3|Overall Study|Adverse Event|1
3040057|NCT00676052|10451032|P2|Overall Study|Adverse Event|1
3040058|NCT00676052|10451033|P1|Overall Study|Adverse Event|0
3040059|NCT00675948|10451103|P2|Overall Study|Patient feels unable to take medication|1
3040060|NCT00675948|10451104|P1|Overall Study|Patient feels unable to take medication|0
3040061|NCT00675948|10451103|P2|Overall Study|Patient unable to comply with diaries|0
3040062|NCT00675948|10451104|P1|Overall Study|Patient unable to comply with diaries|1
3040063|NCT00675948|10451103|P2|Overall Study|Patient died|0
3040064|NCT00675948|10451104|P1|Overall Study|Patient died|1
3040065|NCT00675948|10451103|P2|Overall Study|Sponsor decision|1
3040066|NCT00675948|10451104|P1|Overall Study|Sponsor decision|0
3040067|NCT00675948|10451103|P2|Overall Study|Pain under control|0
3040068|NCT00675948|10451104|P1|Overall Study|Pain under control|1
3040069|NCT00675948|10451103|P2|Overall Study|Protocol Violation|0
3040070|NCT00675948|10451104|P1|Overall Study|Protocol Violation|1
3040071|NCT00675948|10451103|P2|Overall Study|Lost to Follow-up|0
3040072|NCT00675948|10451104|P1|Overall Study|Lost to Follow-up|2
3040073|NCT00675948|10451103|P2|Overall Study|Withdrawal by Subject|0
3040074|NCT00675948|10451104|P1|Overall Study|Withdrawal by Subject|7
3040075|NCT00675948|10451103|P2|Overall Study|Lack of Efficacy|0
3040076|NCT00675948|10451104|P1|Overall Study|Lack of Efficacy|3
3040077|NCT00675948|10451103|P2|Overall Study|Adverse Event|1
3040078|NCT00675948|10451104|P1|Overall Study|Adverse Event|23
3040079|NCT00675766|10451167|P4|Overall Study|Lost to Follow-up|26
3040080|NCT00675766|10451168|P3|Overall Study|Lost to Follow-up|21
3040081|NCT00675766|10451169|P2|Overall Study|Lost to Follow-up|5
3040082|NCT00675766|10451170|P1|Overall Study|Lost to Follow-up|6
3040083|NCT00675597|10451180|P1|Overall Study|Withdrawal by Subject|3
3040084|NCT00675506|10451234|P2|Overall Study|Schedule conflict|1
3040085|NCT00675506|10451235|P1|Overall Study|Schedule conflict|0
3040086|NCT00675506|10451234|P2|Overall Study|Declined participation|0
3040087|NCT00675506|10451235|P1|Overall Study|Declined participation|1
3040088|NCT00675506|10451234|P2|Overall Study|Disclosed history of cancer|0
3040089|NCT00675506|10451235|P1|Overall Study|Disclosed history of cancer|1
3040090|NCT00675506|10451234|P2|Overall Study|Hypersensitivity Reaction|0
3040091|NCT00675506|10451235|P1|Overall Study|Hypersensitivity Reaction|1
3040092|NCT00675506|10451234|P2|Overall Study|Elevated IGF-1|0
3040093|NCT00675506|10451235|P1|Overall Study|Elevated IGF-1|2
3040094|NCT00675506|10451234|P2|Overall Study|Elevated IGF-1 prior to treatment|0
3040095|NCT00675506|10451235|P1|Overall Study|Elevated IGF-1 prior to treatment|1
3040096|NCT00675506|10451234|P2|Overall Study|Elevated fasting glucose|1
3040097|NCT00675506|10451235|P1|Overall Study|Elevated fasting glucose|2
3040098|NCT00675506|10451234|P2|Overall Study|Lost interest|5
3040099|NCT00675506|10451235|P1|Overall Study|Lost interest|3
3040100|NCT00675506|10451234|P2|Overall Study|Lost to Follow-up|5
3040101|NCT00675506|10451235|P1|Overall Study|Lost to Follow-up|1
3040102|NCT00675441|10451251|P1|Overall Study|Death|1
3040103|NCT00675441|10451251|P1|Overall Study|Withdrawal by Subject|2
3040104|NCT00675428|10451257|P2|Overall Study|Physician Decision|0
3040105|NCT00675428|10451258|P1|Overall Study|Physician Decision|1
3040106|NCT00675428|10451257|P2|Overall Study|No Disease Response After Cycle 6|1
3040107|NCT00675428|10451258|P1|Overall Study|No Disease Response After Cycle 6|0
3040108|NCT00675428|10451257|P2|Overall Study|Disease Progression|2
3040109|NCT00675428|10451258|P1|Overall Study|Disease Progression|2
3040110|NCT00675103|10451300|P1|Overall Study|Adverse Event|1
3040111|NCT00675103|10451300|P1|Overall Study|Lack of Efficacy|2
3040112|NCT00674986|10451307|P2|Overall Study|Other reasons|8
3040113|NCT00674986|10451308|P1|Overall Study|Other reasons|4
3040114|NCT00674986|10451307|P2|Overall Study|Lost to Follow-up|53
3040115|NCT00674986|10451308|P1|Overall Study|Lost to Follow-up|25
3040116|NCT00674986|10451307|P2|Overall Study|Subject withdrew consent|19
3040117|NCT00674986|10451308|P1|Overall Study|Subject withdrew consent|12
3040118|NCT00674986|10451307|P2|Overall Study|Adverse Event|1
3040119|NCT00674986|10451308|P1|Overall Study|Adverse Event|2
3040120|NCT00674973|10451329|P2|Overall Study|Protocol Violation|1
3040121|NCT00674973|10451330|P1|Overall Study|Protocol Violation|0
3040122|NCT00674973|10451329|P2|Overall Study|Death|15
3040123|NCT00674973|10451330|P1|Overall Study|Death|19
3040124|NCT00674973|10451329|P2|Overall Study|Adverse Event|9
3040125|NCT00674973|10451330|P1|Overall Study|Adverse Event|2
3040126|NCT00674973|10451329|P2|Overall Study|Failure to Return|0
3040127|NCT00674973|10451330|P1|Overall Study|Failure to Return|1
3040128|NCT00674973|10451329|P2|Overall Study|Refused Treatment|5
3040129|NCT00674973|10451330|P1|Overall Study|Refused Treatment|1
3040130|NCT00674973|10451329|P2|Overall Study|Insufficient Therapeutic Response|72
3040131|NCT00674973|10451330|P1|Overall Study|Insufficient Therapeutic Response|77
3040132|NCT00674817|10451344|P1|Period 4|Adverse Event|1
3040133|NCT00674817|10451344|P1|Period 3|Protocol Violation|1
3040134|NCT00674817|10451344|P1|Period 3|Adverse Event|1
3040135|NCT00674817|10451344|P1|Period 1|Protocol Violation|1
3040136|NCT00674817|10451344|P1|Period 1|Withdrawal by Subject|2
3040137|NCT00674700|10451521|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
3040138|NCT00674700|10451522|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
3040139|NCT00674700|10451523|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
3040140|NCT00674700|10451521|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
3040141|NCT00674700|10451522|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
3040142|NCT00674700|10451523|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
3040143|NCT00674700|10451521|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
3040144|NCT00674700|10451522|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
3040145|NCT00674700|10451523|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
3040146|NCT00674700|10451521|P3|Year 1|Any other reason not above-mentioned|6
3040147|NCT00674700|10451522|P2|Year 1|Any other reason not above-mentioned|7
3040148|NCT00674700|10451523|P1|Year 1|Any other reason not above-mentioned|7
3040149|NCT00674700|10451521|P3|Year 1|Withdrawal by Subject|6
3040150|NCT00674700|10451522|P2|Year 1|Withdrawal by Subject|7
3040151|NCT00674700|10451523|P1|Year 1|Withdrawal by Subject|7
3040152|NCT00674700|10451521|P3|Year 1|Adverse Event|5
3040153|NCT00674700|10451522|P2|Year 1|Adverse Event|20
3040154|NCT00674700|10451523|P1|Year 1|Adverse Event|17
3040155|NCT00674661|10451536|P2|Overall Study|Withdrawal by Subject|5
3040156|NCT00674661|10451537|P1|Overall Study|Withdrawal by Subject|0
3040157|NCT00674661|10451536|P2|Overall Study|Lost to Follow-up|3
3040158|NCT00674661|10451537|P1|Overall Study|Lost to Follow-up|6
3040159|NCT00674661|10451536|P2|Overall Study|Other|7
3040160|NCT00674661|10451537|P1|Overall Study|Other|5
3040161|NCT00674570|10451635|P3|Overall Study|Withdrawal by Subject|0
3040162|NCT00674570|10451636|P2|Overall Study|Withdrawal by Subject|2
3040163|NCT00674570|10451637|P1|Overall Study|Withdrawal by Subject|0
3040164|NCT00674362|10451676|P2|Open Label|Other: Subject moved to extension study|0
3040165|NCT00674362|10451677|P1|Open Label|Other: Subject moved to extension study|1
3040166|NCT00674362|10451676|P2|Open Label|Adverse Event|0
3040167|NCT00674362|10451677|P1|Open Label|Adverse Event|1
3040168|NCT00674362|10451676|P2|Double Blind|Other: Surgery|1
3040169|NCT00674362|10451677|P1|Double Blind|Other: Surgery|0
3040170|NCT00674362|10451676|P2|Double Blind|Other: Loss of Patient Compliance|1
3040171|NCT00674362|10451677|P1|Double Blind|Other: Loss of Patient Compliance|0
3040172|NCT00674362|10451676|P2|Double Blind|Withdrawal by Subject|3
3040173|NCT00674362|10451677|P1|Double Blind|Withdrawal by Subject|4
3040174|NCT00674362|10451676|P2|Double Blind|Loss of efficacy|1
3040175|NCT00674362|10451677|P1|Double Blind|Loss of efficacy|0
3040176|NCT00674362|10451676|P2|Double Blind|Lack of Efficacy|6
3040177|NCT00674362|10451677|P1|Double Blind|Lack of Efficacy|2
3040178|NCT00674362|10451676|P2|Double Blind|Adverse Event|6
3040179|NCT00674362|10451677|P1|Double Blind|Adverse Event|6
3040180|NCT00674323|10451745|P3|Overall Study|Protocol Violation|0
3040181|NCT00674323|10451746|P2|Overall Study|Protocol Violation|0
3040182|NCT00674323|10451747|P1|Overall Study|Protocol Violation|1
3040183|NCT00674323|10451745|P3|Overall Study|Adverse Event|0
3040184|NCT00674323|10451746|P2|Overall Study|Adverse Event|1
3040185|NCT00674323|10451747|P1|Overall Study|Adverse Event|0
3040186|NCT00674154|10451798|P2|Overall Study|Did not want parathyroidectomy|2
3040187|NCT00674154|10451799|P1|Overall Study|Did not want parathyroidectomy|0
3040188|NCT00674154|10451798|P2|Overall Study|Withdrawal by Subject|1
3040189|NCT00674154|10451799|P1|Overall Study|Withdrawal by Subject|3
3040190|NCT00674128|10451807|P2|Overall Study|Withdrawal by Subject|23
3040191|NCT00674128|10451808|P1|Overall Study|Withdrawal by Subject|25
3040192|NCT00673933|10451833|P1|Overall Study|Lost to Follow-up|1
3040193|NCT00673933|10451833|P1|Overall Study|Withdrawal by Subject|2
3040194|NCT00673894|10451851|P2|First Intervention 4 Weeks|Adverse Event|0
3040195|NCT00673894|10451852|P1|First Intervention 4 Weeks|Adverse Event|1
3040196|NCT00673894|10451851|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
3040197|NCT00673894|10451852|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
3040198|NCT00673881|10451860|P1|Overall Study|Withdrawal by Subject|1
3040199|NCT00673816|10451874|P1|Overall Study|Withdrawal by Subject|1
3040200|NCT00673816|10451874|P1|Overall Study|Adverse Event|1
3040201|NCT00673790|10451884|P3|Overall Study|Randomization criteria not met|0
3040202|NCT00673790|10451885|P2|Overall Study|Randomization criteria not met|1
3040203|NCT00673790|10451886|P1|Overall Study|Randomization criteria not met|0
3040204|NCT00673790|10451884|P3|Overall Study|Unconfirmed pregnancy|0
3040205|NCT00673790|10451885|P2|Overall Study|Unconfirmed pregnancy|1
3040206|NCT00673790|10451886|P1|Overall Study|Unconfirmed pregnancy|0
3040207|NCT00673790|10451884|P3|Overall Study|Participated in two Nebivolol studies|1
3040208|NCT00673790|10451885|P2|Overall Study|Participated in two Nebivolol studies|0
3040209|NCT00673790|10451886|P1|Overall Study|Participated in two Nebivolol studies|0
3040210|NCT00673790|10451884|P3|Overall Study|Poor compliance|0
3040211|NCT00673790|10451885|P2|Overall Study|Poor compliance|0
3040212|NCT00673790|10451886|P1|Overall Study|Poor compliance|1
3040213|NCT00673790|10451884|P3|Overall Study|Sponsor Terminated due to PI oversight|0
3040214|NCT00673790|10451885|P2|Overall Study|Sponsor Terminated due to PI oversight|1
3040215|NCT00673790|10451886|P1|Overall Study|Sponsor Terminated due to PI oversight|0
3040216|NCT00673790|10451884|P3|Overall Study|Lost to Follow-up|5
3040217|NCT00673790|10451885|P2|Overall Study|Lost to Follow-up|6
3040218|NCT00673790|10451886|P1|Overall Study|Lost to Follow-up|6
3040219|NCT00673790|10451884|P3|Overall Study|Withdrawal by Subject|1
3040220|NCT00673790|10451885|P2|Overall Study|Withdrawal by Subject|4
3040221|NCT00673790|10451886|P1|Overall Study|Withdrawal by Subject|7
3040222|NCT00673790|10451884|P3|Overall Study|Protocol Violation|1
3040223|NCT00673790|10451885|P2|Overall Study|Protocol Violation|9
3040224|NCT00673790|10451886|P1|Overall Study|Protocol Violation|6
3040225|NCT00673790|10451884|P3|Overall Study|Lack of Efficacy|2
3040226|NCT00673790|10451885|P2|Overall Study|Lack of Efficacy|2
3040227|NCT00673790|10451886|P1|Overall Study|Lack of Efficacy|2
3040228|NCT00673790|10451884|P3|Overall Study|Adverse Event|2
3040229|NCT00673790|10451885|P2|Overall Study|Adverse Event|14
3040230|NCT00673790|10451886|P1|Overall Study|Adverse Event|23
3040231|NCT00673673|10451924|P1|Overall Study|Investigators' discretion|2
3040232|NCT00673673|10451924|P1|Overall Study|Withdrawal by Subject|3
3040233|NCT00673673|10451924|P1|Overall Study|Adverse Event|4
3040234|NCT00673673|10451924|P1|Overall Study|Progressive disease|27
3040235|NCT00673660|10451930|P1|Overall Study|Lost to Follow-up|107
3040236|NCT00673465|10451952|P12|Part 1/Period 2 (United States)|Protocol Violation|0
3040237|NCT00673465|10451953|P11|Part 1/Period 2 (United States)|Protocol Violation|0
3040238|NCT00673465|10451954|P10|Part 1/Period 2 (United States)|Protocol Violation|0
3040239|NCT00673465|10451955|P9|Part 1/Period 2 (United States)|Protocol Violation|0
3040240|NCT00673465|10451956|P8|Part 1/Period 2 (United States)|Protocol Violation|0
3040241|NCT00673465|10451957|P7|Part 1/Period 2 (United States)|Protocol Violation|0
3040242|NCT00673465|10451958|P6|Part 1/Period 2 (United States)|Protocol Violation|0
3040243|NCT00673465|10451959|P5|Part 1/Period 2 (United States)|Protocol Violation|1
3040244|NCT00673465|10451960|P4|Part 1/Period 2 (United States)|Protocol Violation|0
3040245|NCT00673465|10451961|P3|Part 1/Period 2 (United States)|Protocol Violation|0
3040246|NCT00673465|10451962|P2|Part 1/Period 2 (United States)|Protocol Violation|0
3040247|NCT00673465|10451963|P1|Part 1/Period 2 (United States)|Protocol Violation|0
3040248|NCT00673465|10451952|P12|Part 1/Period 1 (United States)|Protocol Violation|0
3040249|NCT00673465|10451953|P11|Part 1/Period 1 (United States)|Protocol Violation|0
3040250|NCT00673465|10451954|P10|Part 1/Period 1 (United States)|Protocol Violation|0
3040251|NCT00673465|10451955|P9|Part 1/Period 1 (United States)|Protocol Violation|0
3040252|NCT00673465|10451956|P8|Part 1/Period 1 (United States)|Protocol Violation|0
3040253|NCT00673465|10451957|P7|Part 1/Period 1 (United States)|Protocol Violation|0
3040254|NCT00673465|10451958|P6|Part 1/Period 1 (United States)|Protocol Violation|1
3040255|NCT00673465|10451959|P5|Part 1/Period 1 (United States)|Protocol Violation|1
3040256|NCT00673465|10451960|P4|Part 1/Period 1 (United States)|Protocol Violation|0
3040257|NCT00673465|10451961|P3|Part 1/Period 1 (United States)|Protocol Violation|0
3040258|NCT00673465|10451962|P2|Part 1/Period 1 (United States)|Protocol Violation|0
3040259|NCT00673465|10451963|P1|Part 1/Period 1 (United States)|Protocol Violation|0
3040260|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
3040261|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
3040262|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Physician Decision|0
3040263|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Physician Decision|2
3040264|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Sponsor Decision|3
3040265|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Sponsor Decision|0
3040266|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Protocol Violation|3
3040267|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Protocol Violation|2
3040268|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
3040269|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
3040270|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
3040271|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
3040272|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
3040273|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
3040274|NCT00673452|10452012|P2|Continuation Double-Blind Phase|Adverse Event|13
3040275|NCT00673452|10452013|P1|Continuation Double-Blind Phase|Adverse Event|5
3040276|NCT00673452|10452012|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
3040277|NCT00673452|10452013|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
3040278|NCT00673452|10452012|P2|Acute Double-Blind Phase|Sponsor Decision|1
3040279|NCT00673452|10452013|P1|Acute Double-Blind Phase|Sponsor Decision|0
3040280|NCT00673452|10452012|P2|Acute Double-Blind Phase|Protocol Violation|3
3040281|NCT00673452|10452013|P1|Acute Double-Blind Phase|Protocol Violation|5
3040282|NCT00673452|10452012|P2|Acute Double-Blind Phase|Physician Decision|6
3040283|NCT00673452|10452013|P1|Acute Double-Blind Phase|Physician Decision|0
3040284|NCT00673452|10452012|P2|Acute Double-Blind Phase|Lost to Follow-up|19
3040285|NCT00673452|10452013|P1|Acute Double-Blind Phase|Lost to Follow-up|16
3040286|NCT00673452|10452012|P2|Acute Double-Blind Phase|Lack of Efficacy|14
3040287|NCT00673452|10452013|P1|Acute Double-Blind Phase|Lack of Efficacy|9
3040288|NCT00673452|10452012|P2|Acute Double-Blind Phase|Adverse Event|24
3040289|NCT00673452|10452013|P1|Acute Double-Blind Phase|Adverse Event|41
3040290|NCT00673387|10452077|P8|Overall Study|Lost to Follow-up|5
3040291|NCT00673387|10452078|P7|Overall Study|Lost to Follow-up|8
3040292|NCT00673387|10452079|P6|Overall Study|Lost to Follow-up|5
3040293|NCT00673387|10452080|P5|Overall Study|Lost to Follow-up|6
3040294|NCT00673387|10452081|P4|Overall Study|Lost to Follow-up|6
3040295|NCT00673387|10452082|P3|Overall Study|Lost to Follow-up|5
3040296|NCT00673387|10452083|P2|Overall Study|Lost to Follow-up|6
3040297|NCT00673387|10452084|P1|Overall Study|Lost to Follow-up|8
3040298|NCT00673387|10452077|P8|Overall Study|Protocol Violation|3
3040299|NCT00673387|10452078|P7|Overall Study|Protocol Violation|1
3040300|NCT00673387|10452079|P6|Overall Study|Protocol Violation|1
3040301|NCT00673387|10452080|P5|Overall Study|Protocol Violation|0
3040302|NCT00673387|10452081|P4|Overall Study|Protocol Violation|2
3040303|NCT00673387|10452082|P3|Overall Study|Protocol Violation|1
3040304|NCT00673387|10452083|P2|Overall Study|Protocol Violation|0
3040305|NCT00673387|10452084|P1|Overall Study|Protocol Violation|3
3040306|NCT00673387|10452077|P8|Overall Study|Physician Decision|1
3040307|NCT00673387|10452078|P7|Overall Study|Physician Decision|1
3040308|NCT00673387|10452079|P6|Overall Study|Physician Decision|5
3040309|NCT00673387|10452080|P5|Overall Study|Physician Decision|0
3040310|NCT00673387|10452081|P4|Overall Study|Physician Decision|0
3040311|NCT00673387|10452082|P3|Overall Study|Physician Decision|0
3040312|NCT00673387|10452083|P2|Overall Study|Physician Decision|0
3040313|NCT00673387|10452084|P1|Overall Study|Physician Decision|0
3040314|NCT00673387|10452077|P8|Overall Study|Adverse Event|5
3040315|NCT00673387|10452078|P7|Overall Study|Adverse Event|5
3040316|NCT00673387|10452079|P6|Overall Study|Adverse Event|2
3040317|NCT00673387|10452080|P5|Overall Study|Adverse Event|6
3040318|NCT00673387|10452081|P4|Overall Study|Adverse Event|2
3040319|NCT00673387|10452082|P3|Overall Study|Adverse Event|5
3040320|NCT00673387|10452083|P2|Overall Study|Adverse Event|1
3040321|NCT00673387|10452084|P1|Overall Study|Adverse Event|3
3040322|NCT00673387|10452077|P8|Overall Study|Withdrawal by Subject|21
3040323|NCT00673387|10452078|P7|Overall Study|Withdrawal by Subject|15
3040324|NCT00673387|10452079|P6|Overall Study|Withdrawal by Subject|21
3040325|NCT00673387|10452080|P5|Overall Study|Withdrawal by Subject|18
3040326|NCT00673387|10452081|P4|Overall Study|Withdrawal by Subject|16
3040327|NCT00673387|10452082|P3|Overall Study|Withdrawal by Subject|20
3040328|NCT00673387|10452083|P2|Overall Study|Withdrawal by Subject|16
3040329|NCT00673387|10452084|P1|Overall Study|Withdrawal by Subject|15
3040330|NCT00673361|10452300|P1|Overall Study|Screen Failure|2
3040331|NCT00673257|10452336|P1|Overall Study|Unable to obtain specimen|1
3040332|NCT00673257|10452336|P1|Overall Study|Withdrawal by Subject|4
3040333|NCT00673231|10452345|P4|Overall Study|Study criteria,compliance,safety, other|4
3040334|NCT00673231|10452346|P3|Overall Study|Study criteria,compliance,safety, other|7
3040335|NCT00673231|10452347|P2|Overall Study|Study criteria,compliance,safety, other|5
3040336|NCT00673231|10452348|P1|Overall Study|Study criteria,compliance,safety, other|8
3040337|NCT00673231|10452345|P4|Overall Study|Death|0
3040338|NCT00673231|10452346|P3|Overall Study|Death|1
3040339|NCT00673231|10452347|P2|Overall Study|Death|0
3040340|NCT00673231|10452348|P1|Overall Study|Death|0
3040341|NCT00673231|10452345|P4|Overall Study|Lost to Follow-up|2
3040342|NCT00673231|10452346|P3|Overall Study|Lost to Follow-up|1
3040343|NCT00673231|10452347|P2|Overall Study|Lost to Follow-up|2
3040344|NCT00673231|10452348|P1|Overall Study|Lost to Follow-up|1
3040345|NCT00673231|10452345|P4|Overall Study|Adverse Event|6
3040346|NCT00673231|10452346|P3|Overall Study|Adverse Event|9
3040347|NCT00673231|10452347|P2|Overall Study|Adverse Event|5
3040348|NCT00673231|10452348|P1|Overall Study|Adverse Event|6
3040349|NCT00673231|10452345|P4|Overall Study|Withdrawal by Subject|6
3040350|NCT00673231|10452346|P3|Overall Study|Withdrawal by Subject|8
3040351|NCT00673231|10452347|P2|Overall Study|Withdrawal by Subject|10
3040352|NCT00673231|10452348|P1|Overall Study|Withdrawal by Subject|14
3040353|NCT00673179|10452380|P2|Overall Study|Toxicity/Complications|0
3040354|NCT00673179|10452381|P1|Overall Study|Toxicity/Complications|3
3040355|NCT00673049|10452430|P4|After Progression on Erlotinib|study terminated by sponsor|4
3040356|NCT00673049|10452431|P3|After Progression on Erlotinib|study terminated by sponsor|0
3040357|NCT00673049|10452432|P2|After Progression on Erlotinib|study terminated by sponsor|0
3040358|NCT00673049|10452433|P1|After Progression on Erlotinib|study terminated by sponsor|0
3040359|NCT00673049|10452430|P4|After Progression on Erlotinib|Withdrawal by Subject|5
3040360|NCT00673049|10452431|P3|After Progression on Erlotinib|Withdrawal by Subject|0
3040361|NCT00673049|10452432|P2|After Progression on Erlotinib|Withdrawal by Subject|0
3040362|NCT00673049|10452433|P1|After Progression on Erlotinib|Withdrawal by Subject|0
3040363|NCT00673049|10452430|P4|After Progression on Erlotinib|Lost to Follow-up|3
3040364|NCT00673049|10452431|P3|After Progression on Erlotinib|Lost to Follow-up|0
3040365|NCT00673049|10452432|P2|After Progression on Erlotinib|Lost to Follow-up|0
3040366|NCT00673049|10452433|P1|After Progression on Erlotinib|Lost to Follow-up|0
3040367|NCT00673049|10452430|P4|After Progression on Erlotinib|Death|71
3040368|NCT00673049|10452431|P3|After Progression on Erlotinib|Death|0
3040369|NCT00673049|10452432|P2|After Progression on Erlotinib|Death|0
3040370|NCT00673049|10452433|P1|After Progression on Erlotinib|Death|0
3040371|NCT00673049|10452430|P4|Before Progression on Erlotinib|Switched to figitumumab|0
3040372|NCT00673049|10452431|P3|Before Progression on Erlotinib|Switched to figitumumab|0
3040373|NCT00673049|10452432|P2|Before Progression on Erlotinib|Switched to figitumumab|83
3040374|NCT00673049|10452433|P1|Before Progression on Erlotinib|Switched to figitumumab|0
3040375|NCT00673049|10452430|P4|Before Progression on Erlotinib|study terminated by sponsor|0
3040376|NCT00673049|10452431|P3|Before Progression on Erlotinib|study terminated by sponsor|0
3040377|NCT00673049|10452432|P2|Before Progression on Erlotinib|study terminated by sponsor|14
3040378|NCT00673049|10452433|P1|Before Progression on Erlotinib|study terminated by sponsor|18
3040379|NCT00673049|10452430|P4|Before Progression on Erlotinib|Other|0
3040380|NCT00673049|10452431|P3|Before Progression on Erlotinib|Other|0
3040381|NCT00673049|10452432|P2|Before Progression on Erlotinib|Other|2
3040382|NCT00673049|10452433|P1|Before Progression on Erlotinib|Other|1
3040383|NCT00673049|10452430|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
3040384|NCT00673049|10452431|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
3040385|NCT00673049|10452432|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
3040386|NCT00673049|10452433|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
3040387|NCT00673049|10452430|P4|Before Progression on Erlotinib|Lost to Follow-up|0
3040388|NCT00673049|10452431|P3|Before Progression on Erlotinib|Lost to Follow-up|0
3040389|NCT00673049|10452432|P2|Before Progression on Erlotinib|Lost to Follow-up|5
3040390|NCT00673049|10452433|P1|Before Progression on Erlotinib|Lost to Follow-up|9
3040391|NCT00673049|10452430|P4|Before Progression on Erlotinib|Death|0
3040392|NCT00673049|10452431|P3|Before Progression on Erlotinib|Death|1
3040393|NCT00673049|10452432|P2|Before Progression on Erlotinib|Death|167
3040394|NCT00673049|10452433|P1|Before Progression on Erlotinib|Death|235
3040395|NCT00673049|10452430|P4|Before Progression on Erlotinib|Randomized but not treated|0
3040482|NCT00672490|10452721|P2|Overall Study|No reason was provided|2
3040396|NCT00673049|10452431|P3|Before Progression on Erlotinib|Randomized but not treated|0
3040397|NCT00673049|10452432|P2|Before Progression on Erlotinib|Randomized but not treated|1
3040398|NCT00673049|10452433|P1|Before Progression on Erlotinib|Randomized but not treated|3
3040399|NCT00672984|10452457|P3|Third Intervention|Adverse Event|1
3040400|NCT00672984|10452458|P2|Third Intervention|Adverse Event|0
3040401|NCT00672984|10452459|P1|Third Intervention|Adverse Event|1
3040402|NCT00672984|10452457|P3|Second Intervention|Protocol Violation|1
3040403|NCT00672984|10452458|P2|Second Intervention|Protocol Violation|1
3040404|NCT00672984|10452459|P1|Second Intervention|Protocol Violation|0
3040405|NCT00672984|10452457|P3|Second Intervention|Withdrawal by Subject|0
3040406|NCT00672984|10452458|P2|Second Intervention|Withdrawal by Subject|3
3040407|NCT00672984|10452459|P1|Second Intervention|Withdrawal by Subject|0
3040408|NCT00672984|10452457|P3|Second Intervention|Non-compliance with facility policies|0
3040409|NCT00672984|10452458|P2|Second Intervention|Non-compliance with facility policies|2
3040410|NCT00672984|10452459|P1|Second Intervention|Non-compliance with facility policies|0
3040411|NCT00672984|10452457|P3|First Intervention|Sponsor decision|0
3040412|NCT00672984|10452458|P2|First Intervention|Sponsor decision|0
3040413|NCT00672984|10452459|P1|First Intervention|Sponsor decision|3
3040414|NCT00672984|10452457|P3|First Intervention|Withdrawal by Subject|2
3040415|NCT00672984|10452458|P2|First Intervention|Withdrawal by Subject|2
3040416|NCT00672984|10452459|P1|First Intervention|Withdrawal by Subject|1
3040417|NCT00672984|10452457|P3|First Intervention|Adverse Event|0
3040418|NCT00672984|10452458|P2|First Intervention|Adverse Event|0
3040419|NCT00672984|10452459|P1|First Intervention|Adverse Event|5
3040420|NCT00672958|10452510|P2|Overall Study|Reason not specified|3
3040421|NCT00672958|10452511|P1|Overall Study|Reason not specified|0
3040422|NCT00672958|10452510|P2|Overall Study|Lost to Follow-up|17
3040423|NCT00672958|10452511|P1|Overall Study|Lost to Follow-up|22
3040424|NCT00672958|10452510|P2|Overall Study|Voluntary withdrawal|8
3040425|NCT00672958|10452511|P1|Overall Study|Voluntary withdrawal|12
3040426|NCT00672958|10452510|P2|Overall Study|Protocol deviations|5
3040427|NCT00672958|10452511|P1|Overall Study|Protocol deviations|11
3040428|NCT00672958|10452510|P2|Overall Study|Non-compliance with study drug|3
3040429|NCT00672958|10452511|P1|Overall Study|Non-compliance with study drug|2
3040430|NCT00672958|10452510|P2|Overall Study|Lack of Efficacy|11
3040431|NCT00672958|10452511|P1|Overall Study|Lack of Efficacy|6
3040432|NCT00672958|10452510|P2|Overall Study|Adverse Event|9
3040433|NCT00672958|10452511|P1|Overall Study|Adverse Event|11
3040434|NCT00672841|10452577|P2|Overall Study|Pregnancy|1
3040435|NCT00672841|10452578|P1|Overall Study|Pregnancy|0
3040436|NCT00672841|10452577|P2|Overall Study|Adverse Event|3
3040437|NCT00672841|10452578|P1|Overall Study|Adverse Event|0
3040438|NCT00672841|10452577|P2|Overall Study|Antifungal therapy, negative glucan|4
3040439|NCT00672841|10452578|P1|Overall Study|Antifungal therapy, negative glucan|0
3040440|NCT00672841|10452577|P2|Overall Study|icteric specimens|3
3040441|NCT00672841|10452578|P1|Overall Study|icteric specimens|0
3040442|NCT00672841|10452577|P2|Overall Study|Comfort care|4
3040443|NCT00672841|10452578|P1|Overall Study|Comfort care|1
3040444|NCT00672646|10452600|P3|Overall Study|Withdrawal by Subject|1
3040445|NCT00672646|10452601|P2|Overall Study|Withdrawal by Subject|0
3040446|NCT00672646|10452602|P1|Overall Study|Withdrawal by Subject|0
3040447|NCT00672646|10452600|P3|Overall Study|Lost to Follow-up|2
3040448|NCT00672646|10452601|P2|Overall Study|Lost to Follow-up|1
3040449|NCT00672646|10452602|P1|Overall Study|Lost to Follow-up|0
3040450|NCT00672633|10452627|P2|Overall Study|Withdrawal by Subject|1
3040451|NCT00672633|10452628|P1|Overall Study|Withdrawal by Subject|0
3040452|NCT00672620|10452642|P4|Overall Study|Reason not Specified|1
3040453|NCT00672620|10452643|P3|Overall Study|Reason not Specified|2
3040454|NCT00672620|10452644|P2|Overall Study|Reason not Specified|3
3040455|NCT00672620|10452645|P1|Overall Study|Reason not Specified|3
3040456|NCT00672620|10452642|P4|Overall Study|Lost to Follow-up|11
3040457|NCT00672620|10452643|P3|Overall Study|Lost to Follow-up|8
3040458|NCT00672620|10452644|P2|Overall Study|Lost to Follow-up|19
3040459|NCT00672620|10452645|P1|Overall Study|Lost to Follow-up|8
3040460|NCT00672620|10452642|P4|Overall Study|Withdrawal of Consent|6
3040461|NCT00672620|10452643|P3|Overall Study|Withdrawal of Consent|5
3040462|NCT00672620|10452644|P2|Overall Study|Withdrawal of Consent|12
3040463|NCT00672620|10452645|P1|Overall Study|Withdrawal of Consent|6
3040464|NCT00672620|10452642|P4|Overall Study|Protocol Deviations|5
3040465|NCT00672620|10452643|P3|Overall Study|Protocol Deviations|2
3040466|NCT00672620|10452644|P2|Overall Study|Protocol Deviations|7
3040467|NCT00672620|10452645|P1|Overall Study|Protocol Deviations|5
3040468|NCT00672620|10452642|P4|Overall Study|Noncompliance with Study Drug|2
3040469|NCT00672620|10452643|P3|Overall Study|Noncompliance with Study Drug|0
3040470|NCT00672620|10452644|P2|Overall Study|Noncompliance with Study Drug|4
3040471|NCT00672620|10452645|P1|Overall Study|Noncompliance with Study Drug|3
3040472|NCT00672620|10452642|P4|Overall Study|Lack of Efficacy|0
3040473|NCT00672620|10452643|P3|Overall Study|Lack of Efficacy|2
3040474|NCT00672620|10452644|P2|Overall Study|Lack of Efficacy|2
3040475|NCT00672620|10452645|P1|Overall Study|Lack of Efficacy|1
3040476|NCT00672620|10452642|P4|Overall Study|Adverse Event|17
3040477|NCT00672620|10452643|P3|Overall Study|Adverse Event|12
3040478|NCT00672620|10452644|P2|Overall Study|Adverse Event|7
3040479|NCT00672620|10452645|P1|Overall Study|Adverse Event|7
3040480|NCT00672555|10452710|P1|Overall Study|Did not want to answer questionnaire|2
3040481|NCT00672555|10452710|P1|Overall Study|Lost to Follow-up|4
3040483|NCT00672490|10452722|P1|Overall Study|No reason was provided|6
3040484|NCT00672490|10452721|P2|Overall Study|Lost to Follow-up|5
3040485|NCT00672490|10452722|P1|Overall Study|Lost to Follow-up|1
3040486|NCT00672490|10452721|P2|Overall Study|Intolerance|2
3040487|NCT00672490|10452722|P1|Overall Study|Intolerance|0
3040488|NCT00672490|10452721|P2|Overall Study|Violation of Concomitant Medicine|0
3040489|NCT00672490|10452722|P1|Overall Study|Violation of Concomitant Medicine|1
3040490|NCT00672490|10452721|P2|Overall Study|Adverse Event|8
3040491|NCT00672490|10452722|P1|Overall Study|Adverse Event|5
3040492|NCT00672490|10452721|P2|Overall Study|Mismatch Include/Exclude Criteria|0
3040493|NCT00672490|10452722|P1|Overall Study|Mismatch Include/Exclude Criteria|1
3040494|NCT00672490|10452721|P2|Overall Study|Lack of Compliance|7
3040495|NCT00672490|10452722|P1|Overall Study|Lack of Compliance|2
3040496|NCT00672490|10452721|P2|Overall Study|Withdrawal by Subject|8
3040497|NCT00672490|10452722|P1|Overall Study|Withdrawal by Subject|8
3040498|NCT00672477|10452746|P2|Overall Study|no study drug for low GFR, health cond.|3
3040499|NCT00672477|10452747|P1|Overall Study|no study drug for low GFR, health cond.|1
3040500|NCT00672477|10452746|P2|Overall Study|Lack of Efficacy|1
3040501|NCT00672477|10452747|P1|Overall Study|Lack of Efficacy|1
3040502|NCT00672477|10452746|P2|Overall Study|Withdrawal by Subject|3
3040503|NCT00672477|10452747|P1|Overall Study|Withdrawal by Subject|5
3040504|NCT00672477|10452746|P2|Overall Study|Protocol Violation|1
3040505|NCT00672477|10452747|P1|Overall Study|Protocol Violation|1
3040506|NCT00672477|10452746|P2|Overall Study|Physician Decision|0
3040507|NCT00672477|10452747|P1|Overall Study|Physician Decision|2
3040508|NCT00672477|10452746|P2|Overall Study|Death|11
3040509|NCT00672477|10452747|P1|Overall Study|Death|7
3040510|NCT00672477|10452746|P2|Overall Study|Adverse Event|7
3040511|NCT00672477|10452747|P1|Overall Study|Adverse Event|10
3040512|NCT00672256|10452800|P1|Overall Study|PI dropped, bad data|44
3040513|NCT00672139|10452825|P2|Overall Study|hospice discharge, caregiver requests|2
3040514|NCT00672139|10452826|P1|Overall Study|hospice discharge, caregiver requests|3
3040515|NCT00672139|10452825|P2|Overall Study|Protocol Violation|1
3040516|NCT00672139|10452826|P1|Overall Study|Protocol Violation|1
3040517|NCT00672139|10452825|P2|Overall Study|Lack of Efficacy|1
3040518|NCT00672139|10452826|P1|Overall Study|Lack of Efficacy|4
3040519|NCT00672139|10452825|P2|Overall Study|Physician Decision|0
3040520|NCT00672139|10452826|P1|Overall Study|Physician Decision|2
3040521|NCT00672139|10452825|P2|Overall Study|Adverse Event|7
3040522|NCT00672139|10452826|P1|Overall Study|Adverse Event|4
3040523|NCT00672139|10452825|P2|Overall Study|Withdrawal by Subject|11
3040524|NCT00672139|10452826|P1|Overall Study|Withdrawal by Subject|2
3040525|NCT00672139|10452825|P2|Overall Study|Death|23
3040526|NCT00672139|10452826|P1|Overall Study|Death|14
3040527|NCT00671931|10452883|P5|Overall Study|Physician Decision|1
3040528|NCT00671931|10452884|P4|Overall Study|Physician Decision|2
3040529|NCT00671931|10452885|P3|Overall Study|Physician Decision|0
3040530|NCT00671931|10452886|P2|Overall Study|Physician Decision|0
3040531|NCT00671931|10452887|P1|Overall Study|Physician Decision|1
3040532|NCT00671879|10452907|P3|Overall Study|Withdrawal by Subject|6
3040533|NCT00671879|10452908|P2|Overall Study|Withdrawal by Subject|4
3040534|NCT00671879|10452909|P1|Overall Study|Withdrawal by Subject|0
3040535|NCT00671853|10452922|P2|Overall Study|Non-adherence with study procedures|4
3040536|NCT00671853|10452923|P1|Overall Study|Non-adherence with study procedures|1
3040537|NCT00671853|10452922|P2|Overall Study|Physician Decision|2
3040538|NCT00671853|10452923|P1|Overall Study|Physician Decision|0
3040539|NCT00671853|10452922|P2|Overall Study|Lost to Follow-up|8
3040540|NCT00671853|10452923|P1|Overall Study|Lost to Follow-up|8
3040541|NCT00671853|10452922|P2|Overall Study|Withdrawal by Subject|5
3040542|NCT00671853|10452923|P1|Overall Study|Withdrawal by Subject|1
3040543|NCT00671853|10452922|P2|Overall Study|Adverse Event|1
3040544|NCT00671853|10452923|P1|Overall Study|Adverse Event|7
3040545|NCT00671853|10452922|P2|Overall Study|Lack of Efficacy|7
3040546|NCT00671853|10452923|P1|Overall Study|Lack of Efficacy|3
3040547|NCT00671788|10452939|P1|Overall Study|Other|1
3040548|NCT00671788|10452939|P1|Overall Study|MD Decision|1
3040549|NCT00671788|10452939|P1|Overall Study|Ineligible|1
3040550|NCT00671788|10452939|P1|Overall Study|Refused further treatment|3
3040551|NCT00671788|10452939|P1|Overall Study|Adverse Event|8
3040552|NCT00671749|10452946|P1|Overall Study|Lost to Follow-up|1
3040553|NCT00671749|10452946|P1|Overall Study|Protocol Violation|1
3040554|NCT00671749|10452946|P1|Overall Study|Withdrawal by Subject|4
3040555|NCT00671749|10452946|P1|Overall Study|Adverse Event|2
3040556|NCT00671554|10453005|P1|Overall Study|Disease progression|3
3040557|NCT00671437|10453044|P1|Overall Study|Ineligible post-hoc|1
3040558|NCT00671437|10453044|P1|Overall Study|Adverse Event|3
3040559|NCT00671437|10453044|P1|Overall Study|Cutaneous SCC of head and neck|3
3040560|NCT00671437|10453044|P1|Overall Study|Progressive disease before C1 week 8|8
3040561|NCT00671060|10453078|P2|Overall Study|Physician Decision|1
3040562|NCT00671060|10453079|P1|Overall Study|Physician Decision|0
3040563|NCT00671060|10453078|P2|Overall Study|Protocol Violation|0
3040564|NCT00671060|10453079|P1|Overall Study|Protocol Violation|1
3040565|NCT00671034|10453088|P3|Overall Study|includes Alternative therapy, etc.|7
3040566|NCT00671034|10453089|P2|Overall Study|includes Alternative therapy, etc.|1
3040567|NCT00671034|10453090|P1|Overall Study|includes Alternative therapy, etc.|6
3040568|NCT00671034|10453088|P3|Overall Study|Refusal|5
3040569|NCT00671034|10453089|P2|Overall Study|Refusal|3
3040570|NCT00671034|10453090|P1|Overall Study|Refusal|5
3040571|NCT00671034|10453088|P3|Overall Study|VHR ALL feature|5
3040572|NCT00671034|10453089|P2|Overall Study|VHR ALL feature|3
3040573|NCT00671034|10453090|P1|Overall Study|VHR ALL feature|8
3040574|NCT00671034|10453088|P3|Overall Study|Physician Decision|5
3040575|NCT00671034|10453089|P2|Overall Study|Physician Decision|4
3040576|NCT00671034|10453090|P1|Overall Study|Physician Decision|12
3040577|NCT00671034|10453088|P3|Overall Study|Death|1
3040578|NCT00671034|10453089|P2|Overall Study|Death|2
3040579|NCT00671034|10453090|P1|Overall Study|Death|3
3040580|NCT00671034|10453088|P3|Overall Study|Adverse Event|1
3040581|NCT00671034|10453089|P2|Overall Study|Adverse Event|7
3040582|NCT00671034|10453090|P1|Overall Study|Adverse Event|5
3040583|NCT00670930|10453145|P2|Overall Study|Lost to Follow-up|0
3040584|NCT00670930|10453146|P1|Overall Study|Lost to Follow-up|1
3040585|NCT00670930|10453145|P2|Overall Study|Adminstrative Problem|1
3040586|NCT00670930|10453146|P1|Overall Study|Adminstrative Problem|0
3040587|NCT00670800|10453162|P2|Overall Study|2 controls were insulin resistant|2
3040588|NCT00670800|10453163|P1|Overall Study|2 controls were insulin resistant|0
3040589|NCT00670748|10453194|P4|Overall Study|Not off study|1
3040590|NCT00670748|10453195|P3|Overall Study|Not off study|1
3040591|NCT00670748|10453196|P2|Overall Study|Not off study|1
3040592|NCT00670748|10453197|P1|Overall Study|Not off study|2
3040593|NCT00670748|10453194|P4|Overall Study|Death during treatment|0
3040594|NCT00670748|10453195|P3|Overall Study|Death during treatment|1
3040595|NCT00670748|10453196|P2|Overall Study|Death during treatment|1
3040596|NCT00670748|10453197|P1|Overall Study|Death during treatment|1
3040597|NCT00670540|10453232|P1|Overall Study|missing information inclusion criteria|1
3040598|NCT00670540|10453232|P1|Overall Study|controls randomised for no follow up|2770
3040599|NCT00670540|10453232|P1|Overall Study|refused to participate|189
3040600|NCT00670540|10453232|P1|Overall Study|not living in France|348
3040601|NCT00670540|10453232|P1|Overall Study|ineligible|17
3040602|NCT00670488|10453252|P10|Overall Study|Withdrawal by Subject|0
3040603|NCT00670488|10453253|P9|Overall Study|Withdrawal by Subject|1
3040604|NCT00670488|10453254|P8|Overall Study|Withdrawal by Subject|0
3040605|NCT00670488|10453255|P7|Overall Study|Withdrawal by Subject|1
3040606|NCT00670488|10453256|P6|Overall Study|Withdrawal by Subject|0
3040607|NCT00670488|10453257|P5|Overall Study|Withdrawal by Subject|0
3040608|NCT00670488|10453258|P4|Overall Study|Withdrawal by Subject|1
3040609|NCT00670488|10453259|P3|Overall Study|Withdrawal by Subject|0
3040610|NCT00670488|10453260|P2|Overall Study|Withdrawal by Subject|1
3040611|NCT00670488|10453261|P1|Overall Study|Withdrawal by Subject|0
3040612|NCT00670488|10453252|P10|Overall Study|Progressive Disease|1
3040613|NCT00670488|10453253|P9|Overall Study|Progressive Disease|2
3040614|NCT00670488|10453254|P8|Overall Study|Progressive Disease|2
3040615|NCT00670488|10453255|P7|Overall Study|Progressive Disease|11
3040616|NCT00670488|10453256|P6|Overall Study|Progressive Disease|4
3040617|NCT00670488|10453257|P5|Overall Study|Progressive Disease|2
3040618|NCT00670488|10453258|P4|Overall Study|Progressive Disease|2
3040619|NCT00670488|10453259|P3|Overall Study|Progressive Disease|3
3040620|NCT00670488|10453260|P2|Overall Study|Progressive Disease|41
3040621|NCT00670488|10453261|P1|Overall Study|Progressive Disease|2
3040622|NCT00670488|10453252|P10|Overall Study|Physician Decision|0
3040623|NCT00670488|10453253|P9|Overall Study|Physician Decision|0
3040624|NCT00670488|10453254|P8|Overall Study|Physician Decision|0
3040625|NCT00670488|10453255|P7|Overall Study|Physician Decision|0
3040626|NCT00670488|10453256|P6|Overall Study|Physician Decision|0
3040627|NCT00670488|10453257|P5|Overall Study|Physician Decision|0
3040628|NCT00670488|10453258|P4|Overall Study|Physician Decision|1
3040629|NCT00670488|10453259|P3|Overall Study|Physician Decision|0
3040630|NCT00670488|10453260|P2|Overall Study|Physician Decision|9
3040631|NCT00670488|10453261|P1|Overall Study|Physician Decision|1
3040632|NCT00670488|10453252|P10|Overall Study|Adverse Event|1
3040633|NCT00670488|10453253|P9|Overall Study|Adverse Event|0
3040634|NCT00670488|10453254|P8|Overall Study|Adverse Event|1
3040635|NCT00670488|10453255|P7|Overall Study|Adverse Event|5
3040636|NCT00670488|10453256|P6|Overall Study|Adverse Event|1
3040637|NCT00670488|10453257|P5|Overall Study|Adverse Event|1
3040638|NCT00670488|10453258|P4|Overall Study|Adverse Event|3
3040639|NCT00670488|10453259|P3|Overall Study|Adverse Event|0
3040640|NCT00670488|10453260|P2|Overall Study|Adverse Event|7
3040641|NCT00670488|10453261|P1|Overall Study|Adverse Event|0
3040642|NCT00670449|10453448|P4|Overall Study|Abnormal Laboratory Value(s)|0
3040643|NCT00670449|10453449|P3|Overall Study|Abnormal Laboratory Value(s)|0
3040644|NCT00670449|10453450|P2|Overall Study|Abnormal Laboratory Value(s)|2
3040645|NCT00670449|10453451|P1|Overall Study|Abnormal Laboratory Value(s)|0
3040646|NCT00670449|10453448|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
3040647|NCT00670449|10453449|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
3040648|NCT00670449|10453450|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
3040649|NCT00670449|10453451|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
3040650|NCT00670449|10453448|P4|Overall Study|Subject Withdrew Consent|1
3040651|NCT00670449|10453449|P3|Overall Study|Subject Withdrew Consent|0
3040652|NCT00670449|10453450|P2|Overall Study|Subject Withdrew Consent|2
3040653|NCT00670449|10453451|P1|Overall Study|Subject Withdrew Consent|0
3040654|NCT00670449|10453448|P4|Overall Study|Administrative Problems|1
3040655|NCT00670449|10453449|P3|Overall Study|Administrative Problems|0
3040656|NCT00670449|10453450|P2|Overall Study|Administrative Problems|2
3040657|NCT00670449|10453451|P1|Overall Study|Administrative Problems|0
3040658|NCT00670449|10453448|P4|Overall Study|Protocol Deviation|1
3040659|NCT00670449|10453449|P3|Overall Study|Protocol Deviation|0
3040660|NCT00670449|10453450|P2|Overall Study|Protocol Deviation|2
3040661|NCT00670449|10453451|P1|Overall Study|Protocol Deviation|1
3040662|NCT00670449|10453448|P4|Overall Study|Adverse Event|5
3040663|NCT00670449|10453449|P3|Overall Study|Adverse Event|8
3040664|NCT00670449|10453450|P2|Overall Study|Adverse Event|2
3040665|NCT00670449|10453451|P1|Overall Study|Adverse Event|6
3040666|NCT00670306|10453475|P1|Overall Study|incl/excl criterias did not meet|19
3040667|NCT00670306|10453475|P1|Overall Study|Lost to Follow-up|8
3040668|NCT00670306|10453475|P1|Overall Study|Physician Decision|1
3040669|NCT00670306|10453475|P1|Overall Study|Withdrawal by Subject|9
3040670|NCT00670306|10453475|P1|Overall Study|Lack of Efficacy|10
3040671|NCT00670306|10453475|P1|Overall Study|Adverse Event|8
3040672|NCT00670228|10453514|P2|Overall Study|Not meeting the selection criteria|0
3040673|NCT00670228|10453515|P1|Overall Study|Not meeting the selection criteria|2
3040674|NCT00670228|10453514|P2|Overall Study|Not treated|2
3040675|NCT00670228|10453515|P1|Overall Study|Not treated|2
3040676|NCT00670228|10453514|P2|Overall Study|Death or MACE|1
3040677|NCT00670228|10453515|P1|Overall Study|Death or MACE|0
3040678|NCT00670228|10453514|P2|Overall Study|Adverse Event|0
3040679|NCT00670228|10453515|P1|Overall Study|Adverse Event|1
3040680|NCT00670111|10453539|P3|Enrollment to One Month|Physician Decision|0
3040681|NCT00670111|10453540|P2|Enrollment to One Month|Physician Decision|0
3040682|NCT00670111|10453541|P1|Enrollment to One Month|Physician Decision|1
3040683|NCT00670111|10453539|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
3040684|NCT00670111|10453540|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
3040685|NCT00670111|10453541|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
3040686|NCT00670111|10453539|P3|Enrollment to One Month|Testing Failure|13
3040687|NCT00670111|10453540|P2|Enrollment to One Month|Testing Failure|0
3040688|NCT00670111|10453541|P1|Enrollment to One Month|Testing Failure|0
3040689|NCT00670046|10453551|P2|Overall Study|Withdrawal by Subject|1
3040690|NCT00670046|10453552|P1|Overall Study|Withdrawal by Subject|0
3040691|NCT00670046|10453551|P2|Overall Study|Lost to Follow-up|1
3040692|NCT00670046|10453552|P1|Overall Study|Lost to Follow-up|1
3040693|NCT00670007|10453566|P1|Overall Study|Withdrawal by Subject|4
3040694|NCT00670007|10453566|P1|Overall Study|Adverse Event|1
3040695|NCT00670007|10453566|P1|Overall Study|Adverse event, serious fatal|1
3040696|NCT00670007|10453566|P1|Overall Study|Travel/Vacation|1
3040697|NCT00670007|10453566|P1|Overall Study|Lung transplant|1
3040698|NCT00670007|10453566|P1|Overall Study|Drug abuse|1
3040699|NCT00669955|10453593|P2|Overall Study|not compliant with study drug/visit|3
3040700|NCT00669955|10453594|P1|Overall Study|not compliant with study drug/visit|2
3040701|NCT00669955|10453593|P2|Overall Study|Investigator Sponsor Judgement|1
3040702|NCT00669955|10453594|P1|Overall Study|Investigator Sponsor Judgement|0
3040703|NCT00669955|10453593|P2|Overall Study|Protocol Violation|7
3040704|NCT00669955|10453594|P1|Overall Study|Protocol Violation|2
3040705|NCT00669955|10453593|P2|Overall Study|Lost to Follow-up|7
3040706|NCT00669955|10453594|P1|Overall Study|Lost to Follow-up|5
3040707|NCT00669955|10453593|P2|Overall Study|Withdrawal by Subject|3
3040708|NCT00669955|10453594|P1|Overall Study|Withdrawal by Subject|2
3040709|NCT00669955|10453593|P2|Overall Study|Death|1
3040710|NCT00669955|10453594|P1|Overall Study|Death|0
3040711|NCT00669955|10453593|P2|Overall Study|Adverse Event|5
3040712|NCT00669955|10453594|P1|Overall Study|Adverse Event|3
3040713|NCT00669942|10453624|P12|Parts 2 and 3|Protocol Violation|0
3040714|NCT00669942|10453625|P11|Parts 2 and 3|Protocol Violation|0
3040715|NCT00669942|10453626|P10|Parts 2 and 3|Protocol Violation|0
3040716|NCT00669942|10453627|P9|Parts 2 and 3|Protocol Violation|0
3040717|NCT00669942|10453628|P8|Parts 2 and 3|Protocol Violation|0
3040718|NCT00669942|10453629|P7|Parts 2 and 3|Protocol Violation|0
3040719|NCT00669942|10453630|P6|Parts 2 and 3|Protocol Violation|1
3040720|NCT00669942|10453631|P5|Parts 2 and 3|Protocol Violation|0
3040721|NCT00669942|10453632|P4|Parts 2 and 3|Protocol Violation|0
3040722|NCT00669942|10453633|P3|Parts 2 and 3|Protocol Violation|0
3040723|NCT00669942|10453634|P2|Parts 2 and 3|Protocol Violation|0
3040724|NCT00669942|10453635|P1|Parts 2 and 3|Protocol Violation|0
3040725|NCT00669942|10453624|P12|Parts 2 and 3|Withdrawal by Subject|0
3040726|NCT00669942|10453625|P11|Parts 2 and 3|Withdrawal by Subject|0
3040727|NCT00669942|10453626|P10|Parts 2 and 3|Withdrawal by Subject|0
3040728|NCT00669942|10453627|P9|Parts 2 and 3|Withdrawal by Subject|2
3040729|NCT00669942|10453628|P8|Parts 2 and 3|Withdrawal by Subject|0
3040730|NCT00669942|10453629|P7|Parts 2 and 3|Withdrawal by Subject|0
3040731|NCT00669942|10453630|P6|Parts 2 and 3|Withdrawal by Subject|1
3040732|NCT00669942|10453631|P5|Parts 2 and 3|Withdrawal by Subject|0
3040733|NCT00669942|10453632|P4|Parts 2 and 3|Withdrawal by Subject|0
3040734|NCT00669942|10453633|P3|Parts 2 and 3|Withdrawal by Subject|0
3040735|NCT00669942|10453634|P2|Parts 2 and 3|Withdrawal by Subject|0
3040736|NCT00669942|10453635|P1|Parts 2 and 3|Withdrawal by Subject|0
3040737|NCT00669942|10453624|P12|Parts 2 and 3|Adverse Event|0
3040738|NCT00669942|10453625|P11|Parts 2 and 3|Adverse Event|0
3040739|NCT00669942|10453626|P10|Parts 2 and 3|Adverse Event|0
3040740|NCT00669942|10453627|P9|Parts 2 and 3|Adverse Event|1
3040741|NCT00669942|10453628|P8|Parts 2 and 3|Adverse Event|2
3040742|NCT00669942|10453629|P7|Parts 2 and 3|Adverse Event|0
3040743|NCT00669942|10453630|P6|Parts 2 and 3|Adverse Event|0
3040744|NCT00669942|10453631|P5|Parts 2 and 3|Adverse Event|0
3040745|NCT00669942|10453632|P4|Parts 2 and 3|Adverse Event|0
3040746|NCT00669942|10453633|P3|Parts 2 and 3|Adverse Event|0
3040747|NCT00669942|10453634|P2|Parts 2 and 3|Adverse Event|0
3040748|NCT00669942|10453635|P1|Parts 2 and 3|Adverse Event|0
3040749|NCT00669903|10453718|P4|Overall Study|Protocol Violation|0
3040750|NCT00669903|10453719|P3|Overall Study|Protocol Violation|0
3040751|NCT00669903|10453720|P2|Overall Study|Protocol Violation|1
3040752|NCT00669903|10453721|P1|Overall Study|Protocol Violation|0
3040753|NCT00669903|10453718|P4|Overall Study|Lost to Follow-up|1
3040754|NCT00669903|10453719|P3|Overall Study|Lost to Follow-up|0
3040755|NCT00669903|10453720|P2|Overall Study|Lost to Follow-up|1
3040756|NCT00669903|10453721|P1|Overall Study|Lost to Follow-up|1
3040757|NCT00669903|10453718|P4|Overall Study|Withdrawal by Subject|2
3040758|NCT00669903|10453719|P3|Overall Study|Withdrawal by Subject|2
3040759|NCT00669903|10453720|P2|Overall Study|Withdrawal by Subject|2
3040760|NCT00669903|10453721|P1|Overall Study|Withdrawal by Subject|0
3040761|NCT00669903|10453718|P4|Overall Study|Adverse Event|1
3040762|NCT00669903|10453719|P3|Overall Study|Adverse Event|3
3040763|NCT00669903|10453720|P2|Overall Study|Adverse Event|1
3040764|NCT00669903|10453721|P1|Overall Study|Adverse Event|0
3040765|NCT00669877|10453751|P1|Overall Study|Disease Progression/Death|4
3040766|NCT00669864|10453756|P1|Overall Study|Other|2
3040767|NCT00669864|10453756|P1|Overall Study|Withdrawal by Subject|3
3040768|NCT00669864|10453756|P1|Overall Study|Protocol Violation|2
3040769|NCT00669864|10453756|P1|Overall Study|Lost to Follow-up|2
3040770|NCT00669669|10453770|P1|Overall Study|To late to start treatment|1
3040771|NCT00669617|10453775|P5|Period 3|Lost to Follow-up|0
3040772|NCT00669617|10453776|P4|Period 3|Lost to Follow-up|0
3040773|NCT00669617|10453777|P3|Period 3|Lost to Follow-up|0
3040774|NCT00669617|10453778|P2|Period 3|Lost to Follow-up|0
3040775|NCT00669617|10453779|P1|Period 3|Lost to Follow-up|1
3040776|NCT00669617|10453775|P5|Period 1|Protocol Deviation|1
3040777|NCT00669617|10453776|P4|Period 1|Protocol Deviation|0
3040778|NCT00669617|10453777|P3|Period 1|Protocol Deviation|0
3040779|NCT00669617|10453778|P2|Period 1|Protocol Deviation|0
3040780|NCT00669617|10453779|P1|Period 1|Protocol Deviation|0
3040781|NCT00669617|10453775|P5|Period 1|Withdrawal by Subject|0
3040782|NCT00669617|10453776|P4|Period 1|Withdrawal by Subject|0
3040783|NCT00669617|10453777|P3|Period 1|Withdrawal by Subject|1
3040784|NCT00669617|10453778|P2|Period 1|Withdrawal by Subject|0
3040785|NCT00669617|10453779|P1|Period 1|Withdrawal by Subject|0
3040786|NCT00669396|10453827|P2|Overall Study|Lost to Follow-up|12
3040787|NCT00669396|10453828|P1|Overall Study|Lost to Follow-up|10
3040788|NCT00669331|10453855|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
3040789|NCT00669331|10453856|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
3040790|NCT00669331|10453855|P2|Blinded Treatment Period|Physician Decision|3
3040791|NCT00669331|10453856|P1|Blinded Treatment Period|Physician Decision|3
3040792|NCT00669331|10453855|P2|Blinded Treatment Period|Death|2
3040793|NCT00669331|10453856|P1|Blinded Treatment Period|Death|0
3040794|NCT00669331|10453855|P2|Blinded Treatment Period|Lost to Follow-up|2
3040795|NCT00669331|10453856|P1|Blinded Treatment Period|Lost to Follow-up|3
3040796|NCT00669331|10453855|P2|Blinded Treatment Period|Withdrawal by Subject|19
3040797|NCT00669331|10453856|P1|Blinded Treatment Period|Withdrawal by Subject|17
3040798|NCT00669331|10453855|P2|Blinded Treatment Period|Protocol Violation|1
3040799|NCT00669331|10453856|P1|Blinded Treatment Period|Protocol Violation|1
3040800|NCT00669331|10453855|P2|Blinded Treatment Period|Adverse Event|10
3040801|NCT00669331|10453856|P1|Blinded Treatment Period|Adverse Event|16
3040802|NCT00669331|10453855|P2|Randomisation to First Dose|Randomised in error|10
3040803|NCT00669331|10453856|P1|Randomisation to First Dose|Randomised in error|3
3040804|NCT00669331|10453855|P2|Randomisation to First Dose|Sponsor decision|1
3040805|NCT00669331|10453856|P1|Randomisation to First Dose|Sponsor decision|0
3040806|NCT00669331|10453855|P2|Randomisation to First Dose|Death|0
3040807|NCT00669331|10453856|P1|Randomisation to First Dose|Death|1
3040808|NCT00669331|10453855|P2|Randomisation to First Dose|Lost to Follow-up|0
3040809|NCT00669331|10453856|P1|Randomisation to First Dose|Lost to Follow-up|2
3040810|NCT00669331|10453855|P2|Randomisation to First Dose|Withdrawal by Subject|2
3040811|NCT00669331|10453856|P1|Randomisation to First Dose|Withdrawal by Subject|3
3040812|NCT00669331|10453855|P2|Randomisation to First Dose|Protocol Violation|0
3040813|NCT00669331|10453856|P1|Randomisation to First Dose|Protocol Violation|1
3040814|NCT00669331|10453855|P2|Randomisation to First Dose|Adverse Event|0
3040815|NCT00669331|10453856|P1|Randomisation to First Dose|Adverse Event|1
3040816|NCT00669318|10453898|P1|Overall Study|Withdrawal by Subject|2
3040817|NCT00669240|10453915|P1|Overall Study|Enrolled but no dosing record|1
3040818|NCT00669240|10453915|P1|Overall Study|Enrolled but not treated|15
3040819|NCT00669240|10453915|P1|Overall Study|Other|19
3040820|NCT00669240|10453915|P1|Overall Study|Adverse Event|21
3040821|NCT00669240|10453915|P1|Overall Study|Lost to Follow-up|34
3040822|NCT00669240|10453915|P1|Overall Study|Withdrawal by Subject|42
3040823|NCT00669240|10453915|P1|Overall Study|Lack of Efficacy|33
3040824|NCT00669162|10453964|P1|Overall Study|Withdrawal by Subject|1
3040825|NCT00669110|10453970|P2|Overall Study|Withdrawal by Subject|2
3040826|NCT00669110|10453971|P1|Overall Study|Withdrawal by Subject|0
3040827|NCT00669110|10453970|P2|Overall Study|Protocol Violation|5
3040828|NCT00669110|10453971|P1|Overall Study|Protocol Violation|0
3040829|NCT00669110|10453970|P2|Overall Study|Lost to Follow-up|0
3040830|NCT00669110|10453971|P1|Overall Study|Lost to Follow-up|1
3040831|NCT00669110|10453970|P2|Overall Study|Physician Decision|1
3040832|NCT00669110|10453971|P1|Overall Study|Physician Decision|0
3040833|NCT00669110|10453970|P2|Overall Study|Caregiver request|2
3040834|NCT00669110|10453971|P1|Overall Study|Caregiver request|3
3040835|NCT00669110|10453970|P2|Overall Study|Adverse Event|3
3040836|NCT00669110|10453971|P1|Overall Study|Adverse Event|4
3040837|NCT00669071|10454007|P1|Overall Study|Final visit 40 days out of window|1
3040838|NCT00669071|10454007|P1|Overall Study|Lost to Follow-up|3
3040839|NCT00669032|10454028|P2|Overall Study|No fulfilment of the selection criteria|5
3040840|NCT00669032|10454029|P1|Overall Study|No fulfilment of the selection criteria|5
3040841|NCT00669032|10454028|P2|Overall Study|Physician Decision|1
3040842|NCT00669032|10454029|P1|Overall Study|Physician Decision|1
3040843|NCT00669032|10454028|P2|Overall Study|Adverse Event|16
3040844|NCT00669032|10454029|P1|Overall Study|Adverse Event|12
3040845|NCT00669032|10454028|P2|Overall Study|Withdrawal by Subject|13
3040846|NCT00669032|10454029|P1|Overall Study|Withdrawal by Subject|12
3040847|NCT00669032|10454028|P2|Overall Study|Lack of Efficacy|19
3040848|NCT00669032|10454029|P1|Overall Study|Lack of Efficacy|8
3040849|NCT00669032|10454028|P2|Overall Study|Lost to Follow-up|5
3040850|NCT00669032|10454029|P1|Overall Study|Lost to Follow-up|6
3040851|NCT00668863|10454075|P1|Overall Study|Physician Decision|1
3040852|NCT00668863|10454075|P1|Overall Study|Subject’s work scheduling problem|1
3040853|NCT00668863|10454075|P1|Overall Study|Surgery|1
3040854|NCT00668863|10454075|P1|Overall Study|Withdrawal by Subject|1
3040855|NCT00668863|10454075|P1|Overall Study|Global Deterioration of Health Status|4
3040856|NCT00668863|10454075|P1|Overall Study|Study Terminated by Sponsor|8
3040857|NCT00668863|10454075|P1|Overall Study|Adverse Event|13
3040858|NCT00668863|10454075|P1|Overall Study|Objective Progression or Relapse|42
3040859|NCT00668746|10454107|P2|Overall Study|Lost to Follow-up|1
3040860|NCT00668746|10454108|P1|Overall Study|Lost to Follow-up|2
3040861|NCT00668733|10454128|P2|Overall Study|Withdrawal by Subject|4
3040862|NCT00668733|10454129|P1|Overall Study|Withdrawal by Subject|0
3040863|NCT00668733|10454128|P2|Overall Study|Lost to Follow-up|3
3040864|NCT00668733|10454129|P1|Overall Study|Lost to Follow-up|2
3040865|NCT00668395|10454174|P3|Overall Study|Physician Decision|0
3040866|NCT00668395|10454175|P2|Overall Study|Physician Decision|1
3040867|NCT00668395|10454176|P1|Overall Study|Physician Decision|1
3040868|NCT00668395|10454174|P3|Overall Study|Adverse Event|0
3040869|NCT00668395|10454175|P2|Overall Study|Adverse Event|1
3040870|NCT00668395|10454176|P1|Overall Study|Adverse Event|1
3040871|NCT00668395|10454174|P3|Overall Study|Withdrawal by Subject|1
3040872|NCT00668395|10454175|P2|Overall Study|Withdrawal by Subject|4
3040873|NCT00668395|10454176|P1|Overall Study|Withdrawal by Subject|4
3040874|NCT00668317|10454188|P1|Overall Study|Adverse Event|2
3040875|NCT00668200|10454203|P1|Overall Study|Lost to Follow-up|1
3040876|NCT00668200|10454203|P1|Overall Study|Withdrawal by Subject|2
3040877|NCT00668148|10454209|P1|Overall Study|Withdrawal of Consent|2
3040878|NCT00668148|10454209|P1|Overall Study|Progressive Disease Before Treatment|2
3040879|NCT00668148|10454209|P1|Overall Study|Subject Non-compliance|1
3040880|NCT00668148|10454209|P1|Overall Study|Adverse Event|5
3040881|NCT00667992|10454248|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
3040882|NCT00667992|10454249|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
3040883|NCT00667992|10454248|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
3040884|NCT00667992|10454249|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
3040885|NCT00667992|10454248|P2|Wash-out|Withdrawal by Subject|0
3040886|NCT00667992|10454249|P1|Wash-out|Withdrawal by Subject|1
3040887|NCT00667992|10454248|P2|Wash-out|Failure to wash-out|2
3040888|NCT00667992|10454249|P1|Wash-out|Failure to wash-out|2
3040889|NCT00667992|10454248|P2|Wash-out|Not within one doubling dilution|3
3040890|NCT00667992|10454249|P1|Wash-out|Not within one doubling dilution|4
3040891|NCT00667992|10454248|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
3040892|NCT00667992|10454249|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
3040893|NCT00667992|10454248|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
3040894|NCT00667992|10454249|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
3040895|NCT00667992|10454248|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
3040896|NCT00667992|10454249|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
3040897|NCT00667992|10454248|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
3040898|NCT00667992|10454249|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
3040899|NCT00667992|10454248|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
3040900|NCT00667992|10454249|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
3040901|NCT00667992|10454248|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
3040902|NCT00667992|10454249|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
3040903|NCT00667992|10454248|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
3040904|NCT00667992|10454249|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
3040905|NCT00667992|10454248|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
3040906|NCT00667992|10454249|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
3040907|NCT00667875|10454306|P3|Overall Study|Withdrawal by Subject|7
3040908|NCT00667875|10454307|P2|Overall Study|Withdrawal by Subject|9
3040909|NCT00667875|10454308|P1|Overall Study|Withdrawal by Subject|10
3040910|NCT00667875|10454306|P3|Overall Study|Adverse Event|6
3040911|NCT00667875|10454307|P2|Overall Study|Adverse Event|2
3040912|NCT00667875|10454308|P1|Overall Study|Adverse Event|0
3040913|NCT00667810|10454342|P4|Overall Study|Other|0
3040914|NCT00667810|10454343|P3|Overall Study|Other|5
3040915|NCT00667810|10454344|P2|Overall Study|Other|6
3040916|NCT00667810|10454345|P1|Overall Study|Other|6
3040917|NCT00667810|10454342|P4|Overall Study|Vasogenic Edema Recurrence|0
3040918|NCT00667810|10454343|P3|Overall Study|Vasogenic Edema Recurrence|0
3040919|NCT00667810|10454344|P2|Overall Study|Vasogenic Edema Recurrence|3
3040920|NCT00667810|10454345|P1|Overall Study|Vasogenic Edema Recurrence|0
3040921|NCT00667810|10454342|P4|Overall Study|Loss of Caregiver|0
3040922|NCT00667810|10454343|P3|Overall Study|Loss of Caregiver|3
3040923|NCT00667810|10454344|P2|Overall Study|Loss of Caregiver|1
3040924|NCT00667810|10454345|P1|Overall Study|Loss of Caregiver|0
3040925|NCT00667810|10454342|P4|Overall Study|Failed to Return|0
3040926|NCT00667810|10454343|P3|Overall Study|Failed to Return|2
3040927|NCT00667810|10454344|P2|Overall Study|Failed to Return|0
3040928|NCT00667810|10454345|P1|Overall Study|Failed to Return|0
3040929|NCT00667810|10454342|P4|Overall Study|Discontinuation of Study by Sponsor|0
3040930|NCT00667810|10454343|P3|Overall Study|Discontinuation of Study by Sponsor|155
3040931|NCT00667810|10454344|P2|Overall Study|Discontinuation of Study by Sponsor|118
3040932|NCT00667810|10454345|P1|Overall Study|Discontinuation of Study by Sponsor|130
3040933|NCT00667810|10454342|P4|Overall Study|Withdrawal by Subject|1
3040934|NCT00667810|10454343|P3|Overall Study|Withdrawal by Subject|29
3040935|NCT00667810|10454344|P2|Overall Study|Withdrawal by Subject|20
3040936|NCT00667810|10454345|P1|Overall Study|Withdrawal by Subject|14
3040937|NCT00667810|10454342|P4|Overall Study|Protocol Violation|0
3040938|NCT00667810|10454343|P3|Overall Study|Protocol Violation|0
3040939|NCT00667810|10454344|P2|Overall Study|Protocol Violation|2
3040940|NCT00667810|10454345|P1|Overall Study|Protocol Violation|0
3040941|NCT00667810|10454342|P4|Overall Study|Physician Decision|0
3040942|NCT00667810|10454343|P3|Overall Study|Physician Decision|2
3040943|NCT00667810|10454344|P2|Overall Study|Physician Decision|1
3040944|NCT00667810|10454345|P1|Overall Study|Physician Decision|1
3040945|NCT00667810|10454342|P4|Overall Study|Lost to Follow-up|0
3040946|NCT00667810|10454343|P3|Overall Study|Lost to Follow-up|2
3040947|NCT00667810|10454344|P2|Overall Study|Lost to Follow-up|4
3040948|NCT00667810|10454345|P1|Overall Study|Lost to Follow-up|1
3040949|NCT00667810|10454342|P4|Overall Study|Lack of Efficacy|0
3040950|NCT00667810|10454343|P3|Overall Study|Lack of Efficacy|2
3040951|NCT00667810|10454344|P2|Overall Study|Lack of Efficacy|0
3040952|NCT00667810|10454345|P1|Overall Study|Lack of Efficacy|1
3040953|NCT00667810|10454342|P4|Overall Study|Death|0
3040954|NCT00667810|10454343|P3|Overall Study|Death|3
3040955|NCT00667810|10454344|P2|Overall Study|Death|1
3040956|NCT00667810|10454345|P1|Overall Study|Death|1
3040957|NCT00667810|10454342|P4|Overall Study|Adverse Event|1
3040958|NCT00667810|10454343|P3|Overall Study|Adverse Event|19
3040959|NCT00667810|10454344|P2|Overall Study|Adverse Event|14
3040960|NCT00667810|10454345|P1|Overall Study|Adverse Event|13
3040961|NCT00667732|10454421|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
3040962|NCT00667732|10454422|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
3040963|NCT00667732|10454423|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
3040964|NCT00667732|10454421|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
3040965|NCT00667732|10454422|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
3040966|NCT00667732|10454423|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
3040967|NCT00667732|10454421|P3|Run -In (8 Weeks)|Adverse Event|0
3040968|NCT00667732|10454422|P2|Run -In (8 Weeks)|Adverse Event|0
3040969|NCT00667732|10454423|P1|Run -In (8 Weeks)|Adverse Event|4
3040970|NCT00667602|10454459|P3|Overall Study|Protocol Violation|0
3040971|NCT00667602|10454460|P2|Overall Study|Protocol Violation|1
3040972|NCT00667602|10454461|P1|Overall Study|Protocol Violation|0
3040973|NCT00667602|10454459|P3|Overall Study|Administrative reason|2
3040974|NCT00667602|10454460|P2|Overall Study|Administrative reason|0
3040975|NCT00667602|10454461|P1|Overall Study|Administrative reason|0
3040976|NCT00667602|10454459|P3|Overall Study|Lost to Follow-up|6
3040977|NCT00667602|10454460|P2|Overall Study|Lost to Follow-up|5
3040978|NCT00667602|10454461|P1|Overall Study|Lost to Follow-up|4
3040979|NCT00667602|10454459|P3|Overall Study|Withdrawal by Subject|10
3040980|NCT00667602|10454460|P2|Overall Study|Withdrawal by Subject|9
3040981|NCT00667602|10454461|P1|Overall Study|Withdrawal by Subject|4
3040982|NCT00667576|10454529|P5|Overall Study|Missed Visit|0
3040983|NCT00667576|10454530|P4|Overall Study|Missed Visit|1
3040984|NCT00667576|10454531|P3|Overall Study|Missed Visit|0
3040985|NCT00667576|10454532|P2|Overall Study|Missed Visit|0
3040986|NCT00667576|10454533|P1|Overall Study|Missed Visit|0
3040987|NCT00667576|10454529|P5|Overall Study|Physician Decision|0
3040988|NCT00667576|10454530|P4|Overall Study|Physician Decision|1
3040989|NCT00667576|10454531|P3|Overall Study|Physician Decision|0
3040990|NCT00667576|10454532|P2|Overall Study|Physician Decision|0
3040991|NCT00667576|10454533|P1|Overall Study|Physician Decision|0
3040992|NCT00667576|10454529|P5|Overall Study|Protocol Violation|0
3040993|NCT00667576|10454530|P4|Overall Study|Protocol Violation|1
3040994|NCT00667576|10454531|P3|Overall Study|Protocol Violation|0
3040995|NCT00667576|10454532|P2|Overall Study|Protocol Violation|0
3040996|NCT00667576|10454533|P1|Overall Study|Protocol Violation|0
3040997|NCT00667576|10454529|P5|Overall Study|Lost to Follow-up|0
3040998|NCT00667576|10454530|P4|Overall Study|Lost to Follow-up|0
3040999|NCT00667576|10454531|P3|Overall Study|Lost to Follow-up|1
3041000|NCT00667576|10454532|P2|Overall Study|Lost to Follow-up|0
3041001|NCT00667576|10454533|P1|Overall Study|Lost to Follow-up|0
3041002|NCT00667576|10454529|P5|Overall Study|Adverse Event|0
3041003|NCT00667576|10454530|P4|Overall Study|Adverse Event|0
3041004|NCT00667576|10454531|P3|Overall Study|Adverse Event|0
3041005|NCT00667576|10454532|P2|Overall Study|Adverse Event|1
3041006|NCT00667576|10454533|P1|Overall Study|Adverse Event|1
3041007|NCT00667576|10454529|P5|Overall Study|Withdrawal by Subject|1
3041008|NCT00667576|10454530|P4|Overall Study|Withdrawal by Subject|1
3041009|NCT00667576|10454531|P3|Overall Study|Withdrawal by Subject|1
3041010|NCT00667576|10454532|P2|Overall Study|Withdrawal by Subject|0
3041011|NCT00667576|10454533|P1|Overall Study|Withdrawal by Subject|1
3041012|NCT00667563|10454580|P1|Overall Study|Protocol Violation|24
3041013|NCT00667459|10454600|P2|Overall Study|Lost to Follow-up|43
3041014|NCT00667459|10454601|P1|Overall Study|Lost to Follow-up|8
3041015|NCT00667459|10454600|P2|Overall Study|Death|2
3041016|NCT00667459|10454601|P1|Overall Study|Death|0
3041017|NCT00667446|10454643|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
3041018|NCT00667446|10454644|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
3041019|NCT00667446|10454643|P2|Treatment Period (36 Months)|Therapeutic Failure|1
3041020|NCT00667446|10454644|P1|Treatment Period (36 Months)|Therapeutic Failure|1
3041021|NCT00667446|10454643|P2|Treatment Period (36 Months)|Protocol Violation|1
3041022|NCT00667446|10454644|P1|Treatment Period (36 Months)|Protocol Violation|1
3041023|NCT00667446|10454643|P2|Treatment Period (36 Months)|Lost to Follow-up|0
3041024|NCT00667446|10454644|P1|Treatment Period (36 Months)|Lost to Follow-up|1
3041025|NCT00667446|10454643|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
3041026|NCT00667446|10454644|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
3041027|NCT00667446|10454643|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
3041028|NCT00667446|10454644|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
3041029|NCT00667446|10454643|P2|Treatment Period (36 Months)|Personal reasons|2
3041030|NCT00667446|10454644|P1|Treatment Period (36 Months)|Personal reasons|2
3041031|NCT00667446|10454643|P2|Treatment Period (36 Months)|Other|2
3041032|NCT00667446|10454644|P1|Treatment Period (36 Months)|Other|2
3041033|NCT00667446|10454643|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
3041034|NCT00667446|10454644|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
3041035|NCT00667420|10454666|P1|Overall Study|Withdrawal by Subject|2
3041036|NCT00667420|10454666|P1|Overall Study|Physician Decision|1
3041037|NCT00667420|10454666|P1|Overall Study|Lack of Efficacy|5
3041038|NCT00667420|10454666|P1|Overall Study|Adverse Event|2
3041039|NCT00667394|10454676|P2|Overall Study|Progressive disease|0
3041040|NCT00667394|10454677|P1|Overall Study|Progressive disease|1
3041041|NCT00667394|10454676|P2|Overall Study|Adverse Event|0
3041042|NCT00667394|10454677|P1|Overall Study|Adverse Event|3
3041043|NCT00667368|10454704|P2|Overall Study|Discontinued early|17
3041044|NCT00667368|10454705|P1|Overall Study|Discontinued early|24
3041045|NCT00667368|10454704|P2|Overall Study|Lost to Follow-up|155
3041046|NCT00667368|10454705|P1|Overall Study|Lost to Follow-up|176
3041047|NCT00667355|10454713|P1|Overall Study|Other reason was not specified|5
3041048|NCT00667355|10454713|P1|Overall Study|Lost to Follow-up|1
3041049|NCT00667355|10454713|P1|Overall Study|Adverse Event|5
3041050|NCT00667342|10454738|P3|Overall Study|Ineligible|1
3041051|NCT00667342|10454739|P2|Overall Study|Ineligible|0
3041052|NCT00667342|10454740|P1|Overall Study|Ineligible|0
3041053|NCT00667342|10454738|P3|Overall Study|Adverse Event|1
3041054|NCT00667342|10454739|P2|Overall Study|Adverse Event|0
3041055|NCT00667342|10454740|P1|Overall Study|Adverse Event|0
3041056|NCT00667342|10454738|P3|Overall Study|Relapse or tumor progression|7
3041057|NCT00667342|10454739|P2|Overall Study|Relapse or tumor progression|0
3041058|NCT00667342|10454740|P1|Overall Study|Relapse or tumor progression|9
3041059|NCT00667342|10454738|P3|Overall Study|Physician Decision|0
3041060|NCT00667342|10454739|P2|Overall Study|Physician Decision|0
3041061|NCT00667342|10454740|P1|Overall Study|Physician Decision|3
3041062|NCT00667342|10454738|P3|Overall Study|Withdrawal by Subject|0
3041063|NCT00667342|10454739|P2|Overall Study|Withdrawal by Subject|0
3041064|NCT00667342|10454740|P1|Overall Study|Withdrawal by Subject|1
3041065|NCT00667342|10454738|P3|Overall Study|Protocol Violation|0
3041066|NCT00667342|10454739|P2|Overall Study|Protocol Violation|0
3041067|NCT00667342|10454740|P1|Overall Study|Protocol Violation|1
3041068|NCT00667277|10454778|P1|Overall Study|Withdrawal by Subject|2
3041069|NCT00667251|10454785|P2|Overall Study|Symptomatic progression|2
3041070|NCT00667251|10454786|P1|Overall Study|Symptomatic progression|1
3041071|NCT00667251|10454785|P2|Overall Study|Intercurrent Illness|3
3041072|NCT00667251|10454786|P1|Overall Study|Intercurrent Illness|4
3041073|NCT00667251|10454785|P2|Overall Study|Other/missing|84
3041074|NCT00667251|10454786|P1|Overall Study|Other/missing|46
3041075|NCT00667251|10454785|P2|Overall Study|Withdrawal by Subject|2
3041076|NCT00667251|10454786|P1|Overall Study|Withdrawal by Subject|6
3041077|NCT00667251|10454785|P2|Overall Study|Adverse Event|4
3041078|NCT00667251|10454786|P1|Overall Study|Adverse Event|13
3041079|NCT00667225|10454812|P2|Overall Study|Lost to Follow-up|1
3041080|NCT00667225|10454813|P1|Overall Study|Lost to Follow-up|0
3041081|NCT00667225|10454812|P2|Overall Study|Subject had no more lesions to treat.|0
3041082|NCT00667225|10454813|P1|Overall Study|Subject had no more lesions to treat.|1
3041083|NCT00667095|10454834|P2|Overall Study|Withdrawal by Subject|1
3041084|NCT00667095|10454835|P1|Overall Study|Withdrawal by Subject|0
3041085|NCT00667017|10454851|P1|Overall Study|Withdrawal by Subject|1
3041086|NCT00666965|10454871|P4|Overall Study|Withdrawal by Subject|2
3041087|NCT00666965|10454872|P3|Overall Study|Withdrawal by Subject|0
3041088|NCT00666965|10454873|P2|Overall Study|Withdrawal by Subject|0
3041089|NCT00666965|10454874|P1|Overall Study|Withdrawal by Subject|0
3041090|NCT00666965|10454871|P4|Overall Study|Discontinuation criteria|2
3041091|NCT00666965|10454872|P3|Overall Study|Discontinuation criteria|1
3041092|NCT00666965|10454873|P2|Overall Study|Discontinuation criteria|1
3041093|NCT00666965|10454874|P1|Overall Study|Discontinuation criteria|2
3041094|NCT00666965|10454871|P4|Overall Study|Protocol Violation|2
3041095|NCT00666965|10454872|P3|Overall Study|Protocol Violation|0
3041096|NCT00666965|10454873|P2|Overall Study|Protocol Violation|0
3041097|NCT00666965|10454874|P1|Overall Study|Protocol Violation|0
3041098|NCT00666965|10454871|P4|Overall Study|Lack of Efficacy|0
3041099|NCT00666965|10454872|P3|Overall Study|Lack of Efficacy|0
3041100|NCT00666965|10454873|P2|Overall Study|Lack of Efficacy|1
3041101|NCT00666965|10454874|P1|Overall Study|Lack of Efficacy|1
3041102|NCT00666965|10454871|P4|Overall Study|Adverse Event|9
3041103|NCT00666965|10454872|P3|Overall Study|Adverse Event|1
3041104|NCT00666965|10454873|P2|Overall Study|Adverse Event|2
3041105|NCT00666965|10454874|P1|Overall Study|Adverse Event|0
3041106|NCT00666926|10454904|P16|Overall Study|Death|0
3041107|NCT00666926|10454905|P15|Overall Study|Death|0
3041108|NCT00666926|10454906|P14|Overall Study|Death|0
3041109|NCT00666926|10454907|P13|Overall Study|Death|0
3041110|NCT00666926|10454908|P12|Overall Study|Death|1
3041111|NCT00666926|10454909|P11|Overall Study|Death|0
3041112|NCT00666926|10454910|P10|Overall Study|Death|0
3041113|NCT00666926|10454911|P9|Overall Study|Death|0
3041114|NCT00666926|10454912|P8|Overall Study|Death|0
3041115|NCT00666926|10454913|P7|Overall Study|Death|0
3041116|NCT00666926|10454914|P6|Overall Study|Death|0
3041117|NCT00666926|10454915|P5|Overall Study|Death|0
3041118|NCT00666926|10454916|P4|Overall Study|Death|0
3041119|NCT00666926|10454917|P3|Overall Study|Death|0
3041120|NCT00666926|10454918|P2|Overall Study|Death|0
3041121|NCT00666926|10454919|P1|Overall Study|Death|0
3041122|NCT00666926|10454904|P16|Overall Study|Withdrawal by Subject|3
3041123|NCT00666926|10454905|P15|Overall Study|Withdrawal by Subject|3
3041124|NCT00666926|10454906|P14|Overall Study|Withdrawal by Subject|1
3041125|NCT00666926|10454907|P13|Overall Study|Withdrawal by Subject|0
3041126|NCT00666926|10454908|P12|Overall Study|Withdrawal by Subject|3
3041127|NCT00666926|10454909|P11|Overall Study|Withdrawal by Subject|0
3041128|NCT00666926|10454910|P10|Overall Study|Withdrawal by Subject|3
3041129|NCT00666926|10454911|P9|Overall Study|Withdrawal by Subject|0
3041130|NCT00666926|10454912|P8|Overall Study|Withdrawal by Subject|1
3041131|NCT00666926|10454913|P7|Overall Study|Withdrawal by Subject|0
3041132|NCT00666926|10454914|P6|Overall Study|Withdrawal by Subject|0
3041133|NCT00666926|10454915|P5|Overall Study|Withdrawal by Subject|0
3041134|NCT00666926|10454916|P4|Overall Study|Withdrawal by Subject|0
3041135|NCT00666926|10454917|P3|Overall Study|Withdrawal by Subject|0
3041136|NCT00666926|10454918|P2|Overall Study|Withdrawal by Subject|0
3041137|NCT00666926|10454919|P1|Overall Study|Withdrawal by Subject|0
3041138|NCT00666926|10454904|P16|Overall Study|Other|4
3041139|NCT00666926|10454905|P15|Overall Study|Other|4
3041140|NCT00666926|10454906|P14|Overall Study|Other|2
3041141|NCT00666926|10454907|P13|Overall Study|Other|3
3041142|NCT00666926|10454908|P12|Overall Study|Other|26
3041143|NCT00666926|10454909|P11|Overall Study|Other|3
3041144|NCT00666926|10454910|P10|Overall Study|Other|5
3041145|NCT00666926|10454911|P9|Overall Study|Other|3
3041146|NCT00666926|10454912|P8|Overall Study|Other|0
3041147|NCT00666926|10454913|P7|Overall Study|Other|4
3041148|NCT00666926|10454914|P6|Overall Study|Other|3
3041149|NCT00666926|10454915|P5|Overall Study|Other|3
3041150|NCT00666926|10454916|P4|Overall Study|Other|3
3041151|NCT00666926|10454917|P3|Overall Study|Other|3
3041152|NCT00666926|10454918|P2|Overall Study|Other|4
3041153|NCT00666926|10454919|P1|Overall Study|Other|2
3041154|NCT00666926|10454904|P16|Overall Study|Lost to Follow-up|0
3041155|NCT00666926|10454905|P15|Overall Study|Lost to Follow-up|0
3041156|NCT00666926|10454906|P14|Overall Study|Lost to Follow-up|0
3041157|NCT00666926|10454907|P13|Overall Study|Lost to Follow-up|0
3041158|NCT00666926|10454908|P12|Overall Study|Lost to Follow-up|0
3041159|NCT00666926|10454909|P11|Overall Study|Lost to Follow-up|0
3041160|NCT00666926|10454910|P10|Overall Study|Lost to Follow-up|0
3041161|NCT00666926|10454911|P9|Overall Study|Lost to Follow-up|0
3041162|NCT00666926|10454912|P8|Overall Study|Lost to Follow-up|0
3041163|NCT00666926|10454913|P7|Overall Study|Lost to Follow-up|0
3041164|NCT00666926|10454914|P6|Overall Study|Lost to Follow-up|0
3041165|NCT00666926|10454915|P5|Overall Study|Lost to Follow-up|0
3041166|NCT00666926|10454916|P4|Overall Study|Lost to Follow-up|1
3041167|NCT00666926|10454917|P3|Overall Study|Lost to Follow-up|0
3041168|NCT00666926|10454918|P2|Overall Study|Lost to Follow-up|0
3041169|NCT00666926|10454919|P1|Overall Study|Lost to Follow-up|0
3041170|NCT00666926|10454904|P16|Overall Study|Lack of Efficacy|0
3041171|NCT00666926|10454905|P15|Overall Study|Lack of Efficacy|0
3041172|NCT00666926|10454906|P14|Overall Study|Lack of Efficacy|0
3041173|NCT00666926|10454907|P13|Overall Study|Lack of Efficacy|0
3041174|NCT00666926|10454908|P12|Overall Study|Lack of Efficacy|1
3041175|NCT00666926|10454909|P11|Overall Study|Lack of Efficacy|0
3041176|NCT00666926|10454910|P10|Overall Study|Lack of Efficacy|0
3041177|NCT00666926|10454911|P9|Overall Study|Lack of Efficacy|0
3041178|NCT00666926|10454912|P8|Overall Study|Lack of Efficacy|0
3041179|NCT00666926|10454913|P7|Overall Study|Lack of Efficacy|0
3041180|NCT00666926|10454914|P6|Overall Study|Lack of Efficacy|1
3041181|NCT00666926|10454915|P5|Overall Study|Lack of Efficacy|0
3041182|NCT00666926|10454916|P4|Overall Study|Lack of Efficacy|0
3041183|NCT00666926|10454917|P3|Overall Study|Lack of Efficacy|0
3041184|NCT00666926|10454918|P2|Overall Study|Lack of Efficacy|0
3041185|NCT00666926|10454919|P1|Overall Study|Lack of Efficacy|0
3041186|NCT00666926|10454904|P16|Overall Study|Laboratory abnormality|1
3041187|NCT00666926|10454905|P15|Overall Study|Laboratory abnormality|0
3041188|NCT00666926|10454906|P14|Overall Study|Laboratory abnormality|0
3041189|NCT00666926|10454907|P13|Overall Study|Laboratory abnormality|0
3041190|NCT00666926|10454908|P12|Overall Study|Laboratory abnormality|0
3041191|NCT00666926|10454909|P11|Overall Study|Laboratory abnormality|1
3041192|NCT00666926|10454910|P10|Overall Study|Laboratory abnormality|0
3041193|NCT00666926|10454911|P9|Overall Study|Laboratory abnormality|0
3041194|NCT00666926|10454912|P8|Overall Study|Laboratory abnormality|0
3041195|NCT00666926|10454913|P7|Overall Study|Laboratory abnormality|0
3041196|NCT00666926|10454914|P6|Overall Study|Laboratory abnormality|0
3041197|NCT00666926|10454915|P5|Overall Study|Laboratory abnormality|0
3041198|NCT00666926|10454916|P4|Overall Study|Laboratory abnormality|0
3041199|NCT00666926|10454917|P3|Overall Study|Laboratory abnormality|0
3041200|NCT00666926|10454918|P2|Overall Study|Laboratory abnormality|0
3041201|NCT00666926|10454919|P1|Overall Study|Laboratory abnormality|0
3041202|NCT00666926|10454904|P16|Overall Study|Adverse Event|0
3041203|NCT00666926|10454905|P15|Overall Study|Adverse Event|0
3041204|NCT00666926|10454906|P14|Overall Study|Adverse Event|1
3041205|NCT00666926|10454907|P13|Overall Study|Adverse Event|0
3041206|NCT00666926|10454908|P12|Overall Study|Adverse Event|2
3041207|NCT00666926|10454909|P11|Overall Study|Adverse Event|2
3041208|NCT00666926|10454910|P10|Overall Study|Adverse Event|2
3041209|NCT00666926|10454911|P9|Overall Study|Adverse Event|0
3041210|NCT00666926|10454912|P8|Overall Study|Adverse Event|0
3041211|NCT00666926|10454913|P7|Overall Study|Adverse Event|0
3041212|NCT00666926|10454914|P6|Overall Study|Adverse Event|0
3041213|NCT00666926|10454915|P5|Overall Study|Adverse Event|0
3041214|NCT00666926|10454916|P4|Overall Study|Adverse Event|0
3041215|NCT00666926|10454917|P3|Overall Study|Adverse Event|0
3041216|NCT00666926|10454918|P2|Overall Study|Adverse Event|0
3041217|NCT00666926|10454919|P1|Overall Study|Adverse Event|0
3041218|NCT00666835|10455228|P2|Overall Study|Physician Decision|2
3041219|NCT00666835|10455229|P1|Overall Study|Physician Decision|1
3041220|NCT00666835|10455228|P2|Overall Study|Planned operation|0
3041221|NCT00666835|10455229|P1|Overall Study|Planned operation|2
3041222|NCT00666835|10455228|P2|Overall Study|Hemoglobulin concentration|3
3041223|NCT00666835|10455229|P1|Overall Study|Hemoglobulin concentration|4
3041224|NCT00666835|10455228|P2|Overall Study|Kidney Transplantation (NTX)|2
3041225|NCT00666835|10455229|P1|Overall Study|Kidney Transplantation (NTX)|10
3041226|NCT00666835|10455228|P2|Overall Study|Death|4
3041227|NCT00666835|10455229|P1|Overall Study|Death|15
3041228|NCT00666835|10455228|P2|Overall Study|Protocol Violation|0
3041229|NCT00666835|10455229|P1|Overall Study|Protocol Violation|2
3041230|NCT00666835|10455228|P2|Overall Study|Adverse Event|6
3041231|NCT00666835|10455229|P1|Overall Study|Adverse Event|7
3041232|NCT00666835|10455228|P2|Overall Study|Incl./excl. not fulfilled|2
3041233|NCT00666835|10455229|P1|Overall Study|Incl./excl. not fulfilled|7
3041234|NCT00666835|10455228|P2|Overall Study|Lack of Efficacy|1
3041235|NCT00666835|10455229|P1|Overall Study|Lack of Efficacy|0
3041236|NCT00666835|10455228|P2|Overall Study|Withdrawal by Subject|2
3041237|NCT00666835|10455229|P1|Overall Study|Withdrawal by Subject|5
3041238|NCT00666757|10455239|P2|Overall Study|Sponsor decision|1
3041239|NCT00666757|10455240|P1|Overall Study|Sponsor decision|0
3041240|NCT00666757|10455239|P2|Overall Study|Physician Decision|2
3041241|NCT00666757|10455240|P1|Overall Study|Physician Decision|0
3041242|NCT00666757|10455239|P2|Overall Study|Lack of Efficacy|6
3041243|NCT00666757|10455240|P1|Overall Study|Lack of Efficacy|3
3041244|NCT00666757|10455239|P2|Overall Study|Withdrawal by Subject|17
3041245|NCT00666757|10455240|P1|Overall Study|Withdrawal by Subject|13
3041246|NCT00666757|10455239|P2|Overall Study|Adverse Event|12
3041247|NCT00666757|10455240|P1|Overall Study|Adverse Event|22
3041248|NCT00666757|10455239|P2|Overall Study|Protocol Violation|24
3041249|NCT00666757|10455240|P1|Overall Study|Protocol Violation|23
3041250|NCT00666757|10455239|P2|Overall Study|Lost to Follow-up|35
3041251|NCT00666757|10455240|P1|Overall Study|Lost to Follow-up|39
3041252|NCT00666718|10455299|P2|Overall Study|Physician Decision|2
3041253|NCT00666718|10455300|P1|Overall Study|Physician Decision|0
3041254|NCT00666718|10455299|P2|Overall Study|Withdrawal by Subject|12
3041255|NCT00666718|10455300|P1|Overall Study|Withdrawal by Subject|7
3041256|NCT00666718|10455299|P2|Overall Study|Protocol Violation|3
3041257|NCT00666718|10455300|P1|Overall Study|Protocol Violation|1
3041258|NCT00666718|10455299|P2|Overall Study|Entry Criteria Not Met|0
3041259|NCT00666718|10455300|P1|Overall Study|Entry Criteria Not Met|2
3041260|NCT00666718|10455299|P2|Overall Study|Lost to Follow-up|0
3041261|NCT00666718|10455300|P1|Overall Study|Lost to Follow-up|1
3041262|NCT00666718|10455299|P2|Overall Study|Death|0
3041263|NCT00666718|10455300|P1|Overall Study|Death|1
3041264|NCT00666718|10455299|P2|Overall Study|Adverse Event|1
3041265|NCT00666718|10455300|P1|Overall Study|Adverse Event|0
3041266|NCT00666705|10455326|P1|Overall Study|Withdrawal by Subject|1
3041267|NCT00666679|10455345|P2|Second Intervention|Death|1
3041268|NCT00666679|10455346|P1|Second Intervention|Death|0
3041269|NCT00666679|10455345|P2|Second Intervention|Adverse Event|0
3041270|NCT00666679|10455346|P1|Second Intervention|Adverse Event|1
3041271|NCT00666679|10455345|P2|Washout Period of 1 Week|Protocol Violation|1
3041272|NCT00666679|10455346|P1|Washout Period of 1 Week|Protocol Violation|0
3041273|NCT00666679|10455345|P2|Washout Period of 1 Week|Lost to Follow-up|1
3041274|NCT00666679|10455346|P1|Washout Period of 1 Week|Lost to Follow-up|0
3041275|NCT00666679|10455345|P2|First Intervention|Randomized did not start treatment|1
3041276|NCT00666679|10455346|P1|First Intervention|Randomized did not start treatment|1
3041277|NCT00666679|10455345|P2|First Intervention|Withdrawal by Subject|0
3041278|NCT00666679|10455346|P1|First Intervention|Withdrawal by Subject|1
3041279|NCT00666679|10455345|P2|First Intervention|Protocol Violation|0
3041280|NCT00666679|10455346|P1|First Intervention|Protocol Violation|1
3041281|NCT00666679|10455345|P2|First Intervention|Lost to Follow-up|0
3041282|NCT00666679|10455346|P1|First Intervention|Lost to Follow-up|1
3041283|NCT00666588|10455376|P4|Overall Study|inevaluable|0
3041284|NCT00666588|10455377|P3|Overall Study|inevaluable|0
3041285|NCT00666588|10455378|P2|Overall Study|inevaluable|0
3041286|NCT00666588|10455379|P1|Overall Study|inevaluable|2
3041287|NCT00666588|10455376|P4|Overall Study|ineligible|2
3041288|NCT00666588|10455377|P3|Overall Study|ineligible|0
3041289|NCT00666588|10455378|P2|Overall Study|ineligible|0
3041290|NCT00666588|10455379|P1|Overall Study|ineligible|2
3041291|NCT00666562|10455412|P3|Overall Study|Concomitant Medication|0
3041292|NCT00666562|10455413|P2|Overall Study|Concomitant Medication|1
3041293|NCT00666562|10455414|P1|Overall Study|Concomitant Medication|0
3041294|NCT00666562|10455412|P3|Overall Study|Withdrawal by Subject|0
3041295|NCT00666562|10455413|P2|Overall Study|Withdrawal by Subject|1
3041296|NCT00666562|10455414|P1|Overall Study|Withdrawal by Subject|0
3041297|NCT00666536|10455461|P2|Overall Study|Lost to Follow-up|3
3041298|NCT00666536|10455462|P1|Overall Study|Lost to Follow-up|4
3041299|NCT00666536|10455461|P2|Overall Study|Withdrawal by Subject|9
3041300|NCT00666536|10455462|P1|Overall Study|Withdrawal by Subject|10
3041301|NCT00666536|10455461|P2|Overall Study|Protocol deviation(s)|6
3041302|NCT00666536|10455462|P1|Overall Study|Protocol deviation(s)|8
3041303|NCT00666536|10455461|P2|Overall Study|Unsatisfactory therapeutic effect|0
3041304|NCT00666536|10455462|P1|Overall Study|Unsatisfactory therapeutic effect|2
3041305|NCT00666536|10455461|P2|Overall Study|Adverse Event|19
3041306|NCT00666536|10455462|P1|Overall Study|Adverse Event|9
3041307|NCT00666458|10455480|P2|Overall Study|Medical history of anemia|0
3041308|NCT00666458|10455481|P1|Overall Study|Medical history of anemia|1
3041309|NCT00666458|10455480|P2|Overall Study|Safety reasons|0
3041310|NCT00666458|10455481|P1|Overall Study|Safety reasons|1
3041311|NCT00666458|10455480|P2|Overall Study|Severe non-compliance to the protocol|1
3041312|NCT00666458|10455481|P1|Overall Study|Severe non-compliance to the protocol|1
3041313|NCT00666458|10455480|P2|Overall Study|Study specific discontinuation criteria|7
3041314|NCT00666458|10455481|P1|Overall Study|Study specific discontinuation criteria|14
3041315|NCT00666458|10455480|P2|Overall Study|Incorrect enrollment|1
3041316|NCT00666458|10455481|P1|Overall Study|Incorrect enrollment|7
3041317|NCT00666458|10455480|P2|Overall Study|Administrative reason by sponsor|1
3041318|NCT00666458|10455481|P1|Overall Study|Administrative reason by sponsor|1
3041319|NCT00666458|10455480|P2|Overall Study|Lost to Follow-up|3
3041320|NCT00666458|10455481|P1|Overall Study|Lost to Follow-up|0
3041321|NCT00666458|10455480|P2|Overall Study|Withdrawal by Subject|4
3041322|NCT00666458|10455481|P1|Overall Study|Withdrawal by Subject|5
3041323|NCT00666458|10455480|P2|Overall Study|Adverse Event|7
3041324|NCT00666458|10455481|P1|Overall Study|Adverse Event|8
3041325|NCT00666328|10455569|P1|Overall Study|No longer met eligibility criteria|1
3041326|NCT00666328|10455569|P1|Overall Study|Lost to Follow-up|2
3041327|NCT00666328|10455569|P1|Overall Study|Death|2
3041328|NCT00666276|10455582|P1|Overall Study|Protocol Violation|34
3041329|NCT00666263|10455606|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
3041330|NCT00666263|10455607|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
3041331|NCT00666263|10455606|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
3041332|NCT00666263|10455607|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
3041333|NCT00666263|10455606|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
3041334|NCT00666263|10455607|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
3041335|NCT00666224|10455751|P2|Open-Label|Undefined/Unknown|1
3041336|NCT00666224|10455752|P1|Open-Label|Undefined/Unknown|1
3041337|NCT00666224|10455751|P2|Open-Label|Noncompliance|1
3041338|NCT00666224|10455752|P1|Open-Label|Noncompliance|2
3041339|NCT00666224|10455751|P2|Open-Label|Pregnancy|5
3041340|NCT00666224|10455752|P1|Open-Label|Pregnancy|1
3041341|NCT00666224|10455751|P2|Open-Label|Physician Decision|5
3041342|NCT00666224|10455752|P1|Open-Label|Physician Decision|7
3041343|NCT00666224|10455751|P2|Open-Label|Withdrawal by Subject|25
3041344|NCT00666224|10455752|P1|Open-Label|Withdrawal by Subject|12
3041345|NCT00666224|10455751|P2|Open-Label|Lost to Follow-up|5
3041346|NCT00666224|10455752|P1|Open-Label|Lost to Follow-up|4
3041347|NCT00666224|10455751|P2|Open-Label|Adverse Event|43
3041348|NCT00666224|10455752|P1|Open-Label|Adverse Event|8
3041349|NCT00666224|10455751|P2|Double-Blind|Undefined/Unknown|1
3041350|NCT00666224|10455752|P1|Double-Blind|Undefined/Unknown|4
3041351|NCT00666224|10455751|P2|Double-Blind|Death|0
3041352|NCT00666224|10455752|P1|Double-Blind|Death|1
3041353|NCT00666224|10455751|P2|Double-Blind|Noncompliance|0
3041354|NCT00666224|10455752|P1|Double-Blind|Noncompliance|1
3041355|NCT00666224|10455751|P2|Double-Blind|Pregnancy|2
3041356|NCT00666224|10455752|P1|Double-Blind|Pregnancy|3
3041357|NCT00666224|10455751|P2|Double-Blind|Sponsor decision|0
3041358|NCT00666224|10455752|P1|Double-Blind|Sponsor decision|1
3041359|NCT00666224|10455751|P2|Double-Blind|Physician Decision|3
3041360|NCT00666224|10455752|P1|Double-Blind|Physician Decision|0
3041361|NCT00666224|10455751|P2|Double-Blind|Withdrawal by Subject|14
3041362|NCT00666224|10455752|P1|Double-Blind|Withdrawal by Subject|18
3041363|NCT00666224|10455751|P2|Double-Blind|Lost to Follow-up|2
3041364|NCT00666224|10455752|P1|Double-Blind|Lost to Follow-up|2
3041365|NCT00666224|10455751|P2|Double-Blind|Adverse Event|5
3041366|NCT00666224|10455752|P1|Double-Blind|Adverse Event|15
3041367|NCT00666211|10455771|P2|Overall Study|Physician Decision|1
3041368|NCT00666211|10455772|P1|Overall Study|Physician Decision|0
3041369|NCT00666211|10455771|P2|Overall Study|off tx for other complicating disease|1
3041370|NCT00666211|10455772|P1|Overall Study|off tx for other complicating disease|0
3041371|NCT00666211|10455771|P2|Overall Study|Death|2
3041372|NCT00666211|10455772|P1|Overall Study|Death|0
3041373|NCT00666211|10455771|P2|Overall Study|hospital admission|5
3041374|NCT00666211|10455772|P1|Overall Study|hospital admission|0
3041375|NCT00666211|10455771|P2|Overall Study|toxicity|2
3041376|NCT00666211|10455772|P1|Overall Study|toxicity|0
3041377|NCT00666211|10455771|P2|Overall Study|Lost to Follow-up|0
3041378|NCT00666211|10455772|P1|Overall Study|Lost to Follow-up|2
3041379|NCT00666211|10455771|P2|Overall Study|disease progression|8
3041380|NCT00666211|10455772|P1|Overall Study|disease progression|1
3041381|NCT00666211|10455771|P2|Overall Study|patient non-compliant|6
3041382|NCT00666211|10455772|P1|Overall Study|patient non-compliant|6
3041383|NCT00666211|10455771|P2|Overall Study|went off medication, no more pain|0
3041384|NCT00666211|10455772|P1|Overall Study|went off medication, no more pain|1
3041385|NCT00666211|10455771|P2|Overall Study|Withdrawal by Subject|13
3041386|NCT00666211|10455772|P1|Overall Study|Withdrawal by Subject|10
3041387|NCT00666198|10455790|P1|Overall Study|No Drug Administration|4
3041388|NCT00666198|10455790|P1|Overall Study|Safety Not Assessable|6
3041389|NCT00666198|10455790|P1|Overall Study|No Visit After First Day of Treatment|13
3041390|NCT00666198|10455790|P1|Overall Study|Protocol Violation|10
3041391|NCT00665925|10455818|P4|Overall Study|Due to exclusion criteria|0
3041392|NCT00665925|10455819|P3|Overall Study|Due to exclusion criteria|0
3041393|NCT00665925|10455820|P2|Overall Study|Due to exclusion criteria|0
3041394|NCT00665925|10455821|P1|Overall Study|Due to exclusion criteria|1
3041395|NCT00665925|10455818|P4|Overall Study|Enrolled by mistake|1
3041396|NCT00665925|10455819|P3|Overall Study|Enrolled by mistake|0
3041397|NCT00665925|10455820|P2|Overall Study|Enrolled by mistake|0
3041398|NCT00665925|10455821|P1|Overall Study|Enrolled by mistake|0
3041399|NCT00665925|10455818|P4|Overall Study|Adverse Event|5
3041400|NCT00665925|10455819|P3|Overall Study|Adverse Event|10
3041401|NCT00665925|10455820|P2|Overall Study|Adverse Event|5
3041402|NCT00665925|10455821|P1|Overall Study|Adverse Event|1
3041403|NCT00665925|10455818|P4|Overall Study|Severe Non-Compliance to Protocol|1
3041404|NCT00665925|10455819|P3|Overall Study|Severe Non-Compliance to Protocol|1
3041405|NCT00665925|10455820|P2|Overall Study|Severe Non-Compliance to Protocol|0
3041406|NCT00665925|10455821|P1|Overall Study|Severe Non-Compliance to Protocol|0
3041407|NCT00665925|10455818|P4|Overall Study|Physician Decision|2
3041408|NCT00665925|10455819|P3|Overall Study|Physician Decision|1
3041409|NCT00665925|10455820|P2|Overall Study|Physician Decision|0
3041410|NCT00665925|10455821|P1|Overall Study|Physician Decision|0
3041411|NCT00665925|10455818|P4|Overall Study|Withdrawal by Subject|2
3041412|NCT00665925|10455819|P3|Overall Study|Withdrawal by Subject|3
3041413|NCT00665925|10455820|P2|Overall Study|Withdrawal by Subject|2
3041414|NCT00665925|10455821|P1|Overall Study|Withdrawal by Subject|2
3041415|NCT00665925|10455818|P4|Overall Study|Lost to Follow-up|2
3041416|NCT00665925|10455819|P3|Overall Study|Lost to Follow-up|2
3041417|NCT00665925|10455820|P2|Overall Study|Lost to Follow-up|2
3041418|NCT00665925|10455821|P1|Overall Study|Lost to Follow-up|1
3041419|NCT00665925|10455818|P4|Overall Study|Lack of Efficacy|8
3041420|NCT00665925|10455819|P3|Overall Study|Lack of Efficacy|9
3041421|NCT00665925|10455820|P2|Overall Study|Lack of Efficacy|8
3041422|NCT00665925|10455821|P1|Overall Study|Lack of Efficacy|10
3041423|NCT00665847|10456232|P1|Overall Study|Switch to Commercial Medication|1
3041424|NCT00665847|10456232|P1|Overall Study|Subject ineligible to continue the trial|1
3041425|NCT00665847|10456232|P1|Overall Study|Resistance to TMC125|1
3041426|NCT00665847|10456232|P1|Overall Study|Subject reached a virologic endpoint|4
3041427|NCT00665847|10456232|P1|Overall Study|Subject non-compliant|8
3041428|NCT00665847|10456232|P1|Overall Study|Withdrawal by Subject|2
3041429|NCT00665847|10456232|P1|Overall Study|Adverse Event|8
3041430|NCT00665652|10456249|P1|Overall Study|No longer met inclusion criteria.|1
3041431|NCT00665652|10456249|P1|Overall Study|Death|1
3041432|NCT00665652|10456249|P1|Overall Study|Adverse Event|4
3041433|NCT00665626|10456255|P2|Overall Study|Death|0
3041434|NCT00665626|10456256|P1|Overall Study|Death|1
3041435|NCT00665626|10456255|P2|Overall Study|Unably to comply with dosing regimen|1
3041436|NCT00665626|10456256|P1|Overall Study|Unably to comply with dosing regimen|0
3041437|NCT00665626|10456255|P2|Overall Study|Did not fulfil inclusion criteria|1
3041438|NCT00665626|10456256|P1|Overall Study|Did not fulfil inclusion criteria|0
3041439|NCT00665626|10456255|P2|Overall Study|Due to exclusion criteria|1
3041440|NCT00665626|10456256|P1|Overall Study|Due to exclusion criteria|0
3041441|NCT00665626|10456255|P2|Overall Study|Adverse Event|9
3041442|NCT00665626|10456256|P1|Overall Study|Adverse Event|1
3041443|NCT00665626|10456255|P2|Overall Study|Protocol Violation|2
3041444|NCT00665626|10456256|P1|Overall Study|Protocol Violation|0
3041445|NCT00665626|10456255|P2|Overall Study|Withdrawal by Subject|1
3041446|NCT00665626|10456256|P1|Overall Study|Withdrawal by Subject|0
3041447|NCT00665626|10456255|P2|Overall Study|Lost to Follow-up|2
3041448|NCT00665626|10456256|P1|Overall Study|Lost to Follow-up|0
3041449|NCT00665626|10456255|P2|Overall Study|Lack of Efficacy|5
3041450|NCT00665626|10456256|P1|Overall Study|Lack of Efficacy|8
3041451|NCT00665561|10456324|P2|Overall Study|Withdrawn due to pregnancy|1
3041452|NCT00665561|10456325|P1|Overall Study|Withdrawn due to pregnancy|0
3041453|NCT00665561|10456324|P2|Overall Study|Site closed|0
3041454|NCT00665561|10456325|P1|Overall Study|Site closed|8
3041455|NCT00665561|10456324|P2|Overall Study|Other|108
3041456|NCT00665561|10456325|P1|Overall Study|Other|123
3041457|NCT00665561|10456324|P2|Overall Study|Withdrawal by Subject|65
3041458|NCT00665561|10456325|P1|Overall Study|Withdrawal by Subject|74
3041459|NCT00665561|10456324|P2|Overall Study|Lost to Follow-up|264
3041460|NCT00665561|10456325|P1|Overall Study|Lost to Follow-up|203
3041461|NCT00665561|10456324|P2|Overall Study|Does not meet entrance criteria|21
3041462|NCT00665561|10456325|P1|Overall Study|Does not meet entrance criteria|19
3041463|NCT00665561|10456324|P2|Overall Study|Death recorded on subject summary pages|75
3041464|NCT00665561|10456325|P1|Overall Study|Death recorded on subject summary pages|75
3041465|NCT00665444|10456375|P1|Overall Study|Study Terminated by Study Sponsor|1
3041466|NCT00665444|10456375|P1|Overall Study|Physician Decision|1
3041467|NCT00665431|10456387|P3|Overall Study|Other|2
3041468|NCT00665431|10456388|P2|Overall Study|Other|7
3041469|NCT00665431|10456389|P1|Overall Study|Other|4
3041470|NCT00665431|10456387|P3|Overall Study|Lost to Follow-up|1
3041471|NCT00665431|10456388|P2|Overall Study|Lost to Follow-up|3
3041472|NCT00665431|10456389|P1|Overall Study|Lost to Follow-up|3
3041473|NCT00665431|10456387|P3|Overall Study|Withdrawal by Subject|15
3041474|NCT00665431|10456388|P2|Overall Study|Withdrawal by Subject|25
3041475|NCT00665431|10456389|P1|Overall Study|Withdrawal by Subject|17
3041476|NCT00665431|10456387|P3|Overall Study|Adverse Event|6
3041477|NCT00665431|10456388|P2|Overall Study|Adverse Event|22
3041478|NCT00665431|10456389|P1|Overall Study|Adverse Event|16
3041479|NCT00665366|10456432|P2|Overall Study|Other reasons|1
3041480|NCT00665366|10456433|P1|Overall Study|Other reasons|4
3041481|NCT00665366|10456432|P2|Overall Study|No longer meets study criteria|1
3041482|NCT00665366|10456433|P1|Overall Study|No longer meets study criteria|0
3041483|NCT00665366|10456432|P2|Overall Study|Pregnancy|0
3041484|NCT00665366|10456433|P1|Overall Study|Pregnancy|1
3041485|NCT00665366|10456432|P2|Overall Study|Poor compliance/noncompliance|5
3041486|NCT00665366|10456433|P1|Overall Study|Poor compliance/noncompliance|3
3041487|NCT00665366|10456432|P2|Overall Study|Lost to Follow-up|5
3041488|NCT00665366|10456433|P1|Overall Study|Lost to Follow-up|3
3041489|NCT00665366|10456432|P2|Overall Study|Withdrawal by Subject|14
3041490|NCT00665366|10456433|P1|Overall Study|Withdrawal by Subject|11
3041491|NCT00665366|10456432|P2|Overall Study|Adverse Event|23
3041492|NCT00665366|10456433|P1|Overall Study|Adverse Event|25
3041493|NCT00665366|10456432|P2|Overall Study|Lack of Efficacy|10
3041494|NCT00665366|10456433|P1|Overall Study|Lack of Efficacy|11
3041495|NCT00665353|10456461|P1|Study Step 2|Lack of Efficacy|12
3041496|NCT00665353|10456461|P1|Study Step 2|Lost to Follow-up|2
3041497|NCT00665353|10456461|P1|Study Step 1|Withdrawal by Subject|2
3041498|NCT00665353|10456461|P1|Study Step 1|Adverse Event|1
3041499|NCT00665002|10456478|P1|Overall Study|Cytogenetic resistance|1
3041500|NCT00665002|10456478|P1|Overall Study|Progression/relapse during treatment|11
3041501|NCT00664859|10456486|P3|Overall Study|Other|2
3041502|NCT00664859|10456487|P2|Overall Study|Other|1
3041503|NCT00664859|10456488|P1|Overall Study|Other|0
3041504|NCT00664859|10456486|P3|Overall Study|Lost to Follow-up|1
3041505|NCT00664859|10456487|P2|Overall Study|Lost to Follow-up|2
3041506|NCT00664859|10456488|P1|Overall Study|Lost to Follow-up|2
3041507|NCT00664859|10456486|P3|Overall Study|Withdrawal by Subject|3
3041508|NCT00664859|10456487|P2|Overall Study|Withdrawal by Subject|1
3041509|NCT00664859|10456488|P1|Overall Study|Withdrawal by Subject|4
3041510|NCT00664859|10456486|P3|Overall Study|Laboratory abnormality|4
3041511|NCT00664859|10456487|P2|Overall Study|Laboratory abnormality|1
3041512|NCT00664859|10456488|P1|Overall Study|Laboratory abnormality|2
3041513|NCT00664859|10456486|P3|Overall Study|Noncompliance with protocol|4
3041514|NCT00664859|10456487|P2|Overall Study|Noncompliance with protocol|0
3041515|NCT00664859|10456488|P1|Overall Study|Noncompliance with protocol|1
3041516|NCT00664859|10456486|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
3041517|NCT00664859|10456487|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
3041518|NCT00664859|10456488|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
3041519|NCT00664859|10456486|P3|Overall Study|Adverse Event|3
3041520|NCT00664859|10456487|P2|Overall Study|Adverse Event|1
3041521|NCT00664859|10456488|P1|Overall Study|Adverse Event|2
3041522|NCT00664742|10456508|P1|Overall Study|Lost to Follow-up|92
3041523|NCT00664742|10456508|P1|Overall Study|Withdrawal by Subject|31
3041524|NCT00664742|10456508|P1|Overall Study|Withdrawn due to adverse events|3
3041525|NCT00664560|10456516|P3|Overall Study|Other|5
3041526|NCT00664560|10456517|P2|Overall Study|Other|4
3041527|NCT00664560|10456518|P1|Overall Study|Other|11
3041528|NCT00664560|10456516|P3|Overall Study|Lost to Follow-up|0
3041529|NCT00664560|10456517|P2|Overall Study|Lost to Follow-up|2
3041530|NCT00664560|10456518|P1|Overall Study|Lost to Follow-up|0
3041531|NCT00664560|10456516|P3|Overall Study|Withdrawal by Subject|7
3041532|NCT00664560|10456517|P2|Overall Study|Withdrawal by Subject|13
3041533|NCT00664560|10456518|P1|Overall Study|Withdrawal by Subject|9
3041534|NCT00664560|10456516|P3|Overall Study|Adverse Event|7
3041535|NCT00664560|10456517|P2|Overall Study|Adverse Event|16
3041536|NCT00664560|10456518|P1|Overall Study|Adverse Event|19
3041537|NCT00664534|10456561|P2|Overall Study|Sponsor decision|6
3041538|NCT00664534|10456562|P1|Overall Study|Sponsor decision|8
3041539|NCT00664534|10456561|P2|Overall Study|Physician Decision|0
3041540|NCT00664534|10456562|P1|Overall Study|Physician Decision|8
3041541|NCT00664534|10456561|P2|Overall Study|Withdrawal by Subject|6
3041542|NCT00664534|10456562|P1|Overall Study|Withdrawal by Subject|7
3041543|NCT00664534|10456561|P2|Overall Study|Protocol Violation|8
3041544|NCT00664534|10456562|P1|Overall Study|Protocol Violation|10
3041545|NCT00664534|10456561|P2|Overall Study|Lost to Follow-up|10
3041546|NCT00664534|10456562|P1|Overall Study|Lost to Follow-up|6
3041547|NCT00664534|10456561|P2|Overall Study|Adverse Event|3
3041548|NCT00664534|10456562|P1|Overall Study|Adverse Event|2
3041549|NCT00664521|10456590|P2|Overall Study|Other|0
3041550|NCT00664521|10456591|P1|Overall Study|Other|1
3041551|NCT00664521|10456590|P2|Overall Study|Lost to Follow-up|0
3041552|NCT00664521|10456591|P1|Overall Study|Lost to Follow-up|1
3041553|NCT00664521|10456590|P2|Overall Study|Adverse Event|1
3041554|NCT00664521|10456591|P1|Overall Study|Adverse Event|4
3041555|NCT00664326|10456617|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
3041556|NCT00664326|10456617|P1|Overall Study|Death|2
3041557|NCT00664326|10456617|P1|Overall Study|Other Reasons|3
3041558|NCT00664326|10456617|P1|Overall Study|Physician Decision|1
3041559|NCT00664326|10456617|P1|Overall Study|Withdrawal by Subject|1
3041560|NCT00664326|10456617|P1|Overall Study|Noncompliance with study medication|3
3041561|NCT00664326|10456617|P1|Overall Study|Adverse Event|14
3041562|NCT00664209|10456636|P1|Study Treatment Period|Withdrawal by Subject|2
3041563|NCT00664209|10456636|P1|Study Treatment Period|Physician Decision|4
3041564|NCT00664209|10456636|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
3041565|NCT00664105|10456644|P1|Overall Study|Disease progression|7
3041566|NCT00664105|10456644|P1|Overall Study|Adverse Event|9
3041567|NCT00664105|10456644|P1|Overall Study|Withdrawal by Subject|5
3041568|NCT00664105|10456644|P1|Overall Study|Death|3
3041569|NCT00664066|10456651|P1|Overall Study|Study terminated|3
3041570|NCT00663962|10456657|P2|Overall Study|somnolence|0
3041571|NCT00663962|10456658|P1|Overall Study|somnolence|1
3041572|NCT00663923|10456664|P1|Overall Study|Lost to Follow-up|2
3041573|NCT00663858|10456681|P3|Overall Study|Other|4
3041574|NCT00663858|10456682|P2|Overall Study|Other|2
3041575|NCT00663858|10456683|P1|Overall Study|Other|8
3041576|NCT00663858|10456681|P3|Overall Study|Protocol Violation|4
3041577|NCT00663858|10456682|P2|Overall Study|Protocol Violation|3
3041578|NCT00663858|10456683|P1|Overall Study|Protocol Violation|5
3041579|NCT00663858|10456681|P3|Overall Study|Withdrawal by Subject|3
3041580|NCT00663858|10456682|P2|Overall Study|Withdrawal by Subject|3
3041581|NCT00663858|10456683|P1|Overall Study|Withdrawal by Subject|7
3041582|NCT00663858|10456681|P3|Overall Study|Lack of Efficacy|3
3041583|NCT00663858|10456682|P2|Overall Study|Lack of Efficacy|1
3041584|NCT00663858|10456683|P1|Overall Study|Lack of Efficacy|5
3041585|NCT00663858|10456681|P3|Overall Study|Adverse Event|6
3041586|NCT00663858|10456682|P2|Overall Study|Adverse Event|1
3041587|NCT00663858|10456683|P1|Overall Study|Adverse Event|9
3041588|NCT00663702|10456721|P2|Overall Study|Lack of Efficacy|3
3041589|NCT00663702|10456722|P1|Overall Study|Lack of Efficacy|3
3041590|NCT00663702|10456721|P2|Overall Study|Death|1
3041591|NCT00663702|10456722|P1|Overall Study|Death|1
3041592|NCT00663702|10456721|P2|Overall Study|Lost to Follow-up|0
3041593|NCT00663702|10456722|P1|Overall Study|Lost to Follow-up|3
3041594|NCT00663702|10456721|P2|Overall Study|Pregnancy|1
3041595|NCT00663702|10456722|P1|Overall Study|Pregnancy|0
3041596|NCT00663702|10456721|P2|Overall Study|Withdrawal by Subject|1
3041597|NCT00663702|10456722|P1|Overall Study|Withdrawal by Subject|3
3041598|NCT00663702|10456721|P2|Overall Study|Adverse Event|4
3041599|NCT00663702|10456722|P1|Overall Study|Adverse Event|8
3041600|NCT00663260|10456758|P3|Overall Study|non-compliance, not met criteria, etc.|3
3041601|NCT00663260|10456759|P2|Overall Study|non-compliance, not met criteria, etc.|2
3041602|NCT00663260|10456760|P1|Overall Study|non-compliance, not met criteria, etc.|3
3041603|NCT00663260|10456758|P3|Overall Study|Lost to Follow-up|0
3041604|NCT00663260|10456759|P2|Overall Study|Lost to Follow-up|1
3041605|NCT00663260|10456760|P1|Overall Study|Lost to Follow-up|0
3041606|NCT00663260|10456758|P3|Overall Study|Death|1
3041607|NCT00663260|10456759|P2|Overall Study|Death|0
3041608|NCT00663260|10456760|P1|Overall Study|Death|1
3041609|NCT00663260|10456758|P3|Overall Study|Withdrawal by Subject|6
3041610|NCT00663260|10456759|P2|Overall Study|Withdrawal by Subject|1
3041611|NCT00663260|10456760|P1|Overall Study|Withdrawal by Subject|3
3041612|NCT00663260|10456758|P3|Overall Study|Adverse Event|6
3041613|NCT00663260|10456759|P2|Overall Study|Adverse Event|7
3041614|NCT00663260|10456760|P1|Overall Study|Adverse Event|12
3041615|NCT00663260|10456758|P3|Overall Study|Lack of Efficacy|0
3041616|NCT00663260|10456759|P2|Overall Study|Lack of Efficacy|0
3041617|NCT00663260|10456760|P1|Overall Study|Lack of Efficacy|2
3041618|NCT00663234|10456774|P1|Overall Study|Not willing to adhere to requirements|1
3041619|NCT00663208|10456807|P7|Follow-up Period|Other reason|1
3041620|NCT00663208|10456808|P6|Follow-up Period|Other reason|0
3041621|NCT00663208|10456809|P5|Follow-up Period|Other reason|0
3041622|NCT00663208|10456810|P4|Follow-up Period|Other reason|0
3041623|NCT00663208|10456811|P3|Follow-up Period|Other reason|0
3041624|NCT00663208|10456812|P2|Follow-up Period|Other reason|0
3041625|NCT00663208|10456813|P1|Follow-up Period|Other reason|1
3041626|NCT00663208|10456807|P7|Follow-up Period|Lost to Follow-up|0
3041627|NCT00663208|10456808|P6|Follow-up Period|Lost to Follow-up|0
3041628|NCT00663208|10456809|P5|Follow-up Period|Lost to Follow-up|0
3041629|NCT00663208|10456810|P4|Follow-up Period|Lost to Follow-up|2
3041630|NCT00663208|10456811|P3|Follow-up Period|Lost to Follow-up|3
3041631|NCT00663208|10456812|P2|Follow-up Period|Lost to Follow-up|0
3041632|NCT00663208|10456813|P1|Follow-up Period|Lost to Follow-up|2
3041633|NCT00663208|10456807|P7|Treatment Period|Lost to Follow-up|0
3041634|NCT00663208|10456808|P6|Treatment Period|Lost to Follow-up|0
3041635|NCT00663208|10456809|P5|Treatment Period|Lost to Follow-up|0
3041636|NCT00663208|10456810|P4|Treatment Period|Lost to Follow-up|0
3041637|NCT00663208|10456811|P3|Treatment Period|Lost to Follow-up|0
3041638|NCT00663208|10456812|P2|Treatment Period|Lost to Follow-up|1
3041639|NCT00663208|10456813|P1|Treatment Period|Lost to Follow-up|0
3041640|NCT00663117|10456991|P2|Overall Study|Lack of Efficacy|0
3041641|NCT00663117|10456992|P1|Overall Study|Lack of Efficacy|1
3041642|NCT00663052|10457006|P2|Overall Study|Other|1
3041643|NCT00663052|10457007|P1|Overall Study|Other|0
3041644|NCT00663052|10457006|P2|Overall Study|Unsatisfactory Response - Efficacy|1
3041645|NCT00663052|10457007|P1|Overall Study|Unsatisfactory Response - Efficacy|1
3041646|NCT00663052|10457006|P2|Overall Study|Withdrawal by Subject|5
3041647|NCT00663052|10457007|P1|Overall Study|Withdrawal by Subject|2
3041648|NCT00663052|10457006|P2|Overall Study|Protocol Violation|0
3041649|NCT00663052|10457007|P1|Overall Study|Protocol Violation|1
3041650|NCT00663052|10457006|P2|Overall Study|Discontinuation of Study by Sponsor|0
3041651|NCT00663052|10457007|P1|Overall Study|Discontinuation of Study by Sponsor|2
3041652|NCT00663052|10457006|P2|Overall Study|Adverse Event|3
3041653|NCT00663052|10457007|P1|Overall Study|Adverse Event|6
3041654|NCT00663026|10457113|P3|Overall Study|Withdrawal by Subject|1
3041655|NCT00663026|10457114|P2|Overall Study|Withdrawal by Subject|0
3041656|NCT00663026|10457115|P1|Overall Study|Withdrawal by Subject|0
3041657|NCT00663026|10457113|P3|Overall Study|Caregiver Request|0
3041658|NCT00663026|10457114|P2|Overall Study|Caregiver Request|2
3041659|NCT00663026|10457115|P1|Overall Study|Caregiver Request|0
3041660|NCT00663026|10457113|P3|Overall Study|Adverse Event|3
3041661|NCT00663026|10457114|P2|Overall Study|Adverse Event|2
3041662|NCT00663026|10457115|P1|Overall Study|Adverse Event|0
3041663|NCT00663026|10457113|P3|Overall Study|Other|0
3041664|NCT00663026|10457114|P2|Overall Study|Other|2
3041665|NCT00663026|10457115|P1|Overall Study|Other|1
3041666|NCT00663026|10457113|P3|Overall Study|Lost to Follow-up|0
3041667|NCT00663026|10457114|P2|Overall Study|Lost to Follow-up|0
3041668|NCT00663026|10457115|P1|Overall Study|Lost to Follow-up|1
3041669|NCT00662909|10457138|P3|Overall Study|Eligibility criterion not met|1
3041670|NCT00662909|10457139|P2|Overall Study|Eligibility criterion not met|1
3041671|NCT00662909|10457140|P1|Overall Study|Eligibility criterion not met|0
3041672|NCT00662909|10457138|P3|Overall Study|Physician Decision|2
3041673|NCT00662909|10457139|P2|Overall Study|Physician Decision|1
3041674|NCT00662909|10457140|P1|Overall Study|Physician Decision|1
3041675|NCT00662909|10457138|P3|Overall Study|Non-compliance with study procedures|2
3041676|NCT00662909|10457139|P2|Overall Study|Non-compliance with study procedures|3
3041677|NCT00662909|10457140|P1|Overall Study|Non-compliance with study procedures|3
3041678|NCT00662909|10457138|P3|Overall Study|Randomized- never received study drug|0
3041679|NCT00662909|10457139|P2|Overall Study|Randomized- never received study drug|0
3041680|NCT00662909|10457140|P1|Overall Study|Randomized- never received study drug|1
3041681|NCT00662909|10457138|P3|Overall Study|Protocol Violation|5
3041682|NCT00662909|10457139|P2|Overall Study|Protocol Violation|4
3041683|NCT00662909|10457140|P1|Overall Study|Protocol Violation|7
3041684|NCT00662909|10457138|P3|Overall Study|Lost to Follow-up|3
3041685|NCT00662909|10457139|P2|Overall Study|Lost to Follow-up|9
3041686|NCT00662909|10457140|P1|Overall Study|Lost to Follow-up|2
3041687|NCT00662909|10457138|P3|Overall Study|Withdrawal by Subject|16
3041688|NCT00662909|10457139|P2|Overall Study|Withdrawal by Subject|22
3041689|NCT00662909|10457140|P1|Overall Study|Withdrawal by Subject|29
3041690|NCT00662909|10457138|P3|Overall Study|Lack of Efficacy|5
3041691|NCT00662909|10457139|P2|Overall Study|Lack of Efficacy|1
3041692|NCT00662909|10457140|P1|Overall Study|Lack of Efficacy|9
3041693|NCT00662909|10457138|P3|Overall Study|Adverse Event|19
3041694|NCT00662909|10457139|P2|Overall Study|Adverse Event|18
3041695|NCT00662909|10457140|P1|Overall Study|Adverse Event|17
3041696|NCT00662857|10457238|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
3041697|NCT00662857|10457239|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
3041698|NCT00662857|10457238|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
3041699|NCT00662857|10457239|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
3041700|NCT00662857|10457238|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
3041701|NCT00662857|10457239|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
3041702|NCT00662831|10457254|P2|Overall Study|Adverse Event|16
3041703|NCT00662831|10457255|P1|Overall Study|Adverse Event|23
3041704|NCT00662831|10457254|P2|Overall Study|Protocol Violation|4
3041705|NCT00662831|10457255|P1|Overall Study|Protocol Violation|8
3041706|NCT00662831|10457254|P2|Overall Study|Other|31
3041707|NCT00662831|10457255|P1|Overall Study|Other|62
3041708|NCT00662831|10457254|P2|Overall Study|Withdrawal by Subject|1
3041709|NCT00662831|10457255|P1|Overall Study|Withdrawal by Subject|2
3041710|NCT00662831|10457254|P2|Overall Study|Lost to Follow-up|0
3041711|NCT00662831|10457255|P1|Overall Study|Lost to Follow-up|1
3041712|NCT00662831|10457254|P2|Overall Study|Lack of Efficacy|6
3041713|NCT00662831|10457255|P1|Overall Study|Lack of Efficacy|6
3041714|NCT00662831|10457254|P2|Overall Study|Death|1
3041715|NCT00662831|10457255|P1|Overall Study|Death|4
3041716|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
3041717|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
3041718|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
3041719|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
3041720|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
3041721|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
3041722|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
3041723|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
3041724|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
3041725|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
3041726|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
3041727|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
3041728|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
3041729|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
3041730|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
3041731|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
3041732|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
3041733|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
3041734|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
3041735|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
3041736|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
3041737|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
3041738|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
3041739|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
3041740|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
3041741|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Adverse Event|10
3041742|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Adverse Event|6
3041743|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Adverse Event|0
3041744|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Adverse Event|9
3041745|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Adverse Event|6
3041746|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Administrative problems|0
3041747|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Administrative problems|1
3041748|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Administrative problems|0
3041749|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Administrative problems|0
3041750|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Administrative problems|0
3041751|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
3041752|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
3041753|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
3041754|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
3041755|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
3041756|NCT00662649|10457335|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
3041757|NCT00662649|10457336|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
3041758|NCT00662649|10457337|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
3041759|NCT00662649|10457338|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
3041760|NCT00662649|10457339|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
3041761|NCT00662649|10457335|P5|Core Study (24 Months)|Death|0
3041762|NCT00662649|10457336|P4|Core Study (24 Months)|Death|0
3041763|NCT00662649|10457337|P3|Core Study (24 Months)|Death|2
3041764|NCT00662649|10457338|P2|Core Study (24 Months)|Death|0
3041765|NCT00662649|10457339|P1|Core Study (24 Months)|Death|1
3041766|NCT00662649|10457335|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
3041767|NCT00662649|10457336|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
3041768|NCT00662649|10457337|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
3041769|NCT00662649|10457338|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
3041770|NCT00662649|10457339|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
3041771|NCT00662649|10457335|P5|Core Study (24 Months)|Protocol Violation|0
3041772|NCT00662649|10457336|P4|Core Study (24 Months)|Protocol Violation|0
3041773|NCT00662649|10457337|P3|Core Study (24 Months)|Protocol Violation|4
3041774|NCT00662649|10457338|P2|Core Study (24 Months)|Protocol Violation|5
3041775|NCT00662649|10457339|P1|Core Study (24 Months)|Protocol Violation|5
3041776|NCT00662649|10457335|P5|Core Study (24 Months)|Lost to Follow-up|0
3041777|NCT00662649|10457336|P4|Core Study (24 Months)|Lost to Follow-up|0
3041778|NCT00662649|10457337|P3|Core Study (24 Months)|Lost to Follow-up|7
3041779|NCT00662649|10457338|P2|Core Study (24 Months)|Lost to Follow-up|5
3041780|NCT00662649|10457339|P1|Core Study (24 Months)|Lost to Follow-up|3
3041781|NCT00662649|10457335|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
3041782|NCT00662649|10457336|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
3041783|NCT00662649|10457337|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
3041784|NCT00662649|10457338|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
3041785|NCT00662649|10457339|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
3041786|NCT00662649|10457335|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
3041787|NCT00662649|10457336|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
3041788|NCT00662649|10457337|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
3041789|NCT00662649|10457338|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
3041790|NCT00662649|10457339|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
3041791|NCT00662649|10457335|P5|Core Study (24 Months)|Adverse Event|0
3041792|NCT00662649|10457336|P4|Core Study (24 Months)|Adverse Event|0
3041793|NCT00662649|10457337|P3|Core Study (24 Months)|Adverse Event|18
3041794|NCT00662649|10457338|P2|Core Study (24 Months)|Adverse Event|13
3041795|NCT00662649|10457339|P1|Core Study (24 Months)|Adverse Event|22
3041796|NCT00662649|10457335|P5|Core Study (24 Months)|Withdrawal by Subject|0
3041797|NCT00662649|10457336|P4|Core Study (24 Months)|Withdrawal by Subject|0
3041798|NCT00662649|10457337|P3|Core Study (24 Months)|Withdrawal by Subject|28
3041799|NCT00662649|10457338|P2|Core Study (24 Months)|Withdrawal by Subject|17
3041800|NCT00662649|10457339|P1|Core Study (24 Months)|Withdrawal by Subject|31
3041801|NCT00662558|10457379|P2|Overall Study|Randomized But Did Not Receive Treatment|8
3041802|NCT00662558|10457380|P1|Overall Study|Randomized But Did Not Receive Treatment|2
3041803|NCT00662558|10457379|P2|Overall Study|Withdrawal by Subject|12
3041804|NCT00662558|10457380|P1|Overall Study|Withdrawal by Subject|7
3041805|NCT00662558|10457379|P2|Overall Study|Other|14
3041806|NCT00662558|10457380|P1|Overall Study|Other|9
3041807|NCT00662558|10457379|P2|Overall Study|Lost to Follow-up|10
3041808|NCT00662558|10457380|P1|Overall Study|Lost to Follow-up|13
3041809|NCT00662558|10457379|P2|Overall Study|Lack of Efficacy|7
3041810|NCT00662558|10457380|P1|Overall Study|Lack of Efficacy|4
3041811|NCT00662558|10457379|P2|Overall Study|Adverse Event|59
3041812|NCT00662558|10457380|P1|Overall Study|Adverse Event|21
3041813|NCT00662532|10457431|P2|Overall Study|Lost to Follow-up|1
3041814|NCT00662532|10457432|P1|Overall Study|Lost to Follow-up|0
3041815|NCT00662532|10457431|P2|Overall Study|Adverse Event|1
3041816|NCT00662532|10457432|P1|Overall Study|Adverse Event|0
3041817|NCT00662363|10457447|P2|Overall Study|Protocol Violation|1
3041818|NCT00662363|10457448|P1|Overall Study|Protocol Violation|1
3041819|NCT00662363|10457447|P2|Overall Study|Discharged early from rehab|1
3041820|NCT00662363|10457448|P1|Overall Study|Discharged early from rehab|4
3041821|NCT00662363|10457447|P2|Overall Study|Adverse Event|3
3041822|NCT00662363|10457448|P1|Overall Study|Adverse Event|0
3041823|NCT00662363|10457447|P2|Overall Study|Withdrawal by Subject|5
3041824|NCT00662363|10457448|P1|Overall Study|Withdrawal by Subject|6
3041825|NCT00662311|10457459|P3|Overall Study|Respiratory Infection|0
3041826|NCT00662311|10457460|P2|Overall Study|Respiratory Infection|0
3041827|NCT00662311|10457461|P1|Overall Study|Respiratory Infection|1
3041828|NCT00662259|10457496|P2|Overall Study|Adverse Event|0
3041829|NCT00662259|10457497|P1|Overall Study|Adverse Event|2
3041830|NCT00662129|10457539|P1|Overall Study|Ineligible|1
3041831|NCT00662129|10457539|P1|Overall Study|Cancel prior to beginning treatment|1
3041832|NCT00662129|10457539|P1|Overall Study|Protocol Violation|1
3041833|NCT00662038|10457549|P1|Overall Study|Continued treatment|5
3041834|NCT00662038|10457549|P1|Overall Study|Adverse Event|358
3041835|NCT00662038|10457549|P1|Overall Study|Death|95
3041836|NCT00662038|10457549|P1|Overall Study|Lost to Follow-up|1
3041837|NCT00662038|10457549|P1|Overall Study|Lung transplantation|44
3041838|NCT00662038|10457549|P1|Overall Study|Physician Decision|19
3041839|NCT00662038|10457549|P1|Overall Study|Sponsor decision|1
3041840|NCT00662038|10457549|P1|Overall Study|Withdrawal by Subject|83
3041841|NCT00662038|10457549|P1|Overall Study|Withdrawn consent|22
3041842|NCT00662038|10457549|P1|Overall Study|Reason not specified|3
3041843|NCT00662025|10457553|P1|Overall Study|Domestic circumstances|1
3041844|NCT00662025|10457553|P1|Overall Study|Target lesion cannot be evaluated|1
3041845|NCT00662025|10457553|P1|Overall Study|Results of other clinical study|2
3041846|NCT00662025|10457553|P1|Overall Study|Withdrawal by Subject|1
3041847|NCT00662025|10457553|P1|Overall Study|Adverse Event|7
3041848|NCT00662025|10457553|P1|Overall Study|Objective progression or relapse|51
3041849|NCT00662012|10457573|P1|Overall Study|Withdrawal by Subject|1
3041850|NCT00662012|10457573|P1|Overall Study|Death|1
3041851|NCT00662012|10457573|P1|Overall Study|Lost to Follow-up|85
3041852|NCT00661999|10457581|P3|Overall Study|Other Medical Problems|9
3041853|NCT00661999|10457582|P2|Overall Study|Other Medical Problems|4
3041854|NCT00661999|10457583|P1|Overall Study|Other Medical Problems|4
3041855|NCT00661999|10457581|P3|Overall Study|Alternative Treatment|0
3041856|NCT00661999|10457582|P2|Overall Study|Alternative Treatment|0
3041857|NCT00661999|10457583|P1|Overall Study|Alternative Treatment|1
3041858|NCT00661999|10457581|P3|Overall Study|Withdrawal by Subject|14
3041859|NCT00661999|10457582|P2|Overall Study|Withdrawal by Subject|23
3041860|NCT00661999|10457583|P1|Overall Study|Withdrawal by Subject|30
3041861|NCT00661999|10457581|P3|Overall Study|Other Reasons|23
3041862|NCT00661999|10457582|P2|Overall Study|Other Reasons|12
3041863|NCT00661999|10457583|P1|Overall Study|Other Reasons|5
3041864|NCT00661999|10457581|P3|Overall Study|Death|3
3041865|NCT00661999|10457582|P2|Overall Study|Death|6
3041866|NCT00661999|10457583|P1|Overall Study|Death|8
3041867|NCT00661999|10457581|P3|Overall Study|Adverse Event|8
3041868|NCT00661999|10457582|P2|Overall Study|Adverse Event|5
3041869|NCT00661999|10457583|P1|Overall Study|Adverse Event|11
3041870|NCT00661830|10457660|P2|Overall Study|Other reason|5
3041871|NCT00661830|10457661|P1|Overall Study|Other reason|1
3041872|NCT00661830|10457660|P2|Overall Study|Withdrawal by Subject|1
3041873|NCT00661830|10457661|P1|Overall Study|Withdrawal by Subject|1
3041874|NCT00661830|10457660|P2|Overall Study|Lost to Follow-up|3
3041875|NCT00661830|10457661|P1|Overall Study|Lost to Follow-up|1
3041876|NCT00661830|10457660|P2|Overall Study|Death|33
3041877|NCT00661830|10457661|P1|Overall Study|Death|37
3041878|NCT00661778|10457673|P1|Overall Study|Withdrawal of Consent|1
3041879|NCT00661778|10457673|P1|Overall Study|Protocol Violation|2
3041880|NCT00661778|10457673|P1|Overall Study|Reason not Specified|6
3041881|NCT00661778|10457673|P1|Overall Study|Adverse Event|18
3041882|NCT00661778|10457673|P1|Overall Study|Disease Progression|23
3041883|NCT00661726|10457680|P1|Overall Study|Adverse Event|1
3041884|NCT00661713|10457703|P8|Overall Study|Inappropriate Enrollment|0
3041885|NCT00661713|10457704|P7|Overall Study|Inappropriate Enrollment|1
3041886|NCT00661713|10457705|P6|Overall Study|Inappropriate Enrollment|0
3041887|NCT00661713|10457706|P5|Overall Study|Inappropriate Enrollment|0
3041888|NCT00661713|10457707|P4|Overall Study|Inappropriate Enrollment|0
3041889|NCT00661713|10457708|P3|Overall Study|Inappropriate Enrollment|0
3041890|NCT00661713|10457709|P2|Overall Study|Inappropriate Enrollment|0
3041891|NCT00661713|10457710|P1|Overall Study|Inappropriate Enrollment|0
3041892|NCT00661713|10457703|P8|Overall Study|Adverse Event|0
3041893|NCT00661713|10457704|P7|Overall Study|Adverse Event|1
3041894|NCT00661713|10457705|P6|Overall Study|Adverse Event|0
3041895|NCT00661713|10457706|P5|Overall Study|Adverse Event|0
3041896|NCT00661713|10457707|P4|Overall Study|Adverse Event|0
3041897|NCT00661713|10457708|P3|Overall Study|Adverse Event|0
3041898|NCT00661713|10457709|P2|Overall Study|Adverse Event|0
3041899|NCT00661713|10457710|P1|Overall Study|Adverse Event|0
3041900|NCT00661713|10457703|P8|Overall Study|Administrative Reason|0
3041901|NCT00661713|10457704|P7|Overall Study|Administrative Reason|1
3041902|NCT00661713|10457705|P6|Overall Study|Administrative Reason|2
3041903|NCT00661713|10457706|P5|Overall Study|Administrative Reason|2
3041904|NCT00661713|10457707|P4|Overall Study|Administrative Reason|2
3041905|NCT00661713|10457708|P3|Overall Study|Administrative Reason|0
3041906|NCT00661713|10457709|P2|Overall Study|Administrative Reason|1
3041907|NCT00661713|10457710|P1|Overall Study|Administrative Reason|0
3041908|NCT00661713|10457703|P8|Overall Study|Lost to Follow-up|1
3041909|NCT00661713|10457704|P7|Overall Study|Lost to Follow-up|14
3041910|NCT00661713|10457705|P6|Overall Study|Lost to Follow-up|7
3041911|NCT00661713|10457706|P5|Overall Study|Lost to Follow-up|5
3041912|NCT00661713|10457707|P4|Overall Study|Lost to Follow-up|2
3041913|NCT00661713|10457708|P3|Overall Study|Lost to Follow-up|2
3041914|NCT00661713|10457709|P2|Overall Study|Lost to Follow-up|7
3041915|NCT00661713|10457710|P1|Overall Study|Lost to Follow-up|2
3041916|NCT00661713|10457703|P8|Overall Study|Withdrawal by Subject|9
3041917|NCT00661713|10457704|P7|Overall Study|Withdrawal by Subject|45
3041918|NCT00661713|10457705|P6|Overall Study|Withdrawal by Subject|26
3041919|NCT00661713|10457706|P5|Overall Study|Withdrawal by Subject|12
3041920|NCT00661713|10457707|P4|Overall Study|Withdrawal by Subject|21
3041921|NCT00661713|10457708|P3|Overall Study|Withdrawal by Subject|12
3041922|NCT00661713|10457709|P2|Overall Study|Withdrawal by Subject|25
3041923|NCT00661713|10457710|P1|Overall Study|Withdrawal by Subject|11
3041924|NCT00661713|10457703|P8|Overall Study|Protocol Violation|1
3041925|NCT00661713|10457704|P7|Overall Study|Protocol Violation|2
3041926|NCT00661713|10457705|P6|Overall Study|Protocol Violation|2
3041927|NCT00661713|10457706|P5|Overall Study|Protocol Violation|0
3041928|NCT00661713|10457707|P4|Overall Study|Protocol Violation|3
3041929|NCT00661713|10457708|P3|Overall Study|Protocol Violation|3
3041930|NCT00661713|10457709|P2|Overall Study|Protocol Violation|6
3041931|NCT00661713|10457710|P1|Overall Study|Protocol Violation|1
3041932|NCT00661713|10457703|P8|Overall Study|Unable to Classify|0
3041933|NCT00661713|10457704|P7|Overall Study|Unable to Classify|0
3041934|NCT00661713|10457705|P6|Overall Study|Unable to Classify|0
3041935|NCT00661713|10457706|P5|Overall Study|Unable to Classify|0
3041936|NCT00661713|10457707|P4|Overall Study|Unable to Classify|0
3041937|NCT00661713|10457708|P3|Overall Study|Unable to Classify|0
3041938|NCT00661713|10457709|P2|Overall Study|Unable to Classify|0
3041939|NCT00661713|10457710|P1|Overall Study|Unable to Classify|1
3041940|NCT00661713|10457703|P8|Overall Study|Death|0
3041941|NCT00661713|10457704|P7|Overall Study|Death|0
3041942|NCT00661713|10457705|P6|Overall Study|Death|0
3041943|NCT00661713|10457706|P5|Overall Study|Death|1
3041944|NCT00661713|10457707|P4|Overall Study|Death|0
3041945|NCT00661713|10457708|P3|Overall Study|Death|0
3041946|NCT00661713|10457709|P2|Overall Study|Death|0
3041947|NCT00661713|10457710|P1|Overall Study|Death|1
3041948|NCT00661687|10457802|P1|Overall Study|Adverse Event|2
3041949|NCT00661687|10457802|P1|Overall Study|Physician Decision|1
3041950|NCT00661687|10457802|P1|Overall Study|Inability to maintain wearing schedule|3
3041951|NCT00661687|10457802|P1|Overall Study|Positive slit lamp findings|4
3041952|NCT00661687|10457802|P1|Overall Study|Study related symptoms and complaints|5
3041953|NCT00661661|10457830|P2|Overall Study|Not assigned treatment|0
3041954|NCT00661661|10457831|P1|Overall Study|Not assigned treatment|1
3041955|NCT00661661|10457830|P2|Overall Study|Other|7
3041956|NCT00661661|10457831|P1|Overall Study|Other|22
3041957|NCT00661661|10457830|P2|Overall Study|Withdrawal by Subject|5
3041958|NCT00661661|10457831|P1|Overall Study|Withdrawal by Subject|15
3041959|NCT00661661|10457830|P2|Overall Study|Lost to Follow-up|1
3041960|NCT00661661|10457831|P1|Overall Study|Lost to Follow-up|0
3041961|NCT00661661|10457830|P2|Overall Study|Lack of Efficacy|2
3041962|NCT00661661|10457831|P1|Overall Study|Lack of Efficacy|3
3041963|NCT00661661|10457830|P2|Overall Study|Adverse Event|24
3041964|NCT00661661|10457831|P1|Overall Study|Adverse Event|99
3041965|NCT00661622|10457907|P2|Overall Study|Protocol Violation|0
3041966|NCT00661622|10457908|P1|Overall Study|Protocol Violation|1
3041967|NCT00661609|10457922|P1|Overall Study|Disease progression|3
3041968|NCT00661609|10457922|P1|Overall Study|Survival follow up stage discontinued|11
3041969|NCT00661609|10457922|P1|Overall Study|PI Decision|1
3041970|NCT00661609|10457922|P1|Overall Study|Withdrawal by Subject|2
3041971|NCT00661609|10457922|P1|Overall Study|Death|20
3041972|NCT00661609|10457922|P1|Overall Study|Adverse Event|4
3041973|NCT00661531|10457989|P1|Overall Study|Withdrawal by Subject|3
3041974|NCT00661505|10457994|P1|Overall Study|Other|2
3041975|NCT00661505|10457994|P1|Overall Study|Lost to Follow-up|3
3041976|NCT00661505|10457994|P1|Overall Study|Withdrawal by Subject|8
3041977|NCT00661505|10457994|P1|Overall Study|Protocol Violation|14
3041978|NCT00661505|10457994|P1|Overall Study|Adverse Event|3
3041979|NCT00661492|10458022|P2|Overall Study|Other|0
3041980|NCT00661492|10458023|P1|Overall Study|Other|1
3041981|NCT00661492|10458022|P2|Overall Study|Lost to Follow-up|1
3041982|NCT00661492|10458023|P1|Overall Study|Lost to Follow-up|0
3041983|NCT00661492|10458022|P2|Overall Study|Investigator Request|0
3041984|NCT00661492|10458023|P1|Overall Study|Investigator Request|1
3041985|NCT00661492|10458022|P2|Overall Study|Patient Request|1
3041986|NCT00661492|10458023|P1|Overall Study|Patient Request|6
3041987|NCT00661492|10458022|P2|Overall Study|Disease Progression|14
3041988|NCT00661492|10458023|P1|Overall Study|Disease Progression|44
3041989|NCT00661492|10458022|P2|Overall Study|Adverse Event|13
3041990|NCT00661492|10458023|P1|Overall Study|Adverse Event|16
3041991|NCT00661427|10458069|P2|Overall Study|Patient not treated|2
3041992|NCT00661427|10458070|P1|Overall Study|Patient not treated|0
3041993|NCT00661427|10458069|P2|Overall Study|Adverse Event|5
3041994|NCT00661427|10458070|P1|Overall Study|Adverse Event|5
3041995|NCT00661388|10458078|P1|Overall Study|Administrative reasons|1
3041996|NCT00661388|10458078|P1|Overall Study|Dialysis initiation|1
3041997|NCT00661388|10458078|P1|Overall Study|Renal transplantation|1
3041998|NCT00661388|10458078|P1|Overall Study|Protocol Violation|7
3041999|NCT00661388|10458078|P1|Overall Study|Adverse Event|14
3042000|NCT00661362|10458101|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
3042001|NCT00661362|10458102|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
3042002|NCT00661362|10458101|P2|Overall Study|Safety reasons|0
3042003|NCT00661362|10458102|P1|Overall Study|Safety reasons|1
3042004|NCT00661362|10458101|P2|Overall Study|Severe non-compliance to protocol|1
3042005|NCT00661362|10458102|P1|Overall Study|Severe non-compliance to protocol|0
3042006|NCT00661362|10458101|P2|Overall Study|Lost to Follow-up|1
3042007|NCT00661362|10458102|P1|Overall Study|Lost to Follow-up|3
3042008|NCT00661362|10458101|P2|Overall Study|Withdrawal by Subject|23
3042009|NCT00661362|10458102|P1|Overall Study|Withdrawal by Subject|13
3042010|NCT00661362|10458101|P2|Overall Study|Study specific discontinuation criteria|11
3042011|NCT00661362|10458102|P1|Overall Study|Study specific discontinuation criteria|4
3042012|NCT00661362|10458101|P2|Overall Study|Incorrect enrollment|0
3042013|NCT00661362|10458102|P1|Overall Study|Incorrect enrollment|2
3042014|NCT00661362|10458101|P2|Overall Study|Adverse Event|4
3042015|NCT00661362|10458102|P1|Overall Study|Adverse Event|5
3042016|NCT00661271|10458120|P2|Overall Study|Lost to Follow-up|25
3042017|NCT00661271|10458121|P1|Overall Study|Lost to Follow-up|28
3042018|NCT00661258|10458131|P2|Overall Study|caught by police and in detox center|1
3042019|NCT00661258|10458132|P1|Overall Study|caught by police and in detox center|2
3042020|NCT00661258|10458131|P2|Overall Study|Death|0
3042021|NCT00661258|10458132|P1|Overall Study|Death|1
3042022|NCT00661193|10458142|P2|Overall Study|Not protocol specified|0
3042023|NCT00661193|10458143|P1|Overall Study|Not protocol specified|1
3042024|NCT00661193|10458142|P2|Overall Study|Progression|24
3042025|NCT00661193|10458143|P1|Overall Study|Progression|27
3042026|NCT00661193|10458142|P2|Overall Study|Withdrawal by Subject|1
3042027|NCT00661193|10458143|P1|Overall Study|Withdrawal by Subject|3
3042028|NCT00661193|10458142|P2|Overall Study|Adverse Event|1
3042029|NCT00661193|10458143|P1|Overall Study|Adverse Event|2
3042030|NCT00661089|10458368|P2|Overall Study|death at 8 weeks due to new stroke|1
3042031|NCT00661089|10458369|P1|Overall Study|death at 8 weeks due to new stroke|0
3042032|NCT00661089|10458368|P2|Overall Study|1 subject withdrawal|1
3042033|NCT00661089|10458369|P1|Overall Study|1 subject withdrawal|0
3042034|NCT00660907|10458417|P2|Overall Study|Various|8
3042035|NCT00660907|10458418|P1|Overall Study|Various|11
3042036|NCT00660907|10458417|P2|Overall Study|Death|3
3042037|NCT00660907|10458418|P1|Overall Study|Death|1
3042038|NCT00660907|10458417|P2|Overall Study|Safety|0
3042039|NCT00660907|10458418|P1|Overall Study|Safety|1
3042040|NCT00660907|10458417|P2|Overall Study|Poor/Non-Compliance|1
3042041|NCT00660907|10458418|P1|Overall Study|Poor/Non-Compliance|5
3042042|NCT00660907|10458417|P2|Overall Study|Lost to Follow-up|3
3042043|NCT00660907|10458418|P1|Overall Study|Lost to Follow-up|3
3042044|NCT00660907|10458417|P2|Overall Study|Withdrawal by Subject|32
3042045|NCT00660907|10458418|P1|Overall Study|Withdrawal by Subject|23
3042046|NCT00660907|10458417|P2|Overall Study|Subject No Longer Meets Study Criteria|27
3042047|NCT00660907|10458418|P1|Overall Study|Subject No Longer Meets Study Criteria|6
3042048|NCT00660907|10458417|P2|Overall Study|Adverse Event|19
3042049|NCT00660907|10458418|P1|Overall Study|Adverse Event|33
3042050|NCT00660907|10458417|P2|Overall Study|Incorrect Enrollment|1
3042051|NCT00660907|10458418|P1|Overall Study|Incorrect Enrollment|1
3042052|NCT00660829|10458432|P2|Overall Study|Other|4
3042053|NCT00660829|10458433|P1|Overall Study|Other|9
3042054|NCT00660829|10458432|P2|Overall Study|Lost to Follow-up|2
3042055|NCT00660829|10458433|P1|Overall Study|Lost to Follow-up|3
3042056|NCT00660829|10458432|P2|Overall Study|Withdrawal by Subject|2
3042057|NCT00660829|10458433|P1|Overall Study|Withdrawal by Subject|1
3042058|NCT00660829|10458432|P2|Overall Study|Non-Compliance|4
3042059|NCT00660829|10458433|P1|Overall Study|Non-Compliance|0
3042060|NCT00660829|10458432|P2|Overall Study|Lack of Efficacy|3
3042061|NCT00660829|10458433|P1|Overall Study|Lack of Efficacy|2
3042062|NCT00660829|10458432|P2|Overall Study|Adverse Event|4
3042063|NCT00660829|10458433|P1|Overall Study|Adverse Event|3
3042064|NCT00660816|10458451|P2|Overall Study|Complicating Disease|1
3042065|NCT00660816|10458452|P1|Overall Study|Complicating Disease|0
3042066|NCT00660816|10458451|P2|Overall Study|Disease Progression|12
3042067|NCT00660816|10458452|P1|Overall Study|Disease Progression|16
3042068|NCT00660816|10458451|P2|Overall Study|Protocol Violation|0
3042069|NCT00660816|10458452|P1|Overall Study|Protocol Violation|1
3042070|NCT00660816|10458451|P2|Overall Study|Physician Decision|2
3042071|NCT00660816|10458452|P1|Overall Study|Physician Decision|0
3042072|NCT00660816|10458451|P2|Overall Study|Lack of Efficacy|0
3042073|NCT00660816|10458452|P1|Overall Study|Lack of Efficacy|1
3042074|NCT00660816|10458451|P2|Overall Study|Death|2
3042075|NCT00660816|10458452|P1|Overall Study|Death|0
3042076|NCT00660816|10458451|P2|Overall Study|Withdrawal by Subject|0
3042077|NCT00660816|10458452|P1|Overall Study|Withdrawal by Subject|1
3042078|NCT00660816|10458451|P2|Overall Study|Adverse Event|2
3042079|NCT00660816|10458452|P1|Overall Study|Adverse Event|1
3042080|NCT00660790|10458464|P1|3 Months to 2 Years|Withdrawal by Subject|17
3042081|NCT00660790|10458464|P1|Baseline to 3 Months|Withdrawal by Subject|2
3042082|NCT00660790|10458464|P1|Baseline to 3 Months|Death|1
3042083|NCT00660699|10458468|P1|Overall Study|Withdrawal by Subject|2
3042084|NCT00660660|10458484|P2|Overall Study|New medication after randomization|0
3042085|NCT00660660|10458485|P1|Overall Study|New medication after randomization|1
3042086|NCT00660660|10458484|P2|Overall Study|Incorrect enrollment and other|1
3042087|NCT00660660|10458485|P1|Overall Study|Incorrect enrollment and other|0
3042088|NCT00660660|10458484|P2|Overall Study|Withdrawal by Subject|0
3042089|NCT00660660|10458485|P1|Overall Study|Withdrawal by Subject|3
3042090|NCT00660660|10458484|P2|Overall Study|Lack of Efficacy|2
3042091|NCT00660660|10458485|P1|Overall Study|Lack of Efficacy|0
3042092|NCT00660660|10458484|P2|Overall Study|Lost to Follow-up|6
3042093|NCT00660660|10458485|P1|Overall Study|Lost to Follow-up|0
3042094|NCT00660660|10458484|P2|Overall Study|Adverse Event|0
3042095|NCT00660660|10458485|P1|Overall Study|Adverse Event|1
3042096|NCT00660595|10458585|P2|Overall Study|Non Specified reasons|0
3042097|NCT00660595|10458586|P1|Overall Study|Non Specified reasons|5
3042098|NCT00660595|10458585|P2|Overall Study|Participant left hospital|0
3042099|NCT00660595|10458586|P1|Overall Study|Participant left hospital|1
3042100|NCT00660595|10458585|P2|Overall Study|Did not consent to participate in study|8
3042101|NCT00660595|10458586|P1|Overall Study|Did not consent to participate in study|12
3042102|NCT00660595|10458585|P2|Overall Study|Lost to Follow-up|1
3042103|NCT00660595|10458586|P1|Overall Study|Lost to Follow-up|0
3042104|NCT00660400|10458647|P1|Overall Study|Withdrawal by Subject|1
3042105|NCT00660400|10458647|P1|Overall Study|Intracranial hemorrhage|1
3042106|NCT00660400|10458647|P1|Overall Study|Suboptimal organ function|1
3042107|NCT00660400|10458647|P1|Overall Study|Lack of insurance approval|1
3042108|NCT00660387|10458656|P2|Overall Study|Protocol Violation|0
3042109|NCT00660387|10458657|P1|Overall Study|Protocol Violation|1
3042110|NCT00660387|10458656|P2|Overall Study|Lack of Efficacy|1
3042111|NCT00660387|10458657|P1|Overall Study|Lack of Efficacy|0
3042112|NCT00660387|10458656|P2|Overall Study|Adverse Event|2
3042113|NCT00660387|10458657|P1|Overall Study|Adverse Event|1
3042114|NCT00660348|10458711|P2|Overall Study|Withdrawal by Subject|0
3042115|NCT00660348|10458712|P1|Overall Study|Withdrawal by Subject|1
3042116|NCT00660309|10458720|P2|Overall Study|Withdrawal by Subject|3
3042117|NCT00660309|10458721|P1|Overall Study|Withdrawal by Subject|0
3042118|NCT00660309|10458720|P2|Overall Study|Adverse Event|0
3042119|NCT00660309|10458721|P1|Overall Study|Adverse Event|2
3042120|NCT00660192|10458762|P2|Overall Study|Lost to Follow-up|3
3042121|NCT00660192|10458763|P1|Overall Study|Lost to Follow-up|2
3042122|NCT00660179|10458774|P3|Overall Study|Incorrect randomization|0
3042123|NCT00660179|10458775|P2|Overall Study|Incorrect randomization|0
3042124|NCT00660179|10458776|P1|Overall Study|Incorrect randomization|1
3042125|NCT00660179|10458774|P3|Overall Study|Administrative reason|1
3042126|NCT00660179|10458775|P2|Overall Study|Administrative reason|0
3042127|NCT00660179|10458776|P1|Overall Study|Administrative reason|0
3042128|NCT00660179|10458774|P3|Overall Study|Lost to Follow-up|2
3042129|NCT00660179|10458775|P2|Overall Study|Lost to Follow-up|5
3042130|NCT00660179|10458776|P1|Overall Study|Lost to Follow-up|7
3042131|NCT00660179|10458774|P3|Overall Study|Withdrawal of consent|4
3042132|NCT00660179|10458775|P2|Overall Study|Withdrawal of consent|6
3042133|NCT00660179|10458776|P1|Overall Study|Withdrawal of consent|4
3042134|NCT00660179|10458774|P3|Overall Study|Death|34
3042135|NCT00660179|10458775|P2|Overall Study|Death|47
3042136|NCT00660179|10458776|P1|Overall Study|Death|44
3042137|NCT00660023|10458821|P1|Overall Study|Other Screening Failure|9
3042138|NCT00660023|10458821|P1|Overall Study|Missed Pregnancy Test|1
3042139|NCT00660023|10458821|P1|Overall Study|Withdrawal by Subject|1
3042140|NCT00660023|10458821|P1|Overall Study|Renal Transplantation|3
3042141|NCT00660023|10458821|P1|Overall Study|Blood Transfusion|5
3042142|NCT00660023|10458821|P1|Overall Study|Death|8
3042143|NCT00660023|10458821|P1|Overall Study|Adverse Event|2
3042144|NCT00660010|10458832|P1|Overall Study|Noncompliance with visit schedule|3
3042145|NCT00660010|10458832|P1|Overall Study|Adverse Event|1
3042146|NCT00660010|10458832|P1|Overall Study|Lost to Follow-up|3
3042147|NCT00660010|10458832|P1|Overall Study|Withdrawal by Subject|2
3042148|NCT00659984|10458846|P1|Overall Study|Adverse Event|1
3042149|NCT00659880|10458866|P1|Overall Study|Lost to Follow-up|5
3042150|NCT00659815|10458879|P2|Overall Study|Withdrawal by Subject|1
3042151|NCT00659815|10458880|P1|Overall Study|Withdrawal by Subject|1
3042152|NCT00659815|10458879|P2|Overall Study|Inability to maintain wearing schedule|2
3042153|NCT00659815|10458880|P1|Overall Study|Inability to maintain wearing schedule|1
3042154|NCT00659815|10458879|P2|Overall Study|Study related symptoms and complaints|1
3042155|NCT00659815|10458880|P1|Overall Study|Study related symptoms and complaints|2
3042156|NCT00659607|10458940|P1|Overall Study|Inconsistent BP measuring date|2
3042157|NCT00659607|10458940|P1|Overall Study|No recorded efficacy data|15
3042158|NCT00659607|10458940|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
3042159|NCT00659607|10458940|P1|Overall Study|Unknown measuring date of blood pressure|85
3042160|NCT00659607|10458940|P1|Overall Study|No blood pressure recorded|147
3042161|NCT00659581|10458958|P1|Overall Study|Other|6393
3042162|NCT00659581|10458958|P1|Overall Study|Lack of Efficacy|1183
3042163|NCT00659581|10458958|P1|Overall Study|Adverse Event|1006
3042164|NCT00659529|10458970|P1|Overall Study|Screen failure|9
3042165|NCT00659529|10458970|P1|Overall Study|Protocol Violation|3
3042166|NCT00659529|10458970|P1|Overall Study|Withdrawal by Subject|4
3042167|NCT00659490|10458977|P3|Overall Study|Lost to Follow-up|1
3042168|NCT00659490|10458978|P2|Overall Study|Lost to Follow-up|0
3042169|NCT00659490|10458979|P1|Overall Study|Lost to Follow-up|2
3042170|NCT00659438|10459052|P2|Overall Study|Lost to Follow-up|0
3042171|NCT00659438|10459053|P1|Overall Study|Lost to Follow-up|1
3042172|NCT00659438|10459052|P2|Overall Study|Death|6
3042173|NCT00659438|10459053|P1|Overall Study|Death|11
3042174|NCT00659438|10459052|P2|Overall Study|Withdrawal by Subject|2
3042175|NCT00659438|10459053|P1|Overall Study|Withdrawal by Subject|2
3042176|NCT00659425|10459085|P10|Overall Study|Other|6
3042177|NCT00659425|10459086|P9|Overall Study|Other|0
3042178|NCT00659425|10459087|P8|Overall Study|Other|2
3042179|NCT00659425|10459088|P7|Overall Study|Other|3
3042180|NCT00659425|10459089|P6|Overall Study|Other|0
3042181|NCT00659425|10459090|P5|Overall Study|Other|4
3042182|NCT00659425|10459091|P4|Overall Study|Other|2
3042183|NCT00659425|10459092|P3|Overall Study|Other|1
3042184|NCT00659425|10459093|P2|Overall Study|Other|1
3042185|NCT00659425|10459094|P1|Overall Study|Other|0
3042186|NCT00659425|10459085|P10|Overall Study|Investigator Discretion|0
3042187|NCT00659425|10459086|P9|Overall Study|Investigator Discretion|0
3042188|NCT00659425|10459087|P8|Overall Study|Investigator Discretion|3
3042189|NCT00659425|10459088|P7|Overall Study|Investigator Discretion|0
3042190|NCT00659425|10459089|P6|Overall Study|Investigator Discretion|1
3042191|NCT00659425|10459090|P5|Overall Study|Investigator Discretion|0
3042192|NCT00659425|10459091|P4|Overall Study|Investigator Discretion|0
3042193|NCT00659425|10459092|P3|Overall Study|Investigator Discretion|0
3042194|NCT00659425|10459093|P2|Overall Study|Investigator Discretion|0
3042195|NCT00659425|10459094|P1|Overall Study|Investigator Discretion|0
3042196|NCT00659425|10459085|P10|Overall Study|Adverse Event|4
3042197|NCT00659425|10459086|P9|Overall Study|Adverse Event|1
3042198|NCT00659425|10459087|P8|Overall Study|Adverse Event|3
3042199|NCT00659425|10459088|P7|Overall Study|Adverse Event|0
3042200|NCT00659425|10459089|P6|Overall Study|Adverse Event|1
3042201|NCT00659425|10459090|P5|Overall Study|Adverse Event|0
3042202|NCT00659425|10459091|P4|Overall Study|Adverse Event|0
3042203|NCT00659425|10459092|P3|Overall Study|Adverse Event|0
3042204|NCT00659425|10459093|P2|Overall Study|Adverse Event|0
3042205|NCT00659425|10459094|P1|Overall Study|Adverse Event|0
3042206|NCT00659425|10459085|P10|Overall Study|Death|0
3042207|NCT00659425|10459086|P9|Overall Study|Death|0
3042208|NCT00659425|10459087|P8|Overall Study|Death|0
3042209|NCT00659425|10459088|P7|Overall Study|Death|1
3042210|NCT00659425|10459089|P6|Overall Study|Death|0
3042211|NCT00659425|10459090|P5|Overall Study|Death|0
3042212|NCT00659425|10459091|P4|Overall Study|Death|1
3042213|NCT00659425|10459092|P3|Overall Study|Death|0
3042214|NCT00659425|10459093|P2|Overall Study|Death|0
3042215|NCT00659425|10459094|P1|Overall Study|Death|0
3042216|NCT00659425|10459085|P10|Overall Study|Disease progression|3
3042217|NCT00659425|10459086|P9|Overall Study|Disease progression|5
3042218|NCT00659425|10459087|P8|Overall Study|Disease progression|3
3042219|NCT00659425|10459088|P7|Overall Study|Disease progression|4
3042220|NCT00659425|10459089|P6|Overall Study|Disease progression|2
3042221|NCT00659425|10459090|P5|Overall Study|Disease progression|0
3042222|NCT00659425|10459091|P4|Overall Study|Disease progression|1
3042223|NCT00659425|10459092|P3|Overall Study|Disease progression|0
3042224|NCT00659425|10459093|P2|Overall Study|Disease progression|0
3042225|NCT00659425|10459094|P1|Overall Study|Disease progression|1
3042226|NCT00659373|10459325|P2|Overall Study|Assessment Missed|2
3042227|NCT00659373|10459326|P1|Overall Study|Assessment Missed|2
3042228|NCT00659373|10459325|P2|Overall Study|Withdrawal by Subject|5
3042229|NCT00659373|10459326|P1|Overall Study|Withdrawal by Subject|3
3042230|NCT00659334|10459348|P7|Overall Study|Screen Failure|1
3042231|NCT00659334|10459349|P6|Overall Study|Screen Failure|0
3042232|NCT00659334|10459350|P5|Overall Study|Screen Failure|0
3042233|NCT00659334|10459351|P4|Overall Study|Screen Failure|0
3042234|NCT00659334|10459352|P3|Overall Study|Screen Failure|0
3042235|NCT00659334|10459353|P2|Overall Study|Screen Failure|5
3042236|NCT00659334|10459354|P1|Overall Study|Screen Failure|8
3042237|NCT00659269|10459381|P2|Overall Study|Physician Decision|1
3042238|NCT00659269|10459382|P1|Overall Study|Physician Decision|1
3042239|NCT00659230|10459412|P2|Overall Study|Did not return post-randomization|3
3042240|NCT00659230|10459413|P1|Overall Study|Did not return post-randomization|2
3042241|NCT00659230|10459412|P2|Overall Study|Lost source documentation|4
3042242|NCT00659230|10459413|P1|Overall Study|Lost source documentation|5
3042243|NCT00659230|10459412|P2|Overall Study|Lost to Follow-up|5
3042244|NCT00659230|10459413|P1|Overall Study|Lost to Follow-up|2
3042245|NCT00659061|10459436|P2|Overall Study|Migration due to political unrest|15
3042246|NCT00659061|10459437|P1|Overall Study|Migration due to political unrest|21
3042247|NCT00658996|10459455|P2|Second Intervention|Positive slit lamp finding|1
3042248|NCT00658996|10459456|P1|Second Intervention|Positive slit lamp finding|0
3042249|NCT00658996|10459455|P2|Second Intervention|Developed a stye on upper lid|0
3042250|NCT00658996|10459456|P1|Second Intervention|Developed a stye on upper lid|1
3042251|NCT00658996|10459455|P2|Crossover Period|Ineligible|1
3042252|NCT00658996|10459456|P1|Crossover Period|Ineligible|1
3042253|NCT00658996|10459455|P2|Crossover Period|Physician Decision|0
3042254|NCT00658996|10459456|P1|Crossover Period|Physician Decision|1
3042255|NCT00658996|10459455|P2|First Intervention|Lack of lenses|1
3042256|NCT00658996|10459456|P1|First Intervention|Lack of lenses|0
3042257|NCT00658996|10459455|P2|First Intervention|Positive slit lamp finding|0
3042258|NCT00658996|10459456|P1|First Intervention|Positive slit lamp finding|1
3042259|NCT00658879|10459466|P1|Overall Study|Protocol Violation|1
3042260|NCT00658814|10459483|P2|Maintenance Therapy|Not eligible|0
3042261|NCT00658814|10459484|P1|Maintenance Therapy|Not eligible|1
3042262|NCT00658814|10459483|P2|Maintenance Therapy|Not protocol specified|0
3042263|NCT00658814|10459484|P1|Maintenance Therapy|Not protocol specified|1
3042264|NCT00658814|10459483|P2|Maintenance Therapy|Adverse Event|1
3042265|NCT00658814|10459484|P1|Maintenance Therapy|Adverse Event|1
3042266|NCT00658814|10459483|P2|Consolidation Therapy|Not eligible|2
3042267|NCT00658814|10459484|P1|Consolidation Therapy|Not eligible|2
3042268|NCT00658814|10459483|P2|Consolidation Therapy|Not protocol specified|1
3042269|NCT00658814|10459484|P1|Consolidation Therapy|Not protocol specified|0
3042270|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Not eligible|2
3042271|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Not eligible|1
3042272|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Not protocol specified|4
3042273|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Not protocol specified|2
3042274|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Death|4
3042275|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Death|1
3042276|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Progression/Relapse|1
3042277|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Progression/Relapse|0
3042278|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
3042279|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
3042280|NCT00658814|10459483|P2|Remission Induction Chemotherapy|Adverse Event|3
3042281|NCT00658814|10459484|P1|Remission Induction Chemotherapy|Adverse Event|1
3042282|NCT00658788|10459498|P1|Overall Study|Treatment Discontinuation|32
3042283|NCT00658788|10459498|P1|Overall Study|Lost to Follow-up|18
3042284|NCT00658788|10459498|P1|Overall Study|Withdrawal by Subject|13
3042285|NCT00658788|10459498|P1|Overall Study|Adverse Event|11
3042286|NCT00658775|10459553|P2|Overall Study|Other|8
3042287|NCT00658775|10459554|P1|Overall Study|Other|7
3042288|NCT00658775|10459553|P2|Overall Study|Withdrawal of consent|7
3042289|NCT00658775|10459554|P1|Overall Study|Withdrawal of consent|8
3042290|NCT00658775|10459553|P2|Overall Study|Withdrawal by Subject|4
3042291|NCT00658775|10459554|P1|Overall Study|Withdrawal by Subject|6
3042292|NCT00658775|10459553|P2|Overall Study|Lost to Follow-up|18
3042293|NCT00658775|10459554|P1|Overall Study|Lost to Follow-up|17
3042294|NCT00658775|10459553|P2|Overall Study|Adverse Event|6
3042295|NCT00658775|10459554|P1|Overall Study|Adverse Event|4
3042296|NCT00658723|10459577|P3|Overall Study|Withdrawal by Subject|1
3042297|NCT00658723|10459578|P2|Overall Study|Withdrawal by Subject|0
3042298|NCT00658723|10459579|P1|Overall Study|Withdrawal by Subject|1
3042299|NCT00658723|10459577|P3|Overall Study|Scheduling Issue|0
3042300|NCT00658723|10459578|P2|Overall Study|Scheduling Issue|1
3042301|NCT00658723|10459579|P1|Overall Study|Scheduling Issue|1
3042302|NCT00658723|10459577|P3|Overall Study|Death|4
3042303|NCT00658723|10459578|P2|Overall Study|Death|1
3042304|NCT00658723|10459579|P1|Overall Study|Death|2
3042305|NCT00658723|10459577|P3|Overall Study|Lost to Follow-up|2
3042306|NCT00658723|10459578|P2|Overall Study|Lost to Follow-up|2
3042307|NCT00658723|10459579|P1|Overall Study|Lost to Follow-up|0
3042308|NCT00658684|10459617|P4|Overall Study|Pregnancy|0
3042309|NCT00658684|10459618|P3|Overall Study|Pregnancy|0
3042310|NCT00658684|10459619|P2|Overall Study|Pregnancy|1
3042311|NCT00658684|10459620|P1|Overall Study|Pregnancy|1
3042312|NCT00658684|10459617|P4|Overall Study|Protocol Violation|0
3042313|NCT00658684|10459618|P3|Overall Study|Protocol Violation|0
3042314|NCT00658684|10459619|P2|Overall Study|Protocol Violation|1
3042315|NCT00658684|10459620|P1|Overall Study|Protocol Violation|1
3042316|NCT00658684|10459617|P4|Overall Study|Lack of Efficacy|0
3042317|NCT00658684|10459618|P3|Overall Study|Lack of Efficacy|0
3042318|NCT00658684|10459619|P2|Overall Study|Lack of Efficacy|1
3042319|NCT00658684|10459620|P1|Overall Study|Lack of Efficacy|1
3042320|NCT00658684|10459617|P4|Overall Study|Withdrawal by Subject|1
3042321|NCT00658684|10459618|P3|Overall Study|Withdrawal by Subject|1
3042322|NCT00658684|10459619|P2|Overall Study|Withdrawal by Subject|4
3042323|NCT00658684|10459620|P1|Overall Study|Withdrawal by Subject|6
3042324|NCT00658684|10459617|P4|Overall Study|Adverse Event|0
3042325|NCT00658684|10459618|P3|Overall Study|Adverse Event|2
3042326|NCT00658684|10459619|P2|Overall Study|Adverse Event|8
3042327|NCT00658684|10459620|P1|Overall Study|Adverse Event|10
3042328|NCT00658658|10459675|P5|Overall Study|Other|1
3042329|NCT00658658|10459676|P4|Overall Study|Other|0
3042330|NCT00658658|10459677|P3|Overall Study|Other|0
3042331|NCT00658658|10459678|P2|Overall Study|Other|0
3042332|NCT00658658|10459679|P1|Overall Study|Other|0
3042333|NCT00658658|10459675|P5|Overall Study|Protocol-specified Criteria|0
3042334|NCT00658658|10459676|P4|Overall Study|Protocol-specified Criteria|0
3042335|NCT00658658|10459677|P3|Overall Study|Protocol-specified Criteria|0
3042336|NCT00658658|10459678|P2|Overall Study|Protocol-specified Criteria|0
3042337|NCT00658658|10459679|P1|Overall Study|Protocol-specified Criteria|1
3042338|NCT00658658|10459675|P5|Overall Study|Disease Progression|3
3042339|NCT00658658|10459676|P4|Overall Study|Disease Progression|1
3042340|NCT00658658|10459677|P3|Overall Study|Disease Progression|0
3042341|NCT00658658|10459678|P2|Overall Study|Disease Progression|1
3042342|NCT00658658|10459679|P1|Overall Study|Disease Progression|0
3042343|NCT00658658|10459675|P5|Overall Study|Death|1
3042344|NCT00658658|10459676|P4|Overall Study|Death|1
3042345|NCT00658658|10459677|P3|Overall Study|Death|0
3042346|NCT00658658|10459678|P2|Overall Study|Death|0
3042347|NCT00658658|10459679|P1|Overall Study|Death|4
3042348|NCT00658658|10459675|P5|Overall Study|Withdrawal by Subject|0
3042349|NCT00658658|10459676|P4|Overall Study|Withdrawal by Subject|0
3042350|NCT00658658|10459677|P3|Overall Study|Withdrawal by Subject|0
3042351|NCT00658658|10459678|P2|Overall Study|Withdrawal by Subject|1
3042352|NCT00658658|10459679|P1|Overall Study|Withdrawal by Subject|0
3042353|NCT00658632|10459738|P2|Overall Study|Other|8
3042354|NCT00658632|10459739|P1|Overall Study|Other|7
3042355|NCT00658632|10459738|P2|Overall Study|Pregnancy|1
3042356|NCT00658632|10459739|P1|Overall Study|Pregnancy|1
3042357|NCT00658632|10459738|P2|Overall Study|Withdrawal of consent|14
3042358|NCT00658632|10459739|P1|Overall Study|Withdrawal of consent|8
3042359|NCT00658632|10459738|P2|Overall Study|Lack of Efficacy|1
3042360|NCT00658632|10459739|P1|Overall Study|Lack of Efficacy|0
3042361|NCT00658632|10459738|P2|Overall Study|Withdrawal by Subject|7
3042362|NCT00658632|10459739|P1|Overall Study|Withdrawal by Subject|10
3042363|NCT00658632|10459738|P2|Overall Study|Lost to Follow-up|23
3042364|NCT00658632|10459739|P1|Overall Study|Lost to Follow-up|25
3042365|NCT00658632|10459738|P2|Overall Study|Adverse Event|11
3042366|NCT00658632|10459739|P1|Overall Study|Adverse Event|13
3042367|NCT00658606|10459780|P2|Overall Study|Lack of Compliance|3
3042368|NCT00658606|10459781|P1|Overall Study|Lack of Compliance|0
3042369|NCT00658606|10459780|P2|Overall Study|Withdrawal by Subject|16
3042370|NCT00658606|10459781|P1|Overall Study|Withdrawal by Subject|7
3042371|NCT00658606|10459780|P2|Overall Study|Lost to Follow-up|0
3042372|NCT00658606|10459781|P1|Overall Study|Lost to Follow-up|1
3042373|NCT00658606|10459780|P2|Overall Study|Lack of Efficacy|3
3042374|NCT00658606|10459781|P1|Overall Study|Lack of Efficacy|6
3042375|NCT00658606|10459780|P2|Overall Study|Adverse Event|1
3042376|NCT00658606|10459781|P1|Overall Study|Adverse Event|2
3042377|NCT00658567|10459810|P3|Overall Study|At Discretion of Sponsor|1
3042378|NCT00658567|10459811|P2|Overall Study|At Discretion of Sponsor|1
3042379|NCT00658567|10459812|P1|Overall Study|At Discretion of Sponsor|1
3042380|NCT00658567|10459810|P3|Overall Study|Physician Decision|0
3042381|NCT00658567|10459811|P2|Overall Study|Physician Decision|1
3042382|NCT00658567|10459812|P1|Overall Study|Physician Decision|0
3042383|NCT00658567|10459810|P3|Overall Study|Voluntary Withdrawal of Consent|2
3042384|NCT00658567|10459811|P2|Overall Study|Voluntary Withdrawal of Consent|0
3042385|NCT00658567|10459812|P1|Overall Study|Voluntary Withdrawal of Consent|2
3042386|NCT00658567|10459810|P3|Overall Study|Adverse Event|3
3042387|NCT00658567|10459811|P2|Overall Study|Adverse Event|2
3042388|NCT00658567|10459812|P1|Overall Study|Adverse Event|5
3042389|NCT00658541|10459823|P2|Washout Period of 7 Days|Withdrawal by Subject|1
3042390|NCT00658541|10459824|P1|Washout Period of 7 Days|Withdrawal by Subject|0
3042391|NCT00658541|10459823|P2|Washout Period of 7 Days|Withdrawal by Subject|1
3042392|NCT00658541|10459824|P1|Washout Period of 7 Days|Withdrawal by Subject|1
3042393|NCT00658528|10459836|P2|Overall Study|Other|4
3042394|NCT00658528|10459837|P1|Overall Study|Other|8
3042395|NCT00658528|10459836|P2|Overall Study|Withdrawal of consent|6
3042396|NCT00658528|10459837|P1|Overall Study|Withdrawal of consent|5
3042397|NCT00658528|10459836|P2|Overall Study|Withdrawal by Subject|6
3042398|NCT00658528|10459837|P1|Overall Study|Withdrawal by Subject|8
3042399|NCT00658528|10459836|P2|Overall Study|Lost to Follow-up|22
3042400|NCT00658528|10459837|P1|Overall Study|Lost to Follow-up|14
3042401|NCT00658528|10459836|P2|Overall Study|Adverse Event|7
3042402|NCT00658528|10459837|P1|Overall Study|Adverse Event|5
3042403|NCT00658359|10459877|P3|Overall Study|Lack of Efficacy|0
3042404|NCT00658359|10459878|P2|Overall Study|Lack of Efficacy|1
3042405|NCT00658359|10459879|P1|Overall Study|Lack of Efficacy|0
3042406|NCT00658359|10459877|P3|Overall Study|Lost to Follow-up|4
3042407|NCT00658359|10459878|P2|Overall Study|Lost to Follow-up|2
3042408|NCT00658359|10459879|P1|Overall Study|Lost to Follow-up|2
3042409|NCT00658359|10459877|P3|Overall Study|Withdrawal by Subject|2
3042410|NCT00658359|10459878|P2|Overall Study|Withdrawal by Subject|4
3042411|NCT00658359|10459879|P1|Overall Study|Withdrawal by Subject|7
3042412|NCT00658359|10459877|P3|Overall Study|Includes protocol Amendments 3 and 4|29
3042413|NCT00658359|10459878|P2|Overall Study|Includes protocol Amendments 3 and 4|31
3042414|NCT00658359|10459879|P1|Overall Study|Includes protocol Amendments 3 and 4|2
3042415|NCT00658359|10459877|P3|Overall Study|Protocol Violation|0
3042416|NCT00658359|10459878|P2|Overall Study|Protocol Violation|0
3042417|NCT00658359|10459879|P1|Overall Study|Protocol Violation|1
3042418|NCT00658359|10459877|P3|Overall Study|Adverse Event|9
3042419|NCT00658359|10459878|P2|Overall Study|Adverse Event|6
3042420|NCT00658359|10459879|P1|Overall Study|Adverse Event|13
3042421|NCT00658359|10459877|P3|Overall Study|Death|2
3042422|NCT00658359|10459878|P2|Overall Study|Death|1
3042423|NCT00658359|10459879|P1|Overall Study|Death|3
3042424|NCT00658333|10459967|P2|Overall Study|Adverse Event|1
3042425|NCT00658333|10459968|P1|Overall Study|Adverse Event|2
3042426|NCT00658320|10459978|P2|Extension Study: After Month 24|Subject withdrew consent|0
3042427|NCT00658320|10459979|P1|Extension Study: After Month 24|Subject withdrew consent|2
3042428|NCT00658320|10459978|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
3042429|NCT00658320|10459979|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
3042430|NCT00658320|10459978|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
3042431|NCT00658320|10459979|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
3042432|NCT00658320|10459978|P2|Core Study: 12 Months|Subject withdrew consent|3
3042433|NCT00658320|10459979|P1|Core Study: 12 Months|Subject withdrew consent|5
3042434|NCT00657709|10460022|P5|Overall Study|Protocol Violation|2
3042435|NCT00657709|10460023|P4|Overall Study|Protocol Violation|1
3042436|NCT00657709|10460024|P3|Overall Study|Protocol Violation|0
3042437|NCT00657709|10460025|P2|Overall Study|Protocol Violation|2
3042438|NCT00657709|10460026|P1|Overall Study|Protocol Violation|0
3042439|NCT00657709|10460022|P5|Overall Study|Lost to Follow-up|21
3042440|NCT00657709|10460023|P4|Overall Study|Lost to Follow-up|1
3042441|NCT00657709|10460024|P3|Overall Study|Lost to Follow-up|7
3042442|NCT00657709|10460025|P2|Overall Study|Lost to Follow-up|9
3042443|NCT00657709|10460026|P1|Overall Study|Lost to Follow-up|9
3042444|NCT00657709|10460022|P5|Overall Study|Withdrawal by Subject|9
3042445|NCT00657709|10460023|P4|Overall Study|Withdrawal by Subject|5
3042446|NCT00657709|10460024|P3|Overall Study|Withdrawal by Subject|15
3042447|NCT00657709|10460025|P2|Overall Study|Withdrawal by Subject|15
3042448|NCT00657709|10460026|P1|Overall Study|Withdrawal by Subject|7
3042449|NCT00657709|10460022|P5|Overall Study|AE or Death|1
3042450|NCT00657709|10460023|P4|Overall Study|AE or Death|7
3042451|NCT00657709|10460024|P3|Overall Study|AE or Death|6
3042452|NCT00657709|10460025|P2|Overall Study|AE or Death|7
3042453|NCT00657709|10460026|P1|Overall Study|AE or Death|7
3042454|NCT00657618|10460075|P1|Overall Study|didn't start due to schedule conflicts|1
3042455|NCT00657618|10460075|P1|Overall Study|negative for leishmaniasis|2
3042456|NCT00657618|10460075|P1|Overall Study|Withdrawal by Subject|8
3042457|NCT00657618|10460075|P1|Overall Study|Adverse Event|32
3042458|NCT00657553|10460087|P2|Overall Study|low accrual, no analysis run|5
3042459|NCT00657553|10460088|P1|Overall Study|low accrual, no analysis run|5
3042460|NCT00657540|10460096|P2|Overall Study|Lost to Follow-up|4
3042461|NCT00657540|10460097|P1|Overall Study|Lost to Follow-up|1
3042462|NCT00657371|10460111|P1|Overall Study|Pre-existing medical condition|4
3042463|NCT00657371|10460111|P1|Overall Study|Device- related reasons|13
3042464|NCT00657371|10460111|P1|Overall Study|Protocol Violation|2
3042465|NCT00657371|10460111|P1|Overall Study|Unable to intubate the cecum|5
3042466|NCT00657371|10460111|P1|Overall Study|Poor bowel preparation|15
3042467|NCT00657358|10460116|P1|Overall Study|Lack of Efficacy|6
3042468|NCT00657267|10460128|P1|Overall Study|Adverse Event|9
3042469|NCT00657267|10460128|P1|Overall Study|Progressive disease|45
3042470|NCT00657150|10460138|P2|Treatment|Other|15
3042471|NCT00657150|10460139|P1|Treatment|Other|13
3042472|NCT00657150|10460138|P2|Treatment|Withdrawal by Subject|20
3042473|NCT00657150|10460139|P1|Treatment|Withdrawal by Subject|23
3042474|NCT00657150|10460138|P2|Treatment|Lost to Follow-up|0
3042475|NCT00657150|10460139|P1|Treatment|Lost to Follow-up|1
3042476|NCT00657150|10460138|P2|Treatment|Non-compliant with protocol|9
3042477|NCT00657150|10460139|P1|Treatment|Non-compliant with protocol|10
3042478|NCT00657150|10460138|P2|Treatment|Adverse Event|53
3042479|NCT00657150|10460139|P1|Treatment|Adverse Event|60
3042480|NCT00657150|10460138|P2|Overall Study|Other|38
3042481|NCT00657150|10460139|P1|Overall Study|Other|38
3042482|NCT00657150|10460138|P2|Overall Study|Withdrawal by Subject|36
3042483|NCT00657150|10460139|P1|Overall Study|Withdrawal by Subject|51
3042484|NCT00657150|10460138|P2|Overall Study|Lost to Follow-up|0
3042485|NCT00657150|10460139|P1|Overall Study|Lost to Follow-up|2
3042486|NCT00657150|10460138|P2|Overall Study|Non-compliant with protocol|9
3042487|NCT00657150|10460139|P1|Overall Study|Non-compliant with protocol|5
3042488|NCT00657150|10460138|P2|Overall Study|Adverse Event|10
3042489|NCT00657150|10460139|P1|Overall Study|Adverse Event|19
3042490|NCT00657046|10460170|P3|Overall Study|Surgery|1
3042491|NCT00657046|10460171|P2|Overall Study|Surgery|0
3042492|NCT00657046|10460172|P1|Overall Study|Surgery|0
3042493|NCT00657046|10460170|P3|Overall Study|Death|1
3042494|NCT00657046|10460171|P2|Overall Study|Death|0
3042495|NCT00657046|10460172|P1|Overall Study|Death|0
3042496|NCT00657046|10460170|P3|Overall Study|Withdrawal by Subject|0
3042497|NCT00657046|10460171|P2|Overall Study|Withdrawal by Subject|0
3042498|NCT00657046|10460172|P1|Overall Study|Withdrawal by Subject|1
3042499|NCT00657046|10460170|P3|Overall Study|Protocol Violation|0
3042500|NCT00657046|10460171|P2|Overall Study|Protocol Violation|2
3042501|NCT00657046|10460172|P1|Overall Study|Protocol Violation|2
3042502|NCT00657046|10460170|P3|Overall Study|Adverse Event|0
3042503|NCT00657046|10460171|P2|Overall Study|Adverse Event|1
3042504|NCT00657046|10460172|P1|Overall Study|Adverse Event|1
3042505|NCT00657020|10460204|P2|PERIOD 1|Adverse Event|1
3042506|NCT00657020|10460205|P1|PERIOD 1|Adverse Event|0
3042507|NCT00656851|10460255|P2|Overall Study|Withdrawal by Subject|4
3042508|NCT00656851|10460256|P1|Overall Study|Withdrawal by Subject|0
3042509|NCT00656799|10460278|P1|Overall Study|Death|2
3042510|NCT00656669|10460300|P1|AC (Cycles 6-9)|Did not start segment 3|1
3042511|NCT00656669|10460300|P1|AC (Cycles 6-9)|Adverse Event|1
3042512|NCT00656669|10460300|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
3042513|NCT00656669|10460300|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
3042514|NCT00656617|10460339|P1|Overall Study|Move to different clinical trial|2
3042515|NCT00656617|10460339|P1|Overall Study|Insurance Issues|2
3042516|NCT00656617|10460339|P1|Overall Study|Death|2
3042517|NCT00656617|10460339|P1|Overall Study|Adverse Event|1
3042518|NCT00656513|10460348|P3|Overall Study|Missing baseline form|5
3042519|NCT00656513|10460349|P2|Overall Study|Missing baseline form|5
3042520|NCT00656513|10460350|P1|Overall Study|Missing baseline form|0
3042521|NCT00656513|10460348|P3|Overall Study|Treatment completed outside of timeframe|1
3042522|NCT00656513|10460349|P2|Overall Study|Treatment completed outside of timeframe|3
3042523|NCT00656513|10460350|P1|Overall Study|Treatment completed outside of timeframe|0
3042524|NCT00656513|10460348|P3|Overall Study|Incomplete treatment|0
3042525|NCT00656513|10460349|P2|Overall Study|Incomplete treatment|0
3042526|NCT00656513|10460350|P1|Overall Study|Incomplete treatment|3
3042527|NCT00656513|10460348|P3|Overall Study|Missing data|9
3042528|NCT00656513|10460349|P2|Overall Study|Missing data|11
3042529|NCT00656513|10460350|P1|Overall Study|Missing data|0
3042530|NCT00656513|10460348|P3|Overall Study|Death|1
3042531|NCT00656513|10460349|P2|Overall Study|Death|0
3042532|NCT00656513|10460350|P1|Overall Study|Death|0
3042533|NCT00656513|10460348|P3|Overall Study|Withdrawal by Subject|4
3042534|NCT00656513|10460349|P2|Overall Study|Withdrawal by Subject|11
3042535|NCT00656513|10460350|P1|Overall Study|Withdrawal by Subject|0
3042536|NCT00656513|10460348|P3|Overall Study|Protocol Violation|2
3042537|NCT00656513|10460349|P2|Overall Study|Protocol Violation|0
3042538|NCT00656513|10460350|P1|Overall Study|Protocol Violation|1
3042539|NCT00656474|10460397|P1|Overall Study|Other Reason|1
3042540|NCT00656370|10460415|P1|Overall Study|Alternates|3
3042541|NCT00656370|10460415|P1|Overall Study|Screen Failures|7
3042542|NCT00656292|10460444|P2|Overall Study|Screen failure|2
3042543|NCT00656292|10460445|P1|Overall Study|Screen failure|1
3042544|NCT00656292|10460444|P2|Overall Study|Withdrawal by Subject|3
3042545|NCT00656292|10460445|P1|Overall Study|Withdrawal by Subject|2
3042546|NCT00656175|10460472|P2|Overall Study|Transportation issues|1
3042547|NCT00656175|10460473|P1|Overall Study|Transportation issues|0
3042548|NCT00656175|10460472|P2|Overall Study|Adverse Event|0
3042549|NCT00656175|10460473|P1|Overall Study|Adverse Event|1
3042550|NCT00656136|10460481|P2|Overall Study|Unknown and others|4
3042551|NCT00656136|10460482|P1|Overall Study|Unknown and others|4
3042552|NCT00656136|10460481|P2|Overall Study|Patient refused to take study medication|10
3042553|NCT00656136|10460482|P1|Overall Study|Patient refused to take study medication|7
3042554|NCT00656136|10460481|P2|Overall Study|Protocol Violation|3
3042555|NCT00656136|10460482|P1|Overall Study|Protocol Violation|2
3042556|NCT00656136|10460481|P2|Overall Study|Other Adverse Event|51
3042557|NCT00656136|10460482|P1|Overall Study|Other Adverse Event|5
3042558|NCT00656136|10460481|P2|Overall Study|Progressive disease|322
3042559|NCT00656136|10460482|P1|Overall Study|Progressive disease|177
3042560|NCT00656084|10460492|P1|Overall Study|Investigator Request|1
3042561|NCT00656084|10460492|P1|Overall Study|Patient Request|1
3042562|NCT00656084|10460492|P1|Overall Study|Withdrawal by Subject|1
3042563|NCT00656084|10460492|P1|Overall Study|Adverse Event|4
3042564|NCT00656058|10460499|P1|Overall Study|Withdrawal by Subject|4
3042565|NCT00656058|10460499|P1|Overall Study|Withdrawal by Subject|2
3042566|NCT00656019|10460512|P4|Overall Study|Lost to Follow-up|0
3042567|NCT00656019|10460513|P3|Overall Study|Lost to Follow-up|0
3042568|NCT00656019|10460514|P2|Overall Study|Lost to Follow-up|1
3042569|NCT00656019|10460515|P1|Overall Study|Lost to Follow-up|2
3042570|NCT00656019|10460512|P4|Overall Study|Withdrawal by Subject|0
3042571|NCT00656019|10460513|P3|Overall Study|Withdrawal by Subject|0
3042572|NCT00656019|10460514|P2|Overall Study|Withdrawal by Subject|0
3042573|NCT00656019|10460515|P1|Overall Study|Withdrawal by Subject|2
3042574|NCT00656019|10460512|P4|Overall Study|Not Eligible|0
3042575|NCT00656019|10460513|P3|Overall Study|Not Eligible|0
3042576|NCT00656019|10460514|P2|Overall Study|Not Eligible|0
3042577|NCT00656019|10460515|P1|Overall Study|Not Eligible|10
3042578|NCT00655928|10460527|P2|Overall Study|Physician Decision|1
3042579|NCT00655928|10460528|P1|Overall Study|Physician Decision|1
3042580|NCT00655928|10460527|P2|Overall Study|Withdrawal by Subject|1
3042581|NCT00655928|10460528|P1|Overall Study|Withdrawal by Subject|2
3042582|NCT00655889|10460534|P1|Overall Study|Protocol Violation|1
3042583|NCT00655889|10460534|P1|Overall Study|Inadequate cell growth|1
3042584|NCT00655876|10460541|P2|Overall Study|Protocol Violation|7
3042585|NCT00655876|10460542|P1|Overall Study|Protocol Violation|9
3042586|NCT00655863|10460561|P3|Overall Study|Lost to Follow-up|1
3042587|NCT00655863|10460562|P2|Overall Study|Lost to Follow-up|0
3042588|NCT00655863|10460563|P1|Overall Study|Lost to Follow-up|0
3042589|NCT00655850|10460622|P1|Overall Study|Withdrawal by Subject|1
3042590|NCT00655850|10460622|P1|Overall Study|Death|2
3042591|NCT00655824|10460629|P1|Overall Study|Deterioration of Trial Disease|2
3042592|NCT00655824|10460629|P1|Overall Study|Withdrawal by Subject|4
3042593|NCT00655824|10460629|P1|Overall Study|Protocol Violation|1
3042594|NCT00655824|10460629|P1|Overall Study|Early Termination of Study by Sponsor|74
3042595|NCT00655824|10460629|P1|Overall Study|Adverse Event|3
3042596|NCT00655746|10460677|P1|Overall Study|Withdrawal by Subject|1
3042597|NCT00655733|10460696|P2|Overall Study|Physician Decision|1
3042598|NCT00655733|10460697|P1|Overall Study|Physician Decision|0
3042599|NCT00655733|10460696|P2|Overall Study|Withdrawal by Subject|3
3042600|NCT00655733|10460697|P1|Overall Study|Withdrawal by Subject|3
3042601|NCT00655733|10460696|P2|Overall Study|Adverse Event|2
3042602|NCT00655733|10460697|P1|Overall Study|Adverse Event|2
3042603|NCT00655733|10460696|P2|Overall Study|Lost to Follow-up|2
3042604|NCT00655733|10460697|P1|Overall Study|Lost to Follow-up|2
3042605|NCT00655668|10460730|P1|Overall Study|Withdrawal by Subject|2
3042606|NCT00655668|10460730|P1|Overall Study|New Lymphoma Treatment Started|4
3042607|NCT00655668|10460730|P1|Overall Study|Other|1
3042608|NCT00655668|10460730|P1|Overall Study|Study Terminated|9
3042609|NCT00655668|10460730|P1|Overall Study|Disease Progression|27
3042610|NCT00655668|10460730|P1|Overall Study|Death|5
3042611|NCT00655668|10460730|P1|Overall Study|Adverse Event|6
3042612|NCT00655629|10460757|P2|Overall Study|consent withdrawn|4
3042613|NCT00655629|10460758|P1|Overall Study|consent withdrawn|6
3042614|NCT00655629|10460757|P2|Overall Study|Protocol Violation|3
3042615|NCT00655629|10460758|P1|Overall Study|Protocol Violation|5
3042616|NCT00655629|10460757|P2|Overall Study|Lost to Follow-up|3
3042617|NCT00655629|10460758|P1|Overall Study|Lost to Follow-up|4
3042618|NCT00655629|10460757|P2|Overall Study|Lack of Efficacy|12
3042619|NCT00655629|10460758|P1|Overall Study|Lack of Efficacy|2
3042620|NCT00655629|10460757|P2|Overall Study|Adverse Event|1
3042621|NCT00655629|10460758|P1|Overall Study|Adverse Event|4
3042622|NCT00655564|10460794|P1|Overall Study|Desired Alternate Therapy|1
3042623|NCT00655564|10460794|P1|Overall Study|Lost to Follow-up|1
3042624|NCT00655564|10460794|P1|Overall Study|Adverse Event|1
3042625|NCT00655551|10460802|P3|Period 4 (up to 7 Days)|Adverse Event|0
3042626|NCT00655551|10460803|P2|Period 4 (up to 7 Days)|Adverse Event|2
3042627|NCT00655551|10460804|P1|Period 4 (up to 7 Days)|Adverse Event|0
3042628|NCT00655551|10460802|P3|Period 3 (up to 7 Days)|Adverse Event|4
3042629|NCT00655551|10460803|P2|Period 3 (up to 7 Days)|Adverse Event|0
3042630|NCT00655551|10460804|P1|Period 3 (up to 7 Days)|Adverse Event|0
3042631|NCT00655551|10460802|P3|Period 2 (up to 7 Days)|Adverse Event|0
3042632|NCT00655551|10460803|P2|Period 2 (up to 7 Days)|Adverse Event|1
3042633|NCT00655551|10460804|P1|Period 2 (up to 7 Days)|Adverse Event|0
3042634|NCT00655551|10460802|P3|All Periods Combined|Adverse Event|4
3042635|NCT00655551|10460803|P2|All Periods Combined|Adverse Event|3
3042636|NCT00655551|10460804|P1|All Periods Combined|Adverse Event|0
3042637|NCT00655486|10460841|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
3042638|NCT00655486|10460841|P1|Overall Study|Other: Could not tolerate BID dosing|1
3042639|NCT00655486|10460841|P1|Overall Study|Other: Pregnancy|1
3042640|NCT00655486|10460841|P1|Overall Study|Unsatisfactory compliance|2
3042641|NCT00655486|10460841|P1|Overall Study|Protocol Violation|1
3042642|NCT00655486|10460841|P1|Overall Study|Withdrawal by Subject|4
3042643|NCT00655486|10460841|P1|Overall Study|Lack of Efficacy|8
3042644|NCT00655486|10460841|P1|Overall Study|Adverse Event|10
3042645|NCT00655356|10460869|P2|Overall Study|Other Reason|0
3042646|NCT00655356|10460870|P1|Overall Study|Other Reason|1
3042647|NCT00655356|10460869|P2|Overall Study|Protocol Violation|1
3042648|NCT00655356|10460870|P1|Overall Study|Protocol Violation|2
3042649|NCT00655356|10460869|P2|Overall Study|Adverse Event|1
3042650|NCT00655356|10460870|P1|Overall Study|Adverse Event|1
3042651|NCT00655356|10460869|P2|Overall Study|Sponsor Request|4
3042652|NCT00655356|10460870|P1|Overall Study|Sponsor Request|10
3042653|NCT00655356|10460869|P2|Overall Study|Withdrawal by Subject|4
3042654|NCT00655356|10460870|P1|Overall Study|Withdrawal by Subject|3
3042655|NCT00654940|10460934|P2|Period 1|Intolerable Pain Level|0
3042656|NCT00654940|10460935|P1|Period 1|Intolerable Pain Level|1
3042657|NCT00654940|10460934|P2|Period 1|Adverse Event|1
3042658|NCT00654940|10460935|P1|Period 1|Adverse Event|0
3042659|NCT00654901|10460959|P4|Overall Study|Withdrawal by Subject|0
3042660|NCT00654901|10460960|P3|Overall Study|Withdrawal by Subject|1
3042661|NCT00654901|10460961|P2|Overall Study|Withdrawal by Subject|0
3042662|NCT00654901|10460962|P1|Overall Study|Withdrawal by Subject|3
3042663|NCT00654901|10460959|P4|Overall Study|Lost to Follow-up|0
3042664|NCT00654901|10460960|P3|Overall Study|Lost to Follow-up|1
3042665|NCT00654901|10460961|P2|Overall Study|Lost to Follow-up|0
3042666|NCT00654901|10460962|P1|Overall Study|Lost to Follow-up|1
3042667|NCT00654875|10460982|P2|Overall Study|Administrative Problems|0
3042668|NCT00654875|10460983|P1|Overall Study|Administrative Problems|1
3042669|NCT00654875|10460982|P2|Overall Study|Abnormal Test Procedure Result(s)|0
3042670|NCT00654875|10460983|P1|Overall Study|Abnormal Test Procedure Result(s)|1
3042671|NCT00654875|10460982|P2|Overall Study|Lost to Follow-up|3
3042672|NCT00654875|10460983|P1|Overall Study|Lost to Follow-up|1
3042673|NCT00654875|10460982|P2|Overall Study|Lack of Efficacy|2
3042674|NCT00654875|10460983|P1|Overall Study|Lack of Efficacy|2
3042675|NCT00654875|10460982|P2|Overall Study|Protocol Violation|3
3042676|NCT00654875|10460983|P1|Overall Study|Protocol Violation|3
3042677|NCT00654875|10460982|P2|Overall Study|Withdrawal by Subject|4
3042678|NCT00654875|10460983|P1|Overall Study|Withdrawal by Subject|4
3042679|NCT00654875|10460982|P2|Overall Study|Adverse Event|5
3042680|NCT00654875|10460983|P1|Overall Study|Adverse Event|5
3042681|NCT00654745|10461016|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
3042682|NCT00654745|10461016|P1|Overall Study|Withdrawal by Subject|10
3042683|NCT00654745|10461016|P1|Overall Study|Protocol Violation|11
3042684|NCT00654745|10461016|P1|Overall Study|Lost to Follow-up|7
3042685|NCT00654745|10461016|P1|Overall Study|Adverse Event|12
3042686|NCT00654732|10461056|P2|Overall Study|Adverse Event|6
3042687|NCT00654732|10461057|P1|Overall Study|Adverse Event|4
3042688|NCT00654641|10461070|P2|Overall Study|Lost to Follow-up|3
3042689|NCT00654641|10461071|P1|Overall Study|Lost to Follow-up|2
3042690|NCT00654628|10461077|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
3042691|NCT00654628|10461077|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
3042692|NCT00654628|10461077|P1|6-week Active Treatment Period|Out of window period|1
3042693|NCT00654628|10461077|P1|6-week Active Treatment Period|Transferred to branch hospital|1
3042694|NCT00654628|10461077|P1|6-week Active Treatment Period|Lost to Follow-up|10
3042695|NCT00654628|10461077|P1|6-week Active Treatment Period|Adverse Event|9
3042696|NCT00654498|10461126|P2|Overall Study|Other reason not defined above|5
3042697|NCT00654498|10461127|P1|Overall Study|Other reason not defined above|4
3042698|NCT00654498|10461126|P2|Overall Study|Withdrawal by Subject|0
3042699|NCT00654498|10461127|P1|Overall Study|Withdrawal by Subject|1
3042700|NCT00654498|10461126|P2|Overall Study|Lost to Follow-up|5
3042701|NCT00654498|10461127|P1|Overall Study|Lost to Follow-up|1
3042702|NCT00654498|10461126|P2|Overall Study|Protocol Violation|1
3042703|NCT00654498|10461127|P1|Overall Study|Protocol Violation|1
3042704|NCT00654498|10461126|P2|Overall Study|Adverse Event|1
3042705|NCT00654498|10461127|P1|Overall Study|Adverse Event|6
3042706|NCT00654498|10461126|P2|Overall Study|Not Treated|0
3042707|NCT00654498|10461127|P1|Overall Study|Not Treated|1
3042708|NCT00654420|10461159|P4|Phase II|Missing Disposition Record|0
3042709|NCT00654420|10461160|P3|Phase II|Missing Disposition Record|1
3042710|NCT00654420|10461161|P2|Phase II|Missing Disposition Record|0
3042711|NCT00654420|10461162|P1|Phase II|Missing Disposition Record|0
3042712|NCT00654420|10461159|P4|Phase II|Withdrawal by Subject|1
3042713|NCT00654420|10461160|P3|Phase II|Withdrawal by Subject|4
3042714|NCT00654420|10461161|P2|Phase II|Withdrawal by Subject|0
3042715|NCT00654420|10461162|P1|Phase II|Withdrawal by Subject|0
3042716|NCT00654420|10461159|P4|Phase II|Progressive Disease|29
3042717|NCT00654420|10461160|P3|Phase II|Progressive Disease|29
3042718|NCT00654420|10461161|P2|Phase II|Progressive Disease|0
3042719|NCT00654420|10461162|P1|Phase II|Progressive Disease|0
3042720|NCT00654420|10461159|P4|Phase II|Physician Decision|4
3042721|NCT00654420|10461160|P3|Phase II|Physician Decision|0
3042722|NCT00654420|10461161|P2|Phase II|Physician Decision|0
3042723|NCT00654420|10461162|P1|Phase II|Physician Decision|0
3042724|NCT00654420|10461159|P4|Phase II|Lost to Follow-up|1
3042725|NCT00654420|10461160|P3|Phase II|Lost to Follow-up|0
3042726|NCT00654420|10461161|P2|Phase II|Lost to Follow-up|0
3042727|NCT00654420|10461162|P1|Phase II|Lost to Follow-up|0
3042728|NCT00654420|10461159|P4|Phase II|Adverse Event|3
3042729|NCT00654420|10461160|P3|Phase II|Adverse Event|3
3042730|NCT00654420|10461161|P2|Phase II|Adverse Event|0
3042731|NCT00654420|10461162|P1|Phase II|Adverse Event|0
3042732|NCT00654420|10461159|P4|Phase I (Dose Escalation)|Progressive Disease|0
3042733|NCT00654420|10461160|P3|Phase I (Dose Escalation)|Progressive Disease|0
3042734|NCT00654420|10461161|P2|Phase I (Dose Escalation)|Progressive Disease|15
3042735|NCT00654420|10461162|P1|Phase I (Dose Escalation)|Progressive Disease|4
3042736|NCT00654420|10461159|P4|Phase I (Dose Escalation)|Adverse Event|0
3042737|NCT00654420|10461160|P3|Phase I (Dose Escalation)|Adverse Event|0
3042738|NCT00654420|10461161|P2|Phase I (Dose Escalation)|Adverse Event|1
3042739|NCT00654420|10461162|P1|Phase I (Dose Escalation)|Adverse Event|0
3042740|NCT00654381|10461188|P6|Extension Stage|Closure of the trial site|1
3042741|NCT00654381|10461189|P5|Extension Stage|Closure of the trial site|1
3042742|NCT00654381|10461190|P4|Extension Stage|Closure of the trial site|0
3042743|NCT00654381|10461191|P3|Extension Stage|Closure of the trial site|0
3042744|NCT00654381|10461192|P2|Extension Stage|Closure of the trial site|0
3042745|NCT00654381|10461193|P1|Extension Stage|Closure of the trial site|0
3042746|NCT00654381|10461188|P6|Extension Stage|Withdrawal by Subject|1
3042747|NCT00654381|10461189|P5|Extension Stage|Withdrawal by Subject|1
3042748|NCT00654381|10461190|P4|Extension Stage|Withdrawal by Subject|1
3042749|NCT00654381|10461191|P3|Extension Stage|Withdrawal by Subject|1
3042750|NCT00654381|10461192|P2|Extension Stage|Withdrawal by Subject|0
3042751|NCT00654381|10461193|P1|Extension Stage|Withdrawal by Subject|0
3042752|NCT00654381|10461188|P6|Extension Stage|Lack of Efficacy|0
3042753|NCT00654381|10461189|P5|Extension Stage|Lack of Efficacy|0
3042754|NCT00654381|10461190|P4|Extension Stage|Lack of Efficacy|0
3042755|NCT00654381|10461191|P3|Extension Stage|Lack of Efficacy|1
3042756|NCT00654381|10461192|P2|Extension Stage|Lack of Efficacy|0
3042757|NCT00654381|10461193|P1|Extension Stage|Lack of Efficacy|0
3042758|NCT00654381|10461188|P6|Extension Stage|Protocol Violation|0
3042759|NCT00654381|10461189|P5|Extension Stage|Protocol Violation|0
3042760|NCT00654381|10461190|P4|Extension Stage|Protocol Violation|1
3042761|NCT00654381|10461191|P3|Extension Stage|Protocol Violation|0
3042762|NCT00654381|10461192|P2|Extension Stage|Protocol Violation|0
3042763|NCT00654381|10461193|P1|Extension Stage|Protocol Violation|0
3042764|NCT00654381|10461188|P6|Extension Stage|Adverse Event|1
3042765|NCT00654381|10461189|P5|Extension Stage|Adverse Event|1
3042766|NCT00654381|10461190|P4|Extension Stage|Adverse Event|7
3042767|NCT00654381|10461191|P3|Extension Stage|Adverse Event|9
3042768|NCT00654381|10461192|P2|Extension Stage|Adverse Event|2
3042769|NCT00654381|10461193|P1|Extension Stage|Adverse Event|1
3042770|NCT00654381|10461188|P6|2nd Stage|Investigator's decision|0
3042771|NCT00654381|10461189|P5|2nd Stage|Investigator's decision|0
3042772|NCT00654381|10461190|P4|2nd Stage|Investigator's decision|1
3042773|NCT00654381|10461191|P3|2nd Stage|Investigator's decision|1
3042774|NCT00654381|10461192|P2|2nd Stage|Investigator's decision|0
3042775|NCT00654381|10461193|P1|2nd Stage|Investigator's decision|0
3042776|NCT00654381|10461188|P6|2nd Stage|Withdrawal by Subject|1
3042777|NCT00654381|10461189|P5|2nd Stage|Withdrawal by Subject|1
3042778|NCT00654381|10461190|P4|2nd Stage|Withdrawal by Subject|0
3042779|NCT00654381|10461191|P3|2nd Stage|Withdrawal by Subject|0
3042780|NCT00654381|10461192|P2|2nd Stage|Withdrawal by Subject|0
3042781|NCT00654381|10461193|P1|2nd Stage|Withdrawal by Subject|0
3042782|NCT00654381|10461188|P6|2nd Stage|Adverse Event|2
3042783|NCT00654381|10461189|P5|2nd Stage|Adverse Event|7
3042784|NCT00654381|10461190|P4|2nd Stage|Adverse Event|3
3042785|NCT00654381|10461191|P3|2nd Stage|Adverse Event|2
3042786|NCT00654381|10461192|P2|2nd Stage|Adverse Event|0
3042787|NCT00654381|10461193|P1|2nd Stage|Adverse Event|2
3042788|NCT00654381|10461188|P6|1st Stage|Investigator's decision|0
3042789|NCT00654381|10461189|P5|1st Stage|Investigator's decision|0
3042790|NCT00654381|10461190|P4|1st Stage|Investigator's decision|1
3042791|NCT00654381|10461191|P3|1st Stage|Investigator's decision|0
3042792|NCT00654381|10461192|P2|1st Stage|Investigator's decision|0
3042793|NCT00654381|10461193|P1|1st Stage|Investigator's decision|0
3042794|NCT00654381|10461188|P6|1st Stage|Withdrawal by Subject|1
3042795|NCT00654381|10461189|P5|1st Stage|Withdrawal by Subject|0
3042796|NCT00654381|10461190|P4|1st Stage|Withdrawal by Subject|1
3042797|NCT00654381|10461191|P3|1st Stage|Withdrawal by Subject|0
3042798|NCT00654381|10461192|P2|1st Stage|Withdrawal by Subject|0
3042799|NCT00654381|10461193|P1|1st Stage|Withdrawal by Subject|0
3042800|NCT00654381|10461188|P6|1st Stage|Adverse Event|1
3042801|NCT00654381|10461189|P5|1st Stage|Adverse Event|2
3042802|NCT00654381|10461190|P4|1st Stage|Adverse Event|3
3042803|NCT00654381|10461191|P3|1st Stage|Adverse Event|3
3042804|NCT00654381|10461192|P2|1st Stage|Adverse Event|3
3042805|NCT00654381|10461193|P1|1st Stage|Adverse Event|3
3042806|NCT00654368|10461230|P3|Overall Study|Adverse Event|6
3042807|NCT00654368|10461231|P2|Overall Study|Adverse Event|9
3042808|NCT00654368|10461232|P1|Overall Study|Adverse Event|14
3042809|NCT00654368|10461230|P3|Overall Study|Other|3
3042810|NCT00654368|10461231|P2|Overall Study|Other|2
3042811|NCT00654368|10461232|P1|Overall Study|Other|0
3042812|NCT00654368|10461230|P3|Overall Study|Pregnancy|2
3042813|NCT00654368|10461231|P2|Overall Study|Pregnancy|0
3042814|NCT00654368|10461232|P1|Overall Study|Pregnancy|0
3042815|NCT00654368|10461230|P3|Overall Study|Death|0
3042816|NCT00654368|10461231|P2|Overall Study|Death|0
3042817|NCT00654368|10461232|P1|Overall Study|Death|1
3042818|NCT00654368|10461230|P3|Overall Study|Physician Decision|2
3042819|NCT00654368|10461231|P2|Overall Study|Physician Decision|0
3042820|NCT00654368|10461232|P1|Overall Study|Physician Decision|0
3042821|NCT00654368|10461230|P3|Overall Study|Requirement for alternative therapy|1
3042822|NCT00654368|10461231|P2|Overall Study|Requirement for alternative therapy|1
3042823|NCT00654368|10461232|P1|Overall Study|Requirement for alternative therapy|1
3042824|NCT00654368|10461230|P3|Overall Study|Disease progression|13
3042825|NCT00654368|10461231|P2|Overall Study|Disease progression|31
3042826|NCT00654368|10461232|P1|Overall Study|Disease progression|21
3042827|NCT00654368|10461230|P3|Overall Study|Withdrawal by Subject|2
3042828|NCT00654368|10461231|P2|Overall Study|Withdrawal by Subject|2
3042829|NCT00654368|10461232|P1|Overall Study|Withdrawal by Subject|5
3042830|NCT00654368|10461230|P3|Overall Study|Non-compliance|2
3042831|NCT00654368|10461231|P2|Overall Study|Non-compliance|1
3042832|NCT00654368|10461232|P1|Overall Study|Non-compliance|2
3042833|NCT00654368|10461230|P3|Overall Study|Protocol deviation|1
3042834|NCT00654368|10461231|P2|Overall Study|Protocol deviation|2
3042835|NCT00654368|10461232|P1|Overall Study|Protocol deviation|3
3042836|NCT00654368|10461230|P3|Overall Study|Ineligibility determined|0
3042837|NCT00654368|10461231|P2|Overall Study|Ineligibility determined|0
3042838|NCT00654368|10461232|P1|Overall Study|Ineligibility determined|6
3042839|NCT00654355|10461265|P2|Overall Study|Lost to Follow-up|2
3042840|NCT00654355|10461266|P1|Overall Study|Lost to Follow-up|2
3042841|NCT00654238|10461297|P1|Overall Study|Screen Failures|4
3042842|NCT00654186|10461302|P1|Overall Study|Withdrawal by Subject|5
3042843|NCT00654095|10461327|P1|Overall Study|Did not meet inclusion criteria|1
3042844|NCT00654095|10461327|P1|Overall Study|Adverse reaction did not improve (5)|4
3042845|NCT00654095|10461327|P1|Overall Study|Elevated alanine aminotransferase (4)|7
3042846|NCT00654095|10461327|P1|Overall Study|Withdrawal by Subject|5
3042847|NCT00654095|10461327|P1|Overall Study|Adverse Event|11
3042848|NCT00654095|10461327|P1|Overall Study|Elevated alanine aminotransferase (3)|1
3042849|NCT00654095|10461327|P1|Overall Study|Elevated triglyceride level (2)|1
3042850|NCT00654095|10461327|P1|Overall Study|Drop in low density lipoprotein (1)|2
3042851|NCT00654004|10461350|P2|Overall Study|Lost to Follow-up|0
3042852|NCT00654004|10461351|P1|Overall Study|Lost to Follow-up|1
3042853|NCT00653991|10461367|P2|6 Month Follow-up|Participant would not respond|141
3042854|NCT00653991|10461368|P1|6 Month Follow-up|Participant would not respond|133
3042855|NCT00653991|10461367|P2|3 Month Follow-up|Participant would not respond|157
3042856|NCT00653991|10461368|P1|3 Month Follow-up|Participant would not respond|150
3042857|NCT00653939|10461380|P2|Overall Study|Other|6
3042858|NCT00653939|10461381|P1|Overall Study|Other|2
3042859|NCT00653939|10461380|P2|Overall Study|Disease Progression|3
3042860|NCT00653939|10461381|P1|Overall Study|Disease Progression|2
3042861|NCT00653939|10461380|P2|Overall Study|Physician Decision|0
3042862|NCT00653939|10461381|P1|Overall Study|Physician Decision|4
3042863|NCT00653939|10461380|P2|Overall Study|Withdrawal by Subject|3
3042864|NCT00653939|10461381|P1|Overall Study|Withdrawal by Subject|3
3042865|NCT00653939|10461380|P2|Overall Study|Adverse Event|3
3042866|NCT00653939|10461381|P1|Overall Study|Adverse Event|1
3042867|NCT00653523|10461406|P1|Overall Study|Adverse reaction did not improve (4)|1
3042868|NCT00653523|10461406|P1|Overall Study|Elevated alanine aminotransferase (3)|2
3042869|NCT00653523|10461406|P1|Overall Study|Withdrawal by Subject|6
3042870|NCT00653523|10461406|P1|Overall Study|Adverse Event|7
3042871|NCT00653523|10461406|P1|Overall Study|Elevated creatine phosphokinase (2)|1
3042872|NCT00653523|10461406|P1|Overall Study|Drop in low density lipoprotein (1)|2
3042873|NCT00653328|10461410|P1|Overall Study|Drug manufacturer no longing making drug|2
3042874|NCT00653328|10461410|P1|Overall Study|Disease progression|10
3042875|NCT00653328|10461410|P1|Overall Study|Adverse Event|2
3042876|NCT00653328|10461410|P1|Overall Study|Withdrawal by Subject|1
3042877|NCT00653263|10461417|P1|Overall Study|Physician Decision|1
3042878|NCT00653263|10461417|P1|Overall Study|Withdrawal by Subject|1
3042879|NCT00653224|10461425|P2|Overall Study|Other|4
3042880|NCT00653224|10461426|P1|Overall Study|Other|2
3042881|NCT00653224|10461425|P2|Overall Study|Lost to Follow-up|0
3042882|NCT00653224|10461426|P1|Overall Study|Lost to Follow-up|1
3042883|NCT00653224|10461425|P2|Overall Study|Loss of efficacy|0
3042884|NCT00653224|10461426|P1|Overall Study|Loss of efficacy|1
3042885|NCT00653224|10461425|P2|Overall Study|Lack of Efficacy|2
3042886|NCT00653224|10461426|P1|Overall Study|Lack of Efficacy|1
3042887|NCT00653224|10461425|P2|Overall Study|Adverse Event|1
3042888|NCT00653224|10461426|P1|Overall Study|Adverse Event|2
3042889|NCT00653159|10461612|P2|Overall Study|Lost to Follow-up|2
3042890|NCT00653159|10461613|P1|Overall Study|Lost to Follow-up|1
3042891|NCT00653159|10461612|P2|Overall Study|Adverse Event|1
3042892|NCT00653159|10461613|P1|Overall Study|Adverse Event|4
3042893|NCT00653068|10461640|P1|Overall Study|Ineligible|2
3042894|NCT00653068|10461640|P1|Overall Study|Withdrawal by Subject|1
3042895|NCT00653068|10461640|P1|Overall Study|Physician Decision|4
3042896|NCT00653068|10461640|P1|Overall Study|Lack of Efficacy|34
3042897|NCT00653068|10461640|P1|Overall Study|Death|9
3042898|NCT00652951|10461654|P3|Booster Phase|Other|0
3042899|NCT00652951|10461655|P2|Booster Phase|Other|0
3042900|NCT00652951|10461656|P1|Booster Phase|Other|1
3042901|NCT00652951|10461654|P3|Booster Phase|Adverse event, non-fatal|0
3042902|NCT00652951|10461655|P2|Booster Phase|Adverse event, non-fatal|1
3042903|NCT00652951|10461656|P1|Booster Phase|Adverse event, non-fatal|0
3042904|NCT00652938|10461793|P3|Overall Study|fear of blood sampling|0
3042905|NCT00652938|10461794|P2|Overall Study|fear of blood sampling|1
3042906|NCT00652938|10461795|P1|Overall Study|fear of blood sampling|0
3042907|NCT00652938|10461793|P3|Overall Study|Lost to Follow-up|2
3042908|NCT00652938|10461794|P2|Overall Study|Lost to Follow-up|0
3042909|NCT00652938|10461795|P1|Overall Study|Lost to Follow-up|0
3042910|NCT00652938|10461793|P3|Overall Study|Withdrawal by Subject|1
3042911|NCT00652938|10461794|P2|Overall Study|Withdrawal by Subject|6
3042912|NCT00652938|10461795|P1|Overall Study|Withdrawal by Subject|0
3042913|NCT00652938|10461793|P3|Overall Study|Adverse Event|2
3042914|NCT00652938|10461794|P2|Overall Study|Adverse Event|0
3042915|NCT00652938|10461795|P1|Overall Study|Adverse Event|1
3042916|NCT00652899|10461860|P1|Overall Study|Treating physician decision|1
3042917|NCT00652899|10461860|P1|Overall Study|Death|1
3042918|NCT00652834|10461870|P1|Overall Study|Lost to Follow-up|2
3042919|NCT00652834|10461870|P1|Overall Study|Withdrawal by Subject|3
3042920|NCT00652743|10461877|P3|Months 36-42|Other|8
3042921|NCT00652743|10461878|P2|Months 36-42|Other|2
3042922|NCT00652743|10461879|P1|Months 36-42|Other|4
3042923|NCT00652743|10461877|P3|Months 36-42|Migrated/moved from study area|0
3042924|NCT00652743|10461878|P2|Months 36-42|Migrated/moved from study area|0
3042925|NCT00652743|10461879|P1|Months 36-42|Migrated/moved from study area|1
3042926|NCT00652743|10461877|P3|Months 36-42|Lost to Follow-up|0
3042927|NCT00652743|10461878|P2|Months 36-42|Lost to Follow-up|1
3042928|NCT00652743|10461879|P1|Months 36-42|Lost to Follow-up|0
3042929|NCT00652743|10461877|P3|Months 36-42|Withdrawal by Subject|0
3042930|NCT00652743|10461878|P2|Months 36-42|Withdrawal by Subject|1
3042931|NCT00652743|10461879|P1|Months 36-42|Withdrawal by Subject|1
3042932|NCT00652743|10461877|P3|Months 36-42|Serious Adverse Events|1
3042933|NCT00652743|10461878|P2|Months 36-42|Serious Adverse Events|1
3042934|NCT00652743|10461879|P1|Months 36-42|Serious Adverse Events|0
3042935|NCT00652743|10461877|P3|Months 24-30|Other|11
3042936|NCT00652743|10461878|P2|Months 24-30|Other|1
3042937|NCT00652743|10461879|P1|Months 24-30|Other|5
3042938|NCT00652743|10461877|P3|Months 12-18|Lost to Follow-up|7
3042939|NCT00652743|10461878|P2|Months 12-18|Lost to Follow-up|2
3042940|NCT00652743|10461879|P1|Months 12-18|Lost to Follow-up|1
3042941|NCT00652626|10461961|P7|Extension Phase|Death|1
3042942|NCT00652626|10461962|P6|Extension Phase|Death|1
3042943|NCT00652626|10461963|P5|Extension Phase|Death|0
3042944|NCT00652626|10461964|P4|Extension Phase|Death|0
3042945|NCT00652626|10461965|P3|Extension Phase|Death|0
3042946|NCT00652626|10461966|P2|Extension Phase|Death|0
3042947|NCT00652626|10461967|P1|Extension Phase|Death|0
3042948|NCT00652626|10461961|P7|Extension Phase|Physician Decision|1
3042949|NCT00652626|10461962|P6|Extension Phase|Physician Decision|1
3042950|NCT00652626|10461963|P5|Extension Phase|Physician Decision|0
3042951|NCT00652626|10461964|P4|Extension Phase|Physician Decision|0
3042952|NCT00652626|10461965|P3|Extension Phase|Physician Decision|0
3042953|NCT00652626|10461966|P2|Extension Phase|Physician Decision|0
3042954|NCT00652626|10461967|P1|Extension Phase|Physician Decision|0
3042955|NCT00652626|10461961|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
3042956|NCT00652626|10461962|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
3042957|NCT00652626|10461963|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
3042958|NCT00652626|10461964|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
3042959|NCT00652626|10461965|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
3042960|NCT00652626|10461966|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
3042961|NCT00652626|10461967|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
3042962|NCT00652626|10461961|P7|Extension Phase|Adverse Event|1
3042963|NCT00652626|10461962|P6|Extension Phase|Adverse Event|2
3042964|NCT00652626|10461963|P5|Extension Phase|Adverse Event|0
3042965|NCT00652626|10461964|P4|Extension Phase|Adverse Event|0
3042966|NCT00652626|10461965|P3|Extension Phase|Adverse Event|0
3042967|NCT00652626|10461966|P2|Extension Phase|Adverse Event|0
3042968|NCT00652626|10461967|P1|Extension Phase|Adverse Event|0
3042969|NCT00652626|10461961|P7|Extension Phase|Withdrawal by Subject|0
3042970|NCT00652626|10461962|P6|Extension Phase|Withdrawal by Subject|2
3042971|NCT00652626|10461963|P5|Extension Phase|Withdrawal by Subject|0
3042972|NCT00652626|10461964|P4|Extension Phase|Withdrawal by Subject|0
3042973|NCT00652626|10461965|P3|Extension Phase|Withdrawal by Subject|0
3042974|NCT00652626|10461966|P2|Extension Phase|Withdrawal by Subject|0
3042975|NCT00652626|10461967|P1|Extension Phase|Withdrawal by Subject|0
3042976|NCT00652626|10461961|P7|Initial Treatment Phase|Lost to Follow-up|0
3042977|NCT00652626|10461962|P6|Initial Treatment Phase|Lost to Follow-up|0
3042978|NCT00652626|10461963|P5|Initial Treatment Phase|Lost to Follow-up|1
3042979|NCT00652626|10461964|P4|Initial Treatment Phase|Lost to Follow-up|0
3042980|NCT00652626|10461965|P3|Initial Treatment Phase|Lost to Follow-up|0
3042981|NCT00652626|10461966|P2|Initial Treatment Phase|Lost to Follow-up|0
3042982|NCT00652626|10461967|P1|Initial Treatment Phase|Lost to Follow-up|0
3042983|NCT00652626|10461961|P7|Initial Treatment Phase|Sponsor Request|0
3042984|NCT00652626|10461962|P6|Initial Treatment Phase|Sponsor Request|0
3042985|NCT00652626|10461963|P5|Initial Treatment Phase|Sponsor Request|0
3042986|NCT00652626|10461964|P4|Initial Treatment Phase|Sponsor Request|0
3042987|NCT00652626|10461965|P3|Initial Treatment Phase|Sponsor Request|1
3042988|NCT00652626|10461966|P2|Initial Treatment Phase|Sponsor Request|0
3042989|NCT00652626|10461967|P1|Initial Treatment Phase|Sponsor Request|0
3042990|NCT00652626|10461961|P7|Initial Treatment Phase|Physician Decision|0
3042991|NCT00652626|10461962|P6|Initial Treatment Phase|Physician Decision|0
3042992|NCT00652626|10461963|P5|Initial Treatment Phase|Physician Decision|1
3042993|NCT00652626|10461964|P4|Initial Treatment Phase|Physician Decision|0
3042994|NCT00652626|10461965|P3|Initial Treatment Phase|Physician Decision|0
3042995|NCT00652626|10461966|P2|Initial Treatment Phase|Physician Decision|0
3042996|NCT00652626|10461967|P1|Initial Treatment Phase|Physician Decision|0
3042997|NCT00652626|10461961|P7|Initial Treatment Phase|Protocol Violation|0
3042998|NCT00652626|10461962|P6|Initial Treatment Phase|Protocol Violation|0
3042999|NCT00652626|10461963|P5|Initial Treatment Phase|Protocol Violation|0
3043000|NCT00652626|10461964|P4|Initial Treatment Phase|Protocol Violation|1
3043001|NCT00652626|10461965|P3|Initial Treatment Phase|Protocol Violation|0
3043002|NCT00652626|10461966|P2|Initial Treatment Phase|Protocol Violation|0
3043003|NCT00652626|10461967|P1|Initial Treatment Phase|Protocol Violation|0
3043004|NCT00652626|10461961|P7|Initial Treatment Phase|Adverse Event|0
3043005|NCT00652626|10461962|P6|Initial Treatment Phase|Adverse Event|0
3043006|NCT00652626|10461963|P5|Initial Treatment Phase|Adverse Event|1
3043007|NCT00652626|10461964|P4|Initial Treatment Phase|Adverse Event|0
3043008|NCT00652626|10461965|P3|Initial Treatment Phase|Adverse Event|0
3043009|NCT00652626|10461966|P2|Initial Treatment Phase|Adverse Event|0
3043010|NCT00652626|10461967|P1|Initial Treatment Phase|Adverse Event|0
3043011|NCT00652366|10462036|P5|Overall Study|Other|0
3043012|NCT00652366|10462037|P4|Overall Study|Other|4
3043013|NCT00652366|10462038|P3|Overall Study|Other|3
3043014|NCT00652366|10462039|P2|Overall Study|Other|2
3043015|NCT00652366|10462040|P1|Overall Study|Other|5
3043016|NCT00652366|10462036|P5|Overall Study|Refused treatment|5
3043017|NCT00652366|10462037|P4|Overall Study|Refused treatment|17
3043018|NCT00652366|10462038|P3|Overall Study|Refused treatment|6
3043019|NCT00652366|10462039|P2|Overall Study|Refused treatment|7
3043020|NCT00652366|10462040|P1|Overall Study|Refused treatment|3
3043021|NCT00652366|10462036|P5|Overall Study|Protocol Violation|0
3043022|NCT00652366|10462037|P4|Overall Study|Protocol Violation|0
3043023|NCT00652366|10462038|P3|Overall Study|Protocol Violation|0
3043024|NCT00652366|10462039|P2|Overall Study|Protocol Violation|0
3043025|NCT00652366|10462040|P1|Overall Study|Protocol Violation|1
3043026|NCT00652366|10462036|P5|Overall Study|Violation of Selection Criteria|0
3043027|NCT00652366|10462037|P4|Overall Study|Violation of Selection Criteria|0
3043028|NCT00652366|10462038|P3|Overall Study|Violation of Selection Criteria|1
3043029|NCT00652366|10462039|P2|Overall Study|Violation of Selection Criteria|0
3043030|NCT00652366|10462040|P1|Overall Study|Violation of Selection Criteria|0
3043031|NCT00652366|10462036|P5|Overall Study|Lack of Efficacy|13
3043032|NCT00652366|10462037|P4|Overall Study|Lack of Efficacy|133
3043033|NCT00652366|10462038|P3|Overall Study|Lack of Efficacy|53
3043034|NCT00652366|10462039|P2|Overall Study|Lack of Efficacy|58
3043035|NCT00652366|10462040|P1|Overall Study|Lack of Efficacy|84
3043036|NCT00652366|10462036|P5|Overall Study|Death|5
3043037|NCT00652366|10462037|P4|Overall Study|Death|8
3043038|NCT00652366|10462038|P3|Overall Study|Death|1
3043039|NCT00652366|10462039|P2|Overall Study|Death|4
3043040|NCT00652366|10462040|P1|Overall Study|Death|5
3043041|NCT00652366|10462036|P5|Overall Study|Adverse Event|13
3043042|NCT00652366|10462037|P4|Overall Study|Adverse Event|17
3043043|NCT00652366|10462038|P3|Overall Study|Adverse Event|7
3043044|NCT00652366|10462039|P2|Overall Study|Adverse Event|4
3043045|NCT00652366|10462040|P1|Overall Study|Adverse Event|8
3043046|NCT00652340|10462075|P2|Overall Study|Had not progressed.|3
3043047|NCT00652340|10462076|P1|Overall Study|Had not progressed.|4
3043048|NCT00652327|10462086|P2|Overall Study|Lost to Follow-up|3
3043049|NCT00652327|10462087|P1|Overall Study|Lost to Follow-up|0
3043050|NCT00652327|10462086|P2|Overall Study|Adverse Event|2
3043051|NCT00652327|10462087|P1|Overall Study|Adverse Event|0
3043052|NCT00652093|10462129|P6|Overall Study|Physician Decision|0
3043053|NCT00652093|10462130|P5|Overall Study|Physician Decision|1
3043054|NCT00652093|10462131|P4|Overall Study|Physician Decision|0
3043055|NCT00652093|10462132|P3|Overall Study|Physician Decision|0
3043056|NCT00652093|10462133|P2|Overall Study|Physician Decision|0
3043057|NCT00652093|10462134|P1|Overall Study|Physician Decision|0
3043058|NCT00652093|10462129|P6|Overall Study|Withdrawal by Subject|0
3043059|NCT00652093|10462130|P5|Overall Study|Withdrawal by Subject|1
3043060|NCT00652093|10462131|P4|Overall Study|Withdrawal by Subject|0
3043061|NCT00652093|10462132|P3|Overall Study|Withdrawal by Subject|1
3043062|NCT00652093|10462133|P2|Overall Study|Withdrawal by Subject|0
3043063|NCT00652093|10462134|P1|Overall Study|Withdrawal by Subject|0
3043064|NCT00652028|10462224|P4|Overall Study|Physician Decision|0
3043065|NCT00652028|10462225|P3|Overall Study|Physician Decision|1
3043066|NCT00652028|10462226|P2|Overall Study|Physician Decision|0
3043067|NCT00652028|10462227|P1|Overall Study|Physician Decision|0
3043068|NCT00652028|10462224|P4|Overall Study|No Longer Meets Entry Criteria|0
3043069|NCT00652028|10462225|P3|Overall Study|No Longer Meets Entry Criteria|0
3043070|NCT00652028|10462226|P2|Overall Study|No Longer Meets Entry Criteria|1
3043071|NCT00652028|10462227|P1|Overall Study|No Longer Meets Entry Criteria|0
3043072|NCT00652028|10462224|P4|Overall Study|Adverse Event|0
3043073|NCT00652028|10462225|P3|Overall Study|Adverse Event|0
3043074|NCT00652028|10462226|P2|Overall Study|Adverse Event|0
3043075|NCT00652028|10462227|P1|Overall Study|Adverse Event|1
3043076|NCT00651937|10462271|P2|Overall Study|Withdrawal by Subject|1
3043077|NCT00651937|10462272|P1|Overall Study|Withdrawal by Subject|4
3043078|NCT00651924|10462282|P2|Overall Study|Withdrawal by Subject|5
3043079|NCT00651924|10462283|P1|Overall Study|Withdrawal by Subject|0
3043080|NCT00651924|10462282|P2|Overall Study|Withdrawal by PI|2
3043081|NCT00651924|10462283|P1|Overall Study|Withdrawal by PI|0
3043082|NCT00651820|10462289|P1|Overall Study|Lost to Follow-up|2
3043083|NCT00651755|10462321|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
3043084|NCT00651755|10462322|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
3043085|NCT00651755|10462321|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
3043086|NCT00651755|10462322|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
3043087|NCT00651664|10462348|P10|Overall Study|Reason not Specified|0
3043088|NCT00651664|10462349|P9|Overall Study|Reason not Specified|0
3043089|NCT00651664|10462350|P8|Overall Study|Reason not Specified|0
3043090|NCT00651664|10462351|P7|Overall Study|Reason not Specified|1
3043091|NCT00651664|10462352|P6|Overall Study|Reason not Specified|0
3043092|NCT00651664|10462353|P5|Overall Study|Reason not Specified|0
3043093|NCT00651664|10462354|P4|Overall Study|Reason not Specified|0
3043094|NCT00651664|10462355|P3|Overall Study|Reason not Specified|0
3043095|NCT00651664|10462356|P2|Overall Study|Reason not Specified|0
3043096|NCT00651664|10462357|P1|Overall Study|Reason not Specified|0
3043097|NCT00651664|10462348|P10|Overall Study|Symptomatic Deterioration|0
3043098|NCT00651664|10462349|P9|Overall Study|Symptomatic Deterioration|1
3043099|NCT00651664|10462350|P8|Overall Study|Symptomatic Deterioration|0
3043100|NCT00651664|10462351|P7|Overall Study|Symptomatic Deterioration|1
3043101|NCT00651664|10462352|P6|Overall Study|Symptomatic Deterioration|0
3043102|NCT00651664|10462353|P5|Overall Study|Symptomatic Deterioration|0
3043103|NCT00651664|10462354|P4|Overall Study|Symptomatic Deterioration|1
3043104|NCT00651664|10462355|P3|Overall Study|Symptomatic Deterioration|0
3043105|NCT00651664|10462356|P2|Overall Study|Symptomatic Deterioration|0
3043106|NCT00651664|10462357|P1|Overall Study|Symptomatic Deterioration|0
3043107|NCT00651664|10462348|P10|Overall Study|Patient Declined Further Treatment|1
3043108|NCT00651664|10462349|P9|Overall Study|Patient Declined Further Treatment|0
3043109|NCT00651664|10462350|P8|Overall Study|Patient Declined Further Treatment|0
3043110|NCT00651664|10462351|P7|Overall Study|Patient Declined Further Treatment|0
3043111|NCT00651664|10462352|P6|Overall Study|Patient Declined Further Treatment|1
3043112|NCT00651664|10462353|P5|Overall Study|Patient Declined Further Treatment|1
3043198|NCT00651118|10462579|P3|Overall Study|Lost to Follow-up|1
3043113|NCT00651664|10462354|P4|Overall Study|Patient Declined Further Treatment|1
3043114|NCT00651664|10462355|P3|Overall Study|Patient Declined Further Treatment|0
3043115|NCT00651664|10462356|P2|Overall Study|Patient Declined Further Treatment|0
3043116|NCT00651664|10462357|P1|Overall Study|Patient Declined Further Treatment|0
3043117|NCT00651664|10462348|P10|Overall Study|Progressive Disease|5
3043118|NCT00651664|10462349|P9|Overall Study|Progressive Disease|5
3043119|NCT00651664|10462350|P8|Overall Study|Progressive Disease|6
3043120|NCT00651664|10462351|P7|Overall Study|Progressive Disease|3
3043121|NCT00651664|10462352|P6|Overall Study|Progressive Disease|1
3043122|NCT00651664|10462353|P5|Overall Study|Progressive Disease|4
3043123|NCT00651664|10462354|P4|Overall Study|Progressive Disease|12
3043124|NCT00651664|10462355|P3|Overall Study|Progressive Disease|3
3043125|NCT00651664|10462356|P2|Overall Study|Progressive Disease|3
3043126|NCT00651664|10462357|P1|Overall Study|Progressive Disease|3
3043127|NCT00651664|10462348|P10|Overall Study|Unsatisfactory Therapeutic Response|1
3043128|NCT00651664|10462349|P9|Overall Study|Unsatisfactory Therapeutic Response|0
3043129|NCT00651664|10462350|P8|Overall Study|Unsatisfactory Therapeutic Response|1
3043130|NCT00651664|10462351|P7|Overall Study|Unsatisfactory Therapeutic Response|0
3043131|NCT00651664|10462352|P6|Overall Study|Unsatisfactory Therapeutic Response|1
3043132|NCT00651664|10462353|P5|Overall Study|Unsatisfactory Therapeutic Response|1
3043133|NCT00651664|10462354|P4|Overall Study|Unsatisfactory Therapeutic Response|0
3043134|NCT00651664|10462355|P3|Overall Study|Unsatisfactory Therapeutic Response|0
3043135|NCT00651664|10462356|P2|Overall Study|Unsatisfactory Therapeutic Response|0
3043136|NCT00651664|10462357|P1|Overall Study|Unsatisfactory Therapeutic Response|0
3043137|NCT00651664|10462348|P10|Overall Study|Occurrence of Adverse Event(s)|0
3043138|NCT00651664|10462349|P9|Overall Study|Occurrence of Adverse Event(s)|1
3043139|NCT00651664|10462350|P8|Overall Study|Occurrence of Adverse Event(s)|0
3043140|NCT00651664|10462351|P7|Overall Study|Occurrence of Adverse Event(s)|1
3043141|NCT00651664|10462352|P6|Overall Study|Occurrence of Adverse Event(s)|0
3043142|NCT00651664|10462353|P5|Overall Study|Occurrence of Adverse Event(s)|0
3043143|NCT00651664|10462354|P4|Overall Study|Occurrence of Adverse Event(s)|0
3043144|NCT00651664|10462355|P3|Overall Study|Occurrence of Adverse Event(s)|0
3043145|NCT00651664|10462356|P2|Overall Study|Occurrence of Adverse Event(s)|0
3043146|NCT00651664|10462357|P1|Overall Study|Occurrence of Adverse Event(s)|0
3043147|NCT00651313|10462529|P2|Overall Study|Adminstrative Discontinuation|3
3043148|NCT00651313|10462530|P1|Overall Study|Adminstrative Discontinuation|2
3043149|NCT00651313|10462529|P2|Overall Study|Lost to Follow-up|1
3043150|NCT00651313|10462530|P1|Overall Study|Lost to Follow-up|1
3043151|NCT00651313|10462529|P2|Overall Study|Withdrawal by Subject|1
3043152|NCT00651313|10462530|P1|Overall Study|Withdrawal by Subject|3
3043153|NCT00651313|10462529|P2|Overall Study|Adverse Event|1
3043154|NCT00651313|10462530|P1|Overall Study|Adverse Event|0
3043155|NCT00651261|10462538|P2|Overall Study|Never treated|3
3043156|NCT00651261|10462539|P1|Overall Study|Never treated|5
3043157|NCT00651261|10462538|P2|Overall Study|Other disease or participant decisions|23
3043158|NCT00651261|10462539|P1|Overall Study|Other disease or participant decisions|23
3043159|NCT00651261|10462538|P2|Overall Study|Alternative therapy|107
3043160|NCT00651261|10462539|P1|Overall Study|Alternative therapy|109
3043161|NCT00651261|10462538|P2|Overall Study|Disease progression|58
3043162|NCT00651261|10462539|P1|Overall Study|Disease progression|58
3043163|NCT00651261|10462538|P2|Overall Study|Induction failure|35
3043164|NCT00651261|10462539|P1|Overall Study|Induction failure|24
3043165|NCT00651261|10462538|P2|Overall Study|Withdrawal by Subject|40
3043166|NCT00651261|10462539|P1|Overall Study|Withdrawal by Subject|22
3043167|NCT00651261|10462538|P2|Overall Study|Death|18
3043168|NCT00651261|10462539|P1|Overall Study|Death|18
3043169|NCT00651261|10462538|P2|Overall Study|Adverse Event|22
3043170|NCT00651261|10462539|P1|Overall Study|Adverse Event|32
3043171|NCT00651183|10462555|P2|Overall Study|missing|0
3043172|NCT00651183|10462556|P1|Overall Study|missing|1
3043173|NCT00651183|10462555|P2|Overall Study|Other reasons|2
3043174|NCT00651183|10462556|P1|Overall Study|Other reasons|4
3043175|NCT00651183|10462555|P2|Overall Study|Lost to Follow-up|1
3043176|NCT00651183|10462556|P1|Overall Study|Lost to Follow-up|3
3043177|NCT00651183|10462555|P2|Overall Study|Withdrawal by Subject|3
3043178|NCT00651183|10462556|P1|Overall Study|Withdrawal by Subject|6
3043179|NCT00651183|10462555|P2|Overall Study|Tolerability insufficient +Patients wish|1
3043180|NCT00651183|10462556|P1|Overall Study|Tolerability insufficient +Patients wish|0
3043181|NCT00651183|10462555|P2|Overall Study|Tolerability insufficient|2
3043182|NCT00651183|10462556|P1|Overall Study|Tolerability insufficient|5
3043183|NCT00651183|10462555|P2|Overall Study|Efficacy insufficient + patients wish|1
3043184|NCT00651183|10462556|P1|Overall Study|Efficacy insufficient + patients wish|0
3043185|NCT00651183|10462555|P2|Overall Study|Lack of Efficacy|0
3043186|NCT00651183|10462556|P1|Overall Study|Lack of Efficacy|1
3043187|NCT00651157|10462568|P1|Overall Study|Protocol Violation|1
3043188|NCT00651157|10462568|P1|Overall Study|Death|1
3043189|NCT00651118|10462578|P4|Overall Study|Withdrawal by Subject|1
3043190|NCT00651118|10462579|P3|Overall Study|Withdrawal by Subject|1
3043191|NCT00651118|10462580|P2|Overall Study|Withdrawal by Subject|1
3043192|NCT00651118|10462581|P1|Overall Study|Withdrawal by Subject|0
3043193|NCT00651118|10462578|P4|Overall Study|administrative|1
3043194|NCT00651118|10462579|P3|Overall Study|administrative|2
3043195|NCT00651118|10462580|P2|Overall Study|administrative|4
3043196|NCT00651118|10462581|P1|Overall Study|administrative|1
3043197|NCT00651118|10462578|P4|Overall Study|Lost to Follow-up|2
3043199|NCT00651118|10462580|P2|Overall Study|Lost to Follow-up|0
3043200|NCT00651118|10462581|P1|Overall Study|Lost to Follow-up|2
3043201|NCT00651118|10462578|P4|Overall Study|Protocol Violation|2
3043202|NCT00651118|10462579|P3|Overall Study|Protocol Violation|6
3043203|NCT00651118|10462580|P2|Overall Study|Protocol Violation|2
3043204|NCT00651118|10462581|P1|Overall Study|Protocol Violation|2
3043205|NCT00651118|10462578|P4|Overall Study|Adverse Event|1
3043206|NCT00651118|10462579|P3|Overall Study|Adverse Event|1
3043207|NCT00651118|10462580|P2|Overall Study|Adverse Event|0
3043208|NCT00651118|10462581|P1|Overall Study|Adverse Event|4
3043209|NCT00650845|10462650|P2|Overall Study|Protocol Violation|13
3043210|NCT00650845|10462651|P1|Overall Study|Protocol Violation|0
3043211|NCT00650845|10462650|P2|Overall Study|Withdrawal by Subject|0
3043212|NCT00650845|10462651|P1|Overall Study|Withdrawal by Subject|5
3043213|NCT00650806|10462671|P4|Overall Study|Other|0
3043214|NCT00650806|10462672|P3|Overall Study|Other|2
3043215|NCT00650806|10462673|P2|Overall Study|Other|1
3043216|NCT00650806|10462674|P1|Overall Study|Other|1
3043217|NCT00650806|10462671|P4|Overall Study|Study terminated by sponsor|4
3043218|NCT00650806|10462672|P3|Overall Study|Study terminated by sponsor|5
3043219|NCT00650806|10462673|P2|Overall Study|Study terminated by sponsor|3
3043220|NCT00650806|10462674|P1|Overall Study|Study terminated by sponsor|2
3043221|NCT00650806|10462671|P4|Overall Study|Noncompliance with study drug regimen|0
3043222|NCT00650806|10462672|P3|Overall Study|Noncompliance with study drug regimen|0
3043223|NCT00650806|10462673|P2|Overall Study|Noncompliance with study drug regimen|1
3043224|NCT00650806|10462674|P1|Overall Study|Noncompliance with study drug regimen|1
3043225|NCT00650806|10462671|P4|Overall Study|Withdrawal by Subject|6
3043226|NCT00650806|10462672|P3|Overall Study|Withdrawal by Subject|8
3043227|NCT00650806|10462673|P2|Overall Study|Withdrawal by Subject|5
3043228|NCT00650806|10462674|P1|Overall Study|Withdrawal by Subject|7
3043229|NCT00650806|10462671|P4|Overall Study|Pregnancy|1
3043230|NCT00650806|10462672|P3|Overall Study|Pregnancy|0
3043231|NCT00650806|10462673|P2|Overall Study|Pregnancy|0
3043232|NCT00650806|10462674|P1|Overall Study|Pregnancy|0
3043233|NCT00650806|10462671|P4|Overall Study|Protocol Violation|1
3043234|NCT00650806|10462672|P3|Overall Study|Protocol Violation|0
3043235|NCT00650806|10462673|P2|Overall Study|Protocol Violation|0
3043236|NCT00650806|10462674|P1|Overall Study|Protocol Violation|0
3043237|NCT00650806|10462671|P4|Overall Study|Lost to Follow-up|10
3043238|NCT00650806|10462672|P3|Overall Study|Lost to Follow-up|11
3043239|NCT00650806|10462673|P2|Overall Study|Lost to Follow-up|6
3043240|NCT00650806|10462674|P1|Overall Study|Lost to Follow-up|7
3043241|NCT00650806|10462671|P4|Overall Study|Adverse Event|4
3043242|NCT00650806|10462672|P3|Overall Study|Adverse Event|3
3043243|NCT00650806|10462673|P2|Overall Study|Adverse Event|5
3043244|NCT00650806|10462674|P1|Overall Study|Adverse Event|0
3043245|NCT00650767|10462716|P4|Overall Study|Other|0
3043246|NCT00650767|10462717|P3|Overall Study|Other|0
3043247|NCT00650767|10462718|P2|Overall Study|Other|1
3043248|NCT00650767|10462719|P1|Overall Study|Other|1
3043249|NCT00650767|10462716|P4|Overall Study|Lost to Follow-up|0
3043250|NCT00650767|10462717|P3|Overall Study|Lost to Follow-up|1
3043251|NCT00650767|10462718|P2|Overall Study|Lost to Follow-up|1
3043252|NCT00650767|10462719|P1|Overall Study|Lost to Follow-up|1
3043253|NCT00650767|10462716|P4|Overall Study|Withdrawal by Subject|3
3043254|NCT00650767|10462717|P3|Overall Study|Withdrawal by Subject|3
3043255|NCT00650767|10462718|P2|Overall Study|Withdrawal by Subject|4
3043256|NCT00650767|10462719|P1|Overall Study|Withdrawal by Subject|2
3043257|NCT00650767|10462716|P4|Overall Study|Death|0
3043258|NCT00650767|10462717|P3|Overall Study|Death|0
3043259|NCT00650767|10462718|P2|Overall Study|Death|0
3043260|NCT00650767|10462719|P1|Overall Study|Death|1
3043261|NCT00650767|10462716|P4|Overall Study|Adverse Event|8
3043262|NCT00650767|10462717|P3|Overall Study|Adverse Event|10
3043263|NCT00650767|10462718|P2|Overall Study|Adverse Event|3
3043264|NCT00650767|10462719|P1|Overall Study|Adverse Event|0
3043265|NCT00650585|10463223|P2|Overall Study|Excluded/ruled ineligible|129
3043266|NCT00650585|10463224|P1|Overall Study|Excluded/ruled ineligible|357
3043267|NCT00650585|10463223|P2|Overall Study|No parental consent|866
3043268|NCT00650585|10463224|P1|Overall Study|No parental consent|935
3043269|NCT00650585|10463223|P2|Overall Study|Lost to Follow-up|482
3043270|NCT00650585|10463224|P1|Overall Study|Lost to Follow-up|505
3043271|NCT00650104|10463268|P1|Overall Study|Sponsor Terminated Dosing|1
3043272|NCT00650104|10463268|P1|Overall Study|Non-compliance|2
3043273|NCT00650104|10463268|P1|Overall Study|Lost to Follow-up|1
3043274|NCT00650104|10463268|P1|Overall Study|Physician Decision|7
3043275|NCT00650104|10463268|P1|Overall Study|Withdrawal by Subject|11
3043276|NCT00650104|10463268|P1|Overall Study|Death|2
3043277|NCT00650104|10463268|P1|Overall Study|Adverse Event|17
3043278|NCT00650091|10463283|P3|Amended Study Design|Other|0
3043279|NCT00650091|10463284|P2|Amended Study Design|Other|3
3043280|NCT00650091|10463285|P1|Amended Study Design|Other|1
3043281|NCT00650091|10463283|P3|Amended Study Design|Lung transplantation|0
3043282|NCT00650091|10463284|P2|Amended Study Design|Lung transplantation|2
3043283|NCT00650091|10463285|P1|Amended Study Design|Lung transplantation|4
3043284|NCT00650091|10463283|P3|Amended Study Design|Adverse Event|0
3043285|NCT00650091|10463284|P2|Amended Study Design|Adverse Event|4
3043286|NCT00650091|10463285|P1|Amended Study Design|Adverse Event|1
3043287|NCT00650091|10463283|P3|Amended Study Design|Physician Decision|0
3043288|NCT00650091|10463284|P2|Amended Study Design|Physician Decision|0
3043289|NCT00650091|10463285|P1|Amended Study Design|Physician Decision|5
3043290|NCT00650091|10463283|P3|Amended Study Design|Withdrawal by Subject|0
3043291|NCT00650091|10463284|P2|Amended Study Design|Withdrawal by Subject|11
3043292|NCT00650091|10463285|P1|Amended Study Design|Withdrawal by Subject|12
3043293|NCT00649428|10463328|P2|Overall Study|Physician Decision|1
3043294|NCT00649428|10463329|P1|Overall Study|Physician Decision|0
3043295|NCT00649428|10463328|P2|Overall Study|Protocol Violation|2
3043296|NCT00649428|10463329|P1|Overall Study|Protocol Violation|6
3043297|NCT00649428|10463328|P2|Overall Study|Insufficient manufacturing yield|1
3043298|NCT00649428|10463329|P1|Overall Study|Insufficient manufacturing yield|5
3043299|NCT00649428|10463328|P2|Overall Study|Lost to Follow-up|3
3043300|NCT00649428|10463329|P1|Overall Study|Lost to Follow-up|1
3043301|NCT00649428|10463328|P2|Overall Study|Withdrawal by Subject|6
3043302|NCT00649428|10463329|P1|Overall Study|Withdrawal by Subject|6
3043303|NCT00649428|10463328|P2|Overall Study|Adverse Event|2
3043304|NCT00649428|10463329|P1|Overall Study|Adverse Event|2
3043305|NCT00649389|10463345|P4|Overall Study|Other|6
3043306|NCT00649389|10463346|P3|Overall Study|Other|1
3043307|NCT00649389|10463347|P2|Overall Study|Other|9
3043308|NCT00649389|10463348|P1|Overall Study|Other|3
3043309|NCT00649389|10463345|P4|Overall Study|Withdrawal by Subject|23
3043310|NCT00649389|10463346|P3|Overall Study|Withdrawal by Subject|19
3043311|NCT00649389|10463347|P2|Overall Study|Withdrawal by Subject|21
3043312|NCT00649389|10463348|P1|Overall Study|Withdrawal by Subject|20
3043313|NCT00649389|10463345|P4|Overall Study|Protocol Violation|8
3043314|NCT00649389|10463346|P3|Overall Study|Protocol Violation|9
3043315|NCT00649389|10463347|P2|Overall Study|Protocol Violation|13
3043316|NCT00649389|10463348|P1|Overall Study|Protocol Violation|11
3043317|NCT00649389|10463345|P4|Overall Study|Lost to Follow-up|26
3043318|NCT00649389|10463346|P3|Overall Study|Lost to Follow-up|21
3043319|NCT00649389|10463347|P2|Overall Study|Lost to Follow-up|17
3043320|NCT00649389|10463348|P1|Overall Study|Lost to Follow-up|15
3043321|NCT00649389|10463345|P4|Overall Study|Adverse Event|48
3043322|NCT00649389|10463346|P3|Overall Study|Adverse Event|38
3043323|NCT00649389|10463347|P2|Overall Study|Adverse Event|46
3043324|NCT00649389|10463348|P1|Overall Study|Adverse Event|22
3043325|NCT00649220|10463370|P1|Overall Study|Withdrawal by Subject|1
3043326|NCT00649220|10463370|P1|Overall Study|Adverse Event|2
3043327|NCT00648895|10463391|P2|Overall Study|Lack of Efficacy|1
3043328|NCT00648895|10463392|P1|Overall Study|Lack of Efficacy|0
3043329|NCT00648739|10463398|P7|Overall Study|Follow-up Visits Not Completed|0
3043330|NCT00648739|10463399|P6|Overall Study|Follow-up Visits Not Completed|0
3043331|NCT00648739|10463400|P5|Overall Study|Follow-up Visits Not Completed|0
3043332|NCT00648739|10463401|P4|Overall Study|Follow-up Visits Not Completed|0
3043333|NCT00648739|10463402|P3|Overall Study|Follow-up Visits Not Completed|0
3043334|NCT00648739|10463403|P2|Overall Study|Follow-up Visits Not Completed|1
3043335|NCT00648739|10463404|P1|Overall Study|Follow-up Visits Not Completed|0
3043336|NCT00648739|10463398|P7|Overall Study|Positive Human Anti-human Antibody|0
3043337|NCT00648739|10463399|P6|Overall Study|Positive Human Anti-human Antibody|0
3043338|NCT00648739|10463400|P5|Overall Study|Positive Human Anti-human Antibody|0
3043339|NCT00648739|10463401|P4|Overall Study|Positive Human Anti-human Antibody|0
3043340|NCT00648739|10463402|P3|Overall Study|Positive Human Anti-human Antibody|1
3043341|NCT00648739|10463403|P2|Overall Study|Positive Human Anti-human Antibody|0
3043342|NCT00648739|10463404|P1|Overall Study|Positive Human Anti-human Antibody|0
3043343|NCT00648739|10463398|P7|Overall Study|Death|0
3043344|NCT00648739|10463399|P6|Overall Study|Death|0
3043345|NCT00648739|10463400|P5|Overall Study|Death|0
3043346|NCT00648739|10463401|P4|Overall Study|Death|0
3043347|NCT00648739|10463402|P3|Overall Study|Death|0
3043348|NCT00648739|10463403|P2|Overall Study|Death|1
3043349|NCT00648739|10463404|P1|Overall Study|Death|0
3043350|NCT00648739|10463398|P7|Overall Study|Investigator Considered it Advisable|1
3043351|NCT00648739|10463399|P6|Overall Study|Investigator Considered it Advisable|1
3043352|NCT00648739|10463400|P5|Overall Study|Investigator Considered it Advisable|0
3043353|NCT00648739|10463401|P4|Overall Study|Investigator Considered it Advisable|0
3043354|NCT00648739|10463402|P3|Overall Study|Investigator Considered it Advisable|0
3043355|NCT00648739|10463403|P2|Overall Study|Investigator Considered it Advisable|0
3043356|NCT00648739|10463404|P1|Overall Study|Investigator Considered it Advisable|0
3043357|NCT00648739|10463398|P7|Overall Study|Lack of Efficacy|0
3043358|NCT00648739|10463399|P6|Overall Study|Lack of Efficacy|2
3043359|NCT00648739|10463400|P5|Overall Study|Lack of Efficacy|1
3043360|NCT00648739|10463401|P4|Overall Study|Lack of Efficacy|0
3043361|NCT00648739|10463402|P3|Overall Study|Lack of Efficacy|0
3043362|NCT00648739|10463403|P2|Overall Study|Lack of Efficacy|0
3043363|NCT00648739|10463404|P1|Overall Study|Lack of Efficacy|0
3043364|NCT00648739|10463398|P7|Overall Study|Withdrawal by Subject|0
3043365|NCT00648739|10463399|P6|Overall Study|Withdrawal by Subject|2
3043366|NCT00648739|10463400|P5|Overall Study|Withdrawal by Subject|0
3043367|NCT00648739|10463401|P4|Overall Study|Withdrawal by Subject|0
3043368|NCT00648739|10463402|P3|Overall Study|Withdrawal by Subject|1
3043369|NCT00648739|10463403|P2|Overall Study|Withdrawal by Subject|0
3043370|NCT00648739|10463404|P1|Overall Study|Withdrawal by Subject|1
3043371|NCT00648739|10463398|P7|Overall Study|Adverse Event|0
3043372|NCT00648739|10463399|P6|Overall Study|Adverse Event|0
3043373|NCT00648739|10463400|P5|Overall Study|Adverse Event|1
3043374|NCT00648739|10463401|P4|Overall Study|Adverse Event|2
3043375|NCT00648739|10463402|P3|Overall Study|Adverse Event|1
3043376|NCT00648739|10463403|P2|Overall Study|Adverse Event|0
3043377|NCT00648739|10463404|P1|Overall Study|Adverse Event|1
3043378|NCT00648167|10463738|P1|Overall Study|unable to swallow tablets|1
3043379|NCT00648167|10463738|P1|Overall Study|Adverse Event|6
3043380|NCT00648037|10463758|P1|Overall Study|Other|1
3043381|NCT00648037|10463758|P1|Overall Study|Relapse|2
3043382|NCT00648037|10463758|P1|Overall Study|Adverse Event|11
3043383|NCT00648037|10463758|P1|Overall Study|Withdrawal by Subject|1
3043384|NCT00648037|10463758|P1|Overall Study|Not Treated|1
3043385|NCT00647699|10463777|P2|Overall Study|Withdrawal by Subject|8
3043386|NCT00647699|10463778|P1|Overall Study|Withdrawal by Subject|3
3043387|NCT00647699|10463777|P2|Overall Study|Lost to Follow-up|4
3043388|NCT00647699|10463778|P1|Overall Study|Lost to Follow-up|5
3043389|NCT00647556|10463786|P2|Overall Study|Surgery for pre-existing neck pain|0
3043390|NCT00647556|10463787|P1|Overall Study|Surgery for pre-existing neck pain|1
3043391|NCT00647556|10463786|P2|Overall Study|Withdrawal by Subject|0
3043392|NCT00647556|10463787|P1|Overall Study|Withdrawal by Subject|1
3043393|NCT00647556|10463786|P2|Overall Study|Protocol Violation|1
3043394|NCT00647556|10463787|P1|Overall Study|Protocol Violation|0
3043395|NCT00647556|10463786|P2|Overall Study|Lost to Follow-up|0
3043396|NCT00647556|10463787|P1|Overall Study|Lost to Follow-up|1
3043397|NCT00647556|10463786|P2|Overall Study|Adverse Event|1
3043398|NCT00647556|10463787|P1|Overall Study|Adverse Event|0
3043399|NCT00647426|10463801|P1|Overall Study|Withdrawal by Subject|2
3043400|NCT00647348|10463823|P2|Overall Study|Lost to Follow-up|6
3043401|NCT00647348|10463824|P1|Overall Study|Lost to Follow-up|3
3043402|NCT00647270|10463849|P3|Period 2, Placebo Switched to Adalimumab|Other|0
3043403|NCT00647270|10463850|P2|Period 2, Placebo Switched to Adalimumab|Other|6
3043404|NCT00647270|10463851|P1|Period 2, Placebo Switched to Adalimumab|Other|2
3043405|NCT00647270|10463849|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
3043406|NCT00647270|10463850|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
3043407|NCT00647270|10463851|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
3043408|NCT00647270|10463849|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
3043409|NCT00647270|10463850|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
3043410|NCT00647270|10463851|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
3043411|NCT00647270|10463849|P3|Period 1, Placebo-control (12 Weeks)|Other|8
3043412|NCT00647270|10463850|P2|Period 1, Placebo-control (12 Weeks)|Other|4
3043413|NCT00647270|10463851|P1|Period 1, Placebo-control (12 Weeks)|Other|4
3043414|NCT00647270|10463849|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
3043415|NCT00647270|10463850|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
3043416|NCT00647270|10463851|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
3043417|NCT00647270|10463849|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
3043418|NCT00647270|10463850|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
3043419|NCT00647270|10463851|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
3043420|NCT00647270|10463849|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
3043421|NCT00647270|10463850|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
3043422|NCT00647270|10463851|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
3043423|NCT00646958|10463877|P3|Overall Study|Did not receive study drug|2
3043424|NCT00646958|10463878|P2|Overall Study|Did not receive study drug|0
3043425|NCT00646958|10463879|P1|Overall Study|Did not receive study drug|2
3043426|NCT00646958|10463877|P3|Overall Study|Withdrawal by Subject|0
3043427|NCT00646958|10463878|P2|Overall Study|Withdrawal by Subject|2
3043428|NCT00646958|10463879|P1|Overall Study|Withdrawal by Subject|1
3043429|NCT00646958|10463877|P3|Overall Study|Abnormal screening lab tests|0
3043430|NCT00646958|10463878|P2|Overall Study|Abnormal screening lab tests|1
3043431|NCT00646958|10463879|P1|Overall Study|Abnormal screening lab tests|1
3043432|NCT00646958|10463877|P3|Overall Study|Protocol Violation|0
3043433|NCT00646958|10463878|P2|Overall Study|Protocol Violation|1
3043434|NCT00646958|10463879|P1|Overall Study|Protocol Violation|1
3043435|NCT00646958|10463877|P3|Overall Study|Lost to Follow-up|7
3043436|NCT00646958|10463878|P2|Overall Study|Lost to Follow-up|5
3043437|NCT00646958|10463879|P1|Overall Study|Lost to Follow-up|1
3043438|NCT00646958|10463877|P3|Overall Study|Adverse Event|0
3043439|NCT00646958|10463878|P2|Overall Study|Adverse Event|0
3043440|NCT00646958|10463879|P1|Overall Study|Adverse Event|4
3043441|NCT00646958|10463877|P3|Overall Study|Lack of Efficacy|0
3043442|NCT00646958|10463878|P2|Overall Study|Lack of Efficacy|0
3043443|NCT00646958|10463879|P1|Overall Study|Lack of Efficacy|1
3043444|NCT00646906|10463894|P7|Crossover Period 2|Physician Decision|1
3043445|NCT00646906|10463895|P6|Crossover Period 2|Physician Decision|0
3043446|NCT00646906|10463896|P5|Crossover Period 2|Physician Decision|0
3043447|NCT00646906|10463897|P4|Crossover Period 2|Physician Decision|0
3043448|NCT00646906|10463898|P3|Crossover Period 2|Physician Decision|0
3043449|NCT00646906|10463899|P2|Crossover Period 2|Physician Decision|0
3043450|NCT00646906|10463900|P1|Crossover Period 2|Physician Decision|0
3043451|NCT00646906|10463894|P7|Crossover Period 2|Withdrawal by Subject|0
3043452|NCT00646906|10463895|P6|Crossover Period 2|Withdrawal by Subject|0
3043453|NCT00646906|10463896|P5|Crossover Period 2|Withdrawal by Subject|0
3043454|NCT00646906|10463897|P4|Crossover Period 2|Withdrawal by Subject|1
3043455|NCT00646906|10463898|P3|Crossover Period 2|Withdrawal by Subject|2
3043456|NCT00646906|10463899|P2|Crossover Period 2|Withdrawal by Subject|1
3043457|NCT00646906|10463900|P1|Crossover Period 2|Withdrawal by Subject|0
3043458|NCT00646906|10463894|P7|Crossover Period 1|Withdrawal by Subject|0
3043459|NCT00646906|10463895|P6|Crossover Period 1|Withdrawal by Subject|1
3043460|NCT00646906|10463896|P5|Crossover Period 1|Withdrawal by Subject|0
3043461|NCT00646906|10463897|P4|Crossover Period 1|Withdrawal by Subject|0
3043462|NCT00646906|10463898|P3|Crossover Period 1|Withdrawal by Subject|0
3043463|NCT00646906|10463899|P2|Crossover Period 1|Withdrawal by Subject|0
3043464|NCT00646906|10463900|P1|Crossover Period 1|Withdrawal by Subject|1
3043465|NCT00646776|10463919|P2|Overall Study|Investigator discretion|4
3043466|NCT00646776|10463920|P1|Overall Study|Investigator discretion|0
3043467|NCT00646776|10463919|P2|Overall Study|Adverse Event|9
3043468|NCT00646776|10463920|P1|Overall Study|Adverse Event|1
3043469|NCT00646399|10464018|P2|Overall Study|Other Reason|11
3043470|NCT00646399|10464019|P1|Overall Study|Other Reason|11
3043471|NCT00646399|10464018|P2|Overall Study|Withdrawal by Subject|10
3043472|NCT00646399|10464019|P1|Overall Study|Withdrawal by Subject|9
3043473|NCT00646399|10464018|P2|Overall Study|Death|53
3043474|NCT00646399|10464019|P1|Overall Study|Death|63
3043475|NCT00646282|10464027|P2|Overall Study|Protocol terminated|4
3043476|NCT00646282|10464028|P1|Overall Study|Protocol terminated|4
3043477|NCT00646113|10464034|P1|Overall Study|Adverse Event|3
3043478|NCT00646113|10464034|P1|Overall Study|Lost to Follow-up|5
3043479|NCT00645944|10464055|P2|Received Medication|Protocol Violation|1
3043480|NCT00645944|10464056|P1|Received Medication|Protocol Violation|2
3043481|NCT00645944|10464055|P2|Received Medication|Lost to Follow-up|0
3043482|NCT00645944|10464056|P1|Received Medication|Lost to Follow-up|1
3043483|NCT00645944|10464055|P2|Received Medication|Withdrawal by Subject|1
3043484|NCT00645944|10464056|P1|Received Medication|Withdrawal by Subject|1
3043485|NCT00645944|10464055|P2|Received Medication|Adverse Event|1
3043486|NCT00645944|10464056|P1|Received Medication|Adverse Event|2
3043487|NCT00645944|10464055|P2|Randomized|Withdrawal by Subject|2
3043488|NCT00645944|10464056|P1|Randomized|Withdrawal by Subject|1
3043489|NCT00645853|10464064|P2|Overall Study|recall of ICF, planned operation, death|4
3043490|NCT00645853|10464065|P1|Overall Study|recall of ICF, planned operation, death|7
3043491|NCT00645853|10464064|P2|Overall Study|Discontinuation criteria|2
3043492|NCT00645853|10464065|P1|Overall Study|Discontinuation criteria|2
3043493|NCT00645853|10464064|P2|Overall Study|Protocol Violation|2
3043494|NCT00645853|10464065|P1|Overall Study|Protocol Violation|0
3043495|NCT00645853|10464064|P2|Overall Study|Withdrawal by Subject|2
3043496|NCT00645853|10464065|P1|Overall Study|Withdrawal by Subject|5
3043497|NCT00645853|10464064|P2|Overall Study|AZ study closure in Hungary|40
3043498|NCT00645853|10464065|P1|Overall Study|AZ study closure in Hungary|60
3043499|NCT00645853|10464064|P2|Overall Study|Adverse Event|7
3043500|NCT00645853|10464065|P1|Overall Study|Adverse Event|18
3043501|NCT00645840|10464083|P1|Overall Study|Protocol Violation|3
3043502|NCT00645788|10464101|P4|Overall Study|Pulmonary exacerbation|9
3043503|NCT00645788|10464102|P3|Overall Study|Pulmonary exacerbation|11
3043504|NCT00645788|10464103|P2|Overall Study|Pulmonary exacerbation|16
3043505|NCT00645788|10464104|P1|Overall Study|Pulmonary exacerbation|13
3043506|NCT00645788|10464101|P4|Overall Study|Withdrawal by Subject|2
3043507|NCT00645788|10464102|P3|Overall Study|Withdrawal by Subject|0
3043508|NCT00645788|10464103|P2|Overall Study|Withdrawal by Subject|1
3043509|NCT00645788|10464104|P1|Overall Study|Withdrawal by Subject|0
3043510|NCT00645788|10464101|P4|Overall Study|Protocol Violation|0
3043511|NCT00645788|10464102|P3|Overall Study|Protocol Violation|2
3043512|NCT00645788|10464103|P2|Overall Study|Protocol Violation|0
3043513|NCT00645788|10464104|P1|Overall Study|Protocol Violation|1
3043514|NCT00645788|10464101|P4|Overall Study|Lost to Follow-up|0
3043515|NCT00645788|10464102|P3|Overall Study|Lost to Follow-up|0
3043516|NCT00645788|10464103|P2|Overall Study|Lost to Follow-up|0
3043517|NCT00645788|10464104|P1|Overall Study|Lost to Follow-up|1
3043518|NCT00645788|10464101|P4|Overall Study|Adverse Event|3
3043519|NCT00645788|10464102|P3|Overall Study|Adverse Event|5
3043520|NCT00645788|10464103|P2|Overall Study|Adverse Event|9
3043521|NCT00645788|10464104|P1|Overall Study|Adverse Event|4
3043522|NCT00645788|10464101|P4|Overall Study|Did not receive study drug|0
3043523|NCT00645788|10464102|P3|Overall Study|Did not receive study drug|0
3043524|NCT00645788|10464103|P2|Overall Study|Did not receive study drug|1
3043525|NCT00645788|10464104|P1|Overall Study|Did not receive study drug|1
3043526|NCT00645671|10464182|P2|Overall Study|Physician Decision|1
3043527|NCT00645671|10464183|P1|Overall Study|Physician Decision|0
3043528|NCT00645671|10464182|P2|Overall Study|Adverse Event|1
3043529|NCT00645671|10464183|P1|Overall Study|Adverse Event|0
3043530|NCT00645671|10464182|P2|Overall Study|Withdrawal by Subject|4
3043531|NCT00645671|10464183|P1|Overall Study|Withdrawal by Subject|0
3043532|NCT00645671|10464182|P2|Overall Study|Protocol Violation|0
3043533|NCT00645671|10464183|P1|Overall Study|Protocol Violation|1
3043534|NCT00645593|10464197|P2|Overall Study|Later found to be ineligible|0
3043535|NCT00645593|10464198|P1|Overall Study|Later found to be ineligible|1
3043536|NCT00645567|10464210|P1|Overall Study|Adverse Event|1
3043537|NCT00645528|10464218|P1|Overall Study|Did not show up for Visit 2|7
3043538|NCT00645411|10464240|P4|Overall Study|Unable to classify|4
3043539|NCT00645411|10464241|P3|Overall Study|Unable to classify|3
3043540|NCT00645411|10464242|P2|Overall Study|Unable to classify|0
3043541|NCT00645411|10464243|P1|Overall Study|Unable to classify|0
3043542|NCT00645411|10464240|P4|Overall Study|Inappropriate enrollment|1
3043543|NCT00645411|10464241|P3|Overall Study|Inappropriate enrollment|4
3043544|NCT00645411|10464242|P2|Overall Study|Inappropriate enrollment|0
3043545|NCT00645411|10464243|P1|Overall Study|Inappropriate enrollment|0
3043546|NCT00645411|10464240|P4|Overall Study|Protocol Violation|0
3043547|NCT00645411|10464241|P3|Overall Study|Protocol Violation|1
3043548|NCT00645411|10464242|P2|Overall Study|Protocol Violation|0
3043549|NCT00645411|10464243|P1|Overall Study|Protocol Violation|1
3043550|NCT00645411|10464240|P4|Overall Study|Lost to Follow-up|75
3043551|NCT00645411|10464241|P3|Overall Study|Lost to Follow-up|124
3043552|NCT00645411|10464242|P2|Overall Study|Lost to Follow-up|5
3043553|NCT00645411|10464243|P1|Overall Study|Lost to Follow-up|10
3043554|NCT00645411|10464240|P4|Overall Study|Withdrawal by Subject|21
3043555|NCT00645411|10464241|P3|Overall Study|Withdrawal by Subject|19
3043556|NCT00645411|10464242|P2|Overall Study|Withdrawal by Subject|1
3043557|NCT00645411|10464243|P1|Overall Study|Withdrawal by Subject|2
3043558|NCT00645411|10464240|P4|Overall Study|Adverse Event|2
3043559|NCT00645411|10464241|P3|Overall Study|Adverse Event|0
3043560|NCT00645411|10464242|P2|Overall Study|Adverse Event|0
3043561|NCT00645411|10464243|P1|Overall Study|Adverse Event|0
3043562|NCT00645164|10464285|P1|Overall Study|Protocol Violation|1
3043563|NCT00645164|10464285|P1|Overall Study|Withdrawal by Subject|4
3043564|NCT00645164|10464285|P1|Overall Study|Lost to Follow-up|2
3043565|NCT00645099|10464291|P2|Overall Study|Other|5
3043566|NCT00645099|10464292|P1|Overall Study|Other|9
3043567|NCT00645099|10464291|P2|Overall Study|Adverse Event|5
3043568|NCT00645099|10464292|P1|Overall Study|Adverse Event|11
3043569|NCT00645099|10464291|P2|Overall Study|Lost to Follow-up|4
3043570|NCT00645099|10464292|P1|Overall Study|Lost to Follow-up|6
3043571|NCT00645099|10464291|P2|Overall Study|Withdrawal by Subject|22
3043572|NCT00645099|10464292|P1|Overall Study|Withdrawal by Subject|30
3043573|NCT00645099|10464291|P2|Overall Study|Lack of Efficacy|6
3043574|NCT00645099|10464292|P1|Overall Study|Lack of Efficacy|15
3043575|NCT00644995|10464361|P2|Overall Study|Refused|0
3043576|NCT00644995|10464362|P1|Overall Study|Refused|1
3043577|NCT00644995|10464361|P2|Overall Study|Lost to Follow-up|4
3043578|NCT00644995|10464362|P1|Overall Study|Lost to Follow-up|1
3043579|NCT00644969|10464382|P2|Post Treatment Phase|Other|0
3043580|NCT00644969|10464383|P1|Post Treatment Phase|Other|1
3043581|NCT00644969|10464382|P2|Post Treatment Phase|Lost to Follow-up|1
3043582|NCT00644969|10464383|P1|Post Treatment Phase|Lost to Follow-up|4
3043583|NCT00644969|10464382|P2|Post Treatment Phase|Withdrawal by Subject|2
3043584|NCT00644969|10464383|P1|Post Treatment Phase|Withdrawal by Subject|4
3043585|NCT00644969|10464382|P2|Post Treatment Phase|Death|0
3043586|NCT00644969|10464383|P1|Post Treatment Phase|Death|1
3043587|NCT00644969|10464382|P2|Treatment Phase|Other|1
3043588|NCT00644969|10464383|P1|Treatment Phase|Other|4
3043589|NCT00644969|10464382|P2|Treatment Phase|Lost to Follow-up|2
3043590|NCT00644969|10464383|P1|Treatment Phase|Lost to Follow-up|2
3043591|NCT00644969|10464382|P2|Treatment Phase|Withdrawal by Subject|0
3043592|NCT00644969|10464383|P1|Treatment Phase|Withdrawal by Subject|4
3043593|NCT00644969|10464382|P2|Treatment Phase|Adverse Event|0
3043594|NCT00644969|10464383|P1|Treatment Phase|Adverse Event|3
3043595|NCT00644969|10464382|P2|Treatment Phase|Randomized, not treated|0
3043596|NCT00644969|10464383|P1|Treatment Phase|Randomized, not treated|1
3043597|NCT00644917|10464429|P1|Overall Study|Withdrawal by Subject|2
3043598|NCT00644787|10464437|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
3043599|NCT00644787|10464438|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
3043600|NCT00644787|10464439|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
3043601|NCT00644787|10464437|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
3043602|NCT00644787|10464438|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
3043603|NCT00644787|10464439|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
3043604|NCT00644787|10464437|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
3043605|NCT00644787|10464438|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
3043606|NCT00644787|10464439|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
3043607|NCT00644787|10464437|P3|Period 2: Double Blind Phase|Adverse Event|4
3043608|NCT00644787|10464438|P2|Period 2: Double Blind Phase|Adverse Event|2
3043609|NCT00644787|10464439|P1|Period 2: Double Blind Phase|Adverse Event|0
3043610|NCT00644787|10464437|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
3043611|NCT00644787|10464438|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
3043612|NCT00644787|10464439|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
3043613|NCT00644787|10464437|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
3043614|NCT00644787|10464438|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
3043615|NCT00644787|10464439|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
3043616|NCT00644787|10464437|P3|Period 1: Titration Phase|Worsening of symptoms|0
3043617|NCT00644787|10464438|P2|Period 1: Titration Phase|Worsening of symptoms|0
3043618|NCT00644787|10464439|P1|Period 1: Titration Phase|Worsening of symptoms|1
3043619|NCT00644787|10464437|P3|Period 1: Titration Phase|Worsening of complications|0
3043620|NCT00644787|10464438|P2|Period 1: Titration Phase|Worsening of complications|0
3043621|NCT00644787|10464439|P1|Period 1: Titration Phase|Worsening of complications|1
3043622|NCT00644787|10464437|P3|Period 1: Titration Phase|Worsening of underlying disease|0
3043623|NCT00644787|10464438|P2|Period 1: Titration Phase|Worsening of underlying disease|0
3043624|NCT00644787|10464439|P1|Period 1: Titration Phase|Worsening of underlying disease|5
3043625|NCT00644787|10464437|P3|Period 1: Titration Phase|Physician Decision|0
3043626|NCT00644787|10464438|P2|Period 1: Titration Phase|Physician Decision|0
3043627|NCT00644787|10464439|P1|Period 1: Titration Phase|Physician Decision|1
3043628|NCT00644787|10464437|P3|Period 1: Titration Phase|Withdrawal by Subject|0
3043629|NCT00644787|10464438|P2|Period 1: Titration Phase|Withdrawal by Subject|0
3043630|NCT00644787|10464439|P1|Period 1: Titration Phase|Withdrawal by Subject|2
3043631|NCT00644787|10464437|P3|Period 1: Titration Phase|Adverse Event|0
3043632|NCT00644787|10464438|P2|Period 1: Titration Phase|Adverse Event|0
3043633|NCT00644787|10464439|P1|Period 1: Titration Phase|Adverse Event|11
3043634|NCT00644423|10464483|P2|Overall Study|Lost to Follow-up|1
3043635|NCT00644423|10464484|P1|Overall Study|Lost to Follow-up|1
3043636|NCT00644358|10464502|P1|Overall Study|Other Unspecified|11
3043637|NCT00644358|10464502|P1|Overall Study|Noncompliance|14
3043638|NCT00644358|10464502|P1|Overall Study|Protocol Violation|5
3043639|NCT00644358|10464502|P1|Overall Study|Lack of Effectiveness|39
3043640|NCT00644358|10464502|P1|Overall Study|Consent Withdrawal|64
3043641|NCT00644358|10464502|P1|Overall Study|Lost to Follow-up|105
3043642|NCT00644358|10464502|P1|Overall Study|Adverse Event|124
3043643|NCT00644332|10464509|P1|Overall Study|Could Not Attend Scheduled Visits|1
3043644|NCT00644332|10464509|P1|Overall Study|Did Not Meet Eligibility Requirements|1
3043645|NCT00644332|10464509|P1|Overall Study|Completion Status Unknown|2
3043646|NCT00644332|10464509|P1|Overall Study|Withdrawal by Subject|6
3043647|NCT00644332|10464509|P1|Overall Study|Adverse Event|11
3043648|NCT00644228|10464535|P2|Maintenance|On Treatment|40
3043649|NCT00644228|10464536|P1|Maintenance|On Treatment|26
3043650|NCT00644228|10464535|P2|Maintenance|Not Protocol-Specified|15
3043651|NCT00644228|10464536|P1|Maintenance|Not Protocol-Specified|14
3043652|NCT00644228|10464535|P2|Maintenance|Death|3
3043653|NCT00644228|10464536|P1|Maintenance|Death|3
3043654|NCT00644228|10464535|P2|Maintenance|Progression/Relapse|42
3043655|NCT00644228|10464536|P1|Maintenance|Progression/Relapse|67
3043656|NCT00644228|10464535|P2|Maintenance|Withdrawal by Subject|4
3043657|NCT00644228|10464536|P1|Maintenance|Withdrawal by Subject|6
3043658|NCT00644228|10464535|P2|Maintenance|Adverse Event|31
3043659|NCT00644228|10464536|P1|Maintenance|Adverse Event|27
3043660|NCT00644228|10464535|P2|Induction Therapy|Not Protocol-Specified|28
3043661|NCT00644228|10464536|P1|Induction Therapy|Not Protocol-Specified|24
3043662|NCT00644228|10464535|P2|Induction Therapy|Death|7
3043663|NCT00644228|10464536|P1|Induction Therapy|Death|3
3043664|NCT00644228|10464535|P2|Induction Therapy|Progression/Relapse|12
3043665|NCT00644228|10464536|P1|Induction Therapy|Progression/Relapse|24
3043666|NCT00644228|10464535|P2|Induction Therapy|Withdrawal by Subject|3
3043667|NCT00644228|10464536|P1|Induction Therapy|Withdrawal by Subject|10
3043668|NCT00644228|10464535|P2|Induction Therapy|Adverse Event|55
3043669|NCT00644228|10464536|P1|Induction Therapy|Adverse Event|22
3043670|NCT00644228|10464535|P2|Randomization & Eligibility|Invalid Consent|1
3043671|NCT00644228|10464536|P1|Randomization & Eligibility|Invalid Consent|0
3043672|NCT00644228|10464535|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
3043673|NCT00644228|10464536|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
3043674|NCT00644228|10464535|P2|Randomization & Eligibility|Ineligible|21
3043675|NCT00644228|10464536|P1|Randomization & Eligibility|Ineligible|31
3043676|NCT00644059|10464565|P3|Overall Study|Unable to classify|3
3043677|NCT00644059|10464566|P2|Overall Study|Unable to classify|2
3043678|NCT00644059|10464567|P1|Overall Study|Unable to classify|6
3043679|NCT00644059|10464565|P3|Overall Study|Protocol Deviation/violation|15
3043680|NCT00644059|10464566|P2|Overall Study|Protocol Deviation/violation|19
3043681|NCT00644059|10464567|P1|Overall Study|Protocol Deviation/violation|20
3043682|NCT00644059|10464565|P3|Overall Study|Inappropriate Enrollment|0
3043683|NCT00644059|10464566|P2|Overall Study|Inappropriate Enrollment|3
3043684|NCT00644059|10464567|P1|Overall Study|Inappropriate Enrollment|1
3043685|NCT00644059|10464565|P3|Overall Study|Adverse Event|1
3043686|NCT00644059|10464566|P2|Overall Study|Adverse Event|5
3043687|NCT00644059|10464567|P1|Overall Study|Adverse Event|8
3043688|NCT00644059|10464565|P3|Overall Study|Withdrawal by Subject|30
3043689|NCT00644059|10464566|P2|Overall Study|Withdrawal by Subject|60
3043690|NCT00644059|10464567|P1|Overall Study|Withdrawal by Subject|52
3043691|NCT00644059|10464565|P3|Overall Study|Lost to Follow-up|16
3043692|NCT00644059|10464566|P2|Overall Study|Lost to Follow-up|34
3043693|NCT00644059|10464567|P1|Overall Study|Lost to Follow-up|37
3043694|NCT00643916|10464657|P6|Overall Study|Not Vaccinated|0
3043695|NCT00643916|10464658|P5|Overall Study|Not Vaccinated|2
3043696|NCT00643916|10464659|P4|Overall Study|Not Vaccinated|0
3043697|NCT00643916|10464660|P3|Overall Study|Not Vaccinated|3
3043698|NCT00643916|10464661|P2|Overall Study|Not Vaccinated|2
3043699|NCT00643916|10464662|P1|Overall Study|Not Vaccinated|2
3043700|NCT00643916|10464657|P6|Overall Study|Withdrawal by Subject|1
3043701|NCT00643916|10464658|P5|Overall Study|Withdrawal by Subject|0
3043702|NCT00643916|10464659|P4|Overall Study|Withdrawal by Subject|1
3043703|NCT00643916|10464660|P3|Overall Study|Withdrawal by Subject|2
3043704|NCT00643916|10464661|P2|Overall Study|Withdrawal by Subject|2
3043705|NCT00643916|10464662|P1|Overall Study|Withdrawal by Subject|2
3043706|NCT00643916|10464657|P6|Overall Study|Lost to Follow-up|0
3043707|NCT00643916|10464658|P5|Overall Study|Lost to Follow-up|0
3043708|NCT00643916|10464659|P4|Overall Study|Lost to Follow-up|0
3043709|NCT00643916|10464660|P3|Overall Study|Lost to Follow-up|0
3043710|NCT00643916|10464661|P2|Overall Study|Lost to Follow-up|1
3043711|NCT00643916|10464662|P1|Overall Study|Lost to Follow-up|0
3043712|NCT00643916|10464657|P6|Overall Study|Protocol Violation|0
3043713|NCT00643916|10464658|P5|Overall Study|Protocol Violation|0
3043714|NCT00643916|10464659|P4|Overall Study|Protocol Violation|1
3043715|NCT00643916|10464660|P3|Overall Study|Protocol Violation|1
3043716|NCT00643916|10464661|P2|Overall Study|Protocol Violation|1
3043717|NCT00643916|10464662|P1|Overall Study|Protocol Violation|0
3043718|NCT00643851|10464691|P3|Overall Study|Non-compl., not met criteria, etc.|6
3043719|NCT00643851|10464692|P2|Overall Study|Non-compl., not met criteria, etc.|4
3043720|NCT00643851|10464693|P1|Overall Study|Non-compl., not met criteria, etc.|3
3043721|NCT00643851|10464691|P3|Overall Study|Withdrawal by Subject|9
3043722|NCT00643851|10464692|P2|Overall Study|Withdrawal by Subject|15
3043723|NCT00643851|10464693|P1|Overall Study|Withdrawal by Subject|8
3043724|NCT00643851|10464691|P3|Overall Study|Lost to Follow-up|9
3043725|NCT00643851|10464692|P2|Overall Study|Lost to Follow-up|6
3043726|NCT00643851|10464693|P1|Overall Study|Lost to Follow-up|4
3043727|NCT00643851|10464691|P3|Overall Study|Adverse Event|6
3043728|NCT00643851|10464692|P2|Overall Study|Adverse Event|6
3043729|NCT00643851|10464693|P1|Overall Study|Adverse Event|2
3043730|NCT00643851|10464691|P3|Overall Study|Lack of Efficacy|0
3043731|NCT00643851|10464692|P2|Overall Study|Lack of Efficacy|1
3043732|NCT00643851|10464693|P1|Overall Study|Lack of Efficacy|0
3043733|NCT00643851|10464691|P3|Overall Study|Death|0
3043734|NCT00643851|10464692|P2|Overall Study|Death|1
3043735|NCT00643851|10464693|P1|Overall Study|Death|0
3043736|NCT00643760|10464721|P5|Overall Study|Withdrawal by Subject|1
3043737|NCT00643760|10464722|P4|Overall Study|Withdrawal by Subject|4
3043738|NCT00643760|10464723|P3|Overall Study|Withdrawal by Subject|2
3043739|NCT00643760|10464724|P2|Overall Study|Withdrawal by Subject|1
3043740|NCT00643760|10464725|P1|Overall Study|Withdrawal by Subject|3
3043741|NCT00643760|10464721|P5|Overall Study|Investigator Discretion|0
3043742|NCT00643760|10464722|P4|Overall Study|Investigator Discretion|2
3043743|NCT00643760|10464723|P3|Overall Study|Investigator Discretion|0
3043744|NCT00643760|10464724|P2|Overall Study|Investigator Discretion|0
3043745|NCT00643760|10464725|P1|Overall Study|Investigator Discretion|0
3043746|NCT00643760|10464721|P5|Overall Study|Lost to Follow-up|3
3043747|NCT00643760|10464722|P4|Overall Study|Lost to Follow-up|3
3043748|NCT00643760|10464723|P3|Overall Study|Lost to Follow-up|1
3043749|NCT00643760|10464724|P2|Overall Study|Lost to Follow-up|2
3043750|NCT00643760|10464725|P1|Overall Study|Lost to Follow-up|6
3043751|NCT00643760|10464721|P5|Overall Study|Protocol Violation|6
3043752|NCT00643760|10464722|P4|Overall Study|Protocol Violation|4
3043753|NCT00643760|10464723|P3|Overall Study|Protocol Violation|4
3043754|NCT00643760|10464724|P2|Overall Study|Protocol Violation|6
3043755|NCT00643760|10464725|P1|Overall Study|Protocol Violation|7
3043756|NCT00643760|10464721|P5|Overall Study|Lack of Efficacy|3
3043757|NCT00643760|10464722|P4|Overall Study|Lack of Efficacy|4
3043758|NCT00643760|10464723|P3|Overall Study|Lack of Efficacy|0
3043759|NCT00643760|10464724|P2|Overall Study|Lack of Efficacy|1
3043760|NCT00643760|10464725|P1|Overall Study|Lack of Efficacy|3
3043761|NCT00643760|10464721|P5|Overall Study|Adverse Event|6
3043762|NCT00643760|10464722|P4|Overall Study|Adverse Event|21
3043763|NCT00643760|10464723|P3|Overall Study|Adverse Event|12
3043764|NCT00643760|10464724|P2|Overall Study|Adverse Event|5
3043765|NCT00643760|10464725|P1|Overall Study|Adverse Event|11
3043766|NCT00643682|10464829|P2|Overall Study|did not keep appointment|509
3043767|NCT00643682|10464830|P1|Overall Study|did not keep appointment|522
3043768|NCT00643604|10464842|P1|Overall Study|Death|1
3043769|NCT00643565|10464870|P2|Overall Study|Adverse Event|8
3043770|NCT00643565|10464871|P1|Overall Study|Adverse Event|5
3043771|NCT00643565|10464870|P2|Overall Study|Administrative|16
3043772|NCT00643565|10464871|P1|Overall Study|Administrative|22
3043773|NCT00643565|10464870|P2|Overall Study|Did Not Cooperate|1
3043774|NCT00643565|10464871|P1|Overall Study|Did Not Cooperate|0
3043775|NCT00643565|10464870|P2|Overall Study|Protocol Violation|0
3043776|NCT00643565|10464871|P1|Overall Study|Protocol Violation|3
3043777|NCT00643565|10464870|P2|Overall Study|Progression of Disease|14
3043778|NCT00643565|10464871|P1|Overall Study|Progression of Disease|18
3043779|NCT00643565|10464870|P2|Overall Study|Recurrence of Disease|1
3043780|NCT00643565|10464871|P1|Overall Study|Recurrence of Disease|2
3043781|NCT00643565|10464870|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
3043782|NCT00643565|10464871|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
3043783|NCT00643565|10464870|P2|Overall Study|Other|8
3043784|NCT00643565|10464871|P1|Overall Study|Other|7
3043785|NCT00643565|10464870|P2|Overall Study|Lost to Follow-up|6
3043786|NCT00643565|10464871|P1|Overall Study|Lost to Follow-up|0
3043787|NCT00643565|10464870|P2|Overall Study|Withdrawal by Subject|1
3043788|NCT00643565|10464871|P1|Overall Study|Withdrawal by Subject|4
3043789|NCT00643565|10464870|P2|Overall Study|Death|11
3043790|NCT00643565|10464871|P1|Overall Study|Death|12
3043791|NCT00643487|10464893|P1|Overall Study|Technical difficulty|3
3043792|NCT00643448|10464900|P3|Overall Study|QTcF>550 ms|0
3043793|NCT00643448|10464901|P2|Overall Study|QTcF>550 ms|3
3043794|NCT00643448|10464902|P1|Overall Study|QTcF>550 ms|0
3043795|NCT00643448|10464900|P3|Overall Study|Adverse Event|2
3043796|NCT00643448|10464901|P2|Overall Study|Adverse Event|2
3043797|NCT00643448|10464902|P1|Overall Study|Adverse Event|2
3043798|NCT00643448|10464900|P3|Overall Study|Lack of Efficacy|4
3043799|NCT00643448|10464901|P2|Overall Study|Lack of Efficacy|0
3043800|NCT00643448|10464902|P1|Overall Study|Lack of Efficacy|2
3043801|NCT00643279|10464919|P2|Overall Study|Physician Decision|1
3043802|NCT00643279|10464920|P1|Overall Study|Physician Decision|0
3043803|NCT00643279|10464919|P2|Overall Study|Lost to Follow-up|1
3043804|NCT00643279|10464920|P1|Overall Study|Lost to Follow-up|0
3043805|NCT00643279|10464919|P2|Overall Study|Withdrawal by Subject|0
3043806|NCT00643279|10464920|P1|Overall Study|Withdrawal by Subject|3
3043807|NCT00643279|10464919|P2|Overall Study|Death|11
3043808|NCT00643279|10464920|P1|Overall Study|Death|13
3043809|NCT00643201|10464942|P2|Completed Study Follow Up|non-specified|0
3043810|NCT00643201|10464943|P1|Completed Study Follow Up|non-specified|1
3043811|NCT00643201|10464942|P2|Completed Study Follow Up|Lost to Follow-up|16
3043812|NCT00643201|10464943|P1|Completed Study Follow Up|Lost to Follow-up|18
3043813|NCT00643201|10464942|P2|Completed Study Follow Up|Withdrawal by Subject|29
3043814|NCT00643201|10464943|P1|Completed Study Follow Up|Withdrawal by Subject|23
3043815|NCT00643201|10464942|P2|Completed Study Follow Up|Death|34
3043816|NCT00643201|10464943|P1|Completed Study Follow Up|Death|28
3043817|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Other|107
3043818|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Other|107
3043819|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
3043820|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
3043821|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
3043822|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
3043823|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
3043824|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
3043825|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
3043826|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
3043827|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
3043828|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
3043829|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
3043830|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
3043831|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
3043832|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
3043833|NCT00643201|10464942|P2|Randomized, Completed 6 Months of Study|Death|26
3043834|NCT00643201|10464943|P1|Randomized, Completed 6 Months of Study|Death|20
3043835|NCT00643162|10464991|P2|Overall Study|Withdrawal by Subject|1
3043836|NCT00643162|10464992|P1|Overall Study|Withdrawal by Subject|1
3043837|NCT00643123|10465004|P2|Overall Study|Withdrawal by Subject|1
3043838|NCT00643123|10465005|P1|Overall Study|Withdrawal by Subject|1
3043839|NCT00643123|10465004|P2|Overall Study|Lost to Follow-up|0
3043840|NCT00643123|10465005|P1|Overall Study|Lost to Follow-up|4
3043841|NCT00643006|10465037|P2|Overall Study|Lost to Follow-up|4
3043842|NCT00643006|10465038|P1|Overall Study|Lost to Follow-up|5
3043843|NCT00642993|10465048|P2|Overall Study|Administrative|0
3043844|NCT00642993|10465049|P1|Overall Study|Administrative|1
3043845|NCT00642993|10465048|P2|Overall Study|Did not meet protocol eligibility|1
3043846|NCT00642993|10465049|P1|Overall Study|Did not meet protocol eligibility|0
3043847|NCT00642993|10465048|P2|Overall Study|Protocol Violation|4
3043848|NCT00642993|10465049|P1|Overall Study|Protocol Violation|1
3043849|NCT00642993|10465048|P2|Overall Study|Withdrew - reason unrelated to treatment|3
3043850|NCT00642993|10465049|P1|Overall Study|Withdrew - reason unrelated to treatment|11
3043851|NCT00642993|10465048|P2|Overall Study|Lost to Follow-up|4
3043852|NCT00642993|10465049|P1|Overall Study|Lost to Follow-up|8
3043853|NCT00642993|10465048|P2|Overall Study|Adverse Event|4
3043854|NCT00642993|10465049|P1|Overall Study|Adverse Event|85
3043855|NCT00642902|10465067|P4|Overall Study|Other|4
3043856|NCT00642902|10465068|P3|Overall Study|Other|1
3043857|NCT00642902|10465069|P2|Overall Study|Other|5
3043858|NCT00642902|10465070|P1|Overall Study|Other|1
3043859|NCT00642902|10465067|P4|Overall Study|Randomized, but not treated|0
3043860|NCT00642902|10465068|P3|Overall Study|Randomized, but not treated|1
3043861|NCT00642902|10465069|P2|Overall Study|Randomized, but not treated|0
3043862|NCT00642902|10465070|P1|Overall Study|Randomized, but not treated|0
3043863|NCT00642902|10465067|P4|Overall Study|Premature termination of clinical trial|35
3043864|NCT00642902|10465068|P3|Overall Study|Premature termination of clinical trial|35
3043865|NCT00642902|10465069|P2|Overall Study|Premature termination of clinical trial|32
3043866|NCT00642902|10465070|P1|Overall Study|Premature termination of clinical trial|37
3043867|NCT00642902|10465067|P4|Overall Study|Death|0
3043868|NCT00642902|10465068|P3|Overall Study|Death|0
3043869|NCT00642902|10465069|P2|Overall Study|Death|0
3043870|NCT00642902|10465070|P1|Overall Study|Death|1
3043871|NCT00642902|10465067|P4|Overall Study|Lack of Efficacy|0
3043872|NCT00642902|10465068|P3|Overall Study|Lack of Efficacy|3
3043873|NCT00642902|10465069|P2|Overall Study|Lack of Efficacy|3
3043874|NCT00642902|10465070|P1|Overall Study|Lack of Efficacy|0
3043875|NCT00642902|10465067|P4|Overall Study|Lost to Follow-up|0
3043876|NCT00642902|10465068|P3|Overall Study|Lost to Follow-up|0
3043877|NCT00642902|10465069|P2|Overall Study|Lost to Follow-up|1
3043878|NCT00642902|10465070|P1|Overall Study|Lost to Follow-up|1
3043879|NCT00642902|10465067|P4|Overall Study|Adverse Event|1
3043880|NCT00642902|10465068|P3|Overall Study|Adverse Event|3
3043881|NCT00642902|10465069|P2|Overall Study|Adverse Event|1
3043882|NCT00642902|10465070|P1|Overall Study|Adverse Event|0
3043883|NCT00642850|10465092|P1|Overall Study|Other reasons|7
3043884|NCT00642850|10465092|P1|Overall Study|Blood transfusion|6
3043885|NCT00642850|10465092|P1|Overall Study|Kidney transplantation|8
3043886|NCT00642850|10465092|P1|Overall Study|Protocol Violation|2
3043887|NCT00642850|10465092|P1|Overall Study|Lack of Efficacy|1
3043888|NCT00642850|10465092|P1|Overall Study|Adverse Event|2
3043889|NCT00642850|10465092|P1|Overall Study|Death|7
3043890|NCT00642811|10465108|P6|Overall Study|Other|0
3043891|NCT00642811|10465109|P5|Overall Study|Other|0
3043892|NCT00642811|10465110|P4|Overall Study|Other|1
3043893|NCT00642811|10465111|P3|Overall Study|Other|0
3043894|NCT00642811|10465112|P2|Overall Study|Other|1
3043895|NCT00642811|10465113|P1|Overall Study|Other|0
3043896|NCT00642811|10465108|P6|Overall Study|Severe Non-compliance to protocol|0
3043897|NCT00642811|10465109|P5|Overall Study|Severe Non-compliance to protocol|0
3043898|NCT00642811|10465110|P4|Overall Study|Severe Non-compliance to protocol|0
3043899|NCT00642811|10465111|P3|Overall Study|Severe Non-compliance to protocol|0
3043900|NCT00642811|10465112|P2|Overall Study|Severe Non-compliance to protocol|0
3043901|NCT00642811|10465113|P1|Overall Study|Severe Non-compliance to protocol|1
3043902|NCT00642811|10465108|P6|Overall Study|Developement of discontinuation criteria|0
3043903|NCT00642811|10465109|P5|Overall Study|Developement of discontinuation criteria|1
3043904|NCT00642811|10465110|P4|Overall Study|Developement of discontinuation criteria|0
3043905|NCT00642811|10465111|P3|Overall Study|Developement of discontinuation criteria|0
3043906|NCT00642811|10465112|P2|Overall Study|Developement of discontinuation criteria|0
3043907|NCT00642811|10465113|P1|Overall Study|Developement of discontinuation criteria|0
3043908|NCT00642811|10465108|P6|Overall Study|Adverse Event|1
3043909|NCT00642811|10465109|P5|Overall Study|Adverse Event|0
3043910|NCT00642811|10465110|P4|Overall Study|Adverse Event|0
3043911|NCT00642811|10465111|P3|Overall Study|Adverse Event|0
3043912|NCT00642811|10465112|P2|Overall Study|Adverse Event|3
3043913|NCT00642811|10465113|P1|Overall Study|Adverse Event|2
3043914|NCT00642772|10465135|P1|Overall Study|Withdrawal by Subject|7
3043915|NCT00642772|10465135|P1|Overall Study|Lost to Follow-up|3
3043916|NCT00642759|10465139|P1|Overall Study|Protocol Violation|1
3043917|NCT00642746|10465148|P2|Overall Study|Patient unevaluable|0
3043918|NCT00642746|10465149|P1|Overall Study|Patient unevaluable|1
3043919|NCT00642707|10465163|P4|Overall Study|Withdrawal by Subject|0
3043920|NCT00642707|10465164|P3|Overall Study|Withdrawal by Subject|0
3043921|NCT00642707|10465165|P2|Overall Study|Withdrawal by Subject|0
3043922|NCT00642707|10465166|P1|Overall Study|Withdrawal by Subject|1
3043923|NCT00642707|10465163|P4|Overall Study|Adverse Event|2
3043924|NCT00642707|10465164|P3|Overall Study|Adverse Event|0
3043925|NCT00642707|10465165|P2|Overall Study|Adverse Event|0
3043926|NCT00642707|10465166|P1|Overall Study|Adverse Event|0
3043927|NCT00642668|10465201|P1|Overall Study|Blood Transfusion|2
3043928|NCT00642668|10465201|P1|Overall Study|Dialysis Initiation|5
3043929|NCT00642668|10465201|P1|Overall Study|Failure to Return|1
3043930|NCT00642668|10465201|P1|Overall Study|Insufficient Therapeutic Response|1
3043931|NCT00642668|10465201|P1|Overall Study|Death|2
3043932|NCT00642668|10465201|P1|Overall Study|Adverse Event|2
3043933|NCT00642668|10465201|P1|Overall Study|Lost to Follow-up|1
3043934|NCT00642642|10465209|P1|Treatment & Follow Up|Lost to Follow-up|10
3043935|NCT00642642|10465209|P1|Treatment & Follow Up|Withdrawal by Subject|5
3043936|NCT00642642|10465209|P1|Treatment & Follow Up|Adverse Event|2
3043937|NCT00642616|10465226|P4|Overall Study|Physician Decision|1
3043938|NCT00642616|10465227|P3|Overall Study|Physician Decision|1
3043939|NCT00642616|10465228|P2|Overall Study|Physician Decision|0
3043940|NCT00642616|10465229|P1|Overall Study|Physician Decision|0
3043941|NCT00642616|10465226|P4|Overall Study|Protocol Violation|0
3043942|NCT00642616|10465227|P3|Overall Study|Protocol Violation|2
3043943|NCT00642616|10465228|P2|Overall Study|Protocol Violation|0
3043944|NCT00642616|10465229|P1|Overall Study|Protocol Violation|0
3043945|NCT00642616|10465226|P4|Overall Study|Withdrawal by Subject|1
3043946|NCT00642616|10465227|P3|Overall Study|Withdrawal by Subject|1
3043947|NCT00642616|10465228|P2|Overall Study|Withdrawal by Subject|1
3043948|NCT00642616|10465229|P1|Overall Study|Withdrawal by Subject|0
3043949|NCT00642616|10465226|P4|Overall Study|Study Terminated by Sponsor|5
3043950|NCT00642616|10465227|P3|Overall Study|Study Terminated by Sponsor|4
3043951|NCT00642616|10465228|P2|Overall Study|Study Terminated by Sponsor|6
3043952|NCT00642616|10465229|P1|Overall Study|Study Terminated by Sponsor|7
3043953|NCT00642616|10465226|P4|Overall Study|Adverse Event|0
3043954|NCT00642616|10465227|P3|Overall Study|Adverse Event|1
3043955|NCT00642616|10465228|P2|Overall Study|Adverse Event|0
3043956|NCT00642616|10465229|P1|Overall Study|Adverse Event|2
3043957|NCT00642473|10465262|P2|Overall Study|Other|2
3043958|NCT00642473|10465263|P1|Overall Study|Other|2
3043959|NCT00642473|10465262|P2|Overall Study|Progression or death|4
3043960|NCT00642473|10465263|P1|Overall Study|Progression or death|2
3043961|NCT00642473|10465262|P2|Overall Study|Withdrawal by Subject|5
3043962|NCT00642473|10465263|P1|Overall Study|Withdrawal by Subject|0
3043963|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
3043964|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
3043965|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
3043966|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
3043967|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
3043968|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
3043969|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
3043970|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
3043971|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
3043972|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
3043973|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
3043974|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
3043975|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Death|3
3043976|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Death|0
3043977|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Death|0
3043978|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Death|0
3043979|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Death|0
3043980|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Death|0
3043981|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Other|2
3043982|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Other|2
3043983|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Other|0
3043984|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Other|0
3043985|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Other|0
3043986|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Other|0
3043987|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
3043988|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
3043989|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
3043990|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
3043991|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
3043992|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
3043993|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
3043994|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
3043995|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
3043996|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
3043997|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
3043998|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
3043999|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
3044000|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
3044001|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
3044002|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
3044003|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
3044004|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
3044005|NCT00642460|10465277|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
3044006|NCT00642460|10465278|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
3044007|NCT00642460|10465279|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
3044008|NCT00642460|10465280|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
3044009|NCT00642460|10465281|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
3044010|NCT00642460|10465282|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
3044011|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
3044012|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
3044013|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
3044014|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
3044015|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
3044016|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
3044017|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Failure to return|0
3044018|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Failure to return|0
3044019|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Failure to return|0
3044020|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Failure to return|0
3044021|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Failure to return|1
3044022|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Failure to return|0
3044023|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
3044024|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
3044025|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
3044026|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
3044027|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
3044028|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
3044029|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
3044030|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
3044031|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
3044032|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
3044033|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
3044034|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
3044035|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Death|0
3044036|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Death|0
3044037|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Death|2
3044038|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Death|0
3044039|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Death|1
3044040|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Death|0
3044041|NCT00642460|10465277|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
3044042|NCT00642460|10465278|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
3044043|NCT00642460|10465279|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
3044044|NCT00642460|10465280|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
3044045|NCT00642460|10465281|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
3044046|NCT00642460|10465282|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
3044047|NCT00642460|10465277|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
3044048|NCT00642460|10465278|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
3044049|NCT00642460|10465279|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
3044050|NCT00642460|10465280|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
3044051|NCT00642460|10465281|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
3044052|NCT00642460|10465282|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
3044053|NCT00642460|10465277|P6|Part I: 12 Week Double-Blind|Adverse Event|0
3044054|NCT00642460|10465278|P5|Part I: 12 Week Double-Blind|Adverse Event|0
3044055|NCT00642460|10465279|P4|Part I: 12 Week Double-Blind|Adverse Event|0
3044056|NCT00642460|10465280|P3|Part I: 12 Week Double-Blind|Adverse Event|1
3044057|NCT00642460|10465281|P2|Part I: 12 Week Double-Blind|Adverse Event|1
3044058|NCT00642460|10465282|P1|Part I: 12 Week Double-Blind|Adverse Event|0
3044059|NCT00642369|10465357|P2|Overall Study|Lack of Efficacy|2
3044060|NCT00642369|10465358|P1|Overall Study|Lack of Efficacy|2
3044061|NCT00642369|10465357|P2|Overall Study|misdiagnosis|1
3044062|NCT00642369|10465358|P1|Overall Study|misdiagnosis|0
3044063|NCT00642369|10465357|P2|Overall Study|Withdrawal by Subject|0
3044064|NCT00642369|10465358|P1|Overall Study|Withdrawal by Subject|1
3044065|NCT00642369|10465357|P2|Overall Study|Adverse Event|3
3044066|NCT00642369|10465358|P1|Overall Study|Adverse Event|2
3044067|NCT00642356|10465368|P2|Overall Study|Lack of Efficacy|0
3044068|NCT00642356|10465369|P1|Overall Study|Lack of Efficacy|1
3044069|NCT00642356|10465368|P2|Overall Study|Protocol Violation|3
3044070|NCT00642356|10465369|P1|Overall Study|Protocol Violation|0
3044071|NCT00642356|10465368|P2|Overall Study|Adverse Event|0
3044072|NCT00642356|10465369|P1|Overall Study|Adverse Event|1
3044073|NCT00642304|10465377|P1|Overall Study|Transplantation|1
3044074|NCT00642304|10465377|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
3044075|NCT00642304|10465377|P1|Overall Study|Blood transfusion|2
3044076|NCT00642304|10465377|P1|Overall Study|Death|1
3044077|NCT00642304|10465377|P1|Overall Study|Adverse Event|1
3044078|NCT00642278|10465393|P7|Overall Study|Other|0
3044079|NCT00642278|10465394|P6|Overall Study|Other|1
3044080|NCT00642278|10465395|P5|Overall Study|Other|0
3044081|NCT00642278|10465396|P4|Overall Study|Other|1
3044082|NCT00642278|10465397|P3|Overall Study|Other|0
3044083|NCT00642278|10465398|P2|Overall Study|Other|1
3044084|NCT00642278|10465399|P1|Overall Study|Other|2
3044085|NCT00642278|10465393|P7|Overall Study|Noncompliance with study drug regimen|0
3044086|NCT00642278|10465394|P6|Overall Study|Noncompliance with study drug regimen|0
3044087|NCT00642278|10465395|P5|Overall Study|Noncompliance with study drug regimen|0
3044088|NCT00642278|10465396|P4|Overall Study|Noncompliance with study drug regimen|1
3044089|NCT00642278|10465397|P3|Overall Study|Noncompliance with study drug regimen|0
3044090|NCT00642278|10465398|P2|Overall Study|Noncompliance with study drug regimen|0
3044091|NCT00642278|10465399|P1|Overall Study|Noncompliance with study drug regimen|0
3044092|NCT00642278|10465393|P7|Overall Study|Withdrawal by Subject|2
3044093|NCT00642278|10465394|P6|Overall Study|Withdrawal by Subject|2
3044094|NCT00642278|10465395|P5|Overall Study|Withdrawal by Subject|6
3044095|NCT00642278|10465396|P4|Overall Study|Withdrawal by Subject|3
3044096|NCT00642278|10465397|P3|Overall Study|Withdrawal by Subject|1
3044097|NCT00642278|10465398|P2|Overall Study|Withdrawal by Subject|1
3044098|NCT00642278|10465399|P1|Overall Study|Withdrawal by Subject|1
3044099|NCT00642278|10465393|P7|Overall Study|Protocol Violation|2
3044100|NCT00642278|10465394|P6|Overall Study|Protocol Violation|1
3044101|NCT00642278|10465395|P5|Overall Study|Protocol Violation|0
3044102|NCT00642278|10465396|P4|Overall Study|Protocol Violation|1
3044103|NCT00642278|10465397|P3|Overall Study|Protocol Violation|1
3044104|NCT00642278|10465398|P2|Overall Study|Protocol Violation|0
3044105|NCT00642278|10465399|P1|Overall Study|Protocol Violation|0
3044106|NCT00642278|10465393|P7|Overall Study|Physician Decision|0
3044107|NCT00642278|10465394|P6|Overall Study|Physician Decision|0
3044108|NCT00642278|10465395|P5|Overall Study|Physician Decision|0
3044109|NCT00642278|10465396|P4|Overall Study|Physician Decision|1
3044110|NCT00642278|10465397|P3|Overall Study|Physician Decision|0
3044111|NCT00642278|10465398|P2|Overall Study|Physician Decision|0
3044112|NCT00642278|10465399|P1|Overall Study|Physician Decision|0
3044113|NCT00642278|10465393|P7|Overall Study|Lost to Follow-up|1
3044114|NCT00642278|10465394|P6|Overall Study|Lost to Follow-up|1
3044115|NCT00642278|10465395|P5|Overall Study|Lost to Follow-up|0
3044116|NCT00642278|10465396|P4|Overall Study|Lost to Follow-up|1
3044117|NCT00642278|10465397|P3|Overall Study|Lost to Follow-up|0
3044118|NCT00642278|10465398|P2|Overall Study|Lost to Follow-up|1
3044119|NCT00642278|10465399|P1|Overall Study|Lost to Follow-up|5
3044120|NCT00642278|10465393|P7|Overall Study|Lack of Efficacy|0
3044121|NCT00642278|10465394|P6|Overall Study|Lack of Efficacy|0
3044122|NCT00642278|10465395|P5|Overall Study|Lack of Efficacy|0
3044123|NCT00642278|10465396|P4|Overall Study|Lack of Efficacy|0
3044124|NCT00642278|10465397|P3|Overall Study|Lack of Efficacy|0
3044125|NCT00642278|10465398|P2|Overall Study|Lack of Efficacy|1
3044126|NCT00642278|10465399|P1|Overall Study|Lack of Efficacy|0
3044127|NCT00642278|10465393|P7|Overall Study|Adverse Event|0
3044128|NCT00642278|10465394|P6|Overall Study|Adverse Event|2
3044129|NCT00642278|10465395|P5|Overall Study|Adverse Event|2
3044130|NCT00642278|10465396|P4|Overall Study|Adverse Event|1
3044131|NCT00642278|10465397|P3|Overall Study|Adverse Event|3
3044132|NCT00642278|10465398|P2|Overall Study|Adverse Event|1
3044133|NCT00642278|10465399|P1|Overall Study|Adverse Event|2
3044134|NCT00642174|10465452|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
3044135|NCT00642174|10465453|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
3044136|NCT00642018|10465469|P2|Overall Study|Entry Criteria Not Met|1
3044137|NCT00642018|10465470|P1|Overall Study|Entry Criteria Not Met|0
3044138|NCT00642018|10465469|P2|Overall Study|Death|3
3044139|NCT00642018|10465470|P1|Overall Study|Death|0
3044140|NCT00642018|10465469|P2|Overall Study|Protocol Violation|1
3044141|NCT00642018|10465470|P1|Overall Study|Protocol Violation|0
3044142|NCT00642018|10465469|P2|Overall Study|Physician Decision|10
3044143|NCT00642018|10465470|P1|Overall Study|Physician Decision|0
3044144|NCT00642018|10465469|P2|Overall Study|Progressive Disease|18
3044145|NCT00642018|10465470|P1|Overall Study|Progressive Disease|13
3044146|NCT00642018|10465469|P2|Overall Study|Withdrawal by Subject|10
3044147|NCT00642018|10465470|P1|Overall Study|Withdrawal by Subject|4
3044148|NCT00642018|10465469|P2|Overall Study|Adverse Event|36
3044149|NCT00642018|10465470|P1|Overall Study|Adverse Event|11
3044150|NCT00641719|10465537|P2|Overall Study|Reason Not Specified|2
3044151|NCT00641719|10465538|P1|Overall Study|Reason Not Specified|1
3044152|NCT00641719|10465537|P2|Overall Study|Withdrawal by Subject|4
3044153|NCT00641719|10465538|P1|Overall Study|Withdrawal by Subject|4
3044154|NCT00641719|10465537|P2|Overall Study|Adverse Event|29
3044155|NCT00641719|10465538|P1|Overall Study|Adverse Event|24
3044156|NCT00641719|10465537|P2|Overall Study|Lack of Efficacy|2
3044157|NCT00641719|10465538|P1|Overall Study|Lack of Efficacy|1
3044158|NCT00641706|10465562|P2|Overall Study|Lead Investigator Decision|1
3044159|NCT00641706|10465563|P1|Overall Study|Lead Investigator Decision|0
3044160|NCT00641706|10465562|P2|Overall Study|Clinical Decline|0
3044161|NCT00641706|10465563|P1|Overall Study|Clinical Decline|1
3044162|NCT00641706|10465562|P2|Overall Study|Withdrawal by Subject|1
3044163|NCT00641706|10465563|P1|Overall Study|Withdrawal by Subject|6
3044164|NCT00641706|10465562|P2|Overall Study|Adverse Event|1
3044165|NCT00641706|10465563|P1|Overall Study|Adverse Event|2
3044166|NCT00641667|10465575|P1|Overall Study|Worsening of underlying disease|3
3044167|NCT00641667|10465575|P1|Overall Study|Physician Decision|1
3044168|NCT00641667|10465575|P1|Overall Study|Adverse Event|1
3044169|NCT00641667|10465575|P1|Overall Study|Withdrawal by Subject|1
3044170|NCT00641537|10465603|P8|24-Week Supplemental Follow-up Period|Other|1
3044171|NCT00641537|10465604|P7|24-Week Supplemental Follow-up Period|Other|1
3044172|NCT00641537|10465605|P6|24-Week Supplemental Follow-up Period|Other|0
3044173|NCT00641537|10465606|P5|24-Week Supplemental Follow-up Period|Other|3
3044174|NCT00641537|10465607|P4|24-Week Supplemental Follow-up Period|Other|1
3044175|NCT00641537|10465608|P3|24-Week Supplemental Follow-up Period|Other|2
3044176|NCT00641537|10465609|P2|24-Week Supplemental Follow-up Period|Other|2
3044177|NCT00641537|10465610|P1|24-Week Supplemental Follow-up Period|Other|0
3044178|NCT00641537|10465603|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
3044179|NCT00641537|10465604|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
3044180|NCT00641537|10465605|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
3044181|NCT00641537|10465606|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
3044182|NCT00641537|10465607|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
3044183|NCT00641537|10465608|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
3044184|NCT00641537|10465609|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
3044185|NCT00641537|10465610|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
3044186|NCT00641537|10465603|P8|96-week Period|Other|6
3044187|NCT00641537|10465604|P7|96-week Period|Other|4
3044188|NCT00641537|10465605|P6|96-week Period|Other|6
3044189|NCT00641537|10465606|P5|96-week Period|Other|12
3044190|NCT00641537|10465607|P4|96-week Period|Other|9
3044191|NCT00641537|10465608|P3|96-week Period|Other|14
3044192|NCT00641537|10465609|P2|96-week Period|Other|7
3044193|NCT00641537|10465610|P1|96-week Period|Other|4
3044194|NCT00641537|10465603|P8|96-week Period|Death|0
3044195|NCT00641537|10465604|P7|96-week Period|Death|0
3044196|NCT00641537|10465605|P6|96-week Period|Death|0
3044197|NCT00641537|10465606|P5|96-week Period|Death|0
3044198|NCT00641537|10465607|P4|96-week Period|Death|0
3044199|NCT00641537|10465608|P3|96-week Period|Death|1
3044200|NCT00641537|10465609|P2|96-week Period|Death|0
3044201|NCT00641537|10465610|P1|96-week Period|Death|2
3044202|NCT00641537|10465603|P8|96-week Period|Protocol Violation|0
3044203|NCT00641537|10465604|P7|96-week Period|Protocol Violation|0
3044204|NCT00641537|10465605|P6|96-week Period|Protocol Violation|1
3044205|NCT00641537|10465606|P5|96-week Period|Protocol Violation|0
3044206|NCT00641537|10465607|P4|96-week Period|Protocol Violation|1
3044207|NCT00641537|10465608|P3|96-week Period|Protocol Violation|0
3044208|NCT00641537|10465609|P2|96-week Period|Protocol Violation|1
3044209|NCT00641537|10465610|P1|96-week Period|Protocol Violation|0
3044210|NCT00641537|10465603|P8|96-week Period|Lost to Follow-up|0
3044211|NCT00641537|10465604|P7|96-week Period|Lost to Follow-up|1
3044212|NCT00641537|10465605|P6|96-week Period|Lost to Follow-up|0
3044213|NCT00641537|10465606|P5|96-week Period|Lost to Follow-up|4
3044214|NCT00641537|10465607|P4|96-week Period|Lost to Follow-up|2
3044215|NCT00641537|10465608|P3|96-week Period|Lost to Follow-up|2
3044216|NCT00641537|10465609|P2|96-week Period|Lost to Follow-up|1
3044217|NCT00641537|10465610|P1|96-week Period|Lost to Follow-up|3
3044218|NCT00641537|10465603|P8|96-week Period|Adverse Event|0
3044219|NCT00641537|10465604|P7|96-week Period|Adverse Event|0
3044220|NCT00641537|10465605|P6|96-week Period|Adverse Event|0
3044221|NCT00641537|10465606|P5|96-week Period|Adverse Event|2
3044222|NCT00641537|10465607|P4|96-week Period|Adverse Event|0
3044223|NCT00641537|10465608|P3|96-week Period|Adverse Event|3
3044224|NCT00641537|10465609|P2|96-week Period|Adverse Event|1
3044225|NCT00641537|10465610|P1|96-week Period|Adverse Event|0
3044226|NCT00641147|10465665|P2|Completed 16 Months.|Lost to Follow-up|0
3044227|NCT00641147|10465666|P1|Completed 16 Months.|Lost to Follow-up|1
3044228|NCT00641147|10465665|P2|Completed 16 Months.|Physician Decision|0
3044229|NCT00641147|10465666|P1|Completed 16 Months.|Physician Decision|1
3044230|NCT00641147|10465665|P2|Completed 12 Months.|Withdrawal by Subject|1
3044231|NCT00641147|10465666|P1|Completed 12 Months.|Withdrawal by Subject|0
3044232|NCT00641147|10465665|P2|Completed 12 Months.|Physician Decision|1
3044233|NCT00641147|10465666|P1|Completed 12 Months.|Physician Decision|1
3044234|NCT00641147|10465665|P2|Completed 8 Months.|Withdrawal by Subject|1
3044235|NCT00641147|10465666|P1|Completed 8 Months.|Withdrawal by Subject|0
3044236|NCT00641147|10465665|P2|Completed 8 Months.|non compliance|0
3044237|NCT00641147|10465666|P1|Completed 8 Months.|non compliance|1
3044238|NCT00641147|10465665|P2|Completed 8 Months.|Physician Decision|1
3044239|NCT00641147|10465666|P1|Completed 8 Months.|Physician Decision|2
3044240|NCT00641147|10465665|P2|Completed 4 Months.|Adverse Event|0
3044241|NCT00641147|10465666|P1|Completed 4 Months.|Adverse Event|1
3044242|NCT00641147|10465665|P2|Completed 4 Months.|Physician Decision|0
3044243|NCT00641147|10465666|P1|Completed 4 Months.|Physician Decision|1
3044244|NCT00641056|10465719|P2|Overall Study|Sponsor Decision|2
3044245|NCT00641056|10465720|P1|Overall Study|Sponsor Decision|1
3044246|NCT00641056|10465719|P2|Overall Study|Subject Decision|19
3044247|NCT00641056|10465720|P1|Overall Study|Subject Decision|6
3044248|NCT00641056|10465719|P2|Overall Study|Entry Criteria Not Met|0
3044249|NCT00641056|10465720|P1|Overall Study|Entry Criteria Not Met|3
3044250|NCT00641056|10465719|P2|Overall Study|Protocol Violation|0
3044251|NCT00641056|10465720|P1|Overall Study|Protocol Violation|2
3044252|NCT00641056|10465719|P2|Overall Study|Physician Decision|1
3044253|NCT00641056|10465720|P1|Overall Study|Physician Decision|3
3044254|NCT00641056|10465719|P2|Overall Study|Lost to Follow-up|1
3044255|NCT00641056|10465720|P1|Overall Study|Lost to Follow-up|2
3044256|NCT00641056|10465719|P2|Overall Study|Adverse Event|2
3044257|NCT00641056|10465720|P1|Overall Study|Adverse Event|12
3044258|NCT00641043|10465748|P2|Overall Study|Other incl. lack of efficacy|2
3044259|NCT00641043|10465749|P1|Overall Study|Other incl. lack of efficacy|4
3044260|NCT00641043|10465748|P2|Overall Study|Withdrawal by Subject|4
3044261|NCT00641043|10465749|P1|Overall Study|Withdrawal by Subject|4
3044262|NCT00641043|10465748|P2|Overall Study|Lost to Follow-up|2
3044263|NCT00641043|10465749|P1|Overall Study|Lost to Follow-up|3
3044264|NCT00641043|10465748|P2|Overall Study|Protocol Violation|3
3044265|NCT00641043|10465749|P1|Overall Study|Protocol Violation|2
3044266|NCT00641043|10465748|P2|Overall Study|Adverse Event|4
3044267|NCT00641043|10465749|P1|Overall Study|Adverse Event|6
3044268|NCT00640926|10465786|P3|Overall Study|Withdrawal by Subject|1
3044269|NCT00640926|10465787|P2|Overall Study|Withdrawal by Subject|0
3044270|NCT00640926|10465788|P1|Overall Study|Withdrawal by Subject|1
3044271|NCT00640926|10465786|P3|Overall Study|Lost to Follow-up|2
3044272|NCT00640926|10465787|P2|Overall Study|Lost to Follow-up|1
3044273|NCT00640926|10465788|P1|Overall Study|Lost to Follow-up|3
3044274|NCT00640926|10465786|P3|Overall Study|Protocol Violation|2
3044275|NCT00640926|10465787|P2|Overall Study|Protocol Violation|0
3044276|NCT00640926|10465788|P1|Overall Study|Protocol Violation|2
3044277|NCT00640926|10465786|P3|Overall Study|Lack of Efficacy|1
3044278|NCT00640926|10465787|P2|Overall Study|Lack of Efficacy|2
3044279|NCT00640926|10465788|P1|Overall Study|Lack of Efficacy|0
3044280|NCT00640926|10465786|P3|Overall Study|Adverse Event|2
3044281|NCT00640926|10465787|P2|Overall Study|Adverse Event|3
3044282|NCT00640926|10465788|P1|Overall Study|Adverse Event|2
3044283|NCT00640835|10465801|P2|Overall Study|Other Reason|4
3044284|NCT00640835|10465802|P1|Overall Study|Other Reason|19
3044285|NCT00640835|10465801|P2|Overall Study|Lost to Follow-up|13
3044286|NCT00640835|10465802|P1|Overall Study|Lost to Follow-up|17
3044287|NCT00640835|10465801|P2|Overall Study|Protocol Violation|2
3044288|NCT00640835|10465802|P1|Overall Study|Protocol Violation|2
3044289|NCT00640835|10465801|P2|Overall Study|Sponsor's Decision|7
3044290|NCT00640835|10465802|P1|Overall Study|Sponsor's Decision|11
3044291|NCT00640835|10465801|P2|Overall Study|Physician Decision|14
3044292|NCT00640835|10465802|P1|Overall Study|Physician Decision|10
3044293|NCT00640835|10465801|P2|Overall Study|Withdrawal by Subject|14
3044294|NCT00640835|10465802|P1|Overall Study|Withdrawal by Subject|12
3044295|NCT00640835|10465801|P2|Overall Study|Adverse Event|3
3044296|NCT00640835|10465802|P1|Overall Study|Adverse Event|5
3044297|NCT00640614|10465866|P2|Overall Study|Lost to Follow-up|0
3044298|NCT00640614|10465867|P1|Overall Study|Lost to Follow-up|1
3044299|NCT00640601|10465909|P1|Overall Study|treatment naive, combination therapy|10
3044300|NCT00640601|10465909|P1|Overall Study|Physician Decision|8
3044301|NCT00640601|10465909|P1|Overall Study|Lost to Follow-up|9
3044302|NCT00640601|10465909|P1|Overall Study|Lack of Efficacy|16
3044303|NCT00640601|10465909|P1|Overall Study|Protocol Violation|6
3044304|NCT00640601|10465909|P1|Overall Study|Withdrawal by Subject|20
3044305|NCT00640601|10465909|P1|Overall Study|Adverse Event|43
3044306|NCT00640562|10465925|P2|Overall Study|Glycosylated Hemoglobin >8|0
3044307|NCT00640562|10465926|P1|Overall Study|Glycosylated Hemoglobin >8|1
3044308|NCT00640562|10465925|P2|Overall Study|Low study drug dose|1
3044309|NCT00640562|10465926|P1|Overall Study|Low study drug dose|0
3044310|NCT00640562|10465925|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
3044311|NCT00640562|10465926|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
3044312|NCT00640562|10465925|P2|Overall Study|Known risperidone intolerance|1
3044313|NCT00640562|10465926|P1|Overall Study|Known risperidone intolerance|0
3044314|NCT00640562|10465925|P2|Overall Study|Withdrawal by Subject|10
3044315|NCT00640562|10465926|P1|Overall Study|Withdrawal by Subject|6
3044316|NCT00640562|10465925|P2|Overall Study|Protocol Violation|4
3044317|NCT00640562|10465926|P1|Overall Study|Protocol Violation|2
3044318|NCT00640562|10465925|P2|Overall Study|Lack of Efficacy|4
3044319|NCT00640562|10465926|P1|Overall Study|Lack of Efficacy|1
3044320|NCT00640562|10465925|P2|Overall Study|Adverse Event|5
3044321|NCT00640562|10465926|P1|Overall Study|Adverse Event|8
3044322|NCT00640510|10465954|P2|Overall Study|Physician Decision|1
3044323|NCT00640510|10465955|P1|Overall Study|Physician Decision|0
3044324|NCT00640510|10465954|P2|Overall Study|Protocol Violation|0
3044325|NCT00640510|10465955|P1|Overall Study|Protocol Violation|1
3044326|NCT00640510|10465954|P2|Overall Study|Lack of Efficacy|1
3044327|NCT00640510|10465955|P1|Overall Study|Lack of Efficacy|0
3044328|NCT00640393|10465967|P3|Part 2|Adverse Event|0
3044329|NCT00640393|10465968|P2|Part 2|Adverse Event|1
3044330|NCT00640393|10465969|P1|Part 2|Adverse Event|0
3044331|NCT00640393|10465967|P3|Part 2|Non-adherence|0
3044332|NCT00640393|10465968|P2|Part 2|Non-adherence|1
3044333|NCT00640393|10465969|P1|Part 2|Non-adherence|0
3044334|NCT00640393|10465967|P3|Part 2|Withdrawal by Subject|1
3044335|NCT00640393|10465968|P2|Part 2|Withdrawal by Subject|6
3044336|NCT00640393|10465969|P1|Part 2|Withdrawal by Subject|0
3044337|NCT00640393|10465967|P3|Part 2|Lost to Follow-up|2
3044338|NCT00640393|10465968|P2|Part 2|Lost to Follow-up|2
3044339|NCT00640393|10465969|P1|Part 2|Lost to Follow-up|0
3044340|NCT00640393|10465967|P3|Randomization|Never randomized by site|0
3044341|NCT00640393|10465968|P2|Randomization|Never randomized by site|0
3044342|NCT00640393|10465969|P1|Randomization|Never randomized by site|2
3044343|NCT00640393|10465967|P3|Randomization|Withdrawn per protocol|0
3044344|NCT00640393|10465968|P2|Randomization|Withdrawn per protocol|0
3044345|NCT00640393|10465969|P1|Randomization|Withdrawn per protocol|17
3044346|NCT00640393|10465967|P3|Part 1|Withdrawal by Subject|0
3044347|NCT00640393|10465968|P2|Part 1|Withdrawal by Subject|0
3044348|NCT00640393|10465969|P1|Part 1|Withdrawal by Subject|3
3044349|NCT00640393|10465967|P3|Part 1|Lost to Follow-up|0
3044350|NCT00640393|10465968|P2|Part 1|Lost to Follow-up|0
3044351|NCT00640393|10465969|P1|Part 1|Lost to Follow-up|2
3044352|NCT00640341|10466034|P3|Overall Study|Adverse event and positive slit lamp|0
3044353|NCT00640341|10466035|P2|Overall Study|Adverse event and positive slit lamp|0
3044354|NCT00640341|10466036|P1|Overall Study|Adverse event and positive slit lamp|1
3044355|NCT00640341|10466034|P3|Overall Study|Ineligable at Baseline|2
3044356|NCT00640341|10466035|P2|Overall Study|Ineligable at Baseline|3
3044357|NCT00640341|10466036|P1|Overall Study|Ineligable at Baseline|5
3044358|NCT00640341|10466034|P3|Overall Study|Poor fit/Uncomfortable|0
3044359|NCT00640341|10466035|P2|Overall Study|Poor fit/Uncomfortable|0
3044360|NCT00640341|10466036|P1|Overall Study|Poor fit/Uncomfortable|4
3044361|NCT00640341|10466034|P3|Overall Study|Unacceptable Lens Movement|0
3044362|NCT00640341|10466035|P2|Overall Study|Unacceptable Lens Movement|0
3044363|NCT00640341|10466036|P1|Overall Study|Unacceptable Lens Movement|1
3044364|NCT00640341|10466034|P3|Overall Study|Withdrawal by Subject|1
3044365|NCT00640341|10466035|P2|Overall Study|Withdrawal by Subject|0
3044366|NCT00640341|10466036|P1|Overall Study|Withdrawal by Subject|4
3044367|NCT00640341|10466034|P3|Overall Study|Lost to Follow-up|0
3044368|NCT00640341|10466035|P2|Overall Study|Lost to Follow-up|0
3044369|NCT00640341|10466036|P1|Overall Study|Lost to Follow-up|2
3044370|NCT00640341|10466034|P3|Overall Study|Failure to Follow Subject Instructions|0
3044371|NCT00640341|10466035|P2|Overall Study|Failure to Follow Subject Instructions|0
3044372|NCT00640341|10466036|P1|Overall Study|Failure to Follow Subject Instructions|1
3044373|NCT00640341|10466034|P3|Overall Study|Inability to Maintain Wearing Schedule|0
3044374|NCT00640341|10466035|P2|Overall Study|Inability to Maintain Wearing Schedule|1
3044375|NCT00640341|10466036|P1|Overall Study|Inability to Maintain Wearing Schedule|1
3044376|NCT00640341|10466034|P3|Overall Study|Study Related Symptoms/Complaints|2
3044377|NCT00640341|10466035|P2|Overall Study|Study Related Symptoms/Complaints|1
3044378|NCT00640341|10466036|P1|Overall Study|Study Related Symptoms/Complaints|2
3044379|NCT00640341|10466034|P3|Overall Study|Positive Slit Lamp Findings|1
3044380|NCT00640341|10466035|P2|Overall Study|Positive Slit Lamp Findings|0
3044381|NCT00640341|10466036|P1|Overall Study|Positive Slit Lamp Findings|0
3044382|NCT00640341|10466034|P3|Overall Study|Adverse Event|1
3044383|NCT00640341|10466035|P2|Overall Study|Adverse Event|0
3044384|NCT00640341|10466036|P1|Overall Study|Adverse Event|0
3044385|NCT00640328|10466056|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
3044386|NCT00640328|10466057|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
3044387|NCT00640328|10466058|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
3044388|NCT00640328|10466059|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
3044389|NCT00640328|10466060|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
3044390|NCT00640328|10466061|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
3044391|NCT00640328|10466056|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
3044392|NCT00640328|10466057|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
3044393|NCT00640328|10466058|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
3044394|NCT00640328|10466059|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
3044395|NCT00640328|10466060|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
3044396|NCT00640328|10466061|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
3044397|NCT00640328|10466056|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
3044398|NCT00640328|10466057|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
3044399|NCT00640328|10466058|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
3044400|NCT00640328|10466059|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
3044401|NCT00640328|10466060|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
3044402|NCT00640328|10466061|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
3044403|NCT00640328|10466056|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
3044404|NCT00640328|10466057|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
3044405|NCT00640328|10466058|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
3044406|NCT00640328|10466059|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
3044407|NCT00640328|10466060|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
3044408|NCT00640328|10466061|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
3044409|NCT00640315|10466227|P2|Overall Study|Withdrawal by Subject|1
3044410|NCT00640315|10466228|P1|Overall Study|Withdrawal by Subject|0
3044411|NCT00640289|10466354|P1|Overall Study|Missing status|5
3044412|NCT00640289|10466354|P1|Overall Study|Transferred to another center|1
3044413|NCT00640289|10466354|P1|Overall Study|Data collected under different amendment|2
3044414|NCT00640289|10466354|P1|Overall Study|Lost to Follow-up|1
3044415|NCT00640289|10466354|P1|Overall Study|Withdrawal by Subject|1
3044416|NCT00640289|10466354|P1|Overall Study|Death|3
3044417|NCT00640224|10466466|P4|Overall Study|Headaches|0
3044418|NCT00640224|10466467|P3|Overall Study|Headaches|0
3044419|NCT00640224|10466468|P2|Overall Study|Headaches|1
3044420|NCT00640224|10466469|P1|Overall Study|Headaches|0
3044421|NCT00640224|10466466|P4|Overall Study|Withdrawal by Subject|0
3044422|NCT00640224|10466467|P3|Overall Study|Withdrawal by Subject|0
3044423|NCT00640224|10466468|P2|Overall Study|Withdrawal by Subject|0
3044424|NCT00640224|10466469|P1|Overall Study|Withdrawal by Subject|1
3044425|NCT00640224|10466466|P4|Overall Study|Lost to Follow-up|0
3044426|NCT00640224|10466467|P3|Overall Study|Lost to Follow-up|0
3044427|NCT00640224|10466468|P2|Overall Study|Lost to Follow-up|2
3044428|NCT00640224|10466469|P1|Overall Study|Lost to Follow-up|5
3044429|NCT00640146|10466569|P2|Overall Study|Randomized but not treated|3
3044430|NCT00640146|10466570|P1|Overall Study|Randomized but not treated|1
3044431|NCT00640146|10466569|P2|Overall Study|Withdrawal by Subject|1
3044432|NCT00640146|10466570|P1|Overall Study|Withdrawal by Subject|1
3044433|NCT00640146|10466569|P2|Overall Study|Lack of Efficacy|1
3044434|NCT00640146|10466570|P1|Overall Study|Lack of Efficacy|0
3044435|NCT00640146|10466569|P2|Overall Study|Lost to Follow-up|1
3044436|NCT00640146|10466570|P1|Overall Study|Lost to Follow-up|0
3044437|NCT00640146|10466569|P2|Overall Study|Adverse Event|0
3044438|NCT00640146|10466570|P1|Overall Study|Adverse Event|2
3044439|NCT00640133|10466582|P2|Open Label Phase (Month 4-12)|Adverse Event|0
3044440|NCT00640133|10466583|P1|Open Label Phase (Month 4-12)|Adverse Event|1
3044441|NCT00640133|10466582|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
3044442|NCT00640133|10466583|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
3044443|NCT00640133|10466582|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
3044444|NCT00640133|10466583|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
3044445|NCT00640042|10466603|P1|Enrollment|Did not receive study drug|83
3044446|NCT00640016|10466619|P4|Overall Study|Adverse Event|1
3044447|NCT00640016|10466620|P3|Overall Study|Adverse Event|0
3044448|NCT00640016|10466621|P2|Overall Study|Adverse Event|0
3044449|NCT00640016|10466622|P1|Overall Study|Adverse Event|0
3044450|NCT00640016|10466619|P4|Overall Study|Study termination|2
3044451|NCT00640016|10466620|P3|Overall Study|Study termination|3
3044452|NCT00640016|10466621|P2|Overall Study|Study termination|1
3044453|NCT00640016|10466622|P1|Overall Study|Study termination|2
3044454|NCT00640016|10466619|P4|Overall Study|Withdrawal by Subject|0
3044455|NCT00640016|10466620|P3|Overall Study|Withdrawal by Subject|0
3044456|NCT00640016|10466621|P2|Overall Study|Withdrawal by Subject|1
3044457|NCT00640016|10466622|P1|Overall Study|Withdrawal by Subject|0
3044458|NCT00639769|10466674|P1|Overall Study|Withdrawal by Subject|4
3044459|NCT00639769|10466674|P1|Overall Study|Disease progression|26
3044460|NCT00639769|10466674|P1|Overall Study|Lack of Efficacy|1
3044461|NCT00639769|10466674|P1|Overall Study|Adverse Event|7
3044462|NCT00639769|10466674|P1|Overall Study|Death|2
3044463|NCT00639678|10466691|P4|Overall Study|Lack of Compliance|0
3044464|NCT00639678|10466692|P3|Overall Study|Lack of Compliance|1
3044465|NCT00639678|10466693|P2|Overall Study|Lack of Compliance|0
3044466|NCT00639678|10466694|P1|Overall Study|Lack of Compliance|0
3044467|NCT00639678|10466691|P4|Overall Study|Adverse Event|0
3044468|NCT00639678|10466692|P3|Overall Study|Adverse Event|0
3044469|NCT00639678|10466693|P2|Overall Study|Adverse Event|1
3044470|NCT00639678|10466694|P1|Overall Study|Adverse Event|0
3044471|NCT00639678|10466691|P4|Overall Study|Lost to Follow-up|0
3044472|NCT00639678|10466692|P3|Overall Study|Lost to Follow-up|6
3044473|NCT00639678|10466693|P2|Overall Study|Lost to Follow-up|0
3044474|NCT00639678|10466694|P1|Overall Study|Lost to Follow-up|1
3044475|NCT00639678|10466691|P4|Overall Study|Withdrawal by Subject|0
3044476|NCT00639678|10466692|P3|Overall Study|Withdrawal by Subject|4
3044477|NCT00639678|10466693|P2|Overall Study|Withdrawal by Subject|0
3044478|NCT00639678|10466694|P1|Overall Study|Withdrawal by Subject|3
3044479|NCT00639509|10466759|P1|Overall Study|Death|1
3044480|NCT00639457|10466767|P2|Overall Study|Withdrawal by Subject|3
3044481|NCT00639457|10466768|P1|Overall Study|Withdrawal by Subject|2
3044482|NCT00639379|10466827|P2|Period 1 - 2 Weeks|lens issue|0
3044483|NCT00639379|10466828|P1|Period 1 - 2 Weeks|lens issue|3
3044484|NCT00639379|10466827|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
3044485|NCT00639379|10466828|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
3044486|NCT00639223|10466844|P2|Overall Study|Lost to Follow-up|2
3044487|NCT00639223|10466845|P1|Overall Study|Lost to Follow-up|0
3044488|NCT00639002|10466885|P1|Overall Study|Lack of Efficacy|1
3044489|NCT00639002|10466885|P1|Overall Study|Physician Decision|6
3044490|NCT00639002|10466885|P1|Overall Study|Disease progression|3
3044491|NCT00639002|10466885|P1|Overall Study|Protocol Violation|1
3044492|NCT00639002|10466885|P1|Overall Study|Adverse Event|1
3044493|NCT00639002|10466885|P1|Overall Study|Death|1
3044494|NCT00638989|10466894|P3|Overall Study|Lost to Follow-up|1
3044495|NCT00638989|10466895|P2|Overall Study|Lost to Follow-up|0
3044496|NCT00638989|10466896|P1|Overall Study|Lost to Follow-up|0
3044497|NCT00638963|10466936|P2|Overall Study|Withdrawal by Subject|0
3044498|NCT00638963|10466937|P1|Overall Study|Withdrawal by Subject|1
3044499|NCT00638846|10466978|P2|Overall Study|lens issue|3
3044500|NCT00638846|10466979|P1|Overall Study|lens issue|1
3044501|NCT00638846|10466978|P2|Overall Study|Lost to Follow-up|2
3044502|NCT00638846|10466979|P1|Overall Study|Lost to Follow-up|3
3044503|NCT00638846|10466978|P2|Overall Study|Adverse Event|1
3044504|NCT00638846|10466979|P1|Overall Study|Adverse Event|0
3044505|NCT00638690|10467023|P2|Overall Study|Lost to Follow-up|2
3044506|NCT00638690|10467024|P1|Overall Study|Lost to Follow-up|4
3044507|NCT00638690|10467023|P2|Overall Study|Withdrawal by Subject|5
3044508|NCT00638690|10467024|P1|Overall Study|Withdrawal by Subject|22
3044509|NCT00638690|10467023|P2|Overall Study|Death|335
3044510|NCT00638690|10467024|P1|Overall Study|Death|655
3044511|NCT00638508|10467044|P2|Overall Study|Physician Decision|2
3044512|NCT00638508|10467045|P1|Overall Study|Physician Decision|5
3044513|NCT00638456|10467091|P2|Overall Study|Withdrawal by Subject|2
3044514|NCT00638456|10467092|P1|Overall Study|Withdrawal by Subject|6
3044515|NCT00638443|10467102|P2|First Intervention|Adverse Event|1
3044516|NCT00638443|10467103|P1|First Intervention|Adverse Event|2
3044517|NCT00638404|10467133|P2|Overall Study|Physician Decision|0
3044518|NCT00638404|10467134|P1|Overall Study|Physician Decision|8
3044519|NCT00638378|10467146|P1|Overall Study|Physician Decision|4
3044520|NCT00638378|10467146|P1|Overall Study|Disease progression|15
3044521|NCT00638378|10467146|P1|Overall Study|Adverse Event|1
3044522|NCT00638378|10467146|P1|Overall Study|Death|2
3044523|NCT00638235|10467186|P9|Overall Study|Lost to Follow-up|18
3044524|NCT00638235|10467187|P8|Overall Study|Lost to Follow-up|1
3044525|NCT00638235|10467188|P7|Overall Study|Lost to Follow-up|0
3044526|NCT00638235|10467189|P6|Overall Study|Lost to Follow-up|26
3044527|NCT00638235|10467190|P5|Overall Study|Lost to Follow-up|13
3044528|NCT00638235|10467191|P4|Overall Study|Lost to Follow-up|10
3044529|NCT00638235|10467192|P3|Overall Study|Lost to Follow-up|18
3044530|NCT00638235|10467193|P2|Overall Study|Lost to Follow-up|3
3044531|NCT00638235|10467194|P1|Overall Study|Lost to Follow-up|31
3044532|NCT00638183|10467604|P1|Overall Study|Other reason not defined above|27
3044533|NCT00638183|10467604|P1|Overall Study|Lost to Follow-up|46
3044534|NCT00638183|10467604|P1|Overall Study|Physician Decision|9
3044535|NCT00638183|10467604|P1|Overall Study|Lack of Efficacy|14
3044536|NCT00638183|10467604|P1|Overall Study|Adverse Event|23
3044537|NCT00638157|10467613|P2|Overall Study|Randomized, not treated|0
3044538|NCT00638157|10467614|P1|Overall Study|Randomized, not treated|2
3044539|NCT00638157|10467613|P2|Overall Study|Other|2
3044540|NCT00638157|10467614|P1|Overall Study|Other|1
3044541|NCT00638157|10467613|P2|Overall Study|Physician Decision|0
3044542|NCT00638157|10467614|P1|Overall Study|Physician Decision|1
3044543|NCT00638157|10467613|P2|Overall Study|Lost to Follow-up|0
3044544|NCT00638157|10467614|P1|Overall Study|Lost to Follow-up|1
3044545|NCT00638157|10467613|P2|Overall Study|Microbiological failure|0
3044546|NCT00638157|10467614|P1|Overall Study|Microbiological failure|1
3044547|NCT00638157|10467613|P2|Overall Study|Clinical (symptomatic) failure|1
3044548|NCT00638157|10467614|P1|Overall Study|Clinical (symptomatic) failure|1
3044549|NCT00638157|10467613|P2|Overall Study|Adverse Event|1
3044550|NCT00638157|10467614|P1|Overall Study|Adverse Event|0
3044551|NCT00638027|10467624|P2|Overall Study|Adverse Event|2
3044552|NCT00638027|10467625|P1|Overall Study|Adverse Event|0
3044553|NCT00637806|10467672|P4|Extension Phase|Study Discontinued|1
3044554|NCT00637806|10467673|P3|Extension Phase|Study Discontinued|0
3044555|NCT00637806|10467674|P2|Extension Phase|Study Discontinued|0
3044556|NCT00637806|10467675|P1|Extension Phase|Study Discontinued|0
3044557|NCT00637806|10467672|P4|Double-blind Phase|Study Discontinued|0
3044558|NCT00637806|10467673|P3|Double-blind Phase|Study Discontinued|1
3044559|NCT00637806|10467674|P2|Double-blind Phase|Study Discontinued|0
3044560|NCT00637806|10467675|P1|Double-blind Phase|Study Discontinued|2
3044561|NCT00637728|10467710|P3|Double-blind Phase|Study Discontinued|0
3044562|NCT00637728|10467711|P2|Double-blind Phase|Study Discontinued|1
3044563|NCT00637728|10467712|P1|Double-blind Phase|Study Discontinued|1
3044564|NCT00637728|10467710|P3|Double-blind Phase|Non-compliance|0
3044565|NCT00637728|10467711|P2|Double-blind Phase|Non-compliance|0
3044566|NCT00637728|10467712|P1|Double-blind Phase|Non-compliance|2
3044567|NCT00637728|10467710|P3|Double-blind Phase|Adverse Event|0
3044568|NCT00637728|10467711|P2|Double-blind Phase|Adverse Event|0
3044569|NCT00637728|10467712|P1|Double-blind Phase|Adverse Event|1
3044570|NCT00637572|10467727|P2|Overall Study|Illicit Drug Use|0
3044571|NCT00637572|10467728|P1|Overall Study|Illicit Drug Use|1
3044572|NCT00637572|10467727|P2|Overall Study|Withdrawal by Subject|2
3044573|NCT00637572|10467728|P1|Overall Study|Withdrawal by Subject|0
3044574|NCT00637572|10467727|P2|Overall Study|Physician Decision|1
3044575|NCT00637572|10467728|P1|Overall Study|Physician Decision|1
3044576|NCT00637572|10467727|P2|Overall Study|Lost to Follow-up|1
3044577|NCT00637572|10467728|P1|Overall Study|Lost to Follow-up|0
3044578|NCT00637572|10467727|P2|Overall Study|Death|1
3044579|NCT00637572|10467728|P1|Overall Study|Death|0
3044580|NCT00637572|10467727|P2|Overall Study|Adverse Event|2
3044581|NCT00637572|10467728|P1|Overall Study|Adverse Event|1
3044582|NCT00637416|10467767|P2|Overall Study|Unable to take study drug|1
3044583|NCT00637416|10467768|P1|Overall Study|Unable to take study drug|0
3044584|NCT00637416|10467767|P2|Overall Study|Lost to Follow-up|1
3044585|NCT00637416|10467768|P1|Overall Study|Lost to Follow-up|1
3044586|NCT00637377|10467778|P4|Overall Study|Other (no further information available)|5
3044587|NCT00637377|10467779|P3|Overall Study|Other (no further information available)|10
3044588|NCT00637377|10467780|P2|Overall Study|Other (no further information available)|6
3044589|NCT00637377|10467781|P1|Overall Study|Other (no further information available)|7
3044590|NCT00637377|10467778|P4|Overall Study|Withdrawal by Subject|11
3044591|NCT00637377|10467779|P3|Overall Study|Withdrawal by Subject|13
3044592|NCT00637377|10467780|P2|Overall Study|Withdrawal by Subject|15
3044593|NCT00637377|10467781|P1|Overall Study|Withdrawal by Subject|11
3044594|NCT00637377|10467778|P4|Overall Study|Protocol Violation|0
3044595|NCT00637377|10467779|P3|Overall Study|Protocol Violation|1
3044596|NCT00637377|10467780|P2|Overall Study|Protocol Violation|1
3044597|NCT00637377|10467781|P1|Overall Study|Protocol Violation|2
3044598|NCT00637377|10467778|P4|Overall Study|Lost to Follow-up|2
3044599|NCT00637377|10467779|P3|Overall Study|Lost to Follow-up|2
3044600|NCT00637377|10467780|P2|Overall Study|Lost to Follow-up|1
3044601|NCT00637377|10467781|P1|Overall Study|Lost to Follow-up|4
3044602|NCT00637377|10467778|P4|Overall Study|Lack of Efficacy|1
3044603|NCT00637377|10467779|P3|Overall Study|Lack of Efficacy|1
3044604|NCT00637377|10467780|P2|Overall Study|Lack of Efficacy|0
3044605|NCT00637377|10467781|P1|Overall Study|Lack of Efficacy|0
3044606|NCT00637377|10467778|P4|Overall Study|Death|1
3044607|NCT00637377|10467779|P3|Overall Study|Death|2
3044608|NCT00637377|10467780|P2|Overall Study|Death|3
3044609|NCT00637377|10467781|P1|Overall Study|Death|1
3044610|NCT00637377|10467778|P4|Overall Study|Adverse Event|9
3044611|NCT00637377|10467779|P3|Overall Study|Adverse Event|8
3044612|NCT00637377|10467780|P2|Overall Study|Adverse Event|6
3044613|NCT00637377|10467781|P1|Overall Study|Adverse Event|2
3044614|NCT00637273|10467830|P3|Overall Study|Loss of Glucose Control|1
3044615|NCT00637273|10467831|P2|Overall Study|Loss of Glucose Control|1
3044616|NCT00637273|10467832|P1|Overall Study|Loss of Glucose Control|1
3044617|NCT00637273|10467830|P3|Overall Study|Administrative|0
3044618|NCT00637273|10467831|P2|Overall Study|Administrative|0
3044619|NCT00637273|10467832|P1|Overall Study|Administrative|2
3044620|NCT00637273|10467830|P3|Overall Study|Investigator Decision|1
3044621|NCT00637273|10467831|P2|Overall Study|Investigator Decision|3
3044622|NCT00637273|10467832|P1|Overall Study|Investigator Decision|1
3044623|NCT00637273|10467830|P3|Overall Study|Withdrawal of Consent|18
3044624|NCT00637273|10467831|P2|Overall Study|Withdrawal of Consent|6
3044625|NCT00637273|10467832|P1|Overall Study|Withdrawal of Consent|18
3044626|NCT00637273|10467830|P3|Overall Study|Protocol Violation|1
3044627|NCT00637273|10467831|P2|Overall Study|Protocol Violation|4
3044628|NCT00637273|10467832|P1|Overall Study|Protocol Violation|2
3044629|NCT00637273|10467830|P3|Overall Study|Lost to Follow-up|13
3044630|NCT00637273|10467831|P2|Overall Study|Lost to Follow-up|9
3044631|NCT00637273|10467832|P1|Overall Study|Lost to Follow-up|8
3044632|NCT00637273|10467830|P3|Overall Study|Adverse Event|7
3044633|NCT00637273|10467831|P2|Overall Study|Adverse Event|5
3044634|NCT00637273|10467832|P1|Overall Study|Adverse Event|11
3044635|NCT00637195|10467890|P2|Overall Study|Withdrawal by Subject|1
3044636|NCT00637195|10467891|P1|Overall Study|Withdrawal by Subject|0
3044637|NCT00637195|10467890|P2|Overall Study|Other|0
3044638|NCT00637195|10467891|P1|Overall Study|Other|2
3044639|NCT00637195|10467890|P2|Overall Study|Lost to Follow-up|0
3044640|NCT00637195|10467891|P1|Overall Study|Lost to Follow-up|1
3044641|NCT00637156|10467927|P2|Overall Study|Lost to Follow-up|16
3044642|NCT00637156|10467928|P1|Overall Study|Lost to Follow-up|10
3044643|NCT00637156|10467927|P2|Overall Study|Death|1
3044644|NCT00637156|10467928|P1|Overall Study|Death|0
3044645|NCT00637156|10467927|P2|Overall Study|Withdrawal by Subject|7
3044646|NCT00637156|10467928|P1|Overall Study|Withdrawal by Subject|0
3044647|NCT00637000|10467970|P2|Overall Study|Withdrawal by Subject|3
3044648|NCT00637000|10467971|P1|Overall Study|Withdrawal by Subject|4
3044649|NCT00636987|10468011|P1|Overall Study|5 year visit window not complete|69
3044650|NCT00636987|10468011|P1|Overall Study|Lost to Follow-up|63
3044651|NCT00636987|10468011|P1|Overall Study|Explanted|13
3044652|NCT00636987|10468011|P1|Overall Study|Death|44
3044653|NCT00636961|10468021|P2|Period 2|Adverse Event|0
3044654|NCT00636961|10468022|P1|Period 2|Adverse Event|1
3044655|NCT00636961|10468021|P2|Period 1|Administrative problems|1
3044656|NCT00636961|10468022|P1|Period 1|Administrative problems|1
3044657|NCT00636818|10468036|P1|Overall Study|Withdrawal by Subject|4
3044658|NCT00636818|10468036|P1|Overall Study|Protocol Violation|1
3044659|NCT00636818|10468036|P1|Overall Study|Entry Criteria Exclusion|3
3044660|NCT00636818|10468036|P1|Overall Study|Lost to Follow-up|2
3044661|NCT00636818|10468036|P1|Overall Study|Adverse Event|1
3044662|NCT00636792|10468061|P1|Overall Study|Other|3
3044663|NCT00636792|10468061|P1|Overall Study|Withdrawal by Subject|3
3044664|NCT00636792|10468061|P1|Overall Study|Progressive Disease|4
3044665|NCT00636792|10468061|P1|Overall Study|Physician Decision|7
3044666|NCT00636792|10468061|P1|Overall Study|Adverse Event|16
3044667|NCT00636675|10468077|P2|Overall Study|Withdrawal by Subject|10
3044668|NCT00636675|10468078|P1|Overall Study|Withdrawal by Subject|19
3044669|NCT00636675|10468077|P2|Overall Study|Lost to Follow-up|31
3044670|NCT00636675|10468078|P1|Overall Study|Lost to Follow-up|121
3044671|NCT00636636|10468121|P2|Overall Study|Withdrawal by Subject|9
3044672|NCT00636636|10468122|P1|Overall Study|Withdrawal by Subject|4
3044673|NCT00636636|10468121|P2|Overall Study|Death|1
3044674|NCT00636636|10468122|P1|Overall Study|Death|0
3044675|NCT00636636|10468121|P2|Overall Study|Lost to Follow-up|1
3044676|NCT00636636|10468122|P1|Overall Study|Lost to Follow-up|0
3044677|NCT00636636|10468121|P2|Overall Study|Protocol Violation|2
3044678|NCT00636636|10468122|P1|Overall Study|Protocol Violation|2
3044679|NCT00636636|10468121|P2|Overall Study|Lack of Efficacy|12
3044680|NCT00636636|10468122|P1|Overall Study|Lack of Efficacy|7
3044681|NCT00636636|10468121|P2|Overall Study|Adverse Event|8
3044682|NCT00636636|10468122|P1|Overall Study|Adverse Event|19
3044683|NCT00636636|10468121|P2|Overall Study|Other reason|6
3044684|NCT00636636|10468122|P1|Overall Study|Other reason|4
3044685|NCT00636610|10468138|P2|Overall Study|Reason for discontinuation not available|2
3044686|NCT00636610|10468139|P1|Overall Study|Reason for discontinuation not available|3
3044687|NCT00636610|10468138|P2|Overall Study|Disease progression - clinical|3
3044688|NCT00636610|10468139|P1|Overall Study|Disease progression - clinical|8
3044689|NCT00636610|10468138|P2|Overall Study|Disease progression - radiographic|51
3044690|NCT00636610|10468139|P1|Overall Study|Disease progression - radiographic|41
3044691|NCT00636610|10468138|P2|Overall Study|Subject decision to withdraw|11
3044692|NCT00636610|10468139|P1|Overall Study|Subject decision to withdraw|15
3044693|NCT00636610|10468138|P2|Overall Study|Physician decision to withdraw patient|9
3044694|NCT00636610|10468139|P1|Overall Study|Physician decision to withdraw patient|15
3044695|NCT00636610|10468138|P2|Overall Study|Death|3
3044696|NCT00636610|10468139|P1|Overall Study|Death|6
3044697|NCT00636610|10468138|P2|Overall Study|Adverse Event|4
3044698|NCT00636610|10468139|P1|Overall Study|Adverse Event|4
3044699|NCT00636506|10468149|P1|Overall Study|Procedure aborted|1
3044700|NCT00636506|10468149|P1|Overall Study|Withdrawal by Subject|6
3044701|NCT00636506|10468149|P1|Overall Study|Explanted|1
3044702|NCT00636506|10468149|P1|Overall Study|Lost to Follow-up|8
3044703|NCT00636441|10468196|P7|Overall Study|Screen Failure|17
3044704|NCT00636441|10468197|P6|Overall Study|Screen Failure|0
3044705|NCT00636441|10468198|P5|Overall Study|Screen Failure|0
3044706|NCT00636441|10468199|P4|Overall Study|Screen Failure|0
3044707|NCT00636441|10468200|P3|Overall Study|Screen Failure|0
3044708|NCT00636441|10468201|P2|Overall Study|Screen Failure|0
3044709|NCT00636441|10468202|P1|Overall Study|Screen Failure|0
3044710|NCT00636441|10468196|P7|Overall Study|Late, ineligible|1
3044711|NCT00636441|10468197|P6|Overall Study|Late, ineligible|0
3044712|NCT00636441|10468198|P5|Overall Study|Late, ineligible|0
3044713|NCT00636441|10468199|P4|Overall Study|Late, ineligible|0
3044714|NCT00636441|10468200|P3|Overall Study|Late, ineligible|0
3044715|NCT00636441|10468201|P2|Overall Study|Late, ineligible|0
3044716|NCT00636441|10468202|P1|Overall Study|Late, ineligible|0
3044717|NCT00636441|10468196|P7|Overall Study|Adverse Event|0
3044718|NCT00636441|10468197|P6|Overall Study|Adverse Event|1
3044719|NCT00636441|10468198|P5|Overall Study|Adverse Event|0
3044720|NCT00636441|10468199|P4|Overall Study|Adverse Event|0
3044721|NCT00636441|10468200|P3|Overall Study|Adverse Event|1
3044722|NCT00636441|10468201|P2|Overall Study|Adverse Event|1
3044723|NCT00636441|10468202|P1|Overall Study|Adverse Event|0
3044724|NCT00636363|10468245|P3|Overall Study|Withdrawal by Subject|2
3044725|NCT00636363|10468246|P2|Overall Study|Withdrawal by Subject|3
3044726|NCT00636363|10468247|P1|Overall Study|Withdrawal by Subject|1
3044727|NCT00636363|10468245|P3|Overall Study|Lost to Follow-up|2
3044728|NCT00636363|10468246|P2|Overall Study|Lost to Follow-up|4
3044729|NCT00636363|10468247|P1|Overall Study|Lost to Follow-up|3
3044730|NCT00636363|10468245|P3|Overall Study|Protocol Violation|0
3044731|NCT00636363|10468246|P2|Overall Study|Protocol Violation|3
3044732|NCT00636363|10468247|P1|Overall Study|Protocol Violation|0
3044733|NCT00636363|10468245|P3|Overall Study|Lack of motivation|1
3044734|NCT00636363|10468246|P2|Overall Study|Lack of motivation|0
3044735|NCT00636363|10468247|P1|Overall Study|Lack of motivation|1
3044736|NCT00636363|10468245|P3|Overall Study|Missed > 1 visit|3
3044737|NCT00636363|10468246|P2|Overall Study|Missed > 1 visit|1
3044738|NCT00636363|10468247|P1|Overall Study|Missed > 1 visit|0
3044739|NCT00636363|10468245|P3|Overall Study|Met ineligibility criteria|3
3044740|NCT00636363|10468246|P2|Overall Study|Met ineligibility criteria|0
3044741|NCT00636363|10468247|P1|Overall Study|Met ineligibility criteria|0
3044742|NCT00636363|10468245|P3|Overall Study|Study related symptoms/complaints|4
3044743|NCT00636363|10468246|P2|Overall Study|Study related symptoms/complaints|7
3044744|NCT00636363|10468247|P1|Overall Study|Study related symptoms/complaints|8
3044745|NCT00636363|10468245|P3|Overall Study|Positive slit lamp finding|1
3044746|NCT00636363|10468246|P2|Overall Study|Positive slit lamp finding|2
3044747|NCT00636363|10468247|P1|Overall Study|Positive slit lamp finding|0
3044748|NCT00636363|10468245|P3|Overall Study|Adverse Event|1
3044749|NCT00636363|10468246|P2|Overall Study|Adverse Event|0
3044750|NCT00636363|10468247|P1|Overall Study|Adverse Event|0
3044751|NCT00636363|10468245|P3|Overall Study|Conjunctivitis|1
3044752|NCT00636363|10468246|P2|Overall Study|Conjunctivitis|0
3044753|NCT00636363|10468247|P1|Overall Study|Conjunctivitis|0
3044754|NCT00636207|10468268|P7|Overall Study|Withdrawal by Subject|0
3044755|NCT00636207|10468269|P6|Overall Study|Withdrawal by Subject|0
3044756|NCT00636207|10468270|P5|Overall Study|Withdrawal by Subject|1
3044757|NCT00636207|10468271|P4|Overall Study|Withdrawal by Subject|0
3044758|NCT00636207|10468272|P3|Overall Study|Withdrawal by Subject|0
3044759|NCT00636207|10468273|P2|Overall Study|Withdrawal by Subject|1
3044760|NCT00636207|10468274|P1|Overall Study|Withdrawal by Subject|0
3044761|NCT00636207|10468268|P7|Overall Study|Adverse Event|0
3044762|NCT00636207|10468269|P6|Overall Study|Adverse Event|0
3044763|NCT00636207|10468270|P5|Overall Study|Adverse Event|0
3044764|NCT00636207|10468271|P4|Overall Study|Adverse Event|0
3044765|NCT00636207|10468272|P3|Overall Study|Adverse Event|0
3044766|NCT00636207|10468273|P2|Overall Study|Adverse Event|0
3044767|NCT00636207|10468274|P1|Overall Study|Adverse Event|1
3044768|NCT00636194|10468338|P2|Overall Study|Protocol Violation|0
3044769|NCT00636194|10468339|P1|Overall Study|Protocol Violation|2
3044770|NCT00636194|10468338|P2|Overall Study|Study related symptoms and complaints|0
3044771|NCT00636194|10468339|P1|Overall Study|Study related symptoms and complaints|1
3044772|NCT00636181|10468352|P3|Overall Study|Withdrawal by Subject|10
3044773|NCT00636181|10468353|P2|Overall Study|Withdrawal by Subject|6
3044774|NCT00636181|10468354|P1|Overall Study|Withdrawal by Subject|8
3044775|NCT00636168|10468382|P2|Long Term Follow-Up|Death|9
3044776|NCT00636168|10468383|P1|Long Term Follow-Up|Death|8
3044777|NCT00636168|10468382|P2|Long Term Follow-Up|Participant withdrew consent|2
3044778|NCT00636168|10468383|P1|Long Term Follow-Up|Participant withdrew consent|0
3044779|NCT00636168|10468382|P2|Long Term Follow-Up|Lost to Follow-up|3
3044780|NCT00636168|10468383|P1|Long Term Follow-Up|Lost to Follow-up|3
3044781|NCT00636168|10468382|P2|Treated With Study Drug|Other reason|3
3044782|NCT00636168|10468383|P1|Treated With Study Drug|Other reason|1
3044783|NCT00636168|10468382|P2|Treated With Study Drug|No longer meets study criteria|0
3044784|NCT00636168|10468383|P1|Treated With Study Drug|No longer meets study criteria|1
3044785|NCT00636168|10468382|P2|Treated With Study Drug|Pregnancy|0
3044786|NCT00636168|10468383|P1|Treated With Study Drug|Pregnancy|1
3044787|NCT00636168|10468382|P2|Treated With Study Drug|Death|0
3044788|NCT00636168|10468383|P1|Treated With Study Drug|Death|3
3044789|NCT00636168|10468382|P2|Treated With Study Drug|Poor/non-compliance|3
3044790|NCT00636168|10468383|P1|Treated With Study Drug|Poor/non-compliance|1
3044791|NCT00636168|10468382|P2|Treated With Study Drug|Participant withdrew consent|21
3044792|NCT00636168|10468383|P1|Treated With Study Drug|Participant withdrew consent|16
3044793|NCT00636168|10468382|P2|Treated With Study Drug|Adverse Event|22
3044794|NCT00636168|10468383|P1|Treated With Study Drug|Adverse Event|250
3044795|NCT00636168|10468382|P2|Treated With Study Drug|Recurrence of disease|282
3044796|NCT00636168|10468383|P1|Treated With Study Drug|Recurrence of disease|135
3044797|NCT00636168|10468382|P2|Randomized to Study Drug|No longer meets study criteria|0
3044798|NCT00636168|10468383|P1|Randomized to Study Drug|No longer meets study criteria|1
3044799|NCT00636168|10468382|P2|Randomized to Study Drug|Adverse Event|0
3044800|NCT00636168|10468383|P1|Randomized to Study Drug|Adverse Event|1
3044801|NCT00636168|10468382|P2|Randomized to Study Drug|Withdrawal by Subject|2
3044802|NCT00636168|10468383|P1|Randomized to Study Drug|Withdrawal by Subject|2
3044803|NCT00636155|10468411|P1|Overall Study|Physician Decision|5
3044804|NCT00636155|10468411|P1|Overall Study|Stem cell transplant|1
3044805|NCT00636155|10468411|P1|Overall Study|Withdrawal by Subject|3
3044806|NCT00636155|10468411|P1|Overall Study|Lack of Efficacy|1
3044807|NCT00636155|10468411|P1|Overall Study|Adverse Event|8
3044808|NCT00635999|10468453|P3|Overall Study|Withdrawal by Subject|1
3044809|NCT00635999|10468454|P2|Overall Study|Withdrawal by Subject|2
3044810|NCT00635999|10468455|P1|Overall Study|Withdrawal by Subject|4
3044811|NCT00635882|10468472|P6|Overall Study|Protocol Violation|0
3044812|NCT00635882|10468473|P5|Overall Study|Protocol Violation|0
3044813|NCT00635882|10468474|P4|Overall Study|Protocol Violation|0
3044814|NCT00635882|10468475|P3|Overall Study|Protocol Violation|0
3044815|NCT00635882|10468476|P2|Overall Study|Protocol Violation|0
3044816|NCT00635882|10468477|P1|Overall Study|Protocol Violation|1
3044817|NCT00635804|10468607|P8|Overall Study|Withdrawal by Subject|0
3044818|NCT00635804|10468608|P7|Overall Study|Withdrawal by Subject|0
3044819|NCT00635804|10468609|P6|Overall Study|Withdrawal by Subject|0
3044820|NCT00635804|10468610|P5|Overall Study|Withdrawal by Subject|0
3044821|NCT00635804|10468611|P4|Overall Study|Withdrawal by Subject|0
3044822|NCT00635804|10468612|P3|Overall Study|Withdrawal by Subject|0
3044823|NCT00635804|10468613|P2|Overall Study|Withdrawal by Subject|0
3044824|NCT00635804|10468614|P1|Overall Study|Withdrawal by Subject|1
3044825|NCT00635804|10468607|P8|Overall Study|Adverse Event|0
3044826|NCT00635804|10468608|P7|Overall Study|Adverse Event|0
3044827|NCT00635804|10468609|P6|Overall Study|Adverse Event|1
3044828|NCT00635804|10468610|P5|Overall Study|Adverse Event|0
3044829|NCT00635804|10468611|P4|Overall Study|Adverse Event|0
3044830|NCT00635804|10468612|P3|Overall Study|Adverse Event|0
3044831|NCT00635804|10468613|P2|Overall Study|Adverse Event|0
3044832|NCT00635804|10468614|P1|Overall Study|Adverse Event|0
3044833|NCT00635778|10468718|P7|Overall Study|Progressive disease|4
3044834|NCT00635778|10468719|P6|Overall Study|Progressive disease|14
3044835|NCT00635778|10468720|P5|Overall Study|Progressive disease|5
3044836|NCT00635778|10468721|P4|Overall Study|Progressive disease|4
3044837|NCT00635778|10468722|P3|Overall Study|Progressive disease|3
3044838|NCT00635778|10468723|P2|Overall Study|Progressive disease|3
3044839|NCT00635778|10468724|P1|Overall Study|Progressive disease|0
3044840|NCT00635778|10468718|P7|Overall Study|Withdrawal by Subject|1
3044841|NCT00635778|10468719|P6|Overall Study|Withdrawal by Subject|1
3044842|NCT00635778|10468720|P5|Overall Study|Withdrawal by Subject|0
3044843|NCT00635778|10468721|P4|Overall Study|Withdrawal by Subject|1
3044844|NCT00635778|10468722|P3|Overall Study|Withdrawal by Subject|0
3044845|NCT00635778|10468723|P2|Overall Study|Withdrawal by Subject|0
3044846|NCT00635778|10468724|P1|Overall Study|Withdrawal by Subject|0
3044847|NCT00635778|10468718|P7|Overall Study|Adverse Event|1
3044848|NCT00635778|10468719|P6|Overall Study|Adverse Event|6
3044849|NCT00635778|10468720|P5|Overall Study|Adverse Event|3
3044850|NCT00635778|10468721|P4|Overall Study|Adverse Event|3
3044851|NCT00635778|10468722|P3|Overall Study|Adverse Event|0
3044852|NCT00635778|10468723|P2|Overall Study|Adverse Event|0
3044853|NCT00635778|10468724|P1|Overall Study|Adverse Event|1
3044854|NCT00635661|10468795|P1|Overall Study|Withdrawal by Subject|4
3044855|NCT00635648|10468799|P1|Overall Study|Other reason|2
3044856|NCT00635648|10468799|P1|Overall Study|Noncompliance with protocol|1
3044857|NCT00635648|10468799|P1|Overall Study|No improvement after 7-10 days treatment|4
3044858|NCT00635648|10468799|P1|Overall Study|Use of other antifungal agent needed|1
3044859|NCT00635648|10468799|P1|Overall Study|Rapid progression of baseline disease|4
3044860|NCT00635648|10468799|P1|Overall Study|Physician Decision|4
3044861|NCT00635648|10468799|P1|Overall Study|Withdrawal by Subject|9
3044862|NCT00635648|10468799|P1|Overall Study|Adverse Event|12
3044863|NCT00635570|10468821|P2|Overall Study|Early termination(No sexual activity)|1
3044864|NCT00635570|10468822|P1|Overall Study|Early termination(No sexual activity)|1
3044865|NCT00635570|10468821|P2|Overall Study|Did not complete survey|1
3044866|NCT00635570|10468822|P1|Overall Study|Did not complete survey|2
3044867|NCT00635570|10468821|P2|Overall Study|Physician Decision|0
3044868|NCT00635570|10468822|P1|Overall Study|Physician Decision|1
3044869|NCT00635570|10468821|P2|Overall Study|Adverse Event|0
3044870|NCT00635570|10468822|P1|Overall Study|Adverse Event|2
3044871|NCT00635570|10468821|P2|Overall Study|Withdrawal by Subject|1
3044872|NCT00635570|10468822|P1|Overall Study|Withdrawal by Subject|1
3044873|NCT00635570|10468821|P2|Overall Study|Lost to Follow-up|8
3044874|NCT00635570|10468822|P1|Overall Study|Lost to Follow-up|8
3044875|NCT00635492|10468836|P2|Overall Study|Withdrawal by Subject|45
3044876|NCT00635492|10468837|P1|Overall Study|Withdrawal by Subject|82
3044877|NCT00635492|10468836|P2|Overall Study|Sponsor decision|3
3044878|NCT00635492|10468837|P1|Overall Study|Sponsor decision|2
3044879|NCT00635492|10468836|P2|Overall Study|Physician Decision|22
3044880|NCT00635492|10468837|P1|Overall Study|Physician Decision|32
3044881|NCT00635492|10468836|P2|Overall Study|Lost to Follow-up|172
3044882|NCT00635492|10468837|P1|Overall Study|Lost to Follow-up|151
3044883|NCT00635492|10468836|P2|Overall Study|Death|40
3044884|NCT00635492|10468837|P1|Overall Study|Death|12
3044885|NCT00635427|10468910|P5|Overall Study|Withdrawal Of Consent|2
3044886|NCT00635427|10468911|P4|Overall Study|Withdrawal Of Consent|2
3044887|NCT00635427|10468912|P3|Overall Study|Withdrawal Of Consent|0
3044888|NCT00635427|10468913|P2|Overall Study|Withdrawal Of Consent|0
3044889|NCT00635427|10468914|P1|Overall Study|Withdrawal Of Consent|0
3044890|NCT00635427|10468910|P5|Overall Study|Termination Of Study By Sponsor|6
3044891|NCT00635427|10468911|P4|Overall Study|Termination Of Study By Sponsor|6
3044892|NCT00635427|10468912|P3|Overall Study|Termination Of Study By Sponsor|10
3044893|NCT00635427|10468913|P2|Overall Study|Termination Of Study By Sponsor|6
3044894|NCT00635427|10468914|P1|Overall Study|Termination Of Study By Sponsor|12
3044895|NCT00635427|10468910|P5|Overall Study|Death|0
3044896|NCT00635427|10468911|P4|Overall Study|Death|1
3044897|NCT00635427|10468912|P3|Overall Study|Death|0
3044898|NCT00635427|10468913|P2|Overall Study|Death|0
3044899|NCT00635427|10468914|P1|Overall Study|Death|0
3044900|NCT00635427|10468910|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
3044901|NCT00635427|10468911|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
3044902|NCT00635427|10468912|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
3044903|NCT00635427|10468913|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
3044904|NCT00635427|10468914|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
3044905|NCT00635349|10468953|P2|Overall Study|Adverse Event|9
3044906|NCT00635349|10468954|P1|Overall Study|Adverse Event|11
3044907|NCT00635349|10468953|P2|Overall Study|Lost to Follow-up|3
3044908|NCT00635349|10468954|P1|Overall Study|Lost to Follow-up|4
3044909|NCT00635349|10468953|P2|Overall Study|Withdrawal by Subject|8
3044910|NCT00635349|10468954|P1|Overall Study|Withdrawal by Subject|3
3044911|NCT00635349|10468953|P2|Overall Study|Protocol Violation|22
3044912|NCT00635349|10468954|P1|Overall Study|Protocol Violation|18
3044913|NCT00635349|10468953|P2|Overall Study|Other|6
3044914|NCT00635349|10468954|P1|Overall Study|Other|8
3044915|NCT00635219|10469008|P5|Overall Study|Administrative or Other Reasons|1
3044916|NCT00635219|10469009|P4|Overall Study|Administrative or Other Reasons|0
3044917|NCT00635219|10469010|P3|Overall Study|Administrative or Other Reasons|1
3044918|NCT00635219|10469011|P2|Overall Study|Administrative or Other Reasons|1
3044919|NCT00635219|10469012|P1|Overall Study|Administrative or Other Reasons|0
3044920|NCT00635219|10469008|P5|Overall Study|Lost to Follow-up|3
3044921|NCT00635219|10469009|P4|Overall Study|Lost to Follow-up|0
3044922|NCT00635219|10469010|P3|Overall Study|Lost to Follow-up|2
3044923|NCT00635219|10469011|P2|Overall Study|Lost to Follow-up|0
3044924|NCT00635219|10469012|P1|Overall Study|Lost to Follow-up|0
3044925|NCT00635219|10469008|P5|Overall Study|Withdrawal of Consent|8
3044926|NCT00635219|10469009|P4|Overall Study|Withdrawal of Consent|11
3044927|NCT00635219|10469010|P3|Overall Study|Withdrawal of Consent|8
3044928|NCT00635219|10469011|P2|Overall Study|Withdrawal of Consent|6
3044929|NCT00635219|10469012|P1|Overall Study|Withdrawal of Consent|8
3044930|NCT00635219|10469008|P5|Overall Study|Protocol Violation|4
3044931|NCT00635219|10469009|P4|Overall Study|Protocol Violation|2
3044932|NCT00635219|10469010|P3|Overall Study|Protocol Violation|3
3044933|NCT00635219|10469011|P2|Overall Study|Protocol Violation|2
3044934|NCT00635219|10469012|P1|Overall Study|Protocol Violation|0
3044935|NCT00635219|10469008|P5|Overall Study|Non-compliance With Study Product|1
3044936|NCT00635219|10469009|P4|Overall Study|Non-compliance With Study Product|2
3044937|NCT00635219|10469010|P3|Overall Study|Non-compliance With Study Product|0
3044938|NCT00635219|10469011|P2|Overall Study|Non-compliance With Study Product|0
3044939|NCT00635219|10469012|P1|Overall Study|Non-compliance With Study Product|0
3044940|NCT00635219|10469008|P5|Overall Study|Lack of Efficacy|6
3044941|NCT00635219|10469009|P4|Overall Study|Lack of Efficacy|4
3044942|NCT00635219|10469010|P3|Overall Study|Lack of Efficacy|3
3044943|NCT00635219|10469011|P2|Overall Study|Lack of Efficacy|6
3044944|NCT00635219|10469012|P1|Overall Study|Lack of Efficacy|5
3044945|NCT00635219|10469008|P5|Overall Study|Adverse Event|19
3044946|NCT00635219|10469009|P4|Overall Study|Adverse Event|15
3044947|NCT00635219|10469010|P3|Overall Study|Adverse Event|18
3044948|NCT00635219|10469011|P2|Overall Study|Adverse Event|10
3044949|NCT00635219|10469012|P1|Overall Study|Adverse Event|12
3044950|NCT00635154|10469075|P1|Overall Study|Still on treatment|21
3044951|NCT00635154|10469075|P1|Overall Study|Other|4
3044952|NCT00635154|10469075|P1|Overall Study|Alternative Treatment|8
3044953|NCT00635102|10469118|P2|Overall Study|Withdrawal by Subject|8
3044954|NCT00635102|10469119|P1|Overall Study|Withdrawal by Subject|7
3044955|NCT00635089|10469213|P1|Overall Study|Other|31
3044956|NCT00635089|10469213|P1|Overall Study|Lost to Follow-up|8
3044957|NCT00635089|10469213|P1|Overall Study|Protocol Deviation|4
3044958|NCT00635089|10469213|P1|Overall Study|Lack of Efficacy|28
3044959|NCT00635089|10469213|P1|Overall Study|Adverse Event|7
3044960|NCT00635050|10469240|P1|Overall Study|Withdrawal by Subject|1
3044961|NCT00635024|10469247|P1|Overall Study|Adverse Event|1
3044962|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Other|1
3044963|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Other|0
3044964|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Other|5
3044965|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Other|0
3044966|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Other|0
3044967|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
3044968|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
3044969|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
3044970|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
3044971|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
3044972|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
3044973|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
3044974|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
3044975|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
3044976|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
3044977|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Protocol Violation|1
3044978|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Protocol Violation|0
3044979|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Protocol Violation|0
3044980|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Protocol Violation|0
3044981|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Protocol Violation|0
3044982|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Physician Decision|0
3044983|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Physician Decision|0
3044984|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Physician Decision|1
3044985|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Physician Decision|1
3044986|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Physician Decision|0
3044987|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
3044988|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
3044989|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
3044990|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
3044991|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
3044992|NCT00634933|10469258|P5|Part B: Week 24 to Week 52|Adverse Event|0
3044993|NCT00634933|10469259|P4|Part B: Week 24 to Week 52|Adverse Event|1
3044994|NCT00634933|10469260|P3|Part B: Week 24 to Week 52|Adverse Event|1
3044995|NCT00634933|10469261|P2|Part B: Week 24 to Week 52|Adverse Event|1
3044996|NCT00634933|10469262|P1|Part B: Week 24 to Week 52|Adverse Event|0
3044997|NCT00634933|10469258|P5|Between Part A and Part B|Physician Decision|0
3044998|NCT00634933|10469259|P4|Between Part A and Part B|Physician Decision|0
3044999|NCT00634933|10469260|P3|Between Part A and Part B|Physician Decision|0
3045000|NCT00634933|10469261|P2|Between Part A and Part B|Physician Decision|1
3045001|NCT00634933|10469262|P1|Between Part A and Part B|Physician Decision|0
3045002|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Other|0
3045003|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Other|0
3045004|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Other|5
3045005|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Other|8
3045006|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Other|1
3045007|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
3045008|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
3045009|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
3045010|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
3045011|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
3045012|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
3045013|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
3045014|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
3045015|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
3045016|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
3045017|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
3045018|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
3045019|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
3045020|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
3045021|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
3045022|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Investigator Request|0
3045023|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Investigator Request|0
3045024|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Investigator Request|1
3045025|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Investigator Request|1
3045026|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Investigator Request|1
3045027|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Failed to Return|0
3045028|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Failed to Return|0
3045029|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Failed to Return|0
3045030|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Failed to Return|0
3045031|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Failed to Return|1
3045032|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Death|0
3045033|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Death|0
3045034|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Death|0
3045035|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Death|0
3045036|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Death|1
3045037|NCT00634933|10469258|P5|Part A: Baseline to Week 24|Adverse Event|0
3045038|NCT00634933|10469259|P4|Part A: Baseline to Week 24|Adverse Event|0
3045039|NCT00634933|10469260|P3|Part A: Baseline to Week 24|Adverse Event|8
3045040|NCT00634933|10469261|P2|Part A: Baseline to Week 24|Adverse Event|4
3045041|NCT00634933|10469262|P1|Part A: Baseline to Week 24|Adverse Event|4
3045042|NCT00634920|10469331|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
3045043|NCT00634920|10469332|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
3045044|NCT00634920|10469333|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
3045045|NCT00634920|10469331|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
3045046|NCT00634920|10469332|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
3045047|NCT00634920|10469333|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
3045048|NCT00634920|10469331|P3|Period 2 - Post-Randomization|Death|0
3045049|NCT00634920|10469332|P2|Period 2 - Post-Randomization|Death|5
3045050|NCT00634920|10469333|P1|Period 2 - Post-Randomization|Death|2
3045051|NCT00634920|10469331|P3|Period 2 - Post-Randomization|Rejection|0
3045052|NCT00634920|10469332|P2|Period 2 - Post-Randomization|Rejection|5
3045053|NCT00634920|10469333|P1|Period 2 - Post-Randomization|Rejection|11
3045054|NCT00634920|10469331|P3|Period 2 - Post-Randomization|Adverse Event|0
3045055|NCT00634920|10469332|P2|Period 2 - Post-Randomization|Adverse Event|9
3045056|NCT00634920|10469333|P1|Period 2 - Post-Randomization|Adverse Event|37
3045057|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Other issues|6
3045058|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Other issues|0
3045059|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Other issues|0
3045060|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Non-Compliance|3
3045061|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Non-Compliance|0
3045062|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Non-Compliance|0
3045063|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
3045064|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
3045065|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
3045066|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Rejections|55
3045067|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Rejections|0
3045068|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Rejections|0
3045069|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Wound healing problems|16
3045070|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Wound healing problems|0
3045071|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Wound healing problems|0
3045072|NCT00634920|10469331|P3|Period 1 - Pre-Randomization|Adverse Event|36
3045073|NCT00634920|10469332|P2|Period 1 - Pre-Randomization|Adverse Event|0
3045074|NCT00634920|10469333|P1|Period 1 - Pre-Randomization|Adverse Event|0
3045075|NCT00634907|10469377|P2|Overall Study|Withdrawal by Subject|8
3045076|NCT00634907|10469378|P1|Overall Study|Withdrawal by Subject|11
3045077|NCT00634907|10469377|P2|Overall Study|Physician Decision|9
3045078|NCT00634907|10469378|P1|Overall Study|Physician Decision|3
3045079|NCT00634907|10469377|P2|Overall Study|Withdrawal by Subject|0
3045080|NCT00634907|10469378|P1|Overall Study|Withdrawal by Subject|3
3045081|NCT00634842|10469402|P2|Overall Study|Subject off study drug for too long|1
3045082|NCT00634842|10469403|P1|Overall Study|Subject off study drug for too long|0
3045083|NCT00634842|10469402|P2|Overall Study|No wish to keep taking Avandia|1
3045084|NCT00634842|10469403|P1|Overall Study|No wish to keep taking Avandia|0
3045085|NCT00634842|10469402|P2|Overall Study|No need of study drug to treat diabetes|1
3045086|NCT00634842|10469403|P1|Overall Study|No need of study drug to treat diabetes|0
3045087|NCT00634842|10469402|P2|Overall Study|Discontinued due to injection|2
3045088|NCT00634842|10469403|P1|Overall Study|Discontinued due to injection|0
3045089|NCT00634842|10469402|P2|Overall Study|Lack of time and intolerance to drug|1
3045090|NCT00634842|10469403|P1|Overall Study|Lack of time and intolerance to drug|0
3045091|NCT00634842|10469402|P2|Overall Study|Withdrawal by Subject|3
3045092|NCT00634842|10469403|P1|Overall Study|Withdrawal by Subject|1
3045093|NCT00634842|10469402|P2|Overall Study|Physician Decision|0
3045094|NCT00634842|10469403|P1|Overall Study|Physician Decision|1
3045095|NCT00634842|10469402|P2|Overall Study|Lost to Follow-up|2
3045096|NCT00634842|10469403|P1|Overall Study|Lost to Follow-up|1
3045097|NCT00634842|10469402|P2|Overall Study|Inclusion criteria were not met|0
3045098|NCT00634842|10469403|P1|Overall Study|Inclusion criteria were not met|1
3045099|NCT00634842|10469402|P2|Overall Study|Move to another state|0
3045100|NCT00634842|10469403|P1|Overall Study|Move to another state|1
3045101|NCT00634842|10469402|P2|Overall Study|Protocol Violation|4
3045102|NCT00634842|10469403|P1|Overall Study|Protocol Violation|8
3045103|NCT00634842|10469402|P2|Overall Study|Adverse Event|3
3045104|NCT00634842|10469403|P1|Overall Study|Adverse Event|2
3045105|NCT00634751|10469419|P4|Pancreatic and Bilial Tract Cancer|Death|1
3045106|NCT00634751|10469420|P3|Pancreatic and Bilial Tract Cancer|Death|1
3045107|NCT00634751|10469421|P2|Pancreatic and Bilial Tract Cancer|Death|0
3045108|NCT00634751|10469422|P1|Pancreatic and Bilial Tract Cancer|Death|0
3045109|NCT00634751|10469419|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
3045110|NCT00634751|10469420|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
3045111|NCT00634751|10469421|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
3045112|NCT00634751|10469422|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
3045113|NCT00634751|10469419|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
3045114|NCT00634751|10469420|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
3045115|NCT00634751|10469421|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
3045116|NCT00634751|10469422|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
3045117|NCT00634647|10469440|P1|Overall Study|declined to participate before treatment|1
3045118|NCT00634647|10469440|P1|Overall Study|refused further treatment|3
3045119|NCT00634647|10469440|P1|Overall Study|death on study|3
3045120|NCT00634569|10469460|P2|Overall Study|Physician Decision|1
3045121|NCT00634569|10469461|P1|Overall Study|Physician Decision|0
3045122|NCT00634569|10469460|P2|Overall Study|Withdrawal by Subject|4
3045123|NCT00634569|10469461|P1|Overall Study|Withdrawal by Subject|0
3045124|NCT00634543|10469475|P2|Overall Study|Lost to Follow-up|1
3045125|NCT00634543|10469476|P1|Overall Study|Lost to Follow-up|0
3045126|NCT00634543|10469475|P2|Overall Study|Withdrawal by Subject|4
3045127|NCT00634543|10469476|P1|Overall Study|Withdrawal by Subject|4
3045128|NCT00634543|10469475|P2|Overall Study|Adverse Event|11
3045129|NCT00634543|10469476|P1|Overall Study|Adverse Event|11
3045130|NCT00634543|10469475|P2|Overall Study|Protocol Violation|3
3045131|NCT00634543|10469476|P1|Overall Study|Protocol Violation|3
3045132|NCT00634543|10469475|P2|Overall Study|Other|2
3045133|NCT00634543|10469476|P1|Overall Study|Other|1
3045134|NCT00634504|10469494|P2|Overall Study|Protocol Violation|0
3045135|NCT00634504|10469495|P1|Overall Study|Protocol Violation|1
3045136|NCT00634244|10469554|P3|Overall Study|Other complicating disease|0
3045137|NCT00634244|10469555|P2|Overall Study|Other complicating disease|1
3045138|NCT00634244|10469556|P1|Overall Study|Other complicating disease|0
3045139|NCT00634244|10469554|P3|Overall Study|Disease progression/relapse|0
3045140|NCT00634244|10469555|P2|Overall Study|Disease progression/relapse|1
3045141|NCT00634244|10469556|P1|Overall Study|Disease progression/relapse|0
3045142|NCT00634244|10469554|P3|Overall Study|Physician Decision|0
3045143|NCT00634244|10469555|P2|Overall Study|Physician Decision|1
3045144|NCT00634244|10469556|P1|Overall Study|Physician Decision|0
3045145|NCT00634244|10469554|P3|Overall Study|Withdrawal by Subject|0
3045146|NCT00634244|10469555|P2|Overall Study|Withdrawal by Subject|1
3045147|NCT00634244|10469556|P1|Overall Study|Withdrawal by Subject|0
3045148|NCT00634244|10469554|P3|Overall Study|Adverse Event|0
3045149|NCT00634244|10469555|P2|Overall Study|Adverse Event|2
3045150|NCT00634244|10469556|P1|Overall Study|Adverse Event|0
3045151|NCT00634244|10469554|P3|Overall Study|Death|0
3045152|NCT00634244|10469555|P2|Overall Study|Death|6
3045153|NCT00634244|10469556|P1|Overall Study|Death|1
3045154|NCT00634244|10469554|P3|Overall Study|Never started treatment|0
3045155|NCT00634244|10469555|P2|Overall Study|Never started treatment|1
3045156|NCT00634244|10469556|P1|Overall Study|Never started treatment|0
3045157|NCT00634179|10469567|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
3045158|NCT00634114|10469586|P3|Overall Study|Other reason|1
3045159|NCT00634114|10469587|P2|Overall Study|Other reason|1
3045160|NCT00634114|10469588|P1|Overall Study|Other reason|1
3045161|NCT00634114|10469586|P3|Overall Study|Difficult to continue|1
3045162|NCT00634114|10469587|P2|Overall Study|Difficult to continue|1
3045163|NCT00634114|10469588|P1|Overall Study|Difficult to continue|3
3045164|NCT00634114|10469586|P3|Overall Study|Recurrence of reflux esophagitis|21
3045165|NCT00634114|10469587|P2|Overall Study|Recurrence of reflux esophagitis|15
3045166|NCT00634114|10469588|P1|Overall Study|Recurrence of reflux esophagitis|5
3045167|NCT00634114|10469586|P3|Overall Study|Incorrect enrolment|0
3045168|NCT00634114|10469587|P2|Overall Study|Incorrect enrolment|1
3045169|NCT00634114|10469588|P1|Overall Study|Incorrect enrolment|0
3045170|NCT00634114|10469586|P3|Overall Study|Pregnancy|0
3045171|NCT00634114|10469587|P2|Overall Study|Pregnancy|0
3045172|NCT00634114|10469588|P1|Overall Study|Pregnancy|1
3045173|NCT00634114|10469586|P3|Overall Study|Protocol Violation|1
3045174|NCT00634114|10469587|P2|Overall Study|Protocol Violation|3
3045175|NCT00634114|10469588|P1|Overall Study|Protocol Violation|3
3045176|NCT00634114|10469586|P3|Overall Study|Lost to Follow-up|1
3045177|NCT00634114|10469587|P2|Overall Study|Lost to Follow-up|0
3045178|NCT00634114|10469588|P1|Overall Study|Lost to Follow-up|0
3045179|NCT00634114|10469586|P3|Overall Study|Withdrawal by Subject|11
3045180|NCT00634114|10469587|P2|Overall Study|Withdrawal by Subject|6
3045181|NCT00634114|10469588|P1|Overall Study|Withdrawal by Subject|9
3045182|NCT00634114|10469586|P3|Overall Study|Adverse Event|3
3045183|NCT00634114|10469587|P2|Overall Study|Adverse Event|8
3045184|NCT00634114|10469588|P1|Overall Study|Adverse Event|6
3045185|NCT00634088|10469606|P4|Time Period 3: Dose Level 3|Progressive disease|0
3045186|NCT00634088|10469607|P3|Time Period 3: Dose Level 3|Progressive disease|1
3045187|NCT00634088|10469608|P2|Time Period 3: Dose Level 3|Progressive disease|0
3045188|NCT00634088|10469609|P1|Time Period 3: Dose Level 3|Progressive disease|0
3045189|NCT00634088|10469606|P4|Time Period 2: Dose Level 2|Progressive disease|0
3045190|NCT00634088|10469607|P3|Time Period 2: Dose Level 2|Progressive disease|0
3045191|NCT00634088|10469608|P2|Time Period 2: Dose Level 2|Progressive disease|1
3045192|NCT00634088|10469609|P1|Time Period 2: Dose Level 2|Progressive disease|0
3045193|NCT00634088|10469606|P4|Time Period 2: Dose Level 2|Adverse Event|0
3045194|NCT00634088|10469607|P3|Time Period 2: Dose Level 2|Adverse Event|0
3045195|NCT00634088|10469608|P2|Time Period 2: Dose Level 2|Adverse Event|2
3045196|NCT00634088|10469609|P1|Time Period 2: Dose Level 2|Adverse Event|0
3045197|NCT00634088|10469606|P4|Time Period 1: Dose Level 1|Adverse Event|0
3045198|NCT00634088|10469607|P3|Time Period 1: Dose Level 1|Adverse Event|0
3045199|NCT00634088|10469608|P2|Time Period 1: Dose Level 1|Adverse Event|0
3045200|NCT00634088|10469609|P1|Time Period 1: Dose Level 1|Adverse Event|3
3045201|NCT00634088|10469606|P4|Time Period 1: Dose Level 1|Physician Decision|0
3045202|NCT00634088|10469607|P3|Time Period 1: Dose Level 1|Physician Decision|0
3045203|NCT00634088|10469608|P2|Time Period 1: Dose Level 1|Physician Decision|0
3045204|NCT00634088|10469609|P1|Time Period 1: Dose Level 1|Physician Decision|1
3045205|NCT00634088|10469606|P4|Time Period 1: Dose Level 1|Disease progression|0
3045206|NCT00634088|10469607|P3|Time Period 1: Dose Level 1|Disease progression|0
3045207|NCT00634088|10469608|P2|Time Period 1: Dose Level 1|Disease progression|0
3045208|NCT00634088|10469609|P1|Time Period 1: Dose Level 1|Disease progression|2
3045209|NCT00634049|10469660|P1|Overall Study|Screening failure|1
3045210|NCT00634049|10469660|P1|Overall Study|Died prior to receiving study drug|1
3045211|NCT00634049|10469660|P1|Overall Study|Never received study drug|1
3045212|NCT00634036|10469739|P2|Overall Study|Withdrawal by Subject|1
3045213|NCT00634036|10469740|P1|Overall Study|Withdrawal by Subject|1
3045214|NCT00634036|10469739|P2|Overall Study|Lost to Follow-up|1
3045215|NCT00634036|10469740|P1|Overall Study|Lost to Follow-up|1
3045216|NCT00634010|10469754|P2|Overall Study|Non-Compliant|1
3045217|NCT00634010|10469755|P1|Overall Study|Non-Compliant|1
3045218|NCT00634010|10469754|P2|Overall Study|Disease Progression|1
3045219|NCT00634010|10469755|P1|Overall Study|Disease Progression|1
3045220|NCT00634010|10469754|P2|Overall Study|Physician Decision|1
3045221|NCT00634010|10469755|P1|Overall Study|Physician Decision|1
3045222|NCT00634010|10469754|P2|Overall Study|Withdrawal by Subject|6
3045223|NCT00634010|10469755|P1|Overall Study|Withdrawal by Subject|5
3045224|NCT00634010|10469754|P2|Overall Study|Adverse Event|5
3045225|NCT00634010|10469755|P1|Overall Study|Adverse Event|2
3045226|NCT00633984|10469763|P2|Overall Study|Hospitalized|0
3045227|NCT00633984|10469764|P1|Overall Study|Hospitalized|1
3045228|NCT00633984|10469763|P2|Overall Study|Withdrawal by Subject|7
3045229|NCT00633984|10469764|P1|Overall Study|Withdrawal by Subject|8
3045230|NCT00633984|10469763|P2|Overall Study|Lost to Follow-up|6
3045231|NCT00633984|10469764|P1|Overall Study|Lost to Follow-up|0
3045232|NCT00633945|10469772|P1|Overall Study|Physician Decision|2
3045233|NCT00633932|10469788|P3|Overall Study|Moved Away|0
3045234|NCT00633932|10469789|P2|Overall Study|Moved Away|0
3045235|NCT00633932|10469790|P1|Overall Study|Moved Away|1
3045236|NCT00633932|10469788|P3|Overall Study|Doctor's judgement|0
3045237|NCT00633932|10469789|P2|Overall Study|Doctor's judgement|0
3045238|NCT00633932|10469790|P1|Overall Study|Doctor's judgement|1
3045239|NCT00633932|10469788|P3|Overall Study|Physician Decision|1
3045240|NCT00633932|10469789|P2|Overall Study|Physician Decision|0
3045241|NCT00633932|10469790|P1|Overall Study|Physician Decision|0
3045242|NCT00633932|10469788|P3|Overall Study|Protocol Violation|3
3045243|NCT00633932|10469789|P2|Overall Study|Protocol Violation|2
3045244|NCT00633932|10469790|P1|Overall Study|Protocol Violation|5
3045245|NCT00633932|10469788|P3|Overall Study|Lost to Follow-up|2
3045246|NCT00633932|10469789|P2|Overall Study|Lost to Follow-up|0
3045247|NCT00633932|10469790|P1|Overall Study|Lost to Follow-up|1
3045248|NCT00633932|10469788|P3|Overall Study|Withdrawal by Subject|1
3045249|NCT00633932|10469789|P2|Overall Study|Withdrawal by Subject|9
3045250|NCT00633932|10469790|P1|Overall Study|Withdrawal by Subject|3
3045251|NCT00633932|10469788|P3|Overall Study|Adverse Event|4
3045252|NCT00633932|10469789|P2|Overall Study|Adverse Event|3
3045253|NCT00633932|10469790|P1|Overall Study|Adverse Event|1
3045254|NCT00633893|10469821|P3|Overall Study|Other|31
3045255|NCT00633893|10469822|P2|Overall Study|Other|33
3045256|NCT00633893|10469823|P1|Overall Study|Other|28
3045257|NCT00633893|10469821|P3|Overall Study|Not meet/no longer meets criteria|4
3045258|NCT00633893|10469822|P2|Overall Study|Not meet/no longer meets criteria|6
3045259|NCT00633893|10469823|P1|Overall Study|Not meet/no longer meets criteria|4
3045260|NCT00633893|10469821|P3|Overall Study|Pregnancy|1
3045261|NCT00633893|10469822|P2|Overall Study|Pregnancy|1
3045262|NCT00633893|10469823|P1|Overall Study|Pregnancy|2
3045263|NCT00633893|10469821|P3|Overall Study|Poor/non-compliance|3
3045264|NCT00633893|10469822|P2|Overall Study|Poor/non-compliance|12
3045265|NCT00633893|10469823|P1|Overall Study|Poor/non-compliance|5
3045266|NCT00633893|10469821|P3|Overall Study|Lost to Follow-up|8
3045267|NCT00633893|10469822|P2|Overall Study|Lost to Follow-up|4
3045268|NCT00633893|10469823|P1|Overall Study|Lost to Follow-up|2
3045269|NCT00633893|10469821|P3|Overall Study|Withdrawal by Subject|6
3045270|NCT00633893|10469822|P2|Overall Study|Withdrawal by Subject|12
3045271|NCT00633893|10469823|P1|Overall Study|Withdrawal by Subject|7
3045272|NCT00633893|10469821|P3|Overall Study|Adverse Event|126
3045273|NCT00633893|10469822|P2|Overall Study|Adverse Event|58
3045274|NCT00633893|10469823|P1|Overall Study|Adverse Event|65
3045275|NCT00633893|10469821|P3|Overall Study|Death|9
3045276|NCT00633893|10469822|P2|Overall Study|Death|3
3045277|NCT00633893|10469823|P1|Overall Study|Death|1
3045278|NCT00633880|10469897|P3|Open Label Titration|Withdrawal by Subject|0
3045279|NCT00633880|10469898|P2|Open Label Titration|Withdrawal by Subject|0
3045280|NCT00633880|10469899|P1|Open Label Titration|Withdrawal by Subject|4
3045281|NCT00633880|10469897|P3|Open Label Titration|Physician Decision|0
3045282|NCT00633880|10469898|P2|Open Label Titration|Physician Decision|0
3045283|NCT00633880|10469899|P1|Open Label Titration|Physician Decision|1
3045284|NCT00633880|10469897|P3|Open Label Titration|Protocol Violation|0
3045285|NCT00633880|10469898|P2|Open Label Titration|Protocol Violation|0
3045286|NCT00633880|10469899|P1|Open Label Titration|Protocol Violation|6
3045287|NCT00633880|10469897|P3|Open Label Titration|Treatment Failure|0
3045288|NCT00633880|10469898|P2|Open Label Titration|Treatment Failure|0
3045289|NCT00633880|10469899|P1|Open Label Titration|Treatment Failure|55
3045290|NCT00633880|10469897|P3|Open Label Titration|Adverse Event|0
3045291|NCT00633880|10469898|P2|Open Label Titration|Adverse Event|0
3045292|NCT00633880|10469899|P1|Open Label Titration|Adverse Event|13
3045293|NCT00633880|10469897|P3|Open Label Titration|Lack of Efficacy|0
3045294|NCT00633880|10469898|P2|Open Label Titration|Lack of Efficacy|0
3045295|NCT00633880|10469899|P1|Open Label Titration|Lack of Efficacy|1
3045296|NCT00633750|10469935|P1|Overall Study|Withdrawal by Subject|3
3045297|NCT00633750|10469935|P1|Overall Study|Adverse Event|2
3045298|NCT00633594|10469944|P3|Overall Study|Disease Progression|1
3045299|NCT00633594|10469945|P2|Overall Study|Disease Progression|0
3045300|NCT00633594|10469946|P1|Overall Study|Disease Progression|0
3045301|NCT00633594|10469944|P3|Overall Study|Death|2
3045302|NCT00633594|10469945|P2|Overall Study|Death|1
3045303|NCT00633594|10469946|P1|Overall Study|Death|0
3045304|NCT00633594|10469944|P3|Overall Study|Adverse Event|7
3045305|NCT00633594|10469945|P2|Overall Study|Adverse Event|4
3045306|NCT00633594|10469946|P1|Overall Study|Adverse Event|0
3045307|NCT00633477|10469975|P2|Overall Study|Randomized but not treated|0
3045308|NCT00633477|10469976|P1|Overall Study|Randomized but not treated|1
3045309|NCT00633477|10469975|P2|Overall Study|Death|0
3045310|NCT00633477|10469976|P1|Overall Study|Death|1
3045311|NCT00633464|10469992|P2|Overall Study|Never Treated (Randomized in error)|1
3045312|NCT00633464|10469993|P1|Overall Study|Never Treated (Randomized in error)|0
3045313|NCT00633464|10469992|P2|Overall Study|Never Treated (Not met study criteria)|1
3045314|NCT00633464|10469993|P1|Overall Study|Never Treated (Not met study criteria)|0
3045315|NCT00633360|10470028|P2|Overall Study|Protocol Violation|1
3045316|NCT00633360|10470029|P1|Overall Study|Protocol Violation|0
3045317|NCT00633360|10470028|P2|Overall Study|Adverse Event|1
3045318|NCT00633360|10470029|P1|Overall Study|Adverse Event|3
3045319|NCT00633360|10470028|P2|Overall Study|Lost to Follow-up|1
3045320|NCT00633360|10470029|P1|Overall Study|Lost to Follow-up|1
3045321|NCT00633243|10470052|P2|Overall Study|Couldn't tolerate side-effects|1
3045322|NCT00633243|10470053|P1|Overall Study|Couldn't tolerate side-effects|1
3045323|NCT00633243|10470052|P2|Overall Study|Mental Health--Depression|1
3045324|NCT00633243|10470053|P1|Overall Study|Mental Health--Depression|0
3045325|NCT00633243|10470052|P2|Overall Study|Not comfortable with self-injecting|1
3045326|NCT00633243|10470053|P1|Overall Study|Not comfortable with self-injecting|0
3045327|NCT00633243|10470052|P2|Overall Study|Homeless--no refrigeration for meds|1
3045328|NCT00633243|10470053|P1|Overall Study|Homeless--no refrigeration for meds|0
3045329|NCT00633243|10470052|P2|Overall Study|incarceration|2
3045330|NCT00633243|10470053|P1|Overall Study|incarceration|0
3045331|NCT00633243|10470052|P2|Overall Study|Withdrawal by Subject|1
3045332|NCT00633243|10470053|P1|Overall Study|Withdrawal by Subject|0
3045333|NCT00633217|10470061|P2|Overall Study|Withdrew Consent|3
3045334|NCT00633217|10470062|P1|Overall Study|Withdrew Consent|3
3045335|NCT00633217|10470061|P2|Overall Study|Investigator Discretion|0
3045336|NCT00633217|10470062|P1|Overall Study|Investigator Discretion|2
3045337|NCT00633217|10470061|P2|Overall Study|Lost to Follow-up|2
3045338|NCT00633217|10470062|P1|Overall Study|Lost to Follow-up|2
3045339|NCT00633217|10470061|P2|Overall Study|Protocol Violation|7
3045340|NCT00633217|10470062|P1|Overall Study|Protocol Violation|3
3045341|NCT00633217|10470061|P2|Overall Study|Lack of Efficacy|2
3045342|NCT00633217|10470062|P1|Overall Study|Lack of Efficacy|0
3045343|NCT00633217|10470061|P2|Overall Study|Adverse Event|9
3045344|NCT00633217|10470062|P1|Overall Study|Adverse Event|5
3045345|NCT00633152|10470074|P2|Overall Study|Miscellaneous Other|2
3045346|NCT00633152|10470075|P1|Overall Study|Miscellaneous Other|3
3045347|NCT00633152|10470074|P2|Overall Study|Lost to Follow-up|1
3045348|NCT00633152|10470075|P1|Overall Study|Lost to Follow-up|4
3045349|NCT00633152|10470074|P2|Overall Study|Withdrawal by Subject|1
3045350|NCT00633152|10470075|P1|Overall Study|Withdrawal by Subject|1
3045351|NCT00633152|10470074|P2|Overall Study|Randomized, did not receive study drug|2
3045352|NCT00633152|10470075|P1|Overall Study|Randomized, did not receive study drug|5
3045353|NCT00633152|10470074|P2|Overall Study|Adverse Event|0
3045354|NCT00633152|10470075|P1|Overall Study|Adverse Event|1
3045355|NCT00633139|10470086|P3|Overall Study|Withdrawal by Subject|0
3045356|NCT00633139|10470087|P2|Overall Study|Withdrawal by Subject|1
3045357|NCT00633139|10470088|P1|Overall Study|Withdrawal by Subject|0
3045358|NCT00633139|10470086|P3|Overall Study|Non compliance|1
3045359|NCT00633139|10470087|P2|Overall Study|Non compliance|0
3045360|NCT00633139|10470088|P1|Overall Study|Non compliance|0
3045361|NCT00633126|10470102|P1|Overall Study|Did not receive full dose|1
3045362|NCT00633074|10470116|P2|Overall Study|Adverse Event|0
3045363|NCT00633074|10470117|P1|Overall Study|Adverse Event|1
3045364|NCT00633061|10470147|P2|Overall Study|Study closed|0
3045365|NCT00633061|10470148|P1|Overall Study|Study closed|86
3045366|NCT00633022|10470159|P3|Overall Study|Physician Decision|0
3045367|NCT00633022|10470160|P2|Overall Study|Physician Decision|1
3045368|NCT00633022|10470161|P1|Overall Study|Physician Decision|0
3045369|NCT00633022|10470159|P3|Overall Study|Adverse Event|5
3045370|NCT00633022|10470160|P2|Overall Study|Adverse Event|0
3045371|NCT00633022|10470161|P1|Overall Study|Adverse Event|1
3045372|NCT00632931|10470223|P3|Part 2|Withdrawal by Subject|3
3045373|NCT00632931|10470224|P2|Part 2|Withdrawal by Subject|0
3045374|NCT00632931|10470225|P1|Part 2|Withdrawal by Subject|0
3045375|NCT00632931|10470223|P3|Part 2|Lack of Efficacy|17
3045376|NCT00632931|10470224|P2|Part 2|Lack of Efficacy|0
3045377|NCT00632931|10470225|P1|Part 2|Lack of Efficacy|0
3045378|NCT00632931|10470223|P3|Part 2|Death|1
3045379|NCT00632931|10470224|P2|Part 2|Death|0
3045380|NCT00632931|10470225|P1|Part 2|Death|0
3045381|NCT00632931|10470223|P3|Part 2|Adverse Event|3
3045382|NCT00632931|10470224|P2|Part 2|Adverse Event|0
3045383|NCT00632931|10470225|P1|Part 2|Adverse Event|0
3045384|NCT00632931|10470223|P3|Part 1, Period 1|Withdrawal by Subject|0
3045385|NCT00632931|10470224|P2|Part 1, Period 1|Withdrawal by Subject|0
3045386|NCT00632931|10470225|P1|Part 1, Period 1|Withdrawal by Subject|1
3045387|NCT00632931|10470223|P3|Part 1, Period 1|Protocol Violation|0
3045388|NCT00632931|10470224|P2|Part 1, Period 1|Protocol Violation|0
3045389|NCT00632931|10470225|P1|Part 1, Period 1|Protocol Violation|1
3045390|NCT00632827|10470244|P1|Overall Study|Lost to Follow-up|1
3045391|NCT00632827|10470244|P1|Overall Study|Adverse Event|5
3045392|NCT00632827|10470244|P1|Overall Study|Death|2
3045393|NCT00632827|10470244|P1|Overall Study|Excluded after GVD (Not evaluable)|2
3045394|NCT00632749|10470302|P14|Overall Study|Reason other than those specified above|2
3045395|NCT00632749|10470303|P13|Overall Study|Reason other than those specified above|0
3045396|NCT00632749|10470304|P12|Overall Study|Reason other than those specified above|1
3045397|NCT00632749|10470305|P11|Overall Study|Reason other than those specified above|2
3045398|NCT00632749|10470306|P10|Overall Study|Reason other than those specified above|0
3045399|NCT00632749|10470307|P9|Overall Study|Reason other than those specified above|0
3045400|NCT00632749|10470308|P8|Overall Study|Reason other than those specified above|0
3045401|NCT00632749|10470309|P7|Overall Study|Reason other than those specified above|1
3045402|NCT00632749|10470310|P6|Overall Study|Reason other than those specified above|0
3045403|NCT00632749|10470311|P5|Overall Study|Reason other than those specified above|1
3045404|NCT00632749|10470312|P4|Overall Study|Reason other than those specified above|0
3045405|NCT00632749|10470313|P3|Overall Study|Reason other than those specified above|0
3045406|NCT00632749|10470314|P2|Overall Study|Reason other than those specified above|2
3045407|NCT00632749|10470315|P1|Overall Study|Reason other than those specified above|0
3045408|NCT00632749|10470302|P14|Overall Study|Refuse to continue medication|0
3045409|NCT00632749|10470303|P13|Overall Study|Refuse to continue medication|0
3045410|NCT00632749|10470304|P12|Overall Study|Refuse to continue medication|0
3045411|NCT00632749|10470305|P11|Overall Study|Refuse to continue medication|0
3045412|NCT00632749|10470306|P10|Overall Study|Refuse to continue medication|1
3045413|NCT00632749|10470307|P9|Overall Study|Refuse to continue medication|0
3045414|NCT00632749|10470308|P8|Overall Study|Refuse to continue medication|0
3045415|NCT00632749|10470309|P7|Overall Study|Refuse to continue medication|0
3045416|NCT00632749|10470310|P6|Overall Study|Refuse to continue medication|0
3045417|NCT00632749|10470311|P5|Overall Study|Refuse to continue medication|0
3045418|NCT00632749|10470312|P4|Overall Study|Refuse to continue medication|1
3045419|NCT00632749|10470313|P3|Overall Study|Refuse to continue medication|0
3045420|NCT00632749|10470314|P2|Overall Study|Refuse to continue medication|0
3045421|NCT00632749|10470315|P1|Overall Study|Refuse to continue medication|0
3045422|NCT00632749|10470302|P14|Overall Study|Other Adverse event|0
3045423|NCT00632749|10470303|P13|Overall Study|Other Adverse event|1
3045424|NCT00632749|10470304|P12|Overall Study|Other Adverse event|0
3045425|NCT00632749|10470305|P11|Overall Study|Other Adverse event|1
3045426|NCT00632749|10470306|P10|Overall Study|Other Adverse event|0
3045427|NCT00632749|10470307|P9|Overall Study|Other Adverse event|2
3045428|NCT00632749|10470308|P8|Overall Study|Other Adverse event|2
3045429|NCT00632749|10470309|P7|Overall Study|Other Adverse event|1
3045430|NCT00632749|10470310|P6|Overall Study|Other Adverse event|4
3045431|NCT00632749|10470311|P5|Overall Study|Other Adverse event|2
3045432|NCT00632749|10470312|P4|Overall Study|Other Adverse event|1
3045433|NCT00632749|10470313|P3|Overall Study|Other Adverse event|1
3045434|NCT00632749|10470314|P2|Overall Study|Other Adverse event|1
3045435|NCT00632749|10470315|P1|Overall Study|Other Adverse event|1
3045436|NCT00632749|10470302|P14|Overall Study|Progressive disease|4
3045437|NCT00632749|10470303|P13|Overall Study|Progressive disease|2
3045438|NCT00632749|10470304|P12|Overall Study|Progressive disease|3
3045439|NCT00632749|10470305|P11|Overall Study|Progressive disease|4
3045440|NCT00632749|10470306|P10|Overall Study|Progressive disease|2
3045441|NCT00632749|10470307|P9|Overall Study|Progressive disease|3
3045442|NCT00632749|10470308|P8|Overall Study|Progressive disease|2
3045443|NCT00632749|10470309|P7|Overall Study|Progressive disease|3
3045444|NCT00632749|10470310|P6|Overall Study|Progressive disease|4
3045445|NCT00632749|10470311|P5|Overall Study|Progressive disease|4
3045446|NCT00632749|10470312|P4|Overall Study|Progressive disease|2
3045447|NCT00632749|10470313|P3|Overall Study|Progressive disease|2
3045448|NCT00632749|10470314|P2|Overall Study|Progressive disease|2
3045449|NCT00632749|10470315|P1|Overall Study|Progressive disease|3
3045450|NCT00632736|10470609|P1|Overall Study|Other|16
3045451|NCT00632736|10470609|P1|Overall Study|Non-compliance|10
3045452|NCT00632736|10470609|P1|Overall Study|Sponsor terminated study|5
3045453|NCT00632736|10470609|P1|Overall Study|Lack of Efficacy|5
3045454|NCT00632736|10470609|P1|Overall Study|Withdrawal by Subject|99
3045455|NCT00632736|10470609|P1|Overall Study|Protocol Violation|14
3045456|NCT00632736|10470609|P1|Overall Study|Lost to Follow-up|15
3045457|NCT00632736|10470609|P1|Overall Study|Adverse Event|104
3045458|NCT00632541|10470644|P1|Overall Study|Adverse Event|7
3045459|NCT00632502|10470653|P2|Overall Study|Randomized not treated|0
3045460|NCT00632502|10470654|P1|Overall Study|Randomized not treated|3
3045461|NCT00632502|10470653|P2|Overall Study|Adverse Event|1
3045462|NCT00632502|10470654|P1|Overall Study|Adverse Event|0
3045463|NCT00632463|10470698|P3|Overall Study|Adverse Event|0
3045464|NCT00632463|10470699|P2|Overall Study|Adverse Event|1
3045465|NCT00632463|10470700|P1|Overall Study|Adverse Event|0
3045466|NCT00632424|10470717|P1|Overall Study|Study Drug Toxicity|1
3045467|NCT00632424|10470717|P1|Overall Study|Disease Progression|17
3045468|NCT00632359|10470748|P1|Overall Study|Withdrawal by Subject|2
3045469|NCT00632229|10470761|P2|Overall Study|Undisclosed reasons within the first wee|1
3045470|NCT00632229|10470762|P1|Overall Study|Undisclosed reasons within the first wee|0
3045471|NCT00632229|10470761|P2|Overall Study|Lack of Efficacy|2
3045472|NCT00632229|10470762|P1|Overall Study|Lack of Efficacy|0
3045473|NCT00632229|10470761|P2|Overall Study|Lost to Follow-up|3
3045474|NCT00632229|10470762|P1|Overall Study|Lost to Follow-up|0
3045475|NCT00632229|10470761|P2|Overall Study|Adverse Event|0
3045476|NCT00632229|10470762|P1|Overall Study|Adverse Event|6
3045477|NCT00632203|10470772|P2|Overall Study|Did not start study treatment|0
3045478|NCT00632203|10470773|P1|Overall Study|Did not start study treatment|1
3045479|NCT00632125|10470791|P1|Overall Study|Moved to other dialysis unit, etc.|102
3045480|NCT00632125|10470791|P1|Overall Study|Development of uncontrolled hypertension|5
3045481|NCT00632125|10470791|P1|Overall Study|Non-compliance|8
3045482|NCT00632125|10470791|P1|Overall Study|Need for systemic immunosuppressive medi|8
3045483|NCT00632125|10470791|P1|Overall Study|Renal transplantation|17
3045484|NCT00632125|10470791|P1|Overall Study|Adverse Event|36
3045485|NCT00632125|10470791|P1|Overall Study|Withdrawal by Subject|44
3045486|NCT00632125|10470791|P1|Overall Study|Death|82
3045487|NCT00632099|10470797|P2|Overall Study|Lost to Follow-up|3
3045488|NCT00632099|10470798|P1|Overall Study|Lost to Follow-up|3
3045489|NCT00632021|10470806|P2|Overall Study|Withdrawal/death|7
3045490|NCT00632021|10470807|P1|Overall Study|Withdrawal/death|4
3045491|NCT00631969|10470817|P2|Overall Study|No Drug Exposure|2
3045492|NCT00631969|10470818|P1|Overall Study|No Drug Exposure|2
3045493|NCT00631969|10470817|P2|Overall Study|Noncompliant With Study Medication|1
3045494|NCT00631969|10470818|P1|Overall Study|Noncompliant With Study Medication|0
3045495|NCT00631969|10470817|P2|Overall Study|Consent Withdrawn|7
3045496|NCT00631969|10470818|P1|Overall Study|Consent Withdrawn|5
3045497|NCT00631969|10470817|P2|Overall Study|Protocol Violation|1
3045498|NCT00631969|10470818|P1|Overall Study|Protocol Violation|1
3045499|NCT00631969|10470817|P2|Overall Study|Lost to Follow-up|1
3045500|NCT00631969|10470818|P1|Overall Study|Lost to Follow-up|2
3045501|NCT00631969|10470817|P2|Overall Study|Lack of Efficacy|8
3045502|NCT00631969|10470818|P1|Overall Study|Lack of Efficacy|2
3045503|NCT00631969|10470817|P2|Overall Study|Adverse Event|1
3045504|NCT00631969|10470818|P1|Overall Study|Adverse Event|3
3045505|NCT00631917|10470864|P2|Overall Study|Death|0
3045506|NCT00631917|10470865|P1|Overall Study|Death|1
3045507|NCT00631917|10470864|P2|Overall Study|Administrative problems|0
3045508|NCT00631917|10470865|P1|Overall Study|Administrative problems|2
3045509|NCT00631917|10470864|P2|Overall Study|Lost to Follow-up|7
3045510|NCT00631917|10470865|P1|Overall Study|Lost to Follow-up|7
3045511|NCT00631917|10470864|P2|Overall Study|Subject withdrew consent|33
3045512|NCT00631917|10470865|P1|Overall Study|Subject withdrew consent|25
3045513|NCT00631917|10470864|P2|Overall Study|Protocol deviation|5
3045514|NCT00631917|10470865|P1|Overall Study|Protocol deviation|6
3045515|NCT00631917|10470864|P2|Overall Study|No longer required study drug|1
3045516|NCT00631917|10470865|P1|Overall Study|No longer required study drug|0
3045517|NCT00631917|10470864|P2|Overall Study|Unsatisfactory therapeutic effect|14
3045518|NCT00631917|10470865|P1|Overall Study|Unsatisfactory therapeutic effect|8
3045519|NCT00631917|10470864|P2|Overall Study|Abnormal test procedure result(s)|2
3045520|NCT00631917|10470865|P1|Overall Study|Abnormal test procedure result(s)|3
3045521|NCT00631917|10470864|P2|Overall Study|Abnormal laboratory value(s)|1
3045522|NCT00631917|10470865|P1|Overall Study|Abnormal laboratory value(s)|2
3045523|NCT00631917|10470864|P2|Overall Study|Adverse Event|45
3045524|NCT00631917|10470865|P1|Overall Study|Adverse Event|34
3045525|NCT00631696|10470892|P2|Overall Study|Adverse Event|0
3045526|NCT00631696|10470893|P1|Overall Study|Adverse Event|5
3045527|NCT00631696|10470892|P2|Overall Study|Study terminated by sponsor|3
3045528|NCT00631696|10470893|P1|Overall Study|Study terminated by sponsor|3
3045529|NCT00631696|10470892|P2|Overall Study|Protocol Violation|9
3045530|NCT00631696|10470893|P1|Overall Study|Protocol Violation|9
3045531|NCT00631696|10470892|P2|Overall Study|Other|8
3045532|NCT00631696|10470893|P1|Overall Study|Other|8
3045533|NCT00631696|10470892|P2|Overall Study|Withdrawal by Subject|9
3045534|NCT00631696|10470893|P1|Overall Study|Withdrawal by Subject|2
3045535|NCT00631696|10470892|P2|Overall Study|Lost to Follow-up|10
3045536|NCT00631696|10470893|P1|Overall Study|Lost to Follow-up|7
3045537|NCT00631696|10470892|P2|Overall Study|Follow up after database release date|0
3045538|NCT00631696|10470893|P1|Overall Study|Follow up after database release date|1
3045539|NCT00631696|10470892|P2|Overall Study|Discontinued after database release date|0
3045540|NCT00631696|10470893|P1|Overall Study|Discontinued after database release date|1
3045541|NCT00631696|10470892|P2|Overall Study|Entered, not randomized to treatment|1
3045542|NCT00631696|10470893|P1|Overall Study|Entered, not randomized to treatment|1
3045543|NCT00631657|10470936|P3|7-Day Discontinuation Period|Other|0
3045544|NCT00631657|10470937|P2|7-Day Discontinuation Period|Other|0
3045545|NCT00631657|10470938|P1|7-Day Discontinuation Period|Other|1
3045546|NCT00631657|10470936|P3|7-Day Discontinuation Period|Not Treated|1
3045547|NCT00631657|10470937|P2|7-Day Discontinuation Period|Not Treated|1
3045548|NCT00631657|10470938|P1|7-Day Discontinuation Period|Not Treated|1
3045549|NCT00631657|10470936|P3|6-Month Treatment Period|Not Treated|1
3045550|NCT00631657|10470937|P2|6-Month Treatment Period|Not Treated|0
3045551|NCT00631657|10470938|P1|6-Month Treatment Period|Not Treated|2
3045552|NCT00631657|10470936|P3|6-Month Treatment Period|Other|4
3045553|NCT00631657|10470937|P2|6-Month Treatment Period|Other|0
3045554|NCT00631657|10470938|P1|6-Month Treatment Period|Other|16
3045555|NCT00631657|10470936|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
3045556|NCT00631657|10470937|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
3045557|NCT00631657|10470938|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
3045558|NCT00631657|10470936|P3|6-Month Treatment Period|Lost to Follow-up|2
3045559|NCT00631657|10470937|P2|6-Month Treatment Period|Lost to Follow-up|0
3045560|NCT00631657|10470938|P1|6-Month Treatment Period|Lost to Follow-up|7
3045561|NCT00631657|10470936|P3|6-Month Treatment Period|Lack of Efficacy|25
3045562|NCT00631657|10470937|P2|6-Month Treatment Period|Lack of Efficacy|0
3045563|NCT00631657|10470938|P1|6-Month Treatment Period|Lack of Efficacy|34
3045564|NCT00631657|10470936|P3|6-Month Treatment Period|Withdrawal by Subject|5
3045565|NCT00631657|10470937|P2|6-Month Treatment Period|Withdrawal by Subject|0
3045566|NCT00631657|10470938|P1|6-Month Treatment Period|Withdrawal by Subject|14
3045567|NCT00631657|10470936|P3|6-Month Treatment Period|Adverse Event|7
3045568|NCT00631657|10470937|P2|6-Month Treatment Period|Adverse Event|0
3045569|NCT00631657|10470938|P1|6-Month Treatment Period|Adverse Event|47
3045570|NCT00631540|10470987|P1|Overall Study|Core Lab Data Unavailable|3
3045571|NCT00631540|10470987|P1|Overall Study|Lost to Follow-up|2
3045572|NCT00631540|10470987|P1|Overall Study|Death|4
3045573|NCT00631540|10470987|P1|Overall Study|Withdrawal by Subject|5
3045574|NCT00631488|10470999|P3|Overall Study|Protocol Violation|1
3045575|NCT00631488|10471000|P2|Overall Study|Protocol Violation|0
3045576|NCT00631488|10471001|P1|Overall Study|Protocol Violation|0
3045577|NCT00631488|10470999|P3|Overall Study|Physician Decision|1
3045578|NCT00631488|10471000|P2|Overall Study|Physician Decision|0
3045579|NCT00631488|10471001|P1|Overall Study|Physician Decision|1
3045580|NCT00631488|10470999|P3|Overall Study|Lost to Follow-up|0
3045581|NCT00631488|10471000|P2|Overall Study|Lost to Follow-up|2
3045582|NCT00631488|10471001|P1|Overall Study|Lost to Follow-up|2
3045583|NCT00631488|10470999|P3|Overall Study|Adverse Event|0
3045584|NCT00631488|10471000|P2|Overall Study|Adverse Event|0
3045585|NCT00631488|10471001|P1|Overall Study|Adverse Event|1
3045586|NCT00631475|10471021|P1|Overall Study|Preparation for lung transplant|8
3045587|NCT00631475|10471021|P1|Overall Study|Withdrew consent|5
3045588|NCT00631475|10471021|P1|Overall Study|Adverse Event|14
3045589|NCT00631475|10471021|P1|Overall Study|Death|18
3045590|NCT00631410|10471040|P2|Overall Study|Surgery|0
3045591|NCT00631410|10471041|P1|Overall Study|Surgery|1
3045592|NCT00631410|10471040|P2|Overall Study|Objective Progression or Relapse|3
3045593|NCT00631410|10471041|P1|Overall Study|Objective Progression or Relapse|4
3045594|NCT00631410|10471040|P2|Overall Study|Adverse Event|3
3045595|NCT00631410|10471041|P1|Overall Study|Adverse Event|1
3045596|NCT00631371|10471060|P2|Overall Study|Death|239
3045597|NCT00631371|10471061|P1|Overall Study|Death|263
3045598|NCT00631371|10471060|P2|Overall Study|Discontinuation of study by Sponsor|76
3045599|NCT00631371|10471061|P1|Overall Study|Discontinuation of study by Sponsor|70
3045600|NCT00631371|10471060|P2|Overall Study|subject request|45
3045601|NCT00631371|10471061|P1|Overall Study|subject request|38
3045602|NCT00631371|10471060|P2|Overall Study|Other reason|12
3045603|NCT00631371|10471061|P1|Overall Study|Other reason|5
3045604|NCT00631371|10471060|P2|Overall Study|Lost to Follow-up|19
3045605|NCT00631371|10471061|P1|Overall Study|Lost to Follow-up|24
3045606|NCT00631189|10471094|P4|Treatment Phase|patient did not take pravastatin|0
3045607|NCT00631189|10471095|P3|Treatment Phase|patient did not take pravastatin|1
3045608|NCT00631189|10471096|P2|Treatment Phase|patient did not take pravastatin|0
3045609|NCT00631189|10471097|P1|Treatment Phase|patient did not take pravastatin|0
3045610|NCT00631189|10471094|P4|Treatment Phase|Pregnancy|0
3045611|NCT00631189|10471095|P3|Treatment Phase|Pregnancy|1
3045612|NCT00631189|10471096|P2|Treatment Phase|Pregnancy|0
3045613|NCT00631189|10471097|P1|Treatment Phase|Pregnancy|0
3045614|NCT00631189|10471094|P4|Treatment Phase|Lost to Follow-up|0
3045615|NCT00631189|10471095|P3|Treatment Phase|Lost to Follow-up|0
3045616|NCT00631189|10471096|P2|Treatment Phase|Lost to Follow-up|1
3045617|NCT00631189|10471097|P1|Treatment Phase|Lost to Follow-up|0
3045618|NCT00631189|10471094|P4|Treatment Phase|Adverse Event|4
3045619|NCT00631189|10471095|P3|Treatment Phase|Adverse Event|2
3045620|NCT00631189|10471096|P2|Treatment Phase|Adverse Event|3
3045621|NCT00631189|10471097|P1|Treatment Phase|Adverse Event|0
3045622|NCT00631189|10471094|P4|Treatment Phase|Protocol Violation|2
3045623|NCT00631189|10471095|P3|Treatment Phase|Protocol Violation|6
3045624|NCT00631189|10471096|P2|Treatment Phase|Protocol Violation|1
3045625|NCT00631189|10471097|P1|Treatment Phase|Protocol Violation|0
3045626|NCT00631189|10471094|P4|Treatment Phase|Withdrawal by Subject|1
3045627|NCT00631189|10471095|P3|Treatment Phase|Withdrawal by Subject|1
3045628|NCT00631189|10471096|P2|Treatment Phase|Withdrawal by Subject|2
3045629|NCT00631189|10471097|P1|Treatment Phase|Withdrawal by Subject|0
3045630|NCT00631189|10471094|P4|Initial Phase|Withdrawal by Subject|0
3045631|NCT00631189|10471095|P3|Initial Phase|Withdrawal by Subject|0
3045632|NCT00631189|10471096|P2|Initial Phase|Withdrawal by Subject|0
3045633|NCT00631189|10471097|P1|Initial Phase|Withdrawal by Subject|4
3045634|NCT00631189|10471094|P4|Initial Phase|Protocol Violation|0
3045635|NCT00631189|10471095|P3|Initial Phase|Protocol Violation|0
3045636|NCT00631189|10471096|P2|Initial Phase|Protocol Violation|0
3045637|NCT00631189|10471097|P1|Initial Phase|Protocol Violation|347
3045638|NCT00631137|10471141|P2|Overall Study|Withdrawal by Subject|0
3045639|NCT00631137|10471142|P1|Overall Study|Withdrawal by Subject|1
3045640|NCT00631020|10471160|P1|Overall Study|Incarcerated|1
3045641|NCT00631020|10471160|P1|Overall Study|Lost to Follow-up|7
3045642|NCT00631007|10471175|P6|Overall Study|Other|0
3045643|NCT00631007|10471176|P5|Overall Study|Other|1
3045644|NCT00631007|10471177|P4|Overall Study|Other|0
3045645|NCT00631007|10471178|P3|Overall Study|Other|0
3045646|NCT00631007|10471179|P2|Overall Study|Other|1
3045647|NCT00631007|10471180|P1|Overall Study|Other|2
3045648|NCT00631007|10471175|P6|Overall Study|Withdrawal by Subject|3
3045649|NCT00631007|10471176|P5|Overall Study|Withdrawal by Subject|1
3045650|NCT00631007|10471177|P4|Overall Study|Withdrawal by Subject|2
3045651|NCT00631007|10471178|P3|Overall Study|Withdrawal by Subject|2
3045652|NCT00631007|10471179|P2|Overall Study|Withdrawal by Subject|5
3045653|NCT00631007|10471180|P1|Overall Study|Withdrawal by Subject|4
3045654|NCT00631007|10471175|P6|Overall Study|Persistent Hyperglycemia|5
3045655|NCT00631007|10471176|P5|Overall Study|Persistent Hyperglycemia|2
3045656|NCT00631007|10471177|P4|Overall Study|Persistent Hyperglycemia|1
3045657|NCT00631007|10471178|P3|Overall Study|Persistent Hyperglycemia|5
3045658|NCT00631007|10471179|P2|Overall Study|Persistent Hyperglycemia|2
3045659|NCT00631007|10471180|P1|Overall Study|Persistent Hyperglycemia|2
3045660|NCT00631007|10471175|P6|Overall Study|Physician Decision|2
3045661|NCT00631007|10471176|P5|Overall Study|Physician Decision|0
3045662|NCT00631007|10471177|P4|Overall Study|Physician Decision|0
3045663|NCT00631007|10471178|P3|Overall Study|Physician Decision|1
3045664|NCT00631007|10471179|P2|Overall Study|Physician Decision|0
3045665|NCT00631007|10471180|P1|Overall Study|Physician Decision|1
3045666|NCT00631007|10471175|P6|Overall Study|Lost to Follow-up|3
3045667|NCT00631007|10471176|P5|Overall Study|Lost to Follow-up|5
3045668|NCT00631007|10471177|P4|Overall Study|Lost to Follow-up|4
3045669|NCT00631007|10471178|P3|Overall Study|Lost to Follow-up|2
3045670|NCT00631007|10471179|P2|Overall Study|Lost to Follow-up|1
3045671|NCT00631007|10471180|P1|Overall Study|Lost to Follow-up|2
3045672|NCT00631007|10471175|P6|Overall Study|Adverse Event|2
3045673|NCT00631007|10471176|P5|Overall Study|Adverse Event|3
3045674|NCT00631007|10471177|P4|Overall Study|Adverse Event|2
3045675|NCT00631007|10471178|P3|Overall Study|Adverse Event|0
3045676|NCT00631007|10471179|P2|Overall Study|Adverse Event|2
3045677|NCT00631007|10471180|P1|Overall Study|Adverse Event|0
3045678|NCT00630994|10471200|P1|Overall Study|Other|1
3045679|NCT00630994|10471200|P1|Overall Study|Lack of Efficacy|1
3045680|NCT00630994|10471200|P1|Overall Study|Disease Progression|1
3045681|NCT00630994|10471200|P1|Overall Study|Adverse Event|1
3045682|NCT00630916|10471230|P1|Overall Study|Lack of Efficacy|3
3045683|NCT00630916|10471230|P1|Overall Study|Physician Decision|47
3045684|NCT00630916|10471230|P1|Overall Study|Protocol Violation|7
3045685|NCT00630916|10471230|P1|Overall Study|Withdrawal by Subject|30
3045686|NCT00630916|10471230|P1|Overall Study|Lost to Follow-up|5
3045687|NCT00630916|10471230|P1|Overall Study|Explant|8
3045688|NCT00630916|10471230|P1|Overall Study|Death|110
3045689|NCT00630877|10471240|P3|Overall Study|Personal reasons|1
3045690|NCT00630877|10471241|P2|Overall Study|Personal reasons|0
3045691|NCT00630877|10471242|P1|Overall Study|Personal reasons|0
3045692|NCT00630877|10471240|P3|Overall Study|Protocol violation|1
3045693|NCT00630877|10471241|P2|Overall Study|Protocol violation|0
3045694|NCT00630877|10471242|P1|Overall Study|Protocol violation|1
3045695|NCT00630877|10471240|P3|Overall Study|Noncompliance|1
3045696|NCT00630877|10471241|P2|Overall Study|Noncompliance|3
3045697|NCT00630877|10471242|P1|Overall Study|Noncompliance|2
3045698|NCT00630877|10471240|P3|Overall Study|Lost to Follow-up|0
3045699|NCT00630877|10471241|P2|Overall Study|Lost to Follow-up|0
3045700|NCT00630877|10471242|P1|Overall Study|Lost to Follow-up|2
3045701|NCT00630877|10471240|P3|Overall Study|Withdrawal by Subject|0
3045702|NCT00630877|10471241|P2|Overall Study|Withdrawal by Subject|4
3045703|NCT00630877|10471242|P1|Overall Study|Withdrawal by Subject|3
3045704|NCT00630877|10471240|P3|Overall Study|Adverse Event|7
3045705|NCT00630877|10471241|P2|Overall Study|Adverse Event|8
3045706|NCT00630877|10471242|P1|Overall Study|Adverse Event|11
3045707|NCT00630864|10471260|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
3045708|NCT00630864|10471260|P1|Part 1 (up to Week 6)|Adverse Event|1
3045709|NCT00630838|10471299|P2|Overall Study|Lost to Follow-up|1
3045710|NCT00630838|10471300|P1|Overall Study|Lost to Follow-up|0
3045711|NCT00630838|10471299|P2|Overall Study|Death|1
3045712|NCT00630838|10471300|P1|Overall Study|Death|0
3045713|NCT00630825|10471312|P4|Overall Study|Withdrawal by Subject|3
3045714|NCT00630825|10471313|P3|Overall Study|Withdrawal by Subject|2
3045715|NCT00630825|10471314|P2|Overall Study|Withdrawal by Subject|2
3045716|NCT00630825|10471315|P1|Overall Study|Withdrawal by Subject|2
3045717|NCT00630825|10471312|P4|Overall Study|Physician Decision|0
3045718|NCT00630825|10471313|P3|Overall Study|Physician Decision|0
3045719|NCT00630825|10471314|P2|Overall Study|Physician Decision|0
3045720|NCT00630825|10471315|P1|Overall Study|Physician Decision|1
3045721|NCT00630825|10471312|P4|Overall Study|Lost to Follow-up|1
3045722|NCT00630825|10471313|P3|Overall Study|Lost to Follow-up|1
3045723|NCT00630825|10471314|P2|Overall Study|Lost to Follow-up|1
3045724|NCT00630825|10471315|P1|Overall Study|Lost to Follow-up|1
3045725|NCT00630825|10471312|P4|Overall Study|Entry Criteria Not Met|1
3045726|NCT00630825|10471313|P3|Overall Study|Entry Criteria Not Met|2
3045727|NCT00630825|10471314|P2|Overall Study|Entry Criteria Not Met|0
3045728|NCT00630825|10471315|P1|Overall Study|Entry Criteria Not Met|1
3045729|NCT00630825|10471312|P4|Overall Study|Adverse Event|1
3045730|NCT00630825|10471313|P3|Overall Study|Adverse Event|3
3045731|NCT00630825|10471314|P2|Overall Study|Adverse Event|4
3045732|NCT00630825|10471315|P1|Overall Study|Adverse Event|4
3045733|NCT00630786|10471387|P3|Overall Study|Other|0
3045734|NCT00630786|10471388|P2|Overall Study|Other|0
3045735|NCT00630786|10471389|P1|Overall Study|Other|1
3045736|NCT00630786|10471387|P3|Overall Study|Lost to Follow-up|0
3045737|NCT00630786|10471388|P2|Overall Study|Lost to Follow-up|1
3045738|NCT00630786|10471389|P1|Overall Study|Lost to Follow-up|0
3045739|NCT00630786|10471387|P3|Overall Study|Withdrawal by Subject|1
3045740|NCT00630786|10471388|P2|Overall Study|Withdrawal by Subject|1
3045741|NCT00630786|10471389|P1|Overall Study|Withdrawal by Subject|0
3045742|NCT00630786|10471387|P3|Overall Study|Physician Decision|1
3045743|NCT00630786|10471388|P2|Overall Study|Physician Decision|0
3045744|NCT00630786|10471389|P1|Overall Study|Physician Decision|0
3045745|NCT00630747|10471408|P1|Overall Study|Returned to country of origin|1
3045746|NCT00630747|10471408|P1|Overall Study|Transferred to Study TKT031NPU|7
3045747|NCT00630747|10471408|P1|Overall Study|Death|1
3045748|NCT00630539|10471461|P4|Overall Study|Withdrawal by Subject|1
3045749|NCT00630539|10471462|P3|Overall Study|Withdrawal by Subject|0
3045750|NCT00630539|10471463|P2|Overall Study|Withdrawal by Subject|1
3045751|NCT00630539|10471464|P1|Overall Study|Withdrawal by Subject|0
3045752|NCT00630539|10471461|P4|Overall Study|Adverse Event|2
3045753|NCT00630539|10471462|P3|Overall Study|Adverse Event|1
3045754|NCT00630539|10471463|P2|Overall Study|Adverse Event|3
3045755|NCT00630539|10471464|P1|Overall Study|Adverse Event|1
3045756|NCT00630396|10471560|P1|Overall Study|Lost to Follow-up|3
3045757|NCT00630396|10471560|P1|Overall Study|Death|4
3045758|NCT00630344|10471566|P1|Overall Study|Other|1
3045759|NCT00630344|10471566|P1|Overall Study|Intercurrent Illness|1
3045760|NCT00630344|10471566|P1|Overall Study|Withdrawal by Subject|1
3045761|NCT00630344|10471566|P1|Overall Study|Physician Decision|9
3045762|NCT00630344|10471566|P1|Overall Study|Progressive Disease|19
3045763|NCT00630344|10471566|P1|Overall Study|Adverse Event|5
3045764|NCT00630331|10471578|P3|Overall Study|Protocol Violation|6
3045765|NCT00630331|10471579|P2|Overall Study|Protocol Violation|5
3045766|NCT00630331|10471580|P1|Overall Study|Protocol Violation|4
3045767|NCT00630331|10471578|P3|Overall Study|Unable to classify|3
3045768|NCT00630331|10471579|P2|Overall Study|Unable to classify|4
3045769|NCT00630331|10471580|P1|Overall Study|Unable to classify|9
3045770|NCT00630331|10471578|P3|Overall Study|Inappropriate enrollment|3
3045771|NCT00630331|10471579|P2|Overall Study|Inappropriate enrollment|6
3045772|NCT00630331|10471580|P1|Overall Study|Inappropriate enrollment|3
3045773|NCT00630331|10471578|P3|Overall Study|Lost to Follow-up|170
3045774|NCT00630331|10471579|P2|Overall Study|Lost to Follow-up|143
3045775|NCT00630331|10471580|P1|Overall Study|Lost to Follow-up|175
3045776|NCT00630331|10471578|P3|Overall Study|Withdrawal by Subject|5
3045777|NCT00630331|10471579|P2|Overall Study|Withdrawal by Subject|7
3045778|NCT00630331|10471580|P1|Overall Study|Withdrawal by Subject|12
3045779|NCT00630331|10471578|P3|Overall Study|Adverse Event|0
3045780|NCT00630331|10471579|P2|Overall Study|Adverse Event|0
3045781|NCT00630331|10471580|P1|Overall Study|Adverse Event|1
3045782|NCT00630331|10471578|P3|Overall Study|Death|1
3045783|NCT00630331|10471579|P2|Overall Study|Death|1
3045784|NCT00630331|10471580|P1|Overall Study|Death|2
3045785|NCT00630305|10471621|P1|Overall Study|Inability to insert contact lens|1
3045786|NCT00630305|10471621|P1|Overall Study|Withdrawal by Subject|1
3045787|NCT00630292|10471643|P1|Overall Study|Withdrawal by Subject|1
3045788|NCT00630058|10471649|P2|Overall Study|stopping criteria|2
3045789|NCT00630058|10471650|P1|Overall Study|stopping criteria|3
3045790|NCT00630058|10471649|P2|Overall Study|Withdrawal by Subject|1
3045791|NCT00630058|10471650|P1|Overall Study|Withdrawal by Subject|0
3045792|NCT00630058|10471649|P2|Overall Study|Adverse Event|1
3045793|NCT00630058|10471650|P1|Overall Study|Adverse Event|1
3045794|NCT00629772|10471681|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
3045795|NCT00629772|10471682|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
3045796|NCT00629772|10471681|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
3045797|NCT00629772|10471682|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
3045798|NCT00629707|10471702|P2|Overall Study|Physician Decision|1
3045799|NCT00629707|10471703|P1|Overall Study|Physician Decision|0
3045800|NCT00629707|10471702|P2|Overall Study|Withdrawal by Subject|1
3045801|NCT00629707|10471703|P1|Overall Study|Withdrawal by Subject|0
3045802|NCT00629265|10471723|P2|Overall Study|Unknown Reason|2
3045803|NCT00629265|10471724|P1|Overall Study|Unknown Reason|2
3045804|NCT00629265|10471723|P2|Overall Study|Unrelated Medical Complications|1
3045805|NCT00629265|10471724|P1|Overall Study|Unrelated Medical Complications|3
3045806|NCT00629265|10471723|P2|Overall Study|Needed Esophageal Dilation|1
3045807|NCT00629265|10471724|P1|Overall Study|Needed Esophageal Dilation|4
3045808|NCT00629265|10471723|P2|Overall Study|Other CA Requiring Treatment|3
3045809|NCT00629265|10471724|P1|Overall Study|Other CA Requiring Treatment|1
3045810|NCT00629265|10471723|P2|Overall Study|HNC Recurrence|0
3045811|NCT00629265|10471724|P1|Overall Study|HNC Recurrence|4
3045812|NCT00629265|10471723|P2|Overall Study|Adverse Event|0
3045813|NCT00629265|10471724|P1|Overall Study|Adverse Event|2
3045814|NCT00629265|10471723|P2|Overall Study|Death|0
3045815|NCT00629265|10471724|P1|Overall Study|Death|1
3045816|NCT00629265|10471723|P2|Overall Study|Withdrawal by Subject|8
3045817|NCT00629265|10471724|P1|Overall Study|Withdrawal by Subject|11
3045818|NCT00629265|10471723|P2|Overall Study|Lost to Follow-up|5
3045819|NCT00629265|10471724|P1|Overall Study|Lost to Follow-up|4
3045820|NCT00629239|10471734|P2|Overall Study|Physician Decision|0
3045821|NCT00629239|10471735|P1|Overall Study|Physician Decision|1
3045822|NCT00629239|10471734|P2|Overall Study|Adverse Event|4
3045823|NCT00629239|10471735|P1|Overall Study|Adverse Event|7
3045824|NCT00629083|10471788|P2|Overall Study|Refused to return for 12 month visit|0
3045825|NCT00629083|10471789|P1|Overall Study|Refused to return for 12 month visit|1
3045826|NCT00629083|10471788|P2|Overall Study|Moved out of country/state|1
3045827|NCT00629083|10471789|P1|Overall Study|Moved out of country/state|2
3045828|NCT00629083|10471788|P2|Overall Study|Lost to Follow-up|8
3045829|NCT00629083|10471789|P1|Overall Study|Lost to Follow-up|12
3045830|NCT00629083|10471788|P2|Overall Study|Withdrawal by Subject|2
3045831|NCT00629083|10471789|P1|Overall Study|Withdrawal by Subject|10
3045832|NCT00629083|10471788|P2|Overall Study|Lack of Efficacy|1
3045833|NCT00629083|10471789|P1|Overall Study|Lack of Efficacy|3
3045834|NCT00629083|10471788|P2|Overall Study|Adverse Event|2
3045835|NCT00629083|10471789|P1|Overall Study|Adverse Event|0
3045836|NCT00628927|10471820|P2|Overall Study|Equipment failure|0
3045837|NCT00628927|10471821|P1|Overall Study|Equipment failure|1
3045838|NCT00628927|10471820|P2|Overall Study|Lost to Follow-up|0
3045839|NCT00628927|10471821|P1|Overall Study|Lost to Follow-up|1
3045840|NCT00628927|10471820|P2|Overall Study|Problems performing blood draw|0
3045841|NCT00628927|10471821|P1|Overall Study|Problems performing blood draw|6
3045842|NCT00628862|10471866|P3|Overall Study|COPD Exacerbation|0
3045843|NCT00628862|10471867|P2|Overall Study|COPD Exacerbation|1
3045844|NCT00628862|10471868|P1|Overall Study|COPD Exacerbation|0
3045845|NCT00628862|10471866|P3|Overall Study|Protocol Violation|0
3045846|NCT00628862|10471867|P2|Overall Study|Protocol Violation|0
3045847|NCT00628862|10471868|P1|Overall Study|Protocol Violation|1
3045848|NCT00628862|10471866|P3|Overall Study|Lost to Follow-up|1
3045849|NCT00628862|10471867|P2|Overall Study|Lost to Follow-up|2
3045850|NCT00628862|10471868|P1|Overall Study|Lost to Follow-up|0
3045851|NCT00628862|10471866|P3|Overall Study|Withdrawal by Subject|11
3045852|NCT00628862|10471867|P2|Overall Study|Withdrawal by Subject|6
3045853|NCT00628862|10471868|P1|Overall Study|Withdrawal by Subject|4
3045854|NCT00628862|10471866|P3|Overall Study|Adverse Event|10
3045855|NCT00628862|10471867|P2|Overall Study|Adverse Event|8
3045856|NCT00628862|10471868|P1|Overall Study|Adverse Event|6
3045857|NCT00628758|10471914|P2|Overall Study|Treatment Failure|2
3045858|NCT00628758|10471915|P1|Overall Study|Treatment Failure|0
3045859|NCT00628758|10471914|P2|Overall Study|Investigator Moved|0
3045860|NCT00628758|10471915|P1|Overall Study|Investigator Moved|3
3045861|NCT00628758|10471914|P2|Overall Study|Pregnancy|2
3045862|NCT00628758|10471915|P1|Overall Study|Pregnancy|2
3045863|NCT00628758|10471914|P2|Overall Study|Lost to Follow-up|31
3045864|NCT00628758|10471915|P1|Overall Study|Lost to Follow-up|25
3045865|NCT00628758|10471914|P2|Overall Study|Protocol Violation|1
3045866|NCT00628758|10471915|P1|Overall Study|Protocol Violation|5
3045867|NCT00628758|10471914|P2|Overall Study|Death|0
3045868|NCT00628758|10471915|P1|Overall Study|Death|1
3045869|NCT00628758|10471914|P2|Overall Study|Withdrawal by Subject|3
3045870|NCT00628758|10471915|P1|Overall Study|Withdrawal by Subject|6
3045871|NCT00628758|10471914|P2|Overall Study|Adverse Event|3
3045872|NCT00628758|10471915|P1|Overall Study|Adverse Event|2
3045873|NCT00628446|10471959|P1|Overall Study|Protocol Violation|3
3045874|NCT00628446|10471959|P1|Overall Study|Withdrawal by Subject|1
3045875|NCT00628446|10471959|P1|Overall Study|Lost to Follow-up|3
3045876|NCT00628355|10471970|P2|Overall Study|Withdrawal by Subject|1
3045877|NCT00628355|10471971|P1|Overall Study|Withdrawal by Subject|1
3045878|NCT00628251|10471982|P3|Ongoing Initial Study Treatment at DCO|Other|2
3045879|NCT00628251|10471983|P2|Ongoing Initial Study Treatment at DCO|Other|0
3045880|NCT00628251|10471984|P1|Ongoing Initial Study Treatment at DCO|Other|1
3045881|NCT00628251|10471982|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
3045882|NCT00628251|10471983|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
3045883|NCT00628251|10471984|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
3045884|NCT00628251|10471982|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
3045885|NCT00628251|10471983|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
3045886|NCT00628251|10471984|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
3045887|NCT00628251|10471982|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
3045888|NCT00628251|10471983|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
3045889|NCT00628251|10471984|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
3045890|NCT00628251|10471982|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
3045891|NCT00628251|10471983|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
3045892|NCT00628251|10471984|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
3045893|NCT00628251|10471982|P3|Randomised Part|Withdrawal by Subject|1
3045894|NCT00628251|10471983|P2|Randomised Part|Withdrawal by Subject|0
3045895|NCT00628251|10471984|P1|Randomised Part|Withdrawal by Subject|0
3045896|NCT00628212|10472030|P4|Overall Study|Physician Decision|3
3045897|NCT00628212|10472031|P3|Overall Study|Physician Decision|2
3045898|NCT00628212|10472032|P2|Overall Study|Physician Decision|1
3045899|NCT00628212|10472033|P1|Overall Study|Physician Decision|1
3045900|NCT00628212|10472030|P4|Overall Study|Adverse Event|2
3045901|NCT00628212|10472031|P3|Overall Study|Adverse Event|1
3045902|NCT00628212|10472032|P2|Overall Study|Adverse Event|0
3045903|NCT00628212|10472033|P1|Overall Study|Adverse Event|2
3045904|NCT00628108|10472081|P2|Overall Study|Withdrawal by Subject|0
3045905|NCT00628108|10472082|P1|Overall Study|Withdrawal by Subject|1
3045906|NCT00628108|10472081|P2|Overall Study|Adverse Event|3
3045907|NCT00628108|10472082|P1|Overall Study|Adverse Event|0
3045908|NCT00628030|10472114|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
3045909|NCT00628030|10472115|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
3045910|NCT00628030|10472114|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
3045911|NCT00628030|10472115|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
3045912|NCT00628030|10472114|P2|Baseline to Post-Assessment|Lost to Follow-up|29
3045913|NCT00628030|10472115|P1|Baseline to Post-Assessment|Lost to Follow-up|28
3045914|NCT00627926|10472141|P3|Overall Study|Noncompliance/unspecified|17
3045915|NCT00627926|10472142|P2|Overall Study|Noncompliance/unspecified|23
3045916|NCT00627926|10472143|P1|Overall Study|Noncompliance/unspecified|8
3045917|NCT00627926|10472141|P3|Overall Study|Lack of Efficacy|38
3045918|NCT00627926|10472142|P2|Overall Study|Lack of Efficacy|40
3045919|NCT00627926|10472143|P1|Overall Study|Lack of Efficacy|118
3045920|NCT00627926|10472141|P3|Overall Study|Withdrawal by Subject|0
3045921|NCT00627926|10472142|P2|Overall Study|Withdrawal by Subject|1
3045922|NCT00627926|10472143|P1|Overall Study|Withdrawal by Subject|2
3045923|NCT00627926|10472141|P3|Overall Study|Lost to Follow-up|4
3045924|NCT00627926|10472142|P2|Overall Study|Lost to Follow-up|3
3045925|NCT00627926|10472143|P1|Overall Study|Lost to Follow-up|4
3045926|NCT00627926|10472141|P3|Overall Study|Death|0
3045927|NCT00627926|10472142|P2|Overall Study|Death|0
3045928|NCT00627926|10472143|P1|Overall Study|Death|1
3045929|NCT00627926|10472141|P3|Overall Study|Adverse Event|36
3045930|NCT00627926|10472142|P2|Overall Study|Adverse Event|37
3045931|NCT00627926|10472143|P1|Overall Study|Adverse Event|26
3045932|NCT00627705|10472195|P2|Overall Study|Lost to Follow-up|1
3045933|NCT00627705|10472196|P1|Overall Study|Lost to Follow-up|0
3045934|NCT00627705|10472195|P2|Overall Study|Withdrawal by Subject|2
3045935|NCT00627705|10472196|P1|Overall Study|Withdrawal by Subject|0
3045936|NCT00627705|10472195|P2|Overall Study|Adverse Event|0
3045937|NCT00627705|10472196|P1|Overall Study|Adverse Event|1
3045938|NCT00627705|10472195|P2|Overall Study|Unwilling to take the compound (taste)|3
3045939|NCT00627705|10472196|P1|Overall Study|Unwilling to take the compound (taste)|1
3045940|NCT00627523|10472247|P2|Overall Study|Other|0
3045941|NCT00627523|10472248|P1|Overall Study|Other|1
3045942|NCT00627523|10472247|P2|Overall Study|Withdrawal by Subject|2
3045943|NCT00627523|10472248|P1|Overall Study|Withdrawal by Subject|0
3045944|NCT00627523|10472247|P2|Overall Study|Lack of Efficacy|0
3045945|NCT00627523|10472248|P1|Overall Study|Lack of Efficacy|1
3045946|NCT00627497|10472276|P4|Overall Study|Lost to Follow-up|0
3045947|NCT00627497|10472277|P3|Overall Study|Lost to Follow-up|0
3045948|NCT00627497|10472278|P2|Overall Study|Lost to Follow-up|1
3045949|NCT00627497|10472279|P1|Overall Study|Lost to Follow-up|1
3045950|NCT00627458|10472340|P3|Overall Study|Lost to Follow-up|0
3045951|NCT00627458|10472341|P2|Overall Study|Lost to Follow-up|1
3045952|NCT00627458|10472342|P1|Overall Study|Lost to Follow-up|1
3045953|NCT00627458|10472340|P3|Overall Study|Withdrawal by Subject|5
3045954|NCT00627458|10472341|P2|Overall Study|Withdrawal by Subject|6
3045955|NCT00627458|10472342|P1|Overall Study|Withdrawal by Subject|2
3045956|NCT00627458|10472340|P3|Overall Study|Migrated from study area|1
3045957|NCT00627458|10472341|P2|Overall Study|Migrated from study area|0
3045958|NCT00627458|10472342|P1|Overall Study|Migrated from study area|1
3045959|NCT00627445|10472417|P2|Overall Study|Other|8
3045960|NCT00627445|10472418|P1|Overall Study|Other|6
3045961|NCT00627445|10472417|P2|Overall Study|Lack of Efficacy|1
3045962|NCT00627445|10472418|P1|Overall Study|Lack of Efficacy|0
3045963|NCT00627445|10472417|P2|Overall Study|Adverse Event|3
3045964|NCT00627445|10472418|P1|Overall Study|Adverse Event|3
3045965|NCT00627393|10472461|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
3045966|NCT00627393|10472462|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
3045967|NCT00627393|10472461|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
3045968|NCT00627393|10472462|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
3045969|NCT00627393|10472461|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
3045970|NCT00627393|10472462|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
3045971|NCT00627393|10472461|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
3045972|NCT00627393|10472462|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
3045973|NCT00627094|10472498|P2|Overall Study|Other reason|0
3045974|NCT00627094|10472499|P1|Overall Study|Other reason|1
3045975|NCT00627094|10472498|P2|Overall Study|ulcer healed|7
3045976|NCT00627094|10472499|P1|Overall Study|ulcer healed|1
3045977|NCT00627094|10472498|P2|Overall Study|Withdrawal by Subject|1
3045978|NCT00627094|10472499|P1|Overall Study|Withdrawal by Subject|1
3045979|NCT00627094|10472498|P2|Overall Study|Lost to Follow-up|0
3045980|NCT00627094|10472499|P1|Overall Study|Lost to Follow-up|1
3045981|NCT00627094|10472498|P2|Overall Study|Adverse Event|7
3045982|NCT00627094|10472499|P1|Overall Study|Adverse Event|8
3045983|NCT00627042|10472511|P1|Overall Study|Withdrawal by Subject|2
3045984|NCT00627016|10472523|P2|Overall Study|Pregnancy|0
3045985|NCT00627016|10472524|P1|Overall Study|Pregnancy|1
3045986|NCT00627016|10472523|P2|Overall Study|Placed on Excluded Drugs|0
3045987|NCT00627016|10472524|P1|Overall Study|Placed on Excluded Drugs|1
3045988|NCT00627016|10472523|P2|Overall Study|Lack of Efficacy|0
3045989|NCT00627016|10472524|P1|Overall Study|Lack of Efficacy|1
3045990|NCT00627016|10472523|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
3045991|NCT00627016|10472524|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
3045992|NCT00627016|10472523|P2|Overall Study|Withdrawal by Subject|1
3045993|NCT00627016|10472524|P1|Overall Study|Withdrawal by Subject|2
3045994|NCT00627016|10472523|P2|Overall Study|Lost to Follow-up|1
3045995|NCT00627016|10472524|P1|Overall Study|Lost to Follow-up|0
3045996|NCT00627016|10472523|P2|Overall Study|Protocol Violation|2
3045997|NCT00627016|10472524|P1|Overall Study|Protocol Violation|0
3045998|NCT00627016|10472523|P2|Overall Study|Adverse Event|1
3045999|NCT00627016|10472524|P1|Overall Study|Adverse Event|1
3046000|NCT00626925|10472536|P2|Overall Study|Time constraints|1
3046001|NCT00626925|10472537|P1|Overall Study|Time constraints|3
3046002|NCT00626925|10472536|P2|Overall Study|Lack of Efficacy|4
3046003|NCT00626925|10472537|P1|Overall Study|Lack of Efficacy|1
3046004|NCT00626925|10472536|P2|Overall Study|Adverse effect|2
3046005|NCT00626925|10472537|P1|Overall Study|Adverse effect|6
3046006|NCT00626925|10472536|P2|Overall Study|relapse|0
3046007|NCT00626925|10472537|P1|Overall Study|relapse|1
3046008|NCT00626925|10472536|P2|Overall Study|Lost to Follow-up|2
3046009|NCT00626925|10472537|P1|Overall Study|Lost to Follow-up|1
3046010|NCT00626821|10472584|P1|Overall Study|other/unknown reason|104
3046011|NCT00626821|10472584|P1|Overall Study|Product dysfunction|21
3046012|NCT00626821|10472584|P1|Overall Study|Physician Decision|9
3046013|NCT00626821|10472584|P1|Overall Study|Withdrawal by Subject|10
3046014|NCT00626821|10472584|P1|Overall Study|Protocol Violation|33
3046015|NCT00626821|10472584|P1|Overall Study|Adverse Event|44
3046016|NCT00626795|10472664|P3|Blinded Treatment|Missing reason for withdrawal|5
3046017|NCT00626795|10472665|P2|Blinded Treatment|Missing reason for withdrawal|3
3046018|NCT00626795|10472666|P1|Blinded Treatment|Missing reason for withdrawal|5
3046019|NCT00626795|10472664|P3|Blinded Treatment|Other reasons|2
3046020|NCT00626795|10472665|P2|Blinded Treatment|Other reasons|0
3046021|NCT00626795|10472666|P1|Blinded Treatment|Other reasons|2
3046022|NCT00626795|10472664|P3|Blinded Treatment|Withdrawal by Subject|0
3046023|NCT00626795|10472665|P2|Blinded Treatment|Withdrawal by Subject|1
3046024|NCT00626795|10472666|P1|Blinded Treatment|Withdrawal by Subject|1
3046025|NCT00626795|10472664|P3|Blinded Treatment|Protocol Violation|1
3046026|NCT00626795|10472665|P2|Blinded Treatment|Protocol Violation|1
3046027|NCT00626795|10472666|P1|Blinded Treatment|Protocol Violation|0
3046028|NCT00626795|10472664|P3|Blinded Treatment|Unacceptable adverse event|1
3046029|NCT00626795|10472665|P2|Blinded Treatment|Unacceptable adverse event|0
3046030|NCT00626795|10472666|P1|Blinded Treatment|Unacceptable adverse event|0
3046031|NCT00626795|10472664|P3|Blinded Treatment|Lack of Efficacy|0
3046032|NCT00626795|10472665|P2|Blinded Treatment|Lack of Efficacy|0
3046033|NCT00626795|10472666|P1|Blinded Treatment|Lack of Efficacy|2
3046034|NCT00626795|10472664|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
3046035|NCT00626795|10472665|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
3046036|NCT00626795|10472666|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
3046037|NCT00626639|10472717|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
3046038|NCT00626639|10472718|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
3046039|NCT00626561|10472764|P1|Overall Study|Disease Progression|2
3046040|NCT00626561|10472764|P1|Overall Study|Withdrawal by Subject|2
3046041|NCT00626548|10472770|P2|Overall Study|Other termination reason|613
3046042|NCT00626548|10472771|P1|Overall Study|Other termination reason|493
3046043|NCT00626548|10472770|P2|Overall Study|Lost to Follow-up|2
3046044|NCT00626548|10472771|P1|Overall Study|Lost to Follow-up|2
3046045|NCT00626548|10472770|P2|Overall Study|Protocol Violation|11
3046046|NCT00626548|10472771|P1|Overall Study|Protocol Violation|4
3046047|NCT00626548|10472770|P2|Overall Study|Withdrawal by Subject|46
3046048|NCT00626548|10472771|P1|Overall Study|Withdrawal by Subject|42
3046049|NCT00626548|10472770|P2|Overall Study|Adverse Event|44
3046050|NCT00626548|10472771|P1|Overall Study|Adverse Event|164
3046051|NCT00626522|10472785|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
3046052|NCT00626522|10472786|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
3046053|NCT00626522|10472787|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
3046054|NCT00626522|10472788|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
3046055|NCT00626522|10472789|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
3046056|NCT00626522|10472790|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
3046057|NCT00626522|10472785|P6|Overall Study|Inconsistent reason reported|0
3046058|NCT00626522|10472786|P5|Overall Study|Inconsistent reason reported|0
3046059|NCT00626522|10472787|P4|Overall Study|Inconsistent reason reported|0
3046060|NCT00626522|10472788|P3|Overall Study|Inconsistent reason reported|0
3046061|NCT00626522|10472789|P2|Overall Study|Inconsistent reason reported|0
3046062|NCT00626522|10472790|P1|Overall Study|Inconsistent reason reported|1
3046063|NCT00626522|10472785|P6|Overall Study|Lost to Follow-up|0
3046064|NCT00626522|10472786|P5|Overall Study|Lost to Follow-up|0
3046065|NCT00626522|10472787|P4|Overall Study|Lost to Follow-up|0
3046066|NCT00626522|10472788|P3|Overall Study|Lost to Follow-up|0
3046067|NCT00626522|10472789|P2|Overall Study|Lost to Follow-up|1
3046068|NCT00626522|10472790|P1|Overall Study|Lost to Follow-up|0
3046069|NCT00626522|10472785|P6|Overall Study|COPD exacerbation|0
3046070|NCT00626522|10472786|P5|Overall Study|COPD exacerbation|1
3046071|NCT00626522|10472787|P4|Overall Study|COPD exacerbation|1
3046072|NCT00626522|10472788|P3|Overall Study|COPD exacerbation|0
3046073|NCT00626522|10472789|P2|Overall Study|COPD exacerbation|0
3046074|NCT00626522|10472790|P1|Overall Study|COPD exacerbation|0
3046075|NCT00626522|10472785|P6|Overall Study|Withdrawal by Subject|1
3046076|NCT00626522|10472786|P5|Overall Study|Withdrawal by Subject|4
3046077|NCT00626522|10472787|P4|Overall Study|Withdrawal by Subject|0
3046078|NCT00626522|10472788|P3|Overall Study|Withdrawal by Subject|5
3046079|NCT00626522|10472789|P2|Overall Study|Withdrawal by Subject|5
3046080|NCT00626522|10472790|P1|Overall Study|Withdrawal by Subject|2
3046081|NCT00626522|10472785|P6|Overall Study|Adverse Event|1
3046082|NCT00626522|10472786|P5|Overall Study|Adverse Event|1
3046083|NCT00626522|10472787|P4|Overall Study|Adverse Event|0
3046084|NCT00626522|10472788|P3|Overall Study|Adverse Event|2
3046085|NCT00626522|10472789|P2|Overall Study|Adverse Event|1
3046086|NCT00626522|10472790|P1|Overall Study|Adverse Event|2
3046087|NCT00626522|10472785|P6|Overall Study|Protocol Violation|0
3046088|NCT00626522|10472786|P5|Overall Study|Protocol Violation|1
3046089|NCT00626522|10472787|P4|Overall Study|Protocol Violation|0
3046090|NCT00626522|10472788|P3|Overall Study|Protocol Violation|0
3046091|NCT00626522|10472789|P2|Overall Study|Protocol Violation|0
3046092|NCT00626522|10472790|P1|Overall Study|Protocol Violation|0
3046093|NCT00626405|10472853|P2|Overall Study|Withdrawal by Subject|1
3046094|NCT00626405|10472854|P1|Overall Study|Withdrawal by Subject|0
3046095|NCT00626405|10472853|P2|Overall Study|Deemed Ineligible|0
3046096|NCT00626405|10472854|P1|Overall Study|Deemed Ineligible|1
3046097|NCT00626392|10472870|P6|Coadministration Period|Other|1
3046098|NCT00626392|10472871|P5|Coadministration Period|Other|1
3046099|NCT00626392|10472872|P4|Coadministration Period|Other|1
3046100|NCT00626392|10472873|P3|Coadministration Period|Other|3
3046101|NCT00626392|10472874|P2|Coadministration Period|Other|2
3046102|NCT00626392|10472875|P1|Coadministration Period|Other|0
3046103|NCT00626392|10472870|P6|Coadministration Period|Protocol Violation|0
3046104|NCT00626392|10472871|P5|Coadministration Period|Protocol Violation|1
3046105|NCT00626392|10472872|P4|Coadministration Period|Protocol Violation|1
3046106|NCT00626392|10472873|P3|Coadministration Period|Protocol Violation|0
3046107|NCT00626392|10472874|P2|Coadministration Period|Protocol Violation|1
3046108|NCT00626392|10472875|P1|Coadministration Period|Protocol Violation|0
3046109|NCT00626392|10472870|P6|Coadministration Period|Withdrawal by Subject|1
3046110|NCT00626392|10472871|P5|Coadministration Period|Withdrawal by Subject|0
3046111|NCT00626392|10472872|P4|Coadministration Period|Withdrawal by Subject|1
3046112|NCT00626392|10472873|P3|Coadministration Period|Withdrawal by Subject|0
3046113|NCT00626392|10472874|P2|Coadministration Period|Withdrawal by Subject|1
3046114|NCT00626392|10472875|P1|Coadministration Period|Withdrawal by Subject|1
3046115|NCT00626392|10472870|P6|Coadministration Period|Adverse Event|4
3046116|NCT00626392|10472871|P5|Coadministration Period|Adverse Event|3
3046117|NCT00626392|10472872|P4|Coadministration Period|Adverse Event|4
3046118|NCT00626392|10472873|P3|Coadministration Period|Adverse Event|7
3046119|NCT00626392|10472874|P2|Coadministration Period|Adverse Event|1
3046120|NCT00626392|10472875|P1|Coadministration Period|Adverse Event|3
3046121|NCT00626392|10472870|P6|Run-in Period|Noncompliance|0
3046122|NCT00626392|10472871|P5|Run-in Period|Noncompliance|0
3046123|NCT00626392|10472872|P4|Run-in Period|Noncompliance|0
3046124|NCT00626392|10472873|P3|Run-in Period|Noncompliance|1
3046125|NCT00626392|10472874|P2|Run-in Period|Noncompliance|0
3046126|NCT00626392|10472875|P1|Run-in Period|Noncompliance|1
3046127|NCT00626392|10472870|P6|Run-in Period|Withdrawal by Subject|1
3046128|NCT00626392|10472871|P5|Run-in Period|Withdrawal by Subject|3
3046129|NCT00626392|10472872|P4|Run-in Period|Withdrawal by Subject|1
3046130|NCT00626392|10472873|P3|Run-in Period|Withdrawal by Subject|1
3046131|NCT00626392|10472874|P2|Run-in Period|Withdrawal by Subject|1
3046132|NCT00626392|10472875|P1|Run-in Period|Withdrawal by Subject|0
3046133|NCT00626392|10472870|P6|Run-in Period|Adverse Event|0
3046134|NCT00626392|10472871|P5|Run-in Period|Adverse Event|1
3046135|NCT00626392|10472872|P4|Run-in Period|Adverse Event|0
3046136|NCT00626392|10472873|P3|Run-in Period|Adverse Event|1
3046137|NCT00626392|10472874|P2|Run-in Period|Adverse Event|0
3046138|NCT00626392|10472875|P1|Run-in Period|Adverse Event|0
3046139|NCT00626327|10472903|P3|Overall Study|Protocol Violation|26
3046140|NCT00626327|10472904|P2|Overall Study|Protocol Violation|4
3046141|NCT00626327|10472905|P1|Overall Study|Protocol Violation|26
3046142|NCT00626327|10472903|P3|Overall Study|Administrative Reason|6
3046143|NCT00626327|10472904|P2|Overall Study|Administrative Reason|0
3046144|NCT00626327|10472905|P1|Overall Study|Administrative Reason|2
3046145|NCT00626327|10472903|P3|Overall Study|Inappropriate enrollment|3
3046146|NCT00626327|10472904|P2|Overall Study|Inappropriate enrollment|5
3046147|NCT00626327|10472905|P1|Overall Study|Inappropriate enrollment|4
3046148|NCT00626327|10472903|P3|Overall Study|Lost to Follow-up|23
3046149|NCT00626327|10472904|P2|Overall Study|Lost to Follow-up|21
3046150|NCT00626327|10472905|P1|Overall Study|Lost to Follow-up|24
3046151|NCT00626327|10472903|P3|Overall Study|Adverse Event|0
3046152|NCT00626327|10472904|P2|Overall Study|Adverse Event|0
3046153|NCT00626327|10472905|P1|Overall Study|Adverse Event|1
3046154|NCT00626327|10472903|P3|Overall Study|Withdrawal by Subject|30
3046155|NCT00626327|10472904|P2|Overall Study|Withdrawal by Subject|29
3046156|NCT00626327|10472905|P1|Overall Study|Withdrawal by Subject|21
3046157|NCT00626275|10472931|P8|Part B|Withdrawal by Subject|1
3046158|NCT00626275|10472932|P7|Part B|Withdrawal by Subject|0
3046159|NCT00626275|10472933|P6|Part B|Withdrawal by Subject|0
3046160|NCT00626275|10472934|P5|Part B|Withdrawal by Subject|0
3046161|NCT00626275|10472935|P4|Part B|Withdrawal by Subject|0
3046162|NCT00626275|10472936|P3|Part B|Withdrawal by Subject|0
3046163|NCT00626275|10472937|P2|Part B|Withdrawal by Subject|0
3046164|NCT00626275|10472938|P1|Part B|Withdrawal by Subject|0
3046165|NCT00626275|10472931|P8|Part B|Lost to Follow-up|0
3046166|NCT00626275|10472932|P7|Part B|Lost to Follow-up|1
3046167|NCT00626275|10472933|P6|Part B|Lost to Follow-up|0
3046168|NCT00626275|10472934|P5|Part B|Lost to Follow-up|0
3046169|NCT00626275|10472935|P4|Part B|Lost to Follow-up|0
3046170|NCT00626275|10472936|P3|Part B|Lost to Follow-up|0
3046171|NCT00626275|10472937|P2|Part B|Lost to Follow-up|0
3046172|NCT00626275|10472938|P1|Part B|Lost to Follow-up|0
3046173|NCT00626275|10472931|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
3046174|NCT00626275|10472932|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
3046175|NCT00626275|10472933|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
3046176|NCT00626275|10472934|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
3046177|NCT00626275|10472935|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
3046178|NCT00626275|10472936|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
3046179|NCT00626275|10472937|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
3046180|NCT00626275|10472938|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
3046181|NCT00626275|10472931|P8|Part A - Treatment Period 1|Adverse Event|0
3046182|NCT00626275|10472932|P7|Part A - Treatment Period 1|Adverse Event|0
3046183|NCT00626275|10472933|P6|Part A - Treatment Period 1|Adverse Event|0
3046184|NCT00626275|10472934|P5|Part A - Treatment Period 1|Adverse Event|0
3046185|NCT00626275|10472935|P4|Part A - Treatment Period 1|Adverse Event|0
3046186|NCT00626275|10472936|P3|Part A - Treatment Period 1|Adverse Event|0
3046187|NCT00626275|10472937|P2|Part A - Treatment Period 1|Adverse Event|0
3046188|NCT00626275|10472938|P1|Part A - Treatment Period 1|Adverse Event|1
3046189|NCT00626093|10472982|P1|Overall Study|One of the required devices not implante|6
3046190|NCT00626093|10472982|P1|Overall Study|Protocol Violation|1
3046191|NCT00626093|10472982|P1|Overall Study|Withdrawal by Subject|6
3046192|NCT00626093|10472982|P1|Overall Study|Physician Decision|4
3046193|NCT00626093|10472982|P1|Overall Study|Death|1
3046194|NCT00626093|10472982|P1|Overall Study|Lost to Follow-up|5
3046195|NCT00626028|10472989|P2|Overall Study|Inclusion/Exclusion Criteria|6
3046196|NCT00626028|10472990|P1|Overall Study|Inclusion/Exclusion Criteria|3
3046197|NCT00626028|10472989|P2|Overall Study|Physician Decision|1
3046198|NCT00626028|10472990|P1|Overall Study|Physician Decision|2
3046199|NCT00626028|10472989|P2|Overall Study|Device Failure|1
3046200|NCT00626028|10472990|P1|Overall Study|Device Failure|0
3046201|NCT00626028|10472989|P2|Overall Study|Adverse Event|1
3046202|NCT00626028|10472990|P1|Overall Study|Adverse Event|1
3046203|NCT00625872|10473014|P2|Overall Study|Randomized but not treated|1
3046204|NCT00625872|10473015|P1|Overall Study|Randomized but not treated|0
3046205|NCT00625872|10473014|P2|Overall Study|Terminated by sponsor|5
3046206|NCT00625872|10473015|P1|Overall Study|Terminated by sponsor|2
3046207|NCT00625872|10473014|P2|Overall Study|Does not meet inclusion criteria|0
3046208|NCT00625872|10473015|P1|Overall Study|Does not meet inclusion criteria|1
3046209|NCT00625872|10473014|P2|Overall Study|Withdrawal by Subject|0
3046210|NCT00625872|10473015|P1|Overall Study|Withdrawal by Subject|1
3046211|NCT00625846|10473129|P4|Overall Study|Withdrawal by Subject|2
3046212|NCT00625846|10473130|P3|Overall Study|Withdrawal by Subject|1
3046213|NCT00625846|10473131|P2|Overall Study|Withdrawal by Subject|0
3046214|NCT00625846|10473132|P1|Overall Study|Withdrawal by Subject|2
3046215|NCT00625820|10473158|P1|Overall Study|Withdrawal by Subject|1
3046216|NCT00625807|10473166|P2|Overall Study|schedule conflict|8
3046217|NCT00625807|10473167|P1|Overall Study|schedule conflict|2
3046218|NCT00625742|10473183|P1|Overall Study|Ineligible|1
3046219|NCT00625742|10473183|P1|Overall Study|Lost to Follow-up|4
3046220|NCT00625742|10473183|P1|Overall Study|Adverse Event|4
3046221|NCT00625742|10473183|P1|Overall Study|Withdrawal by Subject|1
3046222|NCT00625742|10473183|P1|Overall Study|Disease Progression|2
3046223|NCT00625586|10473202|P1|Overall Study|Adverse Event|1
3046224|NCT00625443|10473215|P3|Overall Study|Other|1
3046225|NCT00625443|10473216|P2|Overall Study|Other|1
3046226|NCT00625443|10473217|P1|Overall Study|Other|0
3046227|NCT00625443|10473215|P3|Overall Study|Physician Decision|2
3046228|NCT00625443|10473216|P2|Overall Study|Physician Decision|4
3046229|NCT00625443|10473217|P1|Overall Study|Physician Decision|0
3046230|NCT00625443|10473215|P3|Overall Study|Withdrawal by Subject|2
3046231|NCT00625443|10473216|P2|Overall Study|Withdrawal by Subject|1
3046232|NCT00625443|10473217|P1|Overall Study|Withdrawal by Subject|0
3046233|NCT00625443|10473215|P3|Overall Study|Platelet count increase >=500,000/mm3|0
3046234|NCT00625443|10473216|P2|Overall Study|Platelet count increase >=500,000/mm3|0
3046235|NCT00625443|10473217|P1|Overall Study|Platelet count increase >=500,000/mm3|1
3046236|NCT00625443|10473215|P3|Overall Study|Non-compliance with protocol|0
3046237|NCT00625443|10473216|P2|Overall Study|Non-compliance with protocol|1
3046238|NCT00625443|10473217|P1|Overall Study|Non-compliance with protocol|0
3046239|NCT00625443|10473215|P3|Overall Study|Adverse Event|0
3046240|NCT00625443|10473216|P2|Overall Study|Adverse Event|4
3046241|NCT00625443|10473217|P1|Overall Study|Adverse Event|1
3046242|NCT00625365|10473297|P1|Overall Study|VSD|1
3046243|NCT00625365|10473297|P1|Overall Study|No IV access|5
3046244|NCT00625365|10473297|P1|Overall Study|Withdrawal by Subject|1
3046245|NCT00625183|10473303|P1|Overall Study|Disease Progression|1
3046246|NCT00625131|10473314|P3|Overall Study|Withdrawal by Subject|5
3046247|NCT00625131|10473315|P2|Overall Study|Withdrawal by Subject|0
3046248|NCT00625131|10473316|P1|Overall Study|Withdrawal by Subject|1
3046249|NCT00625131|10473314|P3|Overall Study|Lost to Follow-up|0
3046250|NCT00625131|10473315|P2|Overall Study|Lost to Follow-up|2
3046251|NCT00625131|10473316|P1|Overall Study|Lost to Follow-up|3
3046252|NCT00624832|10473345|P4|Overall Study|Abnormal Laboratory Value|0
3046253|NCT00624832|10473346|P3|Overall Study|Abnormal Laboratory Value|0
3046254|NCT00624832|10473347|P2|Overall Study|Abnormal Laboratory Value|0
3046255|NCT00624832|10473348|P1|Overall Study|Abnormal Laboratory Value|2
3046256|NCT00624832|10473345|P4|Overall Study|Adverse Event|1
3046257|NCT00624832|10473346|P3|Overall Study|Adverse Event|0
3046258|NCT00624832|10473347|P2|Overall Study|Adverse Event|1
3046259|NCT00624832|10473348|P1|Overall Study|Adverse Event|0
3046260|NCT00624819|10473364|P4|Follow-up Period: Year 4|Lost to Follow-up|0
3046261|NCT00624819|10473365|P3|Follow-up Period: Year 4|Lost to Follow-up|0
3046262|NCT00624819|10473366|P2|Follow-up Period: Year 4|Lost to Follow-up|1
3046263|NCT00624819|10473367|P1|Follow-up Period: Year 4|Lost to Follow-up|1
3046264|NCT00624819|10473364|P4|Follow-up Period: Year 4|Parents decision|0
3046265|NCT00624819|10473365|P3|Follow-up Period: Year 4|Parents decision|1
3046266|NCT00624819|10473366|P2|Follow-up Period: Year 4|Parents decision|0
3046267|NCT00624819|10473367|P1|Follow-up Period: Year 4|Parents decision|0
3046268|NCT00624780|10473544|P6|Follow-up (Week 26)|Other|0
3046269|NCT00624780|10473545|P5|Follow-up (Week 26)|Other|0
3046270|NCT00624780|10473546|P4|Follow-up (Week 26)|Other|0
3046271|NCT00624780|10473547|P3|Follow-up (Week 26)|Other|0
3046272|NCT00624780|10473548|P2|Follow-up (Week 26)|Other|1
3046273|NCT00624780|10473549|P1|Follow-up (Week 26)|Other|1
3046274|NCT00624780|10473544|P6|Follow-up (Week 26)|Withdrawal by Subject|0
3046275|NCT00624780|10473545|P5|Follow-up (Week 26)|Withdrawal by Subject|0
3046276|NCT00624780|10473546|P4|Follow-up (Week 26)|Withdrawal by Subject|0
3046277|NCT00624780|10473547|P3|Follow-up (Week 26)|Withdrawal by Subject|0
3046278|NCT00624780|10473548|P2|Follow-up (Week 26)|Withdrawal by Subject|0
3046279|NCT00624780|10473549|P1|Follow-up (Week 26)|Withdrawal by Subject|1
3046280|NCT00624780|10473544|P6|Follow-up (Week 26)|Lost to Follow-up|0
3046281|NCT00624780|10473545|P5|Follow-up (Week 26)|Lost to Follow-up|1
3046282|NCT00624780|10473546|P4|Follow-up (Week 26)|Lost to Follow-up|0
3046283|NCT00624780|10473547|P3|Follow-up (Week 26)|Lost to Follow-up|1
3046284|NCT00624780|10473548|P2|Follow-up (Week 26)|Lost to Follow-up|0
3046285|NCT00624780|10473549|P1|Follow-up (Week 26)|Lost to Follow-up|0
3046286|NCT00624780|10473544|P6|Follow-up (Week 26)|Adverse Event|0
3046287|NCT00624780|10473545|P5|Follow-up (Week 26)|Adverse Event|1
3046288|NCT00624780|10473546|P4|Follow-up (Week 26)|Adverse Event|0
3046289|NCT00624780|10473547|P3|Follow-up (Week 26)|Adverse Event|0
3046290|NCT00624780|10473548|P2|Follow-up (Week 26)|Adverse Event|0
3046291|NCT00624780|10473549|P1|Follow-up (Week 26)|Adverse Event|0
3046292|NCT00624780|10473544|P6|Follow-up (Week 26)|Death|0
3046293|NCT00624780|10473545|P5|Follow-up (Week 26)|Death|0
3046294|NCT00624780|10473546|P4|Follow-up (Week 26)|Death|0
3046295|NCT00624780|10473547|P3|Follow-up (Week 26)|Death|1
3046296|NCT00624780|10473548|P2|Follow-up (Week 26)|Death|0
3046297|NCT00624780|10473549|P1|Follow-up (Week 26)|Death|0
3046298|NCT00624780|10473544|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
3046299|NCT00624780|10473545|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
3046300|NCT00624780|10473546|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
3046301|NCT00624780|10473547|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
3046302|NCT00624780|10473548|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
3046303|NCT00624780|10473549|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
3046304|NCT00624780|10473544|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
3046305|NCT00624780|10473545|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
3046306|NCT00624780|10473546|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
3046307|NCT00624780|10473547|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
3046308|NCT00624780|10473548|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
3046309|NCT00624780|10473549|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
3046310|NCT00624780|10473544|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
3046311|NCT00624780|10473545|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
3046312|NCT00624780|10473546|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
3046313|NCT00624780|10473547|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
3046314|NCT00624780|10473548|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
3046315|NCT00624780|10473549|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
3046316|NCT00624780|10473544|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
3046317|NCT00624780|10473545|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
3046318|NCT00624780|10473546|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
3046319|NCT00624780|10473547|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
3046320|NCT00624780|10473548|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
3046321|NCT00624780|10473549|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
3046322|NCT00624780|10473544|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
3046323|NCT00624780|10473545|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
3046324|NCT00624780|10473546|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
3046325|NCT00624780|10473547|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
3046326|NCT00624780|10473548|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
3046327|NCT00624780|10473549|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
3046328|NCT00624780|10473544|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
3046329|NCT00624780|10473545|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
3046330|NCT00624780|10473546|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
3046331|NCT00624780|10473547|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
3046332|NCT00624780|10473548|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
3046333|NCT00624780|10473549|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
3046334|NCT00624780|10473544|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
3046335|NCT00624780|10473545|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
3046336|NCT00624780|10473546|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
3046337|NCT00624780|10473547|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
3046338|NCT00624780|10473548|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
3046339|NCT00624780|10473549|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
3046340|NCT00624780|10473544|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
3046341|NCT00624780|10473545|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
3046342|NCT00624780|10473546|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
3046343|NCT00624780|10473547|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
3046344|NCT00624780|10473548|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
3046345|NCT00624780|10473549|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
3046346|NCT00624780|10473544|P6|Treatment Optimization (Up to Week 12)|Other|0
3046347|NCT00624780|10473545|P5|Treatment Optimization (Up to Week 12)|Other|9
3046348|NCT00624780|10473546|P4|Treatment Optimization (Up to Week 12)|Other|2
3046349|NCT00624780|10473547|P3|Treatment Optimization (Up to Week 12)|Other|8
3046350|NCT00624780|10473548|P2|Treatment Optimization (Up to Week 12)|Other|4
3046351|NCT00624780|10473549|P1|Treatment Optimization (Up to Week 12)|Other|10
3046352|NCT00624780|10473544|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
3046353|NCT00624780|10473545|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
3046354|NCT00624780|10473546|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
3046355|NCT00624780|10473547|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
3046356|NCT00624780|10473548|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
3046357|NCT00624780|10473549|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
3046358|NCT00624780|10473544|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
3046359|NCT00624780|10473545|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
3046360|NCT00624780|10473546|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
3046361|NCT00624780|10473547|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
3046362|NCT00624780|10473548|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
3046363|NCT00624780|10473549|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
3046364|NCT00624780|10473544|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
3046365|NCT00624780|10473545|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
3046366|NCT00624780|10473546|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
3046367|NCT00624780|10473547|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
3046368|NCT00624780|10473548|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
3046369|NCT00624780|10473549|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
3046370|NCT00624780|10473544|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
3046371|NCT00624780|10473545|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
3046372|NCT00624780|10473546|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
3046373|NCT00624780|10473547|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
3046374|NCT00624780|10473548|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
3046375|NCT00624780|10473549|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
3046376|NCT00624585|10473740|P1|Overall Study|Adverse Event|3
3046377|NCT00624585|10473740|P1|Overall Study|Disease Progression|6
3046378|NCT00624585|10473740|P1|Overall Study|Death|3
3046379|NCT00624520|10473770|P2|Overall Study|Death|1
3046380|NCT00624520|10473771|P1|Overall Study|Death|0
3046381|NCT00624520|10473770|P2|Overall Study|Withdrawal by Subject|7
3046382|NCT00624520|10473771|P1|Overall Study|Withdrawal by Subject|12
3046383|NCT00624468|10473798|P4|Safety Follow-up (SFU) Period|Other|1
3046384|NCT00624468|10473799|P3|Safety Follow-up (SFU) Period|Other|1
3046385|NCT00624468|10473800|P2|Safety Follow-up (SFU) Period|Other|0
3046386|NCT00624468|10473801|P1|Safety Follow-up (SFU) Period|Other|0
3046387|NCT00624468|10473798|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
3046388|NCT00624468|10473799|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
3046389|NCT00624468|10473800|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
3046390|NCT00624468|10473801|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
3046391|NCT00624468|10473798|P4|Double-blind Period|Withdrew Prematurely|0
3046392|NCT00624468|10473799|P3|Double-blind Period|Withdrew Prematurely|0
3046393|NCT00624468|10473800|P2|Double-blind Period|Withdrew Prematurely|1
3046394|NCT00624468|10473801|P1|Double-blind Period|Withdrew Prematurely|1
3046395|NCT00624468|10473798|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
3046396|NCT00624468|10473799|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
3046397|NCT00624468|10473800|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
3046398|NCT00624468|10473801|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
3046399|NCT00624377|10473868|P1|Overall Study|Non-evaluable population|84
3046400|NCT00624377|10473868|P1|Overall Study|Other|91
3046401|NCT00624377|10473868|P1|Overall Study|Adverse Event|14
3046402|NCT00624377|10473868|P1|Overall Study|Withdrawal by Subject|100
3046403|NCT00624377|10473868|P1|Overall Study|Lost to Follow-up|355
3046404|NCT00624338|10473882|P3|Overall Study|Randomized but not treated|3
3046405|NCT00624338|10473883|P2|Overall Study|Randomized but not treated|1
3046406|NCT00624338|10473884|P1|Overall Study|Randomized but not treated|2
3046407|NCT00624338|10473882|P3|Overall Study|Other|9
3046408|NCT00624338|10473883|P2|Overall Study|Other|5
3046409|NCT00624338|10473884|P1|Overall Study|Other|15
3046410|NCT00624338|10473882|P3|Overall Study|Termination of 150 mg group by Sponsor|0
3046411|NCT00624338|10473883|P2|Overall Study|Termination of 150 mg group by Sponsor|55
3046412|NCT00624338|10473884|P1|Overall Study|Termination of 150 mg group by Sponsor|0
3046413|NCT00624338|10473882|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
3046414|NCT00624338|10473883|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
3046415|NCT00624338|10473884|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
3046416|NCT00624338|10473882|P3|Overall Study|Death|0
3046417|NCT00624338|10473883|P2|Overall Study|Death|2
3046418|NCT00624338|10473884|P1|Overall Study|Death|0
3046419|NCT00624338|10473882|P3|Overall Study|Protocol Violation|2
3046420|NCT00624338|10473883|P2|Overall Study|Protocol Violation|3
3046421|NCT00624338|10473884|P1|Overall Study|Protocol Violation|3
3046422|NCT00624338|10473882|P3|Overall Study|Lack of Efficacy|14
3046423|NCT00624338|10473883|P2|Overall Study|Lack of Efficacy|3
3046424|NCT00624338|10473884|P1|Overall Study|Lack of Efficacy|11
3046425|NCT00624338|10473882|P3|Overall Study|Lost to Follow-up|0
3046426|NCT00624338|10473883|P2|Overall Study|Lost to Follow-up|0
3046427|NCT00624338|10473884|P1|Overall Study|Lost to Follow-up|1
3046428|NCT00624338|10473882|P3|Overall Study|Adverse Event|18
3046429|NCT00624338|10473883|P2|Overall Study|Adverse Event|14
3046430|NCT00624338|10473884|P1|Overall Study|Adverse Event|14
3046431|NCT00624286|10473906|P2|Overall Study|Death|1
3046432|NCT00624286|10473907|P1|Overall Study|Death|0
3046433|NCT00624286|10473906|P2|Overall Study|Abnormal test procedure result(s)|1
3046434|NCT00624286|10473907|P1|Overall Study|Abnormal test procedure result(s)|0
3046435|NCT00624286|10473906|P2|Overall Study|Not stated|1
3046436|NCT00624286|10473907|P1|Overall Study|Not stated|0
3046437|NCT00624286|10473906|P2|Overall Study|Lack of Efficacy|6
3046438|NCT00624286|10473907|P1|Overall Study|Lack of Efficacy|1
3046439|NCT00624286|10473906|P2|Overall Study|Administrative problems|0
3046440|NCT00624286|10473907|P1|Overall Study|Administrative problems|3
3046441|NCT00624286|10473906|P2|Overall Study|Lost to Follow-up|2
3046442|NCT00624286|10473907|P1|Overall Study|Lost to Follow-up|3
3046443|NCT00624286|10473906|P2|Overall Study|Withdrawal by Subject|4
3046444|NCT00624286|10473907|P1|Overall Study|Withdrawal by Subject|5
3046445|NCT00624286|10473906|P2|Overall Study|Adverse Event|3
3046446|NCT00624286|10473907|P1|Overall Study|Adverse Event|6
3046447|NCT00624286|10473906|P2|Overall Study|Protocol Deviation|9
3046448|NCT00624286|10473907|P1|Overall Study|Protocol Deviation|7
3046449|NCT00624065|10473960|P2|Overall Study|Met protocol-defined stopping criteria|9
3046450|NCT00624065|10473961|P1|Overall Study|Met protocol-defined stopping criteria|4
3046451|NCT00624065|10473960|P2|Overall Study|Lack of Efficacy|3
3046452|NCT00624065|10473961|P1|Overall Study|Lack of Efficacy|0
3046453|NCT00624065|10473960|P2|Overall Study|Consent withdrawn|5
3046454|NCT00624065|10473961|P1|Overall Study|Consent withdrawn|6
3046455|NCT00624065|10473960|P2|Overall Study|Lost to Follow-up|1
3046456|NCT00624065|10473961|P1|Overall Study|Lost to Follow-up|4
3046457|NCT00624065|10473960|P2|Overall Study|Adverse Event|6
3046458|NCT00624065|10473961|P1|Overall Study|Adverse Event|5
3046459|NCT00624052|10473973|P4|Overall Study|Changed job/ran out if meds|0
3046460|NCT00624052|10473974|P3|Overall Study|Changed job/ran out if meds|0
3046461|NCT00624052|10473975|P2|Overall Study|Changed job/ran out if meds|2
3046462|NCT00624052|10473976|P1|Overall Study|Changed job/ran out if meds|0
3046463|NCT00624052|10473973|P4|Overall Study|Consent withdrawn|0
3046464|NCT00624052|10473974|P3|Overall Study|Consent withdrawn|1
3046465|NCT00624052|10473975|P2|Overall Study|Consent withdrawn|1
3046466|NCT00624052|10473976|P1|Overall Study|Consent withdrawn|3
3046467|NCT00624052|10473973|P4|Overall Study|Non compliant with the protocol|1
3046468|NCT00624052|10473974|P3|Overall Study|Non compliant with the protocol|1
3046469|NCT00624052|10473975|P2|Overall Study|Non compliant with the protocol|1
3046470|NCT00624052|10473976|P1|Overall Study|Non compliant with the protocol|2
3046471|NCT00624052|10473973|P4|Overall Study|Lost to Follow-up|0
3046472|NCT00624052|10473974|P3|Overall Study|Lost to Follow-up|1
3046473|NCT00624052|10473975|P2|Overall Study|Lost to Follow-up|3
3046474|NCT00624052|10473976|P1|Overall Study|Lost to Follow-up|2
3046475|NCT00624052|10473973|P4|Overall Study|Lack of Efficacy|0
3046476|NCT00624052|10473974|P3|Overall Study|Lack of Efficacy|0
3046477|NCT00624052|10473975|P2|Overall Study|Lack of Efficacy|1
3046478|NCT00624052|10473976|P1|Overall Study|Lack of Efficacy|1
3046479|NCT00624052|10473973|P4|Overall Study|Adverse Event|3
3046480|NCT00624052|10473974|P3|Overall Study|Adverse Event|0
3046481|NCT00624052|10473975|P2|Overall Study|Adverse Event|6
3046482|NCT00624052|10473976|P1|Overall Study|Adverse Event|7
3046483|NCT00623935|10474053|P1|Overall Study|Patient Declined Transplant|1
3046484|NCT00623935|10474053|P1|Overall Study|Death|1
3046485|NCT00623831|10474060|P2|Overall Study|Progressive Disease|1
3046486|NCT00623831|10474061|P1|Overall Study|Progressive Disease|0
3046487|NCT00623831|10474060|P2|Overall Study|Withdrawal by Subject|0
3046488|NCT00623831|10474061|P1|Overall Study|Withdrawal by Subject|1
3046489|NCT00623805|10474073|P2|Overall Study|Reason not Specified|6
3046490|NCT00623805|10474074|P1|Overall Study|Reason not Specified|3
3046491|NCT00623805|10474073|P2|Overall Study|Protocol Violation|1
3046492|NCT00623805|10474074|P1|Overall Study|Protocol Violation|1
3046493|NCT00623805|10474073|P2|Overall Study|Lost to Follow-up|2
3046494|NCT00623805|10474074|P1|Overall Study|Lost to Follow-up|2
3046495|NCT00623805|10474073|P2|Overall Study|Lack of Efficacy|7
3046496|NCT00623805|10474074|P1|Overall Study|Lack of Efficacy|3
3046497|NCT00623805|10474073|P2|Overall Study|Death|0
3046498|NCT00623805|10474074|P1|Overall Study|Death|2
3046499|NCT00623805|10474073|P2|Overall Study|Adverse Event|6
3046500|NCT00623805|10474074|P1|Overall Study|Adverse Event|9
3046501|NCT00623779|10474091|P3|Overall Study|Criteria from CSR|1
3046502|NCT00623779|10474092|P2|Overall Study|Criteria from CSR|0
3046503|NCT00623779|10474093|P1|Overall Study|Criteria from CSR|2
3046504|NCT00623779|10474091|P3|Overall Study|Adverse Event|0
3046505|NCT00623779|10474092|P2|Overall Study|Adverse Event|3
3046506|NCT00623779|10474093|P1|Overall Study|Adverse Event|1
3046507|NCT00623766|10474142|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
3046508|NCT00623766|10474143|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
3046509|NCT00623766|10474142|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
3046510|NCT00623766|10474143|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
3046511|NCT00623766|10474142|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
3046512|NCT00623766|10474143|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
3046513|NCT00623766|10474142|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
3046514|NCT00623766|10474143|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
3046515|NCT00623766|10474142|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
3046516|NCT00623766|10474143|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
3046517|NCT00623727|10474167|P2|Open Label Follow-up|Participant convenience|1
3046518|NCT00623727|10474168|P1|Open Label Follow-up|Participant convenience|0
3046519|NCT00623727|10474167|P2|Open Label Follow-up|Study termination|6
3046520|NCT00623727|10474168|P1|Open Label Follow-up|Study termination|0
3046521|NCT00623727|10474167|P2|Open Label Follow-up|Withdrawal by Subject|1
3046522|NCT00623727|10474168|P1|Open Label Follow-up|Withdrawal by Subject|0
3046523|NCT00623727|10474167|P2|Double Blind (DB)|Protocol Violation|2
3046524|NCT00623727|10474168|P1|Double Blind (DB)|Protocol Violation|2
3046525|NCT00623727|10474167|P2|Double Blind (DB)|Lost to Follow-up|1
3046526|NCT00623727|10474168|P1|Double Blind (DB)|Lost to Follow-up|1
3046527|NCT00623727|10474167|P2|Double Blind (DB)|Termination of the double-blind period|21
3046528|NCT00623727|10474168|P1|Double Blind (DB)|Termination of the double-blind period|22
3046529|NCT00623727|10474167|P2|Double Blind (DB)|Lack of Efficacy|2
3046530|NCT00623727|10474168|P1|Double Blind (DB)|Lack of Efficacy|2
3046531|NCT00623727|10474167|P2|Double Blind (DB)|Withdrawal by Subject|2
3046532|NCT00623727|10474168|P1|Double Blind (DB)|Withdrawal by Subject|8
3046533|NCT00623727|10474167|P2|Double Blind (DB)|Physician Decision|1
3046534|NCT00623727|10474168|P1|Double Blind (DB)|Physician Decision|0
3046535|NCT00623727|10474167|P2|Double Blind (DB)|Adverse Event|3
3046536|NCT00623727|10474168|P1|Double Blind (DB)|Adverse Event|1
3046537|NCT00623623|10474223|P2|Overall Study|Previous enrolment into this study|1
3046538|NCT00623623|10474224|P1|Overall Study|Previous enrolment into this study|1
3046539|NCT00623597|10474280|P2|Overall Study|Failed to return|0
3046540|NCT00623597|10474281|P1|Overall Study|Failed to return|1
3046541|NCT00623545|10474344|P1|Overall Study|Withdrawal by Subject|4
3046542|NCT00623545|10474344|P1|Overall Study|Adverse Event|6
3046543|NCT00623480|10474364|P2|Overall Study|Site closed by sponsor|1
3046544|NCT00623480|10474365|P1|Overall Study|Site closed by sponsor|0
3046545|NCT00623480|10474364|P2|Overall Study|Protocol Violation|1
3046546|NCT00623480|10474365|P1|Overall Study|Protocol Violation|0
3046547|NCT00623480|10474364|P2|Overall Study|Non-compliant with study medication|0
3046548|NCT00623480|10474365|P1|Overall Study|Non-compliant with study medication|4
3046549|NCT00623480|10474364|P2|Overall Study|Lack of Efficacy|0
3046550|NCT00623480|10474365|P1|Overall Study|Lack of Efficacy|1
3046551|NCT00623480|10474364|P2|Overall Study|Withdrawal by Subject|4
3046552|NCT00623480|10474365|P1|Overall Study|Withdrawal by Subject|2
3046553|NCT00623480|10474364|P2|Overall Study|Lost to Follow-up|1
3046554|NCT00623480|10474365|P1|Overall Study|Lost to Follow-up|0
3046555|NCT00623467|10474377|P1|Overall Study|Withdrawal by Subject|2
3046556|NCT00623467|10474377|P1|Overall Study|Protocol Violation|4
3046557|NCT00623467|10474377|P1|Overall Study|Lost to Follow-up|1
3046558|NCT00623428|10474447|P2|Follow-up Period|Death|1
3046559|NCT00623428|10474448|P1|Follow-up Period|Death|0
3046560|NCT00623428|10474447|P2|Follow-up Period|Reason not specified|1
3046561|NCT00623428|10474448|P1|Follow-up Period|Reason not specified|1
3046562|NCT00623428|10474447|P2|Follow-up Period|Did not cooperate|3
3046563|NCT00623428|10474448|P1|Follow-up Period|Did not cooperate|0
3046564|NCT00623428|10474447|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
3046565|NCT00623428|10474448|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
3046566|NCT00623428|10474447|P2|Follow-up Period|Patient withdrew consent|4
3046567|NCT00623428|10474448|P1|Follow-up Period|Patient withdrew consent|5
3046568|NCT00623428|10474447|P2|Follow-up Period|Failure to return|2
3046569|NCT00623428|10474448|P1|Follow-up Period|Failure to return|10
3046570|NCT00623428|10474447|P2|Follow-up Period|Relapse post-treatment|3
3046571|NCT00623428|10474448|P1|Follow-up Period|Relapse post-treatment|11
3046572|NCT00623428|10474447|P2|Treatment Period|Withdrawal by Subject|1
3046573|NCT00623428|10474448|P1|Treatment Period|Withdrawal by Subject|0
3046574|NCT00623428|10474447|P2|Treatment Period|Other|1
3046575|NCT00623428|10474448|P1|Treatment Period|Other|0
3046576|NCT00623428|10474447|P2|Treatment Period|Insufficient therapeutic response|2
3046577|NCT00623428|10474448|P1|Treatment Period|Insufficient therapeutic response|0
3046578|NCT00623428|10474447|P2|Treatment Period|Did not cooperate / refused treatment|13
3046579|NCT00623428|10474448|P1|Treatment Period|Did not cooperate / refused treatment|0
3046580|NCT00623428|10474447|P2|Treatment Period|Death|1
3046581|NCT00623428|10474448|P1|Treatment Period|Death|0
3046582|NCT00623428|10474447|P2|Treatment Period|Adverse event/intercurrent illness|9
3046583|NCT00623428|10474448|P1|Treatment Period|Adverse event/intercurrent illness|0
3046584|NCT00623233|10474466|P1|Overall Study|Withdrawal by Subject|3
3046585|NCT00623233|10474466|P1|Overall Study|Lost to Follow-up|1
3046586|NCT00623233|10474466|P1|Overall Study|Physician Decision|10
3046587|NCT00623233|10474466|P1|Overall Study|Adverse Event|10
3046588|NCT00623194|10474473|P1|Overall Study|Unclassified|1
3046589|NCT00623194|10474473|P1|Overall Study|Protocol Violation|3
3046590|NCT00623194|10474473|P1|Overall Study|Lack of Efficacy|1
3046591|NCT00623103|10474510|P2|Overall Study|Protocol deviation|1
3046592|NCT00623103|10474511|P1|Overall Study|Protocol deviation|2
3046593|NCT00623103|10474510|P2|Overall Study|Death|11
3046594|NCT00623103|10474511|P1|Overall Study|Death|11
3046595|NCT00623103|10474510|P2|Overall Study|Administrative problems|4
3046596|NCT00623103|10474511|P1|Overall Study|Administrative problems|2
3046597|NCT00623103|10474510|P2|Overall Study|Lost to Follow-up|1
3046598|NCT00623103|10474511|P1|Overall Study|Lost to Follow-up|4
3046599|NCT00623103|10474510|P2|Overall Study|Withdrawal by Subject|24
3046600|NCT00623103|10474511|P1|Overall Study|Withdrawal by Subject|18
3046601|NCT00623103|10474510|P2|Overall Study|Unsatisfactory therapeutic effect|12
3046602|NCT00623103|10474511|P1|Overall Study|Unsatisfactory therapeutic effect|4
3046603|NCT00623103|10474510|P2|Overall Study|Adverse Event|60
3046604|NCT00623103|10474511|P1|Overall Study|Adverse Event|70
3046605|NCT00622908|10474539|P2|Overall Study|Termination by study sponser|1
3046606|NCT00622908|10474540|P1|Overall Study|Termination by study sponser|0
3046607|NCT00622908|10474539|P2|Overall Study|Refusal|1
3046608|NCT00622908|10474540|P1|Overall Study|Refusal|0
3046609|NCT00622908|10474539|P2|Overall Study|Lost to Follow-up|0
3046610|NCT00622908|10474540|P1|Overall Study|Lost to Follow-up|1
3046611|NCT00622908|10474539|P2|Overall Study|Lack of Efficacy|7
3046612|NCT00622908|10474540|P1|Overall Study|Lack of Efficacy|1
3046613|NCT00622908|10474539|P2|Overall Study|Adverse Event|1
3046614|NCT00622908|10474540|P1|Overall Study|Adverse Event|0
3046615|NCT00622908|10474539|P2|Overall Study|Protocol Violation|0
3046616|NCT00622908|10474540|P1|Overall Study|Protocol Violation|1
3046617|NCT00622869|10474570|P3|Overall Study|Missing|1
3046618|NCT00622869|10474571|P2|Overall Study|Missing|1
3046619|NCT00622869|10474572|P1|Overall Study|Missing|0
3046620|NCT00622869|10474570|P3|Overall Study|Graft Loss|2
3046621|NCT00622869|10474571|P2|Overall Study|Graft Loss|3
3046622|NCT00622869|10474572|P1|Overall Study|Graft Loss|5
3046623|NCT00622869|10474570|P3|Overall Study|Lost to Follow-up|2
3046624|NCT00622869|10474571|P2|Overall Study|Lost to Follow-up|4
3046625|NCT00622869|10474572|P1|Overall Study|Lost to Follow-up|2
3046626|NCT00622869|10474570|P3|Overall Study|Death|10
3046627|NCT00622869|10474571|P2|Overall Study|Death|15
3046628|NCT00622869|10474572|P1|Overall Study|Death|12
3046629|NCT00622869|10474570|P3|Overall Study|Administrative Problems|13
3046630|NCT00622869|10474571|P2|Overall Study|Administrative Problems|17
3046631|NCT00622869|10474572|P1|Overall Study|Administrative Problems|11
3046632|NCT00622869|10474570|P3|Overall Study|Subject Withdrew Consent|11
3046633|NCT00622869|10474571|P2|Overall Study|Subject Withdrew Consent|17
3046634|NCT00622869|10474572|P1|Overall Study|Subject Withdrew Consent|13
3046635|NCT00622739|10474591|P2|Overall Study|Lost to Follow-up|1
3046636|NCT00622739|10474592|P1|Overall Study|Lost to Follow-up|0
3046637|NCT00622739|10474591|P2|Overall Study|Withdrawal by Subject|1
3046638|NCT00622739|10474592|P1|Overall Study|Withdrawal by Subject|0
3046639|NCT00622739|10474591|P2|Overall Study|Lack of Efficacy|2
3046640|NCT00622739|10474592|P1|Overall Study|Lack of Efficacy|0
3046641|NCT00622739|10474591|P2|Overall Study|Adverse Event|2
3046642|NCT00622739|10474592|P1|Overall Study|Adverse Event|1
3046643|NCT00622739|10474591|P2|Overall Study|Physician Decision|0
3046644|NCT00622739|10474592|P1|Overall Study|Physician Decision|1
3046645|NCT00622726|10474610|P2|August, 2010 to April, 2013|Death|5
3046646|NCT00622726|10474611|P1|August, 2010 to April, 2013|Death|1
3046647|NCT00622726|10474610|P2|March, 2008 to August, 2010|Death|2
3046648|NCT00622726|10474611|P1|March, 2008 to August, 2010|Death|5
3046649|NCT00622713|10474621|P1|Overall Study|Did not meet eligibility criteria|1
3046650|NCT00622713|10474621|P1|Overall Study|Subject no longer required study drug|1
3046651|NCT00622713|10474621|P1|Overall Study|Death|2
3046652|NCT00622713|10474621|P1|Overall Study|Lost to Follow-up|5
3046653|NCT00622713|10474621|P1|Overall Study|Withdrawal by Subject|11
3046654|NCT00622713|10474621|P1|Overall Study|Administrative problems|4
3046655|NCT00622713|10474621|P1|Overall Study|Adverse Event|35
3046656|NCT00622700|10474632|P7|Extension Treatment Period|Other than specified above|1
3046657|NCT00622700|10474633|P6|Extension Treatment Period|Other than specified above|1
3046658|NCT00622700|10474634|P5|Extension Treatment Period|Other than specified above|0
3046659|NCT00622700|10474635|P4|Extension Treatment Period|Other than specified above|0
3046660|NCT00622700|10474636|P3|Extension Treatment Period|Other than specified above|0
3046661|NCT00622700|10474637|P2|Extension Treatment Period|Other than specified above|0
3046662|NCT00622700|10474638|P1|Extension Treatment Period|Other than specified above|0
3046663|NCT00622700|10474632|P7|Extension Treatment Period|Missing|0
3046664|NCT00622700|10474633|P6|Extension Treatment Period|Missing|1
3046665|NCT00622700|10474634|P5|Extension Treatment Period|Missing|3
3046666|NCT00622700|10474635|P4|Extension Treatment Period|Missing|2
3046667|NCT00622700|10474636|P3|Extension Treatment Period|Missing|0
3046668|NCT00622700|10474637|P2|Extension Treatment Period|Missing|0
3046669|NCT00622700|10474638|P1|Extension Treatment Period|Missing|0
3046670|NCT00622700|10474632|P7|Extension Treatment Period|Withdrawal by Subject|10
3046671|NCT00622700|10474633|P6|Extension Treatment Period|Withdrawal by Subject|6
3046672|NCT00622700|10474634|P5|Extension Treatment Period|Withdrawal by Subject|16
3046673|NCT00622700|10474635|P4|Extension Treatment Period|Withdrawal by Subject|11
3046674|NCT00622700|10474636|P3|Extension Treatment Period|Withdrawal by Subject|0
3046675|NCT00622700|10474637|P2|Extension Treatment Period|Withdrawal by Subject|0
3046676|NCT00622700|10474638|P1|Extension Treatment Period|Withdrawal by Subject|0
3046677|NCT00622700|10474632|P7|Extension Treatment Period|Progressive Disease|2
3046678|NCT00622700|10474633|P6|Extension Treatment Period|Progressive Disease|0
3046679|NCT00622700|10474634|P5|Extension Treatment Period|Progressive Disease|2
3046680|NCT00622700|10474635|P4|Extension Treatment Period|Progressive Disease|1
3046681|NCT00622700|10474636|P3|Extension Treatment Period|Progressive Disease|0
3046682|NCT00622700|10474637|P2|Extension Treatment Period|Progressive Disease|0
3046683|NCT00622700|10474638|P1|Extension Treatment Period|Progressive Disease|0
3046684|NCT00622700|10474632|P7|Extension Treatment Period|Lost to Follow-up|0
3046685|NCT00622700|10474633|P6|Extension Treatment Period|Lost to Follow-up|0
3046686|NCT00622700|10474634|P5|Extension Treatment Period|Lost to Follow-up|1
3046687|NCT00622700|10474635|P4|Extension Treatment Period|Lost to Follow-up|0
3046688|NCT00622700|10474636|P3|Extension Treatment Period|Lost to Follow-up|0
3046689|NCT00622700|10474637|P2|Extension Treatment Period|Lost to Follow-up|0
3046690|NCT00622700|10474638|P1|Extension Treatment Period|Lost to Follow-up|0
3046691|NCT00622700|10474632|P7|Extension Treatment Period|Protocol Violation|0
3046692|NCT00622700|10474633|P6|Extension Treatment Period|Protocol Violation|2
3046693|NCT00622700|10474634|P5|Extension Treatment Period|Protocol Violation|0
3046694|NCT00622700|10474635|P4|Extension Treatment Period|Protocol Violation|0
3046695|NCT00622700|10474636|P3|Extension Treatment Period|Protocol Violation|0
3046696|NCT00622700|10474637|P2|Extension Treatment Period|Protocol Violation|0
3046697|NCT00622700|10474638|P1|Extension Treatment Period|Protocol Violation|0
3046698|NCT00622700|10474632|P7|Extension Treatment Period|Lack of Efficacy|9
3046699|NCT00622700|10474633|P6|Extension Treatment Period|Lack of Efficacy|1
3046700|NCT00622700|10474634|P5|Extension Treatment Period|Lack of Efficacy|8
3046701|NCT00622700|10474635|P4|Extension Treatment Period|Lack of Efficacy|2
3046702|NCT00622700|10474636|P3|Extension Treatment Period|Lack of Efficacy|0
3046703|NCT00622700|10474637|P2|Extension Treatment Period|Lack of Efficacy|0
3046704|NCT00622700|10474638|P1|Extension Treatment Period|Lack of Efficacy|0
3046705|NCT00622700|10474632|P7|Extension Treatment Period|Adverse Event|8
3046706|NCT00622700|10474633|P6|Extension Treatment Period|Adverse Event|6
3046707|NCT00622700|10474634|P5|Extension Treatment Period|Adverse Event|9
3046708|NCT00622700|10474635|P4|Extension Treatment Period|Adverse Event|5
3046709|NCT00622700|10474636|P3|Extension Treatment Period|Adverse Event|0
3046710|NCT00622700|10474637|P2|Extension Treatment Period|Adverse Event|0
3046711|NCT00622700|10474638|P1|Extension Treatment Period|Adverse Event|0
3046712|NCT00622700|10474632|P7|Core Treatment Period|Other than specified above|0
3046713|NCT00622700|10474633|P6|Core Treatment Period|Other than specified above|0
3046714|NCT00622700|10474634|P5|Core Treatment Period|Other than specified above|0
3046715|NCT00622700|10474635|P4|Core Treatment Period|Other than specified above|0
3046716|NCT00622700|10474636|P3|Core Treatment Period|Other than specified above|5
3046717|NCT00622700|10474637|P2|Core Treatment Period|Other than specified above|2
3046718|NCT00622700|10474638|P1|Core Treatment Period|Other than specified above|2
3046719|NCT00622700|10474632|P7|Core Treatment Period|Withdrawal by Subject|0
3046720|NCT00622700|10474633|P6|Core Treatment Period|Withdrawal by Subject|0
3046721|NCT00622700|10474634|P5|Core Treatment Period|Withdrawal by Subject|0
3046722|NCT00622700|10474635|P4|Core Treatment Period|Withdrawal by Subject|0
3046723|NCT00622700|10474636|P3|Core Treatment Period|Withdrawal by Subject|15
3046724|NCT00622700|10474637|P2|Core Treatment Period|Withdrawal by Subject|18
3046725|NCT00622700|10474638|P1|Core Treatment Period|Withdrawal by Subject|12
3046726|NCT00622700|10474632|P7|Core Treatment Period|Progressive Disease|0
3046727|NCT00622700|10474633|P6|Core Treatment Period|Progressive Disease|0
3046728|NCT00622700|10474634|P5|Core Treatment Period|Progressive Disease|0
3046729|NCT00622700|10474635|P4|Core Treatment Period|Progressive Disease|0
3046730|NCT00622700|10474636|P3|Core Treatment Period|Progressive Disease|0
3046731|NCT00622700|10474637|P2|Core Treatment Period|Progressive Disease|1
3046732|NCT00622700|10474638|P1|Core Treatment Period|Progressive Disease|3
3046733|NCT00622700|10474632|P7|Core Treatment Period|Death|0
3046734|NCT00622700|10474633|P6|Core Treatment Period|Death|0
3046735|NCT00622700|10474634|P5|Core Treatment Period|Death|0
3046736|NCT00622700|10474635|P4|Core Treatment Period|Death|0
3046737|NCT00622700|10474636|P3|Core Treatment Period|Death|0
3046738|NCT00622700|10474637|P2|Core Treatment Period|Death|0
3046739|NCT00622700|10474638|P1|Core Treatment Period|Death|1
3046740|NCT00622700|10474632|P7|Core Treatment Period|Lost to Follow-up|0
3046741|NCT00622700|10474633|P6|Core Treatment Period|Lost to Follow-up|0
3046742|NCT00622700|10474634|P5|Core Treatment Period|Lost to Follow-up|0
3046743|NCT00622700|10474635|P4|Core Treatment Period|Lost to Follow-up|0
3046744|NCT00622700|10474636|P3|Core Treatment Period|Lost to Follow-up|1
3046745|NCT00622700|10474637|P2|Core Treatment Period|Lost to Follow-up|1
3046746|NCT00622700|10474638|P1|Core Treatment Period|Lost to Follow-up|1
3046747|NCT00622700|10474632|P7|Core Treatment Period|Lack of Efficacy|0
3046748|NCT00622700|10474633|P6|Core Treatment Period|Lack of Efficacy|0
3046749|NCT00622700|10474634|P5|Core Treatment Period|Lack of Efficacy|0
3046750|NCT00622700|10474635|P4|Core Treatment Period|Lack of Efficacy|0
3046751|NCT00622700|10474636|P3|Core Treatment Period|Lack of Efficacy|12
3046752|NCT00622700|10474637|P2|Core Treatment Period|Lack of Efficacy|6
3046753|NCT00622700|10474638|P1|Core Treatment Period|Lack of Efficacy|19
3046754|NCT00622700|10474632|P7|Core Treatment Period|Adverse Event|0
3046755|NCT00622700|10474633|P6|Core Treatment Period|Adverse Event|0
3046756|NCT00622700|10474634|P5|Core Treatment Period|Adverse Event|0
3046757|NCT00622700|10474635|P4|Core Treatment Period|Adverse Event|0
3046758|NCT00622700|10474636|P3|Core Treatment Period|Adverse Event|18
3046759|NCT00622700|10474637|P2|Core Treatment Period|Adverse Event|25
3046760|NCT00622700|10474638|P1|Core Treatment Period|Adverse Event|18
3046761|NCT00622700|10474632|P7|Core Treatment Period|Randomized but Not Treated|0
3046762|NCT00622700|10474633|P6|Core Treatment Period|Randomized but Not Treated|0
3046763|NCT00622700|10474634|P5|Core Treatment Period|Randomized but Not Treated|0
3046764|NCT00622700|10474635|P4|Core Treatment Period|Randomized but Not Treated|0
3046765|NCT00622700|10474636|P3|Core Treatment Period|Randomized but Not Treated|2
3046766|NCT00622700|10474637|P2|Core Treatment Period|Randomized but Not Treated|2
3046767|NCT00622700|10474638|P1|Core Treatment Period|Randomized but Not Treated|0
3046768|NCT00622635|10474697|P6|Treatment Period 3|Withdrawal by Subject|0
3046769|NCT00622635|10474698|P5|Treatment Period 3|Withdrawal by Subject|0
3046770|NCT00622635|10474699|P4|Treatment Period 3|Withdrawal by Subject|1
3046771|NCT00622635|10474700|P3|Treatment Period 3|Withdrawal by Subject|0
3046772|NCT00622635|10474701|P2|Treatment Period 3|Withdrawal by Subject|0
3046773|NCT00622635|10474702|P1|Treatment Period 3|Withdrawal by Subject|0
3046774|NCT00622635|10474697|P6|Treatment Period 3|Adverse Event|0
3046775|NCT00622635|10474698|P5|Treatment Period 3|Adverse Event|0
3046776|NCT00622635|10474699|P4|Treatment Period 3|Adverse Event|2
3046777|NCT00622635|10474700|P3|Treatment Period 3|Adverse Event|0
3046778|NCT00622635|10474701|P2|Treatment Period 3|Adverse Event|0
3046779|NCT00622635|10474702|P1|Treatment Period 3|Adverse Event|0
3046780|NCT00622635|10474697|P6|Treatment Period 2|Adverse Event|0
3046781|NCT00622635|10474698|P5|Treatment Period 2|Adverse Event|0
3046782|NCT00622635|10474699|P4|Treatment Period 2|Adverse Event|0
3046783|NCT00622635|10474700|P3|Treatment Period 2|Adverse Event|0
3046784|NCT00622635|10474701|P2|Treatment Period 2|Adverse Event|0
3046785|NCT00622635|10474702|P1|Treatment Period 2|Adverse Event|1
3046786|NCT00622635|10474697|P6|Treatment Period 1|Abnormal test procedure result(s)|0
3046787|NCT00622635|10474698|P5|Treatment Period 1|Abnormal test procedure result(s)|1
3046788|NCT00622635|10474699|P4|Treatment Period 1|Abnormal test procedure result(s)|0
3046789|NCT00622635|10474700|P3|Treatment Period 1|Abnormal test procedure result(s)|0
3046790|NCT00622635|10474701|P2|Treatment Period 1|Abnormal test procedure result(s)|0
3046791|NCT00622635|10474702|P1|Treatment Period 1|Abnormal test procedure result(s)|0
3046792|NCT00622635|10474697|P6|Treatment Period 1|Withdrawal by Subject|0
3046793|NCT00622635|10474698|P5|Treatment Period 1|Withdrawal by Subject|0
3046794|NCT00622635|10474699|P4|Treatment Period 1|Withdrawal by Subject|0
3046795|NCT00622635|10474700|P3|Treatment Period 1|Withdrawal by Subject|0
3046796|NCT00622635|10474701|P2|Treatment Period 1|Withdrawal by Subject|1
3046797|NCT00622635|10474702|P1|Treatment Period 1|Withdrawal by Subject|0
3046798|NCT00622635|10474697|P6|Treatment Period 1|Adverse Event|0
3046799|NCT00622635|10474698|P5|Treatment Period 1|Adverse Event|0
3046800|NCT00622635|10474699|P4|Treatment Period 1|Adverse Event|0
3046801|NCT00622635|10474700|P3|Treatment Period 1|Adverse Event|1
3046802|NCT00622635|10474701|P2|Treatment Period 1|Adverse Event|0
3046803|NCT00622635|10474702|P1|Treatment Period 1|Adverse Event|0
3046804|NCT00622440|10474785|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
3046805|NCT00622440|10474786|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
3046806|NCT00622440|10474785|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
3046807|NCT00622440|10474786|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
3046808|NCT00622440|10474785|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
3046809|NCT00622440|10474786|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
3046810|NCT00622440|10474785|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
3046811|NCT00622440|10474786|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
3046812|NCT00622401|10474812|P3|Overall Study|Disease progression prior to treatment|0
3046813|NCT00622401|10474813|P2|Overall Study|Disease progression prior to treatment|2
3046814|NCT00622401|10474814|P1|Overall Study|Disease progression prior to treatment|3
3046815|NCT00622388|10474821|P1|Overall Study|Insurance Expired|1
3046816|NCT00622388|10474821|P1|Overall Study|Withdrew Consent|1
3046817|NCT00622388|10474821|P1|Overall Study|Took Prohibited Medication|2
3046818|NCT00622388|10474821|P1|Overall Study|Received Alternate Anticancer Therapy|8
3046819|NCT00622388|10474821|P1|Overall Study|Death|3
3046820|NCT00622388|10474821|P1|Overall Study|Participant Refusal|1
3046821|NCT00622388|10474821|P1|Overall Study|Protocol Violation|3
3046822|NCT00622388|10474821|P1|Overall Study|Adverse Event|6
3046823|NCT00622388|10474821|P1|Overall Study|Disease Progression|47
3046824|NCT00622336|10474839|P1|Extension Phase|Other|9
3046825|NCT00622336|10474839|P1|Extension Phase|Lost to Follow-up|1
3046826|NCT00622336|10474839|P1|Extension Phase|Withdrawal by Subject|1
3046827|NCT00622336|10474839|P1|Extension Phase|Lack of therapeutic effect|2
3046828|NCT00622336|10474839|P1|Extension Phase|Progressive Disease|6
3046829|NCT00622336|10474839|P1|Extension Phase|Adverse Event|2
3046830|NCT00622336|10474839|P1|Treatment Phase|Lost to Follow-up|2
3046831|NCT00622336|10474839|P1|Treatment Phase|Withdrawal by Subject|13
3046832|NCT00622336|10474839|P1|Treatment Phase|Lack of therapeutic effect|13
3046833|NCT00622336|10474839|P1|Treatment Phase|Death|14
3046834|NCT00622336|10474839|P1|Treatment Phase|Other|40
3046835|NCT00622336|10474839|P1|Treatment Phase|Adverse Event|46
3046836|NCT00622336|10474839|P1|Treatment Phase|Progression of Disease|181
3046837|NCT00622284|10474850|P2|Overall Study|Other reason (not specified)|24
3046838|NCT00622284|10474851|P1|Overall Study|Other reason (not specified)|33
3046839|NCT00622284|10474850|P2|Overall Study|Withdrawal by Subject|24
3046840|NCT00622284|10474851|P1|Overall Study|Withdrawal by Subject|27
3046841|NCT00622284|10474850|P2|Overall Study|Lost to Follow-up|13
3046842|NCT00622284|10474851|P1|Overall Study|Lost to Follow-up|11
3046843|NCT00622284|10474850|P2|Overall Study|Protocol Violation|5
3046844|NCT00622284|10474851|P1|Overall Study|Protocol Violation|12
3046845|NCT00622284|10474850|P2|Overall Study|Adverse Event|90
3046846|NCT00622284|10474851|P1|Overall Study|Adverse Event|61
3046847|NCT00622284|10474850|P2|Overall Study|Lack of Efficacy|15
3046848|NCT00622284|10474851|P1|Overall Study|Lack of Efficacy|45
3046849|NCT00622180|10474913|P2|Overall Study|Lost to Follow-up|2
3046850|NCT00622180|10474914|P1|Overall Study|Lost to Follow-up|1
3046851|NCT00622167|10474920|P1|Overall Study|Did not meet angiographic criteria|20
3046852|NCT00621985|10474924|P1|Dexamethasone Admission|Adverse Event|1
3046853|NCT00621959|10474932|P2|Overall Study|Other|3
3046854|NCT00621959|10474933|P1|Overall Study|Other|1
3046855|NCT00621959|10474932|P2|Overall Study|Withdrawal by Subject|1
3046856|NCT00621959|10474933|P1|Overall Study|Withdrawal by Subject|1
3046857|NCT00621959|10474932|P2|Overall Study|Lost to Follow-up|2
3046858|NCT00621959|10474933|P1|Overall Study|Lost to Follow-up|0
3046859|NCT00621959|10474932|P2|Overall Study|Lack of Efficacy|1
3046860|NCT00621959|10474933|P1|Overall Study|Lack of Efficacy|1
3046861|NCT00621959|10474932|P2|Overall Study|Adverse Event|2
3046862|NCT00621959|10474933|P1|Overall Study|Adverse Event|4
3046863|NCT00621855|10474972|P5|Overall Study|Patients did not receive study drug|2
3046864|NCT00621855|10474973|P4|Overall Study|Patients did not receive study drug|4
3046865|NCT00621855|10474974|P3|Overall Study|Patients did not receive study drug|5
3046866|NCT00621855|10474975|P2|Overall Study|Patients did not receive study drug|3
3046867|NCT00621855|10474976|P1|Overall Study|Patients did not receive study drug|3
3046868|NCT00621855|10474972|P5|Overall Study|Other|4
3046869|NCT00621855|10474973|P4|Overall Study|Other|5
3046870|NCT00621855|10474974|P3|Overall Study|Other|6
3046871|NCT00621855|10474975|P2|Overall Study|Other|7
3046872|NCT00621855|10474976|P1|Overall Study|Other|9
3046873|NCT00621855|10474972|P5|Overall Study|Withdrawal by Subject|9
3046874|NCT00621855|10474973|P4|Overall Study|Withdrawal by Subject|13
3046875|NCT00621855|10474974|P3|Overall Study|Withdrawal by Subject|13
3046876|NCT00621855|10474975|P2|Overall Study|Withdrawal by Subject|11
3046877|NCT00621855|10474976|P1|Overall Study|Withdrawal by Subject|16
3046878|NCT00621855|10474972|P5|Overall Study|Protocol Violation|8
3046879|NCT00621855|10474973|P4|Overall Study|Protocol Violation|7
3046880|NCT00621855|10474974|P3|Overall Study|Protocol Violation|6
3046881|NCT00621855|10474975|P2|Overall Study|Protocol Violation|8
3046882|NCT00621855|10474976|P1|Overall Study|Protocol Violation|16
3046883|NCT00621855|10474972|P5|Overall Study|Lost to Follow-up|1
3046884|NCT00621855|10474973|P4|Overall Study|Lost to Follow-up|4
3046885|NCT00621855|10474974|P3|Overall Study|Lost to Follow-up|3
3046886|NCT00621855|10474975|P2|Overall Study|Lost to Follow-up|1
3046887|NCT00621855|10474976|P1|Overall Study|Lost to Follow-up|0
3046888|NCT00621855|10474972|P5|Overall Study|Adverse Event|31
3046889|NCT00621855|10474973|P4|Overall Study|Adverse Event|34
3046890|NCT00621855|10474974|P3|Overall Study|Adverse Event|48
3046891|NCT00621855|10474975|P2|Overall Study|Adverse Event|31
3046892|NCT00621855|10474976|P1|Overall Study|Adverse Event|32
3046893|NCT00621842|10475018|P1|Overall Study|Lack of Efficacy|2
3046894|NCT00621842|10475018|P1|Overall Study|Protocol Violation|4
3046895|NCT00621842|10475018|P1|Overall Study|Withdrawal by Subject|7
3046896|NCT00621842|10475018|P1|Overall Study|Adverse Event|6
3046897|NCT00621777|10475035|P2|Randomized Phase|Death|1
3046898|NCT00621777|10475036|P1|Randomized Phase|Death|0
3046899|NCT00621777|10475035|P2|Randomized Phase|administrative|3
3046900|NCT00621777|10475036|P1|Randomized Phase|administrative|0
3046901|NCT00621777|10475035|P2|Randomized Phase|Withdrawal by Subject|9
3046902|NCT00621777|10475036|P1|Randomized Phase|Withdrawal by Subject|1
3046903|NCT00621777|10475035|P2|Randomized Phase|Lost to Follow-up|3
3046904|NCT00621777|10475036|P1|Randomized Phase|Lost to Follow-up|3
3046905|NCT00621777|10475035|P2|Randomized Phase|Adverse Event|3
3046906|NCT00621777|10475036|P1|Randomized Phase|Adverse Event|3
3046907|NCT00621777|10475035|P2|Open Phase|Lost to Follow-up|0
3046908|NCT00621777|10475036|P1|Open Phase|Lost to Follow-up|10
3046909|NCT00621777|10475035|P2|Open Phase|administrative|0
3046910|NCT00621777|10475036|P1|Open Phase|administrative|13
3046911|NCT00621777|10475035|P2|Open Phase|Withdrawal by Subject|0
3046912|NCT00621777|10475036|P1|Open Phase|Withdrawal by Subject|17
3046913|NCT00621777|10475035|P2|Open Phase|Did not abstain during open phase|0
3046914|NCT00621777|10475036|P1|Open Phase|Did not abstain during open phase|56
3046915|NCT00621777|10475035|P2|Open Phase|Adverse Event|0
3046916|NCT00621777|10475036|P1|Open Phase|Adverse Event|20
3046917|NCT00621764|10475051|P4|Overall Study|Protocol Violation|1
3046918|NCT00621764|10475052|P3|Overall Study|Protocol Violation|0
3046919|NCT00621764|10475053|P2|Overall Study|Protocol Violation|0
3046920|NCT00621764|10475054|P1|Overall Study|Protocol Violation|0
3046921|NCT00621621|10475100|P2|Overall Study|Subjects were exited at EP study|0
3046922|NCT00621621|10475101|P1|Overall Study|Subjects were exited at EP study|30
3046923|NCT00621582|10475109|P1|Overall Study|issues not identified by investigators|18
3046924|NCT00621582|10475109|P1|Overall Study|Lost to Follow-up|24
3046925|NCT00621582|10475109|P1|Overall Study|Protocol Violation|57
3046926|NCT00621582|10475109|P1|Overall Study|Adverse Event|7
3046927|NCT00621543|10475116|P1|Overall Study|Lost to Follow-up|23
3046928|NCT00621517|10475140|P2|Overall Study|Adverse Event|0
3046929|NCT00621517|10475141|P1|Overall Study|Adverse Event|1
3046930|NCT00621517|10475140|P2|Overall Study|Withdrawal by Subject|4
3046931|NCT00621517|10475141|P1|Overall Study|Withdrawal by Subject|3
3046932|NCT00621517|10475140|P2|Overall Study|Lost to Follow-up|3
3046933|NCT00621517|10475141|P1|Overall Study|Lost to Follow-up|3
3046934|NCT00621504|10475153|P2|Overall Study|Death|6
3046935|NCT00621504|10475154|P1|Overall Study|Death|6
3046936|NCT00621504|10475153|P2|Overall Study|Other|0
3046937|NCT00621504|10475154|P1|Overall Study|Other|1
3046938|NCT00621504|10475153|P2|Overall Study|Lost to Follow-up|10
3046939|NCT00621504|10475154|P1|Overall Study|Lost to Follow-up|8
3046940|NCT00621504|10475153|P2|Overall Study|Withdrew consent|6
3046941|NCT00621504|10475154|P1|Overall Study|Withdrew consent|9
3046942|NCT00621504|10475153|P2|Overall Study|At the request of sponsor/investigator|0
3046943|NCT00621504|10475154|P1|Overall Study|At the request of sponsor/investigator|1
3046944|NCT00621504|10475153|P2|Overall Study|Adverse Event|3
3046945|NCT00621504|10475154|P1|Overall Study|Adverse Event|1
3046946|NCT00621322|10475188|P6|Overall Study|Migrated/moved from study area|2
3046947|NCT00621322|10475189|P5|Overall Study|Migrated/moved from study area|0
3046948|NCT00621322|10475190|P4|Overall Study|Migrated/moved from study area|1
3046949|NCT00621322|10475191|P3|Overall Study|Migrated/moved from study area|1
3046950|NCT00621322|10475192|P2|Overall Study|Migrated/moved from study area|0
3046951|NCT00621322|10475193|P1|Overall Study|Migrated/moved from study area|1
3046952|NCT00621322|10475188|P6|Overall Study|Withdrawal by Subject|2
3046953|NCT00621322|10475189|P5|Overall Study|Withdrawal by Subject|0
3046954|NCT00621322|10475190|P4|Overall Study|Withdrawal by Subject|1
3046955|NCT00621322|10475191|P3|Overall Study|Withdrawal by Subject|0
3046956|NCT00621322|10475192|P2|Overall Study|Withdrawal by Subject|0
3046957|NCT00621322|10475193|P1|Overall Study|Withdrawal by Subject|0
3046958|NCT00621322|10475188|P6|Overall Study|Physician Decision|0
3046959|NCT00621322|10475189|P5|Overall Study|Physician Decision|0
3046960|NCT00621322|10475190|P4|Overall Study|Physician Decision|1
3046961|NCT00621322|10475191|P3|Overall Study|Physician Decision|1
3046962|NCT00621322|10475192|P2|Overall Study|Physician Decision|0
3046963|NCT00621322|10475193|P1|Overall Study|Physician Decision|0
3046964|NCT00621322|10475188|P6|Overall Study|Lost to Follow-up|0
3046965|NCT00621322|10475189|P5|Overall Study|Lost to Follow-up|1
3046966|NCT00621322|10475190|P4|Overall Study|Lost to Follow-up|0
3046967|NCT00621322|10475191|P3|Overall Study|Lost to Follow-up|0
3046968|NCT00621322|10475192|P2|Overall Study|Lost to Follow-up|0
3046969|NCT00621322|10475193|P1|Overall Study|Lost to Follow-up|0
3046970|NCT00621309|10475273|P6|Overall Study|Withdrawal by Subject|1
3046971|NCT00621309|10475274|P5|Overall Study|Withdrawal by Subject|1
3046972|NCT00621309|10475275|P4|Overall Study|Withdrawal by Subject|1
3046973|NCT00621309|10475276|P3|Overall Study|Withdrawal by Subject|1
3046974|NCT00621309|10475277|P2|Overall Study|Withdrawal by Subject|0
3046975|NCT00621309|10475278|P1|Overall Study|Withdrawal by Subject|2
3046976|NCT00621296|10475284|P1|Overall Study|Stopping Criteria|3
3046977|NCT00621296|10475284|P1|Overall Study|Unmatch Criteria|1
3046978|NCT00621296|10475284|P1|Overall Study|Physician Decision|7
3046979|NCT00621296|10475284|P1|Overall Study|Lack of Efficacy|1
3046980|NCT00621296|10475284|P1|Overall Study|Adverse Event|2
3046981|NCT00621257|10475293|P5|Overall Study|Withdrawal by Subject|1
3046982|NCT00621257|10475294|P4|Overall Study|Withdrawal by Subject|1
3046983|NCT00621257|10475295|P3|Overall Study|Withdrawal by Subject|0
3046984|NCT00621257|10475296|P2|Overall Study|Withdrawal by Subject|0
3046985|NCT00621257|10475297|P1|Overall Study|Withdrawal by Subject|0
3046986|NCT00621257|10475293|P5|Overall Study|Physician Decision|1
3046987|NCT00621257|10475294|P4|Overall Study|Physician Decision|1
3046988|NCT00621257|10475295|P3|Overall Study|Physician Decision|0
3046989|NCT00621257|10475296|P2|Overall Study|Physician Decision|2
3046990|NCT00621257|10475297|P1|Overall Study|Physician Decision|0
3046991|NCT00621257|10475293|P5|Overall Study|Adverse Event|0
3046992|NCT00621257|10475294|P4|Overall Study|Adverse Event|0
3046993|NCT00621257|10475295|P3|Overall Study|Adverse Event|1
3046994|NCT00621257|10475296|P2|Overall Study|Adverse Event|1
3046995|NCT00621257|10475297|P1|Overall Study|Adverse Event|0
3046996|NCT00621257|10475293|P5|Overall Study|Lost to Follow-up|7
3046997|NCT00621257|10475294|P4|Overall Study|Lost to Follow-up|4
3046998|NCT00621257|10475295|P3|Overall Study|Lost to Follow-up|2
3046999|NCT00621257|10475296|P2|Overall Study|Lost to Follow-up|0
3047000|NCT00621257|10475297|P1|Overall Study|Lost to Follow-up|4
3047001|NCT00621244|10475313|P4|Overall Study|Administrative problems|2
3047002|NCT00621244|10475314|P3|Overall Study|Administrative problems|0
3047003|NCT00621244|10475315|P2|Overall Study|Administrative problems|1
3047004|NCT00621244|10475316|P1|Overall Study|Administrative problems|5
3047005|NCT00621244|10475313|P4|Overall Study|Adverse Event|2
3047006|NCT00621244|10475314|P3|Overall Study|Adverse Event|9
3047007|NCT00621244|10475315|P2|Overall Study|Adverse Event|7
3047008|NCT00621244|10475316|P1|Overall Study|Adverse Event|27
3047009|NCT00621244|10475313|P4|Overall Study|Death|1
3047010|NCT00621244|10475314|P3|Overall Study|Death|1
3047011|NCT00621244|10475315|P2|Overall Study|Death|3
3047012|NCT00621244|10475316|P1|Overall Study|Death|3
3047013|NCT00621244|10475313|P4|Overall Study|Disease progression|15
3047014|NCT00621244|10475314|P3|Overall Study|Disease progression|20
3047015|NCT00621244|10475315|P2|Overall Study|Disease progression|20
3047016|NCT00621244|10475316|P1|Overall Study|Disease progression|44
3047017|NCT00621244|10475313|P4|Overall Study|Withdrawal by Subject|3
3047018|NCT00621244|10475314|P3|Overall Study|Withdrawal by Subject|3
3047019|NCT00621244|10475315|P2|Overall Study|Withdrawal by Subject|3
3047020|NCT00621244|10475316|P1|Overall Study|Withdrawal by Subject|7
3047021|NCT00621192|10475420|P4|Overall Study|Final Assessments not Completed|1
3047022|NCT00621192|10475421|P3|Overall Study|Final Assessments not Completed|3
3047023|NCT00621192|10475422|P2|Overall Study|Final Assessments not Completed|0
3047024|NCT00621192|10475423|P1|Overall Study|Final Assessments not Completed|0
3047025|NCT00621192|10475420|P4|Overall Study|Death|0
3047026|NCT00621192|10475421|P3|Overall Study|Death|0
3047027|NCT00621192|10475422|P2|Overall Study|Death|5
3047028|NCT00621192|10475423|P1|Overall Study|Death|2
3047029|NCT00621192|10475420|P4|Overall Study|Adverse Event|1
3047030|NCT00621192|10475421|P3|Overall Study|Adverse Event|0
3047031|NCT00621192|10475422|P2|Overall Study|Adverse Event|1
3047032|NCT00621192|10475423|P1|Overall Study|Adverse Event|0
3047033|NCT00621192|10475420|P4|Overall Study|Protocol Violation|1
3047034|NCT00621192|10475421|P3|Overall Study|Protocol Violation|0
3047035|NCT00621192|10475422|P2|Overall Study|Protocol Violation|0
3047036|NCT00621192|10475423|P1|Overall Study|Protocol Violation|1
3047037|NCT00621192|10475420|P4|Overall Study|Physician Decision|0
3047038|NCT00621192|10475421|P3|Overall Study|Physician Decision|0
3047039|NCT00621192|10475422|P2|Overall Study|Physician Decision|3
3047040|NCT00621192|10475423|P1|Overall Study|Physician Decision|1
3047041|NCT00621192|10475420|P4|Overall Study|Withdrawal by Subject|0
3047042|NCT00621192|10475421|P3|Overall Study|Withdrawal by Subject|2
3047043|NCT00621192|10475422|P2|Overall Study|Withdrawal by Subject|0
3047044|NCT00621192|10475423|P1|Overall Study|Withdrawal by Subject|0
3047045|NCT00621153|10475447|P2|Overall Study|Withdrawal by Subject|5
3047046|NCT00621153|10475448|P1|Overall Study|Withdrawal by Subject|4
3047047|NCT00621153|10475447|P2|Overall Study|Lost to Follow-up|1
3047048|NCT00621153|10475448|P1|Overall Study|Lost to Follow-up|5
3047049|NCT00621153|10475447|P2|Overall Study|Adverse Event|2
3047050|NCT00621153|10475448|P1|Overall Study|Adverse Event|3
3047051|NCT00621153|10475447|P2|Overall Study|Safety Reason|7
3047052|NCT00621153|10475448|P1|Overall Study|Safety Reason|8
3047053|NCT00621140|10475456|P2|Overall Study|Other incl. lack of efficacy|5
3047054|NCT00621140|10475457|P1|Overall Study|Other incl. lack of efficacy|6
3047055|NCT00621140|10475456|P2|Overall Study|Withdrawal by Subject|6
3047056|NCT00621140|10475457|P1|Overall Study|Withdrawal by Subject|4
3047057|NCT00621140|10475456|P2|Overall Study|Lost to Follow-up|2
3047058|NCT00621140|10475457|P1|Overall Study|Lost to Follow-up|1
3047059|NCT00621140|10475456|P2|Overall Study|Adverse Event|5
3047060|NCT00621140|10475457|P1|Overall Study|Adverse Event|4
3047061|NCT00621023|10475504|P1|Overall Study|Follow up discontinued|1
3047062|NCT00621023|10475504|P1|Overall Study|Death|5
3047063|NCT00620854|10475521|P6|Washout 1|Withdrawal by Subject|0
3047064|NCT00620854|10475522|P5|Washout 1|Withdrawal by Subject|0
3047065|NCT00620854|10475523|P4|Washout 1|Withdrawal by Subject|1
3047066|NCT00620854|10475524|P3|Washout 1|Withdrawal by Subject|1
3047067|NCT00620854|10475525|P2|Washout 1|Withdrawal by Subject|0
3047068|NCT00620854|10475526|P1|Washout 1|Withdrawal by Subject|0
3047069|NCT00620815|10475557|P3|Overall Study|Protocol Violation|1
3047070|NCT00620815|10475558|P2|Overall Study|Protocol Violation|2
3047071|NCT00620815|10475559|P1|Overall Study|Protocol Violation|1
3047072|NCT00620815|10475557|P3|Overall Study|Inappropriate enrolment|1
3047073|NCT00620815|10475558|P2|Overall Study|Inappropriate enrolment|0
3047074|NCT00620815|10475559|P1|Overall Study|Inappropriate enrolment|0
3047075|NCT00620815|10475557|P3|Overall Study|Lost to Follow-up|3
3047076|NCT00620815|10475558|P2|Overall Study|Lost to Follow-up|6
3047077|NCT00620815|10475559|P1|Overall Study|Lost to Follow-up|1
3047078|NCT00620815|10475557|P3|Overall Study|Withdrawal by Subject|0
3047079|NCT00620815|10475558|P2|Overall Study|Withdrawal by Subject|2
3047080|NCT00620815|10475559|P1|Overall Study|Withdrawal by Subject|1
3047081|NCT00620815|10475557|P3|Overall Study|Adverse Event|2
3047082|NCT00620815|10475558|P2|Overall Study|Adverse Event|1
3047083|NCT00620815|10475559|P1|Overall Study|Adverse Event|1
3047084|NCT00620776|10475599|P2|Overall Study|Withdrawal by Subject|2
3047085|NCT00620776|10475600|P1|Overall Study|Withdrawal by Subject|3
3047086|NCT00620776|10475599|P2|Overall Study|Lost to Follow-up|5
3047087|NCT00620776|10475600|P1|Overall Study|Lost to Follow-up|2
3047088|NCT00620776|10475599|P2|Overall Study|Lack of Efficacy|1
3047089|NCT00620776|10475600|P1|Overall Study|Lack of Efficacy|2
3047090|NCT00620776|10475599|P2|Overall Study|Adverse Event|3
3047091|NCT00620776|10475600|P1|Overall Study|Adverse Event|2
3047092|NCT00620776|10475599|P2|Overall Study|Did not receive treatment|5
3047093|NCT00620776|10475600|P1|Overall Study|Did not receive treatment|3
3047094|NCT00620763|10475628|P2|Period: Second Intervention|Withdrawal by Subject|0
3047095|NCT00620763|10475629|P1|Period: Second Intervention|Withdrawal by Subject|1
3047096|NCT00620763|10475628|P2|Period: First Intervention|Protocol Violation|3
3047097|NCT00620763|10475629|P1|Period: First Intervention|Protocol Violation|0
3047098|NCT00620763|10475628|P2|Period: First Intervention|Withdrawal by Subject|2
3047099|NCT00620763|10475629|P1|Period: First Intervention|Withdrawal by Subject|0
3047100|NCT00620750|10475635|P1|Overall Study|Lost to Follow-up|25
3047101|NCT00620659|10475650|P6|Treatment Period 3|Withdrawal by Subject|0
3047102|NCT00620659|10475651|P5|Treatment Period 3|Withdrawal by Subject|0
3047103|NCT00620659|10475652|P4|Treatment Period 3|Withdrawal by Subject|1
3047104|NCT00620659|10475653|P3|Treatment Period 3|Withdrawal by Subject|0
3047105|NCT00620659|10475654|P2|Treatment Period 3|Withdrawal by Subject|0
3047106|NCT00620659|10475655|P1|Treatment Period 3|Withdrawal by Subject|0
3047107|NCT00620659|10475650|P6|Treatment Period 3|Adverse Event|0
3047108|NCT00620659|10475651|P5|Treatment Period 3|Adverse Event|0
3047109|NCT00620659|10475652|P4|Treatment Period 3|Adverse Event|0
3047110|NCT00620659|10475653|P3|Treatment Period 3|Adverse Event|0
3047111|NCT00620659|10475654|P2|Treatment Period 3|Adverse Event|2
3047112|NCT00620659|10475655|P1|Treatment Period 3|Adverse Event|0
3047113|NCT00620659|10475650|P6|Placebo Washout Period 2|Adverse Event|0
3047114|NCT00620659|10475651|P5|Placebo Washout Period 2|Adverse Event|0
3047115|NCT00620659|10475652|P4|Placebo Washout Period 2|Adverse Event|0
3047116|NCT00620659|10475653|P3|Placebo Washout Period 2|Adverse Event|0
3047117|NCT00620659|10475654|P2|Placebo Washout Period 2|Adverse Event|0
3047118|NCT00620659|10475655|P1|Placebo Washout Period 2|Adverse Event|2
3047119|NCT00620659|10475650|P6|Treatment Period 2|Withdrawal by Subject|0
3047120|NCT00620659|10475651|P5|Treatment Period 2|Withdrawal by Subject|3
3047121|NCT00620659|10475652|P4|Treatment Period 2|Withdrawal by Subject|0
3047122|NCT00620659|10475653|P3|Treatment Period 2|Withdrawal by Subject|1
3047123|NCT00620659|10475654|P2|Treatment Period 2|Withdrawal by Subject|0
3047124|NCT00620659|10475655|P1|Treatment Period 2|Withdrawal by Subject|0
3047125|NCT00620659|10475650|P6|Treatment Period 2|Adverse Event|0
3047126|NCT00620659|10475651|P5|Treatment Period 2|Adverse Event|2
3047127|NCT00620659|10475652|P4|Treatment Period 2|Adverse Event|0
3047128|NCT00620659|10475653|P3|Treatment Period 2|Adverse Event|0
3047129|NCT00620659|10475654|P2|Treatment Period 2|Adverse Event|3
3047130|NCT00620659|10475655|P1|Treatment Period 2|Adverse Event|0
3047131|NCT00620659|10475650|P6|Placebo Washout Period 1|Withdrawal by Subject|0
3047132|NCT00620659|10475651|P5|Placebo Washout Period 1|Withdrawal by Subject|0
3047133|NCT00620659|10475652|P4|Placebo Washout Period 1|Withdrawal by Subject|1
3047134|NCT00620659|10475653|P3|Placebo Washout Period 1|Withdrawal by Subject|0
3047135|NCT00620659|10475654|P2|Placebo Washout Period 1|Withdrawal by Subject|0
3047136|NCT00620659|10475655|P1|Placebo Washout Period 1|Withdrawal by Subject|0
3047137|NCT00620659|10475650|P6|Treatment Period 1|Withdrawal by Subject|0
3047138|NCT00620659|10475651|P5|Treatment Period 1|Withdrawal by Subject|1
3047139|NCT00620659|10475652|P4|Treatment Period 1|Withdrawal by Subject|0
3047140|NCT00620659|10475653|P3|Treatment Period 1|Withdrawal by Subject|1
3047141|NCT00620659|10475654|P2|Treatment Period 1|Withdrawal by Subject|0
3047142|NCT00620659|10475655|P1|Treatment Period 1|Withdrawal by Subject|1
3047143|NCT00620659|10475650|P6|Treatment Period 1|Protocol Violation|0
3047144|NCT00620659|10475651|P5|Treatment Period 1|Protocol Violation|0
3047145|NCT00620659|10475652|P4|Treatment Period 1|Protocol Violation|0
3047146|NCT00620659|10475653|P3|Treatment Period 1|Protocol Violation|0
3047147|NCT00620659|10475654|P2|Treatment Period 1|Protocol Violation|0
3047148|NCT00620659|10475655|P1|Treatment Period 1|Protocol Violation|1
3047149|NCT00620659|10475650|P6|Treatment Period 1|Adverse Event|0
3047150|NCT00620659|10475651|P5|Treatment Period 1|Adverse Event|0
3047151|NCT00620659|10475652|P4|Treatment Period 1|Adverse Event|3
3047152|NCT00620659|10475653|P3|Treatment Period 1|Adverse Event|0
3047153|NCT00620659|10475654|P2|Treatment Period 1|Adverse Event|0
3047154|NCT00620659|10475655|P1|Treatment Period 1|Adverse Event|1
3047155|NCT00620555|10475673|P1|Overall Study|Visit failure against planned|1
3047156|NCT00620555|10475673|P1|Overall Study|Choice of other treatment|1
3047157|NCT00620555|10475673|P1|Overall Study|Withdrawal by Subject|1
3047158|NCT00620555|10475673|P1|Overall Study|Lack of Efficacy|12
3047159|NCT00620555|10475673|P1|Overall Study|Protocol Violation|2
3047160|NCT00620555|10475673|P1|Overall Study|Adverse Event|4
3047161|NCT00620542|10475682|P4|Part B (2 Year Core Study)|IVUS not available|2
3047162|NCT00620542|10475683|P3|Part B (2 Year Core Study)|IVUS not available|3
3047163|NCT00620542|10475684|P2|Part B (2 Year Core Study)|IVUS not available|0
3047164|NCT00620542|10475685|P1|Part B (2 Year Core Study)|IVUS not available|0
3047165|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
3047166|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
3047167|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
3047168|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
3047169|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Safety reasons|3
3047170|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Safety reasons|2
3047171|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Safety reasons|0
3047172|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Safety reasons|0
3047173|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Protocol Violation|16
3047174|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Protocol Violation|13
3047175|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Protocol Violation|0
3047176|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Protocol Violation|0
3047177|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
3047178|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
3047179|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
3047180|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
3047181|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
3047182|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
3047183|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
3047184|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
3047185|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Protocol Violation|5
3047186|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Protocol Violation|3
3047187|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Protocol Violation|0
3047188|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Protocol Violation|0
3047189|NCT00620542|10475682|P4|Part B (2 Year Core Study)|Adverse Event|49
3047190|NCT00620542|10475683|P3|Part B (2 Year Core Study)|Adverse Event|46
3047191|NCT00620542|10475684|P2|Part B (2 Year Core Study)|Adverse Event|0
3047192|NCT00620542|10475685|P1|Part B (2 Year Core Study)|Adverse Event|0
3047193|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
3047194|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
3047195|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
3047196|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
3047197|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
3047198|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
3047199|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
3047200|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
3047201|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
3047202|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
3047203|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
3047204|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
3047205|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
3047206|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
3047207|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
3047208|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
3047209|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
3047210|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
3047211|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
3047212|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
3047213|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
3047214|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
3047215|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
3047216|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
3047217|NCT00620542|10475682|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
3047218|NCT00620542|10475683|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
3047219|NCT00620542|10475684|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
3047220|NCT00620542|10475685|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
3047221|NCT00620464|10475750|P2|Overall Study|Used prohibited medication|0
3047222|NCT00620464|10475751|P1|Overall Study|Used prohibited medication|1
3047223|NCT00620464|10475750|P2|Overall Study|Personal|2
3047224|NCT00620464|10475751|P1|Overall Study|Personal|2
3047225|NCT00620464|10475750|P2|Overall Study|Planning Pregnancy|4
3047226|NCT00620464|10475751|P1|Overall Study|Planning Pregnancy|1
3047227|NCT00620464|10475750|P2|Overall Study|Lost to Follow-up|1
3047228|NCT00620464|10475751|P1|Overall Study|Lost to Follow-up|1
3047229|NCT00620464|10475750|P2|Overall Study|Adverse Event|17
3047230|NCT00620464|10475751|P1|Overall Study|Adverse Event|15
3047231|NCT00620373|10475770|P1|Overall Study|Unverified cancer status|33
3047232|NCT00620321|10475788|P2|Overall Study|Withdrawal by Subject|1
3047233|NCT00620321|10475789|P1|Overall Study|Withdrawal by Subject|1
3047234|NCT00620321|10475788|P2|Overall Study|Sponsor Decision|1
3047235|NCT00620321|10475789|P1|Overall Study|Sponsor Decision|0
3047236|NCT00620321|10475788|P2|Overall Study|Progressive Disease|5
3047237|NCT00620321|10475789|P1|Overall Study|Progressive Disease|5
3047238|NCT00620321|10475788|P2|Overall Study|Physician Decision|7
3047239|NCT00620321|10475789|P1|Overall Study|Physician Decision|0
3047240|NCT00620321|10475788|P2|Overall Study|Death|1
3047241|NCT00620321|10475789|P1|Overall Study|Death|1
3047242|NCT00620321|10475788|P2|Overall Study|Adverse Event|1
3047243|NCT00620321|10475789|P1|Overall Study|Adverse Event|1
3047244|NCT00620282|10475808|P3|Overall Study|Withdrawal by Subject|0
3047245|NCT00620282|10475809|P2|Overall Study|Withdrawal by Subject|1
3047246|NCT00620282|10475810|P1|Overall Study|Withdrawal by Subject|0
3047247|NCT00620282|10475808|P3|Overall Study|Arterial line unable to be placed|1
3047248|NCT00620282|10475809|P2|Overall Study|Arterial line unable to be placed|0
3047249|NCT00620282|10475810|P1|Overall Study|Arterial line unable to be placed|0
3047250|NCT00620282|10475808|P3|Overall Study|Adverse Event|0
3047251|NCT00620282|10475809|P2|Overall Study|Adverse Event|1
3047252|NCT00620282|10475810|P1|Overall Study|Adverse Event|0
3047253|NCT00620113|10475874|P4|Overall Study|Withdrawal by Subject|5
3047254|NCT00620113|10475875|P3|Overall Study|Withdrawal by Subject|3
3047255|NCT00620113|10475876|P2|Overall Study|Withdrawal by Subject|1
3047256|NCT00620113|10475877|P1|Overall Study|Withdrawal by Subject|5
3047257|NCT00620113|10475874|P4|Overall Study|Protocol Violation|0
3047258|NCT00620113|10475875|P3|Overall Study|Protocol Violation|0
3047259|NCT00620113|10475876|P2|Overall Study|Protocol Violation|1
3047260|NCT00620113|10475877|P1|Overall Study|Protocol Violation|2
3047261|NCT00620113|10475874|P4|Overall Study|Physician Decision|2
3047262|NCT00620113|10475875|P3|Overall Study|Physician Decision|0
3047263|NCT00620113|10475876|P2|Overall Study|Physician Decision|0
3047264|NCT00620113|10475877|P1|Overall Study|Physician Decision|1
3047265|NCT00620113|10475874|P4|Overall Study|Lack of Efficacy|2
3047266|NCT00620113|10475875|P3|Overall Study|Lack of Efficacy|0
3047267|NCT00620113|10475876|P2|Overall Study|Lack of Efficacy|3
3047268|NCT00620113|10475877|P1|Overall Study|Lack of Efficacy|2
3047269|NCT00620113|10475874|P4|Overall Study|Adverse Event|1
3047270|NCT00620113|10475875|P3|Overall Study|Adverse Event|2
3047271|NCT00620113|10475876|P2|Overall Study|Adverse Event|2
3047272|NCT00620113|10475877|P1|Overall Study|Adverse Event|3
3047273|NCT00620074|10475927|P1|Overall Study|Adverse Event|1
3047274|NCT00620035|10475950|P1|Overall Study|Other Reason|38
3047275|NCT00620035|10475950|P1|Overall Study|Withdrawal of Informed Consent|1
3047276|NCT00620035|10475950|P1|Overall Study|Adverse Event|106
3047277|NCT00620022|10475960|P2|Treatment Period 2|Adverse Event|2
3047278|NCT00620022|10475961|P1|Treatment Period 2|Adverse Event|2
3047279|NCT00620022|10475960|P2|Treatment Period 1|Subject withdrew consent|0
3047280|NCT00620022|10475961|P1|Treatment Period 1|Subject withdrew consent|1
3047281|NCT00620022|10475960|P2|Treatment Period 1|Adverse Event|6
3047282|NCT00620022|10475961|P1|Treatment Period 1|Adverse Event|4
3047283|NCT00619983|10475973|P4|Test Drug Alone|Failure of daily diary device|2
3047284|NCT00619983|10475974|P3|Test Drug Alone|Failure of daily diary device|2
3047285|NCT00619983|10475975|P2|Test Drug Alone|Failure of daily diary device|1
3047286|NCT00619983|10475976|P1|Test Drug Alone|Failure of daily diary device|1
3047287|NCT00619983|10475973|P4|Test Drug Alone|Withdrawal by Subject|1
3047288|NCT00619983|10475974|P3|Test Drug Alone|Withdrawal by Subject|0
3047289|NCT00619983|10475975|P2|Test Drug Alone|Withdrawal by Subject|0
3047290|NCT00619983|10475976|P1|Test Drug Alone|Withdrawal by Subject|1
3047291|NCT00619957|10476003|P2|Month 48 Open-Label|Withdrawal by Subject|9
3047292|NCT00619957|10476004|P1|Month 48 Open-Label|Withdrawal by Subject|6
3047293|NCT00619957|10476003|P2|Month 48 Open-Label|Lost to Follow-up|4
3047294|NCT00619957|10476004|P1|Month 48 Open-Label|Lost to Follow-up|2
3047295|NCT00619957|10476003|P2|Month 48 Open-Label|Adverse Event|4
3047296|NCT00619957|10476004|P1|Month 48 Open-Label|Adverse Event|4
3047297|NCT00619957|10476003|P2|Month 24 Double-Blind|Did not take any study medication|1
3047298|NCT00619957|10476004|P1|Month 24 Double-Blind|Did not take any study medication|0
3047299|NCT00619957|10476003|P2|Month 24 Double-Blind|Lost to Follow-up|0
3047300|NCT00619957|10476004|P1|Month 24 Double-Blind|Lost to Follow-up|1
3047301|NCT00619957|10476003|P2|Month 24 Double-Blind|Withdrawal by Subject|9
3047302|NCT00619957|10476004|P1|Month 24 Double-Blind|Withdrawal by Subject|7
3047303|NCT00619957|10476003|P2|Month 24 Double-Blind|Protocol Violation|0
3047304|NCT00619957|10476004|P1|Month 24 Double-Blind|Protocol Violation|1
3047305|NCT00619957|10476003|P2|Month 24 Double-Blind|Adverse Event|7
3047306|NCT00619957|10476004|P1|Month 24 Double-Blind|Adverse Event|9
3047307|NCT00619918|10476086|P2|Overall Study|Left before receiving first dose|8
3047308|NCT00619918|10476087|P1|Overall Study|Left before receiving first dose|5
3047309|NCT00619918|10476086|P2|Overall Study|Transfer to outside facility|3
3047310|NCT00619918|10476087|P1|Overall Study|Transfer to outside facility|3
3047311|NCT00619918|10476086|P2|Overall Study|Physician Decision|8
3047312|NCT00619918|10476087|P1|Overall Study|Physician Decision|8
3047313|NCT00619918|10476086|P2|Overall Study|Withdrawal by Subject|3
3047314|NCT00619918|10476087|P1|Overall Study|Withdrawal by Subject|4
3047315|NCT00619892|10476097|P2|Overall Study|Intercurrent illness|1
3047316|NCT00619892|10476098|P1|Overall Study|Intercurrent illness|0
3047317|NCT00619892|10476097|P2|Overall Study|Lost to Follow-up|1
3047318|NCT00619892|10476098|P1|Overall Study|Lost to Follow-up|0
3047319|NCT00619892|10476097|P2|Overall Study|Adverse Event|0
3047320|NCT00619892|10476098|P1|Overall Study|Adverse Event|3
3047321|NCT00619866|10476109|P5|Weeks 13 - 24|Lost to Follow-up|0
3047322|NCT00619866|10476110|P4|Weeks 13 - 24|Lost to Follow-up|0
3047323|NCT00619866|10476111|P3|Weeks 13 - 24|Lost to Follow-up|0
3047324|NCT00619866|10476112|P2|Weeks 13 - 24|Lost to Follow-up|3
3047325|NCT00619866|10476113|P1|Weeks 13 - 24|Lost to Follow-up|0
3047326|NCT00619866|10476109|P5|Weeks 13 - 24|Non-compliance|0
3047327|NCT00619866|10476110|P4|Weeks 13 - 24|Non-compliance|0
3047328|NCT00619866|10476111|P3|Weeks 13 - 24|Non-compliance|1
3047329|NCT00619866|10476112|P2|Weeks 13 - 24|Non-compliance|1
3047330|NCT00619866|10476113|P1|Weeks 13 - 24|Non-compliance|0
3047331|NCT00619866|10476109|P5|Weeks 13 - 24|Withdrawal by Subject|2
3047332|NCT00619866|10476110|P4|Weeks 13 - 24|Withdrawal by Subject|2
3047333|NCT00619866|10476111|P3|Weeks 13 - 24|Withdrawal by Subject|2
3047334|NCT00619866|10476112|P2|Weeks 13 - 24|Withdrawal by Subject|3
3047335|NCT00619866|10476113|P1|Weeks 13 - 24|Withdrawal by Subject|0
3047336|NCT00619866|10476109|P5|Weeks 13 - 24|Protocol Deviation|0
3047337|NCT00619866|10476110|P4|Weeks 13 - 24|Protocol Deviation|1
3047338|NCT00619866|10476111|P3|Weeks 13 - 24|Protocol Deviation|0
3047339|NCT00619866|10476112|P2|Weeks 13 - 24|Protocol Deviation|0
3047340|NCT00619866|10476113|P1|Weeks 13 - 24|Protocol Deviation|0
3047341|NCT00619866|10476109|P5|Weeks 13 - 24|Adverse Event|0
3047342|NCT00619866|10476110|P4|Weeks 13 - 24|Adverse Event|1
3047343|NCT00619866|10476111|P3|Weeks 13 - 24|Adverse Event|2
3047344|NCT00619866|10476112|P2|Weeks 13 - 24|Adverse Event|0
3047345|NCT00619866|10476113|P1|Weeks 13 - 24|Adverse Event|0
3047346|NCT00619866|10476109|P5|Weeks 1 - 12|Sponsor Decision|0
3047347|NCT00619866|10476110|P4|Weeks 1 - 12|Sponsor Decision|0
3047348|NCT00619866|10476111|P3|Weeks 1 - 12|Sponsor Decision|0
3047349|NCT00619866|10476112|P2|Weeks 1 - 12|Sponsor Decision|1
3047350|NCT00619866|10476113|P1|Weeks 1 - 12|Sponsor Decision|0
3047351|NCT00619866|10476109|P5|Weeks 1 - 12|Lost to Follow-up|0
3047352|NCT00619866|10476110|P4|Weeks 1 - 12|Lost to Follow-up|0
3047353|NCT00619866|10476111|P3|Weeks 1 - 12|Lost to Follow-up|2
3047354|NCT00619866|10476112|P2|Weeks 1 - 12|Lost to Follow-up|0
3047355|NCT00619866|10476113|P1|Weeks 1 - 12|Lost to Follow-up|4
3047356|NCT00619866|10476109|P5|Weeks 1 - 12|Lack of Efficacy|0
3047357|NCT00619866|10476110|P4|Weeks 1 - 12|Lack of Efficacy|0
3047358|NCT00619866|10476111|P3|Weeks 1 - 12|Lack of Efficacy|1
3047359|NCT00619866|10476112|P2|Weeks 1 - 12|Lack of Efficacy|2
3047360|NCT00619866|10476113|P1|Weeks 1 - 12|Lack of Efficacy|3
3047361|NCT00619866|10476109|P5|Weeks 1 - 12|Withdrawal by Subject|0
3047362|NCT00619866|10476110|P4|Weeks 1 - 12|Withdrawal by Subject|0
3047363|NCT00619866|10476111|P3|Weeks 1 - 12|Withdrawal by Subject|4
3047364|NCT00619866|10476112|P2|Weeks 1 - 12|Withdrawal by Subject|2
3047365|NCT00619866|10476113|P1|Weeks 1 - 12|Withdrawal by Subject|7
3047366|NCT00619866|10476109|P5|Weeks 1 - 12|Non-compliance|0
3047367|NCT00619866|10476110|P4|Weeks 1 - 12|Non-compliance|0
3047368|NCT00619866|10476111|P3|Weeks 1 - 12|Non-compliance|1
3047369|NCT00619866|10476112|P2|Weeks 1 - 12|Non-compliance|0
3047370|NCT00619866|10476113|P1|Weeks 1 - 12|Non-compliance|0
3047371|NCT00619866|10476109|P5|Weeks 1 - 12|Adverse Event|0
3047372|NCT00619866|10476110|P4|Weeks 1 - 12|Adverse Event|0
3047373|NCT00619866|10476111|P3|Weeks 1 - 12|Adverse Event|2
3047374|NCT00619866|10476112|P2|Weeks 1 - 12|Adverse Event|1
3047375|NCT00619866|10476113|P1|Weeks 1 - 12|Adverse Event|0
3047376|NCT00619827|10476200|P2|Overall Study|Withdrawal by Subject|2
3047377|NCT00619827|10476201|P1|Overall Study|Withdrawal by Subject|2
3047378|NCT00619827|10476200|P2|Overall Study|Adverse Event|2
3047379|NCT00619827|10476201|P1|Overall Study|Adverse Event|1
3047380|NCT00619801|10476209|P2|Overall Study|Loss of efficacy|1
3047381|NCT00619801|10476210|P1|Overall Study|Loss of efficacy|0
3047382|NCT00619801|10476209|P2|Overall Study|Withdrawal by Subject|1
3047383|NCT00619801|10476210|P1|Overall Study|Withdrawal by Subject|1
3047384|NCT00619801|10476209|P2|Overall Study|Lack of Efficacy|1
3047385|NCT00619801|10476210|P1|Overall Study|Lack of Efficacy|0
3047386|NCT00619645|10476267|P1|Overall Study|Adverse Event|1
3047387|NCT00619619|10476281|P8|Overall Study|Adverse Event|2
3047388|NCT00619619|10476282|P7|Overall Study|Adverse Event|0
3047389|NCT00619619|10476283|P6|Overall Study|Adverse Event|0
3047390|NCT00619619|10476284|P5|Overall Study|Adverse Event|2
3047391|NCT00619619|10476285|P4|Overall Study|Adverse Event|0
3047392|NCT00619619|10476286|P3|Overall Study|Adverse Event|0
3047393|NCT00619619|10476287|P2|Overall Study|Adverse Event|0
3047394|NCT00619619|10476288|P1|Overall Study|Adverse Event|0
3047395|NCT00619619|10476281|P8|Overall Study|Protocol Violation|1
3047396|NCT00619619|10476282|P7|Overall Study|Protocol Violation|1
3047397|NCT00619619|10476283|P6|Overall Study|Protocol Violation|0
3047398|NCT00619619|10476284|P5|Overall Study|Protocol Violation|0
3047399|NCT00619619|10476285|P4|Overall Study|Protocol Violation|1
3047400|NCT00619619|10476286|P3|Overall Study|Protocol Violation|0
3047401|NCT00619619|10476287|P2|Overall Study|Protocol Violation|0
3047402|NCT00619619|10476288|P1|Overall Study|Protocol Violation|0
3047403|NCT00619619|10476281|P8|Overall Study|Physician Decision|0
3047404|NCT00619619|10476282|P7|Overall Study|Physician Decision|0
3047405|NCT00619619|10476283|P6|Overall Study|Physician Decision|0
3047406|NCT00619619|10476284|P5|Overall Study|Physician Decision|0
3047407|NCT00619619|10476285|P4|Overall Study|Physician Decision|0
3047408|NCT00619619|10476286|P3|Overall Study|Physician Decision|1
3047409|NCT00619619|10476287|P2|Overall Study|Physician Decision|0
3047410|NCT00619619|10476288|P1|Overall Study|Physician Decision|0
3047411|NCT00619515|10476373|P1|Overall Study|Study Termination by IRB|73
3047412|NCT00619502|10476387|P2|Overall Study|Lost to Follow-up|10
3047413|NCT00619502|10476388|P1|Overall Study|Lost to Follow-up|8
3047414|NCT00619489|10476400|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
3047415|NCT00619489|10476401|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
3047416|NCT00619489|10476400|P2|Overall Study|Lack of Efficacy|11
3047417|NCT00619489|10476401|P1|Overall Study|Lack of Efficacy|0
3047418|NCT00619489|10476400|P2|Overall Study|Withdrawal by Subject|1
3047419|NCT00619489|10476401|P1|Overall Study|Withdrawal by Subject|1
3047420|NCT00619489|10476400|P2|Overall Study|Adverse Event|7
3047421|NCT00619489|10476401|P1|Overall Study|Adverse Event|0
3047422|NCT00619476|10476423|P4|Overall Study|Withdrawal by Subject|4
3047423|NCT00619476|10476424|P3|Overall Study|Withdrawal by Subject|5
3047424|NCT00619476|10476425|P2|Overall Study|Withdrawal by Subject|7
3047425|NCT00619476|10476426|P1|Overall Study|Withdrawal by Subject|5
3047426|NCT00619476|10476423|P4|Overall Study|Investigator Discretion|0
3047427|NCT00619476|10476424|P3|Overall Study|Investigator Discretion|2
3047428|NCT00619476|10476425|P2|Overall Study|Investigator Discretion|2
3047429|NCT00619476|10476426|P1|Overall Study|Investigator Discretion|2
3047430|NCT00619476|10476423|P4|Overall Study|Lost to Follow-up|1
3047431|NCT00619476|10476424|P3|Overall Study|Lost to Follow-up|0
3047432|NCT00619476|10476425|P2|Overall Study|Lost to Follow-up|2
3047433|NCT00619476|10476426|P1|Overall Study|Lost to Follow-up|1
3047434|NCT00619476|10476423|P4|Overall Study|Protocol Violation|9
3047435|NCT00619476|10476424|P3|Overall Study|Protocol Violation|4
3047436|NCT00619476|10476425|P2|Overall Study|Protocol Violation|4
3047437|NCT00619476|10476426|P1|Overall Study|Protocol Violation|5
3047438|NCT00619476|10476423|P4|Overall Study|Lack of Efficacy|4
3047439|NCT00619476|10476424|P3|Overall Study|Lack of Efficacy|1
3047440|NCT00619476|10476425|P2|Overall Study|Lack of Efficacy|1
3047441|NCT00619476|10476426|P1|Overall Study|Lack of Efficacy|6
3047442|NCT00619476|10476423|P4|Overall Study|Adverse Event|16
3047443|NCT00619476|10476424|P3|Overall Study|Adverse Event|12
3047444|NCT00619476|10476425|P2|Overall Study|Adverse Event|6
3047445|NCT00619476|10476426|P1|Overall Study|Adverse Event|12
3047446|NCT00619385|10476511|P3|Overall Study|Other|1
3047447|NCT00619385|10476512|P2|Overall Study|Other|2
3047448|NCT00619385|10476513|P1|Overall Study|Other|1
3047449|NCT00619385|10476511|P3|Overall Study|Adverse Event|3
3047450|NCT00619385|10476512|P2|Overall Study|Adverse Event|0
3047451|NCT00619385|10476513|P1|Overall Study|Adverse Event|0
3047452|NCT00619359|10476528|P2|Overall Study|Progressive Disease|1
3047453|NCT00619359|10476529|P1|Overall Study|Progressive Disease|3
3047454|NCT00619359|10476528|P2|Overall Study|Withdrawal by Subject|20
3047455|NCT00619359|10476529|P1|Overall Study|Withdrawal by Subject|19
3047456|NCT00619359|10476528|P2|Overall Study|Protocol Violation|1
3047457|NCT00619359|10476529|P1|Overall Study|Protocol Violation|1
3047458|NCT00619359|10476528|P2|Overall Study|Physician Decision|7
3047459|NCT00619359|10476529|P1|Overall Study|Physician Decision|0
3047460|NCT00619359|10476528|P2|Overall Study|Lost to Follow-up|16
3047461|NCT00619359|10476529|P1|Overall Study|Lost to Follow-up|12
3047462|NCT00619359|10476528|P2|Overall Study|Adverse Event|36
3047463|NCT00619359|10476529|P1|Overall Study|Adverse Event|32
3047464|NCT00619307|10476541|P2|Overall Study|MS attack plus steroids|1
3047465|NCT00619307|10476542|P1|Overall Study|MS attack plus steroids|0
3047466|NCT00619307|10476541|P2|Overall Study|Severe migraine|1
3047467|NCT00619307|10476542|P1|Overall Study|Severe migraine|0
3047468|NCT00619307|10476541|P2|Overall Study|Withdrew consent|0
3047469|NCT00619307|10476542|P1|Overall Study|Withdrew consent|1
3047470|NCT00619307|10476541|P2|Overall Study|Protocol Violation|0
3047471|NCT00619307|10476542|P1|Overall Study|Protocol Violation|3
3047472|NCT00619307|10476541|P2|Overall Study|Lost to Follow-up|1
3047473|NCT00619307|10476542|P1|Overall Study|Lost to Follow-up|0
3047474|NCT00619307|10476541|P2|Overall Study|Adverse Event|1
3047475|NCT00619307|10476542|P1|Overall Study|Adverse Event|0
3047476|NCT00619229|10476579|P2|Overall Study|Investigator planned Cataract Operation|0
3047477|NCT00619229|10476580|P1|Overall Study|Investigator planned Cataract Operation|1
3047478|NCT00619229|10476579|P2|Overall Study|Termination of the Study by the Sponsor|1
3047479|NCT00619229|10476580|P1|Overall Study|Termination of the Study by the Sponsor|1
3047480|NCT00619229|10476579|P2|Overall Study|Lost to Follow-up|0
3047481|NCT00619229|10476580|P1|Overall Study|Lost to Follow-up|1
3047482|NCT00619229|10476579|P2|Overall Study|Withdrawal by Subject|1
3047483|NCT00619229|10476580|P1|Overall Study|Withdrawal by Subject|1
3047484|NCT00619177|10476619|P1|Overall Study|Not specified reasons|6
3047485|NCT00619177|10476619|P1|Overall Study|Missing termination information|481
3047486|NCT00619177|10476619|P1|Overall Study|Lack of Efficacy|1
3047487|NCT00619177|10476619|P1|Overall Study|Lost to Follow-up|2
3047488|NCT00619177|10476619|P1|Overall Study|Adverse Event|18
3047489|NCT00619151|10476629|P2|Overall Study|Study terminated prior to followup|0
3047490|NCT00619151|10476630|P1|Overall Study|Study terminated prior to followup|1
3047491|NCT00619112|10476640|P2|Overall Study|Adverse Event|2
3047492|NCT00619112|10476641|P1|Overall Study|Adverse Event|1
3047493|NCT00619099|10476662|P2|Overall Study|Physician Decision|6
3047494|NCT00619099|10476663|P1|Overall Study|Physician Decision|9
3047495|NCT00619099|10476662|P2|Overall Study|Withdrawal by Subject|2
3047496|NCT00619099|10476663|P1|Overall Study|Withdrawal by Subject|10
3047497|NCT00619099|10476662|P2|Overall Study|Emergence of Clinically Significant Lab|2
3047498|NCT00619099|10476663|P1|Overall Study|Emergence of Clinically Significant Lab|1
3047499|NCT00619099|10476662|P2|Overall Study|Adverse Event|3
3047500|NCT00619099|10476663|P1|Overall Study|Adverse Event|4
3047501|NCT00619099|10476662|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
3047502|NCT00619099|10476663|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
3047503|NCT00619099|10476662|P2|Overall Study|Progressive Disease|5
3047504|NCT00619099|10476663|P1|Overall Study|Progressive Disease|7
3047505|NCT00618995|10476685|P4|Period 4|Adverse Event|0
3047506|NCT00618995|10476686|P3|Period 4|Adverse Event|0
3047507|NCT00618995|10476687|P2|Period 4|Adverse Event|0
3047508|NCT00618995|10476688|P1|Period 4|Adverse Event|1
3047509|NCT00618995|10476685|P4|Period 2|Protocol Violation|0
3047510|NCT00618995|10476686|P3|Period 2|Protocol Violation|1
3047511|NCT00618995|10476687|P2|Period 2|Protocol Violation|0
3047512|NCT00618995|10476688|P1|Period 2|Protocol Violation|0
3047513|NCT00618995|10476685|P4|Period 1|Protocol Violation|0
3047514|NCT00618995|10476686|P3|Period 1|Protocol Violation|1
3047515|NCT00618995|10476687|P2|Period 1|Protocol Violation|1
3047516|NCT00618995|10476688|P1|Period 1|Protocol Violation|0
3047517|NCT00618995|10476685|P4|Period 1|Adverse Event|0
3047518|NCT00618995|10476686|P3|Period 1|Adverse Event|1
3047519|NCT00618995|10476687|P2|Period 1|Adverse Event|0
3047520|NCT00618995|10476688|P1|Period 1|Adverse Event|0
3047521|NCT00618982|10476702|P1|Overall Study|ongoing, still treated with study med.|25
3047522|NCT00618982|10476702|P1|Overall Study|Protocol Violation|1
3047523|NCT00618982|10476702|P1|Overall Study|Withdrawal by Subject|1
3047524|NCT00618982|10476702|P1|Overall Study|Adverse Event|23
3047525|NCT00618956|10476725|P2|Overall Study|did not meet criteria, non-compliance|1
3047526|NCT00618956|10476726|P1|Overall Study|did not meet criteria, non-compliance|2
3047527|NCT00618956|10476725|P2|Overall Study|Protocol Violation|2
3047528|NCT00618956|10476726|P1|Overall Study|Protocol Violation|2
3047529|NCT00618956|10476725|P2|Overall Study|Lost to Follow-up|5
3047530|NCT00618956|10476726|P1|Overall Study|Lost to Follow-up|4
3047531|NCT00618956|10476725|P2|Overall Study|Withdrawal by Subject|7
3047532|NCT00618956|10476726|P1|Overall Study|Withdrawal by Subject|5
3047533|NCT00618956|10476725|P2|Overall Study|Lack of Efficacy|1
3047534|NCT00618956|10476726|P1|Overall Study|Lack of Efficacy|2
3047535|NCT00618956|10476725|P2|Overall Study|Adverse Event|34
3047536|NCT00618956|10476726|P1|Overall Study|Adverse Event|10
3047537|NCT00618826|10476751|P1|Overall Study|Adverse Event|1
3047538|NCT00618813|10476756|P1|Overall Study|Withdrawal by Subject|1
3047539|NCT00618813|10476756|P1|Overall Study|Physician Decision|2
3047540|NCT00618813|10476756|P1|Overall Study|Lack of Efficacy|1
3047541|NCT00618787|10476766|P2|Overall Study|Lost to Follow-up|0
3047542|NCT00618787|10476767|P1|Overall Study|Lost to Follow-up|1
3047543|NCT00618787|10476766|P2|Overall Study|Withdrawal by Subject|1
3047544|NCT00618787|10476767|P1|Overall Study|Withdrawal by Subject|2
3047545|NCT00618787|10476766|P2|Overall Study|Adverse Event|1
3047546|NCT00618787|10476767|P1|Overall Study|Adverse Event|0
3047547|NCT00618774|10476775|P2|Overall Study|Withdrawal by Subject|0
3047548|NCT00618774|10476776|P1|Overall Study|Withdrawal by Subject|1
3047549|NCT00618774|10476775|P2|Overall Study|Adverse Event|3
3047550|NCT00618774|10476776|P1|Overall Study|Adverse Event|5
3047551|NCT00618748|10476809|P3|Overall Study|Withdrawal by Subject|5
3047552|NCT00618748|10476810|P2|Overall Study|Withdrawal by Subject|1
3047553|NCT00618748|10476811|P1|Overall Study|Withdrawal by Subject|4
3047554|NCT00618748|10476809|P3|Overall Study|Physician Decision|1
3047555|NCT00618748|10476810|P2|Overall Study|Physician Decision|1
3047556|NCT00618748|10476811|P1|Overall Study|Physician Decision|3
3047557|NCT00618748|10476809|P3|Overall Study|Adverse Event|8
3047558|NCT00618748|10476810|P2|Overall Study|Adverse Event|3
3047559|NCT00618748|10476811|P1|Overall Study|Adverse Event|4
3047560|NCT00618722|10476856|P4|Overall Study|Miscellaneous Reasons|1
3047561|NCT00618722|10476857|P3|Overall Study|Miscellaneous Reasons|1
3047562|NCT00618722|10476858|P2|Overall Study|Miscellaneous Reasons|0
3047563|NCT00618722|10476859|P1|Overall Study|Miscellaneous Reasons|0
3047564|NCT00618722|10476856|P4|Overall Study|Lost to Follow-up|2
3047565|NCT00618722|10476857|P3|Overall Study|Lost to Follow-up|0
3047566|NCT00618722|10476858|P2|Overall Study|Lost to Follow-up|0
3047567|NCT00618722|10476859|P1|Overall Study|Lost to Follow-up|2
3047568|NCT00618722|10476856|P4|Overall Study|Inability to Complete Study Procedure|0
3047569|NCT00618722|10476857|P3|Overall Study|Inability to Complete Study Procedure|0
3047570|NCT00618722|10476858|P2|Overall Study|Inability to Complete Study Procedure|1
3047571|NCT00618722|10476859|P1|Overall Study|Inability to Complete Study Procedure|0
3047572|NCT00618722|10476856|P4|Overall Study|Patient Request|1
3047573|NCT00618722|10476857|P3|Overall Study|Patient Request|1
3047574|NCT00618722|10476858|P2|Overall Study|Patient Request|1
3047575|NCT00618722|10476859|P1|Overall Study|Patient Request|1
3047576|NCT00618722|10476856|P4|Overall Study|Refusal of Treatment|0
3047577|NCT00618722|10476857|P3|Overall Study|Refusal of Treatment|1
3047578|NCT00618722|10476858|P2|Overall Study|Refusal of Treatment|0
3047579|NCT00618722|10476859|P1|Overall Study|Refusal of Treatment|0
3047580|NCT00618618|10476897|P4|Overall Study|Death|0
3047581|NCT00618618|10476898|P3|Overall Study|Death|0
3047582|NCT00618618|10476899|P2|Overall Study|Death|1
3047583|NCT00618618|10476900|P1|Overall Study|Death|0
3047584|NCT00618618|10476897|P4|Overall Study|Did Not Meet Entry Criteria|0
3047585|NCT00618618|10476898|P3|Overall Study|Did Not Meet Entry Criteria|1
3047586|NCT00618618|10476899|P2|Overall Study|Did Not Meet Entry Criteria|0
3047587|NCT00618618|10476900|P1|Overall Study|Did Not Meet Entry Criteria|0
3047588|NCT00618618|10476897|P4|Overall Study|Non-compliance|0
3047589|NCT00618618|10476898|P3|Overall Study|Non-compliance|0
3047590|NCT00618618|10476899|P2|Overall Study|Non-compliance|1
3047591|NCT00618618|10476900|P1|Overall Study|Non-compliance|1
3047592|NCT00618618|10476897|P4|Overall Study|Lost to Follow-up|1
3047593|NCT00618618|10476898|P3|Overall Study|Lost to Follow-up|0
3047594|NCT00618618|10476899|P2|Overall Study|Lost to Follow-up|0
3047595|NCT00618618|10476900|P1|Overall Study|Lost to Follow-up|3
3047596|NCT00618618|10476897|P4|Overall Study|Inability to Complete Study Procedures|0
3047597|NCT00618618|10476898|P3|Overall Study|Inability to Complete Study Procedures|0
3047598|NCT00618618|10476899|P2|Overall Study|Inability to Complete Study Procedures|1
3047599|NCT00618618|10476900|P1|Overall Study|Inability to Complete Study Procedures|0
3047600|NCT00618618|10476897|P4|Overall Study|Patient Request|0
3047601|NCT00618618|10476898|P3|Overall Study|Patient Request|2
3047602|NCT00618618|10476899|P2|Overall Study|Patient Request|0
3047603|NCT00618618|10476900|P1|Overall Study|Patient Request|0
3047604|NCT00618514|10476959|P3|Overall Study|Lost to Follow-up|4
3047605|NCT00618514|10476960|P2|Overall Study|Lost to Follow-up|12
3047606|NCT00618514|10476961|P1|Overall Study|Lost to Follow-up|11
3047607|NCT00618449|10476981|P2|Overall Study|Lost to Follow-up|110
3047608|NCT00618449|10476982|P1|Overall Study|Lost to Follow-up|98
3047609|NCT00618410|10477001|P2|Washout Period (2 Weeks)|Physician Decision|1
3047610|NCT00618410|10477002|P1|Washout Period (2 Weeks)|Physician Decision|0
3047611|NCT00618371|10477018|P1|Overall Study|Withdrawal by Subject|2
3047612|NCT00618072|10477051|P3|Overall Study|Physician Decision|1
3047613|NCT00618072|10477052|P2|Overall Study|Physician Decision|1
3047614|NCT00618072|10477053|P1|Overall Study|Physician Decision|0
3047615|NCT00618072|10477051|P3|Overall Study|Lost to Follow-up|3
3047616|NCT00618072|10477052|P2|Overall Study|Lost to Follow-up|0
3047617|NCT00618072|10477053|P1|Overall Study|Lost to Follow-up|2
3047618|NCT00617929|10477109|P1|Overall Study|Physician Decision|1
3047619|NCT00617903|10477121|P2|Overall Study|noncompliance|1
3047620|NCT00617903|10477122|P1|Overall Study|noncompliance|0
3047621|NCT00617903|10477121|P2|Overall Study|Adverse Event|1
3047622|NCT00617903|10477122|P1|Overall Study|Adverse Event|0
3047623|NCT00617903|10477121|P2|Overall Study|Lack of Efficacy|1
3047624|NCT00617903|10477122|P1|Overall Study|Lack of Efficacy|0
3047625|NCT00617903|10477121|P2|Overall Study|Lost to Follow-up|1
3047626|NCT00617903|10477122|P1|Overall Study|Lost to Follow-up|1
3047627|NCT00617903|10477121|P2|Overall Study|Withdrawal by Subject|3
3047628|NCT00617903|10477122|P1|Overall Study|Withdrawal by Subject|2
3047629|NCT00617890|10477168|P4|Overall Study|Not treated|1
3047630|NCT00617890|10477169|P3|Overall Study|Not treated|1
3047631|NCT00617890|10477170|P2|Overall Study|Not treated|0
3047632|NCT00617890|10477171|P1|Overall Study|Not treated|1
3047633|NCT00617890|10477168|P4|Overall Study|Adverse Event|8
3047634|NCT00617890|10477169|P3|Overall Study|Adverse Event|3
3047635|NCT00617890|10477170|P2|Overall Study|Adverse Event|0
3047636|NCT00617890|10477171|P1|Overall Study|Adverse Event|1
3047637|NCT00617890|10477168|P4|Overall Study|Protocol Violation|0
3047638|NCT00617890|10477169|P3|Overall Study|Protocol Violation|0
3047639|NCT00617890|10477170|P2|Overall Study|Protocol Violation|1
3047640|NCT00617890|10477171|P1|Overall Study|Protocol Violation|2
3047641|NCT00617890|10477168|P4|Overall Study|Withdrawal by Subject|2
3047642|NCT00617890|10477169|P3|Overall Study|Withdrawal by Subject|0
3047643|NCT00617890|10477170|P2|Overall Study|Withdrawal by Subject|1
3047644|NCT00617890|10477171|P1|Overall Study|Withdrawal by Subject|4
3047645|NCT00617890|10477168|P4|Overall Study|Lost to Follow-up|2
3047646|NCT00617890|10477169|P3|Overall Study|Lost to Follow-up|1
3047647|NCT00617890|10477170|P2|Overall Study|Lost to Follow-up|0
3047648|NCT00617890|10477171|P1|Overall Study|Lost to Follow-up|0
3047649|NCT00617890|10477168|P4|Overall Study|Lack of Efficacy|97
3047650|NCT00617890|10477169|P3|Overall Study|Lack of Efficacy|30
3047651|NCT00617890|10477170|P2|Overall Study|Lack of Efficacy|26
3047652|NCT00617890|10477171|P1|Overall Study|Lack of Efficacy|23
3047653|NCT00617890|10477168|P4|Overall Study|Treatment ongoing at data cut-off|5
3047654|NCT00617890|10477169|P3|Overall Study|Treatment ongoing at data cut-off|0
3047655|NCT00617890|10477170|P2|Overall Study|Treatment ongoing at data cut-off|0
3047656|NCT00617890|10477171|P1|Overall Study|Treatment ongoing at data cut-off|0
3047657|NCT00617851|10477207|P4|Overall Study|Unable to classify|0
3047658|NCT00617851|10477208|P3|Overall Study|Unable to classify|1
3047659|NCT00617851|10477209|P2|Overall Study|Unable to classify|0
3047660|NCT00617851|10477210|P1|Overall Study|Unable to classify|1
3047661|NCT00617851|10477207|P4|Overall Study|Inappropriate Enrollment|1
3047662|NCT00617851|10477208|P3|Overall Study|Inappropriate Enrollment|1
3047663|NCT00617851|10477209|P2|Overall Study|Inappropriate Enrollment|4
3047664|NCT00617851|10477210|P1|Overall Study|Inappropriate Enrollment|5
3047665|NCT00617851|10477207|P4|Overall Study|Lost to Follow-up|19
3047666|NCT00617851|10477208|P3|Overall Study|Lost to Follow-up|31
3047667|NCT00617851|10477209|P2|Overall Study|Lost to Follow-up|29
3047668|NCT00617851|10477210|P1|Overall Study|Lost to Follow-up|27
3047669|NCT00617851|10477207|P4|Overall Study|Withdrawal by Subject|4
3047670|NCT00617851|10477208|P3|Overall Study|Withdrawal by Subject|12
3047671|NCT00617851|10477209|P2|Overall Study|Withdrawal by Subject|7
3047672|NCT00617851|10477210|P1|Overall Study|Withdrawal by Subject|14
3047673|NCT00617851|10477207|P4|Overall Study|Death|1
3047674|NCT00617851|10477208|P3|Overall Study|Death|0
3047675|NCT00617851|10477209|P2|Overall Study|Death|0
3047676|NCT00617851|10477210|P1|Overall Study|Death|0
3047677|NCT00617773|10477248|P1|Overall Study|Protocol Violation|1
3047678|NCT00617773|10477248|P1|Overall Study|Progressive disease|19
3047679|NCT00617773|10477248|P1|Overall Study|Death|1
3047680|NCT00617773|10477248|P1|Overall Study|Withdrawal by Subject|1
3047681|NCT00617773|10477248|P1|Overall Study|Lack of compliance with the protocol|1
3047682|NCT00617773|10477248|P1|Overall Study|Physician Decision|1
3047683|NCT00617734|10477265|P2|Overall Study|Lost to Follow-up|1
3047684|NCT00617734|10477266|P1|Overall Study|Lost to Follow-up|0
3047685|NCT00617734|10477265|P2|Overall Study|Found Ineligible After Randomization|4
3047686|NCT00617734|10477266|P1|Overall Study|Found Ineligible After Randomization|1
3047687|NCT00617734|10477265|P2|Overall Study|Protocol Violation|0
3047688|NCT00617734|10477266|P1|Overall Study|Protocol Violation|1
3047689|NCT00617734|10477265|P2|Overall Study|Adverse Event|1
3047690|NCT00617734|10477266|P1|Overall Study|Adverse Event|4
3047691|NCT00617734|10477265|P2|Overall Study|Withdrew Consent|0
3047692|NCT00617734|10477266|P1|Overall Study|Withdrew Consent|2
3047693|NCT00617708|10477287|P3|Overall Study|Not eligible|5
3047694|NCT00617708|10477288|P2|Overall Study|Not eligible|3
3047695|NCT00617708|10477289|P1|Overall Study|Not eligible|1
3047696|NCT00617708|10477287|P3|Overall Study|Not protocol specified|2
3047697|NCT00617708|10477288|P2|Overall Study|Not protocol specified|4
3047698|NCT00617708|10477289|P1|Overall Study|Not protocol specified|1
3047699|NCT00617708|10477287|P3|Overall Study|Progression/Relapse|36
3047700|NCT00617708|10477288|P2|Overall Study|Progression/Relapse|40
3047701|NCT00617708|10477289|P1|Overall Study|Progression/Relapse|7
3047702|NCT00617708|10477287|P3|Overall Study|Death|5
3047703|NCT00617708|10477288|P2|Overall Study|Death|6
3047704|NCT00617708|10477289|P1|Overall Study|Death|0
3047705|NCT00617708|10477287|P3|Overall Study|Withdrawal by Subject|7
3047706|NCT00617708|10477288|P2|Overall Study|Withdrawal by Subject|1
3047707|NCT00617708|10477289|P1|Overall Study|Withdrawal by Subject|1
3047708|NCT00617708|10477287|P3|Overall Study|Adverse Event|9
3047709|NCT00617708|10477288|P2|Overall Study|Adverse Event|6
3047710|NCT00617708|10477289|P1|Overall Study|Adverse Event|0
3047711|NCT00617669|10477306|P2|Overall Study|Patients randomized but not treated|3
3047712|NCT00617669|10477307|P1|Overall Study|Patients randomized but not treated|2
3047713|NCT00617669|10477306|P2|Overall Study|Reason not otherwise captured, eg; death|290
3047714|NCT00617669|10477307|P1|Overall Study|Reason not otherwise captured, eg; death|265
3047715|NCT00617669|10477306|P2|Overall Study|Protocol Violation|3
3047716|NCT00617669|10477307|P1|Overall Study|Protocol Violation|2
3047717|NCT00617669|10477306|P2|Overall Study|Adverse Event|76
3047718|NCT00617669|10477307|P1|Overall Study|Adverse Event|87
3047719|NCT00617669|10477306|P2|Overall Study|Lost to Follow-up|2
3047720|NCT00617669|10477307|P1|Overall Study|Lost to Follow-up|3
3047721|NCT00617669|10477306|P2|Overall Study|Withdrawal by Subject|77
3047722|NCT00617669|10477307|P1|Overall Study|Withdrawal by Subject|71
3047723|NCT00617604|10477329|P2|Overall Study|Randomized but Never Received Study Drug|3
3047724|NCT00617604|10477330|P1|Overall Study|Randomized but Never Received Study Drug|3
3047725|NCT00617604|10477329|P2|Overall Study|Withdrawal by Subject|6
3047726|NCT00617604|10477330|P1|Overall Study|Withdrawal by Subject|4
3047727|NCT00617604|10477329|P2|Overall Study|Miscellaneous Reasons|10
3047728|NCT00617604|10477330|P1|Overall Study|Miscellaneous Reasons|8
3047729|NCT00617604|10477329|P2|Overall Study|Lost to Follow-up|0
3047730|NCT00617604|10477330|P1|Overall Study|Lost to Follow-up|1
3047731|NCT00617604|10477329|P2|Overall Study|Death|1
3047732|NCT00617604|10477330|P1|Overall Study|Death|2
3047733|NCT00617591|10477374|P1|Overall Study|Withdrew consent during Maintenance|6
3047734|NCT00617591|10477374|P1|Overall Study|Withdrew consent during Induction|4
3047735|NCT00617461|10477390|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
3047736|NCT00617461|10477391|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
3047737|NCT00617461|10477390|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
3047738|NCT00617461|10477391|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
3047739|NCT00617461|10477390|P2|Second Treatment Intervention Period|Lack of Efficacy|3
3047740|NCT00617461|10477391|P1|Second Treatment Intervention Period|Lack of Efficacy|0
3047741|NCT00617461|10477390|P2|Second Treatment Intervention Period|Adverse Event|1
3047742|NCT00617461|10477391|P1|Second Treatment Intervention Period|Adverse Event|0
3047743|NCT00617461|10477390|P2|4-Day Crossover Period|Withdrawal by Subject|0
3047744|NCT00617461|10477391|P1|4-Day Crossover Period|Withdrawal by Subject|1
3047745|NCT00617461|10477390|P2|First Treatment Intervention Period|Withdrawal by Subject|0
3047746|NCT00617461|10477391|P1|First Treatment Intervention Period|Withdrawal by Subject|4
3047747|NCT00617461|10477390|P2|First Treatment Intervention Period|Investigator Discretion|1
3047748|NCT00617461|10477391|P1|First Treatment Intervention Period|Investigator Discretion|1
3047749|NCT00617461|10477390|P2|First Treatment Intervention Period|Lost to Follow-up|1
3047750|NCT00617461|10477391|P1|First Treatment Intervention Period|Lost to Follow-up|0
3047751|NCT00617461|10477390|P2|First Treatment Intervention Period|Protocol Violation|1
3047752|NCT00617461|10477391|P1|First Treatment Intervention Period|Protocol Violation|2
3047753|NCT00617461|10477390|P2|First Treatment Intervention Period|Lack of Efficacy|0
3047754|NCT00617461|10477391|P1|First Treatment Intervention Period|Lack of Efficacy|1
3047755|NCT00617461|10477390|P2|First Treatment Intervention Period|Adverse Event|0
3047756|NCT00617461|10477391|P1|First Treatment Intervention Period|Adverse Event|2
3047757|NCT00617409|10477447|P3|Overall Study|Alternative Therapy|0
3047758|NCT00617409|10477448|P2|Overall Study|Alternative Therapy|2
3047759|NCT00617409|10477449|P1|Overall Study|Alternative Therapy|1
3047760|NCT00617409|10477447|P3|Overall Study|Death|4
3047761|NCT00617409|10477448|P2|Overall Study|Death|5
3047762|NCT00617409|10477449|P1|Overall Study|Death|3
3047763|NCT00617409|10477447|P3|Overall Study|Disease Progression|18
3047764|NCT00617409|10477448|P2|Overall Study|Disease Progression|8
3047765|NCT00617409|10477449|P1|Overall Study|Disease Progression|8
3047766|NCT00617409|10477447|P3|Overall Study|Adverse Event|3
3047767|NCT00617409|10477448|P2|Overall Study|Adverse Event|2
3047768|NCT00617409|10477449|P1|Overall Study|Adverse Event|0
3047769|NCT00617409|10477447|P3|Overall Study|Withdrawal by Subject|2
3047770|NCT00617409|10477448|P2|Overall Study|Withdrawal by Subject|1
3047771|NCT00617409|10477449|P1|Overall Study|Withdrawal by Subject|4
3047772|NCT00617357|10477464|P1|Overall Study|Physician Decision|1
3047773|NCT00617357|10477464|P1|Overall Study|Withdrawal by Subject|1
3047774|NCT00617357|10477464|P1|Overall Study|insurance concerns|2
3047775|NCT00617357|10477464|P1|Overall Study|Death|5
3047776|NCT00617357|10477464|P1|Overall Study|Lost to Follow-up|7
3047777|NCT00617344|10477477|P3|Overall Study|Withdrawal by Subject|2
3047778|NCT00617344|10477478|P2|Overall Study|Withdrawal by Subject|9
3047779|NCT00617344|10477479|P1|Overall Study|Withdrawal by Subject|8
3047780|NCT00617344|10477477|P3|Overall Study|Lost to Follow-up|1
3047781|NCT00617344|10477478|P2|Overall Study|Lost to Follow-up|4
3047782|NCT00617344|10477479|P1|Overall Study|Lost to Follow-up|5
3047783|NCT00617344|10477477|P3|Overall Study|Protocol Violation|5
3047784|NCT00617344|10477478|P2|Overall Study|Protocol Violation|8
3047785|NCT00617344|10477479|P1|Overall Study|Protocol Violation|10
3047786|NCT00617344|10477477|P3|Overall Study|Other Adverse Event|0
3047787|NCT00617344|10477478|P2|Overall Study|Other Adverse Event|1
3047788|NCT00617344|10477479|P1|Overall Study|Other Adverse Event|1
3047789|NCT00617344|10477477|P3|Overall Study|Serious adverse event|0
3047790|NCT00617344|10477478|P2|Overall Study|Serious adverse event|0
3047791|NCT00617344|10477479|P1|Overall Study|Serious adverse event|1
3047792|NCT00617305|10477507|P3|Overall Study|Withdrawal by Subject|0
3047793|NCT00617305|10477508|P2|Overall Study|Withdrawal by Subject|0
3047794|NCT00617305|10477509|P1|Overall Study|Withdrawal by Subject|1
3047795|NCT00617305|10477507|P3|Overall Study|Protocol Violation|1
3047796|NCT00617305|10477508|P2|Overall Study|Protocol Violation|0
3047797|NCT00617305|10477509|P1|Overall Study|Protocol Violation|1
3047798|NCT00617305|10477507|P3|Overall Study|Physician Decision|0
3047799|NCT00617305|10477508|P2|Overall Study|Physician Decision|0
3047800|NCT00617305|10477509|P1|Overall Study|Physician Decision|1
3047801|NCT00617305|10477507|P3|Overall Study|Death|0
3047802|NCT00617305|10477508|P2|Overall Study|Death|0
3047803|NCT00617305|10477509|P1|Overall Study|Death|1
3047804|NCT00617305|10477507|P3|Overall Study|Adverse Event|0
3047805|NCT00617305|10477508|P2|Overall Study|Adverse Event|0
3047806|NCT00617305|10477509|P1|Overall Study|Adverse Event|4
3047807|NCT00617279|10477565|P2|Overall Study|Death|2
3047808|NCT00617279|10477566|P1|Overall Study|Death|1
3047809|NCT00617279|10477565|P2|Overall Study|Lost to Follow-up|0
3047810|NCT00617279|10477566|P1|Overall Study|Lost to Follow-up|1
3047811|NCT00617279|10477565|P2|Overall Study|Graft abandonment|0
3047812|NCT00617279|10477566|P1|Overall Study|Graft abandonment|2
3047813|NCT00617279|10477565|P2|Overall Study|Study terminated by Sponsor|15
3047814|NCT00617279|10477566|P1|Overall Study|Study terminated by Sponsor|10
3047815|NCT00617240|10477622|P2|Overall Study|Lack of Efficacy|0
3047816|NCT00617240|10477623|P1|Overall Study|Lack of Efficacy|1
3047817|NCT00617201|10477643|P2|Overall Study|Lost to Follow-up|13
3047818|NCT00617201|10477644|P1|Overall Study|Lost to Follow-up|9
3047819|NCT00617123|10477672|P2|Study Treatment Period|Noncompliance with Protocol|1
3047820|NCT00617123|10477673|P1|Study Treatment Period|Noncompliance with Protocol|0
3047821|NCT00617123|10477672|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
3047822|NCT00617123|10477673|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
3047823|NCT00617123|10477672|P2|Study Treatment Period|Adverse Event|3
3047824|NCT00617123|10477673|P1|Study Treatment Period|Adverse Event|7
3047825|NCT00617123|10477672|P2|Study Treatment Period|Withdrawal by Subject|12
3047826|NCT00617123|10477673|P1|Study Treatment Period|Withdrawal by Subject|8
3047827|NCT00617123|10477672|P2|Referral Screening Period|Adverse Event|1
3047828|NCT00617123|10477673|P1|Referral Screening Period|Adverse Event|0
3047829|NCT00617123|10477672|P2|Referral Screening Period|Did Not Wish To Continue|1
3047830|NCT00617123|10477673|P1|Referral Screening Period|Did Not Wish To Continue|3
3047831|NCT00617123|10477672|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
3047832|NCT00617123|10477673|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
3047833|NCT00617084|10477704|P2|Overall Study|Missed 12 Months visit|19
3047834|NCT00617084|10477705|P1|Overall Study|Missed 12 Months visit|16
3047835|NCT00617084|10477704|P2|Overall Study|Withdrawal by Subject|7
3047836|NCT00617084|10477705|P1|Overall Study|Withdrawal by Subject|5
3047837|NCT00616967|10477758|P3|Overall Study|Withdrawal by Subject|1
3047838|NCT00616967|10477759|P2|Overall Study|Withdrawal by Subject|0
3047839|NCT00616967|10477760|P1|Overall Study|Withdrawal by Subject|0
3047840|NCT00616941|10477785|P3|Overall Study|Vaccination Suspended|3
3047841|NCT00616941|10477786|P2|Overall Study|Vaccination Suspended|0
3047842|NCT00616941|10477787|P1|Overall Study|Vaccination Suspended|0
3047843|NCT00616941|10477785|P3|Overall Study|Unrelated Medical Illness/Complication|0
3047844|NCT00616941|10477786|P2|Overall Study|Unrelated Medical Illness/Complication|2
3047845|NCT00616941|10477787|P1|Overall Study|Unrelated Medical Illness/Complication|0
3047846|NCT00616941|10477785|P3|Overall Study|Subject Non-compliance|1
3047847|NCT00616941|10477786|P2|Overall Study|Subject Non-compliance|0
3047848|NCT00616941|10477787|P1|Overall Study|Subject Non-compliance|0
3047849|NCT00616941|10477785|P3|Overall Study|Adverse Event|1
3047850|NCT00616941|10477786|P2|Overall Study|Adverse Event|1
3047851|NCT00616941|10477787|P1|Overall Study|Adverse Event|0
3047852|NCT00616941|10477785|P3|Overall Study|Progressive Disease|1
3047853|NCT00616941|10477786|P2|Overall Study|Progressive Disease|2
3047854|NCT00616941|10477787|P1|Overall Study|Progressive Disease|1
3047855|NCT00616928|10477814|P4|Overall Study|Lost to Follow-up|0
3047856|NCT00616928|10477815|P3|Overall Study|Lost to Follow-up|0
3047857|NCT00616928|10477816|P2|Overall Study|Lost to Follow-up|7
3047858|NCT00616928|10477817|P1|Overall Study|Lost to Follow-up|5
3047859|NCT00616928|10477814|P4|Overall Study|Other|5
3047860|NCT00616928|10477815|P3|Overall Study|Other|15
3047861|NCT00616928|10477816|P2|Overall Study|Other|8
3047862|NCT00616928|10477817|P1|Overall Study|Other|51
3047863|NCT00616928|10477814|P4|Overall Study|Adverse Event|2
3047864|NCT00616928|10477815|P3|Overall Study|Adverse Event|2
3047865|NCT00616928|10477816|P2|Overall Study|Adverse Event|3
3047866|NCT00616928|10477817|P1|Overall Study|Adverse Event|6
3047867|NCT00616902|10477881|P2|Overall Study|Termination of study|6
3047868|NCT00616902|10477882|P1|Overall Study|Termination of study|6
3047869|NCT00616759|10477925|P2|Overall Study|Withdrawal by Subject|2
3047870|NCT00616759|10477926|P1|Overall Study|Withdrawal by Subject|1
3047871|NCT00616759|10477925|P2|Overall Study|Physician Decision|0
3047872|NCT00616759|10477926|P1|Overall Study|Physician Decision|2
3047873|NCT00616655|10477935|P3|Overall Study|Other|5
3047874|NCT00616655|10477936|P2|Overall Study|Other|6
3047875|NCT00616655|10477937|P1|Overall Study|Other|6
3047876|NCT00616655|10477935|P3|Overall Study|Does not meet in/ex criteria|2
3047877|NCT00616655|10477936|P2|Overall Study|Does not meet in/ex criteria|0
3047878|NCT00616655|10477937|P1|Overall Study|Does not meet in/ex criteria|0
3047879|NCT00616655|10477935|P3|Overall Study|Withdrawal by Subject|11
3047880|NCT00616655|10477936|P2|Overall Study|Withdrawal by Subject|7
3047881|NCT00616655|10477937|P1|Overall Study|Withdrawal by Subject|9
3047882|NCT00616655|10477935|P3|Overall Study|Protocol Violation|3
3047883|NCT00616655|10477936|P2|Overall Study|Protocol Violation|4
3047884|NCT00616655|10477937|P1|Overall Study|Protocol Violation|2
3047885|NCT00616655|10477935|P3|Overall Study|Lost to Follow-up|10
3047886|NCT00616655|10477936|P2|Overall Study|Lost to Follow-up|12
3047887|NCT00616655|10477937|P1|Overall Study|Lost to Follow-up|3
3047888|NCT00616655|10477935|P3|Overall Study|Lack of Efficacy|5
3047889|NCT00616655|10477936|P2|Overall Study|Lack of Efficacy|5
3047890|NCT00616655|10477937|P1|Overall Study|Lack of Efficacy|5
3047891|NCT00616655|10477935|P3|Overall Study|Adverse Event|12
3047892|NCT00616655|10477936|P2|Overall Study|Adverse Event|7
3047893|NCT00616655|10477937|P1|Overall Study|Adverse Event|10
3047894|NCT00616642|10477977|P2|Overall Study|Withdrawal by Subject|1
3047895|NCT00616642|10477978|P1|Overall Study|Withdrawal by Subject|0
3047896|NCT00616629|10477989|P5|Overall Study|AV-block|0
3047897|NCT00616629|10477990|P4|Overall Study|AV-block|0
3047898|NCT00616629|10477991|P3|Overall Study|AV-block|0
3047899|NCT00616629|10477992|P2|Overall Study|AV-block|0
3047900|NCT00616629|10477993|P1|Overall Study|AV-block|1
3047901|NCT00616629|10477989|P5|Overall Study|Protocol Violation|0
3047902|NCT00616629|10477990|P4|Overall Study|Protocol Violation|0
3047903|NCT00616629|10477991|P3|Overall Study|Protocol Violation|1
3047904|NCT00616629|10477992|P2|Overall Study|Protocol Violation|2
3047905|NCT00616629|10477993|P1|Overall Study|Protocol Violation|1
3047906|NCT00616603|10478038|P3|Overall Study|Physician Decision|2
3047907|NCT00616603|10478039|P2|Overall Study|Physician Decision|0
3047908|NCT00616603|10478040|P1|Overall Study|Physician Decision|2
3047909|NCT00616434|10478063|P2|Overall Study|Protocol deviation|1
3047910|NCT00616434|10478064|P1|Overall Study|Protocol deviation|0
3047911|NCT00616434|10478063|P2|Overall Study|Withdrawal by Subject|1
3047912|NCT00616434|10478064|P1|Overall Study|Withdrawal by Subject|1
3047913|NCT00616434|10478063|P2|Overall Study|Physician Decision|4
3047914|NCT00616434|10478064|P1|Overall Study|Physician Decision|0
3047915|NCT00616434|10478063|P2|Overall Study|Adverse Event|2
3047916|NCT00616434|10478064|P1|Overall Study|Adverse Event|5
3047917|NCT00616421|10478077|P3|Overall Study|Unable to classify|0
3047918|NCT00616421|10478078|P2|Overall Study|Unable to classify|0
3047919|NCT00616421|10478079|P1|Overall Study|Unable to classify|1
3047920|NCT00616421|10478077|P3|Overall Study|Protocol Violation|2
3047921|NCT00616421|10478078|P2|Overall Study|Protocol Violation|1
3047922|NCT00616421|10478079|P1|Overall Study|Protocol Violation|0
3047923|NCT00616421|10478077|P3|Overall Study|Administrative reason|0
3047924|NCT00616421|10478078|P2|Overall Study|Administrative reason|0
3047925|NCT00616421|10478079|P1|Overall Study|Administrative reason|1
3047926|NCT00616421|10478077|P3|Overall Study|Inappropriate enrollment|1
3047927|NCT00616421|10478078|P2|Overall Study|Inappropriate enrollment|0
3047928|NCT00616421|10478079|P1|Overall Study|Inappropriate enrollment|3
3047929|NCT00616421|10478077|P3|Overall Study|Lost to Follow-up|30
3047930|NCT00616421|10478078|P2|Overall Study|Lost to Follow-up|26
3047931|NCT00616421|10478079|P1|Overall Study|Lost to Follow-up|12
3047932|NCT00616421|10478077|P3|Overall Study|Withdrawal by Subject|8
3047933|NCT00616421|10478078|P2|Overall Study|Withdrawal by Subject|11
3047934|NCT00616421|10478079|P1|Overall Study|Withdrawal by Subject|9
3047935|NCT00616239|10478120|P1|Overall Study|Withdrawal by Subject|2
3047936|NCT00616018|10478150|P1|Overall Study|Protocol Violation|3
3047937|NCT00615992|10478155|P1|Overall Study|Protocol Violation|67
3047938|NCT00615914|10478181|P1|Overall Study|Irregularly enrolled patients|10
3047939|NCT00615914|10478181|P1|Overall Study|No treatment|2
3047940|NCT00615914|10478181|P1|Overall Study|No data was collected.|65
3047941|NCT00615914|10478181|P1|Overall Study|Physician Decision|4
3047942|NCT00615914|10478181|P1|Overall Study|Withdrawal by Subject|16
3047943|NCT00615914|10478181|P1|Overall Study|Lost to Follow-up|187
3047944|NCT00615914|10478181|P1|Overall Study|Lack of Efficacy|59
3047945|NCT00615914|10478181|P1|Overall Study|Death|20
3047946|NCT00615914|10478181|P1|Overall Study|Adverse Event|274
3047947|NCT00615901|10478188|P1|Overall Study|Adverse Event|7
3047948|NCT00615901|10478188|P1|Overall Study|Withdrawal by Subject|2
3047949|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
3047950|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
3047951|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
3047952|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
3047953|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
3047954|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Not reported|0
3047955|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Not reported|4
3047956|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Not reported|1
3047957|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Not reported|4
3047958|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Not reported|6
3047959|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Other|0
3047960|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Other|8
3047961|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Other|8
3047962|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Other|7
3047963|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Other|10
3047964|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
3047965|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
3047966|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
3047967|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
3047968|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
3047969|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
3047970|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
3047971|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
3047972|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
3047973|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
3047974|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
3047975|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
3047976|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
3047977|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
3047978|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
3047979|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
3047980|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
3047981|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
3047982|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
3047983|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
3047984|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
3047985|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
3047986|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
3047987|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
3047988|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
3047989|NCT00615836|10478196|P5|Extension Study (FE992026 CS31)|Adverse Event|0
3047990|NCT00615836|10478197|P4|Extension Study (FE992026 CS31)|Adverse Event|13
3047991|NCT00615836|10478198|P3|Extension Study (FE992026 CS31)|Adverse Event|15
3047992|NCT00615836|10478199|P2|Extension Study (FE992026 CS31)|Adverse Event|12
3047993|NCT00615836|10478200|P1|Extension Study (FE992026 CS31)|Adverse Event|7
3047994|NCT00615719|10478260|P1|Overall Study|Physician Decision|5
3047995|NCT00615550|10478274|P2|Overall Study|Lost to Follow-up|1
3047996|NCT00615550|10478275|P1|Overall Study|Lost to Follow-up|6
3047997|NCT00615459|10478298|P4|Period III|Unsatisfactory therapeutic effect|0
3047998|NCT00615459|10478299|P3|Period III|Unsatisfactory therapeutic effect|0
3047999|NCT00615459|10478300|P2|Period III|Unsatisfactory therapeutic effect|1
3048000|NCT00615459|10478301|P1|Period III|Unsatisfactory therapeutic effect|0
3048001|NCT00615459|10478298|P4|Period III|Administrative problems|0
3048002|NCT00615459|10478299|P3|Period III|Administrative problems|1
3048003|NCT00615459|10478300|P2|Period III|Administrative problems|1
3048004|NCT00615459|10478301|P1|Period III|Administrative problems|0
3048005|NCT00615459|10478298|P4|Period III|Adverse Event|0
3048006|NCT00615459|10478299|P3|Period III|Adverse Event|0
3048007|NCT00615459|10478300|P2|Period III|Adverse Event|1
3048008|NCT00615459|10478301|P1|Period III|Adverse Event|0
3048009|NCT00615459|10478298|P4|Period II|Lost to Follow-up|1
3048010|NCT00615459|10478299|P3|Period II|Lost to Follow-up|0
3048011|NCT00615459|10478300|P2|Period II|Lost to Follow-up|0
3048012|NCT00615459|10478301|P1|Period II|Lost to Follow-up|0
3048013|NCT00615459|10478298|P4|Period II|Adverse Event|0
3048014|NCT00615459|10478299|P3|Period II|Adverse Event|0
3048015|NCT00615459|10478300|P2|Period II|Adverse Event|0
3048016|NCT00615459|10478301|P1|Period II|Adverse Event|1
3048017|NCT00615459|10478298|P4|Period I|Abnormal test procedure results|0
3048018|NCT00615459|10478299|P3|Period I|Abnormal test procedure results|1
3048019|NCT00615459|10478300|P2|Period I|Abnormal test procedure results|1
3048020|NCT00615459|10478301|P1|Period I|Abnormal test procedure results|1
3048021|NCT00615459|10478298|P4|Period I|Subject withdrew consent|1
3048022|NCT00615459|10478299|P3|Period I|Subject withdrew consent|0
3048023|NCT00615459|10478300|P2|Period I|Subject withdrew consent|0
3048024|NCT00615459|10478301|P1|Period I|Subject withdrew consent|1
3048025|NCT00615459|10478298|P4|Period I|Adverse Event|0
3048026|NCT00615459|10478299|P3|Period I|Adverse Event|1
3048027|NCT00615459|10478300|P2|Period I|Adverse Event|0
3048028|NCT00615459|10478301|P1|Period I|Adverse Event|2
3048029|NCT00615290|10478347|P1|Overall Study|Other|2
3048030|NCT00615290|10478347|P1|Overall Study|Withdrawal by Subject|1
3048031|NCT00615290|10478347|P1|Overall Study|Lost to Follow-up|3
3048032|NCT00615290|10478347|P1|Overall Study|Adverse Event|2
3048033|NCT00615264|10478361|P2|Overall Study|Dermal Hypersensitivity|3
3048034|NCT00615264|10478362|P1|Overall Study|Dermal Hypersensitivity|0
3048035|NCT00615264|10478361|P2|Overall Study|Not defined|4
3048036|NCT00615264|10478362|P1|Overall Study|Not defined|7
3048037|NCT00615264|10478361|P2|Overall Study|Protocol Violation|7
3048038|NCT00615264|10478362|P1|Overall Study|Protocol Violation|11
3048039|NCT00615264|10478361|P2|Overall Study|Death|1
3048040|NCT00615264|10478362|P1|Overall Study|Death|1
3048041|NCT00615264|10478361|P2|Overall Study|Adverse Event|5
3048042|NCT00615264|10478362|P1|Overall Study|Adverse Event|8
3048043|NCT00615264|10478361|P2|Overall Study|Lost to Follow-up|13
3048044|NCT00615264|10478362|P1|Overall Study|Lost to Follow-up|6
3048045|NCT00615264|10478361|P2|Overall Study|Withdrawal by Subject|19
3048046|NCT00615264|10478362|P1|Overall Study|Withdrawal by Subject|17
3048047|NCT00615199|10478374|P4|Overall Study|Withdrawal by Subject|0
3048048|NCT00615199|10478375|P3|Overall Study|Withdrawal by Subject|0
3048049|NCT00615199|10478376|P2|Overall Study|Withdrawal by Subject|1
3048050|NCT00615199|10478377|P1|Overall Study|Withdrawal by Subject|2
3048051|NCT00615199|10478374|P4|Overall Study|Other|1
3048052|NCT00615199|10478375|P3|Overall Study|Other|0
3048053|NCT00615199|10478376|P2|Overall Study|Other|0
3048054|NCT00615199|10478377|P1|Overall Study|Other|0
3048055|NCT00615199|10478374|P4|Overall Study|Lost to Follow-up|0
3048056|NCT00615199|10478375|P3|Overall Study|Lost to Follow-up|0
3048057|NCT00615199|10478376|P2|Overall Study|Lost to Follow-up|0
3048058|NCT00615199|10478377|P1|Overall Study|Lost to Follow-up|1
3048059|NCT00615199|10478374|P4|Overall Study|Lack of Efficacy|1
3048060|NCT00615199|10478375|P3|Overall Study|Lack of Efficacy|0
3048061|NCT00615199|10478376|P2|Overall Study|Lack of Efficacy|0
3048062|NCT00615199|10478377|P1|Overall Study|Lack of Efficacy|2
3048063|NCT00615199|10478374|P4|Overall Study|Adverse Event|0
3048064|NCT00615199|10478375|P3|Overall Study|Adverse Event|1
3048065|NCT00615199|10478376|P2|Overall Study|Adverse Event|1
3048066|NCT00615199|10478377|P1|Overall Study|Adverse Event|3
3048067|NCT00615108|10478411|P1|Overall Study|Lost to Follow-up|15
3048068|NCT00615108|10478411|P1|Overall Study|Other|370
3048069|NCT00615108|10478411|P1|Overall Study|Adverse Event|122
3048070|NCT00615069|10478426|P1|Overall Study|Withdrawal by Subject|4
3048071|NCT00615069|10478426|P1|Overall Study|Physician Decision|2
3048072|NCT00615069|10478426|P1|Overall Study|Death|10
3048073|NCT00615056|10478435|P4|Overall Study|Randomized but not treated|0
3048074|NCT00615056|10478436|P3|Overall Study|Randomized but not treated|0
3048075|NCT00615056|10478437|P2|Overall Study|Randomized but not treated|0
3048076|NCT00615056|10478438|P1|Overall Study|Randomized but not treated|3
3048077|NCT00615056|10478435|P4|Overall Study|Discontinued by Sponsor|0
3048078|NCT00615056|10478436|P3|Overall Study|Discontinued by Sponsor|0
3048079|NCT00615056|10478437|P2|Overall Study|Discontinued by Sponsor|0
3048080|NCT00615056|10478438|P1|Overall Study|Discontinued by Sponsor|1
3048081|NCT00615056|10478435|P4|Overall Study|Withdrawal by Subject|0
3048082|NCT00615056|10478436|P3|Overall Study|Withdrawal by Subject|1
3048083|NCT00615056|10478437|P2|Overall Study|Withdrawal by Subject|1
3048084|NCT00615056|10478438|P1|Overall Study|Withdrawal by Subject|0
3048085|NCT00615056|10478435|P4|Overall Study|Objective progression or relapse|0
3048086|NCT00615056|10478436|P3|Overall Study|Objective progression or relapse|0
3048087|NCT00615056|10478437|P2|Overall Study|Objective progression or relapse|2
3048088|NCT00615056|10478438|P1|Overall Study|Objective progression or relapse|0
3048089|NCT00615056|10478435|P4|Overall Study|Other|7
3048090|NCT00615056|10478436|P3|Overall Study|Other|10
3048091|NCT00615056|10478437|P2|Overall Study|Other|15
3048092|NCT00615056|10478438|P1|Overall Study|Other|13
3048093|NCT00615056|10478435|P4|Overall Study|Lost to Follow-up|5
3048094|NCT00615056|10478436|P3|Overall Study|Lost to Follow-up|4
3048095|NCT00615056|10478437|P2|Overall Study|Lost to Follow-up|2
3048096|NCT00615056|10478438|P1|Overall Study|Lost to Follow-up|1
3048097|NCT00615056|10478435|P4|Overall Study|Death|23
3048098|NCT00615056|10478436|P3|Overall Study|Death|21
3048099|NCT00615056|10478437|P2|Overall Study|Death|31
3048100|NCT00615056|10478438|P1|Overall Study|Death|31
3048101|NCT00615030|10478468|P12|Period III|Administrative problems|0
3048102|NCT00615030|10478469|P11|Period III|Administrative problems|0
3048103|NCT00615030|10478470|P10|Period III|Administrative problems|0
3048104|NCT00615030|10478471|P9|Period III|Administrative problems|0
3048105|NCT00615030|10478472|P8|Period III|Administrative problems|0
3048106|NCT00615030|10478473|P7|Period III|Administrative problems|0
3048107|NCT00615030|10478474|P6|Period III|Administrative problems|0
3048108|NCT00615030|10478475|P5|Period III|Administrative problems|0
3048109|NCT00615030|10478476|P4|Period III|Administrative problems|1
3048110|NCT00615030|10478477|P3|Period III|Administrative problems|0
3048111|NCT00615030|10478478|P2|Period III|Administrative problems|0
3048112|NCT00615030|10478479|P1|Period III|Administrative problems|1
3048113|NCT00615030|10478468|P12|Period II|Subject withdrew consent|0
3048114|NCT00615030|10478469|P11|Period II|Subject withdrew consent|0
3048115|NCT00615030|10478470|P10|Period II|Subject withdrew consent|0
3048116|NCT00615030|10478471|P9|Period II|Subject withdrew consent|0
3048117|NCT00615030|10478472|P8|Period II|Subject withdrew consent|0
3048118|NCT00615030|10478473|P7|Period II|Subject withdrew consent|1
3048119|NCT00615030|10478474|P6|Period II|Subject withdrew consent|0
3048120|NCT00615030|10478475|P5|Period II|Subject withdrew consent|0
3048121|NCT00615030|10478476|P4|Period II|Subject withdrew consent|1
3048122|NCT00615030|10478477|P3|Period II|Subject withdrew consent|0
3048123|NCT00615030|10478478|P2|Period II|Subject withdrew consent|0
3048124|NCT00615030|10478479|P1|Period II|Subject withdrew consent|0
3048125|NCT00615030|10478468|P12|Period II|Adverse Event|0
3048126|NCT00615030|10478469|P11|Period II|Adverse Event|0
3048127|NCT00615030|10478470|P10|Period II|Adverse Event|0
3048128|NCT00615030|10478471|P9|Period II|Adverse Event|1
3048129|NCT00615030|10478472|P8|Period II|Adverse Event|0
3048130|NCT00615030|10478473|P7|Period II|Adverse Event|0
3048131|NCT00615030|10478474|P6|Period II|Adverse Event|0
3048132|NCT00615030|10478475|P5|Period II|Adverse Event|0
3048133|NCT00615030|10478476|P4|Period II|Adverse Event|0
3048134|NCT00615030|10478477|P3|Period II|Adverse Event|1
3048135|NCT00615030|10478478|P2|Period II|Adverse Event|0
3048136|NCT00615030|10478479|P1|Period II|Adverse Event|0
3048137|NCT00615030|10478468|P12|Period I|Abnormal laboratory value(s)|0
3048138|NCT00615030|10478469|P11|Period I|Abnormal laboratory value(s)|0
3048139|NCT00615030|10478470|P10|Period I|Abnormal laboratory value(s)|0
3048140|NCT00615030|10478471|P9|Period I|Abnormal laboratory value(s)|0
3048141|NCT00615030|10478472|P8|Period I|Abnormal laboratory value(s)|0
3048142|NCT00615030|10478473|P7|Period I|Abnormal laboratory value(s)|0
3048143|NCT00615030|10478474|P6|Period I|Abnormal laboratory value(s)|1
3048144|NCT00615030|10478475|P5|Period I|Abnormal laboratory value(s)|0
3048145|NCT00615030|10478476|P4|Period I|Abnormal laboratory value(s)|0
3048146|NCT00615030|10478477|P3|Period I|Abnormal laboratory value(s)|0
3048147|NCT00615030|10478478|P2|Period I|Abnormal laboratory value(s)|0
3048148|NCT00615030|10478479|P1|Period I|Abnormal laboratory value(s)|0
3048149|NCT00615030|10478468|P12|Period I|Subject withdrew consent|1
3048150|NCT00615030|10478469|P11|Period I|Subject withdrew consent|1
3048151|NCT00615030|10478470|P10|Period I|Subject withdrew consent|0
3048152|NCT00615030|10478471|P9|Period I|Subject withdrew consent|1
3048153|NCT00615030|10478472|P8|Period I|Subject withdrew consent|0
3048154|NCT00615030|10478473|P7|Period I|Subject withdrew consent|0
3048155|NCT00615030|10478474|P6|Period I|Subject withdrew consent|0
3048156|NCT00615030|10478475|P5|Period I|Subject withdrew consent|0
3048157|NCT00615030|10478476|P4|Period I|Subject withdrew consent|0
3048158|NCT00615030|10478477|P3|Period I|Subject withdrew consent|0
3048159|NCT00615030|10478478|P2|Period I|Subject withdrew consent|0
3048160|NCT00615030|10478479|P1|Period I|Subject withdrew consent|0
3048161|NCT00615030|10478468|P12|Period I|Protocol deviation|0
3048162|NCT00615030|10478469|P11|Period I|Protocol deviation|0
3048163|NCT00615030|10478470|P10|Period I|Protocol deviation|0
3048164|NCT00615030|10478471|P9|Period I|Protocol deviation|0
3048165|NCT00615030|10478472|P8|Period I|Protocol deviation|0
3048166|NCT00615030|10478473|P7|Period I|Protocol deviation|0
3048167|NCT00615030|10478474|P6|Period I|Protocol deviation|0
3048168|NCT00615030|10478475|P5|Period I|Protocol deviation|0
3048169|NCT00615030|10478476|P4|Period I|Protocol deviation|0
3048170|NCT00615030|10478477|P3|Period I|Protocol deviation|0
3048171|NCT00615030|10478478|P2|Period I|Protocol deviation|0
3048172|NCT00615030|10478479|P1|Period I|Protocol deviation|1
3048173|NCT00615030|10478468|P12|Period I|Administrative problem|0
3048174|NCT00615030|10478469|P11|Period I|Administrative problem|0
3048175|NCT00615030|10478470|P10|Period I|Administrative problem|0
3048176|NCT00615030|10478471|P9|Period I|Administrative problem|0
3048177|NCT00615030|10478472|P8|Period I|Administrative problem|0
3048178|NCT00615030|10478473|P7|Period I|Administrative problem|0
3048179|NCT00615030|10478474|P6|Period I|Administrative problem|0
3048180|NCT00615030|10478475|P5|Period I|Administrative problem|1
3048181|NCT00615030|10478476|P4|Period I|Administrative problem|0
3048182|NCT00615030|10478477|P3|Period I|Administrative problem|0
3048183|NCT00615030|10478478|P2|Period I|Administrative problem|0
3048184|NCT00615030|10478479|P1|Period I|Administrative problem|0
3048185|NCT00615017|10478499|P6|Overall Study|Physician discontinued drug|1
3048186|NCT00615017|10478500|P5|Overall Study|Physician discontinued drug|0
3048187|NCT00615017|10478501|P4|Overall Study|Physician discontinued drug|0
3048188|NCT00615017|10478502|P3|Overall Study|Physician discontinued drug|0
3048189|NCT00615017|10478503|P2|Overall Study|Physician discontinued drug|0
3048190|NCT00615017|10478504|P1|Overall Study|Physician discontinued drug|0
3048191|NCT00615017|10478499|P6|Overall Study|Transferred out of Intensive Care Unit|0
3048192|NCT00615017|10478500|P5|Overall Study|Transferred out of Intensive Care Unit|0
3048193|NCT00615017|10478501|P4|Overall Study|Transferred out of Intensive Care Unit|1
3048194|NCT00615017|10478502|P3|Overall Study|Transferred out of Intensive Care Unit|0
3048195|NCT00615017|10478503|P2|Overall Study|Transferred out of Intensive Care Unit|0
3048196|NCT00615017|10478504|P1|Overall Study|Transferred out of Intensive Care Unit|0
3048197|NCT00615017|10478499|P6|Overall Study|Sepsis resolved|0
3048198|NCT00615017|10478500|P5|Overall Study|Sepsis resolved|0
3048199|NCT00615017|10478501|P4|Overall Study|Sepsis resolved|0
3048200|NCT00615017|10478502|P3|Overall Study|Sepsis resolved|1
3048201|NCT00615017|10478503|P2|Overall Study|Sepsis resolved|0
3048202|NCT00615017|10478504|P1|Overall Study|Sepsis resolved|0
3048203|NCT00615017|10478499|P6|Overall Study|Death|1
3048204|NCT00615017|10478500|P5|Overall Study|Death|1
3048205|NCT00615017|10478501|P4|Overall Study|Death|0
3048206|NCT00615017|10478502|P3|Overall Study|Death|2
3048207|NCT00615017|10478503|P2|Overall Study|Death|0
3048208|NCT00615017|10478504|P1|Overall Study|Death|0
3048209|NCT00615017|10478499|P6|Overall Study|Adverse Event|1
3048210|NCT00615017|10478500|P5|Overall Study|Adverse Event|0
3048211|NCT00615017|10478501|P4|Overall Study|Adverse Event|0
3048212|NCT00615017|10478502|P3|Overall Study|Adverse Event|2
3048213|NCT00615017|10478503|P2|Overall Study|Adverse Event|1
3048214|NCT00615017|10478504|P1|Overall Study|Adverse Event|0
3048215|NCT00614991|10478662|P6|Overall Study|Adverse Event|0
3048216|NCT00614991|10478663|P5|Overall Study|Adverse Event|1
3048217|NCT00614991|10478664|P4|Overall Study|Adverse Event|0
3048218|NCT00614991|10478665|P3|Overall Study|Adverse Event|0
3048219|NCT00614991|10478666|P2|Overall Study|Adverse Event|3
3048220|NCT00614991|10478667|P1|Overall Study|Adverse Event|3
3048221|NCT00614939|10478701|P2|Overall Study|Hospitalized due to kidney transplant|0
3048222|NCT00614939|10478702|P1|Overall Study|Hospitalized due to kidney transplant|1
3048223|NCT00614939|10478701|P2|Overall Study|Poor/non-compliance|0
3048224|NCT00614939|10478702|P1|Overall Study|Poor/non-compliance|4
3048225|NCT00614939|10478701|P2|Overall Study|Death|3
3048226|NCT00614939|10478702|P1|Overall Study|Death|4
3048227|NCT00614939|10478701|P2|Overall Study|Incorrect enrollment|2
3048228|NCT00614939|10478702|P1|Overall Study|Incorrect enrollment|1
3048229|NCT00614939|10478701|P2|Overall Study|Adverse Event|5
3048230|NCT00614939|10478702|P1|Overall Study|Adverse Event|2
3048231|NCT00614939|10478701|P2|Overall Study|Study specific discontinuation criteris|16
3048232|NCT00614939|10478702|P1|Overall Study|Study specific discontinuation criteris|13
3048233|NCT00614939|10478701|P2|Overall Study|Withdrawal by Subject|17
3048234|NCT00614939|10478702|P1|Overall Study|Withdrawal by Subject|10
3048235|NCT00614926|10478736|P2|Overall Study|Adverse Event|0
3048236|NCT00614926|10478737|P1|Overall Study|Adverse Event|3
3048237|NCT00614926|10478736|P2|Overall Study|Burden of travel|0
3048238|NCT00614926|10478737|P1|Overall Study|Burden of travel|1
3048239|NCT00614874|10478750|P1|Overall Study|Withdrawal by Subject|1
3048240|NCT00614874|10478750|P1|Overall Study|Protocol Violation|1
3048241|NCT00614822|10478757|P1|Overall Study|Adverse Event|3
3048242|NCT00614744|10478766|P2|Overall Study|Incomplete for Behavior Issues|2
3048243|NCT00614744|10478767|P1|Overall Study|Incomplete for Behavior Issues|0
3048244|NCT00614744|10478766|P2|Overall Study|Lost to Follow-up|4
3048245|NCT00614744|10478767|P1|Overall Study|Lost to Follow-up|5
3048246|NCT00614614|10478793|P5|Booster Vaccination Phase|Other|1
3048247|NCT00614614|10478794|P4|Booster Vaccination Phase|Other|2
3048248|NCT00614614|10478795|P3|Booster Vaccination Phase|Other|3
3048249|NCT00614614|10478796|P2|Booster Vaccination Phase|Other|1
3048250|NCT00614614|10478797|P1|Booster Vaccination Phase|Other|0
3048251|NCT00614614|10478793|P5|Booster Vaccination Phase|Protocol Violation|0
3048252|NCT00614614|10478794|P4|Booster Vaccination Phase|Protocol Violation|3
3048253|NCT00614614|10478795|P3|Booster Vaccination Phase|Protocol Violation|2
3048254|NCT00614614|10478796|P2|Booster Vaccination Phase|Protocol Violation|0
3048255|NCT00614614|10478797|P1|Booster Vaccination Phase|Protocol Violation|0
3048256|NCT00614614|10478793|P5|Booster Vaccination Phase|Lost to Follow-up|8
3048257|NCT00614614|10478794|P4|Booster Vaccination Phase|Lost to Follow-up|10
3048258|NCT00614614|10478795|P3|Booster Vaccination Phase|Lost to Follow-up|17
3048259|NCT00614614|10478796|P2|Booster Vaccination Phase|Lost to Follow-up|5
3048260|NCT00614614|10478797|P1|Booster Vaccination Phase|Lost to Follow-up|0
3048261|NCT00614614|10478793|P5|Booster Vaccination Phase|Withdrawal by Subject|4
3048262|NCT00614614|10478794|P4|Booster Vaccination Phase|Withdrawal by Subject|3
3048263|NCT00614614|10478795|P3|Booster Vaccination Phase|Withdrawal by Subject|4
3048264|NCT00614614|10478796|P2|Booster Vaccination Phase|Withdrawal by Subject|0
3048265|NCT00614614|10478797|P1|Booster Vaccination Phase|Withdrawal by Subject|0
3048266|NCT00614614|10478793|P5|Booster Vaccination Phase|Adverse Event|0
3048267|NCT00614614|10478794|P4|Booster Vaccination Phase|Adverse Event|1
3048268|NCT00614614|10478795|P3|Booster Vaccination Phase|Adverse Event|1
3048269|NCT00614614|10478796|P2|Booster Vaccination Phase|Adverse Event|0
3048270|NCT00614614|10478797|P1|Booster Vaccination Phase|Adverse Event|0
3048271|NCT00614614|10478793|P5|Primary Vaccination Phase|Other|0
3048272|NCT00614614|10478794|P4|Primary Vaccination Phase|Other|0
3048273|NCT00614614|10478795|P3|Primary Vaccination Phase|Other|0
3048274|NCT00614614|10478796|P2|Primary Vaccination Phase|Other|0
3048275|NCT00614614|10478797|P1|Primary Vaccination Phase|Other|4
3048276|NCT00614614|10478793|P5|Primary Vaccination Phase|Protocol Violation|0
3048277|NCT00614614|10478794|P4|Primary Vaccination Phase|Protocol Violation|0
3048278|NCT00614614|10478795|P3|Primary Vaccination Phase|Protocol Violation|0
3048279|NCT00614614|10478796|P2|Primary Vaccination Phase|Protocol Violation|3
3048280|NCT00614614|10478797|P1|Primary Vaccination Phase|Protocol Violation|9
3048281|NCT00614614|10478793|P5|Primary Vaccination Phase|Lost to Follow-up|0
3048282|NCT00614614|10478794|P4|Primary Vaccination Phase|Lost to Follow-up|0
3048283|NCT00614614|10478795|P3|Primary Vaccination Phase|Lost to Follow-up|0
3048284|NCT00614614|10478796|P2|Primary Vaccination Phase|Lost to Follow-up|8
3048285|NCT00614614|10478797|P1|Primary Vaccination Phase|Lost to Follow-up|26
3048286|NCT00614614|10478793|P5|Primary Vaccination Phase|Withdrawal by Subject|0
3048287|NCT00614614|10478794|P4|Primary Vaccination Phase|Withdrawal by Subject|0
3048288|NCT00614614|10478795|P3|Primary Vaccination Phase|Withdrawal by Subject|0
3048289|NCT00614614|10478796|P2|Primary Vaccination Phase|Withdrawal by Subject|6
3048290|NCT00614614|10478797|P1|Primary Vaccination Phase|Withdrawal by Subject|45
3048291|NCT00614614|10478793|P5|Primary Vaccination Phase|Adverse Event|0
3048292|NCT00614614|10478794|P4|Primary Vaccination Phase|Adverse Event|0
3048293|NCT00614614|10478795|P3|Primary Vaccination Phase|Adverse Event|0
3048294|NCT00614614|10478796|P2|Primary Vaccination Phase|Adverse Event|0
3048295|NCT00614614|10478797|P1|Primary Vaccination Phase|Adverse Event|6
3048296|NCT00614575|10478920|P1|Overall Study|No treatment|1
3048297|NCT00614575|10478920|P1|Overall Study|Irregularly enrolled patients|23
3048298|NCT00614575|10478920|P1|Overall Study|No data were collected.|18
3048299|NCT00614575|10478920|P1|Overall Study|Physician Decision|2
3048300|NCT00614575|10478920|P1|Overall Study|Death|3
3048301|NCT00614575|10478920|P1|Overall Study|Withdrawal by Subject|6
3048302|NCT00614575|10478920|P1|Overall Study|Lack of Efficacy|14
3048303|NCT00614575|10478920|P1|Overall Study|Lost to Follow-up|55
3048304|NCT00614575|10478920|P1|Overall Study|Adverse Event|106
3048305|NCT00614523|10478931|P2|Overall Study|Administrative Decision|46
3048306|NCT00614523|10478932|P1|Overall Study|Administrative Decision|23
3048307|NCT00614523|10478931|P2|Overall Study|Disease Progression|8
3048308|NCT00614523|10478932|P1|Overall Study|Disease Progression|0
3048309|NCT00614523|10478931|P2|Overall Study|Ineligibility Determined|2
3048310|NCT00614523|10478932|P1|Overall Study|Ineligibility Determined|1
3048311|NCT00614523|10478931|P2|Overall Study|Other|11
3048312|NCT00614523|10478932|P1|Overall Study|Other|6
3048313|NCT00614523|10478931|P2|Overall Study|Withdrawal by Subject|22
3048314|NCT00614523|10478932|P1|Overall Study|Withdrawal by Subject|12
3048315|NCT00614523|10478931|P2|Overall Study|Protocol Violation|2
3048316|NCT00614523|10478932|P1|Overall Study|Protocol Violation|3
3048317|NCT00614523|10478931|P2|Overall Study|Lost to Follow-up|1
3048318|NCT00614523|10478932|P1|Overall Study|Lost to Follow-up|0
3048319|NCT00614523|10478931|P2|Overall Study|Lack of Efficacy|11
3048320|NCT00614523|10478932|P1|Overall Study|Lack of Efficacy|9
3048321|NCT00614523|10478931|P2|Overall Study|Death|8
3048322|NCT00614523|10478932|P1|Overall Study|Death|5
3048323|NCT00614523|10478931|P2|Overall Study|Adverse Event|20
3048324|NCT00614523|10478932|P1|Overall Study|Adverse Event|4
3048325|NCT00614393|10478997|P5|Overall Study|Not Treated|2
3048326|NCT00614393|10478998|P4|Overall Study|Not Treated|0
3048327|NCT00614393|10478999|P3|Overall Study|Not Treated|0
3048328|NCT00614393|10479000|P2|Overall Study|Not Treated|0
3048329|NCT00614393|10479001|P1|Overall Study|Not Treated|0
3048330|NCT00614393|10478997|P5|Overall Study|Other|2
3048331|NCT00614393|10478998|P4|Overall Study|Other|4
3048332|NCT00614393|10478999|P3|Overall Study|Other|0
3048333|NCT00614393|10479000|P2|Overall Study|Other|0
3048334|NCT00614393|10479001|P1|Overall Study|Other|4
3048335|NCT00614393|10478997|P5|Overall Study|Withdrawal by Subject|13
3048336|NCT00614393|10478998|P4|Overall Study|Withdrawal by Subject|16
3048337|NCT00614393|10478999|P3|Overall Study|Withdrawal by Subject|1
3048338|NCT00614393|10479000|P2|Overall Study|Withdrawal by Subject|1
3048339|NCT00614393|10479001|P1|Overall Study|Withdrawal by Subject|20
3048340|NCT00614393|10478997|P5|Overall Study|Terminated by Sponsor|1
3048341|NCT00614393|10478998|P4|Overall Study|Terminated by Sponsor|0
3048342|NCT00614393|10478999|P3|Overall Study|Terminated by Sponsor|0
3048343|NCT00614393|10479000|P2|Overall Study|Terminated by Sponsor|0
3048344|NCT00614393|10479001|P1|Overall Study|Terminated by Sponsor|0
3048345|NCT00614393|10478997|P5|Overall Study|Protocol Violation|0
3048346|NCT00614393|10478998|P4|Overall Study|Protocol Violation|0
3048347|NCT00614393|10478999|P3|Overall Study|Protocol Violation|0
3048348|NCT00614393|10479000|P2|Overall Study|Protocol Violation|0
3048349|NCT00614393|10479001|P1|Overall Study|Protocol Violation|1
3048350|NCT00614393|10478997|P5|Overall Study|Progressive Disease|130
3048351|NCT00614393|10478998|P4|Overall Study|Progressive Disease|138
3048352|NCT00614393|10478999|P3|Overall Study|Progressive Disease|5
3048353|NCT00614393|10479000|P2|Overall Study|Progressive Disease|5
3048354|NCT00614393|10479001|P1|Overall Study|Progressive Disease|118
3048355|NCT00614393|10478997|P5|Overall Study|Physician Decision|9
3048356|NCT00614393|10478998|P4|Overall Study|Physician Decision|8
3048357|NCT00614393|10478999|P3|Overall Study|Physician Decision|1
3048358|NCT00614393|10479000|P2|Overall Study|Physician Decision|0
3048359|NCT00614393|10479001|P1|Overall Study|Physician Decision|17
3048360|NCT00614393|10478997|P5|Overall Study|Lost to Follow-up|2
3048361|NCT00614393|10478998|P4|Overall Study|Lost to Follow-up|1
3048362|NCT00614393|10478999|P3|Overall Study|Lost to Follow-up|0
3048363|NCT00614393|10479000|P2|Overall Study|Lost to Follow-up|0
3048364|NCT00614393|10479001|P1|Overall Study|Lost to Follow-up|0
3048365|NCT00614393|10478997|P5|Overall Study|Adverse Event|21
3048366|NCT00614393|10478998|P4|Overall Study|Adverse Event|13
3048367|NCT00614393|10478999|P3|Overall Study|Adverse Event|3
3048368|NCT00614393|10479000|P2|Overall Study|Adverse Event|2
3048369|NCT00614393|10479001|P1|Overall Study|Adverse Event|20
3048370|NCT00614380|10479047|P4|Overall Study|Consent withdrawn|0
3048371|NCT00614380|10479048|P3|Overall Study|Consent withdrawn|0
3048372|NCT00614380|10479049|P2|Overall Study|Consent withdrawn|1
3048373|NCT00614380|10479050|P1|Overall Study|Consent withdrawn|3
3048374|NCT00614380|10479047|P4|Overall Study|Non compliant with the protocol|2
3048375|NCT00614380|10479048|P3|Overall Study|Non compliant with the protocol|1
3048376|NCT00614380|10479049|P2|Overall Study|Non compliant with the protocol|2
3048377|NCT00614380|10479050|P1|Overall Study|Non compliant with the protocol|12
3048378|NCT00614380|10479047|P4|Overall Study|Lost to Follow-up|0
3048379|NCT00614380|10479048|P3|Overall Study|Lost to Follow-up|0
3048380|NCT00614380|10479049|P2|Overall Study|Lost to Follow-up|1
3048381|NCT00614380|10479050|P1|Overall Study|Lost to Follow-up|6
3048382|NCT00614380|10479047|P4|Overall Study|Adverse Event|0
3048383|NCT00614380|10479048|P3|Overall Study|Adverse Event|0
3048384|NCT00614380|10479049|P2|Overall Study|Adverse Event|4
3048385|NCT00614380|10479050|P1|Overall Study|Adverse Event|14
3048386|NCT00614120|10479117|P4|Overall Study|Lost to Follow-up|4
3048387|NCT00614120|10479118|P3|Overall Study|Lost to Follow-up|3
3048388|NCT00614120|10479119|P2|Overall Study|Lost to Follow-up|2
3048389|NCT00614120|10479120|P1|Overall Study|Lost to Follow-up|1
3048390|NCT00614120|10479117|P4|Overall Study|Taken inhibition medication eg Prandin|1
3048391|NCT00614120|10479118|P3|Overall Study|Taken inhibition medication eg Prandin|1
3048392|NCT00614120|10479119|P2|Overall Study|Taken inhibition medication eg Prandin|0
3048393|NCT00614120|10479120|P1|Overall Study|Taken inhibition medication eg Prandin|0
3048394|NCT00614120|10479117|P4|Overall Study|Late syphilis, latent|0
3048395|NCT00614120|10479118|P3|Overall Study|Late syphilis, latent|0
3048396|NCT00614120|10479119|P2|Overall Study|Late syphilis, latent|0
3048397|NCT00614120|10479120|P1|Overall Study|Late syphilis, latent|1
3048398|NCT00614120|10479117|P4|Overall Study|Lack of trial product|0
3048399|NCT00614120|10479118|P3|Overall Study|Lack of trial product|2
3048400|NCT00614120|10479119|P2|Overall Study|Lack of trial product|3
3048401|NCT00614120|10479120|P1|Overall Study|Lack of trial product|3
3048402|NCT00614120|10479117|P4|Overall Study|Hypoglycaemia|1
3048403|NCT00614120|10479118|P3|Overall Study|Hypoglycaemia|0
3048404|NCT00614120|10479119|P2|Overall Study|Hypoglycaemia|0
3048405|NCT00614120|10479120|P1|Overall Study|Hypoglycaemia|0
3048406|NCT00614120|10479117|P4|Overall Study|hCG positive (not pregnant)|0
3048407|NCT00614120|10479118|P3|Overall Study|hCG positive (not pregnant)|1
3048408|NCT00614120|10479119|P2|Overall Study|hCG positive (not pregnant)|0
3048409|NCT00614120|10479120|P1|Overall Study|hCG positive (not pregnant)|0
3048410|NCT00614120|10479117|P4|Overall Study|Did not meet trial criteria|1
3048411|NCT00614120|10479118|P3|Overall Study|Did not meet trial criteria|1
3048412|NCT00614120|10479119|P2|Overall Study|Did not meet trial criteria|1
3048413|NCT00614120|10479120|P1|Overall Study|Did not meet trial criteria|0
3048414|NCT00614120|10479117|P4|Overall Study|Withdrawal by Subject|3
3048415|NCT00614120|10479118|P3|Overall Study|Withdrawal by Subject|16
3048416|NCT00614120|10479119|P2|Overall Study|Withdrawal by Subject|10
3048417|NCT00614120|10479120|P1|Overall Study|Withdrawal by Subject|9
3048418|NCT00614120|10479117|P4|Overall Study|Withdrawal criteria|0
3048419|NCT00614120|10479118|P3|Overall Study|Withdrawal criteria|0
3048420|NCT00614120|10479119|P2|Overall Study|Withdrawal criteria|0
3048421|NCT00614120|10479120|P1|Overall Study|Withdrawal criteria|1
3048422|NCT00614120|10479117|P4|Overall Study|Protocol Violation|1
3048423|NCT00614120|10479118|P3|Overall Study|Protocol Violation|3
3048424|NCT00614120|10479119|P2|Overall Study|Protocol Violation|5
3048425|NCT00614120|10479120|P1|Overall Study|Protocol Violation|2
3048426|NCT00614120|10479117|P4|Overall Study|Lack of Efficacy|2
3048427|NCT00614120|10479118|P3|Overall Study|Lack of Efficacy|2
3048428|NCT00614120|10479119|P2|Overall Study|Lack of Efficacy|3
3048429|NCT00614120|10479120|P1|Overall Study|Lack of Efficacy|3
3048430|NCT00614120|10479117|P4|Overall Study|Adverse Event|3
3048431|NCT00614120|10479118|P3|Overall Study|Adverse Event|30
3048432|NCT00614120|10479119|P2|Overall Study|Adverse Event|22
3048433|NCT00614120|10479120|P1|Overall Study|Adverse Event|9
3048434|NCT00614055|10479161|P3|Overall Study|Unclassified|2
3048435|NCT00614055|10479162|P2|Overall Study|Unclassified|4
3048436|NCT00614055|10479163|P1|Overall Study|Unclassified|1
3048437|NCT00614055|10479161|P3|Overall Study|Lack of Efficacy|2
3048438|NCT00614055|10479162|P2|Overall Study|Lack of Efficacy|0
3048439|NCT00614055|10479163|P1|Overall Study|Lack of Efficacy|0
3048440|NCT00614055|10479161|P3|Overall Study|Protocol Violation|1
3048441|NCT00614055|10479162|P2|Overall Study|Protocol Violation|2
3048442|NCT00614055|10479163|P1|Overall Study|Protocol Violation|2
3048443|NCT00614055|10479161|P3|Overall Study|Adverse Event|0
3048444|NCT00614055|10479162|P2|Overall Study|Adverse Event|0
3048445|NCT00614055|10479163|P1|Overall Study|Adverse Event|1
3048446|NCT00613951|10479210|P3|Overall Study|Unclassified|2
3048447|NCT00613951|10479211|P2|Overall Study|Unclassified|3
3048448|NCT00613951|10479212|P1|Overall Study|Unclassified|5
3048449|NCT00613951|10479210|P3|Overall Study|Protocol Violation|1
3048450|NCT00613951|10479211|P2|Overall Study|Protocol Violation|1
3048451|NCT00613951|10479212|P1|Overall Study|Protocol Violation|1
3048452|NCT00613951|10479210|P3|Overall Study|Lack of Efficacy|1
3048453|NCT00613951|10479211|P2|Overall Study|Lack of Efficacy|1
3048454|NCT00613951|10479212|P1|Overall Study|Lack of Efficacy|0
3048455|NCT00613951|10479210|P3|Overall Study|Adverse Event|1
3048456|NCT00613951|10479211|P2|Overall Study|Adverse Event|0
3048457|NCT00613951|10479212|P1|Overall Study|Adverse Event|1
3048458|NCT00613938|10479257|P4|Overall Study|Other|3
3048459|NCT00613938|10479258|P3|Overall Study|Other|1
3048460|NCT00613938|10479259|P2|Overall Study|Other|2
3048461|NCT00613938|10479260|P1|Overall Study|Other|1
3048462|NCT00613938|10479257|P4|Overall Study|Lack of Efficacy|9
3048463|NCT00613938|10479258|P3|Overall Study|Lack of Efficacy|5
3048464|NCT00613938|10479259|P2|Overall Study|Lack of Efficacy|18
3048465|NCT00613938|10479260|P1|Overall Study|Lack of Efficacy|16
3048466|NCT00613938|10479257|P4|Overall Study|Adverse Event|5
3048467|NCT00613938|10479258|P3|Overall Study|Adverse Event|8
3048468|NCT00613938|10479259|P2|Overall Study|Adverse Event|4
3048469|NCT00613938|10479260|P1|Overall Study|Adverse Event|1
3048470|NCT00613938|10479257|P4|Overall Study|Withdrawal by Subject|9
3048471|NCT00613938|10479258|P3|Overall Study|Withdrawal by Subject|9
3048472|NCT00613938|10479259|P2|Overall Study|Withdrawal by Subject|4
3048473|NCT00613938|10479260|P1|Overall Study|Withdrawal by Subject|2
3048474|NCT00613925|10479292|P2|Overall Study|1 did not tolerate outpatient biopsy|1
3048475|NCT00613925|10479293|P1|Overall Study|1 did not tolerate outpatient biopsy|0
3048476|NCT00613834|10479303|P2|Overall Study|Withdrawal by Subject|3
3048477|NCT00613834|10479304|P1|Overall Study|Withdrawal by Subject|0
3048478|NCT00613821|10479316|P2|Overall Study|Physician Decision|1
3048479|NCT00613821|10479317|P1|Overall Study|Physician Decision|1
3048480|NCT00613821|10479316|P2|Overall Study|Withdrawal by Subject|0
3048481|NCT00613821|10479317|P1|Overall Study|Withdrawal by Subject|1
3048482|NCT00613730|10479323|P1|Overall Study|Administrative decision|1
3048483|NCT00613730|10479323|P1|Overall Study|Disease progression|2
3048484|NCT00613626|10479332|P3|Overall Study|Ineligible|0
3048485|NCT00613626|10479333|P2|Overall Study|Ineligible|1
3048486|NCT00613626|10479334|P1|Overall Study|Ineligible|0
3048487|NCT00613574|10479350|P1|Overall Study|Other|1
3048488|NCT00613574|10479350|P1|Overall Study|Lost to Follow-up|2
3048489|NCT00613574|10479350|P1|Overall Study|Adverse Event|3
3048490|NCT00613509|10479362|P2|Cycle 1|Other administrative reason|1
3048491|NCT00613509|10479363|P1|Cycle 1|Other administrative reason|0
3048492|NCT00613509|10479362|P2|Cycle 1|Unacceptable Toxicity|0
3048493|NCT00613509|10479363|P1|Cycle 1|Unacceptable Toxicity|1
3048494|NCT00613509|10479362|P2|Cycle 1|Disease Progression|6
3048495|NCT00613509|10479363|P1|Cycle 1|Disease Progression|2
3048496|NCT00613509|10479362|P2|Cycle 1|Adverse Event|1
3048497|NCT00613509|10479363|P1|Cycle 1|Adverse Event|2
3048498|NCT00613366|10479409|P2|Overall Study|Withdrawal by Subject|2
3048499|NCT00613366|10479410|P1|Overall Study|Withdrawal by Subject|3
3048500|NCT00613327|10479418|P1|Overall Study|Other|47
3048501|NCT00613327|10479418|P1|Overall Study|Protocol Violation|2
3048502|NCT00613327|10479418|P1|Overall Study|Withdrawal by Subject|6
3048503|NCT00613327|10479418|P1|Overall Study|Lost to Follow-up|8
3048504|NCT00613327|10479418|P1|Overall Study|Adverse Event|38
3048505|NCT00613314|10479437|P1|Overall Study|Other reason not defined above|90
3048506|NCT00613314|10479437|P1|Overall Study|Lost to Follow-up|46
3048507|NCT00613314|10479437|P1|Overall Study|Protocol Violation|14
3048508|NCT00613314|10479437|P1|Overall Study|Adverse Event|5
3048509|NCT00613301|10479445|P1|Overall Study|Irregularly enrolled patients|12
3048510|NCT00613301|10479445|P1|Overall Study|No data was collected|53
3048511|NCT00613301|10479445|P1|Overall Study|Physician Decision|2
3048512|NCT00613301|10479445|P1|Overall Study|Lack of Efficacy|13
3048513|NCT00613301|10479445|P1|Overall Study|Death|6
3048514|NCT00613301|10479445|P1|Overall Study|Withdrawal by Subject|5
3048515|NCT00613301|10479445|P1|Overall Study|Lost to Follow-up|88
3048516|NCT00613301|10479445|P1|Overall Study|Adverse Event|49
3048517|NCT00613106|10479454|P2|Overall Study|misc|3
3048518|NCT00613106|10479455|P1|Overall Study|misc|4
3048519|NCT00613106|10479454|P2|Overall Study|Lost to Follow-up|2
3048520|NCT00613106|10479455|P1|Overall Study|Lost to Follow-up|7
3048521|NCT00613106|10479454|P2|Overall Study|Withdrawal by Subject|3
3048522|NCT00613106|10479455|P1|Overall Study|Withdrawal by Subject|6
3048523|NCT00613106|10479454|P2|Overall Study|Adverse Event|1
3048524|NCT00613106|10479455|P1|Overall Study|Adverse Event|3
3048525|NCT00613080|10479461|P1|Overall Study|Ineligible / no protocol treatment|11
3048526|NCT00613015|10479496|P6|Overall Study|Lost to Follow-up|3
3048527|NCT00613015|10479497|P5|Overall Study|Lost to Follow-up|2
3048528|NCT00613015|10479498|P4|Overall Study|Lost to Follow-up|3
3048529|NCT00613015|10479499|P3|Overall Study|Lost to Follow-up|3
3048530|NCT00613015|10479500|P2|Overall Study|Lost to Follow-up|1
3048531|NCT00613015|10479501|P1|Overall Study|Lost to Follow-up|0
3048532|NCT00612807|10479537|P2|Overall Study|Withdrawal by Subject|0
3048533|NCT00612807|10479538|P1|Overall Study|Withdrawal by Subject|2
3048534|NCT00612690|10479573|P2|Overall Study|Withdrawal by Site|0
3048535|NCT00612690|10479574|P1|Overall Study|Withdrawal by Site|11
3048536|NCT00612690|10479573|P2|Overall Study|Withdrawal by Subject|20
3048537|NCT00612690|10479574|P1|Overall Study|Withdrawal by Subject|32
3048538|NCT00612690|10479573|P2|Overall Study|Lost to Follow-up|98
3048539|NCT00612690|10479574|P1|Overall Study|Lost to Follow-up|72
3048540|NCT00612677|10479582|P1|Overall Study|study closed before treatment started|1
3048541|NCT00612534|10479650|P4|Overall Study|Other Reason|0
3048542|NCT00612534|10479651|P3|Overall Study|Other Reason|0
3048543|NCT00612534|10479652|P2|Overall Study|Other Reason|1
3048544|NCT00612534|10479653|P1|Overall Study|Other Reason|0
3048545|NCT00612534|10479650|P4|Overall Study|Lack of Efficacy|16
3048546|NCT00612534|10479651|P3|Overall Study|Lack of Efficacy|5
3048547|NCT00612534|10479652|P2|Overall Study|Lack of Efficacy|12
3048548|NCT00612534|10479653|P1|Overall Study|Lack of Efficacy|13
3048549|NCT00612534|10479650|P4|Overall Study|Adverse Event|1
3048550|NCT00612534|10479651|P3|Overall Study|Adverse Event|2
3048551|NCT00612534|10479652|P2|Overall Study|Adverse Event|4
3048552|NCT00612534|10479653|P1|Overall Study|Adverse Event|0
3048553|NCT00612508|10479665|P2|Overall Study|Withdrawal by Subject|4
3048554|NCT00612508|10479666|P1|Overall Study|Withdrawal by Subject|3
3048555|NCT00612456|10479677|P3|Overall Study|Withdrawal by Subject|0
3048556|NCT00612456|10479678|P2|Overall Study|Withdrawal by Subject|1
3048557|NCT00612456|10479679|P1|Overall Study|Withdrawal by Subject|0
3048558|NCT00612456|10479677|P3|Overall Study|Lack of Efficacy|0
3048559|NCT00612456|10479678|P2|Overall Study|Lack of Efficacy|1
3048560|NCT00612456|10479679|P1|Overall Study|Lack of Efficacy|1
3048561|NCT00612456|10479677|P3|Overall Study|Adverse Event|0
3048562|NCT00612456|10479678|P2|Overall Study|Adverse Event|0
3048563|NCT00612456|10479679|P1|Overall Study|Adverse Event|1
3048564|NCT00612352|10479742|P2|Overall Study|didn't return calls/show up on test date|1
3048565|NCT00612352|10479743|P1|Overall Study|didn't return calls/show up on test date|4
3048566|NCT00612352|10479742|P2|Overall Study|moved out of state|0
3048567|NCT00612352|10479743|P1|Overall Study|moved out of state|1
3048568|NCT00612352|10479742|P2|Overall Study|Withdrawal by Subject|5
3048569|NCT00612352|10479743|P1|Overall Study|Withdrawal by Subject|3
3048570|NCT00612352|10479742|P2|Overall Study|Adverse Event|0
3048571|NCT00612352|10479743|P1|Overall Study|Adverse Event|1
3048572|NCT00612313|10479863|P2|Overall Study|Lost to Follow-up|4
3048573|NCT00612313|10479864|P1|Overall Study|Lost to Follow-up|11
3048574|NCT00612313|10479863|P2|Overall Study|Withdrawal by Subject|9
3048575|NCT00612313|10479864|P1|Overall Study|Withdrawal by Subject|6
3048576|NCT00612105|10479906|P2|Period Title 3: 3-Week Taper Phase|Other|0
3048577|NCT00612105|10479907|P1|Period Title 3: 3-Week Taper Phase|Other|1
3048578|NCT00612105|10479906|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
3048579|NCT00612105|10479907|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
3048580|NCT00612105|10479906|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
3048581|NCT00612105|10479907|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
3048582|NCT00612105|10479906|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
3048583|NCT00612105|10479907|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
3048584|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Other|1
3048585|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Other|0
3048586|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
3048587|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
3048588|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
3048589|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
3048590|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
3048591|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
3048592|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
3048593|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
3048594|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
3048595|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
3048596|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
3048597|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
3048598|NCT00612105|10479906|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
3048599|NCT00612105|10479907|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
3048600|NCT00612066|10479957|P1|Overall Study|Adverse Event|1
3048601|NCT00612040|10479964|P3|Overall Study|Unclassified|5
3048602|NCT00612040|10479965|P2|Overall Study|Unclassified|2
3048603|NCT00612040|10479966|P1|Overall Study|Unclassified|2
3048604|NCT00612040|10479964|P3|Overall Study|Lack of Efficacy|0
3048605|NCT00612040|10479965|P2|Overall Study|Lack of Efficacy|1
3048606|NCT00612040|10479966|P1|Overall Study|Lack of Efficacy|2
3048607|NCT00612040|10479964|P3|Overall Study|Protocol Violation|1
3048608|NCT00612040|10479965|P2|Overall Study|Protocol Violation|2
3048609|NCT00612040|10479966|P1|Overall Study|Protocol Violation|1
3048610|NCT00612040|10479964|P3|Overall Study|Adverse Event|1
3048611|NCT00612040|10479965|P2|Overall Study|Adverse Event|2
3048612|NCT00612040|10479966|P1|Overall Study|Adverse Event|0
3048613|NCT00611923|10480012|P2|Overall Study|Withdrawal by Subject|2
3048614|NCT00611923|10480013|P1|Overall Study|Withdrawal by Subject|2
3048615|NCT00611884|10480058|P4|Overall Study|Unclassified|3
3048616|NCT00611884|10480059|P3|Overall Study|Unclassified|2
3048617|NCT00611884|10480060|P2|Overall Study|Unclassified|4
3048618|NCT00611884|10480061|P1|Overall Study|Unclassified|7
3048619|NCT00611884|10480058|P4|Overall Study|Lack of Efficacy|0
3048620|NCT00611884|10480059|P3|Overall Study|Lack of Efficacy|0
3048621|NCT00611884|10480060|P2|Overall Study|Lack of Efficacy|1
3048622|NCT00611884|10480061|P1|Overall Study|Lack of Efficacy|0
3048623|NCT00611884|10480058|P4|Overall Study|Non-Compliance|2
3048624|NCT00611884|10480059|P3|Overall Study|Non-Compliance|2
3048625|NCT00611884|10480060|P2|Overall Study|Non-Compliance|4
3048626|NCT00611884|10480061|P1|Overall Study|Non-Compliance|1
3048627|NCT00611884|10480058|P4|Overall Study|Adverse Event|1
3048628|NCT00611884|10480059|P3|Overall Study|Adverse Event|0
3048629|NCT00611884|10480060|P2|Overall Study|Adverse Event|0
3048630|NCT00611884|10480061|P1|Overall Study|Adverse Event|1
3048631|NCT00611858|10480115|P1|Overall Study|Withdrawal by Subject|2
3048632|NCT00611858|10480115|P1|Overall Study|Adverse Event|2
3048633|NCT00611806|10480127|P2|Overall Study|Lost to Follow-up|0
3048634|NCT00611806|10480128|P1|Overall Study|Lost to Follow-up|6
3048635|NCT00611806|10480127|P2|Overall Study|Adverse Event|1
3048636|NCT00611806|10480128|P1|Overall Study|Adverse Event|2
3048637|NCT00611806|10480127|P2|Overall Study|Withdrawal by Subject|2
3048638|NCT00611806|10480128|P1|Overall Study|Withdrawal by Subject|8
3048639|NCT00611767|10480142|P2|Overall Study|Physician Decision|0
3048640|NCT00611767|10480143|P1|Overall Study|Physician Decision|1
3048641|NCT00611767|10480142|P2|Overall Study|didn't like the medication|1
3048642|NCT00611767|10480143|P1|Overall Study|didn't like the medication|1
3048643|NCT00611767|10480142|P2|Overall Study|Thiopental not available|0
3048644|NCT00611767|10480143|P1|Overall Study|Thiopental not available|3
3048645|NCT00611767|10480142|P2|Overall Study|Withdrawal by Subject|1
3048646|NCT00611767|10480143|P1|Overall Study|Withdrawal by Subject|4
3048647|NCT00611715|10480305|P2|Overall Study|two patients are still on treatment|0
3048648|NCT00611715|10480306|P1|Overall Study|two patients are still on treatment|2
3048649|NCT00611715|10480305|P2|Overall Study|Death|0
3048650|NCT00611715|10480306|P1|Overall Study|Death|1
3048651|NCT00611715|10480305|P2|Overall Study|Adverse Event|1
3048652|NCT00611715|10480306|P1|Overall Study|Adverse Event|9
3048653|NCT00611715|10480305|P2|Overall Study|Withdrawal by Subject|1
3048654|NCT00611715|10480306|P1|Overall Study|Withdrawal by Subject|5
3048655|NCT00611715|10480305|P2|Overall Study|Disease Progression|4
3048656|NCT00611715|10480306|P1|Overall Study|Disease Progression|24
3048657|NCT00611559|10480326|P3|Overall Study|Protocol Violation|1
3048658|NCT00611559|10480327|P2|Overall Study|Protocol Violation|0
3048659|NCT00611559|10480328|P1|Overall Study|Protocol Violation|1
3048660|NCT00611559|10480326|P3|Overall Study|Lost to Follow-up|0
3048661|NCT00611559|10480327|P2|Overall Study|Lost to Follow-up|1
3048662|NCT00611559|10480328|P1|Overall Study|Lost to Follow-up|0
3048663|NCT00611533|10480387|P2|Second Intervention (6 Weeks)|Adverse Event|2
3048664|NCT00611533|10480388|P1|Second Intervention (6 Weeks)|Adverse Event|0
3048665|NCT00611533|10480387|P2|First Intervention (6 Weeks)|Adverse Event|1
3048666|NCT00611533|10480388|P1|First Intervention (6 Weeks)|Adverse Event|0
3048667|NCT00611533|10480387|P2|First Intervention (6 Weeks)|Never started study|1
3048668|NCT00611533|10480388|P1|First Intervention (6 Weeks)|Never started study|0
3048669|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
3048670|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
3048671|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
3048672|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
3048673|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
3048674|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
3048675|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
3048676|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
3048677|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
3048678|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
3048679|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
3048680|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
3048681|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
3048682|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
3048683|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
3048684|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
3048685|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
3048686|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
3048687|NCT00611455|10480422|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
3048688|NCT00611455|10480423|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
3048689|NCT00611455|10480424|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
3048690|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
3048691|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
3048692|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
3048693|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
3048694|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
3048695|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
3048696|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
3048697|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
3048698|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
3048699|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
3048700|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
3048701|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
3048702|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
3048703|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
3048704|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
3048705|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
3048706|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
3048707|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
3048708|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
3048709|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
3048710|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
3048711|NCT00611455|10480422|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
3048712|NCT00611455|10480423|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
3048713|NCT00611455|10480424|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
3048714|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
3048715|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
3048716|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
3048717|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
3048718|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
3048719|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
3048720|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
3048721|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
3048722|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
3048723|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
3048724|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
3048725|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
3048726|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
3048727|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
3048728|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
3048729|NCT00611455|10480422|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
3048730|NCT00611455|10480423|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
3048731|NCT00611455|10480424|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
3048732|NCT00611247|10480604|P2|Overall Study|Lack of Efficacy|16
3048733|NCT00611247|10480605|P1|Overall Study|Lack of Efficacy|1
3048734|NCT00611247|10480604|P2|Overall Study|Death|5
3048735|NCT00611247|10480605|P1|Overall Study|Death|1
3048736|NCT00611130|10480617|P2|Overall Study|Death|0
3048737|NCT00611130|10480618|P1|Overall Study|Death|1
3048738|NCT00611130|10480617|P2|Overall Study|Adverse Event|0
3048739|NCT00611130|10480618|P1|Overall Study|Adverse Event|1
3048740|NCT00611130|10480617|P2|Overall Study|Administrative|1
3048741|NCT00611130|10480618|P1|Overall Study|Administrative|1
3048742|NCT00611130|10480617|P2|Overall Study|Incarceration|2
3048743|NCT00611130|10480618|P1|Overall Study|Incarceration|3
3048744|NCT00611130|10480617|P2|Overall Study|Other|4
3048745|NCT00611130|10480618|P1|Overall Study|Other|5
3048746|NCT00611130|10480617|P2|Overall Study|Withdrawal by Subject|5
3048747|NCT00611130|10480618|P1|Overall Study|Withdrawal by Subject|6
3048748|NCT00611130|10480617|P2|Overall Study|Protocol noncompliance|6
3048749|NCT00611130|10480618|P1|Overall Study|Protocol noncompliance|7
3048750|NCT00611130|10480617|P2|Overall Study|Lost to Follow-up|29
3048751|NCT00611130|10480618|P1|Overall Study|Lost to Follow-up|25
3048752|NCT00611026|10480628|P3|Double-blind Treatment Period|Other|18
3048753|NCT00611026|10480629|P2|Double-blind Treatment Period|Other|20
3048754|NCT00611026|10480630|P1|Double-blind Treatment Period|Other|13
3048755|NCT00611026|10480628|P3|Double-blind Treatment Period|Withdrawal by Subject|16
3048756|NCT00611026|10480629|P2|Double-blind Treatment Period|Withdrawal by Subject|19
3048757|NCT00611026|10480630|P1|Double-blind Treatment Period|Withdrawal by Subject|7
3048758|NCT00611026|10480628|P3|Double-blind Treatment Period|Lost to Follow-up|14
3048759|NCT00611026|10480629|P2|Double-blind Treatment Period|Lost to Follow-up|11
3048760|NCT00611026|10480630|P1|Double-blind Treatment Period|Lost to Follow-up|6
3048761|NCT00611026|10480628|P3|Double-blind Treatment Period|Lack of Efficacy|4
3048762|NCT00611026|10480629|P2|Double-blind Treatment Period|Lack of Efficacy|10
3048763|NCT00611026|10480630|P1|Double-blind Treatment Period|Lack of Efficacy|11
3048764|NCT00611026|10480628|P3|Double-blind Treatment Period|Adverse Event|46
3048765|NCT00611026|10480629|P2|Double-blind Treatment Period|Adverse Event|28
3048766|NCT00611026|10480630|P1|Double-blind Treatment Period|Adverse Event|9
3048767|NCT00611026|10480628|P3|Double-blind Treatment Period|Death|0
3048768|NCT00611026|10480629|P2|Double-blind Treatment Period|Death|0
3048769|NCT00611026|10480630|P1|Double-blind Treatment Period|Death|1
3048770|NCT00611026|10480628|P3|Randomized to Double-blind Treatment|Not treated|3
3048771|NCT00611026|10480629|P2|Randomized to Double-blind Treatment|Not treated|1
3048772|NCT00611026|10480630|P1|Randomized to Double-blind Treatment|Not treated|2
3048773|NCT00610857|10480707|P1|Overall Study|Not evaluable for response|2
3048774|NCT00610714|10480751|P2|Overall Study|Study completion at 120 PFS events|2
3048775|NCT00610714|10480752|P1|Overall Study|Study completion at 120 PFS events|2
3048776|NCT00610714|10480751|P2|Overall Study|Withdrawal by Subject|3
3048777|NCT00610714|10480752|P1|Overall Study|Withdrawal by Subject|9
3048778|NCT00610714|10480751|P2|Overall Study|Death|18
3048779|NCT00610714|10480752|P1|Overall Study|Death|12
3048780|NCT00610714|10480751|P2|Overall Study|Adverse Event|1
3048781|NCT00610714|10480752|P1|Overall Study|Adverse Event|3
3048782|NCT00610675|10480790|P1|Overall Study|Other reason (not specified)|25
3048783|NCT00610675|10480790|P1|Overall Study|Lost to Follow-up|31
3048784|NCT00610675|10480790|P1|Overall Study|Lack of Compliance|7
3048785|NCT00610675|10480790|P1|Overall Study|Reasons unrelated to trial|27
3048786|NCT00610675|10480790|P1|Overall Study|Withdrawal by Subject|28
3048787|NCT00610675|10480790|P1|Overall Study|Insufficient Effect|31
3048788|NCT00610675|10480790|P1|Overall Study|Adverse Event|67
3048789|NCT00610675|10480790|P1|Overall Study|Untreated|4
3048790|NCT00610649|10480812|P11|Overall Study|Withdrawal by Subject|0
3048791|NCT00610649|10480813|P10|Overall Study|Withdrawal by Subject|1
3048792|NCT00610649|10480814|P9|Overall Study|Withdrawal by Subject|0
3048793|NCT00610649|10480815|P8|Overall Study|Withdrawal by Subject|0
3048794|NCT00610649|10480816|P7|Overall Study|Withdrawal by Subject|0
3048795|NCT00610649|10480817|P6|Overall Study|Withdrawal by Subject|0
3048796|NCT00610649|10480818|P5|Overall Study|Withdrawal by Subject|0
3048797|NCT00610649|10480819|P4|Overall Study|Withdrawal by Subject|0
3048798|NCT00610649|10480820|P3|Overall Study|Withdrawal by Subject|0
3048799|NCT00610649|10480821|P2|Overall Study|Withdrawal by Subject|0
3048800|NCT00610649|10480822|P1|Overall Study|Withdrawal by Subject|0
3048801|NCT00610649|10480812|P11|Overall Study|Family Emergency|0
3048802|NCT00610649|10480813|P10|Overall Study|Family Emergency|0
3048803|NCT00610649|10480814|P9|Overall Study|Family Emergency|0
3048804|NCT00610649|10480815|P8|Overall Study|Family Emergency|0
3048805|NCT00610649|10480816|P7|Overall Study|Family Emergency|0
3048806|NCT00610649|10480817|P6|Overall Study|Family Emergency|0
3048807|NCT00610649|10480818|P5|Overall Study|Family Emergency|0
3048808|NCT00610649|10480819|P4|Overall Study|Family Emergency|0
3048809|NCT00610649|10480820|P3|Overall Study|Family Emergency|0
3048810|NCT00610649|10480821|P2|Overall Study|Family Emergency|1
3048811|NCT00610649|10480822|P1|Overall Study|Family Emergency|0
3048812|NCT00610649|10480812|P11|Overall Study|Adverse Event|1
3048813|NCT00610649|10480813|P10|Overall Study|Adverse Event|0
3048814|NCT00610649|10480814|P9|Overall Study|Adverse Event|0
3048815|NCT00610649|10480815|P8|Overall Study|Adverse Event|0
3048816|NCT00610649|10480816|P7|Overall Study|Adverse Event|0
3048817|NCT00610649|10480817|P6|Overall Study|Adverse Event|0
3048818|NCT00610649|10480818|P5|Overall Study|Adverse Event|0
3048819|NCT00610649|10480819|P4|Overall Study|Adverse Event|0
3048820|NCT00610649|10480820|P3|Overall Study|Adverse Event|0
3048821|NCT00610649|10480821|P2|Overall Study|Adverse Event|0
3048822|NCT00610649|10480822|P1|Overall Study|Adverse Event|1
3048823|NCT00610441|10480908|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
3048824|NCT00610441|10480909|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
3048825|NCT00610441|10480910|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
3048826|NCT00610441|10480911|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
3048827|NCT00610441|10480908|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
3048828|NCT00610441|10480909|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
3048829|NCT00610441|10480910|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
3048830|NCT00610441|10480911|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
3048831|NCT00610441|10480908|P4|Treatment Period 2 - 3 Weeks|Other|1
3048832|NCT00610441|10480909|P3|Treatment Period 2 - 3 Weeks|Other|0
3048833|NCT00610441|10480910|P2|Treatment Period 2 - 3 Weeks|Other|1
3048834|NCT00610441|10480911|P1|Treatment Period 2 - 3 Weeks|Other|1
3048835|NCT00610441|10480908|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
3048836|NCT00610441|10480909|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
3048837|NCT00610441|10480910|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
3048838|NCT00610441|10480911|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
3048839|NCT00610441|10480908|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
3048840|NCT00610441|10480909|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
3048841|NCT00610441|10480910|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
3048842|NCT00610441|10480911|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
3048843|NCT00610441|10480908|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
3048844|NCT00610441|10480909|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
3048845|NCT00610441|10480910|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
3048846|NCT00610441|10480911|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
3048847|NCT00610441|10480908|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
3048848|NCT00610441|10480909|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
3048849|NCT00610441|10480910|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
3048850|NCT00610441|10480911|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
3048851|NCT00610441|10480908|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
3048852|NCT00610441|10480909|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
3048853|NCT00610441|10480910|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
3048854|NCT00610441|10480911|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
3048855|NCT00610441|10480908|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
3048856|NCT00610441|10480909|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
3048857|NCT00610441|10480910|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
3048858|NCT00610441|10480911|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
3048859|NCT00610363|10481020|P2|Overall Study|Other than specified above|1
3048860|NCT00610363|10481021|P1|Overall Study|Other than specified above|1
3048861|NCT00610363|10481020|P2|Overall Study|Withdrawal by Subject|0
3048862|NCT00610363|10481021|P1|Overall Study|Withdrawal by Subject|1
3048863|NCT00610363|10481020|P2|Overall Study|Lost to Follow-up|0
3048864|NCT00610363|10481021|P1|Overall Study|Lost to Follow-up|4
3048865|NCT00610363|10481020|P2|Overall Study|Lack of Efficacy|0
3048866|NCT00610363|10481021|P1|Overall Study|Lack of Efficacy|2
3048867|NCT00610363|10481020|P2|Overall Study|Adverse Event|1
3048868|NCT00610363|10481021|P1|Overall Study|Adverse Event|3
3048869|NCT00610363|10481020|P2|Overall Study|Non-compliance with protocol|1
3048870|NCT00610363|10481021|P1|Overall Study|Non-compliance with protocol|0
3048871|NCT00610207|10481046|P1|Overall Study|Lost to Follow-up|3
3048872|NCT00610168|10481053|P2|Overall Study|Withdrawal by Subject|0
3048873|NCT00610168|10481054|P1|Overall Study|Withdrawal by Subject|2
3048874|NCT00610155|10481073|P6|Period 3|Adverse Event|0
3048875|NCT00610155|10481074|P5|Period 3|Adverse Event|0
3048876|NCT00610155|10481075|P4|Period 3|Adverse Event|0
3048877|NCT00610155|10481076|P3|Period 3|Adverse Event|0
3048878|NCT00610155|10481077|P2|Period 3|Adverse Event|0
3048879|NCT00610155|10481078|P1|Period 3|Adverse Event|1
3048880|NCT00610155|10481073|P6|Period 1|Withdrawal by Subject|0
3048881|NCT00610155|10481074|P5|Period 1|Withdrawal by Subject|0
3048882|NCT00610155|10481075|P4|Period 1|Withdrawal by Subject|0
3048883|NCT00610155|10481076|P3|Period 1|Withdrawal by Subject|1
3048884|NCT00610155|10481077|P2|Period 1|Withdrawal by Subject|0
3048885|NCT00610155|10481078|P1|Period 1|Withdrawal by Subject|0
3048886|NCT00610129|10481125|P1|Overall Study|Not treated since patients ineligible|3
3048887|NCT00609986|10481131|P2|Overall Study|Did not receive transplant or treatment|3
3048888|NCT00609986|10481132|P1|Overall Study|Did not receive transplant or treatment|8
3048889|NCT00609973|10481146|P2|Overall Study|Withdrawal by Subject|1
3048890|NCT00609973|10481147|P1|Overall Study|Withdrawal by Subject|0
3048891|NCT00609973|10481146|P2|Overall Study|Lost to Follow-up|1
3048892|NCT00609973|10481147|P1|Overall Study|Lost to Follow-up|2
3048893|NCT00609973|10481146|P2|Overall Study|Protocol Violation|3
3048894|NCT00609973|10481147|P1|Overall Study|Protocol Violation|4
3048895|NCT00609973|10481146|P2|Overall Study|Adverse Event|1
3048896|NCT00609973|10481147|P1|Overall Study|Adverse Event|2
3048897|NCT00609947|10481155|P1|Overall Study|Death|1
3048898|NCT00609869|10481160|P1|Overall Study|Mantle cell: not evaluable|4
3048899|NCT00609869|10481160|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
3048900|NCT00609869|10481160|P1|Overall Study|Hepatitis B infection|1
3048901|NCT00609869|10481160|P1|Overall Study|Severe tumor flare reaction|1
3048902|NCT00609869|10481160|P1|Overall Study|Seizures|1
3048903|NCT00609869|10481160|P1|Overall Study|Withdrawal by Subject|1
3048904|NCT00609869|10481160|P1|Overall Study|Severe hematologic toxicity|1
3048905|NCT00609869|10481160|P1|Overall Study|Withdrawn, ischemic stroke|1
3048906|NCT00609765|10481179|P1|Overall Study|Study ended prior to 12 months|1
3048907|NCT00609674|10481193|P2|Overall Study|Withdrew consent|1
3048908|NCT00609674|10481194|P1|Overall Study|Withdrew consent|2
3048909|NCT00609674|10481193|P2|Overall Study|Lost to Follow-up|0
3048910|NCT00609674|10481194|P1|Overall Study|Lost to Follow-up|1
3048911|NCT00609674|10481193|P2|Overall Study|Protocol Violation|5
3048912|NCT00609674|10481194|P1|Overall Study|Protocol Violation|3
3048913|NCT00609674|10481193|P2|Overall Study|Adverse Event|1
3048914|NCT00609674|10481194|P1|Overall Study|Adverse Event|1
3048915|NCT00609622|10481230|P2|Overall Study|Global deterioration of health status|2
3048916|NCT00609622|10481231|P1|Overall Study|Global deterioration of health status|6
3048917|NCT00609622|10481230|P2|Overall Study|Other|14
3048918|NCT00609622|10481231|P1|Overall Study|Other|7
3048919|NCT00609622|10481230|P2|Overall Study|Study terminated by sponsor|3
3048920|NCT00609622|10481231|P1|Overall Study|Study terminated by sponsor|16
3048921|NCT00609622|10481230|P2|Overall Study|Objective progression or relapse|41
3048922|NCT00609622|10481231|P1|Overall Study|Objective progression or relapse|47
3048923|NCT00609622|10481230|P2|Overall Study|Protocol Violation|1
3048924|NCT00609622|10481231|P1|Overall Study|Protocol Violation|1
3048925|NCT00609622|10481230|P2|Overall Study|Death|4
3048926|NCT00609622|10481231|P1|Overall Study|Death|1
3048927|NCT00609622|10481230|P2|Overall Study|Withdrawal by Subject|20
3048928|NCT00609622|10481231|P1|Overall Study|Withdrawal by Subject|4
3048929|NCT00609622|10481230|P2|Overall Study|Adverse Event|10
3048930|NCT00609622|10481231|P1|Overall Study|Adverse Event|14
3048931|NCT00609609|10481253|P2|Overall Study|Progression|2
3048932|NCT00609609|10481254|P1|Overall Study|Progression|4
3048933|NCT00609609|10481253|P2|Overall Study|Withdrawal by Subject|0
3048934|NCT00609609|10481254|P1|Overall Study|Withdrawal by Subject|2
3048935|NCT00609518|10481266|P2|Overall Study|Death from Adverse Event|2
3048936|NCT00609518|10481267|P1|Overall Study|Death from Adverse Event|2
3048937|NCT00609518|10481266|P2|Overall Study|Physician Decision|3
3048938|NCT00609518|10481267|P1|Overall Study|Physician Decision|1
3048939|NCT00609518|10481266|P2|Overall Study|Lost to Follow-up|0
3048940|NCT00609518|10481267|P1|Overall Study|Lost to Follow-up|3
3048941|NCT00609518|10481266|P2|Overall Study|Withdrawal by Subject|3
3048942|NCT00609518|10481267|P1|Overall Study|Withdrawal by Subject|5
3048943|NCT00609518|10481266|P2|Overall Study|Death from Study Disease|32
3048944|NCT00609518|10481267|P1|Overall Study|Death from Study Disease|32
3048945|NCT00609492|10481282|P3|Overall Study|Lost to Follow-up|4
3048946|NCT00609492|10481283|P2|Overall Study|Lost to Follow-up|1
3048947|NCT00609492|10481284|P1|Overall Study|Lost to Follow-up|1
3048948|NCT00609492|10481282|P3|Overall Study|Withdrawal by Subject|3
3048949|NCT00609492|10481283|P2|Overall Study|Withdrawal by Subject|2
3048950|NCT00609492|10481284|P1|Overall Study|Withdrawal by Subject|0
3048951|NCT00609466|10481369|P3|Overall Study|Lack of Efficacy|2
3048952|NCT00609466|10481370|P2|Overall Study|Lack of Efficacy|2
3048953|NCT00609466|10481371|P1|Overall Study|Lack of Efficacy|0
3048954|NCT00609466|10481369|P3|Overall Study|Adverse Event|1
3048955|NCT00609466|10481370|P2|Overall Study|Adverse Event|3
3048956|NCT00609466|10481371|P1|Overall Study|Adverse Event|2
3048957|NCT00609466|10481369|P3|Overall Study|Withdrawal by Subject|1
3048958|NCT00609466|10481370|P2|Overall Study|Withdrawal by Subject|1
3048959|NCT00609466|10481371|P1|Overall Study|Withdrawal by Subject|0
3048960|NCT00609362|10481399|P2|Overall Study|Adverse Event|0
3048961|NCT00609362|10481400|P1|Overall Study|Adverse Event|1
3048962|NCT00609362|10481399|P2|Overall Study|Withdrawal by Subject|1
3048963|NCT00609362|10481400|P1|Overall Study|Withdrawal by Subject|2
3048964|NCT00609336|10481410|P1|Overall Study|LA or Met at Surgery|9
3048965|NCT00609336|10481410|P1|Overall Study|Death|1
3048966|NCT00609336|10481410|P1|Overall Study|Protocol Violation|3
3048967|NCT00609245|10481461|P1|Overall Study|Adverse Event|1
3048968|NCT00609167|10481469|P2|Overall Study|Stem Cell Transplant|6
3048969|NCT00609167|10481470|P1|Overall Study|Stem Cell Transplant|0
3048970|NCT00609167|10481469|P2|Overall Study|Disease Progression|0
3048971|NCT00609167|10481470|P1|Overall Study|Disease Progression|1
3048972|NCT00609167|10481469|P2|Overall Study|Adverse Event|1
3048973|NCT00609167|10481470|P1|Overall Study|Adverse Event|5
3048974|NCT00609167|10481469|P2|Overall Study|Lack of Efficacy|0
3048975|NCT00609167|10481470|P1|Overall Study|Lack of Efficacy|1
3048976|NCT00609167|10481469|P2|Overall Study|Withdrawal by Subject|0
3048977|NCT00609167|10481470|P1|Overall Study|Withdrawal by Subject|1
3048978|NCT00608985|10481501|P4|Overall Study|Lost to Follow-up|0
3048979|NCT00608985|10481502|P3|Overall Study|Lost to Follow-up|0
3048980|NCT00608985|10481503|P2|Overall Study|Lost to Follow-up|1
3048981|NCT00608985|10481504|P1|Overall Study|Lost to Follow-up|2
3048982|NCT00608985|10481501|P4|Overall Study|Withdrawal of Consent|1
3048983|NCT00608985|10481502|P3|Overall Study|Withdrawal of Consent|1
3048984|NCT00608985|10481503|P2|Overall Study|Withdrawal of Consent|1
3048985|NCT00608985|10481504|P1|Overall Study|Withdrawal of Consent|5
3048986|NCT00608985|10481501|P4|Overall Study|Administrative/Other|2
3048987|NCT00608985|10481502|P3|Overall Study|Administrative/Other|1
3048988|NCT00608985|10481503|P2|Overall Study|Administrative/Other|4
3048989|NCT00608985|10481504|P1|Overall Study|Administrative/Other|7
3048990|NCT00608985|10481501|P4|Overall Study|Adverse Event|6
3048991|NCT00608985|10481502|P3|Overall Study|Adverse Event|4
3048992|NCT00608985|10481503|P2|Overall Study|Adverse Event|7
3048993|NCT00608985|10481504|P1|Overall Study|Adverse Event|2
3048994|NCT00608959|10481536|P1|Part 1|Did not meet eligibility criteria|1
3048995|NCT00608907|10481549|P3|Overall Study|Progressive Disease|0
3048996|NCT00608907|10481550|P2|Overall Study|Progressive Disease|0
3048997|NCT00608907|10481551|P1|Overall Study|Progressive Disease|1
3048998|NCT00608907|10481549|P3|Overall Study|Withdrawal by Subject|0
3048999|NCT00608907|10481550|P2|Overall Study|Withdrawal by Subject|0
3049000|NCT00608907|10481551|P1|Overall Study|Withdrawal by Subject|4
3049001|NCT00608907|10481549|P3|Overall Study|Death|0
3049002|NCT00608907|10481550|P2|Overall Study|Death|0
3049003|NCT00608907|10481551|P1|Overall Study|Death|1
3049004|NCT00608907|10481549|P3|Overall Study|Adverse Event|1
3049005|NCT00608907|10481550|P2|Overall Study|Adverse Event|0
3049006|NCT00608907|10481551|P1|Overall Study|Adverse Event|6
3049007|NCT00608894|10481561|P2|Overall Study|Withdrawal by Subject|2
3049008|NCT00608894|10481562|P1|Overall Study|Withdrawal by Subject|0
3049009|NCT00608881|10481574|P2|Overall Study|Institutionalized|2
3049010|NCT00608881|10481575|P1|Overall Study|Institutionalized|1
3049011|NCT00608881|10481574|P2|Overall Study|Physician Decision|5
3049012|NCT00608881|10481575|P1|Overall Study|Physician Decision|5
3049013|NCT00608881|10481574|P2|Overall Study|Withdrawal by Subject|29
3049014|NCT00608881|10481575|P1|Overall Study|Withdrawal by Subject|18
3049015|NCT00608881|10481574|P2|Overall Study|Lost to Follow-up|14
3049016|NCT00608881|10481575|P1|Overall Study|Lost to Follow-up|28
3049017|NCT00608881|10481574|P2|Overall Study|Adverse Event|3
3049018|NCT00608881|10481575|P1|Overall Study|Adverse Event|5
3049019|NCT00608881|10481574|P2|Overall Study|Death|13
3049020|NCT00608881|10481575|P1|Overall Study|Death|22
3049021|NCT00608868|10481609|P1|Overall Study|Physician Decision|2
3049022|NCT00608868|10481609|P1|Overall Study|Adverse Event|1
3049023|NCT00608868|10481609|P1|Overall Study|Lost to Follow-up|2
3049024|NCT00608868|10481609|P1|Overall Study|Protocol Violation|3
3049025|NCT00608868|10481609|P1|Overall Study|Withdrawal by Subject|7
3049026|NCT00608842|10481620|P4|Overall Study|Lost to Follow-up|0
3049027|NCT00608842|10481621|P3|Overall Study|Lost to Follow-up|0
3049028|NCT00608842|10481622|P2|Overall Study|Lost to Follow-up|0
3049029|NCT00608842|10481623|P1|Overall Study|Lost to Follow-up|1
3049030|NCT00608842|10481620|P4|Overall Study|Participant's Request|1
3049031|NCT00608842|10481621|P3|Overall Study|Participant's Request|2
3049032|NCT00608842|10481622|P2|Overall Study|Participant's Request|1
3049033|NCT00608842|10481623|P1|Overall Study|Participant's Request|0
3049034|NCT00608829|10481657|P1|Overall Study|Subject refuses to follow up or return.|5
3049035|NCT00608829|10481657|P1|Overall Study|Withdrawal by Subject|4
3049036|NCT00608829|10481657|P1|Overall Study|Death|6
3049037|NCT00608582|10481683|P2|Overall Study|Early stage Design Change|3
3049038|NCT00608582|10481684|P1|Overall Study|Early stage Design Change|0
3049039|NCT00608582|10481683|P2|Overall Study|Illicit Drug Use|0
3049040|NCT00608582|10481684|P1|Overall Study|Illicit Drug Use|1
3049041|NCT00608582|10481683|P2|Overall Study|No Best Response in Phase 1 located|1
3049042|NCT00608582|10481684|P1|Overall Study|No Best Response in Phase 1 located|1
3049043|NCT00608582|10481683|P2|Overall Study|Lost to Follow-up|0
3049044|NCT00608582|10481684|P1|Overall Study|Lost to Follow-up|2
3049045|NCT00608569|10481694|P2|Overall Study|Unable to adhere with study requirements|1
3049046|NCT00608569|10481695|P1|Overall Study|Unable to adhere with study requirements|0
3049047|NCT00608569|10481694|P2|Overall Study|Adverse Event|0
3049048|NCT00608569|10481695|P1|Overall Study|Adverse Event|1
3049049|NCT00608569|10481694|P2|Overall Study|Withdrawal by Subject|0
3049050|NCT00608569|10481695|P1|Overall Study|Withdrawal by Subject|1
3049051|NCT00608569|10481694|P2|Overall Study|Lost to Follow-up|5
3049052|NCT00608569|10481695|P1|Overall Study|Lost to Follow-up|4
3049053|NCT00608569|10481694|P2|Overall Study|Death|3
3049054|NCT00608569|10481695|P1|Overall Study|Death|4
3049055|NCT00608543|10481715|P1|Overall Study|Adverse Event|4
3049056|NCT00608530|10481728|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
3049057|NCT00608530|10481729|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
3049058|NCT00608530|10481730|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
3049059|NCT00608530|10481731|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
3049060|NCT00608530|10481728|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
3049061|NCT00608530|10481729|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
3049062|NCT00608530|10481730|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
3049063|NCT00608530|10481731|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
3049064|NCT00608530|10481728|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
3049065|NCT00608530|10481729|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
3049066|NCT00608530|10481730|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
3049067|NCT00608530|10481731|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
3049068|NCT00608530|10481728|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
3049069|NCT00608530|10481729|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
3049070|NCT00608530|10481730|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
3049071|NCT00608530|10481731|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
3049072|NCT00608530|10481728|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
3049073|NCT00608530|10481729|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
3049074|NCT00608530|10481730|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
3049075|NCT00608530|10481731|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
3049076|NCT00608530|10481728|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
3049077|NCT00608530|10481729|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
3049078|NCT00608530|10481730|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
3049079|NCT00608530|10481731|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
3049080|NCT00608517|10481752|P3|Overall Study|Death|0
3049081|NCT00608517|10481753|P2|Overall Study|Death|0
3049082|NCT00608517|10481754|P1|Overall Study|Death|1
3049083|NCT00608426|10481934|P2|Overall Study|refused, health issues, wrong address|348
3049084|NCT00608426|10481935|P1|Overall Study|refused, health issues, wrong address|319
3049085|NCT00608426|10481934|P2|Overall Study|Lost to Follow-up|521
3049086|NCT00608426|10481935|P1|Overall Study|Lost to Follow-up|485
3049087|NCT00608426|10481934|P2|Overall Study|Death|36
3049088|NCT00608426|10481935|P1|Overall Study|Death|32
3049089|NCT00608322|10481947|P2|Overall Study|Death|1
3049090|NCT00608322|10481948|P1|Overall Study|Death|2
3049091|NCT00608244|10481954|P1|Overall Study|Low trough levels|1
3049092|NCT00608244|10481954|P1|Overall Study|Adverse Event|1
3049093|NCT00608205|10481965|P2|Overall Study|Patient non-compliant|1
3049094|NCT00608205|10481966|P1|Overall Study|Patient non-compliant|0
3049095|NCT00608205|10481965|P2|Overall Study|Adverse Event|2
3049096|NCT00608205|10481966|P1|Overall Study|Adverse Event|3
3049097|NCT00608023|10482083|P3|Overall Study|Unknown reason|0
3049098|NCT00608023|10482084|P2|Overall Study|Unknown reason|3
3049099|NCT00608023|10482085|P1|Overall Study|Unknown reason|0
3049100|NCT00608023|10482083|P3|Overall Study|Protocol Violation|1
3049101|NCT00608023|10482084|P2|Overall Study|Protocol Violation|3
3049102|NCT00608023|10482085|P1|Overall Study|Protocol Violation|1
3049103|NCT00608023|10482083|P3|Overall Study|Lost to Follow-up|1
3049104|NCT00608023|10482084|P2|Overall Study|Lost to Follow-up|2
3049105|NCT00608023|10482085|P1|Overall Study|Lost to Follow-up|2
3049106|NCT00608023|10482083|P3|Overall Study|Adverse Event|5
3049107|NCT00608023|10482084|P2|Overall Study|Adverse Event|4
3049108|NCT00608023|10482085|P1|Overall Study|Adverse Event|1
3049109|NCT00608023|10482083|P3|Overall Study|Withdrawal by Subject|7
3049110|NCT00608023|10482084|P2|Overall Study|Withdrawal by Subject|10
3049111|NCT00608023|10482085|P1|Overall Study|Withdrawal by Subject|8
3049112|NCT00607997|10482109|P4|Overall Study|Other without explanation|1
3049113|NCT00607997|10482110|P3|Overall Study|Other without explanation|4
3049114|NCT00607997|10482111|P2|Overall Study|Other without explanation|0
3049115|NCT00607997|10482112|P1|Overall Study|Other without explanation|2
3049116|NCT00607997|10482109|P4|Overall Study|Relapse, recurrent illness|0
3049117|NCT00607997|10482110|P3|Overall Study|Relapse, recurrent illness|2
3049118|NCT00607997|10482111|P2|Overall Study|Relapse, recurrent illness|0
3049119|NCT00607997|10482112|P1|Overall Study|Relapse, recurrent illness|4
3049120|NCT00607997|10482109|P4|Overall Study|Physician Decision|0
3049121|NCT00607997|10482110|P3|Overall Study|Physician Decision|0
3049122|NCT00607997|10482111|P2|Overall Study|Physician Decision|1
3049123|NCT00607997|10482112|P1|Overall Study|Physician Decision|4
3049124|NCT00607997|10482109|P4|Overall Study|Adverse Event|0
3049125|NCT00607997|10482110|P3|Overall Study|Adverse Event|2
3049126|NCT00607997|10482111|P2|Overall Study|Adverse Event|1
3049127|NCT00607997|10482112|P1|Overall Study|Adverse Event|3
3049128|NCT00607997|10482109|P4|Overall Study|Death|5
3049129|NCT00607997|10482110|P3|Overall Study|Death|2
3049130|NCT00607997|10482111|P2|Overall Study|Death|5
3049131|NCT00607997|10482112|P1|Overall Study|Death|8
3049132|NCT00607997|10482109|P4|Overall Study|Lack of Efficacy|10
3049133|NCT00607997|10482110|P3|Overall Study|Lack of Efficacy|14
3049134|NCT00607997|10482111|P2|Overall Study|Lack of Efficacy|20
3049135|NCT00607997|10482112|P1|Overall Study|Lack of Efficacy|6
3049136|NCT00607919|10482170|P2|Open-Label Phase|Parent/Caregiver Decision|2
3049137|NCT00607919|10482171|P1|Open-Label Phase|Parent/Caregiver Decision|1
3049138|NCT00607919|10482170|P2|Open-Label Phase|Withdrawal by Subject|2
3049139|NCT00607919|10482171|P1|Open-Label Phase|Withdrawal by Subject|2
3049140|NCT00607919|10482170|P2|Open-Label Phase|Protocol Violation|2
3049141|NCT00607919|10482171|P1|Open-Label Phase|Protocol Violation|2
3049142|NCT00607919|10482170|P2|Open-Label Phase|Lost to Follow-up|1
3049143|NCT00607919|10482171|P1|Open-Label Phase|Lost to Follow-up|4
3049144|NCT00607919|10482170|P2|Open-Label Phase|Adverse Event|5
3049145|NCT00607919|10482171|P1|Open-Label Phase|Adverse Event|1
3049146|NCT00607919|10482170|P2|Acute Phase|Withdrawal by Subject|3
3049147|NCT00607919|10482171|P1|Acute Phase|Withdrawal by Subject|3
3049148|NCT00607919|10482170|P2|Acute Phase|Protocol Violation|1
3049149|NCT00607919|10482171|P1|Acute Phase|Protocol Violation|5
3049150|NCT00607919|10482170|P2|Acute Phase|Parent/Caregiver Decision|4
3049151|NCT00607919|10482171|P1|Acute Phase|Parent/Caregiver Decision|6
3049152|NCT00607919|10482170|P2|Acute Phase|Lost to Follow-up|3
3049153|NCT00607919|10482171|P1|Acute Phase|Lost to Follow-up|9
3049154|NCT00607919|10482170|P2|Acute Phase|Lack of Efficacy|2
3049155|NCT00607919|10482171|P1|Acute Phase|Lack of Efficacy|1
3049156|NCT00607919|10482170|P2|Acute Phase|Entry Criteria Not Met|1
3049157|NCT00607919|10482171|P1|Acute Phase|Entry Criteria Not Met|1
3049158|NCT00607919|10482170|P2|Acute Phase|Adverse Event|2
3049159|NCT00607919|10482171|P1|Acute Phase|Adverse Event|9
3049160|NCT00607893|10482229|P2|Overall Study|Withdrew due to hypertensive urgency|1
3049161|NCT00607893|10482230|P1|Overall Study|Withdrew due to hypertensive urgency|1
3049162|NCT00607893|10482229|P2|Overall Study|Declined to be treated|0
3049163|NCT00607893|10482230|P1|Overall Study|Declined to be treated|1
3049164|NCT00607893|10482229|P2|Overall Study|withdrew could not tolerate CPAP|1
3049165|NCT00607893|10482230|P1|Overall Study|withdrew could not tolerate CPAP|0
3049166|NCT00607893|10482229|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
3049167|NCT00607893|10482230|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
3049168|NCT00607893|10482229|P2|Overall Study|withdrew due to loss of interest|1
3049169|NCT00607893|10482230|P1|Overall Study|withdrew due to loss of interest|0
3049170|NCT00607893|10482229|P2|Overall Study|Lost to Follow-up|0
3049171|NCT00607893|10482230|P1|Overall Study|Lost to Follow-up|4
3049172|NCT00607880|10482258|P2|Overall Study|Unable to place port due to occlusion|0
3049173|NCT00607880|10482259|P1|Overall Study|Unable to place port due to occlusion|1
3049174|NCT00607789|10482309|P2|Overall Study|Withdrawal by Subject|0
3049175|NCT00607789|10482310|P1|Overall Study|Withdrawal by Subject|1
3049176|NCT00607789|10482309|P2|Overall Study|Lost to Follow-up|5
3049177|NCT00607789|10482310|P1|Overall Study|Lost to Follow-up|0
3049178|NCT00607789|10482309|P2|Overall Study|Inadequate adherence|0
3049179|NCT00607789|10482310|P1|Overall Study|Inadequate adherence|3
3049180|NCT00607789|10482309|P2|Overall Study|Lack of Efficacy|1
3049181|NCT00607789|10482310|P1|Overall Study|Lack of Efficacy|0
3049182|NCT00607789|10482309|P2|Overall Study|Adverse Event|0
3049183|NCT00607789|10482310|P1|Overall Study|Adverse Event|3
3049184|NCT00607724|10482325|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049185|NCT00607724|10482326|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049186|NCT00607724|10482327|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049187|NCT00607724|10482328|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
3049188|NCT00607724|10482329|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049189|NCT00607724|10482330|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049190|NCT00607724|10482331|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
3049191|NCT00607724|10482325|P7|Stage 2: Expanded Cohort|Physician Decision|0
3049192|NCT00607724|10482326|P6|Stage 2: Expanded Cohort|Physician Decision|1
3049193|NCT00607724|10482327|P5|Stage 2: Expanded Cohort|Physician Decision|1
3049194|NCT00607724|10482328|P4|Stage 2: Expanded Cohort|Physician Decision|0
3049195|NCT00607724|10482329|P3|Stage 2: Expanded Cohort|Physician Decision|0
3049196|NCT00607724|10482330|P2|Stage 2: Expanded Cohort|Physician Decision|0
3049197|NCT00607724|10482331|P1|Stage 2: Expanded Cohort|Physician Decision|0
3049198|NCT00607724|10482325|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
3049199|NCT00607724|10482326|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
3049200|NCT00607724|10482327|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
3049201|NCT00607724|10482328|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
3049202|NCT00607724|10482329|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
3049203|NCT00607724|10482330|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
3049204|NCT00607724|10482331|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
3049205|NCT00607724|10482325|P7|Stage 2: Expanded Cohort|Adverse Event|1
3049206|NCT00607724|10482326|P6|Stage 2: Expanded Cohort|Adverse Event|0
3049207|NCT00607724|10482327|P5|Stage 2: Expanded Cohort|Adverse Event|0
3049208|NCT00607724|10482328|P4|Stage 2: Expanded Cohort|Adverse Event|0
3049209|NCT00607724|10482329|P3|Stage 2: Expanded Cohort|Adverse Event|0
3049210|NCT00607724|10482330|P2|Stage 2: Expanded Cohort|Adverse Event|0
3049211|NCT00607724|10482331|P1|Stage 2: Expanded Cohort|Adverse Event|0
3049212|NCT00607724|10482325|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
3049213|NCT00607724|10482326|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
3049214|NCT00607724|10482327|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
3049215|NCT00607724|10482328|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
3049216|NCT00607724|10482329|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
3049217|NCT00607724|10482330|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
3049218|NCT00607724|10482331|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
3049219|NCT00607386|10482494|P1|Overall Study|Physician Decision|1
3049220|NCT00607373|10482509|P2|Follow-up Period|Withdrawal by Subject|3
3049221|NCT00607373|10482510|P1|Follow-up Period|Withdrawal by Subject|1
3049222|NCT00607373|10482509|P2|Follow-up Period|Protocol Violation|1
3049223|NCT00607373|10482510|P1|Follow-up Period|Protocol Violation|0
3049224|NCT00607373|10482509|P2|Follow-up Period|Other|1
3049225|NCT00607373|10482510|P1|Follow-up Period|Other|0
3049226|NCT00607373|10482509|P2|Treatment Period|Withdrawal by Subject|1
3049227|NCT00607373|10482510|P1|Treatment Period|Withdrawal by Subject|0
3049228|NCT00607373|10482509|P2|Treatment Period|Physician Decision|1
3049229|NCT00607373|10482510|P1|Treatment Period|Physician Decision|0
3049230|NCT00607373|10482509|P2|Treatment Period|Adverse Event|4
3049231|NCT00607373|10482510|P1|Treatment Period|Adverse Event|0
3049232|NCT00607087|10482612|P3|Period 3|Adverse Event|0
3049233|NCT00607087|10482613|P2|Period 3|Adverse Event|1
3049234|NCT00607087|10482614|P1|Period 3|Adverse Event|0
3049235|NCT00607087|10482612|P3|Period 3|Withdrawal by Subject|0
3049236|NCT00607087|10482613|P2|Period 3|Withdrawal by Subject|1
3049237|NCT00607087|10482614|P1|Period 3|Withdrawal by Subject|2
3049238|NCT00607087|10482612|P3|Period 2|Poor compliance to protocol|1
3049239|NCT00607087|10482613|P2|Period 2|Poor compliance to protocol|0
3049240|NCT00607087|10482614|P1|Period 2|Poor compliance to protocol|0
3049241|NCT00607087|10482612|P3|Period 2|Adverse Event|3
3049242|NCT00607087|10482613|P2|Period 2|Adverse Event|1
3049243|NCT00607087|10482614|P1|Period 2|Adverse Event|0
3049244|NCT00607087|10482612|P3|Period 2|Other reason|0
3049245|NCT00607087|10482613|P2|Period 2|Other reason|1
3049246|NCT00607087|10482614|P1|Period 2|Other reason|1
3049247|NCT00607087|10482612|P3|Period 2|Withdrawal by Subject|1
3049248|NCT00607087|10482613|P2|Period 2|Withdrawal by Subject|1
3049249|NCT00607087|10482614|P1|Period 2|Withdrawal by Subject|0
3049250|NCT00607087|10482612|P3|Period 1|Other reason|2
3049251|NCT00607087|10482613|P2|Period 1|Other reason|4
3049252|NCT00607087|10482614|P1|Period 1|Other reason|0
3049253|NCT00607087|10482612|P3|Period 1|Lost to Follow-up|0
3049254|NCT00607087|10482613|P2|Period 1|Lost to Follow-up|0
3049255|NCT00607087|10482614|P1|Period 1|Lost to Follow-up|1
3049256|NCT00607087|10482612|P3|Period 1|Poor compliance to protocol|0
3049257|NCT00607087|10482613|P2|Period 1|Poor compliance to protocol|0
3049258|NCT00607087|10482614|P1|Period 1|Poor compliance to protocol|1
3049259|NCT00607087|10482612|P3|Period 1|Adverse Event|0
3049260|NCT00607087|10482613|P2|Period 1|Adverse Event|0
3049261|NCT00607087|10482614|P1|Period 1|Adverse Event|3
3049262|NCT00607087|10482612|P3|Period 1|Withdrawal by Subject|3
3049263|NCT00607087|10482613|P2|Period 1|Withdrawal by Subject|2
3049264|NCT00607087|10482614|P1|Period 1|Withdrawal by Subject|7
3049265|NCT00607087|10482612|P3|Overall Study|Lost to Follow-up|0
3049266|NCT00607087|10482613|P2|Overall Study|Lost to Follow-up|0
3049267|NCT00607087|10482614|P1|Overall Study|Lost to Follow-up|1
3049268|NCT00607087|10482612|P3|Overall Study|Poor compliance to protocol|1
3049269|NCT00607087|10482613|P2|Overall Study|Poor compliance to protocol|0
3049270|NCT00607087|10482614|P1|Overall Study|Poor compliance to protocol|1
3049271|NCT00607087|10482612|P3|Overall Study|Other reason|2
3049272|NCT00607087|10482613|P2|Overall Study|Other reason|5
3049273|NCT00607087|10482614|P1|Overall Study|Other reason|1
3049274|NCT00607087|10482612|P3|Overall Study|Adverse Event|3
3049275|NCT00607087|10482613|P2|Overall Study|Adverse Event|2
3049276|NCT00607087|10482614|P1|Overall Study|Adverse Event|3
3049277|NCT00607087|10482612|P3|Overall Study|Withdrawal by Subject|4
3049278|NCT00607087|10482613|P2|Overall Study|Withdrawal by Subject|4
3049279|NCT00607087|10482614|P1|Overall Study|Withdrawal by Subject|9
3049280|NCT00607048|10482672|P6|Overall Study|Other|1
3049281|NCT00607048|10482673|P5|Overall Study|Other|0
3049282|NCT00607048|10482674|P4|Overall Study|Other|0
3049283|NCT00607048|10482675|P3|Overall Study|Other|0
3049284|NCT00607048|10482676|P2|Overall Study|Other|1
3049285|NCT00607048|10482677|P1|Overall Study|Other|1
3049286|NCT00607048|10482672|P6|Overall Study|Withdrawal by Subject|2
3049287|NCT00607048|10482673|P5|Overall Study|Withdrawal by Subject|0
3049288|NCT00607048|10482674|P4|Overall Study|Withdrawal by Subject|1
3049289|NCT00607048|10482675|P3|Overall Study|Withdrawal by Subject|0
3049290|NCT00607048|10482676|P2|Overall Study|Withdrawal by Subject|0
3049291|NCT00607048|10482677|P1|Overall Study|Withdrawal by Subject|0
3049292|NCT00607048|10482672|P6|Overall Study|Objective disease progression - relapse|2
3049293|NCT00607048|10482673|P5|Overall Study|Objective disease progression - relapse|2
3049294|NCT00607048|10482674|P4|Overall Study|Objective disease progression - relapse|2
3049295|NCT00607048|10482675|P3|Overall Study|Objective disease progression - relapse|4
3049296|NCT00607048|10482676|P2|Overall Study|Objective disease progression - relapse|2
3049297|NCT00607048|10482677|P1|Overall Study|Objective disease progression - relapse|1
3049298|NCT00607048|10482672|P6|Overall Study|Global deterioration of health|0
3049299|NCT00607048|10482673|P5|Overall Study|Global deterioration of health|0
3049300|NCT00607048|10482674|P4|Overall Study|Global deterioration of health|0
3049301|NCT00607048|10482675|P3|Overall Study|Global deterioration of health|0
3049302|NCT00607048|10482676|P2|Overall Study|Global deterioration of health|0
3049303|NCT00607048|10482677|P1|Overall Study|Global deterioration of health|1
3049304|NCT00607048|10482672|P6|Overall Study|Adverse Event|0
3049305|NCT00607048|10482673|P5|Overall Study|Adverse Event|4
3049306|NCT00607048|10482674|P4|Overall Study|Adverse Event|0
3049307|NCT00607048|10482675|P3|Overall Study|Adverse Event|0
3049308|NCT00607048|10482676|P2|Overall Study|Adverse Event|1
3049309|NCT00607048|10482677|P1|Overall Study|Adverse Event|0
3049310|NCT00607022|10482762|P3|Overall Study|Withdrawal by Subject|0
3049311|NCT00607022|10482763|P2|Overall Study|Withdrawal by Subject|0
3049312|NCT00607022|10482764|P1|Overall Study|Withdrawal by Subject|1
3049313|NCT00606931|10482781|P1|Overall Study|Withdrawal by Subject|3
3049314|NCT00606905|10482789|P2|Overall Study|Withdrew|5
3049315|NCT00606905|10482790|P1|Overall Study|Withdrew|5
3049316|NCT00606905|10482789|P2|Overall Study|Non-Index Pregnancy|4
3049317|NCT00606905|10482790|P1|Overall Study|Non-Index Pregnancy|1
3049318|NCT00606905|10482789|P2|Overall Study|No Pregnancy|6
3049319|NCT00606905|10482790|P1|Overall Study|No Pregnancy|9
3049320|NCT00606892|10482796|P2|First Intervention|Protocol Violation|4
3049321|NCT00606892|10482797|P1|First Intervention|Protocol Violation|1
3049322|NCT00606801|10482831|P2|Intervention|Protocol Violation|3
3049323|NCT00606801|10482832|P1|Intervention|Protocol Violation|3
3049324|NCT00606684|10482860|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
3049325|NCT00606684|10482861|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
3049326|NCT00606684|10482862|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
3049327|NCT00606684|10482863|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
3049328|NCT00606684|10482864|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
3049329|NCT00606684|10482865|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
3049330|NCT00606684|10482866|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
3049331|NCT00606684|10482860|P7|Double-Blind Treatment Period|Physician Decision|2
3049332|NCT00606684|10482861|P6|Double-Blind Treatment Period|Physician Decision|1
3049333|NCT00606684|10482862|P5|Double-Blind Treatment Period|Physician Decision|3
3049334|NCT00606684|10482863|P4|Double-Blind Treatment Period|Physician Decision|0
3049335|NCT00606684|10482864|P3|Double-Blind Treatment Period|Physician Decision|1
3049336|NCT00606684|10482865|P2|Double-Blind Treatment Period|Physician Decision|5
3049337|NCT00606684|10482866|P1|Double-Blind Treatment Period|Physician Decision|0
3049338|NCT00606684|10482860|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
3049339|NCT00606684|10482861|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
3049340|NCT00606684|10482862|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
3049341|NCT00606684|10482863|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
3049342|NCT00606684|10482864|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
3049343|NCT00606684|10482865|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
3049344|NCT00606684|10482866|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
3049345|NCT00606684|10482860|P7|Double-Blind Treatment Period|Protocol Violation|4
3049346|NCT00606684|10482861|P6|Double-Blind Treatment Period|Protocol Violation|3
3049347|NCT00606684|10482862|P5|Double-Blind Treatment Period|Protocol Violation|0
3049348|NCT00606684|10482863|P4|Double-Blind Treatment Period|Protocol Violation|3
3049349|NCT00606684|10482864|P3|Double-Blind Treatment Period|Protocol Violation|5
3049350|NCT00606684|10482865|P2|Double-Blind Treatment Period|Protocol Violation|5
3049351|NCT00606684|10482866|P1|Double-Blind Treatment Period|Protocol Violation|0
3049352|NCT00606684|10482860|P7|Double-Blind Treatment Period|Lack of Efficacy|0
3049353|NCT00606684|10482861|P6|Double-Blind Treatment Period|Lack of Efficacy|0
3049354|NCT00606684|10482862|P5|Double-Blind Treatment Period|Lack of Efficacy|1
3049355|NCT00606684|10482863|P4|Double-Blind Treatment Period|Lack of Efficacy|0
3049356|NCT00606684|10482864|P3|Double-Blind Treatment Period|Lack of Efficacy|0
3049357|NCT00606684|10482865|P2|Double-Blind Treatment Period|Lack of Efficacy|1
3049358|NCT00606684|10482866|P1|Double-Blind Treatment Period|Lack of Efficacy|0
3049359|NCT00606684|10482860|P7|Double-Blind Treatment Period|Adverse Event|1
3049360|NCT00606684|10482861|P6|Double-Blind Treatment Period|Adverse Event|0
3049361|NCT00606684|10482862|P5|Double-Blind Treatment Period|Adverse Event|2
3049362|NCT00606684|10482863|P4|Double-Blind Treatment Period|Adverse Event|4
3049363|NCT00606684|10482864|P3|Double-Blind Treatment Period|Adverse Event|2
3049364|NCT00606684|10482865|P2|Double-Blind Treatment Period|Adverse Event|3
3049365|NCT00606684|10482866|P1|Double-Blind Treatment Period|Adverse Event|0
3049366|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049367|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049368|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049369|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049370|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049371|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
3049372|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
3049373|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Adverse Event|0
3049374|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Adverse Event|0
3049375|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Adverse Event|0
3049376|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Adverse Event|0
3049377|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Adverse Event|0
3049378|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Adverse Event|0
3049379|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Adverse Event|2
3049380|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049381|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049382|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049383|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049384|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049385|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
3049386|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
3049387|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049388|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049389|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049390|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049391|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049392|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
3049393|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
3049394|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Physician Decision|0
3049395|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Physician Decision|0
3049396|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Physician Decision|0
3049397|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Physician Decision|0
3049398|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Physician Decision|0
3049399|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Physician Decision|0
3049400|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Physician Decision|18
3049401|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049402|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049403|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049404|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049405|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049406|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
3049407|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
3049408|NCT00606684|10482860|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049409|NCT00606684|10482861|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049410|NCT00606684|10482862|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049411|NCT00606684|10482863|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049412|NCT00606684|10482864|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049413|NCT00606684|10482865|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
3049414|NCT00606684|10482866|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
3049415|NCT00606632|10482898|P1|Overall Study|Miscellaneous reasons|9
3049416|NCT00606632|10482898|P1|Overall Study|Withdrawal by Subject|13
3049417|NCT00606593|10482911|P10|Overall Study|Administrative/Other|0
3049418|NCT00606593|10482912|P9|Overall Study|Administrative/Other|0
3049419|NCT00606593|10482913|P8|Overall Study|Administrative/Other|0
3049420|NCT00606593|10482914|P7|Overall Study|Administrative/Other|0
3049421|NCT00606593|10482915|P6|Overall Study|Administrative/Other|0
3049422|NCT00606593|10482916|P5|Overall Study|Administrative/Other|0
3049423|NCT00606593|10482917|P4|Overall Study|Administrative/Other|0
3049424|NCT00606593|10482918|P3|Overall Study|Administrative/Other|1
3049425|NCT00606593|10482919|P2|Overall Study|Administrative/Other|0
3049426|NCT00606593|10482920|P1|Overall Study|Administrative/Other|0
3049427|NCT00606593|10482911|P10|Overall Study|Withdrawal of consent|0
3049428|NCT00606593|10482912|P9|Overall Study|Withdrawal of consent|0
3049429|NCT00606593|10482913|P8|Overall Study|Withdrawal of consent|0
3049430|NCT00606593|10482914|P7|Overall Study|Withdrawal of consent|0
3049431|NCT00606593|10482915|P6|Overall Study|Withdrawal of consent|0
3049432|NCT00606593|10482916|P5|Overall Study|Withdrawal of consent|0
3049433|NCT00606593|10482917|P4|Overall Study|Withdrawal of consent|0
3049434|NCT00606593|10482918|P3|Overall Study|Withdrawal of consent|1
3049435|NCT00606593|10482919|P2|Overall Study|Withdrawal of consent|0
3049436|NCT00606593|10482920|P1|Overall Study|Withdrawal of consent|1
3049437|NCT00606593|10482911|P10|Overall Study|Adverse Event|0
3049438|NCT00606593|10482912|P9|Overall Study|Adverse Event|1
3049439|NCT00606593|10482913|P8|Overall Study|Adverse Event|2
3049440|NCT00606593|10482914|P7|Overall Study|Adverse Event|1
3049441|NCT00606593|10482915|P6|Overall Study|Adverse Event|0
3049442|NCT00606593|10482916|P5|Overall Study|Adverse Event|1
3049443|NCT00606593|10482917|P4|Overall Study|Adverse Event|1
3049444|NCT00606593|10482918|P3|Overall Study|Adverse Event|0
3049445|NCT00606593|10482919|P2|Overall Study|Adverse Event|0
3049446|NCT00606593|10482920|P1|Overall Study|Adverse Event|0
3049447|NCT00606580|10482941|P3|Overall Study|Withdrawal by Subject|0
3049448|NCT00606580|10482942|P2|Overall Study|Withdrawal by Subject|1
3049449|NCT00606580|10482943|P1|Overall Study|Withdrawal by Subject|0
3049450|NCT00606580|10482941|P3|Overall Study|Withdrawal by investigator|6
3049451|NCT00606580|10482942|P2|Overall Study|Withdrawal by investigator|1
3049452|NCT00606580|10482943|P1|Overall Study|Withdrawal by investigator|0
3049453|NCT00606580|10482941|P3|Overall Study|Clinical failures|12
3049454|NCT00606580|10482942|P2|Overall Study|Clinical failures|0
3049455|NCT00606580|10482943|P1|Overall Study|Clinical failures|1
3049456|NCT00606580|10482941|P3|Overall Study|Lost to Follow-up|4
3049457|NCT00606580|10482942|P2|Overall Study|Lost to Follow-up|1
3049458|NCT00606580|10482943|P1|Overall Study|Lost to Follow-up|1
3049459|NCT00606502|10483009|P2|Treatment|Treatment ongoing at time of data cutoff|3
3049460|NCT00606502|10483010|P1|Treatment|Treatment ongoing at time of data cutoff|0
3049461|NCT00606502|10483009|P2|Randomization|Randomized but not treated|0
3049462|NCT00606502|10483010|P1|Randomization|Randomized but not treated|3
3049463|NCT00606320|10483031|P1|Overall Study|Progression to depressive phase|4
3049464|NCT00606320|10483031|P1|Overall Study|Withdrawal by Subject|10
3049465|NCT00606320|10483031|P1|Overall Study|Protocol Violation|8
3049466|NCT00606320|10483031|P1|Overall Study|Physician Decision|7
3049467|NCT00606320|10483031|P1|Overall Study|Lack of Efficacy|5
3049468|NCT00606320|10483031|P1|Overall Study|Adverse Event|3
3049469|NCT00606307|10483036|P1|Overall Study|QTc prolongation|1
3049470|NCT00606307|10483036|P1|Overall Study|Disease progression|6
3049471|NCT00606307|10483036|P1|Overall Study|Withdrawal by Subject|2
3049472|NCT00606307|10483036|P1|Overall Study|Adverse Event|2
3049473|NCT00606281|10483044|P2|Overall Study|Change of residence or other commitments|1
3049474|NCT00606281|10483045|P1|Overall Study|Change of residence or other commitments|1
3049475|NCT00606281|10483044|P2|Overall Study|Progression to depressive phase|1
3049476|NCT00606281|10483045|P1|Overall Study|Progression to depressive phase|1
3049477|NCT00606281|10483044|P2|Overall Study|Withdrawal by Subject|13
3049478|NCT00606281|10483045|P1|Overall Study|Withdrawal by Subject|11
3049479|NCT00606281|10483044|P2|Overall Study|Protocol Violation|3
3049480|NCT00606281|10483045|P1|Overall Study|Protocol Violation|3
3049481|NCT00606281|10483044|P2|Overall Study|Physician Decision|1
3049482|NCT00606281|10483045|P1|Overall Study|Physician Decision|0
3049483|NCT00606281|10483044|P2|Overall Study|Lack of Efficacy|35
3049484|NCT00606281|10483045|P1|Overall Study|Lack of Efficacy|28
3049485|NCT00606281|10483044|P2|Overall Study|Death|0
3049486|NCT00606281|10483045|P1|Overall Study|Death|1
3049487|NCT00606281|10483044|P2|Overall Study|Adverse Event|12
3049488|NCT00606281|10483045|P1|Overall Study|Adverse Event|11
3049489|NCT00606229|10483053|P1|Overall Study|change of residence or other commitments|2
3049490|NCT00606229|10483053|P1|Overall Study|does not meet inclusion criterion 1-3|4
3049491|NCT00606229|10483053|P1|Overall Study|Withdrawal by Subject|4
3049492|NCT00606229|10483053|P1|Overall Study|Lack of Efficacy|1
3049493|NCT00606229|10483053|P1|Overall Study|Adverse Event|11
3049494|NCT00606177|10483060|P2|Overall Study|Change of residence or other commitments|1
3049495|NCT00606177|10483061|P1|Overall Study|Change of residence or other commitments|1
3049496|NCT00606177|10483060|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
3049497|NCT00606177|10483061|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
3049498|NCT00606177|10483060|P2|Overall Study|Progression to depressive phase|1
3049499|NCT00606177|10483061|P1|Overall Study|Progression to depressive phase|6
3049500|NCT00606177|10483060|P2|Overall Study|Withdrawal by Subject|6
3049501|NCT00606177|10483061|P1|Overall Study|Withdrawal by Subject|5
3049502|NCT00606177|10483060|P2|Overall Study|Protocol Violation|4
3049503|NCT00606177|10483061|P1|Overall Study|Protocol Violation|1
3049504|NCT00606177|10483060|P2|Overall Study|Physician Decision|0
3049505|NCT00606177|10483061|P1|Overall Study|Physician Decision|1
3049506|NCT00606177|10483060|P2|Overall Study|Lack of Efficacy|7
3049507|NCT00606177|10483061|P1|Overall Study|Lack of Efficacy|3
3049508|NCT00606177|10483060|P2|Overall Study|Adverse Event|5
3049509|NCT00606177|10483061|P1|Overall Study|Adverse Event|9
3049510|NCT00606086|10483088|P2|Overall Study|Randomized, not treated|2
3049511|NCT00606086|10483089|P1|Overall Study|Randomized, not treated|1
3049512|NCT00606086|10483088|P2|Overall Study|Non-compliance|1
3049513|NCT00606086|10483089|P1|Overall Study|Non-compliance|0
3049514|NCT00606086|10483088|P2|Overall Study|Withdrawal by Subject|3
3049515|NCT00606086|10483089|P1|Overall Study|Withdrawal by Subject|5
3049516|NCT00606086|10483088|P2|Overall Study|Protocol Violation|0
3049517|NCT00606086|10483089|P1|Overall Study|Protocol Violation|1
3049518|NCT00606086|10483088|P2|Overall Study|Lost to Follow-up|8
3049519|NCT00606086|10483089|P1|Overall Study|Lost to Follow-up|4
3049520|NCT00606086|10483088|P2|Overall Study|Adverse Event|1
3049521|NCT00606086|10483089|P1|Overall Study|Adverse Event|1
3049522|NCT00606034|10483099|P1|Overall Study|incarceration|1
3049523|NCT00606021|10483107|P3|Maintenance Phase|Lost to Follow-up|2
3049524|NCT00606021|10483108|P2|Maintenance Phase|Lost to Follow-up|5
3049525|NCT00606021|10483109|P1|Maintenance Phase|Lost to Follow-up|0
3049526|NCT00606021|10483107|P3|Maintenance Phase|Physician Decision|0
3049527|NCT00606021|10483108|P2|Maintenance Phase|Physician Decision|1
3049528|NCT00606021|10483109|P1|Maintenance Phase|Physician Decision|0
3049529|NCT00606021|10483107|P3|Maintenance Phase|Death|15
3049530|NCT00606021|10483108|P2|Maintenance Phase|Death|17
3049531|NCT00606021|10483109|P1|Maintenance Phase|Death|0
3049532|NCT00606021|10483107|P3|Induction Phase|Lost to Follow-up|0
3049533|NCT00606021|10483108|P2|Induction Phase|Lost to Follow-up|0
3049534|NCT00606021|10483109|P1|Induction Phase|Lost to Follow-up|10
3049535|NCT00606021|10483107|P3|Induction Phase|Withdrawal by Subject|0
3049536|NCT00606021|10483108|P2|Induction Phase|Withdrawal by Subject|0
3049537|NCT00606021|10483109|P1|Induction Phase|Withdrawal by Subject|2
3049538|NCT00606021|10483107|P3|Induction Phase|Physician Decision|0
3049539|NCT00606021|10483108|P2|Induction Phase|Physician Decision|0
3049540|NCT00606021|10483109|P1|Induction Phase|Physician Decision|2
3049541|NCT00606021|10483107|P3|Induction Phase|Death|0
3049542|NCT00606021|10483108|P2|Induction Phase|Death|0
3049543|NCT00606021|10483109|P1|Induction Phase|Death|73
3049544|NCT00606008|10483127|P1|Overall Study|Withdrawal by Subject|4
3049545|NCT00606008|10483127|P1|Overall Study|Adverse Event|1
3049546|NCT00605917|10483141|P1|Overall Study|Protocol Violation|79
3049547|NCT00605865|10483193|P1|Overall Study|Protocol Violation|115
3049548|NCT00605839|10483235|P3|Overall Study|Protocol Violation|0
3049549|NCT00605839|10483236|P2|Overall Study|Protocol Violation|0
3049550|NCT00605839|10483237|P1|Overall Study|Protocol Violation|1
3049551|NCT00605813|10483245|P1|Overall Study|Protocol Violation|25
3049552|NCT00605722|10483258|P1|Overall Study|Failure to return|1
3049553|NCT00605722|10483258|P1|Overall Study|Insufficient therapeutic response|44
3049554|NCT00605722|10483258|P1|Overall Study|Adverse Event|6
3049555|NCT00605657|10483279|P1|Overall Study|Protocol Violation|1
3049556|NCT00605657|10483279|P1|Overall Study|Adverse Event|1
3049557|NCT00605566|10483284|P1|Overall Study|Poor compliance in run-in period|1
3049558|NCT00605566|10483284|P1|Overall Study|Clinical deterioration|1
3049559|NCT00605566|10483284|P1|Overall Study|Adverse Event|1
3049560|NCT00605540|10483292|P1|Overall Study|Lost to Follow-up|23
3049561|NCT00605540|10483292|P1|Overall Study|Death|15
3049562|NCT00605475|10483310|P10|Overall Study|Withdrawal by Subject|1
3049563|NCT00605475|10483311|P9|Overall Study|Withdrawal by Subject|0
3049564|NCT00605475|10483312|P8|Overall Study|Withdrawal by Subject|0
3049565|NCT00605475|10483313|P7|Overall Study|Withdrawal by Subject|0
3049566|NCT00605475|10483314|P6|Overall Study|Withdrawal by Subject|2
3049567|NCT00605475|10483315|P5|Overall Study|Withdrawal by Subject|0
3049568|NCT00605475|10483316|P4|Overall Study|Withdrawal by Subject|0
3049569|NCT00605475|10483317|P3|Overall Study|Withdrawal by Subject|0
3049570|NCT00605475|10483318|P2|Overall Study|Withdrawal by Subject|0
3049571|NCT00605475|10483319|P1|Overall Study|Withdrawal by Subject|0
3049572|NCT00605475|10483310|P10|Overall Study|Protocol Violation|0
3049573|NCT00605475|10483311|P9|Overall Study|Protocol Violation|0
3049574|NCT00605475|10483312|P8|Overall Study|Protocol Violation|0
3049575|NCT00605475|10483313|P7|Overall Study|Protocol Violation|0
3049576|NCT00605475|10483314|P6|Overall Study|Protocol Violation|0
3049577|NCT00605475|10483315|P5|Overall Study|Protocol Violation|1
3049578|NCT00605475|10483316|P4|Overall Study|Protocol Violation|0
3049579|NCT00605475|10483317|P3|Overall Study|Protocol Violation|0
3049580|NCT00605475|10483318|P2|Overall Study|Protocol Violation|0
3049581|NCT00605475|10483319|P1|Overall Study|Protocol Violation|0
3049582|NCT00605475|10483310|P10|Overall Study|Lost to Follow-up|1
3049583|NCT00605475|10483311|P9|Overall Study|Lost to Follow-up|1
3049584|NCT00605475|10483312|P8|Overall Study|Lost to Follow-up|0
3049585|NCT00605475|10483313|P7|Overall Study|Lost to Follow-up|0
3049586|NCT00605475|10483314|P6|Overall Study|Lost to Follow-up|0
3049587|NCT00605475|10483315|P5|Overall Study|Lost to Follow-up|0
3049588|NCT00605475|10483316|P4|Overall Study|Lost to Follow-up|0
3049589|NCT00605475|10483317|P3|Overall Study|Lost to Follow-up|0
3049590|NCT00605475|10483318|P2|Overall Study|Lost to Follow-up|0
3049591|NCT00605475|10483319|P1|Overall Study|Lost to Follow-up|0
3049592|NCT00605475|10483310|P10|Overall Study|Administrative problems|0
3049593|NCT00605475|10483311|P9|Overall Study|Administrative problems|0
3049594|NCT00605475|10483312|P8|Overall Study|Administrative problems|0
3049595|NCT00605475|10483313|P7|Overall Study|Administrative problems|1
3049596|NCT00605475|10483314|P6|Overall Study|Administrative problems|0
3049597|NCT00605475|10483315|P5|Overall Study|Administrative problems|0
3049598|NCT00605475|10483316|P4|Overall Study|Administrative problems|0
3049599|NCT00605475|10483317|P3|Overall Study|Administrative problems|0
3049600|NCT00605475|10483318|P2|Overall Study|Administrative problems|0
3049601|NCT00605475|10483319|P1|Overall Study|Administrative problems|0
3049602|NCT00605475|10483310|P10|Overall Study|Abnormal Laboratory Values|0
3049603|NCT00605475|10483311|P9|Overall Study|Abnormal Laboratory Values|1
3049604|NCT00605475|10483312|P8|Overall Study|Abnormal Laboratory Values|0
3049605|NCT00605475|10483313|P7|Overall Study|Abnormal Laboratory Values|0
3049606|NCT00605475|10483314|P6|Overall Study|Abnormal Laboratory Values|0
3049607|NCT00605475|10483315|P5|Overall Study|Abnormal Laboratory Values|0
3049608|NCT00605475|10483316|P4|Overall Study|Abnormal Laboratory Values|0
3049609|NCT00605475|10483317|P3|Overall Study|Abnormal Laboratory Values|0
3049610|NCT00605475|10483318|P2|Overall Study|Abnormal Laboratory Values|0
3049611|NCT00605475|10483319|P1|Overall Study|Abnormal Laboratory Values|0
3049612|NCT00605345|10483496|P2|Overall Study|Protocol Violation|2
3049613|NCT00605345|10483497|P1|Overall Study|Protocol Violation|0
3049614|NCT00605345|10483496|P2|Overall Study|Adverse Event|1
3049615|NCT00605345|10483497|P1|Overall Study|Adverse Event|0
3049616|NCT00605345|10483496|P2|Overall Study|Withdrawal by Subject|0
3049617|NCT00605345|10483497|P1|Overall Study|Withdrawal by Subject|1
3049618|NCT00605319|10483513|P1|Overall Study|Adverse Event|6
3049619|NCT00605306|10483525|P2|Overall Study|Adverse Event|1
3049620|NCT00605306|10483526|P1|Overall Study|Adverse Event|0
3049621|NCT00605293|10483540|P2|Overall Study|Principal Investigator Decision|1
3049622|NCT00605293|10483541|P1|Overall Study|Principal Investigator Decision|0
3049623|NCT00605293|10483540|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
3049624|NCT00605293|10483541|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
3049625|NCT00605293|10483540|P2|Overall Study|Incorrect Epoetin Beta Administration|0
3049626|NCT00605293|10483541|P1|Overall Study|Incorrect Epoetin Beta Administration|1
3049627|NCT00605293|10483540|P2|Overall Study|Renal Transplantation|1
3049628|NCT00605293|10483541|P1|Overall Study|Renal Transplantation|3
3049629|NCT00605293|10483540|P2|Overall Study|Blood Transfusion|1
3049630|NCT00605293|10483541|P1|Overall Study|Blood Transfusion|7
3049631|NCT00605293|10483540|P2|Overall Study|Holidays Dialysis Out|0
3049632|NCT00605293|10483541|P1|Overall Study|Holidays Dialysis Out|1
3049633|NCT00605293|10483540|P2|Overall Study|Adverse Event|0
3049634|NCT00605293|10483541|P1|Overall Study|Adverse Event|1
3049635|NCT00605293|10483540|P2|Overall Study|Insufficient Therapeutic Response|0
3049636|NCT00605293|10483541|P1|Overall Study|Insufficient Therapeutic Response|2
3049637|NCT00605293|10483540|P2|Overall Study|Death|1
3049638|NCT00605293|10483541|P1|Overall Study|Death|2
3049639|NCT00605280|10483561|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
3049640|NCT00605280|10483562|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
3049641|NCT00605280|10483563|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
3049642|NCT00605280|10483564|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
3049643|NCT00605280|10483561|P4|Year 3 Extension|Other|0
3049644|NCT00605280|10483562|P3|Year 3 Extension|Other|0
3049645|NCT00605280|10483563|P2|Year 3 Extension|Other|0
3049646|NCT00605280|10483564|P1|Year 3 Extension|Other|2
3049647|NCT00605280|10483561|P4|Year 3 Extension|Withdrawal by Subject|5
3049648|NCT00605280|10483562|P3|Year 3 Extension|Withdrawal by Subject|0
3049649|NCT00605280|10483563|P2|Year 3 Extension|Withdrawal by Subject|0
3049650|NCT00605280|10483564|P1|Year 3 Extension|Withdrawal by Subject|2
3049651|NCT00605280|10483561|P4|Year 3 Extension|Physician Decision|2
3049652|NCT00605280|10483562|P3|Year 3 Extension|Physician Decision|0
3049653|NCT00605280|10483563|P2|Year 3 Extension|Physician Decision|0
3049654|NCT00605280|10483564|P1|Year 3 Extension|Physician Decision|0
3049655|NCT00605280|10483561|P4|Year 3 Extension|Adverse Event|2
3049656|NCT00605280|10483562|P3|Year 3 Extension|Adverse Event|0
3049657|NCT00605280|10483563|P2|Year 3 Extension|Adverse Event|0
3049658|NCT00605280|10483564|P1|Year 3 Extension|Adverse Event|2
3049659|NCT00605280|10483561|P4|Year 2|Lost to Follow-up or Patient non-comply|2
3049660|NCT00605280|10483562|P3|Year 2|Lost to Follow-up or Patient non-comply|0
3049661|NCT00605280|10483563|P2|Year 2|Lost to Follow-up or Patient non-comply|0
3049662|NCT00605280|10483564|P1|Year 2|Lost to Follow-up or Patient non-comply|4
3049663|NCT00605280|10483561|P4|Year 2|Other|1
3049664|NCT00605280|10483562|P3|Year 2|Other|0
3049665|NCT00605280|10483563|P2|Year 2|Other|0
3049666|NCT00605280|10483564|P1|Year 2|Other|1
3049667|NCT00605280|10483561|P4|Year 2|Withdrawal by Subject|4
3049668|NCT00605280|10483562|P3|Year 2|Withdrawal by Subject|0
3049669|NCT00605280|10483563|P2|Year 2|Withdrawal by Subject|0
3049670|NCT00605280|10483564|P1|Year 2|Withdrawal by Subject|4
3049671|NCT00605280|10483561|P4|Year 2|Physician Decision|11
3049672|NCT00605280|10483562|P3|Year 2|Physician Decision|4
3049673|NCT00605280|10483563|P2|Year 2|Physician Decision|6
3049674|NCT00605280|10483564|P1|Year 2|Physician Decision|11
3049675|NCT00605280|10483561|P4|Year 2|Adverse Event|4
3049676|NCT00605280|10483562|P3|Year 2|Adverse Event|2
3049677|NCT00605280|10483563|P2|Year 2|Adverse Event|0
3049678|NCT00605280|10483564|P1|Year 2|Adverse Event|4
3049679|NCT00605280|10483561|P4|Year 1|Lost to Follow-up or Patient non-comply|2
3049680|NCT00605280|10483562|P3|Year 1|Lost to Follow-up or Patient non-comply|0
3049681|NCT00605280|10483563|P2|Year 1|Lost to Follow-up or Patient non-comply|1
3049682|NCT00605280|10483564|P1|Year 1|Lost to Follow-up or Patient non-comply|5
3049683|NCT00605280|10483561|P4|Year 1|Other|1
3049684|NCT00605280|10483562|P3|Year 1|Other|0
3049685|NCT00605280|10483563|P2|Year 1|Other|1
3049686|NCT00605280|10483564|P1|Year 1|Other|2
3049687|NCT00605280|10483561|P4|Year 1|Withdrawal by Subject|4
3049688|NCT00605280|10483562|P3|Year 1|Withdrawal by Subject|0
3049689|NCT00605280|10483563|P2|Year 1|Withdrawal by Subject|4
3049690|NCT00605280|10483564|P1|Year 1|Withdrawal by Subject|2
3049691|NCT00605280|10483561|P4|Year 1|Physician Decision|6
3049692|NCT00605280|10483562|P3|Year 1|Physician Decision|0
3049693|NCT00605280|10483563|P2|Year 1|Physician Decision|4
3049694|NCT00605280|10483564|P1|Year 1|Physician Decision|7
3049695|NCT00605280|10483561|P4|Year 1|Adverse Event|5
3049696|NCT00605280|10483562|P3|Year 1|Adverse Event|1
3049697|NCT00605280|10483563|P2|Year 1|Adverse Event|1
3049698|NCT00605280|10483564|P1|Year 1|Adverse Event|3
3049699|NCT00605280|10483561|P4|Year 1|Protocol Violation|1
3049700|NCT00605280|10483562|P3|Year 1|Protocol Violation|0
3049701|NCT00605280|10483563|P2|Year 1|Protocol Violation|0
3049702|NCT00605280|10483564|P1|Year 1|Protocol Violation|0
3049703|NCT00605267|10483598|P2|Overall Study|Withdrawal by Subject|3
3049704|NCT00605267|10483599|P1|Overall Study|Withdrawal by Subject|2
3049705|NCT00605267|10483598|P2|Overall Study|Lack of Efficacy|5
3049706|NCT00605267|10483599|P1|Overall Study|Lack of Efficacy|1
3049707|NCT00605267|10483598|P2|Overall Study|Adverse Event|1
3049708|NCT00605267|10483599|P1|Overall Study|Adverse Event|0
3049709|NCT00605189|10483647|P3|Overall Study|Other|0
3049710|NCT00605189|10483648|P2|Overall Study|Other|2
3049711|NCT00605189|10483649|P1|Overall Study|Other|2
3049712|NCT00605189|10483647|P3|Overall Study|Adverse Event|0
3049713|NCT00605189|10483648|P2|Overall Study|Adverse Event|0
3049714|NCT00605189|10483649|P1|Overall Study|Adverse Event|1
3049715|NCT00605176|10483660|P3|Overall Study|Other (not due to AE)|0
3049716|NCT00605176|10483661|P2|Overall Study|Other (not due to AE)|1
3049717|NCT00605176|10483662|P1|Overall Study|Other (not due to AE)|1
3049718|NCT00605176|10483660|P3|Overall Study|Use of concomitant therapy|1
3049719|NCT00605176|10483661|P2|Overall Study|Use of concomitant therapy|0
3049720|NCT00605176|10483662|P1|Overall Study|Use of concomitant therapy|1
3049721|NCT00605176|10483660|P3|Overall Study|Non-complicance with study procedures|0
3049722|NCT00605176|10483661|P2|Overall Study|Non-complicance with study procedures|0
3049723|NCT00605176|10483662|P1|Overall Study|Non-complicance with study procedures|1
3049724|NCT00605176|10483660|P3|Overall Study|Lost to Follow-up|1
3049725|NCT00605176|10483661|P2|Overall Study|Lost to Follow-up|2
3049726|NCT00605176|10483662|P1|Overall Study|Lost to Follow-up|2
3049727|NCT00605176|10483660|P3|Overall Study|Withdrawal by Subject|4
3049728|NCT00605176|10483661|P2|Overall Study|Withdrawal by Subject|2
3049729|NCT00605176|10483662|P1|Overall Study|Withdrawal by Subject|4
3049730|NCT00605176|10483660|P3|Overall Study|Adverse Event|3
3049731|NCT00605176|10483661|P2|Overall Study|Adverse Event|1
3049732|NCT00605176|10483662|P1|Overall Study|Adverse Event|2
3049733|NCT00605085|10483686|P2|Overall Study|administrative reasons|8
3049734|NCT00605085|10483687|P1|Overall Study|administrative reasons|18
3049735|NCT00605085|10483686|P2|Overall Study|Lost to Follow-up|5
3049736|NCT00605085|10483687|P1|Overall Study|Lost to Follow-up|10
3049737|NCT00605085|10483686|P2|Overall Study|Protocol Violation|2
3049738|NCT00605085|10483687|P1|Overall Study|Protocol Violation|3
3049739|NCT00605085|10483686|P2|Overall Study|Pregnancy|0
3049740|NCT00605085|10483687|P1|Overall Study|Pregnancy|2
3049741|NCT00605085|10483686|P2|Overall Study|Adverse Event|5
3049742|NCT00605085|10483687|P1|Overall Study|Adverse Event|9
3049743|NCT00605085|10483686|P2|Overall Study|Withdrawal by Subject|5
3049744|NCT00605085|10483687|P1|Overall Study|Withdrawal by Subject|8
3049745|NCT00605033|10483720|P2|Overall Study|Protocol Violation|1
3049746|NCT00605033|10483721|P1|Overall Study|Protocol Violation|1
3049747|NCT00605033|10483720|P2|Overall Study|Withdrawal by Subject|4
3049748|NCT00605033|10483721|P1|Overall Study|Withdrawal by Subject|3
3049749|NCT00605033|10483720|P2|Overall Study|Lost to Follow-up|1
3049750|NCT00605033|10483721|P1|Overall Study|Lost to Follow-up|1
3049751|NCT00605033|10483720|P2|Overall Study|Adverse Event|2
3049752|NCT00605033|10483721|P1|Overall Study|Adverse Event|2
3049753|NCT00604825|10483765|P4|Overall Study|Exclusion criterion met|1
3049754|NCT00604825|10483766|P3|Overall Study|Exclusion criterion met|0
3049755|NCT00604825|10483767|P2|Overall Study|Exclusion criterion met|0
3049756|NCT00604825|10483768|P1|Overall Study|Exclusion criterion met|0
3049757|NCT00604825|10483765|P4|Overall Study|Physician Decision|1
3049758|NCT00604825|10483766|P3|Overall Study|Physician Decision|0
3049759|NCT00604825|10483767|P2|Overall Study|Physician Decision|0
3049760|NCT00604825|10483768|P1|Overall Study|Physician Decision|0
3049761|NCT00604825|10483765|P4|Overall Study|Did not meet eligibility criteria|0
3049762|NCT00604825|10483766|P3|Overall Study|Did not meet eligibility criteria|2
3049763|NCT00604825|10483767|P2|Overall Study|Did not meet eligibility criteria|0
3049764|NCT00604825|10483768|P1|Overall Study|Did not meet eligibility criteria|0
3049765|NCT00604825|10483765|P4|Overall Study|Lack of Efficacy|0
3049766|NCT00604825|10483766|P3|Overall Study|Lack of Efficacy|1
3049767|NCT00604825|10483767|P2|Overall Study|Lack of Efficacy|2
3049768|NCT00604825|10483768|P1|Overall Study|Lack of Efficacy|3
3049769|NCT00604825|10483765|P4|Overall Study|Withdrawal by Subject|5
3049770|NCT00604825|10483766|P3|Overall Study|Withdrawal by Subject|5
3049771|NCT00604825|10483767|P2|Overall Study|Withdrawal by Subject|3
3049772|NCT00604825|10483768|P1|Overall Study|Withdrawal by Subject|4
3049773|NCT00604825|10483765|P4|Overall Study|Protocol Violation|0
3049774|NCT00604825|10483766|P3|Overall Study|Protocol Violation|0
3049775|NCT00604825|10483767|P2|Overall Study|Protocol Violation|1
3049776|NCT00604825|10483768|P1|Overall Study|Protocol Violation|0
3049777|NCT00604825|10483765|P4|Overall Study|Lost to Follow-up|0
3049778|NCT00604825|10483766|P3|Overall Study|Lost to Follow-up|1
3049779|NCT00604825|10483767|P2|Overall Study|Lost to Follow-up|3
3049780|NCT00604825|10483768|P1|Overall Study|Lost to Follow-up|0
3049781|NCT00604825|10483765|P4|Overall Study|Adverse Event|4
3049782|NCT00604825|10483766|P3|Overall Study|Adverse Event|7
3049783|NCT00604825|10483767|P2|Overall Study|Adverse Event|6
3049784|NCT00604825|10483768|P1|Overall Study|Adverse Event|2
3049785|NCT00604786|10483996|P2|Overall Study|Lost to Follow-up|0
3049786|NCT00604786|10483997|P1|Overall Study|Lost to Follow-up|2
3049787|NCT00604721|10484003|P1|Overall Study|Withdrawal by Subject|1
3049788|NCT00604721|10484003|P1|Overall Study|Physician Decision|1
3049789|NCT00604708|10484011|P2|Overall Study|Adverse Event|6
3049790|NCT00604708|10484012|P1|Overall Study|Adverse Event|6
3049791|NCT00604708|10484011|P2|Overall Study|administrative reasons|11
3049792|NCT00604708|10484012|P1|Overall Study|administrative reasons|9
3049793|NCT00604708|10484011|P2|Overall Study|Lost to Follow-up|5
3049794|NCT00604708|10484012|P1|Overall Study|Lost to Follow-up|5
3049795|NCT00604708|10484011|P2|Overall Study|Protocol Violation|8
3049796|NCT00604708|10484012|P1|Overall Study|Protocol Violation|2
3049797|NCT00604708|10484011|P2|Overall Study|Withdrawal by Subject|10
3049798|NCT00604708|10484012|P1|Overall Study|Withdrawal by Subject|9
3049799|NCT00604695|10484022|P2|Overall Study|Did not receive first bolus.|4
3049800|NCT00604695|10484023|P1|Overall Study|Did not receive first bolus.|0
3049801|NCT00604669|10484045|P1|Overall Study|lack of information in chart|7
3049802|NCT00604565|10484051|P2|Overall Study|Study terminated|3
3049803|NCT00604565|10484052|P1|Overall Study|Study terminated|0
3049804|NCT00604500|10484071|P1|Overall Study|Did not meet protocol eligibility|1
3049805|NCT00604500|10484071|P1|Overall Study|Administrative|1
3049806|NCT00604500|10484071|P1|Overall Study|Withdrawal by Subject|4
3049807|NCT00604500|10484071|P1|Overall Study|Treatment Failure|1
3049808|NCT00604500|10484071|P1|Overall Study|Protocol Violation|2
3049809|NCT00604500|10484071|P1|Overall Study|Adverse Event|2
3049810|NCT00604383|10484085|P2|Overall Study|Physician Decision|3
3049811|NCT00604383|10484086|P1|Overall Study|Physician Decision|0
3049812|NCT00604383|10484085|P2|Overall Study|Adverse Event|9
3049813|NCT00604383|10484086|P1|Overall Study|Adverse Event|16
3049814|NCT00604383|10484085|P2|Overall Study|Death|22
3049815|NCT00604383|10484086|P1|Overall Study|Death|14
3049816|NCT00604383|10484085|P2|Overall Study|Lost to Follow-up|19
3049817|NCT00604383|10484086|P1|Overall Study|Lost to Follow-up|24
3049818|NCT00604383|10484085|P2|Overall Study|Withdrawal by Subject|31
3049819|NCT00604383|10484086|P1|Overall Study|Withdrawal by Subject|33
3049820|NCT00604279|10484102|P2|Overall Study|Other|4
3049821|NCT00604279|10484103|P1|Overall Study|Other|8
3049822|NCT00604279|10484102|P2|Overall Study|Adverse Event|5
3049823|NCT00604279|10484103|P1|Overall Study|Adverse Event|4
3049824|NCT00604279|10484102|P2|Overall Study|Withdrawal by Subject|5
3049825|NCT00604279|10484103|P1|Overall Study|Withdrawal by Subject|16
3049826|NCT00604279|10484102|P2|Overall Study|Protocol Violation|1
3049827|NCT00604279|10484103|P1|Overall Study|Protocol Violation|3
3049828|NCT00604279|10484102|P2|Overall Study|Pregnancy|0
3049829|NCT00604279|10484103|P1|Overall Study|Pregnancy|2
3049830|NCT00604279|10484102|P2|Overall Study|Lost to Follow-up|14
3049831|NCT00604279|10484103|P1|Overall Study|Lost to Follow-up|9
3049832|NCT00604279|10484102|P2|Overall Study|Lack of Efficacy|9
3049833|NCT00604279|10484103|P1|Overall Study|Lack of Efficacy|22
3049834|NCT00604214|10484119|P2|Day 91 to Day 180|Withdrawal by Subject|1
3049835|NCT00604214|10484120|P1|Day 91 to Day 180|Withdrawal by Subject|1
3049836|NCT00604214|10484119|P2|Day 91 to Day 180|Lost to Follow-up|8
3049837|NCT00604214|10484120|P1|Day 91 to Day 180|Lost to Follow-up|6
3049838|NCT00604214|10484119|P2|Day 91 to Day 180|Death|23
3049839|NCT00604214|10484120|P1|Day 91 to Day 180|Death|19
3049840|NCT00604214|10484119|P2|Day 29 to Day 90|Withdrawal by Subject|6
3049841|NCT00604214|10484120|P1|Day 29 to Day 90|Withdrawal by Subject|0
3049842|NCT00604214|10484119|P2|Day 29 to Day 90|Lost to Follow-up|6
3049843|NCT00604214|10484120|P1|Day 29 to Day 90|Lost to Follow-up|4
3049844|NCT00604214|10484119|P2|Day 29 to Day 90|Death|67
3049845|NCT00604214|10484120|P1|Day 29 to Day 90|Death|64
3049846|NCT00604214|10484119|P2|Baseline to Day 28|Withdrawal by Subject|7
3049847|NCT00604214|10484120|P1|Baseline to Day 28|Withdrawal by Subject|3
3049848|NCT00604214|10484119|P2|Baseline to Day 28|Lost to Follow-up|4
3049849|NCT00604214|10484120|P1|Baseline to Day 28|Lost to Follow-up|2
3049850|NCT00604214|10484119|P2|Baseline to Day 28|Death|202
3049851|NCT00604214|10484120|P1|Baseline to Day 28|Death|223
3049852|NCT00604188|10484152|P2|Overall Study|Did not receive study drug|1
3049853|NCT00604188|10484153|P1|Overall Study|Did not receive study drug|0
3049854|NCT00604188|10484152|P2|Overall Study|Non-compliance with protocol|4
3049855|NCT00604188|10484153|P1|Overall Study|Non-compliance with protocol|4
3049856|NCT00604188|10484152|P2|Overall Study|Withdrawal by Subject|1
3049857|NCT00604188|10484153|P1|Overall Study|Withdrawal by Subject|5
3049858|NCT00604188|10484152|P2|Overall Study|Lost to Follow-up|15
3049859|NCT00604188|10484153|P1|Overall Study|Lost to Follow-up|17
3049860|NCT00604188|10484152|P2|Overall Study|Adverse Event|4
3049861|NCT00604188|10484153|P1|Overall Study|Adverse Event|1
3049862|NCT00604175|10484176|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
3049863|NCT00604175|10484177|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
3049864|NCT00604175|10484178|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
3049865|NCT00604175|10484176|P3|Week 29 Through Week 72|Site closure|0
3049866|NCT00604175|10484177|P2|Week 29 Through Week 72|Site closure|1
3049867|NCT00604175|10484178|P1|Week 29 Through Week 72|Site closure|0
3049868|NCT00604175|10484176|P3|Week 29 Through Week 72|Lost to Follow-up|2
3049869|NCT00604175|10484177|P2|Week 29 Through Week 72|Lost to Follow-up|6
3049870|NCT00604175|10484178|P1|Week 29 Through Week 72|Lost to Follow-up|12
3049871|NCT00604175|10484176|P3|Week 29 Through Week 72|Death|1
3049872|NCT00604175|10484177|P2|Week 29 Through Week 72|Death|0
3049873|NCT00604175|10484178|P1|Week 29 Through Week 72|Death|0
3049874|NCT00604175|10484176|P3|Entry Through Week 28|Did not start intervention|1
3049875|NCT00604175|10484177|P2|Entry Through Week 28|Did not start intervention|0
3049876|NCT00604175|10484178|P1|Entry Through Week 28|Did not start intervention|2
3049877|NCT00604175|10484176|P3|Entry Through Week 28|Ineligible|0
3049878|NCT00604175|10484177|P2|Entry Through Week 28|Ineligible|0
3049879|NCT00604175|10484178|P1|Entry Through Week 28|Ineligible|1
3049880|NCT00604175|10484176|P3|Entry Through Week 28|Lost to Follow-up|0
3049881|NCT00604175|10484177|P2|Entry Through Week 28|Lost to Follow-up|3
3049882|NCT00604175|10484178|P1|Entry Through Week 28|Lost to Follow-up|4
3049883|NCT00604175|10484176|P3|Entry Through Week 28|Withdrawal by Subject|0
3049884|NCT00604175|10484177|P2|Entry Through Week 28|Withdrawal by Subject|0
3049885|NCT00604175|10484178|P1|Entry Through Week 28|Withdrawal by Subject|1
3049886|NCT00604175|10484176|P3|Entry Through Week 28|Death|0
3049887|NCT00604175|10484177|P2|Entry Through Week 28|Death|0
3049888|NCT00604175|10484178|P1|Entry Through Week 28|Death|2
3049889|NCT00604162|10484231|P1|Overall Study|Withdrawal by Subject|1
3049890|NCT00604162|10484231|P1|Overall Study|Physician Decision|3
3049891|NCT00603980|10484273|P1|Main Study|14th subject completed trial|1
3049892|NCT00603980|10484273|P1|Study Qualification|Inconsistent data reporting|13
3049893|NCT00603980|10484273|P1|Study Qualification|Protocol Violation|3
3049894|NCT00603915|10484389|P1|Overall Study|Physician Decision|1
3049895|NCT00603837|10484419|P2|Overall Study|Physician Decision|0
3049896|NCT00603837|10484420|P1|Overall Study|Physician Decision|3
3049897|NCT00603798|10484429|P3|Overall Study|Not due to AE|4
3049898|NCT00603798|10484430|P2|Overall Study|Not due to AE|1
3049899|NCT00603798|10484431|P1|Overall Study|Not due to AE|1
3049900|NCT00603798|10484429|P3|Overall Study|Non-compliance with study procedures|0
3049901|NCT00603798|10484430|P2|Overall Study|Non-compliance with study procedures|1
3049902|NCT00603798|10484431|P1|Overall Study|Non-compliance with study procedures|0
3049903|NCT00603798|10484429|P3|Overall Study|Lost to Follow-up|1
3049904|NCT00603798|10484430|P2|Overall Study|Lost to Follow-up|0
3049905|NCT00603798|10484431|P1|Overall Study|Lost to Follow-up|1
3049906|NCT00603798|10484429|P3|Overall Study|Withdrawal by Subject|4
3049907|NCT00603798|10484430|P2|Overall Study|Withdrawal by Subject|3
3049908|NCT00603798|10484431|P1|Overall Study|Withdrawal by Subject|4
3049909|NCT00603798|10484429|P3|Overall Study|Adverse Event|1
3049910|NCT00603798|10484430|P2|Overall Study|Adverse Event|2
3049911|NCT00603798|10484431|P1|Overall Study|Adverse Event|4
3049912|NCT00603746|10484454|P6|Overall Study|Withdrawal by Subject|1
3049913|NCT00603746|10484455|P5|Overall Study|Withdrawal by Subject|3
3049914|NCT00603746|10484456|P4|Overall Study|Withdrawal by Subject|1
3049915|NCT00603746|10484457|P3|Overall Study|Withdrawal by Subject|0
3049916|NCT00603746|10484458|P2|Overall Study|Withdrawal by Subject|0
3049917|NCT00603746|10484459|P1|Overall Study|Withdrawal by Subject|1
3049918|NCT00603746|10484454|P6|Overall Study|Physician Decision|0
3049919|NCT00603746|10484455|P5|Overall Study|Physician Decision|1
3049920|NCT00603746|10484456|P4|Overall Study|Physician Decision|0
3049921|NCT00603746|10484457|P3|Overall Study|Physician Decision|0
3049922|NCT00603746|10484458|P2|Overall Study|Physician Decision|0
3049923|NCT00603746|10484459|P1|Overall Study|Physician Decision|1
3049924|NCT00603746|10484454|P6|Overall Study|Lost to Follow-up|0
3049925|NCT00603746|10484455|P5|Overall Study|Lost to Follow-up|0
3049926|NCT00603746|10484456|P4|Overall Study|Lost to Follow-up|0
3049927|NCT00603746|10484457|P3|Overall Study|Lost to Follow-up|1
3049928|NCT00603746|10484458|P2|Overall Study|Lost to Follow-up|1
3049929|NCT00603746|10484459|P1|Overall Study|Lost to Follow-up|0
3049930|NCT00603746|10484454|P6|Overall Study|Protocol Violation|0
3049931|NCT00603746|10484455|P5|Overall Study|Protocol Violation|1
3049932|NCT00603746|10484456|P4|Overall Study|Protocol Violation|0
3049933|NCT00603746|10484457|P3|Overall Study|Protocol Violation|1
3049934|NCT00603746|10484458|P2|Overall Study|Protocol Violation|3
3049935|NCT00603746|10484459|P1|Overall Study|Protocol Violation|0
3049936|NCT00603746|10484454|P6|Overall Study|Lack of Efficacy|8
3049937|NCT00603746|10484455|P5|Overall Study|Lack of Efficacy|12
3049938|NCT00603746|10484456|P4|Overall Study|Lack of Efficacy|11
3049939|NCT00603746|10484457|P3|Overall Study|Lack of Efficacy|6
3049940|NCT00603746|10484458|P2|Overall Study|Lack of Efficacy|11
3049941|NCT00603746|10484459|P1|Overall Study|Lack of Efficacy|34
3049942|NCT00603746|10484454|P6|Overall Study|Adverse Event|4
3049943|NCT00603746|10484455|P5|Overall Study|Adverse Event|0
3049944|NCT00603746|10484456|P4|Overall Study|Adverse Event|1
3049945|NCT00603746|10484457|P3|Overall Study|Adverse Event|0
3049946|NCT00603746|10484458|P2|Overall Study|Adverse Event|3
3049947|NCT00603746|10484459|P1|Overall Study|Adverse Event|2
3049948|NCT00603733|10484607|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
3049949|NCT00603733|10484608|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
3049950|NCT00603733|10484607|P2|Maintenance Phase ITT|Physician Decision|1
3049951|NCT00603733|10484608|P1|Maintenance Phase ITT|Physician Decision|0
3049952|NCT00603733|10484607|P2|Maintenance Phase ITT|Lack of Efficacy|2
3049953|NCT00603733|10484608|P1|Maintenance Phase ITT|Lack of Efficacy|2
3049954|NCT00603733|10484607|P2|Maintenance Phase ITT|Lost to Follow-up|1
3049955|NCT00603733|10484608|P1|Maintenance Phase ITT|Lost to Follow-up|0
3049956|NCT00603733|10484607|P2|Maintenance Phase ITT|Protocol Violation|1
3049957|NCT00603733|10484608|P1|Maintenance Phase ITT|Protocol Violation|1
3049958|NCT00603733|10484607|P2|Maintenance Phase ITT|Withdrawal by Subject|0
3049959|NCT00603733|10484608|P1|Maintenance Phase ITT|Withdrawal by Subject|1
3049960|NCT00603733|10484607|P2|Maintenance Phase ITT|Adverse Event|6
3049961|NCT00603733|10484608|P1|Maintenance Phase ITT|Adverse Event|3
3049962|NCT00603733|10484607|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
3049963|NCT00603733|10484608|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
3049964|NCT00603733|10484607|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
3049965|NCT00603733|10484608|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
3049966|NCT00603733|10484607|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
3049967|NCT00603733|10484608|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
3049968|NCT00603733|10484607|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
3049969|NCT00603733|10484608|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
3049970|NCT00603733|10484607|P2|Run-In Phase - 4 Weeks|Adverse Event|1
3049971|NCT00603733|10484608|P1|Run-In Phase - 4 Weeks|Adverse Event|2
3049972|NCT00603733|10484607|P2|Active Phase ITT|Subject moved, site closed|1
3049973|NCT00603733|10484608|P1|Active Phase ITT|Subject moved, site closed|1
3049974|NCT00603733|10484607|P2|Active Phase ITT|Lack of Efficacy|2
3049975|NCT00603733|10484608|P1|Active Phase ITT|Lack of Efficacy|1
3049976|NCT00603733|10484607|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
3049977|NCT00603733|10484608|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
3049978|NCT00603733|10484607|P2|Active Phase ITT|Lost to Follow-up|1
3049979|NCT00603733|10484608|P1|Active Phase ITT|Lost to Follow-up|0
3049980|NCT00603733|10484607|P2|Active Phase ITT|Withdrawal by Subject|3
3049981|NCT00603733|10484608|P1|Active Phase ITT|Withdrawal by Subject|0
3049982|NCT00603733|10484607|P2|Active Phase ITT|Adverse Event|7
3049983|NCT00603733|10484608|P1|Active Phase ITT|Adverse Event|8
3049984|NCT00603590|10484658|P2|Overall Study|Cardiovascular event|1
3049985|NCT00603590|10484659|P1|Overall Study|Cardiovascular event|0
3049986|NCT00603590|10484658|P2|Overall Study|Lost to Follow-up|4
3049987|NCT00603590|10484659|P1|Overall Study|Lost to Follow-up|8
3049988|NCT00603590|10484658|P2|Overall Study|Adverse Event|0
3049989|NCT00603590|10484659|P1|Overall Study|Adverse Event|2
3049990|NCT00603590|10484658|P2|Overall Study|Patient discontinued study drug|15
3049991|NCT00603590|10484659|P1|Overall Study|Patient discontinued study drug|22
3049992|NCT00603590|10484658|P2|Overall Study|Refused blood test|1
3049993|NCT00603590|10484659|P1|Overall Study|Refused blood test|5
3049994|NCT00603590|10484658|P2|Overall Study|Did not attend study clinic|30
3049995|NCT00603590|10484659|P1|Overall Study|Did not attend study clinic|39
3049996|NCT00603538|10484683|P3|Overall Study|Objective progression or relapse|0
3049997|NCT00603538|10484684|P2|Overall Study|Objective progression or relapse|0
3049998|NCT00603538|10484685|P1|Overall Study|Objective progression or relapse|3
3049999|NCT00603538|10484683|P3|Overall Study|Adverse Event|2
3050000|NCT00603538|10484684|P2|Overall Study|Adverse Event|4
3050001|NCT00603538|10484685|P1|Overall Study|Adverse Event|0
3050002|NCT00603525|10484725|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
3050003|NCT00603525|10484726|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
3050004|NCT00603525|10484727|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
3050005|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
3050006|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
3050007|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
3050008|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
3050009|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
3050010|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
3050011|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
3050012|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
3050013|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
3050014|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
3050015|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
3050016|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
3050017|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
3050018|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
3050019|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
3050020|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
3050021|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
3050022|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
3050023|NCT00603525|10484725|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
3050024|NCT00603525|10484726|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
3050025|NCT00603525|10484727|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
3050026|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
3050027|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
3050028|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
3050029|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
3050030|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
3050031|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
3050032|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
3050033|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
3050034|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
3050035|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
3050036|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
3050037|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
3050038|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
3050039|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
3050040|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
3050041|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
3050042|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
3050043|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
3050044|NCT00603525|10484725|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
3050045|NCT00603525|10484726|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
3050046|NCT00603525|10484727|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
3050047|NCT00603512|10484859|P5|Overall Study|Randomized but not treated|0
3050048|NCT00603512|10484860|P4|Overall Study|Randomized but not treated|2
3050049|NCT00603512|10484861|P3|Overall Study|Randomized but not treated|1
3050050|NCT00603512|10484862|P2|Overall Study|Randomized but not treated|1
3050051|NCT00603512|10484863|P1|Overall Study|Randomized but not treated|0
3050052|NCT00603512|10484859|P5|Overall Study|Withdrawal by Subject|1
3050053|NCT00603512|10484860|P4|Overall Study|Withdrawal by Subject|0
3050054|NCT00603512|10484861|P3|Overall Study|Withdrawal by Subject|0
3050055|NCT00603512|10484862|P2|Overall Study|Withdrawal by Subject|0
3050056|NCT00603512|10484863|P1|Overall Study|Withdrawal by Subject|0
3050057|NCT00603512|10484859|P5|Overall Study|Other|1
3050058|NCT00603512|10484860|P4|Overall Study|Other|1
3050059|NCT00603512|10484861|P3|Overall Study|Other|0
3050060|NCT00603512|10484862|P2|Overall Study|Other|1
3050061|NCT00603512|10484863|P1|Overall Study|Other|2
3050062|NCT00603512|10484859|P5|Overall Study|Lack of Efficacy|1
3050063|NCT00603512|10484860|P4|Overall Study|Lack of Efficacy|0
3050064|NCT00603512|10484861|P3|Overall Study|Lack of Efficacy|0
3050065|NCT00603512|10484862|P2|Overall Study|Lack of Efficacy|1
3050066|NCT00603512|10484863|P1|Overall Study|Lack of Efficacy|0
3050067|NCT00603512|10484859|P5|Overall Study|Adverse Event|2
3050068|NCT00603512|10484860|P4|Overall Study|Adverse Event|4
3050069|NCT00603512|10484861|P3|Overall Study|Adverse Event|4
3050070|NCT00603512|10484862|P2|Overall Study|Adverse Event|2
3050071|NCT00603512|10484863|P1|Overall Study|Adverse Event|0
3050072|NCT00603473|10485005|P1|Overall Study|Protocol Violation|1
3050073|NCT00603473|10485005|P1|Overall Study|Lack of Efficacy|4
3050074|NCT00603473|10485005|P1|Overall Study|Adverse Event|4
3050075|NCT00603447|10485018|P7|Overall Study|Withdrew Consent|1
3050076|NCT00603447|10485019|P6|Overall Study|Withdrew Consent|0
3050077|NCT00603447|10485020|P5|Overall Study|Withdrew Consent|1
3050078|NCT00603447|10485021|P4|Overall Study|Withdrew Consent|0
3050079|NCT00603447|10485022|P3|Overall Study|Withdrew Consent|0
3050080|NCT00603447|10485023|P2|Overall Study|Withdrew Consent|2
3050081|NCT00603447|10485024|P1|Overall Study|Withdrew Consent|0
3050082|NCT00603447|10485018|P7|Overall Study|Other|13
3050083|NCT00603447|10485019|P6|Overall Study|Other|0
3050084|NCT00603447|10485020|P5|Overall Study|Other|3
3050085|NCT00603447|10485021|P4|Overall Study|Other|0
3050086|NCT00603447|10485022|P3|Overall Study|Other|1
3050087|NCT00603447|10485023|P2|Overall Study|Other|0
3050088|NCT00603447|10485024|P1|Overall Study|Other|0
3050089|NCT00603447|10485018|P7|Overall Study|Adverse Event|10
3050090|NCT00603447|10485019|P6|Overall Study|Adverse Event|2
3050091|NCT00603447|10485020|P5|Overall Study|Adverse Event|1
3050092|NCT00603447|10485021|P4|Overall Study|Adverse Event|2
3050093|NCT00603447|10485022|P3|Overall Study|Adverse Event|1
3050094|NCT00603447|10485023|P2|Overall Study|Adverse Event|1
3050095|NCT00603447|10485024|P1|Overall Study|Adverse Event|0
3050096|NCT00603382|10485063|P6|Overall Study|Withdrawal by Subject|1
3050097|NCT00603382|10485064|P5|Overall Study|Withdrawal by Subject|0
3050098|NCT00603382|10485065|P4|Overall Study|Withdrawal by Subject|1
3050099|NCT00603382|10485066|P3|Overall Study|Withdrawal by Subject|1
3050100|NCT00603382|10485067|P2|Overall Study|Withdrawal by Subject|3
3050101|NCT00603382|10485068|P1|Overall Study|Withdrawal by Subject|3
3050102|NCT00603382|10485063|P6|Overall Study|Physician Decision|3
3050103|NCT00603382|10485064|P5|Overall Study|Physician Decision|1
3050104|NCT00603382|10485065|P4|Overall Study|Physician Decision|0
3050105|NCT00603382|10485066|P3|Overall Study|Physician Decision|2
3050106|NCT00603382|10485067|P2|Overall Study|Physician Decision|0
3050107|NCT00603382|10485068|P1|Overall Study|Physician Decision|0
3050108|NCT00603382|10485063|P6|Overall Study|Lost to Follow-up|1
3050109|NCT00603382|10485064|P5|Overall Study|Lost to Follow-up|0
3050110|NCT00603382|10485065|P4|Overall Study|Lost to Follow-up|1
3050111|NCT00603382|10485066|P3|Overall Study|Lost to Follow-up|1
3050112|NCT00603382|10485067|P2|Overall Study|Lost to Follow-up|1
3050113|NCT00603382|10485068|P1|Overall Study|Lost to Follow-up|0
3050114|NCT00603382|10485063|P6|Overall Study|Protocol Violation|0
3050115|NCT00603382|10485064|P5|Overall Study|Protocol Violation|1
3050116|NCT00603382|10485065|P4|Overall Study|Protocol Violation|2
3050117|NCT00603382|10485066|P3|Overall Study|Protocol Violation|1
3050118|NCT00603382|10485067|P2|Overall Study|Protocol Violation|0
3050119|NCT00603382|10485068|P1|Overall Study|Protocol Violation|1
3050120|NCT00603382|10485063|P6|Overall Study|Lack of Efficacy|11
3050121|NCT00603382|10485064|P5|Overall Study|Lack of Efficacy|6
3050122|NCT00603382|10485065|P4|Overall Study|Lack of Efficacy|6
3050123|NCT00603382|10485066|P3|Overall Study|Lack of Efficacy|3
3050124|NCT00603382|10485067|P2|Overall Study|Lack of Efficacy|9
3050125|NCT00603382|10485068|P1|Overall Study|Lack of Efficacy|14
3050126|NCT00603382|10485063|P6|Overall Study|Adverse Event|2
3050127|NCT00603382|10485064|P5|Overall Study|Adverse Event|1
3050128|NCT00603382|10485065|P4|Overall Study|Adverse Event|2
3050129|NCT00603382|10485066|P3|Overall Study|Adverse Event|1
3050130|NCT00603382|10485067|P2|Overall Study|Adverse Event|1
3050131|NCT00603382|10485068|P1|Overall Study|Adverse Event|0
3050132|NCT00603304|10485216|P2|Overall Study|Patient Decision|0
3050133|NCT00603304|10485217|P1|Overall Study|Patient Decision|2
3050134|NCT00603304|10485216|P2|Overall Study|Other|0
3050135|NCT00603304|10485217|P1|Overall Study|Other|2
3050136|NCT00603304|10485216|P2|Overall Study|Moved Away|2
3050137|NCT00603304|10485217|P1|Overall Study|Moved Away|0
3050138|NCT00603304|10485216|P2|Overall Study|Non-Compliant|1
3050139|NCT00603304|10485217|P1|Overall Study|Non-Compliant|0
3050140|NCT00603304|10485216|P2|Overall Study|Exclusionary Medication|3
3050141|NCT00603304|10485217|P1|Overall Study|Exclusionary Medication|2
3050142|NCT00603304|10485216|P2|Overall Study|Crossed Over to Open Label Therapy|3
3050143|NCT00603304|10485217|P1|Overall Study|Crossed Over to Open Label Therapy|3
3050144|NCT00603304|10485216|P2|Overall Study|Unacceptable Treatment Toxicity|8
3050145|NCT00603304|10485217|P1|Overall Study|Unacceptable Treatment Toxicity|5
3050146|NCT00603304|10485216|P2|Overall Study|Adverse Event|2
3050147|NCT00603304|10485217|P1|Overall Study|Adverse Event|4
3050148|NCT00603304|10485216|P2|Overall Study|Protocol Violation|0
3050149|NCT00603304|10485217|P1|Overall Study|Protocol Violation|1
3050150|NCT00603304|10485216|P2|Overall Study|Withdrawal by Subject|5
3050151|NCT00603304|10485217|P1|Overall Study|Withdrawal by Subject|8
3050152|NCT00603304|10485216|P2|Overall Study|Lost to Follow-up|7
3050153|NCT00603304|10485217|P1|Overall Study|Lost to Follow-up|5
3050154|NCT00603278|10485273|P6|Overall Study|Lost to Follow-up|0
3050155|NCT00603278|10485274|P5|Overall Study|Lost to Follow-up|1
3050156|NCT00603278|10485275|P4|Overall Study|Lost to Follow-up|0
3050157|NCT00603278|10485276|P3|Overall Study|Lost to Follow-up|0
3050158|NCT00603278|10485277|P2|Overall Study|Lost to Follow-up|0
3050159|NCT00603278|10485278|P1|Overall Study|Lost to Follow-up|1
3050160|NCT00603278|10485273|P6|Overall Study|Physician Decision|1
3050161|NCT00603278|10485274|P5|Overall Study|Physician Decision|2
3050162|NCT00603278|10485275|P4|Overall Study|Physician Decision|0
3050163|NCT00603278|10485276|P3|Overall Study|Physician Decision|0
3050164|NCT00603278|10485277|P2|Overall Study|Physician Decision|1
3050165|NCT00603278|10485278|P1|Overall Study|Physician Decision|0
3050166|NCT00603278|10485273|P6|Overall Study|Protocol Violation|1
3050167|NCT00603278|10485274|P5|Overall Study|Protocol Violation|0
3050168|NCT00603278|10485275|P4|Overall Study|Protocol Violation|1
3050169|NCT00603278|10485276|P3|Overall Study|Protocol Violation|1
3050170|NCT00603278|10485277|P2|Overall Study|Protocol Violation|0
3050171|NCT00603278|10485278|P1|Overall Study|Protocol Violation|3
3050172|NCT00603278|10485273|P6|Overall Study|Withdrawal by Subject|2
3050173|NCT00603278|10485274|P5|Overall Study|Withdrawal by Subject|1
3050174|NCT00603278|10485275|P4|Overall Study|Withdrawal by Subject|2
3050175|NCT00603278|10485276|P3|Overall Study|Withdrawal by Subject|1
3050176|NCT00603278|10485277|P2|Overall Study|Withdrawal by Subject|3
3050177|NCT00603278|10485278|P1|Overall Study|Withdrawal by Subject|2
3050178|NCT00603278|10485273|P6|Overall Study|Adverse Event|1
3050179|NCT00603278|10485274|P5|Overall Study|Adverse Event|2
3050180|NCT00603278|10485275|P4|Overall Study|Adverse Event|0
3050181|NCT00603278|10485276|P3|Overall Study|Adverse Event|1
3050182|NCT00603278|10485277|P2|Overall Study|Adverse Event|3
3050183|NCT00603278|10485278|P1|Overall Study|Adverse Event|0
3050184|NCT00603278|10485273|P6|Overall Study|Lack of Efficacy|14
3050185|NCT00603278|10485274|P5|Overall Study|Lack of Efficacy|7
3050186|NCT00603278|10485275|P4|Overall Study|Lack of Efficacy|8
3050187|NCT00603278|10485276|P3|Overall Study|Lack of Efficacy|11
3050188|NCT00603278|10485277|P2|Overall Study|Lack of Efficacy|10
3050189|NCT00603278|10485278|P1|Overall Study|Lack of Efficacy|35
3050190|NCT00603265|10485427|P3|Overall Study|Protocol Violation|0
3050191|NCT00603265|10485428|P2|Overall Study|Protocol Violation|0
3050192|NCT00603265|10485429|P1|Overall Study|Protocol Violation|1
3050193|NCT00603265|10485427|P3|Overall Study|Participant Left Country, No Responses|0
3050194|NCT00603265|10485428|P2|Overall Study|Participant Left Country, No Responses|1
3050195|NCT00603265|10485429|P1|Overall Study|Participant Left Country, No Responses|0
3050196|NCT00603265|10485427|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
3050197|NCT00603265|10485428|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
3050198|NCT00603265|10485429|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
3050199|NCT00603265|10485427|P3|Overall Study|Lost to Follow-up|0
3050200|NCT00603265|10485428|P2|Overall Study|Lost to Follow-up|1
3050201|NCT00603265|10485429|P1|Overall Study|Lost to Follow-up|0
3050202|NCT00603265|10485427|P3|Overall Study|Lack of Efficacy|3
3050203|NCT00603265|10485428|P2|Overall Study|Lack of Efficacy|0
3050204|NCT00603265|10485429|P1|Overall Study|Lack of Efficacy|3
3050205|NCT00603265|10485427|P3|Overall Study|Withdrawal by Subject|1
3050206|NCT00603265|10485428|P2|Overall Study|Withdrawal by Subject|2
3050207|NCT00603265|10485429|P1|Overall Study|Withdrawal by Subject|1
3050208|NCT00603265|10485427|P3|Overall Study|Adverse Event|1
3050209|NCT00603265|10485428|P2|Overall Study|Adverse Event|11
3050210|NCT00603265|10485429|P1|Overall Study|Adverse Event|2
3050211|NCT00603239|10485457|P2|Overall Study|Subject decision|1
3050212|NCT00603239|10485458|P1|Overall Study|Subject decision|2
3050213|NCT00603239|10485457|P2|Overall Study|Protocol Violation|0
3050214|NCT00603239|10485458|P1|Overall Study|Protocol Violation|2
3050215|NCT00603239|10485457|P2|Overall Study|Physician Decision|0
3050216|NCT00603239|10485458|P1|Overall Study|Physician Decision|2
3050217|NCT00603239|10485457|P2|Overall Study|Lost to Follow-up|1
3050218|NCT00603239|10485458|P1|Overall Study|Lost to Follow-up|2
3050219|NCT00603239|10485457|P2|Overall Study|Loss of glucose control|0
3050220|NCT00603239|10485458|P1|Overall Study|Loss of glucose control|3
3050221|NCT00603239|10485457|P2|Overall Study|Entry criteria not met|1
3050222|NCT00603239|10485458|P1|Overall Study|Entry criteria not met|0
3050223|NCT00603239|10485457|P2|Overall Study|Adverse Event|1
3050224|NCT00603239|10485458|P1|Overall Study|Adverse Event|4
3050225|NCT00602979|10485519|P5|Overall Study|Failed Intubation|0
3050226|NCT00602979|10485520|P4|Overall Study|Failed Intubation|1
3050227|NCT00602979|10485521|P3|Overall Study|Failed Intubation|0
3050228|NCT00602979|10485522|P2|Overall Study|Failed Intubation|1
3050229|NCT00602979|10485523|P1|Overall Study|Failed Intubation|0
3050230|NCT00602979|10485519|P5|Overall Study|Lost to Follow-up|3
3050231|NCT00602979|10485520|P4|Overall Study|Lost to Follow-up|2
3050232|NCT00602979|10485521|P3|Overall Study|Lost to Follow-up|3
3050233|NCT00602979|10485522|P2|Overall Study|Lost to Follow-up|2
3050234|NCT00602979|10485523|P1|Overall Study|Lost to Follow-up|3
3050235|NCT00602927|10485573|P2|Period 3: 13 Days|MRI data quality|2
3050236|NCT00602927|10485574|P1|Period 3: 13 Days|MRI data quality|2
3050237|NCT00602927|10485573|P2|Period 3: 13 Days|Protocol Violation|1
3050238|NCT00602927|10485574|P1|Period 3: 13 Days|Protocol Violation|0
3050239|NCT00602927|10485573|P2|Period 2: 14 Days|Protocol Violation|2
3050240|NCT00602927|10485574|P1|Period 2: 14 Days|Protocol Violation|0
3050241|NCT00602927|10485573|P2|Period 1: 13 Days|Claustrophobia|1
3050242|NCT00602927|10485574|P1|Period 1: 13 Days|Claustrophobia|0
3050243|NCT00602927|10485573|P2|Period 1: 13 Days|Time|0
3050244|NCT00602927|10485574|P1|Period 1: 13 Days|Time|1
3050245|NCT00602927|10485573|P2|Period 1: 13 Days|MRI scanner technical issue|0
3050246|NCT00602927|10485574|P1|Period 1: 13 Days|MRI scanner technical issue|1
3050247|NCT00602927|10485573|P2|Period 1: 13 Days|Protocol Violation|4
3050248|NCT00602927|10485574|P1|Period 1: 13 Days|Protocol Violation|2
3050249|NCT00602797|10485591|P1|Overall Study|Adverse Event|1
3050250|NCT00602667|10485609|P3|Overall Study|Progressive disease prior to therapy|1
3050251|NCT00602667|10485610|P2|Overall Study|Progressive disease prior to therapy|0
3050252|NCT00602667|10485611|P1|Overall Study|Progressive disease prior to therapy|0
3050253|NCT00602667|10485609|P3|Overall Study|Progressive disease|45
3050254|NCT00602667|10485610|P2|Overall Study|Progressive disease|48
3050255|NCT00602667|10485611|P1|Overall Study|Progressive disease|13
3050256|NCT00602667|10485609|P3|Overall Study|Physician Decision|8
3050257|NCT00602667|10485610|P2|Overall Study|Physician Decision|3
3050258|NCT00602667|10485611|P1|Overall Study|Physician Decision|2
3050259|NCT00602667|10485609|P3|Overall Study|Second malignancy|0
3050260|NCT00602667|10485610|P2|Overall Study|Second malignancy|1
3050261|NCT00602667|10485611|P1|Overall Study|Second malignancy|0
3050262|NCT00602667|10485609|P3|Overall Study|Excessive toxicity|0
3050263|NCT00602667|10485610|P2|Overall Study|Excessive toxicity|1
3050264|NCT00602667|10485611|P1|Overall Study|Excessive toxicity|1
3050265|NCT00602667|10485609|P3|Overall Study|Family request|6
3050266|NCT00602667|10485610|P2|Overall Study|Family request|25
3050267|NCT00602667|10485611|P1|Overall Study|Family request|3
3050268|NCT00602667|10485609|P3|Overall Study|Death|1
3050269|NCT00602667|10485610|P2|Overall Study|Death|1
3050270|NCT00602667|10485611|P1|Overall Study|Death|0
3050271|NCT00602667|10485609|P3|Overall Study|Still on Therapy|2
3050272|NCT00602667|10485610|P2|Overall Study|Still on Therapy|2
3050273|NCT00602667|10485611|P1|Overall Study|Still on Therapy|0
3050274|NCT00602641|10485790|P2|Overall Study|Other|1
3050275|NCT00602641|10485791|P1|Overall Study|Other|3
3050276|NCT00602641|10485790|P2|Overall Study|Administrative Closure|1
3050277|NCT00602641|10485791|P1|Overall Study|Administrative Closure|1
3050278|NCT00602641|10485790|P2|Overall Study|Physician Decision|4
3050279|NCT00602641|10485791|P1|Overall Study|Physician Decision|5
3050280|NCT00602641|10485790|P2|Overall Study|Other Complicating Disease|2
3050281|NCT00602641|10485791|P1|Overall Study|Other Complicating Disease|5
3050282|NCT00602641|10485790|P2|Overall Study|Alternative therapy|2
3050283|NCT00602641|10485791|P1|Overall Study|Alternative therapy|5
3050284|NCT00602641|10485790|P2|Overall Study|Withdrawal by Subject|12
3050285|NCT00602641|10485791|P1|Overall Study|Withdrawal by Subject|15
3050286|NCT00602641|10485790|P2|Overall Study|Death|5
3050287|NCT00602641|10485791|P1|Overall Study|Death|6
3050288|NCT00602641|10485790|P2|Overall Study|Disease progression|55
3050289|NCT00602641|10485791|P1|Overall Study|Disease progression|38
3050290|NCT00602641|10485790|P2|Overall Study|Adverse Event|53
3050291|NCT00602641|10485791|P1|Overall Study|Adverse Event|62
3050292|NCT00602641|10485790|P2|Overall Study|Still on treatment at time of analysis|15
3050293|NCT00602641|10485791|P1|Overall Study|Still on treatment at time of analysis|8
3050294|NCT00602641|10485790|P2|Overall Study|Never started protocol therapy|2
3050295|NCT00602641|10485791|P1|Overall Study|Never started protocol therapy|6
3050296|NCT00602537|10485805|P2|Follow Up Study Comparison|Withdrawal by Subject|2
3050297|NCT00602537|10485806|P1|Follow Up Study Comparison|Withdrawal by Subject|2
3050298|NCT00602537|10485805|P2|Follow Up Study Comparison|Lost to Follow-up|1
3050299|NCT00602537|10485806|P1|Follow Up Study Comparison|Lost to Follow-up|8
3050300|NCT00602537|10485805|P2|Follow Up Study Comparison|Adverse Event|0
3050301|NCT00602537|10485806|P1|Follow Up Study Comparison|Adverse Event|1
3050302|NCT00602537|10485805|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
3050303|NCT00602537|10485806|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
3050304|NCT00602537|10485805|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
3050305|NCT00602537|10485806|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
3050306|NCT00602537|10485805|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
3050307|NCT00602537|10485806|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
3050308|NCT00602537|10485805|P2|12 Week Double Blind Comparison|Adverse Event|5
3050309|NCT00602537|10485806|P1|12 Week Double Blind Comparison|Adverse Event|2
3050310|NCT00602472|10485816|P2|Overall Study|Other incl. lack of efficacy|2
3050311|NCT00602472|10485817|P1|Overall Study|Other incl. lack of efficacy|4
3050312|NCT00602472|10485816|P2|Overall Study|Withdrawal by Subject|14
3050313|NCT00602472|10485817|P1|Overall Study|Withdrawal by Subject|8
3050314|NCT00602472|10485816|P2|Overall Study|Protocol Violation|19
3050315|NCT00602472|10485817|P1|Overall Study|Protocol Violation|4
3050316|NCT00602472|10485816|P2|Overall Study|Adverse Event|23
3050317|NCT00602472|10485817|P1|Overall Study|Adverse Event|5
3050318|NCT00602420|10485882|P2|Overall Study|Adverse Event|0
3050319|NCT00602420|10485883|P1|Overall Study|Adverse Event|1
3050320|NCT00602420|10485882|P2|Overall Study|Withdrawal by Subject|17
3050321|NCT00602420|10485883|P1|Overall Study|Withdrawal by Subject|18
3050322|NCT00602420|10485882|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
3050323|NCT00602420|10485883|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
3050324|NCT00602420|10485882|P2|Overall Study|Death|4
3050325|NCT00602420|10485883|P1|Overall Study|Death|1
3050326|NCT00601900|10485991|P2|Overall Study|Withdrawal by Subject|3
3050327|NCT00601900|10485992|P1|Overall Study|Withdrawal by Subject|0
3050328|NCT00601835|10486008|P2|Overall Study|Relocate|2
3050329|NCT00601835|10486009|P1|Overall Study|Relocate|12
3050330|NCT00601835|10486008|P2|Overall Study|Adverse Event|1
3050331|NCT00601835|10486009|P1|Overall Study|Adverse Event|1
3050332|NCT00601835|10486008|P2|Overall Study|Lost to Follow-up|5
3050333|NCT00601835|10486009|P1|Overall Study|Lost to Follow-up|37
3050334|NCT00601835|10486008|P2|Overall Study|Physician Decision|0
3050335|NCT00601835|10486009|P1|Overall Study|Physician Decision|1
3050336|NCT00601835|10486008|P2|Overall Study|Withdrawal by Subject|6
3050337|NCT00601835|10486009|P1|Overall Study|Withdrawal by Subject|9
3050338|NCT00601705|10486098|P1|Overall Study|Withdrawal by Subject|1
3050339|NCT00601640|10486110|P3|Overall Study|change in eligibility status|1
3050340|NCT00601640|10486111|P2|Overall Study|change in eligibility status|1
3050341|NCT00601640|10486112|P1|Overall Study|change in eligibility status|0
3050342|NCT00601640|10486110|P3|Overall Study|intercurrent illness|0
3050343|NCT00601640|10486111|P2|Overall Study|intercurrent illness|0
3050344|NCT00601640|10486112|P1|Overall Study|intercurrent illness|1
3050345|NCT00601640|10486110|P3|Overall Study|Adverse Event|2
3050346|NCT00601640|10486111|P2|Overall Study|Adverse Event|4
3050347|NCT00601640|10486112|P1|Overall Study|Adverse Event|0
3050348|NCT00601640|10486110|P3|Overall Study|Death|0
3050349|NCT00601640|10486111|P2|Overall Study|Death|0
3050350|NCT00601640|10486112|P1|Overall Study|Death|1
3050351|NCT00601640|10486110|P3|Overall Study|Withdrawal by Subject|7
3050352|NCT00601640|10486111|P2|Overall Study|Withdrawal by Subject|0
3050353|NCT00601640|10486112|P1|Overall Study|Withdrawal by Subject|3
3050354|NCT00601523|10486137|P2|Overall Study|Other|1
3050355|NCT00601523|10486138|P1|Overall Study|Other|9
3050356|NCT00601523|10486137|P2|Overall Study|Withdrawal by Subject|9
3050357|NCT00601523|10486138|P1|Overall Study|Withdrawal by Subject|18
3050358|NCT00601523|10486137|P2|Overall Study|Lost to Follow-up|1
3050359|NCT00601523|10486138|P1|Overall Study|Lost to Follow-up|0
3050360|NCT00601523|10486137|P2|Overall Study|Protocol Violation|1
3050361|NCT00601523|10486138|P1|Overall Study|Protocol Violation|5
3050362|NCT00601523|10486137|P2|Overall Study|Lack of Efficacy|0
3050363|NCT00601523|10486138|P1|Overall Study|Lack of Efficacy|3
3050364|NCT00601523|10486137|P2|Overall Study|Adverse Event|14
3050365|NCT00601523|10486138|P1|Overall Study|Adverse Event|42
3050366|NCT00601458|10486173|P3|Overall Study|Early Termination|1
3050367|NCT00601458|10486174|P2|Overall Study|Early Termination|1
3050368|NCT00601458|10486175|P1|Overall Study|Early Termination|0
3050369|NCT00601458|10486173|P3|Overall Study|Protocol Violation|1
3050370|NCT00601458|10486174|P2|Overall Study|Protocol Violation|2
3050371|NCT00601458|10486175|P1|Overall Study|Protocol Violation|3
3050372|NCT00601458|10486173|P3|Overall Study|Incomplete Data|0
3050373|NCT00601458|10486174|P2|Overall Study|Incomplete Data|2
3050374|NCT00601458|10486175|P1|Overall Study|Incomplete Data|0
3050375|NCT00601458|10486173|P3|Overall Study|Dosing Error|0
3050376|NCT00601458|10486174|P2|Overall Study|Dosing Error|0
3050377|NCT00601458|10486175|P1|Overall Study|Dosing Error|1
3050378|NCT00601419|10486186|P1|Overall Study|Missed Visits|1
3050379|NCT00601419|10486186|P1|Overall Study|Lost to Follow-up|3
3050380|NCT00601354|10486216|P2|Overall Study|Lost to Follow-up|5
3050381|NCT00601354|10486217|P1|Overall Study|Lost to Follow-up|4
3050382|NCT00601250|10486229|P2|Overall Study|Other incl. lack of efficacy|9
3050383|NCT00601250|10486230|P1|Overall Study|Other incl. lack of efficacy|2
3050384|NCT00601250|10486229|P2|Overall Study|Withdrawal by Subject|13
3050385|NCT00601250|10486230|P1|Overall Study|Withdrawal by Subject|4
3050386|NCT00601250|10486229|P2|Overall Study|Lost to Follow-up|6
3050387|NCT00601250|10486230|P1|Overall Study|Lost to Follow-up|2
3050388|NCT00601250|10486229|P2|Overall Study|Protocol Violation|2
3050389|NCT00601250|10486230|P1|Overall Study|Protocol Violation|3
3050390|NCT00601250|10486229|P2|Overall Study|Adverse Event|9
3050391|NCT00601250|10486230|P1|Overall Study|Adverse Event|3
3050392|NCT00601172|10486266|P2|Overall Study|Did not meet continuation criteria|20
3050393|NCT00601172|10486267|P1|Overall Study|Did not meet continuation criteria|19
3050394|NCT00601172|10486266|P2|Overall Study|Withdrawal by Subject|27
3050395|NCT00601172|10486267|P1|Overall Study|Withdrawal by Subject|35
3050396|NCT00601172|10486266|P2|Overall Study|Physician Decision|28
3050397|NCT00601172|10486267|P1|Overall Study|Physician Decision|27
3050398|NCT00601172|10486266|P2|Overall Study|Lost to Follow-up|3
3050399|NCT00601172|10486267|P1|Overall Study|Lost to Follow-up|4
3050400|NCT00601172|10486266|P2|Overall Study|Protocol Violation|5
3050401|NCT00601172|10486267|P1|Overall Study|Protocol Violation|2
3050402|NCT00601172|10486266|P2|Overall Study|Lack of Efficacy|12
3050403|NCT00601172|10486267|P1|Overall Study|Lack of Efficacy|11
3050404|NCT00601172|10486266|P2|Overall Study|Adverse Event|32
3050405|NCT00601172|10486267|P1|Overall Study|Adverse Event|43
3050406|NCT00601107|10486324|P4|Overall Study|Undefined|0
3050407|NCT00601107|10486325|P3|Overall Study|Undefined|1
3050408|NCT00601107|10486326|P2|Overall Study|Undefined|0
3050409|NCT00601107|10486327|P1|Overall Study|Undefined|1
3050410|NCT00601107|10486324|P4|Overall Study|Worsening of Psoriasis|4
3050411|NCT00601107|10486325|P3|Overall Study|Worsening of Psoriasis|1
3050412|NCT00601107|10486326|P2|Overall Study|Worsening of Psoriasis|1
3050413|NCT00601107|10486327|P1|Overall Study|Worsening of Psoriasis|4
3050414|NCT00601107|10486324|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
3050415|NCT00601107|10486325|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
3050573|NCT00600171|10486690|P4|Overall Study|Lost to Follow-up|1
3050416|NCT00601107|10486326|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
3050417|NCT00601107|10486327|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
3050418|NCT00601107|10486324|P4|Overall Study|Lost to Follow-up|3
3050419|NCT00601107|10486325|P3|Overall Study|Lost to Follow-up|0
3050420|NCT00601107|10486326|P2|Overall Study|Lost to Follow-up|3
3050421|NCT00601107|10486327|P1|Overall Study|Lost to Follow-up|3
3050422|NCT00601107|10486324|P4|Overall Study|Withdrawal by Subject|4
3050423|NCT00601107|10486325|P3|Overall Study|Withdrawal by Subject|7
3050424|NCT00601107|10486326|P2|Overall Study|Withdrawal by Subject|4
3050425|NCT00601107|10486327|P1|Overall Study|Withdrawal by Subject|5
3050426|NCT00601107|10486324|P4|Overall Study|Adverse Event|0
3050427|NCT00601107|10486325|P3|Overall Study|Adverse Event|3
3050428|NCT00601107|10486326|P2|Overall Study|Adverse Event|1
3050429|NCT00601107|10486327|P1|Overall Study|Adverse Event|0
3050430|NCT00600938|10486347|P4|Extension Study|Death|0
3050431|NCT00600938|10486348|P3|Extension Study|Death|0
3050432|NCT00600938|10486349|P2|Extension Study|Death|0
3050433|NCT00600938|10486350|P1|Extension Study|Death|1
3050434|NCT00600938|10486347|P4|Extension Study|Lost to Follow-up|0
3050435|NCT00600938|10486348|P3|Extension Study|Lost to Follow-up|2
3050436|NCT00600938|10486349|P2|Extension Study|Lost to Follow-up|1
3050437|NCT00600938|10486350|P1|Extension Study|Lost to Follow-up|1
3050438|NCT00600938|10486347|P4|Extension Study|Withdrawal by Subject|0
3050439|NCT00600938|10486348|P3|Extension Study|Withdrawal by Subject|3
3050440|NCT00600938|10486349|P2|Extension Study|Withdrawal by Subject|2
3050441|NCT00600938|10486350|P1|Extension Study|Withdrawal by Subject|2
3050442|NCT00600938|10486347|P4|Extension Study|Unsatisfactory therapeutic effect|0
3050443|NCT00600938|10486348|P3|Extension Study|Unsatisfactory therapeutic effect|1
3050444|NCT00600938|10486349|P2|Extension Study|Unsatisfactory therapeutic effect|1
3050445|NCT00600938|10486350|P1|Extension Study|Unsatisfactory therapeutic effect|4
3050446|NCT00600938|10486347|P4|Extension Study|Abnormal test procedure results|1
3050447|NCT00600938|10486348|P3|Extension Study|Abnormal test procedure results|1
3050448|NCT00600938|10486349|P2|Extension Study|Abnormal test procedure results|1
3050449|NCT00600938|10486350|P1|Extension Study|Abnormal test procedure results|0
3050450|NCT00600938|10486347|P4|Extension Study|Adverse Event|0
3050451|NCT00600938|10486348|P3|Extension Study|Adverse Event|2
3050452|NCT00600938|10486349|P2|Extension Study|Adverse Event|0
3050453|NCT00600938|10486350|P1|Extension Study|Adverse Event|1
3050454|NCT00600938|10486347|P4|Core Study|Protocol Violation|0
3050455|NCT00600938|10486348|P3|Core Study|Protocol Violation|0
3050456|NCT00600938|10486349|P2|Core Study|Protocol Violation|2
3050457|NCT00600938|10486350|P1|Core Study|Protocol Violation|1
3050458|NCT00600938|10486347|P4|Core Study|Death|0
3050459|NCT00600938|10486348|P3|Core Study|Death|0
3050460|NCT00600938|10486349|P2|Core Study|Death|1
3050461|NCT00600938|10486350|P1|Core Study|Death|1
3050462|NCT00600938|10486347|P4|Core Study|Lost to Follow-up|0
3050463|NCT00600938|10486348|P3|Core Study|Lost to Follow-up|0
3050464|NCT00600938|10486349|P2|Core Study|Lost to Follow-up|2
3050465|NCT00600938|10486350|P1|Core Study|Lost to Follow-up|3
3050466|NCT00600938|10486347|P4|Core Study|Patient withdrew consent|0
3050467|NCT00600938|10486348|P3|Core Study|Patient withdrew consent|0
3050468|NCT00600938|10486349|P2|Core Study|Patient withdrew consent|12
3050469|NCT00600938|10486350|P1|Core Study|Patient withdrew consent|7
3050470|NCT00600938|10486347|P4|Core Study|Unsatisfactory therapeutic effect|0
3050471|NCT00600938|10486348|P3|Core Study|Unsatisfactory therapeutic effect|0
3050472|NCT00600938|10486349|P2|Core Study|Unsatisfactory therapeutic effect|2
3050473|NCT00600938|10486350|P1|Core Study|Unsatisfactory therapeutic effect|1
3050474|NCT00600938|10486347|P4|Core Study|Abnormal test procedure result(s)|0
3050475|NCT00600938|10486348|P3|Core Study|Abnormal test procedure result(s)|0
3050476|NCT00600938|10486349|P2|Core Study|Abnormal test procedure result(s)|2
3050477|NCT00600938|10486350|P1|Core Study|Abnormal test procedure result(s)|3
3050478|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Death|0
3050479|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Death|1
3050480|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
3050481|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
3050482|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
3050483|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
3050484|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Administrative Problems|4
3050485|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Administrative Problems|4
3050486|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
3050487|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
3050488|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
3050489|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
3050490|NCT00600886|10486414|P2|Extension - After Crossover (CAS)|Adverse Event|1
3050491|NCT00600886|10486415|P1|Extension - After Crossover (CAS)|Adverse Event|19
3050492|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
3050493|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
3050494|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Death|1
3050495|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Death|1
3050496|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
3050497|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
3050498|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Adverse Event|1
3050499|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Adverse Event|4
3050500|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
3050501|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
3050502|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
3050503|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
3050504|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
3050505|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
3050506|NCT00600886|10486414|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
3050507|NCT00600886|10486415|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
3050508|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Death|1
3050509|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Death|0
3050510|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
3050511|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
3050512|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
3050513|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
3050514|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
3050515|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
3050516|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
3050517|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
3050518|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
3050519|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
3050520|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
3050521|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
3050522|NCT00600886|10486414|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
3050523|NCT00600886|10486415|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
3050524|NCT00600821|10486479|P2|Overall Study|Other|3
3050525|NCT00600821|10486480|P1|Overall Study|Other|2
3050526|NCT00600821|10486479|P2|Overall Study|Randomized but not treated|1
3050527|NCT00600821|10486480|P1|Overall Study|Randomized but not treated|0
3050528|NCT00600821|10486479|P2|Overall Study|Objective progression or relapse|1
3050529|NCT00600821|10486480|P1|Overall Study|Objective progression or relapse|0
3050530|NCT00600821|10486479|P2|Overall Study|Terminated by sponsor|6
3050531|NCT00600821|10486480|P1|Overall Study|Terminated by sponsor|8
3050532|NCT00600821|10486479|P2|Overall Study|Withdrawal by Subject|1
3050533|NCT00600821|10486480|P1|Overall Study|Withdrawal by Subject|1
3050534|NCT00600821|10486479|P2|Overall Study|Lost to Follow-up|2
3050535|NCT00600821|10486480|P1|Overall Study|Lost to Follow-up|2
3050536|NCT00600821|10486479|P2|Overall Study|Death|46
3050537|NCT00600821|10486480|P1|Overall Study|Death|45
3050538|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
3050539|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
3050540|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
3050541|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
3050542|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
3050543|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
3050544|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
3050545|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
3050546|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
3050547|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
3050548|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
3050549|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
3050550|NCT00600756|10486508|P2|Overall Study Analysis After 12 Months|Adverse Event|44
3050551|NCT00600756|10486509|P1|Overall Study Analysis After 12 Months|Adverse Event|53
3050552|NCT00600756|10486508|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
3050553|NCT00600756|10486509|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
3050554|NCT00600756|10486508|P2|Analysis After 6 Months|Lost to Follow-up|8
3050555|NCT00600756|10486509|P1|Analysis After 6 Months|Lost to Follow-up|10
3050556|NCT00600756|10486508|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
3050557|NCT00600756|10486509|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
3050558|NCT00600756|10486508|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
3050559|NCT00600756|10486509|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
3050560|NCT00600756|10486508|P2|Analysis After 6 Months|Incorrect Enrollment|21
3050561|NCT00600756|10486509|P1|Analysis After 6 Months|Incorrect Enrollment|12
3050562|NCT00600756|10486508|P2|Analysis After 6 Months|Withdrawal by Subject|30
3050563|NCT00600756|10486509|P1|Analysis After 6 Months|Withdrawal by Subject|38
3050564|NCT00600756|10486508|P2|Analysis After 6 Months|Adverse Event|33
3050565|NCT00600756|10486509|P1|Analysis After 6 Months|Adverse Event|43
3050566|NCT00600613|10486618|P1|Overall Study|Protocol Deviation|1
3050567|NCT00600353|10486624|P2|Overall Study|History of prepartive regimen|1
3050568|NCT00600353|10486625|P1|Overall Study|History of prepartive regimen|0
3050569|NCT00600353|10486624|P2|Overall Study|history of malignancy within 5 years|0
3050570|NCT00600353|10486625|P1|Overall Study|history of malignancy within 5 years|1
3050571|NCT00600171|10486688|P6|Overall Study|Lost to Follow-up|0
3050572|NCT00600171|10486689|P5|Overall Study|Lost to Follow-up|0
3050574|NCT00600171|10486691|P3|Overall Study|Lost to Follow-up|0
3050575|NCT00600171|10486692|P2|Overall Study|Lost to Follow-up|0
3050576|NCT00600171|10486693|P1|Overall Study|Lost to Follow-up|0
3050577|NCT00600171|10486688|P6|Overall Study|Physician Decision|2
3050578|NCT00600171|10486689|P5|Overall Study|Physician Decision|0
3050579|NCT00600171|10486690|P4|Overall Study|Physician Decision|1
3050580|NCT00600171|10486691|P3|Overall Study|Physician Decision|0
3050581|NCT00600171|10486692|P2|Overall Study|Physician Decision|1
3050582|NCT00600171|10486693|P1|Overall Study|Physician Decision|0
3050583|NCT00600171|10486688|P6|Overall Study|Withdrawal by Subject|1
3050584|NCT00600171|10486689|P5|Overall Study|Withdrawal by Subject|1
3050585|NCT00600171|10486690|P4|Overall Study|Withdrawal by Subject|1
3050586|NCT00600171|10486691|P3|Overall Study|Withdrawal by Subject|0
3050587|NCT00600171|10486692|P2|Overall Study|Withdrawal by Subject|0
3050588|NCT00600171|10486693|P1|Overall Study|Withdrawal by Subject|3
3050589|NCT00600171|10486688|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
3050590|NCT00600171|10486689|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
3050591|NCT00600171|10486690|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
3050592|NCT00600171|10486691|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
3050593|NCT00600171|10486692|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
3050594|NCT00600171|10486693|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
3050595|NCT00600171|10486688|P6|Overall Study|Protocol Violation|0
3050596|NCT00600171|10486689|P5|Overall Study|Protocol Violation|0
3050597|NCT00600171|10486690|P4|Overall Study|Protocol Violation|1
3050598|NCT00600171|10486691|P3|Overall Study|Protocol Violation|0
3050599|NCT00600171|10486692|P2|Overall Study|Protocol Violation|2
3050600|NCT00600171|10486693|P1|Overall Study|Protocol Violation|1
3050601|NCT00600171|10486688|P6|Overall Study|Lack of Efficacy|0
3050602|NCT00600171|10486689|P5|Overall Study|Lack of Efficacy|4
3050603|NCT00600171|10486690|P4|Overall Study|Lack of Efficacy|5
3050604|NCT00600171|10486691|P3|Overall Study|Lack of Efficacy|3
3050605|NCT00600171|10486692|P2|Overall Study|Lack of Efficacy|12
3050606|NCT00600171|10486693|P1|Overall Study|Lack of Efficacy|9
3050607|NCT00600171|10486688|P6|Overall Study|Adverse Event|0
3050608|NCT00600171|10486689|P5|Overall Study|Adverse Event|1
3050609|NCT00600171|10486690|P4|Overall Study|Adverse Event|0
3050610|NCT00600171|10486691|P3|Overall Study|Adverse Event|0
3050611|NCT00600171|10486692|P2|Overall Study|Adverse Event|1
3050612|NCT00600171|10486693|P1|Overall Study|Adverse Event|0
3050613|NCT00600119|10486767|P6|Follow-up Period|Other|0
3050614|NCT00600119|10486768|P5|Follow-up Period|Other|0
3050615|NCT00600119|10486769|P4|Follow-up Period|Other|0
3050616|NCT00600119|10486770|P3|Follow-up Period|Other|0
3050617|NCT00600119|10486771|P2|Follow-up Period|Other|0
3050618|NCT00600119|10486772|P1|Follow-up Period|Other|1
3050619|NCT00600119|10486767|P6|Follow-up Period|Adverse Event|1
3050620|NCT00600119|10486768|P5|Follow-up Period|Adverse Event|0
3050621|NCT00600119|10486769|P4|Follow-up Period|Adverse Event|0
3050622|NCT00600119|10486770|P3|Follow-up Period|Adverse Event|0
3050623|NCT00600119|10486771|P2|Follow-up Period|Adverse Event|0
3050624|NCT00600119|10486772|P1|Follow-up Period|Adverse Event|0
3050625|NCT00600119|10486767|P6|Double-blind Treatment Period|Adverse Event|10
3050626|NCT00600119|10486768|P5|Double-blind Treatment Period|Adverse Event|2
3050627|NCT00600119|10486769|P4|Double-blind Treatment Period|Adverse Event|1
3050628|NCT00600119|10486770|P3|Double-blind Treatment Period|Adverse Event|0
3050629|NCT00600119|10486771|P2|Double-blind Treatment Period|Adverse Event|1
3050630|NCT00600119|10486772|P1|Double-blind Treatment Period|Adverse Event|1
3050631|NCT00600119|10486767|P6|Double-blind Treatment Period|Lost to Follow-up|0
3050632|NCT00600119|10486768|P5|Double-blind Treatment Period|Lost to Follow-up|0
3050633|NCT00600119|10486769|P4|Double-blind Treatment Period|Lost to Follow-up|0
3050634|NCT00600119|10486770|P3|Double-blind Treatment Period|Lost to Follow-up|0
3050635|NCT00600119|10486771|P2|Double-blind Treatment Period|Lost to Follow-up|1
3050636|NCT00600119|10486772|P1|Double-blind Treatment Period|Lost to Follow-up|0
3050637|NCT00600119|10486767|P6|Double-blind Treatment Period|Physician Decision|0
3050638|NCT00600119|10486768|P5|Double-blind Treatment Period|Physician Decision|0
3050639|NCT00600119|10486769|P4|Double-blind Treatment Period|Physician Decision|0
3050640|NCT00600119|10486770|P3|Double-blind Treatment Period|Physician Decision|0
3050641|NCT00600119|10486771|P2|Double-blind Treatment Period|Physician Decision|0
3050642|NCT00600119|10486772|P1|Double-blind Treatment Period|Physician Decision|2
3050643|NCT00600119|10486767|P6|Double-blind Treatment Period|Sponsor Decision|0
3050644|NCT00600119|10486768|P5|Double-blind Treatment Period|Sponsor Decision|1
3050645|NCT00600119|10486769|P4|Double-blind Treatment Period|Sponsor Decision|0
3050646|NCT00600119|10486770|P3|Double-blind Treatment Period|Sponsor Decision|0
3050647|NCT00600119|10486771|P2|Double-blind Treatment Period|Sponsor Decision|1
3050648|NCT00600119|10486772|P1|Double-blind Treatment Period|Sponsor Decision|0
3050649|NCT00600119|10486767|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
3050650|NCT00600119|10486768|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
3050651|NCT00600119|10486769|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
3050652|NCT00600119|10486770|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
3050653|NCT00600119|10486771|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
3050654|NCT00600119|10486772|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
3050655|NCT00600119|10486767|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
3050656|NCT00600119|10486768|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
3050657|NCT00600119|10486769|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
3050658|NCT00600119|10486770|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
3050659|NCT00600119|10486771|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
3050660|NCT00600119|10486772|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
3050661|NCT00600119|10486767|P6|Double-blind Treatment Period|Other|1
3050662|NCT00600119|10486768|P5|Double-blind Treatment Period|Other|2
3050663|NCT00600119|10486769|P4|Double-blind Treatment Period|Other|0
3050664|NCT00600119|10486770|P3|Double-blind Treatment Period|Other|0
3050665|NCT00600119|10486771|P2|Double-blind Treatment Period|Other|0
3050666|NCT00600119|10486772|P1|Double-blind Treatment Period|Other|0
3050667|NCT00600119|10486767|P6|Double-blind Treatment Period|Withdrawal by Subject|3
3050668|NCT00600119|10486768|P5|Double-blind Treatment Period|Withdrawal by Subject|0
3050669|NCT00600119|10486769|P4|Double-blind Treatment Period|Withdrawal by Subject|1
3050670|NCT00600119|10486770|P3|Double-blind Treatment Period|Withdrawal by Subject|0
3050671|NCT00600119|10486771|P2|Double-blind Treatment Period|Withdrawal by Subject|0
3050672|NCT00600119|10486772|P1|Double-blind Treatment Period|Withdrawal by Subject|2
3050673|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
3050674|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
3050675|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
3050676|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
3050677|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
3050678|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
3050679|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Adverse Event|1
3050680|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Adverse Event|0
3050681|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Adverse Event|1
3050682|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Adverse Event|0
3050683|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Adverse Event|0
3050684|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Adverse Event|0
3050685|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
3050686|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
3050687|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
3050688|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
3050689|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
3050690|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
3050691|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
3050692|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
3050693|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
3050694|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
3050695|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
3050696|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
3050697|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
3050698|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
3050699|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
3050700|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
3050701|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
3050702|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
3050703|NCT00600119|10486767|P6|Single-blind Placebo run-in Period|Other - Not specified|1
3050704|NCT00600119|10486768|P5|Single-blind Placebo run-in Period|Other - Not specified|1
3050705|NCT00600119|10486769|P4|Single-blind Placebo run-in Period|Other - Not specified|0
3050706|NCT00600119|10486770|P3|Single-blind Placebo run-in Period|Other - Not specified|0
3050707|NCT00600119|10486771|P2|Single-blind Placebo run-in Period|Other - Not specified|0
3050708|NCT00600119|10486772|P1|Single-blind Placebo run-in Period|Other - Not specified|1
3050709|NCT00600106|10486806|P2|Overall Study|Withdrawal by Subject|1
3050710|NCT00600106|10486807|P1|Overall Study|Withdrawal by Subject|1
3050711|NCT00600067|10486854|P2|Overall Study|Lack of Efficacy|0
3050712|NCT00600067|10486855|P1|Overall Study|Lack of Efficacy|1
3050713|NCT00600067|10486854|P2|Overall Study|protocol non-compliance|3
3050714|NCT00600067|10486855|P1|Overall Study|protocol non-compliance|0
3050715|NCT00600067|10486854|P2|Overall Study|Lost to Follow-up|3
3050716|NCT00600067|10486855|P1|Overall Study|Lost to Follow-up|2
3050717|NCT00600067|10486854|P2|Overall Study|Adverse Event|1
3050718|NCT00600067|10486855|P1|Overall Study|Adverse Event|0
3050719|NCT00600028|10486865|P2|Second Intervention (12 Weeks)|Adverse Event|2
3050720|NCT00600028|10486866|P1|Second Intervention (12 Weeks)|Adverse Event|0
3050721|NCT00600028|10486865|P2|First Intervention (12 Weeks)|Adverse Event|1
3050722|NCT00600028|10486866|P1|First Intervention (12 Weeks)|Adverse Event|0
3050723|NCT00600028|10486865|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
3050724|NCT00600028|10486866|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
3050725|NCT00599924|10486896|P7|Overall Study|Other|2
3050726|NCT00599924|10486897|P6|Overall Study|Other|0
3050727|NCT00599924|10486898|P5|Overall Study|Other|2
3050728|NCT00599924|10486899|P4|Overall Study|Other|1
3050729|NCT00599924|10486900|P3|Overall Study|Other|0
3050730|NCT00599924|10486901|P2|Overall Study|Other|0
3050731|NCT00599924|10486902|P1|Overall Study|Other|0
3050732|NCT00599924|10486896|P7|Overall Study|Withdrawal by Subject|0
3050733|NCT00599924|10486897|P6|Overall Study|Withdrawal by Subject|0
3050734|NCT00599924|10486898|P5|Overall Study|Withdrawal by Subject|1
3050735|NCT00599924|10486899|P4|Overall Study|Withdrawal by Subject|0
3050736|NCT00599924|10486900|P3|Overall Study|Withdrawal by Subject|1
3050737|NCT00599924|10486901|P2|Overall Study|Withdrawal by Subject|0
3050738|NCT00599924|10486902|P1|Overall Study|Withdrawal by Subject|0
3050739|NCT00599924|10486896|P7|Overall Study|Protocol Violation|0
3050740|NCT00599924|10486897|P6|Overall Study|Protocol Violation|0
3050741|NCT00599924|10486898|P5|Overall Study|Protocol Violation|0
3050742|NCT00599924|10486899|P4|Overall Study|Protocol Violation|1
3050743|NCT00599924|10486900|P3|Overall Study|Protocol Violation|0
3050744|NCT00599924|10486901|P2|Overall Study|Protocol Violation|0
3050745|NCT00599924|10486902|P1|Overall Study|Protocol Violation|0
3050746|NCT00599924|10486896|P7|Overall Study|Death|1
3050747|NCT00599924|10486897|P6|Overall Study|Death|2
3050748|NCT00599924|10486898|P5|Overall Study|Death|0
3050749|NCT00599924|10486899|P4|Overall Study|Death|2
3050750|NCT00599924|10486900|P3|Overall Study|Death|0
3050751|NCT00599924|10486901|P2|Overall Study|Death|0
3050752|NCT00599924|10486902|P1|Overall Study|Death|0
3050753|NCT00599924|10486896|P7|Overall Study|Adverse Event|2
3050754|NCT00599924|10486897|P6|Overall Study|Adverse Event|0
3050755|NCT00599924|10486898|P5|Overall Study|Adverse Event|0
3050756|NCT00599924|10486899|P4|Overall Study|Adverse Event|2
3050757|NCT00599924|10486900|P3|Overall Study|Adverse Event|0
3050758|NCT00599924|10486901|P2|Overall Study|Adverse Event|0
3050759|NCT00599924|10486902|P1|Overall Study|Adverse Event|0
3050760|NCT00599924|10486896|P7|Overall Study|Lack of Efficacy|0
3050761|NCT00599924|10486897|P6|Overall Study|Lack of Efficacy|2
3050762|NCT00599924|10486898|P5|Overall Study|Lack of Efficacy|3
3050763|NCT00599924|10486899|P4|Overall Study|Lack of Efficacy|2
3050764|NCT00599924|10486900|P3|Overall Study|Lack of Efficacy|1
3050765|NCT00599924|10486901|P2|Overall Study|Lack of Efficacy|5
3050766|NCT00599924|10486902|P1|Overall Study|Lack of Efficacy|3
3050767|NCT00599755|10487006|P1|Overall Study|No data available|1
3050768|NCT00599755|10487006|P1|Overall Study|Other Reason|2
3050769|NCT00599755|10487006|P1|Overall Study|Progression of Disease|3
3050770|NCT00599755|10487006|P1|Overall Study|Withdrawal by Subject|2
3050771|NCT00599755|10487006|P1|Overall Study|Adverse Event|11
3050772|NCT00599521|10487017|P2|Overall Study|Pregnancy|2
3050773|NCT00599521|10487018|P1|Overall Study|Pregnancy|0
3050774|NCT00599521|10487017|P2|Overall Study|Lost to Follow-up|23
3050775|NCT00599521|10487018|P1|Overall Study|Lost to Follow-up|23
3050776|NCT00599521|10487017|P2|Overall Study|Protocol Violation|1
3050777|NCT00599521|10487018|P1|Overall Study|Protocol Violation|1
3050778|NCT00599521|10487017|P2|Overall Study|Withdrawal by Subject|34
3050779|NCT00599521|10487018|P1|Overall Study|Withdrawal by Subject|28
3050780|NCT00599521|10487017|P2|Overall Study|Adverse Event|1
3050781|NCT00599521|10487018|P1|Overall Study|Adverse Event|4
3050782|NCT00599521|10487017|P2|Overall Study|Lack of Efficacy|8
3050783|NCT00599521|10487018|P1|Overall Study|Lack of Efficacy|4
3050784|NCT00599339|10487032|P1|Overall Study|Study Termination Status Unknown|12
3050785|NCT00599339|10487032|P1|Overall Study|No valid data consent|36
3050786|NCT00599339|10487032|P1|Overall Study|Lost to Follow-up|221
3050787|NCT00599339|10487032|P1|Overall Study|Other Reason|179
3050788|NCT00599339|10487032|P1|Overall Study|Withdrawal by Subject|137
3050789|NCT00599339|10487032|P1|Overall Study|Adverse Event|79
3050790|NCT00599326|10487134|P1|Overall Study|Noncompliant|1
3050791|NCT00599326|10487134|P1|Overall Study|Lost to Follow-up|1
3050792|NCT00599313|10487139|P1|Overall Study|Ineligible|1
3050793|NCT00599313|10487139|P1|Overall Study|Patient Request|4
3050794|NCT00599313|10487139|P1|Overall Study|Disease Progression|12
3050795|NCT00599313|10487139|P1|Overall Study|Adverse Event|19
3050796|NCT00599196|10487181|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
3050797|NCT00599196|10487181|P1|Overall Study|Other: Patient Stopped Due To Moving|1
3050798|NCT00599196|10487181|P1|Overall Study|Other: Pt Moved To Australia|1
3050799|NCT00599196|10487181|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
3050800|NCT00599196|10487181|P1|Overall Study|Other: Spouse Withdrew Consent|1
3050801|NCT00599196|10487181|P1|Overall Study|Other: Patient Leaving For Israel|1
3050802|NCT00599196|10487181|P1|Overall Study|Lost to Follow-up|17
3050803|NCT00599196|10487181|P1|Overall Study|Study ended per sponsor|197
3050804|NCT00599196|10487181|P1|Overall Study|Subject withdrew consent|43
3050805|NCT00599196|10487181|P1|Overall Study|Unsatisfactory compliance of subject|3
3050806|NCT00599196|10487181|P1|Overall Study|Adverse Event|93
3050807|NCT00599196|10487181|P1|Overall Study|Lack of Efficacy|22
3050808|NCT00599027|10487212|P2|Overall Study|Treatment Failure|1
3050809|NCT00599027|10487213|P1|Overall Study|Treatment Failure|0
3050810|NCT00599027|10487212|P2|Overall Study|Adverse Event|1
3050811|NCT00599027|10487213|P1|Overall Study|Adverse Event|0
3050812|NCT00599027|10487212|P2|Overall Study|Withdrawal by Subject|1
3050813|NCT00599027|10487213|P1|Overall Study|Withdrawal by Subject|1
3050814|NCT00598871|10487226|P2|Overall Study|Adverse Event|1
3050815|NCT00598871|10487227|P1|Overall Study|Adverse Event|0
3050816|NCT00598832|10487237|P2|Overall Study|Non compliance|0
3050817|NCT00598832|10487238|P1|Overall Study|Non compliance|1
3050818|NCT00598832|10487237|P2|Overall Study|Physician Decision|4
3050819|NCT00598832|10487238|P1|Overall Study|Physician Decision|1
3050820|NCT00598832|10487237|P2|Overall Study|Pregnancy|2
3050821|NCT00598832|10487238|P1|Overall Study|Pregnancy|2
3050822|NCT00598832|10487237|P2|Overall Study|Lost to Follow-up|29
3050823|NCT00598832|10487238|P1|Overall Study|Lost to Follow-up|24
3050824|NCT00598832|10487237|P2|Overall Study|Protocol Violation|2
3050825|NCT00598832|10487238|P1|Overall Study|Protocol Violation|0
3050826|NCT00598832|10487237|P2|Overall Study|Withdrawal by Subject|36
3050827|NCT00598832|10487238|P1|Overall Study|Withdrawal by Subject|25
3050828|NCT00598832|10487237|P2|Overall Study|Adverse Event|2
3050829|NCT00598832|10487238|P1|Overall Study|Adverse Event|6
3050830|NCT00598832|10487237|P2|Overall Study|Lack of Efficacy|7
3050831|NCT00598832|10487238|P1|Overall Study|Lack of Efficacy|3
3050832|NCT00598702|10487291|P8|Overall Study|Dose limiting toxicity|0
3050833|NCT00598702|10487292|P7|Overall Study|Dose limiting toxicity|0
3050834|NCT00598702|10487293|P6|Overall Study|Dose limiting toxicity|1
3050835|NCT00598702|10487294|P5|Overall Study|Dose limiting toxicity|1
3050836|NCT00598702|10487295|P4|Overall Study|Dose limiting toxicity|1
3050837|NCT00598702|10487296|P3|Overall Study|Dose limiting toxicity|0
3050838|NCT00598702|10487297|P2|Overall Study|Dose limiting toxicity|0
3050839|NCT00598702|10487298|P1|Overall Study|Dose limiting toxicity|0
3050840|NCT00598702|10487291|P8|Overall Study|Physician Decision|0
3050841|NCT00598702|10487292|P7|Overall Study|Physician Decision|0
3050842|NCT00598702|10487293|P6|Overall Study|Physician Decision|0
3050843|NCT00598702|10487294|P5|Overall Study|Physician Decision|1
3050844|NCT00598702|10487295|P4|Overall Study|Physician Decision|0
3050845|NCT00598702|10487296|P3|Overall Study|Physician Decision|0
3050846|NCT00598702|10487297|P2|Overall Study|Physician Decision|0
3050847|NCT00598702|10487298|P1|Overall Study|Physician Decision|0
3050848|NCT00598702|10487291|P8|Overall Study|Withdrawal by Subject|0
3050849|NCT00598702|10487292|P7|Overall Study|Withdrawal by Subject|0
3050850|NCT00598702|10487293|P6|Overall Study|Withdrawal by Subject|0
3050851|NCT00598702|10487294|P5|Overall Study|Withdrawal by Subject|1
3050852|NCT00598702|10487295|P4|Overall Study|Withdrawal by Subject|1
3050853|NCT00598702|10487296|P3|Overall Study|Withdrawal by Subject|0
3050854|NCT00598702|10487297|P2|Overall Study|Withdrawal by Subject|0
3050855|NCT00598702|10487298|P1|Overall Study|Withdrawal by Subject|0
3050856|NCT00598702|10487291|P8|Overall Study|Adverse Event|0
3050857|NCT00598702|10487292|P7|Overall Study|Adverse Event|0
3050858|NCT00598702|10487293|P6|Overall Study|Adverse Event|0
3050859|NCT00598702|10487294|P5|Overall Study|Adverse Event|0
3050860|NCT00598702|10487295|P4|Overall Study|Adverse Event|1
3050861|NCT00598702|10487296|P3|Overall Study|Adverse Event|0
3050862|NCT00598702|10487297|P2|Overall Study|Adverse Event|0
3050863|NCT00598702|10487298|P1|Overall Study|Adverse Event|0
3050864|NCT00598702|10487291|P8|Overall Study|Early discharge from hospital|0
3050865|NCT00598702|10487292|P7|Overall Study|Early discharge from hospital|1
3050866|NCT00598702|10487293|P6|Overall Study|Early discharge from hospital|10
3050867|NCT00598702|10487294|P5|Overall Study|Early discharge from hospital|0
3050868|NCT00598702|10487295|P4|Overall Study|Early discharge from hospital|5
3050869|NCT00598702|10487296|P3|Overall Study|Early discharge from hospital|2
3050870|NCT00598702|10487297|P2|Overall Study|Early discharge from hospital|0
3050871|NCT00598702|10487298|P1|Overall Study|Early discharge from hospital|0
3050872|NCT00598702|10487291|P8|Overall Study|Other|0
3050873|NCT00598702|10487292|P7|Overall Study|Other|0
3050874|NCT00598702|10487293|P6|Overall Study|Other|1
3050875|NCT00598702|10487294|P5|Overall Study|Other|0
3050876|NCT00598702|10487295|P4|Overall Study|Other|0
3050877|NCT00598702|10487296|P3|Overall Study|Other|0
3050878|NCT00598702|10487297|P2|Overall Study|Other|2
3050879|NCT00598702|10487298|P1|Overall Study|Other|0
3050880|NCT00598650|10487374|P1|Overall Study|Physician Decision|2
3050881|NCT00598650|10487374|P1|Overall Study|Prohibited Concomitant Medication|2
3050882|NCT00598650|10487374|P1|Overall Study|Not eligible|1
3050883|NCT00598650|10487374|P1|Overall Study|No treatment for 3 weeks|1
3050884|NCT00598650|10487374|P1|Overall Study|Adverse Event|18
3050885|NCT00598650|10487374|P1|Overall Study|Withdrawal by Subject|3
3050886|NCT00598585|10487383|P2|Overall Study|Lost to Follow-up|0
3050887|NCT00598585|10487384|P1|Overall Study|Lost to Follow-up|1
3050888|NCT00598559|10487393|P3|Overall Study|Subject unable/unwilling to attend visit|0
3050889|NCT00598559|10487394|P2|Overall Study|Subject unable/unwilling to attend visit|7
3050890|NCT00598559|10487395|P1|Overall Study|Subject unable/unwilling to attend visit|4
3050891|NCT00598559|10487393|P3|Overall Study|Early discharge from hospital|3
3050892|NCT00598559|10487394|P2|Overall Study|Early discharge from hospital|12
3050893|NCT00598559|10487395|P1|Overall Study|Early discharge from hospital|9
3050894|NCT00598559|10487393|P3|Overall Study|Protocol Non-compliance|0
3050895|NCT00598559|10487394|P2|Overall Study|Protocol Non-compliance|0
3050896|NCT00598559|10487395|P1|Overall Study|Protocol Non-compliance|1
3050897|NCT00598559|10487393|P3|Overall Study|Withdrawal by Subject|0
3050898|NCT00598559|10487394|P2|Overall Study|Withdrawal by Subject|2
3050899|NCT00598559|10487395|P1|Overall Study|Withdrawal by Subject|2
3050900|NCT00598559|10487393|P3|Overall Study|Adverse Event|0
3050901|NCT00598559|10487394|P2|Overall Study|Adverse Event|7
3050902|NCT00598559|10487395|P1|Overall Study|Adverse Event|11
3050903|NCT00598442|10487422|P3|Overall Study|Started dialysis|0
3050904|NCT00598442|10487423|P2|Overall Study|Started dialysis|0
3050905|NCT00598442|10487424|P1|Overall Study|Started dialysis|1
3050906|NCT00598442|10487422|P3|Overall Study|Site closed by sponsor|1
3050907|NCT00598442|10487423|P2|Overall Study|Site closed by sponsor|2
3050908|NCT00598442|10487424|P1|Overall Study|Site closed by sponsor|5
3050909|NCT00598442|10487422|P3|Overall Study|Renal transplant|1
3050910|NCT00598442|10487423|P2|Overall Study|Renal transplant|0
3050911|NCT00598442|10487424|P1|Overall Study|Renal transplant|0
3050912|NCT00598442|10487422|P3|Overall Study|Relocation|0
3050913|NCT00598442|10487423|P2|Overall Study|Relocation|4
3050914|NCT00598442|10487424|P1|Overall Study|Relocation|1
3050915|NCT00598442|10487422|P3|Overall Study|Noncompliance|1
3050916|NCT00598442|10487423|P2|Overall Study|Noncompliance|2
3050917|NCT00598442|10487424|P1|Overall Study|Noncompliance|0
3050918|NCT00598442|10487422|P3|Overall Study|Withdrawal by Subject|6
3050919|NCT00598442|10487423|P2|Overall Study|Withdrawal by Subject|16
3050920|NCT00598442|10487424|P1|Overall Study|Withdrawal by Subject|8
3050921|NCT00598442|10487422|P3|Overall Study|Physician Decision|1
3050922|NCT00598442|10487423|P2|Overall Study|Physician Decision|1
3050923|NCT00598442|10487424|P1|Overall Study|Physician Decision|2
3050924|NCT00598442|10487422|P3|Overall Study|Lost to Follow-up|3
3050925|NCT00598442|10487423|P2|Overall Study|Lost to Follow-up|3
3050926|NCT00598442|10487424|P1|Overall Study|Lost to Follow-up|4
3050927|NCT00598442|10487422|P3|Overall Study|Death|11
3050928|NCT00598442|10487423|P2|Overall Study|Death|11
3050929|NCT00598442|10487424|P1|Overall Study|Death|19
3050930|NCT00598442|10487422|P3|Overall Study|Adverse Event|0
3050931|NCT00598442|10487423|P2|Overall Study|Adverse Event|0
3050932|NCT00598442|10487424|P1|Overall Study|Adverse Event|3
3050933|NCT00598273|10487441|P3|Overall Study|Started dialysis|5
3050934|NCT00598273|10487442|P2|Overall Study|Started dialysis|4
3050935|NCT00598273|10487443|P1|Overall Study|Started dialysis|6
3050936|NCT00598273|10487441|P3|Overall Study|Site elected to close|0
3050937|NCT00598273|10487442|P2|Overall Study|Site elected to close|0
3050938|NCT00598273|10487443|P1|Overall Study|Site elected to close|1
3050939|NCT00598273|10487441|P3|Overall Study|Renal transplant|1
3050940|NCT00598273|10487442|P2|Overall Study|Renal transplant|0
3050941|NCT00598273|10487443|P1|Overall Study|Renal transplant|1
3050942|NCT00598273|10487441|P3|Overall Study|Relocation|4
3050943|NCT00598273|10487442|P2|Overall Study|Relocation|2
3050944|NCT00598273|10487443|P1|Overall Study|Relocation|0
3050945|NCT00598273|10487441|P3|Overall Study|Noncompliance|3
3050946|NCT00598273|10487442|P2|Overall Study|Noncompliance|2
3050947|NCT00598273|10487443|P1|Overall Study|Noncompliance|3
3050948|NCT00598273|10487441|P3|Overall Study|Withdrawal by Subject|10
3050949|NCT00598273|10487442|P2|Overall Study|Withdrawal by Subject|10
3050950|NCT00598273|10487443|P1|Overall Study|Withdrawal by Subject|12
3050951|NCT00598273|10487441|P3|Overall Study|Physician Decision|1
3050952|NCT00598273|10487442|P2|Overall Study|Physician Decision|0
3050953|NCT00598273|10487443|P1|Overall Study|Physician Decision|0
3050954|NCT00598273|10487441|P3|Overall Study|Lost to Follow-up|5
3050955|NCT00598273|10487442|P2|Overall Study|Lost to Follow-up|3
3050956|NCT00598273|10487443|P1|Overall Study|Lost to Follow-up|8
3050957|NCT00598273|10487441|P3|Overall Study|Death|8
3050958|NCT00598273|10487442|P2|Overall Study|Death|12
3050959|NCT00598273|10487443|P1|Overall Study|Death|6
3050960|NCT00598273|10487441|P3|Overall Study|Adverse Event|2
3050961|NCT00598273|10487442|P2|Overall Study|Adverse Event|5
3050962|NCT00598273|10487443|P1|Overall Study|Adverse Event|4
3050963|NCT00598078|10487457|P2|Period 2 (Day 2)|Adverse Event|0
3050964|NCT00598078|10487458|P1|Period 2 (Day 2)|Adverse Event|1
3050965|NCT00597766|10487540|P3|Follow-up 2, Week 8|Lost to Follow-up|1
3050966|NCT00597766|10487541|P2|Follow-up 2, Week 8|Lost to Follow-up|0
3050967|NCT00597766|10487542|P1|Follow-up 2, Week 8|Lost to Follow-up|0
3050968|NCT00597766|10487540|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
3050969|NCT00597766|10487541|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
3050970|NCT00597766|10487542|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
3050971|NCT00597753|10487561|P2|Overall Study|Site elected to close|4
3050972|NCT00597753|10487562|P1|Overall Study|Site elected to close|2
3050973|NCT00597753|10487561|P2|Overall Study|Site closed by sponsor|7
3050974|NCT00597753|10487562|P1|Overall Study|Site closed by sponsor|19
3050975|NCT00597753|10487561|P2|Overall Study|Renal transplant|3
3050976|NCT00597753|10487562|P1|Overall Study|Renal transplant|10
3050977|NCT00597753|10487561|P2|Overall Study|Relocation|6
3050978|NCT00597753|10487562|P1|Overall Study|Relocation|17
3050979|NCT00597753|10487561|P2|Overall Study|Noncompliance|1
3050980|NCT00597753|10487562|P1|Overall Study|Noncompliance|2
3050981|NCT00597753|10487561|P2|Overall Study|Never dosed|0
3050982|NCT00597753|10487562|P1|Overall Study|Never dosed|2
3050983|NCT00597753|10487561|P2|Overall Study|Discontinued Dialysis|1
3050984|NCT00597753|10487562|P1|Overall Study|Discontinued Dialysis|0
3050985|NCT00597753|10487561|P2|Overall Study|Withdrawal by Subject|12
3050986|NCT00597753|10487562|P1|Overall Study|Withdrawal by Subject|35
3050987|NCT00597753|10487561|P2|Overall Study|Pregnancy|0
3050988|NCT00597753|10487562|P1|Overall Study|Pregnancy|1
3050989|NCT00597753|10487561|P2|Overall Study|Physician Decision|1
3050990|NCT00597753|10487562|P1|Overall Study|Physician Decision|5
3050991|NCT00597753|10487561|P2|Overall Study|Lost to Follow-up|3
3050992|NCT00597753|10487562|P1|Overall Study|Lost to Follow-up|10
3050993|NCT00597753|10487561|P2|Overall Study|Lack of Efficacy|0
3050994|NCT00597753|10487562|P1|Overall Study|Lack of Efficacy|2
3050995|NCT00597753|10487561|P2|Overall Study|Death|29
3050996|NCT00597753|10487562|P1|Overall Study|Death|55
3050997|NCT00597753|10487561|P2|Overall Study|Adverse Event|2
3050998|NCT00597753|10487562|P1|Overall Study|Adverse Event|6
3050999|NCT00597714|10487596|P3|Overall Study|Recipient death|10
3051000|NCT00597714|10487597|P2|Overall Study|Recipient death|0
3051001|NCT00597714|10487598|P1|Overall Study|Recipient death|0
3051002|NCT00597714|10487596|P3|Overall Study|Death|0
3051003|NCT00597714|10487597|P2|Overall Study|Death|46
3051004|NCT00597714|10487598|P1|Overall Study|Death|56
3051005|NCT00597701|10487610|P2|Overall Study|Did not start intervention (pharmacy er)|2
3051006|NCT00597701|10487611|P1|Overall Study|Did not start intervention (pharmacy er)|0
3051007|NCT00597701|10487610|P2|Overall Study|Physician Decision|0
3051008|NCT00597701|10487611|P1|Overall Study|Physician Decision|2
3051009|NCT00597701|10487610|P2|Overall Study|Death|1
3051010|NCT00597701|10487611|P1|Overall Study|Death|0
3051011|NCT00597701|10487610|P2|Overall Study|Withdrawal by Subject|5
3051012|NCT00597701|10487611|P1|Overall Study|Withdrawal by Subject|5
3051013|NCT00597584|10487633|P2|Overall Study|Renal transplant|7
3051014|NCT00597584|10487634|P1|Overall Study|Renal transplant|9
3051015|NCT00597584|10487633|P2|Overall Study|Relocation|6
3051016|NCT00597584|10487634|P1|Overall Study|Relocation|8
3051017|NCT00597584|10487633|P2|Overall Study|Never dosed|0
3051018|NCT00597584|10487634|P1|Overall Study|Never dosed|1
3051019|NCT00597584|10487633|P2|Overall Study|Lost ability to consent|1
3051020|NCT00597584|10487634|P1|Overall Study|Lost ability to consent|1
3051021|NCT00597584|10487633|P2|Overall Study|Discontinued Dialysis|1
3051022|NCT00597584|10487634|P1|Overall Study|Discontinued Dialysis|0
3051023|NCT00597584|10487633|P2|Overall Study|Withdrawal by Subject|12
3051024|NCT00597584|10487634|P1|Overall Study|Withdrawal by Subject|44
3051025|NCT00597584|10487633|P2|Overall Study|Pregnancy|0
3051026|NCT00597584|10487634|P1|Overall Study|Pregnancy|2
3051027|NCT00597584|10487633|P2|Overall Study|Physician Decision|0
3051028|NCT00597584|10487634|P1|Overall Study|Physician Decision|3
3051029|NCT00597584|10487633|P2|Overall Study|Lost to Follow-up|4
3051030|NCT00597584|10487634|P1|Overall Study|Lost to Follow-up|2
3051031|NCT00597584|10487633|P2|Overall Study|Lack of Efficacy|0
3051032|NCT00597584|10487634|P1|Overall Study|Lack of Efficacy|1
3051033|NCT00597584|10487633|P2|Overall Study|Death|30
3051034|NCT00597584|10487634|P1|Overall Study|Death|53
3051035|NCT00597584|10487633|P2|Overall Study|Adverse Event|2
3051036|NCT00597584|10487634|P1|Overall Study|Adverse Event|4
3051037|NCT00597519|10487659|P1|Overall Study|Death|1
3051038|NCT00597506|10487663|P1|Overall Study|Subject is being followed for survival|1
3051039|NCT00597376|10487713|P2|Overall Study|Adverse Event|1
3051040|NCT00597376|10487714|P1|Overall Study|Adverse Event|4
3051041|NCT00597376|10487713|P2|Overall Study|Withdrawal by Subject|3
3051042|NCT00597376|10487714|P1|Overall Study|Withdrawal by Subject|4
3051043|NCT00597207|10487755|P2|Overall Study|Lost to Follow-up|7
3051044|NCT00597207|10487756|P1|Overall Study|Lost to Follow-up|5
3051045|NCT00597116|10487764|P2|Overall Study|Progressive disease|6
3051046|NCT00597116|10487765|P1|Overall Study|Progressive disease|11
3051047|NCT00597116|10487764|P2|Overall Study|Lost to Follow-up|0
3051048|NCT00597116|10487765|P1|Overall Study|Lost to Follow-up|1
3051049|NCT00597116|10487764|P2|Overall Study|Death|1
3051050|NCT00597116|10487765|P1|Overall Study|Death|0
3051051|NCT00597116|10487764|P2|Overall Study|Physician Decision|1
3051052|NCT00597116|10487765|P1|Overall Study|Physician Decision|0
3051053|NCT00597116|10487764|P2|Overall Study|Withdrawal by Subject|2
3051054|NCT00597116|10487765|P1|Overall Study|Withdrawal by Subject|0
3051055|NCT00597116|10487764|P2|Overall Study|Adverse Event|1
3051056|NCT00597116|10487765|P1|Overall Study|Adverse Event|2
3051057|NCT00597012|10487791|P2|Overall Study|Lost to Follow-up|2
3051058|NCT00597012|10487792|P1|Overall Study|Lost to Follow-up|0
3051059|NCT00597012|10487791|P2|Overall Study|Ineligible|0
3051060|NCT00597012|10487792|P1|Overall Study|Ineligible|2
3051061|NCT00597012|10487791|P2|Overall Study|Withdrawal by Subject|4
3051062|NCT00597012|10487792|P1|Overall Study|Withdrawal by Subject|7
3051063|NCT00597012|10487791|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
3051064|NCT00597012|10487792|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
3051065|NCT00597012|10487791|P2|Overall Study|Death|1
3051066|NCT00597012|10487792|P1|Overall Study|Death|1
3051067|NCT00596960|10487804|P2|Overall Study|No alcohol use data|1
3051068|NCT00596960|10487805|P1|Overall Study|No alcohol use data|0
3051069|NCT00596960|10487804|P2|Overall Study|Protocol Violation|1
3051070|NCT00596960|10487805|P1|Overall Study|Protocol Violation|0
3051071|NCT00596960|10487804|P2|Overall Study|Physician Decision|0
3051072|NCT00596960|10487805|P1|Overall Study|Physician Decision|1
3051073|NCT00596960|10487804|P2|Overall Study|Incarcerated|0
3051074|NCT00596960|10487805|P1|Overall Study|Incarcerated|2
3051075|NCT00596960|10487804|P2|Overall Study|Withdrawal by Subject|0
3051076|NCT00596960|10487805|P1|Overall Study|Withdrawal by Subject|1
3051077|NCT00596960|10487804|P2|Overall Study|Lost to Follow-up|5
3051078|NCT00596960|10487805|P1|Overall Study|Lost to Follow-up|6
3051079|NCT00596960|10487804|P2|Overall Study|Death|2
3051080|NCT00596960|10487805|P1|Overall Study|Death|1
3051081|NCT00596947|10487817|P2|Overall Study|Lost to Follow-up|0
3051082|NCT00596947|10487818|P1|Overall Study|Lost to Follow-up|1
3051083|NCT00596947|10487817|P2|Overall Study|study halted due to low enrollment|3
3051084|NCT00596947|10487818|P1|Overall Study|study halted due to low enrollment|5
3051085|NCT00596934|10487858|P1|Overall Study|Withdrawal by Subject|1
3051086|NCT00596934|10487858|P1|Overall Study|Protocol Violation|1
3051087|NCT00596830|10487871|P2|Overall Study|Randomized but not treated|7
3051088|NCT00596830|10487872|P1|Overall Study|Randomized but not treated|3
3051089|NCT00596830|10487871|P2|Overall Study|Follow-up was discontinued|0
3051090|NCT00596830|10487872|P1|Overall Study|Follow-up was discontinued|1
3051091|NCT00596830|10487871|P2|Overall Study|Study terminated by sponsor|62
3051092|NCT00596830|10487872|P1|Overall Study|Study terminated by sponsor|51
3051093|NCT00596830|10487871|P2|Overall Study|Withdrawal by Subject|12
3051094|NCT00596830|10487872|P1|Overall Study|Withdrawal by Subject|22
3051095|NCT00596830|10487871|P2|Overall Study|Lost to Follow-up|11
3051096|NCT00596830|10487872|P1|Overall Study|Lost to Follow-up|7
3051097|NCT00596830|10487871|P2|Overall Study|Death|247
3051098|NCT00596830|10487872|P1|Overall Study|Death|258
3051099|NCT00596817|10487898|P2|Double-blind Period|Other Reasons|18
3051100|NCT00596817|10487899|P1|Double-blind Period|Other Reasons|10
3051101|NCT00596817|10487898|P2|Double-blind Period|Lost to Follow-up|2
3051102|NCT00596817|10487899|P1|Double-blind Period|Lost to Follow-up|0
3051103|NCT00596817|10487898|P2|Double-blind Period|Withdrawal of Consent|3
3051104|NCT00596817|10487899|P1|Double-blind Period|Withdrawal of Consent|7
3051105|NCT00596817|10487898|P2|Double-blind Period|Protocol Violation|8
3051106|NCT00596817|10487899|P1|Double-blind Period|Protocol Violation|11
3051107|NCT00596817|10487898|P2|Double-blind Period|Non-compliance With Study Product|4
3051108|NCT00596817|10487899|P1|Double-blind Period|Non-compliance With Study Product|3
3051109|NCT00596817|10487898|P2|Double-blind Period|Lack of Efficacy|28
3051110|NCT00596817|10487899|P1|Double-blind Period|Lack of Efficacy|52
3051111|NCT00596817|10487898|P2|Double-blind Period|Adverse Event|16
3051112|NCT00596817|10487899|P1|Double-blind Period|Adverse Event|5
3051113|NCT00596817|10487898|P2|Open-label Period to Double-blind Period|Other Reasons|14
3051114|NCT00596817|10487899|P1|Open-label Period to Double-blind Period|Other Reasons|0
3051115|NCT00596817|10487898|P2|Open-label Period to Double-blind Period|Not Eligible|49
3051116|NCT00596817|10487899|P1|Open-label Period to Double-blind Period|Not Eligible|0
3051117|NCT00596817|10487898|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
3051118|NCT00596817|10487899|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
3051119|NCT00596817|10487898|P2|Open-label Period to Double-blind Period|Adverse Event|5
3051120|NCT00596817|10487899|P1|Open-label Period to Double-blind Period|Adverse Event|0
3051121|NCT00596817|10487898|P2|Open-label Period|Other Reasons|65
3051122|NCT00596817|10487899|P1|Open-label Period|Other Reasons|0
3051123|NCT00596817|10487898|P2|Open-label Period|Lack of Efficacy|33
3051124|NCT00596817|10487899|P1|Open-label Period|Lack of Efficacy|0
3051125|NCT00596817|10487898|P2|Open-label Period|Adverse Event|49
3051126|NCT00596817|10487899|P1|Open-label Period|Adverse Event|0
3051127|NCT00596752|10487924|P2|Overall Study|Protocol Violation|0
3051128|NCT00596752|10487925|P1|Overall Study|Protocol Violation|1
3051129|NCT00596752|10487924|P2|Overall Study|Lack of Efficacy|7
3051130|NCT00596752|10487925|P1|Overall Study|Lack of Efficacy|4
3051131|NCT00596752|10487924|P2|Overall Study|Unsatisfactory Compliance|6
3051132|NCT00596752|10487925|P1|Overall Study|Unsatisfactory Compliance|9
3051133|NCT00596752|10487924|P2|Overall Study|Withdrawal by Subject|9
3051134|NCT00596752|10487925|P1|Overall Study|Withdrawal by Subject|12
3051135|NCT00596752|10487924|P2|Overall Study|Lost to Follow-up|38
3051136|NCT00596752|10487925|P1|Overall Study|Lost to Follow-up|22
3051137|NCT00596752|10487924|P2|Overall Study|Adverse Event|34
3051138|NCT00596752|10487925|P1|Overall Study|Adverse Event|34
3051139|NCT00596752|10487924|P2|Overall Study|Other Reason|49
3051140|NCT00596752|10487925|P1|Overall Study|Other Reason|44
3051141|NCT00596687|10487955|P2|Overall Study|cancelled surgery|1
3051142|NCT00596687|10487956|P1|Overall Study|cancelled surgery|1
3051143|NCT00596687|10487955|P2|Overall Study|Withdrawal by Subject|1
3051144|NCT00596687|10487956|P1|Overall Study|Withdrawal by Subject|3
3051145|NCT00596687|10487955|P2|Overall Study|continuous insulin infusion during TPN|1
3051146|NCT00596687|10487956|P1|Overall Study|continuous insulin infusion during TPN|2
3051147|NCT00596687|10487955|P2|Overall Study|< 24 hours of insulin treatment|6
3051148|NCT00596687|10487956|P1|Overall Study|< 24 hours of insulin treatment|8
3051149|NCT00596635|10487967|P3|Overall Study|Could not provide urine specimen|2
3051150|NCT00596635|10487968|P2|Overall Study|Could not provide urine specimen|2
3051151|NCT00596635|10487969|P1|Overall Study|Could not provide urine specimen|1
3051152|NCT00596635|10487967|P3|Overall Study|Hip fracture|3
3051153|NCT00596635|10487968|P2|Overall Study|Hip fracture|3
3051154|NCT00596635|10487969|P1|Overall Study|Hip fracture|2
3051155|NCT00596635|10487967|P3|Overall Study|Treatment for symptomatic UTI|3
3051156|NCT00596635|10487968|P2|Overall Study|Treatment for symptomatic UTI|6
3051157|NCT00596635|10487969|P1|Overall Study|Treatment for symptomatic UTI|4
3051158|NCT00596635|10487967|P3|Overall Study|Lost to Follow-up|0
3051159|NCT00596635|10487968|P2|Overall Study|Lost to Follow-up|2
3051160|NCT00596635|10487969|P1|Overall Study|Lost to Follow-up|0
3051161|NCT00596466|10487995|P1|Overall Study|Enrolled, not treated|2
3051162|NCT00596466|10487995|P1|Overall Study|Unpecified|2
3051163|NCT00596466|10487995|P1|Overall Study|Protocol Violation|2
3051164|NCT00596466|10487995|P1|Overall Study|Withdrawal by Subject|2
3051165|NCT00596466|10487995|P1|Overall Study|Adverse Event|4
3051166|NCT00596466|10487995|P1|Overall Study|Lack of Efficacy|5
3051167|NCT00596427|10488025|P2|Overall Study|Protocol Violation|0
3051168|NCT00596427|10488026|P1|Overall Study|Protocol Violation|1
3051169|NCT00596427|10488025|P2|Overall Study|Increased Fasting Triacylglycerol level|0
3051170|NCT00596427|10488026|P1|Overall Study|Increased Fasting Triacylglycerol level|1
3051171|NCT00596427|10488025|P2|Overall Study|Withdrawal by Subject|2
3051172|NCT00596427|10488026|P1|Overall Study|Withdrawal by Subject|2
3051173|NCT00596362|10488054|P1|Overall Study|Progressive Disease|1
3051174|NCT00596011|10488090|P2|Overall Study|Adverse Event|7
3051175|NCT00596011|10488091|P1|Overall Study|Adverse Event|11
3051176|NCT00596011|10488090|P2|Overall Study|Withdrawal by Subject|3
3051177|NCT00596011|10488091|P1|Overall Study|Withdrawal by Subject|2
3051178|NCT00595959|10488107|P1|Overall Study|Lost to Follow-up|1
3051179|NCT00595959|10488107|P1|Overall Study|Withdrawal by Subject|1
3051180|NCT00595920|10488141|P1|Overall Study|The OLTERMS study was discontinued by th|116
3051181|NCT00595868|10488152|P2|Overall Study|Lost to Follow-up|50
3051182|NCT00595868|10488153|P1|Overall Study|Lost to Follow-up|45
3051183|NCT00595764|10488176|P2|Overall Study|Withdrawal by Subject|0
3051184|NCT00595764|10488177|P1|Overall Study|Withdrawal by Subject|4
3051185|NCT00595764|10488176|P2|Overall Study|Missed 3 PM visits|7
3051186|NCT00595764|10488177|P1|Overall Study|Missed 3 PM visits|1
3051187|NCT00595764|10488176|P2|Overall Study|Missed Medication >1 week|17
3051188|NCT00595764|10488177|P1|Overall Study|Missed Medication >1 week|10
3051189|NCT00595764|10488176|P2|Overall Study|Protocol Violation|19
3051190|NCT00595764|10488177|P1|Overall Study|Protocol Violation|24
3051191|NCT00595621|10488193|P2|Randomization and Study|Withdrawal by Subject|1
3051192|NCT00595621|10488194|P1|Randomization and Study|Withdrawal by Subject|0
3051193|NCT00595621|10488193|P2|Randomization and Study|Adverse Event|0
3051194|NCT00595621|10488194|P1|Randomization and Study|Adverse Event|2
3051195|NCT00595621|10488193|P2|Open Label Run in|Withdrawal by Subject|0
3051196|NCT00595621|10488194|P1|Open Label Run in|Withdrawal by Subject|1
3051197|NCT00595621|10488193|P2|Open Label Run in|Physician Decision|0
3051198|NCT00595621|10488194|P1|Open Label Run in|Physician Decision|1
3051199|NCT00595621|10488193|P2|Open Label Run in|Adverse Event|0
3051200|NCT00595621|10488194|P1|Open Label Run in|Adverse Event|1
3051201|NCT00595582|10488211|P1|Overall Study|Physician Decision|5
3051202|NCT00595582|10488211|P1|Overall Study|Adverse Event|2
3051203|NCT00595582|10488211|P1|Overall Study|Lost to Follow-up|1
3051204|NCT00595582|10488211|P1|Overall Study|Pilot study that PI terminated|2
3051205|NCT00595517|10488237|P1|Overall Study|No intention to attend regularly|1
3051206|NCT00595517|10488237|P1|Overall Study|usage of prohibited treatment|1
3051207|NCT00595517|10488237|P1|Overall Study|Recurrence of ulcer|5
3051208|NCT00595517|10488237|P1|Overall Study|Protocol Violation|2
3051209|NCT00595517|10488237|P1|Overall Study|Withdrawal by Subject|4
3051210|NCT00595517|10488237|P1|Overall Study|Adverse Event|6
3051211|NCT00595504|10488246|P2|Overall Study|Physician Decision|0
3051212|NCT00595504|10488247|P1|Overall Study|Physician Decision|1
3051213|NCT00595504|10488246|P2|Overall Study|Withdrawal by Subject|3
3051214|NCT00595504|10488247|P1|Overall Study|Withdrawal by Subject|1
3051215|NCT00595478|10488259|P2|36-week Follow-up Period|Withdrawal by Subject|4
3051216|NCT00595478|10488260|P1|36-week Follow-up Period|Withdrawal by Subject|4
3051217|NCT00595478|10488259|P2|36-week Follow-up Period|Lost to Follow-up|4
3051218|NCT00595478|10488260|P1|36-week Follow-up Period|Lost to Follow-up|5
3051219|NCT00595465|10488271|P3|Overall Study|administrative reason|1
3051220|NCT00595465|10488272|P2|Overall Study|administrative reason|0
3051221|NCT00595465|10488273|P1|Overall Study|administrative reason|0
3051222|NCT00595465|10488271|P3|Overall Study|Lost to Follow-up|2
3051223|NCT00595465|10488272|P2|Overall Study|Lost to Follow-up|0
3051224|NCT00595465|10488273|P1|Overall Study|Lost to Follow-up|0
3051225|NCT00595465|10488271|P3|Overall Study|Protocol Violation|0
3051226|NCT00595465|10488272|P2|Overall Study|Protocol Violation|1
3051227|NCT00595465|10488273|P1|Overall Study|Protocol Violation|2
3051228|NCT00595465|10488271|P3|Overall Study|Pregnancy|1
3051229|NCT00595465|10488272|P2|Overall Study|Pregnancy|0
3051230|NCT00595465|10488273|P1|Overall Study|Pregnancy|0
3051231|NCT00595465|10488271|P3|Overall Study|Adverse Event|3
3051232|NCT00595465|10488272|P2|Overall Study|Adverse Event|3
3051233|NCT00595465|10488273|P1|Overall Study|Adverse Event|4
3051234|NCT00595413|10488285|P4|Overall Study|Other|0
3051235|NCT00595413|10488286|P3|Overall Study|Other|5
3051236|NCT00595413|10488287|P2|Overall Study|Other|1
3051237|NCT00595413|10488288|P1|Overall Study|Other|5
3051238|NCT00595413|10488285|P4|Overall Study|Death|0
3051239|NCT00595413|10488286|P3|Overall Study|Death|1
3051240|NCT00595413|10488287|P2|Overall Study|Death|0
3051241|NCT00595413|10488288|P1|Overall Study|Death|0
3051242|NCT00595413|10488285|P4|Overall Study|Lost to Follow-up|3
3051243|NCT00595413|10488286|P3|Overall Study|Lost to Follow-up|1
3051244|NCT00595413|10488287|P2|Overall Study|Lost to Follow-up|2
3051245|NCT00595413|10488288|P1|Overall Study|Lost to Follow-up|2
3051246|NCT00595413|10488285|P4|Overall Study|Adverse Event|1
3051247|NCT00595413|10488286|P3|Overall Study|Adverse Event|1
3051248|NCT00595413|10488287|P2|Overall Study|Adverse Event|2
3051249|NCT00595413|10488288|P1|Overall Study|Adverse Event|0
3051250|NCT00595335|10488329|P2|Six Months to Twelve Months|Disease Progression|0
3051251|NCT00595335|10488330|P1|Six Months to Twelve Months|Disease Progression|1
3051252|NCT00595335|10488329|P2|Six Months to Twelve Months|Withdrawal by Subject|1
3051253|NCT00595335|10488330|P1|Six Months to Twelve Months|Withdrawal by Subject|0
3051254|NCT00595335|10488329|P2|Baseline to Six Months|Adverse Event|0
3051255|NCT00595335|10488330|P1|Baseline to Six Months|Adverse Event|1
3051256|NCT00595335|10488329|P2|Baseline to Six Months|Disease Progression|1
3051257|NCT00595335|10488330|P1|Baseline to Six Months|Disease Progression|1
3051258|NCT00595335|10488329|P2|Baseline to Six Months|Withdrawal by Subject|1
3051259|NCT00595335|10488330|P1|Baseline to Six Months|Withdrawal by Subject|0
3051260|NCT00595309|10488350|P1|Overall Study|personal reason|1
3051261|NCT00595309|10488350|P1|Overall Study|acute infection after V0|1
3051262|NCT00595309|10488350|P1|Overall Study|planned vaccination against yellow fever|1
3051263|NCT00595309|10488350|P1|Overall Study|Lost to Follow-up|1
3051264|NCT00595127|10488399|P1|Overall Study|joined another trial|1
3051265|NCT00595127|10488399|P1|Overall Study|Relapsed|3
3051266|NCT00595127|10488399|P1|Overall Study|Death|6
3051267|NCT00595075|10488420|P2|Overall Study|Withdrawal by Subject|0
3051268|NCT00595075|10488421|P1|Overall Study|Withdrawal by Subject|1
3051269|NCT00594958|10488442|P3|Overall Study|administrative|2
3051270|NCT00594958|10488443|P2|Overall Study|administrative|0
3051271|NCT00594958|10488444|P1|Overall Study|administrative|3
3051272|NCT00594958|10488442|P3|Overall Study|Lost to Follow-up|3
3051273|NCT00594958|10488443|P2|Overall Study|Lost to Follow-up|0
3051274|NCT00594958|10488444|P1|Overall Study|Lost to Follow-up|5
3051275|NCT00594958|10488442|P3|Overall Study|Protocol Violation|2
3051276|NCT00594958|10488443|P2|Overall Study|Protocol Violation|0
3051277|NCT00594958|10488444|P1|Overall Study|Protocol Violation|1
3051278|NCT00594958|10488442|P3|Overall Study|Pregnancy|0
3051279|NCT00594958|10488443|P2|Overall Study|Pregnancy|2
3051280|NCT00594958|10488444|P1|Overall Study|Pregnancy|0
3051281|NCT00594958|10488442|P3|Overall Study|Adverse Event|2
3051282|NCT00594958|10488443|P2|Overall Study|Adverse Event|1
3051283|NCT00594958|10488444|P1|Overall Study|Adverse Event|4
3051284|NCT00594958|10488442|P3|Overall Study|Withdrawal by Subject|1
3051285|NCT00594958|10488443|P2|Overall Study|Withdrawal by Subject|0
3051286|NCT00594958|10488444|P1|Overall Study|Withdrawal by Subject|1
3051287|NCT00594906|10488465|P2|Overall Study|Death|1
3051288|NCT00594906|10488466|P1|Overall Study|Death|0
3051289|NCT00594906|10488465|P2|Overall Study|Physician Decision|1
3051290|NCT00594906|10488466|P1|Overall Study|Physician Decision|0
3051291|NCT00594906|10488465|P2|Overall Study|Physician Decision|0
3051292|NCT00594906|10488466|P1|Overall Study|Physician Decision|1
3051293|NCT00594880|10488474|P2|Overall Study|Lost to Follow-up|0
3051294|NCT00594880|10488475|P1|Overall Study|Lost to Follow-up|1
3051295|NCT00594880|10488474|P2|Overall Study|Withdrawal by Subject|1
3051296|NCT00594880|10488475|P1|Overall Study|Withdrawal by Subject|1
3051297|NCT00594854|10488487|P2|Overall Study|Study terminated|10
3051298|NCT00594854|10488488|P1|Overall Study|Study terminated|7
3051299|NCT00594815|10488498|P1|Overall Study|Toxicity|4
3051300|NCT00594815|10488498|P1|Overall Study|Withdrawal by Subject|2
3051301|NCT00594815|10488498|P1|Overall Study|Never Treated|3
3051302|NCT00594659|10488523|P3|Overall Study|Lost to Follow-up|7
3051303|NCT00594659|10488524|P2|Overall Study|Lost to Follow-up|9
3051304|NCT00594659|10488525|P1|Overall Study|Lost to Follow-up|13
3051305|NCT00594646|10488536|P1|Overall Study|Lost to Follow-up|15
3051306|NCT00594646|10488536|P1|Overall Study|Withdrawal by Subject|1
3051307|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
3051308|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
3051309|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
3051310|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
3051311|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
3051312|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
3051313|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
3051314|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
3051315|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
3051316|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
3051317|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
3051318|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
3051319|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
3051320|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
3051321|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
3051322|NCT00594568|10488544|P3|Safety Follow Up (SFU)-Optional|Death|0
3051323|NCT00594568|10488545|P2|Safety Follow Up (SFU)-Optional|Death|1
3051324|NCT00594568|10488546|P1|Safety Follow Up (SFU)-Optional|Death|0
3051325|NCT00594568|10488544|P3|Delayed Start|Sponsor Decision|59
3051326|NCT00594568|10488545|P2|Delayed Start|Sponsor Decision|66
3051327|NCT00594568|10488546|P1|Delayed Start|Sponsor Decision|77
3051328|NCT00594568|10488544|P3|Delayed Start|Caregiver Decision|2
3051329|NCT00594568|10488545|P2|Delayed Start|Caregiver Decision|6
3051330|NCT00594568|10488546|P1|Delayed Start|Caregiver Decision|5
3051331|NCT00594568|10488544|P3|Delayed Start|Lost to Follow-up|1
3051332|NCT00594568|10488545|P2|Delayed Start|Lost to Follow-up|0
3051333|NCT00594568|10488546|P1|Delayed Start|Lost to Follow-up|0
3051334|NCT00594568|10488544|P3|Delayed Start|Physician Decision|1
3051335|NCT00594568|10488545|P2|Delayed Start|Physician Decision|0
3051336|NCT00594568|10488546|P1|Delayed Start|Physician Decision|0
3051337|NCT00594568|10488544|P3|Delayed Start|Withdrawal by Subject|0
3051338|NCT00594568|10488545|P2|Delayed Start|Withdrawal by Subject|3
3051339|NCT00594568|10488546|P1|Delayed Start|Withdrawal by Subject|4
3051340|NCT00594568|10488544|P3|Delayed Start|Adverse Event|2
3051341|NCT00594568|10488545|P2|Delayed Start|Adverse Event|2
3051342|NCT00594568|10488546|P1|Delayed Start|Adverse Event|12
3051343|NCT00594568|10488544|P3|Delayed Start|Death|1
3051344|NCT00594568|10488545|P2|Delayed Start|Death|0
3051345|NCT00594568|10488546|P1|Delayed Start|Death|0
3051346|NCT00594568|10488544|P3|Initial Treatment|Entry criteria exclusion|1
3051347|NCT00594568|10488545|P2|Initial Treatment|Entry criteria exclusion|1
3051348|NCT00594568|10488546|P1|Initial Treatment|Entry criteria exclusion|0
3051349|NCT00594568|10488544|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
3051350|NCT00594568|10488545|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
3051351|NCT00594568|10488546|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
3051352|NCT00594568|10488544|P3|Initial Treatment|Caregiver decision|36
3051353|NCT00594568|10488545|P2|Initial Treatment|Caregiver decision|36
3051354|NCT00594568|10488546|P1|Initial Treatment|Caregiver decision|21
3051355|NCT00594568|10488544|P3|Initial Treatment|Sponsor decision|147
3051356|NCT00594568|10488545|P2|Initial Treatment|Sponsor decision|142
3051357|NCT00594568|10488546|P1|Initial Treatment|Sponsor decision|193
3051358|NCT00594568|10488544|P3|Initial Treatment|Withdrawal by Subject|46
3051359|NCT00594568|10488545|P2|Initial Treatment|Withdrawal by Subject|31
3051360|NCT00594568|10488546|P1|Initial Treatment|Withdrawal by Subject|25
3051361|NCT00594568|10488544|P3|Initial Treatment|Protocol Violation|5
3051362|NCT00594568|10488545|P2|Initial Treatment|Protocol Violation|2
3051363|NCT00594568|10488546|P1|Initial Treatment|Protocol Violation|2
3051364|NCT00594568|10488544|P3|Initial Treatment|Physician Decision|4
3051365|NCT00594568|10488545|P2|Initial Treatment|Physician Decision|2
3051366|NCT00594568|10488546|P1|Initial Treatment|Physician Decision|3
3051367|NCT00594568|10488544|P3|Initial Treatment|Lost to Follow-up|4
3051368|NCT00594568|10488545|P2|Initial Treatment|Lost to Follow-up|1
3051369|NCT00594568|10488546|P1|Initial Treatment|Lost to Follow-up|4
3051370|NCT00594568|10488544|P3|Initial Treatment|Death|15
3051371|NCT00594568|10488545|P2|Initial Treatment|Death|11
3051372|NCT00594568|10488546|P1|Initial Treatment|Death|6
3051373|NCT00594568|10488544|P3|Initial Treatment|Adverse Event|144
3051374|NCT00594568|10488545|P2|Initial Treatment|Adverse Event|121
3051375|NCT00594568|10488546|P1|Initial Treatment|Adverse Event|51
3051376|NCT00594516|10488634|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
3051377|NCT00594516|10488635|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
3051378|NCT00594516|10488636|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
3051379|NCT00594516|10488634|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
3051380|NCT00594516|10488635|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
3051381|NCT00594516|10488636|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
3051382|NCT00594516|10488634|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
3051383|NCT00594516|10488635|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
3051384|NCT00594516|10488636|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
3051385|NCT00594516|10488634|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
3051386|NCT00594516|10488635|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
3051387|NCT00594516|10488636|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
3051388|NCT00594516|10488634|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
3051389|NCT00594516|10488635|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
3051390|NCT00594516|10488636|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
3051391|NCT00594516|10488634|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
3051392|NCT00594516|10488635|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
3051393|NCT00594516|10488636|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
3051394|NCT00594516|10488634|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
3051395|NCT00594516|10488635|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
3051396|NCT00594516|10488636|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
3051397|NCT00594516|10488634|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
3051398|NCT00594516|10488635|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
3051399|NCT00594516|10488636|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
3051400|NCT00594516|10488634|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
3051401|NCT00594516|10488635|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
3051402|NCT00594516|10488636|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
3051403|NCT00594464|10488644|P1|Overall Study|Delay in operation|2
3051404|NCT00594464|10488644|P1|Overall Study|Withdrawal by Subject|1
3051405|NCT00594399|10488773|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
3051406|NCT00594399|10488774|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
3051407|NCT00594399|10488775|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
3051408|NCT00594399|10488773|P3|Rerandomization Arm 1 Only|Death|0
3051409|NCT00594399|10488774|P2|Rerandomization Arm 1 Only|Death|1
3051410|NCT00594399|10488775|P1|Rerandomization Arm 1 Only|Death|2
3051411|NCT00594399|10488773|P3|Initial 3 Month Counseling|Family illness|0
3051412|NCT00594399|10488774|P2|Initial 3 Month Counseling|Family illness|0
3051413|NCT00594399|10488775|P1|Initial 3 Month Counseling|Family illness|1
3051414|NCT00594399|10488773|P3|Initial 3 Month Counseling|Moved|0
3051415|NCT00594399|10488774|P2|Initial 3 Month Counseling|Moved|0
3051416|NCT00594399|10488775|P1|Initial 3 Month Counseling|Moved|1
3051417|NCT00594399|10488773|P3|Initial 3 Month Counseling|Pain|0
3051418|NCT00594399|10488774|P2|Initial 3 Month Counseling|Pain|0
3051419|NCT00594399|10488775|P1|Initial 3 Month Counseling|Pain|2
3051420|NCT00594399|10488773|P3|Initial 3 Month Counseling|Too busy|0
3051421|NCT00594399|10488774|P2|Initial 3 Month Counseling|Too busy|1
3051422|NCT00594399|10488775|P1|Initial 3 Month Counseling|Too busy|7
3051423|NCT00594399|10488773|P3|Initial 3 Month Counseling|Personal issues|0
3051424|NCT00594399|10488774|P2|Initial 3 Month Counseling|Personal issues|0
3051425|NCT00594399|10488775|P1|Initial 3 Month Counseling|Personal issues|2
3051426|NCT00594399|10488773|P3|Initial 3 Month Counseling|Lack of Interest|0
3051427|NCT00594399|10488774|P2|Initial 3 Month Counseling|Lack of Interest|3
3051428|NCT00594399|10488775|P1|Initial 3 Month Counseling|Lack of Interest|3
3051429|NCT00594399|10488773|P3|Initial 3 Month Counseling|Not ready to exercise|0
3051430|NCT00594399|10488774|P2|Initial 3 Month Counseling|Not ready to exercise|0
3051596|NCT00592852|10489603|P1|Overall Study|Adverse Event|3
3051431|NCT00594399|10488775|P1|Initial 3 Month Counseling|Not ready to exercise|1
3051432|NCT00594386|10488797|P1|Overall Study|Other: Loss of drivers license|1
3051433|NCT00594386|10488797|P1|Overall Study|Other: Patient wants prescription Neupro|1
3051434|NCT00594386|10488797|P1|Overall Study|Other: Site terminated participation|1
3051435|NCT00594386|10488797|P1|Overall Study|Other: Sponsor closure of study|1
3051436|NCT00594386|10488797|P1|Overall Study|Other: Study terminated per investigator|2
3051437|NCT00594386|10488797|P1|Overall Study|Other: Subject admitted to nursing home|1
3051438|NCT00594386|10488797|P1|Overall Study|Other: Subject moved to Seattle|1
3051439|NCT00594386|10488797|P1|Overall Study|Other: Patient went off patch (hospital)|1
3051440|NCT00594386|10488797|P1|Overall Study|Lost to Follow-up|6
3051441|NCT00594386|10488797|P1|Overall Study|Study ended per sponsor|115
3051442|NCT00594386|10488797|P1|Overall Study|Subject withdrew consent|35
3051443|NCT00594386|10488797|P1|Overall Study|Unsatisfactory compliance of subject|11
3051444|NCT00594386|10488797|P1|Overall Study|Adverse Event|68
3051445|NCT00594386|10488797|P1|Overall Study|Lack of Efficacy|12
3051446|NCT00594386|10488797|P1|Overall Study|Major protocol violation|2
3051447|NCT00594204|10488830|P2|Overall Study|Randomized but not treated|1
3051448|NCT00594204|10488831|P1|Overall Study|Randomized but not treated|4
3051449|NCT00594204|10488830|P2|Overall Study|Lack of Efficacy|4
3051450|NCT00594204|10488831|P1|Overall Study|Lack of Efficacy|3
3051451|NCT00594204|10488830|P2|Overall Study|Other|3
3051452|NCT00594204|10488831|P1|Overall Study|Other|4
3051453|NCT00594204|10488830|P2|Overall Study|Withdrawal by Subject|29
3051454|NCT00594204|10488831|P1|Overall Study|Withdrawal by Subject|23
3051455|NCT00594204|10488830|P2|Overall Study|Lost to Follow-up|5
3051456|NCT00594204|10488831|P1|Overall Study|Lost to Follow-up|9
3051457|NCT00594204|10488830|P2|Overall Study|Adverse Event|3
3051458|NCT00594204|10488831|P1|Overall Study|Adverse Event|15
3051459|NCT00594178|10488841|P1|Overall Study|Physician Decision|5
3051460|NCT00594165|10488846|P1|Overall Study|Other: Site terminated participation|2
3051461|NCT00594165|10488846|P1|Overall Study|Other: Subject enrolled in other trial|1
3051462|NCT00594165|10488846|P1|Overall Study|Other: House bound; can't get to clinic|1
3051463|NCT00594165|10488846|P1|Overall Study|Other: Brain surgery controlled symptoms|1
3051464|NCT00594165|10488846|P1|Overall Study|Other: Subject moving|3
3051465|NCT00594165|10488846|P1|Overall Study|Other: PI discretion|5
3051466|NCT00594165|10488846|P1|Overall Study|Lost to Follow-up|4
3051467|NCT00594165|10488846|P1|Overall Study|Study ended per sponsor|102
3051468|NCT00594165|10488846|P1|Overall Study|Subject withdrew consent|27
3051469|NCT00594165|10488846|P1|Overall Study|Unsatisfactory compliance of subject|6
3051470|NCT00594165|10488846|P1|Overall Study|Adverse Event|52
3051471|NCT00594165|10488846|P1|Overall Study|Lack of Efficacy|12
3051472|NCT00594165|10488846|P1|Overall Study|Major protocol violation|1
3051473|NCT00594100|10488852|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
3051474|NCT00594100|10488852|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
3051475|NCT00594100|10488852|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
3051476|NCT00594100|10488852|P1|Procedure|Technical Failure|9
3051477|NCT00594035|10488868|P2|Overall Study|Subject couldn't return due to job|1
3051478|NCT00594035|10488869|P1|Overall Study|Subject couldn't return due to job|0
3051479|NCT00594035|10488868|P2|Overall Study|Subject transferred to nursing home|1
3051480|NCT00594035|10488869|P1|Overall Study|Subject transferred to nursing home|0
3051481|NCT00594035|10488868|P2|Overall Study|Withdrawal by Subject|0
3051482|NCT00594035|10488869|P1|Overall Study|Withdrawal by Subject|1
3051483|NCT00594035|10488868|P2|Overall Study|Lost to Follow-up|1
3051484|NCT00594035|10488869|P1|Overall Study|Lost to Follow-up|1
3051485|NCT00593957|10488899|P3|Overall Study|Physician Decision|2
3051486|NCT00593957|10488900|P2|Overall Study|Physician Decision|1
3051487|NCT00593957|10488901|P1|Overall Study|Physician Decision|0
3051488|NCT00593918|10488925|P2|Overall Study|Withdrawal by Subject|24
3051489|NCT00593918|10488926|P1|Overall Study|Withdrawal by Subject|5
3051490|NCT00593840|10488939|P1|Overall Study|Withdrawal by Subject|1
3051491|NCT00593827|10488951|P2|Overall Study|On Active Treatment/Pending|2
3051492|NCT00593827|10488952|P1|Overall Study|On Active Treatment/Pending|0
3051493|NCT00593814|10488976|P2|Overall Study|Physician Decision|0
3051494|NCT00593814|10488977|P1|Overall Study|Physician Decision|3
3051495|NCT00593814|10488976|P2|Overall Study|Lost to Follow-up|0
3051496|NCT00593814|10488977|P1|Overall Study|Lost to Follow-up|7
3051497|NCT00593814|10488976|P2|Overall Study|Withdrawal by Subject|0
3051498|NCT00593814|10488977|P1|Overall Study|Withdrawal by Subject|7
3051499|NCT00593814|10488976|P2|Overall Study|Death|0
3051500|NCT00593814|10488977|P1|Overall Study|Death|7
3051501|NCT00593736|10488989|P4|Treatment Period and Placebo Run-out|Various|0
3051502|NCT00593736|10488990|P3|Treatment Period and Placebo Run-out|Various|1
3051503|NCT00593736|10488991|P2|Treatment Period and Placebo Run-out|Various|1
3051504|NCT00593736|10488992|P1|Treatment Period and Placebo Run-out|Various|1
3051505|NCT00593736|10488989|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
3051506|NCT00593736|10488990|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
3051507|NCT00593736|10488991|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
3051508|NCT00593736|10488992|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
3051509|NCT00593736|10488989|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
3051510|NCT00593736|10488990|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
3051511|NCT00593736|10488991|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
3051512|NCT00593736|10488992|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
3051513|NCT00593736|10488989|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
3051514|NCT00593736|10488990|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
3051515|NCT00593736|10488991|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
3051516|NCT00593736|10488992|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
3051517|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Various|25
3051518|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Various|0
3051519|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Various|0
3051520|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Various|0
3051521|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
3051522|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
3051523|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
3051524|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
3051525|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Study Termination|15
3051526|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Study Termination|0
3051527|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Study Termination|0
3051528|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Study Termination|0
3051529|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
3051530|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
3051531|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
3051532|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
3051533|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
3051534|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
3051535|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
3051536|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
3051537|NCT00593736|10488989|P4|Screening Period and Placebo Run-in|Adverse Event|3
3051538|NCT00593736|10488990|P3|Screening Period and Placebo Run-in|Adverse Event|0
3051539|NCT00593736|10488991|P2|Screening Period and Placebo Run-in|Adverse Event|0
3051540|NCT00593736|10488992|P1|Screening Period and Placebo Run-in|Adverse Event|0
3051541|NCT00593684|10489240|P2|Overall Study|Death|1
3051542|NCT00593684|10489241|P1|Overall Study|Death|2
3051543|NCT00593606|10489267|P1|Overall Study|Screen Failure|3
3051544|NCT00593606|10489267|P1|Overall Study|Run-In Failure|5
3051545|NCT00593606|10489267|P1|Overall Study|Lost to Follow-up|2
3051546|NCT00593606|10489267|P1|Overall Study|Protocol Violation|3
3051547|NCT00593606|10489267|P1|Overall Study|Withdrawal by Subject|1
3051548|NCT00593606|10489267|P1|Overall Study|Adverse Event|13
3051549|NCT00593554|10489365|P2|Overall Study|Disease Progression|2
3051550|NCT00593554|10489366|P1|Overall Study|Disease Progression|1
3051551|NCT00593554|10489365|P2|Overall Study|Withdrawal by Subject|0
3051552|NCT00593554|10489366|P1|Overall Study|Withdrawal by Subject|1
3051553|NCT00593554|10489365|P2|Overall Study|Physician Decision|1
3051554|NCT00593554|10489366|P1|Overall Study|Physician Decision|0
3051555|NCT00593554|10489365|P2|Overall Study|Death|2
3051556|NCT00593554|10489366|P1|Overall Study|Death|1
3051557|NCT00593385|10489461|P1|Overall Study|Withdrawal by Subject|9
3051558|NCT00593385|10489461|P1|Overall Study|Lost to Follow-up|17
3051559|NCT00593385|10489461|P1|Overall Study|Death|14
3051560|NCT00593333|10489522|P2|Overall Study|Lost to Follow-up|11
3051561|NCT00593333|10489523|P1|Overall Study|Lost to Follow-up|10
3051562|NCT00593112|10489546|P2|Overall Study|Withdrawal by Subject|0
3051563|NCT00593112|10489547|P1|Overall Study|Withdrawal by Subject|5
3051564|NCT00593112|10489546|P2|Overall Study|Unreadable Scan|0
3051565|NCT00593112|10489547|P1|Overall Study|Unreadable Scan|1
3051566|NCT00593112|10489546|P2|Overall Study|Abnormal Scan|0
3051567|NCT00593112|10489547|P1|Overall Study|Abnormal Scan|1
3051568|NCT00593112|10489546|P2|Overall Study|Scan Anxiety|0
3051569|NCT00593112|10489547|P1|Overall Study|Scan Anxiety|3
3051570|NCT00592904|10489574|P4|Overall Study|Other|0
3051571|NCT00592904|10489575|P3|Overall Study|Other|0
3051572|NCT00592904|10489576|P2|Overall Study|Other|3
3051573|NCT00592904|10489577|P1|Overall Study|Other|3
3051574|NCT00592904|10489574|P4|Overall Study|Physician Decision|0
3051575|NCT00592904|10489575|P3|Overall Study|Physician Decision|1
3051576|NCT00592904|10489576|P2|Overall Study|Physician Decision|3
3051577|NCT00592904|10489577|P1|Overall Study|Physician Decision|0
3051578|NCT00592904|10489574|P4|Overall Study|Lack of Efficacy|3
3051579|NCT00592904|10489575|P3|Overall Study|Lack of Efficacy|2
3051580|NCT00592904|10489576|P2|Overall Study|Lack of Efficacy|7
3051581|NCT00592904|10489577|P1|Overall Study|Lack of Efficacy|2
3051582|NCT00592904|10489574|P4|Overall Study|Withdrawal by Subject|2
3051583|NCT00592904|10489575|P3|Overall Study|Withdrawal by Subject|1
3051584|NCT00592904|10489576|P2|Overall Study|Withdrawal by Subject|16
3051585|NCT00592904|10489577|P1|Overall Study|Withdrawal by Subject|4
3051586|NCT00592904|10489574|P4|Overall Study|Protocol Violation|1
3051587|NCT00592904|10489575|P3|Overall Study|Protocol Violation|0
3051588|NCT00592904|10489576|P2|Overall Study|Protocol Violation|1
3051589|NCT00592904|10489577|P1|Overall Study|Protocol Violation|1
3051590|NCT00592904|10489574|P4|Overall Study|Adverse Event|5
3051591|NCT00592904|10489575|P3|Overall Study|Adverse Event|13
3051592|NCT00592904|10489576|P2|Overall Study|Adverse Event|25
3051593|NCT00592904|10489577|P1|Overall Study|Adverse Event|15
3051594|NCT00592852|10489603|P1|Overall Study|Withdrawal by Subject|1
3051595|NCT00592852|10489603|P1|Overall Study|Found ineligible|1
3051597|NCT00592852|10489603|P1|Overall Study|Non-compliance|1
3051598|NCT00592839|10489611|P3|Overall Study|Lost to Follow-up|1
3051599|NCT00592839|10489612|P2|Overall Study|Lost to Follow-up|1
3051600|NCT00592839|10489613|P1|Overall Study|Lost to Follow-up|0
3051601|NCT00592839|10489611|P3|Overall Study|Adverse Event|0
3051602|NCT00592839|10489612|P2|Overall Study|Adverse Event|1
3051603|NCT00592839|10489613|P1|Overall Study|Adverse Event|0
3051604|NCT00592839|10489611|P3|Overall Study|Protocol Violation|2
3051605|NCT00592839|10489612|P2|Overall Study|Protocol Violation|1
3051606|NCT00592839|10489613|P1|Overall Study|Protocol Violation|1
3051607|NCT00592839|10489611|P3|Overall Study|Withdrawal by Subject|3
3051608|NCT00592839|10489612|P2|Overall Study|Withdrawal by Subject|1
3051609|NCT00592839|10489613|P1|Overall Study|Withdrawal by Subject|1
3051610|NCT00592774|10489641|P5|Overall Study|Other|2
3051611|NCT00592774|10489642|P4|Overall Study|Other|0
3051612|NCT00592774|10489643|P3|Overall Study|Other|1
3051613|NCT00592774|10489644|P2|Overall Study|Other|1
3051614|NCT00592774|10489645|P1|Overall Study|Other|0
3051615|NCT00592774|10489641|P5|Overall Study|Physician Decision|1
3051616|NCT00592774|10489642|P4|Overall Study|Physician Decision|0
3051617|NCT00592774|10489643|P3|Overall Study|Physician Decision|1
3051618|NCT00592774|10489644|P2|Overall Study|Physician Decision|1
3051619|NCT00592774|10489645|P1|Overall Study|Physician Decision|0
3051620|NCT00592774|10489641|P5|Overall Study|Lack of Efficacy|2
3051621|NCT00592774|10489642|P4|Overall Study|Lack of Efficacy|0
3051622|NCT00592774|10489643|P3|Overall Study|Lack of Efficacy|0
3051623|NCT00592774|10489644|P2|Overall Study|Lack of Efficacy|3
3051624|NCT00592774|10489645|P1|Overall Study|Lack of Efficacy|3
3051625|NCT00592774|10489641|P5|Overall Study|Withdrawal by Subject|0
3051626|NCT00592774|10489642|P4|Overall Study|Withdrawal by Subject|0
3051627|NCT00592774|10489643|P3|Overall Study|Withdrawal by Subject|0
3051628|NCT00592774|10489644|P2|Overall Study|Withdrawal by Subject|7
3051629|NCT00592774|10489645|P1|Overall Study|Withdrawal by Subject|3
3051630|NCT00592774|10489641|P5|Overall Study|Protocol Violation|1
3051631|NCT00592774|10489642|P4|Overall Study|Protocol Violation|0
3051632|NCT00592774|10489643|P3|Overall Study|Protocol Violation|0
3051633|NCT00592774|10489644|P2|Overall Study|Protocol Violation|1
3051634|NCT00592774|10489645|P1|Overall Study|Protocol Violation|0
3051635|NCT00592774|10489641|P5|Overall Study|Adverse Event|8
3051636|NCT00592774|10489642|P4|Overall Study|Adverse Event|14
3051637|NCT00592774|10489643|P3|Overall Study|Adverse Event|2
3051638|NCT00592774|10489644|P2|Overall Study|Adverse Event|19
3051639|NCT00592774|10489645|P1|Overall Study|Adverse Event|5
3051640|NCT00592683|10489717|P2|Overall Study|Lost to Follow-up|1
3051641|NCT00592683|10489718|P1|Overall Study|Lost to Follow-up|0
3051642|NCT00592683|10489717|P2|Overall Study|Other|0
3051643|NCT00592683|10489718|P1|Overall Study|Other|1
3051644|NCT00592683|10489717|P2|Overall Study|Study drug expired|0
3051645|NCT00592683|10489718|P1|Overall Study|Study drug expired|1
3051646|NCT00592683|10489717|P2|Overall Study|Protocol Violation|0
3051647|NCT00592683|10489718|P1|Overall Study|Protocol Violation|1
3051648|NCT00592683|10489717|P2|Overall Study|Adverse Event|2
3051649|NCT00592683|10489718|P1|Overall Study|Adverse Event|0
3051650|NCT00592683|10489717|P2|Overall Study|Withdrawal by Subject|0
3051651|NCT00592683|10489718|P1|Overall Study|Withdrawal by Subject|1
3051652|NCT00592683|10489717|P2|Overall Study|Found ineligible|1
3051653|NCT00592683|10489718|P1|Overall Study|Found ineligible|0
3051654|NCT00592631|10489728|P2|Overall Study|Lost to Follow-up|2
3051655|NCT00592631|10489729|P1|Overall Study|Lost to Follow-up|0
3051656|NCT00592553|10489738|P3|Overall Study|Protocol Noncompliance|0
3051657|NCT00592553|10489739|P2|Overall Study|Protocol Noncompliance|0
3051658|NCT00592553|10489740|P1|Overall Study|Protocol Noncompliance|1
3051659|NCT00592384|10489857|P2|Overall Study|Withdrawal by Subject|6
3051660|NCT00592384|10489858|P1|Overall Study|Withdrawal by Subject|5
3051661|NCT00592358|10489866|P1|Overall Study|Inability to swallow pills|1
3051662|NCT00592358|10489866|P1|Overall Study|Lack of Efficacy|2
3051663|NCT00592358|10489866|P1|Overall Study|Adverse Event|1
3051664|NCT00592358|10489866|P1|Overall Study|Withdrawal by Subject|2
3051665|NCT00592319|10489873|P2|Overall Study|Lost to Follow-up|3
3051666|NCT00592319|10489874|P1|Overall Study|Lost to Follow-up|0
3051667|NCT00592072|10489949|P2|Wash Out Period|Lost to Follow-up|1
3051668|NCT00592072|10489950|P1|Wash Out Period|Lost to Follow-up|1
3051669|NCT00592007|10489972|P1|Overall Study|patient ineligible (out of lab range)|1
3051670|NCT00592007|10489972|P1|Overall Study|Withdrawal by Subject|1
3051671|NCT00591864|10489984|P1|Overall Study|Incomplete Imaging|5
3051672|NCT00591851|10489990|P1|Overall Study|Progressive Disease|1
3051673|NCT00591851|10489990|P1|Overall Study|Adverse Event|2
3051674|NCT00591851|10489990|P1|Overall Study|Withdrawal by Subject|3
3051675|NCT00591838|10489999|P5|Overall Study|Withdrawal by Subject|0
3051676|NCT00591838|10490000|P4|Overall Study|Withdrawal by Subject|1
3051677|NCT00591838|10490001|P3|Overall Study|Withdrawal by Subject|0
3051678|NCT00591838|10490002|P2|Overall Study|Withdrawal by Subject|0
3051679|NCT00591838|10490003|P1|Overall Study|Withdrawal by Subject|0
3051680|NCT00591786|10490067|P10|Overall Study|Withdrawal of Informed Consent|0
3051681|NCT00591786|10490068|P9|Overall Study|Withdrawal of Informed Consent|0
3051682|NCT00591786|10490069|P8|Overall Study|Withdrawal of Informed Consent|0
3051683|NCT00591786|10490070|P7|Overall Study|Withdrawal of Informed Consent|0
3051684|NCT00591786|10490071|P6|Overall Study|Withdrawal of Informed Consent|0
3051685|NCT00591786|10490072|P5|Overall Study|Withdrawal of Informed Consent|0
3051686|NCT00591786|10490073|P4|Overall Study|Withdrawal of Informed Consent|0
3051687|NCT00591786|10490074|P3|Overall Study|Withdrawal of Informed Consent|1
3051688|NCT00591786|10490075|P2|Overall Study|Withdrawal of Informed Consent|0
3051689|NCT00591786|10490076|P1|Overall Study|Withdrawal of Informed Consent|0
3051690|NCT00591773|10490121|P3|Overall Study|Other|4
3051691|NCT00591773|10490122|P2|Overall Study|Other|1
3051692|NCT00591773|10490123|P1|Overall Study|Other|1
3051693|NCT00591773|10490121|P3|Overall Study|Lack of Efficacy|2
3051694|NCT00591773|10490122|P2|Overall Study|Lack of Efficacy|2
3051695|NCT00591773|10490123|P1|Overall Study|Lack of Efficacy|1
3051696|NCT00591773|10490121|P3|Overall Study|Withdrawal by Subject|3
3051697|NCT00591773|10490122|P2|Overall Study|Withdrawal by Subject|5
3051698|NCT00591773|10490123|P1|Overall Study|Withdrawal by Subject|2
3051699|NCT00591773|10490121|P3|Overall Study|Lost to Follow-up|1
3051700|NCT00591773|10490122|P2|Overall Study|Lost to Follow-up|4
3051701|NCT00591773|10490123|P1|Overall Study|Lost to Follow-up|1
3051702|NCT00591773|10490121|P3|Overall Study|Protocol Violation|0
3051703|NCT00591773|10490122|P2|Overall Study|Protocol Violation|3
3051704|NCT00591773|10490123|P1|Overall Study|Protocol Violation|2
3051705|NCT00591773|10490121|P3|Overall Study|Adverse Event|6
3051706|NCT00591773|10490122|P2|Overall Study|Adverse Event|9
3051707|NCT00591773|10490123|P1|Overall Study|Adverse Event|9
3051708|NCT00591734|10490182|P1|Overall Study|Intercurrent Illness|8
3051709|NCT00591734|10490182|P1|Overall Study|Physician Decision|5
3051710|NCT00591734|10490182|P1|Overall Study|Adverse Event|5
3051711|NCT00591734|10490182|P1|Overall Study|Lack of Efficacy|35
3051712|NCT00591721|10490188|P2|Overall Study|Intervention not received|8
3051713|NCT00591721|10490189|P1|Overall Study|Intervention not received|10
3051714|NCT00591721|10490188|P2|Overall Study|Lost to Follow-up|4
3051715|NCT00591721|10490189|P1|Overall Study|Lost to Follow-up|1
3051716|NCT00591721|10490188|P2|Overall Study|Withdrawal by Subject|10
3051717|NCT00591721|10490189|P1|Overall Study|Withdrawal by Subject|10
3051718|NCT00591591|10490197|P2|Overall Study|Lack of Efficacy|2
3051719|NCT00591591|10490198|P1|Overall Study|Lack of Efficacy|10
3051720|NCT00591591|10490197|P2|Overall Study|Withdrawal by Subject|37
3051721|NCT00591591|10490198|P1|Overall Study|Withdrawal by Subject|1
3051722|NCT00591578|10490215|P3|Open-Label Extension Phase|Other|0
3051723|NCT00591578|10490216|P2|Open-Label Extension Phase|Other|0
3051724|NCT00591578|10490217|P1|Open-Label Extension Phase|Other|1
3051725|NCT00591578|10490215|P3|Open-Label Extension Phase|Withdrawal by Subject|0
3051726|NCT00591578|10490216|P2|Open-Label Extension Phase|Withdrawal by Subject|1
3051727|NCT00591578|10490217|P1|Open-Label Extension Phase|Withdrawal by Subject|1
3051728|NCT00591578|10490215|P3|Open-Label Extension Phase|Lost to Follow-up|0
3051729|NCT00591578|10490216|P2|Open-Label Extension Phase|Lost to Follow-up|4
3051730|NCT00591578|10490217|P1|Open-Label Extension Phase|Lost to Follow-up|1
3051731|NCT00591578|10490215|P3|Open-Label Extension Phase|Adverse Event|0
3051732|NCT00591578|10490216|P2|Open-Label Extension Phase|Adverse Event|5
3051733|NCT00591578|10490217|P1|Open-Label Extension Phase|Adverse Event|3
3051734|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Other|4
3051735|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Other|9
3051736|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Other|4
3051737|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
3051738|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
3051739|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
3051740|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Pregnancy|0
3051741|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Pregnancy|0
3051742|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Pregnancy|1
3051743|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
3051744|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
3051745|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
3051746|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
3051747|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
3051748|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
3051749|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Protocol Violation|3
3051750|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Protocol Violation|2
3051751|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Protocol Violation|3
3051752|NCT00591578|10490215|P3|Double-Blind Treatment Phase|Adverse Event|19
3051753|NCT00591578|10490216|P2|Double-Blind Treatment Phase|Adverse Event|26
3051754|NCT00591578|10490217|P1|Double-Blind Treatment Phase|Adverse Event|20
3051755|NCT00591565|10490268|P1|Overall Study|lost follow up, withdrawn|5
3051756|NCT00591409|10490282|P10|Overall Study|Not Treated|1
3051757|NCT00591409|10490283|P9|Overall Study|Not Treated|0
3051758|NCT00591409|10490284|P8|Overall Study|Not Treated|0
3051759|NCT00591409|10490285|P7|Overall Study|Not Treated|0
3051760|NCT00591409|10490286|P6|Overall Study|Not Treated|0
3051761|NCT00591409|10490287|P5|Overall Study|Not Treated|1
3051762|NCT00591409|10490288|P4|Overall Study|Not Treated|0
3051763|NCT00591409|10490289|P3|Overall Study|Not Treated|0
3051764|NCT00591409|10490290|P2|Overall Study|Not Treated|0
3051765|NCT00591409|10490291|P1|Overall Study|Not Treated|0
3051766|NCT00591370|10490333|P1|Overall Study|Not Treated|2
3051767|NCT00591344|10490341|P2|Overall Study|Did not want to come off medication|1
3051768|NCT00591344|10490342|P1|Overall Study|Did not want to come off medication|0
3051769|NCT00591344|10490341|P2|Overall Study|Lost to Follow-up|1
3051770|NCT00591344|10490342|P1|Overall Study|Lost to Follow-up|0
3051771|NCT00591344|10490341|P2|Overall Study|Death|1
3051772|NCT00591344|10490342|P1|Overall Study|Death|0
3051773|NCT00591344|10490341|P2|Overall Study|Underwent DBS|2
3051774|NCT00591344|10490342|P1|Overall Study|Underwent DBS|2
3051775|NCT00591344|10490341|P2|Overall Study|Medical complications|3
3051776|NCT00591344|10490342|P1|Overall Study|Medical complications|1
3051777|NCT00591344|10490341|P2|Overall Study|Moved out of state|0
3051778|NCT00591344|10490342|P1|Overall Study|Moved out of state|1
3051779|NCT00591344|10490341|P2|Overall Study|Transportation issues|0
3051780|NCT00591344|10490342|P1|Overall Study|Transportation issues|1
3051781|NCT00591266|10490368|P3|Overall Study|Other|5
3051782|NCT00591266|10490369|P2|Overall Study|Other|4
3051783|NCT00591266|10490370|P1|Overall Study|Other|1
3051784|NCT00591266|10490368|P3|Overall Study|Lack of Efficacy|0
3051785|NCT00591266|10490369|P2|Overall Study|Lack of Efficacy|2
3051786|NCT00591266|10490370|P1|Overall Study|Lack of Efficacy|0
3051787|NCT00591266|10490368|P3|Overall Study|Withdrawal by Subject|5
3051788|NCT00591266|10490369|P2|Overall Study|Withdrawal by Subject|2
3051789|NCT00591266|10490370|P1|Overall Study|Withdrawal by Subject|6
3051790|NCT00591266|10490368|P3|Overall Study|Protocol Violation|1
3051791|NCT00591266|10490369|P2|Overall Study|Protocol Violation|0
3051792|NCT00591266|10490370|P1|Overall Study|Protocol Violation|0
3051793|NCT00591266|10490368|P3|Overall Study|Lost to Follow-up|0
3051794|NCT00591266|10490369|P2|Overall Study|Lost to Follow-up|1
3051795|NCT00591266|10490370|P1|Overall Study|Lost to Follow-up|0
3051796|NCT00591266|10490368|P3|Overall Study|Adverse Event|3
3051797|NCT00591266|10490369|P2|Overall Study|Adverse Event|2
3051798|NCT00591266|10490370|P1|Overall Study|Adverse Event|2
3051799|NCT00591253|10490423|P3|Overall Study|Other|3
3051800|NCT00591253|10490424|P2|Overall Study|Other|5
3051801|NCT00591253|10490425|P1|Overall Study|Other|5
3051802|NCT00591253|10490423|P3|Overall Study|Lack of Efficacy|3
3051803|NCT00591253|10490424|P2|Overall Study|Lack of Efficacy|0
3051804|NCT00591253|10490425|P1|Overall Study|Lack of Efficacy|1
3051805|NCT00591253|10490423|P3|Overall Study|Withdrawal by Subject|6
3051806|NCT00591253|10490424|P2|Overall Study|Withdrawal by Subject|7
3051807|NCT00591253|10490425|P1|Overall Study|Withdrawal by Subject|1
3051808|NCT00591253|10490423|P3|Overall Study|Lost to Follow-up|0
3051809|NCT00591253|10490424|P2|Overall Study|Lost to Follow-up|4
3051810|NCT00591253|10490425|P1|Overall Study|Lost to Follow-up|2
3051811|NCT00591253|10490423|P3|Overall Study|Protocol Violation|2
3051812|NCT00591253|10490424|P2|Overall Study|Protocol Violation|2
3051813|NCT00591253|10490425|P1|Overall Study|Protocol Violation|2
3051814|NCT00591253|10490423|P3|Overall Study|Adverse Event|1
3051815|NCT00591253|10490424|P2|Overall Study|Adverse Event|3
3051816|NCT00591253|10490425|P1|Overall Study|Adverse Event|3
3051817|NCT00591214|10490493|P1|Overall Study|Withdrawal by Subject|1
3051818|NCT00591214|10490493|P1|Overall Study|Physician Decision|7
3051819|NCT00591149|10490502|P1|Overall Study|Withdrawal by Subject|1
3051820|NCT00591149|10490502|P1|Overall Study|Adverse Event|4
3051821|NCT00591006|10490518|P24|Overall Study|Adverse Event|0
3051822|NCT00591006|10490519|P23|Overall Study|Adverse Event|1
3051823|NCT00591006|10490520|P22|Overall Study|Adverse Event|0
3051824|NCT00591006|10490521|P21|Overall Study|Adverse Event|0
3051825|NCT00591006|10490522|P20|Overall Study|Adverse Event|0
3051826|NCT00591006|10490523|P19|Overall Study|Adverse Event|0
3051827|NCT00591006|10490524|P18|Overall Study|Adverse Event|0
3051828|NCT00591006|10490525|P17|Overall Study|Adverse Event|0
3051829|NCT00591006|10490526|P16|Overall Study|Adverse Event|0
3051830|NCT00591006|10490527|P15|Overall Study|Adverse Event|0
3051831|NCT00591006|10490528|P14|Overall Study|Adverse Event|0
3051832|NCT00591006|10490529|P13|Overall Study|Adverse Event|0
3051833|NCT00591006|10490530|P12|Overall Study|Adverse Event|0
3051834|NCT00591006|10490531|P11|Overall Study|Adverse Event|0
3051835|NCT00591006|10490532|P10|Overall Study|Adverse Event|0
3051836|NCT00591006|10490533|P9|Overall Study|Adverse Event|0
3051837|NCT00591006|10490534|P8|Overall Study|Adverse Event|0
3051838|NCT00591006|10490535|P7|Overall Study|Adverse Event|0
3051839|NCT00591006|10490536|P6|Overall Study|Adverse Event|0
3051840|NCT00591006|10490537|P5|Overall Study|Adverse Event|0
3051841|NCT00591006|10490538|P4|Overall Study|Adverse Event|0
3051842|NCT00591006|10490539|P3|Overall Study|Adverse Event|0
3051843|NCT00591006|10490540|P2|Overall Study|Adverse Event|0
3051844|NCT00591006|10490541|P1|Overall Study|Adverse Event|0
3051845|NCT00591006|10490518|P24|Overall Study|Withdrawal by Subject|1
3051846|NCT00591006|10490519|P23|Overall Study|Withdrawal by Subject|0
3051847|NCT00591006|10490520|P22|Overall Study|Withdrawal by Subject|0
3051848|NCT00591006|10490521|P21|Overall Study|Withdrawal by Subject|0
3051849|NCT00591006|10490522|P20|Overall Study|Withdrawal by Subject|0
3051850|NCT00591006|10490523|P19|Overall Study|Withdrawal by Subject|0
3051851|NCT00591006|10490524|P18|Overall Study|Withdrawal by Subject|0
3051852|NCT00591006|10490525|P17|Overall Study|Withdrawal by Subject|0
3051853|NCT00591006|10490526|P16|Overall Study|Withdrawal by Subject|1
3051854|NCT00591006|10490527|P15|Overall Study|Withdrawal by Subject|0
3051855|NCT00591006|10490528|P14|Overall Study|Withdrawal by Subject|0
3051856|NCT00591006|10490529|P13|Overall Study|Withdrawal by Subject|0
3051857|NCT00591006|10490530|P12|Overall Study|Withdrawal by Subject|0
3051858|NCT00591006|10490531|P11|Overall Study|Withdrawal by Subject|0
3051859|NCT00591006|10490532|P10|Overall Study|Withdrawal by Subject|0
3051860|NCT00591006|10490533|P9|Overall Study|Withdrawal by Subject|0
3051861|NCT00591006|10490534|P8|Overall Study|Withdrawal by Subject|0
3051862|NCT00591006|10490535|P7|Overall Study|Withdrawal by Subject|0
3051863|NCT00591006|10490536|P6|Overall Study|Withdrawal by Subject|0
3051864|NCT00591006|10490537|P5|Overall Study|Withdrawal by Subject|0
3051865|NCT00591006|10490538|P4|Overall Study|Withdrawal by Subject|0
3051866|NCT00591006|10490539|P3|Overall Study|Withdrawal by Subject|0
3051867|NCT00591006|10490540|P2|Overall Study|Withdrawal by Subject|0
3051868|NCT00591006|10490541|P1|Overall Study|Withdrawal by Subject|0
3051869|NCT00590980|10490559|P1|Overall Study|Did not meet all inclusion criteria|10
3051870|NCT00590967|10490565|P2|Overall Study|Did not receive chemo per protocol|0
3051871|NCT00590967|10490566|P1|Overall Study|Did not receive chemo per protocol|1
3051872|NCT00590967|10490565|P2|Overall Study|Did not sign consent form|1
3051873|NCT00590967|10490566|P1|Overall Study|Did not sign consent form|0
3051874|NCT00590967|10490565|P2|Overall Study|Non-compliant|2
3051875|NCT00590967|10490566|P1|Overall Study|Non-compliant|0
3051876|NCT00590967|10490565|P2|Overall Study|Poor performance status|1
3051877|NCT00590967|10490566|P1|Overall Study|Poor performance status|0
3051878|NCT00590967|10490565|P2|Overall Study|Ineligible|0
3051879|NCT00590967|10490566|P1|Overall Study|Ineligible|1
3051880|NCT00590967|10490565|P2|Overall Study|Withdrawal by Subject|1
3051881|NCT00590967|10490566|P1|Overall Study|Withdrawal by Subject|1
3051882|NCT00590902|10490578|P1|Overall Study|Death|1
3051883|NCT00590824|10490611|P4|Overall Study|Adverse Event|1
3051884|NCT00590824|10490612|P3|Overall Study|Adverse Event|0
3051885|NCT00590824|10490613|P2|Overall Study|Adverse Event|0
3051886|NCT00590824|10490614|P1|Overall Study|Adverse Event|0
3051887|NCT00590824|10490611|P4|Overall Study|Disease could not be resected|0
3051888|NCT00590824|10490612|P3|Overall Study|Disease could not be resected|1
3051889|NCT00590824|10490613|P2|Overall Study|Disease could not be resected|2
3051890|NCT00590824|10490614|P1|Overall Study|Disease could not be resected|0
3051891|NCT00590759|10490640|P1|Overall Study|Lost to Follow-up|28
3051892|NCT00590759|10490640|P1|Overall Study|Death|52
3051893|NCT00590720|10490647|P2|Overall Study|Withdrawal by Subject|1
3051894|NCT00590720|10490648|P1|Overall Study|Withdrawal by Subject|0
3051895|NCT00590720|10490647|P2|Overall Study|Lost to Follow-up|0
3051896|NCT00590720|10490648|P1|Overall Study|Lost to Follow-up|1
3051897|NCT00590590|10490710|P3|Overall Study|Did not complete study|0
3051898|NCT00590590|10490711|P2|Overall Study|Did not complete study|1
3051899|NCT00590590|10490712|P1|Overall Study|Did not complete study|0
3051900|NCT00590590|10490710|P3|Overall Study|Did not complete due to study closure|1
3051901|NCT00590590|10490711|P2|Overall Study|Did not complete due to study closure|1
3051902|NCT00590590|10490712|P1|Overall Study|Did not complete due to study closure|1
3051903|NCT00590590|10490710|P3|Overall Study|Withdrawal by Subject|1
3051904|NCT00590590|10490711|P2|Overall Study|Withdrawal by Subject|1
3051905|NCT00590590|10490712|P1|Overall Study|Withdrawal by Subject|0
3051906|NCT00590590|10490710|P3|Overall Study|Lost to Follow-up|2
3051907|NCT00590590|10490711|P2|Overall Study|Lost to Follow-up|1
3051908|NCT00590590|10490712|P1|Overall Study|Lost to Follow-up|4
3051909|NCT00590590|10490710|P3|Overall Study|Protocol Violation|2
3051910|NCT00590590|10490711|P2|Overall Study|Protocol Violation|0
3051911|NCT00590590|10490712|P1|Overall Study|Protocol Violation|0
3051912|NCT00590590|10490710|P3|Overall Study|Adverse Event|0
3051913|NCT00590590|10490711|P2|Overall Study|Adverse Event|0
3051914|NCT00590590|10490712|P1|Overall Study|Adverse Event|1
3051915|NCT00590590|10490710|P3|Overall Study|Lack of Efficacy|0
3051916|NCT00590590|10490711|P2|Overall Study|Lack of Efficacy|2
3051917|NCT00590590|10490712|P1|Overall Study|Lack of Efficacy|1
3051918|NCT00590577|10490739|P4|Overall Study|Various reasons|2
3051919|NCT00590577|10490740|P3|Overall Study|Various reasons|1
3051920|NCT00590577|10490741|P2|Overall Study|Various reasons|3
3051921|NCT00590577|10490742|P1|Overall Study|Various reasons|1
3051922|NCT00590577|10490739|P4|Overall Study|Pregnancy|0
3051923|NCT00590577|10490740|P3|Overall Study|Pregnancy|0
3051924|NCT00590577|10490741|P2|Overall Study|Pregnancy|1
3051925|NCT00590577|10490742|P1|Overall Study|Pregnancy|0
3051926|NCT00590577|10490739|P4|Overall Study|Lost to Follow-up|9
3051927|NCT00590577|10490740|P3|Overall Study|Lost to Follow-up|6
3051928|NCT00590577|10490741|P2|Overall Study|Lost to Follow-up|6
3051929|NCT00590577|10490742|P1|Overall Study|Lost to Follow-up|12
3051930|NCT00590577|10490739|P4|Overall Study|Adverse Event|11
3051931|NCT00590577|10490740|P3|Overall Study|Adverse Event|13
3051932|NCT00590577|10490741|P2|Overall Study|Adverse Event|10
3051933|NCT00590577|10490742|P1|Overall Study|Adverse Event|10
3051934|NCT00590577|10490739|P4|Overall Study|Withdrawal by Subject|26
3051935|NCT00590577|10490740|P3|Overall Study|Withdrawal by Subject|30
3051936|NCT00590577|10490741|P2|Overall Study|Withdrawal by Subject|28
3051937|NCT00590577|10490742|P1|Overall Study|Withdrawal by Subject|23
3051938|NCT00590577|10490739|P4|Overall Study|Lack of Efficacy|45
3051939|NCT00590577|10490740|P3|Overall Study|Lack of Efficacy|23
3051940|NCT00590577|10490741|P2|Overall Study|Lack of Efficacy|28
3051941|NCT00590577|10490742|P1|Overall Study|Lack of Efficacy|31
3051942|NCT00590564|10490760|P1|Overall Study|Patient Non-compliance|6
3051943|NCT00590564|10490760|P1|Overall Study|Patient Found to be Ineligible|1
3051944|NCT00590564|10490760|P1|Overall Study|Protocol Violation|1
3051945|NCT00590564|10490760|P1|Overall Study|Lost to Follow-up|6
3051946|NCT00590564|10490760|P1|Overall Study|Withdrawal by Subject|4
3051947|NCT00590538|10490764|P1|Overall Study|Study terminated before completed|2
3051948|NCT00590317|10490810|P2|Overall Study|Lack of Efficacy|5
3051949|NCT00590317|10490811|P1|Overall Study|Lack of Efficacy|1
3051950|NCT00590135|10490841|P1|Overall Study|Primary endpoint measure not obtainable|59
3051951|NCT00590044|10490851|P2|Overall Study|Protocol Violation|0
3051952|NCT00590044|10490852|P1|Overall Study|Protocol Violation|1
3051953|NCT00590044|10490851|P2|Overall Study|wrong insulin arm assigned|0
3051954|NCT00590044|10490852|P1|Overall Study|wrong insulin arm assigned|1
3051955|NCT00590044|10490851|P2|Overall Study|Withdrawal by Subject|2
3051956|NCT00590044|10490852|P1|Overall Study|Withdrawal by Subject|2
3051957|NCT00590031|10490864|P1|Overall Study|Admin Hold|1
3051958|NCT00590031|10490864|P1|Overall Study|Metastatic Disease|1
3051959|NCT00590031|10490864|P1|Overall Study|Withdrawal by Subject|1
3051960|NCT00590031|10490864|P1|Overall Study|Adverse Event|3
3051961|NCT00589979|10490891|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
3051962|NCT00589979|10490892|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
3051963|NCT00589979|10490893|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
3051964|NCT00589979|10490891|P3|Double-Blind Treatment Period 3|Protocol Violation|0
3051965|NCT00589979|10490892|P2|Double-Blind Treatment Period 3|Protocol Violation|1
3051966|NCT00589979|10490893|P1|Double-Blind Treatment Period 3|Protocol Violation|0
3051967|NCT00589979|10490891|P3|Double-Blind Treatment Period 2|Other|1
3051968|NCT00589979|10490892|P2|Double-Blind Treatment Period 2|Other|0
3051969|NCT00589979|10490893|P1|Double-Blind Treatment Period 2|Other|0
3051970|NCT00589979|10490891|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
3051971|NCT00589979|10490892|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
3051972|NCT00589979|10490893|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
3051973|NCT00589979|10490891|P3|Double-Blind Treatment Period 2|Adverse Event|0
3051974|NCT00589979|10490892|P2|Double-Blind Treatment Period 2|Adverse Event|1
3051975|NCT00589979|10490893|P1|Double-Blind Treatment Period 2|Adverse Event|0
3051976|NCT00589979|10490891|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
3051977|NCT00589979|10490892|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
3051978|NCT00589979|10490893|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
3051979|NCT00589979|10490891|P3|Double-Blind Treatment Period 1|Protocol Violation|1
3051980|NCT00589979|10490892|P2|Double-Blind Treatment Period 1|Protocol Violation|1
3051981|NCT00589979|10490893|P1|Double-Blind Treatment Period 1|Protocol Violation|0
3051982|NCT00589979|10490891|P3|Double-Blind Treatment Period 1|Adverse Event|0
3051983|NCT00589979|10490892|P2|Double-Blind Treatment Period 1|Adverse Event|1
3051984|NCT00589979|10490893|P1|Double-Blind Treatment Period 1|Adverse Event|0
3051985|NCT00589979|10490891|P3|Run-In Period|Informed Consent Withdrawn|0
3051986|NCT00589979|10490892|P2|Run-In Period|Informed Consent Withdrawn|0
3051987|NCT00589979|10490893|P1|Run-In Period|Informed Consent Withdrawn|4
3051988|NCT00589979|10490891|P3|Run-In Period|Withdrawal by Subject|0
3051989|NCT00589979|10490892|P2|Run-In Period|Withdrawal by Subject|0
3051990|NCT00589979|10490893|P1|Run-In Period|Withdrawal by Subject|10
3051991|NCT00589979|10490891|P3|Run-In Period|Did not qualify for randomization|0
3051992|NCT00589979|10490892|P2|Run-In Period|Did not qualify for randomization|0
3051993|NCT00589979|10490893|P1|Run-In Period|Did not qualify for randomization|54
3051994|NCT00589979|10490891|P3|Run-In Period|Protocol Violation|0
3051995|NCT00589979|10490892|P2|Run-In Period|Protocol Violation|0
3051996|NCT00589979|10490893|P1|Run-In Period|Protocol Violation|3
3051997|NCT00589979|10490891|P3|Run-In Period|Adverse Event|0
3051998|NCT00589979|10490892|P2|Run-In Period|Adverse Event|0
3051999|NCT00589979|10490893|P1|Run-In Period|Adverse Event|5
3052000|NCT00589914|10490932|P2|Overall Study|Other|17
3052001|NCT00589914|10490933|P1|Overall Study|Other|22
3052002|NCT00589914|10490932|P2|Overall Study|Withdrawal by Subject|49
3052003|NCT00589914|10490933|P1|Overall Study|Withdrawal by Subject|55
3052004|NCT00589914|10490932|P2|Overall Study|Pregnancy|0
3052005|NCT00589914|10490933|P1|Overall Study|Pregnancy|1
3052006|NCT00589914|10490932|P2|Overall Study|Lost to Follow-up|18
3052007|NCT00589914|10490933|P1|Overall Study|Lost to Follow-up|11
3052008|NCT00589914|10490932|P2|Overall Study|Lack of Efficacy|43
3052009|NCT00589914|10490933|P1|Overall Study|Lack of Efficacy|40
3052010|NCT00589914|10490932|P2|Overall Study|Death|0
3052011|NCT00589914|10490933|P1|Overall Study|Death|2
3052012|NCT00589914|10490932|P2|Overall Study|Adverse Event|10
3052013|NCT00589914|10490933|P1|Overall Study|Adverse Event|19
3052014|NCT00589797|10490989|P2|Overall Study|Non-Randomized Training Subjects|6
3052015|NCT00589797|10490990|P1|Overall Study|Non-Randomized Training Subjects|46
3052016|NCT00589797|10490989|P2|Overall Study|Withdrawal by Subject|5
3052017|NCT00589797|10490990|P1|Overall Study|Withdrawal by Subject|6
3052018|NCT00589797|10490989|P2|Overall Study|Physician Decision|3
3052019|NCT00589797|10490990|P1|Overall Study|Physician Decision|8
3052020|NCT00589797|10490989|P2|Overall Study|Lost to Follow-up|9
3052021|NCT00589797|10490990|P1|Overall Study|Lost to Follow-up|12
3052022|NCT00589797|10490989|P2|Overall Study|Death|0
3052023|NCT00589797|10490990|P1|Overall Study|Death|1
3052024|NCT00589784|10491014|P2|Overall Study|Adverse Event|4
3052025|NCT00589784|10491015|P1|Overall Study|Adverse Event|0
3052026|NCT00589784|10491014|P2|Overall Study|Patient inevaluable|0
3052027|NCT00589784|10491015|P1|Overall Study|Patient inevaluable|1
3052028|NCT00589784|10491014|P2|Overall Study|Withdrawal by Subject|6
3052029|NCT00589784|10491015|P1|Overall Study|Withdrawal by Subject|0
3052030|NCT00589693|10491022|P2|Overall Study|Protocol Violation|1
3052031|NCT00589693|10491023|P1|Overall Study|Protocol Violation|1
3052032|NCT00589693|10491022|P2|Overall Study|Physician Decision|1
3052033|NCT00589693|10491023|P1|Overall Study|Physician Decision|0
3052034|NCT00589693|10491022|P2|Overall Study|Lost to Follow-up|0
3052035|NCT00589693|10491023|P1|Overall Study|Lost to Follow-up|1
3052036|NCT00589693|10491022|P2|Overall Study|Lack of Efficacy|1
3052037|NCT00589693|10491023|P1|Overall Study|Lack of Efficacy|0
3052038|NCT00589693|10491022|P2|Overall Study|Death|16
3052039|NCT00589693|10491023|P1|Overall Study|Death|26
3052040|NCT00589693|10491022|P2|Overall Study|Adverse Event|4
3052041|NCT00589693|10491023|P1|Overall Study|Adverse Event|4
3052042|NCT00589693|10491022|P2|Overall Study|randomized in error|6
3052043|NCT00589693|10491023|P1|Overall Study|randomized in error|12
3052044|NCT00589667|10491037|P1|Overall Study|Withdrawal by Subject|1
3052045|NCT00589667|10491037|P1|Overall Study|Adverse Event|2
3052046|NCT00589628|10491044|P2|Overall Study|Lost to Follow-up|1
3052047|NCT00589628|10491045|P1|Overall Study|Lost to Follow-up|0
3052048|NCT00589602|10491051|P1|Overall Study|Did not collect enough CD34+ cells|1
3052049|NCT00589472|10491086|P1|Overall Study|Adverse Event|1
3052050|NCT00589303|10491109|P2|Overall Study|Withdrawal by Subject|1
3052051|NCT00589303|10491110|P1|Overall Study|Withdrawal by Subject|2
3052052|NCT00589290|10491116|P1|Overall Study|Withdrawal by Subject|1
3052053|NCT00589121|10491139|P2|Overall Study|No protocol treatment received|1
3052054|NCT00589121|10491140|P1|Overall Study|No protocol treatment received|0
3052055|NCT00589121|10491139|P2|Overall Study|Protocol Violation|6
3052056|NCT00589121|10491140|P1|Overall Study|Protocol Violation|2
3052057|NCT00589108|10491162|P3|Overall Study|Death|4
3052058|NCT00589108|10491163|P2|Overall Study|Death|3
3052059|NCT00589108|10491164|P1|Overall Study|Death|3
3052060|NCT00589108|10491162|P3|Overall Study|Lost to Follow-up|1
3052061|NCT00589108|10491163|P2|Overall Study|Lost to Follow-up|1
3052062|NCT00589108|10491164|P1|Overall Study|Lost to Follow-up|1
3052063|NCT00588952|10491200|P2|Overall Study|Withdrawal by Subject|5
3052064|NCT00588952|10491201|P1|Overall Study|Withdrawal by Subject|3
3052065|NCT00588952|10491200|P2|Overall Study|Adverse Event|2
3052066|NCT00588952|10491201|P1|Overall Study|Adverse Event|0
3052067|NCT00588861|10491229|P2|10 Years|Incomplete due to study termination|114
3052068|NCT00588861|10491230|P1|10 Years|Incomplete due to study termination|107
3052069|NCT00588861|10491229|P2|8 Years|Patients did not return for follow-up|114
3052070|NCT00588861|10491230|P1|8 Years|Patients did not return for follow-up|105
3052071|NCT00588861|10491229|P2|6 Years|Patients did not return for follow-up|109
3052072|NCT00588861|10491230|P1|6 Years|Patients did not return for follow-up|104
3052073|NCT00588861|10491229|P2|4 Years|Patients did not return for follow-up|103
3052074|NCT00588861|10491230|P1|4 Years|Patients did not return for follow-up|91
3052075|NCT00588861|10491229|P2|2 Years|Patients did not return for follow-up|87
3052076|NCT00588861|10491230|P1|2 Years|Patients did not return for follow-up|92
3052077|NCT00588861|10491229|P2|1 Year|Patients did not return for follow-up|82
3052078|NCT00588861|10491230|P1|1 Year|Patients did not return for follow-up|89
3052079|NCT00588861|10491229|P2|6 Months|Patients did not return for follow-up|73
3052080|NCT00588861|10491230|P1|6 Months|Patients did not return for follow-up|98
3052081|NCT00588861|10491229|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
3052082|NCT00588861|10491230|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
3052083|NCT00588848|10491240|P2|Overall Study|Physician Decision|3
3052084|NCT00588848|10491241|P1|Overall Study|Physician Decision|0
3052085|NCT00588822|10491251|P1|Overall Study|progression of disease|8
3052086|NCT00588770|10491271|P2|Overall Study|Patient non-compliance|2
3052087|NCT00588770|10491272|P1|Overall Study|Patient non-compliance|2
3052088|NCT00588770|10491271|P2|Overall Study|Physician discretion|0
3052089|NCT00588770|10491272|P1|Overall Study|Physician discretion|2
3052090|NCT00588770|10491271|P2|Overall Study|Lack of Efficacy|10
3052091|NCT00588770|10491272|P1|Overall Study|Lack of Efficacy|8
3052092|NCT00588770|10491271|P2|Overall Study|Not start protocol therapy|9
3052093|NCT00588770|10491272|P1|Overall Study|Not start protocol therapy|0
3052094|NCT00588770|10491271|P2|Overall Study|Other complicating disease|2
3052095|NCT00588770|10491272|P1|Overall Study|Other complicating disease|3
3052096|NCT00588770|10491271|P2|Overall Study|Alternative therapy|4
3052097|NCT00588770|10491272|P1|Overall Study|Alternative therapy|2
3052098|NCT00588770|10491271|P2|Overall Study|Withdrawal by Subject|25
3052099|NCT00588770|10491272|P1|Overall Study|Withdrawal by Subject|15
3052100|NCT00588770|10491271|P2|Overall Study|Death|22
3052101|NCT00588770|10491272|P1|Overall Study|Death|13
3052102|NCT00588770|10491271|P2|Overall Study|Adverse Event|58
3052103|NCT00588770|10491272|P1|Overall Study|Adverse Event|29
3052104|NCT00588770|10491271|P2|Overall Study|Disease progression|68
3052105|NCT00588770|10491272|P1|Overall Study|Disease progression|85
3052106|NCT00588731|10491284|P2|Overall Study|Withdrawal by Subject|2
3052107|NCT00588731|10491285|P1|Overall Study|Withdrawal by Subject|3
3052108|NCT00588692|10491295|P2|Overall Study|Death|0
3052109|NCT00588692|10491296|P1|Overall Study|Death|1
3052110|NCT00588692|10491295|P2|Overall Study|Cancer|0
3052111|NCT00588692|10491296|P1|Overall Study|Cancer|1
3052112|NCT00588692|10491295|P2|Overall Study|Severe Peptic Ulcer Disease|0
3052113|NCT00588692|10491296|P1|Overall Study|Severe Peptic Ulcer Disease|1
3052114|NCT00588692|10491295|P2|Overall Study|Hip Surgery|1
3052115|NCT00588692|10491296|P1|Overall Study|Hip Surgery|0
3052116|NCT00588692|10491295|P2|Overall Study|Withdrawal by Subject|2
3052117|NCT00588692|10491296|P1|Overall Study|Withdrawal by Subject|4
3052118|NCT00588666|10491332|P1|Overall Study|Adverse Event|4
3052119|NCT00588640|10491337|P1|Overall Study|Ineligible Patient|1
3052120|NCT00588640|10491337|P1|Overall Study|Physician Decision|1
3052121|NCT00588445|10491356|P1|Overall Study|Not Treated|10
3052122|NCT00588445|10491356|P1|Overall Study|Disease Progression|1
3052123|NCT00588445|10491356|P1|Overall Study|Withdrawal by Subject|3
3052124|NCT00588445|10491356|P1|Overall Study|Protocol Violation|1
3052125|NCT00588354|10491380|P2|Baseline to 4 Weeks|Lost to Follow-up|1
3052126|NCT00588354|10491381|P1|Baseline to 4 Weeks|Lost to Follow-up|0
3052127|NCT00588354|10491380|P2|Baseline to 2 Weeks|Lack of Efficacy|0
3052128|NCT00588354|10491381|P1|Baseline to 2 Weeks|Lack of Efficacy|1
3052129|NCT00588354|10491380|P2|Baseline to 2 Weeks|Adverse Event|0
3052130|NCT00588354|10491381|P1|Baseline to 2 Weeks|Adverse Event|1
3052131|NCT00588341|10491401|P1|Overall Study|Patient ineligible|1
3052132|NCT00588341|10491401|P1|Overall Study|Not treated due to metastatic disease|1
3052133|NCT00588341|10491401|P1|Overall Study|Withdrawal by Subject|3
3052134|NCT00588237|10491405|P1|Overall Study|Patien not treated|1
3052135|NCT00588237|10491405|P1|Overall Study|Evaluable for toxicity only|3
3052136|NCT00588146|10491428|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
3052137|NCT00588146|10491429|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
3052138|NCT00588094|10491435|P1|Overall Study|Progression of Disease|2
3052139|NCT00588094|10491435|P1|Overall Study|Adverse Event|3
3052140|NCT00587990|10491442|P3|Overall Study|Death|1
3052141|NCT00587990|10491443|P2|Overall Study|Death|0
3052142|NCT00587990|10491444|P1|Overall Study|Death|0
3052143|NCT00587964|10491487|P1|Overall Study|Progression of Disease|4
3052144|NCT00587964|10491487|P1|Overall Study|Patient did not receive intervention|5
3052145|NCT00587964|10491487|P1|Overall Study|Patient found to be ineligible|1
3052146|NCT00587964|10491487|P1|Overall Study|Lost to Follow-up|1
3052147|NCT00587964|10491487|P1|Overall Study|Withdrawal by Subject|1
3052148|NCT00587860|10491493|P2|Overall Study|Withdrawal by Subject|3
3052149|NCT00587860|10491494|P1|Overall Study|Withdrawal by Subject|3
3052150|NCT00587860|10491493|P2|Overall Study|Lost to Follow-up|2
3052151|NCT00587860|10491494|P1|Overall Study|Lost to Follow-up|2
3052152|NCT00587847|10491514|P1|Overall Study|Adverse Event|2
3052153|NCT00587847|10491514|P1|Overall Study|Lack of Efficacy|5
3052154|NCT00587795|10491537|P2|Overall Study|Withdrawal by Subject|0
3052155|NCT00587795|10491538|P1|Overall Study|Withdrawal by Subject|1
3052156|NCT00587639|10491592|P1|Overall Study|Withdrawal by Subject|1
3052157|NCT00587587|10491599|P2|Overall Study|Lost to Follow-up|1
3052158|NCT00587587|10491600|P1|Overall Study|Lost to Follow-up|6
3052159|NCT00587457|10491654|P3|Overall Study|Development of neutralizing Abs|1
3052160|NCT00587457|10491655|P2|Overall Study|Development of neutralizing Abs|0
3052161|NCT00587457|10491656|P1|Overall Study|Development of neutralizing Abs|0
3052162|NCT00587457|10491654|P3|Overall Study|Undefined|1
3052163|NCT00587457|10491655|P2|Overall Study|Undefined|0
3052164|NCT00587457|10491656|P1|Overall Study|Undefined|0
3052165|NCT00587457|10491654|P3|Overall Study|Initiation of alternative therapy|0
3052166|NCT00587457|10491655|P2|Overall Study|Initiation of alternative therapy|1
3052167|NCT00587457|10491656|P1|Overall Study|Initiation of alternative therapy|0
3052168|NCT00587457|10491654|P3|Overall Study|Disease progression|2
3052169|NCT00587457|10491655|P2|Overall Study|Disease progression|0
3052170|NCT00587457|10491656|P1|Overall Study|Disease progression|2
3052171|NCT00587457|10491654|P3|Overall Study|Adverse Event|1
3052172|NCT00587457|10491655|P2|Overall Study|Adverse Event|2
3052173|NCT00587457|10491656|P1|Overall Study|Adverse Event|1
3052174|NCT00587431|10491693|P2|Overall Study|Withdrawal by Subject|1
3052175|NCT00587431|10491694|P1|Overall Study|Withdrawal by Subject|0
3052176|NCT00587431|10491693|P2|Overall Study|Adverse Event|0
3052177|NCT00587431|10491694|P1|Overall Study|Adverse Event|1
3052178|NCT00587288|10491705|P2|Overall Study|Protocol Violation|0
3052179|NCT00587288|10491706|P1|Overall Study|Protocol Violation|1
3052180|NCT00587288|10491705|P2|Overall Study|Lack of Efficacy|8
3052181|NCT00587288|10491706|P1|Overall Study|Lack of Efficacy|2
3052182|NCT00587288|10491705|P2|Overall Study|Adverse Event|1
3052183|NCT00587288|10491706|P1|Overall Study|Adverse Event|0
3052184|NCT00587223|10491724|P1|Overall Study|Adverse Event|1
3052185|NCT00587171|10491741|P2|Overall Study|Lost to Follow-up|1
3052186|NCT00587171|10491742|P1|Overall Study|Lost to Follow-up|1
3052187|NCT00587158|10491772|P2|Overall Study|Subject did not want to take study med|1
3052188|NCT00587158|10491773|P1|Overall Study|Subject did not want to take study med|0
3052189|NCT00587158|10491772|P2|Overall Study|Death|1
3052190|NCT00587158|10491773|P1|Overall Study|Death|0
3052191|NCT00587158|10491772|P2|Overall Study|Lost to Follow-up|2
3052192|NCT00587158|10491773|P1|Overall Study|Lost to Follow-up|1
3052193|NCT00587158|10491772|P2|Overall Study|Physician Decision|1
3052194|NCT00587158|10491773|P1|Overall Study|Physician Decision|0
3052195|NCT00587158|10491772|P2|Overall Study|Did not want to do 24 hr urine collect.|3
3052196|NCT00587158|10491773|P1|Overall Study|Did not want to do 24 hr urine collect.|4
3052197|NCT00587054|10491826|P1|Overall Study|Patient not treated|9
3052198|NCT00586924|10491852|P6|Overall Study|Other|6
3052199|NCT00586924|10491853|P5|Overall Study|Other|1
3052200|NCT00586924|10491854|P4|Overall Study|Other|1
3052201|NCT00586924|10491855|P3|Overall Study|Other|1
3052202|NCT00586924|10491856|P2|Overall Study|Other|0
3052203|NCT00586924|10491857|P1|Overall Study|Other|1
3052204|NCT00586924|10491852|P6|Overall Study|Complete response|2
3052205|NCT00586924|10491853|P5|Overall Study|Complete response|2
3052206|NCT00586924|10491854|P4|Overall Study|Complete response|0
3052207|NCT00586924|10491855|P3|Overall Study|Complete response|0
3052208|NCT00586924|10491856|P2|Overall Study|Complete response|1
3052209|NCT00586924|10491857|P1|Overall Study|Complete response|0
3052210|NCT00586924|10491852|P6|Overall Study|Development of neutralizing antibodies|22
3052211|NCT00586924|10491853|P5|Overall Study|Development of neutralizing antibodies|0
3052212|NCT00586924|10491854|P4|Overall Study|Development of neutralizing antibodies|0
3052213|NCT00586924|10491855|P3|Overall Study|Development of neutralizing antibodies|2
3052214|NCT00586924|10491856|P2|Overall Study|Development of neutralizing antibodies|2
3052215|NCT00586924|10491857|P1|Overall Study|Development of neutralizing antibodies|2
3052216|NCT00586924|10491852|P6|Overall Study|Disease progression|0
3052217|NCT00586924|10491853|P5|Overall Study|Disease progression|1
3052218|NCT00586924|10491854|P4|Overall Study|Disease progression|1
3052219|NCT00586924|10491855|P3|Overall Study|Disease progression|0
3052220|NCT00586924|10491856|P2|Overall Study|Disease progression|0
3052221|NCT00586924|10491857|P1|Overall Study|Disease progression|0
3052222|NCT00586924|10491852|P6|Overall Study|Initiation of alternative cancer therapy|1
3052223|NCT00586924|10491853|P5|Overall Study|Initiation of alternative cancer therapy|0
3052224|NCT00586924|10491854|P4|Overall Study|Initiation of alternative cancer therapy|0
3052225|NCT00586924|10491855|P3|Overall Study|Initiation of alternative cancer therapy|0
3052226|NCT00586924|10491856|P2|Overall Study|Initiation of alternative cancer therapy|0
3052227|NCT00586924|10491857|P1|Overall Study|Initiation of alternative cancer therapy|0
3052228|NCT00586924|10491852|P6|Overall Study|Adverse event/serious adverse event|2
3052229|NCT00586924|10491853|P5|Overall Study|Adverse event/serious adverse event|0
3052230|NCT00586924|10491854|P4|Overall Study|Adverse event/serious adverse event|1
3052231|NCT00586924|10491855|P3|Overall Study|Adverse event/serious adverse event|0
3052232|NCT00586924|10491856|P2|Overall Study|Adverse event/serious adverse event|0
3052233|NCT00586924|10491857|P1|Overall Study|Adverse event/serious adverse event|0
3052234|NCT00586898|10492057|P1|Overall Study|Evaluable for Toxicity Only|5
3052235|NCT00586898|10492057|P1|Overall Study|Patiemt Non-compliance|1
3052236|NCT00586898|10492057|P1|Overall Study|Adverse Event|1
3052237|NCT00586846|10492061|P1|Overall Study|Evaluable for Toxicity Only|4
3052238|NCT00586846|10492061|P1|Overall Study|Death|1
3052239|NCT00586846|10492061|P1|Overall Study|Physician Decision|1
3052240|NCT00586820|10492067|P2|Overall Study|Unsuccessful PCI|0
3052241|NCT00586820|10492068|P1|Overall Study|Unsuccessful PCI|1
3052242|NCT00586703|10492099|P1|Overall Study|Death|12
3052243|NCT00586690|10492106|P2|Overall Study|Lab can't accommodate|0
3052244|NCT00586690|10492107|P1|Overall Study|Lab can't accommodate|1
3052245|NCT00586690|10492106|P2|Overall Study|Lack of Efficacy|0
3052246|NCT00586690|10492107|P1|Overall Study|Lack of Efficacy|2
3052247|NCT00586690|10492106|P2|Overall Study|Adverse Event|0
3052248|NCT00586690|10492107|P1|Overall Study|Adverse Event|1
3052249|NCT00586690|10492106|P2|Overall Study|Disease Progression|0
3052250|NCT00586690|10492107|P1|Overall Study|Disease Progression|10
3052251|NCT00586690|10492106|P2|Overall Study|Death|0
3052252|NCT00586690|10492107|P1|Overall Study|Death|2
3052253|NCT00586664|10492117|P3|Overall Study|Exclusion criteria met|0
3052254|NCT00586664|10492118|P2|Overall Study|Exclusion criteria met|0
3052255|NCT00586664|10492119|P1|Overall Study|Exclusion criteria met|2
3052256|NCT00586664|10492117|P3|Overall Study|Withdrawal by Subject|1
3052257|NCT00586664|10492118|P2|Overall Study|Withdrawal by Subject|7
3052258|NCT00586664|10492119|P1|Overall Study|Withdrawal by Subject|3
3052259|NCT00586625|10492165|P2|Overall Study|Subject unable to return for visit|0
3052260|NCT00586625|10492166|P1|Overall Study|Subject unable to return for visit|2
3052261|NCT00586625|10492165|P2|Overall Study|Subject non-compliance|1
3052262|NCT00586625|10492166|P1|Overall Study|Subject non-compliance|0
3052263|NCT00586625|10492165|P2|Overall Study|Withdrawal by Subject|10
3052264|NCT00586625|10492166|P1|Overall Study|Withdrawal by Subject|32
3052265|NCT00586625|10492165|P2|Overall Study|Protocol Violation|0
3052266|NCT00586625|10492166|P1|Overall Study|Protocol Violation|3
3052267|NCT00586625|10492165|P2|Overall Study|Adverse Event|6
3052268|NCT00586625|10492166|P1|Overall Study|Adverse Event|6
3052269|NCT00586612|10492174|P2|Booster Phase|Lost to Follow-up|1
3052270|NCT00586612|10492175|P1|Booster Phase|Lost to Follow-up|3
3052271|NCT00586612|10492174|P2|Primary Phase|Withdrawal by Subject|2
3052272|NCT00586612|10492175|P1|Primary Phase|Withdrawal by Subject|0
3052273|NCT00586612|10492174|P2|Primary Phase|Lost to Follow-up|1
3052274|NCT00586612|10492175|P1|Primary Phase|Lost to Follow-up|0
3052275|NCT00586612|10492174|P2|Primary Phase|Protocol Violation|0
3052276|NCT00586612|10492175|P1|Primary Phase|Protocol Violation|1
3052277|NCT00586521|10492245|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
3052278|NCT00586495|10492252|P1|Follow-up|Switch to commercial drug|10
3052279|NCT00586495|10492252|P1|Follow-up|Protocol driven decision point|37
3052280|NCT00586495|10492252|P1|Follow-up|Withdrawal by Subject|4
3052281|NCT00586495|10492252|P1|Follow-up|Lost to Follow-up|1
3052282|NCT00586495|10492252|P1|Follow-up|Death|40
3052283|NCT00586495|10492252|P1|Treatment Period|Switch to commercial drug|10
3052284|NCT00586495|10492252|P1|Treatment Period|Disease progression, recurrence/relapse|71
3052285|NCT00586495|10492252|P1|Treatment Period|Withdrawal by Subject|1
3052286|NCT00586495|10492252|P1|Treatment Period|Protocol Violation|1
3052287|NCT00586495|10492252|P1|Treatment Period|Death|1
3052288|NCT00586495|10492252|P1|Treatment Period|Adverse Event|11
3052289|NCT00586469|10492281|P2|Overall Study|Adverse Event|1
3052290|NCT00586469|10492282|P1|Overall Study|Adverse Event|0
3052291|NCT00586339|10492309|P3|Overall Study|Lost to Follow-up|1
3052292|NCT00586339|10492310|P2|Overall Study|Lost to Follow-up|2
3052293|NCT00586339|10492311|P1|Overall Study|Lost to Follow-up|3
3052294|NCT00586339|10492309|P3|Overall Study|Migrated/moved from study area|4
3052295|NCT00586339|10492310|P2|Overall Study|Migrated/moved from study area|2
3052296|NCT00586339|10492311|P1|Overall Study|Migrated/moved from study area|3
3052297|NCT00586339|10492309|P3|Overall Study|Withdrawal by Subject|1
3052298|NCT00586339|10492310|P2|Overall Study|Withdrawal by Subject|3
3052299|NCT00586339|10492311|P1|Overall Study|Withdrawal by Subject|1
3052300|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Other|2
3052301|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
3052302|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
3052303|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
3052304|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Death|2
3052305|NCT00586326|10492412|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
3052306|NCT00586326|10492412|P1|Device Placed toTreatment-ITT|Physician Decision|1
3052307|NCT00586326|10492412|P1|Device Placed toTreatment-ITT|Positive Margins|3
3052308|NCT00586326|10492412|P1|Device Placed toTreatment-ITT|Microinvasion|1
3052309|NCT00586326|10492412|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
3052310|NCT00586326|10492412|P1|Device Placed toTreatment-ITT|Skin Distance|7
3052311|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Other|1
3052312|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
3052313|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
3052314|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
3052315|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
3052316|NCT00586326|10492412|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
3052317|NCT00586313|10492423|P1|Overall Study|Lack of Efficacy|2
3052318|NCT00586157|10492459|P2|Second Intervention|Adverse Event|1
3052319|NCT00586157|10492460|P1|Second Intervention|Adverse Event|0
3052320|NCT00586157|10492459|P2|Second Intervention|Worsening behavior|0
3052321|NCT00586157|10492460|P1|Second Intervention|Worsening behavior|1
3052322|NCT00586157|10492459|P2|Second Intervention|Withdrawal by Subject|0
3052323|NCT00586157|10492460|P1|Second Intervention|Withdrawal by Subject|1
3052324|NCT00586157|10492459|P2|First Intervention|Worsening behavior|0
3052325|NCT00586157|10492460|P1|First Intervention|Worsening behavior|1
3052326|NCT00586105|10492470|P1|Overall Study|Reason not reported|1
3052327|NCT00586105|10492470|P1|Overall Study|Switched to commercial drug|9
3052328|NCT00586105|10492470|P1|Overall Study|Disease progression|19
3052329|NCT00586105|10492470|P1|Overall Study|Withdrawal by Subject|3
3052330|NCT00586105|10492470|P1|Overall Study|Protocol Violation|1
3052331|NCT00586105|10492470|P1|Overall Study|Death|2
3052332|NCT00586105|10492470|P1|Overall Study|Adverse Event|4
3052333|NCT00586066|10492485|P2|Overall Study|Withdrawal of consent|2
3052334|NCT00586066|10492486|P1|Overall Study|Withdrawal of consent|4
3052335|NCT00586066|10492485|P2|Overall Study|Physician Decision|0
3052336|NCT00586066|10492486|P1|Overall Study|Physician Decision|1
3052337|NCT00586066|10492485|P2|Overall Study|Adverse Event|2
3052338|NCT00586066|10492486|P1|Overall Study|Adverse Event|2
3052339|NCT00586066|10492485|P2|Overall Study|Lack of Efficacy|3
3052340|NCT00586066|10492486|P1|Overall Study|Lack of Efficacy|5
3052341|NCT00586066|10492485|P2|Overall Study|Lost to Follow-up|3
3052342|NCT00586066|10492486|P1|Overall Study|Lost to Follow-up|6
3052343|NCT00585975|10492543|P2|Overall Study|Enrollment met/over-enrolled|9
3052344|NCT00585975|10492544|P1|Overall Study|Enrollment met/over-enrolled|10
3052345|NCT00585975|10492543|P2|Overall Study|Lost to Follow-up|1
3052346|NCT00585975|10492544|P1|Overall Study|Lost to Follow-up|2
3052347|NCT00585975|10492543|P2|Overall Study|Withdrawal by Subject|3
3052348|NCT00585975|10492544|P1|Overall Study|Withdrawal by Subject|3
3052349|NCT00585923|10492554|P2|Overall Study|Physician decided not to continue|33
3052350|NCT00585923|10492555|P1|Overall Study|Physician decided not to continue|31
3052351|NCT00585689|10492586|P1|Overall Study|Death|1
3052352|NCT00585689|10492586|P1|Overall Study|Patient had unresectable disease|1
3052353|NCT00585689|10492586|P1|Overall Study|Patient Declined Surgery|1
3052354|NCT00585689|10492586|P1|Overall Study|Adverse Event|1
3052355|NCT00585689|10492586|P1|Overall Study|Received different ABI-007 schedule|3
3052356|NCT00585585|10492645|P1|Overall Study|Adverse Event|1
3052357|NCT00585546|10492649|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
3052358|NCT00585546|10492649|P1|Clenbuterol Treatment - up to 12 Months|Death|1
3052359|NCT00585533|10492663|P1|Overall Study|objective or symptomatic progression|9
3052360|NCT00585468|10492672|P2|First Intervention|Withdrawal by Subject|1
3052361|NCT00585468|10492673|P1|First Intervention|Withdrawal by Subject|1
3052362|NCT00585351|10492705|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052363|NCT00585351|10492706|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052364|NCT00585351|10492707|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
3052365|NCT00585351|10492708|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
3052366|NCT00585351|10492709|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052367|NCT00585351|10492710|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052368|NCT00585351|10492711|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052369|NCT00585351|10492712|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
3052370|NCT00585351|10492705|P8|Enrollment Period (Intervention)|Death|0
3052371|NCT00585351|10492706|P7|Enrollment Period (Intervention)|Death|1
3052372|NCT00585351|10492707|P6|Enrollment Period (Intervention)|Death|0
3052373|NCT00585351|10492708|P5|Enrollment Period (Intervention)|Death|1
3052374|NCT00585351|10492709|P4|Enrollment Period (Intervention)|Death|0
3052375|NCT00585351|10492710|P3|Enrollment Period (Intervention)|Death|0
3052376|NCT00585351|10492711|P2|Enrollment Period (Intervention)|Death|0
3052377|NCT00585351|10492712|P1|Enrollment Period (Intervention)|Death|0
3052378|NCT00585351|10492705|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
3052379|NCT00585351|10492706|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
3052380|NCT00585351|10492707|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
3052381|NCT00585351|10492708|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
3052382|NCT00585351|10492709|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
3052383|NCT00585351|10492710|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
3052384|NCT00585351|10492711|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
3052385|NCT00585351|10492712|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
3052386|NCT00585351|10492705|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052387|NCT00585351|10492706|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052388|NCT00585351|10492707|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052389|NCT00585351|10492708|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052390|NCT00585351|10492709|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052391|NCT00585351|10492710|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
3052392|NCT00585351|10492711|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
3052393|NCT00585351|10492712|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
3052394|NCT00585351|10492705|P8|Notification Period (Informed Consent)|No study medication on flight|0
3052395|NCT00585351|10492706|P7|Notification Period (Informed Consent)|No study medication on flight|0
3052396|NCT00585351|10492707|P6|Notification Period (Informed Consent)|No study medication on flight|0
3052397|NCT00585351|10492708|P5|Notification Period (Informed Consent)|No study medication on flight|0
3052398|NCT00585351|10492709|P4|Notification Period (Informed Consent)|No study medication on flight|0
3052399|NCT00585351|10492710|P3|Notification Period (Informed Consent)|No study medication on flight|0
3052400|NCT00585351|10492711|P2|Notification Period (Informed Consent)|No study medication on flight|1
3052401|NCT00585351|10492712|P1|Notification Period (Informed Consent)|No study medication on flight|0
3052402|NCT00585351|10492705|P8|Notification Period (Informed Consent)|Flight aborted|0
3052403|NCT00585351|10492706|P7|Notification Period (Informed Consent)|Flight aborted|0
3052404|NCT00585351|10492707|P6|Notification Period (Informed Consent)|Flight aborted|0
3052405|NCT00585351|10492708|P5|Notification Period (Informed Consent)|Flight aborted|0
3052406|NCT00585351|10492709|P4|Notification Period (Informed Consent)|Flight aborted|0
3052407|NCT00585351|10492710|P3|Notification Period (Informed Consent)|Flight aborted|0
3052408|NCT00585351|10492711|P2|Notification Period (Informed Consent)|Flight aborted|1
3052409|NCT00585351|10492712|P1|Notification Period (Informed Consent)|Flight aborted|2
3052410|NCT00585351|10492705|P8|Notification Period (Informed Consent)|Physician Decision|0
3052411|NCT00585351|10492706|P7|Notification Period (Informed Consent)|Physician Decision|0
3052412|NCT00585351|10492707|P6|Notification Period (Informed Consent)|Physician Decision|0
3052413|NCT00585351|10492708|P5|Notification Period (Informed Consent)|Physician Decision|0
3052414|NCT00585351|10492709|P4|Notification Period (Informed Consent)|Physician Decision|0
3052415|NCT00585351|10492710|P3|Notification Period (Informed Consent)|Physician Decision|0
3052416|NCT00585351|10492711|P2|Notification Period (Informed Consent)|Physician Decision|2
3052417|NCT00585351|10492712|P1|Notification Period (Informed Consent)|Physician Decision|0
3052418|NCT00585325|10492728|P2|Overall Study|Withdrawal by Subject|1
3052419|NCT00585325|10492729|P1|Overall Study|Withdrawal by Subject|1
3052420|NCT00585312|10492737|P2|Overall Study|Study terminated by the sponsor|31
3052421|NCT00585312|10492738|P1|Overall Study|Study terminated by the sponsor|34
3052422|NCT00585312|10492737|P2|Overall Study|Withdrawal by Subject|1
3052423|NCT00585312|10492738|P1|Overall Study|Withdrawal by Subject|5
3052424|NCT00585312|10492737|P2|Overall Study|Reason not specified|0
3052425|NCT00585312|10492738|P1|Overall Study|Reason not specified|2
3052426|NCT00585312|10492737|P2|Overall Study|Lost to Follow-up|1
3052427|NCT00585312|10492738|P1|Overall Study|Lost to Follow-up|1
3052428|NCT00585312|10492737|P2|Overall Study|Lack of Efficacy|11
3052429|NCT00585312|10492738|P1|Overall Study|Lack of Efficacy|6
3052430|NCT00585312|10492737|P2|Overall Study|Adverse Event|0
3052431|NCT00585312|10492738|P1|Overall Study|Adverse Event|3
3052432|NCT00585286|10492750|P1|Overall Study|Lost to Follow-up|1
3052433|NCT00585221|10492766|P1|Overall Study|Protocol Violation|8
3052434|NCT00585169|10492776|P1|Overall Study|Withdrawal by Subject|1
3052435|NCT00585078|10492786|P1|Overall Study|Death|1
3052436|NCT00585078|10492786|P1|Overall Study|Adverse Event|10
3052437|NCT00585078|10492786|P1|Overall Study|Disease Progression|24
3052438|NCT00585078|10492786|P1|Overall Study|Poor performance status|1
3052439|NCT00585078|10492786|P1|Overall Study|Withdrawal by Subject|4
3052440|NCT00585052|10492793|P1|Overall Study|Withdrawal by Subject|1
3052441|NCT00585039|10492800|P2|Overall Study|medication spilled|0
3052442|NCT00585039|10492801|P1|Overall Study|medication spilled|2
3052443|NCT00584987|10492830|P4|Overall Study|Adverse Event|1
3052444|NCT00584987|10492831|P3|Overall Study|Adverse Event|0
3052445|NCT00584987|10492832|P2|Overall Study|Adverse Event|0
3052446|NCT00584987|10492833|P1|Overall Study|Adverse Event|0
3052447|NCT00584987|10492830|P4|Overall Study|Protocol Violation|0
3052448|NCT00584987|10492831|P3|Overall Study|Protocol Violation|1
3052449|NCT00584987|10492832|P2|Overall Study|Protocol Violation|1
3052450|NCT00584987|10492833|P1|Overall Study|Protocol Violation|1
3052451|NCT00584909|10492885|P1|Overall Study|Adverse Event|4
3052452|NCT00584844|10492895|P1|Overall Study|Screen Failure|20
3052453|NCT00584844|10492895|P1|Overall Study|Withdrawal by Subject|59
3052454|NCT00584805|10492945|P1|Overall Study|Screen failures|2
3052455|NCT00584805|10492945|P1|Overall Study|Lost to follow up|3
3052456|NCT00584805|10492945|P1|Overall Study|Non-compliance|1
3052457|NCT00584805|10492945|P1|Overall Study|Withdrawal by Subject|18
3052458|NCT00584805|10492945|P1|Overall Study|Relocation|36
3052459|NCT00584805|10492945|P1|Overall Study|No longer at risk of exposure|39
3052460|NCT00584740|10492958|P2|Overall Study|Lost to Follow-up|1
3052461|NCT00584740|10492959|P1|Overall Study|Lost to Follow-up|0
3052462|NCT00584740|10492958|P2|Overall Study|Withdrawal by Subject|2
3052463|NCT00584740|10492959|P1|Overall Study|Withdrawal by Subject|3
3052464|NCT00584740|10492958|P2|Overall Study|Lack of Efficacy|2
3052465|NCT00584740|10492959|P1|Overall Study|Lack of Efficacy|8
3052466|NCT00584740|10492958|P2|Overall Study|Adverse Event|1
3052467|NCT00584740|10492959|P1|Overall Study|Adverse Event|1
3052468|NCT00584727|10492977|P6|Third Intervention|Protocol Violation|2
3052469|NCT00584727|10492978|P5|Third Intervention|Protocol Violation|4
3052470|NCT00584727|10492979|P4|Third Intervention|Protocol Violation|0
3052471|NCT00584727|10492980|P3|Third Intervention|Protocol Violation|1
3052472|NCT00584727|10492981|P2|Third Intervention|Protocol Violation|0
3052473|NCT00584727|10492982|P1|Third Intervention|Protocol Violation|0
3052474|NCT00584727|10492977|P6|First Intervention|Discontinuation|0
3052475|NCT00584727|10492978|P5|First Intervention|Discontinuation|0
3052476|NCT00584727|10492979|P4|First Intervention|Discontinuation|0
3052477|NCT00584727|10492980|P3|First Intervention|Discontinuation|1
3052478|NCT00584727|10492981|P2|First Intervention|Discontinuation|0
3052479|NCT00584727|10492982|P1|First Intervention|Discontinuation|0
3052480|NCT00584454|10493020|P1|Overall Study|Clinical Hold|2
3052481|NCT00584454|10493020|P1|Overall Study|Relocation|1
3052482|NCT00584454|10493020|P1|Overall Study|Adverse Event|1
3052483|NCT00584415|10493024|P1|Overall Study|Adverse Event|7
3052484|NCT00584194|10493047|P1|Overall Study|Other|135
3052485|NCT00584012|10493060|P1|Overall Study|Withdrawal by Subject|1
3052486|NCT00583947|10493066|P2|Cross-over Period|Other|1
3052487|NCT00583947|10493067|P1|Cross-over Period|Other|1
3052488|NCT00583947|10493066|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
3052489|NCT00583947|10493067|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
3052490|NCT00583947|10493066|P2|Cross-over Period|Withdrawal by Subject|0
3052491|NCT00583947|10493067|P1|Cross-over Period|Withdrawal by Subject|2
3052492|NCT00583947|10493066|P2|Cross-over Period|Adverse Event|0
3052493|NCT00583947|10493067|P1|Cross-over Period|Adverse Event|2
3052494|NCT00583791|10493188|P1|Overall Study|Death|6
3052495|NCT00583791|10493188|P1|Overall Study|Other|67
3052496|NCT00583596|10493243|P1|Overall Study|Outside f-up window|26
3052497|NCT00583596|10493243|P1|Overall Study|Not consented|15
3052498|NCT00583596|10493243|P1|Overall Study|Data not complete|1
3052499|NCT00583596|10493243|P1|Overall Study|Lost to Follow-up|94
3052500|NCT00583596|10493243|P1|Overall Study|Withdrawal by Subject|6
3052501|NCT00583596|10493243|P1|Overall Study|Death|2
3052502|NCT00583596|10493243|P1|Overall Study|Excluded due to Hurricane Katrina|30
3052503|NCT00583596|10493243|P1|Overall Study|Lost to Follow-up|110
3052504|NCT00583557|10493248|P1|Overall Study|Did not receive belimumab in LBRA99|2
3052505|NCT00583557|10493248|P1|Overall Study|Other|5
3052506|NCT00583557|10493248|P1|Overall Study|Lack of Compliance|5
3052507|NCT00583557|10493248|P1|Overall Study|Lack of Efficacy|31
3052508|NCT00583557|10493248|P1|Overall Study|Adverse Event|9
3052509|NCT00583557|10493248|P1|Overall Study|Withdrawal by Subject|18
3052510|NCT00583453|10493279|P2|Overall Study|discontinued intervention|2
3052511|NCT00583453|10493280|P1|Overall Study|discontinued intervention|0
3052512|NCT00583362|10493317|P1|Overall Study|Withdrawal by Subject|57
3052513|NCT00583362|10493317|P1|Overall Study|Protocol Violation|2
3052514|NCT00583362|10493317|P1|Overall Study|Physician Decision|19
3052515|NCT00583362|10493317|P1|Overall Study|Sponsor request due to missed doses|1
3052516|NCT00583362|10493317|P1|Overall Study|Behavioral problems and non-compliance|1
3052517|NCT00583362|10493317|P1|Overall Study|Misunderstanding of protocol|1
3052518|NCT00583362|10493317|P1|Overall Study|Missed visits due to staff changes|1
3052519|NCT00583362|10493317|P1|Overall Study|Subject moved out of the country/state|2
3052520|NCT00583362|10493317|P1|Overall Study|Subject not dosed in LBSL99|1
3052521|NCT00583362|10493317|P1|Overall Study|Current site closed|7
3052522|NCT00583362|10493317|P1|Overall Study|Miscommunication of visit window|5
3052523|NCT00583362|10493317|P1|Overall Study|Pregnancy|7
3052524|NCT00583362|10493317|P1|Overall Study|Non-compliance with study drug|28
3052525|NCT00583362|10493317|P1|Overall Study|Lost to Follow-up|4
3052526|NCT00583362|10493317|P1|Overall Study|Lack of Efficacy|22
3052527|NCT00583362|10493317|P1|Overall Study|Adverse Event|44
3052528|NCT00583219|10493341|P1|Phase 2|Withdrawal by Subject|1
3052529|NCT00583115|10493358|P1|Overall Study|Death|1
3052530|NCT00583102|10493363|P1|Overall Study|Adverse Event|3
3052531|NCT00582972|10493380|P1|Overall Study|Protocol Violation|2
3052532|NCT00582933|10493389|P1|Overall Study|Physician Decision|3
3052533|NCT00582907|10493393|P4|2nd Course|Lack of Efficacy|0
3052534|NCT00582907|10493394|P3|2nd Course|Lack of Efficacy|0
3052535|NCT00582907|10493395|P2|2nd Course|Lack of Efficacy|0
3052536|NCT00582907|10493396|P1|2nd Course|Lack of Efficacy|1
3052537|NCT00582907|10493393|P4|1st Course|Lost to Follow-up|1
3052538|NCT00582907|10493394|P3|1st Course|Lost to Follow-up|0
3052539|NCT00582907|10493395|P2|1st Course|Lost to Follow-up|0
3052540|NCT00582907|10493396|P1|1st Course|Lost to Follow-up|0
3052541|NCT00582907|10493393|P4|1st Course|Withdrawal by Subject|0
3052542|NCT00582907|10493394|P3|1st Course|Withdrawal by Subject|0
3052543|NCT00582907|10493395|P2|1st Course|Withdrawal by Subject|0
3052544|NCT00582907|10493396|P1|1st Course|Withdrawal by Subject|1
3052545|NCT00582816|10493435|P1|Overall Study|Engraftment Failure|3
3052546|NCT00582790|10493445|P1|Overall Study|Rapid progression of disease|1
3052547|NCT00582738|10493454|P2|Overall Study|Withdrawal by Subject|3
3052548|NCT00582738|10493455|P1|Overall Study|Withdrawal by Subject|0
3052549|NCT00582738|10493454|P2|Overall Study|Protocol Violation|1
3052550|NCT00582738|10493455|P1|Overall Study|Protocol Violation|1
3052551|NCT00582738|10493454|P2|Overall Study|Other|0
3052552|NCT00582738|10493455|P1|Overall Study|Other|1
3052553|NCT00582738|10493454|P2|Overall Study|Graft Lost|1
3052554|NCT00582738|10493455|P1|Overall Study|Graft Lost|0
3052555|NCT00582738|10493454|P2|Overall Study|Adverse Event|5
3052556|NCT00582738|10493455|P1|Overall Study|Adverse Event|0
3052557|NCT00582738|10493454|P2|Overall Study|Administrative Problems|8
3052558|NCT00582738|10493455|P1|Overall Study|Administrative Problems|7
3052559|NCT00582712|10493479|P1|Overall Study|Complicating disease requiring treatment|1
3052560|NCT00582712|10493479|P1|Overall Study|Withdrawal by Subject|1
3052561|NCT00582712|10493479|P1|Overall Study|Lack of Efficacy|1
3052562|NCT00582712|10493479|P1|Overall Study|Adverse Event|1
3052563|NCT00582608|10493494|P1|Overall Study|Lack of accrual|4
3052564|NCT00582608|10493494|P1|Overall Study|Patient Ineligible|1
3052565|NCT00582608|10493494|P1|Overall Study|Not Treated|7
3052566|NCT00582556|10493501|P3|Overall Study|Physician Decision|1
3052567|NCT00582556|10493502|P2|Overall Study|Physician Decision|0
3052568|NCT00582556|10493503|P1|Overall Study|Physician Decision|0
3052569|NCT00582556|10493501|P3|Overall Study|Withdrawal by Subject|1
3052570|NCT00582556|10493502|P2|Overall Study|Withdrawal by Subject|1
3052571|NCT00582556|10493503|P1|Overall Study|Withdrawal by Subject|0
3052572|NCT00582491|10493531|P2|Overall Study|Withdrawal by Subject|0
3052573|NCT00582491|10493532|P1|Overall Study|Withdrawal by Subject|1
3052574|NCT00582426|10493556|P2|Overall Study|Use of illicit drugs|0
3052575|NCT00582426|10493557|P1|Overall Study|Use of illicit drugs|1
3052576|NCT00582426|10493556|P2|Overall Study|Disease Progression|2
3052577|NCT00582426|10493557|P1|Overall Study|Disease Progression|2
3052578|NCT00582426|10493556|P2|Overall Study|Withdrawal by Subject|2
3052579|NCT00582426|10493557|P1|Overall Study|Withdrawal by Subject|3
3052580|NCT00582426|10493556|P2|Overall Study|Death|3
3052581|NCT00582426|10493557|P1|Overall Study|Death|4
3052582|NCT00582426|10493556|P2|Overall Study|Protocol Violation|2
3052583|NCT00582426|10493557|P1|Overall Study|Protocol Violation|6
3052584|NCT00582426|10493556|P2|Overall Study|Adverse Event|2
3052585|NCT00582426|10493557|P1|Overall Study|Adverse Event|4
3052586|NCT00582426|10493556|P2|Overall Study|Lost to Follow-up|2
3052587|NCT00582426|10493557|P1|Overall Study|Lost to Follow-up|0
3052588|NCT00582309|10493604|P3|Overall Study|Protocol Violation|2
3052589|NCT00582309|10493605|P2|Overall Study|Protocol Violation|0
3052590|NCT00582309|10493606|P1|Overall Study|Protocol Violation|0
3052591|NCT00582166|10493619|P1|Overall Study|Ineligible pathology|1
3052592|NCT00582166|10493619|P1|Overall Study|Death|1
3052593|NCT00582114|10493629|P2|Overall Study|Stopped by data safety monitoring board|20
3052594|NCT00582114|10493630|P1|Overall Study|Stopped by data safety monitoring board|19
3052595|NCT00582114|10493629|P2|Overall Study|Physician Decision|6
3052596|NCT00582114|10493630|P1|Overall Study|Physician Decision|0
3052597|NCT00582114|10493629|P2|Overall Study|Adverse Event|1
3052598|NCT00582114|10493630|P1|Overall Study|Adverse Event|1
3052599|NCT00582114|10493629|P2|Overall Study|Withdrawal by Subject|16
3052600|NCT00582114|10493630|P1|Overall Study|Withdrawal by Subject|8
3052601|NCT00582114|10493629|P2|Overall Study|Lost to Follow-up|6
3052602|NCT00582114|10493630|P1|Overall Study|Lost to Follow-up|7
3052603|NCT00582114|10493629|P2|Overall Study|Kidney Transplant|1
3052604|NCT00582114|10493630|P1|Overall Study|Kidney Transplant|3
3052605|NCT00582114|10493629|P2|Overall Study|Death|4
3052606|NCT00582114|10493630|P1|Overall Study|Death|4
3052607|NCT00582036|10493645|P2|Overall Study|Withdrawal by Subject|1
3052608|NCT00582036|10493646|P1|Overall Study|Withdrawal by Subject|0
3052609|NCT00582010|10493654|P2|Overall Study|Death|1
3052610|NCT00582010|10493655|P1|Overall Study|Death|0
3052611|NCT00581945|10493684|P2|Overall Study|Death|0
3052612|NCT00581945|10493685|P1|Overall Study|Death|1
3052613|NCT00581945|10493684|P2|Overall Study|Withdrawal by Subject|6
3052614|NCT00581945|10493685|P1|Overall Study|Withdrawal by Subject|2
3052615|NCT00581945|10493684|P2|Overall Study|Unsatisfactory therapeutic effect|0
3052616|NCT00581945|10493685|P1|Overall Study|Unsatisfactory therapeutic effect|2
3052617|NCT00581945|10493684|P2|Overall Study|Adverse Event|4
3052618|NCT00581945|10493685|P1|Overall Study|Adverse Event|4
3052619|NCT00581919|10493701|P1|Overall Study|Withdrawal by Subject|1
3052620|NCT00581919|10493701|P1|Overall Study|Started Non-Protocol Therapy|2
3052621|NCT00581919|10493701|P1|Overall Study|Other Complicating Disease|1
3052622|NCT00581919|10493701|P1|Overall Study|Physician Decision|1
3052623|NCT00581919|10493701|P1|Overall Study|Disease Progression|10
3052624|NCT00581919|10493701|P1|Overall Study|Death|1
3052625|NCT00581919|10493701|P1|Overall Study|Adverse Event|8
3052626|NCT00581828|10493720|P1|Overall Study|Protocol Violation|1
3052627|NCT00581776|10493724|P1|Overall Study|Disease progression or no response|3
3052628|NCT00581555|10493742|P2|Overall Study|Other reasons|4
3052629|NCT00581555|10493743|P1|Overall Study|Other reasons|16
3052630|NCT00581555|10493742|P2|Overall Study|Lost to Follow-up|2
3052631|NCT00581555|10493743|P1|Overall Study|Lost to Follow-up|2
3052632|NCT00581555|10493742|P2|Overall Study|Withdrawal by Subject|9
3052633|NCT00581555|10493743|P1|Overall Study|Withdrawal by Subject|18
3052634|NCT00581555|10493742|P2|Overall Study|Physician Decision|2
3052635|NCT00581555|10493743|P1|Overall Study|Physician Decision|3
3052636|NCT00581555|10493742|P2|Overall Study|Adverse Event|3
3052637|NCT00581555|10493743|P1|Overall Study|Adverse Event|4
3052638|NCT00581542|10493767|P2|Overall Study|Lost to Follow-up|21
3052639|NCT00581542|10493768|P1|Overall Study|Lost to Follow-up|9
3052640|NCT00581542|10493767|P2|Overall Study|they met an exclusion criteria|2
3052641|NCT00581542|10493768|P1|Overall Study|they met an exclusion criteria|2
3052642|NCT00581360|10493822|P1|Overall Study|Withdrawal by Subject|1
3052643|NCT00581308|10493841|P1|Month 12|Other|1
3052644|NCT00581308|10493841|P1|Month 12|Device Removed|1
3052645|NCT00581308|10493841|P1|Month 12|Withdrawal by Subject|3
3052646|NCT00581308|10493841|P1|Month 12|Lost to Follow-up|14
3052647|NCT00581308|10493841|P1|Month 12|Death|1
3052648|NCT00581308|10493841|P1|Month 6|Withdrawal by Subject|2
3052649|NCT00581308|10493841|P1|Month 6|Lost to Follow-up|1
3052650|NCT00581308|10493841|P1|Month 1|Uknown|1
3052651|NCT00581308|10493841|P1|Month 1|Device Removed|2
3052652|NCT00581308|10493841|P1|Month 1|Withdrawal by Subject|2
3052653|NCT00581308|10493841|P1|Month 1|Lost to Follow-up|3
3052654|NCT00581308|10493841|P1|Pre Discharge|Device Removed|1
3052655|NCT00581308|10493841|P1|Pre Discharge|Lost to Follow-up|1
3052656|NCT00581113|10493872|P2|Overall Study|Withdrawal by Subject|1
3052657|NCT00581113|10493873|P1|Overall Study|Withdrawal by Subject|0
3052658|NCT00581100|10493883|P2|Overall Study|Other|0
3052659|NCT00581100|10493884|P1|Overall Study|Other|3
3052660|NCT00581100|10493883|P2|Overall Study|Withdrawal by Subject|4
3052661|NCT00581100|10493884|P1|Overall Study|Withdrawal by Subject|1
3052662|NCT00581100|10493883|P2|Overall Study|Adverse Event|1
3052663|NCT00581100|10493884|P1|Overall Study|Adverse Event|2
3052664|NCT00581100|10493883|P2|Overall Study|Death|0
3052665|NCT00581100|10493884|P1|Overall Study|Death|1
3052666|NCT00580983|10493937|P1|Overall Study|Did not complete 12 mon post RT studies|7
3052667|NCT00580970|10493944|P1|Treatment (Lovastatin)|Death|1
3052668|NCT00580970|10493944|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
3052669|NCT00580970|10493944|P1|Treatment (Lovastatin)|Physician Decision|4
3052670|NCT00580970|10493944|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
3052671|NCT00580970|10493944|P1|Treatment (Lovastatin)|Non-compliance|6
3052672|NCT00580970|10493944|P1|Pre-treatment|Non-compliance|1
3052673|NCT00580866|10493959|P2|Overall Study|Lost to Follow-up|2
3052674|NCT00580866|10493960|P1|Overall Study|Lost to Follow-up|2
3052675|NCT00580840|10493984|P4|Double-Blind|Other: Forbidden Medication|0
3052676|NCT00580840|10493985|P3|Double-Blind|Other: Forbidden Medication|1
3052677|NCT00580840|10493986|P2|Double-Blind|Other: Forbidden Medication|0
3052678|NCT00580840|10493987|P1|Double-Blind|Other: Forbidden Medication|0
3052679|NCT00580840|10493984|P4|Double-Blind|Other: Discontinued Methotrexate|0
3052680|NCT00580840|10493985|P3|Double-Blind|Other: Discontinued Methotrexate|0
3052681|NCT00580840|10493986|P2|Double-Blind|Other: Discontinued Methotrexate|1
3052682|NCT00580840|10493987|P1|Double-Blind|Other: Discontinued Methotrexate|0
3052683|NCT00580840|10493984|P4|Double-Blind|Withdrawal by Subject|2
3052684|NCT00580840|10493985|P3|Double-Blind|Withdrawal by Subject|2
3052685|NCT00580840|10493986|P2|Double-Blind|Withdrawal by Subject|1
3052686|NCT00580840|10493987|P1|Double-Blind|Withdrawal by Subject|0
3052687|NCT00580840|10493984|P4|Double-Blind|Lost to Follow-up|2
3052688|NCT00580840|10493985|P3|Double-Blind|Lost to Follow-up|0
3052689|NCT00580840|10493986|P2|Double-Blind|Lost to Follow-up|1
3052690|NCT00580840|10493987|P1|Double-Blind|Lost to Follow-up|0
3052691|NCT00580840|10493984|P4|Double-Blind|Loss of Efficacy|10
3052692|NCT00580840|10493985|P3|Double-Blind|Loss of Efficacy|2
3052693|NCT00580840|10493986|P2|Double-Blind|Loss of Efficacy|1
3052694|NCT00580840|10493987|P1|Double-Blind|Loss of Efficacy|0
3052695|NCT00580840|10493984|P4|Double-Blind|Adverse Event|1
3052696|NCT00580840|10493985|P3|Double-Blind|Adverse Event|4
3052697|NCT00580840|10493986|P2|Double-Blind|Adverse Event|3
3052698|NCT00580840|10493987|P1|Double-Blind|Adverse Event|0
3052699|NCT00580840|10493984|P4|Run-in|Other: Exclusionary Lab Value|0
3052700|NCT00580840|10493985|P3|Run-in|Other: Exclusionary Lab Value|0
3052701|NCT00580840|10493986|P2|Run-in|Other: Exclusionary Lab Value|0
3052702|NCT00580840|10493987|P1|Run-in|Other: Exclusionary Lab Value|1
3052703|NCT00580840|10493984|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
3052704|NCT00580840|10493985|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
3052705|NCT00580840|10493986|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
3052706|NCT00580840|10493987|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
3052707|NCT00580840|10493984|P4|Run-in|Other: Per Sponsor Request|0
3052708|NCT00580840|10493985|P3|Run-in|Other: Per Sponsor Request|0
3052709|NCT00580840|10493986|P2|Run-in|Other: Per Sponsor Request|0
3052710|NCT00580840|10493987|P1|Run-in|Other: Per Sponsor Request|2
3052711|NCT00580840|10493984|P4|Run-in|Withdrawal by Subject|0
3052712|NCT00580840|10493985|P3|Run-in|Withdrawal by Subject|0
3052713|NCT00580840|10493986|P2|Run-in|Withdrawal by Subject|0
3052714|NCT00580840|10493987|P1|Run-in|Withdrawal by Subject|5
3052715|NCT00580840|10493984|P4|Run-in|Lost to Follow-up|0
3052716|NCT00580840|10493985|P3|Run-in|Lost to Follow-up|0
3052717|NCT00580840|10493986|P2|Run-in|Lost to Follow-up|0
3052718|NCT00580840|10493987|P1|Run-in|Lost to Follow-up|4
3052719|NCT00580840|10493984|P4|Run-in|Loss of Efficacy|0
3052720|NCT00580840|10493985|P3|Run-in|Loss of Efficacy|0
3052721|NCT00580840|10493986|P2|Run-in|Loss of Efficacy|0
3052722|NCT00580840|10493987|P1|Run-in|Loss of Efficacy|1
3052723|NCT00580840|10493984|P4|Run-in|Lack of Efficacy|0
3052724|NCT00580840|10493985|P3|Run-in|Lack of Efficacy|0
3052725|NCT00580840|10493986|P2|Run-in|Lack of Efficacy|0
3052726|NCT00580840|10493987|P1|Run-in|Lack of Efficacy|93
3052727|NCT00580840|10493984|P4|Run-in|Adverse Event|0
3052728|NCT00580840|10493985|P3|Run-in|Adverse Event|0
3052729|NCT00580840|10493986|P2|Run-in|Adverse Event|0
3052730|NCT00580840|10493987|P1|Run-in|Adverse Event|17
3052731|NCT00580801|10494095|P3|Overall Study|Travel|0
3052732|NCT00580801|10494096|P2|Overall Study|Travel|0
3052733|NCT00580801|10494097|P1|Overall Study|Travel|1
3052734|NCT00580801|10494095|P3|Overall Study|Participant non-compliant|1
3052735|NCT00580801|10494096|P2|Overall Study|Participant non-compliant|0
3052736|NCT00580801|10494097|P1|Overall Study|Participant non-compliant|0
3052737|NCT00580801|10494095|P3|Overall Study|Reached a virologic endpoint|2
3052738|NCT00580801|10494096|P2|Overall Study|Reached a virologic endpoint|1
3052739|NCT00580801|10494097|P1|Overall Study|Reached a virologic endpoint|0
3052740|NCT00580801|10494095|P3|Overall Study|Lost to Follow-up|0
3052741|NCT00580801|10494096|P2|Overall Study|Lost to Follow-up|0
3052742|NCT00580801|10494097|P1|Overall Study|Lost to Follow-up|2
3052743|NCT00580801|10494095|P3|Overall Study|Adverse Event|0
3052744|NCT00580801|10494096|P2|Overall Study|Adverse Event|0
3052745|NCT00580801|10494097|P1|Overall Study|Adverse Event|2
3052746|NCT00580801|10494095|P3|Overall Study|Physician Decision|0
3052747|NCT00580801|10494096|P2|Overall Study|Physician Decision|0
3052748|NCT00580801|10494097|P1|Overall Study|Physician Decision|1
3052749|NCT00580788|10494136|P4|Overall Study|Adverse Event|1
3052750|NCT00580788|10494137|P3|Overall Study|Adverse Event|0
3052751|NCT00580788|10494138|P2|Overall Study|Adverse Event|0
3052752|NCT00580788|10494139|P1|Overall Study|Adverse Event|0
3052753|NCT00580723|10494197|P1|Overall Study|Lost to Follow-up|5
3052754|NCT00580723|10494197|P1|Overall Study|Did not want to participate in extension|3
3052755|NCT00580606|10494240|P2|Open Label (OL)|Needed Prohibited Medication|1
3052756|NCT00580606|10494241|P1|Open Label (OL)|Needed Prohibited Medication|0
3052757|NCT00580606|10494240|P2|Open Label (OL)|Physician Decision|1
3052758|NCT00580606|10494241|P1|Open Label (OL)|Physician Decision|1
3052759|NCT00580606|10494240|P2|Open Label (OL)|Non-compliance|0
3052760|NCT00580606|10494241|P1|Open Label (OL)|Non-compliance|2
3052761|NCT00580606|10494240|P2|Open Label (OL)|Pregnancy|1
3052762|NCT00580606|10494241|P1|Open Label (OL)|Pregnancy|0
3052763|NCT00580606|10494240|P2|Open Label (OL)|Lost to Follow-up|1
3052764|NCT00580606|10494241|P1|Open Label (OL)|Lost to Follow-up|0
3052765|NCT00580606|10494240|P2|Open Label (OL)|Dosing Symptoms|1
3052766|NCT00580606|10494241|P1|Open Label (OL)|Dosing Symptoms|0
3052767|NCT00580606|10494240|P2|Open Label (OL)|Withdrawal by Subject|6
3052768|NCT00580606|10494241|P1|Open Label (OL)|Withdrawal by Subject|4
3052769|NCT00580606|10494240|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
3052770|NCT00580606|10494241|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
3052771|NCT00580047|10494322|P3|Overall Study|Withdrawal by Subject|0
3052772|NCT00580047|10494323|P2|Overall Study|Withdrawal by Subject|0
3052773|NCT00580047|10494324|P1|Overall Study|Withdrawal by Subject|1
3052774|NCT00580047|10494322|P3|Overall Study|Withdrawal by Subject|2
3052775|NCT00580047|10494323|P2|Overall Study|Withdrawal by Subject|1
3052776|NCT00580047|10494324|P1|Overall Study|Withdrawal by Subject|1
3052777|NCT00580047|10494322|P3|Overall Study|Lost to Follow-up|0
3052778|NCT00580047|10494323|P2|Overall Study|Lost to Follow-up|1
3052779|NCT00580047|10494324|P1|Overall Study|Lost to Follow-up|1
3052780|NCT00580034|10494335|P2|Overall Study|Toxicity|0
3052781|NCT00580034|10494336|P1|Overall Study|Toxicity|10
3052782|NCT00579982|10494342|P1|Overall Study|Protocol Violation|4
3052783|NCT00579982|10494342|P1|Overall Study|Adverse Event|4
3052784|NCT00579826|10494376|P2|Overall Study|Withdrawal by Subject|3
3052785|NCT00579826|10494377|P1|Overall Study|Withdrawal by Subject|5
3052786|NCT00579670|10494411|P5|Overall Study|Withdrawal by Subject|0
3052787|NCT00579670|10494412|P4|Overall Study|Withdrawal by Subject|0
3052788|NCT00579670|10494413|P3|Overall Study|Withdrawal by Subject|1
3052789|NCT00579670|10494414|P2|Overall Study|Withdrawal by Subject|0
3052790|NCT00579670|10494415|P1|Overall Study|Withdrawal by Subject|0
3052791|NCT00579670|10494411|P5|Overall Study|Other|0
3052792|NCT00579670|10494412|P4|Overall Study|Other|2
3052793|NCT00579670|10494413|P3|Overall Study|Other|1
3052794|NCT00579670|10494414|P2|Overall Study|Other|0
3052795|NCT00579670|10494415|P1|Overall Study|Other|0
3052796|NCT00579670|10494411|P5|Overall Study|Lost to Follow-up|0
3052797|NCT00579670|10494412|P4|Overall Study|Lost to Follow-up|4
3052798|NCT00579670|10494413|P3|Overall Study|Lost to Follow-up|0
3052799|NCT00579670|10494414|P2|Overall Study|Lost to Follow-up|1
3052800|NCT00579670|10494415|P1|Overall Study|Lost to Follow-up|0
3052801|NCT00579670|10494411|P5|Overall Study|Lack of Efficacy|0
3052802|NCT00579670|10494412|P4|Overall Study|Lack of Efficacy|14
3052803|NCT00579670|10494413|P3|Overall Study|Lack of Efficacy|1
3052804|NCT00579670|10494414|P2|Overall Study|Lack of Efficacy|0
3052805|NCT00579670|10494415|P1|Overall Study|Lack of Efficacy|0
3052806|NCT00579670|10494411|P5|Overall Study|Adverse Event|0
3052807|NCT00579670|10494412|P4|Overall Study|Adverse Event|2
3052808|NCT00579670|10494413|P3|Overall Study|Adverse Event|1
3052809|NCT00579670|10494414|P2|Overall Study|Adverse Event|0
3052810|NCT00579670|10494415|P1|Overall Study|Adverse Event|1
3052811|NCT00579670|10494411|P5|Overall Study|Death|0
3052812|NCT00579670|10494412|P4|Overall Study|Death|0
3052813|NCT00579670|10494413|P3|Overall Study|Death|0
3052814|NCT00579670|10494414|P2|Overall Study|Death|0
3052815|NCT00579670|10494415|P1|Overall Study|Death|1
3052816|NCT00579527|10494627|P1|Overall Study|Death|4
3052817|NCT00579501|10494639|P1|Overall Study|Radiation therapy before surgery|1
3052818|NCT00579501|10494639|P1|Overall Study|Secondary lesion|1
3052819|NCT00579501|10494639|P1|Overall Study|toxicity|1
3052820|NCT00579501|10494639|P1|Overall Study|End of neoadjuvant therapy|25
3052821|NCT00579501|10494639|P1|Overall Study|Death|1
3052822|NCT00579345|10494667|P8|Overall Study|Death|0
3052823|NCT00579345|10494668|P7|Overall Study|Death|0
3052824|NCT00579345|10494669|P6|Overall Study|Death|0
3052825|NCT00579345|10494670|P5|Overall Study|Death|0
3052826|NCT00579345|10494671|P4|Overall Study|Death|1
3052827|NCT00579345|10494672|P3|Overall Study|Death|1
3052828|NCT00579345|10494673|P2|Overall Study|Death|1
3052829|NCT00579345|10494674|P1|Overall Study|Death|1
3052830|NCT00579345|10494667|P8|Overall Study|Protocol Violation|1
3052831|NCT00579345|10494668|P7|Overall Study|Protocol Violation|0
3052832|NCT00579345|10494669|P6|Overall Study|Protocol Violation|0
3052833|NCT00579345|10494670|P5|Overall Study|Protocol Violation|0
3052834|NCT00579345|10494671|P4|Overall Study|Protocol Violation|0
3052835|NCT00579345|10494672|P3|Overall Study|Protocol Violation|0
3052836|NCT00579345|10494673|P2|Overall Study|Protocol Violation|0
3052837|NCT00579345|10494674|P1|Overall Study|Protocol Violation|1
3052838|NCT00579345|10494667|P8|Overall Study|Adverse Event|0
3052839|NCT00579345|10494668|P7|Overall Study|Adverse Event|0
3052840|NCT00579345|10494669|P6|Overall Study|Adverse Event|0
3052841|NCT00579345|10494670|P5|Overall Study|Adverse Event|0
3052842|NCT00579345|10494671|P4|Overall Study|Adverse Event|0
3052843|NCT00579345|10494672|P3|Overall Study|Adverse Event|1
3052844|NCT00579345|10494673|P2|Overall Study|Adverse Event|0
3052845|NCT00579345|10494674|P1|Overall Study|Adverse Event|0
3052846|NCT00579345|10494667|P8|Overall Study|Lost to Follow-up|0
3052847|NCT00579345|10494668|P7|Overall Study|Lost to Follow-up|0
3052848|NCT00579345|10494669|P6|Overall Study|Lost to Follow-up|0
3052849|NCT00579345|10494670|P5|Overall Study|Lost to Follow-up|0
3052850|NCT00579345|10494671|P4|Overall Study|Lost to Follow-up|0
3052851|NCT00579345|10494672|P3|Overall Study|Lost to Follow-up|0
3052852|NCT00579345|10494673|P2|Overall Study|Lost to Follow-up|0
3052853|NCT00579345|10494674|P1|Overall Study|Lost to Follow-up|1
3052854|NCT00579345|10494667|P8|Overall Study|Withdrawal by Subject|1
3052855|NCT00579345|10494668|P7|Overall Study|Withdrawal by Subject|0
3052856|NCT00579345|10494669|P6|Overall Study|Withdrawal by Subject|0
3052857|NCT00579345|10494670|P5|Overall Study|Withdrawal by Subject|0
3052858|NCT00579345|10494671|P4|Overall Study|Withdrawal by Subject|0
3052859|NCT00579345|10494672|P3|Overall Study|Withdrawal by Subject|0
3052860|NCT00579345|10494673|P2|Overall Study|Withdrawal by Subject|0
3052861|NCT00579345|10494674|P1|Overall Study|Withdrawal by Subject|2
3052862|NCT00579254|10494706|P1|Overall Study|Discontinued when study terminated|73
3052863|NCT00579254|10494706|P1|Overall Study|Lost to Follow-up|39
3052864|NCT00579098|10494730|P2|Overall Study|AF returned after ablation|2
3052865|NCT00579098|10494731|P1|Overall Study|AF returned after ablation|3
3052866|NCT00579098|10494730|P2|Overall Study|Withdrawal by Subject|3
3052867|NCT00579098|10494731|P1|Overall Study|Withdrawal by Subject|2
3052868|NCT00579098|10494730|P2|Overall Study|Adverse Event|3
3052869|NCT00579098|10494731|P1|Overall Study|Adverse Event|2
3052870|NCT00579098|10494730|P2|Overall Study|Lost to Follow-up|0
3052871|NCT00579098|10494731|P1|Overall Study|Lost to Follow-up|2
3052872|NCT00579059|10494747|P2|Overall Study|Study Canceled at 1 Year|10
3052873|NCT00579059|10494748|P1|Overall Study|Study Canceled at 1 Year|21
3052874|NCT00578942|10494822|P1|Overall Study|Lost to Follow-up|1
3052875|NCT00578877|10494861|P2|Overall Study|did not provide follow-up data|17
3052876|NCT00578877|10494862|P1|Overall Study|did not provide follow-up data|12
3052877|NCT00578877|10494861|P2|Overall Study|early discontinue|101
3052878|NCT00578877|10494862|P1|Overall Study|early discontinue|61
3052879|NCT00578877|10494861|P2|Overall Study|Lost to Follow-up|10
3052880|NCT00578877|10494862|P1|Overall Study|Lost to Follow-up|8
3052881|NCT00578864|10494870|P2|Overall Study|Death|0
3052882|NCT00578864|10494871|P1|Overall Study|Death|1
3052883|NCT00578812|10494887|P2|Overall Study|Not treated|7
3052884|NCT00578812|10494888|P1|Overall Study|Not treated|6
3052885|NCT00578786|10494927|P3|Overall Study|Qualified but Not Enrolled in Extension|0
3052886|NCT00578786|10494928|P2|Overall Study|Qualified but Not Enrolled in Extension|3
3052887|NCT00578786|10494929|P1|Overall Study|Qualified but Not Enrolled in Extension|0
3052888|NCT00578786|10494927|P3|Overall Study|Not Otherwise Specified|1
3052889|NCT00578786|10494928|P2|Overall Study|Not Otherwise Specified|4
3052890|NCT00578786|10494929|P1|Overall Study|Not Otherwise Specified|0
3052891|NCT00578786|10494927|P3|Overall Study|Pregnancy|0
3052892|NCT00578786|10494928|P2|Overall Study|Pregnancy|1
3052893|NCT00578786|10494929|P1|Overall Study|Pregnancy|0
3052894|NCT00578786|10494927|P3|Overall Study|Lost to Follow-up|0
3052895|NCT00578786|10494928|P2|Overall Study|Lost to Follow-up|4
3052896|NCT00578786|10494929|P1|Overall Study|Lost to Follow-up|0
3052897|NCT00578786|10494927|P3|Overall Study|Sponsor Decision|1
3052898|NCT00578786|10494928|P2|Overall Study|Sponsor Decision|0
3052899|NCT00578786|10494929|P1|Overall Study|Sponsor Decision|0
3052900|NCT00578786|10494927|P3|Overall Study|Physician Decision|1
3052901|NCT00578786|10494928|P2|Overall Study|Physician Decision|0
3052902|NCT00578786|10494929|P1|Overall Study|Physician Decision|1
3052903|NCT00578786|10494927|P3|Overall Study|Protocol Violation|1
3052904|NCT00578786|10494928|P2|Overall Study|Protocol Violation|3
3052905|NCT00578786|10494929|P1|Overall Study|Protocol Violation|0
3052906|NCT00578786|10494927|P3|Overall Study|Withdrawal by Subject|5
3052907|NCT00578786|10494928|P2|Overall Study|Withdrawal by Subject|8
3052908|NCT00578786|10494929|P1|Overall Study|Withdrawal by Subject|7
3052909|NCT00578786|10494927|P3|Overall Study|Early Escape from Prior Study|2
3052910|NCT00578786|10494928|P2|Overall Study|Early Escape from Prior Study|1
3052911|NCT00578786|10494929|P1|Overall Study|Early Escape from Prior Study|2
3052912|NCT00578786|10494927|P3|Overall Study|Lack of Efficacy|2
3052913|NCT00578786|10494928|P2|Overall Study|Lack of Efficacy|5
3052914|NCT00578786|10494929|P1|Overall Study|Lack of Efficacy|2
3052915|NCT00578786|10494927|P3|Overall Study|Adverse Event|17
3052916|NCT00578786|10494928|P2|Overall Study|Adverse Event|37
3052917|NCT00578786|10494929|P1|Overall Study|Adverse Event|27
3052918|NCT00578643|10495030|P1|Overall Study|Lost to Follow-up|1
3052919|NCT00578643|10495030|P1|Overall Study|Death|1
3052920|NCT00578565|10495046|P1|Overall Study|Adverse Event|3
3052921|NCT00578448|10495076|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
3052922|NCT00578448|10495076|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
3052923|NCT00578448|10495076|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
3052924|NCT00578448|10495076|P1|Day 1 up to 3 Years of Planned Study|Death|1
3052925|NCT00578318|10495140|P2|Overall Study|Physician Decision|0
3052926|NCT00578318|10495141|P1|Overall Study|Physician Decision|1
3052927|NCT00578318|10495140|P2|Overall Study|Lost to Follow-up|0
3052928|NCT00578318|10495141|P1|Overall Study|Lost to Follow-up|2
3052929|NCT00578292|10495211|P1|Overall Study|Graft failure|2
3052930|NCT00578292|10495211|P1|Overall Study|Death|1
3052931|NCT00578227|10495235|P3|Overall Study|Withdrawal by Subject|3
3052932|NCT00578227|10495236|P2|Overall Study|Withdrawal by Subject|1
3052933|NCT00578227|10495237|P1|Overall Study|Withdrawal by Subject|5
3052934|NCT00578227|10495235|P3|Overall Study|Lost to Follow-up|1
3052935|NCT00578227|10495236|P2|Overall Study|Lost to Follow-up|1
3052936|NCT00578227|10495237|P1|Overall Study|Lost to Follow-up|0
3052937|NCT00578175|10495362|P3|Overall Study|Other reasons|23
3052938|NCT00578175|10495363|P2|Overall Study|Other reasons|42
3052939|NCT00578175|10495364|P1|Overall Study|Other reasons|70
3052940|NCT00578175|10495362|P3|Overall Study|Adverse Event|1
3052941|NCT00578175|10495363|P2|Overall Study|Adverse Event|1
3052942|NCT00578175|10495364|P1|Overall Study|Adverse Event|0
3052943|NCT00578136|10495443|P2|Overall Study|Not given intervention|1
3052944|NCT00578136|10495444|P1|Overall Study|Not given intervention|1
3052945|NCT00577889|10495462|P3|Overall Study|Withdrawal by Subject|0
3052946|NCT00577889|10495463|P2|Overall Study|Withdrawal by Subject|0
3052947|NCT00577889|10495464|P1|Overall Study|Withdrawal by Subject|1
3052948|NCT00577863|10495483|P2|Overall Study|Did Not Receive at Least One Injection|1
3052949|NCT00577863|10495484|P1|Overall Study|Did Not Receive at Least One Injection|0
3052950|NCT00577863|10495483|P2|Overall Study|Sponsor Decision|7
3052951|NCT00577863|10495484|P1|Overall Study|Sponsor Decision|2
3052952|NCT00577863|10495483|P2|Overall Study|Withdrawal by Subject|2
3052953|NCT00577863|10495484|P1|Overall Study|Withdrawal by Subject|0
3052954|NCT00577863|10495483|P2|Overall Study|Entry Criteria Exclusion|0
3052955|NCT00577863|10495484|P1|Overall Study|Entry Criteria Exclusion|1
3052956|NCT00577863|10495483|P2|Overall Study|Lost to Follow-up|2
3052957|NCT00577863|10495484|P1|Overall Study|Lost to Follow-up|2
3052958|NCT00577863|10495483|P2|Overall Study|Death|0
3052959|NCT00577863|10495484|P1|Overall Study|Death|1
3052960|NCT00577863|10495483|P2|Overall Study|Adverse Event|2
3052961|NCT00577863|10495484|P1|Overall Study|Adverse Event|4
3052962|NCT00577824|10495526|P3|Overall Study|Protocol Violation|0
3052963|NCT00577824|10495527|P2|Overall Study|Protocol Violation|1
3052964|NCT00577824|10495528|P1|Overall Study|Protocol Violation|1
3052965|NCT00577824|10495526|P3|Overall Study|Patient decision|1
3052966|NCT00577824|10495527|P2|Overall Study|Patient decision|1
3052967|NCT00577824|10495528|P1|Overall Study|Patient decision|0
3052968|NCT00577824|10495526|P3|Overall Study|Adverse Event|1
3052969|NCT00577824|10495527|P2|Overall Study|Adverse Event|18
3052970|NCT00577824|10495528|P1|Overall Study|Adverse Event|6
3052971|NCT00577772|10495586|P2|Overall Study|Lost to Follow-up|1
3052972|NCT00577772|10495587|P1|Overall Study|Lost to Follow-up|0
3052973|NCT00577720|10495597|P4|Overall Study|Withdrawal by Subject|2
3052974|NCT00577720|10495598|P3|Overall Study|Withdrawal by Subject|0
3052975|NCT00577720|10495599|P2|Overall Study|Withdrawal by Subject|0
3052976|NCT00577720|10495600|P1|Overall Study|Withdrawal by Subject|2
3052977|NCT00577720|10495597|P4|Overall Study|Protocol Violation|1
3052978|NCT00577720|10495598|P3|Overall Study|Protocol Violation|0
3052979|NCT00577720|10495599|P2|Overall Study|Protocol Violation|0
3052980|NCT00577720|10495600|P1|Overall Study|Protocol Violation|0
3052981|NCT00577720|10495597|P4|Overall Study|Lost to Follow-up|0
3052982|NCT00577720|10495598|P3|Overall Study|Lost to Follow-up|1
3052983|NCT00577720|10495599|P2|Overall Study|Lost to Follow-up|0
3052984|NCT00577720|10495600|P1|Overall Study|Lost to Follow-up|0
3052985|NCT00577720|10495597|P4|Overall Study|Adverse Event|4
3052986|NCT00577720|10495598|P3|Overall Study|Adverse Event|0
3052987|NCT00577720|10495599|P2|Overall Study|Adverse Event|1
3052988|NCT00577720|10495600|P1|Overall Study|Adverse Event|2
3052989|NCT00577707|10495618|P1|Overall Study|Withdrawal by Subject|3
3052990|NCT00577655|10495626|P2|Overall Study|Lost to Follow-up|1
3052991|NCT00577655|10495627|P1|Overall Study|Lost to Follow-up|1
3052992|NCT00577655|10495626|P2|Overall Study|Protocol Violation|1
3052993|NCT00577655|10495627|P1|Overall Study|Protocol Violation|0
3052994|NCT00577655|10495626|P2|Overall Study|Patient Request|2
3052995|NCT00577655|10495627|P1|Overall Study|Patient Request|0
3052996|NCT00577642|10495665|P1|Overall Study|Clinical Disease Progression|1
3052997|NCT00577629|10495669|P1|Long Term Follow-Up|Physician Decision|1
3052998|NCT00577629|10495669|P1|Long Term Follow-Up|Withdrawal by Subject|4
3052999|NCT00577629|10495669|P1|Long Term Follow-Up|Lost to Follow-up|5
3053000|NCT00577629|10495669|P1|Long Term Follow-Up|Death|15
3053001|NCT00577629|10495669|P1|Treatment Period|Death|1
3053002|NCT00577473|10495696|P2|Overall Study|Lack of Efficacy|7
3053003|NCT00577473|10495697|P1|Overall Study|Lack of Efficacy|8
3053004|NCT00577473|10495696|P2|Overall Study|Physician Decision|2
3053005|NCT00577473|10495697|P1|Overall Study|Physician Decision|2
3053006|NCT00577473|10495696|P2|Overall Study|Withdrawal by Subject|6
3053007|NCT00577473|10495697|P1|Overall Study|Withdrawal by Subject|2
3053008|NCT00577473|10495696|P2|Overall Study|Adverse Event|5
3053009|NCT00577473|10495697|P1|Overall Study|Adverse Event|8
3053010|NCT00577473|10495696|P2|Overall Study|Protocol Violation|4
3053011|NCT00577473|10495697|P1|Overall Study|Protocol Violation|1
3053012|NCT00577460|10495728|P3|Overall Study|Other|2
3053013|NCT00577460|10495729|P2|Overall Study|Other|3
3053014|NCT00577460|10495730|P1|Overall Study|Other|0
3053015|NCT00577460|10495728|P3|Overall Study|Withdrawal by Subject|6
3053016|NCT00577460|10495729|P2|Overall Study|Withdrawal by Subject|5
3053017|NCT00577460|10495730|P1|Overall Study|Withdrawal by Subject|5
3053018|NCT00577460|10495728|P3|Overall Study|Lost to Follow-up|4
3053019|NCT00577460|10495729|P2|Overall Study|Lost to Follow-up|3
3053020|NCT00577460|10495730|P1|Overall Study|Lost to Follow-up|0
3053021|NCT00577460|10495728|P3|Overall Study|Protocol Violation|1
3053022|NCT00577460|10495729|P2|Overall Study|Protocol Violation|1
3053023|NCT00577460|10495730|P1|Overall Study|Protocol Violation|0
3053024|NCT00577460|10495728|P3|Overall Study|Adverse Event|14
3053025|NCT00577460|10495729|P2|Overall Study|Adverse Event|7
3053026|NCT00577460|10495730|P1|Overall Study|Adverse Event|11
3053027|NCT00577408|10495839|P2|Overall Study|Psychiatric hospitalization|1
3053028|NCT00577408|10495840|P1|Overall Study|Psychiatric hospitalization|0
3053029|NCT00577408|10495839|P2|Overall Study|Death|1
3053030|NCT00577408|10495840|P1|Overall Study|Death|0
3053031|NCT00577408|10495839|P2|Overall Study|Scheduling Issues|3
3053032|NCT00577408|10495840|P1|Overall Study|Scheduling Issues|0
3053033|NCT00577408|10495839|P2|Overall Study|Moved out of state|1
3053034|NCT00577408|10495840|P1|Overall Study|Moved out of state|0
3053035|NCT00577408|10495839|P2|Overall Study|Refused Oral Naltrexone|1
3053036|NCT00577408|10495840|P1|Overall Study|Refused Oral Naltrexone|0
3053037|NCT00577408|10495839|P2|Overall Study|Non-compliance with study meds|3
3053038|NCT00577408|10495840|P1|Overall Study|Non-compliance with study meds|0
3053039|NCT00577408|10495839|P2|Overall Study|Continued opioid use|2
3053040|NCT00577408|10495840|P1|Overall Study|Continued opioid use|3
3053041|NCT00577408|10495839|P2|Overall Study|Stopped attending study visits|11
3053042|NCT00577408|10495840|P1|Overall Study|Stopped attending study visits|9
3053043|NCT00577395|10495848|P2|Overall Study|Study was terminated early by Sponsor|6
3053044|NCT00577395|10495849|P1|Overall Study|Study was terminated early by Sponsor|7
3053045|NCT00577382|10495859|P2|Overall Study|Lost to Follow-up|2
3053046|NCT00577382|10495860|P1|Overall Study|Lost to Follow-up|2
3053047|NCT00577382|10495859|P2|Overall Study|Death|1
3053048|NCT00577382|10495860|P1|Overall Study|Death|1
3053049|NCT00577382|10495859|P2|Overall Study|Intercurrent Illness|2
3053050|NCT00577382|10495860|P1|Overall Study|Intercurrent Illness|1
3053051|NCT00577382|10495859|P2|Overall Study|Progressive Disease|19
3053052|NCT00577382|10495860|P1|Overall Study|Progressive Disease|17
3053053|NCT00577382|10495859|P2|Overall Study|Withdrawal by Subject|1
3053054|NCT00577382|10495860|P1|Overall Study|Withdrawal by Subject|0
3053055|NCT00577382|10495859|P2|Overall Study|Adverse Event|6
3053056|NCT00577382|10495860|P1|Overall Study|Adverse Event|0
3053057|NCT00577122|10496003|P2|Overall Study|Alternative Therapy|1
3053058|NCT00577122|10496004|P1|Overall Study|Alternative Therapy|0
3053059|NCT00577122|10496003|P2|Overall Study|Prog, refract disease during active trt|5
3053060|NCT00577122|10496004|P1|Overall Study|Prog, refract disease during active trt|8
3053061|NCT00577122|10496003|P2|Overall Study|Progression, relapse during active trt|8
3053062|NCT00577122|10496004|P1|Overall Study|Progression, relapse during active trt|6
3053063|NCT00577122|10496003|P2|Overall Study|Adverse Event|2
3053064|NCT00577122|10496004|P1|Overall Study|Adverse Event|0
3053065|NCT00577096|10496018|P2|Short Term Participation|Death|1
3053066|NCT00577096|10496019|P1|Short Term Participation|Death|1
3053067|NCT00577096|10496018|P2|Short Term Participation|Withdrawal by Subject|5
3053068|NCT00577096|10496019|P1|Short Term Participation|Withdrawal by Subject|3
3053069|NCT00577096|10496018|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
3053070|NCT00577096|10496019|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
3053071|NCT00577031|10496058|P1|Overall Study|Death|6
3053072|NCT00577031|10496058|P1|Overall Study|Medical decision|14
3053073|NCT00577031|10496058|P1|Overall Study|Need for surgery|17
3053074|NCT00577031|10496058|P1|Overall Study|Participant non-compliance|5
3053075|NCT00577031|10496058|P1|Overall Study|Participant withdrew consent|13
3053076|NCT00577031|10496058|P1|Overall Study|Protocol Violation|5
3053077|NCT00577031|10496058|P1|Overall Study|Progression of disease|93
3053078|NCT00577031|10496058|P1|Overall Study|Adverse Event|52
3053079|NCT00577005|10496079|P2|Overall Study|Withdrawal by Subject|1
3053080|NCT00577005|10496080|P1|Overall Study|Withdrawal by Subject|2
3053081|NCT00577005|10496079|P2|Overall Study|Lost to Follow-up|2
3053082|NCT00577005|10496080|P1|Overall Study|Lost to Follow-up|3
3053083|NCT00576927|10496094|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
3053084|NCT00576927|10496094|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
3053085|NCT00576927|10496094|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
3053086|NCT00576927|10496094|P1|Sleep Hygiene Behavioral Intervention|Death|1
3053087|NCT00576927|10496094|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
3053088|NCT00576927|10496094|P1|Baseline|Withdrawal by Subject|3
3053089|NCT00576927|10496094|P1|Baseline|Medication Change by PCP of subject|1
3053090|NCT00576927|10496094|P1|Baseline|Physician Decision|9
3053091|NCT00576927|10496094|P1|Clinical Assessment|Physician Decision|1
3053092|NCT00576927|10496094|P1|Clinical Assessment|Withdrawal by Subject|10
3053093|NCT00576927|10496094|P1|Clinical Assessment|Death|1
3053094|NCT00576927|10496094|P1|Clinical Assessment|Lack of Efficacy|24
3053095|NCT00576901|10496106|P1|Overall Study|Protocol Violation|1
3053096|NCT00576901|10496106|P1|Overall Study|Disease course|1
3053097|NCT00576901|10496106|P1|Overall Study|Withdrawal by Subject|1
3053098|NCT00576836|10496114|P2|Overall Study|Physician Decision|1
3053099|NCT00576836|10496115|P1|Overall Study|Physician Decision|0
3053100|NCT00576836|10496114|P2|Overall Study|Death|1
3053101|NCT00576836|10496115|P1|Overall Study|Death|0
3053102|NCT00576823|10496130|P3|40-week Safety Extension Phase|Lack of Efficacy|0
3053103|NCT00576823|10496131|P2|40-week Safety Extension Phase|Lack of Efficacy|0
3053104|NCT00576823|10496132|P1|40-week Safety Extension Phase|Lack of Efficacy|1
3053105|NCT00576823|10496130|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
3053106|NCT00576823|10496131|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
3053107|NCT00576823|10496132|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
3053108|NCT00576758|10496148|P2|Follow-up Period|Withdrew consent|1
3053109|NCT00576758|10496149|P1|Follow-up Period|Withdrew consent|2
3053110|NCT00576758|10496148|P2|Follow-up Period|Insufficient therapeutic response|5
3053111|NCT00576758|10496149|P1|Follow-up Period|Insufficient therapeutic response|16
3053112|NCT00576758|10496148|P2|Follow-up Period|Death|3
3053113|NCT00576758|10496149|P1|Follow-up Period|Death|3
3053114|NCT00576758|10496148|P2|Follow-up Period|Administrative/Other|8
3053115|NCT00576758|10496149|P1|Follow-up Period|Administrative/Other|6
3053116|NCT00576758|10496148|P2|Extension Treatment Period|Administrative/Other|1
3053117|NCT00576758|10496149|P1|Extension Treatment Period|Administrative/Other|3
3053118|NCT00576758|10496148|P2|Extension Treatment Period|Insufficient therapeutic response|33
3053119|NCT00576758|10496149|P1|Extension Treatment Period|Insufficient therapeutic response|30
3053120|NCT00576758|10496148|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
3053121|NCT00576758|10496149|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
3053122|NCT00576758|10496148|P2|Extension Treatment Period|Death|1
3053123|NCT00576758|10496149|P1|Extension Treatment Period|Death|1
3053124|NCT00576758|10496148|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
3053125|NCT00576758|10496149|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
3053126|NCT00576758|10496148|P2|Induction Treatment Period|Withdrew consent|0
3053127|NCT00576758|10496149|P1|Induction Treatment Period|Withdrew consent|1
3053128|NCT00576758|10496148|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
3053129|NCT00576758|10496149|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
3053130|NCT00576758|10496148|P2|Induction Treatment Period|Death|0
3053131|NCT00576758|10496149|P1|Induction Treatment Period|Death|1
3053132|NCT00576758|10496148|P2|Induction Treatment Period|Violation of selection criteria at entry|1
3053133|NCT00576758|10496149|P1|Induction Treatment Period|Violation of selection criteria at entry|1
3053134|NCT00576758|10496148|P2|Induction Treatment Period|Insufficient therapeutic response|0
3053135|NCT00576758|10496149|P1|Induction Treatment Period|Insufficient therapeutic response|2
3053136|NCT00576758|10496148|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
3053137|NCT00576758|10496149|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
3053138|NCT00576732|10496195|P6|OPEN LABEL|Protocol Violation|0
3053139|NCT00576732|10496196|P5|OPEN LABEL|Protocol Violation|1
3053140|NCT00576732|10496197|P4|OPEN LABEL|Protocol Violation|2
3053141|NCT00576732|10496198|P3|OPEN LABEL|Protocol Violation|0
3053142|NCT00576732|10496199|P2|OPEN LABEL|Protocol Violation|0
3053143|NCT00576732|10496200|P1|OPEN LABEL|Protocol Violation|0
3053144|NCT00576732|10496195|P6|OPEN LABEL|Lack of Efficacy|3
3053145|NCT00576732|10496196|P5|OPEN LABEL|Lack of Efficacy|2
3053146|NCT00576732|10496197|P4|OPEN LABEL|Lack of Efficacy|2
3053147|NCT00576732|10496198|P3|OPEN LABEL|Lack of Efficacy|0
3053148|NCT00576732|10496199|P2|OPEN LABEL|Lack of Efficacy|0
3053149|NCT00576732|10496200|P1|OPEN LABEL|Lack of Efficacy|0
3053150|NCT00576732|10496195|P6|OPEN LABEL|OTHER|2
3053151|NCT00576732|10496196|P5|OPEN LABEL|OTHER|0
3053152|NCT00576732|10496197|P4|OPEN LABEL|OTHER|0
3053153|NCT00576732|10496198|P3|OPEN LABEL|OTHER|0
3053154|NCT00576732|10496199|P2|OPEN LABEL|OTHER|0
3053155|NCT00576732|10496200|P1|OPEN LABEL|OTHER|0
3053156|NCT00576732|10496195|P6|OPEN LABEL|Withdrawal by Subject|1
3053157|NCT00576732|10496196|P5|OPEN LABEL|Withdrawal by Subject|0
3053158|NCT00576732|10496197|P4|OPEN LABEL|Withdrawal by Subject|1
3053159|NCT00576732|10496198|P3|OPEN LABEL|Withdrawal by Subject|0
3053160|NCT00576732|10496199|P2|OPEN LABEL|Withdrawal by Subject|0
3053161|NCT00576732|10496200|P1|OPEN LABEL|Withdrawal by Subject|0
3053162|NCT00576732|10496195|P6|OPEN LABEL|Lost to Follow-up|1
3053163|NCT00576732|10496196|P5|OPEN LABEL|Lost to Follow-up|1
3053164|NCT00576732|10496197|P4|OPEN LABEL|Lost to Follow-up|2
3053165|NCT00576732|10496198|P3|OPEN LABEL|Lost to Follow-up|0
3053166|NCT00576732|10496199|P2|OPEN LABEL|Lost to Follow-up|0
3053167|NCT00576732|10496200|P1|OPEN LABEL|Lost to Follow-up|0
3053168|NCT00576732|10496195|P6|OPEN LABEL|Adverse Event|1
3053169|NCT00576732|10496196|P5|OPEN LABEL|Adverse Event|0
3053170|NCT00576732|10496197|P4|OPEN LABEL|Adverse Event|4
3053171|NCT00576732|10496198|P3|OPEN LABEL|Adverse Event|0
3053172|NCT00576732|10496199|P2|OPEN LABEL|Adverse Event|0
3053173|NCT00576732|10496200|P1|OPEN LABEL|Adverse Event|0
3053174|NCT00576732|10496195|P6|DOUBLE BLIND|Protocol Violation|0
3053175|NCT00576732|10496196|P5|DOUBLE BLIND|Protocol Violation|0
3053176|NCT00576732|10496197|P4|DOUBLE BLIND|Protocol Violation|0
3053177|NCT00576732|10496198|P3|DOUBLE BLIND|Protocol Violation|0
3053178|NCT00576732|10496199|P2|DOUBLE BLIND|Protocol Violation|0
3053179|NCT00576732|10496200|P1|DOUBLE BLIND|Protocol Violation|1
3053180|NCT00576732|10496195|P6|DOUBLE BLIND|Lack of Efficacy|0
3053181|NCT00576732|10496196|P5|DOUBLE BLIND|Lack of Efficacy|0
3053182|NCT00576732|10496197|P4|DOUBLE BLIND|Lack of Efficacy|0
3053183|NCT00576732|10496198|P3|DOUBLE BLIND|Lack of Efficacy|0
3053184|NCT00576732|10496199|P2|DOUBLE BLIND|Lack of Efficacy|1
3053185|NCT00576732|10496200|P1|DOUBLE BLIND|Lack of Efficacy|6
3053186|NCT00576732|10496195|P6|DOUBLE BLIND|OTHER|0
3053187|NCT00576732|10496196|P5|DOUBLE BLIND|OTHER|0
3053188|NCT00576732|10496197|P4|DOUBLE BLIND|OTHER|0
3053189|NCT00576732|10496198|P3|DOUBLE BLIND|OTHER|1
3053190|NCT00576732|10496199|P2|DOUBLE BLIND|OTHER|2
3053191|NCT00576732|10496200|P1|DOUBLE BLIND|OTHER|0
3053192|NCT00576732|10496195|P6|DOUBLE BLIND|Withdrawal by Subject|0
3053193|NCT00576732|10496196|P5|DOUBLE BLIND|Withdrawal by Subject|0
3053194|NCT00576732|10496197|P4|DOUBLE BLIND|Withdrawal by Subject|0
3053195|NCT00576732|10496198|P3|DOUBLE BLIND|Withdrawal by Subject|3
3053196|NCT00576732|10496199|P2|DOUBLE BLIND|Withdrawal by Subject|1
3053197|NCT00576732|10496200|P1|DOUBLE BLIND|Withdrawal by Subject|1
3053198|NCT00576732|10496195|P6|DOUBLE BLIND|Lost to Follow-up|0
3053199|NCT00576732|10496196|P5|DOUBLE BLIND|Lost to Follow-up|0
3053200|NCT00576732|10496197|P4|DOUBLE BLIND|Lost to Follow-up|0
3053201|NCT00576732|10496198|P3|DOUBLE BLIND|Lost to Follow-up|1
3053202|NCT00576732|10496199|P2|DOUBLE BLIND|Lost to Follow-up|1
3053203|NCT00576732|10496200|P1|DOUBLE BLIND|Lost to Follow-up|0
3053204|NCT00576732|10496195|P6|DOUBLE BLIND|Adverse Event|0
3053205|NCT00576732|10496196|P5|DOUBLE BLIND|Adverse Event|0
3053206|NCT00576732|10496197|P4|DOUBLE BLIND|Adverse Event|0
3053207|NCT00576732|10496198|P3|DOUBLE BLIND|Adverse Event|1
3053208|NCT00576732|10496199|P2|DOUBLE BLIND|Adverse Event|0
3053209|NCT00576732|10496200|P1|DOUBLE BLIND|Adverse Event|0
3053210|NCT00576693|10496232|P2|Overall Study|Withdrawal by Subject|13
3053211|NCT00576693|10496233|P1|Overall Study|Withdrawal by Subject|3
3053212|NCT00576693|10496232|P2|Overall Study|Lost to Follow-up|11
3053213|NCT00576693|10496233|P1|Overall Study|Lost to Follow-up|7
3053214|NCT00576628|10496239|P1|Overall Study|Dialysis|15
3053215|NCT00576628|10496239|P1|Overall Study|Transplantation|1
3053216|NCT00576628|10496239|P1|Overall Study|The patient move into other town|1
3053217|NCT00576628|10496239|P1|Overall Study|Progression of Renal Failure|1
3053218|NCT00576628|10496239|P1|Overall Study|Progression of Kidney Disease|1
3053219|NCT00576628|10496239|P1|Overall Study|RBC transfusion|1
3053220|NCT00576628|10496239|P1|Overall Study|Pregnancy|1
3053221|NCT00576628|10496239|P1|Overall Study|Refused Treatment|8
3053222|NCT00576628|10496239|P1|Overall Study|Failure to return|1
3053223|NCT00576628|10496239|P1|Overall Study|Death|2
3053224|NCT00576628|10496239|P1|Overall Study|Adverse Event|11
3053225|NCT00576576|10496259|P1|Overall Study|Protocol Violation|1
3053226|NCT00576576|10496259|P1|Overall Study|Lost to Follow-up|6
3053227|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
3053228|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
3053229|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
3053230|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
3053231|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
3053232|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
3053233|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
3053234|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
3053235|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
3053236|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
3053237|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
3053238|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
3053239|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
3053240|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
3053241|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
3053242|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Medical reasons|6
3053243|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Medical reasons|0
3053244|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Medical reasons|0
3053245|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Medical reasons|0
3053246|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Medical reasons|0
3053247|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Medical reasons|0
3053248|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Medical reasons|0
3053249|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Medical reasons|0
3053250|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Medical reasons|0
3053251|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Medical reasons|0
3053252|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Medical reasons|0
3053253|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Medical reasons|0
3053254|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Medical reasons|0
3053255|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Medical reasons|0
3053256|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Medical reasons|0
3053257|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
3053258|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053259|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053260|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053261|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053262|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053263|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053264|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053265|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053266|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053267|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053268|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053269|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053270|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053271|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
3053272|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Side effects|8
3053273|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Side effects|0
3053274|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Side effects|0
3053275|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Side effects|0
3053276|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Side effects|0
3053277|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Side effects|0
3053278|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Side effects|0
3053279|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Side effects|0
3053280|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Side effects|0
3053281|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Side effects|0
3053282|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Side effects|0
3053283|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Side effects|0
3053284|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Side effects|0
3053285|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Side effects|0
3053286|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Side effects|0
3053287|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Insufficient data|0
3053288|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Insufficient data|4
3053289|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Insufficient data|0
3053290|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Insufficient data|0
3053291|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Insufficient data|0
3053292|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Insufficient data|0
3053293|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Insufficient data|0
3053294|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Insufficient data|0
3053295|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Insufficient data|0
3053296|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Insufficient data|0
3053297|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Insufficient data|0
3053298|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Insufficient data|0
3053299|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Insufficient data|0
3053300|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Insufficient data|0
3053301|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Insufficient data|0
3053302|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Declined to participate|0
3053303|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Declined to participate|7
3053304|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Declined to participate|0
3053305|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Declined to participate|0
3053306|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Declined to participate|0
3053307|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Declined to participate|0
3053308|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Declined to participate|0
3053309|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Declined to participate|0
3053310|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Declined to participate|0
3053311|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Declined to participate|0
3053312|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Declined to participate|0
3053313|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Declined to participate|0
3053314|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Declined to participate|0
3053315|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Declined to participate|0
3053316|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Declined to participate|0
3053317|NCT00576472|10496293|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
3053318|NCT00576472|10496294|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
3053319|NCT00576472|10496295|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
3053320|NCT00576472|10496296|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
3053321|NCT00576472|10496297|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
3053322|NCT00576472|10496298|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
3053323|NCT00576472|10496299|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
3053324|NCT00576472|10496300|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
3053325|NCT00576472|10496301|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
3053326|NCT00576472|10496302|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
3053327|NCT00576472|10496303|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
3053328|NCT00576472|10496304|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
3053329|NCT00576472|10496305|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
3053330|NCT00576472|10496306|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
3053331|NCT00576472|10496307|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
3053332|NCT00576472|10496293|P15|MPH Cross Over Phase|Did not complete cross over phase|0
3053333|NCT00576472|10496294|P14|MPH Cross Over Phase|Did not complete cross over phase|0
3053334|NCT00576472|10496295|P13|MPH Cross Over Phase|Did not complete cross over phase|0
3053335|NCT00576472|10496296|P12|MPH Cross Over Phase|Did not complete cross over phase|1
3053336|NCT00576472|10496297|P11|MPH Cross Over Phase|Did not complete cross over phase|1
3053337|NCT00576472|10496298|P10|MPH Cross Over Phase|Did not complete cross over phase|0
3053338|NCT00576472|10496299|P9|MPH Cross Over Phase|Did not complete cross over phase|2
3053339|NCT00576472|10496300|P8|MPH Cross Over Phase|Did not complete cross over phase|0
3053340|NCT00576472|10496301|P7|MPH Cross Over Phase|Did not complete cross over phase|0
3053341|NCT00576472|10496302|P6|MPH Cross Over Phase|Did not complete cross over phase|0
3053342|NCT00576472|10496303|P5|MPH Cross Over Phase|Did not complete cross over phase|0
3053343|NCT00576472|10496304|P4|MPH Cross Over Phase|Did not complete cross over phase|0
3053344|NCT00576472|10496305|P3|MPH Cross Over Phase|Did not complete cross over phase|0
3053345|NCT00576472|10496306|P2|MPH Cross Over Phase|Did not complete cross over phase|0
3053346|NCT00576472|10496307|P1|MPH Cross Over Phase|Did not complete cross over phase|0
3053347|NCT00576472|10496293|P15|MPH Cross Over Phase|Physician Decision|0
3053348|NCT00576472|10496294|P14|MPH Cross Over Phase|Physician Decision|0
3053349|NCT00576472|10496295|P13|MPH Cross Over Phase|Physician Decision|0
3053350|NCT00576472|10496296|P12|MPH Cross Over Phase|Physician Decision|0
3053351|NCT00576472|10496297|P11|MPH Cross Over Phase|Physician Decision|0
3053352|NCT00576472|10496298|P10|MPH Cross Over Phase|Physician Decision|0
3053353|NCT00576472|10496299|P9|MPH Cross Over Phase|Physician Decision|0
3053354|NCT00576472|10496300|P8|MPH Cross Over Phase|Physician Decision|0
3053355|NCT00576472|10496301|P7|MPH Cross Over Phase|Physician Decision|4
3053356|NCT00576472|10496302|P6|MPH Cross Over Phase|Physician Decision|0
3053357|NCT00576472|10496303|P5|MPH Cross Over Phase|Physician Decision|0
3053358|NCT00576472|10496304|P4|MPH Cross Over Phase|Physician Decision|0
3053359|NCT00576472|10496305|P3|MPH Cross Over Phase|Physician Decision|0
3053360|NCT00576472|10496306|P2|MPH Cross Over Phase|Physician Decision|0
3053361|NCT00576472|10496307|P1|MPH Cross Over Phase|Physician Decision|0
3053362|NCT00576472|10496293|P15|MPH Cross Over Phase|Ineligible due to disease|0
3053363|NCT00576472|10496294|P14|MPH Cross Over Phase|Ineligible due to disease|0
3053364|NCT00576472|10496295|P13|MPH Cross Over Phase|Ineligible due to disease|0
3053365|NCT00576472|10496296|P12|MPH Cross Over Phase|Ineligible due to disease|0
3053366|NCT00576472|10496297|P11|MPH Cross Over Phase|Ineligible due to disease|0
3053367|NCT00576472|10496298|P10|MPH Cross Over Phase|Ineligible due to disease|0
3053368|NCT00576472|10496299|P9|MPH Cross Over Phase|Ineligible due to disease|0
3053369|NCT00576472|10496300|P8|MPH Cross Over Phase|Ineligible due to disease|0
3053370|NCT00576472|10496301|P7|MPH Cross Over Phase|Ineligible due to disease|2
3053371|NCT00576472|10496302|P6|MPH Cross Over Phase|Ineligible due to disease|0
3053372|NCT00576472|10496303|P5|MPH Cross Over Phase|Ineligible due to disease|0
3053373|NCT00576472|10496304|P4|MPH Cross Over Phase|Ineligible due to disease|0
3053374|NCT00576472|10496305|P3|MPH Cross Over Phase|Ineligible due to disease|0
3053375|NCT00576472|10496306|P2|MPH Cross Over Phase|Ineligible due to disease|0
3053376|NCT00576472|10496307|P1|MPH Cross Over Phase|Ineligible due to disease|0
3053377|NCT00576472|10496293|P15|MPH Cross Over Phase|Withdrawal by Subject|0
3053378|NCT00576472|10496294|P14|MPH Cross Over Phase|Withdrawal by Subject|0
3053379|NCT00576472|10496295|P13|MPH Cross Over Phase|Withdrawal by Subject|0
3053380|NCT00576472|10496296|P12|MPH Cross Over Phase|Withdrawal by Subject|0
3053381|NCT00576472|10496297|P11|MPH Cross Over Phase|Withdrawal by Subject|0
3053382|NCT00576472|10496298|P10|MPH Cross Over Phase|Withdrawal by Subject|0
3053383|NCT00576472|10496299|P9|MPH Cross Over Phase|Withdrawal by Subject|0
3053384|NCT00576472|10496300|P8|MPH Cross Over Phase|Withdrawal by Subject|0
3053385|NCT00576472|10496301|P7|MPH Cross Over Phase|Withdrawal by Subject|6
3053386|NCT00576472|10496302|P6|MPH Cross Over Phase|Withdrawal by Subject|0
3053387|NCT00576472|10496303|P5|MPH Cross Over Phase|Withdrawal by Subject|0
3053388|NCT00576472|10496304|P4|MPH Cross Over Phase|Withdrawal by Subject|0
3053389|NCT00576472|10496305|P3|MPH Cross Over Phase|Withdrawal by Subject|0
3053390|NCT00576472|10496306|P2|MPH Cross Over Phase|Withdrawal by Subject|0
3053391|NCT00576472|10496307|P1|MPH Cross Over Phase|Withdrawal by Subject|0
3053392|NCT00576472|10496293|P15|MPH In-Lab Phase|Psychiatric exclusion|0
3053393|NCT00576472|10496294|P14|MPH In-Lab Phase|Psychiatric exclusion|0
3053394|NCT00576472|10496295|P13|MPH In-Lab Phase|Psychiatric exclusion|0
3053395|NCT00576472|10496296|P12|MPH In-Lab Phase|Psychiatric exclusion|0
3053396|NCT00576472|10496297|P11|MPH In-Lab Phase|Psychiatric exclusion|0
3053397|NCT00576472|10496298|P10|MPH In-Lab Phase|Psychiatric exclusion|0
3053398|NCT00576472|10496299|P9|MPH In-Lab Phase|Psychiatric exclusion|0
3053399|NCT00576472|10496300|P8|MPH In-Lab Phase|Psychiatric exclusion|0
3053400|NCT00576472|10496301|P7|MPH In-Lab Phase|Psychiatric exclusion|0
3053401|NCT00576472|10496302|P6|MPH In-Lab Phase|Psychiatric exclusion|0
3053402|NCT00576472|10496303|P5|MPH In-Lab Phase|Psychiatric exclusion|0
3053403|NCT00576472|10496304|P4|MPH In-Lab Phase|Psychiatric exclusion|10
3053404|NCT00576472|10496305|P3|MPH In-Lab Phase|Psychiatric exclusion|0
3053405|NCT00576472|10496306|P2|MPH In-Lab Phase|Psychiatric exclusion|0
3053406|NCT00576472|10496307|P1|MPH In-Lab Phase|Psychiatric exclusion|0
3053407|NCT00576472|10496293|P15|MPH In-Lab Phase|No attention/academic problems|0
3053408|NCT00576472|10496294|P14|MPH In-Lab Phase|No attention/academic problems|0
3053409|NCT00576472|10496295|P13|MPH In-Lab Phase|No attention/academic problems|0
3053410|NCT00576472|10496296|P12|MPH In-Lab Phase|No attention/academic problems|0
3053411|NCT00576472|10496297|P11|MPH In-Lab Phase|No attention/academic problems|0
3053412|NCT00576472|10496298|P10|MPH In-Lab Phase|No attention/academic problems|0
3053413|NCT00576472|10496299|P9|MPH In-Lab Phase|No attention/academic problems|0
3053414|NCT00576472|10496300|P8|MPH In-Lab Phase|No attention/academic problems|0
3053415|NCT00576472|10496301|P7|MPH In-Lab Phase|No attention/academic problems|0
3053416|NCT00576472|10496302|P6|MPH In-Lab Phase|No attention/academic problems|0
3053417|NCT00576472|10496303|P5|MPH In-Lab Phase|No attention/academic problems|0
3053418|NCT00576472|10496304|P4|MPH In-Lab Phase|No attention/academic problems|245
3053419|NCT00576472|10496305|P3|MPH In-Lab Phase|No attention/academic problems|0
3053420|NCT00576472|10496306|P2|MPH In-Lab Phase|No attention/academic problems|0
3053421|NCT00576472|10496307|P1|MPH In-Lab Phase|No attention/academic problems|0
3053422|NCT00576472|10496293|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053423|NCT00576472|10496294|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053424|NCT00576472|10496295|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053425|NCT00576472|10496296|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053426|NCT00576472|10496297|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053427|NCT00576472|10496298|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053428|NCT00576472|10496299|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053429|NCT00576472|10496300|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053430|NCT00576472|10496301|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053431|NCT00576472|10496302|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053432|NCT00576472|10496303|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053433|NCT00576472|10496304|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
3053434|NCT00576472|10496305|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053435|NCT00576472|10496306|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053436|NCT00576472|10496307|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
3053437|NCT00576472|10496293|P15|MPH In-Lab Phase|Lost to Follow-up|0
3053438|NCT00576472|10496294|P14|MPH In-Lab Phase|Lost to Follow-up|0
3053439|NCT00576472|10496295|P13|MPH In-Lab Phase|Lost to Follow-up|0
3053440|NCT00576472|10496296|P12|MPH In-Lab Phase|Lost to Follow-up|0
3053441|NCT00576472|10496297|P11|MPH In-Lab Phase|Lost to Follow-up|0
3053442|NCT00576472|10496298|P10|MPH In-Lab Phase|Lost to Follow-up|0
3053443|NCT00576472|10496299|P9|MPH In-Lab Phase|Lost to Follow-up|0
3053444|NCT00576472|10496300|P8|MPH In-Lab Phase|Lost to Follow-up|0
3053445|NCT00576472|10496301|P7|MPH In-Lab Phase|Lost to Follow-up|0
3053446|NCT00576472|10496302|P6|MPH In-Lab Phase|Lost to Follow-up|0
3053447|NCT00576472|10496303|P5|MPH In-Lab Phase|Lost to Follow-up|0
3053448|NCT00576472|10496304|P4|MPH In-Lab Phase|Lost to Follow-up|1
3053449|NCT00576472|10496305|P3|MPH In-Lab Phase|Lost to Follow-up|0
3053450|NCT00576472|10496306|P2|MPH In-Lab Phase|Lost to Follow-up|0
3053451|NCT00576472|10496307|P1|MPH In-Lab Phase|Lost to Follow-up|0
3053452|NCT00576472|10496293|P15|MPH In-Lab Phase|Declined participation in medication pha|0
3053453|NCT00576472|10496294|P14|MPH In-Lab Phase|Declined participation in medication pha|0
3053454|NCT00576472|10496295|P13|MPH In-Lab Phase|Declined participation in medication pha|0
3053455|NCT00576472|10496296|P12|MPH In-Lab Phase|Declined participation in medication pha|0
3053456|NCT00576472|10496297|P11|MPH In-Lab Phase|Declined participation in medication pha|0
3053457|NCT00576472|10496298|P10|MPH In-Lab Phase|Declined participation in medication pha|0
3053458|NCT00576472|10496299|P9|MPH In-Lab Phase|Declined participation in medication pha|0
3053459|NCT00576472|10496300|P8|MPH In-Lab Phase|Declined participation in medication pha|0
3053460|NCT00576472|10496301|P7|MPH In-Lab Phase|Declined participation in medication pha|0
3053461|NCT00576472|10496302|P6|MPH In-Lab Phase|Declined participation in medication pha|0
3053462|NCT00576472|10496303|P5|MPH In-Lab Phase|Declined participation in medication pha|0
3053463|NCT00576472|10496304|P4|MPH In-Lab Phase|Declined participation in medication pha|75
3053464|NCT00576472|10496305|P3|MPH In-Lab Phase|Declined participation in medication pha|0
3053465|NCT00576472|10496306|P2|MPH In-Lab Phase|Declined participation in medication pha|0
3053466|NCT00576472|10496307|P1|MPH In-Lab Phase|Declined participation in medication pha|0
3053467|NCT00576420|10496400|P3|Overall Study|Death|1
3053468|NCT00576420|10496401|P2|Overall Study|Death|0
3053469|NCT00576420|10496402|P1|Overall Study|Death|0
3053470|NCT00576407|10496567|P1|Overall Study|Physician Decision|1
3053471|NCT00576407|10496567|P1|Overall Study|Death|7
3053472|NCT00576381|10496579|P1|Overall Study|Adverse Event|4
3053473|NCT00576381|10496579|P1|Overall Study|Reoperation|3
3053474|NCT00576316|10496583|P1|Overall Study|Protocol Violation|9
3053475|NCT00576316|10496583|P1|Overall Study|Withdrawal by Subject|2
3053476|NCT00576316|10496583|P1|Overall Study|Adverse Event|9
3053477|NCT00576303|10496588|P1|Long Term Safety Period|Early withdrawal|16
3053478|NCT00576303|10496588|P1|Efficacy Evaluation Period|Early withdrawal|5
3053479|NCT00576303|10496588|P1|Dose Titration Period|Early withdrawal|17
3053480|NCT00576199|10496606|P1|Overall Study|Reason Unspecified|2
3053481|NCT00576199|10496606|P1|Overall Study|Refused Treatment|2
3053482|NCT00576199|10496606|P1|Overall Study|Insufficient Therapeutic Response|14
3053483|NCT00576199|10496606|P1|Overall Study|Adverse Event|12
3053484|NCT00576056|10496619|P1|Overall Study|Physician Decision|1
3053485|NCT00576056|10496619|P1|Overall Study|did not meet eligibility criteria|8
3053486|NCT00576056|10496619|P1|Overall Study|Withdrawal by Subject|2
3053487|NCT00576056|10496619|P1|Overall Study|Lack of Efficacy|1
3053488|NCT00576056|10496619|P1|Overall Study|Death|1
3053489|NCT00576056|10496619|P1|Overall Study|Adverse Event|1
3053490|NCT00575666|10496635|P2|Overall Study|Physician Decision|1
3053491|NCT00575666|10496636|P1|Overall Study|Physician Decision|1
3053492|NCT00575666|10496635|P2|Overall Study|Withdrawal by Subject|2
3053493|NCT00575666|10496636|P1|Overall Study|Withdrawal by Subject|3
3053494|NCT00575588|10496676|P2|Overall Study|Impossible to determine HbA1c|1
3053495|NCT00575588|10496677|P1|Overall Study|Impossible to determine HbA1c|0
3053496|NCT00575588|10496676|P2|Overall Study|Patient moved|3
3053497|NCT00575588|10496677|P1|Overall Study|Patient moved|1
3053498|NCT00575588|10496676|P2|Overall Study|Elevated triglyceride|0
3053499|NCT00575588|10496677|P1|Overall Study|Elevated triglyceride|1
3053500|NCT00575588|10496676|P2|Overall Study|Safety reasons|1
3053501|NCT00575588|10496677|P1|Overall Study|Safety reasons|2
3053502|NCT00575588|10496676|P2|Overall Study|Severe non-compliance to protocol|7
3053503|NCT00575588|10496677|P1|Overall Study|Severe non-compliance to protocol|5
3053504|NCT00575588|10496676|P2|Overall Study|Study specific discontinuation criteria|218
3053505|NCT00575588|10496677|P1|Overall Study|Study specific discontinuation criteria|203
3053506|NCT00575588|10496676|P2|Overall Study|Incorrect enrollment|4
3053507|NCT00575588|10496677|P1|Overall Study|Incorrect enrollment|8
3053508|NCT00575588|10496676|P2|Overall Study|Death|2
3053509|NCT00575588|10496677|P1|Overall Study|Death|4
3053510|NCT00575588|10496676|P2|Overall Study|Lost to Follow-up|3
3053511|NCT00575588|10496677|P1|Overall Study|Lost to Follow-up|1
3053512|NCT00575588|10496676|P2|Overall Study|Withdrawal by Subject|31
3053513|NCT00575588|10496677|P1|Overall Study|Withdrawal by Subject|27
3053514|NCT00575588|10496676|P2|Overall Study|Adverse Event|13
3053515|NCT00575588|10496677|P1|Overall Study|Adverse Event|11
3053516|NCT00575510|10496700|P3|Overall Study|Pregnancy|1
3053517|NCT00575510|10496701|P2|Overall Study|Pregnancy|0
3053518|NCT00575510|10496702|P1|Overall Study|Pregnancy|0
3053519|NCT00575510|10496700|P3|Overall Study|Clinic Called Patient|7
3053520|NCT00575510|10496701|P2|Overall Study|Clinic Called Patient|7
3053521|NCT00575510|10496702|P1|Overall Study|Clinic Called Patient|7
3053522|NCT00575510|10496700|P3|Overall Study|Withdrawal by Subject|0
3053523|NCT00575510|10496701|P2|Overall Study|Withdrawal by Subject|0
3053524|NCT00575510|10496702|P1|Overall Study|Withdrawal by Subject|1
3053525|NCT00575510|10496700|P3|Overall Study|Lost to Follow-up|9
3053526|NCT00575510|10496701|P2|Overall Study|Lost to Follow-up|6
3053527|NCT00575510|10496702|P1|Overall Study|Lost to Follow-up|4
3053528|NCT00575380|10496715|P2|Overall Study|Various|2
3053529|NCT00575380|10496716|P1|Overall Study|Various|0
3053530|NCT00575380|10496715|P2|Overall Study|Adverse Event|1
3053531|NCT00575380|10496716|P1|Overall Study|Adverse Event|0
3053532|NCT00575380|10496715|P2|Overall Study|Withdrawal by Subject|0
3053533|NCT00575380|10496716|P1|Overall Study|Withdrawal by Subject|1
3053534|NCT00575094|10496858|P1|Overall Study|Withdrawal by Subject|1
3053535|NCT00575094|10496858|P1|Overall Study|Adverse Event|2
3053536|NCT00575042|10496862|P1|Overall Study|Lost to Follow-up|1
3053537|NCT00575042|10496862|P1|Overall Study|Adverse Event|2
3053538|NCT00574951|10496913|P1|Overall Study|Ineligible - improper prior treatment|1
3053539|NCT00574912|10496921|P1|Overall Study|Physician Decision|2
3053540|NCT00574912|10496921|P1|Overall Study|scheduling conflicts|3
3053541|NCT00574912|10496921|P1|Overall Study|Could not place IV lines.|3
3053542|NCT00574873|10496935|P2|Overall Study|Extension Study|0
3053543|NCT00574873|10496936|P1|Overall Study|Extension Study|126
3053544|NCT00574873|10496935|P2|Overall Study|Blank, site closed per local regulations|2
3053545|NCT00574873|10496936|P1|Overall Study|Blank, site closed per local regulations|2
3053546|NCT00574873|10496935|P2|Overall Study|Discontinuation of study by sponsor|199
3053547|NCT00574873|10496936|P1|Overall Study|Discontinuation of study by sponsor|5
3053548|NCT00574873|10496935|P2|Overall Study|Other|4
3053549|NCT00574873|10496936|P1|Overall Study|Other|40
3053550|NCT00574873|10496935|P2|Overall Study|Lost to Follow-up|5
3053551|NCT00574873|10496936|P1|Overall Study|Lost to Follow-up|14
3053552|NCT00574873|10496935|P2|Overall Study|Death|14
3053553|NCT00574873|10496936|P1|Overall Study|Death|15
3053554|NCT00574873|10496935|P2|Overall Study|Investigator request|8
3053555|NCT00574873|10496936|P1|Overall Study|Investigator request|18
3053556|NCT00574873|10496935|P2|Overall Study|Withdrawal by Subject|19
3053557|NCT00574873|10496936|P1|Overall Study|Withdrawal by Subject|18
3053558|NCT00574847|10496954|P2|Overall Study|Did not receive medication (declined)|5
3053559|NCT00574847|10496955|P1|Overall Study|Did not receive medication (declined)|2
3053560|NCT00574847|10496954|P2|Overall Study|Physician Decision|0
3053561|NCT00574847|10496955|P1|Overall Study|Physician Decision|1
3053562|NCT00574847|10496954|P2|Overall Study|Withdrawal by Subject|2
3053563|NCT00574847|10496955|P1|Overall Study|Withdrawal by Subject|2
3053564|NCT00574847|10496954|P2|Overall Study|Death|0
3053565|NCT00574847|10496955|P1|Overall Study|Death|1
3053566|NCT00574847|10496954|P2|Overall Study|Adverse Event|0
3053567|NCT00574847|10496955|P1|Overall Study|Adverse Event|2
3053568|NCT00574795|10497000|P1|Toddler Dose|Withdrawal by Subject|1
3053569|NCT00574795|10497000|P1|After Infant Series|Adverse Event|2
3053570|NCT00574795|10497000|P1|After Infant Series|Withdrawal by Subject|1
3053571|NCT00574795|10497000|P1|Infant Series|Adverse Event|1
3053572|NCT00574795|10497000|P1|Infant Series|Protocol Violation|2
3053573|NCT00574795|10497000|P1|Infant Series|Withdrawal by Subject|2
3053574|NCT00574405|10497083|P2|Overall Study|Withdrawal by Subject|2
3053575|NCT00574405|10497084|P1|Overall Study|Withdrawal by Subject|3
3053576|NCT00574288|10497104|P7|Overall Study|Other|0
3053577|NCT00574288|10497105|P6|Overall Study|Other|0
3053578|NCT00574288|10497106|P5|Overall Study|Other|0
3053579|NCT00574288|10497107|P4|Overall Study|Other|0
3053580|NCT00574288|10497108|P3|Overall Study|Other|0
3053581|NCT00574288|10497109|P2|Overall Study|Other|1
3053582|NCT00574288|10497110|P1|Overall Study|Other|1
3053583|NCT00574288|10497104|P7|Overall Study|Progressive Disease|0
3053584|NCT00574288|10497105|P6|Overall Study|Progressive Disease|0
3053585|NCT00574288|10497106|P5|Overall Study|Progressive Disease|1
3053586|NCT00574288|10497107|P4|Overall Study|Progressive Disease|2
3053587|NCT00574288|10497108|P3|Overall Study|Progressive Disease|3
3053588|NCT00574288|10497109|P2|Overall Study|Progressive Disease|2
3053589|NCT00574288|10497110|P1|Overall Study|Progressive Disease|17
3053590|NCT00574288|10497104|P7|Overall Study|Study Terminated By Sponsor|5
3053591|NCT00574288|10497105|P6|Overall Study|Study Terminated By Sponsor|0
3053592|NCT00574288|10497106|P5|Overall Study|Study Terminated By Sponsor|0
3053593|NCT00574288|10497107|P4|Overall Study|Study Terminated By Sponsor|0
3053594|NCT00574288|10497108|P3|Overall Study|Study Terminated By Sponsor|0
3053595|NCT00574288|10497109|P2|Overall Study|Study Terminated By Sponsor|0
3053596|NCT00574288|10497110|P1|Overall Study|Study Terminated By Sponsor|0
3053597|NCT00574288|10497104|P7|Overall Study|Lost to Follow-up|2
3053598|NCT00574288|10497105|P6|Overall Study|Lost to Follow-up|1
3053599|NCT00574288|10497106|P5|Overall Study|Lost to Follow-up|0
3053600|NCT00574288|10497107|P4|Overall Study|Lost to Follow-up|0
3053601|NCT00574288|10497108|P3|Overall Study|Lost to Follow-up|0
3053602|NCT00574288|10497109|P2|Overall Study|Lost to Follow-up|0
3053603|NCT00574288|10497110|P1|Overall Study|Lost to Follow-up|0
3053604|NCT00574288|10497104|P7|Overall Study|Death|21
3053605|NCT00574288|10497105|P6|Overall Study|Death|25
3053606|NCT00574288|10497106|P5|Overall Study|Death|0
3053607|NCT00574288|10497107|P4|Overall Study|Death|0
3053608|NCT00574288|10497108|P3|Overall Study|Death|0
3053609|NCT00574288|10497109|P2|Overall Study|Death|0
3053610|NCT00574288|10497110|P1|Overall Study|Death|0
3053611|NCT00574288|10497104|P7|Overall Study|Adverse Event|0
3053612|NCT00574288|10497105|P6|Overall Study|Adverse Event|0
3053613|NCT00574288|10497106|P5|Overall Study|Adverse Event|1
3053614|NCT00574288|10497107|P4|Overall Study|Adverse Event|0
3053615|NCT00574288|10497108|P3|Overall Study|Adverse Event|0
3053616|NCT00574288|10497109|P2|Overall Study|Adverse Event|0
3053617|NCT00574288|10497110|P1|Overall Study|Adverse Event|2
3053618|NCT00574275|10497148|P2|Overall Study|Operation for curative intent|1
3053619|NCT00574275|10497149|P1|Overall Study|Operation for curative intent|0
3053620|NCT00574275|10497148|P2|Overall Study|Insurance change|1
3053621|NCT00574275|10497149|P1|Overall Study|Insurance change|0
3053622|NCT00574275|10497148|P2|Overall Study|Patient and Investigator decision|1
3053623|NCT00574275|10497149|P1|Overall Study|Patient and Investigator decision|0
3053624|NCT00574275|10497148|P2|Overall Study|Protocol Violation|1
3053625|NCT00574275|10497149|P1|Overall Study|Protocol Violation|0
3053626|NCT00574275|10497148|P2|Overall Study|Physician Decision|1
3053627|NCT00574275|10497149|P1|Overall Study|Physician Decision|1
3053628|NCT00574275|10497148|P2|Overall Study|Error calculating tumor measurement|0
3053629|NCT00574275|10497149|P1|Overall Study|Error calculating tumor measurement|1
3053630|NCT00574275|10497148|P2|Overall Study|Withdrawal by Subject|17
3053631|NCT00574275|10497149|P1|Overall Study|Withdrawal by Subject|15
3053632|NCT00574275|10497148|P2|Overall Study|Study stopped based on DMC decision|23
3053633|NCT00574275|10497149|P1|Overall Study|Study stopped based on DMC decision|62
3053634|NCT00574275|10497148|P2|Overall Study|Lost to Follow-up|1
3053635|NCT00574275|10497149|P1|Overall Study|Lost to Follow-up|2
3053636|NCT00574275|10497148|P2|Overall Study|Disease progression|146
3053637|NCT00574275|10497149|P1|Overall Study|Disease progression|160
3053638|NCT00574275|10497148|P2|Overall Study|Adverse Event|76
3053639|NCT00574275|10497149|P1|Overall Study|Adverse Event|32
3053640|NCT00574275|10497148|P2|Overall Study|Randomized but not treated|3
3053641|NCT00574275|10497149|P1|Overall Study|Randomized but not treated|2
3053642|NCT00574249|10497167|P2|Overall Study|PPD test taken twice|1
3053643|NCT00574249|10497168|P1|Overall Study|PPD test taken twice|0
3053644|NCT00574249|10497167|P2|Overall Study|Excluded by company|1
3053645|NCT00574249|10497168|P1|Overall Study|Excluded by company|0
3053646|NCT00574249|10497167|P2|Overall Study|Pregnancy|0
3053647|NCT00574249|10497168|P1|Overall Study|Pregnancy|1
3053648|NCT00574249|10497167|P2|Overall Study|Physician Decision|0
3053649|NCT00574249|10497168|P1|Overall Study|Physician Decision|1
3053650|NCT00574249|10497167|P2|Overall Study|Withdrawal by Subject|0
3053651|NCT00574249|10497168|P1|Overall Study|Withdrawal by Subject|3
3053652|NCT00574249|10497167|P2|Overall Study|History of carcinoma|0
3053653|NCT00574249|10497168|P1|Overall Study|History of carcinoma|1
3053654|NCT00574249|10497167|P2|Overall Study|Protocol Violation|2
3053655|NCT00574249|10497168|P1|Overall Study|Protocol Violation|5
3053656|NCT00574249|10497167|P2|Overall Study|Lost to Follow-up|3
3053657|NCT00574249|10497168|P1|Overall Study|Lost to Follow-up|4
3053658|NCT00574249|10497167|P2|Overall Study|Lack of Efficacy|3
3053659|NCT00574249|10497168|P1|Overall Study|Lack of Efficacy|5
3053660|NCT00574249|10497167|P2|Overall Study|Adverse Event|18
3053661|NCT00574249|10497168|P1|Overall Study|Adverse Event|6
3053662|NCT00574145|10497219|P2|Overall Study|Withdrawal by Subject|1
3053663|NCT00574145|10497220|P1|Overall Study|Withdrawal by Subject|2
3053664|NCT00574119|10497230|P1|Overall Study|Physician Decision|1
3053665|NCT00574119|10497230|P1|Overall Study|Withdrawal by Subject|1
3053666|NCT00574119|10497230|P1|Overall Study|Protocol Violation|1
3053667|NCT00574119|10497230|P1|Overall Study|Adverse Event|1
3053668|NCT00574080|10497244|P2|Overall Study|Death|10
3053669|NCT00574080|10497245|P1|Overall Study|Death|10
3053670|NCT00573937|10497314|P2|Overall Study|Study Terminated|1
3053671|NCT00573937|10497315|P1|Overall Study|Study Terminated|0
3053672|NCT00573859|10497329|P1|Smoking Versus Abstinence|Scheduling conflicts|12
3053673|NCT00573859|10497329|P1|Medication Versus Placebo|Scheduling conflicts|12
3053674|NCT00573833|10497335|P1|Overall Study|Not Treated|2
3053675|NCT00573794|10497342|P1|Overall Study|Other|46
3053676|NCT00573794|10497342|P1|Overall Study|Lack of Efficacy|94
3053677|NCT00573794|10497342|P1|Overall Study|Protocol Violation|6
3053678|NCT00573794|10497342|P1|Overall Study|Lost to Follow-up|13
3053679|NCT00573794|10497342|P1|Overall Study|Withdrew Consent|90
3053680|NCT00573794|10497342|P1|Overall Study|Adverse Event|81
3053681|NCT00573768|10497373|P3|Overall Study|Lost to Follow-up|1
3053682|NCT00573768|10497374|P2|Overall Study|Lost to Follow-up|0
3053683|NCT00573768|10497375|P1|Overall Study|Lost to Follow-up|0
3053684|NCT00573768|10497373|P3|Overall Study|Withdrawal by Subject|0
3053685|NCT00573768|10497374|P2|Overall Study|Withdrawal by Subject|1
3053686|NCT00573768|10497375|P1|Overall Study|Withdrawal by Subject|0
3053687|NCT00573768|10497373|P3|Overall Study|Protocol Violation|1
3053688|NCT00573768|10497374|P2|Overall Study|Protocol Violation|0
3053689|NCT00573768|10497375|P1|Overall Study|Protocol Violation|1
3053690|NCT00573768|10497373|P3|Overall Study|Adverse Event|2
3053691|NCT00573768|10497374|P2|Overall Study|Adverse Event|1
3053692|NCT00573768|10497375|P1|Overall Study|Adverse Event|1
3053693|NCT00573755|10497385|P2|Overall Study|Still receiving treatment|0
3053694|NCT00573755|10497386|P1|Overall Study|Still receiving treatment|1
3053695|NCT00573534|10497402|P1|Overall Study|oppositional behavior|3
3053696|NCT00573469|10497443|P3|Overall Study|Other|3
3053697|NCT00573469|10497444|P2|Overall Study|Other|1
3053698|NCT00573469|10497445|P1|Overall Study|Other|5
3053699|NCT00573469|10497443|P3|Overall Study|Withdrawal by Subject|0
3053700|NCT00573469|10497444|P2|Overall Study|Withdrawal by Subject|2
3053701|NCT00573469|10497445|P1|Overall Study|Withdrawal by Subject|0
3053702|NCT00573469|10497443|P3|Overall Study|Adverse Event|1
3053703|NCT00573469|10497444|P2|Overall Study|Adverse Event|1
3053704|NCT00573469|10497445|P1|Overall Study|Adverse Event|1
3053705|NCT00573443|10497468|P3|Open-Label Extension Phase|Other|0
3053706|NCT00573443|10497469|P2|Open-Label Extension Phase|Other|0
3053707|NCT00573443|10497470|P1|Open-Label Extension Phase|Other|2
3053708|NCT00573443|10497468|P3|Open-Label Extension Phase|Protocol Violation|0
3053709|NCT00573443|10497469|P2|Open-Label Extension Phase|Protocol Violation|0
3053710|NCT00573443|10497470|P1|Open-Label Extension Phase|Protocol Violation|2
3053711|NCT00573443|10497468|P3|Open-Label Extension Phase|Withdrawal by Subject|0
3053712|NCT00573443|10497469|P2|Open-Label Extension Phase|Withdrawal by Subject|0
3053713|NCT00573443|10497470|P1|Open-Label Extension Phase|Withdrawal by Subject|3
3053714|NCT00573443|10497468|P3|Open-Label Extension Phase|Serious Adverse Event|0
3053715|NCT00573443|10497469|P2|Open-Label Extension Phase|Serious Adverse Event|0
3053716|NCT00573443|10497470|P1|Open-Label Extension Phase|Serious Adverse Event|5
3053717|NCT00573443|10497468|P3|Open-Label Extension Phase|Adverse Event|0
3053718|NCT00573443|10497469|P2|Open-Label Extension Phase|Adverse Event|0
3053719|NCT00573443|10497470|P1|Open-Label Extension Phase|Adverse Event|3
3053720|NCT00573443|10497468|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
3053721|NCT00573443|10497469|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
3053722|NCT00573443|10497470|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
3053723|NCT00573443|10497468|P3|Open-Label Extension Phase|Lost to Follow-up|0
3053724|NCT00573443|10497469|P2|Open-Label Extension Phase|Lost to Follow-up|0
3053725|NCT00573443|10497470|P1|Open-Label Extension Phase|Lost to Follow-up|1
3053726|NCT00573443|10497468|P3|Double-Blind Phase|Other|3
3053727|NCT00573443|10497469|P2|Double-Blind Phase|Other|2
3053728|NCT00573443|10497470|P1|Double-Blind Phase|Other|0
3053729|NCT00573443|10497468|P3|Double-Blind Phase|Protocol Violation|1
3053730|NCT00573443|10497469|P2|Double-Blind Phase|Protocol Violation|2
3053731|NCT00573443|10497470|P1|Double-Blind Phase|Protocol Violation|0
3053732|NCT00573443|10497468|P3|Double-Blind Phase|Withdrawal by Subject|7
3053733|NCT00573443|10497469|P2|Double-Blind Phase|Withdrawal by Subject|2
3053734|NCT00573443|10497470|P1|Double-Blind Phase|Withdrawal by Subject|2
3053735|NCT00573443|10497468|P3|Double-Blind Phase|Medication refusal due to AE|0
3053736|NCT00573443|10497469|P2|Double-Blind Phase|Medication refusal due to AE|2
3053737|NCT00573443|10497470|P1|Double-Blind Phase|Medication refusal due to AE|2
3053738|NCT00573443|10497468|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
3053739|NCT00573443|10497469|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
3053740|NCT00573443|10497470|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
3053741|NCT00573443|10497468|P3|Double-Blind Phase|Adverse Event|0
3053742|NCT00573443|10497469|P2|Double-Blind Phase|Adverse Event|5
3053743|NCT00573443|10497470|P1|Double-Blind Phase|Adverse Event|1
3053744|NCT00573443|10497468|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
3053745|NCT00573443|10497469|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
3053746|NCT00573443|10497470|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
3053747|NCT00573443|10497468|P3|Double-Blind Phase|Lost to Follow-up|2
3053748|NCT00573443|10497469|P2|Double-Blind Phase|Lost to Follow-up|3
3053749|NCT00573443|10497470|P1|Double-Blind Phase|Lost to Follow-up|1
3053750|NCT00573430|10497500|P3|Overall Study|Eligibility criteria not fulfilled|3
3053751|NCT00573430|10497501|P2|Overall Study|Eligibility criteria not fulfilled|0
3053752|NCT00573430|10497502|P1|Overall Study|Eligibility criteria not fulfilled|0
3053753|NCT00573430|10497500|P3|Overall Study|Protocol Violation|1
3053754|NCT00573430|10497501|P2|Overall Study|Protocol Violation|1
3053755|NCT00573430|10497502|P1|Overall Study|Protocol Violation|0
3053756|NCT00573430|10497500|P3|Overall Study|Withdrawal by Subject|1
3053757|NCT00573430|10497501|P2|Overall Study|Withdrawal by Subject|0
3053758|NCT00573430|10497502|P1|Overall Study|Withdrawal by Subject|1
3053759|NCT00573430|10497500|P3|Overall Study|Adverse Event|2
3053760|NCT00573430|10497501|P2|Overall Study|Adverse Event|0
3053761|NCT00573430|10497502|P1|Overall Study|Adverse Event|0
3053762|NCT00573430|10497500|P3|Overall Study|Incorrect enrollment of randomization|3
3053763|NCT00573430|10497501|P2|Overall Study|Incorrect enrollment of randomization|4
3053764|NCT00573430|10497502|P1|Overall Study|Incorrect enrollment of randomization|0
3053765|NCT00573391|10497524|P2|Overall Study|Death|0
3053766|NCT00573391|10497525|P1|Overall Study|Death|1
3053767|NCT00573391|10497524|P2|Overall Study|study stopped|2
3053768|NCT00573391|10497525|P1|Overall Study|study stopped|2
3053769|NCT00573313|10497535|P4|Overall Study|Protocol Violation|0
3053770|NCT00573313|10497536|P3|Overall Study|Protocol Violation|6
3053771|NCT00573313|10497537|P2|Overall Study|Protocol Violation|0
3053772|NCT00573313|10497538|P1|Overall Study|Protocol Violation|5
3053773|NCT00573248|10497588|P2|Overall Study|scheduling conflicts|11
3053774|NCT00573248|10497589|P1|Overall Study|scheduling conflicts|15
3053775|NCT00573183|10497603|P2|Overall Study|Other|2
3053776|NCT00573183|10497604|P1|Overall Study|Other|5
3053777|NCT00573183|10497603|P2|Overall Study|Incarceration|8
3053778|NCT00573183|10497604|P1|Overall Study|Incarceration|5
3053779|NCT00573183|10497603|P2|Overall Study|Adverse Event|0
3053780|NCT00573183|10497604|P1|Overall Study|Adverse Event|2
3053781|NCT00573183|10497603|P2|Overall Study|Death|1
3053782|NCT00573183|10497604|P1|Overall Study|Death|0
3053783|NCT00573183|10497603|P2|Overall Study|Withdrawal by Subject|2
3053784|NCT00573183|10497604|P1|Overall Study|Withdrawal by Subject|8
3053785|NCT00573183|10497603|P2|Overall Study|Lost to Follow-up|50
3053786|NCT00573183|10497604|P1|Overall Study|Lost to Follow-up|52
3053787|NCT00573170|10497612|P6|Third Treatment Period|Lost to Follow-up|2
3053788|NCT00573170|10497613|P5|Third Treatment Period|Lost to Follow-up|0
3053789|NCT00573170|10497614|P4|Third Treatment Period|Lost to Follow-up|0
3053790|NCT00573170|10497615|P3|Third Treatment Period|Lost to Follow-up|0
3053791|NCT00573170|10497616|P2|Third Treatment Period|Lost to Follow-up|0
3053792|NCT00573170|10497617|P1|Third Treatment Period|Lost to Follow-up|0
3053793|NCT00573170|10497612|P6|Third Treatment Period|Withdrawal by Subject|0
3053794|NCT00573170|10497613|P5|Third Treatment Period|Withdrawal by Subject|0
3053795|NCT00573170|10497614|P4|Third Treatment Period|Withdrawal by Subject|0
3053796|NCT00573170|10497615|P3|Third Treatment Period|Withdrawal by Subject|0
3053797|NCT00573170|10497616|P2|Third Treatment Period|Withdrawal by Subject|0
3053798|NCT00573170|10497617|P1|Third Treatment Period|Withdrawal by Subject|1
3053799|NCT00573170|10497612|P6|Second Washout Period|Other|2
3053800|NCT00573170|10497613|P5|Second Washout Period|Other|6
3053801|NCT00573170|10497614|P4|Second Washout Period|Other|4
3053802|NCT00573170|10497615|P3|Second Washout Period|Other|1
3053803|NCT00573170|10497616|P2|Second Washout Period|Other|2
3053804|NCT00573170|10497617|P1|Second Washout Period|Other|1
3053805|NCT00573170|10497612|P6|Second Washout Period|Lost to Follow-up|0
3053806|NCT00573170|10497613|P5|Second Washout Period|Lost to Follow-up|0
3053807|NCT00573170|10497614|P4|Second Washout Period|Lost to Follow-up|1
3053808|NCT00573170|10497615|P3|Second Washout Period|Lost to Follow-up|0
3053809|NCT00573170|10497616|P2|Second Washout Period|Lost to Follow-up|0
3053810|NCT00573170|10497617|P1|Second Washout Period|Lost to Follow-up|0
3053811|NCT00573170|10497612|P6|Second Washout Period|Withdrawal by Subject|0
3053812|NCT00573170|10497613|P5|Second Washout Period|Withdrawal by Subject|1
3053813|NCT00573170|10497614|P4|Second Washout Period|Withdrawal by Subject|0
3053814|NCT00573170|10497615|P3|Second Washout Period|Withdrawal by Subject|2
3053815|NCT00573170|10497616|P2|Second Washout Period|Withdrawal by Subject|1
3053816|NCT00573170|10497617|P1|Second Washout Period|Withdrawal by Subject|1
3053817|NCT00573170|10497612|P6|Second Washout Period|Protocol Violation|0
3053818|NCT00573170|10497613|P5|Second Washout Period|Protocol Violation|0
3053819|NCT00573170|10497614|P4|Second Washout Period|Protocol Violation|0
3053820|NCT00573170|10497615|P3|Second Washout Period|Protocol Violation|1
3053821|NCT00573170|10497616|P2|Second Washout Period|Protocol Violation|1
3053822|NCT00573170|10497617|P1|Second Washout Period|Protocol Violation|2
3053823|NCT00573170|10497612|P6|Second Washout Period|Adverse Event|0
3053824|NCT00573170|10497613|P5|Second Washout Period|Adverse Event|1
3053825|NCT00573170|10497614|P4|Second Washout Period|Adverse Event|0
3053826|NCT00573170|10497615|P3|Second Washout Period|Adverse Event|0
3053827|NCT00573170|10497616|P2|Second Washout Period|Adverse Event|0
3053828|NCT00573170|10497617|P1|Second Washout Period|Adverse Event|1
3053829|NCT00573170|10497612|P6|First Washout Period|Other|0
3053830|NCT00573170|10497613|P5|First Washout Period|Other|0
3053831|NCT00573170|10497614|P4|First Washout Period|Other|1
3053832|NCT00573170|10497615|P3|First Washout Period|Other|1
3053833|NCT00573170|10497616|P2|First Washout Period|Other|0
3053834|NCT00573170|10497617|P1|First Washout Period|Other|4
3053835|NCT00573170|10497612|P6|First Washout Period|Withdrawal by Subject|3
3053836|NCT00573170|10497613|P5|First Washout Period|Withdrawal by Subject|3
3053837|NCT00573170|10497614|P4|First Washout Period|Withdrawal by Subject|2
3053838|NCT00573170|10497615|P3|First Washout Period|Withdrawal by Subject|0
3053839|NCT00573170|10497616|P2|First Washout Period|Withdrawal by Subject|0
3053840|NCT00573170|10497617|P1|First Washout Period|Withdrawal by Subject|2
3053841|NCT00573170|10497612|P6|First Washout Period|Lost to Follow-up|2
3053842|NCT00573170|10497613|P5|First Washout Period|Lost to Follow-up|0
3053843|NCT00573170|10497614|P4|First Washout Period|Lost to Follow-up|2
3053844|NCT00573170|10497615|P3|First Washout Period|Lost to Follow-up|0
3053845|NCT00573170|10497616|P2|First Washout Period|Lost to Follow-up|1
3053846|NCT00573170|10497617|P1|First Washout Period|Lost to Follow-up|1
3053847|NCT00573170|10497612|P6|First Washout Period|Lack of Efficacy|1
3053848|NCT00573170|10497613|P5|First Washout Period|Lack of Efficacy|0
3053849|NCT00573170|10497614|P4|First Washout Period|Lack of Efficacy|0
3053850|NCT00573170|10497615|P3|First Washout Period|Lack of Efficacy|0
3053851|NCT00573170|10497616|P2|First Washout Period|Lack of Efficacy|0
3053852|NCT00573170|10497617|P1|First Washout Period|Lack of Efficacy|0
3053853|NCT00573170|10497612|P6|First Washout Period|Adverse Event|1
3053854|NCT00573170|10497613|P5|First Washout Period|Adverse Event|0
3053855|NCT00573170|10497614|P4|First Washout Period|Adverse Event|0
3053856|NCT00573170|10497615|P3|First Washout Period|Adverse Event|0
3053857|NCT00573170|10497616|P2|First Washout Period|Adverse Event|1
3053858|NCT00573170|10497617|P1|First Washout Period|Adverse Event|1
3053859|NCT00573170|10497612|P6|First Treatment Period|Did Not Treat Attack 1|0
3053860|NCT00573170|10497613|P5|First Treatment Period|Did Not Treat Attack 1|1
3053861|NCT00573170|10497614|P4|First Treatment Period|Did Not Treat Attack 1|0
3053862|NCT00573170|10497615|P3|First Treatment Period|Did Not Treat Attack 1|0
3053863|NCT00573170|10497616|P2|First Treatment Period|Did Not Treat Attack 1|0
3053864|NCT00573170|10497617|P1|First Treatment Period|Did Not Treat Attack 1|0
3053865|NCT00573157|10497693|P2|Overall Study|Other|1
3053866|NCT00573157|10497694|P1|Overall Study|Other|1
3053867|NCT00573157|10497693|P2|Overall Study|Adverse Event|1
3053868|NCT00573157|10497694|P1|Overall Study|Adverse Event|3
3053869|NCT00573144|10497706|P2|Overall Study|Withdrawal by Subject|3
3053870|NCT00573144|10497707|P1|Overall Study|Withdrawal by Subject|2
3053871|NCT00573131|10497719|P2|Overall Study|Withdrawal by Subject|8
3053872|NCT00573131|10497720|P1|Overall Study|Withdrawal by Subject|10
3053873|NCT00573066|10497726|P1|Overall Study|Postoperative bleeding|1
3053874|NCT00573066|10497726|P1|Overall Study|IV malfunction|1
3053875|NCT00573066|10497726|P1|Overall Study|Exclusion criteria|18
3053876|NCT00572910|10497770|P11|Overall Study|Withdrawal by Subject|1
3053877|NCT00572910|10497771|P10|Overall Study|Withdrawal by Subject|2
3053878|NCT00572910|10497772|P9|Overall Study|Withdrawal by Subject|2
3053879|NCT00572910|10497773|P8|Overall Study|Withdrawal by Subject|2
3053880|NCT00572910|10497774|P7|Overall Study|Withdrawal by Subject|0
3053881|NCT00572910|10497775|P6|Overall Study|Withdrawal by Subject|3
3053882|NCT00572910|10497776|P5|Overall Study|Withdrawal by Subject|1
3053883|NCT00572910|10497777|P4|Overall Study|Withdrawal by Subject|0
3053884|NCT00572910|10497778|P3|Overall Study|Withdrawal by Subject|1
3053885|NCT00572910|10497779|P2|Overall Study|Withdrawal by Subject|0
3053886|NCT00572910|10497780|P1|Overall Study|Withdrawal by Subject|3
3053887|NCT00572910|10497770|P11|Overall Study|Lost to Follow-up|0
3053888|NCT00572910|10497771|P10|Overall Study|Lost to Follow-up|1
3053889|NCT00572910|10497772|P9|Overall Study|Lost to Follow-up|0
3053890|NCT00572910|10497773|P8|Overall Study|Lost to Follow-up|0
3053891|NCT00572910|10497774|P7|Overall Study|Lost to Follow-up|0
3053892|NCT00572910|10497775|P6|Overall Study|Lost to Follow-up|0
3053893|NCT00572910|10497776|P5|Overall Study|Lost to Follow-up|1
3053894|NCT00572910|10497777|P4|Overall Study|Lost to Follow-up|2
3053895|NCT00572910|10497778|P3|Overall Study|Lost to Follow-up|1
3053896|NCT00572910|10497779|P2|Overall Study|Lost to Follow-up|1
3053897|NCT00572910|10497780|P1|Overall Study|Lost to Follow-up|0
3053898|NCT00572910|10497770|P11|Overall Study|Adverse Event|2
3053899|NCT00572910|10497771|P10|Overall Study|Adverse Event|3
3053900|NCT00572910|10497772|P9|Overall Study|Adverse Event|1
3053901|NCT00572910|10497773|P8|Overall Study|Adverse Event|2
3053902|NCT00572910|10497774|P7|Overall Study|Adverse Event|4
3053903|NCT00572910|10497775|P6|Overall Study|Adverse Event|0
3053904|NCT00572910|10497776|P5|Overall Study|Adverse Event|0
3053905|NCT00572910|10497777|P4|Overall Study|Adverse Event|2
3053906|NCT00572910|10497778|P3|Overall Study|Adverse Event|0
3053907|NCT00572910|10497779|P2|Overall Study|Adverse Event|2
3053908|NCT00572910|10497780|P1|Overall Study|Adverse Event|1
3053909|NCT00572832|10497847|P2|Overall Study|Pregnancy|1
3053910|NCT00572832|10497848|P1|Overall Study|Pregnancy|0
3053911|NCT00572832|10497847|P2|Overall Study|Lost to Follow-up|11
3053912|NCT00572832|10497848|P1|Overall Study|Lost to Follow-up|0
3053913|NCT00572728|10497854|P1|Overall Study|Pathology missing|1
3053914|NCT00572728|10497854|P1|Overall Study|FLT2 after second chemotherapy initiated|7
3053915|NCT00572728|10497854|P1|Overall Study|Second chemotherapy not initiated|1
3053916|NCT00572728|10497854|P1|Overall Study|FLT2 not completed|5
3053917|NCT00572728|10497854|P1|Overall Study|First Chemotherapy not initiated|2
3053918|NCT00572728|10497854|P1|Overall Study|FLT1 not completed|4
3053919|NCT00572728|10497854|P1|Overall Study|Offstudy due to complicating disease|1
3053920|NCT00572728|10497854|P1|Overall Study|Enrolled under Amendment 4|5
3053921|NCT00572728|10497854|P1|Overall Study|Ineligible|3
3053922|NCT00572728|10497854|P1|Overall Study|Withdrawal by Subject|10
3053923|NCT00572624|10497868|P2|Overall Study|Health issues unrelated to the study|0
3053924|NCT00572624|10497869|P1|Overall Study|Health issues unrelated to the study|1
3053925|NCT00572624|10497868|P2|Overall Study|Problem with vascular access|0
3053926|NCT00572624|10497869|P1|Overall Study|Problem with vascular access|1
3053927|NCT00572624|10497868|P2|Overall Study|Refused to do the stress test|0
3053928|NCT00572624|10497869|P1|Overall Study|Refused to do the stress test|1
3053929|NCT00572624|10497868|P2|Overall Study|Admitted to being a smoker|0
3053930|NCT00572624|10497869|P1|Overall Study|Admitted to being a smoker|1
3053931|NCT00572624|10497868|P2|Overall Study|Started a new job-- no time for study|0
3053932|NCT00572624|10497869|P1|Overall Study|Started a new job-- no time for study|1
3053933|NCT00572624|10497868|P2|Overall Study|Medication change|0
3053934|NCT00572624|10497869|P1|Overall Study|Medication change|1
3053935|NCT00572624|10497868|P2|Overall Study|Wanted to do a different diet program|0
3053936|NCT00572624|10497869|P1|Overall Study|Wanted to do a different diet program|1
3053937|NCT00572624|10497868|P2|Overall Study|Lost to Follow-up|4
3053938|NCT00572624|10497869|P1|Overall Study|Lost to Follow-up|10
3053939|NCT00572572|10497897|P2|Overall Study|Withdrawal by Subject|6
3053940|NCT00572572|10497898|P1|Overall Study|Withdrawal by Subject|3
3053941|NCT00572533|10497916|P2|Overall Study|Transfer out of Facility|1
3053942|NCT00572533|10497917|P1|Overall Study|Transfer out of Facility|0
3053943|NCT00572533|10497916|P2|Overall Study|Social Issues|0
3053944|NCT00572533|10497917|P1|Overall Study|Social Issues|1
3053945|NCT00572533|10497916|P2|Overall Study|Received Kidney Transplant|1
3053946|NCT00572533|10497917|P1|Overall Study|Received Kidney Transplant|2
3053947|NCT00572533|10497916|P2|Overall Study|Death|1
3053948|NCT00572533|10497917|P1|Overall Study|Death|4
3053949|NCT00572195|10497961|P1|Overall Study|Lost to Follow-up|5
3053950|NCT00572195|10497961|P1|Overall Study|Adverse Event|4
3053951|NCT00572195|10497961|P1|Overall Study|Death|9
3053952|NCT00572195|10497961|P1|Overall Study|Withdrawal by Subject|50
3053953|NCT00572156|10497973|P4|Overall Study|Sponsor Decision|19
3053954|NCT00572156|10497974|P3|Overall Study|Sponsor Decision|17
3053955|NCT00572156|10497975|P2|Overall Study|Sponsor Decision|16
3053956|NCT00572156|10497976|P1|Overall Study|Sponsor Decision|20
3053957|NCT00572156|10497973|P4|Overall Study|Patient/Parent Decision|3
3053958|NCT00572156|10497974|P3|Overall Study|Patient/Parent Decision|4
3053959|NCT00572156|10497975|P2|Overall Study|Patient/Parent Decision|6
3053960|NCT00572156|10497976|P1|Overall Study|Patient/Parent Decision|1
3053961|NCT00572156|10497973|P4|Overall Study|Protocol Violation|2
3053962|NCT00572156|10497974|P3|Overall Study|Protocol Violation|0
3053963|NCT00572156|10497975|P2|Overall Study|Protocol Violation|2
3053964|NCT00572156|10497976|P1|Overall Study|Protocol Violation|1
3053965|NCT00572156|10497973|P4|Overall Study|Lost to Follow-up|0
3053966|NCT00572156|10497974|P3|Overall Study|Lost to Follow-up|1
3053967|NCT00572156|10497975|P2|Overall Study|Lost to Follow-up|1
3053968|NCT00572156|10497976|P1|Overall Study|Lost to Follow-up|1
3053969|NCT00572156|10497973|P4|Overall Study|Adverse Event|1
3053970|NCT00572156|10497974|P3|Overall Study|Adverse Event|5
3053971|NCT00572156|10497975|P2|Overall Study|Adverse Event|1
3053972|NCT00572156|10497976|P1|Overall Study|Adverse Event|3
3053973|NCT00572039|10498047|P2|Overall Study|Ill|1
3053974|NCT00572039|10498048|P1|Overall Study|Ill|5
3053975|NCT00572039|10498047|P2|Overall Study|Death|3
3053976|NCT00572039|10498048|P1|Overall Study|Death|2
3053977|NCT00572039|10498047|P2|Overall Study|Withdrawal by Subject|6
3053978|NCT00572039|10498048|P1|Overall Study|Withdrawal by Subject|9
3053979|NCT00571948|10498080|P2|Overall Study|Parent were afraid of blood colection|5
3053980|NCT00571948|10498081|P1|Overall Study|Parent were afraid of blood colection|2
3053981|NCT00571948|10498080|P2|Overall Study|infant refused study meal|4
3053982|NCT00571948|10498081|P1|Overall Study|infant refused study meal|3
3053983|NCT00571948|10498080|P2|Overall Study|Protocol Violation|3
3053984|NCT00571948|10498081|P1|Overall Study|Protocol Violation|3
3053985|NCT00571948|10498080|P2|Overall Study|Withdrawal by Subject|2
3053986|NCT00571948|10498081|P1|Overall Study|Withdrawal by Subject|1
3053987|NCT00571948|10498080|P2|Overall Study|Lost to Follow-up|0
3053988|NCT00571948|10498081|P1|Overall Study|Lost to Follow-up|2
3053989|NCT00571922|10498089|P2|Overall Study|Completion unknown|36
3053990|NCT00571922|10498090|P1|Overall Study|Completion unknown|36
3053991|NCT00571701|10498100|P2|Second Intervention 12 Months|Withdrawal by Subject|0
3053992|NCT00571701|10498101|P1|Second Intervention 12 Months|Withdrawal by Subject|3
3053993|NCT00571701|10498100|P2|Second Intervention 12 Months|Adverse Event|1
3053994|NCT00571701|10498101|P1|Second Intervention 12 Months|Adverse Event|0
3053995|NCT00571701|10498100|P2|First Intervention 12 Months|Death|0
3053996|NCT00571701|10498101|P1|First Intervention 12 Months|Death|1
3053997|NCT00571701|10498100|P2|First Intervention 12 Months|Withdrawal by Subject|1
3053998|NCT00571701|10498101|P1|First Intervention 12 Months|Withdrawal by Subject|2
3053999|NCT00571688|10498127|P2|Overall Study|subject moved out of the area|0
3054000|NCT00571688|10498128|P1|Overall Study|subject moved out of the area|1
3054001|NCT00571688|10498127|P2|Overall Study|subject did not tolerate Consta|0
3054002|NCT00571688|10498128|P1|Overall Study|subject did not tolerate Consta|1
3054003|NCT00571688|10498127|P2|Overall Study|Lost to Follow-up|6
3054004|NCT00571688|10498128|P1|Overall Study|Lost to Follow-up|3
3054005|NCT00571662|10498134|P1|Overall Study|Adverse Event|5
3054006|NCT00571662|10498134|P1|Overall Study|psychiatric instability|1
3054007|NCT00571662|10498134|P1|Overall Study|Withdrawal by Subject|2
3054008|NCT00571649|10498145|P2|Follow-up Period|Protocol Violation|12
3054009|NCT00571649|10498146|P1|Follow-up Period|Protocol Violation|5
3054010|NCT00571649|10498145|P2|Follow-up Period|Patient convenience|121
3054011|NCT00571649|10498146|P1|Follow-up Period|Patient convenience|136
3054012|NCT00571649|10498145|P2|Follow-up Period|Lost to Follow-up|92
3054013|NCT00571649|10498146|P1|Follow-up Period|Lost to Follow-up|95
3054014|NCT00571649|10498145|P2|Follow-up Period|Physician Decision|13
3054015|NCT00571649|10498146|P1|Follow-up Period|Physician Decision|7
3054016|NCT00571649|10498145|P2|Follow-up Period|Death|133
3054017|NCT00571649|10498146|P1|Follow-up Period|Death|132
3054018|NCT00571649|10498145|P2|Follow-up Period|Withdrawal by Subject|115
3054019|NCT00571649|10498146|P1|Follow-up Period|Withdrawal by Subject|119
3054020|NCT00571649|10498145|P2|Follow-up Period|Clinical endpoint reached|2
3054021|NCT00571649|10498146|P1|Follow-up Period|Clinical endpoint reached|5
3054022|NCT00571649|10498145|P2|Follow-up Period|Adverse Event|40
3054023|NCT00571649|10498146|P1|Follow-up Period|Adverse Event|46
3054024|NCT00571649|10498145|P2|Treatment Period|Technical problems|5
3054025|NCT00571649|10498146|P1|Treatment Period|Technical problems|3
3054026|NCT00571649|10498145|P2|Treatment Period|Protocol Violation|92
3054027|NCT00571649|10498146|P1|Treatment Period|Protocol Violation|90
3054028|NCT00571649|10498145|P2|Treatment Period|Patient convenience|13
3054029|NCT00571649|10498146|P1|Treatment Period|Patient convenience|11
3054030|NCT00571649|10498145|P2|Treatment Period|Non-compliant with study medication|89
3054031|NCT00571649|10498146|P1|Treatment Period|Non-compliant with study medication|88
3054032|NCT00571649|10498145|P2|Treatment Period|Lost to Follow-up|41
3054033|NCT00571649|10498146|P1|Treatment Period|Lost to Follow-up|43
3054034|NCT00571649|10498145|P2|Treatment Period|Physician Decision|9
3054035|NCT00571649|10498146|P1|Treatment Period|Physician Decision|8
3054036|NCT00571649|10498145|P2|Treatment Period|Death|59
3054037|NCT00571649|10498146|P1|Treatment Period|Death|76
3054038|NCT00571649|10498145|P2|Treatment Period|Withdrawal by Subject|255
3054039|NCT00571649|10498146|P1|Treatment Period|Withdrawal by Subject|285
3054040|NCT00571649|10498145|P2|Treatment Period|Clinical endpoint reached|56
3054041|NCT00571649|10498146|P1|Treatment Period|Clinical endpoint reached|50
3054042|NCT00571649|10498145|P2|Treatment Period|Adverse Event|385
3054043|NCT00571649|10498146|P1|Treatment Period|Adverse Event|438
3054044|NCT00571103|10498244|P1|Overall Study|Lost to Follow-up|1
3054045|NCT00571103|10498244|P1|Overall Study|Withdrawal by Subject|1
3054046|NCT00571064|10498249|P1|Overall Study|Other|2
3054047|NCT00571064|10498249|P1|Overall Study|Withdrawal by Subject|2
3054048|NCT00571064|10498249|P1|Overall Study|Protocol Violation|4
3054049|NCT00571064|10498249|P1|Overall Study|Adverse Event|13
3054050|NCT00571038|10498264|P2|Overall Study|Moved out of state|2
3054051|NCT00571038|10498265|P1|Overall Study|Moved out of state|2
3054052|NCT00571038|10498264|P2|Overall Study|Withdrawal by Subject|3
3054053|NCT00571038|10498265|P1|Overall Study|Withdrawal by Subject|1
3054054|NCT00571038|10498264|P2|Overall Study|Death|5
3054055|NCT00571038|10498265|P1|Overall Study|Death|7
3054056|NCT00571038|10498264|P2|Overall Study|Lost to Follow-up|4
3054057|NCT00571038|10498265|P1|Overall Study|Lost to Follow-up|1
3054058|NCT00570921|10498320|P1|Overall Study|Physician Decision|1
3054059|NCT00570921|10498320|P1|Overall Study|Protocol Violation|1
3054060|NCT00570908|10498326|P1|Overall Study|Withdrawal by Subject|2
3054061|NCT00570908|10498326|P1|Overall Study|Adverse Event|5
3054062|NCT00570778|10498330|P4|Overall Study|Subject no longer requires study drug|0
3054063|NCT00570778|10498331|P3|Overall Study|Subject no longer requires study drug|0
3054064|NCT00570778|10498332|P2|Overall Study|Subject no longer requires study drug|1
3054065|NCT00570778|10498333|P1|Overall Study|Subject no longer requires study drug|0
3054066|NCT00570778|10498330|P4|Overall Study|Lost to Follow-up|0
3054067|NCT00570778|10498331|P3|Overall Study|Lost to Follow-up|1
3054068|NCT00570778|10498332|P2|Overall Study|Lost to Follow-up|0
3054069|NCT00570778|10498333|P1|Overall Study|Lost to Follow-up|0
3054070|NCT00570778|10498330|P4|Overall Study|Unsatisfactory therapeutic effect|0
3054071|NCT00570778|10498331|P3|Overall Study|Unsatisfactory therapeutic effect|0
3054072|NCT00570778|10498332|P2|Overall Study|Unsatisfactory therapeutic effect|0
3054073|NCT00570778|10498333|P1|Overall Study|Unsatisfactory therapeutic effect|1
3054074|NCT00570778|10498330|P4|Overall Study|Abnormal test procedure|0
3054075|NCT00570778|10498331|P3|Overall Study|Abnormal test procedure|0
3054076|NCT00570778|10498332|P2|Overall Study|Abnormal test procedure|0
3054077|NCT00570778|10498333|P1|Overall Study|Abnormal test procedure|1
3054078|NCT00570778|10498330|P4|Overall Study|Subject withdrew consent|1
3054079|NCT00570778|10498331|P3|Overall Study|Subject withdrew consent|0
3054080|NCT00570778|10498332|P2|Overall Study|Subject withdrew consent|1
3054081|NCT00570778|10498333|P1|Overall Study|Subject withdrew consent|0
3054082|NCT00570778|10498330|P4|Overall Study|Adverse Event|1
3054083|NCT00570778|10498331|P3|Overall Study|Adverse Event|4
3054084|NCT00570778|10498332|P2|Overall Study|Adverse Event|1
3054085|NCT00570778|10498333|P1|Overall Study|Adverse Event|0
3054086|NCT00570778|10498330|P4|Overall Study|Protocol deviation|2
3054087|NCT00570778|10498331|P3|Overall Study|Protocol deviation|2
3054088|NCT00570778|10498332|P2|Overall Study|Protocol deviation|1
3054089|NCT00570778|10498333|P1|Overall Study|Protocol deviation|2
3054090|NCT00570739|10498374|P4|Overall Study|Other|3
3054091|NCT00570739|10498375|P3|Overall Study|Other|5
3054092|NCT00570739|10498376|P2|Overall Study|Other|2
3054093|NCT00570739|10498377|P1|Overall Study|Other|0
3054094|NCT00570739|10498374|P4|Overall Study|Met discontinuation criteria|1
3054095|NCT00570739|10498375|P3|Overall Study|Met discontinuation criteria|1
3054096|NCT00570739|10498376|P2|Overall Study|Met discontinuation criteria|0
3054097|NCT00570739|10498377|P1|Overall Study|Met discontinuation criteria|1
3054098|NCT00570739|10498374|P4|Overall Study|Required restricted medication|0
3054099|NCT00570739|10498375|P3|Overall Study|Required restricted medication|1
3054100|NCT00570739|10498376|P2|Overall Study|Required restricted medication|0
3054101|NCT00570739|10498377|P1|Overall Study|Required restricted medication|0
3054102|NCT00570739|10498374|P4|Overall Study|Withdrawal by Subject|5
3054103|NCT00570739|10498375|P3|Overall Study|Withdrawal by Subject|3
3054104|NCT00570739|10498376|P2|Overall Study|Withdrawal by Subject|7
3054105|NCT00570739|10498377|P1|Overall Study|Withdrawal by Subject|7
3054106|NCT00570739|10498374|P4|Overall Study|Physician Decision|0
3054107|NCT00570739|10498375|P3|Overall Study|Physician Decision|0
3054108|NCT00570739|10498376|P2|Overall Study|Physician Decision|1
3054109|NCT00570739|10498377|P1|Overall Study|Physician Decision|1
3054110|NCT00570739|10498374|P4|Overall Study|Lost to Follow-up|1
3054111|NCT00570739|10498375|P3|Overall Study|Lost to Follow-up|4
3054112|NCT00570739|10498376|P2|Overall Study|Lost to Follow-up|5
3054113|NCT00570739|10498377|P1|Overall Study|Lost to Follow-up|4
3054114|NCT00570739|10498374|P4|Overall Study|Adverse Event|2
3054115|NCT00570739|10498375|P3|Overall Study|Adverse Event|2
3054116|NCT00570739|10498376|P2|Overall Study|Adverse Event|6
3054117|NCT00570739|10498377|P1|Overall Study|Adverse Event|8
3054118|NCT00570713|10498529|P2|Overall Study|Discontinuation of Study by the Sponsor|7
3054119|NCT00570713|10498530|P1|Overall Study|Discontinuation of Study by the Sponsor|10
3054120|NCT00570713|10498529|P2|Overall Study|Withdrawal by Subject|3
3054121|NCT00570713|10498530|P1|Overall Study|Withdrawal by Subject|3
3054122|NCT00570713|10498529|P2|Overall Study|Physician Decision|2
3054123|NCT00570713|10498530|P1|Overall Study|Physician Decision|2
3054124|NCT00570713|10498529|P2|Overall Study|Lack of Efficacy|49
3054125|NCT00570713|10498530|P1|Overall Study|Lack of Efficacy|40
3054126|NCT00570713|10498529|P2|Overall Study|Death|7
3054127|NCT00570713|10498530|P1|Overall Study|Death|7
3054128|NCT00570713|10498529|P2|Overall Study|Adverse Event|9
3054129|NCT00570713|10498530|P1|Overall Study|Adverse Event|16
3054130|NCT00570687|10498548|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054131|NCT00570687|10498549|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054132|NCT00570687|10498550|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054133|NCT00570687|10498551|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
3054134|NCT00570687|10498552|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054135|NCT00570687|10498553|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054136|NCT00570687|10498554|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054137|NCT00570687|10498555|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054138|NCT00570687|10498556|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054139|NCT00570687|10498557|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054140|NCT00570687|10498548|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054141|NCT00570687|10498549|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
3054142|NCT00570687|10498550|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054143|NCT00570687|10498551|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054144|NCT00570687|10498552|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054145|NCT00570687|10498553|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054146|NCT00570687|10498554|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054147|NCT00570687|10498555|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054148|NCT00570687|10498556|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054149|NCT00570687|10498557|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054150|NCT00570687|10498548|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
3054151|NCT00570687|10498549|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
3054152|NCT00570687|10498550|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
3054153|NCT00570687|10498551|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
3054154|NCT00570687|10498552|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
3054155|NCT00570687|10498553|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
3054156|NCT00570687|10498554|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054157|NCT00570687|10498555|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054158|NCT00570687|10498556|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054159|NCT00570687|10498557|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
3054160|NCT00570674|10498583|P7|Overall Study|Withdrawal by Subject|0
3054161|NCT00570674|10498584|P6|Overall Study|Withdrawal by Subject|0
3054162|NCT00570674|10498585|P5|Overall Study|Withdrawal by Subject|0
3054163|NCT00570674|10498586|P4|Overall Study|Withdrawal by Subject|0
3054164|NCT00570674|10498587|P3|Overall Study|Withdrawal by Subject|1
3054165|NCT00570674|10498588|P2|Overall Study|Withdrawal by Subject|0
3054166|NCT00570674|10498589|P1|Overall Study|Withdrawal by Subject|0
3054167|NCT00570505|10498612|P1|Overall Study|Other loss to follow-up|4
3054168|NCT00570505|10498612|P1|Overall Study|Lost to Follow-up|23
3054169|NCT00570505|10498612|P1|Overall Study|Withdrawal by Subject|7
3054170|NCT00570505|10498612|P1|Overall Study|Adverse Event|7
3054171|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
3054334|NCT00568776|10499280|P3|Overall Study|Miscellaeneous|1
3054172|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
3054173|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
3054174|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
3054175|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
3054176|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
3054177|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Physician Decision|4
3054178|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Physician Decision|2
3054179|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Physician Decision|0
3054180|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Adverse Event|5
3054181|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Adverse Event|5
3054182|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Adverse Event|0
3054183|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
3054184|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
3054185|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
3054186|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Protocol Violation|15
3054187|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Protocol Violation|12
3054188|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Protocol Violation|0
3054189|NCT00570492|10498625|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
3054190|NCT00570492|10498626|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
3054191|NCT00570492|10498627|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
3054192|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
3054193|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
3054194|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
3054195|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Adverse Event|0
3054196|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Adverse Event|0
3054197|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Adverse Event|1
3054198|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
3054199|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
3054200|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
3054201|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Protocol Violation|0
3054202|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Protocol Violation|0
3054203|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Protocol Violation|15
3054204|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
3054205|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
3054206|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
3054207|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
3054208|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
3054209|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
3054210|NCT00570492|10498625|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
3054211|NCT00570492|10498626|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
3054212|NCT00570492|10498627|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
3054213|NCT00570401|10498665|P1|Overall Study|Adverse Event|2
3054214|NCT00570323|10498699|P2|Complete Study After Start|Physician Decision|0
3054215|NCT00570323|10498700|P1|Complete Study After Start|Physician Decision|1
3054216|NCT00570323|10498699|P2|Complete Study After Start|Withdrawal by Subject|0
3054217|NCT00570323|10498700|P1|Complete Study After Start|Withdrawal by Subject|2
3054218|NCT00570323|10498699|P2|Complete Study After Start|Lost to Follow-up|1
3054219|NCT00570323|10498700|P1|Complete Study After Start|Lost to Follow-up|0
3054220|NCT00570323|10498699|P2|Started Treatment After Randomization|Physician Decision|0
3054221|NCT00570323|10498700|P1|Started Treatment After Randomization|Physician Decision|1
3054222|NCT00570323|10498699|P2|Started Treatment After Randomization|Protocol Violation|0
3054223|NCT00570323|10498700|P1|Started Treatment After Randomization|Protocol Violation|1
3054224|NCT00570323|10498699|P2|Started Treatment After Randomization|Withdrawal by Subject|1
3054225|NCT00570323|10498700|P1|Started Treatment After Randomization|Withdrawal by Subject|0
3054226|NCT00570310|10498712|P2|Overall Study|Lack of Efficacy|4
3054227|NCT00570310|10498713|P1|Overall Study|Lack of Efficacy|1
3054228|NCT00570310|10498712|P2|Overall Study|Adverse Event|2
3054229|NCT00570310|10498713|P1|Overall Study|Adverse Event|1
3054230|NCT00570232|10498732|P1|Overall Study|discontinued due to noncompliance|2
3054231|NCT00570232|10498732|P1|Overall Study|discontinued due to recurrence|8
3054232|NCT00570232|10498732|P1|Overall Study|discontinued due to medical condition|3
3054233|NCT00570232|10498732|P1|Overall Study|Adverse Event|10
3054234|NCT00570141|10498738|P1|Overall Study|Lost to Follow-up|1
3054235|NCT00570141|10498738|P1|Overall Study|Missed visits|1
3054236|NCT00570141|10498738|P1|Overall Study|Adverse Event|1
3054237|NCT00570063|10498754|P2|Overall Study|Sponsor's Decision|3
3054238|NCT00570063|10498755|P1|Overall Study|Sponsor's Decision|7
3054239|NCT00570063|10498754|P2|Overall Study|Withdrawal by Subject|3
3054240|NCT00570063|10498755|P1|Overall Study|Withdrawal by Subject|4
3054241|NCT00570063|10498754|P2|Overall Study|Lack of Efficacy|1
3054242|NCT00570063|10498755|P1|Overall Study|Lack of Efficacy|0
3054243|NCT00570063|10498754|P2|Overall Study|Adverse Event|1
3054244|NCT00570063|10498755|P1|Overall Study|Adverse Event|4
3054245|NCT00570037|10498821|P2|Overall Study|Could not reach for 6-8 week contact|69
3054246|NCT00570037|10498822|P1|Overall Study|Could not reach for 6-8 week contact|44
3054247|NCT00569946|10498832|P1|Overall Study|Global Deterioration of Health Status|1
3054248|NCT00569946|10498832|P1|Overall Study|Objective Progression or Relapse|42
3054249|NCT00569946|10498832|P1|Overall Study|Adverse Event|16
3054250|NCT00569803|10498864|P8|Overall Study|Withdrawal by Subject|1
3054251|NCT00569803|10498865|P7|Overall Study|Withdrawal by Subject|0
3054252|NCT00569803|10498866|P6|Overall Study|Withdrawal by Subject|0
3054253|NCT00569803|10498867|P5|Overall Study|Withdrawal by Subject|0
3054254|NCT00569803|10498868|P4|Overall Study|Withdrawal by Subject|0
3054255|NCT00569803|10498869|P3|Overall Study|Withdrawal by Subject|0
3054256|NCT00569803|10498870|P2|Overall Study|Withdrawal by Subject|0
3054257|NCT00569803|10498871|P1|Overall Study|Withdrawal by Subject|0
3054258|NCT00569803|10498864|P8|Overall Study|injection syringe leaked during dosing|0
3054259|NCT00569803|10498865|P7|Overall Study|injection syringe leaked during dosing|0
3054260|NCT00569803|10498866|P6|Overall Study|injection syringe leaked during dosing|0
3054261|NCT00569803|10498867|P5|Overall Study|injection syringe leaked during dosing|0
3054262|NCT00569803|10498868|P4|Overall Study|injection syringe leaked during dosing|1
3054263|NCT00569803|10498869|P3|Overall Study|injection syringe leaked during dosing|0
3054264|NCT00569803|10498870|P2|Overall Study|injection syringe leaked during dosing|0
3054265|NCT00569803|10498871|P1|Overall Study|injection syringe leaked during dosing|0
3054266|NCT00569803|10498864|P8|Overall Study|Lost to Follow-up|0
3054267|NCT00569803|10498865|P7|Overall Study|Lost to Follow-up|0
3054268|NCT00569803|10498866|P6|Overall Study|Lost to Follow-up|0
3054269|NCT00569803|10498867|P5|Overall Study|Lost to Follow-up|0
3054270|NCT00569803|10498868|P4|Overall Study|Lost to Follow-up|0
3054271|NCT00569803|10498869|P3|Overall Study|Lost to Follow-up|0
3054272|NCT00569803|10498870|P2|Overall Study|Lost to Follow-up|0
3054273|NCT00569803|10498871|P1|Overall Study|Lost to Follow-up|1
3054274|NCT00569777|10498998|P2|Overall Study|pregnant|0
3054275|NCT00569777|10498999|P1|Overall Study|pregnant|1
3054276|NCT00569777|10498998|P2|Overall Study|did not meet exclusion criteria|2
3054277|NCT00569777|10498999|P1|Overall Study|did not meet exclusion criteria|1
3054278|NCT00569777|10498998|P2|Overall Study|scheduled eye surgery|1
3054279|NCT00569777|10498999|P1|Overall Study|scheduled eye surgery|0
3054280|NCT00569777|10498998|P2|Overall Study|Lost to Follow-up|0
3054281|NCT00569777|10498999|P1|Overall Study|Lost to Follow-up|1
3054282|NCT00569777|10498998|P2|Overall Study|Adverse Event|0
3054283|NCT00569777|10498999|P1|Overall Study|Adverse Event|3
3054284|NCT00569777|10498998|P2|Overall Study|Withdrawal by Subject|0
3054285|NCT00569777|10498999|P1|Overall Study|Withdrawal by Subject|4
3054286|NCT00569582|10499050|P1|Overall Study|Subject was non-compliant.|1
3054287|NCT00569582|10499050|P1|Overall Study|Subject was too ill to travel.|1
3054288|NCT00569582|10499050|P1|Overall Study|Adverse Event|7
3054289|NCT00569582|10499050|P1|Overall Study|Death|2
3054290|NCT00569582|10499050|P1|Overall Study|Withdrawal by Subject|5
3054291|NCT00569374|10499066|P1|Overall Study|Withdrawal by Subject|4
3054292|NCT00569270|10499085|P2|Period: First Intervention|Protocol Violation|1
3054293|NCT00569270|10499086|P1|Period: First Intervention|Protocol Violation|0
3054294|NCT00569231|10499121|P1|Overall Study|Non-compliance|2
3054295|NCT00569231|10499121|P1|Overall Study|Car accident injury|1
3054296|NCT00569231|10499121|P1|Overall Study|Withdrawal by Subject|1
3054297|NCT00569231|10499121|P1|Overall Study|Airfare expense|2
3054298|NCT00569231|10499121|P1|Overall Study|Study unrelated surgery|1
3054299|NCT00569166|10499159|P3|Overall Study|Lost to Follow-up|1
3054300|NCT00569166|10499160|P2|Overall Study|Lost to Follow-up|1
3054301|NCT00569166|10499161|P1|Overall Study|Lost to Follow-up|2
3054302|NCT00569166|10499159|P3|Overall Study|Withdrawal by Subject|3
3054303|NCT00569166|10499160|P2|Overall Study|Withdrawal by Subject|5
3054304|NCT00569166|10499161|P1|Overall Study|Withdrawal by Subject|7
3054305|NCT00569127|10499195|P2|Overall Study|Still on Treatment|3
3054306|NCT00569127|10499196|P1|Overall Study|Still on Treatment|7
3054307|NCT00569127|10499195|P2|Overall Study|Not Eligible|11
3054308|NCT00569127|10499196|P1|Overall Study|Not Eligible|14
3054309|NCT00569127|10499195|P2|Overall Study|Lost to Follow-up|3
3054310|NCT00569127|10499196|P1|Overall Study|Lost to Follow-up|0
3054311|NCT00569127|10499195|P2|Overall Study|Other|19
3054312|NCT00569127|10499196|P1|Overall Study|Other|20
3054313|NCT00569127|10499195|P2|Overall Study|Death|3
3054314|NCT00569127|10499196|P1|Overall Study|Death|4
3054315|NCT00569127|10499195|P2|Overall Study|Progression|100
3054316|NCT00569127|10499196|P1|Overall Study|Progression|99
3054317|NCT00569127|10499195|P2|Overall Study|Withdrawal by Subject|27
3054318|NCT00569127|10499196|P1|Overall Study|Withdrawal by Subject|13
3054319|NCT00569127|10499195|P2|Overall Study|Adverse Event|47
3054320|NCT00569127|10499196|P1|Overall Study|Adverse Event|57
3054321|NCT00568958|10499231|P2|Follow-Up|Adverse Event|0
3054322|NCT00568958|10499232|P1|Follow-Up|Adverse Event|1
3054323|NCT00568958|10499231|P2|Follow-Up|Family Emergency|0
3054324|NCT00568958|10499232|P1|Follow-Up|Family Emergency|1
3054325|NCT00568958|10499231|P2|Follow-Up|Physician Decision|1
3054326|NCT00568958|10499232|P1|Follow-Up|Physician Decision|1
3054327|NCT00568958|10499231|P2|Follow-Up|Withdrawal by Subject|6
3054328|NCT00568958|10499232|P1|Follow-Up|Withdrawal by Subject|6
3054329|NCT00568958|10499231|P2|Allocation|Physician Decision|0
3054330|NCT00568958|10499232|P1|Allocation|Physician Decision|2
3054331|NCT00568958|10499231|P2|Allocation|Withdrawal by Subject|3
3054332|NCT00568958|10499232|P1|Allocation|Withdrawal by Subject|7
3054333|NCT00568776|10499279|P4|Overall Study|Miscellaeneous|4
3054335|NCT00568776|10499281|P2|Overall Study|Miscellaeneous|3
3054336|NCT00568776|10499282|P1|Overall Study|Miscellaeneous|3
3054337|NCT00568776|10499279|P4|Overall Study|Sponsor Decision|42
3054338|NCT00568776|10499280|P3|Overall Study|Sponsor Decision|41
3054339|NCT00568776|10499281|P2|Overall Study|Sponsor Decision|2
3054340|NCT00568776|10499282|P1|Overall Study|Sponsor Decision|2
3054341|NCT00568776|10499279|P4|Overall Study|Loss of Caregiver|2
3054342|NCT00568776|10499280|P3|Overall Study|Loss of Caregiver|1
3054343|NCT00568776|10499281|P2|Overall Study|Loss of Caregiver|2
3054344|NCT00568776|10499282|P1|Overall Study|Loss of Caregiver|0
3054345|NCT00568776|10499279|P4|Overall Study|Withdrawal by Subject|7
3054346|NCT00568776|10499280|P3|Overall Study|Withdrawal by Subject|13
3054347|NCT00568776|10499281|P2|Overall Study|Withdrawal by Subject|15
3054348|NCT00568776|10499282|P1|Overall Study|Withdrawal by Subject|13
3054349|NCT00568776|10499279|P4|Overall Study|Protocol Violation|1
3054350|NCT00568776|10499280|P3|Overall Study|Protocol Violation|1
3054351|NCT00568776|10499281|P2|Overall Study|Protocol Violation|0
3054352|NCT00568776|10499282|P1|Overall Study|Protocol Violation|1
3054353|NCT00568776|10499279|P4|Overall Study|Lost to Follow-up|1
3054354|NCT00568776|10499280|P3|Overall Study|Lost to Follow-up|1
3054355|NCT00568776|10499281|P2|Overall Study|Lost to Follow-up|1
3054356|NCT00568776|10499282|P1|Overall Study|Lost to Follow-up|1
3054357|NCT00568776|10499279|P4|Overall Study|Lack of Efficacy|4
3054358|NCT00568776|10499280|P3|Overall Study|Lack of Efficacy|2
3054359|NCT00568776|10499281|P2|Overall Study|Lack of Efficacy|2
3054360|NCT00568776|10499282|P1|Overall Study|Lack of Efficacy|2
3054361|NCT00568776|10499279|P4|Overall Study|Physician Decision|0
3054362|NCT00568776|10499280|P3|Overall Study|Physician Decision|0
3054363|NCT00568776|10499281|P2|Overall Study|Physician Decision|2
3054364|NCT00568776|10499282|P1|Overall Study|Physician Decision|0
3054365|NCT00568776|10499279|P4|Overall Study|Death|3
3054366|NCT00568776|10499280|P3|Overall Study|Death|4
3054367|NCT00568776|10499281|P2|Overall Study|Death|1
3054368|NCT00568776|10499282|P1|Overall Study|Death|0
3054369|NCT00568776|10499279|P4|Overall Study|Adverse Event|8
3054370|NCT00568776|10499280|P3|Overall Study|Adverse Event|10
3054371|NCT00568776|10499281|P2|Overall Study|Adverse Event|8
3054372|NCT00568776|10499282|P1|Overall Study|Adverse Event|8
3054373|NCT00568685|10499331|P3|Overall Study|Protocol Violation|0
3054374|NCT00568685|10499332|P2|Overall Study|Protocol Violation|0
3054375|NCT00568685|10499333|P1|Overall Study|Protocol Violation|1
3054376|NCT00568685|10499331|P3|Overall Study|Withdrawal by Subject|2
3054377|NCT00568685|10499332|P2|Overall Study|Withdrawal by Subject|2
3054378|NCT00568685|10499333|P1|Overall Study|Withdrawal by Subject|7
3054379|NCT00568685|10499331|P3|Overall Study|Adverse Event|3
3054380|NCT00568685|10499332|P2|Overall Study|Adverse Event|3
3054381|NCT00568685|10499333|P1|Overall Study|Adverse Event|2
3054382|NCT00568555|10499390|P2|Overall Study|Withdrawal by Subject|1
3054383|NCT00568555|10499391|P1|Overall Study|Withdrawal by Subject|1
3054384|NCT00568451|10499409|P4|Overall Study|Disease Progression|7
3054385|NCT00568451|10499410|P3|Overall Study|Disease Progression|2
3054386|NCT00568451|10499411|P2|Overall Study|Disease Progression|0
3054387|NCT00568451|10499412|P1|Overall Study|Disease Progression|0
3054388|NCT00568399|10499428|P1|Overall Study|Withdrawal by Subject|8
3054389|NCT00568399|10499428|P1|Overall Study|Adverse Event|5
3054390|NCT00568399|10499428|P1|Overall Study|Death|2
3054391|NCT00568334|10499443|P2|Overall Study|Lost to Follow-up|0
3054392|NCT00568334|10499444|P1|Overall Study|Lost to Follow-up|1
3054393|NCT00568334|10499443|P2|Overall Study|Withdrawal by Subject|1
3054394|NCT00568334|10499444|P1|Overall Study|Withdrawal by Subject|0
3054395|NCT00568178|10499470|P6|Open Label Extension|Withdrawal by Subject|4
3054396|NCT00568178|10499471|P5|Open Label Extension|Withdrawal by Subject|4
3054397|NCT00568178|10499472|P4|Open Label Extension|Withdrawal by Subject|0
3054398|NCT00568178|10499473|P3|Open Label Extension|Withdrawal by Subject|0
3054399|NCT00568178|10499474|P2|Open Label Extension|Withdrawal by Subject|0
3054400|NCT00568178|10499475|P1|Open Label Extension|Withdrawal by Subject|0
3054401|NCT00568178|10499470|P6|Open Label Extension|Termination of Trial|47
3054402|NCT00568178|10499471|P5|Open Label Extension|Termination of Trial|45
3054403|NCT00568178|10499472|P4|Open Label Extension|Termination of Trial|0
3054404|NCT00568178|10499473|P3|Open Label Extension|Termination of Trial|0
3054405|NCT00568178|10499474|P2|Open Label Extension|Termination of Trial|0
3054406|NCT00568178|10499475|P1|Open Label Extension|Termination of Trial|0
3054407|NCT00568178|10499470|P6|Open Label Extension|Progressive Disease|1
3054408|NCT00568178|10499471|P5|Open Label Extension|Progressive Disease|3
3054409|NCT00568178|10499472|P4|Open Label Extension|Progressive Disease|0
3054410|NCT00568178|10499473|P3|Open Label Extension|Progressive Disease|0
3054411|NCT00568178|10499474|P2|Open Label Extension|Progressive Disease|0
3054412|NCT00568178|10499475|P1|Open Label Extension|Progressive Disease|0
3054413|NCT00568178|10499470|P6|Open Label Extension|Pregnancy|1
3054414|NCT00568178|10499471|P5|Open Label Extension|Pregnancy|0
3054415|NCT00568178|10499472|P4|Open Label Extension|Pregnancy|0
3054416|NCT00568178|10499473|P3|Open Label Extension|Pregnancy|0
3054417|NCT00568178|10499474|P2|Open Label Extension|Pregnancy|0
3054418|NCT00568178|10499475|P1|Open Label Extension|Pregnancy|0
3054419|NCT00568178|10499470|P6|Open Label Extension|Physician Decision|8
3054420|NCT00568178|10499471|P5|Open Label Extension|Physician Decision|9
3054421|NCT00568178|10499472|P4|Open Label Extension|Physician Decision|0
3054422|NCT00568178|10499473|P3|Open Label Extension|Physician Decision|0
3054423|NCT00568178|10499474|P2|Open Label Extension|Physician Decision|0
3054424|NCT00568178|10499475|P1|Open Label Extension|Physician Decision|0
3054425|NCT00568178|10499470|P6|Open Label Extension|Lost to Follow-up|11
3054426|NCT00568178|10499471|P5|Open Label Extension|Lost to Follow-up|6
3054427|NCT00568178|10499472|P4|Open Label Extension|Lost to Follow-up|0
3054428|NCT00568178|10499473|P3|Open Label Extension|Lost to Follow-up|0
3054429|NCT00568178|10499474|P2|Open Label Extension|Lost to Follow-up|0
3054430|NCT00568178|10499475|P1|Open Label Extension|Lost to Follow-up|0
3054431|NCT00568178|10499470|P6|Open Label Extension|Protocol Violation|0
3054432|NCT00568178|10499471|P5|Open Label Extension|Protocol Violation|1
3054433|NCT00568178|10499472|P4|Open Label Extension|Protocol Violation|0
3054434|NCT00568178|10499473|P3|Open Label Extension|Protocol Violation|0
3054435|NCT00568178|10499474|P2|Open Label Extension|Protocol Violation|0
3054436|NCT00568178|10499475|P1|Open Label Extension|Protocol Violation|0
3054437|NCT00568178|10499470|P6|Open Label Extension|Adverse Event|8
3054438|NCT00568178|10499471|P5|Open Label Extension|Adverse Event|11
3054439|NCT00568178|10499472|P4|Open Label Extension|Adverse Event|0
3054440|NCT00568178|10499473|P3|Open Label Extension|Adverse Event|0
3054441|NCT00568178|10499474|P2|Open Label Extension|Adverse Event|0
3054442|NCT00568178|10499475|P1|Open Label Extension|Adverse Event|0
3054443|NCT00568178|10499470|P6|Double Blind Base Study|Progressive Disease|0
3054444|NCT00568178|10499471|P5|Double Blind Base Study|Progressive Disease|0
3054445|NCT00568178|10499472|P4|Double Blind Base Study|Progressive Disease|1
3054446|NCT00568178|10499473|P3|Double Blind Base Study|Progressive Disease|0
3054447|NCT00568178|10499474|P2|Double Blind Base Study|Progressive Disease|0
3054448|NCT00568178|10499475|P1|Double Blind Base Study|Progressive Disease|0
3054449|NCT00568178|10499470|P6|Double Blind Base Study|Withdrawal by Subject|0
3054450|NCT00568178|10499471|P5|Double Blind Base Study|Withdrawal by Subject|0
3054451|NCT00568178|10499472|P4|Double Blind Base Study|Withdrawal by Subject|0
3054452|NCT00568178|10499473|P3|Double Blind Base Study|Withdrawal by Subject|0
3054453|NCT00568178|10499474|P2|Double Blind Base Study|Withdrawal by Subject|1
3054454|NCT00568178|10499475|P1|Double Blind Base Study|Withdrawal by Subject|1
3054455|NCT00568178|10499470|P6|Double Blind Base Study|Protocol Violation|0
3054456|NCT00568178|10499471|P5|Double Blind Base Study|Protocol Violation|0
3054457|NCT00568178|10499472|P4|Double Blind Base Study|Protocol Violation|0
3054458|NCT00568178|10499473|P3|Double Blind Base Study|Protocol Violation|0
3054459|NCT00568178|10499474|P2|Double Blind Base Study|Protocol Violation|2
3054460|NCT00568178|10499475|P1|Double Blind Base Study|Protocol Violation|3
3054461|NCT00568178|10499470|P6|Double Blind Base Study|Physician Decision|0
3054462|NCT00568178|10499471|P5|Double Blind Base Study|Physician Decision|0
3054463|NCT00568178|10499472|P4|Double Blind Base Study|Physician Decision|1
3054464|NCT00568178|10499473|P3|Double Blind Base Study|Physician Decision|0
3054465|NCT00568178|10499474|P2|Double Blind Base Study|Physician Decision|1
3054466|NCT00568178|10499475|P1|Double Blind Base Study|Physician Decision|1
3054467|NCT00568178|10499470|P6|Double Blind Base Study|Lost to Follow-up|0
3054468|NCT00568178|10499471|P5|Double Blind Base Study|Lost to Follow-up|0
3054469|NCT00568178|10499472|P4|Double Blind Base Study|Lost to Follow-up|1
3054470|NCT00568178|10499473|P3|Double Blind Base Study|Lost to Follow-up|0
3054471|NCT00568178|10499474|P2|Double Blind Base Study|Lost to Follow-up|0
3054472|NCT00568178|10499475|P1|Double Blind Base Study|Lost to Follow-up|1
3054473|NCT00568178|10499470|P6|Double Blind Base Study|Adverse Event|0
3054474|NCT00568178|10499471|P5|Double Blind Base Study|Adverse Event|0
3054475|NCT00568178|10499472|P4|Double Blind Base Study|Adverse Event|2
3054476|NCT00568178|10499473|P3|Double Blind Base Study|Adverse Event|1
3054477|NCT00568178|10499474|P2|Double Blind Base Study|Adverse Event|2
3054478|NCT00568178|10499475|P1|Double Blind Base Study|Adverse Event|0
3054479|NCT00568061|10499508|P2|Overall Study|Adverse Event|1
3054480|NCT00568061|10499509|P1|Overall Study|Adverse Event|0
3054481|NCT00568061|10499508|P2|Overall Study|Inclusion / exclusion criteria|1
3054482|NCT00568061|10499509|P1|Overall Study|Inclusion / exclusion criteria|5
3054483|NCT00567996|10499572|P3|Overall Study|Patient's inability to use the device|0
3054484|NCT00567996|10499573|P2|Overall Study|Patient's inability to use the device|1
3054485|NCT00567996|10499574|P1|Overall Study|Patient's inability to use the device|0
3054486|NCT00567996|10499572|P3|Overall Study|Death|2
3054487|NCT00567996|10499573|P2|Overall Study|Death|0
3054488|NCT00567996|10499574|P1|Overall Study|Death|1
3054489|NCT00567996|10499572|P3|Overall Study|Administrative problems|0
3054490|NCT00567996|10499573|P2|Overall Study|Administrative problems|1
3054491|NCT00567996|10499574|P1|Overall Study|Administrative problems|1
3054492|NCT00567996|10499572|P3|Overall Study|Unsatisfactory therapeutic effect|15
3054493|NCT00567996|10499573|P2|Overall Study|Unsatisfactory therapeutic effect|2
3054494|NCT00567996|10499574|P1|Overall Study|Unsatisfactory therapeutic effect|1
3054495|NCT00567996|10499572|P3|Overall Study|Lost to Follow-up|2
3054496|NCT00567996|10499573|P2|Overall Study|Lost to Follow-up|5
3054497|NCT00567996|10499574|P1|Overall Study|Lost to Follow-up|2
3054498|NCT00567996|10499572|P3|Overall Study|Abnormal test procedure result(s)|1
3054499|NCT00567996|10499573|P2|Overall Study|Abnormal test procedure result(s)|1
3054500|NCT00567996|10499574|P1|Overall Study|Abnormal test procedure result(s)|2
3054501|NCT00567996|10499572|P3|Overall Study|Abnormal Lab value(s)|2
3054502|NCT00567996|10499573|P2|Overall Study|Abnormal Lab value(s)|1
3054503|NCT00567996|10499574|P1|Overall Study|Abnormal Lab value(s)|2
3054504|NCT00567996|10499572|P3|Overall Study|Withdrawal by Subject|22
3054505|NCT00567996|10499573|P2|Overall Study|Withdrawal by Subject|12
3054506|NCT00567996|10499574|P1|Overall Study|Withdrawal by Subject|8
3054507|NCT00567996|10499572|P3|Overall Study|Protocol Deviation|13
3054508|NCT00567996|10499573|P2|Overall Study|Protocol Deviation|11
3054509|NCT00567996|10499574|P1|Overall Study|Protocol Deviation|9
3054510|NCT00567996|10499572|P3|Overall Study|Adverse Event|13
3054511|NCT00567996|10499573|P2|Overall Study|Adverse Event|16
3054512|NCT00567996|10499574|P1|Overall Study|Adverse Event|18
3054513|NCT00567892|10499590|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
3054514|NCT00567892|10499591|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
3054515|NCT00567892|10499592|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
3054516|NCT00567892|10499593|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
3054517|NCT00567892|10499590|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
3054518|NCT00567892|10499591|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
3054519|NCT00567892|10499592|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
3054520|NCT00567892|10499593|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
3054521|NCT00567879|10499611|P6|Overall Study|Disease progression|3
3054522|NCT00567879|10499612|P5|Overall Study|Disease progression|11
3054523|NCT00567879|10499613|P4|Overall Study|Disease progression|5
3054524|NCT00567879|10499614|P3|Overall Study|Disease progression|15
3054525|NCT00567879|10499615|P2|Overall Study|Disease progression|7
3054526|NCT00567879|10499616|P1|Overall Study|Disease progression|5
3054527|NCT00567879|10499611|P6|Overall Study|New cancer therapy|0
3054528|NCT00567879|10499612|P5|Overall Study|New cancer therapy|0
3054529|NCT00567879|10499613|P4|Overall Study|New cancer therapy|0
3054530|NCT00567879|10499614|P3|Overall Study|New cancer therapy|1
3054531|NCT00567879|10499615|P2|Overall Study|New cancer therapy|0
3054532|NCT00567879|10499616|P1|Overall Study|New cancer therapy|0
3054533|NCT00567879|10499611|P6|Overall Study|Withdrawal by Subject|0
3054534|NCT00567879|10499612|P5|Overall Study|Withdrawal by Subject|0
3054535|NCT00567879|10499613|P4|Overall Study|Withdrawal by Subject|1
3054536|NCT00567879|10499614|P3|Overall Study|Withdrawal by Subject|3
3054537|NCT00567879|10499615|P2|Overall Study|Withdrawal by Subject|0
3054538|NCT00567879|10499616|P1|Overall Study|Withdrawal by Subject|0
3054539|NCT00567879|10499611|P6|Overall Study|Abnormal test procedure(s)|0
3054540|NCT00567879|10499612|P5|Overall Study|Abnormal test procedure(s)|0
3054541|NCT00567879|10499613|P4|Overall Study|Abnormal test procedure(s)|0
3054542|NCT00567879|10499614|P3|Overall Study|Abnormal test procedure(s)|1
3054543|NCT00567879|10499615|P2|Overall Study|Abnormal test procedure(s)|0
3054544|NCT00567879|10499616|P1|Overall Study|Abnormal test procedure(s)|0
3054545|NCT00567879|10499611|P6|Overall Study|Adverse Event|0
3054546|NCT00567879|10499612|P5|Overall Study|Adverse Event|1
3054547|NCT00567879|10499613|P4|Overall Study|Adverse Event|0
3054548|NCT00567879|10499614|P3|Overall Study|Adverse Event|1
3054549|NCT00567879|10499615|P2|Overall Study|Adverse Event|0
3054550|NCT00567879|10499616|P1|Overall Study|Adverse Event|2
3054551|NCT00567593|10499683|P1|Overall Study|Physician Decision|1
3054552|NCT00567593|10499683|P1|Overall Study|Adverse Event|1
3054553|NCT00567567|10499690|P3|Overall Study|Unable adequate stem cell for transplant|2
3054554|NCT00567567|10499691|P2|Overall Study|Unable adequate stem cell for transplant|0
3054555|NCT00567567|10499692|P1|Overall Study|Unable adequate stem cell for transplant|0
3054556|NCT00567567|10499690|P3|Overall Study|Enrolled another COG therapeutic study|0
3054557|NCT00567567|10499691|P2|Overall Study|Enrolled another COG therapeutic study|80
3054558|NCT00567567|10499692|P1|Overall Study|Enrolled another COG therapeutic study|99
3054559|NCT00567567|10499690|P3|Overall Study|Refusal by patient/parent/guardian|122
3054560|NCT00567567|10499691|P2|Overall Study|Refusal by patient/parent/guardian|16
3054561|NCT00567567|10499692|P1|Overall Study|Refusal by patient/parent/guardian|9
3054562|NCT00567567|10499690|P3|Overall Study|Ineligible|9
3054563|NCT00567567|10499691|P2|Overall Study|Ineligible|0
3054564|NCT00567567|10499692|P1|Overall Study|Ineligible|4
3054565|NCT00567567|10499690|P3|Overall Study|Withdrawal by Subject|2
3054566|NCT00567567|10499691|P2|Overall Study|Withdrawal by Subject|0
3054567|NCT00567567|10499692|P1|Overall Study|Withdrawal by Subject|0
3054568|NCT00567567|10499690|P3|Overall Study|Physician Decision|84
3054569|NCT00567567|10499691|P2|Overall Study|Physician Decision|18
3054570|NCT00567567|10499692|P1|Overall Study|Physician Decision|16
3054571|NCT00567567|10499690|P3|Overall Study|Lost to Follow-up|1
3054572|NCT00567567|10499691|P2|Overall Study|Lost to Follow-up|0
3054573|NCT00567567|10499692|P1|Overall Study|Lost to Follow-up|0
3054574|NCT00567567|10499690|P3|Overall Study|Lack of Efficacy|48
3054575|NCT00567567|10499691|P2|Overall Study|Lack of Efficacy|17
3054576|NCT00567567|10499692|P1|Overall Study|Lack of Efficacy|16
3054577|NCT00567567|10499690|P3|Overall Study|Death|5
3054578|NCT00567567|10499691|P2|Overall Study|Death|1
3054579|NCT00567567|10499692|P1|Overall Study|Death|8
3054580|NCT00567567|10499690|P3|Overall Study|Adverse Event|5
3054581|NCT00567567|10499691|P2|Overall Study|Adverse Event|2
3054582|NCT00567567|10499692|P1|Overall Study|Adverse Event|0
3054583|NCT00567541|10499740|P2|Overall Study|Adverse Event|1
3054584|NCT00567541|10499741|P1|Overall Study|Adverse Event|0
3054585|NCT00567502|10499751|P4|Overall Study|Never Initiated Treatment|72
3054586|NCT00567502|10499752|P3|Overall Study|Never Initiated Treatment|0
3054587|NCT00567502|10499753|P2|Overall Study|Never Initiated Treatment|0
3054588|NCT00567502|10499754|P1|Overall Study|Never Initiated Treatment|0
3054589|NCT00567502|10499751|P4|Overall Study|Sponsor request|1
3054590|NCT00567502|10499752|P3|Overall Study|Sponsor request|30
3054591|NCT00567502|10499753|P2|Overall Study|Sponsor request|0
3054592|NCT00567502|10499754|P1|Overall Study|Sponsor request|9
3054593|NCT00567502|10499751|P4|Overall Study|Participant request|1
3054594|NCT00567502|10499752|P3|Overall Study|Participant request|33
3054595|NCT00567502|10499753|P2|Overall Study|Participant request|1
3054596|NCT00567502|10499754|P1|Overall Study|Participant request|12
3054597|NCT00567502|10499751|P4|Overall Study|Other|6
3054598|NCT00567502|10499752|P3|Overall Study|Other|134
3054599|NCT00567502|10499753|P2|Overall Study|Other|2
3054600|NCT00567502|10499754|P1|Overall Study|Other|64
3054601|NCT00567502|10499751|P4|Overall Study|Death|5
3054602|NCT00567502|10499752|P3|Overall Study|Death|360
3054603|NCT00567502|10499753|P2|Overall Study|Death|16
3054604|NCT00567502|10499754|P1|Overall Study|Death|65
3054605|NCT00567502|10499751|P4|Overall Study|Lost to Follow-up|2
3054606|NCT00567502|10499752|P3|Overall Study|Lost to Follow-up|351
3054607|NCT00567502|10499753|P2|Overall Study|Lost to Follow-up|14
3054608|NCT00567502|10499754|P1|Overall Study|Lost to Follow-up|91
3054609|NCT00567489|10499791|P2|Overall Study|Other|0
3054610|NCT00567489|10499792|P1|Overall Study|Other|1
3054611|NCT00567489|10499791|P2|Overall Study|Renal Transplantation|3
3054612|NCT00567489|10499792|P1|Overall Study|Renal Transplantation|0
3054613|NCT00567489|10499791|P2|Overall Study|Withdrawal by Subject|2
3054614|NCT00567489|10499792|P1|Overall Study|Withdrawal by Subject|0
3054615|NCT00567489|10499791|P2|Overall Study|Physician Decision|4
3054616|NCT00567489|10499792|P1|Overall Study|Physician Decision|0
3054617|NCT00567489|10499791|P2|Overall Study|Adverse Event|14
3054618|NCT00567489|10499792|P1|Overall Study|Adverse Event|6
3054619|NCT00567476|10499842|P2|Overall Study|Non-adherence to protocol|1
3054620|NCT00567476|10499843|P1|Overall Study|Non-adherence to protocol|0
3054621|NCT00567476|10499842|P2|Overall Study|Medical Decision|1
3054622|NCT00567476|10499843|P1|Overall Study|Medical Decision|0
3054623|NCT00567476|10499842|P2|Overall Study|Administrative issues|0
3054624|NCT00567476|10499843|P1|Overall Study|Administrative issues|1
3054625|NCT00567476|10499842|P2|Overall Study|Lost to Follow-up|1
3054626|NCT00567476|10499843|P1|Overall Study|Lost to Follow-up|0
3054627|NCT00567476|10499842|P2|Overall Study|Protocol Violation|1
3054628|NCT00567476|10499843|P1|Overall Study|Protocol Violation|4
3054629|NCT00567476|10499842|P2|Overall Study|Pregnancy|0
3054630|NCT00567476|10499843|P1|Overall Study|Pregnancy|1
3054631|NCT00567476|10499842|P2|Overall Study|Adverse Event|0
3054632|NCT00567476|10499843|P1|Overall Study|Adverse Event|2
3054633|NCT00567398|10499869|P2|Overall Study|Other|0
3054634|NCT00567398|10499870|P1|Overall Study|Other|1
3054635|NCT00567398|10499869|P2|Overall Study|Renal Transplantation|3
3054636|NCT00567398|10499870|P1|Overall Study|Renal Transplantation|0
3054637|NCT00567398|10499869|P2|Overall Study|Withdrawal by Subject|2
3054638|NCT00567398|10499870|P1|Overall Study|Withdrawal by Subject|0
3054639|NCT00567398|10499869|P2|Overall Study|Physician Decision|4
3054640|NCT00567398|10499870|P1|Overall Study|Physician Decision|0
3054641|NCT00567398|10499869|P2|Overall Study|Adverse Event|14
3054642|NCT00567398|10499870|P1|Overall Study|Adverse Event|6
3054643|NCT00567359|10499918|P1|Overall Study|Withdrawal by Subject|1
3054644|NCT00567268|10499943|P1|Overall Study|"Safety Evaluation Not Assessable"|1
3054645|NCT00567268|10499943|P1|Overall Study|No Drug Administration|4
3054646|NCT00567268|10499943|P1|Overall Study|No Visit After First Day of Treatment|2
3054647|NCT00567268|10499943|P1|Overall Study|Lost to Follow-up|36
3054648|NCT00567268|10499943|P1|Overall Study|Protocol Violation|7
3054649|NCT00567255|10499994|P2|Overall Study|Drug noncompliance,moved,other|15
3054650|NCT00567255|10499995|P1|Overall Study|Drug noncompliance,moved,other|25
3054651|NCT00567255|10499994|P2|Overall Study|Pregnancy|0
3054652|NCT00567255|10499995|P1|Overall Study|Pregnancy|6
3054653|NCT00567255|10499994|P2|Overall Study|Protocol Violation|8
3054654|NCT00567255|10499995|P1|Overall Study|Protocol Violation|20
3054655|NCT00567255|10499994|P2|Overall Study|Lack of Efficacy|33
3054656|NCT00567255|10499995|P1|Overall Study|Lack of Efficacy|19
3054657|NCT00567255|10499994|P2|Overall Study|Withdrawal by Subject|56
3054658|NCT00567255|10499995|P1|Overall Study|Withdrawal by Subject|75
3054659|NCT00567255|10499994|P2|Overall Study|Lost to Follow-up|48
3054660|NCT00567255|10499995|P1|Overall Study|Lost to Follow-up|77
3054661|NCT00567255|10499994|P2|Overall Study|Adverse Event|68
3054662|NCT00567255|10499995|P1|Overall Study|Adverse Event|241
3054663|NCT00567190|10500058|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
3054664|NCT00567190|10500059|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
3054665|NCT00567190|10500058|P2|Overall Study|Death|280
3054666|NCT00567190|10500059|P1|Overall Study|Death|235
3054667|NCT00567164|10500110|P3|Overall Study|Missing|0
3054668|NCT00567164|10500111|P2|Overall Study|Missing|0
3054669|NCT00567164|10500112|P1|Overall Study|Missing|1
3054670|NCT00567164|10500110|P3|Overall Study|Primary Reason coded as 'Other'|16
3054671|NCT00567164|10500111|P2|Overall Study|Primary Reason coded as 'Other'|8
3054672|NCT00567164|10500112|P1|Overall Study|Primary Reason coded as 'Other'|37
3054673|NCT00567164|10500110|P3|Overall Study|Pregnancy|6
3054674|NCT00567164|10500111|P2|Overall Study|Pregnancy|4
3054675|NCT00567164|10500112|P1|Overall Study|Pregnancy|20
3054676|NCT00567164|10500110|P3|Overall Study|Lost to Follow-up|21
3054677|NCT00567164|10500111|P2|Overall Study|Lost to Follow-up|23
3054678|NCT00567164|10500112|P1|Overall Study|Lost to Follow-up|202
3054679|NCT00567164|10500110|P3|Overall Study|Death|1
3054680|NCT00567164|10500111|P2|Overall Study|Death|0
3054681|NCT00567164|10500112|P1|Overall Study|Death|0
3054682|NCT00567164|10500110|P3|Overall Study|Adverse Event|9
3054683|NCT00567164|10500111|P2|Overall Study|Adverse Event|13
3054684|NCT00567164|10500112|P1|Overall Study|Adverse Event|92
3054685|NCT00567164|10500110|P3|Overall Study|Protocol Violation|2
3054686|NCT00567164|10500111|P2|Overall Study|Protocol Violation|4
3054687|NCT00567164|10500112|P1|Overall Study|Protocol Violation|23
3054688|NCT00567164|10500110|P3|Overall Study|Withdrawal by Subject|17
3054689|NCT00567164|10500111|P2|Overall Study|Withdrawal by Subject|21
3054690|NCT00567164|10500112|P1|Overall Study|Withdrawal by Subject|171
3054691|NCT00567112|10500184|P3|Washout Period 3 (3 Days)|Protocol Violation|0
3054692|NCT00567112|10500185|P2|Washout Period 3 (3 Days)|Protocol Violation|0
3054693|NCT00567112|10500186|P1|Washout Period 3 (3 Days)|Protocol Violation|1
3054694|NCT00567112|10500184|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
3054695|NCT00567112|10500185|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
3054696|NCT00567112|10500186|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
3054697|NCT00567112|10500184|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
3054698|NCT00567112|10500185|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
3054699|NCT00567112|10500186|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
3054700|NCT00566995|10500217|P1|Overall Study|Withdrew consent|3
3054701|NCT00566995|10500217|P1|Overall Study|Toxicity|4
3054702|NCT00566982|10500232|P2|Overall Study|Other-family problems & doctor's request|2
3054703|NCT00566982|10500233|P1|Overall Study|Other-family problems & doctor's request|0
3054704|NCT00566982|10500232|P2|Overall Study|Lost to Follow-up|1
3054705|NCT00566982|10500233|P1|Overall Study|Lost to Follow-up|0
3054706|NCT00566982|10500232|P2|Overall Study|Protocol Violation|4
3054707|NCT00566982|10500233|P1|Overall Study|Protocol Violation|1
3054708|NCT00566982|10500232|P2|Overall Study|Withdrawal by Subject|14
3054709|NCT00566982|10500233|P1|Overall Study|Withdrawal by Subject|1
3054710|NCT00566982|10500232|P2|Overall Study|Adverse Event|48
3054711|NCT00566982|10500233|P1|Overall Study|Adverse Event|6
3054712|NCT00566852|10500298|P2|Overall Study|Missing reason not reported|20
3054713|NCT00566852|10500299|P1|Overall Study|Missing reason not reported|16
3054714|NCT00566852|10500298|P2|Overall Study|Missing reason not specified|2
3054715|NCT00566852|10500299|P1|Overall Study|Missing reason not specified|1
3054716|NCT00566852|10500298|P2|Overall Study|Not tested due to disability|12
3054717|NCT00566852|10500299|P1|Overall Study|Not tested due to disability|6
3054718|NCT00566852|10500298|P2|Overall Study|Patient refusal|37
3054719|NCT00566852|10500299|P1|Overall Study|Patient refusal|37
3054720|NCT00566852|10500298|P2|Overall Study|Withdrawal by Subject|25
3054721|NCT00566852|10500299|P1|Overall Study|Withdrawal by Subject|30
3054722|NCT00566852|10500298|P2|Overall Study|Death|78
3054723|NCT00566852|10500299|P1|Overall Study|Death|95
3054724|NCT00566852|10500298|P2|Overall Study|Protocol Violation|24
3054725|NCT00566852|10500299|P1|Overall Study|Protocol Violation|22
3054726|NCT00566735|10500330|P2|Overall Study|Switched into a manic episode|1
3054727|NCT00566735|10500331|P1|Overall Study|Switched into a manic episode|0
3054728|NCT00566735|10500330|P2|Overall Study|Refused neuropsychological testing|5
3054729|NCT00566735|10500331|P1|Overall Study|Refused neuropsychological testing|2
3054730|NCT00566735|10500330|P2|Overall Study|Withdrawal by Subject|1
3054731|NCT00566735|10500331|P1|Overall Study|Withdrawal by Subject|0
3054732|NCT00566722|10500344|P3|Overall Study|Noncompliant with drug administration|1
3054733|NCT00566722|10500345|P2|Overall Study|Noncompliant with drug administration|0
3054734|NCT00566722|10500346|P1|Overall Study|Noncompliant with drug administration|0
3054735|NCT00566722|10500344|P3|Overall Study|Serious adverse event|0
3054736|NCT00566722|10500345|P2|Overall Study|Serious adverse event|1
3054737|NCT00566722|10500346|P1|Overall Study|Serious adverse event|0
3054738|NCT00566722|10500344|P3|Overall Study|Did not meet exclusion criteria|2
3054739|NCT00566722|10500345|P2|Overall Study|Did not meet exclusion criteria|0
3054740|NCT00566722|10500346|P1|Overall Study|Did not meet exclusion criteria|0
3054741|NCT00566722|10500344|P3|Overall Study|Lack of Efficacy|4
3054742|NCT00566722|10500345|P2|Overall Study|Lack of Efficacy|2
3054743|NCT00566722|10500346|P1|Overall Study|Lack of Efficacy|1
3054744|NCT00566722|10500344|P3|Overall Study|Lost to Follow-up|1
3054745|NCT00566722|10500345|P2|Overall Study|Lost to Follow-up|1
3054746|NCT00566722|10500346|P1|Overall Study|Lost to Follow-up|1
3054747|NCT00566722|10500344|P3|Overall Study|Withdrawal by Subject|1
3054748|NCT00566722|10500345|P2|Overall Study|Withdrawal by Subject|0
3054749|NCT00566722|10500346|P1|Overall Study|Withdrawal by Subject|0
3054750|NCT00566722|10500344|P3|Overall Study|Adverse Event|0
3054751|NCT00566722|10500345|P2|Overall Study|Adverse Event|1
3054752|NCT00566722|10500346|P1|Overall Study|Adverse Event|0
3054753|NCT00566709|10500392|P2|Overall Study|Protocol Violation|0
3054754|NCT00566709|10500393|P1|Overall Study|Protocol Violation|5
3054755|NCT00566696|10500409|P1|Overall Study|Non-Patient Donors|37
3054756|NCT00566696|10500409|P1|Overall Study|Physician Decision|1
3054757|NCT00566696|10500409|P1|Overall Study|Health Status Change|1
3054758|NCT00566696|10500409|P1|Overall Study|Muromonab not available|1
3054759|NCT00566696|10500409|P1|Overall Study|Met Exclusion Criteria|2
3054760|NCT00566631|10500419|P1|Part 2: Extension Phase|Other|5
3054761|NCT00566631|10500419|P1|Part 2: Extension Phase|Death|1
3054762|NCT00566631|10500419|P1|Part 2: Extension Phase|Lost to Follow-up|6
3054763|NCT00566631|10500419|P1|Part 2: Extension Phase|Adverse Event|11
3054764|NCT00566631|10500419|P1|Part 2: Extension Phase|Withdrawal by Subject|34
3054765|NCT00566631|10500419|P1|Part 2: Extension Phase|Lack of Efficacy|25
3054766|NCT00566631|10500419|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
3054767|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
3054768|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
3054769|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
3054770|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
3054771|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Adverse Event|9
3054772|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Physician Decision|1
3054773|NCT00566631|10500419|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
3054774|NCT00566527|10500446|P3|Overall Study|Withdrawal by Subject|43
3054775|NCT00566527|10500447|P2|Overall Study|Withdrawal by Subject|43
3054776|NCT00566527|10500448|P1|Overall Study|Withdrawal by Subject|6
3054777|NCT00566527|10500446|P3|Overall Study|Lost to Follow-up|4
3054778|NCT00566527|10500447|P2|Overall Study|Lost to Follow-up|4
3054779|NCT00566527|10500448|P1|Overall Study|Lost to Follow-up|3
3054780|NCT00566527|10500446|P3|Overall Study|Physician Decision|20
3054781|NCT00566527|10500447|P2|Overall Study|Physician Decision|8
3054782|NCT00566527|10500448|P1|Overall Study|Physician Decision|3
3054783|NCT00566527|10500446|P3|Overall Study|Adverse Event|1
3054784|NCT00566527|10500447|P2|Overall Study|Adverse Event|0
3054785|NCT00566527|10500448|P1|Overall Study|Adverse Event|2
3054786|NCT00566527|10500446|P3|Overall Study|Reason not provided|10
3054787|NCT00566527|10500447|P2|Overall Study|Reason not provided|11
3054788|NCT00566527|10500448|P1|Overall Study|Reason not provided|3
3054789|NCT00566254|10500509|P2|Overall Study|Other|2
3054790|NCT00566254|10500510|P1|Overall Study|Other|0
3054791|NCT00566254|10500509|P2|Overall Study|Lack of Efficacy|6
3054792|NCT00566254|10500510|P1|Overall Study|Lack of Efficacy|5
3054793|NCT00566254|10500509|P2|Overall Study|Withdrawal by Subject|2
3054794|NCT00566254|10500510|P1|Overall Study|Withdrawal by Subject|1
3054795|NCT00566254|10500509|P2|Overall Study|Protocol Violation|3
3054796|NCT00566254|10500510|P1|Overall Study|Protocol Violation|1
3054797|NCT00566254|10500509|P2|Overall Study|Adverse Event|1
3054798|NCT00566254|10500510|P1|Overall Study|Adverse Event|3
3054799|NCT00566228|10500524|P2|Overall Study|progressed before infusion could occur|1
3054800|NCT00566228|10500525|P1|Overall Study|progressed before infusion could occur|0
3054801|NCT00566228|10500524|P2|Overall Study|Unable to collect sufficient CD34 cells|2
3054802|NCT00566228|10500525|P1|Overall Study|Unable to collect sufficient CD34 cells|3
3054803|NCT00566228|10500524|P2|Overall Study|Attempt to mobilize stem cells failed|2
3054804|NCT00566228|10500525|P1|Overall Study|Attempt to mobilize stem cells failed|2
3054805|NCT00566228|10500524|P2|Overall Study|Withdrawal by Subject|0
3054806|NCT00566228|10500525|P1|Overall Study|Withdrawal by Subject|1
3054807|NCT00566111|10500558|P2|Overall Study|Adverse Event|2
3054808|NCT00566111|10500559|P1|Overall Study|Adverse Event|0
3054809|NCT00566098|10500573|P1|Administration of ASCT+MILs|Lack of Efficacy|8
3054810|NCT00566098|10500573|P1|Administration of ASCT+MILs|Death|10
3054811|NCT00566098|10500573|P1|Generation of MILs Product|Relapsed|1
3054812|NCT00566098|10500573|P1|Collection of MILs|Relapsed|1
3054813|NCT00566098|10500573|P1|Collection of MILs|Withdrawal by Subject|1
3054814|NCT00566020|10500583|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
3054815|NCT00566020|10500584|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
3054816|NCT00566020|10500583|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
3054817|NCT00566020|10500584|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
3054818|NCT00566020|10500583|P2|46-week Long-term Administration Phase|Physician Decision|7
3054819|NCT00566020|10500584|P1|46-week Long-term Administration Phase|Physician Decision|0
3054820|NCT00566020|10500583|P2|46-week Long-term Administration Phase|Adverse Event|7
3054821|NCT00566020|10500584|P1|46-week Long-term Administration Phase|Adverse Event|0
3054822|NCT00566020|10500583|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
3054823|NCT00566020|10500584|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
3054824|NCT00566020|10500583|P2|6-week Dosage Adjustment Phase|Adverse Event|0
3054825|NCT00566020|10500584|P1|6-week Dosage Adjustment Phase|Adverse Event|5
3054826|NCT00565812|10500673|P3|Overall Study|Physician Decision|0
3054827|NCT00565812|10500674|P2|Overall Study|Physician Decision|0
3054828|NCT00565812|10500675|P1|Overall Study|Physician Decision|2
3054829|NCT00565812|10500673|P3|Overall Study|Follow-up Visit Not Completed|1
3054830|NCT00565812|10500674|P2|Overall Study|Follow-up Visit Not Completed|0
3054831|NCT00565812|10500675|P1|Overall Study|Follow-up Visit Not Completed|2
3054832|NCT00565812|10500673|P3|Overall Study|Low Compliance|1
3054833|NCT00565812|10500674|P2|Overall Study|Low Compliance|0
3054834|NCT00565812|10500675|P1|Overall Study|Low Compliance|1
3054835|NCT00565812|10500673|P3|Overall Study|Surgical Intervention|2
3054836|NCT00565812|10500674|P2|Overall Study|Surgical Intervention|1
3054837|NCT00565812|10500675|P1|Overall Study|Surgical Intervention|0
3054838|NCT00565812|10500673|P3|Overall Study|Research Site Closure|8
3054839|NCT00565812|10500674|P2|Overall Study|Research Site Closure|1
3054840|NCT00565812|10500675|P1|Overall Study|Research Site Closure|6
3054841|NCT00565812|10500673|P3|Overall Study|Domestic Reasons|3
3054842|NCT00565812|10500674|P2|Overall Study|Domestic Reasons|1
3054843|NCT00565812|10500675|P1|Overall Study|Domestic Reasons|7
3054844|NCT00565812|10500673|P3|Overall Study|Sponsor Decision|1
3054845|NCT00565812|10500674|P2|Overall Study|Sponsor Decision|5
3054846|NCT00565812|10500675|P1|Overall Study|Sponsor Decision|1
3054847|NCT00565812|10500673|P3|Overall Study|Relocated Out of Area|9
3054848|NCT00565812|10500674|P2|Overall Study|Relocated Out of Area|8
3054849|NCT00565812|10500675|P1|Overall Study|Relocated Out of Area|5
3054850|NCT00565812|10500673|P3|Overall Study|Jury Duty|0
3054851|NCT00565812|10500674|P2|Overall Study|Jury Duty|0
3054852|NCT00565812|10500675|P1|Overall Study|Jury Duty|1
3054853|NCT00565812|10500673|P3|Overall Study|Adverse Event|40
3054854|NCT00565812|10500674|P2|Overall Study|Adverse Event|54
3054855|NCT00565812|10500675|P1|Overall Study|Adverse Event|41
3054856|NCT00565812|10500673|P3|Overall Study|Protocol Violation|4
3054857|NCT00565812|10500674|P2|Overall Study|Protocol Violation|6
3054858|NCT00565812|10500675|P1|Overall Study|Protocol Violation|2
3054859|NCT00565812|10500673|P3|Overall Study|Work Schedule|1
3054860|NCT00565812|10500674|P2|Overall Study|Work Schedule|3
3054861|NCT00565812|10500675|P1|Overall Study|Work Schedule|5
3054862|NCT00565812|10500673|P3|Overall Study|Withdrawal by Subject|48
3054863|NCT00565812|10500674|P2|Overall Study|Withdrawal by Subject|47
3054864|NCT00565812|10500675|P1|Overall Study|Withdrawal by Subject|58
3054865|NCT00565812|10500673|P3|Overall Study|Lost to Follow-up|8
3054866|NCT00565812|10500674|P2|Overall Study|Lost to Follow-up|8
3054867|NCT00565812|10500675|P1|Overall Study|Lost to Follow-up|10
3054868|NCT00565812|10500673|P3|Overall Study|Did not Meet Entrance Criteria|1
3054869|NCT00565812|10500674|P2|Overall Study|Did not Meet Entrance Criteria|0
3054870|NCT00565812|10500675|P1|Overall Study|Did not Meet Entrance Criteria|1
3054871|NCT00565812|10500673|P3|Overall Study|Death|3
3054872|NCT00565812|10500674|P2|Overall Study|Death|1
3054873|NCT00565812|10500675|P1|Overall Study|Death|2
3054874|NCT00565773|10500812|P1|Overall Study|Physician Decision|1
3054875|NCT00565773|10500812|P1|Overall Study|Withdrawal by Subject|1
3054876|NCT00565747|10500824|P2|Overall Study|No embryo transfer|73
3054877|NCT00565747|10500825|P1|Overall Study|No embryo transfer|67
3054878|NCT00565721|10500835|P1|Overall Study|Other reasons|6
3054879|NCT00565721|10500835|P1|Overall Study|Physician Decision|2
3054880|NCT00565721|10500835|P1|Overall Study|Technical Problems|1
3054881|NCT00565721|10500835|P1|Overall Study|Lost to Follow-up|6
3054882|NCT00565721|10500835|P1|Overall Study|Screen Failure|2
3054883|NCT00565617|10500884|P1|Overall Study|Withdrawal by Subject|1
3054884|NCT00565604|10500888|P1|Overall Study|Lost to Follow-up|2
3054885|NCT00565604|10500888|P1|Overall Study|Failure to treat|2
3054886|NCT00565448|10500934|P2|Overall Study|Withdrawal by Subject|0
3054887|NCT00565448|10500935|P1|Overall Study|Withdrawal by Subject|1
3054888|NCT00565448|10500934|P2|Overall Study|Disease progression|0
3054889|NCT00565448|10500935|P1|Overall Study|Disease progression|1
3054890|NCT00565448|10500934|P2|Overall Study|Adverse Event|2
3054891|NCT00565448|10500935|P1|Overall Study|Adverse Event|1
3054892|NCT00565409|10500946|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
3054893|NCT00565409|10500947|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
3054894|NCT00565409|10500948|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
3054895|NCT00565409|10500949|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
3054896|NCT00565409|10500946|P4|Period 2 Double-Blind|Other|9
3054897|NCT00565409|10500947|P3|Period 2 Double-Blind|Other|5
3054898|NCT00565409|10500948|P2|Period 2 Double-Blind|Other|4
3054899|NCT00565409|10500949|P1|Period 2 Double-Blind|Other|0
3054900|NCT00565409|10500946|P4|Period 2 Double-Blind|Lost to Follow-up|0
3054901|NCT00565409|10500947|P3|Period 2 Double-Blind|Lost to Follow-up|1
3054902|NCT00565409|10500948|P2|Period 2 Double-Blind|Lost to Follow-up|0
3054903|NCT00565409|10500949|P1|Period 2 Double-Blind|Lost to Follow-up|0
3054904|NCT00565409|10500946|P4|Period 2 Double-Blind|Protocol Violation|2
3054905|NCT00565409|10500947|P3|Period 2 Double-Blind|Protocol Violation|6
3054906|NCT00565409|10500948|P2|Period 2 Double-Blind|Protocol Violation|4
3054907|NCT00565409|10500949|P1|Period 2 Double-Blind|Protocol Violation|0
3054908|NCT00565409|10500946|P4|Period 2 Double-Blind|Death|0
3054909|NCT00565409|10500947|P3|Period 2 Double-Blind|Death|0
3054910|NCT00565409|10500948|P2|Period 2 Double-Blind|Death|2
3054911|NCT00565409|10500949|P1|Period 2 Double-Blind|Death|0
3054912|NCT00565409|10500946|P4|Period 2 Double-Blind|Adverse Event|5
3054913|NCT00565409|10500947|P3|Period 2 Double-Blind|Adverse Event|4
3054914|NCT00565409|10500948|P2|Period 2 Double-Blind|Adverse Event|7
3054915|NCT00565409|10500949|P1|Period 2 Double-Blind|Adverse Event|0
3054916|NCT00565409|10500946|P4|After Period 1, Prior to Period 2|did not meet criteria|0
3054917|NCT00565409|10500947|P3|After Period 1, Prior to Period 2|did not meet criteria|0
3054918|NCT00565409|10500948|P2|After Period 1, Prior to Period 2|did not meet criteria|0
3054919|NCT00565409|10500949|P1|After Period 1, Prior to Period 2|did not meet criteria|152
3054920|NCT00565409|10500946|P4|Period 1 Open Label|no conclusion of participation record|0
3054921|NCT00565409|10500947|P3|Period 1 Open Label|no conclusion of participation record|0
3054922|NCT00565409|10500948|P2|Period 1 Open Label|no conclusion of participation record|0
3054923|NCT00565409|10500949|P1|Period 1 Open Label|no conclusion of participation record|1
3054924|NCT00565409|10500946|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
3054925|NCT00565409|10500947|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
3054926|NCT00565409|10500948|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
3054927|NCT00565409|10500949|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
3054928|NCT00565409|10500946|P4|Period 1 Open Label|Protocol Violation|0
3054929|NCT00565409|10500947|P3|Period 1 Open Label|Protocol Violation|0
3054930|NCT00565409|10500948|P2|Period 1 Open Label|Protocol Violation|0
3054931|NCT00565409|10500949|P1|Period 1 Open Label|Protocol Violation|14
3054932|NCT00565409|10500946|P4|Period 1 Open Label|Other|0
3054933|NCT00565409|10500947|P3|Period 1 Open Label|Other|0
3054934|NCT00565409|10500948|P2|Period 1 Open Label|Other|0
3054935|NCT00565409|10500949|P1|Period 1 Open Label|Other|21
3054936|NCT00565409|10500946|P4|Period 1 Open Label|Lost to Follow-up|0
3054937|NCT00565409|10500947|P3|Period 1 Open Label|Lost to Follow-up|0
3054938|NCT00565409|10500948|P2|Period 1 Open Label|Lost to Follow-up|0
3054939|NCT00565409|10500949|P1|Period 1 Open Label|Lost to Follow-up|1
3054940|NCT00565409|10500946|P4|Period 1 Open Label|Death|0
3054941|NCT00565409|10500947|P3|Period 1 Open Label|Death|0
3054942|NCT00565409|10500948|P2|Period 1 Open Label|Death|0
3054943|NCT00565409|10500949|P1|Period 1 Open Label|Death|2
3054944|NCT00565409|10500946|P4|Period 1 Open Label|Adverse Event|0
3054945|NCT00565409|10500947|P3|Period 1 Open Label|Adverse Event|0
3054946|NCT00565409|10500948|P2|Period 1 Open Label|Adverse Event|0
3054947|NCT00565409|10500949|P1|Period 1 Open Label|Adverse Event|17
3054948|NCT00565136|10501085|P1|Overall Study|Protocol Violation|1
3054949|NCT00565136|10501085|P1|Overall Study|Withdrawal by Subject|1
3054950|NCT00565136|10501085|P1|Overall Study|Lost to Follow-up|1
3054951|NCT00565058|10501126|P2|Overall Study|Adverse Event|0
3054952|NCT00565058|10501127|P1|Overall Study|Adverse Event|1
3054953|NCT00564902|10501174|P3|Overall Study|Death|0
3054954|NCT00564902|10501175|P2|Overall Study|Death|1
3054955|NCT00564902|10501176|P1|Overall Study|Death|1
3054956|NCT00564902|10501174|P3|Overall Study|Withdrawal by Subject|4
3054957|NCT00564902|10501175|P2|Overall Study|Withdrawal by Subject|3
3054958|NCT00564902|10501176|P1|Overall Study|Withdrawal by Subject|0
3054959|NCT00564889|10501208|P1|Overall Study|Other, not specified|4
3054960|NCT00564889|10501208|P1|Overall Study|Disease progression|3
3054961|NCT00564889|10501208|P1|Overall Study|Alternative treatment|3
3054962|NCT00564889|10501208|P1|Overall Study|Adverse Event|12
3054963|NCT00564889|10501208|P1|Overall Study|Death|7
3054964|NCT00564850|10501223|P1|Overall Study|Protocol Violation|2
3054965|NCT00564733|10501241|P1|Overall Study|Ineligible|5
3054966|NCT00564733|10501241|P1|Overall Study|Withdrawal by Subject|4
3054967|NCT00564629|10501275|P2|Overall Study|Vomited within 2 hours of receiving drug|9
3054968|NCT00564629|10501276|P1|Overall Study|Vomited within 2 hours of receiving drug|15
3054969|NCT00564486|10501301|P4|Overall Study|Lost to Follow-up|2
3054970|NCT00564486|10501302|P3|Overall Study|Lost to Follow-up|2
3054971|NCT00564486|10501303|P2|Overall Study|Lost to Follow-up|0
3054972|NCT00564486|10501304|P1|Overall Study|Lost to Follow-up|3
3054973|NCT00564486|10501301|P4|Overall Study|Subject refused to have blood drawn|0
3054974|NCT00564486|10501302|P3|Overall Study|Subject refused to have blood drawn|1
3054975|NCT00564486|10501303|P2|Overall Study|Subject refused to have blood drawn|0
3054976|NCT00564486|10501304|P1|Overall Study|Subject refused to have blood drawn|0
3054977|NCT00564486|10501301|P4|Overall Study|Withdrawal by Subject|5
3054978|NCT00564486|10501302|P3|Overall Study|Withdrawal by Subject|0
3054979|NCT00564486|10501303|P2|Overall Study|Withdrawal by Subject|0
3054980|NCT00564486|10501304|P1|Overall Study|Withdrawal by Subject|4
3054981|NCT00564486|10501301|P4|Overall Study|Adverse Event|0
3054982|NCT00564486|10501302|P3|Overall Study|Adverse Event|0
3054983|NCT00564486|10501303|P2|Overall Study|Adverse Event|1
3054984|NCT00564486|10501304|P1|Overall Study|Adverse Event|0
3054985|NCT00564395|10501353|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
3054986|NCT00564395|10501354|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
3054987|NCT00564395|10501353|P2|First Intervention (10 Days)|Withdrawal by Subject|0
3054988|NCT00564395|10501354|P1|First Intervention (10 Days)|Withdrawal by Subject|1
3054989|NCT00564278|10501362|P2|Overall Study|Withdrawal by Subject|7
3054990|NCT00564278|10501363|P1|Overall Study|Withdrawal by Subject|11
3054991|NCT00564278|10501362|P2|Overall Study|Physician Decision|2
3054992|NCT00564278|10501363|P1|Overall Study|Physician Decision|1
3054993|NCT00564278|10501362|P2|Overall Study|Lost to Follow-up|33
3054994|NCT00564278|10501363|P1|Overall Study|Lost to Follow-up|35
3054995|NCT00564070|10501385|P2|Overall Study|Worsening depression, referred to care|0
3054996|NCT00564070|10501386|P1|Overall Study|Worsening depression, referred to care|3
3054997|NCT00564070|10501385|P2|Overall Study|Lost to Follow-up|7
3054998|NCT00564070|10501386|P1|Overall Study|Lost to Follow-up|9
3054999|NCT00564018|10501413|P3|Overall Study|Withdrawal by Subject|1
3055000|NCT00564018|10501414|P2|Overall Study|Withdrawal by Subject|3
3055001|NCT00564018|10501415|P1|Overall Study|Withdrawal by Subject|2
3055002|NCT00563797|10501428|P2|Overall Study|Lost to Follow-up|2
3055003|NCT00563797|10501429|P1|Overall Study|Lost to Follow-up|7
3055004|NCT00563784|10501441|P1|Overall Study|Screen Failures|20
3055005|NCT00563784|10501441|P1|Overall Study|Withdrawal by Subject|2
3055006|NCT00563706|10501455|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
3055007|NCT00563706|10501456|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
3055008|NCT00563706|10501457|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055009|NCT00563706|10501458|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055010|NCT00563706|10501459|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055011|NCT00563706|10501460|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055012|NCT00563706|10501461|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055013|NCT00563706|10501462|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055014|NCT00563706|10501463|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
3055015|NCT00563706|10501455|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055016|NCT00563706|10501456|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
3055017|NCT00563706|10501457|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055018|NCT00563706|10501458|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055019|NCT00563706|10501459|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055099|NCT00563368|10501656|P6|Overall Study|Adverse Event|10
3055020|NCT00563706|10501460|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055021|NCT00563706|10501461|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055022|NCT00563706|10501462|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
3055023|NCT00563706|10501463|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
3055024|NCT00563706|10501455|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
3055025|NCT00563706|10501456|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
3055026|NCT00563706|10501457|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
3055027|NCT00563706|10501458|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
3055028|NCT00563706|10501459|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
3055029|NCT00563706|10501460|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
3055030|NCT00563706|10501461|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
3055031|NCT00563706|10501462|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
3055032|NCT00563706|10501463|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
3055033|NCT00563706|10501455|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
3055034|NCT00563706|10501456|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
3055035|NCT00563706|10501457|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
3055036|NCT00563706|10501458|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
3055037|NCT00563706|10501459|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
3055038|NCT00563706|10501460|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
3055039|NCT00563706|10501461|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
3055040|NCT00563706|10501462|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
3055041|NCT00563706|10501463|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
3055042|NCT00563706|10501455|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
3055043|NCT00563706|10501456|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
3055044|NCT00563706|10501457|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
3055045|NCT00563706|10501458|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
3055046|NCT00563706|10501459|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
3055047|NCT00563706|10501460|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
3055048|NCT00563706|10501461|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
3055049|NCT00563706|10501462|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
3055050|NCT00563706|10501463|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
3055051|NCT00563381|10501581|P2|Overall Study|Individual different reasons|34
3055052|NCT00563381|10501582|P1|Overall Study|Individual different reasons|24
3055053|NCT00563381|10501581|P2|Overall Study|Lack of Efficacy|24
3055054|NCT00563381|10501582|P1|Overall Study|Lack of Efficacy|32
3055055|NCT00563381|10501581|P2|Overall Study|Withdrawal by Subject|209
3055056|NCT00563381|10501582|P1|Overall Study|Withdrawal by Subject|192
3055057|NCT00563381|10501581|P2|Overall Study|Lost to Follow-up|15
3055058|NCT00563381|10501582|P1|Overall Study|Lost to Follow-up|7
3055059|NCT00563381|10501581|P2|Overall Study|Protocol Violation|74
3055060|NCT00563381|10501582|P1|Overall Study|Protocol Violation|66
3055061|NCT00563381|10501581|P2|Overall Study|Adverse Event|292
3055062|NCT00563381|10501582|P1|Overall Study|Adverse Event|264
3055063|NCT00563368|10501655|P7|Overall Study|Other|0
3055064|NCT00563368|10501656|P6|Overall Study|Other|4
3055065|NCT00563368|10501657|P5|Overall Study|Other|4
3055066|NCT00563368|10501658|P4|Overall Study|Other|4
3055067|NCT00563368|10501659|P3|Overall Study|Other|3
3055068|NCT00563368|10501660|P2|Overall Study|Other|5
3055069|NCT00563368|10501661|P1|Overall Study|Other|5
3055070|NCT00563368|10501655|P7|Overall Study|requirement for restricted medication|0
3055071|NCT00563368|10501656|P6|Overall Study|requirement for restricted medication|0
3055072|NCT00563368|10501657|P5|Overall Study|requirement for restricted medication|0
3055073|NCT00563368|10501658|P4|Overall Study|requirement for restricted medication|0
3055074|NCT00563368|10501659|P3|Overall Study|requirement for restricted medication|2
3055075|NCT00563368|10501660|P2|Overall Study|requirement for restricted medication|0
3055076|NCT00563368|10501661|P1|Overall Study|requirement for restricted medication|0
3055077|NCT00563368|10501655|P7|Overall Study|Pregnancy|0
3055078|NCT00563368|10501656|P6|Overall Study|Pregnancy|2
3055079|NCT00563368|10501657|P5|Overall Study|Pregnancy|1
3055080|NCT00563368|10501658|P4|Overall Study|Pregnancy|2
3055081|NCT00563368|10501659|P3|Overall Study|Pregnancy|1
3055082|NCT00563368|10501660|P2|Overall Study|Pregnancy|0
3055083|NCT00563368|10501661|P1|Overall Study|Pregnancy|1
3055084|NCT00563368|10501655|P7|Overall Study|protocol non-compliance|3
3055085|NCT00563368|10501656|P6|Overall Study|protocol non-compliance|1
3055086|NCT00563368|10501657|P5|Overall Study|protocol non-compliance|0
3055087|NCT00563368|10501658|P4|Overall Study|protocol non-compliance|1
3055088|NCT00563368|10501659|P3|Overall Study|protocol non-compliance|2
3055089|NCT00563368|10501660|P2|Overall Study|protocol non-compliance|1
3055090|NCT00563368|10501661|P1|Overall Study|protocol non-compliance|1
3055091|NCT00563368|10501655|P7|Overall Study|Withdrawal by Subject|4
3055092|NCT00563368|10501656|P6|Overall Study|Withdrawal by Subject|5
3055093|NCT00563368|10501657|P5|Overall Study|Withdrawal by Subject|8
3055094|NCT00563368|10501658|P4|Overall Study|Withdrawal by Subject|7
3055095|NCT00563368|10501659|P3|Overall Study|Withdrawal by Subject|5
3055096|NCT00563368|10501660|P2|Overall Study|Withdrawal by Subject|6
3055097|NCT00563368|10501661|P1|Overall Study|Withdrawal by Subject|11
3055098|NCT00563368|10501655|P7|Overall Study|Adverse Event|17
3055100|NCT00563368|10501657|P5|Overall Study|Adverse Event|6
3055101|NCT00563368|10501658|P4|Overall Study|Adverse Event|9
3055102|NCT00563368|10501659|P3|Overall Study|Adverse Event|5
3055103|NCT00563368|10501660|P2|Overall Study|Adverse Event|4
3055104|NCT00563368|10501661|P1|Overall Study|Adverse Event|3
3055105|NCT00563368|10501655|P7|Overall Study|Lost to Follow-up|9
3055106|NCT00563368|10501656|P6|Overall Study|Lost to Follow-up|8
3055107|NCT00563368|10501657|P5|Overall Study|Lost to Follow-up|9
3055108|NCT00563368|10501658|P4|Overall Study|Lost to Follow-up|6
3055109|NCT00563368|10501659|P3|Overall Study|Lost to Follow-up|12
3055110|NCT00563368|10501660|P2|Overall Study|Lost to Follow-up|14
3055111|NCT00563368|10501661|P1|Overall Study|Lost to Follow-up|14
3055112|NCT00563316|10501684|P1|Overall Study|Other|1
3055113|NCT00563316|10501684|P1|Overall Study|On-going in study as of 16 July 2009.|5
3055114|NCT00563316|10501684|P1|Overall Study|Death|1
3055115|NCT00563316|10501684|P1|Overall Study|Lost to Follow-up|2
3055116|NCT00563316|10501684|P1|Overall Study|Physician Decision|1
3055117|NCT00563316|10501684|P1|Overall Study|Adverse Event|2
3055118|NCT00563186|10501709|P2|Overall Study|Incomplete data|1
3055119|NCT00563186|10501710|P1|Overall Study|Incomplete data|1
3055120|NCT00563186|10501709|P2|Overall Study|LOS<48 hours|74
3055121|NCT00563186|10501710|P1|Overall Study|LOS<48 hours|97
3055122|NCT00562965|10501721|P2|Overall Study|Other|1
3055123|NCT00562965|10501722|P1|Overall Study|Other|0
3055124|NCT00562965|10501721|P2|Overall Study|Lost to Follow-up|0
3055125|NCT00562965|10501722|P1|Overall Study|Lost to Follow-up|1
3055126|NCT00562965|10501721|P2|Overall Study|Death|4
3055127|NCT00562965|10501722|P1|Overall Study|Death|2
3055128|NCT00562965|10501721|P2|Overall Study|Withdrawal by Subject|1
3055129|NCT00562965|10501722|P1|Overall Study|Withdrawal by Subject|0
3055130|NCT00562861|10501743|P2|Overall Study|Lost to Follow-up|3
3055131|NCT00562861|10501744|P1|Overall Study|Lost to Follow-up|7
3055132|NCT00562861|10501743|P2|Overall Study|noncompliance, moved|2
3055133|NCT00562861|10501744|P1|Overall Study|noncompliance, moved|7
3055134|NCT00562861|10501743|P2|Overall Study|Lack of Efficacy|5
3055135|NCT00562861|10501744|P1|Overall Study|Lack of Efficacy|5
3055136|NCT00562861|10501743|P2|Overall Study|Adverse Event|1
3055137|NCT00562861|10501744|P1|Overall Study|Adverse Event|1
3055138|NCT00562718|10501750|P1|Overall Study|not stated|1
3055139|NCT00562718|10501750|P1|Overall Study|Lack of Efficacy|2
3055140|NCT00562718|10501750|P1|Overall Study|Adverse Event|4
3055141|NCT00562718|10501750|P1|Overall Study|Withdrawal by Subject|3
3055142|NCT00562718|10501750|P1|Overall Study|Death|1
3055143|NCT00562627|10501759|P3|Overall Study|Protocol Violation|1
3055144|NCT00562627|10501760|P2|Overall Study|Protocol Violation|1
3055145|NCT00562627|10501761|P1|Overall Study|Protocol Violation|1
3055146|NCT00562588|10501777|P2|Overall Study|Other|2
3055147|NCT00562588|10501778|P1|Overall Study|Other|0
3055148|NCT00562588|10501777|P2|Overall Study|Withdrawal by Subject|9
3055149|NCT00562588|10501778|P1|Overall Study|Withdrawal by Subject|10
3055150|NCT00562588|10501777|P2|Overall Study|Lost to Follow-up|4
3055151|NCT00562588|10501778|P1|Overall Study|Lost to Follow-up|12
3055152|NCT00562588|10501777|P2|Overall Study|Protocol Violation|26
3055153|NCT00562588|10501778|P1|Overall Study|Protocol Violation|30
3055154|NCT00562588|10501777|P2|Overall Study|Adverse Event|58
3055155|NCT00562588|10501778|P1|Overall Study|Adverse Event|40
3055156|NCT00562484|10501808|P2|Overall Study|Reason not provided or not specified|12
3055157|NCT00562484|10501809|P1|Overall Study|Reason not provided or not specified|25
3055158|NCT00562484|10501808|P2|Overall Study|Lost to Follow-up|71
3055159|NCT00562484|10501809|P1|Overall Study|Lost to Follow-up|132
3055160|NCT00562484|10501808|P2|Overall Study|Moved away from the study area|9
3055161|NCT00562484|10501809|P1|Overall Study|Moved away from the study area|20
3055162|NCT00562484|10501808|P2|Overall Study|Withdrawal by Subject|9
3055163|NCT00562484|10501809|P1|Overall Study|Withdrawal by Subject|12
3055164|NCT00562484|10501808|P2|Overall Study|Protocol Violation|2
3055165|NCT00562484|10501809|P1|Overall Study|Protocol Violation|11
3055166|NCT00562484|10501808|P2|Overall Study|Adverse Event|1
3055167|NCT00562484|10501809|P1|Overall Study|Adverse Event|6
3055168|NCT00562354|10501841|P2|Overall Study|Lost to Follow-up|1
3055169|NCT00562354|10501842|P1|Overall Study|Lost to Follow-up|0
3055170|NCT00562354|10501841|P2|Overall Study|Physician Decision|1
3055171|NCT00562354|10501842|P1|Overall Study|Physician Decision|0
3055172|NCT00562302|10501908|P2|Overall Study|Not stated|4
3055173|NCT00562302|10501909|P1|Overall Study|Not stated|1
3055174|NCT00562302|10501908|P2|Overall Study|Lung resection prior to study completion|7
3055175|NCT00562302|10501909|P1|Overall Study|Lung resection prior to study completion|7
3055176|NCT00562302|10501908|P2|Overall Study|Death|2
3055177|NCT00562302|10501909|P1|Overall Study|Death|1
3055178|NCT00562302|10501908|P2|Overall Study|Withdrawal by Subject|8
3055179|NCT00562302|10501909|P1|Overall Study|Withdrawal by Subject|7
3055180|NCT00562302|10501908|P2|Overall Study|Non-compliance|2
3055181|NCT00562302|10501909|P1|Overall Study|Non-compliance|1
3055182|NCT00562302|10501908|P2|Overall Study|Adverse Event|6
3055183|NCT00562302|10501909|P1|Overall Study|Adverse Event|0
3055184|NCT00562302|10501908|P2|Overall Study|Lost to Follow-up|3
3055185|NCT00562302|10501909|P1|Overall Study|Lost to Follow-up|3
3055186|NCT00562159|10501931|P2|Overall Study|Did not meet protocol eligibility|1
3055187|NCT00562159|10501932|P1|Overall Study|Did not meet protocol eligibility|1
3055188|NCT00562159|10501931|P2|Overall Study|Protocol Violation|12
3055189|NCT00562159|10501932|P1|Overall Study|Protocol Violation|12
3055190|NCT00562159|10501931|P2|Overall Study|Withdrawal by Subject|8
3055191|NCT00562159|10501932|P1|Overall Study|Withdrawal by Subject|9
3055192|NCT00562159|10501931|P2|Overall Study|Lost to Follow-up|4
3055193|NCT00562159|10501932|P1|Overall Study|Lost to Follow-up|5
3055194|NCT00562159|10501931|P2|Overall Study|Adverse Event|8
3055195|NCT00562159|10501932|P1|Overall Study|Adverse Event|11
3055196|NCT00562120|10501944|P4|First Intervention Period|Randomized but not Treated|0
3055197|NCT00562120|10501945|P3|First Intervention Period|Randomized but not Treated|0
3055198|NCT00562120|10501946|P2|First Intervention Period|Randomized but not Treated|0
3055199|NCT00562120|10501947|P1|First Intervention Period|Randomized but not Treated|1
3055200|NCT00562120|10501944|P4|First Intervention Period|Adverse Event|0
3055201|NCT00562120|10501945|P3|First Intervention Period|Adverse Event|0
3055202|NCT00562120|10501946|P2|First Intervention Period|Adverse Event|0
3055203|NCT00562120|10501947|P1|First Intervention Period|Adverse Event|1
3055204|NCT00562094|10501979|P1|Overall Study|Lost to Follow-up|62
3055205|NCT00561977|10501994|P3|Overall Study|Pregnancy|1
3055206|NCT00561977|10501995|P2|Overall Study|Pregnancy|1
3055207|NCT00561977|10501996|P1|Overall Study|Pregnancy|0
3055208|NCT00561977|10501994|P3|Overall Study|Withdrawal by Subject|1
3055209|NCT00561977|10501995|P2|Overall Study|Withdrawal by Subject|2
3055210|NCT00561977|10501996|P1|Overall Study|Withdrawal by Subject|0
3055211|NCT00561951|10502022|P3|Overall Study|Adverse Event Occured Before Treatment|1
3055212|NCT00561951|10502023|P2|Overall Study|Adverse Event Occured Before Treatment|2
3055213|NCT00561951|10502024|P1|Overall Study|Adverse Event Occured Before Treatment|1
3055214|NCT00561951|10502022|P3|Overall Study|Meet Withdrawal Criterion|1
3055215|NCT00561951|10502023|P2|Overall Study|Meet Withdrawal Criterion|1
3055216|NCT00561951|10502024|P1|Overall Study|Meet Withdrawal Criterion|0
3055217|NCT00561951|10502022|P3|Overall Study|Pregnancy|0
3055218|NCT00561951|10502023|P2|Overall Study|Pregnancy|1
3055219|NCT00561951|10502024|P1|Overall Study|Pregnancy|0
3055220|NCT00561951|10502022|P3|Overall Study|Physician Decision|0
3055221|NCT00561951|10502023|P2|Overall Study|Physician Decision|0
3055222|NCT00561951|10502024|P1|Overall Study|Physician Decision|1
3055223|NCT00561951|10502022|P3|Overall Study|Protocol Violation|4
3055224|NCT00561951|10502023|P2|Overall Study|Protocol Violation|3
3055225|NCT00561951|10502024|P1|Overall Study|Protocol Violation|4
3055226|NCT00561951|10502022|P3|Overall Study|Withdrawal by Subject|10
3055227|NCT00561951|10502023|P2|Overall Study|Withdrawal by Subject|9
3055228|NCT00561951|10502024|P1|Overall Study|Withdrawal by Subject|10
3055229|NCT00561951|10502022|P3|Overall Study|Lost to Follow-up|0
3055230|NCT00561951|10502023|P2|Overall Study|Lost to Follow-up|1
3055231|NCT00561951|10502024|P1|Overall Study|Lost to Follow-up|1
3055232|NCT00561951|10502022|P3|Overall Study|Lack of Efficacy|2
3055233|NCT00561951|10502023|P2|Overall Study|Lack of Efficacy|3
3055234|NCT00561951|10502024|P1|Overall Study|Lack of Efficacy|5
3055235|NCT00561951|10502022|P3|Overall Study|Adverse Event|14
3055236|NCT00561951|10502023|P2|Overall Study|Adverse Event|14
3055237|NCT00561951|10502024|P1|Overall Study|Adverse Event|11
3055238|NCT00561925|10502080|P5|Open-Label Extension Period|Declined entry into extension period|50
3055239|NCT00561925|10502081|P4|Open-Label Extension Period|Declined entry into extension period|43
3055240|NCT00561925|10502082|P3|Open-Label Extension Period|Declined entry into extension period|0
3055241|NCT00561925|10502083|P2|Open-Label Extension Period|Declined entry into extension period|0
3055242|NCT00561925|10502084|P1|Open-Label Extension Period|Declined entry into extension period|0
3055243|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Other|0
3055244|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Other|0
3055245|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Other|11
3055246|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Other|8
3055247|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Other|0
3055248|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
3055249|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
3055250|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
3055251|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
3055252|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
3055253|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Death|0
3055254|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Death|0
3055255|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Death|3
3055256|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Death|6
3055257|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Death|0
3055258|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Pregnancy|0
3055259|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Pregnancy|0
3055260|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Pregnancy|9
3055261|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Pregnancy|1
3055262|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Pregnancy|0
3055263|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
3055264|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
3055265|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
3055266|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
3055267|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
3055268|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
3055269|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
3055270|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
3055271|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
3055272|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
3055273|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
3055274|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
3055275|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
3055276|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
3055277|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
3055278|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
3055279|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
3055280|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
3055281|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
3055282|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
3055283|NCT00561925|10502080|P5|144-week Double-blind, Double-dummy|Adverse Event|0
3055284|NCT00561925|10502081|P4|144-week Double-blind, Double-dummy|Adverse Event|0
3055285|NCT00561925|10502082|P3|144-week Double-blind, Double-dummy|Adverse Event|43
3055286|NCT00561925|10502083|P2|144-week Double-blind, Double-dummy|Adverse Event|48
3055287|NCT00561925|10502084|P1|144-week Double-blind, Double-dummy|Adverse Event|0
3055288|NCT00561925|10502080|P5|14 Day Lead-In Period|Other|0
3055289|NCT00561925|10502081|P4|14 Day Lead-In Period|Other|0
3055290|NCT00561925|10502082|P3|14 Day Lead-In Period|Other|0
3055291|NCT00561925|10502083|P2|14 Day Lead-In Period|Other|0
3055292|NCT00561925|10502084|P1|14 Day Lead-In Period|Other|5
3055293|NCT00561925|10502080|P5|14 Day Lead-In Period|Withdrawal by Subject|0
3055294|NCT00561925|10502081|P4|14 Day Lead-In Period|Withdrawal by Subject|0
3055295|NCT00561925|10502082|P3|14 Day Lead-In Period|Withdrawal by Subject|0
3055296|NCT00561925|10502083|P2|14 Day Lead-In Period|Withdrawal by Subject|0
3055297|NCT00561925|10502084|P1|14 Day Lead-In Period|Withdrawal by Subject|4
3055298|NCT00561925|10502080|P5|14 Day Lead-In Period|Lost to Follow-up|0
3055299|NCT00561925|10502081|P4|14 Day Lead-In Period|Lost to Follow-up|0
3055300|NCT00561925|10502082|P3|14 Day Lead-In Period|Lost to Follow-up|0
3055301|NCT00561925|10502083|P2|14 Day Lead-In Period|Lost to Follow-up|0
3055302|NCT00561925|10502084|P1|14 Day Lead-In Period|Lost to Follow-up|4
3055303|NCT00561925|10502080|P5|14 Day Lead-In Period|In/Exclusion criteria|0
3055304|NCT00561925|10502081|P4|14 Day Lead-In Period|In/Exclusion criteria|0
3055305|NCT00561925|10502082|P3|14 Day Lead-In Period|In/Exclusion criteria|0
3055306|NCT00561925|10502083|P2|14 Day Lead-In Period|In/Exclusion criteria|0
3055307|NCT00561925|10502084|P1|14 Day Lead-In Period|In/Exclusion criteria|4
3055308|NCT00561925|10502080|P5|14 Day Lead-In Period|Adverse Event|0
3055309|NCT00561925|10502081|P4|14 Day Lead-In Period|Adverse Event|0
3055310|NCT00561925|10502082|P3|14 Day Lead-In Period|Adverse Event|0
3055311|NCT00561925|10502083|P2|14 Day Lead-In Period|Adverse Event|0
3055312|NCT00561925|10502084|P1|14 Day Lead-In Period|Adverse Event|38
3055313|NCT00561912|10502133|P1|Overall Study|ineligible|1
3055314|NCT00561821|10502145|P4|Overall Study|Adverse Event|1
3055315|NCT00561821|10502146|P3|Overall Study|Adverse Event|1
3055316|NCT00561821|10502147|P2|Overall Study|Adverse Event|3
3055317|NCT00561821|10502148|P1|Overall Study|Adverse Event|2
3055318|NCT00561821|10502145|P4|Overall Study|Other (reason not specified)|0
3055319|NCT00561821|10502146|P3|Overall Study|Other (reason not specified)|0
3055320|NCT00561821|10502147|P2|Overall Study|Other (reason not specified)|1
3055321|NCT00561821|10502148|P1|Overall Study|Other (reason not specified)|1
3055322|NCT00561821|10502145|P4|Overall Study|Reasons not related to trial|0
3055323|NCT00561821|10502146|P3|Overall Study|Reasons not related to trial|0
3055324|NCT00561821|10502147|P2|Overall Study|Reasons not related to trial|1
3055325|NCT00561821|10502148|P1|Overall Study|Reasons not related to trial|2
3055326|NCT00561821|10502145|P4|Overall Study|Withdrawal by Subject|2
3055327|NCT00561821|10502146|P3|Overall Study|Withdrawal by Subject|0
3055328|NCT00561821|10502147|P2|Overall Study|Withdrawal by Subject|1
3055329|NCT00561821|10502148|P1|Overall Study|Withdrawal by Subject|0
3055330|NCT00561821|10502145|P4|Overall Study|Not treated|0
3055331|NCT00561821|10502146|P3|Overall Study|Not treated|1
3055332|NCT00561821|10502147|P2|Overall Study|Not treated|0
3055333|NCT00561821|10502148|P1|Overall Study|Not treated|0
3055334|NCT00561795|10502224|P4|Overall Study|Physician Decision|0
3055335|NCT00561795|10502225|P3|Overall Study|Physician Decision|0
3055336|NCT00561795|10502226|P2|Overall Study|Physician Decision|0
3055337|NCT00561795|10502227|P1|Overall Study|Physician Decision|1
3055338|NCT00561795|10502224|P4|Overall Study|Study Closed/Terminated|0
3055339|NCT00561795|10502225|P3|Overall Study|Study Closed/Terminated|0
3055340|NCT00561795|10502226|P2|Overall Study|Study Closed/Terminated|3
3055341|NCT00561795|10502227|P1|Overall Study|Study Closed/Terminated|0
3055342|NCT00561795|10502224|P4|Overall Study|Adverse Event|0
3055343|NCT00561795|10502225|P3|Overall Study|Adverse Event|0
3055344|NCT00561795|10502226|P2|Overall Study|Adverse Event|3
3055345|NCT00561795|10502227|P1|Overall Study|Adverse Event|3
3055346|NCT00561730|10502247|P1|Overall Study|Not specified reasons|1
3055347|NCT00561730|10502247|P1|Overall Study|Lost to Follow-up|5
3055348|NCT00561730|10502247|P1|Overall Study|Handling of the drug|1
3055349|NCT00561730|10502247|P1|Overall Study|Adverse Event|2
3055350|NCT00561678|10502263|P2|Overall Study|anesthesia provider refusal|0
3055351|NCT00561678|10502264|P1|Overall Study|anesthesia provider refusal|1
3055352|NCT00561678|10502263|P2|Overall Study|surgery rescheduled to different site|2
3055353|NCT00561678|10502264|P1|Overall Study|surgery rescheduled to different site|2
3055354|NCT00561678|10502263|P2|Overall Study|surgery cancelled|1
3055355|NCT00561678|10502264|P1|Overall Study|surgery cancelled|1
3055356|NCT00561678|10502263|P2|Overall Study|Withdrawal by Subject|3
3055357|NCT00561678|10502264|P1|Overall Study|Withdrawal by Subject|4
3055358|NCT00561652|10502282|P2|Overall Study|Withdrawal by Subject|1
3055359|NCT00561652|10502283|P1|Overall Study|Withdrawal by Subject|0
3055360|NCT00561574|10502366|P2|Overall Study|Other|7
3055361|NCT00561574|10502367|P1|Overall Study|Other|5
3055362|NCT00561574|10502366|P2|Overall Study|Lost to Follow-up|0
3055363|NCT00561574|10502367|P1|Overall Study|Lost to Follow-up|1
3055364|NCT00561574|10502366|P2|Overall Study|Reason Unrelated to Trial|2
3055365|NCT00561574|10502367|P1|Overall Study|Reason Unrelated to Trial|6
3055366|NCT00561574|10502366|P2|Overall Study|Withdrawal by Subject|4
3055367|NCT00561574|10502367|P1|Overall Study|Withdrawal by Subject|4
3055368|NCT00561574|10502366|P2|Overall Study|Lack of Efficacy|21
3055369|NCT00561574|10502367|P1|Overall Study|Lack of Efficacy|11
3055370|NCT00561574|10502366|P2|Overall Study|Adverse Event|24
3055371|NCT00561574|10502367|P1|Overall Study|Adverse Event|21
3055372|NCT00561470|10502393|P2|Overall Study|Ongoing Treatment|14
3055373|NCT00561470|10502394|P1|Overall Study|Ongoing Treatment|11
3055374|NCT00561470|10502393|P2|Overall Study|Planning surgery|1
3055375|NCT00561470|10502394|P1|Overall Study|Planning surgery|1
3055376|NCT00561470|10502393|P2|Overall Study|Missed visit window|4
3055377|NCT00561470|10502394|P1|Overall Study|Missed visit window|1
3055378|NCT00561470|10502393|P2|Overall Study|Randomized but not treated|5
3055379|NCT00561470|10502394|P1|Overall Study|Randomized but not treated|5
3055380|NCT00561470|10502393|P2|Overall Study|Unauthorized procedure|1
3055381|NCT00561470|10502394|P1|Overall Study|Unauthorized procedure|3
3055382|NCT00561470|10502393|P2|Overall Study|Metastatic surgery|12
3055383|NCT00561470|10502394|P1|Overall Study|Metastatic surgery|10
3055384|NCT00561470|10502393|P2|Overall Study|Subject request|77
3055385|NCT00561470|10502394|P1|Overall Study|Subject request|43
3055386|NCT00561470|10502393|P2|Overall Study|Consent Withdrawn|6
3055387|NCT00561470|10502394|P1|Overall Study|Consent Withdrawn|2
3055388|NCT00561470|10502393|P2|Overall Study|Physician Decision|20
3055389|NCT00561470|10502394|P1|Overall Study|Physician Decision|21
3055390|NCT00561470|10502393|P2|Overall Study|Lost to Follow-up|0
3055391|NCT00561470|10502394|P1|Overall Study|Lost to Follow-up|2
3055392|NCT00561470|10502393|P2|Overall Study|poor compliance to protocol|4
3055393|NCT00561470|10502394|P1|Overall Study|poor compliance to protocol|4
3055394|NCT00561470|10502393|P2|Overall Study|Disease progression|305
3055395|NCT00561470|10502394|P1|Overall Study|Disease progression|437
3055396|NCT00561470|10502393|P2|Overall Study|Adverse Event|163
3055397|NCT00561470|10502394|P1|Overall Study|Adverse Event|74
3055398|NCT00561392|10502430|P1|Overall Study|Administrative problems|4
3055399|NCT00561392|10502430|P1|Overall Study|Withdrawal by Subject|8
3055400|NCT00561392|10502430|P1|Overall Study|Protocol Violation|1
3055401|NCT00561392|10502430|P1|Overall Study|Lack of Efficacy|2
3055402|NCT00561392|10502430|P1|Overall Study|Adverse Event|38
3055403|NCT00561353|10502452|P10|Overall Study|Withdrawal by Subject|0
3055404|NCT00561353|10502453|P9|Overall Study|Withdrawal by Subject|0
3055405|NCT00561353|10502454|P8|Overall Study|Withdrawal by Subject|0
3055406|NCT00561353|10502455|P7|Overall Study|Withdrawal by Subject|0
3055407|NCT00561353|10502456|P6|Overall Study|Withdrawal by Subject|0
3055408|NCT00561353|10502457|P5|Overall Study|Withdrawal by Subject|0
3055409|NCT00561353|10502458|P4|Overall Study|Withdrawal by Subject|0
3055410|NCT00561353|10502459|P3|Overall Study|Withdrawal by Subject|0
3055411|NCT00561353|10502460|P2|Overall Study|Withdrawal by Subject|2
3055412|NCT00561353|10502461|P1|Overall Study|Withdrawal by Subject|0
3055413|NCT00561353|10502452|P10|Overall Study|Lost to Follow-up|0
3055414|NCT00561353|10502453|P9|Overall Study|Lost to Follow-up|0
3055415|NCT00561353|10502454|P8|Overall Study|Lost to Follow-up|0
3055416|NCT00561353|10502455|P7|Overall Study|Lost to Follow-up|0
3055417|NCT00561353|10502456|P6|Overall Study|Lost to Follow-up|0
3055418|NCT00561353|10502457|P5|Overall Study|Lost to Follow-up|0
3055419|NCT00561353|10502458|P4|Overall Study|Lost to Follow-up|0
3055420|NCT00561353|10502459|P3|Overall Study|Lost to Follow-up|1
3055421|NCT00561353|10502460|P2|Overall Study|Lost to Follow-up|0
3055422|NCT00561353|10502461|P1|Overall Study|Lost to Follow-up|2
3055423|NCT00561353|10502452|P10|Overall Study|Adverse Event|1
3055424|NCT00561353|10502453|P9|Overall Study|Adverse Event|0
3055425|NCT00561353|10502454|P8|Overall Study|Adverse Event|0
3055426|NCT00561353|10502455|P7|Overall Study|Adverse Event|1
3055427|NCT00561353|10502456|P6|Overall Study|Adverse Event|0
3055428|NCT00561353|10502457|P5|Overall Study|Adverse Event|0
3055429|NCT00561353|10502458|P4|Overall Study|Adverse Event|2
3055430|NCT00561353|10502459|P3|Overall Study|Adverse Event|0
3055431|NCT00561353|10502460|P2|Overall Study|Adverse Event|0
3055432|NCT00561353|10502461|P1|Overall Study|Adverse Event|0
3055433|NCT00561353|10502452|P10|Overall Study|Other|0
3055434|NCT00561353|10502453|P9|Overall Study|Other|0
3055435|NCT00561353|10502454|P8|Overall Study|Other|0
3055436|NCT00561353|10502455|P7|Overall Study|Other|0
3055437|NCT00561353|10502456|P6|Overall Study|Other|2
3055438|NCT00561353|10502457|P5|Overall Study|Other|0
3055439|NCT00561353|10502458|P4|Overall Study|Other|0
3055440|NCT00561353|10502459|P3|Overall Study|Other|1
3055441|NCT00561353|10502460|P2|Overall Study|Other|0
3055442|NCT00561353|10502461|P1|Overall Study|Other|1
3055443|NCT00561353|10502452|P10|Overall Study|Subject ineligible to continue the trial|1
3055444|NCT00561353|10502453|P9|Overall Study|Subject ineligible to continue the trial|2
3055445|NCT00561353|10502454|P8|Overall Study|Subject ineligible to continue the trial|0
3055446|NCT00561353|10502455|P7|Overall Study|Subject ineligible to continue the trial|1
3055447|NCT00561353|10502456|P6|Overall Study|Subject ineligible to continue the trial|1
3055448|NCT00561353|10502457|P5|Overall Study|Subject ineligible to continue the trial|0
3055449|NCT00561353|10502458|P4|Overall Study|Subject ineligible to continue the trial|0
3055450|NCT00561353|10502459|P3|Overall Study|Subject ineligible to continue the trial|0
3055451|NCT00561353|10502460|P2|Overall Study|Subject ineligible to continue the trial|0
3055452|NCT00561353|10502461|P1|Overall Study|Subject ineligible to continue the trial|0
3055453|NCT00561353|10502452|P10|Overall Study|Subject reached a virologic endpoint|0
3055454|NCT00561353|10502453|P9|Overall Study|Subject reached a virologic endpoint|5
3055455|NCT00561353|10502454|P8|Overall Study|Subject reached a virologic endpoint|4
3055456|NCT00561353|10502455|P7|Overall Study|Subject reached a virologic endpoint|4
3055457|NCT00561353|10502456|P6|Overall Study|Subject reached a virologic endpoint|3
3055458|NCT00561353|10502457|P5|Overall Study|Subject reached a virologic endpoint|1
3055459|NCT00561353|10502458|P4|Overall Study|Subject reached a virologic endpoint|4
3055460|NCT00561353|10502459|P3|Overall Study|Subject reached a virologic endpoint|1
3055461|NCT00561353|10502460|P2|Overall Study|Subject reached a virologic endpoint|1
3055462|NCT00561353|10502461|P1|Overall Study|Subject reached a virologic endpoint|2
3055463|NCT00561340|10502616|P2|Overall Study|refused to drink pediasure|0
3055464|NCT00561340|10502617|P1|Overall Study|refused to drink pediasure|6
3055465|NCT00561080|10502637|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
3055466|NCT00561080|10502638|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
3055467|NCT00561080|10502639|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
3055468|NCT00561080|10502637|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
3055469|NCT00561080|10502638|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
3055470|NCT00561080|10502639|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
3055471|NCT00561080|10502637|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
3055472|NCT00561080|10502638|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
3055473|NCT00561080|10502639|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
3055474|NCT00561080|10502637|P3|12-month Post Last Dose Follow-up|Adverse Event|1
3055475|NCT00561080|10502638|P2|12-month Post Last Dose Follow-up|Adverse Event|3
3055476|NCT00561080|10502639|P1|12-month Post Last Dose Follow-up|Adverse Event|3
3055477|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Other|1
3055478|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Other|2
3055479|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Other|0
3055480|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
3055481|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
3055482|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
3055483|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
3055484|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
3055485|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
3055486|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
3055487|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
3055488|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
3055489|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
3055490|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
3055491|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
3055492|NCT00561080|10502637|P3|Vaccination Period (up to Month 4)|Adverse Event|6
3055493|NCT00561080|10502638|P2|Vaccination Period (up to Month 4)|Adverse Event|4
3055494|NCT00561080|10502639|P1|Vaccination Period (up to Month 4)|Adverse Event|0
3055495|NCT00561015|10502716|P6|Overall Study|Participant non-compliance|0
3055496|NCT00561015|10502717|P5|Overall Study|Participant non-compliance|0
3055497|NCT00561015|10502718|P4|Overall Study|Participant non-compliance|0
3055498|NCT00561015|10502719|P3|Overall Study|Participant non-compliance|0
3055499|NCT00561015|10502720|P2|Overall Study|Participant non-compliance|0
3055500|NCT00561015|10502721|P1|Overall Study|Participant non-compliance|2
3055501|NCT00561015|10502716|P6|Overall Study|Lost to Follow-up|3
3055502|NCT00561015|10502717|P5|Overall Study|Lost to Follow-up|0
3055503|NCT00561015|10502718|P4|Overall Study|Lost to Follow-up|1
3055504|NCT00561015|10502719|P3|Overall Study|Lost to Follow-up|0
3055505|NCT00561015|10502720|P2|Overall Study|Lost to Follow-up|0
3055506|NCT00561015|10502721|P1|Overall Study|Lost to Follow-up|2
3055507|NCT00561015|10502716|P6|Overall Study|Adverse Event|0
3055508|NCT00561015|10502717|P5|Overall Study|Adverse Event|1
3055509|NCT00561015|10502718|P4|Overall Study|Adverse Event|0
3055510|NCT00561015|10502719|P3|Overall Study|Adverse Event|0
3055511|NCT00561015|10502720|P2|Overall Study|Adverse Event|0
3055512|NCT00561015|10502721|P1|Overall Study|Adverse Event|0
3055513|NCT00560950|10502812|P2|Overall Study|Lost to Follow-up|0
3055514|NCT00560950|10502813|P1|Overall Study|Lost to Follow-up|1
3055515|NCT00560937|10502851|P2|Overall Study|Physician Decision|1
3055516|NCT00560937|10502852|P1|Overall Study|Physician Decision|1
3055517|NCT00560937|10502851|P2|Overall Study|Withdrawal by Subject|1
3055518|NCT00560937|10502852|P1|Overall Study|Withdrawal by Subject|0
3055519|NCT00560885|10502868|P1|Overall Study|Withdrawal by Subject|1
3055520|NCT00560885|10502868|P1|Overall Study|Death|7
3055521|NCT00560833|10502893|P5|Overall Study|Never received drug|1
3055522|NCT00560833|10502894|P4|Overall Study|Never received drug|0
3055523|NCT00560833|10502895|P3|Overall Study|Never received drug|0
3055524|NCT00560833|10502896|P2|Overall Study|Never received drug|1
3055525|NCT00560833|10502897|P1|Overall Study|Never received drug|0
3055526|NCT00560833|10502893|P5|Overall Study|Other|0
3055527|NCT00560833|10502894|P4|Overall Study|Other|0
3055528|NCT00560833|10502895|P3|Overall Study|Other|3
3055529|NCT00560833|10502896|P2|Overall Study|Other|1
3055530|NCT00560833|10502897|P1|Overall Study|Other|1
3055531|NCT00560833|10502893|P5|Overall Study|Participant uncooperative|2
3055532|NCT00560833|10502894|P4|Overall Study|Participant uncooperative|4
3055533|NCT00560833|10502895|P3|Overall Study|Participant uncooperative|4
3055534|NCT00560833|10502896|P2|Overall Study|Participant uncooperative|5
3055535|NCT00560833|10502897|P1|Overall Study|Participant uncooperative|5
3055536|NCT00560833|10502893|P5|Overall Study|Lack of Efficacy|4
3055537|NCT00560833|10502894|P4|Overall Study|Lack of Efficacy|4
3055538|NCT00560833|10502895|P3|Overall Study|Lack of Efficacy|6
3055539|NCT00560833|10502896|P2|Overall Study|Lack of Efficacy|9
3055540|NCT00560833|10502897|P1|Overall Study|Lack of Efficacy|22
3055541|NCT00560833|10502893|P5|Overall Study|Lost to Follow-up|0
3055542|NCT00560833|10502894|P4|Overall Study|Lost to Follow-up|0
3055543|NCT00560833|10502895|P3|Overall Study|Lost to Follow-up|1
3055544|NCT00560833|10502896|P2|Overall Study|Lost to Follow-up|0
3055545|NCT00560833|10502897|P1|Overall Study|Lost to Follow-up|0
3055546|NCT00560833|10502893|P5|Overall Study|Adverse Event|35
3055547|NCT00560833|10502894|P4|Overall Study|Adverse Event|23
3055548|NCT00560833|10502895|P3|Overall Study|Adverse Event|25
3055549|NCT00560833|10502896|P2|Overall Study|Adverse Event|10
3055550|NCT00560833|10502897|P1|Overall Study|Adverse Event|16
3055551|NCT00560794|10502929|P1|Overall Study|Received Bone Marrow Transplant|6
3055552|NCT00560794|10502929|P1|Overall Study|Hematological Relapse|1
3055553|NCT00560794|10502929|P1|Overall Study|Minimal Residual Disease Relapse|1
3055554|NCT00560794|10502929|P1|Overall Study|Patient was not Compliant|1
3055555|NCT00560794|10502929|P1|Overall Study|Adverse Event|2
3055556|NCT00560755|10502946|P1|Overall Study|Physician Decision|2
3055557|NCT00560755|10502946|P1|Overall Study|Adverse Event|8
3055558|NCT00560755|10502946|P1|Overall Study|Lost to Follow-up|9
3055559|NCT00560755|10502946|P1|Overall Study|Withdrawal by Subject|26
3055560|NCT00560755|10502946|P1|Overall Study|Protocol Violation|15
3055561|NCT00560703|10502967|P2|Overall Study|non-compliance|1
3055562|NCT00560703|10502968|P1|Overall Study|non-compliance|0
3055563|NCT00560703|10502967|P2|Overall Study|Withdrawal by Subject|1
3055564|NCT00560703|10502968|P1|Overall Study|Withdrawal by Subject|0
3055565|NCT00560703|10502967|P2|Overall Study|Protocol Violation|2
3055566|NCT00560703|10502968|P1|Overall Study|Protocol Violation|0
3055567|NCT00560703|10502967|P2|Overall Study|Adverse Event|2
3055568|NCT00560703|10502968|P1|Overall Study|Adverse Event|0
3055569|NCT00560573|10502991|P6|Overall Study|Enrolled, not treated|0
3055570|NCT00560573|10502992|P5|Overall Study|Enrolled, not treated|1
3055571|NCT00560573|10502993|P4|Overall Study|Enrolled, not treated|0
3055572|NCT00560573|10502994|P3|Overall Study|Enrolled, not treated|0
3055573|NCT00560573|10502995|P2|Overall Study|Enrolled, not treated|0
3055574|NCT00560573|10502996|P1|Overall Study|Enrolled, not treated|0
3055575|NCT00560573|10502991|P6|Overall Study|Other|3
3055576|NCT00560573|10502992|P5|Overall Study|Other|3
3055577|NCT00560573|10502993|P4|Overall Study|Other|3
3055578|NCT00560573|10502994|P3|Overall Study|Other|2
3055579|NCT00560573|10502995|P2|Overall Study|Other|2
3055580|NCT00560573|10502996|P1|Overall Study|Other|2
3055581|NCT00560573|10502991|P6|Overall Study|Withdrawal by Subject|0
3055582|NCT00560573|10502992|P5|Overall Study|Withdrawal by Subject|1
3055583|NCT00560573|10502993|P4|Overall Study|Withdrawal by Subject|1
3055584|NCT00560573|10502994|P3|Overall Study|Withdrawal by Subject|0
3055585|NCT00560573|10502995|P2|Overall Study|Withdrawal by Subject|0
3055586|NCT00560573|10502996|P1|Overall Study|Withdrawal by Subject|0
3055587|NCT00560573|10502991|P6|Overall Study|Lost to Follow-up|0
3055588|NCT00560573|10502992|P5|Overall Study|Lost to Follow-up|1
3055589|NCT00560573|10502993|P4|Overall Study|Lost to Follow-up|1
3055590|NCT00560573|10502994|P3|Overall Study|Lost to Follow-up|0
3055591|NCT00560573|10502995|P2|Overall Study|Lost to Follow-up|0
3055592|NCT00560573|10502996|P1|Overall Study|Lost to Follow-up|0
3055593|NCT00560573|10502991|P6|Overall Study|Death|10
3055594|NCT00560573|10502992|P5|Overall Study|Death|1
3055595|NCT00560573|10502993|P4|Overall Study|Death|5
3055596|NCT00560573|10502994|P3|Overall Study|Death|4
3055597|NCT00560573|10502995|P2|Overall Study|Death|1
3055598|NCT00560573|10502996|P1|Overall Study|Death|4
3055599|NCT00560508|10503073|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
3055600|NCT00560508|10503074|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
3055601|NCT00560508|10503073|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
3055602|NCT00560508|10503074|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
3055603|NCT00560508|10503073|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
3055604|NCT00560508|10503074|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
3055605|NCT00560508|10503073|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
3055606|NCT00560508|10503074|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
3055607|NCT00560508|10503073|P2|12 Week Double-blind Period|Withdrawal by Subject|1
3055608|NCT00560508|10503074|P1|12 Week Double-blind Period|Withdrawal by Subject|1
3055609|NCT00560508|10503073|P2|12 Week Double-blind Period|Protocol Violation|0
3055610|NCT00560508|10503074|P1|12 Week Double-blind Period|Protocol Violation|1
3055611|NCT00560508|10503073|P2|12 Week Double-blind Period|Adverse Event|2
3055612|NCT00560508|10503074|P1|12 Week Double-blind Period|Adverse Event|3
3055613|NCT00560417|10503133|P2|Overall Study|Withdrawal by Subject|3
3055614|NCT00560417|10503134|P1|Overall Study|Withdrawal by Subject|3
3055615|NCT00560417|10503133|P2|Overall Study|Sponsor Decision|0
3055616|NCT00560417|10503134|P1|Overall Study|Sponsor Decision|2
3055617|NCT00560417|10503133|P2|Overall Study|Protocol Violation|5
3055618|NCT00560417|10503134|P1|Overall Study|Protocol Violation|6
3055619|NCT00560417|10503133|P2|Overall Study|Physician Decision|6
3055620|NCT00560417|10503134|P1|Overall Study|Physician Decision|2
3055621|NCT00560417|10503133|P2|Overall Study|Lost to Follow-up|1
3055622|NCT00560417|10503134|P1|Overall Study|Lost to Follow-up|0
3055623|NCT00560417|10503133|P2|Overall Study|Entry Criteria Not Met|0
3055624|NCT00560417|10503134|P1|Overall Study|Entry Criteria Not Met|1
3055625|NCT00560417|10503133|P2|Overall Study|Adverse Event|2
3055626|NCT00560417|10503134|P1|Overall Study|Adverse Event|3
3055627|NCT00560404|10503162|P2|Overall Study|Other withdrawal reason|5
3055628|NCT00560404|10503163|P1|Overall Study|Other withdrawal reason|13
3055629|NCT00560404|10503162|P2|Overall Study|Failure to return|2
3055630|NCT00560404|10503163|P1|Overall Study|Failure to return|1
3055631|NCT00560404|10503162|P2|Overall Study|Withdrew Consent|0
3055632|NCT00560404|10503163|P1|Overall Study|Withdrew Consent|4
3055633|NCT00560404|10503162|P2|Overall Study|Administrative Reasons|1
3055634|NCT00560404|10503163|P1|Overall Study|Administrative Reasons|1
3055635|NCT00560404|10503162|P2|Overall Study|Protocol Violation|7
3055636|NCT00560404|10503163|P1|Overall Study|Protocol Violation|12
3055637|NCT00560404|10503162|P2|Overall Study|Death|3
3055638|NCT00560404|10503163|P1|Overall Study|Death|3
3055639|NCT00560404|10503162|P2|Overall Study|Adverse Event|3
3055640|NCT00560404|10503163|P1|Overall Study|Adverse Event|2
3055641|NCT00560391|10503210|P5|Overall Study|Still on treatment|2
3055642|NCT00560391|10503211|P4|Overall Study|Still on treatment|1
3055643|NCT00560391|10503212|P3|Overall Study|Still on treatment|0
3055644|NCT00560391|10503213|P2|Overall Study|Still on treatment|0
3055645|NCT00560391|10503214|P1|Overall Study|Still on treatment|0
3055646|NCT00560352|10503270|P3|Overall Study|Maximum clinical benefit|0
3055647|NCT00560352|10503271|P2|Overall Study|Maximum clinical benefit|0
3055648|NCT00560352|10503272|P1|Overall Study|Maximum clinical benefit|1
3055649|NCT00560352|10503270|P3|Overall Study|Withdrawal by Subject|1
3055650|NCT00560352|10503271|P2|Overall Study|Withdrawal by Subject|1
3055651|NCT00560352|10503272|P1|Overall Study|Withdrawal by Subject|1
3055652|NCT00560352|10503270|P3|Overall Study|Disease progression|1
3055653|NCT00560352|10503271|P2|Overall Study|Disease progression|1
3055654|NCT00560352|10503272|P1|Overall Study|Disease progression|0
3055655|NCT00560352|10503270|P3|Overall Study|Study drug toxicity|1
3055656|NCT00560352|10503271|P2|Overall Study|Study drug toxicity|0
3055657|NCT00560352|10503272|P1|Overall Study|Study drug toxicity|3
3055658|NCT00560352|10503270|P3|Overall Study|Adverse event unrelated to study drug|1
3055659|NCT00560352|10503271|P2|Overall Study|Adverse event unrelated to study drug|1
3055660|NCT00560352|10503272|P1|Overall Study|Adverse event unrelated to study drug|2
3055661|NCT00560313|10503289|P1|Overall Study|Protocol Violation|1
3055662|NCT00560313|10503289|P1|Overall Study|Lost to Follow-up|1
3055663|NCT00560313|10503289|P1|Overall Study|Withdrawal by Subject|2
3055664|NCT00560313|10503289|P1|Overall Study|Adverse Events or Death|2
3055665|NCT00560235|10503316|P3|Phase 2|Ongoing at Date of Cut-Off|1
3055666|NCT00560235|10503317|P2|Phase 2|Ongoing at Date of Cut-Off|0
3055667|NCT00560235|10503318|P1|Phase 2|Ongoing at Date of Cut-Off|0
3055668|NCT00560235|10503316|P3|Phase 2|Discontinued|96
3055669|NCT00560235|10503317|P2|Phase 2|Discontinued|0
3055670|NCT00560235|10503318|P1|Phase 2|Discontinued|0
3055671|NCT00560235|10503316|P3|Phase 1B|Discontinued|0
3055672|NCT00560235|10503317|P2|Phase 1B|Discontinued|19
3055673|NCT00560235|10503318|P1|Phase 1B|Discontinued|0
3055674|NCT00560235|10503316|P3|Phase 1|Discontinued|0
3055675|NCT00560235|10503317|P2|Phase 1|Discontinued|0
3055676|NCT00560235|10503318|P1|Phase 1|Discontinued|8
3055677|NCT00560105|10503349|P2|Overall Study|musculoskeletal chest discomfort with us|2
3055678|NCT00560105|10503350|P1|Overall Study|musculoskeletal chest discomfort with us|1
3055679|NCT00560066|10503364|P2|Overall Study|Missing primary reason|2
3055680|NCT00560066|10503365|P1|Overall Study|Missing primary reason|0
3055681|NCT00560066|10503364|P2|Overall Study|Administrative reason|5
3055682|NCT00560066|10503365|P1|Overall Study|Administrative reason|0
3055683|NCT00560066|10503364|P2|Overall Study|Protocol Violation|1
3055684|NCT00560066|10503365|P1|Overall Study|Protocol Violation|0
3055685|NCT00560066|10503364|P2|Overall Study|Lost to Follow-up|10
3055686|NCT00560066|10503365|P1|Overall Study|Lost to Follow-up|4
3055687|NCT00560066|10503364|P2|Overall Study|Withdrawal by Subject|3
3055688|NCT00560066|10503365|P1|Overall Study|Withdrawal by Subject|0
3055689|NCT00560066|10503364|P2|Overall Study|Death|1
3055690|NCT00560066|10503365|P1|Overall Study|Death|2
3055691|NCT00559988|10503397|P2|Overall Study|ICD device explanted|17
3055692|NCT00559988|10503398|P1|Overall Study|ICD device explanted|10
3055693|NCT00559988|10503397|P2|Overall Study|Lost to Follow-up|56
3055694|NCT00559988|10503398|P1|Overall Study|Lost to Follow-up|42
3055695|NCT00559988|10503397|P2|Overall Study|Withdrawal by Subject|139
3055696|NCT00559988|10503398|P1|Overall Study|Withdrawal by Subject|152
3055697|NCT00559988|10503397|P2|Overall Study|Death|140
3055698|NCT00559988|10503398|P1|Overall Study|Death|147
3055699|NCT00559962|10503428|P8|Overall Study|Inclusion/exclusion criteria not met|0
3055700|NCT00559962|10503429|P7|Overall Study|Inclusion/exclusion criteria not met|1
3055701|NCT00559962|10503430|P6|Overall Study|Inclusion/exclusion criteria not met|0
3055702|NCT00559962|10503431|P5|Overall Study|Inclusion/exclusion criteria not met|0
3055703|NCT00559962|10503432|P4|Overall Study|Inclusion/exclusion criteria not met|0
3055704|NCT00559962|10503433|P3|Overall Study|Inclusion/exclusion criteria not met|0
3055705|NCT00559962|10503434|P2|Overall Study|Inclusion/exclusion criteria not met|0
3055706|NCT00559962|10503435|P1|Overall Study|Inclusion/exclusion criteria not met|0
3055707|NCT00559962|10503428|P8|Overall Study|Withdrawal by Subject|2
3055708|NCT00559962|10503429|P7|Overall Study|Withdrawal by Subject|0
3055709|NCT00559962|10503430|P6|Overall Study|Withdrawal by Subject|1
3055710|NCT00559962|10503431|P5|Overall Study|Withdrawal by Subject|3
3055711|NCT00559962|10503432|P4|Overall Study|Withdrawal by Subject|0
3055712|NCT00559962|10503433|P3|Overall Study|Withdrawal by Subject|2
3055713|NCT00559962|10503434|P2|Overall Study|Withdrawal by Subject|1
3055714|NCT00559962|10503435|P1|Overall Study|Withdrawal by Subject|1
3055715|NCT00559962|10503428|P8|Overall Study|Lost to Follow-up|0
3055716|NCT00559962|10503429|P7|Overall Study|Lost to Follow-up|0
3055717|NCT00559962|10503430|P6|Overall Study|Lost to Follow-up|0
3055718|NCT00559962|10503431|P5|Overall Study|Lost to Follow-up|0
3055719|NCT00559962|10503432|P4|Overall Study|Lost to Follow-up|0
3055720|NCT00559962|10503433|P3|Overall Study|Lost to Follow-up|0
3055721|NCT00559962|10503434|P2|Overall Study|Lost to Follow-up|1
3055722|NCT00559962|10503435|P1|Overall Study|Lost to Follow-up|0
3055723|NCT00559962|10503428|P8|Overall Study|Adverse Event|2
3055724|NCT00559962|10503429|P7|Overall Study|Adverse Event|4
3055725|NCT00559962|10503430|P6|Overall Study|Adverse Event|4
3055726|NCT00559962|10503431|P5|Overall Study|Adverse Event|11
3055727|NCT00559962|10503432|P4|Overall Study|Adverse Event|5
3055728|NCT00559962|10503433|P3|Overall Study|Adverse Event|8
3055729|NCT00559962|10503434|P2|Overall Study|Adverse Event|7
3055730|NCT00559962|10503435|P1|Overall Study|Adverse Event|1
3055731|NCT00559949|10503455|P1|Overall Study|No disease evaluation per protocol|1
3055732|NCT00559949|10503455|P1|Overall Study|Withdrawal by Subject|4
3055733|NCT00559949|10503455|P1|Overall Study|Adverse Event|1
3055734|NCT00559949|10503455|P1|Overall Study|Progressive Disease during cycle 1|1
3055735|NCT00559845|10503471|P1|Overall Study|Premature Surgery-Investigator Decision|1
3055736|NCT00559845|10503471|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
3055737|NCT00559845|10503471|P1|Overall Study|Adverse Event|3
3055738|NCT00559845|10503471|P1|Overall Study|Disease Progression|1
3055739|NCT00559845|10503471|P1|Overall Study|Withdrew Consent|1
3055740|NCT00559754|10503480|P1|Overall Study|Withdrawal by Subject|2
3055741|NCT00559754|10503480|P1|Overall Study|Investigator criteria|2
3055742|NCT00559754|10503480|P1|Overall Study|Protocol Violation|1
3055743|NCT00559754|10503480|P1|Overall Study|Adverse Event|5
3055744|NCT00559754|10503480|P1|Overall Study|Disease progression|1
3055745|NCT00559637|10503504|P1|Overall Study|Inclusion or exclusion criteria violated|2
3055746|NCT00559637|10503504|P1|Overall Study|Change of home|1
3055747|NCT00559637|10503504|P1|Overall Study|Change of center|1
3055748|NCT00559637|10503504|P1|Overall Study|Delayed administration of C.E.R.A|1
3055749|NCT00559637|10503504|P1|Overall Study|Participation in another study|1
3055750|NCT00559637|10503504|P1|Overall Study|Suspected lung cancer|1
3055751|NCT00559637|10503504|P1|Overall Study|Started requiring dialysis after month 7|2
3055752|NCT00559637|10503504|P1|Overall Study|Insufficient response|3
3055753|NCT00559637|10503504|P1|Overall Study|Failure to return|6
3055754|NCT00559637|10503504|P1|Overall Study|Withdrawal criteria fulfilled|4
3055755|NCT00559637|10503504|P1|Overall Study|Protocol Violation|6
3055756|NCT00559637|10503504|P1|Overall Study|Withdrawal by Subject|4
3055757|NCT00559637|10503504|P1|Overall Study|Adverse Event|22
3055758|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
3055759|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
3055760|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|non-specified|0
3055761|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|non-specified|71
3055762|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
3055763|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
3055764|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
3055765|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
3055766|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
3055767|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
3055768|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Death|0
3055769|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Death|20
3055770|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
3055771|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
3055772|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
3055773|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
3055774|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
3055775|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
3055776|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
3055777|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
3055778|NCT00559585|10503517|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
3055779|NCT00559585|10503518|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
3055780|NCT00559585|10503517|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
3055781|NCT00559585|10503518|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
3055782|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
3055783|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
3055784|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Investigator Decision|1
3055785|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Investigator Decision|0
3055786|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
3055787|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
3055788|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
3055789|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
3055790|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Early Discontinuation|1
3055791|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Early Discontinuation|0
3055792|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
3055793|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
3055794|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
3055795|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
3055796|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Missed Doses|1
3055797|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Missed Doses|0
3055798|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
3055799|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
3055800|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
3055801|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
3055802|NCT00559585|10503517|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
3055803|NCT00559585|10503518|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
3055804|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Death|1
3055805|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Death|1
3055806|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
3055807|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
3055808|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
3055809|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
3055810|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
3055811|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
3055812|NCT00559585|10503517|P2|Double Blind ST Period Main Study|Adverse Event|25
3055813|NCT00559585|10503518|P1|Double Blind ST Period Main Study|Adverse Event|17
3055814|NCT00559507|10503578|P1|Overall Study|Not treated, patient ineligible|3
3055815|NCT00559377|10503597|P1|Overall Study|Withdrawal by Subject|9
3055816|NCT00559364|10503607|P2|Overall Study|Inclusion/exclusion criteria failure|0
3055817|NCT00559364|10503608|P1|Overall Study|Inclusion/exclusion criteria failure|1
3055818|NCT00559273|10503620|P2|Evaluation Period (8 Weeks)|Physician Decision|1
3055819|NCT00559273|10503621|P1|Evaluation Period (8 Weeks)|Physician Decision|0
3055820|NCT00559273|10503620|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
3055821|NCT00559273|10503621|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
3055822|NCT00559273|10503620|P2|Evaluation Period (8 Weeks)|Adverse Event|1
3055823|NCT00559273|10503621|P1|Evaluation Period (8 Weeks)|Adverse Event|0
3055824|NCT00559273|10503620|P2|Evaluation Period (8 Weeks)|Death|3
3055825|NCT00559273|10503621|P1|Evaluation Period (8 Weeks)|Death|1
3055826|NCT00559273|10503620|P2|Correction Period (20 Weeks)|Did not received study treatment|0
3055827|NCT00559273|10503621|P1|Correction Period (20 Weeks)|Did not received study treatment|2
3055828|NCT00559273|10503620|P2|Correction Period (20 Weeks)|Participant treated by another center|1
3055829|NCT00559273|10503621|P1|Correction Period (20 Weeks)|Participant treated by another center|0
3055830|NCT00559273|10503620|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
3055831|NCT00559273|10503621|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
3055832|NCT00559273|10503620|P2|Correction Period (20 Weeks)|Adverse Event|1
3055833|NCT00559273|10503621|P1|Correction Period (20 Weeks)|Adverse Event|2
3055834|NCT00559273|10503620|P2|Correction Period (20 Weeks)|Death|4
3055835|NCT00559273|10503621|P1|Correction Period (20 Weeks)|Death|3
3055836|NCT00559104|10503643|P2|Overall Study|Lack of Efficacy|0
3055837|NCT00559104|10503644|P1|Overall Study|Lack of Efficacy|9
3055838|NCT00558896|10503665|P7|Overall Study|Continues on treatment|6
3055839|NCT00558896|10503666|P6|Overall Study|Continues on treatment|25
3055840|NCT00558896|10503667|P5|Overall Study|Continues on treatment|9
3055841|NCT00558896|10503668|P4|Overall Study|Continues on treatment|1
3055842|NCT00558896|10503669|P3|Overall Study|Continues on treatment|0
3055843|NCT00558896|10503670|P2|Overall Study|Continues on treatment|1
3055844|NCT00558896|10503671|P1|Overall Study|Continues on treatment|10
3055845|NCT00558896|10503665|P7|Overall Study|Physician discretion|3
3055846|NCT00558896|10503666|P6|Overall Study|Physician discretion|3
3055847|NCT00558896|10503667|P5|Overall Study|Physician discretion|1
3055848|NCT00558896|10503668|P4|Overall Study|Physician discretion|2
3055849|NCT00558896|10503669|P3|Overall Study|Physician discretion|1
3055850|NCT00558896|10503670|P2|Overall Study|Physician discretion|2
3055851|NCT00558896|10503671|P1|Overall Study|Physician discretion|3
3055852|NCT00558896|10503665|P7|Overall Study|Alternative Treatment|1
3055853|NCT00558896|10503666|P6|Overall Study|Alternative Treatment|7
3055854|NCT00558896|10503667|P5|Overall Study|Alternative Treatment|6
3055855|NCT00558896|10503668|P4|Overall Study|Alternative Treatment|2
3055856|NCT00558896|10503669|P3|Overall Study|Alternative Treatment|0
3055857|NCT00558896|10503670|P2|Overall Study|Alternative Treatment|2
3055858|NCT00558896|10503671|P1|Overall Study|Alternative Treatment|2
3055859|NCT00558896|10503665|P7|Overall Study|Withdrawal by Subject|5
3055860|NCT00558896|10503666|P6|Overall Study|Withdrawal by Subject|5
3055861|NCT00558896|10503667|P5|Overall Study|Withdrawal by Subject|1
3055862|NCT00558896|10503668|P4|Overall Study|Withdrawal by Subject|1
3055863|NCT00558896|10503669|P3|Overall Study|Withdrawal by Subject|1
3055864|NCT00558896|10503670|P2|Overall Study|Withdrawal by Subject|1
3055865|NCT00558896|10503671|P1|Overall Study|Withdrawal by Subject|2
3055866|NCT00558896|10503665|P7|Overall Study|Death|6
3055867|NCT00558896|10503666|P6|Overall Study|Death|2
3055868|NCT00558896|10503667|P5|Overall Study|Death|2
3055869|NCT00558896|10503668|P4|Overall Study|Death|3
3055870|NCT00558896|10503669|P3|Overall Study|Death|2
3055871|NCT00558896|10503670|P2|Overall Study|Death|0
3055872|NCT00558896|10503671|P1|Overall Study|Death|3
3055873|NCT00558896|10503665|P7|Overall Study|Adverse Event|3
3055874|NCT00558896|10503666|P6|Overall Study|Adverse Event|10
3055875|NCT00558896|10503667|P5|Overall Study|Adverse Event|4
3055876|NCT00558896|10503668|P4|Overall Study|Adverse Event|3
3055877|NCT00558896|10503669|P3|Overall Study|Adverse Event|1
3055878|NCT00558896|10503670|P2|Overall Study|Adverse Event|1
3055879|NCT00558896|10503671|P1|Overall Study|Adverse Event|1
3055880|NCT00558831|10503773|P1|Overall Study|Lost to Follow-up|1
3055881|NCT00558753|10503830|P2|Overall Study|Lost to Follow-up|7
3055882|NCT00558753|10503831|P1|Overall Study|Lost to Follow-up|5
3055883|NCT00558701|10503843|P2|Overall Study|Protocol Deviations|4
3055884|NCT00558701|10503844|P1|Overall Study|Protocol Deviations|1
3055885|NCT00558636|10503852|P2|Follow-up|Premature termination of the study|7
3055886|NCT00558636|10503853|P1|Follow-up|Premature termination of the study|12
3055887|NCT00558636|10503852|P2|Treatment|Disease progression|5
3055888|NCT00558636|10503853|P1|Treatment|Disease progression|1
3055889|NCT00558636|10503852|P2|Treatment|Premature termination of the study|37
3055890|NCT00558636|10503853|P1|Treatment|Premature termination of the study|35
3055891|NCT00558636|10503852|P2|Treatment|Withdrawal by Subject|0
3055892|NCT00558636|10503853|P1|Treatment|Withdrawal by Subject|2
3055893|NCT00558636|10503852|P2|Treatment|Adverse Event|2
3055894|NCT00558636|10503853|P1|Treatment|Adverse Event|9
3055895|NCT00558558|10503953|P1|Overall Study|Lack of Efficacy|4
3055896|NCT00558558|10503953|P1|Overall Study|Withdrawal by Subject|1
3055897|NCT00558558|10503953|P1|Overall Study|Unable to swallow|1
3055898|NCT00558519|10503957|P1|Overall Study|Never received treatment|1
3055899|NCT00558519|10503957|P1|Overall Study|Insufficient data|1
3055900|NCT00558519|10503957|P1|Overall Study|Ineligible|1
3055901|NCT00558519|10503957|P1|Overall Study|Ph+|20
3055902|NCT00558467|10503967|P2|Overall Study|Patient moving out of state|1
3055903|NCT00558467|10503968|P1|Overall Study|Patient moving out of state|0
3055904|NCT00558467|10503967|P2|Overall Study|Lack of Efficacy|1
3055905|NCT00558467|10503968|P1|Overall Study|Lack of Efficacy|0
3055906|NCT00558467|10503967|P2|Overall Study|Adverse Event|2
3055907|NCT00558467|10503968|P1|Overall Study|Adverse Event|1
3055908|NCT00558428|10504028|P4|Overall Study|Other|1
3055909|NCT00558428|10504029|P3|Overall Study|Other|0
3055910|NCT00558428|10504030|P2|Overall Study|Other|0
3055911|NCT00558428|10504031|P1|Overall Study|Other|3
3055912|NCT00558428|10504028|P4|Overall Study|Consent withdrawn|1
3055913|NCT00558428|10504029|P3|Overall Study|Consent withdrawn|0
3055914|NCT00558428|10504030|P2|Overall Study|Consent withdrawn|1
3055915|NCT00558428|10504031|P1|Overall Study|Consent withdrawn|2
3055916|NCT00558428|10504028|P4|Overall Study|Non compliant with protocol|3
3055917|NCT00558428|10504029|P3|Overall Study|Non compliant with protocol|0
3055918|NCT00558428|10504030|P2|Overall Study|Non compliant with protocol|0
3055919|NCT00558428|10504031|P1|Overall Study|Non compliant with protocol|1
3055920|NCT00558428|10504028|P4|Overall Study|Lack of Efficacy|2
3055921|NCT00558428|10504029|P3|Overall Study|Lack of Efficacy|1
3055922|NCT00558428|10504030|P2|Overall Study|Lack of Efficacy|0
3055923|NCT00558428|10504031|P1|Overall Study|Lack of Efficacy|0
3055924|NCT00558428|10504028|P4|Overall Study|Lost to Follow-up|0
3055925|NCT00558428|10504029|P3|Overall Study|Lost to Follow-up|0
3055926|NCT00558428|10504030|P2|Overall Study|Lost to Follow-up|1
3055927|NCT00558428|10504031|P1|Overall Study|Lost to Follow-up|0
3055928|NCT00558428|10504028|P4|Overall Study|Adverse Event|4
3055929|NCT00558428|10504029|P3|Overall Study|Adverse Event|3
3055930|NCT00558428|10504030|P2|Overall Study|Adverse Event|22
3055931|NCT00558428|10504031|P1|Overall Study|Adverse Event|6
3055932|NCT00558363|10504071|P2|Overall Study|Hospitalized; Unable to Continue|1
3055933|NCT00558363|10504072|P1|Overall Study|Hospitalized; Unable to Continue|0
3055934|NCT00558363|10504071|P2|Overall Study|Randomized in Error|2
3055935|NCT00558363|10504072|P1|Overall Study|Randomized in Error|1
3055936|NCT00558363|10504071|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
3055937|NCT00558363|10504072|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
3055938|NCT00558363|10504071|P2|Overall Study|Lost to Follow-up|1
3055939|NCT00558363|10504072|P1|Overall Study|Lost to Follow-up|0
3055940|NCT00558363|10504071|P2|Overall Study|Protocol Violation|1
3055941|NCT00558363|10504072|P1|Overall Study|Protocol Violation|2
3055942|NCT00558363|10504071|P2|Overall Study|Lack of Efficacy|2
3055943|NCT00558363|10504072|P1|Overall Study|Lack of Efficacy|2
3055944|NCT00558363|10504071|P2|Overall Study|Adverse Event|5
3055945|NCT00558363|10504072|P1|Overall Study|Adverse Event|5
3055946|NCT00558363|10504071|P2|Overall Study|Withdrawal by Subject|4
3055947|NCT00558363|10504072|P1|Overall Study|Withdrawal by Subject|11
3055948|NCT00558363|10504071|P2|Overall Study|Physician Decision|4
3055949|NCT00558363|10504072|P1|Overall Study|Physician Decision|18
3055950|NCT00558285|10504127|P5|Overall Study|Protocol deviation|0
3055951|NCT00558285|10504128|P4|Overall Study|Protocol deviation|1
3055952|NCT00558285|10504129|P3|Overall Study|Protocol deviation|0
3055953|NCT00558285|10504130|P2|Overall Study|Protocol deviation|1
3055954|NCT00558285|10504131|P1|Overall Study|Protocol deviation|1
3055955|NCT00558285|10504127|P5|Overall Study|Administrative problems|1
3055956|NCT00558285|10504128|P4|Overall Study|Administrative problems|1
3055957|NCT00558285|10504129|P3|Overall Study|Administrative problems|0
3055958|NCT00558285|10504130|P2|Overall Study|Administrative problems|0
3055959|NCT00558285|10504131|P1|Overall Study|Administrative problems|0
3055960|NCT00558285|10504127|P5|Overall Study|Lost to Follow-up|0
3055961|NCT00558285|10504128|P4|Overall Study|Lost to Follow-up|0
3055962|NCT00558285|10504129|P3|Overall Study|Lost to Follow-up|0
3055963|NCT00558285|10504130|P2|Overall Study|Lost to Follow-up|1
3055964|NCT00558285|10504131|P1|Overall Study|Lost to Follow-up|1
3055965|NCT00558285|10504127|P5|Overall Study|Subject withdrew consent|1
3055966|NCT00558285|10504128|P4|Overall Study|Subject withdrew consent|1
3055967|NCT00558285|10504129|P3|Overall Study|Subject withdrew consent|1
3055968|NCT00558285|10504130|P2|Overall Study|Subject withdrew consent|0
3055969|NCT00558285|10504131|P1|Overall Study|Subject withdrew consent|2
3055970|NCT00558285|10504127|P5|Overall Study|Abnormal test procedure result(s)|0
3055971|NCT00558285|10504128|P4|Overall Study|Abnormal test procedure result(s)|0
3055972|NCT00558285|10504129|P3|Overall Study|Abnormal test procedure result(s)|0
3055973|NCT00558285|10504130|P2|Overall Study|Abnormal test procedure result(s)|0
3055974|NCT00558285|10504131|P1|Overall Study|Abnormal test procedure result(s)|1
3055975|NCT00558285|10504127|P5|Overall Study|Adverse Event|2
3055976|NCT00558285|10504128|P4|Overall Study|Adverse Event|1
3055977|NCT00558285|10504129|P3|Overall Study|Adverse Event|4
3055978|NCT00558285|10504130|P2|Overall Study|Adverse Event|1
3055979|NCT00558285|10504131|P1|Overall Study|Adverse Event|1
3055980|NCT00558272|10504175|P2|Overall Study|Withdrawal by Subject|1
3055981|NCT00558272|10504176|P1|Overall Study|Withdrawal by Subject|0
3055982|NCT00558272|10504175|P2|Overall Study|Incorrectly enrolled|0
3055983|NCT00558272|10504176|P1|Overall Study|Incorrectly enrolled|1
3055984|NCT00558272|10504175|P2|Overall Study|AZ study team decision|1
3055985|NCT00558272|10504176|P1|Overall Study|AZ study team decision|0
3055986|NCT00558272|10504175|P2|Overall Study|Dev. of study specific discon. criteria|0
3055987|NCT00558272|10504176|P1|Overall Study|Dev. of study specific discon. criteria|1
3055988|NCT00558272|10504175|P2|Overall Study|Death|0
3055989|NCT00558272|10504176|P1|Overall Study|Death|1
3055990|NCT00558272|10504175|P2|Overall Study|Adverse Event|0
3055991|NCT00558272|10504176|P1|Overall Study|Adverse Event|10
3055992|NCT00558259|10504216|P2|Overall Study|Withdrawal by Subject|13
3055993|NCT00558259|10504217|P1|Overall Study|Withdrawal by Subject|12
3055994|NCT00558259|10504216|P2|Overall Study|Protocol Violation|5
3055995|NCT00558259|10504217|P1|Overall Study|Protocol Violation|9
3055996|NCT00558259|10504216|P2|Overall Study|Adverse Event|81
3055997|NCT00558259|10504217|P1|Overall Study|Adverse Event|50
3055998|NCT00558103|10504257|P6|Monotherapy Extension Phase|Disease Progression|8
3055999|NCT00558103|10504258|P5|Monotherapy Extension Phase|Disease Progression|0
3056000|NCT00558103|10504259|P4|Monotherapy Extension Phase|Disease Progression|0
3056001|NCT00558103|10504260|P3|Monotherapy Extension Phase|Disease Progression|0
3056002|NCT00558103|10504261|P2|Monotherapy Extension Phase|Disease Progression|0
3056003|NCT00558103|10504262|P1|Monotherapy Extension Phase|Disease Progression|0
3056004|NCT00558103|10504257|P6|Monotherapy Extension Phase|Protocol Violation|1
3056005|NCT00558103|10504258|P5|Monotherapy Extension Phase|Protocol Violation|0
3056006|NCT00558103|10504259|P4|Monotherapy Extension Phase|Protocol Violation|0
3056007|NCT00558103|10504260|P3|Monotherapy Extension Phase|Protocol Violation|0
3056008|NCT00558103|10504261|P2|Monotherapy Extension Phase|Protocol Violation|0
3056009|NCT00558103|10504262|P1|Monotherapy Extension Phase|Protocol Violation|0
3056010|NCT00558103|10504257|P6|Randomized Treatment Phase|Adverse Event|0
3056011|NCT00558103|10504258|P5|Randomized Treatment Phase|Adverse Event|1
3056012|NCT00558103|10504259|P4|Randomized Treatment Phase|Adverse Event|1
3056013|NCT00558103|10504260|P3|Randomized Treatment Phase|Adverse Event|0
3056014|NCT00558103|10504261|P2|Randomized Treatment Phase|Adverse Event|0
3056015|NCT00558103|10504262|P1|Randomized Treatment Phase|Adverse Event|0
3056016|NCT00558103|10504257|P6|Randomized Treatment Phase|Disease Progression|0
3056017|NCT00558103|10504258|P5|Randomized Treatment Phase|Disease Progression|0
3056018|NCT00558103|10504259|P4|Randomized Treatment Phase|Disease Progression|0
3056019|NCT00558103|10504260|P3|Randomized Treatment Phase|Disease Progression|1
3056020|NCT00558103|10504261|P2|Randomized Treatment Phase|Disease Progression|0
3056021|NCT00558103|10504262|P1|Randomized Treatment Phase|Disease Progression|1
3056022|NCT00558103|10504257|P6|Randomized Treatment Phase|Withdrawal by Subject|0
3056023|NCT00558103|10504258|P5|Randomized Treatment Phase|Withdrawal by Subject|1
3056024|NCT00558103|10504259|P4|Randomized Treatment Phase|Withdrawal by Subject|0
3056025|NCT00558103|10504260|P3|Randomized Treatment Phase|Withdrawal by Subject|0
3056026|NCT00558103|10504261|P2|Randomized Treatment Phase|Withdrawal by Subject|2
3056027|NCT00558103|10504262|P1|Randomized Treatment Phase|Withdrawal by Subject|2
3056028|NCT00558103|10504257|P6|Randomized Treatment Phase|Lost to Follow-up|0
3056029|NCT00558103|10504258|P5|Randomized Treatment Phase|Lost to Follow-up|3
3056030|NCT00558103|10504259|P4|Randomized Treatment Phase|Lost to Follow-up|1
3056031|NCT00558103|10504260|P3|Randomized Treatment Phase|Lost to Follow-up|2
3056032|NCT00558103|10504261|P2|Randomized Treatment Phase|Lost to Follow-up|2
3056033|NCT00558103|10504262|P1|Randomized Treatment Phase|Lost to Follow-up|2
3056034|NCT00558064|10504292|P2|Overall Study|No visit within allowance period|0
3056035|NCT00558064|10504293|P1|Overall Study|No visit within allowance period|1
3056036|NCT00558064|10504292|P2|Overall Study|Withdrawal by Subject|1
3056037|NCT00558064|10504293|P1|Overall Study|Withdrawal by Subject|0
3056038|NCT00558064|10504292|P2|Overall Study|Lost to Follow-up|1
3056039|NCT00558064|10504293|P1|Overall Study|Lost to Follow-up|0
3056040|NCT00558064|10504292|P2|Overall Study|Protocol Violation|0
3056041|NCT00558064|10504293|P1|Overall Study|Protocol Violation|1
3056042|NCT00558064|10504292|P2|Overall Study|Lack of Efficacy|1
3056043|NCT00558064|10504293|P1|Overall Study|Lack of Efficacy|0
3056044|NCT00558064|10504292|P2|Overall Study|Adverse Event|2
3056045|NCT00558064|10504293|P1|Overall Study|Adverse Event|3
3056046|NCT00558025|10504315|P2|Overall Study|Protocol Violation|0
3056047|NCT00558025|10504316|P1|Overall Study|Protocol Violation|1
3056048|NCT00558025|10504315|P2|Overall Study|Withdrawal by Subject|2
3056049|NCT00558025|10504316|P1|Overall Study|Withdrawal by Subject|2
3056050|NCT00558025|10504315|P2|Overall Study|Adverse Event|1
3056051|NCT00558025|10504316|P1|Overall Study|Adverse Event|1
3056052|NCT00557856|10504363|P9|Part 2: Exploratory Phase|global deterioration of health status|1
3056053|NCT00557856|10504364|P8|Part 2: Exploratory Phase|global deterioration of health status|0
3056054|NCT00557856|10504365|P7|Part 2: Exploratory Phase|global deterioration of health status|0
3056055|NCT00557856|10504366|P6|Part 2: Exploratory Phase|global deterioration of health status|0
3056056|NCT00557856|10504367|P5|Part 2: Exploratory Phase|global deterioration of health status|0
3056057|NCT00557856|10504368|P4|Part 2: Exploratory Phase|global deterioration of health status|0
3056058|NCT00557856|10504369|P3|Part 2: Exploratory Phase|global deterioration of health status|0
3056059|NCT00557856|10504370|P2|Part 2: Exploratory Phase|global deterioration of health status|0
3056060|NCT00557856|10504371|P1|Part 2: Exploratory Phase|global deterioration of health status|0
3056061|NCT00557856|10504363|P9|Part 2: Exploratory Phase|Death|2
3056062|NCT00557856|10504364|P8|Part 2: Exploratory Phase|Death|0
3056063|NCT00557856|10504365|P7|Part 2: Exploratory Phase|Death|0
3056064|NCT00557856|10504366|P6|Part 2: Exploratory Phase|Death|0
3056065|NCT00557856|10504367|P5|Part 2: Exploratory Phase|Death|0
3056066|NCT00557856|10504368|P4|Part 2: Exploratory Phase|Death|0
3056067|NCT00557856|10504369|P3|Part 2: Exploratory Phase|Death|0
3056068|NCT00557856|10504370|P2|Part 2: Exploratory Phase|Death|0
3056069|NCT00557856|10504371|P1|Part 2: Exploratory Phase|Death|0
3056070|NCT00557856|10504363|P9|Part 2: Exploratory Phase|Other|1
3056071|NCT00557856|10504364|P8|Part 2: Exploratory Phase|Other|0
3056072|NCT00557856|10504365|P7|Part 2: Exploratory Phase|Other|0
3056073|NCT00557856|10504366|P6|Part 2: Exploratory Phase|Other|0
3056074|NCT00557856|10504367|P5|Part 2: Exploratory Phase|Other|0
3056075|NCT00557856|10504368|P4|Part 2: Exploratory Phase|Other|0
3056076|NCT00557856|10504369|P3|Part 2: Exploratory Phase|Other|0
3056077|NCT00557856|10504370|P2|Part 2: Exploratory Phase|Other|0
3056078|NCT00557856|10504371|P1|Part 2: Exploratory Phase|Other|0
3056079|NCT00557856|10504363|P9|Part 2: Exploratory Phase|Adverse Event|4
3056080|NCT00557856|10504364|P8|Part 2: Exploratory Phase|Adverse Event|0
3056081|NCT00557856|10504365|P7|Part 2: Exploratory Phase|Adverse Event|0
3056082|NCT00557856|10504366|P6|Part 2: Exploratory Phase|Adverse Event|0
3056083|NCT00557856|10504367|P5|Part 2: Exploratory Phase|Adverse Event|0
3056084|NCT00557856|10504368|P4|Part 2: Exploratory Phase|Adverse Event|0
3056085|NCT00557856|10504369|P3|Part 2: Exploratory Phase|Adverse Event|0
3056086|NCT00557856|10504370|P2|Part 2: Exploratory Phase|Adverse Event|0
3056087|NCT00557856|10504371|P1|Part 2: Exploratory Phase|Adverse Event|0
3056088|NCT00557856|10504363|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
3056089|NCT00557856|10504364|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056090|NCT00557856|10504365|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056091|NCT00557856|10504366|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056092|NCT00557856|10504367|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056093|NCT00557856|10504368|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056094|NCT00557856|10504369|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056095|NCT00557856|10504370|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056096|NCT00557856|10504371|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
3056097|NCT00557856|10504363|P9|Part 2: Exploratory Phase|objective progression or relapse|15
3056098|NCT00557856|10504364|P8|Part 2: Exploratory Phase|objective progression or relapse|0
3056099|NCT00557856|10504365|P7|Part 2: Exploratory Phase|objective progression or relapse|0
3056100|NCT00557856|10504366|P6|Part 2: Exploratory Phase|objective progression or relapse|0
3056101|NCT00557856|10504367|P5|Part 2: Exploratory Phase|objective progression or relapse|0
3056102|NCT00557856|10504368|P4|Part 2: Exploratory Phase|objective progression or relapse|0
3056103|NCT00557856|10504369|P3|Part 2: Exploratory Phase|objective progression or relapse|0
3056104|NCT00557856|10504370|P2|Part 2: Exploratory Phase|objective progression or relapse|0
3056105|NCT00557856|10504371|P1|Part 2: Exploratory Phase|objective progression or relapse|0
3056106|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
3056107|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
3056108|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
3056109|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
3056110|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
3056111|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
3056112|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
3056113|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
3056114|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
3056115|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056116|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056117|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
3056118|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
3056119|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056120|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056121|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056122|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056123|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
3056124|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|Death|0
3056125|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|Death|0
3056126|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|Death|0
3056127|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|Death|1
3056128|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|Death|0
3056129|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|Death|0
3056130|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|Death|0
3056131|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|Death|0
3056132|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|Death|0
3056133|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|Other|0
3056134|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|Other|1
3056135|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|Other|0
3056136|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|Other|0
3056137|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|Other|0
3056138|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|Other|1
3056139|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|Other|1
3056140|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|Other|0
3056141|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|Other|0
3056142|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|Adverse Event|0
3056143|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|Adverse Event|2
3056144|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|Adverse Event|1
3056145|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|Adverse Event|3
3056146|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|Adverse Event|1
3056147|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|Adverse Event|1
3056148|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|Adverse Event|1
3056149|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|Adverse Event|0
3056150|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|Adverse Event|1
3056151|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056152|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056153|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056154|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056155|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056156|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056157|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
3056158|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
3056159|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
3056160|NCT00557856|10504363|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
3056161|NCT00557856|10504364|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
3056162|NCT00557856|10504365|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
3056163|NCT00557856|10504366|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
3056164|NCT00557856|10504367|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
3056165|NCT00557856|10504368|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
3056166|NCT00557856|10504369|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
3056167|NCT00557856|10504370|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
3056168|NCT00557856|10504371|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
3056169|NCT00557830|10504570|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
3056170|NCT00557830|10504571|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
3056171|NCT00557830|10504572|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
3056172|NCT00557830|10504570|P3|Screening Treatment Phase|Adverse Event|0
3056173|NCT00557830|10504571|P2|Screening Treatment Phase|Adverse Event|0
3056174|NCT00557830|10504572|P1|Screening Treatment Phase|Adverse Event|2
3056175|NCT00557830|10504570|P3|Screening Treatment Phase|Withdrawal by Subject|0
3056176|NCT00557830|10504571|P2|Screening Treatment Phase|Withdrawal by Subject|0
3056177|NCT00557830|10504572|P1|Screening Treatment Phase|Withdrawal by Subject|1
3056178|NCT00557622|10504594|P2|12-Week Treatment Phase|Lost to Follow-up|1
3056179|NCT00557622|10504595|P1|12-Week Treatment Phase|Lost to Follow-up|0
3056180|NCT00557622|10504594|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
3056181|NCT00557622|10504595|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
3056182|NCT00557622|10504594|P2|4-Week Run-in Phase|Withdrawal by Subject|0
3056183|NCT00557622|10504595|P1|4-Week Run-in Phase|Withdrawal by Subject|1
3056184|NCT00557505|10504624|P9|Overall Study|Withdrawal by Subject|1
3056185|NCT00557505|10504625|P8|Overall Study|Withdrawal by Subject|0
3056186|NCT00557505|10504626|P7|Overall Study|Withdrawal by Subject|0
3056187|NCT00557505|10504627|P6|Overall Study|Withdrawal by Subject|0
3056188|NCT00557505|10504628|P5|Overall Study|Withdrawal by Subject|0
3056189|NCT00557505|10504629|P4|Overall Study|Withdrawal by Subject|1
3056190|NCT00557505|10504630|P3|Overall Study|Withdrawal by Subject|0
3056191|NCT00557505|10504631|P2|Overall Study|Withdrawal by Subject|0
3056192|NCT00557505|10504632|P1|Overall Study|Withdrawal by Subject|0
3056193|NCT00557505|10504624|P9|Overall Study|Objective progression or relapse|15
3056194|NCT00557505|10504625|P8|Overall Study|Objective progression or relapse|5
3056195|NCT00557505|10504626|P7|Overall Study|Objective progression or relapse|2
3056196|NCT00557505|10504627|P6|Overall Study|Objective progression or relapse|3
3056197|NCT00557505|10504628|P5|Overall Study|Objective progression or relapse|2
3056198|NCT00557505|10504629|P4|Overall Study|Objective progression or relapse|2
3056199|NCT00557505|10504630|P3|Overall Study|Objective progression or relapse|3
3056200|NCT00557505|10504631|P2|Overall Study|Objective progression or relapse|3
3056201|NCT00557505|10504632|P1|Overall Study|Objective progression or relapse|2
3056202|NCT00557505|10504624|P9|Overall Study|Global deterioration of health|0
3056203|NCT00557505|10504625|P8|Overall Study|Global deterioration of health|0
3056204|NCT00557505|10504626|P7|Overall Study|Global deterioration of health|0
3056205|NCT00557505|10504627|P6|Overall Study|Global deterioration of health|0
3056206|NCT00557505|10504628|P5|Overall Study|Global deterioration of health|0
3056207|NCT00557505|10504629|P4|Overall Study|Global deterioration of health|0
3056208|NCT00557505|10504630|P3|Overall Study|Global deterioration of health|0
3056209|NCT00557505|10504631|P2|Overall Study|Global deterioration of health|0
3056210|NCT00557505|10504632|P1|Overall Study|Global deterioration of health|1
3056211|NCT00557505|10504624|P9|Overall Study|Adverse Event|0
3056212|NCT00557505|10504625|P8|Overall Study|Adverse Event|0
3056213|NCT00557505|10504626|P7|Overall Study|Adverse Event|1
3056214|NCT00557505|10504627|P6|Overall Study|Adverse Event|0
3056215|NCT00557505|10504628|P5|Overall Study|Adverse Event|0
3056216|NCT00557505|10504629|P4|Overall Study|Adverse Event|0
3056217|NCT00557505|10504630|P3|Overall Study|Adverse Event|1
3056218|NCT00557505|10504631|P2|Overall Study|Adverse Event|0
3056219|NCT00557505|10504632|P1|Overall Study|Adverse Event|0
3056220|NCT00557505|10504624|P9|Overall Study|Death|1
3056221|NCT00557505|10504625|P8|Overall Study|Death|0
3056222|NCT00557505|10504626|P7|Overall Study|Death|0
3056223|NCT00557505|10504627|P6|Overall Study|Death|0
3056224|NCT00557505|10504628|P5|Overall Study|Death|0
3056225|NCT00557505|10504629|P4|Overall Study|Death|0
3056226|NCT00557505|10504630|P3|Overall Study|Death|0
3056227|NCT00557505|10504631|P2|Overall Study|Death|0
3056228|NCT00557505|10504632|P1|Overall Study|Death|0
3056229|NCT00557492|10504796|P1|Overall Study|Change in health insurance|1
3056230|NCT00557466|10504814|P6|Overall Study|Lost to Follow-up|0
3056231|NCT00557466|10504815|P5|Overall Study|Lost to Follow-up|0
3056232|NCT00557466|10504816|P4|Overall Study|Lost to Follow-up|1
3056233|NCT00557466|10504817|P3|Overall Study|Lost to Follow-up|0
3056234|NCT00557466|10504818|P2|Overall Study|Lost to Follow-up|0
3056235|NCT00557466|10504819|P1|Overall Study|Lost to Follow-up|0
3056236|NCT00557466|10504814|P6|Overall Study|Abnormal test procedure results|0
3056237|NCT00557466|10504815|P5|Overall Study|Abnormal test procedure results|0
3056238|NCT00557466|10504816|P4|Overall Study|Abnormal test procedure results|0
3056239|NCT00557466|10504817|P3|Overall Study|Abnormal test procedure results|1
3056240|NCT00557466|10504818|P2|Overall Study|Abnormal test procedure results|0
3056241|NCT00557466|10504819|P1|Overall Study|Abnormal test procedure results|0
3056242|NCT00557466|10504814|P6|Overall Study|Administrative problems|0
3056243|NCT00557466|10504815|P5|Overall Study|Administrative problems|0
3056244|NCT00557466|10504816|P4|Overall Study|Administrative problems|0
3056245|NCT00557466|10504817|P3|Overall Study|Administrative problems|1
3056246|NCT00557466|10504818|P2|Overall Study|Administrative problems|1
3056247|NCT00557466|10504819|P1|Overall Study|Administrative problems|0
3056248|NCT00557466|10504814|P6|Overall Study|Subject withdrew consent|2
3056249|NCT00557466|10504815|P5|Overall Study|Subject withdrew consent|1
3056250|NCT00557466|10504816|P4|Overall Study|Subject withdrew consent|0
3056251|NCT00557466|10504817|P3|Overall Study|Subject withdrew consent|0
3056252|NCT00557466|10504818|P2|Overall Study|Subject withdrew consent|0
3056253|NCT00557466|10504819|P1|Overall Study|Subject withdrew consent|0
3056254|NCT00557466|10504814|P6|Overall Study|Protocol deviation|0
3056255|NCT00557466|10504815|P5|Overall Study|Protocol deviation|0
3056256|NCT00557466|10504816|P4|Overall Study|Protocol deviation|2
3056257|NCT00557466|10504817|P3|Overall Study|Protocol deviation|0
3056258|NCT00557466|10504818|P2|Overall Study|Protocol deviation|1
3056259|NCT00557466|10504819|P1|Overall Study|Protocol deviation|0
3056260|NCT00557466|10504814|P6|Overall Study|Abnormal laboratory value(s)|0
3056261|NCT00557466|10504815|P5|Overall Study|Abnormal laboratory value(s)|0
3056262|NCT00557466|10504816|P4|Overall Study|Abnormal laboratory value(s)|0
3056263|NCT00557466|10504817|P3|Overall Study|Abnormal laboratory value(s)|0
3056264|NCT00557466|10504818|P2|Overall Study|Abnormal laboratory value(s)|2
3056265|NCT00557466|10504819|P1|Overall Study|Abnormal laboratory value(s)|1
3056266|NCT00557466|10504814|P6|Overall Study|Adverse Event|4
3056267|NCT00557466|10504815|P5|Overall Study|Adverse Event|2
3056268|NCT00557466|10504816|P4|Overall Study|Adverse Event|1
3056269|NCT00557466|10504817|P3|Overall Study|Adverse Event|4
3056270|NCT00557466|10504818|P2|Overall Study|Adverse Event|1
3056271|NCT00557466|10504819|P1|Overall Study|Adverse Event|3
3056272|NCT00557440|10504872|P3|Treatment Period 1|Adverse Event|1
3056273|NCT00557440|10504873|P2|Treatment Period 1|Adverse Event|0
3056274|NCT00557440|10504874|P1|Treatment Period 1|Adverse Event|0
3056275|NCT00557323|10504928|P1|Overall Study|Administrative change|2
3056276|NCT00557323|10504928|P1|Overall Study|Withdrawal by Subject|2
3056277|NCT00557323|10504928|P1|Overall Study|Death|3
3056278|NCT00557310|10504933|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
3056279|NCT00557310|10504933|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
3056280|NCT00557310|10504933|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
3056281|NCT00557310|10504933|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
3056282|NCT00557310|10504933|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
3056283|NCT00557310|10504933|P1|Main Study (0 - 18 Months)|Adverse Event|4
3056284|NCT00557245|10504979|P3|Overall Study|Ineligible|2
3056285|NCT00557245|10504980|P2|Overall Study|Ineligible|4
3056286|NCT00557245|10504981|P1|Overall Study|Ineligible|5
3056287|NCT00557245|10504979|P3|Overall Study|Lost to Follow-up|10
3056288|NCT00557245|10504980|P2|Overall Study|Lost to Follow-up|8
3056289|NCT00557245|10504981|P1|Overall Study|Lost to Follow-up|7
3056290|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
3056291|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
3056292|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
3056293|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
3056294|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
3056295|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
3056296|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
3056297|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
3056298|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
3056299|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
3056300|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
3056301|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
3056302|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
3056303|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
3056304|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
3056305|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
3056306|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
3056307|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
3056308|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Relapse|20
3056309|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Relapse|1
3056310|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Relapse|3
3056311|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Relapse|16
3056312|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Relapse|5
3056313|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Relapse|0
3056314|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
3056315|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
3056316|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
3056317|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
3056318|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
3056319|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
3056320|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
3056321|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
3056322|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
3056323|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
3056324|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
3056325|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
3056326|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Death|2
3056327|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Death|2
3056328|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Death|0
3056329|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Death|2
3056330|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Death|0
3056331|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Death|0
3056332|NCT00557193|10505019|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
3056333|NCT00557193|10505020|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
3056334|NCT00557193|10505021|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
3056335|NCT00557193|10505022|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
3056336|NCT00557193|10505023|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
3056337|NCT00557193|10505024|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
3056338|NCT00557193|10505019|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
3056339|NCT00557193|10505020|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
3056340|NCT00557193|10505021|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
3056341|NCT00557193|10505022|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
3056342|NCT00557193|10505023|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
3056343|NCT00557193|10505024|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
3056344|NCT00557193|10505019|P6|Induction|Inevaluable for post Induction|0
3056345|NCT00557193|10505020|P5|Induction|Inevaluable for post Induction|0
3056346|NCT00557193|10505021|P4|Induction|Inevaluable for post Induction|0
3056347|NCT00557193|10505022|P3|Induction|Inevaluable for post Induction|0
3056348|NCT00557193|10505023|P2|Induction|Inevaluable for post Induction|0
3056349|NCT00557193|10505024|P1|Induction|Inevaluable for post Induction|2
3056350|NCT00557193|10505019|P6|Induction|Ineligible|0
3056351|NCT00557193|10505020|P5|Induction|Ineligible|0
3056352|NCT00557193|10505021|P4|Induction|Ineligible|0
3056353|NCT00557193|10505022|P3|Induction|Ineligible|0
3056354|NCT00557193|10505023|P2|Induction|Ineligible|0
3056355|NCT00557193|10505024|P1|Induction|Ineligible|8
3056356|NCT00557193|10505019|P6|Induction|Refusal of Further Protocol Therapy|0
3056357|NCT00557193|10505020|P5|Induction|Refusal of Further Protocol Therapy|0
3056358|NCT00557193|10505021|P4|Induction|Refusal of Further Protocol Therapy|0
3056359|NCT00557193|10505022|P3|Induction|Refusal of Further Protocol Therapy|0
3056360|NCT00557193|10505023|P2|Induction|Refusal of Further Protocol Therapy|0
3056361|NCT00557193|10505024|P1|Induction|Refusal of Further Protocol Therapy|2
3056362|NCT00557193|10505019|P6|Induction|Withdrawal by Subject|0
3056363|NCT00557193|10505020|P5|Induction|Withdrawal by Subject|0
3056364|NCT00557193|10505021|P4|Induction|Withdrawal by Subject|0
3056365|NCT00557193|10505022|P3|Induction|Withdrawal by Subject|0
3056366|NCT00557193|10505023|P2|Induction|Withdrawal by Subject|0
3056367|NCT00557193|10505024|P1|Induction|Withdrawal by Subject|1
3056368|NCT00557193|10505019|P6|Induction|Physician Decision|0
3056369|NCT00557193|10505020|P5|Induction|Physician Decision|0
3056370|NCT00557193|10505021|P4|Induction|Physician Decision|0
3056371|NCT00557193|10505022|P3|Induction|Physician Decision|0
3056372|NCT00557193|10505023|P2|Induction|Physician Decision|0
3056373|NCT00557193|10505024|P1|Induction|Physician Decision|3
3056374|NCT00557193|10505019|P6|Induction|Death|0
3056375|NCT00557193|10505020|P5|Induction|Death|0
3056376|NCT00557193|10505021|P4|Induction|Death|0
3056377|NCT00557193|10505022|P3|Induction|Death|0
3056378|NCT00557193|10505023|P2|Induction|Death|0
3056379|NCT00557193|10505024|P1|Induction|Death|6
3056380|NCT00557193|10505019|P6|Induction|Adverse Event|0
3056381|NCT00557193|10505020|P5|Induction|Adverse Event|0
3056382|NCT00557193|10505021|P4|Induction|Adverse Event|0
3056383|NCT00557193|10505022|P3|Induction|Adverse Event|0
3056384|NCT00557193|10505023|P2|Induction|Adverse Event|0
3056385|NCT00557193|10505024|P1|Induction|Adverse Event|2
3056386|NCT00557076|10505064|P2|Overall Study|Unblinding|1
3056387|NCT00557076|10505065|P1|Overall Study|Unblinding|0
3056388|NCT00556998|10505073|P1|Voriconazole Oral|Intolerant of oral treatment|1
3056389|NCT00556998|10505073|P1|Voriconazole Oral|Adverse Event|1
3056390|NCT00556998|10505073|P1|Voriconazole Intravenous (IV)|Other|4
3056391|NCT00556998|10505073|P1|Voriconazole Intravenous (IV)|Adverse Event|1
3056392|NCT00556933|10505108|P4|CNI Withdrawal vs. Minimization|Death|1
3056393|NCT00556933|10505109|P3|CNI Withdrawal vs. Minimization|Death|0
3056394|NCT00556933|10505110|P2|CNI Withdrawal vs. Minimization|Death|0
3056395|NCT00556933|10505111|P1|CNI Withdrawal vs. Minimization|Death|0
3056396|NCT00556933|10505108|P4|CNI Withdrawal vs. Minimization|Graft loss|0
3056397|NCT00556933|10505109|P3|CNI Withdrawal vs. Minimization|Graft loss|2
3056398|NCT00556933|10505110|P2|CNI Withdrawal vs. Minimization|Graft loss|1
3056399|NCT00556933|10505111|P1|CNI Withdrawal vs. Minimization|Graft loss|0
3056400|NCT00556933|10505108|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
3056401|NCT00556933|10505109|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
3056402|NCT00556933|10505110|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
3056403|NCT00556933|10505111|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
3056404|NCT00556933|10505108|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
3056405|NCT00556933|10505109|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
3056406|NCT00556933|10505110|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
3056407|NCT00556933|10505111|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
3056408|NCT00556933|10505108|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
3056409|NCT00556933|10505109|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
3056410|NCT00556933|10505110|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
3056411|NCT00556933|10505111|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
3056412|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
3056413|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
3056414|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
3056415|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
3056416|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
3056417|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
3056418|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
3056419|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
3056420|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Death|0
3056421|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Death|0
3056422|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Death|1
3056423|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Death|0
3056424|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
3056425|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
3056426|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
3056427|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
3056428|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
3056429|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
3056430|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
3056431|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
3056432|NCT00556933|10505108|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
3056433|NCT00556933|10505109|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
3056434|NCT00556933|10505110|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
3056435|NCT00556933|10505111|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
3056436|NCT00556894|10505168|P3|Overall Study|Withdrawal by Subject|1
3056437|NCT00556894|10505169|P2|Overall Study|Withdrawal by Subject|1
3056438|NCT00556894|10505170|P1|Overall Study|Withdrawal by Subject|1
3056439|NCT00556894|10505168|P3|Overall Study|Change in therapy|2
3056440|NCT00556894|10505169|P2|Overall Study|Change in therapy|1
3056441|NCT00556894|10505170|P1|Overall Study|Change in therapy|2
3056442|NCT00556894|10505168|P3|Overall Study|regulatory decision in Bulgaria|13
3056443|NCT00556894|10505169|P2|Overall Study|regulatory decision in Bulgaria|14
3056444|NCT00556894|10505170|P1|Overall Study|regulatory decision in Bulgaria|10
3056445|NCT00556894|10505168|P3|Overall Study|Death|0
3056446|NCT00556894|10505169|P2|Overall Study|Death|0
3056447|NCT00556894|10505170|P1|Overall Study|Death|1
3056448|NCT00556894|10505168|P3|Overall Study|Adverse Event|3
3056449|NCT00556894|10505169|P2|Overall Study|Adverse Event|3
3056450|NCT00556894|10505170|P1|Overall Study|Adverse Event|2
3056451|NCT00556712|10505180|P2|Overall Study|Ongoing at Data Cutoff|66
3056452|NCT00556712|10505181|P1|Overall Study|Ongoing at Data Cutoff|32
3056453|NCT00556712|10505180|P2|Overall Study|Other|2
3056454|NCT00556712|10505181|P1|Overall Study|Other|2
3056455|NCT00556712|10505180|P2|Overall Study|Failure to Return|3
3056456|NCT00556712|10505181|P1|Overall Study|Failure to Return|2
3056457|NCT00556712|10505180|P2|Overall Study|Refused Treatment|16
3056458|NCT00556712|10505181|P1|Overall Study|Refused Treatment|17
3056459|NCT00556712|10505180|P2|Overall Study|Protocol Violation|2
3056460|NCT00556712|10505181|P1|Overall Study|Protocol Violation|3
3056461|NCT00556712|10505180|P2|Overall Study|Progressive Disease|320
3056462|NCT00556712|10505181|P1|Overall Study|Progressive Disease|383
3056463|NCT00556712|10505180|P2|Overall Study|Death|10
3056464|NCT00556712|10505181|P1|Overall Study|Death|5
3056465|NCT00556712|10505180|P2|Overall Study|Adverse Event|19
3056466|NCT00556712|10505181|P1|Overall Study|Adverse Event|7
3056467|NCT00556673|10505259|P2|Overall Study|Protocol deviation|2
3056468|NCT00556673|10505260|P1|Overall Study|Protocol deviation|3
3056469|NCT00556439|10505396|P4|After Week 12 (Randomized Study Period)|Severe infection|0
3056470|NCT00556439|10505397|P3|After Week 12 (Randomized Study Period)|Severe infection|0
3056471|NCT00556439|10505398|P2|After Week 12 (Randomized Study Period)|Severe infection|0
3056472|NCT00556439|10505399|P1|After Week 12 (Randomized Study Period)|Severe infection|1
3056473|NCT00556439|10505396|P4|After Week 12 (Randomized Study Period)|Malignancy|1
3056474|NCT00556439|10505397|P3|After Week 12 (Randomized Study Period)|Malignancy|0
3056475|NCT00556439|10505398|P2|After Week 12 (Randomized Study Period)|Malignancy|1
3056476|NCT00556439|10505399|P1|After Week 12 (Randomized Study Period)|Malignancy|0
3056477|NCT00556439|10505396|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
3056478|NCT00556439|10505397|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
3056479|NCT00556439|10505398|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
3056480|NCT00556439|10505399|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
3056481|NCT00556439|10505396|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
3056482|NCT00556439|10505397|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
3056483|NCT00556439|10505398|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
3056484|NCT00556439|10505399|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
3056485|NCT00556439|10505396|P4|Study Entry to Week 12|Malignancy|0
3056486|NCT00556439|10505397|P3|Study Entry to Week 12|Malignancy|1
3056487|NCT00556439|10505398|P2|Study Entry to Week 12|Malignancy|0
3056488|NCT00556439|10505399|P1|Study Entry to Week 12|Malignancy|0
3056489|NCT00556439|10505396|P4|Study Entry to Week 12|Recurrent infection|0
3056490|NCT00556439|10505397|P3|Study Entry to Week 12|Recurrent infection|0
3056491|NCT00556439|10505398|P2|Study Entry to Week 12|Recurrent infection|0
3056492|NCT00556439|10505399|P1|Study Entry to Week 12|Recurrent infection|1
3056493|NCT00556439|10505396|P4|Study Entry to Week 12|Withdrawal by Subject|0
3056494|NCT00556439|10505397|P3|Study Entry to Week 12|Withdrawal by Subject|1
3056495|NCT00556439|10505398|P2|Study Entry to Week 12|Withdrawal by Subject|0
3056496|NCT00556439|10505399|P1|Study Entry to Week 12|Withdrawal by Subject|1
3056497|NCT00556439|10505396|P4|Study Entry to Week 12|Physician Decision|0
3056498|NCT00556439|10505397|P3|Study Entry to Week 12|Physician Decision|0
3056499|NCT00556439|10505398|P2|Study Entry to Week 12|Physician Decision|0
3056500|NCT00556439|10505399|P1|Study Entry to Week 12|Physician Decision|1
3056501|NCT00556439|10505396|P4|Study Entry to Week 12|Lack of Efficacy|0
3056502|NCT00556439|10505397|P3|Study Entry to Week 12|Lack of Efficacy|6
3056503|NCT00556439|10505398|P2|Study Entry to Week 12|Lack of Efficacy|0
3056504|NCT00556439|10505399|P1|Study Entry to Week 12|Lack of Efficacy|5
3056505|NCT00556426|10505409|P1|Overall Study|Death|6
3056506|NCT00556426|10505409|P1|Overall Study|Withdrawal by Subject|3
3056507|NCT00556374|10505431|P2|Overall Study|Lost to Follow-up|5
3056508|NCT00556374|10505432|P1|Overall Study|Lost to Follow-up|7
3056509|NCT00556374|10505431|P2|Overall Study|Death|43
3056510|NCT00556374|10505432|P1|Overall Study|Death|50
3056511|NCT00556374|10505431|P2|Overall Study|Withdrawal by Subject|172
3056512|NCT00556374|10505432|P1|Overall Study|Withdrawal by Subject|190
3056513|NCT00556322|10505452|P2|Overall Study|Death|14
3056514|NCT00556322|10505453|P1|Overall Study|Death|20
3056515|NCT00556322|10505452|P2|Overall Study|Ongoing at data cutoff|5
3056516|NCT00556322|10505453|P1|Overall Study|Ongoing at data cutoff|3
3056517|NCT00556322|10505452|P2|Overall Study|Protocol Violation|1
3056518|NCT00556322|10505453|P1|Overall Study|Protocol Violation|5
3056519|NCT00556322|10505452|P2|Overall Study|Withdrawal by Subject|7
3056520|NCT00556322|10505453|P1|Overall Study|Withdrawal by Subject|19
3056521|NCT00556322|10505452|P2|Overall Study|Lost to Follow-up|3
3056522|NCT00556322|10505453|P1|Overall Study|Lost to Follow-up|5
3056523|NCT00556322|10505452|P2|Overall Study|Other|1
3056524|NCT00556322|10505453|P1|Overall Study|Other|4
3056525|NCT00556322|10505452|P2|Overall Study|Adverse Event|4
3056526|NCT00556322|10505453|P1|Overall Study|Adverse Event|7
3056527|NCT00556322|10505452|P2|Overall Study|Insufficient therapeutic response|168
3056528|NCT00556322|10505453|P1|Overall Study|Insufficient therapeutic response|158
3056529|NCT00556166|10505501|P1|Overall Study|Withdrawal by Subject|1
3056530|NCT00556075|10505514|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
3056531|NCT00556075|10505515|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
3056532|NCT00556075|10505516|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
3056533|NCT00556075|10505514|P3|Overall Study|Personal issues|0
3056534|NCT00556075|10505515|P2|Overall Study|Personal issues|1
3056535|NCT00556075|10505516|P1|Overall Study|Personal issues|4
3056536|NCT00556075|10505514|P3|Overall Study|Adverse Event|0
3056537|NCT00556075|10505515|P2|Overall Study|Adverse Event|2
3056538|NCT00556075|10505516|P1|Overall Study|Adverse Event|1
3056539|NCT00556075|10505514|P3|Overall Study|Not eligible|2
3056540|NCT00556075|10505515|P2|Overall Study|Not eligible|1
3056541|NCT00556075|10505516|P1|Overall Study|Not eligible|1
3056542|NCT00556075|10505514|P3|Overall Study|Protocol Violation|3
3056543|NCT00556075|10505515|P2|Overall Study|Protocol Violation|1
3056544|NCT00556075|10505516|P1|Overall Study|Protocol Violation|1
3056545|NCT00556075|10505514|P3|Overall Study|Withdrawal by Subject|0
3056546|NCT00556075|10505515|P2|Overall Study|Withdrawal by Subject|3
3056547|NCT00556075|10505516|P1|Overall Study|Withdrawal by Subject|3
3056548|NCT00556075|10505514|P3|Overall Study|Lost to Follow-up|3
3056549|NCT00556075|10505515|P2|Overall Study|Lost to Follow-up|0
3056550|NCT00556075|10505516|P1|Overall Study|Lost to Follow-up|3
3056551|NCT00555971|10505567|P2|Overall Study|Adverse Event|1
3056552|NCT00555971|10505568|P1|Overall Study|Adverse Event|1
3056553|NCT00555906|10505579|P5|Phase 2|Randomized but not Treated|2
3056554|NCT00555906|10505580|P4|Phase 2|Randomized but not Treated|0
3056555|NCT00555906|10505581|P3|Phase 2|Randomized but not Treated|0
3056556|NCT00555906|10505582|P2|Phase 2|Randomized but not Treated|0
3056557|NCT00555906|10505583|P1|Phase 2|Randomized but not Treated|0
3056558|NCT00555906|10505579|P5|Phase 2|Other|6
3056559|NCT00555906|10505580|P4|Phase 2|Other|0
3056560|NCT00555906|10505581|P3|Phase 2|Other|0
3056561|NCT00555906|10505582|P2|Phase 2|Other|0
3056562|NCT00555906|10505583|P1|Phase 2|Other|0
3056563|NCT00555906|10505579|P5|Phase 2|Withdrawal by Subject|2
3056564|NCT00555906|10505580|P4|Phase 2|Withdrawal by Subject|0
3056565|NCT00555906|10505581|P3|Phase 2|Withdrawal by Subject|0
3056566|NCT00555906|10505582|P2|Phase 2|Withdrawal by Subject|0
3056567|NCT00555906|10505583|P1|Phase 2|Withdrawal by Subject|0
3056568|NCT00555906|10505579|P5|Phase 2|Objective Progression or Relapse|16
3056569|NCT00555906|10505580|P4|Phase 2|Objective Progression or Relapse|0
3056570|NCT00555906|10505581|P3|Phase 2|Objective Progression or Relapse|0
3056571|NCT00555906|10505582|P2|Phase 2|Objective Progression or Relapse|0
3056572|NCT00555906|10505583|P1|Phase 2|Objective Progression or Relapse|0
3056573|NCT00555906|10505579|P5|Phase 2|Global Deterioration of Health Status|2
3056574|NCT00555906|10505580|P4|Phase 2|Global Deterioration of Health Status|0
3056575|NCT00555906|10505581|P3|Phase 2|Global Deterioration of Health Status|0
3056576|NCT00555906|10505582|P2|Phase 2|Global Deterioration of Health Status|0
3056577|NCT00555906|10505583|P1|Phase 2|Global Deterioration of Health Status|0
3056578|NCT00555906|10505579|P5|Phase 2|Adverse Event|4
3056579|NCT00555906|10505580|P4|Phase 2|Adverse Event|0
3056580|NCT00555906|10505581|P3|Phase 2|Adverse Event|0
3056581|NCT00555906|10505582|P2|Phase 2|Adverse Event|0
3056582|NCT00555906|10505583|P1|Phase 2|Adverse Event|0
3056583|NCT00555906|10505579|P5|Phase 1|Withdrawal by Subject|0
3056584|NCT00555906|10505580|P4|Phase 1|Withdrawal by Subject|1
3056585|NCT00555906|10505581|P3|Phase 1|Withdrawal by Subject|0
3056586|NCT00555906|10505582|P2|Phase 1|Withdrawal by Subject|0
3056587|NCT00555906|10505583|P1|Phase 1|Withdrawal by Subject|0
3056588|NCT00555906|10505579|P5|Phase 1|Adverse Event|0
3056589|NCT00555906|10505580|P4|Phase 1|Adverse Event|2
3056590|NCT00555906|10505581|P3|Phase 1|Adverse Event|3
3056591|NCT00555906|10505582|P2|Phase 1|Adverse Event|0
3056592|NCT00555906|10505583|P1|Phase 1|Adverse Event|0
3056593|NCT00555906|10505579|P5|Phase 1|Global Deterioration of Health Status|0
3056594|NCT00555906|10505580|P4|Phase 1|Global Deterioration of Health Status|1
3056595|NCT00555906|10505581|P3|Phase 1|Global Deterioration of Health Status|1
3056596|NCT00555906|10505582|P2|Phase 1|Global Deterioration of Health Status|1
3056597|NCT00555906|10505583|P1|Phase 1|Global Deterioration of Health Status|0
3056598|NCT00555906|10505579|P5|Phase 1|Objective Progression or Relapse|0
3056599|NCT00555906|10505580|P4|Phase 1|Objective Progression or Relapse|1
3056600|NCT00555906|10505581|P3|Phase 1|Objective Progression or Relapse|3
3056601|NCT00555906|10505582|P2|Phase 1|Objective Progression or Relapse|5
3056602|NCT00555906|10505583|P1|Phase 1|Objective Progression or Relapse|3
3056603|NCT00555672|10505705|P2|Overall Study|Participant refused|0
3056604|NCT00555672|10505706|P1|Overall Study|Participant refused|2
3056605|NCT00555672|10505705|P2|Overall Study|Other|1
3056606|NCT00555672|10505706|P1|Overall Study|Other|3
3056607|NCT00555672|10505705|P2|Overall Study|Objective progression or relapse|5
3056608|NCT00555672|10505706|P1|Overall Study|Objective progression or relapse|11
3056609|NCT00555672|10505705|P2|Overall Study|Adverse Event|2
3056610|NCT00555672|10505706|P1|Overall Study|Adverse Event|8
3056611|NCT00555672|10505705|P2|Overall Study|Death|2
3056612|NCT00555672|10505706|P1|Overall Study|Death|0
3056613|NCT00555620|10505731|P6|Overall Study|Other|3
3056614|NCT00555620|10505732|P5|Overall Study|Other|0
3056615|NCT00555620|10505733|P4|Overall Study|Other|1
3056616|NCT00555620|10505734|P3|Overall Study|Other|0
3056617|NCT00555620|10505735|P2|Overall Study|Other|0
3056618|NCT00555620|10505736|P1|Overall Study|Other|0
3056619|NCT00555620|10505731|P6|Overall Study|Participant refused treatment|1
3056620|NCT00555620|10505732|P5|Overall Study|Participant refused treatment|0
3056621|NCT00555620|10505733|P4|Overall Study|Participant refused treatment|0
3056622|NCT00555620|10505734|P3|Overall Study|Participant refused treatment|1
3056623|NCT00555620|10505735|P2|Overall Study|Participant refused treatment|1
3056624|NCT00555620|10505736|P1|Overall Study|Participant refused treatment|0
3056625|NCT00555620|10505731|P6|Overall Study|Objective progression or relapse|16
3056626|NCT00555620|10505732|P5|Overall Study|Objective progression or relapse|3
3056627|NCT00555620|10505733|P4|Overall Study|Objective progression or relapse|17
3056628|NCT00555620|10505734|P3|Overall Study|Objective progression or relapse|12
3056629|NCT00555620|10505735|P2|Overall Study|Objective progression or relapse|5
3056630|NCT00555620|10505736|P1|Overall Study|Objective progression or relapse|6
3056631|NCT00555620|10505731|P6|Overall Study|Adverse Event|1
3056632|NCT00555620|10505732|P5|Overall Study|Adverse Event|0
3056633|NCT00555620|10505733|P4|Overall Study|Adverse Event|5
3056634|NCT00555620|10505734|P3|Overall Study|Adverse Event|1
3056635|NCT00555620|10505735|P2|Overall Study|Adverse Event|0
3056636|NCT00555620|10505736|P1|Overall Study|Adverse Event|0
3056637|NCT00555620|10505731|P6|Overall Study|Study terminated by sponsor|0
3056638|NCT00555620|10505732|P5|Overall Study|Study terminated by sponsor|0
3056639|NCT00555620|10505733|P4|Overall Study|Study terminated by sponsor|0
3056640|NCT00555620|10505734|P3|Overall Study|Study terminated by sponsor|1
3056641|NCT00555620|10505735|P2|Overall Study|Study terminated by sponsor|0
3056642|NCT00555620|10505736|P1|Overall Study|Study terminated by sponsor|0
3056643|NCT00555620|10505731|P6|Overall Study|Death|1
3056644|NCT00555620|10505732|P5|Overall Study|Death|0
3056645|NCT00555620|10505733|P4|Overall Study|Death|0
3056646|NCT00555620|10505734|P3|Overall Study|Death|0
3056647|NCT00555620|10505735|P2|Overall Study|Death|1
3056648|NCT00555620|10505736|P1|Overall Study|Death|0
3056649|NCT00555568|10505860|P3|Overall Study|Lost to Follow-up|16
3056650|NCT00555568|10505861|P2|Overall Study|Lost to Follow-up|16
3056651|NCT00555568|10505862|P1|Overall Study|Lost to Follow-up|26
3056652|NCT00555477|10505884|P2|Overall Study|Physician Decision|2
3056653|NCT00555477|10505885|P1|Overall Study|Physician Decision|1
3056654|NCT00555477|10505884|P2|Overall Study|Withdrawal by Subject|2
3056655|NCT00555477|10505885|P1|Overall Study|Withdrawal by Subject|1
3056656|NCT00555477|10505884|P2|Overall Study|Adverse Event|9
3056657|NCT00555477|10505885|P1|Overall Study|Adverse Event|0
3056658|NCT00555438|10505901|P1|Between 10 Days and 30 Days Postoperativ|Death|5
3056659|NCT00555438|10505901|P1|10 Days Post-operative|Death|4
3056660|NCT00555425|10505911|P2|Overall Study|Became pregnant and transferred care|1
3056661|NCT00555425|10505912|P1|Overall Study|Became pregnant and transferred care|0
3056662|NCT00555425|10505911|P2|Overall Study|Met criteria for protective transfer|3
3056663|NCT00555425|10505912|P1|Overall Study|Met criteria for protective transfer|16
3056664|NCT00555425|10505911|P2|Overall Study|Missed 3 physician management visits|0
3056665|NCT00555425|10505912|P1|Overall Study|Missed 3 physician management visits|1
3056666|NCT00555425|10505911|P2|Overall Study|Missed Medication > 1 wk|15
3056667|NCT00555425|10505912|P1|Overall Study|Missed Medication > 1 wk|34
3056668|NCT00555321|10505948|P5|Long-term Extension Phase|Other Reason|0
3056669|NCT00555321|10505949|P4|Long-term Extension Phase|Other Reason|0
3056670|NCT00555321|10505950|P3|Long-term Extension Phase|Other Reason|2
3056671|NCT00555321|10505951|P2|Long-term Extension Phase|Other Reason|0
3056672|NCT00555321|10505952|P1|Long-term Extension Phase|Other Reason|1
3056673|NCT00555321|10505948|P5|Long-term Extension Phase|Participant did not meet study criteria|1
3056674|NCT00555321|10505949|P4|Long-term Extension Phase|Participant did not meet study criteria|0
3056675|NCT00555321|10505950|P3|Long-term Extension Phase|Participant did not meet study criteria|0
3056676|NCT00555321|10505951|P2|Long-term Extension Phase|Participant did not meet study criteria|0
3056677|NCT00555321|10505952|P1|Long-term Extension Phase|Participant did not meet study criteria|0
3056678|NCT00555321|10505948|P5|Long-term Extension Phase|Death|0
3056679|NCT00555321|10505949|P4|Long-term Extension Phase|Death|3
3056680|NCT00555321|10505950|P3|Long-term Extension Phase|Death|0
3056681|NCT00555321|10505951|P2|Long-term Extension Phase|Death|0
3056682|NCT00555321|10505952|P1|Long-term Extension Phase|Death|2
3056683|NCT00555321|10505948|P5|Long-term Extension Phase|Administrative reason by sponsor|23
3056684|NCT00555321|10505949|P4|Long-term Extension Phase|Administrative reason by sponsor|31
3056685|NCT00555321|10505950|P3|Long-term Extension Phase|Administrative reason by sponsor|18
3056686|NCT00555321|10505951|P2|Long-term Extension Phase|Administrative reason by sponsor|21
3056687|NCT00555321|10505952|P1|Long-term Extension Phase|Administrative reason by sponsor|23
3056688|NCT00555321|10505948|P5|Long-term Extension Phase|Withdrawal by Subject|2
3056689|NCT00555321|10505949|P4|Long-term Extension Phase|Withdrawal by Subject|3
3056690|NCT00555321|10505950|P3|Long-term Extension Phase|Withdrawal by Subject|2
3056691|NCT00555321|10505951|P2|Long-term Extension Phase|Withdrawal by Subject|1
3056692|NCT00555321|10505952|P1|Long-term Extension Phase|Withdrawal by Subject|2
3056693|NCT00555321|10505948|P5|Long-term Extension Phase|Adverse Event|0
3056694|NCT00555321|10505949|P4|Long-term Extension Phase|Adverse Event|1
3056695|NCT00555321|10505950|P3|Long-term Extension Phase|Adverse Event|2
3056696|NCT00555321|10505951|P2|Long-term Extension Phase|Adverse Event|5
3056697|NCT00555321|10505952|P1|Long-term Extension Phase|Adverse Event|2
3056698|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Never treated|4
3056699|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Never treated|0
3056700|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Never treated|1
3056701|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Never treated|3
3056702|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Never treated|2
3056703|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Other Reason|0
3056704|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Other Reason|0
3056705|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Other Reason|2
3056706|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Other Reason|3
3056707|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Other Reason|1
3056708|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
3056709|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
3056710|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
3056711|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
3056712|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
3056713|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Death|0
3056714|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Death|0
3056715|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Death|4
3056716|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Death|1
3056717|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Death|2
3056718|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
3056719|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
3056720|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
3056721|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
3056722|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
3056723|NCT00555321|10505948|P5|Treatment Phase up to 12-months|Adverse Event|18
3056724|NCT00555321|10505949|P4|Treatment Phase up to 12-months|Adverse Event|7
3056725|NCT00555321|10505950|P3|Treatment Phase up to 12-months|Adverse Event|11
3056726|NCT00555321|10505951|P2|Treatment Phase up to 12-months|Adverse Event|7
3056727|NCT00555321|10505952|P1|Treatment Phase up to 12-months|Adverse Event|6
3056728|NCT00555217|10506256|P2|Overall Study|close out sites|17
3056729|NCT00555217|10506257|P1|Overall Study|close out sites|21
3056730|NCT00555217|10506256|P2|Overall Study|Lost to Follow-up|20
3056731|NCT00555217|10506257|P1|Overall Study|Lost to Follow-up|19
3056732|NCT00555217|10506256|P2|Overall Study|Withdrawal by Subject|31
3056733|NCT00555217|10506257|P1|Overall Study|Withdrawal by Subject|35
3056734|NCT00555061|10506294|P1|Overall Study|Participant enrolled, but never treated|1
3056735|NCT00555061|10506294|P1|Overall Study|Withdrawal by Subject|2
3056736|NCT00555061|10506294|P1|Overall Study|Lost to Follow-up|2
3056737|NCT00555061|10506294|P1|Overall Study|Protocol Violation|1
3056738|NCT00555061|10506294|P1|Overall Study|Adverse Event|3
3056739|NCT00555009|10506313|P2|Overall Study|Terminated by Sponsor|5
3056740|NCT00555009|10506314|P1|Overall Study|Terminated by Sponsor|2
3056741|NCT00555009|10506313|P2|Overall Study|Withdrawal by Subject|1
3056742|NCT00555009|10506314|P1|Overall Study|Withdrawal by Subject|0
3056743|NCT00554840|10506394|P2|Overall Study|Physician Decision|1
3056744|NCT00554840|10506395|P1|Overall Study|Physician Decision|0
3056745|NCT00554801|10506413|P2|Overall Study|Withdrawal by Subject|0
3056746|NCT00554801|10506414|P1|Overall Study|Withdrawal by Subject|14
3056747|NCT00554801|10506413|P2|Overall Study|left area before completion|0
3056748|NCT00554801|10506414|P1|Overall Study|left area before completion|5
3056749|NCT00554788|10506425|P3|Overall Study|Ineligible|1
3056750|NCT00554788|10506426|P2|Overall Study|Ineligible|0
3056751|NCT00554788|10506427|P1|Overall Study|Ineligible|2
3056752|NCT00554788|10506425|P3|Overall Study|Progressive disease|3
3056753|NCT00554788|10506426|P2|Overall Study|Progressive disease|0
3056754|NCT00554788|10506427|P1|Overall Study|Progressive disease|0
3056755|NCT00554788|10506425|P3|Overall Study|Refusal of further protocol therapy|1
3056756|NCT00554788|10506426|P2|Overall Study|Refusal of further protocol therapy|1
3056757|NCT00554788|10506427|P1|Overall Study|Refusal of further protocol therapy|0
3056758|NCT00554788|10506425|P3|Overall Study|Withdrawal by Subject|1
3056759|NCT00554788|10506426|P2|Overall Study|Withdrawal by Subject|0
3056760|NCT00554788|10506427|P1|Overall Study|Withdrawal by Subject|0
3056761|NCT00554788|10506425|P3|Overall Study|Physician Decision|3
3056762|NCT00554788|10506426|P2|Overall Study|Physician Decision|1
3056763|NCT00554788|10506427|P1|Overall Study|Physician Decision|1
3056764|NCT00554788|10506425|P3|Overall Study|Lost to Follow-up|3
3056765|NCT00554788|10506426|P2|Overall Study|Lost to Follow-up|3
3056766|NCT00554788|10506427|P1|Overall Study|Lost to Follow-up|4
3056767|NCT00554788|10506425|P3|Overall Study|Adverse Event|2
3056768|NCT00554788|10506426|P2|Overall Study|Adverse Event|1
3056769|NCT00554788|10506427|P1|Overall Study|Adverse Event|0
3056770|NCT00554619|10506459|P1|Overall Study|Liver Function Test Abnormality|1
3056771|NCT00554619|10506459|P1|Overall Study|Physician Decision|1
3056772|NCT00554619|10506459|P1|Overall Study|Adverse Event|1
3056773|NCT00554515|10506471|P1|Overall Study|Misc|15
3056774|NCT00554515|10506471|P1|Overall Study|Other|1
3056775|NCT00554515|10506471|P1|Overall Study|Achieved Stable Disease|7
3056776|NCT00554515|10506471|P1|Overall Study|Death|2
3056777|NCT00554515|10506471|P1|Overall Study|Adverse Event|9
3056778|NCT00554515|10506471|P1|Overall Study|Withdrawal by Subject|11
3056779|NCT00554515|10506471|P1|Overall Study|Physician Decision|18
3056780|NCT00554515|10506471|P1|Overall Study|Disease progression|52
3056781|NCT00554515|10506471|P1|Overall Study|Withdrawal by Subject|3
3056782|NCT00554229|10506534|P2|Overall Study|Randomised but no treatment received|0
3056783|NCT00554229|10506535|P1|Overall Study|Randomised but no treatment received|1
3056784|NCT00554229|10506534|P2|Overall Study|Reason not otherwise captured, eg; death|140
3056785|NCT00554229|10506535|P1|Overall Study|Reason not otherwise captured, eg; death|119
3056786|NCT00554229|10506534|P2|Overall Study|Protocol Violation|3
3056787|NCT00554229|10506535|P1|Overall Study|Protocol Violation|3
3056788|NCT00554229|10506534|P2|Overall Study|Adverse Event|39
3056789|NCT00554229|10506535|P1|Overall Study|Adverse Event|71
3056790|NCT00554229|10506534|P2|Overall Study|Withdrawal by Subject|37
3056791|NCT00554229|10506535|P1|Overall Study|Withdrawal by Subject|29
3056792|NCT00554229|10506534|P2|Overall Study|Lost to Follow-up|6
3056793|NCT00554229|10506535|P1|Overall Study|Lost to Follow-up|3
3056794|NCT00554216|10506560|P3|Overall Study|Lack of Efficacy|0
3056795|NCT00554216|10506561|P2|Overall Study|Lack of Efficacy|3
3056796|NCT00554216|10506562|P1|Overall Study|Lack of Efficacy|15
3056797|NCT00554216|10506560|P3|Overall Study|Other|10
3056798|NCT00554216|10506561|P2|Overall Study|Other|7
3056799|NCT00554216|10506562|P1|Overall Study|Other|12
3056800|NCT00554216|10506560|P3|Overall Study|Restricted med|1
3056801|NCT00554216|10506561|P2|Overall Study|Restricted med|1
3056802|NCT00554216|10506562|P1|Overall Study|Restricted med|3
3056803|NCT00554216|10506560|P3|Overall Study|Pregnancy|14
3056804|NCT00554216|10506561|P2|Overall Study|Pregnancy|1
3056805|NCT00554216|10506562|P1|Overall Study|Pregnancy|2
3056806|NCT00554216|10506560|P3|Overall Study|Non compliance|5
3056807|NCT00554216|10506561|P2|Overall Study|Non compliance|4
3056808|NCT00554216|10506562|P1|Overall Study|Non compliance|10
3056809|NCT00554216|10506560|P3|Overall Study|Withdrawal by Subject|43
3056810|NCT00554216|10506561|P2|Overall Study|Withdrawal by Subject|31
3056811|NCT00554216|10506562|P1|Overall Study|Withdrawal by Subject|92
3056812|NCT00554216|10506560|P3|Overall Study|Adverse Event|36
3056813|NCT00554216|10506561|P2|Overall Study|Adverse Event|16
3056814|NCT00554216|10506562|P1|Overall Study|Adverse Event|16
3056815|NCT00554216|10506560|P3|Overall Study|Lost to Follow-up|63
3056816|NCT00554216|10506561|P2|Overall Study|Lost to Follow-up|31
3056817|NCT00554216|10506562|P1|Overall Study|Lost to Follow-up|92
3056818|NCT00554190|10506573|P1|Overall Study|Termination forms not completed|10
3056819|NCT00554099|10506582|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
3056820|NCT00554099|10506583|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
3056821|NCT00554099|10506584|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
3056822|NCT00554099|10506582|P3|Non-Treatment Phase (9 Months)|Relapse|1
3056823|NCT00554099|10506583|P2|Non-Treatment Phase (9 Months)|Relapse|1
3056824|NCT00554099|10506584|P1|Non-Treatment Phase (9 Months)|Relapse|2
3056825|NCT00554099|10506582|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
3056826|NCT00554099|10506583|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
3056827|NCT00554099|10506584|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
3056828|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
3056829|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
3056830|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
3056831|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Protocol Violation|2
3056832|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Protocol Violation|0
3056833|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Protocol Violation|0
3056834|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
3056835|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
3056836|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
3056837|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
3056838|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
3056839|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
3056840|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Physician Decision|0
3056841|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Physician Decision|0
3056842|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Physician Decision|3
3056843|NCT00554099|10506582|P3|Treatment Period (12 Weeks)|Adverse Event|1
3056844|NCT00554099|10506583|P2|Treatment Period (12 Weeks)|Adverse Event|5
3056845|NCT00554099|10506584|P1|Treatment Period (12 Weeks)|Adverse Event|3
3056846|NCT00553787|10506639|P3|Overall Study|Other|13
3056847|NCT00553787|10506640|P2|Overall Study|Other|10
3056848|NCT00553787|10506641|P1|Overall Study|Other|18
3056849|NCT00553787|10506639|P3|Overall Study|Requirement for restricted medication|5
3056850|NCT00553787|10506640|P2|Overall Study|Requirement for restricted medication|7
3056851|NCT00553787|10506641|P1|Overall Study|Requirement for restricted medication|8
3056852|NCT00553787|10506639|P3|Overall Study|non compliance|11
3056853|NCT00553787|10506640|P2|Overall Study|non compliance|0
3056854|NCT00553787|10506641|P1|Overall Study|non compliance|4
3056855|NCT00553787|10506639|P3|Overall Study|Pregnancy|2
3056856|NCT00553787|10506640|P2|Overall Study|Pregnancy|1
3056857|NCT00553787|10506641|P1|Overall Study|Pregnancy|0
3056858|NCT00553787|10506639|P3|Overall Study|Lack of Efficacy|3
3056859|NCT00553787|10506640|P2|Overall Study|Lack of Efficacy|1
3056860|NCT00553787|10506641|P1|Overall Study|Lack of Efficacy|31
3056861|NCT00553787|10506639|P3|Overall Study|Withdrawal by Subject|83
3056862|NCT00553787|10506640|P2|Overall Study|Withdrawal by Subject|40
3056863|NCT00553787|10506641|P1|Overall Study|Withdrawal by Subject|151
3056864|NCT00553787|10506639|P3|Overall Study|Lost to Follow-up|78
3056865|NCT00553787|10506640|P2|Overall Study|Lost to Follow-up|44
3056866|NCT00553787|10506641|P1|Overall Study|Lost to Follow-up|132
3056867|NCT00553787|10506639|P3|Overall Study|Adverse Event|67
3056868|NCT00553787|10506640|P2|Overall Study|Adverse Event|21
3056869|NCT00553787|10506641|P1|Overall Study|Adverse Event|34
3056870|NCT00553696|10506673|P4|Overall Study|Withdrawal by Subject|0
3056871|NCT00553696|10506674|P3|Overall Study|Withdrawal by Subject|0
3056872|NCT00553696|10506675|P2|Overall Study|Withdrawal by Subject|1
3056873|NCT00553696|10506676|P1|Overall Study|Withdrawal by Subject|0
3056874|NCT00553696|10506673|P4|Overall Study|Objective progression or relapse|0
3056875|NCT00553696|10506674|P3|Overall Study|Objective progression or relapse|6
3056876|NCT00553696|10506675|P2|Overall Study|Objective progression or relapse|9
3056877|NCT00553696|10506676|P1|Overall Study|Objective progression or relapse|2
3056878|NCT00553696|10506673|P4|Overall Study|Global deterioration of health status|0
3056879|NCT00553696|10506674|P3|Overall Study|Global deterioration of health status|0
3056880|NCT00553696|10506675|P2|Overall Study|Global deterioration of health status|2
3056881|NCT00553696|10506676|P1|Overall Study|Global deterioration of health status|0
3056882|NCT00553696|10506673|P4|Overall Study|Adverse Event|1
3056883|NCT00553696|10506674|P3|Overall Study|Adverse Event|0
3056884|NCT00553696|10506675|P2|Overall Study|Adverse Event|4
3056885|NCT00553696|10506676|P1|Overall Study|Adverse Event|2
3056886|NCT00553644|10506714|P1|Overall Study|Alternative therapy|6
3056887|NCT00553644|10506714|P1|Overall Study|Physician Decision|1
3056888|NCT00553644|10506714|P1|Overall Study|Withdrawal by Subject|4
3056889|NCT00553644|10506714|P1|Overall Study|Adverse Event|17
3056890|NCT00553631|10506723|P2|Overall Study|Lost to Follow-up|0
3056891|NCT00553631|10506724|P1|Overall Study|Lost to Follow-up|1
3056892|NCT00553631|10506723|P2|Overall Study|Withdrawal by Subject|1
3056893|NCT00553631|10506724|P1|Overall Study|Withdrawal by Subject|0
3056894|NCT00553605|10506746|P2|Overall Study|Randomized but not treated|0
3056895|NCT00553605|10506747|P1|Overall Study|Randomized but not treated|2
3056896|NCT00553605|10506746|P2|Overall Study|Did not receive full dose|0
3056897|NCT00553605|10506747|P1|Overall Study|Did not receive full dose|1
3056898|NCT00553605|10506746|P2|Overall Study|Did not meet entrance criteria|3
3056899|NCT00553605|10506747|P1|Overall Study|Did not meet entrance criteria|1
3056900|NCT00553540|10506773|P2|Overall Study|discharged after first visit|5
3056901|NCT00553540|10506774|P1|Overall Study|discharged after first visit|2
3056902|NCT00553514|10506785|P5|Overall Study|Other|1
3056903|NCT00553514|10506786|P4|Overall Study|Other|0
3056904|NCT00553514|10506787|P3|Overall Study|Other|0
3056905|NCT00553514|10506788|P2|Overall Study|Other|1
3056906|NCT00553514|10506789|P1|Overall Study|Other|1
3056907|NCT00553514|10506785|P5|Overall Study|Risk of multiple pregnancy|0
3056908|NCT00553514|10506786|P4|Overall Study|Risk of multiple pregnancy|1
3056909|NCT00553514|10506787|P3|Overall Study|Risk of multiple pregnancy|0
3056910|NCT00553514|10506788|P2|Overall Study|Risk of multiple pregnancy|2
3056911|NCT00553514|10506789|P1|Overall Study|Risk of multiple pregnancy|0
3056912|NCT00553514|10506785|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
3056913|NCT00553514|10506786|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
3056914|NCT00553514|10506787|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
3056915|NCT00553514|10506788|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
3056916|NCT00553514|10506789|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
3056917|NCT00553514|10506785|P5|Overall Study|Lack of ovarian response|6
3056918|NCT00553514|10506786|P4|Overall Study|Lack of ovarian response|5
3056919|NCT00553514|10506787|P3|Overall Study|Lack of ovarian response|5
3056920|NCT00553514|10506788|P2|Overall Study|Lack of ovarian response|5
3056921|NCT00553514|10506789|P1|Overall Study|Lack of ovarian response|4
3056922|NCT00553514|10506785|P5|Overall Study|Protocol deviation|0
3056923|NCT00553514|10506786|P4|Overall Study|Protocol deviation|1
3056924|NCT00553514|10506787|P3|Overall Study|Protocol deviation|0
3056925|NCT00553514|10506788|P2|Overall Study|Protocol deviation|0
3056926|NCT00553514|10506789|P1|Overall Study|Protocol deviation|0
3056927|NCT00553501|10506826|P1|Overall Study|Progression|1
3056928|NCT00553501|10506826|P1|Overall Study|Death|1
3056929|NCT00553501|10506826|P1|Overall Study|Adverse Event|2
3056930|NCT00553475|10506835|P3|Overall Study|Due to moving|0
3056931|NCT00553475|10506836|P2|Overall Study|Due to moving|1
3056932|NCT00553475|10506837|P1|Overall Study|Due to moving|0
3056933|NCT00553475|10506835|P3|Overall Study|Physician Decision|0
3056934|NCT00553475|10506836|P2|Overall Study|Physician Decision|0
3056935|NCT00553475|10506837|P1|Overall Study|Physician Decision|1
3056936|NCT00553475|10506835|P3|Overall Study|Withdrawal by Subject|0
3056937|NCT00553475|10506836|P2|Overall Study|Withdrawal by Subject|1
3056938|NCT00553475|10506837|P1|Overall Study|Withdrawal by Subject|1
3056939|NCT00553475|10506835|P3|Overall Study|Lack of Efficacy|0
3056940|NCT00553475|10506836|P2|Overall Study|Lack of Efficacy|1
3056941|NCT00553475|10506837|P1|Overall Study|Lack of Efficacy|7
3056942|NCT00553475|10506835|P3|Overall Study|Adverse Event|13
3056943|NCT00553475|10506836|P2|Overall Study|Adverse Event|17
3056944|NCT00553475|10506837|P1|Overall Study|Adverse Event|7
3056945|NCT00553462|10506959|P1|Overall Study|Physician Decision|1
3056946|NCT00553462|10506959|P1|Overall Study|Withdrawal by Subject|5
3056947|NCT00553462|10506959|P1|Overall Study|Progression|4
3056948|NCT00553462|10506959|P1|Overall Study|Adverse Event|4
3056949|NCT00553436|10506965|P1|Overall Study|Conversion to another procedure|1
3056950|NCT00553358|10506989|P3|Overall Study|Other: Reason Not Specified|20
3056951|NCT00553358|10506990|P2|Overall Study|Other: Reason Not Specified|4
3056952|NCT00553358|10506991|P1|Overall Study|Other: Reason Not Specified|15
3056953|NCT00553358|10506989|P3|Overall Study|Missing|1
3056954|NCT00553358|10506990|P2|Overall Study|Missing|1
3056955|NCT00553358|10506991|P1|Overall Study|Missing|1
3056956|NCT00553358|10506989|P3|Overall Study|Participant Withdrawal from Drug|3
3056957|NCT00553358|10506990|P2|Overall Study|Participant Withdrawal from Drug|0
3056958|NCT00553358|10506991|P1|Overall Study|Participant Withdrawal from Drug|0
3056959|NCT00553358|10506989|P3|Overall Study|Recurrence of Disease|1
3056960|NCT00553358|10506990|P2|Overall Study|Recurrence of Disease|4
3056961|NCT00553358|10506991|P1|Overall Study|Recurrence of Disease|3
3056962|NCT00553358|10506989|P3|Overall Study|Withdrawal by Subject|1
3056963|NCT00553358|10506990|P2|Overall Study|Withdrawal by Subject|0
3056964|NCT00553358|10506991|P1|Overall Study|Withdrawal by Subject|5
3056965|NCT00553358|10506989|P3|Overall Study|Protocol Violation|1
3056966|NCT00553358|10506990|P2|Overall Study|Protocol Violation|1
3056967|NCT00553358|10506991|P1|Overall Study|Protocol Violation|0
3056968|NCT00553358|10506989|P3|Overall Study|Lost to Follow-up|1
3056969|NCT00553358|10506990|P2|Overall Study|Lost to Follow-up|0
3056970|NCT00553358|10506991|P1|Overall Study|Lost to Follow-up|0
3056971|NCT00553358|10506989|P3|Overall Study|Adverse Event|32
3056972|NCT00553358|10506990|P2|Overall Study|Adverse Event|2
3056973|NCT00553358|10506991|P1|Overall Study|Adverse Event|29
3056974|NCT00553332|10507017|P1|Overall Study|ineligible, incorrect diagnosis|1
3056975|NCT00553319|10507029|P3|Overall Study|moved|1
3056976|NCT00553319|10507030|P2|Overall Study|moved|0
3056977|NCT00553319|10507031|P1|Overall Study|moved|1
3056978|NCT00553319|10507029|P3|Overall Study|incarceration|0
3056979|NCT00553319|10507030|P2|Overall Study|incarceration|0
3056980|NCT00553319|10507031|P1|Overall Study|incarceration|1
3056981|NCT00553319|10507029|P3|Overall Study|non-compliance|2
3056982|NCT00553319|10507030|P2|Overall Study|non-compliance|0
3056983|NCT00553319|10507031|P1|Overall Study|non-compliance|0
3056984|NCT00553319|10507029|P3|Overall Study|wanted treatment elsewhere|1
3056985|NCT00553319|10507030|P2|Overall Study|wanted treatment elsewhere|1
3056986|NCT00553319|10507031|P1|Overall Study|wanted treatment elsewhere|2
3056987|NCT00553319|10507029|P3|Overall Study|Lost to Follow-up|5
3056988|NCT00553319|10507030|P2|Overall Study|Lost to Follow-up|9
3056989|NCT00553319|10507031|P1|Overall Study|Lost to Follow-up|10
3056990|NCT00553280|10507042|P1|Overall Study|Physician Decision|1
3056991|NCT00553280|10507042|P1|Overall Study|Withdrawal by Subject|3
3056992|NCT00553280|10507042|P1|Overall Study|Lack of Efficacy|3
3056993|NCT00553280|10507042|P1|Overall Study|Adverse Event|19
3056994|NCT00553267|10507054|P3|Overall Study|Specified category|1
3056995|NCT00553267|10507055|P2|Overall Study|Specified category|2
3056996|NCT00553267|10507056|P1|Overall Study|Specified category|1
3056997|NCT00553267|10507054|P3|Overall Study|Consent withdrawn|1
3056998|NCT00553267|10507055|P2|Overall Study|Consent withdrawn|3
3056999|NCT00553267|10507056|P1|Overall Study|Consent withdrawn|2
3057000|NCT00553267|10507054|P3|Overall Study|Lost to Follow-up|1
3057001|NCT00553267|10507055|P2|Overall Study|Lost to Follow-up|0
3057002|NCT00553267|10507056|P1|Overall Study|Lost to Follow-up|0
3057003|NCT00553267|10507054|P3|Overall Study|Non compliant with protocol|2
3057004|NCT00553267|10507055|P2|Overall Study|Non compliant with protocol|3
3057005|NCT00553267|10507056|P1|Overall Study|Non compliant with protocol|3
3057006|NCT00553267|10507054|P3|Overall Study|Adverse Event|5
3057007|NCT00553267|10507055|P2|Overall Study|Adverse Event|10
3057008|NCT00553267|10507056|P1|Overall Study|Adverse Event|8
3057009|NCT00553202|10507091|P1|Overall Study|Fails to meet organ function|6
3057010|NCT00553202|10507091|P1|Overall Study|No donor identified|16
3057011|NCT00553202|10507091|P1|Overall Study|Withdrawal by Subject|1
3057012|NCT00553202|10507091|P1|Overall Study|Physician Decision|28
3057013|NCT00553202|10507091|P1|Overall Study|Lost to Follow-up|1
3057014|NCT00553202|10507091|P1|Overall Study|Death|16
3057015|NCT00553150|10507118|P4|Overall Study|Ineligible|1
3057016|NCT00553150|10507119|P3|Overall Study|Ineligible|0
3057017|NCT00553150|10507120|P2|Overall Study|Ineligible|0
3057018|NCT00553150|10507121|P1|Overall Study|Ineligible|0
3057019|NCT00553150|10507118|P4|Overall Study|Protocol Violation|1
3057020|NCT00553150|10507119|P3|Overall Study|Protocol Violation|0
3057021|NCT00553150|10507120|P2|Overall Study|Protocol Violation|0
3057022|NCT00553150|10507121|P1|Overall Study|Protocol Violation|0
3057023|NCT00553150|10507118|P4|Overall Study|Withdrawal by Subject|2
3057024|NCT00553150|10507119|P3|Overall Study|Withdrawal by Subject|0
3057025|NCT00553150|10507120|P2|Overall Study|Withdrawal by Subject|0
3057026|NCT00553150|10507121|P1|Overall Study|Withdrawal by Subject|0
3057027|NCT00552929|10507157|P10|Overall Study|Not Eligible|0
3057028|NCT00552929|10507158|P9|Overall Study|Not Eligible|0
3057029|NCT00552929|10507159|P8|Overall Study|Not Eligible|0
3057030|NCT00552929|10507160|P7|Overall Study|Not Eligible|0
3057031|NCT00552929|10507161|P6|Overall Study|Not Eligible|1
3057032|NCT00552929|10507162|P5|Overall Study|Not Eligible|0
3057033|NCT00552929|10507163|P4|Overall Study|Not Eligible|0
3057034|NCT00552929|10507164|P3|Overall Study|Not Eligible|0
3057035|NCT00552929|10507165|P2|Overall Study|Not Eligible|0
3057036|NCT00552929|10507166|P1|Overall Study|Not Eligible|0
3057037|NCT00552929|10507157|P10|Overall Study|Lost to Follow-up|0
3057038|NCT00552929|10507158|P9|Overall Study|Lost to Follow-up|1
3057039|NCT00552929|10507159|P8|Overall Study|Lost to Follow-up|0
3057040|NCT00552929|10507160|P7|Overall Study|Lost to Follow-up|0
3057041|NCT00552929|10507161|P6|Overall Study|Lost to Follow-up|0
3057042|NCT00552929|10507162|P5|Overall Study|Lost to Follow-up|0
3057043|NCT00552929|10507163|P4|Overall Study|Lost to Follow-up|0
3057044|NCT00552929|10507164|P3|Overall Study|Lost to Follow-up|0
3057045|NCT00552929|10507165|P2|Overall Study|Lost to Follow-up|0
3057046|NCT00552929|10507166|P1|Overall Study|Lost to Follow-up|0
3057047|NCT00552760|10507237|P2|Overall Study|Medication Change|0
3057048|NCT00552760|10507238|P1|Overall Study|Medication Change|1
3057049|NCT00552760|10507237|P2|Overall Study|Withdrawal by Subject|0
3057050|NCT00552760|10507238|P1|Overall Study|Withdrawal by Subject|3
3057051|NCT00552760|10507237|P2|Overall Study|Medical Condition|1
3057052|NCT00552760|10507238|P1|Overall Study|Medical Condition|1
3057053|NCT00552760|10507237|P2|Overall Study|Non-compliance|1
3057054|NCT00552760|10507238|P1|Overall Study|Non-compliance|1
3057055|NCT00552760|10507237|P2|Overall Study|Lost to Follow-up|1
3057056|NCT00552760|10507238|P1|Overall Study|Lost to Follow-up|1
3057057|NCT00552760|10507237|P2|Overall Study|Protocol Violation|1
3057058|NCT00552760|10507238|P1|Overall Study|Protocol Violation|0
3057059|NCT00552760|10507237|P2|Overall Study|Relapsed- Mixed Event|5
3057060|NCT00552760|10507238|P1|Overall Study|Relapsed- Mixed Event|3
3057061|NCT00552760|10507237|P2|Overall Study|Relapse- Manic Event|3
3057062|NCT00552760|10507238|P1|Overall Study|Relapse- Manic Event|3
3057063|NCT00552760|10507237|P2|Overall Study|Relapsed- Depressed Event|16
3057064|NCT00552760|10507238|P1|Overall Study|Relapsed- Depressed Event|10
3057065|NCT00552760|10507237|P2|Overall Study|Adverse Event|5
3057066|NCT00552760|10507238|P1|Overall Study|Adverse Event|3
3057067|NCT00552669|10507265|P2|Overall Study|Death|7
3057068|NCT00552669|10507266|P1|Overall Study|Death|3
3057069|NCT00552617|10507286|P10|Overall Study|Lost to Follow-up|0
3057070|NCT00552617|10507287|P9|Overall Study|Lost to Follow-up|2
3057071|NCT00552617|10507288|P8|Overall Study|Lost to Follow-up|0
3057072|NCT00552617|10507289|P7|Overall Study|Lost to Follow-up|0
3057073|NCT00552617|10507290|P6|Overall Study|Lost to Follow-up|2
3057074|NCT00552617|10507291|P5|Overall Study|Lost to Follow-up|0
3057075|NCT00552617|10507292|P4|Overall Study|Lost to Follow-up|1
3057076|NCT00552617|10507293|P3|Overall Study|Lost to Follow-up|0
3057077|NCT00552617|10507294|P2|Overall Study|Lost to Follow-up|0
3057078|NCT00552617|10507295|P1|Overall Study|Lost to Follow-up|0
3057079|NCT00552617|10507286|P10|Overall Study|Not Treated|1
3057080|NCT00552617|10507287|P9|Overall Study|Not Treated|0
3057081|NCT00552617|10507288|P8|Overall Study|Not Treated|0
3057082|NCT00552617|10507289|P7|Overall Study|Not Treated|0
3057083|NCT00552617|10507290|P6|Overall Study|Not Treated|0
3057084|NCT00552617|10507291|P5|Overall Study|Not Treated|0
3057085|NCT00552617|10507292|P4|Overall Study|Not Treated|0
3057086|NCT00552617|10507293|P3|Overall Study|Not Treated|1
3057087|NCT00552617|10507294|P2|Overall Study|Not Treated|0
3057088|NCT00552617|10507295|P1|Overall Study|Not Treated|0
3057089|NCT00552578|10507339|P2|Overall Study|Lost to Follow-up|1
3057090|NCT00552578|10507340|P1|Overall Study|Lost to Follow-up|1
3057091|NCT00552513|10507352|P2|Overall Study|Lost to Follow-up|1
3057092|NCT00552513|10507353|P1|Overall Study|Lost to Follow-up|5
3057093|NCT00552396|10507398|P7|Overall Study|protocol withdrawal criteria|9
3057094|NCT00552396|10507399|P6|Overall Study|protocol withdrawal criteria|3
3057095|NCT00552396|10507400|P5|Overall Study|protocol withdrawal criteria|3
3057096|NCT00552396|10507401|P4|Overall Study|protocol withdrawal criteria|6
3057097|NCT00552396|10507402|P3|Overall Study|protocol withdrawal criteria|3
3057098|NCT00552396|10507403|P2|Overall Study|protocol withdrawal criteria|3
3057099|NCT00552396|10507404|P1|Overall Study|protocol withdrawal criteria|3
3057100|NCT00552344|10507441|P1|Overall Study|Other Reason|22
3057101|NCT00552344|10507441|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
3057102|NCT00552344|10507441|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
3057103|NCT00552344|10507441|P1|Overall Study|AE, non-serious non-fatal|38
3057104|NCT00552344|10507441|P1|Overall Study|SAE, non-fatal|6
3057105|NCT00552344|10507441|P1|Overall Study|Withdrawal by Subject|48
3057106|NCT00552344|10507441|P1|Overall Study|Lost to Follow-up|8
3057107|NCT00552344|10507441|P1|Overall Study|Loss of efficacy|75
3057108|NCT00552344|10507441|P1|Overall Study|Lack of Efficacy|55
3057109|NCT00552305|10507450|P1|Overall Study|Other: Subject went to rehab|1
3057110|NCT00552305|10507450|P1|Overall Study|Other: Subject incarcerated|1
3057111|NCT00552305|10507450|P1|Overall Study|Other: Subject moved from area|2
3057112|NCT00552305|10507450|P1|Overall Study|Other: Health problems, not drug related|1
3057113|NCT00552305|10507450|P1|Overall Study|Other: Subject became pregnant|1
3057114|NCT00552305|10507450|P1|Overall Study|Other: Subject underwent surgery|4
3057115|NCT00552305|10507450|P1|Overall Study|Other: Unable to attend visits|1
3057116|NCT00552305|10507450|P1|Overall Study|Other: Personal problems|1
3057117|NCT00552305|10507450|P1|Overall Study|Other: Site closed|4
3057118|NCT00552305|10507450|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
3057119|NCT00552305|10507450|P1|Overall Study|AE/Other: prohibited drug required|1
3057120|NCT00552305|10507450|P1|Overall Study|Poor compliance/lost to follow-up|1
3057121|NCT00552305|10507450|P1|Overall Study|Unsatisfactory compliance|11
3057122|NCT00552305|10507450|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
3057123|NCT00552305|10507450|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
3057124|NCT00552305|10507450|P1|Overall Study|Lack of efficacy/withdrew consent|1
3057125|NCT00552305|10507450|P1|Overall Study|Withdrawal by Subject|44
3057126|NCT00552305|10507450|P1|Overall Study|Protocol Violation|3
3057127|NCT00552305|10507450|P1|Overall Study|Lost to Follow-up|4
3057128|NCT00552305|10507450|P1|Overall Study|Lack of Efficacy|120
3057129|NCT00552305|10507450|P1|Overall Study|Adverse Event|43
3057130|NCT00552279|10507460|P2|Overall Study|Other|1
3057131|NCT00552279|10507461|P1|Overall Study|Other|1
3057132|NCT00552279|10507460|P2|Overall Study|Lost to Follow-up|0
3057133|NCT00552279|10507461|P1|Overall Study|Lost to Follow-up|1
3057134|NCT00552279|10507460|P2|Overall Study|Withdrawal by Subject|1
3057135|NCT00552279|10507461|P1|Overall Study|Withdrawal by Subject|12
3057136|NCT00552279|10507460|P2|Overall Study|Adverse Event|1
3057137|NCT00552279|10507461|P1|Overall Study|Adverse Event|0
3057138|NCT00552240|10507487|P2|Overall Study|Other|0
3057139|NCT00552240|10507488|P1|Overall Study|Other|1
3057140|NCT00552240|10507487|P2|Overall Study|Lack of Efficacy|0
3057141|NCT00552240|10507488|P1|Overall Study|Lack of Efficacy|6
3057142|NCT00552240|10507487|P2|Overall Study|Withdrawal by Subject|2
3057143|NCT00552240|10507488|P1|Overall Study|Withdrawal by Subject|2
3057144|NCT00552240|10507487|P2|Overall Study|Lost to Follow-up|6
3057145|NCT00552240|10507488|P1|Overall Study|Lost to Follow-up|5
3057146|NCT00552240|10507487|P2|Overall Study|Protocol Violation|1
3057147|NCT00552240|10507488|P1|Overall Study|Protocol Violation|1
3057148|NCT00552240|10507487|P2|Overall Study|Adverse Event|9
3057149|NCT00552240|10507488|P1|Overall Study|Adverse Event|9
3057150|NCT00552188|10507590|P2|Overall Study|Subject returned to home country|1
3057151|NCT00552188|10507591|P1|Overall Study|Subject returned to home country|0
3057152|NCT00552188|10507590|P2|Overall Study|Withdrawal of consent|1
3057153|NCT00552188|10507591|P1|Overall Study|Withdrawal of consent|0
3057154|NCT00552188|10507590|P2|Overall Study|Lost to Follow-up|1
3057155|NCT00552188|10507591|P1|Overall Study|Lost to Follow-up|2
3057156|NCT00552188|10507590|P2|Overall Study|Adverse Event|2
3057157|NCT00552188|10507591|P1|Overall Study|Adverse Event|0
3057158|NCT00552175|10507602|P3|Overall Study|Reason Not Specified|1
3057159|NCT00552175|10507603|P2|Overall Study|Reason Not Specified|1
3057160|NCT00552175|10507604|P1|Overall Study|Reason Not Specified|3
3057161|NCT00552175|10507602|P3|Overall Study|Entry Criteria Not Met|0
3057162|NCT00552175|10507603|P2|Overall Study|Entry Criteria Not Met|1
3057163|NCT00552175|10507604|P1|Overall Study|Entry Criteria Not Met|1
3057164|NCT00552175|10507602|P3|Overall Study|Lost to Follow-up|1
3057165|NCT00552175|10507603|P2|Overall Study|Lost to Follow-up|0
3057166|NCT00552175|10507604|P1|Overall Study|Lost to Follow-up|0
3057167|NCT00552175|10507602|P3|Overall Study|Withdrawal by Subject|1
3057168|NCT00552175|10507603|P2|Overall Study|Withdrawal by Subject|2
3057169|NCT00552175|10507604|P1|Overall Study|Withdrawal by Subject|2
3057170|NCT00552175|10507602|P3|Overall Study|Adverse Event|10
3057171|NCT00552175|10507603|P2|Overall Study|Adverse Event|9
3057172|NCT00552175|10507604|P1|Overall Study|Adverse Event|9
3057173|NCT00552175|10507602|P3|Overall Study|Lack of Efficacy|1
3057174|NCT00552175|10507603|P2|Overall Study|Lack of Efficacy|0
3057175|NCT00552175|10507604|P1|Overall Study|Lack of Efficacy|2
3057176|NCT00552110|10507644|P5|Overall Study|Nonserious Adverse Event (AE)|0
3057177|NCT00552110|10507645|P4|Overall Study|Nonserious Adverse Event (AE)|1
3057178|NCT00552110|10507646|P3|Overall Study|Nonserious Adverse Event (AE)|0
3057179|NCT00552110|10507647|P2|Overall Study|Nonserious Adverse Event (AE)|0
3057180|NCT00552110|10507648|P1|Overall Study|Nonserious Adverse Event (AE)|1
3057181|NCT00552110|10507644|P5|Overall Study|Increased Blood Pressure at Visit 2|0
3057182|NCT00552110|10507645|P4|Overall Study|Increased Blood Pressure at Visit 2|1
3057183|NCT00552110|10507646|P3|Overall Study|Increased Blood Pressure at Visit 2|0
3057184|NCT00552110|10507647|P2|Overall Study|Increased Blood Pressure at Visit 2|0
3057185|NCT00552110|10507648|P1|Overall Study|Increased Blood Pressure at Visit 2|0
3057186|NCT00552110|10507644|P5|Overall Study|Delay of Study due to Relabeling|0
3057187|NCT00552110|10507645|P4|Overall Study|Delay of Study due to Relabeling|1
3057188|NCT00552110|10507646|P3|Overall Study|Delay of Study due to Relabeling|0
3057189|NCT00552110|10507647|P2|Overall Study|Delay of Study due to Relabeling|0
3057190|NCT00552110|10507648|P1|Overall Study|Delay of Study due to Relabeling|0
3057191|NCT00552110|10507644|P5|Overall Study|Use of Prohibited Medication|0
3057192|NCT00552110|10507645|P4|Overall Study|Use of Prohibited Medication|0
3057193|NCT00552110|10507646|P3|Overall Study|Use of Prohibited Medication|0
3057194|NCT00552110|10507647|P2|Overall Study|Use of Prohibited Medication|1
3057195|NCT00552110|10507648|P1|Overall Study|Use of Prohibited Medication|1
3057196|NCT00552110|10507644|P5|Overall Study|Withdrawn per Sponsor|1
3057197|NCT00552110|10507645|P4|Overall Study|Withdrawn per Sponsor|0
3057198|NCT00552110|10507646|P3|Overall Study|Withdrawn per Sponsor|0
3057199|NCT00552110|10507647|P2|Overall Study|Withdrawn per Sponsor|1
3057200|NCT00552110|10507648|P1|Overall Study|Withdrawn per Sponsor|0
3057201|NCT00552110|10507644|P5|Overall Study|Failed to Comply With Study Requirements|1
3057202|NCT00552110|10507645|P4|Overall Study|Failed to Comply With Study Requirements|0
3057203|NCT00552110|10507646|P3|Overall Study|Failed to Comply With Study Requirements|1
3057204|NCT00552110|10507647|P2|Overall Study|Failed to Comply With Study Requirements|1
3057205|NCT00552110|10507648|P1|Overall Study|Failed to Comply With Study Requirements|1
3057206|NCT00552110|10507644|P5|Overall Study|Lost to Follow-up|1
3057207|NCT00552110|10507645|P4|Overall Study|Lost to Follow-up|1
3057208|NCT00552110|10507646|P3|Overall Study|Lost to Follow-up|0
3057209|NCT00552110|10507647|P2|Overall Study|Lost to Follow-up|0
3057210|NCT00552110|10507648|P1|Overall Study|Lost to Follow-up|0
3057211|NCT00552110|10507644|P5|Overall Study|Withdrawal by Subject|2
3057212|NCT00552110|10507645|P4|Overall Study|Withdrawal by Subject|3
3057213|NCT00552110|10507646|P3|Overall Study|Withdrawal by Subject|0
3057214|NCT00552110|10507647|P2|Overall Study|Withdrawal by Subject|2
3057215|NCT00552110|10507648|P1|Overall Study|Withdrawal by Subject|0
3057216|NCT00552110|10507644|P5|Overall Study|Lack of Efficacy|4
3057217|NCT00552110|10507645|P4|Overall Study|Lack of Efficacy|1
3057218|NCT00552110|10507646|P3|Overall Study|Lack of Efficacy|0
3057219|NCT00552110|10507647|P2|Overall Study|Lack of Efficacy|0
3057220|NCT00552110|10507648|P1|Overall Study|Lack of Efficacy|1
3057221|NCT00552110|10507644|P5|Overall Study|Serious or Life-Threatening AE|0
3057222|NCT00552110|10507645|P4|Overall Study|Serious or Life-Threatening AE|0
3057223|NCT00552110|10507646|P3|Overall Study|Serious or Life-Threatening AE|1
3057224|NCT00552110|10507647|P2|Overall Study|Serious or Life-Threatening AE|0
3057225|NCT00552110|10507648|P1|Overall Study|Serious or Life-Threatening AE|0
3057226|NCT00552084|10507667|P2|Overall Study|change in anti-arrythmic drug|1
3057227|NCT00552084|10507668|P1|Overall Study|change in anti-arrythmic drug|1
3057228|NCT00552084|10507667|P2|Overall Study|Protocol Violation|0
3057229|NCT00552084|10507668|P1|Overall Study|Protocol Violation|1
3057230|NCT00552084|10507667|P2|Overall Study|Withdrawal by Subject|5
3057231|NCT00552084|10507668|P1|Overall Study|Withdrawal by Subject|4
3057232|NCT00552084|10507667|P2|Overall Study|Adverse Event|3
3057233|NCT00552084|10507668|P1|Overall Study|Adverse Event|2
3057234|NCT00552071|10507676|P2|Overall Study|Withdrawal by Subject|1
3057235|NCT00552071|10507677|P1|Overall Study|Withdrawal by Subject|0
3057236|NCT00552071|10507676|P2|Overall Study|Death|1
3057237|NCT00552071|10507677|P1|Overall Study|Death|0
3057238|NCT00552071|10507676|P2|Overall Study|Pregnancy|0
3057239|NCT00552071|10507677|P1|Overall Study|Pregnancy|1
3057240|NCT00552071|10507676|P2|Overall Study|Physician Decision|0
3057241|NCT00552071|10507677|P1|Overall Study|Physician Decision|1
3057242|NCT00552071|10507676|P2|Overall Study|Lack of Efficacy|0
3057243|NCT00552071|10507677|P1|Overall Study|Lack of Efficacy|1
3057244|NCT00552071|10507676|P2|Overall Study|Adverse Event|0
3057245|NCT00552071|10507677|P1|Overall Study|Adverse Event|1
3057246|NCT00552058|10507687|P2|Overall Study|Other: Early Roll Over|0
3057247|NCT00552058|10507688|P1|Overall Study|Other: Early Roll Over|1
3057248|NCT00552058|10507687|P2|Overall Study|Other: Sponsors Decision|1
3057249|NCT00552058|10507688|P1|Overall Study|Other: Sponsors Decision|0
3057250|NCT00552058|10507687|P2|Overall Study|Other: Randomized in error|1
3057251|NCT00552058|10507688|P1|Overall Study|Other: Randomized in error|0
3057252|NCT00552058|10507687|P2|Overall Study|Other: Positive Stool Result|1
3057253|NCT00552058|10507688|P1|Overall Study|Other: Positive Stool Result|0
3057254|NCT00552058|10507687|P2|Overall Study|Other: Low CDAI score, entry violation|1
3057255|NCT00552058|10507688|P1|Overall Study|Other: Low CDAI score, entry violation|0
3057256|NCT00552058|10507687|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
3057257|NCT00552058|10507688|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
3057258|NCT00552058|10507687|P2|Overall Study|Other: Non Compliance|2
3057259|NCT00552058|10507688|P1|Overall Study|Other: Non Compliance|1
3057260|NCT00552058|10507687|P2|Overall Study|Other: Protocol Violation|1
3057261|NCT00552058|10507688|P1|Overall Study|Other: Protocol Violation|0
3057262|NCT00552058|10507687|P2|Overall Study|Withdrawal by Subject|4
3057263|NCT00552058|10507688|P1|Overall Study|Withdrawal by Subject|4
3057264|NCT00552058|10507687|P2|Overall Study|Lost to Follow-up|0
3057265|NCT00552058|10507688|P1|Overall Study|Lost to Follow-up|1
3057266|NCT00552058|10507687|P2|Overall Study|Lack of Efficacy|5
3057267|NCT00552058|10507688|P1|Overall Study|Lack of Efficacy|1
3057268|NCT00552058|10507687|P2|Overall Study|Adverse Event|7
3057269|NCT00552058|10507688|P1|Overall Study|Adverse Event|8
3057270|NCT00552032|10507728|P2|Overall Study|Lost to Follow-up|5
3057271|NCT00552032|10507729|P1|Overall Study|Lost to Follow-up|8
3057272|NCT00552032|10507728|P2|Overall Study|Protocol Violation|12
3057273|NCT00552032|10507729|P1|Overall Study|Protocol Violation|7
3057274|NCT00552032|10507728|P2|Overall Study|Withdrawal by Subject|2
3057275|NCT00552032|10507729|P1|Overall Study|Withdrawal by Subject|2
3057276|NCT00551759|10507773|P1|Overall Study|Ineligible|1
3057277|NCT00551759|10507773|P1|Overall Study|Death|5
3057278|NCT00551759|10507773|P1|Overall Study|Adverse Event|7
3057279|NCT00551642|10507814|P2|Overall Study|Inclusion/Exclusion criteria|4
3057280|NCT00551642|10507815|P1|Overall Study|Inclusion/Exclusion criteria|4
3057281|NCT00551642|10507814|P2|Overall Study|Delivery device failure|3
3057282|NCT00551642|10507815|P1|Overall Study|Delivery device failure|1
3057283|NCT00551642|10507814|P2|Overall Study|Physician Decision|1
3057284|NCT00551642|10507815|P1|Overall Study|Physician Decision|0
3057285|NCT00551642|10507814|P2|Overall Study|Protocol Violation|11
3057286|NCT00551642|10507815|P1|Overall Study|Protocol Violation|6
3057287|NCT00551642|10507814|P2|Overall Study|Death|31
3057288|NCT00551642|10507815|P1|Overall Study|Death|33
3057289|NCT00551642|10507814|P2|Overall Study|Adverse Event|12
3057290|NCT00551642|10507815|P1|Overall Study|Adverse Event|15
3057291|NCT00551642|10507814|P2|Overall Study|Withdrawal by Subject|1
3057292|NCT00551642|10507815|P1|Overall Study|Withdrawal by Subject|2
3057293|NCT00551525|10507821|P1|Overall Study|Protocol Violation|5
3057294|NCT00551460|10507830|P1|Overall Study|Not analyzable (did not start treatment)|4
3057295|NCT00551460|10507830|P1|Overall Study|Ineligible|4
3057296|NCT00551460|10507830|P1|Overall Study|Death|7
3057297|NCT00551460|10507830|P1|Overall Study|Physician Decision|1
3057298|NCT00551460|10507830|P1|Overall Study|Withdrawal by Subject|1
3057299|NCT00551460|10507830|P1|Overall Study|Adverse Event|1
3057300|NCT00551421|10507836|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
3057301|NCT00551369|10507843|P1|Overall Study|Not treated per protocol and re|1
3057302|NCT00551369|10507843|P1|Overall Study|Withdrawal by Subject|1
3057303|NCT00551369|10507843|P1|Overall Study|Protocol Violation|5
3057304|NCT00551291|10507852|P1|Overall Study|Physician Decision|1
3057305|NCT00551213|10507860|P2|Overall Study|Not Treated|2
3057306|NCT00551213|10507861|P1|Overall Study|Not Treated|1
3057307|NCT00551213|10507860|P2|Overall Study|Withdrawal by Subject|0
3057308|NCT00551213|10507861|P1|Overall Study|Withdrawal by Subject|2
3057309|NCT00551213|10507860|P2|Overall Study|Progressive Disease|12
3057310|NCT00551213|10507861|P1|Overall Study|Progressive Disease|41
3057311|NCT00551213|10507860|P2|Overall Study|Adverse Event|3
3057312|NCT00551213|10507861|P1|Overall Study|Adverse Event|6
3057313|NCT00551161|10507905|P1|Overall Study|Withdrawal by Subject|1
3057314|NCT00551135|10507913|P4|Overall Study|Withdrawal by Subject|1
3057315|NCT00551135|10507914|P3|Overall Study|Withdrawal by Subject|3
3057316|NCT00551135|10507915|P2|Overall Study|Withdrawal by Subject|0
3057317|NCT00551135|10507916|P1|Overall Study|Withdrawal by Subject|1
3057318|NCT00551135|10507913|P4|Overall Study|Other|2
3057319|NCT00551135|10507914|P3|Overall Study|Other|1
3057320|NCT00551135|10507915|P2|Overall Study|Other|2
3057321|NCT00551135|10507916|P1|Overall Study|Other|3
3057322|NCT00551135|10507913|P4|Overall Study|Lost to Follow-up|1
3057323|NCT00551135|10507914|P3|Overall Study|Lost to Follow-up|0
3057324|NCT00551135|10507915|P2|Overall Study|Lost to Follow-up|0
3057325|NCT00551135|10507916|P1|Overall Study|Lost to Follow-up|0
3057326|NCT00551135|10507913|P4|Overall Study|Adverse Event|1
3057327|NCT00551135|10507914|P3|Overall Study|Adverse Event|1
3057328|NCT00551135|10507915|P2|Overall Study|Adverse Event|0
3057329|NCT00551135|10507916|P1|Overall Study|Adverse Event|1
3057330|NCT00551031|10508045|P5|Overall Study|Did not receive vaccine|0
3057331|NCT00551031|10508046|P4|Overall Study|Did not receive vaccine|0
3057332|NCT00551031|10508047|P3|Overall Study|Did not receive vaccine|0
3057333|NCT00551031|10508048|P2|Overall Study|Did not receive vaccine|2
3057334|NCT00551031|10508049|P1|Overall Study|Did not receive vaccine|1
3057335|NCT00551031|10508045|P5|Overall Study|Serious Adverse Event|0
3057336|NCT00551031|10508046|P4|Overall Study|Serious Adverse Event|0
3057337|NCT00551031|10508047|P3|Overall Study|Serious Adverse Event|1
3057338|NCT00551031|10508048|P2|Overall Study|Serious Adverse Event|2
3057339|NCT00551031|10508049|P1|Overall Study|Serious Adverse Event|0
3057340|NCT00551031|10508045|P5|Overall Study|Withdrawal by Subject|0
3057341|NCT00551031|10508046|P4|Overall Study|Withdrawal by Subject|2
3057342|NCT00551031|10508047|P3|Overall Study|Withdrawal by Subject|1
3057343|NCT00551031|10508048|P2|Overall Study|Withdrawal by Subject|4
3057344|NCT00551031|10508049|P1|Overall Study|Withdrawal by Subject|0
3057345|NCT00551031|10508045|P5|Overall Study|Lost to Follow-up|1
3057346|NCT00551031|10508046|P4|Overall Study|Lost to Follow-up|1
3057347|NCT00551031|10508047|P3|Overall Study|Lost to Follow-up|0
3057348|NCT00551031|10508048|P2|Overall Study|Lost to Follow-up|1
3057349|NCT00551031|10508049|P1|Overall Study|Lost to Follow-up|0
3057350|NCT00551031|10508045|P5|Overall Study|Protocol Violation|0
3057351|NCT00551031|10508046|P4|Overall Study|Protocol Violation|0
3057352|NCT00551031|10508047|P3|Overall Study|Protocol Violation|0
3057353|NCT00551031|10508048|P2|Overall Study|Protocol Violation|1
3057354|NCT00551031|10508049|P1|Overall Study|Protocol Violation|1
3057355|NCT00551031|10508045|P5|Overall Study|Adverse Event|0
3057356|NCT00551031|10508046|P4|Overall Study|Adverse Event|0
3057357|NCT00551031|10508047|P3|Overall Study|Adverse Event|0
3057358|NCT00551031|10508048|P2|Overall Study|Adverse Event|1
3057359|NCT00551031|10508049|P1|Overall Study|Adverse Event|0
3057360|NCT00550953|10508078|P2|Overall Study|Not able to visit the site|3
3057361|NCT00550953|10508079|P1|Overall Study|Not able to visit the site|2
3057362|NCT00550953|10508078|P2|Overall Study|Adverse Event|3
3057363|NCT00550953|10508079|P1|Overall Study|Adverse Event|4
3057364|NCT00550836|10508126|P2|Overall Study|Withdrawal by Subject|9
3057365|NCT00550836|10508127|P1|Overall Study|Withdrawal by Subject|3
3057366|NCT00550771|10508143|P2|Overall Study|Protocol Violation|5
3057367|NCT00550771|10508144|P1|Overall Study|Protocol Violation|4
3057368|NCT00550771|10508143|P2|Overall Study|Withdrawal by Subject|1
3057369|NCT00550771|10508144|P1|Overall Study|Withdrawal by Subject|0
3057370|NCT00550771|10508143|P2|Overall Study|Physician Decision|0
3057371|NCT00550771|10508144|P1|Overall Study|Physician Decision|2
3057372|NCT00550771|10508143|P2|Overall Study|Discontinued for study-related reasons|1
3057373|NCT00550771|10508144|P1|Overall Study|Discontinued for study-related reasons|0
3057374|NCT00550771|10508143|P2|Overall Study|Adverse Event|3
3057375|NCT00550771|10508144|P1|Overall Study|Adverse Event|11
3057376|NCT00550745|10508158|P2|Overall Study|Screen failure|0
3057377|NCT00550745|10508159|P1|Overall Study|Screen failure|1
3057378|NCT00550745|10508158|P2|Overall Study|Withdrawal by Subject|10
3057379|NCT00550745|10508159|P1|Overall Study|Withdrawal by Subject|17
3057380|NCT00550745|10508158|P2|Overall Study|Protocol Violation|2
3057381|NCT00550745|10508159|P1|Overall Study|Protocol Violation|4
3057382|NCT00550745|10508158|P2|Overall Study|Physician Decision|2
3057383|NCT00550745|10508159|P1|Overall Study|Physician Decision|0
3057384|NCT00550745|10508158|P2|Overall Study|Lost to Follow-up|30
3057385|NCT00550745|10508159|P1|Overall Study|Lost to Follow-up|45
3057386|NCT00550745|10508158|P2|Overall Study|Death|16
3057387|NCT00550745|10508159|P1|Overall Study|Death|20
3057388|NCT00550732|10508167|P1|Overall Study|Adverse Event|1
3057389|NCT00550732|10508167|P1|Overall Study|Palliative care|1
3057390|NCT00550732|10508167|P1|Overall Study|Lost to Follow-up|1
3057391|NCT00550732|10508167|P1|Overall Study|Physician Decision|2
3057392|NCT00550732|10508167|P1|Overall Study|Withdrawal by Subject|2
3057393|NCT00550732|10508167|P1|Overall Study|Death|4
3057394|NCT00550680|10508178|P1|Overall Study|Screen Failure|6
3057395|NCT00550680|10508178|P1|Overall Study|Refused Treatment|19
3057396|NCT00550680|10508178|P1|Overall Study|Protocol Violation|7
3057397|NCT00550680|10508178|P1|Overall Study|Other|10
3057398|NCT00550680|10508178|P1|Overall Study|Lack of Efficacy|1
3057399|NCT00550680|10508178|P1|Overall Study|Lost to Follow-up|3
3057400|NCT00550680|10508178|P1|Overall Study|Early Improvement|1
3057401|NCT00550680|10508178|P1|Overall Study|Death|3
3057402|NCT00550680|10508178|P1|Overall Study|Adverse Event|5
3057403|NCT00550680|10508178|P1|Overall Study|Administrative Reasons|1
3057404|NCT00550615|10508199|P4|Overall Study|Not evaluable|7
3057405|NCT00550615|10508200|P3|Overall Study|Not evaluable|2
3057406|NCT00550615|10508201|P2|Overall Study|Not evaluable|0
3057407|NCT00550615|10508202|P1|Overall Study|Not evaluable|0
3057408|NCT00550615|10508199|P4|Overall Study|Withdrawal by Subject|3
3057409|NCT00550615|10508200|P3|Overall Study|Withdrawal by Subject|2
3057410|NCT00550615|10508201|P2|Overall Study|Withdrawal by Subject|0
3057411|NCT00550615|10508202|P1|Overall Study|Withdrawal by Subject|0
3057412|NCT00550550|10508221|P2|Overall Study|Randomized But Not Treated|0
3057413|NCT00550550|10508222|P1|Overall Study|Randomized But Not Treated|1
3057414|NCT00550550|10508221|P2|Overall Study|Did Not Meet Protocol Eligibility|1
3057415|NCT00550550|10508222|P1|Overall Study|Did Not Meet Protocol Eligibility|1
3057416|NCT00550550|10508221|P2|Overall Study|Protocol Violation|14
3057417|NCT00550550|10508222|P1|Overall Study|Protocol Violation|5
3057418|NCT00550550|10508221|P2|Overall Study|Withdrawal by Subject|8
3057419|NCT00550550|10508222|P1|Overall Study|Withdrawal by Subject|10
3057420|NCT00550550|10508221|P2|Overall Study|Lost to Follow-up|0
3057421|NCT00550550|10508222|P1|Overall Study|Lost to Follow-up|4
3057422|NCT00550550|10508221|P2|Overall Study|Treatment Failure|1
3057423|NCT00550550|10508222|P1|Overall Study|Treatment Failure|0
3057424|NCT00550550|10508221|P2|Overall Study|Adverse Event|5
3057425|NCT00550550|10508222|P1|Overall Study|Adverse Event|13
3057426|NCT00550537|10508234|P1|Overall Study|Treated closer to home|4
3057427|NCT00550537|10508234|P1|Overall Study|Declining performance status|2
3057428|NCT00550537|10508234|P1|Overall Study|Other complicating ilness|3
3057429|NCT00550537|10508234|P1|Overall Study|Change in treatment plan|4
3057430|NCT00550537|10508234|P1|Overall Study|Withdrawal by Subject|7
3057431|NCT00550537|10508234|P1|Overall Study|Disease progression before|46
3057432|NCT00550537|10508234|P1|Overall Study|Adverse Event|20
3057433|NCT00550537|10508234|P1|Overall Study|Death|18
3057434|NCT00550459|10508251|P2|Overall Study|Withdrawal by Subject|1
3057435|NCT00550459|10508252|P1|Overall Study|Withdrawal by Subject|1
3057436|NCT00550459|10508251|P2|Overall Study|Adverse Event|2
3057437|NCT00550459|10508252|P1|Overall Study|Adverse Event|0
3057438|NCT00550446|10508321|P11|Post Week 12|Other|0
3057439|NCT00550446|10508322|P10|Post Week 12|Other|1
3057440|NCT00550446|10508323|P9|Post Week 12|Other|1
3057441|NCT00550446|10508324|P8|Post Week 12|Other|0
3057442|NCT00550446|10508325|P7|Post Week 12|Other|1
3057443|NCT00550446|10508326|P6|Post Week 12|Other|0
3057444|NCT00550446|10508327|P5|Post Week 12|Other|0
3057445|NCT00550446|10508328|P4|Post Week 12|Other|1
3057446|NCT00550446|10508329|P3|Post Week 12|Other|0
3057447|NCT00550446|10508330|P2|Post Week 12|Other|1
3057448|NCT00550446|10508331|P1|Post Week 12|Other|1
3057449|NCT00550446|10508321|P11|Post Week 12|Withdrawal by Subject|0
3057450|NCT00550446|10508322|P10|Post Week 12|Withdrawal by Subject|0
3057451|NCT00550446|10508323|P9|Post Week 12|Withdrawal by Subject|0
3057452|NCT00550446|10508324|P8|Post Week 12|Withdrawal by Subject|0
3057453|NCT00550446|10508325|P7|Post Week 12|Withdrawal by Subject|0
3057454|NCT00550446|10508326|P6|Post Week 12|Withdrawal by Subject|0
3057455|NCT00550446|10508327|P5|Post Week 12|Withdrawal by Subject|1
3057456|NCT00550446|10508328|P4|Post Week 12|Withdrawal by Subject|0
3057457|NCT00550446|10508329|P3|Post Week 12|Withdrawal by Subject|0
3057458|NCT00550446|10508330|P2|Post Week 12|Withdrawal by Subject|0
3057459|NCT00550446|10508331|P1|Post Week 12|Withdrawal by Subject|0
3057460|NCT00550446|10508321|P11|Post Week 12|Lost to Follow-up|0
3057461|NCT00550446|10508322|P10|Post Week 12|Lost to Follow-up|0
3057462|NCT00550446|10508323|P9|Post Week 12|Lost to Follow-up|0
3057463|NCT00550446|10508324|P8|Post Week 12|Lost to Follow-up|0
3057464|NCT00550446|10508325|P7|Post Week 12|Lost to Follow-up|1
3057465|NCT00550446|10508326|P6|Post Week 12|Lost to Follow-up|0
3057466|NCT00550446|10508327|P5|Post Week 12|Lost to Follow-up|0
3057467|NCT00550446|10508328|P4|Post Week 12|Lost to Follow-up|1
3057468|NCT00550446|10508329|P3|Post Week 12|Lost to Follow-up|1
3057469|NCT00550446|10508330|P2|Post Week 12|Lost to Follow-up|0
3057470|NCT00550446|10508331|P1|Post Week 12|Lost to Follow-up|0
3057471|NCT00550446|10508321|P11|Post Week 12|Lack of Efficacy|1
3057472|NCT00550446|10508322|P10|Post Week 12|Lack of Efficacy|2
3057473|NCT00550446|10508323|P9|Post Week 12|Lack of Efficacy|1
3057474|NCT00550446|10508324|P8|Post Week 12|Lack of Efficacy|1
3057475|NCT00550446|10508325|P7|Post Week 12|Lack of Efficacy|0
3057476|NCT00550446|10508326|P6|Post Week 12|Lack of Efficacy|0
3057477|NCT00550446|10508327|P5|Post Week 12|Lack of Efficacy|0
3057478|NCT00550446|10508328|P4|Post Week 12|Lack of Efficacy|0
3057479|NCT00550446|10508329|P3|Post Week 12|Lack of Efficacy|1
3057480|NCT00550446|10508330|P2|Post Week 12|Lack of Efficacy|0
3057481|NCT00550446|10508331|P1|Post Week 12|Lack of Efficacy|0
3057482|NCT00550446|10508321|P11|Post Week 12|Adverse Event|0
3057483|NCT00550446|10508322|P10|Post Week 12|Adverse Event|4
3057484|NCT00550446|10508323|P9|Post Week 12|Adverse Event|0
3057485|NCT00550446|10508324|P8|Post Week 12|Adverse Event|0
3057486|NCT00550446|10508325|P7|Post Week 12|Adverse Event|0
3057487|NCT00550446|10508326|P6|Post Week 12|Adverse Event|1
3057488|NCT00550446|10508327|P5|Post Week 12|Adverse Event|1
3057489|NCT00550446|10508328|P4|Post Week 12|Adverse Event|1
3057490|NCT00550446|10508329|P3|Post Week 12|Adverse Event|1
3057491|NCT00550446|10508330|P2|Post Week 12|Adverse Event|1
3057492|NCT00550446|10508331|P1|Post Week 12|Adverse Event|2
3057493|NCT00550446|10508321|P11|Up To Week 12|Randomized not treated|0
3057494|NCT00550446|10508322|P10|Up To Week 12|Randomized not treated|0
3057495|NCT00550446|10508323|P9|Up To Week 12|Randomized not treated|0
3057496|NCT00550446|10508324|P8|Up To Week 12|Randomized not treated|0
3057497|NCT00550446|10508325|P7|Up To Week 12|Randomized not treated|0
3057498|NCT00550446|10508326|P6|Up To Week 12|Randomized not treated|0
3057499|NCT00550446|10508327|P5|Up To Week 12|Randomized not treated|0
3057500|NCT00550446|10508328|P4|Up To Week 12|Randomized not treated|0
3057501|NCT00550446|10508329|P3|Up To Week 12|Randomized not treated|1
3057502|NCT00550446|10508330|P2|Up To Week 12|Randomized not treated|1
3057503|NCT00550446|10508331|P1|Up To Week 12|Randomized not treated|0
3057504|NCT00550446|10508321|P11|Up To Week 12|Other|0
3057505|NCT00550446|10508322|P10|Up To Week 12|Other|0
3057506|NCT00550446|10508323|P9|Up To Week 12|Other|0
3057507|NCT00550446|10508324|P8|Up To Week 12|Other|0
3057508|NCT00550446|10508325|P7|Up To Week 12|Other|4
3057509|NCT00550446|10508326|P6|Up To Week 12|Other|1
3057510|NCT00550446|10508327|P5|Up To Week 12|Other|0
3057511|NCT00550446|10508328|P4|Up To Week 12|Other|0
3057512|NCT00550446|10508329|P3|Up To Week 12|Other|0
3057513|NCT00550446|10508330|P2|Up To Week 12|Other|0
3057514|NCT00550446|10508331|P1|Up To Week 12|Other|3
3057515|NCT00550446|10508321|P11|Up To Week 12|Withdrawal by Subject|0
3057516|NCT00550446|10508322|P10|Up To Week 12|Withdrawal by Subject|0
3057517|NCT00550446|10508323|P9|Up To Week 12|Withdrawal by Subject|0
3057518|NCT00550446|10508324|P8|Up To Week 12|Withdrawal by Subject|0
3057519|NCT00550446|10508325|P7|Up To Week 12|Withdrawal by Subject|3
3057520|NCT00550446|10508326|P6|Up To Week 12|Withdrawal by Subject|1
3057521|NCT00550446|10508327|P5|Up To Week 12|Withdrawal by Subject|0
3057522|NCT00550446|10508328|P4|Up To Week 12|Withdrawal by Subject|2
3057523|NCT00550446|10508329|P3|Up To Week 12|Withdrawal by Subject|3
3057524|NCT00550446|10508330|P2|Up To Week 12|Withdrawal by Subject|0
3057525|NCT00550446|10508331|P1|Up To Week 12|Withdrawal by Subject|2
3057526|NCT00550446|10508321|P11|Up To Week 12|Lost to Follow-up|0
3057527|NCT00550446|10508322|P10|Up To Week 12|Lost to Follow-up|0
3057528|NCT00550446|10508323|P9|Up To Week 12|Lost to Follow-up|0
3057529|NCT00550446|10508324|P8|Up To Week 12|Lost to Follow-up|0
3057530|NCT00550446|10508325|P7|Up To Week 12|Lost to Follow-up|2
3057531|NCT00550446|10508326|P6|Up To Week 12|Lost to Follow-up|1
3057532|NCT00550446|10508327|P5|Up To Week 12|Lost to Follow-up|1
3057533|NCT00550446|10508328|P4|Up To Week 12|Lost to Follow-up|0
3057534|NCT00550446|10508329|P3|Up To Week 12|Lost to Follow-up|0
3057535|NCT00550446|10508330|P2|Up To Week 12|Lost to Follow-up|1
3057536|NCT00550446|10508331|P1|Up To Week 12|Lost to Follow-up|0
3057537|NCT00550446|10508321|P11|Up To Week 12|Lack of Efficacy|0
3057538|NCT00550446|10508322|P10|Up To Week 12|Lack of Efficacy|0
3057539|NCT00550446|10508323|P9|Up To Week 12|Lack of Efficacy|0
3057540|NCT00550446|10508324|P8|Up To Week 12|Lack of Efficacy|0
3057541|NCT00550446|10508325|P7|Up To Week 12|Lack of Efficacy|3
3057542|NCT00550446|10508326|P6|Up To Week 12|Lack of Efficacy|3
3057543|NCT00550446|10508327|P5|Up To Week 12|Lack of Efficacy|0
3057544|NCT00550446|10508328|P4|Up To Week 12|Lack of Efficacy|1
3057545|NCT00550446|10508329|P3|Up To Week 12|Lack of Efficacy|0
3057546|NCT00550446|10508330|P2|Up To Week 12|Lack of Efficacy|1
3057547|NCT00550446|10508331|P1|Up To Week 12|Lack of Efficacy|3
3057548|NCT00550446|10508321|P11|Up To Week 12|Adverse Event|0
3057549|NCT00550446|10508322|P10|Up To Week 12|Adverse Event|0
3057550|NCT00550446|10508323|P9|Up To Week 12|Adverse Event|0
3057551|NCT00550446|10508324|P8|Up To Week 12|Adverse Event|0
3057552|NCT00550446|10508325|P7|Up To Week 12|Adverse Event|1
3057553|NCT00550446|10508326|P6|Up To Week 12|Adverse Event|2
3057554|NCT00550446|10508327|P5|Up To Week 12|Adverse Event|2
3057555|NCT00550446|10508328|P4|Up To Week 12|Adverse Event|0
3057556|NCT00550446|10508329|P3|Up To Week 12|Adverse Event|0
3057557|NCT00550446|10508330|P2|Up To Week 12|Adverse Event|2
3057558|NCT00550446|10508331|P1|Up To Week 12|Adverse Event|2
3057559|NCT00550420|10508763|P1|Overall Study|Prohibited medicine|1
3057560|NCT00550420|10508763|P1|Overall Study|Exclusion criteria|1
3057561|NCT00550420|10508763|P1|Overall Study|Out of Electrocardiogram criteria|1
3057562|NCT00550420|10508763|P1|Overall Study|Caregiver's decision to withdraw|1
3057563|NCT00550420|10508763|P1|Overall Study|Unethical stop of enrollment|2
3057564|NCT00550420|10508763|P1|Overall Study|Lack of curative effect|1
3057565|NCT00550420|10508763|P1|Overall Study|Investigators opinion|1
3057566|NCT00550420|10508763|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
3057567|NCT00550420|10508763|P1|Overall Study|Missing|2
3057568|NCT00550420|10508763|P1|Overall Study|Still in study at termination|206
3057569|NCT00550420|10508763|P1|Overall Study|Withdrawal by Subject|30
3057570|NCT00550420|10508763|P1|Overall Study|Protocol Violation|11
3057571|NCT00550420|10508763|P1|Overall Study|Lost to Follow-up|8
3057572|NCT00550420|10508763|P1|Overall Study|Adverse Event|28
3057573|NCT00550407|10508786|P3|26-Week Randomized Phase|Withdrawal by Subject|3
3057574|NCT00550407|10508787|P2|26-Week Randomized Phase|Withdrawal by Subject|1
3057575|NCT00550407|10508788|P1|26-Week Randomized Phase|Withdrawal by Subject|0
3057576|NCT00550407|10508786|P3|26-Week Randomized Phase|Investigator Discretion|0
3057577|NCT00550407|10508787|P2|26-Week Randomized Phase|Investigator Discretion|1
3057578|NCT00550407|10508788|P1|26-Week Randomized Phase|Investigator Discretion|0
3057579|NCT00550407|10508786|P3|26-Week Randomized Phase|Lack of Efficacy|19
3057580|NCT00550407|10508787|P2|26-Week Randomized Phase|Lack of Efficacy|36
3057581|NCT00550407|10508788|P1|26-Week Randomized Phase|Lack of Efficacy|0
3057582|NCT00550407|10508786|P3|26-Week Randomized Phase|Adverse Event|2
3057583|NCT00550407|10508787|P2|26-Week Randomized Phase|Adverse Event|5
3057584|NCT00550407|10508788|P1|26-Week Randomized Phase|Adverse Event|0
3057585|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
3057586|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
3057587|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
3057588|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
3057589|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
3057590|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
3057591|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
3057592|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
3057593|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
3057594|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
3057595|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
3057596|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
3057597|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
3057598|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
3057599|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
3057600|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
3057601|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
3057602|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
3057603|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
3057604|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
3057605|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
3057606|NCT00550407|10508786|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
3057607|NCT00550407|10508787|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
3057608|NCT00550407|10508788|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
3057609|NCT00550238|10508860|P1|Overall Study|Sponsor decision|55
3057610|NCT00550238|10508860|P1|Overall Study|Lost to Follow-up|13
3057611|NCT00550238|10508860|P1|Overall Study|Patient noncompliance|25
3057612|NCT00550238|10508860|P1|Overall Study|Physician Decision|31
3057613|NCT00550238|10508860|P1|Overall Study|Withdrawal by Subject|167
3057614|NCT00550238|10508860|P1|Overall Study|Disease progression|46
3057615|NCT00550238|10508860|P1|Overall Study|Death|34
3057616|NCT00550238|10508860|P1|Overall Study|Adverse Event|88
3057617|NCT00550173|10508867|P3|Overall Study|Lost to Follow-up|3
3057618|NCT00550173|10508868|P2|Overall Study|Lost to Follow-up|4
3057619|NCT00550173|10508869|P1|Overall Study|Lost to Follow-up|4
3057620|NCT00550173|10508867|P3|Overall Study|Sponsor Decision|1
3057621|NCT00550173|10508868|P2|Overall Study|Sponsor Decision|7
3057622|NCT00550173|10508869|P1|Overall Study|Sponsor Decision|13
3057623|NCT00550173|10508867|P3|Overall Study|Withdrawal by Subject|17
3057624|NCT00550173|10508868|P2|Overall Study|Withdrawal by Subject|12
3057625|NCT00550173|10508869|P1|Overall Study|Withdrawal by Subject|9
3057626|NCT00550173|10508867|P3|Overall Study|Physician Decision|2
3057627|NCT00550173|10508868|P2|Overall Study|Physician Decision|2
3057628|NCT00550173|10508869|P1|Overall Study|Physician Decision|1
3057629|NCT00550173|10508867|P3|Overall Study|Death|50
3057630|NCT00550173|10508868|P2|Overall Study|Death|38
3057631|NCT00550173|10508869|P1|Overall Study|Death|45
3057632|NCT00550147|10508898|P1|Quetiapine Addition Treatment Period|Moved out of state|1
3057633|NCT00550147|10508898|P1|Quetiapine Addition Treatment Period|Noncompliance|2
3057634|NCT00550147|10508898|P1|Quetiapine Addition Treatment Period|Adverse Event|3
3057635|NCT00550147|10508898|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
3057636|NCT00550147|10508898|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
3057637|NCT00550043|10508921|P5|Overall Study|Other Reasons- Unspecified|0
3057638|NCT00550043|10508922|P4|Overall Study|Other Reasons- Unspecified|1
3057639|NCT00550043|10508923|P3|Overall Study|Other Reasons- Unspecified|0
3057640|NCT00550043|10508924|P2|Overall Study|Other Reasons- Unspecified|1
3057641|NCT00550043|10508925|P1|Overall Study|Other Reasons- Unspecified|0
3057642|NCT00550043|10508921|P5|Overall Study|Subject Withdrew Consent|0
3057643|NCT00550043|10508922|P4|Overall Study|Subject Withdrew Consent|0
3057644|NCT00550043|10508923|P3|Overall Study|Subject Withdrew Consent|1
3057645|NCT00550043|10508924|P2|Overall Study|Subject Withdrew Consent|2
3057646|NCT00550043|10508925|P1|Overall Study|Subject Withdrew Consent|0
3057647|NCT00550043|10508921|P5|Overall Study|Adverse Event|1
3057648|NCT00550043|10508922|P4|Overall Study|Adverse Event|1
3057649|NCT00550043|10508923|P3|Overall Study|Adverse Event|0
3057650|NCT00550043|10508924|P2|Overall Study|Adverse Event|0
3057651|NCT00550043|10508925|P1|Overall Study|Adverse Event|0
3057652|NCT00549939|10508980|P3|40-week Open Label Treatment Period|Other|4
3057653|NCT00549939|10508981|P2|40-week Open Label Treatment Period|Other|1
3057654|NCT00549939|10508982|P1|40-week Open Label Treatment Period|Other|0
3057655|NCT00549939|10508980|P3|40-week Open Label Treatment Period|Protocol Violation|0
3057656|NCT00549939|10508981|P2|40-week Open Label Treatment Period|Protocol Violation|1
3057657|NCT00549939|10508982|P1|40-week Open Label Treatment Period|Protocol Violation|0
3057658|NCT00549939|10508980|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
3057659|NCT00549939|10508981|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
3057660|NCT00549939|10508982|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
3057661|NCT00549939|10508980|P3|40-week Open Label Treatment Period|Adverse Event|1
3057662|NCT00549939|10508981|P2|40-week Open Label Treatment Period|Adverse Event|2
3057663|NCT00549939|10508982|P1|40-week Open Label Treatment Period|Adverse Event|0
3057664|NCT00549939|10508980|P3|12-week Double Blind Treatment Period|Too many blood draws|0
3057665|NCT00549939|10508981|P2|12-week Double Blind Treatment Period|Too many blood draws|1
3057666|NCT00549939|10508982|P1|12-week Double Blind Treatment Period|Too many blood draws|0
3057667|NCT00549939|10508980|P3|12-week Double Blind Treatment Period|Adverse Event|2
3057668|NCT00549939|10508981|P2|12-week Double Blind Treatment Period|Adverse Event|1
3057669|NCT00549939|10508982|P1|12-week Double Blind Treatment Period|Adverse Event|1
3057670|NCT00549900|10509009|P1|Overall Study|Adverse Event|1
3057671|NCT00549770|10509065|P8|Overall Study|Adverse Event|4
3057672|NCT00549770|10509066|P7|Overall Study|Adverse Event|5
3057673|NCT00549770|10509067|P6|Overall Study|Adverse Event|0
3057674|NCT00549770|10509068|P5|Overall Study|Adverse Event|1
3057675|NCT00549770|10509069|P4|Overall Study|Adverse Event|2
3057676|NCT00549770|10509070|P3|Overall Study|Adverse Event|1
3057677|NCT00549770|10509071|P2|Overall Study|Adverse Event|3
3057678|NCT00549770|10509072|P1|Overall Study|Adverse Event|1
3057679|NCT00549770|10509065|P8|Overall Study|Abnormal laboratory values|0
3057680|NCT00549770|10509066|P7|Overall Study|Abnormal laboratory values|0
3057681|NCT00549770|10509067|P6|Overall Study|Abnormal laboratory values|1
3057682|NCT00549770|10509068|P5|Overall Study|Abnormal laboratory values|0
3057683|NCT00549770|10509069|P4|Overall Study|Abnormal laboratory values|0
3057684|NCT00549770|10509070|P3|Overall Study|Abnormal laboratory values|0
3057685|NCT00549770|10509071|P2|Overall Study|Abnormal laboratory values|0
3057686|NCT00549770|10509072|P1|Overall Study|Abnormal laboratory values|0
3057687|NCT00549770|10509065|P8|Overall Study|Abnormal test procedure results|1
3057688|NCT00549770|10509066|P7|Overall Study|Abnormal test procedure results|1
3057689|NCT00549770|10509067|P6|Overall Study|Abnormal test procedure results|1
3057690|NCT00549770|10509068|P5|Overall Study|Abnormal test procedure results|0
3057691|NCT00549770|10509069|P4|Overall Study|Abnormal test procedure results|2
3057692|NCT00549770|10509070|P3|Overall Study|Abnormal test procedure results|0
3057693|NCT00549770|10509071|P2|Overall Study|Abnormal test procedure results|0
3057694|NCT00549770|10509072|P1|Overall Study|Abnormal test procedure results|0
3057695|NCT00549770|10509065|P8|Overall Study|Lack of Efficacy|8
3057696|NCT00549770|10509066|P7|Overall Study|Lack of Efficacy|3
3057697|NCT00549770|10509067|P6|Overall Study|Lack of Efficacy|1
3057698|NCT00549770|10509068|P5|Overall Study|Lack of Efficacy|5
3057699|NCT00549770|10509069|P4|Overall Study|Lack of Efficacy|3
3057700|NCT00549770|10509070|P3|Overall Study|Lack of Efficacy|2
3057701|NCT00549770|10509071|P2|Overall Study|Lack of Efficacy|0
3057702|NCT00549770|10509072|P1|Overall Study|Lack of Efficacy|1
3057703|NCT00549770|10509065|P8|Overall Study|Withdrawal by Subject|9
3057704|NCT00549770|10509066|P7|Overall Study|Withdrawal by Subject|4
3057705|NCT00549770|10509067|P6|Overall Study|Withdrawal by Subject|6
3057706|NCT00549770|10509068|P5|Overall Study|Withdrawal by Subject|6
3057707|NCT00549770|10509069|P4|Overall Study|Withdrawal by Subject|5
3057708|NCT00549770|10509070|P3|Overall Study|Withdrawal by Subject|4
3057709|NCT00549770|10509071|P2|Overall Study|Withdrawal by Subject|6
3057710|NCT00549770|10509072|P1|Overall Study|Withdrawal by Subject|4
3057711|NCT00549770|10509065|P8|Overall Study|Lost to Follow-up|0
3057712|NCT00549770|10509066|P7|Overall Study|Lost to Follow-up|0
3057713|NCT00549770|10509067|P6|Overall Study|Lost to Follow-up|2
3057714|NCT00549770|10509068|P5|Overall Study|Lost to Follow-up|3
3057715|NCT00549770|10509069|P4|Overall Study|Lost to Follow-up|2
3057716|NCT00549770|10509070|P3|Overall Study|Lost to Follow-up|2
3057717|NCT00549770|10509071|P2|Overall Study|Lost to Follow-up|0
3057718|NCT00549770|10509072|P1|Overall Study|Lost to Follow-up|0
3057719|NCT00549770|10509065|P8|Overall Study|Administrative problems|1
3057720|NCT00549770|10509066|P7|Overall Study|Administrative problems|0
3057721|NCT00549770|10509067|P6|Overall Study|Administrative problems|0
3057722|NCT00549770|10509068|P5|Overall Study|Administrative problems|0
3057723|NCT00549770|10509069|P4|Overall Study|Administrative problems|0
3057724|NCT00549770|10509070|P3|Overall Study|Administrative problems|0
3057725|NCT00549770|10509071|P2|Overall Study|Administrative problems|1
3057726|NCT00549770|10509072|P1|Overall Study|Administrative problems|0
3057727|NCT00549770|10509065|P8|Overall Study|Protocol deviation|2
3057728|NCT00549770|10509066|P7|Overall Study|Protocol deviation|1
3057729|NCT00549770|10509067|P6|Overall Study|Protocol deviation|2
3057730|NCT00549770|10509068|P5|Overall Study|Protocol deviation|2
3057731|NCT00549770|10509069|P4|Overall Study|Protocol deviation|2
3057732|NCT00549770|10509070|P3|Overall Study|Protocol deviation|1
3057733|NCT00549770|10509071|P2|Overall Study|Protocol deviation|1
3057734|NCT00549770|10509072|P1|Overall Study|Protocol deviation|1
3057735|NCT00549757|10509156|P2|Extension Period (in Average 9 Months)|Patient's request|436
3057736|NCT00549757|10509157|P1|Extension Period (in Average 9 Months)|Patient's request|421
3057737|NCT00549757|10509156|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
3057738|NCT00549757|10509157|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
3057739|NCT00549757|10509156|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
3057740|NCT00549757|10509157|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
3057741|NCT00549757|10509156|P2|Extension Period (in Average 9 Months)|Death|136
3057742|NCT00549757|10509157|P1|Extension Period (in Average 9 Months)|Death|143
3057743|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
3057744|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
3057745|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
3057746|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
3057747|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
3057748|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
3057749|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Death|200
3057750|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Death|188
3057751|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
3057752|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
3057753|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
3057754|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
3057755|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
3057756|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
3057757|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
3057758|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
3057759|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
3057760|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
3057761|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
3057762|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
3057763|NCT00549757|10509156|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
3057764|NCT00549757|10509157|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
3057765|NCT00549718|10509219|P4|Overall Study|Administrative|1
3057766|NCT00549718|10509220|P3|Overall Study|Administrative|2
3057767|NCT00549718|10509221|P2|Overall Study|Administrative|2
3057768|NCT00549718|10509222|P1|Overall Study|Administrative|2
3057769|NCT00549718|10509219|P4|Overall Study|Withdrawal by Subject|13
3057770|NCT00549718|10509220|P3|Overall Study|Withdrawal by Subject|12
3057771|NCT00549718|10509221|P2|Overall Study|Withdrawal by Subject|18
3057772|NCT00549718|10509222|P1|Overall Study|Withdrawal by Subject|9
3057773|NCT00549718|10509219|P4|Overall Study|Lost to Follow-up|6
3057774|NCT00549718|10509220|P3|Overall Study|Lost to Follow-up|0
3057775|NCT00549718|10509221|P2|Overall Study|Lost to Follow-up|2
3057776|NCT00549718|10509222|P1|Overall Study|Lost to Follow-up|4
3057777|NCT00549718|10509219|P4|Overall Study|Adverse Event|3
3057778|NCT00549718|10509220|P3|Overall Study|Adverse Event|7
3057779|NCT00549718|10509221|P2|Overall Study|Adverse Event|8
3057780|NCT00549718|10509222|P1|Overall Study|Adverse Event|6
3057781|NCT00549718|10509219|P4|Overall Study|Insufficient clinical response|32
3057782|NCT00549718|10509220|P3|Overall Study|Insufficient clinical response|18
3057783|NCT00549718|10509221|P2|Overall Study|Insufficient clinical response|7
3057784|NCT00549718|10509222|P1|Overall Study|Insufficient clinical response|20
3057785|NCT00549640|10509238|P2|Overall Study|Lost to Follow-up|4
3057786|NCT00549640|10509239|P1|Overall Study|Lost to Follow-up|7
3057787|NCT00549640|10509238|P2|Overall Study|Adverse Event|0
3057788|NCT00549640|10509239|P1|Overall Study|Adverse Event|5
3057789|NCT00549640|10509238|P2|Overall Study|Withdrawal by Subject|12
3057790|NCT00549640|10509239|P1|Overall Study|Withdrawal by Subject|6
3057791|NCT00549601|10509252|P3|Received Study Drug|Withdrawal by Subject|1
3057792|NCT00549601|10509253|P2|Received Study Drug|Withdrawal by Subject|0
3057793|NCT00549601|10509254|P1|Received Study Drug|Withdrawal by Subject|2
3057794|NCT00549601|10509252|P3|Received Study Drug|Protocol Violation|1
3057795|NCT00549601|10509253|P2|Received Study Drug|Protocol Violation|4
3057796|NCT00549601|10509254|P1|Received Study Drug|Protocol Violation|3
3057797|NCT00549601|10509252|P3|Received Study Drug|Lost to Follow-up|1
3057798|NCT00549601|10509253|P2|Received Study Drug|Lost to Follow-up|1
3057799|NCT00549601|10509254|P1|Received Study Drug|Lost to Follow-up|0
3057800|NCT00549601|10509252|P3|Received Study Drug|Death|0
3057801|NCT00549601|10509253|P2|Received Study Drug|Death|1
3057802|NCT00549601|10509254|P1|Received Study Drug|Death|0
3057803|NCT00549601|10509252|P3|Received Study Drug|Adverse Event|1
3057804|NCT00549601|10509253|P2|Received Study Drug|Adverse Event|5
3057805|NCT00549601|10509254|P1|Received Study Drug|Adverse Event|2
3057806|NCT00549601|10509252|P3|Randomized|Withdrawal by Subject|1
3057807|NCT00549601|10509253|P2|Randomized|Withdrawal by Subject|1
3057808|NCT00549601|10509254|P1|Randomized|Withdrawal by Subject|0
3057809|NCT00549601|10509252|P3|Randomized|Protocol Violation|1
3057810|NCT00549601|10509253|P2|Randomized|Protocol Violation|0
3057811|NCT00549601|10509254|P1|Randomized|Protocol Violation|0
3057812|NCT00549562|10509276|P1|Overall Study|Lack of Efficacy|1
3057813|NCT00549562|10509276|P1|Overall Study|Adverse Event|1
3057814|NCT00549549|10509288|P4|Overall Study|Randomized but not treated|1
3057815|NCT00549549|10509289|P3|Overall Study|Randomized but not treated|1
3057816|NCT00549549|10509290|P2|Overall Study|Randomized but not treated|0
3057817|NCT00549549|10509291|P1|Overall Study|Randomized but not treated|0
3057818|NCT00549549|10509288|P4|Overall Study|Other|11
3057819|NCT00549549|10509289|P3|Overall Study|Other|9
3057820|NCT00549549|10509290|P2|Overall Study|Other|9
3057821|NCT00549549|10509291|P1|Overall Study|Other|9
3057822|NCT00549549|10509288|P4|Overall Study|Withdrawal by Subject|0
3057823|NCT00549549|10509289|P3|Overall Study|Withdrawal by Subject|1
3057824|NCT00549549|10509290|P2|Overall Study|Withdrawal by Subject|4
3057825|NCT00549549|10509291|P1|Overall Study|Withdrawal by Subject|0
3057826|NCT00549549|10509288|P4|Overall Study|Lost to Follow-up|2
3057827|NCT00549549|10509289|P3|Overall Study|Lost to Follow-up|1
3057828|NCT00549549|10509290|P2|Overall Study|Lost to Follow-up|0
3057829|NCT00549549|10509291|P1|Overall Study|Lost to Follow-up|1
3057830|NCT00549549|10509288|P4|Overall Study|Lack of Efficacy|2
3057831|NCT00549549|10509289|P3|Overall Study|Lack of Efficacy|4
3057832|NCT00549549|10509290|P2|Overall Study|Lack of Efficacy|6
3057833|NCT00549549|10509291|P1|Overall Study|Lack of Efficacy|9
3057834|NCT00549549|10509288|P4|Overall Study|Adverse Event|9
3057835|NCT00549549|10509289|P3|Overall Study|Adverse Event|1
3057836|NCT00549549|10509290|P2|Overall Study|Adverse Event|3
3057837|NCT00549549|10509291|P1|Overall Study|Adverse Event|5
3057838|NCT00549445|10509359|P2|Overall Study|Sputum & Blood Samples Not Available|17
3057839|NCT00549445|10509360|P1|Overall Study|Sputum & Blood Samples Not Available|15
3057840|NCT00549328|10509379|P1|Overall Study|Use of Prohibited Medication|1
3057841|NCT00549328|10509379|P1|Overall Study|Death|1
3057842|NCT00549328|10509379|P1|Overall Study|Disease Progression|10
3057843|NCT00549328|10509379|P1|Overall Study|Adverse Event|2
3057844|NCT00549302|10509390|P3|Open-Label|Withdrawal by Subject|6
3057845|NCT00549302|10509391|P2|Open-Label|Withdrawal by Subject|0
3057846|NCT00549302|10509392|P1|Open-Label|Withdrawal by Subject|0
3057847|NCT00549302|10509390|P3|Open-Label|New drug pulmonary atrial hypertension|2
3057848|NCT00549302|10509391|P2|Open-Label|New drug pulmonary atrial hypertension|0
3057849|NCT00549302|10509392|P1|Open-Label|New drug pulmonary atrial hypertension|0
3057850|NCT00549302|10509390|P3|Open-Label|Other|3
3057851|NCT00549302|10509391|P2|Open-Label|Other|0
3057852|NCT00549302|10509392|P1|Open-Label|Other|0
3057853|NCT00549302|10509390|P3|Open-Label|Lost to Follow-up|2
3057854|NCT00549302|10509391|P2|Open-Label|Lost to Follow-up|0
3057855|NCT00549302|10509392|P1|Open-Label|Lost to Follow-up|0
3057856|NCT00549302|10509390|P3|Open-Label|Investigator Decision|5
3057857|NCT00549302|10509391|P2|Open-Label|Investigator Decision|0
3057858|NCT00549302|10509392|P1|Open-Label|Investigator Decision|0
3057859|NCT00549302|10509390|P3|Open-Label|Death|40
3057860|NCT00549302|10509391|P2|Open-Label|Death|0
3057861|NCT00549302|10509392|P1|Open-Label|Death|0
3057862|NCT00549302|10509390|P3|Open-Label|Adverse Event|11
3057863|NCT00549302|10509391|P2|Open-Label|Adverse Event|0
3057864|NCT00549302|10509392|P1|Open-Label|Adverse Event|0
3057865|NCT00549302|10509390|P3|Double-Blind|New condition or starts new therapy|0
3057866|NCT00549302|10509391|P2|Double-Blind|New condition or starts new therapy|2
3057867|NCT00549302|10509392|P1|Double-Blind|New condition or starts new therapy|0
3057868|NCT00549302|10509390|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
3057869|NCT00549302|10509391|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
3057870|NCT00549302|10509392|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
3057871|NCT00549302|10509390|P3|Double-Blind|Lost to Follow-up|0
3057872|NCT00549302|10509391|P2|Double-Blind|Lost to Follow-up|2
3057873|NCT00549302|10509392|P1|Double-Blind|Lost to Follow-up|1
3057874|NCT00549302|10509390|P3|Double-Blind|Sponsor Decision|0
3057875|NCT00549302|10509391|P2|Double-Blind|Sponsor Decision|1
3057876|NCT00549302|10509392|P1|Double-Blind|Sponsor Decision|0
3057877|NCT00549302|10509390|P3|Double-Blind|Investigator Decision|0
3057878|NCT00549302|10509391|P2|Double-Blind|Investigator Decision|5
3057879|NCT00549302|10509392|P1|Double-Blind|Investigator Decision|1
3057880|NCT00549302|10509390|P3|Double-Blind|Withdrawal by Subject|0
3057881|NCT00549302|10509391|P2|Double-Blind|Withdrawal by Subject|8
3057882|NCT00549302|10509392|P1|Double-Blind|Withdrawal by Subject|3
3057883|NCT00549302|10509390|P3|Double-Blind|Adverse Event|0
3057884|NCT00549302|10509391|P2|Double-Blind|Adverse Event|16
3057885|NCT00549302|10509392|P1|Double-Blind|Adverse Event|3
3057886|NCT00549302|10509390|P3|Double-Blind|Death|0
3057887|NCT00549302|10509391|P2|Double-Blind|Death|9
3057888|NCT00549302|10509392|P1|Double-Blind|Death|2
3057889|NCT00549198|10509404|P2|Overall Study|Not Exposed to Study Drug|4
3057890|NCT00549198|10509405|P1|Overall Study|Not Exposed to Study Drug|3
3057891|NCT00549198|10509404|P2|Overall Study|Pregnancy|3
3057892|NCT00549198|10509405|P1|Overall Study|Pregnancy|0
3057893|NCT00549198|10509404|P2|Overall Study|No scan facilities|2
3057894|NCT00549198|10509405|P1|Overall Study|No scan facilities|0
3057895|NCT00549198|10509404|P2|Overall Study|Participant overweight, no scan possible|0
3057896|NCT00549198|10509405|P1|Overall Study|Participant overweight, no scan possible|1
3057897|NCT00549198|10509404|P2|Overall Study|Participant planning pregnancy|0
3057898|NCT00549198|10509405|P1|Overall Study|Participant planning pregnancy|1
3057899|NCT00549198|10509404|P2|Overall Study|Prohibited Medication|2
3057900|NCT00549198|10509405|P1|Overall Study|Prohibited Medication|1
3057901|NCT00549198|10509404|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
3057902|NCT00549198|10509405|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
3057903|NCT00549198|10509404|P2|Overall Study|Participant not able to perform Week 96|0
3057904|NCT00549198|10509405|P1|Overall Study|Participant not able to perform Week 96|1
3057905|NCT00549198|10509404|P2|Overall Study|Participant Moved|0
3057906|NCT00549198|10509405|P1|Overall Study|Participant Moved|2
3057907|NCT00549198|10509404|P2|Overall Study|Disease Progression|0
3057908|NCT00549198|10509405|P1|Overall Study|Disease Progression|1
3057909|NCT00549198|10509404|P2|Overall Study|Withdrawal by Subject|7
3057910|NCT00549198|10509405|P1|Overall Study|Withdrawal by Subject|7
3057911|NCT00549198|10509404|P2|Overall Study|Investigator Decision|3
3057912|NCT00549198|10509405|P1|Overall Study|Investigator Decision|4
3057913|NCT00549198|10509404|P2|Overall Study|Protocol Violation|2
3057914|NCT00549198|10509405|P1|Overall Study|Protocol Violation|7
3057915|NCT00549198|10509404|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
3057916|NCT00549198|10509405|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
3057917|NCT00549198|10509404|P2|Overall Study|Lost to Follow-up|8
3057918|NCT00549198|10509405|P1|Overall Study|Lost to Follow-up|7
3057919|NCT00549198|10509404|P2|Overall Study|Non-compliance|4
3057920|NCT00549198|10509405|P1|Overall Study|Non-compliance|2
3057921|NCT00549198|10509404|P2|Overall Study|Protocol-defined Virological Failure|0
3057922|NCT00549198|10509405|P1|Overall Study|Protocol-defined Virological Failure|7
3057923|NCT00549198|10509404|P2|Overall Study|Insufficient Viral Load Response|2
3057924|NCT00549198|10509405|P1|Overall Study|Insufficient Viral Load Response|4
3057925|NCT00549198|10509404|P2|Overall Study|Adverse Event|26
3057926|NCT00549198|10509405|P1|Overall Study|Adverse Event|28
3057927|NCT00549055|10509542|P1|Overall Study|Very low visual acuity (VA)|1
3057928|NCT00549055|10509542|P1|Overall Study|Choroidal neovascularization|1
3057929|NCT00549055|10509542|P1|Overall Study|Growth choroidal neovascularisation|1
3057930|NCT00549055|10509542|P1|Overall Study|Vitreous hemorrhage|1
3057931|NCT00549055|10509542|P1|Overall Study|Active choroidal neovascula increased|1
3057932|NCT00549055|10509542|P1|Overall Study|Decrease of size|1
3057933|NCT00549055|10509542|P1|Overall Study|Progression to fibrosis|2
3057934|NCT00549055|10509542|P1|Overall Study|Stabilization|5
3057935|NCT00549055|10509542|P1|Overall Study|Lack of Efficacy|18
3057936|NCT00549055|10509542|P1|Overall Study|Adverse Event|4
3057937|NCT00548847|10509566|P1|Overall Study|Disease progression|7
3057938|NCT00548808|10509573|P2|Overall Study|Sponsor Decision|1
3057939|NCT00548808|10509574|P1|Overall Study|Sponsor Decision|1
3057940|NCT00548808|10509573|P2|Overall Study|Lack of Efficacy|0
3057941|NCT00548808|10509574|P1|Overall Study|Lack of Efficacy|2
3057942|NCT00548808|10509573|P2|Overall Study|Entry Criteria Not Met|2
3057943|NCT00548808|10509574|P1|Overall Study|Entry Criteria Not Met|2
3057944|NCT00548808|10509573|P2|Overall Study|Death|0
3057945|NCT00548808|10509574|P1|Overall Study|Death|2
3057946|NCT00548808|10509573|P2|Overall Study|Adverse Event|5
3057947|NCT00548808|10509574|P1|Overall Study|Adverse Event|4
3057948|NCT00548808|10509573|P2|Overall Study|Physician Decision|3
3057949|NCT00548808|10509574|P1|Overall Study|Physician Decision|6
3057950|NCT00548808|10509573|P2|Overall Study|Withdrawal by Subject|4
3057951|NCT00548808|10509574|P1|Overall Study|Withdrawal by Subject|8
3057952|NCT00548808|10509573|P2|Overall Study|Protocol Violation|8
3057953|NCT00548808|10509574|P1|Overall Study|Protocol Violation|8
3057954|NCT00548808|10509573|P2|Overall Study|Lost to Follow-up|3
3057955|NCT00548808|10509574|P1|Overall Study|Lost to Follow-up|9
3057956|NCT00548717|10509598|P2|Overall Study|Alternative treatment for GVHD|0
3057957|NCT00548717|10509599|P1|Overall Study|Alternative treatment for GVHD|1
3057958|NCT00548717|10509598|P2|Overall Study|Relapse|0
3057959|NCT00548717|10509599|P1|Overall Study|Relapse|3
3057960|NCT00548717|10509598|P2|Overall Study|Death|2
3057961|NCT00548717|10509599|P1|Overall Study|Death|5
3057962|NCT00548548|10509643|P2|Overall Study|Lost to Follow-up|18
3057963|NCT00548548|10509644|P1|Overall Study|Lost to Follow-up|17
3057964|NCT00548548|10509643|P2|Overall Study|Death|348
3057965|NCT00548548|10509644|P1|Overall Study|Death|345
3057966|NCT00548405|10509687|P3|Overall Study|Randomized but not treated|0
3057967|NCT00548405|10509688|P2|Overall Study|Randomized but not treated|0
3057968|NCT00548405|10509689|P1|Overall Study|Randomized but not treated|1
3057969|NCT00548405|10509687|P3|Overall Study|Sponsor decision|0
3057970|NCT00548405|10509688|P2|Overall Study|Sponsor decision|0
3057971|NCT00548405|10509689|P1|Overall Study|Sponsor decision|1
3057972|NCT00548405|10509687|P3|Overall Study|Death|1
3057973|NCT00548405|10509688|P2|Overall Study|Death|1
3057974|NCT00548405|10509689|P1|Overall Study|Death|0
3057975|NCT00548405|10509687|P3|Overall Study|Lost to Follow-up|2
3057976|NCT00548405|10509688|P2|Overall Study|Lost to Follow-up|1
3057977|NCT00548405|10509689|P1|Overall Study|Lost to Follow-up|1
3057978|NCT00548405|10509687|P3|Overall Study|Withdrawal by Subject|5
3057979|NCT00548405|10509688|P2|Overall Study|Withdrawal by Subject|12
3057980|NCT00548405|10509689|P1|Overall Study|Withdrawal by Subject|36
3057981|NCT00548405|10509687|P3|Overall Study|Protocol Violation|0
3057982|NCT00548405|10509688|P2|Overall Study|Protocol Violation|0
3057983|NCT00548405|10509689|P1|Overall Study|Protocol Violation|1
3057984|NCT00548405|10509687|P3|Overall Study|Pregnancy|0
3057985|NCT00548405|10509688|P2|Overall Study|Pregnancy|0
3057986|NCT00548405|10509689|P1|Overall Study|Pregnancy|1
3057987|NCT00548405|10509687|P3|Overall Study|Physician Decision|1
3057988|NCT00548405|10509688|P2|Overall Study|Physician Decision|4
3057989|NCT00548405|10509689|P1|Overall Study|Physician Decision|3
3057990|NCT00548405|10509687|P3|Overall Study|Lack of Efficacy|0
3057991|NCT00548405|10509688|P2|Overall Study|Lack of Efficacy|0
3057992|NCT00548405|10509689|P1|Overall Study|Lack of Efficacy|6
3057993|NCT00548405|10509687|P3|Overall Study|Adverse Event|0
3057994|NCT00548405|10509688|P2|Overall Study|Adverse Event|2
3057995|NCT00548405|10509689|P1|Overall Study|Adverse Event|6
3057996|NCT00548340|10509710|P3|Overall Study|Other|1
3057997|NCT00548340|10509711|P2|Overall Study|Other|1
3057998|NCT00548340|10509712|P1|Overall Study|Other|1
3057999|NCT00548340|10509710|P3|Overall Study|Withdrawal by Subject|3
3058000|NCT00548340|10509711|P2|Overall Study|Withdrawal by Subject|4
3058001|NCT00548340|10509712|P1|Overall Study|Withdrawal by Subject|2
3058002|NCT00548340|10509710|P3|Overall Study|Lost to Follow-up|0
3058003|NCT00548340|10509711|P2|Overall Study|Lost to Follow-up|1
3058004|NCT00548340|10509712|P1|Overall Study|Lost to Follow-up|1
3058005|NCT00548340|10509710|P3|Overall Study|Adverse Event|2
3058006|NCT00548340|10509711|P2|Overall Study|Adverse Event|2
3058007|NCT00548340|10509712|P1|Overall Study|Adverse Event|2
3058008|NCT00548340|10509710|P3|Overall Study|Protocol Violation|3
3058009|NCT00548340|10509711|P2|Overall Study|Protocol Violation|3
3058010|NCT00548340|10509712|P1|Overall Study|Protocol Violation|2
3058011|NCT00548327|10509731|P2|Overall Study|Adverse Event|1
3058012|NCT00548327|10509732|P1|Overall Study|Adverse Event|0
3058013|NCT00548262|10509750|P1|Overall Study|Withdrawal by Subject|1
3058014|NCT00548262|10509750|P1|Overall Study|Other|3
3058015|NCT00548262|10509750|P1|Overall Study|Lost to Follow-up|1
3058016|NCT00548262|10509750|P1|Overall Study|Lack of Efficacy|4
3058017|NCT00548262|10509750|P1|Overall Study|Adverse Event|2
3058018|NCT00548262|10509750|P1|Overall Study|Death|21
3058019|NCT00548249|10509780|P5|Overall Study|Sponsor's request|0
3058020|NCT00548249|10509781|P4|Overall Study|Sponsor's request|1
3058021|NCT00548249|10509782|P3|Overall Study|Sponsor's request|0
3058022|NCT00548249|10509783|P2|Overall Study|Sponsor's request|0
3058023|NCT00548249|10509784|P1|Overall Study|Sponsor's request|0
3058024|NCT00548249|10509780|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
3058025|NCT00548249|10509781|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
3058026|NCT00548249|10509782|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
3058027|NCT00548249|10509783|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
3058028|NCT00548249|10509784|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
3058029|NCT00548249|10509780|P5|Overall Study|Withdrawal by Subject|0
3058030|NCT00548249|10509781|P4|Overall Study|Withdrawal by Subject|0
3058031|NCT00548249|10509782|P3|Overall Study|Withdrawal by Subject|0
3058032|NCT00548249|10509783|P2|Overall Study|Withdrawal by Subject|0
3058033|NCT00548249|10509784|P1|Overall Study|Withdrawal by Subject|2
3058034|NCT00548249|10509780|P5|Overall Study|Prolonged hospitalization|0
3058035|NCT00548249|10509781|P4|Overall Study|Prolonged hospitalization|1
3058036|NCT00548249|10509782|P3|Overall Study|Prolonged hospitalization|2
3058037|NCT00548249|10509783|P2|Overall Study|Prolonged hospitalization|0
3058038|NCT00548249|10509784|P1|Overall Study|Prolonged hospitalization|0
3058039|NCT00548249|10509780|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
3058040|NCT00548249|10509781|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
3058041|NCT00548249|10509782|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
3058042|NCT00548249|10509783|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
3058043|NCT00548249|10509784|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
3058044|NCT00548249|10509780|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
3058045|NCT00548249|10509781|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
3058046|NCT00548249|10509782|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
3058047|NCT00548249|10509783|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
3058048|NCT00548249|10509784|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
3058049|NCT00548249|10509780|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
3058050|NCT00548249|10509781|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
3058051|NCT00548249|10509782|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
3058052|NCT00548249|10509783|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
3058053|NCT00548249|10509784|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
3058054|NCT00548249|10509780|P5|Overall Study|Adverse Event|1
3058055|NCT00548249|10509781|P4|Overall Study|Adverse Event|1
3058056|NCT00548249|10509782|P3|Overall Study|Adverse Event|0
3058057|NCT00548249|10509783|P2|Overall Study|Adverse Event|2
3058058|NCT00548249|10509784|P1|Overall Study|Adverse Event|2
3058059|NCT00548249|10509780|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
3058060|NCT00548249|10509781|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
3058061|NCT00548249|10509782|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
3058062|NCT00548249|10509783|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
3058063|NCT00548249|10509784|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
3058064|NCT00548249|10509780|P5|Overall Study|Miscellaneous|2
3058065|NCT00548249|10509781|P4|Overall Study|Miscellaneous|0
3058066|NCT00548249|10509782|P3|Overall Study|Miscellaneous|2
3058067|NCT00548249|10509783|P2|Overall Study|Miscellaneous|3
3058068|NCT00548249|10509784|P1|Overall Study|Miscellaneous|2
3058069|NCT00548249|10509780|P5|Overall Study|Protocol Violation|3
3058070|NCT00548249|10509781|P4|Overall Study|Protocol Violation|0
3058071|NCT00548249|10509782|P3|Overall Study|Protocol Violation|4
3058072|NCT00548249|10509783|P2|Overall Study|Protocol Violation|1
3058073|NCT00548249|10509784|P1|Overall Study|Protocol Violation|1
3058074|NCT00548249|10509780|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
3058075|NCT00548249|10509781|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
3058076|NCT00548249|10509782|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
3058077|NCT00548249|10509783|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
3058078|NCT00548249|10509784|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
3058079|NCT00548249|10509780|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
3058080|NCT00548249|10509781|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
3058081|NCT00548249|10509782|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
3058082|NCT00548249|10509783|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
3058083|NCT00548249|10509784|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
3058084|NCT00548184|10509832|P1|Overall Study|Found Her2 negative|1
3058085|NCT00548184|10509832|P1|Overall Study|took other drug|1
3058086|NCT00548184|10509832|P1|Overall Study|Adverse Event|3
3058087|NCT00548145|10509880|P2|Overall Study|Physician Decision|1
3058088|NCT00548145|10509881|P1|Overall Study|Physician Decision|1
3058089|NCT00548145|10509880|P2|Overall Study|Withdrawal by Subject|2
3058090|NCT00548145|10509881|P1|Overall Study|Withdrawal by Subject|0
3058091|NCT00548145|10509880|P2|Overall Study|Death|1
3058092|NCT00548145|10509881|P1|Overall Study|Death|0
3058093|NCT00548093|10509900|P2|Overall Study|Completed post-treatment follow-up|0
3058094|NCT00548093|10509901|P1|Overall Study|Completed post-treatment follow-up|1
3058095|NCT00548093|10509900|P2|Overall Study|Withdrawal by Subject|0
3058096|NCT00548093|10509901|P1|Overall Study|Withdrawal by Subject|1
3058097|NCT00548093|10509900|P2|Overall Study|Other|1
3058098|NCT00548093|10509901|P1|Overall Study|Other|11
3058099|NCT00548093|10509900|P2|Overall Study|Objective progression or relapse|1
3058100|NCT00548093|10509901|P1|Overall Study|Objective progression or relapse|1
3058101|NCT00548093|10509900|P2|Overall Study|Lost to Follow-up|1
3058102|NCT00548093|10509901|P1|Overall Study|Lost to Follow-up|3
3058103|NCT00548093|10509900|P2|Overall Study|Death|13
3058104|NCT00548093|10509901|P1|Overall Study|Death|33
3058105|NCT00547911|10509939|P6|Overall Study|Adverse Event|0
3058106|NCT00547911|10509940|P5|Overall Study|Adverse Event|0
3058107|NCT00547911|10509941|P4|Overall Study|Adverse Event|1
3058108|NCT00547911|10509942|P3|Overall Study|Adverse Event|0
3058109|NCT00547911|10509943|P2|Overall Study|Adverse Event|0
3058110|NCT00547911|10509944|P1|Overall Study|Adverse Event|0
3058111|NCT00547703|10509975|P2|Overall Study|Lost to Follow-up|0
3058112|NCT00547703|10509976|P1|Overall Study|Lost to Follow-up|1
3058113|NCT00547534|10510001|P1|Overall Study|Disease Progression|4
3058114|NCT00547534|10510001|P1|Overall Study|Adverse Event|7
3058115|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
3058116|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
3058117|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Other|2
3058118|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Other|0
3058119|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
3058120|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
3058121|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
3058122|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
3058123|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Adverse Event|9
3058124|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Adverse Event|0
3058125|NCT00547521|10510009|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
3058126|NCT00547521|10510010|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
3058127|NCT00547521|10510009|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
3058128|NCT00547521|10510010|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
3058129|NCT00547521|10510009|P2|Short Term Study (4 Months)|Withdrawal of consent|1
3058130|NCT00547521|10510010|P1|Short Term Study (4 Months)|Withdrawal of consent|0
3058131|NCT00547521|10510009|P2|Short Term Study (4 Months)|Lack of Efficacy|2
3058132|NCT00547521|10510010|P1|Short Term Study (4 Months)|Lack of Efficacy|0
3058133|NCT00547521|10510009|P2|Short Term Study (4 Months)|Adverse Event|0
3058134|NCT00547521|10510010|P1|Short Term Study (4 Months)|Adverse Event|1
3058135|NCT00547378|10510087|P3|All Implanted Cohort|Other reasons|1
3058136|NCT00547378|10510088|P2|All Implanted Cohort|Other reasons|0
3058137|NCT00547378|10510089|P1|All Implanted Cohort|Other reasons|1
3058138|NCT00547378|10510087|P3|All Implanted Cohort|Site closure|1
3058139|NCT00547378|10510088|P2|All Implanted Cohort|Site closure|0
3058140|NCT00547378|10510089|P1|All Implanted Cohort|Site closure|2
3058141|NCT00547378|10510087|P3|All Implanted Cohort|Physician Decision|6
3058142|NCT00547378|10510088|P2|All Implanted Cohort|Physician Decision|2
3058143|NCT00547378|10510089|P1|All Implanted Cohort|Physician Decision|0
3058144|NCT00547378|10510087|P3|All Implanted Cohort|Death|4
3058145|NCT00547378|10510088|P2|All Implanted Cohort|Death|1
3058146|NCT00547378|10510089|P1|All Implanted Cohort|Death|3
3058147|NCT00547378|10510087|P3|All Implanted Cohort|Lost to Follow-up|14
3058148|NCT00547378|10510088|P2|All Implanted Cohort|Lost to Follow-up|1
3058149|NCT00547378|10510089|P1|All Implanted Cohort|Lost to Follow-up|0
3058150|NCT00547378|10510087|P3|All Implanted Cohort|Adverse Event|17
3058151|NCT00547378|10510088|P2|All Implanted Cohort|Adverse Event|10
3058152|NCT00547378|10510089|P1|All Implanted Cohort|Adverse Event|4
3058153|NCT00547378|10510087|P3|All Implanted Cohort|Withdrawal by Subject|27
3058154|NCT00547378|10510088|P2|All Implanted Cohort|Withdrawal by Subject|4
3058155|NCT00547378|10510089|P1|All Implanted Cohort|Withdrawal by Subject|5
3058156|NCT00547378|10510087|P3|Randomized Cohort|Other reasons|0
3058157|NCT00547378|10510088|P2|Randomized Cohort|Other reasons|0
3058158|NCT00547378|10510089|P1|Randomized Cohort|Other reasons|2
3058159|NCT00547378|10510087|P3|Randomized Cohort|Adverse Event|0
3058160|NCT00547378|10510088|P2|Randomized Cohort|Adverse Event|0
3058161|NCT00547378|10510089|P1|Randomized Cohort|Adverse Event|1
3058162|NCT00547378|10510087|P3|Randomized Cohort|Lost to Follow-up|0
3058163|NCT00547378|10510088|P2|Randomized Cohort|Lost to Follow-up|0
3058164|NCT00547378|10510089|P1|Randomized Cohort|Lost to Follow-up|1
3058165|NCT00547378|10510087|P3|Randomized Cohort|Death|0
3058166|NCT00547378|10510088|P2|Randomized Cohort|Death|1
3058167|NCT00547378|10510089|P1|Randomized Cohort|Death|0
3058168|NCT00547378|10510087|P3|Randomized Cohort|Withdrawal by Subject|0
3058169|NCT00547378|10510088|P2|Randomized Cohort|Withdrawal by Subject|5
3058170|NCT00547378|10510089|P1|Randomized Cohort|Withdrawal by Subject|7
3058171|NCT00547365|10510099|P1|Overall Study|death (not related to study)|4
3058172|NCT00547365|10510099|P1|Overall Study|Protocol Violation|2
3058173|NCT00547365|10510099|P1|Overall Study|Lost to Follow-up|1
3058174|NCT00547365|10510099|P1|Overall Study|Physician Decision|1
3058175|NCT00547300|10510106|P2|Overall Study|Did not Meet Entry Criteria|2
3058176|NCT00547300|10510107|P1|Overall Study|Did not Meet Entry Criteria|0
3058177|NCT00547300|10510106|P2|Overall Study|Study was Administratively Terminated|24
3058178|NCT00547300|10510107|P1|Overall Study|Study was Administratively Terminated|25
3058179|NCT00547248|10510121|P4|Overall Study|Withdrawal by Subject|1
3058180|NCT00547248|10510122|P3|Overall Study|Withdrawal by Subject|7
3058181|NCT00547248|10510123|P2|Overall Study|Withdrawal by Subject|0
3058182|NCT00547248|10510124|P1|Overall Study|Withdrawal by Subject|0
3058183|NCT00547248|10510121|P4|Overall Study|Migrated/moved from study area|0
3058184|NCT00547248|10510122|P3|Overall Study|Migrated/moved from study area|2
3058185|NCT00547248|10510123|P2|Overall Study|Migrated/moved from study area|0
3058186|NCT00547248|10510124|P1|Overall Study|Migrated/moved from study area|0
3058187|NCT00547248|10510121|P4|Overall Study|Protocol Violation|1
3058188|NCT00547248|10510122|P3|Overall Study|Protocol Violation|1
3058189|NCT00547248|10510123|P2|Overall Study|Protocol Violation|0
3058190|NCT00547248|10510124|P1|Overall Study|Protocol Violation|0
3058191|NCT00547157|10510242|P2|Overall Study|Lost to Follow-up|2
3058192|NCT00547157|10510243|P1|Overall Study|Lost to Follow-up|4
3058193|NCT00547157|10510242|P2|Overall Study|Administrative decision|2
3058194|NCT00547157|10510243|P1|Overall Study|Administrative decision|3
3058195|NCT00547157|10510242|P2|Overall Study|Withdrawal by Subject|1
3058196|NCT00547157|10510243|P1|Overall Study|Withdrawal by Subject|3
3058197|NCT00547157|10510242|P2|Overall Study|Death|18
3058198|NCT00547157|10510243|P1|Overall Study|Death|38
3058199|NCT00547157|10510242|P2|Overall Study|Other|0
3058200|NCT00547157|10510243|P1|Overall Study|Other|1
3058201|NCT00547118|10510261|P2|Overall Study|Study suspended|8
3058202|NCT00547118|10510262|P1|Overall Study|Study suspended|7
3058203|NCT00547118|10510261|P2|Overall Study|Did not qualify prior to starting drug|1
3058204|NCT00547118|10510262|P1|Overall Study|Did not qualify prior to starting drug|1
3058205|NCT00546910|10510306|P2|Overall Study|Withdrawal by Subject|0
3058206|NCT00546910|10510307|P1|Overall Study|Withdrawal by Subject|2
3058207|NCT00546910|10510306|P2|Overall Study|Physician Decision|1
3058208|NCT00546910|10510307|P1|Overall Study|Physician Decision|0
3058209|NCT00546910|10510306|P2|Overall Study|Lack of Efficacy|7
3058210|NCT00546910|10510307|P1|Overall Study|Lack of Efficacy|5
3058211|NCT00546910|10510306|P2|Overall Study|Adverse Event|3
3058212|NCT00546910|10510307|P1|Overall Study|Adverse Event|2
3058213|NCT00546871|10510373|P2|Study Extension Period|Withdrawal by Subject|1
3058214|NCT00546871|10510374|P1|Study Extension Period|Withdrawal by Subject|0
3058215|NCT00546871|10510373|P2|Study Extension Period|Protocol Violation|0
3058216|NCT00546871|10510374|P1|Study Extension Period|Protocol Violation|1
3058217|NCT00546871|10510373|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
3058218|NCT00546871|10510374|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
3058219|NCT00546871|10510373|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
3058220|NCT00546871|10510374|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
3058221|NCT00546871|10510373|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
3058222|NCT00546871|10510374|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
3058223|NCT00546819|10510479|P2|Overall Study|Withdrawal by Subject|2
3058224|NCT00546819|10510480|P1|Overall Study|Withdrawal by Subject|4
3058225|NCT00546819|10510479|P2|Overall Study|Lost to Follow-up|1
3058226|NCT00546819|10510480|P1|Overall Study|Lost to Follow-up|2
3058227|NCT00546819|10510479|P2|Overall Study|Adverse Event|3
3058228|NCT00546819|10510480|P1|Overall Study|Adverse Event|2
3058229|NCT00546754|10510492|P2|Overall Study|Missing|7
3058230|NCT00546754|10510493|P1|Overall Study|Missing|14
3058231|NCT00546754|10510492|P2|Overall Study|Patient's Decision|1
3058232|NCT00546754|10510493|P1|Overall Study|Patient's Decision|0
3058233|NCT00546754|10510492|P2|Overall Study|Elevated Creatinine and Potassium levels|1
3058234|NCT00546754|10510493|P1|Overall Study|Elevated Creatinine and Potassium levels|0
3058235|NCT00546754|10510492|P2|Overall Study|Missing Cooperation|0
3058236|NCT00546754|10510493|P1|Overall Study|Missing Cooperation|1
3058237|NCT00546754|10510492|P2|Overall Study|Suicide|0
3058238|NCT00546754|10510493|P1|Overall Study|Suicide|1
3058239|NCT00546754|10510492|P2|Overall Study|Hip Replacement|0
3058240|NCT00546754|10510493|P1|Overall Study|Hip Replacement|1
3058241|NCT00546754|10510492|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
3058242|NCT00546754|10510493|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
3058243|NCT00546754|10510492|P2|Overall Study|Dyspnea|0
3058244|NCT00546754|10510493|P1|Overall Study|Dyspnea|1
3058245|NCT00546754|10510492|P2|Overall Study|Withdrawal by Subject|7
3058246|NCT00546754|10510493|P1|Overall Study|Withdrawal by Subject|6
3058247|NCT00546754|10510492|P2|Overall Study|Protocol Violation|0
3058248|NCT00546754|10510493|P1|Overall Study|Protocol Violation|3
3058249|NCT00546754|10510492|P2|Overall Study|Lost to Follow-up|15
3058250|NCT00546754|10510493|P1|Overall Study|Lost to Follow-up|9
3058251|NCT00546754|10510492|P2|Overall Study|Lack of Efficacy|1
3058252|NCT00546754|10510493|P1|Overall Study|Lack of Efficacy|1
3058253|NCT00546754|10510492|P2|Overall Study|Adverse Event|16
3058254|NCT00546754|10510493|P1|Overall Study|Adverse Event|11
3058255|NCT00546754|10510492|P2|Overall Study|Serious Adverse Event|1
3058256|NCT00546754|10510493|P1|Overall Study|Serious Adverse Event|1
3058257|NCT00546715|10510536|P4|Overall Study|Withdrawal by Subject|0
3058258|NCT00546715|10510537|P3|Overall Study|Withdrawal by Subject|0
3058259|NCT00546715|10510538|P2|Overall Study|Withdrawal by Subject|1
3058260|NCT00546715|10510539|P1|Overall Study|Withdrawal by Subject|0
3058261|NCT00546637|10510594|P2|Overall Study|Randomized, but not treated|1
3058262|NCT00546637|10510595|P1|Overall Study|Randomized, but not treated|3
3058263|NCT00546637|10510594|P2|Overall Study|Withdrawal by Subject|9
3058264|NCT00546637|10510595|P1|Overall Study|Withdrawal by Subject|7
3058265|NCT00546637|10510594|P2|Overall Study|Other|12
3058266|NCT00546637|10510595|P1|Overall Study|Other|10
3058267|NCT00546637|10510594|P2|Overall Study|Lost to Follow-up|2
3058268|NCT00546637|10510595|P1|Overall Study|Lost to Follow-up|2
3058269|NCT00546637|10510594|P2|Overall Study|Lack of Efficacy|5
3058270|NCT00546637|10510595|P1|Overall Study|Lack of Efficacy|5
3058271|NCT00546637|10510594|P2|Overall Study|Adverse Event|20
3058272|NCT00546637|10510595|P1|Overall Study|Adverse Event|46
3058273|NCT00546572|10510669|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
3058274|NCT00546572|10510670|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
3058275|NCT00546572|10510669|P2|Vax 2 / Year 1|Adverse Event|0
3058276|NCT00546572|10510670|P1|Vax 2 / Year 1|Adverse Event|1
3058277|NCT00546572|10510669|P2|Vax 2 / Year 1|Other|1
3058278|NCT00546572|10510670|P1|Vax 2 / Year 1|Other|1
3058279|NCT00546572|10510669|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
3058280|NCT00546572|10510670|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
3058281|NCT00546572|10510669|P2|Vax 1 / Year 0|Lost to Follow-up|1
3058282|NCT00546572|10510670|P1|Vax 1 / Year 0|Lost to Follow-up|0
3058283|NCT00546572|10510669|P2|Vax 1 / Year 0|Adverse Event|1
3058284|NCT00546572|10510670|P1|Vax 1 / Year 0|Adverse Event|0
3058285|NCT00546572|10510669|P2|Vax 1 / Year 0|Death|2
3058286|NCT00546572|10510670|P1|Vax 1 / Year 0|Death|2
3058287|NCT00546572|10510669|P2|Vax 1 / Year 0|Protocol Violation|4
3058288|NCT00546572|10510670|P1|Vax 1 / Year 0|Protocol Violation|3
3058289|NCT00546572|10510669|P2|Vax 1 / Year 0|Withdrawal by Subject|2
3058290|NCT00546572|10510670|P1|Vax 1 / Year 0|Withdrawal by Subject|3
3058291|NCT00546572|10510669|P2|Vax 1 / Year 0|Randomized, not treated|1
3058292|NCT00546572|10510670|P1|Vax 1 / Year 0|Randomized, not treated|1
3058293|NCT00546481|10510714|P3|Maintenance Phase (CERA)|Other Reason|1
3058294|NCT00546481|10510715|P2|Maintenance Phase (CERA)|Other Reason|0
3058295|NCT00546481|10510716|P1|Maintenance Phase (CERA)|Other Reason|0
3058296|NCT00546481|10510714|P3|Maintenance Phase (CERA)|Kidney transplantation|1
3058297|NCT00546481|10510715|P2|Maintenance Phase (CERA)|Kidney transplantation|0
3058298|NCT00546481|10510716|P1|Maintenance Phase (CERA)|Kidney transplantation|0
3058299|NCT00546481|10510714|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
3058300|NCT00546481|10510715|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
3058301|NCT00546481|10510716|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
3058302|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
3058303|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
3058304|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
3058305|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
3058306|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
3058307|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
3058308|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
3058309|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
3058310|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
3058311|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
3058312|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
3058313|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
3058314|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
3058315|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
3058316|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
3058317|NCT00546481|10510714|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
3058318|NCT00546481|10510715|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
3058319|NCT00546481|10510716|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
3058320|NCT00546377|10510754|P1|Overall Study|Adverse Event|6
3058321|NCT00546377|10510754|P1|Overall Study|Deemed ineligible|1
3058322|NCT00546364|10510762|P3|Overall Study|Sponsor decision|1
3058323|NCT00546364|10510763|P2|Overall Study|Sponsor decision|0
3058324|NCT00546364|10510764|P1|Overall Study|Sponsor decision|0
3058325|NCT00546364|10510762|P3|Overall Study|Physician Decision|1
3058326|NCT00546364|10510763|P2|Overall Study|Physician Decision|0
3058327|NCT00546364|10510764|P1|Overall Study|Physician Decision|0
3058328|NCT00546364|10510762|P3|Overall Study|Target lesions resected|0
3058329|NCT00546364|10510763|P2|Overall Study|Target lesions resected|0
3058330|NCT00546364|10510764|P1|Overall Study|Target lesions resected|1
3058331|NCT00546364|10510762|P3|Overall Study|Palliative treatment|1
3058332|NCT00546364|10510763|P2|Overall Study|Palliative treatment|0
3058333|NCT00546364|10510764|P1|Overall Study|Palliative treatment|1
3058334|NCT00546364|10510762|P3|Overall Study|Mixed response|0
3058335|NCT00546364|10510763|P2|Overall Study|Mixed response|0
3058336|NCT00546364|10510764|P1|Overall Study|Mixed response|1
3058337|NCT00546364|10510762|P3|Overall Study|Prior taxotere|0
3058338|NCT00546364|10510763|P2|Overall Study|Prior taxotere|0
3058339|NCT00546364|10510764|P1|Overall Study|Prior taxotere|1
3058340|NCT00546364|10510762|P3|Overall Study|Withdrawal by Subject|3
3058341|NCT00546364|10510763|P2|Overall Study|Withdrawal by Subject|6
3058342|NCT00546364|10510764|P1|Overall Study|Withdrawal by Subject|5
3058343|NCT00546364|10510762|P3|Overall Study|No longer meets study criteria|0
3058344|NCT00546364|10510763|P2|Overall Study|No longer meets study criteria|1
3058345|NCT00546364|10510764|P1|Overall Study|No longer meets study criteria|1
3058346|NCT00546364|10510762|P3|Overall Study|Poor compliance/noncompliance|1
3058347|NCT00546364|10510763|P2|Overall Study|Poor compliance/noncompliance|0
3058348|NCT00546364|10510764|P1|Overall Study|Poor compliance/noncompliance|0
3058349|NCT00546364|10510762|P3|Overall Study|Administrative reason by sponsor|0
3058350|NCT00546364|10510763|P2|Overall Study|Administrative reason by sponsor|0
3058351|NCT00546364|10510764|P1|Overall Study|Administrative reason by sponsor|1
3058352|NCT00546364|10510762|P3|Overall Study|Completed and off treatment|2
3058353|NCT00546364|10510763|P2|Overall Study|Completed and off treatment|0
3058354|NCT00546364|10510764|P1|Overall Study|Completed and off treatment|1
3058355|NCT00546364|10510762|P3|Overall Study|Disease progression|8
3058356|NCT00546364|10510763|P2|Overall Study|Disease progression|11
3058357|NCT00546364|10510764|P1|Overall Study|Disease progression|5
3058358|NCT00546351|10510799|P1|Overall Study|Other reasons for premature termination|17
3058359|NCT00546351|10510799|P1|Overall Study|Unsatisfactory compliance|9
3058360|NCT00546351|10510799|P1|Overall Study|Protocol Deviation|1
3058361|NCT00546351|10510799|P1|Overall Study|Lost to Follow-up|9
3058362|NCT00546351|10510799|P1|Overall Study|Withdrawal by Subject|109
3058363|NCT00546351|10510799|P1|Overall Study|Lack of Efficacy|15
3058364|NCT00546351|10510799|P1|Overall Study|Adverse Event|76
3058365|NCT00546260|10510845|P2|Overall Study|Drug not given pre diagnostic angiogr|2
3058366|NCT00546260|10510846|P1|Overall Study|Drug not given pre diagnostic angiogr|8
3058367|NCT00546117|10510868|P2|Overall Study|Inability to schedule follow-up visit|0
3058368|NCT00546117|10510869|P1|Overall Study|Inability to schedule follow-up visit|1
3058369|NCT00546117|10510868|P2|Overall Study|Withdrawal by Subject|0
3058370|NCT00546117|10510869|P1|Overall Study|Withdrawal by Subject|3
3058371|NCT00546078|10510894|P2|Overall Study|Other reason|1
3058372|NCT00546078|10510895|P1|Overall Study|Other reason|1
3058373|NCT00546078|10510894|P2|Overall Study|Withdrawal by Subject|3
3058374|NCT00546078|10510895|P1|Overall Study|Withdrawal by Subject|2
3058375|NCT00546078|10510894|P2|Overall Study|Lost to Follow-up|3
3058376|NCT00546078|10510895|P1|Overall Study|Lost to Follow-up|1
3058377|NCT00546052|10510933|P1|Overall Study|Non Compliance|7
3058378|NCT00546052|10510933|P1|Overall Study|Withdrawal by Subject|20
3058379|NCT00546052|10510933|P1|Overall Study|Protocol Violation|9
3058380|NCT00546052|10510933|P1|Overall Study|Lost to Follow-up|144
3058381|NCT00546052|10510933|P1|Overall Study|Adverse Event|47
3058382|NCT00546000|10510951|P1|Overall Study|Baseline HPA Axis Supression|2
3058383|NCT00546000|10510951|P1|Overall Study|Lost to Follow-up|1
3058384|NCT00546000|10510951|P1|Overall Study|Adverse Event|1
3058385|NCT00545948|10510970|P3|Overall Study|Not Treated|7
3058386|NCT00545948|10510971|P2|Overall Study|Not Treated|1
3058387|NCT00545948|10510972|P1|Overall Study|Not Treated|1
3058388|NCT00545844|10510982|P1|Overall Study|Withdrawal by Subject|2
3058389|NCT00545844|10510982|P1|Overall Study|Protocol Violation|1
3058390|NCT00545844|10510982|P1|Overall Study|Lost to Follow-up|9
3058391|NCT00545818|10510998|P2|Overall Study|Lost to Follow-up|6
3058392|NCT00545818|10510999|P1|Overall Study|Lost to Follow-up|1
3058393|NCT00545818|10510998|P2|Overall Study|Adverse Event|1
3058394|NCT00545818|10510999|P1|Overall Study|Adverse Event|1
3058395|NCT00545818|10510998|P2|Overall Study|Protocol Violation|0
3058396|NCT00545818|10510999|P1|Overall Study|Protocol Violation|1
3058397|NCT00545792|10511013|P1|Overall Study|Withdrawal by Subject|1
3058398|NCT00545779|10511018|P1|Overall Study|Failure to return|3
3058399|NCT00545779|10511018|P1|Overall Study|Adverse Event/intercurrent illness|5
3058400|NCT00545779|10511018|P1|Overall Study|Withdrawal by Subject|20
3058401|NCT00545779|10511018|P1|Overall Study|Did not cooperate|7
3058402|NCT00545779|10511018|P1|Overall Study|Other protocol violation|1
3058403|NCT00545779|10511018|P1|Overall Study|Violation of selection criteria at entry|8
3058404|NCT00545753|10511038|P3|Overall Study|Protocol Violation|4
3058405|NCT00545753|10511039|P2|Overall Study|Protocol Violation|1
3058406|NCT00545753|10511040|P1|Overall Study|Protocol Violation|3
3058407|NCT00545753|10511038|P3|Overall Study|Lost to Follow-up|12
3058408|NCT00545753|10511039|P2|Overall Study|Lost to Follow-up|3
3058409|NCT00545753|10511040|P1|Overall Study|Lost to Follow-up|13
3058410|NCT00545753|10511038|P3|Overall Study|Withdrawal by Subject|10
3058411|NCT00545753|10511039|P2|Overall Study|Withdrawal by Subject|1
3058412|NCT00545753|10511040|P1|Overall Study|Withdrawal by Subject|0
3058413|NCT00545740|10511053|P4|Overall Study|Husband against study|0
3058414|NCT00545740|10511054|P3|Overall Study|Husband against study|1
3058415|NCT00545740|10511055|P2|Overall Study|Husband against study|0
3058416|NCT00545740|10511056|P1|Overall Study|Husband against study|0
3058417|NCT00545740|10511053|P4|Overall Study|Patient difficulties|0
3058418|NCT00545740|10511054|P3|Overall Study|Patient difficulties|0
3058419|NCT00545740|10511055|P2|Overall Study|Patient difficulties|1
3058420|NCT00545740|10511056|P1|Overall Study|Patient difficulties|0
3058421|NCT00545740|10511053|P4|Overall Study|Non-adherence to visits|0
3058422|NCT00545740|10511054|P3|Overall Study|Non-adherence to visits|0
3058423|NCT00545740|10511055|P2|Overall Study|Non-adherence to visits|1
3058424|NCT00545740|10511056|P1|Overall Study|Non-adherence to visits|0
3058425|NCT00545740|10511053|P4|Overall Study|Lack of time|0
3058426|NCT00545740|10511054|P3|Overall Study|Lack of time|0
3058427|NCT00545740|10511055|P2|Overall Study|Lack of time|1
3058428|NCT00545740|10511056|P1|Overall Study|Lack of time|0
3058429|NCT00545740|10511053|P4|Overall Study|Sponsor decision|0
3058430|NCT00545740|10511054|P3|Overall Study|Sponsor decision|0
3058431|NCT00545740|10511055|P2|Overall Study|Sponsor decision|1
3058432|NCT00545740|10511056|P1|Overall Study|Sponsor decision|0
3058433|NCT00545740|10511053|P4|Overall Study|Accepted only monthly telephone calls|0
3058434|NCT00545740|10511054|P3|Overall Study|Accepted only monthly telephone calls|0
3058435|NCT00545740|10511055|P2|Overall Study|Accepted only monthly telephone calls|0
3058436|NCT00545740|10511056|P1|Overall Study|Accepted only monthly telephone calls|1
3058437|NCT00545740|10511053|P4|Overall Study|Physician Decision|0
3058438|NCT00545740|10511054|P3|Overall Study|Physician Decision|3
3058439|NCT00545740|10511055|P2|Overall Study|Physician Decision|0
3058440|NCT00545740|10511056|P1|Overall Study|Physician Decision|0
3058441|NCT00545740|10511053|P4|Overall Study|Missed visit|0
3058442|NCT00545740|10511054|P3|Overall Study|Missed visit|0
3058443|NCT00545740|10511055|P2|Overall Study|Missed visit|0
3058444|NCT00545740|10511056|P1|Overall Study|Missed visit|1
3058445|NCT00545740|10511053|P4|Overall Study|Site closure|0
3058446|NCT00545740|10511054|P3|Overall Study|Site closure|0
3058447|NCT00545740|10511055|P2|Overall Study|Site closure|0
3058448|NCT00545740|10511056|P1|Overall Study|Site closure|1
3058449|NCT00545740|10511053|P4|Overall Study|Suspected Diverticulitis Recurrence|1
3058450|NCT00545740|10511054|P3|Overall Study|Suspected Diverticulitis Recurrence|1
3058451|NCT00545740|10511055|P2|Overall Study|Suspected Diverticulitis Recurrence|1
3058452|NCT00545740|10511056|P1|Overall Study|Suspected Diverticulitis Recurrence|1
3058453|NCT00545740|10511053|P4|Overall Study|Diverticulitis attack|1
3058454|NCT00545740|10511054|P3|Overall Study|Diverticulitis attack|1
3058455|NCT00545740|10511055|P2|Overall Study|Diverticulitis attack|0
3058456|NCT00545740|10511056|P1|Overall Study|Diverticulitis attack|0
3058457|NCT00545740|10511053|P4|Overall Study|Moved|0
3058458|NCT00545740|10511054|P3|Overall Study|Moved|1
3058459|NCT00545740|10511055|P2|Overall Study|Moved|0
3058460|NCT00545740|10511056|P1|Overall Study|Moved|2
3058461|NCT00545740|10511053|P4|Overall Study|Non-compliance|0
3058462|NCT00545740|10511054|P3|Overall Study|Non-compliance|1
3058463|NCT00545740|10511055|P2|Overall Study|Non-compliance|2
3058464|NCT00545740|10511056|P1|Overall Study|Non-compliance|0
3058465|NCT00545740|10511053|P4|Overall Study|Protocol Violation|0
3058466|NCT00545740|10511054|P3|Overall Study|Protocol Violation|1
3058467|NCT00545740|10511055|P2|Overall Study|Protocol Violation|3
3058468|NCT00545740|10511056|P1|Overall Study|Protocol Violation|1
3058469|NCT00545740|10511053|P4|Overall Study|Lost to Follow-up|6
3058470|NCT00545740|10511054|P3|Overall Study|Lost to Follow-up|5
3058471|NCT00545740|10511055|P2|Overall Study|Lost to Follow-up|5
3058472|NCT00545740|10511056|P1|Overall Study|Lost to Follow-up|7
3058473|NCT00545740|10511053|P4|Overall Study|Adverse Event|9
3058474|NCT00545740|10511054|P3|Overall Study|Adverse Event|19
3058475|NCT00545740|10511055|P2|Overall Study|Adverse Event|18
3058476|NCT00545740|10511056|P1|Overall Study|Adverse Event|10
3058477|NCT00545740|10511053|P4|Overall Study|Withdrawal by Subject|18
3058478|NCT00545740|10511054|P3|Overall Study|Withdrawal by Subject|16
3058479|NCT00545740|10511055|P2|Overall Study|Withdrawal by Subject|15
3058480|NCT00545740|10511056|P1|Overall Study|Withdrawal by Subject|17
3058481|NCT00545740|10511053|P4|Overall Study|Lack of Efficacy|36
3058482|NCT00545740|10511054|P3|Overall Study|Lack of Efficacy|47
3058483|NCT00545740|10511055|P2|Overall Study|Lack of Efficacy|35
3058484|NCT00545740|10511056|P1|Overall Study|Lack of Efficacy|34
3058485|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Death|2
3058486|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
3058487|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Protocol Violation|1
3058488|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Physician Decision|1
3058489|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Disease Progression|9
3058490|NCT00545714|10511090|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
3058491|NCT00545714|10511090|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
3058492|NCT00545714|10511090|P1|Induction Phase (6 Months)|Disease Progression|1
3058493|NCT00545714|10511090|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
3058494|NCT00545714|10511090|P1|Induction Phase (6 Months)|Physician Decision|3
3058495|NCT00545688|10511111|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
3058496|NCT00545688|10511112|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
3058497|NCT00545688|10511113|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
3058498|NCT00545688|10511114|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
3058499|NCT00545688|10511111|P4|Follow-Up Period|Unspecified Reason|8
3058500|NCT00545688|10511112|P3|Follow-Up Period|Unspecified Reason|6
3058501|NCT00545688|10511113|P2|Follow-Up Period|Unspecified Reason|5
3058502|NCT00545688|10511114|P1|Follow-Up Period|Unspecified Reason|2
3058503|NCT00545688|10511111|P4|Follow-Up Period|Lost to Follow-up|1
3058504|NCT00545688|10511112|P3|Follow-Up Period|Lost to Follow-up|3
3058505|NCT00545688|10511113|P2|Follow-Up Period|Lost to Follow-up|3
3058506|NCT00545688|10511114|P1|Follow-Up Period|Lost to Follow-up|3
3058507|NCT00545688|10511111|P4|Follow-Up Period|Refused Treatment|2
3058508|NCT00545688|10511112|P3|Follow-Up Period|Refused Treatment|0
3058509|NCT00545688|10511113|P2|Follow-Up Period|Refused Treatment|2
3058510|NCT00545688|10511114|P1|Follow-Up Period|Refused Treatment|6
3058511|NCT00545688|10511111|P4|Follow-Up Period|Disease Progression|9
3058512|NCT00545688|10511112|P3|Follow-Up Period|Disease Progression|9
3058513|NCT00545688|10511113|P2|Follow-Up Period|Disease Progression|5
3058514|NCT00545688|10511114|P1|Follow-Up Period|Disease Progression|6
3058515|NCT00545688|10511111|P4|Follow-Up Period|Death|6
3058516|NCT00545688|10511112|P3|Follow-Up Period|Death|2
3058517|NCT00545688|10511113|P2|Follow-Up Period|Death|2
3058518|NCT00545688|10511114|P1|Follow-Up Period|Death|4
3058519|NCT00545688|10511111|P4|Adjuvant Treatment Period|Unknown Reason|0
3058520|NCT00545688|10511112|P3|Adjuvant Treatment Period|Unknown Reason|0
3058521|NCT00545688|10511113|P2|Adjuvant Treatment Period|Unknown Reason|1
3058522|NCT00545688|10511114|P1|Adjuvant Treatment Period|Unknown Reason|0
3058523|NCT00545688|10511111|P4|Adjuvant Treatment Period|Adverse Event|2
3058524|NCT00545688|10511112|P3|Adjuvant Treatment Period|Adverse Event|2
3058525|NCT00545688|10511113|P2|Adjuvant Treatment Period|Adverse Event|3
3058526|NCT00545688|10511114|P1|Adjuvant Treatment Period|Adverse Event|0
3058527|NCT00545688|10511111|P4|Adjuvant Treatment Period|Lost to Follow-up|0
3058528|NCT00545688|10511112|P3|Adjuvant Treatment Period|Lost to Follow-up|1
3058529|NCT00545688|10511113|P2|Adjuvant Treatment Period|Lost to Follow-up|0
3058530|NCT00545688|10511114|P1|Adjuvant Treatment Period|Lost to Follow-up|1
3058531|NCT00545688|10511111|P4|Adjuvant Treatment Period|Refused Treatment|5
3058532|NCT00545688|10511112|P3|Adjuvant Treatment Period|Refused Treatment|1
3058533|NCT00545688|10511113|P2|Adjuvant Treatment Period|Refused Treatment|1
3058534|NCT00545688|10511114|P1|Adjuvant Treatment Period|Refused Treatment|1
3058535|NCT00545688|10511111|P4|Adjuvant Treatment Period|Disease Progression|7
3058536|NCT00545688|10511112|P3|Adjuvant Treatment Period|Disease Progression|0
3058537|NCT00545688|10511113|P2|Adjuvant Treatment Period|Disease Progression|3
3058538|NCT00545688|10511114|P1|Adjuvant Treatment Period|Disease Progression|3
3058539|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
3058540|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
3058541|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
3058542|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
3058543|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
3058544|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
3058545|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
3058546|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
3058547|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
3058548|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
3058549|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
3058550|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
3058551|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Death|0
3058552|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Death|0
3058553|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Death|1
3058554|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Death|0
3058555|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
3058556|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
3058557|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
3058558|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
3058559|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
3058560|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
3058561|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
3058562|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
3058563|NCT00545688|10511111|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
3058564|NCT00545688|10511112|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
3058565|NCT00545688|10511113|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
3058566|NCT00545688|10511114|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
3058567|NCT00545584|10511213|P3|Overall Study|Two or more reasons for discontinuation|8
3058568|NCT00545584|10511214|P2|Overall Study|Two or more reasons for discontinuation|19
3058569|NCT00545584|10511215|P1|Overall Study|Two or more reasons for discontinuation|17
3058570|NCT00545584|10511213|P3|Overall Study|Only one reason for discontinuation|48
3058571|NCT00545584|10511214|P2|Overall Study|Only one reason for discontinuation|61
3058572|NCT00545584|10511215|P1|Overall Study|Only one reason for discontinuation|62
3058573|NCT00545571|10511226|P1|Overall Study|Kidney Transplantation|3
3058574|NCT00545571|10511226|P1|Overall Study|Early Termination of Study|24
3058575|NCT00545571|10511226|P1|Overall Study|Transfusion|12
3058576|NCT00545571|10511226|P1|Overall Study|Screen Failure|16
3058577|NCT00545571|10511226|P1|Overall Study|Refused Treatment|1
3058578|NCT00545571|10511226|P1|Overall Study|Protocol Violation|2
3058579|NCT00545571|10511226|P1|Overall Study|Lack of Efficacy|1
3058580|NCT00545571|10511226|P1|Overall Study|Death|5
3058581|NCT00545571|10511226|P1|Overall Study|Adverse Event|2
3058582|NCT00545571|10511226|P1|Overall Study|Administrative Reasons|1
3058583|NCT00545532|10511241|P2|Overall Study|Death|1
3058584|NCT00545532|10511242|P1|Overall Study|Death|0
3058585|NCT00545532|10511241|P2|Overall Study|Lost to Follow-up|6
3058586|NCT00545532|10511242|P1|Overall Study|Lost to Follow-up|5
3058587|NCT00545532|10511241|P2|Overall Study|Withdrawal by Subject|3
3058588|NCT00545532|10511242|P1|Overall Study|Withdrawal by Subject|1
3058589|NCT00545441|10511333|P2|Overall Study|Patients were not treated|3
3058590|NCT00545441|10511334|P1|Overall Study|Patients were not treated|1
3058591|NCT00545441|10511333|P2|Overall Study|Persistence or recurrence of fistula|2
3058592|NCT00545441|10511334|P1|Overall Study|Persistence or recurrence of fistula|5
3058593|NCT00545441|10511333|P2|Overall Study|Withdrawal by Subject|1
3058594|NCT00545441|10511334|P1|Overall Study|Withdrawal by Subject|1
3058595|NCT00545441|10511333|P2|Overall Study|Technical failure|1
3058596|NCT00545441|10511334|P1|Overall Study|Technical failure|0
3058597|NCT00545441|10511333|P2|Overall Study|Lost to Follow-up|5
3058598|NCT00545441|10511334|P1|Overall Study|Lost to Follow-up|9
3058599|NCT00545441|10511333|P2|Overall Study|Fistula draining at 6 months|4
3058600|NCT00545441|10511334|P1|Overall Study|Fistula draining at 6 months|2
3058601|NCT00545402|10511342|P2|Overall Study|Reason not specified|1
3058602|NCT00545402|10511343|P1|Overall Study|Reason not specified|1
3058603|NCT00545402|10511342|P2|Overall Study|Protocol Violation|0
3058604|NCT00545402|10511343|P1|Overall Study|Protocol Violation|1
3058605|NCT00545402|10511342|P2|Overall Study|Withdrawal by Subject|1
3058606|NCT00545402|10511343|P1|Overall Study|Withdrawal by Subject|0
3058607|NCT00545402|10511342|P2|Overall Study|Graft loss|4
3058608|NCT00545402|10511343|P1|Overall Study|Graft loss|2
3058609|NCT00545402|10511342|P2|Overall Study|Death|7
3058610|NCT00545402|10511343|P1|Overall Study|Death|5
3058611|NCT00545402|10511342|P2|Overall Study|Use of unauthorized immunosuppressant|7
3058612|NCT00545402|10511343|P1|Overall Study|Use of unauthorized immunosuppressant|8
3058613|NCT00545402|10511342|P2|Overall Study|Discontinuation of treatment|9
3058614|NCT00545402|10511343|P1|Overall Study|Discontinuation of treatment|17
3058615|NCT00545363|10511361|P2|Overall Study|Other|1
3058616|NCT00545363|10511362|P1|Overall Study|Other|1
3058617|NCT00545363|10511361|P2|Overall Study|Lost to Follow-up|0
3058618|NCT00545363|10511362|P1|Overall Study|Lost to Follow-up|2
3058619|NCT00545363|10511361|P2|Overall Study|Did not meet entry criteria|1
3058620|NCT00545363|10511362|P1|Overall Study|Did not meet entry criteria|1
3058621|NCT00545363|10511361|P2|Overall Study|Non-compliance|1
3058622|NCT00545363|10511362|P1|Overall Study|Non-compliance|3
3058623|NCT00545363|10511361|P2|Overall Study|Withdrawal by Subject|5
3058624|NCT00545363|10511362|P1|Overall Study|Withdrawal by Subject|6
3058625|NCT00545363|10511361|P2|Overall Study|Adverse Event|7
3058626|NCT00545363|10511362|P1|Overall Study|Adverse Event|6
3058627|NCT00545298|10511377|P3|Overall Study|Issues with Standard of Care|1
3058628|NCT00545298|10511378|P2|Overall Study|Issues with Standard of Care|0
3058629|NCT00545298|10511379|P1|Overall Study|Issues with Standard of Care|2
3058630|NCT00545272|10511396|P6|Overall Study|Lost to Follow-up|0
3058631|NCT00545272|10511397|P5|Overall Study|Lost to Follow-up|1
3058632|NCT00545272|10511398|P4|Overall Study|Lost to Follow-up|0
3058633|NCT00545272|10511399|P3|Overall Study|Lost to Follow-up|0
3058634|NCT00545272|10511400|P2|Overall Study|Lost to Follow-up|0
3058635|NCT00545272|10511401|P1|Overall Study|Lost to Follow-up|0
3058636|NCT00545272|10511396|P6|Overall Study|Abnormal test procedure result(s)|0
3058637|NCT00545272|10511397|P5|Overall Study|Abnormal test procedure result(s)|1
3058638|NCT00545272|10511398|P4|Overall Study|Abnormal test procedure result(s)|0
3058639|NCT00545272|10511399|P3|Overall Study|Abnormal test procedure result(s)|0
3058640|NCT00545272|10511400|P2|Overall Study|Abnormal test procedure result(s)|0
3058641|NCT00545272|10511401|P1|Overall Study|Abnormal test procedure result(s)|0
3058642|NCT00545272|10511396|P6|Overall Study|Abnormal laboratory value(s)|1
3058643|NCT00545272|10511397|P5|Overall Study|Abnormal laboratory value(s)|0
3058644|NCT00545272|10511398|P4|Overall Study|Abnormal laboratory value(s)|0
3058645|NCT00545272|10511399|P3|Overall Study|Abnormal laboratory value(s)|0
3058646|NCT00545272|10511400|P2|Overall Study|Abnormal laboratory value(s)|0
3058647|NCT00545272|10511401|P1|Overall Study|Abnormal laboratory value(s)|0
3058648|NCT00545272|10511396|P6|Overall Study|Adverse Event|1
3058649|NCT00545272|10511397|P5|Overall Study|Adverse Event|0
3058650|NCT00545272|10511398|P4|Overall Study|Adverse Event|0
3058651|NCT00545272|10511399|P3|Overall Study|Adverse Event|1
3058652|NCT00545272|10511400|P2|Overall Study|Adverse Event|0
3058653|NCT00545272|10511401|P1|Overall Study|Adverse Event|0
3058654|NCT00545272|10511396|P6|Overall Study|Protocol deviation|1
3058655|NCT00545272|10511397|P5|Overall Study|Protocol deviation|0
3058656|NCT00545272|10511398|P4|Overall Study|Protocol deviation|1
3058657|NCT00545272|10511399|P3|Overall Study|Protocol deviation|0
3058658|NCT00545272|10511400|P2|Overall Study|Protocol deviation|1
3058659|NCT00545272|10511401|P1|Overall Study|Protocol deviation|0
3058660|NCT00545233|10511453|P2|Overall Study|Physician Decision|1
3058661|NCT00545233|10511454|P1|Overall Study|Physician Decision|2
3058662|NCT00545233|10511453|P2|Overall Study|Insufficient response|15
3058663|NCT00545233|10511454|P1|Overall Study|Insufficient response|14
3058664|NCT00545233|10511453|P2|Overall Study|Failure to Return|6
3058665|NCT00545233|10511454|P1|Overall Study|Failure to Return|4
3058666|NCT00545233|10511453|P2|Overall Study|Refused Treatment|7
3058667|NCT00545233|10511454|P1|Overall Study|Refused Treatment|9
3058668|NCT00545233|10511453|P2|Overall Study|Protocol Violation|0
3058669|NCT00545233|10511454|P1|Overall Study|Protocol Violation|2
3058670|NCT00545233|10511453|P2|Overall Study|Violation of Selection Criteria at Entry|1
3058671|NCT00545233|10511454|P1|Overall Study|Violation of Selection Criteria at Entry|5
3058672|NCT00545233|10511453|P2|Overall Study|Adverse Event|5
3058673|NCT00545233|10511454|P1|Overall Study|Adverse Event|10
3058674|NCT00545168|10511513|P3|Overall Study|Visit for Day 21 was not done in error|2
3058675|NCT00545168|10511514|P2|Overall Study|Visit for Day 21 was not done in error|0
3058676|NCT00545168|10511515|P1|Overall Study|Visit for Day 21 was not done in error|1
3058677|NCT00545168|10511513|P3|Overall Study|Protocol Violation|1
3058678|NCT00545168|10511514|P2|Overall Study|Protocol Violation|0
3058679|NCT00545168|10511515|P1|Overall Study|Protocol Violation|1
3058680|NCT00545168|10511513|P3|Overall Study|Withdrawal by Subject|13
3058681|NCT00545168|10511514|P2|Overall Study|Withdrawal by Subject|0
3058682|NCT00545168|10511515|P1|Overall Study|Withdrawal by Subject|9
3058683|NCT00545168|10511513|P3|Overall Study|Lost to Follow-up|5
3058684|NCT00545168|10511514|P2|Overall Study|Lost to Follow-up|5
3058685|NCT00545168|10511515|P1|Overall Study|Lost to Follow-up|5
3058686|NCT00545103|10511541|P4|Overall Study|Death|0
3058687|NCT00545103|10511542|P3|Overall Study|Death|0
3058688|NCT00545103|10511543|P2|Overall Study|Death|1
3058689|NCT00545103|10511544|P1|Overall Study|Death|0
3058690|NCT00545103|10511541|P4|Overall Study|Subject met endpoint under protocol v. 1|0
3058691|NCT00545103|10511542|P3|Overall Study|Subject met endpoint under protocol v. 1|1
3058692|NCT00545103|10511543|P2|Overall Study|Subject met endpoint under protocol v. 1|0
3058693|NCT00545103|10511544|P1|Overall Study|Subject met endpoint under protocol v. 1|0
3058694|NCT00545103|10511541|P4|Overall Study|Does not want to take study drug anymore|0
3058695|NCT00545103|10511542|P3|Overall Study|Does not want to take study drug anymore|1
3058696|NCT00545103|10511543|P2|Overall Study|Does not want to take study drug anymore|0
3058697|NCT00545103|10511544|P1|Overall Study|Does not want to take study drug anymore|1
3058698|NCT00545103|10511541|P4|Overall Study|Use of prohibited medication|0
3058699|NCT00545103|10511542|P3|Overall Study|Use of prohibited medication|1
3058700|NCT00545103|10511543|P2|Overall Study|Use of prohibited medication|0
3058701|NCT00545103|10511544|P1|Overall Study|Use of prohibited medication|0
3058702|NCT00545103|10511541|P4|Overall Study|Subject moved|0
3058703|NCT00545103|10511542|P3|Overall Study|Subject moved|0
3058704|NCT00545103|10511543|P2|Overall Study|Subject moved|1
3058705|NCT00545103|10511544|P1|Overall Study|Subject moved|0
3058706|NCT00545103|10511541|P4|Overall Study|Investigator decision|0
3058707|NCT00545103|10511542|P3|Overall Study|Investigator decision|1
3058708|NCT00545103|10511543|P2|Overall Study|Investigator decision|0
3058709|NCT00545103|10511544|P1|Overall Study|Investigator decision|0
3058710|NCT00545103|10511541|P4|Overall Study|Noncompliance|0
3058711|NCT00545103|10511542|P3|Overall Study|Noncompliance|0
3058712|NCT00545103|10511543|P2|Overall Study|Noncompliance|1
3058713|NCT00545103|10511544|P1|Overall Study|Noncompliance|0
3058714|NCT00545103|10511541|P4|Overall Study|Subject's decision|0
3058715|NCT00545103|10511542|P3|Overall Study|Subject's decision|0
3058716|NCT00545103|10511543|P2|Overall Study|Subject's decision|0
3058717|NCT00545103|10511544|P1|Overall Study|Subject's decision|1
3058718|NCT00545103|10511541|P4|Overall Study|Personal reasons|0
3058719|NCT00545103|10511542|P3|Overall Study|Personal reasons|0
3058720|NCT00545103|10511543|P2|Overall Study|Personal reasons|0
3058721|NCT00545103|10511544|P1|Overall Study|Personal reasons|1
3058722|NCT00545103|10511541|P4|Overall Study|Diverticulitis crisis|1
3058723|NCT00545103|10511542|P3|Overall Study|Diverticulitis crisis|0
3058724|NCT00545103|10511543|P2|Overall Study|Diverticulitis crisis|0
3058725|NCT00545103|10511544|P1|Overall Study|Diverticulitis crisis|0
3058726|NCT00545103|10511541|P4|Overall Study|Wish to start a family|1
3058727|NCT00545103|10511542|P3|Overall Study|Wish to start a family|0
3058728|NCT00545103|10511543|P2|Overall Study|Wish to start a family|0
3058729|NCT00545103|10511544|P1|Overall Study|Wish to start a family|0
3058730|NCT00545103|10511541|P4|Overall Study|Investigational product not taken|1
3058731|NCT00545103|10511542|P3|Overall Study|Investigational product not taken|0
3058732|NCT00545103|10511543|P2|Overall Study|Investigational product not taken|0
3058733|NCT00545103|10511544|P1|Overall Study|Investigational product not taken|1
3058734|NCT00545103|10511541|P4|Overall Study|Difficult to open package|1
3058735|NCT00545103|10511542|P3|Overall Study|Difficult to open package|0
3058736|NCT00545103|10511543|P2|Overall Study|Difficult to open package|0
3058737|NCT00545103|10511544|P1|Overall Study|Difficult to open package|0
3058738|NCT00545103|10511541|P4|Overall Study|Suspected recurrence of diverticulitis|3
3058739|NCT00545103|10511542|P3|Overall Study|Suspected recurrence of diverticulitis|0
3058740|NCT00545103|10511543|P2|Overall Study|Suspected recurrence of diverticulitis|0
3058741|NCT00545103|10511544|P1|Overall Study|Suspected recurrence of diverticulitis|1
3058742|NCT00545103|10511541|P4|Overall Study|Protocol Violation|0
3058743|NCT00545103|10511542|P3|Overall Study|Protocol Violation|3
3058744|NCT00545103|10511543|P2|Overall Study|Protocol Violation|2
3058745|NCT00545103|10511544|P1|Overall Study|Protocol Violation|1
3058746|NCT00545103|10511541|P4|Overall Study|Lost to Follow-up|4
3058747|NCT00545103|10511542|P3|Overall Study|Lost to Follow-up|3
3058748|NCT00545103|10511543|P2|Overall Study|Lost to Follow-up|6
3058749|NCT00545103|10511544|P1|Overall Study|Lost to Follow-up|4
3058750|NCT00545103|10511541|P4|Overall Study|Adverse Event|10
3058751|NCT00545103|10511542|P3|Overall Study|Adverse Event|17
3058752|NCT00545103|10511543|P2|Overall Study|Adverse Event|12
3058753|NCT00545103|10511544|P1|Overall Study|Adverse Event|11
3058754|NCT00545103|10511541|P4|Overall Study|Withdrawal by Subject|22
3058755|NCT00545103|10511542|P3|Overall Study|Withdrawal by Subject|18
3058756|NCT00545103|10511543|P2|Overall Study|Withdrawal by Subject|10
3058757|NCT00545103|10511544|P1|Overall Study|Withdrawal by Subject|6
3058758|NCT00545103|10511541|P4|Overall Study|Lack of Efficacy|27
3058759|NCT00545103|10511542|P3|Overall Study|Lack of Efficacy|31
3058760|NCT00545103|10511543|P2|Overall Study|Lack of Efficacy|45
3058761|NCT00545103|10511544|P1|Overall Study|Lack of Efficacy|48
3058762|NCT00545077|10511580|P2|Overall Study|Death|8
3058763|NCT00545077|10511581|P1|Overall Study|Death|0
3058764|NCT00545077|10511580|P2|Overall Study|Adverse Event|31
3058765|NCT00545077|10511581|P1|Overall Study|Adverse Event|0
3058766|NCT00545077|10511580|P2|Overall Study|Protocol Violation|0
3058767|NCT00545077|10511581|P1|Overall Study|Protocol Violation|1
3058768|NCT00545077|10511580|P2|Overall Study|Lost to Follow-up|0
3058769|NCT00545077|10511581|P1|Overall Study|Lost to Follow-up|2
3058770|NCT00545077|10511580|P2|Overall Study|Physician Decision|3
3058771|NCT00545077|10511581|P1|Overall Study|Physician Decision|6
3058772|NCT00545077|10511580|P2|Overall Study|Withdrawal by Subject|14
3058773|NCT00545077|10511581|P1|Overall Study|Withdrawal by Subject|3
3058774|NCT00545077|10511580|P2|Overall Study|Disease Progression|98
3058775|NCT00545077|10511581|P1|Overall Study|Disease Progression|131
3058776|NCT00545077|10511580|P2|Overall Study|Treatment not received|1
3058777|NCT00545077|10511581|P1|Overall Study|Treatment not received|5
3058778|NCT00545064|10511597|P1|Overall Study|inclement weather|1
3058779|NCT00545064|10511597|P1|Overall Study|cancel all appointments, no rebooking|1
3058780|NCT00545064|10511597|P1|Overall Study|did not complete course of treatment|1
3058781|NCT00545064|10511597|P1|Overall Study|Withdrawal by Subject|2
3058782|NCT00545064|10511597|P1|Overall Study|Lost to Follow-up|3
3058783|NCT00545051|10511608|P2|Overall Study|Administrative reasons|1
3058784|NCT00545051|10511609|P1|Overall Study|Administrative reasons|0
3058785|NCT00545051|10511608|P2|Overall Study|Withdrawal by Subject|1
3058786|NCT00545051|10511609|P1|Overall Study|Withdrawal by Subject|0
3058787|NCT00545051|10511608|P2|Overall Study|Protocol Violation|0
3058788|NCT00545051|10511609|P1|Overall Study|Protocol Violation|1
3058789|NCT00545051|10511608|P2|Overall Study|Violation of inclusion/exclusion|2
3058790|NCT00545051|10511609|P1|Overall Study|Violation of inclusion/exclusion|0
3058791|NCT00545051|10511608|P2|Overall Study|Death|0
3058792|NCT00545051|10511609|P1|Overall Study|Death|1
3058793|NCT00545051|10511608|P2|Overall Study|Adverse Event|3
3058794|NCT00545051|10511609|P1|Overall Study|Adverse Event|7
3058795|NCT00544882|10511653|P3|Cycle 3: Follow-up|Pregnancy|0
3058796|NCT00544882|10511654|P2|Cycle 3: Follow-up|Pregnancy|1
3058797|NCT00544882|10511655|P1|Cycle 3: Follow-up|Pregnancy|0
3058798|NCT00544882|10511653|P3|Cycle 3: Follow-up|Noncompliance|0
3058799|NCT00544882|10511654|P2|Cycle 3: Follow-up|Noncompliance|1
3058800|NCT00544882|10511655|P1|Cycle 3: Follow-up|Noncompliance|0
3058801|NCT00544882|10511653|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
3058802|NCT00544882|10511654|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
3058803|NCT00544882|10511655|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
3058804|NCT00544882|10511653|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
3058805|NCT00544882|10511654|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
3058806|NCT00544882|10511655|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
3058807|NCT00544882|10511653|P3|Cycle 1: Run-in Cycle|Adverse Event|0
3058808|NCT00544882|10511654|P2|Cycle 1: Run-in Cycle|Adverse Event|0
3058809|NCT00544882|10511655|P1|Cycle 1: Run-in Cycle|Adverse Event|1
3058810|NCT00544882|10511653|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
3058811|NCT00544882|10511654|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
3058812|NCT00544882|10511655|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
3058813|NCT00544869|10511680|P3|Overall Study|Physician Decision|0
3058814|NCT00544869|10511681|P2|Overall Study|Physician Decision|0
3058815|NCT00544869|10511682|P1|Overall Study|Physician Decision|2
3058816|NCT00544869|10511680|P3|Overall Study|Lack of Efficacy|0
3058817|NCT00544869|10511681|P2|Overall Study|Lack of Efficacy|1
3058818|NCT00544869|10511682|P1|Overall Study|Lack of Efficacy|1
3058819|NCT00544869|10511680|P3|Overall Study|Adverse Event|0
3058820|NCT00544869|10511681|P2|Overall Study|Adverse Event|1
3058821|NCT00544869|10511682|P1|Overall Study|Adverse Event|6
3058822|NCT00544869|10511680|P3|Overall Study|Rsolution of congenitive symptoms|0
3058823|NCT00544869|10511681|P2|Overall Study|Rsolution of congenitive symptoms|0
3058824|NCT00544869|10511682|P1|Overall Study|Rsolution of congenitive symptoms|3
3058825|NCT00544817|10511690|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
3058826|NCT00544817|10511690|P1|Follow-up Systemic Therapy|Physician Decision|3
3058827|NCT00544817|10511690|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
3058828|NCT00544817|10511690|P1|No Treatment Interval|Adverse Event|1
3058829|NCT00544817|10511690|P1|No Treatment Interval|Physician Decision|3
3058830|NCT00544817|10511690|P1|No Treatment Interval|Lack of Efficacy|8
3058831|NCT00544817|10511690|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
3058832|NCT00544817|10511690|P1|Combined Modality|Adverse Event|2
3058833|NCT00544817|10511690|P1|Combined Modality|Worsening Neurologic Symptoms|2
3058834|NCT00544817|10511690|P1|Combined Modality|Lack of Efficacy|2
3058835|NCT00544648|10511739|P2|Overall Study|progression of disease|0
3058836|NCT00544648|10511740|P1|Overall Study|progression of disease|1
3058837|NCT00544648|10511739|P2|Overall Study|Adverse Event|1
3058838|NCT00544648|10511740|P1|Overall Study|Adverse Event|1
3058839|NCT00544648|10511739|P2|Overall Study|Withdrawal by Subject|0
3058840|NCT00544648|10511740|P1|Overall Study|Withdrawal by Subject|1
3058841|NCT00544557|10511754|P1|Overall Study|Other|98
3058842|NCT00544557|10511754|P1|Overall Study|Lack of Efficacy|196
3058843|NCT00544557|10511754|P1|Overall Study|Adverse Event|140
3058844|NCT00544544|10511785|P1|Overall Study|Lost to Follow-up|1
3058845|NCT00544544|10511785|P1|Overall Study|Adverse Event|1
3058846|NCT00544544|10511785|P1|Overall Study|Withdrawal by Subject|1
3058847|NCT00544440|10511792|P1|Overall Study|Other|5
3058848|NCT00544440|10511792|P1|Overall Study|Progressive Disease|47
3058849|NCT00544440|10511792|P1|Overall Study|Subject Non-compliance|1
3058850|NCT00544440|10511792|P1|Overall Study|Withdrawal by Subject|2
3058851|NCT00544440|10511792|P1|Overall Study|Adverse Event|1
3058852|NCT00544440|10511792|P1|Overall Study|Other|1
3058853|NCT00544167|10511799|P1|Overall Study|Physician Decision|8
3058854|NCT00544167|10511799|P1|Overall Study|Adverse Event|21
3058855|NCT00543985|10511825|P1|Overall Study|Withdrawal by Subject|4
3058856|NCT00543855|10511836|P4|Overall Study|Protocol Violation|0
3058857|NCT00543855|10511837|P3|Overall Study|Protocol Violation|0
3058858|NCT00543855|10511838|P2|Overall Study|Protocol Violation|0
3058859|NCT00543855|10511839|P1|Overall Study|Protocol Violation|1
3058860|NCT00543855|10511836|P4|Overall Study|Withdrawal by Subject|0
3058861|NCT00543855|10511837|P3|Overall Study|Withdrawal by Subject|2
3058862|NCT00543855|10511838|P2|Overall Study|Withdrawal by Subject|1
3058863|NCT00543855|10511839|P1|Overall Study|Withdrawal by Subject|0
3058864|NCT00543855|10511836|P4|Overall Study|Lost to Follow-up|0
3058865|NCT00543855|10511837|P3|Overall Study|Lost to Follow-up|1
3058866|NCT00543855|10511838|P2|Overall Study|Lost to Follow-up|0
3058867|NCT00543855|10511839|P1|Overall Study|Lost to Follow-up|0
3058868|NCT00543855|10511836|P4|Overall Study|Adverse Event|4
3058869|NCT00543855|10511837|P3|Overall Study|Adverse Event|3
3058870|NCT00543855|10511838|P2|Overall Study|Adverse Event|1
3058871|NCT00543855|10511839|P1|Overall Study|Adverse Event|3
3058872|NCT00543803|10511861|P1|Overall Study|Other|86
3058873|NCT00543803|10511861|P1|Overall Study|Lost to Follow-up|20
3058874|NCT00543803|10511861|P1|Overall Study|Lack of Efficacy|22
3058875|NCT00543803|10511861|P1|Overall Study|Adverse Event|14
3058876|NCT00543725|10511889|P2|Overall Study|Other|3
3058877|NCT00543725|10511890|P1|Overall Study|Other|3
3058878|NCT00543725|10511889|P2|Overall Study|Lost to Follow-up|11
3058879|NCT00543725|10511890|P1|Overall Study|Lost to Follow-up|15
3058880|NCT00543725|10511889|P2|Overall Study|Withdrawal by Subject|13
3058881|NCT00543725|10511890|P1|Overall Study|Withdrawal by Subject|4
3058882|NCT00543725|10511889|P2|Overall Study|Protocol Violation|1
3058883|NCT00543725|10511890|P1|Overall Study|Protocol Violation|0
3058884|NCT00543725|10511889|P2|Overall Study|Subject Reached A Virologic Endpoint|14
3058885|NCT00543725|10511890|P1|Overall Study|Subject Reached A Virologic Endpoint|22
3058886|NCT00543725|10511889|P2|Overall Study|Subject Ineligible To Continue The Trial|0
3058887|NCT00543725|10511890|P1|Overall Study|Subject Ineligible To Continue The Trial|2
3058888|NCT00543725|10511889|P2|Overall Study|Subject Non-Compliant|4
3058889|NCT00543725|10511890|P1|Overall Study|Subject Non-Compliant|4
3058890|NCT00543725|10511889|P2|Overall Study|Sponsor's Decision|1
3058891|NCT00543725|10511890|P1|Overall Study|Sponsor's Decision|0
3058892|NCT00543725|10511889|P2|Overall Study|Adverse Event|27
3058893|NCT00543725|10511890|P1|Overall Study|Adverse Event|18
3058894|NCT00543569|10511916|P4|Overall Study|Randomized but never received study drug|3
3058895|NCT00543569|10511917|P3|Overall Study|Randomized but never received study drug|5
3058896|NCT00543569|10511918|P2|Overall Study|Randomized but never received study drug|3
3058897|NCT00543569|10511919|P1|Overall Study|Randomized but never received study drug|3
3058898|NCT00543569|10511916|P4|Overall Study|Miscellaneous Reasons|4
3058899|NCT00543569|10511917|P3|Overall Study|Miscellaneous Reasons|11
3058900|NCT00543569|10511918|P2|Overall Study|Miscellaneous Reasons|3
3058901|NCT00543569|10511919|P1|Overall Study|Miscellaneous Reasons|7
3058902|NCT00543569|10511916|P4|Overall Study|Lost to Follow-up|1
3058903|NCT00543569|10511917|P3|Overall Study|Lost to Follow-up|1
3058904|NCT00543569|10511918|P2|Overall Study|Lost to Follow-up|0
3058905|NCT00543569|10511919|P1|Overall Study|Lost to Follow-up|0
3058906|NCT00543569|10511916|P4|Overall Study|Death|1
3058907|NCT00543569|10511917|P3|Overall Study|Death|3
3058908|NCT00543569|10511918|P2|Overall Study|Death|2
3058909|NCT00543569|10511919|P1|Overall Study|Death|2
3058910|NCT00543543|10512025|P4|Extension Study|Withdrawal by Subject|120
3058911|NCT00543543|10512026|P3|Extension Study|Withdrawal by Subject|0
3058912|NCT00543543|10512027|P2|Extension Study|Withdrawal by Subject|0
3058913|NCT00543543|10512028|P1|Extension Study|Withdrawal by Subject|0
3058914|NCT00543543|10512025|P4|Extension Study|Protocol Violation|11
3058915|NCT00543543|10512026|P3|Extension Study|Protocol Violation|0
3058916|NCT00543543|10512027|P2|Extension Study|Protocol Violation|0
3058917|NCT00543543|10512028|P1|Extension Study|Protocol Violation|0
3058918|NCT00543543|10512025|P4|Extension Study|Pregnancy|6
3058919|NCT00543543|10512026|P3|Extension Study|Pregnancy|0
3058920|NCT00543543|10512027|P2|Extension Study|Pregnancy|0
3058921|NCT00543543|10512028|P1|Extension Study|Pregnancy|0
3058922|NCT00543543|10512025|P4|Extension Study|Physician Decision|7
3058923|NCT00543543|10512026|P3|Extension Study|Physician Decision|0
3058924|NCT00543543|10512027|P2|Extension Study|Physician Decision|0
3058925|NCT00543543|10512028|P1|Extension Study|Physician Decision|0
3058926|NCT00543543|10512025|P4|Extension Study|Lost to Follow-up|77
3058927|NCT00543543|10512026|P3|Extension Study|Lost to Follow-up|0
3058928|NCT00543543|10512027|P2|Extension Study|Lost to Follow-up|0
3058929|NCT00543543|10512028|P1|Extension Study|Lost to Follow-up|0
3058930|NCT00543543|10512025|P4|Extension Study|Adverse Event|5
3058931|NCT00543543|10512026|P3|Extension Study|Adverse Event|0
3058932|NCT00543543|10512027|P2|Extension Study|Adverse Event|0
3058933|NCT00543543|10512028|P1|Extension Study|Adverse Event|0
3058934|NCT00543543|10512025|P4|Base Study|Withdrawal by Subject|503
3058935|NCT00543543|10512026|P3|Base Study|Withdrawal by Subject|5
3058936|NCT00543543|10512027|P2|Base Study|Withdrawal by Subject|482
3058937|NCT00543543|10512028|P1|Base Study|Withdrawal by Subject|7
3058938|NCT00543543|10512025|P4|Base Study|Protocol Violation|6
3058939|NCT00543543|10512026|P3|Base Study|Protocol Violation|0
3058940|NCT00543543|10512027|P2|Base Study|Protocol Violation|6
3058941|NCT00543543|10512028|P1|Base Study|Protocol Violation|0
3058942|NCT00543543|10512025|P4|Base Study|Physician Decision|7
3058943|NCT00543543|10512026|P3|Base Study|Physician Decision|0
3058944|NCT00543543|10512027|P2|Base Study|Physician Decision|4
3058945|NCT00543543|10512028|P1|Base Study|Physician Decision|0
3058946|NCT00543543|10512025|P4|Base Study|Lost to Follow-up|701
3058947|NCT00543543|10512026|P3|Base Study|Lost to Follow-up|9
3058948|NCT00543543|10512027|P2|Base Study|Lost to Follow-up|749
3058949|NCT00543543|10512028|P1|Base Study|Lost to Follow-up|12
3058950|NCT00543543|10512025|P4|Base Study|Adverse Event|5
3058951|NCT00543543|10512026|P3|Base Study|Adverse Event|0
3058952|NCT00543543|10512027|P2|Base Study|Adverse Event|11
3058953|NCT00543543|10512028|P1|Base Study|Adverse Event|1
3058954|NCT00543439|10512072|P3|Period 2|Adverse Event|1
3058955|NCT00543439|10512073|P2|Period 2|Adverse Event|1
3058956|NCT00543439|10512074|P1|Period 2|Adverse Event|0
3058957|NCT00543439|10512072|P3|Period 2|Protocol Violation|1
3058958|NCT00543439|10512073|P2|Period 2|Protocol Violation|0
3058959|NCT00543439|10512074|P1|Period 2|Protocol Violation|1
3058960|NCT00543439|10512072|P3|Period 1|Physician Decision|1
3058961|NCT00543439|10512073|P2|Period 1|Physician Decision|0
3058962|NCT00543439|10512074|P1|Period 1|Physician Decision|0
3058963|NCT00543439|10512072|P3|Period 1|Withdrawal by Subject|0
3058964|NCT00543439|10512073|P2|Period 1|Withdrawal by Subject|1
3058965|NCT00543439|10512074|P1|Period 1|Withdrawal by Subject|1
3058966|NCT00543439|10512072|P3|Period 1|Adverse Event|1
3058967|NCT00543439|10512073|P2|Period 1|Adverse Event|2
3058968|NCT00543439|10512074|P1|Period 1|Adverse Event|0
3058969|NCT00543387|10512143|P11|Crossover Participants|Study Terminated by Sponsor|1
3058970|NCT00543387|10512144|P10|Crossover Participants|Study Terminated by Sponsor|0
3058971|NCT00543387|10512145|P9|Crossover Participants|Study Terminated by Sponsor|0
3058972|NCT00543387|10512146|P8|Crossover Participants|Study Terminated by Sponsor|0
3058973|NCT00543387|10512147|P7|Crossover Participants|Study Terminated by Sponsor|0
3058974|NCT00543387|10512148|P6|Crossover Participants|Study Terminated by Sponsor|0
3058975|NCT00543387|10512149|P5|Crossover Participants|Study Terminated by Sponsor|0
3058976|NCT00543387|10512150|P4|Crossover Participants|Study Terminated by Sponsor|0
3058977|NCT00543387|10512151|P3|Crossover Participants|Study Terminated by Sponsor|0
3058978|NCT00543387|10512152|P2|Crossover Participants|Study Terminated by Sponsor|0
3058979|NCT00543387|10512153|P1|Crossover Participants|Study Terminated by Sponsor|0
3058980|NCT00543387|10512143|P11|Crossover Participants|Progressive Disease|2
3058981|NCT00543387|10512144|P10|Crossover Participants|Progressive Disease|1
3058982|NCT00543387|10512145|P9|Crossover Participants|Progressive Disease|0
3058983|NCT00543387|10512146|P8|Crossover Participants|Progressive Disease|0
3058984|NCT00543387|10512147|P7|Crossover Participants|Progressive Disease|0
3058985|NCT00543387|10512148|P6|Crossover Participants|Progressive Disease|0
3058986|NCT00543387|10512149|P5|Crossover Participants|Progressive Disease|0
3058987|NCT00543387|10512150|P4|Crossover Participants|Progressive Disease|0
3058988|NCT00543387|10512151|P3|Crossover Participants|Progressive Disease|0
3058989|NCT00543387|10512152|P2|Crossover Participants|Progressive Disease|0
3058990|NCT00543387|10512153|P1|Crossover Participants|Progressive Disease|0
3058991|NCT00543387|10512143|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
3058992|NCT00543387|10512144|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
3058993|NCT00543387|10512145|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
3058994|NCT00543387|10512146|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
3058995|NCT00543387|10512147|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
3058996|NCT00543387|10512148|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
3058997|NCT00543387|10512149|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
3058998|NCT00543387|10512150|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
3058999|NCT00543387|10512151|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
3059000|NCT00543387|10512152|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
3059001|NCT00543387|10512153|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
3059002|NCT00543387|10512143|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
3059003|NCT00543387|10512144|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
3059004|NCT00543387|10512145|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
3059005|NCT00543387|10512146|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
3059006|NCT00543387|10512147|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
3059007|NCT00543387|10512148|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
3059008|NCT00543387|10512149|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
3059009|NCT00543387|10512150|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
3059010|NCT00543387|10512151|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
3059011|NCT00543387|10512152|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
3059012|NCT00543387|10512153|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
3059013|NCT00543387|10512143|P11|Panel 1 + Panel 2|Physician Decision|0
3059014|NCT00543387|10512144|P10|Panel 1 + Panel 2|Physician Decision|0
3059015|NCT00543387|10512145|P9|Panel 1 + Panel 2|Physician Decision|0
3059016|NCT00543387|10512146|P8|Panel 1 + Panel 2|Physician Decision|1
3059017|NCT00543387|10512147|P7|Panel 1 + Panel 2|Physician Decision|0
3059018|NCT00543387|10512148|P6|Panel 1 + Panel 2|Physician Decision|0
3059019|NCT00543387|10512149|P5|Panel 1 + Panel 2|Physician Decision|0
3059020|NCT00543387|10512150|P4|Panel 1 + Panel 2|Physician Decision|0
3059021|NCT00543387|10512151|P3|Panel 1 + Panel 2|Physician Decision|1
3059022|NCT00543387|10512152|P2|Panel 1 + Panel 2|Physician Decision|0
3059023|NCT00543387|10512153|P1|Panel 1 + Panel 2|Physician Decision|0
3059024|NCT00543387|10512143|P11|Panel 1 + Panel 2|Adverse Event|0
3059025|NCT00543387|10512144|P10|Panel 1 + Panel 2|Adverse Event|0
3059026|NCT00543387|10512145|P9|Panel 1 + Panel 2|Adverse Event|1
3059027|NCT00543387|10512146|P8|Panel 1 + Panel 2|Adverse Event|1
3059028|NCT00543387|10512147|P7|Panel 1 + Panel 2|Adverse Event|0
3059029|NCT00543387|10512148|P6|Panel 1 + Panel 2|Adverse Event|0
3059030|NCT00543387|10512149|P5|Panel 1 + Panel 2|Adverse Event|0
3059031|NCT00543387|10512150|P4|Panel 1 + Panel 2|Adverse Event|0
3059032|NCT00543387|10512151|P3|Panel 1 + Panel 2|Adverse Event|0
3059033|NCT00543387|10512152|P2|Panel 1 + Panel 2|Adverse Event|1
3059034|NCT00543387|10512153|P1|Panel 1 + Panel 2|Adverse Event|0
3059035|NCT00543309|10512191|P3|Overall Study|Physician Decision|0
3059036|NCT00543309|10512192|P2|Overall Study|Physician Decision|1
3059037|NCT00543309|10512193|P1|Overall Study|Physician Decision|0
3059038|NCT00543296|10512243|P1|Overall Study|Physician Decision|7
3059039|NCT00543140|10512250|P1|Overall Study|Conversion to different procedure|1
3059040|NCT00543140|10512250|P1|Overall Study|Subject moved|1
3059041|NCT00543140|10512250|P1|Overall Study|Death|1
3059042|NCT00543140|10512250|P1|Overall Study|SAE leading to explant of SAGB|3
3059043|NCT00543140|10512250|P1|Overall Study|Insufficient weight loss|10
3059044|NCT00543140|10512250|P1|Overall Study|Protocol Violation|10
3059045|NCT00543140|10512250|P1|Overall Study|Withdrawal by Subject|13
3059046|NCT00543140|10512250|P1|Overall Study|Lost to Follow-up|33
3059047|NCT00543062|10512288|P4|Overall Study|Protocol Violation|0
3059048|NCT00543062|10512289|P3|Overall Study|Protocol Violation|0
3059049|NCT00543062|10512290|P2|Overall Study|Protocol Violation|0
3059050|NCT00543062|10512291|P1|Overall Study|Protocol Violation|1
3059051|NCT00543062|10512288|P4|Overall Study|Adverse Event|1
3059052|NCT00543062|10512289|P3|Overall Study|Adverse Event|1
3059053|NCT00543062|10512290|P2|Overall Study|Adverse Event|1
3059054|NCT00543062|10512291|P1|Overall Study|Adverse Event|0
3059055|NCT00543062|10512288|P4|Overall Study|Withdrawal by Subject|0
3059056|NCT00543062|10512289|P3|Overall Study|Withdrawal by Subject|2
3059057|NCT00543062|10512290|P2|Overall Study|Withdrawal by Subject|0
3059058|NCT00543062|10512291|P1|Overall Study|Withdrawal by Subject|1
3059059|NCT00542997|10512313|P1|Efficacy Period|Adverse Event|3
3059060|NCT00542997|10512313|P1|Wash in / Wash Out Period|Adverse Event|3
3059061|NCT00542997|10512313|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
3059062|NCT00542880|10512335|P2|Period 3|Adverse Event|2
3059063|NCT00542880|10512336|P1|Period 3|Adverse Event|0
3059064|NCT00542880|10512335|P2|Period 2|Other|1
3059065|NCT00542880|10512336|P1|Period 2|Other|0
3059066|NCT00542880|10512335|P2|Period 2|Severe non-compliance|1
3059067|NCT00542880|10512336|P1|Period 2|Severe non-compliance|0
3059068|NCT00542880|10512335|P2|Period 2|Discontinuation criteria|0
3059069|NCT00542880|10512336|P1|Period 2|Discontinuation criteria|2
3059070|NCT00542880|10512335|P2|Period 2|Eligibility not fulfilled|1
3059071|NCT00542880|10512336|P1|Period 2|Eligibility not fulfilled|0
3059072|NCT00542880|10512335|P2|Period 2|Adverse Event|7
3059073|NCT00542880|10512336|P1|Period 2|Adverse Event|5
3059074|NCT00542880|10512335|P2|Period 1|Protocol Violation|1
3059075|NCT00542880|10512336|P1|Period 1|Protocol Violation|0
3059076|NCT00542880|10512335|P2|Period 1|Withdrawal by Subject|1
3059077|NCT00542880|10512336|P1|Period 1|Withdrawal by Subject|1
3059078|NCT00542880|10512335|P2|Period 1|Development of study-specific criteria|2
3059079|NCT00542880|10512336|P1|Period 1|Development of study-specific criteria|1
3059080|NCT00542880|10512335|P2|Period 1|Adverse Event|2
3059081|NCT00542880|10512336|P1|Period 1|Adverse Event|2
3059082|NCT00542880|10512335|P2|Period 1|Eligibility criteria not fulfilled|6
3059083|NCT00542880|10512336|P1|Period 1|Eligibility criteria not fulfilled|2
3059084|NCT00542828|10512372|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
3059085|NCT00542828|10512372|P1|Overall Study|Study Prematurely Discontinued|7
3059086|NCT00542828|10512372|P1|Overall Study|Need for Prohibited Treatment|3
3059087|NCT00542828|10512372|P1|Overall Study|Physician Decision|1
3059088|NCT00542815|10512390|P3|Overall Study|Other reasons|10
3059089|NCT00542815|10512391|P2|Overall Study|Other reasons|10
3059090|NCT00542815|10512392|P1|Overall Study|Other reasons|24
3059091|NCT00542815|10512390|P3|Overall Study|Withdrawal by Subject|8
3059092|NCT00542815|10512391|P2|Overall Study|Withdrawal by Subject|5
3059093|NCT00542815|10512392|P1|Overall Study|Withdrawal by Subject|41
3059094|NCT00542815|10512390|P3|Overall Study|Protocol Violation|2
3059095|NCT00542815|10512391|P2|Overall Study|Protocol Violation|1
3059096|NCT00542815|10512392|P1|Overall Study|Protocol Violation|1
3059097|NCT00542815|10512390|P3|Overall Study|Physician Decision|0
3059098|NCT00542815|10512391|P2|Overall Study|Physician Decision|1
3059099|NCT00542815|10512392|P1|Overall Study|Physician Decision|2
3059100|NCT00542815|10512390|P3|Overall Study|Lack of Efficacy|0
3059101|NCT00542815|10512391|P2|Overall Study|Lack of Efficacy|2
3059102|NCT00542815|10512392|P1|Overall Study|Lack of Efficacy|9
3059103|NCT00542815|10512390|P3|Overall Study|Death|3
3059104|NCT00542815|10512391|P2|Overall Study|Death|7
3059105|NCT00542815|10512392|P1|Overall Study|Death|10
3059106|NCT00542815|10512390|P3|Overall Study|Adverse Event|9
3059107|NCT00542815|10512391|P2|Overall Study|Adverse Event|6
3059108|NCT00542815|10512392|P1|Overall Study|Adverse Event|19
3059109|NCT00542789|10512405|P2|Overall Study|Recurrence of Gastric Ulcer|57
3059110|NCT00542789|10512406|P1|Overall Study|Recurrence of Gastric Ulcer|8
3059111|NCT00542789|10512405|P2|Overall Study|Protocol Violation|1
3059112|NCT00542789|10512406|P1|Overall Study|Protocol Violation|8
3059113|NCT00542789|10512405|P2|Overall Study|Withdrawal by Subject|3
3059114|NCT00542789|10512406|P1|Overall Study|Withdrawal by Subject|7
3059115|NCT00542789|10512405|P2|Overall Study|Adverse Event|17
3059116|NCT00542789|10512406|P1|Overall Study|Adverse Event|18
3059117|NCT00542425|10512506|P5|Extended 24 Weeks of Treatment|Other|1
3059118|NCT00542425|10512507|P4|Extended 24 Weeks of Treatment|Other|0
3059119|NCT00542425|10512508|P3|Extended 24 Weeks of Treatment|Other|0
3059120|NCT00542425|10512509|P2|Extended 24 Weeks of Treatment|Other|1
3059121|NCT00542425|10512510|P1|Extended 24 Weeks of Treatment|Other|1
3059122|NCT00542425|10512506|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
3059123|NCT00542425|10512507|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
3059124|NCT00542425|10512508|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
3059125|NCT00542425|10512509|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
3059126|NCT00542425|10512510|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
3059127|NCT00542425|10512506|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
3059128|NCT00542425|10512507|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
3059129|NCT00542425|10512508|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
3059130|NCT00542425|10512509|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
3059131|NCT00542425|10512510|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
3059132|NCT00542425|10512506|P5|Extended 24 Weeks of Treatment|Adverse Event|0
3059133|NCT00542425|10512507|P4|Extended 24 Weeks of Treatment|Adverse Event|1
3059134|NCT00542425|10512508|P3|Extended 24 Weeks of Treatment|Adverse Event|1
3059135|NCT00542425|10512509|P2|Extended 24 Weeks of Treatment|Adverse Event|0
3059136|NCT00542425|10512510|P1|Extended 24 Weeks of Treatment|Adverse Event|0
3059137|NCT00542425|10512506|P5|Initial 24 Weeks|Other|0
3059138|NCT00542425|10512507|P4|Initial 24 Weeks|Other|0
3059139|NCT00542425|10512508|P3|Initial 24 Weeks|Other|1
3059140|NCT00542425|10512509|P2|Initial 24 Weeks|Other|2
3059141|NCT00542425|10512510|P1|Initial 24 Weeks|Other|0
3059142|NCT00542425|10512506|P5|Initial 24 Weeks|Refusal of treatment|1
3059143|NCT00542425|10512507|P4|Initial 24 Weeks|Refusal of treatment|4
3059144|NCT00542425|10512508|P3|Initial 24 Weeks|Refusal of treatment|1
3059145|NCT00542425|10512509|P2|Initial 24 Weeks|Refusal of treatment|2
3059146|NCT00542425|10512510|P1|Initial 24 Weeks|Refusal of treatment|2
3059147|NCT00542425|10512506|P5|Initial 24 Weeks|Protocol Violation|0
3059148|NCT00542425|10512507|P4|Initial 24 Weeks|Protocol Violation|1
3059149|NCT00542425|10512508|P3|Initial 24 Weeks|Protocol Violation|0
3059150|NCT00542425|10512509|P2|Initial 24 Weeks|Protocol Violation|0
3059151|NCT00542425|10512510|P1|Initial 24 Weeks|Protocol Violation|0
3059152|NCT00542425|10512506|P5|Initial 24 Weeks|Non-compliance|1
3059153|NCT00542425|10512507|P4|Initial 24 Weeks|Non-compliance|1
3059154|NCT00542425|10512508|P3|Initial 24 Weeks|Non-compliance|0
3059155|NCT00542425|10512509|P2|Initial 24 Weeks|Non-compliance|0
3059156|NCT00542425|10512510|P1|Initial 24 Weeks|Non-compliance|0
3059157|NCT00542425|10512506|P5|Initial 24 Weeks|Lost to Follow-up|0
3059158|NCT00542425|10512507|P4|Initial 24 Weeks|Lost to Follow-up|0
3059159|NCT00542425|10512508|P3|Initial 24 Weeks|Lost to Follow-up|1
3059160|NCT00542425|10512509|P2|Initial 24 Weeks|Lost to Follow-up|2
3059161|NCT00542425|10512510|P1|Initial 24 Weeks|Lost to Follow-up|2
3059162|NCT00542425|10512506|P5|Initial 24 Weeks|Inability to complete procedures|2
3059163|NCT00542425|10512507|P4|Initial 24 Weeks|Inability to complete procedures|1
3059164|NCT00542425|10512508|P3|Initial 24 Weeks|Inability to complete procedures|2
3059165|NCT00542425|10512509|P2|Initial 24 Weeks|Inability to complete procedures|3
3059166|NCT00542425|10512510|P1|Initial 24 Weeks|Inability to complete procedures|0
3059167|NCT00542425|10512506|P5|Initial 24 Weeks|Adverse Event|2
3059168|NCT00542425|10512507|P4|Initial 24 Weeks|Adverse Event|3
3059169|NCT00542425|10512508|P3|Initial 24 Weeks|Adverse Event|1
3059170|NCT00542425|10512509|P2|Initial 24 Weeks|Adverse Event|1
3059171|NCT00542425|10512510|P1|Initial 24 Weeks|Adverse Event|0
3059172|NCT00542425|10512506|P5|Initial 24 Weeks|Administrative reasons|0
3059173|NCT00542425|10512507|P4|Initial 24 Weeks|Administrative reasons|1
3059174|NCT00542425|10512508|P3|Initial 24 Weeks|Administrative reasons|1
3059175|NCT00542425|10512509|P2|Initial 24 Weeks|Administrative reasons|0
3059176|NCT00542425|10512510|P1|Initial 24 Weeks|Administrative reasons|0
3059177|NCT00542386|10512548|P6|Overall Study|Other Reasons|2
3059178|NCT00542386|10512549|P5|Overall Study|Other Reasons|4
3059179|NCT00542386|10512550|P4|Overall Study|Other Reasons|3
3059180|NCT00542386|10512551|P3|Overall Study|Other Reasons|4
3059181|NCT00542386|10512552|P2|Overall Study|Other Reasons|1
3059182|NCT00542386|10512553|P1|Overall Study|Other Reasons|4
3059183|NCT00542386|10512548|P6|Overall Study|Withdrawal by Subject|7
3059184|NCT00542386|10512549|P5|Overall Study|Withdrawal by Subject|15
3059185|NCT00542386|10512550|P4|Overall Study|Withdrawal by Subject|11
3059186|NCT00542386|10512551|P3|Overall Study|Withdrawal by Subject|10
3059187|NCT00542386|10512552|P2|Overall Study|Withdrawal by Subject|8
3059188|NCT00542386|10512553|P1|Overall Study|Withdrawal by Subject|5
3059189|NCT00542386|10512548|P6|Overall Study|Protocol Violation|4
3059190|NCT00542386|10512549|P5|Overall Study|Protocol Violation|0
3059191|NCT00542386|10512550|P4|Overall Study|Protocol Violation|0
3059192|NCT00542386|10512551|P3|Overall Study|Protocol Violation|1
3059193|NCT00542386|10512552|P2|Overall Study|Protocol Violation|0
3059194|NCT00542386|10512553|P1|Overall Study|Protocol Violation|0
3059195|NCT00542386|10512548|P6|Overall Study|Physician Decision|0
3059196|NCT00542386|10512549|P5|Overall Study|Physician Decision|0
3059197|NCT00542386|10512550|P4|Overall Study|Physician Decision|1
3059198|NCT00542386|10512551|P3|Overall Study|Physician Decision|0
3059199|NCT00542386|10512552|P2|Overall Study|Physician Decision|0
3059200|NCT00542386|10512553|P1|Overall Study|Physician Decision|1
3059201|NCT00542386|10512548|P6|Overall Study|Lack of Efficacy|31
3059202|NCT00542386|10512549|P5|Overall Study|Lack of Efficacy|7
3059203|NCT00542386|10512550|P4|Overall Study|Lack of Efficacy|13
3059204|NCT00542386|10512551|P3|Overall Study|Lack of Efficacy|10
3059205|NCT00542386|10512552|P2|Overall Study|Lack of Efficacy|12
3059206|NCT00542386|10512553|P1|Overall Study|Lack of Efficacy|32
3059207|NCT00542386|10512548|P6|Overall Study|Death|2
3059208|NCT00542386|10512549|P5|Overall Study|Death|1
3059209|NCT00542386|10512550|P4|Overall Study|Death|2
3059210|NCT00542386|10512551|P3|Overall Study|Death|1
3059211|NCT00542386|10512552|P2|Overall Study|Death|0
3059212|NCT00542386|10512553|P1|Overall Study|Death|0
3059213|NCT00542386|10512548|P6|Overall Study|Adverse Event|4
3059214|NCT00542386|10512549|P5|Overall Study|Adverse Event|13
3059215|NCT00542386|10512550|P4|Overall Study|Adverse Event|8
3059216|NCT00542386|10512551|P3|Overall Study|Adverse Event|7
3059217|NCT00542386|10512552|P2|Overall Study|Adverse Event|7
3059218|NCT00542386|10512553|P1|Overall Study|Adverse Event|1
3059219|NCT00542321|10512575|P2|Overall Study|Death|1
3059220|NCT00542321|10512576|P1|Overall Study|Death|0
3059221|NCT00542269|10512598|P3|Overall Study|Administrative problems|1
3059222|NCT00542269|10512599|P2|Overall Study|Administrative problems|1
3059223|NCT00542269|10512600|P1|Overall Study|Administrative problems|1
3059224|NCT00542269|10512598|P3|Overall Study|Withdrawal by Subject|0
3059225|NCT00542269|10512599|P2|Overall Study|Withdrawal by Subject|0
3059226|NCT00542269|10512600|P1|Overall Study|Withdrawal by Subject|1
3059227|NCT00542269|10512598|P3|Overall Study|Protocol Violation|0
3059228|NCT00542269|10512599|P2|Overall Study|Protocol Violation|1
3059229|NCT00542269|10512600|P1|Overall Study|Protocol Violation|1
3059230|NCT00542269|10512598|P3|Overall Study|Adverse Event|5
3059231|NCT00542269|10512599|P2|Overall Study|Adverse Event|4
3059232|NCT00542269|10512600|P1|Overall Study|Adverse Event|10
3059233|NCT00542191|10512629|P1|Overall Study|Death|3
3059234|NCT00542178|10512639|P8|Overall Study|did not complete year 4 follow-up|85
3059235|NCT00542178|10512640|P7|Overall Study|did not complete year 4 follow-up|87
3059236|NCT00542178|10512641|P6|Overall Study|did not complete year 4 follow-up|89
3059237|NCT00542178|10512642|P5|Overall Study|did not complete year 4 follow-up|64
3059238|NCT00542178|10512643|P4|Overall Study|did not complete year 4 follow-up|62
3059239|NCT00542178|10512644|P3|Overall Study|did not complete year 4 follow-up|74
3059240|NCT00542178|10512645|P2|Overall Study|did not complete year 4 follow-up|80
3059241|NCT00542178|10512646|P1|Overall Study|did not complete year 4 follow-up|75
3059242|NCT00541970|10512682|P4|Month 60|Protocol Violation|72
3059243|NCT00541970|10512683|P3|Month 60|Protocol Violation|82
3059244|NCT00541970|10512684|P2|Month 60|Protocol Violation|77
3059245|NCT00541970|10512685|P1|Month 60|Protocol Violation|78
3059246|NCT00541970|10512682|P4|Month 48|Lost to Follow-up|73
3059247|NCT00541970|10512683|P3|Month 48|Lost to Follow-up|68
3059248|NCT00541970|10512684|P2|Month 48|Lost to Follow-up|68
3059249|NCT00541970|10512685|P1|Month 48|Lost to Follow-up|66
3059250|NCT00541970|10512682|P4|Month 48|Other|0
3059251|NCT00541970|10512683|P3|Month 48|Other|1
3059252|NCT00541970|10512684|P2|Month 48|Other|1
3059253|NCT00541970|10512685|P1|Month 48|Other|3
3059254|NCT00541970|10512682|P4|Month 48|Withdrawal by Subject|2
3059255|NCT00541970|10512683|P3|Month 48|Withdrawal by Subject|4
3059256|NCT00541970|10512684|P2|Month 48|Withdrawal by Subject|4
3059257|NCT00541970|10512685|P1|Month 48|Withdrawal by Subject|2
3059258|NCT00541970|10512682|P4|Month 36|Protocol Violation|60
3059259|NCT00541970|10512683|P3|Month 36|Protocol Violation|66
3059260|NCT00541970|10512684|P2|Month 36|Protocol Violation|66
3059261|NCT00541970|10512685|P1|Month 36|Protocol Violation|61
3059262|NCT00541970|10512682|P4|Month 24|Protocol Violation|21
3059263|NCT00541970|10512683|P3|Month 24|Protocol Violation|31
3059264|NCT00541970|10512684|P2|Month 24|Protocol Violation|31
3059265|NCT00541970|10512685|P1|Month 24|Protocol Violation|29
3059266|NCT00541970|10512682|P4|Month 24|Adverse Event|1
3059267|NCT00541970|10512683|P3|Month 24|Adverse Event|1
3059268|NCT00541970|10512684|P2|Month 24|Adverse Event|1
3059269|NCT00541970|10512685|P1|Month 24|Adverse Event|0
3059270|NCT00541970|10512682|P4|Month 18|Protocol Violation|16
3059271|NCT00541970|10512683|P3|Month 18|Protocol Violation|24
3059272|NCT00541970|10512684|P2|Month 18|Protocol Violation|23
3059273|NCT00541970|10512685|P1|Month 18|Protocol Violation|14
3059274|NCT00541970|10512682|P4|Month 18|Adverse Event|1
3059275|NCT00541970|10512683|P3|Month 18|Adverse Event|1
3059276|NCT00541970|10512684|P2|Month 18|Adverse Event|1
3059277|NCT00541970|10512685|P1|Month 18|Adverse Event|0
3059278|NCT00541970|10512682|P4|Month 12|Protocol Violation|15
3059279|NCT00541970|10512683|P3|Month 12|Protocol Violation|20
3059280|NCT00541970|10512684|P2|Month 12|Protocol Violation|21
3059281|NCT00541970|10512685|P1|Month 12|Protocol Violation|12
3059282|NCT00541970|10512682|P4|Month 12|Adverse Event|1
3059283|NCT00541970|10512683|P3|Month 12|Adverse Event|1
3059284|NCT00541970|10512684|P2|Month 12|Adverse Event|1
3059285|NCT00541970|10512685|P1|Month 12|Adverse Event|0
3059286|NCT00541970|10512682|P4|Month 7|Protocol Violation|5
3059287|NCT00541970|10512683|P3|Month 7|Protocol Violation|11
3059288|NCT00541970|10512684|P2|Month 7|Protocol Violation|13
3059289|NCT00541970|10512685|P1|Month 7|Protocol Violation|9
3059290|NCT00541931|10512836|P2|Overall Study|Transportation Issue|1
3059291|NCT00541931|10512837|P1|Overall Study|Transportation Issue|0
3059292|NCT00541931|10512836|P2|Overall Study|Withdrawal by Subject|0
3059293|NCT00541931|10512837|P1|Overall Study|Withdrawal by Subject|1
3059294|NCT00541931|10512836|P2|Overall Study|Lost to Follow-up|3
3059295|NCT00541931|10512837|P1|Overall Study|Lost to Follow-up|3
3059296|NCT00541931|10512836|P2|Overall Study|Adverse Event|0
3059297|NCT00541931|10512837|P1|Overall Study|Adverse Event|1
3059298|NCT00541866|10512850|P5|Overall Study|Physician Decision|0
3059299|NCT00541866|10512851|P4|Overall Study|Physician Decision|1
3059300|NCT00541866|10512852|P3|Overall Study|Physician Decision|2
3059301|NCT00541866|10512853|P2|Overall Study|Physician Decision|0
3059302|NCT00541866|10512854|P1|Overall Study|Physician Decision|0
3059303|NCT00541866|10512850|P5|Overall Study|Not Reported or Other|1
3059304|NCT00541866|10512851|P4|Overall Study|Not Reported or Other|3
3059305|NCT00541866|10512852|P3|Overall Study|Not Reported or Other|3
3059306|NCT00541866|10512853|P2|Overall Study|Not Reported or Other|3
3059307|NCT00541866|10512854|P1|Overall Study|Not Reported or Other|11
3059308|NCT00541866|10512850|P5|Overall Study|Lack of Efficacy|14
3059309|NCT00541866|10512851|P4|Overall Study|Lack of Efficacy|12
3059310|NCT00541866|10512852|P3|Overall Study|Lack of Efficacy|10
3059311|NCT00541866|10512853|P2|Overall Study|Lack of Efficacy|15
3059312|NCT00541866|10512854|P1|Overall Study|Lack of Efficacy|19
3059313|NCT00541866|10512850|P5|Overall Study|Death|0
3059314|NCT00541866|10512851|P4|Overall Study|Death|0
3059315|NCT00541866|10512852|P3|Overall Study|Death|0
3059316|NCT00541866|10512853|P2|Overall Study|Death|0
3059317|NCT00541866|10512854|P1|Overall Study|Death|1
3059318|NCT00541866|10512850|P5|Overall Study|Adverse Event|0
3059319|NCT00541866|10512851|P4|Overall Study|Adverse Event|0
3059320|NCT00541866|10512852|P3|Overall Study|Adverse Event|0
3059321|NCT00541866|10512853|P2|Overall Study|Adverse Event|0
3059322|NCT00541866|10512854|P1|Overall Study|Adverse Event|3
3059323|NCT00541775|10512895|P3|Overall Study|Withdrawal by Subject and Other|2
3059324|NCT00541775|10512896|P2|Overall Study|Withdrawal by Subject and Other|0
3059325|NCT00541775|10512897|P1|Overall Study|Withdrawal by Subject and Other|5
3059326|NCT00541775|10512895|P3|Overall Study|Protocol Violation|0
3059327|NCT00541775|10512896|P2|Overall Study|Protocol Violation|0
3059328|NCT00541775|10512897|P1|Overall Study|Protocol Violation|1
3059329|NCT00541775|10512895|P3|Overall Study|Lost to Follow-up|2
3059330|NCT00541775|10512896|P2|Overall Study|Lost to Follow-up|0
3059331|NCT00541775|10512897|P1|Overall Study|Lost to Follow-up|0
3059332|NCT00541775|10512895|P3|Overall Study|Lack of Efficacy|3
3059333|NCT00541775|10512896|P2|Overall Study|Lack of Efficacy|0
3059334|NCT00541775|10512897|P1|Overall Study|Lack of Efficacy|0
3059335|NCT00541775|10512895|P3|Overall Study|Adverse Event|1
3059336|NCT00541775|10512896|P2|Overall Study|Adverse Event|2
3059337|NCT00541775|10512897|P1|Overall Study|Adverse Event|3
3059338|NCT00541658|10512923|P3|Overall Study|Took No Study Drug|0
3059339|NCT00541658|10512924|P2|Overall Study|Took No Study Drug|0
3059340|NCT00541658|10512925|P1|Overall Study|Took No Study Drug|1
3059341|NCT00541658|10512923|P3|Overall Study|Withdrawal by Subject|32
3059342|NCT00541658|10512924|P2|Overall Study|Withdrawal by Subject|32
3059343|NCT00541658|10512925|P1|Overall Study|Withdrawal by Subject|28
3059344|NCT00541658|10512923|P3|Overall Study|Protocol Violation|1
3059345|NCT00541658|10512924|P2|Overall Study|Protocol Violation|1
3059346|NCT00541658|10512925|P1|Overall Study|Protocol Violation|0
3059347|NCT00541658|10512923|P3|Overall Study|Lost to Follow-up|6
3059348|NCT00541658|10512924|P2|Overall Study|Lost to Follow-up|3
3059349|NCT00541658|10512925|P1|Overall Study|Lost to Follow-up|3
3059350|NCT00541658|10512923|P3|Overall Study|Physician Decision|4
3059351|NCT00541658|10512924|P2|Overall Study|Physician Decision|0
3059352|NCT00541658|10512925|P1|Overall Study|Physician Decision|0
3059353|NCT00541658|10512923|P3|Overall Study|Adverse Event|25
3059354|NCT00541658|10512924|P2|Overall Study|Adverse Event|37
3059355|NCT00541658|10512925|P1|Overall Study|Adverse Event|28
3059356|NCT00541450|10513088|P2|Phase B|Withdrawal by Subject|6
3059357|NCT00541450|10513089|P1|Phase B|Withdrawal by Subject|8
3059358|NCT00541450|10513088|P2|Phase B|Protocol Violation|3
3059359|NCT00541450|10513089|P1|Phase B|Protocol Violation|3
3059360|NCT00541450|10513088|P2|Phase B|Pregnancy|1
3059361|NCT00541450|10513089|P1|Phase B|Pregnancy|0
3059362|NCT00541450|10513088|P2|Phase B|Physician Decision|2
3059363|NCT00541450|10513089|P1|Phase B|Physician Decision|4
3059364|NCT00541450|10513088|P2|Phase B|Lost to Follow-up|4
3059365|NCT00541450|10513089|P1|Phase B|Lost to Follow-up|6
3059366|NCT00541450|10513088|P2|Phase B|Hyperglycemia|9
3059367|NCT00541450|10513089|P1|Phase B|Hyperglycemia|10
3059368|NCT00541450|10513088|P2|Phase B|Adverse Event|6
3059369|NCT00541450|10513089|P1|Phase B|Adverse Event|6
3059370|NCT00541450|10513088|P2|Phase A|Withdrawal by Subject|7
3059371|NCT00541450|10513089|P1|Phase A|Withdrawal by Subject|7
3059372|NCT00541450|10513088|P2|Phase A|Protocol Violation|3
3059373|NCT00541450|10513089|P1|Phase A|Protocol Violation|2
3059374|NCT00541450|10513088|P2|Phase A|Physician Decision|0
3059375|NCT00541450|10513089|P1|Phase A|Physician Decision|2
3059376|NCT00541450|10513088|P2|Phase A|Lost to Follow-up|4
3059377|NCT00541450|10513089|P1|Phase A|Lost to Follow-up|6
3059378|NCT00541450|10513088|P2|Phase A|Hyperglycemia|1
3059379|NCT00541450|10513089|P1|Phase A|Hyperglycemia|0
3059380|NCT00541450|10513088|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
3059381|NCT00541450|10513089|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
3059382|NCT00541450|10513088|P2|Phase A|Adverse Event|0
3059383|NCT00541450|10513089|P1|Phase A|Adverse Event|3
3059384|NCT00541346|10513107|P1|Follow-up|Adverse Event|1
3059385|NCT00541307|10513121|P1|Overall Study|Surgical Bypass|5
3059386|NCT00541307|10513121|P1|Overall Study|Subject returned early (outside window)|1
3059387|NCT00541307|10513121|P1|Overall Study|Lost to Follow-up|4
3059388|NCT00541307|10513121|P1|Overall Study|Withdrawal by Subject|6
3059389|NCT00541307|10513121|P1|Overall Study|Physician Decision|3
3059390|NCT00541307|10513121|P1|Overall Study|Death|5
3059391|NCT00541229|10513146|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
3059392|NCT00541229|10513147|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
3059393|NCT00541229|10513148|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
3059394|NCT00541229|10513149|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
3059395|NCT00541229|10513150|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
3059396|NCT00541229|10513151|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
3059397|NCT00541229|10513146|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
3059398|NCT00541229|10513147|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
3059399|NCT00541229|10513148|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
3059400|NCT00541229|10513149|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
3059401|NCT00541229|10513150|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
3059402|NCT00541229|10513151|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
3059403|NCT00541229|10513146|P6|Treatment Period III (Week 11)|Adverse Event|0
3059404|NCT00541229|10513147|P5|Treatment Period III (Week 11)|Adverse Event|1
3059405|NCT00541229|10513148|P4|Treatment Period III (Week 11)|Adverse Event|0
3059406|NCT00541229|10513149|P3|Treatment Period III (Week 11)|Adverse Event|0
3059407|NCT00541229|10513150|P2|Treatment Period III (Week 11)|Adverse Event|0
3059408|NCT00541229|10513151|P1|Treatment Period III (Week 11)|Adverse Event|0
3059409|NCT00541229|10513146|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
3059410|NCT00541229|10513147|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
3059411|NCT00541229|10513148|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
3059412|NCT00541229|10513149|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
3059413|NCT00541229|10513150|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
3059414|NCT00541229|10513151|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
3059415|NCT00541229|10513146|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
3059416|NCT00541229|10513147|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
3059417|NCT00541229|10513148|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
3059418|NCT00541229|10513149|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
3059419|NCT00541229|10513150|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
3059420|NCT00541229|10513151|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
3059421|NCT00541229|10513146|P6|Washout Period II (Week 7-10)|Protocol Violation|0
3059422|NCT00541229|10513147|P5|Washout Period II (Week 7-10)|Protocol Violation|0
3059423|NCT00541229|10513148|P4|Washout Period II (Week 7-10)|Protocol Violation|0
3059424|NCT00541229|10513149|P3|Washout Period II (Week 7-10)|Protocol Violation|0
3059425|NCT00541229|10513150|P2|Washout Period II (Week 7-10)|Protocol Violation|0
3059426|NCT00541229|10513151|P1|Washout Period II (Week 7-10)|Protocol Violation|1
3059427|NCT00541229|10513146|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
3059428|NCT00541229|10513147|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
3059429|NCT00541229|10513148|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
3059430|NCT00541229|10513149|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
3059431|NCT00541229|10513150|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
3059432|NCT00541229|10513151|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
3059433|NCT00541229|10513146|P6|Treatment Period II (Week 6)|Protocol Violation|1
3059434|NCT00541229|10513147|P5|Treatment Period II (Week 6)|Protocol Violation|1
3059435|NCT00541229|10513148|P4|Treatment Period II (Week 6)|Protocol Violation|0
3059515|NCT00540592|10513254|P4|Overall Study|Lost to Follow-up|0
3059436|NCT00541229|10513149|P3|Treatment Period II (Week 6)|Protocol Violation|0
3059437|NCT00541229|10513150|P2|Treatment Period II (Week 6)|Protocol Violation|0
3059438|NCT00541229|10513151|P1|Treatment Period II (Week 6)|Protocol Violation|0
3059439|NCT00541229|10513146|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
3059440|NCT00541229|10513147|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
3059441|NCT00541229|10513148|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
3059442|NCT00541229|10513149|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
3059443|NCT00541229|10513150|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
3059444|NCT00541229|10513151|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
3059445|NCT00541229|10513146|P6|Washout Period I (Week 2-5)|Protocol Violation|1
3059446|NCT00541229|10513147|P5|Washout Period I (Week 2-5)|Protocol Violation|0
3059447|NCT00541229|10513148|P4|Washout Period I (Week 2-5)|Protocol Violation|0
3059448|NCT00541229|10513149|P3|Washout Period I (Week 2-5)|Protocol Violation|0
3059449|NCT00541229|10513150|P2|Washout Period I (Week 2-5)|Protocol Violation|0
3059450|NCT00541229|10513151|P1|Washout Period I (Week 2-5)|Protocol Violation|0
3059451|NCT00541229|10513146|P6|Washout Period I (Week 2-5)|Physician Decision|0
3059452|NCT00541229|10513147|P5|Washout Period I (Week 2-5)|Physician Decision|0
3059453|NCT00541229|10513148|P4|Washout Period I (Week 2-5)|Physician Decision|1
3059454|NCT00541229|10513149|P3|Washout Period I (Week 2-5)|Physician Decision|0
3059455|NCT00541229|10513150|P2|Washout Period I (Week 2-5)|Physician Decision|0
3059456|NCT00541229|10513151|P1|Washout Period I (Week 2-5)|Physician Decision|0
3059457|NCT00541229|10513146|P6|Washout Period I (Week 2-5)|Adverse Event|0
3059458|NCT00541229|10513147|P5|Washout Period I (Week 2-5)|Adverse Event|0
3059459|NCT00541229|10513148|P4|Washout Period I (Week 2-5)|Adverse Event|0
3059460|NCT00541229|10513149|P3|Washout Period I (Week 2-5)|Adverse Event|1
3059461|NCT00541229|10513150|P2|Washout Period I (Week 2-5)|Adverse Event|0
3059462|NCT00541229|10513151|P1|Washout Period I (Week 2-5)|Adverse Event|1
3059463|NCT00541229|10513146|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
3059464|NCT00541229|10513147|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
3059465|NCT00541229|10513148|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
3059466|NCT00541229|10513149|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
3059467|NCT00541229|10513150|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
3059468|NCT00541229|10513151|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
3059469|NCT00541229|10513146|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
3059470|NCT00541229|10513147|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
3059471|NCT00541229|10513148|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
3059472|NCT00541229|10513149|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
3059473|NCT00541229|10513150|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
3059474|NCT00541229|10513151|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
3059475|NCT00541229|10513146|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
3059476|NCT00541229|10513147|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
3059477|NCT00541229|10513148|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
3059478|NCT00541229|10513149|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
3059479|NCT00541229|10513150|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
3059480|NCT00541229|10513151|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
3059481|NCT00541229|10513146|P6|Treatment Period I (Week 1)|Physician Decision|0
3059482|NCT00541229|10513147|P5|Treatment Period I (Week 1)|Physician Decision|0
3059483|NCT00541229|10513148|P4|Treatment Period I (Week 1)|Physician Decision|0
3059484|NCT00541229|10513149|P3|Treatment Period I (Week 1)|Physician Decision|1
3059485|NCT00541229|10513150|P2|Treatment Period I (Week 1)|Physician Decision|0
3059486|NCT00541229|10513151|P1|Treatment Period I (Week 1)|Physician Decision|0
3059487|NCT00541099|10513170|P1|Overall Study|Ineligible|3
3059488|NCT00541034|10513178|P1|Overall Study|Non-Compliance|3
3059489|NCT00540644|10513227|P2|Overall Study|Noncomplilance|0
3059490|NCT00540644|10513228|P1|Overall Study|Noncomplilance|1
3059491|NCT00540644|10513227|P2|Overall Study|Withdrawal by Subject|2
3059492|NCT00540644|10513228|P1|Overall Study|Withdrawal by Subject|2
3059493|NCT00540644|10513227|P2|Overall Study|Physician Decision|5
3059494|NCT00540644|10513228|P1|Overall Study|Physician Decision|0
3059495|NCT00540644|10513227|P2|Overall Study|Disease Progression|1
3059496|NCT00540644|10513228|P1|Overall Study|Disease Progression|3
3059497|NCT00540644|10513227|P2|Overall Study|Adverse Event|1
3059498|NCT00540644|10513228|P1|Overall Study|Adverse Event|3
3059499|NCT00540592|10513248|P10|Overall Study|Withdrawal by Subject|0
3059500|NCT00540592|10513249|P9|Overall Study|Withdrawal by Subject|0
3059501|NCT00540592|10513250|P8|Overall Study|Withdrawal by Subject|0
3059502|NCT00540592|10513251|P7|Overall Study|Withdrawal by Subject|0
3059503|NCT00540592|10513252|P6|Overall Study|Withdrawal by Subject|0
3059504|NCT00540592|10513253|P5|Overall Study|Withdrawal by Subject|0
3059505|NCT00540592|10513254|P4|Overall Study|Withdrawal by Subject|1
3059506|NCT00540592|10513255|P3|Overall Study|Withdrawal by Subject|1
3059507|NCT00540592|10513256|P2|Overall Study|Withdrawal by Subject|0
3059508|NCT00540592|10513257|P1|Overall Study|Withdrawal by Subject|0
3059509|NCT00540592|10513248|P10|Overall Study|Lost to Follow-up|0
3059510|NCT00540592|10513249|P9|Overall Study|Lost to Follow-up|0
3059511|NCT00540592|10513250|P8|Overall Study|Lost to Follow-up|0
3059512|NCT00540592|10513251|P7|Overall Study|Lost to Follow-up|0
3059513|NCT00540592|10513252|P6|Overall Study|Lost to Follow-up|0
3059514|NCT00540592|10513253|P5|Overall Study|Lost to Follow-up|0
3059516|NCT00540592|10513255|P3|Overall Study|Lost to Follow-up|0
3059517|NCT00540592|10513256|P2|Overall Study|Lost to Follow-up|0
3059518|NCT00540592|10513257|P1|Overall Study|Lost to Follow-up|2
3059519|NCT00540592|10513248|P10|Overall Study|Adverse Event|2
3059520|NCT00540592|10513249|P9|Overall Study|Adverse Event|1
3059521|NCT00540592|10513250|P8|Overall Study|Adverse Event|1
3059522|NCT00540592|10513251|P7|Overall Study|Adverse Event|0
3059523|NCT00540592|10513252|P6|Overall Study|Adverse Event|0
3059524|NCT00540592|10513253|P5|Overall Study|Adverse Event|1
3059525|NCT00540592|10513254|P4|Overall Study|Adverse Event|0
3059526|NCT00540592|10513255|P3|Overall Study|Adverse Event|0
3059527|NCT00540592|10513256|P2|Overall Study|Adverse Event|1
3059528|NCT00540592|10513257|P1|Overall Study|Adverse Event|0
3059529|NCT00540514|10513496|P2|Overall Study|Paclitaxel not available|2
3059530|NCT00540514|10513497|P1|Overall Study|Paclitaxel not available|0
3059531|NCT00540514|10513496|P2|Overall Study|Excluded prior to treatment|7
3059532|NCT00540514|10513497|P1|Overall Study|Excluded prior to treatment|7
3059533|NCT00540514|10513496|P2|Overall Study|Withdrawal by Subject|67
3059534|NCT00540514|10513497|P1|Overall Study|Withdrawal by Subject|65
3059535|NCT00540514|10513496|P2|Overall Study|Lost to Follow-up|1
3059536|NCT00540514|10513497|P1|Overall Study|Lost to Follow-up|1
3059537|NCT00540514|10513496|P2|Overall Study|Protocol Deviation|4
3059538|NCT00540514|10513497|P1|Overall Study|Protocol Deviation|3
3059539|NCT00540514|10513496|P2|Overall Study|Physician Decision|99
3059540|NCT00540514|10513497|P1|Overall Study|Physician Decision|86
3059541|NCT00540514|10513496|P2|Overall Study|Adverse Event|24
3059542|NCT00540514|10513497|P1|Overall Study|Adverse Event|20
3059543|NCT00540514|10513496|P2|Overall Study|Unacceptable Toxicity|62
3059544|NCT00540514|10513497|P1|Overall Study|Unacceptable Toxicity|61
3059545|NCT00540514|10513496|P2|Overall Study|Still on treatment|0
3059546|NCT00540514|10513497|P1|Overall Study|Still on treatment|3
3059547|NCT00540449|10513529|P2|Overall Study|Other|4
3059548|NCT00540449|10513530|P1|Overall Study|Other|1
3059549|NCT00540449|10513529|P2|Overall Study|Withdrawal by Subject|10
3059550|NCT00540449|10513530|P1|Overall Study|Withdrawal by Subject|10
3059551|NCT00540449|10513529|P2|Overall Study|Subject Reached A Virologic Endpoint|8
3059552|NCT00540449|10513530|P1|Overall Study|Subject Reached A Virologic Endpoint|32
3059553|NCT00540449|10513529|P2|Overall Study|Subject Non-Compliant|5
3059554|NCT00540449|10513530|P1|Overall Study|Subject Non-Compliant|7
3059555|NCT00540449|10513529|P2|Overall Study|Lost to Follow-up|17
3059556|NCT00540449|10513530|P1|Overall Study|Lost to Follow-up|19
3059557|NCT00540449|10513529|P2|Overall Study|Subject Ineligible To Continue The Trial|1
3059558|NCT00540449|10513530|P1|Overall Study|Subject Ineligible To Continue The Trial|2
3059559|NCT00540449|10513529|P2|Overall Study|Sponsor's Decision|1
3059560|NCT00540449|10513530|P1|Overall Study|Sponsor's Decision|1
3059561|NCT00540449|10513529|P2|Overall Study|Adverse Event|32
3059562|NCT00540449|10513530|P1|Overall Study|Adverse Event|12
3059563|NCT00540436|10513552|P1|Second 12-Week Treatment Period|Adverse Event|1
3059564|NCT00540436|10513552|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
3059565|NCT00540436|10513552|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
3059566|NCT00540436|10513552|P1|First 12-Week Treatment Period|Adverse Event|1
3059567|NCT00540423|10513567|P3|Open-Label Treatment Period|Lack of Efficacy|2
3059568|NCT00540423|10513568|P2|Open-Label Treatment Period|Lack of Efficacy|0
3059569|NCT00540423|10513569|P1|Open-Label Treatment Period|Lack of Efficacy|0
3059570|NCT00540423|10513567|P3|Double-Blind Treatment Period|Adverse Event|0
3059571|NCT00540423|10513568|P2|Double-Blind Treatment Period|Adverse Event|1
3059572|NCT00540423|10513569|P1|Double-Blind Treatment Period|Adverse Event|0
3059573|NCT00540293|10513619|P1|Overall Study|Protocol violation, & subject schedule|12
3059574|NCT00540293|10513619|P1|Overall Study|Withdrawal by Subject|6
3059575|NCT00540293|10513619|P1|Overall Study|Adverse event not related to study drug|7
3059576|NCT00540293|10513619|P1|Overall Study|Adverse event related to study drug|10
3059577|NCT00540228|10513667|P5|Overall Study|Lost to Follow-up|0
3059578|NCT00540228|10513668|P4|Overall Study|Lost to Follow-up|0
3059579|NCT00540228|10513669|P3|Overall Study|Lost to Follow-up|0
3059580|NCT00540228|10513670|P2|Overall Study|Lost to Follow-up|1
3059581|NCT00540228|10513671|P1|Overall Study|Lost to Follow-up|1
3059582|NCT00540228|10513667|P5|Overall Study|Adverse Event|0
3059583|NCT00540228|10513668|P4|Overall Study|Adverse Event|0
3059584|NCT00540228|10513669|P3|Overall Study|Adverse Event|0
3059585|NCT00540228|10513670|P2|Overall Study|Adverse Event|0
3059586|NCT00540228|10513671|P1|Overall Study|Adverse Event|2
3059587|NCT00540124|10513741|P3|Overall Study|Withdrawal by Subject|0
3059588|NCT00540124|10513742|P2|Overall Study|Withdrawal by Subject|1
3059589|NCT00540124|10513743|P1|Overall Study|Withdrawal by Subject|1
3059590|NCT00540124|10513741|P3|Overall Study|Lack of Efficacy|0
3059591|NCT00540124|10513742|P2|Overall Study|Lack of Efficacy|0
3059592|NCT00540124|10513743|P1|Overall Study|Lack of Efficacy|1
3059593|NCT00540124|10513741|P3|Overall Study|Entry Criteria Not Met|0
3059594|NCT00540124|10513742|P2|Overall Study|Entry Criteria Not Met|0
3059595|NCT00540124|10513743|P1|Overall Study|Entry Criteria Not Met|2
3059596|NCT00540124|10513741|P3|Overall Study|Adverse Event|1
3059597|NCT00540124|10513742|P2|Overall Study|Adverse Event|2
3059598|NCT00540124|10513743|P1|Overall Study|Adverse Event|0
3059599|NCT00540046|10513789|P2|Overall Study|Lost to Follow-up|23
3059600|NCT00540046|10513790|P1|Overall Study|Lost to Follow-up|33
3059601|NCT00539994|10513826|P3|Overall Study|Physician Decision|1
3059602|NCT00539994|10513827|P2|Overall Study|Physician Decision|0
3059603|NCT00539994|10513828|P1|Overall Study|Physician Decision|0
3059604|NCT00539994|10513826|P3|Overall Study|Withdrawal by Subject|1
3059605|NCT00539994|10513827|P2|Overall Study|Withdrawal by Subject|0
3059606|NCT00539994|10513828|P1|Overall Study|Withdrawal by Subject|1
3059607|NCT00539994|10513826|P3|Overall Study|Lost to Follow-up|0
3059608|NCT00539994|10513827|P2|Overall Study|Lost to Follow-up|1
3059609|NCT00539994|10513828|P1|Overall Study|Lost to Follow-up|2
3059610|NCT00539864|10513878|P2|Overall Study|Withdrawal by Subject|1
3059611|NCT00539864|10513879|P1|Overall Study|Withdrawal by Subject|1
3059612|NCT00539864|10513878|P2|Overall Study|Lost to Follow-up|1
3059613|NCT00539864|10513879|P1|Overall Study|Lost to Follow-up|0
3059614|NCT00539734|10513891|P1|Overall Study|Protocol Violation|1
3059615|NCT00539591|10513917|P3|Overall Study|Disease progression|3
3059616|NCT00539591|10513918|P2|Overall Study|Disease progression|2
3059617|NCT00539591|10513919|P1|Overall Study|Disease progression|2
3059618|NCT00539591|10513917|P3|Overall Study|Toxicity|0
3059619|NCT00539591|10513918|P2|Overall Study|Toxicity|0
3059620|NCT00539591|10513919|P1|Overall Study|Toxicity|3
3059621|NCT00539513|10514071|P2|Overall Study|Lost to Follow-up|1
3059622|NCT00539513|10514072|P1|Overall Study|Lost to Follow-up|0
3059623|NCT00539513|10514071|P2|Overall Study|Withdrawal by Subject|1
3059624|NCT00539513|10514072|P1|Overall Study|Withdrawal by Subject|2
3059625|NCT00539500|10514084|P1|Overall Study|Lost to Follow-up|2
3059626|NCT00539500|10514084|P1|Overall Study|Disease Progression|1
3059627|NCT00539305|10514092|P2|Overall Study|Withdrawal by Subject|1
3059628|NCT00539305|10514093|P1|Overall Study|Withdrawal by Subject|0
3059629|NCT00539305|10514092|P2|Overall Study|Substance Use|1
3059630|NCT00539305|10514093|P1|Overall Study|Substance Use|0
3059631|NCT00539305|10514092|P2|Overall Study|Adverse Event|0
3059632|NCT00539305|10514093|P1|Overall Study|Adverse Event|1
3059633|NCT00539279|10514107|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
3059634|NCT00539279|10514108|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
3059635|NCT00539279|10514107|P2|Post-Treatment Assessment|Lost to Follow-up|9
3059636|NCT00539279|10514108|P1|Post-Treatment Assessment|Lost to Follow-up|12
3059637|NCT00539279|10514107|P2|Treatment|Death|0
3059638|NCT00539279|10514108|P1|Treatment|Death|1
3059639|NCT00539279|10514107|P2|Treatment|Withdrawal by Subject|8
3059640|NCT00539279|10514108|P1|Treatment|Withdrawal by Subject|10
3059641|NCT00539240|10514134|P3|Overall Study|Adverse Event|10
3059642|NCT00539240|10514135|P2|Overall Study|Adverse Event|1
3059643|NCT00539240|10514136|P1|Overall Study|Adverse Event|3
3059644|NCT00539240|10514134|P3|Overall Study|Lost to Follow-up|1
3059645|NCT00539240|10514135|P2|Overall Study|Lost to Follow-up|3
3059646|NCT00539240|10514136|P1|Overall Study|Lost to Follow-up|2
3059647|NCT00539240|10514134|P3|Overall Study|Protocol Violation|4
3059648|NCT00539240|10514135|P2|Overall Study|Protocol Violation|1
3059649|NCT00539240|10514136|P1|Overall Study|Protocol Violation|1
3059650|NCT00539240|10514134|P3|Overall Study|Withdrawal by Subject|0
3059651|NCT00539240|10514135|P2|Overall Study|Withdrawal by Subject|2
3059652|NCT00539240|10514136|P1|Overall Study|Withdrawal by Subject|0
3059653|NCT00539188|10514155|P2|Overall Study|Lost to Follow-up|1
3059654|NCT00539188|10514156|P1|Overall Study|Lost to Follow-up|2
3059655|NCT00539188|10514155|P2|Overall Study|Withdrawal by Subject|0
3059656|NCT00539188|10514156|P1|Overall Study|Withdrawal by Subject|1
3059657|NCT00539032|10514179|P2|Overall Study|Withdrawal by Subject|1
3059658|NCT00539032|10514180|P1|Overall Study|Withdrawal by Subject|2
3059659|NCT00539006|10514194|P4|Treatment Period 2|Other|0
3059660|NCT00539006|10514195|P3|Treatment Period 2|Other|0
3059661|NCT00539006|10514196|P2|Treatment Period 2|Other|1
3059662|NCT00539006|10514197|P1|Treatment Period 2|Other|0
3059663|NCT00539006|10514194|P4|Treatment Period 2|Protocol Violation|0
3059664|NCT00539006|10514195|P3|Treatment Period 2|Protocol Violation|0
3059665|NCT00539006|10514196|P2|Treatment Period 2|Protocol Violation|0
3059666|NCT00539006|10514197|P1|Treatment Period 2|Protocol Violation|1
3059667|NCT00539006|10514194|P4|Washout|Other|3
3059668|NCT00539006|10514195|P3|Washout|Other|2
3059669|NCT00539006|10514196|P2|Washout|Other|1
3059670|NCT00539006|10514197|P1|Washout|Other|1
3059671|NCT00539006|10514194|P4|Washout|Failed to meet continuation criteria|6
3059672|NCT00539006|10514195|P3|Washout|Failed to meet continuation criteria|14
3059673|NCT00539006|10514196|P2|Washout|Failed to meet continuation criteria|5
3059674|NCT00539006|10514197|P1|Washout|Failed to meet continuation criteria|16
3059675|NCT00539006|10514194|P4|Washout|Withdrawal by Subject|0
3059676|NCT00539006|10514195|P3|Washout|Withdrawal by Subject|0
3059677|NCT00539006|10514196|P2|Washout|Withdrawal by Subject|2
3059678|NCT00539006|10514197|P1|Washout|Withdrawal by Subject|0
3059679|NCT00539006|10514194|P4|Washout|Protocol Violation|0
3059680|NCT00539006|10514195|P3|Washout|Protocol Violation|0
3059681|NCT00539006|10514196|P2|Washout|Protocol Violation|1
3059682|NCT00539006|10514197|P1|Washout|Protocol Violation|1
3059683|NCT00539006|10514194|P4|Washout|Adverse Event|0
3059684|NCT00539006|10514195|P3|Washout|Adverse Event|0
3059685|NCT00539006|10514196|P2|Washout|Adverse Event|1
3059686|NCT00539006|10514197|P1|Washout|Adverse Event|2
3059687|NCT00539006|10514194|P4|Treatment Period 1|Lack of Efficacy|1
3059688|NCT00539006|10514195|P3|Treatment Period 1|Lack of Efficacy|0
3059689|NCT00539006|10514196|P2|Treatment Period 1|Lack of Efficacy|0
3059690|NCT00539006|10514197|P1|Treatment Period 1|Lack of Efficacy|0
3059691|NCT00539006|10514194|P4|Treatment Period 1|Protocol Violation|0
3059692|NCT00539006|10514195|P3|Treatment Period 1|Protocol Violation|1
3059693|NCT00539006|10514196|P2|Treatment Period 1|Protocol Violation|0
3059694|NCT00539006|10514197|P1|Treatment Period 1|Protocol Violation|0
3059695|NCT00539006|10514194|P4|Treatment Period 1|Lost to Follow-up|0
3059696|NCT00539006|10514195|P3|Treatment Period 1|Lost to Follow-up|1
3059697|NCT00539006|10514196|P2|Treatment Period 1|Lost to Follow-up|0
3059698|NCT00539006|10514197|P1|Treatment Period 1|Lost to Follow-up|0
3059699|NCT00539006|10514194|P4|Pre-treatment|Other|0
3059700|NCT00539006|10514195|P3|Pre-treatment|Other|0
3059701|NCT00539006|10514196|P2|Pre-treatment|Other|1
3059702|NCT00539006|10514197|P1|Pre-treatment|Other|0
3059703|NCT00538902|10514242|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
3059704|NCT00538902|10514243|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
3059705|NCT00538902|10514244|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
3059706|NCT00538902|10514242|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
3059707|NCT00538902|10514243|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
3059708|NCT00538902|10514244|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
3059709|NCT00538902|10514242|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
3059710|NCT00538902|10514243|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
3059711|NCT00538902|10514244|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
3059712|NCT00538902|10514242|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
3059713|NCT00538902|10514243|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
3059714|NCT00538902|10514244|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
3059715|NCT00538902|10514242|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
3059716|NCT00538902|10514243|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
3059717|NCT00538902|10514244|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
3059718|NCT00538902|10514242|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
3059719|NCT00538902|10514243|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
3059720|NCT00538902|10514244|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
3059721|NCT00538902|10514242|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
3059722|NCT00538902|10514243|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
3059723|NCT00538902|10514244|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
3059724|NCT00538902|10514242|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
3059725|NCT00538902|10514243|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
3059726|NCT00538902|10514244|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
3059727|NCT00538785|10514305|P2|Overall Study|Lost to Follow-up|0
3059728|NCT00538785|10514306|P1|Overall Study|Lost to Follow-up|1
3059729|NCT00538785|10514305|P2|Overall Study|Withdrawal of consent|7
3059730|NCT00538785|10514306|P1|Overall Study|Withdrawal of consent|9
3059731|NCT00538785|10514305|P2|Overall Study|Death|10
3059732|NCT00538785|10514306|P1|Overall Study|Death|9
3059733|NCT00538733|10514348|P1|Overall Study|still on therapy|1
3059734|NCT00538733|10514348|P1|Overall Study|declined to participate|2
3059735|NCT00538733|10514348|P1|Overall Study|Death|1
3059736|NCT00538733|10514348|P1|Overall Study|Adverse Event|8
3059737|NCT00538629|10514398|P1|Overall Study|Subject's untimely distrust of medicine|1
3059738|NCT00538629|10514398|P1|Overall Study|Lost to Follow-up|6
3059739|NCT00538629|10514398|P1|Overall Study|Lack of Efficacy|12
3059740|NCT00538629|10514398|P1|Overall Study|Adverse Event|2
3059741|NCT00538629|10514398|P1|Overall Study|At subject's request|1
3059742|NCT00538590|10514454|P2|Overall Study|Death|0
3059743|NCT00538590|10514455|P1|Overall Study|Death|1
3059744|NCT00538473|10514493|P2|Overall Study|Adverse Event|0
3059745|NCT00538473|10514494|P1|Overall Study|Adverse Event|1
3059746|NCT00538291|10514574|P1|Overall Study|Withdrawal by Subject|1
3059747|NCT00538291|10514574|P1|Overall Study|Adverse Event|2
3059748|NCT00537979|10514632|P2|Overall Study|Heart failure|1
3059749|NCT00537979|10514633|P1|Overall Study|Heart failure|0
3059750|NCT00537979|10514632|P2|Overall Study|Kidney transplant|3
3059751|NCT00537979|10514633|P1|Overall Study|Kidney transplant|0
3059752|NCT00537979|10514632|P2|Overall Study|Death|3
3059753|NCT00537979|10514633|P1|Overall Study|Death|0
3059754|NCT00537979|10514632|P2|Overall Study|Non-compliance with treatment/procedure|2
3059755|NCT00537979|10514633|P1|Overall Study|Non-compliance with treatment/procedure|2
3059756|NCT00537979|10514632|P2|Overall Study|Lack of Efficacy|1
3059757|NCT00537979|10514633|P1|Overall Study|Lack of Efficacy|0
3059758|NCT00537979|10514632|P2|Overall Study|Lost to Follow-up|4
3059759|NCT00537979|10514633|P1|Overall Study|Lost to Follow-up|1
3059760|NCT00537979|10514632|P2|Overall Study|Withdrawal by Subject|4
3059761|NCT00537979|10514633|P1|Overall Study|Withdrawal by Subject|1
3059762|NCT00537979|10514632|P2|Overall Study|Adverse Event|2
3059763|NCT00537979|10514633|P1|Overall Study|Adverse Event|2
3059764|NCT00537940|10514649|P2|Overall Study|Other|12
3059765|NCT00537940|10514650|P1|Overall Study|Other|10
3059766|NCT00537940|10514649|P2|Overall Study|Study terminated by sponsor|3
3059767|NCT00537940|10514650|P1|Overall Study|Study terminated by sponsor|2
3059768|NCT00537940|10514649|P2|Overall Study|Pregnancy|1
3059769|NCT00537940|10514650|P1|Overall Study|Pregnancy|1
3059770|NCT00537940|10514649|P2|Overall Study|Protocol Violation|4
3059771|NCT00537940|10514650|P1|Overall Study|Protocol Violation|6
3059772|NCT00537940|10514649|P2|Overall Study|Withdrawal by Subject|95
3059773|NCT00537940|10514650|P1|Overall Study|Withdrawal by Subject|113
3059774|NCT00537940|10514649|P2|Overall Study|Lost to Follow-up|29
3059775|NCT00537940|10514650|P1|Overall Study|Lost to Follow-up|23
3059776|NCT00537940|10514649|P2|Overall Study|Lack of Efficacy|16
3059777|NCT00537940|10514650|P1|Overall Study|Lack of Efficacy|8
3059778|NCT00537940|10514649|P2|Overall Study|Adverse Event|19
3059779|NCT00537940|10514650|P1|Overall Study|Adverse Event|20
3059780|NCT00537823|10514674|P2|Overall Study|Adverse Event|0
3059781|NCT00537823|10514675|P1|Overall Study|Adverse Event|2
3059782|NCT00537810|10514701|P4|Overall Study|Medically withdrawn|1
3059783|NCT00537810|10514702|P3|Overall Study|Medically withdrawn|0
3059784|NCT00537810|10514703|P2|Overall Study|Medically withdrawn|2
3059785|NCT00537810|10514704|P1|Overall Study|Medically withdrawn|2
3059786|NCT00537810|10514701|P4|Overall Study|Withdrawal by Subject|3
3059787|NCT00537810|10514702|P3|Overall Study|Withdrawal by Subject|4
3059788|NCT00537810|10514703|P2|Overall Study|Withdrawal by Subject|11
3059789|NCT00537810|10514704|P1|Overall Study|Withdrawal by Subject|4
3059790|NCT00537771|10514720|P2|Overall Study|Severe Non-Compliance to Protocol|2
3059791|NCT00537771|10514721|P1|Overall Study|Severe Non-Compliance to Protocol|4
3059792|NCT00537771|10514720|P2|Overall Study|Protocol Violation|6
3059793|NCT00537771|10514721|P1|Overall Study|Protocol Violation|2
3059794|NCT00537771|10514720|P2|Overall Study|Lost to Follow-up|15
3059795|NCT00537771|10514721|P1|Overall Study|Lost to Follow-up|9
3059796|NCT00537771|10514720|P2|Overall Study|Adverse Event|15
3059797|NCT00537771|10514721|P1|Overall Study|Adverse Event|8
3059798|NCT00537771|10514720|P2|Overall Study|Withdrawal by Subject|23
3059799|NCT00537771|10514721|P1|Overall Study|Withdrawal by Subject|6
3059800|NCT00537745|10514731|P1|Overall Study|Subject unable to provide Interlock info|1
3059801|NCT00537745|10514731|P1|Overall Study|Withdrawal by Subject|2
3059802|NCT00537745|10514731|P1|Overall Study|Did not meet eligibility criteria|2
3059803|NCT00537485|10514776|P2|Overall Study|Physician Decision|0
3059804|NCT00537485|10514777|P1|Overall Study|Physician Decision|1
3059805|NCT00537485|10514776|P2|Overall Study|Withdrawal by Subject|3
3059806|NCT00537485|10514777|P1|Overall Study|Withdrawal by Subject|1
3059807|NCT00537485|10514776|P2|Overall Study|Withdrawal by Subject|2
3059808|NCT00537485|10514777|P1|Overall Study|Withdrawal by Subject|3
3059809|NCT00537485|10514776|P2|Overall Study|Adverse Event|5
3059810|NCT00537485|10514777|P1|Overall Study|Adverse Event|10
3059811|NCT00537394|10514850|P3|2nd Year of Follow-up|Clinic site closure|0
3059812|NCT00537394|10514851|P2|2nd Year of Follow-up|Clinic site closure|0
3059813|NCT00537394|10514852|P1|2nd Year of Follow-up|Clinic site closure|1
3059814|NCT00537394|10514850|P3|2nd Year of Follow-up|Lost to Follow-up|2
3059815|NCT00537394|10514851|P2|2nd Year of Follow-up|Lost to Follow-up|7
3059816|NCT00537394|10514852|P1|2nd Year of Follow-up|Lost to Follow-up|6
3059817|NCT00537394|10514850|P3|2nd Year of Follow-up|Withdrawal by Subject|2
3059818|NCT00537394|10514851|P2|2nd Year of Follow-up|Withdrawal by Subject|1
3059819|NCT00537394|10514852|P1|2nd Year of Follow-up|Withdrawal by Subject|0
3059820|NCT00537394|10514850|P3|2nd Year of Follow-up|Death|2
3059821|NCT00537394|10514851|P2|2nd Year of Follow-up|Death|1
3059822|NCT00537394|10514852|P1|2nd Year of Follow-up|Death|4
3059823|NCT00537394|10514850|P3|First Year of Follow-up|Lost to Follow-up|1
3059824|NCT00537394|10514851|P2|First Year of Follow-up|Lost to Follow-up|5
3059825|NCT00537394|10514852|P1|First Year of Follow-up|Lost to Follow-up|1
3059826|NCT00537394|10514850|P3|First Year of Follow-up|Withdrawal by Subject|1
3059827|NCT00537394|10514851|P2|First Year of Follow-up|Withdrawal by Subject|6
3059828|NCT00537394|10514852|P1|First Year of Follow-up|Withdrawal by Subject|3
3059829|NCT00537394|10514850|P3|First Year of Follow-up|Severe debilitation|1
3059830|NCT00537394|10514851|P2|First Year of Follow-up|Severe debilitation|0
3059831|NCT00537394|10514852|P1|First Year of Follow-up|Severe debilitation|1
3059832|NCT00537394|10514850|P3|First Year of Follow-up|Death|0
3059833|NCT00537394|10514851|P2|First Year of Follow-up|Death|0
3059834|NCT00537394|10514852|P1|First Year of Follow-up|Death|7
3059835|NCT00537381|10514888|P2|Overall Study|Other|3
3059836|NCT00537381|10514889|P1|Overall Study|Other|5
3059837|NCT00537381|10514888|P2|Overall Study|Sponsor decision|9
3059838|NCT00537381|10514889|P1|Overall Study|Sponsor decision|14
3059839|NCT00537381|10514888|P2|Overall Study|Disease Progression|18
3059840|NCT00537381|10514889|P1|Overall Study|Disease Progression|9
3059841|NCT00537381|10514888|P2|Overall Study|Physician Decision|6
3059842|NCT00537381|10514889|P1|Overall Study|Physician Decision|7
3059843|NCT00537381|10514888|P2|Overall Study|Withdrawal by Subject|14
3059844|NCT00537381|10514889|P1|Overall Study|Withdrawal by Subject|5
3059845|NCT00537381|10514888|P2|Overall Study|Death|3
3059846|NCT00537381|10514889|P1|Overall Study|Death|3
3059847|NCT00537381|10514888|P2|Overall Study|Adverse Event|9
3059848|NCT00537381|10514889|P1|Overall Study|Adverse Event|13
3059849|NCT00537329|10514909|P1|Overall Study|Other|1
3059850|NCT00537329|10514909|P1|Overall Study|Withdrawal by Subject|4
3059851|NCT00537329|10514909|P1|Overall Study|Lost to Follow-up|6
3059852|NCT00537329|10514909|P1|Overall Study|Lack of Efficacy|2
3059853|NCT00537329|10514909|P1|Overall Study|Adverse Event|3
3059854|NCT00537329|10514909|P1|Overall Study|Death|10
3059855|NCT00537316|10514929|P7|Part 2|Administrative|1
3059856|NCT00537316|10514930|P6|Part 2|Administrative|4
3059857|NCT00537316|10514931|P5|Part 2|Administrative|1
3059858|NCT00537316|10514932|P4|Part 2|Administrative|3
3059859|NCT00537316|10514933|P3|Part 2|Administrative|24
3059860|NCT00537316|10514934|P2|Part 2|Administrative|8
3059861|NCT00537316|10514935|P1|Part 2|Administrative|16
3059862|NCT00537316|10514929|P7|Part 2|Withdrawal by Subject|0
3059863|NCT00537316|10514930|P6|Part 2|Withdrawal by Subject|0
3059864|NCT00537316|10514931|P5|Part 2|Withdrawal by Subject|0
3059865|NCT00537316|10514932|P4|Part 2|Withdrawal by Subject|0
3059866|NCT00537316|10514933|P3|Part 2|Withdrawal by Subject|4
3059867|NCT00537316|10514934|P2|Part 2|Withdrawal by Subject|1
3059868|NCT00537316|10514935|P1|Part 2|Withdrawal by Subject|5
3059869|NCT00537316|10514929|P7|Part 2|Lost to Follow-up|0
3059870|NCT00537316|10514930|P6|Part 2|Lost to Follow-up|0
3059871|NCT00537316|10514931|P5|Part 2|Lost to Follow-up|0
3059872|NCT00537316|10514932|P4|Part 2|Lost to Follow-up|0
3059873|NCT00537316|10514933|P3|Part 2|Lost to Follow-up|2
3059874|NCT00537316|10514934|P2|Part 2|Lost to Follow-up|0
3059875|NCT00537316|10514935|P1|Part 2|Lost to Follow-up|1
3059876|NCT00537316|10514929|P7|Part 2|Adverse Event|0
3059877|NCT00537316|10514930|P6|Part 2|Adverse Event|0
3059878|NCT00537316|10514931|P5|Part 2|Adverse Event|0
3059879|NCT00537316|10514932|P4|Part 2|Adverse Event|0
3059880|NCT00537316|10514933|P3|Part 2|Adverse Event|2
3059881|NCT00537316|10514934|P2|Part 2|Adverse Event|0
3059882|NCT00537316|10514935|P1|Part 2|Adverse Event|4
3059883|NCT00537316|10514929|P7|Part 2|Never entered follow-up|1
3059884|NCT00537316|10514930|P6|Part 2|Never entered follow-up|0
3059885|NCT00537316|10514931|P5|Part 2|Never entered follow-up|0
3059886|NCT00537316|10514932|P4|Part 2|Never entered follow-up|0
3059887|NCT00537316|10514933|P3|Part 2|Never entered follow-up|0
3059888|NCT00537316|10514934|P2|Part 2|Never entered follow-up|0
3059889|NCT00537316|10514935|P1|Part 2|Never entered follow-up|0
3059890|NCT00537316|10514929|P7|Part 1|Administrative|0
3059891|NCT00537316|10514930|P6|Part 1|Administrative|0
3059892|NCT00537316|10514931|P5|Part 1|Administrative|0
3059893|NCT00537316|10514932|P4|Part 1|Administrative|0
3059894|NCT00537316|10514933|P3|Part 1|Administrative|2
3059895|NCT00537316|10514934|P2|Part 1|Administrative|0
3059896|NCT00537316|10514935|P1|Part 1|Administrative|0
3059897|NCT00537316|10514929|P7|Part 1|Did not meet protocol eligibility|0
3059898|NCT00537316|10514930|P6|Part 1|Did not meet protocol eligibility|0
3059899|NCT00537316|10514931|P5|Part 1|Did not meet protocol eligibility|0
3059900|NCT00537316|10514932|P4|Part 1|Did not meet protocol eligibility|0
3059901|NCT00537316|10514933|P3|Part 1|Did not meet protocol eligibility|2
3059902|NCT00537316|10514934|P2|Part 1|Did not meet protocol eligibility|3
3059903|NCT00537316|10514935|P1|Part 1|Did not meet protocol eligibility|1
3059904|NCT00537316|10514929|P7|Part 1|Protocol Violation|0
3059905|NCT00537316|10514930|P6|Part 1|Protocol Violation|0
3059906|NCT00537316|10514931|P5|Part 1|Protocol Violation|0
3059907|NCT00537316|10514932|P4|Part 1|Protocol Violation|0
3059908|NCT00537316|10514933|P3|Part 1|Protocol Violation|1
3059909|NCT00537316|10514934|P2|Part 1|Protocol Violation|5
3059910|NCT00537316|10514935|P1|Part 1|Protocol Violation|1
3059911|NCT00537316|10514929|P7|Part 1|Withdrawal by Subject|0
3059912|NCT00537316|10514930|P6|Part 1|Withdrawal by Subject|0
3059913|NCT00537316|10514931|P5|Part 1|Withdrawal by Subject|0
3059914|NCT00537316|10514932|P4|Part 1|Withdrawal by Subject|0
3059915|NCT00537316|10514933|P3|Part 1|Withdrawal by Subject|4
3059916|NCT00537316|10514934|P2|Part 1|Withdrawal by Subject|8
3059917|NCT00537316|10514935|P1|Part 1|Withdrawal by Subject|3
3059918|NCT00537316|10514929|P7|Part 1|Lost to Follow-up|0
3059919|NCT00537316|10514930|P6|Part 1|Lost to Follow-up|0
3059920|NCT00537316|10514931|P5|Part 1|Lost to Follow-up|0
3059921|NCT00537316|10514932|P4|Part 1|Lost to Follow-up|0
3059922|NCT00537316|10514933|P3|Part 1|Lost to Follow-up|0
3059923|NCT00537316|10514934|P2|Part 1|Lost to Follow-up|0
3059924|NCT00537316|10514935|P1|Part 1|Lost to Follow-up|1
3059925|NCT00537316|10514929|P7|Part 1|Protocol defined clinical event|0
3059926|NCT00537316|10514930|P6|Part 1|Protocol defined clinical event|0
3059927|NCT00537316|10514931|P5|Part 1|Protocol defined clinical event|0
3059928|NCT00537316|10514932|P4|Part 1|Protocol defined clinical event|0
3059929|NCT00537316|10514933|P3|Part 1|Protocol defined clinical event|0
3059930|NCT00537316|10514934|P2|Part 1|Protocol defined clinical event|0
3059931|NCT00537316|10514935|P1|Part 1|Protocol defined clinical event|1
3059932|NCT00537316|10514929|P7|Part 1|Adverse Event|0
3059933|NCT00537316|10514930|P6|Part 1|Adverse Event|0
3059934|NCT00537316|10514931|P5|Part 1|Adverse Event|0
3059935|NCT00537316|10514932|P4|Part 1|Adverse Event|0
3059936|NCT00537316|10514933|P3|Part 1|Adverse Event|8
3059937|NCT00537316|10514934|P2|Part 1|Adverse Event|11
3059938|NCT00537316|10514935|P1|Part 1|Adverse Event|7
3059939|NCT00537303|10514962|P2|Overall Study|Unclassified|7
3059940|NCT00537303|10514963|P1|Overall Study|Unclassified|8
3059941|NCT00537303|10514962|P2|Overall Study|Withdrawal criteria|3
3059942|NCT00537303|10514963|P1|Overall Study|Withdrawal criteria|3
3059943|NCT00537303|10514962|P2|Overall Study|Protocol Violation|4
3059944|NCT00537303|10514963|P1|Overall Study|Protocol Violation|8
3059945|NCT00537303|10514962|P2|Overall Study|Lack of Efficacy|7
3059946|NCT00537303|10514963|P1|Overall Study|Lack of Efficacy|6
3059947|NCT00537303|10514962|P2|Overall Study|Adverse Event|4
3059948|NCT00537303|10514963|P1|Overall Study|Adverse Event|1
3059949|NCT00537277|10514984|P1|Overall Study|Non-compliance with trial procedures|15
3059950|NCT00537277|10514984|P1|Overall Study|Inability to tolerate trial medication|4
3059951|NCT00537277|10514984|P1|Overall Study|Unclassified|4
3059952|NCT00537277|10514984|P1|Overall Study|Protocol Violation|11
3059953|NCT00537277|10514984|P1|Overall Study|Lost to Follow-up|12
3059954|NCT00537277|10514984|P1|Overall Study|Lack of Efficacy|2
3059955|NCT00537277|10514984|P1|Overall Study|Adverse Event|1
3059956|NCT00537238|10514995|P2|Overall Study|Other|52
3059957|NCT00537238|10514996|P1|Overall Study|Other|44
3059958|NCT00537238|10514995|P2|Overall Study|Does not meet entrance criteria|2
3059959|NCT00537238|10514996|P1|Overall Study|Does not meet entrance criteria|0
3059960|NCT00537238|10514995|P2|Overall Study|Protocol Violation|19
3059961|NCT00537238|10514996|P1|Overall Study|Protocol Violation|15
3059962|NCT00537238|10514995|P2|Overall Study|Withdrawal by Subject|47
3059963|NCT00537238|10514996|P1|Overall Study|Withdrawal by Subject|51
3059964|NCT00537238|10514995|P2|Overall Study|Lost to Follow-up|8
3059965|NCT00537238|10514996|P1|Overall Study|Lost to Follow-up|12
3059966|NCT00537238|10514995|P2|Overall Study|Lack of Efficacy|21
3059967|NCT00537238|10514996|P1|Overall Study|Lack of Efficacy|20
3059968|NCT00537238|10514995|P2|Overall Study|Adverse Event|22
3059969|NCT00537238|10514996|P1|Overall Study|Adverse Event|31
3059970|NCT00537238|10514995|P2|Overall Study|Death|2
3059971|NCT00537238|10514996|P1|Overall Study|Death|1
3059972|NCT00537199|10515016|P1|Overall Study|Study Terminated|1
3059973|NCT00537095|10515022|P2|Overall Study|Incorrect enrolment|1
3059974|NCT00537095|10515023|P1|Overall Study|Incorrect enrolment|0
3059975|NCT00537095|10515022|P2|Overall Study|subjective disease progression|1
3059976|NCT00537095|10515023|P1|Overall Study|subjective disease progression|0
3059977|NCT00537095|10515022|P2|Overall Study|Withdrawal by Subject|2
3059978|NCT00537095|10515023|P1|Overall Study|Withdrawal by Subject|2
3059979|NCT00537095|10515022|P2|Overall Study|Death|1
3059980|NCT00537095|10515023|P1|Overall Study|Death|3
3059981|NCT00537095|10515022|P2|Overall Study|disease progression|48
3059982|NCT00537095|10515023|P1|Overall Study|disease progression|21
3059983|NCT00537095|10515022|P2|Overall Study|Adverse Event|4
3059984|NCT00537095|10515023|P1|Overall Study|Adverse Event|24
3059985|NCT00537095|10515022|P2|Overall Study|surgery|0
3059986|NCT00537095|10515023|P1|Overall Study|surgery|1
3059987|NCT00537082|10515038|P3|Overall Study|Discontinued before initiating treatment|0
3059988|NCT00537082|10515039|P2|Overall Study|Discontinued before initiating treatment|0
3059989|NCT00537082|10515040|P1|Overall Study|Discontinued before initiating treatment|3
3059990|NCT00537082|10515038|P3|Overall Study|Withdrawal by Subject|0
3059991|NCT00537082|10515039|P2|Overall Study|Withdrawal by Subject|1
3059992|NCT00537082|10515040|P1|Overall Study|Withdrawal by Subject|0
3059993|NCT00537082|10515038|P3|Overall Study|Lack of Efficacy|2
3059994|NCT00537082|10515039|P2|Overall Study|Lack of Efficacy|0
3059995|NCT00537082|10515040|P1|Overall Study|Lack of Efficacy|0
3059996|NCT00537082|10515038|P3|Overall Study|Protocol Violation|1
3059997|NCT00537082|10515039|P2|Overall Study|Protocol Violation|2
3059998|NCT00537082|10515040|P1|Overall Study|Protocol Violation|0
3059999|NCT00537082|10515038|P3|Overall Study|Adverse Event|3
3060000|NCT00537082|10515039|P2|Overall Study|Adverse Event|6
3060001|NCT00537082|10515040|P1|Overall Study|Adverse Event|6
3060002|NCT00537056|10515057|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
3060003|NCT00537030|10515069|P1|Overall Study|Inevaluable|2
3060004|NCT00537030|10515069|P1|Overall Study|Ineligible|2
3060005|NCT00537030|10515069|P1|Overall Study|Disease progression/ relapse during Tx|1
3060006|NCT00537030|10515069|P1|Overall Study|≥ Grade 2 allergy|7
3060007|NCT00537030|10515069|P1|Overall Study|Withdrawal by Subject|2
3060008|NCT00537030|10515069|P1|Overall Study|Physician Decision|2
3060009|NCT00537017|10515076|P1|Follow-up Phase|Withdrawal by Subject|9
3060010|NCT00537017|10515076|P1|Treatment Phase|Protocol Violation|2
3060011|NCT00537017|10515076|P1|Treatment Phase|Withdrawal by Subject|13
3060012|NCT00537017|10515076|P1|Treatment Phase|Adverse Event|19
3060013|NCT00536991|10515087|P1|Overall Study|patient ineligible|2
3060014|NCT00536991|10515087|P1|Overall Study|Physician Decision|1
3060015|NCT00536991|10515087|P1|Overall Study|Withdrawal by Subject|10
3060016|NCT00536978|10515094|P1|Overall Study|Not eligible for Adback Infusion|22
3060017|NCT00536874|10515123|P1|Overall Study|Withdrawal by Subject|1
3060018|NCT00536874|10515123|P1|Overall Study|Death|2
3060019|NCT00536874|10515123|P1|Overall Study|Adverse Event|1
3060020|NCT00536809|10515133|P1|Phase II|Referred for surgical resection|1
3060021|NCT00536809|10515133|P1|Phase II|Adverse Event|1
3060022|NCT00536744|10515156|P2|Overall Study|PI tried alternative treatment|3
3060023|NCT00536744|10515157|P1|Overall Study|PI tried alternative treatment|1
3060024|NCT00536744|10515156|P2|Overall Study|Withdrawal by Subject|8
3060025|NCT00536744|10515157|P1|Overall Study|Withdrawal by Subject|7
3060026|NCT00536744|10515156|P2|Overall Study|Lost to Follow-up|5
3060027|NCT00536744|10515157|P1|Overall Study|Lost to Follow-up|3
3060028|NCT00536744|10515156|P2|Overall Study|Physician Decision|1
3060029|NCT00536744|10515157|P1|Overall Study|Physician Decision|3
3060030|NCT00536744|10515156|P2|Overall Study|Death|1
3060031|NCT00536744|10515157|P1|Overall Study|Death|2
3060032|NCT00536744|10515156|P2|Overall Study|Adverse Event|10
3060033|NCT00536744|10515157|P1|Overall Study|Adverse Event|13
3060034|NCT00536731|10515166|P3|Overall Study|Other|0
3060035|NCT00536731|10515167|P2|Overall Study|Other|1
3060036|NCT00536731|10515168|P1|Overall Study|Other|1
3060037|NCT00536731|10515166|P3|Overall Study|Safety reasons|1
3060038|NCT00536731|10515167|P2|Overall Study|Safety reasons|0
3060039|NCT00536731|10515168|P1|Overall Study|Safety reasons|0
3060040|NCT00536731|10515166|P3|Overall Study|Intake of prohibited conc. medication|1
3060041|NCT00536731|10515167|P2|Overall Study|Intake of prohibited conc. medication|0
3060042|NCT00536731|10515168|P1|Overall Study|Intake of prohibited conc. medication|0
3060043|NCT00536731|10515166|P3|Overall Study|Withdrawal by Subject|0
3060044|NCT00536731|10515167|P2|Overall Study|Withdrawal by Subject|2
3060045|NCT00536731|10515168|P1|Overall Study|Withdrawal by Subject|0
3060046|NCT00536731|10515166|P3|Overall Study|Adverse Event|3
3060047|NCT00536731|10515167|P2|Overall Study|Adverse Event|2
3060048|NCT00536731|10515168|P1|Overall Study|Adverse Event|3
3060049|NCT00536575|10515212|P1|Overall Study|Death|1
3060050|NCT00536575|10515212|P1|Overall Study|Withdrawal by Subject|1
3060051|NCT00536510|10515218|P2|Overall Study|Patient Discontinued for Other Reasons|2
3060052|NCT00536510|10515219|P1|Overall Study|Patient Discontinued for Other Reasons|2
3060053|NCT00536510|10515218|P2|Overall Study|Laboratory Adverse Event|1
3060054|NCT00536510|10515219|P1|Overall Study|Laboratory Adverse Event|2
3060055|NCT00536510|10515218|P2|Overall Study|Flushing with Product|0
3060056|NCT00536510|10515219|P1|Overall Study|Flushing with Product|20
3060057|NCT00536510|10515218|P2|Overall Study|Withdrawal by Subject|9
3060058|NCT00536510|10515219|P1|Overall Study|Withdrawal by Subject|16
3060059|NCT00536510|10515218|P2|Overall Study|Protocol Violation|5
3060060|NCT00536510|10515219|P1|Overall Study|Protocol Violation|4
3060061|NCT00536510|10515218|P2|Overall Study|Lost to Follow-up|8
3060062|NCT00536510|10515219|P1|Overall Study|Lost to Follow-up|11
3060063|NCT00536510|10515218|P2|Overall Study|Adverse Event|4
3060064|NCT00536510|10515219|P1|Overall Study|Adverse Event|27
3060065|NCT00536484|10515229|P2|Overall Study|Other|0
3060066|NCT00536484|10515230|P1|Overall Study|Other|4
3060067|NCT00536484|10515229|P2|Overall Study|Lack of Efficacy|5
3060068|NCT00536484|10515230|P1|Overall Study|Lack of Efficacy|16
3060069|NCT00536484|10515229|P2|Overall Study|Lost to Follow-up|6
3060070|NCT00536484|10515230|P1|Overall Study|Lost to Follow-up|8
3060071|NCT00536484|10515229|P2|Overall Study|Withdrawal by Subject|11
3060072|NCT00536484|10515230|P1|Overall Study|Withdrawal by Subject|11
3060073|NCT00536484|10515229|P2|Overall Study|Adverse Event|34
3060074|NCT00536484|10515230|P1|Overall Study|Adverse Event|21
3060075|NCT00536471|10515264|P4|Overall Study|Sponsor Decision|2
3060076|NCT00536471|10515265|P3|Overall Study|Sponsor Decision|3
3060077|NCT00536471|10515266|P2|Overall Study|Sponsor Decision|1
3060078|NCT00536471|10515267|P1|Overall Study|Sponsor Decision|0
3060079|NCT00536471|10515264|P4|Overall Study|Death|2
3060080|NCT00536471|10515265|P3|Overall Study|Death|1
3060081|NCT00536471|10515266|P2|Overall Study|Death|0
3060082|NCT00536471|10515267|P1|Overall Study|Death|0
3060083|NCT00536471|10515264|P4|Overall Study|Physician Decision|2
3060084|NCT00536471|10515265|P3|Overall Study|Physician Decision|3
3060085|NCT00536471|10515266|P2|Overall Study|Physician Decision|1
3060086|NCT00536471|10515267|P1|Overall Study|Physician Decision|11
3060087|NCT00536471|10515264|P4|Overall Study|Protocol Violation|3
3060088|NCT00536471|10515265|P3|Overall Study|Protocol Violation|2
3060089|NCT00536471|10515266|P2|Overall Study|Protocol Violation|1
3060090|NCT00536471|10515267|P1|Overall Study|Protocol Violation|8
3060091|NCT00536471|10515264|P4|Overall Study|Lack of Efficacy|9
3060092|NCT00536471|10515265|P3|Overall Study|Lack of Efficacy|11
3060093|NCT00536471|10515266|P2|Overall Study|Lack of Efficacy|18
3060094|NCT00536471|10515267|P1|Overall Study|Lack of Efficacy|17
3060095|NCT00536471|10515264|P4|Overall Study|Withdrawal by Subject|21
3060096|NCT00536471|10515265|P3|Overall Study|Withdrawal by Subject|43
3060097|NCT00536471|10515266|P2|Overall Study|Withdrawal by Subject|24
3060098|NCT00536471|10515267|P1|Overall Study|Withdrawal by Subject|40
3060099|NCT00536471|10515264|P4|Overall Study|Adverse Event|13
3060100|NCT00536471|10515265|P3|Overall Study|Adverse Event|28
3060101|NCT00536471|10515266|P2|Overall Study|Adverse Event|16
3060102|NCT00536471|10515267|P1|Overall Study|Adverse Event|32
3060103|NCT00536471|10515264|P4|Overall Study|Lost to Follow-up|22
3060104|NCT00536471|10515265|P3|Overall Study|Lost to Follow-up|48
3060105|NCT00536471|10515266|P2|Overall Study|Lost to Follow-up|23
3060106|NCT00536471|10515267|P1|Overall Study|Lost to Follow-up|48
3060107|NCT00536380|10515512|P3|Overall Study|Administrative|1
3060108|NCT00536380|10515513|P2|Overall Study|Administrative|0
3060109|NCT00536380|10515514|P1|Overall Study|Administrative|0
3060110|NCT00536380|10515512|P3|Overall Study|Did not meet protocol eligibility|1
3060111|NCT00536380|10515513|P2|Overall Study|Did not meet protocol eligibility|0
3060112|NCT00536380|10515514|P1|Overall Study|Did not meet protocol eligibility|0
3060113|NCT00536380|10515512|P3|Overall Study|Noncompliance with protocol|2
3060114|NCT00536380|10515513|P2|Overall Study|Noncompliance with protocol|2
3060115|NCT00536380|10515514|P1|Overall Study|Noncompliance with protocol|3
3060116|NCT00536380|10515512|P3|Overall Study|Withdrawal related to study drug|2
3060117|NCT00536380|10515513|P2|Overall Study|Withdrawal related to study drug|5
3060118|NCT00536380|10515514|P1|Overall Study|Withdrawal related to study drug|7
3060119|NCT00536380|10515512|P3|Overall Study|Withdrawal unrelated to study drug|1
3060120|NCT00536380|10515513|P2|Overall Study|Withdrawal unrelated to study drug|0
3060121|NCT00536380|10515514|P1|Overall Study|Withdrawal unrelated to study drug|2
3060122|NCT00536380|10515512|P3|Overall Study|Lost to Follow-up|1
3060123|NCT00536380|10515513|P2|Overall Study|Lost to Follow-up|0
3060124|NCT00536380|10515514|P1|Overall Study|Lost to Follow-up|0
3060125|NCT00536380|10515512|P3|Overall Study|Adverse Event|2
3060126|NCT00536380|10515513|P2|Overall Study|Adverse Event|2
3060127|NCT00536380|10515514|P1|Overall Study|Adverse Event|0
3060128|NCT00536263|10515538|P3|Overall Study|Did not meet protocol eligibility|2
3060129|NCT00536263|10515539|P2|Overall Study|Did not meet protocol eligibility|2
3060130|NCT00536263|10515540|P1|Overall Study|Did not meet protocol eligibility|1
3060131|NCT00536263|10515538|P3|Overall Study|Noncompliance with protocol|1
3060132|NCT00536263|10515539|P2|Overall Study|Noncompliance with protocol|0
3060133|NCT00536263|10515540|P1|Overall Study|Noncompliance with protocol|0
3060134|NCT00536263|10515538|P3|Overall Study|Subject withdrew - treatment related|2
3060135|NCT00536263|10515539|P2|Overall Study|Subject withdrew - treatment related|3
3060136|NCT00536263|10515540|P1|Overall Study|Subject withdrew - treatment related|0
3060137|NCT00536263|10515538|P3|Overall Study|Subject withdrew - not treatment related|5
3060138|NCT00536263|10515539|P2|Overall Study|Subject withdrew - not treatment related|0
3060139|NCT00536263|10515540|P1|Overall Study|Subject withdrew - not treatment related|2
3060140|NCT00536263|10515538|P3|Overall Study|Lost to Follow-up|4
3060141|NCT00536263|10515539|P2|Overall Study|Lost to Follow-up|4
3060142|NCT00536263|10515540|P1|Overall Study|Lost to Follow-up|3
3060143|NCT00536263|10515538|P3|Overall Study|Adverse Event|7
3060144|NCT00536263|10515539|P2|Overall Study|Adverse Event|5
3060145|NCT00536263|10515540|P1|Overall Study|Adverse Event|5
3060146|NCT00536198|10515580|P2|Overall Study|Protocol Violation|1
3060147|NCT00536198|10515581|P1|Overall Study|Protocol Violation|0
3060148|NCT00536198|10515580|P2|Overall Study|Pregnancy|1
3060149|NCT00536198|10515581|P1|Overall Study|Pregnancy|1
3060150|NCT00536198|10515580|P2|Overall Study|Rescue|9
3060151|NCT00536198|10515581|P1|Overall Study|Rescue|3
3060152|NCT00536198|10515580|P2|Overall Study|Adverse Event|2
3060153|NCT00536198|10515581|P1|Overall Study|Adverse Event|2
3060154|NCT00536198|10515580|P2|Overall Study|Withdrawal by Subject|12
3060155|NCT00536198|10515581|P1|Overall Study|Withdrawal by Subject|16
3060156|NCT00536198|10515580|P2|Overall Study|Lost to Follow-up|14
3060157|NCT00536198|10515581|P1|Overall Study|Lost to Follow-up|15
3060158|NCT00536120|10515620|P2|Overall Study|Missed Study Visit|1
3060159|NCT00536120|10515621|P1|Overall Study|Missed Study Visit|0
3060160|NCT00536120|10515620|P2|Overall Study|Steroid Use|2
3060161|NCT00536120|10515621|P1|Overall Study|Steroid Use|0
3060162|NCT00536120|10515620|P2|Overall Study|Sponsor Decision Due to Lab Values|0
3060163|NCT00536120|10515621|P1|Overall Study|Sponsor Decision Due to Lab Values|1
3060164|NCT00536120|10515620|P2|Overall Study|Non-compliance|0
3060165|NCT00536120|10515621|P1|Overall Study|Non-compliance|1
3060166|NCT00536120|10515620|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
3060167|NCT00536120|10515621|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
3060168|NCT00536120|10515620|P2|Overall Study|Lost to Follow-up|0
3060169|NCT00536120|10515621|P1|Overall Study|Lost to Follow-up|1
3060170|NCT00536107|10515635|P2|Overall Study|Study Termination|4
3060171|NCT00536107|10515636|P1|Overall Study|Study Termination|2
3060172|NCT00536107|10515635|P2|Overall Study|Withdrawal by Subject|1
3060173|NCT00536107|10515636|P1|Overall Study|Withdrawal by Subject|0
3060174|NCT00536107|10515635|P2|Overall Study|Incorrect enrolment|0
3060175|NCT00536107|10515636|P1|Overall Study|Incorrect enrolment|1
3060176|NCT00536107|10515635|P2|Overall Study|Death|1
3060177|NCT00536107|10515636|P1|Overall Study|Death|5
3060178|NCT00535847|10515699|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
3060179|NCT00535847|10515700|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
3060180|NCT00535847|10515701|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
3060181|NCT00535847|10515699|P3|Overall Study|Non compliance|0
3060182|NCT00535847|10515700|P2|Overall Study|Non compliance|1
3060183|NCT00535847|10515701|P1|Overall Study|Non compliance|1
3060184|NCT00535847|10515699|P3|Overall Study|Adverse Event|2
3060185|NCT00535847|10515700|P2|Overall Study|Adverse Event|3
3060186|NCT00535847|10515701|P1|Overall Study|Adverse Event|5
3060187|NCT00535730|10515936|P2|Overall Study|Withdrawal by Subject|4
3060188|NCT00535730|10515937|P1|Overall Study|Withdrawal by Subject|0
3060189|NCT00535730|10515936|P2|Overall Study|Protocol Violation|0
3060190|NCT00535730|10515937|P1|Overall Study|Protocol Violation|1
3060191|NCT00535730|10515936|P2|Overall Study|Physician Decision|1
3060192|NCT00535730|10515937|P1|Overall Study|Physician Decision|0
3060193|NCT00535730|10515936|P2|Overall Study|Lost to Follow-up|1
3060194|NCT00535730|10515937|P1|Overall Study|Lost to Follow-up|0
3060195|NCT00535730|10515936|P2|Overall Study|Adverse Event|1
3060196|NCT00535730|10515937|P1|Overall Study|Adverse Event|1
3060197|NCT00535626|10515958|P1|Overall Study|Unable to return|2
3060198|NCT00535626|10515958|P1|Overall Study|Subject terminated|31
3060199|NCT00535626|10515958|P1|Overall Study|Removal/revision of study component|8
3060200|NCT00535626|10515958|P1|Overall Study|Withdrawal by Subject|20
3060201|NCT00535626|10515958|P1|Overall Study|Lost to Follow-up|29
3060202|NCT00535626|10515958|P1|Overall Study|Death|15
3060203|NCT00535496|10515998|P4|Overall Study|Not treated with sugammadex|0
3060204|NCT00535496|10515999|P3|Overall Study|Not treated with sugammadex|0
3060205|NCT00535496|10516000|P2|Overall Study|Not treated with sugammadex|1
3060206|NCT00535496|10516001|P1|Overall Study|Not treated with sugammadex|0
3060207|NCT00535496|10515998|P4|Overall Study|Lost to Follow-up|0
3060208|NCT00535496|10515999|P3|Overall Study|Lost to Follow-up|0
3060209|NCT00535496|10516000|P2|Overall Study|Lost to Follow-up|1
3060210|NCT00535496|10516001|P1|Overall Study|Lost to Follow-up|0
3060211|NCT00535405|10516021|P5|Overall Study|Withdrawal by Subject|8
3060212|NCT00535405|10516022|P4|Overall Study|Withdrawal by Subject|10
3060213|NCT00535405|10516023|P3|Overall Study|Withdrawal by Subject|10
3060214|NCT00535405|10516024|P2|Overall Study|Withdrawal by Subject|11
3060215|NCT00535405|10516025|P1|Overall Study|Withdrawal by Subject|5
3060216|NCT00535405|10516021|P5|Overall Study|Protocol Violation|0
3060217|NCT00535405|10516022|P4|Overall Study|Protocol Violation|1
3060218|NCT00535405|10516023|P3|Overall Study|Protocol Violation|2
3060219|NCT00535405|10516024|P2|Overall Study|Protocol Violation|2
3060220|NCT00535405|10516025|P1|Overall Study|Protocol Violation|2
3060221|NCT00535405|10516021|P5|Overall Study|Physician Decision|1
3060222|NCT00535405|10516022|P4|Overall Study|Physician Decision|1
3060223|NCT00535405|10516023|P3|Overall Study|Physician Decision|0
3060224|NCT00535405|10516024|P2|Overall Study|Physician Decision|2
3060225|NCT00535405|10516025|P1|Overall Study|Physician Decision|3
3060226|NCT00535405|10516021|P5|Overall Study|Lost to Follow-up|1
3060227|NCT00535405|10516022|P4|Overall Study|Lost to Follow-up|2
3060228|NCT00535405|10516023|P3|Overall Study|Lost to Follow-up|3
3060229|NCT00535405|10516024|P2|Overall Study|Lost to Follow-up|3
3060230|NCT00535405|10516025|P1|Overall Study|Lost to Follow-up|1
3060231|NCT00535405|10516021|P5|Overall Study|Adverse Event|6
3060232|NCT00535405|10516022|P4|Overall Study|Adverse Event|8
3060233|NCT00535405|10516023|P3|Overall Study|Adverse Event|3
3060234|NCT00535405|10516024|P2|Overall Study|Adverse Event|8
3060235|NCT00535405|10516025|P1|Overall Study|Adverse Event|6
3060236|NCT00535288|10516086|P5|Overall Study|Other|1
3060237|NCT00535288|10516087|P4|Overall Study|Other|2
3060238|NCT00535288|10516088|P3|Overall Study|Other|1
3060239|NCT00535288|10516089|P2|Overall Study|Other|1
3060240|NCT00535288|10516090|P1|Overall Study|Other|2
3060241|NCT00535288|10516086|P5|Overall Study|Unwilling to cooperate|4
3060242|NCT00535288|10516087|P4|Overall Study|Unwilling to cooperate|3
3060243|NCT00535288|10516088|P3|Overall Study|Unwilling to cooperate|3
3060244|NCT00535288|10516089|P2|Overall Study|Unwilling to cooperate|6
3060245|NCT00535288|10516090|P1|Overall Study|Unwilling to cooperate|6
3060246|NCT00535288|10516086|P5|Overall Study|Lack of Efficacy|7
3060247|NCT00535288|10516087|P4|Overall Study|Lack of Efficacy|4
3060248|NCT00535288|10516088|P3|Overall Study|Lack of Efficacy|4
3060249|NCT00535288|10516089|P2|Overall Study|Lack of Efficacy|3
3060250|NCT00535288|10516090|P1|Overall Study|Lack of Efficacy|26
3060251|NCT00535288|10516086|P5|Overall Study|Lost to Follow-up|0
3060252|NCT00535288|10516087|P4|Overall Study|Lost to Follow-up|0
3060253|NCT00535288|10516088|P3|Overall Study|Lost to Follow-up|0
3060254|NCT00535288|10516089|P2|Overall Study|Lost to Follow-up|3
3060255|NCT00535288|10516090|P1|Overall Study|Lost to Follow-up|0
3060256|NCT00535288|10516086|P5|Overall Study|Adverse Event|30
3060257|NCT00535288|10516087|P4|Overall Study|Adverse Event|20
3060258|NCT00535288|10516088|P3|Overall Study|Adverse Event|25
3060259|NCT00535288|10516089|P2|Overall Study|Adverse Event|19
3060260|NCT00535288|10516090|P1|Overall Study|Adverse Event|20
3060261|NCT00535262|10516167|P1|Overall Study|No funding|3
3060262|NCT00535236|10516181|P10|Overall Study|Withdrawal by Subject|2
3060263|NCT00535236|10516182|P9|Overall Study|Withdrawal by Subject|4
3060264|NCT00535236|10516183|P8|Overall Study|Withdrawal by Subject|0
3060265|NCT00535236|10516184|P7|Overall Study|Withdrawal by Subject|5
3060266|NCT00535236|10516185|P6|Overall Study|Withdrawal by Subject|1
3060267|NCT00535236|10516186|P5|Overall Study|Withdrawal by Subject|6
3060268|NCT00535236|10516187|P4|Overall Study|Withdrawal by Subject|1
3060269|NCT00535236|10516188|P3|Overall Study|Withdrawal by Subject|2
3060270|NCT00535236|10516189|P2|Overall Study|Withdrawal by Subject|0
3060271|NCT00535236|10516190|P1|Overall Study|Withdrawal by Subject|3
3060272|NCT00535236|10516181|P10|Overall Study|Protocol Violation|0
3060273|NCT00535236|10516182|P9|Overall Study|Protocol Violation|1
3060274|NCT00535236|10516183|P8|Overall Study|Protocol Violation|0
3060275|NCT00535236|10516184|P7|Overall Study|Protocol Violation|0
3060276|NCT00535236|10516185|P6|Overall Study|Protocol Violation|0
3060277|NCT00535236|10516186|P5|Overall Study|Protocol Violation|0
3060278|NCT00535236|10516187|P4|Overall Study|Protocol Violation|0
3060279|NCT00535236|10516188|P3|Overall Study|Protocol Violation|1
3060280|NCT00535236|10516189|P2|Overall Study|Protocol Violation|0
3060281|NCT00535236|10516190|P1|Overall Study|Protocol Violation|2
3060282|NCT00535236|10516181|P10|Overall Study|Physician Decision|0
3060283|NCT00535236|10516182|P9|Overall Study|Physician Decision|0
3060284|NCT00535236|10516183|P8|Overall Study|Physician Decision|0
3060285|NCT00535236|10516184|P7|Overall Study|Physician Decision|1
3060286|NCT00535236|10516185|P6|Overall Study|Physician Decision|0
3060287|NCT00535236|10516186|P5|Overall Study|Physician Decision|1
3060288|NCT00535236|10516187|P4|Overall Study|Physician Decision|0
3060289|NCT00535236|10516188|P3|Overall Study|Physician Decision|0
3060290|NCT00535236|10516189|P2|Overall Study|Physician Decision|0
3060291|NCT00535236|10516190|P1|Overall Study|Physician Decision|0
3060292|NCT00535236|10516181|P10|Overall Study|Lost to Follow-up|1
3060293|NCT00535236|10516182|P9|Overall Study|Lost to Follow-up|6
3060294|NCT00535236|10516183|P8|Overall Study|Lost to Follow-up|0
3060295|NCT00535236|10516184|P7|Overall Study|Lost to Follow-up|0
3060296|NCT00535236|10516185|P6|Overall Study|Lost to Follow-up|0
3060297|NCT00535236|10516186|P5|Overall Study|Lost to Follow-up|2
3060298|NCT00535236|10516187|P4|Overall Study|Lost to Follow-up|0
3060299|NCT00535236|10516188|P3|Overall Study|Lost to Follow-up|0
3060300|NCT00535236|10516189|P2|Overall Study|Lost to Follow-up|2
3060301|NCT00535236|10516190|P1|Overall Study|Lost to Follow-up|1
3060302|NCT00535236|10516181|P10|Overall Study|Adverse Event|1
3060303|NCT00535236|10516182|P9|Overall Study|Adverse Event|2
3060304|NCT00535236|10516183|P8|Overall Study|Adverse Event|1
3060305|NCT00535236|10516184|P7|Overall Study|Adverse Event|5
3060306|NCT00535236|10516185|P6|Overall Study|Adverse Event|0
3060307|NCT00535236|10516186|P5|Overall Study|Adverse Event|3
3060308|NCT00535236|10516187|P4|Overall Study|Adverse Event|3
3060309|NCT00535236|10516188|P3|Overall Study|Adverse Event|9
3060310|NCT00535236|10516189|P2|Overall Study|Adverse Event|0
3060311|NCT00535236|10516190|P1|Overall Study|Adverse Event|1
3060312|NCT00535223|10516250|P2|Overall Study|Withdrawal by Subject|1
3060313|NCT00535223|10516251|P1|Overall Study|Withdrawal by Subject|4
3060314|NCT00535145|10516259|P1|Phase II|Subject non-compliance|2
3060315|NCT00535145|10516259|P1|Phase II|Withdrawal by Subject|5
3060316|NCT00535145|10516259|P1|Phase II|Lost to Follow-up|5
3060317|NCT00535145|10516259|P1|Phase II|Lack of Efficacy|1
3060318|NCT00535145|10516259|P1|Phase II|Adverse Event|2
3060319|NCT00535145|10516259|P1|Phase I|(diagnosis)|3
3060320|NCT00535145|10516259|P1|Phase I|(PI decision)|1
3060321|NCT00535145|10516259|P1|Phase I|(protocol violation)|1
3060322|NCT00535145|10516259|P1|Phase I|(eligibility)|8
3060323|NCT00535145|10516259|P1|Phase I|Withdrawal by Subject|6
3060324|NCT00535145|10516259|P1|Phase I|Lost to Follow-up|7
3060325|NCT00535145|10516259|P1|Phase I|Adverse Event|3
3060326|NCT00535132|10516271|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
3060327|NCT00535132|10516272|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
3060328|NCT00535132|10516271|P2|Safety Analysis Set|Did Not Receive Study Medication|2
3060329|NCT00535132|10516272|P1|Safety Analysis Set|Did Not Receive Study Medication|2
3060330|NCT00534976|10516353|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
3060331|NCT00534976|10516354|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
3060332|NCT00534976|10516353|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
3060333|NCT00534976|10516354|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
3060334|NCT00534976|10516353|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
3060335|NCT00534976|10516354|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
3060336|NCT00534638|10516434|P2|Overall Study|Other|902
3060337|NCT00534638|10516435|P1|Overall Study|Other|1685
3060338|NCT00534638|10516434|P2|Overall Study|Lost to follow-up, complete vaccination|10757
3060339|NCT00534638|10516435|P1|Overall Study|Lost to follow-up, complete vaccination|4707
3060340|NCT00534638|10516434|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
3060341|NCT00534638|10516435|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
3060342|NCT00534638|10516434|P2|Overall Study|Migrated/moved from study area|11
3060343|NCT00534638|10516435|P1|Overall Study|Migrated/moved from study area|13
3060344|NCT00534638|10516434|P2|Overall Study|Withdrawal by Subject|4
3060345|NCT00534638|10516435|P1|Overall Study|Withdrawal by Subject|3
3060346|NCT00534599|10516473|P2|Overall Study|Other|0
3060347|NCT00534599|10516474|P1|Overall Study|Other|7
3060348|NCT00534599|10516473|P2|Overall Study|Withdrawal by Subject|6
3060349|NCT00534599|10516474|P1|Overall Study|Withdrawal by Subject|4
3060350|NCT00534599|10516473|P2|Overall Study|Lost to Follow-up|14
3060351|NCT00534599|10516474|P1|Overall Study|Lost to Follow-up|11
3060352|NCT00534599|10516473|P2|Overall Study|Protocol Violation|3
3060353|NCT00534599|10516474|P1|Overall Study|Protocol Violation|1
3060354|NCT00534599|10516473|P2|Overall Study|Generalized anxiety disorder worsened|1
3060355|NCT00534599|10516474|P1|Overall Study|Generalized anxiety disorder worsened|0
3060356|NCT00534599|10516473|P2|Overall Study|Lack of Efficacy|1
3060357|NCT00534599|10516474|P1|Overall Study|Lack of Efficacy|0
3060358|NCT00534599|10516473|P2|Overall Study|Developed study-specific d/c criteria|0
3060359|NCT00534599|10516474|P1|Overall Study|Developed study-specific d/c criteria|5
3060360|NCT00534599|10516473|P2|Overall Study|Mis-randomization|2
3060361|NCT00534599|10516474|P1|Overall Study|Mis-randomization|2
3060362|NCT00534599|10516473|P2|Overall Study|Incorrect enrollment|1
3060363|NCT00534599|10516474|P1|Overall Study|Incorrect enrollment|2
3060364|NCT00534599|10516473|P2|Overall Study|Adverse Event|4
3060365|NCT00534599|10516474|P1|Overall Study|Adverse Event|25
3060366|NCT00534495|10516510|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
3060367|NCT00534495|10516511|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
3060368|NCT00534495|10516512|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
3060369|NCT00534495|10516510|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
3060370|NCT00534495|10516511|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
3060371|NCT00534495|10516512|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
3060372|NCT00534495|10516510|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
3060373|NCT00534495|10516511|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
3060374|NCT00534495|10516512|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
3060375|NCT00534495|10516510|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
3060376|NCT00534495|10516511|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
3060377|NCT00534495|10516512|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
3060378|NCT00534495|10516510|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
3060379|NCT00534495|10516511|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
3060380|NCT00534495|10516512|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
3060381|NCT00534495|10516510|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
3060382|NCT00534495|10516511|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
3060383|NCT00534495|10516512|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
3060384|NCT00534495|10516510|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
3060385|NCT00534495|10516511|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
3060386|NCT00534495|10516512|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
3060387|NCT00534495|10516510|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
3060388|NCT00534495|10516511|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
3060389|NCT00534495|10516512|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
3060390|NCT00534495|10516510|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
3060391|NCT00534495|10516511|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
3060392|NCT00534495|10516512|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
3060393|NCT00534404|10516550|P3|Overall Study|Lost to Follow-up|201
3060394|NCT00534404|10516551|P2|Overall Study|Lost to Follow-up|138
3060395|NCT00534404|10516552|P1|Overall Study|Lost to Follow-up|170
3060396|NCT00534404|10516550|P3|Overall Study|Removed by study staff|1
3060397|NCT00534404|10516551|P2|Overall Study|Removed by study staff|3
3060398|NCT00534404|10516552|P1|Overall Study|Removed by study staff|2
3060399|NCT00534404|10516550|P3|Overall Study|Withdrawal by Subject|38
3060400|NCT00534404|10516551|P2|Overall Study|Withdrawal by Subject|2
3060401|NCT00534404|10516552|P1|Overall Study|Withdrawal by Subject|8
3060402|NCT00534404|10516550|P3|Overall Study|Death|2
3060403|NCT00534404|10516551|P2|Overall Study|Death|0
3060404|NCT00534404|10516552|P1|Overall Study|Death|0
3060405|NCT00534352|10516583|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
3060406|NCT00534352|10516583|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
3060407|NCT00534352|10516583|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
3060408|NCT00534352|10516583|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
3060409|NCT00534352|10516583|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
3060410|NCT00534352|10516583|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
3060411|NCT00534313|10516627|P4|Long-term Period|Other|2
3060412|NCT00534313|10516628|P3|Long-term Period|Other|2
3060413|NCT00534313|10516629|P2|Long-term Period|Other|2
3060414|NCT00534313|10516630|P1|Long-term Period|Other|1
3060415|NCT00534313|10516627|P4|Long-term Period|Administrative reason by sponsor|18
3060416|NCT00534313|10516628|P3|Long-term Period|Administrative reason by sponsor|26
3060417|NCT00534313|10516629|P2|Long-term Period|Administrative reason by sponsor|15
3060418|NCT00534313|10516630|P1|Long-term Period|Administrative reason by sponsor|17
3060419|NCT00534313|10516627|P4|Long-term Period|Poor compliance/noncompliance|0
3060420|NCT00534313|10516628|P3|Long-term Period|Poor compliance/noncompliance|1
3060421|NCT00534313|10516629|P2|Long-term Period|Poor compliance/noncompliance|1
3060422|NCT00534313|10516630|P1|Long-term Period|Poor compliance/noncompliance|0
3060423|NCT00534313|10516627|P4|Long-term Period|No longer meets study criteria|0
3060424|NCT00534313|10516628|P3|Long-term Period|No longer meets study criteria|0
3060425|NCT00534313|10516629|P2|Long-term Period|No longer meets study criteria|1
3060426|NCT00534313|10516630|P1|Long-term Period|No longer meets study criteria|0
3060427|NCT00534313|10516627|P4|Long-term Period|Withdrawal by Subject|0
3060428|NCT00534313|10516628|P3|Long-term Period|Withdrawal by Subject|0
3060429|NCT00534313|10516629|P2|Long-term Period|Withdrawal by Subject|2
3060430|NCT00534313|10516630|P1|Long-term Period|Withdrawal by Subject|2
3060431|NCT00534313|10516627|P4|Long-term Period|Lost to Follow-up|0
3060432|NCT00534313|10516628|P3|Long-term Period|Lost to Follow-up|0
3060433|NCT00534313|10516629|P2|Long-term Period|Lost to Follow-up|2
3060434|NCT00534313|10516630|P1|Long-term Period|Lost to Follow-up|1
3060435|NCT00534313|10516627|P4|Long-term Period|Lack of Efficacy|12
3060436|NCT00534313|10516628|P3|Long-term Period|Lack of Efficacy|14
3060437|NCT00534313|10516629|P2|Long-term Period|Lack of Efficacy|10
3060438|NCT00534313|10516630|P1|Long-term Period|Lack of Efficacy|14
3060439|NCT00534313|10516627|P4|Long-term Period|Adverse Event|1
3060440|NCT00534313|10516628|P3|Long-term Period|Adverse Event|0
3060441|NCT00534313|10516629|P2|Long-term Period|Adverse Event|1
3060442|NCT00534313|10516630|P1|Long-term Period|Adverse Event|2
3060443|NCT00534313|10516627|P4|Short-term Period|Pregnancy|0
3060444|NCT00534313|10516628|P3|Short-term Period|Pregnancy|1
3060445|NCT00534313|10516629|P2|Short-term Period|Pregnancy|0
3060446|NCT00534313|10516630|P1|Short-term Period|Pregnancy|0
3060447|NCT00534313|10516627|P4|Short-term Period|Participant withdrew consent|2
3060448|NCT00534313|10516628|P3|Short-term Period|Participant withdrew consent|0
3060449|NCT00534313|10516629|P2|Short-term Period|Participant withdrew consent|0
3060450|NCT00534313|10516630|P1|Short-term Period|Participant withdrew consent|2
3060451|NCT00534313|10516627|P4|Short-term Period|Participant not meeting study criteria|1
3060452|NCT00534313|10516628|P3|Short-term Period|Participant not meeting study criteria|0
3060453|NCT00534313|10516629|P2|Short-term Period|Participant not meeting study criteria|0
3060454|NCT00534313|10516630|P1|Short-term Period|Participant not meeting study criteria|0
3060455|NCT00534313|10516627|P4|Short-term Period|Lack of Efficacy|3
3060456|NCT00534313|10516628|P3|Short-term Period|Lack of Efficacy|0
3060457|NCT00534313|10516629|P2|Short-term Period|Lack of Efficacy|4
3060458|NCT00534313|10516630|P1|Short-term Period|Lack of Efficacy|3
3060459|NCT00534313|10516627|P4|Short-term Period|Adverse Event|3
3060460|NCT00534313|10516628|P3|Short-term Period|Adverse Event|1
3060461|NCT00534313|10516629|P2|Short-term Period|Adverse Event|2
3060462|NCT00534313|10516630|P1|Short-term Period|Adverse Event|1
3060463|NCT00534248|10516725|P2|Overall Study|Withdrawal by Subject|255
3060464|NCT00534248|10516726|P1|Overall Study|Withdrawal by Subject|263
3060465|NCT00534248|10516725|P2|Overall Study|Protocol Violation|4
3060466|NCT00534248|10516726|P1|Overall Study|Protocol Violation|3
3060467|NCT00534248|10516725|P2|Overall Study|Physician Decision|7
3060468|NCT00534248|10516726|P1|Overall Study|Physician Decision|10
3060469|NCT00534248|10516725|P2|Overall Study|Other protocol specified criteria|3
3060470|NCT00534248|10516726|P1|Overall Study|Other protocol specified criteria|13
3060471|NCT00534248|10516725|P2|Overall Study|Lost to Follow-up|375
3060472|NCT00534248|10516726|P1|Overall Study|Lost to Follow-up|353
3060473|NCT00534248|10516725|P2|Overall Study|Adverse Event|29
3060474|NCT00534248|10516726|P1|Overall Study|Adverse Event|19
3060475|NCT00534105|10516883|P2|Overall Study|Lost to Follow-up|39
3060476|NCT00534105|10516884|P1|Overall Study|Lost to Follow-up|23
3060477|NCT00534092|10516898|P2|Overall Study|personal reasons/family concerns|0
3060478|NCT00534092|10516899|P1|Overall Study|personal reasons/family concerns|1
3060479|NCT00534092|10516898|P2|Overall Study|Lost to Follow-up|0
3060480|NCT00534092|10516899|P1|Overall Study|Lost to Follow-up|1
3060481|NCT00533949|10516937|P4|Overall Study|Withdrawal by Subject|1
3060482|NCT00533949|10516938|P3|Overall Study|Withdrawal by Subject|1
3060483|NCT00533949|10516939|P2|Overall Study|Withdrawal by Subject|2
3060484|NCT00533949|10516940|P1|Overall Study|Withdrawal by Subject|3
3060485|NCT00533949|10516937|P4|Overall Study|Protocol Violation|9
3060486|NCT00533949|10516938|P3|Overall Study|Protocol Violation|9
3060487|NCT00533949|10516939|P2|Overall Study|Protocol Violation|12
3060488|NCT00533949|10516940|P1|Overall Study|Protocol Violation|12
3060489|NCT00533897|10516981|P8|Long Term Extension (LTE)|Other|6
3060490|NCT00533897|10516982|P7|Long Term Extension (LTE)|Other|1
3060491|NCT00533897|10516983|P6|Long Term Extension (LTE)|Other|0
3060492|NCT00533897|10516984|P5|Long Term Extension (LTE)|Other|0
3060493|NCT00533897|10516985|P4|Long Term Extension (LTE)|Other|0
3060494|NCT00533897|10516986|P3|Long Term Extension (LTE)|Other|0
3060495|NCT00533897|10516987|P2|Long Term Extension (LTE)|Other|0
3060496|NCT00533897|10516988|P1|Long Term Extension (LTE)|Other|0
3060497|NCT00533897|10516981|P8|Long Term Extension (LTE)|Lost to Follow-up|1
3060498|NCT00533897|10516982|P7|Long Term Extension (LTE)|Lost to Follow-up|1
3060499|NCT00533897|10516983|P6|Long Term Extension (LTE)|Lost to Follow-up|0
3060500|NCT00533897|10516984|P5|Long Term Extension (LTE)|Lost to Follow-up|0
3060501|NCT00533897|10516985|P4|Long Term Extension (LTE)|Lost to Follow-up|0
3060502|NCT00533897|10516986|P3|Long Term Extension (LTE)|Lost to Follow-up|0
3060503|NCT00533897|10516987|P2|Long Term Extension (LTE)|Lost to Follow-up|0
3060504|NCT00533897|10516988|P1|Long Term Extension (LTE)|Lost to Follow-up|0
3060505|NCT00533897|10516981|P8|Long Term Extension (LTE)|Pregnancy|2
3060506|NCT00533897|10516982|P7|Long Term Extension (LTE)|Pregnancy|0
3060507|NCT00533897|10516983|P6|Long Term Extension (LTE)|Pregnancy|0
3060508|NCT00533897|10516984|P5|Long Term Extension (LTE)|Pregnancy|0
3060509|NCT00533897|10516985|P4|Long Term Extension (LTE)|Pregnancy|0
3060510|NCT00533897|10516986|P3|Long Term Extension (LTE)|Pregnancy|0
3060511|NCT00533897|10516987|P2|Long Term Extension (LTE)|Pregnancy|0
3060512|NCT00533897|10516988|P1|Long Term Extension (LTE)|Pregnancy|0
3060513|NCT00533897|10516981|P8|Long Term Extension (LTE)|Adverse Event|5
3060514|NCT00533897|10516982|P7|Long Term Extension (LTE)|Adverse Event|2
3060515|NCT00533897|10516983|P6|Long Term Extension (LTE)|Adverse Event|0
3060516|NCT00533897|10516984|P5|Long Term Extension (LTE)|Adverse Event|0
3060517|NCT00533897|10516985|P4|Long Term Extension (LTE)|Adverse Event|0
3060518|NCT00533897|10516986|P3|Long Term Extension (LTE)|Adverse Event|0
3060519|NCT00533897|10516987|P2|Long Term Extension (LTE)|Adverse Event|0
3060520|NCT00533897|10516988|P1|Long Term Extension (LTE)|Adverse Event|0
3060521|NCT00533897|10516981|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
3060522|NCT00533897|10516982|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
3060523|NCT00533897|10516983|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
3060524|NCT00533897|10516984|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
3060525|NCT00533897|10516985|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
3060526|NCT00533897|10516986|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
3060527|NCT00533897|10516987|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
3060528|NCT00533897|10516988|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
3060529|NCT00533897|10516981|P8|Long Term Extension (LTE)|Lack of Efficacy|3
3060530|NCT00533897|10516982|P7|Long Term Extension (LTE)|Lack of Efficacy|5
3060531|NCT00533897|10516983|P6|Long Term Extension (LTE)|Lack of Efficacy|0
3060532|NCT00533897|10516984|P5|Long Term Extension (LTE)|Lack of Efficacy|0
3060533|NCT00533897|10516985|P4|Long Term Extension (LTE)|Lack of Efficacy|0
3060534|NCT00533897|10516986|P3|Long Term Extension (LTE)|Lack of Efficacy|0
3060535|NCT00533897|10516987|P2|Long Term Extension (LTE)|Lack of Efficacy|0
3060536|NCT00533897|10516988|P1|Long Term Extension (LTE)|Lack of Efficacy|0
3060537|NCT00533897|10516981|P8|Long Term Extension (LTE)|Death|3
3060538|NCT00533897|10516982|P7|Long Term Extension (LTE)|Death|1
3060539|NCT00533897|10516983|P6|Long Term Extension (LTE)|Death|0
3060540|NCT00533897|10516984|P5|Long Term Extension (LTE)|Death|0
3060541|NCT00533897|10516985|P4|Long Term Extension (LTE)|Death|0
3060542|NCT00533897|10516986|P3|Long Term Extension (LTE)|Death|0
3060543|NCT00533897|10516987|P2|Long Term Extension (LTE)|Death|0
3060544|NCT00533897|10516988|P1|Long Term Extension (LTE)|Death|0
3060545|NCT00533897|10516981|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
3060546|NCT00533897|10516982|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
3060547|NCT00533897|10516983|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060548|NCT00533897|10516984|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060549|NCT00533897|10516985|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060550|NCT00533897|10516986|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060551|NCT00533897|10516987|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060552|NCT00533897|10516988|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
3060553|NCT00533897|10516981|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060554|NCT00533897|10516982|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060555|NCT00533897|10516983|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
3060556|NCT00533897|10516984|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060557|NCT00533897|10516985|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060558|NCT00533897|10516986|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060559|NCT00533897|10516987|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060560|NCT00533897|10516988|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
3060561|NCT00533897|10516981|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060562|NCT00533897|10516982|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060563|NCT00533897|10516983|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
3060564|NCT00533897|10516984|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060565|NCT00533897|10516985|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060566|NCT00533897|10516986|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060567|NCT00533897|10516987|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060568|NCT00533897|10516988|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
3060569|NCT00533897|10516981|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060570|NCT00533897|10516982|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060571|NCT00533897|10516983|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060572|NCT00533897|10516984|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060573|NCT00533897|10516985|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060574|NCT00533897|10516986|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
3060575|NCT00533897|10516987|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060576|NCT00533897|10516988|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
3060577|NCT00533897|10516981|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060578|NCT00533897|10516982|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060579|NCT00533897|10516983|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060580|NCT00533897|10516984|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060581|NCT00533897|10516985|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060582|NCT00533897|10516986|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
3060583|NCT00533897|10516987|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
3060584|NCT00533897|10516988|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
3060585|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060586|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060587|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060588|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060589|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060590|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060591|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
3060592|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
3060593|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
3060594|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
3060595|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
3060596|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
3060597|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
3060598|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
3060599|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
3060600|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
3060601|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060602|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060603|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060604|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060605|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060606|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060607|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
3060608|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
3060609|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
3060610|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
3060611|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
3060612|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
3060613|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
3060614|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
3060615|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
3060616|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
3060617|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060618|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060619|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060620|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060621|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060622|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060623|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
3060624|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
3060625|NCT00533897|10516981|P8|Lead-in (LI) Period 1|Adverse Event|0
3060626|NCT00533897|10516982|P7|Lead-in (LI) Period 1|Adverse Event|0
3060627|NCT00533897|10516983|P6|Lead-in (LI) Period 1|Adverse Event|0
3060628|NCT00533897|10516984|P5|Lead-in (LI) Period 1|Adverse Event|0
3060629|NCT00533897|10516985|P4|Lead-in (LI) Period 1|Adverse Event|0
3060630|NCT00533897|10516986|P3|Lead-in (LI) Period 1|Adverse Event|0
3060631|NCT00533897|10516987|P2|Lead-in (LI) Period 1|Adverse Event|0
3060632|NCT00533897|10516988|P1|Lead-in (LI) Period 1|Adverse Event|1
3060633|NCT00533845|10517128|P2|Overall Study|Physician Decision|0
3060634|NCT00533845|10517129|P1|Overall Study|Physician Decision|1
3060635|NCT00533702|10517137|P2|Overall Study|Found ineligible after randomization|1
3060636|NCT00533702|10517138|P1|Overall Study|Found ineligible after randomization|2
3060637|NCT00533702|10517137|P2|Overall Study|Withdrawal by Subject|1
3060638|NCT00533702|10517138|P1|Overall Study|Withdrawal by Subject|3
3060639|NCT00533507|10517169|P1|Overall Study|Withdrawal by Subject|1
3060640|NCT00533273|10517214|P2|Open-label|Withdrawal by Subject|0
3060641|NCT00533273|10517215|P1|Open-label|Withdrawal by Subject|6
3060642|NCT00533273|10517214|P2|Double-blind|Withdrew consent|2
3060643|NCT00533273|10517215|P1|Double-blind|Withdrew consent|0
3060644|NCT00532948|10517266|P3|Overall Study|Failure to return|0
3060645|NCT00532948|10517267|P2|Overall Study|Failure to return|1
3060646|NCT00532948|10517268|P1|Overall Study|Failure to return|0
3060647|NCT00532948|10517266|P3|Overall Study|Violation of selection criteria at entry|0
3060648|NCT00532948|10517267|P2|Overall Study|Violation of selection criteria at entry|1
3060649|NCT00532948|10517268|P1|Overall Study|Violation of selection criteria at entry|0
3060650|NCT00532948|10517266|P3|Overall Study|Death|4
3060651|NCT00532948|10517267|P2|Overall Study|Death|3
3060652|NCT00532948|10517268|P1|Overall Study|Death|3
3060653|NCT00532948|10517266|P3|Overall Study|Protocol Violation|0
3060654|NCT00532948|10517267|P2|Overall Study|Protocol Violation|0
3060655|NCT00532948|10517268|P1|Overall Study|Protocol Violation|1
3060656|NCT00532935|10517300|P2|Overall Study|Protocol Specific Criteria|15
3060657|NCT00532935|10517301|P1|Overall Study|Protocol Specific Criteria|11
3060658|NCT00532935|10517300|P2|Overall Study|Withdrawal by Subject|9
3060659|NCT00532935|10517301|P1|Overall Study|Withdrawal by Subject|10
3060660|NCT00532935|10517300|P2|Overall Study|Protocol Violation|2
3060661|NCT00532935|10517301|P1|Overall Study|Protocol Violation|4
3060662|NCT00532935|10517300|P2|Overall Study|Pregnancy|0
3060663|NCT00532935|10517301|P1|Overall Study|Pregnancy|1
3060664|NCT00532935|10517300|P2|Overall Study|Physician Decision|5
3060665|NCT00532935|10517301|P1|Overall Study|Physician Decision|4
3060666|NCT00532935|10517300|P2|Overall Study|Lost to Follow-up|6
3060667|NCT00532935|10517301|P1|Overall Study|Lost to Follow-up|10
3060668|NCT00532935|10517300|P2|Overall Study|Lack of Efficacy|3
3060669|NCT00532935|10517301|P1|Overall Study|Lack of Efficacy|0
3060670|NCT00532935|10517300|P2|Overall Study|Adverse Event|12
3060671|NCT00532935|10517301|P1|Overall Study|Adverse Event|11
3060672|NCT00532883|10517319|P4|Overall Study|Early Study Termination|4
3060673|NCT00532883|10517320|P3|Overall Study|Early Study Termination|1
3060674|NCT00532883|10517321|P2|Overall Study|Early Study Termination|4
3060675|NCT00532883|10517322|P1|Overall Study|Early Study Termination|4
3060676|NCT00532883|10517319|P4|Overall Study|Subject was Nonadherent|0
3060677|NCT00532883|10517320|P3|Overall Study|Subject was Nonadherent|1
3060678|NCT00532883|10517321|P2|Overall Study|Subject was Nonadherent|1
3060679|NCT00532883|10517322|P1|Overall Study|Subject was Nonadherent|0
3060680|NCT00532883|10517319|P4|Overall Study|Withdrawal by Subject|0
3060681|NCT00532883|10517320|P3|Overall Study|Withdrawal by Subject|1
3060682|NCT00532883|10517321|P2|Overall Study|Withdrawal by Subject|1
3060683|NCT00532883|10517322|P1|Overall Study|Withdrawal by Subject|0
3060684|NCT00532883|10517319|P4|Overall Study|Lost to Follow-up|0
3060685|NCT00532883|10517320|P3|Overall Study|Lost to Follow-up|1
3060686|NCT00532883|10517321|P2|Overall Study|Lost to Follow-up|1
3060687|NCT00532883|10517322|P1|Overall Study|Lost to Follow-up|1
3060688|NCT00532883|10517319|P4|Overall Study|Adverse Event|1
3060689|NCT00532883|10517320|P3|Overall Study|Adverse Event|0
3060690|NCT00532883|10517321|P2|Overall Study|Adverse Event|0
3060691|NCT00532883|10517322|P1|Overall Study|Adverse Event|1
3060692|NCT00532779|10517335|P3|Overall Study|Drug noncompliance, moved, other|29
3060693|NCT00532779|10517336|P2|Overall Study|Drug noncompliance, moved, other|23
3060694|NCT00532779|10517337|P1|Overall Study|Drug noncompliance, moved, other|14
3060695|NCT00532779|10517335|P3|Overall Study|Death|0
3060696|NCT00532779|10517336|P2|Overall Study|Death|1
3060697|NCT00532779|10517337|P1|Overall Study|Death|0
3060698|NCT00532779|10517335|P3|Overall Study|Pregnancy|3
3060699|NCT00532779|10517336|P2|Overall Study|Pregnancy|5
3060700|NCT00532779|10517337|P1|Overall Study|Pregnancy|2
3060701|NCT00532779|10517335|P3|Overall Study|Protocol Violation|7
3060702|NCT00532779|10517336|P2|Overall Study|Protocol Violation|9
3060703|NCT00532779|10517337|P1|Overall Study|Protocol Violation|5
3060704|NCT00532779|10517335|P3|Overall Study|Lack of Efficacy|40
3060705|NCT00532779|10517336|P2|Overall Study|Lack of Efficacy|12
3060706|NCT00532779|10517337|P1|Overall Study|Lack of Efficacy|12
3060707|NCT00532779|10517335|P3|Overall Study|Withdrawal by Subject|90
3060708|NCT00532779|10517336|P2|Overall Study|Withdrawal by Subject|60
3060709|NCT00532779|10517337|P1|Overall Study|Withdrawal by Subject|63
3060710|NCT00532779|10517335|P3|Overall Study|Lost to Follow-up|66
3060711|NCT00532779|10517336|P2|Overall Study|Lost to Follow-up|65
3060712|NCT00532779|10517337|P1|Overall Study|Lost to Follow-up|76
3060713|NCT00532779|10517335|P3|Overall Study|Adverse Event|56
3060714|NCT00532779|10517336|P2|Overall Study|Adverse Event|112
3060715|NCT00532779|10517337|P1|Overall Study|Adverse Event|122
3060716|NCT00532493|10517398|P2|Overall Study|Contraindicative Medication|0
3060717|NCT00532493|10517399|P1|Overall Study|Contraindicative Medication|1
3060718|NCT00532493|10517398|P2|Overall Study|Subject Moved Away|1
3060719|NCT00532493|10517399|P1|Overall Study|Subject Moved Away|3
3060720|NCT00532493|10517398|P2|Overall Study|Protocol Deviation|0
3060721|NCT00532493|10517399|P1|Overall Study|Protocol Deviation|1
3060722|NCT00532493|10517398|P2|Overall Study|Adverse Event|5
3060723|NCT00532493|10517399|P1|Overall Study|Adverse Event|6
3060724|NCT00532493|10517398|P2|Overall Study|Physician Decision|6
3060725|NCT00532493|10517399|P1|Overall Study|Physician Decision|1
3060726|NCT00532493|10517398|P2|Overall Study|Withdrawal by Subject|9
3060727|NCT00532493|10517399|P1|Overall Study|Withdrawal by Subject|7
3060728|NCT00532493|10517398|P2|Overall Study|Lost to Follow-up|7
3060729|NCT00532493|10517399|P1|Overall Study|Lost to Follow-up|10
3060730|NCT00532493|10517398|P2|Overall Study|Death|1
3060731|NCT00532493|10517399|P1|Overall Study|Death|1
3060732|NCT00532441|10517433|P2|Overall Study|Death|0
3060733|NCT00532441|10517434|P1|Overall Study|Death|1
3060734|NCT00532298|10517449|P6|Overall Study|Lost to Follow-up|1
3060735|NCT00532298|10517450|P5|Overall Study|Lost to Follow-up|0
3060736|NCT00532298|10517451|P4|Overall Study|Lost to Follow-up|0
3060737|NCT00532298|10517452|P3|Overall Study|Lost to Follow-up|1
3060738|NCT00532298|10517453|P2|Overall Study|Lost to Follow-up|1
3060739|NCT00532298|10517454|P1|Overall Study|Lost to Follow-up|1
3060740|NCT00532298|10517449|P6|Overall Study|Adverse Event|1
3060741|NCT00532298|10517450|P5|Overall Study|Adverse Event|1
3060742|NCT00532298|10517451|P4|Overall Study|Adverse Event|0
3060743|NCT00532298|10517452|P3|Overall Study|Adverse Event|0
3060744|NCT00532298|10517453|P2|Overall Study|Adverse Event|0
3060745|NCT00532298|10517454|P1|Overall Study|Adverse Event|1
3060746|NCT00532259|10517534|P1|Overall Study|Protocol Violation|1
3060747|NCT00532259|10517534|P1|Overall Study|Physician Decision|3
3060748|NCT00532259|10517534|P1|Overall Study|Lost to Follow-up|3
3060749|NCT00532259|10517534|P1|Overall Study|Lack of Efficacy|21
3060750|NCT00532259|10517534|P1|Overall Study|Death|1
3060751|NCT00532259|10517534|P1|Overall Study|Adverse Event|1
3060752|NCT00532259|10517534|P1|Overall Study|Withdrawal by Subject|2
3060753|NCT00532155|10517541|P2|Overall Study|Did not receive study medication|6
3060754|NCT00532155|10517542|P1|Overall Study|Did not receive study medication|2
3060755|NCT00532155|10517541|P2|Overall Study|Study termination stop further treatment|0
3060756|NCT00532155|10517542|P1|Overall Study|Study termination stop further treatment|4
3060757|NCT00532155|10517541|P2|Overall Study|Study terminated by sponsor|0
3060758|NCT00532155|10517542|P1|Overall Study|Study terminated by sponsor|1
3060759|NCT00532155|10517541|P2|Overall Study|Study stopped|0
3060760|NCT00532155|10517542|P1|Overall Study|Study stopped|1
3060761|NCT00532155|10517541|P2|Overall Study|Had brain metastasis, was mis-randomized|0
3060762|NCT00532155|10517542|P1|Overall Study|Had brain metastasis, was mis-randomized|1
3060763|NCT00532155|10517541|P2|Overall Study|Progressive disease (by incorrect scan)|1
3060764|NCT00532155|10517542|P1|Overall Study|Progressive disease (by incorrect scan)|0
3060765|NCT00532155|10517541|P2|Overall Study|Promotor ended study|0
3060766|NCT00532155|10517542|P1|Overall Study|Promotor ended study|1
3060767|NCT00532155|10517541|P2|Overall Study|Occurence of a secondary cancer|1
3060768|NCT00532155|10517542|P1|Overall Study|Occurence of a secondary cancer|0
3060769|NCT00532155|10517541|P2|Overall Study|Occurence of a second cancer|1
3060770|NCT00532155|10517542|P1|Overall Study|Occurence of a second cancer|0
3060771|NCT00532155|10517541|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
3060772|NCT00532155|10517542|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
3060773|NCT00532155|10517541|P2|Overall Study|Moved|0
3060774|NCT00532155|10517542|P1|Overall Study|Moved|1
3060775|NCT00532155|10517541|P2|Overall Study|Consent withdrawn|7
3060776|NCT00532155|10517542|P1|Overall Study|Consent withdrawn|5
3060777|NCT00532155|10517541|P2|Overall Study|Withdrawal by Subject|44
3060778|NCT00532155|10517542|P1|Overall Study|Withdrawal by Subject|23
3060779|NCT00532155|10517541|P2|Overall Study|Physician Decision|15
3060780|NCT00532155|10517542|P1|Overall Study|Physician Decision|16
3060781|NCT00532155|10517541|P2|Overall Study|Lost to Follow-up|0
3060782|NCT00532155|10517542|P1|Overall Study|Lost to Follow-up|2
3060783|NCT00532155|10517541|P2|Overall Study|Protocol Violation|3
3060784|NCT00532155|10517542|P1|Overall Study|Protocol Violation|1
3060785|NCT00532155|10517541|P2|Overall Study|Lack of Efficacy|255
3060786|NCT00532155|10517542|P1|Overall Study|Lack of Efficacy|332
3060787|NCT00532155|10517541|P2|Overall Study|Adverse Event|123
3060788|NCT00532155|10517542|P1|Overall Study|Adverse Event|66
3060789|NCT00532129|10517556|P1|Follow-up Period|Other|6
3060790|NCT00532129|10517556|P1|Follow-up Period|Lost to Follow-up|1
3060791|NCT00532129|10517556|P1|Follow-up Period|Disease progression|57
3060792|NCT00532129|10517556|P1|Follow-up Period|Adverse event/Serious adverse event|1
3060793|NCT00532129|10517556|P1|Treatment Period|Other|5
3060794|NCT00532129|10517556|P1|Treatment Period|Protocol Violation|1
3060795|NCT00532129|10517556|P1|Treatment Period|Disease progression|3
3060796|NCT00532129|10517556|P1|Treatment Period|Physician Decision|15
3060797|NCT00532129|10517556|P1|Treatment Period|Adverse event/Serious adverse event|25
3060798|NCT00531960|10517576|P2|Overall Study|Other|10
3060799|NCT00531960|10517577|P1|Overall Study|Other|4
3060800|NCT00531960|10517576|P2|Overall Study|Refused Treatment|6
3060801|NCT00531960|10517577|P1|Overall Study|Refused Treatment|5
3060802|NCT00531960|10517576|P2|Overall Study|Violation of Selection Criteria|0
3060803|NCT00531960|10517577|P1|Overall Study|Violation of Selection Criteria|2
3060804|NCT00531960|10517576|P2|Overall Study|Lack of Efficacy|41
3060805|NCT00531960|10517577|P1|Overall Study|Lack of Efficacy|42
3060806|NCT00531960|10517576|P2|Overall Study|Death|2
3060807|NCT00531960|10517577|P1|Overall Study|Death|3
3060808|NCT00531960|10517576|P2|Overall Study|Adverse Event|4
3060809|NCT00531960|10517577|P1|Overall Study|Adverse Event|5
3060810|NCT00531947|10517595|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
3060811|NCT00531947|10517596|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
3060812|NCT00531947|10517595|P2|Overall Study|Non-Compliance|7
3060813|NCT00531947|10517596|P1|Overall Study|Non-Compliance|4
3060814|NCT00531947|10517595|P2|Overall Study|Protocol Violation|1
3060815|NCT00531947|10517596|P1|Overall Study|Protocol Violation|2
3060816|NCT00531947|10517595|P2|Overall Study|Withdrawal by Subject|19
3060817|NCT00531947|10517596|P1|Overall Study|Withdrawal by Subject|14
3060818|NCT00531947|10517595|P2|Overall Study|Lost to Follow-up|9
3060819|NCT00531947|10517596|P1|Overall Study|Lost to Follow-up|12
3060820|NCT00531947|10517595|P2|Overall Study|Adverse Event|10
3060821|NCT00531947|10517596|P1|Overall Study|Adverse Event|5
3060822|NCT00531934|10517640|P2|Overall Study|Other|2
3060823|NCT00531934|10517641|P1|Overall Study|Other|2
3060824|NCT00531934|10517640|P2|Overall Study|Withdrawal by Subject|1
3060825|NCT00531934|10517641|P1|Overall Study|Withdrawal by Subject|1
3060826|NCT00531934|10517640|P2|Overall Study|Death|10
3060827|NCT00531934|10517641|P1|Overall Study|Death|7
3060828|NCT00531934|10517640|P2|Overall Study|Progression|42
3060829|NCT00531934|10517641|P1|Overall Study|Progression|52
3060830|NCT00531934|10517640|P2|Overall Study|Adverse Event|8
3060831|NCT00531934|10517641|P1|Overall Study|Adverse Event|4
3060832|NCT00531752|10517769|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
3060833|NCT00531752|10517770|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
3060834|NCT00531752|10517771|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
3060835|NCT00531752|10517772|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
3060836|NCT00531752|10517769|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
3060837|NCT00531752|10517770|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
3060838|NCT00531752|10517771|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
3060839|NCT00531752|10517772|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
3060840|NCT00531752|10517769|P4|Second Double-blind Intervention Period|Other|0
3060841|NCT00531752|10517770|P3|Second Double-blind Intervention Period|Other|0
3060842|NCT00531752|10517771|P2|Second Double-blind Intervention Period|Other|1
3060843|NCT00531752|10517772|P1|Second Double-blind Intervention Period|Other|1
3060844|NCT00531752|10517769|P4|Second Double-blind Intervention Period|Adverse Event|0
3060845|NCT00531752|10517770|P3|Second Double-blind Intervention Period|Adverse Event|0
3060846|NCT00531752|10517771|P2|Second Double-blind Intervention Period|Adverse Event|1
3060847|NCT00531752|10517772|P1|Second Double-blind Intervention Period|Adverse Event|1
3060848|NCT00531752|10517769|P4|First Double-blind Intervention Period|Randomized but not treated|0
3060849|NCT00531752|10517770|P3|First Double-blind Intervention Period|Randomized but not treated|0
3060850|NCT00531752|10517771|P2|First Double-blind Intervention Period|Randomized but not treated|0
3060851|NCT00531752|10517772|P1|First Double-blind Intervention Period|Randomized but not treated|1
3060852|NCT00531752|10517769|P4|First Double-blind Intervention Period|Lost to Follow-up|1
3060853|NCT00531752|10517770|P3|First Double-blind Intervention Period|Lost to Follow-up|1
3060854|NCT00531752|10517771|P2|First Double-blind Intervention Period|Lost to Follow-up|0
3060855|NCT00531752|10517772|P1|First Double-blind Intervention Period|Lost to Follow-up|0
3060856|NCT00531752|10517769|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
3060857|NCT00531752|10517770|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
3060858|NCT00531752|10517771|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
3060859|NCT00531752|10517772|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
3060860|NCT00531752|10517769|P4|First Double-blind Intervention Period|Other|0
3060861|NCT00531752|10517770|P3|First Double-blind Intervention Period|Other|4
3060862|NCT00531752|10517771|P2|First Double-blind Intervention Period|Other|4
3060863|NCT00531752|10517772|P1|First Double-blind Intervention Period|Other|1
3060864|NCT00531752|10517769|P4|First Double-blind Intervention Period|Adverse Event|1
3060865|NCT00531752|10517770|P3|First Double-blind Intervention Period|Adverse Event|1
3060866|NCT00531752|10517771|P2|First Double-blind Intervention Period|Adverse Event|0
3060867|NCT00531752|10517772|P1|First Double-blind Intervention Period|Adverse Event|2
3060868|NCT00531479|10517883|P2|Overall Study|Did not receive treatment|3
3060869|NCT00531479|10517884|P1|Overall Study|Did not receive treatment|2
3060870|NCT00531479|10517883|P2|Overall Study|Withdrawal by Subject|6
3060871|NCT00531479|10517884|P1|Overall Study|Withdrawal by Subject|6
3060872|NCT00531479|10517883|P2|Overall Study|Other|1
3060873|NCT00531479|10517884|P1|Overall Study|Other|0
3060874|NCT00531479|10517883|P2|Overall Study|Lost to Follow-up|2
3060875|NCT00531479|10517884|P1|Overall Study|Lost to Follow-up|0
3060876|NCT00531479|10517883|P2|Overall Study|Death|71
3060877|NCT00531479|10517884|P1|Overall Study|Death|68
3060878|NCT00531427|10517915|P2|Overall Study|Administrative|9
3060879|NCT00531427|10517916|P1|Overall Study|Administrative|4
3060880|NCT00531427|10517915|P2|Overall Study|Lack of Efficacy|39
3060881|NCT00531427|10517916|P1|Overall Study|Lack of Efficacy|14
3060882|NCT00531427|10517915|P2|Overall Study|Lost to Follow-up|3
3060883|NCT00531427|10517916|P1|Overall Study|Lost to Follow-up|4
3060884|NCT00531427|10517915|P2|Overall Study|Adverse Event|30
3060885|NCT00531427|10517916|P1|Overall Study|Adverse Event|44
3060886|NCT00531427|10517915|P2|Overall Study|Withdrawal by Subject|13
3060887|NCT00531427|10517916|P1|Overall Study|Withdrawal by Subject|7
3060888|NCT00531284|10517944|P17|Overall Study|Other|0
3060889|NCT00531284|10517945|P16|Overall Study|Other|0
3060890|NCT00531284|10517946|P15|Overall Study|Other|1
3060891|NCT00531284|10517947|P14|Overall Study|Other|0
3060892|NCT00531284|10517948|P13|Overall Study|Other|0
3060893|NCT00531284|10517949|P12|Overall Study|Other|2
3060894|NCT00531284|10517950|P11|Overall Study|Other|0
3060895|NCT00531284|10517951|P10|Overall Study|Other|1
3060896|NCT00531284|10517952|P9|Overall Study|Other|2
3060897|NCT00531284|10517953|P8|Overall Study|Other|0
3060898|NCT00531284|10517954|P7|Overall Study|Other|0
3060899|NCT00531284|10517955|P6|Overall Study|Other|1
3060900|NCT00531284|10517956|P5|Overall Study|Other|2
3060901|NCT00531284|10517957|P4|Overall Study|Other|10
3060902|NCT00531284|10517958|P3|Overall Study|Other|0
3060903|NCT00531284|10517959|P2|Overall Study|Other|0
3060904|NCT00531284|10517960|P1|Overall Study|Other|1
3060905|NCT00531284|10517944|P17|Overall Study|Withdrawal by Subject|1
3060906|NCT00531284|10517945|P16|Overall Study|Withdrawal by Subject|1
3060907|NCT00531284|10517946|P15|Overall Study|Withdrawal by Subject|0
3060908|NCT00531284|10517947|P14|Overall Study|Withdrawal by Subject|1
3060909|NCT00531284|10517948|P13|Overall Study|Withdrawal by Subject|0
3060910|NCT00531284|10517949|P12|Overall Study|Withdrawal by Subject|3
3060911|NCT00531284|10517950|P11|Overall Study|Withdrawal by Subject|0
3060912|NCT00531284|10517951|P10|Overall Study|Withdrawal by Subject|0
3060913|NCT00531284|10517952|P9|Overall Study|Withdrawal by Subject|0
3060914|NCT00531284|10517953|P8|Overall Study|Withdrawal by Subject|0
3060915|NCT00531284|10517954|P7|Overall Study|Withdrawal by Subject|0
3060916|NCT00531284|10517955|P6|Overall Study|Withdrawal by Subject|0
3060917|NCT00531284|10517956|P5|Overall Study|Withdrawal by Subject|0
3060918|NCT00531284|10517957|P4|Overall Study|Withdrawal by Subject|4
3060919|NCT00531284|10517958|P3|Overall Study|Withdrawal by Subject|0
3060920|NCT00531284|10517959|P2|Overall Study|Withdrawal by Subject|0
3060921|NCT00531284|10517960|P1|Overall Study|Withdrawal by Subject|1
3060922|NCT00531284|10517944|P17|Overall Study|Adverse Event|2
3060923|NCT00531284|10517945|P16|Overall Study|Adverse Event|0
3060924|NCT00531284|10517946|P15|Overall Study|Adverse Event|1
3060925|NCT00531284|10517947|P14|Overall Study|Adverse Event|1
3060926|NCT00531284|10517948|P13|Overall Study|Adverse Event|0
3060927|NCT00531284|10517949|P12|Overall Study|Adverse Event|5
3060928|NCT00531284|10517950|P11|Overall Study|Adverse Event|0
3060929|NCT00531284|10517951|P10|Overall Study|Adverse Event|0
3060930|NCT00531284|10517952|P9|Overall Study|Adverse Event|3
3060931|NCT00531284|10517953|P8|Overall Study|Adverse Event|2
3060932|NCT00531284|10517954|P7|Overall Study|Adverse Event|3
3060933|NCT00531284|10517955|P6|Overall Study|Adverse Event|2
3060934|NCT00531284|10517956|P5|Overall Study|Adverse Event|0
3060935|NCT00531284|10517957|P4|Overall Study|Adverse Event|7
3060936|NCT00531284|10517958|P3|Overall Study|Adverse Event|1
3060937|NCT00531284|10517959|P2|Overall Study|Adverse Event|1
3060938|NCT00531284|10517960|P1|Overall Study|Adverse Event|0
3060939|NCT00531284|10517944|P17|Overall Study|Progressive Disease|5
3060940|NCT00531284|10517945|P16|Overall Study|Progressive Disease|11
3060941|NCT00531284|10517946|P15|Overall Study|Progressive Disease|2
3060942|NCT00531284|10517947|P14|Overall Study|Progressive Disease|1
3060943|NCT00531284|10517948|P13|Overall Study|Progressive Disease|2
3060944|NCT00531284|10517949|P12|Overall Study|Progressive Disease|14
3060945|NCT00531284|10517950|P11|Overall Study|Progressive Disease|3
3060946|NCT00531284|10517951|P10|Overall Study|Progressive Disease|3
3060947|NCT00531284|10517952|P9|Overall Study|Progressive Disease|6
3060948|NCT00531284|10517953|P8|Overall Study|Progressive Disease|8
3060949|NCT00531284|10517954|P7|Overall Study|Progressive Disease|3
3060950|NCT00531284|10517955|P6|Overall Study|Progressive Disease|4
3060951|NCT00531284|10517956|P5|Overall Study|Progressive Disease|4
3060952|NCT00531284|10517957|P4|Overall Study|Progressive Disease|42
3060953|NCT00531284|10517958|P3|Overall Study|Progressive Disease|5
3060954|NCT00531284|10517959|P2|Overall Study|Progressive Disease|3
3060955|NCT00531284|10517960|P1|Overall Study|Progressive Disease|1
3060956|NCT00531206|10518110|P1|Overall Study|including non-related adverse events|8
3060957|NCT00531206|10518110|P1|Overall Study|Lost to Follow-up|5
3060958|NCT00531206|10518110|P1|Overall Study|Lack of Efficacy|2
3060959|NCT00531206|10518110|P1|Overall Study|Adverse Event related|5
3060960|NCT00531050|10518140|P6|Part 2: Period 3|Abnormal test procedure|1
3060961|NCT00531050|10518141|P5|Part 2: Period 3|Abnormal test procedure|0
3060962|NCT00531050|10518142|P4|Part 2: Period 3|Abnormal test procedure|0
3060963|NCT00531050|10518143|P3|Part 2: Period 3|Abnormal test procedure|0
3060964|NCT00531050|10518144|P2|Part 2: Period 3|Abnormal test procedure|0
3060965|NCT00531050|10518145|P1|Part 2: Period 3|Abnormal test procedure|1
3060966|NCT00531050|10518140|P6|Part 2: Period 1|Adverse Event|1
3060967|NCT00531050|10518141|P5|Part 2: Period 1|Adverse Event|0
3060968|NCT00531050|10518142|P4|Part 2: Period 1|Adverse Event|0
3060969|NCT00531050|10518143|P3|Part 2: Period 1|Adverse Event|0
3060970|NCT00531050|10518144|P2|Part 2: Period 1|Adverse Event|0
3060971|NCT00531050|10518145|P1|Part 2: Period 1|Adverse Event|0
3060972|NCT00531050|10518140|P6|Part 1: Period 3|Adverse Event|0
3060973|NCT00531050|10518141|P5|Part 1: Period 3|Adverse Event|0
3060974|NCT00531050|10518142|P4|Part 1: Period 3|Adverse Event|0
3060975|NCT00531050|10518143|P3|Part 1: Period 3|Adverse Event|0
3060976|NCT00531050|10518144|P2|Part 1: Period 3|Adverse Event|0
3060977|NCT00531050|10518145|P1|Part 1: Period 3|Adverse Event|1
3060978|NCT00531050|10518140|P6|Part 1: Period 1|Protocol Deviation|0
3060979|NCT00531050|10518141|P5|Part 1: Period 1|Protocol Deviation|0
3060980|NCT00531050|10518142|P4|Part 1: Period 1|Protocol Deviation|1
3060981|NCT00531050|10518143|P3|Part 1: Period 1|Protocol Deviation|0
3060982|NCT00531050|10518144|P2|Part 1: Period 1|Protocol Deviation|0
3060983|NCT00531050|10518145|P1|Part 1: Period 1|Protocol Deviation|0
3060984|NCT00531050|10518140|P6|Part 1: Period 1|Adverse Event|0
3060985|NCT00531050|10518141|P5|Part 1: Period 1|Adverse Event|0
3060986|NCT00531050|10518142|P4|Part 1: Period 1|Adverse Event|0
3060987|NCT00531050|10518143|P3|Part 1: Period 1|Adverse Event|0
3060988|NCT00531050|10518144|P2|Part 1: Period 1|Adverse Event|1
3060989|NCT00531050|10518145|P1|Part 1: Period 1|Adverse Event|0
3060990|NCT00531011|10518174|P2|Overall Study|Physician Decision|3
3060991|NCT00531011|10518175|P1|Overall Study|Physician Decision|0
3060992|NCT00531011|10518174|P2|Overall Study|Lost to Follow-up|0
3060993|NCT00531011|10518175|P1|Overall Study|Lost to Follow-up|1
3060994|NCT00531011|10518174|P2|Overall Study|Death|0
3060995|NCT00531011|10518175|P1|Overall Study|Death|1
3060996|NCT00531011|10518174|P2|Overall Study|Withdrawal by Subject|4
3060997|NCT00531011|10518175|P1|Overall Study|Withdrawal by Subject|2
3060998|NCT00530946|10518221|P4|Overall Study|Noncompliance|0
3060999|NCT00530946|10518222|P3|Overall Study|Noncompliance|0
3061000|NCT00530946|10518223|P2|Overall Study|Noncompliance|0
3061001|NCT00530946|10518224|P1|Overall Study|Noncompliance|1
3061002|NCT00530946|10518221|P4|Overall Study|Protocol Violation|1
3061003|NCT00530946|10518222|P3|Overall Study|Protocol Violation|0
3061004|NCT00530946|10518223|P2|Overall Study|Protocol Violation|0
3061005|NCT00530946|10518224|P1|Overall Study|Protocol Violation|0
3061006|NCT00530946|10518221|P4|Overall Study|Adverse Event|1
3061007|NCT00530946|10518222|P3|Overall Study|Adverse Event|1
3061008|NCT00530946|10518223|P2|Overall Study|Adverse Event|2
3061009|NCT00530946|10518224|P1|Overall Study|Adverse Event|1
3061010|NCT00530920|10518277|P3|Overall Study|Withdrawal by Subject|1
3061011|NCT00530920|10518278|P2|Overall Study|Withdrawal by Subject|0
3061012|NCT00530920|10518279|P1|Overall Study|Withdrawal by Subject|0
3061013|NCT00530920|10518277|P3|Overall Study|Adverse Event|3
3061014|NCT00530920|10518278|P2|Overall Study|Adverse Event|0
3061015|NCT00530920|10518279|P1|Overall Study|Adverse Event|0
3061016|NCT00530920|10518277|P3|Overall Study|Randomized but not treated|0
3061017|NCT00530920|10518278|P2|Overall Study|Randomized but not treated|2
3061018|NCT00530920|10518279|P1|Overall Study|Randomized but not treated|0
3061019|NCT00530894|10518339|P4|Overall Study|Alive and censored prior to 1 year|0
3061020|NCT00530894|10518340|P3|Overall Study|Alive and censored prior to 1 year|0
3061021|NCT00530894|10518341|P2|Overall Study|Alive and censored prior to 1 year|0
3061022|NCT00530894|10518342|P1|Overall Study|Alive and censored prior to 1 year|2
3061023|NCT00530894|10518339|P4|Overall Study|Withdrawal by Subject|5
3061024|NCT00530894|10518340|P3|Overall Study|Withdrawal by Subject|0
3061025|NCT00530894|10518341|P2|Overall Study|Withdrawal by Subject|23
3061026|NCT00530894|10518342|P1|Overall Study|Withdrawal by Subject|1
3061027|NCT00530894|10518339|P4|Overall Study|Lost to Follow-up|0
3061028|NCT00530894|10518340|P3|Overall Study|Lost to Follow-up|0
3061029|NCT00530894|10518341|P2|Overall Study|Lost to Follow-up|3
3061030|NCT00530894|10518342|P1|Overall Study|Lost to Follow-up|1
3061031|NCT00530894|10518339|P4|Overall Study|Death|89
3061032|NCT00530894|10518340|P3|Overall Study|Death|55
3061033|NCT00530894|10518341|P2|Overall Study|Death|89
3061034|NCT00530894|10518342|P1|Overall Study|Death|84
3061035|NCT00530855|10518370|P1|Overall Study|Other reason for premature termination|17
3061036|NCT00530855|10518370|P1|Overall Study|Lost to Follow-up|9
3061037|NCT00530855|10518370|P1|Overall Study|Unsatisfactory compliance of subject|11
3061038|NCT00530855|10518370|P1|Overall Study|Protocol Violation|3
3061039|NCT00530855|10518370|P1|Overall Study|Non Fatal Non Serious AE|12
3061040|NCT00530855|10518370|P1|Overall Study|Non Fatal Serious AE|7
3061041|NCT00530855|10518370|P1|Overall Study|Fatal Serious AE|3
3061042|NCT00530855|10518370|P1|Overall Study|Withdrawal by Subject|30
3061043|NCT00530855|10518370|P1|Overall Study|Lack of Efficacy|20
3061044|NCT00530842|10518379|P2|Period 2|Individual different reasons|0
3061045|NCT00530842|10518380|P1|Period 2|Individual different reasons|2
3061046|NCT00530842|10518379|P2|Period 2|Withdrawal by Subject|2
3061047|NCT00530842|10518380|P1|Period 2|Withdrawal by Subject|1
3061048|NCT00530842|10518379|P2|Period 2|Protocol Violation|0
3061049|NCT00530842|10518380|P1|Period 2|Protocol Violation|1
3061050|NCT00530842|10518379|P2|Period 2|Lost to Follow-up|4
3061051|NCT00530842|10518380|P1|Period 2|Lost to Follow-up|0
3061052|NCT00530842|10518379|P2|Period 2|Lack of Efficacy|0
3061053|NCT00530842|10518380|P1|Period 2|Lack of Efficacy|1
3061054|NCT00530842|10518379|P2|Period 2|Adverse Event|3
3061055|NCT00530842|10518380|P1|Period 2|Adverse Event|3
3061056|NCT00530842|10518379|P2|Period 1|Individual different reasons|3
3061057|NCT00530842|10518380|P1|Period 1|Individual different reasons|2
3061058|NCT00530842|10518379|P2|Period 1|Withdrawal by Subject|3
3061059|NCT00530842|10518380|P1|Period 1|Withdrawal by Subject|2
3061060|NCT00530842|10518379|P2|Period 1|Protocol Violation|1
3061061|NCT00530842|10518380|P1|Period 1|Protocol Violation|2
3061062|NCT00530842|10518379|P2|Period 1|Lack of Efficacy|1
3061063|NCT00530842|10518380|P1|Period 1|Lack of Efficacy|1
3061064|NCT00530842|10518379|P2|Period 1|Adverse Event|3
3061065|NCT00530842|10518380|P1|Period 1|Adverse Event|7
3061066|NCT00530842|10518379|P2|Overall Study|Individual different reasons|3
3061067|NCT00530842|10518380|P1|Overall Study|Individual different reasons|4
3061068|NCT00530842|10518379|P2|Overall Study|Withdrawal by Subject|5
3061069|NCT00530842|10518380|P1|Overall Study|Withdrawal by Subject|4
3061070|NCT00530842|10518379|P2|Overall Study|Protocol Violation|2
3061071|NCT00530842|10518380|P1|Overall Study|Protocol Violation|3
3061072|NCT00530842|10518379|P2|Overall Study|Lost to Follow-up|4
3061073|NCT00530842|10518380|P1|Overall Study|Lost to Follow-up|0
3061074|NCT00530842|10518379|P2|Overall Study|Lack of Efficacy|1
3061075|NCT00530842|10518380|P1|Overall Study|Lack of Efficacy|2
3061076|NCT00530842|10518379|P2|Overall Study|Adverse Event|6
3061077|NCT00530842|10518380|P1|Overall Study|Adverse Event|10
3061078|NCT00530816|10518507|P3|Overall Study|Withdrawal by Subject|6
3061079|NCT00530816|10518508|P2|Overall Study|Withdrawal by Subject|2
3061080|NCT00530816|10518509|P1|Overall Study|Withdrawal by Subject|1
3061081|NCT00530816|10518507|P3|Overall Study|Other|4
3061082|NCT00530816|10518508|P2|Overall Study|Other|3
3061083|NCT00530816|10518509|P1|Overall Study|Other|3
3061084|NCT00530816|10518507|P3|Overall Study|Adverse Event|7
3061085|NCT00530816|10518508|P2|Overall Study|Adverse Event|13
3061086|NCT00530816|10518509|P1|Overall Study|Adverse Event|6
3061087|NCT00530816|10518507|P3|Overall Study|Progressive Disease|24
3061088|NCT00530816|10518508|P2|Overall Study|Progressive Disease|24
3061089|NCT00530816|10518509|P1|Overall Study|Progressive Disease|16
3061090|NCT00530790|10518552|P1|Overall Study|Physician Decision|1
3061091|NCT00530790|10518552|P1|Overall Study|Withdrawal by Subject|2
3061092|NCT00530790|10518552|P1|Overall Study|Adverse Event|2
3061093|NCT00530777|10518574|P2|Overall Study|Unable to adhere to visit schedule|1
3061094|NCT00530777|10518575|P1|Overall Study|Unable to adhere to visit schedule|5
3061095|NCT00530777|10518574|P2|Overall Study|Withdrawal by Subject|1
3061096|NCT00530777|10518575|P1|Overall Study|Withdrawal by Subject|0
3061097|NCT00530777|10518574|P2|Overall Study|Physician Decision|0
3061098|NCT00530777|10518575|P1|Overall Study|Physician Decision|1
3061099|NCT00530777|10518574|P2|Overall Study|Death|2
3061100|NCT00530777|10518575|P1|Overall Study|Death|1
3061101|NCT00530777|10518574|P2|Overall Study|Lost to Follow-up|1
3061102|NCT00530777|10518575|P1|Overall Study|Lost to Follow-up|0
3061103|NCT00530712|10518632|P1|12 Month Follow-up Visit|Death|9
3061104|NCT00530712|10518632|P1|12 Month Follow-up Visit|Lost to Follow-up|7
3061105|NCT00530712|10518632|P1|12 Month Follow-up Visit|Missed Visit|3
3061106|NCT00530712|10518632|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
3061107|NCT00530712|10518632|P1|6 Month Follow-up Visit|Death|2
3061108|NCT00530712|10518632|P1|6 Month Follow-up Visit|Lost to Follow-up|3
3061109|NCT00530712|10518632|P1|6 Month Follow-up Visit|Missed Visit|3
3061110|NCT00530712|10518632|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
3061111|NCT00530712|10518632|P1|30 Day Follow-up Visit|Missed Visit|5
3061112|NCT00530712|10518632|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
3061113|NCT00530504|10518653|P1|Overall Study|Exited study due to other reasons|33
3061114|NCT00530504|10518653|P1|Overall Study|Withdrawal by Subject|39
3061115|NCT00530504|10518653|P1|Overall Study|Lost to Follow-up|26
3061116|NCT00530504|10518653|P1|Overall Study|Death|54
3061117|NCT00530439|10518659|P2|Overall Study|Severe malformation/abortion|3
3061118|NCT00530439|10518660|P1|Overall Study|Severe malformation/abortion|0
3061119|NCT00530439|10518659|P2|Overall Study|Twin pregnancy|2
3061120|NCT00530439|10518660|P1|Overall Study|Twin pregnancy|0
3061121|NCT00530439|10518659|P2|Overall Study|Misclassification|0
3061122|NCT00530439|10518660|P1|Overall Study|Misclassification|2
3061123|NCT00530439|10518659|P2|Overall Study|Missed abortion|4
3061124|NCT00530439|10518660|P1|Overall Study|Missed abortion|1
3061125|NCT00530439|10518659|P2|Overall Study|Withdraw|14
3061126|NCT00530439|10518660|P1|Overall Study|Withdraw|18
3061127|NCT00530439|10518659|P2|Overall Study|GDM|3
3061128|NCT00530439|10518660|P1|Overall Study|GDM|9
3061129|NCT00530348|10518668|P2|Overall Study|Noncompliance with inclusion criterion 3|1
3061130|NCT00530348|10518669|P1|Overall Study|Noncompliance with inclusion criterion 3|0
3061131|NCT00530348|10518668|P2|Overall Study|Randomised in error|0
3061132|NCT00530348|10518669|P1|Overall Study|Randomised in error|1
3061133|NCT00530348|10518668|P2|Overall Study|Withdrawal by Subject|12
3061134|NCT00530348|10518669|P1|Overall Study|Withdrawal by Subject|12
3061135|NCT00530348|10518668|P2|Overall Study|Pregnancy|0
3061136|NCT00530348|10518669|P1|Overall Study|Pregnancy|1
3061137|NCT00530348|10518668|P2|Overall Study|Physician Decision|2
3061138|NCT00530348|10518669|P1|Overall Study|Physician Decision|1
3061139|NCT00530348|10518668|P2|Overall Study|Lost to Follow-up|2
3061140|NCT00530348|10518669|P1|Overall Study|Lost to Follow-up|0
3061141|NCT00530348|10518668|P2|Overall Study|Lack of Efficacy|0
3061142|NCT00530348|10518669|P1|Overall Study|Lack of Efficacy|2
3061143|NCT00530348|10518668|P2|Overall Study|Death|1
3061144|NCT00530348|10518669|P1|Overall Study|Death|0
3061145|NCT00530348|10518668|P2|Overall Study|Adverse Event|1
3061146|NCT00530348|10518669|P1|Overall Study|Adverse Event|5
3061147|NCT00530335|10518685|P1|Overall Study|Physician Decision|1
3061148|NCT00530335|10518685|P1|Overall Study|Withdrawal by Subject|1
3061149|NCT00530335|10518685|P1|Overall Study|Protocol Violation|1
3061150|NCT00530335|10518685|P1|Overall Study|Adverse Event|3
3061151|NCT00530270|10518702|P2|Overall Study|Protocol Violation|0
3061152|NCT00530270|10518703|P1|Overall Study|Protocol Violation|1
3061153|NCT00530257|10518717|P1|Overall Study|Lost to Follow-up|1
3061154|NCT00530218|10518745|P1|Overall Study|Death|12
3061155|NCT00530218|10518745|P1|Overall Study|CMV Not Detected|13
3061156|NCT00530088|10518752|P1|Overall Study|Other Not Specified|2
3061157|NCT00530088|10518752|P1|Overall Study|Physician Decision|4
3061158|NCT00530088|10518752|P1|Overall Study|Disease Progression|4
3061159|NCT00530075|10518757|P1|Overall Study|Withdrawal by Subject|1
3061160|NCT00530075|10518757|P1|Overall Study|Protocol Violation|1
3061161|NCT00530075|10518757|P1|Overall Study|Lack of Efficacy|3
3061162|NCT00530075|10518757|P1|Overall Study|Death|1
3061163|NCT00530075|10518757|P1|Overall Study|Adverse Event|1
3061164|NCT00530023|10518770|P2|Overall Study|Withdrawal by Subject|1
3061165|NCT00530023|10518771|P1|Overall Study|Withdrawal by Subject|0
3061166|NCT00529958|10518788|P3|5-Year Follow-up|Withdrawal by Subject|0
3061167|NCT00529958|10518789|P2|5-Year Follow-up|Withdrawal by Subject|0
3061168|NCT00529958|10518790|P1|5-Year Follow-up|Withdrawal by Subject|1
3061169|NCT00529958|10518788|P3|5-Year Follow-up|Lost to Follow-up|1
3061170|NCT00529958|10518789|P2|5-Year Follow-up|Lost to Follow-up|3
3061171|NCT00529958|10518790|P1|5-Year Follow-up|Lost to Follow-up|2
3061172|NCT00529958|10518788|P3|2-Year Follow-up|Withdrawal by Subject|0
3061173|NCT00529958|10518789|P2|2-Year Follow-up|Withdrawal by Subject|0
3061174|NCT00529958|10518790|P1|2-Year Follow-up|Withdrawal by Subject|3
3061175|NCT00529958|10518788|P3|2-Year Follow-up|Lost to Follow-up|2
3061176|NCT00529958|10518789|P2|2-Year Follow-up|Lost to Follow-up|2
3061177|NCT00529958|10518790|P1|2-Year Follow-up|Lost to Follow-up|1
3061178|NCT00529802|10518831|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
3061179|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
3061180|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
3061181|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Death|1
3061182|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Adverse Event|2
3061183|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Worsening performance status|2
3061184|NCT00529802|10518831|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
3061185|NCT00529789|10518837|P1|Study Period IV|Lost to Follow-up|3
3061186|NCT00529789|10518837|P1|Study Period IV|Lack of Efficacy|1
3061187|NCT00529789|10518837|P1|Study Period IV|Adverse Event|1
3061188|NCT00529789|10518837|P1|Study Period IV|Parent/Caregiver Decision|1
3061189|NCT00529789|10518837|P1|Study Period II/III|Lost to Follow-up|3
3061190|NCT00529789|10518837|P1|Study Period II/III|Physician Decision|3
3061191|NCT00529789|10518837|P1|Study Period II/III|Protocol Violation|3
3061192|NCT00529789|10518837|P1|Study Period II/III|Withdrawal by Subject|1
3061193|NCT00529789|10518837|P1|Study Period II/III|Lack of Efficacy|2
3061194|NCT00529789|10518837|P1|Study Period II/III|Adverse Event|3
3061195|NCT00529789|10518837|P1|Study Period II/III|Parent/Caregiver Decision|9
3061196|NCT00529763|10518862|P3|Overall Study|Patient Withdrew Consent|2
3061197|NCT00529763|10518863|P2|Overall Study|Patient Withdrew Consent|3
3061198|NCT00529763|10518864|P1|Overall Study|Patient Withdrew Consent|2
3061199|NCT00529763|10518862|P3|Overall Study|Study Drug Toxicity|1
3061200|NCT00529763|10518863|P2|Overall Study|Study Drug Toxicity|6
3061201|NCT00529763|10518864|P1|Overall Study|Study Drug Toxicity|1
3061202|NCT00529763|10518862|P3|Overall Study|Stem Cell Transplant|0
3061203|NCT00529763|10518863|P2|Overall Study|Stem Cell Transplant|3
3061204|NCT00529763|10518864|P1|Overall Study|Stem Cell Transplant|0
3061205|NCT00529763|10518862|P3|Overall Study|Lost to Follow-up|1
3061206|NCT00529763|10518863|P2|Overall Study|Lost to Follow-up|1
3061207|NCT00529763|10518864|P1|Overall Study|Lost to Follow-up|0
3061208|NCT00529763|10518862|P3|Overall Study|Disease Progression|1
3061209|NCT00529763|10518863|P2|Overall Study|Disease Progression|16
3061210|NCT00529763|10518864|P1|Overall Study|Disease Progression|6
3061211|NCT00529763|10518862|P3|Overall Study|Death|1
3061212|NCT00529763|10518863|P2|Overall Study|Death|1
3061213|NCT00529763|10518864|P1|Overall Study|Death|0
3061214|NCT00529763|10518862|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
3061215|NCT00529763|10518863|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
3061216|NCT00529763|10518864|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
3061217|NCT00529659|10518902|P2|Overall Study|Withdrawal by Subject|6
3061218|NCT00529659|10518903|P1|Overall Study|Withdrawal by Subject|1
3061219|NCT00529659|10518902|P2|Overall Study|Protocol Violation|6
3061220|NCT00529659|10518903|P1|Overall Study|Protocol Violation|2
3061221|NCT00529659|10518902|P2|Overall Study|Physician Decision|2
3061222|NCT00529659|10518903|P1|Overall Study|Physician Decision|0
3061223|NCT00529659|10518902|P2|Overall Study|Lost to Follow-up|2
3061224|NCT00529659|10518903|P1|Overall Study|Lost to Follow-up|0
3061225|NCT00529659|10518902|P2|Overall Study|Adverse Event|7
3061226|NCT00529659|10518903|P1|Overall Study|Adverse Event|8
3061227|NCT00529633|10518921|P2|Overall Study|Withdrawal by Subject|1
3061228|NCT00529633|10518922|P1|Overall Study|Withdrawal by Subject|1
3061229|NCT00529568|10518934|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
3061230|NCT00529568|10518935|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
3061231|NCT00529568|10518936|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
3061232|NCT00529568|10518934|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
3061233|NCT00529568|10518935|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
3061234|NCT00529568|10518936|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
3061235|NCT00529568|10518934|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
3061236|NCT00529568|10518935|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
3061237|NCT00529568|10518936|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
3061238|NCT00529568|10518934|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
3061239|NCT00529568|10518935|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
3061240|NCT00529568|10518936|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
3061241|NCT00529568|10518934|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
3061242|NCT00529568|10518935|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
3061243|NCT00529568|10518936|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
3061244|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
3061327|NCT00529399|10519222|P2|Overall Study|Withdrawal by Subject|0
3061245|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
3061246|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
3061247|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
3061248|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
3061249|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
3061250|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
3061251|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
3061252|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
3061253|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
3061254|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
3061255|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
3061256|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
3061257|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
3061258|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
3061259|NCT00529568|10518934|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
3061260|NCT00529568|10518935|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
3061261|NCT00529568|10518936|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
3061262|NCT00529542|10518999|P2|Overall Study|Lost to Follow-up|1
3061263|NCT00529542|10519000|P1|Overall Study|Lost to Follow-up|0
3061264|NCT00529542|10518999|P2|Overall Study|Withdrawal by Subject|0
3061265|NCT00529542|10519000|P1|Overall Study|Withdrawal by Subject|1
3061266|NCT00529529|10519043|P3|Overall Study|Administrative problems|3
3061267|NCT00529529|10519044|P2|Overall Study|Administrative problems|0
3061268|NCT00529529|10519045|P1|Overall Study|Administrative problems|1
3061269|NCT00529529|10519043|P3|Overall Study|Abnormal test procedure result(s)|0
3061270|NCT00529529|10519044|P2|Overall Study|Abnormal test procedure result(s)|0
3061271|NCT00529529|10519045|P1|Overall Study|Abnormal test procedure result(s)|1
3061272|NCT00529529|10519043|P3|Overall Study|Death|0
3061273|NCT00529529|10519044|P2|Overall Study|Death|0
3061274|NCT00529529|10519045|P1|Overall Study|Death|2
3061275|NCT00529529|10519043|P3|Overall Study|Unsatisfactory therapeutic effect|2
3061276|NCT00529529|10519044|P2|Overall Study|Unsatisfactory therapeutic effect|2
3061277|NCT00529529|10519045|P1|Overall Study|Unsatisfactory therapeutic effect|2
3061278|NCT00529529|10519043|P3|Overall Study|Lost to Follow-up|1
3061279|NCT00529529|10519044|P2|Overall Study|Lost to Follow-up|3
3061280|NCT00529529|10519045|P1|Overall Study|Lost to Follow-up|5
3061281|NCT00529529|10519043|P3|Overall Study|Protocol deviation|5
3061282|NCT00529529|10519044|P2|Overall Study|Protocol deviation|12
3061283|NCT00529529|10519045|P1|Overall Study|Protocol deviation|8
3061284|NCT00529529|10519043|P3|Overall Study|Subject withdrew consent|12
3061285|NCT00529529|10519044|P2|Overall Study|Subject withdrew consent|9
3061286|NCT00529529|10519045|P1|Overall Study|Subject withdrew consent|12
3061287|NCT00529529|10519043|P3|Overall Study|Adverse Event|8
3061288|NCT00529529|10519044|P2|Overall Study|Adverse Event|17
3061289|NCT00529529|10519045|P1|Overall Study|Adverse Event|12
3061290|NCT00529516|10519104|P3|Overall Study|Lost to Follow-up|1
3061291|NCT00529516|10519105|P2|Overall Study|Lost to Follow-up|0
3061292|NCT00529516|10519106|P1|Overall Study|Lost to Follow-up|0
3061293|NCT00529516|10519104|P3|Overall Study|Withdrawal by Subject|0
3061294|NCT00529516|10519105|P2|Overall Study|Withdrawal by Subject|1
3061295|NCT00529516|10519106|P1|Overall Study|Withdrawal by Subject|1
3061296|NCT00529516|10519104|P3|Overall Study|Adverse Event|0
3061297|NCT00529516|10519105|P2|Overall Study|Adverse Event|1
3061298|NCT00529516|10519106|P1|Overall Study|Adverse Event|2
3061299|NCT00529451|10519191|P4|Overall Study|Administrative problems|2
3061300|NCT00529451|10519192|P3|Overall Study|Administrative problems|0
3061301|NCT00529451|10519193|P2|Overall Study|Administrative problems|1
3061302|NCT00529451|10519194|P1|Overall Study|Administrative problems|1
3061303|NCT00529451|10519191|P4|Overall Study|Protocol deviation|1
3061304|NCT00529451|10519192|P3|Overall Study|Protocol deviation|4
3061305|NCT00529451|10519193|P2|Overall Study|Protocol deviation|1
3061306|NCT00529451|10519194|P1|Overall Study|Protocol deviation|1
3061307|NCT00529451|10519191|P4|Overall Study|Lost to Follow-up|4
3061308|NCT00529451|10519192|P3|Overall Study|Lost to Follow-up|4
3061309|NCT00529451|10519193|P2|Overall Study|Lost to Follow-up|7
3061310|NCT00529451|10519194|P1|Overall Study|Lost to Follow-up|4
3061311|NCT00529451|10519191|P4|Overall Study|Unsatisfactory therapeutic response|4
3061312|NCT00529451|10519192|P3|Overall Study|Unsatisfactory therapeutic response|5
3061313|NCT00529451|10519193|P2|Overall Study|Unsatisfactory therapeutic response|2
3061314|NCT00529451|10519194|P1|Overall Study|Unsatisfactory therapeutic response|6
3061315|NCT00529451|10519191|P4|Overall Study|Adverse Event|8
3061316|NCT00529451|10519192|P3|Overall Study|Adverse Event|14
3061317|NCT00529451|10519193|P2|Overall Study|Adverse Event|16
3061318|NCT00529451|10519194|P1|Overall Study|Adverse Event|9
3061319|NCT00529451|10519191|P4|Overall Study|Subject withdrew consent|12
3061320|NCT00529451|10519192|P3|Overall Study|Subject withdrew consent|13
3061321|NCT00529451|10519193|P2|Overall Study|Subject withdrew consent|21
3061322|NCT00529451|10519194|P1|Overall Study|Subject withdrew consent|16
3061323|NCT00529399|10519221|P3|Overall Study|Non-compliant|0
3061324|NCT00529399|10519222|P2|Overall Study|Non-compliant|1
3061325|NCT00529399|10519223|P1|Overall Study|Non-compliant|0
3061326|NCT00529399|10519221|P3|Overall Study|Withdrawal by Subject|1
3061328|NCT00529399|10519223|P1|Overall Study|Withdrawal by Subject|1
3061329|NCT00529399|10519221|P3|Overall Study|Lost to Follow-up|1
3061330|NCT00529399|10519222|P2|Overall Study|Lost to Follow-up|0
3061331|NCT00529399|10519223|P1|Overall Study|Lost to Follow-up|1
3061332|NCT00529386|10519231|P1|Overall Study|Lost to Follow-up|1
3061333|NCT00529373|10519237|P2|Second Extension Study|Status Missing|5
3061334|NCT00529373|10519238|P1|Second Extension Study|Status Missing|5
3061335|NCT00529373|10519237|P2|Second Extension Study|Withdrawal by Subject|75
3061336|NCT00529373|10519238|P1|Second Extension Study|Withdrawal by Subject|97
3061337|NCT00529373|10519237|P2|Second Extension Study|Protocol Violation|1
3061338|NCT00529373|10519238|P1|Second Extension Study|Protocol Violation|2
3061339|NCT00529373|10519237|P2|Second Extension Study|Physician Decision|26
3061340|NCT00529373|10519238|P1|Second Extension Study|Physician Decision|63
3061341|NCT00529373|10519237|P2|Second Extension Study|Other|12
3061342|NCT00529373|10519238|P1|Second Extension Study|Other|7
3061343|NCT00529373|10519237|P2|Second Extension Study|Lost to Follow-up|12
3061344|NCT00529373|10519238|P1|Second Extension Study|Lost to Follow-up|18
3061345|NCT00529373|10519237|P2|Second Extension Study|Lack of Efficacy|15
3061346|NCT00529373|10519238|P1|Second Extension Study|Lack of Efficacy|7
3061347|NCT00529373|10519237|P2|Second Extension Study|Adverse Event|51
3061348|NCT00529373|10519238|P1|Second Extension Study|Adverse Event|101
3061349|NCT00529373|10519237|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
3061350|NCT00529373|10519238|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
3061351|NCT00529373|10519237|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
3061352|NCT00529373|10519238|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
3061353|NCT00529373|10519237|P2|First Extension Study|Discontinued after 5 years completion|346
3061354|NCT00529373|10519238|P1|First Extension Study|Discontinued after 5 years completion|208
3061355|NCT00529373|10519237|P2|First Extension Study|Disposition record non-existing|1
3061356|NCT00529373|10519238|P1|First Extension Study|Disposition record non-existing|0
3061357|NCT00529373|10519237|P2|First Extension Study|Withdrawal by Subject|287
3061358|NCT00529373|10519238|P1|First Extension Study|Withdrawal by Subject|296
3061359|NCT00529373|10519237|P2|First Extension Study|Protocol Violation|13
3061360|NCT00529373|10519238|P1|First Extension Study|Protocol Violation|16
3061361|NCT00529373|10519237|P2|First Extension Study|Physician Decision|45
3061362|NCT00529373|10519238|P1|First Extension Study|Physician Decision|50
3061363|NCT00529373|10519237|P2|First Extension Study|Other|47
3061364|NCT00529373|10519238|P1|First Extension Study|Other|27
3061365|NCT00529373|10519237|P2|First Extension Study|Lost to Follow-up|37
3061366|NCT00529373|10519238|P1|First Extension Study|Lost to Follow-up|41
3061367|NCT00529373|10519237|P2|First Extension Study|Lack of Efficacy|427
3061368|NCT00529373|10519238|P1|First Extension Study|Lack of Efficacy|65
3061369|NCT00529373|10519237|P2|First Extension Study|Adverse Event|142
3061370|NCT00529373|10519238|P1|First Extension Study|Adverse Event|162
3061371|NCT00529373|10519237|P2|Base Study|Did not continue into Extension|2238
3061372|NCT00529373|10519238|P1|Base Study|Did not continue into Extension|1795
3061373|NCT00529373|10519237|P2|Base Study|Withdrawal by Subject|967
3061374|NCT00529373|10519238|P1|Base Study|Withdrawal by Subject|1062
3061375|NCT00529373|10519237|P2|Base Study|Protocol Violation|38
3061376|NCT00529373|10519238|P1|Base Study|Protocol Violation|48
3061377|NCT00529373|10519237|P2|Base Study|Physician Decision|52
3061378|NCT00529373|10519238|P1|Base Study|Physician Decision|60
3061379|NCT00529373|10519237|P2|Base Study|Other Protocol Specified Criteria|20
3061380|NCT00529373|10519238|P1|Base Study|Other Protocol Specified Criteria|19
3061381|NCT00529373|10519237|P2|Base Study|Lost to Follow-up|208
3061382|NCT00529373|10519238|P1|Base Study|Lost to Follow-up|221
3061383|NCT00529373|10519237|P2|Base Study|Lack of Efficacy|75
3061384|NCT00529373|10519238|P1|Base Study|Lack of Efficacy|16
3061385|NCT00529373|10519237|P2|Base Study|Adverse Event|470
3061386|NCT00529373|10519238|P1|Base Study|Adverse Event|525
3061387|NCT00529308|10519432|P2|Overall Study|Withdrawal by Subject|1
3061388|NCT00529308|10519433|P1|Overall Study|Withdrawal by Subject|1
3061389|NCT00529243|10519462|P1|Overall Study|Relocated|1
3061390|NCT00529243|10519462|P1|Overall Study|Death|1
3061391|NCT00529243|10519462|P1|Overall Study|Adverse Event|1
3061392|NCT00529217|10519467|P1|Overall Study|Unable to adhere to study schedule|2
3061393|NCT00529217|10519467|P1|Overall Study|Lack of Efficacy|2
3061394|NCT00529152|10519503|P1|Overall Study|Lost to Follow-up|1
3061395|NCT00529152|10519503|P1|Overall Study|Withdrawal by Subject|2
3061396|NCT00529152|10519503|P1|Overall Study|Adverse Event|2
3061397|NCT00529100|10519527|P2|Overall Study|Participant Ineligibility|1
3061398|NCT00529100|10519528|P1|Overall Study|Participant Ineligibility|0
3061399|NCT00529100|10519527|P2|Overall Study|Withdrawal by Subject|1
3061400|NCT00529100|10519528|P1|Overall Study|Withdrawal by Subject|0
3061401|NCT00529100|10519527|P2|Overall Study|Progressive Disease|1
3061402|NCT00529100|10519528|P1|Overall Study|Progressive Disease|0
3061403|NCT00529100|10519527|P2|Overall Study|Protocol Violation|1
3061404|NCT00529100|10519528|P1|Overall Study|Protocol Violation|0
3061405|NCT00529100|10519527|P2|Overall Study|Adverse Event|5
3061406|NCT00529100|10519528|P1|Overall Study|Adverse Event|0
3061407|NCT00529087|10519545|P3|Overall Study|Protocol deviation|2
3061408|NCT00529087|10519546|P2|Overall Study|Protocol deviation|1
3061409|NCT00529087|10519547|P1|Overall Study|Protocol deviation|1
3061410|NCT00529087|10519545|P3|Overall Study|Withdrawal by Subject|3
3061411|NCT00529087|10519546|P2|Overall Study|Withdrawal by Subject|3
3061412|NCT00529087|10519547|P1|Overall Study|Withdrawal by Subject|3
3061413|NCT00529087|10519545|P3|Overall Study|Protocol Violation|6
3061414|NCT00529087|10519546|P2|Overall Study|Protocol Violation|7
3061415|NCT00529087|10519547|P1|Overall Study|Protocol Violation|8
3061416|NCT00529087|10519545|P3|Overall Study|Lost to Follow-up|1
3061417|NCT00529087|10519546|P2|Overall Study|Lost to Follow-up|4
3061418|NCT00529087|10519547|P1|Overall Study|Lost to Follow-up|6
3061419|NCT00529087|10519545|P3|Overall Study|Adverse Event|4
3061420|NCT00529087|10519546|P2|Overall Study|Adverse Event|13
3061421|NCT00529087|10519547|P1|Overall Study|Adverse Event|10
3061422|NCT00529035|10519611|P1|Overall Study|Withdrawal by Subject|1
3061423|NCT00528970|10519625|P3|Overall Study|Randomized but not treated|1
3061424|NCT00528970|10519626|P2|Overall Study|Randomized but not treated|0
3061425|NCT00528970|10519627|P1|Overall Study|Randomized but not treated|0
3061426|NCT00528970|10519625|P3|Overall Study|Withdrawal by Subject|5
3061427|NCT00528970|10519626|P2|Overall Study|Withdrawal by Subject|3
3061428|NCT00528970|10519627|P1|Overall Study|Withdrawal by Subject|4
3061429|NCT00528970|10519625|P3|Overall Study|Lack of Efficacy|1
3061430|NCT00528970|10519626|P2|Overall Study|Lack of Efficacy|0
3061431|NCT00528970|10519627|P1|Overall Study|Lack of Efficacy|0
3061432|NCT00528970|10519625|P3|Overall Study|Protocol Violation|4
3061433|NCT00528970|10519626|P2|Overall Study|Protocol Violation|1
3061434|NCT00528970|10519627|P1|Overall Study|Protocol Violation|2
3061435|NCT00528970|10519625|P3|Overall Study|Other than specified|3
3061436|NCT00528970|10519626|P2|Overall Study|Other than specified|3
3061437|NCT00528970|10519627|P1|Overall Study|Other than specified|2
3061438|NCT00528970|10519625|P3|Overall Study|Lost to Follow-up|1
3061439|NCT00528970|10519626|P2|Overall Study|Lost to Follow-up|0
3061440|NCT00528970|10519627|P1|Overall Study|Lost to Follow-up|0
3061441|NCT00528970|10519625|P3|Overall Study|Adverse Event|5
3061442|NCT00528970|10519626|P2|Overall Study|Adverse Event|8
3061443|NCT00528970|10519627|P1|Overall Study|Adverse Event|6
3061444|NCT00528957|10519646|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
3061445|NCT00528957|10519647|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
3061446|NCT00528957|10519646|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
3061447|NCT00528957|10519647|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
3061448|NCT00528957|10519646|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
3061449|NCT00528957|10519647|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
3061450|NCT00528957|10519646|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
3061451|NCT00528957|10519647|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
3061452|NCT00528957|10519646|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
3061453|NCT00528957|10519647|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
3061454|NCT00528957|10519646|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
3061455|NCT00528957|10519647|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
3061456|NCT00528957|10519646|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
3061457|NCT00528957|10519647|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
3061458|NCT00528957|10519646|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
3061459|NCT00528957|10519647|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
3061460|NCT00528957|10519646|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
3061461|NCT00528957|10519647|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
3061462|NCT00528957|10519646|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
3061463|NCT00528957|10519647|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
3061464|NCT00528957|10519646|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
3061465|NCT00528957|10519647|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
3061466|NCT00528957|10519646|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
3061467|NCT00528957|10519647|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
3061468|NCT00528957|10519646|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
3061469|NCT00528957|10519647|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
3061470|NCT00528957|10519646|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
3061471|NCT00528957|10519647|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
3061472|NCT00528957|10519646|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
3061473|NCT00528957|10519647|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
3061474|NCT00528957|10519646|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
3061475|NCT00528957|10519647|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
3061476|NCT00528931|10519788|P1|Overall Study|Lost to Follow-up|1
3061477|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
3061478|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
3061479|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
3061480|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
3061481|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
3061482|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
3061483|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
3061484|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
3061485|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
3061486|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
3061487|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
3061488|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
3061489|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
3061490|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
3061491|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
3061492|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
3061493|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Death|0
3061494|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Death|0
3061495|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Death|1
3061496|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Death|0
3061497|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
3061498|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
3061499|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
3061500|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
3061501|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
3061502|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
3061503|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
3061504|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
3061505|NCT00528879|10519800|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
3061506|NCT00528879|10519801|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
3061507|NCT00528879|10519802|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
3061508|NCT00528879|10519803|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
3061509|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Other|1
3061510|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Other|1
3061511|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Other|0
3061512|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Other|0
3061513|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
3061514|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
3061515|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
3061516|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
3061517|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
3061518|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
3061519|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
3061520|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
3061521|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
3061522|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
3061523|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
3061524|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
3061525|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
3061526|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
3061527|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
3061528|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
3061529|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
3061530|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
3061531|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
3061532|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
3061533|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
3061534|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
3061535|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
3061536|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
3061537|NCT00528879|10519800|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
3061538|NCT00528879|10519801|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
3061539|NCT00528879|10519802|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
3061540|NCT00528879|10519803|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
3061541|NCT00528866|10519869|P1|Overall Study|Protocol Violation|6
3061542|NCT00528840|10519882|P1|Overall Study|Other|2
3061543|NCT00528840|10519882|P1|Overall Study|Administrative Reasons|1
3061544|NCT00528840|10519882|P1|Overall Study|Death|2
3061545|NCT00528840|10519882|P1|Overall Study|Withdrawal by Subject|17
3061546|NCT00528840|10519882|P1|Overall Study|Adverse Event|1
3061547|NCT00528840|10519882|P1|Overall Study|Lost to Follow-up|10
3061548|NCT00528801|10519896|P2|Overall Study|Administrative Reasons|1
3061549|NCT00528801|10519897|P1|Overall Study|Administrative Reasons|0
3061550|NCT00528801|10519896|P2|Overall Study|Lost to Follow-up|4
3061551|NCT00528801|10519897|P1|Overall Study|Lost to Follow-up|15
3061552|NCT00528801|10519896|P2|Overall Study|Protocol Violation|5
3061553|NCT00528801|10519897|P1|Overall Study|Protocol Violation|11
3061554|NCT00528801|10519896|P2|Overall Study|Withdrawal by Subject|1
3061555|NCT00528801|10519897|P1|Overall Study|Withdrawal by Subject|1
3061556|NCT00528775|10519911|P1|Overall Study|Other not specified|1
3061557|NCT00528645|10519919|P1|Overall Study|Adverse Event|3
3061558|NCT00528606|10519928|P2|Overall Study|Other|0
3061559|NCT00528606|10519929|P1|Overall Study|Other|2
3061560|NCT00528606|10519928|P2|Overall Study|Adverse Event|0
3061561|NCT00528606|10519929|P1|Overall Study|Adverse Event|3
3061562|NCT00528606|10519928|P2|Overall Study|Lost to Follow-up|1
3061563|NCT00528606|10519929|P1|Overall Study|Lost to Follow-up|4
3061564|NCT00528606|10519928|P2|Overall Study|Withdrew consent|3
3061565|NCT00528606|10519929|P1|Overall Study|Withdrew consent|4
3061566|NCT00528567|10519962|P2|Overall Study|Administrative/Other|75
3061567|NCT00528567|10519963|P1|Overall Study|Administrative/Other|22
3061568|NCT00528567|10519962|P2|Overall Study|Other Protocol Violation|21
3061569|NCT00528567|10519963|P1|Overall Study|Other Protocol Violation|5
3061570|NCT00528567|10519962|P2|Overall Study|Failure to Return|4
3061571|NCT00528567|10519963|P1|Overall Study|Failure to Return|1
3061572|NCT00528567|10519962|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
3061573|NCT00528567|10519963|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
3061574|NCT00528567|10519962|P2|Overall Study|Withdrew Consent|55
3061575|NCT00528567|10519963|P1|Overall Study|Withdrew Consent|59
3061576|NCT00528567|10519962|P2|Overall Study|Violation Criteria at Entry|17
3061577|NCT00528567|10519963|P1|Overall Study|Violation Criteria at Entry|3
3061578|NCT00528567|10519962|P2|Overall Study|Adverse Event/Intermittent Illness|29
3061579|NCT00528567|10519963|P1|Overall Study|Adverse Event/Intermittent Illness|255
3061580|NCT00528567|10519962|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
3061581|NCT00528567|10519963|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
3061582|NCT00528567|10519962|P2|Overall Study|Death|5
3061583|NCT00528567|10519963|P1|Overall Study|Death|4
3061584|NCT00528528|10520030|P4|Overall Study|Ongoing participant|0
3061585|NCT00528528|10520031|P3|Overall Study|Ongoing participant|1
3061586|NCT00528528|10520032|P2|Overall Study|Ongoing participant|0
3061587|NCT00528528|10520033|P1|Overall Study|Ongoing participant|0
3061588|NCT00528528|10520030|P4|Overall Study|Withdrawal by Subject|1
3061589|NCT00528528|10520031|P3|Overall Study|Withdrawal by Subject|1
3061590|NCT00528528|10520032|P2|Overall Study|Withdrawal by Subject|2
3061591|NCT00528528|10520033|P1|Overall Study|Withdrawal by Subject|3
3061592|NCT00528528|10520030|P4|Overall Study|Other|0
3061593|NCT00528528|10520031|P3|Overall Study|Other|0
3061594|NCT00528528|10520032|P2|Overall Study|Other|1
3061595|NCT00528528|10520033|P1|Overall Study|Other|0
3061596|NCT00528528|10520030|P4|Overall Study|Ineligible to continue the trial|1
3061597|NCT00528528|10520031|P3|Overall Study|Ineligible to continue the trial|0
3061598|NCT00528528|10520032|P2|Overall Study|Ineligible to continue the trial|0
3061599|NCT00528528|10520033|P1|Overall Study|Ineligible to continue the trial|0
3061600|NCT00528528|10520030|P4|Overall Study|Lost to Follow-up|1
3061601|NCT00528528|10520031|P3|Overall Study|Lost to Follow-up|1
3061602|NCT00528528|10520032|P2|Overall Study|Lost to Follow-up|0
3061603|NCT00528528|10520033|P1|Overall Study|Lost to Follow-up|0
3061604|NCT00528424|10520071|P1|Overall Study|Other|12
3061605|NCT00528424|10520071|P1|Overall Study|Administrative reason|2
3061606|NCT00528424|10520071|P1|Overall Study|Withdrew consent|2
3061607|NCT00528424|10520071|P1|Overall Study|Lost to Follow-up|13
3061608|NCT00528411|10520086|P3|Overall Study|Prior commitment medication|0
3061609|NCT00528411|10520087|P2|Overall Study|Prior commitment medication|1
3061610|NCT00528411|10520088|P1|Overall Study|Prior commitment medication|0
3061611|NCT00528411|10520086|P3|Overall Study|Severe non-compliance to protocol|0
3061612|NCT00528411|10520087|P2|Overall Study|Severe non-compliance to protocol|1
3061613|NCT00528411|10520088|P1|Overall Study|Severe non-compliance to protocol|0
3061614|NCT00528411|10520086|P3|Overall Study|Incorrect Enrolment|0
3061615|NCT00528411|10520087|P2|Overall Study|Incorrect Enrolment|1
3061616|NCT00528411|10520088|P1|Overall Study|Incorrect Enrolment|1
3061617|NCT00528411|10520086|P3|Overall Study|Adverse Event|1
3061618|NCT00528411|10520087|P2|Overall Study|Adverse Event|0
3061619|NCT00528411|10520088|P1|Overall Study|Adverse Event|4
3061620|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
3061621|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
3061622|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
3061623|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
3061624|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
3061625|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
3061626|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
3061627|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
3061628|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
3061629|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
3061630|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061631|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
3061632|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061633|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061634|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061635|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061636|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
3061637|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
3061638|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061639|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061640|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061641|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
3061642|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
3061643|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061644|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061645|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061646|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
3061647|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
3061648|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
3061649|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
3061650|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
3061651|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
3061652|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
3061653|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
3061654|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
3061655|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
3061656|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
3061657|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
3061658|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
3061659|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
3061660|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
3061661|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
3061662|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
3061663|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
3061664|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
3061665|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
3061666|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
3061667|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
3061668|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
3061669|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
3061670|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
3061671|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
3061672|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
3061673|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
3061674|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
3061675|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
3061676|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
3061677|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
3061678|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
3061679|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
3061680|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
3061681|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
3061682|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
3061683|NCT00528372|10520225|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
3061684|NCT00528372|10520226|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
3061685|NCT00528372|10520227|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
3061686|NCT00528372|10520228|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
3061687|NCT00528372|10520229|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
3061688|NCT00528372|10520230|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
3061689|NCT00528372|10520231|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
3061690|NCT00528372|10520232|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
3061691|NCT00528372|10520233|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
3061692|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061693|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
3061694|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061695|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061696|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061697|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
3061698|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061699|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
3061700|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
3061701|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061702|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061703|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061704|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
3061705|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061706|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061707|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
3061708|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
3061709|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
3061710|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061711|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061712|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061713|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
3061714|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061715|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
3061716|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061717|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061718|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
3061719|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
3061720|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
3061721|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
3061722|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
3061723|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
3061724|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
3061725|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
3061726|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
3061727|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
3061728|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
3061729|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
3061730|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
3061731|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
3061732|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
3061733|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
3061734|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
3061735|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
3061736|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
3061737|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
3061738|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
3061739|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
3061740|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
3061741|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
3061742|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
3061743|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
3061744|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
3061745|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
3061746|NCT00528372|10520225|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061747|NCT00528372|10520226|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061748|NCT00528372|10520227|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061749|NCT00528372|10520228|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061750|NCT00528372|10520229|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061751|NCT00528372|10520230|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061752|NCT00528372|10520231|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061753|NCT00528372|10520232|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
3061754|NCT00528372|10520233|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
3061755|NCT00528112|10520365|P2|Extension Phase|Protocol Violation|2
3061756|NCT00528112|10520366|P1|Extension Phase|Protocol Violation|0
3061757|NCT00528112|10520365|P2|Extension Phase|Adverse Event|36
3061758|NCT00528112|10520366|P1|Extension Phase|Adverse Event|0
3061759|NCT00528112|10520365|P2|Extension Phase|Death|1
3061760|NCT00528112|10520366|P1|Extension Phase|Death|0
3061761|NCT00528112|10520365|P2|Extension Phase|Lost to Follow-up|12
3061762|NCT00528112|10520366|P1|Extension Phase|Lost to Follow-up|0
3061763|NCT00528112|10520365|P2|Extension Phase|Pregnancy|3
3061764|NCT00528112|10520366|P1|Extension Phase|Pregnancy|0
3061765|NCT00528112|10520365|P2|Extension Phase|Other reasons|100
3061766|NCT00528112|10520366|P1|Extension Phase|Other reasons|0
3061767|NCT00528112|10520365|P2|Extension Phase|Withdrawal by Subject|3
3061768|NCT00528112|10520366|P1|Extension Phase|Withdrawal by Subject|0
3061769|NCT00528112|10520365|P2|Treatment up to 3 Years|Other reasons|186
3061770|NCT00528112|10520366|P1|Treatment up to 3 Years|Other reasons|186
3061771|NCT00528112|10520365|P2|Treatment up to 3 Years|Pregnancy|10
3061772|NCT00528112|10520366|P1|Treatment up to 3 Years|Pregnancy|9
3061773|NCT00528112|10520365|P2|Treatment up to 3 Years|Lost to Follow-up|61
3061774|NCT00528112|10520366|P1|Treatment up to 3 Years|Lost to Follow-up|63
3061775|NCT00528112|10520365|P2|Treatment up to 3 Years|Death|1
3061776|NCT00528112|10520366|P1|Treatment up to 3 Years|Death|0
3061777|NCT00528112|10520365|P2|Treatment up to 3 Years|Protocol Violation|16
3061778|NCT00528112|10520366|P1|Treatment up to 3 Years|Protocol Violation|16
3061779|NCT00528112|10520365|P2|Treatment up to 3 Years|Withdrawal by Subject|31
3061780|NCT00528112|10520366|P1|Treatment up to 3 Years|Withdrawal by Subject|26
3061781|NCT00528112|10520365|P2|Treatment up to 3 Years|Adverse Event|278
3061782|NCT00528112|10520366|P1|Treatment up to 3 Years|Adverse Event|313
3061783|NCT00528021|10520424|P4|Overall Study|Lack of Efficacy|9
3061784|NCT00528021|10520425|P3|Overall Study|Lack of Efficacy|7
3061785|NCT00528021|10520426|P2|Overall Study|Lack of Efficacy|13
3061786|NCT00528021|10520427|P1|Overall Study|Lack of Efficacy|17
3061787|NCT00527982|10520439|P2|Overall Study|Physician Decision|0
3061788|NCT00527982|10520440|P1|Overall Study|Physician Decision|1
3061789|NCT00527904|10520481|P1|Overall Study|misc|22
3061790|NCT00527904|10520481|P1|Overall Study|Lost to Follow-up|8
3061791|NCT00527904|10520481|P1|Overall Study|Withdrawal by Subject|21
3061792|NCT00527904|10520481|P1|Overall Study|Adverse Event|45
3061793|NCT00527826|10520500|P2|Overall Study|Participant moved away|1
3061794|NCT00527826|10520501|P1|Overall Study|Participant moved away|0
3061795|NCT00527826|10520500|P2|Overall Study|Additional Intake of Viani forte|1
3061796|NCT00527826|10520501|P1|Overall Study|Additional Intake of Viani forte|0
3061797|NCT00527826|10520500|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
3061798|NCT00527826|10520501|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
3061799|NCT00527826|10520500|P2|Overall Study|Inclusion Criteria Not Met|3
3061800|NCT00527826|10520501|P1|Overall Study|Inclusion Criteria Not Met|3
3061801|NCT00527826|10520500|P2|Overall Study|Withdrawal by Subject|8
3061802|NCT00527826|10520501|P1|Overall Study|Withdrawal by Subject|5
3061803|NCT00527826|10520500|P2|Overall Study|Lost to Follow-up|2
3061804|NCT00527826|10520501|P1|Overall Study|Lost to Follow-up|3
3061805|NCT00527826|10520500|P2|Overall Study|Adverse Event|10
3061806|NCT00527826|10520501|P1|Overall Study|Adverse Event|10
3061807|NCT00527787|10520550|P2|Overall Study|misc|2
3061808|NCT00527787|10520551|P1|Overall Study|misc|5
3061809|NCT00527787|10520550|P2|Overall Study|Duodenal Ulcer|10
3061810|NCT00527787|10520551|P1|Overall Study|Duodenal Ulcer|1
3061811|NCT00527787|10520550|P2|Overall Study|Lost to Follow-up|2
3061812|NCT00527787|10520551|P1|Overall Study|Lost to Follow-up|5
3061813|NCT00527787|10520550|P2|Overall Study|Withdrawal by Subject|25
3061814|NCT00527787|10520551|P1|Overall Study|Withdrawal by Subject|13
3061815|NCT00527787|10520550|P2|Overall Study|Adverse Event|24
3061816|NCT00527787|10520551|P1|Overall Study|Adverse Event|14
3061817|NCT00527748|10520573|P1|Overall Study|Other|3
3061818|NCT00527735|10520580|P3|Overall Study|Completed treatment during maintenance|1
3061819|NCT00527735|10520581|P2|Overall Study|Completed treatment during maintenance|2
3061820|NCT00527735|10520582|P1|Overall Study|Completed treatment during maintenance|2
3061821|NCT00527735|10520580|P3|Overall Study|Poor compliance or noncompliance|1
3061822|NCT00527735|10520581|P2|Overall Study|Poor compliance or noncompliance|1
3061823|NCT00527735|10520582|P1|Overall Study|Poor compliance or noncompliance|0
3061824|NCT00527735|10520580|P3|Overall Study|Lost to Follow-up|3
3061825|NCT00527735|10520581|P2|Overall Study|Lost to Follow-up|0
3061826|NCT00527735|10520582|P1|Overall Study|Lost to Follow-up|0
3061827|NCT00527735|10520580|P3|Overall Study|No longer met study criteria|1
3061828|NCT00527735|10520581|P2|Overall Study|No longer met study criteria|2
3061829|NCT00527735|10520582|P1|Overall Study|No longer met study criteria|2
3061830|NCT00527735|10520580|P3|Overall Study|Withdrawal by Subject|3
3061831|NCT00527735|10520581|P2|Overall Study|Withdrawal by Subject|4
3061832|NCT00527735|10520582|P1|Overall Study|Withdrawal by Subject|5
3061833|NCT00527735|10520580|P3|Overall Study|Not identified|5
3061834|NCT00527735|10520581|P2|Overall Study|Not identified|5
3061835|NCT00527735|10520582|P1|Overall Study|Not identified|5
3061836|NCT00527735|10520580|P3|Overall Study|Adverse Event|7
3061837|NCT00527735|10520581|P2|Overall Study|Adverse Event|6
3061838|NCT00527735|10520582|P1|Overall Study|Adverse Event|10
3061839|NCT00527735|10520580|P3|Overall Study|Completed treatment in treatment phase|18
3061840|NCT00527735|10520581|P2|Overall Study|Completed treatment in treatment phase|13
3061841|NCT00527735|10520582|P1|Overall Study|Completed treatment in treatment phase|14
3061842|NCT00527735|10520580|P3|Overall Study|Death|15
3061843|NCT00527735|10520581|P2|Overall Study|Death|13
3061844|NCT00527735|10520582|P1|Overall Study|Death|23
3061845|NCT00527735|10520580|P3|Overall Study|Disease progression|53
3061846|NCT00527735|10520581|P2|Overall Study|Disease progression|61
3061847|NCT00527735|10520582|P1|Overall Study|Disease progression|47
3061848|NCT00527618|10520668|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
3061849|NCT00527618|10520669|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
3061850|NCT00527618|10520668|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
3061851|NCT00527618|10520669|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
3061852|NCT00527618|10520668|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
3061853|NCT00527618|10520669|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
3061854|NCT00527618|10520668|P2|Week 13-14 (Washout)|Lost to Follow-up|0
3061855|NCT00527618|10520669|P1|Week 13-14 (Washout)|Lost to Follow-up|1
3061856|NCT00527618|10520668|P2|Week 1-12 (First Intervention)|Adverse Event|1
3061857|NCT00527618|10520669|P1|Week 1-12 (First Intervention)|Adverse Event|0
3061858|NCT00527618|10520668|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
3061859|NCT00527618|10520669|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
3061860|NCT00527605|10520684|P2|Overall Study|Protocol Violation|2
3061861|NCT00527605|10520685|P1|Overall Study|Protocol Violation|1
3061862|NCT00527605|10520684|P2|Overall Study|Lost to Follow-up|2
3061863|NCT00527605|10520685|P1|Overall Study|Lost to Follow-up|6
3061864|NCT00527605|10520684|P2|Overall Study|Withdrawal by Subject|7
3061865|NCT00527605|10520685|P1|Overall Study|Withdrawal by Subject|3
3061866|NCT00527605|10520684|P2|Overall Study|Adverse Event|0
3061867|NCT00527605|10520685|P1|Overall Study|Adverse Event|3
3061868|NCT00527514|10520736|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
3061869|NCT00527514|10520736|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
3061870|NCT00527514|10520736|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
3061871|NCT00527514|10520736|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
3061872|NCT00527514|10520736|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
3061873|NCT00527514|10520736|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
3061874|NCT00527514|10520736|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
3061875|NCT00527488|10520752|P4|Overall Study|Withdrawn prior to dosing|0
3061876|NCT00527488|10520753|P3|Overall Study|Withdrawn prior to dosing|1
3061877|NCT00527488|10520754|P2|Overall Study|Withdrawn prior to dosing|1
3061878|NCT00527488|10520755|P1|Overall Study|Withdrawn prior to dosing|0
3061879|NCT00527423|10520838|P1|Overall Study|Death|9
3061880|NCT00527423|10520838|P1|Overall Study|OTHER|4
3061881|NCT00527423|10520838|P1|Overall Study|Lost to Follow-up|4
3061882|NCT00527423|10520838|P1|Overall Study|Withdrawal by Subject|10
3061883|NCT00527423|10520838|P1|Overall Study|Physician Decision|4
3061884|NCT00527423|10520838|P1|Overall Study|Adverse Event|5
3061885|NCT00527423|10520838|P1|Overall Study|Protocol Violation|1
3061886|NCT00527397|10520844|P1|Overall Study|Study terminated by sponsor|13
3061887|NCT00527397|10520844|P1|Overall Study|Withdrawal by Subject|6
3061888|NCT00527397|10520844|P1|Overall Study|Protocol Violation|1
3061889|NCT00527397|10520844|P1|Overall Study|Lack of Efficacy|1
3061890|NCT00527397|10520844|P1|Overall Study|Adverse Event|3
3061891|NCT00527332|10520870|P2|Overall Study|Withdrew consent|1
3061892|NCT00527332|10520871|P1|Overall Study|Withdrew consent|5
3061893|NCT00527332|10520870|P2|Overall Study|Protocol Violation|8
3061894|NCT00527332|10520871|P1|Overall Study|Protocol Violation|4
3061895|NCT00527319|10520880|P3|Overall Study|Adverse Event|1
3061896|NCT00527319|10520881|P2|Overall Study|Adverse Event|0
3061897|NCT00527319|10520882|P1|Overall Study|Adverse Event|0
3061898|NCT00527319|10520880|P3|Overall Study|Intercurrent Medical Illness|3
3061899|NCT00527319|10520881|P2|Overall Study|Intercurrent Medical Illness|1
3061900|NCT00527319|10520882|P1|Overall Study|Intercurrent Medical Illness|0
3061901|NCT00527319|10520880|P3|Overall Study|Death|1
3061902|NCT00527319|10520881|P2|Overall Study|Death|3
3061903|NCT00527319|10520882|P1|Overall Study|Death|0
3061904|NCT00527319|10520880|P3|Overall Study|Lost to Follow-up|0
3061905|NCT00527319|10520881|P2|Overall Study|Lost to Follow-up|0
3061906|NCT00527319|10520882|P1|Overall Study|Lost to Follow-up|1
3061907|NCT00527319|10520880|P3|Overall Study|Withdrawal by Subject|1
3061908|NCT00527319|10520881|P2|Overall Study|Withdrawal by Subject|0
3061909|NCT00527319|10520882|P1|Overall Study|Withdrawal by Subject|5
3061910|NCT00527111|10520912|P2|Overall Study|Other|2
3061911|NCT00527111|10520913|P1|Overall Study|Other|2
3061912|NCT00527111|10520912|P2|Overall Study|Patient Request|5
3061913|NCT00527111|10520913|P1|Overall Study|Patient Request|2
3061914|NCT00527111|10520912|P2|Overall Study|Investigator Request|1
3061915|NCT00527111|10520913|P1|Overall Study|Investigator Request|2
3061916|NCT00527111|10520912|P2|Overall Study|Death|1
3061917|NCT00527111|10520913|P1|Overall Study|Death|0
3061918|NCT00527111|10520912|P2|Overall Study|Adverse Event|13
3061919|NCT00527111|10520913|P1|Overall Study|Adverse Event|14
3061920|NCT00527072|10520935|P1|Overall Study|Withdrawal by Subject|7
3061921|NCT00527072|10520935|P1|Overall Study|Protocol Violation|2
3061922|NCT00527072|10520935|P1|Overall Study|Lost to Follow-up|3
3061923|NCT00527072|10520935|P1|Overall Study|Lack of Efficacy|11
3061924|NCT00527072|10520935|P1|Overall Study|Adverse Event|13
3061925|NCT00526994|10520944|P3|Overall Study|incarcerated, impaired, incomplete|3
3061926|NCT00526994|10520945|P2|Overall Study|incarcerated, impaired, incomplete|3
3061927|NCT00526994|10520946|P1|Overall Study|incarcerated, impaired, incomplete|4
3061928|NCT00526994|10520944|P3|Overall Study|Withdrawal by Subject|5
3061929|NCT00526994|10520945|P2|Overall Study|Withdrawal by Subject|7
3061930|NCT00526994|10520946|P1|Overall Study|Withdrawal by Subject|2
3061931|NCT00526994|10520944|P3|Overall Study|Death|3
3061932|NCT00526994|10520945|P2|Overall Study|Death|3
3061933|NCT00526994|10520946|P1|Overall Study|Death|4
3061934|NCT00526994|10520944|P3|Overall Study|Lost to Follow-up|96
3061935|NCT00526994|10520945|P2|Overall Study|Lost to Follow-up|108
3061936|NCT00526994|10520946|P1|Overall Study|Lost to Follow-up|98
3061937|NCT00526890|10520963|P1|Overall Study|Adverse Event|2
3061938|NCT00526799|10520975|P2|Overall Study|Intercurrent Complicating Disease|1
3061939|NCT00526799|10520976|P1|Overall Study|Intercurrent Complicating Disease|0
3061940|NCT00526799|10520975|P2|Overall Study|Withdrawal by Subject|0
3061941|NCT00526799|10520976|P1|Overall Study|Withdrawal by Subject|1
3061942|NCT00526669|10520984|P2|Combined Treatment Phase|Death|2
3061943|NCT00526669|10520985|P1|Combined Treatment Phase|Death|0
3061944|NCT00526669|10520984|P2|Combined Treatment Phase|Sponsor Terminated Study|2
3061945|NCT00526669|10520985|P1|Combined Treatment Phase|Sponsor Terminated Study|0
3061946|NCT00526669|10520984|P2|Combined Treatment Phase|Withdrawal by Subject|2
3061947|NCT00526669|10520985|P1|Combined Treatment Phase|Withdrawal by Subject|0
3061948|NCT00526669|10520984|P2|Combined Treatment Phase|Lost to Follow-up|2
3061949|NCT00526669|10520985|P1|Combined Treatment Phase|Lost to Follow-up|0
3061950|NCT00526656|10521014|P1|Overall Study|Refused surgery|1
3061951|NCT00526656|10521014|P1|Overall Study|Death|1
3061952|NCT00526630|10521020|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
3061953|NCT00526630|10521021|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
3061954|NCT00526630|10521020|P2|First Intervention Period - 12 Weeks|Withdrawn|3
3061955|NCT00526630|10521021|P1|First Intervention Period - 12 Weeks|Withdrawn|0
3061956|NCT00526331|10521133|P1|Overall Study|Sponsor Termination|55
3061957|NCT00526227|10521141|P1|Overall Study|Death|1
3061958|NCT00526227|10521141|P1|Overall Study|Device not implanted|1
3061959|NCT00526162|10521152|P1|Overall Study|Device not implanted|3
3061960|NCT00526110|10521185|P2|Overall Study|Poor Tolerance|5
3061961|NCT00526110|10521186|P1|Overall Study|Poor Tolerance|0
3061962|NCT00526110|10521185|P2|Overall Study|Withdrawal by Subject|2
3061963|NCT00526110|10521186|P1|Overall Study|Withdrawal by Subject|0
3061964|NCT00526110|10521185|P2|Overall Study|Maximal Response|6
3061965|NCT00526110|10521186|P1|Overall Study|Maximal Response|0
3061966|NCT00526110|10521185|P2|Overall Study|Disease Progression|19
3061967|NCT00526110|10521186|P1|Overall Study|Disease Progression|0
3061968|NCT00526110|10521185|P2|Overall Study|Adverse Event|9
3061969|NCT00526110|10521186|P1|Overall Study|Adverse Event|2
3061970|NCT00526097|10521195|P2|Overall Study|Other|1
3061971|NCT00526097|10521196|P1|Overall Study|Other|2
3061972|NCT00526097|10521195|P2|Overall Study|Withdrawal by Subject|1
3061973|NCT00526097|10521196|P1|Overall Study|Withdrawal by Subject|3
3061974|NCT00526097|10521195|P2|Overall Study|Protocol Violation|10
3061975|NCT00526097|10521196|P1|Overall Study|Protocol Violation|4
3061976|NCT00526097|10521195|P2|Overall Study|Adverse Event|44
3061977|NCT00526097|10521196|P1|Overall Study|Adverse Event|6
3061978|NCT00526071|10521372|P1|Overall Study|Lack of Response to Study Drug|4
3061979|NCT00526071|10521372|P1|Overall Study|Withdrawal by Subject|1
3061980|NCT00526071|10521372|P1|Overall Study|Adverse Event|1
3061981|NCT00525915|10521398|P2|Overall Study|Unrelated illness|0
3061982|NCT00525915|10521399|P1|Overall Study|Unrelated illness|1
3061983|NCT00525915|10521398|P2|Overall Study|Refused Surgery|2
3061984|NCT00525915|10521399|P1|Overall Study|Refused Surgery|1
3061985|NCT00525915|10521398|P2|Overall Study|Withdrawal by Subject|0
3061986|NCT00525915|10521399|P1|Overall Study|Withdrawal by Subject|1
3061987|NCT00525915|10521398|P2|Overall Study|Disease Progression|6
3061988|NCT00525915|10521399|P1|Overall Study|Disease Progression|5
3061989|NCT00525915|10521398|P2|Overall Study|Non-Compliance|1
3061990|NCT00525915|10521399|P1|Overall Study|Non-Compliance|0
3061991|NCT00525902|10521405|P1|Overall Study|Lack of Efficacy|1
3061992|NCT00525824|10521429|P4|Overall Study|Other|1
3061993|NCT00525824|10521430|P3|Overall Study|Other|3
3061994|NCT00525824|10521431|P2|Overall Study|Other|3
3061995|NCT00525824|10521432|P1|Overall Study|Other|1
3061996|NCT00525824|10521429|P4|Overall Study|Safety reasons|0
3061997|NCT00525824|10521430|P3|Overall Study|Safety reasons|1
3061998|NCT00525824|10521431|P2|Overall Study|Safety reasons|0
3061999|NCT00525824|10521432|P1|Overall Study|Safety reasons|1
3062000|NCT00525824|10521429|P4|Overall Study|Severe non-compliance|1
3062001|NCT00525824|10521430|P3|Overall Study|Severe non-compliance|1
3062002|NCT00525824|10521431|P2|Overall Study|Severe non-compliance|1
3062003|NCT00525824|10521432|P1|Overall Study|Severe non-compliance|0
3062004|NCT00525824|10521429|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
3062005|NCT00525824|10521430|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
3062006|NCT00525824|10521431|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
3062007|NCT00525824|10521432|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
3062008|NCT00525824|10521429|P4|Overall Study|Lost to Follow-up|0
3062009|NCT00525824|10521430|P3|Overall Study|Lost to Follow-up|4
3062010|NCT00525824|10521431|P2|Overall Study|Lost to Follow-up|2
3062011|NCT00525824|10521432|P1|Overall Study|Lost to Follow-up|4
3062012|NCT00525824|10521429|P4|Overall Study|Withdrawal by Subject|4
3062013|NCT00525824|10521430|P3|Overall Study|Withdrawal by Subject|3
3062014|NCT00525824|10521431|P2|Overall Study|Withdrawal by Subject|9
3062015|NCT00525824|10521432|P1|Overall Study|Withdrawal by Subject|5
3062016|NCT00525824|10521429|P4|Overall Study|Adverse Event|7
3062017|NCT00525824|10521430|P3|Overall Study|Adverse Event|6
3062018|NCT00525824|10521431|P2|Overall Study|Adverse Event|11
3062019|NCT00525824|10521432|P1|Overall Study|Adverse Event|7
3062020|NCT00525785|10521505|P1|Overall Study|Physician Decision|1
3062021|NCT00525785|10521505|P1|Overall Study|Lack of Efficacy|1
3062022|NCT00525785|10521505|P1|Overall Study|Withdrawal by Subject|1
3062023|NCT00525590|10521529|P1|Overall Study|Other|13
3062024|NCT00525590|10521529|P1|Overall Study|Death|9
3062025|NCT00525590|10521529|P1|Overall Study|Lost to Follow-up|1
3062026|NCT00525590|10521529|P1|Overall Study|Withdrawal by Subject|16
3062027|NCT00525590|10521529|P1|Overall Study|Physician Decision|3
3062028|NCT00525590|10521529|P1|Overall Study|Adverse Event|3
3062029|NCT00525512|10521557|P4|Open-Label Phase|Other reason (not specified)|5
3062030|NCT00525512|10521558|P3|Open-Label Phase|Other reason (not specified)|4
3062031|NCT00525512|10521559|P2|Open-Label Phase|Other reason (not specified)|0
3062032|NCT00525512|10521560|P1|Open-Label Phase|Other reason (not specified)|0
3062033|NCT00525512|10521557|P4|Open-Label Phase|Lost to Follow-up|0
3062034|NCT00525512|10521558|P3|Open-Label Phase|Lost to Follow-up|1
3062035|NCT00525512|10521559|P2|Open-Label Phase|Lost to Follow-up|0
3062036|NCT00525512|10521560|P1|Open-Label Phase|Lost to Follow-up|0
3062037|NCT00525512|10521557|P4|Open-Label Phase|Adverse Event|0
3062038|NCT00525512|10521558|P3|Open-Label Phase|Adverse Event|1
3062039|NCT00525512|10521559|P2|Open-Label Phase|Adverse Event|0
3062040|NCT00525512|10521560|P1|Open-Label Phase|Adverse Event|0
3062041|NCT00525512|10521557|P4|Double-Blind Phase|Other reason (not specified)|0
3062042|NCT00525512|10521558|P3|Double-Blind Phase|Other reason (not specified)|0
3062043|NCT00525512|10521559|P2|Double-Blind Phase|Other reason (not specified)|13
3062044|NCT00525512|10521560|P1|Double-Blind Phase|Other reason (not specified)|12
3062045|NCT00525512|10521557|P4|Double-Blind Phase|Lack of Efficacy|0
3062046|NCT00525512|10521558|P3|Double-Blind Phase|Lack of Efficacy|0
3062047|NCT00525512|10521559|P2|Double-Blind Phase|Lack of Efficacy|5
3062048|NCT00525512|10521560|P1|Double-Blind Phase|Lack of Efficacy|13
3062049|NCT00525512|10521557|P4|Double-Blind Phase|Withdrawal by Subject|0
3062050|NCT00525512|10521558|P3|Double-Blind Phase|Withdrawal by Subject|0
3062051|NCT00525512|10521559|P2|Double-Blind Phase|Withdrawal by Subject|12
3062052|NCT00525512|10521560|P1|Double-Blind Phase|Withdrawal by Subject|17
3062053|NCT00525512|10521557|P4|Double-Blind Phase|Lost to Follow-up|0
3062054|NCT00525512|10521558|P3|Double-Blind Phase|Lost to Follow-up|0
3062055|NCT00525512|10521559|P2|Double-Blind Phase|Lost to Follow-up|7
3062056|NCT00525512|10521560|P1|Double-Blind Phase|Lost to Follow-up|3
3062057|NCT00525512|10521557|P4|Double-Blind Phase|Protocol Violation|0
3062058|NCT00525512|10521558|P3|Double-Blind Phase|Protocol Violation|0
3062059|NCT00525512|10521559|P2|Double-Blind Phase|Protocol Violation|1
3062060|NCT00525512|10521560|P1|Double-Blind Phase|Protocol Violation|3
3062061|NCT00525512|10521557|P4|Double-Blind Phase|Adverse Event|0
3062062|NCT00525512|10521558|P3|Double-Blind Phase|Adverse Event|0
3062063|NCT00525512|10521559|P2|Double-Blind Phase|Adverse Event|28
3062064|NCT00525512|10521560|P1|Double-Blind Phase|Adverse Event|48
3062065|NCT00525499|10521702|P4|Overall Study|Protocol Violation|0
3062066|NCT00525499|10521703|P3|Overall Study|Protocol Violation|1
3062067|NCT00525499|10521704|P2|Overall Study|Protocol Violation|1
3062068|NCT00525499|10521705|P1|Overall Study|Protocol Violation|0
3062069|NCT00525499|10521702|P4|Overall Study|Withdrawal by Subject|2
3062070|NCT00525499|10521703|P3|Overall Study|Withdrawal by Subject|5
3062071|NCT00525499|10521704|P2|Overall Study|Withdrawal by Subject|1
3062072|NCT00525499|10521705|P1|Overall Study|Withdrawal by Subject|5
3062073|NCT00525499|10521702|P4|Overall Study|Adverse Event|1
3062074|NCT00525499|10521703|P3|Overall Study|Adverse Event|0
3062075|NCT00525499|10521704|P2|Overall Study|Adverse Event|1
3062076|NCT00525499|10521705|P1|Overall Study|Adverse Event|0
3062077|NCT00525499|10521702|P4|Overall Study|Lost to Follow-up|4
3062078|NCT00525499|10521703|P3|Overall Study|Lost to Follow-up|1
3062079|NCT00525499|10521704|P2|Overall Study|Lost to Follow-up|4
3062080|NCT00525499|10521705|P1|Overall Study|Lost to Follow-up|2
3062081|NCT00525265|10521732|P2|Overall Study|Protocol Violation|0
3062082|NCT00525265|10521733|P1|Overall Study|Protocol Violation|1
3062083|NCT00525161|10521790|P1|Overall Study|Adverse Event|1
3062084|NCT00525148|10521800|P4|Overall Study|Other than stated|3
3062085|NCT00525148|10521801|P3|Overall Study|Other than stated|0
3062086|NCT00525148|10521802|P2|Overall Study|Other than stated|1
3062087|NCT00525148|10521803|P1|Overall Study|Other than stated|2
3062088|NCT00525148|10521800|P4|Overall Study|Refused continuation of study medication|1
3062089|NCT00525148|10521801|P3|Overall Study|Refused continuation of study medication|0
3062090|NCT00525148|10521802|P2|Overall Study|Refused continuation of study medication|2
3062091|NCT00525148|10521803|P1|Overall Study|Refused continuation of study medication|0
3062092|NCT00525148|10521800|P4|Overall Study|Progressive disease|49
3062093|NCT00525148|10521801|P3|Overall Study|Progressive disease|6
3062094|NCT00525148|10521802|P2|Overall Study|Progressive disease|30
3062095|NCT00525148|10521803|P1|Overall Study|Progressive disease|18
3062096|NCT00525148|10521800|P4|Overall Study|Other Adverse Event|8
3062097|NCT00525148|10521801|P3|Overall Study|Other Adverse Event|1
3062098|NCT00525148|10521802|P2|Overall Study|Other Adverse Event|5
3062099|NCT00525148|10521803|P1|Overall Study|Other Adverse Event|3
3062100|NCT00525044|10521831|P2|Overall Study|Lost to Follow-up|1
3062101|NCT00525044|10521832|P1|Overall Study|Lost to Follow-up|0
3062102|NCT00525031|10521848|P2|Overall Study|Disease Progression|1
3062103|NCT00525031|10521849|P1|Overall Study|Disease Progression|1
3062104|NCT00524771|10521863|P2|Overall Study|Protocol Violation|585
3062105|NCT00524771|10521864|P1|Overall Study|Protocol Violation|220
3062106|NCT00524745|10521878|P4|Overall Study|subject withdrawal or lost to follow up|22
3062107|NCT00524745|10521879|P3|Overall Study|subject withdrawal or lost to follow up|29
3062108|NCT00524745|10521880|P2|Overall Study|subject withdrawal or lost to follow up|13
3062109|NCT00524745|10521881|P1|Overall Study|subject withdrawal or lost to follow up|34
3062110|NCT00524680|10521907|P4|Overall Study|Withdrawal by Subject|1
3062111|NCT00524680|10521908|P3|Overall Study|Withdrawal by Subject|1
3062112|NCT00524680|10521909|P2|Overall Study|Withdrawal by Subject|0
3062113|NCT00524680|10521910|P1|Overall Study|Withdrawal by Subject|1
3062114|NCT00524680|10521907|P4|Overall Study|Other|3
3062115|NCT00524680|10521908|P3|Overall Study|Other|2
3062116|NCT00524680|10521909|P2|Overall Study|Other|1
3062117|NCT00524680|10521910|P1|Overall Study|Other|0
3062118|NCT00524680|10521907|P4|Overall Study|Adverse Event|1
3062119|NCT00524680|10521908|P3|Overall Study|Adverse Event|0
3062120|NCT00524680|10521909|P2|Overall Study|Adverse Event|0
3062121|NCT00524680|10521910|P1|Overall Study|Adverse Event|2
3062122|NCT00524680|10521907|P4|Overall Study|progression|1
3062123|NCT00524680|10521908|P3|Overall Study|progression|0
3062124|NCT00524680|10521909|P2|Overall Study|progression|0
3062125|NCT00524680|10521910|P1|Overall Study|progression|0
3062126|NCT00524589|10521932|P1|Overall Study|Disease Progression|16
3062127|NCT00524589|10521932|P1|Overall Study|Withdrawal by Subject|2
3062128|NCT00524485|10521983|P1|Overall Study|Withdrawal by Subject|5
3062129|NCT00524459|10522012|P1|Overall Study|Other|1
3062130|NCT00524459|10522012|P1|Overall Study|Withdrawal by Subject|1
3062131|NCT00524420|10522022|P2|Overall Study|Lack of Efficacy|0
3062132|NCT00524420|10522023|P1|Overall Study|Lack of Efficacy|1
3062133|NCT00524368|10522041|P2|Overall Study|Other|2
3062134|NCT00524368|10522042|P1|Overall Study|Other|3
3062135|NCT00524368|10522041|P2|Overall Study|Ineligible to Continue the study|5
3062136|NCT00524368|10522042|P1|Overall Study|Ineligible to Continue the study|2
3062137|NCT00524368|10522041|P2|Overall Study|Sponsor's Decision|0
3062138|NCT00524368|10522042|P1|Overall Study|Sponsor's Decision|2
3062139|NCT00524368|10522041|P2|Overall Study|Reached a Virologic Endpoint|2
3062140|NCT00524368|10522042|P1|Overall Study|Reached a Virologic Endpoint|3
3062141|NCT00524368|10522041|P2|Overall Study|Non-compliant|9
3062142|NCT00524368|10522042|P1|Overall Study|Non-compliant|8
3062143|NCT00524368|10522041|P2|Overall Study|Withdrawal by Subject|5
3062144|NCT00524368|10522042|P1|Overall Study|Withdrawal by Subject|4
3062145|NCT00524368|10522041|P2|Overall Study|Lost to Follow-up|13
3062146|NCT00524368|10522042|P1|Overall Study|Lost to Follow-up|9
3062147|NCT00524368|10522041|P2|Overall Study|Adverse Event|12
3062148|NCT00524368|10522042|P1|Overall Study|Adverse Event|10
3062149|NCT00524316|10522076|P1|Overall Study|Disease Progression|7
3062150|NCT00524316|10522076|P1|Overall Study|Adverse Event|7
3062151|NCT00524316|10522076|P1|Overall Study|Withdrawal by Subject|2
3062152|NCT00524303|10522088|P3|Overall Study|Completed 5 years|1
3062153|NCT00524303|10522089|P2|Overall Study|Completed 5 years|0
3062154|NCT00524303|10522090|P1|Overall Study|Completed 5 years|0
3062155|NCT00524303|10522088|P3|Overall Study|Physician Decision|1
3062156|NCT00524303|10522089|P2|Overall Study|Physician Decision|0
3062157|NCT00524303|10522090|P1|Overall Study|Physician Decision|0
3062158|NCT00524303|10522088|P3|Overall Study|Sponsor Request|1
3062159|NCT00524303|10522089|P2|Overall Study|Sponsor Request|0
3062160|NCT00524303|10522090|P1|Overall Study|Sponsor Request|0
3062161|NCT00524303|10522088|P3|Overall Study|Disease Recurrence|0
3062162|NCT00524303|10522089|P2|Overall Study|Disease Recurrence|1
3062163|NCT00524303|10522090|P1|Overall Study|Disease Recurrence|0
3062164|NCT00524303|10522088|P3|Overall Study|Disease Progression|1
3062165|NCT00524303|10522089|P2|Overall Study|Disease Progression|4
3062166|NCT00524303|10522090|P1|Overall Study|Disease Progression|0
3062167|NCT00524303|10522088|P3|Overall Study|Worsening Peripheral Neuropathy|0
3062168|NCT00524303|10522089|P2|Overall Study|Worsening Peripheral Neuropathy|0
3062169|NCT00524303|10522090|P1|Overall Study|Worsening Peripheral Neuropathy|1
3062170|NCT00524303|10522088|P3|Overall Study|Did not Complete Study Dosing|0
3062171|NCT00524303|10522089|P2|Overall Study|Did not Complete Study Dosing|0
3062172|NCT00524303|10522090|P1|Overall Study|Did not Complete Study Dosing|1
3062173|NCT00524303|10522088|P3|Overall Study|Adverse Event|3
3062174|NCT00524303|10522089|P2|Overall Study|Adverse Event|2
3062175|NCT00524303|10522090|P1|Overall Study|Adverse Event|1
3062176|NCT00524303|10522088|P3|Overall Study|Death|3
3062177|NCT00524303|10522089|P2|Overall Study|Death|2
3062178|NCT00524303|10522090|P1|Overall Study|Death|0
3062179|NCT00524303|10522088|P3|Overall Study|Withdrawal by Subject|4
3062180|NCT00524303|10522089|P2|Overall Study|Withdrawal by Subject|0
3062181|NCT00524303|10522090|P1|Overall Study|Withdrawal by Subject|3
3062182|NCT00524303|10522088|P3|Overall Study|Protocol Violation|1
3062183|NCT00524303|10522089|P2|Overall Study|Protocol Violation|1
3062184|NCT00524303|10522090|P1|Overall Study|Protocol Violation|0
3062185|NCT00524303|10522088|P3|Overall Study|Lost to Follow-up|3
3062186|NCT00524303|10522089|P2|Overall Study|Lost to Follow-up|0
3062187|NCT00524303|10522090|P1|Overall Study|Lost to Follow-up|6
3062188|NCT00524173|10522142|P2|Overall Study|Had not reached endpoint at study close|1
3062189|NCT00524173|10522143|P1|Overall Study|Had not reached endpoint at study close|4
3062190|NCT00524173|10522142|P2|Overall Study|Death|0
3062191|NCT00524173|10522143|P1|Overall Study|Death|1
3062192|NCT00524173|10522142|P2|Overall Study|Lost to Follow-up|1
3062193|NCT00524173|10522143|P1|Overall Study|Lost to Follow-up|0
3062194|NCT00524134|10522155|P1|Overall Study|Physician Decision|1
3062195|NCT00524134|10522155|P1|Overall Study|Withdrawal by Subject|1
3062196|NCT00524121|10522162|P1|Overall Study|Not treated (changed mind)|1
3062197|NCT00524121|10522162|P1|Overall Study|Not treated (became ineligible)|4
3062198|NCT00524121|10522162|P1|Overall Study|Death|1
3062199|NCT00524121|10522162|P1|Overall Study|Other|1
3062200|NCT00524121|10522162|P1|Overall Study|Patient refused|2
3062201|NCT00524121|10522162|P1|Overall Study|Adverse Event|4
3062202|NCT00524121|10522162|P1|Overall Study|Disease progression|6
3062203|NCT00524043|10522182|P3|Overall Study|Various (eg, incarceration)|0
3062204|NCT00524043|10522183|P2|Overall Study|Various (eg, incarceration)|1
3062205|NCT00524043|10522184|P1|Overall Study|Various (eg, incarceration)|2
3062206|NCT00524043|10522182|P3|Overall Study|Lost to Follow-up|3
3062207|NCT00524043|10522183|P2|Overall Study|Lost to Follow-up|5
3062208|NCT00524043|10522184|P1|Overall Study|Lost to Follow-up|3
3062209|NCT00524043|10522182|P3|Overall Study|Adverse Event|7
3062210|NCT00524043|10522183|P2|Overall Study|Adverse Event|2
3062211|NCT00524043|10522184|P1|Overall Study|Adverse Event|5
3062212|NCT00524043|10522182|P3|Overall Study|Withdrawal by Subject|7
3062213|NCT00524043|10522183|P2|Overall Study|Withdrawal by Subject|7
3062214|NCT00524043|10522184|P1|Overall Study|Withdrawal by Subject|5
3062215|NCT00524043|10522182|P3|Overall Study|Lack of Efficacy|14
3062216|NCT00524043|10522183|P2|Overall Study|Lack of Efficacy|13
3062217|NCT00524043|10522184|P1|Overall Study|Lack of Efficacy|15
3062218|NCT00524030|10522206|P2|Overall Study|Death|1
3062219|NCT00524030|10522207|P1|Overall Study|Death|0
3062220|NCT00524030|10522206|P2|Overall Study|Adverse Event|21
3062221|NCT00524030|10522207|P1|Overall Study|Adverse Event|3
3062222|NCT00524030|10522206|P2|Overall Study|Pregnancy|0
3062223|NCT00524030|10522207|P1|Overall Study|Pregnancy|1
3062224|NCT00524030|10522206|P2|Overall Study|Protocol Violation|1
3062225|NCT00524030|10522207|P1|Overall Study|Protocol Violation|0
3062226|NCT00524030|10522206|P2|Overall Study|Noncompliance/Investigator discretion|2
3062227|NCT00524030|10522207|P1|Overall Study|Noncompliance/Investigator discretion|0
3062228|NCT00524030|10522206|P2|Overall Study|Withdrawal by Subject|8
3062229|NCT00524030|10522207|P1|Overall Study|Withdrawal by Subject|3
3062230|NCT00524030|10522206|P2|Overall Study|Lost to Follow-up|2
3062231|NCT00524030|10522207|P1|Overall Study|Lost to Follow-up|0
3062232|NCT00524030|10522206|P2|Overall Study|Lack of Efficacy|24
3062233|NCT00524030|10522207|P1|Overall Study|Lack of Efficacy|10
3062234|NCT00523991|10522246|P2|Overall Study|Other reason (not specified)|0
3062235|NCT00523991|10522247|P1|Overall Study|Other reason (not specified)|3
3062236|NCT00523991|10522246|P2|Overall Study|Withdrawal by Subject|17
3062237|NCT00523991|10522247|P1|Overall Study|Withdrawal by Subject|7
3062238|NCT00523991|10522246|P2|Overall Study|Lost to Follow-up|1
3062239|NCT00523991|10522247|P1|Overall Study|Lost to Follow-up|4
3062240|NCT00523991|10522246|P2|Overall Study|Protocol Violation|4
3062241|NCT00523991|10522247|P1|Overall Study|Protocol Violation|1
3062242|NCT00523991|10522246|P2|Overall Study|Adverse Event|5
3062243|NCT00523991|10522247|P1|Overall Study|Adverse Event|6
3062244|NCT00523978|10522527|P2|Overall Study|Death|0
3062245|NCT00523978|10522528|P1|Overall Study|Death|1
3062246|NCT00523978|10522527|P2|Overall Study|Screen Failures|1
3062247|NCT00523978|10522528|P1|Overall Study|Screen Failures|5
3062248|NCT00523978|10522527|P2|Overall Study|Withdrawal by Subject|7
3062249|NCT00523978|10522528|P1|Overall Study|Withdrawal by Subject|3
3062250|NCT00523848|10522550|P1|Overall Study|Other, unspecified|4
3062251|NCT00523848|10522550|P1|Overall Study|Disease Progression|5
3062252|NCT00523848|10522550|P1|Overall Study|NOT TREATED (Became ineligible)|2
3062253|NCT00523848|10522550|P1|Overall Study|Withdrawal by Subject|2
3062254|NCT00523848|10522550|P1|Overall Study|Adverse Event|11
3062255|NCT00523744|10522560|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
3062256|NCT00523744|10522560|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
3062257|NCT00523744|10522560|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
3062258|NCT00523744|10522560|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
3062259|NCT00523744|10522560|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
3062260|NCT00523744|10522560|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
3062261|NCT00523718|10522579|P2|Overall Study|Protocol Violation|0
3062262|NCT00523718|10522580|P1|Overall Study|Protocol Violation|2
3062263|NCT00523718|10522579|P2|Overall Study|Withdrawal by Subject|0
3062264|NCT00523718|10522580|P1|Overall Study|Withdrawal by Subject|1
3062265|NCT00523705|10522594|P2|Overall Study|No time for study.|1
3062266|NCT00523705|10522595|P1|Overall Study|No time for study.|0
3062267|NCT00523640|10522607|P1|Overall Study|Death|1
3062268|NCT00523549|10522624|P2|Overall Study|Lost to Follow-up|5
3062269|NCT00523549|10522625|P1|Overall Study|Lost to Follow-up|3
3062270|NCT00523549|10522624|P2|Overall Study|Patient withdrew consent|6
3062271|NCT00523549|10522625|P1|Overall Study|Patient withdrew consent|7
3062272|NCT00523549|10522624|P2|Overall Study|Protocol Deviation|1
3062273|NCT00523549|10522625|P1|Overall Study|Protocol Deviation|3
3062274|NCT00523549|10522624|P2|Overall Study|Unsatisfactory therapeutic effect|1
3062275|NCT00523549|10522625|P1|Overall Study|Unsatisfactory therapeutic effect|0
3062276|NCT00523549|10522624|P2|Overall Study|Adverse Event|3
3062277|NCT00523549|10522625|P1|Overall Study|Adverse Event|6
3062278|NCT00523419|10522643|P1|Overall Study|Death due to Adverse Event|2
3062279|NCT00523419|10522643|P1|Overall Study|Death due to Study Disease|4
3062280|NCT00523419|10522643|P1|Overall Study|Progressive Disease|22
3062281|NCT00523419|10522643|P1|Overall Study|Physician Decision|2
3062282|NCT00523419|10522643|P1|Overall Study|Withdrawal by Subject|1
3062283|NCT00523419|10522643|P1|Overall Study|Adverse Event|1
3062284|NCT00523367|10522653|P1|Overall Study|4 Withdrawn by PI|4
3062285|NCT00523367|10522653|P1|Overall Study|19 screen failures|19
3062286|NCT00523341|10522659|P2|Overall Study|Disease Progression|0
3062287|NCT00523341|10522660|P1|Overall Study|Disease Progression|1
3062288|NCT00523341|10522659|P2|Overall Study|Ineligibility Determined|4
3062289|NCT00523341|10522660|P1|Overall Study|Ineligibility Determined|3
3062290|NCT00523341|10522659|P2|Overall Study|Protocol Deviation|5
3062291|NCT00523341|10522660|P1|Overall Study|Protocol Deviation|6
3062292|NCT00523341|10522659|P2|Overall Study|Requirement for Alternative Therapy|14
3062293|NCT00523341|10522660|P1|Overall Study|Requirement for Alternative Therapy|4
3062294|NCT00523341|10522659|P2|Overall Study|Physician Decision|13
3062295|NCT00523341|10522660|P1|Overall Study|Physician Decision|14
3062296|NCT00523341|10522659|P2|Overall Study|Non-compliance|13
3062297|NCT00523341|10522660|P1|Overall Study|Non-compliance|20
3062298|NCT00523341|10522659|P2|Overall Study|Lost to Follow-up|61
3062299|NCT00523341|10522660|P1|Overall Study|Lost to Follow-up|73
3062300|NCT00523341|10522659|P2|Overall Study|Death|110
3062301|NCT00523341|10522660|P1|Overall Study|Death|101
3062302|NCT00523341|10522659|P2|Overall Study|Adverse Event|155
3062303|NCT00523341|10522660|P1|Overall Study|Adverse Event|122
3062304|NCT00523341|10522659|P2|Overall Study|Other|198
3062305|NCT00523341|10522660|P1|Overall Study|Other|181
3062306|NCT00523341|10522659|P2|Overall Study|Withdrawal by Subject|427
3062307|NCT00523341|10522660|P1|Overall Study|Withdrawal by Subject|399
3062308|NCT00522951|10522777|P2|Period 2|residual contrast medium|1
3062309|NCT00522951|10522778|P1|Period 2|residual contrast medium|1
3062310|NCT00522951|10522777|P2|Period 2|Withdrawal by Subject|0
3062311|NCT00522951|10522778|P1|Period 2|Withdrawal by Subject|1
3062312|NCT00522951|10522777|P2|Washout Period|Death|1
3062313|NCT00522951|10522778|P1|Washout Period|Death|0
3062314|NCT00522951|10522777|P2|Washout Period|Adverse Event|1
3062315|NCT00522951|10522778|P1|Washout Period|Adverse Event|0
3062316|NCT00522951|10522777|P2|Period 1|body motion|1
3062317|NCT00522951|10522778|P1|Period 1|body motion|0
3062318|NCT00522873|10522833|P2|Overall Study|Never Received Medication|0
3062319|NCT00522873|10522834|P1|Overall Study|Never Received Medication|1
3062320|NCT00522873|10522833|P2|Overall Study|Medication Errors|1
3062321|NCT00522873|10522834|P1|Overall Study|Medication Errors|1
3062322|NCT00522873|10522833|P2|Overall Study|Personal Reasons|1
3062323|NCT00522873|10522834|P1|Overall Study|Personal Reasons|8
3062324|NCT00522873|10522833|P2|Overall Study|Lost to Follow-up|3
3062325|NCT00522873|10522834|P1|Overall Study|Lost to Follow-up|11
3062326|NCT00522873|10522833|P2|Overall Study|Protocol Violation|4
3062327|NCT00522873|10522834|P1|Overall Study|Protocol Violation|14
3062328|NCT00522873|10522833|P2|Overall Study|Withdrawal by Subject|9
3062329|NCT00522873|10522834|P1|Overall Study|Withdrawal by Subject|20
3062330|NCT00522873|10522833|P2|Overall Study|Adverse Event|26
3062331|NCT00522873|10522834|P1|Overall Study|Adverse Event|41
3062332|NCT00522626|10522847|P1|Overall Study|Lost to Follow-up|7
3062333|NCT00522548|10522853|P2|Overall Study|Withdrawal by Subject|2
3062334|NCT00522548|10522854|P1|Overall Study|Withdrawal by Subject|0
3062335|NCT00522548|10522853|P2|Overall Study|Adverse Event|2
3062336|NCT00522548|10522854|P1|Overall Study|Adverse Event|2
3062337|NCT00522457|10522882|P1|Overall Study|Adverse Event|2
3062338|NCT00522457|10522882|P1|Overall Study|Due to disease progression|16
3062339|NCT00522431|10522888|P1|Overall Study|Other/unknown|1
3062340|NCT00522431|10522888|P1|Overall Study|Subject non-compliance|1
3062341|NCT00522431|10522888|P1|Overall Study|Withdrawal by Subject|2
3062342|NCT00522431|10522888|P1|Overall Study|Protocol Violation|2
3062343|NCT00522431|10522888|P1|Overall Study|Adverse Event|5
3062344|NCT00522418|10522895|P2|Overall Study|Lack of Efficacy|1
3062345|NCT00522418|10522896|P1|Overall Study|Lack of Efficacy|0
3062346|NCT00522418|10522895|P2|Overall Study|Consent Withdraw|2
3062347|NCT00522418|10522896|P1|Overall Study|Consent Withdraw|1
3062348|NCT00522418|10522895|P2|Overall Study|Reason Not Specified|1
3062349|NCT00522418|10522896|P1|Overall Study|Reason Not Specified|3
3062350|NCT00522418|10522895|P2|Overall Study|Noncompliance|2
3062351|NCT00522418|10522896|P1|Overall Study|Noncompliance|2
3062352|NCT00522418|10522895|P2|Overall Study|Early Study Termination|47
3062353|NCT00522418|10522896|P1|Overall Study|Early Study Termination|46
3062354|NCT00522418|10522895|P2|Overall Study|Local IRB Consent Violation|5
3062355|NCT00522418|10522896|P1|Overall Study|Local IRB Consent Violation|5
3062356|NCT00522392|10522944|P2|Overall Study|Non-compliance|1
3062357|NCT00522392|10522945|P1|Overall Study|Non-compliance|0
3062358|NCT00522392|10522944|P2|Overall Study|Physician Decision|1
3062359|NCT00522392|10522945|P1|Overall Study|Physician Decision|0
3062360|NCT00522392|10522944|P2|Overall Study|Withdrawal by Subject|1
3062361|NCT00522392|10522945|P1|Overall Study|Withdrawal by Subject|1
3062362|NCT00522392|10522944|P2|Overall Study|Adverse Event|7
3062363|NCT00522392|10522945|P1|Overall Study|Adverse Event|7
3062364|NCT00522392|10522944|P2|Overall Study|Disease progression|3
3062365|NCT00522392|10522945|P1|Overall Study|Disease progression|0
3062366|NCT00522379|10522962|P5|Overall Study|Subject Withdrawal|0
3062367|NCT00522379|10522963|P4|Overall Study|Subject Withdrawal|1
3062368|NCT00522379|10522964|P3|Overall Study|Subject Withdrawal|0
3062369|NCT00522379|10522965|P2|Overall Study|Subject Withdrawal|0
3062370|NCT00522379|10522966|P1|Overall Study|Subject Withdrawal|0
3062371|NCT00522379|10522962|P5|Overall Study|Site Closed|0
3062372|NCT00522379|10522963|P4|Overall Study|Site Closed|1
3062373|NCT00522379|10522964|P3|Overall Study|Site Closed|0
3062374|NCT00522379|10522965|P2|Overall Study|Site Closed|0
3062375|NCT00522379|10522966|P1|Overall Study|Site Closed|0
3062376|NCT00522379|10522962|P5|Overall Study|Family Problem|0
3062377|NCT00522379|10522963|P4|Overall Study|Family Problem|0
3062378|NCT00522379|10522964|P3|Overall Study|Family Problem|1
3062379|NCT00522379|10522965|P2|Overall Study|Family Problem|0
3062380|NCT00522379|10522966|P1|Overall Study|Family Problem|0
3062381|NCT00522379|10522962|P5|Overall Study|Sponsor Request|0
3062382|NCT00522379|10522963|P4|Overall Study|Sponsor Request|0
3062383|NCT00522379|10522964|P3|Overall Study|Sponsor Request|0
3062384|NCT00522379|10522965|P2|Overall Study|Sponsor Request|1
3062385|NCT00522379|10522966|P1|Overall Study|Sponsor Request|0
3062386|NCT00522379|10522962|P5|Overall Study|Subject Moved|0
3062387|NCT00522379|10522963|P4|Overall Study|Subject Moved|0
3062388|NCT00522379|10522964|P3|Overall Study|Subject Moved|0
3062389|NCT00522379|10522965|P2|Overall Study|Subject Moved|1
3062390|NCT00522379|10522966|P1|Overall Study|Subject Moved|1
3062391|NCT00522379|10522962|P5|Overall Study|Dispensing error|0
3062392|NCT00522379|10522963|P4|Overall Study|Dispensing error|1
3062393|NCT00522379|10522964|P3|Overall Study|Dispensing error|0
3062394|NCT00522379|10522965|P2|Overall Study|Dispensing error|0
3062395|NCT00522379|10522966|P1|Overall Study|Dispensing error|1
3062396|NCT00522379|10522962|P5|Overall Study|Randomization error|1
3062397|NCT00522379|10522963|P4|Overall Study|Randomization error|0
3062398|NCT00522379|10522964|P3|Overall Study|Randomization error|0
3062399|NCT00522379|10522965|P2|Overall Study|Randomization error|0
3062400|NCT00522379|10522966|P1|Overall Study|Randomization error|0
3062401|NCT00522379|10522962|P5|Overall Study|Lost to Follow-up|2
3062402|NCT00522379|10522963|P4|Overall Study|Lost to Follow-up|2
3062403|NCT00522379|10522964|P3|Overall Study|Lost to Follow-up|4
3062404|NCT00522379|10522965|P2|Overall Study|Lost to Follow-up|0
3062405|NCT00522379|10522966|P1|Overall Study|Lost to Follow-up|1
3062406|NCT00522379|10522962|P5|Overall Study|Unsatisfactory Subject Compliance|0
3062407|NCT00522379|10522963|P4|Overall Study|Unsatisfactory Subject Compliance|0
3062408|NCT00522379|10522964|P3|Overall Study|Unsatisfactory Subject Compliance|0
3062409|NCT00522379|10522965|P2|Overall Study|Unsatisfactory Subject Compliance|2
3062410|NCT00522379|10522966|P1|Overall Study|Unsatisfactory Subject Compliance|1
3062411|NCT00522379|10522962|P5|Overall Study|Protocol Violation|0
3062412|NCT00522379|10522963|P4|Overall Study|Protocol Violation|0
3062413|NCT00522379|10522964|P3|Overall Study|Protocol Violation|2
3062414|NCT00522379|10522965|P2|Overall Study|Protocol Violation|1
3062415|NCT00522379|10522966|P1|Overall Study|Protocol Violation|1
3062416|NCT00522379|10522962|P5|Overall Study|Withdrawal by Subject|0
3062417|NCT00522379|10522963|P4|Overall Study|Withdrawal by Subject|2
3062418|NCT00522379|10522964|P3|Overall Study|Withdrawal by Subject|1
3062419|NCT00522379|10522965|P2|Overall Study|Withdrawal by Subject|3
3062420|NCT00522379|10522966|P1|Overall Study|Withdrawal by Subject|2
3062421|NCT00522379|10522962|P5|Overall Study|Lack of Efficacy|7
3062422|NCT00522379|10522963|P4|Overall Study|Lack of Efficacy|2
3062423|NCT00522379|10522964|P3|Overall Study|Lack of Efficacy|2
3062424|NCT00522379|10522965|P2|Overall Study|Lack of Efficacy|0
3062425|NCT00522379|10522966|P1|Overall Study|Lack of Efficacy|3
3062426|NCT00522379|10522962|P5|Overall Study|Adverse Event|17
3062427|NCT00522379|10522963|P4|Overall Study|Adverse Event|5
3062428|NCT00522379|10522964|P3|Overall Study|Adverse Event|12
3062429|NCT00522379|10522965|P2|Overall Study|Adverse Event|15
3062430|NCT00522379|10522966|P1|Overall Study|Adverse Event|12
3062431|NCT00522301|10523068|P1|Overall Study|Adverse Event|5
3062432|NCT00522301|10523068|P1|Overall Study|Withdrawal by Subject|1
3062433|NCT00522275|10523072|P1|Overall Study|Other: Subject had surgery for epilepsy|2
3062434|NCT00522275|10523072|P1|Overall Study|Other: Subject ran out of medication|1
3062435|NCT00522275|10523072|P1|Overall Study|Other: Sponsor request|2
3062436|NCT00522275|10523072|P1|Overall Study|Other: Travel to / from site difficulty|3
3062437|NCT00522275|10523072|P1|Overall Study|Other: Site / clinic closed|4
3062438|NCT00522275|10523072|P1|Overall Study|Other: Subject arrested|1
3062439|NCT00522275|10523072|P1|Overall Study|Other: Subject relocated|2
3062440|NCT00522275|10523072|P1|Overall Study|Other: Subject is pregnant|2
3062441|NCT00522275|10523072|P1|Overall Study|Other: Subject wants to become pregnant|2
3062442|NCT00522275|10523072|P1|Overall Study|Lost to Follow-up|8
3062443|NCT00522275|10523072|P1|Overall Study|Unsatisfactory compliance|11
3062444|NCT00522275|10523072|P1|Overall Study|Protocol deviation|1
3062445|NCT00522275|10523072|P1|Overall Study|Subject withdrew consent|16
3062446|NCT00522275|10523072|P1|Overall Study|Lack of Efficacy|80
3062447|NCT00522275|10523072|P1|Overall Study|Adverse Event|35
3062448|NCT00522041|10523093|P2|Overall Study|Did not receive treatment|1
3062449|NCT00522041|10523094|P1|Overall Study|Did not receive treatment|0
3062450|NCT00522041|10523093|P2|Overall Study|Voluntary withdrawal|4
3062451|NCT00522041|10523094|P1|Overall Study|Voluntary withdrawal|5
3062452|NCT00522041|10523093|P2|Overall Study|Lost to Follow-up|4
3062453|NCT00522041|10523094|P1|Overall Study|Lost to Follow-up|1
3062454|NCT00522041|10523093|P2|Overall Study|Protocol Violation|0
3062455|NCT00522041|10523094|P1|Overall Study|Protocol Violation|2
3062456|NCT00522041|10523093|P2|Overall Study|Adverse Event|3
3062457|NCT00522041|10523094|P1|Overall Study|Adverse Event|9
3062458|NCT00521599|10523153|P3|Overall Study|Did not meet protocol eligibility|1
3062459|NCT00521599|10523154|P2|Overall Study|Did not meet protocol eligibility|2
3062460|NCT00521599|10523155|P1|Overall Study|Did not meet protocol eligibility|2
3062461|NCT00521599|10523153|P3|Overall Study|Protocol Violation|2
3062462|NCT00521599|10523154|P2|Overall Study|Protocol Violation|4
3062463|NCT00521599|10523155|P1|Overall Study|Protocol Violation|2
3062464|NCT00521599|10523153|P3|Overall Study|Withdrawal by subject treatment related|2
3062465|NCT00521599|10523154|P2|Overall Study|Withdrawal by subject treatment related|1
3062466|NCT00521599|10523155|P1|Overall Study|Withdrawal by subject treatment related|3
3062467|NCT00521599|10523153|P3|Overall Study|Withdrawal by Subject|1
3062468|NCT00521599|10523154|P2|Overall Study|Withdrawal by Subject|5
3062469|NCT00521599|10523155|P1|Overall Study|Withdrawal by Subject|3
3062470|NCT00521599|10523153|P3|Overall Study|Lost to Follow-up|2
3062471|NCT00521599|10523154|P2|Overall Study|Lost to Follow-up|1
3062472|NCT00521599|10523155|P1|Overall Study|Lost to Follow-up|2
3062473|NCT00521599|10523153|P3|Overall Study|Treatment Failure|22
3062474|NCT00521599|10523154|P2|Overall Study|Treatment Failure|9
3062475|NCT00521599|10523155|P1|Overall Study|Treatment Failure|8
3062476|NCT00521599|10523153|P3|Overall Study|Adverse Event|6
3062477|NCT00521599|10523154|P2|Overall Study|Adverse Event|7
3062478|NCT00521599|10523155|P1|Overall Study|Adverse Event|5
3062479|NCT00521586|10523166|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
3062480|NCT00521586|10523167|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
3062481|NCT00521586|10523166|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
3062482|NCT00521586|10523167|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
3062483|NCT00521586|10523166|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
3062484|NCT00521586|10523167|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
3062485|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
3062486|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
3062487|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
3062488|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
3062489|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
3062490|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
3062491|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
3062492|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
3062493|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
3062494|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
3062495|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
3062496|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
3062497|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
3062498|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
3062499|NCT00521586|10523166|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
3062500|NCT00521586|10523167|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
3062501|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Failed to return|1
3062502|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Failed to return|0
3062503|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Death|0
3062504|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Death|1
3062505|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Adverse Event|1
3062506|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Adverse Event|0
3062507|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Investigator request|0
3062508|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Investigator request|2
3062509|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Other, unspecified|1
3062510|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Other, unspecified|3
3062511|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Protocol Violation|5
3062512|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Protocol Violation|2
3062513|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
3062514|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
3062515|NCT00521586|10523166|P2|Initial Vaccination (Year 0)|Subject request|11
3062516|NCT00521586|10523167|P1|Initial Vaccination (Year 0)|Subject request|8
3062517|NCT00521365|10523240|P1|Overall Study|Usage of not allowed drugs|6
3062518|NCT00521365|10523240|P1|Overall Study|Drug compliance|3
3062519|NCT00521365|10523240|P1|Overall Study|Protocol deviation|2
3062520|NCT00521365|10523240|P1|Overall Study|Lost to Follow-up|6
3062521|NCT00521365|10523240|P1|Overall Study|Adverse Event|3
3062522|NCT00521339|10523270|P3|Treatment Extension Phase|Death|1
3062523|NCT00521339|10523271|P2|Treatment Extension Phase|Death|0
3062524|NCT00521339|10523272|P1|Treatment Extension Phase|Death|0
3062525|NCT00521339|10523270|P3|Treatment Extension Phase|Withdrawal by Subject|2
3062526|NCT00521339|10523271|P2|Treatment Extension Phase|Withdrawal by Subject|0
3062527|NCT00521339|10523272|P1|Treatment Extension Phase|Withdrawal by Subject|0
3062528|NCT00521339|10523270|P3|Treatment Phase|Protocol Violation|0
3062529|NCT00521339|10523271|P2|Treatment Phase|Protocol Violation|0
3062530|NCT00521339|10523272|P1|Treatment Phase|Protocol Violation|1
3062531|NCT00521339|10523270|P3|Treatment Phase|Lost to Follow-up|0
3062532|NCT00521339|10523271|P2|Treatment Phase|Lost to Follow-up|0
3062533|NCT00521339|10523272|P1|Treatment Phase|Lost to Follow-up|1
3062534|NCT00521339|10523270|P3|Treatment Phase|Withdrawal by Subject|0
3062535|NCT00521339|10523271|P2|Treatment Phase|Withdrawal by Subject|0
3062536|NCT00521339|10523272|P1|Treatment Phase|Withdrawal by Subject|3
3062537|NCT00521339|10523270|P3|Treatment Phase|Lack of Efficacy|0
3062538|NCT00521339|10523271|P2|Treatment Phase|Lack of Efficacy|0
3062539|NCT00521339|10523272|P1|Treatment Phase|Lack of Efficacy|3
3062540|NCT00521339|10523270|P3|Treatment Phase|Intolerability to study drug|0
3062541|NCT00521339|10523271|P2|Treatment Phase|Intolerability to study drug|0
3062542|NCT00521339|10523272|P1|Treatment Phase|Intolerability to study drug|2
3062543|NCT00521339|10523270|P3|Treatment Phase|Adverse Event|0
3062544|NCT00521339|10523271|P2|Treatment Phase|Adverse Event|0
3062545|NCT00521339|10523272|P1|Treatment Phase|Adverse Event|2
3062546|NCT00521144|10523340|P5|Overall Study|Progressive Disease|6
3062547|NCT00521144|10523341|P4|Overall Study|Progressive Disease|0
3062548|NCT00521144|10523342|P3|Overall Study|Progressive Disease|2
3062549|NCT00521144|10523343|P2|Overall Study|Progressive Disease|2
3062550|NCT00521144|10523344|P1|Overall Study|Progressive Disease|4
3062551|NCT00521144|10523340|P5|Overall Study|Adverse Event|1
3062552|NCT00521144|10523341|P4|Overall Study|Adverse Event|0
3062553|NCT00521144|10523342|P3|Overall Study|Adverse Event|0
3062554|NCT00521144|10523343|P2|Overall Study|Adverse Event|1
3062555|NCT00521144|10523344|P1|Overall Study|Adverse Event|0
3062556|NCT00521144|10523340|P5|Overall Study|Not Treated|0
3062557|NCT00521144|10523341|P4|Overall Study|Not Treated|1
3062558|NCT00521144|10523342|P3|Overall Study|Not Treated|0
3062559|NCT00521144|10523343|P2|Overall Study|Not Treated|0
3062560|NCT00521144|10523344|P1|Overall Study|Not Treated|0
3062561|NCT00521079|10523358|P2|Overall Study|Withdrawal by Subject|3
3062562|NCT00521079|10523359|P1|Overall Study|Withdrawal by Subject|5
3062563|NCT00521079|10523358|P2|Overall Study|Lost to Follow-up|1
3062564|NCT00521079|10523359|P1|Overall Study|Lost to Follow-up|2
3062565|NCT00521079|10523358|P2|Overall Study|Adverse Event|1
3062566|NCT00521079|10523359|P1|Overall Study|Adverse Event|7
3062567|NCT00521053|10523369|P1|Observation Phase|Physician Decision|1
3062568|NCT00521053|10523369|P1|Observation Phase|Other non-study melanoma treatment|1
3062569|NCT00521053|10523369|P1|Observation Phase|Adverse Event|1
3062570|NCT00521053|10523369|P1|Observation Phase|Death|2
3062571|NCT00521053|10523369|P1|Observation Phase|Additional PV-10 via alternate protocol|8
3062572|NCT00521053|10523369|P1|Observation Phase|Disease Progression|55
3062573|NCT00521014|10523379|P1|Overall Study|Inevaluable, not treated|1
3062574|NCT00521001|10523383|P1|Overall Study|Ineligible|1
3062575|NCT00520975|10523392|P2|Overall Study|Not start protocol therapy|2
3062576|NCT00520975|10523393|P1|Overall Study|Not start protocol therapy|1
3062577|NCT00520975|10523392|P2|Overall Study|Other reasons|2
3062578|NCT00520975|10523393|P1|Overall Study|Other reasons|4
3062579|NCT00520975|10523392|P2|Overall Study|Other therapy|4
3062580|NCT00520975|10523393|P1|Overall Study|Other therapy|2
3062581|NCT00520975|10523392|P2|Overall Study|Withdrawal by Subject|5
3062582|NCT00520975|10523393|P1|Overall Study|Withdrawal by Subject|3
3062583|NCT00520975|10523392|P2|Overall Study|Death|2
3062584|NCT00520975|10523393|P1|Overall Study|Death|0
3062585|NCT00520975|10523392|P2|Overall Study|Adverse Event|10
3062586|NCT00520975|10523393|P1|Overall Study|Adverse Event|7
3062587|NCT00520975|10523392|P2|Overall Study|Disease progression|23
3062588|NCT00520975|10523393|P1|Overall Study|Disease progression|31
3062589|NCT00520936|10523425|P8|Overall Study|Protocol Violation|0
3062590|NCT00520936|10523426|P7|Overall Study|Protocol Violation|1
3062591|NCT00520936|10523427|P6|Overall Study|Protocol Violation|0
3062592|NCT00520936|10523428|P5|Overall Study|Protocol Violation|1
3062593|NCT00520936|10523429|P4|Overall Study|Protocol Violation|0
3062594|NCT00520936|10523430|P3|Overall Study|Protocol Violation|1
3062595|NCT00520936|10523431|P2|Overall Study|Protocol Violation|1
3062596|NCT00520936|10523432|P1|Overall Study|Protocol Violation|0
3062597|NCT00520936|10523425|P8|Overall Study|Death|0
3062598|NCT00520936|10523426|P7|Overall Study|Death|1
3062599|NCT00520936|10523427|P6|Overall Study|Death|0
3062600|NCT00520936|10523428|P5|Overall Study|Death|0
3062601|NCT00520936|10523429|P4|Overall Study|Death|0
3062602|NCT00520936|10523430|P3|Overall Study|Death|0
3062603|NCT00520936|10523431|P2|Overall Study|Death|0
3062604|NCT00520936|10523432|P1|Overall Study|Death|0
3062605|NCT00520936|10523425|P8|Overall Study|Toxicity Requiring Removal from Study|0
3062606|NCT00520936|10523426|P7|Overall Study|Toxicity Requiring Removal from Study|2
3062607|NCT00520936|10523427|P6|Overall Study|Toxicity Requiring Removal from Study|0
3062608|NCT00520936|10523428|P5|Overall Study|Toxicity Requiring Removal from Study|0
3062609|NCT00520936|10523429|P4|Overall Study|Toxicity Requiring Removal from Study|0
3062610|NCT00520936|10523430|P3|Overall Study|Toxicity Requiring Removal from Study|0
3062611|NCT00520936|10523431|P2|Overall Study|Toxicity Requiring Removal from Study|1
3062612|NCT00520936|10523432|P1|Overall Study|Toxicity Requiring Removal from Study|0
3062613|NCT00520936|10523425|P8|Overall Study|Withdrawal by Subject|1
3062614|NCT00520936|10523426|P7|Overall Study|Withdrawal by Subject|0
3062615|NCT00520936|10523427|P6|Overall Study|Withdrawal by Subject|0
3062616|NCT00520936|10523428|P5|Overall Study|Withdrawal by Subject|0
3062617|NCT00520936|10523429|P4|Overall Study|Withdrawal by Subject|0
3062618|NCT00520936|10523430|P3|Overall Study|Withdrawal by Subject|0
3062619|NCT00520936|10523431|P2|Overall Study|Withdrawal by Subject|0
3062620|NCT00520936|10523432|P1|Overall Study|Withdrawal by Subject|0
3062621|NCT00520936|10523425|P8|Overall Study|Physician Decision|0
3062622|NCT00520936|10523426|P7|Overall Study|Physician Decision|0
3062623|NCT00520936|10523427|P6|Overall Study|Physician Decision|0
3062624|NCT00520936|10523428|P5|Overall Study|Physician Decision|0
3062625|NCT00520936|10523429|P4|Overall Study|Physician Decision|0
3062626|NCT00520936|10523430|P3|Overall Study|Physician Decision|1
3062627|NCT00520936|10523431|P2|Overall Study|Physician Decision|2
3062628|NCT00520936|10523432|P1|Overall Study|Physician Decision|0
3062629|NCT00520845|10523487|P1|Overall Study|Alternative Therapy|1
3062630|NCT00520845|10523487|P1|Overall Study|Withdrawal by Subject|1
3062631|NCT00520845|10523487|P1|Overall Study|Disease Progression, relapse|13
3062632|NCT00520845|10523487|P1|Overall Study|Adverse Event|4
3062633|NCT00520845|10523487|P1|Overall Study|Death|3
3062634|NCT00520767|10523495|P1|Overall Study|Death|2
3062635|NCT00520741|10523501|P2|Overall Study|Other reasons for premature termination|6
3062636|NCT00520741|10523502|P1|Overall Study|Other reasons for premature termination|0
3062637|NCT00520741|10523501|P2|Overall Study|Lost to Follow-up|4
3062638|NCT00520741|10523502|P1|Overall Study|Lost to Follow-up|4
3062639|NCT00520741|10523501|P2|Overall Study|Unsatisfactory compliance of subject|3
3062640|NCT00520741|10523502|P1|Overall Study|Unsatisfactory compliance of subject|4
3062641|NCT00520741|10523501|P2|Overall Study|Protocol Violation|15
3062642|NCT00520741|10523502|P1|Overall Study|Protocol Violation|2
3062643|NCT00520741|10523501|P2|Overall Study|Withdrawal by Subject|11
3062644|NCT00520741|10523502|P1|Overall Study|Withdrawal by Subject|0
3062645|NCT00520741|10523501|P2|Overall Study|Lack of Efficacy|30
3062646|NCT00520741|10523502|P1|Overall Study|Lack of Efficacy|11
3062647|NCT00520741|10523501|P2|Overall Study|Adverse Event|56
3062648|NCT00520741|10523502|P1|Overall Study|Adverse Event|16
3062649|NCT00520676|10523520|P2|Overall Study|Withdrawal by Subject|11
3062650|NCT00520676|10523521|P1|Overall Study|Withdrawal by Subject|7
3062651|NCT00520676|10523520|P2|Overall Study|Physician Decision|1
3062652|NCT00520676|10523521|P1|Overall Study|Physician Decision|4
3062653|NCT00520676|10523520|P2|Overall Study|Lost to Follow-up|10
3062654|NCT00520676|10523521|P1|Overall Study|Lost to Follow-up|6
3062655|NCT00520676|10523520|P2|Overall Study|Death|81
3062656|NCT00520676|10523521|P1|Overall Study|Death|84
3062657|NCT00520572|10523547|P6|Overall Study|Did not receive Treatment|0
3062658|NCT00520572|10523548|P5|Overall Study|Did not receive Treatment|0
3062659|NCT00520572|10523549|P4|Overall Study|Did not receive Treatment|0
3062660|NCT00520572|10523550|P3|Overall Study|Did not receive Treatment|1
3062661|NCT00520572|10523551|P2|Overall Study|Did not receive Treatment|0
3062662|NCT00520572|10523552|P1|Overall Study|Did not receive Treatment|1
3062663|NCT00520572|10523547|P6|Overall Study|Long break in taking Medication|0
3062664|NCT00520572|10523548|P5|Overall Study|Long break in taking Medication|0
3062665|NCT00520572|10523549|P4|Overall Study|Long break in taking Medication|1
3062666|NCT00520572|10523550|P3|Overall Study|Long break in taking Medication|0
3062667|NCT00520572|10523551|P2|Overall Study|Long break in taking Medication|0
3062668|NCT00520572|10523552|P1|Overall Study|Long break in taking Medication|0
3062669|NCT00520572|10523547|P6|Overall Study|Oral corticotherapy for acute urticaria|0
3062670|NCT00520572|10523548|P5|Overall Study|Oral corticotherapy for acute urticaria|0
3062671|NCT00520572|10523549|P4|Overall Study|Oral corticotherapy for acute urticaria|0
3062672|NCT00520572|10523550|P3|Overall Study|Oral corticotherapy for acute urticaria|0
3062673|NCT00520572|10523551|P2|Overall Study|Oral corticotherapy for acute urticaria|1
3062674|NCT00520572|10523552|P1|Overall Study|Oral corticotherapy for acute urticaria|0
3062675|NCT00520572|10523547|P6|Overall Study|Incorrect enrollment|0
3062676|NCT00520572|10523548|P5|Overall Study|Incorrect enrollment|1
3062677|NCT00520572|10523549|P4|Overall Study|Incorrect enrollment|0
3062678|NCT00520572|10523550|P3|Overall Study|Incorrect enrollment|1
3062679|NCT00520572|10523551|P2|Overall Study|Incorrect enrollment|0
3062680|NCT00520572|10523552|P1|Overall Study|Incorrect enrollment|1
3062681|NCT00520572|10523547|P6|Overall Study|Lost to Follow-up|0
3062682|NCT00520572|10523548|P5|Overall Study|Lost to Follow-up|1
3062683|NCT00520572|10523549|P4|Overall Study|Lost to Follow-up|0
3062684|NCT00520572|10523550|P3|Overall Study|Lost to Follow-up|0
3062685|NCT00520572|10523551|P2|Overall Study|Lost to Follow-up|0
3062686|NCT00520572|10523552|P1|Overall Study|Lost to Follow-up|0
3062687|NCT00520572|10523547|P6|Overall Study|Lack of Efficacy|0
3062688|NCT00520572|10523548|P5|Overall Study|Lack of Efficacy|1
3062689|NCT00520572|10523549|P4|Overall Study|Lack of Efficacy|2
3062690|NCT00520572|10523550|P3|Overall Study|Lack of Efficacy|1
3062691|NCT00520572|10523551|P2|Overall Study|Lack of Efficacy|1
3062692|NCT00520572|10523552|P1|Overall Study|Lack of Efficacy|1
3062693|NCT00520572|10523547|P6|Overall Study|Protocol Violation|0
3062694|NCT00520572|10523548|P5|Overall Study|Protocol Violation|0
3062695|NCT00520572|10523549|P4|Overall Study|Protocol Violation|0
3062696|NCT00520572|10523550|P3|Overall Study|Protocol Violation|1
3062697|NCT00520572|10523551|P2|Overall Study|Protocol Violation|0
3062698|NCT00520572|10523552|P1|Overall Study|Protocol Violation|0
3062699|NCT00520572|10523547|P6|Overall Study|Withdrawal by Subject|0
3062700|NCT00520572|10523548|P5|Overall Study|Withdrawal by Subject|2
3062701|NCT00520572|10523549|P4|Overall Study|Withdrawal by Subject|2
3062702|NCT00520572|10523550|P3|Overall Study|Withdrawal by Subject|5
3062703|NCT00520572|10523551|P2|Overall Study|Withdrawal by Subject|9
3062704|NCT00520572|10523552|P1|Overall Study|Withdrawal by Subject|0
3062705|NCT00520572|10523547|P6|Overall Study|Adverse Event|2
3062706|NCT00520572|10523548|P5|Overall Study|Adverse Event|7
3062707|NCT00520572|10523549|P4|Overall Study|Adverse Event|9
3062708|NCT00520572|10523550|P3|Overall Study|Adverse Event|6
3062709|NCT00520572|10523551|P2|Overall Study|Adverse Event|3
3062710|NCT00520572|10523552|P1|Overall Study|Adverse Event|9
3062711|NCT00520546|10523590|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
3062712|NCT00520546|10523590|P1|Overall Study|Withdrawal by Subject|1
3062713|NCT00520494|10523605|P1|Overall Study|Withdrawal by Subject|1
3062714|NCT00520481|10523630|P2|Overall Study|Withdrawal by Subject|0
3062715|NCT00520481|10523631|P1|Overall Study|Withdrawal by Subject|3
3062716|NCT00520481|10523630|P2|Overall Study|Adverse Event|1
3062717|NCT00520481|10523631|P1|Overall Study|Adverse Event|4
3062718|NCT00520403|10523655|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
3062719|NCT00520403|10523655|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
3062720|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
3062721|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
3062722|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Death|2
3062723|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
3062724|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
3062725|NCT00520403|10523655|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
3062726|NCT00520351|10523664|P2|First Intervention|Withdrawal by Subject|1
3062727|NCT00520351|10523665|P1|First Intervention|Withdrawal by Subject|1
3062728|NCT00520299|10523680|P3|Overall Study|Progressive disease|4
3062729|NCT00520299|10523681|P2|Overall Study|Progressive disease|3
3062730|NCT00520299|10523682|P1|Overall Study|Progressive disease|0
3062731|NCT00520299|10523680|P3|Overall Study|Withdrawal by Subject|2
3062732|NCT00520299|10523681|P2|Overall Study|Withdrawal by Subject|0
3062733|NCT00520299|10523682|P1|Overall Study|Withdrawal by Subject|0
3062734|NCT00520130|10523737|P2|Overall Study|Physician Decision|1
3062735|NCT00520130|10523738|P1|Overall Study|Physician Decision|1
3062736|NCT00520130|10523737|P2|Overall Study|Disease progression on study|0
3062737|NCT00520130|10523738|P1|Overall Study|Disease progression on study|4
3062738|NCT00520039|10523780|P2|Overall Study|Exclusion criteria met at first visit|5
3062739|NCT00520039|10523781|P1|Overall Study|Exclusion criteria met at first visit|7
3062740|NCT00520013|10523794|P3|Overall Study|Physician Decision|3
3062741|NCT00520013|10523795|P2|Overall Study|Physician Decision|0
3062742|NCT00520013|10523796|P1|Overall Study|Physician Decision|0
3062743|NCT00520013|10523794|P3|Overall Study|Death|0
3062744|NCT00520013|10523795|P2|Overall Study|Death|1
3062745|NCT00520013|10523796|P1|Overall Study|Death|0
3062746|NCT00520013|10523794|P3|Overall Study|Clinical Progression|0
3062747|NCT00520013|10523795|P2|Overall Study|Clinical Progression|1
3062748|NCT00520013|10523796|P1|Overall Study|Clinical Progression|3
3062749|NCT00520013|10523794|P3|Overall Study|Progressive Disease|0
3062750|NCT00520013|10523795|P2|Overall Study|Progressive Disease|3
3062751|NCT00520013|10523796|P1|Overall Study|Progressive Disease|7
3062752|NCT00520013|10523794|P3|Overall Study|Adverse Event|7
3062753|NCT00520013|10523795|P2|Overall Study|Adverse Event|10
3062754|NCT00520013|10523796|P1|Overall Study|Adverse Event|2
3062755|NCT00520013|10523794|P3|Overall Study|Withdrawal by Subject|1
3062756|NCT00520013|10523795|P2|Overall Study|Withdrawal by Subject|0
3062757|NCT00520013|10523796|P1|Overall Study|Withdrawal by Subject|0
3062758|NCT00519896|10523806|P1|Overall Study|Adverse Event|1
3062759|NCT00519896|10523806|P1|Overall Study|Protocol Violation|1
3062760|NCT00519831|10523812|P1|Overall Study|Adverse Event|3
3062761|NCT00519779|10523829|P2|Overall Study|Withdrawal by Subject|1
3062762|NCT00519779|10523830|P1|Overall Study|Withdrawal by Subject|0
3062763|NCT00519649|10523846|P1|Overall Study|Withdrawal by Subject|1
3062764|NCT00519636|10523859|P4|Post Study Period|Subject randomized in error|1
3062765|NCT00519636|10523860|P3|Post Study Period|Subject randomized in error|0
3062766|NCT00519636|10523861|P2|Post Study Period|Subject randomized in error|0
3062767|NCT00519636|10523862|P1|Post Study Period|Subject randomized in error|0
3062768|NCT00519636|10523859|P4|Treatment Period 2|Subject misrandomized|1
3062769|NCT00519636|10523860|P3|Treatment Period 2|Subject misrandomized|0
3062770|NCT00519636|10523861|P2|Treatment Period 2|Subject misrandomized|0
3062771|NCT00519636|10523862|P1|Treatment Period 2|Subject misrandomized|0
3062772|NCT00519636|10523859|P4|Treatment Period 2|Per doctors request|0
3062773|NCT00519636|10523860|P3|Treatment Period 2|Per doctors request|1
3062774|NCT00519636|10523861|P2|Treatment Period 2|Per doctors request|0
3062775|NCT00519636|10523862|P1|Treatment Period 2|Per doctors request|0
3062776|NCT00519636|10523859|P4|Treatment Period 2|Subject randomized in error|0
3062777|NCT00519636|10523860|P3|Treatment Period 2|Subject randomized in error|0
3062778|NCT00519636|10523861|P2|Treatment Period 2|Subject randomized in error|1
3062779|NCT00519636|10523862|P1|Treatment Period 2|Subject randomized in error|0
3062780|NCT00519636|10523859|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
3062781|NCT00519636|10523860|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
3062782|NCT00519636|10523861|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
3062783|NCT00519636|10523862|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
3062784|NCT00519636|10523859|P4|Washout Period|Prohibited medications|0
3062785|NCT00519636|10523860|P3|Washout Period|Prohibited medications|1
3062786|NCT00519636|10523861|P2|Washout Period|Prohibited medications|0
3062787|NCT00519636|10523862|P1|Washout Period|Prohibited medications|0
3062788|NCT00519636|10523859|P4|Washout Period|Subject randomized in error|0
3062789|NCT00519636|10523860|P3|Washout Period|Subject randomized in error|1
3062790|NCT00519636|10523861|P2|Washout Period|Subject randomized in error|0
3062791|NCT00519636|10523862|P1|Washout Period|Subject randomized in error|0
3062792|NCT00519636|10523859|P4|Washout Period|Per doctors request|0
3062793|NCT00519636|10523860|P3|Washout Period|Per doctors request|0
3062794|NCT00519636|10523861|P2|Washout Period|Per doctors request|1
3062795|NCT00519636|10523862|P1|Washout Period|Per doctors request|0
3062796|NCT00519636|10523859|P4|Washout Period|Non-compliant|0
3062797|NCT00519636|10523860|P3|Washout Period|Non-compliant|0
3062798|NCT00519636|10523861|P2|Washout Period|Non-compliant|1
3062799|NCT00519636|10523862|P1|Washout Period|Non-compliant|0
3062800|NCT00519636|10523859|P4|Washout Period|Participating in study at another site|0
3062801|NCT00519636|10523860|P3|Washout Period|Participating in study at another site|0
3062802|NCT00519636|10523861|P2|Washout Period|Participating in study at another site|0
3062803|NCT00519636|10523862|P1|Washout Period|Participating in study at another site|1
3062804|NCT00519636|10523859|P4|Washout Period|Out of pollen area > 48 hours|0
3062805|NCT00519636|10523860|P3|Washout Period|Out of pollen area > 48 hours|0
3062806|NCT00519636|10523861|P2|Washout Period|Out of pollen area > 48 hours|0
3062807|NCT00519636|10523862|P1|Washout Period|Out of pollen area > 48 hours|1
3062808|NCT00519636|10523859|P4|Washout Period|Failed to meet continuation criteria|3
3062809|NCT00519636|10523860|P3|Washout Period|Failed to meet continuation criteria|9
3062810|NCT00519636|10523861|P2|Washout Period|Failed to meet continuation criteria|11
3062811|NCT00519636|10523862|P1|Washout Period|Failed to meet continuation criteria|14
3062812|NCT00519636|10523859|P4|Washout Period|Withdrawal by Subject|0
3062813|NCT00519636|10523860|P3|Washout Period|Withdrawal by Subject|1
3062814|NCT00519636|10523861|P2|Washout Period|Withdrawal by Subject|0
3062815|NCT00519636|10523862|P1|Washout Period|Withdrawal by Subject|1
3062816|NCT00519636|10523859|P4|Washout Period|Protocol Violation|2
3062817|NCT00519636|10523860|P3|Washout Period|Protocol Violation|1
3062818|NCT00519636|10523861|P2|Washout Period|Protocol Violation|0
3062819|NCT00519636|10523862|P1|Washout Period|Protocol Violation|0
3062820|NCT00519636|10523859|P4|Washout Period|Lost to Follow-up|0
3062821|NCT00519636|10523860|P3|Washout Period|Lost to Follow-up|0
3062822|NCT00519636|10523861|P2|Washout Period|Lost to Follow-up|0
3062823|NCT00519636|10523862|P1|Washout Period|Lost to Follow-up|1
3062824|NCT00519636|10523859|P4|Washout Period|Adverse Event|0
3062825|NCT00519636|10523860|P3|Washout Period|Adverse Event|1
3062826|NCT00519636|10523861|P2|Washout Period|Adverse Event|1
3062827|NCT00519636|10523862|P1|Washout Period|Adverse Event|2
3062912|NCT00518986|10524147|P1|Overall Study|Protocol Violation|5
3062828|NCT00519636|10523859|P4|Treatment Period 1|Sponsor request due to missed visit|0
3062829|NCT00519636|10523860|P3|Treatment Period 1|Sponsor request due to missed visit|0
3062830|NCT00519636|10523861|P2|Treatment Period 1|Sponsor request due to missed visit|0
3062831|NCT00519636|10523862|P1|Treatment Period 1|Sponsor request due to missed visit|1
3062832|NCT00519636|10523859|P4|Treatment Period 1|Adverse Event|0
3062833|NCT00519636|10523860|P3|Treatment Period 1|Adverse Event|1
3062834|NCT00519636|10523861|P2|Treatment Period 1|Adverse Event|0
3062835|NCT00519636|10523862|P1|Treatment Period 1|Adverse Event|1
3062836|NCT00519623|10523892|P1|Overall Study|Adverse Event|1
3062837|NCT00519532|10523926|P1|Overall Study|Lost to Follow-up|2
3062838|NCT00519532|10523926|P1|Overall Study|Withdrawal by Subject|5
3062839|NCT00519532|10523926|P1|Overall Study|Adverse Event|11
3062840|NCT00519428|10523936|P3|Overall Study|unstated|2
3062841|NCT00519428|10523937|P2|Overall Study|unstated|3
3062842|NCT00519428|10523938|P1|Overall Study|unstated|1
3062843|NCT00519428|10523936|P3|Overall Study|Withdrawal by Subject|7
3062844|NCT00519428|10523937|P2|Overall Study|Withdrawal by Subject|3
3062845|NCT00519428|10523938|P1|Overall Study|Withdrawal by Subject|8
3062846|NCT00519428|10523936|P3|Overall Study|Lost to Follow-up|6
3062847|NCT00519428|10523937|P2|Overall Study|Lost to Follow-up|7
3062848|NCT00519428|10523938|P1|Overall Study|Lost to Follow-up|7
3062849|NCT00519428|10523936|P3|Overall Study|Adverse Event|10
3062850|NCT00519428|10523937|P2|Overall Study|Adverse Event|2
3062851|NCT00519428|10523938|P1|Overall Study|Adverse Event|5
3062852|NCT00519376|10523958|P16|Treatment Period 4|Lost to Follow-up|0
3062853|NCT00519376|10523959|P15|Treatment Period 4|Lost to Follow-up|0
3062854|NCT00519376|10523960|P14|Treatment Period 4|Lost to Follow-up|0
3062855|NCT00519376|10523961|P13|Treatment Period 4|Lost to Follow-up|0
3062856|NCT00519376|10523962|P12|Treatment Period 4|Lost to Follow-up|0
3062857|NCT00519376|10523963|P11|Treatment Period 4|Lost to Follow-up|0
3062858|NCT00519376|10523964|P10|Treatment Period 4|Lost to Follow-up|0
3062859|NCT00519376|10523965|P9|Treatment Period 4|Lost to Follow-up|0
3062860|NCT00519376|10523966|P8|Treatment Period 4|Lost to Follow-up|0
3062861|NCT00519376|10523967|P7|Treatment Period 4|Lost to Follow-up|0
3062862|NCT00519376|10523968|P6|Treatment Period 4|Lost to Follow-up|0
3062863|NCT00519376|10523969|P5|Treatment Period 4|Lost to Follow-up|0
3062864|NCT00519376|10523970|P4|Treatment Period 4|Lost to Follow-up|0
3062865|NCT00519376|10523971|P3|Treatment Period 4|Lost to Follow-up|1
3062866|NCT00519376|10523972|P2|Treatment Period 4|Lost to Follow-up|0
3062867|NCT00519376|10523973|P1|Treatment Period 4|Lost to Follow-up|0
3062868|NCT00519376|10523958|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062869|NCT00519376|10523959|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062870|NCT00519376|10523960|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062871|NCT00519376|10523961|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
3062872|NCT00519376|10523962|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062873|NCT00519376|10523963|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062874|NCT00519376|10523964|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062875|NCT00519376|10523965|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062876|NCT00519376|10523966|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062877|NCT00519376|10523967|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062878|NCT00519376|10523968|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062879|NCT00519376|10523969|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062880|NCT00519376|10523970|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062881|NCT00519376|10523971|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062882|NCT00519376|10523972|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062883|NCT00519376|10523973|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
3062884|NCT00519285|10524097|P2|Overall Study|Treatment ongoing|2
3062885|NCT00519285|10524098|P1|Overall Study|Treatment ongoing|1
3062886|NCT00519285|10524097|P2|Overall Study|Not treated|7
3062887|NCT00519285|10524098|P1|Overall Study|Not treated|8
3062888|NCT00519285|10524097|P2|Overall Study|Reason unspecified|8
3062889|NCT00519285|10524098|P1|Overall Study|Reason unspecified|5
3062890|NCT00519285|10524097|P2|Overall Study|Poor compliance to protocol|7
3062891|NCT00519285|10524098|P1|Overall Study|Poor compliance to protocol|5
3062892|NCT00519285|10524097|P2|Overall Study|Consent withdrawn|5
3062893|NCT00519285|10524098|P1|Overall Study|Consent withdrawn|4
3062894|NCT00519285|10524097|P2|Overall Study|Participant's request|84
3062895|NCT00519285|10524098|P1|Overall Study|Participant's request|53
3062896|NCT00519285|10524097|P2|Overall Study|Physician Decision|47
3062897|NCT00519285|10524098|P1|Overall Study|Physician Decision|75
3062898|NCT00519285|10524097|P2|Overall Study|Disease progression|186
3062899|NCT00519285|10524098|P1|Overall Study|Disease progression|334
3062900|NCT00519285|10524097|P2|Overall Study|Adverse Event|266
3062901|NCT00519285|10524098|P1|Overall Study|Adverse Event|127
3062902|NCT00519194|10524124|P1|Overall Study|Lost to Follow-up|3
3062903|NCT00519194|10524124|P1|Overall Study|Death|9
3062904|NCT00519194|10524124|P1|Overall Study|Withdrawal by Subject|9
3062905|NCT00519077|10524139|P1|Overall Study|Other|2
3062906|NCT00519077|10524139|P1|Overall Study|Death|6
3062907|NCT00518986|10524146|P2|Overall Study|Non-Specific|1
3062908|NCT00518986|10524147|P1|Overall Study|Non-Specific|2
3062909|NCT00518986|10524146|P2|Overall Study|Withdrawal by Subject|4
3062910|NCT00518986|10524147|P1|Overall Study|Withdrawal by Subject|4
3062911|NCT00518986|10524146|P2|Overall Study|Protocol Violation|7
3062913|NCT00518986|10524146|P2|Overall Study|Physician Decision|3
3062914|NCT00518986|10524147|P1|Overall Study|Physician Decision|0
3062915|NCT00518986|10524146|P2|Overall Study|Lost to Follow-up|2
3062916|NCT00518986|10524147|P1|Overall Study|Lost to Follow-up|3
3062917|NCT00518986|10524146|P2|Overall Study|Lack of Efficacy|2
3062918|NCT00518986|10524147|P1|Overall Study|Lack of Efficacy|0
3062919|NCT00518986|10524146|P2|Overall Study|Adverse Event|7
3062920|NCT00518986|10524147|P1|Overall Study|Adverse Event|12
3062921|NCT00518973|10524273|P2|Overall Study|Withdrawal by Subject|2
3062922|NCT00518973|10524274|P1|Overall Study|Withdrawal by Subject|3
3062923|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
3062924|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
3062925|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Subject decision|0
3062926|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Subject decision|2
3062927|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
3062928|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
3062929|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
3062930|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
3062931|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Creatine increased|0
3062932|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Creatine increased|1
3062933|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Change in treatment|1
3062934|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Change in treatment|1
3062935|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
3062936|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
3062937|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
3062938|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
3062939|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
3062940|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
3062941|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
3062942|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
3062943|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
3062944|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
3062945|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
3062946|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
3062947|NCT00518882|10524290|P2|Open-Label Extension, Week 26-78|Adverse Event|9
3062948|NCT00518882|10524291|P1|Open-Label Extension, Week 26-78|Adverse Event|3
3062949|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Mutual consent|1
3062950|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Mutual consent|0
3062951|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
3062952|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
3062953|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
3062954|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
3062955|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Loss of trust|1
3062956|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Loss of trust|0
3062957|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
3062958|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
3062959|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Subject decision|1
3062960|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Subject decision|1
3062961|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Lost to follow up|1
3062962|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Lost to follow up|2
3062963|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
3062964|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
3062965|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Protocol Violation|3
3062966|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Protocol Violation|4
3062967|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
3062968|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
3062969|NCT00518882|10524290|P2|Double-Blind, Week 0-26|Adverse Event|31
3062970|NCT00518882|10524291|P1|Double-Blind, Week 0-26|Adverse Event|23
3062971|NCT00518687|10524472|P2|Overall Study|Withdrawal by Subject|110
3062972|NCT00518687|10524473|P1|Overall Study|Withdrawal by Subject|110
3062973|NCT00518687|10524472|P2|Overall Study|Study terminated by sponsor|918
3062974|NCT00518687|10524473|P1|Overall Study|Study terminated by sponsor|930
3062975|NCT00518687|10524472|P2|Overall Study|Protocol Violation|10
3062976|NCT00518687|10524473|P1|Overall Study|Protocol Violation|8
3062977|NCT00518687|10524472|P2|Overall Study|Progressive disease|2
3062978|NCT00518687|10524473|P1|Overall Study|Progressive disease|2
3062979|NCT00518687|10524472|P2|Overall Study|Physician Decision|48
3062980|NCT00518687|10524473|P1|Overall Study|Physician Decision|42
3062981|NCT00518687|10524472|P2|Overall Study|Lost to Follow-up|155
3062982|NCT00518687|10524473|P1|Overall Study|Lost to Follow-up|144
3062983|NCT00518687|10524472|P2|Overall Study|Adverse Event|177
3062984|NCT00518687|10524473|P1|Overall Study|Adverse Event|201
3062985|NCT00518622|10524493|P8|Overall Study|Study medication taken incorrectly|0
3062986|NCT00518622|10524494|P7|Overall Study|Study medication taken incorrectly|0
3062987|NCT00518622|10524495|P6|Overall Study|Study medication taken incorrectly|0
3062988|NCT00518622|10524496|P5|Overall Study|Study medication taken incorrectly|0
3062989|NCT00518622|10524497|P4|Overall Study|Study medication taken incorrectly|0
3062990|NCT00518622|10524498|P3|Overall Study|Study medication taken incorrectly|0
3062991|NCT00518622|10524499|P2|Overall Study|Study medication taken incorrectly|1
3062992|NCT00518622|10524500|P1|Overall Study|Study medication taken incorrectly|0
3062993|NCT00518622|10524493|P8|Overall Study|Lost to Follow-up|0
3062994|NCT00518622|10524494|P7|Overall Study|Lost to Follow-up|0
3062995|NCT00518622|10524495|P6|Overall Study|Lost to Follow-up|0
3062996|NCT00518622|10524496|P5|Overall Study|Lost to Follow-up|0
3062997|NCT00518622|10524497|P4|Overall Study|Lost to Follow-up|0
3062998|NCT00518622|10524498|P3|Overall Study|Lost to Follow-up|1
3062999|NCT00518622|10524499|P2|Overall Study|Lost to Follow-up|0
3063000|NCT00518622|10524500|P1|Overall Study|Lost to Follow-up|0
3063001|NCT00518531|10524528|P2|Treatment Period 2|Non-compliance|2
3063002|NCT00518531|10524529|P1|Treatment Period 2|Non-compliance|1
3063003|NCT00518531|10524528|P2|Treatment Period 2|Protocol-specified criteria|1
3063004|NCT00518531|10524529|P1|Treatment Period 2|Protocol-specified criteria|0
3063005|NCT00518531|10524528|P2|Treatment Period 2|Adverse Event|7
3063006|NCT00518531|10524529|P1|Treatment Period 2|Adverse Event|1
3063007|NCT00518531|10524528|P2|Treatment Period 2|Complete out of scheduled visit window|2
3063008|NCT00518531|10524529|P1|Treatment Period 2|Complete out of scheduled visit window|1
3063009|NCT00518531|10524528|P2|Treatment Period 2|Withdrawal by Subject|8
3063010|NCT00518531|10524529|P1|Treatment Period 2|Withdrawal by Subject|0
3063011|NCT00518531|10524528|P2|Treatment Period 1|Early crossover|3
3063012|NCT00518531|10524529|P1|Treatment Period 1|Early crossover|1
3063013|NCT00518531|10524528|P2|Treatment Period 1|Withdrawal by Subject|6
3063014|NCT00518531|10524529|P1|Treatment Period 1|Withdrawal by Subject|4
3063015|NCT00518531|10524528|P2|Treatment Period 1|Protocol Violation|0
3063016|NCT00518531|10524529|P1|Treatment Period 1|Protocol Violation|2
3063017|NCT00518531|10524528|P2|Treatment Period 1|Physician Decision|0
3063018|NCT00518531|10524529|P1|Treatment Period 1|Physician Decision|1
3063019|NCT00518531|10524528|P2|Treatment Period 1|Lost to Follow-up|3
3063020|NCT00518531|10524529|P1|Treatment Period 1|Lost to Follow-up|5
3063021|NCT00518531|10524528|P2|Treatment Period 1|Adverse Event|0
3063022|NCT00518531|10524529|P1|Treatment Period 1|Adverse Event|5
3063023|NCT00518336|10524574|P2|Year 9|Personal reasons|0
3063024|NCT00518336|10524575|P1|Year 9|Personal reasons|1
3063025|NCT00518336|10524574|P2|Year 9|Lost to Follow-up|0
3063026|NCT00518336|10524575|P1|Year 9|Lost to Follow-up|3
3063027|NCT00518336|10524574|P2|Year 9|Migrated/moved from study area|1
3063028|NCT00518336|10524575|P1|Year 9|Migrated/moved from study area|1
3063029|NCT00518336|10524574|P2|Year 8|Could not attend in time|1
3063030|NCT00518336|10524575|P1|Year 8|Could not attend in time|0
3063031|NCT00518336|10524574|P2|Year 8|Lost to Follow-up|1
3063032|NCT00518336|10524575|P1|Year 8|Lost to Follow-up|1
3063033|NCT00518336|10524574|P2|Year 7|Could not attend in time|3
3063034|NCT00518336|10524575|P1|Year 7|Could not attend in time|0
3063035|NCT00518336|10524574|P2|Year 7|Lost to Follow-up|0
3063036|NCT00518336|10524575|P1|Year 7|Lost to Follow-up|2
3063037|NCT00518323|10524741|P4|Overall Study|Prohibited medication and others|0
3063038|NCT00518323|10524742|P3|Overall Study|Prohibited medication and others|1
3063039|NCT00518323|10524743|P2|Overall Study|Prohibited medication and others|1
3063040|NCT00518323|10524744|P1|Overall Study|Prohibited medication and others|3
3063041|NCT00518323|10524741|P4|Overall Study|Adverse Event|0
3063042|NCT00518323|10524742|P3|Overall Study|Adverse Event|1
3063043|NCT00518323|10524743|P2|Overall Study|Adverse Event|1
3063044|NCT00518323|10524744|P1|Overall Study|Adverse Event|1
3063045|NCT00518323|10524741|P4|Overall Study|Lost to Follow-up|3
3063046|NCT00518323|10524742|P3|Overall Study|Lost to Follow-up|1
3063047|NCT00518323|10524743|P2|Overall Study|Lost to Follow-up|2
3063048|NCT00518323|10524744|P1|Overall Study|Lost to Follow-up|0
3063049|NCT00518323|10524741|P4|Overall Study|Withdrawal by Subject|2
3063050|NCT00518323|10524742|P3|Overall Study|Withdrawal by Subject|4
3063051|NCT00518323|10524743|P2|Overall Study|Withdrawal by Subject|2
3063052|NCT00518323|10524744|P1|Overall Study|Withdrawal by Subject|1
3063053|NCT00518323|10524741|P4|Overall Study|Lack of Efficacy|20
3063054|NCT00518323|10524742|P3|Overall Study|Lack of Efficacy|4
3063055|NCT00518323|10524743|P2|Overall Study|Lack of Efficacy|2
3063056|NCT00518323|10524744|P1|Overall Study|Lack of Efficacy|14
3063057|NCT00518284|10524774|P4|Overall Study|Study Termination|2
3063058|NCT00518284|10524775|P3|Overall Study|Study Termination|1
3063059|NCT00518284|10524776|P2|Overall Study|Study Termination|2
3063060|NCT00518284|10524777|P1|Overall Study|Study Termination|0
3063061|NCT00518284|10524774|P4|Overall Study|Adverse Event|0
3063062|NCT00518284|10524775|P3|Overall Study|Adverse Event|0
3063063|NCT00518284|10524776|P2|Overall Study|Adverse Event|1
3063064|NCT00518284|10524777|P1|Overall Study|Adverse Event|0
3063065|NCT00518206|10524833|P2|Overall Study|Completion Status Unknown|0
3063066|NCT00518206|10524834|P1|Overall Study|Completion Status Unknown|1
3063067|NCT00518206|10524833|P2|Overall Study|Reason Unknown|0
3063068|NCT00518206|10524834|P1|Overall Study|Reason Unknown|1
3063069|NCT00518206|10524833|P2|Overall Study|Drug Supply Issue|0
3063070|NCT00518206|10524834|P1|Overall Study|Drug Supply Issue|1
3063071|NCT00518206|10524833|P2|Overall Study|Withdrawal by Subject|0
3063072|NCT00518206|10524834|P1|Overall Study|Withdrawal by Subject|2
3063073|NCT00518206|10524833|P2|Overall Study|Disease Progression Requiring Therapy|6
3063074|NCT00518206|10524834|P1|Overall Study|Disease Progression Requiring Therapy|6
3063075|NCT00518180|10524851|P3|Overall Study|Adverse Event|0
3063076|NCT00518180|10524852|P2|Overall Study|Adverse Event|0
3063077|NCT00518180|10524853|P1|Overall Study|Adverse Event|1
3063078|NCT00518180|10524851|P3|Overall Study|Unable to classify|0
3063079|NCT00518180|10524852|P2|Overall Study|Unable to classify|2
3063080|NCT00518180|10524853|P1|Overall Study|Unable to classify|0
3063081|NCT00518180|10524851|P3|Overall Study|Protocol Violation|4
3063082|NCT00518180|10524852|P2|Overall Study|Protocol Violation|7
3063083|NCT00518180|10524853|P1|Overall Study|Protocol Violation|5
3063084|NCT00518180|10524851|P3|Overall Study|Administrative reason|2
3063085|NCT00518180|10524852|P2|Overall Study|Administrative reason|2
3063086|NCT00518180|10524853|P1|Overall Study|Administrative reason|0
3063087|NCT00518180|10524851|P3|Overall Study|Lost to Follow-up|34
3063088|NCT00518180|10524852|P2|Overall Study|Lost to Follow-up|28
3063089|NCT00518180|10524853|P1|Overall Study|Lost to Follow-up|30
3063090|NCT00518180|10524851|P3|Overall Study|Withdrawal by Subject|42
3063091|NCT00518180|10524852|P2|Overall Study|Withdrawal by Subject|30
3063092|NCT00518180|10524853|P1|Overall Study|Withdrawal by Subject|29
3063093|NCT00518115|10524909|P10|Overall Study|Moved Out of State|1
3063094|NCT00518115|10524910|P9|Overall Study|Moved Out of State|0
3063095|NCT00518115|10524911|P8|Overall Study|Moved Out of State|0
3063096|NCT00518115|10524912|P7|Overall Study|Moved Out of State|0
3063097|NCT00518115|10524913|P6|Overall Study|Moved Out of State|0
3063098|NCT00518115|10524914|P5|Overall Study|Moved Out of State|0
3063099|NCT00518115|10524915|P4|Overall Study|Moved Out of State|0
3063100|NCT00518115|10524916|P3|Overall Study|Moved Out of State|0
3063101|NCT00518115|10524917|P2|Overall Study|Moved Out of State|0
3063102|NCT00518115|10524918|P1|Overall Study|Moved Out of State|0
3063103|NCT00518115|10524909|P10|Overall Study|Withdrew Consent|0
3063104|NCT00518115|10524910|P9|Overall Study|Withdrew Consent|0
3063105|NCT00518115|10524911|P8|Overall Study|Withdrew Consent|0
3063106|NCT00518115|10524912|P7|Overall Study|Withdrew Consent|0
3063107|NCT00518115|10524913|P6|Overall Study|Withdrew Consent|1
3063108|NCT00518115|10524914|P5|Overall Study|Withdrew Consent|0
3063109|NCT00518115|10524915|P4|Overall Study|Withdrew Consent|0
3063110|NCT00518115|10524916|P3|Overall Study|Withdrew Consent|0
3063111|NCT00518115|10524917|P2|Overall Study|Withdrew Consent|0
3063112|NCT00518115|10524918|P1|Overall Study|Withdrew Consent|0
3063113|NCT00518115|10524909|P10|Overall Study|Family Emergency; Had to Go to England|0
3063114|NCT00518115|10524910|P9|Overall Study|Family Emergency; Had to Go to England|0
3063115|NCT00518115|10524911|P8|Overall Study|Family Emergency; Had to Go to England|0
3063116|NCT00518115|10524912|P7|Overall Study|Family Emergency; Had to Go to England|0
3063117|NCT00518115|10524913|P6|Overall Study|Family Emergency; Had to Go to England|0
3063118|NCT00518115|10524914|P5|Overall Study|Family Emergency; Had to Go to England|1
3063119|NCT00518115|10524915|P4|Overall Study|Family Emergency; Had to Go to England|0
3063120|NCT00518115|10524916|P3|Overall Study|Family Emergency; Had to Go to England|0
3063121|NCT00518115|10524917|P2|Overall Study|Family Emergency; Had to Go to England|0
3063122|NCT00518115|10524918|P1|Overall Study|Family Emergency; Had to Go to England|0
3063123|NCT00518115|10524909|P10|Overall Study|Violation of Exclusion Criteria|0
3063124|NCT00518115|10524910|P9|Overall Study|Violation of Exclusion Criteria|0
3063125|NCT00518115|10524911|P8|Overall Study|Violation of Exclusion Criteria|0
3063126|NCT00518115|10524912|P7|Overall Study|Violation of Exclusion Criteria|1
3063127|NCT00518115|10524913|P6|Overall Study|Violation of Exclusion Criteria|0
3063128|NCT00518115|10524914|P5|Overall Study|Violation of Exclusion Criteria|0
3063129|NCT00518115|10524915|P4|Overall Study|Violation of Exclusion Criteria|1
3063130|NCT00518115|10524916|P3|Overall Study|Violation of Exclusion Criteria|0
3063131|NCT00518115|10524917|P2|Overall Study|Violation of Exclusion Criteria|0
3063132|NCT00518115|10524918|P1|Overall Study|Violation of Exclusion Criteria|0
3063133|NCT00518115|10524909|P10|Overall Study|Wrong Monotherapy Administered|0
3063134|NCT00518115|10524910|P9|Overall Study|Wrong Monotherapy Administered|0
3063135|NCT00518115|10524911|P8|Overall Study|Wrong Monotherapy Administered|0
3063136|NCT00518115|10524912|P7|Overall Study|Wrong Monotherapy Administered|1
3063137|NCT00518115|10524913|P6|Overall Study|Wrong Monotherapy Administered|0
3063138|NCT00518115|10524914|P5|Overall Study|Wrong Monotherapy Administered|0
3063139|NCT00518115|10524915|P4|Overall Study|Wrong Monotherapy Administered|0
3063140|NCT00518115|10524916|P3|Overall Study|Wrong Monotherapy Administered|1
3063141|NCT00518115|10524917|P2|Overall Study|Wrong Monotherapy Administered|0
3063142|NCT00518115|10524918|P1|Overall Study|Wrong Monotherapy Administered|0
3063143|NCT00518115|10524909|P10|Overall Study|Different Monotherapy Diabetic Drug|0
3063144|NCT00518115|10524910|P9|Overall Study|Different Monotherapy Diabetic Drug|1
3063145|NCT00518115|10524911|P8|Overall Study|Different Monotherapy Diabetic Drug|0
3063146|NCT00518115|10524912|P7|Overall Study|Different Monotherapy Diabetic Drug|0
3063147|NCT00518115|10524913|P6|Overall Study|Different Monotherapy Diabetic Drug|0
3063148|NCT00518115|10524914|P5|Overall Study|Different Monotherapy Diabetic Drug|0
3063149|NCT00518115|10524915|P4|Overall Study|Different Monotherapy Diabetic Drug|0
3063150|NCT00518115|10524916|P3|Overall Study|Different Monotherapy Diabetic Drug|1
3063151|NCT00518115|10524917|P2|Overall Study|Different Monotherapy Diabetic Drug|0
3063152|NCT00518115|10524918|P1|Overall Study|Different Monotherapy Diabetic Drug|0
3063153|NCT00518115|10524909|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063154|NCT00518115|10524910|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063155|NCT00518115|10524911|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063156|NCT00518115|10524912|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063157|NCT00518115|10524913|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063158|NCT00518115|10524914|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063159|NCT00518115|10524915|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063160|NCT00518115|10524916|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063161|NCT00518115|10524917|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
3063162|NCT00518115|10524918|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
3063163|NCT00518115|10524909|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
3063164|NCT00518115|10524910|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
3063165|NCT00518115|10524911|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
3063166|NCT00518115|10524912|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
3063167|NCT00518115|10524913|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
3063168|NCT00518115|10524914|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
3063169|NCT00518115|10524915|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
3063170|NCT00518115|10524916|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
3063171|NCT00518115|10524917|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
3063172|NCT00518115|10524918|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
3063173|NCT00518115|10524909|P10|Overall Study|Non-Compliance|1
3063174|NCT00518115|10524910|P9|Overall Study|Non-Compliance|0
3063175|NCT00518115|10524911|P8|Overall Study|Non-Compliance|1
3063176|NCT00518115|10524912|P7|Overall Study|Non-Compliance|1
3063177|NCT00518115|10524913|P6|Overall Study|Non-Compliance|1
3063178|NCT00518115|10524914|P5|Overall Study|Non-Compliance|1
3063179|NCT00518115|10524915|P4|Overall Study|Non-Compliance|0
3063180|NCT00518115|10524916|P3|Overall Study|Non-Compliance|1
3063181|NCT00518115|10524917|P2|Overall Study|Non-Compliance|0
3063182|NCT00518115|10524918|P1|Overall Study|Non-Compliance|1
3063183|NCT00518115|10524909|P10|Overall Study|Lack of Efficacy|0
3063184|NCT00518115|10524910|P9|Overall Study|Lack of Efficacy|0
3063185|NCT00518115|10524911|P8|Overall Study|Lack of Efficacy|1
3063186|NCT00518115|10524912|P7|Overall Study|Lack of Efficacy|0
3063187|NCT00518115|10524913|P6|Overall Study|Lack of Efficacy|0
3063188|NCT00518115|10524914|P5|Overall Study|Lack of Efficacy|0
3063189|NCT00518115|10524915|P4|Overall Study|Lack of Efficacy|1
3063190|NCT00518115|10524916|P3|Overall Study|Lack of Efficacy|1
3063191|NCT00518115|10524917|P2|Overall Study|Lack of Efficacy|0
3063192|NCT00518115|10524918|P1|Overall Study|Lack of Efficacy|1
3063193|NCT00518115|10524909|P10|Overall Study|Withdrawal by Subject|3
3063194|NCT00518115|10524910|P9|Overall Study|Withdrawal by Subject|1
3063195|NCT00518115|10524911|P8|Overall Study|Withdrawal by Subject|2
3063196|NCT00518115|10524912|P7|Overall Study|Withdrawal by Subject|0
3063197|NCT00518115|10524913|P6|Overall Study|Withdrawal by Subject|1
3063198|NCT00518115|10524914|P5|Overall Study|Withdrawal by Subject|2
3063199|NCT00518115|10524915|P4|Overall Study|Withdrawal by Subject|0
3063200|NCT00518115|10524916|P3|Overall Study|Withdrawal by Subject|5
3063201|NCT00518115|10524917|P2|Overall Study|Withdrawal by Subject|1
3063202|NCT00518115|10524918|P1|Overall Study|Withdrawal by Subject|1
3063203|NCT00518115|10524909|P10|Overall Study|Protocol Violation|0
3063204|NCT00518115|10524910|P9|Overall Study|Protocol Violation|0
3063205|NCT00518115|10524911|P8|Overall Study|Protocol Violation|0
3063206|NCT00518115|10524912|P7|Overall Study|Protocol Violation|0
3063207|NCT00518115|10524913|P6|Overall Study|Protocol Violation|0
3063208|NCT00518115|10524914|P5|Overall Study|Protocol Violation|0
3063209|NCT00518115|10524915|P4|Overall Study|Protocol Violation|0
3063210|NCT00518115|10524916|P3|Overall Study|Protocol Violation|1
3063211|NCT00518115|10524917|P2|Overall Study|Protocol Violation|3
3063212|NCT00518115|10524918|P1|Overall Study|Protocol Violation|1
3063213|NCT00518115|10524909|P10|Overall Study|Lost to Follow-up|1
3063214|NCT00518115|10524910|P9|Overall Study|Lost to Follow-up|1
3063215|NCT00518115|10524911|P8|Overall Study|Lost to Follow-up|1
3063216|NCT00518115|10524912|P7|Overall Study|Lost to Follow-up|0
3063217|NCT00518115|10524913|P6|Overall Study|Lost to Follow-up|3
3063218|NCT00518115|10524914|P5|Overall Study|Lost to Follow-up|1
3063219|NCT00518115|10524915|P4|Overall Study|Lost to Follow-up|3
3063220|NCT00518115|10524916|P3|Overall Study|Lost to Follow-up|2
3063221|NCT00518115|10524917|P2|Overall Study|Lost to Follow-up|0
3063222|NCT00518115|10524918|P1|Overall Study|Lost to Follow-up|0
3063223|NCT00518115|10524909|P10|Overall Study|Adverse Event|9
3063224|NCT00518115|10524910|P9|Overall Study|Adverse Event|2
3063225|NCT00518115|10524911|P8|Overall Study|Adverse Event|10
3063226|NCT00518115|10524912|P7|Overall Study|Adverse Event|5
3063227|NCT00518115|10524913|P6|Overall Study|Adverse Event|5
3063228|NCT00518115|10524914|P5|Overall Study|Adverse Event|5
3063229|NCT00518115|10524915|P4|Overall Study|Adverse Event|6
3063230|NCT00518115|10524916|P3|Overall Study|Adverse Event|5
3063231|NCT00518115|10524917|P2|Overall Study|Adverse Event|1
3063232|NCT00518115|10524918|P1|Overall Study|Adverse Event|6
3063233|NCT00518011|10525093|P2|Overall Study|Withdrawal by Subject|0
3063234|NCT00518011|10525094|P1|Overall Study|Withdrawal by Subject|1
3063235|NCT00518011|10525093|P2|Overall Study|Other Reasons|2
3063236|NCT00518011|10525094|P1|Overall Study|Other Reasons|3
3063237|NCT00518011|10525093|P2|Overall Study|Disease Progression|2
3063238|NCT00518011|10525094|P1|Overall Study|Disease Progression|2
3063239|NCT00518011|10525093|P2|Overall Study|Adverse Event|3
3063240|NCT00518011|10525094|P1|Overall Study|Adverse Event|2
3063241|NCT00518011|10525093|P2|Overall Study|Death|1
3063242|NCT00518011|10525094|P1|Overall Study|Death|1
3063243|NCT00517933|10525116|P2|Period 2|Underwent lung transplant|2
3063244|NCT00517933|10525117|P1|Period 2|Underwent lung transplant|0
3063245|NCT00517933|10525116|P2|Period 2|Withdrawal by Subject|3
3063246|NCT00517933|10525117|P1|Period 2|Withdrawal by Subject|1
3063247|NCT00517933|10525116|P2|Period 2|Physician Decision|0
3063248|NCT00517933|10525117|P1|Period 2|Physician Decision|1
3063249|NCT00517933|10525116|P2|Period 2|Adverse Event|4
3063250|NCT00517933|10525117|P1|Period 2|Adverse Event|2
3063251|NCT00517933|10525116|P2|Period 2|Death|4
3063252|NCT00517933|10525117|P1|Period 2|Death|2
3063253|NCT00517933|10525116|P2|Period 1|Underwent lung transplant|1
3063254|NCT00517933|10525117|P1|Period 1|Underwent lung transplant|0
3063255|NCT00517933|10525116|P2|Period 1|Lost to Follow-up|0
3063256|NCT00517933|10525117|P1|Period 1|Lost to Follow-up|2
3063257|NCT00517933|10525116|P2|Period 1|Adverse Event|4
3063258|NCT00517933|10525117|P1|Period 1|Adverse Event|4
3063259|NCT00517933|10525116|P2|Period 1|Death|1
3063260|NCT00517933|10525117|P1|Period 1|Death|2
3063261|NCT00517881|10525181|P1|Overall Study|Renal transplantation|2
3063262|NCT00517881|10525181|P1|Overall Study|Adverse Event|1
3063263|NCT00517881|10525181|P1|Overall Study|Protocol Violation|2
3063264|NCT00517829|10525193|P2|Overall Study|Other|1
3063265|NCT00517829|10525194|P1|Overall Study|Other|3
3063266|NCT00517829|10525193|P2|Overall Study|Investigator Request|3
3063267|NCT00517829|10525194|P1|Overall Study|Investigator Request|5
3063268|NCT00517829|10525193|P2|Overall Study|Patient Request|5
3063269|NCT00517829|10525194|P1|Overall Study|Patient Request|6
3063270|NCT00517829|10525193|P2|Overall Study|Disease Progression|32
3063271|NCT00517829|10525194|P1|Overall Study|Disease Progression|39
3063272|NCT00517829|10525193|P2|Overall Study|Adverse Event|34
3063273|NCT00517829|10525194|P1|Overall Study|Adverse Event|22
3063274|NCT00517751|10525208|P1|Overall Study|Missing|3
3063275|NCT00517751|10525208|P1|Overall Study|Patient not due for visit|76
3063276|NCT00517751|10525208|P1|Overall Study|patient not over due|6
3063277|NCT00517751|10525208|P1|Overall Study|Lost to Follow-up|4
3063278|NCT00517751|10525208|P1|Overall Study|Withdrawal by Subject|37
3063279|NCT00517751|10525208|P1|Overall Study|Death|3
3063280|NCT00517699|10525231|P1|Overall Study|Study terminated by Sponsor|2
3063281|NCT00517699|10525231|P1|Overall Study|Administrative error|1
3063282|NCT00517699|10525231|P1|Overall Study|Lack of Efficacy|1
3063283|NCT00517699|10525231|P1|Overall Study|Withdrawal by Subject|1
3063284|NCT00517634|10525239|P6|Second Treatment Period|Withdrawal by Subject|0
3063285|NCT00517634|10525240|P5|Second Treatment Period|Withdrawal by Subject|1
3063286|NCT00517634|10525241|P4|Second Treatment Period|Withdrawal by Subject|0
3063287|NCT00517634|10525242|P3|Second Treatment Period|Withdrawal by Subject|0
3063288|NCT00517634|10525243|P2|Second Treatment Period|Withdrawal by Subject|0
3063289|NCT00517634|10525244|P1|Second Treatment Period|Withdrawal by Subject|0
3063290|NCT00517413|10525346|P1|Overall Study|Other-Reasons|23
3063291|NCT00517413|10525346|P1|Overall Study|Failure to return|1
3063292|NCT00517413|10525346|P1|Overall Study|Withdrawal by Subject|2
3063293|NCT00517413|10525346|P1|Overall Study|Protocol Violation|15
3063294|NCT00517413|10525346|P1|Overall Study|Death|13
3063295|NCT00517413|10525346|P1|Overall Study|Adverse Event|7
3063296|NCT00517361|10525367|P1|Overall Study|The study was terminated|5
3063297|NCT00517361|10525367|P1|Overall Study|Death|6
3063298|NCT00517296|10525376|P2|Overall Study|Withdrawal by Subject|0
3063299|NCT00517296|10525377|P1|Overall Study|Withdrawal by Subject|1
3063300|NCT00517192|10525389|P2|Overall Study|Early termination of the trial|18
3063301|NCT00517192|10525390|P1|Overall Study|Early termination of the trial|16
3063302|NCT00517192|10525389|P2|Overall Study|Withdrawal by Subject|0
3063303|NCT00517192|10525390|P1|Overall Study|Withdrawal by Subject|1
3063304|NCT00517192|10525389|P2|Overall Study|Lost to Follow-up|1
3063305|NCT00517192|10525390|P1|Overall Study|Lost to Follow-up|1
3063306|NCT00517192|10525389|P2|Overall Study|Adverse Event|1
3063307|NCT00517192|10525390|P1|Overall Study|Adverse Event|1
3063308|NCT00516906|10525497|P2|Overall Study|Final Dressing Removal Data not captured|2
3063309|NCT00516906|10525498|P1|Overall Study|Final Dressing Removal Data not captured|6
3063310|NCT00516893|10525508|P1|Overall Study|Received Medication From Another Study|1
3063311|NCT00516893|10525508|P1|Overall Study|Pregnancy|1
3063312|NCT00516893|10525508|P1|Overall Study|Relocated|1
3063313|NCT00516893|10525508|P1|Overall Study|Persistent Antibodies per Protocol|6
3063314|NCT00516893|10525508|P1|Overall Study|Death|1
3063315|NCT00516893|10525508|P1|Overall Study|Noncompliance|2
3063316|NCT00516893|10525508|P1|Overall Study|Withdrawal by Subject|2
3063317|NCT00516893|10525508|P1|Overall Study|Adverse Event|3
3063318|NCT00516893|10525508|P1|Overall Study|Lost to Follow-up|4
3063319|NCT00516737|10525517|P2|Overall Study|Lack of Qualifying Event|6
3063320|NCT00516737|10525518|P1|Overall Study|Lack of Qualifying Event|9
3063321|NCT00516737|10525517|P2|Overall Study|Withdrawal by Subject|1
3063322|NCT00516737|10525518|P1|Overall Study|Withdrawal by Subject|0
3063323|NCT00516737|10525517|P2|Overall Study|Physician Decision|1
3063324|NCT00516737|10525518|P1|Overall Study|Physician Decision|0
3063325|NCT00516737|10525517|P2|Overall Study|Lost to Follow-up|0
3063326|NCT00516737|10525518|P1|Overall Study|Lost to Follow-up|2
3063327|NCT00516386|10525557|P1|Overall Study|Lost to Follow-up|2
3063328|NCT00516386|10525557|P1|Overall Study|not interested in the study|4
3063329|NCT00516321|10525564|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
3063330|NCT00516321|10525565|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
3063331|NCT00516321|10525566|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
3063332|NCT00516321|10525564|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
3063333|NCT00516321|10525565|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
3063334|NCT00516321|10525566|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
3063335|NCT00516321|10525564|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
3063336|NCT00516321|10525565|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
3063337|NCT00516321|10525566|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
3063338|NCT00516321|10525564|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
3063339|NCT00516321|10525565|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
3063340|NCT00516321|10525566|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
3063341|NCT00516321|10525564|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
3063342|NCT00516321|10525565|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
3063343|NCT00516321|10525566|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
3063344|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
3063345|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
3063346|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
3063347|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
3063348|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
3063349|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
3063350|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
3063351|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
3063352|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
3063353|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
3063354|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
3063355|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
3063356|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
3063357|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
3063358|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
3063359|NCT00516321|10525564|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
3063360|NCT00516321|10525565|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
3063361|NCT00516321|10525566|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
3063362|NCT00516295|10525617|P3|Overall Study|Ineligible|0
3063363|NCT00516295|10525618|P2|Overall Study|Ineligible|0
3063364|NCT00516295|10525619|P1|Overall Study|Ineligible|1
3063365|NCT00516295|10525617|P3|Overall Study|Lack of Efficacy|0
3063366|NCT00516295|10525618|P2|Overall Study|Lack of Efficacy|0
3063367|NCT00516295|10525619|P1|Overall Study|Lack of Efficacy|2
3063368|NCT00516269|10525632|P2|Overall Study|Protocol Violation|1
3063369|NCT00516269|10525633|P1|Overall Study|Protocol Violation|0
3063370|NCT00516269|10525632|P2|Overall Study|Lost to Follow-up|1
3063371|NCT00516269|10525633|P1|Overall Study|Lost to Follow-up|0
3063372|NCT00516269|10525632|P2|Overall Study|Adverse Event|1
3063373|NCT00516269|10525633|P1|Overall Study|Adverse Event|2
3063374|NCT00516139|10525654|P1|Overall Study|Lack of Efficacy|1
3063375|NCT00516139|10525654|P1|Overall Study|Withdrawal by Subject|8
3063376|NCT00516139|10525654|P1|Overall Study|Protocol Violation|1
3063377|NCT00516139|10525654|P1|Overall Study|Lost to Follow-up|1
3063378|NCT00516139|10525654|P1|Overall Study|Adverse Event|27
3063379|NCT00516074|10525685|P2|Overall Study|Loss of Glucose Control|0
3063380|NCT00516074|10525686|P1|Overall Study|Loss of Glucose Control|2
3063381|NCT00516074|10525685|P2|Overall Study|Subject Decision|2
3063382|NCT00516074|10525686|P1|Overall Study|Subject Decision|4
3063383|NCT00516074|10525685|P2|Overall Study|Adverse Event|1
3063384|NCT00516074|10525686|P1|Overall Study|Adverse Event|0
3063385|NCT00516048|10525704|P3|Overall Study|Subject Decision|0
3063386|NCT00516048|10525705|P2|Overall Study|Subject Decision|2
3063387|NCT00516048|10525706|P1|Overall Study|Subject Decision|0
3063388|NCT00516048|10525704|P3|Overall Study|Death|1
3063389|NCT00516048|10525705|P2|Overall Study|Death|0
3063390|NCT00516048|10525706|P1|Overall Study|Death|0
3063391|NCT00515827|10525741|P2|Second Intervention (12 Weeks)|Consent withdraw|0
3063392|NCT00515827|10525742|P1|Second Intervention (12 Weeks)|Consent withdraw|1
3063393|NCT00515827|10525741|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
3063394|NCT00515827|10525742|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
3063395|NCT00515671|10525800|P2|Overall Study|incarcerated|2
3063396|NCT00515671|10525801|P1|Overall Study|incarcerated|1
3063397|NCT00515671|10525800|P2|Overall Study|Withdrawal by Subject|5
3063398|NCT00515671|10525801|P1|Overall Study|Withdrawal by Subject|3
3063399|NCT00515671|10525800|P2|Overall Study|Lost to Follow-up|10
3063400|NCT00515671|10525801|P1|Overall Study|Lost to Follow-up|13
3063401|NCT00515619|10525809|P1|Overall Study|Other: Subject interested in other AED|1
3063402|NCT00515619|10525809|P1|Overall Study|Other: Drug available on license|1
3063403|NCT00515619|10525809|P1|Overall Study|Other: Request from sponsor|1
3063404|NCT00515619|10525809|P1|Overall Study|Other: Subject became pregnant|1
3063405|NCT00515619|10525809|P1|Overall Study|Other: Investigator decision|1
3063406|NCT00515619|10525809|P1|Overall Study|Other: Subject moved to another country|1
3063407|NCT00515619|10525809|P1|Overall Study|Other: Subject required surgery|1
3063408|NCT00515619|10525809|P1|Overall Study|Other: Subject cannot attend visits|2
3063409|NCT00515619|10525809|P1|Overall Study|Other: Site discontinuing trials|2
3063410|NCT00515619|10525809|P1|Overall Study|Unsatisfactory compliance|6
3063411|NCT00515619|10525809|P1|Overall Study|Lost to Follow-up|4
3063412|NCT00515619|10525809|P1|Overall Study|Protocol Violation|3
3063413|NCT00515619|10525809|P1|Overall Study|Withdrawal by Subject|66
3063414|NCT00515619|10525809|P1|Overall Study|Lack of Efficacy|92
3063415|NCT00515619|10525809|P1|Overall Study|Adverse Event|34
3063416|NCT00515541|10525821|P4|Overall Study|Withdrawal by Subject|2
3063417|NCT00515541|10525822|P3|Overall Study|Withdrawal by Subject|0
3063418|NCT00515541|10525823|P2|Overall Study|Withdrawal by Subject|2
3063419|NCT00515541|10525824|P1|Overall Study|Withdrawal by Subject|0
3063420|NCT00515541|10525821|P4|Overall Study|No show for appointments|2
3063421|NCT00515541|10525822|P3|Overall Study|No show for appointments|0
3063422|NCT00515541|10525823|P2|Overall Study|No show for appointments|1
3063423|NCT00515541|10525824|P1|Overall Study|No show for appointments|0
3063424|NCT00515541|10525821|P4|Overall Study|Physician Decision|1
3063425|NCT00515541|10525822|P3|Overall Study|Physician Decision|0
3063426|NCT00515541|10525823|P2|Overall Study|Physician Decision|2
3063427|NCT00515541|10525824|P1|Overall Study|Physician Decision|0
3063428|NCT00515502|10525846|P12|Treatment Period 2|Adverse Event|0
3063429|NCT00515502|10525847|P11|Treatment Period 2|Adverse Event|0
3063430|NCT00515502|10525848|P10|Treatment Period 2|Adverse Event|0
3063431|NCT00515502|10525849|P9|Treatment Period 2|Adverse Event|0
3063432|NCT00515502|10525850|P8|Treatment Period 2|Adverse Event|0
3063433|NCT00515502|10525851|P7|Treatment Period 2|Adverse Event|0
3063434|NCT00515502|10525852|P6|Treatment Period 2|Adverse Event|0
3063435|NCT00515502|10525853|P5|Treatment Period 2|Adverse Event|0
3063436|NCT00515502|10525854|P4|Treatment Period 2|Adverse Event|0
3063437|NCT00515502|10525855|P3|Treatment Period 2|Adverse Event|0
3063438|NCT00515502|10525856|P2|Treatment Period 2|Adverse Event|1
3063439|NCT00515502|10525857|P1|Treatment Period 2|Adverse Event|0
3063440|NCT00515502|10525846|P12|Treatment Period 1|Adverse Event|1
3063441|NCT00515502|10525847|P11|Treatment Period 1|Adverse Event|0
3063442|NCT00515502|10525848|P10|Treatment Period 1|Adverse Event|0
3063443|NCT00515502|10525849|P9|Treatment Period 1|Adverse Event|1
3063444|NCT00515502|10525850|P8|Treatment Period 1|Adverse Event|0
3063445|NCT00515502|10525851|P7|Treatment Period 1|Adverse Event|1
3063446|NCT00515502|10525852|P6|Treatment Period 1|Adverse Event|0
3063447|NCT00515502|10525853|P5|Treatment Period 1|Adverse Event|0
3063448|NCT00515502|10525854|P4|Treatment Period 1|Adverse Event|0
3063449|NCT00515502|10525855|P3|Treatment Period 1|Adverse Event|0
3063450|NCT00515502|10525856|P2|Treatment Period 1|Adverse Event|0
3063451|NCT00515502|10525857|P1|Treatment Period 1|Adverse Event|0
3063452|NCT00515463|10526017|P2|Overall Study|Other|1
3063453|NCT00515463|10526018|P1|Overall Study|Other|0
3063454|NCT00515463|10526017|P2|Overall Study|Lost to Follow-up|5
3063455|NCT00515463|10526018|P1|Overall Study|Lost to Follow-up|6
3063456|NCT00515463|10526017|P2|Overall Study|Withdrawal by Subject|4
3063457|NCT00515463|10526018|P1|Overall Study|Withdrawal by Subject|3
3063458|NCT00515463|10526017|P2|Overall Study|Adverse Event|2
3063459|NCT00515463|10526018|P1|Overall Study|Adverse Event|1
3063460|NCT00515463|10526017|P2|Overall Study|Physician Decision|2
3063461|NCT00515463|10526018|P1|Overall Study|Physician Decision|4
3063462|NCT00515294|10526217|P4|Overall Study|Caffeine amount inaccurate|0
3063463|NCT00515294|10526218|P3|Overall Study|Caffeine amount inaccurate|7
3063464|NCT00515294|10526219|P2|Overall Study|Caffeine amount inaccurate|0
3063465|NCT00515294|10526220|P1|Overall Study|Caffeine amount inaccurate|5
3063466|NCT00515294|10526217|P4|Overall Study|Driver simulator problems|3
3063467|NCT00515294|10526218|P3|Overall Study|Driver simulator problems|1
3063468|NCT00515294|10526219|P2|Overall Study|Driver simulator problems|1
3063469|NCT00515294|10526220|P1|Overall Study|Driver simulator problems|1
3063470|NCT00515294|10526217|P4|Overall Study|Lost to Follow-up|1
3063471|NCT00515294|10526218|P3|Overall Study|Lost to Follow-up|3
3063472|NCT00515294|10526219|P2|Overall Study|Lost to Follow-up|2
3063473|NCT00515294|10526220|P1|Overall Study|Lost to Follow-up|3
3063474|NCT00515216|10526234|P1|Overall Study|Withdrawal by Subject|1
3063475|NCT00515112|10526296|P2|Overall Study|The study was terminated|2
3063476|NCT00515112|10526297|P1|Overall Study|The study was terminated|3
3063477|NCT00515112|10526296|P2|Overall Study|Death|1
3063478|NCT00515112|10526297|P1|Overall Study|Death|0
3063479|NCT00515099|10526307|P2|Overall Study|IRB Recommendation|0
3063480|NCT00515099|10526308|P1|Overall Study|IRB Recommendation|1
3063481|NCT00515099|10526307|P2|Overall Study|Withdrawal by Subject|0
3063482|NCT00515099|10526308|P1|Overall Study|Withdrawal by Subject|2
3063483|NCT00515099|10526307|P2|Overall Study|Lost to Follow-up|4
3063484|NCT00515099|10526308|P1|Overall Study|Lost to Follow-up|0
3063485|NCT00515086|10526330|P4|Overall Study|Death|0
3063486|NCT00515086|10526331|P3|Overall Study|Death|0
3063487|NCT00515086|10526332|P2|Overall Study|Death|0
3063488|NCT00515086|10526333|P1|Overall Study|Death|2
3063489|NCT00515086|10526330|P4|Overall Study|Study drug no longer required|0
3063490|NCT00515086|10526331|P3|Overall Study|Study drug no longer required|0
3063491|NCT00515086|10526332|P2|Overall Study|Study drug no longer required|1
3063492|NCT00515086|10526333|P1|Overall Study|Study drug no longer required|0
3063493|NCT00515086|10526330|P4|Overall Study|Lost to Follow-up|0
3063494|NCT00515086|10526331|P3|Overall Study|Lost to Follow-up|0
3063495|NCT00515086|10526332|P2|Overall Study|Lost to Follow-up|0
3063496|NCT00515086|10526333|P1|Overall Study|Lost to Follow-up|1
3063497|NCT00515086|10526330|P4|Overall Study|Unsatisfactory therapeutic effect|2
3063498|NCT00515086|10526331|P3|Overall Study|Unsatisfactory therapeutic effect|3
3063499|NCT00515086|10526332|P2|Overall Study|Unsatisfactory therapeutic effect|3
3063500|NCT00515086|10526333|P1|Overall Study|Unsatisfactory therapeutic effect|18
3063501|NCT00515086|10526330|P4|Overall Study|Withdrawal by Subject|1
3063502|NCT00515086|10526331|P3|Overall Study|Withdrawal by Subject|0
3063503|NCT00515086|10526332|P2|Overall Study|Withdrawal by Subject|0
3063504|NCT00515086|10526333|P1|Overall Study|Withdrawal by Subject|1
3063505|NCT00515086|10526330|P4|Overall Study|Administrative|0
3063506|NCT00515086|10526331|P3|Overall Study|Administrative|0
3063507|NCT00515086|10526332|P2|Overall Study|Administrative|1
3063508|NCT00515086|10526333|P1|Overall Study|Administrative|1
3063509|NCT00515086|10526330|P4|Overall Study|Adverse Event|3
3063510|NCT00515086|10526331|P3|Overall Study|Adverse Event|2
3063511|NCT00515086|10526332|P2|Overall Study|Adverse Event|1
3063512|NCT00515086|10526333|P1|Overall Study|Adverse Event|1
3063513|NCT00515073|10526360|P1|Overall Study|Physician Decision|1
3063514|NCT00515073|10526360|P1|Overall Study|Withdrawal by Subject|1
3063515|NCT00515034|10526368|P4|Overall Study|Other|1
3063516|NCT00515034|10526369|P3|Overall Study|Other|2
3063517|NCT00515034|10526370|P2|Overall Study|Other|0
3063518|NCT00515034|10526371|P1|Overall Study|Other|1
3063519|NCT00515034|10526368|P4|Overall Study|Physician Decision|1
3063520|NCT00515034|10526369|P3|Overall Study|Physician Decision|1
3063521|NCT00515034|10526370|P2|Overall Study|Physician Decision|0
3063522|NCT00515034|10526371|P1|Overall Study|Physician Decision|0
3063523|NCT00515034|10526368|P4|Overall Study|Withdrawal by Subject|0
3063524|NCT00515034|10526369|P3|Overall Study|Withdrawal by Subject|3
3063525|NCT00515034|10526370|P2|Overall Study|Withdrawal by Subject|0
3063526|NCT00515034|10526371|P1|Overall Study|Withdrawal by Subject|1
3063527|NCT00515034|10526368|P4|Overall Study|Death|3
3063528|NCT00515034|10526369|P3|Overall Study|Death|1
3063529|NCT00515034|10526370|P2|Overall Study|Death|2
3063530|NCT00515034|10526371|P1|Overall Study|Death|4
3063531|NCT00515034|10526368|P4|Overall Study|Adverse Event|0
3063532|NCT00515034|10526369|P3|Overall Study|Adverse Event|1
3063533|NCT00515034|10526370|P2|Overall Study|Adverse Event|0
3063534|NCT00515034|10526371|P1|Overall Study|Adverse Event|2
3063535|NCT00515008|10526402|P2|Overall Study|Scheduling conflict|0
3063536|NCT00515008|10526403|P1|Overall Study|Scheduling conflict|1
3063537|NCT00515008|10526402|P2|Overall Study|Left the Boston Area|1
3063538|NCT00515008|10526403|P1|Overall Study|Left the Boston Area|1
3063539|NCT00515008|10526402|P2|Overall Study|Declined|3
3063540|NCT00515008|10526403|P1|Overall Study|Declined|0
3063541|NCT00515008|10526402|P2|Overall Study|Lost to Follow-up|0
3063542|NCT00515008|10526403|P1|Overall Study|Lost to Follow-up|1
3063543|NCT00514943|10526427|P2|Stage 2|Other than stated above|2
3063544|NCT00514943|10526428|P1|Stage 2|Other than stated above|0
3063545|NCT00514943|10526427|P2|Stage 2|Patient refused to continue study meds|0
3063546|NCT00514943|10526428|P1|Stage 2|Patient refused to continue study meds|2
3063547|NCT00514943|10526427|P2|Stage 2|Other Adverse Event|10
3063548|NCT00514943|10526428|P1|Stage 2|Other Adverse Event|3
3063549|NCT00514943|10526427|P2|Stage 2|Progressive disease|24
3063550|NCT00514943|10526428|P1|Stage 2|Progressive disease|27
3063551|NCT00514943|10526427|P2|Stage 1|Other than stated above|7
3063552|NCT00514943|10526428|P1|Stage 1|Other than stated above|1
3063553|NCT00514943|10526427|P2|Stage 1|Patient refused to continue study meds|3
3063554|NCT00514943|10526428|P1|Stage 1|Patient refused to continue study meds|8
3063555|NCT00514943|10526427|P2|Stage 1|Not treated|2
3063556|NCT00514943|10526428|P1|Stage 1|Not treated|1
3063557|NCT00514943|10526427|P2|Stage 1|Other Adverse Event|6
3063558|NCT00514943|10526428|P1|Stage 1|Other Adverse Event|16
3063559|NCT00514943|10526427|P2|Stage 1|Progressive disease|8
3063560|NCT00514943|10526428|P1|Stage 1|Progressive disease|4
3063561|NCT00514917|10526486|P2|Overall Study|Undefined|5
3063562|NCT00514917|10526487|P1|Overall Study|Undefined|11
3063563|NCT00514917|10526486|P2|Overall Study|Discontinued due to study closure|81
3063564|NCT00514917|10526487|P1|Overall Study|Discontinued due to study closure|88
3063565|NCT00514917|10526486|P2|Overall Study|Withdrawal by Subject|16
3063566|NCT00514917|10526487|P1|Overall Study|Withdrawal by Subject|18
3063567|NCT00514917|10526486|P2|Overall Study|Lost to Follow-up|3
3063568|NCT00514917|10526487|P1|Overall Study|Lost to Follow-up|4
3063569|NCT00514917|10526486|P2|Overall Study|Protocol Violation|0
3063570|NCT00514917|10526487|P1|Overall Study|Protocol Violation|1
3063571|NCT00514917|10526486|P2|Overall Study|Death|10
3063572|NCT00514917|10526487|P1|Overall Study|Death|4
3063573|NCT00514904|10526515|P2|Overall Study|Lost to Follow-up|3
3063574|NCT00514904|10526516|P1|Overall Study|Lost to Follow-up|21
3063575|NCT00514904|10526515|P2|Overall Study|Withdrawal by Subject|2
3063576|NCT00514904|10526516|P1|Overall Study|Withdrawal by Subject|3
3063577|NCT00514813|10526581|P4|Overall Study|Death|2
3063578|NCT00514813|10526582|P3|Overall Study|Death|3
3063579|NCT00514813|10526583|P2|Overall Study|Death|2
3063580|NCT00514813|10526584|P1|Overall Study|Death|0
3063581|NCT00514813|10526581|P4|Overall Study|Kidney transplant|0
3063582|NCT00514813|10526582|P3|Overall Study|Kidney transplant|2
3063583|NCT00514813|10526583|P2|Overall Study|Kidney transplant|6
3063584|NCT00514813|10526584|P1|Overall Study|Kidney transplant|0
3063585|NCT00514813|10526581|P4|Overall Study|Lack of Efficacy|0
3063586|NCT00514813|10526582|P3|Overall Study|Lack of Efficacy|0
3063587|NCT00514813|10526583|P2|Overall Study|Lack of Efficacy|1
3063588|NCT00514813|10526584|P1|Overall Study|Lack of Efficacy|0
3063589|NCT00514813|10526581|P4|Overall Study|Withdrawal by Subject|0
3063590|NCT00514813|10526582|P3|Overall Study|Withdrawal by Subject|0
3063591|NCT00514813|10526583|P2|Overall Study|Withdrawal by Subject|1
3063592|NCT00514813|10526584|P1|Overall Study|Withdrawal by Subject|0
3063593|NCT00514813|10526581|P4|Overall Study|Protocol Violation|0
3063594|NCT00514813|10526582|P3|Overall Study|Protocol Violation|0
3063595|NCT00514813|10526583|P2|Overall Study|Protocol Violation|0
3063596|NCT00514813|10526584|P1|Overall Study|Protocol Violation|1
3063597|NCT00514813|10526581|P4|Overall Study|Adverse Event|0
3063598|NCT00514813|10526582|P3|Overall Study|Adverse Event|2
3063599|NCT00514813|10526583|P2|Overall Study|Adverse Event|2
3063600|NCT00514813|10526584|P1|Overall Study|Adverse Event|0
3063601|NCT00514813|10526581|P4|Overall Study|Study terminated|2
3063602|NCT00514813|10526582|P3|Overall Study|Study terminated|40
3063603|NCT00514813|10526583|P2|Overall Study|Study terminated|74
3063604|NCT00514813|10526584|P1|Overall Study|Study terminated|14
3063605|NCT00514735|10526604|P2|Overall Study|Lost to Follow-up|1
3063606|NCT00514735|10526605|P1|Overall Study|Lost to Follow-up|0
3063607|NCT00514735|10526604|P2|Overall Study|Death|0
3063608|NCT00514735|10526605|P1|Overall Study|Death|1
3063609|NCT00514735|10526604|P2|Overall Study|Withdrawal by Subject|5
3063610|NCT00514735|10526605|P1|Overall Study|Withdrawal by Subject|13
3063611|NCT00514683|10526641|P5|Overall Study|Reason other than listed above|1
3063612|NCT00514683|10526642|P4|Overall Study|Reason other than listed above|0
3063613|NCT00514683|10526643|P3|Overall Study|Reason other than listed above|2
3063614|NCT00514683|10526644|P2|Overall Study|Reason other than listed above|1
3063615|NCT00514683|10526645|P1|Overall Study|Reason other than listed above|0
3063616|NCT00514683|10526641|P5|Overall Study|Withdrawal by Subject|4
3063617|NCT00514683|10526642|P4|Overall Study|Withdrawal by Subject|0
3063618|NCT00514683|10526643|P3|Overall Study|Withdrawal by Subject|1
3063619|NCT00514683|10526644|P2|Overall Study|Withdrawal by Subject|2
3063620|NCT00514683|10526645|P1|Overall Study|Withdrawal by Subject|2
3063621|NCT00514683|10526641|P5|Overall Study|Protocol Violation|0
3063622|NCT00514683|10526642|P4|Overall Study|Protocol Violation|1
3063623|NCT00514683|10526643|P3|Overall Study|Protocol Violation|0
3063624|NCT00514683|10526644|P2|Overall Study|Protocol Violation|1
3063625|NCT00514683|10526645|P1|Overall Study|Protocol Violation|1
3063626|NCT00514683|10526641|P5|Overall Study|Adverse Event|27
3063627|NCT00514683|10526642|P4|Overall Study|Adverse Event|13
3063628|NCT00514683|10526643|P3|Overall Study|Adverse Event|15
3063629|NCT00514683|10526644|P2|Overall Study|Adverse Event|20
3063630|NCT00514683|10526645|P1|Overall Study|Adverse Event|21
3063631|NCT00514683|10526641|P5|Overall Study|Not treated|1
3063632|NCT00514683|10526642|P4|Overall Study|Not treated|0
3063633|NCT00514683|10526643|P3|Overall Study|Not treated|0
3063634|NCT00514683|10526644|P2|Overall Study|Not treated|1
3063635|NCT00514683|10526645|P1|Overall Study|Not treated|2
3063636|NCT00514514|10526844|P3|Extension - 4 Years|Adverse Event|3
3063637|NCT00514514|10526845|P2|Extension - 4 Years|Adverse Event|6
3063638|NCT00514514|10526846|P1|Extension - 4 Years|Adverse Event|9
3063639|NCT00514514|10526844|P3|Extension - 4 Years|Death|6
3063640|NCT00514514|10526845|P2|Extension - 4 Years|Death|3
3063641|NCT00514514|10526846|P1|Extension - 4 Years|Death|8
3063642|NCT00514514|10526844|P3|Extension - 4 Years|Administrative problems|1
3063643|NCT00514514|10526845|P2|Extension - 4 Years|Administrative problems|1
3063644|NCT00514514|10526846|P1|Extension - 4 Years|Administrative problems|3
3063645|NCT00514514|10526844|P3|Extension - 4 Years|Lost to Follow-up|9
3063646|NCT00514514|10526845|P2|Extension - 4 Years|Lost to Follow-up|10
3063647|NCT00514514|10526846|P1|Extension - 4 Years|Lost to Follow-up|12
3063648|NCT00514514|10526844|P3|Extension - 4 Years|Withdrawal by Subject|2
3063649|NCT00514514|10526845|P2|Extension - 4 Years|Withdrawal by Subject|2
3063650|NCT00514514|10526846|P1|Extension - 4 Years|Withdrawal by Subject|5
3063651|NCT00514514|10526844|P3|Randomized - 9 Month|Adverse Event|27
3063652|NCT00514514|10526845|P2|Randomized - 9 Month|Adverse Event|44
3063653|NCT00514514|10526846|P1|Randomized - 9 Month|Adverse Event|25
3063654|NCT00514514|10526844|P3|Randomized - 9 Month|Abnormal laboratory values|1
3063655|NCT00514514|10526845|P2|Randomized - 9 Month|Abnormal laboratory values|3
3063656|NCT00514514|10526846|P1|Randomized - 9 Month|Abnormal laboratory values|0
3063657|NCT00514514|10526844|P3|Randomized - 9 Month|Lack of Efficacy|1
3063658|NCT00514514|10526845|P2|Randomized - 9 Month|Lack of Efficacy|3
3063659|NCT00514514|10526846|P1|Randomized - 9 Month|Lack of Efficacy|2
3063660|NCT00514514|10526844|P3|Randomized - 9 Month|Protocol Violation|0
3063661|NCT00514514|10526845|P2|Randomized - 9 Month|Protocol Violation|1
3063662|NCT00514514|10526846|P1|Randomized - 9 Month|Protocol Violation|1
3063663|NCT00514514|10526844|P3|Randomized - 9 Month|Withdrawal by Subject|5
3063664|NCT00514514|10526845|P2|Randomized - 9 Month|Withdrawal by Subject|7
3063665|NCT00514514|10526846|P1|Randomized - 9 Month|Withdrawal by Subject|7
3063666|NCT00514514|10526844|P3|Randomized - 9 Month|Administrative problems|2
3063667|NCT00514514|10526845|P2|Randomized - 9 Month|Administrative problems|1
3063668|NCT00514514|10526846|P1|Randomized - 9 Month|Administrative problems|1
3063669|NCT00514514|10526844|P3|Randomized - 9 Month|Death|2
3063670|NCT00514514|10526845|P2|Randomized - 9 Month|Death|2
3063671|NCT00514514|10526846|P1|Randomized - 9 Month|Death|3
3063672|NCT00514514|10526844|P3|Pre-phase|Withdrawal by Subject|0
3063673|NCT00514514|10526845|P2|Pre-phase|Withdrawal by Subject|0
3063674|NCT00514514|10526846|P1|Pre-phase|Withdrawal by Subject|66
3063675|NCT00514514|10526844|P3|Pre-phase|Adverse Event|0
3063676|NCT00514514|10526845|P2|Pre-phase|Adverse Event|0
3063677|NCT00514514|10526846|P1|Pre-phase|Adverse Event|137
3063678|NCT00514514|10526844|P3|Pre-phase|Lack of Efficacy|0
3063679|NCT00514514|10526845|P2|Pre-phase|Lack of Efficacy|0
3063680|NCT00514514|10526846|P1|Pre-phase|Lack of Efficacy|35
3063681|NCT00514514|10526844|P3|Pre-phase|abnormal lab values|0
3063682|NCT00514514|10526845|P2|Pre-phase|abnormal lab values|0
3063683|NCT00514514|10526846|P1|Pre-phase|abnormal lab values|23
3063684|NCT00514514|10526844|P3|Pre-phase|Lost to Follow-up|0
3063685|NCT00514514|10526845|P2|Pre-phase|Lost to Follow-up|0
3063686|NCT00514514|10526846|P1|Pre-phase|Lost to Follow-up|2
3063687|NCT00514514|10526844|P3|Pre-phase|abnormal test procedure results|0
3063688|NCT00514514|10526845|P2|Pre-phase|abnormal test procedure results|0
3063689|NCT00514514|10526846|P1|Pre-phase|abnormal test procedure results|15
3063690|NCT00514514|10526844|P3|Pre-phase|condition no longer requires study drug|0
3063691|NCT00514514|10526845|P2|Pre-phase|condition no longer requires study drug|0
3063692|NCT00514514|10526846|P1|Pre-phase|condition no longer requires study drug|7
3063693|NCT00514514|10526844|P3|Pre-phase|Protocol Violation|0
3063694|NCT00514514|10526845|P2|Pre-phase|Protocol Violation|0
3063695|NCT00514514|10526846|P1|Pre-phase|Protocol Violation|6
3063696|NCT00514514|10526844|P3|Pre-phase|administrative problems|0
3063697|NCT00514514|10526845|P2|Pre-phase|administrative problems|0
3063698|NCT00514514|10526846|P1|Pre-phase|administrative problems|2
3063699|NCT00514514|10526844|P3|Pre-phase|Death|0
3063700|NCT00514514|10526845|P2|Pre-phase|Death|0
3063701|NCT00514514|10526846|P1|Pre-phase|Death|10
3063702|NCT00514449|10526898|P2|Overall Study|Lost to Follow-up|0
3063703|NCT00514449|10526899|P1|Overall Study|Lost to Follow-up|1
3063704|NCT00514449|10526898|P2|Overall Study|Protocol Violation|2
3063705|NCT00514449|10526899|P1|Overall Study|Protocol Violation|1
3063706|NCT00514449|10526898|P2|Overall Study|Withdrawal by Subject|2
3063707|NCT00514449|10526899|P1|Overall Study|Withdrawal by Subject|1
3063708|NCT00514020|10526923|P1|Overall Study|"patients moved to the no tx group"|6
3063709|NCT00514020|10526923|P1|Overall Study|patient went to radiation treatment|1
3063710|NCT00514020|10526923|P1|Overall Study|other complicating disease|2
3063711|NCT00514020|10526923|P1|Overall Study|disease progression|9
3063712|NCT00514020|10526923|P1|Overall Study|Physician Decision|1
3063713|NCT00514020|10526923|P1|Overall Study|Withdrawal by Subject|3
3063714|NCT00514020|10526923|P1|Overall Study|Adverse Event|6
3063715|NCT00513708|10526977|P3|Overall Study|Lost to Follow-up|4
3063716|NCT00513708|10526978|P2|Overall Study|Lost to Follow-up|4
3063717|NCT00513708|10526979|P1|Overall Study|Lost to Follow-up|4
3063718|NCT00513695|10526993|P1|Overall Study|Progression prior to surgery|3
3063719|NCT00513695|10526993|P1|Overall Study|Discontinued therapy|2
3063720|NCT00513682|10527002|P1|Washout Phase|Adverse Event|2
3063721|NCT00513604|10527032|P5|Overall Study|Death during treatment|0
3063722|NCT00513604|10527033|P4|Overall Study|Death during treatment|0
3063723|NCT00513604|10527034|P3|Overall Study|Death during treatment|2
3063724|NCT00513604|10527035|P2|Overall Study|Death during treatment|3
3063725|NCT00513604|10527036|P1|Overall Study|Death during treatment|0
3063726|NCT00513604|10527032|P5|Overall Study|Not treated|0
3063727|NCT00513604|10527033|P4|Overall Study|Not treated|0
3063728|NCT00513604|10527034|P3|Overall Study|Not treated|1
3063729|NCT00513604|10527035|P2|Overall Study|Not treated|0
3063730|NCT00513604|10527036|P1|Overall Study|Not treated|2
3063731|NCT00513500|10527070|P2|Overall Study|Hospitalized|14
3063732|NCT00513500|10527071|P1|Overall Study|Hospitalized|4
3063733|NCT00513500|10527070|P2|Overall Study|Death|1
3063734|NCT00513500|10527071|P1|Overall Study|Death|2
3063735|NCT00513500|10527070|P2|Overall Study|Lost to Follow-up|39
3063736|NCT00513500|10527071|P1|Overall Study|Lost to Follow-up|35
3063737|NCT00513474|10527083|P2|Overall Study|Participant Withdrew Consent|0
3063738|NCT00513474|10527084|P1|Overall Study|Participant Withdrew Consent|1
3063739|NCT00513474|10527083|P2|Overall Study|Death|9
3063740|NCT00513474|10527084|P1|Overall Study|Death|6
3063741|NCT00513409|10527140|P2|Overall Study|Visit 3 not done|2
3063742|NCT00513409|10527141|P1|Overall Study|Visit 3 not done|1
3063743|NCT00513409|10527140|P2|Overall Study|Physician Decision|0
3063744|NCT00513409|10527141|P1|Overall Study|Physician Decision|1
3063745|NCT00513409|10527140|P2|Overall Study|Lost to Follow-up|1
3063746|NCT00513409|10527141|P1|Overall Study|Lost to Follow-up|0
3063747|NCT00513409|10527140|P2|Overall Study|Withdrawal by Subject|2
3063748|NCT00513409|10527141|P1|Overall Study|Withdrawal by Subject|0
3063749|NCT00513409|10527140|P2|Overall Study|Adverse Event|1
3063750|NCT00513409|10527141|P1|Overall Study|Adverse Event|0
3063751|NCT00513357|10527197|P2|Overall Study|Disease Progression|1
3063752|NCT00513357|10527198|P1|Overall Study|Disease Progression|2
3063753|NCT00513357|10527197|P2|Overall Study|Withdrawal by Subject|4
3063754|NCT00513357|10527198|P1|Overall Study|Withdrawal by Subject|5
3063755|NCT00513357|10527197|P2|Overall Study|Death|0
3063756|NCT00513357|10527198|P1|Overall Study|Death|2
3063757|NCT00513357|10527197|P2|Overall Study|Adverse Event|2
3063758|NCT00513357|10527198|P1|Overall Study|Adverse Event|4
3063759|NCT00513357|10527197|P2|Overall Study|did not receive allocated placebo|3
3063760|NCT00513357|10527198|P1|Overall Study|did not receive allocated placebo|2
3063761|NCT00513305|10527217|P2|Overall Study|Sponsor Decision|2
3063762|NCT00513305|10527218|P1|Overall Study|Sponsor Decision|0
3063763|NCT00513305|10527217|P2|Overall Study|Persistent hypocellularity|1
3063764|NCT00513305|10527218|P1|Overall Study|Persistent hypocellularity|0
3063765|NCT00513305|10527217|P2|Overall Study|Physician Decision|0
3063766|NCT00513305|10527218|P1|Overall Study|Physician Decision|1
3063767|NCT00513305|10527217|P2|Overall Study|Hematologic counts did not recover|0
3063768|NCT00513305|10527218|P1|Overall Study|Hematologic counts did not recover|1
3063769|NCT00513305|10527217|P2|Overall Study|Eligible for stem cell transplant|0
3063770|NCT00513305|10527218|P1|Overall Study|Eligible for stem cell transplant|1
3063771|NCT00513305|10527217|P2|Overall Study|Disease progression|5
3063772|NCT00513305|10527218|P1|Overall Study|Disease progression|8
3063773|NCT00513305|10527217|P2|Overall Study|Withdrawal by Subject|2
3063774|NCT00513305|10527218|P1|Overall Study|Withdrawal by Subject|1
3063775|NCT00513305|10527217|P2|Overall Study|Lack of Efficacy|13
3063776|NCT00513305|10527218|P1|Overall Study|Lack of Efficacy|8
3063777|NCT00513305|10527217|P2|Overall Study|Death (through Consolidation Treatment)|2
3063778|NCT00513305|10527218|P1|Overall Study|Death (through Consolidation Treatment)|2
3063779|NCT00513305|10527217|P2|Overall Study|Adverse Event|2
3063780|NCT00513305|10527218|P1|Overall Study|Adverse Event|6
3063781|NCT00513240|10527261|P2|Overall Study|Withdrawal by Subject|4
3063782|NCT00513240|10527262|P1|Overall Study|Withdrawal by Subject|7
3063783|NCT00513240|10527261|P2|Overall Study|Death|3
3063784|NCT00513240|10527262|P1|Overall Study|Death|3
3063785|NCT00513240|10527261|P2|Overall Study|Did not have intended surgery|0
3063786|NCT00513240|10527262|P1|Overall Study|Did not have intended surgery|3
3063787|NCT00513071|10527275|P1|Overall Study|Physician Decision|3
3063788|NCT00513071|10527275|P1|Overall Study|Withdrawal by Subject|1
3063789|NCT00513071|10527275|P1|Overall Study|Adverse Event|1
3063790|NCT00513019|10527287|P2|Overall Study|Withdrawal by Subject|5
3063791|NCT00513019|10527288|P1|Overall Study|Withdrawal by Subject|4
3063792|NCT00513019|10527287|P2|Overall Study|Adverse Event|0
3063793|NCT00513019|10527288|P1|Overall Study|Adverse Event|1
3063794|NCT00512902|10527294|P1|Overall Study|Lost to Follow-up|1
3063795|NCT00512902|10527294|P1|Overall Study|Adverse Event|7
3063796|NCT00512798|10527309|P2|Overall Study|Withdrawal by Subject|0
3063797|NCT00512798|10527310|P1|Overall Study|Withdrawal by Subject|3
3063798|NCT00512798|10527309|P2|Overall Study|Progression of disease|20
3063799|NCT00512798|10527310|P1|Overall Study|Progression of disease|14
3063800|NCT00512798|10527309|P2|Overall Study|Adverse Event|4
3063801|NCT00512798|10527310|P1|Overall Study|Adverse Event|2
3063802|NCT00512798|10527309|P2|Overall Study|Death|3
3063803|NCT00512798|10527310|P1|Overall Study|Death|0
3063804|NCT00512707|10527321|P2|Overall Study|Unable to tolerate the smell of the gel|0
3063805|NCT00512707|10527322|P1|Overall Study|Unable to tolerate the smell of the gel|1
3063806|NCT00512707|10527321|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
3063807|NCT00512707|10527322|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
3063808|NCT00512707|10527321|P2|Overall Study|Developed skin irritation|1
3063809|NCT00512707|10527322|P1|Overall Study|Developed skin irritation|2
3063810|NCT00512707|10527321|P2|Overall Study|Lost to Follow-up|11
3063811|NCT00512707|10527322|P1|Overall Study|Lost to Follow-up|5
3063812|NCT00512252|10527372|P3|Overall Study|Death|1
3063813|NCT00512252|10527373|P2|Overall Study|Death|0
3063814|NCT00512252|10527374|P1|Overall Study|Death|0
3063815|NCT00512252|10527372|P3|Overall Study|Protocol Violation|1
3063816|NCT00512252|10527373|P2|Overall Study|Protocol Violation|0
3063817|NCT00512252|10527374|P1|Overall Study|Protocol Violation|0
3063818|NCT00512252|10527372|P3|Overall Study|Lost to Follow-up|1
3063819|NCT00512252|10527373|P2|Overall Study|Lost to Follow-up|0
3063820|NCT00512252|10527374|P1|Overall Study|Lost to Follow-up|0
3063821|NCT00512148|10527402|P1|Primay Study Period|Withdrawal by Subject|1
3063822|NCT00512096|10527408|P1|Overall Study|Lack of Efficacy|3
3063823|NCT00512096|10527408|P1|Overall Study|Withdrawal by Subject|2
3063824|NCT00512096|10527408|P1|Overall Study|Adverse Event|2
3063825|NCT00511901|10527436|P2|Overall Study|Withdrawal by Subject|3
3063826|NCT00511901|10527437|P1|Overall Study|Withdrawal by Subject|1
3063827|NCT00511875|10527459|P2|Overall Study|Missing variables|0
3063828|NCT00511875|10527460|P1|Overall Study|Missing variables|1
3063829|NCT00511875|10527459|P2|Overall Study|Lost to Follow-up|0
3063830|NCT00511875|10527460|P1|Overall Study|Lost to Follow-up|4
3063831|NCT00511836|10527500|P2|Double-blind Period|Lost to Follow-up|0
3063832|NCT00511836|10527501|P1|Double-blind Period|Lost to Follow-up|1
3063833|NCT00511810|10527518|P2|Overall Study|Refused second scn|1
3063834|NCT00511810|10527519|P1|Overall Study|Refused second scn|0
3063835|NCT00511810|10527518|P2|Overall Study|Lack of Efficacy|2
3063836|NCT00511810|10527519|P1|Overall Study|Lack of Efficacy|0
3063837|NCT00511810|10527518|P2|Overall Study|Lost to Follow-up|2
3063838|NCT00511810|10527519|P1|Overall Study|Lost to Follow-up|1
3063839|NCT00511797|10527529|P4|Overall Study|Other (moving etc)|2
3063840|NCT00511797|10527530|P3|Overall Study|Other (moving etc)|1
3063841|NCT00511797|10527531|P2|Overall Study|Other (moving etc)|0
3063842|NCT00511797|10527532|P1|Overall Study|Other (moving etc)|1
3063843|NCT00511797|10527529|P4|Overall Study|Partially missing diary|0
3063844|NCT00511797|10527530|P3|Overall Study|Partially missing diary|1
3063845|NCT00511797|10527531|P2|Overall Study|Partially missing diary|0
3063846|NCT00511797|10527532|P1|Overall Study|Partially missing diary|0
3063847|NCT00511797|10527529|P4|Overall Study|Study drug not taken|1
3063848|NCT00511797|10527530|P3|Overall Study|Study drug not taken|0
3063849|NCT00511797|10527531|P2|Overall Study|Study drug not taken|1
3063850|NCT00511797|10527532|P1|Overall Study|Study drug not taken|0
3063851|NCT00511797|10527529|P4|Overall Study|Never dispensed|3
3063852|NCT00511797|10527530|P3|Overall Study|Never dispensed|1
3063853|NCT00511797|10527531|P2|Overall Study|Never dispensed|0
3063854|NCT00511797|10527532|P1|Overall Study|Never dispensed|1
3063855|NCT00511797|10527529|P4|Overall Study|Withdrawal by Subject|2
3063856|NCT00511797|10527530|P3|Overall Study|Withdrawal by Subject|4
3063857|NCT00511797|10527531|P2|Overall Study|Withdrawal by Subject|3
3063858|NCT00511797|10527532|P1|Overall Study|Withdrawal by Subject|3
3063859|NCT00511797|10527529|P4|Overall Study|Protocol Violation|3
3063860|NCT00511797|10527530|P3|Overall Study|Protocol Violation|2
3063861|NCT00511797|10527531|P2|Overall Study|Protocol Violation|2
3063862|NCT00511797|10527532|P1|Overall Study|Protocol Violation|0
3063863|NCT00511797|10527529|P4|Overall Study|Pregnancy|1
3063864|NCT00511797|10527530|P3|Overall Study|Pregnancy|0
3063865|NCT00511797|10527531|P2|Overall Study|Pregnancy|0
3063866|NCT00511797|10527532|P1|Overall Study|Pregnancy|0
3063867|NCT00511797|10527529|P4|Overall Study|Lost to Follow-up|1
3063868|NCT00511797|10527530|P3|Overall Study|Lost to Follow-up|0
3063869|NCT00511797|10527531|P2|Overall Study|Lost to Follow-up|0
3063870|NCT00511797|10527532|P1|Overall Study|Lost to Follow-up|1
3063871|NCT00511797|10527529|P4|Overall Study|Adverse Event|2
3063872|NCT00511797|10527530|P3|Overall Study|Adverse Event|2
3063873|NCT00511797|10527531|P2|Overall Study|Adverse Event|2
3063874|NCT00511797|10527532|P1|Overall Study|Adverse Event|1
3063875|NCT00511667|10527651|P2|Overall Study|Other|1
3063876|NCT00511667|10527652|P1|Overall Study|Other|2
3063877|NCT00511667|10527651|P2|Overall Study|Site terminated|1
3063878|NCT00511667|10527652|P1|Overall Study|Site terminated|6
3063879|NCT00511667|10527651|P2|Overall Study|Withdrawal by Subject|0
3063880|NCT00511667|10527652|P1|Overall Study|Withdrawal by Subject|2
3063881|NCT00511667|10527651|P2|Overall Study|Protocol Violation|1
3063882|NCT00511667|10527652|P1|Overall Study|Protocol Violation|1
3063883|NCT00511667|10527651|P2|Overall Study|Adverse Event|0
3063884|NCT00511667|10527652|P1|Overall Study|Adverse Event|1
3063885|NCT00511472|10527687|P2|Overall Study|Not reported|2
3063886|NCT00511472|10527688|P1|Overall Study|Not reported|2
3063887|NCT00511472|10527687|P2|Overall Study|Laboratory Adverse Event|2
3063888|NCT00511472|10527688|P1|Overall Study|Laboratory Adverse Event|0
3063889|NCT00511472|10527687|P2|Overall Study|Clinical Adverse Event|2
3063890|NCT00511472|10527688|P1|Overall Study|Clinical Adverse Event|1
3063891|NCT00511433|10527707|P2|Overall Study|Other Reason|1
3063892|NCT00511433|10527708|P1|Overall Study|Other Reason|1
3063893|NCT00511433|10527707|P2|Overall Study|Adverse Event|0
3063894|NCT00511433|10527708|P1|Overall Study|Adverse Event|5
3063895|NCT00511355|10527748|P2|Overall Study|Other reason pre-treatment|1
3063896|NCT00511355|10527749|P1|Overall Study|Other reason pre-treatment|0
3063897|NCT00511355|10527748|P2|Overall Study|Withdrawal of informed consent|1
3063898|NCT00511355|10527749|P1|Overall Study|Withdrawal of informed consent|0
3063899|NCT00511355|10527748|P2|Overall Study|Pre-treatment (serious) adverse event|1
3063900|NCT00511355|10527749|P1|Overall Study|Pre-treatment (serious) adverse event|0
3063901|NCT00511355|10527748|P2|Overall Study|Other Reason|1
3063902|NCT00511355|10527749|P1|Overall Study|Other Reason|0
3063903|NCT00511355|10527748|P2|Overall Study|Lost to Follow-up|1
3063904|NCT00511355|10527749|P1|Overall Study|Lost to Follow-up|2
3063905|NCT00511355|10527748|P2|Overall Study|Pregnancy Wish|0
3063906|NCT00511355|10527749|P1|Overall Study|Pregnancy Wish|1
3063907|NCT00511355|10527748|P2|Overall Study|Adverse Event|4
3063908|NCT00511355|10527749|P1|Overall Study|Adverse Event|4
3063909|NCT00511342|10527849|P2|Overall Study|Other Reason|2
3063910|NCT00511342|10527850|P1|Overall Study|Other Reason|2
3063911|NCT00511342|10527849|P2|Overall Study|Lost to Follow-up|5
3063912|NCT00511342|10527850|P1|Overall Study|Lost to Follow-up|1
3063913|NCT00511342|10527849|P2|Overall Study|Pregnancy wish|1
3063914|NCT00511342|10527850|P1|Overall Study|Pregnancy wish|0
3063915|NCT00511342|10527849|P2|Overall Study|Pregnancy|1
3063916|NCT00511342|10527850|P1|Overall Study|Pregnancy|0
3063917|NCT00511342|10527849|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
3063918|NCT00511342|10527850|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
3063919|NCT00511342|10527849|P2|Overall Study|Unacceptable vaginal bleeding|1
3063920|NCT00511342|10527850|P1|Overall Study|Unacceptable vaginal bleeding|2
3063921|NCT00511238|10527881|P2|Overall Study|various reasons|14
3063922|NCT00511238|10527882|P1|Overall Study|various reasons|4
3063923|NCT00511238|10527881|P2|Overall Study|Progressive Disease|157
3063924|NCT00511238|10527882|P1|Overall Study|Progressive Disease|23
3063925|NCT00511238|10527881|P2|Overall Study|Withdrawal by Subject|22
3063926|NCT00511238|10527882|P1|Overall Study|Withdrawal by Subject|2
3063927|NCT00511238|10527881|P2|Overall Study|Adverse Event|33
3063928|NCT00511238|10527882|P1|Overall Study|Adverse Event|13
3063929|NCT00511199|10527901|P2|Overall Study|Other Reason|37
3063930|NCT00511199|10527902|P1|Overall Study|Other Reason|78
3063931|NCT00511199|10527901|P2|Overall Study|Lost to Follow-up|17
3063932|NCT00511199|10527902|P1|Overall Study|Lost to Follow-up|40
3063933|NCT00511199|10527901|P2|Overall Study|Pregnancy Wish|8
3063934|NCT00511199|10527902|P1|Overall Study|Pregnancy Wish|16
3063935|NCT00511199|10527901|P2|Overall Study|Pregnancy|3
3063936|NCT00511199|10527902|P1|Overall Study|Pregnancy|6
3063937|NCT00511199|10527901|P2|Overall Study|Withdrawal of Informed Consent|4
3063938|NCT00511199|10527902|P1|Overall Study|Withdrawal of Informed Consent|19
3063939|NCT00511199|10527901|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
3063940|NCT00511199|10527902|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
3063941|NCT00511199|10527901|P2|Overall Study|Unacceptable Vaginal Bleeding|4
3063942|NCT00511199|10527902|P1|Overall Study|Unacceptable Vaginal Bleeding|63
3063943|NCT00511147|10527931|P1|Overall Study|Required platelet transfusion|1
3063944|NCT00511147|10527931|P1|Overall Study|Disease progression|5
3063945|NCT00511147|10527931|P1|Overall Study|Withdrawal by Subject|1
3063946|NCT00511134|10527940|P2|Overall Study|Withdrawal by Subject|2
3063947|NCT00511134|10527941|P1|Overall Study|Withdrawal by Subject|0
3063948|NCT00511108|10527953|P4|Overall Study|Withdrawal by Subject|2
3063949|NCT00511108|10527954|P3|Overall Study|Withdrawal by Subject|3
3063950|NCT00511108|10527955|P2|Overall Study|Withdrawal by Subject|0
3063951|NCT00511108|10527956|P1|Overall Study|Withdrawal by Subject|4
3063952|NCT00511108|10527953|P4|Overall Study|Physician Decision|1
3063953|NCT00511108|10527954|P3|Overall Study|Physician Decision|0
3063954|NCT00511108|10527955|P2|Overall Study|Physician Decision|0
3063955|NCT00511108|10527956|P1|Overall Study|Physician Decision|0
3063956|NCT00511108|10527953|P4|Overall Study|Lost to Follow-up|0
3063957|NCT00511108|10527954|P3|Overall Study|Lost to Follow-up|1
3063958|NCT00511108|10527955|P2|Overall Study|Lost to Follow-up|2
3063959|NCT00511108|10527956|P1|Overall Study|Lost to Follow-up|0
3063960|NCT00511108|10527953|P4|Overall Study|Adverse Event|2
3063961|NCT00511108|10527954|P3|Overall Study|Adverse Event|1
3063962|NCT00511108|10527955|P2|Overall Study|Adverse Event|0
3063963|NCT00511108|10527956|P1|Overall Study|Adverse Event|2
3063964|NCT00511004|10527987|P3|Overall Study|Lost to Follow-up|4
3063965|NCT00511004|10527988|P2|Overall Study|Lost to Follow-up|0
3063966|NCT00511004|10527989|P1|Overall Study|Lost to Follow-up|0
3063967|NCT00510952|10528008|P2|Overall Study|Did Not Receive Study Drug|0
3063968|NCT00510952|10528009|P1|Overall Study|Did Not Receive Study Drug|2
3063969|NCT00510952|10528008|P2|Overall Study|Withdrawal by Subject|7
3063970|NCT00510952|10528009|P1|Overall Study|Withdrawal by Subject|6
3063971|NCT00510952|10528008|P2|Overall Study|Sponsor Decision|0
3063972|NCT00510952|10528009|P1|Overall Study|Sponsor Decision|1
3063973|NCT00510952|10528008|P2|Overall Study|Protocol Violation|4
3063974|NCT00510952|10528009|P1|Overall Study|Protocol Violation|7
3063975|NCT00510952|10528008|P2|Overall Study|Physician Decision|1
3063976|NCT00510952|10528009|P1|Overall Study|Physician Decision|1
3063977|NCT00510952|10528008|P2|Overall Study|Lost to Follow-up|3
3063978|NCT00510952|10528009|P1|Overall Study|Lost to Follow-up|5
3063979|NCT00510952|10528008|P2|Overall Study|Entry Criteria Not Met|1
3063980|NCT00510952|10528009|P1|Overall Study|Entry Criteria Not Met|3
3063981|NCT00510952|10528008|P2|Overall Study|Adverse Event|0
3063982|NCT00510952|10528009|P1|Overall Study|Adverse Event|1
3063983|NCT00510887|10528035|P1|Overall Study|Lost to Follow-up|1
3063984|NCT00510874|10528051|P7|Overall Study|Lost to Follow-up|1
3063985|NCT00510874|10528052|P6|Overall Study|Lost to Follow-up|0
3063986|NCT00510874|10528053|P5|Overall Study|Lost to Follow-up|4
3063987|NCT00510874|10528054|P4|Overall Study|Lost to Follow-up|3
3063988|NCT00510874|10528055|P3|Overall Study|Lost to Follow-up|1
3063989|NCT00510874|10528056|P2|Overall Study|Lost to Follow-up|3
3063990|NCT00510874|10528057|P1|Overall Study|Lost to Follow-up|2
3063991|NCT00510874|10528051|P7|Overall Study|Withdrawal by Subject|0
3063992|NCT00510874|10528052|P6|Overall Study|Withdrawal by Subject|0
3063993|NCT00510874|10528053|P5|Overall Study|Withdrawal by Subject|3
3063994|NCT00510874|10528054|P4|Overall Study|Withdrawal by Subject|0
3063995|NCT00510874|10528055|P3|Overall Study|Withdrawal by Subject|0
3063996|NCT00510874|10528056|P2|Overall Study|Withdrawal by Subject|1
3063997|NCT00510874|10528057|P1|Overall Study|Withdrawal by Subject|1
3063998|NCT00510835|10528160|P3|Overall Study|Withdrawal by Subject|2
3063999|NCT00510835|10528161|P2|Overall Study|Withdrawal by Subject|2
3064000|NCT00510835|10528162|P1|Overall Study|Withdrawal by Subject|6
3064001|NCT00510783|10528188|P2|Overall Study|Protocol Violation|1
3064002|NCT00510783|10528189|P1|Overall Study|Protocol Violation|0
3064003|NCT00510783|10528188|P2|Overall Study|Withdrawal by Subject|3
3064004|NCT00510783|10528189|P1|Overall Study|Withdrawal by Subject|2
3064005|NCT00510783|10528188|P2|Overall Study|Lost to Follow-up|25
3064006|NCT00510783|10528189|P1|Overall Study|Lost to Follow-up|29
3064007|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|Other|1
3064008|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|Other|1
3064009|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
3064010|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
3064011|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
3064012|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
3064013|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
3064014|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
3064015|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
3064016|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
3064017|NCT00510718|10528206|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
3064018|NCT00510718|10528207|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
3064019|NCT00510692|10528333|P2|Overall Study|Withdrawal by Subject|0
3064020|NCT00510692|10528334|P1|Overall Study|Withdrawal by Subject|1
3064021|NCT00510692|10528333|P2|Overall Study|Adverse Event|3
3064022|NCT00510692|10528334|P1|Overall Study|Adverse Event|1
3064023|NCT00510653|10528348|P1|Overall Study|Monetary|3
3064024|NCT00510653|10528348|P1|Overall Study|Withdrawal by Subject|8
3064025|NCT00510510|10528355|P3|Overall Study|Protocol Violation|4
3064026|NCT00510510|10528356|P2|Overall Study|Protocol Violation|3
3064027|NCT00510510|10528357|P1|Overall Study|Protocol Violation|0
3064028|NCT00510510|10528355|P3|Overall Study|Lost to Follow-up|1
3064029|NCT00510510|10528356|P2|Overall Study|Lost to Follow-up|0
3064030|NCT00510510|10528357|P1|Overall Study|Lost to Follow-up|0
3064031|NCT00510510|10528355|P3|Overall Study|Withdrawal by Subject|3
3064032|NCT00510510|10528356|P2|Overall Study|Withdrawal by Subject|2
3064033|NCT00510510|10528357|P1|Overall Study|Withdrawal by Subject|1
3064034|NCT00510510|10528355|P3|Overall Study|Subjects no longer requires study drug|2
3064035|NCT00510510|10528356|P2|Overall Study|Subjects no longer requires study drug|0
3064036|NCT00510510|10528357|P1|Overall Study|Subjects no longer requires study drug|0
3064037|NCT00510510|10528355|P3|Overall Study|Lack of Efficacy|1
3064038|NCT00510510|10528356|P2|Overall Study|Lack of Efficacy|1
3064039|NCT00510510|10528357|P1|Overall Study|Lack of Efficacy|0
3064040|NCT00510510|10528355|P3|Overall Study|Adverse Event|6
3064041|NCT00510510|10528356|P2|Overall Study|Adverse Event|3
3064042|NCT00510510|10528357|P1|Overall Study|Adverse Event|4
3064043|NCT00510484|10528375|P2|Wash-out Period|Adverse Event|1
3064044|NCT00510484|10528376|P1|Wash-out Period|Adverse Event|0
3064045|NCT00510458|10528396|P1|Overall Study|Revision|2
3064046|NCT00510458|10528396|P1|Overall Study|Withdrawal by Subject|3
3064047|NCT00510458|10528396|P1|Overall Study|Lost to Follow-up|6
3064048|NCT00510458|10528396|P1|Overall Study|Terminated|14
3064049|NCT00510458|10528396|P1|Overall Study|Death|1
3064050|NCT00510458|10528396|P1|Overall Study|5 year not evaluable/missed|21
3064051|NCT00510289|10528409|P1|Overall Study|Progressed prior to starting drug|2
3064052|NCT00510289|10528409|P1|Overall Study|Lost to Follow-up|1
3064053|NCT00510289|10528409|P1|Overall Study|Refused bone marrow biopsy|2
3064054|NCT00510289|10528409|P1|Overall Study|Withdrawal by Subject|7
3064055|NCT00510276|10528419|P2|Extension Open-Label Phase|Subject Decision|9
3064056|NCT00510276|10528420|P1|Extension Open-Label Phase|Subject Decision|7
3064057|NCT00510276|10528419|P2|Extension Open-Label Phase|Sponsor Decision|0
3064058|NCT00510276|10528420|P1|Extension Open-Label Phase|Sponsor Decision|1
3064059|NCT00510276|10528419|P2|Extension Open-Label Phase|Protocol Violation|1
3064060|NCT00510276|10528420|P1|Extension Open-Label Phase|Protocol Violation|0
3064061|NCT00510276|10528419|P2|Extension Open-Label Phase|Physician Decision|3
3064062|NCT00510276|10528420|P1|Extension Open-Label Phase|Physician Decision|2
3064063|NCT00510276|10528419|P2|Extension Open-Label Phase|Lost to Follow-up|10
3064064|NCT00510276|10528420|P1|Extension Open-Label Phase|Lost to Follow-up|12
3064065|NCT00510276|10528419|P2|Extension Open-Label Phase|Lack of Efficacy|7
3064066|NCT00510276|10528420|P1|Extension Open-Label Phase|Lack of Efficacy|2
3064067|NCT00510276|10528419|P2|Extension Open-Label Phase|Adverse Event|18
3064068|NCT00510276|10528420|P1|Extension Open-Label Phase|Adverse Event|9
3064069|NCT00510276|10528419|P2|Acute Double-Blind Phase|Subject Decision|28
3064070|NCT00510276|10528420|P1|Acute Double-Blind Phase|Subject Decision|26
3064071|NCT00510276|10528419|P2|Acute Double-Blind Phase|Sponsor Decision|1
3064072|NCT00510276|10528420|P1|Acute Double-Blind Phase|Sponsor Decision|2
3064073|NCT00510276|10528419|P2|Acute Double-Blind Phase|Protocol Violation|3
3064074|NCT00510276|10528420|P1|Acute Double-Blind Phase|Protocol Violation|4
3064075|NCT00510276|10528419|P2|Acute Double-Blind Phase|Physician Decision|3
3064076|NCT00510276|10528420|P1|Acute Double-Blind Phase|Physician Decision|0
3064077|NCT00510276|10528419|P2|Acute Double-Blind Phase|Lost to Follow-up|49
3064078|NCT00510276|10528420|P1|Acute Double-Blind Phase|Lost to Follow-up|48
3064079|NCT00510276|10528419|P2|Acute Double-Blind Phase|Lack of Efficacy|4
3064080|NCT00510276|10528420|P1|Acute Double-Blind Phase|Lack of Efficacy|3
3064081|NCT00510276|10528419|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
3064082|NCT00510276|10528420|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
3064083|NCT00510276|10528419|P2|Acute Double-Blind Phase|Adverse Event|6
3064084|NCT00510276|10528420|P1|Acute Double-Blind Phase|Adverse Event|21
3064085|NCT00510198|10528514|P2|Overall Study|Withdrawal by Subject|4
3064086|NCT00510198|10528515|P1|Overall Study|Withdrawal by Subject|5
3064087|NCT00510146|10528529|P2|Open-Label Treatment|Sponsor Decision|0
3064088|NCT00510146|10528530|P1|Open-Label Treatment|Sponsor Decision|2
3064089|NCT00510146|10528529|P2|Open-Label Treatment|Clinical Relapse|1
3064090|NCT00510146|10528530|P1|Open-Label Treatment|Clinical Relapse|1
3064091|NCT00510146|10528529|P2|Open-Label Treatment|Withdrawal by Subject|12
3064092|NCT00510146|10528530|P1|Open-Label Treatment|Withdrawal by Subject|24
3064093|NCT00510146|10528529|P2|Open-Label Treatment|Protocol Violation|2
3064094|NCT00510146|10528530|P1|Open-Label Treatment|Protocol Violation|4
3064095|NCT00510146|10528529|P2|Open-Label Treatment|Physician Decision|1
3064096|NCT00510146|10528530|P1|Open-Label Treatment|Physician Decision|3
3064097|NCT00510146|10528529|P2|Open-Label Treatment|Lost to Follow-up|1
3064098|NCT00510146|10528530|P1|Open-Label Treatment|Lost to Follow-up|10
3064099|NCT00510146|10528529|P2|Open-Label Treatment|Lack of Efficacy|0
3064100|NCT00510146|10528530|P1|Open-Label Treatment|Lack of Efficacy|4
3064101|NCT00510146|10528529|P2|Open-Label Treatment|Death|1
3064102|NCT00510146|10528530|P1|Open-Label Treatment|Death|1
3064103|NCT00510146|10528529|P2|Open-Label Treatment|Adverse Event|8
3064104|NCT00510146|10528530|P1|Open-Label Treatment|Adverse Event|22
3064105|NCT00510146|10528529|P2|Double-Blind Treatment|Entry Criteria Not Met|0
3064106|NCT00510146|10528530|P1|Double-Blind Treatment|Entry Criteria Not Met|3
3064107|NCT00510146|10528529|P2|Double-Blind Treatment|Clinical Relapse|1
3064108|NCT00510146|10528530|P1|Double-Blind Treatment|Clinical Relapse|0
3064109|NCT00510146|10528529|P2|Double-Blind Treatment|Withdrawal by Subject|13
3064110|NCT00510146|10528530|P1|Double-Blind Treatment|Withdrawal by Subject|27
3064111|NCT00510146|10528529|P2|Double-Blind Treatment|Protocol Violation|2
3064112|NCT00510146|10528530|P1|Double-Blind Treatment|Protocol Violation|1
3064113|NCT00510146|10528529|P2|Double-Blind Treatment|Physician Decision|0
3064114|NCT00510146|10528530|P1|Double-Blind Treatment|Physician Decision|6
3064115|NCT00510146|10528529|P2|Double-Blind Treatment|Lost to Follow-up|7
3064116|NCT00510146|10528530|P1|Double-Blind Treatment|Lost to Follow-up|3
3064117|NCT00510146|10528529|P2|Double-Blind Treatment|Lack of Efficacy|13
3064118|NCT00510146|10528530|P1|Double-Blind Treatment|Lack of Efficacy|6
3064119|NCT00510146|10528529|P2|Double-Blind Treatment|Adverse Event|13
3064120|NCT00510146|10528530|P1|Double-Blind Treatment|Adverse Event|30
3064121|NCT00510068|10528619|P2|Open-label Period|Abnormal laboratory value (s)|0
3064122|NCT00510068|10528620|P1|Open-label Period|Abnormal laboratory value (s)|1
3064123|NCT00510068|10528619|P2|Open-label Period|Protocol Violation|0
3064124|NCT00510068|10528620|P1|Open-label Period|Protocol Violation|2
3064125|NCT00510068|10528619|P2|Open-label Period|New cancer therapy|0
3064126|NCT00510068|10528620|P1|Open-label Period|New cancer therapy|7
3064127|NCT00510068|10528619|P2|Open-label Period|Death|0
3064128|NCT00510068|10528620|P1|Open-label Period|Death|7
3064129|NCT00510068|10528619|P2|Open-label Period|Administrative problems|0
3064130|NCT00510068|10528620|P1|Open-label Period|Administrative problems|17
3064131|NCT00510068|10528619|P2|Open-label Period|Withdrawal by Subject|0
3064132|NCT00510068|10528620|P1|Open-label Period|Withdrawal by Subject|21
3064133|NCT00510068|10528619|P2|Open-label Period|Adverse Event|0
3064134|NCT00510068|10528620|P1|Open-label Period|Adverse Event|46
3064135|NCT00510068|10528619|P2|Open-label Period|Disease Progression|0
3064136|NCT00510068|10528620|P1|Open-label Period|Disease Progression|124
3064137|NCT00510068|10528619|P2|Double-blind Period|Protocol Violation|0
3064138|NCT00510068|10528620|P1|Double-blind Period|Protocol Violation|6
3064139|NCT00510068|10528619|P2|Double-blind Period|Lost to Follow-up|0
3064140|NCT00510068|10528620|P1|Double-blind Period|Lost to Follow-up|1
3064141|NCT00510068|10528619|P2|Double-blind Period|Abnormal test result (s)|0
3064142|NCT00510068|10528620|P1|Double-blind Period|Abnormal test result (s)|1
3064143|NCT00510068|10528619|P2|Double-blind Period|Death|3
3064144|NCT00510068|10528620|P1|Double-blind Period|Death|4
3064145|NCT00510068|10528619|P2|Double-blind Period|Withdrawal by Subject|6
3064146|NCT00510068|10528620|P1|Double-blind Period|Withdrawal by Subject|8
3064147|NCT00510068|10528619|P2|Double-blind Period|Adverse Event|7
3064148|NCT00510068|10528620|P1|Double-blind Period|Adverse Event|37
3064149|NCT00510068|10528619|P2|Double-blind Period|Final primary analysis|18
3064150|NCT00510068|10528620|P1|Double-blind Period|Final primary analysis|52
3064151|NCT00510068|10528619|P2|Double-blind Period|Disease progression|169
3064152|NCT00510068|10528620|P1|Double-blind Period|Disease progression|98
3064153|NCT00509925|10528661|P2|Overall Study|Personal reasons|1
3064154|NCT00509925|10528662|P1|Overall Study|Personal reasons|0
3064155|NCT00509899|10528710|P8|Overall Study|Lack of Efficacy|0
3064156|NCT00509899|10528711|P7|Overall Study|Lack of Efficacy|0
3064157|NCT00509899|10528712|P6|Overall Study|Lack of Efficacy|1
3064158|NCT00509899|10528713|P5|Overall Study|Lack of Efficacy|0
3064159|NCT00509899|10528714|P4|Overall Study|Lack of Efficacy|0
3064160|NCT00509899|10528715|P3|Overall Study|Lack of Efficacy|2
3064161|NCT00509899|10528716|P2|Overall Study|Lack of Efficacy|0
3064162|NCT00509899|10528717|P1|Overall Study|Lack of Efficacy|1
3064163|NCT00509899|10528710|P8|Overall Study|Death|1
3064164|NCT00509899|10528711|P7|Overall Study|Death|1
3064165|NCT00509899|10528712|P6|Overall Study|Death|1
3064166|NCT00509899|10528713|P5|Overall Study|Death|1
3064167|NCT00509899|10528714|P4|Overall Study|Death|0
3064168|NCT00509899|10528715|P3|Overall Study|Death|3
3064169|NCT00509899|10528716|P2|Overall Study|Death|2
3064170|NCT00509899|10528717|P1|Overall Study|Death|2
3064171|NCT00509899|10528710|P8|Overall Study|Intercurrent Illness|0
3064172|NCT00509899|10528711|P7|Overall Study|Intercurrent Illness|0
3064173|NCT00509899|10528712|P6|Overall Study|Intercurrent Illness|1
3064174|NCT00509899|10528713|P5|Overall Study|Intercurrent Illness|0
3064175|NCT00509899|10528714|P4|Overall Study|Intercurrent Illness|1
3064176|NCT00509899|10528715|P3|Overall Study|Intercurrent Illness|0
3064177|NCT00509899|10528716|P2|Overall Study|Intercurrent Illness|0
3064178|NCT00509899|10528717|P1|Overall Study|Intercurrent Illness|1
3064179|NCT00509899|10528710|P8|Overall Study|Physician Decision|0
3064180|NCT00509899|10528711|P7|Overall Study|Physician Decision|0
3064181|NCT00509899|10528712|P6|Overall Study|Physician Decision|4
3064182|NCT00509899|10528713|P5|Overall Study|Physician Decision|1
3064183|NCT00509899|10528714|P4|Overall Study|Physician Decision|0
3064184|NCT00509899|10528715|P3|Overall Study|Physician Decision|7
3064185|NCT00509899|10528716|P2|Overall Study|Physician Decision|2
3064186|NCT00509899|10528717|P1|Overall Study|Physician Decision|4
3064187|NCT00509899|10528710|P8|Overall Study|Withdrawal by Subject|0
3064188|NCT00509899|10528711|P7|Overall Study|Withdrawal by Subject|0
3064189|NCT00509899|10528712|P6|Overall Study|Withdrawal by Subject|2
3064190|NCT00509899|10528713|P5|Overall Study|Withdrawal by Subject|3
3064191|NCT00509899|10528714|P4|Overall Study|Withdrawal by Subject|0
3064192|NCT00509899|10528715|P3|Overall Study|Withdrawal by Subject|3
3064193|NCT00509899|10528716|P2|Overall Study|Withdrawal by Subject|2
3064194|NCT00509899|10528717|P1|Overall Study|Withdrawal by Subject|6
3064195|NCT00509899|10528710|P8|Overall Study|Unacceptable Toxicity|0
3064196|NCT00509899|10528711|P7|Overall Study|Unacceptable Toxicity|0
3064197|NCT00509899|10528712|P6|Overall Study|Unacceptable Toxicity|0
3064198|NCT00509899|10528713|P5|Overall Study|Unacceptable Toxicity|0
3064199|NCT00509899|10528714|P4|Overall Study|Unacceptable Toxicity|2
3064200|NCT00509899|10528715|P3|Overall Study|Unacceptable Toxicity|0
3064201|NCT00509899|10528716|P2|Overall Study|Unacceptable Toxicity|0
3064202|NCT00509899|10528717|P1|Overall Study|Unacceptable Toxicity|1
3064203|NCT00509899|10528710|P8|Overall Study|Progressive disease|0
3064204|NCT00509899|10528711|P7|Overall Study|Progressive disease|0
3064205|NCT00509899|10528712|P6|Overall Study|Progressive disease|1
3064206|NCT00509899|10528713|P5|Overall Study|Progressive disease|0
3064207|NCT00509899|10528714|P4|Overall Study|Progressive disease|1
3064208|NCT00509899|10528715|P3|Overall Study|Progressive disease|5
3064209|NCT00509899|10528716|P2|Overall Study|Progressive disease|3
3064210|NCT00509899|10528717|P1|Overall Study|Progressive disease|1
3064211|NCT00509821|10528774|P2|Study Period 1 (Induction)|Progressive Disease|1
3064212|NCT00509821|10528775|P1|Study Period 1 (Induction)|Progressive Disease|0
3064213|NCT00509821|10528774|P2|Study Period 1 (Induction)|Adverse Event|2
3064214|NCT00509821|10528775|P1|Study Period 1 (Induction)|Adverse Event|0
3064215|NCT00509821|10528774|P2|Study Period 1 (Induction)|Death|1
3064216|NCT00509821|10528775|P1|Study Period 1 (Induction)|Death|0
3064217|NCT00509795|10528793|P4|Overall Study|Withdrawal by Subject|8
3064218|NCT00509795|10528794|P3|Overall Study|Withdrawal by Subject|7
3064219|NCT00509795|10528795|P2|Overall Study|Withdrawal by Subject|5
3064220|NCT00509795|10528796|P1|Overall Study|Withdrawal by Subject|10
3064221|NCT00509795|10528793|P4|Overall Study|Protocol Violation|1
3064222|NCT00509795|10528794|P3|Overall Study|Protocol Violation|3
3064223|NCT00509795|10528795|P2|Overall Study|Protocol Violation|0
3064224|NCT00509795|10528796|P1|Overall Study|Protocol Violation|3
3064225|NCT00509795|10528793|P4|Overall Study|OTHER|1
3064226|NCT00509795|10528794|P3|Overall Study|OTHER|4
3064227|NCT00509795|10528795|P2|Overall Study|OTHER|0
3064228|NCT00509795|10528796|P1|Overall Study|OTHER|1
3064229|NCT00509795|10528793|P4|Overall Study|Lost to Follow-up|4
3064230|NCT00509795|10528794|P3|Overall Study|Lost to Follow-up|4
3064231|NCT00509795|10528795|P2|Overall Study|Lost to Follow-up|2
3064232|NCT00509795|10528796|P1|Overall Study|Lost to Follow-up|1
3064233|NCT00509795|10528793|P4|Overall Study|Lack of Efficacy|2
3064234|NCT00509795|10528794|P3|Overall Study|Lack of Efficacy|2
3064235|NCT00509795|10528795|P2|Overall Study|Lack of Efficacy|0
3064236|NCT00509795|10528796|P1|Overall Study|Lack of Efficacy|0
3064237|NCT00509795|10528793|P4|Overall Study|Death|7
3064238|NCT00509795|10528794|P3|Overall Study|Death|2
3064239|NCT00509795|10528795|P2|Overall Study|Death|1
3064240|NCT00509795|10528796|P1|Overall Study|Death|3
3064241|NCT00509795|10528793|P4|Overall Study|Adverse Event|4
3064242|NCT00509795|10528794|P3|Overall Study|Adverse Event|5
3064243|NCT00509795|10528795|P2|Overall Study|Adverse Event|3
3064244|NCT00509795|10528796|P1|Overall Study|Adverse Event|4
3064245|NCT00509769|10528827|P1|Overall Study|Use of prohibited therapies during study|1
3064246|NCT00509769|10528827|P1|Overall Study|Physician Decision|8
3064247|NCT00509769|10528827|P1|Overall Study|Patient’s decision|1
3064248|NCT00509769|10528827|P1|Overall Study|Adverse Event|4
3064249|NCT00509769|10528827|P1|Overall Study|Progressive disease|77
3064250|NCT00509600|10528846|P1|Overall Study|Adverse Event|1
3064251|NCT00509366|10528925|P5|Overall Study|Not Treated (Screen Failure)|0
3064252|NCT00509366|10528926|P4|Overall Study|Not Treated (Screen Failure)|0
3064253|NCT00509366|10528927|P3|Overall Study|Not Treated (Screen Failure)|1
3064254|NCT00509366|10528928|P2|Overall Study|Not Treated (Screen Failure)|1
3064255|NCT00509366|10528929|P1|Overall Study|Not Treated (Screen Failure)|1
3064256|NCT00509262|10528953|P2|Overall Study|Withdrawal by Subject|11
3064257|NCT00509262|10528954|P1|Overall Study|Withdrawal by Subject|24
3064258|NCT00509262|10528953|P2|Overall Study|Protocol Violation|2
3064259|NCT00509262|10528954|P1|Overall Study|Protocol Violation|2
3064260|NCT00509262|10528953|P2|Overall Study|Physician Decision|3
3064261|NCT00509262|10528954|P1|Overall Study|Physician Decision|1
3064262|NCT00509262|10528953|P2|Overall Study|Lost to Follow-up|6
3064263|NCT00509262|10528954|P1|Overall Study|Lost to Follow-up|1
3064264|NCT00509262|10528953|P2|Overall Study|Lack of Efficacy|0
3064265|NCT00509262|10528954|P1|Overall Study|Lack of Efficacy|1
3064266|NCT00509262|10528953|P2|Overall Study|Other|2
3064267|NCT00509262|10528954|P1|Overall Study|Other|2
3064268|NCT00509262|10528953|P2|Overall Study|Adverse Event|18
3064269|NCT00509262|10528954|P1|Overall Study|Adverse Event|16
3064270|NCT00509236|10528972|P2|Overall Study|Scheduled Kidney Transplant|0
3064271|NCT00509236|10528973|P1|Overall Study|Scheduled Kidney Transplant|1
3064272|NCT00509236|10528972|P2|Overall Study|Excluded Medication|1
3064273|NCT00509236|10528973|P1|Overall Study|Excluded Medication|1
3064274|NCT00509236|10528972|P2|Overall Study|Protocol Violation|0
3064275|NCT00509236|10528973|P1|Overall Study|Protocol Violation|3
3064276|NCT00509236|10528972|P2|Overall Study|Withdrawal by Subject|10
3064277|NCT00509236|10528973|P1|Overall Study|Withdrawal by Subject|5
3064278|NCT00509236|10528972|P2|Overall Study|Adverse Event|9
3064279|NCT00509236|10528973|P1|Overall Study|Adverse Event|7
3064280|NCT00509223|10528988|P2|Overall Study|Did not meet revised inclusion criteria|62
3064281|NCT00509223|10528989|P1|Overall Study|Did not meet revised inclusion criteria|56
3064282|NCT00509223|10528988|P2|Overall Study|Including: subject change of address|2
3064283|NCT00509223|10528989|P1|Overall Study|Including: subject change of address|5
3064284|NCT00509223|10528988|P2|Overall Study|Withdrawal by Subject|6
3064285|NCT00509223|10528989|P1|Overall Study|Withdrawal by Subject|25
3064286|NCT00509223|10528988|P2|Overall Study|Adverse Event|1
3064287|NCT00509223|10528989|P1|Overall Study|Adverse Event|1
3064288|NCT00509223|10528988|P2|Overall Study|Lost to Follow-up|1
3064289|NCT00509223|10528989|P1|Overall Study|Lost to Follow-up|1
3064290|NCT00509106|10529021|P2|Overall Study|Death|6
3064291|NCT00509106|10529022|P1|Overall Study|Death|6
3064292|NCT00509106|10529021|P2|Overall Study|Other|0
3064293|NCT00509106|10529022|P1|Overall Study|Other|1
3064294|NCT00509106|10529021|P2|Overall Study|Lost to Follow-up|10
3064295|NCT00509106|10529022|P1|Overall Study|Lost to Follow-up|16
3064296|NCT00509106|10529021|P2|Overall Study|Withdrew consent|8
3064297|NCT00509106|10529022|P1|Overall Study|Withdrew consent|4
3064298|NCT00509106|10529021|P2|Overall Study|At the request of sponsor/investigator|2
3064299|NCT00509106|10529022|P1|Overall Study|At the request of sponsor/investigator|1
3064300|NCT00509106|10529021|P2|Overall Study|Noncompliance|1
3064301|NCT00509106|10529022|P1|Overall Study|Noncompliance|0
3064302|NCT00509106|10529021|P2|Overall Study|Adverse Event|2
3064303|NCT00509106|10529022|P1|Overall Study|Adverse Event|3
3064304|NCT00509093|10529028|P1|Overall Study|Physician Decision|1
3064305|NCT00509093|10529028|P1|Overall Study|Withdrawal by Subject|3
3064306|NCT00509093|10529028|P1|Overall Study|Transformed into MDS|1
3064307|NCT00509093|10529028|P1|Overall Study|Disease Progression|9
3064308|NCT00509093|10529028|P1|Overall Study|Adverse Event|10
3064309|NCT00509067|10529038|P2|Overall Study|Protocol Violation|3
3064310|NCT00509067|10529039|P1|Overall Study|Protocol Violation|0
3064311|NCT00509067|10529038|P2|Overall Study|Adverse Event|1
3064312|NCT00509067|10529039|P1|Overall Study|Adverse Event|3
3064313|NCT00509067|10529038|P2|Overall Study|Lost to Follow-up|1
3064314|NCT00509067|10529039|P1|Overall Study|Lost to Follow-up|1
3064315|NCT00509028|10529058|P2|Overall Study|Non-compliance|1
3064316|NCT00509028|10529059|P1|Overall Study|Non-compliance|2
3064317|NCT00509028|10529058|P2|Overall Study|Protocol Violation|2
3064318|NCT00509028|10529059|P1|Overall Study|Protocol Violation|4
3064319|NCT00509028|10529058|P2|Overall Study|Lost to Follow-up|1
3064320|NCT00509028|10529059|P1|Overall Study|Lost to Follow-up|0
3064321|NCT00509028|10529058|P2|Overall Study|Withdrawal by Subject|3
3064322|NCT00509028|10529059|P1|Overall Study|Withdrawal by Subject|4
3064323|NCT00509028|10529058|P2|Overall Study|Adverse Event|0
3064324|NCT00509028|10529059|P1|Overall Study|Adverse Event|2
3064325|NCT00508924|10529099|P4|Overall Study|Protocol Violation|1
3064326|NCT00508924|10529100|P3|Overall Study|Protocol Violation|1
3064327|NCT00508924|10529101|P2|Overall Study|Protocol Violation|0
3064328|NCT00508924|10529102|P1|Overall Study|Protocol Violation|0
3064329|NCT00508872|10529116|P1|Overall Study|Physician Decision|1
3064330|NCT00508872|10529116|P1|Overall Study|Lost to Follow-up|1
3064331|NCT00508820|10529122|P2|Overall Study|Protocol-specified Criteria|12
3064332|NCT00508820|10529123|P1|Overall Study|Protocol-specified Criteria|3
3064333|NCT00508820|10529122|P2|Overall Study|Requirement for alternative therapy|15
3064334|NCT00508820|10529123|P1|Overall Study|Requirement for alternative therapy|7
3064335|NCT00508820|10529122|P2|Overall Study|Noncompliance|0
3064336|NCT00508820|10529123|P1|Overall Study|Noncompliance|1
3064337|NCT00508820|10529122|P2|Overall Study|Other|2
3064338|NCT00508820|10529123|P1|Overall Study|Other|11
3064339|NCT00508820|10529122|P2|Overall Study|Withdrawal by Subject|12
3064340|NCT00508820|10529123|P1|Overall Study|Withdrawal by Subject|10
3064341|NCT00508820|10529122|P2|Overall Study|Protocol Violation|0
3064342|NCT00508820|10529123|P1|Overall Study|Protocol Violation|2
3064343|NCT00508820|10529122|P2|Overall Study|Pregnancy|2
3064344|NCT00508820|10529123|P1|Overall Study|Pregnancy|0
3064345|NCT00508820|10529122|P2|Overall Study|Physician Decision|2
3064346|NCT00508820|10529123|P1|Overall Study|Physician Decision|8
3064347|NCT00508820|10529122|P2|Overall Study|Lost to Follow-up|1
3064348|NCT00508820|10529123|P1|Overall Study|Lost to Follow-up|1
3064349|NCT00508820|10529122|P2|Overall Study|Death|8
3064350|NCT00508820|10529123|P1|Overall Study|Death|6
3064351|NCT00508820|10529122|P2|Overall Study|Adverse Event|10
3064352|NCT00508820|10529123|P1|Overall Study|Adverse Event|6
3064353|NCT00508755|10529133|P1|Overall Study|Withdrawal by Subject|1
3064354|NCT00508742|10529141|P2|Period 3: Toddler Dose|Other|4
3064355|NCT00508742|10529142|P1|Period 3: Toddler Dose|Other|5
3064356|NCT00508742|10529141|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
3064357|NCT00508742|10529142|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
3064358|NCT00508742|10529141|P2|Period 3: Toddler Dose|Lost to Follow-up|3
3064359|NCT00508742|10529142|P1|Period 3: Toddler Dose|Lost to Follow-up|2
3064360|NCT00508742|10529141|P2|Period 3: Toddler Dose|Adverse Event|0
3064361|NCT00508742|10529142|P1|Period 3: Toddler Dose|Adverse Event|1
3064362|NCT00508742|10529141|P2|Period 2: After Infant Series|Other|1
3064363|NCT00508742|10529142|P1|Period 2: After Infant Series|Other|2
3064364|NCT00508742|10529141|P2|Period 2: After Infant Series|Failed to Return|0
3064365|NCT00508742|10529142|P1|Period 2: After Infant Series|Failed to Return|1
3064366|NCT00508742|10529141|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
3064367|NCT00508742|10529142|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
3064368|NCT00508742|10529141|P2|Period 2: After Infant Series|Protocol Violation|0
3064369|NCT00508742|10529142|P1|Period 2: After Infant Series|Protocol Violation|1
3064370|NCT00508742|10529141|P2|Period 2: After Infant Series|Lost to Follow-up|1
3064371|NCT00508742|10529142|P1|Period 2: After Infant Series|Lost to Follow-up|1
3064372|NCT00508742|10529141|P2|Period 2: After Infant Series|Adverse Event|6
3064373|NCT00508742|10529142|P1|Period 2: After Infant Series|Adverse Event|2
3064374|NCT00508742|10529141|P2|Period 1: Infant Series|Other|1
3064375|NCT00508742|10529142|P1|Period 1: Infant Series|Other|4
3064376|NCT00508742|10529141|P2|Period 1: Infant Series|Physician Decision|0
3064377|NCT00508742|10529142|P1|Period 1: Infant Series|Physician Decision|1
3064378|NCT00508742|10529141|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
3064379|NCT00508742|10529142|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
3064380|NCT00508742|10529141|P2|Period 1: Infant Series|Protocol Violation|0
3064381|NCT00508742|10529142|P1|Period 1: Infant Series|Protocol Violation|1
3064382|NCT00508742|10529141|P2|Period 1: Infant Series|Adverse Event|4
3064383|NCT00508742|10529142|P1|Period 1: Infant Series|Adverse Event|5
3064384|NCT00508651|10529167|P2|Overall Study|Withdrawal by Subject|1
3064385|NCT00508651|10529168|P1|Overall Study|Withdrawal by Subject|1
3064386|NCT00508651|10529167|P2|Overall Study|Lost to Follow-up|1
3064387|NCT00508651|10529168|P1|Overall Study|Lost to Follow-up|3
3064388|NCT00508482|10529249|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
3064389|NCT00508482|10529250|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
3064390|NCT00508482|10529251|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
3064391|NCT00508482|10529249|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
3064392|NCT00508482|10529250|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
3064393|NCT00508482|10529251|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
3064394|NCT00508482|10529249|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
3064395|NCT00508482|10529250|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
3064396|NCT00508482|10529251|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
3064397|NCT00508404|10529295|P1|Overall Study|Other - Not Specified|3
3064398|NCT00508404|10529295|P1|Overall Study|Lost to Follow-up|2
3064399|NCT00508404|10529295|P1|Overall Study|Protocol-specified Criteria|2
3064400|NCT00508404|10529295|P1|Overall Study|Withdrawal by Subject|3
3064401|NCT00508404|10529295|P1|Overall Study|Physician Decision|2
3064402|NCT00508404|10529295|P1|Overall Study|Death|16
3064403|NCT00508404|10529295|P1|Overall Study|Adverse Event|2
3064404|NCT00508404|10529295|P1|Overall Study|Ongoing at Data Cut-off|12
3064405|NCT00508391|10529322|P2|Second Treatment|Withdrawal by Subject|0
3064406|NCT00508391|10529323|P1|Second Treatment|Withdrawal by Subject|2
3064407|NCT00508391|10529322|P2|First Treatment|Withdrawal by Subject|3
3064408|NCT00508391|10529323|P1|First Treatment|Withdrawal by Subject|6
3064409|NCT00508274|10529343|P1|Overall Study|Withdrawal by Subject|1
3064410|NCT00508274|10529343|P1|Overall Study|Adverse Event|1
3064411|NCT00508261|10529356|P4|Overall Study|Lost to Follow-up|1
3064412|NCT00508261|10529357|P3|Overall Study|Lost to Follow-up|1
3064413|NCT00508261|10529358|P2|Overall Study|Lost to Follow-up|1
3064414|NCT00508261|10529359|P1|Overall Study|Lost to Follow-up|0
3064415|NCT00508261|10529356|P4|Overall Study|Migrated/ moved from study area|0
3064416|NCT00508261|10529357|P3|Overall Study|Migrated/ moved from study area|0
3064417|NCT00508261|10529358|P2|Overall Study|Migrated/ moved from study area|1
3064418|NCT00508261|10529359|P1|Overall Study|Migrated/ moved from study area|0
3064419|NCT00508261|10529356|P4|Overall Study|Withdrawal by Subject|0
3064420|NCT00508261|10529357|P3|Overall Study|Withdrawal by Subject|4
3064421|NCT00508261|10529358|P2|Overall Study|Withdrawal by Subject|4
3064422|NCT00508261|10529359|P1|Overall Study|Withdrawal by Subject|3
3064423|NCT00508261|10529356|P4|Overall Study|Serious Adverse Event|0
3064424|NCT00508261|10529357|P3|Overall Study|Serious Adverse Event|0
3064425|NCT00508261|10529358|P2|Overall Study|Serious Adverse Event|1
3064426|NCT00508261|10529359|P1|Overall Study|Serious Adverse Event|0
3064427|NCT00508261|10529356|P4|Overall Study|Other|0
3064428|NCT00508261|10529357|P3|Overall Study|Other|1
3064429|NCT00508261|10529358|P2|Overall Study|Other|1
3064430|NCT00508261|10529359|P1|Overall Study|Other|0
3064431|NCT00508157|10529499|P2|Overall Study|Other known cause|1
3064432|NCT00508157|10529500|P1|Overall Study|Other known cause|0
3064433|NCT00508157|10529499|P2|Overall Study|Subject no longer met study criteria|1
3064434|NCT00508157|10529500|P1|Overall Study|Subject no longer met study criteria|0
3064435|NCT00508157|10529499|P2|Overall Study|Lost to Follow-up|0
3064436|NCT00508157|10529500|P1|Overall Study|Lost to Follow-up|1
3064437|NCT00508157|10529499|P2|Overall Study|Subject Withdrew Consent|0
3064438|NCT00508157|10529500|P1|Overall Study|Subject Withdrew Consent|1
3064439|NCT00508157|10529499|P2|Overall Study|Adverse Event|1
3064440|NCT00508157|10529500|P1|Overall Study|Adverse Event|0
3064441|NCT00508144|10529522|P1|Overall Study|Death|5
3064442|NCT00508144|10529522|P1|Overall Study|Not eligible|6
3064443|NCT00508027|10529561|P1|Dose Level 2|Withdrawal by Subject|2
3064444|NCT00508027|10529561|P1|Dose Level 2|Lost to Follow-up|2
3064445|NCT00508027|10529561|P1|Dose Level 1|Physician Decision|2
3064446|NCT00508027|10529561|P1|Dose Level 1|Withdrawal by Subject|2
3064447|NCT00508027|10529561|P1|Dose Level 1|Lost to Follow-up|4
3064448|NCT00508001|10529602|P3|Overall Study|Withdrawal by Subject|1
3064449|NCT00508001|10529603|P2|Overall Study|Withdrawal by Subject|4
3064450|NCT00508001|10529604|P1|Overall Study|Withdrawal by Subject|4
3064451|NCT00508001|10529602|P3|Overall Study|Death|1
3064452|NCT00508001|10529603|P2|Overall Study|Death|1
3064453|NCT00508001|10529604|P1|Overall Study|Death|0
3064454|NCT00508001|10529602|P3|Overall Study|condition under investigation worsened|1
3064455|NCT00508001|10529603|P2|Overall Study|condition under investigation worsened|7
3064456|NCT00508001|10529604|P1|Overall Study|condition under investigation worsened|13
3064457|NCT00508001|10529602|P3|Overall Study|Adverse Event|4
3064458|NCT00508001|10529603|P2|Overall Study|Adverse Event|0
3064459|NCT00508001|10529604|P1|Overall Study|Adverse Event|2
3064460|NCT00507819|10529621|P2|Washout (6 Weeks)|Withdrawal by Subject|0
3064461|NCT00507819|10529622|P1|Washout (6 Weeks)|Withdrawal by Subject|1
3064462|NCT00507689|10529641|P2|Randomized Period|Withdrawal by Subject|1
3064463|NCT00507689|10529642|P1|Randomized Period|Withdrawal by Subject|0
3064464|NCT00507689|10529641|P2|Randomized Period|Adverse Event|1
3064465|NCT00507689|10529642|P1|Randomized Period|Adverse Event|1
3064466|NCT00507689|10529641|P2|Pre-Randomization Period|Withdrawal by Subject|0
3064467|NCT00507689|10529642|P1|Pre-Randomization Period|Withdrawal by Subject|1
3064468|NCT00507689|10529641|P2|Pre-Randomization Period|Physician Decision|0
3064469|NCT00507689|10529642|P1|Pre-Randomization Period|Physician Decision|1
3064470|NCT00507689|10529641|P2|Pre-Randomization Period|Adverse Event|0
3064471|NCT00507689|10529642|P1|Pre-Randomization Period|Adverse Event|1
3064472|NCT00507546|10529674|P2|Overall Study|Physician Decision|1
3064473|NCT00507546|10529675|P1|Overall Study|Physician Decision|0
3064474|NCT00507546|10529674|P2|Overall Study|Protocol Violation|0
3064475|NCT00507546|10529675|P1|Overall Study|Protocol Violation|1
3064476|NCT00507546|10529674|P2|Overall Study|Withdrawal by Subject|0
3064477|NCT00507546|10529675|P1|Overall Study|Withdrawal by Subject|1
3064478|NCT00507507|10529685|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
3064479|NCT00507507|10529686|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
3064480|NCT00507507|10529685|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
3064481|NCT00507507|10529686|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
3064482|NCT00507507|10529685|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
3064483|NCT00507507|10529686|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
3064484|NCT00507507|10529685|P2|Treatment Period|Withdrawal by Subject|47
3064485|NCT00507507|10529686|P1|Treatment Period|Withdrawal by Subject|46
3064486|NCT00507507|10529685|P2|Treatment Period|Adverse Event|1
3064487|NCT00507507|10529686|P1|Treatment Period|Adverse Event|1
3064488|NCT00507507|10529685|P2|Treatment Period|Protocol Violation|2
3064489|NCT00507507|10529686|P1|Treatment Period|Protocol Violation|1
3064490|NCT00507507|10529685|P2|Treatment Period|Physician Decision|1
3064491|NCT00507507|10529686|P1|Treatment Period|Physician Decision|4
3064492|NCT00507507|10529685|P2|Treatment Period|Lost to Follow-up|2
3064493|NCT00507507|10529686|P1|Treatment Period|Lost to Follow-up|0
3064494|NCT00507455|10529721|P3|Overall Study|Other - miscellaneous reason|1
3064495|NCT00507455|10529722|P2|Overall Study|Other - miscellaneous reason|0
3064496|NCT00507455|10529723|P1|Overall Study|Other - miscellaneous reason|1
3064497|NCT00507455|10529721|P3|Overall Study|Lack of Efficacy|0
3064498|NCT00507455|10529722|P2|Overall Study|Lack of Efficacy|1
3064499|NCT00507455|10529723|P1|Overall Study|Lack of Efficacy|0
3064500|NCT00507455|10529721|P3|Overall Study|Lost to Follow-up|2
3064501|NCT00507455|10529722|P2|Overall Study|Lost to Follow-up|0
3064502|NCT00507455|10529723|P1|Overall Study|Lost to Follow-up|2
3064503|NCT00507455|10529721|P3|Overall Study|Protocol Violation|1
3064504|NCT00507455|10529722|P2|Overall Study|Protocol Violation|1
3064505|NCT00507455|10529723|P1|Overall Study|Protocol Violation|4
3064506|NCT00507455|10529721|P3|Overall Study|Withdrawal by Subject|2
3064507|NCT00507455|10529722|P2|Overall Study|Withdrawal by Subject|1
3064508|NCT00507455|10529723|P1|Overall Study|Withdrawal by Subject|2
3064509|NCT00507455|10529721|P3|Overall Study|Adverse Event|6
3064510|NCT00507455|10529722|P2|Overall Study|Adverse Event|3
3064511|NCT00507455|10529723|P1|Overall Study|Adverse Event|3
3064512|NCT00507442|10529786|P4|Overall Study|Other|2
3064513|NCT00507442|10529787|P3|Overall Study|Other|2
3064514|NCT00507442|10529788|P2|Overall Study|Other|5
3064515|NCT00507442|10529789|P1|Overall Study|Other|2
3064516|NCT00507442|10529786|P4|Overall Study|Withdrawal by Subject|1
3064517|NCT00507442|10529787|P3|Overall Study|Withdrawal by Subject|2
3064518|NCT00507442|10529788|P2|Overall Study|Withdrawal by Subject|4
3064519|NCT00507442|10529789|P1|Overall Study|Withdrawal by Subject|4
3064520|NCT00507442|10529786|P4|Overall Study|Progressive Disease|0
3064521|NCT00507442|10529787|P3|Overall Study|Progressive Disease|2
3064522|NCT00507442|10529788|P2|Overall Study|Progressive Disease|4
3064523|NCT00507442|10529789|P1|Overall Study|Progressive Disease|2
3064524|NCT00507442|10529786|P4|Overall Study|Physician Decision|1
3064525|NCT00507442|10529787|P3|Overall Study|Physician Decision|4
3064526|NCT00507442|10529788|P2|Overall Study|Physician Decision|2
3064527|NCT00507442|10529789|P1|Overall Study|Physician Decision|0
3064528|NCT00507442|10529786|P4|Overall Study|Lost to Follow-up|0
3064529|NCT00507442|10529787|P3|Overall Study|Lost to Follow-up|1
3064530|NCT00507442|10529788|P2|Overall Study|Lost to Follow-up|0
3064531|NCT00507442|10529789|P1|Overall Study|Lost to Follow-up|0
3064532|NCT00507442|10529786|P4|Overall Study|Protocol Violation|0
3064533|NCT00507442|10529787|P3|Overall Study|Protocol Violation|0
3064534|NCT00507442|10529788|P2|Overall Study|Protocol Violation|1
3064535|NCT00507442|10529789|P1|Overall Study|Protocol Violation|0
3064536|NCT00507442|10529786|P4|Overall Study|Adverse Event|1
3064537|NCT00507442|10529787|P3|Overall Study|Adverse Event|4
3064538|NCT00507442|10529788|P2|Overall Study|Adverse Event|11
3064539|NCT00507442|10529789|P1|Overall Study|Adverse Event|8
3064540|NCT00507429|10529841|P2|Maintenance Phase|Progressive Disease|0
3064541|NCT00507429|10529842|P1|Maintenance Phase|Progressive Disease|14
3064542|NCT00507429|10529841|P2|Treatment Phase|Other|3
3064543|NCT00507429|10529842|P1|Treatment Phase|Other|6
3064544|NCT00507429|10529841|P2|Treatment Phase|Physician Decision|2
3064545|NCT00507429|10529842|P1|Treatment Phase|Physician Decision|4
3064546|NCT00507429|10529841|P2|Treatment Phase|Withdrawal by Subject|3
3064547|NCT00507429|10529842|P1|Treatment Phase|Withdrawal by Subject|3
3064548|NCT00507429|10529841|P2|Treatment Phase|Adverse Event|5
3064549|NCT00507429|10529842|P1|Treatment Phase|Adverse Event|12
3064550|NCT00507429|10529841|P2|Treatment Phase|Disease Progression|5
3064551|NCT00507429|10529842|P1|Treatment Phase|Disease Progression|12
3064552|NCT00507416|10529853|P3|Overall Study|Did not Receive Study Treatment|4
3064553|NCT00507416|10529854|P2|Overall Study|Did not Receive Study Treatment|9
3064554|NCT00507416|10529855|P1|Overall Study|Did not Receive Study Treatment|3
3064555|NCT00507416|10529853|P3|Overall Study|Other|13
3064556|NCT00507416|10529854|P2|Overall Study|Other|16
3064557|NCT00507416|10529855|P1|Overall Study|Other|11
3064558|NCT00507416|10529853|P3|Overall Study|Patient declined further treatment|11
3064559|NCT00507416|10529854|P2|Overall Study|Patient declined further treatment|14
3064560|NCT00507416|10529855|P1|Overall Study|Patient declined further treatment|18
3064561|NCT00507416|10529853|P3|Overall Study|Progressive Disease|13
3064562|NCT00507416|10529854|P2|Overall Study|Progressive Disease|10
3064563|NCT00507416|10529855|P1|Overall Study|Progressive Disease|20
3064564|NCT00507416|10529853|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
3064565|NCT00507416|10529854|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
3064566|NCT00507416|10529855|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
3064567|NCT00507416|10529853|P3|Overall Study|Protocol Violation|0
3064568|NCT00507416|10529854|P2|Overall Study|Protocol Violation|2
3064569|NCT00507416|10529855|P1|Overall Study|Protocol Violation|1
3064570|NCT00507416|10529853|P3|Overall Study|Adverse Event|65
3064571|NCT00507416|10529854|P2|Overall Study|Adverse Event|67
3064572|NCT00507416|10529855|P1|Overall Study|Adverse Event|58
3064573|NCT00507130|10529897|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
3064574|NCT00507130|10529898|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
3064575|NCT00507130|10529899|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
3064576|NCT00507130|10529900|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
3064577|NCT00507130|10529897|P4|Overall Study|Lost to Follow-up|1
3064578|NCT00507130|10529898|P3|Overall Study|Lost to Follow-up|1
3064579|NCT00507130|10529899|P2|Overall Study|Lost to Follow-up|0
3064580|NCT00507130|10529900|P1|Overall Study|Lost to Follow-up|0
3064581|NCT00506948|10529942|P1|Overall Study|Physician Decision|1
3064582|NCT00506948|10529942|P1|Overall Study|Adverse Event|5
3064583|NCT00506948|10529942|P1|Overall Study|Death|4
3064584|NCT00506922|10529951|P5|Overall Study|Withdrawal by Subject|1
3064585|NCT00506922|10529952|P4|Overall Study|Withdrawal by Subject|0
3064586|NCT00506922|10529953|P3|Overall Study|Withdrawal by Subject|0
3064587|NCT00506922|10529954|P2|Overall Study|Withdrawal by Subject|0
3064588|NCT00506922|10529955|P1|Overall Study|Withdrawal by Subject|0
3064589|NCT00506922|10529951|P5|Overall Study|Physician Decision|0
3064590|NCT00506922|10529952|P4|Overall Study|Physician Decision|2
3064591|NCT00506922|10529953|P3|Overall Study|Physician Decision|0
3064592|NCT00506922|10529954|P2|Overall Study|Physician Decision|0
3064593|NCT00506922|10529955|P1|Overall Study|Physician Decision|0
3064594|NCT00506883|10529982|P3|Overall Study|Other|1
3064595|NCT00506883|10529983|P2|Overall Study|Other|1
3064596|NCT00506883|10529984|P1|Overall Study|Other|5
3064597|NCT00506883|10529982|P3|Overall Study|Lack of Efficacy|1
3064598|NCT00506883|10529983|P2|Overall Study|Lack of Efficacy|1
3064599|NCT00506883|10529984|P1|Overall Study|Lack of Efficacy|0
3064600|NCT00506883|10529982|P3|Overall Study|Withdrawal by Subject|1
3064601|NCT00506883|10529983|P2|Overall Study|Withdrawal by Subject|0
3064602|NCT00506883|10529984|P1|Overall Study|Withdrawal by Subject|1
3064603|NCT00506883|10529982|P3|Overall Study|Lost to Follow-up|1
3064604|NCT00506883|10529983|P2|Overall Study|Lost to Follow-up|1
3064605|NCT00506883|10529984|P1|Overall Study|Lost to Follow-up|1
3064606|NCT00506831|10529997|P1|Overall Study|Withdrawal by Subject|1
3064607|NCT00506831|10529997|P1|Overall Study|Death|1
3064608|NCT00506753|10530010|P2|Overall Study|Lost to Follow-up|15
3064609|NCT00506753|10530011|P1|Overall Study|Lost to Follow-up|21
3064610|NCT00506662|10530049|P2|Overall Study|Not recorded|6
3064611|NCT00506662|10530050|P1|Overall Study|Not recorded|4
3064612|NCT00506662|10530049|P2|Overall Study|Trial terminated|16
3064613|NCT00506662|10530050|P1|Overall Study|Trial terminated|10
3064614|NCT00506662|10530049|P2|Overall Study|Protocol Violation|4
3064615|NCT00506662|10530050|P1|Overall Study|Protocol Violation|2
3064616|NCT00506662|10530049|P2|Overall Study|Lack of Efficacy|0
3064617|NCT00506662|10530050|P1|Overall Study|Lack of Efficacy|1
3064618|NCT00506662|10530049|P2|Overall Study|Adverse Event|2
3064619|NCT00506662|10530050|P1|Overall Study|Adverse Event|0
3064620|NCT00506493|10530084|P1|Overall Study|Withdrawal by Subject|5
3064621|NCT00506493|10530084|P1|Overall Study|Death|6
3064622|NCT00506454|10530093|P2|Overall Study|Withdrawal by Subject|1
3064623|NCT00506454|10530094|P1|Overall Study|Withdrawal by Subject|1
3064624|NCT00506441|10530100|P2|Period 2; Double-blind Period|Other Reason|1
3064625|NCT00506441|10530101|P1|Period 2; Double-blind Period|Other Reason|1
3064626|NCT00506441|10530100|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
3064627|NCT00506441|10530101|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
3064628|NCT00506441|10530100|P2|Period 2; Double-blind Period|Physician Decision|1
3064629|NCT00506441|10530101|P1|Period 2; Double-blind Period|Physician Decision|1
3064630|NCT00506441|10530100|P2|Period 2; Double-blind Period|Lack of Efficacy|2
3064631|NCT00506441|10530101|P1|Period 2; Double-blind Period|Lack of Efficacy|0
3064632|NCT00506441|10530100|P2|Period 2; Double-blind Period|Adverse Event|1
3064633|NCT00506441|10530101|P1|Period 2; Double-blind Period|Adverse Event|0
3064634|NCT00506441|10530100|P2|Period 1; Open-label Period|Other Reasons|0
3064635|NCT00506441|10530101|P1|Period 1; Open-label Period|Other Reasons|13
3064636|NCT00506441|10530100|P2|Period 1; Open-label Period|Withdrawal by Subject|0
3064637|NCT00506441|10530101|P1|Period 1; Open-label Period|Withdrawal by Subject|13
3064638|NCT00506441|10530100|P2|Period 1; Open-label Period|Protocol Violation|0
3064639|NCT00506441|10530101|P1|Period 1; Open-label Period|Protocol Violation|9
3064640|NCT00506441|10530100|P2|Period 1; Open-label Period|Physician Decision|0
3064641|NCT00506441|10530101|P1|Period 1; Open-label Period|Physician Decision|5
3064642|NCT00506441|10530100|P2|Period 1; Open-label Period|Lost to Follow-up|0
3064643|NCT00506441|10530101|P1|Period 1; Open-label Period|Lost to Follow-up|2
3064644|NCT00506441|10530100|P2|Period 1; Open-label Period|Lack of Efficacy|0
3064645|NCT00506441|10530101|P1|Period 1; Open-label Period|Lack of Efficacy|13
3064646|NCT00506441|10530100|P2|Period 1; Open-label Period|Adverse Event|0
3064647|NCT00506441|10530101|P1|Period 1; Open-label Period|Adverse Event|21
3064648|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
3064649|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
3064650|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
3064651|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
3064652|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
3064653|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064654|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064655|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064656|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
3064657|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064658|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064659|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064660|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
3064661|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064662|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064663|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064664|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
3064665|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064666|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064667|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064668|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
3064669|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
3064670|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
3064671|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
3064672|NCT00506415|10530109|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
3064673|NCT00506415|10530110|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
3064674|NCT00506415|10530111|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
3064675|NCT00506415|10530112|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
3064676|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
3064677|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
3064678|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
3064679|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
3064680|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
3064681|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
3064682|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
3064683|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
3064684|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
3064685|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
3064686|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
3064687|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
3064688|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
3064689|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
3064690|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
3064691|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
3064692|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
3064693|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
3064694|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
3064695|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
3064696|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
3064697|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
3064698|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
3064699|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
3064700|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Death|0
3064701|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Death|3
3064702|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Death|5
3064703|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Death|0
3064704|NCT00506415|10530109|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
3064705|NCT00506415|10530110|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
3064706|NCT00506415|10530111|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
3064707|NCT00506415|10530112|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
3064708|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064709|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064710|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
3064711|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
3064712|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
3064713|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
3064714|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
3064715|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
3064716|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
3064717|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
3064718|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
3064719|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
3064720|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064721|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064722|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
3064723|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
3064724|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064725|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064726|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
3064727|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
3064728|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064729|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064730|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
3064731|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
3064732|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
3064733|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
3064734|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
3064735|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
3064736|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
3064737|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
3064738|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
3064739|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
3064740|NCT00506415|10530109|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
3064741|NCT00506415|10530110|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
3064742|NCT00506415|10530111|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
3064743|NCT00506415|10530112|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
3064744|NCT00506389|10530137|P3|In-treatment Period|Randomized but not treated|1
3064745|NCT00506389|10530138|P2|In-treatment Period|Randomized but not treated|1
3064746|NCT00506389|10530139|P1|In-treatment Period|Randomized but not treated|4
3064747|NCT00506389|10530137|P3|In-treatment Period|Adverse Event|2
3064748|NCT00506389|10530138|P2|In-treatment Period|Adverse Event|5
3064749|NCT00506389|10530139|P1|In-treatment Period|Adverse Event|11
3064750|NCT00506389|10530137|P3|In-treatment Period|Lack of Efficacy|0
3064751|NCT00506389|10530138|P2|In-treatment Period|Lack of Efficacy|2
3064752|NCT00506389|10530139|P1|In-treatment Period|Lack of Efficacy|0
3064753|NCT00506389|10530137|P3|In-treatment Period|Withdrawal by Subject|4
3064754|NCT00506389|10530138|P2|In-treatment Period|Withdrawal by Subject|3
3064755|NCT00506389|10530139|P1|In-treatment Period|Withdrawal by Subject|3
3064756|NCT00506389|10530137|P3|In-treatment Period|Reasons not related to trial|0
3064757|NCT00506389|10530138|P2|In-treatment Period|Reasons not related to trial|1
3064758|NCT00506389|10530139|P1|In-treatment Period|Reasons not related to trial|4
3064759|NCT00506389|10530137|P3|In-treatment Period|Lack of compliance|0
3064760|NCT00506389|10530138|P2|In-treatment Period|Lack of compliance|0
3064761|NCT00506389|10530139|P1|In-treatment Period|Lack of compliance|1
3064762|NCT00506389|10530137|P3|In-treatment Period|Lost to Follow-up|1
3064763|NCT00506389|10530138|P2|In-treatment Period|Lost to Follow-up|0
3064764|NCT00506389|10530139|P1|In-treatment Period|Lost to Follow-up|0
3064765|NCT00506389|10530137|P3|In-treatment Period|Other|4
3064766|NCT00506389|10530138|P2|In-treatment Period|Other|3
3064767|NCT00506389|10530139|P1|In-treatment Period|Other|3
3064768|NCT00506350|10530165|P9|Overall Study|Other|2
3064769|NCT00506350|10530166|P8|Overall Study|Other|2
3064770|NCT00506350|10530167|P7|Overall Study|Other|0
3064771|NCT00506350|10530168|P6|Overall Study|Other|0
3064772|NCT00506350|10530169|P5|Overall Study|Other|3
3064773|NCT00506350|10530170|P4|Overall Study|Other|0
3064774|NCT00506350|10530171|P3|Overall Study|Other|3
3064775|NCT00506350|10530172|P2|Overall Study|Other|1
3064776|NCT00506350|10530173|P1|Overall Study|Other|1
3064777|NCT00506350|10530165|P9|Overall Study|Medical Reason|0
3064778|NCT00506350|10530166|P8|Overall Study|Medical Reason|0
3064779|NCT00506350|10530167|P7|Overall Study|Medical Reason|0
3064780|NCT00506350|10530168|P6|Overall Study|Medical Reason|0
3064781|NCT00506350|10530169|P5|Overall Study|Medical Reason|1
3064782|NCT00506350|10530170|P4|Overall Study|Medical Reason|0
3064783|NCT00506350|10530171|P3|Overall Study|Medical Reason|0
3064784|NCT00506350|10530172|P2|Overall Study|Medical Reason|0
3064785|NCT00506350|10530173|P1|Overall Study|Medical Reason|0
3064786|NCT00506350|10530165|P9|Overall Study|Lost to Follow-up|2
3064787|NCT00506350|10530166|P8|Overall Study|Lost to Follow-up|0
3064788|NCT00506350|10530167|P7|Overall Study|Lost to Follow-up|0
3064789|NCT00506350|10530168|P6|Overall Study|Lost to Follow-up|1
3064790|NCT00506350|10530169|P5|Overall Study|Lost to Follow-up|2
3064791|NCT00506350|10530170|P4|Overall Study|Lost to Follow-up|1
3064792|NCT00506350|10530171|P3|Overall Study|Lost to Follow-up|1
3064793|NCT00506350|10530172|P2|Overall Study|Lost to Follow-up|1
3064794|NCT00506350|10530173|P1|Overall Study|Lost to Follow-up|1
3064795|NCT00506350|10530165|P9|Overall Study|Withdrawal by Subject|0
3064796|NCT00506350|10530166|P8|Overall Study|Withdrawal by Subject|2
3064797|NCT00506350|10530167|P7|Overall Study|Withdrawal by Subject|1
3064798|NCT00506350|10530168|P6|Overall Study|Withdrawal by Subject|1
3064799|NCT00506350|10530169|P5|Overall Study|Withdrawal by Subject|4
3064800|NCT00506350|10530170|P4|Overall Study|Withdrawal by Subject|1
3064801|NCT00506350|10530171|P3|Overall Study|Withdrawal by Subject|1
3064802|NCT00506350|10530172|P2|Overall Study|Withdrawal by Subject|1
3064803|NCT00506350|10530173|P1|Overall Study|Withdrawal by Subject|0
3064804|NCT00506350|10530165|P9|Overall Study|Protocol Violation|0
3064805|NCT00506350|10530166|P8|Overall Study|Protocol Violation|0
3064806|NCT00506350|10530167|P7|Overall Study|Protocol Violation|1
3064807|NCT00506350|10530168|P6|Overall Study|Protocol Violation|0
3064808|NCT00506350|10530169|P5|Overall Study|Protocol Violation|0
3064809|NCT00506350|10530170|P4|Overall Study|Protocol Violation|0
3064810|NCT00506350|10530171|P3|Overall Study|Protocol Violation|1
3064811|NCT00506350|10530172|P2|Overall Study|Protocol Violation|0
3064812|NCT00506350|10530173|P1|Overall Study|Protocol Violation|0
3064813|NCT00506350|10530165|P9|Overall Study|Adverse Event|1
3064814|NCT00506350|10530166|P8|Overall Study|Adverse Event|1
3064815|NCT00506350|10530167|P7|Overall Study|Adverse Event|0
3064816|NCT00506350|10530168|P6|Overall Study|Adverse Event|0
3064817|NCT00506350|10530169|P5|Overall Study|Adverse Event|0
3064818|NCT00506350|10530170|P4|Overall Study|Adverse Event|0
3064819|NCT00506350|10530171|P3|Overall Study|Adverse Event|0
3064820|NCT00506350|10530172|P2|Overall Study|Adverse Event|0
3064821|NCT00506350|10530173|P1|Overall Study|Adverse Event|0
3064822|NCT00506350|10530165|P9|Overall Study|Serious Adverse Event|0
3064823|NCT00506350|10530166|P8|Overall Study|Serious Adverse Event|0
3064824|NCT00506350|10530167|P7|Overall Study|Serious Adverse Event|0
3064825|NCT00506350|10530168|P6|Overall Study|Serious Adverse Event|0
3064826|NCT00506350|10530169|P5|Overall Study|Serious Adverse Event|0
3064827|NCT00506350|10530170|P4|Overall Study|Serious Adverse Event|0
3064828|NCT00506350|10530171|P3|Overall Study|Serious Adverse Event|0
3064829|NCT00506350|10530172|P2|Overall Study|Serious Adverse Event|0
3064830|NCT00506350|10530173|P1|Overall Study|Serious Adverse Event|1
3064831|NCT00506285|10530320|P2|6-month Open Label Phase|Withdrawal by Subject|5
3064832|NCT00506285|10530321|P1|6-month Open Label Phase|Withdrawal by Subject|9
3064833|NCT00506285|10530320|P2|6-month Open Label Phase|Lost to Follow-up|7
3064834|NCT00506285|10530321|P1|6-month Open Label Phase|Lost to Follow-up|1
3064835|NCT00506285|10530320|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
3064836|NCT00506285|10530321|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
3064837|NCT00506285|10530320|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
3064838|NCT00506285|10530321|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
3064839|NCT00506285|10530320|P2|3 Week Screening Phase|Withdrawal by Subject|10
3064840|NCT00506285|10530321|P1|3 Week Screening Phase|Withdrawal by Subject|17
3064841|NCT00506142|10530336|P2|Overall Study|New health condition|0
3064842|NCT00506142|10530337|P1|Overall Study|New health condition|1
3064843|NCT00506142|10530336|P2|Overall Study|Physician Decision|0
3064844|NCT00506142|10530337|P1|Overall Study|Physician Decision|1
3064845|NCT00506142|10530336|P2|Overall Study|Withdrawal by Subject|5
3064846|NCT00506142|10530337|P1|Overall Study|Withdrawal by Subject|4
3064847|NCT00506142|10530336|P2|Overall Study|Lack of Efficacy|7
3064848|NCT00506142|10530337|P1|Overall Study|Lack of Efficacy|21
3064849|NCT00506142|10530336|P2|Overall Study|Adverse Event|7
3064850|NCT00506142|10530337|P1|Overall Study|Adverse Event|8
3064851|NCT00506077|10530345|P2|Treatment Period 2|Withdrawal by Subject|0
3064852|NCT00506077|10530346|P1|Treatment Period 2|Withdrawal by Subject|1
3064853|NCT00506077|10530345|P2|Treatment Period 2|Adverse Event|1
3064854|NCT00506077|10530346|P1|Treatment Period 2|Adverse Event|0
3064855|NCT00506077|10530345|P2|Treatment Period 1|Withdrawal by Subject|0
3064856|NCT00506077|10530346|P1|Treatment Period 1|Withdrawal by Subject|2
3064857|NCT00506077|10530345|P2|Treatment Period 1|Lost to Follow-up|2
3064858|NCT00506077|10530346|P1|Treatment Period 1|Lost to Follow-up|0
3064859|NCT00506077|10530345|P2|Treatment Period 1|Adverse Event|1
3064860|NCT00506077|10530346|P1|Treatment Period 1|Adverse Event|2
3064861|NCT00505934|10530388|P1|Overall Study|Other: IV dose needed to be changed|1
3064862|NCT00505934|10530388|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
3064863|NCT00505934|10530388|P1|Overall Study|Adverse Event|1
3064864|NCT00505921|10530394|P1|Overall Study|Failed to Mobilize|8
3064865|NCT00505921|10530394|P1|Overall Study|Ineligible|1
3064866|NCT00505778|10530411|P2|Overall Study|Took No Study Drug|2
3064867|NCT00505778|10530412|P1|Overall Study|Took No Study Drug|2
3064868|NCT00505778|10530411|P2|Overall Study|Relapse|65
3064869|NCT00505778|10530412|P1|Overall Study|Relapse|65
3064870|NCT00505778|10530411|P2|Overall Study|Withdrawal by Subject|14
3064871|NCT00505778|10530412|P1|Overall Study|Withdrawal by Subject|29
3064872|NCT00505778|10530411|P2|Overall Study|Protocol Violation|9
3064873|NCT00505778|10530412|P1|Overall Study|Protocol Violation|7
3064874|NCT00505778|10530411|P2|Overall Study|Unable to Meet Protocol Criteria|1
3064875|NCT00505778|10530412|P1|Overall Study|Unable to Meet Protocol Criteria|4
3064876|NCT00505778|10530411|P2|Overall Study|Lost to Follow-up|23
3064877|NCT00505778|10530412|P1|Overall Study|Lost to Follow-up|17
3064878|NCT00505778|10530411|P2|Overall Study|Physician Decision|14
3064879|NCT00505778|10530412|P1|Overall Study|Physician Decision|8
3064880|NCT00505778|10530411|P2|Overall Study|Adverse Event|7
3064881|NCT00505778|10530412|P1|Overall Study|Adverse Event|2
3064882|NCT00505765|10530431|P3|Overall Study|Noncompliance|3
3064883|NCT00505765|10530432|P2|Overall Study|Noncompliance|1
3064884|NCT00505765|10530433|P1|Overall Study|Noncompliance|0
3064885|NCT00505765|10530431|P3|Overall Study|Adverse Event|0
3064886|NCT00505765|10530432|P2|Overall Study|Adverse Event|2
3064887|NCT00505765|10530433|P1|Overall Study|Adverse Event|1
3064888|NCT00505765|10530431|P3|Overall Study|Withdrawal by Subject|0
3064889|NCT00505765|10530432|P2|Overall Study|Withdrawal by Subject|0
3064890|NCT00505765|10530433|P1|Overall Study|Withdrawal by Subject|1
3064891|NCT00505752|10530460|P4|Overall Study|Other|2
3064892|NCT00505752|10530461|P3|Overall Study|Other|1
3064893|NCT00505752|10530462|P2|Overall Study|Other|2
3064894|NCT00505752|10530463|P1|Overall Study|Other|1
3064895|NCT00505752|10530460|P4|Overall Study|All embryos/blastocysts discarded|1
3064896|NCT00505752|10530461|P3|Overall Study|All embryos/blastocysts discarded|1
3064897|NCT00505752|10530462|P2|Overall Study|All embryos/blastocysts discarded|0
3064898|NCT00505752|10530463|P1|Overall Study|All embryos/blastocysts discarded|0
3064899|NCT00505752|10530460|P4|Overall Study|No Fertilization|1
3064900|NCT00505752|10530461|P3|Overall Study|No Fertilization|2
3064901|NCT00505752|10530462|P2|Overall Study|No Fertilization|1
3064902|NCT00505752|10530463|P1|Overall Study|No Fertilization|1
3064903|NCT00505752|10530460|P4|Overall Study|No oocytes retrieved|1
3064904|NCT00505752|10530461|P3|Overall Study|No oocytes retrieved|0
3064905|NCT00505752|10530462|P2|Overall Study|No oocytes retrieved|2
3064906|NCT00505752|10530463|P1|Overall Study|No oocytes retrieved|0
3064907|NCT00505752|10530460|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
3064908|NCT00505752|10530461|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
3064909|NCT00505752|10530462|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
3064910|NCT00505752|10530463|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
3064911|NCT00505752|10530460|P4|Overall Study|Lack of ovarian response|0
3064912|NCT00505752|10530461|P3|Overall Study|Lack of ovarian response|0
3064913|NCT00505752|10530462|P2|Overall Study|Lack of ovarian response|3
3064914|NCT00505752|10530463|P1|Overall Study|Lack of ovarian response|1
3064915|NCT00505752|10530460|P4|Overall Study|Lost to Follow-up|0
3064916|NCT00505752|10530461|P3|Overall Study|Lost to Follow-up|0
3064917|NCT00505752|10530462|P2|Overall Study|Lost to Follow-up|0
3064918|NCT00505752|10530463|P1|Overall Study|Lost to Follow-up|1
3064919|NCT00505752|10530460|P4|Overall Study|Adverse Event|0
3064920|NCT00505752|10530461|P3|Overall Study|Adverse Event|1
3064921|NCT00505752|10530462|P2|Overall Study|Adverse Event|0
3064922|NCT00505752|10530463|P1|Overall Study|Adverse Event|1
3064923|NCT00505687|10530477|P1|Overall Study|Other: As Per Sponsor|8
3064924|NCT00505687|10530477|P1|Overall Study|Other: Disease Progression|1
3064925|NCT00505687|10530477|P1|Overall Study|Other: Neupro Given In Hospital|1
3064926|NCT00505687|10530477|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
3064927|NCT00505687|10530477|P1|Overall Study|Other: Prolonged Hospitalization|1
3064928|NCT00505687|10530477|P1|Overall Study|Other: Scheduled DBS Surgery|1
3064929|NCT00505687|10530477|P1|Overall Study|Other: Underwent Implantation Of DBS|1
3064930|NCT00505687|10530477|P1|Overall Study|Lost to Follow-up|1
3064931|NCT00505687|10530477|P1|Overall Study|Subject withdrew consent|15
3064932|NCT00505687|10530477|P1|Overall Study|Adverse Event|48
3064933|NCT00505687|10530477|P1|Overall Study|Lack of Efficacy|15
3064934|NCT00505687|10530477|P1|Overall Study|Important protocol violation|2
3064935|NCT00505661|10530483|P1|Overall Study|Not Eligible|4
3064936|NCT00505622|10530494|P3|Overall Study|Study termination by sponsor|90
3064937|NCT00505622|10530495|P2|Overall Study|Study termination by sponsor|98
3064938|NCT00505622|10530496|P1|Overall Study|Study termination by sponsor|115
3064939|NCT00505622|10530494|P3|Overall Study|Withdrawal by Subject|2
3064940|NCT00505622|10530495|P2|Overall Study|Withdrawal by Subject|3
3064941|NCT00505622|10530496|P1|Overall Study|Withdrawal by Subject|0
3064942|NCT00505622|10530494|P3|Overall Study|Protocol Violation|0
3064943|NCT00505622|10530495|P2|Overall Study|Protocol Violation|1
3064944|NCT00505622|10530496|P1|Overall Study|Protocol Violation|1
3064945|NCT00505622|10530494|P3|Overall Study|Adverse Event|4
3064946|NCT00505622|10530495|P2|Overall Study|Adverse Event|6
3064947|NCT00505622|10530496|P1|Overall Study|Adverse Event|5
3064948|NCT00505414|10530521|P5|Maintenance Phase|underlying disease and therapy required|0
3064949|NCT00505414|10530522|P4|Maintenance Phase|underlying disease and therapy required|0
3064950|NCT00505414|10530523|P3|Maintenance Phase|underlying disease and therapy required|2
3064951|NCT00505414|10530524|P2|Maintenance Phase|underlying disease and therapy required|2
3064952|NCT00505414|10530525|P1|Maintenance Phase|underlying disease and therapy required|0
3064953|NCT00505414|10530521|P5|Maintenance Phase|Withdrawal by Subject|0
3064954|NCT00505414|10530522|P4|Maintenance Phase|Withdrawal by Subject|0
3064955|NCT00505414|10530523|P3|Maintenance Phase|Withdrawal by Subject|1
3064956|NCT00505414|10530524|P2|Maintenance Phase|Withdrawal by Subject|0
3064957|NCT00505414|10530525|P1|Maintenance Phase|Withdrawal by Subject|0
3064958|NCT00505414|10530521|P5|Maintenance Phase|Lack of Efficacy|0
3064959|NCT00505414|10530522|P4|Maintenance Phase|Lack of Efficacy|0
3064960|NCT00505414|10530523|P3|Maintenance Phase|Lack of Efficacy|1
3064961|NCT00505414|10530524|P2|Maintenance Phase|Lack of Efficacy|1
3064962|NCT00505414|10530525|P1|Maintenance Phase|Lack of Efficacy|2
3064963|NCT00505414|10530521|P5|Maintenance Phase|Death|0
3064964|NCT00505414|10530522|P4|Maintenance Phase|Death|0
3064965|NCT00505414|10530523|P3|Maintenance Phase|Death|1
3064966|NCT00505414|10530524|P2|Maintenance Phase|Death|0
3064967|NCT00505414|10530525|P1|Maintenance Phase|Death|2
3064968|NCT00505414|10530521|P5|Maintenance Phase|Adverse Event|0
3064969|NCT00505414|10530522|P4|Maintenance Phase|Adverse Event|0
3064970|NCT00505414|10530523|P3|Maintenance Phase|Adverse Event|3
3064971|NCT00505414|10530524|P2|Maintenance Phase|Adverse Event|2
3064972|NCT00505414|10530525|P1|Maintenance Phase|Adverse Event|2
3064973|NCT00505414|10530521|P5|Titration Phase|Underlying disease and therapy required|3
3064974|NCT00505414|10530522|P4|Titration Phase|Underlying disease and therapy required|7
3064975|NCT00505414|10530523|P3|Titration Phase|Underlying disease and therapy required|0
3064976|NCT00505414|10530524|P2|Titration Phase|Underlying disease and therapy required|0
3064977|NCT00505414|10530525|P1|Titration Phase|Underlying disease and therapy required|0
3064978|NCT00505414|10530521|P5|Titration Phase|Withdrawal by Subject|4
3064979|NCT00505414|10530522|P4|Titration Phase|Withdrawal by Subject|3
3064980|NCT00505414|10530523|P3|Titration Phase|Withdrawal by Subject|0
3064981|NCT00505414|10530524|P2|Titration Phase|Withdrawal by Subject|0
3064982|NCT00505414|10530525|P1|Titration Phase|Withdrawal by Subject|0
3064983|NCT00505414|10530521|P5|Titration Phase|Protocol Violation|1
3064984|NCT00505414|10530522|P4|Titration Phase|Protocol Violation|0
3064985|NCT00505414|10530523|P3|Titration Phase|Protocol Violation|0
3064986|NCT00505414|10530524|P2|Titration Phase|Protocol Violation|0
3064987|NCT00505414|10530525|P1|Titration Phase|Protocol Violation|0
3064988|NCT00505414|10530521|P5|Titration Phase|Lack of Efficacy|1
3064989|NCT00505414|10530522|P4|Titration Phase|Lack of Efficacy|10
3064990|NCT00505414|10530523|P3|Titration Phase|Lack of Efficacy|0
3064991|NCT00505414|10530524|P2|Titration Phase|Lack of Efficacy|0
3064992|NCT00505414|10530525|P1|Titration Phase|Lack of Efficacy|0
3064993|NCT00505414|10530521|P5|Titration Phase|Death|0
3064994|NCT00505414|10530522|P4|Titration Phase|Death|2
3064995|NCT00505414|10530523|P3|Titration Phase|Death|0
3064996|NCT00505414|10530524|P2|Titration Phase|Death|0
3064997|NCT00505414|10530525|P1|Titration Phase|Death|0
3064998|NCT00505414|10530521|P5|Titration Phase|Adverse Event|3
3064999|NCT00505414|10530522|P4|Titration Phase|Adverse Event|8
3065000|NCT00505414|10530523|P3|Titration Phase|Adverse Event|0
3065001|NCT00505414|10530524|P2|Titration Phase|Adverse Event|0
3065002|NCT00505414|10530525|P1|Titration Phase|Adverse Event|0
3065003|NCT00505375|10530542|P2|Overall Study|Travel issues|1
3065004|NCT00505375|10530543|P1|Overall Study|Travel issues|0
3065005|NCT00505375|10530542|P2|Overall Study|Pregnancy|0
3065006|NCT00505375|10530543|P1|Overall Study|Pregnancy|1
3065007|NCT00505375|10530542|P2|Overall Study|Lost to Follow-up|2
3065008|NCT00505375|10530543|P1|Overall Study|Lost to Follow-up|0
3065009|NCT00505375|10530542|P2|Overall Study|Withdrawal by Subject|2
3065010|NCT00505375|10530543|P1|Overall Study|Withdrawal by Subject|2
3065011|NCT00505375|10530542|P2|Overall Study|Death|0
3065012|NCT00505375|10530543|P1|Overall Study|Death|1
3065013|NCT00505284|10530565|P5|Overall Study|Other|4
3065014|NCT00505284|10530566|P4|Overall Study|Other|4
3065015|NCT00505284|10530567|P3|Overall Study|Other|0
3065016|NCT00505284|10530568|P2|Overall Study|Other|0
3065017|NCT00505284|10530569|P1|Overall Study|Other|5
3065018|NCT00505284|10530565|P5|Overall Study|Physician Decision|0
3065019|NCT00505284|10530566|P4|Overall Study|Physician Decision|0
3065020|NCT00505284|10530567|P3|Overall Study|Physician Decision|0
3065021|NCT00505284|10530568|P2|Overall Study|Physician Decision|1
3065022|NCT00505284|10530569|P1|Overall Study|Physician Decision|0
3065023|NCT00505284|10530565|P5|Overall Study|Lack of Efficacy|1
3065024|NCT00505284|10530566|P4|Overall Study|Lack of Efficacy|1
3065025|NCT00505284|10530567|P3|Overall Study|Lack of Efficacy|1
3065026|NCT00505284|10530568|P2|Overall Study|Lack of Efficacy|1
3065027|NCT00505284|10530569|P1|Overall Study|Lack of Efficacy|0
3065028|NCT00505284|10530565|P5|Overall Study|Withdrawal by Subject|6
3065029|NCT00505284|10530566|P4|Overall Study|Withdrawal by Subject|0
3065030|NCT00505284|10530567|P3|Overall Study|Withdrawal by Subject|1
3065031|NCT00505284|10530568|P2|Overall Study|Withdrawal by Subject|6
3065032|NCT00505284|10530569|P1|Overall Study|Withdrawal by Subject|2
3065033|NCT00505284|10530565|P5|Overall Study|Protocol Violation|0
3065034|NCT00505284|10530566|P4|Overall Study|Protocol Violation|0
3065035|NCT00505284|10530567|P3|Overall Study|Protocol Violation|1
3065036|NCT00505284|10530568|P2|Overall Study|Protocol Violation|1
3065037|NCT00505284|10530569|P1|Overall Study|Protocol Violation|0
3065038|NCT00505284|10530565|P5|Overall Study|Adverse Event|22
3065039|NCT00505284|10530566|P4|Overall Study|Adverse Event|14
3065040|NCT00505284|10530567|P3|Overall Study|Adverse Event|9
3065041|NCT00505284|10530568|P2|Overall Study|Adverse Event|7
3065042|NCT00505284|10530569|P1|Overall Study|Adverse Event|3
3065043|NCT00505076|10530639|P3|Overall Study|Withdrawal by Subject|2
3065044|NCT00505076|10530640|P2|Overall Study|Withdrawal by Subject|1
3065045|NCT00505076|10530641|P1|Overall Study|Withdrawal by Subject|0
3065046|NCT00505076|10530639|P3|Overall Study|Protocol Violation|2
3065047|NCT00505076|10530640|P2|Overall Study|Protocol Violation|1
3065048|NCT00505076|10530641|P1|Overall Study|Protocol Violation|2
3065049|NCT00505076|10530639|P3|Overall Study|Adverse Event|1
3065050|NCT00505076|10530640|P2|Overall Study|Adverse Event|0
3065051|NCT00505076|10530641|P1|Overall Study|Adverse Event|1
3065052|NCT00504881|10530670|P2|Overall Study|AE of unknown type|0
3065053|NCT00504881|10530671|P1|Overall Study|AE of unknown type|1
3065054|NCT00504881|10530670|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
3065055|NCT00504881|10530671|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
3065056|NCT00504881|10530670|P2|Overall Study|AE, non-serious non-fatal|14
3065057|NCT00504881|10530671|P1|Overall Study|AE, non-serious non-fatal|4
3065058|NCT00504881|10530670|P2|Overall Study|SAE, non-fatal|6
3065059|NCT00504881|10530671|P1|Overall Study|SAE, non-fatal|2
3065060|NCT00504881|10530670|P2|Overall Study|AE, serious fatal|1
3065061|NCT00504881|10530671|P1|Overall Study|AE, serious fatal|0
3065062|NCT00504881|10530670|P2|Overall Study|Safety Visit not performed|1
3065063|NCT00504881|10530671|P1|Overall Study|Safety Visit not performed|0
3065064|NCT00504881|10530670|P2|Overall Study|No Birth Control|1
3065065|NCT00504881|10530671|P1|Overall Study|No Birth Control|0
3065066|NCT00504881|10530670|P2|Overall Study|Non-Compliance|0
3065067|NCT00504881|10530671|P1|Overall Study|Non-Compliance|1
3065068|NCT00504881|10530670|P2|Overall Study|Withdrawal by Subject|4
3065069|NCT00504881|10530671|P1|Overall Study|Withdrawal by Subject|1
3065070|NCT00504881|10530670|P2|Overall Study|Lost to Follow-up|2
3065071|NCT00504881|10530671|P1|Overall Study|Lost to Follow-up|0
3065072|NCT00504881|10530670|P2|Overall Study|Lack of Efficacy|5
3065073|NCT00504881|10530671|P1|Overall Study|Lack of Efficacy|1
3065074|NCT00504829|10530724|P3|Overall Study|Protocol Violation|10
3065075|NCT00504829|10530725|P2|Overall Study|Protocol Violation|4
3065076|NCT00504829|10530726|P1|Overall Study|Protocol Violation|6
3065077|NCT00504777|10530735|P1|Overall Study|Adverse Event|1
3065078|NCT00504725|10530748|P2|Overall Study|Protocol Violation|0
3065079|NCT00504725|10530749|P1|Overall Study|Protocol Violation|1
3065080|NCT00504595|10530772|P4|Overall Study|Other|0
3065081|NCT00504595|10530773|P3|Overall Study|Other|2
3065082|NCT00504595|10530774|P2|Overall Study|Other|0
3065083|NCT00504595|10530775|P1|Overall Study|Other|0
3065084|NCT00504595|10530772|P4|Overall Study|Lack of Efficacy|0
3065085|NCT00504595|10530773|P3|Overall Study|Lack of Efficacy|0
3065086|NCT00504595|10530774|P2|Overall Study|Lack of Efficacy|0
3065087|NCT00504595|10530775|P1|Overall Study|Lack of Efficacy|1
3065088|NCT00504556|10530792|P5|Overall Study|not in safety analysis set|1
3065089|NCT00504556|10530793|P4|Overall Study|not in safety analysis set|0
3065090|NCT00504556|10530794|P3|Overall Study|not in safety analysis set|1
3065091|NCT00504556|10530795|P2|Overall Study|not in safety analysis set|1
3065092|NCT00504556|10530796|P1|Overall Study|not in safety analysis set|0
3065093|NCT00504556|10530792|P5|Overall Study|Other|0
3065094|NCT00504556|10530793|P4|Overall Study|Other|3
3065095|NCT00504556|10530794|P3|Overall Study|Other|2
3065096|NCT00504556|10530795|P2|Overall Study|Other|2
3065097|NCT00504556|10530796|P1|Overall Study|Other|2
3065098|NCT00504556|10530792|P5|Overall Study|data monitor committee decision|0
3065099|NCT00504556|10530793|P4|Overall Study|data monitor committee decision|100
3065100|NCT00504556|10530794|P3|Overall Study|data monitor committee decision|0
3065101|NCT00504556|10530795|P2|Overall Study|data monitor committee decision|0
3065102|NCT00504556|10530796|P1|Overall Study|data monitor committee decision|0
3065103|NCT00504556|10530792|P5|Overall Study|did not meet entry criteria|0
3065104|NCT00504556|10530793|P4|Overall Study|did not meet entry criteria|1
3065105|NCT00504556|10530794|P3|Overall Study|did not meet entry criteria|1
3065106|NCT00504556|10530795|P2|Overall Study|did not meet entry criteria|0
3065107|NCT00504556|10530796|P1|Overall Study|did not meet entry criteria|2
3065108|NCT00504556|10530792|P5|Overall Study|administrative reasons|2
3065109|NCT00504556|10530793|P4|Overall Study|administrative reasons|1
3065110|NCT00504556|10530794|P3|Overall Study|administrative reasons|2
3065111|NCT00504556|10530795|P2|Overall Study|administrative reasons|2
3065112|NCT00504556|10530796|P1|Overall Study|administrative reasons|0
3065113|NCT00504556|10530792|P5|Overall Study|Withdrawal by Subject|12
3065114|NCT00504556|10530793|P4|Overall Study|Withdrawal by Subject|8
3065115|NCT00504556|10530794|P3|Overall Study|Withdrawal by Subject|7
3065116|NCT00504556|10530795|P2|Overall Study|Withdrawal by Subject|16
3065117|NCT00504556|10530796|P1|Overall Study|Withdrawal by Subject|16
3065118|NCT00504556|10530792|P5|Overall Study|Lost to Follow-up|1
3065119|NCT00504556|10530793|P4|Overall Study|Lost to Follow-up|1
3065120|NCT00504556|10530794|P3|Overall Study|Lost to Follow-up|1
3065121|NCT00504556|10530795|P2|Overall Study|Lost to Follow-up|0
3065122|NCT00504556|10530796|P1|Overall Study|Lost to Follow-up|0
3065123|NCT00504556|10530792|P5|Overall Study|Protocol Violation|2
3065124|NCT00504556|10530793|P4|Overall Study|Protocol Violation|1
3065125|NCT00504556|10530794|P3|Overall Study|Protocol Violation|2
3065126|NCT00504556|10530795|P2|Overall Study|Protocol Violation|3
3065127|NCT00504556|10530796|P1|Overall Study|Protocol Violation|1
3065128|NCT00504556|10530792|P5|Overall Study|Death|2
3065129|NCT00504556|10530793|P4|Overall Study|Death|0
3065130|NCT00504556|10530794|P3|Overall Study|Death|1
3065131|NCT00504556|10530795|P2|Overall Study|Death|3
3065132|NCT00504556|10530796|P1|Overall Study|Death|3
3065133|NCT00504556|10530792|P5|Overall Study|Adverse Event|5
3065134|NCT00504556|10530793|P4|Overall Study|Adverse Event|13
3065135|NCT00504556|10530794|P3|Overall Study|Adverse Event|14
3065136|NCT00504556|10530795|P2|Overall Study|Adverse Event|11
3065137|NCT00504556|10530796|P1|Overall Study|Adverse Event|11
3065138|NCT00504426|10530864|P4|Overall Study|Withdrawal by Subject|0
3065139|NCT00504426|10530865|P3|Overall Study|Withdrawal by Subject|0
3065140|NCT00504426|10530866|P2|Overall Study|Withdrawal by Subject|0
3065141|NCT00504426|10530867|P1|Overall Study|Withdrawal by Subject|2
3065142|NCT00504426|10530864|P4|Overall Study|Protocol Violation|0
3065143|NCT00504426|10530865|P3|Overall Study|Protocol Violation|2
3065144|NCT00504426|10530866|P2|Overall Study|Protocol Violation|1
3065145|NCT00504426|10530867|P1|Overall Study|Protocol Violation|1
3065146|NCT00504426|10530864|P4|Overall Study|Adverse Event|0
3065147|NCT00504426|10530865|P3|Overall Study|Adverse Event|2
3065148|NCT00504426|10530866|P2|Overall Study|Adverse Event|0
3065149|NCT00504426|10530867|P1|Overall Study|Adverse Event|0
3065150|NCT00504348|10530881|P1|Overall Study|Physician Decision|1
3065151|NCT00504348|10530881|P1|Overall Study|Lack of Efficacy|4
3065152|NCT00504348|10530881|P1|Overall Study|Adverse Event|3
3065153|NCT00504309|10530892|P6|Overall Study|Withdrawal by Subject|0
3065154|NCT00504309|10530893|P5|Overall Study|Withdrawal by Subject|0
3065155|NCT00504309|10530894|P4|Overall Study|Withdrawal by Subject|0
3065156|NCT00504309|10530895|P3|Overall Study|Withdrawal by Subject|1
3065157|NCT00504309|10530896|P2|Overall Study|Withdrawal by Subject|0
3065158|NCT00504309|10530897|P1|Overall Study|Withdrawal by Subject|0
3065159|NCT00504309|10530892|P6|Overall Study|Death|0
3065160|NCT00504309|10530893|P5|Overall Study|Death|1
3065161|NCT00504309|10530894|P4|Overall Study|Death|0
3065162|NCT00504309|10530895|P3|Overall Study|Death|0
3065163|NCT00504309|10530896|P2|Overall Study|Death|0
3065164|NCT00504309|10530897|P1|Overall Study|Death|0
3065165|NCT00504257|10530935|P1|Overall Study|ineligible histology|2
3065166|NCT00504257|10530935|P1|Overall Study|Withdrawal by Subject|2
3065167|NCT00504231|10530947|P4|Overall Study|Discrepant chart documentation re route|0
3065168|NCT00504231|10530948|P3|Overall Study|Discrepant chart documentation re route|1
3065169|NCT00504231|10530949|P2|Overall Study|Discrepant chart documentation re route|0
3065170|NCT00504231|10530950|P1|Overall Study|Discrepant chart documentation re route|0
3065171|NCT00504166|10530970|P2|Overall Study|Lost to Follow-up|3
3065172|NCT00504166|10530971|P1|Overall Study|Lost to Follow-up|1
3065173|NCT00504166|10530970|P2|Overall Study|Physician Decision|1
3065174|NCT00504166|10530971|P1|Overall Study|Physician Decision|1
3065175|NCT00504166|10530970|P2|Overall Study|Withdrawal by Subject|6
3065176|NCT00504166|10530971|P1|Overall Study|Withdrawal by Subject|3
3065177|NCT00504166|10530970|P2|Overall Study|Adverse Event|4
3065178|NCT00504166|10530971|P1|Overall Study|Adverse Event|1
3065179|NCT00504153|10530977|P1|Overall Study|Death|1
3065180|NCT00504153|10530977|P1|Overall Study|Adverse Event|4
3065181|NCT00504153|10530977|P1|Overall Study|Withdrawal by Subject|1
3065182|NCT00504075|10530985|P1|Overall Study|Required other therapeutic intervention|1
3065183|NCT00504075|10530985|P1|Overall Study|Withdrawal by Subject|1
3065184|NCT00504075|10530985|P1|Overall Study|Lost to Follow-up|5
3065185|NCT00504075|10530985|P1|Overall Study|Adverse Event|1
3065186|NCT00503997|10530995|P1|Overall Study|Withdrawal by Subject|1
3065187|NCT00503997|10530995|P1|Overall Study|Death|1
3065188|NCT00503997|10530995|P1|Overall Study|Adverse Event|5
3065189|NCT00503997|10530995|P1|Overall Study|disease progression|1
3065190|NCT00503984|10531001|P6|Overall Study|Death|0
3065191|NCT00503984|10531002|P5|Overall Study|Death|1
3065192|NCT00503984|10531003|P4|Overall Study|Death|0
3065193|NCT00503984|10531004|P3|Overall Study|Death|0
3065194|NCT00503984|10531005|P2|Overall Study|Death|0
3065195|NCT00503984|10531006|P1|Overall Study|Death|0
3065196|NCT00503984|10531001|P6|Overall Study|Adverse Event|0
3065197|NCT00503984|10531002|P5|Overall Study|Adverse Event|0
3065198|NCT00503984|10531003|P4|Overall Study|Adverse Event|0
3065199|NCT00503984|10531004|P3|Overall Study|Adverse Event|0
3065200|NCT00503984|10531005|P2|Overall Study|Adverse Event|1
3065201|NCT00503984|10531006|P1|Overall Study|Adverse Event|0
3065202|NCT00503984|10531001|P6|Overall Study|Protocol Violation|0
3065203|NCT00503984|10531002|P5|Overall Study|Protocol Violation|0
3065204|NCT00503984|10531003|P4|Overall Study|Protocol Violation|0
3065205|NCT00503984|10531004|P3|Overall Study|Protocol Violation|0
3065206|NCT00503984|10531005|P2|Overall Study|Protocol Violation|1
3065207|NCT00503984|10531006|P1|Overall Study|Protocol Violation|0
3065208|NCT00503906|10531032|P1|Overall Study|Withdrawal by Subject|1
3065209|NCT00503841|10531054|P1|Overall Study|All screen failures|44
3065210|NCT00503776|10531065|P4|Overall Study|Physician Decision|1
3065211|NCT00503776|10531066|P3|Overall Study|Physician Decision|1
3065212|NCT00503776|10531067|P2|Overall Study|Physician Decision|0
3065213|NCT00503776|10531068|P1|Overall Study|Physician Decision|0
3065214|NCT00503776|10531065|P4|Overall Study|Withdrawal by Subject|1
3065215|NCT00503776|10531066|P3|Overall Study|Withdrawal by Subject|1
3065216|NCT00503776|10531067|P2|Overall Study|Withdrawal by Subject|0
3065217|NCT00503776|10531068|P1|Overall Study|Withdrawal by Subject|1
3065218|NCT00503698|10531101|P2|Overall Study|Not exposed to trial drug|6
3065219|NCT00503698|10531102|P1|Overall Study|Not exposed to trial drug|11
3065220|NCT00503698|10531101|P2|Overall Study|Unclassified|32
3065221|NCT00503698|10531102|P1|Overall Study|Unclassified|48
3065222|NCT00503698|10531101|P2|Overall Study|Critically ill|0
3065223|NCT00503698|10531102|P1|Overall Study|Critically ill|2
3065224|NCT00503698|10531101|P2|Overall Study|Move to nonparticipating dialysis center|1
3065225|NCT00503698|10531102|P1|Overall Study|Move to nonparticipating dialysis center|2
3065226|NCT00503698|10531101|P2|Overall Study|Switch to peritoneal or home dialysis|2
3065227|NCT00503698|10531102|P1|Overall Study|Switch to peritoneal or home dialysis|2
3065228|NCT00503698|10531101|P2|Overall Study|Any condition in exclusion criteria|6
3065229|NCT00503698|10531102|P1|Overall Study|Any condition in exclusion criteria|4
3065230|NCT00503698|10531101|P2|Overall Study|Pregnancy/intention to become pregnant|0
3065231|NCT00503698|10531102|P1|Overall Study|Pregnancy/intention to become pregnant|1
3065232|NCT00503698|10531101|P2|Overall Study|End hemodialysis due to renal transplant|4
3065233|NCT00503698|10531102|P1|Overall Study|End hemodialysis due to renal transplant|10
3065234|NCT00503698|10531101|P2|Overall Study|Trial terminated|253
3065235|NCT00503698|10531102|P1|Overall Study|Trial terminated|216
3065236|NCT00503698|10531101|P2|Overall Study|Lack of Efficacy|4
3065237|NCT00503698|10531102|P1|Overall Study|Lack of Efficacy|3
3065238|NCT00503698|10531101|P2|Overall Study|Death|0
3065239|NCT00503698|10531102|P1|Overall Study|Death|1
3065240|NCT00503698|10531101|P2|Overall Study|Adverse Event|41
3065241|NCT00503698|10531102|P1|Overall Study|Adverse Event|52
3065242|NCT00503698|10531101|P2|Overall Study|Protocol Violation|6
3065243|NCT00503698|10531102|P1|Overall Study|Protocol Violation|5
3065244|NCT00503685|10531119|P3|Overall Study|Eligibility Criteria Not Met|0
3065245|NCT00503685|10531120|P2|Overall Study|Eligibility Criteria Not Met|1
3065246|NCT00503685|10531121|P1|Overall Study|Eligibility Criteria Not Met|0
3065247|NCT00503685|10531119|P3|Overall Study|Protocol Violation|0
3065248|NCT00503685|10531120|P2|Overall Study|Protocol Violation|1
3065249|NCT00503685|10531121|P1|Overall Study|Protocol Violation|0
3065250|NCT00503685|10531119|P3|Overall Study|Withdrawal by Subject|0
3065251|NCT00503685|10531120|P2|Overall Study|Withdrawal by Subject|1
3065252|NCT00503685|10531121|P1|Overall Study|Withdrawal by Subject|0
3065253|NCT00503685|10531119|P3|Overall Study|Adverse Event|2
3065254|NCT00503685|10531120|P2|Overall Study|Adverse Event|0
3065255|NCT00503685|10531121|P1|Overall Study|Adverse Event|0
3065256|NCT00503425|10531163|P1|Overall Study|Missing Data/Unknown|4
3065257|NCT00503425|10531163|P1|Overall Study|Death|3
3065258|NCT00503425|10531163|P1|Overall Study|Lost to Follow-up|3
3065259|NCT00503425|10531163|P1|Overall Study|Withdrawal by Subject|8
3065260|NCT00503425|10531163|P1|Overall Study|Lack of Efficacy|25
3065261|NCT00503425|10531163|P1|Overall Study|Adverse Event|5
3065262|NCT00503425|10531163|P1|Overall Study|Participant files lost|6
3065263|NCT00503399|10531173|P2|Overall Study|Lost to Follow-up|2
3065264|NCT00503399|10531174|P1|Overall Study|Lost to Follow-up|0
3065265|NCT00503399|10531173|P2|Overall Study|Adverse Event|3
3065266|NCT00503399|10531174|P1|Overall Study|Adverse Event|0
3065267|NCT00503399|10531173|P2|Overall Study|Withdrawal by Subject|2
3065268|NCT00503399|10531174|P1|Overall Study|Withdrawal by Subject|4
3065269|NCT00503399|10531173|P2|Overall Study|Protocol Violation|0
3065270|NCT00503399|10531174|P1|Overall Study|Protocol Violation|1
3065271|NCT00503399|10531173|P2|Overall Study|Death|1
3065272|NCT00503399|10531174|P1|Overall Study|Death|2
3065273|NCT00503308|10531198|P2|Overall Study|Protocol Violation|1
3065274|NCT00503308|10531199|P1|Overall Study|Protocol Violation|2
3065275|NCT00503139|10531205|P1|Overall Study|Protocol Violation|4
3065276|NCT00503139|10531205|P1|Overall Study|Case Report Forms were not collected|4
3065277|NCT00503009|10531253|P3|Overall Study|Physician Decision|1
3065278|NCT00503009|10531254|P2|Overall Study|Physician Decision|1
3065279|NCT00503009|10531255|P1|Overall Study|Physician Decision|0
3065280|NCT00503009|10531253|P3|Overall Study|Withdrawal by Subject|1
3065281|NCT00503009|10531254|P2|Overall Study|Withdrawal by Subject|1
3065282|NCT00503009|10531255|P1|Overall Study|Withdrawal by Subject|0
3065283|NCT00503009|10531253|P3|Overall Study|Protocol Violation|1
3065284|NCT00503009|10531254|P2|Overall Study|Protocol Violation|0
3065285|NCT00503009|10531255|P1|Overall Study|Protocol Violation|1
3065286|NCT00502996|10531272|P1|Overall Study|Adverse Event|2
3065287|NCT00502996|10531272|P1|Overall Study|Withdrawal Informed Consent|6
3065288|NCT00502996|10531272|P1|Overall Study|Treatment failure|25
3065289|NCT00502996|10531272|P1|Overall Study|Protocol Violation|2
3065290|NCT00502996|10531272|P1|Overall Study|Lost to Follow-up|9
3065291|NCT00502840|10531340|P1|Overall Study|Other|20
3065292|NCT00502840|10531340|P1|Overall Study|Administrative problems|1
3065293|NCT00502840|10531340|P1|Overall Study|Lost to Follow-up|6
3065294|NCT00502840|10531340|P1|Overall Study|Withdrawal by Subject|5
3065295|NCT00502840|10531340|P1|Overall Study|Protocol Violation|4
3065296|NCT00502840|10531340|P1|Overall Study|Lack of Efficacy|11
3065297|NCT00502840|10531340|P1|Overall Study|Additional or changed therapy|48
3065298|NCT00502840|10531340|P1|Overall Study|Adverse Event|5
3065299|NCT00502801|10531368|P1|End of Therapy to Test of Cure|OTHER|2
3065300|NCT00502801|10531368|P1|End of Therapy to Test of Cure|Death|3
3065301|NCT00502801|10531368|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
3065302|NCT00502801|10531368|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
3065303|NCT00502801|10531368|P1|Treatment Period|OTHER|30
3065304|NCT00502801|10531368|P1|Treatment Period|Death|14
3065305|NCT00502801|10531368|P1|Treatment Period|Adverse Event|7
3065306|NCT00502801|10531368|P1|Treatment Period|Withdrawal by Subject|3
3065307|NCT00502775|10531376|P3|Overall Study|Subject took disallowed drug|1
3065308|NCT00502775|10531377|P2|Overall Study|Subject took disallowed drug|0
3065309|NCT00502775|10531378|P1|Overall Study|Subject took disallowed drug|0
3065310|NCT00502775|10531376|P3|Overall Study|Subject in jail|0
3065311|NCT00502775|10531377|P2|Overall Study|Subject in jail|1
3065312|NCT00502775|10531378|P1|Overall Study|Subject in jail|0
3065313|NCT00502775|10531376|P3|Overall Study|Declining pollen counts|1
3065314|NCT00502775|10531377|P2|Overall Study|Declining pollen counts|1
3065315|NCT00502775|10531378|P1|Overall Study|Declining pollen counts|0
3065316|NCT00502775|10531376|P3|Overall Study|Outside pollen area more than 48 hours|0
3065317|NCT00502775|10531377|P2|Overall Study|Outside pollen area more than 48 hours|1
3065318|NCT00502775|10531378|P1|Overall Study|Outside pollen area more than 48 hours|0
3065319|NCT00502775|10531376|P3|Overall Study|Non-compliance|2
3065320|NCT00502775|10531377|P2|Overall Study|Non-compliance|2
3065321|NCT00502775|10531378|P1|Overall Study|Non-compliance|0
3065322|NCT00502775|10531376|P3|Overall Study|Randomized in error|1
3065323|NCT00502775|10531377|P2|Overall Study|Randomized in error|1
3065324|NCT00502775|10531378|P1|Overall Study|Randomized in error|0
3065325|NCT00502775|10531376|P3|Overall Study|Logpad compliance <80%|0
3065326|NCT00502775|10531377|P2|Overall Study|Logpad compliance <80%|0
3065327|NCT00502775|10531378|P1|Overall Study|Logpad compliance <80%|1
3065328|NCT00502775|10531376|P3|Overall Study|Subject unable to swallow capsule|1
3065329|NCT00502775|10531377|P2|Overall Study|Subject unable to swallow capsule|0
3065330|NCT00502775|10531378|P1|Overall Study|Subject unable to swallow capsule|1
3065331|NCT00502775|10531376|P3|Overall Study|Non-compliance with eDiary|1
3065332|NCT00502775|10531377|P2|Overall Study|Non-compliance with eDiary|1
3065333|NCT00502775|10531378|P1|Overall Study|Non-compliance with eDiary|4
3065334|NCT00502775|10531376|P3|Overall Study|Sponsor Terminated Study|1
3065335|NCT00502775|10531377|P2|Overall Study|Sponsor Terminated Study|0
3065336|NCT00502775|10531378|P1|Overall Study|Sponsor Terminated Study|1
3065337|NCT00502775|10531376|P3|Overall Study|Withdrawal by Subject|2
3065338|NCT00502775|10531377|P2|Overall Study|Withdrawal by Subject|1
3065339|NCT00502775|10531378|P1|Overall Study|Withdrawal by Subject|1
3065340|NCT00502775|10531376|P3|Overall Study|Protocol Violation|2
3065341|NCT00502775|10531377|P2|Overall Study|Protocol Violation|5
3065342|NCT00502775|10531378|P1|Overall Study|Protocol Violation|1
3065343|NCT00502775|10531376|P3|Overall Study|Adverse Event|1
3065344|NCT00502775|10531377|P2|Overall Study|Adverse Event|2
3065345|NCT00502775|10531378|P1|Overall Study|Adverse Event|1
3065346|NCT00502697|10531421|P2|Overall Study|did not meet assignment criteria|2
3065347|NCT00502697|10531422|P1|Overall Study|did not meet assignment criteria|4
3065348|NCT00502697|10531421|P2|Overall Study|found not to meet eligibility criteria|4
3065349|NCT00502697|10531422|P1|Overall Study|found not to meet eligibility criteria|3
3065350|NCT00502697|10531421|P2|Overall Study|disenrolled due to pregnancy loss|5
3065351|NCT00502697|10531422|P1|Overall Study|disenrolled due to pregnancy loss|3
3065352|NCT00502697|10531421|P2|Overall Study|Withdrawal by Subject|1
3065353|NCT00502697|10531422|P1|Overall Study|Withdrawal by Subject|3
3065354|NCT00502671|10531430|P1|Overall Study|Adverse Event|19
3065355|NCT00502671|10531430|P1|Overall Study|Protocol Violation|16
3065356|NCT00502671|10531430|P1|Overall Study|Lost to Follow-up|7
3065357|NCT00502671|10531430|P1|Overall Study|Personal Reasons|22
3065358|NCT00502671|10531430|P1|Overall Study|Disease Progression|13
3065359|NCT00502593|10531447|P12|Overall Study|Lost to Follow-up|0
3065360|NCT00502593|10531448|P11|Overall Study|Lost to Follow-up|1
3065361|NCT00502593|10531449|P10|Overall Study|Lost to Follow-up|0
3065362|NCT00502593|10531450|P9|Overall Study|Lost to Follow-up|3
3065363|NCT00502593|10531451|P8|Overall Study|Lost to Follow-up|0
3065364|NCT00502593|10531452|P7|Overall Study|Lost to Follow-up|0
3065365|NCT00502593|10531453|P6|Overall Study|Lost to Follow-up|0
3065366|NCT00502593|10531454|P5|Overall Study|Lost to Follow-up|0
3065367|NCT00502593|10531455|P4|Overall Study|Lost to Follow-up|1
3065368|NCT00502593|10531456|P3|Overall Study|Lost to Follow-up|1
3065369|NCT00502593|10531457|P2|Overall Study|Lost to Follow-up|1
3065370|NCT00502593|10531458|P1|Overall Study|Lost to Follow-up|2
3065371|NCT00502593|10531447|P12|Overall Study|Withdrawal by Subject|0
3065372|NCT00502593|10531448|P11|Overall Study|Withdrawal by Subject|1
3065373|NCT00502593|10531449|P10|Overall Study|Withdrawal by Subject|0
3065374|NCT00502593|10531450|P9|Overall Study|Withdrawal by Subject|3
3065375|NCT00502593|10531451|P8|Overall Study|Withdrawal by Subject|0
3065376|NCT00502593|10531452|P7|Overall Study|Withdrawal by Subject|3
3065377|NCT00502593|10531453|P6|Overall Study|Withdrawal by Subject|0
3065378|NCT00502593|10531454|P5|Overall Study|Withdrawal by Subject|2
3065379|NCT00502593|10531455|P4|Overall Study|Withdrawal by Subject|2
3065380|NCT00502593|10531456|P3|Overall Study|Withdrawal by Subject|6
3065381|NCT00502593|10531457|P2|Overall Study|Withdrawal by Subject|0
3065382|NCT00502593|10531458|P1|Overall Study|Withdrawal by Subject|0
3065383|NCT00502593|10531447|P12|Overall Study|Withdrawn unspecified reason|0
3065384|NCT00502593|10531448|P11|Overall Study|Withdrawn unspecified reason|0
3065385|NCT00502593|10531449|P10|Overall Study|Withdrawn unspecified reason|0
3065386|NCT00502593|10531450|P9|Overall Study|Withdrawn unspecified reason|0
3065387|NCT00502593|10531451|P8|Overall Study|Withdrawn unspecified reason|0
3065388|NCT00502593|10531452|P7|Overall Study|Withdrawn unspecified reason|2
3065389|NCT00502593|10531453|P6|Overall Study|Withdrawn unspecified reason|0
3065390|NCT00502593|10531454|P5|Overall Study|Withdrawn unspecified reason|2
3065391|NCT00502593|10531455|P4|Overall Study|Withdrawn unspecified reason|1
3065392|NCT00502593|10531456|P3|Overall Study|Withdrawn unspecified reason|3
3065393|NCT00502593|10531457|P2|Overall Study|Withdrawn unspecified reason|1
3065394|NCT00502593|10531458|P1|Overall Study|Withdrawn unspecified reason|1
3065395|NCT00502320|10531974|P2|Overall Study|Adverse Event|5
3065396|NCT00502320|10531975|P1|Overall Study|Adverse Event|3
3065397|NCT00502320|10531974|P2|Overall Study|Screen Failure|1
3065398|NCT00502320|10531975|P1|Overall Study|Screen Failure|0
3065399|NCT00502320|10531974|P2|Overall Study|No longer met criteria|0
3065400|NCT00502320|10531975|P1|Overall Study|No longer met criteria|1
3065401|NCT00502320|10531974|P2|Overall Study|Withdrew Consent|0
3065402|NCT00502320|10531975|P1|Overall Study|Withdrew Consent|1
3065403|NCT00502320|10531974|P2|Overall Study|Lost to Follow-up|1
3065404|NCT00502320|10531975|P1|Overall Study|Lost to Follow-up|1
3065405|NCT00502242|10531987|P2|Overall Study|Withdrawal by Subject|7
3065406|NCT00502242|10531988|P1|Overall Study|Withdrawal by Subject|6
3065407|NCT00502242|10531987|P2|Overall Study|Protocol Violation|1
3065408|NCT00502242|10531988|P1|Overall Study|Protocol Violation|3
3065409|NCT00502242|10531987|P2|Overall Study|Other - Unspecified|14
3065410|NCT00502242|10531988|P1|Overall Study|Other - Unspecified|8
3065411|NCT00502242|10531987|P2|Overall Study|Physician Decision|3
3065412|NCT00502242|10531988|P1|Overall Study|Physician Decision|2
3065413|NCT00502242|10531987|P2|Overall Study|Adverse Event|20
3065414|NCT00502242|10531988|P1|Overall Study|Adverse Event|31
3065415|NCT00502242|10531987|P2|Overall Study|Lack of Efficacy|11
3065416|NCT00502242|10531988|P1|Overall Study|Lack of Efficacy|1
3065417|NCT00502203|10532052|P1|Overall Study|Inevaluable|1
3065418|NCT00501969|10532061|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
3065419|NCT00501969|10532061|P1|Overall Study|Other: Admin Request from the Sponsor|3
3065420|NCT00501969|10532061|P1|Overall Study|Other: As Required by Local EC|2
3065421|NCT00501969|10532061|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
3065422|NCT00501969|10532061|P1|Overall Study|Other: Pat Pending Surgery for PD|1
3065423|NCT00501969|10532061|P1|Overall Study|Other: Patient is Going to Have DBS|1
3065424|NCT00501969|10532061|P1|Overall Study|Other: Patients + Investigator Agreement|1
3065425|NCT00501969|10532061|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
3065426|NCT00501969|10532061|P1|Overall Study|Other: Sponsor Stopped Study|12
3065427|NCT00501969|10532061|P1|Overall Study|Other: Sponsor Termination at Site|1
3065428|NCT00501969|10532061|P1|Overall Study|Other: Sponsors Request|10
3065429|NCT00501969|10532061|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
3065430|NCT00501969|10532061|P1|Overall Study|Lost to Follow-up|4
3065431|NCT00501969|10532061|P1|Overall Study|Subject withdrew consent|51
3065432|NCT00501969|10532061|P1|Overall Study|Unsatisfactory compliance of subject|7
3065433|NCT00501969|10532061|P1|Overall Study|Adverse Event|76
3065434|NCT00501969|10532061|P1|Overall Study|Lack of Efficacy|29
3065435|NCT00501969|10532061|P1|Overall Study|Major Protocol Violation|4
3065436|NCT00501852|10532093|P1|Overall Study|Withdrawal by Subject|2
3065437|NCT00501852|10532093|P1|Overall Study|Adverse Event|3
3065438|NCT00501644|10532113|P1|Overall Study|Withdrawal by Subject|1
3065439|NCT00501644|10532113|P1|Overall Study|Adverse Event|4
3065440|NCT00501540|10532142|P1|Overall Study|Death|5
3065441|NCT00501293|10532154|P2|Maintenance Period|Application site reaction|0
3065442|NCT00501293|10532155|P1|Maintenance Period|Application site reaction|1
3065443|NCT00501293|10532154|P2|Maintenance Period|Would not wear patch|0
3065444|NCT00501293|10532155|P1|Maintenance Period|Would not wear patch|1
3065445|NCT00501293|10532154|P2|Maintenance Period|Went into rehabilitation|0
3065446|NCT00501293|10532155|P1|Maintenance Period|Went into rehabilitation|1
3065447|NCT00501293|10532154|P2|Maintenance Period|Noncompliant with study medication|0
3065448|NCT00501293|10532155|P1|Maintenance Period|Noncompliant with study medication|5
3065449|NCT00501293|10532154|P2|Maintenance Period|Lack of Efficacy|1
3065450|NCT00501293|10532155|P1|Maintenance Period|Lack of Efficacy|4
3065451|NCT00501293|10532154|P2|Maintenance Period|Protocol Violation|1
3065452|NCT00501293|10532155|P1|Maintenance Period|Protocol Violation|2
3065453|NCT00501293|10532154|P2|Maintenance Period|Adverse Event|6
3065454|NCT00501293|10532155|P1|Maintenance Period|Adverse Event|6
3065455|NCT00501293|10532154|P2|Maintenance Period|Lost to Follow-up|7
3065456|NCT00501293|10532155|P1|Maintenance Period|Lost to Follow-up|12
3065457|NCT00501293|10532154|P2|Maintenance Period|Withdrawal by Subject|13
3065458|NCT00501293|10532155|P1|Maintenance Period|Withdrawal by Subject|14
3065459|NCT00501293|10532154|P2|Optimization Period|Enrolled in error|0
3065460|NCT00501293|10532155|P1|Optimization Period|Enrolled in error|1
3065461|NCT00501228|10532182|P1|Overall Study|Withdrawal by Subject|1
3065462|NCT00501085|10532186|P1|Overall Study|Other loss to follow-up|32
3065463|NCT00501085|10532186|P1|Overall Study|Study closed by sponsor|109
3065464|NCT00501085|10532186|P1|Overall Study|Non-Compliance|24
3065465|NCT00501085|10532186|P1|Overall Study|Adverse Event|4
3065466|NCT00501085|10532186|P1|Overall Study|Explantation Surgery|26
3065467|NCT00501085|10532186|P1|Overall Study|Revision Surgery|7
3065468|NCT00501085|10532186|P1|Overall Study|Subject Decision|1
3065469|NCT00501085|10532186|P1|Overall Study|Withdrawal by Subject|34
3065470|NCT00501085|10532186|P1|Overall Study|Lost to Follow-up|195
3065471|NCT00501059|10532196|P2|Overall Study|Not treated|17
3065472|NCT00501059|10532197|P1|Overall Study|Not treated|25
3065473|NCT00501059|10532196|P2|Overall Study|Lost to Follow-up|198
3065474|NCT00501059|10532197|P1|Overall Study|Lost to Follow-up|210
3065475|NCT00501059|10532196|P2|Overall Study|Adverse Event|122
3065476|NCT00501059|10532197|P1|Overall Study|Adverse Event|129
3065477|NCT00501059|10532196|P2|Overall Study|Reason not given|1
3065478|NCT00501059|10532197|P1|Overall Study|Reason not given|3
3065479|NCT00501059|10532196|P2|Overall Study|Non-compliant with study treatment|16
3065480|NCT00501059|10532197|P1|Overall Study|Non-compliant with study treatment|23
3065481|NCT00501059|10532196|P2|Overall Study|Consent withdrawn by subject|873
3065482|NCT00501059|10532197|P1|Overall Study|Consent withdrawn by subject|817
3065483|NCT00501059|10532196|P2|Overall Study|Insufficient therapeutic effect|5
3065484|NCT00501059|10532197|P1|Overall Study|Insufficient therapeutic effect|4
3065485|NCT00501059|10532196|P2|Overall Study|Clinical endpoint reached|123
3065486|NCT00501059|10532197|P1|Overall Study|Clinical endpoint reached|110
3065487|NCT00501059|10532196|P2|Overall Study|Missing end-of-study page|92
3065488|NCT00501059|10532197|P1|Overall Study|Missing end-of-study page|91
3065489|NCT00501059|10532196|P2|Overall Study|Other|239
3065490|NCT00501059|10532197|P1|Overall Study|Other|236
3065491|NCT00501059|10532196|P2|Overall Study|Death|137
3065492|NCT00501059|10532197|P1|Overall Study|Death|140
3065493|NCT00501059|10532196|P2|Overall Study|Protocol Violation|69
3065494|NCT00501059|10532197|P1|Overall Study|Protocol Violation|80
3065495|NCT00501046|10532221|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
3065496|NCT00501046|10532222|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
3065497|NCT00501046|10532221|P2|Overall Study|Withdrawal by Subject|83
3065498|NCT00501046|10532222|P1|Overall Study|Withdrawal by Subject|84
3065499|NCT00501046|10532221|P2|Overall Study|Protocol Violation|1
3065500|NCT00501046|10532222|P1|Overall Study|Protocol Violation|2
3065501|NCT00501046|10532221|P2|Overall Study|Pregnancy|3
3065502|NCT00501046|10532222|P1|Overall Study|Pregnancy|0
3065503|NCT00501046|10532221|P2|Overall Study|Physician Decision|2
3065504|NCT00501046|10532222|P1|Overall Study|Physician Decision|7
3065505|NCT00501046|10532221|P2|Overall Study|Lost to Follow-up|13
3065506|NCT00501046|10532222|P1|Overall Study|Lost to Follow-up|14
3065507|NCT00501046|10532221|P2|Overall Study|Death|30
3065508|NCT00501046|10532222|P1|Overall Study|Death|23
3065509|NCT00501046|10532221|P2|Overall Study|Adverse Event|25
3065510|NCT00501046|10532222|P1|Overall Study|Adverse Event|21
3065511|NCT00501007|10532228|P2|Overall Study|Inclusion criteria not met.|25
3065512|NCT00501007|10532229|P1|Overall Study|Inclusion criteria not met.|29
3065513|NCT00500903|10532238|P3|Overall Study|Reason Not Specified|2
3065514|NCT00500903|10532239|P2|Overall Study|Reason Not Specified|0
3065515|NCT00500903|10532240|P1|Overall Study|Reason Not Specified|10
3065516|NCT00500903|10532238|P3|Overall Study|Symptomatic Deterioration|0
3065517|NCT00500903|10532239|P2|Overall Study|Symptomatic Deterioration|0
3065518|NCT00500903|10532240|P1|Overall Study|Symptomatic Deterioration|2
3065519|NCT00500903|10532238|P3|Overall Study|Patient Declined Further Treatment|3
3065520|NCT00500903|10532239|P2|Overall Study|Patient Declined Further Treatment|0
3065521|NCT00500903|10532240|P1|Overall Study|Patient Declined Further Treatment|0
3065522|NCT00500903|10532238|P3|Overall Study|Progressive Disease|15
3065523|NCT00500903|10532239|P2|Overall Study|Progressive Disease|2
3065524|NCT00500903|10532240|P1|Overall Study|Progressive Disease|41
3065525|NCT00500903|10532238|P3|Overall Study|Unsatisfactory Therapeutic Response|0
3065526|NCT00500903|10532239|P2|Overall Study|Unsatisfactory Therapeutic Response|0
3065527|NCT00500903|10532240|P1|Overall Study|Unsatisfactory Therapeutic Response|2
3065528|NCT00500903|10532238|P3|Overall Study|Occurrence of Adverse Event(s)|0
3065529|NCT00500903|10532239|P2|Overall Study|Occurrence of Adverse Event(s)|0
3065530|NCT00500903|10532240|P1|Overall Study|Occurrence of Adverse Event(s)|10
3065531|NCT00500760|10532436|P2|Overall Study|Other|2
3065532|NCT00500760|10532437|P1|Overall Study|Other|1
3065533|NCT00500760|10532436|P2|Overall Study|Lost to Follow-up|0
3065534|NCT00500760|10532437|P1|Overall Study|Lost to Follow-up|3
3065535|NCT00500760|10532436|P2|Overall Study|Administrative decision|0
3065536|NCT00500760|10532437|P1|Overall Study|Administrative decision|2
3065537|NCT00500760|10532436|P2|Overall Study|Withdrawal by Subject|7
3065538|NCT00500760|10532437|P1|Overall Study|Withdrawal by Subject|5
3065539|NCT00500760|10532436|P2|Overall Study|Death|15
3065540|NCT00500760|10532437|P1|Overall Study|Death|32
3065541|NCT00500682|10532457|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
3065542|NCT00500682|10532458|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
3065543|NCT00500682|10532457|P2|Overall Study|Withdrawal by Subject|74
3065544|NCT00500682|10532458|P1|Overall Study|Withdrawal by Subject|80
3065545|NCT00500682|10532457|P2|Overall Study|Protocol Violation|3
3065546|NCT00500682|10532458|P1|Overall Study|Protocol Violation|1
3065547|NCT00500682|10532457|P2|Overall Study|Pregnancy|0
3065548|NCT00500682|10532458|P1|Overall Study|Pregnancy|2
3065549|NCT00500682|10532457|P2|Overall Study|Physician Decision|10
3065550|NCT00500682|10532458|P1|Overall Study|Physician Decision|6
3065551|NCT00500682|10532457|P2|Overall Study|Lost to Follow-up|11
3065552|NCT00500682|10532458|P1|Overall Study|Lost to Follow-up|11
3065553|NCT00500682|10532457|P2|Overall Study|Death|16
3065554|NCT00500682|10532458|P1|Overall Study|Death|25
3065555|NCT00500682|10532457|P2|Overall Study|Adverse Event|29
3065556|NCT00500682|10532458|P1|Overall Study|Adverse Event|37
3065557|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Missing|3
3065558|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
3065559|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Death|1
3065560|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Administrative problems|1
3065561|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
3065562|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
3065563|NCT00500539|10532492|P1|Follow-up Period (16 Weeks)|Adverse Event|1
3065564|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
3065565|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Administrative problems|2
3065566|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
3065567|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
3065568|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
3065569|NCT00500539|10532492|P1|Treatment Period (24 Weeks)|Adverse Event|4
3065570|NCT00500370|10532518|P2|Overall Study|Subject Decision|17
3065571|NCT00500370|10532519|P1|Overall Study|Subject Decision|10
3065572|NCT00500370|10532518|P2|Overall Study|Sponsor Decision|0
3065573|NCT00500370|10532519|P1|Overall Study|Sponsor Decision|2
3065574|NCT00500370|10532518|P2|Overall Study|Protocol Violation|4
3065575|NCT00500370|10532519|P1|Overall Study|Protocol Violation|2
3065576|NCT00500370|10532518|P2|Overall Study|Lost to Follow-up|10
3065577|NCT00500370|10532519|P1|Overall Study|Lost to Follow-up|10
3065578|NCT00500370|10532518|P2|Overall Study|Adverse Event|3
3065579|NCT00500370|10532519|P1|Overall Study|Adverse Event|9
3065580|NCT00500357|10532555|P1|Overall Study|Death|1
3065581|NCT00500331|10532581|P7|Overall Study|Protocol violated|0
3065582|NCT00500331|10532582|P6|Overall Study|Protocol violated|0
3065583|NCT00500331|10532583|P5|Overall Study|Protocol violated|0
3065584|NCT00500331|10532584|P4|Overall Study|Protocol violated|1
3065585|NCT00500331|10532585|P3|Overall Study|Protocol violated|0
3065586|NCT00500331|10532586|P2|Overall Study|Protocol violated|0
3065587|NCT00500331|10532587|P1|Overall Study|Protocol violated|0
3065588|NCT00500331|10532581|P7|Overall Study|State ban of biological samples export|0
3065589|NCT00500331|10532582|P6|Overall Study|State ban of biological samples export|0
3065590|NCT00500331|10532583|P5|Overall Study|State ban of biological samples export|0
3065591|NCT00500331|10532584|P4|Overall Study|State ban of biological samples export|1
3065592|NCT00500331|10532585|P3|Overall Study|State ban of biological samples export|0
3065593|NCT00500331|10532586|P2|Overall Study|State ban of biological samples export|0
3065594|NCT00500331|10532587|P1|Overall Study|State ban of biological samples export|0
3065595|NCT00500331|10532581|P7|Overall Study|Diabetologist nurse in the study|0
3065596|NCT00500331|10532582|P6|Overall Study|Diabetologist nurse in the study|0
3065597|NCT00500331|10532583|P5|Overall Study|Diabetologist nurse in the study|0
3065598|NCT00500331|10532584|P4|Overall Study|Diabetologist nurse in the study|0
3065599|NCT00500331|10532585|P3|Overall Study|Diabetologist nurse in the study|1
3065600|NCT00500331|10532586|P2|Overall Study|Diabetologist nurse in the study|0
3065601|NCT00500331|10532587|P1|Overall Study|Diabetologist nurse in the study|0
3065602|NCT00500331|10532581|P7|Overall Study|Participant was randomized by mistake|0
3065603|NCT00500331|10532582|P6|Overall Study|Participant was randomized by mistake|0
3065604|NCT00500331|10532583|P5|Overall Study|Participant was randomized by mistake|0
3065605|NCT00500331|10532584|P4|Overall Study|Participant was randomized by mistake|0
3065606|NCT00500331|10532585|P3|Overall Study|Participant was randomized by mistake|0
3065607|NCT00500331|10532586|P2|Overall Study|Participant was randomized by mistake|0
3065608|NCT00500331|10532587|P1|Overall Study|Participant was randomized by mistake|1
3065609|NCT00500331|10532581|P7|Overall Study|Sponsor decided to withdraw participant|0
3065610|NCT00500331|10532582|P6|Overall Study|Sponsor decided to withdraw participant|0
3065611|NCT00500331|10532583|P5|Overall Study|Sponsor decided to withdraw participant|0
3065612|NCT00500331|10532584|P4|Overall Study|Sponsor decided to withdraw participant|0
3065613|NCT00500331|10532585|P3|Overall Study|Sponsor decided to withdraw participant|0
3065614|NCT00500331|10532586|P2|Overall Study|Sponsor decided to withdraw participant|0
3065615|NCT00500331|10532587|P1|Overall Study|Sponsor decided to withdraw participant|1
3065616|NCT00500331|10532581|P7|Overall Study|Exclusion citeria not met on Visit 4|0
3065617|NCT00500331|10532582|P6|Overall Study|Exclusion citeria not met on Visit 4|0
3065618|NCT00500331|10532583|P5|Overall Study|Exclusion citeria not met on Visit 4|0
3065619|NCT00500331|10532584|P4|Overall Study|Exclusion citeria not met on Visit 4|0
3065620|NCT00500331|10532585|P3|Overall Study|Exclusion citeria not met on Visit 4|0
3065621|NCT00500331|10532586|P2|Overall Study|Exclusion citeria not met on Visit 4|0
3065622|NCT00500331|10532587|P1|Overall Study|Exclusion citeria not met on Visit 4|1
3065623|NCT00500331|10532581|P7|Overall Study|Didn't return for continuation of study|0
3065624|NCT00500331|10532582|P6|Overall Study|Didn't return for continuation of study|0
3065625|NCT00500331|10532583|P5|Overall Study|Didn't return for continuation of study|0
3065626|NCT00500331|10532584|P4|Overall Study|Didn't return for continuation of study|0
3065627|NCT00500331|10532585|P3|Overall Study|Didn't return for continuation of study|0
3065628|NCT00500331|10532586|P2|Overall Study|Didn't return for continuation of study|0
3065629|NCT00500331|10532587|P1|Overall Study|Didn't return for continuation of study|1
3065630|NCT00500331|10532581|P7|Overall Study|Increased serum creatinine from Baseline|0
3065631|NCT00500331|10532582|P6|Overall Study|Increased serum creatinine from Baseline|1
3065632|NCT00500331|10532583|P5|Overall Study|Increased serum creatinine from Baseline|0
3065633|NCT00500331|10532584|P4|Overall Study|Increased serum creatinine from Baseline|0
3065634|NCT00500331|10532585|P3|Overall Study|Increased serum creatinine from Baseline|0
3065635|NCT00500331|10532586|P2|Overall Study|Increased serum creatinine from Baseline|0
3065636|NCT00500331|10532587|P1|Overall Study|Increased serum creatinine from Baseline|0
3065637|NCT00500331|10532581|P7|Overall Study|Liver function test abnormality|0
3065638|NCT00500331|10532582|P6|Overall Study|Liver function test abnormality|0
3065639|NCT00500331|10532583|P5|Overall Study|Liver function test abnormality|0
3065640|NCT00500331|10532584|P4|Overall Study|Liver function test abnormality|0
3065641|NCT00500331|10532585|P3|Overall Study|Liver function test abnormality|1
3065642|NCT00500331|10532586|P2|Overall Study|Liver function test abnormality|0
3065643|NCT00500331|10532587|P1|Overall Study|Liver function test abnormality|0
3065644|NCT00500331|10532581|P7|Overall Study|Lack of Efficacy|0
3065645|NCT00500331|10532582|P6|Overall Study|Lack of Efficacy|0
3065646|NCT00500331|10532583|P5|Overall Study|Lack of Efficacy|0
3065647|NCT00500331|10532584|P4|Overall Study|Lack of Efficacy|0
3065648|NCT00500331|10532585|P3|Overall Study|Lack of Efficacy|0
3065649|NCT00500331|10532586|P2|Overall Study|Lack of Efficacy|1
3065650|NCT00500331|10532587|P1|Overall Study|Lack of Efficacy|3
3065651|NCT00500331|10532581|P7|Overall Study|Withdrawal by Subject|1
3065652|NCT00500331|10532582|P6|Overall Study|Withdrawal by Subject|1
3065653|NCT00500331|10532583|P5|Overall Study|Withdrawal by Subject|0
3065654|NCT00500331|10532584|P4|Overall Study|Withdrawal by Subject|5
3065655|NCT00500331|10532585|P3|Overall Study|Withdrawal by Subject|1
3065656|NCT00500331|10532586|P2|Overall Study|Withdrawal by Subject|0
3065657|NCT00500331|10532587|P1|Overall Study|Withdrawal by Subject|4
3065658|NCT00500331|10532581|P7|Overall Study|Protocol Violation|1
3065659|NCT00500331|10532582|P6|Overall Study|Protocol Violation|1
3065660|NCT00500331|10532583|P5|Overall Study|Protocol Violation|1
3065661|NCT00500331|10532584|P4|Overall Study|Protocol Violation|0
3065662|NCT00500331|10532585|P3|Overall Study|Protocol Violation|1
3065663|NCT00500331|10532586|P2|Overall Study|Protocol Violation|1
3065664|NCT00500331|10532587|P1|Overall Study|Protocol Violation|3
3065665|NCT00500331|10532581|P7|Overall Study|Lost to Follow-up|0
3065666|NCT00500331|10532582|P6|Overall Study|Lost to Follow-up|0
3065667|NCT00500331|10532583|P5|Overall Study|Lost to Follow-up|1
3065668|NCT00500331|10532584|P4|Overall Study|Lost to Follow-up|2
3065669|NCT00500331|10532585|P3|Overall Study|Lost to Follow-up|1
3065670|NCT00500331|10532586|P2|Overall Study|Lost to Follow-up|1
3065671|NCT00500331|10532587|P1|Overall Study|Lost to Follow-up|1
3065672|NCT00500331|10532581|P7|Overall Study|Adverse Event|0
3065673|NCT00500331|10532582|P6|Overall Study|Adverse Event|2
3065674|NCT00500331|10532583|P5|Overall Study|Adverse Event|2
3065675|NCT00500331|10532584|P4|Overall Study|Adverse Event|1
3065676|NCT00500331|10532585|P3|Overall Study|Adverse Event|0
3065677|NCT00500331|10532586|P2|Overall Study|Adverse Event|2
3065678|NCT00500331|10532587|P1|Overall Study|Adverse Event|0
3065679|NCT00500318|10532724|P2|Overall Study|Other Reason|1
3065680|NCT00500318|10532725|P1|Overall Study|Other Reason|0
3065681|NCT00500318|10532724|P2|Overall Study|Lack of Efficacy|3
3065682|NCT00500318|10532725|P1|Overall Study|Lack of Efficacy|0
3065683|NCT00500318|10532724|P2|Overall Study|Withdrawal by Subject|2
3065684|NCT00500318|10532725|P1|Overall Study|Withdrawal by Subject|1
3065685|NCT00500318|10532724|P2|Overall Study|Protocol Violation|3
3065686|NCT00500318|10532725|P1|Overall Study|Protocol Violation|1
3065687|NCT00500318|10532724|P2|Overall Study|Adverse Event|8
3065688|NCT00500318|10532725|P1|Overall Study|Adverse Event|3
3065689|NCT00500292|10532742|P3|Overall Study|Other|4
3065690|NCT00500292|10532743|P2|Overall Study|Other|1
3065691|NCT00500292|10532744|P1|Overall Study|Other|1
3065692|NCT00500292|10532742|P3|Overall Study|Withdrawal by Subject|0
3065693|NCT00500292|10532743|P2|Overall Study|Withdrawal by Subject|1
3065694|NCT00500292|10532744|P1|Overall Study|Withdrawal by Subject|0
3065695|NCT00500292|10532742|P3|Overall Study|Condition under investigation worsened|19
3065696|NCT00500292|10532743|P2|Overall Study|Condition under investigation worsened|23
3065697|NCT00500292|10532744|P1|Overall Study|Condition under investigation worsened|21
3065698|NCT00500292|10532742|P3|Overall Study|Adverse Event|4
3065699|NCT00500292|10532743|P2|Overall Study|Adverse Event|6
3065700|NCT00500292|10532744|P1|Overall Study|Adverse Event|3
3065701|NCT00500149|10532765|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
3065702|NCT00500149|10532766|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
3065703|NCT00500149|10532765|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
3065704|NCT00500149|10532766|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
3065705|NCT00500149|10532765|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
3065706|NCT00500149|10532766|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
3065707|NCT00500149|10532765|P2|First Intervention (Cross-over Phase)|Adverse Event|1
3065708|NCT00500149|10532766|P1|First Intervention (Cross-over Phase)|Adverse Event|0
3065709|NCT00500149|10532765|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
3065710|NCT00500149|10532766|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
3065711|NCT00500149|10532765|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
3065712|NCT00500149|10532766|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
3065713|NCT00500149|10532765|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
3065714|NCT00500149|10532766|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
3065715|NCT00500110|10532774|P1|Overall Study|Withdrawal by Subject|3
3065716|NCT00500071|10532778|P1|30-day Safety Follow-up|Lost to Follow-up|17
3065717|NCT00500071|10532778|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
3065718|NCT00500071|10532778|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
3065719|NCT00500071|10532778|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
3065720|NCT00500071|10532778|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
3065721|NCT00500071|10532778|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
3065722|NCT00500071|10532778|P1|Screening and Washout Phase|Protocol Violation|1
3065723|NCT00499889|10532801|P1|Overall Study|Infection prior to treatment|1
3065724|NCT00499863|10532809|P2|Overall Study|Lost to Follow-up|1
3065725|NCT00499863|10532810|P1|Overall Study|Lost to Follow-up|1
3065726|NCT00499863|10532809|P2|Overall Study|Sponsor decision|2
3065727|NCT00499863|10532810|P1|Overall Study|Sponsor decision|2
3065728|NCT00499863|10532809|P2|Overall Study|Adverse Event|2
3065729|NCT00499863|10532810|P1|Overall Study|Adverse Event|8
3065730|NCT00499863|10532809|P2|Overall Study|Withdrawal by Subject|4
3065731|NCT00499863|10532810|P1|Overall Study|Withdrawal by Subject|6
3065732|NCT00499863|10532809|P2|Overall Study|Protocol Violation|7
3065733|NCT00499863|10532810|P1|Overall Study|Protocol Violation|12
3065734|NCT00499863|10532809|P2|Overall Study|Lack of Efficacy|27
3065735|NCT00499863|10532810|P1|Overall Study|Lack of Efficacy|21
3065736|NCT00500266|10532838|P1|Overall Study|Assigned, not treated|4
3065737|NCT00500266|10532838|P1|Overall Study|Withdrawal by Subject|3
3065738|NCT00500266|10532838|P1|Overall Study|Lost to Follow-up|3
3065739|NCT00500266|10532838|P1|Overall Study|Death|3
3065740|NCT00499746|10532845|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
3065741|NCT00499746|10532845|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
3065742|NCT00499746|10532845|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
3065743|NCT00499746|10532845|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
3065744|NCT00499694|10532914|P1|Overall Study|Patient never received treatment.|1
3065745|NCT00499681|10532923|P2|Overall Study|disease progression|1
3065746|NCT00499681|10532924|P1|Overall Study|disease progression|0
3065747|NCT00499681|10532923|P2|Overall Study|toxicity|1
3065748|NCT00499681|10532924|P1|Overall Study|toxicity|0
3065749|NCT00499616|10532951|P4|Overall Study|Patient/Parent Refusal|0
3065750|NCT00499616|10532952|P3|Overall Study|Patient/Parent Refusal|3
3065751|NCT00499616|10532953|P2|Overall Study|Patient/Parent Refusal|5
3065752|NCT00499616|10532954|P1|Overall Study|Patient/Parent Refusal|1
3065753|NCT00499616|10532951|P4|Overall Study|Not evaluable|41
3065754|NCT00499616|10532952|P3|Overall Study|Not evaluable|0
3065755|NCT00499616|10532953|P2|Overall Study|Not evaluable|0
3065756|NCT00499616|10532954|P1|Overall Study|Not evaluable|0
3065757|NCT00499616|10532951|P4|Overall Study|Ineligible|15
3065758|NCT00499616|10532952|P3|Overall Study|Ineligible|0
3065759|NCT00499616|10532953|P2|Overall Study|Ineligible|2
3065760|NCT00499616|10532954|P1|Overall Study|Ineligible|1
3065761|NCT00499616|10532951|P4|Overall Study|Withdrawal by Subject|0
3065762|NCT00499616|10532952|P3|Overall Study|Withdrawal by Subject|1
3065763|NCT00499616|10532953|P2|Overall Study|Withdrawal by Subject|0
3065764|NCT00499616|10532954|P1|Overall Study|Withdrawal by Subject|1
3065765|NCT00499616|10532951|P4|Overall Study|Physician Decision|0
3065766|NCT00499616|10532952|P3|Overall Study|Physician Decision|9
3065767|NCT00499616|10532953|P2|Overall Study|Physician Decision|16
3065768|NCT00499616|10532954|P1|Overall Study|Physician Decision|6
3065769|NCT00499616|10532951|P4|Overall Study|Lost to Follow-up|0
3065770|NCT00499616|10532952|P3|Overall Study|Lost to Follow-up|1
3065771|NCT00499616|10532953|P2|Overall Study|Lost to Follow-up|0
3065772|NCT00499616|10532954|P1|Overall Study|Lost to Follow-up|0
3065773|NCT00499616|10532951|P4|Overall Study|Lack of Efficacy|0
3065774|NCT00499616|10532952|P3|Overall Study|Lack of Efficacy|19
3065775|NCT00499616|10532953|P2|Overall Study|Lack of Efficacy|0
3065776|NCT00499616|10532954|P1|Overall Study|Lack of Efficacy|5
3065777|NCT00499616|10532951|P4|Overall Study|Death|1
3065778|NCT00499616|10532952|P3|Overall Study|Death|3
3065779|NCT00499616|10532953|P2|Overall Study|Death|5
3065780|NCT00499616|10532954|P1|Overall Study|Death|1
3065781|NCT00499603|10532999|P2|Overall Study|Adverse Event|1
3065782|NCT00499603|10533000|P1|Overall Study|Adverse Event|0
3065783|NCT00499590|10533013|P3|Overall Study|Not treated|1
3065784|NCT00499590|10533014|P2|Overall Study|Not treated|0
3065785|NCT00499590|10533015|P1|Overall Study|Not treated|1
3065786|NCT00499590|10533013|P3|Overall Study|Study Terminated|112
3065787|NCT00499590|10533014|P2|Overall Study|Study Terminated|112
3065788|NCT00499590|10533015|P1|Overall Study|Study Terminated|112
3065789|NCT00499486|10533026|P1|Overall Study|Withdrawal by Subject|16
3065790|NCT00499460|10533053|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
3065791|NCT00499460|10533054|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
3065792|NCT00499460|10533053|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
3065793|NCT00499460|10533054|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
3065794|NCT00499460|10533053|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
3065795|NCT00499460|10533054|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
3065796|NCT00499369|10533087|P5|Overall Study|Ineligible|0
3065797|NCT00499369|10533088|P4|Overall Study|Ineligible|1
3065798|NCT00499369|10533089|P3|Overall Study|Ineligible|1
3065799|NCT00499369|10533090|P2|Overall Study|Ineligible|2
3065800|NCT00499369|10533091|P1|Overall Study|Ineligible|2
3065801|NCT00499369|10533087|P5|Overall Study|Not protocol specified|0
3065802|NCT00499369|10533088|P4|Overall Study|Not protocol specified|1
3065803|NCT00499369|10533089|P3|Overall Study|Not protocol specified|3
3065804|NCT00499369|10533090|P2|Overall Study|Not protocol specified|0
3065805|NCT00499369|10533091|P1|Overall Study|Not protocol specified|2
3065806|NCT00499369|10533087|P5|Overall Study|Death|0
3065807|NCT00499369|10533088|P4|Overall Study|Death|0
3065808|NCT00499369|10533089|P3|Overall Study|Death|0
3065809|NCT00499369|10533090|P2|Overall Study|Death|1
3065810|NCT00499369|10533091|P1|Overall Study|Death|0
3065811|NCT00499369|10533087|P5|Overall Study|Progression|10
3065812|NCT00499369|10533088|P4|Overall Study|Progression|6
3065813|NCT00499369|10533089|P3|Overall Study|Progression|9
3065814|NCT00499369|10533090|P2|Overall Study|Progression|12
3065815|NCT00499369|10533091|P1|Overall Study|Progression|10
3065816|NCT00499369|10533087|P5|Overall Study|Withdrawal by Subject|0
3065817|NCT00499369|10533088|P4|Overall Study|Withdrawal by Subject|0
3065818|NCT00499369|10533089|P3|Overall Study|Withdrawal by Subject|1
3065819|NCT00499369|10533090|P2|Overall Study|Withdrawal by Subject|1
3065820|NCT00499369|10533091|P1|Overall Study|Withdrawal by Subject|0
3065821|NCT00499369|10533087|P5|Overall Study|Adverse Event|2
3065822|NCT00499369|10533088|P4|Overall Study|Adverse Event|1
3065823|NCT00499369|10533089|P3|Overall Study|Adverse Event|3
3065824|NCT00499369|10533090|P2|Overall Study|Adverse Event|2
3065825|NCT00499369|10533091|P1|Overall Study|Adverse Event|2
3065826|NCT00499252|10533127|P1|Overall Study|<no further label>|3
3065827|NCT00499252|10533127|P1|Overall Study|Ineligible|4
3065828|NCT00499252|10533127|P1|Overall Study|Refused further treatment|2
3065829|NCT00499252|10533127|P1|Overall Study|Adverse Event|3
3065830|NCT00499122|10533137|P1|Overall Study|Withdrawal by Subject|2
3065831|NCT00499083|10533180|P1|Overall Study|Not evaluable|3
3065832|NCT00499031|10533187|P1|Overall Study|Never treated|1
3065833|NCT00499031|10533187|P1|Overall Study|Required test not done|1
3065834|NCT00499031|10533187|P1|Overall Study|Improper pre-protocol treatment|1
3065835|NCT00498797|10533210|P2|Overall Study|Other|1
3065836|NCT00498797|10533211|P1|Overall Study|Other|3
3065837|NCT00498797|10533210|P2|Overall Study|Condition under investigation worsened|21
3065838|NCT00498797|10533211|P1|Overall Study|Condition under investigation worsened|19
3065839|NCT00498797|10533210|P2|Overall Study|Adverse Event|5
3065840|NCT00498797|10533211|P1|Overall Study|Adverse Event|12
3065841|NCT00498797|10533210|P2|Overall Study|Withdrawal by Subject|2
3065842|NCT00498797|10533211|P1|Overall Study|Withdrawal by Subject|4
3065843|NCT00498602|10533295|P7|Overall Study|Other|0
3065844|NCT00498602|10533296|P6|Overall Study|Other|3
3065845|NCT00498602|10533297|P5|Overall Study|Other|0
3065846|NCT00498602|10533298|P4|Overall Study|Other|0
3065847|NCT00498602|10533299|P3|Overall Study|Other|1
3065848|NCT00498602|10533300|P2|Overall Study|Other|3
3065849|NCT00498602|10533301|P1|Overall Study|Other|2
3065850|NCT00498602|10533295|P7|Overall Study|Subject Request|1
3065851|NCT00498602|10533296|P6|Overall Study|Subject Request|4
3065852|NCT00498602|10533297|P5|Overall Study|Subject Request|1
3065853|NCT00498602|10533298|P4|Overall Study|Subject Request|1
3065854|NCT00498602|10533299|P3|Overall Study|Subject Request|1
3065855|NCT00498602|10533300|P2|Overall Study|Subject Request|0
3065856|NCT00498602|10533301|P1|Overall Study|Subject Request|3
3065857|NCT00498602|10533295|P7|Overall Study|Investigator Request|0
3065858|NCT00498602|10533296|P6|Overall Study|Investigator Request|0
3065859|NCT00498602|10533297|P5|Overall Study|Investigator Request|0
3065860|NCT00498602|10533298|P4|Overall Study|Investigator Request|0
3065861|NCT00498602|10533299|P3|Overall Study|Investigator Request|1
3065862|NCT00498602|10533300|P2|Overall Study|Investigator Request|0
3065863|NCT00498602|10533301|P1|Overall Study|Investigator Request|0
3065864|NCT00498602|10533295|P7|Overall Study|Caregiver Request|0
3065865|NCT00498602|10533296|P6|Overall Study|Caregiver Request|2
3065866|NCT00498602|10533297|P5|Overall Study|Caregiver Request|1
3065867|NCT00498602|10533298|P4|Overall Study|Caregiver Request|0
3065868|NCT00498602|10533299|P3|Overall Study|Caregiver Request|2
3065869|NCT00498602|10533300|P2|Overall Study|Caregiver Request|2
3065870|NCT00498602|10533301|P1|Overall Study|Caregiver Request|2
3065871|NCT00498602|10533295|P7|Overall Study|AE not related to Study Drug|1
3065872|NCT00498602|10533296|P6|Overall Study|AE not related to Study Drug|2
3065873|NCT00498602|10533297|P5|Overall Study|AE not related to Study Drug|2
3065874|NCT00498602|10533298|P4|Overall Study|AE not related to Study Drug|0
3065875|NCT00498602|10533299|P3|Overall Study|AE not related to Study Drug|0
3065876|NCT00498602|10533300|P2|Overall Study|AE not related to Study Drug|3
3065877|NCT00498602|10533301|P1|Overall Study|AE not related to Study Drug|1
3065878|NCT00498602|10533295|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
3065879|NCT00498602|10533296|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
3065880|NCT00498602|10533297|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
3065881|NCT00498602|10533298|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
3065882|NCT00498602|10533299|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
3065883|NCT00498602|10533300|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
3065884|NCT00498602|10533301|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
3065885|NCT00498602|10533295|P7|Overall Study|Lost to Follow-up|0
3065886|NCT00498602|10533296|P6|Overall Study|Lost to Follow-up|0
3065887|NCT00498602|10533297|P5|Overall Study|Lost to Follow-up|0
3065888|NCT00498602|10533298|P4|Overall Study|Lost to Follow-up|2
3065889|NCT00498602|10533299|P3|Overall Study|Lost to Follow-up|0
3065890|NCT00498602|10533300|P2|Overall Study|Lost to Follow-up|2
3065891|NCT00498602|10533301|P1|Overall Study|Lost to Follow-up|0
3065892|NCT00498602|10533295|P7|Overall Study|Lack of Efficacy|0
3065893|NCT00498602|10533296|P6|Overall Study|Lack of Efficacy|0
3065894|NCT00498602|10533297|P5|Overall Study|Lack of Efficacy|0
3065895|NCT00498602|10533298|P4|Overall Study|Lack of Efficacy|0
3065896|NCT00498602|10533299|P3|Overall Study|Lack of Efficacy|0
3065897|NCT00498602|10533300|P2|Overall Study|Lack of Efficacy|0
3065898|NCT00498602|10533301|P1|Overall Study|Lack of Efficacy|1
3065899|NCT00498602|10533295|P7|Overall Study|Death|0
3065900|NCT00498602|10533296|P6|Overall Study|Death|1
3065901|NCT00498602|10533297|P5|Overall Study|Death|0
3065902|NCT00498602|10533298|P4|Overall Study|Death|0
3065903|NCT00498602|10533299|P3|Overall Study|Death|0
3065904|NCT00498602|10533300|P2|Overall Study|Death|0
3065905|NCT00498602|10533301|P1|Overall Study|Death|0
3065906|NCT00498485|10533349|P2|Overall Study|Adverse Event|5
3065907|NCT00498485|10533350|P1|Overall Study|Adverse Event|1
3065908|NCT00498433|10533361|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
3065909|NCT00498433|10533362|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
3065910|NCT00498433|10533363|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
3065911|NCT00498433|10533361|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
3065912|NCT00498433|10533362|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
3065913|NCT00498433|10533363|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
3065914|NCT00498433|10533361|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
3065915|NCT00498433|10533362|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
3065916|NCT00498433|10533363|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
3065917|NCT00498433|10533361|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
3065918|NCT00498433|10533362|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
3065919|NCT00498433|10533363|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
3065920|NCT00498368|10533408|P2|Overall Study|Withdrawal by Subject|2
3065921|NCT00498368|10533409|P1|Overall Study|Withdrawal by Subject|3
3065922|NCT00498355|10533421|P1|Overall Study|Lost to Follow-up|1
3065923|NCT00498186|10533429|P1|Overall Study|Other|10
3065924|NCT00498186|10533429|P1|Overall Study|Lost to Follow-up|3
3065925|NCT00498186|10533429|P1|Overall Study|Withdrawal by Subject|18
3065926|NCT00498186|10533429|P1|Overall Study|Unsatisfactory compliance of subject|12
3065927|NCT00498186|10533429|P1|Overall Study|Adverse Event|89
3065928|NCT00498186|10533429|P1|Overall Study|Lack of Efficacy|31
3065929|NCT00498186|10533429|P1|Overall Study|Protocol Violation|10
3065930|NCT00498173|10533436|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
3065931|NCT00498173|10533437|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
3065932|NCT00498173|10533438|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
3065933|NCT00497874|10533468|P2|Overall Study|Unable to schedule|24
3065934|NCT00497874|10533469|P1|Overall Study|Unable to schedule|37
3065935|NCT00497874|10533468|P2|Overall Study|Unable to contact|67
3065936|NCT00497874|10533469|P1|Overall Study|Unable to contact|52
3065937|NCT00497874|10533468|P2|Overall Study|Death|4
3065938|NCT00497874|10533469|P1|Overall Study|Death|2
3065939|NCT00497874|10533468|P2|Overall Study|Illness|4
3065940|NCT00497874|10533469|P1|Overall Study|Illness|8
3065941|NCT00497874|10533468|P2|Overall Study|Withdrawal by Subject|17
3065942|NCT00497874|10533469|P1|Overall Study|Withdrawal by Subject|48
3065943|NCT00497796|10533487|P2|Overall Study|Not applicable (randomized not treated)|4
3065944|NCT00497796|10533488|P1|Overall Study|Not applicable (randomized not treated)|0
3065945|NCT00497796|10533487|P2|Overall Study|Lost to Follow-up|1
3065946|NCT00497796|10533488|P1|Overall Study|Lost to Follow-up|0
3065947|NCT00497796|10533487|P2|Overall Study|Investigator/sponsor discretion|34
3065948|NCT00497796|10533488|P1|Overall Study|Investigator/sponsor discretion|31
3065949|NCT00497796|10533487|P2|Overall Study|Consent withdrawn|3
3065950|NCT00497796|10533488|P1|Overall Study|Consent withdrawn|10
3065951|NCT00497796|10533487|P2|Overall Study|CMV infection or disease treatment|4
3065952|NCT00497796|10533488|P1|Overall Study|CMV infection or disease treatment|30
3065953|NCT00497796|10533487|P2|Overall Study|Adverse event (related)|4
3065954|NCT00497796|10533488|P1|Overall Study|Adverse event (related)|5
3065955|NCT00497796|10533487|P2|Overall Study|Adverse event (not related)|9
3065956|NCT00497796|10533488|P1|Overall Study|Adverse event (not related)|9
3065957|NCT00497198|10533575|P2|Overall Study|Withdrawal by Subject|1
3065958|NCT00497198|10533576|P1|Overall Study|Withdrawal by Subject|0
3065959|NCT00497198|10533575|P2|Overall Study|Physician Decision|2
3065960|NCT00497198|10533576|P1|Overall Study|Physician Decision|1
3065961|NCT00497198|10533575|P2|Overall Study|Adverse Event|2
3065962|NCT00497198|10533576|P1|Overall Study|Adverse Event|4
3065963|NCT00497146|10533592|P2|Long-term Follow-up Period|Other|1
3065964|NCT00497146|10533593|P1|Long-term Follow-up Period|Other|0
3065965|NCT00497146|10533592|P2|Long-term Follow-up Period|Lost to Follow-up|1
3065966|NCT00497146|10533593|P1|Long-term Follow-up Period|Lost to Follow-up|5
3065967|NCT00497146|10533592|P2|Long-term Follow-up Period|Withdrawal by Subject|2
3065968|NCT00497146|10533593|P1|Long-term Follow-up Period|Withdrawal by Subject|8
3065969|NCT00497146|10533592|P2|Long-term Follow-up Period|Adverse Event|2
3065970|NCT00497146|10533593|P1|Long-term Follow-up Period|Adverse Event|2
3065971|NCT00497146|10533592|P2|Treatment Period|Other Reason|3
3065972|NCT00497146|10533593|P1|Treatment Period|Other Reason|2
3065973|NCT00497146|10533592|P2|Treatment Period|Unable to dose reduce per protocol|1
3065974|NCT00497146|10533593|P1|Treatment Period|Unable to dose reduce per protocol|4
3065975|NCT00497146|10533592|P2|Treatment Period|Change in RAAS inhibitor therapy|2
3065976|NCT00497146|10533593|P1|Treatment Period|Change in RAAS inhibitor therapy|5
3065977|NCT00497146|10533592|P2|Treatment Period|Required dialysis|1
3065978|NCT00497146|10533593|P1|Treatment Period|Required dialysis|4
3065979|NCT00497146|10533592|P2|Treatment Period|Lost to Follow-up|3
3065980|NCT00497146|10533593|P1|Treatment Period|Lost to Follow-up|1
3065981|NCT00497146|10533592|P2|Treatment Period|Withdrawal by Subject|9
3065982|NCT00497146|10533593|P1|Treatment Period|Withdrawal by Subject|5
3065983|NCT00497146|10533592|P2|Treatment Period|Adverse Event|2
3065984|NCT00497146|10533593|P1|Treatment Period|Adverse Event|6
3065985|NCT00496964|10533661|P2|Overall Study|Withdrawal by Subject|1
3065986|NCT00496964|10533662|P1|Overall Study|Withdrawal by Subject|0
3065987|NCT00496873|10533680|P1|Overall Study|Withdrawal by Subject|3
3065988|NCT00496873|10533680|P1|Overall Study|Death|2
3065989|NCT00496873|10533680|P1|Overall Study|Ineligible|2
3065990|NCT00496834|10533713|P2|Overall Study|Blood Pressure control failure|1
3065991|NCT00496834|10533714|P1|Overall Study|Blood Pressure control failure|2
3065992|NCT00496834|10533713|P2|Overall Study|Lost to Follow-up|0
3065993|NCT00496834|10533714|P1|Overall Study|Lost to Follow-up|2
3065994|NCT00496834|10533713|P2|Overall Study|IP administration violation|0
3065995|NCT00496834|10533714|P1|Overall Study|IP administration violation|2
3065996|NCT00496834|10533713|P2|Overall Study|Adverse Event|3
3065997|NCT00496834|10533714|P1|Overall Study|Adverse Event|5
3065998|NCT00496834|10533713|P2|Overall Study|Inclusion/exclusion criteria not met|2
3065999|NCT00496834|10533714|P1|Overall Study|Inclusion/exclusion criteria not met|3
3066000|NCT00496834|10533713|P2|Overall Study|Contraindicated medication administered|1
3066001|NCT00496834|10533714|P1|Overall Study|Contraindicated medication administered|0
3066002|NCT00496834|10533713|P2|Overall Study|Withdrawal by Subject|6
3066003|NCT00496834|10533714|P1|Overall Study|Withdrawal by Subject|4
3066004|NCT00496782|10533733|P2|Overall Study|Protocol Violation|2
3066005|NCT00496782|10533734|P1|Overall Study|Protocol Violation|1
3066006|NCT00496769|10533768|P3|Open Label|>=1 reason assigned per patient|1011
3066007|NCT00496769|10533769|P2|Open Label|>=1 reason assigned per patient|0
3066008|NCT00496769|10533770|P1|Open Label|>=1 reason assigned per patient|0
3066009|NCT00496769|10533768|P3|Double Blind|>=1 reason assigned per patient|0
3066010|NCT00496769|10533769|P2|Double Blind|>=1 reason assigned per patient|649
3066011|NCT00496769|10533770|P1|Double Blind|>=1 reason assigned per patient|558
3066012|NCT00496730|10533800|P2|Overall Study|Withdrawal by Subject|2
3066013|NCT00496730|10533801|P1|Overall Study|Withdrawal by Subject|2
3066014|NCT00496730|10533800|P2|Overall Study|Lost to Follow-up|3
3066015|NCT00496730|10533801|P1|Overall Study|Lost to Follow-up|4
3066016|NCT00496626|10533813|P2|Overall Study|Relocated|1
3066017|NCT00496626|10533814|P1|Overall Study|Relocated|0
3066018|NCT00496626|10533813|P2|Overall Study|Withdrawal by Subject|4
3066019|NCT00496626|10533814|P1|Overall Study|Withdrawal by Subject|5
3066020|NCT00496626|10533813|P2|Overall Study|Protocol Violation|0
3066021|NCT00496626|10533814|P1|Overall Study|Protocol Violation|1
3066022|NCT00496626|10533813|P2|Overall Study|Lost to Follow-up|1
3066023|NCT00496626|10533814|P1|Overall Study|Lost to Follow-up|0
3066024|NCT00496587|10533826|P1|Overall Study|Complications unrelated|2
3066025|NCT00496587|10533826|P1|Overall Study|Death|1
3066026|NCT00496587|10533826|P1|Overall Study|Withdrawal by Subject|2
3066027|NCT00496587|10533826|P1|Overall Study|Progressive Disease|24
3066028|NCT00496587|10533826|P1|Overall Study|Adverse Event|2
3066029|NCT00496483|10533832|P1|Overall Study|Lack of Efficacy|1
3066030|NCT00496483|10533832|P1|Overall Study|Adverse Event|2
3066031|NCT00496483|10533832|P1|Overall Study|Not dosed|9
3066032|NCT00496470|10533849|P2|Overall Study|Other reason|2
3066033|NCT00496470|10533850|P1|Overall Study|Other reason|0
3066034|NCT00496470|10533849|P2|Overall Study|Incorrectly enrolled|5
3066035|NCT00496470|10533850|P1|Overall Study|Incorrectly enrolled|13
3066036|NCT00496470|10533849|P2|Overall Study|Withdrawal by Subject|12
3066037|NCT00496470|10533850|P1|Overall Study|Withdrawal by Subject|5
3066038|NCT00496470|10533849|P2|Overall Study|Adverse Event|10
3066039|NCT00496470|10533850|P1|Overall Study|Adverse Event|8
3066040|NCT00496366|10533936|P1|Overall Study|Death|1
3066041|NCT00496197|10533967|P1|Overall Study|Protocol Violation|8
3066042|NCT00496197|10533967|P1|Overall Study|Other|14
3066043|NCT00496197|10533967|P1|Overall Study|Pathogen not isolated baseline specimen|4
3066044|NCT00496197|10533967|P1|Overall Study|Withdrawal by Subject|11
3066045|NCT00496197|10533967|P1|Overall Study|Lost to Follow-up|11
3066046|NCT00496197|10533967|P1|Overall Study|Insufficient bacteriological response|10
3066047|NCT00496197|10533967|P1|Overall Study|Insufficient clinical response|3
3066048|NCT00496197|10533967|P1|Overall Study|Does not meet entrance criteria|5
3066049|NCT00496197|10533967|P1|Overall Study|Adverse Event|13
3066050|NCT00496197|10533967|P1|Overall Study|Discontinued study due to death|43
3066051|NCT00496080|10533994|P1|Overall Study|Physician Decision|6
3066052|NCT00496080|10533994|P1|Overall Study|Withdrawal by Subject|5
3066053|NCT00496080|10533994|P1|Overall Study|Surgical re-intervention|7
3066054|NCT00496080|10533994|P1|Overall Study|Lost to Follow-up|9
3066055|NCT00496054|10534004|P1|Overall Study|Lost to Follow-up|7
3066056|NCT00496054|10534004|P1|Overall Study|Adverse Event|1
3066057|NCT00496015|10534036|P5|Overall Study|Other|0
3066058|NCT00496015|10534037|P4|Overall Study|Other|1
3066059|NCT00496015|10534038|P3|Overall Study|Other|0
3066060|NCT00496015|10534039|P2|Overall Study|Other|0
3066061|NCT00496015|10534040|P1|Overall Study|Other|1
3066062|NCT00495820|10534164|P2|Overall Study|Adverse Event|1
3066063|NCT00495820|10534165|P1|Overall Study|Adverse Event|1
3066064|NCT00495794|10534177|P2|Overall Study|Pharmacist did not activate patient|0
3066065|NCT00495794|10534178|P1|Overall Study|Pharmacist did not activate patient|522
3066066|NCT00495755|10534188|P1|Overall Study|Adverse Event|3
3066067|NCT00495677|10534209|P7|Stage 1 (25 Days)|Adverse Event|0
3066068|NCT00495677|10534210|P6|Stage 1 (25 Days)|Adverse Event|0
3066069|NCT00495677|10534211|P5|Stage 1 (25 Days)|Adverse Event|0
3066070|NCT00495677|10534212|P4|Stage 1 (25 Days)|Adverse Event|0
3066071|NCT00495677|10534213|P3|Stage 1 (25 Days)|Adverse Event|1
3066072|NCT00495677|10534214|P2|Stage 1 (25 Days)|Adverse Event|0
3066073|NCT00495677|10534215|P1|Stage 1 (25 Days)|Adverse Event|0
3066074|NCT00495625|10534270|P1|Overall Study|Did not complete at least 1 42 day cycle|10
3066075|NCT00495612|10534281|P2|Overall Study|Subject's Decision to Withdraw|0
3066076|NCT00495612|10534282|P1|Overall Study|Subject's Decision to Withdraw|3
3066077|NCT00495612|10534281|P2|Overall Study|Lost to Follow-up|0
3066078|NCT00495612|10534282|P1|Overall Study|Lost to Follow-up|1
3066079|NCT00495586|10534300|P2|Overall Study|Withdrawal by Subject|4
3066080|NCT00495586|10534301|P1|Overall Study|Withdrawal by Subject|4
3066081|NCT00495521|10534311|P2|Overall Study|Physician Decision|1
3066082|NCT00495521|10534312|P1|Overall Study|Physician Decision|0
3066083|NCT00495495|10534342|P1|Overall Study|Protocol Violation|99
3066084|NCT00495469|10534362|P7|Overall Study|ST depression at randomisation in ECG|0
3066085|NCT00495469|10534363|P6|Overall Study|ST depression at randomisation in ECG|0
3066086|NCT00495469|10534364|P5|Overall Study|ST depression at randomisation in ECG|0
3066087|NCT00495469|10534365|P4|Overall Study|ST depression at randomisation in ECG|0
3066088|NCT00495469|10534366|P3|Overall Study|ST depression at randomisation in ECG|0
3066089|NCT00495469|10534367|P2|Overall Study|ST depression at randomisation in ECG|1
3066090|NCT00495469|10534368|P1|Overall Study|ST depression at randomisation in ECG|0
3066091|NCT00495469|10534362|P7|Overall Study|Liver function test abnormality|0
3066092|NCT00495469|10534363|P6|Overall Study|Liver function test abnormality|0
3066093|NCT00495469|10534364|P5|Overall Study|Liver function test abnormality|0
3066094|NCT00495469|10534365|P4|Overall Study|Liver function test abnormality|0
3066095|NCT00495469|10534366|P3|Overall Study|Liver function test abnormality|0
3066096|NCT00495469|10534367|P2|Overall Study|Liver function test abnormality|1
3066097|NCT00495469|10534368|P1|Overall Study|Liver function test abnormality|0
3066098|NCT00495469|10534362|P7|Overall Study|Lack of Efficacy|1
3066099|NCT00495469|10534363|P6|Overall Study|Lack of Efficacy|0
3066100|NCT00495469|10534364|P5|Overall Study|Lack of Efficacy|0
3066101|NCT00495469|10534365|P4|Overall Study|Lack of Efficacy|0
3066102|NCT00495469|10534366|P3|Overall Study|Lack of Efficacy|0
3066103|NCT00495469|10534367|P2|Overall Study|Lack of Efficacy|0
3066104|NCT00495469|10534368|P1|Overall Study|Lack of Efficacy|0
3066105|NCT00495469|10534362|P7|Overall Study|Withdrawal by Subject|3
3066106|NCT00495469|10534363|P6|Overall Study|Withdrawal by Subject|2
3066107|NCT00495469|10534364|P5|Overall Study|Withdrawal by Subject|3
3066108|NCT00495469|10534365|P4|Overall Study|Withdrawal by Subject|3
3066109|NCT00495469|10534366|P3|Overall Study|Withdrawal by Subject|1
3066110|NCT00495469|10534367|P2|Overall Study|Withdrawal by Subject|3
3066111|NCT00495469|10534368|P1|Overall Study|Withdrawal by Subject|5
3066112|NCT00495469|10534362|P7|Overall Study|Protocol Violation|0
3066113|NCT00495469|10534363|P6|Overall Study|Protocol Violation|2
3066114|NCT00495469|10534364|P5|Overall Study|Protocol Violation|1
3066115|NCT00495469|10534365|P4|Overall Study|Protocol Violation|0
3066116|NCT00495469|10534366|P3|Overall Study|Protocol Violation|0
3066117|NCT00495469|10534367|P2|Overall Study|Protocol Violation|0
3066118|NCT00495469|10534368|P1|Overall Study|Protocol Violation|0
3066119|NCT00495469|10534362|P7|Overall Study|Lost to Follow-up|0
3066120|NCT00495469|10534363|P6|Overall Study|Lost to Follow-up|0
3066121|NCT00495469|10534364|P5|Overall Study|Lost to Follow-up|0
3066122|NCT00495469|10534365|P4|Overall Study|Lost to Follow-up|1
3066123|NCT00495469|10534366|P3|Overall Study|Lost to Follow-up|3
3066124|NCT00495469|10534367|P2|Overall Study|Lost to Follow-up|1
3066125|NCT00495469|10534368|P1|Overall Study|Lost to Follow-up|1
3066126|NCT00495469|10534362|P7|Overall Study|Adverse Event|1
3066127|NCT00495469|10534363|P6|Overall Study|Adverse Event|1
3066128|NCT00495469|10534364|P5|Overall Study|Adverse Event|1
3066129|NCT00495469|10534365|P4|Overall Study|Adverse Event|0
3066130|NCT00495469|10534366|P3|Overall Study|Adverse Event|3
3066131|NCT00495469|10534367|P2|Overall Study|Adverse Event|1
3066132|NCT00495469|10534368|P1|Overall Study|Adverse Event|0
3066133|NCT00495391|10534512|P2|Overall Study|Withdrawal by Subject|3
3066134|NCT00495391|10534513|P1|Overall Study|Withdrawal by Subject|2
3066135|NCT00495391|10534512|P2|Overall Study|Lack of Efficacy|18
3066136|NCT00495391|10534513|P1|Overall Study|Lack of Efficacy|34
3066137|NCT00495170|10534536|P1|Overall Study|Inappropriate staging|8
3066138|NCT00495170|10534536|P1|Overall Study|Withdrawal by Subject|3
3066139|NCT00495170|10534536|P1|Overall Study|Lost to Follow-up|9
3066140|NCT00495131|10534555|P2|Overall Study|Withdrawal by Subject|0
3066141|NCT00495131|10534556|P1|Overall Study|Withdrawal by Subject|1
3066142|NCT00495131|10534555|P2|Overall Study|Lost to Follow-up|2
3066143|NCT00495131|10534556|P1|Overall Study|Lost to Follow-up|0
3066144|NCT00495131|10534555|P2|Overall Study|Lack of Efficacy|2
3066145|NCT00495131|10534556|P1|Overall Study|Lack of Efficacy|0
3066146|NCT00495131|10534555|P2|Overall Study|Adverse Event|2
3066147|NCT00495131|10534556|P1|Overall Study|Adverse Event|6
3066148|NCT00495040|10534573|P1|Overall Study|Withdrawal by Subject|3
3066149|NCT00494871|10534588|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
3066150|NCT00494871|10534589|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
3066151|NCT00494871|10534588|P2|Follow-up (FU) Period|Withdrawal by Subject|5
3066152|NCT00494871|10534589|P1|Follow-up (FU) Period|Withdrawal by Subject|5
3066153|NCT00494871|10534588|P2|Follow-up (FU) Period|Protocol Violation|0
3066154|NCT00494871|10534589|P1|Follow-up (FU) Period|Protocol Violation|1
3066155|NCT00494871|10534588|P2|Follow-up (FU) Period|Physician Decision|1
3066156|NCT00494871|10534589|P1|Follow-up (FU) Period|Physician Decision|0
3066157|NCT00494871|10534588|P2|Follow-up (FU) Period|Lost to Follow-up|2
3066158|NCT00494871|10534589|P1|Follow-up (FU) Period|Lost to Follow-up|6
3066159|NCT00494871|10534588|P2|Follow-up (FU) Period|Death|12
3066160|NCT00494871|10534589|P1|Follow-up (FU) Period|Death|13
3066161|NCT00494871|10534588|P2|Follow-up (FU) Period|Adverse Event|1
3066162|NCT00494871|10534589|P1|Follow-up (FU) Period|Adverse Event|1
3066163|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
3066164|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
3066165|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
3066166|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
3066167|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
3066168|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
3066169|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
3066170|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
3066171|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
3066172|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
3066173|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
3066174|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
3066175|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
3066176|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
3066177|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
3066178|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
3066179|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Physician Decision|13
3066180|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Physician Decision|4
3066181|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Death|3
3066182|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Death|8
3066183|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
3066184|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
3066185|NCT00494871|10534588|P2|Double-blind (DB) Treatment Period|Adverse Event|70
3066186|NCT00494871|10534589|P1|Double-blind (DB) Treatment Period|Adverse Event|73
3066187|NCT00494780|10534630|P2|Overall Study|Insurance Issues|1
3066188|NCT00494780|10534631|P1|Overall Study|Insurance Issues|0
3066189|NCT00494780|10534630|P2|Overall Study|Residual Tumour Mass|1
3066190|NCT00494780|10534631|P1|Overall Study|Residual Tumour Mass|0
3066191|NCT00494780|10534630|P2|Overall Study|Non-compliance|0
3066192|NCT00494780|10534631|P1|Overall Study|Non-compliance|1
3066193|NCT00494780|10534630|P2|Overall Study|New Treatment|2
3066194|NCT00494780|10534631|P1|Overall Study|New Treatment|2
3066195|NCT00494780|10534630|P2|Overall Study|Progression of Study Disease|8
3066196|NCT00494780|10534631|P1|Overall Study|Progression of Study Disease|7
3066197|NCT00494780|10534630|P2|Overall Study|Withdrew before Dosed|1
3066198|NCT00494780|10534631|P1|Overall Study|Withdrew before Dosed|0
3066199|NCT00494780|10534630|P2|Overall Study|Adverse Event|0
3066200|NCT00494780|10534631|P1|Overall Study|Adverse Event|1
3066201|NCT00494676|10534669|P2|Second Intervention|Withdrawal by Subject|1
3066202|NCT00494676|10534670|P1|Second Intervention|Withdrawal by Subject|1
3066203|NCT00494676|10534669|P2|First Intervention|Withdrawal by Subject|3
3066204|NCT00494676|10534670|P1|First Intervention|Withdrawal by Subject|1
3066205|NCT00494676|10534669|P2|Allocation|Withdrawal by Subject|4
3066206|NCT00494676|10534670|P1|Allocation|Withdrawal by Subject|2
3066207|NCT00494507|10534685|P4|Open-Label Phase|Worsening Disease|2
3066208|NCT00494507|10534686|P3|Open-Label Phase|Worsening Disease|0
3066209|NCT00494507|10534687|P2|Open-Label Phase|Worsening Disease|0
3066210|NCT00494507|10534688|P1|Open-Label Phase|Worsening Disease|0
3066211|NCT00494507|10534685|P4|Open-Label Phase|Adverse Event|3
3066212|NCT00494507|10534686|P3|Open-Label Phase|Adverse Event|5
3066213|NCT00494507|10534687|P2|Open-Label Phase|Adverse Event|1
3066214|NCT00494507|10534688|P1|Open-Label Phase|Adverse Event|0
3066215|NCT00494507|10534685|P4|Double-Blind Phase|Negative DNA test|1
3066216|NCT00494507|10534686|P3|Double-Blind Phase|Negative DNA test|0
3066217|NCT00494507|10534687|P2|Double-Blind Phase|Negative DNA test|0
3066218|NCT00494507|10534688|P1|Double-Blind Phase|Negative DNA test|0
3066219|NCT00494507|10534685|P4|Double-Blind Phase|Subject Non-compliance|0
3066220|NCT00494507|10534686|P3|Double-Blind Phase|Subject Non-compliance|1
3066221|NCT00494507|10534687|P2|Double-Blind Phase|Subject Non-compliance|0
3066222|NCT00494507|10534688|P1|Double-Blind Phase|Subject Non-compliance|0
3066223|NCT00494507|10534685|P4|Double-Blind Phase|Withdrawal by Subject|0
3066224|NCT00494507|10534686|P3|Double-Blind Phase|Withdrawal by Subject|0
3066225|NCT00494507|10534687|P2|Double-Blind Phase|Withdrawal by Subject|0
3066226|NCT00494507|10534688|P1|Double-Blind Phase|Withdrawal by Subject|1
3066227|NCT00494507|10534685|P4|Double-Blind Phase|Adverse Event|0
3066228|NCT00494507|10534686|P3|Double-Blind Phase|Adverse Event|1
3066229|NCT00494507|10534687|P2|Double-Blind Phase|Adverse Event|0
3066230|NCT00494507|10534688|P1|Double-Blind Phase|Adverse Event|2
3066231|NCT00494481|10534755|P2|Overall Study|Never received IP|0
3066232|NCT00494481|10534756|P1|Overall Study|Never received IP|2
3066233|NCT00494481|10534755|P2|Overall Study|Other|0
3066234|NCT00494481|10534756|P1|Overall Study|Other|1
3066235|NCT00494481|10534755|P2|Overall Study|Adverse Event|11
3066236|NCT00494481|10534756|P1|Overall Study|Adverse Event|15
3066237|NCT00494481|10534755|P2|Overall Study|Condition under investigation worsened|13
3066238|NCT00494481|10534756|P1|Overall Study|Condition under investigation worsened|11
3066239|NCT00494442|10534764|P2|Overall Study|Intercurrent illness|1
3066240|NCT00494442|10534765|P1|Overall Study|Intercurrent illness|0
3066241|NCT00494442|10534764|P2|Overall Study|Non-compliance|1
3066242|NCT00494442|10534765|P1|Overall Study|Non-compliance|0
3066243|NCT00494442|10534764|P2|Overall Study|Physician Decision|1
3066244|NCT00494442|10534765|P1|Overall Study|Physician Decision|0
3066245|NCT00494442|10534764|P2|Overall Study|Adverse Event|2
3066246|NCT00494442|10534765|P1|Overall Study|Adverse Event|0
3066247|NCT00494442|10534764|P2|Overall Study|Lack of Efficacy|10
3066248|NCT00494442|10534765|P1|Overall Study|Lack of Efficacy|16
3066249|NCT00494442|10534764|P2|Overall Study|Death|1
3066250|NCT00494442|10534765|P1|Overall Study|Death|1
3066251|NCT00494299|10534781|P2|Overall Study|Protocol Driven Decision Point|22
3066252|NCT00494299|10534782|P1|Overall Study|Protocol Driven Decision Point|11
3066253|NCT00494299|10534781|P2|Overall Study|Site Closed by Sponsor|0
3066254|NCT00494299|10534782|P1|Overall Study|Site Closed by Sponsor|6
3066255|NCT00494299|10534781|P2|Overall Study|Participant Did Not Take Study Drug|2
3066256|NCT00494299|10534782|P1|Overall Study|Participant Did Not Take Study Drug|0
3066257|NCT00494299|10534781|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
3066258|NCT00494299|10534782|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
3066259|NCT00494299|10534781|P2|Overall Study|Withdrawal by Subject|3
3066260|NCT00494299|10534782|P1|Overall Study|Withdrawal by Subject|8
3066261|NCT00494299|10534781|P2|Overall Study|Protocol Violation|2
3066262|NCT00494299|10534782|P1|Overall Study|Protocol Violation|1
3066263|NCT00494299|10534781|P2|Overall Study|Physician Decision|2
3066264|NCT00494299|10534782|P1|Overall Study|Physician Decision|0
3066265|NCT00494299|10534781|P2|Overall Study|Lost to Follow-up|0
3066266|NCT00494299|10534782|P1|Overall Study|Lost to Follow-up|1
3066267|NCT00494299|10534781|P2|Overall Study|Adverse Event|13
3066268|NCT00494299|10534782|P1|Overall Study|Adverse Event|93
3066269|NCT00494234|10534794|P2|Overall Study|Death|1
3066270|NCT00494234|10534795|P1|Overall Study|Death|2
3066271|NCT00494234|10534794|P2|Overall Study|Withdrawal by Subject|0
3066272|NCT00494234|10534795|P1|Overall Study|Withdrawal by Subject|1
3066273|NCT00494234|10534794|P2|Overall Study|Lack of Efficacy|9
3066274|NCT00494234|10534795|P1|Overall Study|Lack of Efficacy|12
3066275|NCT00494221|10534814|P3|Overall Study|Withdrawal by Subject|0
3066276|NCT00494221|10534815|P2|Overall Study|Withdrawal by Subject|2
3066277|NCT00494221|10534816|P1|Overall Study|Withdrawal by Subject|1
3066278|NCT00494221|10534814|P3|Overall Study|Death|14
3066279|NCT00494221|10534815|P2|Overall Study|Death|9
3066280|NCT00494221|10534816|P1|Overall Study|Death|15
3066281|NCT00494091|10534857|P2|Overall Study|Withdrawal by Subject|7
3066282|NCT00494091|10534858|P1|Overall Study|Withdrawal by Subject|0
3066283|NCT00494091|10534857|P2|Overall Study|Other|11
3066284|NCT00494091|10534858|P1|Overall Study|Other|1
3066285|NCT00494091|10534857|P2|Overall Study|Lost to Follow-up|4
3066286|NCT00494091|10534858|P1|Overall Study|Lost to Follow-up|0
3066287|NCT00494091|10534857|P2|Overall Study|Death|54
3066288|NCT00494091|10534858|P1|Overall Study|Death|5
3066289|NCT00494026|10534880|P1|Overall Study|Sponsor Decision|4
3066290|NCT00494013|10534890|P2|Overall Study|Sponsor Decision|1
3066291|NCT00494013|10534891|P1|Overall Study|Sponsor Decision|0
3066292|NCT00494013|10534890|P2|Overall Study|Withdrawal by Subject|14
3066293|NCT00494013|10534891|P1|Overall Study|Withdrawal by Subject|13
3066294|NCT00494013|10534890|P2|Overall Study|Protocol Violation|5
3066295|NCT00494013|10534891|P1|Overall Study|Protocol Violation|8
3066296|NCT00494013|10534890|P2|Overall Study|Physician Decision|5
3066297|NCT00494013|10534891|P1|Overall Study|Physician Decision|3
3066298|NCT00494013|10534890|P2|Overall Study|Lost to Follow-up|6
3066299|NCT00494013|10534891|P1|Overall Study|Lost to Follow-up|5
3066300|NCT00494013|10534890|P2|Overall Study|Entry Criteria Not Met|4
3066301|NCT00494013|10534891|P1|Overall Study|Entry Criteria Not Met|1
3066302|NCT00494013|10534890|P2|Overall Study|Adverse Event|1
3066303|NCT00494013|10534891|P1|Overall Study|Adverse Event|0
3066304|NCT00493974|10534921|P2|Overall Study|Lost to Follow-up|6
3066305|NCT00493974|10534922|P1|Overall Study|Lost to Follow-up|4
3066306|NCT00493974|10534921|P2|Overall Study|Withdrawal by Subject|6
3066307|NCT00493974|10534922|P1|Overall Study|Withdrawal by Subject|8
3066308|NCT00493974|10534921|P2|Overall Study|Death|2
3066309|NCT00493974|10534922|P1|Overall Study|Death|1
3066310|NCT00493779|10534949|P1|Overall Study|Logistical issue at site|1
3066311|NCT00493649|10534956|P1|Overall Study|Other|13
3066312|NCT00493649|10534956|P1|Overall Study|Lost to Follow-up|1
3066313|NCT00493649|10534956|P1|Overall Study|Disease Progression|1
3066314|NCT00493649|10534956|P1|Overall Study|Investigator Request|2
3066315|NCT00493649|10534956|P1|Overall Study|Patient Request|21
3066316|NCT00493649|10534956|P1|Overall Study|Adverse Event|44
3066317|NCT00493636|10534969|P2|Overall Study|Mis-randomization|1
3066318|NCT00493636|10534970|P1|Overall Study|Mis-randomization|1
3066319|NCT00493636|10534969|P2|Overall Study|Disease progression/recurrence/relapse|1
3066320|NCT00493636|10534970|P1|Overall Study|Disease progression/recurrence/relapse|0
3066321|NCT00493636|10534969|P2|Overall Study|Withdrawal by Subject|0
3066322|NCT00493636|10534970|P1|Overall Study|Withdrawal by Subject|1
3066323|NCT00493454|10534984|P1|Overall Study|Withdrawal by Subject|1
3066324|NCT00493311|10534990|P2|Overall Study|Need for rescue medication|2
3066325|NCT00493311|10534991|P1|Overall Study|Need for rescue medication|2
3066326|NCT00493285|10535011|P6|Overall Study|Lost to Follow-up|0
3066327|NCT00493285|10535012|P5|Overall Study|Lost to Follow-up|1
3066328|NCT00493285|10535013|P4|Overall Study|Lost to Follow-up|0
3066329|NCT00493285|10535014|P3|Overall Study|Lost to Follow-up|0
3066330|NCT00493285|10535015|P2|Overall Study|Lost to Follow-up|0
3066331|NCT00493285|10535016|P1|Overall Study|Lost to Follow-up|0
3066332|NCT00493246|10535248|P8|Overall Study|Lost to Follow-up|0
3066333|NCT00493246|10535249|P7|Overall Study|Lost to Follow-up|1
3066334|NCT00493246|10535250|P6|Overall Study|Lost to Follow-up|0
3066335|NCT00493246|10535251|P5|Overall Study|Lost to Follow-up|0
3066336|NCT00493246|10535252|P4|Overall Study|Lost to Follow-up|0
3066337|NCT00493246|10535253|P3|Overall Study|Lost to Follow-up|0
3066338|NCT00493246|10535254|P2|Overall Study|Lost to Follow-up|0
3066339|NCT00493246|10535255|P1|Overall Study|Lost to Follow-up|0
3066340|NCT00493246|10535248|P8|Overall Study|No access to draw blood|0
3066341|NCT00493246|10535249|P7|Overall Study|No access to draw blood|0
3066342|NCT00493246|10535250|P6|Overall Study|No access to draw blood|1
3066343|NCT00493246|10535251|P5|Overall Study|No access to draw blood|0
3066344|NCT00493246|10535252|P4|Overall Study|No access to draw blood|0
3066345|NCT00493246|10535253|P3|Overall Study|No access to draw blood|0
3066346|NCT00493246|10535254|P2|Overall Study|No access to draw blood|0
3066347|NCT00493246|10535255|P1|Overall Study|No access to draw blood|0
3066348|NCT00493246|10535248|P8|Overall Study|Withdrawal by Subject|0
3066349|NCT00493246|10535249|P7|Overall Study|Withdrawal by Subject|0
3066350|NCT00493246|10535250|P6|Overall Study|Withdrawal by Subject|0
3066351|NCT00493246|10535251|P5|Overall Study|Withdrawal by Subject|1
3066352|NCT00493246|10535252|P4|Overall Study|Withdrawal by Subject|0
3066353|NCT00493246|10535253|P3|Overall Study|Withdrawal by Subject|0
3066354|NCT00493246|10535254|P2|Overall Study|Withdrawal by Subject|0
3066355|NCT00493246|10535255|P1|Overall Study|Withdrawal by Subject|0
3066356|NCT00493220|10535319|P6|Third Intervention|Withdrawal by Subject|0
3066357|NCT00493220|10535320|P5|Third Intervention|Withdrawal by Subject|0
3066358|NCT00493220|10535321|P4|Third Intervention|Withdrawal by Subject|0
3066359|NCT00493220|10535322|P3|Third Intervention|Withdrawal by Subject|0
3066360|NCT00493220|10535323|P2|Third Intervention|Withdrawal by Subject|0
3066361|NCT00493220|10535324|P1|Third Intervention|Withdrawal by Subject|1
3066362|NCT00493038|10535352|P2|Follow-up|Lost to Follow-up|0
3066363|NCT00493038|10535353|P1|Follow-up|Lost to Follow-up|1
3066364|NCT00493038|10535352|P2|Treatment|Other|1
3066365|NCT00493038|10535353|P1|Treatment|Other|0
3066366|NCT00493038|10535352|P2|Treatment|Withdrawal by Subject|12
3066367|NCT00493038|10535353|P1|Treatment|Withdrawal by Subject|11
3066368|NCT00493038|10535352|P2|Treatment|Lost to Follow-up|3
3066369|NCT00493038|10535353|P1|Treatment|Lost to Follow-up|5
3066370|NCT00493038|10535352|P2|Treatment|Adverse Event|4
3066371|NCT00493038|10535353|P1|Treatment|Adverse Event|8
3066372|NCT00493025|10535367|P1|Overall Study|Physician Decision|19
3066373|NCT00493012|10535378|P2|Overall Study|Lost to Follow-up|17
3066374|NCT00493012|10535379|P1|Overall Study|Lost to Follow-up|18
3066375|NCT00492921|10535422|P3|Overall Study|Death|1
3066376|NCT00492921|10535423|P2|Overall Study|Death|0
3066377|NCT00492921|10535424|P1|Overall Study|Death|1
3066378|NCT00492856|10535435|P4|Post-consolidation|Observation Arm|0
3066379|NCT00492856|10535436|P3|Post-consolidation|Observation Arm|27
3066380|NCT00492856|10535437|P2|Post-consolidation|Observation Arm|0
3066381|NCT00492856|10535438|P1|Post-consolidation|Observation Arm|0
3066382|NCT00492856|10535435|P4|Post-consolidation|Lost to Follow-up|0
3066383|NCT00492856|10535436|P3|Post-consolidation|Lost to Follow-up|0
3066384|NCT00492856|10535437|P2|Post-consolidation|Lost to Follow-up|2
3066385|NCT00492856|10535438|P1|Post-consolidation|Lost to Follow-up|0
3066386|NCT00492856|10535435|P4|Post-consolidation|Not protocol specified|0
3066387|NCT00492856|10535436|P3|Post-consolidation|Not protocol specified|0
3066388|NCT00492856|10535437|P2|Post-consolidation|Not protocol specified|1
3066389|NCT00492856|10535438|P1|Post-consolidation|Not protocol specified|0
3066390|NCT00492856|10535435|P4|Post-consolidation|Death|0
3066391|NCT00492856|10535436|P3|Post-consolidation|Death|0
3066392|NCT00492856|10535437|P2|Post-consolidation|Death|1
3066393|NCT00492856|10535438|P1|Post-consolidation|Death|0
3066394|NCT00492856|10535435|P4|Post-consolidation|Withdrawal by Subject|0
3066395|NCT00492856|10535436|P3|Post-consolidation|Withdrawal by Subject|0
3066396|NCT00492856|10535437|P2|Post-consolidation|Withdrawal by Subject|4
3066397|NCT00492856|10535438|P1|Post-consolidation|Withdrawal by Subject|0
3066398|NCT00492856|10535435|P4|Post-consolidation|Adverse Event|1
3066399|NCT00492856|10535436|P3|Post-consolidation|Adverse Event|0
3066400|NCT00492856|10535437|P2|Post-consolidation|Adverse Event|4
3066401|NCT00492856|10535438|P1|Post-consolidation|Adverse Event|0
3066402|NCT00492856|10535435|P4|Consolidation|Lost to Follow-up|0
3066403|NCT00492856|10535436|P3|Consolidation|Lost to Follow-up|0
3066404|NCT00492856|10535437|P2|Consolidation|Lost to Follow-up|0
3066405|NCT00492856|10535438|P1|Consolidation|Lost to Follow-up|1
3066406|NCT00492856|10535435|P4|Consolidation|Not protocol specified|0
3066407|NCT00492856|10535436|P3|Consolidation|Not protocol specified|0
3066408|NCT00492856|10535437|P2|Consolidation|Not protocol specified|0
3066409|NCT00492856|10535438|P1|Consolidation|Not protocol specified|2
3066410|NCT00492856|10535435|P4|Consolidation|Adverse Event|0
3066411|NCT00492856|10535436|P3|Consolidation|Adverse Event|0
3066412|NCT00492856|10535437|P2|Consolidation|Adverse Event|0
3066413|NCT00492856|10535438|P1|Consolidation|Adverse Event|6
3066414|NCT00492856|10535435|P4|Induction|Death|0
3066415|NCT00492856|10535436|P3|Induction|Death|0
3066416|NCT00492856|10535437|P2|Induction|Death|0
3066417|NCT00492856|10535438|P1|Induction|Death|3
3066418|NCT00492856|10535435|P4|Induction|Withdrawal by Subject|0
3066419|NCT00492856|10535436|P3|Induction|Withdrawal by Subject|0
3066420|NCT00492856|10535437|P2|Induction|Withdrawal by Subject|0
3066421|NCT00492856|10535438|P1|Induction|Withdrawal by Subject|1
3066422|NCT00492856|10535435|P4|Induction|Adverse Event|0
3066423|NCT00492856|10535436|P3|Induction|Adverse Event|0
3066424|NCT00492856|10535437|P2|Induction|Adverse Event|0
3066425|NCT00492856|10535438|P1|Induction|Adverse Event|2
3066426|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
3066427|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
3066428|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
3066429|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
3066430|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
3066431|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
3066432|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
3066433|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
3066434|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
3066435|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
3066436|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
3066437|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
3066438|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
3066439|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
3066440|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
3066441|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
3066442|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
3066443|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
3066444|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
3066445|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
3066446|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
3066447|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
3066448|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
3066449|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
3066450|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Death|1
3066451|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Death|45
3066452|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Death|5
3066453|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Death|75
3066454|NCT00492752|10535452|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
3066455|NCT00492752|10535453|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
3066456|NCT00492752|10535454|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
3066457|NCT00492752|10535455|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
3066458|NCT00492752|10535452|P4|Double Blind Treatment|Protocol Violation|0
3066459|NCT00492752|10535453|P3|Double Blind Treatment|Protocol Violation|1
3066460|NCT00492752|10535454|P2|Double Blind Treatment|Protocol Violation|0
3066461|NCT00492752|10535455|P1|Double Blind Treatment|Protocol Violation|0
3066462|NCT00492752|10535452|P4|Double Blind Treatment|Adverse Event|0
3066463|NCT00492752|10535453|P3|Double Blind Treatment|Adverse Event|0
3066464|NCT00492752|10535454|P2|Double Blind Treatment|Adverse Event|0
3066465|NCT00492752|10535455|P1|Double Blind Treatment|Adverse Event|1
3066466|NCT00492752|10535452|P4|Double Blind Treatment|Death|0
3066467|NCT00492752|10535453|P3|Double Blind Treatment|Death|2
3066468|NCT00492752|10535454|P2|Double Blind Treatment|Death|0
3066469|NCT00492752|10535455|P1|Double Blind Treatment|Death|13
3066470|NCT00492726|10535490|P2|Overall Study|Non compliant with study medication|3
3066471|NCT00492726|10535491|P1|Overall Study|Non compliant with study medication|0
3066472|NCT00492726|10535490|P2|Overall Study|Withdrawal by Subject|3
3066473|NCT00492726|10535491|P1|Overall Study|Withdrawal by Subject|6
3066474|NCT00492726|10535490|P2|Overall Study|Physician Decision|1
3066475|NCT00492726|10535491|P1|Overall Study|Physician Decision|0
3066476|NCT00492726|10535490|P2|Overall Study|Lost to Follow-up|19
3066477|NCT00492726|10535491|P1|Overall Study|Lost to Follow-up|27
3066478|NCT00492726|10535490|P2|Overall Study|Lack of Efficacy|2
3066479|NCT00492726|10535491|P1|Overall Study|Lack of Efficacy|0
3066480|NCT00492726|10535490|P2|Overall Study|Death|2
3066481|NCT00492726|10535491|P1|Overall Study|Death|7
3066482|NCT00492726|10535490|P2|Overall Study|Adverse Event|6
3066483|NCT00492726|10535491|P1|Overall Study|Adverse Event|10
3066484|NCT00492648|10535517|P2|Month 30 (109671 Study)|Protocol Violation|1
3066485|NCT00492648|10535518|P1|Month 30 (109671 Study)|Protocol Violation|0
3066486|NCT00492557|10535565|P2|Overall Study|Lost to Follow-up|1
3066487|NCT00492557|10535566|P1|Overall Study|Lost to Follow-up|0
3066488|NCT00492557|10535565|P2|Overall Study|Failed to return|0
3066489|NCT00492557|10535566|P1|Overall Study|Failed to return|1
3066490|NCT00492557|10535565|P2|Overall Study|Adverse Event|0
3066491|NCT00492557|10535566|P1|Overall Study|Adverse Event|1
3066492|NCT00492557|10535565|P2|Overall Study|Death|1
3066493|NCT00492557|10535566|P1|Overall Study|Death|1
3066494|NCT00492557|10535565|P2|Overall Study|Other|2
3066495|NCT00492557|10535566|P1|Overall Study|Other|2
3066496|NCT00492557|10535565|P2|Overall Study|Protocol Violation|8
3066497|NCT00492557|10535566|P1|Overall Study|Protocol Violation|7
3066498|NCT00492557|10535565|P2|Overall Study|Subject request|11
3066499|NCT00492557|10535566|P1|Overall Study|Subject request|12
3066500|NCT00492531|10535596|P2|Overall Study|Withdrawn(More than one reason selected)|23
3066501|NCT00492531|10535597|P1|Overall Study|Withdrawn(More than one reason selected)|22
3066502|NCT00492297|10535670|P1|Survival Only Follow-up|Study terminated by sponsor|12
3066503|NCT00492297|10535670|P1|Survival Only Follow-up|Lack of Efficacy|1
3066504|NCT00492297|10535670|P1|Survival Only Follow-up|Death|46
3066505|NCT00492297|10535670|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
3066506|NCT00492297|10535670|P1|Active Follow-up 30(+4) Days Duration|Death|17
3066507|NCT00492297|10535670|P1|Treatment|Study terminated by sponsor|3
3066508|NCT00492297|10535670|P1|Treatment|Death|2
3066509|NCT00492284|10535688|P4|Overall Study|Withdrawal by Subject|2
3066510|NCT00492284|10535689|P3|Overall Study|Withdrawal by Subject|0
3066511|NCT00492284|10535690|P2|Overall Study|Withdrawal by Subject|0
3066512|NCT00492284|10535691|P1|Overall Study|Withdrawal by Subject|1
3066513|NCT00492284|10535688|P4|Overall Study|Death|5
3066514|NCT00492284|10535689|P3|Overall Study|Death|2
3066515|NCT00492284|10535690|P2|Overall Study|Death|3
3066516|NCT00492284|10535691|P1|Overall Study|Death|0
3066517|NCT00492284|10535688|P4|Overall Study|Lost to Follow-up|1
3066518|NCT00492284|10535689|P3|Overall Study|Lost to Follow-up|3
3066519|NCT00492284|10535690|P2|Overall Study|Lost to Follow-up|0
3066520|NCT00492284|10535691|P1|Overall Study|Lost to Follow-up|0
3066521|NCT00492284|10535688|P4|Overall Study|Adverse Event|2
3066522|NCT00492284|10535689|P3|Overall Study|Adverse Event|1
3066523|NCT00492284|10535690|P2|Overall Study|Adverse Event|1
3066524|NCT00492284|10535691|P1|Overall Study|Adverse Event|0
3066525|NCT00492232|10535735|P2|Open-Label Treatment|Withdrawal by Subject|0
3066526|NCT00492232|10535736|P1|Open-Label Treatment|Withdrawal by Subject|1
3066527|NCT00492232|10535735|P2|Double-Blind Treatment|Randomized not treated|0
3066528|NCT00492232|10535736|P1|Double-Blind Treatment|Randomized not treated|1
3066529|NCT00492232|10535735|P2|Double-Blind Treatment|Other|5
3066530|NCT00492232|10535736|P1|Double-Blind Treatment|Other|6
3066531|NCT00492232|10535735|P2|Double-Blind Treatment|Lack of Efficacy|0
3066532|NCT00492232|10535736|P1|Double-Blind Treatment|Lack of Efficacy|1
3066533|NCT00492232|10535735|P2|Double-Blind Treatment|Withdrawal by Subject|8
3066534|NCT00492232|10535736|P1|Double-Blind Treatment|Withdrawal by Subject|4
3066535|NCT00492232|10535735|P2|Double-Blind Treatment|Lost to Follow-up|3
3066536|NCT00492232|10535736|P1|Double-Blind Treatment|Lost to Follow-up|2
3066537|NCT00492232|10535735|P2|Double-Blind Treatment|Protocol Violation|7
3066538|NCT00492232|10535736|P1|Double-Blind Treatment|Protocol Violation|3
3066539|NCT00492232|10535735|P2|Double-Blind Treatment|Adverse Event|2
3066540|NCT00492232|10535736|P1|Double-Blind Treatment|Adverse Event|1
3066541|NCT00492232|10535735|P2|Placebo Run-in|Missing|2
3066542|NCT00492232|10535736|P1|Placebo Run-in|Missing|0
3066543|NCT00492232|10535735|P2|Placebo Run-in|Other|6
3066544|NCT00492232|10535736|P1|Placebo Run-in|Other|0
3066545|NCT00492232|10535735|P2|Placebo Run-in|Entrance criteria not met|45
3066546|NCT00492232|10535736|P1|Placebo Run-in|Entrance criteria not met|0
3066547|NCT00492232|10535735|P2|Placebo Run-in|Pregnancy|1
3066548|NCT00492232|10535736|P1|Placebo Run-in|Pregnancy|0
3066549|NCT00492232|10535735|P2|Placebo Run-in|Withdrawal by Subject|8
3066550|NCT00492232|10535736|P1|Placebo Run-in|Withdrawal by Subject|0
3066551|NCT00492232|10535735|P2|Placebo Run-in|Lost to Follow-up|3
3066552|NCT00492232|10535736|P1|Placebo Run-in|Lost to Follow-up|0
3066553|NCT00492232|10535735|P2|Placebo Run-in|Protocol Violation|3
3066554|NCT00492232|10535736|P1|Placebo Run-in|Protocol Violation|0
3066555|NCT00492232|10535735|P2|Placebo Run-in|Adverse Event|2
3066556|NCT00492232|10535736|P1|Placebo Run-in|Adverse Event|0
3066557|NCT00492115|10535777|P2|Overall Study|Withdrawal by Subject|4
3066558|NCT00492115|10535778|P1|Overall Study|Withdrawal by Subject|3
3066559|NCT00492063|10535799|P4|Overall Study|Protocol Violation|1
3066560|NCT00492063|10535800|P3|Overall Study|Protocol Violation|0
3066561|NCT00492063|10535801|P2|Overall Study|Protocol Violation|0
3066562|NCT00492063|10535802|P1|Overall Study|Protocol Violation|0
3066563|NCT00492063|10535799|P4|Overall Study|Lost to Follow-up|3
3066564|NCT00492063|10535800|P3|Overall Study|Lost to Follow-up|5
3066565|NCT00492063|10535801|P2|Overall Study|Lost to Follow-up|11
3066566|NCT00492063|10535802|P1|Overall Study|Lost to Follow-up|6
3066567|NCT00492063|10535799|P4|Overall Study|Withdrawal by Subject|4
3066568|NCT00492063|10535800|P3|Overall Study|Withdrawal by Subject|5
3066569|NCT00492063|10535801|P2|Overall Study|Withdrawal by Subject|3
3066570|NCT00492063|10535802|P1|Overall Study|Withdrawal by Subject|4
3066571|NCT00492063|10535799|P4|Overall Study|Death|2
3066572|NCT00492063|10535800|P3|Overall Study|Death|1
3066573|NCT00492063|10535801|P2|Overall Study|Death|0
3066574|NCT00492063|10535802|P1|Overall Study|Death|0
3066575|NCT00492024|10535826|P2|Follow up|Lost to Follow-up|1
3066576|NCT00492024|10535827|P1|Follow up|Lost to Follow-up|1
3066577|NCT00492024|10535826|P2|Follow up|Lack of Efficacy|1
3066578|NCT00492024|10535827|P1|Follow up|Lack of Efficacy|0
3066579|NCT00492024|10535826|P2|Treatment|Withdrawal by Subject|0
3066580|NCT00492024|10535827|P1|Treatment|Withdrawal by Subject|2
3066581|NCT00492024|10535826|P2|Treatment|Lost to Follow-up|1
3066582|NCT00492024|10535827|P1|Treatment|Lost to Follow-up|3
3066583|NCT00492024|10535826|P2|Treatment|Lack of Efficacy|20
3066584|NCT00492024|10535827|P1|Treatment|Lack of Efficacy|21
3066585|NCT00492024|10535826|P2|Treatment|Adverse Event|1
3066586|NCT00492024|10535827|P1|Treatment|Adverse Event|3
3066587|NCT00491894|10535843|P1|Overall Study|Other-Intake of prohibited medication|1
3066588|NCT00491894|10535843|P1|Overall Study|Protocol Violation|2
3066589|NCT00491894|10535843|P1|Overall Study|Physician Decision|2
3066590|NCT00491894|10535843|P1|Overall Study|Other-Failed to meet any criteria|2
3066591|NCT00491894|10535843|P1|Overall Study|Lack of Efficacy|2
3066592|NCT00491894|10535843|P1|Overall Study|Lost to Follow-up|3
3066593|NCT00491894|10535843|P1|Overall Study|Death|3
3066594|NCT00491894|10535843|P1|Overall Study|Withdrawal by Subject|5
3066595|NCT00491894|10535843|P1|Overall Study|Adverse Event|14
3066596|NCT00491764|10535870|P6|Overall Study|Administrative|0
3066597|NCT00491764|10535871|P5|Overall Study|Administrative|0
3066598|NCT00491764|10535872|P4|Overall Study|Administrative|1
3066599|NCT00491764|10535873|P3|Overall Study|Administrative|2
3066600|NCT00491764|10535874|P2|Overall Study|Administrative|0
3066601|NCT00491764|10535875|P1|Overall Study|Administrative|1
3066602|NCT00491764|10535870|P6|Overall Study|Did not Meet Protocol Eligibility|1
3066603|NCT00491764|10535871|P5|Overall Study|Did not Meet Protocol Eligibility|1
3066604|NCT00491764|10535872|P4|Overall Study|Did not Meet Protocol Eligibility|0
3066605|NCT00491764|10535873|P3|Overall Study|Did not Meet Protocol Eligibility|1
3066606|NCT00491764|10535874|P2|Overall Study|Did not Meet Protocol Eligibility|1
3066607|NCT00491764|10535875|P1|Overall Study|Did not Meet Protocol Eligibility|0
3066608|NCT00491764|10535870|P6|Overall Study|Non Compliance with the Protocol|0
3066609|NCT00491764|10535871|P5|Overall Study|Non Compliance with the Protocol|0
3066610|NCT00491764|10535872|P4|Overall Study|Non Compliance with the Protocol|0
3066611|NCT00491764|10535873|P3|Overall Study|Non Compliance with the Protocol|0
3066612|NCT00491764|10535874|P2|Overall Study|Non Compliance with the Protocol|0
3066613|NCT00491764|10535875|P1|Overall Study|Non Compliance with the Protocol|1
3066614|NCT00491764|10535870|P6|Overall Study|Withdrawal by Subject|4
3066615|NCT00491764|10535871|P5|Overall Study|Withdrawal by Subject|2
3066616|NCT00491764|10535872|P4|Overall Study|Withdrawal by Subject|2
3066617|NCT00491764|10535873|P3|Overall Study|Withdrawal by Subject|1
3066618|NCT00491764|10535874|P2|Overall Study|Withdrawal by Subject|3
3066619|NCT00491764|10535875|P1|Overall Study|Withdrawal by Subject|2
3066620|NCT00491764|10535870|P6|Overall Study|Lost to Follow-up|3
3066621|NCT00491764|10535871|P5|Overall Study|Lost to Follow-up|0
3066622|NCT00491764|10535872|P4|Overall Study|Lost to Follow-up|1
3066623|NCT00491764|10535873|P3|Overall Study|Lost to Follow-up|0
3066624|NCT00491764|10535874|P2|Overall Study|Lost to Follow-up|1
3066625|NCT00491764|10535875|P1|Overall Study|Lost to Follow-up|0
3066626|NCT00491764|10535870|P6|Overall Study|Adverse Event|1
3066627|NCT00491764|10535871|P5|Overall Study|Adverse Event|0
3066628|NCT00491764|10535872|P4|Overall Study|Adverse Event|4
3066629|NCT00491764|10535873|P3|Overall Study|Adverse Event|4
3066630|NCT00491764|10535874|P2|Overall Study|Adverse Event|2
3066631|NCT00491764|10535875|P1|Overall Study|Adverse Event|1
3066632|NCT00491608|10535923|P1|Overall Study|Withdrawal by Subject|1
3066633|NCT00491608|10535923|P1|Overall Study|Death|2
3066634|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
3066635|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
3066636|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
3066637|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
3066638|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
3066639|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
3066640|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
3066641|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
3066642|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
3066643|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
3066644|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
3066645|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
3066646|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
3066647|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
3066648|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
3066649|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
3066650|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
3066651|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
3066652|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
3066653|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
3066654|NCT00491556|10535934|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
3066655|NCT00491556|10535935|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
3066656|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
3066657|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
3066658|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
3066659|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
3066660|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
3066661|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
3066662|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
3066663|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
3066664|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
3066665|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
3066666|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
3066667|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
3066668|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
3066669|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
3066670|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
3066671|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
3066672|NCT00491556|10535934|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
3066673|NCT00491556|10535935|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
3066674|NCT00491530|10535994|P3|Overall Study|Use of Prohibited Medication|1
3066675|NCT00491530|10535995|P2|Overall Study|Use of Prohibited Medication|0
3066676|NCT00491530|10535996|P1|Overall Study|Use of Prohibited Medication|0
3066677|NCT00491530|10535994|P3|Overall Study|Patient Request|0
3066678|NCT00491530|10535995|P2|Overall Study|Patient Request|1
3066679|NCT00491530|10535996|P1|Overall Study|Patient Request|0
3066680|NCT00491530|10535994|P3|Overall Study|Investigator Discretion|0
3066681|NCT00491530|10535995|P2|Overall Study|Investigator Discretion|1
3066682|NCT00491530|10535996|P1|Overall Study|Investigator Discretion|0
3066683|NCT00491530|10535994|P3|Overall Study|Lack of Efficacy|0
3066684|NCT00491530|10535995|P2|Overall Study|Lack of Efficacy|1
3066685|NCT00491530|10535996|P1|Overall Study|Lack of Efficacy|0
3066686|NCT00491530|10535994|P3|Overall Study|Lost to Follow-up|2
3066687|NCT00491530|10535995|P2|Overall Study|Lost to Follow-up|2
3066688|NCT00491530|10535996|P1|Overall Study|Lost to Follow-up|3
3066689|NCT00491530|10535994|P3|Overall Study|Withdrawal by Subject|0
3066690|NCT00491530|10535995|P2|Overall Study|Withdrawal by Subject|0
3066691|NCT00491530|10535996|P1|Overall Study|Withdrawal by Subject|3
3066692|NCT00491530|10535994|P3|Overall Study|Adverse Event|2
3066693|NCT00491530|10535995|P2|Overall Study|Adverse Event|1
3066694|NCT00491530|10535996|P1|Overall Study|Adverse Event|6
3066695|NCT00491504|10536026|P4|Overall Study|Protocol Violation|2
3066696|NCT00491504|10536027|P3|Overall Study|Protocol Violation|3
3066697|NCT00491504|10536028|P2|Overall Study|Protocol Violation|0
3066698|NCT00491504|10536029|P1|Overall Study|Protocol Violation|0
3066699|NCT00491504|10536026|P4|Overall Study|Withdrawal by Subject|2
3066700|NCT00491504|10536027|P3|Overall Study|Withdrawal by Subject|1
3066701|NCT00491504|10536028|P2|Overall Study|Withdrawal by Subject|0
3066702|NCT00491504|10536029|P1|Overall Study|Withdrawal by Subject|0
3066703|NCT00491504|10536026|P4|Overall Study|Adverse Event|0
3066704|NCT00491504|10536027|P3|Overall Study|Adverse Event|0
3066705|NCT00491504|10536028|P2|Overall Study|Adverse Event|1
3066706|NCT00491504|10536029|P1|Overall Study|Adverse Event|0
3066707|NCT00491400|10536039|P2|Overall Study|Withdrawal by Subject|4
3066708|NCT00491400|10536040|P1|Overall Study|Withdrawal by Subject|5
3066709|NCT00491387|10536048|P1|Overall Study|study terminated|20
3066710|NCT00491322|10536063|P2|Overall Study|Pregnancy|1
3066711|NCT00491322|10536064|P1|Overall Study|Pregnancy|0
3066712|NCT00491322|10536063|P2|Overall Study|Protocol Violation|0
3066713|NCT00491322|10536064|P1|Overall Study|Protocol Violation|1
3066714|NCT00491179|10536083|P2|Overall Study|Withdrawal by Subject|1
3066715|NCT00491179|10536084|P1|Overall Study|Withdrawal by Subject|2
3066716|NCT00491179|10536083|P2|Overall Study|Adverse Event|1
3066717|NCT00491179|10536084|P1|Overall Study|Adverse Event|5
3066718|NCT00491075|10536092|P1|Overall Study|Physician Decision|1
3066719|NCT00491075|10536092|P1|Overall Study|Withdrawal by Subject|1
3066720|NCT00490971|10536098|P5|Maintenance|Other|3
3066721|NCT00490971|10536099|P4|Maintenance|Other|9
3066722|NCT00490971|10536100|P3|Maintenance|Other|11
3066723|NCT00490971|10536101|P2|Maintenance|Other|0
3066724|NCT00490971|10536102|P1|Maintenance|Other|0
3066725|NCT00490971|10536098|P5|Maintenance|Withdrawal by Subject|18
3066726|NCT00490971|10536099|P4|Maintenance|Withdrawal by Subject|28
3066727|NCT00490971|10536100|P3|Maintenance|Withdrawal by Subject|26
3066728|NCT00490971|10536101|P2|Maintenance|Withdrawal by Subject|0
3066729|NCT00490971|10536102|P1|Maintenance|Withdrawal by Subject|0
3066730|NCT00490971|10536098|P5|Maintenance|Protocol Violation|1
3066731|NCT00490971|10536099|P4|Maintenance|Protocol Violation|1
3066732|NCT00490971|10536100|P3|Maintenance|Protocol Violation|4
3066733|NCT00490971|10536101|P2|Maintenance|Protocol Violation|0
3066734|NCT00490971|10536102|P1|Maintenance|Protocol Violation|0
3066735|NCT00490971|10536098|P5|Maintenance|Pregnancy|0
3066736|NCT00490971|10536099|P4|Maintenance|Pregnancy|0
3066737|NCT00490971|10536100|P3|Maintenance|Pregnancy|1
3066738|NCT00490971|10536101|P2|Maintenance|Pregnancy|0
3066739|NCT00490971|10536102|P1|Maintenance|Pregnancy|0
3066740|NCT00490971|10536098|P5|Maintenance|Lost to Follow-up|10
3066741|NCT00490971|10536099|P4|Maintenance|Lost to Follow-up|8
3066742|NCT00490971|10536100|P3|Maintenance|Lost to Follow-up|5
3066743|NCT00490971|10536101|P2|Maintenance|Lost to Follow-up|0
3066744|NCT00490971|10536102|P1|Maintenance|Lost to Follow-up|0
3066745|NCT00490971|10536098|P5|Maintenance|Death|0
3066746|NCT00490971|10536099|P4|Maintenance|Death|2
3066747|NCT00490971|10536100|P3|Maintenance|Death|0
3066748|NCT00490971|10536101|P2|Maintenance|Death|0
3066749|NCT00490971|10536102|P1|Maintenance|Death|0
3066750|NCT00490971|10536098|P5|Maintenance|Adverse Event|7
3066751|NCT00490971|10536099|P4|Maintenance|Adverse Event|5
3066752|NCT00490971|10536100|P3|Maintenance|Adverse Event|4
3066753|NCT00490971|10536101|P2|Maintenance|Adverse Event|0
3066754|NCT00490971|10536102|P1|Maintenance|Adverse Event|0
3066755|NCT00490971|10536098|P5|Acute/Continuation|Other|0
3066756|NCT00490971|10536099|P4|Acute/Continuation|Other|0
3066757|NCT00490971|10536100|P3|Acute/Continuation|Other|0
3066758|NCT00490971|10536101|P2|Acute/Continuation|Other|4
3066759|NCT00490971|10536102|P1|Acute/Continuation|Other|11
3066760|NCT00490971|10536098|P5|Acute/Continuation|Withdrawal by Subject|0
3066761|NCT00490971|10536099|P4|Acute/Continuation|Withdrawal by Subject|0
3066762|NCT00490971|10536100|P3|Acute/Continuation|Withdrawal by Subject|0
3066763|NCT00490971|10536101|P2|Acute/Continuation|Withdrawal by Subject|24
3066764|NCT00490971|10536102|P1|Acute/Continuation|Withdrawal by Subject|92
3066765|NCT00490971|10536098|P5|Acute/Continuation|Protocol Violation|0
3066766|NCT00490971|10536099|P4|Acute/Continuation|Protocol Violation|0
3066767|NCT00490971|10536100|P3|Acute/Continuation|Protocol Violation|0
3066768|NCT00490971|10536101|P2|Acute/Continuation|Protocol Violation|2
3066769|NCT00490971|10536102|P1|Acute/Continuation|Protocol Violation|10
3066770|NCT00490971|10536098|P5|Acute/Continuation|Lost to Follow-up|0
3066771|NCT00490971|10536099|P4|Acute/Continuation|Lost to Follow-up|0
3066772|NCT00490971|10536100|P3|Acute/Continuation|Lost to Follow-up|0
3066773|NCT00490971|10536101|P2|Acute/Continuation|Lost to Follow-up|7
3066774|NCT00490971|10536102|P1|Acute/Continuation|Lost to Follow-up|23
3066775|NCT00490971|10536098|P5|Acute/Continuation|Lack of Efficacy|0
3066776|NCT00490971|10536099|P4|Acute/Continuation|Lack of Efficacy|0
3066777|NCT00490971|10536100|P3|Acute/Continuation|Lack of Efficacy|0
3066778|NCT00490971|10536101|P2|Acute/Continuation|Lack of Efficacy|12
3066779|NCT00490971|10536102|P1|Acute/Continuation|Lack of Efficacy|106
3066780|NCT00490971|10536098|P5|Acute/Continuation|Death|0
3066781|NCT00490971|10536099|P4|Acute/Continuation|Death|0
3066782|NCT00490971|10536100|P3|Acute/Continuation|Death|0
3066783|NCT00490971|10536101|P2|Acute/Continuation|Death|0
3066784|NCT00490971|10536102|P1|Acute/Continuation|Death|2
3066785|NCT00490971|10536098|P5|Acute/Continuation|Adverse Event|0
3066786|NCT00490971|10536099|P4|Acute/Continuation|Adverse Event|0
3066787|NCT00490971|10536100|P3|Acute/Continuation|Adverse Event|0
3066788|NCT00490971|10536101|P2|Acute/Continuation|Adverse Event|13
3066789|NCT00490971|10536102|P1|Acute/Continuation|Adverse Event|62
3066790|NCT00490945|10536149|P5|Overall Study|Adverse Event|0
3066791|NCT00490945|10536150|P4|Overall Study|Adverse Event|0
3066792|NCT00490945|10536151|P3|Overall Study|Adverse Event|0
3066793|NCT00490945|10536152|P2|Overall Study|Adverse Event|1
3066794|NCT00490945|10536153|P1|Overall Study|Adverse Event|0
3066795|NCT00490919|10536189|P3|Double-blind Phase|Administrative|6
3066796|NCT00490919|10536190|P2|Double-blind Phase|Administrative|6
3066797|NCT00490919|10536191|P1|Double-blind Phase|Administrative|0
3066798|NCT00490919|10536189|P3|Double-blind Phase|Lack of Efficacy|36
3066799|NCT00490919|10536190|P2|Double-blind Phase|Lack of Efficacy|22
3066800|NCT00490919|10536191|P1|Double-blind Phase|Lack of Efficacy|0
3066801|NCT00490919|10536189|P3|Double-blind Phase|Lost to Follow-up|11
3066802|NCT00490919|10536190|P2|Double-blind Phase|Lost to Follow-up|8
3066803|NCT00490919|10536191|P1|Double-blind Phase|Lost to Follow-up|0
3066804|NCT00490919|10536189|P3|Double-blind Phase|Withdrawal by Subject|11
3066805|NCT00490919|10536190|P2|Double-blind Phase|Withdrawal by Subject|10
3066806|NCT00490919|10536191|P1|Double-blind Phase|Withdrawal by Subject|0
3066807|NCT00490919|10536189|P3|Double-blind Phase|Adverse Event|20
3066808|NCT00490919|10536190|P2|Double-blind Phase|Adverse Event|40
3066809|NCT00490919|10536191|P1|Double-blind Phase|Adverse Event|0
3066810|NCT00490919|10536189|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
3066811|NCT00490919|10536190|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
3066812|NCT00490919|10536191|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
3066813|NCT00490919|10536189|P3|Open-label Run-in Period|Administrative|0
3066814|NCT00490919|10536190|P2|Open-label Run-in Period|Administrative|0
3066815|NCT00490919|10536191|P1|Open-label Run-in Period|Administrative|40
3066816|NCT00490919|10536189|P3|Open-label Run-in Period|Lack of Efficacy|0
3066817|NCT00490919|10536190|P2|Open-label Run-in Period|Lack of Efficacy|0
3066818|NCT00490919|10536191|P1|Open-label Run-in Period|Lack of Efficacy|143
3066819|NCT00490919|10536189|P3|Open-label Run-in Period|Lost to Follow-up|0
3066820|NCT00490919|10536190|P2|Open-label Run-in Period|Lost to Follow-up|0
3066821|NCT00490919|10536191|P1|Open-label Run-in Period|Lost to Follow-up|21
3066822|NCT00490919|10536189|P3|Open-label Run-in Period|Withdrawal by Subject|0
3066823|NCT00490919|10536190|P2|Open-label Run-in Period|Withdrawal by Subject|0
3066824|NCT00490919|10536191|P1|Open-label Run-in Period|Withdrawal by Subject|37
3066825|NCT00490919|10536189|P3|Open-label Run-in Period|Adverse Event|0
3066826|NCT00490919|10536190|P2|Open-label Run-in Period|Adverse Event|0
3066827|NCT00490919|10536191|P1|Open-label Run-in Period|Adverse Event|239
3066828|NCT00490841|10536202|P1|Overall Study|30 day f/u, only non-study stent used|3
3066829|NCT00490841|10536202|P1|Overall Study|Lost to Follow-up|1
3066830|NCT00490841|10536202|P1|Overall Study|Withdrawal by Subject|4
3066831|NCT00490841|10536202|P1|Overall Study|Death|5
3066832|NCT00490815|10536224|P2|Overall Study|Death|3
3066833|NCT00490815|10536225|P1|Overall Study|Death|1
3066834|NCT00490815|10536224|P2|Overall Study|Lost to Follow-up|3
3066835|NCT00490815|10536225|P1|Overall Study|Lost to Follow-up|1
3066836|NCT00490815|10536224|P2|Overall Study|Withdrawal by Subject|0
3066837|NCT00490815|10536225|P1|Overall Study|Withdrawal by Subject|4
3066838|NCT00490815|10536224|P2|Overall Study|Adverse Event|3
3066839|NCT00490815|10536225|P1|Overall Study|Adverse Event|2
3066840|NCT00490724|10536253|P3|Period II|Treatment Discontinuation|3
3066841|NCT00490724|10536254|P2|Period II|Treatment Discontinuation|1
3066842|NCT00490724|10536255|P1|Period II|Treatment Discontinuation|3
3066843|NCT00490724|10536253|P3|Period I|Physician Decision|1
3066844|NCT00490724|10536254|P2|Period I|Physician Decision|0
3066845|NCT00490724|10536255|P1|Period I|Physician Decision|0
3066846|NCT00490698|10536320|P1|Overall Study|Physician Decision|2
3066847|NCT00490698|10536320|P1|Overall Study|Disease Progression|7
3066848|NCT00490698|10536320|P1|Overall Study|Withdrawal by Subject|1
3066849|NCT00490646|10536326|P2|Overall Study|Never Treated (withdrew consent)|1
3066850|NCT00490646|10536327|P1|Overall Study|Never Treated (withdrew consent)|0
3066851|NCT00490646|10536326|P2|Overall Study|Never Treated (had an adverse event)|0
3066852|NCT00490646|10536327|P1|Overall Study|Never Treated (had an adverse event)|1
3066853|NCT00490646|10536326|P2|Overall Study|Still on trastuzumab monotherapy|1
3066854|NCT00490646|10536327|P1|Overall Study|Still on trastuzumab monotherapy|1
3066855|NCT00490568|10536347|P1|Overall Study|Participant withdrawal due to surgery|1
3066856|NCT00490568|10536347|P1|Overall Study|Participant died|1
3066857|NCT00490568|10536347|P1|Overall Study|Efficacy related|3
3066858|NCT00490568|10536347|P1|Overall Study|Non-Compliance|7
3066859|NCT00490568|10536347|P1|Overall Study|Investigator decision|3
3066860|NCT00490568|10536347|P1|Overall Study|Unmet inclusion-exclusion criteria|5
3066861|NCT00490568|10536347|P1|Overall Study|Disease progression|4
3066862|NCT00490568|10536347|P1|Overall Study|Legal representative withdrew consent|1
3066863|NCT00490568|10536347|P1|Overall Study|Participant refused follow-up|9
3066864|NCT00490568|10536347|P1|Overall Study|Abnormal ECG|25
3066865|NCT00490568|10536347|P1|Overall Study|Caregiver related|20
3066866|NCT00490568|10536347|P1|Overall Study|Exclusion criteria met|1
3066867|NCT00490568|10536347|P1|Overall Study|Other|1
3066868|NCT00490568|10536347|P1|Overall Study|Still in the study at termination|974
3066869|NCT00490568|10536347|P1|Overall Study|Withdrawal by Subject|135
3066870|NCT00490568|10536347|P1|Overall Study|Protocol Violation|45
3066871|NCT00490568|10536347|P1|Overall Study|Lost to Follow-up|13
3066872|NCT00490568|10536347|P1|Overall Study|Adverse Event|116
3066873|NCT00490555|10536371|P4|Overall Study|noncompliant with drug administration|0
3066874|NCT00490555|10536372|P3|Overall Study|noncompliant with drug administration|2
3066875|NCT00490555|10536373|P2|Overall Study|noncompliant with drug administration|0
3066876|NCT00490555|10536374|P1|Overall Study|noncompliant with drug administration|0
3066877|NCT00490542|10536402|P2|Overall Study|Lack of Efficacy|1
3066878|NCT00490542|10536403|P1|Overall Study|Lack of Efficacy|1
3066879|NCT00490542|10536402|P2|Overall Study|Adverse Event|3
3066880|NCT00490542|10536403|P1|Overall Study|Adverse Event|3
3066881|NCT00490542|10536402|P2|Overall Study|Lost to Follow-up|0
3066882|NCT00490542|10536403|P1|Overall Study|Lost to Follow-up|3
3066883|NCT00490529|10536409|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
3066884|NCT00490529|10536409|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
3066885|NCT00490529|10536409|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
3066886|NCT00490529|10536409|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
3066887|NCT00490529|10536409|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
3066888|NCT00490529|10536409|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
3066889|NCT00490490|10536417|P1|Completed Assessment for TTP|Lost to Follow-up|2
3066890|NCT00490490|10536417|P1|Completed Assessment for TTP|Withdrawal by Subject|1
3066891|NCT00490451|10536434|P2|Overall Study|Progressive Disease|34
3066892|NCT00490451|10536435|P1|Overall Study|Progressive Disease|53
3066893|NCT00490451|10536434|P2|Overall Study|Protocol Violation|0
3066894|NCT00490451|10536435|P1|Overall Study|Protocol Violation|1
3066895|NCT00490451|10536434|P2|Overall Study|Investigator Decision|0
3066896|NCT00490451|10536435|P1|Overall Study|Investigator Decision|1
3066897|NCT00490451|10536434|P2|Overall Study|Withdrawal by Subject|0
3066898|NCT00490451|10536435|P1|Overall Study|Withdrawal by Subject|2
3066899|NCT00490451|10536434|P2|Overall Study|Death|1
3066900|NCT00490451|10536435|P1|Overall Study|Death|3
3066901|NCT00490451|10536434|P2|Overall Study|Adverse Event|3
3066902|NCT00490451|10536435|P1|Overall Study|Adverse Event|3
3066903|NCT00490139|10536477|P4|Overall Study|Participant Withdrew Consent|116
3066904|NCT00490139|10536478|P3|Overall Study|Participant Withdrew Consent|208
3066905|NCT00490139|10536479|P2|Overall Study|Participant Withdrew Consent|110
3066906|NCT00490139|10536480|P1|Overall Study|Participant Withdrew Consent|146
3066907|NCT00490139|10536477|P4|Overall Study|Lost to Follow-up|56
3066908|NCT00490139|10536478|P3|Overall Study|Lost to Follow-up|58
3066909|NCT00490139|10536479|P2|Overall Study|Lost to Follow-up|46
3066910|NCT00490139|10536480|P1|Overall Study|Lost to Follow-up|56
3066911|NCT00490139|10536477|P4|Overall Study|Death|135
3066912|NCT00490139|10536478|P3|Overall Study|Death|168
3066913|NCT00490139|10536479|P2|Overall Study|Death|119
3066914|NCT00490139|10536480|P1|Overall Study|Death|106
3066915|NCT00490061|10536515|P1|Overall Study|Physician Decision|1
3066916|NCT00490035|10536524|P4|Overall Study|AE of unknown type|0
3066917|NCT00490035|10536525|P3|Overall Study|AE of unknown type|2
3066918|NCT00490035|10536526|P2|Overall Study|AE of unknown type|0
3066919|NCT00490035|10536527|P1|Overall Study|AE of unknown type|0
3066920|NCT00490035|10536524|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
3066921|NCT00490035|10536525|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
3066922|NCT00490035|10536526|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
3066923|NCT00490035|10536527|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
3066924|NCT00490035|10536524|P4|Overall Study|AE, serious fatal|0
3066925|NCT00490035|10536525|P3|Overall Study|AE, serious fatal|0
3066926|NCT00490035|10536526|P2|Overall Study|AE, serious fatal|0
3066927|NCT00490035|10536527|P1|Overall Study|AE, serious fatal|1
3066928|NCT00490035|10536524|P4|Overall Study|Other reason|1
3066929|NCT00490035|10536525|P3|Overall Study|Other reason|3
3066930|NCT00490035|10536526|P2|Overall Study|Other reason|1
3066931|NCT00490035|10536527|P1|Overall Study|Other reason|0
3066932|NCT00490035|10536524|P4|Overall Study|Withdrawal by Subject|0
3066933|NCT00490035|10536525|P3|Overall Study|Withdrawal by Subject|1
3066934|NCT00490035|10536526|P2|Overall Study|Withdrawal by Subject|1
3066935|NCT00490035|10536527|P1|Overall Study|Withdrawal by Subject|2
3066936|NCT00490035|10536524|P4|Overall Study|Lost to Follow-up|0
3066937|NCT00490035|10536525|P3|Overall Study|Lost to Follow-up|1
3066938|NCT00490035|10536526|P2|Overall Study|Lost to Follow-up|0
3066939|NCT00490035|10536527|P1|Overall Study|Lost to Follow-up|2
3066940|NCT00490035|10536524|P4|Overall Study|AE, non-serious non-fatal|5
3066941|NCT00490035|10536525|P3|Overall Study|AE, non-serious non-fatal|4
3066942|NCT00490035|10536526|P2|Overall Study|AE, non-serious non-fatal|4
3066943|NCT00490035|10536527|P1|Overall Study|AE, non-serious non-fatal|3
3066944|NCT00490022|10536627|P2|Overall Study|Subject failed to disclose concommitant|1
3066945|NCT00490022|10536628|P1|Overall Study|Subject failed to disclose concommitant|0
3066946|NCT00490022|10536627|P2|Overall Study|Withdrawal by Subject|0
3066947|NCT00490022|10536628|P1|Overall Study|Withdrawal by Subject|1
3066948|NCT00490022|10536627|P2|Overall Study|Adverse Event|2
3066949|NCT00490022|10536628|P1|Overall Study|Adverse Event|0
3066950|NCT00489970|10536645|P3|Persistence Year 9|Other|2
3066951|NCT00489970|10536646|P2|Persistence Year 9|Other|0
3066952|NCT00489970|10536647|P1|Persistence Year 9|Other|1
3066953|NCT00489970|10536645|P3|Persistence Year 9|Lost to Follow-up|3
3066954|NCT00489970|10536646|P2|Persistence Year 9|Lost to Follow-up|2
3066955|NCT00489970|10536647|P1|Persistence Year 9|Lost to Follow-up|2
3066956|NCT00489918|10536751|P5|Overall Study|Physician Decision|0
3066957|NCT00489918|10536752|P4|Overall Study|Physician Decision|0
3066958|NCT00489918|10536753|P3|Overall Study|Physician Decision|1
3066959|NCT00489918|10536754|P2|Overall Study|Physician Decision|0
3066960|NCT00489918|10536755|P1|Overall Study|Physician Decision|0
3066961|NCT00489918|10536751|P5|Overall Study|Lost to Follow-up|0
3066962|NCT00489918|10536752|P4|Overall Study|Lost to Follow-up|1
3066963|NCT00489918|10536753|P3|Overall Study|Lost to Follow-up|1
3066964|NCT00489918|10536754|P2|Overall Study|Lost to Follow-up|0
3066965|NCT00489918|10536755|P1|Overall Study|Lost to Follow-up|0
3066966|NCT00489918|10536751|P5|Overall Study|Adverse Event|0
3066967|NCT00489918|10536752|P4|Overall Study|Adverse Event|0
3066968|NCT00489918|10536753|P3|Overall Study|Adverse Event|1
3066969|NCT00489918|10536754|P2|Overall Study|Adverse Event|1
3066970|NCT00489918|10536755|P1|Overall Study|Adverse Event|0
3066971|NCT00489918|10536751|P5|Overall Study|Withdrawal by Subject|1
3066972|NCT00489918|10536752|P4|Overall Study|Withdrawal by Subject|0
3066973|NCT00489918|10536753|P3|Overall Study|Withdrawal by Subject|1
3066974|NCT00489918|10536754|P2|Overall Study|Withdrawal by Subject|1
3066975|NCT00489918|10536755|P1|Overall Study|Withdrawal by Subject|2
3066976|NCT00489853|10536804|P3|Treatment Period 3|Study specific discontinuation criteria|0
3066977|NCT00489853|10536805|P2|Treatment Period 3|Study specific discontinuation criteria|1
3066978|NCT00489853|10536806|P1|Treatment Period 3|Study specific discontinuation criteria|0
3066979|NCT00489853|10536804|P3|Wash-out Period 2|Study specific discontinuation criteria|2
3066980|NCT00489853|10536805|P2|Wash-out Period 2|Study specific discontinuation criteria|2
3066981|NCT00489853|10536806|P1|Wash-out Period 2|Study specific discontinuation criteria|3
3066982|NCT00489853|10536804|P3|Wash-out Period 2|Adverse Event|0
3066983|NCT00489853|10536805|P2|Wash-out Period 2|Adverse Event|1
3066984|NCT00489853|10536806|P1|Wash-out Period 2|Adverse Event|1
3066985|NCT00489853|10536804|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
3066986|NCT00489853|10536805|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
3066987|NCT00489853|10536806|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
3066988|NCT00489853|10536804|P3|Wash-out Period 1|Protocol Violation|1
3066989|NCT00489853|10536805|P2|Wash-out Period 1|Protocol Violation|1
3066990|NCT00489853|10536806|P1|Wash-out Period 1|Protocol Violation|0
3066991|NCT00489853|10536804|P3|Wash-out Period 1|Adverse Event|1
3066992|NCT00489853|10536805|P2|Wash-out Period 1|Adverse Event|1
3066993|NCT00489853|10536806|P1|Wash-out Period 1|Adverse Event|0
3066994|NCT00489853|10536804|P3|Wash-out Period 1|Withdrawal by Subject|0
3066995|NCT00489853|10536805|P2|Wash-out Period 1|Withdrawal by Subject|0
3066996|NCT00489853|10536806|P1|Wash-out Period 1|Withdrawal by Subject|1
3066997|NCT00489827|10536903|P2|Overall Study|Intraoperative exclusion criteria|1
3066998|NCT00489827|10536904|P1|Overall Study|Intraoperative exclusion criteria|1
3066999|NCT00489827|10536903|P2|Overall Study|Intraoperative exclusion criteria|1
3067000|NCT00489827|10536904|P1|Overall Study|Intraoperative exclusion criteria|1
3067001|NCT00489736|10536928|P2|Overall Study|Not coded/ Not pre-specified|8
3067002|NCT00489736|10536929|P1|Overall Study|Not coded/ Not pre-specified|5
3067003|NCT00489736|10536928|P2|Overall Study|Poor compliance|2
3067004|NCT00489736|10536929|P1|Overall Study|Poor compliance|6
3067005|NCT00489736|10536928|P2|Overall Study|Adverse Event|45
3067006|NCT00489736|10536929|P1|Overall Study|Adverse Event|32
3067007|NCT00489736|10536928|P2|Overall Study|Lack of Efficacy|14
3067008|NCT00489736|10536929|P1|Overall Study|Lack of Efficacy|53
3067009|NCT00489554|10536939|P1|Overall Study|Lost to Follow-up|1
3067010|NCT00489554|10536939|P1|Overall Study|Withdrawal by Subject|1
3067011|NCT00489554|10536939|P1|Overall Study|Adverse Event|2
3067012|NCT00489541|10536959|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
3067013|NCT00489541|10536960|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
3067014|NCT00489541|10536959|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
3067015|NCT00489541|10536960|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
3067016|NCT00489541|10536959|P2|12-Month Clinical Follow-up|Death|2
3067017|NCT00489541|10536960|P1|12-Month Clinical Follow-up|Death|3
3067018|NCT00489541|10536959|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
3067019|NCT00489541|10536960|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
3067020|NCT00489541|10536959|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
3067021|NCT00489541|10536960|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
3067022|NCT00489541|10536959|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
3067023|NCT00489541|10536960|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
3067024|NCT00489489|10536971|P3|Overall Study|Other than above|0
3067025|NCT00489489|10536972|P2|Overall Study|Other than above|1
3067026|NCT00489489|10536973|P1|Overall Study|Other than above|0
3067027|NCT00489489|10536971|P3|Overall Study|Participant did not wish to continue|0
3067028|NCT00489489|10536972|P2|Overall Study|Participant did not wish to continue|1
3067029|NCT00489489|10536973|P1|Overall Study|Participant did not wish to continue|1
3067030|NCT00489489|10536971|P3|Overall Study|Progressive disease|0
3067031|NCT00489489|10536972|P2|Overall Study|Progressive disease|1
3067032|NCT00489489|10536973|P1|Overall Study|Progressive disease|0
3067033|NCT00489489|10536971|P3|Overall Study|Protocol Violation|1
3067034|NCT00489489|10536972|P2|Overall Study|Protocol Violation|0
3067035|NCT00489489|10536973|P1|Overall Study|Protocol Violation|1
3067036|NCT00489489|10536971|P3|Overall Study|Adverse Event|1
3067037|NCT00489489|10536972|P2|Overall Study|Adverse Event|1
3067038|NCT00489489|10536973|P1|Overall Study|Adverse Event|1
3067039|NCT00489489|10536971|P3|Overall Study|Not treated due to protocol violation|1
3067040|NCT00489489|10536972|P2|Overall Study|Not treated due to protocol violation|1
3067041|NCT00489489|10536973|P1|Overall Study|Not treated due to protocol violation|0
3067042|NCT00489476|10537005|P4|Overall Study|Lost to Follow-up|0
3067043|NCT00489476|10537006|P3|Overall Study|Lost to Follow-up|0
3067044|NCT00489476|10537007|P2|Overall Study|Lost to Follow-up|1
3067045|NCT00489476|10537008|P1|Overall Study|Lost to Follow-up|0
3067046|NCT00489424|10537029|P3|Overall Study|Administrative problems|1
3067047|NCT00489424|10537030|P2|Overall Study|Administrative problems|2
3067048|NCT00489424|10537031|P1|Overall Study|Administrative problems|0
3067049|NCT00489424|10537029|P3|Overall Study|Lack of Efficacy|0
3067050|NCT00489424|10537030|P2|Overall Study|Lack of Efficacy|0
3067051|NCT00489424|10537031|P1|Overall Study|Lack of Efficacy|1
3067052|NCT00489424|10537029|P3|Overall Study|Adverse Event|4
3067053|NCT00489424|10537030|P2|Overall Study|Adverse Event|3
3067054|NCT00489424|10537031|P1|Overall Study|Adverse Event|3
3067055|NCT00489411|10537062|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
3067056|NCT00489411|10537063|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
3067057|NCT00489411|10537062|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
3067058|NCT00489411|10537063|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
3067059|NCT00489411|10537062|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
3067060|NCT00489411|10537063|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
3067061|NCT00489411|10537062|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
3067062|NCT00489411|10537063|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
3067063|NCT00489411|10537062|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
3067064|NCT00489411|10537063|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
3067065|NCT00489359|10537077|P2|Overall Study|Adverse Event|16
3067066|NCT00489359|10537078|P1|Overall Study|Adverse Event|0
3067067|NCT00489359|10537077|P2|Overall Study|Withdrawal by Subject|5
3067068|NCT00489359|10537078|P1|Overall Study|Withdrawal by Subject|1
3067069|NCT00489359|10537077|P2|Overall Study|Lost to Follow-up|0
3067070|NCT00489359|10537078|P1|Overall Study|Lost to Follow-up|1
3067071|NCT00489359|10537077|P2|Overall Study|Progressive Disease|6
3067072|NCT00489359|10537078|P1|Overall Study|Progressive Disease|5
3067073|NCT00489359|10537077|P2|Overall Study|Death|2
3067074|NCT00489359|10537078|P1|Overall Study|Death|0
3067075|NCT00489255|10537154|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
3067076|NCT00489255|10537155|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
3067077|NCT00489255|10537154|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
3067078|NCT00489255|10537155|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
3067079|NCT00489255|10537154|P2|Period 3: Days 57 to 84|Adverse Event|3
3067080|NCT00489255|10537155|P1|Period 3: Days 57 to 84|Adverse Event|3
3067081|NCT00489255|10537154|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
3067082|NCT00489255|10537155|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
3067083|NCT00489255|10537154|P2|Period 2: Days 29 to 56|Adverse Event|1
3067084|NCT00489255|10537155|P1|Period 2: Days 29 to 56|Adverse Event|3
3067085|NCT00489255|10537154|P2|Period 1: Days 1 to 28|Noncompliance|0
3067086|NCT00489255|10537155|P1|Period 1: Days 1 to 28|Noncompliance|2
3067087|NCT00489255|10537154|P2|Period 1: Days 1 to 28|Physician Decision|4
3067088|NCT00489255|10537155|P1|Period 1: Days 1 to 28|Physician Decision|1
3067089|NCT00489255|10537154|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
3067090|NCT00489255|10537155|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
3067091|NCT00489255|10537154|P2|Period 1: Days 1 to 28|Adverse Event|8
3067092|NCT00489255|10537155|P1|Period 1: Days 1 to 28|Adverse Event|21
3067093|NCT00489255|10537154|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
3067094|NCT00489255|10537155|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
3067095|NCT00489216|10537203|P1|Overall Study|Adverse Event|1
3067096|NCT00488982|10537216|P3|Course 1|Adverse Event|6
3067097|NCT00488982|10537217|P2|Course 1|Adverse Event|0
3067098|NCT00488982|10537218|P1|Course 1|Adverse Event|0
3067099|NCT00488982|10537216|P3|Course 1|nonprotocol therapy|2
3067100|NCT00488982|10537217|P2|Course 1|nonprotocol therapy|2
3067101|NCT00488982|10537218|P1|Course 1|nonprotocol therapy|0
3067102|NCT00488982|10537216|P3|Course 1|Withdrawal by Subject|2
3067103|NCT00488982|10537217|P2|Course 1|Withdrawal by Subject|8
3067104|NCT00488982|10537218|P1|Course 1|Withdrawal by Subject|0
3067105|NCT00488982|10537216|P3|Course 1|Physician Decision|4
3067106|NCT00488982|10537217|P2|Course 1|Physician Decision|2
3067107|NCT00488982|10537218|P1|Course 1|Physician Decision|0
3067108|NCT00488826|10537241|P3|Overall Study|Protocol Deviations|1
3067109|NCT00488826|10537242|P2|Overall Study|Protocol Deviations|1
3067110|NCT00488826|10537243|P1|Overall Study|Protocol Deviations|2
3067111|NCT00488826|10537241|P3|Overall Study|Lost to Follow-up|0
3067112|NCT00488826|10537242|P2|Overall Study|Lost to Follow-up|1
3067113|NCT00488826|10537243|P1|Overall Study|Lost to Follow-up|5
3067114|NCT00488826|10537241|P3|Overall Study|Adverse Event|4
3067115|NCT00488826|10537242|P2|Overall Study|Adverse Event|15
3067116|NCT00488826|10537243|P1|Overall Study|Adverse Event|9
3067117|NCT00488826|10537241|P3|Overall Study|Protocol Violation|2
3067118|NCT00488826|10537242|P2|Overall Study|Protocol Violation|0
3067119|NCT00488826|10537243|P1|Overall Study|Protocol Violation|0
3067120|NCT00488826|10537241|P3|Overall Study|Withdrawal by Subject|19
3067121|NCT00488826|10537242|P2|Overall Study|Withdrawal by Subject|35
3067122|NCT00488826|10537243|P1|Overall Study|Withdrawal by Subject|40
3067123|NCT00488774|10537258|P4|Overall Study|Lost to Follow-up|1
3067124|NCT00488774|10537259|P3|Overall Study|Lost to Follow-up|1
3067125|NCT00488774|10537260|P2|Overall Study|Lost to Follow-up|0
3067126|NCT00488774|10537261|P1|Overall Study|Lost to Follow-up|0
3067127|NCT00488774|10537258|P4|Overall Study|Other|2
3067128|NCT00488774|10537259|P3|Overall Study|Other|2
3067129|NCT00488774|10537260|P2|Overall Study|Other|3
3067130|NCT00488774|10537261|P1|Overall Study|Other|6
3067131|NCT00488774|10537258|P4|Overall Study|Withdrawal of consent|0
3067132|NCT00488774|10537259|P3|Overall Study|Withdrawal of consent|2
3067133|NCT00488774|10537260|P2|Overall Study|Withdrawal of consent|2
3067134|NCT00488774|10537261|P1|Overall Study|Withdrawal of consent|2
3067135|NCT00488683|10537278|P3|Overall Study|Unable to Classify|0
3067136|NCT00488683|10537279|P2|Overall Study|Unable to Classify|0
3067137|NCT00488683|10537280|P1|Overall Study|Unable to Classify|1
3067138|NCT00488683|10537278|P3|Overall Study|Protocol Violation|0
3067139|NCT00488683|10537279|P2|Overall Study|Protocol Violation|1
3067140|NCT00488683|10537280|P1|Overall Study|Protocol Violation|5
3067141|NCT00488683|10537278|P3|Overall Study|Lost to Follow-up|0
3067142|NCT00488683|10537279|P2|Overall Study|Lost to Follow-up|3
3067143|NCT00488683|10537280|P1|Overall Study|Lost to Follow-up|5
3067144|NCT00488683|10537278|P3|Overall Study|Withdrawal by Subject|2
3067145|NCT00488683|10537279|P2|Overall Study|Withdrawal by Subject|2
3067146|NCT00488683|10537280|P1|Overall Study|Withdrawal by Subject|1
3067147|NCT00488644|10537339|P1|Overall Study|Not Evaluable|1
3067148|NCT00488644|10537339|P1|Overall Study|Not Eligible|1
3067149|NCT00488631|10537349|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067150|NCT00488631|10537350|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
3067151|NCT00488631|10537351|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
3067152|NCT00488631|10537352|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
3067153|NCT00488631|10537353|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067154|NCT00488631|10537354|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067155|NCT00488631|10537355|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067156|NCT00488631|10537356|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067157|NCT00488631|10537357|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067158|NCT00488631|10537358|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
3067159|NCT00488631|10537349|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067160|NCT00488631|10537350|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
3067161|NCT00488631|10537351|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067162|NCT00488631|10537352|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
3067163|NCT00488631|10537353|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067164|NCT00488631|10537354|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067165|NCT00488631|10537355|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067166|NCT00488631|10537356|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067167|NCT00488631|10537357|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067168|NCT00488631|10537358|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
3067169|NCT00488631|10537349|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
3067170|NCT00488631|10537350|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
3067171|NCT00488631|10537351|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
3067172|NCT00488631|10537352|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
3067173|NCT00488631|10537353|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067174|NCT00488631|10537354|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067175|NCT00488631|10537355|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067176|NCT00488631|10537356|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067177|NCT00488631|10537357|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067178|NCT00488631|10537358|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
3067179|NCT00488631|10537349|P10|Open Label Study Extension (Week 54-228)|Death|0
3067180|NCT00488631|10537350|P9|Open Label Study Extension (Week 54-228)|Death|1
3067181|NCT00488631|10537351|P8|Open Label Study Extension (Week 54-228)|Death|0
3067182|NCT00488631|10537352|P7|Open Label Study Extension (Week 54-228)|Death|0
3067183|NCT00488631|10537353|P6|Open Label Study Extension (Week 54-228)|Death|0
3067184|NCT00488631|10537354|P5|Open Label Study Extension (Week 54-228)|Death|0
3067185|NCT00488631|10537355|P4|Open Label Study Extension (Week 54-228)|Death|0
3067186|NCT00488631|10537356|P3|Open Label Study Extension (Week 54-228)|Death|0
3067187|NCT00488631|10537357|P2|Open Label Study Extension (Week 54-228)|Death|0
3067188|NCT00488631|10537358|P1|Open Label Study Extension (Week 54-228)|Death|0
3067189|NCT00488631|10537349|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067190|NCT00488631|10537350|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
3067191|NCT00488631|10537351|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
3067192|NCT00488631|10537352|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
3067193|NCT00488631|10537353|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067194|NCT00488631|10537354|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067195|NCT00488631|10537355|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067196|NCT00488631|10537356|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067197|NCT00488631|10537357|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067198|NCT00488631|10537358|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
3067199|NCT00488631|10537349|P10|Double Blind Period (Week 0-54)|Other|0
3067200|NCT00488631|10537350|P9|Double Blind Period (Week 0-54)|Other|0
3067201|NCT00488631|10537351|P8|Double Blind Period (Week 0-54)|Other|0
3067202|NCT00488631|10537352|P7|Double Blind Period (Week 0-54)|Other|0
3067203|NCT00488631|10537353|P6|Double Blind Period (Week 0-54)|Other|34
3067204|NCT00488631|10537354|P5|Double Blind Period (Week 0-54)|Other|14
3067205|NCT00488631|10537355|P4|Double Blind Period (Week 0-54)|Other|11
3067206|NCT00488631|10537356|P3|Double Blind Period (Week 0-54)|Other|10
3067207|NCT00488631|10537357|P2|Double Blind Period (Week 0-54)|Other|12
3067208|NCT00488631|10537358|P1|Double Blind Period (Week 0-54)|Other|6
3067209|NCT00488631|10537349|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
3067210|NCT00488631|10537350|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
3067211|NCT00488631|10537351|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
3067212|NCT00488631|10537352|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
3067213|NCT00488631|10537353|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
3067214|NCT00488631|10537354|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
3067215|NCT00488631|10537355|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
3067216|NCT00488631|10537356|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
3067217|NCT00488631|10537357|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
3067218|NCT00488631|10537358|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
3067219|NCT00488631|10537349|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
3067220|NCT00488631|10537350|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
3067221|NCT00488631|10537351|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
3067222|NCT00488631|10537352|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
3067223|NCT00488631|10537353|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
3067224|NCT00488631|10537354|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
3067225|NCT00488631|10537355|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
3067226|NCT00488631|10537356|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
3067227|NCT00488631|10537357|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
3067228|NCT00488631|10537358|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
3067229|NCT00488631|10537349|P10|Double Blind Period (Week 0-54)|Death|0
3067230|NCT00488631|10537350|P9|Double Blind Period (Week 0-54)|Death|0
3067231|NCT00488631|10537351|P8|Double Blind Period (Week 0-54)|Death|0
3067232|NCT00488631|10537352|P7|Double Blind Period (Week 0-54)|Death|0
3067233|NCT00488631|10537353|P6|Double Blind Period (Week 0-54)|Death|1
3067234|NCT00488631|10537354|P5|Double Blind Period (Week 0-54)|Death|0
3067235|NCT00488631|10537355|P4|Double Blind Period (Week 0-54)|Death|0
3067236|NCT00488631|10537356|P3|Double Blind Period (Week 0-54)|Death|0
3067237|NCT00488631|10537357|P2|Double Blind Period (Week 0-54)|Death|0
3067238|NCT00488631|10537358|P1|Double Blind Period (Week 0-54)|Death|0
3067239|NCT00488631|10537349|P10|Double Blind Period (Week 0-54)|Adverse Event|0
3067240|NCT00488631|10537350|P9|Double Blind Period (Week 0-54)|Adverse Event|0
3067241|NCT00488631|10537351|P8|Double Blind Period (Week 0-54)|Adverse Event|0
3067242|NCT00488631|10537352|P7|Double Blind Period (Week 0-54)|Adverse Event|0
3067243|NCT00488631|10537353|P6|Double Blind Period (Week 0-54)|Adverse Event|50
3067244|NCT00488631|10537354|P5|Double Blind Period (Week 0-54)|Adverse Event|30
3067245|NCT00488631|10537355|P4|Double Blind Period (Week 0-54)|Adverse Event|12
3067246|NCT00488631|10537356|P3|Double Blind Period (Week 0-54)|Adverse Event|12
3067247|NCT00488631|10537357|P2|Double Blind Period (Week 0-54)|Adverse Event|12
3067248|NCT00488631|10537358|P1|Double Blind Period (Week 0-54)|Adverse Event|17
3067249|NCT00488618|10537395|P2|Overall Study|Lost to Follow-up|0
3067250|NCT00488618|10537396|P1|Overall Study|Lost to Follow-up|1
3067251|NCT00488618|10537395|P2|Overall Study|Withdrawal of Consent|13
3067252|NCT00488618|10537396|P1|Overall Study|Withdrawal of Consent|15
3067253|NCT00488618|10537395|P2|Overall Study|Protocol Violation|2
3067254|NCT00488618|10537396|P1|Overall Study|Protocol Violation|0
3067255|NCT00488618|10537395|P2|Overall Study|Insufficient Therapeutic Response|11
3067256|NCT00488618|10537396|P1|Overall Study|Insufficient Therapeutic Response|18
3067257|NCT00488618|10537395|P2|Overall Study|Adverse Event|17
3067258|NCT00488618|10537396|P1|Overall Study|Adverse Event|13
3067259|NCT00488592|10537404|P1|Overall Study|Enrolled but not treated|1
3067260|NCT00488592|10537404|P1|Overall Study|Disease progression|1
3067261|NCT00488592|10537404|P1|Overall Study|Withdrawal by Subject|1
3067262|NCT00488514|10537408|P1|Overall Study|Increased use of concomitant medication|1
3067263|NCT00488514|10537408|P1|Overall Study|Increase in number of migraines|2
3067264|NCT00488514|10537408|P1|Overall Study|Participant had too few migraines|5
3067265|NCT00488514|10537408|P1|Overall Study|Investigator decision|1
3067266|NCT00488514|10537408|P1|Overall Study|Withdrawn per medical monitor decision|2
3067267|NCT00488514|10537408|P1|Overall Study|Postive drug screen|1
3067268|NCT00488514|10537408|P1|Overall Study|Did not meet criteria for treatment|30
3067269|NCT00488514|10537408|P1|Overall Study|Lack of Efficacy|28
3067270|NCT00488514|10537408|P1|Overall Study|Withdrawal by Subject|106
3067271|NCT00488514|10537408|P1|Overall Study|Protocol Violation|32
3067272|NCT00488514|10537408|P1|Overall Study|Lost to Follow-up|44
3067273|NCT00488514|10537408|P1|Overall Study|Adverse Event|41
3067274|NCT00488475|10537496|P1|Overall Study|Other|1754
3067275|NCT00488345|10537525|P3|Overall Study|Parent/legal guardian request|1
3067276|NCT00488345|10537526|P2|Overall Study|Parent/legal guardian request|1
3067277|NCT00488345|10537527|P1|Overall Study|Parent/legal guardian request|0
3067278|NCT00488345|10537525|P3|Overall Study|Surgical team recommendation|0
3067279|NCT00488345|10537526|P2|Overall Study|Surgical team recommendation|1
3067280|NCT00488345|10537527|P1|Overall Study|Surgical team recommendation|0
3067281|NCT00488345|10537525|P3|Overall Study|Institutional Review Board review|1
3067282|NCT00488345|10537526|P2|Overall Study|Institutional Review Board review|0
3067283|NCT00488345|10537527|P1|Overall Study|Institutional Review Board review|0
3067284|NCT00488345|10537525|P3|Overall Study|Unable to administer antibiotics at home|0
3067285|NCT00488345|10537526|P2|Overall Study|Unable to administer antibiotics at home|1
3067286|NCT00488345|10537527|P1|Overall Study|Unable to administer antibiotics at home|0
3067287|NCT00488345|10537525|P3|Overall Study|Adverse Event|1
3067288|NCT00488345|10537526|P2|Overall Study|Adverse Event|1
3067289|NCT00488345|10537527|P1|Overall Study|Adverse Event|0
3067290|NCT00488319|10537553|P3|Overall Study|Other reasons for withdrawal|12
3067291|NCT00488319|10537554|P2|Overall Study|Other reasons for withdrawal|4
3067292|NCT00488319|10537555|P1|Overall Study|Other reasons for withdrawal|0
3067293|NCT00488319|10537553|P3|Overall Study|Withdrawal by Subject|44
3067294|NCT00488319|10537554|P2|Overall Study|Withdrawal by Subject|20
3067295|NCT00488319|10537555|P1|Overall Study|Withdrawal by Subject|5
3067296|NCT00488319|10537553|P3|Overall Study|Lost to Follow-up|16
3067297|NCT00488319|10537554|P2|Overall Study|Lost to Follow-up|5
3067298|NCT00488319|10537555|P1|Overall Study|Lost to Follow-up|3
3067299|NCT00488319|10537553|P3|Overall Study|Lack of Efficacy|27
3067300|NCT00488319|10537554|P2|Overall Study|Lack of Efficacy|12
3067301|NCT00488319|10537555|P1|Overall Study|Lack of Efficacy|6
3067302|NCT00488319|10537553|P3|Overall Study|Adverse Event|23
3067303|NCT00488319|10537554|P2|Overall Study|Adverse Event|2
3067304|NCT00488319|10537555|P1|Overall Study|Adverse Event|1
3067305|NCT00488293|10537642|P2|Overall Study|Misrandomization/Other Unspecified|1
3067306|NCT00488293|10537643|P1|Overall Study|Misrandomization/Other Unspecified|1
3067307|NCT00488293|10537642|P2|Overall Study|Death|1
3067308|NCT00488293|10537643|P1|Overall Study|Death|2
3067309|NCT00488293|10537642|P2|Overall Study|Withdrawal by Subject|3
3067310|NCT00488293|10537643|P1|Overall Study|Withdrawal by Subject|5
3067311|NCT00488293|10537642|P2|Overall Study|Lost to Follow-up|25
3067312|NCT00488293|10537643|P1|Overall Study|Lost to Follow-up|28
3067313|NCT00488033|10537688|P2|Overall Study|Withdrawal by Subject|0
3067314|NCT00488033|10537689|P1|Overall Study|Withdrawal by Subject|1
3067315|NCT00487981|10537705|P1|Overall Study|Hypothyroidism diagnosis|1
3067316|NCT00487942|10537713|P4|Overall Study|Withdrawal by Subject|0
3067317|NCT00487942|10537714|P3|Overall Study|Withdrawal by Subject|2
3067318|NCT00487942|10537715|P2|Overall Study|Withdrawal by Subject|1
3067319|NCT00487942|10537716|P1|Overall Study|Withdrawal by Subject|0
3067320|NCT00487942|10537713|P4|Overall Study|Protocol Violation|0
3067321|NCT00487942|10537714|P3|Overall Study|Protocol Violation|0
3067322|NCT00487942|10537715|P2|Overall Study|Protocol Violation|1
3067323|NCT00487942|10537716|P1|Overall Study|Protocol Violation|1
3067324|NCT00487942|10537713|P4|Overall Study|Lost to Follow-up|1
3067325|NCT00487942|10537714|P3|Overall Study|Lost to Follow-up|0
3067326|NCT00487942|10537715|P2|Overall Study|Lost to Follow-up|0
3067327|NCT00487942|10537716|P1|Overall Study|Lost to Follow-up|1
3067328|NCT00487942|10537713|P4|Overall Study|Adverse Event|1
3067329|NCT00487942|10537714|P3|Overall Study|Adverse Event|1
3067330|NCT00487942|10537715|P2|Overall Study|Adverse Event|1
3067331|NCT00487942|10537716|P1|Overall Study|Adverse Event|1
3067332|NCT00487825|10538100|P2|Overall Study|Other|2
3067333|NCT00487825|10538101|P1|Overall Study|Other|3
3067334|NCT00487825|10538100|P2|Overall Study|Lack of Efficacy|1
3067335|NCT00487825|10538101|P1|Overall Study|Lack of Efficacy|1
3067336|NCT00487825|10538100|P2|Overall Study|Adverse Event|2
3067337|NCT00487825|10538101|P1|Overall Study|Adverse Event|2
3067338|NCT00487747|10538113|P1|Overall Study|Lack of Efficacy|1
3067339|NCT00487747|10538113|P1|Overall Study|Lost to Follow-up|9
3067340|NCT00487747|10538113|P1|Overall Study|Adverse Event|1
3067341|NCT00487695|10538130|P2|Second Procedure|Withdrawal by Subject|2
3067342|NCT00487695|10538131|P1|Second Procedure|Withdrawal by Subject|1
3067343|NCT00487695|10538130|P2|Second Procedure|active wheezing|1
3067344|NCT00487695|10538131|P1|Second Procedure|active wheezing|0
3067345|NCT00487695|10538130|P2|First Procedure|esophageal stricture found (excl crit)|0
3067346|NCT00487695|10538131|P1|First Procedure|esophageal stricture found (excl crit)|1
3067347|NCT00487695|10538130|P2|First Procedure|active wheezing (did not have procedure)|0
3067348|NCT00487695|10538131|P1|First Procedure|active wheezing (did not have procedure)|1
3067349|NCT00487695|10538130|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
3067350|NCT00487695|10538131|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
3067351|NCT00487578|10538159|P2|Overall Study|Lost to Follow-up|1
3067352|NCT00487578|10538160|P1|Overall Study|Lost to Follow-up|0
3067353|NCT00487578|10538159|P2|Overall Study|Lack of Efficacy|1
3067354|NCT00487578|10538160|P1|Overall Study|Lack of Efficacy|0
3067355|NCT00487578|10538159|P2|Overall Study|Adverse Event|2
3067356|NCT00487578|10538160|P1|Overall Study|Adverse Event|1
3067357|NCT00487552|10538180|P1|Overall Study|Stent not placed|1
3067358|NCT00487552|10538180|P1|Overall Study|Death due to progressive malignancy|2
3067359|NCT00487552|10538180|P1|Overall Study|Unsuccessful magnet placements|3
3067360|NCT00487539|10538189|P4|Overall Study|Other|2
3067361|NCT00487539|10538190|P3|Overall Study|Other|2
3067362|NCT00487539|10538191|P2|Overall Study|Other|1
3067363|NCT00487539|10538192|P1|Overall Study|Other|3
3067364|NCT00487539|10538189|P4|Overall Study|Unsatisfactory therapeutic effect|1
3067365|NCT00487539|10538190|P3|Overall Study|Unsatisfactory therapeutic effect|0
3067366|NCT00487539|10538191|P2|Overall Study|Unsatisfactory therapeutic effect|0
3067367|NCT00487539|10538192|P1|Overall Study|Unsatisfactory therapeutic effect|1
3067368|NCT00487539|10538189|P4|Overall Study|Adverse Event|1
3067369|NCT00487539|10538190|P3|Overall Study|Adverse Event|1
3067370|NCT00487539|10538191|P2|Overall Study|Adverse Event|2
3067371|NCT00487539|10538192|P1|Overall Study|Adverse Event|3
3067372|NCT00487435|10538226|P1|Overall Study|Other|83
3067373|NCT00487435|10538226|P1|Overall Study|Study Medication Non-Compliant|32
3067374|NCT00487435|10538226|P1|Overall Study|Resolution Of Pain|1
3067375|NCT00487435|10538226|P1|Overall Study|Withdrawal by Subject|132
3067376|NCT00487435|10538226|P1|Overall Study|Pregnancy|2
3067377|NCT00487435|10538226|P1|Overall Study|Lost to Follow-up|54
3067378|NCT00487435|10538226|P1|Overall Study|Lack of Efficacy|33
3067379|NCT00487435|10538226|P1|Overall Study|Death|2
3067380|NCT00487435|10538226|P1|Overall Study|Adverse Event|146
3067381|NCT00487279|10538239|P2|Overall Study|Withdrawal by Subject|2
3067382|NCT00487279|10538240|P1|Overall Study|Withdrawal by Subject|0
3067383|NCT00487279|10538239|P2|Overall Study|Death|0
3067384|NCT00487279|10538240|P1|Overall Study|Death|1
3067385|NCT00487240|10538250|P2|Overall Study|Physician Decision|0
3067386|NCT00487240|10538251|P1|Overall Study|Physician Decision|2
3067387|NCT00487240|10538250|P2|Overall Study|Sponsor Decision|1
3067388|NCT00487240|10538251|P1|Overall Study|Sponsor Decision|2
3067389|NCT00487240|10538250|P2|Overall Study|Entry Criteria Not Met|4
3067390|NCT00487240|10538251|P1|Overall Study|Entry Criteria Not Met|3
3067391|NCT00487240|10538250|P2|Overall Study|Protocol Violation|5
3067392|NCT00487240|10538251|P1|Overall Study|Protocol Violation|5
3067393|NCT00487240|10538250|P2|Overall Study|Adverse Event|4
3067394|NCT00487240|10538251|P1|Overall Study|Adverse Event|0
3067395|NCT00487240|10538250|P2|Overall Study|Lost to Follow-up|6
3067396|NCT00487240|10538251|P1|Overall Study|Lost to Follow-up|7
3067397|NCT00487240|10538250|P2|Overall Study|Withdrawal by Subject|6
3067398|NCT00487240|10538251|P1|Overall Study|Withdrawal by Subject|12
3067399|NCT00487188|10538279|P3|Maintenance Phase|Administrative|1
3067400|NCT00487188|10538280|P2|Maintenance Phase|Administrative|0
3067401|NCT00487188|10538281|P1|Maintenance Phase|Administrative|0
3067402|NCT00487188|10538279|P3|Maintenance Phase|Lost to Follow-up|0
3067403|NCT00487188|10538280|P2|Maintenance Phase|Lost to Follow-up|0
3067404|NCT00487188|10538281|P1|Maintenance Phase|Lost to Follow-up|1
3067405|NCT00487188|10538279|P3|Maintenance Phase|Death|0
3067406|NCT00487188|10538280|P2|Maintenance Phase|Death|0
3067407|NCT00487188|10538281|P1|Maintenance Phase|Death|1
3067408|NCT00487188|10538279|P3|Maintenance Phase|Adverse Event|0
3067409|NCT00487188|10538280|P2|Maintenance Phase|Adverse Event|0
3067410|NCT00487188|10538281|P1|Maintenance Phase|Adverse Event|1
3067411|NCT00487188|10538279|P3|Induction Phase|Administrative|0
3067412|NCT00487188|10538280|P2|Induction Phase|Administrative|1
3067413|NCT00487188|10538281|P1|Induction Phase|Administrative|0
3067414|NCT00487188|10538279|P3|Induction Phase|Lost to Follow-up|0
3067415|NCT00487188|10538280|P2|Induction Phase|Lost to Follow-up|2
3067416|NCT00487188|10538281|P1|Induction Phase|Lost to Follow-up|2
3067417|NCT00487188|10538279|P3|Induction Phase|Refused Treatment|0
3067418|NCT00487188|10538280|P2|Induction Phase|Refused Treatment|2
3067419|NCT00487188|10538281|P1|Induction Phase|Refused Treatment|1
3067420|NCT00487188|10538279|P3|Induction Phase|Protocol Violation|0
3067421|NCT00487188|10538280|P2|Induction Phase|Protocol Violation|0
3067422|NCT00487188|10538281|P1|Induction Phase|Protocol Violation|1
3067423|NCT00487188|10538279|P3|Induction Phase|Lack of Efficacy|0
3067424|NCT00487188|10538280|P2|Induction Phase|Lack of Efficacy|1
3067425|NCT00487188|10538281|P1|Induction Phase|Lack of Efficacy|0
3067426|NCT00487188|10538279|P3|Induction Phase|Adverse Event|0
3067427|NCT00487188|10538280|P2|Induction Phase|Adverse Event|0
3067428|NCT00487188|10538281|P1|Induction Phase|Adverse Event|5
3067429|NCT00487188|10538279|P3|Induction Phase|Abnormality of Laboratory Test|0
3067430|NCT00487188|10538280|P2|Induction Phase|Abnormality of Laboratory Test|1
3067431|NCT00487188|10538281|P1|Induction Phase|Abnormality of Laboratory Test|0
3067432|NCT00487162|10538320|P2|Overall Study|Withdrawal by Subject|3
3067433|NCT00487162|10538321|P1|Overall Study|Withdrawal by Subject|2
3067434|NCT00487162|10538320|P2|Overall Study|Physician Decision|1
3067435|NCT00487162|10538321|P1|Overall Study|Physician Decision|0
3067436|NCT00487162|10538320|P2|Overall Study|Adverse Event|1
3067437|NCT00487162|10538321|P1|Overall Study|Adverse Event|0
3067438|NCT00487084|10538332|P3|Overall Study|Did not receive intervention|5
3067439|NCT00487084|10538333|P2|Overall Study|Did not receive intervention|3
3067440|NCT00487084|10538334|P1|Overall Study|Did not receive intervention|4
3067441|NCT00486954|10538355|P5|Randomized Part|Sponsor Terminated Study|13
3067442|NCT00486954|10538356|P4|Randomized Part|Sponsor Terminated Study|19
3067443|NCT00486954|10538357|P3|Randomized Part|Sponsor Terminated Study|0
3067444|NCT00486954|10538358|P2|Randomized Part|Sponsor Terminated Study|0
3067445|NCT00486954|10538359|P1|Randomized Part|Sponsor Terminated Study|0
3067446|NCT00486954|10538355|P5|Randomized Part|Withdrawal by Subject|0
3067447|NCT00486954|10538356|P4|Randomized Part|Withdrawal by Subject|1
3067448|NCT00486954|10538357|P3|Randomized Part|Withdrawal by Subject|0
3067449|NCT00486954|10538358|P2|Randomized Part|Withdrawal by Subject|0
3067450|NCT00486954|10538359|P1|Randomized Part|Withdrawal by Subject|0
3067451|NCT00486954|10538355|P5|Randomized Part|Lost to Follow-up|1
3067452|NCT00486954|10538356|P4|Randomized Part|Lost to Follow-up|0
3067453|NCT00486954|10538357|P3|Randomized Part|Lost to Follow-up|0
3067454|NCT00486954|10538358|P2|Randomized Part|Lost to Follow-up|0
3067455|NCT00486954|10538359|P1|Randomized Part|Lost to Follow-up|0
3067456|NCT00486954|10538355|P5|Pilot Part|Disease Progression|0
3067457|NCT00486954|10538356|P4|Pilot Part|Disease Progression|0
3067458|NCT00486954|10538357|P3|Pilot Part|Disease Progression|1
3067459|NCT00486954|10538358|P2|Pilot Part|Disease Progression|0
3067460|NCT00486954|10538359|P1|Pilot Part|Disease Progression|2
3067461|NCT00486954|10538355|P5|Pilot Part|Adverse Event|0
3067462|NCT00486954|10538356|P4|Pilot Part|Adverse Event|0
3067463|NCT00486954|10538357|P3|Pilot Part|Adverse Event|5
3067464|NCT00486954|10538358|P2|Pilot Part|Adverse Event|0
3067465|NCT00486954|10538359|P1|Pilot Part|Adverse Event|4
3067466|NCT00486902|10538457|P2|Overall Study|No toradol due to hemmorhage or allergy|1
3067467|NCT00486902|10538458|P1|Overall Study|No toradol due to hemmorhage or allergy|3
3067468|NCT00486902|10538457|P2|Overall Study|Did not meet inclusion criteria|0
3067469|NCT00486902|10538458|P1|Overall Study|Did not meet inclusion criteria|1
3067470|NCT00486902|10538457|P2|Overall Study|spinal anesthetic protocal violation|1
3067471|NCT00486902|10538458|P1|Overall Study|spinal anesthetic protocal violation|1
3067472|NCT00486902|10538457|P2|Overall Study|decision for postpartum tubal ligation|1
3067473|NCT00486902|10538458|P1|Overall Study|decision for postpartum tubal ligation|3
3067474|NCT00486902|10538457|P2|Overall Study|Withdrawal by Subject|2
3067475|NCT00486902|10538458|P1|Overall Study|Withdrawal by Subject|1
3067476|NCT00486837|10538525|P2|Overall Study|No sputum, devise issues, exacerbation|4
3067477|NCT00486837|10538526|P1|Overall Study|No sputum, devise issues, exacerbation|3
3067478|NCT00486837|10538525|P2|Overall Study|Protocol Violation|2
3067479|NCT00486837|10538526|P1|Overall Study|Protocol Violation|4
3067480|NCT00486837|10538525|P2|Overall Study|Adverse Event|1
3067481|NCT00486837|10538526|P1|Overall Study|Adverse Event|1
3067482|NCT00486837|10538525|P2|Overall Study|Withdrawal by Subject|0
3067483|NCT00486837|10538526|P1|Overall Study|Withdrawal by Subject|1
3067484|NCT00486811|10538566|P3|Overall Study|All other|7
3067485|NCT00486811|10538567|P2|Overall Study|All other|11
3067486|NCT00486811|10538568|P1|Overall Study|All other|18
3067487|NCT00486811|10538566|P3|Overall Study|Study drug non-compliant|3
3067488|NCT00486811|10538567|P2|Overall Study|Study drug non-compliant|6
3067489|NCT00486811|10538568|P1|Overall Study|Study drug non-compliant|5
3067490|NCT00486811|10538566|P3|Overall Study|Withdrawal by Subject|58
3067491|NCT00486811|10538567|P2|Overall Study|Withdrawal by Subject|44
3067492|NCT00486811|10538568|P1|Overall Study|Withdrawal by Subject|33
3067493|NCT00486811|10538566|P3|Overall Study|Lost to Follow-up|4
3067494|NCT00486811|10538567|P2|Overall Study|Lost to Follow-up|6
3067495|NCT00486811|10538568|P1|Overall Study|Lost to Follow-up|4
3067496|NCT00486811|10538566|P3|Overall Study|Lack of Efficacy|7
3067497|NCT00486811|10538567|P2|Overall Study|Lack of Efficacy|14
3067498|NCT00486811|10538568|P1|Overall Study|Lack of Efficacy|34
3067499|NCT00486811|10538566|P3|Overall Study|Adverse Event|135
3067500|NCT00486811|10538567|P2|Overall Study|Adverse Event|60
3067501|NCT00486811|10538568|P1|Overall Study|Adverse Event|28
3067502|NCT00486759|10538611|P2|Safety Follow-up|Adverse event/intercurrent illness|0
3067503|NCT00486759|10538612|P1|Safety Follow-up|Adverse event/intercurrent illness|4
3067504|NCT00486759|10538611|P2|Safety Follow-up|Refused treatment/did not cooperate|4
3067505|NCT00486759|10538612|P1|Safety Follow-up|Refused treatment/did not cooperate|6
3067506|NCT00486759|10538611|P2|Safety Follow-up|Administrative/not specified|6
3067507|NCT00486759|10538612|P1|Safety Follow-up|Administrative/not specified|8
3067508|NCT00486759|10538611|P2|Safety Follow-up|Failure to return|6
3067509|NCT00486759|10538612|P1|Safety Follow-up|Failure to return|9
3067510|NCT00486759|10538611|P2|Safety Follow-up|Withdrew consent|23
3067511|NCT00486759|10538612|P1|Safety Follow-up|Withdrew consent|32
3067512|NCT00486759|10538611|P2|Safety Follow-up|Death|29
3067513|NCT00486759|10538612|P1|Safety Follow-up|Death|40
3067514|NCT00486759|10538611|P2|Safety Follow-up|Insufficient therapeutic response|50
3067515|NCT00486759|10538612|P1|Safety Follow-up|Insufficient therapeutic response|40
3067516|NCT00486759|10538611|P2|Treatment|Failure to return|1
3067517|NCT00486759|10538612|P1|Treatment|Failure to return|1
3067518|NCT00486759|10538611|P2|Treatment|Other protocol violation|5
3067519|NCT00486759|10538612|P1|Treatment|Other protocol violation|1
3067520|NCT00486759|10538611|P2|Treatment|Violation of selection criteria at entry|3
3067521|NCT00486759|10538612|P1|Treatment|Violation of selection criteria at entry|3
3067522|NCT00486759|10538611|P2|Treatment|Refused treatment|7
3067523|NCT00486759|10538612|P1|Treatment|Refused treatment|10
3067524|NCT00486759|10538611|P2|Treatment|Administrative/reason not specified|21
3067525|NCT00486759|10538612|P1|Treatment|Administrative/reason not specified|17
3067526|NCT00486759|10538611|P2|Treatment|Withdrew consent|12
3067527|NCT00486759|10538612|P1|Treatment|Withdrew consent|15
3067528|NCT00486759|10538611|P2|Treatment|Death|10
3067529|NCT00486759|10538612|P1|Treatment|Death|17
3067530|NCT00486759|10538611|P2|Treatment|Insufficient therapeutic response|39
3067531|NCT00486759|10538612|P1|Treatment|Insufficient therapeutic response|37
3067532|NCT00486759|10538611|P2|Treatment|Adverse event/intercurrent illness|39
3067533|NCT00486759|10538612|P1|Treatment|Adverse event/intercurrent illness|86
3067534|NCT00486720|10538624|P2|Overall Study|Progressive Disease|1
3067535|NCT00486720|10538625|P1|Overall Study|Progressive Disease|0
3067536|NCT00486720|10538624|P2|Overall Study|Withdrawal by Subject|1
3067537|NCT00486720|10538625|P1|Overall Study|Withdrawal by Subject|3
3067538|NCT00486720|10538624|P2|Overall Study|Protocol Violation|0
3067539|NCT00486720|10538625|P1|Overall Study|Protocol Violation|1
3067540|NCT00486720|10538624|P2|Overall Study|Physician Decision|2
3067541|NCT00486720|10538625|P1|Overall Study|Physician Decision|1
3067542|NCT00486720|10538624|P2|Overall Study|Lack of Efficacy|6
3067543|NCT00486720|10538625|P1|Overall Study|Lack of Efficacy|4
3067544|NCT00486720|10538624|P2|Overall Study|Adverse Event|2
3067545|NCT00486720|10538625|P1|Overall Study|Adverse Event|1
3067546|NCT00486603|10538660|P5|Overall Study|Physician Decision|0
3067547|NCT00486603|10538661|P4|Overall Study|Physician Decision|0
3067548|NCT00486603|10538662|P3|Overall Study|Physician Decision|0
3067549|NCT00486603|10538663|P2|Overall Study|Physician Decision|1
3067550|NCT00486603|10538664|P1|Overall Study|Physician Decision|0
3067551|NCT00486603|10538660|P5|Overall Study|Withdrawal by Subject|0
3067552|NCT00486603|10538661|P4|Overall Study|Withdrawal by Subject|0
3067553|NCT00486603|10538662|P3|Overall Study|Withdrawal by Subject|0
3067554|NCT00486603|10538663|P2|Overall Study|Withdrawal by Subject|0
3067555|NCT00486603|10538664|P1|Overall Study|Withdrawal by Subject|1
3067556|NCT00486434|10538712|P2|Overall Study|Personal reasons|6
3067557|NCT00486434|10538713|P1|Overall Study|Personal reasons|5
3067558|NCT00486434|10538712|P2|Overall Study|Death|2
3067559|NCT00486434|10538713|P1|Overall Study|Death|1
3067560|NCT00486434|10538712|P2|Overall Study|Lost to Follow-up|3
3067561|NCT00486434|10538713|P1|Overall Study|Lost to Follow-up|2
3067562|NCT00486434|10538712|P2|Overall Study|Lack of Efficacy|19
3067563|NCT00486434|10538713|P1|Overall Study|Lack of Efficacy|12
3067564|NCT00486434|10538712|P2|Overall Study|Protocol Violation|21
3067565|NCT00486434|10538713|P1|Overall Study|Protocol Violation|22
3067566|NCT00486434|10538712|P2|Overall Study|Adverse Event|44
3067567|NCT00486434|10538713|P1|Overall Study|Adverse Event|118
3067568|NCT00486434|10538712|P2|Overall Study|Withdrawal by Subject|39
3067569|NCT00486434|10538713|P1|Overall Study|Withdrawal by Subject|34
3067570|NCT00486330|10538732|P1|Overall Study|Adverse Event|2
3067571|NCT00486291|10538738|P2|Overall Study|requirement for restricted medication|3
3067572|NCT00486291|10538739|P1|Overall Study|requirement for restricted medication|0
3067573|NCT00486291|10538738|P2|Overall Study|protocol non-compliance|15
3067574|NCT00486291|10538739|P1|Overall Study|protocol non-compliance|10
3067575|NCT00486291|10538738|P2|Overall Study|Lost to Follow-up|7
3067576|NCT00486291|10538739|P1|Overall Study|Lost to Follow-up|3
3067577|NCT00486291|10538738|P2|Overall Study|Adverse Event|4
3067578|NCT00486291|10538739|P1|Overall Study|Adverse Event|3
3067579|NCT00486278|10538747|P1|Overall Study|Physician Decision|2
3067580|NCT00486278|10538747|P1|Overall Study|Withdrawal by Subject|2
3067581|NCT00486278|10538747|P1|Overall Study|Adverse Event|5
3067582|NCT00486265|10538881|P1|Overall Study|Lack of Efficacy|8
3067583|NCT00486265|10538881|P1|Overall Study|Adverse Event|1
3067584|NCT00486252|10538885|P1|Overall Study|Other|18
3067585|NCT00486252|10538885|P1|Overall Study|Lost to Follow-up|24
3067586|NCT00486252|10538885|P1|Overall Study|Lack of Efficacy|9
3067587|NCT00486252|10538885|P1|Overall Study|Adverse Event|7
3067588|NCT00486226|10538900|P1|Overall Study|Lost to Follow-up|8
3067589|NCT00486226|10538900|P1|Overall Study|Withdrawal by Subject|1
3067590|NCT00486226|10538900|P1|Overall Study|Adverse Event|1
3067591|NCT00486226|10538900|P1|Overall Study|Death|3
3067592|NCT00486044|10538910|P2|Overall Study|Lost to Follow-up|1
3067593|NCT00486044|10538911|P1|Overall Study|Lost to Follow-up|0
3067594|NCT00486044|10538910|P2|Overall Study|Adverse Event|1
3067595|NCT00486044|10538911|P1|Overall Study|Adverse Event|0
3067596|NCT00486044|10538910|P2|Overall Study|Withdrawal by Subject|1
3067597|NCT00486044|10538911|P1|Overall Study|Withdrawal by Subject|2
3067598|NCT00485758|10539005|P2|Overall Study|Study Terminated by Sponsor|0
3067599|NCT00485758|10539006|P1|Overall Study|Study Terminated by Sponsor|3
3067600|NCT00485758|10539005|P2|Overall Study|Withdrawal by Subject|27
3067601|NCT00485758|10539006|P1|Overall Study|Withdrawal by Subject|32
3067602|NCT00485758|10539005|P2|Overall Study|Protocol Violation|2
3067603|NCT00485758|10539006|P1|Overall Study|Protocol Violation|11
3067604|NCT00485758|10539005|P2|Overall Study|Physician Decision|3
3067605|NCT00485758|10539006|P1|Overall Study|Physician Decision|3
3067606|NCT00485758|10539005|P2|Overall Study|Lost to Follow-up|1
3067607|NCT00485758|10539006|P1|Overall Study|Lost to Follow-up|5
3067608|NCT00485758|10539005|P2|Overall Study|Death|1
3067609|NCT00485758|10539006|P1|Overall Study|Death|0
3067610|NCT00485758|10539005|P2|Overall Study|Adverse Event|31
3067611|NCT00485758|10539006|P1|Overall Study|Adverse Event|102
3067612|NCT00485732|10539018|P2|Overall Study|Lost to Follow-up|2
3067613|NCT00485732|10539019|P1|Overall Study|Lost to Follow-up|2
3067614|NCT00485732|10539018|P2|Overall Study|Withdrawal by Subject|4
3067615|NCT00485732|10539019|P1|Overall Study|Withdrawal by Subject|5
3067616|NCT00485732|10539018|P2|Overall Study|Protocol Violation|3
3067617|NCT00485732|10539019|P1|Overall Study|Protocol Violation|1
3067618|NCT00485472|10539057|P2|Overall Study|Lost to Follow-up|1
3067619|NCT00485472|10539058|P1|Overall Study|Lost to Follow-up|0
3067620|NCT00485472|10539057|P2|Overall Study|Other|1
3067621|NCT00485472|10539058|P1|Overall Study|Other|2
3067622|NCT00485472|10539057|P2|Overall Study|Protocol Violation|1
3067623|NCT00485472|10539058|P1|Overall Study|Protocol Violation|0
3067624|NCT00485472|10539057|P2|Overall Study|Withdrawal by Subject|0
3067625|NCT00485472|10539058|P1|Overall Study|Withdrawal by Subject|1
3067626|NCT00485472|10539057|P2|Overall Study|Lack of Efficacy|4
3067627|NCT00485472|10539058|P1|Overall Study|Lack of Efficacy|5
3067628|NCT00485472|10539057|P2|Overall Study|Adverse Event|5
3067629|NCT00485472|10539058|P1|Overall Study|Adverse Event|8
3067630|NCT00485303|10539095|P1|Overall Study|Treatment ongoing at cutoff date|2
3067631|NCT00485303|10539095|P1|Overall Study|Initiation of new anti-cancer treatment|2
3067632|NCT00485303|10539095|P1|Overall Study|Other|3
3067633|NCT00485303|10539095|P1|Overall Study|Progressive Disease|44
3067634|NCT00485303|10539095|P1|Overall Study|Adverse Event|5
3067635|NCT00485264|10539113|P6|Overall Study|Other Reason|0
3067636|NCT00485264|10539114|P5|Overall Study|Other Reason|0
3067637|NCT00485264|10539115|P4|Overall Study|Other Reason|0
3067638|NCT00485264|10539116|P3|Overall Study|Other Reason|0
3067639|NCT00485264|10539117|P2|Overall Study|Other Reason|0
3067640|NCT00485264|10539118|P1|Overall Study|Other Reason|3
3067641|NCT00485264|10539113|P6|Overall Study|Lost to Follow-up|1
3067642|NCT00485264|10539114|P5|Overall Study|Lost to Follow-up|0
3067643|NCT00485264|10539115|P4|Overall Study|Lost to Follow-up|0
3067644|NCT00485264|10539116|P3|Overall Study|Lost to Follow-up|1
3067645|NCT00485264|10539117|P2|Overall Study|Lost to Follow-up|1
3067646|NCT00485264|10539118|P1|Overall Study|Lost to Follow-up|2
3067647|NCT00485264|10539113|P6|Overall Study|Non-Compliant|0
3067648|NCT00485264|10539114|P5|Overall Study|Non-Compliant|1
3067649|NCT00485264|10539115|P4|Overall Study|Non-Compliant|0
3067650|NCT00485264|10539116|P3|Overall Study|Non-Compliant|1
3067651|NCT00485264|10539117|P2|Overall Study|Non-Compliant|2
3067652|NCT00485264|10539118|P1|Overall Study|Non-Compliant|17
3067653|NCT00485264|10539113|P6|Overall Study|Not Able to Attend Clinic|2
3067654|NCT00485264|10539114|P5|Overall Study|Not Able to Attend Clinic|1
3067655|NCT00485264|10539115|P4|Overall Study|Not Able to Attend Clinic|1
3067656|NCT00485264|10539116|P3|Overall Study|Not Able to Attend Clinic|0
3067657|NCT00485264|10539117|P2|Overall Study|Not Able to Attend Clinic|0
3067658|NCT00485264|10539118|P1|Overall Study|Not Able to Attend Clinic|5
3067659|NCT00485264|10539113|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
3067660|NCT00485264|10539114|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
3067661|NCT00485264|10539115|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
3067662|NCT00485264|10539116|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
3067663|NCT00485264|10539117|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
3067664|NCT00485264|10539118|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
3067665|NCT00485264|10539113|P6|Overall Study|Physician Decision|0
3067666|NCT00485264|10539114|P5|Overall Study|Physician Decision|0
3067667|NCT00485264|10539115|P4|Overall Study|Physician Decision|0
3067668|NCT00485264|10539116|P3|Overall Study|Physician Decision|0
3067669|NCT00485264|10539117|P2|Overall Study|Physician Decision|2
3067670|NCT00485264|10539118|P1|Overall Study|Physician Decision|0
3067671|NCT00485264|10539113|P6|Overall Study|Guardian Consent Withdrawn|0
3067672|NCT00485264|10539114|P5|Overall Study|Guardian Consent Withdrawn|1
3067673|NCT00485264|10539115|P4|Overall Study|Guardian Consent Withdrawn|0
3067674|NCT00485264|10539116|P3|Overall Study|Guardian Consent Withdrawn|0
3067675|NCT00485264|10539117|P2|Overall Study|Guardian Consent Withdrawn|0
3067676|NCT00485264|10539118|P1|Overall Study|Guardian Consent Withdrawn|1
3067677|NCT00485264|10539113|P6|Overall Study|Lack of Efficacy|0
3067678|NCT00485264|10539114|P5|Overall Study|Lack of Efficacy|0
3067679|NCT00485264|10539115|P4|Overall Study|Lack of Efficacy|0
3067680|NCT00485264|10539116|P3|Overall Study|Lack of Efficacy|0
3067681|NCT00485264|10539117|P2|Overall Study|Lack of Efficacy|1
3067682|NCT00485264|10539118|P1|Overall Study|Lack of Efficacy|0
3067683|NCT00485264|10539113|P6|Overall Study|Number/Volume/Timing of Study Meds|0
3067684|NCT00485264|10539114|P5|Overall Study|Number/Volume/Timing of Study Meds|0
3067685|NCT00485264|10539115|P4|Overall Study|Number/Volume/Timing of Study Meds|0
3067686|NCT00485264|10539116|P3|Overall Study|Number/Volume/Timing of Study Meds|1
3067687|NCT00485264|10539117|P2|Overall Study|Number/Volume/Timing of Study Meds|1
3067688|NCT00485264|10539118|P1|Overall Study|Number/Volume/Timing of Study Meds|2
3067689|NCT00485264|10539113|P6|Overall Study|Disallowed Medication|1
3067690|NCT00485264|10539114|P5|Overall Study|Disallowed Medication|0
3067691|NCT00485264|10539115|P4|Overall Study|Disallowed Medication|0
3067692|NCT00485264|10539116|P3|Overall Study|Disallowed Medication|0
3067693|NCT00485264|10539117|P2|Overall Study|Disallowed Medication|0
3067694|NCT00485264|10539118|P1|Overall Study|Disallowed Medication|0
3067695|NCT00485264|10539113|P6|Overall Study|Pregnancy|0
3067696|NCT00485264|10539114|P5|Overall Study|Pregnancy|0
3067697|NCT00485264|10539115|P4|Overall Study|Pregnancy|0
3067698|NCT00485264|10539116|P3|Overall Study|Pregnancy|0
3067699|NCT00485264|10539117|P2|Overall Study|Pregnancy|0
3067700|NCT00485264|10539118|P1|Overall Study|Pregnancy|4
3067701|NCT00485264|10539113|P6|Overall Study|Adverse Event|3
3067702|NCT00485264|10539114|P5|Overall Study|Adverse Event|1
3067703|NCT00485264|10539115|P4|Overall Study|Adverse Event|3
3067704|NCT00485264|10539116|P3|Overall Study|Adverse Event|2
3067705|NCT00485264|10539117|P2|Overall Study|Adverse Event|0
3067706|NCT00485264|10539118|P1|Overall Study|Adverse Event|1
3067707|NCT00485264|10539113|P6|Overall Study|Death|0
3067708|NCT00485264|10539114|P5|Overall Study|Death|1
3067709|NCT00485264|10539115|P4|Overall Study|Death|0
3067710|NCT00485264|10539116|P3|Overall Study|Death|0
3067711|NCT00485264|10539117|P2|Overall Study|Death|0
3067712|NCT00485264|10539118|P1|Overall Study|Death|1
3067713|NCT00485264|10539113|P6|Overall Study|Enrolled But Not Given Treatment|0
3067714|NCT00485264|10539114|P5|Overall Study|Enrolled But Not Given Treatment|1
3067715|NCT00485264|10539115|P4|Overall Study|Enrolled But Not Given Treatment|0
3067716|NCT00485264|10539116|P3|Overall Study|Enrolled But Not Given Treatment|0
3067717|NCT00485264|10539117|P2|Overall Study|Enrolled But Not Given Treatment|0
3067718|NCT00485264|10539118|P1|Overall Study|Enrolled But Not Given Treatment|0
3067719|NCT00485173|10539206|P2|Overall Study|Lost to Follow-up|61
3067720|NCT00485173|10539207|P1|Overall Study|Lost to Follow-up|32
3067721|NCT00485173|10539206|P2|Overall Study|Death|3
3067722|NCT00485173|10539207|P1|Overall Study|Death|4
3067723|NCT00485134|10539255|P8|Overall Study|Pregnancy|0
3067724|NCT00485134|10539256|P7|Overall Study|Pregnancy|1
3067725|NCT00485134|10539257|P6|Overall Study|Pregnancy|0
3067726|NCT00485134|10539258|P5|Overall Study|Pregnancy|0
3067727|NCT00485134|10539259|P4|Overall Study|Pregnancy|0
3067728|NCT00485134|10539260|P3|Overall Study|Pregnancy|0
3067729|NCT00485134|10539261|P2|Overall Study|Pregnancy|0
3067730|NCT00485134|10539262|P1|Overall Study|Pregnancy|0
3067731|NCT00485134|10539255|P8|Overall Study|Unable to comply with study schedule|1
3067732|NCT00485134|10539256|P7|Overall Study|Unable to comply with study schedule|0
3067733|NCT00485134|10539257|P6|Overall Study|Unable to comply with study schedule|0
3067734|NCT00485134|10539258|P5|Overall Study|Unable to comply with study schedule|0
3067735|NCT00485134|10539259|P4|Overall Study|Unable to comply with study schedule|0
3067736|NCT00485134|10539260|P3|Overall Study|Unable to comply with study schedule|0
3067737|NCT00485134|10539261|P2|Overall Study|Unable to comply with study schedule|0
3067738|NCT00485134|10539262|P1|Overall Study|Unable to comply with study schedule|0
3067739|NCT00485134|10539255|P8|Overall Study|Non-compliance|0
3067740|NCT00485134|10539256|P7|Overall Study|Non-compliance|2
3067741|NCT00485134|10539257|P6|Overall Study|Non-compliance|2
3067742|NCT00485134|10539258|P5|Overall Study|Non-compliance|1
3067743|NCT00485134|10539259|P4|Overall Study|Non-compliance|0
3067744|NCT00485134|10539260|P3|Overall Study|Non-compliance|0
3067745|NCT00485134|10539261|P2|Overall Study|Non-compliance|0
3067746|NCT00485134|10539262|P1|Overall Study|Non-compliance|0
3067747|NCT00485134|10539255|P8|Overall Study|Positive drug test|0
3067748|NCT00485134|10539256|P7|Overall Study|Positive drug test|0
3067749|NCT00485134|10539257|P6|Overall Study|Positive drug test|1
3067750|NCT00485134|10539258|P5|Overall Study|Positive drug test|2
3067751|NCT00485134|10539259|P4|Overall Study|Positive drug test|0
3067752|NCT00485134|10539260|P3|Overall Study|Positive drug test|0
3067753|NCT00485134|10539261|P2|Overall Study|Positive drug test|0
3067754|NCT00485134|10539262|P1|Overall Study|Positive drug test|0
3067755|NCT00485134|10539255|P8|Overall Study|Withdrew for adverse event|0
3067756|NCT00485134|10539256|P7|Overall Study|Withdrew for adverse event|0
3067757|NCT00485134|10539257|P6|Overall Study|Withdrew for adverse event|0
3067758|NCT00485134|10539258|P5|Overall Study|Withdrew for adverse event|0
3067759|NCT00485134|10539259|P4|Overall Study|Withdrew for adverse event|0
3067760|NCT00485134|10539260|P3|Overall Study|Withdrew for adverse event|1
3067761|NCT00485134|10539261|P2|Overall Study|Withdrew for adverse event|0
3067762|NCT00485134|10539262|P1|Overall Study|Withdrew for adverse event|0
3067763|NCT00485134|10539255|P8|Overall Study|Change in health status|0
3067764|NCT00485134|10539256|P7|Overall Study|Change in health status|0
3067765|NCT00485134|10539257|P6|Overall Study|Change in health status|1
3067766|NCT00485134|10539258|P5|Overall Study|Change in health status|0
3067767|NCT00485134|10539259|P4|Overall Study|Change in health status|1
3067768|NCT00485134|10539260|P3|Overall Study|Change in health status|2
3067769|NCT00485134|10539261|P2|Overall Study|Change in health status|1
3067770|NCT00485134|10539262|P1|Overall Study|Change in health status|0
3067771|NCT00485134|10539255|P8|Overall Study|Withdrawal by Subject|0
3067772|NCT00485134|10539256|P7|Overall Study|Withdrawal by Subject|0
3067773|NCT00485134|10539257|P6|Overall Study|Withdrawal by Subject|0
3067774|NCT00485134|10539258|P5|Overall Study|Withdrawal by Subject|0
3067775|NCT00485134|10539259|P4|Overall Study|Withdrawal by Subject|0
3067776|NCT00485134|10539260|P3|Overall Study|Withdrawal by Subject|0
3067777|NCT00485134|10539261|P2|Overall Study|Withdrawal by Subject|1
3067778|NCT00485134|10539262|P1|Overall Study|Withdrawal by Subject|0
3067779|NCT00485134|10539255|P8|Overall Study|Lost to Follow-up|0
3067780|NCT00485134|10539256|P7|Overall Study|Lost to Follow-up|0
3067781|NCT00485134|10539257|P6|Overall Study|Lost to Follow-up|0
3067782|NCT00485134|10539258|P5|Overall Study|Lost to Follow-up|0
3067783|NCT00485134|10539259|P4|Overall Study|Lost to Follow-up|0
3067784|NCT00485134|10539260|P3|Overall Study|Lost to Follow-up|0
3067785|NCT00485134|10539261|P2|Overall Study|Lost to Follow-up|0
3067786|NCT00485134|10539262|P1|Overall Study|Lost to Follow-up|1
3067787|NCT00485069|10539284|P2|Overall Study|Withdrawal by Subject|6
3067788|NCT00485069|10539285|P1|Overall Study|Withdrawal by Subject|6
3067789|NCT00485069|10539284|P2|Overall Study|Protocol Violation|1
3067790|NCT00485069|10539285|P1|Overall Study|Protocol Violation|0
3067791|NCT00485069|10539284|P2|Overall Study|Lack of Efficacy|1
3067792|NCT00485069|10539285|P1|Overall Study|Lack of Efficacy|2
3067793|NCT00485069|10539284|P2|Overall Study|Adverse Event|4
3067794|NCT00485069|10539285|P1|Overall Study|Adverse Event|10
3067795|NCT00484939|10539330|P2|Overall Study|Reason Not Specified|6
3067796|NCT00484939|10539331|P1|Overall Study|Reason Not Specified|11
3067797|NCT00484939|10539330|P2|Overall Study|Screen Failure|2
3067798|NCT00484939|10539331|P1|Overall Study|Screen Failure|2
3067799|NCT00484939|10539330|P2|Overall Study|Disease progression|88
3067800|NCT00484939|10539331|P1|Overall Study|Disease progression|67
3067801|NCT00484939|10539330|P2|Overall Study|Discretion of Investigator or Sponsor|3
3067802|NCT00484939|10539331|P1|Overall Study|Discretion of Investigator or Sponsor|7
3067803|NCT00484939|10539330|P2|Overall Study|Lost to Follow-up|3
3067804|NCT00484939|10539331|P1|Overall Study|Lost to Follow-up|0
3067805|NCT00484939|10539330|P2|Overall Study|Protocol Violation|3
3067806|NCT00484939|10539331|P1|Overall Study|Protocol Violation|3
3067807|NCT00484939|10539330|P2|Overall Study|Patient Withdrew Consent|10
3067808|NCT00484939|10539331|P1|Overall Study|Patient Withdrew Consent|19
3067809|NCT00484939|10539330|P2|Overall Study|Adverse Event|12
3067810|NCT00484939|10539331|P1|Overall Study|Adverse Event|22
3067811|NCT00484939|10539330|P2|Overall Study|Death|13
3067812|NCT00484939|10539331|P1|Overall Study|Death|9
3067813|NCT00484679|10539358|P1|Overall Study|Withdrawal by Subject|3
3067814|NCT00484419|10539365|P3|Overall Study|sponsor decision, randomized in error|2
3067815|NCT00484419|10539366|P2|Overall Study|sponsor decision, randomized in error|0
3067816|NCT00484419|10539367|P1|Overall Study|sponsor decision, randomized in error|0
3067817|NCT00484419|10539365|P3|Overall Study|subject relocated|0
3067818|NCT00484419|10539366|P2|Overall Study|subject relocated|1
3067819|NCT00484419|10539367|P1|Overall Study|subject relocated|0
3067820|NCT00484419|10539365|P3|Overall Study|subject unable to receive medication|0
3067821|NCT00484419|10539366|P2|Overall Study|subject unable to receive medication|0
3067822|NCT00484419|10539367|P1|Overall Study|subject unable to receive medication|1
3067823|NCT00484419|10539365|P3|Overall Study|Physician Decision|1
3067824|NCT00484419|10539366|P2|Overall Study|Physician Decision|1
3067825|NCT00484419|10539367|P1|Overall Study|Physician Decision|1
3067826|NCT00484419|10539365|P3|Overall Study|required restricted medication|1
3067827|NCT00484419|10539366|P2|Overall Study|required restricted medication|0
3067828|NCT00484419|10539367|P1|Overall Study|required restricted medication|1
3067829|NCT00484419|10539365|P3|Overall Study|subject met discontinuation criteria|4
3067830|NCT00484419|10539366|P2|Overall Study|subject met discontinuation criteria|2
3067831|NCT00484419|10539367|P1|Overall Study|subject met discontinuation criteria|2
3067832|NCT00484419|10539365|P3|Overall Study|Withdrawal by Subject|1
3067833|NCT00484419|10539366|P2|Overall Study|Withdrawal by Subject|1
3067834|NCT00484419|10539367|P1|Overall Study|Withdrawal by Subject|3
3067835|NCT00484419|10539365|P3|Overall Study|Lost to Follow-up|2
3067836|NCT00484419|10539366|P2|Overall Study|Lost to Follow-up|0
3067837|NCT00484419|10539367|P1|Overall Study|Lost to Follow-up|1
3067838|NCT00484419|10539365|P3|Overall Study|Adverse Event|0
3067839|NCT00484419|10539366|P2|Overall Study|Adverse Event|0
3067840|NCT00484419|10539367|P1|Overall Study|Adverse Event|3
3067841|NCT00484315|10539451|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
3067842|NCT00484315|10539452|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
3067843|NCT00484315|10539451|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
3067844|NCT00484315|10539452|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
3067845|NCT00484315|10539451|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
3067846|NCT00484315|10539452|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
3067847|NCT00484315|10539451|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
3067848|NCT00484315|10539452|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
3067849|NCT00484315|10539451|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
3067850|NCT00484315|10539452|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
3067851|NCT00484315|10539451|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
3067852|NCT00484315|10539452|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
3067853|NCT00484315|10539451|P2|12-Month Clinical Follow-up|Death|2
3067854|NCT00484315|10539452|P1|12-Month Clinical Follow-up|Death|6
3067855|NCT00484289|10539463|P3|Post Marketing Phase|Adverse Event|0
3067856|NCT00484289|10539464|P2|Post Marketing Phase|Adverse Event|1
3067857|NCT00484289|10539465|P1|Post Marketing Phase|Adverse Event|0
3067858|NCT00484289|10539463|P3|Long Term Phase|Other Reason|1
3067859|NCT00484289|10539464|P2|Long Term Phase|Other Reason|5
3067860|NCT00484289|10539465|P1|Long Term Phase|Other Reason|0
3067861|NCT00484289|10539463|P3|Long Term Phase|Inadequate response|4
3067862|NCT00484289|10539464|P2|Long Term Phase|Inadequate response|7
3067863|NCT00484289|10539465|P1|Long Term Phase|Inadequate response|2
3067864|NCT00484289|10539463|P3|Long Term Phase|Withdrawal by Subject|6
3067865|NCT00484289|10539464|P2|Long Term Phase|Withdrawal by Subject|7
3067866|NCT00484289|10539465|P1|Long Term Phase|Withdrawal by Subject|0
3067867|NCT00484289|10539463|P3|Long Term Phase|Adverse Event|5
3067868|NCT00484289|10539464|P2|Long Term Phase|Adverse Event|17
3067869|NCT00484289|10539465|P1|Long Term Phase|Adverse Event|1
3067870|NCT00484185|10539537|P1|Overall Study|Death|2
3067871|NCT00484185|10539537|P1|Overall Study|Randomized but not treated|5
3067872|NCT00484185|10539537|P1|Overall Study|Other|20
3067873|NCT00484185|10539537|P1|Overall Study|Lost to Follow-up|44
3067874|NCT00484159|10539559|P3|Overall Study|Lost to Follow-up|0
3067875|NCT00484159|10539560|P2|Overall Study|Lost to Follow-up|1
3067876|NCT00484159|10539561|P1|Overall Study|Lost to Follow-up|1
3067877|NCT00484094|10539572|P1|Overall Study|Other|3
3067878|NCT00484094|10539572|P1|Overall Study|Discontinued|39
3067879|NCT00483938|10539588|P7|Overall Study|Other|32
3067880|NCT00483938|10539589|P6|Overall Study|Other|4
3067881|NCT00483938|10539590|P5|Overall Study|Other|0
3067882|NCT00483938|10539591|P4|Overall Study|Other|4
3067883|NCT00483938|10539592|P3|Overall Study|Other|0
3067884|NCT00483938|10539593|P2|Overall Study|Other|9
3067885|NCT00483938|10539594|P1|Overall Study|Other|3
3067886|NCT00483938|10539588|P7|Overall Study|Death|0
3067887|NCT00483938|10539589|P6|Overall Study|Death|0
3067888|NCT00483938|10539590|P5|Overall Study|Death|0
3067889|NCT00483938|10539591|P4|Overall Study|Death|0
3067890|NCT00483938|10539592|P3|Overall Study|Death|0
3067891|NCT00483938|10539593|P2|Overall Study|Death|2
3067892|NCT00483938|10539594|P1|Overall Study|Death|0
3067893|NCT00483938|10539588|P7|Overall Study|Lost to Follow-up|3
3067894|NCT00483938|10539589|P6|Overall Study|Lost to Follow-up|1
3067895|NCT00483938|10539590|P5|Overall Study|Lost to Follow-up|1
3067896|NCT00483938|10539591|P4|Overall Study|Lost to Follow-up|2
3067897|NCT00483938|10539592|P3|Overall Study|Lost to Follow-up|0
3067898|NCT00483938|10539593|P2|Overall Study|Lost to Follow-up|2
3067899|NCT00483938|10539594|P1|Overall Study|Lost to Follow-up|1
3067900|NCT00483938|10539588|P7|Overall Study|Withdrawal by Subject|2
3067901|NCT00483938|10539589|P6|Overall Study|Withdrawal by Subject|3
3067902|NCT00483938|10539590|P5|Overall Study|Withdrawal by Subject|1
3067903|NCT00483938|10539591|P4|Overall Study|Withdrawal by Subject|0
3067904|NCT00483938|10539592|P3|Overall Study|Withdrawal by Subject|0
3067905|NCT00483938|10539593|P2|Overall Study|Withdrawal by Subject|6
3067906|NCT00483938|10539594|P1|Overall Study|Withdrawal by Subject|1
3067907|NCT00483938|10539588|P7|Overall Study|Protocol Violation|3
3067908|NCT00483938|10539589|P6|Overall Study|Protocol Violation|0
3067909|NCT00483938|10539590|P5|Overall Study|Protocol Violation|0
3067910|NCT00483938|10539591|P4|Overall Study|Protocol Violation|0
3067911|NCT00483938|10539592|P3|Overall Study|Protocol Violation|0
3067912|NCT00483938|10539593|P2|Overall Study|Protocol Violation|0
3067913|NCT00483938|10539594|P1|Overall Study|Protocol Violation|0
3067914|NCT00483756|10539618|P3|Overall Study|Randomized, Not Treated|4
3067915|NCT00483756|10539619|P2|Overall Study|Randomized, Not Treated|4
3067916|NCT00483756|10539620|P1|Overall Study|Randomized, Not Treated|1
3067917|NCT00483756|10539618|P3|Overall Study|Other|3
3067918|NCT00483756|10539619|P2|Overall Study|Other|4
3067919|NCT00483756|10539620|P1|Overall Study|Other|2
3067920|NCT00483756|10539618|P3|Overall Study|Withdrawal by Subject|4
3067921|NCT00483756|10539619|P2|Overall Study|Withdrawal by Subject|3
3067922|NCT00483756|10539620|P1|Overall Study|Withdrawal by Subject|5
3067923|NCT00483756|10539618|P3|Overall Study|Lost to Follow-up|0
3067924|NCT00483756|10539619|P2|Overall Study|Lost to Follow-up|1
3067925|NCT00483756|10539620|P1|Overall Study|Lost to Follow-up|3
3067926|NCT00483756|10539618|P3|Overall Study|Lack of Efficacy|0
3067927|NCT00483756|10539619|P2|Overall Study|Lack of Efficacy|0
3067928|NCT00483756|10539620|P1|Overall Study|Lack of Efficacy|1
3067929|NCT00483756|10539618|P3|Overall Study|Adverse Event|40
3067930|NCT00483756|10539619|P2|Overall Study|Adverse Event|38
3067931|NCT00483756|10539620|P1|Overall Study|Adverse Event|19
3067932|NCT00483756|10539618|P3|Overall Study|Death|1
3067933|NCT00483756|10539619|P2|Overall Study|Death|0
3067934|NCT00483756|10539620|P1|Overall Study|Death|2
3067935|NCT00483717|10539684|P2|Overall Study|Withdrawal by Subject|0
3067936|NCT00483717|10539685|P1|Overall Study|Withdrawal by Subject|1
3067937|NCT00483717|10539684|P2|Overall Study|Lost to Follow-up|0
3067938|NCT00483717|10539685|P1|Overall Study|Lost to Follow-up|1
3067939|NCT00483717|10539684|P2|Overall Study|No treatment for migraine|13
3067940|NCT00483717|10539685|P1|Overall Study|No treatment for migraine|16
3067941|NCT00483717|10539684|P2|Overall Study|Time of dosing missing|1
3067942|NCT00483717|10539685|P1|Overall Study|Time of dosing missing|1
3067943|NCT00483717|10539684|P2|Overall Study|Protocol Violation|7
3067944|NCT00483717|10539685|P1|Overall Study|Protocol Violation|5
3067945|NCT00483704|10539708|P3|Treatment|Physician Decision|4
3067946|NCT00483704|10539709|P2|Treatment|Physician Decision|1
3067947|NCT00483704|10539710|P1|Treatment|Physician Decision|0
3067948|NCT00483704|10539708|P3|Treatment|Pregnancy|0
3067949|NCT00483704|10539709|P2|Treatment|Pregnancy|1
3067950|NCT00483704|10539710|P1|Treatment|Pregnancy|0
3067951|NCT00483704|10539708|P3|Treatment|Lack of Efficacy|1
3067952|NCT00483704|10539709|P2|Treatment|Lack of Efficacy|1
3067953|NCT00483704|10539710|P1|Treatment|Lack of Efficacy|1
3067954|NCT00483704|10539708|P3|Treatment|Lost to Follow-up|5
3067955|NCT00483704|10539709|P2|Treatment|Lost to Follow-up|7
3067956|NCT00483704|10539710|P1|Treatment|Lost to Follow-up|2
3067957|NCT00483704|10539708|P3|Treatment|Protocol Violation|5
3067958|NCT00483704|10539709|P2|Treatment|Protocol Violation|3
3067959|NCT00483704|10539710|P1|Treatment|Protocol Violation|6
3067960|NCT00483704|10539708|P3|Treatment|Withdrawal by Subject|21
3067961|NCT00483704|10539709|P2|Treatment|Withdrawal by Subject|12
3067962|NCT00483704|10539710|P1|Treatment|Withdrawal by Subject|16
3067963|NCT00483704|10539708|P3|Treatment|Adverse Event|4
3067964|NCT00483704|10539709|P2|Treatment|Adverse Event|5
3067965|NCT00483704|10539710|P1|Treatment|Adverse Event|3
3067966|NCT00483704|10539708|P3|Treatment|Lack of qualifying migraines|116
3067967|NCT00483704|10539709|P2|Treatment|Lack of qualifying migraines|99
3067968|NCT00483704|10539710|P1|Treatment|Lack of qualifying migraines|101
3067969|NCT00483704|10539708|P3|Randomization|Lack of qualifying migraines|31
3067970|NCT00483704|10539709|P2|Randomization|Lack of qualifying migraines|25
3067971|NCT00483704|10539710|P1|Randomization|Lack of qualifying migraines|21
3067972|NCT00483704|10539708|P3|Randomization|Progressive disease|1
3067973|NCT00483704|10539709|P2|Randomization|Progressive disease|0
3067974|NCT00483704|10539710|P1|Randomization|Progressive disease|0
3067975|NCT00483704|10539708|P3|Randomization|Physician Decision|0
3067976|NCT00483704|10539709|P2|Randomization|Physician Decision|4
3067977|NCT00483704|10539710|P1|Randomization|Physician Decision|2
3067978|NCT00483704|10539708|P3|Randomization|Pregnancy|0
3067979|NCT00483704|10539709|P2|Randomization|Pregnancy|0
3067980|NCT00483704|10539710|P1|Randomization|Pregnancy|1
3067981|NCT00483704|10539708|P3|Randomization|Lost to Follow-up|19
3067982|NCT00483704|10539709|P2|Randomization|Lost to Follow-up|14
3067983|NCT00483704|10539710|P1|Randomization|Lost to Follow-up|14
3067984|NCT00483704|10539708|P3|Randomization|Protocol Violation|22
3067985|NCT00483704|10539709|P2|Randomization|Protocol Violation|25
3067986|NCT00483704|10539710|P1|Randomization|Protocol Violation|14
3067987|NCT00483704|10539708|P3|Randomization|Withdrawal by Subject|18
3067988|NCT00483704|10539709|P2|Randomization|Withdrawal by Subject|28
3067989|NCT00483704|10539710|P1|Randomization|Withdrawal by Subject|19
3067990|NCT00483652|10539756|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
3067991|NCT00483652|10539757|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
3067992|NCT00483652|10539756|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
3067993|NCT00483652|10539757|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
3067994|NCT00483652|10539756|P2|Double-blind Treatment Period|Adverse Event|4
3067995|NCT00483652|10539757|P1|Double-blind Treatment Period|Adverse Event|3
3067996|NCT00483652|10539756|P2|Double-blind Treatment Period|Protocol Violation|1
3067997|NCT00483652|10539757|P1|Double-blind Treatment Period|Protocol Violation|2
3067998|NCT00483574|10539767|P2|Overall Study|Withdrawal by Subject|0
3067999|NCT00483574|10539768|P1|Overall Study|Withdrawal by Subject|52
3068000|NCT00483574|10539767|P2|Overall Study|Lost to Follow-up|4
3068001|NCT00483574|10539768|P1|Overall Study|Lost to Follow-up|16
3068002|NCT00483574|10539767|P2|Overall Study|Protocol Violation|9
3068003|NCT00483574|10539768|P1|Overall Study|Protocol Violation|28
3068004|NCT00483574|10539767|P2|Overall Study|Adverse Event|0
3068005|NCT00483574|10539768|P1|Overall Study|Adverse Event|6
3068006|NCT00483548|10539783|P2|Overall Study|Withdrawal by Subject|2
3068007|NCT00483548|10539784|P1|Overall Study|Withdrawal by Subject|5
3068008|NCT00483548|10539783|P2|Overall Study|Lost to Follow-up|4
3068009|NCT00483548|10539784|P1|Overall Study|Lost to Follow-up|3
3068010|NCT00483548|10539783|P2|Overall Study|Non-compliance with medication|0
3068011|NCT00483548|10539784|P1|Overall Study|Non-compliance with medication|2
3068012|NCT00483548|10539783|P2|Overall Study|Unable to comply with protocol schedule|0
3068013|NCT00483548|10539784|P1|Overall Study|Unable to comply with protocol schedule|1
3068014|NCT00483548|10539783|P2|Overall Study|Protocol required discontinuation|6
3068015|NCT00483548|10539784|P1|Overall Study|Protocol required discontinuation|6
3068016|NCT00483548|10539783|P2|Overall Study|Pregnancy|0
3068017|NCT00483548|10539784|P1|Overall Study|Pregnancy|1
3068018|NCT00483548|10539783|P2|Overall Study|Protocol Violation|7
3068019|NCT00483548|10539784|P1|Overall Study|Protocol Violation|11
3068020|NCT00483548|10539783|P2|Overall Study|Lack of Efficacy|8
3068021|NCT00483548|10539784|P1|Overall Study|Lack of Efficacy|4
3068022|NCT00483548|10539783|P2|Overall Study|Laboratory abnormality|2
3068023|NCT00483548|10539784|P1|Overall Study|Laboratory abnormality|1
3068024|NCT00483548|10539783|P2|Overall Study|Adverse Event|14
3068025|NCT00483548|10539784|P1|Overall Study|Adverse Event|25
3068026|NCT00483548|10539783|P2|Overall Study|Randomized; not treated with study drug|3
3068027|NCT00483548|10539784|P1|Overall Study|Randomized; not treated with study drug|1
3068028|NCT00483405|10539842|P1|Overall Study|Other complicating disease|1
3068029|NCT00483405|10539842|P1|Overall Study|Withdrawal by Subject|2
3068030|NCT00483405|10539842|P1|Overall Study|Death|3
3068031|NCT00483405|10539842|P1|Overall Study|Lack of Efficacy|14
3068032|NCT00483405|10539842|P1|Overall Study|Adverse Event|8
3068033|NCT00483379|10539851|P2|Treatment Period|Withdrawal by Subject|0
3068034|NCT00483379|10539852|P1|Treatment Period|Withdrawal by Subject|1
3068035|NCT00483379|10539851|P2|Treatment Period|Adverse Event|0
3068036|NCT00483379|10539852|P1|Treatment Period|Adverse Event|1
3068037|NCT00483327|10539888|P1|Overall Study|Patient Non Compliance|2
3068038|NCT00483327|10539888|P1|Overall Study|Lost to Follow-up|4
3068039|NCT00483327|10539888|P1|Overall Study|Withdrawal by Subject|3
3068040|NCT00483327|10539888|P1|Overall Study|Adverse Event|1
3068041|NCT00483184|10539920|P3|Overall Study|Protocol Violation|1
3068042|NCT00483184|10539921|P2|Overall Study|Protocol Violation|0
3068043|NCT00483184|10539922|P1|Overall Study|Protocol Violation|1
3068044|NCT00483184|10539920|P3|Overall Study|Adverse Event|2
3068045|NCT00483184|10539921|P2|Overall Study|Adverse Event|2
3068046|NCT00483184|10539922|P1|Overall Study|Adverse Event|1
3068047|NCT00483184|10539920|P3|Overall Study|Lost to Follow-up|0
3068048|NCT00483184|10539921|P2|Overall Study|Lost to Follow-up|0
3068049|NCT00483184|10539922|P1|Overall Study|Lost to Follow-up|1
3068050|NCT00483184|10539920|P3|Overall Study|Withdrawal by Subject|0
3068051|NCT00483184|10539921|P2|Overall Study|Withdrawal by Subject|2
3068052|NCT00483184|10539922|P1|Overall Study|Withdrawal by Subject|2
3068053|NCT00483119|10539932|P2|Overall Study|Physician Decision|0
3068054|NCT00483119|10539933|P1|Overall Study|Physician Decision|1
3068055|NCT00483119|10539932|P2|Overall Study|Adverse Event|1
3068056|NCT00483119|10539933|P1|Overall Study|Adverse Event|0
3068057|NCT00483041|10539947|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
3068058|NCT00483041|10539948|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
3068059|NCT00483002|10539978|P1|Overall Study|Other|967
3068060|NCT00483002|10539978|P1|Overall Study|Other|2
3068061|NCT00483002|10539978|P1|Overall Study|Lost to Follow-up|962
3068062|NCT00483002|10539978|P1|Overall Study|Lack of Efficacy|555
3068063|NCT00483002|10539978|P1|Overall Study|Adverse Event|68
3068064|NCT00482729|10540003|P2|Overall Study|Withdrawal by Subject|69
3068065|NCT00482729|10540004|P1|Overall Study|Withdrawal by Subject|67
3068066|NCT00482729|10540003|P2|Overall Study|Protocol Violation|18
3068067|NCT00482729|10540004|P1|Overall Study|Protocol Violation|10
3068068|NCT00482729|10540003|P2|Overall Study|Pregnancy|2
3068069|NCT00482729|10540004|P1|Overall Study|Pregnancy|4
3068070|NCT00482729|10540003|P2|Overall Study|Physician Decision|7
3068071|NCT00482729|10540004|P1|Overall Study|Physician Decision|10
3068072|NCT00482729|10540003|P2|Overall Study|Lost to Follow-up|66
3068073|NCT00482729|10540004|P1|Overall Study|Lost to Follow-up|86
3068074|NCT00482729|10540003|P2|Overall Study|Lack of Efficacy|16
3068075|NCT00482729|10540004|P1|Overall Study|Lack of Efficacy|4
3068076|NCT00482729|10540003|P2|Overall Study|Hyperglycemia Criteria|5
3068077|NCT00482729|10540004|P1|Overall Study|Hyperglycemia Criteria|7
3068078|NCT00482729|10540003|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
3068079|NCT00482729|10540004|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
3068080|NCT00482729|10540003|P2|Overall Study|Adverse Event|33
3068081|NCT00482729|10540004|P1|Overall Study|Adverse Event|29
3068082|NCT00482703|10540020|P2|Overall Study|Poor compliance|0
3068083|NCT00482703|10540021|P1|Overall Study|Poor compliance|1
3068084|NCT00482612|10540092|P4|Follow-up Period|Reasons not related to trial|3
3068085|NCT00482612|10540093|P3|Follow-up Period|Reasons not related to trial|1
3068086|NCT00482612|10540094|P2|Follow-up Period|Reasons not related to trial|0
3068087|NCT00482612|10540095|P1|Follow-up Period|Reasons not related to trial|1
3068088|NCT00482612|10540092|P4|Follow-up Period|Withdrawal by Subject|2
3068089|NCT00482612|10540093|P3|Follow-up Period|Withdrawal by Subject|7
3068090|NCT00482612|10540094|P2|Follow-up Period|Withdrawal by Subject|5
3068091|NCT00482612|10540095|P1|Follow-up Period|Withdrawal by Subject|3
3068092|NCT00482612|10540092|P4|Follow-up Period|Lack of Efficacy|0
3068093|NCT00482612|10540093|P3|Follow-up Period|Lack of Efficacy|1
3068094|NCT00482612|10540094|P2|Follow-up Period|Lack of Efficacy|0
3068095|NCT00482612|10540095|P1|Follow-up Period|Lack of Efficacy|2
3068096|NCT00482612|10540092|P4|Follow-up Period|Adverse Event|0
3068097|NCT00482612|10540093|P3|Follow-up Period|Adverse Event|9
3068098|NCT00482612|10540094|P2|Follow-up Period|Adverse Event|7
3068099|NCT00482612|10540095|P1|Follow-up Period|Adverse Event|4
3068100|NCT00482612|10540092|P4|Follow-up Period|Lost to Follow-up|1
3068101|NCT00482612|10540093|P3|Follow-up Period|Lost to Follow-up|2
3068102|NCT00482612|10540094|P2|Follow-up Period|Lost to Follow-up|4
3068103|NCT00482612|10540095|P1|Follow-up Period|Lost to Follow-up|0
3068104|NCT00482612|10540092|P4|Follow-up Period|Lack of compliance|0
3068105|NCT00482612|10540093|P3|Follow-up Period|Lack of compliance|1
3068106|NCT00482612|10540094|P2|Follow-up Period|Lack of compliance|0
3068107|NCT00482612|10540095|P1|Follow-up Period|Lack of compliance|0
3068108|NCT00482612|10540092|P4|Follow-up Period|Other|2
3068109|NCT00482612|10540093|P3|Follow-up Period|Other|1
3068110|NCT00482612|10540094|P2|Follow-up Period|Other|2
3068111|NCT00482612|10540095|P1|Follow-up Period|Other|4
3068112|NCT00482612|10540092|P4|In-treatment Period|No study medication administered|0
3068113|NCT00482612|10540093|P3|In-treatment Period|No study medication administered|1
3068114|NCT00482612|10540094|P2|In-treatment Period|No study medication administered|0
3068115|NCT00482612|10540095|P1|In-treatment Period|No study medication administered|0
3068116|NCT00482391|10540144|P1|Overall Study|Death|1
3068117|NCT00482391|10540144|P1|Overall Study|Adverse Event|1
3068118|NCT00482391|10540144|P1|Overall Study|Withdrawal by Subject|1
3068119|NCT00482274|10540149|P1|Overall Study|Adverse Event|1
3068120|NCT00482170|10540159|P2|Overall Study|Unspecified reason|2
3068121|NCT00482170|10540160|P1|Overall Study|Unspecified reason|0
3068122|NCT00482170|10540159|P2|Overall Study|Lost to Follow-up|0
3068123|NCT00482170|10540160|P1|Overall Study|Lost to Follow-up|2
3068124|NCT00482170|10540159|P2|Overall Study|Protocol Violation|3
3068125|NCT00482170|10540160|P1|Overall Study|Protocol Violation|2
3068126|NCT00482170|10540159|P2|Overall Study|Withdrawal by Subject|1
3068127|NCT00482170|10540160|P1|Overall Study|Withdrawal by Subject|6
3068128|NCT00482170|10540159|P2|Overall Study|Adverse Event|14
3068129|NCT00482170|10540160|P1|Overall Study|Adverse Event|5
3068130|NCT00482053|10540278|P1|Inter-treatment Period|Disease progression|1
3068131|NCT00482014|10540292|P4|Overall Study|Sponsor Decision|1
3068132|NCT00482014|10540293|P3|Overall Study|Sponsor Decision|1
3068133|NCT00482014|10540294|P2|Overall Study|Sponsor Decision|2
3068134|NCT00482014|10540295|P1|Overall Study|Sponsor Decision|1
3068135|NCT00482014|10540292|P4|Overall Study|Lack of Efficacy|6
3068136|NCT00482014|10540293|P3|Overall Study|Lack of Efficacy|4
3068137|NCT00482014|10540294|P2|Overall Study|Lack of Efficacy|0
3068138|NCT00482014|10540295|P1|Overall Study|Lack of Efficacy|1
3068139|NCT00482014|10540292|P4|Overall Study|Death|4
3068140|NCT00482014|10540293|P3|Overall Study|Death|1
3068141|NCT00482014|10540294|P2|Overall Study|Death|2
3068142|NCT00482014|10540295|P1|Overall Study|Death|1
3068143|NCT00482014|10540292|P4|Overall Study|Adverse Event|8
3068144|NCT00482014|10540293|P3|Overall Study|Adverse Event|2
3068145|NCT00482014|10540294|P2|Overall Study|Adverse Event|0
3068146|NCT00482014|10540295|P1|Overall Study|Adverse Event|3
3068147|NCT00482014|10540292|P4|Overall Study|Withdrawal by Subject|4
3068148|NCT00482014|10540293|P3|Overall Study|Withdrawal by Subject|3
3068149|NCT00482014|10540294|P2|Overall Study|Withdrawal by Subject|2
3068150|NCT00482014|10540295|P1|Overall Study|Withdrawal by Subject|1
3068151|NCT00482001|10540319|P2|Overall Study|Protocol Violation|1
3068152|NCT00482001|10540320|P1|Overall Study|Protocol Violation|1
3068153|NCT00481988|10540340|P2|Overall Study|Withdrawal by Subject|1
3068154|NCT00481988|10540341|P1|Overall Study|Withdrawal by Subject|1
3068155|NCT00481871|10540354|P5|Overall Study|Progressive Disease - pt withdrew|0
3068156|NCT00481871|10540355|P4|Overall Study|Progressive Disease - pt withdrew|0
3068157|NCT00481871|10540356|P3|Overall Study|Progressive Disease - pt withdrew|1
3068158|NCT00481871|10540357|P2|Overall Study|Progressive Disease - pt withdrew|0
3068159|NCT00481871|10540358|P1|Overall Study|Progressive Disease - pt withdrew|0
3068160|NCT00481832|10540383|P1|Inter-transplant Period|Lack of allogeneic donor|5
3068161|NCT00481832|10540383|P1|Inter-transplant Period|Disease relapse|11
3068162|NCT00481832|10540383|P1|Inter-transplant Period|Physician Decision|4
3068163|NCT00481832|10540383|P1|Inter-transplant Period|Death|3
3068164|NCT00481832|10540383|P1|Inter-transplant Period|Adverse Event|4
3068165|NCT00481832|10540383|P1|Enrollment|Unable to collect enough stem cells|2
3068166|NCT00481832|10540383|P1|Enrollment|Physician Decision|8
3068167|NCT00481767|10540398|P2|Overall Study|Lost to Follow-up|10
3068168|NCT00481767|10540399|P1|Overall Study|Lost to Follow-up|16
3068169|NCT00481767|10540398|P2|Overall Study|Withdrawal by Subject|11
3068170|NCT00481767|10540399|P1|Overall Study|Withdrawal by Subject|16
3068171|NCT00481676|10540433|P2|Overall Study|Administrative problem|0
3068172|NCT00481676|10540434|P1|Overall Study|Administrative problem|1
3068173|NCT00481676|10540433|P2|Overall Study|Unsatisfactory therapeutic effect|4
3068174|NCT00481676|10540434|P1|Overall Study|Unsatisfactory therapeutic effect|1
3068175|NCT00481676|10540433|P2|Overall Study|Adverse Event|1
3068176|NCT00481676|10540434|P1|Overall Study|Adverse Event|0
3068177|NCT00481247|10540486|P2|Overall Study|Did not receive treatment|2
3068178|NCT00481247|10540487|P1|Overall Study|Did not receive treatment|1
3068179|NCT00481247|10540486|P2|Overall Study|Varied|15
3068180|NCT00481247|10540487|P1|Overall Study|Varied|6
3068181|NCT00481247|10540486|P2|Overall Study|Administrative reason by sponsor|162
3068182|NCT00481247|10540487|P1|Overall Study|Administrative reason by sponsor|157
3068183|NCT00481247|10540486|P2|Overall Study|Poor compliance/noncompliance|7
3068184|NCT00481247|10540487|P1|Overall Study|Poor compliance/noncompliance|1
3068185|NCT00481247|10540486|P2|Overall Study|Lost to Follow-up|2
3068186|NCT00481247|10540487|P1|Overall Study|Lost to Follow-up|1
3068187|NCT00481247|10540486|P2|Overall Study|Pregnancy|1
3068188|NCT00481247|10540487|P1|Overall Study|Pregnancy|2
3068189|NCT00481247|10540486|P2|Overall Study|Withdrawal by Subject|13
3068190|NCT00481247|10540487|P1|Overall Study|Withdrawal by Subject|8
3068191|NCT00481247|10540486|P2|Overall Study|AE unrelated to study drug|4
3068192|NCT00481247|10540487|P1|Overall Study|AE unrelated to study drug|13
3068193|NCT00481247|10540486|P2|Overall Study|Treatment failure|14
3068194|NCT00481247|10540487|P1|Overall Study|Treatment failure|10
3068195|NCT00481247|10540486|P2|Overall Study|Intolerance|17
3068196|NCT00481247|10540487|P1|Overall Study|Intolerance|42
3068197|NCT00481247|10540486|P2|Overall Study|Disease progression|22
3068198|NCT00481247|10540487|P1|Overall Study|Disease progression|18
3068199|NCT00481247|10540486|P2|Overall Study|Death|1
3068200|NCT00481247|10540487|P1|Overall Study|Death|0
3068201|NCT00481195|10540511|P2|Overall Study|Miscellaneous|2
3068202|NCT00481195|10540512|P1|Overall Study|Miscellaneous|2
3068203|NCT00481195|10540511|P2|Overall Study|Withdrawal by Subject|9
3068204|NCT00481195|10540512|P1|Overall Study|Withdrawal by Subject|3
3068205|NCT00481195|10540511|P2|Overall Study|Protocol Violation|7
3068206|NCT00481195|10540512|P1|Overall Study|Protocol Violation|10
3068207|NCT00481195|10540511|P2|Overall Study|Physician Decision|1
3068208|NCT00481195|10540512|P1|Overall Study|Physician Decision|3
3068209|NCT00481195|10540511|P2|Overall Study|Lost to Follow-up|6
3068210|NCT00481195|10540512|P1|Overall Study|Lost to Follow-up|4
3068211|NCT00481195|10540511|P2|Overall Study|Lack of Efficacy|3
3068212|NCT00481195|10540512|P1|Overall Study|Lack of Efficacy|1
3068213|NCT00481195|10540511|P2|Overall Study|Adverse Event|11
3068214|NCT00481195|10540512|P1|Overall Study|Adverse Event|16
3068215|NCT00481078|10540598|P2|Overall Study|Brain metastasis|1
3068216|NCT00481078|10540599|P1|Overall Study|Brain metastasis|0
3068217|NCT00481078|10540598|P2|Overall Study|Received other treatment|1
3068218|NCT00481078|10540599|P1|Overall Study|Received other treatment|2
3068219|NCT00481078|10540598|P2|Overall Study|Information not available|0
3068220|NCT00481078|10540599|P1|Overall Study|Information not available|1
3068221|NCT00481078|10540598|P2|Overall Study|Withdrawal by Subject|1
3068222|NCT00481078|10540599|P1|Overall Study|Withdrawal by Subject|7
3068223|NCT00481078|10540598|P2|Overall Study|Intercurrent illness|0
3068224|NCT00481078|10540599|P1|Overall Study|Intercurrent illness|1
3068225|NCT00481078|10540598|P2|Overall Study|Death|3
3068226|NCT00481078|10540599|P1|Overall Study|Death|5
3068227|NCT00481078|10540598|P2|Overall Study|Adverse Event|3
3068228|NCT00481078|10540599|P1|Overall Study|Adverse Event|15
3068229|NCT00481078|10540598|P2|Overall Study|Progression of disease|11
3068230|NCT00481078|10540599|P1|Overall Study|Progression of disease|11
3068231|NCT00481065|10540617|P8|Overall Study|Unable to classify|0
3068232|NCT00481065|10540618|P7|Overall Study|Unable to classify|0
3068233|NCT00481065|10540619|P6|Overall Study|Unable to classify|0
3068234|NCT00481065|10540620|P5|Overall Study|Unable to classify|1
3068235|NCT00481065|10540621|P4|Overall Study|Unable to classify|0
3068236|NCT00481065|10540622|P3|Overall Study|Unable to classify|2
3068237|NCT00481065|10540623|P2|Overall Study|Unable to classify|1
3068238|NCT00481065|10540624|P1|Overall Study|Unable to classify|0
3068239|NCT00481065|10540617|P8|Overall Study|Protocol Violation|2
3068240|NCT00481065|10540618|P7|Overall Study|Protocol Violation|3
3068241|NCT00481065|10540619|P6|Overall Study|Protocol Violation|6
3068242|NCT00481065|10540620|P5|Overall Study|Protocol Violation|2
3068243|NCT00481065|10540621|P4|Overall Study|Protocol Violation|1
3068244|NCT00481065|10540622|P3|Overall Study|Protocol Violation|1
3068245|NCT00481065|10540623|P2|Overall Study|Protocol Violation|1
3068246|NCT00481065|10540624|P1|Overall Study|Protocol Violation|2
3068247|NCT00481065|10540617|P8|Overall Study|Administrative reason|0
3068248|NCT00481065|10540618|P7|Overall Study|Administrative reason|1
3068249|NCT00481065|10540619|P6|Overall Study|Administrative reason|2
3068250|NCT00481065|10540620|P5|Overall Study|Administrative reason|0
3068251|NCT00481065|10540621|P4|Overall Study|Administrative reason|0
3068252|NCT00481065|10540622|P3|Overall Study|Administrative reason|0
3068253|NCT00481065|10540623|P2|Overall Study|Administrative reason|0
3068254|NCT00481065|10540624|P1|Overall Study|Administrative reason|0
3068255|NCT00481065|10540617|P8|Overall Study|Inappropriate enrollment|1
3068256|NCT00481065|10540618|P7|Overall Study|Inappropriate enrollment|0
3068257|NCT00481065|10540619|P6|Overall Study|Inappropriate enrollment|1
3068258|NCT00481065|10540620|P5|Overall Study|Inappropriate enrollment|2
3068259|NCT00481065|10540621|P4|Overall Study|Inappropriate enrollment|0
3068260|NCT00481065|10540622|P3|Overall Study|Inappropriate enrollment|2
3068261|NCT00481065|10540623|P2|Overall Study|Inappropriate enrollment|0
3068262|NCT00481065|10540624|P1|Overall Study|Inappropriate enrollment|4
3068263|NCT00481065|10540617|P8|Overall Study|Lost to Follow-up|5
3068264|NCT00481065|10540618|P7|Overall Study|Lost to Follow-up|2
3068265|NCT00481065|10540619|P6|Overall Study|Lost to Follow-up|3
3068266|NCT00481065|10540620|P5|Overall Study|Lost to Follow-up|3
3068267|NCT00481065|10540621|P4|Overall Study|Lost to Follow-up|3
3068268|NCT00481065|10540622|P3|Overall Study|Lost to Follow-up|4
3068269|NCT00481065|10540623|P2|Overall Study|Lost to Follow-up|2
3068270|NCT00481065|10540624|P1|Overall Study|Lost to Follow-up|4
3068271|NCT00481065|10540617|P8|Overall Study|Withdrawal by Subject|10
3068272|NCT00481065|10540618|P7|Overall Study|Withdrawal by Subject|9
3068273|NCT00481065|10540619|P6|Overall Study|Withdrawal by Subject|12
3068274|NCT00481065|10540620|P5|Overall Study|Withdrawal by Subject|13
3068275|NCT00481065|10540621|P4|Overall Study|Withdrawal by Subject|11
3068276|NCT00481065|10540622|P3|Overall Study|Withdrawal by Subject|7
3068277|NCT00481065|10540623|P2|Overall Study|Withdrawal by Subject|12
3068278|NCT00481065|10540624|P1|Overall Study|Withdrawal by Subject|11
3068279|NCT00481065|10540617|P8|Overall Study|Adverse event or death|1
3068280|NCT00481065|10540618|P7|Overall Study|Adverse event or death|1
3068281|NCT00481065|10540619|P6|Overall Study|Adverse event or death|0
3068282|NCT00481065|10540620|P5|Overall Study|Adverse event or death|2
3068283|NCT00481065|10540621|P4|Overall Study|Adverse event or death|0
3068284|NCT00481065|10540622|P3|Overall Study|Adverse event or death|3
3068285|NCT00481065|10540623|P2|Overall Study|Adverse event or death|1
3068286|NCT00481065|10540624|P1|Overall Study|Adverse event or death|1
3068287|NCT00480857|10540714|P1|Overall Study|Lack of Efficacy|2
3068288|NCT00480779|10540724|P2|Overall Study|Job and Health-related|3
3068289|NCT00480779|10540725|P1|Overall Study|Job and Health-related|0
3068290|NCT00480779|10540724|P2|Overall Study|Other|0
3068291|NCT00480779|10540725|P1|Overall Study|Other|2
3068292|NCT00480636|10540762|P1|Overall Study|Lost to follow-up; subsequently died|1
3068293|NCT00480636|10540762|P1|Overall Study|Other|2
3068294|NCT00480636|10540762|P1|Overall Study|Lost to Follow-up|4
3068295|NCT00480636|10540762|P1|Overall Study|Death|12
3068296|NCT00480532|10540774|P4|Overall Study|Protocol Violation|0
3068297|NCT00480532|10540775|P3|Overall Study|Protocol Violation|1
3068298|NCT00480532|10540776|P2|Overall Study|Protocol Violation|0
3068299|NCT00480532|10540777|P1|Overall Study|Protocol Violation|0
3068300|NCT00480532|10540774|P4|Overall Study|Withdrawal by Subject|1
3068301|NCT00480532|10540775|P3|Overall Study|Withdrawal by Subject|3
3068302|NCT00480532|10540776|P2|Overall Study|Withdrawal by Subject|4
3068303|NCT00480532|10540777|P1|Overall Study|Withdrawal by Subject|2
3068304|NCT00480493|10540797|P2|Overall Study|moved|7
3068305|NCT00480493|10540798|P1|Overall Study|moved|2
3068306|NCT00480441|10540810|P3|Randomization|Lost to Follow-up|2
3068307|NCT00480441|10540811|P2|Randomization|Lost to Follow-up|7
3068308|NCT00480441|10540812|P1|Randomization|Lost to Follow-up|0
3068309|NCT00480441|10540810|P3|Baseline Functional MRI|physical contraindication|0
3068310|NCT00480441|10540811|P2|Baseline Functional MRI|physical contraindication|0
3068311|NCT00480441|10540812|P1|Baseline Functional MRI|physical contraindication|4
3068312|NCT00480441|10540810|P3|Baseline Functional MRI|Lost to Follow-up|0
3068313|NCT00480441|10540811|P2|Baseline Functional MRI|Lost to Follow-up|0
3068314|NCT00480441|10540812|P1|Baseline Functional MRI|Lost to Follow-up|4
3068315|NCT00480441|10540810|P3|Baseline Functional MRI|Functional MRI data not usable|0
3068316|NCT00480441|10540811|P2|Baseline Functional MRI|Functional MRI data not usable|0
3068317|NCT00480441|10540812|P1|Baseline Functional MRI|Functional MRI data not usable|4
3068318|NCT00480441|10540810|P3|Screening|Not Eligible|0
3068319|NCT00480441|10540811|P2|Screening|Not Eligible|0
3068320|NCT00480441|10540812|P1|Screening|Not Eligible|37
3068321|NCT00480324|10540821|P2|Overall Study|Subject’s mother pregnant|1
3068322|NCT00480324|10540822|P1|Overall Study|Subject’s mother pregnant|0
3068323|NCT00480324|10540821|P2|Overall Study|Lost to Follow-up|8
3068324|NCT00480324|10540822|P1|Overall Study|Lost to Follow-up|17
3068325|NCT00480324|10540821|P2|Overall Study|Withdrawal by Subject|5
3068326|NCT00480324|10540822|P1|Overall Study|Withdrawal by Subject|14
3068327|NCT00480324|10540821|P2|Overall Study|Protocol Violation|1
3068328|NCT00480324|10540822|P1|Overall Study|Protocol Violation|0
3068329|NCT00480324|10540821|P2|Overall Study|Adverse Event|1
3068330|NCT00480324|10540822|P1|Overall Study|Adverse Event|1
3068331|NCT00480077|10540850|P2|Overall Study|early exit|11
3068332|NCT00480077|10540851|P1|Overall Study|early exit|12
3068333|NCT00480077|10540850|P2|Overall Study|Death|15
3068334|NCT00480077|10540851|P1|Overall Study|Death|19
3068335|NCT00480025|10540859|P2|Overall Study|SAE including intercurrent illness|42
3068336|NCT00480025|10540860|P1|Overall Study|SAE including intercurrent illness|76
3068337|NCT00480025|10540859|P2|Overall Study|Other|29
3068338|NCT00480025|10540860|P1|Overall Study|Other|70
3068339|NCT00480025|10540859|P2|Overall Study|Adverse Event|12
3068340|NCT00480025|10540860|P1|Overall Study|Adverse Event|44
3068341|NCT00480025|10540859|P2|Overall Study|Disease Progression / Recurrence|224
3068342|NCT00480025|10540860|P1|Overall Study|Disease Progression / Recurrence|449
3068343|NCT00480025|10540859|P2|Overall Study|Patients remaining ongoing at Data Lock|55
3068344|NCT00480025|10540860|P1|Overall Study|Patients remaining ongoing at Data Lock|101
3068345|NCT00480025|10540859|P2|Overall Study|Protocol Violation|7
3068346|NCT00480025|10540860|P1|Overall Study|Protocol Violation|12
3068347|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
3068348|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
3068349|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
3068350|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
3068351|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
3068352|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
3068353|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
3068354|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
3068355|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
3068356|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
3068357|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
3068358|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
3068359|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Other|2
3068360|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Other|2
3068361|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Other|0
3068362|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Other|5
3068363|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
3068364|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
3068365|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
3068366|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
3068367|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
3068368|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
3068369|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
3068370|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
3068371|NCT00479882|10540932|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
3068372|NCT00479882|10540933|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
3068373|NCT00479882|10540934|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
3068374|NCT00479882|10540935|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
3068375|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
3068376|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
3068377|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
3068378|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
3068379|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
3068380|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
3068381|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
3068382|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
3068383|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
3068384|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
3068385|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
3068386|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
3068387|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
3068388|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
3068389|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
3068390|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
3068391|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
3068392|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
3068393|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
3068394|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
3068395|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
3068396|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
3068397|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
3068398|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
3068399|NCT00479882|10540932|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
3068400|NCT00479882|10540933|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
3068401|NCT00479882|10540934|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
3068402|NCT00479882|10540935|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
3068403|NCT00479856|10541065|P1|Overall Study|Physician Decision|1
3068404|NCT00479856|10541065|P1|Overall Study|Withdrawal by Subject|1
3068405|NCT00479856|10541065|P1|Overall Study|Adverse Event|1
3068406|NCT00479765|10541074|P1|Overall Study|study terminated|4
3068407|NCT00479713|10541080|P2|Overall Study|Withdrawal by Subject|1
3068408|NCT00479713|10541081|P1|Overall Study|Withdrawal by Subject|4
3068409|NCT00479713|10541080|P2|Overall Study|Protocol Violation|1
3068410|NCT00479713|10541081|P1|Overall Study|Protocol Violation|0
3068411|NCT00479713|10541080|P2|Overall Study|Lost to Follow-up|1
3068412|NCT00479713|10541081|P1|Overall Study|Lost to Follow-up|0
3068413|NCT00479713|10541080|P2|Overall Study|Death|0
3068414|NCT00479713|10541081|P1|Overall Study|Death|1
3068415|NCT00479713|10541080|P2|Overall Study|Adverse Event|6
3068416|NCT00479713|10541081|P1|Overall Study|Adverse Event|8
3068417|NCT00479674|10541105|P1|Overall Study|none provided|3
3068418|NCT00479674|10541105|P1|Overall Study|Physician Decision|14
3068419|NCT00479674|10541105|P1|Overall Study|Withdrawal by Subject|6
3068420|NCT00479674|10541105|P1|Overall Study|Adverse Event|18
3068421|NCT00479557|10541120|P7|Overall Study|Other|0
3068422|NCT00479557|10541121|P6|Overall Study|Other|3
3068423|NCT00479557|10541122|P5|Overall Study|Other|0
3068424|NCT00479557|10541123|P4|Overall Study|Other|0
3068425|NCT00479557|10541124|P3|Overall Study|Other|1
3068426|NCT00479557|10541125|P2|Overall Study|Other|3
3068427|NCT00479557|10541126|P1|Overall Study|Other|2
3068428|NCT00479557|10541120|P7|Overall Study|Subject Request|1
3068429|NCT00479557|10541121|P6|Overall Study|Subject Request|4
3068430|NCT00479557|10541122|P5|Overall Study|Subject Request|1
3068431|NCT00479557|10541123|P4|Overall Study|Subject Request|1
3068432|NCT00479557|10541124|P3|Overall Study|Subject Request|1
3068433|NCT00479557|10541125|P2|Overall Study|Subject Request|0
3068434|NCT00479557|10541126|P1|Overall Study|Subject Request|3
3068435|NCT00479557|10541120|P7|Overall Study|Investigator Request|0
3068436|NCT00479557|10541121|P6|Overall Study|Investigator Request|0
3068437|NCT00479557|10541122|P5|Overall Study|Investigator Request|0
3068438|NCT00479557|10541123|P4|Overall Study|Investigator Request|0
3068439|NCT00479557|10541124|P3|Overall Study|Investigator Request|1
3068440|NCT00479557|10541125|P2|Overall Study|Investigator Request|0
3068441|NCT00479557|10541126|P1|Overall Study|Investigator Request|0
3068442|NCT00479557|10541120|P7|Overall Study|Caregiver Request|0
3068443|NCT00479557|10541121|P6|Overall Study|Caregiver Request|2
3068444|NCT00479557|10541122|P5|Overall Study|Caregiver Request|1
3068445|NCT00479557|10541123|P4|Overall Study|Caregiver Request|0
3068446|NCT00479557|10541124|P3|Overall Study|Caregiver Request|2
3068447|NCT00479557|10541125|P2|Overall Study|Caregiver Request|2
3068448|NCT00479557|10541126|P1|Overall Study|Caregiver Request|2
3068449|NCT00479557|10541120|P7|Overall Study|AE not related to Study Drug|1
3068450|NCT00479557|10541121|P6|Overall Study|AE not related to Study Drug|2
3068451|NCT00479557|10541122|P5|Overall Study|AE not related to Study Drug|2
3068452|NCT00479557|10541123|P4|Overall Study|AE not related to Study Drug|0
3068453|NCT00479557|10541124|P3|Overall Study|AE not related to Study Drug|0
3068454|NCT00479557|10541125|P2|Overall Study|AE not related to Study Drug|3
3068455|NCT00479557|10541126|P1|Overall Study|AE not related to Study Drug|1
3068456|NCT00479557|10541120|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
3068457|NCT00479557|10541121|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
3068458|NCT00479557|10541122|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
3068459|NCT00479557|10541123|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
3068460|NCT00479557|10541124|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
3068461|NCT00479557|10541125|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
3068462|NCT00479557|10541126|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
3068463|NCT00479557|10541120|P7|Overall Study|Lost to Follow-up|0
3068464|NCT00479557|10541121|P6|Overall Study|Lost to Follow-up|0
3068465|NCT00479557|10541122|P5|Overall Study|Lost to Follow-up|0
3068466|NCT00479557|10541123|P4|Overall Study|Lost to Follow-up|2
3068467|NCT00479557|10541124|P3|Overall Study|Lost to Follow-up|0
3068468|NCT00479557|10541125|P2|Overall Study|Lost to Follow-up|2
3068469|NCT00479557|10541126|P1|Overall Study|Lost to Follow-up|0
3068470|NCT00479557|10541120|P7|Overall Study|Lack of Efficacy|0
3068471|NCT00479557|10541121|P6|Overall Study|Lack of Efficacy|0
3068472|NCT00479557|10541122|P5|Overall Study|Lack of Efficacy|0
3068473|NCT00479557|10541123|P4|Overall Study|Lack of Efficacy|0
3068474|NCT00479557|10541124|P3|Overall Study|Lack of Efficacy|0
3068475|NCT00479557|10541125|P2|Overall Study|Lack of Efficacy|0
3068476|NCT00479557|10541126|P1|Overall Study|Lack of Efficacy|1
3068477|NCT00479557|10541120|P7|Overall Study|Death|0
3068478|NCT00479557|10541121|P6|Overall Study|Death|1
3068479|NCT00479557|10541122|P5|Overall Study|Death|0
3068480|NCT00479557|10541123|P4|Overall Study|Death|0
3068481|NCT00479557|10541124|P3|Overall Study|Death|0
3068482|NCT00479557|10541125|P2|Overall Study|Death|0
3068483|NCT00479557|10541126|P1|Overall Study|Death|0
3068484|NCT00479466|10541169|P6|Overall Study|Withdrawal by Subject|1
3068485|NCT00479466|10541170|P5|Overall Study|Withdrawal by Subject|3
3068486|NCT00479466|10541171|P4|Overall Study|Withdrawal by Subject|2
3068487|NCT00479466|10541172|P3|Overall Study|Withdrawal by Subject|0
3068488|NCT00479466|10541173|P2|Overall Study|Withdrawal by Subject|5
3068489|NCT00479466|10541174|P1|Overall Study|Withdrawal by Subject|3
3068490|NCT00479466|10541169|P6|Overall Study|Protocol Violation|0
3068491|NCT00479466|10541170|P5|Overall Study|Protocol Violation|0
3068492|NCT00479466|10541171|P4|Overall Study|Protocol Violation|0
3068493|NCT00479466|10541172|P3|Overall Study|Protocol Violation|0
3068494|NCT00479466|10541173|P2|Overall Study|Protocol Violation|0
3068495|NCT00479466|10541174|P1|Overall Study|Protocol Violation|1
3068496|NCT00479466|10541169|P6|Overall Study|Pregnancy|0
3068497|NCT00479466|10541170|P5|Overall Study|Pregnancy|1
3068498|NCT00479466|10541171|P4|Overall Study|Pregnancy|0
3068499|NCT00479466|10541172|P3|Overall Study|Pregnancy|0
3068500|NCT00479466|10541173|P2|Overall Study|Pregnancy|0
3068501|NCT00479466|10541174|P1|Overall Study|Pregnancy|0
3068502|NCT00479466|10541169|P6|Overall Study|Physician Decision|0
3068503|NCT00479466|10541170|P5|Overall Study|Physician Decision|0
3068504|NCT00479466|10541171|P4|Overall Study|Physician Decision|0
3068505|NCT00479466|10541172|P3|Overall Study|Physician Decision|1
3068506|NCT00479466|10541173|P2|Overall Study|Physician Decision|1
3068507|NCT00479466|10541174|P1|Overall Study|Physician Decision|2
3068508|NCT00479466|10541169|P6|Overall Study|Lost to Follow-up|2
3068509|NCT00479466|10541170|P5|Overall Study|Lost to Follow-up|2
3068510|NCT00479466|10541171|P4|Overall Study|Lost to Follow-up|0
3068511|NCT00479466|10541172|P3|Overall Study|Lost to Follow-up|1
3068512|NCT00479466|10541173|P2|Overall Study|Lost to Follow-up|1
3068513|NCT00479466|10541174|P1|Overall Study|Lost to Follow-up|0
3068514|NCT00479466|10541169|P6|Overall Study|Lack of Efficacy|0
3068515|NCT00479466|10541170|P5|Overall Study|Lack of Efficacy|0
3068516|NCT00479466|10541171|P4|Overall Study|Lack of Efficacy|0
3068517|NCT00479466|10541172|P3|Overall Study|Lack of Efficacy|1
3068518|NCT00479466|10541173|P2|Overall Study|Lack of Efficacy|0
3068519|NCT00479466|10541174|P1|Overall Study|Lack of Efficacy|2
3068520|NCT00479466|10541169|P6|Overall Study|Hyperglycemia|1
3068521|NCT00479466|10541170|P5|Overall Study|Hyperglycemia|0
3068522|NCT00479466|10541171|P4|Overall Study|Hyperglycemia|0
3068523|NCT00479466|10541172|P3|Overall Study|Hyperglycemia|0
3068524|NCT00479466|10541173|P2|Overall Study|Hyperglycemia|0
3068525|NCT00479466|10541174|P1|Overall Study|Hyperglycemia|0
3068526|NCT00479466|10541169|P6|Overall Study|Adverse Event|0
3068527|NCT00479466|10541170|P5|Overall Study|Adverse Event|2
3068528|NCT00479466|10541171|P4|Overall Study|Adverse Event|1
3068529|NCT00479466|10541172|P3|Overall Study|Adverse Event|0
3068530|NCT00479466|10541173|P2|Overall Study|Adverse Event|1
3068531|NCT00479466|10541174|P1|Overall Study|Adverse Event|5
3068532|NCT00479401|10541203|P3|Overall Study|Exclusion criteria, relocation|0
3068533|NCT00479401|10541204|P2|Overall Study|Exclusion criteria, relocation|3
3068534|NCT00479401|10541205|P1|Overall Study|Exclusion criteria, relocation|4
3068535|NCT00479401|10541203|P3|Overall Study|Withdrawal by Subject|2
3068536|NCT00479401|10541204|P2|Overall Study|Withdrawal by Subject|10
3068537|NCT00479401|10541205|P1|Overall Study|Withdrawal by Subject|16
3068538|NCT00479401|10541203|P3|Overall Study|Lost to Follow-up|1
3068539|NCT00479401|10541204|P2|Overall Study|Lost to Follow-up|1
3068540|NCT00479401|10541205|P1|Overall Study|Lost to Follow-up|1
3068541|NCT00479401|10541203|P3|Overall Study|Protocol Violation|1
3068542|NCT00479401|10541204|P2|Overall Study|Protocol Violation|1
3068543|NCT00479401|10541205|P1|Overall Study|Protocol Violation|2
3068544|NCT00479401|10541203|P3|Overall Study|Lack of Efficacy|4
3068545|NCT00479401|10541204|P2|Overall Study|Lack of Efficacy|2
3068546|NCT00479401|10541205|P1|Overall Study|Lack of Efficacy|2
3068547|NCT00479401|10541203|P3|Overall Study|Adverse Event|4
3068548|NCT00479401|10541204|P2|Overall Study|Adverse Event|20
3068549|NCT00479401|10541205|P1|Overall Study|Adverse Event|24
3068550|NCT00479388|10541260|P2|Overall Study|Withdrawal by Subject|17
3068551|NCT00479388|10541261|P1|Overall Study|Withdrawal by Subject|32
3068552|NCT00479388|10541260|P2|Overall Study|Protocol Violation|9
3068553|NCT00479388|10541261|P1|Overall Study|Protocol Violation|10
3068554|NCT00479388|10541260|P2|Overall Study|Lost to Follow-up|2
3068555|NCT00479388|10541261|P1|Overall Study|Lost to Follow-up|0
3068556|NCT00479388|10541260|P2|Overall Study|Adverse Event|45
3068557|NCT00479388|10541261|P1|Overall Study|Adverse Event|90
3068558|NCT00479336|10541275|P4|Overall Study|Resolution of all hepatic edema findings|0
3068559|NCT00479336|10541276|P3|Overall Study|Resolution of all hepatic edema findings|0
3068560|NCT00479336|10541277|P2|Overall Study|Resolution of all hepatic edema findings|1
3068561|NCT00479336|10541278|P1|Overall Study|Resolution of all hepatic edema findings|1
3068562|NCT00479336|10541275|P4|Overall Study|Physician Decision|2
3068563|NCT00479336|10541276|P3|Overall Study|Physician Decision|0
3068564|NCT00479336|10541277|P2|Overall Study|Physician Decision|1
3068565|NCT00479336|10541278|P1|Overall Study|Physician Decision|0
3068566|NCT00479336|10541275|P4|Overall Study|Withdrawal by Subject|0
3068567|NCT00479336|10541276|P3|Overall Study|Withdrawal by Subject|0
3068568|NCT00479336|10541277|P2|Overall Study|Withdrawal by Subject|2
3068569|NCT00479336|10541278|P1|Overall Study|Withdrawal by Subject|1
3068570|NCT00479336|10541275|P4|Overall Study|Protocol Violation|0
3068571|NCT00479336|10541276|P3|Overall Study|Protocol Violation|0
3068572|NCT00479336|10541277|P2|Overall Study|Protocol Violation|1
3068573|NCT00479336|10541278|P1|Overall Study|Protocol Violation|0
3068574|NCT00479336|10541275|P4|Overall Study|Lack of Efficacy|0
3068575|NCT00479336|10541276|P3|Overall Study|Lack of Efficacy|0
3068576|NCT00479336|10541277|P2|Overall Study|Lack of Efficacy|0
3068577|NCT00479336|10541278|P1|Overall Study|Lack of Efficacy|1
3068578|NCT00479336|10541275|P4|Overall Study|Adverse Event|3
3068579|NCT00479336|10541276|P3|Overall Study|Adverse Event|1
3068580|NCT00479336|10541277|P2|Overall Study|Adverse Event|1
3068581|NCT00479336|10541278|P1|Overall Study|Adverse Event|1
3068582|NCT00479232|10541301|P6|Overall Study|Withdrew Consent|3
3068583|NCT00479232|10541302|P5|Overall Study|Withdrew Consent|1
3068584|NCT00479232|10541303|P4|Overall Study|Withdrew Consent|0
3068585|NCT00479232|10541304|P3|Overall Study|Withdrew Consent|6
3068586|NCT00479232|10541305|P2|Overall Study|Withdrew Consent|2
3068587|NCT00479232|10541306|P1|Overall Study|Withdrew Consent|0
3068588|NCT00479232|10541301|P6|Overall Study|Progressive Disease|12
3068589|NCT00479232|10541302|P5|Overall Study|Progressive Disease|3
3068590|NCT00479232|10541303|P4|Overall Study|Progressive Disease|3
3068591|NCT00479232|10541304|P3|Overall Study|Progressive Disease|12
3068592|NCT00479232|10541305|P2|Overall Study|Progressive Disease|1
3068593|NCT00479232|10541306|P1|Overall Study|Progressive Disease|3
3068594|NCT00479232|10541301|P6|Overall Study|Physician Decision|1
3068595|NCT00479232|10541302|P5|Overall Study|Physician Decision|0
3068596|NCT00479232|10541303|P4|Overall Study|Physician Decision|0
3068597|NCT00479232|10541304|P3|Overall Study|Physician Decision|2
3068598|NCT00479232|10541305|P2|Overall Study|Physician Decision|0
3068599|NCT00479232|10541306|P1|Overall Study|Physician Decision|0
3068600|NCT00479232|10541301|P6|Overall Study|Lack of Efficacy|4
3068601|NCT00479232|10541302|P5|Overall Study|Lack of Efficacy|0
3068602|NCT00479232|10541303|P4|Overall Study|Lack of Efficacy|0
3068603|NCT00479232|10541304|P3|Overall Study|Lack of Efficacy|2
3068604|NCT00479232|10541305|P2|Overall Study|Lack of Efficacy|0
3068605|NCT00479232|10541306|P1|Overall Study|Lack of Efficacy|0
3068606|NCT00479232|10541301|P6|Overall Study|Deviation from Protocol|0
3068607|NCT00479232|10541302|P5|Overall Study|Deviation from Protocol|0
3068608|NCT00479232|10541303|P4|Overall Study|Deviation from Protocol|0
3068609|NCT00479232|10541304|P3|Overall Study|Deviation from Protocol|1
3068610|NCT00479232|10541305|P2|Overall Study|Deviation from Protocol|0
3068611|NCT00479232|10541306|P1|Overall Study|Deviation from Protocol|0
3068612|NCT00479232|10541301|P6|Overall Study|Adverse Event|10
3068613|NCT00479232|10541302|P5|Overall Study|Adverse Event|0
3068614|NCT00479232|10541303|P4|Overall Study|Adverse Event|0
3068615|NCT00479232|10541304|P3|Overall Study|Adverse Event|5
3068616|NCT00479232|10541305|P2|Overall Study|Adverse Event|0
3068617|NCT00479232|10541306|P1|Overall Study|Adverse Event|0
3068618|NCT00478933|10541359|P1|Overall Study|Inadequate data available|53
3068619|NCT00478933|10541359|P1|Overall Study|Informed consent not verified|3
3068620|NCT00478933|10541359|P1|Overall Study|Protocol Violation|22
3068621|NCT00478881|10541385|P2|Overall Study|Non-Compliance with Study Medication|2
3068622|NCT00478881|10541386|P1|Overall Study|Non-Compliance with Study Medication|0
3068623|NCT00478881|10541385|P2|Overall Study|Withdrawal by Subject|2
3068624|NCT00478881|10541386|P1|Overall Study|Withdrawal by Subject|6
3068625|NCT00478881|10541385|P2|Overall Study|Protocol Violation|2
3068626|NCT00478881|10541386|P1|Overall Study|Protocol Violation|2
3068627|NCT00478881|10541385|P2|Overall Study|Lost to Follow-up|1
3068628|NCT00478881|10541386|P1|Overall Study|Lost to Follow-up|0
3068629|NCT00478881|10541385|P2|Overall Study|Lack of Efficacy|3
3068630|NCT00478881|10541386|P1|Overall Study|Lack of Efficacy|0
3068631|NCT00478881|10541385|P2|Overall Study|Adverse Event|12
3068632|NCT00478881|10541386|P1|Overall Study|Adverse Event|31
3068633|NCT00478777|10541410|P1|Overall Study|Not treated with lenalidomide|6
3068634|NCT00478777|10541410|P1|Overall Study|End of therapy|2
3068635|NCT00478777|10541410|P1|Overall Study|Lymphocytes infusion|1
3068636|NCT00478777|10541410|P1|Overall Study|Lack of compliance|1
3068637|NCT00478777|10541410|P1|Overall Study|Intolerance of therapy|1
3068638|NCT00478777|10541410|P1|Overall Study|Physician Decision|1
3068639|NCT00478777|10541410|P1|Overall Study|Lost to Follow-up|3
3068640|NCT00478777|10541410|P1|Overall Study|Protocol Violation|3
3068641|NCT00478777|10541410|P1|Overall Study|Death|3
3068642|NCT00478777|10541410|P1|Overall Study|Withdrawal by Subject|4
3068643|NCT00478777|10541410|P1|Overall Study|Lack of Efficacy|23
3068644|NCT00478777|10541410|P1|Overall Study|Adverse Event|29
3068645|NCT00478673|10541417|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
3068646|NCT00478673|10541417|P1|12-Months Post-Procedure|Missed Visit|25
3068647|NCT00478673|10541417|P1|12-Months Post-Procedure|Withdrawal by Subject|6
3068648|NCT00478673|10541417|P1|12-Months Post-Procedure|Lost to Follow-up|4
3068649|NCT00478673|10541417|P1|12-Months Post-Procedure|Death|23
3068650|NCT00478673|10541417|P1|30-Days Post-Procedure|Missed Visit|7
3068651|NCT00478673|10541417|P1|30-Days Post-Procedure|Withdrawal by Subject|1
3068652|NCT00478673|10541417|P1|30-Days Post-Procedure|Death|2
3068653|NCT00478647|10541422|P1|Overall Study|Withdrawal by Subject|1
3068654|NCT00478647|10541422|P1|Overall Study|Adverse Event|1
3068655|NCT00478608|10541430|P1|Overall Study|Protocol Violation|3
3068656|NCT00478608|10541430|P1|Overall Study|Withdrawal by Subject|2
3068657|NCT00478608|10541430|P1|Overall Study|Serious Adverse Event|14
3068658|NCT00478608|10541430|P1|Overall Study|Adverse Event|1
3068659|NCT00478426|10541463|P1|Overall Study|Withdrawal by Subject|1
3068660|NCT00478257|10541482|P2|Overall Study|Withdrawal by Subject|3
3068661|NCT00478257|10541483|P1|Overall Study|Withdrawal by Subject|8
3068662|NCT00478244|10541489|P1|Overall Study|Did not receive transplant|1
3068663|NCT00478231|10541502|P1|Overall Study|Randomized, not treated|3
3068664|NCT00478231|10541502|P1|Overall Study|Adverse Event|5
3068665|NCT00478231|10541502|P1|Overall Study|Other|9
3068666|NCT00478231|10541502|P1|Overall Study|Withdrawal by Subject|6
3068667|NCT00478231|10541502|P1|Overall Study|Lost to Follow-up|7
3068668|NCT00478231|10541502|P1|Overall Study|Lack of Efficacy|47
3068669|NCT00478231|10541502|P1|Overall Study|Death|7
3068670|NCT00478205|10541538|P2|Overall Study|Other|12
3068671|NCT00478205|10541539|P1|Overall Study|Other|24
3068672|NCT00478205|10541538|P2|Overall Study|Lack of Efficacy|0
3068673|NCT00478205|10541539|P1|Overall Study|Lack of Efficacy|1
3068674|NCT00478205|10541538|P2|Overall Study|Withdrawal by Subject|22
3068675|NCT00478205|10541539|P1|Overall Study|Withdrawal by Subject|61
3068676|NCT00478205|10541538|P2|Overall Study|Request of Investigator or Sponsor|5
3068677|NCT00478205|10541539|P1|Overall Study|Request of Investigator or Sponsor|4
3068678|NCT00478205|10541538|P2|Overall Study|Protocol Violation|5
3068679|NCT00478205|10541539|P1|Overall Study|Protocol Violation|15
3068680|NCT00478205|10541538|P2|Overall Study|Medication Non-compliance|4
3068681|NCT00478205|10541539|P1|Overall Study|Medication Non-compliance|9
3068682|NCT00478205|10541538|P2|Overall Study|Adverse Event|39
3068683|NCT00478205|10541539|P1|Overall Study|Adverse Event|182
3068684|NCT00478140|10541583|P1|Overall Study|Clinical Disease Progression|1
3068685|NCT00478023|10541615|P5|Overall Study|Lack of pain, Technical difficulties|3
3068686|NCT00478023|10541616|P4|Overall Study|Lack of pain, Technical difficulties|6
3068687|NCT00478023|10541617|P3|Overall Study|Lack of pain, Technical difficulties|5
3068688|NCT00478023|10541618|P2|Overall Study|Lack of pain, Technical difficulties|3
3068689|NCT00478023|10541619|P1|Overall Study|Lack of pain, Technical difficulties|7
3068690|NCT00478023|10541615|P5|Overall Study|Withdrawal by Subject|5
3068691|NCT00478023|10541616|P4|Overall Study|Withdrawal by Subject|4
3068692|NCT00478023|10541617|P3|Overall Study|Withdrawal by Subject|2
3068693|NCT00478023|10541618|P2|Overall Study|Withdrawal by Subject|3
3068694|NCT00478023|10541619|P1|Overall Study|Withdrawal by Subject|2
3068695|NCT00478023|10541615|P5|Overall Study|Lost to Follow-up|0
3068696|NCT00478023|10541616|P4|Overall Study|Lost to Follow-up|1
3068697|NCT00478023|10541617|P3|Overall Study|Lost to Follow-up|1
3068698|NCT00478023|10541618|P2|Overall Study|Lost to Follow-up|1
3068699|NCT00478023|10541619|P1|Overall Study|Lost to Follow-up|3
3068700|NCT00478023|10541615|P5|Overall Study|Lack of Efficacy|41
3068701|NCT00478023|10541616|P4|Overall Study|Lack of Efficacy|5
3068702|NCT00478023|10541617|P3|Overall Study|Lack of Efficacy|4
3068703|NCT00478023|10541618|P2|Overall Study|Lack of Efficacy|10
3068704|NCT00478023|10541619|P1|Overall Study|Lack of Efficacy|11
3068705|NCT00478023|10541615|P5|Overall Study|Death|0
3068706|NCT00478023|10541616|P4|Overall Study|Death|0
3068707|NCT00478023|10541617|P3|Overall Study|Death|0
3068708|NCT00478023|10541618|P2|Overall Study|Death|0
3068709|NCT00478023|10541619|P1|Overall Study|Death|1
3068710|NCT00478023|10541615|P5|Overall Study|Adverse Event|6
3068711|NCT00478023|10541616|P4|Overall Study|Adverse Event|14
3068712|NCT00478023|10541617|P3|Overall Study|Adverse Event|8
3068713|NCT00478023|10541618|P2|Overall Study|Adverse Event|7
3068714|NCT00478023|10541619|P1|Overall Study|Adverse Event|11
3068715|NCT00477971|10541638|P2|Overall Study|Alternative treatment|1
3068716|NCT00477971|10541639|P1|Overall Study|Alternative treatment|3
3068717|NCT00477971|10541638|P2|Overall Study|Death|4
3068718|NCT00477971|10541639|P1|Overall Study|Death|2
3068719|NCT00477971|10541638|P2|Overall Study|Adverse Event|0
3068720|NCT00477971|10541639|P1|Overall Study|Adverse Event|3
3068721|NCT00477971|10541638|P2|Overall Study|Withdrawal by Subject|1
3068722|NCT00477971|10541639|P1|Overall Study|Withdrawal by Subject|3
3068723|NCT00477971|10541638|P2|Overall Study|Disease progression|0
3068724|NCT00477971|10541639|P1|Overall Study|Disease progression|6
3068725|NCT00477750|10541651|P1|Overall Study|Currently Receiving Treatment|11
3068726|NCT00477672|10541667|P3|Overall Study|Discretion of Sponsor|0
3068727|NCT00477672|10541668|P2|Overall Study|Discretion of Sponsor|2
3068728|NCT00477672|10541669|P1|Overall Study|Discretion of Sponsor|1
3068729|NCT00477672|10541667|P3|Overall Study|Consent withdrawn|10
3068730|NCT00477672|10541668|P2|Overall Study|Consent withdrawn|5
3068731|NCT00477672|10541669|P1|Overall Study|Consent withdrawn|2
3068732|NCT00477672|10541667|P3|Overall Study|Protocol noncompliance|0
3068733|NCT00477672|10541668|P2|Overall Study|Protocol noncompliance|2
3068734|NCT00477672|10541669|P1|Overall Study|Protocol noncompliance|0
3068735|NCT00477672|10541667|P3|Overall Study|Physician Decision|0
3068736|NCT00477672|10541668|P2|Overall Study|Physician Decision|0
3068737|NCT00477672|10541669|P1|Overall Study|Physician Decision|1
3068738|NCT00477672|10541667|P3|Overall Study|Disease progression|0
3068739|NCT00477672|10541668|P2|Overall Study|Disease progression|1
3068740|NCT00477672|10541669|P1|Overall Study|Disease progression|0
3068741|NCT00477672|10541667|P3|Overall Study|Death|0
3068742|NCT00477672|10541668|P2|Overall Study|Death|1
3068743|NCT00477672|10541669|P1|Overall Study|Death|0
3068744|NCT00477672|10541667|P3|Overall Study|Adverse Event|6
3068745|NCT00477672|10541668|P2|Overall Study|Adverse Event|5
3068746|NCT00477672|10541669|P1|Overall Study|Adverse Event|3
3068747|NCT00477633|10541680|P1|Overall Study|Various (Moving, Enrollment closed)|75
3068748|NCT00477633|10541680|P1|Overall Study|Protocol Violation|25
3068749|NCT00477633|10541680|P1|Overall Study|Withdrawal by Subject|149
3068750|NCT00477633|10541680|P1|Overall Study|Lost to Follow-up|271
3068751|NCT00477633|10541680|P1|Overall Study|Pregnancy|23
3068752|NCT00477633|10541680|P1|Overall Study|Adverse Event|143
3068753|NCT00477633|10541680|P1|Overall Study|Did not receive treatment|23
3068754|NCT00477607|10541688|P2|Overall Study|Lost to Follow-up|7
3068755|NCT00477607|10541689|P1|Overall Study|Lost to Follow-up|7
3068756|NCT00477594|10541701|P2|Follow-up Period|Other|0
3068757|NCT00477594|10541702|P1|Follow-up Period|Other|1
3068758|NCT00477594|10541701|P2|Follow-up Period|Withdrawal by Subject|1
3068759|NCT00477594|10541702|P1|Follow-up Period|Withdrawal by Subject|2
3068760|NCT00477594|10541701|P2|Year 3|Withdrawal by Subject|0
3068761|NCT00477594|10541702|P1|Year 3|Withdrawal by Subject|1
3068762|NCT00477594|10541701|P2|Year 3|Adverse Event|0
3068763|NCT00477594|10541702|P1|Year 3|Adverse Event|1
3068764|NCT00477594|10541701|P2|Year 1 and Year 2|Other|0
3068765|NCT00477594|10541702|P1|Year 1 and Year 2|Other|1
3068766|NCT00477594|10541701|P2|Year 1 and Year 2|Withdrawal by Subject|1
3068767|NCT00477594|10541702|P1|Year 1 and Year 2|Withdrawal by Subject|2
3068768|NCT00477594|10541701|P2|Year 1 and Year 2|Physician Decision|1
3068769|NCT00477594|10541702|P1|Year 1 and Year 2|Physician Decision|2
3068770|NCT00477594|10541701|P2|Year 1 and Year 2|Adverse Event|2
3068771|NCT00477594|10541702|P1|Year 1 and Year 2|Adverse Event|4
3068772|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
3068773|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
3068774|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
3068775|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
3068776|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
3068777|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
3068778|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
3068779|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
3068780|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
3068781|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
3068782|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
3068783|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
3068784|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
3068785|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
3068786|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
3068787|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
3068788|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
3068789|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
3068790|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068791|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068792|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068793|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068794|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068795|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068796|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068797|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
3068798|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
3068799|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
3068800|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
3068801|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068802|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068803|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
3068804|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068805|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068806|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068807|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
3068808|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
3068809|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
3068810|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
3068811|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
3068812|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
3068813|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
3068814|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
3068815|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
3068816|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
3068817|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
3068818|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
3068819|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
3068820|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
3068821|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
3068822|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
3068823|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
3068824|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
3068825|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
3068826|NCT00477490|10541763|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
3068827|NCT00477490|10541764|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
3068828|NCT00477490|10541765|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
3068829|NCT00477490|10541766|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
3068830|NCT00477490|10541767|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
3068831|NCT00477490|10541768|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
3068832|NCT00477490|10541769|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
3068833|NCT00477490|10541770|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
3068834|NCT00477490|10541771|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
3068835|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Not Reported|0
3068836|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Not Reported|0
3068837|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Not Reported|0
3068838|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Not Reported|0
3068839|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Not Reported|1
3068840|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Not Reported|0
3068841|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Not Reported|3
3068842|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Not Reported|2
3068843|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Not Reported|1
3068844|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Other, not specified|0
3068845|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Other, not specified|0
3068846|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Other, not specified|0
3068847|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Other, not specified|0
3068848|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Other, not specified|1
3068849|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Other, not specified|1
3068850|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Other, not specified|0
3068851|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Other, not specified|4
3068852|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Other, not specified|2
3068853|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
3068854|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
3068855|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
3068856|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
3068857|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
3068858|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
3068859|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
3068860|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
3068861|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
3068862|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
3068863|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
3068864|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
3068865|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
3068866|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
3068867|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
3068868|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
3068869|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
3068870|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
3068871|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Protocol Violation|0
3068872|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Protocol Violation|0
3068873|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Protocol Violation|0
3068874|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Protocol Violation|0
3068875|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Protocol Violation|1
3068876|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Protocol Violation|0
3068877|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Protocol Violation|0
3068878|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Protocol Violation|0
3068879|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Protocol Violation|2
3068880|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068881|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068882|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068883|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068884|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
3068885|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
3068886|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068887|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
3068888|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
3068889|NCT00477490|10541763|P9|Part I: 4 Week Efficacy|Adverse Event|0
3068890|NCT00477490|10541764|P8|Part I: 4 Week Efficacy|Adverse Event|0
3068891|NCT00477490|10541765|P7|Part I: 4 Week Efficacy|Adverse Event|0
3068892|NCT00477490|10541766|P6|Part I: 4 Week Efficacy|Adverse Event|0
3068893|NCT00477490|10541767|P5|Part I: 4 Week Efficacy|Adverse Event|6
3068894|NCT00477490|10541768|P4|Part I: 4 Week Efficacy|Adverse Event|5
3068895|NCT00477490|10541769|P3|Part I: 4 Week Efficacy|Adverse Event|0
3068896|NCT00477490|10541770|P2|Part I: 4 Week Efficacy|Adverse Event|4
3068897|NCT00477490|10541771|P1|Part I: 4 Week Efficacy|Adverse Event|1
3068898|NCT00477464|10541855|P1|Overall Study|Completion of protocol-defined follow-up|14
3068899|NCT00477464|10541855|P1|Overall Study|Death|36
3068900|NCT00477464|10541855|P1|Overall Study|Lost to Follow-up|1
3068901|NCT00477386|10541899|P2|Overall Study|Withdrawal by Subject|0
3068902|NCT00477386|10541900|P1|Overall Study|Withdrawal by Subject|1
3068903|NCT00477386|10541899|P2|Overall Study|Physician Decision|0
3068904|NCT00477386|10541900|P1|Overall Study|Physician Decision|1
3068905|NCT00477386|10541899|P2|Overall Study|Other|2
3068906|NCT00477386|10541900|P1|Overall Study|Other|1
3068907|NCT00477386|10541899|P2|Overall Study|Disease progression, refractory|3
3068908|NCT00477386|10541900|P1|Overall Study|Disease progression, refractory|1
3068909|NCT00477386|10541899|P2|Overall Study|Disease progression, relapse|4
3068910|NCT00477386|10541900|P1|Overall Study|Disease progression, relapse|3
3068911|NCT00477386|10541899|P2|Overall Study|Adverse Event|8
3068912|NCT00477386|10541900|P1|Overall Study|Adverse Event|4
3068913|NCT00477334|10541910|P2|Overall Study|Protocol Violation|1
3068914|NCT00477334|10541911|P1|Overall Study|Protocol Violation|7
3068915|NCT00477334|10541910|P2|Overall Study|Administrative Problems|15
3068916|NCT00477334|10541911|P1|Overall Study|Administrative Problems|39
3068917|NCT00477334|10541910|P2|Overall Study|Lost to Follow-up|4
3068918|NCT00477334|10541911|P1|Overall Study|Lost to Follow-up|15
3068919|NCT00477334|10541910|P2|Overall Study|Withdrawal by Subject|1
3068920|NCT00477334|10541911|P1|Overall Study|Withdrawal by Subject|2
3068921|NCT00477334|10541910|P2|Overall Study|Adverse Event|2
3068922|NCT00477334|10541911|P1|Overall Study|Adverse Event|1
3068923|NCT00477334|10541910|P2|Overall Study|Discontinued prior to taking study drug|53
3068924|NCT00477334|10541911|P1|Overall Study|Discontinued prior to taking study drug|106
3068925|NCT00477295|10541937|P2|Overall Study|Other|3
3068926|NCT00477295|10541938|P1|Overall Study|Other|4
3068927|NCT00477295|10541937|P2|Overall Study|Lost to Follow-up|11
3068928|NCT00477295|10541938|P1|Overall Study|Lost to Follow-up|21
3068929|NCT00477295|10541937|P2|Overall Study|Physician Decision|5
3068930|NCT00477295|10541938|P1|Overall Study|Physician Decision|4
3068931|NCT00477295|10541937|P2|Overall Study|Protocol Violation|8
3068932|NCT00477295|10541938|P1|Overall Study|Protocol Violation|3
3068933|NCT00477295|10541937|P2|Overall Study|Lack of Efficacy|23
3068934|NCT00477295|10541938|P1|Overall Study|Lack of Efficacy|23
3068935|NCT00477295|10541937|P2|Overall Study|Withdrawal by Subject|24
3068936|NCT00477295|10541938|P1|Overall Study|Withdrawal by Subject|35
3068937|NCT00477295|10541937|P2|Overall Study|Adverse Event|35
3068938|NCT00477295|10541938|P1|Overall Study|Adverse Event|31
3068939|NCT00477269|10541966|P3|Open Label Extension|Death|4
3068940|NCT00477269|10541967|P2|Open Label Extension|Death|0
3068941|NCT00477269|10541968|P1|Open Label Extension|Death|0
3068942|NCT00477269|10541966|P3|Open Label Extension|Adminiatrative problems|2
3068943|NCT00477269|10541967|P2|Open Label Extension|Adminiatrative problems|0
3068944|NCT00477269|10541968|P1|Open Label Extension|Adminiatrative problems|0
3068945|NCT00477269|10541966|P3|Open Label Extension|unsatisfactory therapeutic effects|2
3068946|NCT00477269|10541967|P2|Open Label Extension|unsatisfactory therapeutic effects|0
3068947|NCT00477269|10541968|P1|Open Label Extension|unsatisfactory therapeutic effects|0
3068948|NCT00477269|10541966|P3|Open Label Extension|Abnormal laboratory values|1
3068949|NCT00477269|10541967|P2|Open Label Extension|Abnormal laboratory values|0
3068950|NCT00477269|10541968|P1|Open Label Extension|Abnormal laboratory values|0
3068951|NCT00477269|10541966|P3|Open Label Extension|Adverse Event|4
3068952|NCT00477269|10541967|P2|Open Label Extension|Adverse Event|0
3068953|NCT00477269|10541968|P1|Open Label Extension|Adverse Event|0
3068954|NCT00477269|10541966|P3|Core Study|Withdrawn Consent|0
3068955|NCT00477269|10541967|P2|Core Study|Withdrawn Consent|1
3068956|NCT00477269|10541968|P1|Core Study|Withdrawn Consent|0
3068957|NCT00477269|10541966|P3|Core Study|Death|0
3068958|NCT00477269|10541967|P2|Core Study|Death|3
3068959|NCT00477269|10541968|P1|Core Study|Death|3
3068960|NCT00477269|10541966|P3|Core Study|Adverse Event|0
3068961|NCT00477269|10541967|P2|Core Study|Adverse Event|4
3068962|NCT00477269|10541968|P1|Core Study|Adverse Event|6
3068963|NCT00477165|10542047|P2|Overall Study|Adverse Event|2
3068964|NCT00477165|10542048|P1|Overall Study|Adverse Event|7
3068965|NCT00477152|10542060|P1|Overall Study|Adverse Event|1
3068966|NCT00477152|10542060|P1|Overall Study|Parent withdrew consent|2
3068967|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Early termination of the study|578
3068968|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Early termination of the study|0
3068969|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Early termination of the study|0
3068970|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Early termination of the study|0
3068971|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
3068972|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
3068973|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
3068974|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
3068975|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
3068976|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
3068977|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
3068978|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
3068979|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
3068980|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
3068981|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
3068982|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
3068983|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Death|7
3068984|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Death|0
3068985|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Death|0
3068986|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Death|0
3068987|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Adverse Event|8
3068988|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Adverse Event|0
3068989|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Adverse Event|0
3068990|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Adverse Event|0
3068991|NCT00476996|10542076|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
3068992|NCT00476996|10542077|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
3068993|NCT00476996|10542078|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
3068994|NCT00476996|10542079|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
3068995|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
3068996|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
3068997|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
3068998|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
3068999|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Death|0
3069000|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Death|1
3069001|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Death|1
3069002|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Death|2
3069003|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
3069004|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
3069005|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
3069006|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
3069007|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
3069008|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
3069009|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
3069010|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
3069011|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
3069012|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
3069013|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
3069014|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
3069015|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
3069016|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
3069017|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
3069018|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
3069019|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
3069020|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
3069021|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
3069022|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
3069023|NCT00476996|10542076|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
3069024|NCT00476996|10542077|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
3069025|NCT00476996|10542078|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
3069026|NCT00476996|10542079|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
3069027|NCT00476957|10542111|P2|Overall Study|Lost to Follow-up|193
3069028|NCT00476957|10542112|P1|Overall Study|Lost to Follow-up|176
3069029|NCT00476593|10542176|P4|Overall Study|Lost to Follow-up|22
3069030|NCT00476593|10542177|P3|Overall Study|Lost to Follow-up|8
3069031|NCT00476593|10542178|P2|Overall Study|Lost to Follow-up|2
3069032|NCT00476593|10542179|P1|Overall Study|Lost to Follow-up|10
3069033|NCT00476476|10542191|P2|Overall Study|Progressive Disease|17
3069034|NCT00476476|10542192|P1|Overall Study|Progressive Disease|0
3069035|NCT00476476|10542191|P2|Overall Study|Adverse Event|7
3069036|NCT00476476|10542192|P1|Overall Study|Adverse Event|2
3069037|NCT00476229|10542210|P1|Overall Study|Progressive shortness of breath|1
3069038|NCT00476151|10542216|P2|Overall Study|Physician Decision|2
3069039|NCT00476151|10542217|P1|Overall Study|Physician Decision|0
3069040|NCT00476151|10542216|P2|Overall Study|Withdrawal by Subject|0
3069041|NCT00476151|10542217|P1|Overall Study|Withdrawal by Subject|2
3069042|NCT00476151|10542216|P2|Overall Study|Protocol Violation|3
3069043|NCT00476151|10542217|P1|Overall Study|Protocol Violation|1
3069044|NCT00476151|10542216|P2|Overall Study|Adverse Event|2
3069045|NCT00476151|10542217|P1|Overall Study|Adverse Event|0
3069046|NCT00476086|10542223|P1|Overall Study|Progressive Disease|4
3069047|NCT00476086|10542223|P1|Overall Study|Alternative therapy|1
3069048|NCT00476047|10542229|P1|Overall Study|Lost to Follow-up|1
3069049|NCT00476008|10542255|P2|Overall Study|Death|0
3069050|NCT00476008|10542256|P1|Overall Study|Death|1
3069051|NCT00476008|10542255|P2|Overall Study|Withdrawal by Subject|1
3069052|NCT00476008|10542256|P1|Overall Study|Withdrawal by Subject|0
3069053|NCT00476008|10542255|P2|Overall Study|Physician Decision: Medication Noncompli|1
3069054|NCT00476008|10542256|P1|Overall Study|Physician Decision: Medication Noncompli|2
3069055|NCT00476008|10542255|P2|Overall Study|Placebo concerns|2
3069056|NCT00476008|10542256|P1|Overall Study|Placebo concerns|2
3069057|NCT00476008|10542255|P2|Overall Study|Adverse Event|4
3069058|NCT00476008|10542256|P1|Overall Study|Adverse Event|4
3069059|NCT00475982|10542282|P2|Overall Study|surgery rescheduled|3
3069060|NCT00475982|10542283|P1|Overall Study|surgery rescheduled|7
3069061|NCT00475865|10542331|P3|Overall Study|Other than above|0
3069062|NCT00475865|10542332|P2|Overall Study|Other than above|1
3069063|NCT00475865|10542333|P1|Overall Study|Other than above|0
3069064|NCT00475865|10542331|P3|Overall Study|Participant did not wish to continue|0
3069065|NCT00475865|10542332|P2|Overall Study|Participant did not wish to continue|0
3069066|NCT00475865|10542333|P1|Overall Study|Participant did not wish to continue|1
3069067|NCT00475865|10542331|P3|Overall Study|Progressive disease|2
3069068|NCT00475865|10542332|P2|Overall Study|Progressive disease|1
3069069|NCT00475865|10542333|P1|Overall Study|Progressive disease|0
3069070|NCT00475865|10542331|P3|Overall Study|Lack of Efficacy|0
3069071|NCT00475865|10542332|P2|Overall Study|Lack of Efficacy|0
3069072|NCT00475865|10542333|P1|Overall Study|Lack of Efficacy|1
3069073|NCT00475865|10542331|P3|Overall Study|Adverse Event|4
3069074|NCT00475865|10542332|P2|Overall Study|Adverse Event|3
3069075|NCT00475865|10542333|P1|Overall Study|Adverse Event|0
3069076|NCT00475852|10542363|P2|Overall Study|Lost to Follow-up|68
3069077|NCT00475852|10542364|P1|Overall Study|Lost to Follow-up|54
3069078|NCT00475852|10542363|P2|Overall Study|Withdrawal by Subject|24
3069079|NCT00475852|10542364|P1|Overall Study|Withdrawal by Subject|19
3069080|NCT00475852|10542363|P2|Overall Study|Death|456
3069081|NCT00475852|10542364|P1|Overall Study|Death|444
3069082|NCT00475735|10542415|P6|Treatment Period 2|Withdrawal by Subject|0
3069083|NCT00475735|10542416|P5|Treatment Period 2|Withdrawal by Subject|1
3069084|NCT00475735|10542417|P4|Treatment Period 2|Withdrawal by Subject|0
3069085|NCT00475735|10542418|P3|Treatment Period 2|Withdrawal by Subject|0
3069086|NCT00475735|10542419|P2|Treatment Period 2|Withdrawal by Subject|0
3069087|NCT00475735|10542420|P1|Treatment Period 2|Withdrawal by Subject|0
3069088|NCT00475735|10542415|P6|Treatment Period 2|Lack of Efficacy|1
3069089|NCT00475735|10542416|P5|Treatment Period 2|Lack of Efficacy|0
3069090|NCT00475735|10542417|P4|Treatment Period 2|Lack of Efficacy|0
3069091|NCT00475735|10542418|P3|Treatment Period 2|Lack of Efficacy|0
3069092|NCT00475735|10542419|P2|Treatment Period 2|Lack of Efficacy|0
3069093|NCT00475735|10542420|P1|Treatment Period 2|Lack of Efficacy|0
3069094|NCT00475735|10542415|P6|Treatment Period 2|Adverse Event|0
3069095|NCT00475735|10542416|P5|Treatment Period 2|Adverse Event|0
3069096|NCT00475735|10542417|P4|Treatment Period 2|Adverse Event|2
3069097|NCT00475735|10542418|P3|Treatment Period 2|Adverse Event|0
3069098|NCT00475735|10542419|P2|Treatment Period 2|Adverse Event|1
3069099|NCT00475735|10542420|P1|Treatment Period 2|Adverse Event|0
3069100|NCT00475735|10542415|P6|Treatment Washout|Protocol Violation|0
3069101|NCT00475735|10542416|P5|Treatment Washout|Protocol Violation|0
3069102|NCT00475735|10542417|P4|Treatment Washout|Protocol Violation|0
3069103|NCT00475735|10542418|P3|Treatment Washout|Protocol Violation|0
3069104|NCT00475735|10542419|P2|Treatment Washout|Protocol Violation|1
3069105|NCT00475735|10542420|P1|Treatment Washout|Protocol Violation|0
3069106|NCT00475735|10542415|P6|Treatment Washout|Lost to Follow-up|0
3069107|NCT00475735|10542416|P5|Treatment Washout|Lost to Follow-up|0
3069108|NCT00475735|10542417|P4|Treatment Washout|Lost to Follow-up|0
3069109|NCT00475735|10542418|P3|Treatment Washout|Lost to Follow-up|0
3069110|NCT00475735|10542419|P2|Treatment Washout|Lost to Follow-up|1
3069111|NCT00475735|10542420|P1|Treatment Washout|Lost to Follow-up|0
3069112|NCT00475735|10542415|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
3069113|NCT00475735|10542416|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
3069114|NCT00475735|10542417|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
3069115|NCT00475735|10542418|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
3069116|NCT00475735|10542419|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
3069117|NCT00475735|10542420|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
3069118|NCT00475735|10542415|P6|Treatment Period 1|DC due to AE but continuing|2
3069119|NCT00475735|10542416|P5|Treatment Period 1|DC due to AE but continuing|2
3069120|NCT00475735|10542417|P4|Treatment Period 1|DC due to AE but continuing|1
3069121|NCT00475735|10542418|P3|Treatment Period 1|DC due to AE but continuing|0
3069122|NCT00475735|10542419|P2|Treatment Period 1|DC due to AE but continuing|0
3069123|NCT00475735|10542420|P1|Treatment Period 1|DC due to AE but continuing|0
3069124|NCT00475735|10542415|P6|Treatment Period 1|Withdrawal by Subject|0
3069125|NCT00475735|10542416|P5|Treatment Period 1|Withdrawal by Subject|0
3069126|NCT00475735|10542417|P4|Treatment Period 1|Withdrawal by Subject|0
3069127|NCT00475735|10542418|P3|Treatment Period 1|Withdrawal by Subject|0
3069128|NCT00475735|10542419|P2|Treatment Period 1|Withdrawal by Subject|1
3069129|NCT00475735|10542420|P1|Treatment Period 1|Withdrawal by Subject|1
3069130|NCT00475735|10542415|P6|Treatment Period 1|Protocol Violation|0
3069131|NCT00475735|10542416|P5|Treatment Period 1|Protocol Violation|0
3069132|NCT00475735|10542417|P4|Treatment Period 1|Protocol Violation|1
3069133|NCT00475735|10542418|P3|Treatment Period 1|Protocol Violation|0
3069134|NCT00475735|10542419|P2|Treatment Period 1|Protocol Violation|0
3069135|NCT00475735|10542420|P1|Treatment Period 1|Protocol Violation|0
3069136|NCT00475735|10542415|P6|Treatment Period 1|Lost to Follow-up|1
3069137|NCT00475735|10542416|P5|Treatment Period 1|Lost to Follow-up|0
3069138|NCT00475735|10542417|P4|Treatment Period 1|Lost to Follow-up|0
3069139|NCT00475735|10542418|P3|Treatment Period 1|Lost to Follow-up|0
3069140|NCT00475735|10542419|P2|Treatment Period 1|Lost to Follow-up|0
3069141|NCT00475735|10542420|P1|Treatment Period 1|Lost to Follow-up|0
3069142|NCT00475735|10542415|P6|Treatment Period 1|Lack of Efficacy|0
3069143|NCT00475735|10542416|P5|Treatment Period 1|Lack of Efficacy|0
3069144|NCT00475735|10542417|P4|Treatment Period 1|Lack of Efficacy|0
3069145|NCT00475735|10542418|P3|Treatment Period 1|Lack of Efficacy|0
3069146|NCT00475735|10542419|P2|Treatment Period 1|Lack of Efficacy|0
3069147|NCT00475735|10542420|P1|Treatment Period 1|Lack of Efficacy|1
3069148|NCT00475735|10542415|P6|Treatment Period 1|Adverse Event|0
3069149|NCT00475735|10542416|P5|Treatment Period 1|Adverse Event|0
3069150|NCT00475735|10542417|P4|Treatment Period 1|Adverse Event|0
3069151|NCT00475735|10542418|P3|Treatment Period 1|Adverse Event|0
3069152|NCT00475735|10542419|P2|Treatment Period 1|Adverse Event|0
3069153|NCT00475735|10542420|P1|Treatment Period 1|Adverse Event|2
3069154|NCT00475722|10542433|P2|Overall Study|Protocol Violation|0
3069155|NCT00475722|10542434|P1|Overall Study|Protocol Violation|3
3069156|NCT00475722|10542433|P2|Overall Study|Withdrawal by Subject|12
3069157|NCT00475722|10542434|P1|Overall Study|Withdrawal by Subject|12
3069158|NCT00475709|10542440|P1|Overall Study|Lost to Follow-up|21
3069159|NCT00475709|10542440|P1|Overall Study|Device Explant|6
3069160|NCT00475709|10542440|P1|Overall Study|Death|41
3069161|NCT00475709|10542440|P1|Overall Study|Did not meet eligibility criteria|8
3069162|NCT00475670|10542448|P2|Overall Study|Other|3
3069163|NCT00475670|10542449|P1|Overall Study|Other|0
3069164|NCT00475670|10542448|P2|Overall Study|Failure to Return|1
3069165|NCT00475670|10542449|P1|Overall Study|Failure to Return|0
3069166|NCT00475670|10542448|P2|Overall Study|Refused treatment|2
3069167|NCT00475670|10542449|P1|Overall Study|Refused treatment|0
3069168|NCT00475670|10542448|P2|Overall Study|Lack of Efficacy|34
3069169|NCT00475670|10542449|P1|Overall Study|Lack of Efficacy|3
3069170|NCT00475670|10542448|P2|Overall Study|Death|1
3069171|NCT00475670|10542449|P1|Overall Study|Death|0
3069172|NCT00475657|10542473|P1|Overall Study|Sponsor's Decision|3
3069173|NCT00475657|10542473|P1|Overall Study|Death|1
3069174|NCT00475644|10542481|P1|Overall Study|Protocol Violation|13
3069175|NCT00475423|10542546|P1|Overall Study|Lost to Follow-up|7
3069176|NCT00475423|10542546|P1|Overall Study|Reason not specified|1
3069177|NCT00475423|10542546|P1|Overall Study|Death|1
3069178|NCT00475423|10542546|P1|Overall Study|Lack of Efficacy|8
3069179|NCT00475423|10542546|P1|Overall Study|Withdrawal by Subject|6
3069180|NCT00475423|10542546|P1|Overall Study|Adverse Event|4
3069181|NCT00475423|10542546|P1|Overall Study|Protocol Violation|5
3069182|NCT00475306|10542592|P4|Overall Study|Protocol Violation|1
3069183|NCT00475306|10542593|P3|Overall Study|Protocol Violation|0
3069184|NCT00475306|10542594|P2|Overall Study|Protocol Violation|1
3069185|NCT00475306|10542595|P1|Overall Study|Protocol Violation|1
3069186|NCT00475228|10542626|P2|Overall Study|Lost to Follow-up|17
3069187|NCT00475228|10542627|P1|Overall Study|Lost to Follow-up|17
3069188|NCT00475176|10542666|P1|Overall Study|Protocol Violation|1
3069189|NCT00475176|10542666|P1|Overall Study|Withdrawal by Subject|1
3069190|NCT00475176|10542666|P1|Overall Study|Adverse Event|2
3069191|NCT00475033|10542706|P2|Toddler Dose|Lost to Follow-up|0
3069192|NCT00475033|10542707|P1|Toddler Dose|Lost to Follow-up|1
3069193|NCT00475033|10542706|P2|Toddler Dose|Failed to return|0
3069194|NCT00475033|10542707|P1|Toddler Dose|Failed to return|1
3069195|NCT00475033|10542706|P2|Toddler Dose|Parent or legal guardian request|0
3069196|NCT00475033|10542707|P1|Toddler Dose|Parent or legal guardian request|2
3069197|NCT00475033|10542706|P2|After the Infant Series|Other|1
3069198|NCT00475033|10542707|P1|After the Infant Series|Other|0
3069199|NCT00475033|10542706|P2|After the Infant Series|Lost to Follow-up|0
3069200|NCT00475033|10542707|P1|After the Infant Series|Lost to Follow-up|1
3069201|NCT00475033|10542706|P2|After the Infant Series|Protocol Violation|0
3069202|NCT00475033|10542707|P1|After the Infant Series|Protocol Violation|1
3069203|NCT00475033|10542706|P2|After the Infant Series|Failed to return|1
3069204|NCT00475033|10542707|P1|After the Infant Series|Failed to return|2
3069205|NCT00475033|10542706|P2|After the Infant Series|Parent or legal guardian request|2
3069206|NCT00475033|10542707|P1|After the Infant Series|Parent or legal guardian request|2
3069207|NCT00475033|10542706|P2|After the Infant Series|Adverse Event|4
3069208|NCT00475033|10542707|P1|After the Infant Series|Adverse Event|0
3069209|NCT00475033|10542706|P2|Infant Series|Adverse Event|2
3069210|NCT00475033|10542707|P1|Infant Series|Adverse Event|0
3069211|NCT00475033|10542706|P2|Infant Series|Lost to Follow-up|0
3069212|NCT00475033|10542707|P1|Infant Series|Lost to Follow-up|2
3069213|NCT00475033|10542706|P2|Infant Series|Protocol Violation|2
3069214|NCT00475033|10542707|P1|Infant Series|Protocol Violation|1
3069215|NCT00475033|10542706|P2|Infant Series|Parent or legal guardian request|5
3069216|NCT00475033|10542707|P1|Infant Series|Parent or legal guardian request|1
3069217|NCT00475033|10542706|P2|Infant Series|Failed to return|4
3069218|NCT00475033|10542707|P1|Infant Series|Failed to return|3
3069219|NCT00475020|10542755|P1|Overall Study|Donor not able to donate the last minute|1
3069220|NCT00475020|10542755|P1|Overall Study|Insurance Denial|1
3069221|NCT00475020|10542755|P1|Overall Study|Physician Decision|3
3069222|NCT00474994|10542760|P1|Overall Study|Patient found to be ineligible|1
3069223|NCT00474994|10542760|P1|Overall Study|Patient evaluable for toxicity only|3
3069224|NCT00474994|10542760|P1|Overall Study|Patient Not treated|1
3069225|NCT00474968|10542766|P2|Overall Study|Sample not collected|1
3069226|NCT00474968|10542767|P1|Overall Study|Sample not collected|1
3069227|NCT00474968|10542766|P2|Overall Study|Protocol Violation|8
3069228|NCT00474968|10542767|P1|Overall Study|Protocol Violation|9
3069229|NCT00474968|10542766|P2|Overall Study|Withdrawal by Subject|7
3069230|NCT00474968|10542767|P1|Overall Study|Withdrawal by Subject|8
3069231|NCT00474955|10542777|P1|Overall Study|Personal reasons|5
3069232|NCT00474955|10542777|P1|Overall Study|Drug unavailability|1
3069233|NCT00474955|10542777|P1|Overall Study|Adverse Event|2
3069234|NCT00474929|10542793|P5|Overall Study|Physician Decision|0
3069235|NCT00474929|10542794|P4|Overall Study|Physician Decision|2
3069236|NCT00474929|10542795|P3|Overall Study|Physician Decision|1
3069237|NCT00474929|10542796|P2|Overall Study|Physician Decision|0
3069238|NCT00474929|10542797|P1|Overall Study|Physician Decision|0
3069239|NCT00474929|10542793|P5|Overall Study|Unrelated medical condition|0
3069240|NCT00474929|10542794|P4|Overall Study|Unrelated medical condition|0
3069241|NCT00474929|10542795|P3|Overall Study|Unrelated medical condition|1
3069242|NCT00474929|10542796|P2|Overall Study|Unrelated medical condition|0
3069243|NCT00474929|10542797|P1|Overall Study|Unrelated medical condition|0
3069244|NCT00474929|10542793|P5|Overall Study|Withdrawal by Subject|0
3069245|NCT00474929|10542794|P4|Overall Study|Withdrawal by Subject|0
3069246|NCT00474929|10542795|P3|Overall Study|Withdrawal by Subject|0
3069247|NCT00474929|10542796|P2|Overall Study|Withdrawal by Subject|1
3069248|NCT00474929|10542797|P1|Overall Study|Withdrawal by Subject|0
3069249|NCT00474903|10542814|P3|Overall Study|Protocol Violation|2
3069250|NCT00474903|10542815|P2|Overall Study|Protocol Violation|5
3069251|NCT00474903|10542816|P1|Overall Study|Protocol Violation|1
3069252|NCT00474812|10542838|P1|Overall Study|No Initiation of treatment|2
3069253|NCT00474812|10542838|P1|Overall Study|Withdrawal by Subject|5
3069254|NCT00474786|10542848|P2|Overall Study|Other|0
3069255|NCT00474786|10542849|P1|Overall Study|Other|5
3069256|NCT00474786|10542848|P2|Overall Study|Withdrawal by Subject|15
3069257|NCT00474786|10542849|P1|Overall Study|Withdrawal by Subject|15
3069258|NCT00474786|10542848|P2|Overall Study|Protocol Violation|0
3069259|NCT00474786|10542849|P1|Overall Study|Protocol Violation|2
3069260|NCT00474786|10542848|P2|Overall Study|Lost to Follow-up|7
3069261|NCT00474786|10542849|P1|Overall Study|Lost to Follow-up|4
3069262|NCT00474786|10542848|P2|Overall Study|Discontinuation of Study by Sponsor|59
3069263|NCT00474786|10542849|P1|Overall Study|Discontinuation of Study by Sponsor|42
3069264|NCT00474786|10542848|P2|Overall Study|Death|170
3069265|NCT00474786|10542849|P1|Overall Study|Death|189
3069266|NCT00474786|10542848|P2|Overall Study|Investigator Request|1
3069267|NCT00474786|10542849|P1|Overall Study|Investigator Request|2
3069268|NCT00474786|10542848|P2|Overall Study|Not Meeting Study Criteria|1
3069269|NCT00474786|10542849|P1|Overall Study|Not Meeting Study Criteria|0
3069270|NCT00474760|10542874|P7|Overall Study|Terminated by sponsor|2
3069271|NCT00474760|10542875|P6|Overall Study|Terminated by sponsor|0
3069272|NCT00474760|10542876|P5|Overall Study|Terminated by sponsor|0
3069273|NCT00474760|10542877|P4|Overall Study|Terminated by sponsor|0
3069274|NCT00474760|10542878|P3|Overall Study|Terminated by sponsor|0
3069275|NCT00474760|10542879|P2|Overall Study|Terminated by sponsor|0
3069276|NCT00474760|10542880|P1|Overall Study|Terminated by sponsor|0
3069277|NCT00474760|10542874|P7|Overall Study|Progressive disease|7
3069278|NCT00474760|10542875|P6|Overall Study|Progressive disease|20
3069279|NCT00474760|10542876|P5|Overall Study|Progressive disease|8
3069280|NCT00474760|10542877|P4|Overall Study|Progressive disease|2
3069281|NCT00474760|10542878|P3|Overall Study|Progressive disease|3
3069282|NCT00474760|10542879|P2|Overall Study|Progressive disease|2
3069283|NCT00474760|10542880|P1|Overall Study|Progressive disease|3
3069284|NCT00474760|10542874|P7|Overall Study|Other|0
3069285|NCT00474760|10542875|P6|Overall Study|Other|0
3069286|NCT00474760|10542876|P5|Overall Study|Other|1
3069287|NCT00474760|10542877|P4|Overall Study|Other|0
3069288|NCT00474760|10542878|P3|Overall Study|Other|0
3069289|NCT00474760|10542879|P2|Overall Study|Other|1
3069290|NCT00474760|10542880|P1|Overall Study|Other|0
3069291|NCT00474760|10542874|P7|Overall Study|Withdrawal by Subject|1
3069292|NCT00474760|10542875|P6|Overall Study|Withdrawal by Subject|1
3069293|NCT00474760|10542876|P5|Overall Study|Withdrawal by Subject|0
3069294|NCT00474760|10542877|P4|Overall Study|Withdrawal by Subject|1
3069295|NCT00474760|10542878|P3|Overall Study|Withdrawal by Subject|0
3069296|NCT00474760|10542879|P2|Overall Study|Withdrawal by Subject|0
3069297|NCT00474760|10542880|P1|Overall Study|Withdrawal by Subject|0
3069298|NCT00474760|10542874|P7|Overall Study|Laboratory abnormality|0
3069299|NCT00474760|10542875|P6|Overall Study|Laboratory abnormality|1
3069300|NCT00474760|10542876|P5|Overall Study|Laboratory abnormality|0
3069301|NCT00474760|10542877|P4|Overall Study|Laboratory abnormality|0
3069302|NCT00474760|10542878|P3|Overall Study|Laboratory abnormality|0
3069303|NCT00474760|10542879|P2|Overall Study|Laboratory abnormality|0
3069304|NCT00474760|10542880|P1|Overall Study|Laboratory abnormality|0
3069305|NCT00474760|10542874|P7|Overall Study|Adverse Event|0
3069306|NCT00474760|10542875|P6|Overall Study|Adverse Event|7
3069307|NCT00474760|10542876|P5|Overall Study|Adverse Event|1
3069308|NCT00474760|10542877|P4|Overall Study|Adverse Event|0
3069309|NCT00474760|10542878|P3|Overall Study|Adverse Event|0
3069310|NCT00474760|10542879|P2|Overall Study|Adverse Event|0
3069311|NCT00474760|10542880|P1|Overall Study|Adverse Event|0
3069312|NCT00474760|10542874|P7|Overall Study|Death|0
3069313|NCT00474760|10542875|P6|Overall Study|Death|0
3069314|NCT00474760|10542876|P5|Overall Study|Death|2
3069315|NCT00474760|10542877|P4|Overall Study|Death|0
3069316|NCT00474760|10542878|P3|Overall Study|Death|0
3069317|NCT00474760|10542879|P2|Overall Study|Death|0
3069318|NCT00474760|10542880|P1|Overall Study|Death|0
3069319|NCT00474708|10542987|P2|Overall Study|Physician Decision|6
3069320|NCT00474708|10542988|P1|Overall Study|Physician Decision|9
3069321|NCT00474708|10542987|P2|Overall Study|Lost to Follow-up|9
3069322|NCT00474708|10542988|P1|Overall Study|Lost to Follow-up|18
3069323|NCT00474708|10542987|P2|Overall Study|Lack of compliance|4
3069324|NCT00474708|10542988|P1|Overall Study|Lack of compliance|12
3069325|NCT00474708|10542987|P2|Overall Study|Withdrawal by Subject|0
3069326|NCT00474708|10542988|P1|Overall Study|Withdrawal by Subject|7
3069327|NCT00474708|10542987|P2|Overall Study|Suicide ideation/behavior|1
3069328|NCT00474708|10542988|P1|Overall Study|Suicide ideation/behavior|0
3069329|NCT00474708|10542987|P2|Overall Study|Lack of Efficacy|5
3069330|NCT00474708|10542988|P1|Overall Study|Lack of Efficacy|11
3069331|NCT00474630|10542998|P2|Overall Study|Drug noncompliance, other|4
3069332|NCT00474630|10542999|P1|Overall Study|Drug noncompliance, other|11
3069333|NCT00474630|10542998|P2|Overall Study|Lack of Efficacy|6
3069334|NCT00474630|10542999|P1|Overall Study|Lack of Efficacy|5
3069335|NCT00474630|10542998|P2|Overall Study|Protocol Violation|4
3069336|NCT00474630|10542999|P1|Overall Study|Protocol Violation|3
3069337|NCT00474630|10542998|P2|Overall Study|Withdrawal by Subject|15
3069338|NCT00474630|10542999|P1|Overall Study|Withdrawal by Subject|21
3069339|NCT00474630|10542998|P2|Overall Study|Lost to Follow-up|15
3069340|NCT00474630|10542999|P1|Overall Study|Lost to Follow-up|22
3069341|NCT00474630|10542998|P2|Overall Study|Adverse Event|26
3069342|NCT00474630|10542999|P1|Overall Study|Adverse Event|98
3069343|NCT00474539|10543092|P2|Toddler Dose|Protocol Violation|0
3069344|NCT00474539|10543093|P1|Toddler Dose|Protocol Violation|1
3069345|NCT00474539|10543092|P2|After Infant Series|Withdrawal by Subject|0
3069346|NCT00474539|10543093|P1|After Infant Series|Withdrawal by Subject|1
3069347|NCT00474539|10543092|P2|After Infant Series|Lost to Follow-up|0
3069348|NCT00474539|10543093|P1|After Infant Series|Lost to Follow-up|3
3069349|NCT00474539|10543092|P2|Infant Series|Protocol Violation|1
3069350|NCT00474539|10543093|P1|Infant Series|Protocol Violation|0
3069351|NCT00474539|10543092|P2|Infant Series|Lost to Follow-up|1
3069352|NCT00474539|10543093|P1|Infant Series|Lost to Follow-up|2
3069353|NCT00474539|10543092|P2|Infant Series|Randomization error|0
3069354|NCT00474539|10543093|P1|Infant Series|Randomization error|5
3069355|NCT00474539|10543092|P2|Infant Series|Withdrawal by Subject|4
3069356|NCT00474539|10543093|P1|Infant Series|Withdrawal by Subject|3
3069357|NCT00474526|10543158|P17|Overall Study|Withdrawal by Subject|1
3069358|NCT00474526|10543159|P16|Overall Study|Withdrawal by Subject|1
3069359|NCT00474526|10543160|P15|Overall Study|Withdrawal by Subject|22
3069360|NCT00474526|10543161|P14|Overall Study|Withdrawal by Subject|37
3069361|NCT00474526|10543162|P13|Overall Study|Withdrawal by Subject|4
3069362|NCT00474526|10543163|P12|Overall Study|Withdrawal by Subject|4
3069363|NCT00474526|10543164|P11|Overall Study|Withdrawal by Subject|5
3069364|NCT00474526|10543165|P10|Overall Study|Withdrawal by Subject|13
3069365|NCT00474526|10543166|P9|Overall Study|Withdrawal by Subject|4
3069366|NCT00474526|10543167|P8|Overall Study|Withdrawal by Subject|4
3069367|NCT00474526|10543168|P7|Overall Study|Withdrawal by Subject|12
3069368|NCT00474526|10543169|P6|Overall Study|Withdrawal by Subject|6
3069369|NCT00474526|10543170|P5|Overall Study|Withdrawal by Subject|38
3069370|NCT00474526|10543171|P4|Overall Study|Withdrawal by Subject|52
3069371|NCT00474526|10543172|P3|Overall Study|Withdrawal by Subject|21
3069372|NCT00474526|10543173|P2|Overall Study|Withdrawal by Subject|24
3069373|NCT00474526|10543174|P1|Overall Study|Withdrawal by Subject|9
3069374|NCT00474526|10543158|P17|Overall Study|UNABLE TO CLASSIFY|1
3069375|NCT00474526|10543159|P16|Overall Study|UNABLE TO CLASSIFY|6
3069376|NCT00474526|10543160|P15|Overall Study|UNABLE TO CLASSIFY|12
3069377|NCT00474526|10543161|P14|Overall Study|UNABLE TO CLASSIFY|20
3069378|NCT00474526|10543162|P13|Overall Study|UNABLE TO CLASSIFY|0
3069379|NCT00474526|10543163|P12|Overall Study|UNABLE TO CLASSIFY|0
3069380|NCT00474526|10543164|P11|Overall Study|UNABLE TO CLASSIFY|0
3069381|NCT00474526|10543165|P10|Overall Study|UNABLE TO CLASSIFY|3
3069382|NCT00474526|10543166|P9|Overall Study|UNABLE TO CLASSIFY|0
3069383|NCT00474526|10543167|P8|Overall Study|UNABLE TO CLASSIFY|1
3069384|NCT00474526|10543168|P7|Overall Study|UNABLE TO CLASSIFY|0
3069385|NCT00474526|10543169|P6|Overall Study|UNABLE TO CLASSIFY|2
3069386|NCT00474526|10543170|P5|Overall Study|UNABLE TO CLASSIFY|3
3069387|NCT00474526|10543171|P4|Overall Study|UNABLE TO CLASSIFY|1
3069388|NCT00474526|10543172|P3|Overall Study|UNABLE TO CLASSIFY|0
3069389|NCT00474526|10543173|P2|Overall Study|UNABLE TO CLASSIFY|0
3069390|NCT00474526|10543174|P1|Overall Study|UNABLE TO CLASSIFY|1
3069391|NCT00474526|10543158|P17|Overall Study|Protocol Violation|2
3069392|NCT00474526|10543159|P16|Overall Study|Protocol Violation|6
3069393|NCT00474526|10543160|P15|Overall Study|Protocol Violation|9
3069394|NCT00474526|10543161|P14|Overall Study|Protocol Violation|19
3069395|NCT00474526|10543162|P13|Overall Study|Protocol Violation|4
3069396|NCT00474526|10543163|P12|Overall Study|Protocol Violation|2
3069397|NCT00474526|10543164|P11|Overall Study|Protocol Violation|2
3069398|NCT00474526|10543165|P10|Overall Study|Protocol Violation|4
3069399|NCT00474526|10543166|P9|Overall Study|Protocol Violation|0
3069400|NCT00474526|10543167|P8|Overall Study|Protocol Violation|0
3069401|NCT00474526|10543168|P7|Overall Study|Protocol Violation|3
3069402|NCT00474526|10543169|P6|Overall Study|Protocol Violation|1
3069403|NCT00474526|10543170|P5|Overall Study|Protocol Violation|3
3069404|NCT00474526|10543171|P4|Overall Study|Protocol Violation|12
3069405|NCT00474526|10543172|P3|Overall Study|Protocol Violation|4
3069406|NCT00474526|10543173|P2|Overall Study|Protocol Violation|6
3069407|NCT00474526|10543174|P1|Overall Study|Protocol Violation|2
3069408|NCT00474526|10543158|P17|Overall Study|Lost to Follow-up|5
3069409|NCT00474526|10543159|P16|Overall Study|Lost to Follow-up|4
3069410|NCT00474526|10543160|P15|Overall Study|Lost to Follow-up|29
3069411|NCT00474526|10543161|P14|Overall Study|Lost to Follow-up|74
3069412|NCT00474526|10543162|P13|Overall Study|Lost to Follow-up|6
3069413|NCT00474526|10543163|P12|Overall Study|Lost to Follow-up|4
3069414|NCT00474526|10543164|P11|Overall Study|Lost to Follow-up|2
3069415|NCT00474526|10543165|P10|Overall Study|Lost to Follow-up|6
3069416|NCT00474526|10543166|P9|Overall Study|Lost to Follow-up|0
3069417|NCT00474526|10543167|P8|Overall Study|Lost to Follow-up|1
3069418|NCT00474526|10543168|P7|Overall Study|Lost to Follow-up|8
3069419|NCT00474526|10543169|P6|Overall Study|Lost to Follow-up|5
3069420|NCT00474526|10543170|P5|Overall Study|Lost to Follow-up|11
3069421|NCT00474526|10543171|P4|Overall Study|Lost to Follow-up|29
3069422|NCT00474526|10543172|P3|Overall Study|Lost to Follow-up|13
3069423|NCT00474526|10543173|P2|Overall Study|Lost to Follow-up|6
3069424|NCT00474526|10543174|P1|Overall Study|Lost to Follow-up|8
3069425|NCT00474526|10543158|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069426|NCT00474526|10543159|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069427|NCT00474526|10543160|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
3069428|NCT00474526|10543161|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
3069429|NCT00474526|10543162|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069430|NCT00474526|10543163|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069431|NCT00474526|10543164|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069432|NCT00474526|10543165|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069433|NCT00474526|10543166|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069434|NCT00474526|10543167|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069435|NCT00474526|10543168|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069436|NCT00474526|10543169|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069437|NCT00474526|10543170|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
3069438|NCT00474526|10543171|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
3069439|NCT00474526|10543172|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069440|NCT00474526|10543173|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
3069441|NCT00474526|10543174|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
3069442|NCT00474526|10543158|P17|Overall Study|Death|0
3069443|NCT00474526|10543159|P16|Overall Study|Death|0
3069444|NCT00474526|10543160|P15|Overall Study|Death|0
3069445|NCT00474526|10543161|P14|Overall Study|Death|3
3069446|NCT00474526|10543162|P13|Overall Study|Death|0
3069447|NCT00474526|10543163|P12|Overall Study|Death|0
3069448|NCT00474526|10543164|P11|Overall Study|Death|0
3069449|NCT00474526|10543165|P10|Overall Study|Death|0
3069450|NCT00474526|10543166|P9|Overall Study|Death|0
3069451|NCT00474526|10543167|P8|Overall Study|Death|0
3069452|NCT00474526|10543168|P7|Overall Study|Death|0
3069453|NCT00474526|10543169|P6|Overall Study|Death|0
3069454|NCT00474526|10543170|P5|Overall Study|Death|0
3069455|NCT00474526|10543171|P4|Overall Study|Death|0
3069456|NCT00474526|10543172|P3|Overall Study|Death|0
3069457|NCT00474526|10543173|P2|Overall Study|Death|0
3069458|NCT00474526|10543174|P1|Overall Study|Death|0
3069459|NCT00474526|10543158|P17|Overall Study|Adverse Event|0
3069460|NCT00474526|10543159|P16|Overall Study|Adverse Event|1
3069461|NCT00474526|10543160|P15|Overall Study|Adverse Event|1
3069462|NCT00474526|10543161|P14|Overall Study|Adverse Event|0
3069463|NCT00474526|10543162|P13|Overall Study|Adverse Event|0
3069464|NCT00474526|10543163|P12|Overall Study|Adverse Event|0
3069465|NCT00474526|10543164|P11|Overall Study|Adverse Event|0
3069466|NCT00474526|10543165|P10|Overall Study|Adverse Event|0
3069467|NCT00474526|10543166|P9|Overall Study|Adverse Event|0
3069468|NCT00474526|10543167|P8|Overall Study|Adverse Event|0
3069469|NCT00474526|10543168|P7|Overall Study|Adverse Event|1
3069470|NCT00474526|10543169|P6|Overall Study|Adverse Event|1
3069471|NCT00474526|10543170|P5|Overall Study|Adverse Event|2
3069472|NCT00474526|10543171|P4|Overall Study|Adverse Event|4
3069473|NCT00474526|10543172|P3|Overall Study|Adverse Event|2
3069474|NCT00474526|10543173|P2|Overall Study|Adverse Event|0
3069475|NCT00474526|10543174|P1|Overall Study|Adverse Event|2
3069476|NCT00474526|10543158|P17|Overall Study|ADMINISTRATIVE REASON|0
3069477|NCT00474526|10543159|P16|Overall Study|ADMINISTRATIVE REASON|0
3069478|NCT00474526|10543160|P15|Overall Study|ADMINISTRATIVE REASON|2
3069479|NCT00474526|10543161|P14|Overall Study|ADMINISTRATIVE REASON|1
3069480|NCT00474526|10543162|P13|Overall Study|ADMINISTRATIVE REASON|1
3069481|NCT00474526|10543163|P12|Overall Study|ADMINISTRATIVE REASON|1
3069482|NCT00474526|10543164|P11|Overall Study|ADMINISTRATIVE REASON|1
3069483|NCT00474526|10543165|P10|Overall Study|ADMINISTRATIVE REASON|1
3069484|NCT00474526|10543166|P9|Overall Study|ADMINISTRATIVE REASON|2
3069485|NCT00474526|10543167|P8|Overall Study|ADMINISTRATIVE REASON|0
3069486|NCT00474526|10543168|P7|Overall Study|ADMINISTRATIVE REASON|1
3069487|NCT00474526|10543169|P6|Overall Study|ADMINISTRATIVE REASON|1
3069488|NCT00474526|10543170|P5|Overall Study|ADMINISTRATIVE REASON|9
3069489|NCT00474526|10543171|P4|Overall Study|ADMINISTRATIVE REASON|20
3069490|NCT00474526|10543172|P3|Overall Study|ADMINISTRATIVE REASON|9
3069491|NCT00474526|10543173|P2|Overall Study|ADMINISTRATIVE REASON|9
3069492|NCT00474526|10543174|P1|Overall Study|ADMINISTRATIVE REASON|11
3069493|NCT00474487|10543339|P4|Overall Study|Death|0
3069494|NCT00474487|10543340|P3|Overall Study|Death|0
3069495|NCT00474487|10543341|P2|Overall Study|Death|1
3069496|NCT00474487|10543342|P1|Overall Study|Death|0
3069497|NCT00474487|10543339|P4|Overall Study|Inappropriate enrollment|0
3069498|NCT00474487|10543340|P3|Overall Study|Inappropriate enrollment|7
3069499|NCT00474487|10543341|P2|Overall Study|Inappropriate enrollment|0
3069500|NCT00474487|10543342|P1|Overall Study|Inappropriate enrollment|4
3069501|NCT00474487|10543339|P4|Overall Study|Lost to Follow-up|0
3069502|NCT00474487|10543340|P3|Overall Study|Lost to Follow-up|7
3069503|NCT00474487|10543341|P2|Overall Study|Lost to Follow-up|1
3069504|NCT00474487|10543342|P1|Overall Study|Lost to Follow-up|20
3069505|NCT00474487|10543339|P4|Overall Study|Withdrawal by Subject|0
3069506|NCT00474487|10543340|P3|Overall Study|Withdrawal by Subject|0
3069507|NCT00474487|10543341|P2|Overall Study|Withdrawal by Subject|0
3069508|NCT00474487|10543342|P1|Overall Study|Withdrawal by Subject|6
3069509|NCT00474383|10543362|P2|Extension|Progressive Disease|5
3069510|NCT00474383|10543363|P1|Extension|Progressive Disease|0
3069511|NCT00474383|10543362|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
3069512|NCT00474383|10543363|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
3069513|NCT00474383|10543362|P2|Main Study|Other|0
3069514|NCT00474383|10543363|P1|Main Study|Other|1
3069515|NCT00474383|10543362|P2|Main Study|Progressive Disease|0
3069516|NCT00474383|10543363|P1|Main Study|Progressive Disease|23
3069517|NCT00474383|10543362|P2|Main Study|Symptomatic Deterioration|0
3069518|NCT00474383|10543363|P1|Main Study|Symptomatic Deterioration|1
3069519|NCT00474383|10543362|P2|Main Study|Adverse Event|0
3069520|NCT00474383|10543363|P1|Main Study|Adverse Event|11
3069521|NCT00474266|10543378|P4|Overall Study|Withdrawal by Subject|7
3069522|NCT00474266|10543379|P3|Overall Study|Withdrawal by Subject|4
3069523|NCT00474266|10543380|P2|Overall Study|Withdrawal by Subject|20
3069524|NCT00474266|10543381|P1|Overall Study|Withdrawal by Subject|7
3069525|NCT00474253|10543485|P2|Overall Study|Discharged prior to study completion|1
3069526|NCT00474253|10543486|P1|Overall Study|Discharged prior to study completion|0
3069527|NCT00474253|10543485|P2|Overall Study|Lost to Follow-up|0
3069528|NCT00474253|10543486|P1|Overall Study|Lost to Follow-up|1
3069529|NCT00474253|10543485|P2|Overall Study|Withdrew due to surgery-related issues|3
3069530|NCT00474253|10543486|P1|Overall Study|Withdrew due to surgery-related issues|0
3069531|NCT00474253|10543485|P2|Overall Study|Withdrew consent|0
3069532|NCT00474253|10543486|P1|Overall Study|Withdrew consent|2
3069533|NCT00474240|10543510|P6|Overall Study|Removed due to lab value|1
3069534|NCT00474240|10543511|P5|Overall Study|Removed due to lab value|0
3069535|NCT00474240|10543512|P4|Overall Study|Removed due to lab value|0
3069536|NCT00474240|10543513|P3|Overall Study|Removed due to lab value|0
3069537|NCT00474240|10543514|P2|Overall Study|Removed due to lab value|0
3069538|NCT00474240|10543515|P1|Overall Study|Removed due to lab value|0
3069539|NCT00474240|10543510|P6|Overall Study|Adverse Event|16
3069540|NCT00474240|10543511|P5|Overall Study|Adverse Event|5
3069541|NCT00474240|10543512|P4|Overall Study|Adverse Event|14
3069542|NCT00474240|10543513|P3|Overall Study|Adverse Event|9
3069543|NCT00474240|10543514|P2|Overall Study|Adverse Event|0
3069544|NCT00474240|10543515|P1|Overall Study|Adverse Event|0
3069545|NCT00474240|10543510|P6|Overall Study|Withdrawal by Subject|1
3069546|NCT00474240|10543511|P5|Overall Study|Withdrawal by Subject|3
3069547|NCT00474240|10543512|P4|Overall Study|Withdrawal by Subject|2
3069548|NCT00474240|10543513|P3|Overall Study|Withdrawal by Subject|0
3069549|NCT00474240|10543514|P2|Overall Study|Withdrawal by Subject|1
3069550|NCT00474240|10543515|P1|Overall Study|Withdrawal by Subject|1
3069551|NCT00474188|10543540|P1|Overall Study|Study discontinued by sponsor|5
3069552|NCT00474188|10543540|P1|Overall Study|Withdrawal by Subject|1
3069553|NCT00474175|10543550|P3|Overall Study|Administrative|0
3069554|NCT00474175|10543551|P2|Overall Study|Administrative|1
3069555|NCT00474175|10543552|P1|Overall Study|Administrative|0
3069556|NCT00474175|10543550|P3|Overall Study|Protocol Violation|1
3069557|NCT00474175|10543551|P2|Overall Study|Protocol Violation|2
3069558|NCT00474175|10543552|P1|Overall Study|Protocol Violation|0
3069559|NCT00474175|10543550|P3|Overall Study|Ineligible|1
3069560|NCT00474175|10543551|P2|Overall Study|Ineligible|3
3069561|NCT00474175|10543552|P1|Overall Study|Ineligible|1
3069562|NCT00474175|10543550|P3|Overall Study|Withdrawal by Subject|1
3069563|NCT00474175|10543551|P2|Overall Study|Withdrawal by Subject|1
3069564|NCT00474175|10543552|P1|Overall Study|Withdrawal by Subject|0
3069565|NCT00474175|10543550|P3|Overall Study|Lack of Efficacy|1
3069566|NCT00474175|10543551|P2|Overall Study|Lack of Efficacy|0
3069567|NCT00474175|10543552|P1|Overall Study|Lack of Efficacy|0
3069568|NCT00474058|10543616|P2|Overall Study|Other|0
3069569|NCT00474058|10543617|P1|Overall Study|Other|2
3069570|NCT00474058|10543616|P2|Overall Study|Withdrawal by Subject|7
3069571|NCT00474058|10543617|P1|Overall Study|Withdrawal by Subject|11
3069572|NCT00474058|10543616|P2|Overall Study|Lack of Efficacy|4
3069573|NCT00474058|10543617|P1|Overall Study|Lack of Efficacy|0
3069574|NCT00474058|10543616|P2|Overall Study|Adverse Event|6
3069575|NCT00474058|10543617|P1|Overall Study|Adverse Event|11
3069576|NCT00474045|10543631|P2|Overall Study|Withdrawal criteria|50
3069577|NCT00474045|10543632|P1|Overall Study|Withdrawal criteria|60
3069578|NCT00474045|10543631|P2|Overall Study|Withdrawal by Subject|18
3069579|NCT00474045|10543632|P1|Overall Study|Withdrawal by Subject|16
3069580|NCT00474045|10543631|P2|Overall Study|Protocol Violation|12
3069581|NCT00474045|10543632|P1|Overall Study|Protocol Violation|10
3069582|NCT00474045|10543631|P2|Overall Study|Lost to Follow-up|1
3069583|NCT00474045|10543632|P1|Overall Study|Lost to Follow-up|1
3069584|NCT00474045|10543631|P2|Overall Study|Lack of Efficacy|9
3069585|NCT00474045|10543632|P1|Overall Study|Lack of Efficacy|0
3069586|NCT00474045|10543631|P2|Overall Study|Unclassified|3
3069587|NCT00474045|10543632|P1|Overall Study|Unclassified|1
3069588|NCT00474045|10543631|P2|Overall Study|Adverse Event|8
3069589|NCT00474045|10543632|P1|Overall Study|Adverse Event|18
3069590|NCT00473889|10543732|P2|Overall Study|Withdrawal by Subject|0
3069591|NCT00473889|10543733|P1|Overall Study|Withdrawal by Subject|5
3069592|NCT00473889|10543732|P2|Overall Study|Trial Terminated|6
3069593|NCT00473889|10543733|P1|Overall Study|Trial Terminated|3
3069594|NCT00473889|10543732|P2|Overall Study|Physician Decision|5
3069595|NCT00473889|10543733|P1|Overall Study|Physician Decision|10
3069596|NCT00473889|10543732|P2|Overall Study|Lost to Follow-up|1
3069597|NCT00473889|10543733|P1|Overall Study|Lost to Follow-up|2
3069598|NCT00473889|10543732|P2|Overall Study|Lack of Efficacy|29
3069599|NCT00473889|10543733|P1|Overall Study|Lack of Efficacy|28
3069600|NCT00473889|10543732|P2|Overall Study|Protocol Violation|2
3069601|NCT00473889|10543733|P1|Overall Study|Protocol Violation|4
3069602|NCT00473889|10543732|P2|Overall Study|Adverse Event|17
3069603|NCT00473889|10543733|P1|Overall Study|Adverse Event|30
3069604|NCT00473889|10543732|P2|Overall Study|Did not receive study medication|4
3069605|NCT00473889|10543733|P1|Overall Study|Did not receive study medication|1
3069606|NCT00473876|10543745|P2|Overall Study|Lost to Follow-up|1
3069607|NCT00473876|10543746|P1|Overall Study|Lost to Follow-up|3
3069608|NCT00473824|10543765|P2|Overall Study|Withdrawal by physician|0
3069609|NCT00473824|10543766|P1|Overall Study|Withdrawal by physician|1
3069610|NCT00473824|10543765|P2|Overall Study|Lost to Follow-up|0
3069611|NCT00473824|10543766|P1|Overall Study|Lost to Follow-up|1
3069612|NCT00473824|10543765|P2|Overall Study|Death|0
3069613|NCT00473824|10543766|P1|Overall Study|Death|1
3069614|NCT00473824|10543765|P2|Overall Study|Adverse Event|0
3069615|NCT00473824|10543766|P1|Overall Study|Adverse Event|1
3069616|NCT00473824|10543765|P2|Overall Study|Virologic Breakthrough|0
3069617|NCT00473824|10543766|P1|Overall Study|Virologic Breakthrough|1
3069618|NCT00473746|10543777|P5|Period 2 (Phase 2)|Reason not specified|3
3069619|NCT00473746|10543778|P4|Period 2 (Phase 2)|Reason not specified|0
3069620|NCT00473746|10543779|P3|Period 2 (Phase 2)|Reason not specified|0
3069621|NCT00473746|10543780|P2|Period 2 (Phase 2)|Reason not specified|0
3069622|NCT00473746|10543781|P1|Period 2 (Phase 2)|Reason not specified|0
3069623|NCT00473746|10543777|P5|Period 2 (Phase 2)|Progressive Disease|20
3069624|NCT00473746|10543778|P4|Period 2 (Phase 2)|Progressive Disease|0
3069625|NCT00473746|10543779|P3|Period 2 (Phase 2)|Progressive Disease|0
3069626|NCT00473746|10543780|P2|Period 2 (Phase 2)|Progressive Disease|0
3069627|NCT00473746|10543781|P1|Period 2 (Phase 2)|Progressive Disease|0
3069628|NCT00473746|10543777|P5|Period 2 (Phase 2)|Death|1
3069629|NCT00473746|10543778|P4|Period 2 (Phase 2)|Death|0
3069630|NCT00473746|10543779|P3|Period 2 (Phase 2)|Death|0
3069631|NCT00473746|10543780|P2|Period 2 (Phase 2)|Death|0
3069632|NCT00473746|10543781|P1|Period 2 (Phase 2)|Death|0
3069633|NCT00473746|10543777|P5|Period 2 (Phase 2)|Adverse Event|3
3069634|NCT00473746|10543778|P4|Period 2 (Phase 2)|Adverse Event|0
3069635|NCT00473746|10543779|P3|Period 2 (Phase 2)|Adverse Event|0
3069636|NCT00473746|10543780|P2|Period 2 (Phase 2)|Adverse Event|0
3069637|NCT00473746|10543781|P1|Period 2 (Phase 2)|Adverse Event|0
3069638|NCT00473746|10543777|P5|Period 1 (Phase 1)|Reason not specified|0
3069639|NCT00473746|10543778|P4|Period 1 (Phase 1)|Reason not specified|0
3069640|NCT00473746|10543779|P3|Period 1 (Phase 1)|Reason not specified|0
3069641|NCT00473746|10543780|P2|Period 1 (Phase 1)|Reason not specified|1
3069642|NCT00473746|10543781|P1|Period 1 (Phase 1)|Reason not specified|0
3069643|NCT00473746|10543777|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
3069644|NCT00473746|10543778|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
3069645|NCT00473746|10543779|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
3069646|NCT00473746|10543780|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
3069647|NCT00473746|10543781|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
3069648|NCT00473746|10543777|P5|Period 1 (Phase 1)|Progressive Disease|0
3069649|NCT00473746|10543778|P4|Period 1 (Phase 1)|Progressive Disease|10
3069650|NCT00473746|10543779|P3|Period 1 (Phase 1)|Progressive Disease|6
3069651|NCT00473746|10543780|P2|Period 1 (Phase 1)|Progressive Disease|6
3069652|NCT00473746|10543781|P1|Period 1 (Phase 1)|Progressive Disease|5
3069653|NCT00473746|10543777|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
3069654|NCT00473746|10543778|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
3069655|NCT00473746|10543779|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
3069656|NCT00473746|10543780|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
3069657|NCT00473746|10543781|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
3069658|NCT00473746|10543777|P5|Period 1 (Phase 1)|Adverse Event|0
3069659|NCT00473746|10543778|P4|Period 1 (Phase 1)|Adverse Event|0
3069660|NCT00473746|10543779|P3|Period 1 (Phase 1)|Adverse Event|0
3069661|NCT00473746|10543780|P2|Period 1 (Phase 1)|Adverse Event|0
3069662|NCT00473746|10543781|P1|Period 1 (Phase 1)|Adverse Event|1
3069663|NCT00473694|10543830|P4|Overall Study|Lost to Follow-up|1
3069664|NCT00473694|10543831|P3|Overall Study|Lost to Follow-up|0
3069665|NCT00473694|10543832|P2|Overall Study|Lost to Follow-up|0
3069666|NCT00473694|10543833|P1|Overall Study|Lost to Follow-up|0
3069667|NCT00473694|10543830|P4|Overall Study|Participants did not receive treatment|6
3069668|NCT00473694|10543831|P3|Overall Study|Participants did not receive treatment|5
3069669|NCT00473694|10543832|P2|Overall Study|Participants did not receive treatment|3
3069670|NCT00473694|10543833|P1|Overall Study|Participants did not receive treatment|11
3069671|NCT00473694|10543830|P4|Overall Study|Adverse Event|0
3069672|NCT00473694|10543831|P3|Overall Study|Adverse Event|0
3069673|NCT00473694|10543832|P2|Overall Study|Adverse Event|1
3069674|NCT00473694|10543833|P1|Overall Study|Adverse Event|0
3069675|NCT00473668|10543874|P3|Overall Study|Other|4
3069676|NCT00473668|10543875|P2|Overall Study|Other|3
3069677|NCT00473668|10543876|P1|Overall Study|Other|2
3069678|NCT00473668|10543874|P3|Overall Study|Lost to Follow-up|6
3069679|NCT00473668|10543875|P2|Overall Study|Lost to Follow-up|4
3069680|NCT00473668|10543876|P1|Overall Study|Lost to Follow-up|0
3069681|NCT00473668|10543874|P3|Overall Study|Migrated/moved from study area|0
3069682|NCT00473668|10543875|P2|Overall Study|Migrated/moved from study area|2
3069683|NCT00473668|10543876|P1|Overall Study|Migrated/moved from study area|3
3069684|NCT00473668|10543874|P3|Overall Study|Withdrawal by Subject|0
3069685|NCT00473668|10543875|P2|Overall Study|Withdrawal by Subject|2
3069686|NCT00473668|10543876|P1|Overall Study|Withdrawal by Subject|0
3069687|NCT00473655|10543929|P3|Overall Study|Lost to Follow-up|8
3069688|NCT00473655|10543930|P2|Overall Study|Lost to Follow-up|5
3069689|NCT00473655|10543931|P1|Overall Study|Lost to Follow-up|9
3069690|NCT00473590|10543978|P2|Overall Study|Other|1
3069691|NCT00473590|10543979|P1|Overall Study|Other|0
3069692|NCT00473590|10543978|P2|Overall Study|Withdrawal by Subject|3
3069693|NCT00473590|10543979|P1|Overall Study|Withdrawal by Subject|5
3069694|NCT00473590|10543978|P2|Overall Study|Physician Decision|4
3069695|NCT00473590|10543979|P1|Overall Study|Physician Decision|2
3069696|NCT00473590|10543978|P2|Overall Study|Non–protocol-specified therapy|5
3069697|NCT00473590|10543979|P1|Overall Study|Non–protocol-specified therapy|7
3069698|NCT00473590|10543978|P2|Overall Study|Progression not resulting in death|20
3069699|NCT00473590|10543979|P1|Overall Study|Progression not resulting in death|24
3069700|NCT00473590|10543978|P2|Overall Study|Death|2
3069701|NCT00473590|10543979|P1|Overall Study|Death|4
3069702|NCT00473590|10543978|P2|Overall Study|Adverse Event|3
3069703|NCT00473590|10543979|P1|Overall Study|Adverse Event|3
3069704|NCT00473564|10543995|P1|Overall Study|robot surgery aborted in OR|23
3069705|NCT00473512|10544005|P5|Period 2 (Phase 2)|Other|0
3069706|NCT00473512|10544006|P4|Period 2 (Phase 2)|Other|3
3069707|NCT00473512|10544007|P3|Period 2 (Phase 2)|Other|0
3069708|NCT00473512|10544008|P2|Period 2 (Phase 2)|Other|0
3069709|NCT00473512|10544009|P1|Period 2 (Phase 2)|Other|1
3069710|NCT00473512|10544005|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
3069711|NCT00473512|10544006|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
3069712|NCT00473512|10544007|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
3069713|NCT00473512|10544008|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
3069714|NCT00473512|10544009|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
3069715|NCT00473512|10544005|P5|Period 2 (Phase 2)|Disease Progression|1
3069716|NCT00473512|10544006|P4|Period 2 (Phase 2)|Disease Progression|17
3069717|NCT00473512|10544007|P3|Period 2 (Phase 2)|Disease Progression|2
3069718|NCT00473512|10544008|P2|Period 2 (Phase 2)|Disease Progression|2
3069719|NCT00473512|10544009|P1|Period 2 (Phase 2)|Disease Progression|0
3069720|NCT00473512|10544005|P5|Period 2 (Phase 2)|Death|1
3069721|NCT00473512|10544006|P4|Period 2 (Phase 2)|Death|1
3069722|NCT00473512|10544007|P3|Period 2 (Phase 2)|Death|0
3069723|NCT00473512|10544008|P2|Period 2 (Phase 2)|Death|0
3069724|NCT00473512|10544009|P1|Period 2 (Phase 2)|Death|0
3069725|NCT00473512|10544005|P5|Period 2 (Phase 2)|Adverse Event|0
3069726|NCT00473512|10544006|P4|Period 2 (Phase 2)|Adverse Event|1
3069727|NCT00473512|10544007|P3|Period 2 (Phase 2)|Adverse Event|0
3069728|NCT00473512|10544008|P2|Period 2 (Phase 2)|Adverse Event|0
3069729|NCT00473512|10544009|P1|Period 2 (Phase 2)|Adverse Event|0
3069730|NCT00473512|10544005|P5|Period 1 (Phase 1)|Other|0
3069731|NCT00473512|10544006|P4|Period 1 (Phase 1)|Other|1
3069732|NCT00473512|10544007|P3|Period 1 (Phase 1)|Other|0
3069733|NCT00473512|10544008|P2|Period 1 (Phase 1)|Other|0
3069734|NCT00473512|10544009|P1|Period 1 (Phase 1)|Other|0
3069735|NCT00473512|10544005|P5|Period 1 (Phase 1)|Disease Progression|1
3069736|NCT00473512|10544006|P4|Period 1 (Phase 1)|Disease Progression|10
3069737|NCT00473512|10544007|P3|Period 1 (Phase 1)|Disease Progression|0
3069738|NCT00473512|10544008|P2|Period 1 (Phase 1)|Disease Progression|1
3069739|NCT00473512|10544009|P1|Period 1 (Phase 1)|Disease Progression|1
3069740|NCT00473512|10544005|P5|Period 1 (Phase 1)|Death|0
3069741|NCT00473512|10544006|P4|Period 1 (Phase 1)|Death|1
3069742|NCT00473512|10544007|P3|Period 1 (Phase 1)|Death|0
3069743|NCT00473512|10544008|P2|Period 1 (Phase 1)|Death|0
3069744|NCT00473512|10544009|P1|Period 1 (Phase 1)|Death|0
3069745|NCT00473512|10544005|P5|Period 1 (Phase 1)|Adverse Event|0
3069746|NCT00473512|10544006|P4|Period 1 (Phase 1)|Adverse Event|5
3069747|NCT00473512|10544007|P3|Period 1 (Phase 1)|Adverse Event|0
3069748|NCT00473512|10544008|P2|Period 1 (Phase 1)|Adverse Event|0
3069749|NCT00473512|10544009|P1|Period 1 (Phase 1)|Adverse Event|0
3069750|NCT00473434|10544067|P1|Overall Study|No longer required|1
3069751|NCT00473434|10544067|P1|Overall Study|Switching to trial medication|1
3069752|NCT00473434|10544067|P1|Overall Study|Ceased in favor of Paliperidone|1
3069753|NCT00473434|10544067|P1|Overall Study|Reason not specified|6
3069754|NCT00473434|10544067|P1|Overall Study|Safety evaluation|1
3069755|NCT00473434|10544067|P1|Overall Study|Patient was selling medication to others|1
3069756|NCT00473434|10544067|P1|Overall Study|Adverse Event|3
3069757|NCT00473434|10544067|P1|Overall Study|Lack of Efficacy|3
3069758|NCT00473434|10544067|P1|Overall Study|Compliance|3
3069759|NCT00473434|10544067|P1|Overall Study|Withdrawal by Subject|9
3069760|NCT00473434|10544067|P1|Overall Study|Physician Decision|3
3069761|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
3069762|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
3069763|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
3069764|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
3069765|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
3070006|NCT00471497|10544631|P2|Overall Study|Protocol Violation|3
3069766|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
3069767|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Subject's Decision|6
3069768|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Subject's Decision|1
3069769|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Subject's Decision|7
3069770|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
3069771|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
3069772|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
3069773|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Death|4
3069774|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Death|7
3069775|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Death|1
3069776|NCT00473382|10544132|P3|Open-label Extension Through Month 60|Adverse Event|2
3069777|NCT00473382|10544133|P2|Open-label Extension Through Month 60|Adverse Event|0
3069778|NCT00473382|10544134|P1|Open-label Extension Through Month 60|Adverse Event|0
3069779|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
3069780|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
3069781|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
3069782|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
3069783|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
3069784|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
3069785|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Subject's Decision|6
3069786|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Subject's Decision|1
3069787|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Subject's Decision|5
3069788|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
3069789|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
3069790|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
3069791|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Death|3
3069792|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Death|3
3069793|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Death|1
3069794|NCT00473382|10544132|P3|Open-label Extension Through Month 48|Adverse Event|1
3069795|NCT00473382|10544133|P2|Open-label Extension Through Month 48|Adverse Event|0
3069796|NCT00473382|10544134|P1|Open-label Extension Through Month 48|Adverse Event|0
3069797|NCT00473382|10544132|P3|Core Study|Subject's decision|10
3069798|NCT00473382|10544133|P2|Core Study|Subject's decision|11
3069799|NCT00473382|10544134|P1|Core Study|Subject's decision|12
3069800|NCT00473382|10544132|P3|Core Study|Subject needed other treatment|2
3069801|NCT00473382|10544133|P2|Core Study|Subject needed other treatment|3
3069802|NCT00473382|10544134|P1|Core Study|Subject needed other treatment|1
3069803|NCT00473382|10544132|P3|Core Study|Subject non-compliance|1
3069804|NCT00473382|10544133|P2|Core Study|Subject non-compliance|2
3069805|NCT00473382|10544134|P1|Core Study|Subject non-compliance|5
3069806|NCT00473382|10544132|P3|Core Study|Physician Decision|2
3069807|NCT00473382|10544133|P2|Core Study|Physician Decision|2
3069808|NCT00473382|10544134|P1|Core Study|Physician Decision|1
3069809|NCT00473382|10544132|P3|Core Study|Lost to Follow-up|3
3069810|NCT00473382|10544133|P2|Core Study|Lost to Follow-up|3
3069811|NCT00473382|10544134|P1|Core Study|Lost to Follow-up|3
3069812|NCT00473382|10544132|P3|Core Study|Death|10
3069813|NCT00473382|10544133|P2|Core Study|Death|5
3069814|NCT00473382|10544134|P1|Core Study|Death|3
3069815|NCT00473382|10544132|P3|Core Study|Adverse Event|1
3069816|NCT00473382|10544133|P2|Core Study|Adverse Event|1
3069817|NCT00473382|10544134|P1|Core Study|Adverse Event|3
3069818|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
3069819|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
3069820|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
3069821|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
3069822|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
3069823|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
3069824|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
3069825|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
3069826|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
3069827|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Subject's Decision|4
3069828|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Subject's Decision|3
3069829|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Subject's Decision|1
3069830|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Physician's Decision|3
3069831|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Physician's Decision|1
3069832|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Physician's Decision|2
3069833|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
3069834|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
3069835|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
3069836|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Death|1
3069837|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Death|2
3069838|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Death|2
3069839|NCT00473330|10544192|P3|Open-label Extension Through Month 60|Adverse Event|2
3069840|NCT00473330|10544193|P2|Open-label Extension Through Month 60|Adverse Event|0
3069841|NCT00473330|10544194|P1|Open-label Extension Through Month 60|Adverse Event|0
3069842|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
3069843|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
3069844|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
3069845|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
3069846|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
3069847|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
3069848|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
3069849|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
3069850|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
3069851|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Subject's Decision|3
3069852|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Subject's Decision|3
3069853|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Subject's Decision|1
3069854|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Physician's Decision|3
3069855|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Physician's Decision|1
3069856|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Physician's Decision|2
3069857|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
3069858|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
3069859|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
3069860|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Death|0
3069861|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Death|0
3069862|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Death|2
3069863|NCT00473330|10544192|P3|Open-label Extension Through Month 48|Adverse Event|2
3069864|NCT00473330|10544193|P2|Open-label Extension Through Month 48|Adverse Event|0
3069865|NCT00473330|10544194|P1|Open-label Extension Through Month 48|Adverse Event|0
3069866|NCT00473330|10544192|P3|Core Study|Subject's Decision|19
3069867|NCT00473330|10544193|P2|Core Study|Subject's Decision|8
3069868|NCT00473330|10544194|P1|Core Study|Subject's Decision|9
3069869|NCT00473330|10544192|P3|Core Study|Subject Required Other Therapy|3
3069870|NCT00473330|10544193|P2|Core Study|Subject Required Other Therapy|1
3069871|NCT00473330|10544194|P1|Core Study|Subject Required Other Therapy|0
3069872|NCT00473330|10544192|P3|Core Study|Subject Non-compliance|1
3069873|NCT00473330|10544193|P2|Core Study|Subject Non-compliance|2
3069874|NCT00473330|10544194|P1|Core Study|Subject Non-compliance|1
3069875|NCT00473330|10544192|P3|Core Study|Physician Decision|3
3069876|NCT00473330|10544193|P2|Core Study|Physician Decision|1
3069877|NCT00473330|10544194|P1|Core Study|Physician Decision|2
3069878|NCT00473330|10544192|P3|Core Study|Lost to Follow-up|10
3069879|NCT00473330|10544193|P2|Core Study|Lost to Follow-up|5
3069880|NCT00473330|10544194|P1|Core Study|Lost to Follow-up|5
3069881|NCT00473330|10544192|P3|Core Study|Death|4
3069882|NCT00473330|10544193|P2|Core Study|Death|4
3069883|NCT00473330|10544194|P1|Core Study|Death|6
3069884|NCT00473330|10544192|P3|Core Study|Adverse Event|1
3069885|NCT00473330|10544193|P2|Core Study|Adverse Event|4
3069886|NCT00473330|10544194|P1|Core Study|Adverse Event|4
3069887|NCT00473265|10544249|P1|Overall Study|Off treatment early|15
3069888|NCT00473265|10544249|P1|Overall Study|Unrelated adverse event|5
3069889|NCT00473083|10544261|P3|Overall Study|Adverse Event|0
3069890|NCT00473083|10544262|P2|Overall Study|Adverse Event|0
3069891|NCT00473083|10544263|P1|Overall Study|Adverse Event|1
3069892|NCT00472641|10544338|P1|Overall Study|Lost to Follow-up|1
3069893|NCT00472641|10544338|P1|Overall Study|Adverse Event|3
3069894|NCT00472641|10544338|P1|Overall Study|Lack of Efficacy|3
3069895|NCT00472446|10544358|P4|Overall Study|Questionnaires not returned|4
3069896|NCT00472446|10544359|P3|Overall Study|Questionnaires not returned|6
3069897|NCT00472446|10544360|P2|Overall Study|Questionnaires not returned|6
3069898|NCT00472446|10544361|P1|Overall Study|Questionnaires not returned|5
3069899|NCT00472446|10544358|P4|Overall Study|Reintervention|1
3069900|NCT00472446|10544359|P3|Overall Study|Reintervention|1
3069901|NCT00472446|10544360|P2|Overall Study|Reintervention|0
3069902|NCT00472446|10544361|P1|Overall Study|Reintervention|0
3069903|NCT00472446|10544358|P4|Overall Study|Protocol Violation|1
3069904|NCT00472446|10544359|P3|Overall Study|Protocol Violation|0
3069905|NCT00472446|10544360|P2|Overall Study|Protocol Violation|0
3069906|NCT00472446|10544361|P1|Overall Study|Protocol Violation|0
3069907|NCT00472420|10544391|P1|Follow-up Period|Protocol Violation|1
3069908|NCT00472420|10544391|P1|Follow-up Period|Lost to Follow-up|2
3069909|NCT00472420|10544391|P1|Follow-up Period|Physician Decision|9
3069910|NCT00472420|10544391|P1|Follow-up Period|Death|5
3069911|NCT00472420|10544391|P1|Induction Treatment Period|Death|3
3069912|NCT00472420|10544391|P1|Induction Treatment Period|Non-compliance|1
3069913|NCT00472420|10544391|P1|Induction Treatment Period|Adverse Event|3
3069914|NCT00472420|10544391|P1|Induction Treatment Period|Physician Decision|9
3069915|NCT00472303|10544399|P3|Maintenance Phase|Other|0
3069916|NCT00472303|10544400|P2|Maintenance Phase|Other|1
3069917|NCT00472303|10544401|P1|Maintenance Phase|Other|1
3069918|NCT00472303|10544399|P3|Maintenance Phase|Resolution of pain|1
3069919|NCT00472303|10544400|P2|Maintenance Phase|Resolution of pain|0
3069920|NCT00472303|10544401|P1|Maintenance Phase|Resolution of pain|0
3069921|NCT00472303|10544399|P3|Maintenance Phase|Trial medication non-compliant|1
3069922|NCT00472303|10544400|P2|Maintenance Phase|Trial medication non-compliant|0
3069923|NCT00472303|10544401|P1|Maintenance Phase|Trial medication non-compliant|0
3069924|NCT00472303|10544399|P3|Maintenance Phase|Withdrawal by Subject|3
3069925|NCT00472303|10544400|P2|Maintenance Phase|Withdrawal by Subject|7
3069926|NCT00472303|10544401|P1|Maintenance Phase|Withdrawal by Subject|6
3069927|NCT00472303|10544399|P3|Maintenance Phase|Lack of Efficacy|4
3069928|NCT00472303|10544400|P2|Maintenance Phase|Lack of Efficacy|2
3069929|NCT00472303|10544401|P1|Maintenance Phase|Lack of Efficacy|2
3069930|NCT00472303|10544399|P3|Maintenance Phase|Death|2
3069931|NCT00472303|10544400|P2|Maintenance Phase|Death|0
3069932|NCT00472303|10544401|P1|Maintenance Phase|Death|3
3069933|NCT00472303|10544399|P3|Maintenance Phase|Adverse Event|6
3069934|NCT00472303|10544400|P2|Maintenance Phase|Adverse Event|6
3069935|NCT00472303|10544401|P1|Maintenance Phase|Adverse Event|5
3069936|NCT00472303|10544399|P3|Discontinuations After Titration Phase|Other|0
3069937|NCT00472303|10544400|P2|Discontinuations After Titration Phase|Other|0
3069938|NCT00472303|10544401|P1|Discontinuations After Titration Phase|Other|5
3069939|NCT00472303|10544399|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
3069940|NCT00472303|10544400|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
3069941|NCT00472303|10544401|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
3069942|NCT00472303|10544399|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
3069943|NCT00472303|10544400|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
3069944|NCT00472303|10544401|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
3069945|NCT00472303|10544399|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
3069946|NCT00472303|10544400|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
3069947|NCT00472303|10544401|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
3069948|NCT00472303|10544399|P3|Discontinuations After Titration Phase|Adverse Event|0
3069949|NCT00472303|10544400|P2|Discontinuations After Titration Phase|Adverse Event|0
3069950|NCT00472303|10544401|P1|Discontinuations After Titration Phase|Adverse Event|6
3069951|NCT00472303|10544399|P3|Titration Phase|Other|0
3069952|NCT00472303|10544400|P2|Titration Phase|Other|1
3069953|NCT00472303|10544401|P1|Titration Phase|Other|3
3069954|NCT00472303|10544399|P3|Titration Phase|Trial Medication non-compliant|0
3069955|NCT00472303|10544400|P2|Titration Phase|Trial Medication non-compliant|1
3069956|NCT00472303|10544401|P1|Titration Phase|Trial Medication non-compliant|4
3069957|NCT00472303|10544399|P3|Titration Phase|Withdrawal by Subject|0
3069958|NCT00472303|10544400|P2|Titration Phase|Withdrawal by Subject|13
3069959|NCT00472303|10544401|P1|Titration Phase|Withdrawal by Subject|16
3069960|NCT00472303|10544399|P3|Titration Phase|Lack of Efficacy|0
3069961|NCT00472303|10544400|P2|Titration Phase|Lack of Efficacy|0
3069962|NCT00472303|10544401|P1|Titration Phase|Lack of Efficacy|10
3069963|NCT00472303|10544399|P3|Titration Phase|Death|0
3069964|NCT00472303|10544400|P2|Titration Phase|Death|2
3069965|NCT00472303|10544401|P1|Titration Phase|Death|4
3069966|NCT00472303|10544399|P3|Titration Phase|Adverse Event|0
3069967|NCT00472303|10544400|P2|Titration Phase|Adverse Event|12
3069968|NCT00472303|10544401|P1|Titration Phase|Adverse Event|22
3069969|NCT00472290|10544464|P1|Overall Study|Requirement for alternative therapy|7
3069970|NCT00472290|10544464|P1|Overall Study|Adverse Event|6
3069971|NCT00472290|10544464|P1|Overall Study|Withdrawal by Subject|5
3069972|NCT00472290|10544464|P1|Overall Study|Disease Progression|4
3069973|NCT00472290|10544464|P1|Overall Study|Lack of Efficacy|1
3069974|NCT00472290|10544464|P1|Overall Study|Lost to Follow-up|1
3069975|NCT00472290|10544464|P1|Overall Study|Death|3
3069976|NCT00472290|10544464|P1|Overall Study|Administrative Decision|37
3069977|NCT00472290|10544464|P1|Overall Study|Protocol Specified Criteria|7
3069978|NCT00472290|10544464|P1|Overall Study|Progression of Therapy-Related MDS|1
3069979|NCT00472199|10544476|P2|Overall Study|patient was asymptomatic|0
3069980|NCT00472199|10544477|P1|Overall Study|patient was asymptomatic|1
3069981|NCT00472199|10544476|P2|Overall Study|personal reason|1
3069982|NCT00472199|10544477|P1|Overall Study|personal reason|0
3069983|NCT00472199|10544476|P2|Overall Study|Withdrawal by Subject|5
3069984|NCT00472199|10544477|P1|Overall Study|Withdrawal by Subject|6
3069985|NCT00472199|10544476|P2|Overall Study|Protocol Violation|2
3069986|NCT00472199|10544477|P1|Overall Study|Protocol Violation|3
3069987|NCT00472199|10544476|P2|Overall Study|Lost to Follow-up|4
3069988|NCT00472199|10544477|P1|Overall Study|Lost to Follow-up|2
3069989|NCT00472199|10544476|P2|Overall Study|Lack of Efficacy|25
3069990|NCT00472199|10544477|P1|Overall Study|Lack of Efficacy|4
3069991|NCT00472199|10544476|P2|Overall Study|Adverse Event|23
3069992|NCT00472199|10544477|P1|Overall Study|Adverse Event|19
3069993|NCT00472082|10544543|P1|Overall Study|Study prematurely terminated|5
3069994|NCT00472030|10544565|P2|Overall Study|Physician Decision|0
3069995|NCT00472030|10544566|P1|Overall Study|Physician Decision|1
3069996|NCT00471822|10544582|P1|Overall Study|Protocol Violation|2
3069997|NCT00471718|10544590|P1|Overall Study|Withdrawal by Subject|1
3069998|NCT00471718|10544590|P1|Overall Study|disease progression|22
3069999|NCT00471718|10544590|P1|Overall Study|other complicating disease|1
3070000|NCT00471718|10544590|P1|Overall Study|Adverse Event|3
3070001|NCT00471536|10544618|P1|Overall Study|Withdrawal by Subject|1
3070002|NCT00471497|10544630|P3|Overall Study|Sub optimal response or treat. failure|0
3070003|NCT00471497|10544631|P2|Overall Study|Sub optimal response or treat. failure|3
3070004|NCT00471497|10544632|P1|Overall Study|Sub optimal response or treat. failure|8
3070005|NCT00471497|10544630|P3|Overall Study|Protocol Violation|5
3070007|NCT00471497|10544632|P1|Overall Study|Protocol Violation|3
3070008|NCT00471497|10544630|P3|Overall Study|Disease Progression|2
3070009|NCT00471497|10544631|P2|Overall Study|Disease Progression|2
3070010|NCT00471497|10544632|P1|Overall Study|Disease Progression|8
3070011|NCT00471497|10544630|P3|Overall Study|Death|0
3070012|NCT00471497|10544631|P2|Overall Study|Death|2
3070013|NCT00471497|10544632|P1|Overall Study|Death|0
3070014|NCT00471497|10544630|P3|Overall Study|Lost to Follow-up|1
3070015|NCT00471497|10544631|P2|Overall Study|Lost to Follow-up|2
3070016|NCT00471497|10544632|P1|Overall Study|Lost to Follow-up|1
3070017|NCT00471497|10544630|P3|Overall Study|Withdrawal by Subject|5
3070018|NCT00471497|10544631|P2|Overall Study|Withdrawal by Subject|5
3070019|NCT00471497|10544632|P1|Overall Study|Withdrawal by Subject|3
3070020|NCT00471497|10544630|P3|Overall Study|Condition no longer requires study drug|0
3070021|NCT00471497|10544631|P2|Overall Study|Condition no longer requires study drug|1
3070022|NCT00471497|10544632|P1|Overall Study|Condition no longer requires study drug|0
3070023|NCT00471497|10544630|P3|Overall Study|Abnormal Test Procedure|1
3070024|NCT00471497|10544631|P2|Overall Study|Abnormal Test Procedure|0
3070025|NCT00471497|10544632|P1|Overall Study|Abnormal Test Procedure|1
3070026|NCT00471497|10544630|P3|Overall Study|Abnormal Laboratory Value|4
3070027|NCT00471497|10544631|P2|Overall Study|Abnormal Laboratory Value|6
3070028|NCT00471497|10544632|P1|Overall Study|Abnormal Laboratory Value|3
3070029|NCT00471497|10544630|P3|Overall Study|Adverse Event|22
3070030|NCT00471497|10544631|P2|Overall Study|Adverse Event|11
3070031|NCT00471497|10544632|P1|Overall Study|Adverse Event|19
3070032|NCT00471445|10544642|P2|Overall Study|Protocol Violation|1
3070033|NCT00471445|10544643|P1|Overall Study|Protocol Violation|0
3070034|NCT00471445|10544642|P2|Overall Study|Ineligible|0
3070035|NCT00471445|10544643|P1|Overall Study|Ineligible|1
3070036|NCT00471445|10544642|P2|Overall Study|Withdrawal by Subject|1
3070037|NCT00471445|10544643|P1|Overall Study|Withdrawal by Subject|1
3070038|NCT00471354|10544656|P1|Overall Study|Patient/Caregiver Decision|12
3070039|NCT00471354|10544656|P1|Overall Study|Lack of Efficacy|5
3070040|NCT00471354|10544656|P1|Overall Study|Lost to Follow-up|3
3070041|NCT00471354|10544656|P1|Overall Study|Sponsor Decision|1
3070042|NCT00471354|10544656|P1|Overall Study|Physician Decision|4
3070043|NCT00471354|10544656|P1|Overall Study|Withdrawal by Subject|1
3070044|NCT00471354|10544656|P1|Overall Study|Protocol Violation|12
3070045|NCT00471354|10544656|P1|Overall Study|Adverse Event|13
3070046|NCT00471354|10544656|P1|Overall Study|Protocol Entry Criteria Not Met|1
3070047|NCT00471328|10544668|P2|Extension Phase|Administrative Problem|0
3070048|NCT00471328|10544669|P1|Extension Phase|Administrative Problem|1
3070049|NCT00471328|10544668|P2|Extension Phase|New cancer Therapy|0
3070050|NCT00471328|10544669|P1|Extension Phase|New cancer Therapy|1
3070051|NCT00471328|10544668|P2|Extension Phase|Disease Progression|44
3070052|NCT00471328|10544669|P1|Extension Phase|Disease Progression|32
3070053|NCT00471328|10544668|P2|Extension Phase|Treatment duration as per protocol|1
3070054|NCT00471328|10544669|P1|Extension Phase|Treatment duration as per protocol|0
3070055|NCT00471328|10544668|P2|Extension Phase|Protocol Deviation|1
3070056|NCT00471328|10544669|P1|Extension Phase|Protocol Deviation|3
3070057|NCT00471328|10544668|P2|Extension Phase|Death|7
3070058|NCT00471328|10544669|P1|Extension Phase|Death|1
3070059|NCT00471328|10544668|P2|Extension Phase|Withdrawal by Subject|2
3070060|NCT00471328|10544669|P1|Extension Phase|Withdrawal by Subject|0
3070061|NCT00471328|10544668|P2|Extension Phase|Adverse Event|12
3070062|NCT00471328|10544669|P1|Extension Phase|Adverse Event|3
3070063|NCT00471328|10544668|P2|Core Phase|Protocol Deviation|1
3070064|NCT00471328|10544669|P1|Core Phase|Protocol Deviation|0
3070065|NCT00471328|10544668|P2|Core Phase|Administrative Problem|1
3070066|NCT00471328|10544669|P1|Core Phase|Administrative Problem|0
3070067|NCT00471328|10544668|P2|Core Phase|Disease Progression|53
3070068|NCT00471328|10544669|P1|Core Phase|Disease Progression|78
3070069|NCT00471328|10544668|P2|Core Phase|Abnormal laboratory value|0
3070070|NCT00471328|10544669|P1|Core Phase|Abnormal laboratory value|1
3070071|NCT00471328|10544668|P2|Core Phase|Withdrawal by Subject|2
3070072|NCT00471328|10544669|P1|Core Phase|Withdrawal by Subject|2
3070073|NCT00471328|10544668|P2|Core Phase|Death|4
3070074|NCT00471328|10544669|P1|Core Phase|Death|8
3070075|NCT00471328|10544668|P2|Core Phase|Adverse Event|6
3070076|NCT00471328|10544669|P1|Core Phase|Adverse Event|18
3070077|NCT00471315|10544688|P1|Overall Study|Withdrawal by Subject|1
3070078|NCT00471315|10544688|P1|Overall Study|Adverse Event|7
3070079|NCT00471276|10544693|P1|Overall Study|Refused treatment|6
3070080|NCT00471276|10544693|P1|Overall Study|Other|3
3070081|NCT00471276|10544693|P1|Overall Study|Global deterioration of health status|1
3070082|NCT00471276|10544693|P1|Overall Study|Objective progression or relapse|54
3070083|NCT00471276|10544693|P1|Overall Study|Protocol Violation|1
3070084|NCT00471276|10544693|P1|Overall Study|Adverse Event|16
3070085|NCT00471276|10544693|P1|Overall Study|Death|2
3070086|NCT00471237|10544723|P7|Overall Study|Participant's decision|0
3070087|NCT00471237|10544724|P6|Overall Study|Participant's decision|1
3070088|NCT00471237|10544725|P5|Overall Study|Participant's decision|0
3070089|NCT00471237|10544726|P4|Overall Study|Participant's decision|0
3070090|NCT00471237|10544727|P3|Overall Study|Participant's decision|0
3070091|NCT00471237|10544728|P2|Overall Study|Participant's decision|0
3070092|NCT00471237|10544729|P1|Overall Study|Participant's decision|0
3070093|NCT00471237|10544723|P7|Overall Study|Participant shifted residence|0
3070094|NCT00471237|10544724|P6|Overall Study|Participant shifted residence|0
3070095|NCT00471237|10544725|P5|Overall Study|Participant shifted residence|1
3070096|NCT00471237|10544726|P4|Overall Study|Participant shifted residence|0
3070097|NCT00471237|10544727|P3|Overall Study|Participant shifted residence|0
3070098|NCT00471237|10544728|P2|Overall Study|Participant shifted residence|0
3070099|NCT00471237|10544729|P1|Overall Study|Participant shifted residence|0
3070100|NCT00471237|10544723|P7|Overall Study|Administration of prohibited medicine|0
3070101|NCT00471237|10544724|P6|Overall Study|Administration of prohibited medicine|0
3070102|NCT00471237|10544725|P5|Overall Study|Administration of prohibited medicine|1
3070103|NCT00471237|10544726|P4|Overall Study|Administration of prohibited medicine|0
3070104|NCT00471237|10544727|P3|Overall Study|Administration of prohibited medicine|0
3070105|NCT00471237|10544728|P2|Overall Study|Administration of prohibited medicine|0
3070106|NCT00471237|10544729|P1|Overall Study|Administration of prohibited medicine|0
3070107|NCT00471237|10544723|P7|Overall Study|Participant lost medication|0
3070108|NCT00471237|10544724|P6|Overall Study|Participant lost medication|0
3070109|NCT00471237|10544725|P5|Overall Study|Participant lost medication|1
3070110|NCT00471237|10544726|P4|Overall Study|Participant lost medication|0
3070111|NCT00471237|10544727|P3|Overall Study|Participant lost medication|0
3070112|NCT00471237|10544728|P2|Overall Study|Participant lost medication|0
3070113|NCT00471237|10544729|P1|Overall Study|Participant lost medication|0
3070114|NCT00471237|10544723|P7|Overall Study|High parathyroid hormone|0
3070115|NCT00471237|10544724|P6|Overall Study|High parathyroid hormone|0
3070116|NCT00471237|10544725|P5|Overall Study|High parathyroid hormone|0
3070117|NCT00471237|10544726|P4|Overall Study|High parathyroid hormone|0
3070118|NCT00471237|10544727|P3|Overall Study|High parathyroid hormone|1
3070119|NCT00471237|10544728|P2|Overall Study|High parathyroid hormone|0
3070120|NCT00471237|10544729|P1|Overall Study|High parathyroid hormone|0
3070121|NCT00471237|10544723|P7|Overall Study|Participant planned to travel to abraod|0
3070122|NCT00471237|10544724|P6|Overall Study|Participant planned to travel to abraod|1
3070123|NCT00471237|10544725|P5|Overall Study|Participant planned to travel to abraod|0
3070124|NCT00471237|10544726|P4|Overall Study|Participant planned to travel to abraod|0
3070125|NCT00471237|10544727|P3|Overall Study|Participant planned to travel to abraod|0
3070126|NCT00471237|10544728|P2|Overall Study|Participant planned to travel to abraod|0
3070127|NCT00471237|10544729|P1|Overall Study|Participant planned to travel to abraod|1
3070128|NCT00471237|10544723|P7|Overall Study|Early stopping due to non-efficacy|0
3070129|NCT00471237|10544724|P6|Overall Study|Early stopping due to non-efficacy|0
3070130|NCT00471237|10544725|P5|Overall Study|Early stopping due to non-efficacy|1
3070131|NCT00471237|10544726|P4|Overall Study|Early stopping due to non-efficacy|0
3070132|NCT00471237|10544727|P3|Overall Study|Early stopping due to non-efficacy|0
3070133|NCT00471237|10544728|P2|Overall Study|Early stopping due to non-efficacy|0
3070134|NCT00471237|10544729|P1|Overall Study|Early stopping due to non-efficacy|1
3070135|NCT00471237|10544723|P7|Overall Study|Met serum creatinine withdrawal criteria|0
3070136|NCT00471237|10544724|P6|Overall Study|Met serum creatinine withdrawal criteria|0
3070137|NCT00471237|10544725|P5|Overall Study|Met serum creatinine withdrawal criteria|0
3070138|NCT00471237|10544726|P4|Overall Study|Met serum creatinine withdrawal criteria|2
3070139|NCT00471237|10544727|P3|Overall Study|Met serum creatinine withdrawal criteria|2
3070140|NCT00471237|10544728|P2|Overall Study|Met serum creatinine withdrawal criteria|0
3070141|NCT00471237|10544729|P1|Overall Study|Met serum creatinine withdrawal criteria|1
3070142|NCT00471237|10544723|P7|Overall Study|Non-compliance|0
3070143|NCT00471237|10544724|P6|Overall Study|Non-compliance|0
3070144|NCT00471237|10544725|P5|Overall Study|Non-compliance|0
3070145|NCT00471237|10544726|P4|Overall Study|Non-compliance|1
3070146|NCT00471237|10544727|P3|Overall Study|Non-compliance|0
3070147|NCT00471237|10544728|P2|Overall Study|Non-compliance|1
3070148|NCT00471237|10544729|P1|Overall Study|Non-compliance|0
3070149|NCT00471237|10544723|P7|Overall Study|Sponsor terminated study|0
3070150|NCT00471237|10544724|P6|Overall Study|Sponsor terminated study|24
3070151|NCT00471237|10544725|P5|Overall Study|Sponsor terminated study|18
3070152|NCT00471237|10544726|P4|Overall Study|Sponsor terminated study|22
3070153|NCT00471237|10544727|P3|Overall Study|Sponsor terminated study|19
3070154|NCT00471237|10544728|P2|Overall Study|Sponsor terminated study|23
3070155|NCT00471237|10544729|P1|Overall Study|Sponsor terminated study|20
3070156|NCT00471237|10544723|P7|Overall Study|Withdrawal by Subject|2
3070157|NCT00471237|10544724|P6|Overall Study|Withdrawal by Subject|4
3070158|NCT00471237|10544725|P5|Overall Study|Withdrawal by Subject|7
3070159|NCT00471237|10544726|P4|Overall Study|Withdrawal by Subject|8
3070160|NCT00471237|10544727|P3|Overall Study|Withdrawal by Subject|5
3070161|NCT00471237|10544728|P2|Overall Study|Withdrawal by Subject|6
3070162|NCT00471237|10544729|P1|Overall Study|Withdrawal by Subject|8
3070163|NCT00471237|10544723|P7|Overall Study|Protocol Violation|1
3070164|NCT00471237|10544724|P6|Overall Study|Protocol Violation|4
3070165|NCT00471237|10544725|P5|Overall Study|Protocol Violation|2
3070166|NCT00471237|10544726|P4|Overall Study|Protocol Violation|2
3070167|NCT00471237|10544727|P3|Overall Study|Protocol Violation|3
3070168|NCT00471237|10544728|P2|Overall Study|Protocol Violation|6
3070169|NCT00471237|10544729|P1|Overall Study|Protocol Violation|3
3070170|NCT00471237|10544723|P7|Overall Study|Lost to Follow-up|0
3070171|NCT00471237|10544724|P6|Overall Study|Lost to Follow-up|0
3070172|NCT00471237|10544725|P5|Overall Study|Lost to Follow-up|3
3070173|NCT00471237|10544726|P4|Overall Study|Lost to Follow-up|2
3070174|NCT00471237|10544727|P3|Overall Study|Lost to Follow-up|0
3070175|NCT00471237|10544728|P2|Overall Study|Lost to Follow-up|1
3070176|NCT00471237|10544729|P1|Overall Study|Lost to Follow-up|1
3070177|NCT00471237|10544723|P7|Overall Study|Adverse Event|0
3070178|NCT00471237|10544724|P6|Overall Study|Adverse Event|5
3070179|NCT00471237|10544725|P5|Overall Study|Adverse Event|7
3070180|NCT00471237|10544726|P4|Overall Study|Adverse Event|8
3070181|NCT00471237|10544727|P3|Overall Study|Adverse Event|4
3070182|NCT00471237|10544728|P2|Overall Study|Adverse Event|5
3070183|NCT00471237|10544729|P1|Overall Study|Adverse Event|6
3070184|NCT00471146|10544879|P2|Overall Study|Other|5
3070185|NCT00471146|10544880|P1|Overall Study|Other|4
3070186|NCT00471146|10544879|P2|Overall Study|Randomized but not treated|8
3070187|NCT00471146|10544880|P1|Overall Study|Randomized but not treated|9
3070188|NCT00471146|10544879|P2|Overall Study|Global deterioration of health status|14
3070189|NCT00471146|10544880|P1|Overall Study|Global deterioration of health status|12
3070190|NCT00471146|10544879|P2|Overall Study|Objective progression or relapse|87
3070191|NCT00471146|10544880|P1|Overall Study|Objective progression or relapse|84
3070192|NCT00471146|10544879|P2|Overall Study|Protocol Violation|2
3070193|NCT00471146|10544880|P1|Overall Study|Protocol Violation|2
3070194|NCT00471146|10544879|P2|Overall Study|Lost to Follow-up|2
3070195|NCT00471146|10544880|P1|Overall Study|Lost to Follow-up|4
3070196|NCT00471146|10544879|P2|Overall Study|Death|12
3070197|NCT00471146|10544880|P1|Overall Study|Death|11
3070198|NCT00471146|10544879|P2|Overall Study|Withdrawal by Subject|11
3070199|NCT00471146|10544880|P1|Overall Study|Withdrawal by Subject|14
3070200|NCT00471146|10544879|P2|Overall Study|Adverse Event|33
3070201|NCT00471146|10544880|P1|Overall Study|Adverse Event|32
3070202|NCT00471107|10544905|P3|Overall Study|Technical problems/data loss|3
3070203|NCT00471107|10544906|P2|Overall Study|Technical problems/data loss|1
3070204|NCT00471107|10544907|P1|Overall Study|Technical problems/data loss|3
3070205|NCT00471081|10544917|P2|Extended Safety Follow-Up|Missing confirmed|1
3070206|NCT00471081|10544918|P1|Extended Safety Follow-Up|Missing confirmed|0
3070207|NCT00471081|10544917|P2|Extended Safety Follow-Up|Lost to Follow-up|8
3070208|NCT00471081|10544918|P1|Extended Safety Follow-Up|Lost to Follow-up|1
3070209|NCT00471081|10544917|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
3070210|NCT00471081|10544918|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
3070211|NCT00471081|10544917|P2|Active Phase|Lost health plan/insurance|8
3070212|NCT00471081|10544918|P1|Active Phase|Lost health plan/insurance|1
3070213|NCT00471081|10544917|P2|Active Phase|Lost to Follow-up|1
3070214|NCT00471081|10544918|P1|Active Phase|Lost to Follow-up|0
3070215|NCT00471081|10544917|P2|Active Phase|Withdrawal by Subject|3
3070216|NCT00471081|10544918|P1|Active Phase|Withdrawal by Subject|0
3070217|NCT00471081|10544917|P2|Active Phase|Protocol Violation|1
3070218|NCT00471081|10544918|P1|Active Phase|Protocol Violation|1
3070219|NCT00470847|10544964|P1|Overall Study|Pt still receiving treatment|1
3070220|NCT00470834|10544977|P2|Extension Period (24 Months)|Disease Progression|1
3070221|NCT00470834|10544978|P1|Extension Period (24 Months)|Disease Progression|0
3070222|NCT00470834|10544977|P2|Extension Period (24 Months)|Non-compliance|1
3070223|NCT00470834|10544978|P1|Extension Period (24 Months)|Non-compliance|0
3070224|NCT00470834|10544977|P2|Extension Period (24 Months)|Lost to Follow-up|1
3070225|NCT00470834|10544978|P1|Extension Period (24 Months)|Lost to Follow-up|0
3070226|NCT00470834|10544977|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
3070227|NCT00470834|10544978|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
3070228|NCT00470834|10544977|P2|Extension Period (24 Months)|Physician Decision|3
3070229|NCT00470834|10544978|P1|Extension Period (24 Months)|Physician Decision|4
3070230|NCT00470834|10544977|P2|Extension Period (24 Months)|Withdrawal by Subject|5
3070231|NCT00470834|10544978|P1|Extension Period (24 Months)|Withdrawal by Subject|2
3070232|NCT00470834|10544977|P2|Extension Period (24 Months)|Adverse Event|4
3070233|NCT00470834|10544978|P1|Extension Period (24 Months)|Adverse Event|3
3070234|NCT00470834|10544977|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
3070235|NCT00470834|10544978|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
3070236|NCT00470834|10544977|P2|Treatment Period (18 Months)|Lack of Efficacy|0
3070237|NCT00470834|10544978|P1|Treatment Period (18 Months)|Lack of Efficacy|1
3070238|NCT00470834|10544977|P2|Treatment Period (18 Months)|Non-compliance|0
3070239|NCT00470834|10544978|P1|Treatment Period (18 Months)|Non-compliance|1
3070240|NCT00470834|10544977|P2|Treatment Period (18 Months)|Lost to Follow-up|0
3070241|NCT00470834|10544978|P1|Treatment Period (18 Months)|Lost to Follow-up|1
3070242|NCT00470834|10544977|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
3070243|NCT00470834|10544978|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
3070244|NCT00470834|10544977|P2|Treatment Period (18 Months)|Protocol Violation|1
3070245|NCT00470834|10544978|P1|Treatment Period (18 Months)|Protocol Violation|3
3070246|NCT00470834|10544977|P2|Treatment Period (18 Months)|Physician Decision|4
3070247|NCT00470834|10544978|P1|Treatment Period (18 Months)|Physician Decision|4
3070248|NCT00470834|10544977|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
3070249|NCT00470834|10544978|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
3070250|NCT00470834|10544977|P2|Treatment Period (18 Months)|Adverse Event|6
3070251|NCT00470834|10544978|P1|Treatment Period (18 Months)|Adverse Event|7
3070252|NCT00470834|10544977|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
3070253|NCT00470834|10544978|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
3070254|NCT00470626|10544992|P1|Overall Study|Withdrawal by Subject|7
3070255|NCT00470626|10544992|P1|Overall Study|Lost to Follow-up|10
3070256|NCT00470535|10545034|P1|Overall Study|Other|2
3070257|NCT00470535|10545034|P1|Overall Study|Death|1
3070258|NCT00470535|10545034|P1|Overall Study|Adverse Event|1
3070259|NCT00470535|10545034|P1|Overall Study|Withdrawal by Subject|1
3070260|NCT00470535|10545034|P1|Overall Study|Disease Progression|13
3070261|NCT00470470|10545043|P1|Overall Study|Not treated|1
3070262|NCT00470470|10545043|P1|Overall Study|Death|2
3070263|NCT00470470|10545043|P1|Overall Study|Adverse Event|2
3070264|NCT00470418|10545050|P2|Overall Study|Withdrawal by Subject|0
3070265|NCT00470418|10545051|P1|Overall Study|Withdrawal by Subject|1
3070266|NCT00470366|10545072|P1|Overall Study|Poor compliance|1
3070267|NCT00470366|10545072|P1|Overall Study|Adverse Event|3
3070268|NCT00470275|10545083|P1|Overall Study|Withdrawal by Subject|2
3070269|NCT00470275|10545083|P1|Overall Study|Lack of Efficacy|7
3070270|NCT00470275|10545083|P1|Overall Study|Death|1
3070271|NCT00470262|10545089|P2|Overall Study|Withdrawal by Subject|0
3070272|NCT00470262|10545090|P1|Overall Study|Withdrawal by Subject|2
3070273|NCT00470184|10545098|P1|Overall Study|recurrence|1
3070274|NCT00470184|10545098|P1|Overall Study|other|5
3070275|NCT00470184|10545098|P1|Overall Study|Withdrawal by Subject|4
3070276|NCT00470184|10545098|P1|Overall Study|Adverse Event|3
3070277|NCT00470184|10545098|P1|Overall Study|disease Progression|4
3070278|NCT00470184|10545098|P1|Overall Study|Not treated (other)|1
3070279|NCT00470184|10545098|P1|Overall Study|Not Treated(became ineligible)|4
3070280|NCT00470158|10545110|P5|Overall Study|Protocol Violation|0
3070281|NCT00470158|10545111|P4|Overall Study|Protocol Violation|0
3070282|NCT00470158|10545112|P3|Overall Study|Protocol Violation|0
3070283|NCT00470158|10545113|P2|Overall Study|Protocol Violation|0
3070284|NCT00470158|10545114|P1|Overall Study|Protocol Violation|1
3070285|NCT00470158|10545110|P5|Overall Study|Lost to Follow-up|4
3070286|NCT00470158|10545111|P4|Overall Study|Lost to Follow-up|5
3070287|NCT00470158|10545112|P3|Overall Study|Lost to Follow-up|8
3070288|NCT00470158|10545113|P2|Overall Study|Lost to Follow-up|8
3070289|NCT00470158|10545114|P1|Overall Study|Lost to Follow-up|7
3070290|NCT00470158|10545110|P5|Overall Study|Death|2
3070291|NCT00470158|10545111|P4|Overall Study|Death|0
3070292|NCT00470158|10545112|P3|Overall Study|Death|0
3070293|NCT00470158|10545113|P2|Overall Study|Death|0
3070294|NCT00470158|10545114|P1|Overall Study|Death|0
3070295|NCT00470093|10545147|P1|Overall Study|Adverse Event|2
3070296|NCT00470067|10545154|P1|Overall Study|Disease Progression|6
3070297|NCT00470067|10545154|P1|Overall Study|Death|1
3070298|NCT00470054|10545158|P1|Overall Study|Ineligible|1
3070299|NCT00469898|10545174|P1|Overall Study|Decreased performance status|1
3070300|NCT00469898|10545174|P1|Overall Study|Disease progression|9
3070301|NCT00469898|10545174|P1|Overall Study|Death|4
3070302|NCT00469898|10545174|P1|Overall Study|Withdrawal by Subject|4
3070303|NCT00469898|10545174|P1|Overall Study|Adverse Event|7
3070304|NCT00469859|10545183|P2|Overall Study|Inevaluable|2
3070305|NCT00469859|10545184|P1|Overall Study|Inevaluable|0
3070306|NCT00469833|10545192|P1|Overall Study|No IV access|2
3070307|NCT00469612|10545204|P2|Overall Study|Study terminated before data collected|0
3070308|NCT00469612|10545205|P1|Overall Study|Study terminated before data collected|2
3070309|NCT00469456|10545232|P2|Overall Study|Withdrawal by Subject|1
3070310|NCT00469456|10545233|P1|Overall Study|Withdrawal by Subject|4
3070311|NCT00469456|10545232|P2|Overall Study|Protocol Violation|0
3070312|NCT00469456|10545233|P1|Overall Study|Protocol Violation|1
3070313|NCT00469456|10545232|P2|Overall Study|Adverse Event|3
3070314|NCT00469456|10545233|P1|Overall Study|Adverse Event|4
3070315|NCT00469209|10545262|P3|Overall Study|Adverse Event|1
3070316|NCT00469209|10545263|P2|Overall Study|Adverse Event|0
3070317|NCT00469209|10545264|P1|Overall Study|Adverse Event|1
3070318|NCT00469092|10545274|P2|Overall Study|Use of Corticosteroid|0
3070319|NCT00469092|10545275|P1|Overall Study|Use of Corticosteroid|1
3070320|NCT00469092|10545274|P2|Overall Study|Abnormal lab value|0
3070321|NCT00469092|10545275|P1|Overall Study|Abnormal lab value|1
3070322|NCT00469092|10545274|P2|Overall Study|Hypoglycaemic Episodes|1
3070323|NCT00469092|10545275|P1|Overall Study|Hypoglycaemic Episodes|1
3070324|NCT00469092|10545274|P2|Overall Study|Use of lipid lowering drug|0
3070325|NCT00469092|10545275|P1|Overall Study|Use of lipid lowering drug|1
3070326|NCT00469092|10545274|P2|Overall Study|Contraindication metformin/glimepiride|0
3070327|NCT00469092|10545275|P1|Overall Study|Contraindication metformin/glimepiride|1
3070328|NCT00469092|10545274|P2|Overall Study|Incorrectly Randomised|3
3070329|NCT00469092|10545275|P1|Overall Study|Incorrectly Randomised|4
3070330|NCT00469092|10545274|P2|Overall Study|Withdrawal Criteria|4
3070331|NCT00469092|10545275|P1|Overall Study|Withdrawal Criteria|3
3070332|NCT00469092|10545274|P2|Overall Study|Withdrawal by Subject|4
3070333|NCT00469092|10545275|P1|Overall Study|Withdrawal by Subject|4
3070334|NCT00469092|10545274|P2|Overall Study|Protocol Violation|3
3070335|NCT00469092|10545275|P1|Overall Study|Protocol Violation|3
3070336|NCT00469092|10545274|P2|Overall Study|Lost to Follow-up|2
3070337|NCT00469092|10545275|P1|Overall Study|Lost to Follow-up|1
3070338|NCT00469092|10545274|P2|Overall Study|Lack of Efficacy|0
3070339|NCT00469092|10545275|P1|Overall Study|Lack of Efficacy|1
3070340|NCT00469092|10545274|P2|Overall Study|Adverse Event|4
3070341|NCT00469092|10545275|P1|Overall Study|Adverse Event|5
3070342|NCT00469079|10545294|P3|Overall Study|Ineligible|0
3070343|NCT00469079|10545295|P2|Overall Study|Ineligible|1
3070344|NCT00469079|10545296|P1|Overall Study|Ineligible|0
3070345|NCT00469079|10545294|P3|Overall Study|Withdrawal by Subject|2
3070346|NCT00469079|10545295|P2|Overall Study|Withdrawal by Subject|2
3070347|NCT00469079|10545296|P1|Overall Study|Withdrawal by Subject|1
3070348|NCT00469079|10545294|P3|Overall Study|Lost to Follow-up|10
3070349|NCT00469079|10545295|P2|Overall Study|Lost to Follow-up|8
3070350|NCT00469079|10545296|P1|Overall Study|Lost to Follow-up|4
3070351|NCT00469079|10545294|P3|Overall Study|Adverse Event|2
3070352|NCT00469079|10545295|P2|Overall Study|Adverse Event|3
3070353|NCT00469079|10545296|P1|Overall Study|Adverse Event|1
3070354|NCT00469079|10545294|P3|Overall Study|Lack of Efficacy|5
3070355|NCT00469079|10545295|P2|Overall Study|Lack of Efficacy|8
3070356|NCT00469079|10545296|P1|Overall Study|Lack of Efficacy|3
3070357|NCT00468910|10545315|P2|Overall Study|Medical Contraindication|1
3070358|NCT00468910|10545316|P1|Overall Study|Medical Contraindication|0
3070359|NCT00468910|10545315|P2|Overall Study|Withdrawal by Subject|1
3070360|NCT00468910|10545316|P1|Overall Study|Withdrawal by Subject|2
3070361|NCT00468910|10545315|P2|Overall Study|Lost to Follow-up|1
3070362|NCT00468910|10545316|P1|Overall Study|Lost to Follow-up|2
3070363|NCT00468858|10545335|P3|Overall Study|Other|1
3070364|NCT00468858|10545336|P2|Overall Study|Other|0
3070365|NCT00468858|10545337|P1|Overall Study|Other|0
3070366|NCT00468858|10545335|P3|Overall Study|Lost to Follow-up|5
3070367|NCT00468858|10545336|P2|Overall Study|Lost to Follow-up|2
3070368|NCT00468858|10545337|P1|Overall Study|Lost to Follow-up|1
3070369|NCT00468858|10545335|P3|Overall Study|Relocation|3
3070370|NCT00468858|10545336|P2|Overall Study|Relocation|3
3070371|NCT00468858|10545337|P1|Overall Study|Relocation|1
3070372|NCT00468858|10545335|P3|Overall Study|Withdrawal by Subject|5
3070373|NCT00468858|10545336|P2|Overall Study|Withdrawal by Subject|4
3070374|NCT00468858|10545337|P1|Overall Study|Withdrawal by Subject|7
3070375|NCT00468858|10545335|P3|Overall Study|Adverse Event|0
3070376|NCT00468858|10545336|P2|Overall Study|Adverse Event|1
3070377|NCT00468858|10545337|P1|Overall Study|Adverse Event|0
3070378|NCT00468845|10545458|P3|Overall Study|Randomized, not treated|2
3070379|NCT00468845|10545459|P2|Overall Study|Randomized, not treated|4
3070380|NCT00468845|10545460|P1|Overall Study|Randomized, not treated|1
3070381|NCT00468845|10545458|P3|Overall Study|No longer willing to participate|10
3070382|NCT00468845|10545459|P2|Overall Study|No longer willing to participate|6
3070383|NCT00468845|10545460|P1|Overall Study|No longer willing to participate|5
3070384|NCT00468845|10545458|P3|Overall Study|Other|5
3070385|NCT00468845|10545459|P2|Overall Study|Other|9
3070386|NCT00468845|10545460|P1|Overall Study|Other|4
3070387|NCT00468845|10545458|P3|Overall Study|Lost to Follow-up|2
3070388|NCT00468845|10545459|P2|Overall Study|Lost to Follow-up|1
3070389|NCT00468845|10545460|P1|Overall Study|Lost to Follow-up|2
3070390|NCT00468845|10545458|P3|Overall Study|Adverse Event|11
3070391|NCT00468845|10545459|P2|Overall Study|Adverse Event|14
3070392|NCT00468845|10545460|P1|Overall Study|Adverse Event|9
3070393|NCT00468819|10545597|P3|Overall Study|Drop-outs (Treatment never received)|0
3070394|NCT00468819|10545598|P2|Overall Study|Drop-outs (Treatment never received)|0
3070395|NCT00468819|10545599|P1|Overall Study|Drop-outs (Treatment never received)|2
3070396|NCT00468819|10545597|P3|Overall Study|Lost to Follow-up|1
3070397|NCT00468819|10545598|P2|Overall Study|Lost to Follow-up|0
3070398|NCT00468819|10545599|P1|Overall Study|Lost to Follow-up|0
3070399|NCT00468819|10545597|P3|Overall Study|Withdrawal by Subject|1
3070400|NCT00468819|10545598|P2|Overall Study|Withdrawal by Subject|0
3070401|NCT00468819|10545599|P1|Overall Study|Withdrawal by Subject|4
3070402|NCT00468728|10545679|P2|Follow-up|mITT failure|31
3070403|NCT00468728|10545680|P1|Follow-up|mITT failure|34
3070404|NCT00468728|10545679|P2|Treatment|criteria for mITT population|11
3070405|NCT00468728|10545680|P1|Treatment|criteria for mITT population|4
3070406|NCT00468676|10545692|P2|Overall Study|Death|1
3070407|NCT00468676|10545693|P1|Overall Study|Death|2
3070408|NCT00468676|10545692|P2|Overall Study|Lost to Follow-up|11
3070409|NCT00468676|10545693|P1|Overall Study|Lost to Follow-up|14
3070410|NCT00468650|10545710|P1|Overall Study|Protocol Violation|1
3070411|NCT00468650|10545710|P1|Overall Study|Withdrawal by Subject|2
3070412|NCT00468650|10545710|P1|Overall Study|Lost to Follow-up|4
3070413|NCT00468585|10545758|P4|Overall Study|Withdrawal by Subject|1
3070414|NCT00468585|10545759|P3|Overall Study|Withdrawal by Subject|2
3070415|NCT00468585|10545760|P2|Overall Study|Withdrawal by Subject|0
3070416|NCT00468585|10545761|P1|Overall Study|Withdrawal by Subject|0
3070417|NCT00468585|10545758|P4|Overall Study|Adverse Event|0
3070418|NCT00468585|10545759|P3|Overall Study|Adverse Event|1
3070419|NCT00468585|10545760|P2|Overall Study|Adverse Event|0
3070420|NCT00468585|10545761|P1|Overall Study|Adverse Event|0
3070421|NCT00468585|10545758|P4|Overall Study|Patient found to be ineligible|0
3070422|NCT00468585|10545759|P3|Overall Study|Patient found to be ineligible|1
3070423|NCT00468585|10545760|P2|Overall Study|Patient found to be ineligible|0
3070424|NCT00468585|10545761|P1|Overall Study|Patient found to be ineligible|0
3070425|NCT00468585|10545758|P4|Overall Study|Patient not treated|0
3070426|NCT00468585|10545759|P3|Overall Study|Patient not treated|1
3070427|NCT00468585|10545760|P2|Overall Study|Patient not treated|0
3070428|NCT00468585|10545761|P1|Overall Study|Patient not treated|1
3070429|NCT00468559|10545773|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
3070430|NCT00468559|10545774|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
3070431|NCT00468559|10545775|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
3070432|NCT00468559|10545773|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
3070433|NCT00468559|10545774|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
3070434|NCT00468559|10545775|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
3070435|NCT00468559|10545773|P3|Open-label Treatment Phase|Withdrawal by Subject|0
3070436|NCT00468559|10545774|P2|Open-label Treatment Phase|Withdrawal by Subject|0
3070437|NCT00468559|10545775|P1|Open-label Treatment Phase|Withdrawal by Subject|4
3070438|NCT00468559|10545773|P3|Open-label Treatment Phase|Lack of Efficacy|0
3070439|NCT00468559|10545774|P2|Open-label Treatment Phase|Lack of Efficacy|0
3070440|NCT00468559|10545775|P1|Open-label Treatment Phase|Lack of Efficacy|9
3070441|NCT00468559|10545773|P3|Open-label Treatment Phase|Adverse Event|0
3070442|NCT00468559|10545774|P2|Open-label Treatment Phase|Adverse Event|0
3070443|NCT00468559|10545775|P1|Open-label Treatment Phase|Adverse Event|5
3070444|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Other|14
3070445|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Other|17
3070446|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
3070447|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
3070448|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Failure to return|2
3070449|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Failure to return|1
3070450|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Refused treatment|7
3070451|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Refused treatment|4
3070452|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
3070453|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
3070454|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
3070455|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
3070456|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Death|0
3070457|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Death|1
3070458|NCT00468546|10545803|P2|Week 24 to Week 104 Analysis|Adverse Event|5
3070459|NCT00468546|10545804|P1|Week 24 to Week 104 Analysis|Adverse Event|2
3070460|NCT00468546|10545803|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
3070461|NCT00468546|10545804|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
3070462|NCT00468546|10545803|P2|Week 24 Analysis|Went onto rescue therapy|0
3070463|NCT00468546|10545804|P1|Week 24 Analysis|Went onto rescue therapy|1
3070464|NCT00468546|10545803|P2|Week 24 Analysis|Due to clinical hold|0
3070465|NCT00468546|10545804|P1|Week 24 Analysis|Due to clinical hold|1
3070466|NCT00468546|10545803|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
3070467|NCT00468546|10545804|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
3070468|NCT00468546|10545803|P2|Week 24 Analysis|Rescue therapy|0
3070469|NCT00468546|10545804|P1|Week 24 Analysis|Rescue therapy|2
3070470|NCT00468546|10545803|P2|Week 24 Analysis|Failure to return|4
3070471|NCT00468546|10545804|P1|Week 24 Analysis|Failure to return|3
3070472|NCT00468546|10545803|P2|Week 24 Analysis|Adverse Event|8
3070473|NCT00468546|10545804|P1|Week 24 Analysis|Adverse Event|1
3070474|NCT00468546|10545803|P2|Week 24 Analysis|Refused treatment|5
3070475|NCT00468546|10545804|P1|Week 24 Analysis|Refused treatment|5
3070476|NCT00468546|10545803|P2|Week 24 Analysis|Lack of Efficacy|37
3070477|NCT00468546|10545804|P1|Week 24 Analysis|Lack of Efficacy|83
3070478|NCT00468481|10545834|P2|Overall Study|Other|0
3070479|NCT00468481|10545835|P1|Overall Study|Other|6
3070480|NCT00468481|10545834|P2|Overall Study|Non-Compliance|0
3070481|NCT00468481|10545835|P1|Overall Study|Non-Compliance|5
3070482|NCT00468481|10545834|P2|Overall Study|Moved out of area|1
3070483|NCT00468481|10545835|P1|Overall Study|Moved out of area|4
3070484|NCT00468481|10545834|P2|Overall Study|Egg Donor|0
3070485|NCT00468481|10545835|P1|Overall Study|Egg Donor|1
3070486|NCT00468481|10545834|P2|Overall Study|Prohibited Medication|1
3070487|NCT00468481|10545835|P1|Overall Study|Prohibited Medication|1
3070488|NCT00468481|10545834|P2|Overall Study|susp/diag malignant/premalignant disease|0
3070489|NCT00468481|10545835|P1|Overall Study|susp/diag malignant/premalignant disease|1
3070490|NCT00468481|10545834|P2|Overall Study|Withdrawal by Subject|3
3070491|NCT00468481|10545835|P1|Overall Study|Withdrawal by Subject|12
3070492|NCT00468481|10545834|P2|Overall Study|Protocol Violation|8
3070493|NCT00468481|10545835|P1|Overall Study|Protocol Violation|18
3070494|NCT00468481|10545834|P2|Overall Study|Pregnancy|0
3070495|NCT00468481|10545835|P1|Overall Study|Pregnancy|2
3070496|NCT00468481|10545834|P2|Overall Study|Lost to Follow-up|8
3070497|NCT00468481|10545835|P1|Overall Study|Lost to Follow-up|25
3070498|NCT00468481|10545834|P2|Overall Study|Adverse Event|3
3070499|NCT00468481|10545835|P1|Overall Study|Adverse Event|13
3070500|NCT00468312|10545935|P2|Overall Study|Did not meet protocol eligibility|1
3070501|NCT00468312|10545936|P1|Overall Study|Did not meet protocol eligibility|0
3070502|NCT00468312|10545935|P2|Overall Study|Protocol Violation|1
3070503|NCT00468312|10545936|P1|Overall Study|Protocol Violation|2
3070504|NCT00468312|10545935|P2|Overall Study|Withdrawal by Subject|1
3070505|NCT00468312|10545936|P1|Overall Study|Withdrawal by Subject|0
3070506|NCT00468312|10545935|P2|Overall Study|Lack of Efficacy|1
3070507|NCT00468312|10545936|P1|Overall Study|Lack of Efficacy|0
3070508|NCT00468312|10545935|P2|Overall Study|Adverse Event|1
3070509|NCT00468312|10545936|P1|Overall Study|Adverse Event|2
3070510|NCT00468299|10545952|P2|Overall Study|Withdrawal by Subject|1
3070511|NCT00468299|10545953|P1|Overall Study|Withdrawal by Subject|0
3070512|NCT00468286|10545963|P2|Overall Study|Physician Decision|1
3070513|NCT00468286|10545964|P1|Overall Study|Physician Decision|0
3070514|NCT00468286|10545963|P2|Overall Study|Withdrawal by Subject|3
3070515|NCT00468286|10545964|P1|Overall Study|Withdrawal by Subject|4
3070516|NCT00468286|10545963|P2|Overall Study|Protocol Violation|2
3070517|NCT00468286|10545964|P1|Overall Study|Protocol Violation|2
3070518|NCT00468286|10545963|P2|Overall Study|Adverse Event|6
3070519|NCT00468286|10545964|P1|Overall Study|Adverse Event|1
3070520|NCT00468169|10545996|P2|Overall Study|Withdrawal by Subject|0
3070521|NCT00468169|10545997|P1|Overall Study|Withdrawal by Subject|1
3070522|NCT00468143|10546013|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
3070523|NCT00468143|10546014|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
3070524|NCT00468143|10546013|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
3070525|NCT00468143|10546014|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
3070526|NCT00468104|10546028|P2|Second Intervention|discarded for malposition of chest tube|2
3070527|NCT00468104|10546029|P1|Second Intervention|discarded for malposition of chest tube|0
3070528|NCT00468104|10546028|P2|Second Intervention|Withdrawal by Subject|2
3070529|NCT00468104|10546029|P1|Second Intervention|Withdrawal by Subject|5
3070530|NCT00468104|10546028|P2|First Intervention|trapped lung|0
3070531|NCT00468104|10546029|P1|First Intervention|trapped lung|1
3070532|NCT00468104|10546028|P2|First Intervention|associated prolonged pneumothorax|0
3070533|NCT00468104|10546029|P1|First Intervention|associated prolonged pneumothorax|1
3070534|NCT00468104|10546028|P2|First Intervention|large lung mass with minimal effusion|0
3070535|NCT00468104|10546029|P1|First Intervention|large lung mass with minimal effusion|1
3070536|NCT00468104|10546028|P2|First Intervention|malposition/blocked chest tube tube|0
3070537|NCT00468104|10546029|P1|First Intervention|malposition/blocked chest tube tube|2
3070538|NCT00468104|10546028|P2|First Intervention|died within 3 weeks|0
3070539|NCT00468104|10546029|P1|First Intervention|died within 3 weeks|1
3070540|NCT00468104|10546028|P2|First Intervention|bleeding at chest tube site--first dose|0
3070541|NCT00468104|10546029|P1|First Intervention|bleeding at chest tube site--first dose|1
3070542|NCT00468104|10546028|P2|First Intervention|Protocol Violation|1
3070543|NCT00468104|10546029|P1|First Intervention|Protocol Violation|2
3070544|NCT00468052|10546046|P2|Overall Study|Protocol Violation|8
3070545|NCT00468052|10546047|P1|Overall Study|Protocol Violation|7
3070546|NCT00467961|10546065|P1|Overall Study|Disease Progression|2
3070547|NCT00467961|10546065|P1|Overall Study|Technical Failures|5
3070548|NCT00467896|10546069|P1|Overall Study|Patient had no improvement|1
3070549|NCT00467896|10546069|P1|Overall Study|Started inhaled Remodulin|1
3070550|NCT00467896|10546069|P1|Overall Study|Started intravenous prostacyclin|1
3070551|NCT00467896|10546069|P1|Overall Study|Mainly used Prodose not I-neb® device|1
3070552|NCT00467896|10546069|P1|Overall Study|Patient weaned off iloprost|1
3070553|NCT00467896|10546069|P1|Overall Study|Patient had atrial septostomy|1
3070554|NCT00467896|10546069|P1|Overall Study|Patient received transplant|2
3070555|NCT00467896|10546069|P1|Overall Study|Changed therapy|2
3070556|NCT00467896|10546069|P1|Overall Study|Non-compliance|3
3070557|NCT00467896|10546069|P1|Overall Study|Serious Adverse Event|13
3070558|NCT00467896|10546069|P1|Overall Study|Adverse Event|7
3070559|NCT00467896|10546069|P1|Overall Study|Consent Withdrawal|18
3070560|NCT00467870|10546095|P6|Overall Study|Other/Unknown|0
3070561|NCT00467870|10546096|P5|Overall Study|Other/Unknown|4
3070562|NCT00467870|10546097|P4|Overall Study|Other/Unknown|5
3070563|NCT00467870|10546098|P3|Overall Study|Other/Unknown|1
3070564|NCT00467870|10546099|P2|Overall Study|Other/Unknown|5
3070565|NCT00467870|10546100|P1|Overall Study|Other/Unknown|8
3070566|NCT00467870|10546095|P6|Overall Study|Subject Non-compliance|0
3070567|NCT00467870|10546096|P5|Overall Study|Subject Non-compliance|5
3070568|NCT00467870|10546097|P4|Overall Study|Subject Non-compliance|1
3070569|NCT00467870|10546098|P3|Overall Study|Subject Non-compliance|0
3070570|NCT00467870|10546099|P2|Overall Study|Subject Non-compliance|4
3070571|NCT00467870|10546100|P1|Overall Study|Subject Non-compliance|3
3070572|NCT00467870|10546095|P6|Overall Study|Lost to Follow-up|0
3070573|NCT00467870|10546096|P5|Overall Study|Lost to Follow-up|3
3070574|NCT00467870|10546097|P4|Overall Study|Lost to Follow-up|1
3070575|NCT00467870|10546098|P3|Overall Study|Lost to Follow-up|1
3070576|NCT00467870|10546099|P2|Overall Study|Lost to Follow-up|3
3070577|NCT00467870|10546100|P1|Overall Study|Lost to Follow-up|5
3070578|NCT00467870|10546095|P6|Overall Study|Withdrawal by Subject|1
3070579|NCT00467870|10546096|P5|Overall Study|Withdrawal by Subject|10
3070580|NCT00467870|10546097|P4|Overall Study|Withdrawal by Subject|9
3070581|NCT00467870|10546098|P3|Overall Study|Withdrawal by Subject|0
3070582|NCT00467870|10546099|P2|Overall Study|Withdrawal by Subject|21
3070583|NCT00467870|10546100|P1|Overall Study|Withdrawal by Subject|14
3070584|NCT00467870|10546095|P6|Overall Study|Protocol Violation|0
3070585|NCT00467870|10546096|P5|Overall Study|Protocol Violation|0
3070586|NCT00467870|10546097|P4|Overall Study|Protocol Violation|2
3070587|NCT00467870|10546098|P3|Overall Study|Protocol Violation|1
3070588|NCT00467870|10546099|P2|Overall Study|Protocol Violation|1
3070589|NCT00467870|10546100|P1|Overall Study|Protocol Violation|2
3070590|NCT00467870|10546095|P6|Overall Study|Adverse Event|1
3070591|NCT00467870|10546096|P5|Overall Study|Adverse Event|15
3070592|NCT00467870|10546097|P4|Overall Study|Adverse Event|15
3070593|NCT00467870|10546098|P3|Overall Study|Adverse Event|1
3070594|NCT00467870|10546099|P2|Overall Study|Adverse Event|9
3070595|NCT00467870|10546100|P1|Overall Study|Adverse Event|13
3070596|NCT00467857|10546143|P2|Overall Study|Discontinuation reason missing|3
3070597|NCT00467857|10546144|P1|Overall Study|Discontinuation reason missing|0
3070598|NCT00467857|10546143|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
3070599|NCT00467857|10546144|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
3070600|NCT00467857|10546143|P2|Overall Study|Emergency care required|1
3070601|NCT00467857|10546144|P1|Overall Study|Emergency care required|0
3070602|NCT00467857|10546143|P2|Overall Study|Discharged from court service|1
3070603|NCT00467857|10546144|P1|Overall Study|Discharged from court service|0
3070604|NCT00467857|10546143|P2|Overall Study|Death|1
3070605|NCT00467857|10546144|P1|Overall Study|Death|0
3070606|NCT00467857|10546143|P2|Overall Study|Withdrew consent|0
3070607|NCT00467857|10546144|P1|Overall Study|Withdrew consent|2
3070608|NCT00467857|10546143|P2|Overall Study|Adverse Event|0
3070609|NCT00467857|10546144|P1|Overall Study|Adverse Event|1
3070610|NCT00467831|10546192|P1|Overall Study|Withdrawal by Subject|1
3070611|NCT00467831|10546192|P1|Overall Study|Death|2
3070612|NCT00467779|10546211|P15|Stage 3|Unspecified Reason|5
3070613|NCT00467779|10546212|P14|Stage 3|Unspecified Reason|0
3070614|NCT00467779|10546213|P13|Stage 3|Unspecified Reason|0
3070615|NCT00467779|10546214|P12|Stage 3|Unspecified Reason|0
3070616|NCT00467779|10546215|P11|Stage 3|Unspecified Reason|0
3070617|NCT00467779|10546216|P10|Stage 3|Unspecified Reason|0
3070618|NCT00467779|10546217|P9|Stage 3|Unspecified Reason|0
3070619|NCT00467779|10546218|P8|Stage 3|Unspecified Reason|0
3070620|NCT00467779|10546219|P7|Stage 3|Unspecified Reason|0
3070621|NCT00467779|10546220|P6|Stage 3|Unspecified Reason|0
3070622|NCT00467779|10546221|P5|Stage 3|Unspecified Reason|0
3070623|NCT00467779|10546222|P4|Stage 3|Unspecified Reason|0
3070624|NCT00467779|10546223|P3|Stage 3|Unspecified Reason|0
3070625|NCT00467779|10546224|P2|Stage 3|Unspecified Reason|0
3070626|NCT00467779|10546225|P1|Stage 3|Unspecified Reason|0
3070627|NCT00467779|10546211|P15|Stage 3|Disease Progression|9
3070628|NCT00467779|10546212|P14|Stage 3|Disease Progression|0
3070629|NCT00467779|10546213|P13|Stage 3|Disease Progression|0
3070630|NCT00467779|10546214|P12|Stage 3|Disease Progression|0
3070631|NCT00467779|10546215|P11|Stage 3|Disease Progression|0
3070632|NCT00467779|10546216|P10|Stage 3|Disease Progression|0
3070633|NCT00467779|10546217|P9|Stage 3|Disease Progression|0
3070634|NCT00467779|10546218|P8|Stage 3|Disease Progression|0
3070635|NCT00467779|10546219|P7|Stage 3|Disease Progression|0
3070636|NCT00467779|10546220|P6|Stage 3|Disease Progression|0
3070637|NCT00467779|10546221|P5|Stage 3|Disease Progression|0
3070638|NCT00467779|10546222|P4|Stage 3|Disease Progression|0
3070639|NCT00467779|10546223|P3|Stage 3|Disease Progression|0
3070640|NCT00467779|10546224|P2|Stage 3|Disease Progression|0
3070641|NCT00467779|10546225|P1|Stage 3|Disease Progression|0
3070642|NCT00467779|10546211|P15|Stage 3|Death|1
3070643|NCT00467779|10546212|P14|Stage 3|Death|0
3070644|NCT00467779|10546213|P13|Stage 3|Death|0
3070645|NCT00467779|10546214|P12|Stage 3|Death|0
3070646|NCT00467779|10546215|P11|Stage 3|Death|0
3070647|NCT00467779|10546216|P10|Stage 3|Death|0
3070648|NCT00467779|10546217|P9|Stage 3|Death|0
3070649|NCT00467779|10546218|P8|Stage 3|Death|0
3070650|NCT00467779|10546219|P7|Stage 3|Death|0
3070651|NCT00467779|10546220|P6|Stage 3|Death|0
3070652|NCT00467779|10546221|P5|Stage 3|Death|0
3070653|NCT00467779|10546222|P4|Stage 3|Death|0
3070654|NCT00467779|10546223|P3|Stage 3|Death|0
3070655|NCT00467779|10546224|P2|Stage 3|Death|0
3070656|NCT00467779|10546225|P1|Stage 3|Death|0
3070657|NCT00467779|10546211|P15|Stage 3|Adverse Event|2
3070658|NCT00467779|10546212|P14|Stage 3|Adverse Event|0
3070659|NCT00467779|10546213|P13|Stage 3|Adverse Event|0
3070660|NCT00467779|10546214|P12|Stage 3|Adverse Event|0
3070661|NCT00467779|10546215|P11|Stage 3|Adverse Event|0
3070662|NCT00467779|10546216|P10|Stage 3|Adverse Event|0
3070663|NCT00467779|10546217|P9|Stage 3|Adverse Event|0
3070664|NCT00467779|10546218|P8|Stage 3|Adverse Event|0
3070665|NCT00467779|10546219|P7|Stage 3|Adverse Event|0
3070666|NCT00467779|10546220|P6|Stage 3|Adverse Event|0
3070667|NCT00467779|10546221|P5|Stage 3|Adverse Event|0
3070668|NCT00467779|10546222|P4|Stage 3|Adverse Event|0
3070669|NCT00467779|10546223|P3|Stage 3|Adverse Event|0
3070670|NCT00467779|10546224|P2|Stage 3|Adverse Event|0
3070671|NCT00467779|10546225|P1|Stage 3|Adverse Event|0
3070672|NCT00467779|10546211|P15|Stage 2A|Withdrawal by Subject|0
3070673|NCT00467779|10546212|P14|Stage 2A|Withdrawal by Subject|1
3070674|NCT00467779|10546213|P13|Stage 2A|Withdrawal by Subject|0
3070675|NCT00467779|10546214|P12|Stage 2A|Withdrawal by Subject|0
3070676|NCT00467779|10546215|P11|Stage 2A|Withdrawal by Subject|0
3070677|NCT00467779|10546216|P10|Stage 2A|Withdrawal by Subject|0
3070678|NCT00467779|10546217|P9|Stage 2A|Withdrawal by Subject|0
3070679|NCT00467779|10546218|P8|Stage 2A|Withdrawal by Subject|0
3070680|NCT00467779|10546219|P7|Stage 2A|Withdrawal by Subject|0
3070681|NCT00467779|10546220|P6|Stage 2A|Withdrawal by Subject|0
3070682|NCT00467779|10546221|P5|Stage 2A|Withdrawal by Subject|0
3070683|NCT00467779|10546222|P4|Stage 2A|Withdrawal by Subject|0
3070684|NCT00467779|10546223|P3|Stage 2A|Withdrawal by Subject|0
3070685|NCT00467779|10546224|P2|Stage 2A|Withdrawal by Subject|0
3070686|NCT00467779|10546225|P1|Stage 2A|Withdrawal by Subject|0
3070687|NCT00467779|10546211|P15|Stage 2A|Unspecified Reason|0
3070688|NCT00467779|10546212|P14|Stage 2A|Unspecified Reason|7
3070689|NCT00467779|10546213|P13|Stage 2A|Unspecified Reason|0
3070690|NCT00467779|10546214|P12|Stage 2A|Unspecified Reason|0
3070691|NCT00467779|10546215|P11|Stage 2A|Unspecified Reason|0
3070692|NCT00467779|10546216|P10|Stage 2A|Unspecified Reason|0
3070693|NCT00467779|10546217|P9|Stage 2A|Unspecified Reason|0
3070694|NCT00467779|10546218|P8|Stage 2A|Unspecified Reason|0
3070695|NCT00467779|10546219|P7|Stage 2A|Unspecified Reason|0
3070696|NCT00467779|10546220|P6|Stage 2A|Unspecified Reason|0
3070697|NCT00467779|10546221|P5|Stage 2A|Unspecified Reason|0
3070698|NCT00467779|10546222|P4|Stage 2A|Unspecified Reason|0
3070699|NCT00467779|10546223|P3|Stage 2A|Unspecified Reason|0
3070700|NCT00467779|10546224|P2|Stage 2A|Unspecified Reason|0
3070701|NCT00467779|10546225|P1|Stage 2A|Unspecified Reason|0
3070702|NCT00467779|10546211|P15|Stage 2A|Disease Progression|0
3070703|NCT00467779|10546212|P14|Stage 2A|Disease Progression|10
3070704|NCT00467779|10546213|P13|Stage 2A|Disease Progression|0
3070705|NCT00467779|10546214|P12|Stage 2A|Disease Progression|0
3070706|NCT00467779|10546215|P11|Stage 2A|Disease Progression|0
3070707|NCT00467779|10546216|P10|Stage 2A|Disease Progression|0
3070708|NCT00467779|10546217|P9|Stage 2A|Disease Progression|0
3070709|NCT00467779|10546218|P8|Stage 2A|Disease Progression|0
3070710|NCT00467779|10546219|P7|Stage 2A|Disease Progression|0
3070711|NCT00467779|10546220|P6|Stage 2A|Disease Progression|0
3070712|NCT00467779|10546221|P5|Stage 2A|Disease Progression|0
3070713|NCT00467779|10546222|P4|Stage 2A|Disease Progression|0
3070714|NCT00467779|10546223|P3|Stage 2A|Disease Progression|0
3070715|NCT00467779|10546224|P2|Stage 2A|Disease Progression|0
3070716|NCT00467779|10546225|P1|Stage 2A|Disease Progression|0
3070717|NCT00467779|10546211|P15|Stage 2A|Death|0
3070718|NCT00467779|10546212|P14|Stage 2A|Death|1
3070719|NCT00467779|10546213|P13|Stage 2A|Death|0
3070720|NCT00467779|10546214|P12|Stage 2A|Death|0
3070721|NCT00467779|10546215|P11|Stage 2A|Death|0
3070722|NCT00467779|10546216|P10|Stage 2A|Death|0
3070723|NCT00467779|10546217|P9|Stage 2A|Death|0
3070724|NCT00467779|10546218|P8|Stage 2A|Death|0
3070725|NCT00467779|10546219|P7|Stage 2A|Death|0
3070726|NCT00467779|10546220|P6|Stage 2A|Death|0
3070727|NCT00467779|10546221|P5|Stage 2A|Death|0
3070728|NCT00467779|10546222|P4|Stage 2A|Death|0
3070729|NCT00467779|10546223|P3|Stage 2A|Death|0
3070730|NCT00467779|10546224|P2|Stage 2A|Death|0
3070731|NCT00467779|10546225|P1|Stage 2A|Death|0
3070732|NCT00467779|10546211|P15|Stage 2A|Adverse Event|0
3070733|NCT00467779|10546212|P14|Stage 2A|Adverse Event|2
3070734|NCT00467779|10546213|P13|Stage 2A|Adverse Event|0
3070735|NCT00467779|10546214|P12|Stage 2A|Adverse Event|0
3070736|NCT00467779|10546215|P11|Stage 2A|Adverse Event|0
3070737|NCT00467779|10546216|P10|Stage 2A|Adverse Event|0
3070738|NCT00467779|10546217|P9|Stage 2A|Adverse Event|0
3070739|NCT00467779|10546218|P8|Stage 2A|Adverse Event|0
3070740|NCT00467779|10546219|P7|Stage 2A|Adverse Event|0
3070741|NCT00467779|10546220|P6|Stage 2A|Adverse Event|0
3070742|NCT00467779|10546221|P5|Stage 2A|Adverse Event|0
3070743|NCT00467779|10546222|P4|Stage 2A|Adverse Event|0
3070744|NCT00467779|10546223|P3|Stage 2A|Adverse Event|0
3070745|NCT00467779|10546224|P2|Stage 2A|Adverse Event|0
3070746|NCT00467779|10546225|P1|Stage 2A|Adverse Event|0
3070747|NCT00467779|10546211|P15|Stage 2|Unspecified Reason|0
3070748|NCT00467779|10546212|P14|Stage 2|Unspecified Reason|0
3070749|NCT00467779|10546213|P13|Stage 2|Unspecified Reason|0
3070750|NCT00467779|10546214|P12|Stage 2|Unspecified Reason|0
3070751|NCT00467779|10546215|P11|Stage 2|Unspecified Reason|0
3070752|NCT00467779|10546216|P10|Stage 2|Unspecified Reason|0
3070753|NCT00467779|10546217|P9|Stage 2|Unspecified Reason|3
3070754|NCT00467779|10546218|P8|Stage 2|Unspecified Reason|0
3070755|NCT00467779|10546219|P7|Stage 2|Unspecified Reason|0
3070756|NCT00467779|10546220|P6|Stage 2|Unspecified Reason|0
3070757|NCT00467779|10546221|P5|Stage 2|Unspecified Reason|0
3070758|NCT00467779|10546222|P4|Stage 2|Unspecified Reason|0
3070759|NCT00467779|10546223|P3|Stage 2|Unspecified Reason|0
3070760|NCT00467779|10546224|P2|Stage 2|Unspecified Reason|0
3070761|NCT00467779|10546225|P1|Stage 2|Unspecified Reason|0
3070762|NCT00467779|10546211|P15|Stage 2|Disease Progression|0
3070763|NCT00467779|10546212|P14|Stage 2|Disease Progression|0
3070764|NCT00467779|10546213|P13|Stage 2|Disease Progression|0
3070765|NCT00467779|10546214|P12|Stage 2|Disease Progression|0
3070766|NCT00467779|10546215|P11|Stage 2|Disease Progression|0
3070767|NCT00467779|10546216|P10|Stage 2|Disease Progression|0
3070768|NCT00467779|10546217|P9|Stage 2|Disease Progression|16
3070769|NCT00467779|10546218|P8|Stage 2|Disease Progression|0
3070770|NCT00467779|10546219|P7|Stage 2|Disease Progression|0
3070771|NCT00467779|10546220|P6|Stage 2|Disease Progression|0
3070772|NCT00467779|10546221|P5|Stage 2|Disease Progression|0
3070773|NCT00467779|10546222|P4|Stage 2|Disease Progression|0
3070774|NCT00467779|10546223|P3|Stage 2|Disease Progression|0
3070775|NCT00467779|10546224|P2|Stage 2|Disease Progression|0
3070776|NCT00467779|10546225|P1|Stage 2|Disease Progression|0
3070777|NCT00467779|10546211|P15|Stage 2|Death|0
3070778|NCT00467779|10546212|P14|Stage 2|Death|0
3070779|NCT00467779|10546213|P13|Stage 2|Death|0
3070780|NCT00467779|10546214|P12|Stage 2|Death|0
3070781|NCT00467779|10546215|P11|Stage 2|Death|0
3070782|NCT00467779|10546216|P10|Stage 2|Death|0
3070783|NCT00467779|10546217|P9|Stage 2|Death|1
3070784|NCT00467779|10546218|P8|Stage 2|Death|0
3070785|NCT00467779|10546219|P7|Stage 2|Death|0
3070786|NCT00467779|10546220|P6|Stage 2|Death|0
3070787|NCT00467779|10546221|P5|Stage 2|Death|0
3070788|NCT00467779|10546222|P4|Stage 2|Death|0
3070789|NCT00467779|10546223|P3|Stage 2|Death|0
3070790|NCT00467779|10546224|P2|Stage 2|Death|0
3070791|NCT00467779|10546225|P1|Stage 2|Death|0
3070792|NCT00467779|10546211|P15|Stage 2|Adverse Event|0
3070793|NCT00467779|10546212|P14|Stage 2|Adverse Event|0
3070794|NCT00467779|10546213|P13|Stage 2|Adverse Event|0
3070795|NCT00467779|10546214|P12|Stage 2|Adverse Event|0
3070796|NCT00467779|10546215|P11|Stage 2|Adverse Event|0
3070797|NCT00467779|10546216|P10|Stage 2|Adverse Event|0
3070798|NCT00467779|10546217|P9|Stage 2|Adverse Event|1
3070799|NCT00467779|10546218|P8|Stage 2|Adverse Event|0
3070800|NCT00467779|10546219|P7|Stage 2|Adverse Event|0
3070801|NCT00467779|10546220|P6|Stage 2|Adverse Event|0
3070802|NCT00467779|10546221|P5|Stage 2|Adverse Event|0
3070803|NCT00467779|10546222|P4|Stage 2|Adverse Event|0
3070804|NCT00467779|10546223|P3|Stage 2|Adverse Event|0
3070805|NCT00467779|10546224|P2|Stage 2|Adverse Event|0
3070806|NCT00467779|10546225|P1|Stage 2|Adverse Event|0
3070807|NCT00467779|10546211|P15|Stage 1A|Unspecified Reason|0
3070808|NCT00467779|10546212|P14|Stage 1A|Unspecified Reason|0
3070809|NCT00467779|10546213|P13|Stage 1A|Unspecified Reason|1
3070810|NCT00467779|10546214|P12|Stage 1A|Unspecified Reason|1
3070811|NCT00467779|10546215|P11|Stage 1A|Unspecified Reason|0
3070812|NCT00467779|10546216|P10|Stage 1A|Unspecified Reason|0
3070813|NCT00467779|10546217|P9|Stage 1A|Unspecified Reason|0
3070814|NCT00467779|10546218|P8|Stage 1A|Unspecified Reason|0
3070815|NCT00467779|10546219|P7|Stage 1A|Unspecified Reason|0
3070816|NCT00467779|10546220|P6|Stage 1A|Unspecified Reason|0
3070817|NCT00467779|10546221|P5|Stage 1A|Unspecified Reason|0
3070818|NCT00467779|10546222|P4|Stage 1A|Unspecified Reason|0
3070819|NCT00467779|10546223|P3|Stage 1A|Unspecified Reason|0
3070820|NCT00467779|10546224|P2|Stage 1A|Unspecified Reason|0
3070821|NCT00467779|10546225|P1|Stage 1A|Unspecified Reason|0
3070822|NCT00467779|10546211|P15|Stage 1A|Withdrawal by Subject|0
3070823|NCT00467779|10546212|P14|Stage 1A|Withdrawal by Subject|0
3070824|NCT00467779|10546213|P13|Stage 1A|Withdrawal by Subject|1
3070825|NCT00467779|10546214|P12|Stage 1A|Withdrawal by Subject|1
3070826|NCT00467779|10546215|P11|Stage 1A|Withdrawal by Subject|1
3070827|NCT00467779|10546216|P10|Stage 1A|Withdrawal by Subject|0
3070828|NCT00467779|10546217|P9|Stage 1A|Withdrawal by Subject|0
3070829|NCT00467779|10546218|P8|Stage 1A|Withdrawal by Subject|0
3070830|NCT00467779|10546219|P7|Stage 1A|Withdrawal by Subject|0
3070831|NCT00467779|10546220|P6|Stage 1A|Withdrawal by Subject|0
3070832|NCT00467779|10546221|P5|Stage 1A|Withdrawal by Subject|0
3070833|NCT00467779|10546222|P4|Stage 1A|Withdrawal by Subject|0
3070834|NCT00467779|10546223|P3|Stage 1A|Withdrawal by Subject|0
3070835|NCT00467779|10546224|P2|Stage 1A|Withdrawal by Subject|0
3070836|NCT00467779|10546225|P1|Stage 1A|Withdrawal by Subject|0
3070837|NCT00467779|10546211|P15|Stage 1A|Physician Decision|0
3070838|NCT00467779|10546212|P14|Stage 1A|Physician Decision|0
3070839|NCT00467779|10546213|P13|Stage 1A|Physician Decision|0
3070840|NCT00467779|10546214|P12|Stage 1A|Physician Decision|0
3070841|NCT00467779|10546215|P11|Stage 1A|Physician Decision|0
3070842|NCT00467779|10546216|P10|Stage 1A|Physician Decision|1
3070843|NCT00467779|10546217|P9|Stage 1A|Physician Decision|0
3070844|NCT00467779|10546218|P8|Stage 1A|Physician Decision|0
3070845|NCT00467779|10546219|P7|Stage 1A|Physician Decision|0
3070846|NCT00467779|10546220|P6|Stage 1A|Physician Decision|0
3070847|NCT00467779|10546221|P5|Stage 1A|Physician Decision|0
3070848|NCT00467779|10546222|P4|Stage 1A|Physician Decision|0
3070849|NCT00467779|10546223|P3|Stage 1A|Physician Decision|0
3070850|NCT00467779|10546224|P2|Stage 1A|Physician Decision|0
3070851|NCT00467779|10546225|P1|Stage 1A|Physician Decision|0
3070852|NCT00467779|10546211|P15|Stage 1A|Disease Progression|0
3070853|NCT00467779|10546212|P14|Stage 1A|Disease Progression|0
3070854|NCT00467779|10546213|P13|Stage 1A|Disease Progression|2
3070855|NCT00467779|10546214|P12|Stage 1A|Disease Progression|5
3070856|NCT00467779|10546215|P11|Stage 1A|Disease Progression|2
3070857|NCT00467779|10546216|P10|Stage 1A|Disease Progression|2
3070858|NCT00467779|10546217|P9|Stage 1A|Disease Progression|0
3070859|NCT00467779|10546218|P8|Stage 1A|Disease Progression|0
3070860|NCT00467779|10546219|P7|Stage 1A|Disease Progression|0
3070861|NCT00467779|10546220|P6|Stage 1A|Disease Progression|0
3070862|NCT00467779|10546221|P5|Stage 1A|Disease Progression|0
3070863|NCT00467779|10546222|P4|Stage 1A|Disease Progression|0
3070864|NCT00467779|10546223|P3|Stage 1A|Disease Progression|0
3070865|NCT00467779|10546224|P2|Stage 1A|Disease Progression|0
3070866|NCT00467779|10546225|P1|Stage 1A|Disease Progression|0
3070867|NCT00467779|10546211|P15|Stage 1A|Death|0
3070868|NCT00467779|10546212|P14|Stage 1A|Death|0
3070869|NCT00467779|10546213|P13|Stage 1A|Death|1
3070870|NCT00467779|10546214|P12|Stage 1A|Death|1
3070871|NCT00467779|10546215|P11|Stage 1A|Death|0
3070872|NCT00467779|10546216|P10|Stage 1A|Death|0
3070873|NCT00467779|10546217|P9|Stage 1A|Death|0
3070874|NCT00467779|10546218|P8|Stage 1A|Death|0
3070875|NCT00467779|10546219|P7|Stage 1A|Death|0
3070876|NCT00467779|10546220|P6|Stage 1A|Death|0
3070877|NCT00467779|10546221|P5|Stage 1A|Death|0
3070878|NCT00467779|10546222|P4|Stage 1A|Death|0
3070879|NCT00467779|10546223|P3|Stage 1A|Death|0
3070880|NCT00467779|10546224|P2|Stage 1A|Death|0
3070881|NCT00467779|10546225|P1|Stage 1A|Death|0
3070882|NCT00467779|10546211|P15|Stage 1A|Adverse Event|0
3070883|NCT00467779|10546212|P14|Stage 1A|Adverse Event|0
3070884|NCT00467779|10546213|P13|Stage 1A|Adverse Event|1
3070885|NCT00467779|10546214|P12|Stage 1A|Adverse Event|0
3070886|NCT00467779|10546215|P11|Stage 1A|Adverse Event|0
3070887|NCT00467779|10546216|P10|Stage 1A|Adverse Event|0
3070888|NCT00467779|10546217|P9|Stage 1A|Adverse Event|0
3070889|NCT00467779|10546218|P8|Stage 1A|Adverse Event|0
3070890|NCT00467779|10546219|P7|Stage 1A|Adverse Event|0
3070891|NCT00467779|10546220|P6|Stage 1A|Adverse Event|0
3070892|NCT00467779|10546221|P5|Stage 1A|Adverse Event|0
3070893|NCT00467779|10546222|P4|Stage 1A|Adverse Event|0
3070894|NCT00467779|10546223|P3|Stage 1A|Adverse Event|0
3070895|NCT00467779|10546224|P2|Stage 1A|Adverse Event|0
3070896|NCT00467779|10546225|P1|Stage 1A|Adverse Event|0
3070897|NCT00467779|10546211|P15|Stage 1|Withdrawal by Subject|0
3070898|NCT00467779|10546212|P14|Stage 1|Withdrawal by Subject|0
3070899|NCT00467779|10546213|P13|Stage 1|Withdrawal by Subject|0
3070900|NCT00467779|10546214|P12|Stage 1|Withdrawal by Subject|0
3070901|NCT00467779|10546215|P11|Stage 1|Withdrawal by Subject|0
3070902|NCT00467779|10546216|P10|Stage 1|Withdrawal by Subject|0
3070903|NCT00467779|10546217|P9|Stage 1|Withdrawal by Subject|0
3070904|NCT00467779|10546218|P8|Stage 1|Withdrawal by Subject|1
3070905|NCT00467779|10546219|P7|Stage 1|Withdrawal by Subject|1
3070906|NCT00467779|10546220|P6|Stage 1|Withdrawal by Subject|0
3070907|NCT00467779|10546221|P5|Stage 1|Withdrawal by Subject|0
3070908|NCT00467779|10546222|P4|Stage 1|Withdrawal by Subject|0
3070909|NCT00467779|10546223|P3|Stage 1|Withdrawal by Subject|0
3070910|NCT00467779|10546224|P2|Stage 1|Withdrawal by Subject|0
3070911|NCT00467779|10546225|P1|Stage 1|Withdrawal by Subject|0
3070912|NCT00467779|10546211|P15|Stage 1|Physician Decision|0
3070913|NCT00467779|10546212|P14|Stage 1|Physician Decision|0
3070914|NCT00467779|10546213|P13|Stage 1|Physician Decision|0
3070915|NCT00467779|10546214|P12|Stage 1|Physician Decision|0
3070916|NCT00467779|10546215|P11|Stage 1|Physician Decision|0
3070917|NCT00467779|10546216|P10|Stage 1|Physician Decision|0
3070918|NCT00467779|10546217|P9|Stage 1|Physician Decision|0
3070919|NCT00467779|10546218|P8|Stage 1|Physician Decision|0
3070920|NCT00467779|10546219|P7|Stage 1|Physician Decision|0
3070921|NCT00467779|10546220|P6|Stage 1|Physician Decision|0
3070922|NCT00467779|10546221|P5|Stage 1|Physician Decision|0
3070923|NCT00467779|10546222|P4|Stage 1|Physician Decision|0
3070924|NCT00467779|10546223|P3|Stage 1|Physician Decision|0
3070925|NCT00467779|10546224|P2|Stage 1|Physician Decision|1
3070926|NCT00467779|10546225|P1|Stage 1|Physician Decision|0
3070927|NCT00467779|10546211|P15|Stage 1|Unspecified Reason|0
3070928|NCT00467779|10546212|P14|Stage 1|Unspecified Reason|0
3070929|NCT00467779|10546213|P13|Stage 1|Unspecified Reason|0
3070930|NCT00467779|10546214|P12|Stage 1|Unspecified Reason|0
3070931|NCT00467779|10546215|P11|Stage 1|Unspecified Reason|0
3070932|NCT00467779|10546216|P10|Stage 1|Unspecified Reason|0
3070933|NCT00467779|10546217|P9|Stage 1|Unspecified Reason|0
3070934|NCT00467779|10546218|P8|Stage 1|Unspecified Reason|0
3070935|NCT00467779|10546219|P7|Stage 1|Unspecified Reason|0
3070936|NCT00467779|10546220|P6|Stage 1|Unspecified Reason|2
3070937|NCT00467779|10546221|P5|Stage 1|Unspecified Reason|1
3070938|NCT00467779|10546222|P4|Stage 1|Unspecified Reason|0
3070939|NCT00467779|10546223|P3|Stage 1|Unspecified Reason|1
3070940|NCT00467779|10546224|P2|Stage 1|Unspecified Reason|0
3070941|NCT00467779|10546225|P1|Stage 1|Unspecified Reason|1
3070942|NCT00467779|10546211|P15|Stage 1|Disease Progression|0
3070943|NCT00467779|10546212|P14|Stage 1|Disease Progression|0
3070944|NCT00467779|10546213|P13|Stage 1|Disease Progression|0
3070945|NCT00467779|10546214|P12|Stage 1|Disease Progression|0
3070946|NCT00467779|10546215|P11|Stage 1|Disease Progression|0
3070947|NCT00467779|10546216|P10|Stage 1|Disease Progression|0
3070948|NCT00467779|10546217|P9|Stage 1|Disease Progression|0
3070949|NCT00467779|10546218|P8|Stage 1|Disease Progression|5
3070950|NCT00467779|10546219|P7|Stage 1|Disease Progression|4
3070951|NCT00467779|10546220|P6|Stage 1|Disease Progression|2
3070952|NCT00467779|10546221|P5|Stage 1|Disease Progression|2
3070953|NCT00467779|10546222|P4|Stage 1|Disease Progression|3
3070954|NCT00467779|10546223|P3|Stage 1|Disease Progression|2
3070955|NCT00467779|10546224|P2|Stage 1|Disease Progression|2
3070956|NCT00467779|10546225|P1|Stage 1|Disease Progression|2
3070957|NCT00467779|10546211|P15|Stage 1|Adverse Event|0
3070958|NCT00467779|10546212|P14|Stage 1|Adverse Event|0
3070959|NCT00467779|10546213|P13|Stage 1|Adverse Event|0
3070960|NCT00467779|10546214|P12|Stage 1|Adverse Event|0
3070961|NCT00467779|10546215|P11|Stage 1|Adverse Event|0
3070962|NCT00467779|10546216|P10|Stage 1|Adverse Event|0
3070963|NCT00467779|10546217|P9|Stage 1|Adverse Event|0
3070964|NCT00467779|10546218|P8|Stage 1|Adverse Event|1
3070965|NCT00467779|10546219|P7|Stage 1|Adverse Event|2
3070966|NCT00467779|10546220|P6|Stage 1|Adverse Event|1
3070967|NCT00467779|10546221|P5|Stage 1|Adverse Event|0
3070968|NCT00467779|10546222|P4|Stage 1|Adverse Event|0
3070969|NCT00467779|10546223|P3|Stage 1|Adverse Event|0
3070970|NCT00467779|10546224|P2|Stage 1|Adverse Event|0
3070971|NCT00467779|10546225|P1|Stage 1|Adverse Event|1
3070972|NCT00467753|10546399|P2|Overall Study|Adverse Event|0
3070973|NCT00467753|10546400|P1|Overall Study|Adverse Event|2
3070974|NCT00467753|10546399|P2|Overall Study|Lost to Follow-up|2
3070975|NCT00467753|10546400|P1|Overall Study|Lost to Follow-up|1
3070976|NCT00467740|10546411|P5|Overall Study|Lack of Efficacy|0
3070977|NCT00467740|10546412|P4|Overall Study|Lack of Efficacy|0
3070978|NCT00467740|10546413|P3|Overall Study|Lack of Efficacy|0
3070979|NCT00467740|10546414|P2|Overall Study|Lack of Efficacy|1
3070980|NCT00467740|10546415|P1|Overall Study|Lack of Efficacy|0
3070981|NCT00467740|10546411|P5|Overall Study|Withdrawal by Subject|0
3070982|NCT00467740|10546412|P4|Overall Study|Withdrawal by Subject|1
3070983|NCT00467740|10546413|P3|Overall Study|Withdrawal by Subject|0
3070984|NCT00467740|10546414|P2|Overall Study|Withdrawal by Subject|1
3070985|NCT00467740|10546415|P1|Overall Study|Withdrawal by Subject|1
3070986|NCT00467740|10546411|P5|Overall Study|Lost to Follow-up|0
3070987|NCT00467740|10546412|P4|Overall Study|Lost to Follow-up|0
3070988|NCT00467740|10546413|P3|Overall Study|Lost to Follow-up|0
3070989|NCT00467740|10546414|P2|Overall Study|Lost to Follow-up|1
3070990|NCT00467740|10546415|P1|Overall Study|Lost to Follow-up|0
3070991|NCT00467740|10546411|P5|Overall Study|Protocol Violation|0
3070992|NCT00467740|10546412|P4|Overall Study|Protocol Violation|0
3070993|NCT00467740|10546413|P3|Overall Study|Protocol Violation|1
3070994|NCT00467740|10546414|P2|Overall Study|Protocol Violation|0
3070995|NCT00467740|10546415|P1|Overall Study|Protocol Violation|0
3070996|NCT00467740|10546411|P5|Overall Study|Adverse Event|0
3070997|NCT00467740|10546412|P4|Overall Study|Adverse Event|0
3070998|NCT00467740|10546413|P3|Overall Study|Adverse Event|1
3070999|NCT00467740|10546414|P2|Overall Study|Adverse Event|0
3071000|NCT00467740|10546415|P1|Overall Study|Adverse Event|0
3071001|NCT00467649|10546604|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
3071002|NCT00467649|10546605|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
3071003|NCT00467649|10546606|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
3071004|NCT00467649|10546607|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
3071005|NCT00467649|10546608|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
3071006|NCT00467649|10546609|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
3071007|NCT00467649|10546604|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
3071008|NCT00467649|10546605|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
3071009|NCT00467649|10546606|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
3071010|NCT00467649|10546607|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
3071011|NCT00467649|10546608|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
3071012|NCT00467649|10546609|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
3071013|NCT00467649|10546604|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
3071014|NCT00467649|10546605|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
3071015|NCT00467649|10546606|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
3071016|NCT00467649|10546607|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
3071017|NCT00467649|10546608|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
3071018|NCT00467649|10546609|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
3071019|NCT00467649|10546604|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
3071020|NCT00467649|10546605|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
3071021|NCT00467649|10546606|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
3071022|NCT00467649|10546607|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
3071023|NCT00467649|10546608|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
3071024|NCT00467649|10546609|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
3071025|NCT00467649|10546604|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
3071026|NCT00467649|10546605|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
3071027|NCT00467649|10546606|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
3071028|NCT00467649|10546607|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
3071029|NCT00467649|10546608|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
3071030|NCT00467649|10546609|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
3071031|NCT00467649|10546604|P6|Phase 1 (Randomized Population)|Investigator Decision|0
3071032|NCT00467649|10546605|P5|Phase 1 (Randomized Population)|Investigator Decision|0
3071033|NCT00467649|10546606|P4|Phase 1 (Randomized Population)|Investigator Decision|0
3071034|NCT00467649|10546607|P3|Phase 1 (Randomized Population)|Investigator Decision|0
3071035|NCT00467649|10546608|P2|Phase 1 (Randomized Population)|Investigator Decision|0
3071036|NCT00467649|10546609|P1|Phase 1 (Randomized Population)|Investigator Decision|1
3071037|NCT00467649|10546604|P6|Phase 1 (Randomized Population)|Adverse Event|0
3071038|NCT00467649|10546605|P5|Phase 1 (Randomized Population)|Adverse Event|0
3071039|NCT00467649|10546606|P4|Phase 1 (Randomized Population)|Adverse Event|0
3071040|NCT00467649|10546607|P3|Phase 1 (Randomized Population)|Adverse Event|0
3071041|NCT00467649|10546608|P2|Phase 1 (Randomized Population)|Adverse Event|0
3071042|NCT00467649|10546609|P1|Phase 1 (Randomized Population)|Adverse Event|2
3071043|NCT00467610|10546649|P1|Overall Study|Withdrawal by Subject|1
3071044|NCT00467597|10546660|P2|Overall Study|Withdrawal by Subject|0
3071045|NCT00467597|10546661|P1|Overall Study|Withdrawal by Subject|2
3071046|NCT00467584|10546674|P3|Overall Study|Withdrawal by Subject|1
3071047|NCT00467584|10546675|P2|Overall Study|Withdrawal by Subject|5
3071048|NCT00467584|10546676|P1|Overall Study|Withdrawal by Subject|4
3071049|NCT00467558|10546686|P2|Overall Study|Lost to Follow-up|0
3071050|NCT00467558|10546687|P1|Overall Study|Lost to Follow-up|2
3071051|NCT00467519|10546697|P2|Overall Study|Withdrawal by Subject|10
3071052|NCT00467519|10546698|P1|Overall Study|Withdrawal by Subject|4
3071053|NCT00467519|10546697|P2|Overall Study|Lost to Follow-up|9
3071054|NCT00467519|10546698|P1|Overall Study|Lost to Follow-up|2
3071055|NCT00467519|10546697|P2|Overall Study|Protocol Violation|4
3071056|NCT00467519|10546698|P1|Overall Study|Protocol Violation|8
3071057|NCT00467363|10546727|P2|Overall Study|Lost to Follow-up|70
3071058|NCT00467363|10546728|P1|Overall Study|Lost to Follow-up|80
3071059|NCT00467285|10546775|P2|Overall Study|Lost to Follow-up|4
3071060|NCT00467285|10546776|P1|Overall Study|Lost to Follow-up|4
3071061|NCT00467259|10546796|P2|Overall Study|Site Closed|1
3071062|NCT00467259|10546797|P1|Overall Study|Site Closed|2
3071063|NCT00467259|10546796|P2|Overall Study|Lost to Follow-up|34
3071064|NCT00467259|10546797|P1|Overall Study|Lost to Follow-up|14
3071065|NCT00467259|10546796|P2|Overall Study|Physician Decision|2
3071066|NCT00467259|10546797|P1|Overall Study|Physician Decision|0
3071067|NCT00467259|10546796|P2|Overall Study|Withdrawal by Subject|108
3071068|NCT00467259|10546797|P1|Overall Study|Withdrawal by Subject|34
3071069|NCT00467259|10546796|P2|Overall Study|Protocol Violation|7
3071070|NCT00467259|10546797|P1|Overall Study|Protocol Violation|1
3071071|NCT00467259|10546796|P2|Overall Study|Adverse Event|90
3071072|NCT00467259|10546797|P1|Overall Study|Adverse Event|24
3071073|NCT00467051|10546814|P1|Overall Study|Adverse Event|2
3071074|NCT00466947|10546841|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
3071075|NCT00466947|10546842|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
3071076|NCT00466947|10546841|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
3071077|NCT00466947|10546842|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
3071078|NCT00466947|10546841|P2|Study End Analysis Period|Other – Forbidden vaccination|10
3071079|NCT00466947|10546842|P1|Study End Analysis Period|Other – Forbidden vaccination|21
3071080|NCT00466947|10546841|P2|Study End Analysis Period|Withdrawal by Subject|1267
3071081|NCT00466947|10546842|P1|Study End Analysis Period|Withdrawal by Subject|1264
3071082|NCT00466947|10546841|P2|Study End Analysis Period|Protocol Violation|17
3071083|NCT00466947|10546842|P1|Study End Analysis Period|Protocol Violation|9
3071084|NCT00466947|10546841|P2|Study End Analysis Period|Physician Decision|29
3071085|NCT00466947|10546842|P1|Study End Analysis Period|Physician Decision|29
3071086|NCT00466947|10546841|P2|Study End Analysis Period|Lost to Follow-up|1167
3071087|NCT00466947|10546842|P1|Study End Analysis Period|Lost to Follow-up|1137
3071088|NCT00466947|10546841|P2|Study End Analysis Period|Adverse Event|43
3071089|NCT00466947|10546842|P1|Study End Analysis Period|Adverse Event|35
3071090|NCT00466947|10546841|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
3071091|NCT00466947|10546842|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
3071092|NCT00466726|10547033|P1|Overall Study|Not evaluable for response|14
3071093|NCT00466687|10547039|P1|Overall Study|Disease progression|29
3071094|NCT00466687|10547039|P1|Overall Study|Withdrawal by Subject|1
3071095|NCT00466687|10547039|P1|Overall Study|Other complicating illness|3
3071096|NCT00466687|10547039|P1|Overall Study|Adverse Event|1
3071097|NCT00466505|10547071|P1|Overall Study|Adverse Event|4
3071098|NCT00466505|10547071|P1|Overall Study|disease progression|13
3071099|NCT00466193|10547121|P2|Overall Study|Patient refused Visit 4 procedures|0
3071100|NCT00466193|10547122|P1|Overall Study|Patient refused Visit 4 procedures|1
3071101|NCT00466193|10547121|P2|Overall Study|Withdrawal by Subject|2
3071102|NCT00466193|10547122|P1|Overall Study|Withdrawal by Subject|7
3071103|NCT00466193|10547121|P2|Overall Study|Protocol Violation|1
3071104|NCT00466193|10547122|P1|Overall Study|Protocol Violation|1
3071105|NCT00466193|10547121|P2|Overall Study|Physician Decision|0
3071106|NCT00466193|10547122|P1|Overall Study|Physician Decision|1
3071107|NCT00466193|10547121|P2|Overall Study|Lost to Follow-up|4
3071108|NCT00466193|10547122|P1|Overall Study|Lost to Follow-up|2
3071109|NCT00466193|10547121|P2|Overall Study|Adverse Event|1
3071110|NCT00466193|10547122|P1|Overall Study|Adverse Event|0
3071111|NCT00466167|10547149|P3|Overall Study|Not treated|0
3071112|NCT00466167|10547150|P2|Overall Study|Not treated|0
3071113|NCT00466167|10547151|P1|Overall Study|Not treated|1
3071114|NCT00466167|10547149|P3|Overall Study|patient did not meet inclusion criteria|1
3071115|NCT00466167|10547150|P2|Overall Study|patient did not meet inclusion criteria|0
3071116|NCT00466167|10547151|P1|Overall Study|patient did not meet inclusion criteria|1
3071117|NCT00466167|10547149|P3|Overall Study|Withdrawal by Subject|6
3071118|NCT00466167|10547150|P2|Overall Study|Withdrawal by Subject|1
3071119|NCT00466167|10547151|P1|Overall Study|Withdrawal by Subject|4
3071120|NCT00466167|10547149|P3|Overall Study|Lost to Follow-up|2
3071121|NCT00466167|10547150|P2|Overall Study|Lost to Follow-up|2
3071122|NCT00466167|10547151|P1|Overall Study|Lost to Follow-up|3
3071123|NCT00466167|10547149|P3|Overall Study|Protocol Violation|2
3071124|NCT00466167|10547150|P2|Overall Study|Protocol Violation|1
3071125|NCT00466167|10547151|P1|Overall Study|Protocol Violation|1
3071126|NCT00466167|10547149|P3|Overall Study|Lack of Efficacy|3
3071127|NCT00466167|10547150|P2|Overall Study|Lack of Efficacy|0
3071128|NCT00466167|10547151|P1|Overall Study|Lack of Efficacy|2
3071129|NCT00466167|10547149|P3|Overall Study|Adverse Event|7
3071130|NCT00466167|10547150|P2|Overall Study|Adverse Event|8
3071131|NCT00466167|10547151|P1|Overall Study|Adverse Event|8
3071132|NCT00465985|10547212|P2|Part III - Open-label Treatment Period|Adverse Event|0
3071133|NCT00465985|10547213|P1|Part III - Open-label Treatment Period|Adverse Event|1
3071134|NCT00465985|10547212|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
3071135|NCT00465985|10547213|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
3071136|NCT00465985|10547212|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
3071137|NCT00465985|10547213|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
3071138|NCT00465985|10547212|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
3071139|NCT00465985|10547213|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
3071140|NCT00465972|10547236|P2|Overall Study|Withdrawal by Subject|1
3071141|NCT00465972|10547237|P1|Overall Study|Withdrawal by Subject|2
3071142|NCT00465894|10547247|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
3071143|NCT00465894|10547248|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
3071144|NCT00465894|10547247|P2|Treatment For 12 Weeks|Family Issues|1
3071145|NCT00465894|10547248|P1|Treatment For 12 Weeks|Family Issues|1
3071146|NCT00465894|10547247|P2|Treatment For 12 Weeks|Lost to Follow-up|1
3071147|NCT00465894|10547248|P1|Treatment For 12 Weeks|Lost to Follow-up|4
3071148|NCT00465816|10547281|P3|Overall Study|Lost to Follow-up|2
3071149|NCT00465816|10547282|P2|Overall Study|Lost to Follow-up|0
3071150|NCT00465816|10547283|P1|Overall Study|Lost to Follow-up|0
3071151|NCT00465738|10547346|P2|Overall Study|Other|5
3071152|NCT00465738|10547347|P1|Overall Study|Other|2
3071153|NCT00465738|10547346|P2|Overall Study|Withdrawal by Subject|0
3071154|NCT00465738|10547347|P1|Overall Study|Withdrawal by Subject|2
3071155|NCT00465738|10547346|P2|Overall Study|Adverse Event|1
3071156|NCT00465738|10547347|P1|Overall Study|Adverse Event|0
3071157|NCT00465738|10547346|P2|Overall Study|Lost to Follow-up|0
3071158|NCT00465738|10547347|P1|Overall Study|Lost to Follow-up|2
3071159|NCT00465647|10547441|P4|Overall Study|"The other reasons included loss of IV"|2
3071160|NCT00465647|10547442|P3|Overall Study|"The other reasons included loss of IV"|3
3071161|NCT00465647|10547443|P2|Overall Study|"The other reasons included loss of IV"|4
3071162|NCT00465647|10547444|P1|Overall Study|"The other reasons included loss of IV"|8
3071163|NCT00465647|10547441|P4|Overall Study|Withdrawal by Subject|7
3071164|NCT00465647|10547442|P3|Overall Study|Withdrawal by Subject|2
3071165|NCT00465647|10547443|P2|Overall Study|Withdrawal by Subject|2
3071166|NCT00465647|10547444|P1|Overall Study|Withdrawal by Subject|1
3071167|NCT00465647|10547441|P4|Overall Study|Adverse Event|2
3071168|NCT00465647|10547442|P3|Overall Study|Adverse Event|3
3071169|NCT00465647|10547443|P2|Overall Study|Adverse Event|0
3071170|NCT00465647|10547444|P1|Overall Study|Adverse Event|2
3071171|NCT00465647|10547441|P4|Overall Study|Administrative|2
3071172|NCT00465647|10547442|P3|Overall Study|Administrative|3
3071173|NCT00465647|10547443|P2|Overall Study|Administrative|2
3071174|NCT00465647|10547444|P1|Overall Study|Administrative|2
3071175|NCT00465569|10547492|P2|Overall Study|persistent eczema during dose escalation|0
3071176|NCT00465569|10547493|P1|Overall Study|persistent eczema during dose escalation|1
3071177|NCT00465361|10547516|P1|Baseline Assessment|Personal Issues/Scheduling|4
3071178|NCT00465270|10547522|P2|Overall Study|Investigator request|4
3071179|NCT00465270|10547523|P1|Overall Study|Investigator request|3
3071180|NCT00465270|10547522|P2|Overall Study|Lost to Follow-up|67
3071181|NCT00465270|10547523|P1|Overall Study|Lost to Follow-up|60
3071182|NCT00465270|10547522|P2|Overall Study|Withdrawal by Subject|78
3071183|NCT00465270|10547523|P1|Overall Study|Withdrawal by Subject|34
3071184|NCT00465270|10547522|P2|Overall Study|Death|11
3071185|NCT00465270|10547523|P1|Overall Study|Death|7
3071186|NCT00465179|10547532|P1|Overall Study|Progression of Disease|47
3071187|NCT00465179|10547532|P1|Overall Study|Withdrawal by Subject|2
3071188|NCT00465179|10547532|P1|Overall Study|Adverse Event|4
3071189|NCT00465101|10547538|P1|Overall Study|Withdrew consent prior to procedure|3
3071190|NCT00465101|10547538|P1|Overall Study|Physician Decision|1
3071191|NCT00465101|10547538|P1|Overall Study|Withdrawal by Subject|25
3071192|NCT00465101|10547538|P1|Overall Study|Death|3
3071193|NCT00465101|10547538|P1|Overall Study|Unable to obtain IRB approval|1
3071194|NCT00465101|10547538|P1|Overall Study|Site closed due to IRB expiration|1
3071195|NCT00465101|10547538|P1|Overall Study|Patient postponed procedure|1
3071196|NCT00465101|10547538|P1|Overall Study|Pt. Insurance not accepted at center|2
3071197|NCT00465101|10547538|P1|Overall Study|Other|6
3071198|NCT00465101|10547538|P1|Overall Study|Lost to Follow-up|5
3071199|NCT00465101|10547538|P1|Overall Study|Did not meet study criteria|4
3071200|NCT00465101|10547538|P1|Overall Study|Change in health precluded follow up|4
3071201|NCT00465101|10547538|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
3071202|NCT00464945|10547608|P2|Toddler Dose|Lost to Follow-up|1
3071203|NCT00464945|10547609|P1|Toddler Dose|Lost to Follow-up|0
3071204|NCT00464945|10547608|P2|After Infant Series|Withdrawal by Subject|2
3071205|NCT00464945|10547609|P1|After Infant Series|Withdrawal by Subject|0
3071206|NCT00464945|10547608|P2|Infant Series|Lost to Follow-up|0
3071207|NCT00464945|10547609|P1|Infant Series|Lost to Follow-up|1
3071208|NCT00464945|10547608|P2|Infant Series|Protocol Violation|0
3071209|NCT00464945|10547609|P1|Infant Series|Protocol Violation|1
3071210|NCT00464945|10547608|P2|Infant Series|Withdrawal by parent/guardian request|1
3071211|NCT00464945|10547609|P1|Infant Series|Withdrawal by parent/guardian request|2
3071212|NCT00464815|10547639|P2|Overall Study|Withdrawal by Subject|3
3071213|NCT00464815|10547640|P1|Overall Study|Withdrawal by Subject|6
3071214|NCT00464737|10547673|P3|Overall Study|Other: Subject's disability per sponsor|1
3071215|NCT00464737|10547674|P2|Overall Study|Other: Subject's disability per sponsor|0
3071216|NCT00464737|10547675|P1|Overall Study|Other: Subject's disability per sponsor|0
3071217|NCT00464737|10547673|P3|Overall Study|Other: Personal family reasons|1
3071218|NCT00464737|10547674|P2|Overall Study|Other: Personal family reasons|0
3071219|NCT00464737|10547675|P1|Overall Study|Other: Personal family reasons|0
3071220|NCT00464737|10547673|P3|Overall Study|Other: Study demands too great|0
3071221|NCT00464737|10547674|P2|Overall Study|Other: Study demands too great|1
3071222|NCT00464737|10547675|P1|Overall Study|Other: Study demands too great|0
3071223|NCT00464737|10547673|P3|Overall Study|Other: Subject left town; family illness|0
3071224|NCT00464737|10547674|P2|Overall Study|Other: Subject left town; family illness|0
3071225|NCT00464737|10547675|P1|Overall Study|Other: Subject left town; family illness|1
3071226|NCT00464737|10547673|P3|Overall Study|Other: Subject's schedule doesn't permit|0
3071227|NCT00464737|10547674|P2|Overall Study|Other: Subject's schedule doesn't permit|0
3071228|NCT00464737|10547675|P1|Overall Study|Other: Subject's schedule doesn't permit|1
3071229|NCT00464737|10547673|P3|Overall Study|Lost to Follow-up|5
3071230|NCT00464737|10547674|P2|Overall Study|Lost to Follow-up|2
3071231|NCT00464737|10547675|P1|Overall Study|Lost to Follow-up|5
3071232|NCT00464737|10547673|P3|Overall Study|Non-compliance|1
3071233|NCT00464737|10547674|P2|Overall Study|Non-compliance|1
3071234|NCT00464737|10547675|P1|Overall Study|Non-compliance|0
3071235|NCT00464737|10547673|P3|Overall Study|Protocol Violation|5
3071236|NCT00464737|10547674|P2|Overall Study|Protocol Violation|1
3071237|NCT00464737|10547675|P1|Overall Study|Protocol Violation|1
3071238|NCT00464737|10547673|P3|Overall Study|Withdrawal by Subject|5
3071239|NCT00464737|10547674|P2|Overall Study|Withdrawal by Subject|3
3071240|NCT00464737|10547675|P1|Overall Study|Withdrawal by Subject|5
3071241|NCT00464737|10547673|P3|Overall Study|Lack of Efficacy|4
3071242|NCT00464737|10547674|P2|Overall Study|Lack of Efficacy|7
3071243|NCT00464737|10547675|P1|Overall Study|Lack of Efficacy|7
3071244|NCT00464737|10547673|P3|Overall Study|Adverse Event|33
3071245|NCT00464737|10547674|P2|Overall Study|Adverse Event|17
3071246|NCT00464737|10547675|P1|Overall Study|Adverse Event|12
3071247|NCT00464672|10547755|P6|Overall Study|Lost to Follow-up|0
3071248|NCT00464672|10547756|P5|Overall Study|Lost to Follow-up|1
3071249|NCT00464672|10547757|P4|Overall Study|Lost to Follow-up|0
3071250|NCT00464672|10547758|P3|Overall Study|Lost to Follow-up|0
3071251|NCT00464672|10547759|P2|Overall Study|Lost to Follow-up|10
3071252|NCT00464672|10547760|P1|Overall Study|Lost to Follow-up|25
3071253|NCT00464672|10547755|P6|Overall Study|withdrawal of consent|4
3071254|NCT00464672|10547756|P5|Overall Study|withdrawal of consent|9
3071255|NCT00464672|10547757|P4|Overall Study|withdrawal of consent|1
3071256|NCT00464672|10547758|P3|Overall Study|withdrawal of consent|0
3071257|NCT00464672|10547759|P2|Overall Study|withdrawal of consent|0
3071258|NCT00464672|10547760|P1|Overall Study|withdrawal of consent|0
3071259|NCT00464620|10547839|P3|Overall Study|Use of prohibited concomitant medication|2
3071260|NCT00464620|10547840|P2|Overall Study|Use of prohibited concomitant medication|0
3071261|NCT00464620|10547841|P1|Overall Study|Use of prohibited concomitant medication|0
3071262|NCT00464620|10547839|P3|Overall Study|Ineligible sarcoma subtype|2
3071263|NCT00464620|10547840|P2|Overall Study|Ineligible sarcoma subtype|2
3071264|NCT00464620|10547841|P1|Overall Study|Ineligible sarcoma subtype|0
3071265|NCT00464620|10547839|P3|Overall Study|Withdrawal by Subject|3
3071266|NCT00464620|10547840|P2|Overall Study|Withdrawal by Subject|0
3071267|NCT00464620|10547841|P1|Overall Study|Withdrawal by Subject|1
3071268|NCT00464620|10547839|P3|Overall Study|Physician Decision|0
3071269|NCT00464620|10547840|P2|Overall Study|Physician Decision|0
3071270|NCT00464620|10547841|P1|Overall Study|Physician Decision|1
3071271|NCT00464568|10547868|P1|Overall Study|Adverse Event|2
3071272|NCT00464542|10547941|P1|Pre-treatment|Withdrawal by Subject|2
3071273|NCT00464490|10547948|P2|Overall Study|Physician Decision|11
3071274|NCT00464490|10547949|P1|Overall Study|Physician Decision|11
3071275|NCT00464334|10547996|P11|Overall Study|Withdrawal by Subject|0
3071276|NCT00464334|10547997|P10|Overall Study|Withdrawal by Subject|0
3071277|NCT00464334|10547998|P9|Overall Study|Withdrawal by Subject|3
3071278|NCT00464334|10547999|P8|Overall Study|Withdrawal by Subject|1
3071279|NCT00464334|10548000|P7|Overall Study|Withdrawal by Subject|2
3071280|NCT00464334|10548001|P6|Overall Study|Withdrawal by Subject|2
3071281|NCT00464334|10548002|P5|Overall Study|Withdrawal by Subject|2
3071282|NCT00464334|10548003|P4|Overall Study|Withdrawal by Subject|2
3071283|NCT00464334|10548004|P3|Overall Study|Withdrawal by Subject|4
3071284|NCT00464334|10548005|P2|Overall Study|Withdrawal by Subject|7
3071285|NCT00464334|10548006|P1|Overall Study|Withdrawal by Subject|1
3071286|NCT00464334|10547996|P11|Overall Study|Study Terminated by Sponsor|0
3071287|NCT00464334|10547997|P10|Overall Study|Study Terminated by Sponsor|0
3071288|NCT00464334|10547998|P9|Overall Study|Study Terminated by Sponsor|0
3071289|NCT00464334|10547999|P8|Overall Study|Study Terminated by Sponsor|0
3071290|NCT00464334|10548000|P7|Overall Study|Study Terminated by Sponsor|0
3071291|NCT00464334|10548001|P6|Overall Study|Study Terminated by Sponsor|0
3071292|NCT00464334|10548002|P5|Overall Study|Study Terminated by Sponsor|0
3071293|NCT00464334|10548003|P4|Overall Study|Study Terminated by Sponsor|1
3071294|NCT00464334|10548004|P3|Overall Study|Study Terminated by Sponsor|0
3071295|NCT00464334|10548005|P2|Overall Study|Study Terminated by Sponsor|0
3071296|NCT00464334|10548006|P1|Overall Study|Study Terminated by Sponsor|0
3071297|NCT00464334|10547996|P11|Overall Study|Progressive Disease|0
3071298|NCT00464334|10547997|P10|Overall Study|Progressive Disease|0
3071299|NCT00464334|10547998|P9|Overall Study|Progressive Disease|1
3071300|NCT00464334|10547999|P8|Overall Study|Progressive Disease|0
3071301|NCT00464334|10548000|P7|Overall Study|Progressive Disease|0
3071302|NCT00464334|10548001|P6|Overall Study|Progressive Disease|1
3071303|NCT00464334|10548002|P5|Overall Study|Progressive Disease|0
3071304|NCT00464334|10548003|P4|Overall Study|Progressive Disease|0
3071305|NCT00464334|10548004|P3|Overall Study|Progressive Disease|0
3071306|NCT00464334|10548005|P2|Overall Study|Progressive Disease|0
3071307|NCT00464334|10548006|P1|Overall Study|Progressive Disease|0
3071308|NCT00464334|10547996|P11|Overall Study|Lost to Follow-up|2
3071309|NCT00464334|10547997|P10|Overall Study|Lost to Follow-up|0
3071310|NCT00464334|10547998|P9|Overall Study|Lost to Follow-up|0
3071311|NCT00464334|10547999|P8|Overall Study|Lost to Follow-up|0
3071312|NCT00464334|10548000|P7|Overall Study|Lost to Follow-up|1
3071313|NCT00464334|10548001|P6|Overall Study|Lost to Follow-up|0
3071314|NCT00464334|10548002|P5|Overall Study|Lost to Follow-up|1
3071315|NCT00464334|10548003|P4|Overall Study|Lost to Follow-up|0
3071316|NCT00464334|10548004|P3|Overall Study|Lost to Follow-up|1
3071317|NCT00464334|10548005|P2|Overall Study|Lost to Follow-up|0
3071318|NCT00464334|10548006|P1|Overall Study|Lost to Follow-up|0
3071319|NCT00464334|10547996|P11|Overall Study|Lack of Efficacy|0
3071320|NCT00464334|10547997|P10|Overall Study|Lack of Efficacy|0
3071321|NCT00464334|10547998|P9|Overall Study|Lack of Efficacy|0
3071322|NCT00464334|10547999|P8|Overall Study|Lack of Efficacy|0
3071323|NCT00464334|10548000|P7|Overall Study|Lack of Efficacy|0
3071324|NCT00464334|10548001|P6|Overall Study|Lack of Efficacy|0
3071325|NCT00464334|10548002|P5|Overall Study|Lack of Efficacy|0
3071326|NCT00464334|10548003|P4|Overall Study|Lack of Efficacy|0
3071327|NCT00464334|10548004|P3|Overall Study|Lack of Efficacy|0
3071328|NCT00464334|10548005|P2|Overall Study|Lack of Efficacy|1
3071329|NCT00464334|10548006|P1|Overall Study|Lack of Efficacy|0
3071330|NCT00464334|10547996|P11|Overall Study|Adverse Event|2
3071331|NCT00464334|10547997|P10|Overall Study|Adverse Event|1
3071332|NCT00464334|10547998|P9|Overall Study|Adverse Event|2
3071333|NCT00464334|10547999|P8|Overall Study|Adverse Event|0
3071334|NCT00464334|10548000|P7|Overall Study|Adverse Event|0
3071335|NCT00464334|10548001|P6|Overall Study|Adverse Event|1
3071336|NCT00464334|10548002|P5|Overall Study|Adverse Event|1
3071337|NCT00464334|10548003|P4|Overall Study|Adverse Event|1
3071338|NCT00464334|10548004|P3|Overall Study|Adverse Event|0
3071339|NCT00464334|10548005|P2|Overall Study|Adverse Event|0
3071340|NCT00464334|10548006|P1|Overall Study|Adverse Event|0
3071341|NCT00464308|10548066|P3|Overall Study|Physician Decision|0
3071342|NCT00464308|10548067|P2|Overall Study|Physician Decision|0
3071343|NCT00464308|10548068|P1|Overall Study|Physician Decision|1
3071344|NCT00464308|10548066|P3|Overall Study|Patient discontinued and other reasons|23
3071345|NCT00464308|10548067|P2|Overall Study|Patient discontinued and other reasons|17
3071346|NCT00464308|10548068|P1|Overall Study|Patient discontinued and other reasons|17
3071347|NCT00464308|10548066|P3|Overall Study|Lost to Follow-up|20
3071348|NCT00464308|10548067|P2|Overall Study|Lost to Follow-up|19
3071349|NCT00464308|10548068|P1|Overall Study|Lost to Follow-up|29
3071350|NCT00464308|10548066|P3|Overall Study|Adverse Event|16
3071351|NCT00464308|10548067|P2|Overall Study|Adverse Event|27
3071352|NCT00464308|10548068|P1|Overall Study|Adverse Event|22
3071353|NCT00464269|10548098|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
3071354|NCT00464269|10548099|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
3071355|NCT00464269|10548100|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
3071356|NCT00464269|10548101|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
3071357|NCT00464269|10548098|P4|Overall Study|AE, non-serious non-fatal|4
3071358|NCT00464269|10548099|P3|Overall Study|AE, non-serious non-fatal|3
3071359|NCT00464269|10548100|P2|Overall Study|AE, non-serious non-fatal|8
3071360|NCT00464269|10548101|P1|Overall Study|AE, non-serious non-fatal|2
3071361|NCT00464269|10548098|P4|Overall Study|SAE, non-fatal|1
3071362|NCT00464269|10548099|P3|Overall Study|SAE, non-fatal|0
3071363|NCT00464269|10548100|P2|Overall Study|SAE, non-fatal|0
3071364|NCT00464269|10548101|P1|Overall Study|SAE, non-fatal|0
3071365|NCT00464269|10548098|P4|Overall Study|AE, serious fatal|1
3071366|NCT00464269|10548099|P3|Overall Study|AE, serious fatal|1
3071367|NCT00464269|10548100|P2|Overall Study|AE, serious fatal|0
3071368|NCT00464269|10548101|P1|Overall Study|AE, serious fatal|0
3071369|NCT00464269|10548098|P4|Overall Study|Other reason|1
3071370|NCT00464269|10548099|P3|Overall Study|Other reason|1
3071371|NCT00464269|10548100|P2|Overall Study|Other reason|3
3071372|NCT00464269|10548101|P1|Overall Study|Other reason|3
3071373|NCT00464269|10548098|P4|Overall Study|Withdrawal by Subject|1
3071374|NCT00464269|10548099|P3|Overall Study|Withdrawal by Subject|1
3071375|NCT00464269|10548100|P2|Overall Study|Withdrawal by Subject|2
3071376|NCT00464269|10548101|P1|Overall Study|Withdrawal by Subject|0
3071377|NCT00464269|10548098|P4|Overall Study|Lost to Follow-up|1
3071378|NCT00464269|10548099|P3|Overall Study|Lost to Follow-up|0
3071379|NCT00464269|10548100|P2|Overall Study|Lost to Follow-up|4
3071380|NCT00464269|10548101|P1|Overall Study|Lost to Follow-up|0
3071381|NCT00464269|10548098|P4|Overall Study|Lack of Efficacy|0
3071382|NCT00464269|10548099|P3|Overall Study|Lack of Efficacy|0
3071383|NCT00464269|10548100|P2|Overall Study|Lack of Efficacy|0
3071384|NCT00464269|10548101|P1|Overall Study|Lack of Efficacy|1
3071385|NCT00464087|10548239|P3|Overall Study|No PCI per inclusion criteria|29
3071386|NCT00464087|10548240|P2|Overall Study|No PCI per inclusion criteria|0
3071387|NCT00464087|10548241|P1|Overall Study|No PCI per inclusion criteria|0
3071388|NCT00463866|10548259|P2|Overall Study|Other|22
3071389|NCT00463866|10548260|P1|Overall Study|Other|22
3071390|NCT00463866|10548259|P2|Overall Study|Mis-Randomization of subject|1
3071391|NCT00463866|10548260|P1|Overall Study|Mis-Randomization of subject|0
3071392|NCT00463866|10548259|P2|Overall Study|Safety Reason|3
3071393|NCT00463866|10548260|P1|Overall Study|Safety Reason|1
3071394|NCT00463866|10548259|P2|Overall Study|Severe Non-Compliance to Protocol|21
3071395|NCT00463866|10548260|P1|Overall Study|Severe Non-Compliance to Protocol|25
3071396|NCT00463866|10548259|P2|Overall Study|Incorrect Enrolment|66
3071397|NCT00463866|10548260|P1|Overall Study|Incorrect Enrolment|64
3071398|NCT00463866|10548259|P2|Overall Study|Lost to Follow-up|55
3071399|NCT00463866|10548260|P1|Overall Study|Lost to Follow-up|46
3071400|NCT00463866|10548259|P2|Overall Study|Withdrawal by Subject|79
3071401|NCT00463866|10548260|P1|Overall Study|Withdrawal by Subject|81
3071402|NCT00463866|10548259|P2|Overall Study|Adverse Event|93
3071403|NCT00463866|10548260|P1|Overall Study|Adverse Event|70
3071404|NCT00463840|10548280|P1|Overall Study|Adverse Event|3
3071405|NCT00463840|10548280|P1|Overall Study|Withdrawal by Subject|2
3071406|NCT00463840|10548280|P1|Overall Study|Disease progression|7
3071407|NCT00463801|10548285|P1|Overall Study|No longer require therapy|1
3071408|NCT00463801|10548285|P1|Overall Study|Lost to Follow-up|5
3071409|NCT00463801|10548285|P1|Overall Study|Adverse Event|4
3071410|NCT00463801|10548285|P1|Overall Study|Lack of Efficacy|2
3071411|NCT00463801|10548285|P1|Overall Study|Protocol Violation|1
3071412|NCT00463788|10548291|P2|Overall Study|Randomized but not treated|1
3071413|NCT00463788|10548292|P1|Overall Study|Randomized but not treated|1
3071414|NCT00463788|10548291|P2|Overall Study|Other|0
3071415|NCT00463788|10548292|P1|Overall Study|Other|3
3071416|NCT00463788|10548291|P2|Overall Study|Protocol Violation|1
3071417|NCT00463788|10548292|P1|Overall Study|Protocol Violation|0
3071418|NCT00463788|10548291|P2|Overall Study|Lost to Follow-up|0
3071419|NCT00463788|10548292|P1|Overall Study|Lost to Follow-up|1
3071420|NCT00463788|10548291|P2|Overall Study|Symptomatic Deterioration|3
3071421|NCT00463788|10548292|P1|Overall Study|Symptomatic Deterioration|2
3071422|NCT00463788|10548291|P2|Overall Study|Death|3
3071423|NCT00463788|10548292|P1|Overall Study|Death|4
3071424|NCT00463788|10548291|P2|Overall Study|Withdrawal by Subject|2
3071425|NCT00463788|10548292|P1|Overall Study|Withdrawal by Subject|6
3071426|NCT00463788|10548291|P2|Overall Study|Adverse Event|2
3071427|NCT00463788|10548292|P1|Overall Study|Adverse Event|6
3071428|NCT00463788|10548291|P2|Overall Study|Progressive Disease|42
3071429|NCT00463788|10548292|P1|Overall Study|Progressive Disease|86
3071430|NCT00463684|10548307|P1|Overall Study|Lost to Follow-up|3
3071431|NCT00463684|10548307|P1|Overall Study|Withdrawal by Subject|1
3071432|NCT00463606|10548325|P3|Overall Study|Protocol Violation|1
3071433|NCT00463606|10548326|P2|Overall Study|Protocol Violation|0
3071434|NCT00463606|10548327|P1|Overall Study|Protocol Violation|0
3071435|NCT00463606|10548325|P3|Overall Study|Participation in another ABT-335 trial|0
3071436|NCT00463606|10548326|P2|Overall Study|Participation in another ABT-335 trial|0
3071437|NCT00463606|10548327|P1|Overall Study|Participation in another ABT-335 trial|1
3071438|NCT00463606|10548325|P3|Overall Study|Patient randomized in error|0
3071439|NCT00463606|10548326|P2|Overall Study|Patient randomized in error|0
3071440|NCT00463606|10548327|P1|Overall Study|Patient randomized in error|1
3071441|NCT00463606|10548325|P3|Overall Study|Coordinator error|0
3071442|NCT00463606|10548326|P2|Overall Study|Coordinator error|0
3071443|NCT00463606|10548327|P1|Overall Study|Coordinator error|1
3071444|NCT00463606|10548325|P3|Overall Study|Exclusion criteria violation|0
3071445|NCT00463606|10548326|P2|Overall Study|Exclusion criteria violation|0
3071446|NCT00463606|10548327|P1|Overall Study|Exclusion criteria violation|2
3071447|NCT00463606|10548325|P3|Overall Study|Sponsor request|0
3071448|NCT00463606|10548326|P2|Overall Study|Sponsor request|1
3071449|NCT00463606|10548327|P1|Overall Study|Sponsor request|0
3071450|NCT00463606|10548325|P3|Overall Study|Physician Decision|0
3071451|NCT00463606|10548326|P2|Overall Study|Physician Decision|1
3071452|NCT00463606|10548327|P1|Overall Study|Physician Decision|0
3071453|NCT00463606|10548325|P3|Overall Study|Subject moved out of town|0
3071454|NCT00463606|10548326|P2|Overall Study|Subject moved out of town|0
3071455|NCT00463606|10548327|P1|Overall Study|Subject moved out of town|1
3071456|NCT00463606|10548325|P3|Overall Study|Subject noncompliance|0
3071457|NCT00463606|10548326|P2|Overall Study|Subject noncompliance|1
3071458|NCT00463606|10548327|P1|Overall Study|Subject noncompliance|1
3071459|NCT00463606|10548325|P3|Overall Study|Lost to Follow-up|3
3071460|NCT00463606|10548326|P2|Overall Study|Lost to Follow-up|2
3071461|NCT00463606|10548327|P1|Overall Study|Lost to Follow-up|2
3071462|NCT00463606|10548325|P3|Overall Study|Withdrawal by Subject|5
3071463|NCT00463606|10548326|P2|Overall Study|Withdrawal by Subject|11
3071464|NCT00463606|10548327|P1|Overall Study|Withdrawal by Subject|11
3071465|NCT00463606|10548325|P3|Overall Study|Adverse Event|11
3071466|NCT00463606|10548326|P2|Overall Study|Adverse Event|18
3071467|NCT00463606|10548327|P1|Overall Study|Adverse Event|21
3071468|NCT00463580|10548352|P2|Overall Study|Medical/psychiatric complications|2
3071469|NCT00463580|10548353|P1|Overall Study|Medical/psychiatric complications|0
3071470|NCT00463580|10548352|P2|Overall Study|Schedule conflict|0
3071471|NCT00463580|10548353|P1|Overall Study|Schedule conflict|2
3071472|NCT00463580|10548352|P2|Overall Study|Lost to Follow-up|0
3071473|NCT00463580|10548353|P1|Overall Study|Lost to Follow-up|1
3071474|NCT00463567|10548386|P7|Overall Study|Death|0
3071475|NCT00463567|10548387|P6|Overall Study|Death|0
3071476|NCT00463567|10548388|P5|Overall Study|Death|0
3071477|NCT00463567|10548389|P4|Overall Study|Death|0
3071478|NCT00463567|10548390|P3|Overall Study|Death|2
3071479|NCT00463567|10548391|P2|Overall Study|Death|0
3071480|NCT00463567|10548392|P1|Overall Study|Death|1
3071481|NCT00463567|10548386|P7|Overall Study|Abnormal test procedure result(s)|0
3071482|NCT00463567|10548387|P6|Overall Study|Abnormal test procedure result(s)|2
3071483|NCT00463567|10548388|P5|Overall Study|Abnormal test procedure result(s)|0
3071484|NCT00463567|10548389|P4|Overall Study|Abnormal test procedure result(s)|2
3071485|NCT00463567|10548390|P3|Overall Study|Abnormal test procedure result(s)|6
3071486|NCT00463567|10548391|P2|Overall Study|Abnormal test procedure result(s)|1
3071487|NCT00463567|10548392|P1|Overall Study|Abnormal test procedure result(s)|1
3071488|NCT00463567|10548386|P7|Overall Study|Abnormal lab value(s)|0
3071489|NCT00463567|10548387|P6|Overall Study|Abnormal lab value(s)|0
3071490|NCT00463567|10548388|P5|Overall Study|Abnormal lab value(s)|1
3071491|NCT00463567|10548389|P4|Overall Study|Abnormal lab value(s)|1
3071492|NCT00463567|10548390|P3|Overall Study|Abnormal lab value(s)|2
3071493|NCT00463567|10548391|P2|Overall Study|Abnormal lab value(s)|1
3071494|NCT00463567|10548392|P1|Overall Study|Abnormal lab value(s)|1
3071495|NCT00463567|10548386|P7|Overall Study|Lack of Efficacy|1
3071496|NCT00463567|10548387|P6|Overall Study|Lack of Efficacy|0
3071497|NCT00463567|10548388|P5|Overall Study|Lack of Efficacy|1
3071498|NCT00463567|10548389|P4|Overall Study|Lack of Efficacy|17
3071499|NCT00463567|10548390|P3|Overall Study|Lack of Efficacy|9
3071500|NCT00463567|10548391|P2|Overall Study|Lack of Efficacy|9
3071501|NCT00463567|10548392|P1|Overall Study|Lack of Efficacy|4
3071502|NCT00463567|10548386|P7|Overall Study|Administrative problems|2
3071503|NCT00463567|10548387|P6|Overall Study|Administrative problems|2
3071504|NCT00463567|10548388|P5|Overall Study|Administrative problems|3
3071505|NCT00463567|10548389|P4|Overall Study|Administrative problems|9
3071506|NCT00463567|10548390|P3|Overall Study|Administrative problems|6
3071507|NCT00463567|10548391|P2|Overall Study|Administrative problems|3
3071508|NCT00463567|10548392|P1|Overall Study|Administrative problems|5
3071509|NCT00463567|10548386|P7|Overall Study|Lost to Follow-up|1
3071510|NCT00463567|10548387|P6|Overall Study|Lost to Follow-up|1
3071511|NCT00463567|10548388|P5|Overall Study|Lost to Follow-up|1
3071512|NCT00463567|10548389|P4|Overall Study|Lost to Follow-up|8
3071513|NCT00463567|10548390|P3|Overall Study|Lost to Follow-up|13
3071514|NCT00463567|10548391|P2|Overall Study|Lost to Follow-up|6
3071515|NCT00463567|10548392|P1|Overall Study|Lost to Follow-up|12
3071516|NCT00463567|10548386|P7|Overall Study|Protocol Deviation|2
3071517|NCT00463567|10548387|P6|Overall Study|Protocol Deviation|1
3071518|NCT00463567|10548388|P5|Overall Study|Protocol Deviation|1
3071519|NCT00463567|10548389|P4|Overall Study|Protocol Deviation|11
3071520|NCT00463567|10548390|P3|Overall Study|Protocol Deviation|14
3071521|NCT00463567|10548391|P2|Overall Study|Protocol Deviation|9
3071522|NCT00463567|10548392|P1|Overall Study|Protocol Deviation|13
3071523|NCT00463567|10548386|P7|Overall Study|Withdrawal by Subject|1
3071524|NCT00463567|10548387|P6|Overall Study|Withdrawal by Subject|5
3071525|NCT00463567|10548388|P5|Overall Study|Withdrawal by Subject|6
3071526|NCT00463567|10548389|P4|Overall Study|Withdrawal by Subject|37
3071527|NCT00463567|10548390|P3|Overall Study|Withdrawal by Subject|20
3071528|NCT00463567|10548391|P2|Overall Study|Withdrawal by Subject|22
3071529|NCT00463567|10548392|P1|Overall Study|Withdrawal by Subject|29
3071530|NCT00463567|10548386|P7|Overall Study|Adverse Event|4
3071531|NCT00463567|10548387|P6|Overall Study|Adverse Event|10
3071532|NCT00463567|10548388|P5|Overall Study|Adverse Event|10
3071533|NCT00463567|10548389|P4|Overall Study|Adverse Event|46
3071534|NCT00463567|10548390|P3|Overall Study|Adverse Event|17
3071535|NCT00463567|10548391|P2|Overall Study|Adverse Event|26
3071536|NCT00463567|10548392|P1|Overall Study|Adverse Event|29
3071537|NCT00463476|10548425|P2|Overall Study|Lost to Follow-up|1
3071538|NCT00463476|10548426|P1|Overall Study|Lost to Follow-up|1
3071539|NCT00463476|10548425|P2|Overall Study|Withdrawal by Subject|2
3071540|NCT00463476|10548426|P1|Overall Study|Withdrawal by Subject|1
3071541|NCT00463385|10548515|P4|Overall Study|1 participant received commercial drug|0
3071542|NCT00463385|10548516|P3|Overall Study|1 participant received commercial drug|0
3071543|NCT00463385|10548517|P2|Overall Study|1 participant received commercial drug|1
3071544|NCT00463385|10548518|P1|Overall Study|1 participant received commercial drug|0
3071545|NCT00463385|10548515|P4|Overall Study|Missing|2
3071546|NCT00463385|10548516|P3|Overall Study|Missing|0
3071547|NCT00463385|10548517|P2|Overall Study|Missing|0
3071548|NCT00463385|10548518|P1|Overall Study|Missing|2
3071549|NCT00463385|10548515|P4|Overall Study|Death|0
3071550|NCT00463385|10548516|P3|Overall Study|Death|2
3071551|NCT00463385|10548517|P2|Overall Study|Death|1
3071552|NCT00463385|10548518|P1|Overall Study|Death|2
3071553|NCT00463385|10548515|P4|Overall Study|Lost to Follow-up|1
3071554|NCT00463385|10548516|P3|Overall Study|Lost to Follow-up|0
3071555|NCT00463385|10548517|P2|Overall Study|Lost to Follow-up|0
3071556|NCT00463385|10548518|P1|Overall Study|Lost to Follow-up|0
3071557|NCT00463385|10548515|P4|Overall Study|Withdrawal by Subject|4
3071558|NCT00463385|10548516|P3|Overall Study|Withdrawal by Subject|3
3071559|NCT00463385|10548517|P2|Overall Study|Withdrawal by Subject|3
3071560|NCT00463385|10548518|P1|Overall Study|Withdrawal by Subject|3
3071561|NCT00463385|10548515|P4|Overall Study|Lack of Efficacy|9
3071562|NCT00463385|10548516|P3|Overall Study|Lack of Efficacy|7
3071563|NCT00463385|10548517|P2|Overall Study|Lack of Efficacy|6
3071564|NCT00463385|10548518|P1|Overall Study|Lack of Efficacy|6
3071565|NCT00463385|10548515|P4|Overall Study|Adverse Event|2
3071566|NCT00463385|10548516|P3|Overall Study|Adverse Event|4
3071567|NCT00463385|10548517|P2|Overall Study|Adverse Event|8
3071568|NCT00463385|10548518|P1|Overall Study|Adverse Event|5
3071569|NCT00463385|10548515|P4|Overall Study|Other|4
3071570|NCT00463385|10548516|P3|Overall Study|Other|6
3071571|NCT00463385|10548517|P2|Overall Study|Other|3
3071572|NCT00463385|10548518|P1|Overall Study|Other|4
3071573|NCT00463346|10548570|P2|Overall Study|Withdrawal by Subject|3
3071574|NCT00463346|10548571|P1|Overall Study|Withdrawal by Subject|3
3071575|NCT00463229|10548581|P2|Overall Study|Death|3
3071576|NCT00463229|10548582|P1|Overall Study|Death|4
3071577|NCT00463229|10548581|P2|Overall Study|Lost to Follow-up|7
3071578|NCT00463229|10548582|P1|Overall Study|Lost to Follow-up|5
3071579|NCT00463060|10548602|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
3071580|NCT00463060|10548602|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
3071581|NCT00463047|10548616|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
3071582|NCT00463047|10548617|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
3071583|NCT00463047|10548616|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
3071584|NCT00463047|10548617|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
3071585|NCT00463047|10548616|P2|Double-Blind Treatment Period 2|Adverse Event|1
3071586|NCT00463047|10548617|P1|Double-Blind Treatment Period 2|Adverse Event|0
3071587|NCT00463047|10548616|P2|Double-Blind Treatment Period 1|Other|0
3071588|NCT00463047|10548617|P1|Double-Blind Treatment Period 1|Other|1
3071589|NCT00463047|10548616|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
3071590|NCT00463047|10548617|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
3071591|NCT00463047|10548616|P2|Double-Blind Treatment Period 1|Protocol Violation|2
3071592|NCT00463047|10548617|P1|Double-Blind Treatment Period 1|Protocol Violation|1
3071593|NCT00463047|10548616|P2|Double-Blind Treatment Period 1|Adverse Event|2
3071594|NCT00463047|10548617|P1|Double-Blind Treatment Period 1|Adverse Event|0
3071595|NCT00463047|10548616|P2|Titration Period 2|Other|2
3071596|NCT00463047|10548617|P1|Titration Period 2|Other|3
3071597|NCT00463047|10548616|P2|Titration Period 2|Non-compliance procedures|1
3071598|NCT00463047|10548617|P1|Titration Period 2|Non-compliance procedures|4
3071599|NCT00463047|10548616|P2|Titration Period 2|Non-compliance study medication|2
3071600|NCT00463047|10548617|P1|Titration Period 2|Non-compliance study medication|4
3071601|NCT00463047|10548616|P2|Titration Period 2|Lost to Follow-up|2
3071602|NCT00463047|10548617|P1|Titration Period 2|Lost to Follow-up|1
3071603|NCT00463047|10548616|P2|Titration Period 2|Protocol Violation|3
3071604|NCT00463047|10548617|P1|Titration Period 2|Protocol Violation|2
3071605|NCT00463047|10548616|P2|Titration Period 2|Withdrawal by Subject|0
3071606|NCT00463047|10548617|P1|Titration Period 2|Withdrawal by Subject|1
3071607|NCT00463047|10548616|P2|Titration Period 2|Lack of Efficacy|4
3071608|NCT00463047|10548617|P1|Titration Period 2|Lack of Efficacy|6
3071609|NCT00463047|10548616|P2|Titration Period 2|Adverse Event|9
3071610|NCT00463047|10548617|P1|Titration Period 2|Adverse Event|9
3071611|NCT00463047|10548616|P2|Titration Period 1|Other|2
3071612|NCT00463047|10548617|P1|Titration Period 1|Other|0
3071613|NCT00463047|10548616|P2|Titration Period 1|Non-compliance procedures|10
3071614|NCT00463047|10548617|P1|Titration Period 1|Non-compliance procedures|4
3071615|NCT00463047|10548616|P2|Titration Period 1|Withdrawal by Subject|5
3071616|NCT00463047|10548617|P1|Titration Period 1|Withdrawal by Subject|3
3071617|NCT00463047|10548616|P2|Titration Period 1|Protocol Violation|5
3071618|NCT00463047|10548617|P1|Titration Period 1|Protocol Violation|5
3071619|NCT00463047|10548616|P2|Titration Period 1|Non-compliance with study medication|5
3071620|NCT00463047|10548617|P1|Titration Period 1|Non-compliance with study medication|3
3071621|NCT00463047|10548616|P2|Titration Period 1|Lost to Follow-up|0
3071622|NCT00463047|10548617|P1|Titration Period 1|Lost to Follow-up|2
3071623|NCT00463047|10548616|P2|Titration Period 1|Lack of Efficacy|4
3071624|NCT00463047|10548617|P1|Titration Period 1|Lack of Efficacy|10
3071625|NCT00463047|10548616|P2|Titration Period 1|Adverse Event|8
3071626|NCT00463047|10548617|P1|Titration Period 1|Adverse Event|10
3071627|NCT00462982|10548702|P1|Overall Study|Patient Not Treated|2
3071628|NCT00462982|10548702|P1|Overall Study|Adverse Event|1
3071629|NCT00462943|10548709|P3|Overall Study|Withdrawal by Subject|0
3071630|NCT00462943|10548710|P2|Overall Study|Withdrawal by Subject|1
3071631|NCT00462943|10548711|P1|Overall Study|Withdrawal by Subject|0
3071632|NCT00462943|10548709|P3|Overall Study|Physician Decision|0
3071633|NCT00462943|10548710|P2|Overall Study|Physician Decision|0
3071634|NCT00462943|10548711|P1|Overall Study|Physician Decision|1
3071635|NCT00462943|10548709|P3|Overall Study|Transplant - not specified|1
3071636|NCT00462943|10548710|P2|Overall Study|Transplant - not specified|0
3071637|NCT00462943|10548711|P1|Overall Study|Transplant - not specified|1
3071638|NCT00462943|10548709|P3|Overall Study|Required Lymphocyte Infusion|0
3071639|NCT00462943|10548710|P2|Overall Study|Required Lymphocyte Infusion|0
3071640|NCT00462943|10548711|P1|Overall Study|Required Lymphocyte Infusion|1
3071641|NCT00462943|10548709|P3|Overall Study|Bone Marrow Transplant|0
3071642|NCT00462943|10548710|P2|Overall Study|Bone Marrow Transplant|0
3071643|NCT00462943|10548711|P1|Overall Study|Bone Marrow Transplant|1
3071644|NCT00462943|10548709|P3|Overall Study|Stem Cell Transplant|0
3071645|NCT00462943|10548710|P2|Overall Study|Stem Cell Transplant|1
3071646|NCT00462943|10548711|P1|Overall Study|Stem Cell Transplant|1
3071647|NCT00462943|10548709|P3|Overall Study|Death|7
3071648|NCT00462943|10548710|P2|Overall Study|Death|2
3071649|NCT00462943|10548711|P1|Overall Study|Death|5
3071650|NCT00462943|10548709|P3|Overall Study|Disease Progression|9
3071651|NCT00462943|10548710|P2|Overall Study|Disease Progression|15
3071652|NCT00462943|10548711|P1|Overall Study|Disease Progression|15
3071653|NCT00462943|10548709|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
3071654|NCT00462943|10548710|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
3071655|NCT00462943|10548711|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
3071656|NCT00462943|10548709|P3|Overall Study|Protocol Violation|0
3071657|NCT00462943|10548710|P2|Overall Study|Protocol Violation|0
3071658|NCT00462943|10548711|P1|Overall Study|Protocol Violation|1
3071659|NCT00462943|10548709|P3|Overall Study|Adverse Event|1
3071660|NCT00462943|10548710|P2|Overall Study|Adverse Event|4
3071661|NCT00462943|10548711|P1|Overall Study|Adverse Event|6
3071662|NCT00462943|10548709|P3|Overall Study|Failure to achieve a response|1
3071663|NCT00462943|10548710|P2|Overall Study|Failure to achieve a response|5
3071664|NCT00462943|10548711|P1|Overall Study|Failure to achieve a response|5
3071665|NCT00462904|10548803|P1|Overall Study|Lost to Follow-up|1
3071666|NCT00462865|10548808|P1|Overall Study|Adverse Event|1
3071667|NCT00462826|10548828|P1|Overall Study|Never treated|1
3071668|NCT00462826|10548828|P1|Overall Study|Ineligible - wrong primary|2
3071669|NCT00462826|10548828|P1|Overall Study|Ineligible - wrong cell type|1
3071670|NCT00462826|10548828|P1|Overall Study|Ineligible - second primary|1
3071671|NCT00462761|10548841|P1|Overall Study|Other|1
3071672|NCT00462761|10548841|P1|Overall Study|Death|12
3071673|NCT00462761|10548841|P1|Overall Study|Disease progression|43
3071674|NCT00462761|10548841|P1|Overall Study|Physician Decision|5
3071675|NCT00462761|10548841|P1|Overall Study|Withdrawal by Subject|9
3071676|NCT00462761|10548841|P1|Overall Study|Adverse Event|6
3071677|NCT00462748|10548916|P3|Overall Study|Discontinued after 41 days Rx|0
3071678|NCT00462748|10548917|P2|Overall Study|Discontinued after 41 days Rx|0
3071679|NCT00462748|10548918|P1|Overall Study|Discontinued after 41 days Rx|1
3071680|NCT00462748|10548916|P3|Overall Study|Lost to Follow-up|1
3071681|NCT00462748|10548917|P2|Overall Study|Lost to Follow-up|1
3071682|NCT00462748|10548918|P1|Overall Study|Lost to Follow-up|1
3071683|NCT00462748|10548916|P3|Overall Study|Withdrew consent|0
3071684|NCT00462748|10548917|P2|Overall Study|Withdrew consent|3
3071685|NCT00462748|10548918|P1|Overall Study|Withdrew consent|3
3071686|NCT00462748|10548916|P3|Overall Study|Protocol Violation|1
3071687|NCT00462748|10548917|P2|Overall Study|Protocol Violation|2
3071688|NCT00462748|10548918|P1|Overall Study|Protocol Violation|0
3071689|NCT00462748|10548916|P3|Overall Study|Adverse Event|9
3071690|NCT00462748|10548917|P2|Overall Study|Adverse Event|5
3071691|NCT00462748|10548918|P1|Overall Study|Adverse Event|7
3071692|NCT00462709|10548971|P1|Overall Study|Withdrew to start treatment with Cetor|1
3071693|NCT00462709|10548971|P1|Overall Study|Physician Decision|1
3071694|NCT00462709|10548971|P1|Overall Study|Logistical reasons|2
3071695|NCT00462709|10548971|P1|Overall Study|Death|2
3071696|NCT00462709|10548971|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
3071697|NCT00462709|10548971|P1|Overall Study|Withdrawal by Subject|8
3071698|NCT00462709|10548971|P1|Overall Study|Lost to Follow-up|10
3071699|NCT00462709|10548971|P1|Overall Study|Transitioned to commercial C1INH-nf|40
3071700|NCT00462670|10548980|P2|Overall Study|Resolution of signs and symptoms|2
3071701|NCT00462670|10548981|P1|Overall Study|Resolution of signs and symptoms|0
3071702|NCT00462670|10548980|P2|Overall Study|Protocol Violation|0
3071703|NCT00462670|10548981|P1|Overall Study|Protocol Violation|1
3071704|NCT00462670|10548980|P2|Overall Study|Lack of Efficacy|0
3071705|NCT00462670|10548981|P1|Overall Study|Lack of Efficacy|1
3071706|NCT00462670|10548980|P2|Overall Study|Adverse Event|5
3071707|NCT00462670|10548981|P1|Overall Study|Adverse Event|3
3071708|NCT00462501|10549018|P1|Overall Study|Adverse Event|2
3071709|NCT00462501|10549018|P1|Overall Study|Not treated|3
3071710|NCT00462488|10549024|P2|Overall Study|Lack of Efficacy|17
3071711|NCT00462488|10549025|P1|Overall Study|Lack of Efficacy|19
3071712|NCT00462488|10549024|P2|Overall Study|Protocol Violation|0
3071713|NCT00462488|10549025|P1|Overall Study|Protocol Violation|1
3071714|NCT00462462|10549033|P2|Overall Study|Physician Decision|1
3071715|NCT00462462|10549034|P1|Overall Study|Physician Decision|0
3071716|NCT00462384|10549062|P1|Overall Study|Other|4
3071717|NCT00462384|10549062|P1|Overall Study|Withdrawal by Subject|1
3071718|NCT00462384|10549062|P1|Overall Study|Death|2
3071719|NCT00462384|10549062|P1|Overall Study|Adverse Event|2
3071720|NCT00462345|10549070|P1|Overall Study|Did not complete second course|1
3071721|NCT00462345|10549070|P1|Overall Study|Withdrawal by Subject|2
3071722|NCT00462306|10549105|P2|Overall Study|insufficient data|13
3071723|NCT00462306|10549106|P1|Overall Study|insufficient data|0
3071724|NCT00461981|10549237|P2|Overall Study|Withdrawal by Subject|3
3071725|NCT00461981|10549238|P1|Overall Study|Withdrawal by Subject|2
3071726|NCT00461981|10549237|P2|Overall Study|Lost to Follow-up|6
3071727|NCT00461981|10549238|P1|Overall Study|Lost to Follow-up|9
3071728|NCT00461812|10549354|P1|Overall Study|study terminated|10
3071729|NCT00461786|10549359|P1|Overall Study|Inevaluable (Never Treated)|1
3071730|NCT00461786|10549359|P1|Overall Study|Entry Criteria Not Met|2
3071731|NCT00461708|10549404|P2|Overall Study|Death|1
3071732|NCT00461708|10549405|P1|Overall Study|Death|8
3071733|NCT00461708|10549404|P2|Overall Study|Other|4
3071734|NCT00461708|10549405|P1|Overall Study|Other|4
3071735|NCT00461708|10549404|P2|Overall Study|Withdrawal by Subject|2
3071736|NCT00461708|10549405|P1|Overall Study|Withdrawal by Subject|8
3071737|NCT00461708|10549404|P2|Overall Study|Physician Decision|4
3071738|NCT00461708|10549405|P1|Overall Study|Physician Decision|10
3071739|NCT00461708|10549404|P2|Overall Study|Lack of Efficacy|20
3071740|NCT00461708|10549405|P1|Overall Study|Lack of Efficacy|68
3071741|NCT00461708|10549404|P2|Overall Study|Adverse Event|7
3071742|NCT00461708|10549405|P1|Overall Study|Adverse Event|17
3071743|NCT00461682|10549431|P1|Overall Study|Protocol Violation|1
3071744|NCT00461630|10549459|P2|Overall Study|Lost to Follow-up|95
3071745|NCT00461630|10549460|P1|Overall Study|Lost to Follow-up|108
3071746|NCT00461630|10549459|P2|Overall Study|Death|732
3071747|NCT00461630|10549460|P1|Overall Study|Death|798
3071748|NCT00461552|10549499|P2|Overall Study|Drug Dispensing error|2
3071749|NCT00461552|10549500|P1|Overall Study|Drug Dispensing error|0
3071750|NCT00461500|10549523|P2|Overall Study|Lost to Follow-up|2
3071751|NCT00461500|10549524|P1|Overall Study|Lost to Follow-up|2
3071752|NCT00461500|10549523|P2|Overall Study|No Longer Willing to Take Part in Study|0
3071753|NCT00461500|10549524|P1|Overall Study|No Longer Willing to Take Part in Study|1
3071754|NCT00461500|10549523|P2|Overall Study|Drug Treatment Misuse|0
3071755|NCT00461500|10549524|P1|Overall Study|Drug Treatment Misuse|1
3071756|NCT00461500|10549523|P2|Overall Study|Study Stopped|2
3071757|NCT00461500|10549524|P1|Overall Study|Study Stopped|1
3071758|NCT00461500|10549523|P2|Overall Study|Expired Drug Treatment|1
3071759|NCT00461500|10549524|P1|Overall Study|Expired Drug Treatment|1
3071760|NCT00461500|10549523|P2|Overall Study|Lack of Efficacy|1
3071761|NCT00461500|10549524|P1|Overall Study|Lack of Efficacy|0
3071762|NCT00461500|10549523|P2|Overall Study|Adverse Event|0
3071763|NCT00461500|10549524|P1|Overall Study|Adverse Event|1
3071764|NCT00461305|10549567|P2|Continued Treatment|Other (missing drug etc)|0
3071765|NCT00461305|10549568|P1|Continued Treatment|Other (missing drug etc)|2
3071766|NCT00461305|10549567|P2|Continued Treatment|Partially missing diary|0
3071767|NCT00461305|10549568|P1|Continued Treatment|Partially missing diary|2
3071768|NCT00461305|10549567|P2|Continued Treatment|Withdrawal by Subject|0
3071769|NCT00461305|10549568|P1|Continued Treatment|Withdrawal by Subject|48
3071770|NCT00461305|10549567|P2|Continued Treatment|Protocol Violation|0
3071771|NCT00461305|10549568|P1|Continued Treatment|Protocol Violation|13
3071772|NCT00461305|10549567|P2|Continued Treatment|Lost to Follow-up|0
3071773|NCT00461305|10549568|P1|Continued Treatment|Lost to Follow-up|4
3071774|NCT00461305|10549567|P2|Continued Treatment|Adverse Event|0
3071775|NCT00461305|10549568|P1|Continued Treatment|Adverse Event|26
3071776|NCT00461305|10549567|P2|Treatment|Other (missing drug etc)|0
3071777|NCT00461305|10549568|P1|Treatment|Other (missing drug etc)|2
3071778|NCT00461305|10549567|P2|Treatment|Partially missing diary|0
3071779|NCT00461305|10549568|P1|Treatment|Partially missing diary|2
3071780|NCT00461305|10549567|P2|Treatment|Study drug not taken|0
3071781|NCT00461305|10549568|P1|Treatment|Study drug not taken|1
3071782|NCT00461305|10549567|P2|Treatment|Never dispensed|0
3071783|NCT00461305|10549568|P1|Treatment|Never dispensed|5
3071784|NCT00461305|10549567|P2|Treatment|Withdrawal by Subject|2
3071785|NCT00461305|10549568|P1|Treatment|Withdrawal by Subject|48
3071786|NCT00461305|10549567|P2|Treatment|Protocol Violation|2
3071787|NCT00461305|10549568|P1|Treatment|Protocol Violation|13
3071788|NCT00461305|10549567|P2|Treatment|Lost to Follow-up|2
3071789|NCT00461305|10549568|P1|Treatment|Lost to Follow-up|4
3071790|NCT00461305|10549567|P2|Treatment|Adverse Event|3
3071791|NCT00461305|10549568|P1|Treatment|Adverse Event|26
3071792|NCT00461253|10549652|P2|Overall Study|administrative|7773
3071793|NCT00461253|10549653|P1|Overall Study|administrative|773
3071794|NCT00461253|10549652|P2|Overall Study|no response|11789
3071795|NCT00461253|10549653|P1|Overall Study|no response|2609
3071796|NCT00461253|10549652|P2|Overall Study|Protocol Violation|236
3071797|NCT00461253|10549653|P1|Overall Study|Protocol Violation|613
3071798|NCT00461253|10549652|P2|Overall Study|Death|0
3071799|NCT00461253|10549653|P1|Overall Study|Death|985
3071800|NCT00461175|10549661|P2|Overall Study|Protocol Violation|365
3071801|NCT00461175|10549662|P1|Overall Study|Protocol Violation|522
3071802|NCT00461123|10549672|P2|Overall Study|Withdrawal by Subject|3
3071803|NCT00461123|10549673|P1|Overall Study|Withdrawal by Subject|1
3071804|NCT00461123|10549672|P2|Overall Study|Protocol Violation|2
3071805|NCT00461123|10549673|P1|Overall Study|Protocol Violation|3
3071806|NCT00461123|10549672|P2|Overall Study|Lost to Follow-up|1
3071807|NCT00461123|10549673|P1|Overall Study|Lost to Follow-up|1
3071808|NCT00461123|10549672|P2|Overall Study|Adverse Event|0
3071809|NCT00461123|10549673|P1|Overall Study|Adverse Event|1
3071810|NCT00461032|10549718|P2|Overall Study|Other|5
3071811|NCT00461032|10549719|P1|Overall Study|Other|7
3071812|NCT00461032|10549718|P2|Overall Study|Patient Moved or Relocated|1
3071813|NCT00461032|10549719|P1|Overall Study|Patient Moved or Relocated|2
3071814|NCT00461032|10549718|P2|Overall Study|Withdrawal by Subject|15
3071815|NCT00461032|10549719|P1|Overall Study|Withdrawal by Subject|7
3071816|NCT00461032|10549718|P2|Overall Study|Protocol Violation|4
3071817|NCT00461032|10549719|P1|Overall Study|Protocol Violation|4
3071818|NCT00461032|10549718|P2|Overall Study|Lost to Follow-up|12
3071819|NCT00461032|10549719|P1|Overall Study|Lost to Follow-up|7
3071820|NCT00461032|10549718|P2|Overall Study|Lack of Efficacy|1
3071821|NCT00461032|10549719|P1|Overall Study|Lack of Efficacy|5
3071822|NCT00461032|10549718|P2|Overall Study|Adverse Event|6
3071823|NCT00461032|10549719|P1|Overall Study|Adverse Event|5
3071824|NCT00460811|10549745|P5|Overall Study|Lost to Follow-up|6
3071825|NCT00460811|10549746|P4|Overall Study|Lost to Follow-up|3
3071826|NCT00460811|10549747|P3|Overall Study|Lost to Follow-up|5
3071827|NCT00460811|10549748|P2|Overall Study|Lost to Follow-up|2
3071828|NCT00460811|10549749|P1|Overall Study|Lost to Follow-up|3
3071829|NCT00460811|10549745|P5|Overall Study|Physician Decision|0
3071830|NCT00460811|10549746|P4|Overall Study|Physician Decision|0
3071831|NCT00460811|10549747|P3|Overall Study|Physician Decision|0
3071832|NCT00460811|10549748|P2|Overall Study|Physician Decision|0
3071833|NCT00460811|10549749|P1|Overall Study|Physician Decision|1
3071834|NCT00460811|10549745|P5|Overall Study|Withdrawal by Subject|11
3071835|NCT00460811|10549746|P4|Overall Study|Withdrawal by Subject|3
3071836|NCT00460811|10549747|P3|Overall Study|Withdrawal by Subject|6
3071837|NCT00460811|10549748|P2|Overall Study|Withdrawal by Subject|7
3071838|NCT00460811|10549749|P1|Overall Study|Withdrawal by Subject|7
3071839|NCT00460811|10549745|P5|Overall Study|Noncompliance|1
3071840|NCT00460811|10549746|P4|Overall Study|Noncompliance|2
3071841|NCT00460811|10549747|P3|Overall Study|Noncompliance|0
3071842|NCT00460811|10549748|P2|Overall Study|Noncompliance|0
3071843|NCT00460811|10549749|P1|Overall Study|Noncompliance|1
3071844|NCT00460811|10549745|P5|Overall Study|Adverse Event|2
3071845|NCT00460811|10549746|P4|Overall Study|Adverse Event|10
3071846|NCT00460811|10549747|P3|Overall Study|Adverse Event|3
3071847|NCT00460811|10549748|P2|Overall Study|Adverse Event|6
3071848|NCT00460811|10549749|P1|Overall Study|Adverse Event|4
3071849|NCT00460798|10549791|P1|Overall Study|Missing/Incomplete Dosing Information|27
3071850|NCT00460798|10549791|P1|Overall Study|Ongoing at Date of Cut-Off|82
3071851|NCT00460798|10549791|P1|Overall Study|Other|27
3071852|NCT00460798|10549791|P1|Overall Study|Progressive Disease|99
3071853|NCT00460798|10549791|P1|Overall Study|Lost to Follow-up|19
3071854|NCT00460798|10549791|P1|Overall Study|Adverse Event|27
3071855|NCT00460798|10549791|P1|Overall Study|Death|59
3071856|NCT00460746|10549799|P1|Overall Study|Lost to Follow-up|1
3071857|NCT00460746|10549799|P1|Overall Study|Adverse Event|1
3071858|NCT00460655|10549814|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
3071859|NCT00460655|10549815|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
3071860|NCT00460655|10549816|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
3071861|NCT00460655|10549817|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
3071862|NCT00460655|10549814|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
3071863|NCT00460655|10549815|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
3071864|NCT00460655|10549816|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3071865|NCT00460655|10549817|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3071866|NCT00460655|10549814|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
3071867|NCT00460655|10549815|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
3071868|NCT00460655|10549816|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
3071869|NCT00460655|10549817|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
3071870|NCT00460655|10549814|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
3071871|NCT00460655|10549815|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
3071872|NCT00460655|10549816|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
3071873|NCT00460655|10549817|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
3071874|NCT00460655|10549814|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3071875|NCT00460655|10549815|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3071876|NCT00460655|10549816|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3071877|NCT00460655|10549817|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
3071878|NCT00460655|10549814|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
3071879|NCT00460655|10549815|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
3071880|NCT00460655|10549816|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
3071881|NCT00460655|10549817|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
3071882|NCT00460603|10549861|P12|Phase 2|Randomized, but not treated|0
3071883|NCT00460603|10549862|P11|Phase 2|Randomized, but not treated|0
3071884|NCT00460603|10549863|P10|Phase 2|Randomized, but not treated|3
3071885|NCT00460603|10549864|P9|Phase 2|Randomized, but not treated|0
3071886|NCT00460603|10549865|P8|Phase 2|Randomized, but not treated|0
3071887|NCT00460603|10549866|P7|Phase 2|Randomized, but not treated|0
3071888|NCT00460603|10549867|P6|Phase 2|Randomized, but not treated|0
3071889|NCT00460603|10549868|P5|Phase 2|Randomized, but not treated|0
3071890|NCT00460603|10549869|P4|Phase 2|Randomized, but not treated|0
3071891|NCT00460603|10549870|P3|Phase 2|Randomized, but not treated|0
3071892|NCT00460603|10549871|P2|Phase 2|Randomized, but not treated|0
3071893|NCT00460603|10549872|P1|Phase 2|Randomized, but not treated|0
3071894|NCT00460603|10549861|P12|Phase 2|Withdrawal by Subject|5
3071895|NCT00460603|10549862|P11|Phase 2|Withdrawal by Subject|4
3071896|NCT00460603|10549863|P10|Phase 2|Withdrawal by Subject|5
3071897|NCT00460603|10549864|P9|Phase 2|Withdrawal by Subject|0
3071898|NCT00460603|10549865|P8|Phase 2|Withdrawal by Subject|0
3071899|NCT00460603|10549866|P7|Phase 2|Withdrawal by Subject|0
3071900|NCT00460603|10549867|P6|Phase 2|Withdrawal by Subject|0
3071901|NCT00460603|10549868|P5|Phase 2|Withdrawal by Subject|0
3071902|NCT00460603|10549869|P4|Phase 2|Withdrawal by Subject|0
3071903|NCT00460603|10549870|P3|Phase 2|Withdrawal by Subject|0
3071904|NCT00460603|10549871|P2|Phase 2|Withdrawal by Subject|0
3071905|NCT00460603|10549872|P1|Phase 2|Withdrawal by Subject|0
3071906|NCT00460603|10549861|P12|Phase 2|Global Deterioration of Health Status|0
3071907|NCT00460603|10549862|P11|Phase 2|Global Deterioration of Health Status|1
3071908|NCT00460603|10549863|P10|Phase 2|Global Deterioration of Health Status|0
3071909|NCT00460603|10549864|P9|Phase 2|Global Deterioration of Health Status|0
3071910|NCT00460603|10549865|P8|Phase 2|Global Deterioration of Health Status|0
3071911|NCT00460603|10549866|P7|Phase 2|Global Deterioration of Health Status|0
3071912|NCT00460603|10549867|P6|Phase 2|Global Deterioration of Health Status|0
3071913|NCT00460603|10549868|P5|Phase 2|Global Deterioration of Health Status|0
3071914|NCT00460603|10549869|P4|Phase 2|Global Deterioration of Health Status|0
3071915|NCT00460603|10549870|P3|Phase 2|Global Deterioration of Health Status|0
3071916|NCT00460603|10549871|P2|Phase 2|Global Deterioration of Health Status|0
3071917|NCT00460603|10549872|P1|Phase 2|Global Deterioration of Health Status|0
3071918|NCT00460603|10549861|P12|Phase 2|Objective Progression or Relapse|17
3071919|NCT00460603|10549862|P11|Phase 2|Objective Progression or Relapse|10
3071920|NCT00460603|10549863|P10|Phase 2|Objective Progression or Relapse|9
3071921|NCT00460603|10549864|P9|Phase 2|Objective Progression or Relapse|0
3071922|NCT00460603|10549865|P8|Phase 2|Objective Progression or Relapse|0
3071923|NCT00460603|10549866|P7|Phase 2|Objective Progression or Relapse|0
3071924|NCT00460603|10549867|P6|Phase 2|Objective Progression or Relapse|0
3071925|NCT00460603|10549868|P5|Phase 2|Objective Progression or Relapse|0
3071926|NCT00460603|10549869|P4|Phase 2|Objective Progression or Relapse|0
3071927|NCT00460603|10549870|P3|Phase 2|Objective Progression or Relapse|0
3071928|NCT00460603|10549871|P2|Phase 2|Objective Progression or Relapse|0
3071929|NCT00460603|10549872|P1|Phase 2|Objective Progression or Relapse|0
3071930|NCT00460603|10549861|P12|Phase 2|Other|7
3071931|NCT00460603|10549862|P11|Phase 2|Other|16
3071932|NCT00460603|10549863|P10|Phase 2|Other|6
3071933|NCT00460603|10549864|P9|Phase 2|Other|0
3071934|NCT00460603|10549865|P8|Phase 2|Other|0
3071935|NCT00460603|10549866|P7|Phase 2|Other|0
3071936|NCT00460603|10549867|P6|Phase 2|Other|0
3071937|NCT00460603|10549868|P5|Phase 2|Other|0
3071938|NCT00460603|10549869|P4|Phase 2|Other|0
3071939|NCT00460603|10549870|P3|Phase 2|Other|0
3071940|NCT00460603|10549871|P2|Phase 2|Other|0
3071941|NCT00460603|10549872|P1|Phase 2|Other|0
3071942|NCT00460603|10549861|P12|Phase 2|Lost to Follow-up|0
3071943|NCT00460603|10549862|P11|Phase 2|Lost to Follow-up|0
3071944|NCT00460603|10549863|P10|Phase 2|Lost to Follow-up|1
3071945|NCT00460603|10549864|P9|Phase 2|Lost to Follow-up|0
3071946|NCT00460603|10549865|P8|Phase 2|Lost to Follow-up|0
3071947|NCT00460603|10549866|P7|Phase 2|Lost to Follow-up|0
3071948|NCT00460603|10549867|P6|Phase 2|Lost to Follow-up|0
3071949|NCT00460603|10549868|P5|Phase 2|Lost to Follow-up|0
3071950|NCT00460603|10549869|P4|Phase 2|Lost to Follow-up|0
3071951|NCT00460603|10549870|P3|Phase 2|Lost to Follow-up|0
3071952|NCT00460603|10549871|P2|Phase 2|Lost to Follow-up|0
3071953|NCT00460603|10549872|P1|Phase 2|Lost to Follow-up|0
3071954|NCT00460603|10549861|P12|Phase 2|Protocol Violation|0
3071955|NCT00460603|10549862|P11|Phase 2|Protocol Violation|1
3071956|NCT00460603|10549863|P10|Phase 2|Protocol Violation|1
3071957|NCT00460603|10549864|P9|Phase 2|Protocol Violation|0
3071958|NCT00460603|10549865|P8|Phase 2|Protocol Violation|0
3071959|NCT00460603|10549866|P7|Phase 2|Protocol Violation|0
3071960|NCT00460603|10549867|P6|Phase 2|Protocol Violation|0
3071961|NCT00460603|10549868|P5|Phase 2|Protocol Violation|0
3071962|NCT00460603|10549869|P4|Phase 2|Protocol Violation|0
3071963|NCT00460603|10549870|P3|Phase 2|Protocol Violation|0
3071964|NCT00460603|10549871|P2|Phase 2|Protocol Violation|0
3071965|NCT00460603|10549872|P1|Phase 2|Protocol Violation|0
3071966|NCT00460603|10549861|P12|Phase 2|Death|2
3071967|NCT00460603|10549862|P11|Phase 2|Death|2
3071968|NCT00460603|10549863|P10|Phase 2|Death|4
3071969|NCT00460603|10549864|P9|Phase 2|Death|0
3071970|NCT00460603|10549865|P8|Phase 2|Death|0
3071971|NCT00460603|10549866|P7|Phase 2|Death|0
3071972|NCT00460603|10549867|P6|Phase 2|Death|0
3071973|NCT00460603|10549868|P5|Phase 2|Death|0
3071974|NCT00460603|10549869|P4|Phase 2|Death|0
3071975|NCT00460603|10549870|P3|Phase 2|Death|0
3071976|NCT00460603|10549871|P2|Phase 2|Death|0
3071977|NCT00460603|10549872|P1|Phase 2|Death|0
3071978|NCT00460603|10549861|P12|Phase 2|Adverse Event|10
3071979|NCT00460603|10549862|P11|Phase 2|Adverse Event|9
3071980|NCT00460603|10549863|P10|Phase 2|Adverse Event|12
3071981|NCT00460603|10549864|P9|Phase 2|Adverse Event|0
3071982|NCT00460603|10549865|P8|Phase 2|Adverse Event|0
3071983|NCT00460603|10549866|P7|Phase 2|Adverse Event|0
3071984|NCT00460603|10549867|P6|Phase 2|Adverse Event|0
3071985|NCT00460603|10549868|P5|Phase 2|Adverse Event|0
3071986|NCT00460603|10549869|P4|Phase 2|Adverse Event|0
3071987|NCT00460603|10549870|P3|Phase 2|Adverse Event|0
3071988|NCT00460603|10549871|P2|Phase 2|Adverse Event|0
3071989|NCT00460603|10549872|P1|Phase 2|Adverse Event|0
3071990|NCT00460603|10549861|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071991|NCT00460603|10549862|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071992|NCT00460603|10549863|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
3071993|NCT00460603|10549864|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071994|NCT00460603|10549865|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071995|NCT00460603|10549866|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071996|NCT00460603|10549867|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071997|NCT00460603|10549868|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071998|NCT00460603|10549869|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3071999|NCT00460603|10549870|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3072000|NCT00460603|10549871|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3072001|NCT00460603|10549872|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
3072002|NCT00460603|10549861|P12|Phase 1|Other|0
3072003|NCT00460603|10549862|P11|Phase 1|Other|0
3072004|NCT00460603|10549863|P10|Phase 1|Other|0
3072005|NCT00460603|10549864|P9|Phase 1|Other|0
3072006|NCT00460603|10549865|P8|Phase 1|Other|1
3072007|NCT00460603|10549866|P7|Phase 1|Other|0
3072008|NCT00460603|10549867|P6|Phase 1|Other|2
3072009|NCT00460603|10549868|P5|Phase 1|Other|1
3072010|NCT00460603|10549869|P4|Phase 1|Other|1
3072011|NCT00460603|10549870|P3|Phase 1|Other|1
3072012|NCT00460603|10549871|P2|Phase 1|Other|3
3072013|NCT00460603|10549872|P1|Phase 1|Other|0
3072014|NCT00460603|10549861|P12|Phase 1|Withdrawal by Subject|0
3072015|NCT00460603|10549862|P11|Phase 1|Withdrawal by Subject|0
3072016|NCT00460603|10549863|P10|Phase 1|Withdrawal by Subject|0
3072017|NCT00460603|10549864|P9|Phase 1|Withdrawal by Subject|2
3072018|NCT00460603|10549865|P8|Phase 1|Withdrawal by Subject|0
3072019|NCT00460603|10549866|P7|Phase 1|Withdrawal by Subject|1
3072020|NCT00460603|10549867|P6|Phase 1|Withdrawal by Subject|0
3072021|NCT00460603|10549868|P5|Phase 1|Withdrawal by Subject|3
3072022|NCT00460603|10549869|P4|Phase 1|Withdrawal by Subject|1
3072023|NCT00460603|10549870|P3|Phase 1|Withdrawal by Subject|1
3072024|NCT00460603|10549871|P2|Phase 1|Withdrawal by Subject|2
3072025|NCT00460603|10549872|P1|Phase 1|Withdrawal by Subject|1
3072026|NCT00460603|10549861|P12|Phase 1|Lack of Efficacy|0
3072027|NCT00460603|10549862|P11|Phase 1|Lack of Efficacy|0
3072028|NCT00460603|10549863|P10|Phase 1|Lack of Efficacy|0
3072029|NCT00460603|10549864|P9|Phase 1|Lack of Efficacy|11
3072030|NCT00460603|10549865|P8|Phase 1|Lack of Efficacy|2
3072031|NCT00460603|10549866|P7|Phase 1|Lack of Efficacy|2
3072032|NCT00460603|10549867|P6|Phase 1|Lack of Efficacy|2
3072033|NCT00460603|10549868|P5|Phase 1|Lack of Efficacy|2
3072034|NCT00460603|10549869|P4|Phase 1|Lack of Efficacy|2
3072035|NCT00460603|10549870|P3|Phase 1|Lack of Efficacy|1
3072036|NCT00460603|10549871|P2|Phase 1|Lack of Efficacy|0
3072037|NCT00460603|10549872|P1|Phase 1|Lack of Efficacy|1
3072038|NCT00460603|10549861|P12|Phase 1|Adverse Event|0
3072039|NCT00460603|10549862|P11|Phase 1|Adverse Event|0
3072040|NCT00460603|10549863|P10|Phase 1|Adverse Event|0
3072041|NCT00460603|10549864|P9|Phase 1|Adverse Event|4
3072042|NCT00460603|10549865|P8|Phase 1|Adverse Event|0
3072043|NCT00460603|10549866|P7|Phase 1|Adverse Event|3
3072044|NCT00460603|10549867|P6|Phase 1|Adverse Event|0
3072045|NCT00460603|10549868|P5|Phase 1|Adverse Event|0
3072046|NCT00460603|10549869|P4|Phase 1|Adverse Event|2
3072047|NCT00460603|10549870|P3|Phase 1|Adverse Event|1
3072048|NCT00460603|10549871|P2|Phase 1|Adverse Event|1
3072049|NCT00460603|10549872|P1|Phase 1|Adverse Event|3
3072050|NCT00460603|10549861|P12|Phase 1|Death|0
3072051|NCT00460603|10549862|P11|Phase 1|Death|0
3072052|NCT00460603|10549863|P10|Phase 1|Death|0
3072053|NCT00460603|10549864|P9|Phase 1|Death|1
3072054|NCT00460603|10549865|P8|Phase 1|Death|0
3072055|NCT00460603|10549866|P7|Phase 1|Death|0
3072056|NCT00460603|10549867|P6|Phase 1|Death|0
3072057|NCT00460603|10549868|P5|Phase 1|Death|0
3072058|NCT00460603|10549869|P4|Phase 1|Death|2
3072059|NCT00460603|10549870|P3|Phase 1|Death|0
3072060|NCT00460603|10549871|P2|Phase 1|Death|0
3072061|NCT00460603|10549872|P1|Phase 1|Death|1
3072062|NCT00460577|10549966|P2|Overall Study|Protocol Violation|6
3072063|NCT00460577|10549967|P1|Overall Study|Protocol Violation|2
3072064|NCT00460564|10549985|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072065|NCT00460564|10549986|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072066|NCT00460564|10549987|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072067|NCT00460564|10549988|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
3072068|NCT00460564|10549989|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072069|NCT00460564|10549990|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072070|NCT00460564|10549991|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072071|NCT00460564|10549992|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
3072072|NCT00460564|10549985|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072073|NCT00460564|10549986|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072074|NCT00460564|10549987|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
3072075|NCT00460564|10549988|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
3072076|NCT00460564|10549989|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072077|NCT00460564|10549990|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072078|NCT00460564|10549991|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072079|NCT00460564|10549992|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
3072080|NCT00460564|10549985|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
3072081|NCT00460564|10549986|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
3072082|NCT00460564|10549987|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
3072083|NCT00460564|10549988|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
3072084|NCT00460564|10549989|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
3072085|NCT00460564|10549990|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
3072086|NCT00460564|10549991|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
3072087|NCT00460564|10549992|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
3072088|NCT00460564|10549985|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072089|NCT00460564|10549986|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072090|NCT00460564|10549987|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072091|NCT00460564|10549988|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072092|NCT00460564|10549989|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072093|NCT00460564|10549990|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072094|NCT00460564|10549991|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
3072095|NCT00460564|10549992|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
3072096|NCT00460564|10549985|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072097|NCT00460564|10549986|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072098|NCT00460564|10549987|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072099|NCT00460564|10549988|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072100|NCT00460564|10549989|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072101|NCT00460564|10549990|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
3072102|NCT00460564|10549991|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
3072103|NCT00460564|10549992|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
3072104|NCT00460434|10550136|P2|Overall Study|Lost to Follow-up|7
3072105|NCT00460434|10550137|P1|Overall Study|Lost to Follow-up|3
3072106|NCT00460408|10550216|P4|Overall Study|Other|0
3072107|NCT00460408|10550217|P3|Overall Study|Other|0
3072108|NCT00460408|10550218|P2|Overall Study|Other|2
3072109|NCT00460408|10550219|P1|Overall Study|Other|12
3072110|NCT00460408|10550216|P4|Overall Study|Insufficient clinical response|0
3072111|NCT00460408|10550217|P3|Overall Study|Insufficient clinical response|5
3072112|NCT00460408|10550218|P2|Overall Study|Insufficient clinical response|1
3072113|NCT00460408|10550219|P1|Overall Study|Insufficient clinical response|5
3072114|NCT00460408|10550216|P4|Overall Study|Withdrawal by Subject|0
3072115|NCT00460408|10550217|P3|Overall Study|Withdrawal by Subject|0
3072116|NCT00460408|10550218|P2|Overall Study|Withdrawal by Subject|0
3072117|NCT00460408|10550219|P1|Overall Study|Withdrawal by Subject|31
3072118|NCT00460408|10550216|P4|Overall Study|Lost to Follow-up|0
3072119|NCT00460408|10550217|P3|Overall Study|Lost to Follow-up|1
3072120|NCT00460408|10550218|P2|Overall Study|Lost to Follow-up|0
3072121|NCT00460408|10550219|P1|Overall Study|Lost to Follow-up|11
3072122|NCT00460408|10550216|P4|Overall Study|Death|0
3072123|NCT00460408|10550217|P3|Overall Study|Death|0
3072124|NCT00460408|10550218|P2|Overall Study|Death|0
3072125|NCT00460408|10550219|P1|Overall Study|Death|7
3072126|NCT00460408|10550216|P4|Overall Study|Adverse Event|0
3072127|NCT00460408|10550217|P3|Overall Study|Adverse Event|0
3072128|NCT00460408|10550218|P2|Overall Study|Adverse Event|0
3072129|NCT00460408|10550219|P1|Overall Study|Adverse Event|1
3072130|NCT00460265|10550256|P2|Overall Study|Ongoing|47
3072131|NCT00460265|10550257|P1|Overall Study|Ongoing|60
3072132|NCT00460265|10550256|P2|Overall Study|Withdrawal by Subject|25
3072133|NCT00460265|10550257|P1|Overall Study|Withdrawal by Subject|10
3072134|NCT00460265|10550256|P2|Overall Study|Physician Decision|2
3072135|NCT00460265|10550257|P1|Overall Study|Physician Decision|1
3072136|NCT00460265|10550256|P2|Overall Study|Lost to Follow-up|15
3072137|NCT00460265|10550257|P1|Overall Study|Lost to Follow-up|14
3072138|NCT00460239|10550273|P9|Overall Study|Withdrawal by Subject|0
3072139|NCT00460239|10550274|P8|Overall Study|Withdrawal by Subject|0
3072140|NCT00460239|10550275|P7|Overall Study|Withdrawal by Subject|0
3072141|NCT00460239|10550276|P6|Overall Study|Withdrawal by Subject|1
3072142|NCT00460239|10550277|P5|Overall Study|Withdrawal by Subject|0
3072143|NCT00460239|10550278|P4|Overall Study|Withdrawal by Subject|0
3072144|NCT00460239|10550279|P3|Overall Study|Withdrawal by Subject|0
3072145|NCT00460239|10550280|P2|Overall Study|Withdrawal by Subject|0
3072146|NCT00460239|10550281|P1|Overall Study|Withdrawal by Subject|0
3072147|NCT00460239|10550273|P9|Overall Study|Physician Decision|0
3072148|NCT00460239|10550274|P8|Overall Study|Physician Decision|0
3072149|NCT00460239|10550275|P7|Overall Study|Physician Decision|0
3072150|NCT00460239|10550276|P6|Overall Study|Physician Decision|2
3072151|NCT00460239|10550277|P5|Overall Study|Physician Decision|0
3072152|NCT00460239|10550278|P4|Overall Study|Physician Decision|0
3072153|NCT00460239|10550279|P3|Overall Study|Physician Decision|0
3072154|NCT00460239|10550280|P2|Overall Study|Physician Decision|1
3072155|NCT00460239|10550281|P1|Overall Study|Physician Decision|0
3072156|NCT00460109|10550350|P1|Overall Study|Death|1
3072157|NCT00460031|10550358|P1|Overall Study|Death|1
3072158|NCT00460031|10550358|P1|Overall Study|Withdrawal by Subject|5
3072159|NCT00460031|10550358|P1|Overall Study|Adverse Event|5
3072160|NCT00459979|10550366|P1|Overall Study|Protocol Violation|1
3072161|NCT00459979|10550366|P1|Overall Study|Withdrawal by Subject|1
3072162|NCT00459953|10550378|P2|Overall Study|not analyzed-household member in study|1
3072163|NCT00459953|10550379|P1|Overall Study|not analyzed-household member in study|1
3072164|NCT00459875|10550385|P1|Overall Study|Adverse Event|2
3072165|NCT00459875|10550385|P1|Overall Study|Ineligible participant|1
3072166|NCT00459706|10550421|P2|Overall Study|Other|1
3072167|NCT00459706|10550422|P1|Overall Study|Other|0
3072168|NCT00459706|10550421|P2|Overall Study|Failed to Return|0
3072169|NCT00459706|10550422|P1|Overall Study|Failed to Return|1
3072170|NCT00459706|10550421|P2|Overall Study|Protocol Violation|1
3072171|NCT00459706|10550422|P1|Overall Study|Protocol Violation|2
3072172|NCT00459706|10550421|P2|Overall Study|Discontinuation of Study by Sponsor|0
3072173|NCT00459706|10550422|P1|Overall Study|Discontinuation of Study by Sponsor|1
3072174|NCT00459706|10550421|P2|Overall Study|Physician Decision|0
3072175|NCT00459706|10550422|P1|Overall Study|Physician Decision|2
3072176|NCT00459706|10550421|P2|Overall Study|Withdrawal by Subject|6
3072177|NCT00459706|10550422|P1|Overall Study|Withdrawal by Subject|1
3072178|NCT00459706|10550421|P2|Overall Study|Adverse Event|13
3072179|NCT00459706|10550422|P1|Overall Study|Adverse Event|19
3072180|NCT00459667|10550565|P3|Overall Study|No treatment administered|1
3072181|NCT00459667|10550566|P2|Overall Study|No treatment administered|3
3072182|NCT00459667|10550567|P1|Overall Study|No treatment administered|6
3072183|NCT00459667|10550565|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
3072184|NCT00459667|10550566|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
3072185|NCT00459667|10550567|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
3072186|NCT00459667|10550565|P3|Overall Study|Other disease modifying treatment|1
3072187|NCT00459667|10550566|P2|Overall Study|Other disease modifying treatment|2
3072188|NCT00459667|10550567|P1|Overall Study|Other disease modifying treatment|1
3072189|NCT00459667|10550565|P3|Overall Study|Withdrawal by Subject|5
3072190|NCT00459667|10550566|P2|Overall Study|Withdrawal by Subject|5
3072191|NCT00459667|10550567|P1|Overall Study|Withdrawal by Subject|3
3072192|NCT00459667|10550565|P3|Overall Study|Protocol Violation|0
3072193|NCT00459667|10550566|P2|Overall Study|Protocol Violation|0
3072194|NCT00459667|10550567|P1|Overall Study|Protocol Violation|1
3072195|NCT00459667|10550565|P3|Overall Study|Pregnancy|1
3072196|NCT00459667|10550566|P2|Overall Study|Pregnancy|1
3072197|NCT00459667|10550567|P1|Overall Study|Pregnancy|1
3072198|NCT00459667|10550565|P3|Overall Study|Lost to Follow-up|3
3072199|NCT00459667|10550566|P2|Overall Study|Lost to Follow-up|9
3072200|NCT00459667|10550567|P1|Overall Study|Lost to Follow-up|5
3072201|NCT00459667|10550565|P3|Overall Study|Adverse Event|8
3072202|NCT00459667|10550566|P2|Overall Study|Adverse Event|12
3072203|NCT00459667|10550567|P1|Overall Study|Adverse Event|9
3072204|NCT00459537|10550589|P2|Overall Study|Missing|0
3072205|NCT00459537|10550590|P1|Overall Study|Missing|1
3072206|NCT00459537|10550589|P2|Overall Study|Protocol Violation|3
3072207|NCT00459537|10550590|P1|Overall Study|Protocol Violation|4
3072208|NCT00459537|10550589|P2|Overall Study|Administrative problems|0
3072209|NCT00459537|10550590|P1|Overall Study|Administrative problems|3
3072210|NCT00459537|10550589|P2|Overall Study|Lost to Follow-up|30
3072211|NCT00459537|10550590|P1|Overall Study|Lost to Follow-up|27
3072212|NCT00459537|10550589|P2|Overall Study|Withdrawal by Subject|26
3072213|NCT00459537|10550590|P1|Overall Study|Withdrawal by Subject|20
3072214|NCT00459537|10550589|P2|Overall Study|Lack of Efficacy|11
3072215|NCT00459537|10550590|P1|Overall Study|Lack of Efficacy|10
3072216|NCT00459537|10550589|P2|Overall Study|Adverse Event|6
3072217|NCT00459537|10550590|P1|Overall Study|Adverse Event|1
3072218|NCT00459355|10550625|P2|Overall Study|Subject no longer met inc criteria|18
3072219|NCT00459355|10550626|P1|Overall Study|Subject no longer met inc criteria|20
3072220|NCT00459342|10550638|P1|Overall Study|Not eligible|1
3072221|NCT00459316|10550651|P3|Step 3|Withdrawal by Subject|1
3072222|NCT00459316|10550652|P2|Step 3|Withdrawal by Subject|0
3072223|NCT00459316|10550653|P1|Step 3|Withdrawal by Subject|3
3072224|NCT00459316|10550651|P3|Steps 1 & 2|Lost to Follow-up|2
3072225|NCT00459316|10550652|P2|Steps 1 & 2|Lost to Follow-up|0
3072226|NCT00459316|10550653|P1|Steps 1 & 2|Lost to Follow-up|5
3072227|NCT00459316|10550651|P3|Steps 1 & 2|Not willing to adhere to regulations|0
3072228|NCT00459316|10550652|P2|Steps 1 & 2|Not willing to adhere to regulations|0
3072229|NCT00459316|10550653|P1|Steps 1 & 2|Not willing to adhere to regulations|1
3072230|NCT00459316|10550651|P3|Steps 1 & 2|Withdrawal by Subject|0
3072231|NCT00459316|10550652|P2|Steps 1 & 2|Withdrawal by Subject|1
3072232|NCT00459316|10550653|P1|Steps 1 & 2|Withdrawal by Subject|6
3072233|NCT00459316|10550651|P3|Steps 1 & 2|Not able to get to clinic|0
3072234|NCT00459316|10550652|P2|Steps 1 & 2|Not able to get to clinic|4
3072235|NCT00459316|10550653|P1|Steps 1 & 2|Not able to get to clinic|7
3072236|NCT00459316|10550651|P3|Steps 1 & 2|Death|0
3072237|NCT00459316|10550652|P2|Steps 1 & 2|Death|1
3072238|NCT00459316|10550653|P1|Steps 1 & 2|Death|1
3072239|NCT00459316|10550651|P3|Steps 1 & 2|Other eligibility failure|0
3072240|NCT00459316|10550652|P2|Steps 1 & 2|Other eligibility failure|1
3072241|NCT00459316|10550653|P1|Steps 1 & 2|Other eligibility failure|1
3072242|NCT00459290|10550718|P1|Overall Study|Ineligible|2
3072243|NCT00459290|10550718|P1|Overall Study|Adverse Event|3
3072244|NCT00459186|10550733|P1|PET Imaging and Assessment|Adverse Event|3
3072245|NCT00459186|10550733|P1|Single Agent RAD001|Withdrawal by Subject|1
3072246|NCT00459134|10550740|P2|Overall Study|Multiple Reasons|3
3072247|NCT00459134|10550741|P1|Overall Study|Multiple Reasons|2
3072248|NCT00459134|10550740|P2|Overall Study|Progression|0
3072249|NCT00459134|10550741|P1|Overall Study|Progression|1
3072250|NCT00459134|10550740|P2|Overall Study|Toxicity|5
3072251|NCT00459134|10550741|P1|Overall Study|Toxicity|4
3072252|NCT00459134|10550740|P2|Overall Study|Surgery|2
3072253|NCT00459134|10550741|P1|Overall Study|Surgery|1
3072254|NCT00459134|10550740|P2|Overall Study|Lost to Follow-up|7
3072255|NCT00459134|10550741|P1|Overall Study|Lost to Follow-up|6
3072256|NCT00459134|10550740|P2|Overall Study|Withdrawal by Subject|7
3072257|NCT00459134|10550741|P1|Overall Study|Withdrawal by Subject|8
3072258|NCT00459134|10550740|P2|Overall Study|Physician Decision|1
3072259|NCT00459134|10550741|P1|Overall Study|Physician Decision|1
3072260|NCT00459108|10550757|P1|Overall Study|Progression|1
3072261|NCT00459108|10550757|P1|Overall Study|Death|2
3072262|NCT00459108|10550757|P1|Overall Study|Adverse Event|3
3072263|NCT00459108|10550757|P1|Overall Study|Withdrawal by Subject|5
3072264|NCT00459056|10550767|P2|First Intervention (First Three Months)|Lost to Follow-up|1
3072265|NCT00459056|10550768|P1|First Intervention (First Three Months)|Lost to Follow-up|1
3072266|NCT00459043|10550776|P2|Overall Study|Withdrawal by Subject|0
3072267|NCT00459043|10550777|P1|Overall Study|Withdrawal by Subject|1
3072268|NCT00458705|10550804|P1|Overall Study|Not Treated|1
3072269|NCT00458705|10550804|P1|Overall Study|Adverse Event|4
3072270|NCT00458536|10550808|P1|Overall Study|Progressive disease during treatment|2
3072271|NCT00458536|10550808|P1|Overall Study|Withdrawal by Subject|1
3072272|NCT00458536|10550808|P1|Overall Study|Ineligible due to toxicity|1
3072273|NCT00458536|10550808|P1|Overall Study|Patient did not have surgery|1
3072274|NCT00458536|10550808|P1|Overall Study|Did not have renal cell carcinoma|2
3072275|NCT00458536|10550808|P1|Overall Study|No measurable disease after surgery|2
3072276|NCT00458536|10550808|P1|Overall Study|Unable to make vaccine|3
3072277|NCT00458536|10550808|P1|Overall Study|Disease progression prior to treatment|7
3072278|NCT00458393|10550839|P2|Overall Study|Sites marked other on the form.|20
3072279|NCT00458393|10550840|P1|Overall Study|Sites marked other on the form.|19
3072280|NCT00458393|10550839|P2|Overall Study|Lost to Follow-up|92
3072281|NCT00458393|10550840|P1|Overall Study|Lost to Follow-up|115
3072282|NCT00458393|10550839|P2|Overall Study|Relocated|81
3072283|NCT00458393|10550840|P1|Overall Study|Relocated|77
3072284|NCT00458393|10550839|P2|Overall Study|Physician Decision|22
3072285|NCT00458393|10550840|P1|Overall Study|Physician Decision|31
3072286|NCT00458393|10550839|P2|Overall Study|Withdrawal by Subject|80
3072287|NCT00458393|10550840|P1|Overall Study|Withdrawal by Subject|67
3072288|NCT00458341|10550888|P2|Cycle 1|Adverse Event|0
3072289|NCT00458341|10550889|P1|Cycle 1|Adverse Event|1
3072290|NCT00458302|10550929|P2|Overall Study|Other|2
3072291|NCT00458302|10550930|P1|Overall Study|Other|4
3072292|NCT00458302|10550929|P2|Overall Study|Lost to Follow-up|0
3072293|NCT00458302|10550930|P1|Overall Study|Lost to Follow-up|2
3072294|NCT00458302|10550929|P2|Overall Study|Study Termination By Sponsor|0
3072295|NCT00458302|10550930|P1|Overall Study|Study Termination By Sponsor|1
3072296|NCT00458302|10550929|P2|Overall Study|Inc/Exc Criteria Not Met|1
3072297|NCT00458302|10550930|P1|Overall Study|Inc/Exc Criteria Not Met|1
3072298|NCT00458302|10550929|P2|Overall Study|Withdrawal by Subject|4
3072299|NCT00458302|10550930|P1|Overall Study|Withdrawal by Subject|6
3072300|NCT00458302|10550929|P2|Overall Study|Protocol Violation|2
3072301|NCT00458302|10550930|P1|Overall Study|Protocol Violation|0
3072302|NCT00458302|10550929|P2|Overall Study|Pregnancy|1
3072303|NCT00458302|10550930|P1|Overall Study|Pregnancy|2
3072304|NCT00458302|10550929|P2|Overall Study|Adverse Event|14
3072305|NCT00458302|10550930|P1|Overall Study|Adverse Event|4
3072306|NCT00458211|10550975|P1|Overall Study|Protocol Violation|2
3072307|NCT00458211|10550975|P1|Overall Study|Withdrawal by Subject|2
3072308|NCT00458211|10550975|P1|Overall Study|Lack of Efficacy|12
3072309|NCT00457821|10551025|P8|Part 2|Withdrawal by Subject|1
3072310|NCT00457821|10551026|P7|Part 2|Withdrawal by Subject|0
3072311|NCT00457821|10551027|P6|Part 2|Withdrawal by Subject|0
3072312|NCT00457821|10551028|P5|Part 2|Withdrawal by Subject|0
3072313|NCT00457821|10551029|P4|Part 2|Withdrawal by Subject|0
3072314|NCT00457821|10551030|P3|Part 2|Withdrawal by Subject|0
3072315|NCT00457821|10551031|P2|Part 2|Withdrawal by Subject|0
3072316|NCT00457821|10551032|P1|Part 2|Withdrawal by Subject|0
3072317|NCT00457743|10551071|P3|Overall Study|Lack of Efficacy|3
3072318|NCT00457743|10551072|P2|Overall Study|Lack of Efficacy|23
3072319|NCT00457743|10551073|P1|Overall Study|Lack of Efficacy|3
3072320|NCT00457743|10551071|P3|Overall Study|Adverse Event|0
3072321|NCT00457743|10551072|P2|Overall Study|Adverse Event|4
3072322|NCT00457743|10551073|P1|Overall Study|Adverse Event|0
3072323|NCT00457691|10551130|P2|Overall Study|Disease progression, study terminated|196
3072324|NCT00457691|10551131|P1|Overall Study|Disease progression, study terminated|180
3072325|NCT00457691|10551130|P2|Overall Study|Subject refused (reason other than AE)|19
3072326|NCT00457691|10551131|P1|Overall Study|Subject refused (reason other than AE)|14
3072327|NCT00457691|10551130|P2|Overall Study|Study terminated by Sponsor|1
3072328|NCT00457691|10551131|P1|Overall Study|Study terminated by Sponsor|1
3072329|NCT00457691|10551130|P2|Overall Study|Lost to Follow-up|14
3072330|NCT00457691|10551131|P1|Overall Study|Lost to Follow-up|23
3072331|NCT00457691|10551130|P2|Overall Study|Protocol Violation|3
3072332|NCT00457691|10551131|P1|Overall Study|Protocol Violation|1
3072333|NCT00457691|10551130|P2|Overall Study|Death|148
3072334|NCT00457691|10551131|P1|Overall Study|Death|163
3072335|NCT00457691|10551130|P2|Overall Study|Adverse Event|1
3072336|NCT00457691|10551131|P1|Overall Study|Adverse Event|4
3072337|NCT00457665|10551153|P2|24 Months|Abnormal liver function tests|5
3072338|NCT00457665|10551154|P1|24 Months|Abnormal liver function tests|1
3072339|NCT00457665|10551153|P2|24 Months|Lipodystrophy|1
3072340|NCT00457665|10551154|P1|24 Months|Lipodystrophy|1
3072341|NCT00457665|10551153|P2|24 Months|Withdrawal by Subject|2
3072342|NCT00457665|10551154|P1|24 Months|Withdrawal by Subject|3
3072343|NCT00457665|10551153|P2|12 Months|Abnormal Liver function tests|5
3072344|NCT00457665|10551154|P1|12 Months|Abnormal Liver function tests|0
3072345|NCT00457665|10551153|P2|12 Months|Withdrawal by Subject|2
3072346|NCT00457665|10551154|P1|12 Months|Withdrawal by Subject|0
3072347|NCT00457665|10551153|P2|12 Months|Lipodystrophy|0
3072348|NCT00457665|10551154|P1|12 Months|Lipodystrophy|2
3072349|NCT00457665|10551153|P2|12 Months|High HIV viral load|1
3072350|NCT00457665|10551154|P1|12 Months|High HIV viral load|5
3072351|NCT00457665|10551153|P2|12 Months|Drug allergy|1
3072352|NCT00457665|10551154|P1|12 Months|Drug allergy|1
3072353|NCT00457639|10551160|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
3072354|NCT00457639|10551161|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
3072355|NCT00457639|10551160|P2|Intervention 1 (6 Months)|unrelated illness|2
3072356|NCT00457639|10551161|P1|Intervention 1 (6 Months)|unrelated illness|0
3072357|NCT00457639|10551160|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
3072358|NCT00457639|10551161|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
3072359|NCT00457418|10551169|P1|Post PK Maintenance|Lost to Follow-up|1
3072360|NCT00457418|10551169|P1|Post PK Maintenance|Withdrawal by Subject|11
3072361|NCT00457418|10551169|P1|Post PK Maintenance|Progression of Disease|6
3072362|NCT00457418|10551169|P1|Post PK Maintenance|Adverse Event|10
3072363|NCT00457418|10551169|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
3072364|NCT00457418|10551169|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
3072365|NCT00457418|10551169|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
3072366|NCT00457392|10551181|P2|Overall Study|Randomized, Not Treated|3
3072367|NCT00457392|10551182|P1|Overall Study|Randomized, Not Treated|7
3072368|NCT00457392|10551181|P2|Overall Study|Study Terminated by Sponsor|4
3072369|NCT00457392|10551182|P1|Overall Study|Study Terminated by Sponsor|1
3072370|NCT00457392|10551181|P2|Overall Study|Other|4
3072371|NCT00457392|10551182|P1|Overall Study|Other|7
3072372|NCT00457392|10551181|P2|Overall Study|Protocol Violation|3
3072373|NCT00457392|10551182|P1|Overall Study|Protocol Violation|4
3072374|NCT00457392|10551181|P2|Overall Study|Lost to Follow-up|7
3072375|NCT00457392|10551182|P1|Overall Study|Lost to Follow-up|6
3072376|NCT00457392|10551181|P2|Overall Study|Withdrawal by Subject|8
3072377|NCT00457392|10551182|P1|Overall Study|Withdrawal by Subject|14
3072378|NCT00457392|10551181|P2|Overall Study|Global Deterioration of Health Status|8
3072379|NCT00457392|10551182|P1|Overall Study|Global Deterioration of Health Status|22
3072380|NCT00457392|10551181|P2|Overall Study|Adverse Event|41
3072381|NCT00457392|10551182|P1|Overall Study|Adverse Event|84
3072382|NCT00457392|10551181|P2|Overall Study|Death|106
3072383|NCT00457392|10551182|P1|Overall Study|Death|106
3072384|NCT00457392|10551181|P2|Overall Study|Objective Progression or Relapse|296
3072385|NCT00457392|10551182|P1|Overall Study|Objective Progression or Relapse|229
3072386|NCT00457301|10551209|P2|Overall Study|Death|7
3072387|NCT00457301|10551210|P1|Overall Study|Death|5
3072388|NCT00457301|10551209|P2|Overall Study|Censored out of the study|14
3072389|NCT00457301|10551210|P1|Overall Study|Censored out of the study|15
3072390|NCT00457301|10551209|P2|Overall Study|Withdrawal by Subject|3
3072391|NCT00457301|10551210|P1|Overall Study|Withdrawal by Subject|3
3072392|NCT00457249|10551224|P2|Overall Study|Serious Adverse Events|0
3072393|NCT00457249|10551225|P1|Overall Study|Serious Adverse Events|2
3072394|NCT00457249|10551224|P2|Overall Study|Withdrawal by Subject|1
3072395|NCT00457249|10551225|P1|Overall Study|Withdrawal by Subject|3
3072396|NCT00457249|10551224|P2|Overall Study|Protocol Violation|1
3072397|NCT00457249|10551225|P1|Overall Study|Protocol Violation|4
3072398|NCT00457249|10551224|P2|Overall Study|Lost to Follow-up|0
3072399|NCT00457249|10551225|P1|Overall Study|Lost to Follow-up|3
3072400|NCT00457015|10551264|P2|Overall Study|Left study site against medical advice|1
3072401|NCT00457015|10551265|P1|Overall Study|Left study site against medical advice|0
3072402|NCT00457002|10551281|P2|Overall Study|treated for 1 day; missing status/reason|0
3072403|NCT00457002|10551282|P1|Overall Study|treated for 1 day; missing status/reason|1
3072404|NCT00457002|10551281|P2|Overall Study|non-specified|38
3072405|NCT00457002|10551282|P1|Overall Study|non-specified|29
3072406|NCT00457002|10551281|P2|Overall Study|Administrative reason by Sponsor|0
3072407|NCT00457002|10551282|P1|Overall Study|Administrative reason by Sponsor|1
3072408|NCT00457002|10551281|P2|Overall Study|No longer met criteria|37
3072409|NCT00457002|10551282|P1|Overall Study|No longer met criteria|41
3072410|NCT00457002|10551281|P2|Overall Study|Poor/Non-compliance|33
3072411|NCT00457002|10551282|P1|Overall Study|Poor/Non-compliance|46
3072412|NCT00457002|10551281|P2|Overall Study|Lost to Follow-up|71
3072413|NCT00457002|10551282|P1|Overall Study|Lost to Follow-up|72
3072414|NCT00457002|10551281|P2|Overall Study|Withdrawal by Subject|271
3072415|NCT00457002|10551282|P1|Overall Study|Withdrawal by Subject|299
3072416|NCT00457002|10551281|P2|Overall Study|Adverse Event|260
3072417|NCT00457002|10551282|P1|Overall Study|Adverse Event|284
3072418|NCT00457002|10551281|P2|Overall Study|Death|47
3072419|NCT00457002|10551282|P1|Overall Study|Death|40
3072420|NCT00456846|10551387|P2|Overall Study|Other|2
3072421|NCT00456846|10551388|P1|Overall Study|Other|0
3072422|NCT00456846|10551387|P2|Overall Study|Participant Discretion|5
3072423|NCT00456846|10551388|P1|Overall Study|Participant Discretion|1
3072424|NCT00456846|10551387|P2|Overall Study|Protocol Deviation|0
3072425|NCT00456846|10551388|P1|Overall Study|Protocol Deviation|2
3072426|NCT00456846|10551387|P2|Overall Study|Physician Decision|6
3072427|NCT00456846|10551388|P1|Overall Study|Physician Decision|11
3072428|NCT00456846|10551387|P2|Overall Study|Adverse Event|15
3072429|NCT00456846|10551388|P1|Overall Study|Adverse Event|2
3072430|NCT00456755|10551429|P2|Overall Study|Lost to Follow-up|1
3072431|NCT00456755|10551430|P1|Overall Study|Lost to Follow-up|2
3072432|NCT00456612|10551444|P1|Overall Study|Withdrawal by Subject|3
3072433|NCT00456599|10551449|P1|Overall Study|Withdrawal by Subject|2
3072434|NCT00456599|10551449|P1|Overall Study|Non-compliance|1
3072435|NCT00456521|10551472|P2|Overall Study|Drug non-compliance, moved, other|11
3072436|NCT00456521|10551473|P1|Overall Study|Drug non-compliance, moved, other|26
3072437|NCT00456521|10551472|P2|Overall Study|Pregnancy|1
3072438|NCT00456521|10551473|P1|Overall Study|Pregnancy|1
3072439|NCT00456521|10551472|P2|Overall Study|Protocol Violation|0
3072440|NCT00456521|10551473|P1|Overall Study|Protocol Violation|4
3072441|NCT00456521|10551472|P2|Overall Study|Lack of Efficacy|6
3072442|NCT00456521|10551473|P1|Overall Study|Lack of Efficacy|3
3072443|NCT00456521|10551472|P2|Overall Study|Lost to Follow-up|17
3072444|NCT00456521|10551473|P1|Overall Study|Lost to Follow-up|22
3072445|NCT00456521|10551472|P2|Overall Study|Withdrawal by Subject|24
3072446|NCT00456521|10551473|P1|Overall Study|Withdrawal by Subject|43
3072447|NCT00456521|10551472|P2|Overall Study|Adverse Event|25
3072448|NCT00456521|10551473|P1|Overall Study|Adverse Event|150
3072449|NCT00456495|10551519|P1|Overall Study|Physician Decision|2
3072450|NCT00456365|10551526|P2|Overall Study|oncologic diagnosis|1
3072451|NCT00456365|10551527|P1|Overall Study|oncologic diagnosis|1
3072452|NCT00456365|10551526|P2|Overall Study|Pregnancy|1
3072453|NCT00456365|10551527|P1|Overall Study|Pregnancy|1
3072454|NCT00456365|10551526|P2|Overall Study|Withdrawal by Subject|7
3072455|NCT00456365|10551527|P1|Overall Study|Withdrawal by Subject|4
3072456|NCT00456365|10551526|P2|Overall Study|Lost to Follow-up|3
3072457|NCT00456365|10551527|P1|Overall Study|Lost to Follow-up|1
3072458|NCT00456300|10551539|P2|Overall Study|Adverse Event|0
3072459|NCT00456300|10551540|P1|Overall Study|Adverse Event|1
3072460|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Other|0
3072461|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Other|0
3072462|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Other|1
3072463|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Other|0
3072464|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Other|1
3072465|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
3072466|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
3072467|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
3072468|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
3072469|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
3072470|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
3072471|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
3072472|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
3072473|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
3072474|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
3072475|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
3072476|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
3072477|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
3072478|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
3072479|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
3072480|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
3072481|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
3072482|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
3072483|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
3072484|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
3072485|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
3072486|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
3072487|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
3072488|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
3072489|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
3072490|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
3072491|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
3072492|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
3072493|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
3072494|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
3072495|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
3072496|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
3072497|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
3072498|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
3072499|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
3072500|NCT00456092|10551564|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
3072501|NCT00456092|10551565|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
3072502|NCT00456092|10551566|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
3072503|NCT00456092|10551567|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
3072504|NCT00456092|10551568|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
3072505|NCT00456092|10551564|P5|Extension Phase|Other|1
3072506|NCT00456092|10551565|P4|Extension Phase|Other|1
3072507|NCT00456092|10551566|P3|Extension Phase|Other|0
3072508|NCT00456092|10551567|P2|Extension Phase|Other|0
3072509|NCT00456092|10551568|P1|Extension Phase|Other|2
3072510|NCT00456092|10551564|P5|Extension Phase|Lost to Follow-up|1
3072511|NCT00456092|10551565|P4|Extension Phase|Lost to Follow-up|0
3072512|NCT00456092|10551566|P3|Extension Phase|Lost to Follow-up|0
3072513|NCT00456092|10551567|P2|Extension Phase|Lost to Follow-up|1
3072514|NCT00456092|10551568|P1|Extension Phase|Lost to Follow-up|1
3072515|NCT00456092|10551564|P5|Extension Phase|Withdrew Consent|0
3072516|NCT00456092|10551565|P4|Extension Phase|Withdrew Consent|0
3072517|NCT00456092|10551566|P3|Extension Phase|Withdrew Consent|0
3072518|NCT00456092|10551567|P2|Extension Phase|Withdrew Consent|0
3072519|NCT00456092|10551568|P1|Extension Phase|Withdrew Consent|2
3072520|NCT00456092|10551564|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
3072521|NCT00456092|10551565|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
3072522|NCT00456092|10551566|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
3072523|NCT00456092|10551567|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
3072524|NCT00456092|10551568|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
3072525|NCT00456092|10551564|P5|Extension Phase|Flare of Psoriatic Arthritis|1
3072526|NCT00456092|10551565|P4|Extension Phase|Flare of Psoriatic Arthritis|0
3072527|NCT00456092|10551566|P3|Extension Phase|Flare of Psoriatic Arthritis|0
3072528|NCT00456092|10551567|P2|Extension Phase|Flare of Psoriatic Arthritis|0
3072529|NCT00456092|10551568|P1|Extension Phase|Flare of Psoriatic Arthritis|1
3072530|NCT00456092|10551564|P5|Extension Phase|Grade 2 or Greater AE|2
3072531|NCT00456092|10551565|P4|Extension Phase|Grade 2 or Greater AE|0
3072532|NCT00456092|10551566|P3|Extension Phase|Grade 2 or Greater AE|0
3072533|NCT00456092|10551567|P2|Extension Phase|Grade 2 or Greater AE|2
3072534|NCT00456092|10551568|P1|Extension Phase|Grade 2 or Greater AE|2
3072535|NCT00455923|10551750|P2|Overall Study|Other|1
3072536|NCT00455923|10551751|P1|Overall Study|Other|3
3072537|NCT00455923|10551750|P2|Overall Study|Pregnancy|2
3072538|NCT00455923|10551751|P1|Overall Study|Pregnancy|0
3072539|NCT00455858|10551767|P1|Overall Study|Withdrawal|1
3072540|NCT00455858|10551767|P1|Overall Study|Well controlled FPG without insulin|1
3072541|NCT00455858|10551767|P1|Overall Study|Lack of Efficacy|1
3072542|NCT00455858|10551767|P1|Overall Study|Protocol Violation|1
3072543|NCT00455858|10551767|P1|Overall Study|Lost to Follow-up|2
3072544|NCT00455741|10551777|P2|Overall Study|Physician Decision|1
3072545|NCT00455741|10551778|P1|Overall Study|Physician Decision|0
3072546|NCT00455533|10551874|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
3072547|NCT00455533|10551875|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
3072548|NCT00455533|10551876|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
3072549|NCT00455533|10551874|P3|Period Two: Randomized Period|Study Drug Toxicity|0
3072550|NCT00455533|10551875|P2|Period Two: Randomized Period|Study Drug Toxicity|2
3072551|NCT00455533|10551876|P1|Period Two: Randomized Period|Study Drug Toxicity|0
3072552|NCT00455533|10551874|P3|Period Two: Randomized Period|Other - need reasons|0
3072553|NCT00455533|10551875|P2|Period Two: Randomized Period|Other - need reasons|1
3072554|NCT00455533|10551876|P1|Period Two: Randomized Period|Other - need reasons|0
3072555|NCT00455533|10551874|P3|Period Two: Randomized Period|Lost to Follow-up|1
3072556|NCT00455533|10551875|P2|Period Two: Randomized Period|Lost to Follow-up|0
3072557|NCT00455533|10551876|P1|Period Two: Randomized Period|Lost to Follow-up|0
3072558|NCT00455533|10551874|P3|Period Two: Randomized Period|Disease Progression|1
3072559|NCT00455533|10551875|P2|Period Two: Randomized Period|Disease Progression|1
3072560|NCT00455533|10551876|P1|Period Two: Randomized Period|Disease Progression|0
3072561|NCT00455533|10551874|P3|Period Two: Randomized Period|Death|3
3072562|NCT00455533|10551875|P2|Period Two: Randomized Period|Death|0
3072563|NCT00455533|10551876|P1|Period Two: Randomized Period|Death|0
3072564|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
3072565|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
3072566|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
3072567|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
3072568|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
3072569|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
3072570|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
3072571|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
3072572|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
3072573|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
3072574|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
3072575|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
3072576|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
3072577|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
3072578|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
3072579|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Not Reported|0
3072580|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Not Reported|0
3072581|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Not Reported|1
3072582|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
3072583|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
3072584|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
3072585|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Disease Progression|0
3072586|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Disease Progression|0
3072587|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Disease Progression|5
3072588|NCT00455533|10551874|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
3072589|NCT00455533|10551875|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
3072590|NCT00455533|10551876|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
3072591|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|All other|6
3072592|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|All other|4
3072593|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
3072594|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
3072595|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
3072596|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
3072597|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
3072598|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
3072599|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
3072600|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
3072601|NCT00455520|10551925|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
3072602|NCT00455520|10551926|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
3072603|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|All other|0
3072604|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|All other|33
3072605|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
3072606|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
3072607|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
3072608|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
3072609|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|Adverse Event|0
3072610|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|Adverse Event|100
3072611|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
3072612|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
3072613|NCT00455520|10551925|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
3072614|NCT00455520|10551926|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
3072615|NCT00455455|10551942|P2|Washout|Withdrawal by Subject|0
3072616|NCT00455455|10551943|P1|Washout|Withdrawal by Subject|1
3072617|NCT00455455|10551942|P2|Washout|Withdrawal by Subject|1
3072618|NCT00455455|10551943|P1|Washout|Withdrawal by Subject|0
3072619|NCT00455429|10551963|P4|Overall Study|Other|1
3072620|NCT00455429|10551964|P3|Overall Study|Other|0
3072621|NCT00455429|10551965|P2|Overall Study|Other|2
3072622|NCT00455429|10551966|P1|Overall Study|Other|0
3072623|NCT00455429|10551963|P4|Overall Study|Non-compliance|1
3072624|NCT00455429|10551964|P3|Overall Study|Non-compliance|0
3072625|NCT00455429|10551965|P2|Overall Study|Non-compliance|0
3072626|NCT00455429|10551966|P1|Overall Study|Non-compliance|0
3072627|NCT00455429|10551963|P4|Overall Study|Personal Reason|0
3072628|NCT00455429|10551964|P3|Overall Study|Personal Reason|0
3072629|NCT00455429|10551965|P2|Overall Study|Personal Reason|0
3072630|NCT00455429|10551966|P1|Overall Study|Personal Reason|1
3072631|NCT00455429|10551963|P4|Overall Study|Randomly assigned but not treated|2
3072632|NCT00455429|10551964|P3|Overall Study|Randomly assigned but not treated|0
3072633|NCT00455429|10551965|P2|Overall Study|Randomly assigned but not treated|0
3072634|NCT00455429|10551966|P1|Overall Study|Randomly assigned but not treated|0
3072635|NCT00455429|10551963|P4|Overall Study|Adverse Event|3
3072636|NCT00455429|10551964|P3|Overall Study|Adverse Event|0
3072637|NCT00455429|10551965|P2|Overall Study|Adverse Event|1
3072638|NCT00455429|10551966|P1|Overall Study|Adverse Event|0
3072639|NCT00455429|10551963|P4|Overall Study|Lack of Efficacy|1
3072640|NCT00455429|10551964|P3|Overall Study|Lack of Efficacy|0
3072641|NCT00455429|10551965|P2|Overall Study|Lack of Efficacy|1
3072642|NCT00455429|10551966|P1|Overall Study|Lack of Efficacy|0
3072643|NCT00455429|10551963|P4|Overall Study|Withdrawal by Subject|0
3072644|NCT00455429|10551964|P3|Overall Study|Withdrawal by Subject|1
3072645|NCT00455429|10551965|P2|Overall Study|Withdrawal by Subject|1
3072646|NCT00455429|10551966|P1|Overall Study|Withdrawal by Subject|0
3072647|NCT00455429|10551963|P4|Overall Study|Lost to Follow-up|3
3072648|NCT00455429|10551964|P3|Overall Study|Lost to Follow-up|0
3072649|NCT00455429|10551965|P2|Overall Study|Lost to Follow-up|0
3072650|NCT00455429|10551966|P1|Overall Study|Lost to Follow-up|1
3072651|NCT00455429|10551963|P4|Overall Study|Study Terminated by Sponsor|3
3072652|NCT00455429|10551964|P3|Overall Study|Study Terminated by Sponsor|0
3072653|NCT00455429|10551965|P2|Overall Study|Study Terminated by Sponsor|0
3072654|NCT00455429|10551966|P1|Overall Study|Study Terminated by Sponsor|0
3072655|NCT00455312|10552025|P2|Overall Study|Death|1
3072656|NCT00455312|10552026|P1|Overall Study|Death|0
3072657|NCT00455195|10552052|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
3072658|NCT00455195|10552053|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
3072659|NCT00455195|10552052|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
3072660|NCT00455195|10552053|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
3072661|NCT00455195|10552052|P2|Double-blind Study AGLU02704|Death|0
3072662|NCT00455195|10552053|P1|Double-blind Study AGLU02704|Death|1
3072663|NCT00455195|10552052|P2|Double-blind Study AGLU02704|Adverse Event|1
3072664|NCT00455195|10552053|P1|Double-blind Study AGLU02704|Adverse Event|2
3072665|NCT00455143|10552067|P1|Overall Study|Surgical time, staff not available|1
3072666|NCT00455143|10552067|P1|Overall Study|No longer met Inclusion Criteria|1
3072667|NCT00455143|10552067|P1|Overall Study|Staff was not avail to follow patient|2
3072668|NCT00455143|10552067|P1|Overall Study|Withdrawal by Subject|1
3072669|NCT00455143|10552067|P1|Overall Study|Physician Decision|1
3072670|NCT00455013|10552091|P3|Long Term Extension (LTE)|non-specified|1
3072671|NCT00455013|10552092|P2|Long Term Extension (LTE)|non-specified|0
3072672|NCT00455013|10552093|P1|Long Term Extension (LTE)|non-specified|0
3072673|NCT00455013|10552091|P3|Long Term Extension (LTE)|Poor non-compliance|0
3072674|NCT00455013|10552092|P2|Long Term Extension (LTE)|Poor non-compliance|1
3072675|NCT00455013|10552093|P1|Long Term Extension (LTE)|Poor non-compliance|0
3072676|NCT00455013|10552091|P3|Long Term Extension (LTE)|Subject Request or refused|3
3072677|NCT00455013|10552092|P2|Long Term Extension (LTE)|Subject Request or refused|0
3072678|NCT00455013|10552093|P1|Long Term Extension (LTE)|Subject Request or refused|0
3072679|NCT00455013|10552091|P3|Long Term Extension (LTE)|No longer met criteria|1
3072680|NCT00455013|10552092|P2|Long Term Extension (LTE)|No longer met criteria|0
3072681|NCT00455013|10552093|P1|Long Term Extension (LTE)|No longer met criteria|0
3072682|NCT00455013|10552091|P3|Long Term Extension (LTE)|Death|0
3072683|NCT00455013|10552092|P2|Long Term Extension (LTE)|Death|1
3072684|NCT00455013|10552093|P1|Long Term Extension (LTE)|Death|1
3072685|NCT00455013|10552091|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
3072686|NCT00455013|10552092|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
3072687|NCT00455013|10552093|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
3072688|NCT00455013|10552091|P3|Long Term Extension (LTE)|Adverse Event|1
3072689|NCT00455013|10552092|P2|Long Term Extension (LTE)|Adverse Event|1
3072690|NCT00455013|10552093|P1|Long Term Extension (LTE)|Adverse Event|0
3072691|NCT00455013|10552091|P3|Short Term Period|Other|1
3072692|NCT00455013|10552092|P2|Short Term Period|Other|0
3072693|NCT00455013|10552093|P1|Short Term Period|Other|0
3072694|NCT00455013|10552091|P3|Short Term Period|Lack of Efficacy|0
3072695|NCT00455013|10552092|P2|Short Term Period|Lack of Efficacy|0
3072696|NCT00455013|10552093|P1|Short Term Period|Lack of Efficacy|4
3072697|NCT00455013|10552091|P3|Short Term Period|Withdrawal by Subject|1
3072698|NCT00455013|10552092|P2|Short Term Period|Withdrawal by Subject|0
3072699|NCT00455013|10552093|P1|Short Term Period|Withdrawal by Subject|0
3072700|NCT00455013|10552091|P3|Short Term Period|Adverse Event|0
3072701|NCT00455013|10552092|P2|Short Term Period|Adverse Event|5
3072702|NCT00455013|10552093|P1|Short Term Period|Adverse Event|2
3072703|NCT00454987|10552161|P3|Booster Period|Lost to Follow-up|0
3072704|NCT00454987|10552162|P2|Booster Period|Lost to Follow-up|0
3072705|NCT00454987|10552163|P1|Booster Period|Lost to Follow-up|1
3072706|NCT00454987|10552161|P3|Booster Period|Withdrawal by Subject|0
3072707|NCT00454987|10552162|P2|Booster Period|Withdrawal by Subject|1
3072708|NCT00454987|10552163|P1|Booster Period|Withdrawal by Subject|0
3072709|NCT00454987|10552161|P3|Booster Period|Adverse Event|0
3072710|NCT00454987|10552162|P2|Booster Period|Adverse Event|0
3072711|NCT00454987|10552163|P1|Booster Period|Adverse Event|1
3072712|NCT00454909|10552237|P3|Overall Study|Others|0
3072713|NCT00454909|10552238|P2|Overall Study|Others|0
3072714|NCT00454909|10552239|P1|Overall Study|Others|1
3072715|NCT00454909|10552237|P3|Overall Study|Lost to follow-up (complete vaccination)|1
3072716|NCT00454909|10552238|P2|Overall Study|Lost to follow-up (complete vaccination)|3
3072717|NCT00454909|10552239|P1|Overall Study|Lost to follow-up (complete vaccination)|5
3072718|NCT00454909|10552237|P3|Overall Study|Migrated/moved from study area|1
3072719|NCT00454909|10552238|P2|Overall Study|Migrated/moved from study area|0
3072720|NCT00454909|10552239|P1|Overall Study|Migrated/moved from study area|0
3072721|NCT00454909|10552237|P3|Overall Study|Withdrawal by Subject|0
3072722|NCT00454909|10552238|P2|Overall Study|Withdrawal by Subject|0
3072723|NCT00454909|10552239|P1|Overall Study|Withdrawal by Subject|1
3072724|NCT00454857|10552277|P1|Overall Study|Reason unknown|1
3072725|NCT00454857|10552277|P1|Overall Study|Other|11
3072726|NCT00454857|10552277|P1|Overall Study|Death|5
3072727|NCT00454857|10552277|P1|Overall Study|Noncompliance|6
3072728|NCT00454857|10552277|P1|Overall Study|Lost to Follow-up|16
3072729|NCT00454857|10552277|P1|Overall Study|Withdrawal by Subject|15
3072730|NCT00454818|10552302|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
3072731|NCT00454818|10552303|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
3072732|NCT00454818|10552304|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
3072733|NCT00454818|10552305|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
3072734|NCT00454818|10552306|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
3072735|NCT00454818|10552302|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
3072736|NCT00454818|10552303|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
3072737|NCT00454818|10552304|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
3072738|NCT00454818|10552305|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
3072739|NCT00454818|10552306|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
3072740|NCT00454818|10552302|P5|Phase 2: Randomized Double-blind|Death|1
3072741|NCT00454818|10552303|P4|Phase 2: Randomized Double-blind|Death|0
3072742|NCT00454818|10552304|P3|Phase 2: Randomized Double-blind|Death|0
3072743|NCT00454818|10552305|P2|Phase 2: Randomized Double-blind|Death|1
3072744|NCT00454818|10552306|P1|Phase 2: Randomized Double-blind|Death|0
3072745|NCT00454818|10552302|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
3072746|NCT00454818|10552303|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
3072747|NCT00454818|10552304|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
3072748|NCT00454818|10552305|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
3072749|NCT00454818|10552306|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
3072750|NCT00454818|10552302|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
3072751|NCT00454818|10552303|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
3072752|NCT00454818|10552304|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
3072753|NCT00454818|10552305|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
3072754|NCT00454818|10552306|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
3072755|NCT00454818|10552302|P5|Phase I: Open-label Dose-escalation|Death|0
3072756|NCT00454818|10552303|P4|Phase I: Open-label Dose-escalation|Death|0
3072757|NCT00454818|10552304|P3|Phase I: Open-label Dose-escalation|Death|0
3072758|NCT00454818|10552305|P2|Phase I: Open-label Dose-escalation|Death|1
3072759|NCT00454818|10552306|P1|Phase I: Open-label Dose-escalation|Death|0
3072760|NCT00454818|10552302|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
3072761|NCT00454818|10552303|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
3072762|NCT00454818|10552304|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
3072763|NCT00454818|10552305|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
3072764|NCT00454818|10552306|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
3072765|NCT00454805|10552385|P2|Overall Study|In order to begin radiotherapy|0
3072766|NCT00454805|10552386|P1|Overall Study|In order to begin radiotherapy|1
3072767|NCT00454805|10552385|P2|Overall Study|Disease progression|19
3072768|NCT00454805|10552386|P1|Overall Study|Disease progression|16
3072769|NCT00454805|10552385|P2|Overall Study|Death|2
3072770|NCT00454805|10552386|P1|Overall Study|Death|0
3072771|NCT00454805|10552385|P2|Overall Study|Withdrawal by Subject|2
3072772|NCT00454805|10552386|P1|Overall Study|Withdrawal by Subject|9
3072773|NCT00454779|10552402|P2|Second-line Treatment Phase|Ongoing|1
3072774|NCT00454779|10552403|P1|Second-line Treatment Phase|Ongoing|0
3072775|NCT00454779|10552402|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
3072776|NCT00454779|10552403|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
3072777|NCT00454779|10552402|P2|Second-line Treatment Phase|Withdrawal by Subject|1
3072778|NCT00454779|10552403|P1|Second-line Treatment Phase|Withdrawal by Subject|0
3072779|NCT00454779|10552402|P2|First-line Treatment Phase|Ongoing|0
3072780|NCT00454779|10552403|P1|First-line Treatment Phase|Ongoing|1
3072781|NCT00454779|10552402|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
3072782|NCT00454779|10552403|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
3072783|NCT00454779|10552402|P2|First-line Treatment Phase|Protocol Violation|1
3072784|NCT00454779|10552403|P1|First-line Treatment Phase|Protocol Violation|0
3072785|NCT00454779|10552402|P2|First-line Treatment Phase|Lost to Follow-up|0
3072786|NCT00454779|10552403|P1|First-line Treatment Phase|Lost to Follow-up|1
3072787|NCT00454779|10552402|P2|First-line Treatment Phase|Withdrawal by Subject|4
3072788|NCT00454779|10552403|P1|First-line Treatment Phase|Withdrawal by Subject|2
3072789|NCT00454779|10552402|P2|First-line Treatment Phase|Lack of Efficacy|2
3072790|NCT00454779|10552403|P1|First-line Treatment Phase|Lack of Efficacy|0
3072791|NCT00454649|10552441|P10|Overall Study|Withdrawal by Subject|0
3072792|NCT00454649|10552442|P9|Overall Study|Withdrawal by Subject|1
3072793|NCT00454649|10552443|P8|Overall Study|Withdrawal by Subject|2
3072794|NCT00454649|10552444|P7|Overall Study|Withdrawal by Subject|0
3072795|NCT00454649|10552445|P6|Overall Study|Withdrawal by Subject|1
3072796|NCT00454649|10552446|P5|Overall Study|Withdrawal by Subject|0
3072797|NCT00454649|10552447|P4|Overall Study|Withdrawal by Subject|0
3072798|NCT00454649|10552448|P3|Overall Study|Withdrawal by Subject|0
3072799|NCT00454649|10552449|P2|Overall Study|Withdrawal by Subject|0
3072800|NCT00454649|10552450|P1|Overall Study|Withdrawal by Subject|0
3072801|NCT00454649|10552441|P10|Overall Study|Other|1
3072802|NCT00454649|10552442|P9|Overall Study|Other|3
3072803|NCT00454649|10552443|P8|Overall Study|Other|0
3072804|NCT00454649|10552444|P7|Overall Study|Other|0
3072805|NCT00454649|10552445|P6|Overall Study|Other|0
3072806|NCT00454649|10552446|P5|Overall Study|Other|0
3072807|NCT00454649|10552447|P4|Overall Study|Other|3
3072808|NCT00454649|10552448|P3|Overall Study|Other|5
3072809|NCT00454649|10552449|P2|Overall Study|Other|1
3072810|NCT00454649|10552450|P1|Overall Study|Other|1
3072811|NCT00454649|10552441|P10|Overall Study|Lost to Follow-up|0
3072812|NCT00454649|10552442|P9|Overall Study|Lost to Follow-up|0
3072813|NCT00454649|10552443|P8|Overall Study|Lost to Follow-up|0
3072814|NCT00454649|10552444|P7|Overall Study|Lost to Follow-up|1
3072815|NCT00454649|10552445|P6|Overall Study|Lost to Follow-up|0
3072816|NCT00454649|10552446|P5|Overall Study|Lost to Follow-up|0
3072817|NCT00454649|10552447|P4|Overall Study|Lost to Follow-up|0
3072818|NCT00454649|10552448|P3|Overall Study|Lost to Follow-up|1
3072819|NCT00454649|10552449|P2|Overall Study|Lost to Follow-up|0
3072820|NCT00454649|10552450|P1|Overall Study|Lost to Follow-up|0
3072821|NCT00454649|10552441|P10|Overall Study|Adverse Event|2
3072822|NCT00454649|10552442|P9|Overall Study|Adverse Event|6
3072823|NCT00454649|10552443|P8|Overall Study|Adverse Event|4
3072824|NCT00454649|10552444|P7|Overall Study|Adverse Event|3
3072825|NCT00454649|10552445|P6|Overall Study|Adverse Event|2
3072826|NCT00454649|10552446|P5|Overall Study|Adverse Event|1
3072827|NCT00454649|10552447|P4|Overall Study|Adverse Event|0
3072828|NCT00454649|10552448|P3|Overall Study|Adverse Event|3
3072829|NCT00454649|10552449|P2|Overall Study|Adverse Event|1
3072830|NCT00454649|10552450|P1|Overall Study|Adverse Event|0
3072831|NCT00454649|10552441|P10|Overall Study|Lack of Efficacy|2
3072832|NCT00454649|10552442|P9|Overall Study|Lack of Efficacy|10
3072833|NCT00454649|10552443|P8|Overall Study|Lack of Efficacy|13
3072834|NCT00454649|10552444|P7|Overall Study|Lack of Efficacy|5
3072835|NCT00454649|10552445|P6|Overall Study|Lack of Efficacy|4
3072836|NCT00454649|10552446|P5|Overall Study|Lack of Efficacy|0
3072837|NCT00454649|10552447|P4|Overall Study|Lack of Efficacy|3
3072838|NCT00454649|10552448|P3|Overall Study|Lack of Efficacy|10
3072839|NCT00454649|10552449|P2|Overall Study|Lack of Efficacy|2
3072840|NCT00454649|10552450|P1|Overall Study|Lack of Efficacy|2
3072841|NCT00454636|10552579|P4|Overall Study|Lost to Follow-up|0
3072842|NCT00454636|10552580|P3|Overall Study|Lost to Follow-up|0
3072843|NCT00454636|10552581|P2|Overall Study|Lost to Follow-up|1
3072844|NCT00454636|10552582|P1|Overall Study|Lost to Follow-up|0
3072845|NCT00454636|10552579|P4|Overall Study|Patient refusal|2
3072846|NCT00454636|10552580|P3|Overall Study|Patient refusal|3
3072847|NCT00454636|10552581|P2|Overall Study|Patient refusal|1
3072848|NCT00454636|10552582|P1|Overall Study|Patient refusal|1
3072849|NCT00454636|10552579|P4|Overall Study|Death|1
3072850|NCT00454636|10552580|P3|Overall Study|Death|1
3072851|NCT00454636|10552581|P2|Overall Study|Death|1
3072852|NCT00454636|10552582|P1|Overall Study|Death|6
3072853|NCT00454636|10552579|P4|Overall Study|Protocol Violation|3
3072854|NCT00454636|10552580|P3|Overall Study|Protocol Violation|3
3072855|NCT00454636|10552581|P2|Overall Study|Protocol Violation|2
3072856|NCT00454636|10552582|P1|Overall Study|Protocol Violation|3
3072857|NCT00454636|10552579|P4|Overall Study|Disease Progression|11
3072858|NCT00454636|10552580|P3|Overall Study|Disease Progression|4
3072859|NCT00454636|10552581|P2|Overall Study|Disease Progression|12
3072860|NCT00454636|10552582|P1|Overall Study|Disease Progression|11
3072861|NCT00454636|10552579|P4|Overall Study|Adverse Event|15
3072862|NCT00454636|10552580|P3|Overall Study|Adverse Event|9
3072863|NCT00454636|10552581|P2|Overall Study|Adverse Event|6
3072864|NCT00454636|10552582|P1|Overall Study|Adverse Event|10
3072865|NCT00454584|10552615|P6|After Controlled Period|Other|17
3072866|NCT00454584|10552616|P5|After Controlled Period|Other|5
3072867|NCT00454584|10552617|P4|After Controlled Period|Other|13
3072868|NCT00454584|10552618|P3|After Controlled Period|Other|0
3072869|NCT00454584|10552619|P2|After Controlled Period|Other|0
3072870|NCT00454584|10552620|P1|After Controlled Period|Other|0
3072871|NCT00454584|10552615|P6|After Controlled Period|Other|0
3072872|NCT00454584|10552616|P5|After Controlled Period|Other|0
3072873|NCT00454584|10552617|P4|After Controlled Period|Other|1
3072874|NCT00454584|10552618|P3|After Controlled Period|Other|0
3072875|NCT00454584|10552619|P2|After Controlled Period|Other|0
3072876|NCT00454584|10552620|P1|After Controlled Period|Other|0
3072877|NCT00454584|10552615|P6|After Controlled Period|Lost to Follow-up|6
3072878|NCT00454584|10552616|P5|After Controlled Period|Lost to Follow-up|4
3072879|NCT00454584|10552617|P4|After Controlled Period|Lost to Follow-up|2
3072880|NCT00454584|10552618|P3|After Controlled Period|Lost to Follow-up|0
3072881|NCT00454584|10552619|P2|After Controlled Period|Lost to Follow-up|0
3072882|NCT00454584|10552620|P1|After Controlled Period|Lost to Follow-up|0
3072883|NCT00454584|10552615|P6|After Controlled Period|Lack of Efficacy|0
3072884|NCT00454584|10552616|P5|After Controlled Period|Lack of Efficacy|0
3072885|NCT00454584|10552617|P4|After Controlled Period|Lack of Efficacy|1
3072886|NCT00454584|10552618|P3|After Controlled Period|Lack of Efficacy|0
3072887|NCT00454584|10552619|P2|After Controlled Period|Lack of Efficacy|0
3072888|NCT00454584|10552620|P1|After Controlled Period|Lack of Efficacy|0
3072889|NCT00454584|10552615|P6|After Controlled Period|Adverse Event|9
3072890|NCT00454584|10552616|P5|After Controlled Period|Adverse Event|3
3072891|NCT00454584|10552617|P4|After Controlled Period|Adverse Event|9
3072892|NCT00454584|10552618|P3|After Controlled Period|Adverse Event|0
3072893|NCT00454584|10552619|P2|After Controlled Period|Adverse Event|0
3072894|NCT00454584|10552620|P1|After Controlled Period|Adverse Event|0
3072895|NCT00454584|10552615|P6|Controlled Period|Other|0
3072896|NCT00454584|10552616|P5|Controlled Period|Other|0
3072897|NCT00454584|10552617|P4|Controlled Period|Other|0
3072898|NCT00454584|10552618|P3|Controlled Period|Other|2
3072899|NCT00454584|10552619|P2|Controlled Period|Other|4
3072900|NCT00454584|10552620|P1|Controlled Period|Other|5
3072901|NCT00454584|10552615|P6|Controlled Period|Lost to Follow-up|0
3072902|NCT00454584|10552616|P5|Controlled Period|Lost to Follow-up|0
3072903|NCT00454584|10552617|P4|Controlled Period|Lost to Follow-up|0
3072904|NCT00454584|10552618|P3|Controlled Period|Lost to Follow-up|2
3072905|NCT00454584|10552619|P2|Controlled Period|Lost to Follow-up|2
3072906|NCT00454584|10552620|P1|Controlled Period|Lost to Follow-up|1
3072907|NCT00454584|10552615|P6|Controlled Period|Adverse Event|0
3072908|NCT00454584|10552616|P5|Controlled Period|Adverse Event|0
3072909|NCT00454584|10552617|P4|Controlled Period|Adverse Event|0
3072910|NCT00454584|10552618|P3|Controlled Period|Adverse Event|1
3072911|NCT00454584|10552619|P2|Controlled Period|Adverse Event|2
3072912|NCT00454584|10552620|P1|Controlled Period|Adverse Event|5
3072913|NCT00454571|10552642|P2|Overall Study|Withdrawal by Subject|5
3072914|NCT00454571|10552643|P1|Overall Study|Withdrawal by Subject|10
3072915|NCT00454571|10552642|P2|Overall Study|Protocol Violation|0
3072916|NCT00454571|10552643|P1|Overall Study|Protocol Violation|1
3072917|NCT00454571|10552642|P2|Overall Study|Physician Decision|1
3072918|NCT00454571|10552643|P1|Overall Study|Physician Decision|0
3072919|NCT00454571|10552642|P2|Overall Study|Adverse Event|0
3072920|NCT00454571|10552643|P1|Overall Study|Adverse Event|2
3072921|NCT00454363|10552678|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
3072922|NCT00454363|10552679|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
3072923|NCT00454363|10552678|P2|Overall Study|Adverse Event|2
3072924|NCT00454363|10552679|P1|Overall Study|Adverse Event|1
3072925|NCT00454246|10552708|P3|Overall Study|Early termination of study|9
3072926|NCT00454246|10552709|P2|Overall Study|Early termination of study|26
3072927|NCT00454246|10552710|P1|Overall Study|Early termination of study|62
3072928|NCT00454246|10552708|P3|Overall Study|Failure to return|0
3072929|NCT00454246|10552709|P2|Overall Study|Failure to return|0
3072930|NCT00454246|10552710|P1|Overall Study|Failure to return|1
3072931|NCT00454246|10552708|P3|Overall Study|Refused Treatment|0
3072932|NCT00454246|10552709|P2|Overall Study|Refused Treatment|1
3072933|NCT00454246|10552710|P1|Overall Study|Refused Treatment|1
3072934|NCT00454246|10552708|P3|Overall Study|Protocol Violation|0
3072935|NCT00454246|10552709|P2|Overall Study|Protocol Violation|0
3072936|NCT00454246|10552710|P1|Overall Study|Protocol Violation|1
3072937|NCT00454246|10552708|P3|Overall Study|Violation of selection criteria at entry|0
3072938|NCT00454246|10552709|P2|Overall Study|Violation of selection criteria at entry|0
3072939|NCT00454246|10552710|P1|Overall Study|Violation of selection criteria at entry|6
3072940|NCT00454246|10552708|P3|Overall Study|Adverse Event|0
3072941|NCT00454246|10552709|P2|Overall Study|Adverse Event|2
3072942|NCT00454246|10552710|P1|Overall Study|Adverse Event|2
3072943|NCT00454207|10552726|P2|Overall Study|Protocol Violation|1
3072944|NCT00454207|10552727|P1|Overall Study|Protocol Violation|0
3072945|NCT00454207|10552726|P2|Overall Study|Lack of Efficacy|0
3072946|NCT00454207|10552727|P1|Overall Study|Lack of Efficacy|1
3072947|NCT00454207|10552726|P2|Overall Study|Adverse Event|1
3072948|NCT00454207|10552727|P1|Overall Study|Adverse Event|3
3072949|NCT00454194|10552772|P2|Overall Study|Other Unspecified Reason|2
3072950|NCT00454194|10552773|P1|Overall Study|Other Unspecified Reason|2
3072951|NCT00454194|10552772|P2|Overall Study|Other Medical Problems|2
3072952|NCT00454194|10552773|P1|Overall Study|Other Medical Problems|1
3072953|NCT00454194|10552772|P2|Overall Study|Withdrawal by Subject|8
3072954|NCT00454194|10552773|P1|Overall Study|Withdrawal by Subject|12
3072955|NCT00454194|10552772|P2|Overall Study|Adverse Event|2
3072956|NCT00454194|10552773|P1|Overall Study|Adverse Event|7
3072957|NCT00454181|10552791|P2|Overall Study|Withdrawal by Subject|0
3072958|NCT00454181|10552792|P1|Overall Study|Withdrawal by Subject|2
3072959|NCT00454181|10552791|P2|Overall Study|Protocol Violation|1
3072960|NCT00454181|10552792|P1|Overall Study|Protocol Violation|1
3072961|NCT00454181|10552791|P2|Overall Study|Lost to Follow-up|1
3072962|NCT00454181|10552792|P1|Overall Study|Lost to Follow-up|11
3072963|NCT00454181|10552791|P2|Overall Study|Adverse Event|1
3072964|NCT00454181|10552792|P1|Overall Study|Adverse Event|1
3072965|NCT00454142|10552808|P1|Overall Study|Withdrawal by Subject|1
3072966|NCT00454116|10552826|P3|Overall Study|Other|0
3072967|NCT00454116|10552827|P2|Overall Study|Other|2
3072968|NCT00454116|10552828|P1|Overall Study|Other|2
3072969|NCT00454116|10552826|P3|Overall Study|Withdrawal by Subject|1
3072970|NCT00454116|10552827|P2|Overall Study|Withdrawal by Subject|3
3072971|NCT00454116|10552828|P1|Overall Study|Withdrawal by Subject|3
3072972|NCT00454116|10552826|P3|Overall Study|Condition under investigation worsened|18
3072973|NCT00454116|10552827|P2|Overall Study|Condition under investigation worsened|13
3072974|NCT00454116|10552828|P1|Overall Study|Condition under investigation worsened|17
3072975|NCT00454116|10552826|P3|Overall Study|Adverse Event|9
3072976|NCT00454116|10552827|P2|Overall Study|Adverse Event|11
3072977|NCT00454116|10552828|P1|Overall Study|Adverse Event|5
3072978|NCT00454051|10552838|P2|Overall Study|Protocol Violation|1
3072979|NCT00454051|10552839|P1|Overall Study|Protocol Violation|1
3072980|NCT00454051|10552838|P2|Overall Study|Withdrawal by Subject|0
3072981|NCT00454051|10552839|P1|Overall Study|Withdrawal by Subject|1
3072982|NCT00454051|10552838|P2|Overall Study|Adverse Event|2
3072983|NCT00454051|10552839|P1|Overall Study|Adverse Event|1
3072984|NCT00453999|10552872|P3|Overall Study|Subject Request|0
3072985|NCT00453999|10552873|P2|Overall Study|Subject Request|1
3072986|NCT00453999|10552874|P1|Overall Study|Subject Request|2
3072987|NCT00453999|10552872|P3|Overall Study|Withdrawal by Subject|1
3072988|NCT00453999|10552873|P2|Overall Study|Withdrawal by Subject|1
3072989|NCT00453999|10552874|P1|Overall Study|Withdrawal by Subject|2
3072990|NCT00453999|10552872|P3|Overall Study|Lost to Follow-up|1
3072991|NCT00453999|10552873|P2|Overall Study|Lost to Follow-up|1
3072992|NCT00453999|10552874|P1|Overall Study|Lost to Follow-up|0
3072993|NCT00453999|10552872|P3|Overall Study|Adverse Event|1
3072994|NCT00453999|10552873|P2|Overall Study|Adverse Event|2
3072995|NCT00453999|10552874|P1|Overall Study|Adverse Event|1
3072996|NCT00453986|10552902|P5|Overall Study|Lost to Follow-up|0
3072997|NCT00453986|10552903|P4|Overall Study|Lost to Follow-up|2
3072998|NCT00453986|10552904|P3|Overall Study|Lost to Follow-up|6
3072999|NCT00453986|10552905|P2|Overall Study|Lost to Follow-up|5
3073000|NCT00453986|10552906|P1|Overall Study|Lost to Follow-up|6
3073001|NCT00453973|10552999|P2|Overall Study|Sponsor Decision to Terminate Study|30
3073002|NCT00453973|10553000|P1|Overall Study|Sponsor Decision to Terminate Study|35
3073003|NCT00453973|10552999|P2|Overall Study|Site closed by sponsor|0
3073004|NCT00453973|10553000|P1|Overall Study|Site closed by sponsor|3
3073005|NCT00453973|10552999|P2|Overall Study|Renal transplant|1
3073006|NCT00453973|10553000|P1|Overall Study|Renal transplant|1
3073007|NCT00453973|10552999|P2|Overall Study|Relocation|0
3073008|NCT00453973|10553000|P1|Overall Study|Relocation|1
3073009|NCT00453973|10552999|P2|Overall Study|PI Decision|2
3073010|NCT00453973|10553000|P1|Overall Study|PI Decision|0
3073011|NCT00453973|10552999|P2|Overall Study|Withdrawal by Subject|6
3073012|NCT00453973|10553000|P1|Overall Study|Withdrawal by Subject|7
3073013|NCT00453973|10552999|P2|Overall Study|Adverse Event|9
3073014|NCT00453973|10553000|P1|Overall Study|Adverse Event|4
3073015|NCT00453921|10553010|P4|Overall Study|Lost to Follow-up|0
3073016|NCT00453921|10553011|P3|Overall Study|Lost to Follow-up|1
3073017|NCT00453921|10553012|P2|Overall Study|Lost to Follow-up|0
3073018|NCT00453921|10553013|P1|Overall Study|Lost to Follow-up|0
3073019|NCT00453921|10553010|P4|Overall Study|Withdrawal by Subject|1
3073020|NCT00453921|10553011|P3|Overall Study|Withdrawal by Subject|1
3073021|NCT00453921|10553012|P2|Overall Study|Withdrawal by Subject|1
3073022|NCT00453921|10553013|P1|Overall Study|Withdrawal by Subject|1
3073023|NCT00453362|10553160|P1|Overall Study|Screening Failure|14
3073024|NCT00453362|10553160|P1|Overall Study|Progression of disease|56
3073025|NCT00453362|10553160|P1|Overall Study|Withdrawal by Subject|3
3073026|NCT00453362|10553160|P1|Overall Study|Physician Decision|2
3073027|NCT00453362|10553160|P1|Overall Study|Death|7
3073028|NCT00453362|10553160|P1|Overall Study|Adverse Event|5
3073029|NCT00453349|10553186|P2|Completed Study|Lost to follow up after study treatment|11
3073030|NCT00453349|10553187|P1|Completed Study|Lost to follow up after study treatment|2
3073031|NCT00453349|10553186|P2|Completed Study|Withdrawal by Subject|5
3073032|NCT00453349|10553187|P1|Completed Study|Withdrawal by Subject|3
3073033|NCT00453349|10553186|P2|Completed Study|Protocol Violation|1
3073034|NCT00453349|10553187|P1|Completed Study|Protocol Violation|1
3073035|NCT00453349|10553186|P2|Completed Study|Lost to Follow-up|5
3073036|NCT00453349|10553187|P1|Completed Study|Lost to Follow-up|7
3073037|NCT00453349|10553186|P2|Completed Study|Lack of Efficacy|1
3073038|NCT00453349|10553187|P1|Completed Study|Lack of Efficacy|2
3073039|NCT00453349|10553186|P2|Completed Study|Adverse Event|11
3073040|NCT00453349|10553187|P1|Completed Study|Adverse Event|12
3073041|NCT00453349|10553186|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
3073042|NCT00453349|10553187|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
3073043|NCT00453349|10553186|P2|Randomized|Withdrawal by Subject|5
3073044|NCT00453349|10553187|P1|Randomized|Withdrawal by Subject|3
3073045|NCT00453349|10553186|P2|Randomized|Protocol Violation|1
3073046|NCT00453349|10553187|P1|Randomized|Protocol Violation|1
3073047|NCT00453349|10553186|P2|Randomized|Lost to Follow-up|5
3073048|NCT00453349|10553187|P1|Randomized|Lost to Follow-up|7
3073049|NCT00453349|10553186|P2|Randomized|Lack of Efficacy|1
3073050|NCT00453349|10553187|P1|Randomized|Lack of Efficacy|2
3073051|NCT00453349|10553186|P2|Randomized|Adverse Event|11
3073052|NCT00453349|10553187|P1|Randomized|Adverse Event|12
3073053|NCT00453310|10553218|P1|Overall Study|Progression of Disease|10
3073054|NCT00453206|10553222|P1|Overall Study|Death|1
3073055|NCT00453180|10553232|P2|Overall Study|Adverse Event|2
3073056|NCT00453180|10553233|P1|Overall Study|Adverse Event|1
3073057|NCT00453180|10553232|P2|Overall Study|Lost to Follow-up|1
3073058|NCT00453180|10553233|P1|Overall Study|Lost to Follow-up|2
3073059|NCT00453154|10553252|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
3073060|NCT00453154|10553253|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
3073061|NCT00453154|10553254|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
3073062|NCT00453154|10553255|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
3073063|NCT00453154|10553252|P4|Double BIind Maintenance|Medical Issues|1
3073064|NCT00453154|10553253|P3|Double BIind Maintenance|Medical Issues|3
3073065|NCT00453154|10553254|P2|Double BIind Maintenance|Medical Issues|0
3073066|NCT00453154|10553255|P1|Double BIind Maintenance|Medical Issues|0
3073067|NCT00453154|10553252|P4|Double BIind Maintenance|Progression|26
3073068|NCT00453154|10553253|P3|Double BIind Maintenance|Progression|29
3073069|NCT00453154|10553254|P2|Double BIind Maintenance|Progression|0
3073070|NCT00453154|10553255|P1|Double BIind Maintenance|Progression|0
3073071|NCT00453154|10553252|P4|Double BIind Maintenance|Withdrawal by Subject|4
3073072|NCT00453154|10553253|P3|Double BIind Maintenance|Withdrawal by Subject|4
3073073|NCT00453154|10553254|P2|Double BIind Maintenance|Withdrawal by Subject|0
3073074|NCT00453154|10553255|P1|Double BIind Maintenance|Withdrawal by Subject|0
3073075|NCT00453154|10553252|P4|Double BIind Maintenance|Death|1
3073076|NCT00453154|10553253|P3|Double BIind Maintenance|Death|2
3073077|NCT00453154|10553254|P2|Double BIind Maintenance|Death|0
3073078|NCT00453154|10553255|P1|Double BIind Maintenance|Death|0
3073079|NCT00453154|10553252|P4|Double BIind Maintenance|Adverse Event|12
3073080|NCT00453154|10553253|P3|Double BIind Maintenance|Adverse Event|3
3073081|NCT00453154|10553254|P2|Double BIind Maintenance|Adverse Event|0
3073082|NCT00453154|10553255|P1|Double BIind Maintenance|Adverse Event|0
3073083|NCT00453102|10553268|P1|Overall Study|Withdrawal by Subject|2
3073084|NCT00453063|10553279|P2|Overall Study|Protocol Violation|0
3073085|NCT00453063|10553280|P1|Overall Study|Protocol Violation|1
3073086|NCT00453063|10553279|P2|Overall Study|Withdrawal by Subject|1
3073087|NCT00453063|10553280|P1|Overall Study|Withdrawal by Subject|1
3073088|NCT00453063|10553279|P2|Overall Study|Adverse Event|2
3073089|NCT00453063|10553280|P1|Overall Study|Adverse Event|1
3073090|NCT00452790|10553300|P2|Toddler Dose|Parent/legal guardian request|1
3073091|NCT00452790|10553301|P1|Toddler Dose|Parent/legal guardian request|0
3073092|NCT00452790|10553300|P2|Toddler Dose|Failed to return|1
3073093|NCT00452790|10553301|P1|Toddler Dose|Failed to return|0
3073094|NCT00452790|10553300|P2|After Infant Series|Other reasons|0
3073095|NCT00452790|10553301|P1|After Infant Series|Other reasons|1
3073096|NCT00452790|10553300|P2|After Infant Series|Failed to return|0
3073097|NCT00452790|10553301|P1|After Infant Series|Failed to return|1
3073098|NCT00452790|10553300|P2|After Infant Series|Lost to Follow-up|0
3073099|NCT00452790|10553301|P1|After Infant Series|Lost to Follow-up|4
3073100|NCT00452790|10553300|P2|After Infant Series|Parent/legal guardian request|3
3073101|NCT00452790|10553301|P1|After Infant Series|Parent/legal guardian request|1
3073102|NCT00452790|10553300|P2|After Infant Series|Adverse Event|1
3073103|NCT00452790|10553301|P1|After Infant Series|Adverse Event|4
3073104|NCT00452790|10553300|P2|After Infant Series|Investigator request|10
3073105|NCT00452790|10553301|P1|After Infant Series|Investigator request|10
3073106|NCT00452790|10553300|P2|Infant Series|Death|1
3073107|NCT00452790|10553301|P1|Infant Series|Death|0
3073108|NCT00452790|10553300|P2|Infant Series|Investigator request|1
3073109|NCT00452790|10553301|P1|Infant Series|Investigator request|0
3073110|NCT00452790|10553300|P2|Infant Series|Other reasons|2
3073111|NCT00452790|10553301|P1|Infant Series|Other reasons|1
3073112|NCT00452790|10553300|P2|Infant Series|Adverse Event|2
3073113|NCT00452790|10553301|P1|Infant Series|Adverse Event|1
3073114|NCT00452790|10553300|P2|Infant Series|Lost to Follow-up|2
3073115|NCT00452790|10553301|P1|Infant Series|Lost to Follow-up|2
3073116|NCT00452790|10553300|P2|Infant Series|Protocol Violation|3
3073117|NCT00452790|10553301|P1|Infant Series|Protocol Violation|1
3073118|NCT00452790|10553300|P2|Infant Series|Failed to return|1
3073119|NCT00452790|10553301|P1|Infant Series|Failed to return|4
3073120|NCT00452790|10553300|P2|Infant Series|Parent/legal guardian request|6
3073121|NCT00452790|10553301|P1|Infant Series|Parent/legal guardian request|8
3073122|NCT00452790|10553300|P2|Infant Series|Clinical hold - consent withdrawn|123
3073123|NCT00452790|10553301|P1|Infant Series|Clinical hold - consent withdrawn|118
3073124|NCT00452699|10553337|P2|Overall Study|Other|7
3073125|NCT00452699|10553338|P1|Overall Study|Other|12
3073126|NCT00452699|10553337|P2|Overall Study|Withdrawal by Subject|25
3073127|NCT00452699|10553338|P1|Overall Study|Withdrawal by Subject|26
3073128|NCT00452699|10553337|P2|Overall Study|Protocol Violation|25
3073129|NCT00452699|10553338|P1|Overall Study|Protocol Violation|21
3073130|NCT00452699|10553337|P2|Overall Study|Lost to Follow-up|9
3073131|NCT00452699|10553338|P1|Overall Study|Lost to Follow-up|6
3073132|NCT00452699|10553337|P2|Overall Study|Lack of Efficacy|4
3073133|NCT00452699|10553338|P1|Overall Study|Lack of Efficacy|6
3073134|NCT00452699|10553337|P2|Overall Study|Adverse Event|3
3073135|NCT00452699|10553338|P1|Overall Study|Adverse Event|10
3073136|NCT00452673|10553354|P5|Dose Expansion Period|Other|2
3073137|NCT00452673|10553355|P4|Dose Expansion Period|Other|0
3073138|NCT00452673|10553356|P3|Dose Expansion Period|Other|0
3073139|NCT00452673|10553357|P2|Dose Expansion Period|Other|0
3073140|NCT00452673|10553358|P1|Dose Expansion Period|Other|0
3073141|NCT00452673|10553354|P5|Dose Expansion Period|Disease Progression|19
3073142|NCT00452673|10553355|P4|Dose Expansion Period|Disease Progression|0
3073143|NCT00452673|10553356|P3|Dose Expansion Period|Disease Progression|0
3073144|NCT00452673|10553357|P2|Dose Expansion Period|Disease Progression|0
3073145|NCT00452673|10553358|P1|Dose Expansion Period|Disease Progression|0
3073146|NCT00452673|10553354|P5|Dose Escalation Period|Withdrawal by Subject|0
3073147|NCT00452673|10553355|P4|Dose Escalation Period|Withdrawal by Subject|1
3073148|NCT00452673|10553356|P3|Dose Escalation Period|Withdrawal by Subject|0
3073149|NCT00452673|10553357|P2|Dose Escalation Period|Withdrawal by Subject|0
3073150|NCT00452673|10553358|P1|Dose Escalation Period|Withdrawal by Subject|0
3073151|NCT00452673|10553354|P5|Dose Escalation Period|Adverse Event|0
3073152|NCT00452673|10553355|P4|Dose Escalation Period|Adverse Event|1
3073153|NCT00452673|10553356|P3|Dose Escalation Period|Adverse Event|0
3073154|NCT00452673|10553357|P2|Dose Escalation Period|Adverse Event|0
3073155|NCT00452673|10553358|P1|Dose Escalation Period|Adverse Event|0
3073156|NCT00452673|10553354|P5|Dose Escalation Period|Other|0
3073157|NCT00452673|10553355|P4|Dose Escalation Period|Other|0
3073158|NCT00452673|10553356|P3|Dose Escalation Period|Other|1
3073159|NCT00452673|10553357|P2|Dose Escalation Period|Other|0
3073160|NCT00452673|10553358|P1|Dose Escalation Period|Other|0
3073161|NCT00452673|10553354|P5|Dose Escalation Period|study drug toxicity|0
3073162|NCT00452673|10553355|P4|Dose Escalation Period|study drug toxicity|1
3073163|NCT00452673|10553356|P3|Dose Escalation Period|study drug toxicity|3
3073164|NCT00452673|10553357|P2|Dose Escalation Period|study drug toxicity|3
3073165|NCT00452673|10553358|P1|Dose Escalation Period|study drug toxicity|1
3073166|NCT00452673|10553354|P5|Dose Escalation Period|Disease Progression|0
3073167|NCT00452673|10553355|P4|Dose Escalation Period|Disease Progression|6
3073168|NCT00452673|10553356|P3|Dose Escalation Period|Disease Progression|2
3073169|NCT00452673|10553357|P2|Dose Escalation Period|Disease Progression|6
3073170|NCT00452673|10553358|P1|Dose Escalation Period|Disease Progression|6
3073171|NCT00452530|10553405|P2|Overall Study|Other|11
3073172|NCT00452530|10553406|P1|Overall Study|Other|7
3073173|NCT00452530|10553405|P2|Overall Study|No longer met study criteria|22
3073174|NCT00452530|10553406|P1|Overall Study|No longer met study criteria|18
3073175|NCT00452530|10553405|P2|Overall Study|Poor compliance/noncompliance|2
3073176|NCT00452530|10553406|P1|Overall Study|Poor compliance/noncompliance|1
3073177|NCT00452530|10553405|P2|Overall Study|Lost to Follow-up|0
3073178|NCT00452530|10553406|P1|Overall Study|Lost to Follow-up|1
3073179|NCT00452530|10553405|P2|Overall Study|Withdrawal by Subject|57
3073180|NCT00452530|10553406|P1|Overall Study|Withdrawal by Subject|68
3073181|NCT00452530|10553405|P2|Overall Study|Adverse Event|44
3073182|NCT00452530|10553406|P1|Overall Study|Adverse Event|40
3073183|NCT00452530|10553405|P2|Overall Study|Death|0
3073184|NCT00452530|10553406|P1|Overall Study|Death|1
3073185|NCT00452452|10553427|P3|Overall Study|Lost to Follow-up|0
3073186|NCT00452452|10553428|P2|Overall Study|Lost to Follow-up|0
3073187|NCT00452452|10553429|P1|Overall Study|Lost to Follow-up|1
3073188|NCT00452452|10553427|P3|Overall Study|Withdrawal by Subject|0
3073189|NCT00452452|10553428|P2|Overall Study|Withdrawal by Subject|0
3073190|NCT00452452|10553429|P1|Overall Study|Withdrawal by Subject|1
3073191|NCT00452452|10553427|P3|Overall Study|Protocol Violation|1
3073192|NCT00452452|10553428|P2|Overall Study|Protocol Violation|0
3073193|NCT00452452|10553429|P1|Overall Study|Protocol Violation|0
3073194|NCT00452400|10553474|P5|Overall Study|Other reasons not listed above|1
3073195|NCT00452400|10553475|P4|Overall Study|Other reasons not listed above|1
3073196|NCT00452400|10553476|P3|Overall Study|Other reasons not listed above|0
3073197|NCT00452400|10553477|P2|Overall Study|Other reasons not listed above|0
3073198|NCT00452400|10553478|P1|Overall Study|Other reasons not listed above|0
3073199|NCT00452400|10553474|P5|Overall Study|Lack of Efficacy|0
3073200|NCT00452400|10553475|P4|Overall Study|Lack of Efficacy|0
3073201|NCT00452400|10553476|P3|Overall Study|Lack of Efficacy|0
3073202|NCT00452400|10553477|P2|Overall Study|Lack of Efficacy|0
3073203|NCT00452400|10553478|P1|Overall Study|Lack of Efficacy|2
3073204|NCT00452400|10553474|P5|Overall Study|Withdrawal by Subject|0
3073205|NCT00452400|10553475|P4|Overall Study|Withdrawal by Subject|0
3073206|NCT00452400|10553476|P3|Overall Study|Withdrawal by Subject|1
3073207|NCT00452400|10553477|P2|Overall Study|Withdrawal by Subject|0
3073208|NCT00452400|10553478|P1|Overall Study|Withdrawal by Subject|1
3073209|NCT00452400|10553474|P5|Overall Study|Lost to Follow-up|0
3073210|NCT00452400|10553475|P4|Overall Study|Lost to Follow-up|0
3073211|NCT00452400|10553476|P3|Overall Study|Lost to Follow-up|0
3073212|NCT00452400|10553477|P2|Overall Study|Lost to Follow-up|0
3073213|NCT00452400|10553478|P1|Overall Study|Lost to Follow-up|1
3073214|NCT00452400|10553474|P5|Overall Study|Protocol Violation|0
3073215|NCT00452400|10553475|P4|Overall Study|Protocol Violation|0
3073216|NCT00452400|10553476|P3|Overall Study|Protocol Violation|1
3073217|NCT00452400|10553477|P2|Overall Study|Protocol Violation|0
3073218|NCT00452400|10553478|P1|Overall Study|Protocol Violation|0
3073219|NCT00452400|10553474|P5|Overall Study|Adverse Event|2
3073220|NCT00452400|10553475|P4|Overall Study|Adverse Event|0
3073221|NCT00452400|10553476|P3|Overall Study|Adverse Event|5
3073222|NCT00452400|10553477|P2|Overall Study|Adverse Event|1
3073223|NCT00452400|10553478|P1|Overall Study|Adverse Event|1
3073224|NCT00452361|10553665|P2|Overall Study|Premature termination|9
3073225|NCT00452361|10553666|P1|Overall Study|Premature termination|13
3073226|NCT00452361|10553665|P2|Overall Study|Withdrawal by Subject|1
3073227|NCT00452361|10553666|P1|Overall Study|Withdrawal by Subject|0
3073228|NCT00452361|10553665|P2|Overall Study|Adverse Event|0
3073229|NCT00452361|10553666|P1|Overall Study|Adverse Event|8
3073230|NCT00452348|10553710|P2|Overall Study|Other|9
3073231|NCT00452348|10553711|P1|Overall Study|Other|9
3073232|NCT00452348|10553710|P2|Overall Study|Withdrawal by Subject|21
3073233|NCT00452348|10553711|P1|Overall Study|Withdrawal by Subject|18
3073234|NCT00452348|10553710|P2|Overall Study|Protocol Violation|28
3073235|NCT00452348|10553711|P1|Overall Study|Protocol Violation|22
3073236|NCT00452348|10553710|P2|Overall Study|Lost to Follow-up|8
3073237|NCT00452348|10553711|P1|Overall Study|Lost to Follow-up|14
3073238|NCT00452348|10553710|P2|Overall Study|Lack of Efficacy|9
3073239|NCT00452348|10553711|P1|Overall Study|Lack of Efficacy|10
3073240|NCT00452348|10553710|P2|Overall Study|Adverse Event|9
3073241|NCT00452348|10553711|P1|Overall Study|Adverse Event|6
3073242|NCT00452114|10553765|P2|Overall Study|Physician Decision|3
3073243|NCT00452114|10553766|P1|Overall Study|Physician Decision|3
3073244|NCT00451958|10553782|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
3073245|NCT00451958|10553783|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
3073246|NCT00451958|10553784|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
3073247|NCT00451958|10553785|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
3073248|NCT00451958|10553786|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
3073249|NCT00451958|10553782|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
3073250|NCT00451958|10553783|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
3073251|NCT00451958|10553784|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
3073252|NCT00451958|10553785|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
3073253|NCT00451958|10553786|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
3073254|NCT00451958|10553782|P5|CS21A (NCT00451958)|Physician Decision|0
3073255|NCT00451958|10553783|P4|CS21A (NCT00451958)|Physician Decision|4
3073256|NCT00451958|10553784|P3|CS21A (NCT00451958)|Physician Decision|4
3073257|NCT00451958|10553785|P2|CS21A (NCT00451958)|Physician Decision|4
3073258|NCT00451958|10553786|P1|CS21A (NCT00451958)|Physician Decision|2
3073259|NCT00451958|10553782|P5|CS21A (NCT00451958)|Protocol Violation|0
3073260|NCT00451958|10553783|P4|CS21A (NCT00451958)|Protocol Violation|0
3073261|NCT00451958|10553784|P3|CS21A (NCT00451958)|Protocol Violation|2
3073262|NCT00451958|10553785|P2|CS21A (NCT00451958)|Protocol Violation|3
3073263|NCT00451958|10553786|P1|CS21A (NCT00451958)|Protocol Violation|1
3073264|NCT00451958|10553782|P5|CS21A (NCT00451958)|Lost to Follow-up|0
3073265|NCT00451958|10553783|P4|CS21A (NCT00451958)|Lost to Follow-up|1
3073266|NCT00451958|10553784|P3|CS21A (NCT00451958)|Lost to Follow-up|1
3073267|NCT00451958|10553785|P2|CS21A (NCT00451958)|Lost to Follow-up|5
3073268|NCT00451958|10553786|P1|CS21A (NCT00451958)|Lost to Follow-up|6
3073269|NCT00451958|10553782|P5|CS21A (NCT00451958)|Adverse Event|0
3073270|NCT00451958|10553783|P4|CS21A (NCT00451958)|Adverse Event|17
3073271|NCT00451958|10553784|P3|CS21A (NCT00451958)|Adverse Event|14
3073272|NCT00451958|10553785|P2|CS21A (NCT00451958)|Adverse Event|34
3073273|NCT00451958|10553786|P1|CS21A (NCT00451958)|Adverse Event|21
3073274|NCT00451906|10553816|P1|Overall Study|Did not complete final visit|4
3073275|NCT00451906|10553816|P1|Overall Study|Other Reasons|121
3073276|NCT00451906|10553816|P1|Overall Study|Termination of the study|108
3073277|NCT00451906|10553816|P1|Overall Study|Progressive disease|1328
3073278|NCT00451906|10553816|P1|Overall Study|Protocol Violation|21
3073279|NCT00451906|10553816|P1|Overall Study|Withdrawal by Subject|111
3073280|NCT00451906|10553816|P1|Overall Study|Lost to Follow-up|31
3073281|NCT00451906|10553816|P1|Overall Study|Adverse Event|515
3073282|NCT00451555|10553844|P2|Overall Study|Physician Decision|1
3073283|NCT00451555|10553845|P1|Overall Study|Physician Decision|2
3073284|NCT00451555|10553844|P2|Overall Study|Withdrawal by Subject|0
3073285|NCT00451555|10553845|P1|Overall Study|Withdrawal by Subject|6
3073286|NCT00451555|10553844|P2|Overall Study|Adverse Event|1
3073287|NCT00451555|10553845|P1|Overall Study|Adverse Event|3
3073288|NCT00451555|10553844|P2|Overall Study|Protocol Violation|2
3073289|NCT00451555|10553845|P1|Overall Study|Protocol Violation|2
3073290|NCT00451451|10553879|P4|Overall Study|Other Reasons for Not Completing Study|14
3073291|NCT00451451|10553880|P3|Overall Study|Other Reasons for Not Completing Study|17
3073292|NCT00451451|10553881|P2|Overall Study|Other Reasons for Not Completing Study|30
3073293|NCT00451451|10553882|P1|Overall Study|Other Reasons for Not Completing Study|34
3073294|NCT00451451|10553879|P4|Overall Study|Death|1
3073295|NCT00451451|10553880|P3|Overall Study|Death|0
3073296|NCT00451451|10553881|P2|Overall Study|Death|0
3073297|NCT00451451|10553882|P1|Overall Study|Death|1
3073298|NCT00451451|10553879|P4|Overall Study|Subject Non-Compliance|3
3073299|NCT00451451|10553880|P3|Overall Study|Subject Non-Compliance|3
3073300|NCT00451451|10553881|P2|Overall Study|Subject Non-Compliance|4
3073301|NCT00451451|10553882|P1|Overall Study|Subject Non-Compliance|8
3073302|NCT00451451|10553879|P4|Overall Study|Investigator Decision|2
3073303|NCT00451451|10553880|P3|Overall Study|Investigator Decision|1
3073304|NCT00451451|10553881|P2|Overall Study|Investigator Decision|2
3073305|NCT00451451|10553882|P1|Overall Study|Investigator Decision|6
3073306|NCT00451451|10553879|P4|Overall Study|Consent Withdrawn|17
3073307|NCT00451451|10553880|P3|Overall Study|Consent Withdrawn|17
3073308|NCT00451451|10553881|P2|Overall Study|Consent Withdrawn|9
3073309|NCT00451451|10553882|P1|Overall Study|Consent Withdrawn|14
3073310|NCT00451451|10553879|P4|Overall Study|Lost to Follow-up|11
3073311|NCT00451451|10553880|P3|Overall Study|Lost to Follow-up|8
3073312|NCT00451451|10553881|P2|Overall Study|Lost to Follow-up|9
3073313|NCT00451451|10553882|P1|Overall Study|Lost to Follow-up|11
3073314|NCT00451451|10553879|P4|Overall Study|Adverse Event|10
3073315|NCT00451451|10553880|P3|Overall Study|Adverse Event|26
3073316|NCT00451451|10553881|P2|Overall Study|Adverse Event|21
3073317|NCT00451451|10553882|P1|Overall Study|Adverse Event|11
3073318|NCT00451321|10553917|P8|Overall Study|Sponsor decision to amend protocol|3
3073319|NCT00451321|10553918|P7|Overall Study|Sponsor decision to amend protocol|1
3073320|NCT00451321|10553919|P6|Overall Study|Sponsor decision to amend protocol|1
3073321|NCT00451321|10553920|P5|Overall Study|Sponsor decision to amend protocol|0
3073322|NCT00451321|10553921|P4|Overall Study|Sponsor decision to amend protocol|0
3073323|NCT00451321|10553922|P3|Overall Study|Sponsor decision to amend protocol|0
3073324|NCT00451321|10553923|P2|Overall Study|Sponsor decision to amend protocol|0
3073325|NCT00451321|10553924|P1|Overall Study|Sponsor decision to amend protocol|0
3073326|NCT00451321|10553917|P8|Overall Study|Study closed/terminated|3
3073327|NCT00451321|10553918|P7|Overall Study|Study closed/terminated|5
3073328|NCT00451321|10553919|P6|Overall Study|Study closed/terminated|7
3073329|NCT00451321|10553920|P5|Overall Study|Study closed/terminated|7
3073330|NCT00451321|10553921|P4|Overall Study|Study closed/terminated|5
3073331|NCT00451321|10553922|P3|Overall Study|Study closed/terminated|17
3073332|NCT00451321|10553923|P2|Overall Study|Study closed/terminated|1
3073333|NCT00451321|10553924|P1|Overall Study|Study closed/terminated|1
3073334|NCT00451321|10553917|P8|Overall Study|Withdrawal by Subject|0
3073335|NCT00451321|10553918|P7|Overall Study|Withdrawal by Subject|0
3073336|NCT00451321|10553919|P6|Overall Study|Withdrawal by Subject|0
3073337|NCT00451321|10553920|P5|Overall Study|Withdrawal by Subject|0
3073338|NCT00451321|10553921|P4|Overall Study|Withdrawal by Subject|4
3073339|NCT00451321|10553922|P3|Overall Study|Withdrawal by Subject|0
3073340|NCT00451321|10553923|P2|Overall Study|Withdrawal by Subject|1
3073341|NCT00451321|10553924|P1|Overall Study|Withdrawal by Subject|3
3073342|NCT00451321|10553917|P8|Overall Study|Lost to Follow-up|0
3073343|NCT00451321|10553918|P7|Overall Study|Lost to Follow-up|0
3073344|NCT00451321|10553919|P6|Overall Study|Lost to Follow-up|1
3073345|NCT00451321|10553920|P5|Overall Study|Lost to Follow-up|0
3073346|NCT00451321|10553921|P4|Overall Study|Lost to Follow-up|3
3073347|NCT00451321|10553922|P3|Overall Study|Lost to Follow-up|1
3073348|NCT00451321|10553923|P2|Overall Study|Lost to Follow-up|3
3073349|NCT00451321|10553924|P1|Overall Study|Lost to Follow-up|3
3073350|NCT00451282|10554096|P2|Overall Study|Lost to Follow-up|5
3073351|NCT00451282|10554097|P1|Overall Study|Lost to Follow-up|6
3073352|NCT00451217|10554113|P4|Overall Study|Not Treated|4
3073353|NCT00451217|10554114|P3|Overall Study|Not Treated|3
3073354|NCT00451217|10554115|P2|Overall Study|Not Treated|1
3073355|NCT00451217|10554116|P1|Overall Study|Not Treated|1
3073356|NCT00451217|10554113|P4|Overall Study|Withdrawal by Subject|0
3073357|NCT00451217|10554114|P3|Overall Study|Withdrawal by Subject|0
3073358|NCT00451217|10554115|P2|Overall Study|Withdrawal by Subject|0
3073359|NCT00451217|10554116|P1|Overall Study|Withdrawal by Subject|1
3073360|NCT00451217|10554113|P4|Overall Study|Lost to Follow-up|1
3073361|NCT00451217|10554114|P3|Overall Study|Lost to Follow-up|1
3073362|NCT00451217|10554115|P2|Overall Study|Lost to Follow-up|1
3073363|NCT00451217|10554116|P1|Overall Study|Lost to Follow-up|0
3073364|NCT00451204|10554144|P2|Overall Study|Other|2
3073365|NCT00451204|10554145|P1|Overall Study|Other|1
3073366|NCT00451204|10554144|P2|Overall Study|Patient refusal|4
3073367|NCT00451204|10554145|P1|Overall Study|Patient refusal|8
3073368|NCT00451204|10554144|P2|Overall Study|Protocol Violation|0
3073369|NCT00451204|10554145|P1|Overall Study|Protocol Violation|1
3073370|NCT00451204|10554144|P2|Overall Study|Lost to Follow-up|4
3073371|NCT00451204|10554145|P1|Overall Study|Lost to Follow-up|4
3073372|NCT00451204|10554144|P2|Overall Study|Lack of Efficacy|4
3073373|NCT00451204|10554145|P1|Overall Study|Lack of Efficacy|4
3073374|NCT00451204|10554144|P2|Overall Study|Adverse Event|6
3073375|NCT00451204|10554145|P1|Overall Study|Adverse Event|4
3073376|NCT00451191|10554163|P2|Overall Study|withdrawal or received alternate tx|11
3073377|NCT00451191|10554164|P1|Overall Study|withdrawal or received alternate tx|15
3073378|NCT00450866|10554191|P2|Overall Study|Physician Decision|0
3073379|NCT00450866|10554192|P1|Overall Study|Physician Decision|1
3073380|NCT00450866|10554191|P2|Overall Study|Death|0
3073381|NCT00450866|10554192|P1|Overall Study|Death|1
3073382|NCT00450866|10554191|P2|Overall Study|Withdrawal by Subject|2
3073383|NCT00450866|10554192|P1|Overall Study|Withdrawal by Subject|5
3073384|NCT00450866|10554191|P2|Overall Study|Adverse Event|1
3073385|NCT00450866|10554192|P1|Overall Study|Adverse Event|0
3073386|NCT00450814|10554212|P11|Overall Study|Patient withdrawal prior to treatment|0
3073387|NCT00450814|10554213|P10|Overall Study|Patient withdrawal prior to treatment|1
3073388|NCT00450814|10554214|P9|Overall Study|Patient withdrawal prior to treatment|0
3073389|NCT00450814|10554215|P8|Overall Study|Patient withdrawal prior to treatment|0
3073390|NCT00450814|10554216|P7|Overall Study|Patient withdrawal prior to treatment|0
3073391|NCT00450814|10554217|P6|Overall Study|Patient withdrawal prior to treatment|0
3073392|NCT00450814|10554218|P5|Overall Study|Patient withdrawal prior to treatment|0
3073393|NCT00450814|10554219|P4|Overall Study|Patient withdrawal prior to treatment|0
3073394|NCT00450814|10554220|P3|Overall Study|Patient withdrawal prior to treatment|0
3073395|NCT00450814|10554221|P2|Overall Study|Patient withdrawal prior to treatment|0
3073396|NCT00450814|10554222|P1|Overall Study|Patient withdrawal prior to treatment|0
3073397|NCT00450814|10554212|P11|Overall Study|Failed to complete the initial therapy|0
3073398|NCT00450814|10554213|P10|Overall Study|Failed to complete the initial therapy|0
3073399|NCT00450814|10554214|P9|Overall Study|Failed to complete the initial therapy|0
3073400|NCT00450814|10554215|P8|Overall Study|Failed to complete the initial therapy|0
3073401|NCT00450814|10554216|P7|Overall Study|Failed to complete the initial therapy|0
3073402|NCT00450814|10554217|P6|Overall Study|Failed to complete the initial therapy|1
3073403|NCT00450814|10554218|P5|Overall Study|Failed to complete the initial therapy|1
3073404|NCT00450814|10554219|P4|Overall Study|Failed to complete the initial therapy|1
3073405|NCT00450814|10554220|P3|Overall Study|Failed to complete the initial therapy|0
3073406|NCT00450814|10554221|P2|Overall Study|Failed to complete the initial therapy|0
3073407|NCT00450814|10554222|P1|Overall Study|Failed to complete the initial therapy|0
3073408|NCT00450801|10554256|P1|Overall Study|Death|1
3073409|NCT00450749|10554270|P3|Overall Study|Noncompliant|0
3073410|NCT00450749|10554271|P2|Overall Study|Noncompliant|1
3073411|NCT00450749|10554272|P1|Overall Study|Noncompliant|0
3073412|NCT00450749|10554270|P3|Overall Study|Withdrawal by Subject|2
3073413|NCT00450749|10554271|P2|Overall Study|Withdrawal by Subject|0
3073414|NCT00450749|10554272|P1|Overall Study|Withdrawal by Subject|0
3073415|NCT00450723|10554310|P1|Overall Study|Physician Decision|5
3073416|NCT00450658|10554318|P2|Overall Study|misc|10
3073417|NCT00450658|10554319|P1|Overall Study|misc|21
3073418|NCT00450658|10554318|P2|Overall Study|UGI ulcer|34
3073419|NCT00450658|10554319|P1|Overall Study|UGI ulcer|33
3073420|NCT00450658|10554318|P2|Overall Study|Lost to Follow-up|5
3073421|NCT00450658|10554319|P1|Overall Study|Lost to Follow-up|22
3073422|NCT00450658|10554318|P2|Overall Study|Withdrawal by Subject|26
3073423|NCT00450658|10554319|P1|Overall Study|Withdrawal by Subject|43
3073424|NCT00450658|10554318|P2|Overall Study|Adverse Event|15
3073425|NCT00450658|10554319|P1|Overall Study|Adverse Event|24
3073426|NCT00450619|10554333|P2|Overall Study|Adverse Event|0
3073427|NCT00450619|10554334|P1|Overall Study|Adverse Event|1
3073428|NCT00450619|10554333|P2|Overall Study|did not progress; refused further trmt|1
3073429|NCT00450619|10554334|P1|Overall Study|did not progress; refused further trmt|1
3073430|NCT00450619|10554333|P2|Overall Study|refused treatment after randomization|0
3073431|NCT00450619|10554334|P1|Overall Study|refused treatment after randomization|2
3073432|NCT00450580|10554360|P2|Overall Study|Withdrawal due to pregnancy|1
3073433|NCT00450580|10554361|P1|Overall Study|Withdrawal due to pregnancy|0
3073434|NCT00450580|10554360|P2|Overall Study|Patient could not swallow Norvir|0
3073435|NCT00450580|10554361|P1|Overall Study|Patient could not swallow Norvir|1
3073436|NCT00450580|10554360|P2|Overall Study|Patient went to Brazil|0
3073437|NCT00450580|10554361|P1|Overall Study|Patient went to Brazil|1
3073438|NCT00450580|10554360|P2|Overall Study|Could not comply with scheduled visits|0
3073439|NCT00450580|10554361|P1|Overall Study|Could not comply with scheduled visits|1
3073440|NCT00450580|10554360|P2|Overall Study|Protocol-defined virologic failure|0
3073441|NCT00450580|10554361|P1|Overall Study|Protocol-defined virologic failure|1
3073442|NCT00450580|10554360|P2|Overall Study|Protocol Violation|1
3073443|NCT00450580|10554361|P1|Overall Study|Protocol Violation|1
3073444|NCT00450580|10554360|P2|Overall Study|Withdrawal by Subject|2
3073445|NCT00450580|10554361|P1|Overall Study|Withdrawal by Subject|2
3073446|NCT00450580|10554360|P2|Overall Study|Lost to Follow-up|5
3073447|NCT00450580|10554361|P1|Overall Study|Lost to Follow-up|4
3073448|NCT00450580|10554360|P2|Overall Study|Adverse Event|7
3073449|NCT00450580|10554361|P1|Overall Study|Adverse Event|5
3073450|NCT00450450|10554398|P2|Overall Study|Missing Data|0
3073451|NCT00450450|10554399|P1|Overall Study|Missing Data|2
3073452|NCT00450450|10554398|P2|Overall Study|Relapse|0
3073453|NCT00450450|10554399|P1|Overall Study|Relapse|2
3073454|NCT00450450|10554398|P2|Overall Study|Death|3
3073455|NCT00450450|10554399|P1|Overall Study|Death|1
3073456|NCT00450437|10554423|P4|Overall Study|Unable to Classify|0
3073457|NCT00450437|10554424|P3|Overall Study|Unable to Classify|1
3073458|NCT00450437|10554425|P2|Overall Study|Unable to Classify|0
3073459|NCT00450437|10554426|P1|Overall Study|Unable to Classify|1
3073460|NCT00450437|10554423|P4|Overall Study|Administrative reason|0
3073461|NCT00450437|10554424|P3|Overall Study|Administrative reason|1
3073462|NCT00450437|10554425|P2|Overall Study|Administrative reason|0
3073463|NCT00450437|10554426|P1|Overall Study|Administrative reason|0
3073464|NCT00450437|10554423|P4|Overall Study|Inappropriate enrollment|0
3073465|NCT00450437|10554424|P3|Overall Study|Inappropriate enrollment|3
3073466|NCT00450437|10554425|P2|Overall Study|Inappropriate enrollment|1
3073467|NCT00450437|10554426|P1|Overall Study|Inappropriate enrollment|4
3073468|NCT00450437|10554423|P4|Overall Study|Protocol Violation|1
3073469|NCT00450437|10554424|P3|Overall Study|Protocol Violation|0
3073470|NCT00450437|10554425|P2|Overall Study|Protocol Violation|1
3073471|NCT00450437|10554426|P1|Overall Study|Protocol Violation|0
3073472|NCT00450437|10554423|P4|Overall Study|Lost to Follow-up|9
3073473|NCT00450437|10554424|P3|Overall Study|Lost to Follow-up|19
3073474|NCT00450437|10554425|P2|Overall Study|Lost to Follow-up|12
3073475|NCT00450437|10554426|P1|Overall Study|Lost to Follow-up|31
3073476|NCT00450437|10554423|P4|Overall Study|Withdrawal by Subject|1
3073477|NCT00450437|10554424|P3|Overall Study|Withdrawal by Subject|0
3073478|NCT00450437|10554425|P2|Overall Study|Withdrawal by Subject|2
3073479|NCT00450437|10554426|P1|Overall Study|Withdrawal by Subject|10
3073480|NCT00450411|10554457|P1|Overall Study|No protocol treatment|2
3073481|NCT00450411|10554457|P1|Overall Study|Protocol Violation|6
3073482|NCT00450385|10554462|P1|Overall Study|Other|3
3073483|NCT00450385|10554462|P1|Overall Study|Physician Decision|1
3073484|NCT00450385|10554462|P1|Overall Study|Adverse Event|1
3073485|NCT00450385|10554462|P1|Overall Study|Lack of Efficacy|2
3073486|NCT00450385|10554462|P1|Overall Study|Withdrawal by Subject|2
3073487|NCT00450385|10554462|P1|Overall Study|Protocol Violation|1
3073488|NCT00450385|10554462|P1|Overall Study|Death|3
3073489|NCT00450372|10554471|P1|Overall Study|Physician Decision|1
3073490|NCT00450333|10554484|P4|Overall Study|Death|2
3073491|NCT00450333|10554485|P3|Overall Study|Death|2
3073492|NCT00450333|10554486|P2|Overall Study|Death|2
3073493|NCT00450333|10554487|P1|Overall Study|Death|3
3073494|NCT00450333|10554484|P4|Overall Study|Kidney transplant|3
3073495|NCT00450333|10554485|P3|Overall Study|Kidney transplant|1
3073496|NCT00450333|10554486|P2|Overall Study|Kidney transplant|0
3073497|NCT00450333|10554487|P1|Overall Study|Kidney transplant|1
3073498|NCT00450333|10554484|P4|Overall Study|Withdrawal by Subject|0
3073499|NCT00450333|10554485|P3|Overall Study|Withdrawal by Subject|3
3073500|NCT00450333|10554486|P2|Overall Study|Withdrawal by Subject|0
3073501|NCT00450333|10554487|P1|Overall Study|Withdrawal by Subject|1
3073502|NCT00450333|10554484|P4|Overall Study|Protocol Violation|0
3073503|NCT00450333|10554485|P3|Overall Study|Protocol Violation|1
3073504|NCT00450333|10554486|P2|Overall Study|Protocol Violation|0
3073505|NCT00450333|10554487|P1|Overall Study|Protocol Violation|1
3073506|NCT00450333|10554484|P4|Overall Study|Adverse Event|2
3073507|NCT00450333|10554485|P3|Overall Study|Adverse Event|2
3073508|NCT00450333|10554486|P2|Overall Study|Adverse Event|7
3073509|NCT00450333|10554487|P1|Overall Study|Adverse Event|1
3073510|NCT00450333|10554484|P4|Overall Study|Study terminated|21
3073511|NCT00450333|10554485|P3|Overall Study|Study terminated|16
3073512|NCT00450333|10554486|P2|Overall Study|Study terminated|54
3073513|NCT00450333|10554487|P1|Overall Study|Study terminated|47
3073514|NCT00450255|10554510|P1|Overall Study|Prior RFA ablation of liver|1
3073515|NCT00450216|10554535|P2|Overall Study|misc|20
3073516|NCT00450216|10554536|P1|Overall Study|misc|21
3073517|NCT00450216|10554535|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
3073518|NCT00450216|10554536|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
3073519|NCT00450216|10554535|P2|Overall Study|Lost to Follow-up|9
3073520|NCT00450216|10554536|P1|Overall Study|Lost to Follow-up|16
3073521|NCT00450216|10554535|P2|Overall Study|Withdrawal by Subject|26
3073522|NCT00450216|10554536|P1|Overall Study|Withdrawal by Subject|48
3073523|NCT00450216|10554535|P2|Overall Study|Adverse Event|23
3073524|NCT00450216|10554536|P1|Overall Study|Adverse Event|38
3073525|NCT00450190|10554548|P1|Overall Study|Withdrawal by Subject|2
3073526|NCT00450177|10554558|P2|Overall Study|Withdrawal by Primary Team|1
3073527|NCT00450177|10554559|P1|Overall Study|Withdrawal by Primary Team|1
3073528|NCT00450177|10554558|P2|Overall Study|Withdrawal by Subject|6
3073529|NCT00450177|10554559|P1|Overall Study|Withdrawal by Subject|1
3073530|NCT00450177|10554558|P2|Overall Study|Adverse Event|4
3073531|NCT00450177|10554559|P1|Overall Study|Adverse Event|7
3073532|NCT00450112|10554585|P2|Overall Study|Others|3
3073533|NCT00450112|10554586|P1|Overall Study|Others|2
3073534|NCT00450112|10554585|P2|Overall Study|Lost to Follow-up|1
3073535|NCT00450112|10554586|P1|Overall Study|Lost to Follow-up|2
3073536|NCT00450112|10554585|P2|Overall Study|Withdrawal by Subject|1
3073537|NCT00450112|10554586|P1|Overall Study|Withdrawal by Subject|4
3073538|NCT00450112|10554585|P2|Overall Study|Other Treatment Required|1
3073539|NCT00450112|10554586|P1|Overall Study|Other Treatment Required|5
3073540|NCT00449956|10554624|P3|Overall Study|Physician Decision|1
3073541|NCT00449956|10554625|P2|Overall Study|Physician Decision|1
3073542|NCT00449956|10554626|P1|Overall Study|Physician Decision|2
3073543|NCT00449956|10554624|P3|Overall Study|Withdrawal by Subject|0
3073544|NCT00449956|10554625|P2|Overall Study|Withdrawal by Subject|1
3073545|NCT00449956|10554626|P1|Overall Study|Withdrawal by Subject|0
3073546|NCT00449956|10554624|P3|Overall Study|Protocol Violation|1
3073547|NCT00449956|10554625|P2|Overall Study|Protocol Violation|1
3073548|NCT00449956|10554626|P1|Overall Study|Protocol Violation|1
3073549|NCT00449956|10554624|P3|Overall Study|Lack of Efficacy|1
3073550|NCT00449956|10554625|P2|Overall Study|Lack of Efficacy|0
3073551|NCT00449956|10554626|P1|Overall Study|Lack of Efficacy|0
3073552|NCT00449956|10554624|P3|Overall Study|Adverse Event|6
3073553|NCT00449956|10554625|P2|Overall Study|Adverse Event|1
3073554|NCT00449956|10554626|P1|Overall Study|Adverse Event|7
3073555|NCT00449930|10554642|P2|Overall Study|Glycemic discontinuation criteria|1
3073556|NCT00449930|10554643|P1|Overall Study|Glycemic discontinuation criteria|1
3073557|NCT00449930|10554642|P2|Overall Study|Withdrawal by Subject|23
3073558|NCT00449930|10554643|P1|Overall Study|Withdrawal by Subject|16
3073559|NCT00449930|10554642|P2|Overall Study|Protocol Violation|15
3073560|NCT00449930|10554643|P1|Overall Study|Protocol Violation|14
3073561|NCT00449930|10554642|P2|Overall Study|Physician Decision|2
3073562|NCT00449930|10554643|P1|Overall Study|Physician Decision|1
3073563|NCT00449930|10554642|P2|Overall Study|Lost to Follow-up|14
3073564|NCT00449930|10554643|P1|Overall Study|Lost to Follow-up|9
3073565|NCT00449930|10554642|P2|Overall Study|Lack of Efficacy|1
3073566|NCT00449930|10554643|P1|Overall Study|Lack of Efficacy|10
3073567|NCT00449930|10554642|P2|Overall Study|Trial Terminated ( Site Closed)|0
3073568|NCT00449930|10554643|P1|Overall Study|Trial Terminated ( Site Closed)|1
3073569|NCT00449930|10554642|P2|Overall Study|Adverse Event|19
3073570|NCT00449930|10554643|P1|Overall Study|Adverse Event|9
3073571|NCT00449865|10554659|P2|Overall Study|Study was stopped|328
3073572|NCT00449865|10554660|P1|Overall Study|Study was stopped|324
3073573|NCT00449865|10554659|P2|Overall Study|Protocol Violation|7
3073574|NCT00449865|10554660|P1|Overall Study|Protocol Violation|8
3073575|NCT00449865|10554659|P2|Overall Study|Death|40
3073576|NCT00449865|10554660|P1|Overall Study|Death|31
3073577|NCT00449865|10554659|P2|Overall Study|Physician Decision|12
3073578|NCT00449865|10554660|P1|Overall Study|Physician Decision|13
3073579|NCT00449865|10554659|P2|Overall Study|Lost to Follow-up|37
3073580|NCT00449865|10554660|P1|Overall Study|Lost to Follow-up|36
3073581|NCT00449865|10554659|P2|Overall Study|Withdrawal by Subject|110
3073582|NCT00449865|10554660|P1|Overall Study|Withdrawal by Subject|110
3073583|NCT00449787|10554668|P2|Overall Study|Did not require medication|92
3073584|NCT00449787|10554669|P1|Overall Study|Did not require medication|95
3073585|NCT00449787|10554668|P2|Overall Study|Lost to Follow-up|8
3073586|NCT00449787|10554669|P1|Overall Study|Lost to Follow-up|10
3073587|NCT00449696|10554685|P2|Overall Study|Others|0
3073588|NCT00449696|10554686|P1|Overall Study|Others|7
3073589|NCT00449696|10554685|P2|Overall Study|Lost to Follow-up|3
3073590|NCT00449696|10554686|P1|Overall Study|Lost to Follow-up|2
3073591|NCT00449696|10554685|P2|Overall Study|Withdrawal by Subject|5
3073592|NCT00449696|10554686|P1|Overall Study|Withdrawal by Subject|5
3073593|NCT00449696|10554685|P2|Overall Study|Other Treatment Required|1
3073594|NCT00449696|10554686|P1|Overall Study|Other Treatment Required|6
3073595|NCT00449670|10554710|P2|Booster Phase (Study no.109873)|Other|2
3073596|NCT00449670|10554711|P1|Booster Phase (Study no.109873)|Other|0
3073597|NCT00449670|10554710|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
3073598|NCT00449670|10554711|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
3073599|NCT00449670|10554710|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
3073600|NCT00449670|10554711|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
3073601|NCT00449670|10554710|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
3073602|NCT00449670|10554711|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
3073603|NCT00449670|10554710|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
3073604|NCT00449670|10554711|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
3073605|NCT00449670|10554710|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
3073606|NCT00449670|10554711|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
3073607|NCT00449644|10554824|P4|Overall Study|Rolled-over to treatment with TMC207|1
3073608|NCT00449644|10554825|P3|Overall Study|Rolled-over to treatment with TMC207|0
3073609|NCT00449644|10554826|P2|Overall Study|Rolled-over to treatment with TMC207|0
3073610|NCT00449644|10554827|P1|Overall Study|Rolled-over to treatment with TMC207|0
3073611|NCT00449644|10554824|P4|Overall Study|Other|0
3073612|NCT00449644|10554825|P3|Overall Study|Other|1
3073613|NCT00449644|10554826|P2|Overall Study|Other|4
3073614|NCT00449644|10554827|P1|Overall Study|Other|1
3073615|NCT00449644|10554824|P4|Overall Study|Inclusion/exclusion criteria not met|6
3073616|NCT00449644|10554825|P3|Overall Study|Inclusion/exclusion criteria not met|2
3073617|NCT00449644|10554826|P2|Overall Study|Inclusion/exclusion criteria not met|0
3073618|NCT00449644|10554827|P1|Overall Study|Inclusion/exclusion criteria not met|0
3073619|NCT00449644|10554824|P4|Overall Study|Withdrawal by Subject|7
3073620|NCT00449644|10554825|P3|Overall Study|Withdrawal by Subject|6
3073621|NCT00449644|10554826|P2|Overall Study|Withdrawal by Subject|4
3073622|NCT00449644|10554827|P1|Overall Study|Withdrawal by Subject|3
3073623|NCT00449644|10554824|P4|Overall Study|Protocol Violation|7
3073624|NCT00449644|10554825|P3|Overall Study|Protocol Violation|3
3073625|NCT00449644|10554826|P2|Overall Study|Protocol Violation|4
3073626|NCT00449644|10554827|P1|Overall Study|Protocol Violation|4
3073627|NCT00449644|10554824|P4|Overall Study|Pregnancy|2
3073628|NCT00449644|10554825|P3|Overall Study|Pregnancy|3
3073629|NCT00449644|10554826|P2|Overall Study|Pregnancy|0
3073630|NCT00449644|10554827|P1|Overall Study|Pregnancy|0
3073631|NCT00449644|10554824|P4|Overall Study|Lost to Follow-up|3
3073632|NCT00449644|10554825|P3|Overall Study|Lost to Follow-up|5
3073633|NCT00449644|10554826|P2|Overall Study|Lost to Follow-up|1
3073634|NCT00449644|10554827|P1|Overall Study|Lost to Follow-up|1
3073635|NCT00449644|10554824|P4|Overall Study|Death|1
3073636|NCT00449644|10554825|P3|Overall Study|Death|6
3073637|NCT00449644|10554826|P2|Overall Study|Death|0
3073638|NCT00449644|10554827|P1|Overall Study|Death|1
3073639|NCT00449644|10554824|P4|Overall Study|Adverse Event|5
3073640|NCT00449644|10554825|P3|Overall Study|Adverse Event|3
3073641|NCT00449644|10554826|P2|Overall Study|Adverse Event|0
3073642|NCT00449644|10554827|P1|Overall Study|Adverse Event|0
3073643|NCT00449540|10554847|P3|Treatment Phase|did not experience or treat migraine|17
3073644|NCT00449540|10554848|P2|Treatment Phase|did not experience or treat migraine|20
3073645|NCT00449540|10554849|P1|Treatment Phase|did not experience or treat migraine|0
3073646|NCT00449540|10554847|P3|Pretreatment Phase|No migraine experienced|0
3073647|NCT00449540|10554848|P2|Pretreatment Phase|No migraine experienced|0
3073648|NCT00449540|10554849|P1|Pretreatment Phase|No migraine experienced|66
3073649|NCT00449176|10554866|P3|Overall Study|all other|20
3073650|NCT00449176|10554867|P2|Overall Study|all other|19
3073651|NCT00449176|10554868|P1|Overall Study|all other|22
3073652|NCT00449176|10554866|P3|Overall Study|Study drug non-compliant|11
3073653|NCT00449176|10554867|P2|Overall Study|Study drug non-compliant|11
3073654|NCT00449176|10554868|P1|Overall Study|Study drug non-compliant|14
3073655|NCT00449176|10554866|P3|Overall Study|Lack of Efficacy|50
3073656|NCT00449176|10554867|P2|Overall Study|Lack of Efficacy|7
3073657|NCT00449176|10554868|P1|Overall Study|Lack of Efficacy|13
3073658|NCT00449176|10554866|P3|Overall Study|Adverse Event|15
3073659|NCT00449176|10554867|P2|Overall Study|Adverse Event|107
3073660|NCT00449176|10554868|P1|Overall Study|Adverse Event|51
3073661|NCT00449176|10554866|P3|Overall Study|Lost to Follow-up|12
3073662|NCT00449176|10554867|P2|Overall Study|Lost to Follow-up|8
3073663|NCT00449176|10554868|P1|Overall Study|Lost to Follow-up|13
3073664|NCT00449176|10554866|P3|Overall Study|Withdrawal by Subject|59
3073665|NCT00449176|10554867|P2|Overall Study|Withdrawal by Subject|43
3073666|NCT00449176|10554868|P1|Overall Study|Withdrawal by Subject|39
3073667|NCT00449163|10554894|P1|Overall Study|Physician Decision|3
3073668|NCT00449150|10554904|P3|Overall Study|Protocol Violation|1
3073669|NCT00449150|10554905|P2|Overall Study|Protocol Violation|2
3073670|NCT00449150|10554906|P1|Overall Study|Protocol Violation|1
3073671|NCT00449150|10554904|P3|Overall Study|Withdrawal by Subject|21
3073672|NCT00449150|10554905|P2|Overall Study|Withdrawal by Subject|18
3073673|NCT00449150|10554906|P1|Overall Study|Withdrawal by Subject|17
3073674|NCT00449150|10554904|P3|Overall Study|Other|14
3073675|NCT00449150|10554905|P2|Overall Study|Other|13
3073676|NCT00449150|10554906|P1|Overall Study|Other|16
3073677|NCT00449150|10554904|P3|Overall Study|Lack of Efficacy|2
3073678|NCT00449150|10554905|P2|Overall Study|Lack of Efficacy|2
3073679|NCT00449150|10554906|P1|Overall Study|Lack of Efficacy|1
3073680|NCT00449150|10554904|P3|Overall Study|Adverse Event|9
3073681|NCT00449150|10554905|P2|Overall Study|Adverse Event|18
3073682|NCT00449150|10554906|P1|Overall Study|Adverse Event|11
3073683|NCT00449072|10554919|P2|Overall Study|Relocation|2
3073684|NCT00449072|10554920|P1|Overall Study|Relocation|3
3073685|NCT00449072|10554919|P2|Overall Study|Sponsor decision|3
3073686|NCT00449072|10554920|P1|Overall Study|Sponsor decision|1
3073687|NCT00449072|10554919|P2|Overall Study|Non-compliance|5
3073688|NCT00449072|10554920|P1|Overall Study|Non-compliance|2
3073689|NCT00449072|10554919|P2|Overall Study|Excluded medication|2
3073690|NCT00449072|10554920|P1|Overall Study|Excluded medication|0
3073691|NCT00449072|10554919|P2|Overall Study|Not treated|1
3073692|NCT00449072|10554920|P1|Overall Study|Not treated|0
3073693|NCT00449072|10554919|P2|Overall Study|Physician Decision|0
3073694|NCT00449072|10554920|P1|Overall Study|Physician Decision|1
3073695|NCT00449072|10554919|P2|Overall Study|Lack of Efficacy|1
3073696|NCT00449072|10554920|P1|Overall Study|Lack of Efficacy|1
3073697|NCT00449072|10554919|P2|Overall Study|Withdrawal by Subject|8
3073698|NCT00449072|10554920|P1|Overall Study|Withdrawal by Subject|11
3073699|NCT00449072|10554919|P2|Overall Study|Lost to Follow-up|7
3073700|NCT00449072|10554920|P1|Overall Study|Lost to Follow-up|5
3073701|NCT00449072|10554919|P2|Overall Study|Protocol Violation|12
3073702|NCT00449072|10554920|P1|Overall Study|Protocol Violation|14
3073703|NCT00449072|10554919|P2|Overall Study|Adverse Event|1
3073704|NCT00449072|10554920|P1|Overall Study|Adverse Event|3
3073705|NCT00449033|10554957|P2|Follow-up Period|Reason Missing|113
3073706|NCT00449033|10554958|P1|Follow-up Period|Reason Missing|120
3073707|NCT00449033|10554957|P2|Follow-up Period|Lost to Follow-up|10
3073708|NCT00449033|10554958|P1|Follow-up Period|Lost to Follow-up|6
3073709|NCT00449033|10554957|P2|Follow-up Period|Death|311
3073710|NCT00449033|10554958|P1|Follow-up Period|Death|299
3073711|NCT00449033|10554957|P2|Treatment Period|Treatment Ongoing|4
3073712|NCT00449033|10554958|P1|Treatment Period|Treatment Ongoing|6
3073713|NCT00449033|10554957|P2|Treatment Period|Reason Missing|4
3073714|NCT00449033|10554958|P1|Treatment Period|Reason Missing|0
3073715|NCT00449033|10554957|P2|Treatment Period|Second Malignancy|1
3073716|NCT00449033|10554958|P1|Treatment Period|Second Malignancy|0
3073717|NCT00449033|10554957|P2|Treatment Period|Non-compliance|8
3073718|NCT00449033|10554958|P1|Treatment Period|Non-compliance|7
3073719|NCT00449033|10554957|P2|Treatment Period|Amended Protocol Criteria|18
3073720|NCT00449033|10554958|P1|Treatment Period|Amended Protocol Criteria|22
3073721|NCT00449033|10554957|P2|Treatment Period|Consent Withdrawn|20
3073722|NCT00449033|10554958|P1|Treatment Period|Consent Withdrawn|36
3073723|NCT00449033|10554957|P2|Treatment Period|Disease Progression|288
3073724|NCT00449033|10554958|P1|Treatment Period|Disease Progression|231
3073725|NCT00449033|10554957|P2|Treatment Period|Protocol Violation|7
3073726|NCT00449033|10554958|P1|Treatment Period|Protocol Violation|8
3073727|NCT00449033|10554957|P2|Treatment Period|Physician Decision|5
3073728|NCT00449033|10554958|P1|Treatment Period|Physician Decision|4
3073729|NCT00449033|10554957|P2|Treatment Period|Lost to Follow-up|2
3073730|NCT00449033|10554958|P1|Treatment Period|Lost to Follow-up|0
3073731|NCT00449033|10554957|P2|Treatment Period|Death|12
3073732|NCT00449033|10554958|P1|Treatment Period|Death|21
3073733|NCT00449033|10554957|P2|Treatment Period|Adverse Event|83
3073734|NCT00449033|10554958|P1|Treatment Period|Adverse Event|117
3073735|NCT00448916|10554996|P4|Overall Study|Protocol Violation|1
3073736|NCT00448916|10554997|P3|Overall Study|Protocol Violation|0
3073737|NCT00448916|10554998|P2|Overall Study|Protocol Violation|0
3073738|NCT00448916|10554999|P1|Overall Study|Protocol Violation|0
3073739|NCT00448916|10554996|P4|Overall Study|Lost to Follow-up|1
3073740|NCT00448916|10554997|P3|Overall Study|Lost to Follow-up|0
3073741|NCT00448916|10554998|P2|Overall Study|Lost to Follow-up|1
3073742|NCT00448916|10554999|P1|Overall Study|Lost to Follow-up|0
3073743|NCT00448916|10554996|P4|Overall Study|Other|0
3073744|NCT00448916|10554997|P3|Overall Study|Other|0
3073745|NCT00448916|10554998|P2|Overall Study|Other|0
3073746|NCT00448916|10554999|P1|Overall Study|Other|1
3073747|NCT00448916|10554996|P4|Overall Study|Withdrawal by Subject|1
3073748|NCT00448916|10554997|P3|Overall Study|Withdrawal by Subject|1
3073749|NCT00448916|10554998|P2|Overall Study|Withdrawal by Subject|3
3073750|NCT00448916|10554999|P1|Overall Study|Withdrawal by Subject|3
3073751|NCT00448916|10554996|P4|Overall Study|Lack of Efficacy|1
3073752|NCT00448916|10554997|P3|Overall Study|Lack of Efficacy|2
3073753|NCT00448916|10554998|P2|Overall Study|Lack of Efficacy|0
3073754|NCT00448916|10554999|P1|Overall Study|Lack of Efficacy|1
3073755|NCT00448916|10554996|P4|Overall Study|Adverse Event|2
3073756|NCT00448916|10554997|P3|Overall Study|Adverse Event|3
3073757|NCT00448916|10554998|P2|Overall Study|Adverse Event|2
3073758|NCT00448916|10554999|P1|Overall Study|Adverse Event|2
3073759|NCT00448864|10555073|P3|Overall Study|Protocol Violation|0
3073760|NCT00448864|10555074|P2|Overall Study|Protocol Violation|2
3073761|NCT00448864|10555075|P1|Overall Study|Protocol Violation|0
3073762|NCT00448864|10555073|P3|Overall Study|Withdrawal by Subject|0
3073763|NCT00448864|10555074|P2|Overall Study|Withdrawal by Subject|2
3073764|NCT00448864|10555075|P1|Overall Study|Withdrawal by Subject|0
3073765|NCT00448864|10555073|P3|Overall Study|Physician Decision|1
3073766|NCT00448864|10555074|P2|Overall Study|Physician Decision|0
3073767|NCT00448864|10555075|P1|Overall Study|Physician Decision|1
3073768|NCT00448864|10555073|P3|Overall Study|Lost to Follow-up|0
3073769|NCT00448864|10555074|P2|Overall Study|Lost to Follow-up|1
3073770|NCT00448864|10555075|P1|Overall Study|Lost to Follow-up|3
3073771|NCT00448864|10555073|P3|Overall Study|Death|0
3073772|NCT00448864|10555074|P2|Overall Study|Death|0
3073773|NCT00448864|10555075|P1|Overall Study|Death|1
3073774|NCT00448760|10555091|P1|Overall Study|Death|3
3073775|NCT00448747|10555100|P2|Overall Study|collapsed veins|0
3073776|NCT00448747|10555101|P1|Overall Study|collapsed veins|1
3073777|NCT00448708|10555119|P2|Overall Study|not listed|2
3073778|NCT00448708|10555120|P1|Overall Study|not listed|0
3073779|NCT00448708|10555119|P2|Overall Study|Lost to Follow-up|8
3073780|NCT00448708|10555120|P1|Overall Study|Lost to Follow-up|6
3073781|NCT00448708|10555119|P2|Overall Study|Withdrawal by Subject|4
3073782|NCT00448708|10555120|P1|Overall Study|Withdrawal by Subject|8
3073783|NCT00448708|10555119|P2|Overall Study|Death|17
3073784|NCT00448708|10555120|P1|Overall Study|Death|21
3073785|NCT00448669|10555136|P2|Overall Study|Never started drug|7
3073786|NCT00448669|10555137|P1|Overall Study|Never started drug|9
3073787|NCT00448669|10555136|P2|Overall Study|HIV-infected at enrollment|2
3073788|NCT00448669|10555137|P1|Overall Study|HIV-infected at enrollment|1
3073789|NCT00448669|10555136|P2|Overall Study|Had other reasons|6
3073790|NCT00448669|10555137|P1|Overall Study|Had other reasons|5
3073791|NCT00448669|10555136|P2|Overall Study|Death|4
3073792|NCT00448669|10555137|P1|Overall Study|Death|2
3073793|NCT00448669|10555136|P2|Overall Study|Were withdrawn by investigator|6
3073794|NCT00448669|10555137|P1|Overall Study|Were withdrawn by investigator|10
3073795|NCT00448669|10555136|P2|Overall Study|Relocated|36
3073796|NCT00448669|10555137|P1|Overall Study|Relocated|49
3073797|NCT00448669|10555136|P2|Overall Study|Withdrawal by Subject|74
3073798|NCT00448669|10555137|P1|Overall Study|Withdrawal by Subject|90
3073799|NCT00448669|10555136|P2|Overall Study|Lost to Follow-up|63
3073800|NCT00448669|10555137|P1|Overall Study|Lost to Follow-up|52
3073801|NCT00448591|10555198|P1|Overall Study|Termination of Study|70
3073802|NCT00448591|10555198|P1|Overall Study|Other|154
3073803|NCT00448591|10555198|P1|Overall Study|Treatment Regimen Completed|70
3073804|NCT00448591|10555198|P1|Overall Study|Lost to Follow-up|19
3073805|NCT00448591|10555198|P1|Overall Study|Protocol Violation|41
3073806|NCT00448591|10555198|P1|Overall Study|Adverse Event|382
3073807|NCT00448591|10555198|P1|Overall Study|Progressive Disease|1382
3073808|NCT00448591|10555198|P1|Overall Study|Withdrawal by Subject|178
3073809|NCT00448539|10555209|P2|Overall Study|Lost to Follow-up|3
3073810|NCT00448539|10555210|P1|Overall Study|Lost to Follow-up|1
3073811|NCT00448539|10555209|P2|Overall Study|Change of meds|3
3073812|NCT00448539|10555210|P1|Overall Study|Change of meds|2
3073813|NCT00448539|10555209|P2|Overall Study|Miscellaneous|1
3073814|NCT00448539|10555210|P1|Overall Study|Miscellaneous|2
3073815|NCT00448539|10555209|P2|Overall Study|Lack of Efficacy|40
3073816|NCT00448539|10555210|P1|Overall Study|Lack of Efficacy|27
3073817|NCT00448539|10555209|P2|Overall Study|Adverse Event|26
3073818|NCT00448539|10555210|P1|Overall Study|Adverse Event|9
3073819|NCT00448539|10555209|P2|Overall Study|Diary non-compliance|0
3073820|NCT00448539|10555210|P1|Overall Study|Diary non-compliance|1
3073821|NCT00448539|10555209|P2|Overall Study|Withdrawal by Subject|24
3073822|NCT00448539|10555210|P1|Overall Study|Withdrawal by Subject|20
3073823|NCT00448539|10555209|P2|Overall Study|Request of the investigator or sponsor|54
3073824|NCT00448539|10555210|P1|Overall Study|Request of the investigator or sponsor|67
3073825|NCT00448539|10555209|P2|Overall Study|Protocol Violation|0
3073826|NCT00448539|10555210|P1|Overall Study|Protocol Violation|1
3073827|NCT00448539|10555209|P2|Overall Study|Medication non-compliance|1
3073828|NCT00448539|10555210|P1|Overall Study|Medication non-compliance|4
3073829|NCT00448448|10555218|P2|Overall Study|Signed consent lost|1
3073830|NCT00448448|10555219|P1|Overall Study|Signed consent lost|0
3073831|NCT00448448|10555218|P2|Overall Study|Wrong diagnosis (n=3) or other|1
3073832|NCT00448448|10555219|P1|Overall Study|Wrong diagnosis (n=3) or other|2
3073833|NCT00448448|10555218|P2|Overall Study|Lost to Follow-up|1
3073834|NCT00448448|10555219|P1|Overall Study|Lost to Follow-up|2
3073835|NCT00448448|10555218|P2|Overall Study|On protocol when study ended|36
3073836|NCT00448448|10555219|P1|Overall Study|On protocol when study ended|83
3073837|NCT00448448|10555218|P2|Overall Study|Withdrawal by Subject|2
3073838|NCT00448448|10555219|P1|Overall Study|Withdrawal by Subject|13
3073839|NCT00448435|10555225|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
3073840|NCT00448435|10555226|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
3073841|NCT00448344|10555277|P2|Overall Study|Physician Decision|2
3073842|NCT00448344|10555278|P1|Overall Study|Physician Decision|1
3073843|NCT00448344|10555277|P2|Overall Study|Death|4
3073844|NCT00448344|10555278|P1|Overall Study|Death|3
3073845|NCT00448344|10555277|P2|Overall Study|Withdrawal by Subject|8
3073846|NCT00448344|10555278|P1|Overall Study|Withdrawal by Subject|6
3073847|NCT00448344|10555277|P2|Overall Study|Lost to Follow-up|22
3073848|NCT00448344|10555278|P1|Overall Study|Lost to Follow-up|20
3073849|NCT00448279|10555288|P2|Overall Study|Protocol Violation|1
3073850|NCT00448279|10555289|P1|Overall Study|Protocol Violation|0
3073851|NCT00448279|10555288|P2|Overall Study|Other|4
3073852|NCT00448279|10555289|P1|Overall Study|Other|6
3073853|NCT00448279|10555288|P2|Overall Study|Withdrawal by Subject|3
3073854|NCT00448279|10555289|P1|Overall Study|Withdrawal by Subject|4
3073855|NCT00448279|10555288|P2|Overall Study|Disease progression|18
3073856|NCT00448279|10555289|P1|Overall Study|Disease progression|16
3073857|NCT00448279|10555288|P2|Overall Study|Adverse Event|1
3073858|NCT00448279|10555289|P1|Overall Study|Adverse Event|1
3073859|NCT00448279|10555288|P2|Overall Study|Lost to Follow-up|2
3073860|NCT00448279|10555289|P1|Overall Study|Lost to Follow-up|2
3073861|NCT00448136|10555352|P2|Overall Study|Investigator's decision (progression)|0
3073862|NCT00448136|10555353|P1|Overall Study|Investigator's decision (progression)|1
3073863|NCT00448136|10555352|P2|Overall Study|Death|8
3073864|NCT00448136|10555353|P1|Overall Study|Death|3
3073865|NCT00448123|10555391|P2|Overall Study|Physician Decision|6
3073866|NCT00448123|10555392|P1|Overall Study|Physician Decision|6
3073867|NCT00448123|10555391|P2|Overall Study|Lost to Follow-up|6
3073868|NCT00448123|10555392|P1|Overall Study|Lost to Follow-up|9
3073869|NCT00448019|10555402|P1|Overall Study|Insurance Issues|1
3073870|NCT00448019|10555402|P1|Overall Study|Death|2
3073871|NCT00448019|10555402|P1|Overall Study|Disease progression|1
3073872|NCT00448019|10555402|P1|Overall Study|Withdrawal by Subject|3
3073873|NCT00447902|10555410|P2|Overall Study|Lack of Efficacy|1
3073874|NCT00447902|10555411|P1|Overall Study|Lack of Efficacy|2
3073875|NCT00447902|10555410|P2|Overall Study|included patients who discontinued|1
3073876|NCT00447902|10555411|P1|Overall Study|included patients who discontinued|1
3073877|NCT00447902|10555410|P2|Overall Study|Withdrawal by Subject|1
3073878|NCT00447902|10555411|P1|Overall Study|Withdrawal by Subject|0
3073879|NCT00447902|10555410|P2|Overall Study|Protocol Violation|0
3073880|NCT00447902|10555411|P1|Overall Study|Protocol Violation|1
3073881|NCT00447902|10555410|P2|Overall Study|Adverse Event|3
3073882|NCT00447902|10555411|P1|Overall Study|Adverse Event|0
3073883|NCT00447876|10555453|P2|Overall Study|Deterioration of symptomology|0
3073884|NCT00447876|10555454|P1|Overall Study|Deterioration of symptomology|1
3073885|NCT00447876|10555453|P2|Overall Study|Lost to Follow-up|0
3073886|NCT00447876|10555454|P1|Overall Study|Lost to Follow-up|1
3073887|NCT00447876|10555453|P2|Overall Study|Withdrawal by Subject|4
3073888|NCT00447876|10555454|P1|Overall Study|Withdrawal by Subject|1
3073889|NCT00447772|10555484|P1|Overall Study|Premature re-injection required|1
3073890|NCT00447772|10555484|P1|Overall Study|Chemotherapy for lung cancer|1
3073891|NCT00447772|10555484|P1|Overall Study|Incomplete documentation at visit 1|1
3073892|NCT00447772|10555484|P1|Overall Study|Patient relocated|1
3073893|NCT00447772|10555484|P1|Overall Study|Adverse Event|1
3073894|NCT00447772|10555484|P1|Overall Study|Unable to attend all study visits|2
3073895|NCT00447772|10555484|P1|Overall Study|Withdrawal by Subject|1
3073896|NCT00447772|10555484|P1|Overall Study|Lost to Follow-up|9
3073897|NCT00447772|10555484|P1|Overall Study|Discontinuation of drug therapy|1
3073898|NCT00447772|10555484|P1|Overall Study|Insufficient compliance|6
3073899|NCT00447772|10555484|P1|Overall Study|Lack of Efficacy|3
3073900|NCT00447603|10555504|P3|Filter Period|Study terminated by Sponsor|10
3073901|NCT00447603|10555505|P2|Filter Period|Study terminated by Sponsor|1
3073902|NCT00447603|10555506|P1|Filter Period|Study terminated by Sponsor|0
3073903|NCT00447603|10555504|P3|Filter Period|Screen Failure|4
3073904|NCT00447603|10555505|P2|Filter Period|Screen Failure|3
3073905|NCT00447603|10555506|P1|Filter Period|Screen Failure|0
3073906|NCT00447603|10555504|P3|Filter Period|Adverse Event|1
3073907|NCT00447603|10555505|P2|Filter Period|Adverse Event|0
3073908|NCT00447603|10555506|P1|Filter Period|Adverse Event|0
3073909|NCT00447603|10555504|P3|Screening|Study Terminated by Sponsor|0
3073910|NCT00447603|10555505|P2|Screening|Study Terminated by Sponsor|0
3073911|NCT00447603|10555506|P1|Screening|Study Terminated by Sponsor|15
3073912|NCT00447603|10555504|P3|Screening|Screen Failure|0
3073913|NCT00447603|10555505|P2|Screening|Screen Failure|0
3073914|NCT00447603|10555506|P1|Screening|Screen Failure|4
3073915|NCT00447603|10555504|P3|Screening|Protocol Violation|0
3073916|NCT00447603|10555505|P2|Screening|Protocol Violation|0
3073917|NCT00447603|10555506|P1|Screening|Protocol Violation|1
3073918|NCT00447603|10555504|P3|Screening|Withdrawal by Subject|0
3073919|NCT00447603|10555505|P2|Screening|Withdrawal by Subject|0
3073920|NCT00447603|10555506|P1|Screening|Withdrawal by Subject|1
3073921|NCT00447590|10555526|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
3073922|NCT00447590|10555526|P1|Overall Study|Lost to Follow-up|24
3073923|NCT00447590|10555526|P1|Overall Study|Withdrawal by Subject|26
3073924|NCT00447499|10555535|P1|Overall Study|Physician Decision|1
3073925|NCT00447499|10555535|P1|Overall Study|Sponsor Decision|1
3073926|NCT00447499|10555535|P1|Overall Study|Patient Decision|4
3073927|NCT00447499|10555535|P1|Overall Study|Adverse Event|1
3073928|NCT00447421|10555545|P1|Overall Study|Sponsor Decision|2
3073929|NCT00447421|10555545|P1|Overall Study|Adverse Event|3
3073930|NCT00447421|10555545|P1|Overall Study|Lack of Efficacy|1
3073931|NCT00447382|10555557|P2|Overall Study|Unclassified|5
3073932|NCT00447382|10555558|P1|Overall Study|Unclassified|2
3073933|NCT00447382|10555557|P2|Overall Study|Protocol Violation|0
3073934|NCT00447382|10555558|P1|Overall Study|Protocol Violation|2
3073935|NCT00447382|10555557|P2|Overall Study|Lack of Efficacy|0
3073936|NCT00447382|10555558|P1|Overall Study|Lack of Efficacy|1
3073937|NCT00447382|10555557|P2|Overall Study|Adverse Event|1
3073938|NCT00447382|10555558|P1|Overall Study|Adverse Event|1
3073939|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
3073940|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
3073941|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
3073942|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
3073943|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
3073944|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
3073945|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
3073946|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
3073947|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
3073948|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
3073949|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
3073950|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
3073951|NCT00447278|10555619|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
3073952|NCT00447278|10555620|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
3073953|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
3073954|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
3073955|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
3073956|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
3073957|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Physician Decision|1
3073958|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Physician Decision|4
3073959|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
3073960|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
3073961|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Protocol Violation|7
3073962|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Protocol Violation|10
3073963|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
3073964|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
3073965|NCT00447278|10555619|P2|Period II (6 Month Open-Label)|Adverse Event|3
3073966|NCT00447278|10555620|P1|Period II (6 Month Open-Label)|Adverse Event|7
3073967|NCT00447265|10555641|P2|Overall Study|Physician Decision|0
3073968|NCT00447265|10555642|P1|Overall Study|Physician Decision|1
3073969|NCT00447226|10555655|P2|Double-blind Phase|Disease Progression|3
3073970|NCT00447226|10555656|P1|Double-blind Phase|Disease Progression|4
3073971|NCT00447226|10555655|P2|12-Week Open-label Phase|Physician Decision|1
3073972|NCT00447226|10555656|P1|12-Week Open-label Phase|Physician Decision|0
3073973|NCT00447226|10555655|P2|12-Week Open-label Phase|Disease Progression|20
3073974|NCT00447226|10555656|P1|12-Week Open-label Phase|Disease Progression|0
3073975|NCT00447226|10555655|P2|12-Week Open-label Phase|Protocol Violation|1
3073976|NCT00447226|10555656|P1|12-Week Open-label Phase|Protocol Violation|0
3073977|NCT00447226|10555655|P2|12-Week Open-label Phase|Adverse Event|3
3073978|NCT00447226|10555656|P1|12-Week Open-label Phase|Adverse Event|0
3073979|NCT00447057|10555699|P4|Overall Study|Death, study drug related|0
3073980|NCT00447057|10555700|P3|Overall Study|Death, study drug related|0
3073981|NCT00447057|10555701|P2|Overall Study|Death, study drug related|1
3073982|NCT00447057|10555702|P1|Overall Study|Death, study drug related|0
3073983|NCT00447057|10555699|P4|Overall Study|Death due to adverse event|2
3073984|NCT00447057|10555700|P3|Overall Study|Death due to adverse event|1
3073985|NCT00447057|10555701|P2|Overall Study|Death due to adverse event|0
3073986|NCT00447057|10555702|P1|Overall Study|Death due to adverse event|0
3073987|NCT00447057|10555699|P4|Overall Study|Progressive disease|18
3073988|NCT00447057|10555700|P3|Overall Study|Progressive disease|13
3073989|NCT00447057|10555701|P2|Overall Study|Progressive disease|43
3073990|NCT00447057|10555702|P1|Overall Study|Progressive disease|58
3073991|NCT00447057|10555699|P4|Overall Study|Sponsor decision|0
3073992|NCT00447057|10555700|P3|Overall Study|Sponsor decision|0
3073993|NCT00447057|10555701|P2|Overall Study|Sponsor decision|1
3073994|NCT00447057|10555702|P1|Overall Study|Sponsor decision|1
3073995|NCT00447057|10555699|P4|Overall Study|Physician Decision|1
3073996|NCT00447057|10555700|P3|Overall Study|Physician Decision|3
3073997|NCT00447057|10555701|P2|Overall Study|Physician Decision|6
3073998|NCT00447057|10555702|P1|Overall Study|Physician Decision|9
3073999|NCT00447057|10555699|P4|Overall Study|Withdrawal by Subject|1
3074000|NCT00447057|10555700|P3|Overall Study|Withdrawal by Subject|1
3074001|NCT00447057|10555701|P2|Overall Study|Withdrawal by Subject|5
3074002|NCT00447057|10555702|P1|Overall Study|Withdrawal by Subject|4
3074003|NCT00447057|10555699|P4|Overall Study|Protocol Violation|0
3074004|NCT00447057|10555700|P3|Overall Study|Protocol Violation|0
3074005|NCT00447057|10555701|P2|Overall Study|Protocol Violation|1
3074006|NCT00447057|10555702|P1|Overall Study|Protocol Violation|0
3074007|NCT00447057|10555699|P4|Overall Study|Entry criteria not met|0
3074008|NCT00447057|10555700|P3|Overall Study|Entry criteria not met|0
3074009|NCT00447057|10555701|P2|Overall Study|Entry criteria not met|1
3074010|NCT00447057|10555702|P1|Overall Study|Entry criteria not met|1
3074011|NCT00447057|10555699|P4|Overall Study|Lost to Follow-up|0
3074012|NCT00447057|10555700|P3|Overall Study|Lost to Follow-up|0
3074013|NCT00447057|10555701|P2|Overall Study|Lost to Follow-up|1
3074014|NCT00447057|10555702|P1|Overall Study|Lost to Follow-up|0
3074015|NCT00447057|10555699|P4|Overall Study|Death due to study disease|1
3074016|NCT00447057|10555700|P3|Overall Study|Death due to study disease|1
3074017|NCT00447057|10555701|P2|Overall Study|Death due to study disease|4
3074018|NCT00447057|10555702|P1|Overall Study|Death due to study disease|6
3074019|NCT00447057|10555699|P4|Overall Study|Adverse Event|3
3074020|NCT00447057|10555700|P3|Overall Study|Adverse Event|0
3074021|NCT00447057|10555701|P2|Overall Study|Adverse Event|10
3074022|NCT00447057|10555702|P1|Overall Study|Adverse Event|4
3074023|NCT00447005|10555720|P1|Overall Study|Lack of Efficacy|11
3074024|NCT00447005|10555720|P1|Overall Study|Adverse Event|1
3074025|NCT00446992|10555734|P1|Overall Study|Lost to Follow-up|5
3074026|NCT00446992|10555734|P1|Overall Study|Adverse Event|11
3074027|NCT00446966|10555748|P2|Overall Study|Lost to Follow-up|7
3074028|NCT00446966|10555749|P1|Overall Study|Lost to Follow-up|10
3074029|NCT00446849|10555755|P1|Maintenance Phase|concomitant medication use|1
3074030|NCT00446849|10555755|P1|Maintenance Phase|hydrocodone use|1
3074031|NCT00446849|10555755|P1|Maintenance Phase|study closure|1
3074032|NCT00446849|10555755|P1|Maintenance Phase|antibiotic use|1
3074033|NCT00446849|10555755|P1|Maintenance Phase|prohibited medication use|2
3074034|NCT00446849|10555755|P1|Maintenance Phase|noncompliance|2
3074035|NCT00446849|10555755|P1|Maintenance Phase|Pregnancy|1
3074036|NCT00446849|10555755|P1|Maintenance Phase|Lost to Follow-up|3
3074037|NCT00446849|10555755|P1|Maintenance Phase|Consent withdrawn|5
3074038|NCT00446849|10555755|P1|Maintenance Phase|Adverse Event|6
3074039|NCT00446849|10555755|P1|Maintenance Phase|Protocol Violation|7
3074040|NCT00446849|10555755|P1|Maintenance Phase|Lack of Efficacy|40
3074041|NCT00446849|10555755|P1|Acute Phase|noncompliance|1
3074042|NCT00446849|10555755|P1|Acute Phase|Physician Decision|1
3074043|NCT00446849|10555755|P1|Acute Phase|Lost to Follow-up|2
3074044|NCT00446849|10555755|P1|Acute Phase|Consent withdrawn|4
3074045|NCT00446849|10555755|P1|Acute Phase|Protocol Violation|10
3074046|NCT00446849|10555755|P1|Acute Phase|Lack of Efficacy|64
3074047|NCT00446797|10555767|P2|Overall Study|did not meet entrance criteria|1
3074048|NCT00446797|10555768|P1|Overall Study|did not meet entrance criteria|0
3074049|NCT00446797|10555767|P2|Overall Study|subject entered at another site|1
3074050|NCT00446797|10555768|P1|Overall Study|subject entered at another site|0
3074051|NCT00446797|10555767|P2|Overall Study|Protocol Violation|3
3074052|NCT00446797|10555768|P1|Overall Study|Protocol Violation|1
3074053|NCT00446797|10555767|P2|Overall Study|Withdrawal by Subject|2
3074054|NCT00446797|10555768|P1|Overall Study|Withdrawal by Subject|2
3074055|NCT00446797|10555767|P2|Overall Study|Lost to Follow-up|3
3074056|NCT00446797|10555768|P1|Overall Study|Lost to Follow-up|5
3074057|NCT00446797|10555767|P2|Overall Study|Lack of Efficacy|2
3074058|NCT00446797|10555768|P1|Overall Study|Lack of Efficacy|0
3074059|NCT00446654|10555814|P2|Overall Study|Adverse Event|0
3074060|NCT00446654|10555815|P1|Overall Study|Adverse Event|1
3074061|NCT00446654|10555814|P2|Overall Study|Withdrawal by Subject|0
3074062|NCT00446654|10555815|P1|Overall Study|Withdrawal by Subject|1
3074063|NCT00446641|10555823|P2|Overall Study|Lost to Follow-up|1
3074064|NCT00446641|10555824|P1|Overall Study|Lost to Follow-up|1
3074065|NCT00446641|10555823|P2|Overall Study|poor compliance|6
3074066|NCT00446641|10555824|P1|Overall Study|poor compliance|8
3074067|NCT00446641|10555823|P2|Overall Study|Withdrawal by Subject|3
3074068|NCT00446641|10555824|P1|Overall Study|Withdrawal by Subject|8
3074069|NCT00446563|10555844|P2|Overall Study|Administrative problems|1
3074070|NCT00446563|10555845|P1|Overall Study|Administrative problems|0
3074071|NCT00446563|10555844|P2|Overall Study|Withdrawal by Subject|1
3074072|NCT00446563|10555845|P1|Overall Study|Withdrawal by Subject|2
3074073|NCT00446563|10555844|P2|Overall Study|Unsatisfactory therapeutic effect|3
3074074|NCT00446563|10555845|P1|Overall Study|Unsatisfactory therapeutic effect|0
3074075|NCT00446563|10555844|P2|Overall Study|Abnormal test procedure result(s)|0
3074076|NCT00446563|10555845|P1|Overall Study|Abnormal test procedure result(s)|1
3074077|NCT00446563|10555844|P2|Overall Study|Abnormal laboratory value(s)|1
3074078|NCT00446563|10555845|P1|Overall Study|Abnormal laboratory value(s)|0
3074079|NCT00446563|10555844|P2|Overall Study|Adverse Event|3
3074080|NCT00446563|10555845|P1|Overall Study|Adverse Event|4
3074081|NCT00446550|10555881|P2|Overall Study|Adverse Event|0
3074082|NCT00446550|10555882|P1|Overall Study|Adverse Event|1
3074083|NCT00446511|10555894|P4|Overall Study|Administrative Problems|1
3074084|NCT00446511|10555895|P3|Overall Study|Administrative Problems|4
3074085|NCT00446511|10555896|P2|Overall Study|Administrative Problems|0
3074086|NCT00446511|10555897|P1|Overall Study|Administrative Problems|3
3074087|NCT00446511|10555894|P4|Overall Study|Withdrawal by Subject|3
3074088|NCT00446511|10555895|P3|Overall Study|Withdrawal by Subject|0
3074089|NCT00446511|10555896|P2|Overall Study|Withdrawal by Subject|0
3074090|NCT00446511|10555897|P1|Overall Study|Withdrawal by Subject|0
3074091|NCT00446511|10555894|P4|Overall Study|Protocol Violation|1
3074092|NCT00446511|10555895|P3|Overall Study|Protocol Violation|0
3074093|NCT00446511|10555896|P2|Overall Study|Protocol Violation|0
3074094|NCT00446511|10555897|P1|Overall Study|Protocol Violation|0
3074095|NCT00446511|10555894|P4|Overall Study|Adverse Event|1
3074096|NCT00446511|10555895|P3|Overall Study|Adverse Event|3
3074097|NCT00446511|10555896|P2|Overall Study|Adverse Event|2
3074098|NCT00446511|10555897|P1|Overall Study|Adverse Event|7
3074099|NCT00446459|10555921|P1|12 Months|14 subjects to MMF + Rituximab Study|14
3074100|NCT00446459|10555921|P1|12 Months|Protocol Violation|4
3074101|NCT00446459|10555921|P1|8 Months|Protocol Violation|12
3074102|NCT00446446|10555929|P1|Overall Study|On Treatment at Time of Data Cut-off|1
3074103|NCT00446446|10555929|P1|Overall Study|Adverse Event|1
3074104|NCT00446446|10555929|P1|Overall Study|Disease Progession|2
3074105|NCT00446446|10555929|P1|Overall Study|Other|4
3074106|NCT00446446|10555929|P1|Overall Study|Withdrawal by Subject|6
3074107|NCT00446446|10555929|P1|Overall Study|Death|10
3074108|NCT00446251|10555953|P1|Overall Study|Lost to Follow-up|1
3074109|NCT00446251|10555953|P1|Overall Study|Rituximab Infusion Reaction|2
3074110|NCT00446251|10555953|P1|Overall Study|On-study Transplants|2
3074111|NCT00446199|10555963|P4|Overall Study|Move|0
3074112|NCT00446199|10555964|P3|Overall Study|Move|0
3074113|NCT00446199|10555965|P2|Overall Study|Move|1
3074114|NCT00446199|10555966|P1|Overall Study|Move|0
3074115|NCT00446199|10555963|P4|Overall Study|In-/Exclusion criterion violated|1
3074116|NCT00446199|10555964|P3|Overall Study|In-/Exclusion criterion violated|2
3074117|NCT00446199|10555965|P2|Overall Study|In-/Exclusion criterion violated|1
3074118|NCT00446199|10555966|P1|Overall Study|In-/Exclusion criterion violated|2
3074119|NCT00446199|10555963|P4|Overall Study|Lost interest in study participation|0
3074120|NCT00446199|10555964|P3|Overall Study|Lost interest in study participation|0
3074121|NCT00446199|10555965|P2|Overall Study|Lost interest in study participation|1
3074122|NCT00446199|10555966|P1|Overall Study|Lost interest in study participation|0
3074123|NCT00446199|10555963|P4|Overall Study|Hormone fear|1
3074124|NCT00446199|10555964|P3|Overall Study|Hormone fear|0
3074125|NCT00446199|10555965|P2|Overall Study|Hormone fear|0
3074126|NCT00446199|10555966|P1|Overall Study|Hormone fear|0
3074127|NCT00446199|10555963|P4|Overall Study|Non-compliant with visit schedule|2
3074128|NCT00446199|10555964|P3|Overall Study|Non-compliant with visit schedule|1
3074129|NCT00446199|10555965|P2|Overall Study|Non-compliant with visit schedule|1
3074130|NCT00446199|10555966|P1|Overall Study|Non-compliant with visit schedule|1
3074131|NCT00446199|10555963|P4|Overall Study|Non-compliant with study drug|0
3074132|NCT00446199|10555964|P3|Overall Study|Non-compliant with study drug|5
3074133|NCT00446199|10555965|P2|Overall Study|Non-compliant with study drug|0
3074134|NCT00446199|10555966|P1|Overall Study|Non-compliant with study drug|1
3074135|NCT00446199|10555963|P4|Overall Study|Lack of Efficacy|1
3074136|NCT00446199|10555964|P3|Overall Study|Lack of Efficacy|0
3074137|NCT00446199|10555965|P2|Overall Study|Lack of Efficacy|0
3074138|NCT00446199|10555966|P1|Overall Study|Lack of Efficacy|1
3074139|NCT00446199|10555963|P4|Overall Study|Randomization in Error|1
3074140|NCT00446199|10555964|P3|Overall Study|Randomization in Error|1
3074141|NCT00446199|10555965|P2|Overall Study|Randomization in Error|0
3074142|NCT00446199|10555966|P1|Overall Study|Randomization in Error|2
3074143|NCT00446199|10555963|P4|Overall Study|Site termination|1
3074144|NCT00446199|10555964|P3|Overall Study|Site termination|0
3074145|NCT00446199|10555965|P2|Overall Study|Site termination|0
3074146|NCT00446199|10555966|P1|Overall Study|Site termination|2
3074147|NCT00446199|10555963|P4|Overall Study|Withdrawal by Subject|10
3074148|NCT00446199|10555964|P3|Overall Study|Withdrawal by Subject|9
3074149|NCT00446199|10555965|P2|Overall Study|Withdrawal by Subject|5
3074150|NCT00446199|10555966|P1|Overall Study|Withdrawal by Subject|2
3074151|NCT00446199|10555963|P4|Overall Study|Protocol Violation|3
3074152|NCT00446199|10555964|P3|Overall Study|Protocol Violation|1
3074153|NCT00446199|10555965|P2|Overall Study|Protocol Violation|2
3074154|NCT00446199|10555966|P1|Overall Study|Protocol Violation|1
3074155|NCT00446199|10555963|P4|Overall Study|Lost to Follow-up|6
3074156|NCT00446199|10555964|P3|Overall Study|Lost to Follow-up|2
3074157|NCT00446199|10555965|P2|Overall Study|Lost to Follow-up|5
3074158|NCT00446199|10555966|P1|Overall Study|Lost to Follow-up|4
3074159|NCT00446199|10555963|P4|Overall Study|Adverse Event|4
3074160|NCT00446199|10555964|P3|Overall Study|Adverse Event|6
3074161|NCT00446199|10555965|P2|Overall Study|Adverse Event|4
3074162|NCT00446199|10555966|P1|Overall Study|Adverse Event|7
3074163|NCT00446134|10556059|P4|Overall Study|Reason Not Completed|2
3074164|NCT00446134|10556060|P3|Overall Study|Reason Not Completed|1
3074165|NCT00446134|10556061|P2|Overall Study|Reason Not Completed|0
3074166|NCT00446134|10556062|P1|Overall Study|Reason Not Completed|3
3074167|NCT00446134|10556059|P4|Overall Study|Adverse Event-Diarrhea|0
3074168|NCT00446134|10556060|P3|Overall Study|Adverse Event-Diarrhea|2
3074169|NCT00446134|10556061|P2|Overall Study|Adverse Event-Diarrhea|1
3074170|NCT00446134|10556062|P1|Overall Study|Adverse Event-Diarrhea|1
3074171|NCT00446134|10556059|P4|Overall Study|Physician Decision|2
3074172|NCT00446134|10556060|P3|Overall Study|Physician Decision|0
3074173|NCT00446134|10556061|P2|Overall Study|Physician Decision|0
3074174|NCT00446134|10556062|P1|Overall Study|Physician Decision|0
3074175|NCT00446134|10556059|P4|Overall Study|Withdrawal by Subject|3
3074176|NCT00446134|10556060|P3|Overall Study|Withdrawal by Subject|1
3074177|NCT00446134|10556061|P2|Overall Study|Withdrawal by Subject|3
3074178|NCT00446134|10556062|P1|Overall Study|Withdrawal by Subject|3
3074179|NCT00446134|10556059|P4|Overall Study|Lost to Follow-up|1
3074180|NCT00446134|10556060|P3|Overall Study|Lost to Follow-up|1
3074181|NCT00446134|10556061|P2|Overall Study|Lost to Follow-up|3
3074182|NCT00446134|10556062|P1|Overall Study|Lost to Follow-up|1
3074183|NCT00446134|10556059|P4|Overall Study|Protocol Violation|0
3074184|NCT00446134|10556060|P3|Overall Study|Protocol Violation|1
3074185|NCT00446134|10556061|P2|Overall Study|Protocol Violation|2
3074186|NCT00446134|10556062|P1|Overall Study|Protocol Violation|0
3074187|NCT00446134|10556059|P4|Overall Study|Lack of Efficacy|19
3074188|NCT00446134|10556060|P3|Overall Study|Lack of Efficacy|24
3074189|NCT00446134|10556061|P2|Overall Study|Lack of Efficacy|19
3074190|NCT00446134|10556062|P1|Overall Study|Lack of Efficacy|19
3074191|NCT00446134|10556059|P4|Overall Study|Adverse Event|18
3074192|NCT00446134|10556060|P3|Overall Study|Adverse Event|13
3074193|NCT00446134|10556061|P2|Overall Study|Adverse Event|17
3074194|NCT00446134|10556062|P1|Overall Study|Adverse Event|7
3074195|NCT00446095|10556089|P5|Phase I (28 Days)|Lack of Efficacy|3
3074196|NCT00446095|10556090|P4|Phase I (28 Days)|Lack of Efficacy|0
3074197|NCT00446095|10556091|P3|Phase I (28 Days)|Lack of Efficacy|0
3074198|NCT00446095|10556092|P2|Phase I (28 Days)|Lack of Efficacy|0
3074199|NCT00446095|10556093|P1|Phase I (28 Days)|Lack of Efficacy|0
3074200|NCT00446095|10556089|P5|Phase I (28 Days)|Adverse Event|0
3074201|NCT00446095|10556090|P4|Phase I (28 Days)|Adverse Event|1
3074202|NCT00446095|10556091|P3|Phase I (28 Days)|Adverse Event|0
3074203|NCT00446095|10556092|P2|Phase I (28 Days)|Adverse Event|0
3074204|NCT00446095|10556093|P1|Phase I (28 Days)|Adverse Event|0
3074205|NCT00446095|10556089|P5|Phase II (8 Weeks)|Ongoing|0
3074206|NCT00446095|10556090|P4|Phase II (8 Weeks)|Ongoing|0
3074207|NCT00446095|10556091|P3|Phase II (8 Weeks)|Ongoing|1
3074208|NCT00446095|10556092|P2|Phase II (8 Weeks)|Ongoing|0
3074209|NCT00446095|10556093|P1|Phase II (8 Weeks)|Ongoing|0
3074210|NCT00446095|10556089|P5|Phase II (8 Weeks)|Lack of Efficacy|0
3074211|NCT00446095|10556090|P4|Phase II (8 Weeks)|Lack of Efficacy|0
3074212|NCT00446095|10556091|P3|Phase II (8 Weeks)|Lack of Efficacy|1
3074213|NCT00446095|10556092|P2|Phase II (8 Weeks)|Lack of Efficacy|2
3074214|NCT00446095|10556093|P1|Phase II (8 Weeks)|Lack of Efficacy|9
3074215|NCT00446095|10556089|P5|Phase II (8 Weeks)|Physician Decision|0
3074216|NCT00446095|10556090|P4|Phase II (8 Weeks)|Physician Decision|0
3074217|NCT00446095|10556091|P3|Phase II (8 Weeks)|Physician Decision|0
3074218|NCT00446095|10556092|P2|Phase II (8 Weeks)|Physician Decision|0
3074219|NCT00446095|10556093|P1|Phase II (8 Weeks)|Physician Decision|1
3074220|NCT00446095|10556089|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
3074221|NCT00446095|10556090|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
3074222|NCT00446095|10556091|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
3074223|NCT00446095|10556092|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
3074224|NCT00446095|10556093|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
3074225|NCT00446095|10556089|P5|Phase II (8 Weeks)|Adverse Event|0
3074226|NCT00446095|10556090|P4|Phase II (8 Weeks)|Adverse Event|0
3074227|NCT00446095|10556091|P3|Phase II (8 Weeks)|Adverse Event|1
3074228|NCT00446095|10556092|P2|Phase II (8 Weeks)|Adverse Event|1
3074229|NCT00446095|10556093|P1|Phase II (8 Weeks)|Adverse Event|0
3074230|NCT00446095|10556089|P5|Phase II (8 Weeks)|Lost to Follow-up|0
3074231|NCT00446095|10556090|P4|Phase II (8 Weeks)|Lost to Follow-up|0
3074232|NCT00446095|10556091|P3|Phase II (8 Weeks)|Lost to Follow-up|0
3074233|NCT00446095|10556092|P2|Phase II (8 Weeks)|Lost to Follow-up|0
3074234|NCT00446095|10556093|P1|Phase II (8 Weeks)|Lost to Follow-up|1
3074235|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
3074236|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
3074237|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
3074238|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
3074239|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
3074240|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
3074241|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
3074242|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
3074243|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
3074244|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
3074245|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
3074246|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
3074247|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
3074248|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
3074249|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Death|2
3074250|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Death|2
3074251|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
3074252|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
3074253|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
3074254|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
3074255|NCT00446030|10556116|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
3074256|NCT00446030|10556117|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
3074257|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
3074258|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
3074259|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
3074260|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
3074261|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
3074262|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
3074263|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
3074264|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
3074265|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
3074266|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
3074267|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
3074268|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
3074269|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
3074270|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
3074271|NCT00446030|10556116|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
3074272|NCT00446030|10556117|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
3074273|NCT00445939|10556128|P4|Period B - Week 4 - Week 8|Adverse Event|1
3074274|NCT00445939|10556129|P3|Period B - Week 4 - Week 8|Adverse Event|0
3074275|NCT00445939|10556130|P2|Period B - Week 4 - Week 8|Adverse Event|0
3074276|NCT00445939|10556131|P1|Period B - Week 4 - Week 8|Adverse Event|2
3074277|NCT00445939|10556128|P4|Period A - Week 0 - Week 4|Adverse Event|0
3074278|NCT00445939|10556129|P3|Period A - Week 0 - Week 4|Adverse Event|0
3074279|NCT00445939|10556130|P2|Period A - Week 0 - Week 4|Adverse Event|2
3074280|NCT00445939|10556131|P1|Period A - Week 0 - Week 4|Adverse Event|1
3074281|NCT00445848|10556179|P1|Overall Study|Other-Not protocol specified|5
3074282|NCT00445848|10556179|P1|Overall Study|Progression|62
3074283|NCT00445848|10556179|P1|Overall Study|Withdrawal by Subject|4
3074284|NCT00445848|10556179|P1|Overall Study|Adverse Event|14
3074285|NCT00445770|10556189|P3|Overall Study|Other|6
3074286|NCT00445770|10556190|P2|Overall Study|Other|5
3074287|NCT00445770|10556191|P1|Overall Study|Other|6
3074288|NCT00445770|10556189|P3|Overall Study|Lost to Follow-up|0
3074289|NCT00445770|10556190|P2|Overall Study|Lost to Follow-up|2
3074290|NCT00445770|10556191|P1|Overall Study|Lost to Follow-up|0
3074291|NCT00445770|10556189|P3|Overall Study|Lack of Efficacy|6
3074292|NCT00445770|10556190|P2|Overall Study|Lack of Efficacy|13
3074293|NCT00445770|10556191|P1|Overall Study|Lack of Efficacy|38
3074294|NCT00445770|10556189|P3|Overall Study|Adverse Event|19
3074295|NCT00445770|10556190|P2|Overall Study|Adverse Event|15
3074296|NCT00445770|10556191|P1|Overall Study|Adverse Event|9
3074297|NCT00445692|10556292|P1|Overall Study|Lack of Efficacy|5
3074298|NCT00445692|10556292|P1|Overall Study|Adverse Event|11
3074299|NCT00445679|10556302|P4|Overall Study|Lack of Efficacy|0
3074300|NCT00445679|10556303|P3|Overall Study|Lack of Efficacy|2
3074301|NCT00445679|10556304|P2|Overall Study|Lack of Efficacy|6
3074302|NCT00445679|10556305|P1|Overall Study|Lack of Efficacy|2
3074303|NCT00445679|10556302|P4|Overall Study|Withdrawal by Subject|18
3074304|NCT00445679|10556303|P3|Overall Study|Withdrawal by Subject|20
3074305|NCT00445679|10556304|P2|Overall Study|Withdrawal by Subject|14
3074306|NCT00445679|10556305|P1|Overall Study|Withdrawal by Subject|8
3074307|NCT00445679|10556302|P4|Overall Study|Protocol Violation|1
3074308|NCT00445679|10556303|P3|Overall Study|Protocol Violation|3
3074309|NCT00445679|10556304|P2|Overall Study|Protocol Violation|3
3074310|NCT00445679|10556305|P1|Overall Study|Protocol Violation|2
3074311|NCT00445679|10556302|P4|Overall Study|Withdrawal of Informed Consent|0
3074312|NCT00445679|10556303|P3|Overall Study|Withdrawal of Informed Consent|1
3074313|NCT00445679|10556304|P2|Overall Study|Withdrawal of Informed Consent|0
3074314|NCT00445679|10556305|P1|Overall Study|Withdrawal of Informed Consent|0
3074315|NCT00445679|10556302|P4|Overall Study|Compliance|2
3074316|NCT00445679|10556303|P3|Overall Study|Compliance|1
3074317|NCT00445679|10556304|P2|Overall Study|Compliance|2
3074318|NCT00445679|10556305|P1|Overall Study|Compliance|3
3074319|NCT00445679|10556302|P4|Overall Study|Lost to Follow-up|5
3074320|NCT00445679|10556303|P3|Overall Study|Lost to Follow-up|6
3074321|NCT00445679|10556304|P2|Overall Study|Lost to Follow-up|6
3074322|NCT00445679|10556305|P1|Overall Study|Lost to Follow-up|10
3074323|NCT00445679|10556302|P4|Overall Study|Physician Decision|0
3074324|NCT00445679|10556303|P3|Overall Study|Physician Decision|1
3074325|NCT00445679|10556304|P2|Overall Study|Physician Decision|0
3074326|NCT00445679|10556305|P1|Overall Study|Physician Decision|0
3074327|NCT00445679|10556302|P4|Overall Study|Failed to return|2
3074328|NCT00445679|10556303|P3|Overall Study|Failed to return|2
3074329|NCT00445679|10556304|P2|Overall Study|Failed to return|3
3074330|NCT00445679|10556305|P1|Overall Study|Failed to return|1
3074331|NCT00445679|10556302|P4|Overall Study|Adverse Event|19
3074332|NCT00445679|10556303|P3|Overall Study|Adverse Event|30
3074333|NCT00445679|10556304|P2|Overall Study|Adverse Event|12
3074334|NCT00445679|10556305|P1|Overall Study|Adverse Event|22
3074335|NCT00445601|10556341|P2|Overall Study|Death prior to TURBT|1
3074336|NCT00445601|10556342|P1|Overall Study|Death prior to TURBT|0
3074337|NCT00445601|10556341|P2|Overall Study|Adverse Event|0
3074338|NCT00445601|10556342|P1|Overall Study|Adverse Event|2
3074339|NCT00445601|10556341|P2|Overall Study|Drug Delivery Issue|2
3074340|NCT00445601|10556342|P1|Overall Study|Drug Delivery Issue|2
3074341|NCT00445601|10556341|P2|Overall Study|Incorrect Disease Status|6
3074342|NCT00445601|10556342|P1|Overall Study|Incorrect Disease Status|6
3074343|NCT00445601|10556341|P2|Overall Study|TURBT Complication|8
3074344|NCT00445601|10556342|P1|Overall Study|TURBT Complication|12
3074345|NCT00445601|10556341|P2|Overall Study|Withdrawal by Subject|11
3074346|NCT00445601|10556342|P1|Overall Study|Withdrawal by Subject|11
3074347|NCT00445549|10556359|P1|Overall Study|progressive disease|12
3074348|NCT00445458|10556383|P4|Overall Study|Surgery|0
3074349|NCT00445458|10556384|P3|Overall Study|Surgery|1
3074350|NCT00445458|10556385|P2|Overall Study|Surgery|0
3074351|NCT00445458|10556386|P1|Overall Study|Surgery|0
3074352|NCT00445458|10556383|P4|Overall Study|Physician Decision|1
3074353|NCT00445458|10556384|P3|Overall Study|Physician Decision|1
3074354|NCT00445458|10556385|P2|Overall Study|Physician Decision|0
3074355|NCT00445458|10556386|P1|Overall Study|Physician Decision|0
3074356|NCT00445458|10556383|P4|Overall Study|Death|0
3074357|NCT00445458|10556384|P3|Overall Study|Death|2
3074358|NCT00445458|10556385|P2|Overall Study|Death|1
3074359|NCT00445458|10556386|P1|Overall Study|Death|0
3074360|NCT00445458|10556383|P4|Overall Study|Adverse Event|0
3074361|NCT00445458|10556384|P3|Overall Study|Adverse Event|3
3074362|NCT00445458|10556385|P2|Overall Study|Adverse Event|0
3074363|NCT00445458|10556386|P1|Overall Study|Adverse Event|0
3074364|NCT00445458|10556383|P4|Overall Study|Withdrawal by Subject|0
3074365|NCT00445458|10556384|P3|Overall Study|Withdrawal by Subject|7
3074366|NCT00445458|10556385|P2|Overall Study|Withdrawal by Subject|0
3074367|NCT00445458|10556386|P1|Overall Study|Withdrawal by Subject|0
3074368|NCT00445458|10556383|P4|Overall Study|Disease Progression|27
3074369|NCT00445458|10556384|P3|Overall Study|Disease Progression|54
3074370|NCT00445458|10556385|P2|Overall Study|Disease Progression|4
3074371|NCT00445458|10556386|P1|Overall Study|Disease Progression|3
3074372|NCT00445432|10556404|P4|148 Weeks of Adalimumab Treatment|Other|9
3074373|NCT00445432|10556405|P3|148 Weeks of Adalimumab Treatment|Other|0
3074374|NCT00445432|10556406|P2|148 Weeks of Adalimumab Treatment|Other|0
3074375|NCT00445432|10556407|P1|148 Weeks of Adalimumab Treatment|Other|0
3074376|NCT00445432|10556404|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
3074377|NCT00445432|10556405|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
3074378|NCT00445432|10556406|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
3074379|NCT00445432|10556407|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
3074380|NCT00445432|10556404|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
3074381|NCT00445432|10556405|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
3074382|NCT00445432|10556406|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
3074383|NCT00445432|10556407|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
3074384|NCT00445432|10556404|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
3074385|NCT00445432|10556405|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
3074386|NCT00445432|10556406|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
3074387|NCT00445432|10556407|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
3074388|NCT00445432|10556404|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
3074389|NCT00445432|10556405|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
3074390|NCT00445432|10556406|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
3074391|NCT00445432|10556407|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
3074392|NCT00445432|10556404|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
3074393|NCT00445432|10556405|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
3074394|NCT00445432|10556406|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
3074395|NCT00445432|10556407|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
3074396|NCT00445432|10556404|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
3074397|NCT00445432|10556405|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
3074398|NCT00445432|10556406|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
3074399|NCT00445432|10556407|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
3074400|NCT00445341|10556440|P1|Overall Study|taken off treatment too early|1
3074401|NCT00445341|10556440|P1|Overall Study|refused further treatment|1
3074402|NCT00445328|10556447|P2|Overall Study|Protocol Violation|0
3074403|NCT00445328|10556448|P1|Overall Study|Protocol Violation|1
3074404|NCT00445328|10556447|P2|Overall Study|Withdrawal by Subject|0
3074405|NCT00445328|10556448|P1|Overall Study|Withdrawal by Subject|2
3074406|NCT00445328|10556447|P2|Overall Study|Other|2
3074407|NCT00445328|10556448|P1|Overall Study|Other|0
3074408|NCT00445328|10556447|P2|Overall Study|Adverse Event|3
3074409|NCT00445328|10556448|P1|Overall Study|Adverse Event|0
3074410|NCT00445328|10556447|P2|Overall Study|Death|1
3074411|NCT00445328|10556448|P1|Overall Study|Death|0
3074412|NCT00445224|10556609|P2|Specific Exercises|Withdrawal by Subject|0
3074413|NCT00445224|10556610|P1|Specific Exercises|Withdrawal by Subject|1
3074414|NCT00445224|10556609|P2|Specific Exercises|Withdrawal by Subject|3
3074415|NCT00445224|10556610|P1|Specific Exercises|Withdrawal by Subject|3
3074416|NCT00445146|10556637|P1|Overall Study|Pregnancy|1
3074417|NCT00445146|10556637|P1|Overall Study|Protocol Violation|4
3074418|NCT00445146|10556637|P1|Overall Study|Death|9
3074419|NCT00445146|10556637|P1|Overall Study|Lost to Follow-up|13
3074420|NCT00445146|10556637|P1|Overall Study|Adverse Event|13
3074421|NCT00445146|10556637|P1|Overall Study|Investigator’s Discretion|22
3074422|NCT00445146|10556637|P1|Overall Study|Lack of Efficacy|28
3074423|NCT00445146|10556637|P1|Overall Study|Withdrew Consent|29
3074424|NCT00445003|10556659|P3|Overall Study|Dropped|2
3074425|NCT00445003|10556660|P2|Overall Study|Dropped|3
3074426|NCT00445003|10556661|P1|Overall Study|Dropped|1
3074427|NCT00445003|10556659|P3|Overall Study|Missed Visit|1
3074428|NCT00445003|10556660|P2|Overall Study|Missed Visit|5
3074429|NCT00445003|10556661|P1|Overall Study|Missed Visit|3
3074430|NCT00445003|10556659|P3|Overall Study|Death|1
3074431|NCT00445003|10556660|P2|Overall Study|Death|2
3074432|NCT00445003|10556661|P1|Overall Study|Death|1
3074433|NCT00444951|10556693|P3|Overall Study|Withdrawal by Subject|3
3074434|NCT00444951|10556694|P2|Overall Study|Withdrawal by Subject|5
3074435|NCT00444951|10556695|P1|Overall Study|Withdrawal by Subject|4
3074436|NCT00444951|10556693|P3|Overall Study|Lost to Follow-up|0
3074437|NCT00444951|10556694|P2|Overall Study|Lost to Follow-up|1
3074438|NCT00444951|10556695|P1|Overall Study|Lost to Follow-up|1
3074439|NCT00444925|10556712|P3|Double-blind Treatment Period|Other|12
3074440|NCT00444925|10556713|P2|Double-blind Treatment Period|Other|7
3074441|NCT00444925|10556714|P1|Double-blind Treatment Period|Other|7
3074442|NCT00444925|10556712|P3|Double-blind Treatment Period|Withdrawal by Subject|7
3074443|NCT00444925|10556713|P2|Double-blind Treatment Period|Withdrawal by Subject|8
3074444|NCT00444925|10556714|P1|Double-blind Treatment Period|Withdrawal by Subject|6
3074445|NCT00444925|10556712|P3|Double-blind Treatment Period|Lost to Follow-up|5
3074446|NCT00444925|10556713|P2|Double-blind Treatment Period|Lost to Follow-up|8
3074447|NCT00444925|10556714|P1|Double-blind Treatment Period|Lost to Follow-up|4
3074448|NCT00444925|10556712|P3|Double-blind Treatment Period|Lack of Efficacy|13
3074449|NCT00444925|10556713|P2|Double-blind Treatment Period|Lack of Efficacy|5
3074450|NCT00444925|10556714|P1|Double-blind Treatment Period|Lack of Efficacy|5
3074451|NCT00444925|10556712|P3|Double-blind Treatment Period|Adverse Event|44
3074452|NCT00444925|10556713|P2|Double-blind Treatment Period|Adverse Event|28
3074453|NCT00444925|10556714|P1|Double-blind Treatment Period|Adverse Event|6
3074454|NCT00444925|10556712|P3|Double-blind Treatment Period|Death|0
3074455|NCT00444925|10556713|P2|Double-blind Treatment Period|Death|0
3074456|NCT00444925|10556714|P1|Double-blind Treatment Period|Death|2
3074457|NCT00444925|10556712|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
3074458|NCT00444925|10556713|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
3074459|NCT00444925|10556714|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
3074460|NCT00444912|10556778|P2|Overall Study|Participant Failed Mobilization|0
3074461|NCT00444912|10556779|P1|Overall Study|Participant Failed Mobilization|1
3074462|NCT00444912|10556778|P2|Overall Study|Lost to Follow-up|0
3074463|NCT00444912|10556779|P1|Overall Study|Lost to Follow-up|1
3074464|NCT00444912|10556778|P2|Overall Study|Death|2
3074465|NCT00444912|10556779|P1|Overall Study|Death|1
3074466|NCT00444795|10556820|P1|Overall Study|Treated Prior to the Contract Date|2
3074467|NCT00444795|10556820|P1|Overall Study|Not Treated|1
3074468|NCT00444678|10556825|P1|Overall Study|Withdrawal by Subject|2
3074469|NCT00444678|10556825|P1|Overall Study|Physician Decision|3
3074470|NCT00444678|10556825|P1|Overall Study|Death|3
3074471|NCT00444678|10556825|P1|Overall Study|Disease Progression|12
3074472|NCT00444678|10556825|P1|Overall Study|Toxicity|11
3074473|NCT00444626|10556832|P1|Initial Treatment Period|Lost to Follow-up|9
3074474|NCT00444626|10556832|P1|Initial Treatment Period|Adverse Event|1
3074475|NCT00444626|10556832|P1|Initial Treatment Period|Withdrawal by Subject|2
3074476|NCT00444600|10556862|P4|Overall Study|Missed visit|1
3074477|NCT00444600|10556863|P3|Overall Study|Missed visit|0
3074478|NCT00444600|10556864|P2|Overall Study|Missed visit|0
3074479|NCT00444600|10556865|P1|Overall Study|Missed visit|1
3074480|NCT00444600|10556862|P4|Overall Study|Dropped|7
3074481|NCT00444600|10556863|P3|Overall Study|Dropped|7
3074482|NCT00444600|10556864|P2|Overall Study|Dropped|11
3074483|NCT00444600|10556865|P1|Overall Study|Dropped|11
3074484|NCT00444600|10556862|P4|Overall Study|Death|2
3074485|NCT00444600|10556863|P3|Overall Study|Death|3
3074486|NCT00444600|10556864|P2|Overall Study|Death|5
3074487|NCT00444600|10556865|P1|Overall Study|Death|7
3074488|NCT00444587|10556957|P2|Overall Study|Missing|5
3074489|NCT00444587|10556958|P1|Overall Study|Missing|0
3074490|NCT00444587|10556957|P2|Overall Study|Protocol Violation|0
3074491|NCT00444587|10556958|P1|Overall Study|Protocol Violation|1
3074492|NCT00444587|10556957|P2|Overall Study|Investigator decision|0
3074493|NCT00444587|10556958|P1|Overall Study|Investigator decision|3
3074494|NCT00444587|10556957|P2|Overall Study|Refused treatment/did not cooperate|1
3074495|NCT00444587|10556958|P1|Overall Study|Refused treatment/did not cooperate|4
3074496|NCT00444587|10556957|P2|Overall Study|Progression of the disease|8
3074497|NCT00444587|10556958|P1|Overall Study|Progression of the disease|73
3074498|NCT00444587|10556957|P2|Overall Study|Death|1
3074499|NCT00444587|10556958|P1|Overall Study|Death|2
3074500|NCT00444535|10556979|P1|Overall Study|Adverse Event|3
3074501|NCT00444535|10556979|P1|Overall Study|Investigator decision|2
3074502|NCT00444535|10556979|P1|Overall Study|Withdrawal by Subject|3
3074503|NCT00444535|10556979|P1|Overall Study|Treatment is ongoing|16
3074504|NCT00444457|10556990|P4|Toddler Dose|Protocol Violation|1
3074505|NCT00444457|10556991|P3|Toddler Dose|Protocol Violation|0
3074506|NCT00444457|10556992|P2|Toddler Dose|Protocol Violation|0
3074507|NCT00444457|10556993|P1|Toddler Dose|Protocol Violation|1
3074508|NCT00444457|10556990|P4|Toddler Dose|Parent or legal guardian request|1
3074509|NCT00444457|10556991|P3|Toddler Dose|Parent or legal guardian request|2
3074510|NCT00444457|10556992|P2|Toddler Dose|Parent or legal guardian request|3
3074511|NCT00444457|10556993|P1|Toddler Dose|Parent or legal guardian request|0
3074512|NCT00444457|10556990|P4|Toddler Dose|Failed to return|3
3074513|NCT00444457|10556991|P3|Toddler Dose|Failed to return|1
3074514|NCT00444457|10556992|P2|Toddler Dose|Failed to return|2
3074515|NCT00444457|10556993|P1|Toddler Dose|Failed to return|2
3074516|NCT00444457|10556990|P4|Toddler Dose|Lost to Follow-up|3
3074517|NCT00444457|10556991|P3|Toddler Dose|Lost to Follow-up|1
3074518|NCT00444457|10556992|P2|Toddler Dose|Lost to Follow-up|1
3074519|NCT00444457|10556993|P1|Toddler Dose|Lost to Follow-up|4
3074520|NCT00444457|10556990|P4|After Infant Series|Other|0
3074521|NCT00444457|10556991|P3|After Infant Series|Other|0
3074522|NCT00444457|10556992|P2|After Infant Series|Other|1
3074523|NCT00444457|10556993|P1|After Infant Series|Other|0
3074524|NCT00444457|10556990|P4|After Infant Series|Investigator request|1
3074525|NCT00444457|10556991|P3|After Infant Series|Investigator request|0
3074526|NCT00444457|10556992|P2|After Infant Series|Investigator request|0
3074527|NCT00444457|10556993|P1|After Infant Series|Investigator request|0
3074528|NCT00444457|10556990|P4|After Infant Series|Adverse Event|0
3074529|NCT00444457|10556991|P3|After Infant Series|Adverse Event|0
3074530|NCT00444457|10556992|P2|After Infant Series|Adverse Event|2
3074531|NCT00444457|10556993|P1|After Infant Series|Adverse Event|2
3074532|NCT00444457|10556990|P4|After Infant Series|Protocol Violation|2
3074533|NCT00444457|10556991|P3|After Infant Series|Protocol Violation|2
3074534|NCT00444457|10556992|P2|After Infant Series|Protocol Violation|4
3074535|NCT00444457|10556993|P1|After Infant Series|Protocol Violation|2
3074536|NCT00444457|10556990|P4|After Infant Series|Lost to Follow-up|2
3074537|NCT00444457|10556991|P3|After Infant Series|Lost to Follow-up|5
3074538|NCT00444457|10556992|P2|After Infant Series|Lost to Follow-up|5
3074539|NCT00444457|10556993|P1|After Infant Series|Lost to Follow-up|5
3074540|NCT00444457|10556990|P4|After Infant Series|Failed to return|1
3074541|NCT00444457|10556991|P3|After Infant Series|Failed to return|5
3074542|NCT00444457|10556992|P2|After Infant Series|Failed to return|6
3074543|NCT00444457|10556993|P1|After Infant Series|Failed to return|7
3074544|NCT00444457|10556990|P4|After Infant Series|Parent or legal guardian request|3
3074545|NCT00444457|10556991|P3|After Infant Series|Parent or legal guardian request|6
3074546|NCT00444457|10556992|P2|After Infant Series|Parent or legal guardian request|11
3074547|NCT00444457|10556993|P1|After Infant Series|Parent or legal guardian request|4
3074548|NCT00444457|10556990|P4|After Infant Series|Other|1
3074549|NCT00444457|10556991|P3|After Infant Series|Other|1
3074550|NCT00444457|10556992|P2|After Infant Series|Other|1
3074551|NCT00444457|10556993|P1|After Infant Series|Other|0
3074552|NCT00444457|10556990|P4|Infant Series|Death|1
3074553|NCT00444457|10556991|P3|Infant Series|Death|1
3074554|NCT00444457|10556992|P2|Infant Series|Death|1
3074555|NCT00444457|10556993|P1|Infant Series|Death|0
3074556|NCT00444457|10556990|P4|Infant Series|Adverse Event|0
3074557|NCT00444457|10556991|P3|Infant Series|Adverse Event|2
3074558|NCT00444457|10556992|P2|Infant Series|Adverse Event|2
3074559|NCT00444457|10556993|P1|Infant Series|Adverse Event|1
3074560|NCT00444457|10556990|P4|Infant Series|Other|0
3074561|NCT00444457|10556991|P3|Infant Series|Other|4
3074562|NCT00444457|10556992|P2|Infant Series|Other|2
3074563|NCT00444457|10556993|P1|Infant Series|Other|0
3074564|NCT00444457|10556990|P4|Infant Series|Investigator request|2
3074565|NCT00444457|10556991|P3|Infant Series|Investigator request|3
3074566|NCT00444457|10556992|P2|Infant Series|Investigator request|3
3074567|NCT00444457|10556993|P1|Infant Series|Investigator request|4
3074568|NCT00444457|10556990|P4|Infant Series|Failed to return|2
3074569|NCT00444457|10556991|P3|Infant Series|Failed to return|4
3074570|NCT00444457|10556992|P2|Infant Series|Failed to return|4
3074571|NCT00444457|10556993|P1|Infant Series|Failed to return|5
3074572|NCT00444457|10556990|P4|Infant Series|Protocol Violation|3
3074573|NCT00444457|10556991|P3|Infant Series|Protocol Violation|6
3074574|NCT00444457|10556992|P2|Infant Series|Protocol Violation|8
3074575|NCT00444457|10556993|P1|Infant Series|Protocol Violation|16
3074576|NCT00444457|10556990|P4|Infant Series|Lost to Follow-up|6
3074577|NCT00444457|10556991|P3|Infant Series|Lost to Follow-up|7
3074578|NCT00444457|10556992|P2|Infant Series|Lost to Follow-up|11
3074579|NCT00444457|10556993|P1|Infant Series|Lost to Follow-up|10
3074580|NCT00444457|10556990|P4|Infant Series|Parent or legal guardian request|14
3074581|NCT00444457|10556991|P3|Infant Series|Parent or legal guardian request|34
3074582|NCT00444457|10556992|P2|Infant Series|Parent or legal guardian request|29
3074583|NCT00444457|10556993|P1|Infant Series|Parent or legal guardian request|18
3074584|NCT00444457|10556990|P4|Infant Series|Other|0
3074585|NCT00444457|10556991|P3|Infant Series|Other|0
3074586|NCT00444457|10556992|P2|Infant Series|Other|1
3074587|NCT00444457|10556993|P1|Infant Series|Other|0
3074588|NCT00444275|10557058|P5|Maintenance Treatment Phase|Ineffectiveness|14
3074589|NCT00444275|10557059|P4|Maintenance Treatment Phase|Ineffectiveness|3
3074590|NCT00444275|10557060|P3|Maintenance Treatment Phase|Ineffectiveness|5
3074591|NCT00444275|10557061|P2|Maintenance Treatment Phase|Ineffectiveness|0
3074592|NCT00444275|10557062|P1|Maintenance Treatment Phase|Ineffectiveness|0
3074593|NCT00444275|10557058|P5|Maintenance Treatment Phase|Protocol Violation|87
3074594|NCT00444275|10557059|P4|Maintenance Treatment Phase|Protocol Violation|88
3074595|NCT00444275|10557060|P3|Maintenance Treatment Phase|Protocol Violation|103
3074596|NCT00444275|10557061|P2|Maintenance Treatment Phase|Protocol Violation|0
3074597|NCT00444275|10557062|P1|Maintenance Treatment Phase|Protocol Violation|0
3074598|NCT00444275|10557058|P5|Maintenance Treatment Phase|Patient's wish|20
3074599|NCT00444275|10557059|P4|Maintenance Treatment Phase|Patient's wish|9
3074600|NCT00444275|10557060|P3|Maintenance Treatment Phase|Patient's wish|19
3074601|NCT00444275|10557061|P2|Maintenance Treatment Phase|Patient's wish|0
3074602|NCT00444275|10557062|P1|Maintenance Treatment Phase|Patient's wish|0
3074603|NCT00444275|10557058|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
3074604|NCT00444275|10557059|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
3074605|NCT00444275|10557060|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
3074606|NCT00444275|10557061|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
3074607|NCT00444275|10557062|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
3074608|NCT00444275|10557058|P5|Maintenance Treatment Phase|Adverse Event|13
3074609|NCT00444275|10557059|P4|Maintenance Treatment Phase|Adverse Event|2
3074610|NCT00444275|10557060|P3|Maintenance Treatment Phase|Adverse Event|3
3074611|NCT00444275|10557061|P2|Maintenance Treatment Phase|Adverse Event|0
3074612|NCT00444275|10557062|P1|Maintenance Treatment Phase|Adverse Event|0
3074613|NCT00444275|10557058|P5|Maintenance Treatment Phase|Lost to Follow-up|10
3074614|NCT00444275|10557059|P4|Maintenance Treatment Phase|Lost to Follow-up|14
3074615|NCT00444275|10557060|P3|Maintenance Treatment Phase|Lost to Follow-up|8
3074616|NCT00444275|10557061|P2|Maintenance Treatment Phase|Lost to Follow-up|0
3074617|NCT00444275|10557062|P1|Maintenance Treatment Phase|Lost to Follow-up|0
3074618|NCT00444275|10557058|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
3074619|NCT00444275|10557059|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
3074620|NCT00444275|10557060|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
3074621|NCT00444275|10557061|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
3074622|NCT00444275|10557062|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
3074623|NCT00444145|10557112|P1|Overall Study|Screen Failures|5
3074624|NCT00444145|10557112|P1|Overall Study|non-compliant|11
3074625|NCT00444145|10557112|P1|Overall Study|Lost to Follow-up|1
3074626|NCT00444145|10557112|P1|Overall Study|Withdrawal by Subject|2
3074627|NCT00444106|10557119|P3|Overall Study|Abnormal Test Procedure Results|1
3074628|NCT00444106|10557120|P2|Overall Study|Abnormal Test Procedure Results|0
3074629|NCT00444106|10557121|P1|Overall Study|Abnormal Test Procedure Results|0
3074630|NCT00444106|10557119|P3|Overall Study|Lost to Follow-up|0
3074631|NCT00444106|10557120|P2|Overall Study|Lost to Follow-up|1
3074632|NCT00444106|10557121|P1|Overall Study|Lost to Follow-up|2
3074633|NCT00444067|10557138|P2|Overall Study|Lost to Follow-up|1
3074634|NCT00444067|10557139|P1|Overall Study|Lost to Follow-up|0
3074635|NCT00443898|10557202|P4|Overall Study|Death|0
3074636|NCT00443898|10557203|P3|Overall Study|Death|0
3074637|NCT00443898|10557204|P2|Overall Study|Death|1
3074638|NCT00443898|10557205|P1|Overall Study|Death|0
3074639|NCT00443898|10557202|P4|Overall Study|Lost to Follow-up|10
3074640|NCT00443898|10557203|P3|Overall Study|Lost to Follow-up|14
3074641|NCT00443898|10557204|P2|Overall Study|Lost to Follow-up|10
3074642|NCT00443898|10557205|P1|Overall Study|Lost to Follow-up|10
3074643|NCT00443898|10557202|P4|Overall Study|Withdrawal by Subject|6
3074644|NCT00443898|10557203|P3|Overall Study|Withdrawal by Subject|10
3074645|NCT00443898|10557204|P2|Overall Study|Withdrawal by Subject|10
3074646|NCT00443898|10557205|P1|Overall Study|Withdrawal by Subject|11
3074647|NCT00443898|10557202|P4|Overall Study|Protocol Violation|0
3074648|NCT00443898|10557203|P3|Overall Study|Protocol Violation|1
3074649|NCT00443898|10557204|P2|Overall Study|Protocol Violation|1
3074650|NCT00443898|10557205|P1|Overall Study|Protocol Violation|1
3074651|NCT00443898|10557202|P4|Overall Study|Lack of Efficacy|1
3074652|NCT00443898|10557203|P3|Overall Study|Lack of Efficacy|3
3074653|NCT00443898|10557204|P2|Overall Study|Lack of Efficacy|3
3074654|NCT00443898|10557205|P1|Overall Study|Lack of Efficacy|2
3074655|NCT00443898|10557202|P4|Overall Study|Adverse Event|1
3074656|NCT00443898|10557203|P3|Overall Study|Adverse Event|1
3074657|NCT00443898|10557204|P2|Overall Study|Adverse Event|0
3074658|NCT00443898|10557205|P1|Overall Study|Adverse Event|0
3074659|NCT00443872|10557227|P1|Overall Study|Adverse Event|8
3074660|NCT00443872|10557227|P1|Overall Study|Lost to Follow-up|2
3074661|NCT00443872|10557227|P1|Overall Study|Protocol Violation|7
3074662|NCT00443846|10557242|P2|Overall Study|Lost to Follow-up|2
3074663|NCT00443846|10557243|P1|Overall Study|Lost to Follow-up|1
3074664|NCT00443846|10557242|P2|Overall Study|Personal reason|3
3074665|NCT00443846|10557243|P1|Overall Study|Personal reason|8
3074666|NCT00443846|10557242|P2|Overall Study|Adverse Event|1
3074667|NCT00443846|10557243|P1|Overall Study|Adverse Event|0
3074668|NCT00443846|10557242|P2|Overall Study|Not vaccinated, no blood sample drawn|0
3074669|NCT00443846|10557243|P1|Overall Study|Not vaccinated, no blood sample drawn|1
3074670|NCT00443846|10557242|P2|Overall Study|Withdrawn due to intercurrent disease|0
3074671|NCT00443846|10557243|P1|Overall Study|Withdrawn due to intercurrent disease|1
3074672|NCT00443820|10557253|P4|Overall Study|Death|0
3074673|NCT00443820|10557254|P3|Overall Study|Death|1
3074674|NCT00443820|10557255|P2|Overall Study|Death|0
3074675|NCT00443820|10557256|P1|Overall Study|Death|0
3074676|NCT00443820|10557253|P4|Overall Study|Administrative problems|1
3074677|NCT00443820|10557254|P3|Overall Study|Administrative problems|0
3074678|NCT00443820|10557255|P2|Overall Study|Administrative problems|0
3074679|NCT00443820|10557256|P1|Overall Study|Administrative problems|0
3074680|NCT00443820|10557253|P4|Overall Study|Lost to Follow-up|5
3074681|NCT00443820|10557254|P3|Overall Study|Lost to Follow-up|6
3074682|NCT00443820|10557255|P2|Overall Study|Lost to Follow-up|8
3074683|NCT00443820|10557256|P1|Overall Study|Lost to Follow-up|9
3074684|NCT00443820|10557253|P4|Overall Study|Withdrawal by Subject|9
3074685|NCT00443820|10557254|P3|Overall Study|Withdrawal by Subject|8
3074686|NCT00443820|10557255|P2|Overall Study|Withdrawal by Subject|7
3074687|NCT00443820|10557256|P1|Overall Study|Withdrawal by Subject|6
3074688|NCT00443820|10557253|P4|Overall Study|Protocol Violation|1
3074689|NCT00443820|10557254|P3|Overall Study|Protocol Violation|2
3074690|NCT00443820|10557255|P2|Overall Study|Protocol Violation|1
3074691|NCT00443820|10557256|P1|Overall Study|Protocol Violation|2
3074692|NCT00443820|10557253|P4|Overall Study|Lack of Efficacy|1
3074693|NCT00443820|10557254|P3|Overall Study|Lack of Efficacy|1
3074694|NCT00443820|10557255|P2|Overall Study|Lack of Efficacy|2
3074695|NCT00443820|10557256|P1|Overall Study|Lack of Efficacy|3
3074696|NCT00443820|10557253|P4|Overall Study|Adverse Event|0
3074697|NCT00443820|10557254|P3|Overall Study|Adverse Event|0
3074698|NCT00443820|10557255|P2|Overall Study|Adverse Event|1
3074699|NCT00443820|10557256|P1|Overall Study|Adverse Event|1
3074700|NCT00443781|10557278|P1|Overall Study|PD/FAD not done|1
3074701|NCT00443781|10557278|P1|Overall Study|Insurance not covered|2
3074702|NCT00443781|10557278|P1|Overall Study|Investigator terminated participation|1
3074703|NCT00443781|10557278|P1|Overall Study|Unable to comply with study follow up|2
3074704|NCT00443781|10557278|P1|Overall Study|Withdrawal by Subject|6
3074705|NCT00443781|10557278|P1|Overall Study|Protocol Violation|1
3074706|NCT00443781|10557278|P1|Overall Study|Physician Decision|2
3074707|NCT00443781|10557278|P1|Overall Study|Lost to Follow-up|10
3074708|NCT00443755|10557284|P2|Overall Study|Withdrawal by Subject|1
3074709|NCT00443755|10557285|P1|Overall Study|Withdrawal by Subject|2
3074710|NCT00443729|10557319|P2|Overall Study|Withdrawal by Subject|1
3074711|NCT00443729|10557320|P1|Overall Study|Withdrawal by Subject|3
3074712|NCT00443729|10557319|P2|Overall Study|Protocol Violation|1
3074713|NCT00443729|10557320|P1|Overall Study|Protocol Violation|1
3074714|NCT00443729|10557319|P2|Overall Study|Physician Decision|1
3074715|NCT00443729|10557320|P1|Overall Study|Physician Decision|2
3074716|NCT00443729|10557319|P2|Overall Study|Lost to Follow-up|1
3074717|NCT00443729|10557320|P1|Overall Study|Lost to Follow-up|0
3074718|NCT00443729|10557319|P2|Overall Study|Lack of Efficacy|2
3074719|NCT00443729|10557320|P1|Overall Study|Lack of Efficacy|4
3074720|NCT00443729|10557319|P2|Overall Study|Never Treated|1
3074721|NCT00443729|10557320|P1|Overall Study|Never Treated|0
3074722|NCT00443703|10557368|P2|Overall Study|Progressive Disease|0
3074723|NCT00443703|10557369|P1|Overall Study|Progressive Disease|1
3074724|NCT00443703|10557368|P2|Overall Study|Withdrawal by Subject|6
3074725|NCT00443703|10557369|P1|Overall Study|Withdrawal by Subject|9
3074726|NCT00443703|10557368|P2|Overall Study|Protocol Violation|1
3074727|NCT00443703|10557369|P1|Overall Study|Protocol Violation|1
3074728|NCT00443703|10557368|P2|Overall Study|Physician Decision|2
3074729|NCT00443703|10557369|P1|Overall Study|Physician Decision|4
3074730|NCT00443703|10557368|P2|Overall Study|Lost to Follow-up|4
3074731|NCT00443703|10557369|P1|Overall Study|Lost to Follow-up|0
3074732|NCT00443703|10557368|P2|Overall Study|Lack of Efficacy|1
3074733|NCT00443703|10557369|P1|Overall Study|Lack of Efficacy|3
3074734|NCT00443703|10557368|P2|Overall Study|Adverse Event|3
3074735|NCT00443703|10557369|P1|Overall Study|Adverse Event|7
3074736|NCT00443703|10557368|P2|Overall Study|Never Treated|1
3074737|NCT00443703|10557369|P1|Overall Study|Never Treated|3
3074738|NCT00443651|10557421|P2|Overall Study|Pregnancy|1
3074739|NCT00443651|10557422|P1|Overall Study|Pregnancy|0
3074740|NCT00443651|10557421|P2|Overall Study|Physician Decision|4
3074741|NCT00443651|10557422|P1|Overall Study|Physician Decision|13
3074742|NCT00443651|10557421|P2|Overall Study|Patient's/Guardian's Decision|30
3074743|NCT00443651|10557422|P1|Overall Study|Patient's/Guardian's Decision|58
3074744|NCT00443651|10557421|P2|Overall Study|Lost to Follow-up|12
3074745|NCT00443651|10557422|P1|Overall Study|Lost to Follow-up|18
3074746|NCT00443651|10557421|P2|Overall Study|Adverse Event|6
3074747|NCT00443651|10557422|P1|Overall Study|Adverse Event|5
3074748|NCT00443651|10557421|P2|Overall Study|Death|5
3074749|NCT00443651|10557422|P1|Overall Study|Death|1
3074750|NCT00443599|10557442|P2|Overall Study|Cardiopulmonary bypass canceled|1
3074751|NCT00443599|10557443|P1|Overall Study|Cardiopulmonary bypass canceled|3
3074752|NCT00443599|10557442|P2|Overall Study|Death|1
3074753|NCT00443599|10557443|P1|Overall Study|Death|1
3074754|NCT00443599|10557442|P2|Overall Study|Physician Decision|1
3074755|NCT00443599|10557443|P1|Overall Study|Physician Decision|2
3074756|NCT00443560|10557477|P2|Overall Study|Multiple pregnancies or fetal demise|4
3074757|NCT00443560|10557478|P1|Overall Study|Multiple pregnancies or fetal demise|2
3074758|NCT00443560|10557477|P2|Overall Study|No intrathecal dose|26
3074759|NCT00443560|10557478|P1|Overall Study|No intrathecal dose|58
3074760|NCT00443534|10557513|P1|Overall Study|Enrolled, Not Treated|1
3074761|NCT00443534|10557513|P1|Overall Study|Other|10
3074762|NCT00443534|10557513|P1|Overall Study|Study Terminated by Sponsor|12
3074763|NCT00443534|10557513|P1|Overall Study|Withdrawal by Subject|8
3074764|NCT00443534|10557513|P1|Overall Study|Death|9
3074765|NCT00443534|10557513|P1|Overall Study|Adverse Event|16
3074766|NCT00443534|10557513|P1|Overall Study|Lack of Efficacy|67
3074767|NCT00443456|10557520|P1|Overall Study|Withdrawal by Subject|1
3074768|NCT00443456|10557520|P1|Overall Study|Move|1
3074769|NCT00443456|10557520|P1|Overall Study|Adverse Event|16
3074770|NCT00443430|10557555|P2|Overall Study|Adverse Event|1
3074771|NCT00443430|10557556|P1|Overall Study|Adverse Event|1
3074772|NCT00443430|10557555|P2|Overall Study|Lack of Efficacy|3
3074773|NCT00443430|10557556|P1|Overall Study|Lack of Efficacy|3
3074774|NCT00443261|10557570|P1|Overall Study|Death|1
3074775|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
3074776|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
3074777|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
3074778|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
3074779|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
3074780|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
3074781|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
3074782|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
3074783|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
3074784|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
3074785|NCT00443209|10557576|P2|Months 13 to 18 Treatment Period|Adverse Event|0
3074786|NCT00443209|10557577|P1|Months 13 to 18 Treatment Period|Adverse Event|1
3074787|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Not Treated|43
3074788|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Not Treated|71
3074789|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Missing|1
3074790|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Missing|2
3074791|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
3074792|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
3074793|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
3074794|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
3074795|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Pregnancy|4
3074796|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Pregnancy|3
3074797|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Physician Decision|4
3074798|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Physician Decision|8
3074799|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
3074800|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
3074801|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
3074802|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
3074803|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
3074804|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
3074805|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
3074806|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
3074807|NCT00443209|10557576|P2|Months 1 to 12 Treatment Period|Adverse Event|11
3074808|NCT00443209|10557577|P1|Months 1 to 12 Treatment Period|Adverse Event|22
3074809|NCT00443118|10557594|P3|Overall Study|Withdrawal by Subject|0
3074810|NCT00443118|10557595|P2|Overall Study|Withdrawal by Subject|0
3074811|NCT00443118|10557596|P1|Overall Study|Withdrawal by Subject|1
3074812|NCT00443118|10557594|P3|Overall Study|unknown primary outcome|0
3074813|NCT00443118|10557595|P2|Overall Study|unknown primary outcome|1
3074814|NCT00443118|10557596|P1|Overall Study|unknown primary outcome|3
3074815|NCT00443053|10557645|P2|Overall Study|Physician Decision|4
3074816|NCT00443053|10557646|P1|Overall Study|Physician Decision|0
3074817|NCT00443053|10557645|P2|Overall Study|Other|4
3074818|NCT00443053|10557646|P1|Overall Study|Other|3
3074819|NCT00443053|10557645|P2|Overall Study|Noncompliance|1
3074820|NCT00443053|10557646|P1|Overall Study|Noncompliance|2
3074821|NCT00443053|10557645|P2|Overall Study|Did Not Meet Eligibility Criteria|0
3074822|NCT00443053|10557646|P1|Overall Study|Did Not Meet Eligibility Criteria|1
3074823|NCT00443053|10557645|P2|Overall Study|Lost to Follow-up|5
3074824|NCT00443053|10557646|P1|Overall Study|Lost to Follow-up|4
3074825|NCT00443053|10557645|P2|Overall Study|Withdrawal by Subject|18
3074826|NCT00443053|10557646|P1|Overall Study|Withdrawal by Subject|9
3074827|NCT00443053|10557645|P2|Overall Study|Adverse Event|1
3074828|NCT00443053|10557646|P1|Overall Study|Adverse Event|2
3074829|NCT00443040|10557667|P3|Overall Study|Converted to an open laparotomy|1
3074830|NCT00443040|10557668|P2|Overall Study|Converted to an open laparotomy|0
3074831|NCT00443040|10557669|P1|Overall Study|Converted to an open laparotomy|3
3074832|NCT00443040|10557667|P3|Overall Study|Withdrawal by Subject|0
3074833|NCT00443040|10557668|P2|Overall Study|Withdrawal by Subject|0
3074834|NCT00443040|10557669|P1|Overall Study|Withdrawal by Subject|1
3074835|NCT00442962|10557677|P1|Overall Study|Lost to Follow-up|7
3074836|NCT00442962|10557677|P1|Overall Study|Pregnancy|1
3074837|NCT00442936|10557695|P4|Overall Study|Protocol Violation|1
3074838|NCT00442936|10557696|P3|Overall Study|Protocol Violation|1
3074839|NCT00442936|10557697|P2|Overall Study|Protocol Violation|0
3074840|NCT00442936|10557698|P1|Overall Study|Protocol Violation|1
3074841|NCT00442897|10557746|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
3074842|NCT00442897|10557747|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
3074843|NCT00442897|10557746|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
3074844|NCT00442897|10557747|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
3074845|NCT00442897|10557746|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
3074846|NCT00442897|10557747|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
3074847|NCT00442897|10557746|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
3074848|NCT00442897|10557747|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
3074849|NCT00442897|10557746|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
3074850|NCT00442897|10557747|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
3074851|NCT00442897|10557746|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
3074852|NCT00442897|10557747|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
3074853|NCT00442897|10557746|P2|Base Study (12 Week Follow-up)|Death|1
3074854|NCT00442897|10557747|P1|Base Study (12 Week Follow-up)|Death|0
3074855|NCT00442897|10557746|P2|Base Study (12 Week Follow-up)|Adverse Event|0
3074856|NCT00442897|10557747|P1|Base Study (12 Week Follow-up)|Adverse Event|1
3074857|NCT00442702|10557765|P2|Evaluation Period|Site closure|1
3074858|NCT00442702|10557766|P1|Evaluation Period|Site closure|0
3074859|NCT00442702|10557765|P2|Evaluation Period|Failure to return|0
3074860|NCT00442702|10557766|P1|Evaluation Period|Failure to return|1
3074861|NCT00442702|10557765|P2|Evaluation Period|Renal transplant|1
3074862|NCT00442702|10557766|P1|Evaluation Period|Renal transplant|0
3074863|NCT00442702|10557765|P2|Evaluation Period|Refused treatment|1
3074864|NCT00442702|10557766|P1|Evaluation Period|Refused treatment|1
3074865|NCT00442702|10557765|P2|Evaluation Period|Insufficient Therapeutic Response|0
3074866|NCT00442702|10557766|P1|Evaluation Period|Insufficient Therapeutic Response|1
3074867|NCT00442702|10557765|P2|Evaluation Period|Death|1
3074868|NCT00442702|10557766|P1|Evaluation Period|Death|1
3074869|NCT00442702|10557765|P2|Evaluation Period|Adverse Event|0
3074870|NCT00442702|10557766|P1|Evaluation Period|Adverse Event|1
3074871|NCT00442702|10557765|P2|Titration Period|Hospitalized in another hospital|0
3074872|NCT00442702|10557766|P1|Titration Period|Hospitalized in another hospital|1
3074873|NCT00442702|10557765|P2|Titration Period|Failure to return|0
3074874|NCT00442702|10557766|P1|Titration Period|Failure to return|1
3074875|NCT00442702|10557765|P2|Titration Period|Refused Treatment|1
3074876|NCT00442702|10557766|P1|Titration Period|Refused Treatment|4
3074877|NCT00442702|10557765|P2|Titration Period|Insufficient Therapeutic Response|0
3074878|NCT00442702|10557766|P1|Titration Period|Insufficient Therapeutic Response|1
3074879|NCT00442702|10557765|P2|Titration Period|Death|2
3074880|NCT00442702|10557766|P1|Titration Period|Death|3
3074881|NCT00442702|10557765|P2|Titration Period|Adverse Event|0
3074882|NCT00442702|10557766|P1|Titration Period|Adverse Event|2
3074883|NCT00442598|10557831|P3|Overall Study|Death|0
3074884|NCT00442598|10557832|P2|Overall Study|Death|1
3074885|NCT00442598|10557833|P1|Overall Study|Death|0
3074886|NCT00442598|10557831|P3|Overall Study|Reduced creatinine clearance|0
3074887|NCT00442598|10557832|P2|Overall Study|Reduced creatinine clearance|0
3074888|NCT00442598|10557833|P1|Overall Study|Reduced creatinine clearance|1
3074889|NCT00442598|10557831|P3|Overall Study|CA125 progression|0
3074890|NCT00442598|10557832|P2|Overall Study|CA125 progression|1
3074891|NCT00442598|10557833|P1|Overall Study|CA125 progression|0
3074892|NCT00442598|10557831|P3|Overall Study|Clinical deterioration|0
3074893|NCT00442598|10557832|P2|Overall Study|Clinical deterioration|2
3074894|NCT00442598|10557833|P1|Overall Study|Clinical deterioration|1
3074895|NCT00442598|10557831|P3|Overall Study|Tumor progression|0
3074896|NCT00442598|10557832|P2|Overall Study|Tumor progression|4
3074897|NCT00442598|10557833|P1|Overall Study|Tumor progression|3
3074898|NCT00442598|10557831|P3|Overall Study|Adverse Event|0
3074899|NCT00442598|10557832|P2|Overall Study|Adverse Event|0
3074900|NCT00442598|10557833|P1|Overall Study|Adverse Event|1
3074901|NCT00442572|10557851|P2|Overall Study|Withdrawal by Subject|1
3074902|NCT00442572|10557852|P1|Overall Study|Withdrawal by Subject|0
3074903|NCT00442572|10557851|P2|Overall Study|Lost to Follow-up|1
3074904|NCT00442572|10557852|P1|Overall Study|Lost to Follow-up|0
3074905|NCT00442572|10557851|P2|Overall Study|Relapse|1
3074906|NCT00442572|10557852|P1|Overall Study|Relapse|8
3074907|NCT00442559|10557892|P2|Overall Study|Withdrawal by Subject|0
3074908|NCT00442559|10557893|P1|Overall Study|Withdrawal by Subject|1
3074909|NCT00442559|10557892|P2|Overall Study|Protocol Violation|1
3074910|NCT00442559|10557893|P1|Overall Study|Protocol Violation|1
3074911|NCT00442559|10557892|P2|Overall Study|Lost to Follow-up|34
3074912|NCT00442559|10557893|P1|Overall Study|Lost to Follow-up|32
3074913|NCT00442546|10557908|P3|Overall Study|Randomized But Not Treated|6
3074914|NCT00442546|10557909|P2|Overall Study|Randomized But Not Treated|4
3074915|NCT00442546|10557910|P1|Overall Study|Randomized But Not Treated|5
3074916|NCT00442546|10557908|P3|Overall Study|Withdrawal by Subject|7
3074917|NCT00442546|10557909|P2|Overall Study|Withdrawal by Subject|5
3074918|NCT00442546|10557910|P1|Overall Study|Withdrawal by Subject|5
3074919|NCT00442546|10557908|P3|Overall Study|Other|6
3074920|NCT00442546|10557909|P2|Overall Study|Other|9
3074921|NCT00442546|10557910|P1|Overall Study|Other|4
3074922|NCT00442546|10557908|P3|Overall Study|Lost to Follow-up|1
3074923|NCT00442546|10557909|P2|Overall Study|Lost to Follow-up|2
3074924|NCT00442546|10557910|P1|Overall Study|Lost to Follow-up|1
3074925|NCT00442546|10557908|P3|Overall Study|Adverse Event|13
3074926|NCT00442546|10557909|P2|Overall Study|Adverse Event|17
3074927|NCT00442546|10557910|P1|Overall Study|Adverse Event|11
3074928|NCT00442468|10558039|P1|Overall Study|Did not complete all study procedures|88
3074929|NCT00442468|10558039|P1|Overall Study|Withdrawal by Subject|91
3074930|NCT00442468|10558039|P1|Overall Study|Adverse Event|4
3074931|NCT00442416|10558069|P2|Overall Study|Administrative/Other|33
3074932|NCT00442416|10558070|P1|Overall Study|Administrative/Other|27
3074933|NCT00442416|10558069|P2|Overall Study|Withdrew consent|2
3074934|NCT00442416|10558070|P1|Overall Study|Withdrew consent|1
3074935|NCT00442416|10558069|P2|Overall Study|Protocol Violation|3
3074936|NCT00442416|10558070|P1|Overall Study|Protocol Violation|2
3074937|NCT00442416|10558069|P2|Overall Study|Lack of Efficacy|0
3074938|NCT00442416|10558070|P1|Overall Study|Lack of Efficacy|2
3074939|NCT00442416|10558069|P2|Overall Study|Death|0
3074940|NCT00442416|10558070|P1|Overall Study|Death|1
3074941|NCT00442416|10558069|P2|Overall Study|Adverse Event|1
3074942|NCT00442416|10558070|P1|Overall Study|Adverse Event|4
3074943|NCT00442351|10558109|P2|Overall Study|Other|1
3074944|NCT00442351|10558110|P1|Overall Study|Other|0
3074945|NCT00442351|10558109|P2|Overall Study|Did not meet protocol eligibility|0
3074946|NCT00442351|10558110|P1|Overall Study|Did not meet protocol eligibility|1
3074947|NCT00442351|10558109|P2|Overall Study|Administrative|5
3074948|NCT00442351|10558110|P1|Overall Study|Administrative|6
3074949|NCT00442286|10558132|P2|Overall Study|Patient Injury|0
3074950|NCT00442286|10558133|P1|Overall Study|Patient Injury|1
3074951|NCT00442286|10558132|P2|Overall Study|System explanted|0
3074952|NCT00442286|10558133|P1|Overall Study|System explanted|1
3074953|NCT00442286|10558132|P2|Overall Study|Withdrawal by Subject|0
3074954|NCT00442286|10558133|P1|Overall Study|Withdrawal by Subject|2
3074955|NCT00442286|10558132|P2|Overall Study|Lost to Follow-up|0
3074956|NCT00442286|10558133|P1|Overall Study|Lost to Follow-up|1
3074957|NCT00442286|10558132|P2|Overall Study|Death|2
3074958|NCT00442286|10558133|P1|Overall Study|Death|2
3074959|NCT00442117|10558195|P2|Overall Study|Met Withdrawal Criteria|1
3074960|NCT00442117|10558196|P1|Overall Study|Met Withdrawal Criteria|2
3074961|NCT00442117|10558195|P2|Overall Study|Non compliance with protocol|5
3074962|NCT00442117|10558196|P1|Overall Study|Non compliance with protocol|3
3074963|NCT00442117|10558195|P2|Overall Study|Major Deviation|20
3074964|NCT00442117|10558196|P1|Overall Study|Major Deviation|25
3074965|NCT00442117|10558195|P2|Overall Study|Withdrawal by Subject|2
3074966|NCT00442117|10558196|P1|Overall Study|Withdrawal by Subject|2
3074967|NCT00442117|10558195|P2|Overall Study|Lost to Follow-up|2
3074968|NCT00442117|10558196|P1|Overall Study|Lost to Follow-up|1
3074969|NCT00442117|10558195|P2|Overall Study|Lack of Efficacy|6
3074970|NCT00442117|10558196|P1|Overall Study|Lack of Efficacy|2
3074971|NCT00442117|10558195|P2|Overall Study|Adverse Event|2
3074972|NCT00442117|10558196|P1|Overall Study|Adverse Event|3
3074973|NCT00441974|10558227|P1|Overall Study|Protocol Violation|7
3074974|NCT00441974|10558227|P1|Overall Study|Lost to Follow-up|80
3074975|NCT00441974|10558227|P1|Overall Study|Consent Withdrawn|35
3074976|NCT00441974|10558227|P1|Overall Study|Adverse Event|6
3074977|NCT00441792|10558243|P2|Overall Study|Lost to Follow-up|2
3074978|NCT00441792|10558244|P1|Overall Study|Lost to Follow-up|0
3074979|NCT00441727|10558284|P3|Overall Study|Various reason specified|5
3074980|NCT00441727|10558285|P2|Overall Study|Various reason specified|8
3074981|NCT00441727|10558286|P1|Overall Study|Various reason specified|6
3074982|NCT00441727|10558284|P3|Overall Study|Safety Reasons|3
3074983|NCT00441727|10558285|P2|Overall Study|Safety Reasons|1
3074984|NCT00441727|10558286|P1|Overall Study|Safety Reasons|3
3074985|NCT00441727|10558284|P3|Overall Study|Lost to Follow-up|5
3074986|NCT00441727|10558285|P2|Overall Study|Lost to Follow-up|6
3074987|NCT00441727|10558286|P1|Overall Study|Lost to Follow-up|5
3074988|NCT00441727|10558284|P3|Overall Study|Withdrawal by Subject|47
3074989|NCT00441727|10558285|P2|Overall Study|Withdrawal by Subject|34
3074990|NCT00441727|10558286|P1|Overall Study|Withdrawal by Subject|40
3074991|NCT00441727|10558284|P3|Overall Study|Lack of Efficacy|48
3074992|NCT00441727|10558285|P2|Overall Study|Lack of Efficacy|8
3074993|NCT00441727|10558286|P1|Overall Study|Lack of Efficacy|7
3074994|NCT00441727|10558284|P3|Overall Study|Adverse Event|28
3074995|NCT00441727|10558285|P2|Overall Study|Adverse Event|33
3074996|NCT00441727|10558286|P1|Overall Study|Adverse Event|26
3074997|NCT00441727|10558284|P3|Overall Study|Protocol Violation|32
3074998|NCT00441727|10558285|P2|Overall Study|Protocol Violation|28
3074999|NCT00441727|10558286|P1|Overall Study|Protocol Violation|19
3075000|NCT00441701|10558319|P10|Overall Study|Withdrawal by Subject|0
3075001|NCT00441701|10558320|P9|Overall Study|Withdrawal by Subject|0
3075002|NCT00441701|10558321|P8|Overall Study|Withdrawal by Subject|0
3075003|NCT00441701|10558322|P7|Overall Study|Withdrawal by Subject|0
3075004|NCT00441701|10558323|P6|Overall Study|Withdrawal by Subject|0
3075005|NCT00441701|10558324|P5|Overall Study|Withdrawal by Subject|0
3075006|NCT00441701|10558325|P4|Overall Study|Withdrawal by Subject|1
3075007|NCT00441701|10558326|P3|Overall Study|Withdrawal by Subject|1
3075008|NCT00441701|10558327|P2|Overall Study|Withdrawal by Subject|2
3075009|NCT00441701|10558328|P1|Overall Study|Withdrawal by Subject|0
3075010|NCT00441701|10558319|P10|Overall Study|Lack of Efficacy|0
3075011|NCT00441701|10558320|P9|Overall Study|Lack of Efficacy|0
3075012|NCT00441701|10558321|P8|Overall Study|Lack of Efficacy|0
3075013|NCT00441701|10558322|P7|Overall Study|Lack of Efficacy|0
3075014|NCT00441701|10558323|P6|Overall Study|Lack of Efficacy|1
3075015|NCT00441701|10558324|P5|Overall Study|Lack of Efficacy|0
3075016|NCT00441701|10558325|P4|Overall Study|Lack of Efficacy|2
3075017|NCT00441701|10558326|P3|Overall Study|Lack of Efficacy|2
3075018|NCT00441701|10558327|P2|Overall Study|Lack of Efficacy|0
3075019|NCT00441701|10558328|P1|Overall Study|Lack of Efficacy|2
3075020|NCT00441701|10558319|P10|Overall Study|Adverse Event|0
3075021|NCT00441701|10558320|P9|Overall Study|Adverse Event|0
3075022|NCT00441701|10558321|P8|Overall Study|Adverse Event|0
3075023|NCT00441701|10558322|P7|Overall Study|Adverse Event|0
3075024|NCT00441701|10558323|P6|Overall Study|Adverse Event|2
3075025|NCT00441701|10558324|P5|Overall Study|Adverse Event|2
3075026|NCT00441701|10558325|P4|Overall Study|Adverse Event|0
3075027|NCT00441701|10558326|P3|Overall Study|Adverse Event|1
3075028|NCT00441701|10558327|P2|Overall Study|Adverse Event|2
3075029|NCT00441701|10558328|P1|Overall Study|Adverse Event|3
3075030|NCT00441584|10558410|P1|Overall Study|Failure to meet eligibility criteria|3
3075031|NCT00441584|10558410|P1|Overall Study|Lost to Follow-up|4
3075032|NCT00441584|10558410|P1|Overall Study|Protocol Violation|5
3075033|NCT00441584|10558410|P1|Overall Study|Adverse Event|6
3075034|NCT00441584|10558410|P1|Overall Study|Withdrawal by Subject|8
3075035|NCT00441584|10558410|P1|Overall Study|Lack of Efficacy|79
3075036|NCT00441545|10558418|P2|Second Intervention|Subject moved|1
3075037|NCT00441545|10558419|P1|Second Intervention|Subject moved|0
3075038|NCT00441545|10558418|P2|Second Intervention|Subject exceeded safety criteria|0
3075039|NCT00441545|10558419|P1|Second Intervention|Subject exceeded safety criteria|1
3075040|NCT00441545|10558418|P2|Second Intervention|Lack of Efficacy|1
3075041|NCT00441545|10558419|P1|Second Intervention|Lack of Efficacy|0
3075042|NCT00441545|10558418|P2|Second Intervention|Kidney Transplant|1
3075043|NCT00441545|10558419|P1|Second Intervention|Kidney Transplant|1
3075044|NCT00441545|10558418|P2|Second Intervention|Withdrawal by Subject|1
3075045|NCT00441545|10558419|P1|Second Intervention|Withdrawal by Subject|1
3075046|NCT00441545|10558418|P2|Second Intervention|Protocol Violation|1
3075047|NCT00441545|10558419|P1|Second Intervention|Protocol Violation|4
3075048|NCT00441545|10558418|P2|Second Intervention|Adverse Event|2
3075049|NCT00441545|10558419|P1|Second Intervention|Adverse Event|5
3075050|NCT00441545|10558418|P2|First Intervention|Sponsor's request|0
3075051|NCT00441545|10558419|P1|First Intervention|Sponsor's request|1
3075052|NCT00441545|10558418|P2|First Intervention|Site error|0
3075053|NCT00441545|10558419|P1|First Intervention|Site error|1
3075054|NCT00441545|10558418|P2|First Intervention|Extended hospitalization|0
3075055|NCT00441545|10558419|P1|First Intervention|Extended hospitalization|1
3075056|NCT00441545|10558418|P2|First Intervention|Subject met an exclusionary criteria|0
3075057|NCT00441545|10558419|P1|First Intervention|Subject met an exclusionary criteria|1
3075058|NCT00441545|10558418|P2|First Intervention|Subject exceeded safety criteria|1
3075059|NCT00441545|10558419|P1|First Intervention|Subject exceeded safety criteria|0
3075060|NCT00441545|10558418|P2|First Intervention|Lack of Efficacy|0
3075061|NCT00441545|10558419|P1|First Intervention|Lack of Efficacy|2
3075062|NCT00441545|10558418|P2|First Intervention|Kidney transplant|1
3075063|NCT00441545|10558419|P1|First Intervention|Kidney transplant|1
3075064|NCT00441545|10558418|P2|First Intervention|Withdrawal by Subject|3
3075065|NCT00441545|10558419|P1|First Intervention|Withdrawal by Subject|3
3075066|NCT00441545|10558418|P2|First Intervention|Protocol Violation|2
3075067|NCT00441545|10558419|P1|First Intervention|Protocol Violation|2
3075068|NCT00441545|10558418|P2|First Intervention|Adverse Event|5
3075069|NCT00441545|10558419|P1|First Intervention|Adverse Event|6
3075070|NCT00441480|10558433|P2|Overall Study|Withdrawal by Subject|3
3075071|NCT00441480|10558434|P1|Overall Study|Withdrawal by Subject|2
3075072|NCT00441480|10558433|P2|Overall Study|Protocol Violation|1
3075073|NCT00441480|10558434|P1|Overall Study|Protocol Violation|1
3075074|NCT00441467|10558466|P1|Overall Study|Progressive disease|9
3075075|NCT00441467|10558466|P1|Overall Study|Withdrawal by Subject|3
3075076|NCT00441467|10558466|P1|Overall Study|Adverse Event|6
3075077|NCT00441441|10558474|P2|Overall Study|Other|3
3075078|NCT00441441|10558475|P1|Overall Study|Other|3
3075079|NCT00441441|10558474|P2|Overall Study|Withdrawal by Subject|2
3075080|NCT00441441|10558475|P1|Overall Study|Withdrawal by Subject|1
3075081|NCT00441441|10558474|P2|Overall Study|Exacerbation of asthma|2
3075082|NCT00441441|10558475|P1|Overall Study|Exacerbation of asthma|1
3075083|NCT00441441|10558474|P2|Overall Study|Protocol Violation|6
3075084|NCT00441441|10558475|P1|Overall Study|Protocol Violation|4
3075085|NCT00441441|10558474|P2|Overall Study|Adverse Event|1
3075086|NCT00441441|10558475|P1|Overall Study|Adverse Event|2
3075087|NCT00441363|10558535|P2|Overall Study|Other|0
3075088|NCT00441363|10558536|P1|Overall Study|Other|2
3075089|NCT00441363|10558535|P2|Overall Study|Lost to Follow-up|2
3075090|NCT00441363|10558536|P1|Overall Study|Lost to Follow-up|2
3075091|NCT00441363|10558535|P2|Overall Study|Physician Decision|7
3075092|NCT00441363|10558536|P1|Overall Study|Physician Decision|6
3075093|NCT00441363|10558535|P2|Overall Study|Withdrawal by Subject|4
3075094|NCT00441363|10558536|P1|Overall Study|Withdrawal by Subject|3
3075095|NCT00441363|10558535|P2|Overall Study|Adverse Event|2
3075096|NCT00441363|10558536|P1|Overall Study|Adverse Event|4
3075097|NCT00441337|10558548|P4|Overall Study|Did not meet inclusion criteria|0
3075098|NCT00441337|10558549|P3|Overall Study|Did not meet inclusion criteria|1
3075099|NCT00441337|10558550|P2|Overall Study|Did not meet inclusion criteria|0
3075100|NCT00441337|10558551|P1|Overall Study|Did not meet inclusion criteria|0
3075101|NCT00441337|10558548|P4|Overall Study|Sponsor Decision|2
3075102|NCT00441337|10558549|P3|Overall Study|Sponsor Decision|1
3075103|NCT00441337|10558550|P2|Overall Study|Sponsor Decision|0
3075104|NCT00441337|10558551|P1|Overall Study|Sponsor Decision|0
3075105|NCT00441337|10558548|P4|Overall Study|Lost to Follow-up|1
3075106|NCT00441337|10558549|P3|Overall Study|Lost to Follow-up|0
3075107|NCT00441337|10558550|P2|Overall Study|Lost to Follow-up|0
3075108|NCT00441337|10558551|P1|Overall Study|Lost to Follow-up|0
3075109|NCT00441337|10558548|P4|Overall Study|Disease Progression|18
3075110|NCT00441337|10558549|P3|Overall Study|Disease Progression|4
3075111|NCT00441337|10558550|P2|Overall Study|Disease Progression|6
3075112|NCT00441337|10558551|P1|Overall Study|Disease Progression|6
3075113|NCT00441272|10558664|P2|Overall Study|Study terminated prior to enrollment|25
3075114|NCT00441272|10558665|P1|Overall Study|Study terminated prior to enrollment|25
3075115|NCT00441168|10558692|P2|Follow-up Period|Other|3
3075116|NCT00441168|10558693|P1|Follow-up Period|Other|1
3075117|NCT00441168|10558692|P2|Follow-up Period|Withdrawal by Subject|0
3075118|NCT00441168|10558693|P1|Follow-up Period|Withdrawal by Subject|3
3075119|NCT00441168|10558692|P2|Follow-up Period|Lost to Follow-up|6
3075120|NCT00441168|10558693|P1|Follow-up Period|Lost to Follow-up|5
3075121|NCT00441168|10558692|P2|Follow-up Period|Death|0
3075122|NCT00441168|10558693|P1|Follow-up Period|Death|3
3075123|NCT00441168|10558692|P2|Treatment Period|refractory disease|0
3075124|NCT00441168|10558693|P1|Treatment Period|refractory disease|1
3075125|NCT00441168|10558692|P2|Treatment Period|qualified for stem-cell transplantation|0
3075126|NCT00441168|10558693|P1|Treatment Period|qualified for stem-cell transplantation|3
3075127|NCT00441168|10558692|P2|Treatment Period|Withdrawal by Subject|0
3075128|NCT00441168|10558693|P1|Treatment Period|Withdrawal by Subject|3
3075129|NCT00441168|10558692|P2|Treatment Period|Lost to Follow-up|1
3075130|NCT00441168|10558693|P1|Treatment Period|Lost to Follow-up|0
3075131|NCT00441168|10558692|P2|Treatment Period|Protocol Violation|1
3075132|NCT00441168|10558693|P1|Treatment Period|Protocol Violation|0
3075133|NCT00441168|10558692|P2|Treatment Period|Progressive Disease|2
3075134|NCT00441168|10558693|P1|Treatment Period|Progressive Disease|0
3075135|NCT00441168|10558692|P2|Treatment Period|Adverse Event|2
3075136|NCT00441168|10558693|P1|Treatment Period|Adverse Event|1
3075137|NCT00441168|10558692|P2|Treatment Period|Death|0
3075138|NCT00441168|10558693|P1|Treatment Period|Death|3
3075139|NCT00441142|10558707|P4|Overall Study|Death|1
3075140|NCT00441142|10558708|P3|Overall Study|Death|0
3075141|NCT00441142|10558709|P2|Overall Study|Death|0
3075142|NCT00441142|10558710|P1|Overall Study|Death|0
3075143|NCT00441142|10558707|P4|Overall Study|Physician Decision|1
3075144|NCT00441142|10558708|P3|Overall Study|Physician Decision|0
3075145|NCT00441142|10558709|P2|Overall Study|Physician Decision|1
3075146|NCT00441142|10558710|P1|Overall Study|Physician Decision|0
3075147|NCT00441142|10558707|P4|Overall Study|Patient still receiving active study tx|2
3075148|NCT00441142|10558708|P3|Overall Study|Patient still receiving active study tx|0
3075149|NCT00441142|10558709|P2|Overall Study|Patient still receiving active study tx|0
3075150|NCT00441142|10558710|P1|Overall Study|Patient still receiving active study tx|1
3075151|NCT00441142|10558707|P4|Overall Study|Withdrawal by Subject|10
3075152|NCT00441142|10558708|P3|Overall Study|Withdrawal by Subject|2
3075153|NCT00441142|10558709|P2|Overall Study|Withdrawal by Subject|0
3075154|NCT00441142|10558710|P1|Overall Study|Withdrawal by Subject|0
3075155|NCT00441142|10558707|P4|Overall Study|Lack of Efficacy|32
3075156|NCT00441142|10558708|P3|Overall Study|Lack of Efficacy|17
3075157|NCT00441142|10558709|P2|Overall Study|Lack of Efficacy|3
3075158|NCT00441142|10558710|P1|Overall Study|Lack of Efficacy|3
3075159|NCT00441142|10558707|P4|Overall Study|Adverse Event|22
3075160|NCT00441142|10558708|P3|Overall Study|Adverse Event|3
3075161|NCT00441142|10558709|P2|Overall Study|Adverse Event|3
3075162|NCT00441142|10558710|P1|Overall Study|Adverse Event|2
3075163|NCT00441129|10558732|P2|Overall Study|Withdrawal by Subject|14
3075164|NCT00441129|10558733|P1|Overall Study|Withdrawal by Subject|6
3075165|NCT00441116|10558745|P2|Overall Study|Did not meet Eligibility Criteria|1
3075166|NCT00441116|10558746|P1|Overall Study|Did not meet Eligibility Criteria|1
3075167|NCT00441116|10558745|P2|Overall Study|Withdrawal by Subject|0
3075168|NCT00441116|10558746|P1|Overall Study|Withdrawal by Subject|1
3075169|NCT00441116|10558745|P2|Overall Study|Adverse Event|1
3075170|NCT00441116|10558746|P1|Overall Study|Adverse Event|1
3075171|NCT00441103|10558814|P2|Overall Study|Participant decided to stop|1
3075172|NCT00441103|10558815|P1|Overall Study|Participant decided to stop|0
3075173|NCT00441103|10558814|P2|Overall Study|Participant's reason|1
3075174|NCT00441103|10558815|P1|Overall Study|Participant's reason|0
3075175|NCT00441103|10558814|P2|Overall Study|Participant decided to withdraw|0
3075176|NCT00441103|10558815|P1|Overall Study|Participant decided to withdraw|1
3075177|NCT00441103|10558814|P2|Overall Study|Non-compliant|1
3075178|NCT00441103|10558815|P1|Overall Study|Non-compliant|0
3075179|NCT00441103|10558814|P2|Overall Study|Inclusion criteria absent|0
3075180|NCT00441103|10558815|P1|Overall Study|Inclusion criteria absent|1
3075181|NCT00441103|10558814|P2|Overall Study|Participant refused MRI|0
3075182|NCT00441103|10558815|P1|Overall Study|Participant refused MRI|1
3075183|NCT00441103|10558814|P2|Overall Study|Participant unable to use Rebiject II|0
3075184|NCT00441103|10558815|P1|Overall Study|Participant unable to use Rebiject II|1
3075185|NCT00441103|10558814|P2|Overall Study|Protocol Violation|0
3075186|NCT00441103|10558815|P1|Overall Study|Protocol Violation|1
3075187|NCT00441103|10558814|P2|Overall Study|Lost to Follow-up|0
3075188|NCT00441103|10558815|P1|Overall Study|Lost to Follow-up|1
3075189|NCT00441103|10558814|P2|Overall Study|Disease Progression|0
3075190|NCT00441103|10558815|P1|Overall Study|Disease Progression|2
3075191|NCT00441103|10558814|P2|Overall Study|Death|0
3075192|NCT00441103|10558815|P1|Overall Study|Death|1
3075193|NCT00441103|10558814|P2|Overall Study|Adverse Event|1
3075194|NCT00441103|10558815|P1|Overall Study|Adverse Event|2
3075195|NCT00441090|10558831|P5|Overall Study|Lack of Efficacy|0
3075196|NCT00441090|10558832|P4|Overall Study|Lack of Efficacy|0
3075197|NCT00441090|10558833|P3|Overall Study|Lack of Efficacy|0
3075198|NCT00441090|10558834|P2|Overall Study|Lack of Efficacy|0
3075199|NCT00441090|10558835|P1|Overall Study|Lack of Efficacy|1
3075200|NCT00441090|10558831|P5|Overall Study|Withdrawal by Subject|0
3075201|NCT00441090|10558832|P4|Overall Study|Withdrawal by Subject|0
3075202|NCT00441090|10558833|P3|Overall Study|Withdrawal by Subject|1
3075203|NCT00441090|10558834|P2|Overall Study|Withdrawal by Subject|0
3075204|NCT00441090|10558835|P1|Overall Study|Withdrawal by Subject|1
3075205|NCT00441090|10558831|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
3075206|NCT00441090|10558832|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
3075207|NCT00441090|10558833|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
3075208|NCT00441090|10558834|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
3075209|NCT00441090|10558835|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
3075210|NCT00441090|10558831|P5|Overall Study|Adverse Event|0
3075211|NCT00441090|10558832|P4|Overall Study|Adverse Event|0
3075212|NCT00441090|10558833|P3|Overall Study|Adverse Event|1
3075213|NCT00441090|10558834|P2|Overall Study|Adverse Event|1
3075214|NCT00441090|10558835|P1|Overall Study|Adverse Event|0
3075215|NCT00441064|10558879|P2|Overall Study|Patient withdrew consent|2
3075216|NCT00441064|10558880|P1|Overall Study|Patient withdrew consent|5
3075217|NCT00441064|10558879|P2|Overall Study|Protocol Deviation|2
3075218|NCT00441064|10558880|P1|Overall Study|Protocol Deviation|3
3075219|NCT00441064|10558879|P2|Overall Study|Unsatisfactory therapeutic effect|0
3075220|NCT00441064|10558880|P1|Overall Study|Unsatisfactory therapeutic effect|1
3075221|NCT00441064|10558879|P2|Overall Study|Abnormal test procedure results|1
3075222|NCT00441064|10558880|P1|Overall Study|Abnormal test procedure results|0
3075223|NCT00441064|10558879|P2|Overall Study|Abnormal laboratory values|2
3075224|NCT00441064|10558880|P1|Overall Study|Abnormal laboratory values|0
3075225|NCT00441064|10558879|P2|Overall Study|Adverse Event|0
3075226|NCT00441064|10558880|P1|Overall Study|Adverse Event|1
3075227|NCT00441012|10558892|P2|Overall Study|Subject Randomized but Not Vaccinated|0
3075228|NCT00441012|10558893|P1|Overall Study|Subject Randomized but Not Vaccinated|1
3075229|NCT00441012|10558892|P2|Overall Study|Withdrawal by Subject|0
3075230|NCT00441012|10558893|P1|Overall Study|Withdrawal by Subject|4
3075231|NCT00441012|10558892|P2|Overall Study|Protocol Violation|9
3075232|NCT00441012|10558893|P1|Overall Study|Protocol Violation|10
3075233|NCT00441012|10558892|P2|Overall Study|Lost to Follow-up|3
3075234|NCT00441012|10558893|P1|Overall Study|Lost to Follow-up|3
3075235|NCT00441012|10558892|P2|Overall Study|Adverse Event|1
3075236|NCT00441012|10558893|P1|Overall Study|Adverse Event|0
3075237|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
3075238|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
3075239|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
3075240|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
3075241|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
3075242|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Physician Decision|1
3075243|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Physician Decision|0
3075244|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Physician Decision|0
3075245|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Physician Decision|0
3075246|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Physician Decision|0
3075247|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Other|0
3075248|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Other|1
3075249|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Other|0
3075250|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Other|0
3075251|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Other|0
3075252|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
3075253|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
3075254|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
3075255|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
3075256|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
3075257|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Sponsor Request|1
3075258|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Sponsor Request|1
3075259|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Sponsor Request|0
3075260|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Sponsor Request|0
3075261|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Sponsor Request|0
3075262|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Participant Moved|1
3075263|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Participant Moved|1
3075264|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Participant Moved|0
3075265|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Participant Moved|0
3075266|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Participant Moved|0
3075267|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Pregnancy|0
3075268|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Pregnancy|3
3075269|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Pregnancy|0
3075270|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Pregnancy|0
3075271|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Pregnancy|0
3075272|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
3075273|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
3075274|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
3075275|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
3075276|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
3075277|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Protocol Violation|0
3075278|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Protocol Violation|1
3075279|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Protocol Violation|0
3075280|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Protocol Violation|0
3075281|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Protocol Violation|0
3075282|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
3075283|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
3075284|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
3075285|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
3075286|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
3075287|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Non-compliance|1
3075288|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Non-compliance|1
3075289|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Non-compliance|0
3075290|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Non-compliance|0
3075291|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Non-compliance|0
3075292|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
3075293|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
3075294|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
3075295|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
3075296|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
3075297|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
3075298|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
3075299|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
3075300|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
3075301|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
3075302|NCT00440947|10558907|P5|Optional 60-Week Extension Phase|Adverse Event|3
3075303|NCT00440947|10558908|P4|Optional 60-Week Extension Phase|Adverse Event|1
3075304|NCT00440947|10558909|P3|Optional 60-Week Extension Phase|Adverse Event|0
3075305|NCT00440947|10558910|P2|Optional 60-Week Extension Phase|Adverse Event|0
3075306|NCT00440947|10558911|P1|Optional 60-Week Extension Phase|Adverse Event|0
3075307|NCT00440947|10558907|P5|48-Week Randomization Phase|Physician Decision|0
3075308|NCT00440947|10558908|P4|48-Week Randomization Phase|Physician Decision|0
3075309|NCT00440947|10558909|P3|48-Week Randomization Phase|Physician Decision|0
3075310|NCT00440947|10558910|P2|48-Week Randomization Phase|Physician Decision|2
3075311|NCT00440947|10558911|P1|48-Week Randomization Phase|Physician Decision|0
3075312|NCT00440947|10558907|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
3075313|NCT00440947|10558908|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
3075314|NCT00440947|10558909|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
3075315|NCT00440947|10558910|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
3075316|NCT00440947|10558911|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
3075317|NCT00440947|10558907|P5|48-Week Randomization Phase|Incarceration|0
3075318|NCT00440947|10558908|P4|48-Week Randomization Phase|Incarceration|0
3075319|NCT00440947|10558909|P3|48-Week Randomization Phase|Incarceration|0
3075320|NCT00440947|10558910|P2|48-Week Randomization Phase|Incarceration|3
3075321|NCT00440947|10558911|P1|48-Week Randomization Phase|Incarceration|0
3075322|NCT00440947|10558907|P5|48-Week Randomization Phase|Pregnancy|0
3075323|NCT00440947|10558908|P4|48-Week Randomization Phase|Pregnancy|0
3075324|NCT00440947|10558909|P3|48-Week Randomization Phase|Pregnancy|1
3075325|NCT00440947|10558910|P2|48-Week Randomization Phase|Pregnancy|0
3075326|NCT00440947|10558911|P1|48-Week Randomization Phase|Pregnancy|0
3075327|NCT00440947|10558907|P5|48-Week Randomization Phase|Withdrawal by Subject|0
3075328|NCT00440947|10558908|P4|48-Week Randomization Phase|Withdrawal by Subject|0
3075329|NCT00440947|10558909|P3|48-Week Randomization Phase|Withdrawal by Subject|4
3075330|NCT00440947|10558910|P2|48-Week Randomization Phase|Withdrawal by Subject|2
3075331|NCT00440947|10558911|P1|48-Week Randomization Phase|Withdrawal by Subject|0
3075332|NCT00440947|10558907|P5|48-Week Randomization Phase|Protocol Violation|0
3075333|NCT00440947|10558908|P4|48-Week Randomization Phase|Protocol Violation|0
3075334|NCT00440947|10558909|P3|48-Week Randomization Phase|Protocol Violation|1
3075335|NCT00440947|10558910|P2|48-Week Randomization Phase|Protocol Violation|0
3075336|NCT00440947|10558911|P1|48-Week Randomization Phase|Protocol Violation|0
3075337|NCT00440947|10558907|P5|48-Week Randomization Phase|Lost to Follow-up|0
3075338|NCT00440947|10558908|P4|48-Week Randomization Phase|Lost to Follow-up|0
3075339|NCT00440947|10558909|P3|48-Week Randomization Phase|Lost to Follow-up|8
3075340|NCT00440947|10558910|P2|48-Week Randomization Phase|Lost to Follow-up|2
3075341|NCT00440947|10558911|P1|48-Week Randomization Phase|Lost to Follow-up|0
3075342|NCT00440947|10558907|P5|48-Week Randomization Phase|Non-compliance|0
3075343|NCT00440947|10558908|P4|48-Week Randomization Phase|Non-compliance|0
3075344|NCT00440947|10558909|P3|48-Week Randomization Phase|Non-compliance|4
3075345|NCT00440947|10558910|P2|48-Week Randomization Phase|Non-compliance|3
3075346|NCT00440947|10558911|P1|48-Week Randomization Phase|Non-compliance|0
3075347|NCT00440947|10558907|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
3075348|NCT00440947|10558908|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
3075349|NCT00440947|10558909|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
3075350|NCT00440947|10558910|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
3075351|NCT00440947|10558911|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
3075352|NCT00440947|10558907|P5|48-Week Randomization Phase|Adverse Event|0
3075353|NCT00440947|10558908|P4|48-Week Randomization Phase|Adverse Event|0
3075354|NCT00440947|10558909|P3|48-Week Randomization Phase|Adverse Event|5
3075355|NCT00440947|10558910|P2|48-Week Randomization Phase|Adverse Event|2
3075356|NCT00440947|10558911|P1|48-Week Randomization Phase|Adverse Event|0
3075357|NCT00440947|10558907|P5|36-Week Induction Phase|Pregnancy|0
3075358|NCT00440947|10558908|P4|36-Week Induction Phase|Pregnancy|0
3075359|NCT00440947|10558909|P3|36-Week Induction Phase|Pregnancy|0
3075360|NCT00440947|10558910|P2|36-Week Induction Phase|Pregnancy|0
3075361|NCT00440947|10558911|P1|36-Week Induction Phase|Pregnancy|1
3075362|NCT00440947|10558907|P5|36-Week Induction Phase|Incarceration|0
3075363|NCT00440947|10558908|P4|36-Week Induction Phase|Incarceration|0
3075364|NCT00440947|10558909|P3|36-Week Induction Phase|Incarceration|0
3075365|NCT00440947|10558910|P2|36-Week Induction Phase|Incarceration|0
3075366|NCT00440947|10558911|P1|36-Week Induction Phase|Incarceration|3
3075367|NCT00440947|10558907|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
3075368|NCT00440947|10558908|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
3075369|NCT00440947|10558909|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
3075370|NCT00440947|10558910|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
3075371|NCT00440947|10558911|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
3075372|NCT00440947|10558907|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
3075373|NCT00440947|10558908|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
3075374|NCT00440947|10558909|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
3075375|NCT00440947|10558910|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
3075376|NCT00440947|10558911|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
3075377|NCT00440947|10558907|P5|36-Week Induction Phase|Took Exclusionary Medications|0
3075378|NCT00440947|10558908|P4|36-Week Induction Phase|Took Exclusionary Medications|0
3075379|NCT00440947|10558909|P3|36-Week Induction Phase|Took Exclusionary Medications|0
3075380|NCT00440947|10558910|P2|36-Week Induction Phase|Took Exclusionary Medications|0
3075381|NCT00440947|10558911|P1|36-Week Induction Phase|Took Exclusionary Medications|1
3075382|NCT00440947|10558907|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
3075383|NCT00440947|10558908|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
3075384|NCT00440947|10558909|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
3075385|NCT00440947|10558910|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
3075386|NCT00440947|10558911|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
3075387|NCT00440947|10558907|P5|36-Week Induction Phase|Withdrawal by Subject|0
3075388|NCT00440947|10558908|P4|36-Week Induction Phase|Withdrawal by Subject|0
3075389|NCT00440947|10558909|P3|36-Week Induction Phase|Withdrawal by Subject|0
3075390|NCT00440947|10558910|P2|36-Week Induction Phase|Withdrawal by Subject|0
3075391|NCT00440947|10558911|P1|36-Week Induction Phase|Withdrawal by Subject|7
3075392|NCT00440947|10558907|P5|36-Week Induction Phase|Lost to Follow-up|0
3075393|NCT00440947|10558908|P4|36-Week Induction Phase|Lost to Follow-up|0
3075394|NCT00440947|10558909|P3|36-Week Induction Phase|Lost to Follow-up|0
3075395|NCT00440947|10558910|P2|36-Week Induction Phase|Lost to Follow-up|0
3075396|NCT00440947|10558911|P1|36-Week Induction Phase|Lost to Follow-up|16
3075397|NCT00440947|10558907|P5|36-Week Induction Phase|Non-compliance|0
3075398|NCT00440947|10558908|P4|36-Week Induction Phase|Non-compliance|0
3075399|NCT00440947|10558909|P3|36-Week Induction Phase|Non-compliance|0
3075400|NCT00440947|10558910|P2|36-Week Induction Phase|Non-compliance|0
3075401|NCT00440947|10558911|P1|36-Week Induction Phase|Non-compliance|10
3075402|NCT00440947|10558907|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
3075403|NCT00440947|10558908|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
3075404|NCT00440947|10558909|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
3075405|NCT00440947|10558910|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
3075406|NCT00440947|10558911|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
3075407|NCT00440947|10558907|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
3075408|NCT00440947|10558908|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
3075409|NCT00440947|10558909|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
3075410|NCT00440947|10558910|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
3075411|NCT00440947|10558911|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
3075412|NCT00440947|10558907|P5|36-Week Induction Phase|Adverse Event|0
3075413|NCT00440947|10558908|P4|36-Week Induction Phase|Adverse Event|0
3075414|NCT00440947|10558909|P3|36-Week Induction Phase|Adverse Event|0
3075415|NCT00440947|10558910|P2|36-Week Induction Phase|Adverse Event|0
3075416|NCT00440947|10558911|P1|36-Week Induction Phase|Adverse Event|16
3075417|NCT00440726|10558986|P3|Phase 2|Adverse Event|1
3075418|NCT00440726|10558987|P2|Phase 2|Adverse Event|0
3075419|NCT00440726|10558988|P1|Phase 2|Adverse Event|0
3075420|NCT00440726|10558986|P3|Phase 2|Death|1
3075421|NCT00440726|10558987|P2|Phase 2|Death|0
3075422|NCT00440726|10558988|P1|Phase 2|Death|0
3075423|NCT00440726|10558986|P3|Phase 1|Physician Decision|0
3075424|NCT00440726|10558987|P2|Phase 1|Physician Decision|0
3075425|NCT00440726|10558988|P1|Phase 1|Physician Decision|1
3075426|NCT00440726|10558986|P3|Phase 1|Dose-Limiting Toxicity|0
3075427|NCT00440726|10558987|P2|Phase 1|Dose-Limiting Toxicity|1
3075428|NCT00440726|10558988|P1|Phase 1|Dose-Limiting Toxicity|0
3075429|NCT00440700|10559002|P3|Overall Study|Withdrawal by Subject|4
3075430|NCT00440700|10559003|P2|Overall Study|Withdrawal by Subject|8
3075431|NCT00440700|10559004|P1|Overall Study|Withdrawal by Subject|8
3075432|NCT00440557|10559027|P3|Overall Study|Patient had surgery|0
3075433|NCT00440557|10559028|P2|Overall Study|Patient had surgery|0
3075434|NCT00440557|10559029|P1|Overall Study|Patient had surgery|1
3075435|NCT00440557|10559027|P3|Overall Study|Patient transferred to nursing home|0
3075436|NCT00440557|10559028|P2|Overall Study|Patient transferred to nursing home|1
3075437|NCT00440557|10559029|P1|Overall Study|Patient transferred to nursing home|0
3075438|NCT00440557|10559027|P3|Overall Study|Principal Investigator's office closed|4
3075439|NCT00440557|10559028|P2|Overall Study|Principal Investigator's office closed|6
3075440|NCT00440557|10559029|P1|Overall Study|Principal Investigator's office closed|3
3075441|NCT00440557|10559027|P3|Overall Study|Patient moved|1
3075442|NCT00440557|10559028|P2|Overall Study|Patient moved|2
3075443|NCT00440557|10559029|P1|Overall Study|Patient moved|1
3075444|NCT00440557|10559027|P3|Overall Study|Principal Investigator decision|1
3075445|NCT00440557|10559028|P2|Overall Study|Principal Investigator decision|3
3075446|NCT00440557|10559029|P1|Overall Study|Principal Investigator decision|0
3075447|NCT00440557|10559027|P3|Overall Study|Began Dialysis|4
3075448|NCT00440557|10559028|P2|Overall Study|Began Dialysis|1
3075449|NCT00440557|10559029|P1|Overall Study|Began Dialysis|4
3075450|NCT00440557|10559027|P3|Overall Study|Death|3
3075451|NCT00440557|10559028|P2|Overall Study|Death|6
3075452|NCT00440557|10559029|P1|Overall Study|Death|2
3075453|NCT00440557|10559027|P3|Overall Study|Adverse Event|5
3075454|NCT00440557|10559028|P2|Overall Study|Adverse Event|3
3075455|NCT00440557|10559029|P1|Overall Study|Adverse Event|3
3075456|NCT00440557|10559027|P3|Overall Study|Lost to Follow-up|6
3075457|NCT00440557|10559028|P2|Overall Study|Lost to Follow-up|2
3075458|NCT00440557|10559029|P1|Overall Study|Lost to Follow-up|1
3075459|NCT00440557|10559027|P3|Overall Study|Withdrawal by Subject|11
3075460|NCT00440557|10559028|P2|Overall Study|Withdrawal by Subject|5
3075461|NCT00440557|10559029|P1|Overall Study|Withdrawal by Subject|10
3075462|NCT00440531|10559061|P3|Overall Study|see pre-assignment details|0
3075463|NCT00440531|10559062|P2|Overall Study|see pre-assignment details|0
3075464|NCT00440531|10559063|P1|Overall Study|see pre-assignment details|2
3075465|NCT00440531|10559061|P3|Overall Study|Lost to Follow-up|5
3075466|NCT00440531|10559062|P2|Overall Study|Lost to Follow-up|3
3075467|NCT00440531|10559063|P1|Overall Study|Lost to Follow-up|4
3075468|NCT00440531|10559061|P3|Overall Study|Protocol Violation|0
3075469|NCT00440531|10559062|P2|Overall Study|Protocol Violation|2
3075470|NCT00440531|10559063|P1|Overall Study|Protocol Violation|1
3075471|NCT00440531|10559061|P3|Overall Study|Withdrawal by Subject|0
3075472|NCT00440531|10559062|P2|Overall Study|Withdrawal by Subject|0
3075473|NCT00440531|10559063|P1|Overall Study|Withdrawal by Subject|2
3075474|NCT00440531|10559061|P3|Overall Study|Adverse Event|2
3075475|NCT00440531|10559062|P2|Overall Study|Adverse Event|0
3075476|NCT00440531|10559063|P1|Overall Study|Adverse Event|1
3075477|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
3075478|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
3075479|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
3075480|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Other|2
3075481|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Other|0
3075482|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Other|0
3075483|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
3075484|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
3075485|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
3075486|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
3075487|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
3075488|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
3075489|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
3075490|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
3075491|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
3075492|NCT00440518|10559080|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
3075493|NCT00440518|10559081|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
3075494|NCT00440518|10559082|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
3075495|NCT00440518|10559080|P3|Randomized /Titration Period|Adverse Event|0
3075496|NCT00440518|10559081|P2|Randomized /Titration Period|Adverse Event|3
3075497|NCT00440518|10559082|P1|Randomized /Titration Period|Adverse Event|2
3075498|NCT00440518|10559080|P3|Randomized /Titration Period|Lost to Follow-up|1
3075499|NCT00440518|10559081|P2|Randomized /Titration Period|Lost to Follow-up|2
3075500|NCT00440518|10559082|P1|Randomized /Titration Period|Lost to Follow-up|2
3075501|NCT00440518|10559080|P3|Randomized /Titration Period|Other|0
3075502|NCT00440518|10559081|P2|Randomized /Titration Period|Other|0
3075503|NCT00440518|10559082|P1|Randomized /Titration Period|Other|1
3075504|NCT00440518|10559080|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
3075505|NCT00440518|10559081|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
3075506|NCT00440518|10559082|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
3075507|NCT00440518|10559080|P3|Randomized /Titration Period|Protocol Deviation|0
3075508|NCT00440518|10559081|P2|Randomized /Titration Period|Protocol Deviation|0
3075509|NCT00440518|10559082|P1|Randomized /Titration Period|Protocol Deviation|1
3075510|NCT00440518|10559080|P3|Randomized /Titration Period|Subject Withdrew Consent|0
3075511|NCT00440518|10559081|P2|Randomized /Titration Period|Subject Withdrew Consent|1
3075512|NCT00440518|10559082|P1|Randomized /Titration Period|Subject Withdrew Consent|4
3075513|NCT00440518|10559080|P3|Randomized /Titration Period|Lack of Efficacy|1
3075514|NCT00440518|10559081|P2|Randomized /Titration Period|Lack of Efficacy|0
3075515|NCT00440518|10559082|P1|Randomized /Titration Period|Lack of Efficacy|1
3075516|NCT00440466|10559127|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
3075517|NCT00440466|10559128|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
3075518|NCT00440466|10559129|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
3075519|NCT00440466|10559127|P3|Overall Study|Began Dialysis|1
3075520|NCT00440466|10559128|P2|Overall Study|Began Dialysis|0
3075521|NCT00440466|10559129|P1|Overall Study|Began Dialysis|0
3075522|NCT00440466|10559127|P3|Overall Study|Withdrawal by Subject|9
3075523|NCT00440466|10559128|P2|Overall Study|Withdrawal by Subject|5
3075524|NCT00440466|10559129|P1|Overall Study|Withdrawal by Subject|2
3075525|NCT00440466|10559127|P3|Overall Study|Protocol Violation|4
3075526|NCT00440466|10559128|P2|Overall Study|Protocol Violation|0
3075527|NCT00440466|10559129|P1|Overall Study|Protocol Violation|2
3075528|NCT00440466|10559127|P3|Overall Study|Physician Decision|1
3075529|NCT00440466|10559128|P2|Overall Study|Physician Decision|0
3075530|NCT00440466|10559129|P1|Overall Study|Physician Decision|2
3075531|NCT00440466|10559127|P3|Overall Study|Lost to Follow-up|2
3075532|NCT00440466|10559128|P2|Overall Study|Lost to Follow-up|0
3075533|NCT00440466|10559129|P1|Overall Study|Lost to Follow-up|1
3075534|NCT00440466|10559127|P3|Overall Study|Adverse Event|11
3075535|NCT00440466|10559128|P2|Overall Study|Adverse Event|4
3075536|NCT00440466|10559129|P1|Overall Study|Adverse Event|3
3075537|NCT00440466|10559127|P3|Overall Study|Death|9
3075538|NCT00440466|10559128|P2|Overall Study|Death|2
3075539|NCT00440466|10559129|P1|Overall Study|Death|3
3075540|NCT00440401|10559163|P2|Overall Study|Other|5
3075541|NCT00440401|10559164|P1|Overall Study|Other|2
3075542|NCT00440401|10559163|P2|Overall Study|Adverse Event|1
3075543|NCT00440401|10559164|P1|Overall Study|Adverse Event|2
3075544|NCT00440310|10559174|P2|Overall Study|Status Unknown|3
3075545|NCT00440310|10559175|P1|Overall Study|Status Unknown|1
3075546|NCT00440310|10559174|P2|Overall Study|Other|0
3075547|NCT00440310|10559175|P1|Overall Study|Other|1
3075548|NCT00440310|10559174|P2|Overall Study|No Reply at EOS|7
3075549|NCT00440310|10559175|P1|Overall Study|No Reply at EOS|7
3075550|NCT00440310|10559174|P2|Overall Study|Withdrawal by Subject|14
3075551|NCT00440310|10559175|P1|Overall Study|Withdrawal by Subject|15
3075552|NCT00440310|10559174|P2|Overall Study|Protocol Violation|1
3075553|NCT00440310|10559175|P1|Overall Study|Protocol Violation|0
3075554|NCT00440310|10559174|P2|Overall Study|Lost to Follow-up|5
3075555|NCT00440310|10559175|P1|Overall Study|Lost to Follow-up|4
3075556|NCT00440297|10559183|P2|Overall Study|Randomized by mistake|0
3075557|NCT00440297|10559184|P1|Overall Study|Randomized by mistake|1
3075558|NCT00440297|10559183|P2|Overall Study|Withdrawal by Subject|6
3075559|NCT00440297|10559184|P1|Overall Study|Withdrawal by Subject|1
3075560|NCT00440297|10559183|P2|Overall Study|Protocol Violation|7
3075561|NCT00440297|10559184|P1|Overall Study|Protocol Violation|11
3075562|NCT00440297|10559183|P2|Overall Study|Physician Decision|0
3075563|NCT00440297|10559184|P1|Overall Study|Physician Decision|1
3075564|NCT00440297|10559183|P2|Overall Study|Lost to Follow-up|0
3075565|NCT00440297|10559184|P1|Overall Study|Lost to Follow-up|1
3075566|NCT00440297|10559183|P2|Overall Study|Adverse Event|5
3075567|NCT00440297|10559184|P1|Overall Study|Adverse Event|8
3075568|NCT00440271|10559200|P2|Overall Study|Other|0
3075569|NCT00440271|10559201|P1|Overall Study|Other|2
3075570|NCT00440271|10559200|P2|Overall Study|Due to closure of trial|10
3075571|NCT00440271|10559201|P1|Overall Study|Due to closure of trial|8
3075572|NCT00440271|10559200|P2|Overall Study|Lack of Efficacy|1
3075573|NCT00440271|10559201|P1|Overall Study|Lack of Efficacy|0
3075574|NCT00440271|10559200|P2|Overall Study|Withdrawal by Subject|2
3075575|NCT00440271|10559201|P1|Overall Study|Withdrawal by Subject|0
3075576|NCT00440271|10559200|P2|Overall Study|Lost to Follow-up|0
3075577|NCT00440271|10559201|P1|Overall Study|Lost to Follow-up|1
3075578|NCT00440271|10559200|P2|Overall Study|Adverse Event|1
3075579|NCT00440271|10559201|P1|Overall Study|Adverse Event|0
3075580|NCT00440271|10559200|P2|Overall Study|Protocol Violation|1
3075581|NCT00440271|10559201|P1|Overall Study|Protocol Violation|1
3075582|NCT00440232|10559235|P2|Overall Study|Onset of headache within 4 hours of fast|2
3075583|NCT00440232|10559236|P1|Overall Study|Onset of headache within 4 hours of fast|2
3075584|NCT00440232|10559235|P2|Overall Study|Unable to treat within allowed time|1
3075585|NCT00440232|10559236|P1|Overall Study|Unable to treat within allowed time|0
3075586|NCT00440232|10559235|P2|Overall Study|Lost to Follow-up|1
3075587|NCT00440232|10559236|P1|Overall Study|Lost to Follow-up|1
3075588|NCT00440193|10559246|P2|Observational Period|Participant convenience|0
3075589|NCT00440193|10559247|P1|Observational Period|Participant convenience|2
3075590|NCT00440193|10559246|P2|Observational Period|Clinical endpoint reached|0
3075591|NCT00440193|10559247|P1|Observational Period|Clinical endpoint reached|1
3075592|NCT00440193|10559246|P2|Observational Period|Physician Decision|0
3075593|NCT00440193|10559247|P1|Observational Period|Physician Decision|1
3075594|NCT00440193|10559246|P2|Observational Period|Withdrawal by Subject|8
3075595|NCT00440193|10559247|P1|Observational Period|Withdrawal by Subject|11
3075596|NCT00440193|10559246|P2|Observational Period|Protocol Violation|0
3075597|NCT00440193|10559247|P1|Observational Period|Protocol Violation|1
3075598|NCT00440193|10559246|P2|Observational Period|Lost to Follow-up|8
3075599|NCT00440193|10559247|P1|Observational Period|Lost to Follow-up|12
3075600|NCT00440193|10559246|P2|Observational Period|Death|20
3075601|NCT00440193|10559247|P1|Observational Period|Death|15
3075602|NCT00440193|10559246|P2|Observational Period|Adverse Event|2
3075603|NCT00440193|10559247|P1|Observational Period|Adverse Event|2
3075604|NCT00440193|10559246|P2|Treatment Period|Site closed by investigator|2
3075605|NCT00440193|10559247|P1|Treatment Period|Site closed by investigator|0
3075606|NCT00440193|10559246|P2|Treatment Period|Participant did not receive treatment|13
3075607|NCT00440193|10559247|P1|Treatment Period|Participant did not receive treatment|7
3075608|NCT00440193|10559246|P2|Treatment Period|Participant convenience|2
3075609|NCT00440193|10559247|P1|Treatment Period|Participant convenience|5
3075610|NCT00440193|10559246|P2|Treatment Period|Technical problems|1
3075611|NCT00440193|10559247|P1|Treatment Period|Technical problems|1
3075612|NCT00440193|10559246|P2|Treatment Period|Switch to commercial drug|2
3075613|NCT00440193|10559247|P1|Treatment Period|Switch to commercial drug|0
3075614|NCT00440193|10559246|P2|Treatment Period|Protocol driven decision point|2
3075615|NCT00440193|10559247|P1|Treatment Period|Protocol driven decision point|2
3075616|NCT00440193|10559246|P2|Treatment Period|Study terminated by sponsor|94
3075617|NCT00440193|10559247|P1|Treatment Period|Study terminated by sponsor|102
3075618|NCT00440193|10559246|P2|Treatment Period|Clinical endpoint reached|25
3075619|NCT00440193|10559247|P1|Treatment Period|Clinical endpoint reached|28
3075620|NCT00440193|10559246|P2|Treatment Period|Withdrawal by Subject|77
3075621|NCT00440193|10559247|P1|Treatment Period|Withdrawal by Subject|36
3075622|NCT00440193|10559246|P2|Treatment Period|Protocol Violation|19
3075623|NCT00440193|10559247|P1|Treatment Period|Protocol Violation|16
3075624|NCT00440193|10559246|P2|Treatment Period|Physician Decision|6
3075625|NCT00440193|10559247|P1|Treatment Period|Physician Decision|3
3075626|NCT00440193|10559246|P2|Treatment Period|Lost to Follow-up|18
3075627|NCT00440193|10559247|P1|Treatment Period|Lost to Follow-up|12
3075628|NCT00440193|10559246|P2|Treatment Period|Lack of Efficacy|1
3075629|NCT00440193|10559247|P1|Treatment Period|Lack of Efficacy|0
3075630|NCT00440193|10559246|P2|Treatment Period|Death|22
3075631|NCT00440193|10559247|P1|Treatment Period|Death|19
3075632|NCT00440193|10559246|P2|Treatment Period|Adverse Event|67
3075633|NCT00440193|10559247|P1|Treatment Period|Adverse Event|74
3075634|NCT00440115|10559293|P3|Overall Study|Incarceration|1
3075635|NCT00440115|10559294|P2|Overall Study|Incarceration|2
3075636|NCT00440115|10559295|P1|Overall Study|Incarceration|0
3075637|NCT00440115|10559293|P3|Overall Study|Death|5
3075638|NCT00440115|10559294|P2|Overall Study|Death|9
3075639|NCT00440115|10559295|P1|Overall Study|Death|7
3075640|NCT00440037|10559324|P1|Overall Study|Administrative decision|3
3075641|NCT00440037|10559324|P1|Overall Study|Withdrawal by Subject|6
3075642|NCT00440011|10559334|P2|Overall Study|Withdrawal by Subject|0
3075643|NCT00440011|10559335|P1|Overall Study|Withdrawal by Subject|1
3075644|NCT00440011|10559334|P2|Overall Study|Protocol Violation|1
3075645|NCT00440011|10559335|P1|Overall Study|Protocol Violation|1
3075646|NCT00440011|10559334|P2|Overall Study|Lost to Follow-up|2
3075647|NCT00440011|10559335|P1|Overall Study|Lost to Follow-up|0
3075648|NCT00440011|10559334|P2|Overall Study|Adverse Event|0
3075649|NCT00440011|10559335|P1|Overall Study|Adverse Event|2
3075650|NCT00439777|10559362|P2|Observational Period|Technical problems|1
3075651|NCT00439777|10559363|P1|Observational Period|Technical problems|0
3075652|NCT00439777|10559362|P2|Observational Period|Lack of Efficacy|0
3075653|NCT00439777|10559363|P1|Observational Period|Lack of Efficacy|1
3075654|NCT00439777|10559362|P2|Observational Period|Protocol driven decision point|1
3075655|NCT00439777|10559363|P1|Observational Period|Protocol driven decision point|0
3075656|NCT00439777|10559362|P2|Observational Period|Study terminated by sponsor|1
3075657|NCT00439777|10559363|P1|Observational Period|Study terminated by sponsor|3
3075658|NCT00439777|10559362|P2|Observational Period|Death|20
3075659|NCT00439777|10559363|P1|Observational Period|Death|27
3075660|NCT00439777|10559362|P2|Observational Period|Lost to Follow-up|11
3075661|NCT00439777|10559363|P1|Observational Period|Lost to Follow-up|1
3075662|NCT00439777|10559362|P2|Observational Period|Withdrawal by Subject|5
3075663|NCT00439777|10559363|P1|Observational Period|Withdrawal by Subject|9
3075664|NCT00439777|10559362|P2|Observational Period|Protocol Violation|2
3075665|NCT00439777|10559363|P1|Observational Period|Protocol Violation|0
3075666|NCT00439777|10559362|P2|Treatment Period|Participant convenience|8
3075667|NCT00439777|10559363|P1|Treatment Period|Participant convenience|12
3075668|NCT00439777|10559362|P2|Treatment Period|Technical problems|1
3075669|NCT00439777|10559363|P1|Treatment Period|Technical problems|3
3075670|NCT00439777|10559362|P2|Treatment Period|Clinical endpoint reached|13
3075671|NCT00439777|10559363|P1|Treatment Period|Clinical endpoint reached|26
3075672|NCT00439777|10559362|P2|Treatment Period|Physician Decision|18
3075673|NCT00439777|10559363|P1|Treatment Period|Physician Decision|7
3075674|NCT00439777|10559362|P2|Treatment Period|Protocol driven decision point|3
3075675|NCT00439777|10559363|P1|Treatment Period|Protocol driven decision point|1
3075676|NCT00439777|10559362|P2|Treatment Period|Lost to Follow-up|10
3075677|NCT00439777|10559363|P1|Treatment Period|Lost to Follow-up|8
3075678|NCT00439777|10559362|P2|Treatment Period|Lack of Efficacy|4
3075679|NCT00439777|10559363|P1|Treatment Period|Lack of Efficacy|1
3075680|NCT00439777|10559362|P2|Treatment Period|Withdrawal by Subject|118
3075681|NCT00439777|10559363|P1|Treatment Period|Withdrawal by Subject|66
3075682|NCT00439777|10559362|P2|Treatment Period|Protocol Violation|30
3075683|NCT00439777|10559363|P1|Treatment Period|Protocol Violation|23
3075684|NCT00439777|10559362|P2|Treatment Period|Adverse Event|92
3075685|NCT00439777|10559363|P1|Treatment Period|Adverse Event|111
3075686|NCT00439777|10559362|P2|Treatment Period|Did not take study treatment|8
3075687|NCT00439777|10559363|P1|Treatment Period|Did not take study treatment|7
3075688|NCT00439777|10559362|P2|Treatment Period|Site closed by investigator|1
3075689|NCT00439777|10559363|P1|Treatment Period|Site closed by investigator|0
3075690|NCT00439777|10559362|P2|Treatment Period|Study terminated by sponsor|132
3075691|NCT00439777|10559363|P1|Treatment Period|Study terminated by sponsor|125
3075692|NCT00439777|10559362|P2|Treatment Period|Death|21
3075693|NCT00439777|10559363|P1|Treatment Period|Death|29
3075694|NCT00439738|10559401|P2|Overall Study|Abnormal Lab Values|0
3075695|NCT00439738|10559402|P1|Overall Study|Abnormal Lab Values|1
3075696|NCT00439738|10559401|P2|Overall Study|Lack of Efficacy|2
3075697|NCT00439738|10559402|P1|Overall Study|Lack of Efficacy|2
3075698|NCT00439738|10559401|P2|Overall Study|Protocol Violation|3
3075699|NCT00439738|10559402|P1|Overall Study|Protocol Violation|6
3075700|NCT00439738|10559401|P2|Overall Study|Lost to Follow-up|6
3075701|NCT00439738|10559402|P1|Overall Study|Lost to Follow-up|5
3075702|NCT00439738|10559401|P2|Overall Study|Adverse Event|4
3075703|NCT00439738|10559402|P1|Overall Study|Adverse Event|6
3075704|NCT00439738|10559401|P2|Overall Study|Withdrawal by Subject|13
3075705|NCT00439738|10559402|P1|Overall Study|Withdrawal by Subject|16
3075706|NCT00439725|10559420|P2|Observational Period|Participant convenience|0
3075707|NCT00439725|10559421|P1|Observational Period|Participant convenience|1
3075708|NCT00439725|10559420|P2|Observational Period|Technical problems|0
3075709|NCT00439725|10559421|P1|Observational Period|Technical problems|1
3075710|NCT00439725|10559420|P2|Observational Period|Clinical endpoint reached|1
3075711|NCT00439725|10559421|P1|Observational Period|Clinical endpoint reached|3
3075712|NCT00439725|10559420|P2|Observational Period|Study termination by sponsor|1
3075713|NCT00439725|10559421|P1|Observational Period|Study termination by sponsor|1
3075714|NCT00439725|10559420|P2|Observational Period|Death|2
3075715|NCT00439725|10559421|P1|Observational Period|Death|0
3075716|NCT00439725|10559420|P2|Observational Period|Lost to Follow-up|1
3075717|NCT00439725|10559421|P1|Observational Period|Lost to Follow-up|0
3075718|NCT00439725|10559420|P2|Observational Period|Withdrawal by Subject|2
3075719|NCT00439725|10559421|P1|Observational Period|Withdrawal by Subject|2
3075720|NCT00439725|10559420|P2|Treatment Period|Participant did not receive treatment|4
3075721|NCT00439725|10559421|P1|Treatment Period|Participant did not receive treatment|4
3075722|NCT00439725|10559420|P2|Treatment Period|Death|1
3075723|NCT00439725|10559421|P1|Treatment Period|Death|1
3075724|NCT00439725|10559420|P2|Treatment Period|Protocol driven decision point|1
3075725|NCT00439725|10559421|P1|Treatment Period|Protocol driven decision point|1
3075726|NCT00439725|10559420|P2|Treatment Period|Participant convenience|0
3075727|NCT00439725|10559421|P1|Treatment Period|Participant convenience|1
3075728|NCT00439725|10559420|P2|Treatment Period|Lost to Follow-up|1
3075729|NCT00439725|10559421|P1|Treatment Period|Lost to Follow-up|1
3075730|NCT00439725|10559420|P2|Treatment Period|Technical problems|0
3075731|NCT00439725|10559421|P1|Treatment Period|Technical problems|1
3075732|NCT00439725|10559420|P2|Treatment Period|Clinical endpoint reached|50
3075733|NCT00439725|10559421|P1|Treatment Period|Clinical endpoint reached|6
3075734|NCT00439725|10559420|P2|Treatment Period|Protocol Violation|1
3075735|NCT00439725|10559421|P1|Treatment Period|Protocol Violation|2
3075736|NCT00439725|10559420|P2|Treatment Period|Physician Decision|1
3075737|NCT00439725|10559421|P1|Treatment Period|Physician Decision|1
3075738|NCT00439725|10559420|P2|Treatment Period|Adverse Event|18
3075739|NCT00439725|10559421|P1|Treatment Period|Adverse Event|39
3075740|NCT00439725|10559420|P2|Treatment Period|Site closed by investigator|2
3075741|NCT00439725|10559421|P1|Treatment Period|Site closed by investigator|1
3075742|NCT00439725|10559420|P2|Treatment Period|Study terminated by sponsor|148
3075743|NCT00439725|10559421|P1|Treatment Period|Study terminated by sponsor|156
3075744|NCT00439725|10559420|P2|Treatment Period|Withdrawal by Subject|19
3075745|NCT00439725|10559421|P1|Treatment Period|Withdrawal by Subject|22
3075746|NCT00439647|10559472|P2|Overall Study|Lack of Efficacy|4
3075747|NCT00439647|10559473|P1|Overall Study|Lack of Efficacy|0
3075748|NCT00439647|10559472|P2|Overall Study|Protocol Violation|4
3075749|NCT00439647|10559473|P1|Overall Study|Protocol Violation|3
3075750|NCT00439647|10559472|P2|Overall Study|Lost to Follow-up|12
3075751|NCT00439647|10559473|P1|Overall Study|Lost to Follow-up|4
3075752|NCT00439647|10559472|P2|Overall Study|Adverse Event|11
3075753|NCT00439647|10559473|P1|Overall Study|Adverse Event|11
3075754|NCT00439647|10559472|P2|Overall Study|Death|18
3075755|NCT00439647|10559473|P1|Overall Study|Death|15
3075756|NCT00439647|10559472|P2|Overall Study|Withdrawal by Subject|22
3075757|NCT00439647|10559473|P1|Overall Study|Withdrawal by Subject|25
3075758|NCT00439569|10559510|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
3075759|NCT00439569|10559510|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
3075760|NCT00439569|10559510|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
3075761|NCT00439556|10559524|P3|Overall Study|Patient was taken off study for non-comp|0
3075762|NCT00439556|10559525|P2|Overall Study|Patient was taken off study for non-comp|1
3075763|NCT00439556|10559526|P1|Overall Study|Patient was taken off study for non-comp|0
3075764|NCT00439517|10559539|P2|Overall Study|Subject in survival follow-up|0
3075765|NCT00439517|10559540|P1|Overall Study|Subject in survival follow-up|1
3075766|NCT00439517|10559539|P2|Overall Study|Subject on treatment|0
3075767|NCT00439517|10559540|P1|Overall Study|Subject on treatment|1
3075768|NCT00439309|10559679|P2|Follow-Up|Late response by subject|1
3075769|NCT00439309|10559680|P1|Follow-Up|Late response by subject|0
3075770|NCT00439309|10559679|P2|Follow-Up|Withdrawal by Subject|1
3075771|NCT00439309|10559680|P1|Follow-Up|Withdrawal by Subject|0
3075772|NCT00439309|10559679|P2|Follow-Up|Lost to Follow-up|0
3075773|NCT00439309|10559680|P1|Follow-Up|Lost to Follow-up|2
3075774|NCT00439309|10559679|P2|Follow-Up|Death|0
3075775|NCT00439309|10559680|P1|Follow-Up|Death|1
3075776|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
3075777|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
3075778|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
3075779|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
3075780|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
3075781|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
3075782|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
3075783|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
3075784|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
3075785|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
3075786|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
3075787|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
3075788|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
3075789|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
3075790|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
3075791|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
3075792|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
3075793|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
3075794|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
3075795|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
3075796|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
3075797|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
3075798|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
3075799|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
3075800|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
3075801|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
3075802|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
3075803|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
3075804|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
3075805|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
3075806|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
3075807|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
3075808|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
3075809|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
3075810|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
3075811|NCT00439270|10559699|P5|Phase 2 (51.6 Months)|Disease progression|0
3075812|NCT00439270|10559700|P4|Phase 2 (51.6 Months)|Disease progression|18
3075813|NCT00439270|10559701|P3|Phase 2 (51.6 Months)|Disease progression|0
3075814|NCT00439270|10559702|P2|Phase 2 (51.6 Months)|Disease progression|0
3075815|NCT00439270|10559703|P1|Phase 2 (51.6 Months)|Disease progression|0
3075816|NCT00439270|10559699|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
3075817|NCT00439270|10559700|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
3075818|NCT00439270|10559701|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
3075819|NCT00439270|10559702|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
3075820|NCT00439270|10559703|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
3075821|NCT00439270|10559699|P5|Phase 1 (18.1 Months)|Disease progression|3
3075822|NCT00439270|10559700|P4|Phase 1 (18.1 Months)|Disease progression|0
3075823|NCT00439270|10559701|P3|Phase 1 (18.1 Months)|Disease progression|3
3075824|NCT00439270|10559702|P2|Phase 1 (18.1 Months)|Disease progression|2
3075825|NCT00439270|10559703|P1|Phase 1 (18.1 Months)|Disease progression|3
3075826|NCT00439244|10559745|P3|Overall Study|Administrative problems|0
3075827|NCT00439244|10559746|P2|Overall Study|Administrative problems|0
3075828|NCT00439244|10559747|P1|Overall Study|Administrative problems|1
3075829|NCT00439244|10559745|P3|Overall Study|Protocol Violation|0
3075830|NCT00439244|10559746|P2|Overall Study|Protocol Violation|1
3075831|NCT00439244|10559747|P1|Overall Study|Protocol Violation|0
3075832|NCT00439244|10559745|P3|Overall Study|Death|0
3075833|NCT00439244|10559746|P2|Overall Study|Death|1
3075834|NCT00439244|10559747|P1|Overall Study|Death|0
3075835|NCT00439244|10559745|P3|Overall Study|Lost to Follow-up|2
3075836|NCT00439244|10559746|P2|Overall Study|Lost to Follow-up|1
3075837|NCT00439244|10559747|P1|Overall Study|Lost to Follow-up|2
3075838|NCT00439244|10559745|P3|Overall Study|Withdrawal by Subject|2
3075839|NCT00439244|10559746|P2|Overall Study|Withdrawal by Subject|1
3075840|NCT00439244|10559747|P1|Overall Study|Withdrawal by Subject|3
3075841|NCT00439244|10559745|P3|Overall Study|Adverse Event|3
3075842|NCT00439244|10559746|P2|Overall Study|Adverse Event|2
3075843|NCT00439244|10559747|P1|Overall Study|Adverse Event|5
3075844|NCT00439231|10559767|P1|Overall Study|Lack of Efficacy|28
3075845|NCT00439218|10559771|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
3075846|NCT00439179|10559786|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
3075847|NCT00439179|10559787|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
3075848|NCT00439179|10559788|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
3075849|NCT00439179|10559789|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
3075850|NCT00439140|10559806|P3|Treatment Cycle 2|Lost to Follow-up|0
3075851|NCT00439140|10559807|P2|Treatment Cycle 2|Lost to Follow-up|1
3075852|NCT00439140|10559808|P1|Treatment Cycle 2|Lost to Follow-up|1
3075853|NCT00439140|10559806|P3|Treatment Cycle 2|Withdrawal by Subject|0
3075854|NCT00439140|10559807|P2|Treatment Cycle 2|Withdrawal by Subject|0
3075855|NCT00439140|10559808|P1|Treatment Cycle 2|Withdrawal by Subject|1
3075856|NCT00439140|10559806|P3|Treatment Cycle 1|Withdrawal by Subject|0
3075857|NCT00439140|10559807|P2|Treatment Cycle 1|Withdrawal by Subject|1
3075858|NCT00439140|10559808|P1|Treatment Cycle 1|Withdrawal by Subject|0
3075859|NCT00439140|10559806|P3|Treatment Cycle 1|Personal reasons|0
3075860|NCT00439140|10559807|P2|Treatment Cycle 1|Personal reasons|2
3075861|NCT00439140|10559808|P1|Treatment Cycle 1|Personal reasons|0
3075862|NCT00439140|10559806|P3|Treatment Cycle 1|Lost to Follow-up|1
3075863|NCT00439140|10559807|P2|Treatment Cycle 1|Lost to Follow-up|1
3075864|NCT00439140|10559808|P1|Treatment Cycle 1|Lost to Follow-up|1
3075865|NCT00438815|10559891|P1|Overall Study|Death|1
3075866|NCT00438815|10559891|P1|Overall Study|Withdrawal by Subject|6
3075867|NCT00438815|10559891|P1|Overall Study|Lost to Follow-up|6
3075868|NCT00438815|10559891|P1|Overall Study|Transitioned to commercial C1INH-nf|6
3075869|NCT00438815|10559891|P1|Overall Study|Noncompliance with protocol requirements|9
3075870|NCT00438815|10559891|P1|Overall Study|3-month follow-up no longer required|12
3075871|NCT00438815|10559891|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
3075872|NCT00438672|10559941|P2|Overall Study|Lost to Follow-up|9
3075873|NCT00438672|10559942|P1|Overall Study|Lost to Follow-up|7
3075874|NCT00438659|10559952|P2|Overall Study|Cancel|2
3075875|NCT00438659|10559953|P1|Overall Study|Cancel|5
3075876|NCT00438659|10559952|P2|Overall Study|Discontinued Mometasone/Placebo|2
3075877|NCT00438659|10559953|P1|Overall Study|Discontinued Mometasone/Placebo|1
3075878|NCT00438633|10559977|P2|Overall Study|Lost to Follow-up|17
3075879|NCT00438633|10559978|P1|Overall Study|Lost to Follow-up|15
3075880|NCT00438633|10559977|P2|Overall Study|Withdrawal by Subject|0
3075881|NCT00438633|10559978|P1|Overall Study|Withdrawal by Subject|1
3075882|NCT00438464|10560009|P2|Overall Study|Incomplete data submission|2
3075883|NCT00438464|10560010|P1|Overall Study|Incomplete data submission|0
3075884|NCT00438464|10560009|P2|Overall Study|Terminated Early|5
3075885|NCT00438464|10560010|P1|Overall Study|Terminated Early|14
3075886|NCT00438399|10560111|P6|Overall Study|Patien stopped study at visit 4 by error|0
3075887|NCT00438399|10560112|P5|Overall Study|Patien stopped study at visit 4 by error|0
3075888|NCT00438399|10560113|P4|Overall Study|Patien stopped study at visit 4 by error|0
3075889|NCT00438399|10560114|P3|Overall Study|Patien stopped study at visit 4 by error|0
3075890|NCT00438399|10560115|P2|Overall Study|Patien stopped study at visit 4 by error|0
3075891|NCT00438399|10560116|P1|Overall Study|Patien stopped study at visit 4 by error|1
3075892|NCT00438399|10560111|P6|Overall Study|Pregnancy|1
3075893|NCT00438399|10560112|P5|Overall Study|Pregnancy|0
3075894|NCT00438399|10560113|P4|Overall Study|Pregnancy|0
3075895|NCT00438399|10560114|P3|Overall Study|Pregnancy|0
3075896|NCT00438399|10560115|P2|Overall Study|Pregnancy|0
3075897|NCT00438399|10560116|P1|Overall Study|Pregnancy|0
3075898|NCT00438399|10560111|P6|Overall Study|Subje stopped study|0
3075899|NCT00438399|10560112|P5|Overall Study|Subje stopped study|0
3075900|NCT00438399|10560113|P4|Overall Study|Subje stopped study|0
3075901|NCT00438399|10560114|P3|Overall Study|Subje stopped study|1
3075902|NCT00438399|10560115|P2|Overall Study|Subje stopped study|0
3075903|NCT00438399|10560116|P1|Overall Study|Subje stopped study|0
3075904|NCT00438399|10560111|P6|Overall Study|Protocol Violation|1
3075905|NCT00438399|10560112|P5|Overall Study|Protocol Violation|0
3075906|NCT00438399|10560113|P4|Overall Study|Protocol Violation|0
3075907|NCT00438399|10560114|P3|Overall Study|Protocol Violation|1
3075908|NCT00438399|10560115|P2|Overall Study|Protocol Violation|0
3075909|NCT00438399|10560116|P1|Overall Study|Protocol Violation|0
3075910|NCT00438399|10560111|P6|Overall Study|Withdrawal by Subject|2
3075911|NCT00438399|10560112|P5|Overall Study|Withdrawal by Subject|2
3075912|NCT00438399|10560113|P4|Overall Study|Withdrawal by Subject|2
3075913|NCT00438399|10560114|P3|Overall Study|Withdrawal by Subject|3
3075914|NCT00438399|10560115|P2|Overall Study|Withdrawal by Subject|6
3075915|NCT00438399|10560116|P1|Overall Study|Withdrawal by Subject|5
3075916|NCT00438399|10560111|P6|Overall Study|Adverse Event|1
3075917|NCT00438399|10560112|P5|Overall Study|Adverse Event|0
3075918|NCT00438399|10560113|P4|Overall Study|Adverse Event|1
3075919|NCT00438399|10560114|P3|Overall Study|Adverse Event|1
3075920|NCT00438399|10560115|P2|Overall Study|Adverse Event|0
3075921|NCT00438399|10560116|P1|Overall Study|Adverse Event|0
3075922|NCT00438399|10560111|P6|Overall Study|Lost to Follow-up|1
3075923|NCT00438399|10560112|P5|Overall Study|Lost to Follow-up|1
3075924|NCT00438399|10560113|P4|Overall Study|Lost to Follow-up|1
3075925|NCT00438399|10560114|P3|Overall Study|Lost to Follow-up|1
3075926|NCT00438399|10560115|P2|Overall Study|Lost to Follow-up|2
3075927|NCT00438399|10560116|P1|Overall Study|Lost to Follow-up|2
3075928|NCT00438360|10560127|P2|Overall Study|Other|15
3075929|NCT00438360|10560128|P1|Overall Study|Other|24
3075930|NCT00438360|10560127|P2|Overall Study|Lack of Efficacy|27
3075931|NCT00438360|10560128|P1|Overall Study|Lack of Efficacy|42
3075932|NCT00438360|10560127|P2|Overall Study|Adverse Event|1
3075933|NCT00438360|10560128|P1|Overall Study|Adverse Event|6
3075934|NCT00438256|10560142|P4|Overall Study|Excluded final Diagnosis|2
3075935|NCT00438256|10560143|P3|Overall Study|Excluded final Diagnosis|0
3075936|NCT00438256|10560144|P2|Overall Study|Excluded final Diagnosis|0
3075937|NCT00438256|10560145|P1|Overall Study|Excluded final Diagnosis|0
3075938|NCT00438256|10560142|P4|Overall Study|Ineligible for Resection|7
3075939|NCT00438256|10560143|P3|Overall Study|Ineligible for Resection|1
3075940|NCT00438256|10560144|P2|Overall Study|Ineligible for Resection|1
3075941|NCT00438256|10560145|P1|Overall Study|Ineligible for Resection|2
3075942|NCT00437983|10560195|P2|Overall Study|Withdrawal by Subject|6
3075943|NCT00437983|10560196|P1|Overall Study|Withdrawal by Subject|5
3075944|NCT00437983|10560195|P2|Overall Study|Protocol Violation|1
3075945|NCT00437983|10560196|P1|Overall Study|Protocol Violation|2
3075946|NCT00437983|10560195|P2|Overall Study|Adverse Event|6
3075947|NCT00437983|10560196|P1|Overall Study|Adverse Event|6
3075948|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
3075949|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
3075950|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
3075951|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
3075952|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
3075953|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
3075954|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
3075955|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
3075956|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
3075957|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
3075958|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
3075959|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
3075960|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
3075961|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
3075962|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
3075963|NCT00437658|10560209|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
3075964|NCT00437658|10560210|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
3075965|NCT00437658|10560211|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
3075966|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
3075967|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
3075968|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
3075969|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
3075970|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
3075971|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
3075972|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
3075973|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
3075974|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
3075975|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
3075976|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
3075977|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
3075978|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Non-compliance|4
3075979|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Non-compliance|1
3075980|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Non-compliance|1
3075981|NCT00437658|10560209|P3|Treatment Period (24 Weeks)|Adverse Event|14
3075982|NCT00437658|10560210|P2|Treatment Period (24 Weeks)|Adverse Event|7
3075983|NCT00437658|10560211|P1|Treatment Period (24 Weeks)|Adverse Event|4
3075984|NCT00437645|10560305|P2|Overall Study|Condition no longer requires study drug|1
3075985|NCT00437645|10560306|P1|Overall Study|Condition no longer requires study drug|1
3075986|NCT00437645|10560305|P2|Overall Study|Lack of Efficacy|1
3075987|NCT00437645|10560306|P1|Overall Study|Lack of Efficacy|2
3075988|NCT00437645|10560305|P2|Overall Study|Administrative problems|1
3075989|NCT00437645|10560306|P1|Overall Study|Administrative problems|2
3075990|NCT00437645|10560305|P2|Overall Study|Lost to Follow-up|3
3075991|NCT00437645|10560306|P1|Overall Study|Lost to Follow-up|2
3075992|NCT00437645|10560305|P2|Overall Study|Protocol Violation|3
3075993|NCT00437645|10560306|P1|Overall Study|Protocol Violation|3
3075994|NCT00437645|10560305|P2|Overall Study|Withdrawal by Subject|22
3075995|NCT00437645|10560306|P1|Overall Study|Withdrawal by Subject|10
3075996|NCT00437645|10560305|P2|Overall Study|Adverse Event|84
3075997|NCT00437645|10560306|P1|Overall Study|Adverse Event|15
3075998|NCT00437489|10560322|P2|Overall Study|Lost to Follow-up|1
3075999|NCT00437489|10560323|P1|Overall Study|Lost to Follow-up|0
3076000|NCT00437489|10560322|P2|Overall Study|Study terminated by sponsor|21
3076001|NCT00437489|10560323|P1|Overall Study|Study terminated by sponsor|23
3076002|NCT00437281|10560360|P20|Overall Study|Lost to Follow-up|1
3076003|NCT00437281|10560361|P19|Overall Study|Lost to Follow-up|0
3076004|NCT00437281|10560362|P18|Overall Study|Lost to Follow-up|0
3076005|NCT00437281|10560363|P17|Overall Study|Lost to Follow-up|0
3076006|NCT00437281|10560364|P16|Overall Study|Lost to Follow-up|0
3076007|NCT00437281|10560365|P15|Overall Study|Lost to Follow-up|0
3076008|NCT00437281|10560366|P14|Overall Study|Lost to Follow-up|0
3076009|NCT00437281|10560367|P13|Overall Study|Lost to Follow-up|0
3076010|NCT00437281|10560368|P12|Overall Study|Lost to Follow-up|0
3076011|NCT00437281|10560369|P11|Overall Study|Lost to Follow-up|0
3076012|NCT00437281|10560370|P10|Overall Study|Lost to Follow-up|0
3076013|NCT00437281|10560371|P9|Overall Study|Lost to Follow-up|0
3076014|NCT00437281|10560372|P8|Overall Study|Lost to Follow-up|0
3076015|NCT00437281|10560373|P7|Overall Study|Lost to Follow-up|0
3076016|NCT00437281|10560374|P6|Overall Study|Lost to Follow-up|0
3076017|NCT00437281|10560375|P5|Overall Study|Lost to Follow-up|0
3076018|NCT00437281|10560376|P4|Overall Study|Lost to Follow-up|0
3076019|NCT00437281|10560377|P3|Overall Study|Lost to Follow-up|0
3076020|NCT00437281|10560378|P2|Overall Study|Lost to Follow-up|0
3076021|NCT00437281|10560379|P1|Overall Study|Lost to Follow-up|0
3076022|NCT00437281|10560360|P20|Overall Study|Adverse Event|0
3076023|NCT00437281|10560361|P19|Overall Study|Adverse Event|1
3076024|NCT00437281|10560362|P18|Overall Study|Adverse Event|0
3076025|NCT00437281|10560363|P17|Overall Study|Adverse Event|0
3076026|NCT00437281|10560364|P16|Overall Study|Adverse Event|0
3076027|NCT00437281|10560365|P15|Overall Study|Adverse Event|1
3076028|NCT00437281|10560366|P14|Overall Study|Adverse Event|1
3076029|NCT00437281|10560367|P13|Overall Study|Adverse Event|0
3076030|NCT00437281|10560368|P12|Overall Study|Adverse Event|0
3076031|NCT00437281|10560369|P11|Overall Study|Adverse Event|0
3076032|NCT00437281|10560370|P10|Overall Study|Adverse Event|1
3076033|NCT00437281|10560371|P9|Overall Study|Adverse Event|0
3076034|NCT00437281|10560372|P8|Overall Study|Adverse Event|0
3076035|NCT00437281|10560373|P7|Overall Study|Adverse Event|0
3076036|NCT00437281|10560374|P6|Overall Study|Adverse Event|1
3076037|NCT00437281|10560375|P5|Overall Study|Adverse Event|0
3076038|NCT00437281|10560376|P4|Overall Study|Adverse Event|1
3076039|NCT00437281|10560377|P3|Overall Study|Adverse Event|0
3076040|NCT00437281|10560378|P2|Overall Study|Adverse Event|0
3076041|NCT00437281|10560379|P1|Overall Study|Adverse Event|0
3076042|NCT00437203|10560683|P10|Overall Study|Other|0
3076043|NCT00437203|10560684|P9|Overall Study|Other|0
3076044|NCT00437203|10560685|P8|Overall Study|Other|0
3076045|NCT00437203|10560686|P7|Overall Study|Other|1
3076046|NCT00437203|10560687|P6|Overall Study|Other|0
3076047|NCT00437203|10560688|P5|Overall Study|Other|0
3076048|NCT00437203|10560689|P4|Overall Study|Other|0
3076049|NCT00437203|10560690|P3|Overall Study|Other|0
3076050|NCT00437203|10560691|P2|Overall Study|Other|1
3076051|NCT00437203|10560692|P1|Overall Study|Other|0
3076052|NCT00437203|10560683|P10|Overall Study|Objective progression or relapse|2
3076053|NCT00437203|10560684|P9|Overall Study|Objective progression or relapse|2
3076054|NCT00437203|10560685|P8|Overall Study|Objective progression or relapse|1
3076055|NCT00437203|10560686|P7|Overall Study|Objective progression or relapse|6
3076056|NCT00437203|10560687|P6|Overall Study|Objective progression or relapse|3
3076057|NCT00437203|10560688|P5|Overall Study|Objective progression or relapse|3
3076058|NCT00437203|10560689|P4|Overall Study|Objective progression or relapse|3
3076059|NCT00437203|10560690|P3|Overall Study|Objective progression or relapse|2
3076060|NCT00437203|10560691|P2|Overall Study|Objective progression or relapse|6
3076061|NCT00437203|10560692|P1|Overall Study|Objective progression or relapse|5
3076062|NCT00437203|10560683|P10|Overall Study|Study terminated by sponsor|0
3076063|NCT00437203|10560684|P9|Overall Study|Study terminated by sponsor|1
3076064|NCT00437203|10560685|P8|Overall Study|Study terminated by sponsor|0
3076065|NCT00437203|10560686|P7|Overall Study|Study terminated by sponsor|0
3076066|NCT00437203|10560687|P6|Overall Study|Study terminated by sponsor|0
3076067|NCT00437203|10560688|P5|Overall Study|Study terminated by sponsor|0
3076068|NCT00437203|10560689|P4|Overall Study|Study terminated by sponsor|0
3076069|NCT00437203|10560690|P3|Overall Study|Study terminated by sponsor|0
3076070|NCT00437203|10560691|P2|Overall Study|Study terminated by sponsor|0
3076071|NCT00437203|10560692|P1|Overall Study|Study terminated by sponsor|0
3076072|NCT00437203|10560683|P10|Overall Study|Adverse Event|1
3076073|NCT00437203|10560684|P9|Overall Study|Adverse Event|0
3076074|NCT00437203|10560685|P8|Overall Study|Adverse Event|1
3076075|NCT00437203|10560686|P7|Overall Study|Adverse Event|0
3076076|NCT00437203|10560687|P6|Overall Study|Adverse Event|0
3076077|NCT00437203|10560688|P5|Overall Study|Adverse Event|0
3076078|NCT00437203|10560689|P4|Overall Study|Adverse Event|0
3076079|NCT00437203|10560690|P3|Overall Study|Adverse Event|0
3076080|NCT00437203|10560691|P2|Overall Study|Adverse Event|1
3076081|NCT00437203|10560692|P1|Overall Study|Adverse Event|1
3076082|NCT00437203|10560683|P10|Overall Study|Death|1
3076083|NCT00437203|10560684|P9|Overall Study|Death|0
3076084|NCT00437203|10560685|P8|Overall Study|Death|1
3076085|NCT00437203|10560686|P7|Overall Study|Death|0
3076086|NCT00437203|10560687|P6|Overall Study|Death|0
3076087|NCT00437203|10560688|P5|Overall Study|Death|0
3076088|NCT00437203|10560689|P4|Overall Study|Death|0
3076089|NCT00437203|10560690|P3|Overall Study|Death|1
3076090|NCT00437203|10560691|P2|Overall Study|Death|0
3076091|NCT00437203|10560692|P1|Overall Study|Death|0
3076092|NCT00437125|10560796|P1|Overall Study|Physician Decision|1
3076093|NCT00437125|10560796|P1|Overall Study|Withdrawal by Caregiver|2
3076094|NCT00437125|10560796|P1|Overall Study|Withdrawal by Subject|13
3076095|NCT00437125|10560796|P1|Overall Study|Lost to Follow-up|1
3076096|NCT00437125|10560796|P1|Overall Study|Lack of Efficacy|1
3076097|NCT00437125|10560796|P1|Overall Study|Clinical Relapse|1
3076098|NCT00437125|10560796|P1|Overall Study|Death|1
3076099|NCT00437125|10560796|P1|Overall Study|Adverse Event|12
3076100|NCT00437073|10560817|P2|Overall Study|Physician Decision|1
3076101|NCT00437073|10560818|P1|Overall Study|Physician Decision|0
3076102|NCT00437073|10560817|P2|Overall Study|Sponsor Terminated Study|0
3076103|NCT00437073|10560818|P1|Overall Study|Sponsor Terminated Study|1
3076104|NCT00437034|10560846|P1|Overall Study|Disease progression during treatment|5
3076105|NCT00437034|10560846|P1|Overall Study|Adverse Event|1
3076106|NCT00436982|10560852|P2|Overall Study|no RSA data|2
3076107|NCT00436982|10560853|P1|Overall Study|no RSA data|1
3076108|NCT00436982|10560852|P2|Overall Study|Did not receive allocated intervention|1
3076109|NCT00436982|10560853|P1|Overall Study|Did not receive allocated intervention|0
3076110|NCT00436982|10560852|P2|Overall Study|Withdrawal by Subject|1
3076111|NCT00436982|10560853|P1|Overall Study|Withdrawal by Subject|3
3076112|NCT00436956|10560924|P2|Overall Study|Not evaluable|0
3076113|NCT00436956|10560925|P1|Overall Study|Not evaluable|1
3076114|NCT00436917|10560939|P1|Overall Study|Personal conflicts of patient|1
3076115|NCT00436917|10560939|P1|Overall Study|Increased creatinine|1
3076116|NCT00436917|10560939|P1|Overall Study|Treatment for polymyalgia rheumatic|1
3076117|NCT00436917|10560939|P1|Overall Study|Lost to Follow-up|1
3076118|NCT00436917|10560939|P1|Overall Study|Death|1
3076119|NCT00436917|10560939|P1|Overall Study|Physician Decision|1
3076120|NCT00436917|10560939|P1|Overall Study|Adverse Event|2
3076121|NCT00436917|10560939|P1|Overall Study|Withdrawal by Subject|13
3076122|NCT00436852|10560965|P2|Overall Study|Ineligible|0
3076123|NCT00436852|10560966|P1|Overall Study|Ineligible|1
3076124|NCT00436852|10560965|P2|Overall Study|Withdrawal by Subject|4
3076125|NCT00436852|10560966|P1|Overall Study|Withdrawal by Subject|2
3076126|NCT00436852|10560965|P2|Overall Study|Lack of Efficacy|7
3076127|NCT00436852|10560966|P1|Overall Study|Lack of Efficacy|9
3076128|NCT00436852|10560965|P2|Overall Study|Death|34
3076129|NCT00436852|10560966|P1|Overall Study|Death|23
3076130|NCT00436826|10560985|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
3076131|NCT00436826|10560986|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
3076132|NCT00436826|10560987|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
3076133|NCT00436826|10560988|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
3076134|NCT00436826|10560989|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
3076135|NCT00436826|10560990|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
3076136|NCT00436826|10560985|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
3076137|NCT00436826|10560986|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
3076138|NCT00436826|10560987|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
3076139|NCT00436826|10560988|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
3076140|NCT00436826|10560989|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
3076141|NCT00436826|10560990|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
3076142|NCT00436826|10560985|P6|Double Blind Period|Other|0
3076143|NCT00436826|10560986|P5|Double Blind Period|Other|0
3076144|NCT00436826|10560987|P4|Double Blind Period|Other|0
3076145|NCT00436826|10560988|P3|Double Blind Period|Other|0
3076146|NCT00436826|10560989|P2|Double Blind Period|Other|11
3076147|NCT00436826|10560990|P1|Double Blind Period|Other|10
3076148|NCT00436826|10560985|P6|Double Blind Period|Protocol Violation|0
3076149|NCT00436826|10560986|P5|Double Blind Period|Protocol Violation|0
3076150|NCT00436826|10560987|P4|Double Blind Period|Protocol Violation|0
3076151|NCT00436826|10560988|P3|Double Blind Period|Protocol Violation|0
3076152|NCT00436826|10560989|P2|Double Blind Period|Protocol Violation|0
3076153|NCT00436826|10560990|P1|Double Blind Period|Protocol Violation|1
3076154|NCT00436826|10560985|P6|Double Blind Period|Adverse Event|0
3076155|NCT00436826|10560986|P5|Double Blind Period|Adverse Event|0
3076156|NCT00436826|10560987|P4|Double Blind Period|Adverse Event|0
3076157|NCT00436826|10560988|P3|Double Blind Period|Adverse Event|0
3076158|NCT00436826|10560989|P2|Double Blind Period|Adverse Event|0
3076159|NCT00436826|10560990|P1|Double Blind Period|Adverse Event|2
3076160|NCT00436748|10561012|P2|Overall Study|Other|0
3076161|NCT00436748|10561013|P1|Overall Study|Other|3
3076162|NCT00436748|10561012|P2|Overall Study|Protocol-specified Criteria|4
3076163|NCT00436748|10561013|P1|Overall Study|Protocol-specified Criteria|5
3076164|NCT00436748|10561012|P2|Overall Study|Lost to Follow-up|1
3076165|NCT00436748|10561013|P1|Overall Study|Lost to Follow-up|0
3076166|NCT00436748|10561012|P2|Overall Study|Administrative Decision|0
3076167|NCT00436748|10561013|P1|Overall Study|Administrative Decision|1
3076168|NCT00436748|10561012|P2|Overall Study|Consent Withdrawn|4
3076169|NCT00436748|10561013|P1|Overall Study|Consent Withdrawn|1
3076170|NCT00436748|10561012|P2|Overall Study|Adverse Event|2
3076171|NCT00436748|10561013|P1|Overall Study|Adverse Event|0
3076172|NCT00436748|10561012|P2|Overall Study|Ineligibility Determined|1
3076173|NCT00436748|10561013|P1|Overall Study|Ineligibility Determined|1
3076174|NCT00436644|10561047|P1|Overall Study|Death|1
3076175|NCT00436644|10561047|P1|Overall Study|Adverse Event|2
3076176|NCT00436618|10561057|P3|Overall Study|Still on treatment|7
3076177|NCT00436618|10561058|P2|Overall Study|Still on treatment|2
3076178|NCT00436618|10561059|P1|Overall Study|Still on treatment|1
3076179|NCT00436618|10561057|P3|Overall Study|New Primary or Other Reasons|12
3076180|NCT00436618|10561058|P2|Overall Study|New Primary or Other Reasons|2
3076181|NCT00436618|10561059|P1|Overall Study|New Primary or Other Reasons|6
3076182|NCT00436618|10561057|P3|Overall Study|Death|3
3076183|NCT00436618|10561058|P2|Overall Study|Death|2
3076184|NCT00436618|10561059|P1|Overall Study|Death|4
3076185|NCT00436618|10561057|P3|Overall Study|Other Medical Problems|7
3076186|NCT00436618|10561058|P2|Overall Study|Other Medical Problems|1
3076187|NCT00436618|10561059|P1|Overall Study|Other Medical Problems|3
3076188|NCT00436618|10561057|P3|Overall Study|Alternate Treatment|12
3076189|NCT00436618|10561058|P2|Overall Study|Alternate Treatment|4
3076190|NCT00436618|10561059|P1|Overall Study|Alternate Treatment|3
3076191|NCT00436618|10561057|P3|Overall Study|Adverse Event|9
3076192|NCT00436618|10561058|P2|Overall Study|Adverse Event|8
3076193|NCT00436618|10561059|P1|Overall Study|Adverse Event|8
3076194|NCT00436618|10561057|P3|Overall Study|Withdrawal by Subject|11
3076195|NCT00436618|10561058|P2|Overall Study|Withdrawal by Subject|8
3076196|NCT00436618|10561059|P1|Overall Study|Withdrawal by Subject|5
3076197|NCT00436605|10561076|P1|Overall Study|Protocol Violation|3
3076198|NCT00436566|10561081|P1|Overall Study|Protocol Violation|1
3076199|NCT00436566|10561081|P1|Overall Study|Withdrawal by Subject|2
3076200|NCT00436553|10561088|P3|Overall Study|Withdrawal by Subject|3
3076201|NCT00436553|10561089|P2|Overall Study|Withdrawal by Subject|6
3076202|NCT00436553|10561090|P1|Overall Study|Withdrawal by Subject|5
3076203|NCT00436553|10561088|P3|Overall Study|Protocol Violation|0
3076204|NCT00436553|10561089|P2|Overall Study|Protocol Violation|0
3076205|NCT00436553|10561090|P1|Overall Study|Protocol Violation|1
3076206|NCT00436553|10561088|P3|Overall Study|Lost to Follow-up|0
3076207|NCT00436553|10561089|P2|Overall Study|Lost to Follow-up|2
3076208|NCT00436553|10561090|P1|Overall Study|Lost to Follow-up|0
3076209|NCT00436553|10561088|P3|Overall Study|Death|3
3076210|NCT00436553|10561089|P2|Overall Study|Death|1
3076211|NCT00436553|10561090|P1|Overall Study|Death|3
3076212|NCT00436553|10561088|P3|Overall Study|Adverse Event|4
3076213|NCT00436553|10561089|P2|Overall Study|Adverse Event|3
3076214|NCT00436553|10561090|P1|Overall Study|Adverse Event|4
3076215|NCT00436501|10561111|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
3076216|NCT00436501|10561112|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
3076217|NCT00436501|10561111|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
3076218|NCT00436501|10561112|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
3076219|NCT00436436|10561148|P1|Overall Study|Death|6
3076220|NCT00436436|10561148|P1|Overall Study|Adverse Event|2
3076221|NCT00436436|10561148|P1|Overall Study|Progression|4
3076222|NCT00436345|10561159|P2|Overall Study|ICU resident beyond follow-up period|0
3076223|NCT00436345|10561160|P1|Overall Study|ICU resident beyond follow-up period|3
3076224|NCT00436332|10561213|P1|Overall Study|Never Received Treatment|3
3076225|NCT00436332|10561213|P1|Overall Study|Ineligible|2
3076226|NCT00436332|10561213|P1|Overall Study|Not Protocol Specified|6
3076227|NCT00436332|10561213|P1|Overall Study|Death|2
3076228|NCT00436332|10561213|P1|Overall Study|Progression|59
3076229|NCT00436332|10561213|P1|Overall Study|Withdrawal by Subject|2
3076230|NCT00436332|10561213|P1|Overall Study|Adverse Event|9
3076231|NCT00436215|10561220|P1|Overall Study|Small bowel obstruction|1
3076232|NCT00436215|10561220|P1|Overall Study|Refused further treatment|3
3076233|NCT00436163|10561226|P1|Overall Study|Adverse Event|1
3076234|NCT00436163|10561226|P1|Overall Study|Lost to Follow-up|2
3076235|NCT00436007|10561274|P3|Overall Study|Other|1
3076236|NCT00436007|10561275|P2|Overall Study|Other|0
3076237|NCT00436007|10561276|P1|Overall Study|Other|0
3076238|NCT00436007|10561274|P3|Overall Study|Death|3
3076239|NCT00436007|10561275|P2|Overall Study|Death|1
3076240|NCT00436007|10561276|P1|Overall Study|Death|0
3076241|NCT00436007|10561274|P3|Overall Study|Physician Decision|2
3076242|NCT00436007|10561275|P2|Overall Study|Physician Decision|0
3076243|NCT00436007|10561276|P1|Overall Study|Physician Decision|0
3076244|NCT00436007|10561274|P3|Overall Study|Lost to Follow-up|13
3076245|NCT00436007|10561275|P2|Overall Study|Lost to Follow-up|10
3076246|NCT00436007|10561276|P1|Overall Study|Lost to Follow-up|14
3076247|NCT00436007|10561274|P3|Overall Study|Withdrawal by Subject|4
3076248|NCT00436007|10561275|P2|Overall Study|Withdrawal by Subject|3
3076249|NCT00436007|10561276|P1|Overall Study|Withdrawal by Subject|5
3076250|NCT00435994|10561324|P3|Overall Study|Lost to Follow-up|0
3076251|NCT00435994|10561325|P2|Overall Study|Lost to Follow-up|0
3076252|NCT00435994|10561326|P1|Overall Study|Lost to Follow-up|7
3076253|NCT00435942|10561337|P2|Overall Study|Other|1
3076254|NCT00435942|10561338|P1|Overall Study|Other|0
3076255|NCT00435942|10561337|P2|Overall Study|Technical Failure|0
3076256|NCT00435942|10561338|P1|Overall Study|Technical Failure|3
3076257|NCT00435942|10561337|P2|Overall Study|Conversion to Open Repair|0
3076258|NCT00435942|10561338|P1|Overall Study|Conversion to Open Repair|1
3076259|NCT00435942|10561337|P2|Overall Study|Lost to Follow-up|16
3076260|NCT00435942|10561338|P1|Overall Study|Lost to Follow-up|0
3076261|NCT00435942|10561337|P2|Overall Study|Withdrawal by Subject|0
3076262|NCT00435942|10561338|P1|Overall Study|Withdrawal by Subject|2
3076263|NCT00435942|10561337|P2|Overall Study|Death|10
3076264|NCT00435942|10561338|P1|Overall Study|Death|17
3076265|NCT00435825|10561378|P4|Overall Study|Did not complete full follow-up period|5
3076266|NCT00435825|10561379|P3|Overall Study|Did not complete full follow-up period|4
3076267|NCT00435825|10561380|P2|Overall Study|Did not complete full follow-up period|6
3076268|NCT00435825|10561381|P1|Overall Study|Did not complete full follow-up period|6
3076269|NCT00435825|10561378|P4|Overall Study|Did not enter follow-up|3
3076270|NCT00435825|10561379|P3|Overall Study|Did not enter follow-up|1
3076271|NCT00435825|10561380|P2|Overall Study|Did not enter follow-up|4
3076272|NCT00435825|10561381|P1|Overall Study|Did not enter follow-up|0
3076273|NCT00435825|10561378|P4|Overall Study|Did not receive study drug|0
3076274|NCT00435825|10561379|P3|Overall Study|Did not receive study drug|2
3076275|NCT00435825|10561380|P2|Overall Study|Did not receive study drug|0
3076276|NCT00435825|10561381|P1|Overall Study|Did not receive study drug|1
3076277|NCT00435825|10561378|P4|Overall Study|Failure to return|0
3076278|NCT00435825|10561379|P3|Overall Study|Failure to return|4
3076279|NCT00435825|10561380|P2|Overall Study|Failure to return|0
3076280|NCT00435825|10561381|P1|Overall Study|Failure to return|5
3076281|NCT00435825|10561378|P4|Overall Study|Refused treatment|5
3076282|NCT00435825|10561379|P3|Overall Study|Refused treatment|0
3076283|NCT00435825|10561380|P2|Overall Study|Refused treatment|0
3076284|NCT00435825|10561381|P1|Overall Study|Refused treatment|2
3076285|NCT00435825|10561378|P4|Overall Study|Other Protocol Violation|0
3076286|NCT00435825|10561379|P3|Overall Study|Other Protocol Violation|0
3076287|NCT00435825|10561380|P2|Overall Study|Other Protocol Violation|0
3076288|NCT00435825|10561381|P1|Overall Study|Other Protocol Violation|1
3076289|NCT00435825|10561378|P4|Overall Study|Insufficient Therapeutic Response|3
3076290|NCT00435825|10561379|P3|Overall Study|Insufficient Therapeutic Response|0
3076291|NCT00435825|10561380|P2|Overall Study|Insufficient Therapeutic Response|1
3076459|NCT00434967|10561766|P2|Overall Study|Lost to Follow-up|0
3076292|NCT00435825|10561381|P1|Overall Study|Insufficient Therapeutic Response|3
3076293|NCT00435825|10561378|P4|Overall Study|Abnormality of Laboratory Test|0
3076294|NCT00435825|10561379|P3|Overall Study|Abnormality of Laboratory Test|0
3076295|NCT00435825|10561380|P2|Overall Study|Abnormality of Laboratory Test|1
3076296|NCT00435825|10561381|P1|Overall Study|Abnormality of Laboratory Test|0
3076297|NCT00435487|10561504|P2|Overall Study|Received Drug in Other Treatment Group|1
3076298|NCT00435487|10561505|P1|Overall Study|Received Drug in Other Treatment Group|0
3076299|NCT00435487|10561504|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
3076300|NCT00435487|10561505|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
3076301|NCT00435487|10561504|P2|Overall Study|Withdrawal by Subject|1
3076302|NCT00435487|10561505|P1|Overall Study|Withdrawal by Subject|2
3076303|NCT00435487|10561504|P2|Overall Study|Other|2
3076304|NCT00435487|10561505|P1|Overall Study|Other|5
3076305|NCT00435487|10561504|P2|Overall Study|Lost to Follow-up|2
3076306|NCT00435487|10561505|P1|Overall Study|Lost to Follow-up|2
3076307|NCT00435487|10561504|P2|Overall Study|Adverse Event|3
3076308|NCT00435487|10561505|P1|Overall Study|Adverse Event|0
3076309|NCT00435487|10561504|P2|Overall Study|Death|4
3076310|NCT00435487|10561505|P1|Overall Study|Death|3
3076311|NCT00435461|10561524|P3|Overall Study|Lost to Follow-up|2
3076312|NCT00435461|10561525|P2|Overall Study|Lost to Follow-up|1
3076313|NCT00435461|10561526|P1|Overall Study|Lost to Follow-up|1
3076314|NCT00435461|10561524|P3|Overall Study|Non-Compliance of diary|1
3076315|NCT00435461|10561525|P2|Overall Study|Non-Compliance of diary|0
3076316|NCT00435461|10561526|P1|Overall Study|Non-Compliance of diary|2
3076317|NCT00435461|10561524|P3|Overall Study|Adverse Event|6
3076318|NCT00435461|10561525|P2|Overall Study|Adverse Event|2
3076319|NCT00435461|10561526|P1|Overall Study|Adverse Event|1
3076320|NCT00435461|10561524|P3|Overall Study|Noncompliance with study requirements|1
3076321|NCT00435461|10561525|P2|Overall Study|Noncompliance with study requirements|1
3076322|NCT00435461|10561526|P1|Overall Study|Noncompliance with study requirements|1
3076323|NCT00435461|10561524|P3|Overall Study|Participant ended study one day early|0
3076324|NCT00435461|10561525|P2|Overall Study|Participant ended study one day early|0
3076325|NCT00435461|10561526|P1|Overall Study|Participant ended study one day early|1
3076326|NCT00435461|10561524|P3|Overall Study|Participant moved eDiary,studymedication|0
3076327|NCT00435461|10561525|P2|Overall Study|Participant moved eDiary,studymedication|0
3076328|NCT00435461|10561526|P1|Overall Study|Participant moved eDiary,studymedication|1
3076329|NCT00435461|10561524|P3|Overall Study|Pregnancy|0
3076330|NCT00435461|10561525|P2|Overall Study|Pregnancy|0
3076331|NCT00435461|10561526|P1|Overall Study|Pregnancy|2
3076332|NCT00435461|10561524|P3|Overall Study|Participant could not swallow capsule|1
3076333|NCT00435461|10561525|P2|Overall Study|Participant could not swallow capsule|0
3076334|NCT00435461|10561526|P1|Overall Study|Participant could not swallow capsule|0
3076335|NCT00435461|10561524|P3|Overall Study|Participant could not tolerate symptoms|1
3076336|NCT00435461|10561525|P2|Overall Study|Participant could not tolerate symptoms|0
3076337|NCT00435461|10561526|P1|Overall Study|Participant could not tolerate symptoms|0
3076338|NCT00435461|10561524|P3|Overall Study|Randomized in error|0
3076339|NCT00435461|10561525|P2|Overall Study|Randomized in error|0
3076340|NCT00435461|10561526|P1|Overall Study|Randomized in error|1
3076341|NCT00435461|10561524|P3|Overall Study|Withdrawal by Subject|2
3076342|NCT00435461|10561525|P2|Overall Study|Withdrawal by Subject|0
3076343|NCT00435461|10561526|P1|Overall Study|Withdrawal by Subject|1
3076344|NCT00435461|10561524|P3|Overall Study|Lack of Efficacy|0
3076345|NCT00435461|10561525|P2|Overall Study|Lack of Efficacy|1
3076346|NCT00435461|10561526|P1|Overall Study|Lack of Efficacy|2
3076347|NCT00435461|10561524|P3|Overall Study|In error, two study medications switched|0
3076348|NCT00435461|10561525|P2|Overall Study|In error, two study medications switched|0
3076349|NCT00435461|10561526|P1|Overall Study|In error, two study medications switched|1
3076350|NCT00435461|10561524|P3|Overall Study|Compliance less than 80 percent|0
3076351|NCT00435461|10561525|P2|Overall Study|Compliance less than 80 percent|0
3076352|NCT00435461|10561526|P1|Overall Study|Compliance less than 80 percent|1
3076353|NCT00435461|10561524|P3|Overall Study|Participant randomized(inadequate score)|0
3076354|NCT00435461|10561525|P2|Overall Study|Participant randomized(inadequate score)|0
3076355|NCT00435461|10561526|P1|Overall Study|Participant randomized(inadequate score)|1
3076356|NCT00435461|10561524|P3|Overall Study|Protocol Violation|10
3076357|NCT00435461|10561525|P2|Overall Study|Protocol Violation|9
3076358|NCT00435461|10561526|P1|Overall Study|Protocol Violation|6
3076359|NCT00435461|10561524|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
3076360|NCT00435461|10561525|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
3076361|NCT00435461|10561526|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
3076362|NCT00435409|10561563|P3|Overall Study|Sponsor decision|0
3076363|NCT00435409|10561564|P2|Overall Study|Sponsor decision|3
3076364|NCT00435409|10561565|P1|Overall Study|Sponsor decision|0
3076365|NCT00435409|10561563|P3|Overall Study|Adverse Event|8
3076366|NCT00435409|10561564|P2|Overall Study|Adverse Event|0
3076367|NCT00435409|10561565|P1|Overall Study|Adverse Event|0
3076368|NCT00435409|10561563|P3|Overall Study|Other|1
3076369|NCT00435409|10561564|P2|Overall Study|Other|30
3076370|NCT00435409|10561565|P1|Overall Study|Other|45
3076371|NCT00435409|10561563|P3|Overall Study|Withdrawal by Subject|1
3076372|NCT00435409|10561564|P2|Overall Study|Withdrawal by Subject|7
3076373|NCT00435409|10561565|P1|Overall Study|Withdrawal by Subject|8
3076374|NCT00435409|10561563|P3|Overall Study|Global deterioration of health status|4
3076375|NCT00435409|10561564|P2|Overall Study|Global deterioration of health status|0
3076376|NCT00435409|10561565|P1|Overall Study|Global deterioration of health status|0
3076377|NCT00435409|10561563|P3|Overall Study|Objective progression or relapse|58
3076378|NCT00435409|10561564|P2|Overall Study|Objective progression or relapse|93
3076379|NCT00435409|10561565|P1|Overall Study|Objective progression or relapse|158
3076380|NCT00435409|10561563|P3|Overall Study|Death|6
3076381|NCT00435409|10561564|P2|Overall Study|Death|6
3076382|NCT00435409|10561565|P1|Overall Study|Death|8
3076383|NCT00435409|10561563|P3|Overall Study|Lost to Follow-up|0
3076384|NCT00435409|10561564|P2|Overall Study|Lost to Follow-up|2
3076385|NCT00435409|10561565|P1|Overall Study|Lost to Follow-up|1
3076386|NCT00435409|10561563|P3|Overall Study|Protocol Violation|0
3076387|NCT00435409|10561564|P2|Overall Study|Protocol Violation|2
3076388|NCT00435409|10561565|P1|Overall Study|Protocol Violation|1
3076389|NCT00435370|10561587|P2|Overall Study|Antipsychotic medication changed|2
3076390|NCT00435370|10561588|P1|Overall Study|Antipsychotic medication changed|4
3076391|NCT00435370|10561587|P2|Overall Study|Withdrawal by Subject|10
3076392|NCT00435370|10561588|P1|Overall Study|Withdrawal by Subject|10
3076393|NCT00435370|10561587|P2|Overall Study|Adverse Event|8
3076394|NCT00435370|10561588|P1|Overall Study|Adverse Event|8
3076395|NCT00435188|10561596|P2|Overall Study|Lost to Follow-up|6
3076396|NCT00435188|10561597|P1|Overall Study|Lost to Follow-up|5
3076397|NCT00435188|10561596|P2|Overall Study|Withdrawal by Subject|11
3076398|NCT00435188|10561597|P1|Overall Study|Withdrawal by Subject|16
3076399|NCT00435188|10561596|P2|Overall Study|Death|6
3076400|NCT00435188|10561597|P1|Overall Study|Death|1
3076401|NCT00435162|10561640|P6|Period 2 (2 Weeks)|Adverse Event|0
3076402|NCT00435162|10561641|P5|Period 2 (2 Weeks)|Adverse Event|0
3076403|NCT00435162|10561642|P4|Period 2 (2 Weeks)|Adverse Event|0
3076404|NCT00435162|10561643|P3|Period 2 (2 Weeks)|Adverse Event|0
3076405|NCT00435162|10561644|P2|Period 2 (2 Weeks)|Adverse Event|1
3076406|NCT00435162|10561645|P1|Period 2 (2 Weeks)|Adverse Event|0
3076407|NCT00435045|10561665|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
3076408|NCT00435045|10561666|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
3076409|NCT00435045|10561665|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
3076410|NCT00435045|10561666|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
3076411|NCT00435045|10561665|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
3076412|NCT00435045|10561666|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
3076413|NCT00435045|10561665|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
3076414|NCT00435045|10561666|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
3076415|NCT00435045|10561665|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
3076416|NCT00435045|10561666|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
3076417|NCT00435045|10561665|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
3076418|NCT00435045|10561666|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
3076419|NCT00435045|10561665|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
3076420|NCT00435045|10561666|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
3076421|NCT00435045|10561665|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
3076422|NCT00435045|10561666|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
3076423|NCT00435045|10561665|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
3076424|NCT00435045|10561666|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
3076425|NCT00435045|10561665|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
3076426|NCT00435045|10561666|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
3076427|NCT00435045|10561665|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
3076428|NCT00435045|10561666|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
3076429|NCT00435019|10561722|P2|Overall Study|Personal reasons for withdrawal|7
3076430|NCT00435019|10561723|P1|Overall Study|Personal reasons for withdrawal|8
3076431|NCT00435019|10561722|P2|Overall Study|Protocol Violation|1
3076432|NCT00435019|10561723|P1|Overall Study|Protocol Violation|3
3076433|NCT00435019|10561722|P2|Overall Study|Lack of Efficacy|2
3076434|NCT00435019|10561723|P1|Overall Study|Lack of Efficacy|1
3076435|NCT00435019|10561722|P2|Overall Study|Adverse Event|0
3076436|NCT00435019|10561723|P1|Overall Study|Adverse Event|1
3076437|NCT00434967|10561764|P4|Overall Study|Patient Disposition Challenges|3
3076438|NCT00434967|10561765|P3|Overall Study|Patient Disposition Challenges|0
3076439|NCT00434967|10561766|P2|Overall Study|Patient Disposition Challenges|0
3076440|NCT00434967|10561767|P1|Overall Study|Patient Disposition Challenges|2
3076441|NCT00434967|10561764|P4|Overall Study|Physician Decision|0
3076442|NCT00434967|10561765|P3|Overall Study|Physician Decision|1
3076443|NCT00434967|10561766|P2|Overall Study|Physician Decision|1
3076444|NCT00434967|10561767|P1|Overall Study|Physician Decision|1
3076445|NCT00434967|10561764|P4|Overall Study|Protocol Violation|1
3076446|NCT00434967|10561765|P3|Overall Study|Protocol Violation|0
3076447|NCT00434967|10561766|P2|Overall Study|Protocol Violation|1
3076448|NCT00434967|10561767|P1|Overall Study|Protocol Violation|0
3076449|NCT00434967|10561764|P4|Overall Study|Randomized in error|1
3076450|NCT00434967|10561765|P3|Overall Study|Randomized in error|0
3076451|NCT00434967|10561766|P2|Overall Study|Randomized in error|0
3076452|NCT00434967|10561767|P1|Overall Study|Randomized in error|0
3076453|NCT00434967|10561764|P4|Overall Study|Withdrawal by Subject|6
3076454|NCT00434967|10561765|P3|Overall Study|Withdrawal by Subject|4
3076455|NCT00434967|10561766|P2|Overall Study|Withdrawal by Subject|2
3076456|NCT00434967|10561767|P1|Overall Study|Withdrawal by Subject|2
3076457|NCT00434967|10561764|P4|Overall Study|Lost to Follow-up|0
3076458|NCT00434967|10561765|P3|Overall Study|Lost to Follow-up|1
3076460|NCT00434967|10561767|P1|Overall Study|Lost to Follow-up|0
3076461|NCT00434967|10561764|P4|Overall Study|Adverse Event|3
3076462|NCT00434967|10561765|P3|Overall Study|Adverse Event|3
3076463|NCT00434967|10561766|P2|Overall Study|Adverse Event|4
3076464|NCT00434967|10561767|P1|Overall Study|Adverse Event|2
3076465|NCT00434954|10561787|P2|Overall Study|Subject decision|22
3076466|NCT00434954|10561788|P1|Overall Study|Subject decision|8
3076467|NCT00434954|10561787|P2|Overall Study|Sponsor decision|0
3076468|NCT00434954|10561788|P1|Overall Study|Sponsor decision|1
3076469|NCT00434954|10561787|P2|Overall Study|Protocol Violation|27
3076470|NCT00434954|10561788|P1|Overall Study|Protocol Violation|36
3076471|NCT00434954|10561787|P2|Overall Study|Physician Decision|3
3076472|NCT00434954|10561788|P1|Overall Study|Physician Decision|6
3076473|NCT00434954|10561787|P2|Overall Study|Lost to Follow-up|1
3076474|NCT00434954|10561788|P1|Overall Study|Lost to Follow-up|0
3076475|NCT00434954|10561787|P2|Overall Study|Entry criteria not met|16
3076476|NCT00434954|10561788|P1|Overall Study|Entry criteria not met|14
3076477|NCT00434954|10561787|P2|Overall Study|Adverse Event|2
3076478|NCT00434954|10561788|P1|Overall Study|Adverse Event|17
3076479|NCT00434876|10561818|P2|Overall Study|Lost to Follow-up|1
3076480|NCT00434876|10561819|P1|Overall Study|Lost to Follow-up|1
3076481|NCT00434759|10561833|P2|Overall Study|family affairs|0
3076482|NCT00434759|10561834|P1|Overall Study|family affairs|2
3076483|NCT00434759|10561833|P2|Overall Study|Withdrawal by Subject|1
3076484|NCT00434759|10561834|P1|Overall Study|Withdrawal by Subject|17
3076485|NCT00434759|10561833|P2|Overall Study|Lack of Efficacy|4
3076486|NCT00434759|10561834|P1|Overall Study|Lack of Efficacy|5
3076487|NCT00434642|10561850|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
3076488|NCT00434642|10561851|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
3076489|NCT00434642|10561850|P2|Open-label Treatment Phase|Adverse Event|5
3076490|NCT00434642|10561851|P1|Open-label Treatment Phase|Adverse Event|0
3076491|NCT00434642|10561850|P2|Blinded Treatment Phase|Did not Receive Treatment|1
3076492|NCT00434642|10561851|P1|Blinded Treatment Phase|Did not Receive Treatment|4
3076493|NCT00434642|10561850|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
3076494|NCT00434642|10561851|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
3076495|NCT00434642|10561850|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
3076496|NCT00434642|10561851|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
3076497|NCT00434642|10561850|P2|Blinded Treatment Phase|Physician Decision|27
3076498|NCT00434642|10561851|P1|Blinded Treatment Phase|Physician Decision|19
3076499|NCT00434642|10561850|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
3076500|NCT00434642|10561851|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
3076501|NCT00434642|10561850|P2|Blinded Treatment Phase|Clinical Disease Progression|5
3076502|NCT00434642|10561851|P1|Blinded Treatment Phase|Clinical Disease Progression|4
3076503|NCT00434642|10561850|P2|Blinded Treatment Phase|Adverse Event|58
3076504|NCT00434642|10561851|P1|Blinded Treatment Phase|Adverse Event|12
3076505|NCT00434590|10561869|P2|Overall Study|Administrative problems|5
3076506|NCT00434590|10561870|P1|Overall Study|Administrative problems|5
3076507|NCT00434577|10561881|P5|Months 0-3|Withdrawal by Subject|1
3076508|NCT00434577|10561882|P4|Months 0-3|Withdrawal by Subject|1
3076509|NCT00434577|10561883|P3|Months 0-3|Withdrawal by Subject|1
3076510|NCT00434577|10561884|P2|Months 0-3|Withdrawal by Subject|1
3076511|NCT00434577|10561885|P1|Months 0-3|Withdrawal by Subject|2
3076512|NCT00434577|10561881|P5|Months 0-3|Protocol Violation|0
3076513|NCT00434577|10561882|P4|Months 0-3|Protocol Violation|0
3076514|NCT00434577|10561883|P3|Months 0-3|Protocol Violation|1
3076515|NCT00434577|10561884|P2|Months 0-3|Protocol Violation|0
3076516|NCT00434577|10561885|P1|Months 0-3|Protocol Violation|1
3076517|NCT00434577|10561881|P5|Months 0-3|Lost to Follow-up|2
3076518|NCT00434577|10561882|P4|Months 0-3|Lost to Follow-up|0
3076519|NCT00434577|10561883|P3|Months 0-3|Lost to Follow-up|0
3076520|NCT00434577|10561884|P2|Months 0-3|Lost to Follow-up|0
3076521|NCT00434577|10561885|P1|Months 0-3|Lost to Follow-up|0
3076522|NCT00434577|10561881|P5|Months 0-3|Adverse Event|0
3076523|NCT00434577|10561882|P4|Months 0-3|Adverse Event|0
3076524|NCT00434577|10561883|P3|Months 0-3|Adverse Event|1
3076525|NCT00434577|10561884|P2|Months 0-3|Adverse Event|1
3076526|NCT00434577|10561885|P1|Months 0-3|Adverse Event|0
3076527|NCT00434577|10561881|P5|Months 0-3|Serious Adverse Event|0
3076528|NCT00434577|10561882|P4|Months 0-3|Serious Adverse Event|0
3076529|NCT00434577|10561883|P3|Months 0-3|Serious Adverse Event|1
3076530|NCT00434577|10561884|P2|Months 0-3|Serious Adverse Event|0
3076531|NCT00434577|10561885|P1|Months 0-3|Serious Adverse Event|0
3076532|NCT00434512|10562063|P6|Overall Study|Other|0
3076533|NCT00434512|10562064|P5|Overall Study|Other|0
3076534|NCT00434512|10562065|P4|Overall Study|Other|0
3076535|NCT00434512|10562066|P3|Overall Study|Other|0
3076536|NCT00434512|10562067|P2|Overall Study|Other|1
3076537|NCT00434512|10562068|P1|Overall Study|Other|0
3076538|NCT00434512|10562063|P6|Overall Study|Migrated/moved from study area|1
3076539|NCT00434512|10562064|P5|Overall Study|Migrated/moved from study area|1
3076540|NCT00434512|10562065|P4|Overall Study|Migrated/moved from study area|1
3076541|NCT00434512|10562066|P3|Overall Study|Migrated/moved from study area|0
3076542|NCT00434512|10562067|P2|Overall Study|Migrated/moved from study area|0
3076543|NCT00434512|10562068|P1|Overall Study|Migrated/moved from study area|0
3076544|NCT00434421|10562182|P1|Overall Study|Non-compliance with study treatment|1
3076545|NCT00434421|10562182|P1|Overall Study|Withdrawal by Subject|1
3076546|NCT00434330|10562210|P6|Overall Study|Subject Not Compliant With Study|0
3076547|NCT00434330|10562211|P5|Overall Study|Subject Not Compliant With Study|0
3076548|NCT00434330|10562212|P4|Overall Study|Subject Not Compliant With Study|0
3076549|NCT00434330|10562213|P3|Overall Study|Subject Not Compliant With Study|1
3076550|NCT00434330|10562214|P2|Overall Study|Subject Not Compliant With Study|0
3076551|NCT00434330|10562215|P1|Overall Study|Subject Not Compliant With Study|0
3076552|NCT00434330|10562210|P6|Overall Study|Renal transplant|0
3076553|NCT00434330|10562211|P5|Overall Study|Renal transplant|0
3076554|NCT00434330|10562212|P4|Overall Study|Renal transplant|1
3076555|NCT00434330|10562213|P3|Overall Study|Renal transplant|0
3076556|NCT00434330|10562214|P2|Overall Study|Renal transplant|0
3076557|NCT00434330|10562215|P1|Overall Study|Renal transplant|0
3076558|NCT00434330|10562210|P6|Overall Study|Withdrawal by Subject|0
3076559|NCT00434330|10562211|P5|Overall Study|Withdrawal by Subject|0
3076560|NCT00434330|10562212|P4|Overall Study|Withdrawal by Subject|1
3076561|NCT00434330|10562213|P3|Overall Study|Withdrawal by Subject|1
3076562|NCT00434330|10562214|P2|Overall Study|Withdrawal by Subject|0
3076563|NCT00434330|10562215|P1|Overall Study|Withdrawal by Subject|0
3076564|NCT00434330|10562210|P6|Overall Study|Death|1
3076565|NCT00434330|10562211|P5|Overall Study|Death|1
3076566|NCT00434330|10562212|P4|Overall Study|Death|0
3076567|NCT00434330|10562213|P3|Overall Study|Death|0
3076568|NCT00434330|10562214|P2|Overall Study|Death|0
3076569|NCT00434330|10562215|P1|Overall Study|Death|1
3076570|NCT00434330|10562210|P6|Overall Study|Adverse Event|0
3076571|NCT00434330|10562211|P5|Overall Study|Adverse Event|0
3076572|NCT00434330|10562212|P4|Overall Study|Adverse Event|0
3076573|NCT00434330|10562213|P3|Overall Study|Adverse Event|1
3076574|NCT00434330|10562214|P2|Overall Study|Adverse Event|0
3076575|NCT00434330|10562215|P1|Overall Study|Adverse Event|0
3076576|NCT00434304|10562247|P1|Overall Study|Withdrawal by Subject|4
3076577|NCT00434304|10562247|P1|Overall Study|Lack of Efficacy|2
3076578|NCT00434304|10562247|P1|Overall Study|Adverse Event|14
3076579|NCT00434252|10562296|P2|Overall Study|Withdrawal by Subject|7
3076580|NCT00434252|10562297|P1|Overall Study|Withdrawal by Subject|3
3076581|NCT00434252|10562296|P2|Overall Study|Physician Decision|8
3076582|NCT00434252|10562297|P1|Overall Study|Physician Decision|4
3076583|NCT00434252|10562296|P2|Overall Study|Lost to Follow-up|1
3076584|NCT00434252|10562297|P1|Overall Study|Lost to Follow-up|0
3076585|NCT00434252|10562296|P2|Overall Study|Death|2
3076586|NCT00434252|10562297|P1|Overall Study|Death|1
3076587|NCT00434252|10562296|P2|Overall Study|Adverse Event|13
3076588|NCT00434252|10562297|P1|Overall Study|Adverse Event|6
3076589|NCT00434252|10562296|P2|Overall Study|Lack of Efficacy|100
3076590|NCT00434252|10562297|P1|Overall Study|Lack of Efficacy|50
3076591|NCT00434213|10562331|P1|Overall Study|Non-compliant to study schedule|1
3076592|NCT00434213|10562331|P1|Overall Study|Application site reaction|1
3076593|NCT00434213|10562331|P1|Overall Study|Unable to comply with study visit window|2
3076594|NCT00434213|10562331|P1|Overall Study|Protocol Violation|3
3076595|NCT00434213|10562331|P1|Overall Study|Withdrawal by Subject|7
3076596|NCT00434213|10562331|P1|Overall Study|Lost to Follow-up|14
3076597|NCT00434213|10562331|P1|Overall Study|Lack of Efficacy|9
3076598|NCT00434213|10562331|P1|Overall Study|Adverse Event|12
3076599|NCT00434161|10562339|P3|Overall Study|Logistical error study assessments|3
3076600|NCT00434161|10562340|P2|Overall Study|Logistical error study assessments|0
3076601|NCT00434161|10562341|P1|Overall Study|Logistical error study assessments|1
3076602|NCT00434161|10562339|P3|Overall Study|Withdrawal by Subject|3
3076603|NCT00434161|10562340|P2|Overall Study|Withdrawal by Subject|0
3076604|NCT00434161|10562341|P1|Overall Study|Withdrawal by Subject|2
3076605|NCT00434161|10562339|P3|Overall Study|Non-Compliance|0
3076606|NCT00434161|10562340|P2|Overall Study|Non-Compliance|1
3076607|NCT00434161|10562341|P1|Overall Study|Non-Compliance|1
3076608|NCT00434161|10562339|P3|Overall Study|Death|1
3076609|NCT00434161|10562340|P2|Overall Study|Death|0
3076610|NCT00434161|10562341|P1|Overall Study|Death|1
3076611|NCT00434161|10562339|P3|Overall Study|Lost to Follow-up|0
3076612|NCT00434161|10562340|P2|Overall Study|Lost to Follow-up|1
3076613|NCT00434161|10562341|P1|Overall Study|Lost to Follow-up|0
3076614|NCT00434161|10562339|P3|Overall Study|Adverse Event|4
3076615|NCT00434161|10562340|P2|Overall Study|Adverse Event|1
3076616|NCT00434161|10562341|P1|Overall Study|Adverse Event|5
3076617|NCT00434148|10562385|P2|Overall Study|Abnormal test procedure result|1
3076618|NCT00434148|10562386|P1|Overall Study|Abnormal test procedure result|0
3076619|NCT00434148|10562385|P2|Overall Study|Condition no longer requires study drug|0
3076620|NCT00434148|10562386|P1|Overall Study|Condition no longer requires study drug|1
3076621|NCT00434148|10562385|P2|Overall Study|Lost to Follow-up|1
3076622|NCT00434148|10562386|P1|Overall Study|Lost to Follow-up|0
3076623|NCT00434148|10562385|P2|Overall Study|Administrative problems|10
3076624|NCT00434148|10562386|P1|Overall Study|Administrative problems|6
3076625|NCT00434148|10562385|P2|Overall Study|Protocol Violation|0
3076626|NCT00434148|10562386|P1|Overall Study|Protocol Violation|4
3076627|NCT00434148|10562385|P2|Overall Study|Withdrawal by Subject|15
3076628|NCT00434148|10562386|P1|Overall Study|Withdrawal by Subject|15
3076629|NCT00434148|10562385|P2|Overall Study|Lack of Efficacy|28
3076630|NCT00434148|10562386|P1|Overall Study|Lack of Efficacy|25
3076631|NCT00434148|10562385|P2|Overall Study|Adverse Event|18
3076632|NCT00434148|10562386|P1|Overall Study|Adverse Event|18
3076633|NCT00434122|10562422|P2|Overall Study|Travelling of subject.|0
3076634|NCT00434122|10562423|P1|Overall Study|Travelling of subject.|1
3076635|NCT00434122|10562422|P2|Overall Study|Low follicular response.|2
3076636|NCT00434122|10562423|P1|Overall Study|Low follicular response.|1
3076637|NCT00434122|10562422|P2|Overall Study|Large follicle size|2
3076638|NCT00434122|10562423|P1|Overall Study|Large follicle size|2
3076639|NCT00434122|10562422|P2|Overall Study|Personal reasons|1
3076640|NCT00434122|10562423|P1|Overall Study|Personal reasons|1
3076641|NCT00434122|10562422|P2|Overall Study|loss of subject contact|1
3076642|NCT00434122|10562423|P1|Overall Study|loss of subject contact|1
3076643|NCT00434122|10562422|P2|Overall Study|Non-compliance with protocol|1
3076644|NCT00434122|10562423|P1|Overall Study|Non-compliance with protocol|0
3076645|NCT00434109|10562432|P1|Overall Study|had embolism, did not receive sunitinib|3
3076646|NCT00434109|10562432|P1|Overall Study|Protocol Violation|1
3076647|NCT00434109|10562432|P1|Overall Study|Adverse Event|5
3076648|NCT00434109|10562432|P1|Overall Study|Physician Decision|9
3076649|NCT00434057|10562441|P1|Overall Study|Withdrawal by Subject|1
3076650|NCT00433966|10562479|P4|Stent Intervention/Randomization|Lost to Follow-up|47
3076651|NCT00433966|10562480|P3|Stent Intervention/Randomization|Lost to Follow-up|113
3076652|NCT00433966|10562481|P2|Stent Intervention/Randomization|Lost to Follow-up|0
3076653|NCT00433966|10562482|P1|Stent Intervention/Randomization|Lost to Follow-up|0
3076654|NCT00433966|10562479|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
3076655|NCT00433966|10562480|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
3076656|NCT00433966|10562481|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
3076657|NCT00433966|10562482|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
3076658|NCT00433966|10562479|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
3076659|NCT00433966|10562480|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
3076660|NCT00433966|10562481|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
3076661|NCT00433966|10562482|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
3076662|NCT00433966|10562479|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
3076663|NCT00433966|10562480|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
3076664|NCT00433966|10562481|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
3076665|NCT00433966|10562482|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
3076666|NCT00433966|10562479|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
3076667|NCT00433966|10562480|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
3076668|NCT00433966|10562481|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
3076669|NCT00433966|10562482|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
3076670|NCT00433914|10562504|P2|Overall Study|Lost to Follow-up|1
3076671|NCT00433914|10562505|P1|Overall Study|Lost to Follow-up|0
3076672|NCT00433914|10562504|P2|Overall Study|Withdrawal by Subject|2
3076673|NCT00433914|10562505|P1|Overall Study|Withdrawal by Subject|0
3076674|NCT00433836|10562525|P2|Overall Study|Abnormal laboratory values|1
3076675|NCT00433836|10562526|P1|Overall Study|Abnormal laboratory values|0
3076676|NCT00433836|10562525|P2|Overall Study|Condition no longer requires study drug|1
3076677|NCT00433836|10562526|P1|Overall Study|Condition no longer requires study drug|0
3076678|NCT00433836|10562525|P2|Overall Study|Protocol Violation|2
3076679|NCT00433836|10562526|P1|Overall Study|Protocol Violation|0
3076680|NCT00433836|10562525|P2|Overall Study|Unsatisfactory therapeutic effect|1
3076681|NCT00433836|10562526|P1|Overall Study|Unsatisfactory therapeutic effect|1
3076682|NCT00433836|10562525|P2|Overall Study|Withdrawal by Subject|1
3076683|NCT00433836|10562526|P1|Overall Study|Withdrawal by Subject|2
3076684|NCT00433836|10562525|P2|Overall Study|Lost to Follow-up|0
3076685|NCT00433836|10562526|P1|Overall Study|Lost to Follow-up|3
3076686|NCT00433836|10562525|P2|Overall Study|Adverse Event|0
3076687|NCT00433836|10562526|P1|Overall Study|Adverse Event|7
3076688|NCT00433771|10562538|P1|Overall Study|Failure to deploy stent|1
3076689|NCT00433771|10562538|P1|Overall Study|Death|2
3076690|NCT00433771|10562538|P1|Overall Study|Treated and later found to be ineligible|2
3076691|NCT00433771|10562538|P1|Overall Study|screen fail|14
3076692|NCT00433654|10562561|P2|Overall Study|Withdrawal by Subject|2
3076693|NCT00433654|10562562|P1|Overall Study|Withdrawal by Subject|1
3076694|NCT00433654|10562561|P2|Overall Study|Subject not yet due for visit|0
3076695|NCT00433654|10562562|P1|Overall Study|Subject not yet due for visit|4
3076696|NCT00433654|10562561|P2|Overall Study|Missed visit|3
3076697|NCT00433654|10562562|P1|Overall Study|Missed visit|6
3076698|NCT00433654|10562561|P2|Overall Study|Death|0
3076699|NCT00433654|10562562|P1|Overall Study|Death|4
3076700|NCT00433537|10562608|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
3076701|NCT00433537|10562609|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
3076702|NCT00433537|10562610|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
3076703|NCT00433537|10562608|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
3076704|NCT00433537|10562609|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
3076705|NCT00433537|10562610|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
3076706|NCT00433537|10562608|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
3076707|NCT00433537|10562609|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
3076708|NCT00433537|10562610|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
3076709|NCT00433537|10562608|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
3076710|NCT00433537|10562609|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
3076711|NCT00433537|10562610|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
3076712|NCT00433537|10562608|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
3076713|NCT00433537|10562609|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
3076714|NCT00433537|10562610|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
3076715|NCT00433537|10562608|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
3076716|NCT00433537|10562609|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
3076717|NCT00433537|10562610|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
3076718|NCT00433537|10562608|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
3076719|NCT00433537|10562609|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
3076720|NCT00433537|10562610|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
3076721|NCT00433537|10562608|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
3076722|NCT00433537|10562609|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
3076723|NCT00433537|10562610|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
3076724|NCT00433537|10562608|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
3076725|NCT00433537|10562609|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
3076726|NCT00433537|10562610|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
3076727|NCT00433511|10562622|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
3076728|NCT00433511|10562623|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
3076729|NCT00433511|10562624|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
3076730|NCT00433511|10562622|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
3076731|NCT00433511|10562623|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
3076732|NCT00433511|10562624|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
3076733|NCT00433511|10562622|P3|Step 2 (Arm D)|Suspected recurrence|1
3076734|NCT00433511|10562623|P2|Step 2 (Arm D)|Suspected recurrence|0
3076735|NCT00433511|10562624|P1|Step 2 (Arm D)|Suspected recurrence|0
3076736|NCT00433511|10562622|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
3076737|NCT00433511|10562623|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
3076738|NCT00433511|10562624|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
3076739|NCT00433511|10562622|P3|Step 2 (Arm D)|Other complicating disease|3
3076740|NCT00433511|10562623|P2|Step 2 (Arm D)|Other complicating disease|0
3076741|NCT00433511|10562624|P1|Step 2 (Arm D)|Other complicating disease|0
3076742|NCT00433511|10562622|P3|Step 2 (Arm D)|Disease progression, relapse|7
3076743|NCT00433511|10562623|P2|Step 2 (Arm D)|Disease progression, relapse|0
3076744|NCT00433511|10562624|P1|Step 2 (Arm D)|Disease progression, relapse|0
3076745|NCT00433511|10562622|P3|Step 2 (Arm D)|Physician Decision|9
3076746|NCT00433511|10562623|P2|Step 2 (Arm D)|Physician Decision|0
3076747|NCT00433511|10562624|P1|Step 2 (Arm D)|Physician Decision|0
3076748|NCT00433511|10562622|P3|Step 2 (Arm D)|Never started protocol therapy|148
3076749|NCT00433511|10562623|P2|Step 2 (Arm D)|Never started protocol therapy|0
3076750|NCT00433511|10562624|P1|Step 2 (Arm D)|Never started protocol therapy|0
3076751|NCT00433511|10562622|P3|Step 2 (Arm D)|Withdrawal by Subject|181
3076752|NCT00433511|10562623|P2|Step 2 (Arm D)|Withdrawal by Subject|0
3076753|NCT00433511|10562624|P1|Step 2 (Arm D)|Withdrawal by Subject|0
3076754|NCT00433511|10562622|P3|Step 2 (Arm D)|Adverse Event|135
3076755|NCT00433511|10562623|P2|Step 2 (Arm D)|Adverse Event|0
3076756|NCT00433511|10562624|P1|Step 2 (Arm D)|Adverse Event|0
3076757|NCT00433511|10562622|P3|Step 1|Patient moved|1
3076758|NCT00433511|10562623|P2|Step 1|Patient moved|0
3076759|NCT00433511|10562624|P1|Step 1|Patient moved|0
3076760|NCT00433511|10562622|P3|Step 1|Insurance/drug distribution issues|2
3076761|NCT00433511|10562623|P2|Step 1|Insurance/drug distribution issues|1
3076762|NCT00433511|10562624|P1|Step 1|Insurance/drug distribution issues|0
3076763|NCT00433511|10562622|P3|Step 1|Suspected recurrence|0
3076764|NCT00433511|10562623|P2|Step 1|Suspected recurrence|1
3076765|NCT00433511|10562624|P1|Step 1|Suspected recurrence|0
3076766|NCT00433511|10562622|P3|Step 1|Non-breast cancer surgery/wound issues|1
3076767|NCT00433511|10562623|P2|Step 1|Non-breast cancer surgery/wound issues|4
3076768|NCT00433511|10562624|P1|Step 1|Non-breast cancer surgery/wound issues|0
3076769|NCT00433511|10562622|P3|Step 1|Other complicating disease|3
3076770|NCT00433511|10562623|P2|Step 1|Other complicating disease|6
3076771|NCT00433511|10562624|P1|Step 1|Other complicating disease|2
3076772|NCT00433511|10562622|P3|Step 1|Disease progression, relapse|3
3076773|NCT00433511|10562623|P2|Step 1|Disease progression, relapse|3
3076774|NCT00433511|10562624|P1|Step 1|Disease progression, relapse|5
3076775|NCT00433511|10562622|P3|Step 1|Alternative therapy|3
3076776|NCT00433511|10562623|P2|Step 1|Alternative therapy|1
3076777|NCT00433511|10562624|P1|Step 1|Alternative therapy|2
3076778|NCT00433511|10562622|P3|Step 1|Never started protocol therapy|66
3076779|NCT00433511|10562623|P2|Step 1|Never started protocol therapy|64
3076780|NCT00433511|10562624|P1|Step 1|Never started protocol therapy|28
3076781|NCT00433511|10562622|P3|Step 1|Physician Decision|3
3076782|NCT00433511|10562623|P2|Step 1|Physician Decision|4
3076783|NCT00433511|10562624|P1|Step 1|Physician Decision|1
3076784|NCT00433511|10562622|P3|Step 1|Death|1
3076785|NCT00433511|10562623|P2|Step 1|Death|1
3076786|NCT00433511|10562624|P1|Step 1|Death|3
3076787|NCT00433511|10562622|P3|Step 1|Withdrawal by Subject|154
3076788|NCT00433511|10562623|P2|Step 1|Withdrawal by Subject|143
3076789|NCT00433511|10562624|P1|Step 1|Withdrawal by Subject|45
3076790|NCT00433511|10562622|P3|Step 1|Adverse Event|153
3076791|NCT00433511|10562623|P2|Step 1|Adverse Event|157
3076792|NCT00433511|10562624|P1|Step 1|Adverse Event|50
3076793|NCT00433446|10562638|P1|Overall Study|Ineligible|9
3076794|NCT00433446|10562638|P1|Overall Study|Other - Not Protocol specified|3
3076795|NCT00433446|10562638|P1|Overall Study|Progression|44
3076796|NCT00433446|10562638|P1|Overall Study|Refusal Unrelated to Adverse Event|1
3076797|NCT00433446|10562638|P1|Overall Study|Adverse Event|4
3076798|NCT00433381|10562648|P2|Overall Study|Ineligible / no protocol treatment|3
3076799|NCT00433381|10562649|P1|Overall Study|Ineligible / no protocol treatment|3
3076800|NCT00433329|10562668|P1|Overall Study|Physician Decision|1
3076801|NCT00433329|10562668|P1|Overall Study|Lost to Follow-up|1
3076802|NCT00433329|10562668|P1|Overall Study|Moved out of state|1
3076803|NCT00433329|10562668|P1|Overall Study|Discontinued sildenafil|2
3076804|NCT00433329|10562668|P1|Overall Study|Withdrew consent|3
3076805|NCT00433329|10562668|P1|Overall Study|Death|4
3076806|NCT00433329|10562668|P1|Overall Study|Adverse Event|9
3076807|NCT00433290|10562674|P2|Overall Study|Lost to Follow-up|0
3076808|NCT00433290|10562675|P1|Overall Study|Lost to Follow-up|1
3076809|NCT00433290|10562674|P2|Overall Study|Entry Criteria Not Met|1
3076810|NCT00433290|10562675|P1|Overall Study|Entry Criteria Not Met|0
3076811|NCT00433290|10562674|P2|Overall Study|Physician Decision|0
3076812|NCT00433290|10562675|P1|Overall Study|Physician Decision|2
3076813|NCT00433290|10562674|P2|Overall Study|Protocol Violation|2
3076814|NCT00433290|10562675|P1|Overall Study|Protocol Violation|3
3076815|NCT00433290|10562674|P2|Overall Study|Withdrawal by Subject|2
3076816|NCT00433290|10562675|P1|Overall Study|Withdrawal by Subject|4
3076817|NCT00433290|10562674|P2|Overall Study|Lack of Efficacy|5
3076818|NCT00433290|10562675|P1|Overall Study|Lack of Efficacy|1
3076819|NCT00433290|10562674|P2|Overall Study|Adverse Event|7
3076820|NCT00433290|10562675|P1|Overall Study|Adverse Event|24
3076821|NCT00433199|10562744|P2|Open-Label Period|Administrative|1
3076822|NCT00433199|10562745|P1|Open-Label Period|Administrative|0
3076823|NCT00433199|10562744|P2|Open-Label Period|Protocol Violation|2
3076824|NCT00433199|10562745|P1|Open-Label Period|Protocol Violation|0
3076825|NCT00433199|10562744|P2|Open-Label Period|Withdrawal by Subject|7
3076826|NCT00433199|10562745|P1|Open-Label Period|Withdrawal by Subject|0
3076827|NCT00433199|10562744|P2|Open-Label Period|Lost to Follow-up|3
3076828|NCT00433199|10562745|P1|Open-Label Period|Lost to Follow-up|0
3076829|NCT00433199|10562744|P2|Open-Label Period|Lack of Efficacy|2
3076830|NCT00433199|10562745|P1|Open-Label Period|Lack of Efficacy|0
3076831|NCT00433199|10562744|P2|Open-Label Period|Adverse Event|19
3076832|NCT00433199|10562745|P1|Open-Label Period|Adverse Event|0
3076833|NCT00433199|10562744|P2|Double-Blind Period|Administrative|5
3076834|NCT00433199|10562745|P1|Double-Blind Period|Administrative|1
3076835|NCT00433199|10562744|P2|Double-Blind Period|Protocol Violation|10
3076836|NCT00433199|10562745|P1|Double-Blind Period|Protocol Violation|1
3076837|NCT00433199|10562744|P2|Double-Blind Period|Withdrawal by Subject|19
3076838|NCT00433199|10562745|P1|Double-Blind Period|Withdrawal by Subject|8
3076839|NCT00433199|10562744|P2|Double-Blind Period|Lost to Follow-up|5
3076840|NCT00433199|10562745|P1|Double-Blind Period|Lost to Follow-up|2
3076841|NCT00433199|10562744|P2|Double-Blind Period|Lack of Efficacy|2
3076842|NCT00433199|10562745|P1|Double-Blind Period|Lack of Efficacy|0
3076843|NCT00433199|10562744|P2|Double-Blind Period|Adverse Event|25
3076844|NCT00433199|10562745|P1|Double-Blind Period|Adverse Event|0
3076845|NCT00433160|10562765|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
3076846|NCT00433160|10562766|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
3076847|NCT00433160|10562765|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
3076848|NCT00433160|10562766|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
3076849|NCT00433160|10562765|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
3076850|NCT00433160|10562766|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
3076851|NCT00433160|10562765|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
3076852|NCT00433160|10562766|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
3076853|NCT00433160|10562765|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
3076854|NCT00433160|10562766|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
3076855|NCT00433160|10562765|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
3076856|NCT00433160|10562766|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
3076857|NCT00433160|10562765|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
3076858|NCT00433160|10562766|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
3076859|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
3076860|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
3076861|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
3076862|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
3076863|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
3076864|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
3076865|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
3076866|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
3076867|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
3076868|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
3076869|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
3076870|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
3076871|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
3076872|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
3076873|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Death|0
3076874|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Death|0
3076875|NCT00433160|10562765|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
3076876|NCT00433160|10562766|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
3076877|NCT00433147|10562818|P4|Overall Study|Adverse Event|0
3076878|NCT00433147|10562819|P3|Overall Study|Adverse Event|0
3076879|NCT00433147|10562820|P2|Overall Study|Adverse Event|1
3076880|NCT00433147|10562821|P1|Overall Study|Adverse Event|0
3076881|NCT00433017|10562837|P2|Overall Study|Subject no longer requires study drug|1
3076882|NCT00433017|10562838|P1|Overall Study|Subject no longer requires study drug|1
3076883|NCT00433017|10562837|P2|Overall Study|Death|2
3076884|NCT00433017|10562838|P1|Overall Study|Death|2
3076885|NCT00433017|10562837|P2|Overall Study|Protocol Violation|0
3076886|NCT00433017|10562838|P1|Overall Study|Protocol Violation|1
3076887|NCT00433017|10562837|P2|Overall Study|Administrative problems|86
3076888|NCT00433017|10562838|P1|Overall Study|Administrative problems|80
3076889|NCT00433017|10562837|P2|Overall Study|Lost to Follow-up|4
3076890|NCT00433017|10562838|P1|Overall Study|Lost to Follow-up|3
3076891|NCT00433017|10562837|P2|Overall Study|Withdrawal by Subject|5
3076892|NCT00433017|10562838|P1|Overall Study|Withdrawal by Subject|4
3076893|NCT00433017|10562837|P2|Overall Study|Adverse Event|3
3076894|NCT00433017|10562838|P1|Overall Study|Adverse Event|5
3076895|NCT00433004|10562854|P2|Overall Study|Lost to Follow-up|7
3076896|NCT00433004|10562855|P1|Overall Study|Lost to Follow-up|5
3076897|NCT00432991|10562867|P2|Overall Study|Protocol Violation|12
3076898|NCT00432991|10562868|P1|Overall Study|Protocol Violation|7
3076899|NCT00432965|10562880|P2|Overall Study|Incomplete Data|3
3076900|NCT00432965|10562881|P1|Overall Study|Incomplete Data|4
3076901|NCT00432965|10562880|P2|Overall Study|Exclusionary Methods|2
3076902|NCT00432965|10562881|P1|Overall Study|Exclusionary Methods|1
3076903|NCT00432965|10562880|P2|Overall Study|Death|4
3076904|NCT00432965|10562881|P1|Overall Study|Death|3
3076905|NCT00432965|10562880|P2|Overall Study|Adverse Event|19
3076906|NCT00432965|10562881|P1|Overall Study|Adverse Event|22
3076907|NCT00432965|10562880|P2|Overall Study|Non-compliance|0
3076908|NCT00432965|10562881|P1|Overall Study|Non-compliance|7
3076909|NCT00432965|10562880|P2|Overall Study|Lack of Efficacy|13
3076910|NCT00432965|10562881|P1|Overall Study|Lack of Efficacy|8
3076911|NCT00432965|10562880|P2|Overall Study|Physician Decision|13
3076912|NCT00432965|10562881|P1|Overall Study|Physician Decision|14
3076913|NCT00432965|10562880|P2|Overall Study|Withdrawal by Subject|13
3076914|NCT00432965|10562881|P1|Overall Study|Withdrawal by Subject|13
3076915|NCT00432965|10562880|P2|Overall Study|Lost to Follow-up|19
3076916|NCT00432965|10562881|P1|Overall Study|Lost to Follow-up|22
3076917|NCT00432835|10562889|P2|Overall Study|Adverse event: lead dislodgement.|7
3076918|NCT00432835|10562890|P1|Overall Study|Adverse event: lead dislodgement.|6
3076919|NCT00432809|10562903|P3|1 Year Follow-up|Withdrawal by Subject|1
3076920|NCT00432809|10562904|P2|1 Year Follow-up|Withdrawal by Subject|0
3076921|NCT00432809|10562905|P1|1 Year Follow-up|Withdrawal by Subject|7
3076922|NCT00432809|10562903|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
3076923|NCT00432809|10562904|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
3076924|NCT00432809|10562905|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
3076925|NCT00432744|10562978|P2|Months 7 - 12|Too disabled to score|1
3076926|NCT00432744|10562979|P1|Months 7 - 12|Too disabled to score|0
3076927|NCT00432744|10562978|P2|Months 7 - 12|Withdrawal by Subject|0
3076928|NCT00432744|10562979|P1|Months 7 - 12|Withdrawal by Subject|1
3076929|NCT00432744|10562978|P2|Months 0-6|Too disabled to score|0
3076930|NCT00432744|10562979|P1|Months 0-6|Too disabled to score|1
3076931|NCT00432744|10562978|P2|Months 0-6|Withdrawal by Subject|4
3076932|NCT00432744|10562979|P1|Months 0-6|Withdrawal by Subject|4
3076933|NCT00432679|10562991|P2|Overall Study|Withdrawal by Subject|2
3076934|NCT00432679|10562992|P1|Overall Study|Withdrawal by Subject|3
3076935|NCT00432679|10562991|P2|Overall Study|Adverse Event|1
3076936|NCT00432679|10562992|P1|Overall Study|Adverse Event|2
3076937|NCT00432666|10563016|P2|Open-Label Extension Period|Physician Decision|0
3076938|NCT00432666|10563017|P1|Open-Label Extension Period|Physician Decision|3
3076939|NCT00432666|10563016|P2|Open-Label Extension Period|Consent withdrawn|0
3076940|NCT00432666|10563017|P1|Open-Label Extension Period|Consent withdrawn|10
3076941|NCT00432666|10563016|P2|Open-Label Extension Period|Adverse Event|0
3076942|NCT00432666|10563017|P1|Open-Label Extension Period|Adverse Event|5
3076943|NCT00432666|10563016|P2|Open-Label Extension Period|Lack of Efficacy|0
3076944|NCT00432666|10563017|P1|Open-Label Extension Period|Lack of Efficacy|6
3076945|NCT00432666|10563016|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
3076946|NCT00432666|10563017|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
3076947|NCT00432666|10563016|P2|Main Period|Consent Withdrawn|0
3076948|NCT00432666|10563017|P1|Main Period|Consent Withdrawn|1
3076949|NCT00432666|10563016|P2|Main Period|Adverse Event|1
3076950|NCT00432666|10563017|P1|Main Period|Adverse Event|1
3076951|NCT00432562|10563190|P2|Overall Study|Death|0
3076952|NCT00432562|10563191|P1|Overall Study|Death|3
3076953|NCT00432380|10563243|P3|Overall Study|Adverse Event|0
3076954|NCT00432380|10563244|P2|Overall Study|Adverse Event|0
3076955|NCT00432380|10563245|P1|Overall Study|Adverse Event|1
3076956|NCT00432380|10563243|P3|Overall Study|Migrated/moved from study area|1
3076957|NCT00432380|10563244|P2|Overall Study|Migrated/moved from study area|4
3076958|NCT00432380|10563245|P1|Overall Study|Migrated/moved from study area|3
3076959|NCT00432276|10563298|P2|Overall Study|Other|3
3076960|NCT00432276|10563299|P1|Overall Study|Other|2
3076961|NCT00432276|10563298|P2|Overall Study|Physician Decision|8
3076962|NCT00432276|10563299|P1|Overall Study|Physician Decision|6
3076963|NCT00432276|10563298|P2|Overall Study|Withdrawal by Subject|20
3076964|NCT00432276|10563299|P1|Overall Study|Withdrawal by Subject|25
3076965|NCT00432276|10563298|P2|Overall Study|Lost to Follow-up|2
3076966|NCT00432276|10563299|P1|Overall Study|Lost to Follow-up|6
3076967|NCT00432276|10563298|P2|Overall Study|Protocol Violation|20
3076968|NCT00432276|10563299|P1|Overall Study|Protocol Violation|25
3076969|NCT00432276|10563298|P2|Overall Study|Adverse Event|16
3076970|NCT00432276|10563299|P1|Overall Study|Adverse Event|13
3076971|NCT00432276|10563298|P2|Overall Study|Hyperglycemic Rescue|87
3076972|NCT00432276|10563299|P1|Overall Study|Hyperglycemic Rescue|44
3076973|NCT00432237|10563389|P4|Overall Study|Lack of Qualifying Event|84
3076974|NCT00432237|10563390|P3|Overall Study|Lack of Qualifying Event|69
3076975|NCT00432237|10563391|P2|Overall Study|Lack of Qualifying Event|71
3076976|NCT00432237|10563392|P1|Overall Study|Lack of Qualifying Event|38
3076977|NCT00432237|10563389|P4|Overall Study|Withdrawal by Subject|11
3076978|NCT00432237|10563390|P3|Overall Study|Withdrawal by Subject|9
3076979|NCT00432237|10563391|P2|Overall Study|Withdrawal by Subject|6
3076980|NCT00432237|10563392|P1|Overall Study|Withdrawal by Subject|5
3076981|NCT00432237|10563389|P4|Overall Study|Protocol Violation|8
3076982|NCT00432237|10563390|P3|Overall Study|Protocol Violation|11
3076983|NCT00432237|10563391|P2|Overall Study|Protocol Violation|10
3076984|NCT00432237|10563392|P1|Overall Study|Protocol Violation|13
3076985|NCT00432237|10563389|P4|Overall Study|Pregnancy|0
3076986|NCT00432237|10563390|P3|Overall Study|Pregnancy|0
3076987|NCT00432237|10563391|P2|Overall Study|Pregnancy|1
3076988|NCT00432237|10563392|P1|Overall Study|Pregnancy|0
3076989|NCT00432237|10563389|P4|Overall Study|Physician Decision|1
3076990|NCT00432237|10563390|P3|Overall Study|Physician Decision|2
3076991|NCT00432237|10563391|P2|Overall Study|Physician Decision|3
3076992|NCT00432237|10563392|P1|Overall Study|Physician Decision|1
3076993|NCT00432237|10563389|P4|Overall Study|Lost to Follow-up|18
3076994|NCT00432237|10563390|P3|Overall Study|Lost to Follow-up|18
3076995|NCT00432237|10563391|P2|Overall Study|Lost to Follow-up|10
3076996|NCT00432237|10563392|P1|Overall Study|Lost to Follow-up|10
3076997|NCT00432237|10563389|P4|Overall Study|Lack of Efficacy|1
3076998|NCT00432237|10563390|P3|Overall Study|Lack of Efficacy|0
3076999|NCT00432237|10563391|P2|Overall Study|Lack of Efficacy|0
3077000|NCT00432237|10563392|P1|Overall Study|Lack of Efficacy|0
3077001|NCT00432237|10563389|P4|Overall Study|Adverse Event|1
3077002|NCT00432237|10563390|P3|Overall Study|Adverse Event|0
3077003|NCT00432237|10563391|P2|Overall Study|Adverse Event|0
3077004|NCT00432237|10563392|P1|Overall Study|Adverse Event|0
3077005|NCT00432172|10563434|P4|Overall Study|No treatment received|1
3077006|NCT00432172|10563435|P3|Overall Study|No treatment received|0
3077007|NCT00432172|10563436|P2|Overall Study|No treatment received|2
3077008|NCT00432172|10563437|P1|Overall Study|No treatment received|2
3077009|NCT00432172|10563434|P4|Overall Study|Withdrawal by Subject|2
3077010|NCT00432172|10563435|P3|Overall Study|Withdrawal by Subject|0
3077011|NCT00432172|10563436|P2|Overall Study|Withdrawal by Subject|1
3077012|NCT00432172|10563437|P1|Overall Study|Withdrawal by Subject|0
3077013|NCT00432172|10563434|P4|Overall Study|Disease progression|1
3077014|NCT00432172|10563435|P3|Overall Study|Disease progression|5
3077015|NCT00432172|10563436|P2|Overall Study|Disease progression|2
3077016|NCT00432172|10563437|P1|Overall Study|Disease progression|0
3077017|NCT00432172|10563434|P4|Overall Study|Adverse Event|3
3077018|NCT00432172|10563435|P3|Overall Study|Adverse Event|4
3077019|NCT00432172|10563436|P2|Overall Study|Adverse Event|2
3077020|NCT00432172|10563437|P1|Overall Study|Adverse Event|4
3077021|NCT00432172|10563434|P4|Overall Study|Physician Decision|0
3077022|NCT00432172|10563435|P3|Overall Study|Physician Decision|2
3077023|NCT00432172|10563436|P2|Overall Study|Physician Decision|0
3077024|NCT00432172|10563437|P1|Overall Study|Physician Decision|0
3077025|NCT00432159|10563462|P5|Overall Study|Missing NDI and/or neuro. assessment|7
3077026|NCT00432159|10563463|P4|Overall Study|Missing NDI and/or neuro. assessment|3
3077027|NCT00432159|10563464|P3|Overall Study|Missing NDI and/or neuro. assessment|1
3077028|NCT00432159|10563465|P2|Overall Study|Missing NDI and/or neuro. assessment|24
3077029|NCT00432159|10563466|P1|Overall Study|Missing NDI and/or neuro. assessment|13
3077030|NCT00432159|10563462|P5|Overall Study|Failure|3
3077031|NCT00432159|10563463|P4|Overall Study|Failure|2
3077032|NCT00432159|10563464|P3|Overall Study|Failure|3
3077033|NCT00432159|10563465|P2|Overall Study|Failure|5
3077034|NCT00432159|10563466|P1|Overall Study|Failure|9
3077035|NCT00432159|10563462|P5|Overall Study|Death|0
3077036|NCT00432159|10563463|P4|Overall Study|Death|0
3077037|NCT00432159|10563464|P3|Overall Study|Death|0
3077038|NCT00432159|10563465|P2|Overall Study|Death|1
3077039|NCT00432159|10563466|P1|Overall Study|Death|0
3077040|NCT00432042|10563573|P3|Overall Study|Lost to Follow-up|0
3077041|NCT00432042|10563574|P2|Overall Study|Lost to Follow-up|1
3077042|NCT00432042|10563575|P1|Overall Study|Lost to Follow-up|5
3077043|NCT00432042|10563573|P3|Overall Study|Withdrawal by Subject|2
3077044|NCT00432042|10563574|P2|Overall Study|Withdrawal by Subject|0
3077045|NCT00432042|10563575|P1|Overall Study|Withdrawal by Subject|0
3077046|NCT00432042|10563573|P3|Overall Study|Protocol Violation|0
3077047|NCT00432042|10563574|P2|Overall Study|Protocol Violation|0
3077048|NCT00432042|10563575|P1|Overall Study|Protocol Violation|2
3077049|NCT00431964|10563588|P2|Overall Study|Due to Unstable Health|1
3077050|NCT00431964|10563589|P1|Overall Study|Due to Unstable Health|0
3077051|NCT00431964|10563588|P2|Overall Study|Parental Consent Withdrawn|2
3077052|NCT00431964|10563589|P1|Overall Study|Parental Consent Withdrawn|0
3077053|NCT00431964|10563588|P2|Overall Study|Withdrawal by Subject|1
3077054|NCT00431964|10563589|P1|Overall Study|Withdrawal by Subject|2
3077055|NCT00431964|10563588|P2|Overall Study|Physician Decision|2
3077056|NCT00431964|10563589|P1|Overall Study|Physician Decision|2
3077057|NCT00431964|10563588|P2|Overall Study|Lost to Follow-up|2
3077058|NCT00431964|10563589|P1|Overall Study|Lost to Follow-up|1
3077059|NCT00431964|10563588|P2|Overall Study|Adverse Event|0
3077060|NCT00431964|10563589|P1|Overall Study|Adverse Event|1
3077061|NCT00431951|10563599|P4|Overall Study|Adverse Event|0
3077062|NCT00431951|10563600|P3|Overall Study|Adverse Event|1
3077063|NCT00431951|10563601|P2|Overall Study|Adverse Event|0
3077064|NCT00431951|10563602|P1|Overall Study|Adverse Event|0
3077065|NCT00431951|10563599|P4|Overall Study|Withdrawal by Subject|0
3077066|NCT00431951|10563600|P3|Overall Study|Withdrawal by Subject|0
3077067|NCT00431951|10563601|P2|Overall Study|Withdrawal by Subject|1
3077068|NCT00431951|10563602|P1|Overall Study|Withdrawal by Subject|0
3077069|NCT00431951|10563599|P4|Overall Study|Lost to Follow-up|0
3077070|NCT00431951|10563600|P3|Overall Study|Lost to Follow-up|0
3077071|NCT00431951|10563601|P2|Overall Study|Lost to Follow-up|1
3077072|NCT00431951|10563602|P1|Overall Study|Lost to Follow-up|0
3077073|NCT00431951|10563599|P4|Overall Study|Inability to follow study procedures|2
3077074|NCT00431951|10563600|P3|Overall Study|Inability to follow study procedures|1
3077075|NCT00431951|10563601|P2|Overall Study|Inability to follow study procedures|0
3077076|NCT00431951|10563602|P1|Overall Study|Inability to follow study procedures|1
3077077|NCT00431847|10563664|P5|Overall Study|Protocol Violation|1
3077078|NCT00431847|10563665|P4|Overall Study|Protocol Violation|0
3077079|NCT00431847|10563666|P3|Overall Study|Protocol Violation|0
3077080|NCT00431847|10563667|P2|Overall Study|Protocol Violation|0
3077081|NCT00431847|10563668|P1|Overall Study|Protocol Violation|0
3077082|NCT00431847|10563664|P5|Overall Study|completion of less than two study visits|0
3077083|NCT00431847|10563665|P4|Overall Study|completion of less than two study visits|14
3077084|NCT00431847|10563666|P3|Overall Study|completion of less than two study visits|4
3077085|NCT00431847|10563667|P2|Overall Study|completion of less than two study visits|3
3077086|NCT00431847|10563668|P1|Overall Study|completion of less than two study visits|6
3077087|NCT00431834|10563742|P1|Overall Study|Lost to Follow-up|1
3077088|NCT00431834|10563742|P1|Overall Study|Missed Endpoint Visit|2
3077089|NCT00431834|10563742|P1|Overall Study|Death|3
3077090|NCT00431834|10563742|P1|Overall Study|Withdrawal by Subject|7
3077091|NCT00431496|10563758|P1|Overall Study|Protocol-specified criteria|5
3077092|NCT00431496|10563758|P1|Overall Study|Withdrawal by Subject|2
3077093|NCT00431496|10563758|P1|Overall Study|Lost to Follow-up|1
3077094|NCT00431496|10563758|P1|Overall Study|Adverse Event|3
3077095|NCT00431444|10563769|P2|Overall Study|Administrative Problems|1
3077096|NCT00431444|10563770|P1|Overall Study|Administrative Problems|0
3077097|NCT00431444|10563769|P2|Overall Study|Lost to Follow-up|0
3077098|NCT00431444|10563770|P1|Overall Study|Lost to Follow-up|1
3077099|NCT00431444|10563769|P2|Overall Study|Withdrawal by Subject|1
3077100|NCT00431444|10563770|P1|Overall Study|Withdrawal by Subject|1
3077101|NCT00431444|10563769|P2|Overall Study|Adverse Event|1
3077102|NCT00431444|10563770|P1|Overall Study|Adverse Event|2
3077103|NCT00431444|10563769|P2|Overall Study|Protocol Violation|4
3077104|NCT00431444|10563770|P1|Overall Study|Protocol Violation|1
3077105|NCT00431067|10563810|P1|Overall Study|Non-compliance,lost to follow-up|2
3077106|NCT00431067|10563810|P1|Overall Study|Progressive disease|30
3077107|NCT00431067|10563810|P1|Overall Study|Other Adverse Event|9
3077108|NCT00430989|10563835|P2|Overall Study|Not eligible|6
3077109|NCT00430989|10563836|P1|Overall Study|Not eligible|13
3077110|NCT00430989|10563835|P2|Overall Study|Protocol Violation|37
3077111|NCT00430989|10563836|P1|Overall Study|Protocol Violation|30
3077112|NCT00430989|10563835|P2|Overall Study|Withdrawal by Subject|14
3077113|NCT00430989|10563836|P1|Overall Study|Withdrawal by Subject|15
3077114|NCT00430989|10563835|P2|Overall Study|Lost to Follow-up|3
3077115|NCT00430989|10563836|P1|Overall Study|Lost to Follow-up|2
3077116|NCT00430950|10563856|P2|Overall Study|concomitant medication,etc.|7
3077117|NCT00430950|10563857|P1|Overall Study|concomitant medication,etc.|5
3077118|NCT00430950|10563856|P2|Overall Study|Withdrawal by Subject|0
3077119|NCT00430950|10563857|P1|Overall Study|Withdrawal by Subject|1
3077120|NCT00430950|10563856|P2|Overall Study|Adverse Event|6
3077121|NCT00430950|10563857|P1|Overall Study|Adverse Event|7
3077122|NCT00430937|10563871|P2|Overall Study|Unable to classify|1
3077123|NCT00430937|10563872|P1|Overall Study|Unable to classify|0
3077124|NCT00430937|10563871|P2|Overall Study|Protocol discontinuation criteria met|2
3077125|NCT00430937|10563872|P1|Overall Study|Protocol discontinuation criteria met|1
3077126|NCT00430937|10563871|P2|Overall Study|Administrative reasons|0
3077127|NCT00430937|10563872|P1|Overall Study|Administrative reasons|1
3077128|NCT00430937|10563871|P2|Overall Study|Inappropriate enrollment|1
3077129|NCT00430937|10563872|P1|Overall Study|Inappropriate enrollment|2
3077130|NCT00430937|10563871|P2|Overall Study|Lack of Efficacy|5
3077131|NCT00430937|10563872|P1|Overall Study|Lack of Efficacy|6
3077132|NCT00430937|10563871|P2|Overall Study|Protocol Violation|2
3077133|NCT00430937|10563872|P1|Overall Study|Protocol Violation|3
3077134|NCT00430937|10563871|P2|Overall Study|Withdrawal by Subject|2
3077135|NCT00430937|10563872|P1|Overall Study|Withdrawal by Subject|5
3077136|NCT00430937|10563871|P2|Overall Study|Lost to Follow-up|6
3077137|NCT00430937|10563872|P1|Overall Study|Lost to Follow-up|6
3077138|NCT00430937|10563871|P2|Overall Study|Death|1
3077139|NCT00430937|10563872|P1|Overall Study|Death|0
3077140|NCT00430937|10563871|P2|Overall Study|Adverse Event|8
3077141|NCT00430937|10563872|P1|Overall Study|Adverse Event|3
3077142|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Other|0
3077143|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Other|1
3077144|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Other|4
3077145|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
3077146|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
3077147|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
3077148|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
3077149|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
3077150|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
3077151|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
3077152|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
3077153|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
3077154|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
3077155|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
3077156|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
3077157|NCT00430781|10563883|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
3077158|NCT00430781|10563884|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
3077159|NCT00430781|10563885|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
3077160|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Ongoing|32
3077161|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Ongoing|29
3077162|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Ongoing|0
3077163|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Other|0
3077164|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Other|1
3077165|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Other|0
3077166|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Physician Decision|6
3077167|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Physician Decision|6
3077168|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Physician Decision|0
3077169|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
3077170|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
3077171|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
3077172|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Protocol Violation|0
3077173|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Protocol Violation|1
3077174|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Protocol Violation|0
3077175|NCT00430781|10563883|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
3077176|NCT00430781|10563884|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
3077177|NCT00430781|10563885|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
3077178|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Ongoing|25
3077179|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Ongoing|20
3077180|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Ongoing|23
3077181|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Physician Decision|3
3077182|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Physician Decision|3
3077183|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Physician Decision|2
3077184|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
3077185|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
3077186|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
3077187|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Death|0
3077188|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Death|1
3077189|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Death|0
3077190|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Disease Progression|22
3077191|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Disease Progression|30
3077192|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Disease Progression|16
3077193|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
3077194|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
3077195|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
3077196|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
3077197|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
3077198|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
3077199|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
3077200|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
3077201|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
3077202|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
3077203|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
3077204|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
3077205|NCT00430781|10563883|P3|Interim Analysis; 11 February 2008|Adverse Event|7
3077206|NCT00430781|10563884|P2|Interim Analysis; 11 February 2008|Adverse Event|3
3077207|NCT00430781|10563885|P1|Interim Analysis; 11 February 2008|Adverse Event|10
3077208|NCT00430755|10563927|P1|Overall Study|Withdrawal by Subject|53
3077209|NCT00430716|10563934|P3|Open Label Phase|Study terminated by sponsor|4
3077210|NCT00430716|10563935|P2|Open Label Phase|Study terminated by sponsor|5
3077211|NCT00430716|10563936|P1|Open Label Phase|Study terminated by sponsor|4
3077212|NCT00430716|10563934|P3|Open Label Phase|Protocol Violation|0
3077213|NCT00430716|10563935|P2|Open Label Phase|Protocol Violation|0
3077214|NCT00430716|10563936|P1|Open Label Phase|Protocol Violation|1
3077215|NCT00430716|10563934|P3|Open Label Phase|Other|1
3077216|NCT00430716|10563935|P2|Open Label Phase|Other|1
3077217|NCT00430716|10563936|P1|Open Label Phase|Other|3
3077218|NCT00430716|10563934|P3|Open Label Phase|No longer willing to participate|1
3077219|NCT00430716|10563935|P2|Open Label Phase|No longer willing to participate|1
3077220|NCT00430716|10563936|P1|Open Label Phase|No longer willing to participate|0
3077221|NCT00430716|10563934|P3|Open Label Phase|Lost to Follow-up|1
3077222|NCT00430716|10563935|P2|Open Label Phase|Lost to Follow-up|0
3077223|NCT00430716|10563936|P1|Open Label Phase|Lost to Follow-up|1
3077224|NCT00430716|10563934|P3|Double Blind Phase|Not met eligibility criteria|0
3077225|NCT00430716|10563935|P2|Double Blind Phase|Not met eligibility criteria|0
3077226|NCT00430716|10563936|P1|Double Blind Phase|Not met eligibility criteria|1
3077227|NCT00430716|10563934|P3|Double Blind Phase|Adverse Event|3
3077228|NCT00430716|10563935|P2|Double Blind Phase|Adverse Event|1
3077229|NCT00430716|10563936|P1|Double Blind Phase|Adverse Event|1
3077230|NCT00430716|10563934|P3|Double Blind Phase|Study terminated by sponsor|2
3077231|NCT00430716|10563935|P2|Double Blind Phase|Study terminated by sponsor|1
3077232|NCT00430716|10563936|P1|Double Blind Phase|Study terminated by sponsor|1
3077233|NCT00430716|10563934|P3|Double Blind Phase|Other|0
3077234|NCT00430716|10563935|P2|Double Blind Phase|Other|2
3077235|NCT00430716|10563936|P1|Double Blind Phase|Other|0
3077236|NCT00430716|10563934|P3|Double Blind Phase|No longer willing to participate|1
3077237|NCT00430716|10563935|P2|Double Blind Phase|No longer willing to participate|1
3077238|NCT00430716|10563936|P1|Double Blind Phase|No longer willing to participate|2
3077239|NCT00430716|10563934|P3|Double Blind Phase|Death|0
3077240|NCT00430716|10563935|P2|Double Blind Phase|Death|0
3077241|NCT00430716|10563936|P1|Double Blind Phase|Death|1
3077242|NCT00430677|10563968|P3|Long-term Extension Period|Poor compliance/noncompliance|0
3077243|NCT00430677|10563969|P2|Long-term Extension Period|Poor compliance/noncompliance|0
3077244|NCT00430677|10563970|P1|Long-term Extension Period|Poor compliance/noncompliance|1
3077245|NCT00430677|10563968|P3|Long-term Extension Period|Other|1
3077246|NCT00430677|10563969|P2|Long-term Extension Period|Other|1
3077247|NCT00430677|10563970|P1|Long-term Extension Period|Other|2
3077248|NCT00430677|10563968|P3|Long-term Extension Period|Administrative reason by sponsor|46
3077249|NCT00430677|10563969|P2|Long-term Extension Period|Administrative reason by sponsor|49
3077250|NCT00430677|10563970|P1|Long-term Extension Period|Administrative reason by sponsor|41
3077251|NCT00430677|10563968|P3|Long-term Extension Period|Pregnancy|0
3077252|NCT00430677|10563969|P2|Long-term Extension Period|Pregnancy|1
3077253|NCT00430677|10563970|P1|Long-term Extension Period|Pregnancy|1
3077254|NCT00430677|10563968|P3|Long-term Extension Period|Withdrawal by Subject|2
3077255|NCT00430677|10563969|P2|Long-term Extension Period|Withdrawal by Subject|1
3077256|NCT00430677|10563970|P1|Long-term Extension Period|Withdrawal by Subject|5
3077257|NCT00430677|10563968|P3|Long-term Extension Period|Lost to Follow-up|1
3077258|NCT00430677|10563969|P2|Long-term Extension Period|Lost to Follow-up|1
3077259|NCT00430677|10563970|P1|Long-term Extension Period|Lost to Follow-up|1
3077260|NCT00430677|10563968|P3|Long-term Extension Period|Lack of Efficacy|8
3077261|NCT00430677|10563969|P2|Long-term Extension Period|Lack of Efficacy|3
3077262|NCT00430677|10563970|P1|Long-term Extension Period|Lack of Efficacy|5
3077263|NCT00430677|10563968|P3|Long-term Extension Period|Adverse Event|5
3077264|NCT00430677|10563969|P2|Long-term Extension Period|Adverse Event|2
3077265|NCT00430677|10563970|P1|Long-term Extension Period|Adverse Event|3
3077266|NCT00430677|10563968|P3|Long-term Extension Period|Death|0
3077267|NCT00430677|10563969|P2|Long-term Extension Period|Death|0
3077268|NCT00430677|10563970|P1|Long-term Extension Period|Death|1
3077269|NCT00430677|10563968|P3|Short-term Period|Pregnancy|0
3077270|NCT00430677|10563969|P2|Short-term Period|Pregnancy|2
3077271|NCT00430677|10563970|P1|Short-term Period|Pregnancy|0
3077272|NCT00430677|10563968|P3|Short-term Period|Poor compliance/ noncompliance|0
3077273|NCT00430677|10563969|P2|Short-term Period|Poor compliance/ noncompliance|1
3077274|NCT00430677|10563970|P1|Short-term Period|Poor compliance/ noncompliance|0
3077275|NCT00430677|10563968|P3|Short-term Period|Participant no longer met study criteria|2
3077276|NCT00430677|10563969|P2|Short-term Period|Participant no longer met study criteria|1
3077277|NCT00430677|10563970|P1|Short-term Period|Participant no longer met study criteria|1
3077278|NCT00430677|10563968|P3|Short-term Period|Withdrawal by Subject|2
3077279|NCT00430677|10563969|P2|Short-term Period|Withdrawal by Subject|1
3077280|NCT00430677|10563970|P1|Short-term Period|Withdrawal by Subject|1
3077281|NCT00430677|10563968|P3|Short-term Period|Lack of Efficacy|4
3077282|NCT00430677|10563969|P2|Short-term Period|Lack of Efficacy|6
3077283|NCT00430677|10563970|P1|Short-term Period|Lack of Efficacy|5
3077284|NCT00430677|10563968|P3|Short-term Period|Adverse Event|9
3077285|NCT00430677|10563969|P2|Short-term Period|Adverse Event|13
3077286|NCT00430677|10563970|P1|Short-term Period|Adverse Event|15
3077287|NCT00430677|10563968|P3|Short-term Period|Death|5
3077288|NCT00430677|10563969|P2|Short-term Period|Death|1
3077289|NCT00430677|10563970|P1|Short-term Period|Death|1
3077290|NCT00430638|10564093|P2|Overall Study|Other|2
3077291|NCT00430638|10564094|P1|Overall Study|Other|2
3077292|NCT00430638|10564093|P2|Overall Study|Non-compliant|1
3077293|NCT00430638|10564094|P1|Overall Study|Non-compliant|2
3077294|NCT00430638|10564093|P2|Overall Study|Withdrawal by Subject|6
3077295|NCT00430638|10564094|P1|Overall Study|Withdrawal by Subject|4
3077296|NCT00430638|10564093|P2|Overall Study|Protocol Violation|4
3077297|NCT00430638|10564094|P1|Overall Study|Protocol Violation|6
3077298|NCT00430638|10564093|P2|Overall Study|Lost to Follow-up|7
3077299|NCT00430638|10564094|P1|Overall Study|Lost to Follow-up|1
3077300|NCT00430638|10564093|P2|Overall Study|Uncontrolled blood pressure|13
3077301|NCT00430638|10564094|P1|Overall Study|Uncontrolled blood pressure|48
3077302|NCT00430638|10564093|P2|Overall Study|Adverse Event|15
3077303|NCT00430638|10564094|P1|Overall Study|Adverse Event|15
3077304|NCT00430573|10564129|P1|Overall Study|Withdrawal by Subject|5
3077305|NCT00430521|10564142|P8|Overall Study|Withdrawal by Subject|2
3077306|NCT00430521|10564143|P7|Overall Study|Withdrawal by Subject|0
3077307|NCT00430521|10564144|P6|Overall Study|Withdrawal by Subject|0
3077308|NCT00430521|10564145|P5|Overall Study|Withdrawal by Subject|0
3077309|NCT00430521|10564146|P4|Overall Study|Withdrawal by Subject|3
3077310|NCT00430521|10564147|P3|Overall Study|Withdrawal by Subject|0
3077311|NCT00430521|10564148|P2|Overall Study|Withdrawal by Subject|1
3077312|NCT00430521|10564149|P1|Overall Study|Withdrawal by Subject|3
3077313|NCT00430521|10564142|P8|Overall Study|Protocol Violation|0
3077314|NCT00430521|10564143|P7|Overall Study|Protocol Violation|0
3077315|NCT00430521|10564144|P6|Overall Study|Protocol Violation|0
3077316|NCT00430521|10564145|P5|Overall Study|Protocol Violation|0
3077317|NCT00430521|10564146|P4|Overall Study|Protocol Violation|0
3077318|NCT00430521|10564147|P3|Overall Study|Protocol Violation|0
3077319|NCT00430521|10564148|P2|Overall Study|Protocol Violation|0
3077320|NCT00430521|10564149|P1|Overall Study|Protocol Violation|1
3077321|NCT00430521|10564142|P8|Overall Study|Vaccine Expired|0
3077322|NCT00430521|10564143|P7|Overall Study|Vaccine Expired|0
3077323|NCT00430521|10564144|P6|Overall Study|Vaccine Expired|1
3077324|NCT00430521|10564145|P5|Overall Study|Vaccine Expired|0
3077325|NCT00430521|10564146|P4|Overall Study|Vaccine Expired|0
3077326|NCT00430521|10564147|P3|Overall Study|Vaccine Expired|0
3077327|NCT00430521|10564148|P2|Overall Study|Vaccine Expired|0
3077328|NCT00430521|10564149|P1|Overall Study|Vaccine Expired|0
3077329|NCT00430521|10564142|P8|Overall Study|Pregnancy|0
3077330|NCT00430521|10564143|P7|Overall Study|Pregnancy|1
3077331|NCT00430521|10564144|P6|Overall Study|Pregnancy|0
3077332|NCT00430521|10564145|P5|Overall Study|Pregnancy|0
3077333|NCT00430521|10564146|P4|Overall Study|Pregnancy|0
3077334|NCT00430521|10564147|P3|Overall Study|Pregnancy|0
3077335|NCT00430521|10564148|P2|Overall Study|Pregnancy|0
3077336|NCT00430521|10564149|P1|Overall Study|Pregnancy|0
3077337|NCT00430521|10564142|P8|Overall Study|Lost to Follow-up|10
3077338|NCT00430521|10564143|P7|Overall Study|Lost to Follow-up|8
3077339|NCT00430521|10564144|P6|Overall Study|Lost to Follow-up|2
3077340|NCT00430521|10564145|P5|Overall Study|Lost to Follow-up|5
3077341|NCT00430521|10564146|P4|Overall Study|Lost to Follow-up|5
3077342|NCT00430521|10564147|P3|Overall Study|Lost to Follow-up|3
3077343|NCT00430521|10564148|P2|Overall Study|Lost to Follow-up|8
3077344|NCT00430521|10564149|P1|Overall Study|Lost to Follow-up|7
3077345|NCT00430521|10564142|P8|Overall Study|Adverse Event|0
3077346|NCT00430521|10564143|P7|Overall Study|Adverse Event|1
3077347|NCT00430521|10564144|P6|Overall Study|Adverse Event|2
3077348|NCT00430521|10564145|P5|Overall Study|Adverse Event|0
3077349|NCT00430521|10564146|P4|Overall Study|Adverse Event|0
3077350|NCT00430521|10564147|P3|Overall Study|Adverse Event|0
3077351|NCT00430521|10564148|P2|Overall Study|Adverse Event|0
3077352|NCT00430521|10564149|P1|Overall Study|Adverse Event|0
3077353|NCT00430508|10564391|P4|Overall Study|Other|0
3077354|NCT00430508|10564392|P3|Overall Study|Other|3
3077355|NCT00430508|10564393|P2|Overall Study|Other|1
3077356|NCT00430508|10564394|P1|Overall Study|Other|1
3077357|NCT00430508|10564391|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
3077358|NCT00430508|10564392|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
3077359|NCT00430508|10564393|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
3077360|NCT00430508|10564394|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
3077361|NCT00430508|10564391|P4|Overall Study|responder at visit 4|0
3077362|NCT00430508|10564392|P3|Overall Study|responder at visit 4|2
3077363|NCT00430508|10564393|P2|Overall Study|responder at visit 4|0
3077364|NCT00430508|10564394|P1|Overall Study|responder at visit 4|0
3077365|NCT00430508|10564391|P4|Overall Study|Withdrawal by Subject|1
3077366|NCT00430508|10564392|P3|Overall Study|Withdrawal by Subject|1
3077367|NCT00430508|10564393|P2|Overall Study|Withdrawal by Subject|1
3077368|NCT00430508|10564394|P1|Overall Study|Withdrawal by Subject|0
3077369|NCT00430508|10564391|P4|Overall Study|Adverse Event|3
3077370|NCT00430508|10564392|P3|Overall Study|Adverse Event|5
3077371|NCT00430508|10564393|P2|Overall Study|Adverse Event|3
3077372|NCT00430508|10564394|P1|Overall Study|Adverse Event|2
3077373|NCT00430495|10564432|P4|Overall Study|Randomized but not Treated|0
3077374|NCT00430495|10564433|P3|Overall Study|Randomized but not Treated|0
3077375|NCT00430495|10564434|P2|Overall Study|Randomized but not Treated|0
3077376|NCT00430495|10564435|P1|Overall Study|Randomized but not Treated|2
3077377|NCT00430495|10564432|P4|Overall Study|Other|4
3077378|NCT00430495|10564433|P3|Overall Study|Other|5
3077379|NCT00430495|10564434|P2|Overall Study|Other|2
3077380|NCT00430495|10564435|P1|Overall Study|Other|8
3077381|NCT00430495|10564432|P4|Overall Study|Disease Progression|0
3077382|NCT00430495|10564433|P3|Overall Study|Disease Progression|0
3077383|NCT00430495|10564434|P2|Overall Study|Disease Progression|1
3077384|NCT00430495|10564435|P1|Overall Study|Disease Progression|1
3077385|NCT00430495|10564432|P4|Overall Study|Protocol Violation|0
3077386|NCT00430495|10564433|P3|Overall Study|Protocol Violation|1
3077387|NCT00430495|10564434|P2|Overall Study|Protocol Violation|0
3077388|NCT00430495|10564435|P1|Overall Study|Protocol Violation|1
3077389|NCT00430495|10564432|P4|Overall Study|Lost to Follow-up|0
3077390|NCT00430495|10564433|P3|Overall Study|Lost to Follow-up|4
3077391|NCT00430495|10564434|P2|Overall Study|Lost to Follow-up|1
3077392|NCT00430495|10564435|P1|Overall Study|Lost to Follow-up|0
3077393|NCT00430495|10564432|P4|Overall Study|Death|0
3077394|NCT00430495|10564433|P3|Overall Study|Death|1
3077395|NCT00430495|10564434|P2|Overall Study|Death|0
3077396|NCT00430495|10564435|P1|Overall Study|Death|0
3077397|NCT00430495|10564432|P4|Overall Study|Adverse Event|0
3077398|NCT00430495|10564433|P3|Overall Study|Adverse Event|2
3077399|NCT00430495|10564434|P2|Overall Study|Adverse Event|3
3077400|NCT00430495|10564435|P1|Overall Study|Adverse Event|2
3077401|NCT00430482|10564475|P2|Completed Treatment|Insufficient Treatment|11
3077402|NCT00430482|10564476|P1|Completed Treatment|Insufficient Treatment|7
3077403|NCT00430352|10564484|P1|Overall Study|Other|48
3077404|NCT00430352|10564484|P1|Overall Study|Death|5
3077405|NCT00430352|10564484|P1|Overall Study|Adverse Event|16
3077406|NCT00430352|10564484|P1|Overall Study|Withdrawal by Subject|11
3077407|NCT00430352|10564484|P1|Overall Study|Disease progression|58
3077408|NCT00430300|10564502|P4|Overall Study|Other|1
3077409|NCT00430300|10564503|P3|Overall Study|Other|0
3077410|NCT00430300|10564504|P2|Overall Study|Other|0
3077411|NCT00430300|10564505|P1|Overall Study|Other|0
3077412|NCT00430300|10564502|P4|Overall Study|Laboratory abnormality|0
3077413|NCT00430300|10564503|P3|Overall Study|Laboratory abnormality|0
3077414|NCT00430300|10564504|P2|Overall Study|Laboratory abnormality|0
3077415|NCT00430300|10564505|P1|Overall Study|Laboratory abnormality|1
3077416|NCT00430300|10564502|P4|Overall Study|Withdrawal by Subject|0
3077417|NCT00430300|10564503|P3|Overall Study|Withdrawal by Subject|5
3077418|NCT00430300|10564504|P2|Overall Study|Withdrawal by Subject|0
3077419|NCT00430300|10564505|P1|Overall Study|Withdrawal by Subject|1
3077420|NCT00430300|10564502|P4|Overall Study|Adverse Event|1
3077421|NCT00430300|10564503|P3|Overall Study|Adverse Event|1
3077422|NCT00430300|10564504|P2|Overall Study|Adverse Event|2
3077423|NCT00430300|10564505|P1|Overall Study|Adverse Event|0
3077424|NCT00430248|10564610|P3|Overall Study|Reason Not Specified|11
3077425|NCT00430248|10564611|P2|Overall Study|Reason Not Specified|8
3077426|NCT00430248|10564612|P1|Overall Study|Reason Not Specified|8
3077427|NCT00430248|10564610|P3|Overall Study|Gout Flare|2
3077428|NCT00430248|10564611|P2|Overall Study|Gout Flare|7
3077429|NCT00430248|10564612|P1|Overall Study|Gout Flare|3
3077430|NCT00430248|10564610|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3077431|NCT00430248|10564611|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
3077432|NCT00430248|10564612|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3077433|NCT00430248|10564610|P3|Overall Study|Withdrawal by Subject|16
3077434|NCT00430248|10564611|P2|Overall Study|Withdrawal by Subject|20
3077435|NCT00430248|10564612|P1|Overall Study|Withdrawal by Subject|14
3077436|NCT00430248|10564610|P3|Overall Study|Therapeutic Failure|1
3077437|NCT00430248|10564611|P2|Overall Study|Therapeutic Failure|1
3077438|NCT00430248|10564612|P1|Overall Study|Therapeutic Failure|1
3077439|NCT00430248|10564610|P3|Overall Study|Lost to Follow-up|28
3077440|NCT00430248|10564611|P2|Overall Study|Lost to Follow-up|33
3077441|NCT00430248|10564612|P1|Overall Study|Lost to Follow-up|28
3077442|NCT00430248|10564610|P3|Overall Study|Personal Reasons|9
3077443|NCT00430248|10564611|P2|Overall Study|Personal Reasons|24
3077444|NCT00430248|10564612|P1|Overall Study|Personal Reasons|12
3077445|NCT00430248|10564610|P3|Overall Study|Protocol Violation|4
3077446|NCT00430248|10564611|P2|Overall Study|Protocol Violation|2
3077447|NCT00430248|10564612|P1|Overall Study|Protocol Violation|10
3077448|NCT00430248|10564610|P3|Overall Study|Adverse Event|64
3077449|NCT00430248|10564611|P2|Overall Study|Adverse Event|61
3077450|NCT00430248|10564612|P1|Overall Study|Adverse Event|49
3077451|NCT00430092|10564680|P3|Overall Study|Withdrawal by Subject|1
3077452|NCT00430092|10564681|P2|Overall Study|Withdrawal by Subject|1
3077453|NCT00430092|10564682|P1|Overall Study|Withdrawal by Subject|0
3077454|NCT00430092|10564680|P3|Overall Study|Protocol Violation|1
3077455|NCT00430092|10564681|P2|Overall Study|Protocol Violation|1
3077456|NCT00430092|10564682|P1|Overall Study|Protocol Violation|0
3077457|NCT00430092|10564680|P3|Overall Study|Lost to Follow-up|0
3077458|NCT00430092|10564681|P2|Overall Study|Lost to Follow-up|0
3077459|NCT00430092|10564682|P1|Overall Study|Lost to Follow-up|1
3077460|NCT00430092|10564680|P3|Overall Study|Lack of Efficacy|54
3077461|NCT00430092|10564681|P2|Overall Study|Lack of Efficacy|2
3077462|NCT00430092|10564682|P1|Overall Study|Lack of Efficacy|5
3077463|NCT00430092|10564680|P3|Overall Study|Adverse Event|1
3077464|NCT00430092|10564681|P2|Overall Study|Adverse Event|0
3077465|NCT00430092|10564682|P1|Overall Study|Adverse Event|0
3077466|NCT00430027|10564687|P1|Overall Study|Study terminated|8
3077467|NCT00429923|10564704|P3|Overall Study|Early Termination|0
3077468|NCT00429923|10564705|P2|Overall Study|Early Termination|1
3077469|NCT00429923|10564706|P1|Overall Study|Early Termination|0
3077470|NCT00429923|10564704|P3|Overall Study|Withdrew Consent|1
3077471|NCT00429923|10564705|P2|Overall Study|Withdrew Consent|0
3077472|NCT00429923|10564706|P1|Overall Study|Withdrew Consent|1
3077473|NCT00429923|10564704|P3|Overall Study|Lost to Follow-up|2
3077474|NCT00429923|10564705|P2|Overall Study|Lost to Follow-up|0
3077475|NCT00429923|10564706|P1|Overall Study|Lost to Follow-up|0
3077476|NCT00429923|10564704|P3|Overall Study|Lack of Efficacy|33
3077477|NCT00429923|10564705|P2|Overall Study|Lack of Efficacy|1
3077478|NCT00429923|10564706|P1|Overall Study|Lack of Efficacy|4
3077479|NCT00429923|10564704|P3|Overall Study|Adverse Event|3
3077480|NCT00429923|10564705|P2|Overall Study|Adverse Event|2
3077481|NCT00429923|10564706|P1|Overall Study|Adverse Event|0
3077482|NCT00429793|10564711|P1|Overall Study|Non-measurable|1
3077483|NCT00429793|10564711|P1|Overall Study|Never treated|1
3077484|NCT00429793|10564711|P1|Overall Study|Required test not done|1
3077485|NCT00429793|10564711|P1|Overall Study|Improper pre-protocol treatment|3
3077486|NCT00429663|10564738|P2|Overall Study|Death|0
3077487|NCT00429663|10564739|P1|Overall Study|Death|4
3077488|NCT00429663|10564738|P2|Overall Study|Withdrawal by Subject|5
3077489|NCT00429663|10564739|P1|Overall Study|Withdrawal by Subject|2
3077490|NCT00429663|10564738|P2|Overall Study|Physician Decision|3
3077491|NCT00429663|10564739|P1|Overall Study|Physician Decision|6
3077492|NCT00429663|10564738|P2|Overall Study|Lost to Follow-up|31
3077493|NCT00429663|10564739|P1|Overall Study|Lost to Follow-up|24
3077494|NCT00429572|10564753|P1|Overall Study|Disease progression|1
3077495|NCT00429494|10564765|P1|Overall Study|Death|6
3077496|NCT00429494|10564765|P1|Overall Study|Withdrawal by Subject|9
3077497|NCT00429416|10564769|P1|Overall Study|Death|1
3077498|NCT00429364|10564788|P2|Overall Study|Pregnancy|1
3077499|NCT00429364|10564789|P1|Overall Study|Pregnancy|0
3077500|NCT00429364|10564788|P2|Overall Study|Underwent aortic root surgery|18
3077501|NCT00429364|10564789|P1|Overall Study|Underwent aortic root surgery|10
3077502|NCT00429364|10564788|P2|Overall Study|Death|1
3077503|NCT00429364|10564789|P1|Overall Study|Death|0
3077504|NCT00429364|10564788|P2|Overall Study|Lost to Follow-up|6
3077505|NCT00429364|10564789|P1|Overall Study|Lost to Follow-up|7
3077506|NCT00429364|10564788|P2|Overall Study|Physician Decision|2
3077507|NCT00429364|10564789|P1|Overall Study|Physician Decision|4
3077508|NCT00429364|10564788|P2|Overall Study|Withdrawal by Subject|5
3077509|NCT00429364|10564789|P1|Overall Study|Withdrawal by Subject|11
3077510|NCT00429299|10564848|P3|Overall Study|Withdrawal by Subject|3
3077511|NCT00429299|10564849|P2|Overall Study|Withdrawal by Subject|1
3077512|NCT00429299|10564850|P1|Overall Study|Withdrawal by Subject|0
3077513|NCT00429299|10564848|P3|Overall Study|Protocol Violation|0
3077514|NCT00429299|10564849|P2|Overall Study|Protocol Violation|0
3077515|NCT00429299|10564850|P1|Overall Study|Protocol Violation|1
3077516|NCT00429299|10564848|P3|Overall Study|Adverse Event|1
3077517|NCT00429299|10564849|P2|Overall Study|Adverse Event|5
3077518|NCT00429299|10564850|P1|Overall Study|Adverse Event|2
3077519|NCT00429299|10564848|P3|Overall Study|Disease Progression|0
3077520|NCT00429299|10564849|P2|Overall Study|Disease Progression|1
3077521|NCT00429299|10564850|P1|Overall Study|Disease Progression|1
3077522|NCT00429273|10564882|P3|Overall Study|Adverse Event|2
3077523|NCT00429273|10564883|P2|Overall Study|Adverse Event|1
3077524|NCT00429273|10564884|P1|Overall Study|Adverse Event|1
3077525|NCT00429273|10564882|P3|Overall Study|Physician Decision|5
3077526|NCT00429273|10564883|P2|Overall Study|Physician Decision|5
3077527|NCT00429273|10564884|P1|Overall Study|Physician Decision|6
3077528|NCT00429273|10564882|P3|Overall Study|Lost to Follow-up|2
3077529|NCT00429273|10564883|P2|Overall Study|Lost to Follow-up|2
3077530|NCT00429273|10564884|P1|Overall Study|Lost to Follow-up|1
3077531|NCT00429182|10564892|P1|Overall Study|Not eligible|5
3077532|NCT00429182|10564892|P1|Overall Study|Not evaluable, Disease Progression|2
3077533|NCT00429169|10564899|P2|Overall Study|Ineligibility discovered after entry|1
3077534|NCT00429169|10564900|P1|Overall Study|Ineligibility discovered after entry|2
3077535|NCT00429169|10564899|P2|Overall Study|Lost to Follow-up|1
3077536|NCT00429169|10564900|P1|Overall Study|Lost to Follow-up|0
3077537|NCT00429104|10564920|P1|Overall Study|Protocol Violation|1
3077538|NCT00429026|10564925|P1|Overall Study|Inevaluable for response.|40
3077539|NCT00428948|10564952|P2|Overall Study|Protocol Deviation|1
3077540|NCT00428948|10564953|P1|Overall Study|Protocol Deviation|1
3077541|NCT00428948|10564952|P2|Overall Study|Subject Withdrew Consent|30
3077542|NCT00428948|10564953|P1|Overall Study|Subject Withdrew Consent|50
3077543|NCT00428948|10564952|P2|Overall Study|Investigator Withdrew Subject|4
3077544|NCT00428948|10564953|P1|Overall Study|Investigator Withdrew Subject|3
3077545|NCT00428948|10564952|P2|Overall Study|Subject Met Withdrawal Criteria|0
3077546|NCT00428948|10564953|P1|Overall Study|Subject Met Withdrawal Criteria|4
3077547|NCT00428948|10564952|P2|Overall Study|Adverse Event|24
3077548|NCT00428948|10564953|P1|Overall Study|Adverse Event|148
3077549|NCT00428948|10564952|P2|Overall Study|Lost to Follow-up|8
3077550|NCT00428948|10564953|P1|Overall Study|Lost to Follow-up|15
3077551|NCT00428844|10564981|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
3077552|NCT00428844|10564982|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
3077553|NCT00428844|10564983|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
3077554|NCT00428844|10564981|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
3077555|NCT00428844|10564982|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
3077556|NCT00428844|10564983|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
3077557|NCT00428844|10564981|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
3077558|NCT00428844|10564982|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
3077559|NCT00428844|10564983|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
3077560|NCT00428844|10564981|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
3077561|NCT00428844|10564982|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
3077562|NCT00428844|10564983|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
3077563|NCT00428844|10564981|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
3077564|NCT00428844|10564982|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
3077565|NCT00428844|10564983|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
3077566|NCT00428844|10564981|P3|Completed Study Drug Treatment|Randomized Not Treated|1
3077567|NCT00428844|10564982|P2|Completed Study Drug Treatment|Randomized Not Treated|0
3077568|NCT00428844|10564983|P1|Completed Study Drug Treatment|Randomized Not Treated|0
3077569|NCT00428844|10564981|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
3077570|NCT00428844|10564982|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
3077571|NCT00428844|10564983|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
3077572|NCT00428844|10564981|P3|Completed Study Drug Treatment|Protocol Violation|1
3077573|NCT00428844|10564982|P2|Completed Study Drug Treatment|Protocol Violation|1
3077574|NCT00428844|10564983|P1|Completed Study Drug Treatment|Protocol Violation|0
3077575|NCT00428844|10564981|P3|Completed Study Drug Treatment|Adverse Event|4
3077576|NCT00428844|10564982|P2|Completed Study Drug Treatment|Adverse Event|4
3077577|NCT00428844|10564983|P1|Completed Study Drug Treatment|Adverse Event|2
3077578|NCT00428792|10565006|P2|Overall Study|Lost to Follow-up|1
3077579|NCT00428792|10565007|P1|Overall Study|Lost to Follow-up|0
3077580|NCT00428792|10565006|P2|Overall Study|Lack of Efficacy|3
3077581|NCT00428792|10565007|P1|Overall Study|Lack of Efficacy|1
3077582|NCT00428610|10565034|P3|Overall Study|Withdrawal by Subject|0
3077583|NCT00428610|10565035|P2|Overall Study|Withdrawal by Subject|0
3077584|NCT00428610|10565036|P1|Overall Study|Withdrawal by Subject|4
3077585|NCT00428610|10565034|P3|Overall Study|Progressive Disease|22
3077586|NCT00428610|10565035|P2|Overall Study|Progressive Disease|14
3077587|NCT00428610|10565036|P1|Overall Study|Progressive Disease|42
3077588|NCT00428610|10565034|P3|Overall Study|Investigator Decision|1
3077589|NCT00428610|10565035|P2|Overall Study|Investigator Decision|1
3077590|NCT00428610|10565036|P1|Overall Study|Investigator Decision|2
3077591|NCT00428610|10565034|P3|Overall Study|Adverse Event|2
3077592|NCT00428610|10565035|P2|Overall Study|Adverse Event|3
3077593|NCT00428610|10565036|P1|Overall Study|Adverse Event|2
3077594|NCT00428610|10565034|P3|Overall Study|Death Due to Progressive Disease|2
3077595|NCT00428610|10565035|P2|Overall Study|Death Due to Progressive Disease|0
3077596|NCT00428610|10565036|P1|Overall Study|Death Due to Progressive Disease|0
3077597|NCT00428610|10565034|P3|Overall Study|Death Due to Adverse Event|5
3077598|NCT00428610|10565035|P2|Overall Study|Death Due to Adverse Event|0
3077599|NCT00428610|10565036|P1|Overall Study|Death Due to Adverse Event|3
3077600|NCT00428597|10565070|P2|Overall Study|Death|3
3077601|NCT00428597|10565071|P1|Overall Study|Death|1
3077602|NCT00428597|10565070|P2|Overall Study|Pregnancy|0
3077603|NCT00428597|10565071|P1|Overall Study|Pregnancy|1
3077604|NCT00428597|10565070|P2|Overall Study|Lost to Follow-up|1
3077605|NCT00428597|10565071|P1|Overall Study|Lost to Follow-up|0
3077606|NCT00428597|10565070|P2|Overall Study|Other|1
3077607|NCT00428597|10565071|P1|Overall Study|Other|1
3077608|NCT00428597|10565070|P2|Overall Study|Withdrawal by Subject|1
3077609|NCT00428597|10565071|P1|Overall Study|Withdrawal by Subject|2
3077610|NCT00428597|10565070|P2|Overall Study|Protocol Violation|1
3077611|NCT00428597|10565071|P1|Overall Study|Protocol Violation|2
3077612|NCT00428597|10565070|P2|Overall Study|Global Deterioration of Health Status|5
3077613|NCT00428597|10565071|P1|Overall Study|Global Deterioration of Health Status|1
3077614|NCT00428597|10565070|P2|Overall Study|Adverse Event|7
3077615|NCT00428597|10565071|P1|Overall Study|Adverse Event|15
3077616|NCT00428597|10565070|P2|Overall Study|Study Terminated by Sponsor|16
3077617|NCT00428597|10565071|P1|Overall Study|Study Terminated by Sponsor|41
3077618|NCT00428597|10565070|P2|Overall Study|Objective Progression or Relapse|47
3077619|NCT00428597|10565071|P1|Overall Study|Objective Progression or Relapse|19
3077620|NCT00428597|10565070|P2|Overall Study|Randomized but not treated|3
3077621|NCT00428597|10565071|P1|Overall Study|Randomized but not treated|3
3077622|NCT00428441|10565138|P1|Overall Study|Lost to Follow-up|1
3077623|NCT00428389|10565144|P2|Extension Phase|Administrative problems|1
3077624|NCT00428389|10565145|P1|Extension Phase|Administrative problems|1
3077625|NCT00428389|10565144|P2|Extension Phase|Protocol Violation|2
3077626|NCT00428389|10565145|P1|Extension Phase|Protocol Violation|3
3077627|NCT00428389|10565144|P2|Extension Phase|Death|0
3077628|NCT00428389|10565145|P1|Extension Phase|Death|1
3077629|NCT00428389|10565144|P2|Extension Phase|Lost to Follow-up|3
3077630|NCT00428389|10565145|P1|Extension Phase|Lost to Follow-up|0
3077631|NCT00428389|10565144|P2|Extension Phase|Withdrawal by Subject|6
3077632|NCT00428389|10565145|P1|Extension Phase|Withdrawal by Subject|6
3077633|NCT00428389|10565144|P2|Extension Phase|Lack of Efficacy|3
3077634|NCT00428389|10565145|P1|Extension Phase|Lack of Efficacy|4
3077635|NCT00428389|10565144|P2|Extension Phase|Adverse Event|11
3077636|NCT00428389|10565145|P1|Extension Phase|Adverse Event|17
3077637|NCT00428389|10565144|P2|Core Phase|Protocol deviation|2
3077638|NCT00428389|10565145|P1|Core Phase|Protocol deviation|0
3077639|NCT00428389|10565144|P2|Core Phase|Withdrawal by Subject|4
3077640|NCT00428389|10565145|P1|Core Phase|Withdrawal by Subject|3
3077641|NCT00428389|10565144|P2|Core Phase|Abnormal test procedure result(s)|1
3077642|NCT00428389|10565145|P1|Core Phase|Abnormal test procedure result(s)|0
3077643|NCT00428389|10565144|P2|Core Phase|Lack of Efficacy|0
3077644|NCT00428389|10565145|P1|Core Phase|Lack of Efficacy|2
3077645|NCT00428389|10565144|P2|Core Phase|Adverse Event|4
3077646|NCT00428389|10565145|P1|Core Phase|Adverse Event|6
3077647|NCT00428246|10565179|P3|Overall Study|Adverse Event|0
3077648|NCT00428246|10565180|P2|Overall Study|Adverse Event|0
3077649|NCT00428246|10565181|P1|Overall Study|Adverse Event|1
3077650|NCT00428246|10565179|P3|Overall Study|Withdrawal by Subject|1
3077651|NCT00428246|10565180|P2|Overall Study|Withdrawal by Subject|0
3077652|NCT00428246|10565181|P1|Overall Study|Withdrawal by Subject|0
3077653|NCT00428220|10565189|P1|Overall Study|Other|23
3077654|NCT00428220|10565189|P1|Overall Study|Adverse Event|51
3077655|NCT00428220|10565189|P1|Overall Study|Participant refused continued treatment|7
3077656|NCT00428220|10565189|P1|Overall Study|Objective progression or relapse|123
3077657|NCT00428220|10565189|P1|Overall Study|Lost to Follow-up|4
3077658|NCT00428220|10565189|P1|Overall Study|Global deterioration of health status|7
3077659|NCT00428220|10565189|P1|Overall Study|Participant died|8
3077660|NCT00428116|10565214|P2|Overall Study|Lost to Follow-up|0
3077661|NCT00428116|10565215|P1|Overall Study|Lost to Follow-up|1
3077662|NCT00428116|10565214|P2|Overall Study|Withdrawal by Subject|0
3077663|NCT00428116|10565215|P1|Overall Study|Withdrawal by Subject|1
3077664|NCT00428116|10565214|P2|Overall Study|Death|0
3077665|NCT00428116|10565215|P1|Overall Study|Death|1
3077666|NCT00428090|10565227|P4|Overall Study|Raised Creatinine Value|1
3077667|NCT00428090|10565228|P3|Overall Study|Raised Creatinine Value|0
3077668|NCT00428090|10565229|P2|Overall Study|Raised Creatinine Value|0
3077669|NCT00428090|10565230|P1|Overall Study|Raised Creatinine Value|0
3077670|NCT00428090|10565227|P4|Overall Study|Excluded for heart insufficiency|0
3077671|NCT00428090|10565228|P3|Overall Study|Excluded for heart insufficiency|1
3077672|NCT00428090|10565229|P2|Overall Study|Excluded for heart insufficiency|0
3077673|NCT00428090|10565230|P1|Overall Study|Excluded for heart insufficiency|0
3077674|NCT00428090|10565227|P4|Overall Study|Serious adverse event|0
3077675|NCT00428090|10565228|P3|Overall Study|Serious adverse event|1
3077676|NCT00428090|10565229|P2|Overall Study|Serious adverse event|0
3077677|NCT00428090|10565230|P1|Overall Study|Serious adverse event|0
3077678|NCT00428090|10565227|P4|Overall Study|Deterioration of cognitive status|0
3077679|NCT00428090|10565228|P3|Overall Study|Deterioration of cognitive status|1
3077680|NCT00428090|10565229|P2|Overall Study|Deterioration of cognitive status|0
3077681|NCT00428090|10565230|P1|Overall Study|Deterioration of cognitive status|0
3077682|NCT00428090|10565227|P4|Overall Study|High MMSE scores|0
3077683|NCT00428090|10565228|P3|Overall Study|High MMSE scores|1
3077684|NCT00428090|10565229|P2|Overall Study|High MMSE scores|0
3077685|NCT00428090|10565230|P1|Overall Study|High MMSE scores|0
3077686|NCT00428090|10565227|P4|Overall Study|Insufficient AD documentation|0
3077687|NCT00428090|10565228|P3|Overall Study|Insufficient AD documentation|1
3077688|NCT00428090|10565229|P2|Overall Study|Insufficient AD documentation|0
3077689|NCT00428090|10565230|P1|Overall Study|Insufficient AD documentation|0
3077690|NCT00428090|10565227|P4|Overall Study|Excluded for concerning QTc value|0
3077691|NCT00428090|10565228|P3|Overall Study|Excluded for concerning QTc value|1
3077692|NCT00428090|10565229|P2|Overall Study|Excluded for concerning QTc value|0
3077693|NCT00428090|10565230|P1|Overall Study|Excluded for concerning QTc value|0
3077694|NCT00428090|10565227|P4|Overall Study|Worsening of AD|0
3077695|NCT00428090|10565228|P3|Overall Study|Worsening of AD|1
3077696|NCT00428090|10565229|P2|Overall Study|Worsening of AD|0
3077697|NCT00428090|10565230|P1|Overall Study|Worsening of AD|0
3077698|NCT00428090|10565227|P4|Overall Study|Mental status of par. was|0
3077699|NCT00428090|10565228|P3|Overall Study|Mental status of par. was|0
3077700|NCT00428090|10565229|P2|Overall Study|Mental status of par. was|1
3077701|NCT00428090|10565230|P1|Overall Study|Mental status of par. was|0
3077702|NCT00428090|10565227|P4|Overall Study|Medical monitor terminated par.|0
3077703|NCT00428090|10565228|P3|Overall Study|Medical monitor terminated par.|0
3077704|NCT00428090|10565229|P2|Overall Study|Medical monitor terminated par.|1
3077705|NCT00428090|10565230|P1|Overall Study|Medical monitor terminated par.|0
3077706|NCT00428090|10565227|P4|Overall Study|Visit 7 exceed the visit window|0
3077707|NCT00428090|10565228|P3|Overall Study|Visit 7 exceed the visit window|0
3077708|NCT00428090|10565229|P2|Overall Study|Visit 7 exceed the visit window|1
3077709|NCT00428090|10565230|P1|Overall Study|Visit 7 exceed the visit window|0
3077710|NCT00428090|10565227|P4|Overall Study|Death of par.|0
3077711|NCT00428090|10565228|P3|Overall Study|Death of par.|1
3077712|NCT00428090|10565229|P2|Overall Study|Death of par.|0
3077713|NCT00428090|10565230|P1|Overall Study|Death of par.|1
3077714|NCT00428090|10565227|P4|Overall Study|Prohibited medication used for SAE|0
3077715|NCT00428090|10565228|P3|Overall Study|Prohibited medication used for SAE|0
3077716|NCT00428090|10565229|P2|Overall Study|Prohibited medication used for SAE|0
3077717|NCT00428090|10565230|P1|Overall Study|Prohibited medication used for SAE|1
3077718|NCT00428090|10565227|P4|Overall Study|Follow-Up visit not possible|0
3077719|NCT00428090|10565228|P3|Overall Study|Follow-Up visit not possible|0
3077720|NCT00428090|10565229|P2|Overall Study|Follow-Up visit not possible|0
3077721|NCT00428090|10565230|P1|Overall Study|Follow-Up visit not possible|1
3077722|NCT00428090|10565227|P4|Overall Study|Par. did not returned to visit|1
3077723|NCT00428090|10565228|P3|Overall Study|Par. did not returned to visit|0
3077724|NCT00428090|10565229|P2|Overall Study|Par. did not returned to visit|0
3077725|NCT00428090|10565230|P1|Overall Study|Par. did not returned to visit|1
3077726|NCT00428090|10565227|P4|Overall Study|Non-compliance|3
3077727|NCT00428090|10565228|P3|Overall Study|Non-compliance|1
3077728|NCT00428090|10565229|P2|Overall Study|Non-compliance|0
3077729|NCT00428090|10565230|P1|Overall Study|Non-compliance|4
3077730|NCT00428090|10565227|P4|Overall Study|Sponsor terminated study|0
3077731|NCT00428090|10565228|P3|Overall Study|Sponsor terminated study|0
3077732|NCT00428090|10565229|P2|Overall Study|Sponsor terminated study|1
3077733|NCT00428090|10565230|P1|Overall Study|Sponsor terminated study|0
3077734|NCT00428090|10565227|P4|Overall Study|Withdrawal by Subject|5
3077735|NCT00428090|10565228|P3|Overall Study|Withdrawal by Subject|15
3077736|NCT00428090|10565229|P2|Overall Study|Withdrawal by Subject|12
3077737|NCT00428090|10565230|P1|Overall Study|Withdrawal by Subject|10
3077738|NCT00428090|10565227|P4|Overall Study|Protocol Violation|3
3077739|NCT00428090|10565228|P3|Overall Study|Protocol Violation|3
3077740|NCT00428090|10565229|P2|Overall Study|Protocol Violation|1
3077741|NCT00428090|10565230|P1|Overall Study|Protocol Violation|3
3077742|NCT00428090|10565227|P4|Overall Study|Lost to Follow-up|4
3077743|NCT00428090|10565228|P3|Overall Study|Lost to Follow-up|1
3077744|NCT00428090|10565229|P2|Overall Study|Lost to Follow-up|6
3077745|NCT00428090|10565230|P1|Overall Study|Lost to Follow-up|3
3077746|NCT00428090|10565227|P4|Overall Study|Adverse Event|11
3077747|NCT00428090|10565228|P3|Overall Study|Adverse Event|10
3077748|NCT00428090|10565229|P2|Overall Study|Adverse Event|8
3077749|NCT00428090|10565230|P1|Overall Study|Adverse Event|10
3077750|NCT00427999|10565348|P1|Overall Study|Death|1
3077751|NCT00427999|10565348|P1|Overall Study|Withdrawal by Subject|9
3077752|NCT00427999|10565348|P1|Overall Study|Protocol Violation|2
3077753|NCT00427999|10565348|P1|Overall Study|Unsatisfactory therapeutic effect|13
3077754|NCT00427999|10565348|P1|Overall Study|Abnormal laboratory values|1
3077755|NCT00427999|10565348|P1|Overall Study|Adverse Event|6
3077756|NCT00427960|10565366|P2|Overall Study|Other|1
3077757|NCT00427960|10565367|P1|Overall Study|Other|0
3077758|NCT00427960|10565366|P2|Overall Study|Withdrawal by Subject|3
3077759|NCT00427960|10565367|P1|Overall Study|Withdrawal by Subject|0
3077760|NCT00427960|10565366|P2|Overall Study|Adverse Event|0
3077761|NCT00427960|10565367|P1|Overall Study|Adverse Event|2
3077762|NCT00427934|10565405|P4|Overall Study|Withdrawal by Subject|3
3077763|NCT00427934|10565406|P3|Overall Study|Withdrawal by Subject|1
3077764|NCT00427934|10565407|P2|Overall Study|Withdrawal by Subject|0
3077765|NCT00427934|10565408|P1|Overall Study|Withdrawal by Subject|0
3077766|NCT00427934|10565405|P4|Overall Study|Other|5
3077767|NCT00427934|10565406|P3|Overall Study|Other|11
3077768|NCT00427934|10565407|P2|Overall Study|Other|0
3077769|NCT00427934|10565408|P1|Overall Study|Other|0
3077770|NCT00427934|10565405|P4|Overall Study|Randomized But Did Not Receive Treatment|1
3077771|NCT00427934|10565406|P3|Overall Study|Randomized But Did Not Receive Treatment|1
3077772|NCT00427934|10565407|P2|Overall Study|Randomized But Did Not Receive Treatment|0
3077773|NCT00427934|10565408|P1|Overall Study|Randomized But Did Not Receive Treatment|0
3077774|NCT00427934|10565405|P4|Overall Study|Lack of Efficacy|2
3077775|NCT00427934|10565406|P3|Overall Study|Lack of Efficacy|5
3077776|NCT00427934|10565407|P2|Overall Study|Lack of Efficacy|0
3077777|NCT00427934|10565408|P1|Overall Study|Lack of Efficacy|0
3077778|NCT00427934|10565405|P4|Overall Study|Adverse Event|4
3077779|NCT00427934|10565406|P3|Overall Study|Adverse Event|5
3077780|NCT00427934|10565407|P2|Overall Study|Adverse Event|0
3077781|NCT00427934|10565408|P1|Overall Study|Adverse Event|1
3077782|NCT00427921|10565476|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
3077783|NCT00427921|10565476|P1|Overall Study|Adverse Event + Withdrawn from Study|1
3077784|NCT00427921|10565476|P1|Overall Study|Adverse Event + Lost Response|1
3077785|NCT00427921|10565476|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
3077786|NCT00427921|10565476|P1|Overall Study|Adverse Event + Worsening of CD|1
3077787|NCT00427921|10565476|P1|Overall Study|Adverse Event + No Response|1
3077788|NCT00427921|10565476|P1|Overall Study|Adverse Event + Withdrew Consent|1
3077789|NCT00427921|10565476|P1|Overall Study|Adverse Event + Hospitalization|1
3077790|NCT00427921|10565476|P1|Overall Study|Other reason not specified|10
3077791|NCT00427921|10565476|P1|Overall Study|Lost to Follow-up|2
3077792|NCT00427921|10565476|P1|Overall Study|Withdrawal by Subject|4
3077793|NCT00427921|10565476|P1|Overall Study|Adverse Event|26
3077794|NCT00427908|10565499|P4|Primary Phase|Adverse Event|0
3077795|NCT00427908|10565500|P3|Primary Phase|Adverse Event|0
3077796|NCT00427908|10565501|P2|Primary Phase|Adverse Event|1
3077797|NCT00427908|10565502|P1|Primary Phase|Adverse Event|0
3077798|NCT00427908|10565499|P4|Primary Phase|Withdrawal by Subject|0
3077799|NCT00427908|10565500|P3|Primary Phase|Withdrawal by Subject|1
3077800|NCT00427908|10565501|P2|Primary Phase|Withdrawal by Subject|2
3077801|NCT00427908|10565502|P1|Primary Phase|Withdrawal by Subject|1
3077802|NCT00427908|10565499|P4|Primary Phase|Lost to Follow-up|0
3077803|NCT00427908|10565500|P3|Primary Phase|Lost to Follow-up|2
3077804|NCT00427908|10565501|P2|Primary Phase|Lost to Follow-up|0
3077805|NCT00427908|10565502|P1|Primary Phase|Lost to Follow-up|4
3077806|NCT00427895|10565702|P8|Vax 2/Year 3 to 4|Failed to Return|0
3077807|NCT00427895|10565703|P7|Vax 2/Year 3 to 4|Failed to Return|0
3077808|NCT00427895|10565704|P6|Vax 2/Year 3 to 4|Failed to Return|0
3077809|NCT00427895|10565705|P5|Vax 2/Year 3 to 4|Failed to Return|1
3077810|NCT00427895|10565706|P4|Vax 2/Year 3 to 4|Failed to Return|0
3077811|NCT00427895|10565707|P3|Vax 2/Year 3 to 4|Failed to Return|0
3077812|NCT00427895|10565708|P2|Vax 2/Year 3 to 4|Failed to Return|0
3077813|NCT00427895|10565709|P1|Vax 2/Year 3 to 4|Failed to Return|0
3077814|NCT00427895|10565702|P8|Vax 2/Year 3 to 4|Protocol Violation|1
3077815|NCT00427895|10565703|P7|Vax 2/Year 3 to 4|Protocol Violation|0
3077816|NCT00427895|10565704|P6|Vax 2/Year 3 to 4|Protocol Violation|0
3077817|NCT00427895|10565705|P5|Vax 2/Year 3 to 4|Protocol Violation|0
3077818|NCT00427895|10565706|P4|Vax 2/Year 3 to 4|Protocol Violation|0
3077819|NCT00427895|10565707|P3|Vax 2/Year 3 to 4|Protocol Violation|0
3077820|NCT00427895|10565708|P2|Vax 2/Year 3 to 4|Protocol Violation|0
3077821|NCT00427895|10565709|P1|Vax 2/Year 3 to 4|Protocol Violation|0
3077822|NCT00427895|10565702|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
3077823|NCT00427895|10565703|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077824|NCT00427895|10565704|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077825|NCT00427895|10565705|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077826|NCT00427895|10565706|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077827|NCT00427895|10565707|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077828|NCT00427895|10565708|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077829|NCT00427895|10565709|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
3077830|NCT00427895|10565702|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
3077831|NCT00427895|10565703|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
3077832|NCT00427895|10565704|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
3077833|NCT00427895|10565705|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
3077834|NCT00427895|10565706|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
3077835|NCT00427895|10565707|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
3077836|NCT00427895|10565708|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
3077837|NCT00427895|10565709|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
3077838|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Other|0
3077839|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Other|0
3077840|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Other|0
3077841|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Other|0
3077842|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Other|2
3077843|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Other|0
3077844|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Other|0
3077845|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Other|0
3077846|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
3077847|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
3077848|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
3077849|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
3077850|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
3077851|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
3077852|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
3077853|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
3077854|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Death|0
3077855|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Death|0
3077856|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Death|0
3077857|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Death|0
3077858|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Death|0
3077859|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Death|0
3077860|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Death|0
3077861|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Death|1
3077862|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
3077863|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
3077864|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
3077865|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
3077866|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
3077867|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
3077868|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
3077869|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
3077870|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
3077871|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
3077872|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
3077873|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
3077874|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
3077875|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
3077876|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
3077877|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
3077878|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
3077879|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
3077880|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
3077881|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
3077882|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
3077883|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
3077884|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
3077885|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
3077886|NCT00427895|10565702|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
3077887|NCT00427895|10565703|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
3077888|NCT00427895|10565704|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
3077889|NCT00427895|10565705|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
3077890|NCT00427895|10565706|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
3077891|NCT00427895|10565707|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
3077892|NCT00427895|10565708|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
3077893|NCT00427895|10565709|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
3077894|NCT00427895|10565702|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077895|NCT00427895|10565703|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077896|NCT00427895|10565704|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077897|NCT00427895|10565705|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077898|NCT00427895|10565706|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
3077899|NCT00427895|10565707|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077900|NCT00427895|10565708|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077901|NCT00427895|10565709|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
3077902|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
3077903|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
3077904|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
3077905|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
3077906|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
3077907|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
3077908|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
3077909|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
3077910|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
3077911|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
3077912|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
3077913|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
3077914|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
3077915|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
3077916|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
3077917|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
3077918|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077919|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077920|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077921|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077922|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
3077923|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077924|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077925|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
3077926|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
3077927|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
3077928|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
3077929|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
3077930|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
3077931|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
3077932|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
3077933|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
3077934|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077935|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077936|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077937|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077938|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077939|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
3077940|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
3077941|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
3077942|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
3077943|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
3077944|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
3077945|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
3077946|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
3077947|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
3077948|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
3077949|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
3077950|NCT00427895|10565702|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
3077951|NCT00427895|10565703|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
3077952|NCT00427895|10565704|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
3077953|NCT00427895|10565705|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
3077954|NCT00427895|10565706|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
3077955|NCT00427895|10565707|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
3077956|NCT00427895|10565708|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
3077957|NCT00427895|10565709|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
3077958|NCT00427778|10565784|P2|First Intervention (4 Weeks)|anxious about using ring|0
3077959|NCT00427778|10565785|P1|First Intervention (4 Weeks)|anxious about using ring|1
3077960|NCT00427778|10565784|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
3077961|NCT00427778|10565785|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
3077962|NCT00427778|10565784|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
3077963|NCT00427778|10565785|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
3077964|NCT00427778|10565784|P2|First Intervention (4 Weeks)|no longer interested|0
3077965|NCT00427778|10565785|P1|First Intervention (4 Weeks)|no longer interested|1
3077966|NCT00427700|10565810|P2|Overall Study|Pregnancy|2
3077967|NCT00427700|10565811|P1|Overall Study|Pregnancy|0
3077968|NCT00427700|10565810|P2|Overall Study|no induction of menses|4
3077969|NCT00427700|10565811|P1|Overall Study|no induction of menses|1
3077970|NCT00427700|10565810|P2|Overall Study|Lost to Follow-up|5
3077971|NCT00427700|10565811|P1|Overall Study|Lost to Follow-up|2
3077972|NCT00427648|10565827|P2|Overall Study|Adverse Event|1
3077973|NCT00427648|10565828|P1|Overall Study|Adverse Event|0
3077974|NCT00427648|10565827|P2|Overall Study|Protocol Violation|2
3077975|NCT00427648|10565828|P1|Overall Study|Protocol Violation|1
3077976|NCT00427635|10565848|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
3077977|NCT00427635|10565849|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
3077978|NCT00427635|10565848|P2|Treatment Phase|Withdrawal by Subject|0
3077979|NCT00427635|10565849|P1|Treatment Phase|Withdrawal by Subject|1
3077980|NCT00427349|10565881|P1|Overall Study|Never started therapy|1
3077981|NCT00427349|10565881|P1|Overall Study|Ineligible|1
3077982|NCT00427349|10565881|P1|Overall Study|Other|2
3077983|NCT00427349|10565881|P1|Overall Study|Alternative therapy|1
3077984|NCT00427349|10565881|P1|Overall Study|Withdrawal by Subject|3
3077985|NCT00427349|10565881|P1|Overall Study|Death|1
3077986|NCT00427349|10565881|P1|Overall Study|Adverse Event|14
3077987|NCT00427349|10565881|P1|Overall Study|Lack of Efficacy|23
3077988|NCT00427011|10565938|P1|Overall Study|Other|12
3077989|NCT00427011|10565938|P1|Overall Study|Lack of Efficacy|2
3077990|NCT00427011|10565938|P1|Overall Study|Withdrawal by Subject|1
3077991|NCT00427011|10565938|P1|Overall Study|Adverse Event|10
3077992|NCT00426842|10565953|P1|Overall Study|Lost to Follow-up|1
3077993|NCT00426764|10565959|P1|Overall Study|Other Reasons (Miscellaneous)|10
3077994|NCT00426764|10565959|P1|Overall Study|Death|1
3077995|NCT00426764|10565959|P1|Overall Study|Other|1
3077996|NCT00426764|10565959|P1|Overall Study|Adverse Event|24
3077997|NCT00426764|10565959|P1|Overall Study|Progressive Disease|83
3077998|NCT00426764|10565959|P1|Overall Study|Compassionate Use|1
3077999|NCT00426764|10565959|P1|Overall Study|Physician Decision|6
3078000|NCT00426764|10565959|P1|Overall Study|Withdrawal by Subject|4
3078001|NCT00426764|10565959|P1|Overall Study|Protocol Violation|1
3078002|NCT00426751|10565976|P2|Overall Study|Other Reasons|12
3078003|NCT00426751|10565977|P1|Overall Study|Other Reasons|7
3078004|NCT00426751|10565976|P2|Overall Study|Consent Withdrawn|1
3078005|NCT00426751|10565977|P1|Overall Study|Consent Withdrawn|0
3078006|NCT00426751|10565976|P2|Overall Study|Lost to Follow-up|6
3078007|NCT00426751|10565977|P1|Overall Study|Lost to Follow-up|7
3078008|NCT00426751|10565976|P2|Overall Study|Adverse Event|1
3078009|NCT00426751|10565977|P1|Overall Study|Adverse Event|8
3078010|NCT00426660|10566021|P1|Overall Study|Enrolled Not Treated|15
3078011|NCT00426660|10566021|P1|Overall Study|Protocol Violation|1
3078012|NCT00426660|10566021|P1|Overall Study|Withdrawal by Subject|18
3078013|NCT00426660|10566021|P1|Overall Study|Other|23
3078014|NCT00426660|10566021|P1|Overall Study|Lost to Follow-up|15
3078015|NCT00426660|10566021|P1|Overall Study|Insufficient Clinical Response|22
3078016|NCT00426660|10566021|P1|Overall Study|Adverse Event|23
3078017|NCT00426660|10566021|P1|Overall Study|Death|14
3078018|NCT00426556|10566052|P4|Phase II - Extension Phase|Adverse Event|2
3078019|NCT00426556|10566053|P3|Phase II - Extension Phase|Adverse Event|0
3078020|NCT00426556|10566054|P2|Phase II - Extension Phase|Adverse Event|0
3078021|NCT00426556|10566055|P1|Phase II - Extension Phase|Adverse Event|0
3078022|NCT00426556|10566052|P4|Phase II - Extension Phase|Disease Progression|21
3078023|NCT00426556|10566053|P3|Phase II - Extension Phase|Disease Progression|0
3078024|NCT00426556|10566054|P2|Phase II - Extension Phase|Disease Progression|0
3078025|NCT00426556|10566055|P1|Phase II - Extension Phase|Disease Progression|0
3078026|NCT00426556|10566052|P4|Phase II - Core Phase|Adverse Event|8
3078027|NCT00426556|10566053|P3|Phase II - Core Phase|Adverse Event|0
3078028|NCT00426556|10566054|P2|Phase II - Core Phase|Adverse Event|0
3078029|NCT00426556|10566055|P1|Phase II - Core Phase|Adverse Event|0
3078030|NCT00426556|10566052|P4|Phase II - Core Phase|Disease Progression|16
3078031|NCT00426556|10566053|P3|Phase II - Core Phase|Disease Progression|0
3078032|NCT00426556|10566054|P2|Phase II - Core Phase|Disease Progression|0
3078033|NCT00426556|10566055|P1|Phase II - Core Phase|Disease Progression|0
3078034|NCT00426556|10566052|P4|Phase II - Core Phase|Withdrawal by Subject|3
3078035|NCT00426556|10566053|P3|Phase II - Core Phase|Withdrawal by Subject|0
3078036|NCT00426556|10566054|P2|Phase II - Core Phase|Withdrawal by Subject|0
3078037|NCT00426556|10566055|P1|Phase II - Core Phase|Withdrawal by Subject|0
3078038|NCT00426556|10566052|P4|Phase I - Extension Phase|Disease Progression|0
3078039|NCT00426556|10566053|P3|Phase I - Extension Phase|Disease Progression|6
3078040|NCT00426556|10566054|P2|Phase I - Extension Phase|Disease Progression|5
3078041|NCT00426556|10566055|P1|Phase I - Extension Phase|Disease Progression|5
3078042|NCT00426556|10566052|P4|Phase I - Extension Phase|Adverse Event|0
3078043|NCT00426556|10566053|P3|Phase I - Extension Phase|Adverse Event|1
3078044|NCT00426556|10566054|P2|Phase I - Extension Phase|Adverse Event|1
3078045|NCT00426556|10566055|P1|Phase I - Extension Phase|Adverse Event|0
3078046|NCT00426556|10566052|P4|Phase I - Core Phase|Death|0
3078047|NCT00426556|10566053|P3|Phase I - Core Phase|Death|0
3078048|NCT00426556|10566054|P2|Phase I - Core Phase|Death|1
3078049|NCT00426556|10566055|P1|Phase I - Core Phase|Death|0
3078050|NCT00426556|10566052|P4|Phase I - Core Phase|Adverse Event|0
3078051|NCT00426556|10566053|P3|Phase I - Core Phase|Adverse Event|1
3078052|NCT00426556|10566054|P2|Phase I - Core Phase|Adverse Event|3
3078053|NCT00426556|10566055|P1|Phase I - Core Phase|Adverse Event|1
3078054|NCT00426556|10566052|P4|Phase I - Core Phase|Disease Progression|0
3078055|NCT00426556|10566053|P3|Phase I - Core Phase|Disease Progression|2
3078056|NCT00426556|10566054|P2|Phase I - Core Phase|Disease Progression|6
3078057|NCT00426556|10566055|P1|Phase I - Core Phase|Disease Progression|0
3078058|NCT00426361|10566080|P3|Overall Study|Withdrawal by Subject|0
3078059|NCT00426361|10566081|P2|Overall Study|Withdrawal by Subject|3
3078060|NCT00426361|10566082|P1|Overall Study|Withdrawal by Subject|1
3078061|NCT00426361|10566080|P3|Overall Study|Lost to Follow-up|5
3078062|NCT00426361|10566081|P2|Overall Study|Lost to Follow-up|2
3078063|NCT00426361|10566082|P1|Overall Study|Lost to Follow-up|3
3078064|NCT00426270|10566141|P1|Overall Study|Adverse Event|5
3078065|NCT00426270|10566141|P1|Overall Study|Incorrectly Enrolled in the Study|1
3078066|NCT00426231|10566151|P2|Overall Study|Withdrawal by Subject|12
3078067|NCT00426231|10566152|P1|Overall Study|Withdrawal by Subject|9
3078068|NCT00426127|10566175|P1|Overall Study|Removed due to disease progression|1
3078069|NCT00426127|10566175|P1|Overall Study|Adverse Event|1
3078070|NCT00425945|10566183|P2|Overall Study|Moved from area|1
3078071|NCT00425945|10566184|P1|Overall Study|Moved from area|0
3078072|NCT00425945|10566183|P2|Overall Study|Began cancer treatments|0
3078073|NCT00425945|10566184|P1|Overall Study|Began cancer treatments|1
3078074|NCT00425945|10566183|P2|Overall Study|Began hypertension medication|0
3078075|NCT00425945|10566184|P1|Overall Study|Began hypertension medication|1
3078076|NCT00425945|10566183|P2|Overall Study|Lost to Follow-up|2
3078077|NCT00425945|10566184|P1|Overall Study|Lost to Follow-up|0
3078078|NCT00425945|10566183|P2|Overall Study|Inconvenience|2
3078079|NCT00425945|10566184|P1|Overall Study|Inconvenience|0
3078080|NCT00425945|10566183|P2|Overall Study|Concern about Supplement|0
3078081|NCT00425945|10566184|P1|Overall Study|Concern about Supplement|2
3078082|NCT00425854|10566222|P2|Overall Study|Other Adverse Event|2
3078083|NCT00425854|10566223|P1|Overall Study|Other Adverse Event|2
3078084|NCT00425854|10566222|P2|Overall Study|Dose reduction toxicity AE|7
3078085|NCT00425854|10566223|P1|Overall Study|Dose reduction toxicity AE|8
3078086|NCT00425854|10566222|P2|Overall Study|Progressive Disease|12
3078087|NCT00425854|10566223|P1|Overall Study|Progressive Disease|19
3078088|NCT00425750|10566256|P1|Overall Study|Progression of disease|18
3078089|NCT00425750|10566256|P1|Overall Study|Adverse Event|3
3078090|NCT00425750|10566256|P1|Overall Study|Withdrawal by Subject|3
3078091|NCT00425750|10566256|P1|Overall Study|Death|1
3078092|NCT00425698|10566264|P2|Overall Study|Withdrawal by Subject|1
3078093|NCT00425698|10566265|P1|Overall Study|Withdrawal by Subject|0
3078094|NCT00425698|10566264|P2|Overall Study|Adverse Event|1
3078095|NCT00425698|10566265|P1|Overall Study|Adverse Event|3
3078096|NCT00425607|10566280|P1|Overall Study|Withdrawal by Subject|1
3078097|NCT00425607|10566280|P1|Overall Study|Death|1
3078098|NCT00425503|10566284|P1|Overall Study|Protocol Violation|1
3078099|NCT00425503|10566284|P1|Overall Study|Adverse Event|2
3078100|NCT00425438|10566296|P2|Overall Study|Termination by Sponsor|27
3078101|NCT00425438|10566297|P1|Overall Study|Termination by Sponsor|25
3078102|NCT00425373|10566331|P9|Overall Study|Lack of Efficacy|5
3078103|NCT00425373|10566332|P8|Overall Study|Lack of Efficacy|0
3078104|NCT00425373|10566333|P7|Overall Study|Lack of Efficacy|3
3078105|NCT00425373|10566334|P6|Overall Study|Lack of Efficacy|3
3078106|NCT00425373|10566335|P5|Overall Study|Lack of Efficacy|1
3078107|NCT00425373|10566336|P4|Overall Study|Lack of Efficacy|0
3078108|NCT00425373|10566337|P3|Overall Study|Lack of Efficacy|0
3078109|NCT00425373|10566338|P2|Overall Study|Lack of Efficacy|0
3078110|NCT00425373|10566339|P1|Overall Study|Lack of Efficacy|0
3078111|NCT00425373|10566331|P9|Overall Study|Withdrawal by Subject|2
3078112|NCT00425373|10566332|P8|Overall Study|Withdrawal by Subject|2
3078113|NCT00425373|10566333|P7|Overall Study|Withdrawal by Subject|2
3078114|NCT00425373|10566334|P6|Overall Study|Withdrawal by Subject|0
3078115|NCT00425373|10566335|P5|Overall Study|Withdrawal by Subject|4
3078116|NCT00425373|10566336|P4|Overall Study|Withdrawal by Subject|1
3078117|NCT00425373|10566337|P3|Overall Study|Withdrawal by Subject|2
3078118|NCT00425373|10566338|P2|Overall Study|Withdrawal by Subject|0
3078119|NCT00425373|10566339|P1|Overall Study|Withdrawal by Subject|2
3078120|NCT00425373|10566331|P9|Overall Study|Protocol Violation|3
3078121|NCT00425373|10566332|P8|Overall Study|Protocol Violation|5
3078122|NCT00425373|10566333|P7|Overall Study|Protocol Violation|0
3078123|NCT00425373|10566334|P6|Overall Study|Protocol Violation|0
3078124|NCT00425373|10566335|P5|Overall Study|Protocol Violation|0
3078125|NCT00425373|10566336|P4|Overall Study|Protocol Violation|0
3078126|NCT00425373|10566337|P3|Overall Study|Protocol Violation|1
3078127|NCT00425373|10566338|P2|Overall Study|Protocol Violation|0
3078128|NCT00425373|10566339|P1|Overall Study|Protocol Violation|1
3078129|NCT00425373|10566331|P9|Overall Study|Lost to Follow-up|0
3078130|NCT00425373|10566332|P8|Overall Study|Lost to Follow-up|0
3078131|NCT00425373|10566333|P7|Overall Study|Lost to Follow-up|0
3078132|NCT00425373|10566334|P6|Overall Study|Lost to Follow-up|0
3078133|NCT00425373|10566335|P5|Overall Study|Lost to Follow-up|1
3078134|NCT00425373|10566336|P4|Overall Study|Lost to Follow-up|0
3078135|NCT00425373|10566337|P3|Overall Study|Lost to Follow-up|0
3078136|NCT00425373|10566338|P2|Overall Study|Lost to Follow-up|1
3078137|NCT00425373|10566339|P1|Overall Study|Lost to Follow-up|0
3078138|NCT00425373|10566331|P9|Overall Study|Adverse Event|8
3078139|NCT00425373|10566332|P8|Overall Study|Adverse Event|3
3078140|NCT00425373|10566333|P7|Overall Study|Adverse Event|2
3078141|NCT00425373|10566334|P6|Overall Study|Adverse Event|6
3078142|NCT00425373|10566335|P5|Overall Study|Adverse Event|4
3078143|NCT00425373|10566336|P4|Overall Study|Adverse Event|1
3078144|NCT00425373|10566337|P3|Overall Study|Adverse Event|0
3078145|NCT00425373|10566338|P2|Overall Study|Adverse Event|2
3078146|NCT00425373|10566339|P1|Overall Study|Adverse Event|2
3078147|NCT00425308|10566397|P2|Overall Study|Death|0
3078148|NCT00425308|10566398|P1|Overall Study|Death|1
3078149|NCT00425308|10566397|P2|Overall Study|Withdrawal by Subject|0
3078150|NCT00425308|10566398|P1|Overall Study|Withdrawal by Subject|1
3078151|NCT00425308|10566397|P2|Overall Study|Adverse Event|1
3078152|NCT00425308|10566398|P1|Overall Study|Adverse Event|2
3078153|NCT00425269|10566428|P2|Overall Study|moved or medical reason|4
3078154|NCT00425269|10566429|P1|Overall Study|moved or medical reason|5
3078155|NCT00425269|10566428|P2|Overall Study|Lost to Follow-up|9
3078156|NCT00425269|10566429|P1|Overall Study|Lost to Follow-up|9
3078157|NCT00425269|10566428|P2|Overall Study|Pregnancy|7
3078158|NCT00425269|10566429|P1|Overall Study|Pregnancy|5
3078159|NCT00425113|10566507|P2|Overall Study|Withdrawal by Subject|0
3078160|NCT00425113|10566508|P1|Overall Study|Withdrawal by Subject|1
3078161|NCT00425113|10566507|P2|Overall Study|missing study drug more than 14 days|1
3078162|NCT00425113|10566508|P1|Overall Study|missing study drug more than 14 days|0
3078163|NCT00425113|10566507|P2|Overall Study|diagnosis of abdominal TB|1
3078164|NCT00425113|10566508|P1|Overall Study|diagnosis of abdominal TB|0
3078165|NCT00425113|10566507|P2|Overall Study|uncontrolled diabetes mellitus|0
3078166|NCT00425113|10566508|P1|Overall Study|uncontrolled diabetes mellitus|1
3078167|NCT00425100|10566516|P1|Overall Study|Withdrawal by Subject|7
3078168|NCT00425100|10566516|P1|Overall Study|Protocol Violation|4
3078169|NCT00425100|10566516|P1|Overall Study|Lost to Follow-up|2
3078170|NCT00425100|10566516|P1|Overall Study|Lack of Efficacy|4
3078171|NCT00425100|10566516|P1|Overall Study|Adverse Event|36
3078172|NCT00425061|10566560|P7|Overall Study|Other|1
3078173|NCT00425061|10566561|P6|Overall Study|Other|0
3078174|NCT00425061|10566562|P5|Overall Study|Other|3
3078175|NCT00425061|10566563|P4|Overall Study|Other|0
3078176|NCT00425061|10566564|P3|Overall Study|Other|0
3078177|NCT00425061|10566565|P2|Overall Study|Other|0
3078178|NCT00425061|10566566|P1|Overall Study|Other|0
3078179|NCT00425061|10566560|P7|Overall Study|Physician Decision|0
3078180|NCT00425061|10566561|P6|Overall Study|Physician Decision|0
3078181|NCT00425061|10566562|P5|Overall Study|Physician Decision|1
3078182|NCT00425061|10566563|P4|Overall Study|Physician Decision|0
3078183|NCT00425061|10566564|P3|Overall Study|Physician Decision|0
3078184|NCT00425061|10566565|P2|Overall Study|Physician Decision|0
3078185|NCT00425061|10566566|P1|Overall Study|Physician Decision|0
3078186|NCT00425061|10566560|P7|Overall Study|Sponsor's request|15
3078187|NCT00425061|10566561|P6|Overall Study|Sponsor's request|4
3078188|NCT00425061|10566562|P5|Overall Study|Sponsor's request|19
3078189|NCT00425061|10566563|P4|Overall Study|Sponsor's request|0
3078190|NCT00425061|10566564|P3|Overall Study|Sponsor's request|0
3078191|NCT00425061|10566565|P2|Overall Study|Sponsor's request|0
3078192|NCT00425061|10566566|P1|Overall Study|Sponsor's request|0
3078193|NCT00425061|10566560|P7|Overall Study|Withdrawal by Subject|3
3078194|NCT00425061|10566561|P6|Overall Study|Withdrawal by Subject|0
3078195|NCT00425061|10566562|P5|Overall Study|Withdrawal by Subject|1
3078196|NCT00425061|10566563|P4|Overall Study|Withdrawal by Subject|0
3078197|NCT00425061|10566564|P3|Overall Study|Withdrawal by Subject|0
3078198|NCT00425061|10566565|P2|Overall Study|Withdrawal by Subject|1
3078199|NCT00425061|10566566|P1|Overall Study|Withdrawal by Subject|0
3078200|NCT00425061|10566560|P7|Overall Study|Protocol Violation|0
3078201|NCT00425061|10566561|P6|Overall Study|Protocol Violation|0
3078202|NCT00425061|10566562|P5|Overall Study|Protocol Violation|0
3078203|NCT00425061|10566563|P4|Overall Study|Protocol Violation|0
3078204|NCT00425061|10566564|P3|Overall Study|Protocol Violation|0
3078205|NCT00425061|10566565|P2|Overall Study|Protocol Violation|0
3078206|NCT00425061|10566566|P1|Overall Study|Protocol Violation|1
3078207|NCT00425061|10566560|P7|Overall Study|Lost to Follow-up|0
3078208|NCT00425061|10566561|P6|Overall Study|Lost to Follow-up|0
3078209|NCT00425061|10566562|P5|Overall Study|Lost to Follow-up|0
3078210|NCT00425061|10566563|P4|Overall Study|Lost to Follow-up|0
3078211|NCT00425061|10566564|P3|Overall Study|Lost to Follow-up|0
3078212|NCT00425061|10566565|P2|Overall Study|Lost to Follow-up|1
3078213|NCT00425061|10566566|P1|Overall Study|Lost to Follow-up|0
3078214|NCT00425061|10566560|P7|Overall Study|Adverse Event|0
3078215|NCT00425061|10566561|P6|Overall Study|Adverse Event|0
3078216|NCT00425061|10566562|P5|Overall Study|Adverse Event|2
3078217|NCT00425061|10566563|P4|Overall Study|Adverse Event|2
3078218|NCT00425061|10566564|P3|Overall Study|Adverse Event|0
3078219|NCT00425061|10566565|P2|Overall Study|Adverse Event|0
3078220|NCT00425061|10566566|P1|Overall Study|Adverse Event|1
3078221|NCT00424827|10566690|P1|Overall Study|Adverse Event|1
3078222|NCT00424775|10566698|P2|Overall Study|Lack of Efficacy|0
3078223|NCT00424775|10566699|P1|Overall Study|Lack of Efficacy|1
3078224|NCT00424775|10566698|P2|Overall Study|Adverse Event|0
3078225|NCT00424775|10566699|P1|Overall Study|Adverse Event|2
3078226|NCT00424762|10566709|P2|Overall Study|Lost to Follow-up|3
3078227|NCT00424762|10566710|P1|Overall Study|Lost to Follow-up|2
3078228|NCT00424762|10566709|P2|Overall Study|Withdrawal by Subject|19
3078229|NCT00424762|10566710|P1|Overall Study|Withdrawal by Subject|18
3078230|NCT00424749|10566720|P1|Overall Study|Withdrawal by Subject|1
3078231|NCT00424645|10566727|P2|Overall Study|Death|0
3078232|NCT00424645|10566728|P1|Overall Study|Death|1
3078233|NCT00424632|10566736|P10|Overall Study|Other|0
3078234|NCT00424632|10566737|P9|Overall Study|Other|1
3078235|NCT00424632|10566738|P8|Overall Study|Other|0
3078236|NCT00424632|10566739|P7|Overall Study|Other|0
3078237|NCT00424632|10566740|P6|Overall Study|Other|0
3078238|NCT00424632|10566741|P5|Overall Study|Other|0
3078239|NCT00424632|10566742|P4|Overall Study|Other|1
3078240|NCT00424632|10566743|P3|Overall Study|Other|0
3078241|NCT00424632|10566744|P2|Overall Study|Other|0
3078242|NCT00424632|10566745|P1|Overall Study|Other|0
3078243|NCT00424632|10566736|P10|Overall Study|Objective progression or relapse|4
3078244|NCT00424632|10566737|P9|Overall Study|Objective progression or relapse|12
3078245|NCT00424632|10566738|P8|Overall Study|Objective progression or relapse|3
3078246|NCT00424632|10566739|P7|Overall Study|Objective progression or relapse|7
3078247|NCT00424632|10566740|P6|Overall Study|Objective progression or relapse|13
3078248|NCT00424632|10566741|P5|Overall Study|Objective progression or relapse|2
3078249|NCT00424632|10566742|P4|Overall Study|Objective progression or relapse|2
3078250|NCT00424632|10566743|P3|Overall Study|Objective progression or relapse|1
3078251|NCT00424632|10566744|P2|Overall Study|Objective progression or relapse|1
3078252|NCT00424632|10566745|P1|Overall Study|Objective progression or relapse|1
3078253|NCT00424632|10566736|P10|Overall Study|Global deterioration of health status|0
3078254|NCT00424632|10566737|P9|Overall Study|Global deterioration of health status|0
3078255|NCT00424632|10566738|P8|Overall Study|Global deterioration of health status|0
3078256|NCT00424632|10566739|P7|Overall Study|Global deterioration of health status|0
3078257|NCT00424632|10566740|P6|Overall Study|Global deterioration of health status|0
3078258|NCT00424632|10566741|P5|Overall Study|Global deterioration of health status|1
3078259|NCT00424632|10566742|P4|Overall Study|Global deterioration of health status|1
3078260|NCT00424632|10566743|P3|Overall Study|Global deterioration of health status|0
3078261|NCT00424632|10566744|P2|Overall Study|Global deterioration of health status|0
3078262|NCT00424632|10566745|P1|Overall Study|Global deterioration of health status|0
3078263|NCT00424632|10566736|P10|Overall Study|Adverse Event|2
3078264|NCT00424632|10566737|P9|Overall Study|Adverse Event|3
3078265|NCT00424632|10566738|P8|Overall Study|Adverse Event|0
3078266|NCT00424632|10566739|P7|Overall Study|Adverse Event|0
3078267|NCT00424632|10566740|P6|Overall Study|Adverse Event|0
3078268|NCT00424632|10566741|P5|Overall Study|Adverse Event|0
3078269|NCT00424632|10566742|P4|Overall Study|Adverse Event|0
3078270|NCT00424632|10566743|P3|Overall Study|Adverse Event|0
3078271|NCT00424632|10566744|P2|Overall Study|Adverse Event|0
3078272|NCT00424632|10566745|P1|Overall Study|Adverse Event|0
3078273|NCT00424632|10566736|P10|Overall Study|Death|0
3078274|NCT00424632|10566737|P9|Overall Study|Death|0
3078275|NCT00424632|10566738|P8|Overall Study|Death|0
3078276|NCT00424632|10566739|P7|Overall Study|Death|0
3078277|NCT00424632|10566740|P6|Overall Study|Death|2
3078278|NCT00424632|10566741|P5|Overall Study|Death|0
3078279|NCT00424632|10566742|P4|Overall Study|Death|0
3078280|NCT00424632|10566743|P3|Overall Study|Death|0
3078281|NCT00424632|10566744|P2|Overall Study|Death|0
3078282|NCT00424632|10566745|P1|Overall Study|Death|0
3078283|NCT00424593|10566915|P2|Dose-Blind Extension Period|Physician Decision|0
3078284|NCT00424593|10566916|P1|Dose-Blind Extension Period|Physician Decision|3
3078285|NCT00424593|10566915|P2|Dose-Blind Extension Period|Lost to Follow-up|0
3078286|NCT00424593|10566916|P1|Dose-Blind Extension Period|Lost to Follow-up|6
3078287|NCT00424593|10566915|P2|Dose-Blind Extension Period|Protocol Violation|0
3078288|NCT00424593|10566916|P1|Dose-Blind Extension Period|Protocol Violation|9
3078289|NCT00424593|10566915|P2|Dose-Blind Extension Period|Lack of Efficacy|0
3078290|NCT00424593|10566916|P1|Dose-Blind Extension Period|Lack of Efficacy|9
3078291|NCT00424593|10566915|P2|Dose-Blind Extension Period|Adverse Event|0
3078292|NCT00424593|10566916|P1|Dose-Blind Extension Period|Adverse Event|18
3078293|NCT00424593|10566915|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
3078294|NCT00424593|10566916|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
3078295|NCT00424593|10566915|P2|Acute Double-Blind Period|Lack of Efficacy|1
3078296|NCT00424593|10566916|P1|Acute Double-Blind Period|Lack of Efficacy|0
3078297|NCT00424593|10566915|P2|Acute Double-Blind Period|Lost to Follow-up|1
3078298|NCT00424593|10566916|P1|Acute Double-Blind Period|Lost to Follow-up|1
3078299|NCT00424593|10566915|P2|Acute Double-Blind Period|Physician Decision|2
3078300|NCT00424593|10566916|P1|Acute Double-Blind Period|Physician Decision|1
3078301|NCT00424593|10566915|P2|Acute Double-Blind Period|Protocol Violation|2
3078302|NCT00424593|10566916|P1|Acute Double-Blind Period|Protocol Violation|2
3078303|NCT00424593|10566915|P2|Acute Double-Blind Period|Withdrawal by Subject|10
3078304|NCT00424593|10566916|P1|Acute Double-Blind Period|Withdrawal by Subject|11
3078305|NCT00424593|10566915|P2|Acute Double-Blind Period|Adverse Event|7
3078306|NCT00424593|10566916|P1|Acute Double-Blind Period|Adverse Event|16
3078307|NCT00424528|10566980|P3|Overall Study|noncompliance with study requirements|2
3078308|NCT00424528|10566981|P2|Overall Study|noncompliance with study requirements|1
3078309|NCT00424528|10566982|P1|Overall Study|noncompliance with study requirements|2
3078310|NCT00424528|10566980|P3|Overall Study|Lost to Follow-up|0
3078311|NCT00424528|10566981|P2|Overall Study|Lost to Follow-up|1
3078312|NCT00424528|10566982|P1|Overall Study|Lost to Follow-up|0
3078313|NCT00424528|10566980|P3|Overall Study|Protocol Violation|0
3078314|NCT00424528|10566981|P2|Overall Study|Protocol Violation|1
3078315|NCT00424528|10566982|P1|Overall Study|Protocol Violation|1
3078316|NCT00424528|10566980|P3|Overall Study|Adverse Event|2
3078317|NCT00424528|10566981|P2|Overall Study|Adverse Event|1
3078318|NCT00424528|10566982|P1|Overall Study|Adverse Event|2
3078319|NCT00424515|10567037|P2|Overall Study|Withdrawal by Subject|0
3078320|NCT00424515|10567038|P1|Overall Study|Withdrawal by Subject|1
3078321|NCT00424515|10567037|P2|Overall Study|Intercurrent Illness|1
3078322|NCT00424515|10567038|P1|Overall Study|Intercurrent Illness|0
3078323|NCT00424515|10567037|P2|Overall Study|Adverse Event|1
3078324|NCT00424515|10567038|P1|Overall Study|Adverse Event|0
3078325|NCT00424515|10567037|P2|Overall Study|Progressive Disease|11
3078326|NCT00424515|10567038|P1|Overall Study|Progressive Disease|10
3078327|NCT00424489|10567057|P1|Overall Study|Death|3
3078328|NCT00424476|10567064|P3|Overall Study|Other|9
3078329|NCT00424476|10567065|P2|Overall Study|Other|3
3078330|NCT00424476|10567066|P1|Overall Study|Other|4
3078331|NCT00424476|10567064|P3|Overall Study|Physician Decision|3
3078332|NCT00424476|10567065|P2|Overall Study|Physician Decision|2
3078333|NCT00424476|10567066|P1|Overall Study|Physician Decision|3
3078334|NCT00424476|10567064|P3|Overall Study|Protocol Violation|3
3078335|NCT00424476|10567065|P2|Overall Study|Protocol Violation|2
3078336|NCT00424476|10567066|P1|Overall Study|Protocol Violation|7
3078337|NCT00424476|10567064|P3|Overall Study|Lost to Follow-up|3
3078338|NCT00424476|10567065|P2|Overall Study|Lost to Follow-up|6
3078339|NCT00424476|10567066|P1|Overall Study|Lost to Follow-up|4
3078340|NCT00424476|10567064|P3|Overall Study|Lack of Compliance|1
3078341|NCT00424476|10567065|P2|Overall Study|Lack of Compliance|1
3078342|NCT00424476|10567066|P1|Overall Study|Lack of Compliance|1
3078343|NCT00424476|10567064|P3|Overall Study|Lack of Efficacy|12
3078344|NCT00424476|10567065|P2|Overall Study|Lack of Efficacy|12
3078345|NCT00424476|10567066|P1|Overall Study|Lack of Efficacy|16
3078346|NCT00424476|10567064|P3|Overall Study|Adverse Event|15
3078347|NCT00424476|10567065|P2|Overall Study|Adverse Event|16
3078348|NCT00424476|10567066|P1|Overall Study|Adverse Event|19
3078349|NCT00424476|10567064|P3|Overall Study|Withdrawal by Subject|3
3078350|NCT00424476|10567065|P2|Overall Study|Withdrawal by Subject|6
3078351|NCT00424476|10567066|P1|Overall Study|Withdrawal by Subject|7
3078352|NCT00424463|10567092|P3|Overall Study|Patient’s convenience|1
3078353|NCT00424463|10567093|P2|Overall Study|Patient’s convenience|0
3078354|NCT00424463|10567094|P1|Overall Study|Patient’s convenience|0
3078355|NCT00424463|10567092|P3|Overall Study|Tracheotomy due to worsening of ALS|6
3078356|NCT00424463|10567093|P2|Overall Study|Tracheotomy due to worsening of ALS|7
3078357|NCT00424463|10567094|P1|Overall Study|Tracheotomy due to worsening of ALS|1
3078358|NCT00424463|10567092|P3|Overall Study|Withdrawal by Subject|5
3078359|NCT00424463|10567093|P2|Overall Study|Withdrawal by Subject|2
3078360|NCT00424463|10567094|P1|Overall Study|Withdrawal by Subject|4
3078361|NCT00424463|10567092|P3|Overall Study|Physician Decision|2
3078362|NCT00424463|10567093|P2|Overall Study|Physician Decision|2
3078363|NCT00424463|10567094|P1|Overall Study|Physician Decision|0
3078364|NCT00424463|10567092|P3|Overall Study|Adverse Event|2
3078365|NCT00424463|10567093|P2|Overall Study|Adverse Event|3
3078366|NCT00424463|10567094|P1|Overall Study|Adverse Event|2
3078367|NCT00424398|10567123|P3|Overall Study|Subject met exclusion criteria|0
3078368|NCT00424398|10567124|P2|Overall Study|Subject met exclusion criteria|0
3078369|NCT00424398|10567125|P1|Overall Study|Subject met exclusion criteria|1
3078370|NCT00424398|10567123|P3|Overall Study|Withdrawal by Subject|0
3078371|NCT00424398|10567124|P2|Overall Study|Withdrawal by Subject|1
3078372|NCT00424398|10567125|P1|Overall Study|Withdrawal by Subject|2
3078373|NCT00424385|10567169|P1|Cohort 1|Withdrawal by Subject|1
3078374|NCT00424385|10567169|P1|Cohort 0|Physician Decision|1
3078375|NCT00424385|10567169|P1|Cohort 0|Withdrawal by Subject|5
3078376|NCT00424372|10567176|P1|Overall Study|Lack of Efficacy|6
3078377|NCT00424372|10567176|P1|Overall Study|Protocol Violation|1
3078378|NCT00424372|10567176|P1|Overall Study|Withdrawal by Subject|4
3078379|NCT00424372|10567176|P1|Overall Study|Health deterioration|1
3078380|NCT00424372|10567176|P1|Overall Study|Adverse Event|18
3078381|NCT00424372|10567176|P1|Overall Study|Death|1
3078382|NCT00424346|10567188|P4|Extension Phase|Protocol Violation|0
3078383|NCT00424346|10567189|P3|Extension Phase|Protocol Violation|1
3078384|NCT00424346|10567190|P2|Extension Phase|Protocol Violation|1
3078385|NCT00424346|10567191|P1|Extension Phase|Protocol Violation|0
3078386|NCT00424346|10567188|P4|Extension Phase|Death|1
3078387|NCT00424346|10567189|P3|Extension Phase|Death|0
3078388|NCT00424346|10567190|P2|Extension Phase|Death|0
3078389|NCT00424346|10567191|P1|Extension Phase|Death|0
3078390|NCT00424346|10567188|P4|Extension Phase|Administrative Problems|35
3078391|NCT00424346|10567189|P3|Extension Phase|Administrative Problems|32
3078392|NCT00424346|10567190|P2|Extension Phase|Administrative Problems|69
3078393|NCT00424346|10567191|P1|Extension Phase|Administrative Problems|0
3078394|NCT00424346|10567188|P4|Extension Phase|Lost to Follow-up|0
3078395|NCT00424346|10567189|P3|Extension Phase|Lost to Follow-up|0
3078396|NCT00424346|10567190|P2|Extension Phase|Lost to Follow-up|2
3078397|NCT00424346|10567191|P1|Extension Phase|Lost to Follow-up|0
3078398|NCT00424346|10567188|P4|Extension Phase|Withdrawal by Subject|4
3078399|NCT00424346|10567189|P3|Extension Phase|Withdrawal by Subject|3
3078400|NCT00424346|10567190|P2|Extension Phase|Withdrawal by Subject|5
3078401|NCT00424346|10567191|P1|Extension Phase|Withdrawal by Subject|0
3078402|NCT00424346|10567188|P4|Extension Phase|Lack of Efficacy|11
3078403|NCT00424346|10567189|P3|Extension Phase|Lack of Efficacy|14
3078404|NCT00424346|10567190|P2|Extension Phase|Lack of Efficacy|16
3078405|NCT00424346|10567191|P1|Extension Phase|Lack of Efficacy|0
3078406|NCT00424346|10567188|P4|Extension Phase|Adverse Event|4
3078407|NCT00424346|10567189|P3|Extension Phase|Adverse Event|5
3078408|NCT00424346|10567190|P2|Extension Phase|Adverse Event|9
3078409|NCT00424346|10567191|P1|Extension Phase|Adverse Event|0
3078410|NCT00424346|10567188|P4|Core Study|Protocol Violation|0
3078411|NCT00424346|10567189|P3|Core Study|Protocol Violation|2
3078412|NCT00424346|10567190|P2|Core Study|Protocol Violation|0
3078413|NCT00424346|10567191|P1|Core Study|Protocol Violation|0
3078414|NCT00424346|10567188|P4|Core Study|Administrative Problems|0
3078415|NCT00424346|10567189|P3|Core Study|Administrative Problems|1
3078416|NCT00424346|10567190|P2|Core Study|Administrative Problems|0
3078417|NCT00424346|10567191|P1|Core Study|Administrative Problems|1
3078418|NCT00424346|10567188|P4|Core Study|Lost to Follow-up|0
3078419|NCT00424346|10567189|P3|Core Study|Lost to Follow-up|0
3078420|NCT00424346|10567190|P2|Core Study|Lost to Follow-up|1
3078421|NCT00424346|10567191|P1|Core Study|Lost to Follow-up|1
3078422|NCT00424346|10567188|P4|Core Study|Withdrawal by Subject|2
3078423|NCT00424346|10567189|P3|Core Study|Withdrawal by Subject|0
3078424|NCT00424346|10567190|P2|Core Study|Withdrawal by Subject|0
3078425|NCT00424346|10567191|P1|Core Study|Withdrawal by Subject|1
3078426|NCT00424346|10567188|P4|Core Study|Lack of Efficacy|4
3078427|NCT00424346|10567189|P3|Core Study|Lack of Efficacy|0
3078428|NCT00424346|10567190|P2|Core Study|Lack of Efficacy|3
3078429|NCT00424346|10567191|P1|Core Study|Lack of Efficacy|1
3078430|NCT00424346|10567188|P4|Core Study|Abnormal Laboratory Values|0
3078431|NCT00424346|10567189|P3|Core Study|Abnormal Laboratory Values|0
3078432|NCT00424346|10567190|P2|Core Study|Abnormal Laboratory Values|1
3078433|NCT00424346|10567191|P1|Core Study|Abnormal Laboratory Values|0
3078434|NCT00424346|10567188|P4|Core Study|Adverse Event|1
3078435|NCT00424346|10567189|P3|Core Study|Adverse Event|1
3078436|NCT00424346|10567190|P2|Core Study|Adverse Event|3
3078437|NCT00424346|10567191|P1|Core Study|Adverse Event|5
3078438|NCT00424294|10567306|P2|Overall Study|Randomized but not Treated|0
3078439|NCT00424294|10567307|P1|Overall Study|Randomized but not Treated|1
3078440|NCT00424294|10567306|P2|Overall Study|Other|2
3078441|NCT00424294|10567307|P1|Overall Study|Other|0
3078442|NCT00424294|10567306|P2|Overall Study|Withdrawal by Subject|2
3078443|NCT00424294|10567307|P1|Overall Study|Withdrawal by Subject|1
3078444|NCT00424294|10567306|P2|Overall Study|Lack of Efficacy|1
3078445|NCT00424294|10567307|P1|Overall Study|Lack of Efficacy|2
3078446|NCT00424294|10567306|P2|Overall Study|Adverse Event|10
3078447|NCT00424294|10567307|P1|Overall Study|Adverse Event|4
3078448|NCT00424255|10567374|P2|Overall Study|Sponsor Terminated Study|167
3078449|NCT00424255|10567375|P1|Overall Study|Sponsor Terminated Study|161
3078450|NCT00424255|10567374|P2|Overall Study|Disease Progression|2
3078451|NCT00424255|10567375|P1|Overall Study|Disease Progression|0
3078452|NCT00424255|10567374|P2|Overall Study|Fatigue|0
3078453|NCT00424255|10567375|P1|Overall Study|Fatigue|1
3078454|NCT00424255|10567374|P2|Overall Study|Non-compliance by Participants|0
3078455|NCT00424255|10567375|P1|Overall Study|Non-compliance by Participants|1
3078456|NCT00424255|10567374|P2|Overall Study|Cognitive Disturbance|0
3078457|NCT00424255|10567375|P1|Overall Study|Cognitive Disturbance|1
3078458|NCT00424255|10567374|P2|Overall Study|Physician Decision|7
3078459|NCT00424255|10567375|P1|Overall Study|Physician Decision|3
3078460|NCT00424255|10567374|P2|Overall Study|Withdrawal by Subject|38
3078461|NCT00424255|10567375|P1|Overall Study|Withdrawal by Subject|34
3078462|NCT00424255|10567374|P2|Overall Study|Protocol Violation|1
3078463|NCT00424255|10567375|P1|Overall Study|Protocol Violation|0
3078464|NCT00424255|10567374|P2|Overall Study|Lost to Follow-up|20
3078465|NCT00424255|10567375|P1|Overall Study|Lost to Follow-up|26
3078466|NCT00424255|10567374|P2|Overall Study|Death|111
3078467|NCT00424255|10567375|P1|Overall Study|Death|115
3078468|NCT00424190|10567423|P2|Overall Study|Other|21
3078469|NCT00424190|10567424|P1|Overall Study|Other|15
3078470|NCT00424190|10567423|P2|Overall Study|Diagnosis of osteomyelitis|1
3078471|NCT00424190|10567424|P1|Overall Study|Diagnosis of osteomyelitis|0
3078472|NCT00424190|10567423|P2|Overall Study|Request of sponsor or investigator|2
3078473|NCT00424190|10567424|P1|Overall Study|Request of sponsor or investigator|0
3078474|NCT00424190|10567423|P2|Overall Study|Noncompliance|2
3078475|NCT00424190|10567424|P1|Overall Study|Noncompliance|1
3078476|NCT00424190|10567423|P2|Overall Study|Death|0
3078477|NCT00424190|10567424|P1|Overall Study|Death|3
3078478|NCT00424190|10567423|P2|Overall Study|Withdrew consent|4
3078479|NCT00424190|10567424|P1|Overall Study|Withdrew consent|3
3078480|NCT00424177|10567430|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
3078481|NCT00424177|10567430|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
3078482|NCT00424177|10567430|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
3078483|NCT00424177|10567430|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
3078484|NCT00424177|10567430|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
3078485|NCT00424177|10567430|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
3078486|NCT00424177|10567430|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
3078487|NCT00424177|10567430|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
3078488|NCT00424177|10567430|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
3078489|NCT00424177|10567430|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
3078490|NCT00424047|10567459|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
3078491|NCT00424047|10567460|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
3078492|NCT00424047|10567459|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
3078493|NCT00424047|10567460|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
3078494|NCT00424047|10567459|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
3078495|NCT00424047|10567460|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
3078496|NCT00424047|10567459|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
3078497|NCT00424047|10567460|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
3078498|NCT00424047|10567459|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
3078499|NCT00424047|10567460|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
3078500|NCT00424047|10567459|P2|On Study at Time of Unblinding|Other|4
3078501|NCT00424047|10567460|P1|On Study at Time of Unblinding|Other|5
3078502|NCT00424047|10567459|P2|On Study at Time of Unblinding|Death|11
3078503|NCT00424047|10567460|P1|On Study at Time of Unblinding|Death|11
3078504|NCT00424047|10567459|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
3078505|NCT00424047|10567460|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
3078506|NCT00424047|10567459|P2|On Study at Time of Unblinding|Lack of Efficacy|3
3078507|NCT00424047|10567460|P1|On Study at Time of Unblinding|Lack of Efficacy|1
3078508|NCT00424047|10567459|P2|On Study at Time of Unblinding|Progression of disease|128
3078509|NCT00424047|10567460|P1|On Study at Time of Unblinding|Progression of disease|92
3078510|NCT00424047|10567459|P2|On Study at Time of Unblinding|Adverse Event|12
3078511|NCT00424047|10567460|P1|On Study at Time of Unblinding|Adverse Event|22
3078512|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
3078513|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
3078514|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
3078515|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
3078516|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
3078517|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
3078518|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
3078519|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
3078520|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
3078521|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
3078522|NCT00424047|10567459|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
3078523|NCT00424047|10567460|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
3078524|NCT00424021|10567492|P4|AMB-220-E Study Period|Physician Decision|1
3078525|NCT00424021|10567493|P3|AMB-220-E Study Period|Physician Decision|0
3078526|NCT00424021|10567494|P2|AMB-220-E Study Period|Physician Decision|0
3078527|NCT00424021|10567495|P1|AMB-220-E Study Period|Physician Decision|0
3078528|NCT00424021|10567492|P4|AMB-220-E Study Period|Lost to Follow-up|1
3078529|NCT00424021|10567493|P3|AMB-220-E Study Period|Lost to Follow-up|1
3078530|NCT00424021|10567494|P2|AMB-220-E Study Period|Lost to Follow-up|1
3078531|NCT00424021|10567495|P1|AMB-220-E Study Period|Lost to Follow-up|0
3078532|NCT00424021|10567492|P4|AMB-220-E Study Period|Death|1
3078533|NCT00424021|10567493|P3|AMB-220-E Study Period|Death|1
3078534|NCT00424021|10567494|P2|AMB-220-E Study Period|Death|0
3078535|NCT00424021|10567495|P1|AMB-220-E Study Period|Death|0
3078536|NCT00424021|10567492|P4|AMB-220-E Study Period|Adverse Event|7
3078537|NCT00424021|10567493|P3|AMB-220-E Study Period|Adverse Event|3
3078538|NCT00424021|10567494|P2|AMB-220-E Study Period|Adverse Event|1
3078539|NCT00424021|10567495|P1|AMB-220-E Study Period|Adverse Event|1
3078540|NCT00424021|10567492|P4|NCT00046319 Study Period|Lost to Follow-up|0
3078541|NCT00424021|10567493|P3|NCT00046319 Study Period|Lost to Follow-up|0
3078542|NCT00424021|10567494|P2|NCT00046319 Study Period|Lost to Follow-up|1
3078543|NCT00424021|10567495|P1|NCT00046319 Study Period|Lost to Follow-up|0
3078544|NCT00424021|10567492|P4|NCT00046319 Study Period|Sponsor discretion|0
3078545|NCT00424021|10567493|P3|NCT00046319 Study Period|Sponsor discretion|0
3078546|NCT00424021|10567494|P2|NCT00046319 Study Period|Sponsor discretion|1
3078547|NCT00424021|10567495|P1|NCT00046319 Study Period|Sponsor discretion|0
3078548|NCT00424021|10567492|P4|NCT00046319 Study Period|Withdrawal by Subject|0
3078549|NCT00424021|10567493|P3|NCT00046319 Study Period|Withdrawal by Subject|0
3078550|NCT00424021|10567494|P2|NCT00046319 Study Period|Withdrawal by Subject|1
3078551|NCT00424021|10567495|P1|NCT00046319 Study Period|Withdrawal by Subject|0
3078552|NCT00424021|10567492|P4|NCT00046319 Study Period|Adverse Event|1
3078553|NCT00424021|10567493|P3|NCT00046319 Study Period|Adverse Event|1
3078554|NCT00424021|10567494|P2|NCT00046319 Study Period|Adverse Event|0
3078555|NCT00424021|10567495|P1|NCT00046319 Study Period|Adverse Event|1
3078556|NCT00424008|10567538|P2|Overall Study|Administrative|257
3078557|NCT00424008|10567539|P1|Overall Study|Administrative|266
3078558|NCT00424008|10567538|P2|Overall Study|Did not meet protocol eligibility|21
3078559|NCT00424008|10567539|P1|Overall Study|Did not meet protocol eligibility|16
3078560|NCT00424008|10567538|P2|Overall Study|Noncompliance with protocol|7
3078561|NCT00424008|10567539|P1|Overall Study|Noncompliance with protocol|13
3078562|NCT00424008|10567538|P2|Overall Study|Withdrawal by Subject|8
3078563|NCT00424008|10567539|P1|Overall Study|Withdrawal by Subject|5
3078564|NCT00424008|10567538|P2|Overall Study|Lost to Follow-up|2
3078565|NCT00424008|10567539|P1|Overall Study|Lost to Follow-up|1
3078566|NCT00424008|10567538|P2|Overall Study|Lack of Efficacy|34
3078567|NCT00424008|10567539|P1|Overall Study|Lack of Efficacy|40
3078568|NCT00424008|10567538|P2|Overall Study|Adverse Event|6
3078569|NCT00424008|10567539|P1|Overall Study|Adverse Event|8
3078570|NCT00423943|10567554|P2|Overall Study|Withdrawal by Subject|1
3078571|NCT00423943|10567555|P1|Overall Study|Withdrawal by Subject|3
3078572|NCT00423930|10567569|P1|Overall Study|Withdrawal by Subject|2
3078573|NCT00423917|10567574|P1|Overall Study|Ineligible|1
3078574|NCT00423917|10567574|P1|Overall Study|Cancel|2
3078575|NCT00423891|10567587|P3|Post-Dosing Follow Up|Lost to Follow-up|0
3078576|NCT00423891|10567588|P2|Post-Dosing Follow Up|Lost to Follow-up|0
3078577|NCT00423891|10567589|P1|Post-Dosing Follow Up|Lost to Follow-up|2
3078578|NCT00423891|10567587|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
3078579|NCT00423891|10567588|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
3078580|NCT00423891|10567589|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
3078581|NCT00423891|10567587|P3|Treatment|Lost to Follow-up|0
3078582|NCT00423891|10567588|P2|Treatment|Lost to Follow-up|0
3078583|NCT00423891|10567589|P1|Treatment|Lost to Follow-up|1
3078584|NCT00423891|10567587|P3|Treatment|Withdrawal by Subject|0
3078585|NCT00423891|10567588|P2|Treatment|Withdrawal by Subject|0
3078586|NCT00423891|10567589|P1|Treatment|Withdrawal by Subject|1
3078587|NCT00423891|10567587|P3|Enrolled|No longer met criteria|1
3078588|NCT00423891|10567588|P2|Enrolled|No longer met criteria|2
3078589|NCT00423891|10567589|P1|Enrolled|No longer met criteria|11
3078590|NCT00423891|10567587|P3|Enrolled|Lost to Follow-up|1
3078591|NCT00423891|10567588|P2|Enrolled|Lost to Follow-up|0
3078592|NCT00423891|10567589|P1|Enrolled|Lost to Follow-up|0
3078593|NCT00423891|10567587|P3|Enrolled|Withdrawal by Subject|1
3078594|NCT00423891|10567588|P2|Enrolled|Withdrawal by Subject|0
3078595|NCT00423891|10567589|P1|Enrolled|Withdrawal by Subject|0
3078596|NCT00423852|10567667|P1|Overall Study|Removed pior to the high-dose portion|3
3078597|NCT00423813|10567675|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
3078598|NCT00423813|10567676|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
3078599|NCT00423813|10567677|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
3078600|NCT00423813|10567675|P3|Overall Study|Will start exclusionary medications|0
3078601|NCT00423813|10567676|P2|Overall Study|Will start exclusionary medications|1
3078602|NCT00423813|10567677|P1|Overall Study|Will start exclusionary medications|0
3078603|NCT00423813|10567675|P3|Overall Study|Subject started night shift work|0
3078604|NCT00423813|10567676|P2|Overall Study|Subject started night shift work|0
3078605|NCT00423813|10567677|P1|Overall Study|Subject started night shift work|1
3078606|NCT00423813|10567675|P3|Overall Study|Pregnancy|1
3078607|NCT00423813|10567676|P2|Overall Study|Pregnancy|0
3078608|NCT00423813|10567677|P1|Overall Study|Pregnancy|0
3078609|NCT00423813|10567675|P3|Overall Study|Protocol Violation|4
3078610|NCT00423813|10567676|P2|Overall Study|Protocol Violation|4
3078611|NCT00423813|10567677|P1|Overall Study|Protocol Violation|9
3078612|NCT00423813|10567675|P3|Overall Study|Sponsor Decision|0
3078613|NCT00423813|10567676|P2|Overall Study|Sponsor Decision|1
3078614|NCT00423813|10567677|P1|Overall Study|Sponsor Decision|0
3078615|NCT00423813|10567675|P3|Overall Study|Physician Decision|0
3078616|NCT00423813|10567676|P2|Overall Study|Physician Decision|0
3078617|NCT00423813|10567677|P1|Overall Study|Physician Decision|2
3078618|NCT00423813|10567675|P3|Overall Study|Lack of Efficacy|19
3078619|NCT00423813|10567676|P2|Overall Study|Lack of Efficacy|18
3078620|NCT00423813|10567677|P1|Overall Study|Lack of Efficacy|23
3078621|NCT00423813|10567675|P3|Overall Study|Lost to Follow-up|4
3078622|NCT00423813|10567676|P2|Overall Study|Lost to Follow-up|4
3078623|NCT00423813|10567677|P1|Overall Study|Lost to Follow-up|5
3078624|NCT00423813|10567675|P3|Overall Study|Withdrawal by Subject|5
3078625|NCT00423813|10567676|P2|Overall Study|Withdrawal by Subject|8
3078626|NCT00423813|10567677|P1|Overall Study|Withdrawal by Subject|6
3078627|NCT00423813|10567675|P3|Overall Study|Adverse Event|40
3078628|NCT00423813|10567676|P2|Overall Study|Adverse Event|30
3078629|NCT00423813|10567677|P1|Overall Study|Adverse Event|11
3078630|NCT00423800|10567687|P2|Overall Study|Protocol Violation|1
3078631|NCT00423800|10567688|P1|Overall Study|Protocol Violation|0
3078632|NCT00423735|10567700|P3|Overall Study|Ineligible / No protocol treatment|0
3078633|NCT00423735|10567701|P2|Overall Study|Ineligible / No protocol treatment|6
3078634|NCT00423735|10567702|P1|Overall Study|Ineligible / No protocol treatment|8
3078635|NCT00423722|10567725|P2|Overall Study|Withdrawal by Subject|2
3078636|NCT00423722|10567726|P1|Overall Study|Withdrawal by Subject|4
3078637|NCT00423722|10567725|P2|Overall Study|Unable to complete questionnaires|4
3078638|NCT00423722|10567726|P1|Overall Study|Unable to complete questionnaires|4
3078639|NCT00423722|10567725|P2|Overall Study|Declined to participate|3
3078640|NCT00423722|10567726|P1|Overall Study|Declined to participate|2
3078641|NCT00423722|10567725|P2|Overall Study|Death|4
3078642|NCT00423722|10567726|P1|Overall Study|Death|4
3078643|NCT00423670|10567768|P8|Follow-up Period|Non-compliance with protocol|2
3078644|NCT00423670|10567769|P7|Follow-up Period|Non-compliance with protocol|3
3078645|NCT00423670|10567770|P6|Follow-up Period|Non-compliance with protocol|0
3078646|NCT00423670|10567771|P5|Follow-up Period|Non-compliance with protocol|0
3078647|NCT00423670|10567772|P4|Follow-up Period|Non-compliance with protocol|1
3078648|NCT00423670|10567773|P3|Follow-up Period|Non-compliance with protocol|1
3078649|NCT00423670|10567774|P2|Follow-up Period|Non-compliance with protocol|0
3078650|NCT00423670|10567775|P1|Follow-up Period|Non-compliance with protocol|2
3078651|NCT00423670|10567768|P8|Follow-up Period|Subject withdrew (not treatment related)|1
3078652|NCT00423670|10567769|P7|Follow-up Period|Subject withdrew (not treatment related)|1
3078653|NCT00423670|10567770|P6|Follow-up Period|Subject withdrew (not treatment related)|0
3078654|NCT00423670|10567771|P5|Follow-up Period|Subject withdrew (not treatment related)|1
3078655|NCT00423670|10567772|P4|Follow-up Period|Subject withdrew (not treatment related)|1
3078656|NCT00423670|10567773|P3|Follow-up Period|Subject withdrew (not treatment related)|2
3078657|NCT00423670|10567774|P2|Follow-up Period|Subject withdrew (not treatment related)|4
3078658|NCT00423670|10567775|P1|Follow-up Period|Subject withdrew (not treatment related)|1
3078659|NCT00423670|10567768|P8|Follow-up Period|Lost to Follow-up|0
3078660|NCT00423670|10567769|P7|Follow-up Period|Lost to Follow-up|5
3078661|NCT00423670|10567770|P6|Follow-up Period|Lost to Follow-up|0
3078662|NCT00423670|10567771|P5|Follow-up Period|Lost to Follow-up|1
3078663|NCT00423670|10567772|P4|Follow-up Period|Lost to Follow-up|3
3078664|NCT00423670|10567773|P3|Follow-up Period|Lost to Follow-up|8
3078665|NCT00423670|10567774|P2|Follow-up Period|Lost to Follow-up|12
3078666|NCT00423670|10567775|P1|Follow-up Period|Lost to Follow-up|0
3078667|NCT00423670|10567768|P8|Treatment Period|Non-compliance with protocol|2
3078668|NCT00423670|10567769|P7|Treatment Period|Non-compliance with protocol|2
3078669|NCT00423670|10567770|P6|Treatment Period|Non-compliance with protocol|0
3078670|NCT00423670|10567771|P5|Treatment Period|Non-compliance with protocol|2
3078671|NCT00423670|10567772|P4|Treatment Period|Non-compliance with protocol|3
3078672|NCT00423670|10567773|P3|Treatment Period|Non-compliance with protocol|1
3078673|NCT00423670|10567774|P2|Treatment Period|Non-compliance with protocol|1
3078674|NCT00423670|10567775|P1|Treatment Period|Non-compliance with protocol|3
3078675|NCT00423670|10567768|P8|Treatment Period|Investigator decision|1
3078676|NCT00423670|10567769|P7|Treatment Period|Investigator decision|0
3078677|NCT00423670|10567770|P6|Treatment Period|Investigator decision|0
3078678|NCT00423670|10567771|P5|Treatment Period|Investigator decision|0
3078679|NCT00423670|10567772|P4|Treatment Period|Investigator decision|0
3078680|NCT00423670|10567773|P3|Treatment Period|Investigator decision|0
3078681|NCT00423670|10567774|P2|Treatment Period|Investigator decision|0
3078682|NCT00423670|10567775|P1|Treatment Period|Investigator decision|0
3078683|NCT00423670|10567768|P8|Treatment Period|Subject withdrew (not treatment related)|0
3078684|NCT00423670|10567769|P7|Treatment Period|Subject withdrew (not treatment related)|3
3078685|NCT00423670|10567770|P6|Treatment Period|Subject withdrew (not treatment related)|0
3078686|NCT00423670|10567771|P5|Treatment Period|Subject withdrew (not treatment related)|5
3078687|NCT00423670|10567772|P4|Treatment Period|Subject withdrew (not treatment related)|4
3078688|NCT00423670|10567773|P3|Treatment Period|Subject withdrew (not treatment related)|4
3078689|NCT00423670|10567774|P2|Treatment Period|Subject withdrew (not treatment related)|9
3078690|NCT00423670|10567775|P1|Treatment Period|Subject withdrew (not treatment related)|3
3078691|NCT00423670|10567768|P8|Treatment Period|Lost to Follow-up|1
3078692|NCT00423670|10567769|P7|Treatment Period|Lost to Follow-up|3
3078693|NCT00423670|10567770|P6|Treatment Period|Lost to Follow-up|0
3078694|NCT00423670|10567771|P5|Treatment Period|Lost to Follow-up|6
3078695|NCT00423670|10567772|P4|Treatment Period|Lost to Follow-up|1
3078696|NCT00423670|10567773|P3|Treatment Period|Lost to Follow-up|3
3078697|NCT00423670|10567774|P2|Treatment Period|Lost to Follow-up|1
3078698|NCT00423670|10567775|P1|Treatment Period|Lost to Follow-up|2
3078699|NCT00423670|10567768|P8|Treatment Period|Protocol-defined clinical event|15
3078700|NCT00423670|10567769|P7|Treatment Period|Protocol-defined clinical event|16
3078701|NCT00423670|10567770|P6|Treatment Period|Protocol-defined clinical event|4
3078702|NCT00423670|10567771|P5|Treatment Period|Protocol-defined clinical event|5
3078703|NCT00423670|10567772|P4|Treatment Period|Protocol-defined clinical event|12
3078704|NCT00423670|10567773|P3|Treatment Period|Protocol-defined clinical event|4
3078705|NCT00423670|10567774|P2|Treatment Period|Protocol-defined clinical event|7
3078706|NCT00423670|10567775|P1|Treatment Period|Protocol-defined clinical event|0
3078707|NCT00423670|10567768|P8|Treatment Period|Adverse Event|2
3078708|NCT00423670|10567769|P7|Treatment Period|Adverse Event|7
3078709|NCT00423670|10567770|P6|Treatment Period|Adverse Event|4
3078710|NCT00423670|10567771|P5|Treatment Period|Adverse Event|9
3078711|NCT00423670|10567772|P4|Treatment Period|Adverse Event|20
3078712|NCT00423670|10567773|P3|Treatment Period|Adverse Event|15
3078713|NCT00423670|10567774|P2|Treatment Period|Adverse Event|12
3078714|NCT00423670|10567775|P1|Treatment Period|Adverse Event|8
3078715|NCT00423670|10567768|P8|Treatment Period|Switched to Arm 8 at TW 24|0
3078716|NCT00423670|10567769|P7|Treatment Period|Switched to Arm 8 at TW 24|0
3078717|NCT00423670|10567770|P6|Treatment Period|Switched to Arm 8 at TW 24|0
3078718|NCT00423670|10567771|P5|Treatment Period|Switched to Arm 8 at TW 24|0
3078719|NCT00423670|10567772|P4|Treatment Period|Switched to Arm 8 at TW 24|0
3078720|NCT00423670|10567773|P3|Treatment Period|Switched to Arm 8 at TW 24|0
3078721|NCT00423670|10567774|P2|Treatment Period|Switched to Arm 8 at TW 24|0
3078722|NCT00423670|10567775|P1|Treatment Period|Switched to Arm 8 at TW 24|36
3078723|NCT00423657|10567833|P2|Overall Study|Request of sponsor/investigator|0
3078724|NCT00423657|10567834|P1|Overall Study|Request of sponsor/investigator|1
3078725|NCT00423657|10567833|P2|Overall Study|Other|16
3078726|NCT00423657|10567834|P1|Overall Study|Other|15
3078727|NCT00423657|10567833|P2|Overall Study|Non-compliance|1
3078728|NCT00423657|10567834|P1|Overall Study|Non-compliance|0
3078729|NCT00423657|10567833|P2|Overall Study|Withdrew consent|8
3078730|NCT00423657|10567834|P1|Overall Study|Withdrew consent|10
3078731|NCT00423605|10567840|P1|Overall Study|Not one of the pre-specified options|5
3078732|NCT00423605|10567840|P1|Overall Study|Protocol Violation|7
3078733|NCT00423605|10567840|P1|Overall Study|Physician Decision|8
3078734|NCT00423605|10567840|P1|Overall Study|Sponsor Decision|3
3078735|NCT00423605|10567840|P1|Overall Study|Lack of Efficacy|38
3078736|NCT00423605|10567840|P1|Overall Study|Lost to Follow-up|15
3078737|NCT00423605|10567840|P1|Overall Study|Withdrawal by Subject|36
3078738|NCT00423605|10567840|P1|Overall Study|Adverse Event|129
3078739|NCT00423592|10567844|P1|Overall Study|Adverse Event (post Week 12)|5
3078740|NCT00423592|10567844|P1|Overall Study|Adverse Event (through Week 12)|2
3078741|NCT00423579|10567865|P2|Overall Study|Diagnosis of diabetes|1
3078742|NCT00423579|10567866|P1|Overall Study|Diagnosis of diabetes|0
3078743|NCT00423579|10567865|P2|Overall Study|Protocol Violation|3
3078744|NCT00423579|10567866|P1|Overall Study|Protocol Violation|1
3078745|NCT00423579|10567865|P2|Overall Study|Lost to Follow-up|0
3078746|NCT00423579|10567866|P1|Overall Study|Lost to Follow-up|3
3078747|NCT00423488|10567874|P2|Overall Study|No post baseline data|0
3078748|NCT00423488|10567875|P1|Overall Study|No post baseline data|3
3078749|NCT00423488|10567874|P2|Overall Study|No evidence of study drug intake|1
3078750|NCT00423488|10567875|P1|Overall Study|No evidence of study drug intake|2
3078751|NCT00423449|10567881|P5|Overall Study|Protocol Violation|0
3078752|NCT00423449|10567882|P4|Overall Study|Protocol Violation|1
3078753|NCT00423449|10567883|P3|Overall Study|Protocol Violation|2
3078754|NCT00423449|10567884|P2|Overall Study|Protocol Violation|0
3078755|NCT00423449|10567885|P1|Overall Study|Protocol Violation|0
3078756|NCT00423449|10567881|P5|Overall Study|Other|0
3078757|NCT00423449|10567882|P4|Overall Study|Other|1
3078758|NCT00423449|10567883|P3|Overall Study|Other|0
3078759|NCT00423449|10567884|P2|Overall Study|Other|0
3078760|NCT00423449|10567885|P1|Overall Study|Other|0
3078761|NCT00423449|10567881|P5|Overall Study|Laboratory Adverse Event|0
3078762|NCT00423449|10567882|P4|Overall Study|Laboratory Adverse Event|0
3078763|NCT00423449|10567883|P3|Overall Study|Laboratory Adverse Event|2
3078764|NCT00423449|10567884|P2|Overall Study|Laboratory Adverse Event|1
3078765|NCT00423449|10567885|P1|Overall Study|Laboratory Adverse Event|0
3078766|NCT00423449|10567881|P5|Overall Study|Progressive Disease|4
3078767|NCT00423449|10567882|P4|Overall Study|Progressive Disease|11
3078768|NCT00423449|10567883|P3|Overall Study|Progressive Disease|8
3078769|NCT00423449|10567884|P2|Overall Study|Progressive Disease|3
3078770|NCT00423449|10567885|P1|Overall Study|Progressive Disease|1
3078771|NCT00423449|10567881|P5|Overall Study|Death|1
3078772|NCT00423449|10567882|P4|Overall Study|Death|1
3078773|NCT00423449|10567883|P3|Overall Study|Death|2
3078774|NCT00423449|10567884|P2|Overall Study|Death|0
3078775|NCT00423449|10567885|P1|Overall Study|Death|1
3078776|NCT00423449|10567881|P5|Overall Study|Clinical Adverse Event|2
3078777|NCT00423449|10567882|P4|Overall Study|Clinical Adverse Event|8
3078778|NCT00423449|10567883|P3|Overall Study|Clinical Adverse Event|1
3078779|NCT00423449|10567884|P2|Overall Study|Clinical Adverse Event|0
3078780|NCT00423449|10567885|P1|Overall Study|Clinical Adverse Event|1
3078781|NCT00423332|10567932|P2|Overall Study|Unblinded before 12 weeks|3
3078782|NCT00423332|10567933|P1|Overall Study|Unblinded before 12 weeks|1
3078783|NCT00423332|10567932|P2|Overall Study|Progressive at Week 6|1
3078784|NCT00423332|10567933|P1|Overall Study|Progressive at Week 6|0
3078785|NCT00423332|10567932|P2|Overall Study|Condition under investigation worsened|1
3078786|NCT00423332|10567933|P1|Overall Study|Condition under investigation worsened|1
3078787|NCT00423332|10567932|P2|Overall Study|Withdrawal by Subject|0
3078788|NCT00423332|10567933|P1|Overall Study|Withdrawal by Subject|1
3078789|NCT00423332|10567932|P2|Overall Study|Adverse Event|2
3078790|NCT00423332|10567933|P1|Overall Study|Adverse Event|6
3078791|NCT00423319|10567952|P2|Overall Study|Other|22
3078792|NCT00423319|10567953|P1|Overall Study|Other|23
3078793|NCT00423319|10567952|P2|Overall Study|No longer meets study criteria|15
3078794|NCT00423319|10567953|P1|Overall Study|No longer meets study criteria|15
3078795|NCT00423319|10567952|P2|Overall Study|Poor compliance or noncompliance|1
3078796|NCT00423319|10567953|P1|Overall Study|Poor compliance or noncompliance|1
3078797|NCT00423319|10567952|P2|Overall Study|Lost to Follow-up|3
3078798|NCT00423319|10567953|P1|Overall Study|Lost to Follow-up|4
3078799|NCT00423319|10567952|P2|Overall Study|Withdrawal by Subject|99
3078800|NCT00423319|10567953|P1|Overall Study|Withdrawal by Subject|86
3078801|NCT00423319|10567952|P2|Overall Study|Adverse Event|112
3078802|NCT00423319|10567953|P1|Overall Study|Adverse Event|93
3078803|NCT00423319|10567952|P2|Overall Study|Death|0
3078804|NCT00423319|10567953|P1|Overall Study|Death|2
3078805|NCT00423293|10567985|P1|Overall Study|Ineligible / No protocol treatment|11
3078806|NCT00423267|10568002|P2|Period A|Administrative|0
3078807|NCT00423267|10568003|P1|Period A|Administrative|1
3078808|NCT00423267|10568002|P2|Period A|Non-compliance with protocol|0
3078809|NCT00423267|10568003|P1|Period A|Non-compliance with protocol|1
3078810|NCT00423267|10568002|P2|Period A|Withdrawal by Subject|1
3078811|NCT00423267|10568003|P1|Period A|Withdrawal by Subject|0
3078812|NCT00423189|10568023|P3|Overall Study|Death|0
3078813|NCT00423189|10568024|P2|Overall Study|Death|1
3078814|NCT00423189|10568025|P1|Overall Study|Death|0
3078815|NCT00423176|10568047|P2|Overall Study|Did not meet protocol eligibility|4
3078816|NCT00423176|10568048|P1|Overall Study|Did not meet protocol eligibility|2
3078817|NCT00423176|10568047|P2|Overall Study|Protocol Violation|3
3078818|NCT00423176|10568048|P1|Overall Study|Protocol Violation|1
3078819|NCT00423176|10568047|P2|Overall Study|Withdrawal by Subject|3
3078820|NCT00423176|10568048|P1|Overall Study|Withdrawal by Subject|4
3078821|NCT00423176|10568047|P2|Overall Study|Lost to Follow-up|7
3078822|NCT00423176|10568048|P1|Overall Study|Lost to Follow-up|4
3078823|NCT00423176|10568047|P2|Overall Study|Treatment Failure|6
3078824|NCT00423176|10568048|P1|Overall Study|Treatment Failure|1
3078825|NCT00423176|10568047|P2|Overall Study|Adverse Event|6
3078826|NCT00423176|10568048|P1|Overall Study|Adverse Event|4
3078827|NCT00423150|10568056|P1|Overall Study|Administrative|4
3078828|NCT00423150|10568056|P1|Overall Study|Non-compliance with protocol|1
3078829|NCT00423150|10568056|P1|Overall Study|Withdrawal by Subject|1
3078830|NCT00423150|10568056|P1|Overall Study|Progression of disease being studied|69
3078831|NCT00423150|10568056|P1|Overall Study|Adverse Event|11
3078832|NCT00423098|10568062|P2|Overall Study|Death|0
3078833|NCT00423098|10568063|P1|Overall Study|Death|2
3078834|NCT00423098|10568062|P2|Overall Study|Administrative problems|1
3078835|NCT00423098|10568063|P1|Overall Study|Administrative problems|0
3078836|NCT00423098|10568062|P2|Overall Study|Unsatisfactory therapeutic effect|1
3078837|NCT00423098|10568063|P1|Overall Study|Unsatisfactory therapeutic effect|0
3078838|NCT00423098|10568062|P2|Overall Study|Adverse Event|2
3078839|NCT00423098|10568063|P1|Overall Study|Adverse Event|1
3078840|NCT00423085|10568090|P4|52-Week Open-Label Extension Phase|Death|2
3078841|NCT00423085|10568091|P3|52-Week Open-Label Extension Phase|Death|0
3078842|NCT00423085|10568092|P2|52-Week Open-Label Extension Phase|Death|0
3078843|NCT00423085|10568093|P1|52-Week Open-Label Extension Phase|Death|0
3078844|NCT00423085|10568090|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
3078845|NCT00423085|10568091|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
3078846|NCT00423085|10568092|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
3078847|NCT00423085|10568093|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
3078848|NCT00423085|10568090|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
3078849|NCT00423085|10568091|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
3078850|NCT00423085|10568092|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
3078851|NCT00423085|10568093|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
3078852|NCT00423085|10568090|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
3078853|NCT00423085|10568091|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
3078854|NCT00423085|10568092|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
3078855|NCT00423085|10568093|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
3078856|NCT00423085|10568090|P4|52-Week Open-Label Extension Phase|Adverse Event|97
3078857|NCT00423085|10568091|P3|52-Week Open-Label Extension Phase|Adverse Event|0
3078858|NCT00423085|10568092|P2|52-Week Open-Label Extension Phase|Adverse Event|0
3078859|NCT00423085|10568093|P1|52-Week Open-Label Extension Phase|Adverse Event|0
3078860|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
3078861|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
3078862|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
3078863|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
3078864|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Death|0
3078865|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Death|0
3078866|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Death|1
3078867|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Death|1
3078868|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
3078869|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
3078870|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
3078871|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
3078872|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
3078873|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
3078874|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
3078875|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
3078876|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
3078877|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
3078878|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
3078879|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
3078880|NCT00423085|10568090|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
3078881|NCT00423085|10568091|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
3078882|NCT00423085|10568092|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
3078883|NCT00423085|10568093|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
3078884|NCT00423046|10568122|P2|Overall Study|Other|345
3078885|NCT00423046|10568123|P1|Overall Study|Other|340
3078886|NCT00422942|10568189|P1|Overall Study|Study terminated by Sponsor|3
3078887|NCT00422903|10568208|P2|Overall Study|Informed Consent Withdrawn|2
3078888|NCT00422903|10568209|P1|Overall Study|Informed Consent Withdrawn|1
3078889|NCT00422903|10568208|P2|Overall Study|Adverse Event|2
3078890|NCT00422903|10568209|P1|Overall Study|Adverse Event|0
3078891|NCT00422903|10568208|P2|Overall Study|Disease Progression|1
3078892|NCT00422903|10568209|P1|Overall Study|Disease Progression|3
3078893|NCT00422799|10568258|P1|Overall Study|Adverse Event|7
3078894|NCT00422799|10568258|P1|Overall Study|Withdrawal by Subject|6
3078895|NCT00422734|10568267|P2|Overall Study|Partner Decision|3
3078896|NCT00422734|10568268|P1|Overall Study|Partner Decision|0
3078897|NCT00422734|10568267|P2|Overall Study|Adverse Event|3
3078898|NCT00422734|10568268|P1|Overall Study|Adverse Event|0
3078899|NCT00422734|10568267|P2|Overall Study|Withdrawal by Subject|8
3078900|NCT00422734|10568268|P1|Overall Study|Withdrawal by Subject|12
3078901|NCT00422734|10568267|P2|Overall Study|Protocol Violation|6
3078902|NCT00422734|10568268|P1|Overall Study|Protocol Violation|1
3078903|NCT00422734|10568267|P2|Overall Study|Physician Decision|1
3078904|NCT00422734|10568268|P1|Overall Study|Physician Decision|1
3078905|NCT00422669|10568314|P3|Overall Study|The study was terminated early.|7
3078906|NCT00422669|10568315|P2|Overall Study|The study was terminated early.|100
3078907|NCT00422669|10568316|P1|Overall Study|The study was terminated early.|98
3078908|NCT00422591|10568344|P1|Overall Study|Withdrawal by Subject|2
3078909|NCT00422591|10568344|P1|Overall Study|Physician Decision|4
3078910|NCT00422513|10568352|P2|Overall Study|Death|7
3078911|NCT00422513|10568353|P1|Overall Study|Death|3
3078912|NCT00422513|10568352|P2|Overall Study|Adverse Event|4
3078913|NCT00422513|10568353|P1|Overall Study|Adverse Event|4
3078914|NCT00422513|10568352|P2|Overall Study|early termination of the study|80
3078915|NCT00422513|10568353|P1|Overall Study|early termination of the study|67
3078916|NCT00422513|10568352|P2|Overall Study|Withdrawal by Subject|1
3078917|NCT00422513|10568353|P1|Overall Study|Withdrawal by Subject|2
3078918|NCT00422513|10568352|P2|Overall Study|Refused Treatment|2
3078919|NCT00422513|10568353|P1|Overall Study|Refused Treatment|4
3078920|NCT00422513|10568352|P2|Overall Study|Protocol Violation|7
3078921|NCT00422513|10568353|P1|Overall Study|Protocol Violation|23
3078922|NCT00422513|10568352|P2|Overall Study|Lack of Efficacy|5
3078923|NCT00422513|10568353|P1|Overall Study|Lack of Efficacy|4
3078924|NCT00422422|10568370|P1|Overall Study|AE, non-serious non-fatal|5
3078925|NCT00422422|10568370|P1|Overall Study|SAE, non-fatal|1
3078926|NCT00422422|10568370|P1|Overall Study|Withdrawal by Subject|2
3078927|NCT00422422|10568370|P1|Overall Study|Protocol Violation|1
3078928|NCT00422422|10568370|P1|Overall Study|Lack of Efficacy|1
3078929|NCT00422383|10568387|P5|Overall Study|Withdrawal by Subject|1
3078930|NCT00422383|10568388|P4|Overall Study|Withdrawal by Subject|0
3078931|NCT00422383|10568389|P3|Overall Study|Withdrawal by Subject|0
3078932|NCT00422383|10568390|P2|Overall Study|Withdrawal by Subject|5
3078933|NCT00422383|10568391|P1|Overall Study|Withdrawal by Subject|5
3078934|NCT00422383|10568387|P5|Overall Study|Protocol Violation|0
3078935|NCT00422383|10568388|P4|Overall Study|Protocol Violation|0
3078936|NCT00422383|10568389|P3|Overall Study|Protocol Violation|1
3078937|NCT00422383|10568390|P2|Overall Study|Protocol Violation|1
3078938|NCT00422383|10568391|P1|Overall Study|Protocol Violation|1
3078939|NCT00422383|10568387|P5|Overall Study|Lost to Follow-up|1
3078940|NCT00422383|10568388|P4|Overall Study|Lost to Follow-up|0
3078941|NCT00422383|10568389|P3|Overall Study|Lost to Follow-up|0
3078942|NCT00422383|10568390|P2|Overall Study|Lost to Follow-up|1
3078943|NCT00422383|10568391|P1|Overall Study|Lost to Follow-up|0
3078944|NCT00422383|10568387|P5|Overall Study|Lack of Efficacy|1
3078945|NCT00422383|10568388|P4|Overall Study|Lack of Efficacy|1
3078946|NCT00422383|10568389|P3|Overall Study|Lack of Efficacy|2
3078947|NCT00422383|10568390|P2|Overall Study|Lack of Efficacy|4
3078948|NCT00422383|10568391|P1|Overall Study|Lack of Efficacy|4
3078949|NCT00422383|10568387|P5|Overall Study|Adverse Event|0
3078950|NCT00422383|10568388|P4|Overall Study|Adverse Event|1
3078951|NCT00422383|10568389|P3|Overall Study|Adverse Event|1
3078952|NCT00422383|10568390|P2|Overall Study|Adverse Event|3
3078953|NCT00422383|10568391|P1|Overall Study|Adverse Event|5
3078954|NCT00422292|10568534|P4|Overall Study|Withdrawal by Subject|13
3078955|NCT00422292|10568535|P3|Overall Study|Withdrawal by Subject|7
3078956|NCT00422292|10568536|P2|Overall Study|Withdrawal by Subject|25
3078957|NCT00422292|10568537|P1|Overall Study|Withdrawal by Subject|6
3078958|NCT00422292|10568534|P4|Overall Study|Lost to Follow-up|6
3078959|NCT00422292|10568535|P3|Overall Study|Lost to Follow-up|6
3078960|NCT00422292|10568536|P2|Overall Study|Lost to Follow-up|12
3078961|NCT00422292|10568537|P1|Overall Study|Lost to Follow-up|6
3078962|NCT00422292|10568534|P4|Overall Study|Protocol Violation|5
3078963|NCT00422292|10568535|P3|Overall Study|Protocol Violation|8
3078964|NCT00422292|10568536|P2|Overall Study|Protocol Violation|25
3078965|NCT00422292|10568537|P1|Overall Study|Protocol Violation|4
3078966|NCT00422292|10568534|P4|Overall Study|Adverse Event|0
3078967|NCT00422292|10568535|P3|Overall Study|Adverse Event|1
3078968|NCT00422292|10568536|P2|Overall Study|Adverse Event|0
3078969|NCT00422292|10568537|P1|Overall Study|Adverse Event|1
3078970|NCT00422292|10568534|P4|Overall Study|Serious adverse events|0
3078971|NCT00422292|10568535|P3|Overall Study|Serious adverse events|0
3078972|NCT00422292|10568536|P2|Overall Study|Serious adverse events|4
3078973|NCT00422292|10568537|P1|Overall Study|Serious adverse events|1
3078974|NCT00422227|10568576|P2|Overall Study|Withdrawal by Subject|4
3078975|NCT00422227|10568577|P1|Overall Study|Withdrawal by Subject|0
3078976|NCT00422227|10568576|P2|Overall Study|Lost to Follow-up|3
3078977|NCT00422227|10568577|P1|Overall Study|Lost to Follow-up|1
3078978|NCT00422227|10568576|P2|Overall Study|Adverse Event|8
3078979|NCT00422227|10568577|P1|Overall Study|Adverse Event|3
3078980|NCT00422162|10568608|P2|Overall Study|Didn't Receive Treatment|1
3078981|NCT00422162|10568609|P1|Overall Study|Didn't Receive Treatment|0
3078982|NCT00422162|10568608|P2|Overall Study|Other|1
3078983|NCT00422162|10568609|P1|Overall Study|Other|0
3078984|NCT00422162|10568608|P2|Overall Study|Non-Compliant with Protocol|1
3078985|NCT00422162|10568609|P1|Overall Study|Non-Compliant with Protocol|1
3078986|NCT00422162|10568608|P2|Overall Study|Lost to Follow-up|2
3078987|NCT00422162|10568609|P1|Overall Study|Lost to Follow-up|1
3078988|NCT00422162|10568608|P2|Overall Study|Withdrawal by Subject|6
3078989|NCT00422162|10568609|P1|Overall Study|Withdrawal by Subject|7
3078990|NCT00422162|10568608|P2|Overall Study|Lack of Efficacy|10
3078991|NCT00422162|10568609|P1|Overall Study|Lack of Efficacy|4
3078992|NCT00422162|10568608|P2|Overall Study|Adverse Event|9
3078993|NCT00422162|10568609|P1|Overall Study|Adverse Event|11
3078994|NCT00422097|10568669|P8|Dose Level 2|Still on treatment|0
3078995|NCT00422097|10568670|P7|Dose Level 2|Still on treatment|0
3078996|NCT00422097|10568671|P6|Dose Level 2|Still on treatment|0
3078997|NCT00422097|10568672|P5|Dose Level 2|Still on treatment|0
3078998|NCT00422097|10568673|P4|Dose Level 2|Still on treatment|0
3078999|NCT00422097|10568674|P3|Dose Level 2|Still on treatment|0
3079000|NCT00422097|10568675|P2|Dose Level 2|Still on treatment|1
3079001|NCT00422097|10568676|P1|Dose Level 2|Still on treatment|0
3079002|NCT00422058|10568741|P6|Open-Label Extension, Week 20-104|Other|18
3079003|NCT00422058|10568742|P5|Open-Label Extension, Week 20-104|Other|16
3079004|NCT00422058|10568743|P4|Open-Label Extension, Week 20-104|Other|13
3079005|NCT00422058|10568744|P3|Open-Label Extension, Week 20-104|Other|6
3079006|NCT00422058|10568745|P2|Open-Label Extension, Week 20-104|Other|14
3079007|NCT00422058|10568746|P1|Open-Label Extension, Week 20-104|Other|13
3079008|NCT00422058|10568741|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
3079009|NCT00422058|10568742|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
3079010|NCT00422058|10568743|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
3079011|NCT00422058|10568744|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
3079012|NCT00422058|10568745|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
3079013|NCT00422058|10568746|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
3079014|NCT00422058|10568741|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
3079015|NCT00422058|10568742|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
3079016|NCT00422058|10568743|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
3079017|NCT00422058|10568744|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
3079018|NCT00422058|10568745|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
3079019|NCT00422058|10568746|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
3079020|NCT00422058|10568741|P6|Open-Label Extension, Week 20-104|Adverse Event|0
3079021|NCT00422058|10568742|P5|Open-Label Extension, Week 20-104|Adverse Event|4
3079022|NCT00422058|10568743|P4|Open-Label Extension, Week 20-104|Adverse Event|4
3079023|NCT00422058|10568744|P3|Open-Label Extension, Week 20-104|Adverse Event|7
3079024|NCT00422058|10568745|P2|Open-Label Extension, Week 20-104|Adverse Event|4
3079025|NCT00422058|10568746|P1|Open-Label Extension, Week 20-104|Adverse Event|3
3079026|NCT00422058|10568741|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
3079027|NCT00422058|10568742|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
3079028|NCT00422058|10568743|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
3079029|NCT00422058|10568744|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
3079030|NCT00422058|10568745|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
3079031|NCT00422058|10568746|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
3079032|NCT00422058|10568741|P6|Double-Blind, Week 0-20|Other|10
3079033|NCT00422058|10568742|P5|Double-Blind, Week 0-20|Other|4
3079034|NCT00422058|10568743|P4|Double-Blind, Week 0-20|Other|8
3079035|NCT00422058|10568744|P3|Double-Blind, Week 0-20|Other|8
3079036|NCT00422058|10568745|P2|Double-Blind, Week 0-20|Other|3
3079037|NCT00422058|10568746|P1|Double-Blind, Week 0-20|Other|11
3079038|NCT00422058|10568741|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
3079039|NCT00422058|10568742|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
3079040|NCT00422058|10568743|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
3079041|NCT00422058|10568744|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
3079042|NCT00422058|10568745|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
3079043|NCT00422058|10568746|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
3079044|NCT00422058|10568741|P6|Double-Blind, Week 0-20|Protocol Violation|2
3079045|NCT00422058|10568742|P5|Double-Blind, Week 0-20|Protocol Violation|2
3079046|NCT00422058|10568743|P4|Double-Blind, Week 0-20|Protocol Violation|3
3079047|NCT00422058|10568744|P3|Double-Blind, Week 0-20|Protocol Violation|2
3079048|NCT00422058|10568745|P2|Double-Blind, Week 0-20|Protocol Violation|2
3079049|NCT00422058|10568746|P1|Double-Blind, Week 0-20|Protocol Violation|3
3079050|NCT00422058|10568741|P6|Double-Blind, Week 0-20|Adverse Event|3
3079051|NCT00422058|10568742|P5|Double-Blind, Week 0-20|Adverse Event|5
3079052|NCT00422058|10568743|P4|Double-Blind, Week 0-20|Adverse Event|9
3079053|NCT00422058|10568744|P3|Double-Blind, Week 0-20|Adverse Event|5
3079054|NCT00422058|10568745|P2|Double-Blind, Week 0-20|Adverse Event|4
3079055|NCT00422058|10568746|P1|Double-Blind, Week 0-20|Adverse Event|3
3079056|NCT00421993|10568887|P4|Overall Study|Subject transportation issues|1
3079057|NCT00421993|10568888|P3|Overall Study|Subject transportation issues|0
3079058|NCT00421993|10568889|P2|Overall Study|Subject transportation issues|0
3079059|NCT00421993|10568890|P1|Overall Study|Subject transportation issues|0
3079060|NCT00421993|10568887|P4|Overall Study|Pregnancy|2
3079061|NCT00421993|10568888|P3|Overall Study|Pregnancy|1
3079062|NCT00421993|10568889|P2|Overall Study|Pregnancy|1
3079063|NCT00421993|10568890|P1|Overall Study|Pregnancy|0
3079064|NCT00421993|10568887|P4|Overall Study|Lack of Efficacy|5
3079065|NCT00421993|10568888|P3|Overall Study|Lack of Efficacy|0
3079066|NCT00421993|10568889|P2|Overall Study|Lack of Efficacy|3
3079067|NCT00421993|10568890|P1|Overall Study|Lack of Efficacy|0
3079068|NCT00421993|10568887|P4|Overall Study|Protocol Violation|1
3079069|NCT00421993|10568888|P3|Overall Study|Protocol Violation|0
3079070|NCT00421993|10568889|P2|Overall Study|Protocol Violation|2
3079071|NCT00421993|10568890|P1|Overall Study|Protocol Violation|2
3079072|NCT00421993|10568887|P4|Overall Study|Adverse Event|4
3079073|NCT00421993|10568888|P3|Overall Study|Adverse Event|6
3079074|NCT00421993|10568889|P2|Overall Study|Adverse Event|1
3079075|NCT00421993|10568890|P1|Overall Study|Adverse Event|11
3079076|NCT00421993|10568887|P4|Overall Study|Lost to Follow-up|20
3079077|NCT00421993|10568888|P3|Overall Study|Lost to Follow-up|22
3079078|NCT00421993|10568889|P2|Overall Study|Lost to Follow-up|19
3079079|NCT00421993|10568890|P1|Overall Study|Lost to Follow-up|18
3079080|NCT00421993|10568887|P4|Overall Study|Withdrawal by Subject|24
3079081|NCT00421993|10568888|P3|Overall Study|Withdrawal by Subject|23
3079082|NCT00421993|10568889|P2|Overall Study|Withdrawal by Subject|23
3079083|NCT00421993|10568890|P1|Overall Study|Withdrawal by Subject|22
3079084|NCT00421928|10568927|P3|Overall Study|Death|0
3079085|NCT00421928|10568928|P2|Overall Study|Death|1
3079086|NCT00421928|10568929|P1|Overall Study|Death|0
3079087|NCT00421928|10568927|P3|Overall Study|All other|27
3079088|NCT00421928|10568928|P2|Overall Study|All other|21
3079089|NCT00421928|10568929|P1|Overall Study|All other|26
3079090|NCT00421928|10568927|P3|Overall Study|Study drug non-compliant|4
3079091|NCT00421928|10568928|P2|Overall Study|Study drug non-compliant|7
3079092|NCT00421928|10568929|P1|Overall Study|Study drug non-compliant|6
3079093|NCT00421928|10568927|P3|Overall Study|Lack of Efficacy|35
3079094|NCT00421928|10568928|P2|Overall Study|Lack of Efficacy|7
3079095|NCT00421928|10568929|P1|Overall Study|Lack of Efficacy|15
3079096|NCT00421928|10568927|P3|Overall Study|Withdrawal by Subject|43
3079097|NCT00421928|10568928|P2|Overall Study|Withdrawal by Subject|48
3079098|NCT00421928|10568929|P1|Overall Study|Withdrawal by Subject|50
3079099|NCT00421928|10568927|P3|Overall Study|Lost to Follow-up|3
3079100|NCT00421928|10568928|P2|Overall Study|Lost to Follow-up|0
3079101|NCT00421928|10568929|P1|Overall Study|Lost to Follow-up|5
3079102|NCT00421928|10568927|P3|Overall Study|Adverse Event|22
3079103|NCT00421928|10568928|P2|Overall Study|Adverse Event|140
3079104|NCT00421928|10568929|P1|Overall Study|Adverse Event|61
3079105|NCT00421889|10568964|P9|Overall Study|Lost to Follow-up|1
3079106|NCT00421889|10568965|P8|Overall Study|Lost to Follow-up|0
3079107|NCT00421889|10568966|P7|Overall Study|Lost to Follow-up|0
3079108|NCT00421889|10568967|P6|Overall Study|Lost to Follow-up|0
3079109|NCT00421889|10568968|P5|Overall Study|Lost to Follow-up|0
3079110|NCT00421889|10568969|P4|Overall Study|Lost to Follow-up|0
3079111|NCT00421889|10568970|P3|Overall Study|Lost to Follow-up|0
3079112|NCT00421889|10568971|P2|Overall Study|Lost to Follow-up|0
3079113|NCT00421889|10568972|P1|Overall Study|Lost to Follow-up|0
3079114|NCT00421889|10568964|P9|Overall Study|Patient/Investigator request|3
3079115|NCT00421889|10568965|P8|Overall Study|Patient/Investigator request|1
3079116|NCT00421889|10568966|P7|Overall Study|Patient/Investigator request|0
3079117|NCT00421889|10568967|P6|Overall Study|Patient/Investigator request|9
3079118|NCT00421889|10568968|P5|Overall Study|Patient/Investigator request|0
3079119|NCT00421889|10568969|P4|Overall Study|Patient/Investigator request|0
3079120|NCT00421889|10568970|P3|Overall Study|Patient/Investigator request|0
3079121|NCT00421889|10568971|P2|Overall Study|Patient/Investigator request|0
3079122|NCT00421889|10568972|P1|Overall Study|Patient/Investigator request|0
3079123|NCT00421889|10568964|P9|Overall Study|Progressive disease|5
3079124|NCT00421889|10568965|P8|Overall Study|Progressive disease|1
3079125|NCT00421889|10568966|P7|Overall Study|Progressive disease|3
3079126|NCT00421889|10568967|P6|Overall Study|Progressive disease|21
3079127|NCT00421889|10568968|P5|Overall Study|Progressive disease|2
3079128|NCT00421889|10568969|P4|Overall Study|Progressive disease|3
3079129|NCT00421889|10568970|P3|Overall Study|Progressive disease|2
3079130|NCT00421889|10568971|P2|Overall Study|Progressive disease|2
3079131|NCT00421889|10568972|P1|Overall Study|Progressive disease|3
3079132|NCT00421889|10568964|P9|Overall Study|Death|0
3079133|NCT00421889|10568965|P8|Overall Study|Death|0
3079134|NCT00421889|10568966|P7|Overall Study|Death|0
3079135|NCT00421889|10568967|P6|Overall Study|Death|1
3079136|NCT00421889|10568968|P5|Overall Study|Death|1
3079137|NCT00421889|10568969|P4|Overall Study|Death|0
3079138|NCT00421889|10568970|P3|Overall Study|Death|0
3079139|NCT00421889|10568971|P2|Overall Study|Death|0
3079140|NCT00421889|10568972|P1|Overall Study|Death|0
3079141|NCT00421889|10568964|P9|Overall Study|Withdrawal by Subject|0
3079142|NCT00421889|10568965|P8|Overall Study|Withdrawal by Subject|0
3079143|NCT00421889|10568966|P7|Overall Study|Withdrawal by Subject|0
3079144|NCT00421889|10568967|P6|Overall Study|Withdrawal by Subject|0
3079145|NCT00421889|10568968|P5|Overall Study|Withdrawal by Subject|2
3079146|NCT00421889|10568969|P4|Overall Study|Withdrawal by Subject|0
3079147|NCT00421889|10568970|P3|Overall Study|Withdrawal by Subject|0
3079148|NCT00421889|10568971|P2|Overall Study|Withdrawal by Subject|3
3079149|NCT00421889|10568972|P1|Overall Study|Withdrawal by Subject|1
3079150|NCT00421889|10568964|P9|Overall Study|Adverse Event|2
3079151|NCT00421889|10568965|P8|Overall Study|Adverse Event|0
3079152|NCT00421889|10568966|P7|Overall Study|Adverse Event|1
3079153|NCT00421889|10568967|P6|Overall Study|Adverse Event|4
3079154|NCT00421889|10568968|P5|Overall Study|Adverse Event|1
3079155|NCT00421889|10568969|P4|Overall Study|Adverse Event|1
3079156|NCT00421889|10568970|P3|Overall Study|Adverse Event|1
3079157|NCT00421889|10568971|P2|Overall Study|Adverse Event|0
3079158|NCT00421889|10568972|P1|Overall Study|Adverse Event|1
3079159|NCT00421733|10569017|P3|Overall Study|Protocol deviation|2
3079160|NCT00421733|10569018|P2|Overall Study|Protocol deviation|7
3079161|NCT00421733|10569019|P1|Overall Study|Protocol deviation|4
3079162|NCT00421733|10569017|P3|Overall Study|Sponsor request|3
3079163|NCT00421733|10569018|P2|Overall Study|Sponsor request|0
3079164|NCT00421733|10569019|P1|Overall Study|Sponsor request|1
3079165|NCT00421733|10569017|P3|Overall Study|Did not satisfy entry criteria|2
3079166|NCT00421733|10569018|P2|Overall Study|Did not satisfy entry criteria|3
3079167|NCT00421733|10569019|P1|Overall Study|Did not satisfy entry criteria|1
3079168|NCT00421733|10569017|P3|Overall Study|Administrative|0
3079169|NCT00421733|10569018|P2|Overall Study|Administrative|0
3079170|NCT00421733|10569019|P1|Overall Study|Administrative|2
3079171|NCT00421733|10569017|P3|Overall Study|Required dialysis|0
3079172|NCT00421733|10569018|P2|Overall Study|Required dialysis|0
3079173|NCT00421733|10569019|P1|Overall Study|Required dialysis|1
3079174|NCT00421733|10569017|P3|Overall Study|Death|0
3079175|NCT00421733|10569018|P2|Overall Study|Death|3
3079176|NCT00421733|10569019|P1|Overall Study|Death|0
3079177|NCT00421733|10569017|P3|Overall Study|Withdrawal by Subject|7
3079178|NCT00421733|10569018|P2|Overall Study|Withdrawal by Subject|2
3079179|NCT00421733|10569019|P1|Overall Study|Withdrawal by Subject|1
3079180|NCT00421733|10569017|P3|Overall Study|Lost to Follow-up|4
3079181|NCT00421733|10569018|P2|Overall Study|Lost to Follow-up|2
3079182|NCT00421733|10569019|P1|Overall Study|Lost to Follow-up|1
3079183|NCT00421733|10569017|P3|Overall Study|Adverse Event|2
3079184|NCT00421733|10569018|P2|Overall Study|Adverse Event|9
3079185|NCT00421733|10569019|P1|Overall Study|Adverse Event|4
3079186|NCT00421707|10569039|P2|Period 3:Treatment Period 2|Adverse Event|2
3079187|NCT00421707|10569040|P1|Period 3:Treatment Period 2|Adverse Event|0
3079188|NCT00421707|10569039|P2|Period 3:Treatment Period 2|Protocol Violation|0
3079189|NCT00421707|10569040|P1|Period 3:Treatment Period 2|Protocol Violation|1
3079190|NCT00421707|10569039|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
3079191|NCT00421707|10569040|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
3079192|NCT00421707|10569039|P2|Period 2: Washout|Other: Pregnancy|1
3079193|NCT00421707|10569040|P1|Period 2: Washout|Other: Pregnancy|0
3079194|NCT00421707|10569039|P2|Period 2: Washout|Lost to Follow-up|1
3079195|NCT00421707|10569040|P1|Period 2: Washout|Lost to Follow-up|0
3079196|NCT00421707|10569039|P2|Period 2: Washout|Withdrawal by Subject|1
3079197|NCT00421707|10569040|P1|Period 2: Washout|Withdrawal by Subject|0
3079198|NCT00421707|10569039|P2|Period 2: Washout|Adverse Event|1
3079199|NCT00421707|10569040|P1|Period 2: Washout|Adverse Event|1
3079200|NCT00421707|10569039|P2|Period 1: Treatment Period 1|Protocol Violation|0
3079201|NCT00421707|10569040|P1|Period 1: Treatment Period 1|Protocol Violation|1
3079202|NCT00421707|10569039|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
3079203|NCT00421707|10569040|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
3079204|NCT00421707|10569039|P2|Period 1: Treatment Period 1|Adverse Event|2
3079205|NCT00421707|10569040|P1|Period 1: Treatment Period 1|Adverse Event|7
3079206|NCT00421707|10569039|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
3079207|NCT00421707|10569040|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
3079208|NCT00421408|10569091|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
3079209|NCT00421408|10569092|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
3079210|NCT00421408|10569091|P2|Overall Study|Lost to Follow-up|20
3079211|NCT00421408|10569092|P1|Overall Study|Lost to Follow-up|30
3079212|NCT00421343|10569110|P1|Overall Study|Lost to Follow-up|3
3079213|NCT00421343|10569110|P1|Overall Study|Withdrawal by Subject|2
3079214|NCT00421343|10569110|P1|Overall Study|Death|1
3079215|NCT00421174|10569116|P2|Overall Study|Ineligible due to infection|0
3079216|NCT00421174|10569117|P1|Overall Study|Ineligible due to infection|2
3079217|NCT00421174|10569116|P2|Overall Study|Withdrawal by Subject|1
3079218|NCT00421174|10569117|P1|Overall Study|Withdrawal by Subject|0
3079219|NCT00421148|10569165|P20|Overall Study|Protocol Violation|0
3079220|NCT00421148|10569166|P19|Overall Study|Protocol Violation|1
3079221|NCT00421148|10569167|P18|Overall Study|Protocol Violation|0
3079222|NCT00421148|10569168|P17|Overall Study|Protocol Violation|0
3079223|NCT00421148|10569169|P16|Overall Study|Protocol Violation|0
3079224|NCT00421148|10569170|P15|Overall Study|Protocol Violation|0
3079225|NCT00421148|10569171|P14|Overall Study|Protocol Violation|0
3079226|NCT00421148|10569172|P13|Overall Study|Protocol Violation|0
3079227|NCT00421148|10569173|P12|Overall Study|Protocol Violation|0
3079228|NCT00421148|10569174|P11|Overall Study|Protocol Violation|0
3079229|NCT00421148|10569175|P10|Overall Study|Protocol Violation|0
3079230|NCT00421148|10569176|P9|Overall Study|Protocol Violation|0
3079231|NCT00421148|10569177|P8|Overall Study|Protocol Violation|0
3079232|NCT00421148|10569178|P7|Overall Study|Protocol Violation|0
3079233|NCT00421148|10569179|P6|Overall Study|Protocol Violation|1
3079234|NCT00421148|10569180|P5|Overall Study|Protocol Violation|0
3079235|NCT00421148|10569181|P4|Overall Study|Protocol Violation|0
3079236|NCT00421148|10569182|P3|Overall Study|Protocol Violation|0
3079237|NCT00421148|10569183|P2|Overall Study|Protocol Violation|0
3079238|NCT00421148|10569184|P1|Overall Study|Protocol Violation|0
3079239|NCT00421148|10569165|P20|Overall Study|Withdrawal by Subject|0
3079240|NCT00421148|10569166|P19|Overall Study|Withdrawal by Subject|0
3079241|NCT00421148|10569167|P18|Overall Study|Withdrawal by Subject|1
3079242|NCT00421148|10569168|P17|Overall Study|Withdrawal by Subject|0
3079243|NCT00421148|10569169|P16|Overall Study|Withdrawal by Subject|0
3079244|NCT00421148|10569170|P15|Overall Study|Withdrawal by Subject|0
3079245|NCT00421148|10569171|P14|Overall Study|Withdrawal by Subject|0
3079246|NCT00421148|10569172|P13|Overall Study|Withdrawal by Subject|0
3079247|NCT00421148|10569173|P12|Overall Study|Withdrawal by Subject|0
3079248|NCT00421148|10569174|P11|Overall Study|Withdrawal by Subject|0
3079249|NCT00421148|10569175|P10|Overall Study|Withdrawal by Subject|0
3079250|NCT00421148|10569176|P9|Overall Study|Withdrawal by Subject|0
3079251|NCT00421148|10569177|P8|Overall Study|Withdrawal by Subject|0
3079252|NCT00421148|10569178|P7|Overall Study|Withdrawal by Subject|0
3079253|NCT00421148|10569179|P6|Overall Study|Withdrawal by Subject|0
3079254|NCT00421148|10569180|P5|Overall Study|Withdrawal by Subject|0
3079255|NCT00421148|10569181|P4|Overall Study|Withdrawal by Subject|0
3079256|NCT00421148|10569182|P3|Overall Study|Withdrawal by Subject|0
3079257|NCT00421148|10569183|P2|Overall Study|Withdrawal by Subject|0
3079258|NCT00421148|10569184|P1|Overall Study|Withdrawal by Subject|0
3079259|NCT00421148|10569165|P20|Overall Study|Lost to Follow-up|0
3079260|NCT00421148|10569166|P19|Overall Study|Lost to Follow-up|0
3079261|NCT00421148|10569167|P18|Overall Study|Lost to Follow-up|1
3079262|NCT00421148|10569168|P17|Overall Study|Lost to Follow-up|0
3079263|NCT00421148|10569169|P16|Overall Study|Lost to Follow-up|0
3079264|NCT00421148|10569170|P15|Overall Study|Lost to Follow-up|0
3079265|NCT00421148|10569171|P14|Overall Study|Lost to Follow-up|0
3079266|NCT00421148|10569172|P13|Overall Study|Lost to Follow-up|0
3079267|NCT00421148|10569173|P12|Overall Study|Lost to Follow-up|0
3079268|NCT00421148|10569174|P11|Overall Study|Lost to Follow-up|0
3079269|NCT00421148|10569175|P10|Overall Study|Lost to Follow-up|0
3079270|NCT00421148|10569176|P9|Overall Study|Lost to Follow-up|0
3079271|NCT00421148|10569177|P8|Overall Study|Lost to Follow-up|0
3079272|NCT00421148|10569178|P7|Overall Study|Lost to Follow-up|0
3079273|NCT00421148|10569179|P6|Overall Study|Lost to Follow-up|0
3079274|NCT00421148|10569180|P5|Overall Study|Lost to Follow-up|0
3079275|NCT00421148|10569181|P4|Overall Study|Lost to Follow-up|0
3079276|NCT00421148|10569182|P3|Overall Study|Lost to Follow-up|0
3079277|NCT00421148|10569183|P2|Overall Study|Lost to Follow-up|0
3079278|NCT00421148|10569184|P1|Overall Study|Lost to Follow-up|0
3079279|NCT00420927|10569283|P7|Period 2|Took prohibited medication|0
3079280|NCT00420927|10569284|P6|Period 2|Took prohibited medication|0
3079281|NCT00420927|10569285|P5|Period 2|Took prohibited medication|1
3079282|NCT00420927|10569286|P4|Period 2|Took prohibited medication|0
3079283|NCT00420927|10569287|P3|Period 2|Took prohibited medication|0
3079284|NCT00420927|10569288|P2|Period 2|Took prohibited medication|0
3079285|NCT00420927|10569289|P1|Period 2|Took prohibited medication|0
3079286|NCT00420927|10569283|P7|Period 2|Methotrexate intolerance|1
3079287|NCT00420927|10569284|P6|Period 2|Methotrexate intolerance|0
3079288|NCT00420927|10569285|P5|Period 2|Methotrexate intolerance|0
3079289|NCT00420927|10569286|P4|Period 2|Methotrexate intolerance|0
3079290|NCT00420927|10569287|P3|Period 2|Methotrexate intolerance|0
3079291|NCT00420927|10569288|P2|Period 2|Methotrexate intolerance|0
3079292|NCT00420927|10569289|P1|Period 2|Methotrexate intolerance|0
3079293|NCT00420927|10569283|P7|Period 2|Noncompliant with study drug|2
3079294|NCT00420927|10569284|P6|Period 2|Noncompliant with study drug|0
3079295|NCT00420927|10569285|P5|Period 2|Noncompliant with study drug|0
3079296|NCT00420927|10569286|P4|Period 2|Noncompliant with study drug|1
3079297|NCT00420927|10569287|P3|Period 2|Noncompliant with study drug|0
3079298|NCT00420927|10569288|P2|Period 2|Noncompliant with study drug|0
3079299|NCT00420927|10569289|P1|Period 2|Noncompliant with study drug|0
3079300|NCT00420927|10569283|P7|Period 2|Randomization error|0
3079301|NCT00420927|10569284|P6|Period 2|Randomization error|1
3079302|NCT00420927|10569285|P5|Period 2|Randomization error|1
3079303|NCT00420927|10569286|P4|Period 2|Randomization error|0
3079304|NCT00420927|10569287|P3|Period 2|Randomization error|0
3079305|NCT00420927|10569288|P2|Period 2|Randomization error|0
3079306|NCT00420927|10569289|P1|Period 2|Randomization error|0
3079307|NCT00420927|10569283|P7|Period 2|Sponsor decision|1
3079308|NCT00420927|10569284|P6|Period 2|Sponsor decision|0
3079309|NCT00420927|10569285|P5|Period 2|Sponsor decision|0
3079310|NCT00420927|10569286|P4|Period 2|Sponsor decision|0
3079311|NCT00420927|10569287|P3|Period 2|Sponsor decision|1
3079312|NCT00420927|10569288|P2|Period 2|Sponsor decision|0
3079313|NCT00420927|10569289|P1|Period 2|Sponsor decision|0
3079314|NCT00420927|10569283|P7|Period 2|Physician Decision|0
3079315|NCT00420927|10569284|P6|Period 2|Physician Decision|1
3079316|NCT00420927|10569285|P5|Period 2|Physician Decision|1
3079317|NCT00420927|10569286|P4|Period 2|Physician Decision|0
3079318|NCT00420927|10569287|P3|Period 2|Physician Decision|0
3079319|NCT00420927|10569288|P2|Period 2|Physician Decision|0
3079320|NCT00420927|10569289|P1|Period 2|Physician Decision|0
3079321|NCT00420927|10569283|P7|Period 2|Subject unable to find transportation|1
3079322|NCT00420927|10569284|P6|Period 2|Subject unable to find transportation|0
3079323|NCT00420927|10569285|P5|Period 2|Subject unable to find transportation|0
3079324|NCT00420927|10569286|P4|Period 2|Subject unable to find transportation|0
3079325|NCT00420927|10569287|P3|Period 2|Subject unable to find transportation|0
3079326|NCT00420927|10569288|P2|Period 2|Subject unable to find transportation|0
3079327|NCT00420927|10569289|P1|Period 2|Subject unable to find transportation|0
3079328|NCT00420927|10569283|P7|Period 2|Received wrong treatment/incorrect dose|1
3079329|NCT00420927|10569284|P6|Period 2|Received wrong treatment/incorrect dose|0
3079330|NCT00420927|10569285|P5|Period 2|Received wrong treatment/incorrect dose|0
3079331|NCT00420927|10569286|P4|Period 2|Received wrong treatment/incorrect dose|0
3079332|NCT00420927|10569287|P3|Period 2|Received wrong treatment/incorrect dose|0
3079333|NCT00420927|10569288|P2|Period 2|Received wrong treatment/incorrect dose|0
3079334|NCT00420927|10569289|P1|Period 2|Received wrong treatment/incorrect dose|0
3079335|NCT00420927|10569283|P7|Period 2|Lack of efficacy/Loss of efficacy|6
3079336|NCT00420927|10569284|P6|Period 2|Lack of efficacy/Loss of efficacy|2
3079337|NCT00420927|10569285|P5|Period 2|Lack of efficacy/Loss of efficacy|6
3079338|NCT00420927|10569286|P4|Period 2|Lack of efficacy/Loss of efficacy|1
3079339|NCT00420927|10569287|P3|Period 2|Lack of efficacy/Loss of efficacy|2
3079340|NCT00420927|10569288|P2|Period 2|Lack of efficacy/Loss of efficacy|0
3079341|NCT00420927|10569289|P1|Period 2|Lack of efficacy/Loss of efficacy|0
3079342|NCT00420927|10569283|P7|Period 2|Lost to Follow-up|9
3079343|NCT00420927|10569284|P6|Period 2|Lost to Follow-up|3
3079344|NCT00420927|10569285|P5|Period 2|Lost to Follow-up|6
3079345|NCT00420927|10569286|P4|Period 2|Lost to Follow-up|2
3079346|NCT00420927|10569287|P3|Period 2|Lost to Follow-up|2
3079347|NCT00420927|10569288|P2|Period 2|Lost to Follow-up|0
3079348|NCT00420927|10569289|P1|Period 2|Lost to Follow-up|0
3079349|NCT00420927|10569283|P7|Period 2|Withdrawal by Subject|12
3079350|NCT00420927|10569284|P6|Period 2|Withdrawal by Subject|2
3079351|NCT00420927|10569285|P5|Period 2|Withdrawal by Subject|11
3079352|NCT00420927|10569286|P4|Period 2|Withdrawal by Subject|3
3079353|NCT00420927|10569287|P3|Period 2|Withdrawal by Subject|1
3079354|NCT00420927|10569288|P2|Period 2|Withdrawal by Subject|0
3079355|NCT00420927|10569289|P1|Period 2|Withdrawal by Subject|0
3079356|NCT00420927|10569283|P7|Period 2|Adverse Event|20
3079357|NCT00420927|10569284|P6|Period 2|Adverse Event|6
3079358|NCT00420927|10569285|P5|Period 2|Adverse Event|17
3079359|NCT00420927|10569286|P4|Period 2|Adverse Event|3
3079360|NCT00420927|10569287|P3|Period 2|Adverse Event|7
3079361|NCT00420927|10569288|P2|Period 2|Adverse Event|0
3079362|NCT00420927|10569289|P1|Period 2|Adverse Event|0
3079363|NCT00420927|10569283|P7|Period 1|Took prohibited medication|0
3079364|NCT00420927|10569284|P6|Period 1|Took prohibited medication|0
3079365|NCT00420927|10569285|P5|Period 1|Took prohibited medication|0
3079366|NCT00420927|10569286|P4|Period 1|Took prohibited medication|0
3079367|NCT00420927|10569287|P3|Period 1|Took prohibited medication|0
3079368|NCT00420927|10569288|P2|Period 1|Took prohibited medication|3
3079369|NCT00420927|10569289|P1|Period 1|Took prohibited medication|1
3079370|NCT00420927|10569283|P7|Period 1|Failed to meet entry criteria|0
3079371|NCT00420927|10569284|P6|Period 1|Failed to meet entry criteria|0
3079372|NCT00420927|10569285|P5|Period 1|Failed to meet entry criteria|0
3079373|NCT00420927|10569286|P4|Period 1|Failed to meet entry criteria|0
3079374|NCT00420927|10569287|P3|Period 1|Failed to meet entry criteria|0
3079375|NCT00420927|10569288|P2|Period 1|Failed to meet entry criteria|7
3079376|NCT00420927|10569289|P1|Period 1|Failed to meet entry criteria|8
3079377|NCT00420927|10569283|P7|Period 1|Received wrong treatment/incorrect dose|0
3079378|NCT00420927|10569284|P6|Period 1|Received wrong treatment/incorrect dose|0
3079379|NCT00420927|10569285|P5|Period 1|Received wrong treatment/incorrect dose|0
3079380|NCT00420927|10569286|P4|Period 1|Received wrong treatment/incorrect dose|0
3079381|NCT00420927|10569287|P3|Period 1|Received wrong treatment/incorrect dose|0
3079382|NCT00420927|10569288|P2|Period 1|Received wrong treatment/incorrect dose|1
3079383|NCT00420927|10569289|P1|Period 1|Received wrong treatment/incorrect dose|0
3079384|NCT00420927|10569283|P7|Period 1|Subject received new diagnosis|0
3079385|NCT00420927|10569284|P6|Period 1|Subject received new diagnosis|0
3079386|NCT00420927|10569285|P5|Period 1|Subject received new diagnosis|0
3079387|NCT00420927|10569286|P4|Period 1|Subject received new diagnosis|0
3079388|NCT00420927|10569287|P3|Period 1|Subject received new diagnosis|0
3079389|NCT00420927|10569288|P2|Period 1|Subject received new diagnosis|2
3079390|NCT00420927|10569289|P1|Period 1|Subject received new diagnosis|0
3079391|NCT00420927|10569283|P7|Period 1|Study site closure|0
3079392|NCT00420927|10569284|P6|Period 1|Study site closure|0
3079393|NCT00420927|10569285|P5|Period 1|Study site closure|0
3079394|NCT00420927|10569286|P4|Period 1|Study site closure|0
3079395|NCT00420927|10569287|P3|Period 1|Study site closure|0
3079396|NCT00420927|10569288|P2|Period 1|Study site closure|1
3079397|NCT00420927|10569289|P1|Period 1|Study site closure|0
3079398|NCT00420927|10569283|P7|Period 1|Suspected tuberculosis/positive test|0
3079399|NCT00420927|10569284|P6|Period 1|Suspected tuberculosis/positive test|0
3079400|NCT00420927|10569285|P5|Period 1|Suspected tuberculosis/positive test|0
3079401|NCT00420927|10569286|P4|Period 1|Suspected tuberculosis/positive test|0
3079402|NCT00420927|10569287|P3|Period 1|Suspected tuberculosis/positive test|0
3079403|NCT00420927|10569288|P2|Period 1|Suspected tuberculosis/positive test|1
3079404|NCT00420927|10569289|P1|Period 1|Suspected tuberculosis/positive test|1
3079405|NCT00420927|10569283|P7|Period 1|Randomization error|0
3079406|NCT00420927|10569284|P6|Period 1|Randomization error|0
3079407|NCT00420927|10569285|P5|Period 1|Randomization error|0
3079408|NCT00420927|10569286|P4|Period 1|Randomization error|0
3079409|NCT00420927|10569287|P3|Period 1|Randomization error|0
3079410|NCT00420927|10569288|P2|Period 1|Randomization error|0
3079411|NCT00420927|10569289|P1|Period 1|Randomization error|1
3079412|NCT00420927|10569283|P7|Period 1|Noncompliant with study drug|0
3079413|NCT00420927|10569284|P6|Period 1|Noncompliant with study drug|0
3079414|NCT00420927|10569285|P5|Period 1|Noncompliant with study drug|0
3079415|NCT00420927|10569286|P4|Period 1|Noncompliant with study drug|0
3079416|NCT00420927|10569287|P3|Period 1|Noncompliant with study drug|0
3079417|NCT00420927|10569288|P2|Period 1|Noncompliant with study drug|1
3079418|NCT00420927|10569289|P1|Period 1|Noncompliant with study drug|1
3079419|NCT00420927|10569283|P7|Period 1|Subject moved/relocated|0
3079420|NCT00420927|10569284|P6|Period 1|Subject moved/relocated|0
3079421|NCT00420927|10569285|P5|Period 1|Subject moved/relocated|0
3079422|NCT00420927|10569286|P4|Period 1|Subject moved/relocated|0
3079423|NCT00420927|10569287|P3|Period 1|Subject moved/relocated|0
3079424|NCT00420927|10569288|P2|Period 1|Subject moved/relocated|2
3079425|NCT00420927|10569289|P1|Period 1|Subject moved/relocated|0
3079426|NCT00420927|10569283|P7|Period 1|Death|0
3079427|NCT00420927|10569284|P6|Period 1|Death|0
3079428|NCT00420927|10569285|P5|Period 1|Death|0
3079429|NCT00420927|10569286|P4|Period 1|Death|0
3079430|NCT00420927|10569287|P3|Period 1|Death|0
3079431|NCT00420927|10569288|P2|Period 1|Death|0
3079432|NCT00420927|10569289|P1|Period 1|Death|2
3079433|NCT00420927|10569283|P7|Period 1|Lack of efficacy/Loss of efficacy|0
3079434|NCT00420927|10569284|P6|Period 1|Lack of efficacy/Loss of efficacy|0
3079435|NCT00420927|10569285|P5|Period 1|Lack of efficacy/Loss of efficacy|0
3079436|NCT00420927|10569286|P4|Period 1|Lack of efficacy/Loss of efficacy|0
3079437|NCT00420927|10569287|P3|Period 1|Lack of efficacy/Loss of efficacy|0
3079438|NCT00420927|10569288|P2|Period 1|Lack of efficacy/Loss of efficacy|6
3079439|NCT00420927|10569289|P1|Period 1|Lack of efficacy/Loss of efficacy|1
3079440|NCT00420927|10569283|P7|Period 1|Lost to Follow-up|0
3079441|NCT00420927|10569284|P6|Period 1|Lost to Follow-up|0
3079442|NCT00420927|10569285|P5|Period 1|Lost to Follow-up|0
3079443|NCT00420927|10569286|P4|Period 1|Lost to Follow-up|0
3079444|NCT00420927|10569287|P3|Period 1|Lost to Follow-up|0
3079445|NCT00420927|10569288|P2|Period 1|Lost to Follow-up|6
3079446|NCT00420927|10569289|P1|Period 1|Lost to Follow-up|8
3079447|NCT00420927|10569283|P7|Period 1|Withdrawal by Subject|0
3079448|NCT00420927|10569284|P6|Period 1|Withdrawal by Subject|0
3079449|NCT00420927|10569285|P5|Period 1|Withdrawal by Subject|0
3079450|NCT00420927|10569286|P4|Period 1|Withdrawal by Subject|0
3079451|NCT00420927|10569287|P3|Period 1|Withdrawal by Subject|0
3079452|NCT00420927|10569288|P2|Period 1|Withdrawal by Subject|12
3079453|NCT00420927|10569289|P1|Period 1|Withdrawal by Subject|7
3079454|NCT00420927|10569283|P7|Period 1|Adverse Event|0
3079455|NCT00420927|10569284|P6|Period 1|Adverse Event|0
3079456|NCT00420927|10569285|P5|Period 1|Adverse Event|0
3079457|NCT00420927|10569286|P4|Period 1|Adverse Event|0
3079458|NCT00420927|10569287|P3|Period 1|Adverse Event|0
3079459|NCT00420927|10569288|P2|Period 1|Adverse Event|15
3079460|NCT00420927|10569289|P1|Period 1|Adverse Event|19
3079461|NCT00420849|10569393|P1|Overall Study|Lost to Follow-up|1
3079462|NCT00420849|10569393|P1|Overall Study|Protocol Violation|1
3079463|NCT00420849|10569393|P1|Overall Study|Transplant|8
3079464|NCT00420849|10569393|P1|Overall Study|Other|14
3079465|NCT00420849|10569393|P1|Overall Study|Death|18
3079466|NCT00420849|10569393|P1|Overall Study|Withdrawal by Subject|28
3079467|NCT00420849|10569393|P1|Overall Study|Adverse Event|107
3079468|NCT00420849|10569393|P1|Overall Study|Lack of Efficacy|154
3079469|NCT00420784|10569462|P4|Overall Study|Other|5
3079470|NCT00420784|10569463|P3|Overall Study|Other|0
3079471|NCT00420784|10569464|P2|Overall Study|Other|2
3079472|NCT00420784|10569465|P1|Overall Study|Other|1
3079473|NCT00420784|10569462|P4|Overall Study|Virologic Stopping Rule|67
3079474|NCT00420784|10569463|P3|Overall Study|Virologic Stopping Rule|41
3079475|NCT00420784|10569464|P2|Overall Study|Virologic Stopping Rule|26
3079476|NCT00420784|10569465|P1|Overall Study|Virologic Stopping Rule|17
3079477|NCT00420784|10569462|P4|Overall Study|Lost to Follow-up|1
3079478|NCT00420784|10569463|P3|Overall Study|Lost to Follow-up|2
3079479|NCT00420784|10569464|P2|Overall Study|Lost to Follow-up|0
3079480|NCT00420784|10569465|P1|Overall Study|Lost to Follow-up|0
3079481|NCT00420784|10569462|P4|Overall Study|Withdrawal by Subject|0
3079482|NCT00420784|10569463|P3|Overall Study|Withdrawal by Subject|0
3079483|NCT00420784|10569464|P2|Overall Study|Withdrawal by Subject|1
3079484|NCT00420784|10569465|P1|Overall Study|Withdrawal by Subject|0
3079485|NCT00420784|10569462|P4|Overall Study|Adverse Event|5
3079486|NCT00420784|10569463|P3|Overall Study|Adverse Event|10
3079487|NCT00420784|10569464|P2|Overall Study|Adverse Event|29
3079488|NCT00420784|10569465|P1|Overall Study|Adverse Event|11
3079489|NCT00420745|10569503|P2|Overall Study|Age limit exceeded for Dose 2|0
3079490|NCT00420745|10569504|P1|Overall Study|Age limit exceeded for Dose 2|1
3079491|NCT00420745|10569503|P2|Overall Study|Recurrent pneumonia & bronchitis|1
3079492|NCT00420745|10569504|P1|Overall Study|Recurrent pneumonia & bronchitis|0
3079493|NCT00420745|10569503|P2|Overall Study|Physician Decision|1
3079494|NCT00420745|10569504|P1|Overall Study|Physician Decision|1
3079495|NCT00420745|10569503|P2|Overall Study|Protocol Violation|0
3079496|NCT00420745|10569504|P1|Overall Study|Protocol Violation|1
3079497|NCT00420745|10569503|P2|Overall Study|Lost to Follow-up|2
3079498|NCT00420745|10569504|P1|Overall Study|Lost to Follow-up|10
3079499|NCT00420745|10569503|P2|Overall Study|Adverse Event|2
3079500|NCT00420745|10569504|P1|Overall Study|Adverse Event|2
3079501|NCT00420641|10569523|P3|Overall Study|Other|3
3079502|NCT00420641|10569524|P2|Overall Study|Other|4
3079503|NCT00420641|10569525|P1|Overall Study|Other|4
3079504|NCT00420641|10569523|P3|Overall Study|Non-compliance|4
3079505|NCT00420641|10569524|P2|Overall Study|Non-compliance|5
3079506|NCT00420641|10569525|P1|Overall Study|Non-compliance|7
3079507|NCT00420641|10569523|P3|Overall Study|Lack of Efficacy|4
3079508|NCT00420641|10569524|P2|Overall Study|Lack of Efficacy|5
3079509|NCT00420641|10569525|P1|Overall Study|Lack of Efficacy|6
3079510|NCT00420641|10569523|P3|Overall Study|Withdrawal by Subject|14
3079511|NCT00420641|10569524|P2|Overall Study|Withdrawal by Subject|21
3079512|NCT00420641|10569525|P1|Overall Study|Withdrawal by Subject|15
3079513|NCT00420641|10569523|P3|Overall Study|Protocol Violation|7
3079514|NCT00420641|10569524|P2|Overall Study|Protocol Violation|8
3079515|NCT00420641|10569525|P1|Overall Study|Protocol Violation|8
3079516|NCT00420641|10569523|P3|Overall Study|Lost to Follow-up|2
3079517|NCT00420641|10569524|P2|Overall Study|Lost to Follow-up|4
3079518|NCT00420641|10569525|P1|Overall Study|Lost to Follow-up|2
3079519|NCT00420641|10569523|P3|Overall Study|Adverse Event|10
3079520|NCT00420641|10569524|P2|Overall Study|Adverse Event|25
3079521|NCT00420641|10569525|P1|Overall Study|Adverse Event|3
3079522|NCT00420628|10569601|P2|Overall Study|Adverse Event|0
3079523|NCT00420628|10569602|P1|Overall Study|Adverse Event|1
3079524|NCT00420628|10569601|P2|Overall Study|Lost to Follow-up|2
3079525|NCT00420628|10569602|P1|Overall Study|Lost to Follow-up|3
3079526|NCT00420628|10569601|P2|Overall Study|Withdrawn by parent or gaurdian|2
3079527|NCT00420628|10569602|P1|Overall Study|Withdrawn by parent or gaurdian|5
3079528|NCT00420511|10569618|P2|Overall Study|Lost to Follow-up|0
3079529|NCT00420511|10569619|P1|Overall Study|Lost to Follow-up|1
3079530|NCT00420511|10569618|P2|Overall Study|Adverse Event|1
3079531|NCT00420511|10569619|P1|Overall Study|Adverse Event|1
3079532|NCT00420420|10569640|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
3079533|NCT00420420|10569641|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
3079534|NCT00420420|10569640|P2|Overall Study|Withdrawal by Subject|0
3079535|NCT00420420|10569641|P1|Overall Study|Withdrawal by Subject|1
3079536|NCT00420420|10569640|P2|Overall Study|Protocol Violation|1
3079537|NCT00420420|10569641|P1|Overall Study|Protocol Violation|1
3079538|NCT00420420|10569640|P2|Overall Study|Adverse Event|3
3079539|NCT00420420|10569641|P1|Overall Study|Adverse Event|5
3079540|NCT00420407|10569659|P2|Overall Study|Withdrawal by Subject|2
3079541|NCT00420407|10569660|P1|Overall Study|Withdrawal by Subject|0
3079542|NCT00420407|10569659|P2|Overall Study|subject identified as Jehovah's witness|0
3079543|NCT00420407|10569660|P1|Overall Study|subject identified as Jehovah's witness|1
3079544|NCT00420407|10569659|P2|Overall Study|subject identified as detainee|0
3079545|NCT00420407|10569660|P1|Overall Study|subject identified as detainee|1
3079546|NCT00420407|10569659|P2|Overall Study|Physician Decision|1
3079547|NCT00420407|10569660|P1|Overall Study|Physician Decision|2
3079548|NCT00420407|10569659|P2|Overall Study|Lost to Follow-up|3
3079549|NCT00420407|10569660|P1|Overall Study|Lost to Follow-up|0
3079550|NCT00420342|10569670|P3|Overall Study|Withdrawal by Subject|0
3079551|NCT00420342|10569671|P2|Overall Study|Withdrawal by Subject|2
3079552|NCT00420342|10569672|P1|Overall Study|Withdrawal by Subject|0
3079553|NCT00420342|10569670|P3|Overall Study|Lost to Follow-up|1
3079554|NCT00420342|10569671|P2|Overall Study|Lost to Follow-up|0
3079555|NCT00420342|10569672|P1|Overall Study|Lost to Follow-up|1
3079556|NCT00420316|10569715|P2|Overall Study|Lost to Follow-up|8
3079557|NCT00420316|10569716|P1|Overall Study|Lost to Follow-up|12
3079558|NCT00420316|10569715|P2|Overall Study|Withdrawal by Subject|1
3079559|NCT00420316|10569716|P1|Overall Study|Withdrawal by Subject|0
3079560|NCT00420303|10569740|P2|Overall Study|Physician Decision|1
3079561|NCT00420303|10569741|P1|Overall Study|Physician Decision|0
3079562|NCT00420303|10569740|P2|Overall Study|Lack of Efficacy|3
3079563|NCT00420303|10569741|P1|Overall Study|Lack of Efficacy|0
3079564|NCT00420303|10569740|P2|Overall Study|Serious Adverse Event|0
3079565|NCT00420303|10569741|P1|Overall Study|Serious Adverse Event|1
3079566|NCT00420290|10569753|P2|Overall Study|did not meet inclusion/exclusion|1
3079567|NCT00420290|10569754|P1|Overall Study|did not meet inclusion/exclusion|1
3079568|NCT00420290|10569753|P2|Overall Study|Withdrawal by Subject|2
3079569|NCT00420290|10569754|P1|Overall Study|Withdrawal by Subject|0
3079570|NCT00420290|10569753|P2|Overall Study|Adverse Event|1
3079571|NCT00420290|10569754|P1|Overall Study|Adverse Event|3
3079572|NCT00420238|10569770|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
3079573|NCT00420238|10569771|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
3079574|NCT00420238|10569770|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
3079575|NCT00420238|10569771|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
3079576|NCT00420238|10569770|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
3079577|NCT00420238|10569771|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
3079578|NCT00420238|10569770|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
3079579|NCT00420238|10569771|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
3079580|NCT00420238|10569770|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
3079581|NCT00420238|10569771|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
3079582|NCT00420238|10569770|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
3079583|NCT00420238|10569771|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
3079584|NCT00420212|10569910|P3|Overall Study|Other-Unspecified|18
3079585|NCT00420212|10569911|P2|Overall Study|Other-Unspecified|14
3079586|NCT00420212|10569912|P1|Overall Study|Other-Unspecified|21
3079587|NCT00420212|10569910|P3|Overall Study|Death|1
3079588|NCT00420212|10569911|P2|Overall Study|Death|0
3079589|NCT00420212|10569912|P1|Overall Study|Death|0
3079590|NCT00420212|10569910|P3|Overall Study|Protocol Violation|8
3079591|NCT00420212|10569911|P2|Overall Study|Protocol Violation|4
3079592|NCT00420212|10569912|P1|Overall Study|Protocol Violation|4
3079593|NCT00420212|10569910|P3|Overall Study|Physician Decision|3
3079594|NCT00420212|10569911|P2|Overall Study|Physician Decision|4
3079595|NCT00420212|10569912|P1|Overall Study|Physician Decision|4
3079596|NCT00420212|10569910|P3|Overall Study|Withdrawal by Subject|19
3079597|NCT00420212|10569911|P2|Overall Study|Withdrawal by Subject|22
3079598|NCT00420212|10569912|P1|Overall Study|Withdrawal by Subject|31
3079599|NCT00420212|10569910|P3|Overall Study|Lost to Follow-up|11
3079600|NCT00420212|10569911|P2|Overall Study|Lost to Follow-up|11
3079601|NCT00420212|10569912|P1|Overall Study|Lost to Follow-up|9
3079602|NCT00420212|10569910|P3|Overall Study|Adverse Event|36
3079603|NCT00420212|10569911|P2|Overall Study|Adverse Event|40
3079604|NCT00420212|10569912|P1|Overall Study|Adverse Event|22
3079605|NCT00420199|10569938|P2|Overall Study|Participant no longer met study criteria|0
3079606|NCT00420199|10569939|P1|Overall Study|Participant no longer met study criteria|1
3079607|NCT00420095|10570005|P2|Overall Study|Lost to Follow-up|0
3079608|NCT00420095|10570006|P1|Overall Study|Lost to Follow-up|1
3079609|NCT00420095|10570005|P2|Overall Study|Protocol Violation|1
3079610|NCT00420095|10570006|P1|Overall Study|Protocol Violation|1
3079611|NCT00420095|10570005|P2|Overall Study|Adverse Event|0
3079612|NCT00420095|10570006|P1|Overall Study|Adverse Event|1
3079613|NCT00420056|10570024|P1|Overall Study|Objective progression or relapse|17
3079614|NCT00420004|10570064|P3|Overall Study|Sponsor Decision|1
3079615|NCT00420004|10570065|P2|Overall Study|Sponsor Decision|3
3079616|NCT00420004|10570066|P1|Overall Study|Sponsor Decision|3
3079617|NCT00420004|10570064|P3|Overall Study|Withdrawal by Subject|14
3079618|NCT00420004|10570065|P2|Overall Study|Withdrawal by Subject|42
3079619|NCT00420004|10570066|P1|Overall Study|Withdrawal by Subject|67
3079620|NCT00420004|10570064|P3|Overall Study|Protocol Violation|3
3079621|NCT00420004|10570065|P2|Overall Study|Protocol Violation|4
3079622|NCT00420004|10570066|P1|Overall Study|Protocol Violation|5
3079623|NCT00420004|10570064|P3|Overall Study|Physician Decision|2
3079624|NCT00420004|10570065|P2|Overall Study|Physician Decision|4
3079625|NCT00420004|10570066|P1|Overall Study|Physician Decision|14
3079626|NCT00420004|10570064|P3|Overall Study|Entry Criteria Not Met|0
3079627|NCT00420004|10570065|P2|Overall Study|Entry Criteria Not Met|1
3079628|NCT00420004|10570066|P1|Overall Study|Entry Criteria Not Met|0
3079629|NCT00420004|10570064|P3|Overall Study|Lost to Follow-up|10
3079630|NCT00420004|10570065|P2|Overall Study|Lost to Follow-up|12
3079631|NCT00420004|10570066|P1|Overall Study|Lost to Follow-up|31
3079632|NCT00420004|10570064|P3|Overall Study|Lack of Efficacy|1
3079633|NCT00420004|10570065|P2|Overall Study|Lack of Efficacy|4
3079634|NCT00420004|10570066|P1|Overall Study|Lack of Efficacy|5
3079635|NCT00420004|10570064|P3|Overall Study|Adverse Event|1
3079636|NCT00420004|10570065|P2|Overall Study|Adverse Event|1
3079637|NCT00420004|10570066|P1|Overall Study|Adverse Event|4
3079638|NCT00419952|10570131|P2|Overall Study|Abnormal ECG|0
3079639|NCT00419952|10570132|P1|Overall Study|Abnormal ECG|1
3079640|NCT00419952|10570131|P2|Overall Study|Diary or medication non-compliance|4
3079641|NCT00419952|10570132|P1|Overall Study|Diary or medication non-compliance|2
3079642|NCT00419952|10570131|P2|Overall Study|Occurence of 2 or more exacerbations|0
3079643|NCT00419952|10570132|P1|Overall Study|Occurence of 2 or more exacerbations|2
3079644|NCT00419952|10570131|P2|Overall Study|Intake of prohibited medication|2
3079645|NCT00419952|10570132|P1|Overall Study|Intake of prohibited medication|2
3079646|NCT00419952|10570131|P2|Overall Study|Incorrectly enrolled|3
3079647|NCT00419952|10570132|P1|Overall Study|Incorrectly enrolled|10
3079648|NCT00419952|10570131|P2|Overall Study|Physician Decision|3
3079649|NCT00419952|10570132|P1|Overall Study|Physician Decision|1
3079650|NCT00419952|10570131|P2|Overall Study|Pregnancy|2
3079651|NCT00419952|10570132|P1|Overall Study|Pregnancy|4
3079652|NCT00419952|10570131|P2|Overall Study|Protocol Violation|24
3079653|NCT00419952|10570132|P1|Overall Study|Protocol Violation|32
3079654|NCT00419952|10570131|P2|Overall Study|Lost to Follow-up|34
3079655|NCT00419952|10570132|P1|Overall Study|Lost to Follow-up|43
3079656|NCT00419952|10570131|P2|Overall Study|Withdrawal by Subject|43
3079657|NCT00419952|10570132|P1|Overall Study|Withdrawal by Subject|44
3079658|NCT00419952|10570131|P2|Overall Study|Adverse Event|10
3079659|NCT00419952|10570132|P1|Overall Study|Adverse Event|8
3079660|NCT00419926|10570166|P2|Overall Study|Death|1
3079661|NCT00419926|10570167|P1|Overall Study|Death|2
3079662|NCT00419926|10570166|P2|Overall Study|Lost to Follow-up|2
3079663|NCT00419926|10570167|P1|Overall Study|Lost to Follow-up|1
3079664|NCT00419926|10570166|P2|Overall Study|Administrative Problem|4
3079665|NCT00419926|10570167|P1|Overall Study|Administrative Problem|4
3079666|NCT00419926|10570166|P2|Overall Study|Withdrawal by Subject|3
3079667|NCT00419926|10570167|P1|Overall Study|Withdrawal by Subject|7
3079668|NCT00419770|10570183|P2|Overall Study|Withdrawal by Subject|1
3079669|NCT00419770|10570184|P1|Overall Study|Withdrawal by Subject|5
3079670|NCT00419757|10570192|P2|Overall Study|Multiple reasons|1
3079671|NCT00419757|10570193|P1|Overall Study|Multiple reasons|3
3079672|NCT00419757|10570192|P2|Overall Study|Study specific discontinuation criteria|8
3079673|NCT00419757|10570193|P1|Overall Study|Study specific discontinuation criteria|4
3079674|NCT00419757|10570192|P2|Overall Study|Protocol Violation|3
3079675|NCT00419757|10570193|P1|Overall Study|Protocol Violation|2
3079676|NCT00419757|10570192|P2|Overall Study|Withdrawal by Subject|1
3079677|NCT00419757|10570193|P1|Overall Study|Withdrawal by Subject|7
3079678|NCT00419757|10570192|P2|Overall Study|Lost to Follow-up|4
3079679|NCT00419757|10570193|P1|Overall Study|Lost to Follow-up|1
3079680|NCT00419757|10570192|P2|Overall Study|Adverse Event|4
3079681|NCT00419757|10570193|P1|Overall Study|Adverse Event|1
3079682|NCT00419744|10570232|P3|Overall Study|Incorrect medication kit dispensed|1
3079683|NCT00419744|10570233|P2|Overall Study|Incorrect medication kit dispensed|0
3079684|NCT00419744|10570234|P1|Overall Study|Incorrect medication kit dispensed|0
3079685|NCT00419744|10570232|P3|Overall Study|Spirometry mouthpiece issues|2
3079686|NCT00419744|10570233|P2|Overall Study|Spirometry mouthpiece issues|1
3079687|NCT00419744|10570234|P1|Overall Study|Spirometry mouthpiece issues|0
3079688|NCT00419744|10570232|P3|Overall Study|Physician Decision|6
3079689|NCT00419744|10570233|P2|Overall Study|Physician Decision|5
3079690|NCT00419744|10570234|P1|Overall Study|Physician Decision|10
3079691|NCT00419744|10570232|P3|Overall Study|Moving out of state|1
3079692|NCT00419744|10570233|P2|Overall Study|Moving out of state|0
3079693|NCT00419744|10570234|P1|Overall Study|Moving out of state|2
3079694|NCT00419744|10570232|P3|Overall Study|Randomized in error|7
3079695|NCT00419744|10570233|P2|Overall Study|Randomized in error|6
3079696|NCT00419744|10570234|P1|Overall Study|Randomized in error|9
3079697|NCT00419744|10570232|P3|Overall Study|Protocol Violation|8
3079698|NCT00419744|10570233|P2|Overall Study|Protocol Violation|7
3079699|NCT00419744|10570234|P1|Overall Study|Protocol Violation|4
3079700|NCT00419744|10570232|P3|Overall Study|Lost to Follow-up|6
3079701|NCT00419744|10570233|P2|Overall Study|Lost to Follow-up|10
3079702|NCT00419744|10570234|P1|Overall Study|Lost to Follow-up|8
3079703|NCT00419744|10570232|P3|Overall Study|Withdrawal by Subject|52
3079704|NCT00419744|10570233|P2|Overall Study|Withdrawal by Subject|49
3079705|NCT00419744|10570234|P1|Overall Study|Withdrawal by Subject|45
3079706|NCT00419744|10570232|P3|Overall Study|Adverse Event|50
3079707|NCT00419744|10570233|P2|Overall Study|Adverse Event|40
3079708|NCT00419744|10570234|P1|Overall Study|Adverse Event|39
3079709|NCT00419562|10570277|P2|Overall Study|Participant Institutionalized|0
3079710|NCT00419562|10570278|P1|Overall Study|Participant Institutionalized|1
3079711|NCT00419562|10570277|P2|Overall Study|Withdrawal by Subject|18
3079712|NCT00419562|10570278|P1|Overall Study|Withdrawal by Subject|20
3079713|NCT00419562|10570277|P2|Overall Study|Lost to Follow-up|13
3079714|NCT00419562|10570278|P1|Overall Study|Lost to Follow-up|12
3079715|NCT00419393|10570301|P1|Overall Study|Other: Investigator decision|1
3079716|NCT00419393|10570301|P1|Overall Study|Other: Other health problems|1
3079717|NCT00419393|10570301|P1|Overall Study|Other: Site closure|1
3079718|NCT00419393|10570301|P1|Overall Study|Other: Subject had temporal lobectomy|1
3079719|NCT00419393|10570301|P1|Overall Study|Other: Sponsor request|3
3079720|NCT00419393|10570301|P1|Overall Study|Withdrawal by Subject|7
3079721|NCT00419393|10570301|P1|Overall Study|Protocol Violation|5
3079722|NCT00419393|10570301|P1|Overall Study|Adverse Event|5
3079723|NCT00419380|10570311|P2|Overall Study|Withdrawal by Subject|1
3079724|NCT00419380|10570312|P1|Overall Study|Withdrawal by Subject|0
3079725|NCT00419380|10570311|P2|Overall Study|Lost to Follow-up|1
3079726|NCT00419380|10570312|P1|Overall Study|Lost to Follow-up|0
3079727|NCT00419380|10570311|P2|Overall Study|Physician Decision|1
3079728|NCT00419380|10570312|P1|Overall Study|Physician Decision|0
3079729|NCT00419380|10570311|P2|Overall Study|Lack of Efficacy|7
3079730|NCT00419380|10570312|P1|Overall Study|Lack of Efficacy|1
3079731|NCT00419341|10570320|P1|Efficacy Period|Termination of study site|1
3079732|NCT00419341|10570320|P1|Efficacy Period|Non-compliance|1
3079733|NCT00419341|10570320|P1|Efficacy Period|Lost to Follow-up|1
3079734|NCT00419341|10570320|P1|Efficacy Period|Protocol Violation|1
3079735|NCT00419341|10570320|P1|Efficacy Period|Withdrawal by Subject|6
3079736|NCT00419341|10570320|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
3079737|NCT00419341|10570320|P1|Wash in/Wash Out Period|Adverse Event|2
3079738|NCT00419341|10570320|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
3079739|NCT00419263|10570355|P3|Overall Study|Withdrawal by Subject|1
3079740|NCT00419263|10570356|P2|Overall Study|Withdrawal by Subject|0
3079741|NCT00419263|10570357|P1|Overall Study|Withdrawal by Subject|0
3079742|NCT00419263|10570355|P3|Overall Study|Adverse Event|1
3079743|NCT00419263|10570356|P2|Overall Study|Adverse Event|0
3079744|NCT00419263|10570357|P1|Overall Study|Adverse Event|0
3079745|NCT00419263|10570355|P3|Overall Study|Randomized in Error, Not Treated|0
3079746|NCT00419263|10570356|P2|Overall Study|Randomized in Error, Not Treated|1
3079747|NCT00419263|10570357|P1|Overall Study|Randomized in Error, Not Treated|1
3079748|NCT00419263|10570355|P3|Overall Study|Lost to Follow-up|1
3079749|NCT00419263|10570356|P2|Overall Study|Lost to Follow-up|1
3079750|NCT00419263|10570357|P1|Overall Study|Lost to Follow-up|2
3079751|NCT00419159|10570386|P2|Overall Study|Disease progression|76
3079752|NCT00419159|10570387|P1|Overall Study|Disease progression|79
3079753|NCT00419159|10570386|P2|Overall Study|Death|2
3079754|NCT00419159|10570387|P1|Overall Study|Death|2
3079755|NCT00419159|10570386|P2|Overall Study|Lost to Follow-up|1
3079756|NCT00419159|10570387|P1|Overall Study|Lost to Follow-up|0
3079757|NCT00419159|10570386|P2|Overall Study|Withdrawal by Subject|3
3079758|NCT00419159|10570387|P1|Overall Study|Withdrawal by Subject|10
3079759|NCT00419159|10570386|P2|Overall Study|Protocol Violation|0
3079760|NCT00419159|10570387|P1|Overall Study|Protocol Violation|1
3079761|NCT00419159|10570386|P2|Overall Study|Subject's no longer requires study drug|1
3079762|NCT00419159|10570387|P1|Overall Study|Subject's no longer requires study drug|0
3079763|NCT00419159|10570386|P2|Overall Study|Abnormal laboratory value(s)|2
3079764|NCT00419159|10570387|P1|Overall Study|Abnormal laboratory value(s)|0
3079765|NCT00419159|10570386|P2|Overall Study|Adverse Event|15
3079766|NCT00419159|10570387|P1|Overall Study|Adverse Event|7
3079767|NCT00419120|10570417|P1|Long Term Follow up Period|study ongoing|10
3079768|NCT00419094|10570424|P2|Overall Study|Other: No contact for extended period|1
3079769|NCT00419094|10570425|P1|Overall Study|Other: No contact for extended period|0
3079770|NCT00419094|10570424|P2|Overall Study|Other: Patient non-compliant|1
3079771|NCT00419094|10570425|P1|Overall Study|Other: Patient non-compliant|0
3079772|NCT00419094|10570424|P2|Overall Study|Other: Error determining exit criteria|0
3079773|NCT00419094|10570425|P1|Overall Study|Other: Error determining exit criteria|1
3079774|NCT00419094|10570424|P2|Overall Study|Withdrawal of consent|5
3079775|NCT00419094|10570425|P1|Overall Study|Withdrawal of consent|1
3079776|NCT00419094|10570424|P2|Overall Study|Protocol Violation|14
3079777|NCT00419094|10570425|P1|Overall Study|Protocol Violation|1
3079778|NCT00419094|10570424|P2|Overall Study|Lost to Follow-up|2
3079779|NCT00419094|10570425|P1|Overall Study|Lost to Follow-up|0
3079780|NCT00419094|10570424|P2|Overall Study|Lack of Efficacy|0
3079781|NCT00419094|10570425|P1|Overall Study|Lack of Efficacy|1
3079782|NCT00419094|10570424|P2|Overall Study|Adverse Event|7
3079783|NCT00419094|10570425|P1|Overall Study|Adverse Event|3
3079784|NCT00419003|10570439|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
3079785|NCT00419003|10570440|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
3079786|NCT00419003|10570439|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
3079787|NCT00419003|10570440|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
3079788|NCT00418938|10570494|P2|Overall Study|Ineligibility Determined|0
3079789|NCT00418938|10570495|P1|Overall Study|Ineligibility Determined|1
3079790|NCT00418938|10570494|P2|Overall Study|On-going|1
3079791|NCT00418938|10570495|P1|Overall Study|On-going|1
3079792|NCT00418938|10570494|P2|Overall Study|Adverse Event|1
3079793|NCT00418938|10570495|P1|Overall Study|Adverse Event|1
3079794|NCT00418938|10570494|P2|Overall Study|Lost to Follow-up|3
3079795|NCT00418938|10570495|P1|Overall Study|Lost to Follow-up|1
3079796|NCT00418938|10570494|P2|Overall Study|Withdrawal by Subject|15
3079797|NCT00418938|10570495|P1|Overall Study|Withdrawal by Subject|16
3079798|NCT00418938|10570494|P2|Overall Study|Administrative decision|3
3079799|NCT00418938|10570495|P1|Overall Study|Administrative decision|3
3079800|NCT00418938|10570494|P2|Overall Study|Reimbursement|0
3079801|NCT00418938|10570495|P1|Overall Study|Reimbursement|1
3079802|NCT00418886|10570515|P2|Overall Study|randomised but no treatment received|1
3079803|NCT00418886|10570516|P1|Overall Study|randomised but no treatment received|0
3079804|NCT00418886|10570515|P2|Overall Study|withdrawn due to other reason|0
3079805|NCT00418886|10570516|P1|Overall Study|withdrawn due to other reason|1
3079806|NCT00418886|10570515|P2|Overall Study|Lost to Follow-up|6
3079807|NCT00418886|10570516|P1|Overall Study|Lost to Follow-up|4
3079808|NCT00418886|10570515|P2|Overall Study|Withdrawal by Subject|10
3079809|NCT00418886|10570516|P1|Overall Study|Withdrawal by Subject|9
3079810|NCT00418886|10570515|P2|Overall Study|Death|147
3079811|NCT00418886|10570516|P1|Overall Study|Death|122
3079812|NCT00418886|10570515|P2|Overall Study|discontinue treatment survival follow up|91
3079813|NCT00418886|10570516|P1|Overall Study|discontinue treatment survival follow up|90
3079814|NCT00418834|10570542|P2|Overall Study|Withdrawal by Subject|7
3079815|NCT00418834|10570543|P1|Overall Study|Withdrawal by Subject|3
3079816|NCT00418834|10570542|P2|Overall Study|Protocol Violation|3
3079817|NCT00418834|10570543|P1|Overall Study|Protocol Violation|4
3079818|NCT00418834|10570542|P2|Overall Study|Lost to Follow-up|1
3079819|NCT00418834|10570543|P1|Overall Study|Lost to Follow-up|0
3079820|NCT00418834|10570542|P2|Overall Study|Adverse Event|9
3079821|NCT00418834|10570543|P1|Overall Study|Adverse Event|16
3079822|NCT00418717|10570603|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
3079823|NCT00418717|10570603|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
3079824|NCT00418691|10570611|P3|Overall Study|Progressive Disease|1
3079825|NCT00418691|10570612|P2|Overall Study|Progressive Disease|0
3079826|NCT00418691|10570613|P1|Overall Study|Progressive Disease|1
3079827|NCT00418691|10570611|P3|Overall Study|Started new medication voiding entry|1
3079828|NCT00418691|10570612|P2|Overall Study|Started new medication voiding entry|0
3079829|NCT00418691|10570613|P1|Overall Study|Started new medication voiding entry|0
3079830|NCT00418691|10570611|P3|Overall Study|Lost to Follow-up|3
3079831|NCT00418691|10570612|P2|Overall Study|Lost to Follow-up|2
3079832|NCT00418691|10570613|P1|Overall Study|Lost to Follow-up|1
3079833|NCT00418665|10570624|P3|Treatment Extension|Death|1
3079834|NCT00418665|10570625|P2|Treatment Extension|Death|0
3079835|NCT00418665|10570626|P1|Treatment Extension|Death|0
3079836|NCT00418665|10570624|P3|Treatment Extension|Physician Decision|1
3079837|NCT00418665|10570625|P2|Treatment Extension|Physician Decision|2
3079838|NCT00418665|10570626|P1|Treatment Extension|Physician Decision|2
3079839|NCT00418665|10570624|P3|Treatment Extension|Requirement for alternative therapy|0
3079840|NCT00418665|10570625|P2|Treatment Extension|Requirement for alternative therapy|2
3079841|NCT00418665|10570626|P1|Treatment Extension|Requirement for alternative therapy|2
3079842|NCT00418665|10570624|P3|Treatment Extension|Withdrawal by Subject|0
3079843|NCT00418665|10570625|P2|Treatment Extension|Withdrawal by Subject|0
3079844|NCT00418665|10570626|P1|Treatment Extension|Withdrawal by Subject|1
3079845|NCT00418665|10570624|P3|Treatment Extension|Adverse Event|0
3079846|NCT00418665|10570625|P2|Treatment Extension|Adverse Event|0
3079847|NCT00418665|10570626|P1|Treatment Extension|Adverse Event|1
3079848|NCT00418665|10570624|P3|Treatment Period|Physician Decision|3
3079849|NCT00418665|10570625|P2|Treatment Period|Physician Decision|0
3079850|NCT00418665|10570626|P1|Treatment Period|Physician Decision|1
3079851|NCT00418665|10570624|P3|Treatment Period|Requirement for alternative therapy|0
3079852|NCT00418665|10570625|P2|Treatment Period|Requirement for alternative therapy|0
3079853|NCT00418665|10570626|P1|Treatment Period|Requirement for alternative therapy|1
3079854|NCT00418665|10570624|P3|Treatment Period|Withdrawal by Subject|1
3079855|NCT00418665|10570625|P2|Treatment Period|Withdrawal by Subject|3
3079856|NCT00418665|10570626|P1|Treatment Period|Withdrawal by Subject|0
3079857|NCT00418665|10570624|P3|Treatment Period|Adverse Event|0
3079858|NCT00418665|10570625|P2|Treatment Period|Adverse Event|2
3079859|NCT00418665|10570626|P1|Treatment Period|Adverse Event|2
3079860|NCT00418665|10570624|P3|Treatment Period|Ineligibility determined|0
3079861|NCT00418665|10570625|P2|Treatment Period|Ineligibility determined|1
3079862|NCT00418665|10570626|P1|Treatment Period|Ineligibility determined|1
3079863|NCT00418561|10570660|P3|Overall Study|Participant's (guardian's) decision|0
3079864|NCT00418561|10570661|P2|Overall Study|Participant's (guardian's) decision|1
3079865|NCT00418561|10570662|P1|Overall Study|Participant's (guardian's) decision|0
3079866|NCT00418522|10570732|P2|Overall Study|Randomized but did not receive treatment|4
3079867|NCT00418522|10570733|P1|Overall Study|Randomized but did not receive treatment|7
3079868|NCT00418522|10570732|P2|Overall Study|Other|23
3079869|NCT00418522|10570733|P1|Overall Study|Other|27
3079870|NCT00418522|10570732|P2|Overall Study|Withdrawal by Subject|7
3079871|NCT00418522|10570733|P1|Overall Study|Withdrawal by Subject|31
3079872|NCT00418522|10570732|P2|Overall Study|Lost to Follow-up|4
3079873|NCT00418522|10570733|P1|Overall Study|Lost to Follow-up|10
3079874|NCT00418522|10570732|P2|Overall Study|Lack of Efficacy|3
3079875|NCT00418522|10570733|P1|Overall Study|Lack of Efficacy|1
3079876|NCT00418522|10570732|P2|Overall Study|Adverse Event|1
3079877|NCT00418522|10570733|P1|Overall Study|Adverse Event|7
3079878|NCT00418379|10570780|P3|Year 5|Any other reason not above-mentioned|3
3079879|NCT00418379|10570781|P2|Year 5|Any other reason not above-mentioned|4
3079880|NCT00418379|10570782|P1|Year 5|Any other reason not above-mentioned|2
3079881|NCT00418379|10570780|P3|Year 5|Adverse Event|0
3079882|NCT00418379|10570781|P2|Year 5|Adverse Event|1
3079883|NCT00418379|10570782|P1|Year 5|Adverse Event|0
3079884|NCT00418379|10570780|P3|Year 4|Any other reason not above-mentioned|0
3079885|NCT00418379|10570781|P2|Year 4|Any other reason not above-mentioned|1
3079886|NCT00418379|10570782|P1|Year 4|Any other reason not above-mentioned|1
3079887|NCT00418379|10570780|P3|Year 4|Withdrawal by Subject|2
3079888|NCT00418379|10570781|P2|Year 4|Withdrawal by Subject|3
3079889|NCT00418379|10570782|P1|Year 4|Withdrawal by Subject|2
3079890|NCT00418379|10570780|P3|Year 4|Adverse Event|0
3079891|NCT00418379|10570781|P2|Year 4|Adverse Event|1
3079892|NCT00418379|10570782|P1|Year 4|Adverse Event|0
3079893|NCT00418379|10570780|P3|Year 3|Any other reason not above-mentioned|1
3079894|NCT00418379|10570781|P2|Year 3|Any other reason not above-mentioned|1
3079895|NCT00418379|10570782|P1|Year 3|Any other reason not above-mentioned|2
3079896|NCT00418379|10570780|P3|Year 3|Withdrawal by Subject|2
3079897|NCT00418379|10570781|P2|Year 3|Withdrawal by Subject|1
3079898|NCT00418379|10570782|P1|Year 3|Withdrawal by Subject|1
3079899|NCT00418379|10570780|P3|Year 2|Any other reason not above-mentioned|6
3079900|NCT00418379|10570781|P2|Year 2|Any other reason not above-mentioned|1
3079901|NCT00418379|10570782|P1|Year 2|Any other reason not above-mentioned|2
3079902|NCT00418379|10570780|P3|Year 2|Withdrawal by Subject|3
3079903|NCT00418379|10570781|P2|Year 2|Withdrawal by Subject|1
3079904|NCT00418379|10570782|P1|Year 2|Withdrawal by Subject|1
3079905|NCT00418379|10570780|P3|Year 2|Adverse Event|1
3079906|NCT00418379|10570781|P2|Year 2|Adverse Event|2
3079907|NCT00418379|10570782|P1|Year 2|Adverse Event|5
3079908|NCT00418379|10570780|P3|Year 1|Any other reason not above-mentioned|7
3079909|NCT00418379|10570781|P2|Year 1|Any other reason not above-mentioned|5
3079910|NCT00418379|10570782|P1|Year 1|Any other reason not above-mentioned|2
3079911|NCT00418379|10570780|P3|Year 1|Withdrawal by Subject|5
3079912|NCT00418379|10570781|P2|Year 1|Withdrawal by Subject|8
3079913|NCT00418379|10570782|P1|Year 1|Withdrawal by Subject|7
3079914|NCT00418379|10570780|P3|Year 1|Adverse Event|3
3079915|NCT00418379|10570781|P2|Year 1|Adverse Event|15
3079916|NCT00418379|10570782|P1|Year 1|Adverse Event|9
3079917|NCT00418314|10570792|P2|Overall Study|Withdrawal by Subject|2
3079918|NCT00418314|10570793|P1|Overall Study|Withdrawal by Subject|1
3079919|NCT00418184|10570823|P2|Double-blind Phase|Poor compliance|1
3079920|NCT00418184|10570824|P1|Double-blind Phase|Poor compliance|3
3079921|NCT00418184|10570823|P2|Double-blind Phase|Adverse Event|1
3079922|NCT00418184|10570824|P1|Double-blind Phase|Adverse Event|2
3079923|NCT00418184|10570823|P2|Double-blind Phase|Withdrawal by Subject|9
3079924|NCT00418184|10570824|P1|Double-blind Phase|Withdrawal by Subject|22
3079925|NCT00418145|10570832|P1|Overall Study|study terminated|6
3079926|NCT00417989|10570907|P2|Overall Study|Physician Decision|2
3079927|NCT00417989|10570908|P1|Overall Study|Physician Decision|5
3079928|NCT00417989|10570907|P2|Overall Study|Death|1
3079929|NCT00417989|10570908|P1|Overall Study|Death|0
3079930|NCT00417989|10570907|P2|Overall Study|Protocol Violation|0
3079931|NCT00417989|10570908|P1|Overall Study|Protocol Violation|1
3079932|NCT00417989|10570907|P2|Overall Study|Lost to Follow-up|6
3079933|NCT00417989|10570908|P1|Overall Study|Lost to Follow-up|1
3079934|NCT00417989|10570907|P2|Overall Study|Withdrawal by Subject|13
3079935|NCT00417989|10570908|P1|Overall Study|Withdrawal by Subject|13
3079936|NCT00417976|10570930|P1|Overall Study|Treatment -related toxicity|2
3079937|NCT00417976|10570930|P1|Overall Study|Non compliance unrelated to toxicity|1
3079938|NCT00417963|10570935|P1|Overall Study|Study device could not be deployed|3
3079939|NCT00417963|10570935|P1|Overall Study|Death|17
3079940|NCT00417963|10570935|P1|Overall Study|Withdrawal by Subject|18
3079941|NCT00417963|10570935|P1|Overall Study|Lost to Follow-up|3
3079942|NCT00417885|10570952|P1|Overall Study|Transferred to Another Sunitinib Study|2
3079943|NCT00417885|10570952|P1|Overall Study|Objective Progression or Relapse|3
3079944|NCT00417885|10570952|P1|Overall Study|Adverse Event|1
3079945|NCT00417612|10570978|P2|Overall Study|Lost to Follow-up|0
3079946|NCT00417612|10570979|P1|Overall Study|Lost to Follow-up|1
3079947|NCT00417612|10570978|P2|Overall Study|Protocol Violation|2
3079948|NCT00417612|10570979|P1|Overall Study|Protocol Violation|0
3079949|NCT00417612|10570978|P2|Overall Study|Adverse Event|0
3079950|NCT00417612|10570979|P1|Overall Study|Adverse Event|2
3079951|NCT00417612|10570978|P2|Overall Study|Errant diagnosis|1
3079952|NCT00417612|10570979|P1|Overall Study|Errant diagnosis|0
3079953|NCT00417482|10571005|P3|Phase B 2nd 16 Weeks|Death|0
3079954|NCT00417482|10571006|P2|Phase B 2nd 16 Weeks|Death|1
3079955|NCT00417482|10571007|P1|Phase B 2nd 16 Weeks|Death|1
3079956|NCT00417482|10571005|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
3079957|NCT00417482|10571006|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
3079958|NCT00417482|10571007|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
3079959|NCT00417482|10571005|P3|Phase B 2nd 16 Weeks|Adverse Event|1
3079960|NCT00417482|10571006|P2|Phase B 2nd 16 Weeks|Adverse Event|0
3079961|NCT00417482|10571007|P1|Phase B 2nd 16 Weeks|Adverse Event|0
3079962|NCT00417482|10571005|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
3079963|NCT00417482|10571006|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
3079964|NCT00417482|10571007|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
3079965|NCT00417482|10571005|P3|Phase B 1st 16 Weeks|Death|0
3079966|NCT00417482|10571006|P2|Phase B 1st 16 Weeks|Death|0
3079967|NCT00417482|10571007|P1|Phase B 1st 16 Weeks|Death|1
3079968|NCT00417482|10571005|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
3079969|NCT00417482|10571006|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
3079970|NCT00417482|10571007|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
3079971|NCT00417482|10571005|P3|Phase B 1st 16 Weeks|Adverse Event|1
3079972|NCT00417482|10571006|P2|Phase B 1st 16 Weeks|Adverse Event|0
3079973|NCT00417482|10571007|P1|Phase B 1st 16 Weeks|Adverse Event|2
3079974|NCT00417482|10571005|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
3079975|NCT00417482|10571006|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
3079976|NCT00417482|10571007|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
3079977|NCT00417248|10571046|P1|Overall Study|Lack of Efficacy|1
3079978|NCT00417248|10571046|P1|Overall Study|Death|1
3079979|NCT00417248|10571046|P1|Overall Study|Study Terminated|6
3079980|NCT00417170|10571053|P2|Overall Study|Lost to Follow-up|1
3079981|NCT00417170|10571054|P1|Overall Study|Lost to Follow-up|0
3079982|NCT00417170|10571053|P2|Overall Study|Withdrawal by Subject|1
3079983|NCT00417170|10571054|P1|Overall Study|Withdrawal by Subject|1
3079984|NCT00417170|10571053|P2|Overall Study|Adverse Event|1
3079985|NCT00417170|10571054|P1|Overall Study|Adverse Event|1
3079986|NCT00417079|10571070|P2|Overall Study|abnormal liver function tests|1
3079987|NCT00417079|10571071|P1|Overall Study|abnormal liver function tests|0
3079988|NCT00417079|10571070|P2|Overall Study|Patient unable to come to the clinic|1
3079989|NCT00417079|10571071|P1|Overall Study|Patient unable to come to the clinic|0
3079990|NCT00417079|10571070|P2|Overall Study|Withdrawal by subject's family|1
3079991|NCT00417079|10571071|P1|Overall Study|Withdrawal by subject's family|0
3079992|NCT00417079|10571070|P2|Overall Study|Screening error|1
3079993|NCT00417079|10571071|P1|Overall Study|Screening error|2
3079994|NCT00417079|10571070|P2|Overall Study|Clinical deterioration|0
3079995|NCT00417079|10571071|P1|Overall Study|Clinical deterioration|1
3079996|NCT00417079|10571070|P2|Overall Study|Non-confirmed Disease progression|1
3079997|NCT00417079|10571071|P1|Overall Study|Non-confirmed Disease progression|1
3079998|NCT00417079|10571070|P2|Overall Study|Investigator's decision|4
3079999|NCT00417079|10571071|P1|Overall Study|Investigator's decision|1
3080000|NCT00417079|10571070|P2|Overall Study|Screened failure|1
3080001|NCT00417079|10571071|P1|Overall Study|Screened failure|2
3080002|NCT00417079|10571070|P2|Overall Study|Not treated|7
3080003|NCT00417079|10571071|P1|Overall Study|Not treated|6
3080004|NCT00417079|10571070|P2|Overall Study|Withdrawal by Subject|8
3080005|NCT00417079|10571071|P1|Overall Study|Withdrawal by Subject|17
3080006|NCT00417079|10571070|P2|Overall Study|Lost to Follow-up|0
3080007|NCT00417079|10571071|P1|Overall Study|Lost to Follow-up|2
3080008|NCT00417079|10571070|P2|Overall Study|Non-compliance to protocol|1
3080009|NCT00417079|10571071|P1|Overall Study|Non-compliance to protocol|0
3080010|NCT00417079|10571070|P2|Overall Study|Adverse Event|67
3080011|NCT00417079|10571071|P1|Overall Study|Adverse Event|32
3080012|NCT00417079|10571070|P2|Overall Study|Disease progression|180
3080013|NCT00417079|10571071|P1|Overall Study|Disease progression|267
3080014|NCT00417027|10571094|P3|Overall Study|Protocol Violation|5
3080015|NCT00417027|10571095|P2|Overall Study|Protocol Violation|5
3080016|NCT00417027|10571096|P1|Overall Study|Protocol Violation|0
3080017|NCT00416949|10571122|P1|Overall Study|Patients refused to participate|5
3080018|NCT00416884|10571126|P1|Overall Study|Study terminated due to low accrual|1
3080019|NCT00416715|10571135|P1|Overall Study|Vitamin D levels not evaluable|8
3080020|NCT00416715|10571135|P1|Overall Study|Not evaluable for joint aches|7
3080021|NCT00416624|10571146|P4|Overall Study|Cancel|0
3080022|NCT00416624|10571147|P3|Overall Study|Cancel|0
3080023|NCT00416624|10571148|P2|Overall Study|Cancel|0
3080024|NCT00416624|10571149|P1|Overall Study|Cancel|1
3080025|NCT00416624|10571146|P4|Overall Study|Other|5
3080026|NCT00416624|10571147|P3|Overall Study|Other|5
3080027|NCT00416624|10571148|P2|Overall Study|Other|11
3080028|NCT00416624|10571149|P1|Overall Study|Other|8
3080029|NCT00416624|10571146|P4|Overall Study|Adverse Event|2
3080030|NCT00416624|10571147|P3|Overall Study|Adverse Event|2
3080031|NCT00416624|10571148|P2|Overall Study|Adverse Event|3
3080032|NCT00416624|10571149|P1|Overall Study|Adverse Event|8
3080033|NCT00416624|10571146|P4|Overall Study|Death|1
3080034|NCT00416624|10571147|P3|Overall Study|Death|7
3080035|NCT00416624|10571148|P2|Overall Study|Death|7
3080036|NCT00416624|10571149|P1|Overall Study|Death|4
3080037|NCT00416624|10571146|P4|Overall Study|Withdrawal by Subject|9
3080038|NCT00416624|10571147|P3|Overall Study|Withdrawal by Subject|4
3080039|NCT00416624|10571148|P2|Overall Study|Withdrawal by Subject|6
3080040|NCT00416624|10571149|P1|Overall Study|Withdrawal by Subject|1
3080041|NCT00416598|10571203|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
3080042|NCT00416598|10571203|P1|Decitabine Maintenance|Alternative treatment|2
3080043|NCT00416598|10571203|P1|Decitabine Maintenance|Progression/relapse|38
3080044|NCT00416598|10571203|P1|Decitabine Maintenance|Withdrawal by Subject|18
3080045|NCT00416598|10571203|P1|Decitabine Maintenance|Adverse Event|5
3080046|NCT00416598|10571203|P1|Induction & Intensification|Failed induction|87
3080047|NCT00416598|10571203|P1|Induction & Intensification|Relapse/progression|29
3080048|NCT00416598|10571203|P1|Induction & Intensification|Physician discretion/other medical issue|45
3080049|NCT00416598|10571203|P1|Induction & Intensification|Alternative Treatment|135
3080050|NCT00416598|10571203|P1|Induction & Intensification|Withdrawal by Subject|46
3080051|NCT00416598|10571203|P1|Induction & Intensification|Death|32
3080052|NCT00416598|10571203|P1|Induction & Intensification|Adverse Event|38
3080053|NCT00416520|10571229|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
3080054|NCT00416520|10571230|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
3080055|NCT00416520|10571231|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
3080056|NCT00416520|10571232|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
3080057|NCT00416520|10571229|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
3080058|NCT00416520|10571230|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
3080059|NCT00416520|10571231|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
3080060|NCT00416520|10571232|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
3080061|NCT00416520|10571229|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
3080062|NCT00416520|10571230|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
3080063|NCT00416520|10571231|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
3080064|NCT00416520|10571232|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
3080065|NCT00416520|10571229|P4|Open-label Period|Other Reasons|0
3080066|NCT00416520|10571230|P3|Open-label Period|Other Reasons|0
3080067|NCT00416520|10571231|P2|Open-label Period|Other Reasons|12
3080068|NCT00416520|10571232|P1|Open-label Period|Other Reasons|3
3080069|NCT00416520|10571229|P4|Open-label Period|Withdrawal by Subject|0
3080070|NCT00416520|10571230|P3|Open-label Period|Withdrawal by Subject|0
3080071|NCT00416520|10571231|P2|Open-label Period|Withdrawal by Subject|5
3080072|NCT00416520|10571232|P1|Open-label Period|Withdrawal by Subject|16
3080073|NCT00416520|10571229|P4|Open-label Period|Protocol Violation|0
3080074|NCT00416520|10571230|P3|Open-label Period|Protocol Violation|0
3080075|NCT00416520|10571231|P2|Open-label Period|Protocol Violation|3
3080076|NCT00416520|10571232|P1|Open-label Period|Protocol Violation|3
3080077|NCT00416520|10571229|P4|Open-label Period|Lack of Efficacy|0
3080078|NCT00416520|10571230|P3|Open-label Period|Lack of Efficacy|0
3080079|NCT00416520|10571231|P2|Open-label Period|Lack of Efficacy|1
3080080|NCT00416520|10571232|P1|Open-label Period|Lack of Efficacy|8
3080081|NCT00416520|10571229|P4|Open-label Period|Death|0
3080082|NCT00416520|10571230|P3|Open-label Period|Death|0
3080083|NCT00416520|10571231|P2|Open-label Period|Death|1
3080084|NCT00416520|10571232|P1|Open-label Period|Death|2
3080085|NCT00416520|10571229|P4|Open-label Period|Adverse Event|0
3080086|NCT00416520|10571230|P3|Open-label Period|Adverse Event|0
3080087|NCT00416520|10571231|P2|Open-label Period|Adverse Event|10
3080088|NCT00416520|10571232|P1|Open-label Period|Adverse Event|28
3080089|NCT00416455|10571261|P2|Overall Study|Inadequate pathology|2
3080090|NCT00416455|10571262|P1|Overall Study|Inadequate pathology|11
3080091|NCT00416455|10571261|P2|Overall Study|PET / CT poor quality|1
3080092|NCT00416455|10571262|P1|Overall Study|PET / CT poor quality|2
3080093|NCT00416455|10571261|P2|Overall Study|PET / CT not done|5
3080094|NCT00416455|10571262|P1|Overall Study|PET / CT not done|3
3080095|NCT00416312|10571297|P1|Overall Study|tumors not visible on imaging|2
3080096|NCT00416195|10571303|P2|Overall Study|Other|1
3080097|NCT00416195|10571304|P1|Overall Study|Other|0
3080098|NCT00416195|10571303|P2|Overall Study|Protocol Violation|1
3080099|NCT00416195|10571304|P1|Overall Study|Protocol Violation|1
3080100|NCT00416195|10571303|P2|Overall Study|Adverse Event|2
3080101|NCT00416195|10571304|P1|Overall Study|Adverse Event|1
3080102|NCT00416078|10571329|P2|Overall Study|Lost to Follow-up|2
3080103|NCT00416078|10571330|P1|Overall Study|Lost to Follow-up|4
3080104|NCT00416078|10571329|P2|Overall Study|Physician Decision|0
3080105|NCT00416078|10571330|P1|Overall Study|Physician Decision|1
3080106|NCT00416078|10571329|P2|Overall Study|Withdrawal by Subject|2
3080107|NCT00416078|10571330|P1|Overall Study|Withdrawal by Subject|3
3080108|NCT00416078|10571329|P2|Overall Study|Death|4
3080109|NCT00416078|10571330|P1|Overall Study|Death|3
3080110|NCT00415909|10571346|P1|Overall Study|Death|1
3080111|NCT00415909|10571346|P1|Overall Study|Withdrawal by Subject|2
3080112|NCT00415636|10571380|P6|Overall Study|Disease progression|1
3080113|NCT00415636|10571381|P5|Overall Study|Disease progression|0
3080114|NCT00415636|10571382|P4|Overall Study|Disease progression|3
3080115|NCT00415636|10571383|P3|Overall Study|Disease progression|0
3080116|NCT00415636|10571384|P2|Overall Study|Disease progression|0
3080117|NCT00415636|10571385|P1|Overall Study|Disease progression|0
3080118|NCT00415636|10571380|P6|Overall Study|Withdrawal by Subject|0
3080119|NCT00415636|10571381|P5|Overall Study|Withdrawal by Subject|1
3080120|NCT00415636|10571382|P4|Overall Study|Withdrawal by Subject|0
3080121|NCT00415636|10571383|P3|Overall Study|Withdrawal by Subject|0
3080122|NCT00415636|10571384|P2|Overall Study|Withdrawal by Subject|0
3080123|NCT00415636|10571385|P1|Overall Study|Withdrawal by Subject|0
3080124|NCT00415636|10571380|P6|Overall Study|Adverse Event|0
3080125|NCT00415636|10571381|P5|Overall Study|Adverse Event|1
3080126|NCT00415636|10571382|P4|Overall Study|Adverse Event|1
3080127|NCT00415636|10571383|P3|Overall Study|Adverse Event|0
3080128|NCT00415636|10571384|P2|Overall Study|Adverse Event|0
3080129|NCT00415636|10571385|P1|Overall Study|Adverse Event|0
3080130|NCT00415636|10571380|P6|Overall Study|Symptomatic deterioration|1
3080131|NCT00415636|10571381|P5|Overall Study|Symptomatic deterioration|0
3080132|NCT00415636|10571382|P4|Overall Study|Symptomatic deterioration|2
3080133|NCT00415636|10571383|P3|Overall Study|Symptomatic deterioration|1
3080134|NCT00415636|10571384|P2|Overall Study|Symptomatic deterioration|0
3080135|NCT00415636|10571385|P1|Overall Study|Symptomatic deterioration|1
3080136|NCT00415623|10571419|P2|Overall Study|Withdrawal by Subject|1
3080137|NCT00415623|10571420|P1|Overall Study|Withdrawal by Subject|1
3080138|NCT00415623|10571419|P2|Overall Study|Death|0
3080139|NCT00415623|10571420|P1|Overall Study|Death|1
3080140|NCT00415623|10571419|P2|Overall Study|Adverse Event|4
3080141|NCT00415623|10571420|P1|Overall Study|Adverse Event|3
3080142|NCT00415610|10571447|P3|Overall Study|Death|5
3080143|NCT00415610|10571448|P2|Overall Study|Death|2
3080144|NCT00415610|10571449|P1|Overall Study|Death|3
3080145|NCT00415597|10571469|P1|Treatment|Multiple Reasons|1
3080146|NCT00415597|10571469|P1|Treatment|Sponsor Decision|1
3080147|NCT00415597|10571469|P1|Treatment|Administrative|3
3080148|NCT00415597|10571469|P1|Treatment|Drug Screen|2
3080149|NCT00415597|10571469|P1|Treatment|Lost to Follow-up|28
3080150|NCT00415597|10571469|P1|Treatment|Withdrawal by Subject|51
3080151|NCT00415597|10571469|P1|Treatment|Physician Decision|3
3080152|NCT00415597|10571469|P1|Treatment|Protocol Violation|67
3080153|NCT00415597|10571469|P1|Treatment|Lack of Efficacy|39
3080154|NCT00415597|10571469|P1|Treatment|Adverse Event|110
3080155|NCT00415597|10571469|P1|Enrollment|Protocol Violation|1
3080156|NCT00415597|10571469|P1|Enrollment|Withdrawal by Subject|1
3080157|NCT00415532|10571477|P2|Safety Follow Up Period|Requirement for alternative therapy|1
3080158|NCT00415532|10571478|P1|Safety Follow Up Period|Requirement for alternative therapy|0
3080159|NCT00415532|10571477|P2|Safety Follow Up Period|Noncompliance|0
3080160|NCT00415532|10571478|P1|Safety Follow Up Period|Noncompliance|1
3080161|NCT00415532|10571477|P2|Safety Follow Up Period|Ineligibility determined|1
3080162|NCT00415532|10571478|P1|Safety Follow Up Period|Ineligibility determined|1
3080163|NCT00415532|10571477|P2|Safety Follow Up Period|Other|4
3080164|NCT00415532|10571478|P1|Safety Follow Up Period|Other|1
3080165|NCT00415532|10571477|P2|Safety Follow Up Period|Withdrawal by Subject|3
3080166|NCT00415532|10571478|P1|Safety Follow Up Period|Withdrawal by Subject|2
3080167|NCT00415532|10571477|P2|Safety Follow Up Period|Death|0
3080168|NCT00415532|10571478|P1|Safety Follow Up Period|Death|3
3080169|NCT00415532|10571477|P2|Safety Follow Up Period|Adverse Event|3
3080170|NCT00415532|10571478|P1|Safety Follow Up Period|Adverse Event|1
3080171|NCT00415532|10571477|P2|Treatment Period|Requirement for alternative therapy|0
3080172|NCT00415532|10571478|P1|Treatment Period|Requirement for alternative therapy|1
3080173|NCT00415532|10571477|P2|Treatment Period|Noncompliance|1
3080174|NCT00415532|10571478|P1|Treatment Period|Noncompliance|1
3080175|NCT00415532|10571477|P2|Treatment Period|Ineligibility determined|1
3080176|NCT00415532|10571478|P1|Treatment Period|Ineligibility determined|1
3080177|NCT00415532|10571477|P2|Treatment Period|Other|2
3080178|NCT00415532|10571478|P1|Treatment Period|Other|2
3080179|NCT00415532|10571477|P2|Treatment Period|Withdrawal by Subject|6
3080180|NCT00415532|10571478|P1|Treatment Period|Withdrawal by Subject|6
3080181|NCT00415532|10571477|P2|Treatment Period|Protocol Violation|0
3080182|NCT00415532|10571478|P1|Treatment Period|Protocol Violation|1
3080183|NCT00415532|10571477|P2|Treatment Period|Lost to Follow-up|1
3080184|NCT00415532|10571478|P1|Treatment Period|Lost to Follow-up|1
3080185|NCT00415532|10571477|P2|Treatment Period|Death|1
3080186|NCT00415532|10571478|P1|Treatment Period|Death|2
3080187|NCT00415532|10571477|P2|Treatment Period|Adverse Event|3
3080188|NCT00415532|10571478|P1|Treatment Period|Adverse Event|2
3080189|NCT00415519|10571500|P2|Overall Study|Patient’s convenience|0
3080190|NCT00415519|10571501|P1|Overall Study|Patient’s convenience|1
3080191|NCT00415519|10571500|P2|Overall Study|Withdrawal by Subject|0
3080192|NCT00415519|10571501|P1|Overall Study|Withdrawal by Subject|2
3080193|NCT00415519|10571500|P2|Overall Study|Adverse Event|0
3080194|NCT00415519|10571501|P1|Overall Study|Adverse Event|1
3080195|NCT00415194|10571541|P2|Overall Study|Death Due to AE (Other Causes)|15
3080196|NCT00415194|10571542|P1|Overall Study|Death Due to AE (Other Causes)|27
3080197|NCT00415194|10571541|P2|Overall Study|Death Due to Procedural Related AE|1
3080198|NCT00415194|10571542|P1|Overall Study|Death Due to Procedural Related AE|0
3080199|NCT00415194|10571541|P2|Overall Study|Death Due to Study Drug Related AE|1
3080200|NCT00415194|10571542|P1|Overall Study|Death Due to Study Drug Related AE|11
3080201|NCT00415194|10571541|P2|Overall Study|Death Due to Study Disease|29
3080202|NCT00415194|10571542|P1|Overall Study|Death Due to Study Disease|26
3080203|NCT00415194|10571541|P2|Overall Study|Withdrawal by Subject|21
3080204|NCT00415194|10571542|P1|Overall Study|Withdrawal by Subject|28
3080205|NCT00415194|10571541|P2|Overall Study|Protocol Violation|2
3080206|NCT00415194|10571542|P1|Overall Study|Protocol Violation|4
3080207|NCT00415194|10571541|P2|Overall Study|Progressive Disease|217
3080208|NCT00415194|10571542|P1|Overall Study|Progressive Disease|180
3080209|NCT00415194|10571541|P2|Overall Study|Physician Decision|16
3080210|NCT00415194|10571542|P1|Overall Study|Physician Decision|10
3080211|NCT00415194|10571541|P2|Overall Study|Lost to Follow-up|0
3080212|NCT00415194|10571542|P1|Overall Study|Lost to Follow-up|1
3080213|NCT00415194|10571541|P2|Overall Study|Entry Criteria Not Met|8
3080214|NCT00415194|10571542|P1|Overall Study|Entry Criteria Not Met|4
3080215|NCT00415194|10571541|P2|Overall Study|Adverse Event|32
3080216|NCT00415194|10571542|P1|Overall Study|Adverse Event|37
3080217|NCT00415168|10571558|P1|Overall Study|Withdrawal by Subject|6
3080218|NCT00415168|10571558|P1|Overall Study|Sponsor Decision|4
3080219|NCT00415168|10571558|P1|Overall Study|Physician Decision|13
3080220|NCT00415168|10571558|P1|Overall Study|Lost to Follow-up|3
3080221|NCT00415168|10571558|P1|Overall Study|Death|26
3080222|NCT00415051|10571568|P1|Overall Study|Protocol Violation|1
3080223|NCT00414973|10571579|P4|Overall Study|Death|0
3080224|NCT00414973|10571580|P3|Overall Study|Death|1
3080225|NCT00414973|10571581|P2|Overall Study|Death|0
3080226|NCT00414973|10571582|P1|Overall Study|Death|0
3080227|NCT00414973|10571579|P4|Overall Study|Sponsor Decision|0
3080228|NCT00414973|10571580|P3|Overall Study|Sponsor Decision|0
3080229|NCT00414973|10571581|P2|Overall Study|Sponsor Decision|0
3080230|NCT00414973|10571582|P1|Overall Study|Sponsor Decision|1
3080231|NCT00414973|10571579|P4|Overall Study|Lost to Follow-up|0
3080232|NCT00414973|10571580|P3|Overall Study|Lost to Follow-up|0
3080233|NCT00414973|10571581|P2|Overall Study|Lost to Follow-up|2
3080234|NCT00414973|10571582|P1|Overall Study|Lost to Follow-up|0
3080235|NCT00414973|10571579|P4|Overall Study|Protocol Violation|0
3080236|NCT00414973|10571580|P3|Overall Study|Protocol Violation|0
3080237|NCT00414973|10571581|P2|Overall Study|Protocol Violation|4
3080238|NCT00414973|10571582|P1|Overall Study|Protocol Violation|3
3080239|NCT00414973|10571579|P4|Overall Study|Adverse Event|0
3080240|NCT00414973|10571580|P3|Overall Study|Adverse Event|1
3080241|NCT00414973|10571581|P2|Overall Study|Adverse Event|0
3080242|NCT00414973|10571582|P1|Overall Study|Adverse Event|10
3080243|NCT00414973|10571579|P4|Overall Study|Withdrawal by Subject|0
3080244|NCT00414973|10571580|P3|Overall Study|Withdrawal by Subject|1
3080245|NCT00414973|10571581|P2|Overall Study|Withdrawal by Subject|4
3080246|NCT00414973|10571582|P1|Overall Study|Withdrawal by Subject|14
3080247|NCT00414908|10571602|P2|Overall Study|Protocol Violation|1
3080248|NCT00414908|10571603|P1|Overall Study|Protocol Violation|1
3080249|NCT00414726|10571640|P2|Overall Study|Withdrawal by Subject|1
3080250|NCT00414726|10571641|P1|Overall Study|Withdrawal by Subject|0
3080251|NCT00414661|10571676|P4|Overall Study|Other|0
3080252|NCT00414661|10571677|P3|Overall Study|Other|0
3080253|NCT00414661|10571678|P2|Overall Study|Other|3
3080254|NCT00414661|10571679|P1|Overall Study|Other|6
3080255|NCT00414661|10571676|P4|Overall Study|Withdrawal by Subject|2
3080256|NCT00414661|10571677|P3|Overall Study|Withdrawal by Subject|2
3080257|NCT00414661|10571678|P2|Overall Study|Withdrawal by Subject|2
3080258|NCT00414661|10571679|P1|Overall Study|Withdrawal by Subject|5
3080259|NCT00414661|10571676|P4|Overall Study|Lost to Follow-up|1
3080260|NCT00414661|10571677|P3|Overall Study|Lost to Follow-up|0
3080261|NCT00414661|10571678|P2|Overall Study|Lost to Follow-up|4
3080262|NCT00414661|10571679|P1|Overall Study|Lost to Follow-up|1
3080263|NCT00414661|10571676|P4|Overall Study|Death|0
3080264|NCT00414661|10571677|P3|Overall Study|Death|0
3080265|NCT00414661|10571678|P2|Overall Study|Death|5
3080266|NCT00414661|10571679|P1|Overall Study|Death|2
3080267|NCT00414609|10571724|P3|Extension Study|Death|17
3080268|NCT00414609|10571725|P2|Extension Study|Death|0
3080269|NCT00414609|10571726|P1|Extension Study|Death|0
3080270|NCT00414609|10571724|P3|Extension Study|Administrative problems|1
3080271|NCT00414609|10571725|P2|Extension Study|Administrative problems|0
3080272|NCT00414609|10571726|P1|Extension Study|Administrative problems|0
3080273|NCT00414609|10571724|P3|Extension Study|Lost to Follow-up|10
3080274|NCT00414609|10571725|P2|Extension Study|Lost to Follow-up|0
3080275|NCT00414609|10571726|P1|Extension Study|Lost to Follow-up|0
3080276|NCT00414609|10571724|P3|Extension Study|Withdrawal by Subject|13
3080277|NCT00414609|10571725|P2|Extension Study|Withdrawal by Subject|0
3080278|NCT00414609|10571726|P1|Extension Study|Withdrawal by Subject|0
3080279|NCT00414609|10571724|P3|Extension Study|Unsatisfactory therapeutic effect|2
3080280|NCT00414609|10571725|P2|Extension Study|Unsatisfactory therapeutic effect|0
3080281|NCT00414609|10571726|P1|Extension Study|Unsatisfactory therapeutic effect|0
3080282|NCT00414609|10571724|P3|Extension Study|Adverse Event|14
3080283|NCT00414609|10571725|P2|Extension Study|Adverse Event|0
3080284|NCT00414609|10571726|P1|Extension Study|Adverse Event|0
3080285|NCT00414609|10571724|P3|Core Study|Death|0
3080286|NCT00414609|10571725|P2|Core Study|Death|14
3080287|NCT00414609|10571726|P1|Core Study|Death|7
3080288|NCT00414609|10571724|P3|Core Study|Administrative problems|0
3080289|NCT00414609|10571725|P2|Core Study|Administrative problems|2
3080290|NCT00414609|10571726|P1|Core Study|Administrative problems|0
3080291|NCT00414609|10571724|P3|Core Study|Lost to Follow-up|0
3080292|NCT00414609|10571725|P2|Core Study|Lost to Follow-up|4
3080293|NCT00414609|10571726|P1|Core Study|Lost to Follow-up|7
3080294|NCT00414609|10571724|P3|Core Study|Patient withdrew consent|0
3080295|NCT00414609|10571725|P2|Core Study|Patient withdrew consent|11
3080296|NCT00414609|10571726|P1|Core Study|Patient withdrew consent|10
3080297|NCT00414609|10571724|P3|Core Study|Protocol deviation|0
3080298|NCT00414609|10571725|P2|Core Study|Protocol deviation|1
3080299|NCT00414609|10571726|P1|Core Study|Protocol deviation|0
3080300|NCT00414609|10571724|P3|Core Study|Abnormal test procedure results|0
3080301|NCT00414609|10571725|P2|Core Study|Abnormal test procedure results|1
3080302|NCT00414609|10571726|P1|Core Study|Abnormal test procedure results|1
3080303|NCT00414609|10571724|P3|Core Study|Abnormal laboratory values|0
3080304|NCT00414609|10571725|P2|Core Study|Abnormal laboratory values|1
3080305|NCT00414609|10571726|P1|Core Study|Abnormal laboratory values|0
3080306|NCT00414609|10571724|P3|Core Study|Adverse Event|0
3080307|NCT00414609|10571725|P2|Core Study|Adverse Event|11
3080308|NCT00414609|10571726|P1|Core Study|Adverse Event|9
3080309|NCT00414596|10571749|P1|Overall Study|Protocol Violation|2
3080310|NCT00414544|10571758|P1|Overall Study|Lost to Follow-up|14
3080311|NCT00414466|10571781|P4|Overall Study|Withdrawn by Sponsor|0
3080312|NCT00414466|10571782|P3|Overall Study|Withdrawn by Sponsor|0
3080313|NCT00414466|10571783|P2|Overall Study|Withdrawn by Sponsor|0
3080314|NCT00414466|10571784|P1|Overall Study|Withdrawn by Sponsor|1
3080315|NCT00414466|10571781|P4|Overall Study|Lack of Efficacy|0
3080316|NCT00414466|10571782|P3|Overall Study|Lack of Efficacy|0
3080317|NCT00414466|10571783|P2|Overall Study|Lack of Efficacy|0
3080318|NCT00414466|10571784|P1|Overall Study|Lack of Efficacy|1
3080319|NCT00414466|10571781|P4|Overall Study|Adverse Event|1
3080320|NCT00414466|10571782|P3|Overall Study|Adverse Event|1
3080321|NCT00414466|10571783|P2|Overall Study|Adverse Event|0
3080322|NCT00414466|10571784|P1|Overall Study|Adverse Event|0
3080323|NCT00414453|10571802|P1|Overall Study|Abnormal lab work|16
3080324|NCT00414440|10571850|P2|Extension Period|Not included in follow up period|8
3080325|NCT00414440|10571851|P1|Extension Period|Not included in follow up period|18
3080326|NCT00414440|10571850|P2|Extension Period|Withdrawal by Subject|7
3080327|NCT00414440|10571851|P1|Extension Period|Withdrawal by Subject|9
3080328|NCT00414440|10571850|P2|Extension Period|Death|2
3080329|NCT00414440|10571851|P1|Extension Period|Death|1
3080330|NCT00414440|10571850|P2|Extension Period|Administrative|16
3080331|NCT00414440|10571851|P1|Extension Period|Administrative|16
3080332|NCT00414440|10571850|P2|Extension Period|Other|1
3080333|NCT00414440|10571851|P1|Extension Period|Other|1
3080334|NCT00414440|10571850|P2|Extension Period|Did not consent to continue follow up|54
3080335|NCT00414440|10571851|P1|Extension Period|Did not consent to continue follow up|61
3080336|NCT00414440|10571850|P2|Extension Period|Lost to Follow-up|52
3080337|NCT00414440|10571851|P1|Extension Period|Lost to Follow-up|44
3080338|NCT00414440|10571850|P2|Core Period|Withdrawal by Subject|32
3080339|NCT00414440|10571851|P1|Core Period|Withdrawal by Subject|70
3080340|NCT00414388|10571865|P1|Overall Study|Adverse Event|1
3080341|NCT00414310|10571873|P2|Overall Study|Not treated|0
3080342|NCT00414310|10571874|P1|Overall Study|Not treated|1
3080343|NCT00414076|10571918|P2|Overall Study|Adverse Event|0
3080344|NCT00414076|10571919|P1|Overall Study|Adverse Event|1
3080345|NCT00414076|10571918|P2|Overall Study|Withdrawal by Subject|3
3080346|NCT00414076|10571919|P1|Overall Study|Withdrawal by Subject|1
3080347|NCT00414076|10571918|P2|Overall Study|Progression|2
3080348|NCT00414076|10571919|P1|Overall Study|Progression|1
3080349|NCT00414050|10571929|P4|Overall Study|Subject Moved|1
3080350|NCT00414050|10571930|P3|Overall Study|Subject Moved|0
3080351|NCT00414050|10571931|P2|Overall Study|Subject Moved|0
3080352|NCT00414050|10571932|P1|Overall Study|Subject Moved|0
3080353|NCT00414050|10571929|P4|Overall Study|Subject discontinued for other reason|1
3080354|NCT00414050|10571930|P3|Overall Study|Subject discontinued for other reason|2
3080355|NCT00414050|10571931|P2|Overall Study|Subject discontinued for other reason|2
3080356|NCT00414050|10571932|P1|Overall Study|Subject discontinued for other reason|1
3080357|NCT00414050|10571929|P4|Overall Study|Withdrawal by Subject|4
3080358|NCT00414050|10571930|P3|Overall Study|Withdrawal by Subject|2
3080359|NCT00414050|10571931|P2|Overall Study|Withdrawal by Subject|3
3080360|NCT00414050|10571932|P1|Overall Study|Withdrawal by Subject|5
3080361|NCT00414050|10571929|P4|Overall Study|Lost to Follow-up|1
3080362|NCT00414050|10571930|P3|Overall Study|Lost to Follow-up|1
3080363|NCT00414050|10571931|P2|Overall Study|Lost to Follow-up|2
3080364|NCT00414050|10571932|P1|Overall Study|Lost to Follow-up|2
3080365|NCT00414050|10571929|P4|Overall Study|Adverse Event|1
3080366|NCT00414050|10571930|P3|Overall Study|Adverse Event|1
3080367|NCT00414050|10571931|P2|Overall Study|Adverse Event|1
3080368|NCT00414050|10571932|P1|Overall Study|Adverse Event|1
3080369|NCT00414011|10571946|P1|Overall Study|Withdrawal by Subject|2
3080370|NCT00414011|10571946|P1|Overall Study|Physician Decision|3
3080371|NCT00413972|10571955|P4|Overall Study|Other|1
3080372|NCT00413972|10571956|P3|Overall Study|Other|0
3080373|NCT00413972|10571957|P2|Overall Study|Other|0
3080374|NCT00413972|10571958|P1|Overall Study|Other|0
3080375|NCT00413972|10571955|P4|Overall Study|Protocol Violation|0
3080376|NCT00413972|10571956|P3|Overall Study|Protocol Violation|2
3080377|NCT00413972|10571957|P2|Overall Study|Protocol Violation|0
3080378|NCT00413972|10571958|P1|Overall Study|Protocol Violation|0
3080379|NCT00413972|10571955|P4|Overall Study|Withdrawal by Subject|2
3080380|NCT00413972|10571956|P3|Overall Study|Withdrawal by Subject|7
3080381|NCT00413972|10571957|P2|Overall Study|Withdrawal by Subject|5
3080382|NCT00413972|10571958|P1|Overall Study|Withdrawal by Subject|4
3080383|NCT00413972|10571955|P4|Overall Study|Lost to Follow-up|0
3080384|NCT00413972|10571956|P3|Overall Study|Lost to Follow-up|1
3080385|NCT00413972|10571957|P2|Overall Study|Lost to Follow-up|2
3080386|NCT00413972|10571958|P1|Overall Study|Lost to Follow-up|1
3080387|NCT00413972|10571955|P4|Overall Study|Adverse Event|0
3080388|NCT00413972|10571956|P3|Overall Study|Adverse Event|0
3080389|NCT00413972|10571957|P2|Overall Study|Adverse Event|1
3080390|NCT00413972|10571958|P1|Overall Study|Adverse Event|2
3080391|NCT00413959|10571968|P1|Overall Study|Pt had only one cycle.|1
3080392|NCT00413920|10571975|P2|Overall Study|Graft Loss|3
3080393|NCT00413920|10571976|P1|Overall Study|Graft Loss|5
3080394|NCT00413920|10571975|P2|Overall Study|Death|5
3080395|NCT00413920|10571976|P1|Overall Study|Death|3
3080396|NCT00413920|10571975|P2|Overall Study|Lack of Efficacy|9
3080397|NCT00413920|10571976|P1|Overall Study|Lack of Efficacy|11
3080398|NCT00413920|10571975|P2|Overall Study|Adverse Event|11
3080399|NCT00413920|10571976|P1|Overall Study|Adverse Event|9
3080400|NCT00413894|10571991|P1|Overall Study|Other|18
3080401|NCT00413894|10571991|P1|Overall Study|Protocol Violation|11
3080402|NCT00413894|10571991|P1|Overall Study|Adverse Event|28
3080403|NCT00413894|10571991|P1|Overall Study|Hb <10 grams/deciliter|12
3080404|NCT00413894|10571991|P1|Overall Study|Administrative Reasons|1
3080405|NCT00413894|10571991|P1|Overall Study|Withdrawal by Subject|10
3080406|NCT00413777|10572008|P2|Fixed-dose Period|Withdrew Consent|1
3080407|NCT00413777|10572009|P1|Fixed-dose Period|Withdrew Consent|0
3080408|NCT00413777|10572008|P2|Fixed-dose Period|Met Withdrawal Criteria|0
3080409|NCT00413777|10572009|P1|Fixed-dose Period|Met Withdrawal Criteria|1
3080410|NCT00413777|10572008|P2|Fixed-dose Period|Adverse Event|1
3080411|NCT00413777|10572009|P1|Fixed-dose Period|Adverse Event|2
3080412|NCT00413777|10572008|P2|Fixed-dose Period|Lost to Follow-up|1
3080413|NCT00413777|10572009|P1|Fixed-dose Period|Lost to Follow-up|1
3080414|NCT00413699|10572057|P3|Extension Period|Adverse Event|2
3080415|NCT00413699|10572058|P2|Extension Period|Adverse Event|0
3080416|NCT00413699|10572059|P1|Extension Period|Adverse Event|0
3080417|NCT00413699|10572057|P3|Extension Period|Protocol Violation|1
3080418|NCT00413699|10572058|P2|Extension Period|Protocol Violation|0
3080419|NCT00413699|10572059|P1|Extension Period|Protocol Violation|0
3080420|NCT00413699|10572057|P3|Extension Period|No Longer Willing to Participate|2
3080421|NCT00413699|10572058|P2|Extension Period|No Longer Willing to Participate|0
3080422|NCT00413699|10572059|P1|Extension Period|No Longer Willing to Participate|0
3080423|NCT00413699|10572057|P3|Initial Period|No longer willing to participate|0
3080424|NCT00413699|10572058|P2|Initial Period|No longer willing to participate|368
3080425|NCT00413699|10572059|P1|Initial Period|No longer willing to participate|116
3080426|NCT00413699|10572057|P3|Initial Period|Missing end of study page|0
3080427|NCT00413699|10572058|P2|Initial Period|Missing end of study page|4
3080428|NCT00413699|10572059|P1|Initial Period|Missing end of study page|0
3080429|NCT00413699|10572057|P3|Initial Period|Adverse event not related to study drug|0
3080430|NCT00413699|10572058|P2|Initial Period|Adverse event not related to study drug|248
3080431|NCT00413699|10572059|P1|Initial Period|Adverse event not related to study drug|113
3080432|NCT00413699|10572057|P3|Initial Period|Adverse event related to study drug|0
3080433|NCT00413699|10572058|P2|Initial Period|Adverse event related to study drug|527
3080434|NCT00413699|10572059|P1|Initial Period|Adverse event related to study drug|178
3080435|NCT00413699|10572057|P3|Initial Period|Other|0
3080436|NCT00413699|10572058|P2|Initial Period|Other|211
3080437|NCT00413699|10572059|P1|Initial Period|Other|67
3080438|NCT00413699|10572057|P3|Initial Period|Study terminated by Sponsor|0
3080439|NCT00413699|10572058|P2|Initial Period|Study terminated by Sponsor|1
3080440|NCT00413699|10572059|P1|Initial Period|Study terminated by Sponsor|0
3080441|NCT00413699|10572057|P3|Initial Period|Medication error without adverse event|0
3080442|NCT00413699|10572058|P2|Initial Period|Medication error without adverse event|1
3080443|NCT00413699|10572059|P1|Initial Period|Medication error without adverse event|0
3080444|NCT00413699|10572057|P3|Initial Period|Did not meet entrance criteria|0
3080445|NCT00413699|10572058|P2|Initial Period|Did not meet entrance criteria|2
3080446|NCT00413699|10572059|P1|Initial Period|Did not meet entrance criteria|2
3080447|NCT00413699|10572057|P3|Initial Period|Pregnancy|0
3080448|NCT00413699|10572058|P2|Initial Period|Pregnancy|8
3080449|NCT00413699|10572059|P1|Initial Period|Pregnancy|10
3080450|NCT00413699|10572057|P3|Initial Period|Protocol Violation|0
3080451|NCT00413699|10572058|P2|Initial Period|Protocol Violation|89
3080452|NCT00413699|10572059|P1|Initial Period|Protocol Violation|38
3080453|NCT00413699|10572057|P3|Initial Period|Lost to Follow-up|0
3080454|NCT00413699|10572058|P2|Initial Period|Lost to Follow-up|101
3080455|NCT00413699|10572059|P1|Initial Period|Lost to Follow-up|31
3080456|NCT00413699|10572057|P3|Initial Period|Lack of Efficacy|0
3080457|NCT00413699|10572058|P2|Initial Period|Lack of Efficacy|115
3080458|NCT00413699|10572059|P1|Initial Period|Lack of Efficacy|59
3080459|NCT00413699|10572057|P3|Initial Period|Death|0
3080460|NCT00413699|10572058|P2|Initial Period|Death|30
3080461|NCT00413699|10572059|P1|Initial Period|Death|25
3080462|NCT00413660|10572141|P11|Post Week 12|Other|0
3080463|NCT00413660|10572142|P10|Post Week 12|Other|0
3080464|NCT00413660|10572143|P9|Post Week 12|Other|0
3080465|NCT00413660|10572144|P8|Post Week 12|Other|0
3080466|NCT00413660|10572145|P7|Post Week 12|Other|1
3080467|NCT00413660|10572146|P6|Post Week 12|Other|1
3080468|NCT00413660|10572147|P5|Post Week 12|Other|1
3080469|NCT00413660|10572148|P4|Post Week 12|Other|0
3080470|NCT00413660|10572149|P3|Post Week 12|Other|3
3080471|NCT00413660|10572150|P2|Post Week 12|Other|2
3080472|NCT00413660|10572151|P1|Post Week 12|Other|1
3080473|NCT00413660|10572141|P11|Post Week 12|Withdrawal by Subject|1
3080474|NCT00413660|10572142|P10|Post Week 12|Withdrawal by Subject|0
3080475|NCT00413660|10572143|P9|Post Week 12|Withdrawal by Subject|0
3080476|NCT00413660|10572144|P8|Post Week 12|Withdrawal by Subject|0
3080477|NCT00413660|10572145|P7|Post Week 12|Withdrawal by Subject|0
3080478|NCT00413660|10572146|P6|Post Week 12|Withdrawal by Subject|0
3080479|NCT00413660|10572147|P5|Post Week 12|Withdrawal by Subject|1
3080480|NCT00413660|10572148|P4|Post Week 12|Withdrawal by Subject|0
3080481|NCT00413660|10572149|P3|Post Week 12|Withdrawal by Subject|1
3080482|NCT00413660|10572150|P2|Post Week 12|Withdrawal by Subject|1
3080483|NCT00413660|10572151|P1|Post Week 12|Withdrawal by Subject|0
3080484|NCT00413660|10572141|P11|Post Week 12|Lost to Follow-up|0
3080485|NCT00413660|10572142|P10|Post Week 12|Lost to Follow-up|0
3080486|NCT00413660|10572143|P9|Post Week 12|Lost to Follow-up|0
3080487|NCT00413660|10572144|P8|Post Week 12|Lost to Follow-up|0
3080488|NCT00413660|10572145|P7|Post Week 12|Lost to Follow-up|0
3080489|NCT00413660|10572146|P6|Post Week 12|Lost to Follow-up|0
3080490|NCT00413660|10572147|P5|Post Week 12|Lost to Follow-up|0
3080491|NCT00413660|10572148|P4|Post Week 12|Lost to Follow-up|0
3080492|NCT00413660|10572149|P3|Post Week 12|Lost to Follow-up|1
3080493|NCT00413660|10572150|P2|Post Week 12|Lost to Follow-up|1
3080494|NCT00413660|10572151|P1|Post Week 12|Lost to Follow-up|0
3080495|NCT00413660|10572141|P11|Post Week 12|Lack of Efficacy|0
3080496|NCT00413660|10572142|P10|Post Week 12|Lack of Efficacy|1
3080497|NCT00413660|10572143|P9|Post Week 12|Lack of Efficacy|0
3080498|NCT00413660|10572144|P8|Post Week 12|Lack of Efficacy|0
3080499|NCT00413660|10572145|P7|Post Week 12|Lack of Efficacy|0
3080500|NCT00413660|10572146|P6|Post Week 12|Lack of Efficacy|0
3080501|NCT00413660|10572147|P5|Post Week 12|Lack of Efficacy|0
3080502|NCT00413660|10572148|P4|Post Week 12|Lack of Efficacy|0
3080503|NCT00413660|10572149|P3|Post Week 12|Lack of Efficacy|1
3080504|NCT00413660|10572150|P2|Post Week 12|Lack of Efficacy|0
3080505|NCT00413660|10572151|P1|Post Week 12|Lack of Efficacy|0
3080506|NCT00413660|10572141|P11|Post Week 12|Adverse Event|0
3080507|NCT00413660|10572142|P10|Post Week 12|Adverse Event|0
3080508|NCT00413660|10572143|P9|Post Week 12|Adverse Event|0
3080509|NCT00413660|10572144|P8|Post Week 12|Adverse Event|0
3080510|NCT00413660|10572145|P7|Post Week 12|Adverse Event|2
3080511|NCT00413660|10572146|P6|Post Week 12|Adverse Event|2
3080512|NCT00413660|10572147|P5|Post Week 12|Adverse Event|4
3080513|NCT00413660|10572148|P4|Post Week 12|Adverse Event|1
3080514|NCT00413660|10572149|P3|Post Week 12|Adverse Event|2
3080515|NCT00413660|10572150|P2|Post Week 12|Adverse Event|0
3080516|NCT00413660|10572151|P1|Post Week 12|Adverse Event|2
3080517|NCT00413660|10572141|P11|Up To Week 12|Other|0
3080518|NCT00413660|10572142|P10|Up To Week 12|Other|0
3080519|NCT00413660|10572143|P9|Up To Week 12|Other|0
3080520|NCT00413660|10572144|P8|Up To Week 12|Other|0
3080521|NCT00413660|10572145|P7|Up To Week 12|Other|3
3080522|NCT00413660|10572146|P6|Up To Week 12|Other|4
3080523|NCT00413660|10572147|P5|Up To Week 12|Other|2
3080524|NCT00413660|10572148|P4|Up To Week 12|Other|1
3080525|NCT00413660|10572149|P3|Up To Week 12|Other|6
3080526|NCT00413660|10572150|P2|Up To Week 12|Other|1
3080527|NCT00413660|10572151|P1|Up To Week 12|Other|3
3080528|NCT00413660|10572141|P11|Up To Week 12|Randomized, Not Treated|0
3080529|NCT00413660|10572142|P10|Up To Week 12|Randomized, Not Treated|0
3080530|NCT00413660|10572143|P9|Up To Week 12|Randomized, Not Treated|0
3080531|NCT00413660|10572144|P8|Up To Week 12|Randomized, Not Treated|0
3080532|NCT00413660|10572145|P7|Up To Week 12|Randomized, Not Treated|0
3080533|NCT00413660|10572146|P6|Up To Week 12|Randomized, Not Treated|0
3080534|NCT00413660|10572147|P5|Up To Week 12|Randomized, Not Treated|0
3080535|NCT00413660|10572148|P4|Up To Week 12|Randomized, Not Treated|1
3080536|NCT00413660|10572149|P3|Up To Week 12|Randomized, Not Treated|0
3080537|NCT00413660|10572150|P2|Up To Week 12|Randomized, Not Treated|0
3080538|NCT00413660|10572151|P1|Up To Week 12|Randomized, Not Treated|1
3080539|NCT00413660|10572141|P11|Up To Week 12|Withdrawal by Subject|0
3080540|NCT00413660|10572142|P10|Up To Week 12|Withdrawal by Subject|0
3080541|NCT00413660|10572143|P9|Up To Week 12|Withdrawal by Subject|0
3080542|NCT00413660|10572144|P8|Up To Week 12|Withdrawal by Subject|0
3080543|NCT00413660|10572145|P7|Up To Week 12|Withdrawal by Subject|2
3080544|NCT00413660|10572146|P6|Up To Week 12|Withdrawal by Subject|2
3080545|NCT00413660|10572147|P5|Up To Week 12|Withdrawal by Subject|0
3080546|NCT00413660|10572148|P4|Up To Week 12|Withdrawal by Subject|2
3080547|NCT00413660|10572149|P3|Up To Week 12|Withdrawal by Subject|0
3080548|NCT00413660|10572150|P2|Up To Week 12|Withdrawal by Subject|2
3080549|NCT00413660|10572151|P1|Up To Week 12|Withdrawal by Subject|0
3080550|NCT00413660|10572141|P11|Up To Week 12|Lost to Follow-up|0
3080551|NCT00413660|10572142|P10|Up To Week 12|Lost to Follow-up|0
3080552|NCT00413660|10572143|P9|Up To Week 12|Lost to Follow-up|0
3080553|NCT00413660|10572144|P8|Up To Week 12|Lost to Follow-up|0
3080554|NCT00413660|10572145|P7|Up To Week 12|Lost to Follow-up|0
3080555|NCT00413660|10572146|P6|Up To Week 12|Lost to Follow-up|0
3080556|NCT00413660|10572147|P5|Up To Week 12|Lost to Follow-up|1
3080557|NCT00413660|10572148|P4|Up To Week 12|Lost to Follow-up|0
3080558|NCT00413660|10572149|P3|Up To Week 12|Lost to Follow-up|0
3080559|NCT00413660|10572150|P2|Up To Week 12|Lost to Follow-up|1
3080560|NCT00413660|10572151|P1|Up To Week 12|Lost to Follow-up|0
3080561|NCT00413660|10572141|P11|Up To Week 12|Lack of Efficacy|0
3080562|NCT00413660|10572142|P10|Up To Week 12|Lack of Efficacy|0
3080563|NCT00413660|10572143|P9|Up To Week 12|Lack of Efficacy|0
3080564|NCT00413660|10572144|P8|Up To Week 12|Lack of Efficacy|0
3080565|NCT00413660|10572145|P7|Up To Week 12|Lack of Efficacy|5
3080566|NCT00413660|10572146|P6|Up To Week 12|Lack of Efficacy|0
3080567|NCT00413660|10572147|P5|Up To Week 12|Lack of Efficacy|0
3080568|NCT00413660|10572148|P4|Up To Week 12|Lack of Efficacy|0
3080569|NCT00413660|10572149|P3|Up To Week 12|Lack of Efficacy|0
3080570|NCT00413660|10572150|P2|Up To Week 12|Lack of Efficacy|0
3080571|NCT00413660|10572151|P1|Up To Week 12|Lack of Efficacy|2
3080572|NCT00413660|10572141|P11|Up To Week 12|Adverse Event|0
3080573|NCT00413660|10572142|P10|Up To Week 12|Adverse Event|0
3080574|NCT00413660|10572143|P9|Up To Week 12|Adverse Event|0
3080575|NCT00413660|10572144|P8|Up To Week 12|Adverse Event|0
3080576|NCT00413660|10572145|P7|Up To Week 12|Adverse Event|1
3080577|NCT00413660|10572146|P6|Up To Week 12|Adverse Event|4
3080578|NCT00413660|10572147|P5|Up To Week 12|Adverse Event|6
3080579|NCT00413660|10572148|P4|Up To Week 12|Adverse Event|4
3080580|NCT00413660|10572149|P3|Up To Week 12|Adverse Event|1
3080581|NCT00413660|10572150|P2|Up To Week 12|Adverse Event|3
3080582|NCT00413660|10572151|P1|Up To Week 12|Adverse Event|1
3080583|NCT00413413|10572554|P3|Double-Blind|Lost to Follow-up|2
3080584|NCT00413413|10572555|P2|Double-Blind|Lost to Follow-up|4
3080585|NCT00413413|10572556|P1|Double-Blind|Lost to Follow-up|3
3080586|NCT00413413|10572554|P3|Double-Blind|Subject withdrew consent|9
3080587|NCT00413413|10572555|P2|Double-Blind|Subject withdrew consent|6
3080588|NCT00413413|10572556|P1|Double-Blind|Subject withdrew consent|4
3080589|NCT00413413|10572554|P3|Double-Blind|Protocol deviation|1
3080590|NCT00413413|10572555|P2|Double-Blind|Protocol deviation|2
3080591|NCT00413413|10572556|P1|Double-Blind|Protocol deviation|1
3080592|NCT00413413|10572554|P3|Double-Blind|Unsatisfactory therapeutic effect|1
3080593|NCT00413413|10572555|P2|Double-Blind|Unsatisfactory therapeutic effect|2
3080594|NCT00413413|10572556|P1|Double-Blind|Unsatisfactory therapeutic effect|1
3080595|NCT00413413|10572554|P3|Double-Blind|Adverse Event|5
3080596|NCT00413413|10572555|P2|Double-Blind|Adverse Event|0
3080597|NCT00413413|10572556|P1|Double-Blind|Adverse Event|6
3080598|NCT00413413|10572554|P3|Single-Blind|Lost to Follow-up|0
3080599|NCT00413413|10572555|P2|Single-Blind|Lost to Follow-up|8
3080600|NCT00413413|10572556|P1|Single-Blind|Lost to Follow-up|0
3080601|NCT00413413|10572554|P3|Single-Blind|Withdrawal by Subject|0
3080602|NCT00413413|10572555|P2|Single-Blind|Withdrawal by Subject|27
3080603|NCT00413413|10572556|P1|Single-Blind|Withdrawal by Subject|0
3080604|NCT00413413|10572554|P3|Single-Blind|Protocol Violation|0
3080605|NCT00413413|10572555|P2|Single-Blind|Protocol Violation|16
3080606|NCT00413413|10572556|P1|Single-Blind|Protocol Violation|0
3080607|NCT00413413|10572554|P3|Single-Blind|Subject no longer requires study drug|0
3080608|NCT00413413|10572555|P2|Single-Blind|Subject no longer requires study drug|151
3080609|NCT00413413|10572556|P1|Single-Blind|Subject no longer requires study drug|0
3080610|NCT00413413|10572554|P3|Single-Blind|Lack of Efficacy|0
3080611|NCT00413413|10572555|P2|Single-Blind|Lack of Efficacy|5
3080612|NCT00413413|10572556|P1|Single-Blind|Lack of Efficacy|0
3080613|NCT00413413|10572554|P3|Single-Blind|Adverse Event|0
3080614|NCT00413413|10572555|P2|Single-Blind|Adverse Event|9
3080615|NCT00413413|10572556|P1|Single-Blind|Adverse Event|0
3080616|NCT00413374|10572609|P2|Overall Study|Surgery|0
3080617|NCT00413374|10572610|P1|Overall Study|Surgery|1
3080618|NCT00413374|10572609|P2|Overall Study|Lost to Follow-up|0
3080619|NCT00413374|10572610|P1|Overall Study|Lost to Follow-up|1
3080620|NCT00413374|10572609|P2|Overall Study|Adverse Event|0
3080621|NCT00413374|10572610|P1|Overall Study|Adverse Event|1
3080622|NCT00413374|10572609|P2|Overall Study|Ineligible due to screening criteria.|0
3080623|NCT00413374|10572610|P1|Overall Study|Ineligible due to screening criteria.|3
3080624|NCT00413283|10572641|P4|Overall Study|Other|0
3080625|NCT00413283|10572642|P3|Overall Study|Other|1
3080626|NCT00413283|10572643|P2|Overall Study|Other|0
3080627|NCT00413283|10572644|P1|Overall Study|Other|0
3080628|NCT00413283|10572641|P4|Overall Study|Requirement for alternative therapy|0
3080629|NCT00413283|10572642|P3|Overall Study|Requirement for alternative therapy|0
3080630|NCT00413283|10572643|P2|Overall Study|Requirement for alternative therapy|2
3080631|NCT00413283|10572644|P1|Overall Study|Requirement for alternative therapy|0
3080632|NCT00413283|10572641|P4|Overall Study|Protocol deviation|0
3080633|NCT00413283|10572642|P3|Overall Study|Protocol deviation|0
3080634|NCT00413283|10572643|P2|Overall Study|Protocol deviation|1
3080635|NCT00413283|10572644|P1|Overall Study|Protocol deviation|0
3080636|NCT00413283|10572641|P4|Overall Study|Ineligibility determined|1
3080637|NCT00413283|10572642|P3|Overall Study|Ineligibility determined|0
3080638|NCT00413283|10572643|P2|Overall Study|Ineligibility determined|0
3080639|NCT00413283|10572644|P1|Overall Study|Ineligibility determined|0
3080640|NCT00413283|10572641|P4|Overall Study|Adverse Event|1
3080641|NCT00413283|10572642|P3|Overall Study|Adverse Event|0
3080642|NCT00413283|10572643|P2|Overall Study|Adverse Event|0
3080643|NCT00413283|10572644|P1|Overall Study|Adverse Event|0
3080644|NCT00413283|10572641|P4|Overall Study|Death|1
3080645|NCT00413283|10572642|P3|Overall Study|Death|1
3080646|NCT00413283|10572643|P2|Overall Study|Death|0
3080647|NCT00413283|10572644|P1|Overall Study|Death|0
3080648|NCT00413283|10572641|P4|Overall Study|Withdrawal by Subject|1
3080649|NCT00413283|10572642|P3|Overall Study|Withdrawal by Subject|0
3080650|NCT00413283|10572643|P2|Overall Study|Withdrawal by Subject|0
3080651|NCT00413283|10572644|P1|Overall Study|Withdrawal by Subject|1
3080652|NCT00413244|10572676|P2|Overall Study|Withdrawal by Subject|1
3080653|NCT00413244|10572677|P1|Overall Study|Withdrawal by Subject|10
3080654|NCT00413231|10572705|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
3080655|NCT00413231|10572705|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
3080656|NCT00413231|10572705|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
3080657|NCT00413231|10572705|P1|365-day to 60-month Post Treatment|Death|36
3080658|NCT00413231|10572705|P1|30-day to 365-day Post Treatment|Death|13
3080659|NCT00413231|10572705|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
3080660|NCT00413231|10572705|P1|0 to 30-day Post Treatment|Death|5
3080661|NCT00413218|10572737|P2|Overall Study|Withdrawal by Subject|1
3080662|NCT00413218|10572738|P1|Overall Study|Withdrawal by Subject|9
3080663|NCT00413218|10572737|P2|Overall Study|Missing|0
3080664|NCT00413218|10572738|P1|Overall Study|Missing|1
3080665|NCT00413218|10572737|P2|Overall Study|Admin|14
3080666|NCT00413218|10572738|P1|Overall Study|Admin|20
3080667|NCT00413218|10572737|P2|Overall Study|Lost to Follow-up|17
3080668|NCT00413218|10572738|P1|Overall Study|Lost to Follow-up|14
3080669|NCT00413218|10572737|P2|Overall Study|Death|56
3080670|NCT00413218|10572738|P1|Overall Study|Death|57
3080671|NCT00413218|10572737|P2|Overall Study|Randomized but didn't receive study drug|8
3080672|NCT00413218|10572738|P1|Overall Study|Randomized but didn't receive study drug|2
3080673|NCT00413192|10572764|P4|Overall Study|Not treated|1
3080674|NCT00413192|10572765|P3|Overall Study|Not treated|0
3080675|NCT00413192|10572766|P2|Overall Study|Not treated|0
3080676|NCT00413192|10572767|P1|Overall Study|Not treated|0
3080677|NCT00413192|10572764|P4|Overall Study|Other|2
3080678|NCT00413192|10572765|P3|Overall Study|Other|1
3080679|NCT00413192|10572766|P2|Overall Study|Other|1
3080680|NCT00413192|10572767|P1|Overall Study|Other|5
3080681|NCT00413192|10572764|P4|Overall Study|Intercurrent death|0
3080682|NCT00413192|10572765|P3|Overall Study|Intercurrent death|0
3080683|NCT00413192|10572766|P2|Overall Study|Intercurrent death|1
3080684|NCT00413192|10572767|P1|Overall Study|Intercurrent death|0
3080685|NCT00413192|10572764|P4|Overall Study|Intercurrent illness|1
3080686|NCT00413192|10572765|P3|Overall Study|Intercurrent illness|0
3080687|NCT00413192|10572766|P2|Overall Study|Intercurrent illness|0
3080688|NCT00413192|10572767|P1|Overall Study|Intercurrent illness|0
3080689|NCT00413192|10572764|P4|Overall Study|Withdrawal by Subject|1
3080690|NCT00413192|10572765|P3|Overall Study|Withdrawal by Subject|0
3080691|NCT00413192|10572766|P2|Overall Study|Withdrawal by Subject|5
3080692|NCT00413192|10572767|P1|Overall Study|Withdrawal by Subject|3
3080693|NCT00413192|10572764|P4|Overall Study|Toxicity|2
3080694|NCT00413192|10572765|P3|Overall Study|Toxicity|2
3080695|NCT00413192|10572766|P2|Overall Study|Toxicity|2
3080696|NCT00413192|10572767|P1|Overall Study|Toxicity|3
3080697|NCT00413192|10572764|P4|Overall Study|Disease progression|25
3080698|NCT00413192|10572765|P3|Overall Study|Disease progression|16
3080699|NCT00413192|10572766|P2|Overall Study|Disease progression|31
3080700|NCT00413192|10572767|P1|Overall Study|Disease progression|26
3080701|NCT00413153|10572820|P2|Overall Study|Adverse Event|0
3080702|NCT00413153|10572821|P1|Overall Study|Adverse Event|1
3080703|NCT00413153|10572820|P2|Overall Study|Withdrawal by Subject|1
3080704|NCT00413153|10572821|P1|Overall Study|Withdrawal by Subject|1
3080705|NCT00413062|10572845|P2|Overall Study|Other reason|34
3080706|NCT00413062|10572846|P1|Overall Study|Other reason|70
3080707|NCT00413062|10572845|P2|Overall Study|Lost to Follow-up|73
3080708|NCT00413062|10572846|P1|Overall Study|Lost to Follow-up|175
3080709|NCT00413062|10572845|P2|Overall Study|Pregnancy wish|6
3080710|NCT00413062|10572846|P1|Overall Study|Pregnancy wish|17
3080711|NCT00413062|10572845|P2|Overall Study|Pregnancy|5
3080712|NCT00413062|10572846|P1|Overall Study|Pregnancy|15
3080713|NCT00413062|10572845|P2|Overall Study|Withdrawal of informed consent|36
3080714|NCT00413062|10572846|P1|Overall Study|Withdrawal of informed consent|111
3080715|NCT00413062|10572845|P2|Overall Study|Pre-treatment (serious) adverse event|0
3080716|NCT00413062|10572846|P1|Overall Study|Pre-treatment (serious) adverse event|1
3080717|NCT00413062|10572845|P2|Overall Study|Adverse event/serious adverse event|56
3080718|NCT00413062|10572846|P1|Overall Study|Adverse event/serious adverse event|289
3080719|NCT00413049|10572872|P2|Overall Study|Lack of Efficacy|0
3080720|NCT00413049|10572873|P1|Overall Study|Lack of Efficacy|1
3080721|NCT00413049|10572872|P2|Overall Study|Abnormal laboratory value(s)|0
3080722|NCT00413049|10572873|P1|Overall Study|Abnormal laboratory value(s)|1
3080723|NCT00413049|10572872|P2|Overall Study|Subject no longer requires study drug|1
3080724|NCT00413049|10572873|P1|Overall Study|Subject no longer requires study drug|0
3080725|NCT00413049|10572872|P2|Overall Study|Protocol Violation|1
3080726|NCT00413049|10572873|P1|Overall Study|Protocol Violation|3
3080727|NCT00413049|10572872|P2|Overall Study|Lost to Follow-up|3
3080728|NCT00413049|10572873|P1|Overall Study|Lost to Follow-up|2
3080729|NCT00413049|10572872|P2|Overall Study|Withdrawal by Subject|5
3080730|NCT00413049|10572873|P1|Overall Study|Withdrawal by Subject|7
3080731|NCT00413049|10572872|P2|Overall Study|Adverse Event|8
3080732|NCT00413049|10572873|P1|Overall Study|Adverse Event|10
3080733|NCT00413036|10572889|P1|Overall Study|Missing|2
3080734|NCT00413036|10572889|P1|Overall Study|Other|26
3080735|NCT00413036|10572889|P1|Overall Study|Death|9
3080736|NCT00413036|10572889|P1|Overall Study|Withdrawal by Subject|7
3080737|NCT00413036|10572889|P1|Overall Study|Lack of Efficacy|129
3080738|NCT00413036|10572889|P1|Overall Study|Adverse Event|44
3080739|NCT00413010|10572899|P2|Overall Study|Due to termination of the study|52
3080740|NCT00413010|10572900|P1|Overall Study|Due to termination of the study|54
3080741|NCT00413010|10572899|P2|Overall Study|Withdrawal by Subject|2
3080742|NCT00413010|10572900|P1|Overall Study|Withdrawal by Subject|7
3080743|NCT00413010|10572899|P2|Overall Study|Lost to Follow-up|0
3080744|NCT00413010|10572900|P1|Overall Study|Lost to Follow-up|3
3080745|NCT00413010|10572899|P2|Overall Study|Lack of Efficacy|3
3080746|NCT00413010|10572900|P1|Overall Study|Lack of Efficacy|0
3080747|NCT00413010|10572899|P2|Overall Study|Laboratory abnormality|2
3080748|NCT00413010|10572900|P1|Overall Study|Laboratory abnormality|0
3080749|NCT00413010|10572899|P2|Overall Study|Adverse Event|4
3080750|NCT00413010|10572900|P1|Overall Study|Adverse Event|8
3080751|NCT00412984|10572922|P2|Overall Study|Not Reported|12
3080752|NCT00412984|10572923|P1|Overall Study|Not Reported|11
3080753|NCT00412984|10572922|P2|Overall Study|Other Reason|92
3080754|NCT00412984|10572923|P1|Overall Study|Other Reason|80
3080755|NCT00412984|10572922|P2|Overall Study|Physician Refused to Continue Treatment|89
3080756|NCT00412984|10572923|P1|Overall Study|Physician Refused to Continue Treatment|81
3080757|NCT00412984|10572922|P2|Overall Study|Administrative Reason by Sponsor|8
3080758|NCT00412984|10572923|P1|Overall Study|Administrative Reason by Sponsor|11
3080759|NCT00412984|10572922|P2|Overall Study|Subject No Longer Meets Study Criteria|100
3080760|NCT00412984|10572923|P1|Overall Study|Subject No Longer Meets Study Criteria|87
3080761|NCT00412984|10572922|P2|Overall Study|Pregnancy|0
3080762|NCT00412984|10572923|P1|Overall Study|Pregnancy|1
3080763|NCT00412984|10572922|P2|Overall Study|Poor/Noncompliance|77
3080764|NCT00412984|10572923|P1|Overall Study|Poor/Noncompliance|57
3080765|NCT00412984|10572922|P2|Overall Study|Lost to Follow-up|39
3080766|NCT00412984|10572923|P1|Overall Study|Lost to Follow-up|51
3080767|NCT00412984|10572922|P2|Overall Study|Withdrawal by Subject|989
3080768|NCT00412984|10572923|P1|Overall Study|Withdrawal by Subject|921
3080769|NCT00412984|10572922|P2|Overall Study|Adverse Event|738
3080770|NCT00412984|10572923|P1|Overall Study|Adverse Event|679
3080771|NCT00412984|10572922|P2|Overall Study|Death|349
3080772|NCT00412984|10572923|P1|Overall Study|Death|331
3080773|NCT00412971|10572967|P2|Overall Study|Protocol Violation|1
3080774|NCT00412971|10572968|P1|Overall Study|Protocol Violation|13
3080775|NCT00412971|10572967|P2|Overall Study|Lost to Follow-up|9
3080776|NCT00412971|10572968|P1|Overall Study|Lost to Follow-up|17
3080777|NCT00412958|10572981|P4|Overall Study|Transport issue|0
3080778|NCT00412958|10572982|P3|Overall Study|Transport issue|0
3080779|NCT00412958|10572983|P2|Overall Study|Transport issue|1
3080780|NCT00412958|10572984|P1|Overall Study|Transport issue|0
3080781|NCT00412958|10572981|P4|Overall Study|Death|0
3080782|NCT00412958|10572982|P3|Overall Study|Death|0
3080783|NCT00412958|10572983|P2|Overall Study|Death|1
3080784|NCT00412958|10572984|P1|Overall Study|Death|0
3080785|NCT00412958|10572981|P4|Overall Study|Lost to Follow-up|0
3080786|NCT00412958|10572982|P3|Overall Study|Lost to Follow-up|0
3080787|NCT00412958|10572983|P2|Overall Study|Lost to Follow-up|1
3080788|NCT00412958|10572984|P1|Overall Study|Lost to Follow-up|0
3080789|NCT00412958|10572981|P4|Overall Study|Adverse Event|0
3080790|NCT00412958|10572982|P3|Overall Study|Adverse Event|0
3080791|NCT00412958|10572983|P2|Overall Study|Adverse Event|1
3080792|NCT00412958|10572984|P1|Overall Study|Adverse Event|0
3080793|NCT00412958|10572981|P4|Overall Study|Withdrawal by Subject|1
3080794|NCT00412958|10572982|P3|Overall Study|Withdrawal by Subject|0
3080795|NCT00412958|10572983|P2|Overall Study|Withdrawal by Subject|0
3080796|NCT00412958|10572984|P1|Overall Study|Withdrawal by Subject|3
3080797|NCT00412932|10572994|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
3080798|NCT00412932|10572994|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
3080799|NCT00412932|10572994|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
3080800|NCT00412932|10572994|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
3080801|NCT00412932|10572994|P1|Olmesartan 40 mg|Withdrawal by Subject|1
3080802|NCT00412932|10572994|P1|Olmesartan 40 mg|Lack of Efficacy|3
3080803|NCT00412932|10572994|P1|Olmesartan 40 mg|Adverse Event|4
3080804|NCT00412932|10572994|P1|Olmesartan (Olm) 20 mg|Other|1
3080805|NCT00412932|10572994|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
3080806|NCT00412932|10572994|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
3080807|NCT00412932|10572994|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
3080808|NCT00412932|10572994|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
3080809|NCT00412893|10573005|P2|Overall Study|Randomized but Never Received Study Drug|6
3080810|NCT00412893|10573006|P1|Overall Study|Randomized but Never Received Study Drug|5
3080811|NCT00412893|10573005|P2|Overall Study|Administrative Reason|15
3080812|NCT00412893|10573006|P1|Overall Study|Administrative Reason|12
3080813|NCT00412893|10573005|P2|Overall Study|Did Not Cooperate|9
3080814|NCT00412893|10573006|P1|Overall Study|Did Not Cooperate|12
3080815|NCT00412893|10573005|P2|Overall Study|Other Protocol Violation|6
3080816|NCT00412893|10573006|P1|Overall Study|Other Protocol Violation|10
3080817|NCT00412893|10573005|P2|Overall Study|Violation of Selection at Entry|10
3080818|NCT00412893|10573006|P1|Overall Study|Violation of Selection at Entry|17
3080819|NCT00412893|10573005|P2|Overall Study|Lost to Follow-up|1
3080820|NCT00412893|10573006|P1|Overall Study|Lost to Follow-up|2
3080821|NCT00412893|10573005|P2|Overall Study|Insufficient Therapeutic Response|23
3080822|NCT00412893|10573006|P1|Overall Study|Insufficient Therapeutic Response|39
3080823|NCT00412893|10573005|P2|Overall Study|Death|21
3080824|NCT00412893|10573006|P1|Overall Study|Death|17
3080825|NCT00412893|10573005|P2|Overall Study|Adverse Event|53
3080826|NCT00412893|10573006|P1|Overall Study|Adverse Event|31
3080827|NCT00412854|10573044|P2|Overall Study|Withdrawn for other reasons|11
3080828|NCT00412854|10573045|P1|Overall Study|Withdrawn for other reasons|13
3080829|NCT00412854|10573044|P2|Overall Study|Withdrawn due to adverse events|5
3080830|NCT00412854|10573045|P1|Overall Study|Withdrawn due to adverse events|1
3080831|NCT00412750|10573089|P3|Overall Study|Lack of Efficacy|3
3080832|NCT00412750|10573090|P2|Overall Study|Lack of Efficacy|0
3080833|NCT00412750|10573091|P1|Overall Study|Lack of Efficacy|0
3080834|NCT00412750|10573089|P3|Overall Study|Withdrawal by Subject|2
3080835|NCT00412750|10573090|P2|Overall Study|Withdrawal by Subject|1
3080836|NCT00412750|10573091|P1|Overall Study|Withdrawal by Subject|0
3080837|NCT00412750|10573089|P3|Overall Study|Lost to Follow-up|1
3080838|NCT00412750|10573090|P2|Overall Study|Lost to Follow-up|0
3080839|NCT00412750|10573091|P1|Overall Study|Lost to Follow-up|1
3080840|NCT00412750|10573089|P3|Overall Study|Adverse Event|3
3080841|NCT00412750|10573090|P2|Overall Study|Adverse Event|3
3080842|NCT00412750|10573091|P1|Overall Study|Adverse Event|8
3080843|NCT00412750|10573089|P3|Overall Study|Administrative problems|14
3080844|NCT00412750|10573090|P2|Overall Study|Administrative problems|17
3080845|NCT00412750|10573091|P1|Overall Study|Administrative problems|21
3080846|NCT00412750|10573089|P3|Overall Study|Abnormal laboratory value(s)|0
3080847|NCT00412750|10573090|P2|Overall Study|Abnormal laboratory value(s)|0
3080848|NCT00412750|10573091|P1|Overall Study|Abnormal laboratory value(s)|1
3080849|NCT00412737|10573116|P2|Overall Study|Failure to Return|2
3080850|NCT00412737|10573117|P1|Overall Study|Failure to Return|6
3080851|NCT00412737|10573116|P2|Overall Study|Refused Treatment|2
3080852|NCT00412737|10573117|P1|Overall Study|Refused Treatment|6
3080853|NCT00412737|10573116|P2|Overall Study|Adverse Event|2
3080854|NCT00412737|10573117|P1|Overall Study|Adverse Event|3
3080855|NCT00412737|10573116|P2|Overall Study|Death|0
3080856|NCT00412737|10573117|P1|Overall Study|Death|1
3080857|NCT00412607|10573135|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
3080858|NCT00412607|10573135|P1|Overall Study|Death|61
3080859|NCT00412607|10573135|P1|Overall Study|Lost to Follow-up|19
3080860|NCT00412607|10573135|P1|Overall Study|Withdrawal by Subject|9
3080861|NCT00412542|10573148|P2|Overall Study|Not Eligible|1
3080862|NCT00412542|10573149|P1|Overall Study|Not Eligible|0
3080863|NCT00412542|10573148|P2|Overall Study|Withdrawal by Subject|2
3080864|NCT00412542|10573149|P1|Overall Study|Withdrawal by Subject|0
3080865|NCT00412373|10573234|P2|Overall Study|Other|2
3080866|NCT00412373|10573235|P1|Overall Study|Other|2
3080867|NCT00412373|10573234|P2|Overall Study|Withdrawal by Subject|27
3080868|NCT00412373|10573235|P1|Overall Study|Withdrawal by Subject|8
3080869|NCT00412373|10573234|P2|Overall Study|Lost to Follow-up|13
3080870|NCT00412373|10573235|P1|Overall Study|Lost to Follow-up|7
3080871|NCT00412373|10573234|P2|Overall Study|Lack of Efficacy|22
3080872|NCT00412373|10573235|P1|Overall Study|Lack of Efficacy|16
3080873|NCT00412373|10573234|P2|Overall Study|Adverse Event|13
3080874|NCT00412373|10573235|P1|Overall Study|Adverse Event|8
3080875|NCT00412360|10573277|P2|Overall Study|Not Transplanted|2
3080876|NCT00412360|10573278|P1|Overall Study|Not Transplanted|1
3080877|NCT00412360|10573277|P2|Overall Study|Lost to Follow-up|1
3080878|NCT00412360|10573278|P1|Overall Study|Lost to Follow-up|0
3080879|NCT00412217|10573308|P2|Overall Study|Other|1
3080880|NCT00412217|10573309|P1|Overall Study|Other|1
3080881|NCT00412217|10573308|P2|Overall Study|Study Terminated by Sponsor|33
3080882|NCT00412217|10573309|P1|Overall Study|Study Terminated by Sponsor|26
3080883|NCT00412217|10573308|P2|Overall Study|Lost to Follow-up|4
3080884|NCT00412217|10573309|P1|Overall Study|Lost to Follow-up|1
3080885|NCT00412217|10573308|P2|Overall Study|Withdrawal by Subject|0
3080886|NCT00412217|10573309|P1|Overall Study|Withdrawal by Subject|2
3080887|NCT00412217|10573308|P2|Overall Study|Investigator Decision|0
3080888|NCT00412217|10573309|P1|Overall Study|Investigator Decision|1
3080889|NCT00412217|10573308|P2|Overall Study|Disease Progression|3
3080890|NCT00412217|10573309|P1|Overall Study|Disease Progression|2
3080891|NCT00412217|10573308|P2|Overall Study|Death|4
3080892|NCT00412217|10573309|P1|Overall Study|Death|5
3080893|NCT00412217|10573308|P2|Overall Study|Insufficient Data Available|3
3080894|NCT00412217|10573309|P1|Overall Study|Insufficient Data Available|8
3080895|NCT00412113|10573323|P2|Overall Study|did not receive treatment|0
3080896|NCT00412113|10573324|P1|Overall Study|did not receive treatment|1
3080897|NCT00412113|10573323|P2|Overall Study|Adverse Event|15
3080898|NCT00412113|10573324|P1|Overall Study|Adverse Event|11
3080899|NCT00412061|10573408|P2|Open Label Phase|New Cancer Therapy|1
3080900|NCT00412061|10573409|P1|Open Label Phase|New Cancer Therapy|0
3080901|NCT00412061|10573408|P2|Open Label Phase|Lost to Follow-up|2
3080902|NCT00412061|10573409|P1|Open Label Phase|Lost to Follow-up|0
3080903|NCT00412061|10573408|P2|Open Label Phase|Death|7
3080904|NCT00412061|10573409|P1|Open Label Phase|Death|0
3080905|NCT00412061|10573408|P2|Open Label Phase|Administrative Problems|13
3080906|NCT00412061|10573409|P1|Open Label Phase|Administrative Problems|0
3080907|NCT00412061|10573408|P2|Open Label Phase|Withdrawal by Subject|15
3080908|NCT00412061|10573409|P1|Open Label Phase|Withdrawal by Subject|0
3080909|NCT00412061|10573408|P2|Open Label Phase|Adverse Event|46
3080910|NCT00412061|10573409|P1|Open Label Phase|Adverse Event|0
3080911|NCT00412061|10573408|P2|Open Label Phase|Disease Progression|86
3080912|NCT00412061|10573409|P1|Open Label Phase|Disease Progression|0
3080913|NCT00412061|10573408|P2|Double Blind Phase|Lost to Follow-up|1
3080914|NCT00412061|10573409|P1|Double Blind Phase|Lost to Follow-up|0
3080915|NCT00412061|10573408|P2|Double Blind Phase|New Cander Therapy|1
3080916|NCT00412061|10573409|P1|Double Blind Phase|New Cander Therapy|1
3080917|NCT00412061|10573408|P2|Double Blind Phase|Protocol Violation|4
3080918|NCT00412061|10573409|P1|Double Blind Phase|Protocol Violation|3
3080919|NCT00412061|10573408|P2|Double Blind Phase|Death|3
3080920|NCT00412061|10573409|P1|Double Blind Phase|Death|6
3080921|NCT00412061|10573408|P2|Double Blind Phase|Withdrawal by Subject|20
3080922|NCT00412061|10573409|P1|Double Blind Phase|Withdrawal by Subject|18
3080923|NCT00412061|10573408|P2|Double Blind Phase|Final Primary Analysis|14
3080924|NCT00412061|10573409|P1|Double Blind Phase|Final Primary Analysis|26
3080925|NCT00412061|10573408|P2|Double Blind Phase|Adverse Event|16
3080926|NCT00412061|10573409|P1|Double Blind Phase|Adverse Event|61
3080927|NCT00412061|10573408|P2|Double Blind Phase|Disease Progression|154
3080928|NCT00412061|10573409|P1|Double Blind Phase|Disease Progression|101
3080929|NCT00411788|10573427|P1|Overall Study|Adverse Event|1
3080930|NCT00411788|10573427|P1|Overall Study|Protocol Violation|1
3080931|NCT00411762|10573436|P1|Overall Study|Withdrawal by Subject|5
3080932|NCT00411671|10573460|P1|Overall Study|Lost to Follow-up|3
3080933|NCT00411671|10573460|P1|Overall Study|Death|2
3080934|NCT00411671|10573460|P1|Overall Study|Adverse Event|15
3080935|NCT00411645|10573468|P2|Overall Study|Lost to Follow-up|0
3080936|NCT00411645|10573469|P1|Overall Study|Lost to Follow-up|2
3080937|NCT00411645|10573468|P2|Overall Study|Investigator/Sponsor Decision|7
3080938|NCT00411645|10573469|P1|Overall Study|Investigator/Sponsor Decision|10
3080939|NCT00411645|10573468|P2|Overall Study|Death|135
3080940|NCT00411645|10573469|P1|Overall Study|Death|56
3080941|NCT00411645|10573468|P2|Overall Study|Consent Withdrawn|22
3080942|NCT00411645|10573469|P1|Overall Study|Consent Withdrawn|13
3080943|NCT00411632|10573493|P1|Overall Study|Death|1
3080944|NCT00411554|10573504|P2|Overall Study|Patient Moved|0
3080945|NCT00411554|10573505|P1|Overall Study|Patient Moved|1
3080946|NCT00411554|10573504|P2|Overall Study|Withdrawal by Subject|0
3080947|NCT00411554|10573505|P1|Overall Study|Withdrawal by Subject|3
3080948|NCT00411554|10573504|P2|Overall Study|Lack of Efficacy|5
3080949|NCT00411554|10573505|P1|Overall Study|Lack of Efficacy|2
3080950|NCT00411554|10573504|P2|Overall Study|Adverse Event|4
3080951|NCT00411554|10573505|P1|Overall Study|Adverse Event|2
3080952|NCT00411450|10573531|P1|Overall Study|Ongoing at time of data cut-off.|3
3080953|NCT00411216|10573574|P2|Overall Study|Ten participants were entered into the c|2
3080954|NCT00411216|10573575|P1|Overall Study|Ten participants were entered into the c|0
3080955|NCT00411151|10573581|P1|Overall Study|Trial prematurely closed|4
3080956|NCT00411151|10573581|P1|Overall Study|Protocol Violation|1
3080957|NCT00411151|10573581|P1|Overall Study|Lost to Follow-up|2
3080958|NCT00411151|10573581|P1|Overall Study|Withdrawal by Subject|2
3080959|NCT00411151|10573581|P1|Overall Study|Death|38
3080960|NCT00410813|10573625|P2|Overall Study|Death|2
3080961|NCT00410813|10573626|P1|Overall Study|Death|0
3080962|NCT00410813|10573625|P2|Overall Study|Ineligible|4
3080963|NCT00410813|10573626|P1|Overall Study|Ineligible|2
3080964|NCT00410813|10573625|P2|Overall Study|Not protocol specified|4
3080965|NCT00410813|10573626|P1|Overall Study|Not protocol specified|3
3080966|NCT00410813|10573625|P2|Overall Study|Progression|21
3080967|NCT00410813|10573626|P1|Overall Study|Progression|32
3080968|NCT00410813|10573625|P2|Overall Study|Adverse Event|11
3080969|NCT00410813|10573626|P1|Overall Study|Adverse Event|6
3080970|NCT00410761|10573663|P2|Overall Study|Never received randomised treatment|1
3080971|NCT00410761|10573664|P1|Overall Study|Never received randomised treatment|0
3080972|NCT00410761|10573663|P2|Overall Study|Other|9
3080973|NCT00410761|10573664|P1|Overall Study|Other|12
3080974|NCT00410761|10573663|P2|Overall Study|Withdrawal by Subject|4
3080975|NCT00410761|10573664|P1|Overall Study|Withdrawal by Subject|8
3080976|NCT00410761|10573663|P2|Overall Study|objective disease progression|55
3080977|NCT00410761|10573664|P1|Overall Study|objective disease progression|71
3080978|NCT00410761|10573663|P2|Overall Study|Adverse Event|3
3080979|NCT00410761|10573664|P1|Overall Study|Adverse Event|29
3080980|NCT00410605|10573684|P1|Overall Study|Transferred to another Institution|1
3080981|NCT00410605|10573684|P1|Overall Study|Stopped treatmen to collect stem cells|1
3080982|NCT00410605|10573684|P1|Overall Study|Started Non-Protocol Therapy|3
3080983|NCT00410605|10573684|P1|Overall Study|Withdrawal by Subject|5
3080984|NCT00410605|10573684|P1|Overall Study|Physician Decision|3
3080985|NCT00410605|10573684|P1|Overall Study|Adverse Event|12
3080986|NCT00410514|10573696|P3|Overall Study|Non-compliant with study procedures|2
3080987|NCT00410514|10573697|P2|Overall Study|Non-compliant with study procedures|0
3080988|NCT00410514|10573698|P1|Overall Study|Non-compliant with study procedures|0
3080989|NCT00410514|10573696|P3|Overall Study|Lost to Follow-up|2
3080990|NCT00410514|10573697|P2|Overall Study|Lost to Follow-up|0
3080991|NCT00410514|10573698|P1|Overall Study|Lost to Follow-up|0
3080992|NCT00410514|10573696|P3|Overall Study|Protocol Violation|1
3080993|NCT00410514|10573697|P2|Overall Study|Protocol Violation|1
3080994|NCT00410514|10573698|P1|Overall Study|Protocol Violation|0
3080995|NCT00410514|10573696|P3|Overall Study|Adverse Event|2
3080996|NCT00410514|10573697|P2|Overall Study|Adverse Event|2
3080997|NCT00410514|10573698|P1|Overall Study|Adverse Event|2
3080998|NCT00410410|10573781|P9|Open-Label Period (OL)|Other|7
3080999|NCT00410410|10573782|P8|Open-Label Period (OL)|Other|0
3081000|NCT00410410|10573783|P7|Open-Label Period (OL)|Other|0
3081001|NCT00410410|10573784|P6|Open-Label Period (OL)|Other|0
3081002|NCT00410410|10573785|P5|Open-Label Period (OL)|Other|0
3081003|NCT00410410|10573786|P4|Open-Label Period (OL)|Other|0
3081004|NCT00410410|10573787|P3|Open-Label Period (OL)|Other|0
3081005|NCT00410410|10573788|P2|Open-Label Period (OL)|Other|0
3081006|NCT00410410|10573789|P1|Open-Label Period (OL)|Other|0
3081007|NCT00410410|10573781|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
3081008|NCT00410410|10573782|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081009|NCT00410410|10573783|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081010|NCT00410410|10573784|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081011|NCT00410410|10573785|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081012|NCT00410410|10573786|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081013|NCT00410410|10573787|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081014|NCT00410410|10573788|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081015|NCT00410410|10573789|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
3081016|NCT00410410|10573781|P9|Open-Label Period (OL)|Pregnancy|1
3081017|NCT00410410|10573782|P8|Open-Label Period (OL)|Pregnancy|0
3081018|NCT00410410|10573783|P7|Open-Label Period (OL)|Pregnancy|0
3081019|NCT00410410|10573784|P6|Open-Label Period (OL)|Pregnancy|0
3081020|NCT00410410|10573785|P5|Open-Label Period (OL)|Pregnancy|0
3081021|NCT00410410|10573786|P4|Open-Label Period (OL)|Pregnancy|0
3081022|NCT00410410|10573787|P3|Open-Label Period (OL)|Pregnancy|0
3081023|NCT00410410|10573788|P2|Open-Label Period (OL)|Pregnancy|0
3081024|NCT00410410|10573789|P1|Open-Label Period (OL)|Pregnancy|0
3081025|NCT00410410|10573781|P9|Open-Label Period (OL)|Withdrawal by Subject|20
3081026|NCT00410410|10573782|P8|Open-Label Period (OL)|Withdrawal by Subject|0
3081027|NCT00410410|10573783|P7|Open-Label Period (OL)|Withdrawal by Subject|0
3081028|NCT00410410|10573784|P6|Open-Label Period (OL)|Withdrawal by Subject|0
3081029|NCT00410410|10573785|P5|Open-Label Period (OL)|Withdrawal by Subject|0
3081030|NCT00410410|10573786|P4|Open-Label Period (OL)|Withdrawal by Subject|0
3081031|NCT00410410|10573787|P3|Open-Label Period (OL)|Withdrawal by Subject|0
3081032|NCT00410410|10573788|P2|Open-Label Period (OL)|Withdrawal by Subject|0
3081033|NCT00410410|10573789|P1|Open-Label Period (OL)|Withdrawal by Subject|0
3081034|NCT00410410|10573781|P9|Open-Label Period (OL)|Lost to Follow-up|4
3081035|NCT00410410|10573782|P8|Open-Label Period (OL)|Lost to Follow-up|0
3081036|NCT00410410|10573783|P7|Open-Label Period (OL)|Lost to Follow-up|0
3081037|NCT00410410|10573784|P6|Open-Label Period (OL)|Lost to Follow-up|0
3081038|NCT00410410|10573785|P5|Open-Label Period (OL)|Lost to Follow-up|0
3081039|NCT00410410|10573786|P4|Open-Label Period (OL)|Lost to Follow-up|0
3081040|NCT00410410|10573787|P3|Open-Label Period (OL)|Lost to Follow-up|0
3081041|NCT00410410|10573788|P2|Open-Label Period (OL)|Lost to Follow-up|0
3081042|NCT00410410|10573789|P1|Open-Label Period (OL)|Lost to Follow-up|0
3081043|NCT00410410|10573781|P9|Open-Label Period (OL)|Lack of Efficacy|161
3081044|NCT00410410|10573782|P8|Open-Label Period (OL)|Lack of Efficacy|0
3081045|NCT00410410|10573783|P7|Open-Label Period (OL)|Lack of Efficacy|0
3081046|NCT00410410|10573784|P6|Open-Label Period (OL)|Lack of Efficacy|0
3081047|NCT00410410|10573785|P5|Open-Label Period (OL)|Lack of Efficacy|0
3081048|NCT00410410|10573786|P4|Open-Label Period (OL)|Lack of Efficacy|0
3081049|NCT00410410|10573787|P3|Open-Label Period (OL)|Lack of Efficacy|0
3081050|NCT00410410|10573788|P2|Open-Label Period (OL)|Lack of Efficacy|0
3081051|NCT00410410|10573789|P1|Open-Label Period (OL)|Lack of Efficacy|0
3081052|NCT00410410|10573781|P9|Open-Label Period (OL)|Adverse Event|10
3081053|NCT00410410|10573782|P8|Open-Label Period (OL)|Adverse Event|0
3081054|NCT00410410|10573783|P7|Open-Label Period (OL)|Adverse Event|0
3081055|NCT00410410|10573784|P6|Open-Label Period (OL)|Adverse Event|0
3081056|NCT00410410|10573785|P5|Open-Label Period (OL)|Adverse Event|0
3081057|NCT00410410|10573786|P4|Open-Label Period (OL)|Adverse Event|0
3081058|NCT00410410|10573787|P3|Open-Label Period (OL)|Adverse Event|0
3081059|NCT00410410|10573788|P2|Open-Label Period (OL)|Adverse Event|0
3081060|NCT00410410|10573789|P1|Open-Label Period (OL)|Adverse Event|0
3081061|NCT00410410|10573781|P9|Open-Label Period (OL)|Death|1
3081062|NCT00410410|10573782|P8|Open-Label Period (OL)|Death|0
3081063|NCT00410410|10573783|P7|Open-Label Period (OL)|Death|0
3081064|NCT00410410|10573784|P6|Open-Label Period (OL)|Death|0
3081065|NCT00410410|10573785|P5|Open-Label Period (OL)|Death|0
3081066|NCT00410410|10573786|P4|Open-Label Period (OL)|Death|0
3081067|NCT00410410|10573787|P3|Open-Label Period (OL)|Death|0
3081068|NCT00410410|10573788|P2|Open-Label Period (OL)|Death|0
3081069|NCT00410410|10573789|P1|Open-Label Period (OL)|Death|0
3081070|NCT00410410|10573781|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081071|NCT00410410|10573782|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
3081072|NCT00410410|10573783|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
3081073|NCT00410410|10573784|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081074|NCT00410410|10573785|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081075|NCT00410410|10573786|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081076|NCT00410410|10573787|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081077|NCT00410410|10573788|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081078|NCT00410410|10573789|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
3081079|NCT00410410|10573781|P9|Maintenance Period (MP)|Withdrawal by Subject|0
3081080|NCT00410410|10573782|P8|Maintenance Period (MP)|Withdrawal by Subject|1
3081081|NCT00410410|10573783|P7|Maintenance Period (MP)|Withdrawal by Subject|1
3081082|NCT00410410|10573784|P6|Maintenance Period (MP)|Withdrawal by Subject|0
3081083|NCT00410410|10573785|P5|Maintenance Period (MP)|Withdrawal by Subject|0
3081084|NCT00410410|10573786|P4|Maintenance Period (MP)|Withdrawal by Subject|0
3081085|NCT00410410|10573787|P3|Maintenance Period (MP)|Withdrawal by Subject|0
3081086|NCT00410410|10573788|P2|Maintenance Period (MP)|Withdrawal by Subject|0
3081087|NCT00410410|10573789|P1|Maintenance Period (MP)|Withdrawal by Subject|0
3081088|NCT00410410|10573781|P9|Maintenance Period (MP)|Lost to Follow-up|0
3081089|NCT00410410|10573782|P8|Maintenance Period (MP)|Lost to Follow-up|2
3081090|NCT00410410|10573783|P7|Maintenance Period (MP)|Lost to Follow-up|1
3081091|NCT00410410|10573784|P6|Maintenance Period (MP)|Lost to Follow-up|0
3081092|NCT00410410|10573785|P5|Maintenance Period (MP)|Lost to Follow-up|0
3081093|NCT00410410|10573786|P4|Maintenance Period (MP)|Lost to Follow-up|0
3081094|NCT00410410|10573787|P3|Maintenance Period (MP)|Lost to Follow-up|0
3081095|NCT00410410|10573788|P2|Maintenance Period (MP)|Lost to Follow-up|0
3081096|NCT00410410|10573789|P1|Maintenance Period (MP)|Lost to Follow-up|0
3081097|NCT00410410|10573781|P9|Maintenance Period (MP)|Lack of Efficacy|0
3081098|NCT00410410|10573782|P8|Maintenance Period (MP)|Lack of Efficacy|24
3081099|NCT00410410|10573783|P7|Maintenance Period (MP)|Lack of Efficacy|25
3081100|NCT00410410|10573784|P6|Maintenance Period (MP)|Lack of Efficacy|0
3081101|NCT00410410|10573785|P5|Maintenance Period (MP)|Lack of Efficacy|0
3081102|NCT00410410|10573786|P4|Maintenance Period (MP)|Lack of Efficacy|0
3081103|NCT00410410|10573787|P3|Maintenance Period (MP)|Lack of Efficacy|0
3081104|NCT00410410|10573788|P2|Maintenance Period (MP)|Lack of Efficacy|0
3081105|NCT00410410|10573789|P1|Maintenance Period (MP)|Lack of Efficacy|0
3081106|NCT00410410|10573781|P9|Maintenance Period (MP)|Adverse Event|0
3081107|NCT00410410|10573782|P8|Maintenance Period (MP)|Adverse Event|3
3081108|NCT00410410|10573783|P7|Maintenance Period (MP)|Adverse Event|1
3081109|NCT00410410|10573784|P6|Maintenance Period (MP)|Adverse Event|0
3081110|NCT00410410|10573785|P5|Maintenance Period (MP)|Adverse Event|0
3081111|NCT00410410|10573786|P4|Maintenance Period (MP)|Adverse Event|0
3081112|NCT00410410|10573787|P3|Maintenance Period (MP)|Adverse Event|0
3081113|NCT00410410|10573788|P2|Maintenance Period (MP)|Adverse Event|0
3081114|NCT00410410|10573789|P1|Maintenance Period (MP)|Adverse Event|0
3081115|NCT00410410|10573781|P9|Maintenance Period (MP)|Death|0
3081116|NCT00410410|10573782|P8|Maintenance Period (MP)|Death|0
3081117|NCT00410410|10573783|P7|Maintenance Period (MP)|Death|1
3081118|NCT00410410|10573784|P6|Maintenance Period (MP)|Death|0
3081119|NCT00410410|10573785|P5|Maintenance Period (MP)|Death|0
3081120|NCT00410410|10573786|P4|Maintenance Period (MP)|Death|0
3081121|NCT00410410|10573787|P3|Maintenance Period (MP)|Death|0
3081122|NCT00410410|10573788|P2|Maintenance Period (MP)|Death|0
3081123|NCT00410410|10573789|P1|Maintenance Period (MP)|Death|0
3081124|NCT00410410|10573781|P9|Induction Period (IP)|Other|0
3081125|NCT00410410|10573782|P8|Induction Period (IP)|Other|0
3081126|NCT00410410|10573783|P7|Induction Period (IP)|Other|0
3081127|NCT00410410|10573784|P6|Induction Period (IP)|Other|0
3081128|NCT00410410|10573785|P5|Induction Period (IP)|Other|0
3081129|NCT00410410|10573786|P4|Induction Period (IP)|Other|0
3081130|NCT00410410|10573787|P3|Induction Period (IP)|Other|1
3081131|NCT00410410|10573788|P2|Induction Period (IP)|Other|0
3081132|NCT00410410|10573789|P1|Induction Period (IP)|Other|0
3081133|NCT00410410|10573781|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
3081134|NCT00410410|10573782|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
3081135|NCT00410410|10573783|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
3081136|NCT00410410|10573784|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
3081137|NCT00410410|10573785|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
3081138|NCT00410410|10573786|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
3081139|NCT00410410|10573787|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
3081140|NCT00410410|10573788|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
3081141|NCT00410410|10573789|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
3081142|NCT00410410|10573781|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081143|NCT00410410|10573782|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081144|NCT00410410|10573783|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081145|NCT00410410|10573784|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081146|NCT00410410|10573785|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081147|NCT00410410|10573786|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081148|NCT00410410|10573787|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
3081149|NCT00410410|10573788|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081150|NCT00410410|10573789|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
3081151|NCT00410410|10573781|P9|Induction Period (IP)|Withdrawal by Subject|0
3081152|NCT00410410|10573782|P8|Induction Period (IP)|Withdrawal by Subject|0
3081153|NCT00410410|10573783|P7|Induction Period (IP)|Withdrawal by Subject|0
3081154|NCT00410410|10573784|P6|Induction Period (IP)|Withdrawal by Subject|0
3081155|NCT00410410|10573785|P5|Induction Period (IP)|Withdrawal by Subject|2
3081156|NCT00410410|10573786|P4|Induction Period (IP)|Withdrawal by Subject|5
3081157|NCT00410410|10573787|P3|Induction Period (IP)|Withdrawal by Subject|3
3081158|NCT00410410|10573788|P2|Induction Period (IP)|Withdrawal by Subject|5
3081159|NCT00410410|10573789|P1|Induction Period (IP)|Withdrawal by Subject|3
3081160|NCT00410410|10573781|P9|Induction Period (IP)|Lost to Follow-up|0
3081161|NCT00410410|10573782|P8|Induction Period (IP)|Lost to Follow-up|0
3081162|NCT00410410|10573783|P7|Induction Period (IP)|Lost to Follow-up|0
3081163|NCT00410410|10573784|P6|Induction Period (IP)|Lost to Follow-up|1
3081164|NCT00410410|10573785|P5|Induction Period (IP)|Lost to Follow-up|0
3081165|NCT00410410|10573786|P4|Induction Period (IP)|Lost to Follow-up|3
3081166|NCT00410410|10573787|P3|Induction Period (IP)|Lost to Follow-up|2
3081167|NCT00410410|10573788|P2|Induction Period (IP)|Lost to Follow-up|2
3081168|NCT00410410|10573789|P1|Induction Period (IP)|Lost to Follow-up|2
3081169|NCT00410410|10573781|P9|Induction Period (IP)|Lack of Efficacy|0
3081170|NCT00410410|10573782|P8|Induction Period (IP)|Lack of Efficacy|0
3081171|NCT00410410|10573783|P7|Induction Period (IP)|Lack of Efficacy|0
3081172|NCT00410410|10573784|P6|Induction Period (IP)|Lack of Efficacy|7
3081173|NCT00410410|10573785|P5|Induction Period (IP)|Lack of Efficacy|7
3081174|NCT00410410|10573786|P4|Induction Period (IP)|Lack of Efficacy|8
3081175|NCT00410410|10573787|P3|Induction Period (IP)|Lack of Efficacy|8
3081176|NCT00410410|10573788|P2|Induction Period (IP)|Lack of Efficacy|24
3081177|NCT00410410|10573789|P1|Induction Period (IP)|Lack of Efficacy|26
3081178|NCT00410410|10573781|P9|Induction Period (IP)|Adverse Event|0
3081179|NCT00410410|10573782|P8|Induction Period (IP)|Adverse Event|0
3081180|NCT00410410|10573783|P7|Induction Period (IP)|Adverse Event|0
3081181|NCT00410410|10573784|P6|Induction Period (IP)|Adverse Event|0
3081182|NCT00410410|10573785|P5|Induction Period (IP)|Adverse Event|1
3081183|NCT00410410|10573786|P4|Induction Period (IP)|Adverse Event|4
3081184|NCT00410410|10573787|P3|Induction Period (IP)|Adverse Event|2
3081185|NCT00410410|10573788|P2|Induction Period (IP)|Adverse Event|4
3081186|NCT00410410|10573789|P1|Induction Period (IP)|Adverse Event|3
3081187|NCT00410410|10573781|P9|Induction Period (IP)|Death|0
3081188|NCT00410410|10573782|P8|Induction Period (IP)|Death|0
3081189|NCT00410410|10573783|P7|Induction Period (IP)|Death|0
3081190|NCT00410410|10573784|P6|Induction Period (IP)|Death|0
3081191|NCT00410410|10573785|P5|Induction Period (IP)|Death|0
3081192|NCT00410410|10573786|P4|Induction Period (IP)|Death|0
3081193|NCT00410410|10573787|P3|Induction Period (IP)|Death|0
3081194|NCT00410410|10573788|P2|Induction Period (IP)|Death|0
3081195|NCT00410410|10573789|P1|Induction Period (IP)|Death|1
3081196|NCT00410384|10573950|P3|Overall Study|Other|4
3081197|NCT00410384|10573951|P2|Overall Study|Other|8
3081198|NCT00410384|10573952|P1|Overall Study|Other|3
3081199|NCT00410384|10573950|P3|Overall Study|Physician Decision|4
3081200|NCT00410384|10573951|P2|Overall Study|Physician Decision|3
3081201|NCT00410384|10573952|P1|Overall Study|Physician Decision|3
3081202|NCT00410384|10573950|P3|Overall Study|Protocol Violation|6
3081203|NCT00410384|10573951|P2|Overall Study|Protocol Violation|6
3081204|NCT00410384|10573952|P1|Overall Study|Protocol Violation|6
3081205|NCT00410384|10573950|P3|Overall Study|Lost to Follow-up|6
3081206|NCT00410384|10573951|P2|Overall Study|Lost to Follow-up|6
3081207|NCT00410384|10573952|P1|Overall Study|Lost to Follow-up|4
3081208|NCT00410384|10573950|P3|Overall Study|Lack of Compliance|2
3081209|NCT00410384|10573951|P2|Overall Study|Lack of Compliance|2
3081210|NCT00410384|10573952|P1|Overall Study|Lack of Compliance|2
3081211|NCT00410384|10573950|P3|Overall Study|Lack of Efficacy|17
3081212|NCT00410384|10573951|P2|Overall Study|Lack of Efficacy|12
3081213|NCT00410384|10573952|P1|Overall Study|Lack of Efficacy|20
3081214|NCT00410384|10573950|P3|Overall Study|Adverse Event|23
3081215|NCT00410384|10573951|P2|Overall Study|Adverse Event|18
3081216|NCT00410384|10573952|P1|Overall Study|Adverse Event|23
3081217|NCT00410384|10573950|P3|Overall Study|Withdrawal by Subject|20
3081218|NCT00410384|10573951|P2|Overall Study|Withdrawal by Subject|17
3081219|NCT00410384|10573952|P1|Overall Study|Withdrawal by Subject|28
3081220|NCT00410202|10574025|P3|Off-treatment Follow up|Lost to Follow-up|0
3081221|NCT00410202|10574026|P2|Off-treatment Follow up|Lost to Follow-up|0
3081222|NCT00410202|10574027|P1|Off-treatment Follow up|Lost to Follow-up|1
3081223|NCT00410202|10574025|P3|Off-treatment Follow up|Follow up not required per protocol|1
3081224|NCT00410202|10574026|P2|Off-treatment Follow up|Follow up not required per protocol|0
3081225|NCT00410202|10574027|P1|Off-treatment Follow up|Follow up not required per protocol|3
3081226|NCT00410202|10574025|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
3081227|NCT00410202|10574026|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
3081228|NCT00410202|10574027|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
3081229|NCT00410202|10574025|P3|On-Treatment|Other Reason|1
3081230|NCT00410202|10574026|P2|On-Treatment|Other Reason|0
3081231|NCT00410202|10574027|P1|On-Treatment|Other Reason|0
3081232|NCT00410202|10574025|P3|On-Treatment|Withdrawal by Subject|1
3081233|NCT00410202|10574026|P2|On-Treatment|Withdrawal by Subject|1
3081234|NCT00410202|10574027|P1|On-Treatment|Withdrawal by Subject|2
3081235|NCT00410202|10574025|P3|On-Treatment|Lack of Efficacy|0
3081236|NCT00410202|10574026|P2|On-Treatment|Lack of Efficacy|4
3081237|NCT00410202|10574027|P1|On-Treatment|Lack of Efficacy|1
3081238|NCT00410202|10574025|P3|On-Treatment|Lost to Follow-up|1
3081239|NCT00410202|10574026|P2|On-Treatment|Lost to Follow-up|0
3081240|NCT00410202|10574027|P1|On-Treatment|Lost to Follow-up|1
3081241|NCT00410202|10574025|P3|On-Treatment|Death|0
3081242|NCT00410202|10574026|P2|On-Treatment|Death|0
3081243|NCT00410202|10574027|P1|On-Treatment|Death|1
3081244|NCT00410202|10574025|P3|On-Treatment|Adverse Event|2
3081245|NCT00410202|10574026|P2|On-Treatment|Adverse Event|3
3081246|NCT00410202|10574027|P1|On-Treatment|Adverse Event|1
3081247|NCT00410202|10574025|P3|On-Treatment|Continuing treatment|66
3081248|NCT00410202|10574026|P2|On-Treatment|Continuing treatment|71
3081249|NCT00410202|10574027|P1|On-Treatment|Continuing treatment|69
3081250|NCT00410163|10574114|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
3081251|NCT00410163|10574115|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
3081252|NCT00410163|10574114|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
3081253|NCT00410163|10574115|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
3081254|NCT00410163|10574114|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
3081255|NCT00410163|10574115|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
3081256|NCT00410163|10574114|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
3081257|NCT00410163|10574115|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
3081258|NCT00410163|10574114|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
3081259|NCT00410163|10574115|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
3081260|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
3081261|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
3081262|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
3081263|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
3081264|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
3081265|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
3081266|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
3081267|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
3081268|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
3081269|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
3081270|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
3081271|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
3081272|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
3081273|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
3081274|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Death|1
3081275|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Death|1
3081276|NCT00410163|10574114|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
3081277|NCT00410163|10574115|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
3081278|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
3081279|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
3081280|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
3081281|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
3081282|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
3081283|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
3081284|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Death|10
3081285|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Death|2
3081286|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
3081287|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
3081288|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
3081289|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
3081290|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
3081291|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
3081292|NCT00410124|10574168|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
3081293|NCT00410124|10574169|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
3081294|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
3081295|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
3081296|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Death|4
3081297|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Death|7
3081298|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
3081299|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
3081300|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
3081301|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
3081302|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
3081303|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
3081304|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
3081305|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
3081306|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
3081307|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
3081308|NCT00410124|10574168|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
3081309|NCT00410124|10574169|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
3081310|NCT00410072|10574200|P2|After Week 48 to Week 96|Withdrawal by Subject|1
3081311|NCT00410072|10574201|P1|After Week 48 to Week 96|Withdrawal by Subject|0
3081312|NCT00410072|10574200|P2|After Week 48 to Week 96|Pregnancy|2
3081313|NCT00410072|10574201|P1|After Week 48 to Week 96|Pregnancy|0
3081314|NCT00410072|10574200|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
3081315|NCT00410072|10574201|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
3081316|NCT00410072|10574200|P2|After Week 48 to Week 96|Other|0
3081317|NCT00410072|10574201|P1|After Week 48 to Week 96|Other|2
3081318|NCT00410072|10574200|P2|After Week 48 to Week 96|Lost to Follow-up|4
3081319|NCT00410072|10574201|P1|After Week 48 to Week 96|Lost to Follow-up|2
3081320|NCT00410072|10574200|P2|After Week 48 to Week 96|Lack of Efficacy|0
3081321|NCT00410072|10574201|P1|After Week 48 to Week 96|Lack of Efficacy|1
3081322|NCT00410072|10574200|P2|After Week 48 to Week 96|Death|1
3081323|NCT00410072|10574201|P1|After Week 48 to Week 96|Death|0
3081324|NCT00410072|10574200|P2|After Week 48 to Week 96|Adverse Event|2
3081325|NCT00410072|10574201|P1|After Week 48 to Week 96|Adverse Event|1
3081326|NCT00410072|10574200|P2|Day 1 to Week 48|Withdrawal by Subject|2
3081327|NCT00410072|10574201|P1|Day 1 to Week 48|Withdrawal by Subject|0
3081328|NCT00410072|10574200|P2|Day 1 to Week 48|Pregnancy|2
3081329|NCT00410072|10574201|P1|Day 1 to Week 48|Pregnancy|0
3081330|NCT00410072|10574200|P2|Day 1 to Week 48|poor compliance/noncompliance|3
3081331|NCT00410072|10574201|P1|Day 1 to Week 48|poor compliance/noncompliance|0
3081332|NCT00410072|10574200|P2|Day 1 to Week 48|Other|1
3081333|NCT00410072|10574201|P1|Day 1 to Week 48|Other|0
3081334|NCT00410072|10574200|P2|Day 1 to Week 48|Lost to Follow-up|2
3081335|NCT00410072|10574201|P1|Day 1 to Week 48|Lost to Follow-up|5
3081336|NCT00410072|10574200|P2|Day 1 to Week 48|Adverse Event|2
3081337|NCT00410072|10574201|P1|Day 1 to Week 48|Adverse Event|1
3081338|NCT00410046|10574241|P1|Overall Study|Lost to Follow-up|1
3081339|NCT00410046|10574241|P1|Overall Study|Withdrawal by Subject|1
3081340|NCT00410046|10574241|P1|Overall Study|Adverse Event|3
3081341|NCT00409838|10574272|P2|Long-term Extension Period|Pregnancy|0
3081342|NCT00409838|10574273|P1|Long-term Extension Period|Pregnancy|1
3081343|NCT00409838|10574272|P2|Long-term Extension Period|Poor compliance/noncompliance|0
3081344|NCT00409838|10574273|P1|Long-term Extension Period|Poor compliance/noncompliance|1
3081345|NCT00409838|10574272|P2|Long-term Extension Period|Withdrawal by Subject|0
3081346|NCT00409838|10574273|P1|Long-term Extension Period|Withdrawal by Subject|3
3081347|NCT00409838|10574272|P2|Long-term Extension Period|Lack of Efficacy|0
3081348|NCT00409838|10574273|P1|Long-term Extension Period|Lack of Efficacy|2
3081349|NCT00409838|10574272|P2|Long-term Extension Period|Death|0
3081350|NCT00409838|10574273|P1|Long-term Extension Period|Death|1
3081351|NCT00409838|10574272|P2|Long-term Extension Period|Adverse Event|0
3081352|NCT00409838|10574273|P1|Long-term Extension Period|Adverse Event|10
3081353|NCT00409838|10574272|P2|Short-term Period|Never Treated|0
3081354|NCT00409838|10574273|P1|Short-term Period|Never Treated|1
3081355|NCT00409838|10574272|P2|Short-term Period|Withdrawal by Subject|3
3081356|NCT00409838|10574273|P1|Short-term Period|Withdrawal by Subject|2
3081357|NCT00409838|10574272|P2|Short-term Period|Lost to Follow-up|1
3081358|NCT00409838|10574273|P1|Short-term Period|Lost to Follow-up|0
3081359|NCT00409838|10574272|P2|Short-term Period|Adverse Event|1
3081360|NCT00409838|10574273|P1|Short-term Period|Adverse Event|0
3081361|NCT00409786|10574338|P1|Overall Study|Withdrawal by Subject|3
3081362|NCT00409773|10574347|P5|Overall Study|Lack of Eligibility|1
3081363|NCT00409773|10574348|P4|Overall Study|Lack of Eligibility|0
3081364|NCT00409773|10574349|P3|Overall Study|Lack of Eligibility|0
3081365|NCT00409773|10574350|P2|Overall Study|Lack of Eligibility|0
3081366|NCT00409773|10574351|P1|Overall Study|Lack of Eligibility|0
3081367|NCT00409773|10574347|P5|Overall Study|Withdrawal by Subject|1
3081368|NCT00409773|10574348|P4|Overall Study|Withdrawal by Subject|2
3081369|NCT00409773|10574349|P3|Overall Study|Withdrawal by Subject|0
3081370|NCT00409773|10574350|P2|Overall Study|Withdrawal by Subject|0
3081371|NCT00409773|10574351|P1|Overall Study|Withdrawal by Subject|0
3081372|NCT00409773|10574347|P5|Overall Study|Protocol Violation|1
3081373|NCT00409773|10574348|P4|Overall Study|Protocol Violation|3
3081374|NCT00409773|10574349|P3|Overall Study|Protocol Violation|3
3081375|NCT00409773|10574350|P2|Overall Study|Protocol Violation|2
3081376|NCT00409773|10574351|P1|Overall Study|Protocol Violation|0
3081377|NCT00409773|10574347|P5|Overall Study|Physician Decision|0
3081378|NCT00409773|10574348|P4|Overall Study|Physician Decision|2
3081379|NCT00409773|10574349|P3|Overall Study|Physician Decision|0
3081380|NCT00409773|10574350|P2|Overall Study|Physician Decision|0
3081381|NCT00409773|10574351|P1|Overall Study|Physician Decision|0
3081382|NCT00409773|10574347|P5|Overall Study|Lost to Follow-up|1
3081383|NCT00409773|10574348|P4|Overall Study|Lost to Follow-up|3
3081384|NCT00409773|10574349|P3|Overall Study|Lost to Follow-up|2
3081385|NCT00409773|10574350|P2|Overall Study|Lost to Follow-up|1
3081386|NCT00409773|10574351|P1|Overall Study|Lost to Follow-up|6
3081387|NCT00409773|10574347|P5|Overall Study|Adverse Event|6
3081388|NCT00409773|10574348|P4|Overall Study|Adverse Event|2
3081389|NCT00409773|10574349|P3|Overall Study|Adverse Event|4
3081390|NCT00409773|10574350|P2|Overall Study|Adverse Event|4
3081391|NCT00409773|10574351|P1|Overall Study|Adverse Event|3
3081392|NCT00409747|10574433|P1|Overall Study|Withdrawal by Subject|1
3081393|NCT00409708|10574440|P2|Washout|Lost to Follow-up|3
3081394|NCT00409708|10574441|P1|Washout|Lost to Follow-up|1
3081395|NCT00409708|10574440|P2|Washout|Withdrawal by Subject|5
3081396|NCT00409708|10574441|P1|Washout|Withdrawal by Subject|11
3081397|NCT00409708|10574440|P2|Washout|Protocol Violation|1
3081398|NCT00409708|10574441|P1|Washout|Protocol Violation|0
3081399|NCT00409708|10574440|P2|Washout|Lack of Efficacy|1
3081400|NCT00409708|10574441|P1|Washout|Lack of Efficacy|9
3081401|NCT00409708|10574440|P2|Treatment|Administrative problems|0
3081402|NCT00409708|10574441|P1|Treatment|Administrative problems|5
3081403|NCT00409708|10574440|P2|Treatment|Lost to Follow-up|6
3081404|NCT00409708|10574441|P1|Treatment|Lost to Follow-up|0
3081405|NCT00409708|10574440|P2|Treatment|Withdrawal by Subject|8
3081406|NCT00409708|10574441|P1|Treatment|Withdrawal by Subject|3
3081407|NCT00409708|10574440|P2|Treatment|Protocol Violation|2
3081408|NCT00409708|10574441|P1|Treatment|Protocol Violation|6
3081409|NCT00409708|10574440|P2|Treatment|Lack of Efficacy|1
3081410|NCT00409708|10574441|P1|Treatment|Lack of Efficacy|0
3081411|NCT00409708|10574440|P2|Treatment|Abnormal test procedure result(s)|0
3081412|NCT00409708|10574441|P1|Treatment|Abnormal test procedure result(s)|1
3081413|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Non-compliance|1
3081414|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Non-compliance|0
3081415|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Non-compliance|0
3081416|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
3081417|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
3081418|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
3081419|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
3081420|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
3081421|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
3081422|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
3081423|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
3081424|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
3081425|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
3081426|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
3081427|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
3081428|NCT00409682|10574462|P3|EOW Double-blind Maintenance Period|Adverse Event|12
3081429|NCT00409682|10574463|P2|EOW Double-blind Maintenance Period|Adverse Event|10
3081430|NCT00409682|10574464|P1|EOW Double-blind Maintenance Period|Adverse Event|0
3081431|NCT00409682|10574462|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
3081432|NCT00409682|10574463|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
3081433|NCT00409682|10574464|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
3081434|NCT00409682|10574462|P3|Open-label Induction Period|Protocol Violation|0
3081435|NCT00409682|10574463|P2|Open-label Induction Period|Protocol Violation|0
3081436|NCT00409682|10574464|P1|Open-label Induction Period|Protocol Violation|1
3081437|NCT00409682|10574462|P3|Open-label Induction Period|Lack of Efficacy|0
3081438|NCT00409682|10574463|P2|Open-label Induction Period|Lack of Efficacy|0
3081439|NCT00409682|10574464|P1|Open-label Induction Period|Lack of Efficacy|1
3081440|NCT00409682|10574462|P3|Open-label Induction Period|Adverse Event|0
3081441|NCT00409682|10574463|P2|Open-label Induction Period|Adverse Event|0
3081442|NCT00409682|10574464|P1|Open-label Induction Period|Adverse Event|1
3081443|NCT00409617|10574481|P1|Overall Study|Not described|14
3081444|NCT00409617|10574481|P1|Overall Study|Administrative reasons|1
3081445|NCT00409617|10574481|P1|Overall Study|Withdrawal by Subject|8
3081446|NCT00409617|10574481|P1|Overall Study|Protocol Violation|24
3081447|NCT00409617|10574481|P1|Overall Study|Lost to Follow-up|2
3081448|NCT00409617|10574481|P1|Overall Study|Lack of Efficacy|54
3081449|NCT00409617|10574481|P1|Overall Study|Adverse Event|57
3081450|NCT00409578|10574497|P4|Overall Study|Missing|1
3081451|NCT00409578|10574498|P3|Overall Study|Missing|0
3081452|NCT00409578|10574499|P2|Overall Study|Missing|1
3081453|NCT00409578|10574500|P1|Overall Study|Missing|0
3081454|NCT00409578|10574497|P4|Overall Study|Protocol Violation|1
3081455|NCT00409578|10574498|P3|Overall Study|Protocol Violation|3
3081456|NCT00409578|10574499|P2|Overall Study|Protocol Violation|2
3081457|NCT00409578|10574500|P1|Overall Study|Protocol Violation|3
3081458|NCT00409578|10574497|P4|Overall Study|Death|2
3081459|NCT00409578|10574498|P3|Overall Study|Death|4
3081460|NCT00409578|10574499|P2|Overall Study|Death|4
3081461|NCT00409578|10574500|P1|Overall Study|Death|2
3081462|NCT00409578|10574497|P4|Overall Study|Administrative problems|4
3081463|NCT00409578|10574498|P3|Overall Study|Administrative problems|2
3081464|NCT00409578|10574499|P2|Overall Study|Administrative problems|9
3081465|NCT00409578|10574500|P1|Overall Study|Administrative problems|8
3081466|NCT00409578|10574497|P4|Overall Study|Lost to Follow-up|2
3081467|NCT00409578|10574498|P3|Overall Study|Lost to Follow-up|2
3081468|NCT00409578|10574499|P2|Overall Study|Lost to Follow-up|0
3081469|NCT00409578|10574500|P1|Overall Study|Lost to Follow-up|2
3081470|NCT00409578|10574497|P4|Overall Study|Withdrawal by Subject|17
3081471|NCT00409578|10574498|P3|Overall Study|Withdrawal by Subject|16
3081472|NCT00409578|10574499|P2|Overall Study|Withdrawal by Subject|15
3081473|NCT00409578|10574500|P1|Overall Study|Withdrawal by Subject|8
3081474|NCT00409578|10574497|P4|Overall Study|Subject no longer requires study drug|1
3081475|NCT00409578|10574498|P3|Overall Study|Subject no longer requires study drug|0
3081476|NCT00409578|10574499|P2|Overall Study|Subject no longer requires study drug|0
3081477|NCT00409578|10574500|P1|Overall Study|Subject no longer requires study drug|0
3081478|NCT00409578|10574497|P4|Overall Study|Lack of Efficacy|2
3081479|NCT00409578|10574498|P3|Overall Study|Lack of Efficacy|0
3081480|NCT00409578|10574499|P2|Overall Study|Lack of Efficacy|0
3081481|NCT00409578|10574500|P1|Overall Study|Lack of Efficacy|0
3081482|NCT00409578|10574497|P4|Overall Study|Abnormal laboratory value(s)|4
3081483|NCT00409578|10574498|P3|Overall Study|Abnormal laboratory value(s)|2
3081484|NCT00409578|10574499|P2|Overall Study|Abnormal laboratory value(s)|2
3081485|NCT00409578|10574500|P1|Overall Study|Abnormal laboratory value(s)|2
3081486|NCT00409578|10574497|P4|Overall Study|Adverse Event|33
3081487|NCT00409578|10574498|P3|Overall Study|Adverse Event|25
3081488|NCT00409578|10574499|P2|Overall Study|Adverse Event|37
3081489|NCT00409578|10574500|P1|Overall Study|Adverse Event|27
3081490|NCT00409409|10574558|P2|Overall Study|Any other reason not above-mentioned|1
3081491|NCT00409409|10574559|P1|Overall Study|Any other reason not above-mentioned|0
3081492|NCT00409409|10574558|P2|Overall Study|Withdrawal by Subject|1
3081493|NCT00409409|10574559|P1|Overall Study|Withdrawal by Subject|1
3081494|NCT00409409|10574558|P2|Overall Study|Adverse Event|2
3081495|NCT00409409|10574559|P1|Overall Study|Adverse Event|7
3081496|NCT00409344|10574567|P2|Overall Study|no enrollment|0
3081497|NCT00409344|10574568|P1|Overall Study|no enrollment|0
3081498|NCT00409331|10574586|P1|Overall Study|Physician Decision|1
3081499|NCT00409188|10574608|P2|Overall Study|Ongoing at data cut-off|175
3081500|NCT00409188|10574609|P1|Overall Study|Ongoing at data cut-off|383
3081501|NCT00409175|10574625|P2|Overall Study|Liver transplantation|13
3081502|NCT00409175|10574626|P1|Overall Study|Liver transplantation|13
3081503|NCT00409175|10574625|P2|Overall Study|Negative genotype|1
3081504|NCT00409175|10574626|P1|Overall Study|Negative genotype|0
3081505|NCT00409175|10574625|P2|Overall Study|Withdrawal by Subject|2
3081506|NCT00409175|10574626|P1|Overall Study|Withdrawal by Subject|1
3081507|NCT00409175|10574625|P2|Overall Study|Adverse Event|3
3081508|NCT00409175|10574626|P1|Overall Study|Adverse Event|4
3081509|NCT00409006|10574652|P2|Overall Study|Physician Decision|2
3081510|NCT00409006|10574653|P1|Overall Study|Physician Decision|1
3081511|NCT00409006|10574652|P2|Overall Study|Withdrawal by Subject|2
3081512|NCT00409006|10574653|P1|Overall Study|Withdrawal by Subject|3
3081513|NCT00409006|10574652|P2|Overall Study|Lost to Follow-up|2
3081514|NCT00409006|10574653|P1|Overall Study|Lost to Follow-up|1
3081515|NCT00409006|10574652|P2|Overall Study|Death|6
3081516|NCT00409006|10574653|P1|Overall Study|Death|15
3081517|NCT00408993|10574669|P2|Overall Study|Withdrawal by Subject|3
3081518|NCT00408993|10574670|P1|Overall Study|Withdrawal by Subject|2
3081519|NCT00408993|10574669|P2|Overall Study|Lack of Efficacy|4
3081520|NCT00408993|10574670|P1|Overall Study|Lack of Efficacy|1
3081521|NCT00408993|10574669|P2|Overall Study|Protocol Violation|6
3081522|NCT00408993|10574670|P1|Overall Study|Protocol Violation|1
3081523|NCT00408993|10574669|P2|Overall Study|Adverse Event|4
3081524|NCT00408993|10574670|P1|Overall Study|Adverse Event|15
3081525|NCT00408928|10574702|P1|Overall Study|Infection indistinguishable from GVHD|1
3081526|NCT00408928|10574702|P1|Overall Study|Death|1
3081527|NCT00408928|10574702|P1|Overall Study|Withdrawal by Subject|1
3081528|NCT00408902|10574707|P1|Overall Study|Adverse Event|3
3081529|NCT00408902|10574707|P1|Overall Study|Lack of Efficacy|7
3081530|NCT00408876|10574717|P4|Overall Study|Physician Decision|0
3081531|NCT00408876|10574718|P3|Overall Study|Physician Decision|3
3081532|NCT00408876|10574719|P2|Overall Study|Physician Decision|0
3081533|NCT00408876|10574720|P1|Overall Study|Physician Decision|1
3081534|NCT00408876|10574717|P4|Overall Study|Protocol Violation|3
3081535|NCT00408876|10574718|P3|Overall Study|Protocol Violation|4
3081536|NCT00408876|10574719|P2|Overall Study|Protocol Violation|3
3081537|NCT00408876|10574720|P1|Overall Study|Protocol Violation|0
3081538|NCT00408876|10574717|P4|Overall Study|Lost to Follow-up|2
3081539|NCT00408876|10574718|P3|Overall Study|Lost to Follow-up|5
3081540|NCT00408876|10574719|P2|Overall Study|Lost to Follow-up|6
3081541|NCT00408876|10574720|P1|Overall Study|Lost to Follow-up|1
3081542|NCT00408876|10574717|P4|Overall Study|Lack of Efficacy|6
3081543|NCT00408876|10574718|P3|Overall Study|Lack of Efficacy|5
3081544|NCT00408876|10574719|P2|Overall Study|Lack of Efficacy|4
3081545|NCT00408876|10574720|P1|Overall Study|Lack of Efficacy|2
3081546|NCT00408876|10574717|P4|Overall Study|Withdrawal by Subject|14
3081547|NCT00408876|10574718|P3|Overall Study|Withdrawal by Subject|6
3081548|NCT00408876|10574719|P2|Overall Study|Withdrawal by Subject|6
3081549|NCT00408876|10574720|P1|Overall Study|Withdrawal by Subject|3
3081550|NCT00408876|10574717|P4|Overall Study|Adverse Event|10
3081551|NCT00408876|10574718|P3|Overall Study|Adverse Event|27
3081552|NCT00408876|10574719|P2|Overall Study|Adverse Event|17
3081553|NCT00408876|10574720|P1|Overall Study|Adverse Event|9
3081554|NCT00408694|10574970|P1|Overall Study|No protocol treatment|1
3081555|NCT00408694|10574970|P1|Overall Study|Ineligible|1
3081556|NCT00408681|10574982|P1|Overall Study|Adverse Event|7
3081557|NCT00408681|10574982|P1|Overall Study|Lack of Efficacy|2
3081558|NCT00408629|10575001|P2|Overall Study|Miscellaneous|15
3081559|NCT00408629|10575002|P1|Overall Study|Miscellaneous|11
3081560|NCT00408629|10575001|P2|Overall Study|Protocol Violation|5
3081561|NCT00408629|10575002|P1|Overall Study|Protocol Violation|1
3081562|NCT00408629|10575001|P2|Overall Study|Lack of Efficacy|73
3081563|NCT00408629|10575002|P1|Overall Study|Lack of Efficacy|63
3081564|NCT00408629|10575001|P2|Overall Study|Lost to Follow-up|1
3081565|NCT00408629|10575002|P1|Overall Study|Lost to Follow-up|1
3081566|NCT00408629|10575001|P2|Overall Study|Withdrawal by Subject|4
3081567|NCT00408629|10575002|P1|Overall Study|Withdrawal by Subject|8
3081568|NCT00408629|10575001|P2|Overall Study|Adverse Event|27
3081569|NCT00408629|10575002|P1|Overall Study|Adverse Event|13
3081570|NCT00408499|10575098|P5|Phase II- MTD Expansion|treatment delay|3
3081571|NCT00408499|10575099|P4|Phase II- MTD Expansion|treatment delay|0
3081572|NCT00408499|10575100|P3|Phase II- MTD Expansion|treatment delay|0
3081573|NCT00408499|10575101|P2|Phase II- MTD Expansion|treatment delay|0
3081574|NCT00408499|10575102|P1|Phase II- MTD Expansion|treatment delay|0
3081575|NCT00408499|10575098|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
3081576|NCT00408499|10575099|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
3081577|NCT00408499|10575100|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
3081578|NCT00408499|10575101|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
3081579|NCT00408499|10575102|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
3081580|NCT00408499|10575098|P5|Phase II- MTD Expansion|Physician Decision|1
3081581|NCT00408499|10575099|P4|Phase II- MTD Expansion|Physician Decision|0
3081582|NCT00408499|10575100|P3|Phase II- MTD Expansion|Physician Decision|0
3081583|NCT00408499|10575101|P2|Phase II- MTD Expansion|Physician Decision|0
3081584|NCT00408499|10575102|P1|Phase II- MTD Expansion|Physician Decision|0
3081585|NCT00408499|10575098|P5|Phase II- MTD Expansion|Death|2
3081586|NCT00408499|10575099|P4|Phase II- MTD Expansion|Death|0
3081587|NCT00408499|10575100|P3|Phase II- MTD Expansion|Death|0
3081588|NCT00408499|10575101|P2|Phase II- MTD Expansion|Death|0
3081589|NCT00408499|10575102|P1|Phase II- MTD Expansion|Death|0
3081590|NCT00408499|10575098|P5|Phase II- MTD Expansion|Adverse Event|9
3081591|NCT00408499|10575099|P4|Phase II- MTD Expansion|Adverse Event|0
3081592|NCT00408499|10575100|P3|Phase II- MTD Expansion|Adverse Event|0
3081593|NCT00408499|10575101|P2|Phase II- MTD Expansion|Adverse Event|0
3081594|NCT00408499|10575102|P1|Phase II- MTD Expansion|Adverse Event|0
3081595|NCT00408499|10575098|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
3081596|NCT00408499|10575099|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
3081597|NCT00408499|10575100|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
3081598|NCT00408499|10575101|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
3081599|NCT00408499|10575102|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
3081600|NCT00408499|10575098|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
3081601|NCT00408499|10575099|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
3081602|NCT00408499|10575100|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
3081603|NCT00408499|10575101|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
3081604|NCT00408499|10575102|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
3081605|NCT00408499|10575098|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
3081606|NCT00408499|10575099|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
3081607|NCT00408499|10575100|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
3081608|NCT00408499|10575101|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
3081609|NCT00408499|10575102|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
3081610|NCT00408421|10575119|P3|Treatment Re-Randomization|Withdrawal by Subject|0
3081611|NCT00408421|10575120|P2|Treatment Re-Randomization|Withdrawal by Subject|1
3081612|NCT00408421|10575121|P1|Treatment Re-Randomization|Withdrawal by Subject|2
3081613|NCT00408421|10575119|P3|Treatment Re-Randomization|Protocol Violation|0
3081614|NCT00408421|10575120|P2|Treatment Re-Randomization|Protocol Violation|1
3081615|NCT00408421|10575121|P1|Treatment Re-Randomization|Protocol Violation|1
3081616|NCT00408421|10575119|P3|Treatment Re-Randomization|Physician Decision|0
3081617|NCT00408421|10575120|P2|Treatment Re-Randomization|Physician Decision|3
3081618|NCT00408421|10575121|P1|Treatment Re-Randomization|Physician Decision|1
3081619|NCT00408421|10575119|P3|Treatment Re-Randomization|Lost to Follow-up|1
3081620|NCT00408421|10575120|P2|Treatment Re-Randomization|Lost to Follow-up|0
3081621|NCT00408421|10575121|P1|Treatment Re-Randomization|Lost to Follow-up|0
3081622|NCT00408421|10575119|P3|Treatment Re-Randomization|Lack of Efficacy|0
3081623|NCT00408421|10575120|P2|Treatment Re-Randomization|Lack of Efficacy|0
3081624|NCT00408421|10575121|P1|Treatment Re-Randomization|Lack of Efficacy|1
3081625|NCT00408421|10575119|P3|Treatment Re-Randomization|Adverse Event|4
3081626|NCT00408421|10575120|P2|Treatment Re-Randomization|Adverse Event|2
3081627|NCT00408421|10575121|P1|Treatment Re-Randomization|Adverse Event|2
3081628|NCT00408421|10575119|P3|Treatment Initial Randomization|Sponsor Decision|0
3081629|NCT00408421|10575120|P2|Treatment Initial Randomization|Sponsor Decision|0
3081630|NCT00408421|10575121|P1|Treatment Initial Randomization|Sponsor Decision|1
3081631|NCT00408421|10575119|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
3081632|NCT00408421|10575120|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
3081633|NCT00408421|10575121|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
3081634|NCT00408421|10575119|P3|Treatment Initial Randomization|Withdrawal by Subject|0
3081635|NCT00408421|10575120|P2|Treatment Initial Randomization|Withdrawal by Subject|7
3081636|NCT00408421|10575121|P1|Treatment Initial Randomization|Withdrawal by Subject|7
3081637|NCT00408421|10575119|P3|Treatment Initial Randomization|Protocol Violation|0
3081638|NCT00408421|10575120|P2|Treatment Initial Randomization|Protocol Violation|1
3081639|NCT00408421|10575121|P1|Treatment Initial Randomization|Protocol Violation|0
3081640|NCT00408421|10575119|P3|Treatment Initial Randomization|Physician Decision|0
3081641|NCT00408421|10575120|P2|Treatment Initial Randomization|Physician Decision|0
3081642|NCT00408421|10575121|P1|Treatment Initial Randomization|Physician Decision|1
3081643|NCT00408421|10575119|P3|Treatment Initial Randomization|Lost to Follow-up|0
3081644|NCT00408421|10575120|P2|Treatment Initial Randomization|Lost to Follow-up|3
3081645|NCT00408421|10575121|P1|Treatment Initial Randomization|Lost to Follow-up|0
3081646|NCT00408421|10575119|P3|Treatment Initial Randomization|Lack of Efficacy|0
3081647|NCT00408421|10575120|P2|Treatment Initial Randomization|Lack of Efficacy|2
3081648|NCT00408421|10575121|P1|Treatment Initial Randomization|Lack of Efficacy|2
3081649|NCT00408421|10575119|P3|Treatment Initial Randomization|Adverse Event|0
3081650|NCT00408421|10575120|P2|Treatment Initial Randomization|Adverse Event|9
3081651|NCT00408421|10575121|P1|Treatment Initial Randomization|Adverse Event|5
3081652|NCT00408408|10575201|P6|Overall Study|No follow up data|3
3081653|NCT00408408|10575202|P5|Overall Study|No follow up data|5
3081654|NCT00408408|10575203|P4|Overall Study|No follow up data|7
3081655|NCT00408408|10575204|P3|Overall Study|No follow up data|0
3081656|NCT00408408|10575205|P2|Overall Study|No follow up data|3
3081657|NCT00408408|10575206|P1|Overall Study|No follow up data|2
3081658|NCT00408317|10575268|P2|Second Intervention Period|Withdrawal of consent|1
3081659|NCT00408317|10575269|P1|Second Intervention Period|Withdrawal of consent|0
3081660|NCT00408317|10575268|P2|Second Intervention Period|Protocol Violation|1
3081661|NCT00408317|10575269|P1|Second Intervention Period|Protocol Violation|0
3081662|NCT00408317|10575268|P2|Second Intervention Period|Adverse Event|0
3081663|NCT00408317|10575269|P1|Second Intervention Period|Adverse Event|2
3081664|NCT00408317|10575268|P2|First Intervention Period|Adverse Event|1
3081665|NCT00408317|10575269|P1|First Intervention Period|Adverse Event|0
3081666|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
3081667|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
3081668|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
3081669|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
3081670|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
3081671|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
3081672|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
3081673|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
3081674|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
3081675|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
3081676|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
3081677|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
3081678|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
3081679|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
3081680|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
3081681|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
3081682|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081683|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081684|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
3081685|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
3081686|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081687|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081688|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081689|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
3081690|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
3081691|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
3081692|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
3081693|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
3081694|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
3081695|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
3081696|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
3081697|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
3081698|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081699|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081700|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
3081701|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081702|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081703|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081704|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081705|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
3081706|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
3081707|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
3081708|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
3081709|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
3081710|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
3081711|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
3081712|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
3081713|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
3081714|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
3081715|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
3081716|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
3081717|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
3081718|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
3081719|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
3081720|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
3081721|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
3081722|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081723|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081724|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081725|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
3081726|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081727|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081728|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081729|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
3081730|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
3081731|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
3081732|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
3081733|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
3081734|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
3081735|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
3081736|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
3081737|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
3081738|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
3081739|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
3081740|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
3081741|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
3081742|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
3081743|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
3081744|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
3081745|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
3081746|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
3081747|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
3081748|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
3081749|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
3081750|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
3081751|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
3081752|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
3081753|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
3081754|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081755|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081756|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081757|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
3081758|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081759|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
3081760|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081761|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
3081762|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Death|1
3081763|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Death|3
3081764|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Death|5
3081765|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Death|5
3081766|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Death|0
3081767|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Death|3
3081768|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Death|0
3081769|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Death|0
3081770|NCT00408005|10575302|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
3081771|NCT00408005|10575303|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
3081772|NCT00408005|10575304|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
3081773|NCT00408005|10575305|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
3081774|NCT00408005|10575306|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
3081775|NCT00408005|10575307|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
3081776|NCT00408005|10575308|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
3081777|NCT00408005|10575309|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
3081778|NCT00408005|10575302|P8|Induction|Recurrent leukemia|0
3081779|NCT00408005|10575303|P7|Induction|Recurrent leukemia|0
3081780|NCT00408005|10575304|P6|Induction|Recurrent leukemia|0
3081781|NCT00408005|10575305|P5|Induction|Recurrent leukemia|0
3081782|NCT00408005|10575306|P4|Induction|Recurrent leukemia|0
3081783|NCT00408005|10575307|P3|Induction|Recurrent leukemia|0
3081784|NCT00408005|10575308|P2|Induction|Recurrent leukemia|0
3081785|NCT00408005|10575309|P1|Induction|Recurrent leukemia|1
3081786|NCT00408005|10575302|P8|Induction|Hematopoietic Stem Cell Transplantation|0
3081787|NCT00408005|10575303|P7|Induction|Hematopoietic Stem Cell Transplantation|0
3081788|NCT00408005|10575304|P6|Induction|Hematopoietic Stem Cell Transplantation|0
3081789|NCT00408005|10575305|P5|Induction|Hematopoietic Stem Cell Transplantation|0
3081790|NCT00408005|10575306|P4|Induction|Hematopoietic Stem Cell Transplantation|0
3081791|NCT00408005|10575307|P3|Induction|Hematopoietic Stem Cell Transplantation|0
3081792|NCT00408005|10575308|P2|Induction|Hematopoietic Stem Cell Transplantation|0
3081793|NCT00408005|10575309|P1|Induction|Hematopoietic Stem Cell Transplantation|1
3081794|NCT00408005|10575302|P8|Induction|Protocol Deviation|0
3081795|NCT00408005|10575303|P7|Induction|Protocol Deviation|0
3081796|NCT00408005|10575304|P6|Induction|Protocol Deviation|0
3081797|NCT00408005|10575305|P5|Induction|Protocol Deviation|0
3081798|NCT00408005|10575306|P4|Induction|Protocol Deviation|0
3081799|NCT00408005|10575307|P3|Induction|Protocol Deviation|0
3081800|NCT00408005|10575308|P2|Induction|Protocol Deviation|1
3081801|NCT00408005|10575309|P1|Induction|Protocol Deviation|3
3081802|NCT00408005|10575302|P8|Induction|Failed to Complete Randomization|0
3081803|NCT00408005|10575303|P7|Induction|Failed to Complete Randomization|0
3081804|NCT00408005|10575304|P6|Induction|Failed to Complete Randomization|0
3081805|NCT00408005|10575305|P5|Induction|Failed to Complete Randomization|0
3081806|NCT00408005|10575306|P4|Induction|Failed to Complete Randomization|0
3081807|NCT00408005|10575307|P3|Induction|Failed to Complete Randomization|0
3081808|NCT00408005|10575308|P2|Induction|Failed to Complete Randomization|2
3081809|NCT00408005|10575309|P1|Induction|Failed to Complete Randomization|3
3081810|NCT00408005|10575302|P8|Induction|Inevaluable|0
3081811|NCT00408005|10575303|P7|Induction|Inevaluable|0
3081812|NCT00408005|10575304|P6|Induction|Inevaluable|0
3081813|NCT00408005|10575305|P5|Induction|Inevaluable|0
3081814|NCT00408005|10575306|P4|Induction|Inevaluable|0
3081815|NCT00408005|10575307|P3|Induction|Inevaluable|0
3081816|NCT00408005|10575308|P2|Induction|Inevaluable|14
3081817|NCT00408005|10575309|P1|Induction|Inevaluable|18
3081818|NCT00408005|10575302|P8|Induction|Progressive Disease|0
3081819|NCT00408005|10575303|P7|Induction|Progressive Disease|0
3081820|NCT00408005|10575304|P6|Induction|Progressive Disease|0
3081821|NCT00408005|10575305|P5|Induction|Progressive Disease|0
3081822|NCT00408005|10575306|P4|Induction|Progressive Disease|0
3081823|NCT00408005|10575307|P3|Induction|Progressive Disease|0
3081824|NCT00408005|10575308|P2|Induction|Progressive Disease|1
3081825|NCT00408005|10575309|P1|Induction|Progressive Disease|0
3081826|NCT00408005|10575302|P8|Induction|Identified as Philadelphia Chr. Positive|0
3081827|NCT00408005|10575303|P7|Induction|Identified as Philadelphia Chr. Positive|0
3081828|NCT00408005|10575304|P6|Induction|Identified as Philadelphia Chr. Positive|0
3081829|NCT00408005|10575305|P5|Induction|Identified as Philadelphia Chr. Positive|0
3081830|NCT00408005|10575306|P4|Induction|Identified as Philadelphia Chr. Positive|0
3081831|NCT00408005|10575307|P3|Induction|Identified as Philadelphia Chr. Positive|0
3081832|NCT00408005|10575308|P2|Induction|Identified as Philadelphia Chr. Positive|0
3081833|NCT00408005|10575309|P1|Induction|Identified as Philadelphia Chr. Positive|6
3081834|NCT00408005|10575302|P8|Induction|Patient transferred Tx to Non-COG Site|0
3081835|NCT00408005|10575303|P7|Induction|Patient transferred Tx to Non-COG Site|0
3081836|NCT00408005|10575304|P6|Induction|Patient transferred Tx to Non-COG Site|0
3081837|NCT00408005|10575305|P5|Induction|Patient transferred Tx to Non-COG Site|0
3081838|NCT00408005|10575306|P4|Induction|Patient transferred Tx to Non-COG Site|0
3081839|NCT00408005|10575307|P3|Induction|Patient transferred Tx to Non-COG Site|0
3081840|NCT00408005|10575308|P2|Induction|Patient transferred Tx to Non-COG Site|2
3081841|NCT00408005|10575309|P1|Induction|Patient transferred Tx to Non-COG Site|3
3081842|NCT00408005|10575302|P8|Induction|Entered another COG therapeutic protocol|0
3081843|NCT00408005|10575303|P7|Induction|Entered another COG therapeutic protocol|0
3081844|NCT00408005|10575304|P6|Induction|Entered another COG therapeutic protocol|0
3081845|NCT00408005|10575305|P5|Induction|Entered another COG therapeutic protocol|0
3081846|NCT00408005|10575306|P4|Induction|Entered another COG therapeutic protocol|0
3081847|NCT00408005|10575307|P3|Induction|Entered another COG therapeutic protocol|0
3081848|NCT00408005|10575308|P2|Induction|Entered another COG therapeutic protocol|0
3081849|NCT00408005|10575309|P1|Induction|Entered another COG therapeutic protocol|4
3081850|NCT00408005|10575302|P8|Induction|Refusal of Further Protocol Therapy|0
3081851|NCT00408005|10575303|P7|Induction|Refusal of Further Protocol Therapy|0
3081852|NCT00408005|10575304|P6|Induction|Refusal of Further Protocol Therapy|0
3081853|NCT00408005|10575305|P5|Induction|Refusal of Further Protocol Therapy|0
3081854|NCT00408005|10575306|P4|Induction|Refusal of Further Protocol Therapy|0
3081855|NCT00408005|10575307|P3|Induction|Refusal of Further Protocol Therapy|0
3081856|NCT00408005|10575308|P2|Induction|Refusal of Further Protocol Therapy|44
3081857|NCT00408005|10575309|P1|Induction|Refusal of Further Protocol Therapy|225
3081858|NCT00408005|10575302|P8|Induction|Ineligible|0
3081859|NCT00408005|10575303|P7|Induction|Ineligible|0
3081860|NCT00408005|10575304|P6|Induction|Ineligible|0
3081861|NCT00408005|10575305|P5|Induction|Ineligible|0
3081862|NCT00408005|10575306|P4|Induction|Ineligible|0
3081863|NCT00408005|10575307|P3|Induction|Ineligible|0
3081864|NCT00408005|10575308|P2|Induction|Ineligible|14
3081865|NCT00408005|10575309|P1|Induction|Ineligible|33
3081866|NCT00408005|10575302|P8|Induction|Withdrawal by Subject|0
3081867|NCT00408005|10575303|P7|Induction|Withdrawal by Subject|0
3081868|NCT00408005|10575304|P6|Induction|Withdrawal by Subject|0
3081869|NCT00408005|10575305|P5|Induction|Withdrawal by Subject|0
3081870|NCT00408005|10575306|P4|Induction|Withdrawal by Subject|0
3081871|NCT00408005|10575307|P3|Induction|Withdrawal by Subject|0
3081872|NCT00408005|10575308|P2|Induction|Withdrawal by Subject|4
3081873|NCT00408005|10575309|P1|Induction|Withdrawal by Subject|2
3081874|NCT00408005|10575302|P8|Induction|Physician Decision|0
3081875|NCT00408005|10575303|P7|Induction|Physician Decision|0
3081876|NCT00408005|10575304|P6|Induction|Physician Decision|0
3081877|NCT00408005|10575305|P5|Induction|Physician Decision|0
3081878|NCT00408005|10575306|P4|Induction|Physician Decision|0
3081879|NCT00408005|10575307|P3|Induction|Physician Decision|0
3081880|NCT00408005|10575308|P2|Induction|Physician Decision|9
3081881|NCT00408005|10575309|P1|Induction|Physician Decision|83
3081882|NCT00408005|10575302|P8|Induction|Death|0
3081883|NCT00408005|10575303|P7|Induction|Death|0
3081884|NCT00408005|10575304|P6|Induction|Death|0
3081885|NCT00408005|10575305|P5|Induction|Death|0
3081886|NCT00408005|10575306|P4|Induction|Death|0
3081887|NCT00408005|10575307|P3|Induction|Death|0
3081888|NCT00408005|10575308|P2|Induction|Death|0
3081889|NCT00408005|10575309|P1|Induction|Death|6
3081890|NCT00408005|10575302|P8|Induction|Adverse Event|0
3081891|NCT00408005|10575303|P7|Induction|Adverse Event|0
3081892|NCT00408005|10575304|P6|Induction|Adverse Event|0
3081893|NCT00408005|10575305|P5|Induction|Adverse Event|0
3081894|NCT00408005|10575306|P4|Induction|Adverse Event|0
3081895|NCT00408005|10575307|P3|Induction|Adverse Event|0
3081896|NCT00408005|10575308|P2|Induction|Adverse Event|3
3081897|NCT00408005|10575309|P1|Induction|Adverse Event|19
3081898|NCT00407797|10575351|P1|Overall Study|Withdrawal by Subject|3
3081899|NCT00407797|10575351|P1|Overall Study|Other|7
3081900|NCT00407797|10575351|P1|Overall Study|Adverse Event|6
3081901|NCT00407797|10575351|P1|Overall Study|Lost to Follow-up|2
3081902|NCT00407758|10575366|P1|Overall Study|ineligible –improper prior treatment|1
3081903|NCT00407745|10575379|P2|Overall Study|Randomized, unknown if treated|1
3081904|NCT00407745|10575380|P1|Overall Study|Randomized, unknown if treated|0
3081905|NCT00407745|10575379|P2|Overall Study|Other|0
3081906|NCT00407745|10575380|P1|Overall Study|Other|2
3081907|NCT00407745|10575379|P2|Overall Study|Adverse Event|8
3081908|NCT00407745|10575380|P1|Overall Study|Adverse Event|8
3081909|NCT00407745|10575379|P2|Overall Study|Protocol Violation|3
3081910|NCT00407745|10575380|P1|Overall Study|Protocol Violation|5
3081911|NCT00407745|10575379|P2|Overall Study|Withdrawal by Subject|3
3081912|NCT00407745|10575380|P1|Overall Study|Withdrawal by Subject|3
3081913|NCT00407745|10575379|P2|Overall Study|Lack of Efficacy|2
3081914|NCT00407745|10575380|P1|Overall Study|Lack of Efficacy|1
3081915|NCT00407563|10575466|P1|Overall Study|Patient continues on treatment|1
3081916|NCT00407550|10575476|P2|Overall Study|Insurance or Other medical condition|1
3081917|NCT00407550|10575477|P1|Overall Study|Insurance or Other medical condition|2
3081918|NCT00407550|10575476|P2|Overall Study|Death|0
3081919|NCT00407550|10575477|P1|Overall Study|Death|1
3081920|NCT00407550|10575476|P2|Overall Study|Withdrawal by Subject|2
3081921|NCT00407550|10575477|P1|Overall Study|Withdrawal by Subject|0
3081922|NCT00407550|10575476|P2|Overall Study|Adverse Event|1
3081923|NCT00407550|10575477|P1|Overall Study|Adverse Event|0
3081924|NCT00407537|10575491|P2|Overall Study|Withdrawal by Subject|16
3081925|NCT00407537|10575492|P1|Overall Study|Withdrawal by Subject|34
3081926|NCT00407537|10575491|P2|Overall Study|Other|7
3081927|NCT00407537|10575492|P1|Overall Study|Other|6
3081928|NCT00407537|10575491|P2|Overall Study|Lost to Follow-up|19
3081929|NCT00407537|10575492|P1|Overall Study|Lost to Follow-up|12
3081930|NCT00407537|10575491|P2|Overall Study|Adverse Event|0
3081931|NCT00407537|10575492|P1|Overall Study|Adverse Event|36
3081932|NCT00407537|10575491|P2|Overall Study|Death|2
3081933|NCT00407537|10575492|P1|Overall Study|Death|5
3081934|NCT00407511|10575540|P1|Overall Study|Withdrawal by Subject|4
3081935|NCT00407511|10575540|P1|Overall Study|Other|5
3081936|NCT00407511|10575540|P1|Overall Study|Lost to Follow-up|4
3081937|NCT00407511|10575540|P1|Overall Study|Adverse Event|9
3081938|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Physician Decision|0
3081939|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Physician Decision|2
3081940|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Physician Decision|1
3081941|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Patient Decision|0
3081942|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Patient Decision|2
3081943|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Patient Decision|1
3081944|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
3081945|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
3081946|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
3081947|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
3081948|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
3081949|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
3081950|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Adverse Event|0
3081951|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Adverse Event|0
3081952|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Adverse Event|1
3081953|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
3081954|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
3081955|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
3081956|NCT00407030|10575601|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
3081957|NCT00407030|10575602|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
3081958|NCT00407030|10575603|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
3081959|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
3081960|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
3081961|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
3081962|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
3081963|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
3081964|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
3081965|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
3081966|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
3081967|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
3081968|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
3081969|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
3081970|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
3081971|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
3081972|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
3081973|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
3081974|NCT00407030|10575601|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
3081975|NCT00407030|10575602|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
3081976|NCT00407030|10575603|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
3081977|NCT00406848|10575631|P2|Overall Study|Sponsor Decision|1
3081978|NCT00406848|10575632|P1|Overall Study|Sponsor Decision|1
3081979|NCT00406848|10575631|P2|Overall Study|Physician Decision|2
3081980|NCT00406848|10575632|P1|Overall Study|Physician Decision|2
3081981|NCT00406848|10575631|P2|Overall Study|Lost to Follow-up|2
3081982|NCT00406848|10575632|P1|Overall Study|Lost to Follow-up|6
3081983|NCT00406848|10575631|P2|Overall Study|Protocol Violation|6
3081984|NCT00406848|10575632|P1|Overall Study|Protocol Violation|10
3081985|NCT00406848|10575631|P2|Overall Study|Lack of Efficacy|14
3081986|NCT00406848|10575632|P1|Overall Study|Lack of Efficacy|9
3081987|NCT00406848|10575631|P2|Overall Study|Adverse Event|7
3081988|NCT00406848|10575632|P1|Overall Study|Adverse Event|38
3081989|NCT00406848|10575631|P2|Overall Study|Withdrawal by Subject|22
3081990|NCT00406848|10575632|P1|Overall Study|Withdrawal by Subject|27
3081991|NCT00406783|10575696|P2|Overall Study|Protocol Violation|4
3081992|NCT00406783|10575697|P1|Overall Study|Protocol Violation|4
3081993|NCT00406783|10575696|P2|Overall Study|Withdrawal by Subject|4
3081994|NCT00406783|10575697|P1|Overall Study|Withdrawal by Subject|1
3081995|NCT00406783|10575696|P2|Overall Study|Lost to Follow-up|0
3081996|NCT00406783|10575697|P1|Overall Study|Lost to Follow-up|3
3081997|NCT00406783|10575696|P2|Overall Study|Treatment Failure|3
3081998|NCT00406783|10575697|P1|Overall Study|Treatment Failure|2
3081999|NCT00406783|10575696|P2|Overall Study|Adverse Event|4
3082000|NCT00406783|10575697|P1|Overall Study|Adverse Event|4
3082001|NCT00406718|10575712|P3|Overall Study|Lost to Follow-up|4
3082002|NCT00406718|10575713|P2|Overall Study|Lost to Follow-up|5
3082003|NCT00406718|10575714|P1|Overall Study|Lost to Follow-up|2
3082004|NCT00406718|10575712|P3|Overall Study|Withdrawal by Subject|4
3082005|NCT00406718|10575713|P2|Overall Study|Withdrawal by Subject|9
3082006|NCT00406718|10575714|P1|Overall Study|Withdrawal by Subject|2
3082007|NCT00406692|10575728|P1|Overall Study|Lack of Efficacy|1
3082008|NCT00406692|10575728|P1|Overall Study|Adverse Event|1
3082009|NCT00406692|10575728|P1|Overall Study|Physician Decision|1
3082010|NCT00406692|10575728|P1|Overall Study|Withdrawal by Subject|4
3082011|NCT00406653|10575738|P7|Open-Label Period|Refused followup|1
3082012|NCT00406653|10575739|P6|Open-Label Period|Refused followup|0
3082013|NCT00406653|10575740|P5|Open-Label Period|Refused followup|0
3082014|NCT00406653|10575741|P4|Open-Label Period|Refused followup|0
3082015|NCT00406653|10575742|P3|Open-Label Period|Refused followup|0
3082016|NCT00406653|10575743|P2|Open-Label Period|Refused followup|0
3082017|NCT00406653|10575744|P1|Open-Label Period|Refused followup|0
3082018|NCT00406653|10575738|P7|Open-Label Period|Discontinued by Sponsor|1
3082019|NCT00406653|10575739|P6|Open-Label Period|Discontinued by Sponsor|0
3082020|NCT00406653|10575740|P5|Open-Label Period|Discontinued by Sponsor|0
3082021|NCT00406653|10575741|P4|Open-Label Period|Discontinued by Sponsor|0
3082022|NCT00406653|10575742|P3|Open-Label Period|Discontinued by Sponsor|0
3082023|NCT00406653|10575743|P2|Open-Label Period|Discontinued by Sponsor|0
3082024|NCT00406653|10575744|P1|Open-Label Period|Discontinued by Sponsor|0
3082025|NCT00406653|10575738|P7|Open-Label Period|Declined participation but followup done|8
3082026|NCT00406653|10575739|P6|Open-Label Period|Declined participation but followup done|0
3082027|NCT00406653|10575740|P5|Open-Label Period|Declined participation but followup done|0
3082028|NCT00406653|10575741|P4|Open-Label Period|Declined participation but followup done|0
3082029|NCT00406653|10575742|P3|Open-Label Period|Declined participation but followup done|0
3082030|NCT00406653|10575743|P2|Open-Label Period|Declined participation but followup done|0
3082031|NCT00406653|10575744|P1|Open-Label Period|Declined participation but followup done|0
3082032|NCT00406653|10575738|P7|Open-Label Period|Administrative Reason By Sponsor|115
3082033|NCT00406653|10575739|P6|Open-Label Period|Administrative Reason By Sponsor|0
3082034|NCT00406653|10575740|P5|Open-Label Period|Administrative Reason By Sponsor|0
3082035|NCT00406653|10575741|P4|Open-Label Period|Administrative Reason By Sponsor|0
3082036|NCT00406653|10575742|P3|Open-Label Period|Administrative Reason By Sponsor|0
3082037|NCT00406653|10575743|P2|Open-Label Period|Administrative Reason By Sponsor|0
3082038|NCT00406653|10575744|P1|Open-Label Period|Administrative Reason By Sponsor|0
3082039|NCT00406653|10575738|P7|Open-Label Period|Pregnancy|2
3082040|NCT00406653|10575739|P6|Open-Label Period|Pregnancy|0
3082041|NCT00406653|10575740|P5|Open-Label Period|Pregnancy|0
3082042|NCT00406653|10575741|P4|Open-Label Period|Pregnancy|0
3082043|NCT00406653|10575742|P3|Open-Label Period|Pregnancy|0
3082044|NCT00406653|10575743|P2|Open-Label Period|Pregnancy|0
3082045|NCT00406653|10575744|P1|Open-Label Period|Pregnancy|0
3082046|NCT00406653|10575738|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
3082047|NCT00406653|10575739|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082048|NCT00406653|10575740|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082049|NCT00406653|10575741|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082050|NCT00406653|10575742|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082051|NCT00406653|10575743|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082052|NCT00406653|10575744|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
3082053|NCT00406653|10575738|P7|Open-Label Period|Withdrawal of Consent|11
3082054|NCT00406653|10575739|P6|Open-Label Period|Withdrawal of Consent|0
3082055|NCT00406653|10575740|P5|Open-Label Period|Withdrawal of Consent|0
3082056|NCT00406653|10575741|P4|Open-Label Period|Withdrawal of Consent|0
3082057|NCT00406653|10575742|P3|Open-Label Period|Withdrawal of Consent|0
3082058|NCT00406653|10575743|P2|Open-Label Period|Withdrawal of Consent|0
3082059|NCT00406653|10575744|P1|Open-Label Period|Withdrawal of Consent|0
3082060|NCT00406653|10575738|P7|Open-Label Period|Lost to Follow-up|6
3082061|NCT00406653|10575739|P6|Open-Label Period|Lost to Follow-up|0
3082062|NCT00406653|10575740|P5|Open-Label Period|Lost to Follow-up|0
3082063|NCT00406653|10575741|P4|Open-Label Period|Lost to Follow-up|0
3082064|NCT00406653|10575742|P3|Open-Label Period|Lost to Follow-up|0
3082065|NCT00406653|10575743|P2|Open-Label Period|Lost to Follow-up|0
3082066|NCT00406653|10575744|P1|Open-Label Period|Lost to Follow-up|0
3082067|NCT00406653|10575738|P7|Open-Label Period|Lack of Efficacy|160
3082068|NCT00406653|10575739|P6|Open-Label Period|Lack of Efficacy|0
3082069|NCT00406653|10575740|P5|Open-Label Period|Lack of Efficacy|0
3082070|NCT00406653|10575741|P4|Open-Label Period|Lack of Efficacy|0
3082071|NCT00406653|10575742|P3|Open-Label Period|Lack of Efficacy|0
3082072|NCT00406653|10575743|P2|Open-Label Period|Lack of Efficacy|0
3082073|NCT00406653|10575744|P1|Open-Label Period|Lack of Efficacy|0
3082074|NCT00406653|10575738|P7|Open-Label Period|Adverse Event|18
3082075|NCT00406653|10575739|P6|Open-Label Period|Adverse Event|0
3082076|NCT00406653|10575740|P5|Open-Label Period|Adverse Event|0
3082077|NCT00406653|10575741|P4|Open-Label Period|Adverse Event|0
3082078|NCT00406653|10575742|P3|Open-Label Period|Adverse Event|0
3082079|NCT00406653|10575743|P2|Open-Label Period|Adverse Event|0
3082080|NCT00406653|10575744|P1|Open-Label Period|Adverse Event|0
3082081|NCT00406653|10575738|P7|Open-Label Period|Death|1
3082082|NCT00406653|10575739|P6|Open-Label Period|Death|0
3082083|NCT00406653|10575740|P5|Open-Label Period|Death|0
3082084|NCT00406653|10575741|P4|Open-Label Period|Death|0
3082085|NCT00406653|10575742|P3|Open-Label Period|Death|0
3082086|NCT00406653|10575743|P2|Open-Label Period|Death|0
3082087|NCT00406653|10575744|P1|Open-Label Period|Death|0
3082088|NCT00406653|10575738|P7|Maintenance Period|Error in disease score evaluation|0
3082089|NCT00406653|10575739|P6|Maintenance Period|Error in disease score evaluation|0
3082090|NCT00406653|10575740|P5|Maintenance Period|Error in disease score evaluation|1
3082091|NCT00406653|10575741|P4|Maintenance Period|Error in disease score evaluation|0
3082092|NCT00406653|10575742|P3|Maintenance Period|Error in disease score evaluation|0
3082093|NCT00406653|10575743|P2|Maintenance Period|Error in disease score evaluation|0
3082094|NCT00406653|10575744|P1|Maintenance Period|Error in disease score evaluation|0
3082095|NCT00406653|10575738|P7|Maintenance Period|Administrative Reason By Sponsor|0
3082096|NCT00406653|10575739|P6|Maintenance Period|Administrative Reason By Sponsor|7
3082097|NCT00406653|10575740|P5|Maintenance Period|Administrative Reason By Sponsor|4
3082098|NCT00406653|10575741|P4|Maintenance Period|Administrative Reason By Sponsor|0
3082099|NCT00406653|10575742|P3|Maintenance Period|Administrative Reason By Sponsor|0
3082100|NCT00406653|10575743|P2|Maintenance Period|Administrative Reason By Sponsor|0
3082101|NCT00406653|10575744|P1|Maintenance Period|Administrative Reason By Sponsor|0
3082102|NCT00406653|10575738|P7|Maintenance Period|Pregnancy|0
3082103|NCT00406653|10575739|P6|Maintenance Period|Pregnancy|1
3082104|NCT00406653|10575740|P5|Maintenance Period|Pregnancy|0
3082105|NCT00406653|10575741|P4|Maintenance Period|Pregnancy|0
3082106|NCT00406653|10575742|P3|Maintenance Period|Pregnancy|0
3082107|NCT00406653|10575743|P2|Maintenance Period|Pregnancy|0
3082108|NCT00406653|10575744|P1|Maintenance Period|Pregnancy|0
3082109|NCT00406653|10575738|P7|Maintenance Period|Withdrawal of Consent|0
3082110|NCT00406653|10575739|P6|Maintenance Period|Withdrawal of Consent|0
3082111|NCT00406653|10575740|P5|Maintenance Period|Withdrawal of Consent|2
3082112|NCT00406653|10575741|P4|Maintenance Period|Withdrawal of Consent|0
3082113|NCT00406653|10575742|P3|Maintenance Period|Withdrawal of Consent|0
3082114|NCT00406653|10575743|P2|Maintenance Period|Withdrawal of Consent|0
3082115|NCT00406653|10575744|P1|Maintenance Period|Withdrawal of Consent|0
3082116|NCT00406653|10575738|P7|Maintenance Period|Lost to Follow-up|0
3082117|NCT00406653|10575739|P6|Maintenance Period|Lost to Follow-up|1
3082118|NCT00406653|10575740|P5|Maintenance Period|Lost to Follow-up|2
3082119|NCT00406653|10575741|P4|Maintenance Period|Lost to Follow-up|0
3082120|NCT00406653|10575742|P3|Maintenance Period|Lost to Follow-up|0
3082121|NCT00406653|10575743|P2|Maintenance Period|Lost to Follow-up|0
3082122|NCT00406653|10575744|P1|Maintenance Period|Lost to Follow-up|0
3082123|NCT00406653|10575738|P7|Maintenance Period|Lack of Efficacy|0
3082124|NCT00406653|10575739|P6|Maintenance Period|Lack of Efficacy|26
3082125|NCT00406653|10575740|P5|Maintenance Period|Lack of Efficacy|20
3082126|NCT00406653|10575741|P4|Maintenance Period|Lack of Efficacy|0
3082127|NCT00406653|10575742|P3|Maintenance Period|Lack of Efficacy|0
3082128|NCT00406653|10575743|P2|Maintenance Period|Lack of Efficacy|0
3082129|NCT00406653|10575744|P1|Maintenance Period|Lack of Efficacy|0
3082130|NCT00406653|10575738|P7|Maintenance Period|Adverse Event|0
3082131|NCT00406653|10575739|P6|Maintenance Period|Adverse Event|1
3082132|NCT00406653|10575740|P5|Maintenance Period|Adverse Event|1
3082133|NCT00406653|10575741|P4|Maintenance Period|Adverse Event|0
3082134|NCT00406653|10575742|P3|Maintenance Period|Adverse Event|0
3082135|NCT00406653|10575743|P2|Maintenance Period|Adverse Event|0
3082136|NCT00406653|10575744|P1|Maintenance Period|Adverse Event|0
3082137|NCT00406653|10575738|P7|Induction Period|Patient relocated|0
3082138|NCT00406653|10575739|P6|Induction Period|Patient relocated|0
3082139|NCT00406653|10575740|P5|Induction Period|Patient relocated|0
3082140|NCT00406653|10575741|P4|Induction Period|Patient relocated|0
3082141|NCT00406653|10575742|P3|Induction Period|Patient relocated|1
3082142|NCT00406653|10575743|P2|Induction Period|Patient relocated|0
3082143|NCT00406653|10575744|P1|Induction Period|Patient relocated|0
3082144|NCT00406653|10575738|P7|Induction Period|Incarcerated|0
3082145|NCT00406653|10575739|P6|Induction Period|Incarcerated|0
3082146|NCT00406653|10575740|P5|Induction Period|Incarcerated|0
3082147|NCT00406653|10575741|P4|Induction Period|Incarcerated|0
3082148|NCT00406653|10575742|P3|Induction Period|Incarcerated|1
3082149|NCT00406653|10575743|P2|Induction Period|Incarcerated|0
3082150|NCT00406653|10575744|P1|Induction Period|Incarcerated|0
3082151|NCT00406653|10575738|P7|Induction Period|Given prohibited drug|0
3082152|NCT00406653|10575739|P6|Induction Period|Given prohibited drug|0
3082153|NCT00406653|10575740|P5|Induction Period|Given prohibited drug|0
3082154|NCT00406653|10575741|P4|Induction Period|Given prohibited drug|0
3082155|NCT00406653|10575742|P3|Induction Period|Given prohibited drug|2
3082156|NCT00406653|10575743|P2|Induction Period|Given prohibited drug|1
3082157|NCT00406653|10575744|P1|Induction Period|Given prohibited drug|0
3082158|NCT00406653|10575738|P7|Induction Period|Declined participation but followup done|0
3082159|NCT00406653|10575739|P6|Induction Period|Declined participation but followup done|0
3082160|NCT00406653|10575740|P5|Induction Period|Declined participation but followup done|0
3082161|NCT00406653|10575741|P4|Induction Period|Declined participation but followup done|1
3082162|NCT00406653|10575742|P3|Induction Period|Declined participation but followup done|1
3082163|NCT00406653|10575743|P2|Induction Period|Declined participation but followup done|2
3082164|NCT00406653|10575744|P1|Induction Period|Declined participation but followup done|0
3082165|NCT00406653|10575738|P7|Induction Period|Pregnancy|0
3082166|NCT00406653|10575739|P6|Induction Period|Pregnancy|0
3082167|NCT00406653|10575740|P5|Induction Period|Pregnancy|0
3082168|NCT00406653|10575741|P4|Induction Period|Pregnancy|0
3082169|NCT00406653|10575742|P3|Induction Period|Pregnancy|0
3082170|NCT00406653|10575743|P2|Induction Period|Pregnancy|0
3082171|NCT00406653|10575744|P1|Induction Period|Pregnancy|1
3082172|NCT00406653|10575738|P7|Induction Period|Subject No Longer Meets Study Criteria|0
3082173|NCT00406653|10575739|P6|Induction Period|Subject No Longer Meets Study Criteria|0
3082174|NCT00406653|10575740|P5|Induction Period|Subject No Longer Meets Study Criteria|0
3082175|NCT00406653|10575741|P4|Induction Period|Subject No Longer Meets Study Criteria|2
3082176|NCT00406653|10575742|P3|Induction Period|Subject No Longer Meets Study Criteria|0
3082177|NCT00406653|10575743|P2|Induction Period|Subject No Longer Meets Study Criteria|0
3082178|NCT00406653|10575744|P1|Induction Period|Subject No Longer Meets Study Criteria|0
3082179|NCT00406653|10575738|P7|Induction Period|Withdrawal of Consent|0
3082180|NCT00406653|10575739|P6|Induction Period|Withdrawal of Consent|0
3082181|NCT00406653|10575740|P5|Induction Period|Withdrawal of Consent|0
3082182|NCT00406653|10575741|P4|Induction Period|Withdrawal of Consent|2
3082183|NCT00406653|10575742|P3|Induction Period|Withdrawal of Consent|1
3082184|NCT00406653|10575743|P2|Induction Period|Withdrawal of Consent|5
3082185|NCT00406653|10575744|P1|Induction Period|Withdrawal of Consent|2
3082186|NCT00406653|10575738|P7|Induction Period|Lost to Follow-up|0
3082187|NCT00406653|10575739|P6|Induction Period|Lost to Follow-up|0
3082188|NCT00406653|10575740|P5|Induction Period|Lost to Follow-up|0
3082189|NCT00406653|10575741|P4|Induction Period|Lost to Follow-up|0
3082190|NCT00406653|10575742|P3|Induction Period|Lost to Follow-up|0
3082191|NCT00406653|10575743|P2|Induction Period|Lost to Follow-up|2
3082192|NCT00406653|10575744|P1|Induction Period|Lost to Follow-up|0
3082193|NCT00406653|10575738|P7|Induction Period|Lack of Efficacy|0
3082194|NCT00406653|10575739|P6|Induction Period|Lack of Efficacy|0
3082195|NCT00406653|10575740|P5|Induction Period|Lack of Efficacy|0
3082196|NCT00406653|10575741|P4|Induction Period|Lack of Efficacy|10
3082197|NCT00406653|10575742|P3|Induction Period|Lack of Efficacy|8
3082198|NCT00406653|10575743|P2|Induction Period|Lack of Efficacy|14
3082199|NCT00406653|10575744|P1|Induction Period|Lack of Efficacy|11
3082200|NCT00406653|10575738|P7|Induction Period|Adverse Event|0
3082201|NCT00406653|10575739|P6|Induction Period|Adverse Event|0
3082202|NCT00406653|10575740|P5|Induction Period|Adverse Event|0
3082203|NCT00406653|10575741|P4|Induction Period|Adverse Event|11
3082204|NCT00406653|10575742|P3|Induction Period|Adverse Event|4
3082205|NCT00406653|10575743|P2|Induction Period|Adverse Event|10
3082206|NCT00406653|10575744|P1|Induction Period|Adverse Event|1
3082207|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
3082208|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
3082209|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
3082210|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
3082211|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|non-compliance|2
3082212|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|non-compliance|3
3082213|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
3082214|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
3082215|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Physician Decision|0
3082216|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Physician Decision|1
3082217|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Failed to Return|0
3082218|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Failed to Return|1
3082219|NCT00406640|10575825|P2|OL Extension Phase for Non-Responders|Adverse Event|6
3082220|NCT00406640|10575826|P1|OL Extension Phase for Non-Responders|Adverse Event|6
3082221|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
3082222|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
3082223|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
3082224|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
3082225|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Protocol Violation|2
3082226|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Protocol Violation|2
3082227|NCT00406640|10575825|P2|DB Continuation Phase for Responders|non-compliance|5
3082228|NCT00406640|10575826|P1|DB Continuation Phase for Responders|non-compliance|7
3082229|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
3082230|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
3082231|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Physician Decision|3
3082232|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Physician Decision|2
3082233|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Failed to Return|2
3082234|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Failed to Return|0
3082235|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Death|0
3082236|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Death|1
3082237|NCT00406640|10575825|P2|DB Continuation Phase for Responders|Adverse Event|11
3082238|NCT00406640|10575826|P1|DB Continuation Phase for Responders|Adverse Event|11
3082239|NCT00406640|10575825|P2|Acute Phase|Lack of Efficacy|3
3082240|NCT00406640|10575826|P1|Acute Phase|Lack of Efficacy|3
3082241|NCT00406640|10575825|P2|Acute Phase|Withdrawal by Subject|9
3082242|NCT00406640|10575826|P1|Acute Phase|Withdrawal by Subject|11
3082243|NCT00406640|10575825|P2|Acute Phase|Protocol Violation|2
3082244|NCT00406640|10575826|P1|Acute Phase|Protocol Violation|3
3082245|NCT00406640|10575825|P2|Acute Phase|Protocol deviation|10
3082246|NCT00406640|10575826|P1|Acute Phase|Protocol deviation|4
3082247|NCT00406640|10575825|P2|Acute Phase|Lost to Follow-up|4
3082248|NCT00406640|10575826|P1|Acute Phase|Lost to Follow-up|7
3082249|NCT00406640|10575825|P2|Acute Phase|Physician Decision|1
3082250|NCT00406640|10575826|P1|Acute Phase|Physician Decision|0
3082251|NCT00406640|10575825|P2|Acute Phase|Failed to Return|1
3082252|NCT00406640|10575826|P1|Acute Phase|Failed to Return|5
3082253|NCT00406640|10575825|P2|Acute Phase|Adverse Event|13
3082254|NCT00406640|10575826|P1|Acute Phase|Adverse Event|18
3082255|NCT00406393|10575858|P2|Overall Study|Did not undergo transplantation|1
3082256|NCT00406393|10575859|P1|Overall Study|Did not undergo transplantation|2
3082257|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
3082258|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
3082259|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
3082260|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
3082261|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
3082262|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
3082263|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
3082264|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
3082265|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
3082266|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
3082267|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
3082268|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
3082269|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
3082270|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
3082271|NCT00406367|10575889|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
3082272|NCT00406367|10575890|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
3082273|NCT00406367|10575889|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
3082274|NCT00406367|10575890|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
3082275|NCT00406367|10575889|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
3082276|NCT00406367|10575890|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
3082277|NCT00406367|10575889|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
3082278|NCT00406367|10575890|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
3082279|NCT00406367|10575889|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
3082280|NCT00406367|10575890|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
3082281|NCT00406354|10575905|P3|All Randomized and Treated Patients|Physician Decision|1
3082282|NCT00406354|10575906|P2|All Randomized and Treated Patients|Physician Decision|0
3082283|NCT00406354|10575907|P1|All Randomized and Treated Patients|Physician Decision|0
3082284|NCT00406354|10575905|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
3082285|NCT00406354|10575906|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
3082286|NCT00406354|10575907|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
3082287|NCT00406354|10575905|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
3082288|NCT00406354|10575906|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
3082289|NCT00406354|10575907|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
3082290|NCT00406354|10575905|P3|All Randomized and Treated Patients|Adverse Event|1
3082291|NCT00406354|10575906|P2|All Randomized and Treated Patients|Adverse Event|2
3082292|NCT00406354|10575907|P1|All Randomized and Treated Patients|Adverse Event|6
3082293|NCT00406354|10575905|P3|All Randomized and Treated Patients|Lack of Efficacy|17
3082294|NCT00406354|10575906|P2|All Randomized and Treated Patients|Lack of Efficacy|4
3082295|NCT00406354|10575907|P1|All Randomized and Treated Patients|Lack of Efficacy|7
3082296|NCT00406354|10575905|P3|All Randomized Patients|Protocol Violation|1
3082297|NCT00406354|10575906|P2|All Randomized Patients|Protocol Violation|0
3082298|NCT00406354|10575907|P1|All Randomized Patients|Protocol Violation|0
3082299|NCT00406315|10575978|P1|Overall Study|Withdrawal by Subject|30
3082300|NCT00406315|10575978|P1|Overall Study|Lost to Follow-up|21
3082301|NCT00406315|10575978|P1|Overall Study|Other|33
3082302|NCT00406315|10575978|P1|Overall Study|Lack of Efficacy|13
3082303|NCT00406315|10575978|P1|Overall Study|Laboratory Abnormality|4
3082304|NCT00406315|10575978|P1|Overall Study|Adverse Event|39
3082305|NCT00406315|10575978|P1|Overall Study|Death|1
3082306|NCT00406029|10576088|P5|Overall Study|Randomized in Error|1
3082307|NCT00406029|10576089|P4|Overall Study|Randomized in Error|3
3082308|NCT00406029|10576090|P3|Overall Study|Randomized in Error|2
3082309|NCT00406029|10576091|P2|Overall Study|Randomized in Error|0
3082310|NCT00406029|10576092|P1|Overall Study|Randomized in Error|0
3082311|NCT00406029|10576088|P5|Overall Study|Did Not Meet Eligibility Criteria|0
3082312|NCT00406029|10576089|P4|Overall Study|Did Not Meet Eligibility Criteria|0
3082313|NCT00406029|10576090|P3|Overall Study|Did Not Meet Eligibility Criteria|1
3082314|NCT00406029|10576091|P2|Overall Study|Did Not Meet Eligibility Criteria|0
3082315|NCT00406029|10576092|P1|Overall Study|Did Not Meet Eligibility Criteria|0
3082316|NCT00406029|10576088|P5|Overall Study|Protocol Violation|0
3082317|NCT00406029|10576089|P4|Overall Study|Protocol Violation|2
3082318|NCT00406029|10576090|P3|Overall Study|Protocol Violation|0
3082319|NCT00406029|10576091|P2|Overall Study|Protocol Violation|2
3082320|NCT00406029|10576092|P1|Overall Study|Protocol Violation|1
3082321|NCT00406029|10576088|P5|Overall Study|Withdrawal by Subject|0
3082322|NCT00406029|10576089|P4|Overall Study|Withdrawal by Subject|2
3082323|NCT00406029|10576090|P3|Overall Study|Withdrawal by Subject|2
3082324|NCT00406029|10576091|P2|Overall Study|Withdrawal by Subject|4
3082325|NCT00406029|10576092|P1|Overall Study|Withdrawal by Subject|3
3082326|NCT00406029|10576088|P5|Overall Study|Adverse Event|7
3082327|NCT00406029|10576089|P4|Overall Study|Adverse Event|10
3082328|NCT00406029|10576090|P3|Overall Study|Adverse Event|5
3082329|NCT00406029|10576091|P2|Overall Study|Adverse Event|2
3082330|NCT00406029|10576092|P1|Overall Study|Adverse Event|12
3082331|NCT00405964|10576196|P2|Overall Study|Protocol Violation|6
3082332|NCT00405964|10576197|P1|Overall Study|Protocol Violation|11
3082333|NCT00405964|10576196|P2|Overall Study|Withdrawal by Subject|23
3082334|NCT00405964|10576197|P1|Overall Study|Withdrawal by Subject|19
3082335|NCT00405964|10576196|P2|Overall Study|Lost to Follow-up|5
3082336|NCT00405964|10576197|P1|Overall Study|Lost to Follow-up|5
3082337|NCT00405964|10576196|P2|Overall Study|Adverse Event|16
3082338|NCT00405964|10576197|P1|Overall Study|Adverse Event|7
3082339|NCT00405964|10576196|P2|Overall Study|Treatment Failure|45
3082340|NCT00405964|10576197|P1|Overall Study|Treatment Failure|17
3082341|NCT00405912|10576219|P3|Overall Study|Lost to Follow-up|4
3082342|NCT00405912|10576220|P2|Overall Study|Lost to Follow-up|8
3082343|NCT00405912|10576221|P1|Overall Study|Lost to Follow-up|4
3082344|NCT00405912|10576219|P3|Overall Study|Withdrawal by Subject|12
3082345|NCT00405912|10576220|P2|Overall Study|Withdrawal by Subject|11
3082346|NCT00405912|10576221|P1|Overall Study|Withdrawal by Subject|12
3082347|NCT00405821|10576234|P2|Overall Study|initiated ART|8
3082348|NCT00405821|10576235|P1|Overall Study|initiated ART|9
3082349|NCT00405821|10576234|P2|Overall Study|Protocol Violation|0
3082350|NCT00405821|10576235|P1|Overall Study|Protocol Violation|1
3082351|NCT00405821|10576234|P2|Overall Study|Lost to Follow-up|7
3082352|NCT00405821|10576235|P1|Overall Study|Lost to Follow-up|7
3082353|NCT00405821|10576234|P2|Overall Study|Death|7
3082354|NCT00405821|10576235|P1|Overall Study|Death|5
3082355|NCT00405756|10576248|P3|Follow-up|Lost to Follow-up|4
3082356|NCT00405756|10576249|P2|Follow-up|Lost to Follow-up|8
3082357|NCT00405756|10576250|P1|Follow-up|Lost to Follow-up|2
3082358|NCT00405756|10576248|P3|Follow-up|Death|24
3082359|NCT00405756|10576249|P2|Follow-up|Death|31
3082360|NCT00405756|10576250|P1|Follow-up|Death|21
3082361|NCT00405756|10576248|P3|Follow-up|Ongoing in Follow-up Period|60
3082362|NCT00405756|10576249|P2|Follow-up|Ongoing in Follow-up Period|51
3082363|NCT00405756|10576250|P1|Follow-up|Ongoing in Follow-up Period|52
3082364|NCT00405756|10576248|P3|Open-label Extension|Other|7
3082365|NCT00405756|10576249|P2|Open-label Extension|Other|1
3082366|NCT00405756|10576250|P1|Open-label Extension|Other|0
3082367|NCT00405756|10576248|P3|Open-label Extension|Death|4
3082368|NCT00405756|10576249|P2|Open-label Extension|Death|2
3082369|NCT00405756|10576250|P1|Open-label Extension|Death|1
3082370|NCT00405756|10576248|P3|Open-label Extension|Withdrawal by Subject|3
3082371|NCT00405756|10576249|P2|Open-label Extension|Withdrawal by Subject|3
3082372|NCT00405756|10576250|P1|Open-label Extension|Withdrawal by Subject|2
3082373|NCT00405756|10576248|P3|Open-label Extension|Disease Progression|26
3082374|NCT00405756|10576249|P2|Open-label Extension|Disease Progression|23
3082375|NCT00405756|10576250|P1|Open-label Extension|Disease Progression|8
3082376|NCT00405756|10576248|P3|Open-label Extension|Adverse Event|7
3082377|NCT00405756|10576249|P2|Open-label Extension|Adverse Event|3
3082378|NCT00405756|10576250|P1|Open-label Extension|Adverse Event|1
3082379|NCT00405756|10576248|P3|Open-label Extension|Ongoing in Open Label Period|25
3082380|NCT00405756|10576249|P2|Open-label Extension|Ongoing in Open Label Period|15
3082381|NCT00405756|10576250|P1|Open-label Extension|Ongoing in Open Label Period|7
3082382|NCT00405756|10576248|P3|Double-blind Treatment|Other|4
3082383|NCT00405756|10576249|P2|Double-blind Treatment|Other|4
3082384|NCT00405756|10576250|P1|Double-blind Treatment|Other|7
3082385|NCT00405756|10576248|P3|Double-blind Treatment|Protocol Violation|2
3082386|NCT00405756|10576249|P2|Double-blind Treatment|Protocol Violation|0
3082387|NCT00405756|10576250|P1|Double-blind Treatment|Protocol Violation|1
3082388|NCT00405756|10576248|P3|Double-blind Treatment|Death|4
3082389|NCT00405756|10576249|P2|Double-blind Treatment|Death|4
3082390|NCT00405756|10576250|P1|Double-blind Treatment|Death|4
3082391|NCT00405756|10576248|P3|Double-blind Treatment|Lost to Follow-up|0
3082392|NCT00405756|10576249|P2|Double-blind Treatment|Lost to Follow-up|0
3082393|NCT00405756|10576250|P1|Double-blind Treatment|Lost to Follow-up|1
3082394|NCT00405756|10576248|P3|Double-blind Treatment|Withdrawal by Subject|10
3082395|NCT00405756|10576249|P2|Double-blind Treatment|Withdrawal by Subject|9
3082396|NCT00405756|10576250|P1|Double-blind Treatment|Withdrawal by Subject|15
3082397|NCT00405756|10576248|P3|Double-blind Treatment|Lack of Efficacy|2
3082398|NCT00405756|10576249|P2|Double-blind Treatment|Lack of Efficacy|4
3082399|NCT00405756|10576250|P1|Double-blind Treatment|Lack of Efficacy|1
3082400|NCT00405756|10576248|P3|Double-blind Treatment|Disease Progression|102
3082401|NCT00405756|10576249|P2|Double-blind Treatment|Disease Progression|81
3082402|NCT00405756|10576250|P1|Double-blind Treatment|Disease Progression|47
3082403|NCT00405756|10576248|P3|Double-blind Treatment|Adverse Event|12
3082404|NCT00405756|10576249|P2|Double-blind Treatment|Adverse Event|27
3082405|NCT00405756|10576250|P1|Double-blind Treatment|Adverse Event|31
3082582|NCT00404651|10576770|P3|Overall Study|Protocol Violation|14
3082406|NCT00405756|10576248|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
3082407|NCT00405756|10576249|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
3082408|NCT00405756|10576250|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
3082409|NCT00405652|10576361|P1|Overall Study|Adverse Event|4
3082410|NCT00405639|10576368|P2|Overall Study|Seizure prior to receiving BNP|0
3082411|NCT00405639|10576369|P1|Overall Study|Seizure prior to receiving BNP|1
3082412|NCT00405639|10576368|P2|Overall Study|Adverse Event|0
3082413|NCT00405639|10576369|P1|Overall Study|Adverse Event|1
3082414|NCT00405639|10576368|P2|Overall Study|Withdrawal by Subject|0
3082415|NCT00405639|10576369|P1|Overall Study|Withdrawal by Subject|1
3082416|NCT00405587|10576385|P4|Overall Study|Participant not dosed|0
3082417|NCT00405587|10576386|P3|Overall Study|Participant not dosed|0
3082418|NCT00405587|10576387|P2|Overall Study|Participant not dosed|1
3082419|NCT00405587|10576388|P1|Overall Study|Participant not dosed|0
3082420|NCT00405587|10576385|P4|Overall Study|Withdrawal by Subject|2
3082421|NCT00405587|10576386|P3|Overall Study|Withdrawal by Subject|0
3082422|NCT00405587|10576387|P2|Overall Study|Withdrawal by Subject|0
3082423|NCT00405587|10576388|P1|Overall Study|Withdrawal by Subject|0
3082424|NCT00405587|10576385|P4|Overall Study|Radiation induced necrosis|0
3082425|NCT00405587|10576386|P3|Overall Study|Radiation induced necrosis|0
3082426|NCT00405587|10576387|P2|Overall Study|Radiation induced necrosis|1
3082427|NCT00405587|10576388|P1|Overall Study|Radiation induced necrosis|0
3082428|NCT00405587|10576385|P4|Overall Study|Lost to Follow-up|0
3082429|NCT00405587|10576386|P3|Overall Study|Lost to Follow-up|1
3082430|NCT00405587|10576387|P2|Overall Study|Lost to Follow-up|1
3082431|NCT00405587|10576388|P1|Overall Study|Lost to Follow-up|0
3082432|NCT00405587|10576385|P4|Overall Study|Adverse Event|0
3082433|NCT00405587|10576386|P3|Overall Study|Adverse Event|0
3082434|NCT00405587|10576387|P2|Overall Study|Adverse Event|0
3082435|NCT00405587|10576388|P1|Overall Study|Adverse Event|1
3082436|NCT00405587|10576385|P4|Overall Study|Physician Decision|0
3082437|NCT00405587|10576386|P3|Overall Study|Physician Decision|0
3082438|NCT00405587|10576387|P2|Overall Study|Physician Decision|2
3082439|NCT00405587|10576388|P1|Overall Study|Physician Decision|3
3082440|NCT00405587|10576385|P4|Overall Study|Disease Progression|17
3082441|NCT00405587|10576386|P3|Overall Study|Disease Progression|21
3082442|NCT00405587|10576387|P2|Overall Study|Disease Progression|23
3082443|NCT00405587|10576388|P1|Overall Study|Disease Progression|22
3082444|NCT00405587|10576385|P4|Overall Study|Death|1
3082445|NCT00405587|10576386|P3|Overall Study|Death|0
3082446|NCT00405587|10576387|P2|Overall Study|Death|0
3082447|NCT00405587|10576388|P1|Overall Study|Death|0
3082448|NCT00405548|10576506|P2|Overall Study|Withdrawal by Subject|0
3082449|NCT00405548|10576507|P1|Overall Study|Withdrawal by Subject|1
3082450|NCT00405548|10576506|P2|Overall Study|Venous access failed during study day|0
3082451|NCT00405548|10576507|P1|Overall Study|Venous access failed during study day|1
3082452|NCT00405548|10576506|P2|Overall Study|Unable to self-administer shots|0
3082453|NCT00405548|10576507|P1|Overall Study|Unable to self-administer shots|1
3082454|NCT00405548|10576506|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
3082455|NCT00405548|10576507|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
3082456|NCT00405548|10576506|P2|Overall Study|Cognitive Memory problems on study day|0
3082457|NCT00405548|10576507|P1|Overall Study|Cognitive Memory problems on study day|1
3082458|NCT00405392|10576551|P2|Overall Study|Other|5
3082459|NCT00405392|10576552|P1|Overall Study|Other|1
3082460|NCT00405392|10576551|P2|Overall Study|Non-compliance|1
3082461|NCT00405392|10576552|P1|Overall Study|Non-compliance|0
3082462|NCT00405392|10576551|P2|Overall Study|Data missing|0
3082463|NCT00405392|10576552|P1|Overall Study|Data missing|2
3082464|NCT00405392|10576551|P2|Overall Study|Lost to Follow-up|2
3082465|NCT00405392|10576552|P1|Overall Study|Lost to Follow-up|1
3082466|NCT00405392|10576551|P2|Overall Study|Withdrawal by Subject|3
3082467|NCT00405392|10576552|P1|Overall Study|Withdrawal by Subject|4
3082468|NCT00405392|10576551|P2|Overall Study|Did not meet Eligibility criteria|2
3082469|NCT00405392|10576552|P1|Overall Study|Did not meet Eligibility criteria|7
3082470|NCT00405392|10576551|P2|Overall Study|Adverse Event|14
3082471|NCT00405392|10576552|P1|Overall Study|Adverse Event|15
3082472|NCT00405275|10576599|P2|Overall Study|Unwilling to continue|9
3082473|NCT00405275|10576600|P1|Overall Study|Unwilling to continue|10
3082474|NCT00405275|10576599|P2|Overall Study|Withdrawal by Subject|9
3082475|NCT00405275|10576600|P1|Overall Study|Withdrawal by Subject|7
3082476|NCT00405275|10576599|P2|Overall Study|Lost to Follow-up|1
3082477|NCT00405275|10576600|P1|Overall Study|Lost to Follow-up|5
3082478|NCT00405275|10576599|P2|Overall Study|Death|0
3082479|NCT00405275|10576600|P1|Overall Study|Death|1
3082480|NCT00405067|10576609|P3|Overall Study|Lost to Follow-up|1
3082481|NCT00405067|10576610|P2|Overall Study|Lost to Follow-up|0
3082482|NCT00405067|10576611|P1|Overall Study|Lost to Follow-up|0
3082483|NCT00405067|10576609|P3|Overall Study|Adverse Event|4
3082484|NCT00405067|10576610|P2|Overall Study|Adverse Event|9
3082485|NCT00405067|10576611|P1|Overall Study|Adverse Event|4
3082486|NCT00404924|10576648|P2|Overall Study|Randomised but not received treatment|1
3082487|NCT00404924|10576649|P1|Overall Study|Randomised but not received treatment|1
3082488|NCT00404924|10576648|P2|Overall Study|Other|11
3082489|NCT00404924|10576649|P1|Overall Study|Other|25
3082490|NCT00404924|10576648|P2|Overall Study|Withdrawal by Subject|13
3082491|NCT00404924|10576649|P1|Overall Study|Withdrawal by Subject|26
3082492|NCT00404924|10576648|P2|Overall Study|Lost to Follow-up|1
3082493|NCT00404924|10576649|P1|Overall Study|Lost to Follow-up|1
3082494|NCT00404924|10576648|P2|Overall Study|Condition under investigation worsened|264
3082495|NCT00404924|10576649|P1|Overall Study|Condition under investigation worsened|475
3082496|NCT00404924|10576648|P2|Overall Study|Adverse Event|16
3082497|NCT00404924|10576649|P1|Overall Study|Adverse Event|75
3082498|NCT00404820|10576667|P2|Overall Study|Other|2
3082499|NCT00404820|10576668|P1|Overall Study|Other|0
3082500|NCT00404820|10576667|P2|Overall Study|Death|0
3082501|NCT00404820|10576668|P1|Overall Study|Death|1
3082502|NCT00404820|10576667|P2|Overall Study|Administrative problems|0
3082503|NCT00404820|10576668|P1|Overall Study|Administrative problems|2
3082504|NCT00404820|10576667|P2|Overall Study|Lost to Follow-up|3
3082505|NCT00404820|10576668|P1|Overall Study|Lost to Follow-up|7
3082506|NCT00404820|10576667|P2|Overall Study|Withdrawal by Subject|3
3082507|NCT00404820|10576668|P1|Overall Study|Withdrawal by Subject|5
3082508|NCT00404820|10576667|P2|Overall Study|Adverse Event|16
3082509|NCT00404820|10576668|P1|Overall Study|Adverse Event|4
3082510|NCT00404768|10576690|P4|Part C|Researcher suspended study medication|1
3082511|NCT00404768|10576691|P3|Part C|Researcher suspended study medication|0
3082512|NCT00404768|10576692|P2|Part C|Researcher suspended study medication|0
3082513|NCT00404768|10576693|P1|Part C|Researcher suspended study medication|0
3082514|NCT00404768|10576690|P4|Part C|Investigator discretion|1
3082515|NCT00404768|10576691|P3|Part C|Investigator discretion|0
3082516|NCT00404768|10576692|P2|Part C|Investigator discretion|0
3082517|NCT00404768|10576693|P1|Part C|Investigator discretion|0
3082518|NCT00404768|10576690|P4|Part C|Treatment failure|1
3082519|NCT00404768|10576691|P3|Part C|Treatment failure|0
3082520|NCT00404768|10576692|P2|Part C|Treatment failure|0
3082521|NCT00404768|10576693|P1|Part C|Treatment failure|0
3082522|NCT00404768|10576690|P4|Part C|Lack of Efficacy|2
3082523|NCT00404768|10576691|P3|Part C|Lack of Efficacy|0
3082524|NCT00404768|10576692|P2|Part C|Lack of Efficacy|0
3082525|NCT00404768|10576693|P1|Part C|Lack of Efficacy|0
3082526|NCT00404768|10576690|P4|Part C|Active labor|1
3082527|NCT00404768|10576691|P3|Part C|Active labor|0
3082528|NCT00404768|10576692|P2|Part C|Active labor|0
3082529|NCT00404768|10576693|P1|Part C|Active labor|0
3082530|NCT00404768|10576690|P4|Part C|Unsatisfactory uterine response to IP|1
3082531|NCT00404768|10576691|P3|Part C|Unsatisfactory uterine response to IP|0
3082532|NCT00404768|10576692|P2|Part C|Unsatisfactory uterine response to IP|0
3082533|NCT00404768|10576693|P1|Part C|Unsatisfactory uterine response to IP|0
3082534|NCT00404768|10576690|P4|Part C|Participant delivered baby|1
3082535|NCT00404768|10576691|P3|Part C|Participant delivered baby|0
3082536|NCT00404768|10576692|P2|Part C|Participant delivered baby|0
3082537|NCT00404768|10576693|P1|Part C|Participant delivered baby|0
3082538|NCT00404768|10576690|P4|Part C|Physician withdrew the study medication|0
3082539|NCT00404768|10576691|P3|Part C|Physician withdrew the study medication|1
3082540|NCT00404768|10576692|P2|Part C|Physician withdrew the study medication|0
3082541|NCT00404768|10576693|P1|Part C|Physician withdrew the study medication|0
3082542|NCT00404768|10576690|P4|Part C|Participant did not respond to therapy|1
3082543|NCT00404768|10576691|P3|Part C|Participant did not respond to therapy|1
3082544|NCT00404768|10576692|P2|Part C|Participant did not respond to therapy|0
3082545|NCT00404768|10576693|P1|Part C|Participant did not respond to therapy|0
3082546|NCT00404768|10576690|P4|Part C|Early withdrawal from study medication|0
3082547|NCT00404768|10576691|P3|Part C|Early withdrawal from study medication|1
3082548|NCT00404768|10576692|P2|Part C|Early withdrawal from study medication|0
3082549|NCT00404768|10576693|P1|Part C|Early withdrawal from study medication|0
3082550|NCT00404768|10576690|P4|Part C|Withdrawal by Subject|1
3082551|NCT00404768|10576691|P3|Part C|Withdrawal by Subject|2
3082552|NCT00404768|10576692|P2|Part C|Withdrawal by Subject|0
3082553|NCT00404768|10576693|P1|Part C|Withdrawal by Subject|0
3082554|NCT00404768|10576690|P4|Part C|Lost to Follow-up|1
3082555|NCT00404768|10576691|P3|Part C|Lost to Follow-up|3
3082556|NCT00404768|10576692|P2|Part C|Lost to Follow-up|0
3082557|NCT00404768|10576693|P1|Part C|Lost to Follow-up|0
3082558|NCT00404768|10576690|P4|Part C|Adverse Event|3
3082559|NCT00404768|10576691|P3|Part C|Adverse Event|0
3082560|NCT00404768|10576692|P2|Part C|Adverse Event|0
3082561|NCT00404768|10576693|P1|Part C|Adverse Event|0
3082562|NCT00404768|10576690|P4|Part A and B|Withdrawn as delivery imminemnt|0
3082563|NCT00404768|10576691|P3|Part A and B|Withdrawn as delivery imminemnt|0
3082564|NCT00404768|10576692|P2|Part A and B|Withdrawn as delivery imminemnt|1
3082565|NCT00404768|10576693|P1|Part A and B|Withdrawn as delivery imminemnt|0
3082566|NCT00404768|10576690|P4|Part A and B|Withdrawn due to labor progression|0
3082567|NCT00404768|10576691|P3|Part A and B|Withdrawn due to labor progression|0
3082568|NCT00404768|10576692|P2|Part A and B|Withdrawn due to labor progression|0
3082569|NCT00404768|10576693|P1|Part A and B|Withdrawn due to labor progression|1
3082570|NCT00404755|10576754|P1|Phase II (Escitalopram)|Lost to Follow-up|2
3082571|NCT00404755|10576754|P1|Phase I (Bupropion)|Other|1
3082572|NCT00404755|10576754|P1|Phase I (Bupropion)|Adverse Event|3
3082573|NCT00404651|10576769|P4|Overall Study|Withdrawal by Subject|6
3082574|NCT00404651|10576770|P3|Overall Study|Withdrawal by Subject|16
3082575|NCT00404651|10576771|P2|Overall Study|Withdrawal by Subject|12
3082576|NCT00404651|10576772|P1|Overall Study|Withdrawal by Subject|14
3082577|NCT00404651|10576769|P4|Overall Study|Lost to Follow-up|10
3082578|NCT00404651|10576770|P3|Overall Study|Lost to Follow-up|13
3082579|NCT00404651|10576771|P2|Overall Study|Lost to Follow-up|11
3082580|NCT00404651|10576772|P1|Overall Study|Lost to Follow-up|15
3082581|NCT00404651|10576769|P4|Overall Study|Protocol Violation|5
3082583|NCT00404651|10576771|P2|Overall Study|Protocol Violation|5
3082584|NCT00404651|10576772|P1|Overall Study|Protocol Violation|10
3082585|NCT00404651|10576769|P4|Overall Study|Serious Adverse Event|0
3082586|NCT00404651|10576770|P3|Overall Study|Serious Adverse Event|2
3082587|NCT00404651|10576771|P2|Overall Study|Serious Adverse Event|0
3082588|NCT00404651|10576772|P1|Overall Study|Serious Adverse Event|0
3082589|NCT00404547|10576800|P2|Overall Study|Reason not stated|6
3082590|NCT00404547|10576801|P1|Overall Study|Reason not stated|3
3082591|NCT00404547|10576800|P2|Overall Study|Other|0
3082592|NCT00404547|10576801|P1|Overall Study|Other|4
3082593|NCT00404547|10576800|P2|Overall Study|Lack of compliance|1
3082594|NCT00404547|10576801|P1|Overall Study|Lack of compliance|5
3082595|NCT00404547|10576800|P2|Overall Study|Lost to Follow-up|9
3082596|NCT00404547|10576801|P1|Overall Study|Lost to Follow-up|20
3082597|NCT00404547|10576800|P2|Overall Study|Protocol Violation|1
3082598|NCT00404547|10576801|P1|Overall Study|Protocol Violation|0
3082599|NCT00404547|10576800|P2|Overall Study|Withdrawal by Subject|2
3082600|NCT00404547|10576801|P1|Overall Study|Withdrawal by Subject|19
3082601|NCT00404547|10576800|P2|Overall Study|Adverse Event|6
3082602|NCT00404547|10576801|P1|Overall Study|Adverse Event|39
3082603|NCT00404495|10576811|P2|Overall Study|Withdrawal by Subject|0
3082604|NCT00404495|10576812|P1|Overall Study|Withdrawal by Subject|1
3082605|NCT00404495|10576811|P2|Overall Study|Other|0
3082606|NCT00404495|10576812|P1|Overall Study|Other|1
3082607|NCT00404495|10576811|P2|Overall Study|Lost to Follow-up|0
3082608|NCT00404495|10576812|P1|Overall Study|Lost to Follow-up|5
3082609|NCT00404495|10576811|P2|Overall Study|Death|11
3082610|NCT00404495|10576812|P1|Overall Study|Death|37
3082611|NCT00404352|10576831|P9|Open Label Extension (up to 36 Months)|Other|2
3082612|NCT00404352|10576832|P8|Open Label Extension (up to 36 Months)|Other|0
3082613|NCT00404352|10576833|P7|Open Label Extension (up to 36 Months)|Other|0
3082614|NCT00404352|10576834|P6|Open Label Extension (up to 36 Months)|Other|0
3082615|NCT00404352|10576835|P5|Open Label Extension (up to 36 Months)|Other|0
3082616|NCT00404352|10576836|P4|Open Label Extension (up to 36 Months)|Other|0
3082617|NCT00404352|10576837|P3|Open Label Extension (up to 36 Months)|Other|0
3082618|NCT00404352|10576838|P2|Open Label Extension (up to 36 Months)|Other|0
3082619|NCT00404352|10576839|P1|Open Label Extension (up to 36 Months)|Other|0
3082620|NCT00404352|10576831|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
3082621|NCT00404352|10576832|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
3082622|NCT00404352|10576833|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
3082623|NCT00404352|10576834|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
3082624|NCT00404352|10576835|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
3082625|NCT00404352|10576836|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
3082626|NCT00404352|10576837|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
3082627|NCT00404352|10576838|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
3082628|NCT00404352|10576839|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
3082629|NCT00404352|10576831|P9|Open Label (up to 24 Month)|Disease progression|0
3082630|NCT00404352|10576832|P8|Open Label (up to 24 Month)|Disease progression|0
3082631|NCT00404352|10576833|P7|Open Label (up to 24 Month)|Disease progression|0
3082632|NCT00404352|10576834|P6|Open Label (up to 24 Month)|Disease progression|0
3082633|NCT00404352|10576835|P5|Open Label (up to 24 Month)|Disease progression|0
3082634|NCT00404352|10576836|P4|Open Label (up to 24 Month)|Disease progression|1
3082635|NCT00404352|10576837|P3|Open Label (up to 24 Month)|Disease progression|0
3082636|NCT00404352|10576838|P2|Open Label (up to 24 Month)|Disease progression|0
3082637|NCT00404352|10576839|P1|Open Label (up to 24 Month)|Disease progression|0
3082638|NCT00404352|10576831|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082639|NCT00404352|10576832|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082640|NCT00404352|10576833|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082641|NCT00404352|10576834|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
3082642|NCT00404352|10576835|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082643|NCT00404352|10576836|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082644|NCT00404352|10576837|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082645|NCT00404352|10576838|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082646|NCT00404352|10576839|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
3082647|NCT00404352|10576831|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
3082648|NCT00404352|10576832|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
3082649|NCT00404352|10576833|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
3082650|NCT00404352|10576834|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
3082651|NCT00404352|10576835|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
3082652|NCT00404352|10576836|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
3082653|NCT00404352|10576837|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
3082654|NCT00404352|10576838|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
3082655|NCT00404352|10576839|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
3082656|NCT00404352|10576831|P9|Open Label (up to 24 Month)|Pregnancy|0
3082657|NCT00404352|10576832|P8|Open Label (up to 24 Month)|Pregnancy|0
3082658|NCT00404352|10576833|P7|Open Label (up to 24 Month)|Pregnancy|0
3082659|NCT00404352|10576834|P6|Open Label (up to 24 Month)|Pregnancy|1
3082660|NCT00404352|10576835|P5|Open Label (up to 24 Month)|Pregnancy|0
3082661|NCT00404352|10576836|P4|Open Label (up to 24 Month)|Pregnancy|0
3082662|NCT00404352|10576837|P3|Open Label (up to 24 Month)|Pregnancy|0
3082663|NCT00404352|10576838|P2|Open Label (up to 24 Month)|Pregnancy|0
3082664|NCT00404352|10576839|P1|Open Label (up to 24 Month)|Pregnancy|0
3082665|NCT00404352|10576831|P9|Open Label (up to 24 Month)|Adverse Event|0
3082666|NCT00404352|10576832|P8|Open Label (up to 24 Month)|Adverse Event|0
3082667|NCT00404352|10576833|P7|Open Label (up to 24 Month)|Adverse Event|0
3082668|NCT00404352|10576834|P6|Open Label (up to 24 Month)|Adverse Event|1
3082669|NCT00404352|10576835|P5|Open Label (up to 24 Month)|Adverse Event|1
3082670|NCT00404352|10576836|P4|Open Label (up to 24 Month)|Adverse Event|2
3082671|NCT00404352|10576837|P3|Open Label (up to 24 Month)|Adverse Event|0
3082672|NCT00404352|10576838|P2|Open Label (up to 24 Month)|Adverse Event|0
3082673|NCT00404352|10576839|P1|Open Label (up to 24 Month)|Adverse Event|0
3082674|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Other|0
3082675|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Other|0
3082676|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Other|0
3082677|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Other|0
3082678|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Other|0
3082679|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Other|0
3082680|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Other|0
3082681|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Other|1
3082682|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Other|0
3082683|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Physician Decision|0
3082684|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Physician Decision|0
3082685|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Physician Decision|0
3082686|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Physician Decision|0
3082687|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Physician Decision|0
3082688|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Physician Decision|0
3082689|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Physician Decision|1
3082690|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Physician Decision|0
3082691|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Physician Decision|0
3082692|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
3082693|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
3082694|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
3082695|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
3082696|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
3082697|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
3082698|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
3082699|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
3082700|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
3082701|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
3082702|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
3082703|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
3082704|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
3082705|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
3082706|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
3082707|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
3082708|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
3082709|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
3082710|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Poor compliance|0
3082711|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Poor compliance|0
3082712|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Poor compliance|0
3082713|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Poor compliance|0
3082714|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Poor compliance|0
3082715|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Poor compliance|0
3082716|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Poor compliance|0
3082717|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Poor compliance|0
3082718|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Poor compliance|1
3082719|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Disease progression|0
3082720|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Disease progression|0
3082721|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Disease progression|0
3082722|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Disease progression|0
3082723|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Disease progression|0
3082724|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Disease progression|0
3082725|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Disease progression|2
3082726|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Disease progression|0
3082727|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Disease progression|3
3082728|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082729|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082730|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082731|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082732|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082733|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
3082734|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
3082735|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
3082736|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
3082737|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082738|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082739|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082740|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082741|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082742|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
3082743|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
3082744|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
3082745|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
3082746|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Death|0
3082747|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Death|0
3082748|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Death|0
3082749|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Death|0
3082750|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Death|0
3082751|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Death|0
3082752|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Death|1
3082753|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Death|0
3082754|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Death|0
3082755|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Pregnancy|0
3082756|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Pregnancy|0
3082757|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Pregnancy|0
3082758|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Pregnancy|0
3082759|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Pregnancy|0
3082760|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Pregnancy|0
3082761|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Pregnancy|2
3082762|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Pregnancy|0
3082763|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Pregnancy|0
3082764|NCT00404352|10576831|P9|Double Blind (up to 24 Month)|Adverse Event|0
3082765|NCT00404352|10576832|P8|Double Blind (up to 24 Month)|Adverse Event|0
3082766|NCT00404352|10576833|P7|Double Blind (up to 24 Month)|Adverse Event|0
3082767|NCT00404352|10576834|P6|Double Blind (up to 24 Month)|Adverse Event|0
3082768|NCT00404352|10576835|P5|Double Blind (up to 24 Month)|Adverse Event|0
3082769|NCT00404352|10576836|P4|Double Blind (up to 24 Month)|Adverse Event|0
3082770|NCT00404352|10576837|P3|Double Blind (up to 24 Month)|Adverse Event|6
3082771|NCT00404352|10576838|P2|Double Blind (up to 24 Month)|Adverse Event|4
3082772|NCT00404352|10576839|P1|Double Blind (up to 24 Month)|Adverse Event|5
3082773|NCT00404248|10576874|P9|Overall Study|pts declining status|0
3082774|NCT00404248|10576875|P8|Overall Study|pts declining status|0
3082775|NCT00404248|10576876|P7|Overall Study|pts declining status|0
3082776|NCT00404248|10576877|P6|Overall Study|pts declining status|0
3082777|NCT00404248|10576878|P5|Overall Study|pts declining status|0
3082778|NCT00404248|10576879|P4|Overall Study|pts declining status|0
3082779|NCT00404248|10576880|P3|Overall Study|pts declining status|0
3082780|NCT00404248|10576881|P2|Overall Study|pts declining status|1
3082781|NCT00404248|10576882|P1|Overall Study|pts declining status|0
3082782|NCT00404235|10576915|P2|Overall Study|Withdrawal by Subject|2
3082783|NCT00404235|10576916|P1|Overall Study|Withdrawal by Subject|1
3082784|NCT00404092|10576934|P4|Overall Study|Adverse Event|0
3082785|NCT00404092|10576935|P3|Overall Study|Adverse Event|1
3082786|NCT00404092|10576936|P2|Overall Study|Adverse Event|0
3082787|NCT00404092|10576937|P1|Overall Study|Adverse Event|0
3082788|NCT00404092|10576934|P4|Overall Study|Death|0
3082789|NCT00404092|10576935|P3|Overall Study|Death|0
3082790|NCT00404092|10576936|P2|Overall Study|Death|0
3082791|NCT00404092|10576937|P1|Overall Study|Death|1
3082792|NCT00404079|10576953|P2|Overall Study|Lost to follow up, adverse event etc|20
3082793|NCT00404079|10576954|P1|Overall Study|Lost to follow up, adverse event etc|22
3082794|NCT00404066|10576960|P1|Overall Study|Withdrawal by Subject - Adverse event|2
3082795|NCT00404066|10576960|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
3082796|NCT00403845|10576965|P4|Treatment Period 3|Adverse Event|1
3082797|NCT00403845|10576966|P3|Treatment Period 3|Adverse Event|0
3082798|NCT00403845|10576967|P2|Treatment Period 3|Adverse Event|0
3082799|NCT00403845|10576968|P1|Treatment Period 3|Adverse Event|0
3082800|NCT00403845|10576965|P4|Treatment Period 3|Subject withdrew consent|1
3082801|NCT00403845|10576966|P3|Treatment Period 3|Subject withdrew consent|0
3082802|NCT00403845|10576967|P2|Treatment Period 3|Subject withdrew consent|0
3082803|NCT00403845|10576968|P1|Treatment Period 3|Subject withdrew consent|0
3082804|NCT00403845|10576965|P4|Treatment Period 2|Subject withdrew consent|0
3082805|NCT00403845|10576966|P3|Treatment Period 2|Subject withdrew consent|0
3082806|NCT00403845|10576967|P2|Treatment Period 2|Subject withdrew consent|0
3082807|NCT00403845|10576968|P1|Treatment Period 2|Subject withdrew consent|1
3082808|NCT00403845|10576965|P4|Treatment Period 1|Subject no longer needs study drug|1
3082809|NCT00403845|10576966|P3|Treatment Period 1|Subject no longer needs study drug|0
3082810|NCT00403845|10576967|P2|Treatment Period 1|Subject no longer needs study drug|0
3082811|NCT00403845|10576968|P1|Treatment Period 1|Subject no longer needs study drug|0
3082812|NCT00403845|10576965|P4|Treatment Period 1|Subject withdrew consent|0
3082813|NCT00403845|10576966|P3|Treatment Period 1|Subject withdrew consent|0
3082814|NCT00403845|10576967|P2|Treatment Period 1|Subject withdrew consent|0
3082815|NCT00403845|10576968|P1|Treatment Period 1|Subject withdrew consent|1
3082816|NCT00403767|10576992|P2|Overall Study|Missing/incomplete data|1
3082817|NCT00403767|10576993|P1|Overall Study|Missing/incomplete data|1
3082818|NCT00403767|10576992|P2|Overall Study|Study terminated by sponsor|69
3082819|NCT00403767|10576993|P1|Overall Study|Study terminated by sponsor|82
3082820|NCT00403767|10576992|P2|Overall Study|Clinical efficacy endpoint reached|332
3082821|NCT00403767|10576993|P1|Overall Study|Clinical efficacy endpoint reached|300
3082822|NCT00403767|10576992|P2|Overall Study|Protocol Violation|124
3082823|NCT00403767|10576993|P1|Overall Study|Protocol Violation|142
3082824|NCT00403767|10576992|P2|Overall Study|Lost to Follow-up|8
3082825|NCT00403767|10576993|P1|Overall Study|Lost to Follow-up|6
3082826|NCT00403767|10576992|P2|Overall Study|Investigator dec./not protocol-related|178
3082827|NCT00403767|10576993|P1|Overall Study|Investigator dec./not protocol-related|191
3082828|NCT00403767|10576992|P2|Overall Study|Consent withdrawn|673
3082829|NCT00403767|10576993|P1|Overall Study|Consent withdrawn|671
3082830|NCT00403767|10576992|P2|Overall Study|Non-compliant with study medication|164
3082831|NCT00403767|10576993|P1|Overall Study|Non-compliant with study medication|134
3082832|NCT00403767|10576992|P2|Overall Study|Adverse Event|919
3082833|NCT00403767|10576993|P1|Overall Study|Adverse Event|993
3082834|NCT00403754|10577017|P4|Core Treatment Period 2|Lack of Efficacy|0
3082835|NCT00403754|10577018|P3|Core Treatment Period 2|Lack of Efficacy|1
3082836|NCT00403754|10577019|P2|Core Treatment Period 2|Lack of Efficacy|0
3082837|NCT00403754|10577020|P1|Core Treatment Period 2|Lack of Efficacy|0
3082838|NCT00403754|10577017|P4|Core Treatment Period 1|Withdrawal by Subject|0
3082839|NCT00403754|10577018|P3|Core Treatment Period 1|Withdrawal by Subject|0
3082840|NCT00403754|10577019|P2|Core Treatment Period 1|Withdrawal by Subject|1
3082841|NCT00403754|10577020|P1|Core Treatment Period 1|Withdrawal by Subject|0
3082842|NCT00403585|10577047|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
3082843|NCT00403585|10577047|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
3082844|NCT00403585|10577047|P1|Initial Treatment Phase|Lost to Follow-up|2
3082845|NCT00403546|10577058|P3|Randomized Trial|Early Terminations|16
3082846|NCT00403546|10577059|P2|Randomized Trial|Early Terminations|17
3082847|NCT00403546|10577060|P1|Randomized Trial|Early Terminations|0
3082848|NCT00403546|10577058|P3|Screening Phase|Terminated Prior to Randomization|0
3082849|NCT00403546|10577059|P2|Screening Phase|Terminated Prior to Randomization|0
3082850|NCT00403546|10577060|P1|Screening Phase|Terminated Prior to Randomization|5
3082851|NCT00403546|10577058|P3|Screening Phase|Adverse Event|0
3082852|NCT00403546|10577059|P2|Screening Phase|Adverse Event|0
3082853|NCT00403546|10577060|P1|Screening Phase|Adverse Event|1
3082854|NCT00403546|10577058|P3|Screening Phase|Screening Failure|0
3082855|NCT00403546|10577059|P2|Screening Phase|Screening Failure|0
3082856|NCT00403546|10577060|P1|Screening Phase|Screening Failure|22
3082857|NCT00403546|10577058|P3|Signed Informed Consent/Open-Label|Adverse Event|0
3082858|NCT00403546|10577059|P2|Signed Informed Consent/Open-Label|Adverse Event|0
3082859|NCT00403546|10577060|P1|Signed Informed Consent/Open-Label|Adverse Event|5
3082860|NCT00403546|10577058|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
3082861|NCT00403546|10577059|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
3082862|NCT00403546|10577060|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
3082863|NCT00403546|10577058|P3|Signed Informed Consent/Open-Label|Early Termination|0
3082864|NCT00403546|10577059|P2|Signed Informed Consent/Open-Label|Early Termination|0
3082865|NCT00403546|10577060|P1|Signed Informed Consent/Open-Label|Early Termination|8
3082866|NCT00403546|10577058|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
3082867|NCT00403546|10577059|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
3082868|NCT00403546|10577060|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
3082869|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
3082870|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
3082871|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
3082872|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
3082873|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
3082874|NCT00403481|10577100|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
3082875|NCT00403481|10577100|P1|Olm 40 mg|Other|1
3082876|NCT00403481|10577100|P1|Olm 40 mg|Withdrawal by Subject|1
3082877|NCT00403481|10577100|P1|Olm 40 mg|Protocol Violation|1
3082878|NCT00403481|10577100|P1|Olm 40 mg|Adverse Event|2
3082879|NCT00403481|10577100|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
3082880|NCT00403481|10577100|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
3082881|NCT00403481|10577100|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
3082882|NCT00403481|10577100|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
3082883|NCT00403455|10577115|P1|Overall Study|Withdrawal by Subject|1
3082884|NCT00403390|10577138|P2|Overall Study|non-compliant|0
3082885|NCT00403390|10577139|P1|Overall Study|non-compliant|1
3082886|NCT00403390|10577138|P2|Overall Study|samples lost|0
3082887|NCT00403390|10577139|P1|Overall Study|samples lost|1
3082888|NCT00403390|10577138|P2|Overall Study|Withdrawal by Subject|0
3082889|NCT00403390|10577139|P1|Overall Study|Withdrawal by Subject|1
3082890|NCT00403273|10577147|P2|Overall Study|pt. wanted to have a surgical procedure|1
3082891|NCT00403273|10577148|P1|Overall Study|pt. wanted to have a surgical procedure|0
3082892|NCT00403273|10577147|P2|Overall Study|Physician Decision|1
3082893|NCT00403273|10577148|P1|Overall Study|Physician Decision|0
3082894|NCT00403273|10577147|P2|Overall Study|Lost to Follow-up|2
3082895|NCT00403273|10577148|P1|Overall Study|Lost to Follow-up|3
3082896|NCT00403234|10577190|P4|Overall Study|Adverse Event|0
3082897|NCT00403234|10577191|P3|Overall Study|Adverse Event|1
3082898|NCT00403234|10577192|P2|Overall Study|Adverse Event|0
3082899|NCT00403234|10577193|P1|Overall Study|Adverse Event|1
3082900|NCT00403234|10577190|P4|Overall Study|Withdrawal by Subject|0
3082901|NCT00403234|10577191|P3|Overall Study|Withdrawal by Subject|0
3082902|NCT00403234|10577192|P2|Overall Study|Withdrawal by Subject|1
3082903|NCT00403234|10577193|P1|Overall Study|Withdrawal by Subject|0
3082904|NCT00403130|10577203|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
3082905|NCT00403130|10577203|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
3082906|NCT00403130|10577203|P1|2 Years From Start of Treatment|Lost to Follow up|1
3082907|NCT00403130|10577203|P1|2 Years From Start of Treatment|Not Eligible|3
3082908|NCT00402987|10577256|P4|Overall Study|Lack of Efficacy|0
3082909|NCT00402987|10577257|P3|Overall Study|Lack of Efficacy|1
3082910|NCT00402987|10577258|P2|Overall Study|Lack of Efficacy|0
3082911|NCT00402987|10577259|P1|Overall Study|Lack of Efficacy|0
3082912|NCT00402831|10577431|P2|Overall Study|Non-compliance with protocol|1
3082913|NCT00402831|10577432|P1|Overall Study|Non-compliance with protocol|0
3082914|NCT00402831|10577431|P2|Overall Study|Lost to Follow-up|2
3082915|NCT00402831|10577432|P1|Overall Study|Lost to Follow-up|1
3082916|NCT00402779|10577466|P2|Overall Study|Screen Failure|76
3082917|NCT00402779|10577467|P1|Overall Study|Screen Failure|77
3082918|NCT00402740|10577473|P1|Overall Study|Subject disposition unknown.|1
3082919|NCT00402740|10577473|P1|Overall Study|No stent. Completed FU at 30 days.|5
3082920|NCT00402740|10577473|P1|Overall Study|Lost to Follow-up|6
3082921|NCT00402740|10577473|P1|Overall Study|Death|50
3082922|NCT00402740|10577473|P1|Overall Study|Withdrawal by Subject|18
3082923|NCT00402727|10577485|P2|Overall Study|non-compliance|1
3082924|NCT00402727|10577486|P1|Overall Study|non-compliance|0
3082925|NCT00402727|10577485|P2|Overall Study|supply problems|1
3082926|NCT00402727|10577486|P1|Overall Study|supply problems|2
3082927|NCT00402727|10577485|P2|Overall Study|Withdrawal by Subject|7
3082928|NCT00402727|10577486|P1|Overall Study|Withdrawal by Subject|3
3082929|NCT00402727|10577485|P2|Overall Study|Protocol Violation|4
3082930|NCT00402727|10577486|P1|Overall Study|Protocol Violation|0
3082931|NCT00402727|10577485|P2|Overall Study|Physician Decision|1
3082932|NCT00402727|10577486|P1|Overall Study|Physician Decision|1
3082933|NCT00402727|10577485|P2|Overall Study|Lost to Follow-up|11
3082934|NCT00402727|10577486|P1|Overall Study|Lost to Follow-up|24
3082935|NCT00402727|10577485|P2|Overall Study|Lack of Efficacy|3
3082936|NCT00402727|10577486|P1|Overall Study|Lack of Efficacy|1
3082937|NCT00402727|10577485|P2|Overall Study|Death|0
3082938|NCT00402727|10577486|P1|Overall Study|Death|1
3082939|NCT00402727|10577485|P2|Overall Study|Adverse Event|6
3082940|NCT00402727|10577486|P1|Overall Study|Adverse Event|10
3082941|NCT00402688|10577528|P3|Overall Study|Patient Left Town and Forgot Medication|1
3082942|NCT00402688|10577529|P2|Overall Study|Patient Left Town and Forgot Medication|0
3082943|NCT00402688|10577530|P1|Overall Study|Patient Left Town and Forgot Medication|0
3082944|NCT00402688|10577528|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
3082945|NCT00402688|10577529|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
3082946|NCT00402688|10577530|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
3082947|NCT00402688|10577528|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
3082948|NCT00402688|10577529|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
3082949|NCT00402688|10577530|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
3082950|NCT00402688|10577528|P3|Overall Study|Lost to Follow-up|2
3082951|NCT00402688|10577529|P2|Overall Study|Lost to Follow-up|0
3082952|NCT00402688|10577530|P1|Overall Study|Lost to Follow-up|1
3082953|NCT00402688|10577528|P3|Overall Study|Protocol Violation|1
3082954|NCT00402688|10577529|P2|Overall Study|Protocol Violation|1
3082955|NCT00402688|10577530|P1|Overall Study|Protocol Violation|1
3082956|NCT00402688|10577528|P3|Overall Study|Lack of Efficacy|5
3082957|NCT00402688|10577529|P2|Overall Study|Lack of Efficacy|4
3082958|NCT00402688|10577530|P1|Overall Study|Lack of Efficacy|4
3082959|NCT00402688|10577528|P3|Overall Study|Physician Decision|1
3082960|NCT00402688|10577529|P2|Overall Study|Physician Decision|0
3082961|NCT00402688|10577530|P1|Overall Study|Physician Decision|0
3082962|NCT00402688|10577528|P3|Overall Study|Withdrawal by Subject|1
3082963|NCT00402688|10577529|P2|Overall Study|Withdrawal by Subject|1
3082964|NCT00402688|10577530|P1|Overall Study|Withdrawal by Subject|3
3082965|NCT00402688|10577528|P3|Overall Study|Adverse Event|3
3082966|NCT00402688|10577529|P2|Overall Study|Adverse Event|9
3082967|NCT00402688|10577530|P1|Overall Study|Adverse Event|12
3082968|NCT00402649|10577553|P1|Overall Study|Withdrawal by Subject|1
3082969|NCT00402649|10577553|P1|Overall Study|Lost to Follow-up|1
3082970|NCT00402597|10577568|P5|Overall Study|reason not specified|20
3082971|NCT00402597|10577569|P4|Overall Study|reason not specified|14
3082972|NCT00402597|10577570|P3|Overall Study|reason not specified|27
3082973|NCT00402597|10577571|P2|Overall Study|reason not specified|4
3082974|NCT00402597|10577572|P1|Overall Study|reason not specified|30
3082975|NCT00402597|10577568|P5|Overall Study|Withdrawal by Subject|24
3082976|NCT00402597|10577569|P4|Overall Study|Withdrawal by Subject|15
3082977|NCT00402597|10577570|P3|Overall Study|Withdrawal by Subject|65
3082978|NCT00402597|10577571|P2|Overall Study|Withdrawal by Subject|16
3082979|NCT00402597|10577572|P1|Overall Study|Withdrawal by Subject|57
3082980|NCT00402597|10577568|P5|Overall Study|Lost to Follow-up|3
3082981|NCT00402597|10577569|P4|Overall Study|Lost to Follow-up|2
3082982|NCT00402597|10577570|P3|Overall Study|Lost to Follow-up|8
3082983|NCT00402597|10577571|P2|Overall Study|Lost to Follow-up|1
3082984|NCT00402597|10577572|P1|Overall Study|Lost to Follow-up|8
3082985|NCT00402597|10577568|P5|Overall Study|Adverse Event|71
3082986|NCT00402597|10577569|P4|Overall Study|Adverse Event|39
3082987|NCT00402597|10577570|P3|Overall Study|Adverse Event|106
3082988|NCT00402597|10577571|P2|Overall Study|Adverse Event|18
3082989|NCT00402597|10577572|P1|Overall Study|Adverse Event|81
3082990|NCT00402597|10577568|P5|Overall Study|Death|6
3082991|NCT00402597|10577569|P4|Overall Study|Death|4
3082992|NCT00402597|10577570|P3|Overall Study|Death|6
3082993|NCT00402597|10577571|P2|Overall Study|Death|7
3082994|NCT00402597|10577572|P1|Overall Study|Death|15
3082995|NCT00402363|10577613|P4|Overall Study|"Captured as Other"|2
3082996|NCT00402363|10577614|P3|Overall Study|"Captured as Other"|2
3082997|NCT00402363|10577615|P2|Overall Study|"Captured as Other"|2
3082998|NCT00402363|10577616|P1|Overall Study|"Captured as Other"|6
3082999|NCT00402363|10577613|P4|Overall Study|Lost to Follow-up|2
3083000|NCT00402363|10577614|P3|Overall Study|Lost to Follow-up|0
3083001|NCT00402363|10577615|P2|Overall Study|Lost to Follow-up|4
3083002|NCT00402363|10577616|P1|Overall Study|Lost to Follow-up|5
3083003|NCT00402363|10577613|P4|Overall Study|Protocol Violation|3
3083004|NCT00402363|10577614|P3|Overall Study|Protocol Violation|0
3083005|NCT00402363|10577615|P2|Overall Study|Protocol Violation|5
3083006|NCT00402363|10577616|P1|Overall Study|Protocol Violation|3
3083007|NCT00402363|10577613|P4|Overall Study|Withdrew Consent|1
3083008|NCT00402363|10577614|P3|Overall Study|Withdrew Consent|2
3083009|NCT00402363|10577615|P2|Overall Study|Withdrew Consent|5
3083010|NCT00402363|10577616|P1|Overall Study|Withdrew Consent|10
3083011|NCT00402363|10577613|P4|Overall Study|Adverse Event|2
3083012|NCT00402363|10577614|P3|Overall Study|Adverse Event|2
3083013|NCT00402363|10577615|P2|Overall Study|Adverse Event|14
3083014|NCT00402363|10577616|P1|Overall Study|Adverse Event|9
3083015|NCT00402337|10577679|P5|Overall Study|Other Reason|0
3083016|NCT00402337|10577680|P4|Overall Study|Other Reason|0
3083017|NCT00402337|10577681|P3|Overall Study|Other Reason|0
3083018|NCT00402337|10577682|P2|Overall Study|Other Reason|1
3083019|NCT00402337|10577683|P1|Overall Study|Other Reason|0
3083020|NCT00402337|10577679|P5|Overall Study|Physician Decision|0
3083021|NCT00402337|10577680|P4|Overall Study|Physician Decision|1
3083022|NCT00402337|10577681|P3|Overall Study|Physician Decision|0
3083023|NCT00402337|10577682|P2|Overall Study|Physician Decision|0
3083024|NCT00402337|10577683|P1|Overall Study|Physician Decision|0
3083025|NCT00402337|10577679|P5|Overall Study|Lost to Follow-up|0
3083026|NCT00402337|10577680|P4|Overall Study|Lost to Follow-up|2
3083027|NCT00402337|10577681|P3|Overall Study|Lost to Follow-up|1
3083028|NCT00402337|10577682|P2|Overall Study|Lost to Follow-up|0
3083029|NCT00402337|10577683|P1|Overall Study|Lost to Follow-up|0
3083030|NCT00402337|10577679|P5|Overall Study|Withdrawal by Subject|4
3083031|NCT00402337|10577680|P4|Overall Study|Withdrawal by Subject|6
3083032|NCT00402337|10577681|P3|Overall Study|Withdrawal by Subject|1
3083033|NCT00402337|10577682|P2|Overall Study|Withdrawal by Subject|3
3083034|NCT00402337|10577683|P1|Overall Study|Withdrawal by Subject|5
3083035|NCT00402337|10577679|P5|Overall Study|Noncompliance|2
3083036|NCT00402337|10577680|P4|Overall Study|Noncompliance|0
3083037|NCT00402337|10577681|P3|Overall Study|Noncompliance|0
3083038|NCT00402337|10577682|P2|Overall Study|Noncompliance|0
3083039|NCT00402337|10577683|P1|Overall Study|Noncompliance|0
3083040|NCT00402337|10577679|P5|Overall Study|Adverse Event|2
3083041|NCT00402337|10577680|P4|Overall Study|Adverse Event|3
3083042|NCT00402337|10577681|P3|Overall Study|Adverse Event|2
3083043|NCT00402337|10577682|P2|Overall Study|Adverse Event|2
3083044|NCT00402337|10577683|P1|Overall Study|Adverse Event|0
3083045|NCT00402324|10577722|P2|Overall Study|Death|0
3083046|NCT00402324|10577723|P1|Overall Study|Death|1
3083047|NCT00402324|10577722|P2|Overall Study|Adverse Event|4
3083048|NCT00402324|10577723|P1|Overall Study|Adverse Event|6
3083049|NCT00402324|10577722|P2|Overall Study|Lack of Efficacy|4
3083050|NCT00402324|10577723|P1|Overall Study|Lack of Efficacy|1
3083051|NCT00402324|10577722|P2|Overall Study|Sponsor Decision|5
3083052|NCT00402324|10577723|P1|Overall Study|Sponsor Decision|4
3083053|NCT00402324|10577722|P2|Overall Study|Physician Decision|4
3083054|NCT00402324|10577723|P1|Overall Study|Physician Decision|2
3083055|NCT00402324|10577722|P2|Overall Study|Withdrawal by Subject|2
3083056|NCT00402324|10577723|P1|Overall Study|Withdrawal by Subject|5
3083057|NCT00402324|10577722|P2|Overall Study|Protocol Violation|7
3083058|NCT00402324|10577723|P1|Overall Study|Protocol Violation|8
3083059|NCT00402324|10577722|P2|Overall Study|Protocol Entry Criteria Not Met|4
3083060|NCT00402324|10577723|P1|Overall Study|Protocol Entry Criteria Not Met|5
3083061|NCT00402324|10577722|P2|Overall Study|Lost to Follow-up|11
3083062|NCT00402324|10577723|P1|Overall Study|Lost to Follow-up|11
3083063|NCT00402285|10577756|P3|Overall Study|insufficient RNA quality|2
3083064|NCT00402285|10577757|P2|Overall Study|insufficient RNA quality|6
3083065|NCT00402285|10577758|P1|Overall Study|insufficient RNA quality|7
3083066|NCT00402246|10577766|P2|Overall Study|Deterioriating Condition|2
3083067|NCT00402246|10577767|P1|Overall Study|Deterioriating Condition|3
3083068|NCT00402246|10577766|P2|Overall Study|Center Closure|3
3083069|NCT00402246|10577767|P1|Overall Study|Center Closure|5
3083070|NCT00402246|10577766|P2|Overall Study|Patient's device explanted|2
3083071|NCT00402246|10577767|P1|Overall Study|Patient's device explanted|6
3083072|NCT00402246|10577766|P2|Overall Study|Heart Transplant|1
3083073|NCT00402246|10577767|P1|Overall Study|Heart Transplant|0
3083074|NCT00402246|10577766|P2|Overall Study|Insurance Issues|1
3083075|NCT00402246|10577767|P1|Overall Study|Insurance Issues|2
3083076|NCT00402246|10577766|P2|Overall Study|Missed Final Visit|2
3083077|NCT00402246|10577767|P1|Overall Study|Missed Final Visit|1
3083078|NCT00402246|10577766|P2|Overall Study|Protocol Violation|24
3083079|NCT00402246|10577767|P1|Overall Study|Protocol Violation|25
3083080|NCT00402246|10577766|P2|Overall Study|Physician Decision|26
3083081|NCT00402246|10577767|P1|Overall Study|Physician Decision|24
3083082|NCT00402246|10577766|P2|Overall Study|Withdrawal by Subject|87
3083083|NCT00402246|10577767|P1|Overall Study|Withdrawal by Subject|72
3083084|NCT00402246|10577766|P2|Overall Study|Lost to Follow-up|28
3083085|NCT00402246|10577767|P1|Overall Study|Lost to Follow-up|20
3083086|NCT00402246|10577766|P2|Overall Study|Death|58
3083087|NCT00402246|10577767|P1|Overall Study|Death|62
3083088|NCT00402233|10577801|P4|Overall Study|Worsening of other pre-existing disease|0
3083089|NCT00402233|10577802|P3|Overall Study|Worsening of other pre-existing disease|0
3083090|NCT00402233|10577803|P2|Overall Study|Worsening of other pre-existing disease|1
3083091|NCT00402233|10577804|P1|Overall Study|Worsening of other pre-existing disease|0
3083092|NCT00402233|10577801|P4|Overall Study|Worsening of disease under study|0
3083093|NCT00402233|10577802|P3|Overall Study|Worsening of disease under study|0
3083094|NCT00402233|10577803|P2|Overall Study|Worsening of disease under study|0
3083095|NCT00402233|10577804|P1|Overall Study|Worsening of disease under study|2
3083096|NCT00402233|10577801|P4|Overall Study|Withdrawal by Subject|2
3083097|NCT00402233|10577802|P3|Overall Study|Withdrawal by Subject|2
3083098|NCT00402233|10577803|P2|Overall Study|Withdrawal by Subject|1
3083099|NCT00402233|10577804|P1|Overall Study|Withdrawal by Subject|2
3083100|NCT00402233|10577801|P4|Overall Study|Protocol Violation|0
3083101|NCT00402233|10577802|P3|Overall Study|Protocol Violation|0
3083102|NCT00402233|10577803|P2|Overall Study|Protocol Violation|1
3083103|NCT00402233|10577804|P1|Overall Study|Protocol Violation|0
3083104|NCT00402233|10577801|P4|Overall Study|Adverse Event|9
3083105|NCT00402233|10577802|P3|Overall Study|Adverse Event|9
3083106|NCT00402233|10577803|P2|Overall Study|Adverse Event|7
3083107|NCT00402233|10577804|P1|Overall Study|Adverse Event|1
3083108|NCT00402168|10577839|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
3083109|NCT00402168|10577840|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
3083110|NCT00402168|10577839|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
3083111|NCT00402168|10577840|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
3083112|NCT00402168|10577839|P2|Long Term (LT)|non-specified|2
3083113|NCT00402168|10577840|P1|Long Term (LT)|non-specified|1
3083114|NCT00402168|10577839|P2|Long Term (LT)|Lack of Efficacy|2
3083115|NCT00402168|10577840|P1|Long Term (LT)|Lack of Efficacy|0
3083116|NCT00402168|10577839|P2|Long Term (LT)|Death|0
3083117|NCT00402168|10577840|P1|Long Term (LT)|Death|4
3083118|NCT00402168|10577839|P2|Long Term (LT)|Lost to Follow-up|0
3083119|NCT00402168|10577840|P1|Long Term (LT)|Lost to Follow-up|1
3083120|NCT00402168|10577839|P2|Long Term (LT)|Pregnancy|1
3083121|NCT00402168|10577840|P1|Long Term (LT)|Pregnancy|0
3083122|NCT00402168|10577839|P2|Long Term (LT)|Withdrawal by Subject|7
3083123|NCT00402168|10577840|P1|Long Term (LT)|Withdrawal by Subject|4
3083124|NCT00402168|10577839|P2|Long Term (LT)|Adverse Event|5
3083125|NCT00402168|10577840|P1|Long Term (LT)|Adverse Event|1
3083126|NCT00402168|10577839|P2|Treatment (up to 12 Months)|non-specified|1
3083127|NCT00402168|10577840|P1|Treatment (up to 12 Months)|non-specified|0
3083128|NCT00402168|10577839|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
3083129|NCT00402168|10577840|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
3083130|NCT00402168|10577839|P2|Treatment (up to 12 Months)|Death|1
3083131|NCT00402168|10577840|P1|Treatment (up to 12 Months)|Death|0
3083132|NCT00402168|10577839|P2|Randomized|Withdrawal by Subject|1
3083133|NCT00402168|10577840|P1|Randomized|Withdrawal by Subject|0
3083134|NCT00402168|10577839|P2|Randomized|Lost to Follow-up|0
3083135|NCT00402168|10577840|P1|Randomized|Lost to Follow-up|1
3083136|NCT00402103|10577897|P2|Overall Study|Administrative problems|0
3083137|NCT00402103|10577898|P1|Overall Study|Administrative problems|2
3083138|NCT00402103|10577897|P2|Overall Study|Lost to Follow-up|3
3083139|NCT00402103|10577898|P1|Overall Study|Lost to Follow-up|6
3083140|NCT00402103|10577897|P2|Overall Study|Patient withdrew consent|1
3083141|NCT00402103|10577898|P1|Overall Study|Patient withdrew consent|12
3083142|NCT00402103|10577897|P2|Overall Study|Protocol Deviation|0
3083143|NCT00402103|10577898|P1|Overall Study|Protocol Deviation|8
3083144|NCT00402103|10577897|P2|Overall Study|Condition no longer requires study drug|0
3083145|NCT00402103|10577898|P1|Overall Study|Condition no longer requires study drug|2
3083146|NCT00402103|10577897|P2|Overall Study|Unsatisfactory therapeutic effect|2
3083147|NCT00402103|10577898|P1|Overall Study|Unsatisfactory therapeutic effect|1
3083148|NCT00402103|10577897|P2|Overall Study|Adverse Event|7
3083149|NCT00402103|10577898|P1|Overall Study|Adverse Event|60
3083150|NCT00402051|10577914|P2|Overall Study|Lost to Follow-up|0
3083151|NCT00402051|10577915|P1|Overall Study|Lost to Follow-up|1
3083152|NCT00402051|10577914|P2|Overall Study|Death Due to Adverse Event|2
3083153|NCT00402051|10577915|P1|Overall Study|Death Due to Adverse Event|0
3083154|NCT00402051|10577914|P2|Overall Study|Death Due to Study Disease|1
3083155|NCT00402051|10577915|P1|Overall Study|Death Due to Study Disease|2
3083156|NCT00402051|10577914|P2|Overall Study|Death - Related to Study Drug|2
3083157|NCT00402051|10577915|P1|Overall Study|Death - Related to Study Drug|1
3083158|NCT00402051|10577914|P2|Overall Study|Withdrawal by Subject|3
3083159|NCT00402051|10577915|P1|Overall Study|Withdrawal by Subject|3
3083160|NCT00402051|10577914|P2|Overall Study|Physician Decision|3
3083161|NCT00402051|10577915|P1|Overall Study|Physician Decision|7
3083162|NCT00402051|10577914|P2|Overall Study|Adverse Event|4
3083163|NCT00402051|10577915|P1|Overall Study|Adverse Event|11
3083164|NCT00402051|10577914|P2|Overall Study|Progressive Disease|20
3083165|NCT00402051|10577915|P1|Overall Study|Progressive Disease|13
3083166|NCT00402025|10577932|P3|Overall Study|Participant Decision|1
3083167|NCT00402025|10577933|P2|Overall Study|Participant Decision|0
3083168|NCT00402025|10577934|P1|Overall Study|Participant Decision|0
3083169|NCT00402025|10577932|P3|Overall Study|Physician Decision|0
3083170|NCT00402025|10577933|P2|Overall Study|Physician Decision|1
3083171|NCT00402025|10577934|P1|Overall Study|Physician Decision|1
3083172|NCT00402025|10577932|P3|Overall Study|Disease Progression|2
3083173|NCT00402025|10577933|P2|Overall Study|Disease Progression|1
3083174|NCT00402025|10577934|P1|Overall Study|Disease Progression|1
3083175|NCT00402025|10577932|P3|Overall Study|Death|5
3083176|NCT00402025|10577933|P2|Overall Study|Death|1
3083177|NCT00402025|10577934|P1|Overall Study|Death|0
3083178|NCT00402025|10577932|P3|Overall Study|Adverse Event|2
3083179|NCT00402025|10577933|P2|Overall Study|Adverse Event|0
3083180|NCT00402025|10577934|P1|Overall Study|Adverse Event|0
3083181|NCT00401973|10577960|P3|Overall Study|Withdrawal by Subject|9
3083182|NCT00401973|10577961|P2|Overall Study|Withdrawal by Subject|12
3083183|NCT00401973|10577962|P1|Overall Study|Withdrawal by Subject|4
3083184|NCT00401973|10577960|P3|Overall Study|Sponsor Decision|0
3083185|NCT00401973|10577961|P2|Overall Study|Sponsor Decision|1
3083186|NCT00401973|10577962|P1|Overall Study|Sponsor Decision|0
3083187|NCT00401973|10577960|P3|Overall Study|Protocol Violation|3
3083188|NCT00401973|10577961|P2|Overall Study|Protocol Violation|2
3083189|NCT00401973|10577962|P1|Overall Study|Protocol Violation|1
3083190|NCT00401973|10577960|P3|Overall Study|Physician Decision|1
3083191|NCT00401973|10577961|P2|Overall Study|Physician Decision|0
3083192|NCT00401973|10577962|P1|Overall Study|Physician Decision|2
3083193|NCT00401973|10577960|P3|Overall Study|Lost to Follow-up|2
3083194|NCT00401973|10577961|P2|Overall Study|Lost to Follow-up|2
3083195|NCT00401973|10577962|P1|Overall Study|Lost to Follow-up|2
3083196|NCT00401973|10577960|P3|Overall Study|Lack of Efficacy|3
3083197|NCT00401973|10577961|P2|Overall Study|Lack of Efficacy|0
3083198|NCT00401973|10577962|P1|Overall Study|Lack of Efficacy|0
3083199|NCT00401973|10577960|P3|Overall Study|Clinical Relapse|1
3083200|NCT00401973|10577961|P2|Overall Study|Clinical Relapse|1
3083201|NCT00401973|10577962|P1|Overall Study|Clinical Relapse|0
3083202|NCT00401973|10577960|P3|Overall Study|Adverse Event|4
3083203|NCT00401973|10577961|P2|Overall Study|Adverse Event|8
3083204|NCT00401973|10577962|P1|Overall Study|Adverse Event|2
3083205|NCT00401960|10578001|P2|Overall Study|Death|0
3083206|NCT00401960|10578002|P1|Overall Study|Death|2
3083207|NCT00401960|10578001|P2|Overall Study|Lost to Follow-up|0
3083208|NCT00401960|10578002|P1|Overall Study|Lost to Follow-up|3
3083209|NCT00401843|10578032|P3|Overall Study|Received incorrect treatment|0
3083210|NCT00401843|10578033|P2|Overall Study|Received incorrect treatment|3
3083211|NCT00401843|10578034|P1|Overall Study|Received incorrect treatment|0
3083212|NCT00401843|10578032|P3|Overall Study|Randomized but not Treated|3
3083213|NCT00401843|10578033|P2|Overall Study|Randomized but not Treated|2
3083214|NCT00401843|10578034|P1|Overall Study|Randomized but not Treated|0
3083215|NCT00401843|10578032|P3|Overall Study|Withdrawal of consent to study agent|17
3083216|NCT00401843|10578033|P2|Overall Study|Withdrawal of consent to study agent|15
3083217|NCT00401843|10578034|P1|Overall Study|Withdrawal of consent to study agent|1
3083218|NCT00401843|10578032|P3|Overall Study|Withdrawal by Subject|5
3083219|NCT00401843|10578033|P2|Overall Study|Withdrawal by Subject|5
3083220|NCT00401843|10578034|P1|Overall Study|Withdrawal by Subject|1
3083221|NCT00401843|10578032|P3|Overall Study|Protocol Violation|1
3083222|NCT00401843|10578033|P2|Overall Study|Protocol Violation|0
3083223|NCT00401843|10578034|P1|Overall Study|Protocol Violation|0
3083224|NCT00401843|10578032|P3|Overall Study|Physician Decision|10
3083225|NCT00401843|10578033|P2|Overall Study|Physician Decision|16
3083226|NCT00401843|10578034|P1|Overall Study|Physician Decision|0
3083227|NCT00401843|10578032|P3|Overall Study|Other Unspecified|5
3083228|NCT00401843|10578033|P2|Overall Study|Other Unspecified|3
3083229|NCT00401843|10578034|P1|Overall Study|Other Unspecified|0
3083230|NCT00401843|10578032|P3|Overall Study|Lost to Follow-up|2
3083231|NCT00401843|10578033|P2|Overall Study|Lost to Follow-up|0
3083232|NCT00401843|10578034|P1|Overall Study|Lost to Follow-up|0
3083233|NCT00401843|10578032|P3|Overall Study|End of Study|2
3083234|NCT00401843|10578033|P2|Overall Study|End of Study|1
3083235|NCT00401843|10578034|P1|Overall Study|End of Study|1
3083236|NCT00401843|10578032|P3|Overall Study|Disease progression|49
3083237|NCT00401843|10578033|P2|Overall Study|Disease progression|60
3083238|NCT00401843|10578034|P1|Overall Study|Disease progression|10
3083239|NCT00401843|10578032|P3|Overall Study|Death|10
3083240|NCT00401843|10578033|P2|Overall Study|Death|8
3083241|NCT00401843|10578034|P1|Overall Study|Death|0
3083242|NCT00401843|10578032|P3|Overall Study|Adverse Event|27
3083243|NCT00401843|10578033|P2|Overall Study|Adverse Event|26
3083244|NCT00401843|10578034|P1|Overall Study|Adverse Event|7
3083245|NCT00401843|10578032|P3|Overall Study|Achieved Complete Response|11
3083246|NCT00401843|10578033|P2|Overall Study|Achieved Complete Response|5
3083247|NCT00401843|10578034|P1|Overall Study|Achieved Complete Response|1
3083248|NCT00401830|10578052|P2|Overall Study|Other: Personal / Family problems|0
3083249|NCT00401830|10578053|P1|Overall Study|Other: Personal / Family problems|1
3083250|NCT00401830|10578052|P2|Overall Study|Lost to Follow-up|3
3083251|NCT00401830|10578053|P1|Overall Study|Lost to Follow-up|1
3083252|NCT00401830|10578052|P2|Overall Study|Non-compliance with drug study|0
3083253|NCT00401830|10578053|P1|Overall Study|Non-compliance with drug study|1
3083254|NCT00401830|10578052|P2|Overall Study|Protocol Violation|3
3083255|NCT00401830|10578053|P1|Overall Study|Protocol Violation|3
3083256|NCT00401830|10578052|P2|Overall Study|Withdrawal by Subject|3
3083257|NCT00401830|10578053|P1|Overall Study|Withdrawal by Subject|4
3083258|NCT00401830|10578052|P2|Overall Study|Lack of Efficacy|5
3083259|NCT00401830|10578053|P1|Overall Study|Lack of Efficacy|11
3083260|NCT00401830|10578052|P2|Overall Study|Adverse Event|18
3083261|NCT00401830|10578053|P1|Overall Study|Adverse Event|10
3083262|NCT00401752|10578111|P2|Overall Study|Physician Decision|1
3083263|NCT00401752|10578112|P1|Overall Study|Physician Decision|1
3083264|NCT00401752|10578111|P2|Overall Study|Development of any exclusion criteria|2
3083265|NCT00401752|10578112|P1|Overall Study|Development of any exclusion criteria|4
3083266|NCT00401752|10578111|P2|Overall Study|Lost to Follow-up|4
3083267|NCT00401752|10578112|P1|Overall Study|Lost to Follow-up|1
3083268|NCT00401752|10578111|P2|Overall Study|Withdrawal by Subject|6
3083269|NCT00401752|10578112|P1|Overall Study|Withdrawal by Subject|2
3083270|NCT00401752|10578111|P2|Overall Study|Adverse Event|5
3083271|NCT00401752|10578112|P1|Overall Study|Adverse Event|2
3083272|NCT00401726|10578130|P2|Overall Study|Protocol Deviation|4
3083273|NCT00401726|10578131|P1|Overall Study|Protocol Deviation|9
3083274|NCT00401726|10578130|P2|Overall Study|Lack of Efficacy|6
3083275|NCT00401726|10578131|P1|Overall Study|Lack of Efficacy|4
3083276|NCT00401726|10578130|P2|Overall Study|Withdrawal by Subject|24
3083277|NCT00401726|10578131|P1|Overall Study|Withdrawal by Subject|18
3083278|NCT00401726|10578130|P2|Overall Study|Protocol Violation|3
3083279|NCT00401726|10578131|P1|Overall Study|Protocol Violation|6
3083280|NCT00401726|10578130|P2|Overall Study|Lost to Follow-up|20
3083281|NCT00401726|10578131|P1|Overall Study|Lost to Follow-up|23
3083282|NCT00401726|10578130|P2|Overall Study|Physician Decision|6
3083283|NCT00401726|10578131|P1|Overall Study|Physician Decision|3
3083284|NCT00401726|10578130|P2|Overall Study|Sponsor Request|1
3083285|NCT00401726|10578131|P1|Overall Study|Sponsor Request|0
3083286|NCT00401726|10578130|P2|Overall Study|Death|3
3083287|NCT00401726|10578131|P1|Overall Study|Death|0
3083288|NCT00401726|10578130|P2|Overall Study|Adverse Event|45
3083289|NCT00401726|10578131|P1|Overall Study|Adverse Event|34
3083290|NCT00401544|10578166|P4|Overall Study|Other|2
3083291|NCT00401544|10578167|P3|Overall Study|Other|2
3083292|NCT00401544|10578168|P2|Overall Study|Other|0
3083293|NCT00401544|10578169|P1|Overall Study|Other|0
3083294|NCT00401544|10578166|P4|Overall Study|Disease progression|0
3083295|NCT00401544|10578167|P3|Overall Study|Disease progression|0
3083296|NCT00401544|10578168|P2|Overall Study|Disease progression|1
3083297|NCT00401544|10578169|P1|Overall Study|Disease progression|0
3083298|NCT00401544|10578166|P4|Overall Study|Ineligibility determined|2
3083299|NCT00401544|10578167|P3|Overall Study|Ineligibility determined|0
3083300|NCT00401544|10578168|P2|Overall Study|Ineligibility determined|1
3083301|NCT00401544|10578169|P1|Overall Study|Ineligibility determined|0
3083302|NCT00401544|10578166|P4|Overall Study|Physician Decision|0
3083303|NCT00401544|10578167|P3|Overall Study|Physician Decision|0
3083304|NCT00401544|10578168|P2|Overall Study|Physician Decision|3
3083305|NCT00401544|10578169|P1|Overall Study|Physician Decision|1
3083306|NCT00401544|10578166|P4|Overall Study|Withdrawal by Subject|5
3083307|NCT00401544|10578167|P3|Overall Study|Withdrawal by Subject|6
3083308|NCT00401544|10578168|P2|Overall Study|Withdrawal by Subject|6
3083309|NCT00401544|10578169|P1|Overall Study|Withdrawal by Subject|7
3083310|NCT00401544|10578166|P4|Overall Study|Lost to Follow-up|1
3083311|NCT00401544|10578167|P3|Overall Study|Lost to Follow-up|1
3083312|NCT00401544|10578168|P2|Overall Study|Lost to Follow-up|0
3083313|NCT00401544|10578169|P1|Overall Study|Lost to Follow-up|2
3083314|NCT00401544|10578166|P4|Overall Study|Death|5
3083315|NCT00401544|10578167|P3|Overall Study|Death|2
3083316|NCT00401544|10578168|P2|Overall Study|Death|6
3083317|NCT00401544|10578169|P1|Overall Study|Death|3
3083318|NCT00401544|10578166|P4|Overall Study|Adverse Event|1
3083319|NCT00401544|10578167|P3|Overall Study|Adverse Event|1
3083320|NCT00401544|10578168|P2|Overall Study|Adverse Event|1
3083321|NCT00401544|10578169|P1|Overall Study|Adverse Event|5
3083322|NCT00401531|10578209|P2|Overall Study|Withdrawal by Subject|2
3083323|NCT00401531|10578210|P1|Overall Study|Withdrawal by Subject|3
3083324|NCT00401531|10578209|P2|Overall Study|Lost to Follow-up|1
3083325|NCT00401531|10578210|P1|Overall Study|Lost to Follow-up|1
3083326|NCT00401531|10578209|P2|Overall Study|Protocol Violation|7
3083327|NCT00401531|10578210|P1|Overall Study|Protocol Violation|3
3083328|NCT00401531|10578209|P2|Overall Study|Adverse Event|0
3083329|NCT00401531|10578210|P1|Overall Study|Adverse Event|2
3083330|NCT00401375|10578283|P3|Overall Study|Randomized but not treated|3
3083331|NCT00401375|10578284|P2|Overall Study|Randomized but not treated|3
3083332|NCT00401375|10578285|P1|Overall Study|Randomized but not treated|3
3083333|NCT00401375|10578283|P3|Overall Study|Other than specified|3
3083334|NCT00401375|10578284|P2|Overall Study|Other than specified|1
3083335|NCT00401375|10578285|P1|Overall Study|Other than specified|2
3083336|NCT00401375|10578283|P3|Overall Study|Lost to Follow-up|1
3083337|NCT00401375|10578284|P2|Overall Study|Lost to Follow-up|1
3083338|NCT00401375|10578285|P1|Overall Study|Lost to Follow-up|0
3083339|NCT00401375|10578283|P3|Overall Study|Withdrawal by Subject|7
3083340|NCT00401375|10578284|P2|Overall Study|Withdrawal by Subject|7
3083341|NCT00401375|10578285|P1|Overall Study|Withdrawal by Subject|9
3083342|NCT00401375|10578283|P3|Overall Study|Adverse Event|10
3083343|NCT00401375|10578284|P2|Overall Study|Adverse Event|11
3083344|NCT00401375|10578285|P1|Overall Study|Adverse Event|6
3083345|NCT00401375|10578283|P3|Overall Study|Protocol Violation|1
3083346|NCT00401375|10578284|P2|Overall Study|Protocol Violation|2
3083347|NCT00401375|10578285|P1|Overall Study|Protocol Violation|2
3083348|NCT00401258|10578302|P1|Overall Study|Adverse Event|7
3083349|NCT00401245|10578317|P8|Double Blind Tapering Phase|Lack of Efficacy|0
3083350|NCT00401245|10578318|P7|Double Blind Tapering Phase|Lack of Efficacy|0
3083351|NCT00401245|10578319|P6|Double Blind Tapering Phase|Lack of Efficacy|1
3083352|NCT00401245|10578320|P5|Double Blind Tapering Phase|Lack of Efficacy|0
3083353|NCT00401245|10578321|P4|Double Blind Tapering Phase|Lack of Efficacy|0
3083354|NCT00401245|10578322|P3|Double Blind Tapering Phase|Lack of Efficacy|0
3083355|NCT00401245|10578323|P2|Double Blind Tapering Phase|Lack of Efficacy|0
3083356|NCT00401245|10578324|P1|Double Blind Tapering Phase|Lack of Efficacy|0
3083357|NCT00401245|10578317|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
3083358|NCT00401245|10578318|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
3083359|NCT00401245|10578319|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
3083360|NCT00401245|10578320|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
3083361|NCT00401245|10578321|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
3083362|NCT00401245|10578322|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
3083363|NCT00401245|10578323|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
3083364|NCT00401245|10578324|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
3083365|NCT00401245|10578317|P8|Double Blind Tapering Phase|Other|2
3083366|NCT00401245|10578318|P7|Double Blind Tapering Phase|Other|2
3083367|NCT00401245|10578319|P6|Double Blind Tapering Phase|Other|0
3083368|NCT00401245|10578320|P5|Double Blind Tapering Phase|Other|1
3083369|NCT00401245|10578321|P4|Double Blind Tapering Phase|Other|0
3083370|NCT00401245|10578322|P3|Double Blind Tapering Phase|Other|0
3083371|NCT00401245|10578323|P2|Double Blind Tapering Phase|Other|0
3083372|NCT00401245|10578324|P1|Double Blind Tapering Phase|Other|0
3083373|NCT00401245|10578317|P8|Double Blind Tapering Phase|Investigator request|1
3083374|NCT00401245|10578318|P7|Double Blind Tapering Phase|Investigator request|0
3083375|NCT00401245|10578319|P6|Double Blind Tapering Phase|Investigator request|0
3083376|NCT00401245|10578320|P5|Double Blind Tapering Phase|Investigator request|0
3083377|NCT00401245|10578321|P4|Double Blind Tapering Phase|Investigator request|0
3083378|NCT00401245|10578322|P3|Double Blind Tapering Phase|Investigator request|0
3083379|NCT00401245|10578323|P2|Double Blind Tapering Phase|Investigator request|0
3083380|NCT00401245|10578324|P1|Double Blind Tapering Phase|Investigator request|0
3083381|NCT00401245|10578317|P8|Double Blind Tapering Phase|Adverse Event|4
3083382|NCT00401245|10578318|P7|Double Blind Tapering Phase|Adverse Event|2
3083383|NCT00401245|10578319|P6|Double Blind Tapering Phase|Adverse Event|1
3083384|NCT00401245|10578320|P5|Double Blind Tapering Phase|Adverse Event|1
3083385|NCT00401245|10578321|P4|Double Blind Tapering Phase|Adverse Event|0
3083386|NCT00401245|10578322|P3|Double Blind Tapering Phase|Adverse Event|0
3083387|NCT00401245|10578323|P2|Double Blind Tapering Phase|Adverse Event|0
3083388|NCT00401245|10578324|P1|Double Blind Tapering Phase|Adverse Event|0
3083389|NCT00401245|10578317|P8|Open Label Phase|Lack of Efficacy|0
3083390|NCT00401245|10578318|P7|Open Label Phase|Lack of Efficacy|0
3083391|NCT00401245|10578319|P6|Open Label Phase|Lack of Efficacy|0
3083392|NCT00401245|10578320|P5|Open Label Phase|Lack of Efficacy|0
3083393|NCT00401245|10578321|P4|Open Label Phase|Lack of Efficacy|0
3083394|NCT00401245|10578322|P3|Open Label Phase|Lack of Efficacy|3
3083395|NCT00401245|10578323|P2|Open Label Phase|Lack of Efficacy|2
3083396|NCT00401245|10578324|P1|Open Label Phase|Lack of Efficacy|4
3083397|NCT00401245|10578317|P8|Open Label Phase|Withdrawal by Subject|0
3083398|NCT00401245|10578318|P7|Open Label Phase|Withdrawal by Subject|0
3083399|NCT00401245|10578319|P6|Open Label Phase|Withdrawal by Subject|0
3083400|NCT00401245|10578320|P5|Open Label Phase|Withdrawal by Subject|0
3083401|NCT00401245|10578321|P4|Open Label Phase|Withdrawal by Subject|1
3083402|NCT00401245|10578322|P3|Open Label Phase|Withdrawal by Subject|2
3083403|NCT00401245|10578323|P2|Open Label Phase|Withdrawal by Subject|3
3083404|NCT00401245|10578324|P1|Open Label Phase|Withdrawal by Subject|3
3083405|NCT00401245|10578317|P8|Open Label Phase|Protocol Violation|0
3083406|NCT00401245|10578318|P7|Open Label Phase|Protocol Violation|0
3083407|NCT00401245|10578319|P6|Open Label Phase|Protocol Violation|0
3083408|NCT00401245|10578320|P5|Open Label Phase|Protocol Violation|0
3083409|NCT00401245|10578321|P4|Open Label Phase|Protocol Violation|1
3083410|NCT00401245|10578322|P3|Open Label Phase|Protocol Violation|0
3083411|NCT00401245|10578323|P2|Open Label Phase|Protocol Violation|1
3083412|NCT00401245|10578324|P1|Open Label Phase|Protocol Violation|0
3083413|NCT00401245|10578317|P8|Open Label Phase|Other|0
3083414|NCT00401245|10578318|P7|Open Label Phase|Other|0
3083415|NCT00401245|10578319|P6|Open Label Phase|Other|0
3083416|NCT00401245|10578320|P5|Open Label Phase|Other|0
3083417|NCT00401245|10578321|P4|Open Label Phase|Other|8
3083418|NCT00401245|10578322|P3|Open Label Phase|Other|7
3083419|NCT00401245|10578323|P2|Open Label Phase|Other|8
3083420|NCT00401245|10578324|P1|Open Label Phase|Other|4
3083421|NCT00401245|10578317|P8|Open Label Phase|Lost to Follow-up|0
3083422|NCT00401245|10578318|P7|Open Label Phase|Lost to Follow-up|0
3083423|NCT00401245|10578319|P6|Open Label Phase|Lost to Follow-up|0
3083424|NCT00401245|10578320|P5|Open Label Phase|Lost to Follow-up|0
3083425|NCT00401245|10578321|P4|Open Label Phase|Lost to Follow-up|4
3083426|NCT00401245|10578322|P3|Open Label Phase|Lost to Follow-up|5
3083427|NCT00401245|10578323|P2|Open Label Phase|Lost to Follow-up|7
3083428|NCT00401245|10578324|P1|Open Label Phase|Lost to Follow-up|5
3083429|NCT00401245|10578317|P8|Open Label Phase|Adverse Event|0
3083430|NCT00401245|10578318|P7|Open Label Phase|Adverse Event|0
3083431|NCT00401245|10578319|P6|Open Label Phase|Adverse Event|0
3083432|NCT00401245|10578320|P5|Open Label Phase|Adverse Event|0
3083433|NCT00401245|10578321|P4|Open Label Phase|Adverse Event|7
3083434|NCT00401245|10578322|P3|Open Label Phase|Adverse Event|6
3083435|NCT00401245|10578323|P2|Open Label Phase|Adverse Event|14
3083436|NCT00401245|10578324|P1|Open Label Phase|Adverse Event|5
3083437|NCT00401245|10578317|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083438|NCT00401245|10578318|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083439|NCT00401245|10578319|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083440|NCT00401245|10578320|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083441|NCT00401245|10578321|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
3083442|NCT00401245|10578322|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083443|NCT00401245|10578323|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
3083444|NCT00401245|10578324|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
3083445|NCT00401245|10578317|P8|Double Blind Titration Phase|Withdrawal by Subject|0
3083446|NCT00401245|10578318|P7|Double Blind Titration Phase|Withdrawal by Subject|0
3083447|NCT00401245|10578319|P6|Double Blind Titration Phase|Withdrawal by Subject|0
3083448|NCT00401245|10578320|P5|Double Blind Titration Phase|Withdrawal by Subject|0
3083449|NCT00401245|10578321|P4|Double Blind Titration Phase|Withdrawal by Subject|2
3083450|NCT00401245|10578322|P3|Double Blind Titration Phase|Withdrawal by Subject|0
3083451|NCT00401245|10578323|P2|Double Blind Titration Phase|Withdrawal by Subject|1
3083452|NCT00401245|10578324|P1|Double Blind Titration Phase|Withdrawal by Subject|1
3083453|NCT00401245|10578317|P8|Double Blind Titration Phase|Protocol Violation|0
3083454|NCT00401245|10578318|P7|Double Blind Titration Phase|Protocol Violation|0
3083455|NCT00401245|10578319|P6|Double Blind Titration Phase|Protocol Violation|0
3083456|NCT00401245|10578320|P5|Double Blind Titration Phase|Protocol Violation|0
3083457|NCT00401245|10578321|P4|Double Blind Titration Phase|Protocol Violation|1
3083458|NCT00401245|10578322|P3|Double Blind Titration Phase|Protocol Violation|0
3083459|NCT00401245|10578323|P2|Double Blind Titration Phase|Protocol Violation|0
3083460|NCT00401245|10578324|P1|Double Blind Titration Phase|Protocol Violation|0
3083461|NCT00401245|10578317|P8|Double Blind Titration Phase|Other|0
3083462|NCT00401245|10578318|P7|Double Blind Titration Phase|Other|0
3083463|NCT00401245|10578319|P6|Double Blind Titration Phase|Other|0
3083464|NCT00401245|10578320|P5|Double Blind Titration Phase|Other|0
3083465|NCT00401245|10578321|P4|Double Blind Titration Phase|Other|0
3083466|NCT00401245|10578322|P3|Double Blind Titration Phase|Other|1
3083467|NCT00401245|10578323|P2|Double Blind Titration Phase|Other|0
3083468|NCT00401245|10578324|P1|Double Blind Titration Phase|Other|0
3083469|NCT00401245|10578317|P8|Double Blind Titration Phase|Adverse Event|0
3083470|NCT00401245|10578318|P7|Double Blind Titration Phase|Adverse Event|0
3083471|NCT00401245|10578319|P6|Double Blind Titration Phase|Adverse Event|0
3083472|NCT00401245|10578320|P5|Double Blind Titration Phase|Adverse Event|0
3083473|NCT00401245|10578321|P4|Double Blind Titration Phase|Adverse Event|12
3083474|NCT00401245|10578322|P3|Double Blind Titration Phase|Adverse Event|5
3083475|NCT00401245|10578323|P2|Double Blind Titration Phase|Adverse Event|2
3083476|NCT00401245|10578324|P1|Double Blind Titration Phase|Adverse Event|3
3083477|NCT00401193|10578392|P3|Overall Study|Other Event|2
3083478|NCT00401193|10578393|P2|Overall Study|Other Event|2
3083479|NCT00401193|10578394|P1|Overall Study|Other Event|3
3083480|NCT00401193|10578392|P3|Overall Study|Withdrawal by Subject|1
3083481|NCT00401193|10578393|P2|Overall Study|Withdrawal by Subject|0
3083482|NCT00401193|10578394|P1|Overall Study|Withdrawal by Subject|2
3083483|NCT00401193|10578392|P3|Overall Study|Lost to Follow-up|1
3083484|NCT00401193|10578393|P2|Overall Study|Lost to Follow-up|5
3083485|NCT00401193|10578394|P1|Overall Study|Lost to Follow-up|6
3083486|NCT00401193|10578392|P3|Overall Study|Protocol Violation|1
3083487|NCT00401193|10578393|P2|Overall Study|Protocol Violation|1
3083488|NCT00401193|10578394|P1|Overall Study|Protocol Violation|3
3083489|NCT00401193|10578392|P3|Overall Study|Adverse Event|1
3083490|NCT00401193|10578393|P2|Overall Study|Adverse Event|3
3083491|NCT00401193|10578394|P1|Overall Study|Adverse Event|1
3083492|NCT00400985|10578412|P1|Overall Study|Lost to Follow-up|9
3083493|NCT00400985|10578412|P1|Overall Study|Death|30
3083494|NCT00400985|10578412|P1|Overall Study|system modification|8
3083495|NCT00400985|10578412|P1|Overall Study|Withdrawal by Subject|5
3083496|NCT00400946|10578421|P5|Overall Study|Other|1
3083497|NCT00400946|10578422|P4|Overall Study|Other|0
3083498|NCT00400946|10578423|P3|Overall Study|Other|0
3083499|NCT00400946|10578424|P2|Overall Study|Other|0
3083500|NCT00400946|10578425|P1|Overall Study|Other|0
3083501|NCT00400946|10578421|P5|Overall Study|Clinical|9
3083502|NCT00400946|10578422|P4|Overall Study|Clinical|2
3083503|NCT00400946|10578423|P3|Overall Study|Clinical|0
3083504|NCT00400946|10578424|P2|Overall Study|Clinical|2
3083505|NCT00400946|10578425|P1|Overall Study|Clinical|1
3083506|NCT00400946|10578421|P5|Overall Study|Withdrawal by Subject|8
3083507|NCT00400946|10578422|P4|Overall Study|Withdrawal by Subject|5
3083508|NCT00400946|10578423|P3|Overall Study|Withdrawal by Subject|1
3083509|NCT00400946|10578424|P2|Overall Study|Withdrawal by Subject|5
3083510|NCT00400946|10578425|P1|Overall Study|Withdrawal by Subject|2
3083511|NCT00400946|10578421|P5|Overall Study|Transplant in CR1|1
3083512|NCT00400946|10578422|P4|Overall Study|Transplant in CR1|10
3083513|NCT00400946|10578423|P3|Overall Study|Transplant in CR1|0
3083514|NCT00400946|10578424|P2|Overall Study|Transplant in CR1|0
3083515|NCT00400946|10578425|P1|Overall Study|Transplant in CR1|0
3083516|NCT00400946|10578421|P5|Overall Study|Relapse|5
3083517|NCT00400946|10578422|P4|Overall Study|Relapse|1
3083518|NCT00400946|10578423|P3|Overall Study|Relapse|1
3083519|NCT00400946|10578424|P2|Overall Study|Relapse|2
3083520|NCT00400946|10578425|P1|Overall Study|Relapse|9
3083521|NCT00400946|10578421|P5|Overall Study|Remission Death|1
3083522|NCT00400946|10578422|P4|Overall Study|Remission Death|0
3083523|NCT00400946|10578423|P3|Overall Study|Remission Death|0
3083524|NCT00400946|10578424|P2|Overall Study|Remission Death|1
3083525|NCT00400946|10578425|P1|Overall Study|Remission Death|1
3083526|NCT00400946|10578421|P5|Overall Study|Lost to Follow-up|1
3083527|NCT00400946|10578422|P4|Overall Study|Lost to Follow-up|0
3083528|NCT00400946|10578423|P3|Overall Study|Lost to Follow-up|0
3083529|NCT00400946|10578424|P2|Overall Study|Lost to Follow-up|1
3083530|NCT00400946|10578425|P1|Overall Study|Lost to Follow-up|1
3083531|NCT00400946|10578421|P5|Overall Study|Induction Death|3
3083532|NCT00400946|10578422|P4|Overall Study|Induction Death|13
3083533|NCT00400946|10578423|P3|Overall Study|Induction Death|0
3083534|NCT00400946|10578424|P2|Overall Study|Induction Death|0
3083535|NCT00400946|10578425|P1|Overall Study|Induction Death|0
3083536|NCT00400946|10578421|P5|Overall Study|Induction Failure|8
3083537|NCT00400946|10578422|P4|Overall Study|Induction Failure|11
3083538|NCT00400946|10578423|P3|Overall Study|Induction Failure|0
3083539|NCT00400946|10578424|P2|Overall Study|Induction Failure|0
3083540|NCT00400946|10578425|P1|Overall Study|Induction Failure|0
3083541|NCT00400946|10578421|P5|Overall Study|Ineligible|1
3083542|NCT00400946|10578422|P4|Overall Study|Ineligible|5
3083543|NCT00400946|10578423|P3|Overall Study|Ineligible|0
3083544|NCT00400946|10578424|P2|Overall Study|Ineligible|0
3083545|NCT00400946|10578425|P1|Overall Study|Ineligible|0
3083546|NCT00400764|10578484|P5|Phase II|Withdrawal by Subject|0
3083547|NCT00400764|10578485|P4|Phase II|Withdrawal by Subject|1
3083548|NCT00400764|10578486|P3|Phase II|Withdrawal by Subject|1
3083549|NCT00400764|10578487|P2|Phase II|Withdrawal by Subject|0
3083550|NCT00400764|10578488|P1|Phase II|Withdrawal by Subject|0
3083551|NCT00400764|10578484|P5|Phase II|Patient began new, non-protocol, therapy|0
3083552|NCT00400764|10578485|P4|Phase II|Patient began new, non-protocol, therapy|0
3083553|NCT00400764|10578486|P3|Phase II|Patient began new, non-protocol, therapy|1
3083554|NCT00400764|10578487|P2|Phase II|Patient began new, non-protocol, therapy|0
3083555|NCT00400764|10578488|P1|Phase II|Patient began new, non-protocol, therapy|0
3083556|NCT00400764|10578484|P5|Phase II|Sponsor’s decision to terminate|11
3083557|NCT00400764|10578485|P4|Phase II|Sponsor’s decision to terminate|22
3083558|NCT00400764|10578486|P3|Phase II|Sponsor’s decision to terminate|18
3083559|NCT00400764|10578487|P2|Phase II|Sponsor’s decision to terminate|0
3083560|NCT00400764|10578488|P1|Phase II|Sponsor’s decision to terminate|0
3083561|NCT00400764|10578484|P5|Phase II|Physician Decision|0
3083562|NCT00400764|10578485|P4|Phase II|Physician Decision|1
3083563|NCT00400764|10578486|P3|Phase II|Physician Decision|1
3083564|NCT00400764|10578487|P2|Phase II|Physician Decision|0
3083565|NCT00400764|10578488|P1|Phase II|Physician Decision|0
3083566|NCT00400764|10578484|P5|Phase II|Lost to Follow-up|0
3083567|NCT00400764|10578485|P4|Phase II|Lost to Follow-up|0
3083568|NCT00400764|10578486|P3|Phase II|Lost to Follow-up|1
3083569|NCT00400764|10578487|P2|Phase II|Lost to Follow-up|0
3083570|NCT00400764|10578488|P1|Phase II|Lost to Follow-up|0
3083571|NCT00400764|10578484|P5|Phase II|Death|0
3083572|NCT00400764|10578485|P4|Phase II|Death|2
3083573|NCT00400764|10578486|P3|Phase II|Death|1
3083574|NCT00400764|10578487|P2|Phase II|Death|0
3083575|NCT00400764|10578488|P1|Phase II|Death|0
3083576|NCT00400764|10578484|P5|Phase Ib|Disease Progression|0
3083577|NCT00400764|10578485|P4|Phase Ib|Disease Progression|0
3083578|NCT00400764|10578486|P3|Phase Ib|Disease Progression|0
3083579|NCT00400764|10578487|P2|Phase Ib|Disease Progression|4
3083580|NCT00400764|10578488|P1|Phase Ib|Disease Progression|4
3083581|NCT00400764|10578484|P5|Phase Ib|Death|0
3083582|NCT00400764|10578485|P4|Phase Ib|Death|0
3083583|NCT00400764|10578486|P3|Phase Ib|Death|0
3083584|NCT00400764|10578487|P2|Phase Ib|Death|0
3083585|NCT00400764|10578488|P1|Phase Ib|Death|1
3083586|NCT00400764|10578484|P5|Phase Ib|Adverse Event|0
3083587|NCT00400764|10578485|P4|Phase Ib|Adverse Event|0
3083588|NCT00400764|10578486|P3|Phase Ib|Adverse Event|0
3083589|NCT00400764|10578487|P2|Phase Ib|Adverse Event|0
3083590|NCT00400764|10578488|P1|Phase Ib|Adverse Event|1
3083591|NCT00400712|10578541|P2|Overall Study|Physician Decision|4
3083592|NCT00400712|10578542|P1|Overall Study|Physician Decision|5
3083593|NCT00400712|10578541|P2|Overall Study|Withdrawal by Subject|12
3083594|NCT00400712|10578542|P1|Overall Study|Withdrawal by Subject|11
3083595|NCT00400712|10578541|P2|Overall Study|Death|0
3083596|NCT00400712|10578542|P1|Overall Study|Death|1
3083597|NCT00400569|10578577|P1|Overall Study|Death|1
3083598|NCT00400517|10578588|P1|Overall Study|Physician Decision|1
3083599|NCT00400517|10578588|P1|Overall Study|Withdrawal by Subject|1
3083600|NCT00400400|10578608|P2|Overall Study|Did not receive study drug|3
3083601|NCT00400400|10578609|P1|Overall Study|Did not receive study drug|1
3083602|NCT00400400|10578608|P2|Overall Study|Lost to Follow-up|1
3083603|NCT00400400|10578609|P1|Overall Study|Lost to Follow-up|0
3083604|NCT00400400|10578608|P2|Overall Study|Administrative Problem|0
3083605|NCT00400400|10578609|P1|Overall Study|Administrative Problem|1
3083606|NCT00400400|10578608|P2|Overall Study|Withdrawal by Subject|3
3083607|NCT00400400|10578609|P1|Overall Study|Withdrawal by Subject|1
3083608|NCT00400400|10578608|P2|Overall Study|Protocol Violation|0
3083609|NCT00400400|10578609|P1|Overall Study|Protocol Violation|2
3083610|NCT00400400|10578608|P2|Overall Study|Adverse Event|8
3083611|NCT00400400|10578609|P1|Overall Study|Adverse Event|9
3083612|NCT00400179|10578634|P2|Overall Study|Randomization error/patient ineligible|6
3083613|NCT00400179|10578635|P1|Overall Study|Randomization error/patient ineligible|1
3083614|NCT00400179|10578634|P2|Overall Study|Investigator judgment|1
3083615|NCT00400179|10578635|P1|Overall Study|Investigator judgment|0
3083616|NCT00400179|10578634|P2|Overall Study|Intercurrent illness|1
3083617|NCT00400179|10578635|P1|Overall Study|Intercurrent illness|0
3083618|NCT00400179|10578634|P2|Overall Study|Disease progression|1
3083619|NCT00400179|10578635|P1|Overall Study|Disease progression|1
3083620|NCT00400179|10578634|P2|Overall Study|Withdrew Consent|5
3083621|NCT00400179|10578635|P1|Overall Study|Withdrew Consent|1
3083622|NCT00400179|10578634|P2|Overall Study|Death|2
3083623|NCT00400179|10578635|P1|Overall Study|Death|1
3083624|NCT00400179|10578634|P2|Overall Study|Adverse Event|2
3083625|NCT00400179|10578635|P1|Overall Study|Adverse Event|2
3083626|NCT00400153|10578652|P3|Overall Study|Other reasons - not mentioned above|3
3083627|NCT00400153|10578653|P2|Overall Study|Other reasons - not mentioned above|5
3083628|NCT00400153|10578654|P1|Overall Study|Other reasons - not mentioned above|8
3083629|NCT00400153|10578652|P3|Overall Study|Withdrawal by Subject|10
3083630|NCT00400153|10578653|P2|Overall Study|Withdrawal by Subject|11
3083631|NCT00400153|10578654|P1|Overall Study|Withdrawal by Subject|12
3083632|NCT00400153|10578652|P3|Overall Study|Lost to Follow-up|4
3083633|NCT00400153|10578653|P2|Overall Study|Lost to Follow-up|1
3083634|NCT00400153|10578654|P1|Overall Study|Lost to Follow-up|2
3083635|NCT00400153|10578652|P3|Overall Study|Protocol Violation|9
3083636|NCT00400153|10578653|P2|Overall Study|Protocol Violation|4
3083637|NCT00400153|10578654|P1|Overall Study|Protocol Violation|7
3083638|NCT00400153|10578652|P3|Overall Study|AE due to other condition|15
3083639|NCT00400153|10578653|P2|Overall Study|AE due to other condition|14
3083640|NCT00400153|10578654|P1|Overall Study|AE due to other condition|3
3083641|NCT00400153|10578652|P3|Overall Study|AE due to other disease worsening|0
3083642|NCT00400153|10578653|P2|Overall Study|AE due to other disease worsening|1
3083643|NCT00400153|10578654|P1|Overall Study|AE due to other disease worsening|2
3083644|NCT00400153|10578652|P3|Overall Study|AE due to study disease worsening|20
3083645|NCT00400153|10578653|P2|Overall Study|AE due to study disease worsening|19
3083646|NCT00400153|10578654|P1|Overall Study|AE due to study disease worsening|14
3083647|NCT00399893|10578901|P2|Overall Study|Withdrawal by Subject|0
3083648|NCT00399893|10578902|P1|Overall Study|Withdrawal by Subject|1
3083649|NCT00399802|10578941|P2|Overall Study|Participant discontinued by mistake|1
3083650|NCT00399802|10578942|P1|Overall Study|Participant discontinued by mistake|0
3083651|NCT00399802|10578941|P2|Overall Study|Adverse Event|2
3083652|NCT00399802|10578942|P1|Overall Study|Adverse Event|0
3083653|NCT00399763|10578956|P2|Overall Study|Lost to Follow-up|3
3083654|NCT00399763|10578957|P1|Overall Study|Lost to Follow-up|2
3083655|NCT00399568|10578969|P2|Overall Study|Lost to Follow-up|2
3083656|NCT00399568|10578970|P1|Overall Study|Lost to Follow-up|2
3083657|NCT00399568|10578969|P2|Overall Study|Protocol non-compliance|2
3083658|NCT00399568|10578970|P1|Overall Study|Protocol non-compliance|2
3083659|NCT00399568|10578969|P2|Overall Study|Withdrawal by Subject|3
3083660|NCT00399568|10578970|P1|Overall Study|Withdrawal by Subject|7
3083661|NCT00399568|10578969|P2|Overall Study|Adverse Event|2
3083662|NCT00399568|10578970|P1|Overall Study|Adverse Event|1
3083663|NCT00399542|10578984|P2|Overall Study|Physician Decision|1
3083664|NCT00399542|10578985|P1|Overall Study|Physician Decision|0
3083665|NCT00399542|10578984|P2|Overall Study|Other|0
3083666|NCT00399542|10578985|P1|Overall Study|Other|1
3083667|NCT00399542|10578984|P2|Overall Study|Lost to Follow-up|6
3083668|NCT00399542|10578985|P1|Overall Study|Lost to Follow-up|6
3083669|NCT00399542|10578984|P2|Overall Study|Lack of Efficacy|8
3083670|NCT00399542|10578985|P1|Overall Study|Lack of Efficacy|18
3083671|NCT00399542|10578984|P2|Overall Study|Withdrawal by Subject|10
3083672|NCT00399542|10578985|P1|Overall Study|Withdrawal by Subject|28
3083673|NCT00399542|10578984|P2|Overall Study|Protocol Violation|3
3083674|NCT00399542|10578985|P1|Overall Study|Protocol Violation|13
3083675|NCT00399542|10578984|P2|Overall Study|Adverse Event|15
3083676|NCT00399542|10578985|P1|Overall Study|Adverse Event|18
3083677|NCT00399529|10579047|P1|Overall Study|Off Study Prior to Treatment|2
3083678|NCT00399516|10579053|P1|Overall Study|Lost to Follow-up|2
3083679|NCT00399360|10579061|P4|Overall Study|Withdrawal by Subject|2
3083680|NCT00399360|10579062|P3|Overall Study|Withdrawal by Subject|0
3083681|NCT00399360|10579063|P2|Overall Study|Withdrawal by Subject|2
3083682|NCT00399360|10579064|P1|Overall Study|Withdrawal by Subject|0
3083683|NCT00399360|10579061|P4|Overall Study|Adverse Event|0
3083684|NCT00399360|10579062|P3|Overall Study|Adverse Event|1
3083685|NCT00399360|10579063|P2|Overall Study|Adverse Event|0
3083686|NCT00399360|10579064|P1|Overall Study|Adverse Event|0
3083687|NCT00399360|10579061|P4|Overall Study|Lost to Follow-up|4
3083688|NCT00399360|10579062|P3|Overall Study|Lost to Follow-up|2
3083689|NCT00399360|10579063|P2|Overall Study|Lost to Follow-up|1
3083690|NCT00399360|10579064|P1|Overall Study|Lost to Follow-up|2
3083691|NCT00399035|10579135|P3|Overall Study|Severe non-compliance with protocol|0
3083692|NCT00399035|10579136|P2|Overall Study|Severe non-compliance with protocol|1
3083693|NCT00399035|10579137|P1|Overall Study|Severe non-compliance with protocol|2
3083694|NCT00399035|10579135|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
3083695|NCT00399035|10579136|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
3083696|NCT00399035|10579137|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
3083697|NCT00399035|10579135|P3|Overall Study|Withdrawal by Subject|12
3083698|NCT00399035|10579136|P2|Overall Study|Withdrawal by Subject|15
3083699|NCT00399035|10579137|P1|Overall Study|Withdrawal by Subject|19
3083700|NCT00399035|10579135|P3|Overall Study|Lost to Follow-up|5
3083701|NCT00399035|10579136|P2|Overall Study|Lost to Follow-up|1
3083702|NCT00399035|10579137|P1|Overall Study|Lost to Follow-up|2
3083703|NCT00399035|10579135|P3|Overall Study|Death|234
3083704|NCT00399035|10579136|P2|Overall Study|Death|141
3083705|NCT00399035|10579137|P1|Overall Study|Death|289
3083706|NCT00398866|10579173|P3|Overall Study|Unable to complete requirements of study|1
3083707|NCT00398866|10579174|P2|Overall Study|Unable to complete requirements of study|1
3083708|NCT00398866|10579175|P1|Overall Study|Unable to complete requirements of study|1
3083709|NCT00398866|10579173|P3|Overall Study|Withdrawal by Subject|2
3083710|NCT00398866|10579174|P2|Overall Study|Withdrawal by Subject|1
3083711|NCT00398866|10579175|P1|Overall Study|Withdrawal by Subject|5
3083712|NCT00398866|10579173|P3|Overall Study|Lost to Follow-up|4
3083713|NCT00398866|10579174|P2|Overall Study|Lost to Follow-up|6
3083714|NCT00398866|10579175|P1|Overall Study|Lost to Follow-up|7
3083715|NCT00398866|10579173|P3|Overall Study|Lack of Efficacy|1
3083716|NCT00398866|10579174|P2|Overall Study|Lack of Efficacy|0
3083717|NCT00398866|10579175|P1|Overall Study|Lack of Efficacy|0
3083718|NCT00398866|10579173|P3|Overall Study|Adverse Event|0
3083719|NCT00398866|10579174|P2|Overall Study|Adverse Event|0
3083720|NCT00398866|10579175|P1|Overall Study|Adverse Event|1
3083721|NCT00398632|10579186|P1|Overall Study|Lack of Efficacy|1
3083722|NCT00398632|10579186|P1|Overall Study|Withdrawal by Subject|1
3083723|NCT00398567|10579194|P3|Overall Study|Protocol Violation|1
3083724|NCT00398567|10579195|P2|Overall Study|Protocol Violation|0
3083725|NCT00398567|10579196|P1|Overall Study|Protocol Violation|0
3083726|NCT00398567|10579194|P3|Overall Study|Adverse Event|2
3083727|NCT00398567|10579195|P2|Overall Study|Adverse Event|0
3083728|NCT00398567|10579196|P1|Overall Study|Adverse Event|0
3083729|NCT00398567|10579194|P3|Overall Study|Withdrawal by Subject|4
3083730|NCT00398567|10579195|P2|Overall Study|Withdrawal by Subject|0
3083731|NCT00398567|10579196|P1|Overall Study|Withdrawal by Subject|1
3083732|NCT00398567|10579194|P3|Overall Study|Disease Progression|27
3083733|NCT00398567|10579195|P2|Overall Study|Disease Progression|4
3083734|NCT00398567|10579196|P1|Overall Study|Disease Progression|3
3083735|NCT00398411|10579250|P2|Overall Study|Death|1
3083736|NCT00398411|10579251|P1|Overall Study|Death|0
3083737|NCT00398320|10579274|P1|Overall Study|Physician Decision|1
3083738|NCT00398320|10579274|P1|Overall Study|Adverse Event|4
3083739|NCT00398320|10579274|P1|Overall Study|Death|1
3083740|NCT00398216|10579287|P5|Overall Study|entrance criteria|2
3083741|NCT00398216|10579288|P4|Overall Study|entrance criteria|0
3083742|NCT00398216|10579289|P3|Overall Study|entrance criteria|0
3083743|NCT00398216|10579290|P2|Overall Study|entrance criteria|0
3083744|NCT00398216|10579291|P1|Overall Study|entrance criteria|0
3083745|NCT00398216|10579287|P5|Overall Study|administrative reasons|3
3083746|NCT00398216|10579288|P4|Overall Study|administrative reasons|3
3083747|NCT00398216|10579289|P3|Overall Study|administrative reasons|4
3083748|NCT00398216|10579290|P2|Overall Study|administrative reasons|4
3083749|NCT00398216|10579291|P1|Overall Study|administrative reasons|3
3083750|NCT00398216|10579287|P5|Overall Study|Withdrawal by Subject|2
3083751|NCT00398216|10579288|P4|Overall Study|Withdrawal by Subject|1
3083752|NCT00398216|10579289|P3|Overall Study|Withdrawal by Subject|3
3083753|NCT00398216|10579290|P2|Overall Study|Withdrawal by Subject|0
3083754|NCT00398216|10579291|P1|Overall Study|Withdrawal by Subject|1
3083755|NCT00398216|10579287|P5|Overall Study|Death|0
3083756|NCT00398216|10579288|P4|Overall Study|Death|0
3083757|NCT00398216|10579289|P3|Overall Study|Death|0
3083758|NCT00398216|10579290|P2|Overall Study|Death|3
3083759|NCT00398216|10579291|P1|Overall Study|Death|0
3083760|NCT00398216|10579287|P5|Overall Study|Lost to Follow-up|1
3083761|NCT00398216|10579288|P4|Overall Study|Lost to Follow-up|4
3083762|NCT00398216|10579289|P3|Overall Study|Lost to Follow-up|4
3083763|NCT00398216|10579290|P2|Overall Study|Lost to Follow-up|6
3083764|NCT00398216|10579291|P1|Overall Study|Lost to Follow-up|1
3083765|NCT00398216|10579287|P5|Overall Study|Protocol Violation|5
3083766|NCT00398216|10579288|P4|Overall Study|Protocol Violation|7
3083767|NCT00398216|10579289|P3|Overall Study|Protocol Violation|5
3083768|NCT00398216|10579290|P2|Overall Study|Protocol Violation|4
3083769|NCT00398216|10579291|P1|Overall Study|Protocol Violation|2
3083770|NCT00398216|10579287|P5|Overall Study|Adverse Event|2
3083771|NCT00398216|10579288|P4|Overall Study|Adverse Event|7
3083772|NCT00398216|10579289|P3|Overall Study|Adverse Event|5
3083773|NCT00398216|10579290|P2|Overall Study|Adverse Event|2
3083774|NCT00398216|10579291|P1|Overall Study|Adverse Event|4
3083775|NCT00398138|10579318|P1|Overall Study|Adverse Event|2
3083776|NCT00398112|10579323|P1|Overall Study|Death|1
3083777|NCT00398112|10579323|P1|Overall Study|Withdrawal by Subject|3
3083778|NCT00398112|10579323|P1|Overall Study|Alternative treatment|1
3083779|NCT00398112|10579323|P1|Overall Study|Disease progression|9
3083780|NCT00398112|10579323|P1|Overall Study|Adverse Event|4
3083781|NCT00398086|10579334|P3|Overall Study|Withdrawal by Subject|0
3083782|NCT00398086|10579335|P2|Overall Study|Withdrawal by Subject|7
3083783|NCT00398086|10579336|P1|Overall Study|Withdrawal by Subject|5
3083784|NCT00398086|10579334|P3|Overall Study|Physician Decision|0
3083785|NCT00398086|10579335|P2|Overall Study|Physician Decision|4
3083786|NCT00398086|10579336|P1|Overall Study|Physician Decision|1
3083787|NCT00398086|10579334|P3|Overall Study|Adverse Event|0
3083788|NCT00398086|10579335|P2|Overall Study|Adverse Event|4
3083789|NCT00398086|10579336|P1|Overall Study|Adverse Event|1
3083790|NCT00398086|10579334|P3|Overall Study|Unacceptable Toxicity|2
3083791|NCT00398086|10579335|P2|Overall Study|Unacceptable Toxicity|8
3083792|NCT00398086|10579336|P1|Overall Study|Unacceptable Toxicity|2
3083793|NCT00398073|10579370|P2|Overall Study|Withdrawal by Subject|0
3083794|NCT00398073|10579371|P1|Overall Study|Withdrawal by Subject|1
3083795|NCT00398047|10579381|P1|Overall Study|all patient progressed before completion|3
3083796|NCT00397982|10579391|P1|Overall Study|Unrelated health issues|1
3083797|NCT00397982|10579391|P1|Overall Study|noncompliance|1
3083798|NCT00397982|10579391|P1|Overall Study|Adverse Event|1
3083799|NCT00397982|10579391|P1|Overall Study|Withdrawal by Subject|1
3083800|NCT00397943|10579405|P5|Overall Study|Unspecified reasons|0
3083801|NCT00397943|10579406|P4|Overall Study|Unspecified reasons|0
3083802|NCT00397943|10579407|P3|Overall Study|Unspecified reasons|0
3083803|NCT00397943|10579408|P2|Overall Study|Unspecified reasons|9
3083804|NCT00397943|10579409|P1|Overall Study|Unspecified reasons|12
3083805|NCT00397930|10579565|P2|Overall Study|Missing data|4
3083806|NCT00397930|10579566|P1|Overall Study|Missing data|0
3083807|NCT00397930|10579565|P2|Overall Study|Withdrawal by Subject|8
3083808|NCT00397930|10579566|P1|Overall Study|Withdrawal by Subject|0
3083809|NCT00397930|10579565|P2|Overall Study|Did not want to be in control group|1
3083810|NCT00397930|10579566|P1|Overall Study|Did not want to be in control group|0
3083811|NCT00397930|10579565|P2|Overall Study|Started own yoga program|1
3083812|NCT00397930|10579566|P1|Overall Study|Started own yoga program|1
3083813|NCT00397930|10579565|P2|Overall Study|Too time-consuming|9
3083814|NCT00397930|10579566|P1|Overall Study|Too time-consuming|2
3083815|NCT00397930|10579565|P2|Overall Study|Noncompliant|2
3083816|NCT00397930|10579566|P1|Overall Study|Noncompliant|3
3083817|NCT00397930|10579565|P2|Overall Study|Unknown reasons|14
3083818|NCT00397930|10579566|P1|Overall Study|Unknown reasons|9
3083819|NCT00397930|10579565|P2|Overall Study|Other medical|4
3083820|NCT00397930|10579566|P1|Overall Study|Other medical|9
3083821|NCT00397930|10579565|P2|Overall Study|Personal reasons|8
3083822|NCT00397930|10579566|P1|Overall Study|Personal reasons|14
3083823|NCT00397891|10579581|P5|Overall Study|Withdrawal by Subject|1
3083824|NCT00397891|10579582|P4|Overall Study|Withdrawal by Subject|0
3083825|NCT00397891|10579583|P3|Overall Study|Withdrawal by Subject|0
3083826|NCT00397891|10579584|P2|Overall Study|Withdrawal by Subject|0
3083827|NCT00397891|10579585|P1|Overall Study|Withdrawal by Subject|1
3083828|NCT00397631|10579758|P2|Overall Study|protocol discontinuation criteria|4
3083829|NCT00397631|10579759|P1|Overall Study|protocol discontinuation criteria|1
3083830|NCT00397631|10579758|P2|Overall Study|Withdrawal by Subject|14
3083831|NCT00397631|10579759|P1|Overall Study|Withdrawal by Subject|7
3083832|NCT00397631|10579758|P2|Overall Study|Protocol Violation|1
3083833|NCT00397631|10579759|P1|Overall Study|Protocol Violation|0
3083834|NCT00397631|10579758|P2|Overall Study|Physician Decision|0
3083835|NCT00397631|10579759|P1|Overall Study|Physician Decision|2
3083836|NCT00397631|10579758|P2|Overall Study|Lost to Follow-up|9
3083837|NCT00397631|10579759|P1|Overall Study|Lost to Follow-up|8
3083838|NCT00397631|10579758|P2|Overall Study|Lack of Efficacy|10
3083839|NCT00397631|10579759|P1|Overall Study|Lack of Efficacy|7
3083840|NCT00397631|10579758|P2|Overall Study|Adverse Event|6
3083841|NCT00397631|10579759|P1|Overall Study|Adverse Event|5
3083842|NCT00397540|10579775|P2|Overall Study|short follow-up duration < 12 months|0
3083843|NCT00397540|10579776|P1|Overall Study|short follow-up duration < 12 months|1
3083844|NCT00397514|10579784|P1|Overall Study|poor echocardiographic windows|1
3083845|NCT00397514|10579784|P1|Overall Study|early extubation|2
3083846|NCT00397514|10579784|P1|Overall Study|Not able to capture & pace LV intraoper.|4
3083847|NCT00397514|10579784|P1|Overall Study|Pacing wire malfunction|1
3083848|NCT00397514|10579784|P1|Overall Study|Withdrawal by Subject|1
3083849|NCT00397488|10579794|P1|Overall Study|Death|1
3083850|NCT00397488|10579794|P1|Overall Study|Adverse Event|3
3083851|NCT00397488|10579794|P1|Overall Study|Withdrawal by Subject|3
3083852|NCT00397254|10579814|P2|Overall Study|Lost to Follow-up|2
3083853|NCT00397254|10579815|P1|Overall Study|Lost to Follow-up|2
3083854|NCT00397215|10579837|P4|Month 6 (Day 180)|Other|0
3083855|NCT00397215|10579838|P3|Month 6 (Day 180)|Other|3
3083856|NCT00397215|10579839|P2|Month 6 (Day 180)|Other|0
3083857|NCT00397215|10579840|P1|Month 6 (Day 180)|Other|2
3083858|NCT00397215|10579837|P4|Month 6 (Day 180)|Adverse Event|0
3083859|NCT00397215|10579838|P3|Month 6 (Day 180)|Adverse Event|2
3083860|NCT00397215|10579839|P2|Month 6 (Day 180)|Adverse Event|3
3083861|NCT00397215|10579840|P1|Month 6 (Day 180)|Adverse Event|0
3083862|NCT00397215|10579837|P4|Month 0 (Day 0)|Other|3
3083863|NCT00397215|10579838|P3|Month 0 (Day 0)|Other|3
3083864|NCT00397215|10579839|P2|Month 0 (Day 0)|Other|1
3083865|NCT00397215|10579840|P1|Month 0 (Day 0)|Other|4
3083866|NCT00397215|10579837|P4|Month 0 (Day 0)|Withdrawal by Subject|1
3083867|NCT00397215|10579838|P3|Month 0 (Day 0)|Withdrawal by Subject|3
3083868|NCT00397215|10579839|P2|Month 0 (Day 0)|Withdrawal by Subject|3
3083869|NCT00397215|10579840|P1|Month 0 (Day 0)|Withdrawal by Subject|3
3083870|NCT00397215|10579837|P4|Month 0 (Day 0)|Adverse Event|0
3083871|NCT00397215|10579838|P3|Month 0 (Day 0)|Adverse Event|0
3083872|NCT00397215|10579839|P2|Month 0 (Day 0)|Adverse Event|1
3083873|NCT00397215|10579840|P1|Month 0 (Day 0)|Adverse Event|0
3083874|NCT00397189|10579976|P2|3 Weeks Period|Other|2
3083875|NCT00397189|10579977|P1|3 Weeks Period|Other|0
3083876|NCT00397189|10579976|P2|3 Weeks Period|Protocol Violation|3
3083877|NCT00397189|10579977|P1|3 Weeks Period|Protocol Violation|0
3083878|NCT00397189|10579976|P2|3 Weeks Period|Physician Decision|2
3083879|NCT00397189|10579977|P1|3 Weeks Period|Physician Decision|0
3083880|NCT00397189|10579976|P2|3 Weeks Period|Withdrawal by Subject|9
3083881|NCT00397189|10579977|P1|3 Weeks Period|Withdrawal by Subject|13
3083882|NCT00397189|10579976|P2|3 Weeks Period|Adverse Event|2
3083883|NCT00397189|10579977|P1|3 Weeks Period|Adverse Event|3
3083884|NCT00397189|10579976|P2|3 Weeks Period|Lost to Follow-up|4
3083885|NCT00397189|10579977|P1|3 Weeks Period|Lost to Follow-up|5
3083886|NCT00397046|10580004|P4|Overall Study|Disease Progression|5
3083887|NCT00397046|10580005|P3|Overall Study|Disease Progression|10
3083888|NCT00397046|10580006|P2|Overall Study|Disease Progression|3
3083889|NCT00397046|10580007|P1|Overall Study|Disease Progression|3
3083890|NCT00397033|10580029|P3|Overall Study|Other|2
3083891|NCT00397033|10580030|P2|Overall Study|Other|5
3083892|NCT00397033|10580031|P1|Overall Study|Other|0
3083893|NCT00397033|10580029|P3|Overall Study|Withdrawal by Subject|5
3083894|NCT00397033|10580030|P2|Overall Study|Withdrawal by Subject|7
3083895|NCT00397033|10580031|P1|Overall Study|Withdrawal by Subject|12
3083896|NCT00397033|10580029|P3|Overall Study|Lost to Follow-up|3
3083897|NCT00397033|10580030|P2|Overall Study|Lost to Follow-up|3
3083898|NCT00397033|10580031|P1|Overall Study|Lost to Follow-up|3
3083899|NCT00397033|10580029|P3|Overall Study|Lack of Efficacy|9
3083900|NCT00397033|10580030|P2|Overall Study|Lack of Efficacy|12
3083901|NCT00397033|10580031|P1|Overall Study|Lack of Efficacy|22
3083902|NCT00397033|10580029|P3|Overall Study|Adverse Event|4
3083903|NCT00397033|10580030|P2|Overall Study|Adverse Event|10
3083904|NCT00397033|10580031|P1|Overall Study|Adverse Event|7
3083905|NCT00396877|10580122|P2|Overall Study|Parent(s)/guardian(s)'s request|7
3083906|NCT00396877|10580123|P1|Overall Study|Parent(s)/guardian(s)'s request|4
3083907|NCT00396877|10580122|P2|Overall Study|Lost to Follow-up|1
3083908|NCT00396877|10580123|P1|Overall Study|Lost to Follow-up|2
3083909|NCT00396812|10580133|P1|Overall Study|Physician Decision|1
3083910|NCT00396656|10580145|P2|Second Treatment Period|Adverse Event|1
3083911|NCT00396656|10580146|P1|Second Treatment Period|Adverse Event|0
3083912|NCT00396656|10580145|P2|First Treatment Period|Withdrawal by Subject|2
3083913|NCT00396656|10580146|P1|First Treatment Period|Withdrawal by Subject|0
3083914|NCT00396630|10580164|P2|Overall Study|Not vaccinated at Visit 3|3
3083915|NCT00396630|10580165|P1|Overall Study|Not vaccinated at Visit 3|3
3083916|NCT00396630|10580164|P2|Overall Study|Withdrawal by Subject|1
3083917|NCT00396630|10580165|P1|Overall Study|Withdrawal by Subject|1
3083918|NCT00396630|10580164|P2|Overall Study|Lost to Follow-up|1
3083919|NCT00396630|10580165|P1|Overall Study|Lost to Follow-up|1
3083920|NCT00396591|10580185|P1|Overall Study|Participant request|1
3083921|NCT00396591|10580185|P1|Overall Study|Adverse Event|2
3083922|NCT00396591|10580185|P1|Overall Study|Disease Progression|13
3083923|NCT00396565|10580198|P3|Overall Study|Lack of Efficacy|11
3083924|NCT00396565|10580199|P2|Overall Study|Lack of Efficacy|64
3083925|NCT00396565|10580200|P1|Overall Study|Lack of Efficacy|32
3083926|NCT00396565|10580198|P3|Overall Study|Withdrawal by Subject|1
3083927|NCT00396565|10580199|P2|Overall Study|Withdrawal by Subject|13
3083928|NCT00396565|10580200|P1|Overall Study|Withdrawal by Subject|8
3083929|NCT00396565|10580198|P3|Overall Study|Adverse Event|3
3083930|NCT00396565|10580199|P2|Overall Study|Adverse Event|13
3083931|NCT00396565|10580200|P1|Overall Study|Adverse Event|5
3083932|NCT00396565|10580198|P3|Overall Study|Physician Decision|2
3083933|NCT00396565|10580199|P2|Overall Study|Physician Decision|1
3083934|NCT00396565|10580200|P1|Overall Study|Physician Decision|3
3083935|NCT00396409|10580225|P2|Period 2 - 2008|Lost to Follow-up|1
3083936|NCT00396409|10580226|P1|Period 2 - 2008|Lost to Follow-up|3
3083937|NCT00396409|10580225|P2|Period 2 - 2008|Withdrawal by Subject|1
3083938|NCT00396409|10580226|P1|Period 2 - 2008|Withdrawal by Subject|3
3083939|NCT00396409|10580225|P2|Period 2 - 2008|Protocol Violation|0
3083940|NCT00396409|10580226|P1|Period 2 - 2008|Protocol Violation|1
3083941|NCT00396409|10580225|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
3083942|NCT00396409|10580226|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
3083943|NCT00396409|10580225|P2|Period 1 - 2007|Lost to Follow-up|3
3083944|NCT00396409|10580226|P1|Period 1 - 2007|Lost to Follow-up|2
3083945|NCT00396409|10580225|P2|Period 1 - 2007|Withdrawal by Subject|1
3083946|NCT00396409|10580226|P1|Period 1 - 2007|Withdrawal by Subject|1
3083947|NCT00396409|10580225|P2|Period 1 - 2007|Lack of Efficacy|1
3083948|NCT00396409|10580226|P1|Period 1 - 2007|Lack of Efficacy|0
3083949|NCT00396409|10580225|P2|Period 1 - 2007|Adverse Event|1
3083950|NCT00396409|10580226|P1|Period 1 - 2007|Adverse Event|0
3083951|NCT00396383|10580256|P1|Overall Study|Lost to Follow-up|1
3083952|NCT00396383|10580256|P1|Overall Study|Death|2
3083953|NCT00396331|10580269|P1|Overall Study|Death|16
3083954|NCT00396331|10580269|P1|Overall Study|Lost to Follow-up|3
3083955|NCT00396331|10580269|P1|Overall Study|Did not go on to transplant|5
3083956|NCT00396331|10580269|P1|Overall Study|Failed to mobilize - no transplant|8
3083957|NCT00396318|10580322|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
3083958|NCT00396279|10580342|P1|Overall Study|Physician Decision|1
3083959|NCT00396279|10580342|P1|Overall Study|Withdrawal by Subject|1
3083960|NCT00396279|10580342|P1|Overall Study|Disease progression|2
3083961|NCT00396279|10580342|P1|Overall Study|Ongoing in study|26
3083962|NCT00396253|10580375|P1|Overall Study|Change in eligibility status|1
3083963|NCT00396253|10580375|P1|Overall Study|Physician Decision|1
3083964|NCT00396253|10580375|P1|Overall Study|Death|3
3083965|NCT00396253|10580375|P1|Overall Study|Withdrawal by Subject|7
3083966|NCT00396253|10580375|P1|Overall Study|Protocol Violation|1
3083967|NCT00396162|10580406|P2|Overall Study|Withdrawal by Subject|3
3083968|NCT00396162|10580407|P1|Overall Study|Withdrawal by Subject|2
3083969|NCT00396136|10580419|P1|Overall Study|Study device explanted|8
3083970|NCT00396136|10580419|P1|Overall Study|Lost to Follow-up|15
3083971|NCT00396136|10580419|P1|Overall Study|Withdrawal by Subject|59
3083972|NCT00396136|10580419|P1|Overall Study|Death|43
3083973|NCT00396097|10580426|P2|Overall Study|Insufficient Clinical Response|4
3083974|NCT00396097|10580427|P1|Overall Study|Insufficient Clinical Response|1
3083975|NCT00396097|10580426|P2|Overall Study|Adverse Event|5
3083976|NCT00396097|10580427|P1|Overall Study|Adverse Event|1
3083977|NCT00396097|10580426|P2|Overall Study|Protocol Violation|6
3083978|NCT00396097|10580427|P1|Overall Study|Protocol Violation|0
3083979|NCT00396097|10580426|P2|Overall Study|Other|5
3083980|NCT00396097|10580427|P1|Overall Study|Other|3
3083981|NCT00396097|10580426|P2|Overall Study|Lost to Follow-up|9
3083982|NCT00396097|10580427|P1|Overall Study|Lost to Follow-up|4
3083983|NCT00396097|10580426|P2|Overall Study|Withdrawal by Subject|17
3083984|NCT00396097|10580427|P1|Overall Study|Withdrawal by Subject|17
3083985|NCT00396084|10580455|P6|Overall Study|Withdrawal by Subject|0
3083986|NCT00396084|10580456|P5|Overall Study|Withdrawal by Subject|0
3083987|NCT00396084|10580457|P4|Overall Study|Withdrawal by Subject|1
3083988|NCT00396084|10580458|P3|Overall Study|Withdrawal by Subject|0
3083989|NCT00396084|10580459|P2|Overall Study|Withdrawal by Subject|0
3083990|NCT00396084|10580460|P1|Overall Study|Withdrawal by Subject|0
3083991|NCT00396084|10580455|P6|Overall Study|Adverse Event|2
3083992|NCT00396084|10580456|P5|Overall Study|Adverse Event|1
3083993|NCT00396084|10580457|P4|Overall Study|Adverse Event|0
3083994|NCT00396084|10580458|P3|Overall Study|Adverse Event|0
3083995|NCT00396084|10580459|P2|Overall Study|Adverse Event|0
3083996|NCT00396084|10580460|P1|Overall Study|Adverse Event|0
3083997|NCT00395967|10580589|P1|Follow-up Period|Lost to Follow-up|1
3083998|NCT00395967|10580589|P1|Follow-up Period|Death|1
3083999|NCT00395967|10580589|P1|Treatment Period|Failed Mobilization|1
3084000|NCT00395863|10580629|P2|Overall Study|Patients did not complete both exams|3
3084001|NCT00395863|10580630|P1|Overall Study|Patients did not complete both exams|2
3084002|NCT00395850|10580665|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
3084003|NCT00395850|10580666|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
3084004|NCT00395850|10580667|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
3084005|NCT00395850|10580668|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
3084006|NCT00395850|10580665|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
3084007|NCT00395850|10580666|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
3084008|NCT00395850|10580667|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
3084009|NCT00395850|10580668|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
3084010|NCT00395850|10580665|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
3084011|NCT00395850|10580666|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
3084012|NCT00395850|10580667|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
3084013|NCT00395850|10580668|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
3084014|NCT00395850|10580665|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
3084015|NCT00395850|10580666|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
3084016|NCT00395850|10580667|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
3084017|NCT00395850|10580668|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
3084018|NCT00395850|10580665|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
3084019|NCT00395850|10580666|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
3084020|NCT00395850|10580667|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
3084021|NCT00395850|10580668|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
3084022|NCT00395850|10580665|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
3084023|NCT00395850|10580666|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
3084024|NCT00395850|10580667|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
3084025|NCT00395850|10580668|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
3084026|NCT00395850|10580665|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
3084027|NCT00395850|10580666|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
3084028|NCT00395850|10580667|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
3084029|NCT00395850|10580668|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
3084030|NCT00395746|10580685|P3|Overall Study|Unable to visit site on schedule|0
3084031|NCT00395746|10580686|P2|Overall Study|Unable to visit site on schedule|0
3084032|NCT00395746|10580687|P1|Overall Study|Unable to visit site on schedule|1
3084033|NCT00395746|10580685|P3|Overall Study|Difficultulty in use of device|1
3084034|NCT00395746|10580686|P2|Overall Study|Difficultulty in use of device|0
3084035|NCT00395746|10580687|P1|Overall Study|Difficultulty in use of device|0
3084036|NCT00395746|10580685|P3|Overall Study|Withdrawal of consent|1
3084037|NCT00395746|10580686|P2|Overall Study|Withdrawal of consent|0
3084038|NCT00395746|10580687|P1|Overall Study|Withdrawal of consent|0
3084039|NCT00395746|10580685|P3|Overall Study|Subject decision|1
3084040|NCT00395746|10580686|P2|Overall Study|Subject decision|0
3084041|NCT00395746|10580687|P1|Overall Study|Subject decision|0
3084042|NCT00395746|10580685|P3|Overall Study|Hypoglycaemia|0
3084043|NCT00395746|10580686|P2|Overall Study|Hypoglycaemia|1
3084044|NCT00395746|10580687|P1|Overall Study|Hypoglycaemia|2
3084045|NCT00395746|10580685|P3|Overall Study|Lack of Efficacy|17
3084046|NCT00395746|10580686|P2|Overall Study|Lack of Efficacy|0
3084047|NCT00395746|10580687|P1|Overall Study|Lack of Efficacy|2
3084048|NCT00395746|10580685|P3|Overall Study|Protocol Violation|0
3084049|NCT00395746|10580686|P2|Overall Study|Protocol Violation|1
3084050|NCT00395746|10580687|P1|Overall Study|Protocol Violation|0
3084051|NCT00395746|10580685|P3|Overall Study|Adverse Event|2
3084052|NCT00395746|10580686|P2|Overall Study|Adverse Event|2
3084053|NCT00395746|10580687|P1|Overall Study|Adverse Event|5
3084054|NCT00395733|10580733|P2|Period 2|Technical problems|0
3084055|NCT00395733|10580734|P1|Period 2|Technical problems|1
3084056|NCT00395733|10580733|P2|Period 2|Adverse Event|2
3084057|NCT00395733|10580734|P1|Period 2|Adverse Event|0
3084058|NCT00395733|10580733|P2|Period 2|Protocol Violation|1
3084059|NCT00395733|10580734|P1|Period 2|Protocol Violation|0
3084060|NCT00395733|10580733|P2|Period 2|Withdrawal by Subject|2
3084061|NCT00395733|10580734|P1|Period 2|Withdrawal by Subject|1
3084062|NCT00395694|10580758|P2|Continuation Phase|Withdrawal by Subject|2
3084063|NCT00395694|10580759|P1|Continuation Phase|Withdrawal by Subject|0
3084064|NCT00395694|10580758|P2|Continuation Phase|Poor Compliance|0
3084065|NCT00395694|10580759|P1|Continuation Phase|Poor Compliance|1
3084066|NCT00395694|10580758|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
3084067|NCT00395694|10580759|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
3084068|NCT00395694|10580758|P2|Continuation Phase|Lack of Efficacy|11
3084069|NCT00395694|10580759|P1|Continuation Phase|Lack of Efficacy|12
3084070|NCT00395694|10580758|P2|Continuation Phase|Adverse Event|0
3084071|NCT00395694|10580759|P1|Continuation Phase|Adverse Event|1
3084072|NCT00395694|10580758|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
3084073|NCT00395694|10580759|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
3084074|NCT00395642|10580790|P1|Overall Study|Withdrawal by Subject|1
3084075|NCT00395642|10580790|P1|Overall Study|Physician Decision|7
3084076|NCT00395642|10580790|P1|Overall Study|Lost to Follow-up|1
3084077|NCT00395642|10580790|P1|Overall Study|Death|4
3084078|NCT00395629|10580797|P3|Extension Study|Administrative problems|1
3084079|NCT00395629|10580798|P2|Extension Study|Administrative problems|0
3084080|NCT00395629|10580799|P1|Extension Study|Administrative problems|0
3084081|NCT00395629|10580797|P3|Extension Study|Adverse Event|2
3084082|NCT00395629|10580798|P2|Extension Study|Adverse Event|0
3084083|NCT00395629|10580799|P1|Extension Study|Adverse Event|0
3084084|NCT00395629|10580797|P3|Core Study|Lost to Follow-up|1
3084085|NCT00395629|10580798|P2|Core Study|Lost to Follow-up|0
3084086|NCT00395629|10580799|P1|Core Study|Lost to Follow-up|0
3084087|NCT00395629|10580797|P3|Core Study|Withdrawal by Subject|1
3084088|NCT00395629|10580798|P2|Core Study|Withdrawal by Subject|1
3084089|NCT00395629|10580799|P1|Core Study|Withdrawal by Subject|0
3084090|NCT00395629|10580797|P3|Core Study|Protocol Violation|0
3084091|NCT00395629|10580798|P2|Core Study|Protocol Violation|0
3084092|NCT00395629|10580799|P1|Core Study|Protocol Violation|1
3084093|NCT00395629|10580797|P3|Core Study|Abnormal laboratory value(s)|1
3084094|NCT00395629|10580798|P2|Core Study|Abnormal laboratory value(s)|0
3084095|NCT00395629|10580799|P1|Core Study|Abnormal laboratory value(s)|0
3084096|NCT00395629|10580797|P3|Core Study|Adverse Event|4
3084097|NCT00395629|10580798|P2|Core Study|Adverse Event|3
3084098|NCT00395629|10580799|P1|Core Study|Adverse Event|0
3084099|NCT00395538|10580816|P3|Overall Study|Participant elected to discontinue|1
3084100|NCT00395538|10580817|P2|Overall Study|Participant elected to discontinue|0
3084101|NCT00395538|10580818|P1|Overall Study|Participant elected to discontinue|0
3084102|NCT00395538|10580816|P3|Overall Study|Partial recovery of parathyroid function|1
3084103|NCT00395538|10580817|P2|Overall Study|Partial recovery of parathyroid function|0
3084104|NCT00395538|10580818|P1|Overall Study|Partial recovery of parathyroid function|0
3084105|NCT00395538|10580816|P3|Overall Study|Pregnancy|0
3084106|NCT00395538|10580817|P2|Overall Study|Pregnancy|0
3084107|NCT00395538|10580818|P1|Overall Study|Pregnancy|1
3084108|NCT00395538|10580816|P3|Overall Study|PTH resistance|1
3084109|NCT00395538|10580817|P2|Overall Study|PTH resistance|0
3084110|NCT00395538|10580818|P1|Overall Study|PTH resistance|0
3084111|NCT00395538|10580816|P3|Overall Study|Non-compliance with study protocol|0
3084112|NCT00395538|10580817|P2|Overall Study|Non-compliance with study protocol|1
3084113|NCT00395538|10580818|P1|Overall Study|Non-compliance with study protocol|0
3084114|NCT00395538|10580816|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
3084115|NCT00395538|10580817|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
3084116|NCT00395538|10580818|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
3084117|NCT00395538|10580816|P3|Overall Study|Adverse Event|2
3084118|NCT00395538|10580817|P2|Overall Study|Adverse Event|0
3084119|NCT00395538|10580818|P1|Overall Study|Adverse Event|1
3084120|NCT00395538|10580816|P3|Overall Study|Switch to Natpara|3
3084121|NCT00395538|10580817|P2|Overall Study|Switch to Natpara|0
3084122|NCT00395538|10580818|P1|Overall Study|Switch to Natpara|0
3084123|NCT00395538|10580816|P3|Overall Study|Failed screening|4
3084124|NCT00395538|10580817|P2|Overall Study|Failed screening|0
3084125|NCT00395538|10580818|P1|Overall Study|Failed screening|0
3084126|NCT00395538|10580816|P3|Overall Study|FDA partial hold on PTH|11
3084127|NCT00395538|10580817|P2|Overall Study|FDA partial hold on PTH|0
3084128|NCT00395538|10580818|P1|Overall Study|FDA partial hold on PTH|0
3084129|NCT00395538|10580816|P3|Overall Study|Did not re-consent to revised protocol|0
3084130|NCT00395538|10580817|P2|Overall Study|Did not re-consent to revised protocol|10
3084131|NCT00395538|10580818|P1|Overall Study|Did not re-consent to revised protocol|1
3084132|NCT00395512|10580891|P4|Overall Study|Hyperglycemic Rescue|6
3084133|NCT00395512|10580892|P3|Overall Study|Hyperglycemic Rescue|4
3084134|NCT00395512|10580893|P2|Overall Study|Hyperglycemic Rescue|10
3084135|NCT00395512|10580894|P1|Overall Study|Hyperglycemic Rescue|18
3084136|NCT00395512|10580891|P4|Overall Study|Other|0
3084137|NCT00395512|10580892|P3|Overall Study|Other|0
3084138|NCT00395512|10580893|P2|Overall Study|Other|1
3084139|NCT00395512|10580894|P1|Overall Study|Other|1
3084140|NCT00395512|10580891|P4|Overall Study|Physician Decision|2
3084141|NCT00395512|10580892|P3|Overall Study|Physician Decision|2
3084142|NCT00395512|10580893|P2|Overall Study|Physician Decision|4
3084143|NCT00395512|10580894|P1|Overall Study|Physician Decision|6
3084144|NCT00395512|10580891|P4|Overall Study|Withdrawal by Subject|12
3084145|NCT00395512|10580892|P3|Overall Study|Withdrawal by Subject|5
3084146|NCT00395512|10580893|P2|Overall Study|Withdrawal by Subject|5
3084147|NCT00395512|10580894|P1|Overall Study|Withdrawal by Subject|6
3084148|NCT00395512|10580891|P4|Overall Study|Lost to Follow-up|5
3084149|NCT00395512|10580892|P3|Overall Study|Lost to Follow-up|5
3084150|NCT00395512|10580893|P2|Overall Study|Lost to Follow-up|6
3084151|NCT00395512|10580894|P1|Overall Study|Lost to Follow-up|2
3084152|NCT00395512|10580891|P4|Overall Study|Protocol Violation|7
3084153|NCT00395512|10580892|P3|Overall Study|Protocol Violation|6
3084154|NCT00395512|10580893|P2|Overall Study|Protocol Violation|3
3084155|NCT00395512|10580894|P1|Overall Study|Protocol Violation|2
3084156|NCT00395512|10580891|P4|Overall Study|Adverse Event|6
3084157|NCT00395512|10580892|P3|Overall Study|Adverse Event|6
3084158|NCT00395512|10580893|P2|Overall Study|Adverse Event|8
3084159|NCT00395512|10580894|P1|Overall Study|Adverse Event|3
3084160|NCT00395486|10581066|P2|Overall Study|Lost to Follow-up|1
3084161|NCT00395486|10581067|P1|Overall Study|Lost to Follow-up|0
3084162|NCT00395486|10581066|P2|Overall Study|Withdrawal by Subject|2
3084163|NCT00395486|10581067|P1|Overall Study|Withdrawal by Subject|5
3084164|NCT00395486|10581066|P2|Overall Study|Adverse Event|2
3084165|NCT00395486|10581067|P1|Overall Study|Adverse Event|1
3084166|NCT00395460|10581097|P2|Overall Study|Withdrawal by Subject|0
3084167|NCT00395460|10581098|P1|Overall Study|Withdrawal by Subject|1
3084168|NCT00395447|10581122|P2|Overall Study|Withdrawl - Other (not subject)|17
3084169|NCT00395447|10581123|P1|Overall Study|Withdrawl - Other (not subject)|8
3084170|NCT00395447|10581122|P2|Overall Study|Withdrawal by Subject|19
3084171|NCT00395447|10581123|P1|Overall Study|Withdrawal by Subject|24
3084172|NCT00395447|10581122|P2|Overall Study|Lost to Follow-up|43
3084173|NCT00395447|10581123|P1|Overall Study|Lost to Follow-up|52
3084174|NCT00395447|10581122|P2|Overall Study|Death|32
3084175|NCT00395447|10581123|P1|Overall Study|Death|37
3084176|NCT00395343|10581131|P2|Overall Study|Other|2
3084177|NCT00395343|10581132|P1|Overall Study|Other|5
3084178|NCT00395343|10581131|P2|Overall Study|Withdrawal by Subject|12
3084179|NCT00395343|10581132|P1|Overall Study|Withdrawal by Subject|11
3084180|NCT00395343|10581131|P2|Overall Study|Protocol Violation|8
3084181|NCT00395343|10581132|P1|Overall Study|Protocol Violation|6
3084182|NCT00395343|10581131|P2|Overall Study|Physician Decision|4
3084183|NCT00395343|10581132|P1|Overall Study|Physician Decision|2
3084184|NCT00395343|10581131|P2|Overall Study|Lost to Follow-up|4
3084185|NCT00395343|10581132|P1|Overall Study|Lost to Follow-up|4
3084186|NCT00395343|10581131|P2|Overall Study|Lack of Efficacy|1
3084187|NCT00395343|10581132|P1|Overall Study|Lack of Efficacy|0
3084188|NCT00395343|10581131|P2|Overall Study|Adverse Event|5
3084189|NCT00395343|10581132|P1|Overall Study|Adverse Event|13
3084190|NCT00395304|10581150|P6|Treatment Period 3|Other|0
3084191|NCT00395304|10581151|P5|Treatment Period 3|Other|0
3084192|NCT00395304|10581152|P4|Treatment Period 3|Other|1
3084193|NCT00395304|10581153|P3|Treatment Period 3|Other|0
3084194|NCT00395304|10581154|P2|Treatment Period 3|Other|0
3084195|NCT00395304|10581155|P1|Treatment Period 3|Other|0
3084196|NCT00395304|10581150|P6|Treatment Period 3|Physician Decision|0
3084197|NCT00395304|10581151|P5|Treatment Period 3|Physician Decision|0
3084198|NCT00395304|10581152|P4|Treatment Period 3|Physician Decision|0
3084199|NCT00395304|10581153|P3|Treatment Period 3|Physician Decision|0
3084200|NCT00395304|10581154|P2|Treatment Period 3|Physician Decision|1
3084201|NCT00395304|10581155|P1|Treatment Period 3|Physician Decision|0
3084202|NCT00395304|10581150|P6|Treatment Period 3|Lost to Follow-up|0
3084203|NCT00395304|10581151|P5|Treatment Period 3|Lost to Follow-up|0
3084204|NCT00395304|10581152|P4|Treatment Period 3|Lost to Follow-up|0
3084205|NCT00395304|10581153|P3|Treatment Period 3|Lost to Follow-up|0
3084206|NCT00395304|10581154|P2|Treatment Period 3|Lost to Follow-up|1
3084207|NCT00395304|10581155|P1|Treatment Period 3|Lost to Follow-up|1
3084208|NCT00395304|10581150|P6|Treatment Period 3|Withdrawal by Subject|1
3084209|NCT00395304|10581151|P5|Treatment Period 3|Withdrawal by Subject|0
3084210|NCT00395304|10581152|P4|Treatment Period 3|Withdrawal by Subject|1
3084211|NCT00395304|10581153|P3|Treatment Period 3|Withdrawal by Subject|0
3084212|NCT00395304|10581154|P2|Treatment Period 3|Withdrawal by Subject|0
3084213|NCT00395304|10581155|P1|Treatment Period 3|Withdrawal by Subject|0
3084214|NCT00395304|10581150|P6|Treatment Period 2|Other|0
3084215|NCT00395304|10581151|P5|Treatment Period 2|Other|0
3084216|NCT00395304|10581152|P4|Treatment Period 2|Other|0
3084217|NCT00395304|10581153|P3|Treatment Period 2|Other|0
3084218|NCT00395304|10581154|P2|Treatment Period 2|Other|1
3084219|NCT00395304|10581155|P1|Treatment Period 2|Other|0
3084220|NCT00395304|10581150|P6|Treatment Period 2|Physician Decision|0
3084221|NCT00395304|10581151|P5|Treatment Period 2|Physician Decision|0
3084222|NCT00395304|10581152|P4|Treatment Period 2|Physician Decision|0
3084223|NCT00395304|10581153|P3|Treatment Period 2|Physician Decision|1
3084224|NCT00395304|10581154|P2|Treatment Period 2|Physician Decision|0
3084225|NCT00395304|10581155|P1|Treatment Period 2|Physician Decision|0
3084226|NCT00395304|10581150|P6|Treatment Period 2|Lost to Follow-up|0
3084227|NCT00395304|10581151|P5|Treatment Period 2|Lost to Follow-up|0
3084228|NCT00395304|10581152|P4|Treatment Period 2|Lost to Follow-up|0
3084229|NCT00395304|10581153|P3|Treatment Period 2|Lost to Follow-up|0
3084230|NCT00395304|10581154|P2|Treatment Period 2|Lost to Follow-up|3
3084231|NCT00395304|10581155|P1|Treatment Period 2|Lost to Follow-up|0
3084232|NCT00395304|10581150|P6|Treatment Period 2|Withdrawal by Subject|2
3084233|NCT00395304|10581151|P5|Treatment Period 2|Withdrawal by Subject|0
3084234|NCT00395304|10581152|P4|Treatment Period 2|Withdrawal by Subject|1
3084235|NCT00395304|10581153|P3|Treatment Period 2|Withdrawal by Subject|0
3084236|NCT00395304|10581154|P2|Treatment Period 2|Withdrawal by Subject|0
3084237|NCT00395304|10581155|P1|Treatment Period 2|Withdrawal by Subject|0
3084238|NCT00395304|10581150|P6|Treatment Period 1|Physician Decision|0
3084239|NCT00395304|10581151|P5|Treatment Period 1|Physician Decision|0
3084240|NCT00395304|10581152|P4|Treatment Period 1|Physician Decision|0
3084241|NCT00395304|10581153|P3|Treatment Period 1|Physician Decision|0
3084242|NCT00395304|10581154|P2|Treatment Period 1|Physician Decision|1
3084243|NCT00395304|10581155|P1|Treatment Period 1|Physician Decision|0
3084244|NCT00395304|10581150|P6|Treatment Period 1|Lost to Follow-up|1
3084245|NCT00395304|10581151|P5|Treatment Period 1|Lost to Follow-up|0
3084246|NCT00395304|10581152|P4|Treatment Period 1|Lost to Follow-up|1
3084247|NCT00395304|10581153|P3|Treatment Period 1|Lost to Follow-up|0
3084248|NCT00395304|10581154|P2|Treatment Period 1|Lost to Follow-up|0
3084249|NCT00395304|10581155|P1|Treatment Period 1|Lost to Follow-up|1
3084250|NCT00395304|10581150|P6|Treatment Period 1|Withdrawal by Subject|1
3084251|NCT00395304|10581151|P5|Treatment Period 1|Withdrawal by Subject|1
3084252|NCT00395304|10581152|P4|Treatment Period 1|Withdrawal by Subject|2
3084253|NCT00395304|10581153|P3|Treatment Period 1|Withdrawal by Subject|0
3084254|NCT00395304|10581154|P2|Treatment Period 1|Withdrawal by Subject|3
3084255|NCT00395304|10581155|P1|Treatment Period 1|Withdrawal by Subject|0
3084256|NCT00395226|10581231|P2|Overall Study|Lost to Follow-up|1
3084257|NCT00395226|10581232|P1|Overall Study|Lost to Follow-up|0
3084258|NCT00395226|10581231|P2|Overall Study|Withdrawal by Subject|1
3084259|NCT00395226|10581232|P1|Overall Study|Withdrawal by Subject|0
3084260|NCT00395226|10581231|P2|Overall Study|Adverse Event|3
3084261|NCT00395226|10581232|P1|Overall Study|Adverse Event|4
3084262|NCT00395083|10581279|P2|Overall Study|Developed another disease|3
3084263|NCT00395083|10581280|P1|Overall Study|Developed another disease|4
3084264|NCT00395083|10581279|P2|Overall Study|Withdrawal by Subject|5
3084265|NCT00395083|10581280|P1|Overall Study|Withdrawal by Subject|6
3084266|NCT00395018|10581346|P1|Off-Treatment Follow-up|Poor/non-compliance|1
3084267|NCT00395018|10581346|P1|Off-Treatment Follow-up|Lost to Follow-up|2
3084268|NCT00395018|10581346|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
3084269|NCT00395018|10581346|P1|On-Treatment|Subject no longer meets study criteria|2
3084270|NCT00395018|10581346|P1|On-Treatment|Poor/non-compliance|2
3084271|NCT00395018|10581346|P1|On-Treatment|Other Reason|2
3084272|NCT00395018|10581346|P1|On-Treatment|Death|4
3084273|NCT00394953|10581367|P2|Second Treatment Period|Not defined|8
3084274|NCT00394953|10581368|P1|Second Treatment Period|Not defined|3
3084275|NCT00394953|10581367|P2|Second Treatment Period|Renal transplant|6
3084276|NCT00394953|10581368|P1|Second Treatment Period|Renal transplant|4
3084277|NCT00394953|10581367|P2|Second Treatment Period|Lost to Follow-up|1
3084278|NCT00394953|10581368|P1|Second Treatment Period|Lost to Follow-up|0
3084279|NCT00394953|10581367|P2|Second Treatment Period|Withdrawal by Subject|3
3084280|NCT00394953|10581368|P1|Second Treatment Period|Withdrawal by Subject|3
3084281|NCT00394953|10581367|P2|Second Treatment Period|Lack of Efficacy|47
3084282|NCT00394953|10581368|P1|Second Treatment Period|Lack of Efficacy|9
3084283|NCT00394953|10581367|P2|Second Treatment Period|Death|4
3084284|NCT00394953|10581368|P1|Second Treatment Period|Death|8
3084285|NCT00394953|10581367|P2|Second Treatment Period|Adverse Event|5
3084286|NCT00394953|10581368|P1|Second Treatment Period|Adverse Event|2
3084287|NCT00394953|10581367|P2|First Treatment Period|Not defined|1
3084288|NCT00394953|10581368|P1|First Treatment Period|Not defined|4
3084289|NCT00394953|10581367|P2|First Treatment Period|Renal transplant|7
3084290|NCT00394953|10581368|P1|First Treatment Period|Renal transplant|11
3084291|NCT00394953|10581367|P2|First Treatment Period|Lost to Follow-up|1
3084292|NCT00394953|10581368|P1|First Treatment Period|Lost to Follow-up|0
3084293|NCT00394953|10581367|P2|First Treatment Period|Withdrawal by Subject|3
3084294|NCT00394953|10581368|P1|First Treatment Period|Withdrawal by Subject|6
3084295|NCT00394953|10581367|P2|First Treatment Period|Lack of Efficacy|1
3084296|NCT00394953|10581368|P1|First Treatment Period|Lack of Efficacy|1
3084297|NCT00394953|10581367|P2|First Treatment Period|Death|7
3084298|NCT00394953|10581368|P1|First Treatment Period|Death|6
3084299|NCT00394953|10581367|P2|First Treatment Period|Adverse Event|2
3084300|NCT00394953|10581368|P1|First Treatment Period|Adverse Event|1
3084301|NCT00394914|10581386|P3|Treatment Period|Did not meet protocol eligibility|1
3084302|NCT00394914|10581387|P2|Treatment Period|Did not meet protocol eligibility|1
3084303|NCT00394914|10581388|P1|Treatment Period|Did not meet protocol eligibility|0
3084304|NCT00394914|10581386|P3|Treatment Period|Noncompliance with protocol|2
3084305|NCT00394914|10581387|P2|Treatment Period|Noncompliance with protocol|3
3084306|NCT00394914|10581388|P1|Treatment Period|Noncompliance with protocol|0
3084307|NCT00394914|10581386|P3|Treatment Period|Withdrawal by Subject|2
3084308|NCT00394914|10581387|P2|Treatment Period|Withdrawal by Subject|2
3084309|NCT00394914|10581388|P1|Treatment Period|Withdrawal by Subject|0
3084310|NCT00394914|10581386|P3|Treatment Period|Lost to Follow-up|0
3084311|NCT00394914|10581387|P2|Treatment Period|Lost to Follow-up|1
3084312|NCT00394914|10581388|P1|Treatment Period|Lost to Follow-up|0
3084313|NCT00394914|10581386|P3|Treatment Period|Adverse Event|1
3084314|NCT00394914|10581387|P2|Treatment Period|Adverse Event|3
3084315|NCT00394914|10581388|P1|Treatment Period|Adverse Event|0
3084316|NCT00394901|10581416|P4|Double-blind Phase|Found not to meet entrance criteria|1
3084317|NCT00394901|10581417|P3|Double-blind Phase|Found not to meet entrance criteria|0
3084318|NCT00394901|10581418|P2|Double-blind Phase|Found not to meet entrance criteria|0
3084319|NCT00394901|10581419|P1|Double-blind Phase|Found not to meet entrance criteria|0
3084320|NCT00394901|10581416|P4|Double-blind Phase|Entry into another study was found|0
3084321|NCT00394901|10581417|P3|Double-blind Phase|Entry into another study was found|1
3084322|NCT00394901|10581418|P2|Double-blind Phase|Entry into another study was found|0
3084323|NCT00394901|10581419|P1|Double-blind Phase|Entry into another study was found|0
3084324|NCT00394901|10581416|P4|Double-blind Phase|Lack of Compliance|0
3084325|NCT00394901|10581417|P3|Double-blind Phase|Lack of Compliance|0
3084326|NCT00394901|10581418|P2|Double-blind Phase|Lack of Compliance|3
3084327|NCT00394901|10581419|P1|Double-blind Phase|Lack of Compliance|0
3084328|NCT00394901|10581416|P4|Double-blind Phase|Subject's Personal Reason|1
3084329|NCT00394901|10581417|P3|Double-blind Phase|Subject's Personal Reason|0
3084330|NCT00394901|10581418|P2|Double-blind Phase|Subject's Personal Reason|0
3084331|NCT00394901|10581419|P1|Double-blind Phase|Subject's Personal Reason|1
3084332|NCT00394901|10581416|P4|Double-blind Phase|Death|0
3084333|NCT00394901|10581417|P3|Double-blind Phase|Death|0
3084334|NCT00394901|10581418|P2|Double-blind Phase|Death|0
3084335|NCT00394901|10581419|P1|Double-blind Phase|Death|1
3084336|NCT00394901|10581416|P4|Double-blind Phase|Protocol Violation|1
3084337|NCT00394901|10581417|P3|Double-blind Phase|Protocol Violation|0
3084338|NCT00394901|10581418|P2|Double-blind Phase|Protocol Violation|0
3084339|NCT00394901|10581419|P1|Double-blind Phase|Protocol Violation|0
3084340|NCT00394901|10581416|P4|Double-blind Phase|Lost to Follow-up|1
3084341|NCT00394901|10581417|P3|Double-blind Phase|Lost to Follow-up|0
3084342|NCT00394901|10581418|P2|Double-blind Phase|Lost to Follow-up|0
3084343|NCT00394901|10581419|P1|Double-blind Phase|Lost to Follow-up|0
3084344|NCT00394901|10581416|P4|Double-blind Phase|Withdrawal by Subject|0
3084345|NCT00394901|10581417|P3|Double-blind Phase|Withdrawal by Subject|0
3084346|NCT00394901|10581418|P2|Double-blind Phase|Withdrawal by Subject|0
3084347|NCT00394901|10581419|P1|Double-blind Phase|Withdrawal by Subject|2
3084348|NCT00394901|10581416|P4|Double-blind Phase|Lack of Efficacy|3
3084349|NCT00394901|10581417|P3|Double-blind Phase|Lack of Efficacy|1
3084350|NCT00394901|10581418|P2|Double-blind Phase|Lack of Efficacy|4
3084351|NCT00394901|10581419|P1|Double-blind Phase|Lack of Efficacy|6
3084352|NCT00394901|10581416|P4|Double-blind Phase|Adverse Event|20
3084353|NCT00394901|10581417|P3|Double-blind Phase|Adverse Event|16
3084354|NCT00394901|10581418|P2|Double-blind Phase|Adverse Event|7
3084355|NCT00394901|10581419|P1|Double-blind Phase|Adverse Event|5
3084356|NCT00394901|10581416|P4|Baseline Phase|Protocol Violation|0
3084357|NCT00394901|10581417|P3|Baseline Phase|Protocol Violation|1
3084358|NCT00394901|10581418|P2|Baseline Phase|Protocol Violation|0
3084359|NCT00394901|10581419|P1|Baseline Phase|Protocol Violation|0
3084360|NCT00394836|10581662|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
3084361|NCT00394836|10581663|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
3084362|NCT00394836|10581662|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
3084363|NCT00394836|10581663|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
3084364|NCT00394836|10581662|P2|Extended Follow-up Phase (2-5 Years)|Death|1
3084365|NCT00394836|10581663|P1|Extended Follow-up Phase (2-5 Years)|Death|0
3084366|NCT00394836|10581662|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
3084367|NCT00394836|10581663|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
3084368|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Non compliance|1
3084369|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Non compliance|0
3084370|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
3084371|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
3084372|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Physician Decision|1
3084373|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Physician Decision|0
3084374|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
3084375|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
3084376|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Started alternative treatment|6
3084377|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Started alternative treatment|0
3084378|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
3084379|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
3084380|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Death|1
3084381|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Death|0
3084382|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Patient Refusal|2
3084383|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Patient Refusal|1
3084384|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Disease Progression|60
3084385|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Disease Progression|27
3084386|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Protocol Violation|2
3084387|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Protocol Violation|0
3084388|NCT00394836|10581662|P2|Teatment or Follow-up Phase|Adverse Event|2
3084389|NCT00394836|10581663|P1|Teatment or Follow-up Phase|Adverse Event|0
3084390|NCT00394771|10581709|P4|Overall Study|Other|0
3084391|NCT00394771|10581710|P3|Overall Study|Other|1
3084392|NCT00394771|10581711|P2|Overall Study|Other|3
3084393|NCT00394771|10581712|P1|Overall Study|Other|3
3084394|NCT00394771|10581709|P4|Overall Study|Lost to Follow-up|10
3084395|NCT00394771|10581710|P3|Overall Study|Lost to Follow-up|13
3084396|NCT00394771|10581711|P2|Overall Study|Lost to Follow-up|15
3084397|NCT00394771|10581712|P1|Overall Study|Lost to Follow-up|15
3084398|NCT00394771|10581709|P4|Overall Study|Participant pregnant|2
3084399|NCT00394771|10581710|P3|Overall Study|Participant pregnant|2
3084400|NCT00394771|10581711|P2|Overall Study|Participant pregnant|1
3084401|NCT00394771|10581712|P1|Overall Study|Participant pregnant|0
3084402|NCT00394771|10581709|P4|Overall Study|Adverse Event|8
3084403|NCT00394771|10581710|P3|Overall Study|Adverse Event|12
3084404|NCT00394771|10581711|P2|Overall Study|Adverse Event|5
3084405|NCT00394771|10581712|P1|Overall Study|Adverse Event|10
3084406|NCT00394771|10581709|P4|Overall Study|Withdrawal by Subject|12
3084407|NCT00394771|10581710|P3|Overall Study|Withdrawal by Subject|8
3084408|NCT00394771|10581711|P2|Overall Study|Withdrawal by Subject|6
3084409|NCT00394771|10581712|P1|Overall Study|Withdrawal by Subject|10
3084410|NCT00394771|10581709|P4|Overall Study|Protocol Violation|7
3084411|NCT00394771|10581710|P3|Overall Study|Protocol Violation|9
3084412|NCT00394771|10581711|P2|Overall Study|Protocol Violation|4
3084413|NCT00394771|10581712|P1|Overall Study|Protocol Violation|2
3084414|NCT00394771|10581709|P4|Overall Study|Did not meet protocol requirements|0
3084415|NCT00394771|10581710|P3|Overall Study|Did not meet protocol requirements|2
3084416|NCT00394771|10581711|P2|Overall Study|Did not meet protocol requirements|0
3084417|NCT00394771|10581712|P1|Overall Study|Did not meet protocol requirements|1
3084418|NCT00394706|10581782|P8|Overall Study|Lost to Follow-up|0
3084419|NCT00394706|10581783|P7|Overall Study|Lost to Follow-up|2
3084420|NCT00394706|10581784|P6|Overall Study|Lost to Follow-up|5
3084421|NCT00394706|10581785|P5|Overall Study|Lost to Follow-up|2
3084422|NCT00394706|10581786|P4|Overall Study|Lost to Follow-up|1
3084423|NCT00394706|10581787|P3|Overall Study|Lost to Follow-up|8
3084424|NCT00394706|10581788|P2|Overall Study|Lost to Follow-up|2
3084425|NCT00394706|10581789|P1|Overall Study|Lost to Follow-up|2
3084426|NCT00394706|10581782|P8|Overall Study|Withdrawal by Subject|0
3084427|NCT00394706|10581783|P7|Overall Study|Withdrawal by Subject|1
3084428|NCT00394706|10581784|P6|Overall Study|Withdrawal by Subject|2
3084429|NCT00394706|10581785|P5|Overall Study|Withdrawal by Subject|0
3084430|NCT00394706|10581786|P4|Overall Study|Withdrawal by Subject|0
3084431|NCT00394706|10581787|P3|Overall Study|Withdrawal by Subject|1
3084432|NCT00394706|10581788|P2|Overall Study|Withdrawal by Subject|0
3084433|NCT00394706|10581789|P1|Overall Study|Withdrawal by Subject|2
3084434|NCT00394654|10581821|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
3084435|NCT00394654|10581822|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
3084436|NCT00394654|10581821|P2|Overall Study|Lost to Follow-up|0
3084437|NCT00394654|10581822|P1|Overall Study|Lost to Follow-up|1
3084438|NCT00394589|10581887|P3|Overall Study|Protocol Violation|2
3084439|NCT00394589|10581888|P2|Overall Study|Protocol Violation|0
3084440|NCT00394589|10581889|P1|Overall Study|Protocol Violation|4
3084441|NCT00394589|10581887|P3|Overall Study|Lack of Efficacy|3
3084442|NCT00394589|10581888|P2|Overall Study|Lack of Efficacy|2
3084443|NCT00394589|10581889|P1|Overall Study|Lack of Efficacy|2
3084444|NCT00394589|10581887|P3|Overall Study|Adverse Event|2
3084445|NCT00394589|10581888|P2|Overall Study|Adverse Event|1
3084446|NCT00394589|10581889|P1|Overall Study|Adverse Event|2
3084447|NCT00394524|10581899|P2|Overall Study|Withdrawal by Subject|1
3084448|NCT00394524|10581900|P1|Overall Study|Withdrawal by Subject|0
3084449|NCT00394524|10581899|P2|Overall Study|Death|0
3084450|NCT00394524|10581900|P1|Overall Study|Death|1
3084451|NCT00394524|10581899|P2|Overall Study|Protocol Violation|3
3084452|NCT00394524|10581900|P1|Overall Study|Protocol Violation|2
3084453|NCT00394472|10581914|P2|Overall Study|Lost to Follow-up|1
3084454|NCT00394472|10581915|P1|Overall Study|Lost to Follow-up|0
3084455|NCT00394472|10581914|P2|Overall Study|Physician Decision|1
3084456|NCT00394472|10581915|P1|Overall Study|Physician Decision|0
3084457|NCT00394472|10581914|P2|Overall Study|Withdrawal by Subject|2
3084458|NCT00394472|10581915|P1|Overall Study|Withdrawal by Subject|0
3084459|NCT00394472|10581914|P2|Overall Study|Adverse Event|2
3084460|NCT00394472|10581915|P1|Overall Study|Adverse Event|4
3084461|NCT00394472|10581914|P2|Overall Study|incorrect enrolment|2
3084462|NCT00394472|10581915|P1|Overall Study|incorrect enrolment|4
3084463|NCT00394472|10581914|P2|Overall Study|Protocol Violation|3
3084464|NCT00394472|10581915|P1|Overall Study|Protocol Violation|1
3084465|NCT00394433|10581923|P1|Overall Study|Alternative Therapy|1
3084466|NCT00394433|10581923|P1|Overall Study|Adverse Event|2
3084467|NCT00394355|10581934|P4|Overall Study|Lack of Efficacy|3
3084468|NCT00394355|10581935|P3|Overall Study|Lack of Efficacy|2
3084469|NCT00394355|10581936|P2|Overall Study|Lack of Efficacy|0
3084470|NCT00394355|10581937|P1|Overall Study|Lack of Efficacy|0
3084471|NCT00394355|10581934|P4|Overall Study|Administrative|1
3084472|NCT00394355|10581935|P3|Overall Study|Administrative|1
3084473|NCT00394355|10581936|P2|Overall Study|Administrative|1
3084474|NCT00394355|10581937|P1|Overall Study|Administrative|0
3084475|NCT00394355|10581934|P4|Overall Study|Noncompliance with protocol|8
3084476|NCT00394355|10581935|P3|Overall Study|Noncompliance with protocol|10
3084477|NCT00394355|10581936|P2|Overall Study|Noncompliance with protocol|3
3084478|NCT00394355|10581937|P1|Overall Study|Noncompliance with protocol|4
3084479|NCT00394355|10581934|P4|Overall Study|Lost to Follow-up|3
3084480|NCT00394355|10581935|P3|Overall Study|Lost to Follow-up|4
3084481|NCT00394355|10581936|P2|Overall Study|Lost to Follow-up|5
3084482|NCT00394355|10581937|P1|Overall Study|Lost to Follow-up|7
3084483|NCT00394355|10581934|P4|Overall Study|Subject withdrawal - related to drug|0
3084484|NCT00394355|10581935|P3|Overall Study|Subject withdrawal - related to drug|0
3084485|NCT00394355|10581936|P2|Overall Study|Subject withdrawal - related to drug|0
3084486|NCT00394355|10581937|P1|Overall Study|Subject withdrawal - related to drug|1
3084487|NCT00394355|10581934|P4|Overall Study|Subject withdrawal - unrelated to drug|6
3084488|NCT00394355|10581935|P3|Overall Study|Subject withdrawal - unrelated to drug|10
3084489|NCT00394355|10581936|P2|Overall Study|Subject withdrawal - unrelated to drug|14
3084490|NCT00394355|10581937|P1|Overall Study|Subject withdrawal - unrelated to drug|12
3084491|NCT00394355|10581934|P4|Overall Study|Did not meet protocol eligibility|2
3084492|NCT00394355|10581935|P3|Overall Study|Did not meet protocol eligibility|4
3084493|NCT00394355|10581936|P2|Overall Study|Did not meet protocol eligibility|5
3084494|NCT00394355|10581937|P1|Overall Study|Did not meet protocol eligibility|1
3084495|NCT00394355|10581934|P4|Overall Study|Adverse Event|8
3084496|NCT00394355|10581935|P3|Overall Study|Adverse Event|7
3084497|NCT00394355|10581936|P2|Overall Study|Adverse Event|6
3084498|NCT00394355|10581937|P1|Overall Study|Adverse Event|10
3084499|NCT00394251|10582043|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
3084500|NCT00394251|10582044|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
3084501|NCT00394251|10582043|P2|Overall Study|Withdrawal by Subject|11
3084502|NCT00394251|10582044|P1|Overall Study|Withdrawal by Subject|7
3084503|NCT00394251|10582043|P2|Overall Study|Protocol Violation|1
3084504|NCT00394251|10582044|P1|Overall Study|Protocol Violation|0
3084505|NCT00394251|10582043|P2|Overall Study|Physician Decision|1
3084506|NCT00394251|10582044|P1|Overall Study|Physician Decision|1
3084507|NCT00394251|10582043|P2|Overall Study|Unacceptable Toxicity|18
3084508|NCT00394251|10582044|P1|Overall Study|Unacceptable Toxicity|20
3084509|NCT00394251|10582043|P2|Overall Study|Adverse Event|5
3084510|NCT00394251|10582044|P1|Overall Study|Adverse Event|7
3084511|NCT00394212|10582072|P2|Overall Study|Withdrawal by Subject|1
3084512|NCT00394212|10582073|P1|Overall Study|Withdrawal by Subject|4
3084513|NCT00394212|10582072|P2|Overall Study|Lost to Follow-up|0
3084514|NCT00394212|10582073|P1|Overall Study|Lost to Follow-up|3
3084515|NCT00394095|10582087|P2|Overall Study|Adverse Event|0
3084516|NCT00394095|10582088|P1|Overall Study|Adverse Event|1
3084517|NCT00394082|10582096|P1|Overall Study|Other|1
3084518|NCT00394082|10582096|P1|Overall Study|Withdrawal by Subject|2
3084519|NCT00394082|10582096|P1|Overall Study|Physician Decision|4
3084520|NCT00394082|10582096|P1|Overall Study|Adverse Event|4
3084521|NCT00394082|10582096|P1|Overall Study|Unacceptable toxicity|15
3084522|NCT00393939|10582118|P2|Overall Study|Other|45
3084523|NCT00393939|10582119|P1|Overall Study|Other|37
3084524|NCT00393939|10582118|P2|Overall Study|Withdrawal by Subject|7
3084525|NCT00393939|10582119|P1|Overall Study|Withdrawal by Subject|2
3084526|NCT00393939|10582118|P2|Overall Study|Objective progression or relapse|223
3084527|NCT00393939|10582119|P1|Overall Study|Objective progression or relapse|239
3084528|NCT00393939|10582118|P2|Overall Study|Sponsor|13
3084529|NCT00393939|10582119|P1|Overall Study|Sponsor|5
3084530|NCT00393939|10582118|P2|Overall Study|Death|4
3084531|NCT00393939|10582119|P1|Overall Study|Death|10
3084532|NCT00393939|10582118|P2|Overall Study|Lost to Follow-up|4
3084533|NCT00393939|10582119|P1|Overall Study|Lost to Follow-up|2
3084534|NCT00393939|10582118|P2|Overall Study|Protocol Violation|1
3084535|NCT00393939|10582119|P1|Overall Study|Protocol Violation|1
3084536|NCT00393913|10582137|P1|CPAP|TEchnical problem with CPAP|3
3084537|NCT00393913|10582137|P1|CPAP|Physician Decision|1
3084538|NCT00393913|10582137|P1|CPAP|Withdrawal by Subject|3
3084539|NCT00393913|10582137|P1|Initial Assessment|Withdrawal by Subject|16
3084540|NCT00393913|10582137|P1|Initial Assessment|diagnosed with other sleep disorder|21
3084541|NCT00393887|10582145|P2|Overall Study|Lost to Follow-up|9
3084542|NCT00393887|10582146|P1|Overall Study|Lost to Follow-up|11
3084543|NCT00393887|10582145|P2|Overall Study|Physician Decision|0
3084544|NCT00393887|10582146|P1|Overall Study|Physician Decision|5
3084545|NCT00393861|10582174|P1|Overall Study|Disease Progression|24
3084546|NCT00393861|10582174|P1|Overall Study|Adverse Event|2
3084547|NCT00393848|10582185|P4|Overall Study|Personal reasons|0
3084548|NCT00393848|10582186|P3|Overall Study|Personal reasons|2
3084549|NCT00393848|10582187|P2|Overall Study|Personal reasons|0
3084550|NCT00393848|10582188|P1|Overall Study|Personal reasons|0
3084551|NCT00393848|10582185|P4|Overall Study|Surgical schedule|1
3084552|NCT00393848|10582186|P3|Overall Study|Surgical schedule|0
3084553|NCT00393848|10582187|P2|Overall Study|Surgical schedule|0
3084554|NCT00393848|10582188|P1|Overall Study|Surgical schedule|0
3084555|NCT00393718|10582211|P2|Overall Study|Move|0
3084556|NCT00393718|10582212|P1|Overall Study|Move|1
3084557|NCT00393718|10582211|P2|Overall Study|Missed measurement|0
3084558|NCT00393718|10582212|P1|Overall Study|Missed measurement|1
3084559|NCT00393718|10582211|P2|Overall Study|Withdrawal of consent|1
3084560|NCT00393718|10582212|P1|Overall Study|Withdrawal of consent|2
3084561|NCT00393718|10582211|P2|Overall Study|Subject decision|0
3084562|NCT00393718|10582212|P1|Overall Study|Subject decision|5
3084563|NCT00393718|10582211|P2|Overall Study|Hypoglycaemia|2
3084564|NCT00393718|10582212|P1|Overall Study|Hypoglycaemia|3
3084565|NCT00393718|10582211|P2|Overall Study|Lack of Efficacy|9
3084566|NCT00393718|10582212|P1|Overall Study|Lack of Efficacy|10
3084567|NCT00393718|10582211|P2|Overall Study|Protocol Violation|2
3084568|NCT00393718|10582212|P1|Overall Study|Protocol Violation|1
3084569|NCT00393718|10582211|P2|Overall Study|Adverse Event|8
3084570|NCT00393718|10582212|P1|Overall Study|Adverse Event|20
3084571|NCT00393705|10582244|P2|Overall Study|Physician Decision|2
3084572|NCT00393705|10582245|P1|Overall Study|Physician Decision|2
3084573|NCT00393705|10582244|P2|Overall Study|Withdrawal by Subject|3
3084574|NCT00393705|10582245|P1|Overall Study|Withdrawal by Subject|5
3084575|NCT00393705|10582244|P2|Overall Study|Protocol Violation|3
3084576|NCT00393705|10582245|P1|Overall Study|Protocol Violation|4
3084577|NCT00393705|10582244|P2|Overall Study|Entry Criteria Not Met|10
3084578|NCT00393705|10582245|P1|Overall Study|Entry Criteria Not Met|10
3084579|NCT00393705|10582244|P2|Overall Study|Lost to Follow-up|2
3084580|NCT00393705|10582245|P1|Overall Study|Lost to Follow-up|2
3084581|NCT00393705|10582244|P2|Overall Study|Death|1
3084582|NCT00393705|10582245|P1|Overall Study|Death|0
3084583|NCT00393705|10582244|P2|Overall Study|Adverse Event|2
3084584|NCT00393705|10582245|P1|Overall Study|Adverse Event|0
3084585|NCT00393523|10582274|P5|Overall Study|Vaccine supply issue|0
3084586|NCT00393523|10582275|P4|Overall Study|Vaccine supply issue|0
3084587|NCT00393523|10582276|P3|Overall Study|Vaccine supply issue|1
3084588|NCT00393523|10582277|P2|Overall Study|Vaccine supply issue|0
3084589|NCT00393523|10582278|P1|Overall Study|Vaccine supply issue|0
3084590|NCT00393523|10582274|P5|Overall Study|Difficulties in specimen collection|0
3084591|NCT00393523|10582275|P4|Overall Study|Difficulties in specimen collection|0
3084592|NCT00393523|10582276|P3|Overall Study|Difficulties in specimen collection|1
3084593|NCT00393523|10582277|P2|Overall Study|Difficulties in specimen collection|0
3084594|NCT00393523|10582278|P1|Overall Study|Difficulties in specimen collection|0
3084595|NCT00393523|10582274|P5|Overall Study|Withdrawal by Subject|0
3084596|NCT00393523|10582275|P4|Overall Study|Withdrawal by Subject|3
3084597|NCT00393523|10582276|P3|Overall Study|Withdrawal by Subject|2
3084598|NCT00393523|10582277|P2|Overall Study|Withdrawal by Subject|7
3084599|NCT00393523|10582278|P1|Overall Study|Withdrawal by Subject|6
3084600|NCT00393523|10582274|P5|Overall Study|Protocol Violation|0
3084601|NCT00393523|10582275|P4|Overall Study|Protocol Violation|1
3084602|NCT00393523|10582276|P3|Overall Study|Protocol Violation|0
3084603|NCT00393523|10582277|P2|Overall Study|Protocol Violation|2
3084604|NCT00393523|10582278|P1|Overall Study|Protocol Violation|6
3084605|NCT00393523|10582274|P5|Overall Study|Lost to Follow-up|1
3084606|NCT00393523|10582275|P4|Overall Study|Lost to Follow-up|2
3084607|NCT00393523|10582276|P3|Overall Study|Lost to Follow-up|0
3084608|NCT00393523|10582277|P2|Overall Study|Lost to Follow-up|0
3084609|NCT00393523|10582278|P1|Overall Study|Lost to Follow-up|0
3084610|NCT00393510|10582295|P2|Overall Study|Physician Decision|9
3084611|NCT00393510|10582296|P1|Overall Study|Physician Decision|3
3084612|NCT00393484|10582308|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
3084613|NCT00393484|10582309|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
3084614|NCT00393484|10582308|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
3084615|NCT00393484|10582309|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
3084616|NCT00393484|10582308|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
3084617|NCT00393484|10582309|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
3084618|NCT00393484|10582308|P2|Open-label Period (Weeks 96 to 240)|Death|0
3084619|NCT00393484|10582309|P1|Open-label Period (Weeks 96 to 240)|Death|1
3084620|NCT00393484|10582308|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
3084621|NCT00393484|10582309|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
3084622|NCT00393484|10582308|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
3084623|NCT00393484|10582309|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
3084624|NCT00393484|10582308|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
3084625|NCT00393484|10582309|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
3084626|NCT00393484|10582308|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
3084627|NCT00393484|10582309|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
3084628|NCT00393484|10582308|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
3084629|NCT00393484|10582309|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
3084630|NCT00393484|10582308|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
3084631|NCT00393484|10582309|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
3084632|NCT00393458|10582345|P4|Overall Study|Subject no longer requires study drug|0
3084633|NCT00393458|10582346|P3|Overall Study|Subject no longer requires study drug|0
3084634|NCT00393458|10582347|P2|Overall Study|Subject no longer requires study drug|1
3084635|NCT00393458|10582348|P1|Overall Study|Subject no longer requires study drug|0
3084636|NCT00393458|10582345|P4|Overall Study|Abnormal test procedure result(s)|2
3084637|NCT00393458|10582346|P3|Overall Study|Abnormal test procedure result(s)|1
3084638|NCT00393458|10582347|P2|Overall Study|Abnormal test procedure result(s)|1
3084639|NCT00393458|10582348|P1|Overall Study|Abnormal test procedure result(s)|0
3084640|NCT00393458|10582345|P4|Overall Study|Death|5
3084641|NCT00393458|10582346|P3|Overall Study|Death|5
3084642|NCT00393458|10582347|P2|Overall Study|Death|1
3084643|NCT00393458|10582348|P1|Overall Study|Death|1
3084644|NCT00393458|10582345|P4|Overall Study|Abnormal laboratory value(s)|0
3084645|NCT00393458|10582346|P3|Overall Study|Abnormal laboratory value(s)|0
3084646|NCT00393458|10582347|P2|Overall Study|Abnormal laboratory value(s)|1
3084647|NCT00393458|10582348|P1|Overall Study|Abnormal laboratory value(s)|1
3084648|NCT00393458|10582345|P4|Overall Study|Lost to Follow-up|3
3084649|NCT00393458|10582346|P3|Overall Study|Lost to Follow-up|5
3084650|NCT00393458|10582347|P2|Overall Study|Lost to Follow-up|6
3084651|NCT00393458|10582348|P1|Overall Study|Lost to Follow-up|5
3084652|NCT00393458|10582345|P4|Overall Study|Administrative problems|2
3084653|NCT00393458|10582346|P3|Overall Study|Administrative problems|5
3084654|NCT00393458|10582347|P2|Overall Study|Administrative problems|8
3084655|NCT00393458|10582348|P1|Overall Study|Administrative problems|7
3084656|NCT00393458|10582345|P4|Overall Study|Protocol deviation|10
3084657|NCT00393458|10582346|P3|Overall Study|Protocol deviation|11
3084658|NCT00393458|10582347|P2|Overall Study|Protocol deviation|11
3084659|NCT00393458|10582348|P1|Overall Study|Protocol deviation|11
3084660|NCT00393458|10582345|P4|Overall Study|Unsatisfactory therapeutic effect|30
3084661|NCT00393458|10582346|P3|Overall Study|Unsatisfactory therapeutic effect|12
3084662|NCT00393458|10582347|P2|Overall Study|Unsatisfactory therapeutic effect|9
3084663|NCT00393458|10582348|P1|Overall Study|Unsatisfactory therapeutic effect|12
3084664|NCT00393458|10582345|P4|Overall Study|Subject withdrew consent|50
3084665|NCT00393458|10582346|P3|Overall Study|Subject withdrew consent|33
3084666|NCT00393458|10582347|P2|Overall Study|Subject withdrew consent|40
3084667|NCT00393458|10582348|P1|Overall Study|Subject withdrew consent|27
3084668|NCT00393458|10582345|P4|Overall Study|Adverse Event|35
3084669|NCT00393458|10582346|P3|Overall Study|Adverse Event|40
3084670|NCT00393458|10582347|P2|Overall Study|Adverse Event|24
3084671|NCT00393458|10582348|P1|Overall Study|Adverse Event|35
3084672|NCT00393367|10582375|P2|Overall Study|Withdrawal by Subject|2
3084673|NCT00393367|10582376|P1|Overall Study|Withdrawal by Subject|0
3084674|NCT00393367|10582375|P2|Overall Study|Protocol Violation|5
3084675|NCT00393367|10582376|P1|Overall Study|Protocol Violation|2
3084676|NCT00393094|10582404|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
3084677|NCT00393094|10582404|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
3084678|NCT00393042|10582415|P2|Second Intervetion|Protocol Violation|1
3084679|NCT00393042|10582416|P1|Second Intervetion|Protocol Violation|1
3084680|NCT00393042|10582415|P2|Second Intervetion|Lost to Follow-up|2
3084681|NCT00393042|10582416|P1|Second Intervetion|Lost to Follow-up|0
3084682|NCT00393042|10582415|P2|Second Intervetion|Lack of Efficacy|0
3084683|NCT00393042|10582416|P1|Second Intervetion|Lack of Efficacy|1
3084684|NCT00393042|10582415|P2|Second Intervetion|Withdrawal by Subject|2
3084685|NCT00393042|10582416|P1|Second Intervetion|Withdrawal by Subject|0
3084686|NCT00393042|10582415|P2|Second Intervetion|Adverse Event|3
3084687|NCT00393042|10582416|P1|Second Intervetion|Adverse Event|0
3084688|NCT00393042|10582415|P2|First Intervention|Adverse Event|1
3084689|NCT00393042|10582416|P1|First Intervention|Adverse Event|0
3084690|NCT00393042|10582415|P2|First Intervention|Protocol Violation|0
3084691|NCT00393042|10582416|P1|First Intervention|Protocol Violation|1
3084692|NCT00393042|10582415|P2|First Intervention|Lost to Follow-up|3
3084693|NCT00393042|10582416|P1|First Intervention|Lost to Follow-up|3
3084694|NCT00393042|10582415|P2|First Intervention|Withdrawal by Subject|2
3084695|NCT00393042|10582416|P1|First Intervention|Withdrawal by Subject|1
3084696|NCT00393029|10582488|P2|Overall Study|Not treated|1
3084697|NCT00393029|10582489|P1|Overall Study|Not treated|0
3084698|NCT00392990|10582500|P2|Follow up for 2 Years|Death|0
3084699|NCT00392990|10582501|P1|Follow up for 2 Years|Death|4
3084700|NCT00392990|10582500|P2|Treatment on Study|Adverse Event|1
3084701|NCT00392990|10582501|P1|Treatment on Study|Adverse Event|3
3084702|NCT00392925|10582525|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
3084703|NCT00392925|10582526|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
3084704|NCT00392925|10582527|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
3084705|NCT00392925|10582528|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
3084706|NCT00392925|10582525|P4|Randomization to Treatment Group Period|Protocol Violation|1
3084707|NCT00392925|10582526|P3|Randomization to Treatment Group Period|Protocol Violation|2
3084708|NCT00392925|10582527|P2|Randomization to Treatment Group Period|Protocol Violation|0
3084709|NCT00392925|10582528|P1|Randomization to Treatment Group Period|Protocol Violation|0
3084710|NCT00392925|10582525|P4|Randomization to Treatment Group Period|Adverse Event|5
3084711|NCT00392925|10582526|P3|Randomization to Treatment Group Period|Adverse Event|3
3084712|NCT00392925|10582527|P2|Randomization to Treatment Group Period|Adverse Event|3
3084713|NCT00392925|10582528|P1|Randomization to Treatment Group Period|Adverse Event|0
3084714|NCT00392925|10582525|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
3084715|NCT00392925|10582526|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
3084716|NCT00392925|10582527|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
3084717|NCT00392925|10582528|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
3084718|NCT00392925|10582525|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
3084719|NCT00392925|10582526|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
3084720|NCT00392925|10582527|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
3084721|NCT00392925|10582528|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
3084722|NCT00392925|10582525|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
3084723|NCT00392925|10582526|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
3084724|NCT00392925|10582527|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
3084725|NCT00392925|10582528|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
3084726|NCT00392925|10582525|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
3084727|NCT00392925|10582526|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
3084728|NCT00392925|10582527|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
3084729|NCT00392925|10582528|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
3084730|NCT00392925|10582525|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
3084731|NCT00392925|10582526|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
3084732|NCT00392925|10582527|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
3084733|NCT00392925|10582528|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
3084734|NCT00392925|10582525|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
3084735|NCT00392925|10582526|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
3084736|NCT00392925|10582527|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
3084737|NCT00392925|10582528|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
3084738|NCT00392808|10582642|P4|Overall Study|Unable to withdraw blood|2
3084739|NCT00392808|10582643|P3|Overall Study|Unable to withdraw blood|1
3084740|NCT00392808|10582644|P2|Overall Study|Unable to withdraw blood|1
3084741|NCT00392808|10582645|P1|Overall Study|Unable to withdraw blood|3
3084742|NCT00392808|10582642|P4|Overall Study|Lost to Follow-up|2
3084743|NCT00392808|10582643|P3|Overall Study|Lost to Follow-up|1
3084744|NCT00392808|10582644|P2|Overall Study|Lost to Follow-up|2
3084745|NCT00392808|10582645|P1|Overall Study|Lost to Follow-up|3
3084746|NCT00392769|10582669|P1|Overall Study|Adverse Event|1
3084747|NCT00392769|10582669|P1|Overall Study|Clinical Deterioration|9
3084748|NCT00392665|10582721|P2|Overall Study|Lost to Follow-up|1
3084749|NCT00392665|10582722|P1|Overall Study|Lost to Follow-up|1
3084750|NCT00392665|10582721|P2|Overall Study|Death|14
3084751|NCT00392665|10582722|P1|Overall Study|Death|16
3084752|NCT00392379|10582748|P2|Overall Study|Adverse Event|1
3084753|NCT00392379|10582749|P1|Overall Study|Adverse Event|1
3084754|NCT00392379|10582748|P2|Overall Study|Lost to Follow-up|9
3084755|NCT00392379|10582749|P1|Overall Study|Lost to Follow-up|4
3084756|NCT00392379|10582748|P2|Overall Study|Withdrawal by Subject|28
3084757|NCT00392379|10582749|P1|Overall Study|Withdrawal by Subject|17
3084758|NCT00392288|10582762|P3|Overall Study|Other|1
3084759|NCT00392288|10582763|P2|Overall Study|Other|4
3084760|NCT00392288|10582764|P1|Overall Study|Other|3
3084761|NCT00392288|10582762|P3|Overall Study|Parent/legal guardian withdrawal|1
3084762|NCT00392288|10582763|P2|Overall Study|Parent/legal guardian withdrawal|2
3084763|NCT00392288|10582764|P1|Overall Study|Parent/legal guardian withdrawal|1
3084764|NCT00392288|10582762|P3|Overall Study|Withdrawal by Subject|2
3084765|NCT00392288|10582763|P2|Overall Study|Withdrawal by Subject|0
3084766|NCT00392288|10582764|P1|Overall Study|Withdrawal by Subject|1
3084767|NCT00392288|10582762|P3|Overall Study|Lost to Follow-up|1
3084768|NCT00392288|10582763|P2|Overall Study|Lost to Follow-up|1
3084769|NCT00392288|10582764|P1|Overall Study|Lost to Follow-up|1
3084770|NCT00392288|10582762|P3|Overall Study|Protocol Violation|1
3084771|NCT00392288|10582763|P2|Overall Study|Protocol Violation|3
3084772|NCT00392288|10582764|P1|Overall Study|Protocol Violation|1
3084773|NCT00392288|10582762|P3|Overall Study|Lack of Efficacy|3
3084774|NCT00392288|10582763|P2|Overall Study|Lack of Efficacy|5
3084775|NCT00392288|10582764|P1|Overall Study|Lack of Efficacy|8
3084776|NCT00392288|10582762|P3|Overall Study|Adverse Event|8
3084777|NCT00392288|10582763|P2|Overall Study|Adverse Event|7
3084778|NCT00392288|10582764|P1|Overall Study|Adverse Event|17
3084779|NCT00392223|10582789|P2|Overall Study|Withdrawal by Subject|2
3084780|NCT00392223|10582790|P1|Overall Study|Withdrawal by Subject|3
3084781|NCT00392223|10582789|P2|Overall Study|Protocol Violation|3
3084782|NCT00392223|10582790|P1|Overall Study|Protocol Violation|0
3084783|NCT00392223|10582789|P2|Overall Study|Lost to Follow-up|4
3084784|NCT00392223|10582790|P1|Overall Study|Lost to Follow-up|1
3084785|NCT00392223|10582789|P2|Overall Study|Adverse Event|4
3084786|NCT00392223|10582790|P1|Overall Study|Adverse Event|5
3084787|NCT00392210|10582808|P2|First Voiding Trial|Physician Decision|2
3084788|NCT00392210|10582809|P1|First Voiding Trial|Physician Decision|2
3084789|NCT00392197|10582817|P2|Overall Study|Withdrawal by Subject|6
3084790|NCT00392197|10582818|P1|Overall Study|Withdrawal by Subject|4
3084791|NCT00392197|10582817|P2|Overall Study|Protocol Violation|5
3084792|NCT00392197|10582818|P1|Overall Study|Protocol Violation|7
3084793|NCT00392197|10582817|P2|Overall Study|Physician Decision|2
3084794|NCT00392197|10582818|P1|Overall Study|Physician Decision|3
3084795|NCT00392197|10582817|P2|Overall Study|Lost to Follow-up|1
3084796|NCT00392197|10582818|P1|Overall Study|Lost to Follow-up|0
3084797|NCT00392197|10582817|P2|Overall Study|Lack of Efficacy|4
3084798|NCT00392197|10582818|P1|Overall Study|Lack of Efficacy|3
3084799|NCT00392197|10582817|P2|Overall Study|Adverse Event|12
3084800|NCT00392197|10582818|P1|Overall Study|Adverse Event|4
3084801|NCT00392171|10582826|P1|Overall Study|Disease progression|101
3084802|NCT00392171|10582826|P1|Overall Study|Did not meet inclusion criteria|4
3084803|NCT00391976|10582860|P3|Overall Study|Positive P. aeruginosa antibody test|31
3084804|NCT00391976|10582861|P2|Overall Study|Positive P. aeruginosa antibody test|0
3084805|NCT00391976|10582862|P1|Overall Study|Positive P. aeruginosa antibody test|0
3084806|NCT00391976|10582860|P3|Overall Study|Unable to classify|1
3084807|NCT00391976|10582861|P2|Overall Study|Unable to classify|0
3084808|NCT00391976|10582862|P1|Overall Study|Unable to classify|0
3084809|NCT00391976|10582860|P3|Overall Study|Recurrence/no eradication of infection|0
3084810|NCT00391976|10582861|P2|Overall Study|Recurrence/no eradication of infection|19
3084811|NCT00391976|10582862|P1|Overall Study|Recurrence/no eradication of infection|21
3084812|NCT00391976|10582860|P3|Overall Study|Protocol deviation/violation|1
3084813|NCT00391976|10582861|P2|Overall Study|Protocol deviation/violation|2
3084814|NCT00391976|10582862|P1|Overall Study|Protocol deviation/violation|4
3084815|NCT00391976|10582860|P3|Overall Study|Inappropriate enrollment|0
3084816|NCT00391976|10582861|P2|Overall Study|Inappropriate enrollment|1
3084817|NCT00391976|10582862|P1|Overall Study|Inappropriate enrollment|1
3084818|NCT00391976|10582860|P3|Overall Study|Lost to Follow-up|0
3084819|NCT00391976|10582861|P2|Overall Study|Lost to Follow-up|2
3084820|NCT00391976|10582862|P1|Overall Study|Lost to Follow-up|1
3084821|NCT00391976|10582860|P3|Overall Study|Withdrawal of consent|1
3084822|NCT00391976|10582861|P2|Overall Study|Withdrawal of consent|1
3084823|NCT00391976|10582862|P1|Overall Study|Withdrawal of consent|0
3084824|NCT00391976|10582860|P3|Overall Study|Adverse Event|1
3084825|NCT00391976|10582861|P2|Overall Study|Adverse Event|0
3084826|NCT00391976|10582862|P1|Overall Study|Adverse Event|0
3084827|NCT00391898|10582886|P2|Overall Study|Other|10
3084828|NCT00391898|10582887|P1|Overall Study|Other|8
3084829|NCT00391898|10582886|P2|Overall Study|Adverse Event|0
3084830|NCT00391898|10582887|P1|Overall Study|Adverse Event|3
3084831|NCT00391872|10582907|P2|Overall Study|Lost to Follow-up|0
3084832|NCT00391872|10582908|P1|Overall Study|Lost to Follow-up|2
3084833|NCT00391872|10582907|P2|Overall Study|Reason unknown|4
3084834|NCT00391872|10582908|P1|Overall Study|Reason unknown|2
3084835|NCT00391872|10582907|P2|Overall Study|Withdrawal by Subject|249
3084836|NCT00391872|10582908|P1|Overall Study|Withdrawal by Subject|296
3084837|NCT00391872|10582907|P2|Overall Study|Protocol Violation|2
3084838|NCT00391872|10582908|P1|Overall Study|Protocol Violation|7
3084839|NCT00391846|10582946|P2|Overall Study|Developed study specific DC criteria|1
3084840|NCT00391846|10582947|P1|Overall Study|Developed study specific DC criteria|0
3084841|NCT00391846|10582946|P2|Overall Study|Withdrawal by Subject|3
3084842|NCT00391846|10582947|P1|Overall Study|Withdrawal by Subject|2
3084843|NCT00391846|10582946|P2|Overall Study|Did not meet the required elig. crit|2
3084844|NCT00391846|10582947|P1|Overall Study|Did not meet the required elig. crit|2
3084845|NCT00391846|10582946|P2|Overall Study|Adverse Event|1
3084846|NCT00391846|10582947|P1|Overall Study|Adverse Event|4
3084847|NCT00391807|10582967|P1|Overall Study|Various|96
3084848|NCT00391807|10582967|P1|Overall Study|Protocol Violation|20
3084849|NCT00391807|10582967|P1|Overall Study|Withdrawal by Subject|147
3084850|NCT00391807|10582967|P1|Overall Study|Lost to Follow-up|227
3084851|NCT00391807|10582967|P1|Overall Study|Pregnancy|25
3084852|NCT00391807|10582967|P1|Overall Study|Adverse Event|177
3084853|NCT00391807|10582967|P1|Overall Study|Did not receive study medication|23
3084854|NCT00391768|10582994|P7|Overall Study|Lost to Follow-up|3
3084855|NCT00391768|10582995|P6|Overall Study|Lost to Follow-up|2
3084856|NCT00391768|10582996|P5|Overall Study|Lost to Follow-up|2
3084857|NCT00391768|10582997|P4|Overall Study|Lost to Follow-up|1
3084858|NCT00391768|10582998|P3|Overall Study|Lost to Follow-up|0
3084859|NCT00391768|10582999|P2|Overall Study|Lost to Follow-up|0
3084860|NCT00391768|10583000|P1|Overall Study|Lost to Follow-up|0
3084861|NCT00391768|10582994|P7|Overall Study|Withdrawal by Subject|1
3084862|NCT00391768|10582995|P6|Overall Study|Withdrawal by Subject|1
3084863|NCT00391768|10582996|P5|Overall Study|Withdrawal by Subject|0
3084864|NCT00391768|10582997|P4|Overall Study|Withdrawal by Subject|0
3084865|NCT00391768|10582998|P3|Overall Study|Withdrawal by Subject|1
3084866|NCT00391768|10582999|P2|Overall Study|Withdrawal by Subject|0
3084867|NCT00391768|10583000|P1|Overall Study|Withdrawal by Subject|0
3084868|NCT00391625|10583087|P1|Month 50|Physician Decision|1
3084869|NCT00391625|10583087|P1|Month 14|Withdrawal by Subject|1
3084870|NCT00391586|10583140|P1|Overall Study|Death|4
3084871|NCT00391586|10583140|P1|Overall Study|Physician Decision|2
3084872|NCT00391586|10583140|P1|Overall Study|Adverse Event|5
3084873|NCT00391586|10583140|P1|Overall Study|Progressive disease|13
3084874|NCT00391391|10583177|P4|Overall Study|Withdrawal by Subject|7
3084875|NCT00391391|10583178|P3|Overall Study|Withdrawal by Subject|10
3084876|NCT00391391|10583179|P2|Overall Study|Withdrawal by Subject|4
3084877|NCT00391391|10583180|P1|Overall Study|Withdrawal by Subject|6
3084878|NCT00391391|10583177|P4|Overall Study|Protocol Violation|7
3084879|NCT00391391|10583178|P3|Overall Study|Protocol Violation|6
3084880|NCT00391391|10583179|P2|Overall Study|Protocol Violation|3
3084881|NCT00391391|10583180|P1|Overall Study|Protocol Violation|2
3084882|NCT00391391|10583177|P4|Overall Study|Lost to Follow-up|4
3084883|NCT00391391|10583178|P3|Overall Study|Lost to Follow-up|7
3084884|NCT00391391|10583179|P2|Overall Study|Lost to Follow-up|3
3084885|NCT00391391|10583180|P1|Overall Study|Lost to Follow-up|1
3084886|NCT00391391|10583177|P4|Overall Study|Adverse Event|1
3084887|NCT00391391|10583178|P3|Overall Study|Adverse Event|0
3084888|NCT00391391|10583179|P2|Overall Study|Adverse Event|0
3084889|NCT00391391|10583180|P1|Overall Study|Adverse Event|0
3084890|NCT00391274|10583225|P2|Overall Study|Death Not Study Related|1
3084891|NCT00391274|10583226|P1|Overall Study|Death Not Study Related|0
3084892|NCT00391274|10583225|P2|Overall Study|Death Due to Indeterminate Cause|0
3084893|NCT00391274|10583226|P1|Overall Study|Death Due to Indeterminate Cause|1
3084894|NCT00391274|10583225|P2|Overall Study|Death Due to Adverse Event|3
3084895|NCT00391274|10583226|P1|Overall Study|Death Due to Adverse Event|1
3084896|NCT00391274|10583225|P2|Overall Study|Withdrawal by Subject|3
3084897|NCT00391274|10583226|P1|Overall Study|Withdrawal by Subject|0
3084898|NCT00391274|10583225|P2|Overall Study|Physician Decision|2
3084899|NCT00391274|10583226|P1|Overall Study|Physician Decision|4
3084900|NCT00391274|10583225|P2|Overall Study|Lost to Follow-up|3
3084901|NCT00391274|10583226|P1|Overall Study|Lost to Follow-up|0
3084902|NCT00391274|10583225|P2|Overall Study|Death Due to Study Disease|45
3084903|NCT00391274|10583226|P1|Overall Study|Death Due to Study Disease|55
3084904|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Other|0
3084905|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Other|6
3084906|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Other|1
3084907|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Other|6
3084908|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
3084909|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
3084910|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
3084911|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
3084912|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Pregnancy|0
3084913|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Pregnancy|0
3084914|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Pregnancy|2
3084915|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Pregnancy|0
3084916|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Adverse Event|0
3084917|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Adverse Event|4
3084918|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Adverse Event|2
3084919|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Adverse Event|5
3084920|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
3084921|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
3084922|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
3084923|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
3084924|NCT00391222|10583245|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
3084925|NCT00391222|10583246|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
3084926|NCT00391222|10583247|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
3084927|NCT00391222|10583248|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
3084928|NCT00391222|10583245|P4|Period II (Open-label Risperidone LAI)|Other|24
3084929|NCT00391222|10583246|P3|Period II (Open-label Risperidone LAI)|Other|0
3084930|NCT00391222|10583247|P2|Period II (Open-label Risperidone LAI)|Other|0
3084931|NCT00391222|10583248|P1|Period II (Open-label Risperidone LAI)|Other|0
3084932|NCT00391222|10583245|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
3084933|NCT00391222|10583246|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
3084934|NCT00391222|10583247|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
3084935|NCT00391222|10583248|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
3084936|NCT00391222|10583245|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
3084937|NCT00391222|10583246|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
3084938|NCT00391222|10583247|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
3084939|NCT00391222|10583248|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
3084940|NCT00391222|10583245|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
3084941|NCT00391222|10583246|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
3084942|NCT00391222|10583247|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
3084943|NCT00391222|10583248|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
3084944|NCT00391222|10583245|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
3084945|NCT00391222|10583246|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
3084946|NCT00391222|10583247|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
3084947|NCT00391222|10583248|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
3084948|NCT00391092|10583274|P2|Overall Study|Alive in follow-up|84
3084949|NCT00391092|10583275|P1|Overall Study|Alive in follow-up|88
3084950|NCT00391092|10583274|P2|Overall Study|Alive on treatment|33
3084951|NCT00391092|10583275|P1|Overall Study|Alive on treatment|29
3084952|NCT00391092|10583274|P2|Overall Study|Lost to Follow-up|18
3084953|NCT00391092|10583275|P1|Overall Study|Lost to Follow-up|13
3084954|NCT00391092|10583274|P2|Overall Study|Death|81
3084955|NCT00391092|10583275|P1|Overall Study|Death|78
3084956|NCT00391053|10583318|P4|Overall Study|Withdrawal by Subject|1
3084957|NCT00391053|10583319|P3|Overall Study|Withdrawal by Subject|1
3084958|NCT00391053|10583320|P2|Overall Study|Withdrawal by Subject|1
3084959|NCT00391053|10583321|P1|Overall Study|Withdrawal by Subject|5
3084960|NCT00391053|10583318|P4|Overall Study|Lost to Follow-up|5
3084961|NCT00391053|10583319|P3|Overall Study|Lost to Follow-up|0
3084962|NCT00391053|10583320|P2|Overall Study|Lost to Follow-up|0
3084963|NCT00391053|10583321|P1|Overall Study|Lost to Follow-up|1
3084964|NCT00391053|10583318|P4|Overall Study|Protocol Violation|0
3084965|NCT00391053|10583319|P3|Overall Study|Protocol Violation|0
3084966|NCT00391053|10583320|P2|Overall Study|Protocol Violation|0
3084967|NCT00391053|10583321|P1|Overall Study|Protocol Violation|2
3084968|NCT00391053|10583318|P4|Overall Study|Serious Adverse Events|4
3084969|NCT00391053|10583319|P3|Overall Study|Serious Adverse Events|1
3084970|NCT00391053|10583320|P2|Overall Study|Serious Adverse Events|0
3084971|NCT00391053|10583321|P1|Overall Study|Serious Adverse Events|1
3084972|NCT00391027|10583345|P2|Overall Study|Other|3
3084973|NCT00391027|10583346|P1|Overall Study|Other|4
3084974|NCT00391027|10583345|P2|Overall Study|Withdrawal by Subject|1
3084975|NCT00391027|10583346|P1|Overall Study|Withdrawal by Subject|10
3084976|NCT00391027|10583345|P2|Overall Study|Lack of Efficacy|0
3084977|NCT00391027|10583346|P1|Overall Study|Lack of Efficacy|3
3084978|NCT00391027|10583345|P2|Overall Study|Adverse Event|8
3084979|NCT00391027|10583346|P1|Overall Study|Adverse Event|8
3084980|NCT00390910|10583396|P3|Overall Study|Migrated/moved from study area|3
3084981|NCT00390910|10583397|P2|Overall Study|Migrated/moved from study area|0
3084982|NCT00390910|10583398|P1|Overall Study|Migrated/moved from study area|0
3084983|NCT00390910|10583396|P3|Overall Study|Withdrawal by Subject|2
3084984|NCT00390910|10583397|P2|Overall Study|Withdrawal by Subject|3
3084985|NCT00390910|10583398|P1|Overall Study|Withdrawal by Subject|1
3084986|NCT00390910|10583396|P3|Overall Study|Lost to Follow-up|5
3084987|NCT00390910|10583397|P2|Overall Study|Lost to Follow-up|1
3084988|NCT00390910|10583398|P1|Overall Study|Lost to Follow-up|0
3084989|NCT00390910|10583396|P3|Overall Study|Adverse Event|0
3084990|NCT00390910|10583397|P2|Overall Study|Adverse Event|0
3084991|NCT00390910|10583398|P1|Overall Study|Adverse Event|1
3084992|NCT00390884|10583486|P2|Overall Study|Withdrawal by Subject|2
3084993|NCT00390884|10583487|P1|Overall Study|Withdrawal by Subject|2
3084994|NCT00390858|10583499|P2|Overall Study|Withdrawal by Subject|4
3084995|NCT00390858|10583500|P1|Overall Study|Withdrawal by Subject|3
3084996|NCT00390858|10583499|P2|Overall Study|Lack of Efficacy|1
3084997|NCT00390858|10583500|P1|Overall Study|Lack of Efficacy|0
3084998|NCT00390858|10583499|P2|Overall Study|Adverse Event|2
3084999|NCT00390858|10583500|P1|Overall Study|Adverse Event|6
3085000|NCT00390806|10583514|P2|Overall Study|Ongoing|2
3085001|NCT00390806|10583515|P1|Overall Study|Ongoing|4
3085002|NCT00390806|10583514|P2|Overall Study|Physician Decision|1
3085003|NCT00390806|10583515|P1|Overall Study|Physician Decision|0
3085004|NCT00390806|10583514|P2|Overall Study|Death|0
3085005|NCT00390806|10583515|P1|Overall Study|Death|1
3085006|NCT00390806|10583514|P2|Overall Study|Investigator Decision|6
3085007|NCT00390806|10583515|P1|Overall Study|Investigator Decision|4
3085008|NCT00390806|10583514|P2|Overall Study|Withdrawal by Subject|15
3085009|NCT00390806|10583515|P1|Overall Study|Withdrawal by Subject|12
3085010|NCT00390806|10583514|P2|Overall Study|Protocol Violation|2
3085011|NCT00390806|10583515|P1|Overall Study|Protocol Violation|2
3085012|NCT00390806|10583514|P2|Overall Study|Lost to Follow-up|6
3085013|NCT00390806|10583515|P1|Overall Study|Lost to Follow-up|7
3085014|NCT00390780|10583583|P2|Overall Study|SAE, death|1
3085015|NCT00390780|10583584|P1|Overall Study|SAE, death|0
3085016|NCT00390780|10583583|P2|Overall Study|Investigator decision, SAE, other reason|1
3085017|NCT00390780|10583584|P1|Overall Study|Investigator decision, SAE, other reason|0
3085018|NCT00390780|10583583|P2|Overall Study|Lost to follow up and other reasons|1
3085019|NCT00390780|10583584|P1|Overall Study|Lost to follow up and other reasons|0
3085020|NCT00390780|10583583|P2|Overall Study|Inclusion criteria not satisfied|2
3085021|NCT00390780|10583584|P1|Overall Study|Inclusion criteria not satisfied|0
3085022|NCT00390780|10583583|P2|Overall Study|Withdrawal by Subject|2
3085023|NCT00390780|10583584|P1|Overall Study|Withdrawal by Subject|1
3085024|NCT00390780|10583583|P2|Overall Study|Death|3
3085025|NCT00390780|10583584|P1|Overall Study|Death|1
3085026|NCT00390780|10583583|P2|Overall Study|Adverse Event|3
3085027|NCT00390780|10583584|P1|Overall Study|Adverse Event|2
3085028|NCT00390780|10583583|P2|Overall Study|Lost to Follow-up|6
3085029|NCT00390780|10583584|P1|Overall Study|Lost to Follow-up|3
3085030|NCT00390780|10583583|P2|Overall Study|Protocol Violation|4
3085031|NCT00390780|10583584|P1|Overall Study|Protocol Violation|6
3085032|NCT00390780|10583583|P2|Overall Study|Not completed|4
3085033|NCT00390780|10583584|P1|Overall Study|Not completed|10
3085034|NCT00390689|10583617|P3|Overall Study|Investigator's judgement|0
3085035|NCT00390689|10583618|P2|Overall Study|Investigator's judgement|0
3085036|NCT00390689|10583619|P1|Overall Study|Investigator's judgement|2
3085037|NCT00390689|10583617|P3|Overall Study|Protocol Violation|0
3085038|NCT00390689|10583618|P2|Overall Study|Protocol Violation|0
3085039|NCT00390689|10583619|P1|Overall Study|Protocol Violation|1
3085040|NCT00390689|10583617|P3|Overall Study|Lack of Efficacy|1
3085041|NCT00390689|10583618|P2|Overall Study|Lack of Efficacy|0
3085042|NCT00390689|10583619|P1|Overall Study|Lack of Efficacy|0
3085043|NCT00390689|10583617|P3|Overall Study|Adverse Event|2
3085044|NCT00390689|10583618|P2|Overall Study|Adverse Event|5
3085045|NCT00390689|10583619|P1|Overall Study|Adverse Event|2
3085046|NCT00390572|10583694|P2|Overall Study|health condition|1
3085047|NCT00390572|10583695|P1|Overall Study|health condition|0
3085048|NCT00390572|10583694|P2|Overall Study|Lost to Follow-up|4
3085049|NCT00390572|10583695|P1|Overall Study|Lost to Follow-up|8
3085050|NCT00390546|10583721|P2|Overall Study|Physician Decision|5
3085051|NCT00390546|10583722|P1|Overall Study|Physician Decision|5
3085052|NCT00390546|10583721|P2|Overall Study|Renal impairment|0
3085053|NCT00390546|10583722|P1|Overall Study|Renal impairment|1
3085054|NCT00390468|10583732|P1|Overall Study|Lack of Efficacy|1
3085055|NCT00390468|10583732|P1|Overall Study|Protocol Violation|2
3085056|NCT00390455|10583738|P2|Overall Study|Other Medical Reasons|11
3085057|NCT00390455|10583739|P1|Overall Study|Other Medical Reasons|7
3085058|NCT00390455|10583738|P2|Overall Study|Alternate Treatment|1
3085059|NCT00390455|10583739|P1|Overall Study|Alternate Treatment|0
3085060|NCT00390455|10583738|P2|Overall Study|Withdrawal by Subject|8
3085061|NCT00390455|10583739|P1|Overall Study|Withdrawal by Subject|8
3085062|NCT00390455|10583738|P2|Overall Study|Adverse Event|3
3085063|NCT00390455|10583739|P1|Overall Study|Adverse Event|17
3085064|NCT00390416|10583784|P1|Overall Study|Not treated|3
3085065|NCT00390416|10583784|P1|Overall Study|Withdrawal by Subject|1
3085066|NCT00390299|10583822|P5|Overall Study|Cancellation|0
3085067|NCT00390299|10583823|P4|Overall Study|Cancellation|0
3085068|NCT00390299|10583824|P3|Overall Study|Cancellation|0
3085069|NCT00390299|10583825|P2|Overall Study|Cancellation|0
3085070|NCT00390299|10583826|P1|Overall Study|Cancellation|1
3085071|NCT00390221|10583857|P3|Overall Study|Other|2
3085072|NCT00390221|10583858|P2|Overall Study|Other|4
3085073|NCT00390221|10583859|P1|Overall Study|Other|3
3085074|NCT00390221|10583857|P3|Overall Study|Subject Non-compliance|2
3085075|NCT00390221|10583858|P2|Overall Study|Subject Non-compliance|0
3085076|NCT00390221|10583859|P1|Overall Study|Subject Non-compliance|1
3085077|NCT00390221|10583857|P3|Overall Study|Withdrawal by Subject|7
3085078|NCT00390221|10583858|P2|Overall Study|Withdrawal by Subject|9
3085079|NCT00390221|10583859|P1|Overall Study|Withdrawal by Subject|13
3085080|NCT00390221|10583857|P3|Overall Study|Investigator Decision|1
3085081|NCT00390221|10583858|P2|Overall Study|Investigator Decision|0
3085082|NCT00390221|10583859|P1|Overall Study|Investigator Decision|0
3085083|NCT00390221|10583857|P3|Overall Study|Adverse Event|3
3085084|NCT00390221|10583858|P2|Overall Study|Adverse Event|4
3085085|NCT00390221|10583859|P1|Overall Study|Adverse Event|1
3085086|NCT00390221|10583857|P3|Overall Study|Lost to Follow-up|0
3085087|NCT00390221|10583858|P2|Overall Study|Lost to Follow-up|3
3085088|NCT00390221|10583859|P1|Overall Study|Lost to Follow-up|0
3085089|NCT00390013|10583889|P4|Phase 2 First Treatment|Withdrawal by Subject|0
3085090|NCT00390013|10583890|P3|Phase 2 First Treatment|Withdrawal by Subject|0
3085091|NCT00390013|10583891|P2|Phase 2 First Treatment|Withdrawal by Subject|1
3085092|NCT00390013|10583892|P1|Phase 2 First Treatment|Withdrawal by Subject|0
3085093|NCT00390013|10583889|P4|Phase 2 First Treatment|tired|0
3085094|NCT00390013|10583890|P3|Phase 2 First Treatment|tired|0
3085095|NCT00390013|10583891|P2|Phase 2 First Treatment|tired|0
3085096|NCT00390013|10583892|P1|Phase 2 First Treatment|tired|1
3085097|NCT00390013|10583889|P4|Phase 1|tired|1
3085098|NCT00390013|10583890|P3|Phase 1|tired|0
3085099|NCT00390013|10583891|P2|Phase 1|tired|0
3085100|NCT00390013|10583892|P1|Phase 1|tired|0
3085101|NCT00389831|10583917|P2|Overall Study|Lost to Follow-up|1
3085102|NCT00389831|10583918|P1|Overall Study|Lost to Follow-up|0
3085103|NCT00389831|10583917|P2|Overall Study|Other reasons|2
3085104|NCT00389831|10583918|P1|Overall Study|Other reasons|0
3085105|NCT00389831|10583917|P2|Overall Study|Did not receive treatment.|2
3085106|NCT00389831|10583918|P1|Overall Study|Did not receive treatment.|0
3085107|NCT00389831|10583917|P2|Overall Study|Lack of Efficacy|2
3085108|NCT00389831|10583918|P1|Overall Study|Lack of Efficacy|0
3085109|NCT00389597|10583981|P4|Overall Study|Lost to Follow-up|6
3085110|NCT00389597|10583982|P3|Overall Study|Lost to Follow-up|4
3085111|NCT00389597|10583983|P2|Overall Study|Lost to Follow-up|6
3085112|NCT00389597|10583984|P1|Overall Study|Lost to Follow-up|8
3085113|NCT00389519|10584009|P4|Treated|Reason not specified|2
3085114|NCT00389519|10584010|P3|Treated|Reason not specified|0
3085115|NCT00389519|10584011|P2|Treated|Reason not specified|1
3085116|NCT00389519|10584012|P1|Treated|Reason not specified|1
3085117|NCT00389519|10584009|P4|Treated|Adverse Event|2
3085118|NCT00389519|10584010|P3|Treated|Adverse Event|0
3085119|NCT00389519|10584011|P2|Treated|Adverse Event|0
3085120|NCT00389519|10584012|P1|Treated|Adverse Event|1
3085121|NCT00389519|10584009|P4|Randomized|Did not receive study drug|0
3085122|NCT00389519|10584010|P3|Randomized|Did not receive study drug|0
3085123|NCT00389519|10584011|P2|Randomized|Did not receive study drug|0
3085124|NCT00389519|10584012|P1|Randomized|Did not receive study drug|2
3085125|NCT00389519|10584009|P4|Placebo Run-In|Reason not specified|0
3085126|NCT00389519|10584010|P3|Placebo Run-In|Reason not specified|0
3085127|NCT00389519|10584011|P2|Placebo Run-In|Reason not specified|0
3085128|NCT00389519|10584012|P1|Placebo Run-In|Reason not specified|40
3085129|NCT00389519|10584009|P4|Placebo Run-In|Withdrawal by Subject|0
3085130|NCT00389519|10584010|P3|Placebo Run-In|Withdrawal by Subject|0
3085131|NCT00389519|10584011|P2|Placebo Run-In|Withdrawal by Subject|0
3085132|NCT00389519|10584012|P1|Placebo Run-In|Withdrawal by Subject|19
3085133|NCT00389519|10584009|P4|Placebo Run-In|Did not meet blood pressure criteria|0
3085134|NCT00389519|10584010|P3|Placebo Run-In|Did not meet blood pressure criteria|0
3085135|NCT00389519|10584011|P2|Placebo Run-In|Did not meet blood pressure criteria|0
3085136|NCT00389519|10584012|P1|Placebo Run-In|Did not meet blood pressure criteria|119
3085137|NCT00389441|10584089|P1|Overall Study|Clinical progression|1
3085138|NCT00389441|10584089|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
3085139|NCT00389441|10584089|P1|Overall Study|Objective progression or relapse|26
3085140|NCT00389441|10584089|P1|Overall Study|Global deterioration of health status|4
3085141|NCT00389441|10584089|P1|Overall Study|Protocol Violation|1
3085142|NCT00389441|10584089|P1|Overall Study|Physician Decision|1
3085143|NCT00389441|10584089|P1|Overall Study|Withdrawal by Subject|4
3085144|NCT00389441|10584089|P1|Overall Study|Lost to Follow-up|2
3085145|NCT00389441|10584089|P1|Overall Study|Death|4
3085146|NCT00389441|10584089|P1|Overall Study|Adverse Event|7
3085147|NCT00389324|10584098|P1|Subcutaneous Phase|Lost to Follow-up|1
3085148|NCT00389324|10584098|P1|Subcutaneous Phase|Withdrawal by Subject|2
3085149|NCT00389324|10584098|P1|Subcutaneous Phase|Non-compliance with study medication|2
3085150|NCT00389324|10584098|P1|Subcutaneous Phase|Adverse Event|2
3085151|NCT00389324|10584098|P1|Run-In Phase|Withdrawal by Subject|1
3085152|NCT00389324|10584098|P1|Run-In Phase|Lost to Follow-up|1
3085153|NCT00389324|10584098|P1|Run-In Phase|Adverse Event|1
3085154|NCT00389207|10584108|P3|Overall Study|Other|9
3085155|NCT00389207|10584109|P2|Overall Study|Other|23
3085156|NCT00389207|10584110|P1|Overall Study|Other|17
3085157|NCT00389207|10584108|P3|Overall Study|Withdrawal by Subject|11
3085158|NCT00389207|10584109|P2|Overall Study|Withdrawal by Subject|7
3085159|NCT00389207|10584110|P1|Overall Study|Withdrawal by Subject|5
3085160|NCT00389207|10584108|P3|Overall Study|Lost to Follow-up|7
3085161|NCT00389207|10584109|P2|Overall Study|Lost to Follow-up|9
3085162|NCT00389207|10584110|P1|Overall Study|Lost to Follow-up|12
3085163|NCT00389207|10584108|P3|Overall Study|Protocol Violation|4
3085164|NCT00389207|10584109|P2|Overall Study|Protocol Violation|1
3085165|NCT00389207|10584110|P1|Overall Study|Protocol Violation|3
3085166|NCT00389207|10584108|P3|Overall Study|Adverse Event|10
3085167|NCT00389207|10584109|P2|Overall Study|Adverse Event|32
3085168|NCT00389207|10584110|P1|Overall Study|Adverse Event|26
3085169|NCT00389064|10584233|P2|Overall Study|Multiple Reasons|11
3085170|NCT00389064|10584234|P1|Overall Study|Multiple Reasons|9
3085171|NCT00389064|10584233|P2|Overall Study|Protocol Violation|0
3085172|NCT00389064|10584234|P1|Overall Study|Protocol Violation|2
3085173|NCT00389064|10584233|P2|Overall Study|Lost to Follow-up|2
3085174|NCT00389064|10584234|P1|Overall Study|Lost to Follow-up|1
3085175|NCT00389064|10584233|P2|Overall Study|Physician Decision|2
3085176|NCT00389064|10584234|P1|Overall Study|Physician Decision|2
3085177|NCT00389064|10584233|P2|Overall Study|Withdrawal by Subject|27
3085178|NCT00389064|10584234|P1|Overall Study|Withdrawal by Subject|17
3085179|NCT00389064|10584233|P2|Overall Study|Lack of Efficacy|14
3085180|NCT00389064|10584234|P1|Overall Study|Lack of Efficacy|3
3085181|NCT00389064|10584233|P2|Overall Study|Adverse Event|3
3085182|NCT00389064|10584234|P1|Overall Study|Adverse Event|11
3085183|NCT00388973|10584262|P2|Overall Study|Did not complete 2-week follow-up visit|17
3085184|NCT00388973|10584263|P1|Overall Study|Did not complete 2-week follow-up visit|17
3085185|NCT00388973|10584262|P2|Overall Study|Left region|1
3085186|NCT00388973|10584263|P1|Overall Study|Left region|0
3085187|NCT00388973|10584262|P2|Overall Study|Did not complete 61 days of treatment|4
3085188|NCT00388973|10584263|P1|Overall Study|Did not complete 61 days of treatment|5
3085189|NCT00388973|10584262|P2|Overall Study|Study specific Discontinuation Criteria|1
3085190|NCT00388973|10584263|P1|Overall Study|Study specific Discontinuation Criteria|0
3085191|NCT00388973|10584262|P2|Overall Study|Withdrawal by Subject|17
3085192|NCT00388973|10584263|P1|Overall Study|Withdrawal by Subject|14
3085193|NCT00388973|10584262|P2|Overall Study|Protocol Violation|0
3085194|NCT00388973|10584263|P1|Overall Study|Protocol Violation|3
3085195|NCT00388973|10584262|P2|Overall Study|Lack of Efficacy|12
3085196|NCT00388973|10584263|P1|Overall Study|Lack of Efficacy|1
3085197|NCT00388973|10584262|P2|Overall Study|Adverse Event|6
3085198|NCT00388973|10584263|P1|Overall Study|Adverse Event|16
3085199|NCT00388947|10584283|P1|Overall Study|Protocol Violation|47
3085200|NCT00388726|10584299|P2|Overall Study|Death|2
3085201|NCT00388726|10584300|P1|Overall Study|Death|3
3085202|NCT00388726|10584299|P2|Overall Study|Physician Decision|13
3085203|NCT00388726|10584300|P1|Overall Study|Physician Decision|18
3085204|NCT00388726|10584299|P2|Overall Study|Administrative|9
3085205|NCT00388726|10584300|P1|Overall Study|Administrative|6
3085206|NCT00388726|10584299|P2|Overall Study|Withdrawal by Subject|7
3085207|NCT00388726|10584300|P1|Overall Study|Withdrawal by Subject|10
3085208|NCT00388726|10584299|P2|Overall Study|Clinical Progression|36
3085209|NCT00388726|10584300|P1|Overall Study|Clinical Progression|61
3085210|NCT00388726|10584299|P2|Overall Study|Progressive Disease|153
3085211|NCT00388726|10584300|P1|Overall Study|Progressive Disease|336
3085212|NCT00388726|10584299|P2|Overall Study|Adverse Event|24
3085213|NCT00388726|10584300|P1|Overall Study|Adverse Event|50
3085214|NCT00388674|10584316|P2|End of Study|Not Reported|1
3085215|NCT00388674|10584317|P1|End of Study|Not Reported|0
3085216|NCT00388674|10584316|P2|End of Study|No Off-Treatment Status Data|30
3085217|NCT00388674|10584317|P1|End of Study|No Off-Treatment Status Data|22
3085218|NCT00388674|10584316|P2|End of Study|Participant Withdrew Consent|673
3085219|NCT00388674|10584317|P1|End of Study|Participant Withdrew Consent|437
3085220|NCT00388674|10584316|P2|End of Study|Not Defined|214
3085221|NCT00388674|10584317|P1|End of Study|Not Defined|135
3085222|NCT00388674|10584316|P2|End of Study|Non-Study Related Comorbidities|4
3085223|NCT00388674|10584317|P1|End of Study|Non-Study Related Comorbidities|3
3085224|NCT00388674|10584316|P2|End of Study|Malignancy (Non-HCC)|1
3085225|NCT00388674|10584317|P1|End of Study|Malignancy (Non-HCC)|1
3085226|NCT00388674|10584316|P2|End of Study|Lost to Follow-up|715
3085227|NCT00388674|10584317|P1|End of Study|Lost to Follow-up|587
3085228|NCT00388674|10584316|P2|End of Study|HCC|7
3085229|NCT00388674|10584317|P1|End of Study|HCC|8
3085230|NCT00388674|10584316|P2|End of Study|HBV Disease Progression (Non-HCC)|9
3085231|NCT00388674|10584317|P1|End of Study|HBV Disease Progression (Non-HCC)|3
3085232|NCT00388674|10584316|P2|End of Study|Death|262
3085233|NCT00388674|10584317|P1|End of Study|Death|239
3085234|NCT00388674|10584316|P2|End of Study|Administrative Reason By Sponsor|253
3085235|NCT00388674|10584317|P1|End of Study|Administrative Reason By Sponsor|299
3085236|NCT00388674|10584316|P2|Initial Treatment|Not Reported|12
3085237|NCT00388674|10584317|P1|Initial Treatment|Not Reported|10
3085238|NCT00388674|10584316|P2|Initial Treatment|No Off-Treatment Status Data|13
3085239|NCT00388674|10584317|P1|Initial Treatment|No Off-Treatment Status Data|11
3085240|NCT00388674|10584316|P2|Initial Treatment|Participant Request|673
3085241|NCT00388674|10584317|P1|Initial Treatment|Participant Request|501
3085242|NCT00388674|10584316|P2|Initial Treatment|Study Drug Toxicity|92
3085243|NCT00388674|10584317|P1|Initial Treatment|Study Drug Toxicity|5
3085244|NCT00388674|10584316|P2|Initial Treatment|Pregnancy|16
3085245|NCT00388674|10584317|P1|Initial Treatment|Pregnancy|26
3085246|NCT00388674|10584316|P2|Initial Treatment|Partial or inadequate Treatment|472
3085247|NCT00388674|10584317|P1|Initial Treatment|Partial or inadequate Treatment|112
3085248|NCT00388674|10584316|P2|Initial Treatment|Not Defined|172
3085249|NCT00388674|10584317|P1|Initial Treatment|Not Defined|125
3085250|NCT00388674|10584316|P2|Initial Treatment|Non-Study related Comorbidities|4
3085251|NCT00388674|10584317|P1|Initial Treatment|Non-Study related Comorbidities|3
3085252|NCT00388674|10584316|P2|Initial Treatment|Never Treated with Study Medication|7
3085253|NCT00388674|10584317|P1|Initial Treatment|Never Treated with Study Medication|1
3085254|NCT00388674|10584316|P2|Initial Treatment|Malignancy (Non-HCC)|3
3085255|NCT00388674|10584317|P1|Initial Treatment|Malignancy (Non-HCC)|7
3085256|NCT00388674|10584316|P2|Initial Treatment|Lost to Follow-up|624
3085257|NCT00388674|10584317|P1|Initial Treatment|Lost to Follow-up|526
3085258|NCT00388674|10584316|P2|Initial Treatment|HCC|20
3085259|NCT00388674|10584317|P1|Initial Treatment|HCC|12
3085260|NCT00388674|10584316|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
3085261|NCT00388674|10584317|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
3085262|NCT00388674|10584316|P2|Initial Treatment|Death|216
3085263|NCT00388674|10584317|P1|Initial Treatment|Death|215
3085264|NCT00388674|10584316|P2|Initial Treatment|Adverse Event|87
3085265|NCT00388674|10584317|P1|Initial Treatment|Adverse Event|22
3085266|NCT00388674|10584316|P2|Initial Treatment|Administrative Reason by Sponsor|158
3085267|NCT00388674|10584317|P1|Initial Treatment|Administrative Reason by Sponsor|241
3085268|NCT00388583|10584335|P2|Overall Study|Did not receive vaccine|1
3085269|NCT00388583|10584336|P1|Overall Study|Did not receive vaccine|0
3085270|NCT00388583|10584335|P2|Overall Study|Serious Adverse Event|0
3085271|NCT00388583|10584336|P1|Overall Study|Serious Adverse Event|2
3085272|NCT00388583|10584335|P2|Overall Study|Withdrawal by Subject|3
3085273|NCT00388583|10584336|P1|Overall Study|Withdrawal by Subject|3
3085274|NCT00388583|10584335|P2|Overall Study|Protocol Violation|0
3085275|NCT00388583|10584336|P1|Overall Study|Protocol Violation|1
3085276|NCT00388505|10584350|P2|Overall Study|Unable to classify|3
3085277|NCT00388505|10584351|P1|Overall Study|Unable to classify|4
3085278|NCT00388505|10584350|P2|Overall Study|Protocol Violation|5
3085279|NCT00388505|10584351|P1|Overall Study|Protocol Violation|6
3085280|NCT00388505|10584350|P2|Overall Study|Administrative Reason|0
3085281|NCT00388505|10584351|P1|Overall Study|Administrative Reason|1
3085282|NCT00388505|10584350|P2|Overall Study|Inappropriate Enrollment|1
3085283|NCT00388505|10584351|P1|Overall Study|Inappropriate Enrollment|0
3085284|NCT00388505|10584350|P2|Overall Study|Lost to Follow-up|3
3085285|NCT00388505|10584351|P1|Overall Study|Lost to Follow-up|5
3085286|NCT00388505|10584350|P2|Overall Study|Withdrawal by Subject|9
3085287|NCT00388505|10584351|P1|Overall Study|Withdrawal by Subject|24
3085288|NCT00388505|10584350|P2|Overall Study|Adverse Event or Death|17
3085289|NCT00388505|10584351|P1|Overall Study|Adverse Event or Death|43
3085290|NCT00388362|10584406|P1|Remained on Study Median of 514 Days|Death|2
3085291|NCT00388362|10584406|P1|Enrolled|Withdrawal by Subject|1
3085292|NCT00388362|10584406|P1|Enrolled|Loss insurance|1
3085293|NCT00388362|10584406|P1|Enrolled|Death|1
3085294|NCT00388362|10584406|P1|Enrolled|Adverse Event|9
3085295|NCT00388362|10584406|P1|Enrolled|Ineligible|1
3085296|NCT00388349|10584411|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
3085297|NCT00388349|10584412|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
3085298|NCT00388297|10584425|P4|Overall Study|Lost to Follow-up|8
3085299|NCT00388297|10584426|P3|Overall Study|Lost to Follow-up|11
3085300|NCT00388297|10584427|P2|Overall Study|Lost to Follow-up|12
3085301|NCT00388297|10584428|P1|Overall Study|Lost to Follow-up|16
3085302|NCT00388154|10584538|P1|Overall Study|Withdrawal by Subject|1
3085303|NCT00388037|10584543|P1|Overall Study|Protocol Violation|1
3085304|NCT00387894|10584551|P1|Overall Study|Withdrawal by Subject|1
3085305|NCT00387881|10584558|P2|Overall Study|Not otherwise specified|7
3085306|NCT00387881|10584559|P1|Overall Study|Not otherwise specified|11
3085307|NCT00387881|10584558|P2|Overall Study|No opportunity to treat headache|34
3085308|NCT00387881|10584559|P1|Overall Study|No opportunity to treat headache|32
3085309|NCT00387881|10584558|P2|Overall Study|Not eligible|7
3085310|NCT00387881|10584559|P1|Overall Study|Not eligible|6
3085311|NCT00387881|10584558|P2|Overall Study|Sponsor terminated Study|1
3085312|NCT00387881|10584559|P1|Overall Study|Sponsor terminated Study|0
3085313|NCT00387881|10584558|P2|Overall Study|Withdrawal by Subject|18
3085314|NCT00387881|10584559|P1|Overall Study|Withdrawal by Subject|15
3085315|NCT00387881|10584558|P2|Overall Study|Protocol Violation|12
3085316|NCT00387881|10584559|P1|Overall Study|Protocol Violation|2
3085317|NCT00387881|10584558|P2|Overall Study|Lost to Follow-up|23
3085318|NCT00387881|10584559|P1|Overall Study|Lost to Follow-up|23
3085319|NCT00387790|10584592|P1|Overall Study|Ineligible for study|2
3085320|NCT00387790|10584592|P1|Overall Study|Withdrawal by Subject|3
3085321|NCT00387790|10584592|P1|Overall Study|Physician Decision|2
3085322|NCT00387790|10584592|P1|Overall Study|Lack of Efficacy|2
3085323|NCT00387790|10584592|P1|Overall Study|Adverse Event|5
3085324|NCT00387764|10584598|P1|Overall Study|Death|7
3085325|NCT00387764|10584598|P1|Overall Study|Other|2
3085326|NCT00387764|10584598|P1|Overall Study|Physician Decision|1
3085327|NCT00387764|10584598|P1|Overall Study|Sponsor Terminated Study|1
3085328|NCT00387764|10584598|P1|Overall Study|Withdrawal by Subject|8
3085329|NCT00387764|10584598|P1|Overall Study|Adverse Event|12
3085330|NCT00387725|10584626|P4|Overall Study|Parent/legal guardian request|1
3085331|NCT00387725|10584627|P3|Overall Study|Parent/legal guardian request|1
3085332|NCT00387725|10584628|P2|Overall Study|Parent/legal guardian request|0
3085333|NCT00387725|10584629|P1|Overall Study|Parent/legal guardian request|0
3085334|NCT00387725|10584626|P4|Overall Study|Withdrawal by Subject|0
3085335|NCT00387725|10584627|P3|Overall Study|Withdrawal by Subject|1
3085336|NCT00387725|10584628|P2|Overall Study|Withdrawal by Subject|0
3085337|NCT00387725|10584629|P1|Overall Study|Withdrawal by Subject|1
3085338|NCT00387725|10584626|P4|Overall Study|Protocol Violation|0
3085339|NCT00387725|10584627|P3|Overall Study|Protocol Violation|0
3085340|NCT00387725|10584628|P2|Overall Study|Protocol Violation|1
3085341|NCT00387725|10584629|P1|Overall Study|Protocol Violation|0
3085342|NCT00387725|10584626|P4|Overall Study|Adverse Event|1
3085343|NCT00387725|10584627|P3|Overall Study|Adverse Event|0
3085344|NCT00387725|10584628|P2|Overall Study|Adverse Event|0
3085345|NCT00387725|10584629|P1|Overall Study|Adverse Event|0
3085346|NCT00387712|10584649|P2|Overall Study|Withdrawal by Subject|12
3085347|NCT00387712|10584650|P1|Overall Study|Withdrawal by Subject|6
3085348|NCT00387712|10584649|P2|Overall Study|Lost to Follow-up|20
3085349|NCT00387712|10584650|P1|Overall Study|Lost to Follow-up|17
3085350|NCT00387712|10584649|P2|Overall Study|Physician Decision|4
3085351|NCT00387712|10584650|P1|Overall Study|Physician Decision|6
3085352|NCT00387647|10584681|P1|Overall Study|Death|18
3085353|NCT00387465|10584724|P3|Overall Study|Withdrawal by Subject|0
3085354|NCT00387465|10584725|P2|Overall Study|Withdrawal by Subject|1
3085355|NCT00387465|10584726|P1|Overall Study|Withdrawal by Subject|0
3085356|NCT00387426|10584743|P1|Overall Study|Disease Progression|3
3085357|NCT00387426|10584743|P1|Overall Study|Toxicities|4
3085358|NCT00387426|10584743|P1|Overall Study|Lack of Response|7
3085359|NCT00387348|10584750|P3|Overall Study|Adverse Event|1
3085360|NCT00387348|10584751|P2|Overall Study|Adverse Event|0
3085361|NCT00387348|10584752|P1|Overall Study|Adverse Event|1
3085362|NCT00387348|10584750|P3|Overall Study|Withdrawal by Subject|2
3085363|NCT00387348|10584751|P2|Overall Study|Withdrawal by Subject|2
3085364|NCT00387348|10584752|P1|Overall Study|Withdrawal by Subject|0
3085365|NCT00387348|10584750|P3|Overall Study|Physician Decision|1
3085366|NCT00387348|10584751|P2|Overall Study|Physician Decision|0
3085367|NCT00387348|10584752|P1|Overall Study|Physician Decision|1
3085368|NCT00387348|10584750|P3|Overall Study|Death|0
3085369|NCT00387348|10584751|P2|Overall Study|Death|1
3085370|NCT00387348|10584752|P1|Overall Study|Death|1
3085371|NCT00387153|10584781|P1|Overall Study|Lack of Response|4
3085372|NCT00387153|10584781|P1|Overall Study|Disease Progression|3
3085373|NCT00387153|10584781|P1|Overall Study|Adverse Event|1
3085374|NCT00387127|10584787|P2|Overall Study|Sponsor Unblinded|0
3085375|NCT00387127|10584788|P1|Overall Study|Sponsor Unblinded|1
3085376|NCT00387127|10584787|P2|Overall Study|Serious Adverse Event|1
3085377|NCT00387127|10584788|P1|Overall Study|Serious Adverse Event|1
3085378|NCT00387127|10584787|P2|Overall Study|Required by Protocol Amendment #4|10
3085379|NCT00387127|10584788|P1|Overall Study|Required by Protocol Amendment #4|12
3085380|NCT00387127|10584787|P2|Overall Study|Withdrawal by Subject|2
3085381|NCT00387127|10584788|P1|Overall Study|Withdrawal by Subject|3
3085382|NCT00387127|10584787|P2|Overall Study|Physician Decision|1
3085383|NCT00387127|10584788|P1|Overall Study|Physician Decision|0
3085384|NCT00387127|10584787|P2|Overall Study|Death|16
3085385|NCT00387127|10584788|P1|Overall Study|Death|16
3085386|NCT00387127|10584787|P2|Overall Study|Lost to Follow-up|4
3085387|NCT00387127|10584788|P1|Overall Study|Lost to Follow-up|0
3085388|NCT00387088|10584830|P2|Overall Study|Other|52
3085389|NCT00387088|10584831|P1|Overall Study|Other|58
3085390|NCT00387088|10584830|P2|Overall Study|Lost to Follow-up|28
3085391|NCT00387088|10584831|P1|Overall Study|Lost to Follow-up|22
3085392|NCT00387088|10584830|P2|Overall Study|Lack of Efficacy|67
3085393|NCT00387088|10584831|P1|Overall Study|Lack of Efficacy|28
3085394|NCT00387088|10584830|P2|Overall Study|Withdrawal by Subject|35
3085395|NCT00387088|10584831|P1|Overall Study|Withdrawal by Subject|20
3085396|NCT00387088|10584830|P2|Overall Study|Protocol Violation|35
3085397|NCT00387088|10584831|P1|Overall Study|Protocol Violation|47
3085398|NCT00387088|10584830|P2|Overall Study|Adverse Event|156
3085399|NCT00387088|10584831|P1|Overall Study|Adverse Event|143
3085400|NCT00387010|10584888|P1|Treatment Period|Participant reported study drug stolen|1
3085401|NCT00387010|10584888|P1|Treatment Period|Noncompliance with study procedures|3
3085402|NCT00387010|10584888|P1|Treatment Period|Noncompliance with study medication|2
3085403|NCT00387010|10584888|P1|Treatment Period|Withdrawal by Subject|1
3085404|NCT00387010|10584888|P1|Treatment Period|Adverse Event|4
3085405|NCT00387010|10584888|P1|Dose Titration Period|Noncompliance with study procedures|7
3085406|NCT00387010|10584888|P1|Dose Titration Period|Noncompliance with study medication|8
3085407|NCT00387010|10584888|P1|Dose Titration Period|Lost to Follow-up|2
3085408|NCT00387010|10584888|P1|Dose Titration Period|Protocol Violation|1
3085409|NCT00387010|10584888|P1|Dose Titration Period|Withdrawal by Subject|3
3085410|NCT00387010|10584888|P1|Dose Titration Period|Lack of Efficacy|5
3085411|NCT00387010|10584888|P1|Dose Titration Period|Adverse Event|12
3085412|NCT00386776|10584915|P1|Overall Study|Withdrawal by Subject|8
3085413|NCT00386607|10584925|P2|Extension|Unsatisfactory therapeutic effect|1
3085414|NCT00386607|10584926|P1|Extension|Unsatisfactory therapeutic effect|0
3085415|NCT00386607|10584925|P2|Extension|Patient withdrew consent|5
3085416|NCT00386607|10584926|P1|Extension|Patient withdrew consent|0
3085417|NCT00386607|10584925|P2|Extension|Lost to Follow-up|3
3085418|NCT00386607|10584926|P1|Extension|Lost to Follow-up|0
3085419|NCT00386607|10584925|P2|Extension|Administrative problems|1
3085420|NCT00386607|10584926|P1|Extension|Administrative problems|0
3085421|NCT00386607|10584925|P2|Extension|Abnormal laboratory value(s)|1
3085422|NCT00386607|10584926|P1|Extension|Abnormal laboratory value(s)|0
3085423|NCT00386607|10584925|P2|Extension|Adverse Event|6
3085424|NCT00386607|10584926|P1|Extension|Adverse Event|0
3085425|NCT00386607|10584925|P2|Core|Protocol Deviation|0
3085426|NCT00386607|10584926|P1|Core|Protocol Deviation|6
3085427|NCT00386607|10584925|P2|Core|Administrative problems|0
3085428|NCT00386607|10584926|P1|Core|Administrative problems|1
3085429|NCT00386607|10584925|P2|Core|Lost to Follow-up|0
3085430|NCT00386607|10584926|P1|Core|Lost to Follow-up|23
3085431|NCT00386607|10584925|P2|Core|Patient withdrew consent|0
3085432|NCT00386607|10584926|P1|Core|Patient withdrew consent|15
3085433|NCT00386607|10584925|P2|Core|Condition no longer requires study drug|0
3085434|NCT00386607|10584926|P1|Core|Condition no longer requires study drug|4
3085435|NCT00386607|10584925|P2|Core|Unsatisfactory therapeutic effect|0
3085436|NCT00386607|10584926|P1|Core|Unsatisfactory therapeutic effect|23
3085437|NCT00386607|10584925|P2|Core|Abnormal laboratory value(s)|0
3085438|NCT00386607|10584926|P1|Core|Abnormal laboratory value(s)|3
3085439|NCT00386607|10584925|P2|Core|Adverse Event|0
3085440|NCT00386607|10584926|P1|Core|Adverse Event|40
3085441|NCT00386425|10584954|P3|Overall Study|Withdrawal by Subject|0
3085442|NCT00386425|10584955|P2|Overall Study|Withdrawal by Subject|1
3085443|NCT00386425|10584956|P1|Overall Study|Withdrawal by Subject|0
3085444|NCT00386425|10584954|P3|Overall Study|Physician Decision|0
3085445|NCT00386425|10584955|P2|Overall Study|Physician Decision|0
3085446|NCT00386425|10584956|P1|Overall Study|Physician Decision|3
3085447|NCT00386360|10584982|P2|Overall Study|Did not take any study medication|2
3085448|NCT00386360|10584983|P1|Overall Study|Did not take any study medication|0
3085449|NCT00386360|10584982|P2|Overall Study|Withdrawal by Subject|6
3085450|NCT00386360|10584983|P1|Overall Study|Withdrawal by Subject|3
3085451|NCT00386360|10584982|P2|Overall Study|Protocol Violation|3
3085452|NCT00386360|10584983|P1|Overall Study|Protocol Violation|0
3085453|NCT00386360|10584982|P2|Overall Study|Lost to Follow-up|2
3085454|NCT00386360|10584983|P1|Overall Study|Lost to Follow-up|0
3085455|NCT00386360|10584982|P2|Overall Study|Physician Decision|2
3085456|NCT00386360|10584983|P1|Overall Study|Physician Decision|2
3085457|NCT00386360|10584982|P2|Overall Study|Adverse Event|2
3085458|NCT00386360|10584983|P1|Overall Study|Adverse Event|4
3085459|NCT00386334|10585017|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
3085460|NCT00386334|10585018|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
3085461|NCT00386334|10585017|P2|Double Blind Period|Other|3
3085462|NCT00386334|10585018|P1|Double Blind Period|Other|3
3085463|NCT00386334|10585017|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
3085464|NCT00386334|10585018|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
3085465|NCT00386334|10585017|P2|Double Blind Period|Lack of Efficacy|11
3085466|NCT00386334|10585018|P1|Double Blind Period|Lack of Efficacy|20
3085467|NCT00386334|10585017|P2|Double Blind Period|Withdrawal by Subject|13
3085468|NCT00386334|10585018|P1|Double Blind Period|Withdrawal by Subject|9
3085469|NCT00386334|10585017|P2|Double Blind Period|Protocol Violation|1
3085470|NCT00386334|10585018|P1|Double Blind Period|Protocol Violation|1
3085471|NCT00386334|10585017|P2|Double Blind Period|Adverse Event|14
3085472|NCT00386334|10585018|P1|Double Blind Period|Adverse Event|9
3085473|NCT00386308|10585162|P2|Overall Study|Other Event|1
3085474|NCT00386308|10585163|P1|Overall Study|Other Event|8
3085475|NCT00386308|10585162|P2|Overall Study|Withdrawal by Subject|2
3085476|NCT00386308|10585163|P1|Overall Study|Withdrawal by Subject|6
3085477|NCT00386308|10585162|P2|Overall Study|Lost to Follow-up|6
3085478|NCT00386308|10585163|P1|Overall Study|Lost to Follow-up|10
3085479|NCT00386308|10585162|P2|Overall Study|Lack of Efficacy|2
3085480|NCT00386308|10585163|P1|Overall Study|Lack of Efficacy|0
3085481|NCT00386308|10585162|P2|Overall Study|Protocol Violation|5
3085482|NCT00386308|10585163|P1|Overall Study|Protocol Violation|2
3085483|NCT00386308|10585162|P2|Overall Study|Adverse Event|3
3085484|NCT00386308|10585163|P1|Overall Study|Adverse Event|3
3085485|NCT00386152|10585220|P3|Overall Study|Withdrawal by Subject|10
3085486|NCT00386152|10585221|P2|Overall Study|Withdrawal by Subject|6
3085487|NCT00386152|10585222|P1|Overall Study|Withdrawal by Subject|3
3085488|NCT00386152|10585220|P3|Overall Study|Protocol Violation|2
3085489|NCT00386152|10585221|P2|Overall Study|Protocol Violation|5
3085490|NCT00386152|10585222|P1|Overall Study|Protocol Violation|3
3085491|NCT00386152|10585220|P3|Overall Study|Completed chemotherapy|1
3085492|NCT00386152|10585221|P2|Overall Study|Completed chemotherapy|5
3085493|NCT00386152|10585222|P1|Overall Study|Completed chemotherapy|4
3085494|NCT00386152|10585220|P3|Overall Study|Lost to Follow-up|0
3085495|NCT00386152|10585221|P2|Overall Study|Lost to Follow-up|0
3085496|NCT00386152|10585222|P1|Overall Study|Lost to Follow-up|1
3085497|NCT00386152|10585220|P3|Overall Study|Physician Decision|4
3085498|NCT00386152|10585221|P2|Overall Study|Physician Decision|10
3085499|NCT00386152|10585222|P1|Overall Study|Physician Decision|13
3085500|NCT00386152|10585220|P3|Overall Study|Disease progression|5
3085501|NCT00386152|10585221|P2|Overall Study|Disease progression|4
3085502|NCT00386152|10585222|P1|Overall Study|Disease progression|7
3085503|NCT00386152|10585220|P3|Overall Study|Death|1
3085504|NCT00386152|10585221|P2|Overall Study|Death|0
3085505|NCT00386152|10585222|P1|Overall Study|Death|3
3085506|NCT00386152|10585220|P3|Overall Study|Chang from original chemo stratification|6
3085507|NCT00386152|10585221|P2|Overall Study|Chang from original chemo stratification|5
3085508|NCT00386152|10585222|P1|Overall Study|Chang from original chemo stratification|4
3085509|NCT00386152|10585220|P3|Overall Study|Adverse Event|4
3085510|NCT00386152|10585221|P2|Overall Study|Adverse Event|5
3085511|NCT00386152|10585222|P1|Overall Study|Adverse Event|6
3085512|NCT00386100|10585241|P2|Overall Study|Participant randomized in error|0
3085513|NCT00386100|10585242|P1|Overall Study|Participant randomized in error|1
3085514|NCT00386100|10585241|P2|Overall Study|Hb1Ac >8%|1
3085515|NCT00386100|10585242|P1|Overall Study|Hb1Ac >8%|0
3085516|NCT00386100|10585241|P2|Overall Study|Out of country for 5 months|0
3085517|NCT00386100|10585242|P1|Overall Study|Out of country for 5 months|1
3085518|NCT00386100|10585241|P2|Overall Study|Positive pregnancy test|3
3085519|NCT00386100|10585242|P1|Overall Study|Positive pregnancy test|1
3085520|NCT00386100|10585241|P2|Overall Study|Osteoporosis|1
3085521|NCT00386100|10585242|P1|Overall Study|Osteoporosis|0
3085522|NCT00386100|10585241|P2|Overall Study|7.6% bone loss|0
3085523|NCT00386100|10585242|P1|Overall Study|7.6% bone loss|1
3085524|NCT00386100|10585241|P2|Overall Study|DBP 93 mmHg at randomization|0
3085525|NCT00386100|10585242|P1|Overall Study|DBP 93 mmHg at randomization|1
3085526|NCT00386100|10585241|P2|Overall Study|Bone loss by DXA bone scan|0
3085527|NCT00386100|10585242|P1|Overall Study|Bone loss by DXA bone scan|1
3085528|NCT00386100|10585241|P2|Overall Study|Bad metabolic control & patient security|0
3085529|NCT00386100|10585242|P1|Overall Study|Bad metabolic control & patient security|1
3085530|NCT00386100|10585241|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
3085531|NCT00386100|10585242|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
3085532|NCT00386100|10585241|P2|Overall Study|Participant's PCP wanted to stop drug|0
3085533|NCT00386100|10585242|P1|Overall Study|Participant's PCP wanted to stop drug|1
3085534|NCT00386100|10585241|P2|Overall Study|Didn't meet entry criteria|1
3085535|NCT00386100|10585242|P1|Overall Study|Didn't meet entry criteria|1
3085536|NCT00386100|10585241|P2|Overall Study|Excessive bone loss vs. baseline value|1
3085537|NCT00386100|10585242|P1|Overall Study|Excessive bone loss vs. baseline value|0
3085538|NCT00386100|10585241|P2|Overall Study|Participant moving out of state|0
3085539|NCT00386100|10585242|P1|Overall Study|Participant moving out of state|2
3085540|NCT00386100|10585241|P2|Overall Study|Participant's concern due to CPK levels|0
3085541|NCT00386100|10585242|P1|Overall Study|Participant's concern due to CPK levels|1
3085542|NCT00386100|10585241|P2|Overall Study|Laboratory findings|0
3085543|NCT00386100|10585242|P1|Overall Study|Laboratory findings|1
3085544|NCT00386100|10585241|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
3085545|NCT00386100|10585242|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
3085546|NCT00386100|10585241|P2|Overall Study|Consecutive elevated Hba1C|0
3085547|NCT00386100|10585242|P1|Overall Study|Consecutive elevated Hba1C|1
3085548|NCT00386100|10585241|P2|Overall Study|BMD <2.5|0
3085549|NCT00386100|10585242|P1|Overall Study|BMD <2.5|1
3085550|NCT00386100|10585241|P2|Overall Study|Bone mass density (BMD) loss >6%|4
3085551|NCT00386100|10585242|P1|Overall Study|Bone mass density (BMD) loss >6%|4
3085552|NCT00386100|10585241|P2|Overall Study|Withdrawal by Subject|31
3085553|NCT00386100|10585242|P1|Overall Study|Withdrawal by Subject|32
3085554|NCT00386100|10585241|P2|Overall Study|Protocol Violation|3
3085555|NCT00386100|10585242|P1|Overall Study|Protocol Violation|5
3085556|NCT00386100|10585241|P2|Overall Study|Non-compliance|19
3085557|NCT00386100|10585242|P1|Overall Study|Non-compliance|18
3085558|NCT00386100|10585241|P2|Overall Study|Lost to Follow-up|29
3085559|NCT00386100|10585242|P1|Overall Study|Lost to Follow-up|29
3085560|NCT00386100|10585241|P2|Overall Study|Insufficient therapeutic effect|6
3085561|NCT00386100|10585242|P1|Overall Study|Insufficient therapeutic effect|30
3085562|NCT00386100|10585241|P2|Overall Study|Death|1
3085563|NCT00386100|10585242|P1|Overall Study|Death|0
3085564|NCT00386100|10585241|P2|Overall Study|Adverse Event|25
3085565|NCT00386100|10585242|P1|Overall Study|Adverse Event|15
3085566|NCT00386100|10585241|P2|Overall Study|Did not receive study medication|4
3085567|NCT00386100|10585242|P1|Overall Study|Did not receive study medication|6
3085568|NCT00386022|10585306|P2|Plus Estrogen|Adverse Event|1
3085569|NCT00386022|10585307|P1|Plus Estrogen|Adverse Event|0
3085570|NCT00386022|10585306|P2|Plus Estrogen|Lost to Follow-up|0
3085571|NCT00386022|10585307|P1|Plus Estrogen|Lost to Follow-up|2
3085572|NCT00386009|10585317|P2|Overall Study|Withdrawal by Subject|4
3085573|NCT00386009|10585318|P1|Overall Study|Withdrawal by Subject|5
3085574|NCT00386009|10585317|P2|Overall Study|Sponsor Decision|1
3085575|NCT00386009|10585318|P1|Overall Study|Sponsor Decision|1
3085576|NCT00386009|10585317|P2|Overall Study|Protocol Violation|0
3085577|NCT00386009|10585318|P1|Overall Study|Protocol Violation|1
3085578|NCT00386009|10585317|P2|Overall Study|Lost to Follow-up|1
3085579|NCT00386009|10585318|P1|Overall Study|Lost to Follow-up|1
3085580|NCT00386009|10585317|P2|Overall Study|Entry Criteria Not Met|2
3085581|NCT00386009|10585318|P1|Overall Study|Entry Criteria Not Met|0
3085582|NCT00386009|10585317|P2|Overall Study|Death|0
3085583|NCT00386009|10585318|P1|Overall Study|Death|1
3085584|NCT00386009|10585317|P2|Overall Study|Adverse Event|2
3085585|NCT00386009|10585318|P1|Overall Study|Adverse Event|0
3085586|NCT00385944|10585365|P3|2nd Maintenance Dose Period|Invalid PD Data|0
3085587|NCT00385944|10585366|P2|2nd Maintenance Dose Period|Invalid PD Data|3
3085588|NCT00385944|10585367|P1|2nd Maintenance Dose Period|Invalid PD Data|2
3085589|NCT00385944|10585365|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
3085590|NCT00385944|10585366|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
3085591|NCT00385944|10585367|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
3085592|NCT00385944|10585365|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
3085593|NCT00385944|10585366|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
3085594|NCT00385944|10585367|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
3085595|NCT00385944|10585365|P3|1st Maintenance Dose Period|Physician Decision|0
3085596|NCT00385944|10585366|P2|1st Maintenance Dose Period|Physician Decision|0
3085597|NCT00385944|10585367|P1|1st Maintenance Dose Period|Physician Decision|1
3085598|NCT00385918|10585410|P3|Intervention Phase After Randomization|Lost to Follow-up|0
3085599|NCT00385918|10585411|P2|Intervention Phase After Randomization|Lost to Follow-up|0
3085600|NCT00385918|10585412|P1|Intervention Phase After Randomization|Lost to Follow-up|1
3085601|NCT00385918|10585410|P3|Intervention Phase After Randomization|Physician Decision|0
3085602|NCT00385918|10585411|P2|Intervention Phase After Randomization|Physician Decision|0
3085603|NCT00385918|10585412|P1|Intervention Phase After Randomization|Physician Decision|1
3085604|NCT00385918|10585410|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
3085605|NCT00385918|10585411|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
3085606|NCT00385918|10585412|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
3085607|NCT00385918|10585410|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
3085608|NCT00385918|10585411|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
3085609|NCT00385918|10585412|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
3085610|NCT00385918|10585410|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
3085611|NCT00385918|10585411|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
3085612|NCT00385918|10585412|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
3085613|NCT00385918|10585410|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
3085614|NCT00385918|10585411|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
3085615|NCT00385918|10585412|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
3085616|NCT00385840|10585436|P2|Overall Study|Lost to Follow-up|13
3085617|NCT00385840|10585437|P1|Overall Study|Lost to Follow-up|3
3085618|NCT00385840|10585436|P2|Overall Study|Adverse Event|1
3085619|NCT00385840|10585437|P1|Overall Study|Adverse Event|1
3085620|NCT00385827|10585460|P3|Part 2|Other|21
3085621|NCT00385827|10585461|P2|Part 2|Other|11
3085622|NCT00385827|10585462|P1|Part 2|Other|0
3085623|NCT00385827|10585460|P3|Part 2|Randomized but not treated|2
3085624|NCT00385827|10585461|P2|Part 2|Randomized but not treated|2
3085625|NCT00385827|10585462|P1|Part 2|Randomized but not treated|0
3085626|NCT00385827|10585460|P3|Part 2|Lack of Efficacy|13
3085627|NCT00385827|10585461|P2|Part 2|Lack of Efficacy|14
3085628|NCT00385827|10585462|P1|Part 2|Lack of Efficacy|0
3085629|NCT00385827|10585460|P3|Part 2|Death|2
3085630|NCT00385827|10585461|P2|Part 2|Death|0
3085631|NCT00385827|10585462|P1|Part 2|Death|0
3085632|NCT00385827|10585460|P3|Part 2|Adverse Event|10
3085633|NCT00385827|10585461|P2|Part 2|Adverse Event|6
3085634|NCT00385827|10585462|P1|Part 2|Adverse Event|0
3085635|NCT00385827|10585460|P3|Part 1|Other|0
3085636|NCT00385827|10585461|P2|Part 1|Other|0
3085637|NCT00385827|10585462|P1|Part 1|Other|1
3085638|NCT00385827|10585460|P3|Part 1|Lack of Efficacy|0
3085639|NCT00385827|10585461|P2|Part 1|Lack of Efficacy|0
3085640|NCT00385827|10585462|P1|Part 1|Lack of Efficacy|5
3085641|NCT00385827|10585460|P3|Part 1|Death|0
3085642|NCT00385827|10585461|P2|Part 1|Death|0
3085643|NCT00385827|10585462|P1|Part 1|Death|2
3085644|NCT00385827|10585460|P3|Part 1|Adverse Event|0
3085645|NCT00385827|10585461|P2|Part 1|Adverse Event|0
3085646|NCT00385827|10585462|P1|Part 1|Adverse Event|1
3085647|NCT00385762|10585506|P1|Overall Study|Lost to Follow-up|1
3085648|NCT00385762|10585506|P1|Overall Study|Adverse Event|1
3085649|NCT00385736|10585516|P3|Safety Analysis Set|Other|4
3085650|NCT00385736|10585517|P2|Safety Analysis Set|Other|4
3085651|NCT00385736|10585518|P1|Safety Analysis Set|Other|1
3085652|NCT00385736|10585516|P3|Safety Analysis Set|Protocol Violation|6
3085653|NCT00385736|10585517|P2|Safety Analysis Set|Protocol Violation|1
3085654|NCT00385736|10585518|P1|Safety Analysis Set|Protocol Violation|2
3085655|NCT00385736|10585516|P3|Safety Analysis Set|Lack of Efficacy|31
3085656|NCT00385736|10585517|P2|Safety Analysis Set|Lack of Efficacy|16
3085657|NCT00385736|10585518|P1|Safety Analysis Set|Lack of Efficacy|38
3085658|NCT00385736|10585516|P3|Safety Analysis Set|Lost to Follow-up|2
3085659|NCT00385736|10585517|P2|Safety Analysis Set|Lost to Follow-up|2
3085660|NCT00385736|10585518|P1|Safety Analysis Set|Lost to Follow-up|0
3085661|NCT00385736|10585516|P3|Safety Analysis Set|Withdrawal by Subject|14
3085662|NCT00385736|10585517|P2|Safety Analysis Set|Withdrawal by Subject|6
3085663|NCT00385736|10585518|P1|Safety Analysis Set|Withdrawal by Subject|6
3085664|NCT00385736|10585516|P3|Safety Analysis Set|Adverse Event|23
3085665|NCT00385736|10585517|P2|Safety Analysis Set|Adverse Event|15
3085666|NCT00385736|10585518|P1|Safety Analysis Set|Adverse Event|23
3085667|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Other|4
3085668|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Other|4
3085669|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Other|0
3085670|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
3085671|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
3085672|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
3085673|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
3085674|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
3085675|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
3085676|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
3085677|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
3085678|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
3085679|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
3085680|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
3085681|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
3085682|NCT00385736|10585516|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
3085683|NCT00385736|10585517|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
3085684|NCT00385736|10585518|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
3085685|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Other|1
3085686|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Other|0
3085687|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Other|0
3085688|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
3085689|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
3085690|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
3085691|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
3085692|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
3085693|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
3085694|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
3085695|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
3085696|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
3085697|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
3085698|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
3085699|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
3085700|NCT00385736|10585516|P3|Efficacy Analysis Set - Induction|Adverse Event|4
3085701|NCT00385736|10585517|P2|Efficacy Analysis Set - Induction|Adverse Event|6
3085702|NCT00385736|10585518|P1|Efficacy Analysis Set - Induction|Adverse Event|5
3085703|NCT00385723|10585563|P3|Overall Study|Withdrawal by Subject|2
3085704|NCT00385723|10585564|P2|Overall Study|Withdrawal by Subject|0
3085705|NCT00385723|10585565|P1|Overall Study|Withdrawal by Subject|1
3085706|NCT00385723|10585563|P3|Overall Study|Lost to Follow-up|0
3085707|NCT00385723|10585564|P2|Overall Study|Lost to Follow-up|1
3085708|NCT00385723|10585565|P1|Overall Study|Lost to Follow-up|1
3085709|NCT00385684|10585579|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
3085710|NCT00385684|10585580|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
3085711|NCT00385684|10585579|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
3085712|NCT00385684|10585580|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
3085713|NCT00385684|10585579|P2|FIRST INTERVENTION OF PHASE A|Death|0
3085714|NCT00385684|10585580|P1|FIRST INTERVENTION OF PHASE A|Death|1
3085715|NCT00385671|10585589|P3|Overall Study|Withdrawal by Subject|4
3085716|NCT00385671|10585590|P2|Overall Study|Withdrawal by Subject|4
3085717|NCT00385671|10585591|P1|Overall Study|Withdrawal by Subject|4
3085718|NCT00385671|10585589|P3|Overall Study|Sponsor Decision|1
3085719|NCT00385671|10585590|P2|Overall Study|Sponsor Decision|2
3085720|NCT00385671|10585591|P1|Overall Study|Sponsor Decision|2
3085721|NCT00385671|10585589|P3|Overall Study|Protocol Violation|1
3085722|NCT00385671|10585590|P2|Overall Study|Protocol Violation|2
3085723|NCT00385671|10585591|P1|Overall Study|Protocol Violation|5
3085724|NCT00385671|10585589|P3|Overall Study|Physician Decision|2
3085725|NCT00385671|10585590|P2|Overall Study|Physician Decision|1
3085726|NCT00385671|10585591|P1|Overall Study|Physician Decision|2
3085727|NCT00385671|10585589|P3|Overall Study|Lost to Follow-up|5
3085728|NCT00385671|10585590|P2|Overall Study|Lost to Follow-up|6
3085729|NCT00385671|10585591|P1|Overall Study|Lost to Follow-up|6
3085730|NCT00385671|10585589|P3|Overall Study|Lack of Efficacy|5
3085731|NCT00385671|10585590|P2|Overall Study|Lack of Efficacy|9
3085732|NCT00385671|10585591|P1|Overall Study|Lack of Efficacy|5
3085733|NCT00385671|10585589|P3|Overall Study|Adverse Event|18
3085734|NCT00385671|10585590|P2|Overall Study|Adverse Event|27
3085735|NCT00385671|10585591|P1|Overall Study|Adverse Event|14
3085736|NCT00385593|10585747|P2|Overall Study|Incorrect randomization|1
3085737|NCT00385593|10585748|P1|Overall Study|Incorrect randomization|0
3085738|NCT00385593|10585747|P2|Overall Study|Incorrect inclusion|0
3085739|NCT00385593|10585748|P1|Overall Study|Incorrect inclusion|2
3085740|NCT00385593|10585747|P2|Overall Study|Several reasons|15
3085741|NCT00385593|10585748|P1|Overall Study|Several reasons|17
3085742|NCT00385593|10585747|P2|Overall Study|Protocol Violation|4
3085743|NCT00385593|10585748|P1|Overall Study|Protocol Violation|7
3085744|NCT00385593|10585747|P2|Overall Study|Lost to Follow-up|8
3085745|NCT00385593|10585748|P1|Overall Study|Lost to Follow-up|12
3085746|NCT00385593|10585747|P2|Overall Study|Withdrawal by Subject|7
3085747|NCT00385593|10585748|P1|Overall Study|Withdrawal by Subject|17
3085748|NCT00385593|10585747|P2|Overall Study|Adverse Event|2
3085749|NCT00385593|10585748|P1|Overall Study|Adverse Event|3
3085750|NCT00385541|10585858|P2|Overall Study|severe pain, clinician requested unblind|1
3085751|NCT00385541|10585859|P1|Overall Study|severe pain, clinician requested unblind|0
3085752|NCT00385255|10585895|P2|Overall Study|Lost to Follow-up|58
3085753|NCT00385255|10585896|P1|Overall Study|Lost to Follow-up|20
3085754|NCT00385255|10585895|P2|Overall Study|Migrated/moved from study area|1
3085755|NCT00385255|10585896|P1|Overall Study|Migrated/moved from study area|0
3085756|NCT00385255|10585895|P2|Overall Study|Withdrawal by Subject|8
3085757|NCT00385255|10585896|P1|Overall Study|Withdrawal by Subject|0
3085758|NCT00385255|10585895|P2|Overall Study|Protocol Violation|4
3085759|NCT00385255|10585896|P1|Overall Study|Protocol Violation|0
3085760|NCT00385255|10585895|P2|Overall Study|Serious Adverse Event|2
3085761|NCT00385255|10585896|P1|Overall Study|Serious Adverse Event|1
3085762|NCT00385203|10585975|P2|Overall Study|Incorrect enrollment|0
3085763|NCT00385203|10585976|P1|Overall Study|Incorrect enrollment|2
3085764|NCT00385203|10585975|P2|Overall Study|Condition under investigation worsened|3
3085765|NCT00385203|10585976|P1|Overall Study|Condition under investigation worsened|18
3085766|NCT00385203|10585975|P2|Overall Study|Death|0
3085767|NCT00385203|10585976|P1|Overall Study|Death|1
3085768|NCT00385203|10585975|P2|Overall Study|Adverse Event|4
3085769|NCT00385203|10585976|P1|Overall Study|Adverse Event|5
3085770|NCT00384956|10586064|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
3085771|NCT00384930|10586081|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
3085772|NCT00384930|10586082|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
3085773|NCT00384930|10586083|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
3085774|NCT00384930|10586084|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
3085775|NCT00384930|10586085|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
3085776|NCT00384930|10586081|P5|Overall Study|Withdrawal by Subject|16
3085777|NCT00384930|10586082|P4|Overall Study|Withdrawal by Subject|6
3085778|NCT00384930|10586083|P3|Overall Study|Withdrawal by Subject|7
3085779|NCT00384930|10586084|P2|Overall Study|Withdrawal by Subject|7
3085780|NCT00384930|10586085|P1|Overall Study|Withdrawal by Subject|9
3085781|NCT00384930|10586081|P5|Overall Study|Sponsor Decision|0
3085782|NCT00384930|10586082|P4|Overall Study|Sponsor Decision|5
3085783|NCT00384930|10586083|P3|Overall Study|Sponsor Decision|0
3085784|NCT00384930|10586084|P2|Overall Study|Sponsor Decision|4
3085785|NCT00384930|10586085|P1|Overall Study|Sponsor Decision|3
3085786|NCT00384930|10586081|P5|Overall Study|Protocol Violation|4
3085787|NCT00384930|10586082|P4|Overall Study|Protocol Violation|6
3085788|NCT00384930|10586083|P3|Overall Study|Protocol Violation|1
3085789|NCT00384930|10586084|P2|Overall Study|Protocol Violation|0
3085790|NCT00384930|10586085|P1|Overall Study|Protocol Violation|1
3085791|NCT00384930|10586081|P5|Overall Study|Physician Decision|1
3085792|NCT00384930|10586082|P4|Overall Study|Physician Decision|0
3085793|NCT00384930|10586083|P3|Overall Study|Physician Decision|1
3085794|NCT00384930|10586084|P2|Overall Study|Physician Decision|1
3085795|NCT00384930|10586085|P1|Overall Study|Physician Decision|0
3085796|NCT00384930|10586081|P5|Overall Study|Lost to Follow-up|6
3085797|NCT00384930|10586082|P4|Overall Study|Lost to Follow-up|4
3085798|NCT00384930|10586083|P3|Overall Study|Lost to Follow-up|0
3085799|NCT00384930|10586084|P2|Overall Study|Lost to Follow-up|3
3085800|NCT00384930|10586085|P1|Overall Study|Lost to Follow-up|5
3085801|NCT00384930|10586081|P5|Overall Study|Lack of Efficacy|2
3085802|NCT00384930|10586082|P4|Overall Study|Lack of Efficacy|1
3085803|NCT00384930|10586083|P3|Overall Study|Lack of Efficacy|2
3085804|NCT00384930|10586084|P2|Overall Study|Lack of Efficacy|1
3085805|NCT00384930|10586085|P1|Overall Study|Lack of Efficacy|1
3085806|NCT00384930|10586081|P5|Overall Study|Entry Criteria Not Met|4
3085807|NCT00384930|10586082|P4|Overall Study|Entry Criteria Not Met|8
3085808|NCT00384930|10586083|P3|Overall Study|Entry Criteria Not Met|7
3085809|NCT00384930|10586084|P2|Overall Study|Entry Criteria Not Met|6
3085810|NCT00384930|10586085|P1|Overall Study|Entry Criteria Not Met|2
3085811|NCT00384930|10586081|P5|Overall Study|Adverse Event|14
3085812|NCT00384930|10586082|P4|Overall Study|Adverse Event|11
3085813|NCT00384930|10586083|P3|Overall Study|Adverse Event|12
3085814|NCT00384930|10586084|P2|Overall Study|Adverse Event|4
3085815|NCT00384930|10586085|P1|Overall Study|Adverse Event|5
3085816|NCT00384839|10586164|P1|Overall Study|Ineligible|2
3085817|NCT00384839|10586164|P1|Overall Study|Patient Request|1
3085818|NCT00384839|10586164|P1|Overall Study|Investigator Request|1
3085819|NCT00384839|10586164|P1|Overall Study|Adverse Event|4
3085820|NCT00384397|10586297|P3|Overall Study|Withdrawal by Subject|15
3085821|NCT00384397|10586298|P2|Overall Study|Withdrawal by Subject|17
3085822|NCT00384397|10586299|P1|Overall Study|Withdrawal by Subject|14
3085823|NCT00384397|10586297|P3|Overall Study|Lost to Follow-up|3
3085824|NCT00384397|10586298|P2|Overall Study|Lost to Follow-up|13
3085825|NCT00384397|10586299|P1|Overall Study|Lost to Follow-up|11
3085826|NCT00384397|10586297|P3|Overall Study|Protocol Violation|13
3085827|NCT00384397|10586298|P2|Overall Study|Protocol Violation|15
3085828|NCT00384397|10586299|P1|Overall Study|Protocol Violation|7
3085829|NCT00384397|10586297|P3|Overall Study|Adverse Event|2
3085830|NCT00384397|10586298|P2|Overall Study|Adverse Event|1
3085831|NCT00384397|10586299|P1|Overall Study|Adverse Event|0
3085832|NCT00384332|10586318|P2|Overall Study|Lost to Follow-up|0
3085833|NCT00384332|10586319|P1|Overall Study|Lost to Follow-up|4
3085834|NCT00384293|10586329|P3|Post-randomization Period|Patient Randomized in Error|1
3085835|NCT00384293|10586330|P2|Post-randomization Period|Patient Randomized in Error|0
3085836|NCT00384293|10586331|P1|Post-randomization Period|Patient Randomized in Error|0
3085837|NCT00384293|10586329|P3|Post-randomization Period|Trial Termination|204
3085838|NCT00384293|10586330|P2|Post-randomization Period|Trial Termination|180
3085839|NCT00384293|10586331|P1|Post-randomization Period|Trial Termination|0
3085840|NCT00384293|10586329|P3|Post-randomization Period|Withdrawal by Subject|6
3085841|NCT00384293|10586330|P2|Post-randomization Period|Withdrawal by Subject|8
3085842|NCT00384293|10586331|P1|Post-randomization Period|Withdrawal by Subject|0
3085843|NCT00384293|10586329|P3|Post-randomization Period|Protocol Violation|0
3085844|NCT00384293|10586330|P2|Post-randomization Period|Protocol Violation|1
3085845|NCT00384293|10586331|P1|Post-randomization Period|Protocol Violation|0
3085846|NCT00384293|10586329|P3|Post-randomization Period|Lost to Follow-up|1
3085847|NCT00384293|10586330|P2|Post-randomization Period|Lost to Follow-up|2
3085848|NCT00384293|10586331|P1|Post-randomization Period|Lost to Follow-up|0
3085849|NCT00384293|10586329|P3|Post-randomization Period|Adverse Event|7
3085850|NCT00384293|10586330|P2|Post-randomization Period|Adverse Event|23
3085851|NCT00384293|10586331|P1|Post-randomization Period|Adverse Event|0
3085852|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
3085853|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
3085854|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
3085855|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
3085856|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
3085857|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
3085858|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
3085859|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
3085860|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
3085861|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
3085862|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
3085863|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
3085864|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
3085865|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
3085866|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
3085867|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
3085868|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
3085869|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
3085870|NCT00384293|10586329|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
3085871|NCT00384293|10586330|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
3085872|NCT00384293|10586331|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
3085873|NCT00384189|10586355|P4|Overall Study|Reason Not Specified|40
3085874|NCT00384189|10586356|P3|Overall Study|Reason Not Specified|58
3085875|NCT00384189|10586357|P2|Overall Study|Reason Not Specified|57
3085876|NCT00384189|10586358|P1|Overall Study|Reason Not Specified|50
3085877|NCT00384176|10586419|P3|Overall Study|Liver metastases, colon resec. planned|0
3085878|NCT00384176|10586420|P2|Overall Study|Liver metastases, colon resec. planned|0
3085879|NCT00384176|10586421|P1|Overall Study|Liver metastases, colon resec. planned|1
3085880|NCT00384176|10586419|P3|Overall Study|Physician Decision|0
3085881|NCT00384176|10586420|P2|Overall Study|Physician Decision|2
3085882|NCT00384176|10586421|P1|Overall Study|Physician Decision|0
3085883|NCT00384176|10586419|P3|Overall Study|Did not receive study treatment|1
3085884|NCT00384176|10586420|P2|Overall Study|Did not receive study treatment|1
3085885|NCT00384176|10586421|P1|Overall Study|Did not receive study treatment|0
3085886|NCT00384176|10586419|P3|Overall Study|Toxicity of treatment|0
3085887|NCT00384176|10586420|P2|Overall Study|Toxicity of treatment|0
3085888|NCT00384176|10586421|P1|Overall Study|Toxicity of treatment|1
3085889|NCT00384176|10586419|P3|Overall Study|Longer QTC as Visit 1|0
3085890|NCT00384176|10586420|P2|Overall Study|Longer QTC as Visit 1|0
3085891|NCT00384176|10586421|P1|Overall Study|Longer QTC as Visit 1|1
3085892|NCT00384176|10586419|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
3085893|NCT00384176|10586420|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
3085894|NCT00384176|10586421|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
3085895|NCT00384176|10586419|P3|Overall Study|Lost to Follow-up|4
3085896|NCT00384176|10586420|P2|Overall Study|Lost to Follow-up|18
3085897|NCT00384176|10586421|P1|Overall Study|Lost to Follow-up|16
3085898|NCT00384176|10586419|P3|Overall Study|Withdrawal by Subject|22
3085899|NCT00384176|10586420|P2|Overall Study|Withdrawal by Subject|48
3085900|NCT00384176|10586421|P1|Overall Study|Withdrawal by Subject|52
3085901|NCT00384176|10586419|P3|Overall Study|Death|105
3085902|NCT00384176|10586420|P2|Overall Study|Death|247
3085903|NCT00384176|10586421|P1|Overall Study|Death|239
3085904|NCT00384085|10586447|P3|Overall Study|Patient required surgery|0
3085905|NCT00384085|10586448|P2|Overall Study|Patient required surgery|1
3085906|NCT00384085|10586449|P1|Overall Study|Patient required surgery|0
3085907|NCT00384085|10586447|P3|Overall Study|Patient moved|1
3085908|NCT00384085|10586448|P2|Overall Study|Patient moved|0
3085909|NCT00384085|10586449|P1|Overall Study|Patient moved|1
3085910|NCT00384085|10586447|P3|Overall Study|Sponsor decision|1
3085911|NCT00384085|10586448|P2|Overall Study|Sponsor decision|2
3085912|NCT00384085|10586449|P1|Overall Study|Sponsor decision|1
3085913|NCT00384085|10586447|P3|Overall Study|Loss of site personnel|1
3085914|NCT00384085|10586448|P2|Overall Study|Loss of site personnel|0
3085915|NCT00384085|10586449|P1|Overall Study|Loss of site personnel|1
3085916|NCT00384085|10586447|P3|Overall Study|Physician Decision|0
3085917|NCT00384085|10586448|P2|Overall Study|Physician Decision|0
3085918|NCT00384085|10586449|P1|Overall Study|Physician Decision|1
3085919|NCT00384085|10586447|P3|Overall Study|Patient non-compliant|5
3085920|NCT00384085|10586448|P2|Overall Study|Patient non-compliant|4
3085921|NCT00384085|10586449|P1|Overall Study|Patient non-compliant|4
3085922|NCT00384085|10586447|P3|Overall Study|Withdrawal by Subject|29
3085923|NCT00384085|10586448|P2|Overall Study|Withdrawal by Subject|19
3085924|NCT00384085|10586449|P1|Overall Study|Withdrawal by Subject|14
3085925|NCT00384085|10586447|P3|Overall Study|Progressive Disease|0
3085926|NCT00384085|10586448|P2|Overall Study|Progressive Disease|1
3085927|NCT00384085|10586449|P1|Overall Study|Progressive Disease|0
3085928|NCT00384085|10586447|P3|Overall Study|Lost to Follow-up|10
3085929|NCT00384085|10586448|P2|Overall Study|Lost to Follow-up|9
3085930|NCT00384085|10586449|P1|Overall Study|Lost to Follow-up|9
3085931|NCT00384085|10586447|P3|Overall Study|Protocol Violation|2
3085932|NCT00384085|10586448|P2|Overall Study|Protocol Violation|2
3085933|NCT00384085|10586449|P1|Overall Study|Protocol Violation|2
3085934|NCT00384085|10586447|P3|Overall Study|No longer Requires Study Treatment|1
3085935|NCT00384085|10586448|P2|Overall Study|No longer Requires Study Treatment|0
3085936|NCT00384085|10586449|P1|Overall Study|No longer Requires Study Treatment|1
3085937|NCT00384085|10586447|P3|Overall Study|Lack of Efficacy|2
3085938|NCT00384085|10586448|P2|Overall Study|Lack of Efficacy|3
3085939|NCT00384085|10586449|P1|Overall Study|Lack of Efficacy|0
3085940|NCT00384085|10586447|P3|Overall Study|Adverse Event|4
3085941|NCT00384085|10586448|P2|Overall Study|Adverse Event|5
3085942|NCT00384085|10586449|P1|Overall Study|Adverse Event|5
3085943|NCT00384059|10586475|P2|Toddler Dose|Failed to return|1
3085944|NCT00384059|10586476|P1|Toddler Dose|Failed to return|0
3085945|NCT00384059|10586475|P2|Toddler Dose|Lost to Follow-up|1
3085946|NCT00384059|10586476|P1|Toddler Dose|Lost to Follow-up|1
3085947|NCT00384059|10586475|P2|After Infant Series|Lost to Follow-up|1
3085948|NCT00384059|10586476|P1|After Infant Series|Lost to Follow-up|0
3085949|NCT00384059|10586475|P2|After Infant Series|Physician Decision|1
3085950|NCT00384059|10586476|P1|After Infant Series|Physician Decision|0
3085951|NCT00384059|10586475|P2|After Infant Series|Adverse Event|1
3085952|NCT00384059|10586476|P1|After Infant Series|Adverse Event|0
3085953|NCT00384059|10586475|P2|After Infant Series|Failed to Return|2
3085954|NCT00384059|10586476|P1|After Infant Series|Failed to Return|0
3085955|NCT00384059|10586475|P2|After Infant Series|Withdrawal by Subject|2
3085956|NCT00384059|10586476|P1|After Infant Series|Withdrawal by Subject|2
3085957|NCT00384059|10586475|P2|After Infant Series|Protocol Violation|3
3085958|NCT00384059|10586476|P1|After Infant Series|Protocol Violation|2
3085959|NCT00384059|10586475|P2|Infant Series|Lost to Follow-up|1
3085960|NCT00384059|10586476|P1|Infant Series|Lost to Follow-up|0
3085961|NCT00384059|10586475|P2|Infant Series|Protocol Violation|2
3085962|NCT00384059|10586476|P1|Infant Series|Protocol Violation|1
3085963|NCT00384059|10586475|P2|Infant Series|Adverse Event|2
3085964|NCT00384059|10586476|P1|Infant Series|Adverse Event|1
3085965|NCT00384059|10586475|P2|Infant Series|Withdrawal by Subject|2
3085966|NCT00384059|10586476|P1|Infant Series|Withdrawal by Subject|2
3085967|NCT00384059|10586475|P2|Infant Series|Not consented|6
3085968|NCT00384059|10586476|P1|Infant Series|Not consented|2
3085969|NCT00384033|10586526|P4|Overall Study|Randomized but not treated|2
3085970|NCT00384033|10586527|P3|Overall Study|Randomized but not treated|10
3085971|NCT00384033|10586528|P2|Overall Study|Randomized but not treated|7
3085972|NCT00384033|10586529|P1|Overall Study|Randomized but not treated|3
3085973|NCT00384033|10586526|P4|Overall Study|Lack of Efficacy|1
3085974|NCT00384033|10586527|P3|Overall Study|Lack of Efficacy|3
3085975|NCT00384033|10586528|P2|Overall Study|Lack of Efficacy|3
3085976|NCT00384033|10586529|P1|Overall Study|Lack of Efficacy|7
3085977|NCT00384033|10586526|P4|Overall Study|Withdrawal by Subject|2
3085978|NCT00384033|10586527|P3|Overall Study|Withdrawal by Subject|5
3085979|NCT00384033|10586528|P2|Overall Study|Withdrawal by Subject|2
3085980|NCT00384033|10586529|P1|Overall Study|Withdrawal by Subject|6
3085981|NCT00384033|10586526|P4|Overall Study|Protocol Violation|6
3085982|NCT00384033|10586527|P3|Overall Study|Protocol Violation|5
3085983|NCT00384033|10586528|P2|Overall Study|Protocol Violation|0
3085984|NCT00384033|10586529|P1|Overall Study|Protocol Violation|5
3085985|NCT00384033|10586526|P4|Overall Study|Other|0
3085986|NCT00384033|10586527|P3|Overall Study|Other|0
3085987|NCT00384033|10586528|P2|Overall Study|Other|0
3085988|NCT00384033|10586529|P1|Overall Study|Other|2
3085989|NCT00384033|10586526|P4|Overall Study|Lost to Follow-up|7
3085990|NCT00384033|10586527|P3|Overall Study|Lost to Follow-up|7
3085991|NCT00384033|10586528|P2|Overall Study|Lost to Follow-up|12
3085992|NCT00384033|10586529|P1|Overall Study|Lost to Follow-up|6
3085993|NCT00384033|10586526|P4|Overall Study|Physician Decision|0
3085994|NCT00384033|10586527|P3|Overall Study|Physician Decision|0
3085995|NCT00384033|10586528|P2|Overall Study|Physician Decision|0
3085996|NCT00384033|10586529|P1|Overall Study|Physician Decision|1
3085997|NCT00384033|10586526|P4|Overall Study|Failed to return|2
3085998|NCT00384033|10586527|P3|Overall Study|Failed to return|2
3085999|NCT00384033|10586528|P2|Overall Study|Failed to return|3
3086000|NCT00384033|10586529|P1|Overall Study|Failed to return|1
3086001|NCT00384033|10586526|P4|Overall Study|Adverse Event|20
3086002|NCT00384033|10586527|P3|Overall Study|Adverse Event|11
3086003|NCT00384033|10586528|P2|Overall Study|Adverse Event|8
3086004|NCT00384033|10586529|P1|Overall Study|Adverse Event|10
3086005|NCT00383786|10586582|P2|Overall Study|Physician Decision|1
3086006|NCT00383786|10586583|P1|Overall Study|Physician Decision|0
3086007|NCT00383786|10586582|P2|Overall Study|Withdrawal by Subject|5
3086008|NCT00383786|10586583|P1|Overall Study|Withdrawal by Subject|2
3086009|NCT00383786|10586582|P2|Overall Study|Protocol Violation|6
3086010|NCT00383786|10586583|P1|Overall Study|Protocol Violation|2
3086011|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Administrative|0
3086012|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Administrative|1
3086013|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Administrative|3
3086014|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Administrative|2
3086015|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Administrative|1
3086016|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
3086017|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
3086018|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
3086019|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
3086020|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
3086021|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
3086022|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
3086023|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
3086024|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
3086025|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
3086026|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
3086027|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086028|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086029|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086030|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086031|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
3086032|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
3086033|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
3086034|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
3086035|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
3086036|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
3086037|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
3086038|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
3086039|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
3086040|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
3086041|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
3086042|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
3086043|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
3086044|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
3086045|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
3086046|NCT00383721|10586633|P5|26-Week Treatment Safety Extension|Adverse Event|0
3086047|NCT00383721|10586634|P4|26-Week Treatment Safety Extension|Adverse Event|1
3086048|NCT00383721|10586635|P3|26-Week Treatment Safety Extension|Adverse Event|10
3086049|NCT00383721|10586636|P2|26-Week Treatment Safety Extension|Adverse Event|7
3086050|NCT00383721|10586637|P1|26-Week Treatment Safety Extension|Adverse Event|6
3086051|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Ongoing|0
3086052|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Ongoing|0
3086053|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Ongoing|0
3086054|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Ongoing|0
3086055|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Ongoing|1
3086056|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Administrative|3
3086057|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Administrative|3
3086058|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Administrative|3
3086059|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Administrative|3
3086060|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Administrative|1
3086061|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
3086062|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
3086063|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
3086064|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
3086065|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
3086066|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
3086067|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
3086068|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
3086069|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
3086070|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
3086071|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
3086072|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
3086073|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
3086074|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
3086075|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
3086076|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
3086077|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
3086078|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
3086079|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
3086080|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
3086081|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
3086082|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
3086083|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
3086084|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
3086085|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
3086086|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
3086087|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
3086088|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
3086089|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
3086090|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
3086091|NCT00383721|10586633|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
3086092|NCT00383721|10586634|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
3086093|NCT00383721|10586635|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
3086094|NCT00383721|10586636|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
3086095|NCT00383721|10586637|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
3086096|NCT00383708|10586674|P1|Co-administration Period|Adverse Event|5
3086097|NCT00383708|10586674|P1|Run-in Period|Claustrophobia|1
3086098|NCT00383708|10586674|P1|Run-in Period|Adverse Event|2
3086099|NCT00383708|10586674|P1|Run-in Period|Protocol Violation|4
3086100|NCT00383708|10586674|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
3086101|NCT00383708|10586674|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
3086102|NCT00383552|10586749|P4|Overall Study|Administrative|1
3086103|NCT00383552|10586750|P3|Overall Study|Administrative|1
3086104|NCT00383552|10586751|P2|Overall Study|Administrative|0
3086105|NCT00383552|10586752|P1|Overall Study|Administrative|1
3086106|NCT00383552|10586749|P4|Overall Study|Did not meet protocol eligibility|3
3086107|NCT00383552|10586750|P3|Overall Study|Did not meet protocol eligibility|2
3086108|NCT00383552|10586751|P2|Overall Study|Did not meet protocol eligibility|6
3086109|NCT00383552|10586752|P1|Overall Study|Did not meet protocol eligibility|8
3086110|NCT00383552|10586749|P4|Overall Study|Noncompliance with the protocol|10
3086111|NCT00383552|10586750|P3|Overall Study|Noncompliance with the protocol|8
3086112|NCT00383552|10586751|P2|Overall Study|Noncompliance with the protocol|6
3086113|NCT00383552|10586752|P1|Overall Study|Noncompliance with the protocol|11
3086114|NCT00383552|10586749|P4|Overall Study|Did not wish to continue (related)|3
3086115|NCT00383552|10586750|P3|Overall Study|Did not wish to continue (related)|2
3086116|NCT00383552|10586751|P2|Overall Study|Did not wish to continue (related)|0
3086117|NCT00383552|10586752|P1|Overall Study|Did not wish to continue (related)|1
3086118|NCT00383552|10586749|P4|Overall Study|Did not wish to continue (unrelated)|6
3086119|NCT00383552|10586750|P3|Overall Study|Did not wish to continue (unrelated)|5
3086120|NCT00383552|10586751|P2|Overall Study|Did not wish to continue (unrelated)|9
3086121|NCT00383552|10586752|P1|Overall Study|Did not wish to continue (unrelated)|4
3086122|NCT00383552|10586749|P4|Overall Study|Lost to Follow-up|1
3086123|NCT00383552|10586750|P3|Overall Study|Lost to Follow-up|5
3086124|NCT00383552|10586751|P2|Overall Study|Lost to Follow-up|1
3086125|NCT00383552|10586752|P1|Overall Study|Lost to Follow-up|0
3086126|NCT00383552|10586749|P4|Overall Study|Lack of Efficacy|42
3086127|NCT00383552|10586750|P3|Overall Study|Lack of Efficacy|29
3086128|NCT00383552|10586751|P2|Overall Study|Lack of Efficacy|13
3086129|NCT00383552|10586752|P1|Overall Study|Lack of Efficacy|4
3086130|NCT00383552|10586749|P4|Overall Study|Adverse Event|6
3086131|NCT00383552|10586750|P3|Overall Study|Adverse Event|9
3086132|NCT00383552|10586751|P2|Overall Study|Adverse Event|6
3086133|NCT00383552|10586752|P1|Overall Study|Adverse Event|7
3086134|NCT00383500|10586794|P3|Overall Study|Lost to Follow-up|2
3086135|NCT00383500|10586795|P2|Overall Study|Lost to Follow-up|0
3086136|NCT00383500|10586796|P1|Overall Study|Lost to Follow-up|0
3086137|NCT00383500|10586794|P3|Overall Study|Withdrawal by Subject|0
3086138|NCT00383500|10586795|P2|Overall Study|Withdrawal by Subject|3
3086139|NCT00383500|10586796|P1|Overall Study|Withdrawal by Subject|8
3086140|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Administrative|0
3086141|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Administrative|1
3086142|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Administrative|0
3086143|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Administrative|1
3086144|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Administrative|1
3086145|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
3086146|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
3086147|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
3086299|NCT00383123|10587022|P2|Overall Study|Protocol Violation|1
3086148|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
3086149|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
3086150|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
3086151|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
3086152|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
3086153|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
3086154|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
3086155|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086156|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
3086157|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
3086158|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
3086159|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
3086160|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
3086161|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
3086162|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
3086163|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
3086164|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
3086165|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
3086166|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
3086167|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
3086168|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
3086169|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
3086170|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
3086171|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
3086172|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
3086173|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
3086174|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
3086175|NCT00383435|10586820|P5|26-Week Treatment Safety Extension|Adverse Event|1
3086176|NCT00383435|10586821|P4|26-Week Treatment Safety Extension|Adverse Event|5
3086177|NCT00383435|10586822|P3|26-Week Treatment Safety Extension|Adverse Event|5
3086178|NCT00383435|10586823|P2|26-Week Treatment Safety Extension|Adverse Event|2
3086179|NCT00383435|10586824|P1|26-Week Treatment Safety Extension|Adverse Event|4
3086180|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Administrative|1
3086181|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Administrative|1
3086182|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Administrative|1
3086183|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Administrative|3
3086184|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Administrative|5
3086185|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
3086186|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
3086187|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
3086188|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
3086189|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
3086190|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
3086191|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
3086192|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
3086193|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
3086194|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
3086195|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
3086196|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
3086197|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
3086198|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
3086199|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
3086200|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
3086201|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
3086202|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
3086203|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
3086204|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
3086205|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
3086206|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
3086207|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
3086208|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
3086209|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
3086210|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
3086211|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
3086212|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
3086213|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
3086214|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
3086215|NCT00383435|10586820|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
3086216|NCT00383435|10586821|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
3086217|NCT00383435|10586822|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
3086218|NCT00383435|10586823|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
3086219|NCT00383435|10586824|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
3086220|NCT00383331|10586863|P2|Overall Study|Protocol Violation|1
3086221|NCT00383331|10586864|P1|Overall Study|Protocol Violation|0
3086222|NCT00383292|10586883|P3|Overall Study|Other|0
3086223|NCT00383292|10586884|P2|Overall Study|Other|0
3086224|NCT00383292|10586885|P1|Overall Study|Other|1
3086225|NCT00383292|10586883|P3|Overall Study|Withdrawal by Subject|2
3086226|NCT00383292|10586884|P2|Overall Study|Withdrawal by Subject|2
3086227|NCT00383292|10586885|P1|Overall Study|Withdrawal by Subject|3
3086228|NCT00383292|10586883|P3|Overall Study|Physician Decision|1
3086229|NCT00383292|10586884|P2|Overall Study|Physician Decision|0
3086230|NCT00383292|10586885|P1|Overall Study|Physician Decision|4
3086231|NCT00383292|10586883|P3|Overall Study|Death|3
3086232|NCT00383292|10586884|P2|Overall Study|Death|3
3086233|NCT00383292|10586885|P1|Overall Study|Death|3
3086234|NCT00383292|10586883|P3|Overall Study|Adverse Event|2
3086235|NCT00383292|10586884|P2|Overall Study|Adverse Event|1
3086236|NCT00383292|10586885|P1|Overall Study|Adverse Event|4
3086237|NCT00383240|10586926|P4|Overall Study|Administrative|0
3086238|NCT00383240|10586927|P3|Overall Study|Administrative|0
3086239|NCT00383240|10586928|P2|Overall Study|Administrative|1
3086240|NCT00383240|10586929|P1|Overall Study|Administrative|1
3086241|NCT00383240|10586926|P4|Overall Study|Did not meet protocol eligibility|3
3086242|NCT00383240|10586927|P3|Overall Study|Did not meet protocol eligibility|9
3086243|NCT00383240|10586928|P2|Overall Study|Did not meet protocol eligibility|4
3086244|NCT00383240|10586929|P1|Overall Study|Did not meet protocol eligibility|9
3086245|NCT00383240|10586926|P4|Overall Study|Protocol Violation|6
3086246|NCT00383240|10586927|P3|Overall Study|Protocol Violation|9
3086247|NCT00383240|10586928|P2|Overall Study|Protocol Violation|5
3086248|NCT00383240|10586929|P1|Overall Study|Protocol Violation|4
3086249|NCT00383240|10586926|P4|Overall Study|Withdrawal by subjects, reasons related|5
3086250|NCT00383240|10586927|P3|Overall Study|Withdrawal by subjects, reasons related|3
3086251|NCT00383240|10586928|P2|Overall Study|Withdrawal by subjects, reasons related|1
3086252|NCT00383240|10586929|P1|Overall Study|Withdrawal by subjects, reasons related|0
3086253|NCT00383240|10586926|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
3086254|NCT00383240|10586927|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
3086255|NCT00383240|10586928|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
3086256|NCT00383240|10586929|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
3086257|NCT00383240|10586926|P4|Overall Study|Lost to Follow-up|2
3086258|NCT00383240|10586927|P3|Overall Study|Lost to Follow-up|0
3086259|NCT00383240|10586928|P2|Overall Study|Lost to Follow-up|0
3086260|NCT00383240|10586929|P1|Overall Study|Lost to Follow-up|3
3086261|NCT00383240|10586926|P4|Overall Study|Treatment Failure|46
3086262|NCT00383240|10586927|P3|Overall Study|Treatment Failure|47
3086263|NCT00383240|10586928|P2|Overall Study|Treatment Failure|13
3086264|NCT00383240|10586929|P1|Overall Study|Treatment Failure|8
3086265|NCT00383240|10586926|P4|Overall Study|Adverse Event|7
3086266|NCT00383240|10586927|P3|Overall Study|Adverse Event|9
3086267|NCT00383240|10586928|P2|Overall Study|Adverse Event|6
3086268|NCT00383240|10586929|P1|Overall Study|Adverse Event|4
3086269|NCT00383162|10586960|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
3086270|NCT00383162|10586961|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
3086271|NCT00383162|10586960|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
3086272|NCT00383162|10586961|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
3086273|NCT00383162|10586960|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
3086274|NCT00383162|10586961|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
3086275|NCT00383162|10586960|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
3086276|NCT00383162|10586961|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
3086277|NCT00383162|10586960|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
3086278|NCT00383162|10586961|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
3086279|NCT00383162|10586960|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
3086280|NCT00383162|10586961|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
3086281|NCT00383162|10586960|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
3086282|NCT00383162|10586961|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
3086283|NCT00383162|10586960|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
3086284|NCT00383162|10586961|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
3086285|NCT00383162|10586960|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
3086286|NCT00383162|10586961|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
3086287|NCT00383149|10587003|P1|Overall Study|Participant Withdrew Consent|1
3086288|NCT00383149|10587003|P1|Overall Study|Request to Discontinue Treatment|4
3086289|NCT00383149|10587003|P1|Overall Study|Study Drug Toxicity|4
3086290|NCT00383149|10587003|P1|Overall Study|Other|1
3086291|NCT00383149|10587003|P1|Overall Study|Lost to Follow-up|1
3086292|NCT00383149|10587003|P1|Overall Study|Disease Progression|38
3086293|NCT00383149|10587003|P1|Overall Study|Death|2
3086294|NCT00383149|10587003|P1|Overall Study|Adverse Event not Related to Study Drug|3
3086295|NCT00383123|10587022|P2|Overall Study|Other reason|6
3086296|NCT00383123|10587023|P1|Overall Study|Other reason|10
3086297|NCT00383123|10587022|P2|Overall Study|Withdrawal by Subject|18
3086298|NCT00383123|10587023|P1|Overall Study|Withdrawal by Subject|27
3086300|NCT00383123|10587023|P1|Overall Study|Protocol Violation|5
3086301|NCT00383123|10587022|P2|Overall Study|Lost to Follow-up|61
3086302|NCT00383123|10587023|P1|Overall Study|Lost to Follow-up|68
3086303|NCT00383123|10587022|P2|Overall Study|Adverse Event|0
3086304|NCT00383123|10587023|P1|Overall Study|Adverse Event|1
3086305|NCT00383084|10587064|P2|Overall Study|Withdrawal by Subject|10
3086306|NCT00383084|10587065|P1|Overall Study|Withdrawal by Subject|12
3086307|NCT00383019|10587096|P2|Overall Study|Withdrawal by Subject|1
3086308|NCT00383019|10587097|P1|Overall Study|Withdrawal by Subject|0
3086309|NCT00383019|10587096|P2|Overall Study|Adverse Event|1
3086310|NCT00383019|10587097|P1|Overall Study|Adverse Event|5
3086311|NCT00382993|10587119|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
3086312|NCT00382993|10587120|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
3086313|NCT00382993|10587119|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
3086314|NCT00382993|10587120|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
3086315|NCT00382993|10587119|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
3086316|NCT00382993|10587120|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
3086317|NCT00382993|10587119|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
3086318|NCT00382993|10587120|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
3086319|NCT00382993|10587119|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
3086320|NCT00382993|10587120|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
3086321|NCT00382993|10587119|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
3086322|NCT00382993|10587120|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
3086323|NCT00382993|10587119|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
3086324|NCT00382993|10587120|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
3086325|NCT00382993|10587119|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
3086326|NCT00382993|10587120|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
3086327|NCT00382993|10587119|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
3086328|NCT00382993|10587120|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
3086329|NCT00382993|10587119|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
3086330|NCT00382993|10587120|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
3086331|NCT00382967|10587164|P2|Overall Study|Protocol Violation|1
3086332|NCT00382967|10587165|P1|Overall Study|Protocol Violation|1
3086333|NCT00382863|10587190|P2|Overall Study|Withdrawal by Subject|25
3086334|NCT00382863|10587191|P1|Overall Study|Withdrawal by Subject|5
3086335|NCT00382863|10587190|P2|Overall Study|Lost to Follow-up|2
3086336|NCT00382863|10587191|P1|Overall Study|Lost to Follow-up|1
3086337|NCT00382863|10587190|P2|Overall Study|Death|9
3086338|NCT00382863|10587191|P1|Overall Study|Death|9
3086339|NCT00382733|10587275|P5|Overall Study|Withdrawal by Subject|0
3086340|NCT00382733|10587276|P4|Overall Study|Withdrawal by Subject|0
3086341|NCT00382733|10587277|P3|Overall Study|Withdrawal by Subject|0
3086342|NCT00382733|10587278|P2|Overall Study|Withdrawal by Subject|1
3086343|NCT00382733|10587279|P1|Overall Study|Withdrawal by Subject|0
3086344|NCT00382720|10587300|P3|Overall Study|Discontinued at end of study|2
3086345|NCT00382720|10587301|P2|Overall Study|Discontinued at end of study|1
3086346|NCT00382720|10587302|P1|Overall Study|Discontinued at end of study|0
3086347|NCT00382720|10587300|P3|Overall Study|Investigator/Clinical decision|6
3086348|NCT00382720|10587301|P2|Overall Study|Investigator/Clinical decision|6
3086349|NCT00382720|10587302|P1|Overall Study|Investigator/Clinical decision|5
3086350|NCT00382720|10587300|P3|Overall Study|Good prognosis|0
3086351|NCT00382720|10587301|P2|Overall Study|Good prognosis|1
3086352|NCT00382720|10587302|P1|Overall Study|Good prognosis|0
3086353|NCT00382720|10587300|P3|Overall Study|Clinically progressive disease|0
3086354|NCT00382720|10587301|P2|Overall Study|Clinically progressive disease|1
3086355|NCT00382720|10587302|P1|Overall Study|Clinically progressive disease|0
3086356|NCT00382720|10587300|P3|Overall Study|Patient did not receive study medication|4
3086357|NCT00382720|10587301|P2|Overall Study|Patient did not receive study medication|1
3086358|NCT00382720|10587302|P1|Overall Study|Patient did not receive study medication|1
3086359|NCT00382720|10587300|P3|Overall Study|Surgery|4
3086360|NCT00382720|10587301|P2|Overall Study|Surgery|1
3086361|NCT00382720|10587302|P1|Overall Study|Surgery|1
3086362|NCT00382720|10587300|P3|Overall Study|Withdrawal by Subject|12
3086363|NCT00382720|10587301|P2|Overall Study|Withdrawal by Subject|20
3086364|NCT00382720|10587302|P1|Overall Study|Withdrawal by Subject|11
3086365|NCT00382720|10587300|P3|Overall Study|Withdrew consent|2
3086366|NCT00382720|10587301|P2|Overall Study|Withdrew consent|1
3086367|NCT00382720|10587302|P1|Overall Study|Withdrew consent|1
3086368|NCT00382720|10587300|P3|Overall Study|Progressive disease|38
3086369|NCT00382720|10587301|P2|Overall Study|Progressive disease|28
3086370|NCT00382720|10587302|P1|Overall Study|Progressive disease|37
3086371|NCT00382720|10587300|P3|Overall Study|Death|2
3086372|NCT00382720|10587301|P2|Overall Study|Death|1
3086373|NCT00382720|10587302|P1|Overall Study|Death|0
3086374|NCT00382720|10587300|P3|Overall Study|Protocol Violation|1
3086375|NCT00382720|10587301|P2|Overall Study|Protocol Violation|5
3086376|NCT00382720|10587302|P1|Overall Study|Protocol Violation|2
3086377|NCT00382720|10587300|P3|Overall Study|Adverse Event|15
3086378|NCT00382720|10587301|P2|Overall Study|Adverse Event|23
3086379|NCT00382720|10587302|P1|Overall Study|Adverse Event|21
3086380|NCT00382408|10587327|P2|Overall Study|Other|35
3086381|NCT00382408|10587328|P1|Overall Study|Other|100
3086382|NCT00382408|10587327|P2|Overall Study|Lost to Follow-up|8
3086383|NCT00382408|10587328|P1|Overall Study|Lost to Follow-up|19
3086384|NCT00382408|10587327|P2|Overall Study|Pregnancy|0
3086385|NCT00382408|10587328|P1|Overall Study|Pregnancy|2
3086386|NCT00382408|10587327|P2|Overall Study|Withdrawal by Subject|6
3086387|NCT00382408|10587328|P1|Overall Study|Withdrawal by Subject|17
3086388|NCT00382408|10587327|P2|Overall Study|Physician Decision|0
3086389|NCT00382408|10587328|P1|Overall Study|Physician Decision|1
3086390|NCT00382408|10587327|P2|Overall Study|Protocol Violation|2
3086391|NCT00382408|10587328|P1|Overall Study|Protocol Violation|2
3086392|NCT00382408|10587327|P2|Overall Study|Did not meet protocol requirement|3
3086393|NCT00382408|10587328|P1|Overall Study|Did not meet protocol requirement|3
3086394|NCT00382291|10587355|P3|Overall Study|Lack of Efficacy|1
3086395|NCT00382291|10587356|P2|Overall Study|Lack of Efficacy|0
3086396|NCT00382291|10587357|P1|Overall Study|Lack of Efficacy|0
3086397|NCT00382291|10587355|P3|Overall Study|Physician Decision|0
3086398|NCT00382291|10587356|P2|Overall Study|Physician Decision|1
3086399|NCT00382291|10587357|P1|Overall Study|Physician Decision|0
3086400|NCT00382291|10587355|P3|Overall Study|Withdrawal by Subject|0
3086401|NCT00382291|10587356|P2|Overall Study|Withdrawal by Subject|2
3086402|NCT00382291|10587357|P1|Overall Study|Withdrawal by Subject|0
3086403|NCT00382291|10587355|P3|Overall Study|Temporary study suspension|5
3086404|NCT00382291|10587356|P2|Overall Study|Temporary study suspension|2
3086405|NCT00382291|10587357|P1|Overall Study|Temporary study suspension|2
3086406|NCT00382291|10587355|P3|Overall Study|Protocol Violation|0
3086407|NCT00382291|10587356|P2|Overall Study|Protocol Violation|0
3086408|NCT00382291|10587357|P1|Overall Study|Protocol Violation|1
3086409|NCT00382291|10587355|P3|Overall Study|Adverse Event|2
3086410|NCT00382291|10587356|P2|Overall Study|Adverse Event|2
3086411|NCT00382291|10587357|P1|Overall Study|Adverse Event|1
3086412|NCT00382174|10587389|P3|Overall Study|Wounds merged|2
3086413|NCT00382174|10587390|P2|Overall Study|Wounds merged|2
3086414|NCT00382174|10587391|P1|Overall Study|Wounds merged|0
3086415|NCT00382174|10587389|P3|Overall Study|Failed to meet criteria|1
3086416|NCT00382174|10587390|P2|Overall Study|Failed to meet criteria|1
3086417|NCT00382174|10587391|P1|Overall Study|Failed to meet criteria|0
3086418|NCT00382174|10587389|P3|Overall Study|Physician Decision|2
3086419|NCT00382174|10587390|P2|Overall Study|Physician Decision|2
3086420|NCT00382174|10587391|P1|Overall Study|Physician Decision|0
3086421|NCT00382174|10587389|P3|Overall Study|Non compliance|1
3086422|NCT00382174|10587390|P2|Overall Study|Non compliance|0
3086423|NCT00382174|10587391|P1|Overall Study|Non compliance|1
3086424|NCT00382174|10587389|P3|Overall Study|Withdrawal by Subject|5
3086425|NCT00382174|10587390|P2|Overall Study|Withdrawal by Subject|4
3086426|NCT00382174|10587391|P1|Overall Study|Withdrawal by Subject|1
3086427|NCT00382174|10587389|P3|Overall Study|Adverse Event|5
3086428|NCT00382174|10587390|P2|Overall Study|Adverse Event|4
3086429|NCT00382174|10587391|P1|Overall Study|Adverse Event|1
3086430|NCT00382174|10587389|P3|Overall Study|Lost to Follow-up|5
3086431|NCT00382174|10587390|P2|Overall Study|Lost to Follow-up|4
3086432|NCT00382174|10587391|P1|Overall Study|Lost to Follow-up|1
3086433|NCT00382109|10587419|P2|Overall Study|consent withdrawal|1
3086434|NCT00382109|10587420|P1|Overall Study|consent withdrawal|0
3086435|NCT00382109|10587419|P2|Overall Study|Other|2
3086436|NCT00382109|10587420|P1|Overall Study|Other|0
3086437|NCT00382109|10587419|P2|Overall Study|ineligible|0
3086438|NCT00382109|10587420|P1|Overall Study|ineligible|2
3086439|NCT00382109|10587419|P2|Overall Study|Withdrawal by Subject|0
3086440|NCT00382109|10587420|P1|Overall Study|Withdrawal by Subject|1
3086441|NCT00382109|10587419|P2|Overall Study|Physician Decision|1
3086442|NCT00382109|10587420|P1|Overall Study|Physician Decision|6
3086443|NCT00382109|10587419|P2|Overall Study|Adverse Event|0
3086444|NCT00382109|10587420|P1|Overall Study|Adverse Event|3
3086445|NCT00382018|10587459|P4|Overall Study|Other, not protocol specified|1
3086446|NCT00382018|10587460|P3|Overall Study|Other, not protocol specified|3
3086447|NCT00382018|10587461|P2|Overall Study|Other, not protocol specified|16
3086448|NCT00382018|10587462|P1|Overall Study|Other, not protocol specified|0
3086449|NCT00382018|10587459|P4|Overall Study|Withdrawal by Subject|4
3086450|NCT00382018|10587460|P3|Overall Study|Withdrawal by Subject|3
3086451|NCT00382018|10587461|P2|Overall Study|Withdrawal by Subject|4
3086452|NCT00382018|10587462|P1|Overall Study|Withdrawal by Subject|0
3086453|NCT00382018|10587459|P4|Overall Study|Death|11
3086454|NCT00382018|10587460|P3|Overall Study|Death|7
3086455|NCT00382018|10587461|P2|Overall Study|Death|9
3086456|NCT00382018|10587462|P1|Overall Study|Death|0
3086457|NCT00382018|10587459|P4|Overall Study|Progression|43
3086458|NCT00382018|10587460|P3|Overall Study|Progression|51
3086459|NCT00382018|10587461|P2|Overall Study|Progression|136
3086460|NCT00382018|10587462|P1|Overall Study|Progression|0
3086461|NCT00381940|10587485|P1|Overall Study|Ineligible|1
3086462|NCT00381940|10587485|P1|Overall Study|Protocol Violation|1
3086463|NCT00381940|10587485|P1|Overall Study|Lack of Efficacy|3
3086464|NCT00381888|10587489|P1|Overall Study|Adverse Event|1
3086465|NCT00381888|10587489|P1|Overall Study|Surgery was cancelled|2
3086466|NCT00381888|10587489|P1|Overall Study|Had laparoscopic surgery|2
3086467|NCT00381888|10587489|P1|Overall Study|Protocol Violation|9
3086468|NCT00381888|10587489|P1|Overall Study|Physician Decision|1
3086469|NCT00381888|10587489|P1|Overall Study|Withdrawal by Subject|1
3086470|NCT00381888|10587489|P1|Overall Study|Death|1
3086471|NCT00381849|10587500|P2|Wash Out|Withdrawal by Subject|1
3086472|NCT00381849|10587501|P1|Wash Out|Withdrawal by Subject|0
3086473|NCT00381797|10587528|P5|Overall Study|Ineligible|0
3086474|NCT00381797|10587529|P4|Overall Study|Ineligible|1
3086475|NCT00381797|10587530|P3|Overall Study|Ineligible|0
3086476|NCT00381797|10587531|P2|Overall Study|Ineligible|0
3086477|NCT00381797|10587532|P1|Overall Study|Ineligible|0
3086478|NCT00381797|10587528|P5|Overall Study|Withdrawal by Subject|2
3086479|NCT00381797|10587529|P4|Overall Study|Withdrawal by Subject|0
3086480|NCT00381797|10587530|P3|Overall Study|Withdrawal by Subject|0
3086481|NCT00381797|10587531|P2|Overall Study|Withdrawal by Subject|1
3086482|NCT00381797|10587532|P1|Overall Study|Withdrawal by Subject|1
3086483|NCT00381706|10587607|P3|Overall Study|Never treated|1
3086484|NCT00381706|10587608|P2|Overall Study|Never treated|2
3086485|NCT00381706|10587609|P1|Overall Study|Never treated|7
3086486|NCT00381693|10587632|P1|Overall Study|Progression|2
3086487|NCT00381693|10587632|P1|Overall Study|Patient Choice|1
3086488|NCT00381693|10587632|P1|Overall Study|Adverse Event|4
3086489|NCT00381693|10587632|P1|Overall Study|Death|1
3086490|NCT00381680|10587641|P2|Overall Study|Ineligible|1
3086491|NCT00381680|10587642|P1|Overall Study|Ineligible|3
3086492|NCT00381680|10587641|P2|Overall Study|Other not otherwise specified|2
3086493|NCT00381680|10587642|P1|Overall Study|Other not otherwise specified|7
3086494|NCT00381680|10587641|P2|Overall Study|Progression|1
3086495|NCT00381680|10587642|P1|Overall Study|Progression|1
3086496|NCT00381680|10587641|P2|Overall Study|Induction Failure|1
3086497|NCT00381680|10587642|P1|Overall Study|Induction Failure|4
3086498|NCT00381680|10587641|P2|Overall Study|Relapse|9
3086499|NCT00381680|10587642|P1|Overall Study|Relapse|18
3086500|NCT00381680|10587641|P2|Overall Study|Stem Cell Transplant|10
3086501|NCT00381680|10587642|P1|Overall Study|Stem Cell Transplant|26
3086502|NCT00381680|10587641|P2|Overall Study|Delay initiation|0
3086503|NCT00381680|10587642|P1|Overall Study|Delay initiation|1
3086504|NCT00381680|10587641|P2|Overall Study|Secondary Malignancy|0
3086505|NCT00381680|10587642|P1|Overall Study|Secondary Malignancy|3
3086506|NCT00381680|10587641|P2|Overall Study|Alternative Therapy|5
3086507|NCT00381680|10587642|P1|Overall Study|Alternative Therapy|11
3086508|NCT00381680|10587641|P2|Overall Study|Entry onto another COG Trial|2
3086509|NCT00381680|10587642|P1|Overall Study|Entry onto another COG Trial|1
3086510|NCT00381680|10587641|P2|Overall Study|Withdrawal by Subject|1
3086511|NCT00381680|10587642|P1|Overall Study|Withdrawal by Subject|3
3086512|NCT00381680|10587641|P2|Overall Study|Physician Decision|6
3086513|NCT00381680|10587642|P1|Overall Study|Physician Decision|25
3086514|NCT00381680|10587641|P2|Overall Study|Lost to Follow-up|2
3086515|NCT00381680|10587642|P1|Overall Study|Lost to Follow-up|3
3086516|NCT00381680|10587641|P2|Overall Study|Death|7
3086517|NCT00381680|10587642|P1|Overall Study|Death|10
3086518|NCT00381680|10587641|P2|Overall Study|Adverse Event|3
3086519|NCT00381680|10587642|P1|Overall Study|Adverse Event|9
3086520|NCT00381641|10587659|P2|Overall Study|Withdrawal by Subject|2
3086521|NCT00381641|10587660|P1|Overall Study|Withdrawal by Subject|0
3086522|NCT00381615|10587693|P4|Overall Study|Protocol Violation|0
3086523|NCT00381615|10587694|P3|Overall Study|Protocol Violation|1
3086524|NCT00381615|10587695|P2|Overall Study|Protocol Violation|0
3086525|NCT00381615|10587696|P1|Overall Study|Protocol Violation|0
3086526|NCT00381615|10587693|P4|Overall Study|Lost to Follow-up|1
3086527|NCT00381615|10587694|P3|Overall Study|Lost to Follow-up|0
3086528|NCT00381615|10587695|P2|Overall Study|Lost to Follow-up|2
3086529|NCT00381615|10587696|P1|Overall Study|Lost to Follow-up|3
3086530|NCT00381615|10587693|P4|Overall Study|Withdrawal by Subject|1
3086531|NCT00381615|10587694|P3|Overall Study|Withdrawal by Subject|0
3086532|NCT00381615|10587695|P2|Overall Study|Withdrawal by Subject|3
3086533|NCT00381615|10587696|P1|Overall Study|Withdrawal by Subject|1
3086534|NCT00381563|10587748|P2|Overall Study|Protocol Violation|1
3086535|NCT00381563|10587749|P1|Overall Study|Protocol Violation|0
3086536|NCT00381563|10587748|P2|Overall Study|Lost to Follow-up|0
3086537|NCT00381563|10587749|P1|Overall Study|Lost to Follow-up|2
3086538|NCT00381563|10587748|P2|Overall Study|Withdrawal by Subject|5
3086539|NCT00381563|10587749|P1|Overall Study|Withdrawal by Subject|5
3086540|NCT00381485|10587764|P4|Double-Blind Treatment Period|Administrative|1
3086541|NCT00381485|10587765|P3|Double-Blind Treatment Period|Administrative|0
3086542|NCT00381485|10587766|P2|Double-Blind Treatment Period|Administrative|1
3086543|NCT00381485|10587767|P1|Double-Blind Treatment Period|Administrative|0
3086544|NCT00381485|10587764|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
3086545|NCT00381485|10587765|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
3086546|NCT00381485|10587766|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
3086547|NCT00381485|10587767|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
3086548|NCT00381485|10587764|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
3086549|NCT00381485|10587765|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
3086550|NCT00381485|10587766|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
3086551|NCT00381485|10587767|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
3086552|NCT00381485|10587764|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
3086553|NCT00381485|10587765|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
3086554|NCT00381485|10587766|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
3086555|NCT00381485|10587767|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
3086556|NCT00381485|10587764|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
3086557|NCT00381485|10587765|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
3086637|NCT00381095|10587871|P2|Overall Study|Withdrawal by Subject|3
3086558|NCT00381485|10587766|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
3086559|NCT00381485|10587767|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
3086560|NCT00381485|10587764|P4|Double-Blind Treatment Period|Lost to Follow-up|1
3086561|NCT00381485|10587765|P3|Double-Blind Treatment Period|Lost to Follow-up|1
3086562|NCT00381485|10587766|P2|Double-Blind Treatment Period|Lost to Follow-up|0
3086563|NCT00381485|10587767|P1|Double-Blind Treatment Period|Lost to Follow-up|0
3086564|NCT00381485|10587764|P4|Double-Blind Treatment Period|Lack of Efficacy|13
3086565|NCT00381485|10587765|P3|Double-Blind Treatment Period|Lack of Efficacy|11
3086566|NCT00381485|10587766|P2|Double-Blind Treatment Period|Lack of Efficacy|8
3086567|NCT00381485|10587767|P1|Double-Blind Treatment Period|Lack of Efficacy|0
3086568|NCT00381485|10587764|P4|Double-Blind Treatment Period|Adverse Event|5
3086569|NCT00381485|10587765|P3|Double-Blind Treatment Period|Adverse Event|2
3086570|NCT00381485|10587766|P2|Double-Blind Treatment Period|Adverse Event|2
3086571|NCT00381485|10587767|P1|Double-Blind Treatment Period|Adverse Event|0
3086572|NCT00381485|10587764|P4|Open-Label Run-In Period|Treatment failure|0
3086573|NCT00381485|10587765|P3|Open-Label Run-In Period|Treatment failure|0
3086574|NCT00381485|10587766|P2|Open-Label Run-In Period|Treatment failure|0
3086575|NCT00381485|10587767|P1|Open-Label Run-In Period|Treatment failure|1
3086576|NCT00381485|10587764|P4|Open-Label Run-In Period|Lost to Follow-up|0
3086577|NCT00381485|10587765|P3|Open-Label Run-In Period|Lost to Follow-up|0
3086578|NCT00381485|10587766|P2|Open-Label Run-In Period|Lost to Follow-up|0
3086579|NCT00381485|10587767|P1|Open-Label Run-In Period|Lost to Follow-up|3
3086580|NCT00381485|10587764|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
3086581|NCT00381485|10587765|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
3086582|NCT00381485|10587766|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
3086583|NCT00381485|10587767|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
3086584|NCT00381485|10587764|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
3086585|NCT00381485|10587765|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
3086586|NCT00381485|10587766|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
3086587|NCT00381485|10587767|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
3086588|NCT00381485|10587764|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
3086589|NCT00381485|10587765|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
3086590|NCT00381485|10587766|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
3086591|NCT00381485|10587767|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
3086592|NCT00381485|10587764|P4|Open-Label Run-In Period|Adverse Event|0
3086593|NCT00381485|10587765|P3|Open-Label Run-In Period|Adverse Event|0
3086594|NCT00381485|10587766|P2|Open-Label Run-In Period|Adverse Event|0
3086595|NCT00381485|10587767|P1|Open-Label Run-In Period|Adverse Event|9
3086596|NCT00381381|10587785|P1|Overall Study|Withdrawal by Subject|9
3086597|NCT00381381|10587785|P1|Overall Study|Lost to Follow-up|52
3086598|NCT00381381|10587785|P1|Overall Study|Adverse Event|3
3086599|NCT00381303|10587794|P2|Overall Study|Subject primary physician's decision|0
3086600|NCT00381303|10587795|P1|Overall Study|Subject primary physician's decision|1
3086601|NCT00381303|10587794|P2|Overall Study|Subject did not continue visits|0
3086602|NCT00381303|10587795|P1|Overall Study|Subject did not continue visits|1
3086603|NCT00381303|10587794|P2|Overall Study|Subject was too busy for appointments|0
3086604|NCT00381303|10587795|P1|Overall Study|Subject was too busy for appointments|1
3086605|NCT00381303|10587794|P2|Overall Study|No virologic response by week 12|0
3086606|NCT00381303|10587795|P1|Overall Study|No virologic response by week 12|1
3086607|NCT00381303|10587794|P2|Overall Study|Subject taking too many different meds|0
3086608|NCT00381303|10587795|P1|Overall Study|Subject taking too many different meds|1
3086609|NCT00381303|10587794|P2|Overall Study|Subject moved out of state|0
3086610|NCT00381303|10587795|P1|Overall Study|Subject moved out of state|2
3086611|NCT00381303|10587794|P2|Overall Study|Physician's decision to close the site|1
3086612|NCT00381303|10587795|P1|Overall Study|Physician's decision to close the site|3
3086613|NCT00381303|10587794|P2|Overall Study|Physician Decision|0
3086614|NCT00381303|10587795|P1|Overall Study|Physician Decision|1
3086615|NCT00381303|10587794|P2|Overall Study|Pregnancy|0
3086616|NCT00381303|10587795|P1|Overall Study|Pregnancy|2
3086617|NCT00381303|10587794|P2|Overall Study|Ineligible to continue the trial|1
3086618|NCT00381303|10587795|P1|Overall Study|Ineligible to continue the trial|2
3086619|NCT00381303|10587794|P2|Overall Study|Virologic failure|4
3086620|NCT00381303|10587795|P1|Overall Study|Virologic failure|6
3086621|NCT00381303|10587794|P2|Overall Study|Withdrawal by Subject|6
3086622|NCT00381303|10587795|P1|Overall Study|Withdrawal by Subject|13
3086623|NCT00381303|10587794|P2|Overall Study|Non-Adherence|6
3086624|NCT00381303|10587795|P1|Overall Study|Non-Adherence|13
3086625|NCT00381303|10587794|P2|Overall Study|AE/HIV-related event|6
3086626|NCT00381303|10587795|P1|Overall Study|AE/HIV-related event|22
3086627|NCT00381303|10587794|P2|Overall Study|Lost to Follow-up|9
3086628|NCT00381303|10587795|P1|Overall Study|Lost to Follow-up|25
3086629|NCT00381238|10587855|P1|Overall Study|Disease progression|1
3086630|NCT00381238|10587855|P1|Overall Study|Withdrew by physician|1
3086631|NCT00381238|10587855|P1|Overall Study|Lack of Efficacy|2
3086632|NCT00381238|10587855|P1|Overall Study|Withdrawal by Subject|4
3086633|NCT00381238|10587855|P1|Overall Study|Protocol Violation|1
3086634|NCT00381238|10587855|P1|Overall Study|Adverse Event|3
3086635|NCT00381095|10587871|P2|Overall Study|Adverse Event|7
3086636|NCT00381095|10587872|P1|Overall Study|Adverse Event|2
3086638|NCT00381095|10587872|P1|Overall Study|Withdrawal by Subject|3
3086639|NCT00381095|10587871|P2|Overall Study|Protocol Violation|1
3086640|NCT00381095|10587872|P1|Overall Study|Protocol Violation|1
3086641|NCT00381095|10587871|P2|Overall Study|Other|2
3086642|NCT00381095|10587872|P1|Overall Study|Other|2
3086643|NCT00381095|10587871|P2|Overall Study|Lack of Efficacy|4
3086644|NCT00381095|10587872|P1|Overall Study|Lack of Efficacy|2
3086645|NCT00381095|10587871|P2|Overall Study|Death|4
3086646|NCT00381095|10587872|P1|Overall Study|Death|3
3086647|NCT00381043|10587904|P2|Overall Study|incarcerated|0
3086648|NCT00381043|10587905|P1|Overall Study|incarcerated|1
3086649|NCT00381043|10587904|P2|Overall Study|wanted more care|1
3086650|NCT00381043|10587905|P1|Overall Study|wanted more care|0
3086651|NCT00381043|10587904|P2|Overall Study|Withdrawal by Subject|1
3086652|NCT00381043|10587905|P1|Overall Study|Withdrawal by Subject|3
3086653|NCT00381043|10587904|P2|Overall Study|Lost to Follow-up|6
3086654|NCT00381043|10587905|P1|Overall Study|Lost to Follow-up|8
3086655|NCT00380978|10587931|P2|Overall Study|Parous patient|0
3086656|NCT00380978|10587932|P1|Overall Study|Parous patient|1
3086657|NCT00380978|10587931|P2|Overall Study|Allocation prior to analgesia request|2
3086658|NCT00380978|10587932|P1|Overall Study|Allocation prior to analgesia request|1
3086659|NCT00380978|10587931|P2|Overall Study|Wrong study envelope|2
3086660|NCT00380978|10587932|P1|Overall Study|Wrong study envelope|0
3086661|NCT00380978|10587931|P2|Overall Study|Refused allocated intervention|6
3086662|NCT00380978|10587932|P1|Overall Study|Refused allocated intervention|0
3086663|NCT00380874|10587954|P2|Overall Study|Not related to study drug|2
3086664|NCT00380874|10587955|P1|Overall Study|Not related to study drug|3
3086665|NCT00380874|10587954|P2|Overall Study|Withdrawal by Subject|1
3086666|NCT00380874|10587955|P1|Overall Study|Withdrawal by Subject|2
3086667|NCT00380874|10587954|P2|Overall Study|Death|0
3086668|NCT00380874|10587955|P1|Overall Study|Death|1
3086669|NCT00380874|10587954|P2|Overall Study|Adverse Event|7
3086670|NCT00380874|10587955|P1|Overall Study|Adverse Event|7
3086671|NCT00380744|10587987|P7|Overall Study|Withdrawal by Subject|0
3086672|NCT00380744|10587988|P6|Overall Study|Withdrawal by Subject|0
3086673|NCT00380744|10587989|P5|Overall Study|Withdrawal by Subject|0
3086674|NCT00380744|10587990|P4|Overall Study|Withdrawal by Subject|0
3086675|NCT00380744|10587991|P3|Overall Study|Withdrawal by Subject|0
3086676|NCT00380744|10587992|P2|Overall Study|Withdrawal by Subject|0
3086677|NCT00380744|10587993|P1|Overall Study|Withdrawal by Subject|1
3086678|NCT00380744|10587987|P7|Overall Study|Death|1
3086679|NCT00380744|10587988|P6|Overall Study|Death|0
3086680|NCT00380744|10587989|P5|Overall Study|Death|0
3086681|NCT00380744|10587990|P4|Overall Study|Death|0
3086682|NCT00380744|10587991|P3|Overall Study|Death|0
3086683|NCT00380744|10587992|P2|Overall Study|Death|0
3086684|NCT00380744|10587993|P1|Overall Study|Death|0
3086685|NCT00380718|10588043|P1|Overall Study|Death after 30-day post-therapy followup|17
3086686|NCT00380718|10588043|P1|Overall Study|Adverse Event|1
3086687|NCT00380692|10588055|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
3086688|NCT00380692|10588056|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
3086689|NCT00380692|10588055|P2|Study Period III - Open Label|Lack of Efficacy|4
3086690|NCT00380692|10588056|P1|Study Period III - Open Label|Lack of Efficacy|0
3086691|NCT00380692|10588055|P2|Study Period III - Open Label|Physician Decision|3
3086692|NCT00380692|10588056|P1|Study Period III - Open Label|Physician Decision|0
3086693|NCT00380692|10588055|P2|Study Period III - Open Label|Withdrawal by Subject|1
3086694|NCT00380692|10588056|P1|Study Period III - Open Label|Withdrawal by Subject|0
3086695|NCT00380692|10588055|P2|Study Period III - Open Label|Protocol Violation|0
3086696|NCT00380692|10588056|P1|Study Period III - Open Label|Protocol Violation|0
3086697|NCT00380692|10588055|P2|Study Period III - Open Label|Adverse Event|3
3086698|NCT00380692|10588056|P1|Study Period III - Open Label|Adverse Event|5
3086699|NCT00380692|10588055|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
3086700|NCT00380692|10588056|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
3086701|NCT00380692|10588055|P2|Study Period II - Double Blind|Lack of Efficacy|0
3086702|NCT00380692|10588056|P1|Study Period II - Double Blind|Lack of Efficacy|1
3086703|NCT00380692|10588055|P2|Study Period II - Double Blind|Physician Decision|1
3086704|NCT00380692|10588056|P1|Study Period II - Double Blind|Physician Decision|0
3086705|NCT00380692|10588055|P2|Study Period II - Double Blind|Withdrawal by Subject|0
3086706|NCT00380692|10588056|P1|Study Period II - Double Blind|Withdrawal by Subject|0
3086707|NCT00380692|10588055|P2|Study Period II - Double Blind|Protocol Violation|2
3086708|NCT00380692|10588056|P1|Study Period II - Double Blind|Protocol Violation|2
3086709|NCT00380692|10588055|P2|Study Period II - Double Blind|Adverse Event|0
3086710|NCT00380692|10588056|P1|Study Period II - Double Blind|Adverse Event|1
3086711|NCT00380588|10588104|P2|Overall Study|Physician Decision|0
3086712|NCT00380588|10588105|P1|Overall Study|Physician Decision|2
3086713|NCT00380588|10588104|P2|Overall Study|Withdrawal by Subject|3
3086714|NCT00380588|10588105|P1|Overall Study|Withdrawal by Subject|1
3086715|NCT00380588|10588104|P2|Overall Study|Adverse Event|3
3086716|NCT00380588|10588105|P1|Overall Study|Adverse Event|7
3086717|NCT00380588|10588104|P2|Overall Study|Next Cycle Not Started|0
3086718|NCT00380588|10588105|P1|Overall Study|Next Cycle Not Started|4
3086719|NCT00380588|10588104|P2|Overall Study|Unequivocal Disease Progression|34
3086720|NCT00380588|10588105|P1|Overall Study|Unequivocal Disease Progression|25
3086721|NCT00380393|10588119|P2|Month 14|Others|6
3086722|NCT00380393|10588120|P1|Month 14|Others|6
3086723|NCT00380393|10588119|P2|Month 14|Protocol Violation|0
3086724|NCT00380393|10588120|P1|Month 14|Protocol Violation|2
3086725|NCT00380393|10588119|P2|Month 14|Migrated/moved from study area|42
3086726|NCT00380393|10588120|P1|Month 14|Migrated/moved from study area|39
3086727|NCT00380393|10588119|P2|Month 14|Lost to Follow-up|1
3086728|NCT00380393|10588120|P1|Month 14|Lost to Follow-up|0
3086729|NCT00380393|10588119|P2|Month 14|Death|0
3086730|NCT00380393|10588120|P1|Month 14|Death|1
3086731|NCT00380393|10588119|P2|Month 14|Withdrawal by Subject|7
3086732|NCT00380393|10588120|P1|Month 14|Withdrawal by Subject|9
3086733|NCT00380393|10588119|P2|Month 8 (Cross-sectional Visit)|Others|4
3086734|NCT00380393|10588120|P1|Month 8 (Cross-sectional Visit)|Others|5
3086735|NCT00380393|10588119|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
3086736|NCT00380393|10588120|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
3086737|NCT00380393|10588119|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
3086738|NCT00380393|10588120|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
3086739|NCT00380393|10588119|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
3086740|NCT00380393|10588120|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
3086741|NCT00380393|10588119|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
3086742|NCT00380393|10588120|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
3086743|NCT00380367|10588168|P1|Overall Study|Withdrawal by Subject|1
3086744|NCT00380367|10588168|P1|Overall Study|Lost to Follow-up|1
3086745|NCT00380250|10588175|P2|Overall Study|Physician Decision|0
3086746|NCT00380250|10588176|P1|Overall Study|Physician Decision|1
3086747|NCT00380250|10588175|P2|Overall Study|Lost to Follow-up|5
3086748|NCT00380250|10588176|P1|Overall Study|Lost to Follow-up|14
3086749|NCT00380250|10588175|P2|Overall Study|Protocol Violation|5
3086750|NCT00380250|10588176|P1|Overall Study|Protocol Violation|15
3086751|NCT00380250|10588175|P2|Overall Study|Lack of Efficacy|8
3086752|NCT00380250|10588176|P1|Overall Study|Lack of Efficacy|10
3086753|NCT00380250|10588175|P2|Overall Study|Adverse Event|9
3086754|NCT00380250|10588176|P1|Overall Study|Adverse Event|20
3086755|NCT00380250|10588175|P2|Overall Study|Withdrawal by Subject|28
3086756|NCT00380250|10588176|P1|Overall Study|Withdrawal by Subject|39
3086757|NCT00380081|10588244|P6|Overall Study|Family Emergency|1
3086758|NCT00380081|10588245|P5|Overall Study|Family Emergency|0
3086759|NCT00380081|10588246|P4|Overall Study|Family Emergency|0
3086760|NCT00380081|10588247|P3|Overall Study|Family Emergency|0
3086761|NCT00380081|10588248|P2|Overall Study|Family Emergency|0
3086762|NCT00380081|10588249|P1|Overall Study|Family Emergency|0
3086763|NCT00380081|10588244|P6|Overall Study|Withdrawal by Subject|0
3086764|NCT00380081|10588245|P5|Overall Study|Withdrawal by Subject|1
3086765|NCT00380081|10588246|P4|Overall Study|Withdrawal by Subject|0
3086766|NCT00380081|10588247|P3|Overall Study|Withdrawal by Subject|0
3086767|NCT00380081|10588248|P2|Overall Study|Withdrawal by Subject|0
3086768|NCT00380081|10588249|P1|Overall Study|Withdrawal by Subject|0
3086769|NCT00380068|10588299|P1|Overall Study|Lack of Efficacy|5
3086770|NCT00380068|10588299|P1|Overall Study|Partipant moved away|1
3086771|NCT00380068|10588299|P1|Overall Study|Physician Decision|2
3086772|NCT00380068|10588299|P1|Overall Study|Lung transplant|3
3086773|NCT00380068|10588299|P1|Overall Study|Addition of other PAH therapeutic agent|1
3086774|NCT00380068|10588299|P1|Overall Study|Lost to Follow-up|1
3086775|NCT00380068|10588299|P1|Overall Study|Not compliant|6
3086776|NCT00380068|10588299|P1|Overall Study|Withdrawal by Subject|10
3086777|NCT00380068|10588299|P1|Overall Study|Adverse Event|40
3086778|NCT00379912|10588331|P2|Overall Study|Lack of Efficacy|0
3086779|NCT00379912|10588332|P1|Overall Study|Lack of Efficacy|1
3086780|NCT00379899|10588354|P2|Overall Study|Other|1
3086781|NCT00379899|10588355|P1|Overall Study|Other|3
3086782|NCT00379899|10588354|P2|Overall Study|Other protocol-specified criteria|4
3086783|NCT00379899|10588355|P1|Overall Study|Other protocol-specified criteria|3
3086784|NCT00379899|10588354|P2|Overall Study|Coronary artery bypass graft|1
3086785|NCT00379899|10588355|P1|Overall Study|Coronary artery bypass graft|1
3086786|NCT00379899|10588354|P2|Overall Study|Renal transplantation|4
3086787|NCT00379899|10588355|P1|Overall Study|Renal transplantation|5
3086788|NCT00379899|10588354|P2|Overall Study|Parathyroidectomy|2
3086789|NCT00379899|10588355|P1|Overall Study|Parathyroidectomy|0
3086790|NCT00379899|10588354|P2|Overall Study|Noncompliance|1
3086791|NCT00379899|10588355|P1|Overall Study|Noncompliance|1
3086792|NCT00379899|10588354|P2|Overall Study|Ineligibility determined|1
3086793|NCT00379899|10588355|P1|Overall Study|Ineligibility determined|0
3086794|NCT00379899|10588354|P2|Overall Study|Withdrawal by Subject|5
3086795|NCT00379899|10588355|P1|Overall Study|Withdrawal by Subject|5
3086796|NCT00379899|10588354|P2|Overall Study|Physician Decision|4
3086797|NCT00379899|10588355|P1|Overall Study|Physician Decision|3
3086798|NCT00379899|10588354|P2|Overall Study|Lost to Follow-up|4
3086799|NCT00379899|10588355|P1|Overall Study|Lost to Follow-up|2
3086800|NCT00379899|10588354|P2|Overall Study|Death|10
3086801|NCT00379899|10588355|P1|Overall Study|Death|10
3086802|NCT00379899|10588354|P2|Overall Study|Adverse Event|3
3086803|NCT00379899|10588355|P1|Overall Study|Adverse Event|7
3086804|NCT00379834|10588383|P1|Overall Study|Time constraints|2
3086805|NCT00379808|10588535|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
3086806|NCT00379808|10588536|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
3086807|NCT00379795|10588557|P5|Overall Study|Sponsor's decision|10
3086808|NCT00379795|10588558|P4|Overall Study|Sponsor's decision|47
3086809|NCT00379795|10588559|P3|Overall Study|Sponsor's decision|54
3086810|NCT00379795|10588560|P2|Overall Study|Sponsor's decision|17
3086811|NCT00379795|10588561|P1|Overall Study|Sponsor's decision|257
3086812|NCT00379795|10588557|P5|Overall Study|Subjects condition mandated intervention|7
3086813|NCT00379795|10588558|P4|Overall Study|Subjects condition mandated intervention|5
3086814|NCT00379795|10588559|P3|Overall Study|Subjects condition mandated intervention|7
3086815|NCT00379795|10588560|P2|Overall Study|Subjects condition mandated intervention|9
3086816|NCT00379795|10588561|P1|Overall Study|Subjects condition mandated intervention|34
3086817|NCT00379795|10588557|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
3086818|NCT00379795|10588558|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
3086819|NCT00379795|10588559|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
3086820|NCT00379795|10588560|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
3086821|NCT00379795|10588561|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
3086822|NCT00379795|10588557|P5|Overall Study|Subject non-compliance|1
3086823|NCT00379795|10588558|P4|Overall Study|Subject non-compliance|0
3086824|NCT00379795|10588559|P3|Overall Study|Subject non-compliance|0
3086825|NCT00379795|10588560|P2|Overall Study|Subject non-compliance|2
3086826|NCT00379795|10588561|P1|Overall Study|Subject non-compliance|7
3086827|NCT00379795|10588557|P5|Overall Study|Withdrawal by Subject|14
3086828|NCT00379795|10588558|P4|Overall Study|Withdrawal by Subject|7
3086829|NCT00379795|10588559|P3|Overall Study|Withdrawal by Subject|19
3086830|NCT00379795|10588560|P2|Overall Study|Withdrawal by Subject|11
3086831|NCT00379795|10588561|P1|Overall Study|Withdrawal by Subject|94
3086832|NCT00379795|10588557|P5|Overall Study|Physician Decision|2
3086833|NCT00379795|10588558|P4|Overall Study|Physician Decision|2
3086834|NCT00379795|10588559|P3|Overall Study|Physician Decision|2
3086835|NCT00379795|10588560|P2|Overall Study|Physician Decision|0
3086836|NCT00379795|10588561|P1|Overall Study|Physician Decision|25
3086837|NCT00379795|10588557|P5|Overall Study|Lost to Follow-up|4
3086838|NCT00379795|10588558|P4|Overall Study|Lost to Follow-up|1
3086839|NCT00379795|10588559|P3|Overall Study|Lost to Follow-up|2
3086840|NCT00379795|10588560|P2|Overall Study|Lost to Follow-up|1
3086841|NCT00379795|10588561|P1|Overall Study|Lost to Follow-up|8
3086842|NCT00379795|10588557|P5|Overall Study|Adverse Event|4
3086843|NCT00379795|10588558|P4|Overall Study|Adverse Event|1
3086844|NCT00379795|10588559|P3|Overall Study|Adverse Event|3
3086845|NCT00379795|10588560|P2|Overall Study|Adverse Event|3
3086846|NCT00379795|10588561|P1|Overall Study|Adverse Event|17
3086847|NCT00379795|10588557|P5|Overall Study|Death|7
3086848|NCT00379795|10588558|P4|Overall Study|Death|4
3086849|NCT00379795|10588559|P3|Overall Study|Death|6
3086850|NCT00379795|10588560|P2|Overall Study|Death|8
3086851|NCT00379795|10588561|P1|Overall Study|Death|31
3086852|NCT00379769|10588591|P6|Observational Follow-up|Unknown; Reason Not Provided|1
3086853|NCT00379769|10588592|P5|Observational Follow-up|Unknown; Reason Not Provided|1
3086854|NCT00379769|10588593|P4|Observational Follow-up|Unknown; Reason Not Provided|0
3086855|NCT00379769|10588594|P3|Observational Follow-up|Unknown; Reason Not Provided|0
3086856|NCT00379769|10588595|P2|Observational Follow-up|Unknown; Reason Not Provided|0
3086857|NCT00379769|10588596|P1|Observational Follow-up|Unknown; Reason Not Provided|0
3086858|NCT00379769|10588591|P6|Observational Follow-up|Participant Moved|1
3086859|NCT00379769|10588592|P5|Observational Follow-up|Participant Moved|0
3086860|NCT00379769|10588593|P4|Observational Follow-up|Participant Moved|0
3086861|NCT00379769|10588594|P3|Observational Follow-up|Participant Moved|0
3086862|NCT00379769|10588595|P2|Observational Follow-up|Participant Moved|0
3086863|NCT00379769|10588596|P1|Observational Follow-up|Participant Moved|0
3086864|NCT00379769|10588591|P6|Observational Follow-up|Site Closed Early|7
3086865|NCT00379769|10588592|P5|Observational Follow-up|Site Closed Early|6
3086866|NCT00379769|10588593|P4|Observational Follow-up|Site Closed Early|0
3086867|NCT00379769|10588594|P3|Observational Follow-up|Site Closed Early|0
3086868|NCT00379769|10588595|P2|Observational Follow-up|Site Closed Early|0
3086869|NCT00379769|10588596|P1|Observational Follow-up|Site Closed Early|0
3086870|NCT00379769|10588591|P6|Observational Follow-up|Physician Decision|8
3086871|NCT00379769|10588592|P5|Observational Follow-up|Physician Decision|8
3086872|NCT00379769|10588593|P4|Observational Follow-up|Physician Decision|0
3086873|NCT00379769|10588594|P3|Observational Follow-up|Physician Decision|0
3086874|NCT00379769|10588595|P2|Observational Follow-up|Physician Decision|0
3086875|NCT00379769|10588596|P1|Observational Follow-up|Physician Decision|0
3086876|NCT00379769|10588591|P6|Observational Follow-up|Entered into Another Clinical Trial|22
3086877|NCT00379769|10588592|P5|Observational Follow-up|Entered into Another Clinical Trial|18
3086878|NCT00379769|10588593|P4|Observational Follow-up|Entered into Another Clinical Trial|0
3086879|NCT00379769|10588594|P3|Observational Follow-up|Entered into Another Clinical Trial|0
3086880|NCT00379769|10588595|P2|Observational Follow-up|Entered into Another Clinical Trial|0
3086881|NCT00379769|10588596|P1|Observational Follow-up|Entered into Another Clinical Trial|0
3086882|NCT00379769|10588591|P6|Observational Follow-up|Withdrawal by Subject|12
3086883|NCT00379769|10588592|P5|Observational Follow-up|Withdrawal by Subject|12
3086884|NCT00379769|10588593|P4|Observational Follow-up|Withdrawal by Subject|0
3086885|NCT00379769|10588594|P3|Observational Follow-up|Withdrawal by Subject|0
3086886|NCT00379769|10588595|P2|Observational Follow-up|Withdrawal by Subject|0
3086887|NCT00379769|10588596|P1|Observational Follow-up|Withdrawal by Subject|0
3086888|NCT00379769|10588591|P6|Observational Follow-up|Lost to Follow-up|27
3086889|NCT00379769|10588592|P5|Observational Follow-up|Lost to Follow-up|25
3086890|NCT00379769|10588593|P4|Observational Follow-up|Lost to Follow-up|0
3086891|NCT00379769|10588594|P3|Observational Follow-up|Lost to Follow-up|0
3086892|NCT00379769|10588595|P2|Observational Follow-up|Lost to Follow-up|0
3086893|NCT00379769|10588596|P1|Observational Follow-up|Lost to Follow-up|0
3086894|NCT00379769|10588591|P6|Observational Follow-up|Adverse Event|0
3086895|NCT00379769|10588592|P5|Observational Follow-up|Adverse Event|1
3086896|NCT00379769|10588593|P4|Observational Follow-up|Adverse Event|0
3086897|NCT00379769|10588594|P3|Observational Follow-up|Adverse Event|0
3086898|NCT00379769|10588595|P2|Observational Follow-up|Adverse Event|0
3086899|NCT00379769|10588596|P1|Observational Follow-up|Adverse Event|0
3086900|NCT00379769|10588591|P6|Observational Follow-up|Death|70
3086901|NCT00379769|10588592|P5|Observational Follow-up|Death|78
3086902|NCT00379769|10588593|P4|Observational Follow-up|Death|0
3086903|NCT00379769|10588594|P3|Observational Follow-up|Death|0
3086904|NCT00379769|10588595|P2|Observational Follow-up|Death|0
3086905|NCT00379769|10588596|P1|Observational Follow-up|Death|0
3086906|NCT00379769|10588591|P6|Main Study|Reason unspecified|0
3086907|NCT00379769|10588592|P5|Main Study|Reason unspecified|0
3086908|NCT00379769|10588593|P4|Main Study|Reason unspecified|0
3086909|NCT00379769|10588594|P3|Main Study|Reason unspecified|1
3086910|NCT00379769|10588595|P2|Main Study|Reason unspecified|0
3086911|NCT00379769|10588596|P1|Main Study|Reason unspecified|0
3086912|NCT00379769|10588591|P6|Main Study|Investigator refused to log temperature|0
3086913|NCT00379769|10588592|P5|Main Study|Investigator refused to log temperature|0
3086914|NCT00379769|10588593|P4|Main Study|Investigator refused to log temperature|0
3086915|NCT00379769|10588594|P3|Main Study|Investigator refused to log temperature|1
3086916|NCT00379769|10588595|P2|Main Study|Investigator refused to log temperature|0
3086917|NCT00379769|10588596|P1|Main Study|Investigator refused to log temperature|0
3086918|NCT00379769|10588591|P6|Main Study|Risk of heart failure|0
3086919|NCT00379769|10588592|P5|Main Study|Risk of heart failure|0
3086920|NCT00379769|10588593|P4|Main Study|Risk of heart failure|0
3086921|NCT00379769|10588594|P3|Main Study|Risk of heart failure|0
3086922|NCT00379769|10588595|P2|Main Study|Risk of heart failure|1
3086923|NCT00379769|10588596|P1|Main Study|Risk of heart failure|0
3086924|NCT00379769|10588591|P6|Main Study|Personal reasons|0
3086925|NCT00379769|10588592|P5|Main Study|Personal reasons|0
3086926|NCT00379769|10588593|P4|Main Study|Personal reasons|0
3086927|NCT00379769|10588594|P3|Main Study|Personal reasons|0
3086928|NCT00379769|10588595|P2|Main Study|Personal reasons|0
3086929|NCT00379769|10588596|P1|Main Study|Personal reasons|1
3086930|NCT00379769|10588591|P6|Main Study|Participant completed study at visit 27|0
3086931|NCT00379769|10588592|P5|Main Study|Participant completed study at visit 27|0
3086932|NCT00379769|10588593|P4|Main Study|Participant completed study at visit 27|0
3086933|NCT00379769|10588594|P3|Main Study|Participant completed study at visit 27|0
3086934|NCT00379769|10588595|P2|Main Study|Participant completed study at visit 27|0
3086935|NCT00379769|10588596|P1|Main Study|Participant completed study at visit 27|1
3086936|NCT00379769|10588591|P6|Main Study|Physician Decision|0
3086937|NCT00379769|10588592|P5|Main Study|Physician Decision|0
3086938|NCT00379769|10588593|P4|Main Study|Physician Decision|1
3086939|NCT00379769|10588594|P3|Main Study|Physician Decision|1
3086940|NCT00379769|10588595|P2|Main Study|Physician Decision|2
3086941|NCT00379769|10588596|P1|Main Study|Physician Decision|2
3086942|NCT00379769|10588591|P6|Main Study|Participant did not take study drug|0
3086943|NCT00379769|10588592|P5|Main Study|Participant did not take study drug|0
3086944|NCT00379769|10588593|P4|Main Study|Participant did not take study drug|0
3086945|NCT00379769|10588594|P3|Main Study|Participant did not take study drug|1
3086946|NCT00379769|10588595|P2|Main Study|Participant did not take study drug|0
3086947|NCT00379769|10588596|P1|Main Study|Participant did not take study drug|0
3086948|NCT00379769|10588591|P6|Main Study|Entry criteria violation|0
3086949|NCT00379769|10588592|P5|Main Study|Entry criteria violation|0
3086950|NCT00379769|10588593|P4|Main Study|Entry criteria violation|1
3086951|NCT00379769|10588594|P3|Main Study|Entry criteria violation|1
3086952|NCT00379769|10588595|P2|Main Study|Entry criteria violation|0
3086953|NCT00379769|10588596|P1|Main Study|Entry criteria violation|0
3086954|NCT00379769|10588591|P6|Main Study|Site closed|0
3086955|NCT00379769|10588592|P5|Main Study|Site closed|0
3086956|NCT00379769|10588593|P4|Main Study|Site closed|8
3086957|NCT00379769|10588594|P3|Main Study|Site closed|4
3086958|NCT00379769|10588595|P2|Main Study|Site closed|4
3086959|NCT00379769|10588596|P1|Main Study|Site closed|4
3086960|NCT00379769|10588591|P6|Main Study|Prohibited glucose lowering medication|0
3086961|NCT00379769|10588592|P5|Main Study|Prohibited glucose lowering medication|0
3086962|NCT00379769|10588593|P4|Main Study|Prohibited glucose lowering medication|1
3086963|NCT00379769|10588594|P3|Main Study|Prohibited glucose lowering medication|0
3086964|NCT00379769|10588595|P2|Main Study|Prohibited glucose lowering medication|3
3086965|NCT00379769|10588596|P1|Main Study|Prohibited glucose lowering medication|0
3086966|NCT00379769|10588591|P6|Main Study|Poor compliance|0
3086967|NCT00379769|10588592|P5|Main Study|Poor compliance|0
3086968|NCT00379769|10588593|P4|Main Study|Poor compliance|1
3086969|NCT00379769|10588594|P3|Main Study|Poor compliance|2
3086970|NCT00379769|10588595|P2|Main Study|Poor compliance|2
3086971|NCT00379769|10588596|P1|Main Study|Poor compliance|3
3086972|NCT00379769|10588591|P6|Main Study|Participant moved|0
3086973|NCT00379769|10588592|P5|Main Study|Participant moved|0
3086974|NCT00379769|10588593|P4|Main Study|Participant moved|3
3086975|NCT00379769|10588594|P3|Main Study|Participant moved|3
3086976|NCT00379769|10588595|P2|Main Study|Participant moved|2
3086977|NCT00379769|10588596|P1|Main Study|Participant moved|3
3086978|NCT00379769|10588591|P6|Main Study|Moved to survival status follow-up only|0
3086979|NCT00379769|10588592|P5|Main Study|Moved to survival status follow-up only|0
3086980|NCT00379769|10588593|P4|Main Study|Moved to survival status follow-up only|36
3086981|NCT00379769|10588594|P3|Main Study|Moved to survival status follow-up only|32
3086982|NCT00379769|10588595|P2|Main Study|Moved to survival status follow-up only|25
3086983|NCT00379769|10588596|P1|Main Study|Moved to survival status follow-up only|27
3086984|NCT00379769|10588591|P6|Main Study|Withdrawal by Subject|0
3086985|NCT00379769|10588592|P5|Main Study|Withdrawal by Subject|0
3086986|NCT00379769|10588593|P4|Main Study|Withdrawal by Subject|70
3086987|NCT00379769|10588594|P3|Main Study|Withdrawal by Subject|72
3086988|NCT00379769|10588595|P2|Main Study|Withdrawal by Subject|56
3086989|NCT00379769|10588596|P1|Main Study|Withdrawal by Subject|46
3086990|NCT00379769|10588591|P6|Main Study|Lost to Follow-up|0
3086991|NCT00379769|10588592|P5|Main Study|Lost to Follow-up|0
3086992|NCT00379769|10588593|P4|Main Study|Lost to Follow-up|26
3086993|NCT00379769|10588594|P3|Main Study|Lost to Follow-up|25
3086994|NCT00379769|10588595|P2|Main Study|Lost to Follow-up|29
3086995|NCT00379769|10588596|P1|Main Study|Lost to Follow-up|29
3086996|NCT00379769|10588591|P6|Main Study|Adverse Event|0
3086997|NCT00379769|10588592|P5|Main Study|Adverse Event|0
3086998|NCT00379769|10588593|P4|Main Study|Adverse Event|11
3086999|NCT00379769|10588594|P3|Main Study|Adverse Event|10
3087000|NCT00379769|10588595|P2|Main Study|Adverse Event|8
3087001|NCT00379769|10588596|P1|Main Study|Adverse Event|5
3087002|NCT00379769|10588591|P6|Main Study|Death|0
3087003|NCT00379769|10588592|P5|Main Study|Death|0
3087004|NCT00379769|10588593|P4|Main Study|Death|72
3087005|NCT00379769|10588594|P3|Main Study|Death|54
3087006|NCT00379769|10588595|P2|Main Study|Death|67
3087007|NCT00379769|10588596|P1|Main Study|Death|57
3087008|NCT00379639|10588755|P5|Overall Study|Other|0
3087009|NCT00379639|10588756|P4|Overall Study|Other|0
3087010|NCT00379639|10588757|P3|Overall Study|Other|3
3087011|NCT00379639|10588758|P2|Overall Study|Other|0
3087012|NCT00379639|10588759|P1|Overall Study|Other|0
3087013|NCT00379639|10588755|P5|Overall Study|Lost to Follow-up|0
3087014|NCT00379639|10588756|P4|Overall Study|Lost to Follow-up|1
3087015|NCT00379639|10588757|P3|Overall Study|Lost to Follow-up|0
3087016|NCT00379639|10588758|P2|Overall Study|Lost to Follow-up|0
3087017|NCT00379639|10588759|P1|Overall Study|Lost to Follow-up|0
3087018|NCT00379639|10588755|P5|Overall Study|Adverse Event|1
3087019|NCT00379639|10588756|P4|Overall Study|Adverse Event|0
3087020|NCT00379639|10588757|P3|Overall Study|Adverse Event|1
3087021|NCT00379639|10588758|P2|Overall Study|Adverse Event|0
3087022|NCT00379639|10588759|P1|Overall Study|Adverse Event|0
3087023|NCT00379639|10588755|P5|Overall Study|Symptomatic Deterioration|1
3087024|NCT00379639|10588756|P4|Overall Study|Symptomatic Deterioration|0
3087025|NCT00379639|10588757|P3|Overall Study|Symptomatic Deterioration|1
3087026|NCT00379639|10588758|P2|Overall Study|Symptomatic Deterioration|0
3087027|NCT00379639|10588759|P1|Overall Study|Symptomatic Deterioration|0
3087028|NCT00379639|10588755|P5|Overall Study|Physician Decision|0
3087029|NCT00379639|10588756|P4|Overall Study|Physician Decision|1
3087030|NCT00379639|10588757|P3|Overall Study|Physician Decision|1
3087031|NCT00379639|10588758|P2|Overall Study|Physician Decision|2
3087032|NCT00379639|10588759|P1|Overall Study|Physician Decision|0
3087033|NCT00379639|10588755|P5|Overall Study|Disease Progression|4
3087034|NCT00379639|10588756|P4|Overall Study|Disease Progression|4
3087035|NCT00379639|10588757|P3|Overall Study|Disease Progression|3
3087036|NCT00379639|10588758|P2|Overall Study|Disease Progression|3
3087037|NCT00379639|10588759|P1|Overall Study|Disease Progression|3
3087038|NCT00379587|10588781|P1|Overall Study|Lost to Follow-up|2
3087039|NCT00379353|10588795|P2|Overall Study|Conflicting drug treatment|1
3087040|NCT00379353|10588796|P1|Overall Study|Conflicting drug treatment|0
3087041|NCT00379353|10588795|P2|Overall Study|Non-compliance|0
3087042|NCT00379353|10588796|P1|Overall Study|Non-compliance|1
3087043|NCT00379353|10588795|P2|Overall Study|Cardiac Tamponade|0
3087044|NCT00379353|10588796|P1|Overall Study|Cardiac Tamponade|1
3087045|NCT00379353|10588795|P2|Overall Study|Death|0
3087046|NCT00379353|10588796|P1|Overall Study|Death|1
3087047|NCT00379353|10588795|P2|Overall Study|Withdrawal by Subject|2
3087048|NCT00379353|10588796|P1|Overall Study|Withdrawal by Subject|5
3087049|NCT00379353|10588795|P2|Overall Study|Hospitalization|3
3087050|NCT00379353|10588796|P1|Overall Study|Hospitalization|3
3087051|NCT00379340|10588831|P5|Overall Study|Delayed nephrectomy and anaplasia|1
3087052|NCT00379340|10588832|P4|Overall Study|Delayed nephrectomy and anaplasia|1
3087053|NCT00379340|10588833|P3|Overall Study|Delayed nephrectomy and anaplasia|0
3087054|NCT00379340|10588834|P2|Overall Study|Delayed nephrectomy and anaplasia|0
3087055|NCT00379340|10588835|P1|Overall Study|Delayed nephrectomy and anaplasia|0
3087056|NCT00379340|10588831|P5|Overall Study|On more than 1 tumor therapeutic study|0
3087057|NCT00379340|10588832|P4|Overall Study|On more than 1 tumor therapeutic study|2
3087058|NCT00379340|10588833|P3|Overall Study|On more than 1 tumor therapeutic study|0
3087059|NCT00379340|10588834|P2|Overall Study|On more than 1 tumor therapeutic study|0
3087060|NCT00379340|10588835|P1|Overall Study|On more than 1 tumor therapeutic study|0
3087061|NCT00379340|10588831|P5|Overall Study|Refusal of further protocol therapy|7
3087062|NCT00379340|10588832|P4|Overall Study|Refusal of further protocol therapy|1
3087063|NCT00379340|10588833|P3|Overall Study|Refusal of further protocol therapy|1
3087064|NCT00379340|10588834|P2|Overall Study|Refusal of further protocol therapy|0
3087065|NCT00379340|10588835|P1|Overall Study|Refusal of further protocol therapy|1
3087066|NCT00379340|10588831|P5|Overall Study|Withdrawal by Subject|0
3087067|NCT00379340|10588832|P4|Overall Study|Withdrawal by Subject|1
3087068|NCT00379340|10588833|P3|Overall Study|Withdrawal by Subject|0
3087069|NCT00379340|10588834|P2|Overall Study|Withdrawal by Subject|0
3087070|NCT00379340|10588835|P1|Overall Study|Withdrawal by Subject|0
3087071|NCT00379340|10588831|P5|Overall Study|Physician Decision|3
3087072|NCT00379340|10588832|P4|Overall Study|Physician Decision|2
3087073|NCT00379340|10588833|P3|Overall Study|Physician Decision|1
3087074|NCT00379340|10588834|P2|Overall Study|Physician Decision|2
3087075|NCT00379340|10588835|P1|Overall Study|Physician Decision|6
3087076|NCT00379340|10588831|P5|Overall Study|Lack of Efficacy|3
3087077|NCT00379340|10588832|P4|Overall Study|Lack of Efficacy|4
3087078|NCT00379340|10588833|P3|Overall Study|Lack of Efficacy|0
3087079|NCT00379340|10588834|P2|Overall Study|Lack of Efficacy|1
3087080|NCT00379340|10588835|P1|Overall Study|Lack of Efficacy|6
3087081|NCT00379340|10588831|P5|Overall Study|Death|0
3087082|NCT00379340|10588832|P4|Overall Study|Death|2
3087083|NCT00379340|10588833|P3|Overall Study|Death|0
3087084|NCT00379340|10588834|P2|Overall Study|Death|0
3087085|NCT00379340|10588835|P1|Overall Study|Death|0
3087086|NCT00379288|10588852|P4|Overall Study|Administrative|1
3087087|NCT00379288|10588853|P3|Overall Study|Administrative|0
3087088|NCT00379288|10588854|P2|Overall Study|Administrative|2
3087089|NCT00379288|10588855|P1|Overall Study|Administrative|2
3087090|NCT00379288|10588852|P4|Overall Study|Did not meet protocol eligibility|2
3087091|NCT00379288|10588853|P3|Overall Study|Did not meet protocol eligibility|0
3087092|NCT00379288|10588854|P2|Overall Study|Did not meet protocol eligibility|1
3087093|NCT00379288|10588855|P1|Overall Study|Did not meet protocol eligibility|0
3087094|NCT00379288|10588852|P4|Overall Study|Noncompliance with protocol|1
3087095|NCT00379288|10588853|P3|Overall Study|Noncompliance with protocol|2
3087096|NCT00379288|10588854|P2|Overall Study|Noncompliance with protocol|6
3087097|NCT00379288|10588855|P1|Overall Study|Noncompliance with protocol|8
3087098|NCT00379288|10588852|P4|Overall Study|Subject withdrew-related to study drug|1
3087099|NCT00379288|10588853|P3|Overall Study|Subject withdrew-related to study drug|0
3087100|NCT00379288|10588854|P2|Overall Study|Subject withdrew-related to study drug|0
3087101|NCT00379288|10588855|P1|Overall Study|Subject withdrew-related to study drug|1
3087102|NCT00379288|10588852|P4|Overall Study|Subject withdrew-unrelated to study drug|2
3087103|NCT00379288|10588853|P3|Overall Study|Subject withdrew-unrelated to study drug|4
3087104|NCT00379288|10588854|P2|Overall Study|Subject withdrew-unrelated to study drug|3
3087105|NCT00379288|10588855|P1|Overall Study|Subject withdrew-unrelated to study drug|0
3087106|NCT00379288|10588852|P4|Overall Study|Lost to Follow-up|0
3087107|NCT00379288|10588853|P3|Overall Study|Lost to Follow-up|2
3087108|NCT00379288|10588854|P2|Overall Study|Lost to Follow-up|3
3087109|NCT00379288|10588855|P1|Overall Study|Lost to Follow-up|3
3087110|NCT00379288|10588852|P4|Overall Study|Treatment Failure|1
3087111|NCT00379288|10588853|P3|Overall Study|Treatment Failure|0
3087112|NCT00379288|10588854|P2|Overall Study|Treatment Failure|1
3087113|NCT00379288|10588855|P1|Overall Study|Treatment Failure|0
3087114|NCT00379288|10588852|P4|Overall Study|Adverse Event|0
3087115|NCT00379288|10588853|P3|Overall Study|Adverse Event|2
3087116|NCT00379288|10588854|P2|Overall Study|Adverse Event|6
3087117|NCT00379288|10588855|P1|Overall Study|Adverse Event|5
3087118|NCT00379236|10588867|P3|Open-label Extension|Other|7
3087119|NCT00379236|10588868|P2|Open-label Extension|Other|0
3087120|NCT00379236|10588869|P1|Open-label Extension|Other|0
3087121|NCT00379236|10588867|P3|Open-label Extension|Use of exclusionary medication|3
3087122|NCT00379236|10588868|P2|Open-label Extension|Use of exclusionary medication|0
3087123|NCT00379236|10588869|P1|Open-label Extension|Use of exclusionary medication|0
3087124|NCT00379236|10588867|P3|Open-label Extension|Lost to Follow-up|12
3087125|NCT00379236|10588868|P2|Open-label Extension|Lost to Follow-up|0
3087126|NCT00379236|10588869|P1|Open-label Extension|Lost to Follow-up|0
3087127|NCT00379236|10588867|P3|Open-label Extension|Withdrawal by Subject|13
3087128|NCT00379236|10588868|P2|Open-label Extension|Withdrawal by Subject|0
3087129|NCT00379236|10588869|P1|Open-label Extension|Withdrawal by Subject|0
3087130|NCT00379236|10588867|P3|Open-label Extension|Protocol Violation|7
3087131|NCT00379236|10588868|P2|Open-label Extension|Protocol Violation|0
3087132|NCT00379236|10588869|P1|Open-label Extension|Protocol Violation|0
3087133|NCT00379236|10588867|P3|Open-label Extension|Adverse Event|13
3087134|NCT00379236|10588868|P2|Open-label Extension|Adverse Event|0
3087135|NCT00379236|10588869|P1|Open-label Extension|Adverse Event|0
3087136|NCT00379236|10588867|P3|Double-blind|Data could not be retrieved|0
3087137|NCT00379236|10588868|P2|Double-blind|Data could not be retrieved|2
3087138|NCT00379236|10588869|P1|Double-blind|Data could not be retrieved|2
3087139|NCT00379236|10588867|P3|Double-blind|Other|0
3087140|NCT00379236|10588868|P2|Double-blind|Other|7
3087141|NCT00379236|10588869|P1|Double-blind|Other|3
3087142|NCT00379236|10588867|P3|Double-blind|Use of exclusionary medication|0
3087143|NCT00379236|10588868|P2|Double-blind|Use of exclusionary medication|2
3087144|NCT00379236|10588869|P1|Double-blind|Use of exclusionary medication|1
3087145|NCT00379236|10588867|P3|Double-blind|Lost to Follow-up|0
3087146|NCT00379236|10588868|P2|Double-blind|Lost to Follow-up|3
3087147|NCT00379236|10588869|P1|Double-blind|Lost to Follow-up|4
3087148|NCT00379236|10588867|P3|Double-blind|Withdrawal by Subject|0
3087149|NCT00379236|10588868|P2|Double-blind|Withdrawal by Subject|13
3087150|NCT00379236|10588869|P1|Double-blind|Withdrawal by Subject|12
3087151|NCT00379236|10588867|P3|Double-blind|Protocol Violation|0
3087152|NCT00379236|10588868|P2|Double-blind|Protocol Violation|3
3087153|NCT00379236|10588869|P1|Double-blind|Protocol Violation|3
3087154|NCT00379236|10588867|P3|Double-blind|Adverse Event|0
3087155|NCT00379236|10588868|P2|Double-blind|Adverse Event|6
3087156|NCT00379236|10588869|P1|Double-blind|Adverse Event|11
3087157|NCT00379210|10588914|P2|Overall Study|Withdrawal by Subject|7
3087158|NCT00379210|10588915|P1|Overall Study|Withdrawal by Subject|10
3087159|NCT00379080|10588938|P3|Overall Study|Withdrawal by Subject|0
3087160|NCT00379080|10588939|P2|Overall Study|Withdrawal by Subject|4
3087161|NCT00379080|10588940|P1|Overall Study|Withdrawal by Subject|0
3087162|NCT00378898|10588985|P2|Overall Study|Protocol Violation|1
3087163|NCT00378898|10588986|P1|Overall Study|Protocol Violation|1
3087164|NCT00378898|10588985|P2|Overall Study|Withdrawal by Subject|5
3087165|NCT00378898|10588986|P1|Overall Study|Withdrawal by Subject|10
3087166|NCT00378703|10588998|P4|Overall Study|Other|3
3087167|NCT00378703|10588999|P3|Overall Study|Other|2
3087168|NCT00378703|10589000|P2|Overall Study|Other|1
3087169|NCT00378703|10589001|P1|Overall Study|Other|1
3087170|NCT00378703|10588998|P4|Overall Study|Never started treatment|0
3087171|NCT00378703|10588999|P3|Overall Study|Never started treatment|0
3087172|NCT00378703|10589000|P2|Overall Study|Never started treatment|4
3087173|NCT00378703|10589001|P1|Overall Study|Never started treatment|1
3087174|NCT00378703|10588998|P4|Overall Study|Ineligible|7
3087175|NCT00378703|10588999|P3|Overall Study|Ineligible|7
3087176|NCT00378703|10589000|P2|Overall Study|Ineligible|7
3087177|NCT00378703|10589001|P1|Overall Study|Ineligible|4
3087178|NCT00378703|10588998|P4|Overall Study|Relocation|0
3087179|NCT00378703|10588999|P3|Overall Study|Relocation|1
3087180|NCT00378703|10589000|P2|Overall Study|Relocation|0
3087181|NCT00378703|10589001|P1|Overall Study|Relocation|0
3087182|NCT00378703|10588998|P4|Overall Study|Adverse events and progressive disease|1
3087183|NCT00378703|10588999|P3|Overall Study|Adverse events and progressive disease|0
3087184|NCT00378703|10589000|P2|Overall Study|Adverse events and progressive disease|0
3087185|NCT00378703|10589001|P1|Overall Study|Adverse events and progressive disease|0
3087186|NCT00378703|10588998|P4|Overall Study|Joint decision of physician and patient|0
3087187|NCT00378703|10588999|P3|Overall Study|Joint decision of physician and patient|0
3087188|NCT00378703|10589000|P2|Overall Study|Joint decision of physician and patient|0
3087189|NCT00378703|10589001|P1|Overall Study|Joint decision of physician and patient|1
3087190|NCT00378703|10588998|P4|Overall Study|Surgery|1
3087191|NCT00378703|10588999|P3|Overall Study|Surgery|0
3087192|NCT00378703|10589000|P2|Overall Study|Surgery|0
3087193|NCT00378703|10589001|P1|Overall Study|Surgery|1
3087194|NCT00378703|10588998|P4|Overall Study|Symptomatic deterioration|2
3087195|NCT00378703|10588999|P3|Overall Study|Symptomatic deterioration|0
3087196|NCT00378703|10589000|P2|Overall Study|Symptomatic deterioration|1
3087197|NCT00378703|10589001|P1|Overall Study|Symptomatic deterioration|0
3087198|NCT00378703|10588998|P4|Overall Study|Other complicated disease|0
3087199|NCT00378703|10588999|P3|Overall Study|Other complicated disease|2
3087200|NCT00378703|10589000|P2|Overall Study|Other complicated disease|2
3087201|NCT00378703|10589001|P1|Overall Study|Other complicated disease|0
3087202|NCT00378703|10588998|P4|Overall Study|Alternative therapy|0
3087203|NCT00378703|10588999|P3|Overall Study|Alternative therapy|0
3087204|NCT00378703|10589000|P2|Overall Study|Alternative therapy|2
3087205|NCT00378703|10589001|P1|Overall Study|Alternative therapy|4
3087206|NCT00378703|10588998|P4|Overall Study|Physician Decision|0
3087207|NCT00378703|10588999|P3|Overall Study|Physician Decision|1
3087208|NCT00378703|10589000|P2|Overall Study|Physician Decision|4
3087209|NCT00378703|10589001|P1|Overall Study|Physician Decision|1
3087210|NCT00378703|10588998|P4|Overall Study|Withdrawal by Subject|7
3087211|NCT00378703|10588999|P3|Overall Study|Withdrawal by Subject|5
3087212|NCT00378703|10589000|P2|Overall Study|Withdrawal by Subject|8
3087213|NCT00378703|10589001|P1|Overall Study|Withdrawal by Subject|4
3087214|NCT00378703|10588998|P4|Overall Study|Death|3
3087215|NCT00378703|10588999|P3|Overall Study|Death|4
3087216|NCT00378703|10589000|P2|Overall Study|Death|2
3087217|NCT00378703|10589001|P1|Overall Study|Death|2
3087218|NCT00378703|10588998|P4|Overall Study|Adverse Event|18
3087219|NCT00378703|10588999|P3|Overall Study|Adverse Event|20
3087220|NCT00378703|10589000|P2|Overall Study|Adverse Event|17
3087221|NCT00378703|10589001|P1|Overall Study|Adverse Event|11
3087222|NCT00378703|10588998|P4|Overall Study|Disease progression|49
3087223|NCT00378703|10588999|P3|Overall Study|Disease progression|48
3087224|NCT00378703|10589000|P2|Overall Study|Disease progression|43
3087225|NCT00378703|10589001|P1|Overall Study|Disease progression|59
3087226|NCT00378599|10589023|P1|Overall Study|Withdrawal by Subject|5
3087227|NCT00378599|10589023|P1|Overall Study|Treatment failure|7
3087228|NCT00378599|10589023|P1|Overall Study|Protocol Violation|2
3087229|NCT00378599|10589023|P1|Overall Study|Adverse Event|38
3087230|NCT00378573|10589027|P1|Follow-up|Withdrawal by Subject|1
3087231|NCT00378573|10589027|P1|Follow-up|Lost to Follow-up|1
3087232|NCT00378573|10589027|P1|Follow-up|Death|12
3087233|NCT00378573|10589027|P1|Treatment Period|Sponsor decision to close study|1
3087234|NCT00378573|10589027|P1|Treatment Period|Disease Progression|4
3087235|NCT00378573|10589027|P1|Treatment Period|Withdrawal by Subject|2
3087236|NCT00378573|10589027|P1|Treatment Period|Physician Decision|1
3087237|NCT00378573|10589027|P1|Treatment Period|Adverse Event|9
3087238|NCT00378560|10589035|P2|Overall Study|Laboratory test values abnormal|0
3087239|NCT00378560|10589036|P1|Overall Study|Laboratory test values abnormal|1
3087240|NCT00378560|10589035|P2|Overall Study|Pregnancy|5
3087241|NCT00378560|10589036|P1|Overall Study|Pregnancy|7
3087242|NCT00378560|10589035|P2|Overall Study|Moved|3
3087243|NCT00378560|10589036|P1|Overall Study|Moved|4
3087244|NCT00378560|10589035|P2|Overall Study|Withdrawal by Subject|21
3087245|NCT00378560|10589036|P1|Overall Study|Withdrawal by Subject|17
3087246|NCT00378560|10589035|P2|Overall Study|Protocol Violation|0
3087247|NCT00378560|10589036|P1|Overall Study|Protocol Violation|2
3087248|NCT00378560|10589035|P2|Overall Study|Lost to Follow-up|29
3087249|NCT00378560|10589036|P1|Overall Study|Lost to Follow-up|24
3087250|NCT00378560|10589035|P2|Overall Study|Adverse Event|0
3087251|NCT00378560|10589036|P1|Overall Study|Adverse Event|1
3087252|NCT00378534|10589050|P1|Overall Study|Subjects did not receive a transplant|3
3087253|NCT00378534|10589050|P1|Overall Study|Donors|57
3087254|NCT00378508|10589056|P2|Overall Study|Lost to Follow-up|0
3087255|NCT00378508|10589057|P1|Overall Study|Lost to Follow-up|1
3087256|NCT00378508|10589056|P2|Overall Study|Withdrawal by Subject|3
3087257|NCT00378508|10589057|P1|Overall Study|Withdrawal by Subject|1
3087258|NCT00378378|10589076|P3|Overall Study|Non-compliance with protocol|1
3087259|NCT00378378|10589077|P2|Overall Study|Non-compliance with protocol|0
3087260|NCT00378378|10589078|P1|Overall Study|Non-compliance with protocol|0
3087261|NCT00378378|10589076|P3|Overall Study|Treatment Failure|1
3087262|NCT00378378|10589077|P2|Overall Study|Treatment Failure|0
3087263|NCT00378378|10589078|P1|Overall Study|Treatment Failure|0
3087264|NCT00378378|10589076|P3|Overall Study|Withdrawal by Subject|0
3087265|NCT00378378|10589077|P2|Overall Study|Withdrawal by Subject|1
3087266|NCT00378378|10589078|P1|Overall Study|Withdrawal by Subject|0
3087267|NCT00378209|10589124|P1|Overall Study|Treatment delay|1
3087268|NCT00378209|10589124|P1|Overall Study|Death|1
3087269|NCT00378209|10589124|P1|Overall Study|Physician Decision|3
3087270|NCT00378209|10589124|P1|Overall Study|Initiation of non-protocol therapy|3
3087271|NCT00378209|10589124|P1|Overall Study|Adverse Event|3
3087272|NCT00378209|10589124|P1|Overall Study|Progressive disease|11
3087273|NCT00378105|10589134|P2|Overall Study|necessity to increase lenalidomide dose|1
3087274|NCT00378105|10589135|P1|Overall Study|necessity to increase lenalidomide dose|0
3087275|NCT00378105|10589134|P2|Overall Study|Going non-protocol therapy|1
3087276|NCT00378105|10589135|P1|Overall Study|Going non-protocol therapy|0
3087277|NCT00378105|10589134|P2|Overall Study|Physician Decision|2
3087278|NCT00378105|10589135|P1|Overall Study|Physician Decision|0
3087279|NCT00378105|10589134|P2|Overall Study|remain on study|11
3087280|NCT00378105|10589135|P1|Overall Study|remain on study|3
3087281|NCT00378105|10589134|P2|Overall Study|Progressive disease|3
3087282|NCT00378105|10589135|P1|Overall Study|Progressive disease|3
3087283|NCT00378105|10589134|P2|Overall Study|Going to transplant|8
3087284|NCT00378105|10589135|P1|Overall Study|Going to transplant|7
3087285|NCT00378105|10589134|P2|Overall Study|Death|0
3087286|NCT00378105|10589135|P1|Overall Study|Death|1
3087287|NCT00378105|10589134|P2|Overall Study|Withdrawal by Subject|3
3087288|NCT00378105|10589135|P1|Overall Study|Withdrawal by Subject|3
3087289|NCT00378105|10589134|P2|Overall Study|Adverse Event|1
3087290|NCT00378105|10589135|P1|Overall Study|Adverse Event|3
3087291|NCT00378079|10589147|P3|Overall Study|Lost to Follow-up|0
3087292|NCT00378079|10589148|P2|Overall Study|Lost to Follow-up|1
3087293|NCT00378079|10589149|P1|Overall Study|Lost to Follow-up|6
3087294|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
3087295|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
3087296|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
3087297|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
3087298|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
3087299|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
3087300|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Administrative problems|0
3087301|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Administrative problems|1
3087302|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Death|2
3087303|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Death|1
3087304|NCT00378014|10589171|P2|Extension (Month 12 to Month 59)|Adverse Event|7
3087305|NCT00378014|10589172|P1|Extension (Month 12 to Month 59)|Adverse Event|8
3087306|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
3087307|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
3087308|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Protocol deviation|1
3087309|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Protocol deviation|0
3087310|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
3087311|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
3087312|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
3087313|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
3087314|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Administrative Problems|2
3087315|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Administrative Problems|2
3087316|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Death|3
3087317|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Death|5
3087318|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Graft loss|2
3087319|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Graft loss|1
3087320|NCT00378014|10589171|P2|Core (Randomization to Month 11)|Adverse Event|0
3087321|NCT00378014|10589172|P1|Core (Randomization to Month 11)|Adverse Event|1
3087322|NCT00377962|10589198|P2|Extension Study: 12-24 Months|Unspecified reason|3
3087323|NCT00377962|10589199|P1|Extension Study: 12-24 Months|Unspecified reason|0
3087324|NCT00377962|10589198|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
3087325|NCT00377962|10589199|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
3087326|NCT00377962|10589198|P2|Extension Study: 12-24 Months|Adverse Event|0
3087327|NCT00377962|10589199|P1|Extension Study: 12-24 Months|Adverse Event|8
3087328|NCT00377962|10589198|P2|Extension Study: 12-24 Months|Death|1
3087329|NCT00377962|10589199|P1|Extension Study: 12-24 Months|Death|1
3087330|NCT00377962|10589198|P2|Core Study: 0-12 Months|Unspecified reasons|4
3087331|NCT00377962|10589199|P1|Core Study: 0-12 Months|Unspecified reasons|1
3087332|NCT00377962|10589198|P2|Core Study: 0-12 Months|Administrative Reason|1
3087333|NCT00377962|10589199|P1|Core Study: 0-12 Months|Administrative Reason|1
3087334|NCT00377962|10589198|P2|Core Study: 0-12 Months|Withdrew Consent|2
3087335|NCT00377962|10589199|P1|Core Study: 0-12 Months|Withdrew Consent|5
3087336|NCT00377962|10589198|P2|Core Study: 0-12 Months|Death|0
3087337|NCT00377962|10589199|P1|Core Study: 0-12 Months|Death|3
3087338|NCT00377962|10589198|P2|Core Study: 0-12 Months|Adverse Event|2
3087339|NCT00377962|10589199|P1|Core Study: 0-12 Months|Adverse Event|18
3087340|NCT00377858|10589235|P2|Overall Study|Death|3
3087341|NCT00377858|10589236|P1|Overall Study|Death|0
3087342|NCT00377858|10589235|P2|Overall Study|Sponsor Decision|2
3087343|NCT00377858|10589236|P1|Overall Study|Sponsor Decision|1
3087344|NCT00377858|10589235|P2|Overall Study|Entry Criteria Not Met|0
3087345|NCT00377858|10589236|P1|Overall Study|Entry Criteria Not Met|2
3087346|NCT00377858|10589235|P2|Overall Study|Adverse Event|1
3087347|NCT00377858|10589236|P1|Overall Study|Adverse Event|2
3087348|NCT00377858|10589235|P2|Overall Study|Protocol Violation|4
3087349|NCT00377858|10589236|P1|Overall Study|Protocol Violation|3
3087350|NCT00377858|10589235|P2|Overall Study|Physician Decision|5
3087351|NCT00377858|10589236|P1|Overall Study|Physician Decision|5
3087352|NCT00377858|10589235|P2|Overall Study|Lost to Follow-up|1
3087353|NCT00377858|10589236|P1|Overall Study|Lost to Follow-up|6
3087354|NCT00377858|10589235|P2|Overall Study|Withdrawal by Subject|11
3087355|NCT00377858|10589236|P1|Overall Study|Withdrawal by Subject|12
3087356|NCT00377819|10589289|P2|Overall Study|Protocol Violation|1
3087357|NCT00377819|10589290|P1|Overall Study|Protocol Violation|1
3087358|NCT00377819|10589289|P2|Overall Study|Lost to Follow-up|1
3087359|NCT00377819|10589290|P1|Overall Study|Lost to Follow-up|0
3087360|NCT00377819|10589289|P2|Overall Study|Death|1
3087361|NCT00377819|10589290|P1|Overall Study|Death|0
3087362|NCT00377819|10589289|P2|Overall Study|Withdrawal by Subject|4
3087363|NCT00377819|10589290|P1|Overall Study|Withdrawal by Subject|10
3087364|NCT00377819|10589289|P2|Overall Study|Adverse Event|3
3087365|NCT00377819|10589290|P1|Overall Study|Adverse Event|2
3087366|NCT00377676|10589319|P2|Overall Study|Other|58
3087367|NCT00377676|10589320|P1|Overall Study|Other|118
3087368|NCT00377676|10589319|P2|Overall Study|Lost to Follow-up|56
3087369|NCT00377676|10589320|P1|Overall Study|Lost to Follow-up|120
3087370|NCT00377676|10589319|P2|Overall Study|Withdrawal by Subject|72
3087371|NCT00377676|10589320|P1|Overall Study|Withdrawal by Subject|187
3087372|NCT00377676|10589319|P2|Overall Study|Death|2
3087373|NCT00377676|10589320|P1|Overall Study|Death|5
3087374|NCT00377676|10589319|P2|Overall Study|Protocol Violation|27
3087375|NCT00377676|10589320|P1|Overall Study|Protocol Violation|33
3087376|NCT00377676|10589319|P2|Overall Study|Adverse Event|107
3087377|NCT00377676|10589320|P1|Overall Study|Adverse Event|498
3087378|NCT00377637|10589336|P4|Maintenance Phase|Death|1
3087379|NCT00377637|10589337|P3|Maintenance Phase|Death|0
3087380|NCT00377637|10589338|P2|Maintenance Phase|Death|0
3087381|NCT00377637|10589339|P1|Maintenance Phase|Death|0
3087382|NCT00377637|10589336|P4|Maintenance Phase|Study medication stopped > 14 days|1
3087383|NCT00377637|10589337|P3|Maintenance Phase|Study medication stopped > 14 days|0
3087384|NCT00377637|10589338|P2|Maintenance Phase|Study medication stopped > 14 days|0
3087385|NCT00377637|10589339|P1|Maintenance Phase|Study medication stopped > 14 days|0
3087386|NCT00377637|10589336|P4|Maintenance Phase|Non-compliance|1
3087387|NCT00377637|10589337|P3|Maintenance Phase|Non-compliance|1
3087388|NCT00377637|10589338|P2|Maintenance Phase|Non-compliance|0
3087389|NCT00377637|10589339|P1|Maintenance Phase|Non-compliance|0
3087390|NCT00377637|10589336|P4|Maintenance Phase|Sponsor decision|3
3087391|NCT00377637|10589337|P3|Maintenance Phase|Sponsor decision|2
3087392|NCT00377637|10589338|P2|Maintenance Phase|Sponsor decision|0
3087393|NCT00377637|10589339|P1|Maintenance Phase|Sponsor decision|0
3087394|NCT00377637|10589336|P4|Maintenance Phase|Withdrawal by Subject|3
3087395|NCT00377637|10589337|P3|Maintenance Phase|Withdrawal by Subject|3
3087396|NCT00377637|10589338|P2|Maintenance Phase|Withdrawal by Subject|0
3087397|NCT00377637|10589339|P1|Maintenance Phase|Withdrawal by Subject|0
3087398|NCT00377637|10589336|P4|Maintenance Phase|Lost to Follow-up|1
3087399|NCT00377637|10589337|P3|Maintenance Phase|Lost to Follow-up|3
3087400|NCT00377637|10589338|P2|Maintenance Phase|Lost to Follow-up|0
3087401|NCT00377637|10589339|P1|Maintenance Phase|Lost to Follow-up|0
3087402|NCT00377637|10589336|P4|Maintenance Phase|Physician Decision|4
3087403|NCT00377637|10589337|P3|Maintenance Phase|Physician Decision|5
3087404|NCT00377637|10589338|P2|Maintenance Phase|Physician Decision|0
3087405|NCT00377637|10589339|P1|Maintenance Phase|Physician Decision|0
3087406|NCT00377637|10589336|P4|Maintenance Phase|Adverse Event|43
3087407|NCT00377637|10589337|P3|Maintenance Phase|Adverse Event|29
3087408|NCT00377637|10589338|P2|Maintenance Phase|Adverse Event|0
3087409|NCT00377637|10589339|P1|Maintenance Phase|Adverse Event|0
3087410|NCT00377637|10589336|P4|Induction Phase|Reason for withdrawal is not noted|0
3087411|NCT00377637|10589337|P3|Induction Phase|Reason for withdrawal is not noted|0
3087412|NCT00377637|10589338|P2|Induction Phase|Reason for withdrawal is not noted|0
3087413|NCT00377637|10589339|P1|Induction Phase|Reason for withdrawal is not noted|2
3087414|NCT00377637|10589336|P4|Induction Phase|Non-Compliance|0
3087415|NCT00377637|10589337|P3|Induction Phase|Non-Compliance|0
3087416|NCT00377637|10589338|P2|Induction Phase|Non-Compliance|0
3087417|NCT00377637|10589339|P1|Induction Phase|Non-Compliance|1
3087418|NCT00377637|10589336|P4|Induction Phase|Sponsor decision|0
3087419|NCT00377637|10589337|P3|Induction Phase|Sponsor decision|0
3087420|NCT00377637|10589338|P2|Induction Phase|Sponsor decision|2
3087421|NCT00377637|10589339|P1|Induction Phase|Sponsor decision|1
3087422|NCT00377637|10589336|P4|Induction Phase|Physician Decision|0
3087423|NCT00377637|10589337|P3|Induction Phase|Physician Decision|0
3087424|NCT00377637|10589338|P2|Induction Phase|Physician Decision|1
3087425|NCT00377637|10589339|P1|Induction Phase|Physician Decision|3
3087426|NCT00377637|10589336|P4|Induction Phase|Withdrawal by Subject|0
3087427|NCT00377637|10589337|P3|Induction Phase|Withdrawal by Subject|0
3087428|NCT00377637|10589338|P2|Induction Phase|Withdrawal by Subject|6
3087429|NCT00377637|10589339|P1|Induction Phase|Withdrawal by Subject|5
3087430|NCT00377637|10589336|P4|Induction Phase|Death|0
3087431|NCT00377637|10589337|P3|Induction Phase|Death|0
3087432|NCT00377637|10589338|P2|Induction Phase|Death|3
3087433|NCT00377637|10589339|P1|Induction Phase|Death|1
3087434|NCT00377637|10589336|P4|Induction Phase|Lost to Follow-up|0
3087435|NCT00377637|10589337|P3|Induction Phase|Lost to Follow-up|0
3087436|NCT00377637|10589338|P2|Induction Phase|Lost to Follow-up|1
3087437|NCT00377637|10589339|P1|Induction Phase|Lost to Follow-up|2
3087438|NCT00377637|10589336|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
3087439|NCT00377637|10589337|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
3087440|NCT00377637|10589338|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
3087441|NCT00377637|10589339|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
3087442|NCT00377637|10589336|P4|Induction Phase|Deterioration/serum creatinine|0
3087443|NCT00377637|10589337|P3|Induction Phase|Deterioration/serum creatinine|0
3087444|NCT00377637|10589338|P2|Induction Phase|Deterioration/serum creatinine|0
3087445|NCT00377637|10589339|P1|Induction Phase|Deterioration/serum creatinine|2
3087446|NCT00377637|10589336|P4|Induction Phase|Adverse Event|0
3087447|NCT00377637|10589337|P3|Induction Phase|Adverse Event|0
3087448|NCT00377637|10589338|P2|Induction Phase|Adverse Event|21
3087449|NCT00377637|10589339|P1|Induction Phase|Adverse Event|12
3087450|NCT00377611|10589375|P2|Overall Study|Other|3
3087451|NCT00377611|10589376|P1|Overall Study|Other|0
3087452|NCT00377611|10589375|P2|Overall Study|Lost to Follow-up|16
3087453|NCT00377611|10589376|P1|Overall Study|Lost to Follow-up|18
3087454|NCT00377611|10589375|P2|Overall Study|Withdrawal by Subject|5
3087455|NCT00377611|10589376|P1|Overall Study|Withdrawal by Subject|0
3087456|NCT00377611|10589375|P2|Overall Study|Protocol Violation|0
3087457|NCT00377611|10589376|P1|Overall Study|Protocol Violation|2
3087458|NCT00377611|10589375|P2|Overall Study|Adverse Event|9
3087459|NCT00377611|10589376|P1|Overall Study|Adverse Event|2
3087460|NCT00377520|10589478|P1|Overall Study|Ineligible (Prior radiation)|1
3087461|NCT00377455|10589483|P1|Overall Study|Withdrawal by Subject|1
3087462|NCT00377429|10589491|P1|Overall Study|Patient non-compliance|1
3087463|NCT00377429|10589491|P1|Overall Study|Physician Decision|1
3087464|NCT00377429|10589491|P1|Overall Study|Adverse Event|8
3087465|NCT00377429|10589491|P1|Overall Study|Withdrawal by Subject|5
3087466|NCT00377403|10589502|P2|Overall Study|Unable to contact for telephone intervie|7
3087467|NCT00377403|10589503|P1|Overall Study|Unable to contact for telephone intervie|4
3087468|NCT00377364|10589511|P2|Overall Study|Withdrawal by Subject|0
3087469|NCT00377364|10589512|P1|Overall Study|Withdrawal by Subject|1
3087470|NCT00377364|10589511|P2|Overall Study|Lost to Follow-up|0
3087471|NCT00377364|10589512|P1|Overall Study|Lost to Follow-up|1
3087472|NCT00377312|10589538|P2|Overall Study|Adverse Event|1
3087473|NCT00377312|10589539|P1|Overall Study|Adverse Event|1
3087474|NCT00377299|10589571|P2|Overall Study|Withdrawal by Subject|4
3087475|NCT00377299|10589572|P1|Overall Study|Withdrawal by Subject|5
3087476|NCT00377299|10589571|P2|Overall Study|Adverse Event|1
3087477|NCT00377299|10589572|P1|Overall Study|Adverse Event|0
3087478|NCT00377299|10589571|P2|Overall Study|Lost to Follow-up|19
3087479|NCT00377299|10589572|P1|Overall Study|Lost to Follow-up|14
3087480|NCT00377260|10589588|P2|Overall Study|Withdrawal by Subject|4
3087481|NCT00377260|10589589|P1|Overall Study|Withdrawal by Subject|2
3087482|NCT00377260|10589588|P2|Overall Study|Lost to Follow-up|1
3087483|NCT00377260|10589589|P1|Overall Study|Lost to Follow-up|0
3087484|NCT00377234|10589643|P2|Overall Study|Not assigned|2
3087485|NCT00377234|10589644|P1|Overall Study|Not assigned|3
3087486|NCT00377234|10589643|P2|Overall Study|Administrative|1
3087487|NCT00377234|10589644|P1|Overall Study|Administrative|2
3087488|NCT00377234|10589643|P2|Overall Study|Lost to Follow-up|2
3087489|NCT00377234|10589644|P1|Overall Study|Lost to Follow-up|4
3087490|NCT00377234|10589643|P2|Overall Study|Withdrawal by Subject|9
3087491|NCT00377234|10589644|P1|Overall Study|Withdrawal by Subject|11
3087492|NCT00377234|10589643|P2|Overall Study|Adverse Event|17
3087493|NCT00377234|10589644|P1|Overall Study|Adverse Event|14
3087494|NCT00377156|10589662|P2|Overall Study|Other|2
3087495|NCT00377156|10589663|P1|Overall Study|Other|5
3087496|NCT00377156|10589662|P2|Overall Study|Disability or language problem|1
3087497|NCT00377156|10589663|P1|Overall Study|Disability or language problem|0
3087498|NCT00377156|10589662|P2|Overall Study|Ineligible|1
3087499|NCT00377156|10589663|P1|Overall Study|Ineligible|0
3087500|NCT00377156|10589662|P2|Overall Study|Refused testing|1
3087501|NCT00377156|10589663|P1|Overall Study|Refused testing|0
3087502|NCT00377156|10589662|P2|Overall Study|Cancellation|0
3087503|NCT00377156|10589663|P1|Overall Study|Cancellation|1
3087504|NCT00377156|10589662|P2|Overall Study|Had follow-up <90 d|6
3087505|NCT00377156|10589663|P1|Overall Study|Had follow-up <90 d|3
3087506|NCT00377156|10589662|P2|Overall Study|Withdrawal by Subject|24
3087507|NCT00377156|10589663|P1|Overall Study|Withdrawal by Subject|16
3087508|NCT00377156|10589662|P2|Overall Study|Death|19
3087509|NCT00377156|10589663|P1|Overall Study|Death|23
3087510|NCT00376961|10589677|P2|Maintenance|Ineligible|3
3087511|NCT00376961|10589678|P1|Maintenance|Ineligible|0
3087512|NCT00376961|10589677|P2|Maintenance|Progression/relapse|18
3087513|NCT00376961|10589678|P1|Maintenance|Progression/relapse|0
3087514|NCT00376961|10589677|P2|Maintenance|Refusal Unrelated to Adverse Event|1
3087515|NCT00376961|10589678|P1|Maintenance|Refusal Unrelated to Adverse Event|0
3087516|NCT00376961|10589677|P2|Maintenance|Adverse Event|1
3087517|NCT00376961|10589678|P1|Maintenance|Adverse Event|0
3087518|NCT00376961|10589677|P2|Initial Registration|Ineligible|0
3087519|NCT00376961|10589678|P1|Initial Registration|Ineligible|3
3087520|NCT00376961|10589677|P2|Initial Registration|Progression/relapse|0
3087521|NCT00376961|10589678|P1|Initial Registration|Progression/relapse|1
3087522|NCT00376961|10589677|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
3087523|NCT00376961|10589678|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
3087524|NCT00376961|10589677|P2|Initial Registration|Adverse Event|0
3087525|NCT00376961|10589678|P1|Initial Registration|Adverse Event|1
3087526|NCT00376688|10589744|P1|Overall Study|Death|1
3087527|NCT00376688|10589744|P1|Overall Study|Adverse Event|3
3087528|NCT00376675|10589750|P2|Overall Study|Other Reason|7
3087529|NCT00376675|10589751|P1|Overall Study|Other Reason|1
3087530|NCT00376675|10589750|P2|Overall Study|Adverse Event|5
3087531|NCT00376675|10589751|P1|Overall Study|Adverse Event|10
3087532|NCT00376675|10589750|P2|Overall Study|Withdrawal by Subject|2
3087533|NCT00376675|10589751|P1|Overall Study|Withdrawal by Subject|9
3087534|NCT00376532|10589800|P2|Overall Study|Lack sufficient blood sample|6
3087535|NCT00376532|10589801|P1|Overall Study|Lack sufficient blood sample|6
3087536|NCT00376506|10589811|P2|Overall Study|Death|2
3087537|NCT00376506|10589812|P1|Overall Study|Death|0
3087538|NCT00376259|10589843|P2|Overall Study|Patient request|0
3087539|NCT00376259|10589844|P1|Overall Study|Patient request|1
3087540|NCT00376259|10589843|P2|Overall Study|Sponsor request - study termination|21
3087541|NCT00376259|10589844|P1|Overall Study|Sponsor request - study termination|21
3087542|NCT00376246|10589856|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
3087543|NCT00376246|10589857|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
3087544|NCT00376246|10589856|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
3087545|NCT00376246|10589857|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
3087546|NCT00376246|10589856|P2|First Intervention (2 Weeks)|Adverse Event|0
3087547|NCT00376246|10589857|P1|First Intervention (2 Weeks)|Adverse Event|2
3087548|NCT00376220|10589867|P2|Overall Study|Withdrawal by Subject|2
3087549|NCT00376220|10589868|P1|Overall Study|Withdrawal by Subject|3
3087550|NCT00376220|10589867|P2|Overall Study|Lost to Follow-up|10
3087551|NCT00376220|10589868|P1|Overall Study|Lost to Follow-up|7
3087552|NCT00376168|10589876|P2|Overall Study|Pregnancy|0
3087553|NCT00376168|10589877|P1|Overall Study|Pregnancy|1
3087554|NCT00376168|10589876|P2|Overall Study|Adverse Event|1
3087555|NCT00376168|10589877|P1|Overall Study|Adverse Event|1
3087556|NCT00375934|10589918|P2|Overall Study|Physician Decision|1
3087557|NCT00375934|10589919|P1|Overall Study|Physician Decision|0
3087558|NCT00375934|10589918|P2|Overall Study|Lack of Efficacy|2
3087559|NCT00375934|10589919|P1|Overall Study|Lack of Efficacy|0
3087560|NCT00375934|10589918|P2|Overall Study|Withdrawal by Subject|2
3087561|NCT00375934|10589919|P1|Overall Study|Withdrawal by Subject|2
3087562|NCT00375934|10589918|P2|Overall Study|Adverse Event|1
3087563|NCT00375934|10589919|P1|Overall Study|Adverse Event|1
3087564|NCT00375752|10589977|P2|Overall Study|Administrative Problems|1
3087565|NCT00375752|10589978|P1|Overall Study|Administrative Problems|0
3087566|NCT00375752|10589977|P2|Overall Study|Protocol Violation|2
3087567|NCT00375752|10589978|P1|Overall Study|Protocol Violation|0
3087568|NCT00375752|10589977|P2|Overall Study|Abnormal Laboratory Value(s)|1
3087569|NCT00375752|10589978|P1|Overall Study|Abnormal Laboratory Value(s)|1
3087570|NCT00375752|10589977|P2|Overall Study|Withdrawal by Subject|1
3087571|NCT00375752|10589978|P1|Overall Study|Withdrawal by Subject|6
3087572|NCT00375752|10589977|P2|Overall Study|Adverse Event|6
3087573|NCT00375752|10589978|P1|Overall Study|Adverse Event|1
3087574|NCT00375752|10589977|P2|Overall Study|Lack of Efficacy|4
3087575|NCT00375752|10589978|P1|Overall Study|Lack of Efficacy|4
3087576|NCT00375674|10590009|P2|Overall Study|Enrolled but not treated|2
3087577|NCT00375674|10590010|P1|Overall Study|Enrolled but not treated|3
3087578|NCT00375674|10590009|P2|Overall Study|Lost to Follow-up|15
3087579|NCT00375674|10590010|P1|Overall Study|Lost to Follow-up|17
3087580|NCT00375674|10590009|P2|Overall Study|Participants refused further follow-up|30
3087581|NCT00375674|10590010|P1|Overall Study|Participants refused further follow-up|31
3087582|NCT00375674|10590009|P2|Overall Study|Death|76
3087583|NCT00375674|10590010|P1|Overall Study|Death|67
3087584|NCT00375674|10590009|P2|Overall Study|Other|18
3087585|NCT00375674|10590010|P1|Overall Study|Other|26
3087586|NCT00375609|10590039|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
3087587|NCT00375609|10590040|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
3087588|NCT00375609|10590041|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
3087589|NCT00375609|10590039|P3|Overall Study|Withdrawal by Subject|0
3087590|NCT00375609|10590040|P2|Overall Study|Withdrawal by Subject|4
3087591|NCT00375609|10590041|P1|Overall Study|Withdrawal by Subject|1
3087592|NCT00375609|10590039|P3|Overall Study|Physician Decision|1
3087593|NCT00375609|10590040|P2|Overall Study|Physician Decision|0
3087594|NCT00375609|10590041|P1|Overall Study|Physician Decision|0
3087595|NCT00375609|10590039|P3|Overall Study|Lost to Follow-up|0
3087596|NCT00375609|10590040|P2|Overall Study|Lost to Follow-up|0
3087597|NCT00375609|10590041|P1|Overall Study|Lost to Follow-up|1
3087598|NCT00375609|10590039|P3|Overall Study|Adverse Event|0
3087599|NCT00375609|10590040|P2|Overall Study|Adverse Event|3
3087600|NCT00375609|10590041|P1|Overall Study|Adverse Event|0
3087601|NCT00375609|10590039|P3|Overall Study|Did not receive treatment|0
3087602|NCT00375609|10590040|P2|Overall Study|Did not receive treatment|0
3087603|NCT00375609|10590041|P1|Overall Study|Did not receive treatment|1
3087604|NCT00375518|10590057|P2|Overall Study|Death|1
3087605|NCT00375518|10590058|P1|Overall Study|Death|0
3087606|NCT00375518|10590057|P2|Overall Study|Patient Not Treated|6
3087607|NCT00375518|10590058|P1|Overall Study|Patient Not Treated|6
3087608|NCT00375518|10590057|P2|Overall Study|Withdrawal by Subject|10
3087609|NCT00375518|10590058|P1|Overall Study|Withdrawal by Subject|2
3087610|NCT00375505|10590066|P2|Overall Study|Adverse Event|2
3087611|NCT00375505|10590067|P1|Overall Study|Adverse Event|1
3087612|NCT00375492|10590111|P2|Overall Study|Withdrawal by Subject|6
3087613|NCT00375492|10590112|P1|Overall Study|Withdrawal by Subject|6
3087614|NCT00375492|10590111|P2|Overall Study|Sponsor Decision|1
3087615|NCT00375492|10590112|P1|Overall Study|Sponsor Decision|0
3087616|NCT00375492|10590111|P2|Overall Study|Protocol Violation|3
3087617|NCT00375492|10590112|P1|Overall Study|Protocol Violation|6
3087618|NCT00375492|10590111|P2|Overall Study|Physician Decision|4
3087619|NCT00375492|10590112|P1|Overall Study|Physician Decision|0
3087620|NCT00375492|10590111|P2|Overall Study|Lost to Follow-up|5
3087621|NCT00375492|10590112|P1|Overall Study|Lost to Follow-up|10
3087622|NCT00375492|10590111|P2|Overall Study|Loss of Glucose Control|1
3087623|NCT00375492|10590112|P1|Overall Study|Loss of Glucose Control|0
3087624|NCT00375492|10590111|P2|Overall Study|Entry Criteria Not Met|1
3087625|NCT00375492|10590112|P1|Overall Study|Entry Criteria Not Met|0
3087626|NCT00375492|10590111|P2|Overall Study|Adverse Event|5
3087627|NCT00375492|10590112|P1|Overall Study|Adverse Event|4
3087628|NCT00375427|10590142|P2|Overall Study|Death|10
3087629|NCT00375427|10590143|P1|Overall Study|Death|11
3087630|NCT00375427|10590142|P2|Overall Study|Administrative reasons|1
3087631|NCT00375427|10590143|P1|Overall Study|Administrative reasons|0
3087632|NCT00375427|10590142|P2|Overall Study|Lost to Follow-up|1
3087633|NCT00375427|10590143|P1|Overall Study|Lost to Follow-up|1
3087634|NCT00375427|10590142|P2|Overall Study|Withdrawal by Subject|13
3087635|NCT00375427|10590143|P1|Overall Study|Withdrawal by Subject|9
3087636|NCT00375427|10590142|P2|Overall Study|Protocol Violation|8
3087637|NCT00375427|10590143|P1|Overall Study|Protocol Violation|10
3087638|NCT00375427|10590142|P2|Overall Study|Patient no longer requires study drug|7
3087639|NCT00375427|10590143|P1|Overall Study|Patient no longer requires study drug|3
3087640|NCT00375427|10590142|P2|Overall Study|Unsatisfactory therapeutic effect|4
3087641|NCT00375427|10590143|P1|Overall Study|Unsatisfactory therapeutic effect|4
3087642|NCT00375427|10590142|P2|Overall Study|Abnormal laboratory value(s)|2
3087643|NCT00375427|10590143|P1|Overall Study|Abnormal laboratory value(s)|1
3087644|NCT00375427|10590142|P2|Overall Study|Abnormal test procedure result(s)|1
3087645|NCT00375427|10590143|P1|Overall Study|Abnormal test procedure result(s)|0
3087646|NCT00375427|10590142|P2|Overall Study|Adverse Event|27
3087647|NCT00375427|10590143|P1|Overall Study|Adverse Event|21
3087648|NCT00375219|10590168|P3|Overall Study|Withdrawal by Subject|0
3087649|NCT00375219|10590169|P2|Overall Study|Withdrawal by Subject|0
3087650|NCT00375219|10590170|P1|Overall Study|Withdrawal by Subject|1
3087651|NCT00375219|10590168|P3|Overall Study|Cord blood transplantation|0
3087652|NCT00375219|10590169|P2|Overall Study|Cord blood transplantation|0
3087653|NCT00375219|10590170|P1|Overall Study|Cord blood transplantation|1
3087654|NCT00375219|10590168|P3|Overall Study|Allograft|0
3087655|NCT00375219|10590169|P2|Overall Study|Allograft|0
3087656|NCT00375219|10590170|P1|Overall Study|Allograft|2
3087657|NCT00375219|10590168|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
3087658|NCT00375219|10590169|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
3087659|NCT00375219|10590170|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
3087660|NCT00375219|10590168|P3|Overall Study|Hematologic resistance|0
3087661|NCT00375219|10590169|P2|Overall Study|Hematologic resistance|0
3087662|NCT00375219|10590170|P1|Overall Study|Hematologic resistance|1
3087663|NCT00375219|10590168|P3|Overall Study|Death|7
3087664|NCT00375219|10590169|P2|Overall Study|Death|3
3087665|NCT00375219|10590170|P1|Overall Study|Death|4
3087666|NCT00375219|10590168|P3|Overall Study|Disease progression|12
3087667|NCT00375219|10590169|P2|Overall Study|Disease progression|9
3087668|NCT00375219|10590170|P1|Overall Study|Disease progression|18
3087669|NCT00375219|10590168|P3|Overall Study|Lost to Follow-up|0
3087670|NCT00375219|10590169|P2|Overall Study|Lost to Follow-up|1
3087671|NCT00375219|10590170|P1|Overall Study|Lost to Follow-up|1
3087672|NCT00375219|10590168|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
3087673|NCT00375219|10590169|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
3087674|NCT00375219|10590170|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
3087675|NCT00375219|10590168|P3|Overall Study|Protocol Violation|1
3087676|NCT00375219|10590169|P2|Overall Study|Protocol Violation|0
3087677|NCT00375219|10590170|P1|Overall Study|Protocol Violation|1
3087678|NCT00375219|10590168|P3|Overall Study|Adverse Event|1
3087679|NCT00375219|10590169|P2|Overall Study|Adverse Event|2
3087680|NCT00375219|10590170|P1|Overall Study|Adverse Event|8
3087681|NCT00375219|10590168|P3|Overall Study|Failure to achieve a response|0
3087682|NCT00375219|10590169|P2|Overall Study|Failure to achieve a response|2
3087683|NCT00375219|10590170|P1|Overall Study|Failure to achieve a response|16
3087684|NCT00374907|10590253|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
3087685|NCT00374907|10590254|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
3087686|NCT00374907|10590253|P2|116-Week Short-term + Long-term Period|Adverse Event|2
3087687|NCT00374907|10590254|P1|116-Week Short-term + Long-term Period|Adverse Event|0
3087688|NCT00374907|10590253|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
3087689|NCT00374907|10590254|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
3087690|NCT00374907|10590253|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
3087691|NCT00374907|10590254|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
3087692|NCT00374907|10590253|P2|12-Week Short-term Period|Subject Withdrew Consent|1
3087693|NCT00374907|10590254|P1|12-Week Short-term Period|Subject Withdrew Consent|3
3087694|NCT00374868|10590266|P1|Overall Study|Other - Not Specified|1
3087695|NCT00374868|10590266|P1|Overall Study|Death|2
3087696|NCT00374868|10590266|P1|Overall Study|Lost to Follow-up|1
3087697|NCT00374868|10590266|P1|Overall Study|Physician Decision|13
3087698|NCT00374868|10590266|P1|Overall Study|Progressive Disease|7
3087699|NCT00374868|10590266|P1|Overall Study|Adverse Event|12
3087700|NCT00374556|10590330|P2|Overall Study|Removed at baseline due to medical cond|1
3087701|NCT00374556|10590331|P1|Overall Study|Removed at baseline due to medical cond|0
3087702|NCT00374556|10590330|P2|Overall Study|Lost to Follow-up|0
3087703|NCT00374556|10590331|P1|Overall Study|Lost to Follow-up|1
3087704|NCT00374452|10590392|P2|Overall Study|Withdrawal by Subject|2
3087705|NCT00374452|10590393|P1|Overall Study|Withdrawal by Subject|0
3087706|NCT00374452|10590392|P2|Overall Study|Left clinic after intervention started|1
3087707|NCT00374452|10590393|P1|Overall Study|Left clinic after intervention started|1
3087708|NCT00374452|10590392|P2|Overall Study|Change in job role before intervention|1
3087709|NCT00374452|10590393|P1|Overall Study|Change in job role before intervention|0
3087710|NCT00374452|10590392|P2|Overall Study|Left clinic before intervention started|1
3087711|NCT00374452|10590393|P1|Overall Study|Left clinic before intervention started|4
3087712|NCT00374322|10590406|P2|Overall Study|Did Not Receive Study Medication|6
3087713|NCT00374322|10590407|P1|Overall Study|Did Not Receive Study Medication|8
3087714|NCT00374322|10590406|P2|Overall Study|Withdrew Consent During Follow-up|5
3087715|NCT00374322|10590407|P1|Overall Study|Withdrew Consent During Follow-up|0
3087716|NCT00374322|10590406|P2|Overall Study|Noncompliance with Study Requirements|1
3087717|NCT00374322|10590407|P1|Overall Study|Noncompliance with Study Requirements|0
3087718|NCT00374322|10590406|P2|Overall Study|Started Another Chemotherapy Regimen|1
3087719|NCT00374322|10590407|P1|Overall Study|Started Another Chemotherapy Regimen|0
3087720|NCT00374322|10590406|P2|Overall Study|Participant Changed Physician|0
3087721|NCT00374322|10590407|P1|Overall Study|Participant Changed Physician|1
3087722|NCT00374322|10590406|P2|Overall Study|Site Closed|2
3087723|NCT00374322|10590407|P1|Overall Study|Site Closed|2
3087724|NCT00374322|10590406|P2|Overall Study|Severe Toxicity|0
3087725|NCT00374322|10590407|P1|Overall Study|Severe Toxicity|1
3087726|NCT00374322|10590406|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
3087727|NCT00374322|10590407|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
3087728|NCT00374322|10590406|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
3087729|NCT00374322|10590407|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
3087730|NCT00374322|10590406|P2|Overall Study|Sponsor Decision|3
3087731|NCT00374322|10590407|P1|Overall Study|Sponsor Decision|2
3087732|NCT00374322|10590406|P2|Overall Study|Par. Consented to Survival FU Only|1
3087733|NCT00374322|10590407|P1|Overall Study|Par. Consented to Survival FU Only|3
3087734|NCT00374322|10590406|P2|Overall Study|Physician Decision|32
3087735|NCT00374322|10590407|P1|Overall Study|Physician Decision|36
3087736|NCT00374322|10590406|P2|Overall Study|Sponsor Terminated Study|990
3087737|NCT00374322|10590407|P1|Overall Study|Sponsor Terminated Study|866
3087738|NCT00374322|10590406|P2|Overall Study|Withdrawal by Subject|167
3087739|NCT00374322|10590407|P1|Overall Study|Withdrawal by Subject|235
3087740|NCT00374322|10590406|P2|Overall Study|Protocol Violation|3
3087741|NCT00374322|10590407|P1|Overall Study|Protocol Violation|8
3087742|NCT00374322|10590406|P2|Overall Study|Lost to Follow-up|90
3087743|NCT00374322|10590407|P1|Overall Study|Lost to Follow-up|92
3087744|NCT00374140|10590498|P1|Overall Study|Protocol Violation|1
3087745|NCT00374140|10590498|P1|Overall Study|Lost to Follow-up|1
3087746|NCT00374127|10590505|P1|Overall Study|Pregnancy|1
3087747|NCT00374127|10590505|P1|Overall Study|Protocol Violation|5
3087748|NCT00374127|10590505|P1|Overall Study|Blood could not be drawn.|2
3087749|NCT00374127|10590505|P1|Overall Study|Did not inhale during smoking procedure.|3
3087750|NCT00373958|10590554|P2|Toddler Dose|Withdrawn after infant series|25
3087751|NCT00373958|10590555|P1|Toddler Dose|Withdrawn after infant series|22
3087752|NCT00373958|10590554|P2|Toddler Dose|Protocol Violation|1
3087753|NCT00373958|10590555|P1|Toddler Dose|Protocol Violation|0
3087754|NCT00373958|10590554|P2|Toddler Dose|Failed to return|2
3087755|NCT00373958|10590555|P1|Toddler Dose|Failed to return|1
3087756|NCT00373958|10590554|P2|Toddler Dose|Withdrawal by Subject|2
3087757|NCT00373958|10590555|P1|Toddler Dose|Withdrawal by Subject|2
3087758|NCT00373958|10590554|P2|Toddler Dose|Lost to Follow-up|8
3087759|NCT00373958|10590555|P1|Toddler Dose|Lost to Follow-up|5
3087760|NCT00373958|10590554|P2|Infant Series|Physician Decision|1
3087761|NCT00373958|10590555|P1|Infant Series|Physician Decision|1
3087762|NCT00373958|10590554|P2|Infant Series|Adverse Event|1
3087763|NCT00373958|10590555|P1|Infant Series|Adverse Event|3
3087764|NCT00373958|10590554|P2|Infant Series|Consent was not received|0
3087765|NCT00373958|10590555|P1|Infant Series|Consent was not received|1
3087766|NCT00373958|10590554|P2|Infant Series|Child relocated|0
3087767|NCT00373958|10590555|P1|Infant Series|Child relocated|1
3087768|NCT00373958|10590554|P2|Infant Series|Lost Kaiser coverage|0
3087769|NCT00373958|10590555|P1|Infant Series|Lost Kaiser coverage|4
3087770|NCT00373958|10590554|P2|Infant Series|Protocol Violation|7
3087771|NCT00373958|10590555|P1|Infant Series|Protocol Violation|3
3087772|NCT00373958|10590554|P2|Infant Series|Lost to Follow-up|5
3087773|NCT00373958|10590555|P1|Infant Series|Lost to Follow-up|6
3087774|NCT00373958|10590554|P2|Infant Series|Failed to return|13
3087775|NCT00373958|10590555|P1|Infant Series|Failed to return|8
3087776|NCT00373958|10590554|P2|Infant Series|Withdrawal by Subject|15
3087777|NCT00373958|10590555|P1|Infant Series|Withdrawal by Subject|13
3087778|NCT00373880|10590603|P1|Overall Study|Protocol Violation|14
3087779|NCT00373880|10590603|P1|Overall Study|Arrested|1
3087780|NCT00373880|10590603|P1|Overall Study|Physician Decision|3
3087781|NCT00373685|10590648|P2|Overall Study|Randomized, not treated|77
3087782|NCT00373685|10590649|P1|Overall Study|Randomized, not treated|51
3087783|NCT00373685|10590648|P2|Overall Study|Final Status Unknown|4
3087784|NCT00373685|10590649|P1|Overall Study|Final Status Unknown|12
3087785|NCT00373685|10590648|P2|Overall Study|Protocol Violation|182
3087786|NCT00373685|10590649|P1|Overall Study|Protocol Violation|191
3087787|NCT00373685|10590648|P2|Overall Study|Other|146
3087788|NCT00373685|10590649|P1|Overall Study|Other|149
3087789|NCT00373685|10590648|P2|Overall Study|No longer willing to participate|352
3087790|NCT00373685|10590649|P1|Overall Study|No longer willing to participate|337
3087791|NCT00373685|10590648|P2|Overall Study|Lost to follow up|103
3087792|NCT00373685|10590649|P1|Overall Study|Lost to follow up|83
3087793|NCT00373685|10590648|P2|Overall Study|Did not meet entrance criteria|184
3087794|NCT00373685|10590649|P1|Overall Study|Did not meet entrance criteria|167
3087795|NCT00373685|10590648|P2|Overall Study|Insufficient clinical response|119
3087796|NCT00373685|10590649|P1|Overall Study|Insufficient clinical response|169
3087797|NCT00373685|10590648|P2|Overall Study|Adverse Event|253
3087798|NCT00373685|10590649|P1|Overall Study|Adverse Event|278
3087799|NCT00373685|10590648|P2|Overall Study|Death|1
3087800|NCT00373685|10590649|P1|Overall Study|Death|2
3087801|NCT00373529|10590683|P1|Overall Study|Consent violation|1
3087802|NCT00373529|10590683|P1|Overall Study|Failed independent confirmation of AML|3
3087803|NCT00373529|10590683|P1|Overall Study|Other|8
3087804|NCT00373529|10590683|P1|Overall Study|Need for treatment prohibited by study|1
3087805|NCT00373529|10590683|P1|Overall Study|Death|16
3087806|NCT00373529|10590683|P1|Overall Study|Disease recurrence|10
3087807|NCT00373529|10590683|P1|Overall Study|Treatment failure|36
3087808|NCT00373529|10590683|P1|Overall Study|Adverse Event|7
3087809|NCT00373529|10590683|P1|Overall Study|Withdrawal by Subject|7
3087810|NCT00373529|10590683|P1|Overall Study|Physician Decision|19
3087811|NCT00373490|10590695|P2|Overall Study|Withdrawal by Subject|1
3087812|NCT00373490|10590696|P1|Overall Study|Withdrawal by Subject|0
3087813|NCT00373490|10590695|P2|Overall Study|Lack of Efficacy|4
3087814|NCT00373490|10590696|P1|Overall Study|Lack of Efficacy|9
3087815|NCT00373490|10590695|P2|Overall Study|Adverse Event|1
3087816|NCT00373490|10590696|P1|Overall Study|Adverse Event|0
3087817|NCT00373425|10590719|P5|Overall Study|Death|0
3087818|NCT00373425|10590720|P4|Overall Study|Death|1
3087819|NCT00373425|10590721|P3|Overall Study|Death|3
3087820|NCT00373425|10590722|P2|Overall Study|Death|0
3087821|NCT00373425|10590723|P1|Overall Study|Death|7
3087822|NCT00373425|10590719|P5|Overall Study|Medical/ethical/noncompliance reason|5
3087823|NCT00373425|10590720|P4|Overall Study|Medical/ethical/noncompliance reason|2
3087824|NCT00373425|10590721|P3|Overall Study|Medical/ethical/noncompliance reason|10
3087825|NCT00373425|10590722|P2|Overall Study|Medical/ethical/noncompliance reason|9
3087826|NCT00373425|10590723|P1|Overall Study|Medical/ethical/noncompliance reason|21
3087827|NCT00373425|10590719|P5|Overall Study|Patient request|7
3087828|NCT00373425|10590720|P4|Overall Study|Patient request|6
3087829|NCT00373425|10590721|P3|Overall Study|Patient request|43
3087830|NCT00373425|10590722|P2|Overall Study|Patient request|18
3087831|NCT00373425|10590723|P1|Overall Study|Patient request|35
3087832|NCT00373425|10590719|P5|Overall Study|Adverse Event|34
3087833|NCT00373425|10590720|P4|Overall Study|Adverse Event|0
3087834|NCT00373425|10590721|P3|Overall Study|Adverse Event|59
3087835|NCT00373425|10590722|P2|Overall Study|Adverse Event|22
3087836|NCT00373425|10590723|P1|Overall Study|Adverse Event|191
3087837|NCT00373425|10590719|P5|Overall Study|Relapse of NSCLC|26
3087838|NCT00373425|10590720|P4|Overall Study|Relapse of NSCLC|2
3087839|NCT00373425|10590721|P3|Overall Study|Relapse of NSCLC|19
3087840|NCT00373425|10590722|P2|Overall Study|Relapse of NSCLC|104
3087841|NCT00373425|10590723|P1|Overall Study|Relapse of NSCLC|116
3087842|NCT00373295|10590818|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
3087843|NCT00373295|10590819|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
3087844|NCT00373295|10590820|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
3087845|NCT00373295|10590821|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
3087846|NCT00373295|10590822|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
3087847|NCT00373295|10590823|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
3087848|NCT00373256|10590844|P2|Overall Study|Study Terminated by Sponsor|13
3087849|NCT00373256|10590845|P1|Overall Study|Study Terminated by Sponsor|41
3087850|NCT00373256|10590844|P2|Overall Study|Protocol Violation|2
3087851|NCT00373256|10590845|P1|Overall Study|Protocol Violation|0
3087852|NCT00373256|10590844|P2|Overall Study|Other|107
3087853|NCT00373256|10590845|P1|Overall Study|Other|73
3087854|NCT00373256|10590844|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
3087855|NCT00373256|10590845|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
3087856|NCT00373256|10590844|P2|Overall Study|Objective Progression or Relapse|104
3087857|NCT00373256|10590845|P1|Overall Study|Objective Progression or Relapse|111
3087858|NCT00373256|10590844|P2|Overall Study|Death|8
3087859|NCT00373256|10590845|P1|Overall Study|Death|9
3087860|NCT00373256|10590844|P2|Overall Study|Lost to Follow-up|1
3087861|NCT00373256|10590845|P1|Overall Study|Lost to Follow-up|2
3087862|NCT00373256|10590844|P2|Overall Study|Adverse Event (AE)|5
3087863|NCT00373256|10590845|P1|Overall Study|Adverse Event (AE)|1
3087864|NCT00373113|10590871|P2|Overall Study|Withdrawal by Subject|15
3087865|NCT00373113|10590872|P1|Overall Study|Withdrawal by Subject|10
3087866|NCT00373113|10590871|P2|Overall Study|Protocol Violation|1
3087867|NCT00373113|10590872|P1|Overall Study|Protocol Violation|5
3087868|NCT00373113|10590871|P2|Overall Study|Other|17
3087869|NCT00373113|10590872|P1|Overall Study|Other|14
3087870|NCT00373113|10590871|P2|Overall Study|Objective progression or relapse|169
3087871|NCT00373113|10590872|P1|Overall Study|Objective progression or relapse|150
3087872|NCT00373113|10590871|P2|Overall Study|Lost to Follow-up|3
3087873|NCT00373113|10590872|P1|Overall Study|Lost to Follow-up|1
3087874|NCT00373113|10590871|P2|Overall Study|Global deterioration of health status|7
3087875|NCT00373113|10590872|P1|Overall Study|Global deterioration of health status|10
3087876|NCT00373113|10590871|P2|Overall Study|Study terminated by sponsor|1
3087877|NCT00373113|10590872|P1|Overall Study|Study terminated by sponsor|9
3087878|NCT00373113|10590871|P2|Overall Study|Adverse Event|24
3087879|NCT00373113|10590872|P1|Overall Study|Adverse Event|38
3087880|NCT00373113|10590871|P2|Overall Study|Death|7
3087881|NCT00373113|10590872|P1|Overall Study|Death|1
3087882|NCT00372996|10590894|P4|Overall Study|Other|7
3087883|NCT00372996|10590895|P3|Overall Study|Other|7
3087884|NCT00372996|10590896|P2|Overall Study|Other|2
3087885|NCT00372996|10590897|P1|Overall Study|Other|10
3087886|NCT00372996|10590894|P4|Overall Study|Study Terminated by Sponsor|0
3087887|NCT00372996|10590895|P3|Overall Study|Study Terminated by Sponsor|4
3087888|NCT00372996|10590896|P2|Overall Study|Study Terminated by Sponsor|0
3087889|NCT00372996|10590897|P1|Overall Study|Study Terminated by Sponsor|4
3087890|NCT00372996|10590894|P4|Overall Study|Withdrawal by Subject|5
3087891|NCT00372996|10590895|P3|Overall Study|Withdrawal by Subject|9
3087892|NCT00372996|10590896|P2|Overall Study|Withdrawal by Subject|6
3087893|NCT00372996|10590897|P1|Overall Study|Withdrawal by Subject|12
3087894|NCT00372996|10590894|P4|Overall Study|Lost to Follow-up|1
3087895|NCT00372996|10590895|P3|Overall Study|Lost to Follow-up|0
3087896|NCT00372996|10590896|P2|Overall Study|Lost to Follow-up|2
3087897|NCT00372996|10590897|P1|Overall Study|Lost to Follow-up|0
3087898|NCT00372996|10590894|P4|Overall Study|Death|7
3087899|NCT00372996|10590895|P3|Overall Study|Death|8
3087900|NCT00372996|10590896|P2|Overall Study|Death|4
3087901|NCT00372996|10590897|P1|Overall Study|Death|11
3087902|NCT00372905|10590982|P4|Follow up Until Relapse or Progression|Other|0
3087903|NCT00372905|10590983|P3|Follow up Until Relapse or Progression|Other|0
3087904|NCT00372905|10590984|P2|Follow up Until Relapse or Progression|Other|1
3087905|NCT00372905|10590985|P1|Follow up Until Relapse or Progression|Other|0
3087906|NCT00372905|10590982|P4|Follow up Until Relapse or Progression|Study closed|3
3087907|NCT00372905|10590983|P3|Follow up Until Relapse or Progression|Study closed|0
3087908|NCT00372905|10590984|P2|Follow up Until Relapse or Progression|Study closed|0
3087909|NCT00372905|10590985|P1|Follow up Until Relapse or Progression|Study closed|0
3087910|NCT00372905|10590982|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
3087911|NCT00372905|10590983|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
3087912|NCT00372905|10590984|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
3087913|NCT00372905|10590985|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
3087914|NCT00372905|10590982|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
3087915|NCT00372905|10590983|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
3087916|NCT00372905|10590984|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
3087917|NCT00372905|10590985|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
3087918|NCT00372905|10590982|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
3087919|NCT00372905|10590983|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
3087920|NCT00372905|10590984|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
3087921|NCT00372905|10590985|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
3087922|NCT00372905|10590982|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
3087923|NCT00372905|10590983|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
3087924|NCT00372905|10590984|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
3087925|NCT00372905|10590985|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
3087926|NCT00372775|10590997|P1|Overall Study|Not Treated|2
3087927|NCT00372775|10590997|P1|Overall Study|Other|1
3087928|NCT00372775|10590997|P1|Overall Study|Withdrawal by Subject|1
3087929|NCT00372775|10590997|P1|Overall Study|Global deterioration of health status|6
3087930|NCT00372775|10590997|P1|Overall Study|Objective progression or relapse|30
3087931|NCT00372775|10590997|P1|Overall Study|Death|15
3087932|NCT00372775|10590997|P1|Overall Study|Adverse Event|8
3087933|NCT00372697|10591019|P2|Overall Study|Protocol Violation|1
3087934|NCT00372697|10591020|P1|Overall Study|Protocol Violation|1
3087935|NCT00372619|10591045|P7|Overall Study|Inevaluable|0
3087936|NCT00372619|10591046|P6|Overall Study|Inevaluable|1
3087937|NCT00372619|10591047|P5|Overall Study|Inevaluable|0
3087938|NCT00372619|10591048|P4|Overall Study|Inevaluable|0
3087939|NCT00372619|10591049|P3|Overall Study|Inevaluable|0
3087940|NCT00372619|10591050|P2|Overall Study|Inevaluable|0
3087941|NCT00372619|10591051|P1|Overall Study|Inevaluable|0
3087942|NCT00372619|10591045|P7|Overall Study|Ineligible|0
3087943|NCT00372619|10591046|P6|Overall Study|Ineligible|2
3087944|NCT00372619|10591047|P5|Overall Study|Ineligible|0
3087945|NCT00372619|10591048|P4|Overall Study|Ineligible|0
3087946|NCT00372619|10591049|P3|Overall Study|Ineligible|0
3087947|NCT00372619|10591050|P2|Overall Study|Ineligible|0
3087948|NCT00372619|10591051|P1|Overall Study|Ineligible|0
3087949|NCT00372593|10591084|P3|Overall Study|Ineligible|1
3087950|NCT00372593|10591085|P2|Overall Study|Ineligible|21
3087951|NCT00372593|10591086|P1|Overall Study|Ineligible|20
3087952|NCT00372593|10591084|P3|Overall Study|Physician Decision|0
3087953|NCT00372593|10591085|P2|Overall Study|Physician Decision|41
3087954|NCT00372593|10591086|P1|Overall Study|Physician Decision|42
3087955|NCT00372593|10591084|P3|Overall Study|Lost to Follow-up|0
3087956|NCT00372593|10591085|P2|Overall Study|Lost to Follow-up|0
3087957|NCT00372593|10591086|P1|Overall Study|Lost to Follow-up|1
3087958|NCT00372593|10591084|P3|Overall Study|Lack of Efficacy|2
3087959|NCT00372593|10591085|P2|Overall Study|Lack of Efficacy|71
3087960|NCT00372593|10591086|P1|Overall Study|Lack of Efficacy|82
3087961|NCT00372593|10591084|P3|Overall Study|Death|1
3087962|NCT00372593|10591085|P2|Overall Study|Death|20
3087963|NCT00372593|10591086|P1|Overall Study|Death|16
3087964|NCT00372593|10591084|P3|Overall Study|Adverse Event|0
3087965|NCT00372593|10591085|P2|Overall Study|Adverse Event|45
3087966|NCT00372593|10591086|P1|Overall Study|Adverse Event|43
3087967|NCT00372567|10591115|P3|Phase 3 Study|study terminated by sponsor|5
3087968|NCT00372567|10591116|P2|Phase 3 Study|study terminated by sponsor|8
3087969|NCT00372567|10591117|P1|Phase 3 Study|study terminated by sponsor|13
3087970|NCT00372567|10591115|P3|Phase 3 Study|Other|1
3087971|NCT00372567|10591116|P2|Phase 3 Study|Other|2
3087972|NCT00372567|10591117|P1|Phase 3 Study|Other|2
3087973|NCT00372567|10591115|P3|Phase 3 Study|Global deterioration of health status|0
3087974|NCT00372567|10591116|P2|Phase 3 Study|Global deterioration of health status|1
3087975|NCT00372567|10591117|P1|Phase 3 Study|Global deterioration of health status|0
3087976|NCT00372567|10591115|P3|Phase 3 Study|Objective progression or relapse|4
3087977|NCT00372567|10591116|P2|Phase 3 Study|Objective progression or relapse|13
3087978|NCT00372567|10591117|P1|Phase 3 Study|Objective progression or relapse|10
3087979|NCT00372567|10591115|P3|Phase 3 Study|Protocol Violation|1
3087980|NCT00372567|10591116|P2|Phase 3 Study|Protocol Violation|0
3087981|NCT00372567|10591117|P1|Phase 3 Study|Protocol Violation|0
3087982|NCT00372567|10591115|P3|Phase 3 Study|Death|0
3087983|NCT00372567|10591116|P2|Phase 3 Study|Death|1
3087984|NCT00372567|10591117|P1|Phase 3 Study|Death|1
3087985|NCT00372567|10591115|P3|Phase 3 Study|Adverse Event|1
3087986|NCT00372567|10591116|P2|Phase 3 Study|Adverse Event|1
3087987|NCT00372567|10591117|P1|Phase 3 Study|Adverse Event|5
3087988|NCT00372528|10591145|P1|Overall Study|Other|1
3087989|NCT00372528|10591145|P1|Overall Study|Study Terminated by Sponsor|18
3087990|NCT00372528|10591145|P1|Overall Study|Adverse Event|1
3087991|NCT00372528|10591145|P1|Overall Study|Lack of Efficacy|1
3087992|NCT00372489|10591150|P1|Overall Study|Sponsor Decision to Terminate Study|41
3087993|NCT00372489|10591150|P1|Overall Study|Renal transplant|6
3087994|NCT00372489|10591150|P1|Overall Study|Patient Relocation|2
3087995|NCT00372489|10591150|P1|Overall Study|Withdrawal by Subject|5
3087996|NCT00372489|10591150|P1|Overall Study|Physician Decision|3
3087997|NCT00372489|10591150|P1|Overall Study|Lost to Follow-up|3
3087998|NCT00372489|10591150|P1|Overall Study|Lack of Efficacy|1
3087999|NCT00372489|10591150|P1|Overall Study|Adverse Event|18
3088000|NCT00372424|10591154|P1|Overall Study|Enrolled, Not Treated|1
3088001|NCT00372424|10591154|P1|Overall Study|Other|7
3088002|NCT00372424|10591154|P1|Overall Study|Objective Progression or Relapse|14
3088003|NCT00372424|10591154|P1|Overall Study|Death|1
3088004|NCT00372424|10591154|P1|Overall Study|Withdrawal by Subject|1
3088005|NCT00372424|10591154|P1|Overall Study|Adverse Event|2
3088006|NCT00372411|10591168|P3|Overall Study|Adverse Event|0
3088007|NCT00372411|10591169|P2|Overall Study|Adverse Event|1
3088008|NCT00372411|10591170|P1|Overall Study|Adverse Event|1
3088009|NCT00372411|10591168|P3|Overall Study|Lost to Follow-up|1
3088010|NCT00372411|10591169|P2|Overall Study|Lost to Follow-up|1
3088011|NCT00372411|10591170|P1|Overall Study|Lost to Follow-up|1
3088012|NCT00372411|10591168|P3|Overall Study|Death|1
3088013|NCT00372411|10591169|P2|Overall Study|Death|2
3088014|NCT00372411|10591170|P1|Overall Study|Death|0
3088015|NCT00372411|10591168|P3|Overall Study|Withdrawal by Subject|1
3088016|NCT00372411|10591169|P2|Overall Study|Withdrawal by Subject|4
3088017|NCT00372411|10591170|P1|Overall Study|Withdrawal by Subject|3
3088018|NCT00372385|10591194|P4|Overall Study|Virologic Stopping Rule|0
3088019|NCT00372385|10591195|P3|Overall Study|Virologic Stopping Rule|0
3088020|NCT00372385|10591196|P2|Overall Study|Virologic Stopping Rule|0
3088021|NCT00372385|10591197|P1|Overall Study|Virologic Stopping Rule|17
3088022|NCT00372385|10591194|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
3088023|NCT00372385|10591195|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
3088024|NCT00372385|10591196|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
3088025|NCT00372385|10591197|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
3088026|NCT00372385|10591194|P4|Overall Study|No Response|0
3088027|NCT00372385|10591195|P3|Overall Study|No Response|0
3088028|NCT00372385|10591196|P2|Overall Study|No Response|1
3088029|NCT00372385|10591197|P1|Overall Study|No Response|1
3088030|NCT00372385|10591194|P4|Overall Study|Refusal of Treatment|0
3088031|NCT00372385|10591195|P3|Overall Study|Refusal of Treatment|0
3088032|NCT00372385|10591196|P2|Overall Study|Refusal of Treatment|6
3088033|NCT00372385|10591197|P1|Overall Study|Refusal of Treatment|3
3088034|NCT00372385|10591194|P4|Overall Study|Withdrawal by Subject|0
3088035|NCT00372385|10591195|P3|Overall Study|Withdrawal by Subject|0
3088036|NCT00372385|10591196|P2|Overall Study|Withdrawal by Subject|1
3088037|NCT00372385|10591197|P1|Overall Study|Withdrawal by Subject|2
3088038|NCT00372385|10591194|P4|Overall Study|Lost to Follow-up|0
3088039|NCT00372385|10591195|P3|Overall Study|Lost to Follow-up|0
3088040|NCT00372385|10591196|P2|Overall Study|Lost to Follow-up|0
3088041|NCT00372385|10591197|P1|Overall Study|Lost to Follow-up|2
3088042|NCT00372385|10591194|P4|Overall Study|Physician Decision|0
3088043|NCT00372385|10591195|P3|Overall Study|Physician Decision|0
3088044|NCT00372385|10591196|P2|Overall Study|Physician Decision|0
3088045|NCT00372385|10591197|P1|Overall Study|Physician Decision|1
3088046|NCT00372385|10591194|P4|Overall Study|Noncompliance|1
3088047|NCT00372385|10591195|P3|Overall Study|Noncompliance|1
3088048|NCT00372385|10591196|P2|Overall Study|Noncompliance|1
3088049|NCT00372385|10591197|P1|Overall Study|Noncompliance|0
3088050|NCT00372385|10591194|P4|Overall Study|Adverse Event|7
3088051|NCT00372385|10591195|P3|Overall Study|Adverse Event|9
3088052|NCT00372385|10591196|P2|Overall Study|Adverse Event|11
3088053|NCT00372385|10591197|P1|Overall Study|Adverse Event|6
3088054|NCT00372255|10591226|P2|Overall Study|Withdrawn for other reasons|1
3088055|NCT00372255|10591227|P1|Overall Study|Withdrawn for other reasons|2
3088056|NCT00372229|10591249|P2|Follow-Up Phase|Lost to Follow-up|10
3088057|NCT00372229|10591250|P1|Follow-Up Phase|Lost to Follow-up|12
3088058|NCT00372229|10591249|P2|Follow-Up Phase|Reason not specified|3
3088059|NCT00372229|10591250|P1|Follow-Up Phase|Reason not specified|2
3088060|NCT00372229|10591249|P2|Follow-Up Phase|Administrative|0
3088061|NCT00372229|10591250|P1|Follow-Up Phase|Administrative|1
3088062|NCT00372229|10591249|P2|Follow-Up Phase|Death|12
3088063|NCT00372229|10591250|P1|Follow-Up Phase|Death|9
3088064|NCT00372229|10591249|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
3088065|NCT00372229|10591250|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
3088066|NCT00372229|10591249|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
3088067|NCT00372229|10591250|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
3088068|NCT00372229|10591249|P2|Follow-Up Phase|Consent withdrawn|19
3088069|NCT00372229|10591250|P1|Follow-Up Phase|Consent withdrawn|13
3088070|NCT00372229|10591249|P2|Follow-Up Phase|Graft loss|7
3088071|NCT00372229|10591250|P1|Follow-Up Phase|Graft loss|8
3088072|NCT00372229|10591249|P2|Study Phase|Lost to Follow-up|3
3088073|NCT00372229|10591250|P1|Study Phase|Lost to Follow-up|3
3088074|NCT00372229|10591249|P2|Study Phase|Reason not specified|2
3088075|NCT00372229|10591250|P1|Study Phase|Reason not specified|3
3088076|NCT00372229|10591249|P2|Study Phase|Death|2
3088077|NCT00372229|10591250|P1|Study Phase|Death|3
3088078|NCT00372229|10591249|P2|Study Phase|Refused treatment/did not cooperate|1
3088079|NCT00372229|10591250|P1|Study Phase|Refused treatment/did not cooperate|3
3088080|NCT00372229|10591249|P2|Study Phase|Consent withdrawn|14
3088081|NCT00372229|10591250|P1|Study Phase|Consent withdrawn|16
3088082|NCT00372229|10591249|P2|Study Phase|Protocol Violation|4
3088083|NCT00372229|10591250|P1|Study Phase|Protocol Violation|3
3088084|NCT00372229|10591249|P2|Study Phase|Graft loss|3
3088085|NCT00372229|10591250|P1|Study Phase|Graft loss|0
3088086|NCT00372190|10591340|P2|Overall Study|Lost to Follow-up|1
3088087|NCT00372190|10591341|P1|Overall Study|Lost to Follow-up|3
3088088|NCT00372112|10591357|P4|Overall Study|Other-protocol violation|0
3088089|NCT00372112|10591358|P3|Overall Study|Other-protocol violation|1
3088090|NCT00372112|10591359|P2|Overall Study|Other-protocol violation|0
3088091|NCT00372112|10591360|P1|Overall Study|Other-protocol violation|0
3088092|NCT00372112|10591357|P4|Overall Study|Hepatitis B|0
3088093|NCT00372112|10591358|P3|Overall Study|Hepatitis B|0
3088094|NCT00372112|10591359|P2|Overall Study|Hepatitis B|0
3088095|NCT00372112|10591360|P1|Overall Study|Hepatitis B|1
3088096|NCT00372112|10591357|P4|Overall Study|PR >240 at Visit 3|1
3088097|NCT00372112|10591358|P3|Overall Study|PR >240 at Visit 3|0
3088098|NCT00372112|10591359|P2|Overall Study|PR >240 at Visit 3|0
3088099|NCT00372112|10591360|P1|Overall Study|PR >240 at Visit 3|0
3088100|NCT00372112|10591357|P4|Overall Study|Exacerbation|1
3088101|NCT00372112|10591358|P3|Overall Study|Exacerbation|0
3088102|NCT00372112|10591359|P2|Overall Study|Exacerbation|0
3088103|NCT00372112|10591360|P1|Overall Study|Exacerbation|0
3088104|NCT00372112|10591357|P4|Overall Study|Withdrawal by Subject|1
3088105|NCT00372112|10591358|P3|Overall Study|Withdrawal by Subject|2
3088106|NCT00372112|10591359|P2|Overall Study|Withdrawal by Subject|0
3088107|NCT00372112|10591360|P1|Overall Study|Withdrawal by Subject|0
3088108|NCT00372112|10591357|P4|Overall Study|Adverse Event|1
3088109|NCT00372112|10591358|P3|Overall Study|Adverse Event|1
3088110|NCT00372112|10591359|P2|Overall Study|Adverse Event|1
3088111|NCT00372112|10591360|P1|Overall Study|Adverse Event|0
3088112|NCT00372060|10591491|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
3088113|NCT00372060|10591492|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
3088114|NCT00372060|10591491|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
3088115|NCT00372060|10591492|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
3088116|NCT00372060|10591491|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
3088117|NCT00372060|10591492|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
3088118|NCT00372060|10591491|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
3088119|NCT00372060|10591492|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
3088120|NCT00372060|10591491|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
3088121|NCT00372060|10591492|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
3088122|NCT00372060|10591491|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
3088123|NCT00372060|10591492|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
3088124|NCT00371865|10591507|P2|Overall Study|Withdrawal by Subject|10
3088125|NCT00371865|10591508|P1|Overall Study|Withdrawal by Subject|12
3088126|NCT00371865|10591507|P2|Overall Study|Protocol Violation|2
3088127|NCT00371865|10591508|P1|Overall Study|Protocol Violation|3
3088128|NCT00371865|10591507|P2|Overall Study|Lack of Efficacy|2
3088129|NCT00371865|10591508|P1|Overall Study|Lack of Efficacy|0
3088130|NCT00371839|10591525|P3|Overall Study|Lost to Follow-up|2
3088131|NCT00371839|10591526|P2|Overall Study|Lost to Follow-up|3
3088132|NCT00371839|10591527|P1|Overall Study|Lost to Follow-up|6
3088133|NCT00371839|10591525|P3|Overall Study|Withdrawal by Subject|0
3088134|NCT00371839|10591526|P2|Overall Study|Withdrawal by Subject|4
3088135|NCT00371839|10591527|P1|Overall Study|Withdrawal by Subject|7
3088136|NCT00371839|10591525|P3|Overall Study|Death|0
3088137|NCT00371839|10591526|P2|Overall Study|Death|0
3088138|NCT00371839|10591527|P1|Overall Study|Death|4
3088139|NCT00371826|10591536|P3|Extension Phase (24 Months)|Administrative problems|2
3088140|NCT00371826|10591537|P2|Extension Phase (24 Months)|Administrative problems|0
3088141|NCT00371826|10591538|P1|Extension Phase (24 Months)|Administrative problems|0
3088142|NCT00371826|10591536|P3|Extension Phase (24 Months)|Subject withdrew consent|0
3088143|NCT00371826|10591537|P2|Extension Phase (24 Months)|Subject withdrew consent|2
3088144|NCT00371826|10591538|P1|Extension Phase (24 Months)|Subject withdrew consent|1
3088145|NCT00371826|10591536|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
3088146|NCT00371826|10591537|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
3088147|NCT00371826|10591538|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
3088148|NCT00371826|10591536|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
3088149|NCT00371826|10591537|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
3088150|NCT00371826|10591538|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
3088151|NCT00371826|10591536|P3|Extension Phase (24 Months)|Adverse Event|0
3088152|NCT00371826|10591537|P2|Extension Phase (24 Months)|Adverse Event|5
3088153|NCT00371826|10591538|P1|Extension Phase (24 Months)|Adverse Event|4
3088154|NCT00371826|10591536|P3|Core Phase (12 Months)|Graft Loss|0
3088155|NCT00371826|10591537|P2|Core Phase (12 Months)|Graft Loss|1
3088156|NCT00371826|10591538|P1|Core Phase (12 Months)|Graft Loss|0
3088157|NCT00371826|10591536|P3|Core Phase (12 Months)|Administrative problems|8
3088158|NCT00371826|10591537|P2|Core Phase (12 Months)|Administrative problems|0
3088159|NCT00371826|10591538|P1|Core Phase (12 Months)|Administrative problems|1
3088160|NCT00371826|10591536|P3|Core Phase (12 Months)|Subject withdrew consent|3
3088161|NCT00371826|10591537|P2|Core Phase (12 Months)|Subject withdrew consent|0
3088162|NCT00371826|10591538|P1|Core Phase (12 Months)|Subject withdrew consent|0
3088163|NCT00371826|10591536|P3|Core Phase (12 Months)|Protocol Violation|1
3088164|NCT00371826|10591537|P2|Core Phase (12 Months)|Protocol Violation|0
3088165|NCT00371826|10591538|P1|Core Phase (12 Months)|Protocol Violation|1
3088166|NCT00371826|10591536|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
3088167|NCT00371826|10591537|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
3088168|NCT00371826|10591538|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
3088169|NCT00371826|10591536|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
3088170|NCT00371826|10591537|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
3088171|NCT00371826|10591538|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
3088172|NCT00371826|10591536|P3|Core Phase (12 Months)|Adverse Event|9
3088173|NCT00371826|10591537|P2|Core Phase (12 Months)|Adverse Event|4
3088174|NCT00371826|10591538|P1|Core Phase (12 Months)|Adverse Event|15
3088175|NCT00371787|10591662|P2|Overall Study|Withdrawal by Subject|1
3088176|NCT00371787|10591663|P1|Overall Study|Withdrawal by Subject|3
3088177|NCT00371761|10591677|P2|Overall Study|Study termination|3
3088178|NCT00371761|10591678|P1|Overall Study|Study termination|4
3088179|NCT00371761|10591677|P2|Overall Study|Investigator Judgment|3
3088180|NCT00371761|10591678|P1|Overall Study|Investigator Judgment|2
3088181|NCT00371761|10591677|P2|Overall Study|Withdrawal by Subject|3
3088182|NCT00371761|10591678|P1|Overall Study|Withdrawal by Subject|1
3088183|NCT00371761|10591677|P2|Overall Study|Adverse Event|1
3088184|NCT00371761|10591678|P1|Overall Study|Adverse Event|1
3088185|NCT00371683|10591686|P2|Follow-Up Period - Randomized Patients|non-specified|12
3088186|NCT00371683|10591687|P1|Follow-Up Period - Randomized Patients|non-specified|6
3088187|NCT00371683|10591686|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
3088188|NCT00371683|10591687|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
3088189|NCT00371683|10591686|P2|Follow-Up Period - Randomized Patients|Death|2
3088190|NCT00371683|10591687|P1|Follow-Up Period - Randomized Patients|Death|0
3088191|NCT00371683|10591686|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
3088192|NCT00371683|10591687|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
3088193|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|non-specified|8
3088194|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|non-specified|9
3088195|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
3088196|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
3088197|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
3088198|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
3088199|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
3088200|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
3088201|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
3088202|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
3088203|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
3088204|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
3088205|NCT00371683|10591686|P2|DB Treatment Period-Randomized Patients|Death|1
3088206|NCT00371683|10591687|P1|DB Treatment Period-Randomized Patients|Death|1
3088207|NCT00371566|10591755|P2|Follow Up Phase|Lost to Follow-up|0
3088208|NCT00371566|10591756|P1|Follow Up Phase|Lost to Follow-up|1
3088209|NCT00371566|10591755|P2|Follow Up Phase|Physician Decision|1
3088210|NCT00371566|10591756|P1|Follow Up Phase|Physician Decision|1
3088211|NCT00371566|10591755|P2|Follow Up Phase|Withdrawal by Subject|1
3088212|NCT00371566|10591756|P1|Follow Up Phase|Withdrawal by Subject|0
3088213|NCT00371566|10591755|P2|Follow Up Phase|Disease progression|0
3088214|NCT00371566|10591756|P1|Follow Up Phase|Disease progression|1
3088215|NCT00371566|10591755|P2|Follow Up Phase|Death|5
3088216|NCT00371566|10591756|P1|Follow Up Phase|Death|0
3088217|NCT00371566|10591755|P2|Chemoradiation Phase|Death|0
3088218|NCT00371566|10591756|P1|Chemoradiation Phase|Death|2
3088219|NCT00371566|10591755|P2|Chemoradiation Phase|Progressive Disease|1
3088220|NCT00371566|10591756|P1|Chemoradiation Phase|Progressive Disease|1
3088221|NCT00371566|10591755|P2|Chemoradiation Phase|Non compliant|1
3088222|NCT00371566|10591756|P1|Chemoradiation Phase|Non compliant|0
3088223|NCT00371566|10591755|P2|Chemoradiation Phase|Withdrawal by Subject|1
3088224|NCT00371566|10591756|P1|Chemoradiation Phase|Withdrawal by Subject|0
3088225|NCT00371566|10591755|P2|Chemoradiation Phase|Physician Decision|0
3088226|NCT00371566|10591756|P1|Chemoradiation Phase|Physician Decision|2
3088227|NCT00371566|10591755|P2|Treatment Phase|Protocol Violation|1
3088228|NCT00371566|10591756|P1|Treatment Phase|Protocol Violation|0
3088229|NCT00371566|10591755|P2|Treatment Phase|Adverse Event|1
3088230|NCT00371566|10591756|P1|Treatment Phase|Adverse Event|0
3088231|NCT00371566|10591755|P2|Treatment Phase|Withdrawal by Subject|1
3088232|NCT00371566|10591756|P1|Treatment Phase|Withdrawal by Subject|0
3088233|NCT00371462|10591841|P2|Overall Study|Other|8
3088234|NCT00371462|10591842|P1|Overall Study|Other|7
3088235|NCT00371462|10591841|P2|Overall Study|Withdrawal by Subject|0
3088236|NCT00371462|10591842|P1|Overall Study|Withdrawal by Subject|1
3088237|NCT00371397|10591866|P12|Session 1|Withdrawal by Subject|0
3088238|NCT00371397|10591867|P11|Session 1|Withdrawal by Subject|0
3088239|NCT00371397|10591868|P10|Session 1|Withdrawal by Subject|0
3088240|NCT00371397|10591869|P9|Session 1|Withdrawal by Subject|0
3088241|NCT00371397|10591870|P8|Session 1|Withdrawal by Subject|1
3088242|NCT00371397|10591871|P7|Session 1|Withdrawal by Subject|0
3088243|NCT00371397|10591872|P6|Session 1|Withdrawal by Subject|0
3088244|NCT00371397|10591873|P5|Session 1|Withdrawal by Subject|0
3088245|NCT00371397|10591874|P4|Session 1|Withdrawal by Subject|0
3088246|NCT00371397|10591875|P3|Session 1|Withdrawal by Subject|0
3088247|NCT00371397|10591876|P2|Session 1|Withdrawal by Subject|0
3088248|NCT00371397|10591877|P1|Session 1|Withdrawal by Subject|1
3088249|NCT00371345|10591885|P2|Overall Study|Participant Withdrew Consent|1
3088250|NCT00371345|10591886|P1|Overall Study|Participant Withdrew Consent|0
3088251|NCT00371345|10591885|P2|Overall Study|Participant Request|1
3088252|NCT00371345|10591886|P1|Overall Study|Participant Request|1
3088253|NCT00371345|10591885|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
3088254|NCT00371345|10591886|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
3088255|NCT00371345|10591885|P2|Overall Study|Study Drug Toxicity|7
3088256|NCT00371345|10591886|P1|Overall Study|Study Drug Toxicity|1
3088257|NCT00371345|10591885|P2|Overall Study|Disease Progression|35
3088258|NCT00371345|10591886|P1|Overall Study|Disease Progression|21
3088259|NCT00371254|10591987|P2|Overall Study|Withdrawal by Subject|1
3088260|NCT00371254|10591988|P1|Overall Study|Withdrawal by Subject|0
3088261|NCT00371254|10591987|P2|Overall Study|Lost to Follow-up|1
3088262|NCT00371254|10591988|P1|Overall Study|Lost to Follow-up|0
3088263|NCT00371254|10591987|P2|Overall Study|Adverse event unrelated to study drug|1
3088264|NCT00371254|10591988|P1|Overall Study|Adverse event unrelated to study drug|0
3088265|NCT00371254|10591987|P2|Overall Study|Investigator Decision|0
3088266|NCT00371254|10591988|P1|Overall Study|Investigator Decision|2
3088267|NCT00371254|10591987|P2|Overall Study|Subject request|0
3088268|NCT00371254|10591988|P1|Overall Study|Subject request|5
3088269|NCT00371254|10591987|P2|Overall Study|Study drug toxicity|5
3088270|NCT00371254|10591988|P1|Overall Study|Study drug toxicity|3
3088271|NCT00371254|10591987|P2|Overall Study|Disease progression|13
3088272|NCT00371254|10591988|P1|Overall Study|Disease progression|13
3088273|NCT00371150|10592071|P2|Overall Study|Lost to Follow-up|2
3088274|NCT00371150|10592072|P1|Overall Study|Lost to Follow-up|3
3088275|NCT00371137|10592107|P3|Overall Study|Protocol Violation|1
3088276|NCT00371137|10592108|P2|Overall Study|Protocol Violation|1
3088277|NCT00371137|10592109|P1|Overall Study|Protocol Violation|2
3088278|NCT00371137|10592107|P3|Overall Study|Physician Decision|1
3088279|NCT00371137|10592108|P2|Overall Study|Physician Decision|1
3088280|NCT00371137|10592109|P1|Overall Study|Physician Decision|1
3088281|NCT00371137|10592107|P3|Overall Study|Sponsor Decision|2
3088282|NCT00371137|10592108|P2|Overall Study|Sponsor Decision|1
3088283|NCT00371137|10592109|P1|Overall Study|Sponsor Decision|2
3088284|NCT00371137|10592107|P3|Overall Study|Lack of Efficacy|13
3088285|NCT00371137|10592108|P2|Overall Study|Lack of Efficacy|12
3088286|NCT00371137|10592109|P1|Overall Study|Lack of Efficacy|30
3088287|NCT00371137|10592107|P3|Overall Study|Lost to Follow-up|5
3088288|NCT00371137|10592108|P2|Overall Study|Lost to Follow-up|3
3088289|NCT00371137|10592109|P1|Overall Study|Lost to Follow-up|6
3088290|NCT00371137|10592107|P3|Overall Study|Withdrawal by Subject|15
3088291|NCT00371137|10592108|P2|Overall Study|Withdrawal by Subject|10
3088292|NCT00371137|10592109|P1|Overall Study|Withdrawal by Subject|11
3088293|NCT00371137|10592107|P3|Overall Study|Adverse Event|42
3088294|NCT00371137|10592108|P2|Overall Study|Adverse Event|35
3088295|NCT00371137|10592109|P1|Overall Study|Adverse Event|20
3088296|NCT00370682|10592152|P3|Overall Study|Lost to Follow-up|1
3088297|NCT00370682|10592153|P2|Overall Study|Lost to Follow-up|1
3088298|NCT00370682|10592154|P1|Overall Study|Lost to Follow-up|0
3088299|NCT00370682|10592152|P3|Overall Study|Moved from area|0
3088300|NCT00370682|10592153|P2|Overall Study|Moved from area|2
3088301|NCT00370682|10592154|P1|Overall Study|Moved from area|0
3088302|NCT00370552|10592196|P3|Overall Study|Planned radiation for palliation|0
3088303|NCT00370552|10592197|P2|Overall Study|Planned radiation for palliation|1
3088304|NCT00370552|10592198|P1|Overall Study|Planned radiation for palliation|0
3088305|NCT00370552|10592196|P3|Overall Study|High risk of allergic reaction|0
3088306|NCT00370552|10592197|P2|Overall Study|High risk of allergic reaction|1
3088307|NCT00370552|10592198|P1|Overall Study|High risk of allergic reaction|0
3088308|NCT00370552|10592196|P3|Overall Study|Investigator decision|0
3088309|NCT00370552|10592197|P2|Overall Study|Investigator decision|1
3088310|NCT00370552|10592198|P1|Overall Study|Investigator decision|2
3088311|NCT00370552|10592196|P3|Overall Study|Physician Decision|0
3088312|NCT00370552|10592197|P2|Overall Study|Physician Decision|1
3088313|NCT00370552|10592198|P1|Overall Study|Physician Decision|1
3088314|NCT00370552|10592196|P3|Overall Study|Never treated|0
3088315|NCT00370552|10592197|P2|Overall Study|Never treated|0
3088316|NCT00370552|10592198|P1|Overall Study|Never treated|1
3088317|NCT00370552|10592196|P3|Overall Study|Still on treatment|2
3088318|NCT00370552|10592197|P2|Overall Study|Still on treatment|3
3088319|NCT00370552|10592198|P1|Overall Study|Still on treatment|1
3088320|NCT00370552|10592196|P3|Overall Study|Withdrawal by Subject|1
3088321|NCT00370552|10592197|P2|Overall Study|Withdrawal by Subject|0
3088322|NCT00370552|10592198|P1|Overall Study|Withdrawal by Subject|2
3088323|NCT00370552|10592196|P3|Overall Study|Study drug toxicity|6
3088324|NCT00370552|10592197|P2|Overall Study|Study drug toxicity|8
3088325|NCT00370552|10592198|P1|Overall Study|Study drug toxicity|11
3088326|NCT00370552|10592196|P3|Overall Study|Poor or noncompliance|1
3088327|NCT00370552|10592197|P2|Overall Study|Poor or noncompliance|0
3088328|NCT00370552|10592198|P1|Overall Study|Poor or noncompliance|0
3088329|NCT00370552|10592196|P3|Overall Study|Maximum clinical benefit|5
3088330|NCT00370552|10592197|P2|Overall Study|Maximum clinical benefit|5
3088331|NCT00370552|10592198|P1|Overall Study|Maximum clinical benefit|3
3088332|NCT00370552|10592196|P3|Overall Study|Disease progression|15
3088333|NCT00370552|10592197|P2|Overall Study|Disease progression|23
3088334|NCT00370552|10592198|P1|Overall Study|Disease progression|23
3088335|NCT00370552|10592196|P3|Overall Study|Adverse Event|2
3088336|NCT00370552|10592197|P2|Overall Study|Adverse Event|2
3088337|NCT00370552|10592198|P1|Overall Study|Adverse Event|2
3088338|NCT00370396|10592239|P3|Overall Study|Lost to Follow-up|0
3088339|NCT00370396|10592240|P2|Overall Study|Lost to Follow-up|1
3088340|NCT00370396|10592241|P1|Overall Study|Lost to Follow-up|11
3088341|NCT00370396|10592239|P3|Overall Study|Withdrawal by Subject|1
3088342|NCT00370396|10592240|P2|Overall Study|Withdrawal by Subject|0
3088343|NCT00370396|10592241|P1|Overall Study|Withdrawal by Subject|0
3088344|NCT00370331|10592295|P2|Overall Study|Protocol Violation|1
3088345|NCT00370331|10592296|P1|Overall Study|Protocol Violation|1
3088346|NCT00370331|10592295|P2|Overall Study|Non-compliance|1
3088347|NCT00370331|10592296|P1|Overall Study|Non-compliance|0
3088348|NCT00370331|10592295|P2|Overall Study|Lack of Efficacy|1
3088349|NCT00370331|10592296|P1|Overall Study|Lack of Efficacy|0
3088350|NCT00370331|10592295|P2|Overall Study|Lost to Follow-up|3
3088351|NCT00370331|10592296|P1|Overall Study|Lost to Follow-up|0
3088352|NCT00370331|10592295|P2|Overall Study|Withdrawal by Subject|4
3088353|NCT00370331|10592296|P1|Overall Study|Withdrawal by Subject|2
3088354|NCT00370331|10592295|P2|Overall Study|Adverse Event|13
3088355|NCT00370331|10592296|P1|Overall Study|Adverse Event|4
3088356|NCT00370292|10592322|P1|Overall Study|Physician Decision|2
3088357|NCT00370292|10592322|P1|Overall Study|Adverse Event|7
3088358|NCT00370292|10592322|P1|Overall Study|Disease Progression|4
3088359|NCT00370149|10592335|P2|Overall Study|Antibiotic coated dressing placed|1
3088360|NCT00370149|10592336|P1|Overall Study|Antibiotic coated dressing placed|0
3088361|NCT00370149|10592335|P2|Overall Study|Pre-existing infection|1
3088362|NCT00370149|10592336|P1|Overall Study|Pre-existing infection|0
3088363|NCT00370149|10592335|P2|Overall Study|Catheter inserted in wrong vessel-|1
3088364|NCT00370149|10592336|P1|Overall Study|Catheter inserted in wrong vessel-|2
3088365|NCT00370149|10592335|P2|Overall Study|Protocol Violation|0
3088366|NCT00370149|10592336|P1|Overall Study|Protocol Violation|1
3088367|NCT00370149|10592335|P2|Overall Study|Physician Decision|16
3088368|NCT00370149|10592336|P1|Overall Study|Physician Decision|16
3088369|NCT00370071|10592346|P1|Overall Study|Withdrawal by Subject|2
3088370|NCT00370032|10592363|P2|Follow-up Period|Withdrawal by Subject|0
3088371|NCT00370032|10592364|P1|Follow-up Period|Withdrawal by Subject|1
3088372|NCT00370032|10592363|P2|Washout Period|Adverse Event|0
3088373|NCT00370032|10592364|P1|Washout Period|Adverse Event|1
3088374|NCT00370032|10592363|P2|Washout Period|Lost to Follow-up|1
3088375|NCT00370032|10592364|P1|Washout Period|Lost to Follow-up|0
3088376|NCT00370032|10592363|P2|Washout Period|Withdrawal by Subject|1
3088377|NCT00370032|10592364|P1|Washout Period|Withdrawal by Subject|0
3088378|NCT00370032|10592363|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
3088379|NCT00370032|10592364|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
3088380|NCT00369967|10592384|P2|Overall Study|Lost to Follow-up|12
3088381|NCT00369967|10592385|P1|Overall Study|Lost to Follow-up|23
3088382|NCT00369941|10592403|P2|Overall Study|Miscellaneous|3
3088383|NCT00369941|10592404|P1|Overall Study|Miscellaneous|3
3088384|NCT00369941|10592403|P2|Overall Study|Study Site Terminated|0
3088385|NCT00369941|10592404|P1|Overall Study|Study Site Terminated|2
3088386|NCT00369941|10592403|P2|Overall Study|Employment Interfered with Study Visits|0
3088387|NCT00369941|10592404|P1|Overall Study|Employment Interfered with Study Visits|1
3088388|NCT00369941|10592403|P2|Overall Study|Treatment with Prohibited Medication|1
3088389|NCT00369941|10592404|P1|Overall Study|Treatment with Prohibited Medication|3
3088390|NCT00369941|10592403|P2|Overall Study|Moved|5
3088391|NCT00369941|10592404|P1|Overall Study|Moved|11
3088392|NCT00369941|10592403|P2|Overall Study|Completed, Did Not Enter Extension|6
3088393|NCT00369941|10592404|P1|Overall Study|Completed, Did Not Enter Extension|5
3088394|NCT00369941|10592403|P2|Overall Study|Pregnancy|2
3088395|NCT00369941|10592404|P1|Overall Study|Pregnancy|4
3088396|NCT00369941|10592403|P2|Overall Study|Withdrawal by Subject|18
3088397|NCT00369941|10592404|P1|Overall Study|Withdrawal by Subject|5
3088398|NCT00369941|10592403|P2|Overall Study|Protocol Violation|3
3088399|NCT00369941|10592404|P1|Overall Study|Protocol Violation|5
3088400|NCT00369941|10592403|P2|Overall Study|Lost to Follow-up|22
3088401|NCT00369941|10592404|P1|Overall Study|Lost to Follow-up|12
3088402|NCT00369941|10592403|P2|Overall Study|Lack of Efficacy|10
3088403|NCT00369941|10592404|P1|Overall Study|Lack of Efficacy|6
3088404|NCT00369941|10592403|P2|Overall Study|Adverse Event|28
3088405|NCT00369941|10592404|P1|Overall Study|Adverse Event|14
3088406|NCT00369941|10592403|P2|Overall Study|Never Treated|2
3088407|NCT00369941|10592404|P1|Overall Study|Never Treated|1
3088408|NCT00369915|10592569|P2|Overall Study|W/drawl by investigators|1
3088409|NCT00369915|10592570|P1|Overall Study|W/drawl by investigators|0
3088410|NCT00369915|10592569|P2|Overall Study|Withdrawal by Subject|1
3088411|NCT00369915|10592570|P1|Overall Study|Withdrawal by Subject|4
3088412|NCT00369915|10592569|P2|Overall Study|expected side effects|1
3088413|NCT00369915|10592570|P1|Overall Study|expected side effects|2
3088414|NCT00369824|10592584|P6|Overall Study|Other|3
3088415|NCT00369824|10592585|P5|Overall Study|Other|1
3088416|NCT00369824|10592586|P4|Overall Study|Other|2
3088417|NCT00369824|10592587|P3|Overall Study|Other|0
3088418|NCT00369824|10592588|P2|Overall Study|Other|0
3088419|NCT00369824|10592589|P1|Overall Study|Other|0
3088420|NCT00369824|10592584|P6|Overall Study|Lost to Follow-up|6
3088421|NCT00369824|10592585|P5|Overall Study|Lost to Follow-up|9
3088422|NCT00369824|10592586|P4|Overall Study|Lost to Follow-up|8
3088423|NCT00369824|10592587|P3|Overall Study|Lost to Follow-up|7
3088424|NCT00369824|10592588|P2|Overall Study|Lost to Follow-up|11
3088425|NCT00369824|10592589|P1|Overall Study|Lost to Follow-up|6
3088426|NCT00369824|10592584|P6|Overall Study|Withdrawal by Subject|2
3088427|NCT00369824|10592585|P5|Overall Study|Withdrawal by Subject|6
3088428|NCT00369824|10592586|P4|Overall Study|Withdrawal by Subject|4
3088429|NCT00369824|10592587|P3|Overall Study|Withdrawal by Subject|5
3088430|NCT00369824|10592588|P2|Overall Study|Withdrawal by Subject|5
3088431|NCT00369824|10592589|P1|Overall Study|Withdrawal by Subject|9
3088432|NCT00369824|10592584|P6|Overall Study|Protocol Violation|0
3088433|NCT00369824|10592585|P5|Overall Study|Protocol Violation|1
3088434|NCT00369824|10592586|P4|Overall Study|Protocol Violation|1
3088435|NCT00369824|10592587|P3|Overall Study|Protocol Violation|0
3088436|NCT00369824|10592588|P2|Overall Study|Protocol Violation|1
3088437|NCT00369824|10592589|P1|Overall Study|Protocol Violation|0
3088438|NCT00369824|10592584|P6|Overall Study|Adverse Event|0
3088439|NCT00369824|10592585|P5|Overall Study|Adverse Event|1
3088440|NCT00369824|10592586|P4|Overall Study|Adverse Event|0
3088441|NCT00369824|10592587|P3|Overall Study|Adverse Event|0
3088442|NCT00369824|10592588|P2|Overall Study|Adverse Event|2
3088443|NCT00369824|10592589|P1|Overall Study|Adverse Event|0
3088444|NCT00369785|10592689|P2|Overall Study|Multiple reasons|5
3088445|NCT00369785|10592690|P1|Overall Study|Multiple reasons|6
3088446|NCT00369785|10592689|P2|Overall Study|Progression|4
3088447|NCT00369785|10592690|P1|Overall Study|Progression|4
3088448|NCT00369785|10592689|P2|Overall Study|Never started|2
3088449|NCT00369785|10592690|P1|Overall Study|Never started|0
3088450|NCT00369785|10592689|P2|Overall Study|Toxicity|4
3088451|NCT00369785|10592690|P1|Overall Study|Toxicity|6
3088452|NCT00369785|10592689|P2|Overall Study|Withdrawal by Subject|6
3088453|NCT00369785|10592690|P1|Overall Study|Withdrawal by Subject|7
3088454|NCT00369785|10592689|P2|Overall Study|Death|2
3088455|NCT00369785|10592690|P1|Overall Study|Death|1
3088456|NCT00369785|10592689|P2|Overall Study|Physician Decision|2
3088457|NCT00369785|10592690|P1|Overall Study|Physician Decision|3
3088458|NCT00369707|10592711|P1|Follow up for 2 Years After Treatment|Other|2
3088459|NCT00369707|10592711|P1|Follow up for 2 Years After Treatment|Death|1
3088460|NCT00369707|10592711|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
3088461|NCT00369707|10592711|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
3088462|NCT00369707|10592711|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
3088463|NCT00369707|10592711|P1|Induction Part B (2 Cycles)|Progressive disease|1
3088464|NCT00369707|10592711|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
3088465|NCT00369707|10592711|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
3088466|NCT00369707|10592711|P1|Induction Part B (2 Cycles)|Adverse Event|3
3088467|NCT00369681|10592724|P1|Overall Study|Death|1
3088468|NCT00369668|10592734|P3|Overall Study|Lack of Efficacy|7
3088469|NCT00369668|10592735|P2|Overall Study|Lack of Efficacy|5
3088470|NCT00369668|10592736|P1|Overall Study|Lack of Efficacy|4
3088471|NCT00369655|10592750|P1|Overall Study|Refusal of further treatment|2
3088472|NCT00369629|10592759|P4|Follow up for 1 Year|stopped being followed as study closed|0
3088473|NCT00369629|10592760|P3|Follow up for 1 Year|stopped being followed as study closed|2
3088474|NCT00369629|10592761|P2|Follow up for 1 Year|stopped being followed as study closed|0
3088475|NCT00369629|10592762|P1|Follow up for 1 Year|stopped being followed as study closed|0
3088476|NCT00369629|10592759|P4|Follow up for 1 Year|Lost to Follow-up|0
3088477|NCT00369629|10592760|P3|Follow up for 1 Year|Lost to Follow-up|0
3088478|NCT00369629|10592761|P2|Follow up for 1 Year|Lost to Follow-up|1
3088479|NCT00369629|10592762|P1|Follow up for 1 Year|Lost to Follow-up|0
3088480|NCT00369629|10592759|P4|Follow up for 1 Year|Death|0
3088481|NCT00369629|10592760|P3|Follow up for 1 Year|Death|1
3088482|NCT00369629|10592761|P2|Follow up for 1 Year|Death|1
3088483|NCT00369629|10592762|P1|Follow up for 1 Year|Death|2
3088484|NCT00369629|10592759|P4|Completed 4 More Cycles|Progressive disease|0
3088485|NCT00369629|10592760|P3|Completed 4 More Cycles|Progressive disease|2
3088486|NCT00369629|10592761|P2|Completed 4 More Cycles|Progressive disease|1
3088487|NCT00369629|10592762|P1|Completed 4 More Cycles|Progressive disease|2
3088488|NCT00369629|10592759|P4|Completed 4 More Cycles|Withdrawal by Subject|0
3088489|NCT00369629|10592760|P3|Completed 4 More Cycles|Withdrawal by Subject|0
3088490|NCT00369629|10592761|P2|Completed 4 More Cycles|Withdrawal by Subject|1
3088491|NCT00369629|10592762|P1|Completed 4 More Cycles|Withdrawal by Subject|2
3088492|NCT00369629|10592759|P4|Moved on to 4 More Cycles|Progressive Disease|0
3088493|NCT00369629|10592760|P3|Moved on to 4 More Cycles|Progressive Disease|1
3088494|NCT00369629|10592761|P2|Moved on to 4 More Cycles|Progressive Disease|0
3088495|NCT00369629|10592762|P1|Moved on to 4 More Cycles|Progressive Disease|0
3088496|NCT00369629|10592759|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
3088497|NCT00369629|10592760|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
3088498|NCT00369629|10592761|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
3088499|NCT00369629|10592762|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
3088500|NCT00369629|10592759|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
3088501|NCT00369629|10592760|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
3088502|NCT00369629|10592761|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
3088503|NCT00369629|10592762|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
3088504|NCT00369629|10592759|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
3088505|NCT00369629|10592760|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
3088506|NCT00369629|10592761|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
3088507|NCT00369629|10592762|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
3088508|NCT00369577|10592793|P3|Overall Study|Withdrawal by Subject|1
3088509|NCT00369577|10592794|P2|Overall Study|Withdrawal by Subject|0
3088510|NCT00369577|10592795|P1|Overall Study|Withdrawal by Subject|0
3088511|NCT00369486|10592832|P5|34-Week Visit|Dropped|3
3088512|NCT00369486|10592833|P4|34-Week Visit|Dropped|3
3088513|NCT00369486|10592834|P3|34-Week Visit|Dropped|1
3088514|NCT00369486|10592835|P2|34-Week Visit|Dropped|1
3088515|NCT00369486|10592836|P1|34-Week Visit|Dropped|0
3088516|NCT00369486|10592832|P5|17-Week Visit|Missed visit|1
3088517|NCT00369486|10592833|P4|17-Week Visit|Missed visit|1
3088518|NCT00369486|10592834|P3|17-Week Visit|Missed visit|1
3088519|NCT00369486|10592835|P2|17-Week Visit|Missed visit|0
3088520|NCT00369486|10592836|P1|17-Week Visit|Missed visit|0
3088521|NCT00369486|10592832|P5|8-Week Visit|Dropped|0
3088522|NCT00369486|10592833|P4|8-Week Visit|Dropped|1
3088523|NCT00369486|10592834|P3|8-Week Visit|Dropped|0
3088524|NCT00369486|10592835|P2|8-Week Visit|Dropped|0
3088525|NCT00369486|10592836|P1|8-Week Visit|Dropped|0
3088526|NCT00369486|10592832|P5|8-Week Visit|Missed visit|1
3088527|NCT00369486|10592833|P4|8-Week Visit|Missed visit|0
3088528|NCT00369486|10592834|P3|8-Week Visit|Missed visit|0
3088529|NCT00369486|10592835|P2|8-Week Visit|Missed visit|1
3088530|NCT00369486|10592836|P1|8-Week Visit|Missed visit|0
3088531|NCT00369486|10592832|P5|4-Week Visit|Dropped|0
3088532|NCT00369486|10592833|P4|4-Week Visit|Dropped|0
3088533|NCT00369486|10592834|P3|4-Week Visit|Dropped|1
3088534|NCT00369486|10592835|P2|4-Week Visit|Dropped|0
3088535|NCT00369486|10592836|P1|4-Week Visit|Dropped|0
3088536|NCT00369486|10592832|P5|4-Week Visit|Missed visit|1
3088537|NCT00369486|10592833|P4|4-Week Visit|Missed visit|2
3088538|NCT00369486|10592834|P3|4-Week Visit|Missed visit|0
3088539|NCT00369486|10592835|P2|4-Week Visit|Missed visit|2
3088540|NCT00369486|10592836|P1|4-Week Visit|Missed visit|2
3088541|NCT00369382|10592875|P2|Overall Study|Other|0
3088542|NCT00369382|10592876|P1|Overall Study|Other|1
3088543|NCT00369382|10592875|P2|Overall Study|Randomized, not treated|0
3088544|NCT00369382|10592876|P1|Overall Study|Randomized, not treated|2
3088545|NCT00369382|10592875|P2|Overall Study|Withdrawal by Subject|0
3088546|NCT00369382|10592876|P1|Overall Study|Withdrawal by Subject|5
3088547|NCT00369382|10592875|P2|Overall Study|Physician Decision|1
3088548|NCT00369382|10592876|P1|Overall Study|Physician Decision|2
3088549|NCT00369382|10592875|P2|Overall Study|Death|2
3088550|NCT00369382|10592876|P1|Overall Study|Death|0
3088551|NCT00369343|10592909|P2|Open-label Phase|did not take study drug|2
3088552|NCT00369343|10592910|P1|Open-label Phase|did not take study drug|1
3088553|NCT00369343|10592909|P2|Open-label Phase|Lack of continuance tolerability|4
3088554|NCT00369343|10592910|P1|Open-label Phase|Lack of continuance tolerability|3
3088555|NCT00369343|10592909|P2|Open-label Phase|Lack of Efficacy|3
3088556|NCT00369343|10592910|P1|Open-label Phase|Lack of Efficacy|4
3088557|NCT00369343|10592909|P2|Open-label Phase|Withdrawal by Subject|6
3088558|NCT00369343|10592910|P1|Open-label Phase|Withdrawal by Subject|15
3088559|NCT00369343|10592909|P2|Open-label Phase|Protocol Violation|3
3088560|NCT00369343|10592910|P1|Open-label Phase|Protocol Violation|1
3088561|NCT00369343|10592909|P2|Open-label Phase|inadvertently reported study completers|2
3088562|NCT00369343|10592910|P1|Open-label Phase|inadvertently reported study completers|3
3088563|NCT00369343|10592909|P2|Open-label Phase|Lost to Follow-up|3
3088564|NCT00369343|10592910|P1|Open-label Phase|Lost to Follow-up|5
3088565|NCT00369343|10592909|P2|Open-label Phase|Physician Decision|0
3088566|NCT00369343|10592910|P1|Open-label Phase|Physician Decision|2
3088567|NCT00369343|10592909|P2|Open-label Phase|Failed to return|0
3088568|NCT00369343|10592910|P1|Open-label Phase|Failed to return|4
3088569|NCT00369343|10592909|P2|Open-label Phase|Adverse Event|7
3088570|NCT00369343|10592910|P1|Open-label Phase|Adverse Event|19
3088571|NCT00369343|10592909|P2|Double-blind Phase|Protocol deviation|0
3088572|NCT00369343|10592910|P1|Double-blind Phase|Protocol deviation|4
3088573|NCT00369343|10592909|P2|Double-blind Phase|Lack of Efficacy|4
3088574|NCT00369343|10592910|P1|Double-blind Phase|Lack of Efficacy|0
3088575|NCT00369343|10592909|P2|Double-blind Phase|Withdrawal by Subject|6
3088576|NCT00369343|10592910|P1|Double-blind Phase|Withdrawal by Subject|8
3088577|NCT00369343|10592909|P2|Double-blind Phase|Protocol Violation|0
3088578|NCT00369343|10592910|P1|Double-blind Phase|Protocol Violation|2
3088579|NCT00369343|10592909|P2|Double-blind Phase|Lost to Follow-up|2
3088580|NCT00369343|10592910|P1|Double-blind Phase|Lost to Follow-up|9
3088581|NCT00369343|10592909|P2|Double-blind Phase|Failed to return|0
3088582|NCT00369343|10592910|P1|Double-blind Phase|Failed to return|2
3088583|NCT00369343|10592909|P2|Double-blind Phase|Adverse Event|4
3088584|NCT00369343|10592910|P1|Double-blind Phase|Adverse Event|19
3088585|NCT00369317|10592943|P1|Overall Study|Ineligible|1
3088586|NCT00369317|10592943|P1|Overall Study|Withdrawal by Subject|8
3088587|NCT00369317|10592943|P1|Overall Study|Physician Decision|2
3088588|NCT00369317|10592943|P1|Overall Study|Lack of Efficacy|5
3088589|NCT00369317|10592943|P1|Overall Study|Death|1
3088590|NCT00369317|10592943|P1|Overall Study|Adverse Event|3
3088591|NCT00369278|10592959|P2|Overall Study|Graft loss|2
3088592|NCT00369278|10592960|P1|Overall Study|Graft loss|1
3088593|NCT00369278|10592959|P2|Overall Study|Lost to Follow-up|0
3088594|NCT00369278|10592960|P1|Overall Study|Lost to Follow-up|1
3088595|NCT00369278|10592959|P2|Overall Study|Withdrawal by Subject|2
3088596|NCT00369278|10592960|P1|Overall Study|Withdrawal by Subject|2
3088597|NCT00369278|10592959|P2|Overall Study|Protocol Violation|1
3088598|NCT00369278|10592960|P1|Overall Study|Protocol Violation|2
3088599|NCT00369278|10592959|P2|Overall Study|Unsatisfactory therapeutic effect|5
3088600|NCT00369278|10592960|P1|Overall Study|Unsatisfactory therapeutic effect|4
3088601|NCT00369278|10592959|P2|Overall Study|Adverse Event|11
3088602|NCT00369278|10592960|P1|Overall Study|Adverse Event|14
3088603|NCT00369265|10592976|P2|Overall Study|Study terminated|7
3088604|NCT00369265|10592977|P1|Overall Study|Study terminated|4
3088605|NCT00369161|10592998|P2|Overall Study|Administrative Problem|2
3088606|NCT00369161|10592999|P1|Overall Study|Administrative Problem|2
3088607|NCT00369161|10592998|P2|Overall Study|Graft loss|0
3088608|NCT00369161|10592999|P1|Overall Study|Graft loss|4
3088609|NCT00369161|10592998|P2|Overall Study|Death|2
3088610|NCT00369161|10592999|P1|Overall Study|Death|1
3088611|NCT00369161|10592998|P2|Overall Study|Withdrawal by Subject|3
3088612|NCT00369161|10592999|P1|Overall Study|Withdrawal by Subject|2
3088613|NCT00369161|10592998|P2|Overall Study|Protocol Violation|2
3088614|NCT00369161|10592999|P1|Overall Study|Protocol Violation|0
3088615|NCT00369161|10592998|P2|Overall Study|Lack of Efficacy|1
3088616|NCT00369161|10592999|P1|Overall Study|Lack of Efficacy|3
3088617|NCT00369161|10592998|P2|Overall Study|Abnormal laboratory value|1
3088618|NCT00369161|10592999|P1|Overall Study|Abnormal laboratory value|0
3088619|NCT00369161|10592998|P2|Overall Study|Adverse Event|13
3088620|NCT00369161|10592999|P1|Overall Study|Adverse Event|15
3088621|NCT00369122|10593009|P1|Overall Study|No protocol treatment|1
3088622|NCT00369122|10593009|P1|Overall Study|Ineligible|10
3088623|NCT00368992|10593016|P1|Overall Study|Other|9
3088624|NCT00368992|10593016|P1|Overall Study|Death|4
3088625|NCT00368992|10593016|P1|Overall Study|Adverse Event|26
3088626|NCT00368992|10593016|P1|Overall Study|Lack of Efficacy|63
3088627|NCT00368992|10593016|P1|Overall Study|Refused treatment|3
3088628|NCT00368992|10593016|P1|Overall Study|Ineligible|5
3088629|NCT00368979|10593025|P2|Overall Study|Withdrawal by Subject|9
3088630|NCT00368979|10593026|P1|Overall Study|Withdrawal by Subject|5
3088631|NCT00368979|10593025|P2|Overall Study|Protocol Violation|1
3088632|NCT00368979|10593026|P1|Overall Study|Protocol Violation|2
3088633|NCT00368979|10593025|P2|Overall Study|Lost to Follow-up|0
3088634|NCT00368979|10593026|P1|Overall Study|Lost to Follow-up|1
3088635|NCT00368979|10593025|P2|Overall Study|Other|1
3088636|NCT00368979|10593026|P1|Overall Study|Other|3
3088637|NCT00368979|10593025|P2|Overall Study|Lack of Efficacy|3
3088638|NCT00368979|10593026|P1|Overall Study|Lack of Efficacy|5
3088639|NCT00368979|10593025|P2|Overall Study|Adverse Event|16
3088640|NCT00368979|10593026|P1|Overall Study|Adverse Event|9
3088641|NCT00368966|10593042|P2|Toddler Dose|Lost to Follow-up|2
3088642|NCT00368966|10593043|P1|Toddler Dose|Lost to Follow-up|0
3088643|NCT00368966|10593042|P2|Toddler Dose|Withdrawal by Subject|1
3088644|NCT00368966|10593043|P1|Toddler Dose|Withdrawal by Subject|1
3088645|NCT00368966|10593042|P2|After Infant|Lost to Follow-up|1
3088646|NCT00368966|10593043|P1|After Infant|Lost to Follow-up|0
3088647|NCT00368966|10593042|P2|After Infant|Death|0
3088648|NCT00368966|10593043|P1|After Infant|Death|1
3088649|NCT00368966|10593042|P2|After Infant|Withdrawal by Subject|1
3088650|NCT00368966|10593043|P1|After Infant|Withdrawal by Subject|1
3088651|NCT00368966|10593042|P2|After Infant|Adverse Event|2
3088652|NCT00368966|10593043|P1|After Infant|Adverse Event|1
3088653|NCT00368966|10593042|P2|After Infant|Failed to return|1
3088654|NCT00368966|10593043|P1|After Infant|Failed to return|3
3088655|NCT00368966|10593042|P2|Infant Series|Failed to return|0
3088656|NCT00368966|10593043|P1|Infant Series|Failed to return|1
3088657|NCT00368966|10593042|P2|Infant Series|Adverse Event|1
3088658|NCT00368966|10593043|P1|Infant Series|Adverse Event|0
3088659|NCT00368966|10593042|P2|Infant Series|Failed to meet eligibility criteria|1
3088660|NCT00368966|10593043|P1|Infant Series|Failed to meet eligibility criteria|0
3088661|NCT00368966|10593042|P2|Infant Series|Randomization error|1
3088662|NCT00368966|10593043|P1|Infant Series|Randomization error|0
3088663|NCT00368966|10593042|P2|Infant Series|Lost to Follow-up|0
3088664|NCT00368966|10593043|P1|Infant Series|Lost to Follow-up|2
3088665|NCT00368966|10593042|P2|Infant Series|Protocol Violation|1
3088666|NCT00368966|10593043|P1|Infant Series|Protocol Violation|2
3088667|NCT00368966|10593042|P2|Infant Series|Withdrawal by Subject|6
3088668|NCT00368966|10593043|P1|Infant Series|Withdrawal by Subject|11
3088669|NCT00368927|10593114|P2|Overall Study|Physician Decision|0
3088670|NCT00368927|10593115|P1|Overall Study|Physician Decision|1
3088671|NCT00368927|10593114|P2|Overall Study|Withdrawal by Subject|2
3088672|NCT00368927|10593115|P1|Overall Study|Withdrawal by Subject|1
3088673|NCT00368927|10593114|P2|Overall Study|Adverse Event|1
3088674|NCT00368927|10593115|P1|Overall Study|Adverse Event|1
3088675|NCT00368927|10593114|P2|Overall Study|Lost to Follow-up|0
3088676|NCT00368927|10593115|P1|Overall Study|Lost to Follow-up|2
3088677|NCT00368875|10593123|P2|Overall Study|Alternative Therapy|1
3088678|NCT00368875|10593124|P1|Overall Study|Alternative Therapy|1
3088679|NCT00368875|10593123|P2|Overall Study|Other Reason|2
3088680|NCT00368875|10593124|P1|Overall Study|Other Reason|0
3088681|NCT00368875|10593123|P2|Overall Study|Withdrawal by Subject|6
3088682|NCT00368875|10593124|P1|Overall Study|Withdrawal by Subject|2
3088683|NCT00368875|10593123|P2|Overall Study|Progressive disease|27
3088684|NCT00368875|10593124|P1|Overall Study|Progressive disease|3
3088685|NCT00368875|10593123|P2|Overall Study|Adverse Event|12
3088686|NCT00368875|10593124|P1|Overall Study|Adverse Event|0
3088687|NCT00368849|10593132|P2|Overall Study|Physician Decision|1
3088688|NCT00368849|10593133|P1|Overall Study|Physician Decision|0
3088689|NCT00368849|10593132|P2|Overall Study|Withdrawal by Subject|1
3088690|NCT00368849|10593133|P1|Overall Study|Withdrawal by Subject|0
3088691|NCT00368745|10593149|P2|Double-blind Treatment Period|Other|6
3088692|NCT00368745|10593150|P1|Double-blind Treatment Period|Other|7
3088693|NCT00368745|10593149|P2|Double-blind Treatment Period|Withdrawal by Subject|3
3088694|NCT00368745|10593150|P1|Double-blind Treatment Period|Withdrawal by Subject|5
3088695|NCT00368745|10593149|P2|Double-blind Treatment Period|Lost to Follow-up|0
3088696|NCT00368745|10593150|P1|Double-blind Treatment Period|Lost to Follow-up|1
3088697|NCT00368745|10593149|P2|Double-blind Treatment Period|Lack of Efficacy|16
3088698|NCT00368745|10593150|P1|Double-blind Treatment Period|Lack of Efficacy|7
3088699|NCT00368745|10593149|P2|Double-blind Treatment Period|Adverse Event|6
3088700|NCT00368745|10593150|P1|Double-blind Treatment Period|Adverse Event|6
3088701|NCT00368641|10593203|P2|Overall Study|Sponsor decision to terminate study|5
3088702|NCT00368641|10593204|P1|Overall Study|Sponsor decision to terminate study|2
3088703|NCT00368641|10593203|P2|Overall Study|Withdrawal by Subject|0
3088704|NCT00368641|10593204|P1|Overall Study|Withdrawal by Subject|1
3088705|NCT00368641|10593203|P2|Overall Study|Death|0
3088706|NCT00368641|10593204|P1|Overall Study|Death|1
3088707|NCT00368641|10593203|P2|Overall Study|Adverse Event|1
3088708|NCT00368641|10593204|P1|Overall Study|Adverse Event|2
3088709|NCT00368550|10593212|P2|Overall Study|Withdrawal by Subject|10
3088710|NCT00368550|10593213|P1|Overall Study|Withdrawal by Subject|17
3088711|NCT00368550|10593212|P2|Overall Study|Lack of Efficacy|9
3088712|NCT00368550|10593213|P1|Overall Study|Lack of Efficacy|4
3088713|NCT00368550|10593212|P2|Overall Study|Adverse Event|4
3088714|NCT00368550|10593213|P1|Overall Study|Adverse Event|7
3088715|NCT00368537|10593225|P2|Baseline Participants|Patient uncompliant|1
3088716|NCT00368537|10593226|P1|Baseline Participants|Patient uncompliant|0
3088717|NCT00368537|10593225|P2|Baseline Participants|No susceptibility|0
3088718|NCT00368537|10593226|P1|Baseline Participants|No susceptibility|1
3088719|NCT00368537|10593225|P2|Baseline Participants|Death|2
3088720|NCT00368537|10593226|P1|Baseline Participants|Death|1
3088721|NCT00368537|10593225|P2|Baseline Participants|Withdrawal by Subject|4
3088722|NCT00368537|10593226|P1|Baseline Participants|Withdrawal by Subject|6
3088723|NCT00368537|10593225|P2|Baseline Participants|Lost to Follow-up|17
3088724|NCT00368537|10593226|P1|Baseline Participants|Lost to Follow-up|16
3088725|NCT00368537|10593225|P2|Randomization|No study drug dosed|6
3088726|NCT00368537|10593226|P1|Randomization|No study drug dosed|13
3088727|NCT00368472|10593240|P1|Overall Study|Missing Final Disposition Date|1
3088728|NCT00368472|10593240|P1|Overall Study|Other|32
3088729|NCT00368472|10593240|P1|Overall Study|Diary non-compliance|1
3088730|NCT00368472|10593240|P1|Overall Study|Withdrawal by Subject|40
3088731|NCT00368472|10593240|P1|Overall Study|Request of Investigator or Sponsor|3
3088732|NCT00368472|10593240|P1|Overall Study|Protocol Violation|2
3088733|NCT00368472|10593240|P1|Overall Study|Medication non-compliance|4
3088734|NCT00368472|10593240|P1|Overall Study|Adverse Event|22
3088735|NCT00368355|10593275|P2|Overall Study|Treatment - hematopoietic cell product|0
3088736|NCT00368355|10593276|P1|Overall Study|Treatment - hematopoietic cell product|2
3088737|NCT00368355|10593275|P2|Overall Study|Subsequent transplant|3
3088738|NCT00368355|10593276|P1|Overall Study|Subsequent transplant|0
3088739|NCT00368355|10593275|P2|Overall Study|Relapse|10
3088740|NCT00368355|10593276|P1|Overall Study|Relapse|6
3088741|NCT00368355|10593275|P2|Overall Study|Death|4
3088742|NCT00368355|10593276|P1|Overall Study|Death|2
3088743|NCT00368355|10593275|P2|Overall Study|Adverse Event|0
3088744|NCT00368355|10593276|P1|Overall Study|Adverse Event|1
3088745|NCT00368277|10593316|P2|Overall Study|Lost to Follow-up|6
3088746|NCT00368277|10593317|P1|Overall Study|Lost to Follow-up|8
3088747|NCT00368277|10593316|P2|Overall Study|Patient withdrew consent|28
3088748|NCT00368277|10593317|P1|Overall Study|Patient withdrew consent|32
3088749|NCT00368277|10593316|P2|Overall Study|Protocol deviation|0
3088750|NCT00368277|10593317|P1|Overall Study|Protocol deviation|7
3088751|NCT00368277|10593316|P2|Overall Study|Unsatisfactory therapeutic effect|24
3088752|NCT00368277|10593317|P1|Overall Study|Unsatisfactory therapeutic effect|31
3088753|NCT00368277|10593316|P2|Overall Study|Death|1
3088754|NCT00368277|10593317|P1|Overall Study|Death|2
3088755|NCT00368277|10593316|P2|Overall Study|Adverse Event|49
3088756|NCT00368277|10593317|P1|Overall Study|Adverse Event|33
3088757|NCT00368251|10593332|P3|Overall Study|AE, non-serious non-fatal|1
3088758|NCT00368251|10593333|P2|Overall Study|AE, non-serious non-fatal|0
3088759|NCT00368251|10593334|P1|Overall Study|AE, non-serious non-fatal|0
3088760|NCT00368251|10593332|P3|Overall Study|SAE, non-fatal|0
3088761|NCT00368251|10593333|P2|Overall Study|SAE, non-fatal|0
3088762|NCT00368251|10593334|P1|Overall Study|SAE, non-fatal|1
3088763|NCT00368108|10593357|P3|Overall Study|Other|1
3088764|NCT00368108|10593358|P2|Overall Study|Other|7
3088765|NCT00368108|10593359|P1|Overall Study|Other|3
3088766|NCT00368108|10593357|P3|Overall Study|Physician Decision|1
3088767|NCT00368108|10593358|P2|Overall Study|Physician Decision|0
3088768|NCT00368108|10593359|P1|Overall Study|Physician Decision|2
3088769|NCT00368108|10593357|P3|Overall Study|Lack of Efficacy|5
3088770|NCT00368108|10593358|P2|Overall Study|Lack of Efficacy|8
3088771|NCT00368108|10593359|P1|Overall Study|Lack of Efficacy|7
3088772|NCT00368108|10593357|P3|Overall Study|Withdrawal by Subject|5
3088773|NCT00368108|10593358|P2|Overall Study|Withdrawal by Subject|3
3088774|NCT00368108|10593359|P1|Overall Study|Withdrawal by Subject|9
3088775|NCT00368108|10593357|P3|Overall Study|Protocol Violation|9
3088776|NCT00368108|10593358|P2|Overall Study|Protocol Violation|9
3088777|NCT00368108|10593359|P1|Overall Study|Protocol Violation|5
3088778|NCT00368108|10593357|P3|Overall Study|Abnormal Laboratory Value|3
3088779|NCT00368108|10593358|P2|Overall Study|Abnormal Laboratory Value|0
3088780|NCT00368108|10593359|P1|Overall Study|Abnormal Laboratory Value|0
3088781|NCT00368108|10593357|P3|Overall Study|Adverse Event|44
3088782|NCT00368108|10593358|P2|Overall Study|Adverse Event|26
3088783|NCT00368108|10593359|P1|Overall Study|Adverse Event|38
3088784|NCT00368069|10593378|P2|Overall Study|no blood sampling possible|1
3088785|NCT00368069|10593379|P1|Overall Study|no blood sampling possible|0
3088786|NCT00368069|10593378|P2|Overall Study|Withdrawal of Consent|1
3088787|NCT00368069|10593379|P1|Overall Study|Withdrawal of Consent|2
3088788|NCT00368069|10593378|P2|Overall Study|Protocol Violation|2
3088789|NCT00368069|10593379|P1|Overall Study|Protocol Violation|0
3088790|NCT00368069|10593378|P2|Overall Study|Lost to Follow-up|0
3088791|NCT00368069|10593379|P1|Overall Study|Lost to Follow-up|1
3088792|NCT00368069|10593378|P2|Overall Study|Lack of Efficacy|1
3088793|NCT00368069|10593379|P1|Overall Study|Lack of Efficacy|0
3088794|NCT00368069|10593378|P2|Overall Study|Adverse Event|2
3088795|NCT00368069|10593379|P1|Overall Study|Adverse Event|5
3088796|NCT00367991|10593397|P2|Overall Study|Adverse Event|1
3088797|NCT00367991|10593398|P1|Overall Study|Adverse Event|1
3088798|NCT00367991|10593397|P2|Overall Study|Withdrawal by Subject|1
3088799|NCT00367991|10593398|P1|Overall Study|Withdrawal by Subject|1
3088800|NCT00367835|10593416|P2|Overall Study|History of lead poisoning|1
3088801|NCT00367835|10593417|P1|Overall Study|History of lead poisoning|0
3088802|NCT00367835|10593416|P2|Overall Study|Did not respond to calls|0
3088803|NCT00367835|10593417|P1|Overall Study|Did not respond to calls|1
3088804|NCT00367835|10593416|P2|Overall Study|refused blood collection|0
3088805|NCT00367835|10593417|P1|Overall Study|refused blood collection|1
3088806|NCT00367835|10593416|P2|Overall Study|Subject in juvenile detention center|0
3088807|NCT00367835|10593417|P1|Overall Study|Subject in juvenile detention center|1
3088808|NCT00367835|10593416|P2|Overall Study|Lack of Efficacy|12
3088809|NCT00367835|10593417|P1|Overall Study|Lack of Efficacy|3
3088810|NCT00367835|10593416|P2|Overall Study|Lost to Follow-up|4
3088811|NCT00367835|10593417|P1|Overall Study|Lost to Follow-up|1
3088812|NCT00367835|10593416|P2|Overall Study|Withdrawal by Subject|6
3088813|NCT00367835|10593417|P1|Overall Study|Withdrawal by Subject|7
3088814|NCT00367835|10593416|P2|Overall Study|Protocol Violation|7
3088815|NCT00367835|10593417|P1|Overall Study|Protocol Violation|1
3088816|NCT00367835|10593416|P2|Overall Study|Adverse Event|1
3088817|NCT00367835|10593417|P1|Overall Study|Adverse Event|14
3088818|NCT00367770|10593443|P1|Overall Study|Withdrawal by Subject|1
3088819|NCT00367770|10593443|P1|Overall Study|Adverse Event|1
3088820|NCT00367744|10593451|P2|Overall Study|Lost to Follow-up|5
3088821|NCT00367744|10593452|P1|Overall Study|Lost to Follow-up|4
3088822|NCT00367640|10593481|P4|Overall Study|Any other reason not above-mentioned|4
3088823|NCT00367640|10593482|P3|Overall Study|Any other reason not above-mentioned|3
3088824|NCT00367640|10593483|P2|Overall Study|Any other reason not above-mentioned|5
3088825|NCT00367640|10593484|P1|Overall Study|Any other reason not above-mentioned|7
3088826|NCT00367640|10593481|P4|Overall Study|Withdrawal by Subject|6
3088827|NCT00367640|10593482|P3|Overall Study|Withdrawal by Subject|8
3088828|NCT00367640|10593483|P2|Overall Study|Withdrawal by Subject|11
3088829|NCT00367640|10593484|P1|Overall Study|Withdrawal by Subject|8
3088830|NCT00367640|10593481|P4|Overall Study|Adverse Event|0
3088831|NCT00367640|10593482|P3|Overall Study|Adverse Event|8
3088832|NCT00367640|10593483|P2|Overall Study|Adverse Event|6
3088833|NCT00367640|10593484|P1|Overall Study|Adverse Event|3
3088834|NCT00367484|10593500|P1|Overall Study|Lack of Efficacy|1
3088835|NCT00367484|10593500|P1|Overall Study|The choice of the patient|1
3088836|NCT00367484|10593500|P1|Overall Study|Protocol Violation|1
3088837|NCT00367484|10593500|P1|Overall Study|Lost to Follow-up|1
3088838|NCT00367484|10593500|P1|Overall Study|Travel to USA|1
3088839|NCT00367484|10593500|P1|Overall Study|Withdrew informed consent|5
3088840|NCT00367484|10593500|P1|Overall Study|Adverse Event|7
3088841|NCT00367458|10593506|P2|First Intervention - 8 Weeks|Adverse Event|0
3088842|NCT00367458|10593507|P1|First Intervention - 8 Weeks|Adverse Event|2
3088843|NCT00367432|10593521|P2|Second Period (up to 54 Months)|Other Reason|2
3088844|NCT00367432|10593522|P1|Second Period (up to 54 Months)|Other Reason|6
3088845|NCT00367432|10593521|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
3088846|NCT00367432|10593522|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
3088847|NCT00367432|10593521|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
3088848|NCT00367432|10593522|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
3088849|NCT00367432|10593521|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
3088850|NCT00367432|10593522|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
3088851|NCT00367432|10593521|P2|Second Period (up to 54 Months)|Adverse Event|3
3088852|NCT00367432|10593522|P1|Second Period (up to 54 Months)|Adverse Event|14
3088853|NCT00367432|10593521|P2|First Period (16 Weeks)|Other Reason|0
3088854|NCT00367432|10593522|P1|First Period (16 Weeks)|Other Reason|2
3088855|NCT00367432|10593521|P2|First Period (16 Weeks)|Withdrawal by Subject|0
3088856|NCT00367432|10593522|P1|First Period (16 Weeks)|Withdrawal by Subject|6
3088857|NCT00367432|10593521|P2|First Period (16 Weeks)|Lack of Efficacy|0
3088858|NCT00367432|10593522|P1|First Period (16 Weeks)|Lack of Efficacy|24
3088859|NCT00367432|10593521|P2|First Period (16 Weeks)|Adverse Event|0
3088860|NCT00367432|10593522|P1|First Period (16 Weeks)|Adverse Event|6
3088861|NCT00367341|10593549|P2|Overall Study|Protocol Violation|0
3088862|NCT00367341|10593550|P1|Overall Study|Protocol Violation|1
3088863|NCT00367341|10593549|P2|Overall Study|Physician Decision|0
3088864|NCT00367341|10593550|P1|Overall Study|Physician Decision|1
3088865|NCT00367237|10593560|P2|Overall Study|Protocol Violation|5
3088866|NCT00367237|10593561|P1|Overall Study|Protocol Violation|2
3088867|NCT00367237|10593560|P2|Overall Study|Withdrawal by Subject|4
3088868|NCT00367237|10593561|P1|Overall Study|Withdrawal by Subject|0
3088869|NCT00367237|10593560|P2|Overall Study|Lost to Follow-up|0
3088870|NCT00367237|10593561|P1|Overall Study|Lost to Follow-up|1
3088871|NCT00367237|10593560|P2|Overall Study|Adverse Event|2
3088872|NCT00367237|10593561|P1|Overall Study|Adverse Event|7
3088873|NCT00367133|10593570|P3|2 Years|Missed visit|4
3088874|NCT00367133|10593571|P2|2 Years|Missed visit|5
3088875|NCT00367133|10593572|P1|2 Years|Missed visit|4
3088876|NCT00367133|10593570|P3|2 Years|Dropped|33
3088877|NCT00367133|10593571|P2|2 Years|Dropped|19
3088878|NCT00367133|10593572|P1|2 Years|Dropped|34
3088879|NCT00367133|10593570|P3|2 Years|Death|12
3088880|NCT00367133|10593571|P2|2 Years|Death|12
3088881|NCT00367133|10593572|P1|2 Years|Death|20
3088970|NCT00366548|10593787|P1|Infant Series|Protocol Violation|0
3088882|NCT00367055|10593624|P2|Overall Study|Participant Living too Far from Hospital|1
3088883|NCT00367055|10593625|P1|Overall Study|Participant Living too Far from Hospital|0
3088884|NCT00367055|10593624|P2|Overall Study|Stopping Criterion Met|1
3088885|NCT00367055|10593625|P1|Overall Study|Stopping Criterion Met|0
3088886|NCT00367055|10593624|P2|Overall Study|Protocol Violation|1
3088887|NCT00367055|10593625|P1|Overall Study|Protocol Violation|0
3088888|NCT00367055|10593624|P2|Overall Study|Lost to Follow-up|1
3088889|NCT00367055|10593625|P1|Overall Study|Lost to Follow-up|1
3088890|NCT00367055|10593624|P2|Overall Study|Lack of Efficacy|2
3088891|NCT00367055|10593625|P1|Overall Study|Lack of Efficacy|1
3088892|NCT00367055|10593624|P2|Overall Study|Patient's Willing|2
3088893|NCT00367055|10593625|P1|Overall Study|Patient's Willing|3
3088894|NCT00367055|10593624|P2|Overall Study|Adverse Event|3
3088895|NCT00367055|10593625|P1|Overall Study|Adverse Event|6
3088896|NCT00366899|10593641|P2|Toddler Dose|Protocol Violation|0
3088897|NCT00366899|10593642|P1|Toddler Dose|Protocol Violation|1
3088898|NCT00366899|10593641|P2|Toddler Dose|Withdrawal by Subject|1
3088899|NCT00366899|10593642|P1|Toddler Dose|Withdrawal by Subject|1
3088900|NCT00366899|10593641|P2|After Infant Series|Protocol Violation|0
3088901|NCT00366899|10593642|P1|After Infant Series|Protocol Violation|1
3088902|NCT00366899|10593641|P2|After Infant Series|Adverse Event|2
3088903|NCT00366899|10593642|P1|After Infant Series|Adverse Event|1
3088904|NCT00366899|10593641|P2|After Infant Series|Withdrawal by Subject|4
3088905|NCT00366899|10593642|P1|After Infant Series|Withdrawal by Subject|1
3088906|NCT00366899|10593641|P2|After Infant Series|Lost to Follow-up|3
3088907|NCT00366899|10593642|P1|After Infant Series|Lost to Follow-up|4
3088908|NCT00366899|10593641|P2|Infant Series|Randomized but not consented|0
3088909|NCT00366899|10593642|P1|Infant Series|Randomized but not consented|1
3088910|NCT00366899|10593641|P2|Infant Series|Physician Decision|0
3088911|NCT00366899|10593642|P1|Infant Series|Physician Decision|1
3088912|NCT00366899|10593641|P2|Infant Series|Adverse Event|1
3088913|NCT00366899|10593642|P1|Infant Series|Adverse Event|0
3088914|NCT00366899|10593641|P2|Infant Series|Lost to Follow-up|2
3088915|NCT00366899|10593642|P1|Infant Series|Lost to Follow-up|0
3088916|NCT00366899|10593641|P2|Infant Series|Failed to return|1
3088917|NCT00366899|10593642|P1|Infant Series|Failed to return|1
3088918|NCT00366899|10593641|P2|Infant Series|Protocol Violation|1
3088919|NCT00366899|10593642|P1|Infant Series|Protocol Violation|2
3088920|NCT00366899|10593641|P2|Infant Series|Withdrawal by Subject|7
3088921|NCT00366899|10593642|P1|Infant Series|Withdrawal by Subject|4
3088922|NCT00366678|10593702|P3|Toddler Dose|protocol deviation|0
3088923|NCT00366678|10593703|P2|Toddler Dose|protocol deviation|0
3088924|NCT00366678|10593704|P1|Toddler Dose|protocol deviation|1
3088925|NCT00366678|10593702|P3|Toddler Dose|Withdrawal by Subject|0
3088926|NCT00366678|10593703|P2|Toddler Dose|Withdrawal by Subject|0
3088927|NCT00366678|10593704|P1|Toddler Dose|Withdrawal by Subject|1
3088928|NCT00366678|10593702|P3|Toddler Dose|Failed to return|0
3088929|NCT00366678|10593703|P2|Toddler Dose|Failed to return|0
3088930|NCT00366678|10593704|P1|Toddler Dose|Failed to return|1
3088931|NCT00366678|10593702|P3|Toddler Dose|Protocol Violation|0
3088932|NCT00366678|10593703|P2|Toddler Dose|Protocol Violation|1
3088933|NCT00366678|10593704|P1|Toddler Dose|Protocol Violation|2
3088934|NCT00366678|10593702|P3|After Infant|Protocol Violation|0
3088935|NCT00366678|10593703|P2|After Infant|Protocol Violation|0
3088936|NCT00366678|10593704|P1|After Infant|Protocol Violation|1
3088937|NCT00366678|10593702|P3|After Infant|Adverse Event|0
3088938|NCT00366678|10593703|P2|After Infant|Adverse Event|0
3088939|NCT00366678|10593704|P1|After Infant|Adverse Event|1
3088940|NCT00366678|10593702|P3|After Infant|Failed to return|0
3088941|NCT00366678|10593703|P2|After Infant|Failed to return|5
3088942|NCT00366678|10593704|P1|After Infant|Failed to return|5
3088943|NCT00366678|10593702|P3|After Infant|Lost to Follow-up|0
3088944|NCT00366678|10593703|P2|After Infant|Lost to Follow-up|1
3088945|NCT00366678|10593704|P1|After Infant|Lost to Follow-up|2
3088946|NCT00366678|10593702|P3|After Infant|Withdrawal by Subject|0
3088947|NCT00366678|10593703|P2|After Infant|Withdrawal by Subject|4
3088948|NCT00366678|10593704|P1|After Infant|Withdrawal by Subject|8
3088949|NCT00366678|10593702|P3|Infant Series|Adverse Event|0
3088950|NCT00366678|10593703|P2|Infant Series|Adverse Event|0
3088951|NCT00366678|10593704|P1|Infant Series|Adverse Event|1
3088952|NCT00366678|10593702|P3|Infant Series|Failed to return|0
3088953|NCT00366678|10593703|P2|Infant Series|Failed to return|1
3088954|NCT00366678|10593704|P1|Infant Series|Failed to return|1
3088955|NCT00366678|10593702|P3|Infant Series|Protocol Violation|0
3088956|NCT00366678|10593703|P2|Infant Series|Protocol Violation|3
3088957|NCT00366678|10593704|P1|Infant Series|Protocol Violation|4
3088958|NCT00366678|10593702|P3|Infant Series|Withdrawal by Subject|0
3088959|NCT00366678|10593703|P2|Infant Series|Withdrawal by Subject|6
3088960|NCT00366678|10593704|P1|Infant Series|Withdrawal by Subject|8
3088961|NCT00366548|10593786|P2|After Infant Series|Lost to Follow-up|0
3088962|NCT00366548|10593787|P1|After Infant Series|Lost to Follow-up|1
3088963|NCT00366548|10593786|P2|After Infant Series|Adverse Event|0
3088964|NCT00366548|10593787|P1|After Infant Series|Adverse Event|2
3088965|NCT00366548|10593786|P2|After Infant Series|Withdrawal by Subject|1
3088966|NCT00366548|10593787|P1|After Infant Series|Withdrawal by Subject|3
3088967|NCT00366548|10593786|P2|Infant Series|Withdrawal by Subject|1
3088968|NCT00366548|10593787|P1|Infant Series|Withdrawal by Subject|3
3088969|NCT00366548|10593786|P2|Infant Series|Protocol Violation|1
3088971|NCT00366548|10593786|P2|Infant Series|Adverse Event|3
3088972|NCT00366548|10593787|P1|Infant Series|Adverse Event|1
3088973|NCT00366535|10593823|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
3088974|NCT00366535|10593824|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
3088975|NCT00366535|10593823|P2|Second Phase: 12 Weeks|Adverse Event|1
3088976|NCT00366535|10593824|P1|Second Phase: 12 Weeks|Adverse Event|1
3088977|NCT00366535|10593823|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
3088978|NCT00366535|10593824|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
3088979|NCT00366535|10593823|P2|First Phase: 12 Weeks|Adverse Event|3
3088980|NCT00366535|10593824|P1|First Phase: 12 Weeks|Adverse Event|1
3088981|NCT00366457|10593838|P1|Overall Study|never began study therapy|2
3088982|NCT00366444|10593847|P2|Overall Study|Lack of Efficacy|1
3088983|NCT00366444|10593848|P1|Overall Study|Lack of Efficacy|0
3088984|NCT00366444|10593847|P2|Overall Study|Withdrawal by Subject|1
3088985|NCT00366444|10593848|P1|Overall Study|Withdrawal by Subject|1
3088986|NCT00366340|10593876|P2|Toddler Dose|Parent/legal guardian request|1
3088987|NCT00366340|10593877|P1|Toddler Dose|Parent/legal guardian request|0
3088988|NCT00366340|10593876|P2|Toddler Dose|Failed to return|0
3088989|NCT00366340|10593877|P1|Toddler Dose|Failed to return|1
3088990|NCT00366340|10593876|P2|After the Infant Series|Lost to Follow-up|1
3088991|NCT00366340|10593877|P1|After the Infant Series|Lost to Follow-up|0
3088992|NCT00366340|10593876|P2|After the Infant Series|Adverse Event|1
3088993|NCT00366340|10593877|P1|After the Infant Series|Adverse Event|0
3088994|NCT00366340|10593876|P2|After the Infant Series|Protocol Violation|2
3088995|NCT00366340|10593877|P1|After the Infant Series|Protocol Violation|2
3088996|NCT00366340|10593876|P2|After the Infant Series|Failed to return|1
3088997|NCT00366340|10593877|P1|After the Infant Series|Failed to return|0
3088998|NCT00366340|10593876|P2|After the Infant Series|Parent/legal guardian request|1
3088999|NCT00366340|10593877|P1|After the Infant Series|Parent/legal guardian request|1
3089000|NCT00366340|10593876|P2|Infant Series|Failure to return|0
3089001|NCT00366340|10593877|P1|Infant Series|Failure to return|1
3089002|NCT00366340|10593876|P2|Infant Series|Lost to Follow-up|1
3089003|NCT00366340|10593877|P1|Infant Series|Lost to Follow-up|1
3089004|NCT00366340|10593876|P2|Infant Series|Adverse Event|2
3089005|NCT00366340|10593877|P1|Infant Series|Adverse Event|0
3089006|NCT00366340|10593876|P2|Infant Series|Withdrawal by Subject|3
3089007|NCT00366340|10593877|P1|Infant Series|Withdrawal by Subject|3
3089008|NCT00366340|10593876|P2|Infant Series|Protocol Violation|4
3089009|NCT00366340|10593877|P1|Infant Series|Protocol Violation|3
3089010|NCT00366301|10593935|P4|Overall Study|Withdrawal by Subject|1
3089011|NCT00366301|10593936|P3|Overall Study|Withdrawal by Subject|1
3089012|NCT00366301|10593937|P2|Overall Study|Withdrawal by Subject|2
3089013|NCT00366301|10593938|P1|Overall Study|Withdrawal by Subject|4
3089014|NCT00366301|10593935|P4|Overall Study|Lost to Follow-up|7
3089015|NCT00366301|10593936|P3|Overall Study|Lost to Follow-up|3
3089016|NCT00366301|10593937|P2|Overall Study|Lost to Follow-up|4
3089017|NCT00366301|10593938|P1|Overall Study|Lost to Follow-up|4
3089018|NCT00366249|10593954|P2|Overall Study|Most due to osteomylitis status|20
3089019|NCT00366249|10593955|P1|Overall Study|Most due to osteomylitis status|31
3089020|NCT00366249|10593954|P2|Overall Study|Lack of Efficacy|21
3089021|NCT00366249|10593955|P1|Overall Study|Lack of Efficacy|21
3089022|NCT00366249|10593954|P2|Overall Study|Withdrawal by Subject|4
3089023|NCT00366249|10593955|P1|Overall Study|Withdrawal by Subject|18
3089024|NCT00366249|10593954|P2|Overall Study|Protocol Violation|2
3089025|NCT00366249|10593955|P1|Overall Study|Protocol Violation|1
3089026|NCT00366249|10593954|P2|Overall Study|Lost to Follow-up|0
3089027|NCT00366249|10593955|P1|Overall Study|Lost to Follow-up|2
3089028|NCT00366249|10593954|P2|Overall Study|Physician Decision|2
3089029|NCT00366249|10593955|P1|Overall Study|Physician Decision|5
3089030|NCT00366249|10593954|P2|Overall Study|Death|1
3089031|NCT00366249|10593955|P1|Overall Study|Death|0
3089032|NCT00366249|10593954|P2|Overall Study|Adverse Event|28
3089033|NCT00366249|10593955|P1|Overall Study|Adverse Event|53
3089034|NCT00365989|10593987|P1|Overall Study|Non-compliance|1
3089035|NCT00365989|10593987|P1|Overall Study|Withdrawal by Subject|1
3089036|NCT00365976|10593995|P2|Overall Study|Withdrawal by Subject|5
3089037|NCT00365976|10593996|P1|Overall Study|Withdrawal by Subject|1
3089038|NCT00365846|10594134|P1|Overall Study|Lost to Follow-up|1
3089039|NCT00365794|10594143|P1|Overall Study|Withdrawal by Subject|2
3089040|NCT00365716|10594172|P7|Extension 2|Withdrawal by Subject|5
3089041|NCT00365716|10594173|P6|Extension 2|Withdrawal by Subject|0
3089042|NCT00365716|10594174|P5|Extension 2|Withdrawal by Subject|0
3089043|NCT00365716|10594175|P4|Extension 2|Withdrawal by Subject|0
3089044|NCT00365716|10594176|P3|Extension 2|Withdrawal by Subject|0
3089045|NCT00365716|10594177|P2|Extension 2|Withdrawal by Subject|0
3089046|NCT00365716|10594178|P1|Extension 2|Withdrawal by Subject|0
3089047|NCT00365716|10594172|P7|Extension 2|Other|3
3089048|NCT00365716|10594173|P6|Extension 2|Other|0
3089049|NCT00365716|10594174|P5|Extension 2|Other|0
3089050|NCT00365716|10594175|P4|Extension 2|Other|0
3089051|NCT00365716|10594176|P3|Extension 2|Other|0
3089052|NCT00365716|10594177|P2|Extension 2|Other|0
3089053|NCT00365716|10594178|P1|Extension 2|Other|0
3089054|NCT00365716|10594172|P7|Extension 2|Lost to Follow-up|2
3089055|NCT00365716|10594173|P6|Extension 2|Lost to Follow-up|0
3089056|NCT00365716|10594174|P5|Extension 2|Lost to Follow-up|0
3089057|NCT00365716|10594175|P4|Extension 2|Lost to Follow-up|0
3089058|NCT00365716|10594176|P3|Extension 2|Lost to Follow-up|0
3089059|NCT00365716|10594177|P2|Extension 2|Lost to Follow-up|0
3089060|NCT00365716|10594178|P1|Extension 2|Lost to Follow-up|0
3089061|NCT00365716|10594172|P7|Extension 1|Protocol Violation|0
3089062|NCT00365716|10594173|P6|Extension 1|Protocol Violation|1
3089063|NCT00365716|10594174|P5|Extension 1|Protocol Violation|0
3089064|NCT00365716|10594175|P4|Extension 1|Protocol Violation|0
3089065|NCT00365716|10594176|P3|Extension 1|Protocol Violation|0
3089066|NCT00365716|10594177|P2|Extension 1|Protocol Violation|0
3089067|NCT00365716|10594178|P1|Extension 1|Protocol Violation|0
3089068|NCT00365716|10594172|P7|Extension 1|Pregnancy|0
3089069|NCT00365716|10594173|P6|Extension 1|Pregnancy|4
3089070|NCT00365716|10594174|P5|Extension 1|Pregnancy|0
3089071|NCT00365716|10594175|P4|Extension 1|Pregnancy|0
3089072|NCT00365716|10594176|P3|Extension 1|Pregnancy|0
3089073|NCT00365716|10594177|P2|Extension 1|Pregnancy|0
3089074|NCT00365716|10594178|P1|Extension 1|Pregnancy|0
3089075|NCT00365716|10594172|P7|Extension 1|Withdrawal by Subject|0
3089076|NCT00365716|10594173|P6|Extension 1|Withdrawal by Subject|3
3089077|NCT00365716|10594174|P5|Extension 1|Withdrawal by Subject|0
3089078|NCT00365716|10594175|P4|Extension 1|Withdrawal by Subject|0
3089079|NCT00365716|10594176|P3|Extension 1|Withdrawal by Subject|0
3089080|NCT00365716|10594177|P2|Extension 1|Withdrawal by Subject|0
3089081|NCT00365716|10594178|P1|Extension 1|Withdrawal by Subject|0
3089082|NCT00365716|10594172|P7|Extension 1|Moved|0
3089083|NCT00365716|10594173|P6|Extension 1|Moved|4
3089084|NCT00365716|10594174|P5|Extension 1|Moved|0
3089085|NCT00365716|10594175|P4|Extension 1|Moved|0
3089086|NCT00365716|10594176|P3|Extension 1|Moved|0
3089087|NCT00365716|10594177|P2|Extension 1|Moved|0
3089088|NCT00365716|10594178|P1|Extension 1|Moved|0
3089089|NCT00365716|10594172|P7|Extension 1|Other|0
3089090|NCT00365716|10594173|P6|Extension 1|Other|9
3089091|NCT00365716|10594174|P5|Extension 1|Other|0
3089092|NCT00365716|10594175|P4|Extension 1|Other|0
3089093|NCT00365716|10594176|P3|Extension 1|Other|0
3089094|NCT00365716|10594177|P2|Extension 1|Other|0
3089095|NCT00365716|10594178|P1|Extension 1|Other|0
3089096|NCT00365716|10594172|P7|Extension 1|Lost to Follow-up|0
3089097|NCT00365716|10594173|P6|Extension 1|Lost to Follow-up|1
3089098|NCT00365716|10594174|P5|Extension 1|Lost to Follow-up|0
3089099|NCT00365716|10594175|P4|Extension 1|Lost to Follow-up|0
3089100|NCT00365716|10594176|P3|Extension 1|Lost to Follow-up|0
3089101|NCT00365716|10594177|P2|Extension 1|Lost to Follow-up|0
3089102|NCT00365716|10594178|P1|Extension 1|Lost to Follow-up|0
3089103|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
3089104|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
3089105|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
3089106|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
3089107|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
3089108|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
3089109|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
3089110|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
3089111|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
3089112|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
3089113|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
3089114|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
3089115|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
3089116|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
3089117|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
3089118|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
3089119|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
3089120|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
3089121|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
3089122|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
3089123|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
3089124|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
3089125|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
3089126|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
3089127|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
3089128|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
3089129|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
3089130|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
3089131|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
3089132|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
3089133|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
3089134|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
3089135|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
3089136|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
3089137|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
3089138|NCT00365716|10594172|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
3089139|NCT00365716|10594173|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
3089140|NCT00365716|10594174|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
3089141|NCT00365716|10594175|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
3089142|NCT00365716|10594176|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
3089143|NCT00365716|10594177|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
3089144|NCT00365716|10594178|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
3089145|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
3089146|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
3089147|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
3089148|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
3089149|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
3089150|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
3089151|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
3089152|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
3089153|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
3089154|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
3089155|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
3089156|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
3089157|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
3089158|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
3089159|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
3089160|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
3089161|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
3089162|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
3089163|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
3089164|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
3089165|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
3089166|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Other|0
3089167|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Other|0
3089168|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Other|0
3089169|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Other|0
3089170|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Other|0
3089171|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Other|1
3089172|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Other|0
3089173|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
3089174|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
3089175|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
3089176|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
3089177|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
3089178|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
3089179|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
3089180|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
3089181|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
3089182|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
3089183|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
3089184|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
3089185|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
3089186|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
3089187|NCT00365716|10594172|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089188|NCT00365716|10594173|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089189|NCT00365716|10594174|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089190|NCT00365716|10594175|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089191|NCT00365716|10594176|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089192|NCT00365716|10594177|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
3089193|NCT00365716|10594178|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
3089194|NCT00365547|10594199|P1|Overall Study|Withdrawal by Subject|1
3089195|NCT00365547|10594199|P1|Overall Study|Screen failure|1
3089196|NCT00365547|10594199|P1|Overall Study|Insurance did not cover Avastin|1
3089197|NCT00365508|10594209|P2|Overall Study|Lost to Follow-up|154
3089198|NCT00365508|10594210|P1|Overall Study|Lost to Follow-up|139
3089199|NCT00365456|10594218|P2|Trial Period III (12 Months)|Other|1
3089200|NCT00365456|10594219|P1|Trial Period III (12 Months)|Other|1
3089201|NCT00365456|10594218|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
3089202|NCT00365456|10594219|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
3089203|NCT00365456|10594218|P2|Trial Period III (12 Months)|Adverse Event|3
3089204|NCT00365456|10594219|P1|Trial Period III (12 Months)|Adverse Event|13
3089205|NCT00365456|10594218|P2|Trial Period II (12 Months)|Other|1
3089206|NCT00365456|10594219|P1|Trial Period II (12 Months)|Other|0
3089207|NCT00365456|10594218|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
3089208|NCT00365456|10594219|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
3089209|NCT00365456|10594218|P2|Trial Period II (12 Months)|Non-compliance|2
3089210|NCT00365456|10594219|P1|Trial Period II (12 Months)|Non-compliance|0
3089211|NCT00365456|10594218|P2|Trial Period II (12 Months)|Adverse Event|6
3089212|NCT00365456|10594219|P1|Trial Period II (12 Months)|Adverse Event|0
3089213|NCT00365456|10594218|P2|Trial Period I (12 Months)|Other|0
3089214|NCT00365456|10594219|P1|Trial Period I (12 Months)|Other|11
3089215|NCT00365456|10594218|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
3089216|NCT00365456|10594219|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
3089217|NCT00365456|10594218|P2|Trial Period I (12 Months)|Non-compliance|0
3089218|NCT00365456|10594219|P1|Trial Period I (12 Months)|Non-compliance|3
3089219|NCT00365456|10594218|P2|Trial Period I (12 Months)|Adverse Event|0
3089220|NCT00365456|10594219|P1|Trial Period I (12 Months)|Adverse Event|84
3089221|NCT00365378|10594246|P3|Extension|Other|31
3089222|NCT00365378|10594247|P2|Extension|Other|0
3089223|NCT00365378|10594248|P1|Extension|Other|0
3089224|NCT00365378|10594246|P3|Extension|Withdrawal by Subject|98
3089225|NCT00365378|10594247|P2|Extension|Withdrawal by Subject|0
3089226|NCT00365378|10594248|P1|Extension|Withdrawal by Subject|0
3089227|NCT00365378|10594246|P3|Extension|Protocol Violation|2
3089228|NCT00365378|10594247|P2|Extension|Protocol Violation|0
3089229|NCT00365378|10594248|P1|Extension|Protocol Violation|0
3089230|NCT00365378|10594246|P3|Extension|Lost to Follow-up|57
3089231|NCT00365378|10594247|P2|Extension|Lost to Follow-up|0
3089232|NCT00365378|10594248|P1|Extension|Lost to Follow-up|0
3089233|NCT00365378|10594246|P3|Extension|Moved|8
3089234|NCT00365378|10594247|P2|Extension|Moved|0
3089235|NCT00365378|10594248|P1|Extension|Moved|0
3089236|NCT00365378|10594246|P3|Extension|Adverse Event|1
3089237|NCT00365378|10594247|P2|Extension|Adverse Event|0
3089238|NCT00365378|10594248|P1|Extension|Adverse Event|0
3089239|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Other|0
3089240|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Other|21
3089241|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Other|11
3089242|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
3089243|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
3089244|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
3089245|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
3089246|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
3089247|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
3089248|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
3089249|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
3089250|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
3089251|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
3089252|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
3089253|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
3089254|NCT00365378|10594246|P3|Follow-up (Month 7 Though Month 48)|Moved|0
3089255|NCT00365378|10594247|P2|Follow-up (Month 7 Though Month 48)|Moved|5
3089256|NCT00365378|10594248|P1|Follow-up (Month 7 Though Month 48)|Moved|6
3089257|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Other|0
3089258|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Other|9
3089259|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Other|17
3089260|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
3089261|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
3089262|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
3089263|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
3089264|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
3089265|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
3089266|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
3089267|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
3089268|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
3089269|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
3089270|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
3089271|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
3089272|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
3089273|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
3089274|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
3089275|NCT00365378|10594246|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
3089276|NCT00365378|10594247|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
3089277|NCT00365378|10594248|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
3089278|NCT00365365|10594262|P3|Overall Study|Patient/physician decision|1
3089279|NCT00365365|10594263|P2|Overall Study|Patient/physician decision|0
3089280|NCT00365365|10594264|P1|Overall Study|Patient/physician decision|0
3089281|NCT00365365|10594262|P3|Overall Study|Second malignancy|0
3089282|NCT00365365|10594263|P2|Overall Study|Second malignancy|1
3089283|NCT00365365|10594264|P1|Overall Study|Second malignancy|0
3089284|NCT00365365|10594262|P3|Overall Study|Withdrew consent|0
3089285|NCT00365365|10594263|P2|Overall Study|Withdrew consent|1
3089286|NCT00365365|10594264|P1|Overall Study|Withdrew consent|1
3089287|NCT00365365|10594262|P3|Overall Study|New cancer|0
3089288|NCT00365365|10594263|P2|Overall Study|New cancer|0
3089289|NCT00365365|10594264|P1|Overall Study|New cancer|1
3089290|NCT00365365|10594262|P3|Overall Study|Moved|0
3089291|NCT00365365|10594263|P2|Overall Study|Moved|0
3089292|NCT00365365|10594264|P1|Overall Study|Moved|2
3089293|NCT00365365|10594262|P3|Overall Study|Adverse Event|3
3089294|NCT00365365|10594263|P2|Overall Study|Adverse Event|6
3089295|NCT00365365|10594264|P1|Overall Study|Adverse Event|6
3089296|NCT00365365|10594262|P3|Overall Study|Disease progression/relapse|7
3089297|NCT00365365|10594263|P2|Overall Study|Disease progression/relapse|6
3089298|NCT00365365|10594264|P1|Overall Study|Disease progression/relapse|9
3089299|NCT00365365|10594262|P3|Overall Study|Subject's request|1
3089300|NCT00365365|10594263|P2|Overall Study|Subject's request|13
3089301|NCT00365365|10594264|P1|Overall Study|Subject's request|11
3089302|NCT00365365|10594262|P3|Overall Study|Death|0
3089303|NCT00365365|10594263|P2|Overall Study|Death|3
3089304|NCT00365365|10594264|P1|Overall Study|Death|1
3089305|NCT00365365|10594262|P3|Overall Study|Lost to Follow-up|3
3089306|NCT00365365|10594263|P2|Overall Study|Lost to Follow-up|3
3089307|NCT00365365|10594264|P1|Overall Study|Lost to Follow-up|3
3089308|NCT00365365|10594262|P3|Overall Study|Poor compliance to protocol|0
3089309|NCT00365365|10594263|P2|Overall Study|Poor compliance to protocol|1
3089310|NCT00365365|10594264|P1|Overall Study|Poor compliance to protocol|0
3089311|NCT00365365|10594262|P3|Overall Study|Randomized but not treated|0
3089312|NCT00365365|10594263|P2|Overall Study|Randomized but not treated|2
3089313|NCT00365365|10594264|P1|Overall Study|Randomized but not treated|0
3089314|NCT00365352|10594281|P3|Overall Study|Withdrawal of Participant by Sponsor|0
3089315|NCT00365352|10594282|P2|Overall Study|Withdrawal of Participant by Sponsor|0
3089316|NCT00365352|10594283|P1|Overall Study|Withdrawal of Participant by Sponsor|1
3089317|NCT00365352|10594281|P3|Overall Study|Lost to Follow-up|0
3089318|NCT00365352|10594282|P2|Overall Study|Lost to Follow-up|1
3089319|NCT00365352|10594283|P1|Overall Study|Lost to Follow-up|1
3089320|NCT00365352|10594281|P3|Overall Study|Non-Compliance (after Randomization)|1
3089321|NCT00365352|10594282|P2|Overall Study|Non-Compliance (after Randomization)|0
3089322|NCT00365352|10594283|P1|Overall Study|Non-Compliance (after Randomization)|1
3089323|NCT00365352|10594281|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
3089324|NCT00365352|10594282|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
3089325|NCT00365352|10594283|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
3089326|NCT00365352|10594281|P3|Overall Study|Lack of Efficacy|0
3089327|NCT00365352|10594282|P2|Overall Study|Lack of Efficacy|0
3089328|NCT00365352|10594283|P1|Overall Study|Lack of Efficacy|3
3089329|NCT00365352|10594281|P3|Overall Study|Participant Withdrew Consent|4
3089330|NCT00365352|10594282|P2|Overall Study|Participant Withdrew Consent|3
3089331|NCT00365352|10594283|P1|Overall Study|Participant Withdrew Consent|8
3089332|NCT00365352|10594281|P3|Overall Study|Adverse Event|8
3089333|NCT00365352|10594282|P2|Overall Study|Adverse Event|7
3089334|NCT00365352|10594283|P1|Overall Study|Adverse Event|6
3089335|NCT00365300|10594367|P2|Double-blind Phase|Lack of Efficacy|6
3089336|NCT00365300|10594368|P1|Double-blind Phase|Lack of Efficacy|6
3089337|NCT00365300|10594367|P2|Double-blind Phase|Protocol Violation|1
3089338|NCT00365300|10594368|P1|Double-blind Phase|Protocol Violation|3
3089339|NCT00365300|10594367|P2|Double-blind Phase|Withdrawal by Subject|1
3089340|NCT00365300|10594368|P1|Double-blind Phase|Withdrawal by Subject|0
3089341|NCT00365300|10594367|P2|Double-blind Phase|Noncompliance|1
3089342|NCT00365300|10594368|P1|Double-blind Phase|Noncompliance|1
3089343|NCT00365300|10594367|P2|Double-blind Phase|Failed to return|0
3089344|NCT00365300|10594368|P1|Double-blind Phase|Failed to return|1
3089345|NCT00365300|10594367|P2|Open-label Phase|Patient skipped open label phase|0
3089346|NCT00365300|10594368|P1|Open-label Phase|Patient skipped open label phase|1
3089347|NCT00365300|10594367|P2|Open-label Phase|Lack of Efficacy|0
3089348|NCT00365300|10594368|P1|Open-label Phase|Lack of Efficacy|1
3089349|NCT00365300|10594367|P2|Open-label Phase|Protocol Violation|0
3089350|NCT00365300|10594368|P1|Open-label Phase|Protocol Violation|1
3089351|NCT00365300|10594367|P2|Open-label Phase|Parent/Legal Guardian Request|0
3089352|NCT00365300|10594368|P1|Open-label Phase|Parent/Legal Guardian Request|4
3089353|NCT00365300|10594367|P2|Open-label Phase|Noncompliance|0
3089354|NCT00365300|10594368|P1|Open-label Phase|Noncompliance|9
3089355|NCT00365300|10594367|P2|Open-label Phase|Physician Decision|0
3089356|NCT00365300|10594368|P1|Open-label Phase|Physician Decision|1
3089357|NCT00365300|10594367|P2|Open-label Phase|Failed to Return|0
3089358|NCT00365300|10594368|P1|Open-label Phase|Failed to Return|1
3089359|NCT00365300|10594367|P2|Open-label Phase|Adverse Event|0
3089360|NCT00365300|10594368|P1|Open-label Phase|Adverse Event|4
3089361|NCT00365105|10594433|P2|Overall Study|Protocol Violation|8
3089362|NCT00365105|10594434|P1|Overall Study|Protocol Violation|5
3089363|NCT00364923|10594480|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
3089364|NCT00364923|10594480|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
3089365|NCT00364858|10594489|P2|Overall Study|Clinical baseline issue|1
3089366|NCT00364858|10594490|P1|Overall Study|Clinical baseline issue|0
3089367|NCT00364858|10594489|P2|Overall Study|Return to Q2 regimen|1
3089368|NCT00364858|10594490|P1|Overall Study|Return to Q2 regimen|0
3089369|NCT00364858|10594489|P2|Overall Study|Non-compliant|0
3089370|NCT00364858|10594490|P1|Overall Study|Non-compliant|1
3089371|NCT00364858|10594489|P2|Overall Study|Discontinuation at baseline|0
3089372|NCT00364858|10594490|P1|Overall Study|Discontinuation at baseline|1
3089373|NCT00364858|10594489|P2|Overall Study|Clinical failure|13
3089374|NCT00364858|10594490|P1|Overall Study|Clinical failure|2
3089375|NCT00364858|10594489|P2|Overall Study|Pregnancy|1
3089376|NCT00364858|10594490|P1|Overall Study|Pregnancy|1
3089377|NCT00364858|10594489|P2|Overall Study|Withdrawal by Subject|1
3089378|NCT00364858|10594490|P1|Overall Study|Withdrawal by Subject|1
3089379|NCT00364858|10594489|P2|Overall Study|Adverse Event|5
3089380|NCT00364858|10594490|P1|Overall Study|Adverse Event|1
3089381|NCT00364845|10594505|P2|Overall Study|Death|1
3089382|NCT00364845|10594506|P1|Overall Study|Death|0
3089383|NCT00364845|10594505|P2|Overall Study|Lost to Follow-up|1
3089384|NCT00364845|10594506|P1|Overall Study|Lost to Follow-up|0
3089385|NCT00364845|10594505|P2|Overall Study|Physician Decision|8
3089386|NCT00364845|10594506|P1|Overall Study|Physician Decision|8
3089387|NCT00364845|10594505|P2|Overall Study|Withdrawal by Subject|1
3089388|NCT00364845|10594506|P1|Overall Study|Withdrawal by Subject|2
3089389|NCT00364845|10594505|P2|Overall Study|Adverse Event|0
3089390|NCT00364845|10594506|P1|Overall Study|Adverse Event|1
3089391|NCT00364832|10594527|P12|Extension Year 2|Early Withdrawals|3
3089392|NCT00364832|10594528|P11|Extension Year 2|Early Withdrawals|5
3089393|NCT00364832|10594529|P10|Extension Year 2|Early Withdrawals|5
3089394|NCT00364832|10594530|P9|Extension Year 2|Early Withdrawals|0
3089395|NCT00364832|10594531|P8|Extension Year 2|Early Withdrawals|0
3089396|NCT00364832|10594532|P7|Extension Year 2|Early Withdrawals|0
3089397|NCT00364832|10594533|P6|Extension Year 2|Early Withdrawals|0
3089398|NCT00364832|10594534|P5|Extension Year 2|Early Withdrawals|0
3089399|NCT00364832|10594535|P4|Extension Year 2|Early Withdrawals|0
3089400|NCT00364832|10594536|P3|Extension Year 2|Early Withdrawals|0
3089401|NCT00364832|10594537|P2|Extension Year 2|Early Withdrawals|0
3089402|NCT00364832|10594538|P1|Extension Year 2|Early Withdrawals|0
3089403|NCT00364832|10594527|P12|Extension Year 1|Early Withdrawals|10
3089404|NCT00364832|10594528|P11|Extension Year 1|Early Withdrawals|2
3089405|NCT00364832|10594529|P10|Extension Year 1|Early Withdrawals|4
3089406|NCT00364832|10594530|P9|Extension Year 1|Early Withdrawals|0
3089407|NCT00364832|10594531|P8|Extension Year 1|Early Withdrawals|0
3089408|NCT00364832|10594532|P7|Extension Year 1|Early Withdrawals|0
3089409|NCT00364832|10594533|P6|Extension Year 1|Early Withdrawals|0
3089410|NCT00364832|10594534|P5|Extension Year 1|Early Withdrawals|0
3089411|NCT00364832|10594535|P4|Extension Year 1|Early Withdrawals|0
3089412|NCT00364832|10594536|P3|Extension Year 1|Early Withdrawals|0
3089413|NCT00364832|10594537|P2|Extension Year 1|Early Withdrawals|0
3089414|NCT00364832|10594538|P1|Extension Year 1|Early Withdrawals|0
3089415|NCT00364832|10594527|P12|Core Period|Early Withdrawals|0
3089416|NCT00364832|10594528|P11|Core Period|Early Withdrawals|0
3089417|NCT00364832|10594529|P10|Core Period|Early Withdrawals|0
3089418|NCT00364832|10594530|P9|Core Period|Early Withdrawals|0
3089419|NCT00364832|10594531|P8|Core Period|Early Withdrawals|1
3089420|NCT00364832|10594532|P7|Core Period|Early Withdrawals|4
3089421|NCT00364832|10594533|P6|Core Period|Early Withdrawals|0
3089422|NCT00364832|10594534|P5|Core Period|Early Withdrawals|0
3089423|NCT00364832|10594535|P4|Core Period|Early Withdrawals|1
3089424|NCT00364832|10594536|P3|Core Period|Early Withdrawals|1
3089425|NCT00364832|10594537|P2|Core Period|Early Withdrawals|2
3089426|NCT00364832|10594538|P1|Core Period|Early Withdrawals|2
3089427|NCT00364793|10594603|P4|Overall Study|Withdrawal by Subject|0
3089428|NCT00364793|10594604|P3|Overall Study|Withdrawal by Subject|0
3089429|NCT00364793|10594605|P2|Overall Study|Withdrawal by Subject|1
3089430|NCT00364793|10594606|P1|Overall Study|Withdrawal by Subject|0
3089431|NCT00364793|10594603|P4|Overall Study|No longer meets criteria|1
3089432|NCT00364793|10594604|P3|Overall Study|No longer meets criteria|0
3089433|NCT00364793|10594605|P2|Overall Study|No longer meets criteria|0
3089434|NCT00364793|10594606|P1|Overall Study|No longer meets criteria|0
3089435|NCT00364793|10594603|P4|Overall Study|Poor or non-compliance|1
3089436|NCT00364793|10594604|P3|Overall Study|Poor or non-compliance|0
3089437|NCT00364793|10594605|P2|Overall Study|Poor or non-compliance|1
3089438|NCT00364793|10594606|P1|Overall Study|Poor or non-compliance|1
3089439|NCT00364793|10594603|P4|Overall Study|Lost to Follow-up|0
3089440|NCT00364793|10594604|P3|Overall Study|Lost to Follow-up|2
3089441|NCT00364793|10594605|P2|Overall Study|Lost to Follow-up|0
3089442|NCT00364793|10594606|P1|Overall Study|Lost to Follow-up|1
3089443|NCT00364793|10594603|P4|Overall Study|Lack of Efficacy|1
3089444|NCT00364793|10594604|P3|Overall Study|Lack of Efficacy|1
3089445|NCT00364793|10594605|P2|Overall Study|Lack of Efficacy|3
3089446|NCT00364793|10594606|P1|Overall Study|Lack of Efficacy|3
3089447|NCT00364793|10594603|P4|Overall Study|Death|0
3089448|NCT00364793|10594604|P3|Overall Study|Death|1
3089449|NCT00364793|10594605|P2|Overall Study|Death|0
3089450|NCT00364793|10594606|P1|Overall Study|Death|1
3089451|NCT00364793|10594603|P4|Overall Study|Adverse Event|0
3089452|NCT00364793|10594604|P3|Overall Study|Adverse Event|0
3089453|NCT00364793|10594605|P2|Overall Study|Adverse Event|0
3089454|NCT00364793|10594606|P1|Overall Study|Adverse Event|2
3089455|NCT00364689|10594743|P1|Overall Study|Lost to Follow-up|1
3089456|NCT00364611|10594763|P2|Overall Study|Receiving Liver Ablation|1
3089457|NCT00364611|10594764|P1|Overall Study|Receiving Liver Ablation|0
3089458|NCT00364611|10594763|P2|Overall Study|Presumed CR on Study|1
3089459|NCT00364611|10594764|P1|Overall Study|Presumed CR on Study|0
3089460|NCT00364611|10594763|P2|Overall Study|Found Ineligible|0
3089461|NCT00364611|10594764|P1|Overall Study|Found Ineligible|1
3089462|NCT00364611|10594763|P2|Overall Study|Investigator decision|2
3089463|NCT00364611|10594764|P1|Overall Study|Investigator decision|2
3089464|NCT00364611|10594763|P2|Overall Study|Disease Progression|8
3089465|NCT00364611|10594764|P1|Overall Study|Disease Progression|38
3089466|NCT00364611|10594763|P2|Overall Study|Participant's Request|4
3089467|NCT00364611|10594764|P1|Overall Study|Participant's Request|3
3089468|NCT00364611|10594763|P2|Overall Study|Adverse Event|4
3089469|NCT00364611|10594764|P1|Overall Study|Adverse Event|7
3089470|NCT00364611|10594763|P2|Overall Study|Did not receive study medication|1
3089471|NCT00364611|10594764|P1|Overall Study|Did not receive study medication|0
3089472|NCT00364533|10594787|P5|Overall Study|Protocol Violation|0
3089473|NCT00364533|10594788|P4|Overall Study|Protocol Violation|0
3089474|NCT00364533|10594789|P3|Overall Study|Protocol Violation|0
3089475|NCT00364533|10594790|P2|Overall Study|Protocol Violation|1
3089476|NCT00364533|10594791|P1|Overall Study|Protocol Violation|1
3089477|NCT00364533|10594787|P5|Overall Study|Non-compliance|0
3089478|NCT00364533|10594788|P4|Overall Study|Non-compliance|0
3089479|NCT00364533|10594789|P3|Overall Study|Non-compliance|0
3089480|NCT00364533|10594790|P2|Overall Study|Non-compliance|0
3089481|NCT00364533|10594791|P1|Overall Study|Non-compliance|1
3089482|NCT00364533|10594787|P5|Overall Study|Variations in drug compliance|0
3089483|NCT00364533|10594788|P4|Overall Study|Variations in drug compliance|0
3089484|NCT00364533|10594789|P3|Overall Study|Variations in drug compliance|1
3089485|NCT00364533|10594790|P2|Overall Study|Variations in drug compliance|1
3089486|NCT00364533|10594791|P1|Overall Study|Variations in drug compliance|2
3089487|NCT00364533|10594787|P5|Overall Study|Subject discharged from hospital|1
3089488|NCT00364533|10594788|P4|Overall Study|Subject discharged from hospital|3
3089489|NCT00364533|10594789|P3|Overall Study|Subject discharged from hospital|2
3089490|NCT00364533|10594790|P2|Overall Study|Subject discharged from hospital|1
3089491|NCT00364533|10594791|P1|Overall Study|Subject discharged from hospital|4
3089492|NCT00364533|10594787|P5|Overall Study|Lack of Efficacy|42
3089493|NCT00364533|10594788|P4|Overall Study|Lack of Efficacy|17
3089494|NCT00364533|10594789|P3|Overall Study|Lack of Efficacy|21
3089495|NCT00364533|10594790|P2|Overall Study|Lack of Efficacy|22
3089496|NCT00364533|10594791|P1|Overall Study|Lack of Efficacy|22
3089497|NCT00364533|10594787|P5|Overall Study|Withdrawal by Subject|6
3089498|NCT00364533|10594788|P4|Overall Study|Withdrawal by Subject|6
3089499|NCT00364533|10594789|P3|Overall Study|Withdrawal by Subject|6
3089500|NCT00364533|10594790|P2|Overall Study|Withdrawal by Subject|8
3089501|NCT00364533|10594791|P1|Overall Study|Withdrawal by Subject|4
3089502|NCT00364533|10594787|P5|Overall Study|Adverse Event|2
3089503|NCT00364533|10594788|P4|Overall Study|Adverse Event|5
3089504|NCT00364533|10594789|P3|Overall Study|Adverse Event|15
3089505|NCT00364533|10594790|P2|Overall Study|Adverse Event|7
3089506|NCT00364533|10594791|P1|Overall Study|Adverse Event|8
3089507|NCT00364351|10594824|P2|Overall Study|Randomised treatment not started|3
3089508|NCT00364351|10594825|P1|Overall Study|Randomised treatment not started|0
3089509|NCT00364351|10594824|P2|Overall Study|Patient could not travel to site|1
3089510|NCT00364351|10594825|P1|Overall Study|Patient could not travel to site|0
3089511|NCT00364351|10594824|P2|Overall Study|Investigator error|2
3089512|NCT00364351|10594825|P1|Overall Study|Investigator error|0
3089513|NCT00364351|10594824|P2|Overall Study|Poor treatment compliance|3
3089514|NCT00364351|10594825|P1|Overall Study|Poor treatment compliance|0
3089515|NCT00364351|10594824|P2|Overall Study|Sponsor decision|0
3089516|NCT00364351|10594825|P1|Overall Study|Sponsor decision|1
3089517|NCT00364351|10594824|P2|Overall Study|Incorrect enrollment|1
3089518|NCT00364351|10594825|P1|Overall Study|Incorrect enrollment|1
3089519|NCT00364351|10594824|P2|Overall Study|Withdrawal by Subject|29
3089520|NCT00364351|10594825|P1|Overall Study|Withdrawal by Subject|30
3089521|NCT00364351|10594824|P2|Overall Study|Lost to Follow-up|1
3089522|NCT00364351|10594825|P1|Overall Study|Lost to Follow-up|1
3089523|NCT00364351|10594824|P2|Overall Study|Prohibited concomitant medication|2
3089524|NCT00364351|10594825|P1|Overall Study|Prohibited concomitant medication|0
3089525|NCT00364351|10594824|P2|Overall Study|Condition under investigation worsened|497
3089526|NCT00364351|10594825|P1|Overall Study|Condition under investigation worsened|469
3089527|NCT00364351|10594824|P2|Overall Study|Adverse Event|44
3089528|NCT00364351|10594825|P1|Overall Study|Adverse Event|90
3089529|NCT00364286|10594843|P1|Overall Study|Adverse Event|2
3089530|NCT00364286|10594843|P1|Overall Study|Withdrawal by Subject|1
3089531|NCT00364182|10594850|P3|Third Intervention|Lost to Follow-up|1
3089532|NCT00364182|10594851|P2|Third Intervention|Lost to Follow-up|0
3089533|NCT00364182|10594852|P1|Third Intervention|Lost to Follow-up|0
3089534|NCT00364182|10594850|P3|Third Intervention|non-compliance|0
3089535|NCT00364182|10594851|P2|Third Intervention|non-compliance|1
3089536|NCT00364182|10594852|P1|Third Intervention|non-compliance|0
3089537|NCT00364182|10594850|P3|Second Intervention|Adverse Event|1
3089538|NCT00364182|10594851|P2|Second Intervention|Adverse Event|0
3089539|NCT00364182|10594852|P1|Second Intervention|Adverse Event|0
3089540|NCT00364182|10594850|P3|Second Intervention|Protocol Violation|0
3089541|NCT00364182|10594851|P2|Second Intervention|Protocol Violation|1
3089542|NCT00364182|10594852|P1|Second Intervention|Protocol Violation|0
3089543|NCT00364182|10594850|P3|Second Intervention|non-compliance|1
3089544|NCT00364182|10594851|P2|Second Intervention|non-compliance|1
3089545|NCT00364182|10594852|P1|Second Intervention|non-compliance|0
3089546|NCT00364182|10594850|P3|First Intervention|Withdrawal by Subject|0
3089547|NCT00364182|10594851|P2|First Intervention|Withdrawal by Subject|0
3089548|NCT00364182|10594852|P1|First Intervention|Withdrawal by Subject|2
3089549|NCT00364182|10594850|P3|First Intervention|Secondary prophylaxis|0
3089550|NCT00364182|10594851|P2|First Intervention|Secondary prophylaxis|0
3089551|NCT00364182|10594852|P1|First Intervention|Secondary prophylaxis|1
3089552|NCT00364156|10594886|P2|Overall Study|Protocol Violation|1
3089553|NCT00364156|10594887|P1|Overall Study|Protocol Violation|6
3089554|NCT00364156|10594886|P2|Overall Study|Withdrawal by Subject|80
3089555|NCT00364156|10594887|P1|Overall Study|Withdrawal by Subject|73
3089556|NCT00364130|10594895|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
3089557|NCT00364130|10594896|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
3089558|NCT00364130|10594895|P2|Intervention Period|Withdrawal by Subject|5
3089559|NCT00364130|10594896|P1|Intervention Period|Withdrawal by Subject|4
3089560|NCT00364130|10594895|P2|Intervention Period|Pregnancy|0
3089561|NCT00364130|10594896|P1|Intervention Period|Pregnancy|1
3089562|NCT00364130|10594895|P2|Intervention Period|Lost to Follow-up|3
3089563|NCT00364130|10594896|P1|Intervention Period|Lost to Follow-up|4
3089564|NCT00364013|10594918|P2|Overall Study|Ongoing|13
3089565|NCT00364013|10594919|P1|Overall Study|Ongoing|20
3089566|NCT00364013|10594918|P2|Overall Study|Other|47
3089567|NCT00364013|10594919|P1|Overall Study|Other|41
3089568|NCT00364013|10594918|P2|Overall Study|Protocol-specified criteria|6
3089569|NCT00364013|10594919|P1|Overall Study|Protocol-specified criteria|6
3089570|NCT00364013|10594918|P2|Overall Study|Lost to Follow-up|3
3089571|NCT00364013|10594919|P1|Overall Study|Lost to Follow-up|10
3089572|NCT00364013|10594918|P2|Overall Study|Physician Decision|3
3089573|NCT00364013|10594919|P1|Overall Study|Physician Decision|3
3089574|NCT00364013|10594918|P2|Overall Study|Withdrawal by Subject|18
3089575|NCT00364013|10594919|P1|Overall Study|Withdrawal by Subject|13
3089576|NCT00364013|10594918|P2|Overall Study|Adverse Event|3
3089577|NCT00364013|10594919|P1|Overall Study|Adverse Event|4
3089578|NCT00364013|10594918|P2|Overall Study|Ineligibility determined|2
3089579|NCT00364013|10594919|P1|Overall Study|Ineligibility determined|4
3089580|NCT00363896|10594947|P2|Overall Study|Other|2
3089581|NCT00363896|10594948|P1|Overall Study|Other|1
3089582|NCT00363896|10594947|P2|Overall Study|Non-fulfilment of entry criteria|0
3089583|NCT00363896|10594948|P1|Overall Study|Non-fulfilment of entry criteria|1
3089584|NCT00363896|10594947|P2|Overall Study|Lost to Follow-up|0
3089585|NCT00363896|10594948|P1|Overall Study|Lost to Follow-up|3
3089586|NCT00363896|10594947|P2|Overall Study|Protocol Violation|1
3089587|NCT00363896|10594948|P1|Overall Study|Protocol Violation|6
3089588|NCT00363896|10594947|P2|Overall Study|Lack of Efficacy|8
3089589|NCT00363896|10594948|P1|Overall Study|Lack of Efficacy|12
3089590|NCT00363896|10594947|P2|Overall Study|COPD exacerbation|7
3089591|NCT00363896|10594948|P1|Overall Study|COPD exacerbation|13
3089592|NCT00363896|10594947|P2|Overall Study|Adverse Event|13
3089593|NCT00363896|10594948|P1|Overall Study|Adverse Event|24
3089594|NCT00363896|10594947|P2|Overall Study|Withdrawal by Subject|16
3089595|NCT00363896|10594948|P1|Overall Study|Withdrawal by Subject|29
3089596|NCT00363766|10594989|P2|Overall Study|Physician Decision|2
3089597|NCT00363766|10594990|P1|Overall Study|Physician Decision|1
3089598|NCT00363766|10594989|P2|Overall Study|Withdrawal by Subject|0
3089599|NCT00363766|10594990|P1|Overall Study|Withdrawal by Subject|2
3089600|NCT00363766|10594989|P2|Overall Study|Not Disease Related Death|4
3089601|NCT00363766|10594990|P1|Overall Study|Not Disease Related Death|3
3089602|NCT00363766|10594989|P2|Overall Study|Disease Related Death|3
3089603|NCT00363766|10594990|P1|Overall Study|Disease Related Death|1
3089604|NCT00363766|10594989|P2|Overall Study|Adverse Event|2
3089605|NCT00363766|10594990|P1|Overall Study|Adverse Event|10
3089606|NCT00363766|10594989|P2|Overall Study|Progressive Disease|9
3089607|NCT00363766|10594990|P1|Overall Study|Progressive Disease|15
3089608|NCT00363649|10595019|P2|Overall Study|Adverse Event|0
3089609|NCT00363649|10595020|P1|Overall Study|Adverse Event|6
3089610|NCT00363649|10595019|P2|Overall Study|Withdrawal by Subject|1
3089611|NCT00363649|10595020|P1|Overall Study|Withdrawal by Subject|1
3089612|NCT00363545|10595036|P2|Overall Study|Others|0
3089613|NCT00363545|10595037|P1|Overall Study|Others|1
3089614|NCT00363545|10595036|P2|Overall Study|Lost to follow-up (complete vaccination)|17
3089615|NCT00363545|10595037|P1|Overall Study|Lost to follow-up (complete vaccination)|14
3089616|NCT00363545|10595036|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
3089617|NCT00363545|10595037|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
3089618|NCT00363545|10595036|P2|Overall Study|Migrated/moved from study area|6
3089619|NCT00363545|10595037|P1|Overall Study|Migrated/moved from study area|3
3089620|NCT00363545|10595036|P2|Overall Study|Withdrawal by Subject|15
3089621|NCT00363545|10595037|P1|Overall Study|Withdrawal by Subject|12
3089622|NCT00363545|10595036|P2|Overall Study|Serious Adverse Event|1
3089623|NCT00363545|10595037|P1|Overall Study|Serious Adverse Event|0
3089624|NCT00363480|10595055|P1|Overall Study|Participant discontinued on its own|1
3089625|NCT00363480|10595055|P1|Overall Study|Non-compliance of subject|1
3089626|NCT00363480|10595055|P1|Overall Study|Withdrawal by Subject|5
3089627|NCT00363480|10595055|P1|Overall Study|Lost to Follow-up|5
3089628|NCT00363480|10595055|P1|Overall Study|Adverse Event|4
3089629|NCT00363480|10595055|P1|Overall Study|Criteria for treatment period not fulfil|1
3089630|NCT00363467|10595075|P1|Overall Study|Physician Decision|1
3089631|NCT00363415|10595085|P2|Overall Study|Protocol Violation|4
3089632|NCT00363415|10595086|P1|Overall Study|Protocol Violation|1
3089633|NCT00363415|10595085|P2|Overall Study|Lost to Follow-up|3
3089634|NCT00363415|10595086|P1|Overall Study|Lost to Follow-up|3
3089635|NCT00363415|10595085|P2|Overall Study|Withdrawal by Subject|15
3089636|NCT00363415|10595086|P1|Overall Study|Withdrawal by Subject|9
3089637|NCT00363415|10595085|P2|Overall Study|Entry Criteria Not Met|10
3089638|NCT00363415|10595086|P1|Overall Study|Entry Criteria Not Met|11
3089639|NCT00363415|10595085|P2|Overall Study|Physician Decision|35
3089640|NCT00363415|10595086|P1|Overall Study|Physician Decision|18
3089641|NCT00363415|10595085|P2|Overall Study|Adverse Event|15
3089642|NCT00363415|10595086|P1|Overall Study|Adverse Event|24
3089643|NCT00363415|10595085|P2|Overall Study|Death|29
3089644|NCT00363415|10595086|P1|Overall Study|Death|32
3089645|NCT00363415|10595085|P2|Overall Study|Sponsor Decision|31
3089646|NCT00363415|10595086|P1|Overall Study|Sponsor Decision|67
3089647|NCT00363415|10595085|P2|Overall Study|Progressive Disease|107
3089648|NCT00363415|10595086|P1|Overall Study|Progressive Disease|196
3089649|NCT00363311|10595104|P2|Overall Study|Participant Moved to Louisiana|1
3089650|NCT00363311|10595105|P1|Overall Study|Participant Moved to Louisiana|0
3089651|NCT00363311|10595104|P2|Overall Study|Withdrawn per Instructions of Monitor|1
3089652|NCT00363311|10595105|P1|Overall Study|Withdrawn per Instructions of Monitor|0
3089653|NCT00363311|10595104|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
3089654|NCT00363311|10595105|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
3089655|NCT00363311|10595104|P2|Overall Study|Participant Moved to Another Country|0
3089656|NCT00363311|10595105|P1|Overall Study|Participant Moved to Another Country|1
3089657|NCT00363311|10595104|P2|Overall Study|Participant Opted for Treatment|0
3089658|NCT00363311|10595105|P1|Overall Study|Participant Opted for Treatment|1
3089659|NCT00363311|10595104|P2|Overall Study|Prostate Volume/PSA Doubled|0
3089660|NCT00363311|10595105|P1|Overall Study|Prostate Volume/PSA Doubled|1
3089661|NCT00363311|10595104|P2|Overall Study|Participant Refused Biopsy|0
3089662|NCT00363311|10595105|P1|Overall Study|Participant Refused Biopsy|1
3089663|NCT00363311|10595104|P2|Overall Study|Non-Compliance|1
3089664|NCT00363311|10595105|P1|Overall Study|Non-Compliance|1
3089665|NCT00363311|10595104|P2|Overall Study|Disease Progression|26
3089666|NCT00363311|10595105|P1|Overall Study|Disease Progression|46
3089667|NCT00363311|10595104|P2|Overall Study|Sponsor Terminated Study|2
3089668|NCT00363311|10595105|P1|Overall Study|Sponsor Terminated Study|2
3089669|NCT00363311|10595104|P2|Overall Study|Physician Decision|1
3089670|NCT00363311|10595105|P1|Overall Study|Physician Decision|1
3089671|NCT00363311|10595104|P2|Overall Study|Withdrawal by Subject|6
3089672|NCT00363311|10595105|P1|Overall Study|Withdrawal by Subject|12
3089673|NCT00363311|10595104|P2|Overall Study|Protocol Violation|2
3089674|NCT00363311|10595105|P1|Overall Study|Protocol Violation|1
3089675|NCT00363311|10595104|P2|Overall Study|Lost to Follow-up|0
3089676|NCT00363311|10595105|P1|Overall Study|Lost to Follow-up|3
3089677|NCT00363311|10595104|P2|Overall Study|Adverse Event|4
3089678|NCT00363311|10595105|P1|Overall Study|Adverse Event|6
3089679|NCT00363298|10595171|P2|4-week Study Continuation Phase|Lack of Efficacy|0
3089680|NCT00363298|10595172|P1|4-week Study Continuation Phase|Lack of Efficacy|1
3089681|NCT00363298|10595171|P2|First Study Week|Lack of Efficacy|5
3089682|NCT00363298|10595172|P1|First Study Week|Lack of Efficacy|6
3089683|NCT00363246|10595180|P1|Overall Study|Eligibility changed due to Hospice move|5
3089684|NCT00363246|10595180|P1|Overall Study|Subject expressed security concerns|2
3089685|NCT00363246|10595180|P1|Overall Study|Stopped using wheelchair|11
3089686|NCT00363246|10595180|P1|Overall Study|Bad health|6
3089687|NCT00363246|10595180|P1|Overall Study|Lost to Follow-up|14
3089688|NCT00363246|10595180|P1|Overall Study|Withdrawal by Subject|19
3089689|NCT00363246|10595180|P1|Overall Study|Death|40
3089690|NCT00363142|10595198|P2|Overall Study|Withdrawal by Subject|1
3089691|NCT00363142|10595199|P1|Overall Study|Withdrawal by Subject|3
3089692|NCT00363142|10595198|P2|Overall Study|Non-compliance|1
3089693|NCT00363142|10595199|P1|Overall Study|Non-compliance|1
3089694|NCT00363142|10595198|P2|Overall Study|Lost to Follow-up|0
3089695|NCT00363142|10595199|P1|Overall Study|Lost to Follow-up|1
3089696|NCT00363142|10595198|P2|Overall Study|Lack of Efficacy|1
3089697|NCT00363142|10595199|P1|Overall Study|Lack of Efficacy|0
3089698|NCT00363142|10595198|P2|Overall Study|Adverse Event|0
3089699|NCT00363142|10595199|P1|Overall Study|Adverse Event|2
3089700|NCT00363129|10595228|P2|Overall Study|Other Reasons|3
3089701|NCT00363129|10595229|P1|Overall Study|Other Reasons|6
3089702|NCT00363129|10595228|P2|Overall Study|Death|1
3089703|NCT00363129|10595229|P1|Overall Study|Death|0
3089704|NCT00363129|10595228|P2|Overall Study|Other Medical Problems|4
3089705|NCT00363129|10595229|P1|Overall Study|Other Medical Problems|2
3089706|NCT00363129|10595228|P2|Overall Study|Alternate Treatment|4
3089707|NCT00363129|10595229|P1|Overall Study|Alternate Treatment|2
3089708|NCT00363129|10595228|P2|Overall Study|Adverse Event|3
3089709|NCT00363129|10595229|P1|Overall Study|Adverse Event|8
3089710|NCT00363129|10595228|P2|Overall Study|Withdrawal by Subject|18
3089711|NCT00363129|10595229|P1|Overall Study|Withdrawal by Subject|11
3089712|NCT00363051|10595272|P2|Overall Study|Death|2
3089713|NCT00363051|10595273|P1|Overall Study|Death|3
3089714|NCT00363051|10595272|P2|Overall Study|Protocol Violation|2
3089715|NCT00363051|10595273|P1|Overall Study|Protocol Violation|0
3089716|NCT00363051|10595272|P2|Overall Study|Lost to Follow-up|1
3089717|NCT00363051|10595273|P1|Overall Study|Lost to Follow-up|0
3089718|NCT00363051|10595272|P2|Overall Study|Withdrawal by Subject|3
3089719|NCT00363051|10595273|P1|Overall Study|Withdrawal by Subject|11
3089720|NCT00363051|10595272|P2|Overall Study|New Cancer Therapy|1
3089721|NCT00363051|10595273|P1|Overall Study|New Cancer Therapy|2
3089722|NCT00363051|10595272|P2|Overall Study|Adverse Event|12
3089723|NCT00363051|10595273|P1|Overall Study|Adverse Event|21
3089724|NCT00363051|10595272|P2|Overall Study|Adminstrative problems|1
3089725|NCT00363051|10595273|P1|Overall Study|Adminstrative problems|1
3089726|NCT00362648|10595322|P4|Overall Study|Withdrawal by Subject|6
3089727|NCT00362648|10595323|P3|Overall Study|Withdrawal by Subject|2
3089728|NCT00362648|10595324|P2|Overall Study|Withdrawal by Subject|42
3089729|NCT00362648|10595325|P1|Overall Study|Withdrawal by Subject|48
3089730|NCT00362648|10595322|P4|Overall Study|Protocol Violation|2
3089731|NCT00362648|10595323|P3|Overall Study|Protocol Violation|2
3089732|NCT00362648|10595324|P2|Overall Study|Protocol Violation|2
3089733|NCT00362648|10595325|P1|Overall Study|Protocol Violation|4
3089734|NCT00362648|10595322|P4|Overall Study|Lost to Follow-up|3
3089735|NCT00362648|10595323|P3|Overall Study|Lost to Follow-up|4
3089736|NCT00362648|10595324|P2|Overall Study|Lost to Follow-up|69
3089737|NCT00362648|10595325|P1|Overall Study|Lost to Follow-up|62
3089738|NCT00362648|10595322|P4|Overall Study|Adverse Event|0
3089739|NCT00362648|10595323|P3|Overall Study|Adverse Event|1
3089740|NCT00362648|10595324|P2|Overall Study|Adverse Event|21
3089741|NCT00362648|10595325|P1|Overall Study|Adverse Event|12
3089742|NCT00362609|10595343|P2|Overall Study|Protocol Violation|1
3089743|NCT00362609|10595344|P1|Overall Study|Protocol Violation|0
3089744|NCT00362609|10595343|P2|Overall Study|Withdrawal by Subject|1
3089745|NCT00362609|10595344|P1|Overall Study|Withdrawal by Subject|0
3089746|NCT00362414|10595425|P1|Overall Study|Adverse Event|1
3089747|NCT00362414|10595425|P1|Overall Study|Death|2
3089748|NCT00362375|10595454|P2|Overall Study|Lost to Follow-up|35
3089749|NCT00362375|10595455|P1|Overall Study|Lost to Follow-up|40
3089750|NCT00362336|10595472|P3|Overall Study|Withdrawal by Subject|1
3089751|NCT00362336|10595473|P2|Overall Study|Withdrawal by Subject|3
3089752|NCT00362336|10595474|P1|Overall Study|Withdrawal by Subject|3
3089753|NCT00362336|10595472|P3|Overall Study|Lost to Follow-up|0
3089754|NCT00362336|10595473|P2|Overall Study|Lost to Follow-up|4
3089755|NCT00362336|10595474|P1|Overall Study|Lost to Follow-up|6
3089756|NCT00362336|10595472|P3|Overall Study|Protocol Violation|1
3089757|NCT00362336|10595473|P2|Overall Study|Protocol Violation|0
3089758|NCT00362336|10595474|P1|Overall Study|Protocol Violation|0
3089759|NCT00362336|10595472|P3|Overall Study|Serious Adverse Event|1
3089760|NCT00362336|10595473|P2|Overall Study|Serious Adverse Event|0
3089761|NCT00362336|10595474|P1|Overall Study|Serious Adverse Event|1
3089762|NCT00362297|10595502|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
3089763|NCT00362297|10595503|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
3089764|NCT00362232|10595511|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
3089765|NCT00362232|10595512|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
3089766|NCT00362232|10595511|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
3089767|NCT00362232|10595512|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
3089768|NCT00362232|10595511|P2|Follow-up (30 (+ 5) Days)|Death|1
3089769|NCT00362232|10595512|P1|Follow-up (30 (+ 5) Days)|Death|1
3089770|NCT00362232|10595511|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
3089771|NCT00362232|10595512|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
3089772|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
3089773|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
3089774|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
3089775|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
3089776|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
3089777|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
3089778|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
3089779|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
3089780|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
3089781|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
3089782|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
3089783|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
3089784|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
3089785|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
3089786|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Death|3
3089787|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Death|1
3089788|NCT00362232|10595511|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
3089789|NCT00362232|10595512|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
3089790|NCT00362180|10595557|P9|Treated Period|Adverse Event|0
3089791|NCT00362180|10595558|P8|Treated Period|Adverse Event|1
3089792|NCT00362180|10595559|P7|Treated Period|Adverse Event|0
3089793|NCT00362180|10595560|P6|Treated Period|Adverse Event|1
3089794|NCT00362180|10595561|P5|Treated Period|Adverse Event|0
3089795|NCT00362180|10595562|P4|Treated Period|Adverse Event|0
3089796|NCT00362180|10595563|P3|Treated Period|Adverse Event|0
3089797|NCT00362180|10595564|P2|Treated Period|Adverse Event|0
3089798|NCT00362180|10595565|P1|Treated Period|Adverse Event|0
3089799|NCT00362180|10595557|P9|Treated Period|Withdrawal by Subject|0
3089800|NCT00362180|10595558|P8|Treated Period|Withdrawal by Subject|0
3089801|NCT00362180|10595559|P7|Treated Period|Withdrawal by Subject|0
3089802|NCT00362180|10595560|P6|Treated Period|Withdrawal by Subject|0
3089803|NCT00362180|10595561|P5|Treated Period|Withdrawal by Subject|0
3089804|NCT00362180|10595562|P4|Treated Period|Withdrawal by Subject|0
3089805|NCT00362180|10595563|P3|Treated Period|Withdrawal by Subject|0
3089806|NCT00362180|10595564|P2|Treated Period|Withdrawal by Subject|0
3089807|NCT00362180|10595565|P1|Treated Period|Withdrawal by Subject|1
3089808|NCT00362115|10595637|P7|Overall Study|Other|0
3089809|NCT00362115|10595638|P6|Overall Study|Other|1
3089810|NCT00362115|10595639|P5|Overall Study|Other|0
3089811|NCT00362115|10595640|P4|Overall Study|Other|1
3089812|NCT00362115|10595641|P3|Overall Study|Other|0
3089813|NCT00362115|10595642|P2|Overall Study|Other|1
3089814|NCT00362115|10595643|P1|Overall Study|Other|0
3089815|NCT00362115|10595637|P7|Overall Study|Physician Decision|3
3089816|NCT00362115|10595638|P6|Overall Study|Physician Decision|0
3089817|NCT00362115|10595639|P5|Overall Study|Physician Decision|0
3089818|NCT00362115|10595640|P4|Overall Study|Physician Decision|0
3089819|NCT00362115|10595641|P3|Overall Study|Physician Decision|0
3089820|NCT00362115|10595642|P2|Overall Study|Physician Decision|0
3089821|NCT00362115|10595643|P1|Overall Study|Physician Decision|0
3089822|NCT00362115|10595637|P7|Overall Study|Lack of Efficacy|3
3089823|NCT00362115|10595638|P6|Overall Study|Lack of Efficacy|0
3089824|NCT00362115|10595639|P5|Overall Study|Lack of Efficacy|2
3089825|NCT00362115|10595640|P4|Overall Study|Lack of Efficacy|2
3089826|NCT00362115|10595641|P3|Overall Study|Lack of Efficacy|5
3089827|NCT00362115|10595642|P2|Overall Study|Lack of Efficacy|0
3089828|NCT00362115|10595643|P1|Overall Study|Lack of Efficacy|1
3089829|NCT00362115|10595637|P7|Overall Study|Withdrawal by Subject|4
3089830|NCT00362115|10595638|P6|Overall Study|Withdrawal by Subject|3
3089831|NCT00362115|10595639|P5|Overall Study|Withdrawal by Subject|1
3089832|NCT00362115|10595640|P4|Overall Study|Withdrawal by Subject|0
3089833|NCT00362115|10595641|P3|Overall Study|Withdrawal by Subject|1
3089834|NCT00362115|10595642|P2|Overall Study|Withdrawal by Subject|3
3089835|NCT00362115|10595643|P1|Overall Study|Withdrawal by Subject|1
3089836|NCT00362115|10595637|P7|Overall Study|Lost to Follow-up|1
3089837|NCT00362115|10595638|P6|Overall Study|Lost to Follow-up|0
3089838|NCT00362115|10595639|P5|Overall Study|Lost to Follow-up|2
3089839|NCT00362115|10595640|P4|Overall Study|Lost to Follow-up|0
3089840|NCT00362115|10595641|P3|Overall Study|Lost to Follow-up|0
3089841|NCT00362115|10595642|P2|Overall Study|Lost to Follow-up|1
3089842|NCT00362115|10595643|P1|Overall Study|Lost to Follow-up|0
3089843|NCT00362115|10595637|P7|Overall Study|Protocol Violation|0
3089844|NCT00362115|10595638|P6|Overall Study|Protocol Violation|1
3089845|NCT00362115|10595639|P5|Overall Study|Protocol Violation|0
3089846|NCT00362115|10595640|P4|Overall Study|Protocol Violation|0
3089847|NCT00362115|10595641|P3|Overall Study|Protocol Violation|0
3089848|NCT00362115|10595642|P2|Overall Study|Protocol Violation|0
3089849|NCT00362115|10595643|P1|Overall Study|Protocol Violation|0
3089850|NCT00362115|10595637|P7|Overall Study|Adverse Event|1
3089851|NCT00362115|10595638|P6|Overall Study|Adverse Event|2
3089852|NCT00362115|10595639|P5|Overall Study|Adverse Event|2
3089853|NCT00362115|10595640|P4|Overall Study|Adverse Event|1
3089854|NCT00362115|10595641|P3|Overall Study|Adverse Event|1
3089855|NCT00362115|10595642|P2|Overall Study|Adverse Event|1
3089856|NCT00362115|10595643|P1|Overall Study|Adverse Event|0
3089857|NCT00361634|10595816|P1|Overall Study|Withdrawal by Subject|1
3089858|NCT00361634|10595816|P1|Overall Study|Lost to Follow-up|1
3089859|NCT00361569|10595845|P4|Overall Study|Not specified by investigator|1
3089860|NCT00361569|10595846|P3|Overall Study|Not specified by investigator|0
3089861|NCT00361569|10595847|P2|Overall Study|Not specified by investigator|0
3089862|NCT00361569|10595848|P1|Overall Study|Not specified by investigator|2
3089863|NCT00361569|10595845|P4|Overall Study|Lost to Follow-up|2
3089864|NCT00361569|10595846|P3|Overall Study|Lost to Follow-up|3
3089865|NCT00361569|10595847|P2|Overall Study|Lost to Follow-up|3
3089866|NCT00361569|10595848|P1|Overall Study|Lost to Follow-up|2
3089867|NCT00361569|10595845|P4|Overall Study|Adverse Event|2
3089868|NCT00361569|10595846|P3|Overall Study|Adverse Event|2
3089869|NCT00361569|10595847|P2|Overall Study|Adverse Event|5
3089870|NCT00361569|10595848|P1|Overall Study|Adverse Event|3
3089871|NCT00361569|10595845|P4|Overall Study|Withdrawal by Subject|14
3089872|NCT00361569|10595846|P3|Overall Study|Withdrawal by Subject|9
3089873|NCT00361569|10595847|P2|Overall Study|Withdrawal by Subject|1
3089874|NCT00361569|10595848|P1|Overall Study|Withdrawal by Subject|2
3089875|NCT00361569|10595845|P4|Overall Study|Protocol Violation|2
3089876|NCT00361569|10595846|P3|Overall Study|Protocol Violation|4
3089877|NCT00361569|10595847|P2|Overall Study|Protocol Violation|2
3089878|NCT00361569|10595848|P1|Overall Study|Protocol Violation|3
3089879|NCT00361504|10595872|P2|Overall Study|All other|3
3089880|NCT00361504|10595873|P1|Overall Study|All other|28
3089881|NCT00361504|10595872|P2|Overall Study|Study medication non compliant|15
3089882|NCT00361504|10595873|P1|Overall Study|Study medication non compliant|42
3089883|NCT00361504|10595872|P2|Overall Study|Resolution of Pain|0
3089884|NCT00361504|10595873|P1|Overall Study|Resolution of Pain|2
3089885|NCT00361504|10595872|P2|Overall Study|Lack of Efficacy|7
3089886|NCT00361504|10595873|P1|Overall Study|Lack of Efficacy|72
3089887|NCT00361504|10595872|P2|Overall Study|Adverse Event|82
3089888|NCT00361504|10595873|P1|Overall Study|Adverse Event|203
3089889|NCT00361504|10595872|P2|Overall Study|Lost to Follow-up|7
3089890|NCT00361504|10595873|P1|Overall Study|Lost to Follow-up|40
3089891|NCT00361504|10595872|P2|Overall Study|Withdrawal by Subject|31
3089892|NCT00361504|10595873|P1|Overall Study|Withdrawal by Subject|94
3089893|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
3089894|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
3089895|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
3089896|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
3089897|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
3089898|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
3089899|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
3089900|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Other|2
3089901|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Other|1
3089902|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Other|0
3089903|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Other|1
3089904|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Other|0
3089905|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Other|0
3089906|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Other|1
3089907|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
3089908|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
3089909|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
3089910|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
3089911|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
3089912|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
3089913|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
3089914|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Death|1
3089915|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Death|0
3089916|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Death|0
3089917|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Death|0
3089918|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Death|0
3089919|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Death|0
3089920|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Death|0
3089921|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
3089922|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
3089923|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
3089924|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
3089925|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
3089926|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
3089927|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
3089928|NCT00361335|10595914|P7|SC Period: Week E0 to Week E24|Adverse Event|2
3089929|NCT00361335|10595915|P6|SC Period: Week E0 to Week E24|Adverse Event|0
3089930|NCT00361335|10595916|P5|SC Period: Week E0 to Week E24|Adverse Event|0
3089931|NCT00361335|10595917|P4|SC Period: Week E0 to Week E24|Adverse Event|2
3089932|NCT00361335|10595918|P3|SC Period: Week E0 to Week E24|Adverse Event|1
3089933|NCT00361335|10595919|P2|SC Period: Week E0 to Week E24|Adverse Event|2
3089934|NCT00361335|10595920|P1|SC Period: Week E0 to Week E24|Adverse Event|0
3089935|NCT00361335|10595914|P7|IV Period: Baseline to E0|Lack of Efficacy|0
3089936|NCT00361335|10595915|P6|IV Period: Baseline to E0|Lack of Efficacy|0
3089937|NCT00361335|10595916|P5|IV Period: Baseline to E0|Lack of Efficacy|8
3089938|NCT00361335|10595917|P4|IV Period: Baseline to E0|Lack of Efficacy|7
3089939|NCT00361335|10595918|P3|IV Period: Baseline to E0|Lack of Efficacy|3
3089940|NCT00361335|10595919|P2|IV Period: Baseline to E0|Lack of Efficacy|9
3089941|NCT00361335|10595920|P1|IV Period: Baseline to E0|Lack of Efficacy|5
3089942|NCT00361335|10595914|P7|IV Period: Baseline to E0|Other|0
3089943|NCT00361335|10595915|P6|IV Period: Baseline to E0|Other|0
3089944|NCT00361335|10595916|P5|IV Period: Baseline to E0|Other|2
3089945|NCT00361335|10595917|P4|IV Period: Baseline to E0|Other|3
3089946|NCT00361335|10595918|P3|IV Period: Baseline to E0|Other|9
3089947|NCT00361335|10595919|P2|IV Period: Baseline to E0|Other|9
3089948|NCT00361335|10595920|P1|IV Period: Baseline to E0|Other|2
3089949|NCT00361335|10595914|P7|IV Period: Baseline to E0|Worsening of RA|0
3089950|NCT00361335|10595915|P6|IV Period: Baseline to E0|Worsening of RA|0
3089951|NCT00361335|10595916|P5|IV Period: Baseline to E0|Worsening of RA|2
3089952|NCT00361335|10595917|P4|IV Period: Baseline to E0|Worsening of RA|4
3089953|NCT00361335|10595918|P3|IV Period: Baseline to E0|Worsening of RA|1
3089954|NCT00361335|10595919|P2|IV Period: Baseline to E0|Worsening of RA|5
3089955|NCT00361335|10595920|P1|IV Period: Baseline to E0|Worsening of RA|0
3089956|NCT00361335|10595914|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089957|NCT00361335|10595915|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089958|NCT00361335|10595916|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089959|NCT00361335|10595917|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089960|NCT00361335|10595918|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
3089961|NCT00361335|10595919|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089962|NCT00361335|10595920|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
3089963|NCT00361335|10595914|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
3089964|NCT00361335|10595915|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
3089965|NCT00361335|10595916|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
3089966|NCT00361335|10595917|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
3089967|NCT00361335|10595918|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
3089968|NCT00361335|10595919|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
3089969|NCT00361335|10595920|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
3089970|NCT00361335|10595914|P7|IV Period: Baseline to E0|Death|0
3089971|NCT00361335|10595915|P6|IV Period: Baseline to E0|Death|0
3089972|NCT00361335|10595916|P5|IV Period: Baseline to E0|Death|0
3089973|NCT00361335|10595917|P4|IV Period: Baseline to E0|Death|1
3089974|NCT00361335|10595918|P3|IV Period: Baseline to E0|Death|1
3089975|NCT00361335|10595919|P2|IV Period: Baseline to E0|Death|1
3089976|NCT00361335|10595920|P1|IV Period: Baseline to E0|Death|1
3089977|NCT00361335|10595914|P7|IV Period: Baseline to E0|Lost to Follow-up|0
3089978|NCT00361335|10595915|P6|IV Period: Baseline to E0|Lost to Follow-up|0
3089979|NCT00361335|10595916|P5|IV Period: Baseline to E0|Lost to Follow-up|2
3089980|NCT00361335|10595917|P4|IV Period: Baseline to E0|Lost to Follow-up|2
3089981|NCT00361335|10595918|P3|IV Period: Baseline to E0|Lost to Follow-up|0
3089982|NCT00361335|10595919|P2|IV Period: Baseline to E0|Lost to Follow-up|0
3089983|NCT00361335|10595920|P1|IV Period: Baseline to E0|Lost to Follow-up|1
3089984|NCT00361335|10595914|P7|IV Period: Baseline to E0|Adverse Event|0
3089985|NCT00361335|10595915|P6|IV Period: Baseline to E0|Adverse Event|0
3089986|NCT00361335|10595916|P5|IV Period: Baseline to E0|Adverse Event|8
3089987|NCT00361335|10595917|P4|IV Period: Baseline to E0|Adverse Event|9
3089988|NCT00361335|10595918|P3|IV Period: Baseline to E0|Adverse Event|5
3089989|NCT00361335|10595919|P2|IV Period: Baseline to E0|Adverse Event|4
3089990|NCT00361335|10595920|P1|IV Period: Baseline to E0|Adverse Event|9
3089991|NCT00361296|10595964|P1|Overall Study|Lack of Efficacy|2
3089992|NCT00361296|10595964|P1|Overall Study|Physician Decision|1
3089993|NCT00361283|10595971|P1|Overall Study|Lost to Follow-up|27
3089994|NCT00361270|10595979|P4|Overall Study|Adverse Event|0
3089995|NCT00361270|10595980|P3|Overall Study|Adverse Event|1
3089996|NCT00361270|10595981|P2|Overall Study|Adverse Event|1
3089997|NCT00361270|10595982|P1|Overall Study|Adverse Event|0
3089998|NCT00361270|10595979|P4|Overall Study|Problems with Transportation|0
3089999|NCT00361270|10595980|P3|Overall Study|Problems with Transportation|0
3090000|NCT00361270|10595981|P2|Overall Study|Problems with Transportation|0
3090001|NCT00361270|10595982|P1|Overall Study|Problems with Transportation|4
3090002|NCT00361270|10595979|P4|Overall Study|Afraid of Hypnosis|0
3090003|NCT00361270|10595980|P3|Overall Study|Afraid of Hypnosis|0
3090004|NCT00361270|10595981|P2|Overall Study|Afraid of Hypnosis|2
3090005|NCT00361270|10595982|P1|Overall Study|Afraid of Hypnosis|1
3090006|NCT00361270|10595979|P4|Overall Study|Withdrawal by Subject|7
3090007|NCT00361270|10595980|P3|Overall Study|Withdrawal by Subject|3
3090008|NCT00361270|10595981|P2|Overall Study|Withdrawal by Subject|6
3090009|NCT00361270|10595982|P1|Overall Study|Withdrawal by Subject|6
3090010|NCT00361270|10595979|P4|Overall Study|Protocol Violation|4
3090011|NCT00361270|10595980|P3|Overall Study|Protocol Violation|5
3090012|NCT00361270|10595981|P2|Overall Study|Protocol Violation|4
3090013|NCT00361270|10595982|P1|Overall Study|Protocol Violation|9
3090014|NCT00361270|10595979|P4|Overall Study|Physician Decision|0
3090015|NCT00361270|10595980|P3|Overall Study|Physician Decision|1
3090016|NCT00361270|10595981|P2|Overall Study|Physician Decision|0
3090017|NCT00361270|10595982|P1|Overall Study|Physician Decision|0
3090018|NCT00361270|10595979|P4|Overall Study|Lost to Follow-up|0
3090019|NCT00361270|10595980|P3|Overall Study|Lost to Follow-up|0
3090020|NCT00361270|10595981|P2|Overall Study|Lost to Follow-up|1
3090021|NCT00361270|10595982|P1|Overall Study|Lost to Follow-up|4
3090022|NCT00361270|10595979|P4|Overall Study|Death|2
3090023|NCT00361270|10595980|P3|Overall Study|Death|0
3090024|NCT00361270|10595981|P2|Overall Study|Death|0
3090025|NCT00361270|10595982|P1|Overall Study|Death|0
3090026|NCT00361231|10596055|P1|Overall Study|Adverse Event|6
3090027|NCT00361231|10596055|P1|Overall Study|Withdrawal by Subject|4
3090028|NCT00361231|10596055|P1|Overall Study|Radiographic disease progression|16
3090029|NCT00361231|10596055|P1|Overall Study|Symptomatic deterioration|5
3090030|NCT00361231|10596055|P1|Overall Study|Physician Decision|3
3090031|NCT00361218|10596060|P1|Overall Study|terminated / withdrawn due to toxicity /|5
3090032|NCT00361218|10596060|P1|Overall Study|Personal Reasons|7
3090033|NCT00361218|10596060|P1|Overall Study|Lost to Follow-up|11
3090034|NCT00360698|10596139|P2|Treatment Period|Early termination by error|1
3090035|NCT00360698|10596140|P1|Treatment Period|Early termination by error|0
3090036|NCT00360698|10596139|P2|Treatment Period|Non compliance with treatment procedure|0
3090037|NCT00360698|10596140|P1|Treatment Period|Non compliance with treatment procedure|1
3090038|NCT00360698|10596139|P2|Run-In|Need of insulin with meals|1
3090039|NCT00360698|10596140|P1|Run-In|Need of insulin with meals|0
3090040|NCT00360698|10596139|P2|Run-In|Patient personal reasons|2
3090041|NCT00360698|10596140|P1|Run-In|Patient personal reasons|0
3090042|NCT00360698|10596139|P2|Run-In|Patient did not meet inclusion criteria|1
3090043|NCT00360698|10596140|P1|Run-In|Patient did not meet inclusion criteria|0
3090044|NCT00360698|10596139|P2|Run-In|Sponsor request|2
3090045|NCT00360698|10596140|P1|Run-In|Sponsor request|0
3090046|NCT00360698|10596139|P2|Run-In|Non compliance with treatment procedure|1
3090047|NCT00360698|10596140|P1|Run-In|Non compliance with treatment procedure|0
3090048|NCT00360698|10596139|P2|Run-In|Withdrawal by Subject|2
3090049|NCT00360698|10596140|P1|Run-In|Withdrawal by Subject|0
3090050|NCT00360698|10596139|P2|Run-In|Physician Decision|1
3090051|NCT00360698|10596140|P1|Run-In|Physician Decision|0
3090052|NCT00360568|10596185|P2|Overall Study|Withdrawal by Subject|3
3090053|NCT00360568|10596186|P1|Overall Study|Withdrawal by Subject|0
3090054|NCT00360568|10596185|P2|Overall Study|Lack of Efficacy|0
3090055|NCT00360568|10596186|P1|Overall Study|Lack of Efficacy|1
3090056|NCT00360568|10596185|P2|Overall Study|Adverse Event|2
3090057|NCT00360568|10596186|P1|Overall Study|Adverse Event|1
3090058|NCT00360529|10596317|P3|Overall Study|Reason discontinued not explained above|11
3090059|NCT00360529|10596318|P2|Overall Study|Reason discontinued not explained above|9
3090060|NCT00360529|10596319|P1|Overall Study|Reason discontinued not explained above|4
3090061|NCT00360529|10596317|P3|Overall Study|Lack of Efficacy|5
3090062|NCT00360529|10596318|P2|Overall Study|Lack of Efficacy|6
3090063|NCT00360529|10596319|P1|Overall Study|Lack of Efficacy|8
3090064|NCT00360529|10596317|P3|Overall Study|Withdrawal by Subject|18
3090065|NCT00360529|10596318|P2|Overall Study|Withdrawal by Subject|14
3090066|NCT00360529|10596319|P1|Overall Study|Withdrawal by Subject|22
3090067|NCT00360529|10596317|P3|Overall Study|Lost to Follow-up|13
3090068|NCT00360529|10596318|P2|Overall Study|Lost to Follow-up|10
3090069|NCT00360529|10596319|P1|Overall Study|Lost to Follow-up|14
3090070|NCT00360529|10596317|P3|Overall Study|Protocol Violation|11
3090071|NCT00360529|10596318|P2|Overall Study|Protocol Violation|3
3090072|NCT00360529|10596319|P1|Overall Study|Protocol Violation|3
3090073|NCT00360529|10596317|P3|Overall Study|Adverse Event|33
3090074|NCT00360529|10596318|P2|Overall Study|Adverse Event|23
3090075|NCT00360529|10596319|P1|Overall Study|Adverse Event|10
3090076|NCT00360490|10596347|P2|Overall Study|Withdrawal by Subject|3
3090077|NCT00360490|10596348|P1|Overall Study|Withdrawal by Subject|1
3090078|NCT00360490|10596347|P2|Overall Study|Protocol Violation|4
3090079|NCT00360490|10596348|P1|Overall Study|Protocol Violation|0
3090080|NCT00360490|10596347|P2|Overall Study|Physician Decision|1
3090081|NCT00360490|10596348|P1|Overall Study|Physician Decision|2
3090082|NCT00360490|10596347|P2|Overall Study|Lost to Follow-up|1
3090083|NCT00360490|10596348|P1|Overall Study|Lost to Follow-up|2
3090084|NCT00360490|10596347|P2|Overall Study|Adverse Event|2
3090085|NCT00360490|10596348|P1|Overall Study|Adverse Event|4
3090086|NCT00360412|10596383|P2|Overall Study|Study termination by Sponsor|469
3090087|NCT00360412|10596384|P1|Overall Study|Study termination by Sponsor|214
3090088|NCT00360412|10596383|P2|Overall Study|Other|6
3090089|NCT00360412|10596384|P1|Overall Study|Other|5
3090090|NCT00360412|10596383|P2|Overall Study|Physician Decision|4
3090091|NCT00360412|10596384|P1|Overall Study|Physician Decision|2
3090092|NCT00360412|10596383|P2|Overall Study|Lack of therapeutic efficacy|61
3090093|NCT00360412|10596384|P1|Overall Study|Lack of therapeutic efficacy|46
3090094|NCT00360412|10596383|P2|Overall Study|Patient withdrew consent|52
3090095|NCT00360412|10596384|P1|Overall Study|Patient withdrew consent|27
3090096|NCT00360412|10596383|P2|Overall Study|Protocol Violation|5
3090097|NCT00360412|10596384|P1|Overall Study|Protocol Violation|2
3090098|NCT00360412|10596383|P2|Overall Study|Adverse Event|65
3090099|NCT00360412|10596384|P1|Overall Study|Adverse Event|37
3090100|NCT00360334|10596431|P2|Overall Study|Subject decision|2
3090101|NCT00360334|10596432|P1|Overall Study|Subject decision|8
3090102|NCT00360334|10596431|P2|Overall Study|Entry criterion not met|2
3090103|NCT00360334|10596432|P1|Overall Study|Entry criterion not met|1
3090104|NCT00360334|10596431|P2|Overall Study|Lack of Efficacy|1
3090105|NCT00360334|10596432|P1|Overall Study|Lack of Efficacy|0
3090106|NCT00360334|10596431|P2|Overall Study|Physician Decision|3
3090107|NCT00360334|10596432|P1|Overall Study|Physician Decision|2
3090108|NCT00360334|10596431|P2|Overall Study|Protocol Violation|1
3090109|NCT00360334|10596432|P1|Overall Study|Protocol Violation|1
3090110|NCT00360334|10596431|P2|Overall Study|Adverse Event|4
3090111|NCT00360334|10596432|P1|Overall Study|Adverse Event|7
3090112|NCT00360308|10596495|P3|Overall Study|Study termination by sponsor|44
3090113|NCT00360308|10596496|P2|Overall Study|Study termination by sponsor|55
3090114|NCT00360308|10596497|P1|Overall Study|Study termination by sponsor|43
3090115|NCT00360308|10596495|P3|Overall Study|Other|1
3090116|NCT00360308|10596496|P2|Overall Study|Other|1
3090117|NCT00360308|10596497|P1|Overall Study|Other|2
3090118|NCT00360308|10596495|P3|Overall Study|Lack of Efficacy|2
3090119|NCT00360308|10596496|P2|Overall Study|Lack of Efficacy|0
3090120|NCT00360308|10596497|P1|Overall Study|Lack of Efficacy|3
3090121|NCT00360308|10596495|P3|Overall Study|Withdrawal by Subject|14
3090122|NCT00360308|10596496|P2|Overall Study|Withdrawal by Subject|7
3090123|NCT00360308|10596497|P1|Overall Study|Withdrawal by Subject|11
3090124|NCT00360308|10596495|P3|Overall Study|Protocol Violation|2
3090125|NCT00360308|10596496|P2|Overall Study|Protocol Violation|1
3090126|NCT00360308|10596497|P1|Overall Study|Protocol Violation|2
3090127|NCT00360308|10596495|P3|Overall Study|Abnormal Laboratory Value(s)|0
3090128|NCT00360308|10596496|P2|Overall Study|Abnormal Laboratory Value(s)|1
3090129|NCT00360308|10596497|P1|Overall Study|Abnormal Laboratory Value(s)|0
3090130|NCT00360308|10596495|P3|Overall Study|Adverse Event|25
3090131|NCT00360308|10596496|P2|Overall Study|Adverse Event|14
3090132|NCT00360308|10596497|P1|Overall Study|Adverse Event|15
3090133|NCT00360282|10596514|P4|Second Intervention|Adverse Event|0
3090134|NCT00360282|10596515|P3|Second Intervention|Adverse Event|0
3090135|NCT00360282|10596516|P2|Second Intervention|Adverse Event|1
3090136|NCT00360282|10596517|P1|Second Intervention|Adverse Event|0
3090137|NCT00360282|10596514|P4|Washout 1-3 Weeks|Lost to Follow-up|0
3090138|NCT00360282|10596515|P3|Washout 1-3 Weeks|Lost to Follow-up|1
3090139|NCT00360282|10596516|P2|Washout 1-3 Weeks|Lost to Follow-up|0
3090140|NCT00360282|10596517|P1|Washout 1-3 Weeks|Lost to Follow-up|0
3090141|NCT00360269|10596529|P2|Overall Study|Withdrawal by Subject|1
3090142|NCT00360269|10596530|P1|Overall Study|Withdrawal by Subject|1
3090143|NCT00360269|10596529|P2|Overall Study|Adverse Event|0
3090144|NCT00360269|10596530|P1|Overall Study|Adverse Event|1
3090145|NCT00360269|10596529|P2|Overall Study|Physician Decision|2
3090146|NCT00360269|10596530|P1|Overall Study|Physician Decision|1
3090147|NCT00360269|10596529|P2|Overall Study|Lost to Follow-up|9
3090148|NCT00360269|10596530|P1|Overall Study|Lost to Follow-up|7
3090149|NCT00360230|10596572|P7|Overall Study|Death|1
3090150|NCT00360230|10596573|P6|Overall Study|Death|1
3090151|NCT00360230|10596574|P5|Overall Study|Death|0
3090152|NCT00360230|10596575|P4|Overall Study|Death|0
3090153|NCT00360230|10596576|P3|Overall Study|Death|0
3090154|NCT00360230|10596577|P2|Overall Study|Death|1
3090155|NCT00360230|10596578|P1|Overall Study|Death|0
3090156|NCT00360230|10596572|P7|Overall Study|Protocol Violation|0
3090157|NCT00360230|10596573|P6|Overall Study|Protocol Violation|1
3090158|NCT00360230|10596574|P5|Overall Study|Protocol Violation|0
3090159|NCT00360230|10596575|P4|Overall Study|Protocol Violation|0
3090160|NCT00360230|10596576|P3|Overall Study|Protocol Violation|0
3090161|NCT00360230|10596577|P2|Overall Study|Protocol Violation|0
3090162|NCT00360230|10596578|P1|Overall Study|Protocol Violation|0
3090163|NCT00360230|10596572|P7|Overall Study|Other|0
3090164|NCT00360230|10596573|P6|Overall Study|Other|0
3090165|NCT00360230|10596574|P5|Overall Study|Other|0
3090166|NCT00360230|10596575|P4|Overall Study|Other|0
3090167|NCT00360230|10596576|P3|Overall Study|Other|0
3090168|NCT00360230|10596577|P2|Overall Study|Other|0
3090169|NCT00360230|10596578|P1|Overall Study|Other|1
3090170|NCT00360230|10596572|P7|Overall Study|Migrated|1
3090171|NCT00360230|10596573|P6|Overall Study|Migrated|1
3090172|NCT00360230|10596574|P5|Overall Study|Migrated|4
3090173|NCT00360230|10596575|P4|Overall Study|Migrated|1
3090174|NCT00360230|10596576|P3|Overall Study|Migrated|3
3090175|NCT00360230|10596577|P2|Overall Study|Migrated|1
3090176|NCT00360230|10596578|P1|Overall Study|Migrated|4
3090177|NCT00360230|10596572|P7|Overall Study|Withdrawal by Subject|0
3090178|NCT00360230|10596573|P6|Overall Study|Withdrawal by Subject|1
3090179|NCT00360230|10596574|P5|Overall Study|Withdrawal by Subject|1
3090180|NCT00360230|10596575|P4|Overall Study|Withdrawal by Subject|1
3090181|NCT00360230|10596576|P3|Overall Study|Withdrawal by Subject|0
3090182|NCT00360230|10596577|P2|Overall Study|Withdrawal by Subject|1
3090183|NCT00360230|10596578|P1|Overall Study|Withdrawal by Subject|1
3090184|NCT00359801|10596734|P2|Overall Study|Sponsor Decision|16
3090185|NCT00359801|10596735|P1|Overall Study|Sponsor Decision|17
3090186|NCT00359801|10596734|P2|Overall Study|Final Status Unknown: missing data|4
3090187|NCT00359801|10596735|P1|Overall Study|Final Status Unknown: missing data|7
3090188|NCT00359801|10596734|P2|Overall Study|Other|46
3090189|NCT00359801|10596735|P1|Overall Study|Other|66
3090190|NCT00359801|10596734|P2|Overall Study|Withdrawal by Subject|96
3090191|NCT00359801|10596735|P1|Overall Study|Withdrawal by Subject|143
3090192|NCT00359801|10596734|P2|Overall Study|Lost to Follow-up|58
3090193|NCT00359801|10596735|P1|Overall Study|Lost to Follow-up|72
3090194|NCT00359788|10596769|P2|Overall Study|Protocol Violation|2
3090195|NCT00359788|10596770|P1|Overall Study|Protocol Violation|4
3090196|NCT00359788|10596769|P2|Overall Study|Withdrawal by Subject|1
3090197|NCT00359788|10596770|P1|Overall Study|Withdrawal by Subject|4
3090198|NCT00359788|10596769|P2|Overall Study|Lost to Follow-up|2
3090199|NCT00359788|10596770|P1|Overall Study|Lost to Follow-up|3
3090200|NCT00359788|10596769|P2|Overall Study|Lack of Efficacy|2
3090201|NCT00359788|10596770|P1|Overall Study|Lack of Efficacy|1
3090202|NCT00359788|10596769|P2|Overall Study|Adverse Event|10
3090203|NCT00359788|10596770|P1|Overall Study|Adverse Event|11
3090204|NCT00359762|10597004|P5|Period III|Subject Decision|0
3090205|NCT00359762|10597005|P4|Period III|Subject Decision|20
3090206|NCT00359762|10597006|P3|Period III|Subject Decision|8
3090207|NCT00359762|10597007|P2|Period III|Subject Decision|7
3090208|NCT00359762|10597008|P1|Period III|Subject Decision|0
3090209|NCT00359762|10597004|P5|Period III|Entry Criteria Not Met|0
3090210|NCT00359762|10597005|P4|Period III|Entry Criteria Not Met|1
3090211|NCT00359762|10597006|P3|Period III|Entry Criteria Not Met|0
3090212|NCT00359762|10597007|P2|Period III|Entry Criteria Not Met|1
3090213|NCT00359762|10597008|P1|Period III|Entry Criteria Not Met|0
3090214|NCT00359762|10597004|P5|Period III|Lost to follow up|0
3090215|NCT00359762|10597005|P4|Period III|Lost to follow up|2
3090216|NCT00359762|10597006|P3|Period III|Lost to follow up|1
3090217|NCT00359762|10597007|P2|Period III|Lost to follow up|1
3090218|NCT00359762|10597008|P1|Period III|Lost to follow up|0
3090219|NCT00359762|10597004|P5|Period III|Lack of Efficacy|0
3090220|NCT00359762|10597005|P4|Period III|Lack of Efficacy|9
3090221|NCT00359762|10597006|P3|Period III|Lack of Efficacy|5
3090222|NCT00359762|10597007|P2|Period III|Lack of Efficacy|7
3090223|NCT00359762|10597008|P1|Period III|Lack of Efficacy|0
3090224|NCT00359762|10597004|P5|Period III|Physician Decision|0
3090225|NCT00359762|10597005|P4|Period III|Physician Decision|15
3090226|NCT00359762|10597006|P3|Period III|Physician Decision|9
3090227|NCT00359762|10597007|P2|Period III|Physician Decision|5
3090228|NCT00359762|10597008|P1|Period III|Physician Decision|0
3090229|NCT00359762|10597004|P5|Period III|Adverse Event|0
3090230|NCT00359762|10597005|P4|Period III|Adverse Event|10
3090231|NCT00359762|10597006|P3|Period III|Adverse Event|4
3090232|NCT00359762|10597007|P2|Period III|Adverse Event|3
3090233|NCT00359762|10597008|P1|Period III|Adverse Event|0
3090234|NCT00359762|10597004|P5|Period III|Protocol Violation|0
3090235|NCT00359762|10597005|P4|Period III|Protocol Violation|8
3090236|NCT00359762|10597006|P3|Period III|Protocol Violation|3
3090237|NCT00359762|10597007|P2|Period III|Protocol Violation|5
3090238|NCT00359762|10597008|P1|Period III|Protocol Violation|0
3090239|NCT00359762|10597004|P5|Period II|Subject Decision|70
3090240|NCT00359762|10597005|P4|Period II|Subject Decision|0
3090241|NCT00359762|10597006|P3|Period II|Subject Decision|0
3090242|NCT00359762|10597007|P2|Period II|Subject Decision|0
3090243|NCT00359762|10597008|P1|Period II|Subject Decision|50
3090244|NCT00359762|10597004|P5|Period II|Entry Criteria Not Met|4
3090245|NCT00359762|10597005|P4|Period II|Entry Criteria Not Met|0
3090246|NCT00359762|10597006|P3|Period II|Entry Criteria Not Met|0
3090247|NCT00359762|10597007|P2|Period II|Entry Criteria Not Met|0
3090248|NCT00359762|10597008|P1|Period II|Entry Criteria Not Met|8
3090249|NCT00359762|10597004|P5|Period II|Lost to follow up|5
3090250|NCT00359762|10597005|P4|Period II|Lost to follow up|0
3090251|NCT00359762|10597006|P3|Period II|Lost to follow up|0
3090252|NCT00359762|10597007|P2|Period II|Lost to follow up|0
3090253|NCT00359762|10597008|P1|Period II|Lost to follow up|5
3090254|NCT00359762|10597004|P5|Period II|Lack of Efficacy|8
3090255|NCT00359762|10597005|P4|Period II|Lack of Efficacy|0
3090256|NCT00359762|10597006|P3|Period II|Lack of Efficacy|0
3090257|NCT00359762|10597007|P2|Period II|Lack of Efficacy|0
3090258|NCT00359762|10597008|P1|Period II|Lack of Efficacy|11
3090259|NCT00359762|10597004|P5|Period II|Death|4
3090260|NCT00359762|10597005|P4|Period II|Death|0
3090261|NCT00359762|10597006|P3|Period II|Death|0
3090262|NCT00359762|10597007|P2|Period II|Death|0
3090263|NCT00359762|10597008|P1|Period II|Death|2
3090264|NCT00359762|10597004|P5|Period II|Physician Decision|23
3090265|NCT00359762|10597005|P4|Period II|Physician Decision|0
3090266|NCT00359762|10597006|P3|Period II|Physician Decision|0
3090267|NCT00359762|10597007|P2|Period II|Physician Decision|0
3090268|NCT00359762|10597008|P1|Period II|Physician Decision|17
3090269|NCT00359762|10597004|P5|Period II|Protocol Violation|11
3090270|NCT00359762|10597005|P4|Period II|Protocol Violation|0
3090271|NCT00359762|10597006|P3|Period II|Protocol Violation|0
3090272|NCT00359762|10597007|P2|Period II|Protocol Violation|0
3090273|NCT00359762|10597008|P1|Period II|Protocol Violation|18
3090274|NCT00359762|10597004|P5|Period II|Adverse Event|49
3090275|NCT00359762|10597005|P4|Period II|Adverse Event|0
3090276|NCT00359762|10597006|P3|Period II|Adverse Event|0
3090277|NCT00359762|10597007|P2|Period II|Adverse Event|0
3090278|NCT00359762|10597008|P1|Period II|Adverse Event|17
3090279|NCT00359632|10597082|P2|Overall Study|Non-compliance with visit schedule|0
3090280|NCT00359632|10597083|P1|Overall Study|Non-compliance with visit schedule|1
3090281|NCT00359632|10597082|P2|Overall Study|Adverse Event|0
3090282|NCT00359632|10597083|P1|Overall Study|Adverse Event|1
3090283|NCT00359632|10597082|P2|Overall Study|Death|0
3090284|NCT00359632|10597083|P1|Overall Study|Death|2
3090285|NCT00359619|10597097|P7|Overall Study|Lost to Follow-up|0
3090286|NCT00359619|10597098|P6|Overall Study|Lost to Follow-up|5
3090287|NCT00359619|10597099|P5|Overall Study|Lost to Follow-up|1
3090288|NCT00359619|10597100|P4|Overall Study|Lost to Follow-up|1
3090289|NCT00359619|10597101|P3|Overall Study|Lost to Follow-up|2
3090290|NCT00359619|10597102|P2|Overall Study|Lost to Follow-up|4
3090291|NCT00359619|10597103|P1|Overall Study|Lost to Follow-up|4
3090292|NCT00359619|10597097|P7|Overall Study|Other|0
3090293|NCT00359619|10597098|P6|Overall Study|Other|0
3090294|NCT00359619|10597099|P5|Overall Study|Other|0
3090295|NCT00359619|10597100|P4|Overall Study|Other|0
3090296|NCT00359619|10597101|P3|Overall Study|Other|0
3090297|NCT00359619|10597102|P2|Overall Study|Other|0
3090298|NCT00359619|10597103|P1|Overall Study|Other|1
3090299|NCT00359619|10597097|P7|Overall Study|Withdrawal by Subject|3
3090300|NCT00359619|10597098|P6|Overall Study|Withdrawal by Subject|0
3090301|NCT00359619|10597099|P5|Overall Study|Withdrawal by Subject|2
3090302|NCT00359619|10597100|P4|Overall Study|Withdrawal by Subject|2
3090303|NCT00359619|10597101|P3|Overall Study|Withdrawal by Subject|4
3090304|NCT00359619|10597102|P2|Overall Study|Withdrawal by Subject|1
3090305|NCT00359619|10597103|P1|Overall Study|Withdrawal by Subject|3
3090306|NCT00359619|10597097|P7|Overall Study|Adverse Event|1
3090307|NCT00359619|10597098|P6|Overall Study|Adverse Event|0
3090308|NCT00359619|10597099|P5|Overall Study|Adverse Event|0
3090309|NCT00359619|10597100|P4|Overall Study|Adverse Event|0
3090310|NCT00359619|10597101|P3|Overall Study|Adverse Event|1
3090311|NCT00359619|10597102|P2|Overall Study|Adverse Event|0
3090312|NCT00359619|10597103|P1|Overall Study|Adverse Event|0
3090313|NCT00359424|10597233|P2|Overall Study|follow up not conducted|0
3090314|NCT00359424|10597234|P1|Overall Study|follow up not conducted|2
3090315|NCT00359424|10597233|P2|Overall Study|Withdrawal by Subject|2
3090316|NCT00359424|10597234|P1|Overall Study|Withdrawal by Subject|10
3090317|NCT00359424|10597233|P2|Overall Study|Lost to Follow-up|7
3090318|NCT00359424|10597234|P1|Overall Study|Lost to Follow-up|19
3090319|NCT00359424|10597233|P2|Overall Study|Death|58
3090320|NCT00359424|10597234|P1|Overall Study|Death|99
3090321|NCT00359281|10597273|P9|Overall Study|Withdrawal by Subject|0
3090322|NCT00359281|10597274|P8|Overall Study|Withdrawal by Subject|0
3090323|NCT00359281|10597275|P7|Overall Study|Withdrawal by Subject|1
3090324|NCT00359281|10597276|P6|Overall Study|Withdrawal by Subject|0
3090325|NCT00359281|10597277|P5|Overall Study|Withdrawal by Subject|0
3090326|NCT00359281|10597278|P4|Overall Study|Withdrawal by Subject|0
3090327|NCT00359281|10597279|P3|Overall Study|Withdrawal by Subject|0
3090328|NCT00359281|10597280|P2|Overall Study|Withdrawal by Subject|0
3090329|NCT00359281|10597281|P1|Overall Study|Withdrawal by Subject|0
3090330|NCT00359281|10597273|P9|Overall Study|Adverse Event|0
3090331|NCT00359281|10597274|P8|Overall Study|Adverse Event|0
3090332|NCT00359281|10597275|P7|Overall Study|Adverse Event|1
3090333|NCT00359281|10597276|P6|Overall Study|Adverse Event|0
3090334|NCT00359281|10597277|P5|Overall Study|Adverse Event|0
3090335|NCT00359281|10597278|P4|Overall Study|Adverse Event|0
3090336|NCT00359281|10597279|P3|Overall Study|Adverse Event|0
3090337|NCT00359281|10597280|P2|Overall Study|Adverse Event|0
3090338|NCT00359281|10597281|P1|Overall Study|Adverse Event|1
3090339|NCT00359073|10597344|P2|Overall Study|developed RV16 antibody|1
3090340|NCT00359073|10597345|P1|Overall Study|developed RV16 antibody|0
3090341|NCT00359073|10597344|P2|Overall Study|Eligibility criteria no longer met|0
3090342|NCT00359073|10597345|P1|Overall Study|Eligibility criteria no longer met|3
3090343|NCT00359073|10597344|P2|Overall Study|Withdrawal by Subject|1
3090344|NCT00359073|10597345|P1|Overall Study|Withdrawal by Subject|1
3090345|NCT00359021|10597357|P2|Overall Study|Pregnancy|0
3090346|NCT00359021|10597358|P1|Overall Study|Pregnancy|1
3090347|NCT00359021|10597357|P2|Overall Study|Other|1
3090348|NCT00359021|10597358|P1|Overall Study|Other|4
3090349|NCT00359021|10597357|P2|Overall Study|Lost to Follow-up|0
3090350|NCT00359021|10597358|P1|Overall Study|Lost to Follow-up|1
3090351|NCT00359021|10597357|P2|Overall Study|Withdrawal by Subject|9
3090352|NCT00359021|10597358|P1|Overall Study|Withdrawal by Subject|2
3090353|NCT00359021|10597357|P2|Overall Study|Subject Reached A Virologic Endpoint|32
3090354|NCT00359021|10597358|P1|Overall Study|Subject Reached A Virologic Endpoint|45
3090355|NCT00359021|10597357|P2|Overall Study|Subject Ineligible To Continue The Trial|0
3090356|NCT00359021|10597358|P1|Overall Study|Subject Ineligible To Continue The Trial|1
3090357|NCT00359021|10597357|P2|Overall Study|Subject Non-Compliant|2
3090358|NCT00359021|10597358|P1|Overall Study|Subject Non-Compliant|1
3090359|NCT00359021|10597357|P2|Overall Study|Adverse Event|8
3090360|NCT00359021|10597358|P1|Overall Study|Adverse Event|26
3090361|NCT00358956|10597370|P1|Overall Study|Withdrawal by Subject|1
3090362|NCT00358956|10597370|P1|Overall Study|condition under investigation worsened|4
3090363|NCT00358956|10597370|P1|Overall Study|Adverse Event|3
3090364|NCT00358917|10597382|P2|Overall Study|Unable to Continue Participation|2
3090365|NCT00358917|10597383|P1|Overall Study|Unable to Continue Participation|2
3090366|NCT00358917|10597382|P2|Overall Study|Virologic failure|8
3090367|NCT00358917|10597383|P1|Overall Study|Virologic failure|11
3090368|NCT00358917|10597382|P2|Overall Study|Death|3
3090369|NCT00358917|10597383|P1|Overall Study|Death|2
3090370|NCT00358917|10597382|P2|Overall Study|Noncompliance|11
3090371|NCT00358917|10597383|P1|Overall Study|Noncompliance|12
3090372|NCT00358917|10597382|P2|Overall Study|Lost to Follow-up|17
3090373|NCT00358917|10597383|P1|Overall Study|Lost to Follow-up|20
3090374|NCT00358917|10597382|P2|Overall Study|Withdrawal by Subject|7
3090375|NCT00358917|10597383|P1|Overall Study|Withdrawal by Subject|5
3090376|NCT00358917|10597382|P2|Overall Study|Adverse Event|21
3090377|NCT00358917|10597383|P1|Overall Study|Adverse Event|14
3090378|NCT00358826|10597401|P8|MDCT Substudy|Withdrawal by Subject|0
3090379|NCT00358826|10597402|P7|MDCT Substudy|Withdrawal by Subject|0
3090380|NCT00358826|10597403|P6|MDCT Substudy|Withdrawal by Subject|1
3090381|NCT00358826|10597404|P5|MDCT Substudy|Withdrawal by Subject|0
3090382|NCT00358826|10597405|P4|MDCT Substudy|Withdrawal by Subject|0
3090383|NCT00358826|10597406|P3|MDCT Substudy|Withdrawal by Subject|0
3090384|NCT00358826|10597407|P2|MDCT Substudy|Withdrawal by Subject|0
3090385|NCT00358826|10597408|P1|MDCT Substudy|Withdrawal by Subject|0
3090386|NCT00358826|10597401|P8|MDCT Substudy|Lost to Follow-up|0
3090387|NCT00358826|10597402|P7|MDCT Substudy|Lost to Follow-up|0
3090388|NCT00358826|10597403|P6|MDCT Substudy|Lost to Follow-up|1
3090389|NCT00358826|10597404|P5|MDCT Substudy|Lost to Follow-up|0
3090390|NCT00358826|10597405|P4|MDCT Substudy|Lost to Follow-up|0
3090391|NCT00358826|10597406|P3|MDCT Substudy|Lost to Follow-up|0
3090392|NCT00358826|10597407|P2|MDCT Substudy|Lost to Follow-up|0
3090393|NCT00358826|10597408|P1|MDCT Substudy|Lost to Follow-up|0
3090394|NCT00358826|10597401|P8|MDCT Substudy|Adverse Event|0
3090395|NCT00358826|10597402|P7|MDCT Substudy|Adverse Event|0
3090396|NCT00358826|10597403|P6|MDCT Substudy|Adverse Event|0
3090397|NCT00358826|10597404|P5|MDCT Substudy|Adverse Event|1
3090398|NCT00358826|10597405|P4|MDCT Substudy|Adverse Event|0
3090399|NCT00358826|10597406|P3|MDCT Substudy|Adverse Event|0
3090400|NCT00358826|10597407|P2|MDCT Substudy|Adverse Event|0
3090401|NCT00358826|10597408|P1|MDCT Substudy|Adverse Event|0
3090402|NCT00358826|10597401|P8|Core Study|Physician Decision|0
3090403|NCT00358826|10597402|P7|Core Study|Physician Decision|0
3090404|NCT00358826|10597403|P6|Core Study|Physician Decision|0
3090405|NCT00358826|10597404|P5|Core Study|Physician Decision|0
3090406|NCT00358826|10597405|P4|Core Study|Physician Decision|0
3090407|NCT00358826|10597406|P3|Core Study|Physician Decision|1
3090408|NCT00358826|10597407|P2|Core Study|Physician Decision|0
3090409|NCT00358826|10597408|P1|Core Study|Physician Decision|0
3090410|NCT00358826|10597401|P8|Core Study|Lost to Follow-up|0
3090411|NCT00358826|10597402|P7|Core Study|Lost to Follow-up|0
3090412|NCT00358826|10597403|P6|Core Study|Lost to Follow-up|0
3090413|NCT00358826|10597404|P5|Core Study|Lost to Follow-up|0
3090414|NCT00358826|10597405|P4|Core Study|Lost to Follow-up|1
3090415|NCT00358826|10597406|P3|Core Study|Lost to Follow-up|0
3090416|NCT00358826|10597407|P2|Core Study|Lost to Follow-up|0
3090417|NCT00358826|10597408|P1|Core Study|Lost to Follow-up|0
3090418|NCT00358826|10597401|P8|Core Study|Withdrawal by Subject|0
3090419|NCT00358826|10597402|P7|Core Study|Withdrawal by Subject|0
3090420|NCT00358826|10597403|P6|Core Study|Withdrawal by Subject|0
3090421|NCT00358826|10597404|P5|Core Study|Withdrawal by Subject|0
3090422|NCT00358826|10597405|P4|Core Study|Withdrawal by Subject|0
3090423|NCT00358826|10597406|P3|Core Study|Withdrawal by Subject|0
3090424|NCT00358826|10597407|P2|Core Study|Withdrawal by Subject|2
3090425|NCT00358826|10597408|P1|Core Study|Withdrawal by Subject|2
3090426|NCT00358826|10597401|P8|Core Study|Adverse Event|0
3090427|NCT00358826|10597402|P7|Core Study|Adverse Event|0
3090428|NCT00358826|10597403|P6|Core Study|Adverse Event|0
3090429|NCT00358826|10597404|P5|Core Study|Adverse Event|0
3090430|NCT00358826|10597405|P4|Core Study|Adverse Event|1
3090431|NCT00358826|10597406|P3|Core Study|Adverse Event|1
3090432|NCT00358826|10597407|P2|Core Study|Adverse Event|3
3090433|NCT00358826|10597408|P1|Core Study|Adverse Event|1
3090434|NCT00358670|10597475|P2|Overall Study|Administrative|125
3090435|NCT00358670|10597476|P1|Overall Study|Administrative|153
3090436|NCT00358670|10597475|P2|Overall Study|Did Not Meet Protocol Eligibility|3
3090437|NCT00358670|10597476|P1|Overall Study|Did Not Meet Protocol Eligibility|0
3090438|NCT00358670|10597475|P2|Overall Study|Protocol Defined Clinical Event|1
3090439|NCT00358670|10597476|P1|Overall Study|Protocol Defined Clinical Event|0
3090440|NCT00358670|10597475|P2|Overall Study|Withdrawal by Subject|24
3090441|NCT00358670|10597476|P1|Overall Study|Withdrawal by Subject|13
3090442|NCT00358670|10597475|P2|Overall Study|Lost to Follow-up|5
3090443|NCT00358670|10597476|P1|Overall Study|Lost to Follow-up|4
3090444|NCT00358670|10597475|P2|Overall Study|Protocol Violation|9
3090445|NCT00358670|10597476|P1|Overall Study|Protocol Violation|6
3090446|NCT00358670|10597475|P2|Overall Study|Lack of Efficacy|23
3090447|NCT00358670|10597476|P1|Overall Study|Lack of Efficacy|20
3090448|NCT00358670|10597475|P2|Overall Study|Adverse Event|29
3090449|NCT00358670|10597476|P1|Overall Study|Adverse Event|26
3090450|NCT00358644|10597490|P1|Overall Study|Patient not eligible for study|1
3090451|NCT00358644|10597490|P1|Overall Study|Physician Decision|6
3090452|NCT00358644|10597490|P1|Overall Study|Withdrawal by Subject|4
3090453|NCT00358644|10597490|P1|Overall Study|Death|11
3090454|NCT00358644|10597490|P1|Overall Study|Adverse Event|7
3090455|NCT00358644|10597490|P1|Overall Study|Progressive Disease|21
3090456|NCT00358527|10597513|P2|Overall Study|Administrative|1
3090457|NCT00358527|10597514|P1|Overall Study|Administrative|2
3090458|NCT00358527|10597513|P2|Overall Study|Non-compliance with protocol|1
3090459|NCT00358527|10597514|P1|Overall Study|Non-compliance with protocol|6
3090460|NCT00358527|10597513|P2|Overall Study|Withdrawal by Subject|1
3090461|NCT00358527|10597514|P1|Overall Study|Withdrawal by Subject|1
3090462|NCT00358527|10597513|P2|Overall Study|Adverse Event|0
3090463|NCT00358527|10597514|P1|Overall Study|Adverse Event|4
3090464|NCT00358449|10597564|P3|Overall Study|Steriod Inhaler was Increased|1
3090465|NCT00358449|10597565|P2|Overall Study|Steriod Inhaler was Increased|0
3090466|NCT00358449|10597566|P1|Overall Study|Steriod Inhaler was Increased|0
3090467|NCT00358449|10597564|P3|Overall Study|Lack of Efficacy|0
3090468|NCT00358449|10597565|P2|Overall Study|Lack of Efficacy|1
3090469|NCT00358449|10597566|P1|Overall Study|Lack of Efficacy|0
3090470|NCT00358449|10597564|P3|Overall Study|Withdrawal by Subject|0
3090471|NCT00358449|10597565|P2|Overall Study|Withdrawal by Subject|0
3090472|NCT00358449|10597566|P1|Overall Study|Withdrawal by Subject|2
3090473|NCT00358449|10597564|P3|Overall Study|Lost to Follow-up|0
3090474|NCT00358449|10597565|P2|Overall Study|Lost to Follow-up|0
3090475|NCT00358449|10597566|P1|Overall Study|Lost to Follow-up|1
3090476|NCT00358449|10597564|P3|Overall Study|Adverse Event|1
3090477|NCT00358449|10597565|P2|Overall Study|Adverse Event|0
3090478|NCT00358449|10597566|P1|Overall Study|Adverse Event|1
3090479|NCT00358436|10597669|P2|Overall Study|Other|1
3090480|NCT00358436|10597670|P1|Overall Study|Other|6
3090481|NCT00358436|10597669|P2|Overall Study|COPD exacerbation|10
3090482|NCT00358436|10597670|P1|Overall Study|COPD exacerbation|22
3090483|NCT00358436|10597669|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
3090484|NCT00358436|10597670|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
3090485|NCT00358436|10597669|P2|Overall Study|Withdrawal by Subject|17
3090486|NCT00358436|10597670|P1|Overall Study|Withdrawal by Subject|40
3090487|NCT00358436|10597669|P2|Overall Study|Protocol Violation|3
3090488|NCT00358436|10597670|P1|Overall Study|Protocol Violation|8
3090489|NCT00358436|10597669|P2|Overall Study|Lost to Follow-up|6
3090490|NCT00358436|10597670|P1|Overall Study|Lost to Follow-up|11
3090491|NCT00358436|10597669|P2|Overall Study|Lack of Efficacy|36
3090492|NCT00358436|10597670|P1|Overall Study|Lack of Efficacy|34
3090493|NCT00358436|10597669|P2|Overall Study|Adverse Event|13
3090494|NCT00358436|10597670|P1|Overall Study|Adverse Event|29
3090495|NCT00358215|10597741|P2|Overall Study|Did not receive investigational product|3
3090496|NCT00358215|10597742|P1|Overall Study|Did not receive investigational product|2
3090497|NCT00358215|10597741|P2|Overall Study|Other|14
3090498|NCT00358215|10597742|P1|Overall Study|Other|21
3090499|NCT00358215|10597741|P2|Overall Study|Pregnancy|0
3090500|NCT00358215|10597742|P1|Overall Study|Pregnancy|1
3090501|NCT00358215|10597741|P2|Overall Study|Protocol Violation|59
3090502|NCT00358215|10597742|P1|Overall Study|Protocol Violation|64
3090503|NCT00358215|10597741|P2|Overall Study|Death|281
3090504|NCT00358215|10597742|P1|Overall Study|Death|265
3090505|NCT00358215|10597741|P2|Overall Study|Lost to Follow-up|22
3090506|NCT00358215|10597742|P1|Overall Study|Lost to Follow-up|16
3090507|NCT00358215|10597741|P2|Overall Study|Physician Decision|39
3090508|NCT00358215|10597742|P1|Overall Study|Physician Decision|47
3090509|NCT00358215|10597741|P2|Overall Study|Participant request|64
3090510|NCT00358215|10597742|P1|Overall Study|Participant request|65
3090511|NCT00358215|10597741|P2|Overall Study|Withdrawal by Subject|102
3090512|NCT00358215|10597742|P1|Overall Study|Withdrawal by Subject|111
3090513|NCT00358215|10597741|P2|Overall Study|Adverse Event|65
3090514|NCT00358215|10597742|P1|Overall Study|Adverse Event|83
3090515|NCT00358215|10597741|P2|Overall Study|Ineligibility determined|3
3090516|NCT00358215|10597742|P1|Overall Study|Ineligibility determined|4
3090517|NCT00358150|10597756|P1|Overall Study|Undefined|3
3090518|NCT00358150|10597756|P1|Overall Study|Withdrawal by Subject|1
3090519|NCT00358150|10597756|P1|Overall Study|Adverse Event|3
3090520|NCT00357994|10597785|P2|Overall Study|Protocol Violation|0
3090521|NCT00357994|10597786|P1|Overall Study|Protocol Violation|1
3090522|NCT00357994|10597785|P2|Overall Study|Lack of Efficacy|1
3090523|NCT00357994|10597786|P1|Overall Study|Lack of Efficacy|0
3090524|NCT00357994|10597785|P2|Overall Study|Adverse Event|2
3090525|NCT00357994|10597786|P1|Overall Study|Adverse Event|1
3090526|NCT00357968|10597840|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
3090527|NCT00357968|10597841|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
3090528|NCT00357968|10597840|P2|First Maintenance Dose Phase|Not a PCI patient|42
3090529|NCT00357968|10597841|P1|First Maintenance Dose Phase|Not a PCI patient|47
3090530|NCT00357903|10597894|P2|Overall Study|Other|10
3090531|NCT00357903|10597895|P1|Overall Study|Other|49
3090532|NCT00357903|10597894|P2|Overall Study|Response status|9
3090533|NCT00357903|10597895|P1|Overall Study|Response status|61
3090534|NCT00357903|10597894|P2|Overall Study|Protocol issues|3
3090535|NCT00357903|10597895|P1|Overall Study|Protocol issues|14
3090536|NCT00357903|10597894|P2|Overall Study|Completed month 12 only|1
3090537|NCT00357903|10597895|P1|Overall Study|Completed month 12 only|0
3090538|NCT00357903|10597894|P2|Overall Study|Withdrawal by Subject|7
3090539|NCT00357903|10597895|P1|Overall Study|Withdrawal by Subject|57
3090540|NCT00357903|10597894|P2|Overall Study|Physician Decision|5
3090541|NCT00357903|10597895|P1|Overall Study|Physician Decision|39
3090542|NCT00357903|10597894|P2|Overall Study|Lost to Follow-up|4
3090543|NCT00357903|10597895|P1|Overall Study|Lost to Follow-up|23
3090544|NCT00357903|10597894|P2|Overall Study|Death|0
3090545|NCT00357903|10597895|P1|Overall Study|Death|33
3090546|NCT00357903|10597894|P2|Overall Study|Adverse Event|4
3090547|NCT00357903|10597895|P1|Overall Study|Adverse Event|87
3090548|NCT00357877|10597935|P2|Overall Study|Other|2
3090549|NCT00357877|10597936|P1|Overall Study|Other|0
3090550|NCT00357877|10597935|P2|Overall Study|Administrative withdrawal|1
3090551|NCT00357877|10597936|P1|Overall Study|Administrative withdrawal|1
3090552|NCT00357877|10597935|P2|Overall Study|Withdrawal by Subject|3
3090553|NCT00357877|10597936|P1|Overall Study|Withdrawal by Subject|3
3090554|NCT00357877|10597935|P2|Overall Study|Lost to Follow-up|23
3090555|NCT00357877|10597936|P1|Overall Study|Lost to Follow-up|20
3090556|NCT00357877|10597935|P2|Overall Study|Death|1
3090557|NCT00357877|10597936|P1|Overall Study|Death|2
3090558|NCT00357760|10597950|P2|Overall Study|To receive hospice care|1
3090559|NCT00357760|10597951|P1|Overall Study|To receive hospice care|0
3090560|NCT00357760|10597950|P2|Overall Study|Protocol Violation|1
3090561|NCT00357760|10597951|P1|Overall Study|Protocol Violation|0
3090562|NCT00357760|10597950|P2|Overall Study|Physician Decision|1
3090563|NCT00357760|10597951|P1|Overall Study|Physician Decision|2
3090564|NCT00357760|10597950|P2|Overall Study|Ineligible|2
3090565|NCT00357760|10597951|P1|Overall Study|Ineligible|0
3090566|NCT00357760|10597950|P2|Overall Study|Never started treatment|1
3090567|NCT00357760|10597951|P1|Overall Study|Never started treatment|2
3090568|NCT00357760|10597950|P2|Overall Study|Withdrawal by Subject|2
3090569|NCT00357760|10597951|P1|Overall Study|Withdrawal by Subject|0
3090570|NCT00357760|10597950|P2|Overall Study|Alternative therapy|0
3090571|NCT00357760|10597951|P1|Overall Study|Alternative therapy|1
3090572|NCT00357760|10597950|P2|Overall Study|Death|3
3090573|NCT00357760|10597951|P1|Overall Study|Death|0
3090574|NCT00357760|10597950|P2|Overall Study|Adverse Event|7
3090575|NCT00357760|10597951|P1|Overall Study|Adverse Event|10
3090576|NCT00357760|10597950|P2|Overall Study|Disease progression|17
3090577|NCT00357760|10597951|P1|Overall Study|Disease progression|44
3090578|NCT00357656|10597972|P2|Overall Study|Other, No surgery performed|3
3090579|NCT00357656|10597973|P1|Overall Study|Other, No surgery performed|0
3090580|NCT00357552|10598024|P1|Weeks 24 to 104|Not able to get to clinic|2
3090581|NCT00357552|10598024|P1|Weeks 24 to 104|Death|3
3090582|NCT00357552|10598024|P1|Weeks 0 to 24|Death|1
3090583|NCT00357552|10598024|P1|Screening|Did not meet eligibility criteria|84
3090584|NCT00357500|10598039|P1|Overall Study|Not Started Protocol Therapy|4
3090585|NCT00357500|10598039|P1|Overall Study|Progressive Disease|65
3090586|NCT00357500|10598039|P1|Overall Study|Withdrawal by Subject|5
3090587|NCT00357500|10598039|P1|Overall Study|Adverse Event|3
3090588|NCT00357396|10598048|P2|Overall Study|Adverse Event|0
3090589|NCT00357396|10598049|P1|Overall Study|Adverse Event|1
3090590|NCT00357370|10598057|P3|Cohort 2|Withdrawal by Subject|0
3090591|NCT00357370|10598058|P2|Cohort 2|Withdrawal by Subject|2
3090592|NCT00357370|10598059|P1|Cohort 2|Withdrawal by Subject|0
3090593|NCT00357370|10598057|P3|Cohort 2|non-compliance, not met criteria, etc|0
3090594|NCT00357370|10598058|P2|Cohort 2|non-compliance, not met criteria, etc|1
3090595|NCT00357370|10598059|P1|Cohort 2|non-compliance, not met criteria, etc|1
3090596|NCT00357370|10598057|P3|Cohort 2|Lost to Follow-up|0
3090597|NCT00357370|10598058|P2|Cohort 2|Lost to Follow-up|1
3090598|NCT00357370|10598059|P1|Cohort 2|Lost to Follow-up|0
3090599|NCT00357370|10598057|P3|Cohort 2|Adverse Event|1
3090600|NCT00357370|10598058|P2|Cohort 2|Adverse Event|1
3090601|NCT00357370|10598059|P1|Cohort 2|Adverse Event|1
3090602|NCT00357370|10598057|P3|Cohort 2|Lack of Efficacy|1
3090603|NCT00357370|10598058|P2|Cohort 2|Lack of Efficacy|2
3090604|NCT00357370|10598059|P1|Cohort 2|Lack of Efficacy|0
3090605|NCT00357110|10598122|P2|Overall Study|Early study termination|5
3090606|NCT00357110|10598123|P1|Overall Study|Early study termination|5
3090607|NCT00357097|10598131|P2|Overall Study|Increase of RLS Symptoms|1
3090608|NCT00357097|10598132|P1|Overall Study|Increase of RLS Symptoms|0
3090609|NCT00357097|10598131|P2|Overall Study|Other|1
3090610|NCT00357097|10598132|P1|Overall Study|Other|1
3090611|NCT00357097|10598131|P2|Overall Study|Met Exclusion Criteria|1
3090612|NCT00357097|10598132|P1|Overall Study|Met Exclusion Criteria|3
3090613|NCT00357097|10598131|P2|Overall Study|Lack of Efficacy|8
3090614|NCT00357097|10598132|P1|Overall Study|Lack of Efficacy|2
3090615|NCT00357097|10598131|P2|Overall Study|Non-compliance|2
3090616|NCT00357097|10598132|P1|Overall Study|Non-compliance|1
3090617|NCT00357097|10598131|P2|Overall Study|Withdrawal by Subject|7
3090618|NCT00357097|10598132|P1|Overall Study|Withdrawal by Subject|8
3090619|NCT00357097|10598131|P2|Overall Study|Adverse Event|6
3090620|NCT00357097|10598132|P1|Overall Study|Adverse Event|34
3090621|NCT00357097|10598131|P2|Overall Study|Did not meet inclusion criteria|3
3090622|NCT00357097|10598132|P1|Overall Study|Did not meet inclusion criteria|5
3090623|NCT00357006|10598186|P3|Overall Study|Withdrawal by Subject|2
3090624|NCT00357006|10598187|P2|Overall Study|Withdrawal by Subject|3
3090625|NCT00357006|10598188|P1|Overall Study|Withdrawal by Subject|1
3090626|NCT00357006|10598186|P3|Overall Study|Lost to Follow-up|1
3090627|NCT00357006|10598187|P2|Overall Study|Lost to Follow-up|2
3090628|NCT00357006|10598188|P1|Overall Study|Lost to Follow-up|1
3090629|NCT00356915|10598203|P3|Overall Study|Miscellaneous reasons|3
3090630|NCT00356915|10598204|P2|Overall Study|Miscellaneous reasons|8
3090631|NCT00356915|10598205|P1|Overall Study|Miscellaneous reasons|11
3090632|NCT00356915|10598203|P3|Overall Study|Adverse Event|8
3090633|NCT00356915|10598204|P2|Overall Study|Adverse Event|31
3090634|NCT00356915|10598205|P1|Overall Study|Adverse Event|21
3090635|NCT00356915|10598203|P3|Overall Study|Physician Decision|0
3090636|NCT00356915|10598204|P2|Overall Study|Physician Decision|2
3090637|NCT00356915|10598205|P1|Overall Study|Physician Decision|0
3090638|NCT00356915|10598203|P3|Overall Study|Administrative Decision|1
3090639|NCT00356915|10598204|P2|Overall Study|Administrative Decision|0
3090640|NCT00356915|10598205|P1|Overall Study|Administrative Decision|0
3090641|NCT00356915|10598203|P3|Overall Study|Lost to Follow-up|14
3090642|NCT00356915|10598204|P2|Overall Study|Lost to Follow-up|34
3090643|NCT00356915|10598205|P1|Overall Study|Lost to Follow-up|27
3090644|NCT00356915|10598203|P3|Overall Study|Lack of Efficacy|3
3090645|NCT00356915|10598204|P2|Overall Study|Lack of Efficacy|0
3090646|NCT00356915|10598205|P1|Overall Study|Lack of Efficacy|0
3090647|NCT00356915|10598203|P3|Overall Study|Withdrawal by Subject|10
3090648|NCT00356915|10598204|P2|Overall Study|Withdrawal by Subject|14
3090649|NCT00356915|10598205|P1|Overall Study|Withdrawal by Subject|14
3090650|NCT00356915|10598203|P3|Overall Study|Protocol Violation|2
3090651|NCT00356915|10598204|P2|Overall Study|Protocol Violation|3
3090652|NCT00356915|10598205|P1|Overall Study|Protocol Violation|2
3090653|NCT00356915|10598203|P3|Overall Study|Non compliance|1
3090654|NCT00356915|10598204|P2|Overall Study|Non compliance|2
3090655|NCT00356915|10598205|P1|Overall Study|Non compliance|1
3090656|NCT00356889|10598222|P1|Overall Study|Adverse Event|1
3090657|NCT00356889|10598222|P1|Overall Study|Protocol Violation|2
3090658|NCT00356863|10598231|P2|Overall Study|Lost to Follow-up|43
3090659|NCT00356863|10598232|P1|Overall Study|Lost to Follow-up|76
3090660|NCT00356863|10598231|P2|Overall Study|Death|32
3090661|NCT00356863|10598232|P1|Overall Study|Death|16
3090662|NCT00356811|10598258|P1|Overall Study|Site Closed during Follow-up|2
3090663|NCT00356811|10598258|P1|Overall Study|Study Is Terminating|3
3090664|NCT00356811|10598258|P1|Overall Study|Participant Could Not Make a Checkup|1
3090665|NCT00356811|10598258|P1|Overall Study|Withdrawal by Subject|6
3090666|NCT00356811|10598258|P1|Overall Study|Lost to Follow-up|2
3090667|NCT00356811|10598258|P1|Overall Study|Death|35
3090668|NCT00356759|10598273|P2|Overall Study|Intercurrent disease or persistent extre|2
3090669|NCT00356759|10598274|P1|Overall Study|Intercurrent disease or persistent extre|5
3090670|NCT00356759|10598273|P2|Overall Study|Lost to Follow-up|1
3090671|NCT00356759|10598274|P1|Overall Study|Lost to Follow-up|1
3090672|NCT00356759|10598273|P2|Overall Study|Adverse Event|3
3090673|NCT00356759|10598274|P1|Overall Study|Adverse Event|1
3090674|NCT00356759|10598273|P2|Overall Study|Withdrawal by Subject|2
3090675|NCT00356759|10598274|P1|Overall Study|Withdrawal by Subject|2
3090676|NCT00356759|10598273|P2|Overall Study|Death|2
3090677|NCT00356759|10598274|P1|Overall Study|Death|5
3090678|NCT00356603|10598292|P2|Overall Study|Other|3
3090679|NCT00356603|10598293|P1|Overall Study|Other|6
3090680|NCT00356590|10598307|P1|Overall Study|Other|52
3090681|NCT00356590|10598307|P1|Overall Study|Response status|28
3090682|NCT00356590|10598307|P1|Overall Study|Protocol issues|6
3090683|NCT00356590|10598307|P1|Overall Study|Completed month 12 only|2
3090684|NCT00356590|10598307|P1|Overall Study|Withdrawal by Subject|41
3090685|NCT00356590|10598307|P1|Overall Study|Physician Decision|46
3090686|NCT00356590|10598307|P1|Overall Study|Lost to Follow-up|35
3090687|NCT00356590|10598307|P1|Overall Study|Death|10
3090688|NCT00356590|10598307|P1|Overall Study|Adverse Event|54
3090689|NCT00356525|10598343|P4|Overall Study|Sponsor Decision|1
3090690|NCT00356525|10598344|P3|Overall Study|Sponsor Decision|0
3090691|NCT00356525|10598345|P2|Overall Study|Sponsor Decision|0
3090692|NCT00356525|10598346|P1|Overall Study|Sponsor Decision|0
3090693|NCT00356525|10598343|P4|Overall Study|Death|1
3090694|NCT00356525|10598344|P3|Overall Study|Death|0
3090695|NCT00356525|10598345|P2|Overall Study|Death|0
3090696|NCT00356525|10598346|P1|Overall Study|Death|0
3090697|NCT00356525|10598343|P4|Overall Study|Withdrawal by Subject|3
3090698|NCT00356525|10598344|P3|Overall Study|Withdrawal by Subject|0
3090699|NCT00356525|10598345|P2|Overall Study|Withdrawal by Subject|1
3090700|NCT00356525|10598346|P1|Overall Study|Withdrawal by Subject|1
3090701|NCT00356525|10598343|P4|Overall Study|Protocol Entry Criteria Not Met|0
3090702|NCT00356525|10598344|P3|Overall Study|Protocol Entry Criteria Not Met|0
3090703|NCT00356525|10598345|P2|Overall Study|Protocol Entry Criteria Not Met|0
3090704|NCT00356525|10598346|P1|Overall Study|Protocol Entry Criteria Not Met|1
3090705|NCT00356525|10598343|P4|Overall Study|Physician Decision|1
3090706|NCT00356525|10598344|P3|Overall Study|Physician Decision|2
3090707|NCT00356525|10598345|P2|Overall Study|Physician Decision|2
3090708|NCT00356525|10598346|P1|Overall Study|Physician Decision|2
3090709|NCT00356525|10598343|P4|Overall Study|Lost to Follow-up|0
3090710|NCT00356525|10598344|P3|Overall Study|Lost to Follow-up|0
3090711|NCT00356525|10598345|P2|Overall Study|Lost to Follow-up|0
3090712|NCT00356525|10598346|P1|Overall Study|Lost to Follow-up|1
3090713|NCT00356525|10598343|P4|Overall Study|Adverse Event|1
3090714|NCT00356525|10598344|P3|Overall Study|Adverse Event|1
3090715|NCT00356525|10598345|P2|Overall Study|Adverse Event|3
3090716|NCT00356525|10598346|P1|Overall Study|Adverse Event|1
3090717|NCT00356525|10598343|P4|Overall Study|Progressive Disease|2
3090718|NCT00356525|10598344|P3|Overall Study|Progressive Disease|4
3090719|NCT00356525|10598345|P2|Overall Study|Progressive Disease|5
3090720|NCT00356525|10598346|P1|Overall Study|Progressive Disease|8
3090721|NCT00356421|10598387|P2|Overall Study|Not related to study drug|3
3090722|NCT00356421|10598388|P1|Overall Study|Not related to study drug|5
3090723|NCT00356421|10598387|P2|Overall Study|Related to study drug|12
3090724|NCT00356421|10598388|P1|Overall Study|Related to study drug|15
3090725|NCT00356421|10598387|P2|Overall Study|Withdrawal by Subject|2
3090726|NCT00356421|10598388|P1|Overall Study|Withdrawal by Subject|9
3090727|NCT00356421|10598387|P2|Overall Study|Lack of Efficacy|0
3090728|NCT00356421|10598388|P1|Overall Study|Lack of Efficacy|3
3090729|NCT00356408|10598428|P1|Overall Study|Other: Subject chose commerical dosing|1
3090730|NCT00356408|10598428|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
3090731|NCT00356408|10598428|P1|Overall Study|Other: Azathioprine stopped|1
3090732|NCT00356408|10598428|P1|Overall Study|Other: Sponsor request|1
3090733|NCT00356408|10598428|P1|Overall Study|Other: Principal investigator discretion|3
3090734|NCT00356408|10598428|P1|Overall Study|Withdrawal by Subject|6
3090735|NCT00356408|10598428|P1|Overall Study|Lost to Follow-up|2
3090736|NCT00356408|10598428|P1|Overall Study|Lack of Efficacy|36
3090737|NCT00356408|10598428|P1|Overall Study|Adverse Event|9
3090738|NCT00356369|10598445|P2|Active Phase|Withdrawal by Subject|1
3090739|NCT00356369|10598446|P1|Active Phase|Withdrawal by Subject|2
3090740|NCT00356278|10598528|P3|Overall Study|Withdrawal by Subject|19
3090741|NCT00356278|10598529|P2|Overall Study|Withdrawal by Subject|15
3090742|NCT00356278|10598530|P1|Overall Study|Withdrawal by Subject|25
3090743|NCT00356265|10598568|P3|Overall Study|Withdrawal by Subject|1
3090744|NCT00356265|10598569|P2|Overall Study|Withdrawal by Subject|0
3090745|NCT00356265|10598570|P1|Overall Study|Withdrawal by Subject|0
3090746|NCT00356200|10598582|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
3090747|NCT00356200|10598583|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
3090748|NCT00356200|10598582|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
3090749|NCT00356200|10598583|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
3090750|NCT00356148|10598612|P2|Overall Study|Reoperation within 30 days|1
3090751|NCT00356148|10598613|P1|Overall Study|Reoperation within 30 days|2
3090752|NCT00356135|10598624|P3|Overall Study|Subject non-compliance|3
3090753|NCT00356135|10598625|P2|Overall Study|Subject non-compliance|1
3090754|NCT00356135|10598626|P1|Overall Study|Subject non-compliance|1
3090755|NCT00356135|10598624|P3|Overall Study|Physician Decision|1
3090756|NCT00356135|10598625|P2|Overall Study|Physician Decision|1
3090757|NCT00356135|10598626|P1|Overall Study|Physician Decision|1
3090758|NCT00356135|10598624|P3|Overall Study|Lost to Follow-up|1
3090759|NCT00356135|10598625|P2|Overall Study|Lost to Follow-up|0
3090760|NCT00356135|10598626|P1|Overall Study|Lost to Follow-up|0
3090761|NCT00356135|10598624|P3|Overall Study|Adverse Event|0
3090762|NCT00356135|10598625|P2|Overall Study|Adverse Event|0
3090763|NCT00356135|10598626|P1|Overall Study|Adverse Event|1
3090764|NCT00356135|10598624|P3|Overall Study|Protocol Violation|0
3090765|NCT00356135|10598625|P2|Overall Study|Protocol Violation|0
3090766|NCT00356135|10598626|P1|Overall Study|Protocol Violation|1
3090767|NCT00356122|10598648|P1|FOLLOW-UP|Other|2
3090768|NCT00356122|10598648|P1|FOLLOW-UP|Lost to Follow-up|2
3090769|NCT00356122|10598648|P1|FOLLOW-UP|Death|37
3090770|NCT00356122|10598648|P1|TREATMENT|Did not receive study medication|1
3090771|NCT00356122|10598648|P1|TREATMENT|Other|4
3090772|NCT00356122|10598648|P1|TREATMENT|Subject's request|4
3090773|NCT00356122|10598648|P1|TREATMENT|Adverse Event|10
3090774|NCT00356122|10598648|P1|TREATMENT|Lack of Efficacy|26
3090775|NCT00355784|10598756|P3|Overall Study|Withdrawal by Subject|2
3090776|NCT00355784|10598757|P2|Overall Study|Withdrawal by Subject|0
3090777|NCT00355784|10598758|P1|Overall Study|Withdrawal by Subject|0
3090778|NCT00355615|10598807|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
3090779|NCT00355615|10598808|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
3090780|NCT00355615|10598809|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
3090781|NCT00355615|10598810|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
3090782|NCT00355615|10598811|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
3090783|NCT00355615|10598807|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
3090784|NCT00355615|10598808|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
3090785|NCT00355615|10598809|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
3090786|NCT00355615|10598810|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
3090787|NCT00355615|10598811|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
3090788|NCT00355615|10598807|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
3090789|NCT00355615|10598808|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
3090790|NCT00355615|10598809|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
3090791|NCT00355615|10598810|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
3090792|NCT00355615|10598811|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
3090793|NCT00355615|10598807|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
3090794|NCT00355615|10598808|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
3090795|NCT00355615|10598809|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
3090796|NCT00355615|10598810|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
3090797|NCT00355615|10598811|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
3090798|NCT00355615|10598807|P5|Randomized Double Blind Period|Protocol Violation|0
3090881|NCT00355134|10598983|P1|Extension Phase|Adverse Event|13
3090799|NCT00355615|10598808|P4|Randomized Double Blind Period|Protocol Violation|1
3090800|NCT00355615|10598809|P3|Randomized Double Blind Period|Protocol Violation|1
3090801|NCT00355615|10598810|P2|Randomized Double Blind Period|Protocol Violation|0
3090802|NCT00355615|10598811|P1|Randomized Double Blind Period|Protocol Violation|0
3090803|NCT00355615|10598807|P5|Randomized Double Blind Period|Adverse Event|0
3090804|NCT00355615|10598808|P4|Randomized Double Blind Period|Adverse Event|0
3090805|NCT00355615|10598809|P3|Randomized Double Blind Period|Adverse Event|0
3090806|NCT00355615|10598810|P2|Randomized Double Blind Period|Adverse Event|0
3090807|NCT00355615|10598811|P1|Randomized Double Blind Period|Adverse Event|1
3090808|NCT00355472|10598870|P1|Overall Study|Physician Decision|1
3090809|NCT00355368|10598916|P2|Overall Study|cardiac arrest prior to intubation|2
3090810|NCT00355368|10598917|P1|Overall Study|cardiac arrest prior to intubation|2
3090811|NCT00355368|10598916|P2|Overall Study|Protocol Violation|7
3090812|NCT00355368|10598917|P1|Overall Study|Protocol Violation|8
3090813|NCT00355342|10598931|P2|Overall Study|Use of protocol excluded medication|1
3090814|NCT00355342|10598932|P1|Overall Study|Use of protocol excluded medication|0
3090815|NCT00355342|10598931|P2|Overall Study|Protocol Violation|1
3090816|NCT00355342|10598932|P1|Overall Study|Protocol Violation|0
3090817|NCT00355342|10598931|P2|Overall Study|Study management|1
3090818|NCT00355342|10598932|P1|Overall Study|Study management|0
3090819|NCT00355342|10598931|P2|Overall Study|Participant discontinued study drug|1
3090820|NCT00355342|10598932|P1|Overall Study|Participant discontinued study drug|0
3090821|NCT00355342|10598931|P2|Overall Study|Participant relocated|1
3090822|NCT00355342|10598932|P1|Overall Study|Participant relocated|0
3090823|NCT00355342|10598931|P2|Overall Study|Withdrawal by participant and physician|0
3090824|NCT00355342|10598932|P1|Overall Study|Withdrawal by participant and physician|1
3090825|NCT00355342|10598931|P2|Overall Study|Non-compliance with Dexa scans|0
3090826|NCT00355342|10598932|P1|Overall Study|Non-compliance with Dexa scans|1
3090827|NCT00355342|10598931|P2|Overall Study|Dispensed wrong study drug kit|0
3090828|NCT00355342|10598932|P1|Overall Study|Dispensed wrong study drug kit|1
3090829|NCT00355342|10598931|P2|Overall Study|COPD exacerbation|1
3090830|NCT00355342|10598932|P1|Overall Study|COPD exacerbation|1
3090831|NCT00355342|10598931|P2|Overall Study|Use of prohibited medication|0
3090832|NCT00355342|10598932|P1|Overall Study|Use of prohibited medication|1
3090833|NCT00355342|10598931|P2|Overall Study|Overcompliant-PI discretion|0
3090834|NCT00355342|10598932|P1|Overall Study|Overcompliant-PI discretion|1
3090835|NCT00355342|10598931|P2|Overall Study|Sponsor terminated study|2
3090836|NCT00355342|10598932|P1|Overall Study|Sponsor terminated study|2
3090837|NCT00355342|10598931|P2|Overall Study|Withdrawal by Subject|11
3090838|NCT00355342|10598932|P1|Overall Study|Withdrawal by Subject|14
3090839|NCT00355342|10598931|P2|Overall Study|Lost to Follow-up|2
3090840|NCT00355342|10598932|P1|Overall Study|Lost to Follow-up|4
3090841|NCT00355342|10598931|P2|Overall Study|Adverse Event|15
3090842|NCT00355342|10598932|P1|Overall Study|Adverse Event|13
3090843|NCT00355147|10598959|P2|Overall Study|Withdrawal by Subject|12
3090844|NCT00355147|10598960|P1|Overall Study|Withdrawal by Subject|8
3090845|NCT00355147|10598959|P2|Overall Study|Lost to Follow-up|8
3090846|NCT00355147|10598960|P1|Overall Study|Lost to Follow-up|10
3090847|NCT00355134|10598979|P5|Extension Phase|Protocol Violation|0
3090848|NCT00355134|10598980|P4|Extension Phase|Protocol Violation|1
3090849|NCT00355134|10598981|P3|Extension Phase|Protocol Violation|0
3090850|NCT00355134|10598982|P2|Extension Phase|Protocol Violation|0
3090851|NCT00355134|10598983|P1|Extension Phase|Protocol Violation|0
3090852|NCT00355134|10598979|P5|Extension Phase|Abnormal test procedure result(s)|1
3090853|NCT00355134|10598980|P4|Extension Phase|Abnormal test procedure result(s)|0
3090854|NCT00355134|10598981|P3|Extension Phase|Abnormal test procedure result(s)|0
3090855|NCT00355134|10598982|P2|Extension Phase|Abnormal test procedure result(s)|1
3090856|NCT00355134|10598983|P1|Extension Phase|Abnormal test procedure result(s)|0
3090857|NCT00355134|10598979|P5|Extension Phase|Unsatisfactory therapeutic effect|1
3090858|NCT00355134|10598980|P4|Extension Phase|Unsatisfactory therapeutic effect|0
3090859|NCT00355134|10598981|P3|Extension Phase|Unsatisfactory therapeutic effect|0
3090860|NCT00355134|10598982|P2|Extension Phase|Unsatisfactory therapeutic effect|4
3090861|NCT00355134|10598983|P1|Extension Phase|Unsatisfactory therapeutic effect|3
3090862|NCT00355134|10598979|P5|Extension Phase|Administrative problems|1
3090863|NCT00355134|10598980|P4|Extension Phase|Administrative problems|1
3090864|NCT00355134|10598981|P3|Extension Phase|Administrative problems|0
3090865|NCT00355134|10598982|P2|Extension Phase|Administrative problems|4
3090866|NCT00355134|10598983|P1|Extension Phase|Administrative problems|2
3090867|NCT00355134|10598979|P5|Extension Phase|Abnormal laboratory value(s)|2
3090868|NCT00355134|10598980|P4|Extension Phase|Abnormal laboratory value(s)|2
3090869|NCT00355134|10598981|P3|Extension Phase|Abnormal laboratory value(s)|0
3090870|NCT00355134|10598982|P2|Extension Phase|Abnormal laboratory value(s)|2
3090871|NCT00355134|10598983|P1|Extension Phase|Abnormal laboratory value(s)|4
3090872|NCT00355134|10598979|P5|Extension Phase|Lost to Follow-up|4
3090873|NCT00355134|10598980|P4|Extension Phase|Lost to Follow-up|2
3090874|NCT00355134|10598981|P3|Extension Phase|Lost to Follow-up|0
3090875|NCT00355134|10598982|P2|Extension Phase|Lost to Follow-up|6
3090876|NCT00355134|10598983|P1|Extension Phase|Lost to Follow-up|2
3090877|NCT00355134|10598979|P5|Extension Phase|Adverse Event|5
3090878|NCT00355134|10598980|P4|Extension Phase|Adverse Event|3
3090879|NCT00355134|10598981|P3|Extension Phase|Adverse Event|0
3090880|NCT00355134|10598982|P2|Extension Phase|Adverse Event|9
3090882|NCT00355134|10598979|P5|Extension Phase|Withdrawal by Subject|5
3090883|NCT00355134|10598980|P4|Extension Phase|Withdrawal by Subject|7
3090884|NCT00355134|10598981|P3|Extension Phase|Withdrawal by Subject|0
3090885|NCT00355134|10598982|P2|Extension Phase|Withdrawal by Subject|11
3090886|NCT00355134|10598983|P1|Extension Phase|Withdrawal by Subject|7
3090887|NCT00355134|10598979|P5|Core Phase|Condition no longer requires study drug|0
3090888|NCT00355134|10598980|P4|Core Phase|Condition no longer requires study drug|0
3090889|NCT00355134|10598981|P3|Core Phase|Condition no longer requires study drug|1
3090890|NCT00355134|10598982|P2|Core Phase|Condition no longer requires study drug|0
3090891|NCT00355134|10598983|P1|Core Phase|Condition no longer requires study drug|1
3090892|NCT00355134|10598979|P5|Core Phase|Abnormal test procedure result(s)|0
3090893|NCT00355134|10598980|P4|Core Phase|Abnormal test procedure result(s)|0
3090894|NCT00355134|10598981|P3|Core Phase|Abnormal test procedure result(s)|1
3090895|NCT00355134|10598982|P2|Core Phase|Abnormal test procedure result(s)|2
3090896|NCT00355134|10598983|P1|Core Phase|Abnormal test procedure result(s)|1
3090897|NCT00355134|10598979|P5|Core Phase|Protocol Violation|0
3090898|NCT00355134|10598980|P4|Core Phase|Protocol Violation|0
3090899|NCT00355134|10598981|P3|Core Phase|Protocol Violation|2
3090900|NCT00355134|10598982|P2|Core Phase|Protocol Violation|2
3090901|NCT00355134|10598983|P1|Core Phase|Protocol Violation|3
3090902|NCT00355134|10598979|P5|Core Phase|Administrative problems|0
3090903|NCT00355134|10598980|P4|Core Phase|Administrative problems|0
3090904|NCT00355134|10598981|P3|Core Phase|Administrative problems|5
3090905|NCT00355134|10598982|P2|Core Phase|Administrative problems|3
3090906|NCT00355134|10598983|P1|Core Phase|Administrative problems|5
3090907|NCT00355134|10598979|P5|Core Phase|Unsatisfactory therapeutic effect|0
3090908|NCT00355134|10598980|P4|Core Phase|Unsatisfactory therapeutic effect|0
3090909|NCT00355134|10598981|P3|Core Phase|Unsatisfactory therapeutic effect|17
3090910|NCT00355134|10598982|P2|Core Phase|Unsatisfactory therapeutic effect|6
3090911|NCT00355134|10598983|P1|Core Phase|Unsatisfactory therapeutic effect|10
3090912|NCT00355134|10598979|P5|Core Phase|Abnormal laboratory value(s)|0
3090913|NCT00355134|10598980|P4|Core Phase|Abnormal laboratory value(s)|0
3090914|NCT00355134|10598981|P3|Core Phase|Abnormal laboratory value(s)|2
3090915|NCT00355134|10598982|P2|Core Phase|Abnormal laboratory value(s)|14
3090916|NCT00355134|10598983|P1|Core Phase|Abnormal laboratory value(s)|19
3090917|NCT00355134|10598979|P5|Core Phase|Lost to Follow-up|0
3090918|NCT00355134|10598980|P4|Core Phase|Lost to Follow-up|0
3090919|NCT00355134|10598981|P3|Core Phase|Lost to Follow-up|21
3090920|NCT00355134|10598982|P2|Core Phase|Lost to Follow-up|13
3090921|NCT00355134|10598983|P1|Core Phase|Lost to Follow-up|17
3090922|NCT00355134|10598979|P5|Core Phase|Adverse Event|0
3090923|NCT00355134|10598980|P4|Core Phase|Adverse Event|0
3090924|NCT00355134|10598981|P3|Core Phase|Adverse Event|16
3090925|NCT00355134|10598982|P2|Core Phase|Adverse Event|22
3090926|NCT00355134|10598983|P1|Core Phase|Adverse Event|28
3090927|NCT00355134|10598979|P5|Core Phase|Withdrawal by Subject|0
3090928|NCT00355134|10598980|P4|Core Phase|Withdrawal by Subject|0
3090929|NCT00355134|10598981|P3|Core Phase|Withdrawal by Subject|35
3090930|NCT00355134|10598982|P2|Core Phase|Withdrawal by Subject|24
3090931|NCT00355134|10598983|P1|Core Phase|Withdrawal by Subject|35
3090932|NCT00355121|10599026|P3|Overall Study|Serious adverse events|0
3090933|NCT00355121|10599027|P2|Overall Study|Serious adverse events|2
3090934|NCT00355121|10599028|P1|Overall Study|Serious adverse events|0
3090935|NCT00355121|10599026|P3|Overall Study|Withdrawal by Subject|2
3090936|NCT00355121|10599027|P2|Overall Study|Withdrawal by Subject|10
3090937|NCT00355121|10599028|P1|Overall Study|Withdrawal by Subject|9
3090938|NCT00355121|10599026|P3|Overall Study|Lost to Follow-up|1
3090939|NCT00355121|10599027|P2|Overall Study|Lost to Follow-up|7
3090940|NCT00355121|10599028|P1|Overall Study|Lost to Follow-up|4
3090941|NCT00355121|10599026|P3|Overall Study|Protocol Violation|1
3090942|NCT00355121|10599027|P2|Overall Study|Protocol Violation|9
3090943|NCT00355121|10599028|P1|Overall Study|Protocol Violation|7
3090944|NCT00355121|10599026|P3|Overall Study|Adverse Event|0
3090945|NCT00355121|10599027|P2|Overall Study|Adverse Event|1
3090946|NCT00355121|10599028|P1|Overall Study|Adverse Event|0
3090947|NCT00355121|10599026|P3|Overall Study|Did not receive study vaccine|1
3090948|NCT00355121|10599027|P2|Overall Study|Did not receive study vaccine|0
3090949|NCT00355121|10599028|P1|Overall Study|Did not receive study vaccine|1
3090950|NCT00355082|10599059|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
3090951|NCT00355082|10599060|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
3090952|NCT00355082|10599061|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
3090953|NCT00355082|10599059|P3|Continuation Phase|Scheduling Error|0
3090954|NCT00355082|10599060|P2|Continuation Phase|Scheduling Error|0
3090955|NCT00355082|10599061|P1|Continuation Phase|Scheduling Error|1
3090956|NCT00355082|10599059|P3|Continuation Phase|Site Closed by Sponsor|0
3090957|NCT00355082|10599060|P2|Continuation Phase|Site Closed by Sponsor|0
3090958|NCT00355082|10599061|P1|Continuation Phase|Site Closed by Sponsor|8
3090959|NCT00355082|10599059|P3|Continuation Phase|Lack of Efficacy|0
3090960|NCT00355082|10599060|P2|Continuation Phase|Lack of Efficacy|0
3090961|NCT00355082|10599061|P1|Continuation Phase|Lack of Efficacy|5
3090962|NCT00355082|10599059|P3|Continuation Phase|Withdrawal by Subject|0
3090963|NCT00355082|10599060|P2|Continuation Phase|Withdrawal by Subject|0
3090964|NCT00355082|10599061|P1|Continuation Phase|Withdrawal by Subject|4
3090965|NCT00355082|10599059|P3|Continuation Phase|Protocol Violation|1
3090966|NCT00355082|10599060|P2|Continuation Phase|Protocol Violation|0
3090967|NCT00355082|10599061|P1|Continuation Phase|Protocol Violation|1
3090968|NCT00355082|10599059|P3|Continuation Phase|Lost to Follow-up|1
3090969|NCT00355082|10599060|P2|Continuation Phase|Lost to Follow-up|0
3090970|NCT00355082|10599061|P1|Continuation Phase|Lost to Follow-up|2
3090971|NCT00355082|10599059|P3|Continuation Phase|Adverse Event|1
3090972|NCT00355082|10599060|P2|Continuation Phase|Adverse Event|0
3090973|NCT00355082|10599061|P1|Continuation Phase|Adverse Event|2
3090974|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
3090975|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
3090976|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
3090977|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
3090978|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
3090979|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
3090980|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
3090981|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
3090982|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
3090983|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
3090984|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
3090985|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
3090986|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
3090987|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
3090988|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
3090989|NCT00355082|10599059|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
3090990|NCT00355082|10599060|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
3090991|NCT00355082|10599061|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
3090992|NCT00355030|10599083|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
3090993|NCT00355030|10599084|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
3090994|NCT00355030|10599083|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
3090995|NCT00355030|10599084|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
3090996|NCT00355030|10599083|P2|Study Period 1 Treatment|Other|6
3090997|NCT00355030|10599084|P1|Study Period 1 Treatment|Other|2
3090998|NCT00355030|10599083|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
3090999|NCT00355030|10599084|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
3091000|NCT00355030|10599083|P2|Study Period 1 Treatment|Sponsor Decision|32
3091001|NCT00355030|10599084|P1|Study Period 1 Treatment|Sponsor Decision|34
3091002|NCT00355030|10599083|P2|Study Period 1 Treatment|Physician Decision|1
3091003|NCT00355030|10599084|P1|Study Period 1 Treatment|Physician Decision|0
3091004|NCT00355030|10599083|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
3091005|NCT00355030|10599084|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
3091006|NCT00355030|10599083|P2|Study Period 1 Treatment|Withdrawal by Subject|1
3091007|NCT00355030|10599084|P1|Study Period 1 Treatment|Withdrawal by Subject|4
3091008|NCT00355030|10599083|P2|Study Period 1 Treatment|Lost to Follow-up|0
3091009|NCT00355030|10599084|P1|Study Period 1 Treatment|Lost to Follow-up|3
3091010|NCT00355030|10599083|P2|Study Period 1 Treatment|Adverse Event|1
3091011|NCT00355030|10599084|P1|Study Period 1 Treatment|Adverse Event|1
3091012|NCT00354835|10599123|P2|Overall Study|Refusal of further therapy|8
3091013|NCT00354835|10599124|P1|Overall Study|Refusal of further therapy|3
3091014|NCT00354835|10599123|P2|Overall Study|Adverse Event|0
3091015|NCT00354835|10599124|P1|Overall Study|Adverse Event|6
3091016|NCT00354835|10599123|P2|Overall Study|Disease progression or relapse|22
3091017|NCT00354835|10599124|P1|Overall Study|Disease progression or relapse|15
3091018|NCT00354835|10599123|P2|Overall Study|Ineligible|16
3091019|NCT00354835|10599124|P1|Overall Study|Ineligible|17
3091020|NCT00354835|10599123|P2|Overall Study|Withdrawal by Subject|1
3091021|NCT00354835|10599124|P1|Overall Study|Withdrawal by Subject|2
3091022|NCT00354835|10599123|P2|Overall Study|Physician Decision|13
3091023|NCT00354835|10599124|P1|Overall Study|Physician Decision|8
3091024|NCT00354835|10599123|P2|Overall Study|Death|1
3091025|NCT00354835|10599124|P1|Overall Study|Death|1
3091026|NCT00354744|10599163|P1|Overall Study|Withdrawal by Subject|14
3091027|NCT00354744|10599163|P1|Overall Study|Physician Decision|11
3091028|NCT00354744|10599163|P1|Overall Study|Lost to Follow-up|2
3091029|NCT00354744|10599163|P1|Overall Study|Lack of Efficacy|11
3091030|NCT00354744|10599163|P1|Overall Study|Death|2
3091031|NCT00354744|10599163|P1|Overall Study|Adverse Event|2
3091032|NCT00354679|10599169|P1|Overall Study|Patient Not Treated|1
3091033|NCT00354614|10599178|P1|Overall Study|Lack of Efficacy|28
3091034|NCT00354601|10599182|P1|Overall Study|progression|1
3091035|NCT00354601|10599182|P1|Overall Study|Protocol Violation|1
3091036|NCT00354432|10599202|P4|Overall Study|Off/Toxicity|5
3091037|NCT00354432|10599203|P3|Overall Study|Off/Toxicity|5
3091038|NCT00354432|10599204|P2|Overall Study|Off/Toxicity|7
3091039|NCT00354432|10599205|P1|Overall Study|Off/Toxicity|3
3091040|NCT00354432|10599202|P4|Overall Study|Adverse Event|5
3091041|NCT00354432|10599203|P3|Overall Study|Adverse Event|5
3091042|NCT00354432|10599204|P2|Overall Study|Adverse Event|1
3091043|NCT00354432|10599205|P1|Overall Study|Adverse Event|3
3091044|NCT00354341|10599221|P2|Overall Study|Other|2
3091045|NCT00354341|10599222|P1|Overall Study|Other|1
3091046|NCT00354341|10599221|P2|Overall Study|Failure to return|1
3091047|NCT00354341|10599222|P1|Overall Study|Failure to return|0
3091048|NCT00354341|10599221|P2|Overall Study|Refused treatment|2
3091049|NCT00354341|10599222|P1|Overall Study|Refused treatment|1
3091050|NCT00354341|10599221|P2|Overall Study|Death|2
3091051|NCT00354341|10599222|P1|Overall Study|Death|0
3091052|NCT00354341|10599221|P2|Overall Study|Adverse Event|0
3091053|NCT00354341|10599222|P1|Overall Study|Adverse Event|1
3091054|NCT00354172|10599244|P1|Overall Study|Did not receive transplant|1
3091055|NCT00354159|10599264|P2|Long-term Follow-up|Study Closed|34
3091056|NCT00354159|10599265|P1|Long-term Follow-up|Study Closed|29
3091057|NCT00354159|10599264|P2|Long-term Follow-up|Death|11
3091058|NCT00354159|10599265|P1|Long-term Follow-up|Death|14
3091059|NCT00354159|10599264|P2|Long-term Follow-up|Lost to Follow-up|0
3091060|NCT00354159|10599265|P1|Long-term Follow-up|Lost to Follow-up|1
3091061|NCT00354159|10599264|P2|Long-term Follow-up|Physician Decision|122
3091062|NCT00354159|10599265|P1|Long-term Follow-up|Physician Decision|127
3091063|NCT00354159|10599264|P2|Long-term Follow-up|Withdrawal by Subject|9
3091064|NCT00354159|10599265|P1|Long-term Follow-up|Withdrawal by Subject|9
3091065|NCT00354159|10599264|P2|Randomized Study Period|Death|9
3091066|NCT00354159|10599265|P1|Randomized Study Period|Death|7
3091067|NCT00354159|10599264|P2|Randomized Study Period|Lost to Follow-up|0
3091068|NCT00354159|10599265|P1|Randomized Study Period|Lost to Follow-up|4
3091069|NCT00354159|10599264|P2|Randomized Study Period|Physician Decision|10
3091070|NCT00354159|10599265|P1|Randomized Study Period|Physician Decision|6
3091071|NCT00354159|10599264|P2|Randomized Study Period|Withdrawal by Subject|3
3091072|NCT00354159|10599265|P1|Randomized Study Period|Withdrawal by Subject|5
3091073|NCT00354107|10599308|P1|Overall Study|Withdrawal by Subject|1
3091074|NCT00354107|10599308|P1|Overall Study|Physician Decision|2
3091075|NCT00354107|10599308|P1|Overall Study|Adverse Event|2
3091076|NCT00354029|10599318|P2|Overall Study|Protocol Violation|2
3091077|NCT00354029|10599319|P1|Overall Study|Protocol Violation|4
3091078|NCT00353873|10599331|P2|Overall Study|Withdrawal by Subject|1
3091079|NCT00353873|10599332|P1|Overall Study|Withdrawal by Subject|1
3091080|NCT00353873|10599331|P2|Overall Study|Physician Decision|0
3091081|NCT00353873|10599332|P1|Overall Study|Physician Decision|2
3091082|NCT00353873|10599331|P2|Overall Study|Adverse Event|0
3091083|NCT00353873|10599332|P1|Overall Study|Adverse Event|1
3091084|NCT00353873|10599331|P2|Overall Study|Exacerbation|0
3091085|NCT00353873|10599332|P1|Overall Study|Exacerbation|1
3091086|NCT00353873|10599331|P2|Overall Study|Protocol Violation|2
3091087|NCT00353873|10599332|P1|Overall Study|Protocol Violation|1
3091088|NCT00353704|10599361|P2|Overall Study|Protocol Violation|1
3091089|NCT00353704|10599362|P1|Overall Study|Protocol Violation|3
3091090|NCT00353496|10599432|P2|Overall Study|Not otherwise specified|2
3091091|NCT00353496|10599433|P1|Overall Study|Not otherwise specified|4
3091092|NCT00353496|10599432|P2|Overall Study|Physician Decision|9
3091093|NCT00353496|10599433|P1|Overall Study|Physician Decision|6
3091094|NCT00353496|10599432|P2|Overall Study|Withdrawal by Subject|4
3091095|NCT00353496|10599433|P1|Overall Study|Withdrawal by Subject|3
3091096|NCT00353496|10599432|P2|Overall Study|Protocol Violation|2
3091097|NCT00353496|10599433|P1|Overall Study|Protocol Violation|2
3091098|NCT00353496|10599432|P2|Overall Study|Adverse Event|0
3091099|NCT00353496|10599433|P1|Overall Study|Adverse Event|1
3091100|NCT00353366|10599486|P1|Overall Study|Other|135
3091101|NCT00353366|10599486|P1|Overall Study|Adverse Event|8
3091102|NCT00353262|10599513|P1|Overall Study|Break from Chemotherapy|1
3091103|NCT00353262|10599513|P1|Overall Study|Surgery|4
3091104|NCT00353262|10599513|P1|Overall Study|Progression|1
3091105|NCT00353262|10599513|P1|Overall Study|Insufficient Therapeutic Response|13
3091106|NCT00353262|10599513|P1|Overall Study|Withdrawal by Subject|2
3091107|NCT00353262|10599513|P1|Overall Study|Adverse Event|8
3091108|NCT00352885|10599554|P2|Overall Study|Side effects of IL-2 administration|0
3091109|NCT00352885|10599555|P1|Overall Study|Side effects of IL-2 administration|1
3091110|NCT00352885|10599554|P2|Overall Study|Progression of metastatic melanoma|3
3091111|NCT00352885|10599555|P1|Overall Study|Progression of metastatic melanoma|5
3091112|NCT00352885|10599554|P2|Overall Study|Development of major depression|1
3091113|NCT00352885|10599555|P1|Overall Study|Development of major depression|0
3091114|NCT00352885|10599554|P2|Overall Study|Withdrawal by Subject|3
3091115|NCT00352885|10599555|P1|Overall Study|Withdrawal by Subject|0
3091116|NCT00352846|10599573|P2|Overall Study|Death|1
3091117|NCT00352846|10599574|P1|Overall Study|Death|0
3091118|NCT00352846|10599573|P2|Overall Study|Non-compliance|0
3091119|NCT00352846|10599574|P1|Overall Study|Non-compliance|2
3091120|NCT00352846|10599573|P2|Overall Study|Ineligible|2
3091121|NCT00352846|10599574|P1|Overall Study|Ineligible|3
3091122|NCT00352846|10599573|P2|Overall Study|Withdrawal by Subject|8
3091123|NCT00352846|10599574|P1|Overall Study|Withdrawal by Subject|3
3091124|NCT00352846|10599573|P2|Overall Study|Disease progression|2
3091125|NCT00352846|10599574|P1|Overall Study|Disease progression|0
3091126|NCT00352755|10599589|P1|Overall Study|Adverse Event|1
3091127|NCT00352755|10599589|P1|Overall Study|Physician Decision|1
3091128|NCT00352690|10599599|P2|Overall Study|Determined to be ineligible|0
3091129|NCT00352690|10599600|P1|Overall Study|Determined to be ineligible|2
3091130|NCT00352664|10599620|P2|Overall Study|Withdrawal by Subject|0
3091131|NCT00352664|10599621|P1|Overall Study|Withdrawal by Subject|7
3091132|NCT00352534|10599638|P7|Final Risk Group Assignment|Death|0
3091133|NCT00352534|10599639|P6|Final Risk Group Assignment|Death|2
3091134|NCT00352534|10599640|P5|Final Risk Group Assignment|Death|0
3091135|NCT00352534|10599641|P4|Final Risk Group Assignment|Death|0
3091136|NCT00352534|10599642|P3|Final Risk Group Assignment|Death|0
3091137|NCT00352534|10599643|P2|Final Risk Group Assignment|Death|0
3091138|NCT00352534|10599644|P1|Final Risk Group Assignment|Death|0
3091139|NCT00352534|10599638|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
3091140|NCT00352534|10599639|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091141|NCT00352534|10599640|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091142|NCT00352534|10599641|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091143|NCT00352534|10599642|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091144|NCT00352534|10599643|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091145|NCT00352534|10599644|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
3091146|NCT00352534|10599638|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
3091147|NCT00352534|10599639|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
3091148|NCT00352534|10599640|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
3091149|NCT00352534|10599641|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
3091150|NCT00352534|10599642|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
3091151|NCT00352534|10599643|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
3091152|NCT00352534|10599644|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
3091153|NCT00352534|10599638|P7|Final Risk Group Assignment|Ineligible|0
3091154|NCT00352534|10599639|P6|Final Risk Group Assignment|Ineligible|13
3091155|NCT00352534|10599640|P5|Final Risk Group Assignment|Ineligible|0
3091156|NCT00352534|10599641|P4|Final Risk Group Assignment|Ineligible|1
3091157|NCT00352534|10599642|P3|Final Risk Group Assignment|Ineligible|3
3091158|NCT00352534|10599643|P2|Final Risk Group Assignment|Ineligible|0
3091159|NCT00352534|10599644|P1|Final Risk Group Assignment|Ineligible|0
3091160|NCT00352534|10599638|P7|Final Risk Group Assignment|Withdrawal by Subject|0
3091161|NCT00352534|10599639|P6|Final Risk Group Assignment|Withdrawal by Subject|3
3091162|NCT00352534|10599640|P5|Final Risk Group Assignment|Withdrawal by Subject|0
3091163|NCT00352534|10599641|P4|Final Risk Group Assignment|Withdrawal by Subject|0
3091164|NCT00352534|10599642|P3|Final Risk Group Assignment|Withdrawal by Subject|0
3091165|NCT00352534|10599643|P2|Final Risk Group Assignment|Withdrawal by Subject|0
3091166|NCT00352534|10599644|P1|Final Risk Group Assignment|Withdrawal by Subject|0
3091167|NCT00352534|10599638|P7|Final Risk Group Assignment|Physician Decision|0
3091168|NCT00352534|10599639|P6|Final Risk Group Assignment|Physician Decision|8
3091169|NCT00352534|10599640|P5|Final Risk Group Assignment|Physician Decision|0
3091170|NCT00352534|10599641|P4|Final Risk Group Assignment|Physician Decision|0
3091171|NCT00352534|10599642|P3|Final Risk Group Assignment|Physician Decision|0
3091172|NCT00352534|10599643|P2|Final Risk Group Assignment|Physician Decision|0
3091173|NCT00352534|10599644|P1|Final Risk Group Assignment|Physician Decision|0
3091174|NCT00352534|10599638|P7|Final Risk Group Assignment|Lack of Efficacy|0
3091175|NCT00352534|10599639|P6|Final Risk Group Assignment|Lack of Efficacy|19
3091176|NCT00352534|10599640|P5|Final Risk Group Assignment|Lack of Efficacy|1
3091177|NCT00352534|10599641|P4|Final Risk Group Assignment|Lack of Efficacy|2
3091178|NCT00352534|10599642|P3|Final Risk Group Assignment|Lack of Efficacy|0
3091179|NCT00352534|10599643|P2|Final Risk Group Assignment|Lack of Efficacy|0
3091180|NCT00352534|10599644|P1|Final Risk Group Assignment|Lack of Efficacy|0
3091181|NCT00352534|10599638|P7|Initial Staging|Ineligible|0
3091182|NCT00352534|10599639|P6|Initial Staging|Ineligible|0
3091183|NCT00352534|10599640|P5|Initial Staging|Ineligible|0
3091184|NCT00352534|10599641|P4|Initial Staging|Ineligible|0
3091185|NCT00352534|10599642|P3|Initial Staging|Ineligible|0
3091186|NCT00352534|10599643|P2|Initial Staging|Ineligible|9
3091187|NCT00352534|10599644|P1|Initial Staging|Ineligible|8
3091188|NCT00352417|10599661|P2|Overall Study|Schedule Change|1
3091189|NCT00352417|10599662|P1|Overall Study|Schedule Change|2
3091190|NCT00352417|10599661|P2|Overall Study|Lost to Follow-up|0
3091191|NCT00352417|10599662|P1|Overall Study|Lost to Follow-up|1
3091192|NCT00352417|10599661|P2|Overall Study|Withdrawal by Subject|2
3091193|NCT00352417|10599662|P1|Overall Study|Withdrawal by Subject|1
3091194|NCT00352417|10599661|P2|Overall Study|Protocol Violation|2
3091195|NCT00352417|10599662|P1|Overall Study|Protocol Violation|0
3091196|NCT00352417|10599661|P2|Overall Study|Adverse Event|0
3091197|NCT00352417|10599662|P1|Overall Study|Adverse Event|1
3091198|NCT00352365|10599676|P1|Maintenance Therapy|Not eligible|4
3091199|NCT00352365|10599676|P1|Maintenance Therapy|Not protocol specified|3
3091200|NCT00352365|10599676|P1|Maintenance Therapy|Death|2
3091201|NCT00352365|10599676|P1|Maintenance Therapy|Progression/Relapse|3
3091202|NCT00352365|10599676|P1|Induction Therapy|Death before starting protocol therapy|1
3091203|NCT00352365|10599676|P1|Induction Therapy|Not eligible|3
3091204|NCT00352365|10599676|P1|Induction Therapy|Not protocol specified|1
3091205|NCT00352365|10599676|P1|Induction Therapy|Death|7
3091206|NCT00352365|10599676|P1|Induction Therapy|Progression/Relapse|8
3091207|NCT00352365|10599676|P1|Induction Therapy|Adverse Event|7
3091208|NCT00352118|10599686|P1|Overall Study|Physician Decision|4
3091209|NCT00352105|10599696|P1|Overall Study|Protocol Violation|2
3091210|NCT00352105|10599696|P1|Overall Study|Adverse Event|19
3091211|NCT00352105|10599696|P1|Overall Study|Lack of Efficacy|9
3091212|NCT00352105|10599696|P1|Overall Study|Withdrawal by Subject|5
3091213|NCT00352105|10599696|P1|Overall Study|Death|5
3091214|NCT00352053|10599707|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
3091215|NCT00352053|10599708|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
3091216|NCT00352053|10599707|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
3091217|NCT00352053|10599708|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
3091218|NCT00352053|10599707|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
3091219|NCT00352053|10599708|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
3091220|NCT00352053|10599707|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
3091221|NCT00352053|10599708|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
3091222|NCT00352053|10599707|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
3091223|NCT00352053|10599708|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
3091224|NCT00352053|10599707|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
3091225|NCT00352053|10599708|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
3091226|NCT00352053|10599707|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
3091227|NCT00352053|10599708|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
3091228|NCT00352053|10599707|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
3091229|NCT00352053|10599708|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
3091230|NCT00352053|10599707|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
3091231|NCT00352053|10599708|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
3091232|NCT00352053|10599707|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
3091233|NCT00352053|10599708|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
3091234|NCT00352053|10599707|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
3091235|NCT00352053|10599708|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
3091236|NCT00352053|10599707|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
3091237|NCT00352053|10599708|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
3091238|NCT00352053|10599707|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
3091239|NCT00352053|10599708|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
3091240|NCT00352027|10599875|P1|Overall Study|Progressive disease|3
3091241|NCT00351819|10600174|P2|Overall Study|Enrolled in another trial|1
3091242|NCT00351819|10600175|P1|Overall Study|Enrolled in another trial|0
3091243|NCT00351819|10600174|P2|Overall Study|Incarcerated|1
3091244|NCT00351819|10600175|P1|Overall Study|Incarcerated|0
3091245|NCT00351819|10600174|P2|Overall Study|Non-compliance|1
3091246|NCT00351819|10600175|P1|Overall Study|Non-compliance|0
3091247|NCT00351819|10600174|P2|Overall Study|Unprofessional behavior|0
3091248|NCT00351819|10600175|P1|Overall Study|Unprofessional behavior|1
3091249|NCT00351819|10600174|P2|Overall Study|Traumatic ankle fracture|0
3091250|NCT00351819|10600175|P1|Overall Study|Traumatic ankle fracture|1
3091251|NCT00351819|10600174|P2|Overall Study|Elevated PSA|1
3091252|NCT00351819|10600175|P1|Overall Study|Elevated PSA|1
3091253|NCT00351819|10600174|P2|Overall Study|Withdrawal by Subject|4
3091254|NCT00351819|10600175|P1|Overall Study|Withdrawal by Subject|0
3091255|NCT00351819|10600174|P2|Overall Study|Lost to Follow-up|4
3091256|NCT00351819|10600175|P1|Overall Study|Lost to Follow-up|4
3091257|NCT00351533|10600246|P2|Overall Study|Withdrawal by Subject|1
3091258|NCT00351533|10600247|P1|Overall Study|Withdrawal by Subject|0
3091259|NCT00351533|10600246|P2|Overall Study|Physician Decision|1
3091260|NCT00351533|10600247|P1|Overall Study|Physician Decision|0
3091261|NCT00351533|10600246|P2|Overall Study|Lost to Follow-up|3
3091262|NCT00351533|10600247|P1|Overall Study|Lost to Follow-up|1
3091263|NCT00351533|10600246|P2|Overall Study|Extubated before first BAL|0
3091264|NCT00351533|10600247|P1|Overall Study|Extubated before first BAL|1
3091265|NCT00351468|10600307|P1|Overall Study|Protocol Violation|3
3091266|NCT00351468|10600307|P1|Overall Study|Lost to Follow-up|4
3091267|NCT00351468|10600307|P1|Overall Study|Non-compliance|8
3091268|NCT00351468|10600307|P1|Overall Study|Lack of Efficacy|32
3091269|NCT00351468|10600307|P1|Overall Study|Various -follow up w clinical team|39
3091270|NCT00351468|10600307|P1|Overall Study|Withdrawal by Subject|39
3091271|NCT00351468|10600307|P1|Overall Study|Adverse Event|42
3091272|NCT00351377|10600331|P1|Overall Study|Unsatisfactory therapeutic effect|1
3091273|NCT00351377|10600331|P1|Overall Study|Death|1
3091274|NCT00351377|10600331|P1|Overall Study|Adverse Event|5
3091275|NCT00351351|10600345|P2|Overall Study|surgical access pbs; device issues|4
3091276|NCT00351351|10600346|P1|Overall Study|surgical access pbs; device issues|9
3091277|NCT00351273|10600372|P3|Overall Study|Lost to Follow-up|5
3091278|NCT00351273|10600373|P2|Overall Study|Lost to Follow-up|2
3091279|NCT00351273|10600374|P1|Overall Study|Lost to Follow-up|1
3091280|NCT00350870|10600417|P4|Overall Study|Physician Decision|1
3091281|NCT00350870|10600418|P3|Overall Study|Physician Decision|1
3091282|NCT00350870|10600419|P2|Overall Study|Physician Decision|0
3091283|NCT00350870|10600420|P1|Overall Study|Physician Decision|1
3091284|NCT00350870|10600417|P4|Overall Study|Withdrawal by Subject|14
3091285|NCT00350870|10600418|P3|Overall Study|Withdrawal by Subject|15
3091286|NCT00350870|10600419|P2|Overall Study|Withdrawal by Subject|17
3091287|NCT00350870|10600420|P1|Overall Study|Withdrawal by Subject|21
3091288|NCT00350844|10600434|P1|Overall Study|Lost to Follow-up|1
3091289|NCT00350792|10600438|P1|Overall Study|Lack of Efficacy|11
3091290|NCT00350792|10600438|P1|Overall Study|Physician Decision|2
3091291|NCT00350792|10600438|P1|Overall Study|Withdrawal by Subject|4
3091292|NCT00350792|10600438|P1|Overall Study|Protocol Violation|1
3091293|NCT00350792|10600438|P1|Overall Study|Death Not Study Drug Related|2
3091294|NCT00350792|10600438|P1|Overall Study|Death from Study Drug Toxicity|1
3091295|NCT00350792|10600438|P1|Overall Study|Death from Study Disease|1
3091296|NCT00350792|10600438|P1|Overall Study|Adverse Event|11
3091297|NCT00350779|10600448|P2|Overall Study|Non-compliance with study procedures|1
3091298|NCT00350779|10600449|P1|Overall Study|Non-compliance with study procedures|0
3091299|NCT00350779|10600448|P2|Overall Study|Patient Moved|1
3091300|NCT00350779|10600449|P1|Overall Study|Patient Moved|2
3091301|NCT00350779|10600448|P2|Overall Study|Withdrawal by Subject|8
3091302|NCT00350779|10600449|P1|Overall Study|Withdrawal by Subject|9
3091303|NCT00350779|10600448|P2|Overall Study|Protocol Violation|1
3091304|NCT00350779|10600449|P1|Overall Study|Protocol Violation|3
3091305|NCT00350779|10600448|P2|Overall Study|Physician Decision|4
3091306|NCT00350779|10600449|P1|Overall Study|Physician Decision|2
3091307|NCT00350779|10600448|P2|Overall Study|Lost to Follow-up|0
3091308|NCT00350779|10600449|P1|Overall Study|Lost to Follow-up|2
3091309|NCT00350779|10600448|P2|Overall Study|Lack of Efficacy|4
3091310|NCT00350779|10600449|P1|Overall Study|Lack of Efficacy|0
3091311|NCT00350779|10600448|P2|Overall Study|Adverse Event|2
3091312|NCT00350779|10600449|P1|Overall Study|Adverse Event|4
3091313|NCT00350727|10600470|P3|Phase II|Enrolled in Rollover Study|1
3091314|NCT00350727|10600471|P2|Phase II|Enrolled in Rollover Study|0
3091315|NCT00350727|10600472|P1|Phase II|Enrolled in Rollover Study|0
3091316|NCT00350727|10600470|P3|Phase II|Sponsor Terminated Study|1
3091317|NCT00350727|10600471|P2|Phase II|Sponsor Terminated Study|0
3091318|NCT00350727|10600472|P1|Phase II|Sponsor Terminated Study|0
3091319|NCT00350727|10600470|P3|Phase II|Death|2
3091320|NCT00350727|10600471|P2|Phase II|Death|0
3091321|NCT00350727|10600472|P1|Phase II|Death|0
3091322|NCT00350727|10600470|P3|Phase II|Adverse Event|1
3091323|NCT00350727|10600471|P2|Phase II|Adverse Event|1
3091324|NCT00350727|10600472|P1|Phase II|Adverse Event|0
3091325|NCT00350727|10600470|P3|Phase II|Withdrawal by Subject|1
3091326|NCT00350727|10600471|P2|Phase II|Withdrawal by Subject|2
3091327|NCT00350727|10600472|P1|Phase II|Withdrawal by Subject|0
3091328|NCT00350727|10600470|P3|Phase II|Clinical Deterioration|0
3091329|NCT00350727|10600471|P2|Phase II|Clinical Deterioration|1
3091330|NCT00350727|10600472|P1|Phase II|Clinical Deterioration|0
3091331|NCT00350727|10600470|P3|Phase II|Disease Progression|16
3091332|NCT00350727|10600471|P2|Phase II|Disease Progression|15
3091333|NCT00350727|10600472|P1|Phase II|Disease Progression|0
3091334|NCT00350727|10600470|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
3091335|NCT00350727|10600471|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
3091336|NCT00350727|10600472|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
3091337|NCT00350727|10600470|P3|Phase I: Dose Escalation|Physician Decision|0
3091338|NCT00350727|10600471|P2|Phase I: Dose Escalation|Physician Decision|0
3091339|NCT00350727|10600472|P1|Phase I: Dose Escalation|Physician Decision|1
3091340|NCT00350727|10600470|P3|Phase I: Dose Escalation|Death|0
3091341|NCT00350727|10600471|P2|Phase I: Dose Escalation|Death|0
3091342|NCT00350727|10600472|P1|Phase I: Dose Escalation|Death|1
3091343|NCT00350727|10600470|P3|Phase I: Dose Escalation|Lack of Efficacy|0
3091344|NCT00350727|10600471|P2|Phase I: Dose Escalation|Lack of Efficacy|0
3091345|NCT00350727|10600472|P1|Phase I: Dose Escalation|Lack of Efficacy|25
3091346|NCT00350727|10600470|P3|Phase I: Dose Escalation|Adverse Event|0
3091347|NCT00350727|10600471|P2|Phase I: Dose Escalation|Adverse Event|0
3091348|NCT00350727|10600472|P1|Phase I: Dose Escalation|Adverse Event|4
3091349|NCT00350636|10600616|P2|Overall Study|Other|2
3091350|NCT00350636|10600617|P1|Overall Study|Other|1
3091351|NCT00350636|10600616|P2|Overall Study|Physician Decision|2
3091352|NCT00350636|10600617|P1|Overall Study|Physician Decision|0
3091353|NCT00350636|10600616|P2|Overall Study|Lost to Follow-up|8
3091354|NCT00350636|10600617|P1|Overall Study|Lost to Follow-up|9
3091355|NCT00350636|10600616|P2|Overall Study|Withdrawal by Subject|17
3091356|NCT00350636|10600617|P1|Overall Study|Withdrawal by Subject|13
3091357|NCT00350636|10600616|P2|Overall Study|Protocol Violation|3
3091358|NCT00350636|10600617|P1|Overall Study|Protocol Violation|1
3091359|NCT00350636|10600616|P2|Overall Study|Adverse Event|13
3091360|NCT00350636|10600617|P1|Overall Study|Adverse Event|19
3091361|NCT00350623|10600636|P3|Overall Study|patient traveling outside the country|1
3091362|NCT00350623|10600637|P2|Overall Study|patient traveling outside the country|0
3091363|NCT00350623|10600638|P1|Overall Study|patient traveling outside the country|0
3091364|NCT00350623|10600636|P3|Overall Study|Withdrawal by Subject|1
3091365|NCT00350623|10600637|P2|Overall Study|Withdrawal by Subject|1
3091366|NCT00350623|10600638|P1|Overall Study|Withdrawal by Subject|0
3091367|NCT00350623|10600636|P3|Overall Study|Lost to Follow-up|4
3091368|NCT00350623|10600637|P2|Overall Study|Lost to Follow-up|3
3091369|NCT00350623|10600638|P1|Overall Study|Lost to Follow-up|8
3091370|NCT00350545|10600646|P1|Overall Study|Withdrawal by Subject|2
3091371|NCT00350519|10600665|P2|Overall Study|Withdrawal by Subject|2
3091372|NCT00350519|10600666|P1|Overall Study|Withdrawal by Subject|3
3091373|NCT00350519|10600665|P2|Overall Study|Protocol Violation|2
3091374|NCT00350519|10600666|P1|Overall Study|Protocol Violation|1
3091375|NCT00350519|10600665|P2|Overall Study|Physician Decision|1
3091376|NCT00350519|10600666|P1|Overall Study|Physician Decision|0
3091377|NCT00350519|10600665|P2|Overall Study|Death|1
3091378|NCT00350519|10600666|P1|Overall Study|Death|0
3091379|NCT00350402|10600680|P2|Overall Study|Lost to Follow-up|1
3091380|NCT00350402|10600681|P1|Overall Study|Lost to Follow-up|1
3091381|NCT00350272|10600754|P2|Open-Label 84 Week Treatment|Sponsor decision|1
3091382|NCT00350272|10600755|P1|Open-Label 84 Week Treatment|Sponsor decision|2
3091383|NCT00350272|10600754|P2|Open-Label 84 Week Treatment|Physician Decision|2
3091384|NCT00350272|10600755|P1|Open-Label 84 Week Treatment|Physician Decision|1
3091385|NCT00350272|10600754|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
3091386|NCT00350272|10600755|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
3091387|NCT00350272|10600754|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
3091388|NCT00350272|10600755|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
3091389|NCT00350272|10600754|P2|Open-Label 84 Week Treatment|Adverse Event|1
3091390|NCT00350272|10600755|P1|Open-Label 84 Week Treatment|Adverse Event|2
3091391|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Sponsor decision|1
3091392|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Sponsor decision|0
3091393|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Physician Decision|1
3091394|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Physician Decision|2
3091395|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
3091396|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
3091397|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
3091398|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
3091399|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Death|0
3091400|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Death|1
3091401|NCT00350272|10600754|P2|Blinded 12 Week Treatment|Adverse Event|0
3091402|NCT00350272|10600755|P1|Blinded 12 Week Treatment|Adverse Event|1
3091403|NCT00350207|10600777|P3|Overall Study|Other|1
3091404|NCT00350207|10600778|P2|Overall Study|Other|3
3091405|NCT00350207|10600779|P1|Overall Study|Other|1
3091406|NCT00350207|10600777|P3|Overall Study|Withdrawal by Subject|1
3091407|NCT00350207|10600778|P2|Overall Study|Withdrawal by Subject|1
3091408|NCT00350207|10600779|P1|Overall Study|Withdrawal by Subject|0
3091409|NCT00350207|10600777|P3|Overall Study|Lost to Follow-up|1
3091410|NCT00350207|10600778|P2|Overall Study|Lost to Follow-up|0
3091411|NCT00350207|10600779|P1|Overall Study|Lost to Follow-up|1
3091412|NCT00350207|10600777|P3|Overall Study|Lack of Efficacy|2
3091413|NCT00350207|10600778|P2|Overall Study|Lack of Efficacy|0
3091414|NCT00350207|10600779|P1|Overall Study|Lack of Efficacy|1
3091415|NCT00350207|10600777|P3|Overall Study|Adverse Event|2
3091416|NCT00350207|10600778|P2|Overall Study|Adverse Event|2
3091417|NCT00350207|10600779|P1|Overall Study|Adverse Event|5
3091418|NCT00349973|10600991|P2|Overall Study|Withdrawal by Subject|0
3091419|NCT00349973|10600992|P1|Overall Study|Withdrawal by Subject|1
3091420|NCT00349973|10600991|P2|Overall Study|Adverse Event|3
3091421|NCT00349973|10600992|P1|Overall Study|Adverse Event|3
3091422|NCT00349921|10601006|P4|First Spinal Injection|Adverse Event|0
3091423|NCT00349921|10601007|P3|First Spinal Injection|Adverse Event|1
3091424|NCT00349921|10601008|P2|First Spinal Injection|Adverse Event|0
3091425|NCT00349921|10601009|P1|First Spinal Injection|Adverse Event|0
3091426|NCT00349921|10601006|P4|First Spinal Injection|Physician Decision|0
3091427|NCT00349921|10601007|P3|First Spinal Injection|Physician Decision|0
3091428|NCT00349921|10601008|P2|First Spinal Injection|Physician Decision|0
3091429|NCT00349921|10601009|P1|First Spinal Injection|Physician Decision|1
3091430|NCT00349908|10601020|P2|Overall Study|Withdrawal by Subject|4
3091431|NCT00349908|10601021|P1|Overall Study|Withdrawal by Subject|0
3091432|NCT00349752|10601047|P2|Overall Study|Other:History of squamous cell carcinoma|0
3091433|NCT00349752|10601048|P1|Overall Study|Other:History of squamous cell carcinoma|1
3091434|NCT00349752|10601047|P2|Overall Study|Other: Inadvertently unblinded|0
3091435|NCT00349752|10601048|P1|Overall Study|Other: Inadvertently unblinded|1
3091436|NCT00349752|10601047|P2|Overall Study|Other: Ineligible|0
3091437|NCT00349752|10601048|P1|Overall Study|Other: Ineligible|1
3091438|NCT00349752|10601047|P2|Overall Study|Other: Patient's steroid use|0
3091439|NCT00349752|10601048|P1|Overall Study|Other: Patient's steroid use|1
3091440|NCT00349752|10601047|P2|Overall Study|Other: Patient stopped steroids|1
3091441|NCT00349752|10601048|P1|Overall Study|Other: Patient stopped steroids|0
3091442|NCT00349752|10601047|P2|Overall Study|Other: Non compliance|1
3091443|NCT00349752|10601048|P1|Overall Study|Other: Non compliance|0
3091444|NCT00349752|10601047|P2|Overall Study|Other: Required exclusionary medication|1
3091445|NCT00349752|10601048|P1|Overall Study|Other: Required exclusionary medication|0
3091446|NCT00349752|10601047|P2|Overall Study|Personal reasons|5
3091447|NCT00349752|10601048|P1|Overall Study|Personal reasons|6
3091448|NCT00349752|10601047|P2|Overall Study|Lost to Follow-up|2
3091449|NCT00349752|10601048|P1|Overall Study|Lost to Follow-up|4
3091450|NCT00349752|10601047|P2|Overall Study|Lack of Efficacy|42
3091451|NCT00349752|10601048|P1|Overall Study|Lack of Efficacy|37
3091452|NCT00349752|10601047|P2|Overall Study|Adverse Event|12
3091453|NCT00349752|10601048|P1|Overall Study|Adverse Event|8
3091454|NCT00349622|10601101|P2|Overall Study|Withdrawal by Subject|9
3091455|NCT00349622|10601102|P1|Overall Study|Withdrawal by Subject|5
3091456|NCT00349622|10601101|P2|Overall Study|Lost to Follow-up|1
3091457|NCT00349622|10601102|P1|Overall Study|Lost to Follow-up|5
3091458|NCT00349622|10601101|P2|Overall Study|Death|86
3091459|NCT00349622|10601102|P1|Overall Study|Death|168
3091460|NCT00349349|10601141|P3|Overall Study|New Malignancy (Bladder Cancer)|0
3091461|NCT00349349|10601142|P2|Overall Study|New Malignancy (Bladder Cancer)|1
3091462|NCT00349349|10601143|P1|Overall Study|New Malignancy (Bladder Cancer)|0
3091463|NCT00349349|10601141|P3|Overall Study|No Response|0
3091464|NCT00349349|10601142|P2|Overall Study|No Response|3
3091465|NCT00349349|10601143|P1|Overall Study|No Response|0
3091466|NCT00349349|10601141|P3|Overall Study|Physician Decision|1
3091467|NCT00349349|10601142|P2|Overall Study|Physician Decision|2
3091468|NCT00349349|10601143|P1|Overall Study|Physician Decision|1
3091469|NCT00349349|10601141|P3|Overall Study|Participant Reduced General Condition|0
3091470|NCT00349349|10601142|P2|Overall Study|Participant Reduced General Condition|1
3091471|NCT00349349|10601143|P1|Overall Study|Participant Reduced General Condition|0
3091472|NCT00349349|10601141|P3|Overall Study|Other Treatment Selected|0
3091473|NCT00349349|10601142|P2|Overall Study|Other Treatment Selected|0
3091474|NCT00349349|10601143|P1|Overall Study|Other Treatment Selected|2
3091475|NCT00349349|10601141|P3|Overall Study|Death|1
3091476|NCT00349349|10601142|P2|Overall Study|Death|10
3091477|NCT00349349|10601143|P1|Overall Study|Death|13
3091478|NCT00349349|10601141|P3|Overall Study|Withdrawn due to Disease Progression|1
3091479|NCT00349349|10601142|P2|Overall Study|Withdrawn due to Disease Progression|37
3091480|NCT00349349|10601143|P1|Overall Study|Withdrawn due to Disease Progression|27
3091481|NCT00349349|10601141|P3|Overall Study|Withdrawal by Subject|1
3091482|NCT00349349|10601142|P2|Overall Study|Withdrawal by Subject|2
3091483|NCT00349349|10601143|P1|Overall Study|Withdrawal by Subject|5
3091484|NCT00349349|10601141|P3|Overall Study|Adverse Event|2
3091485|NCT00349349|10601142|P2|Overall Study|Adverse Event|6
3091486|NCT00349349|10601143|P1|Overall Study|Adverse Event|5
3091487|NCT00348933|10601232|P1|Overall Study|Adverse Event|7
3091488|NCT00348933|10601232|P1|Overall Study|Protocol Violation|2
3091489|NCT00348933|10601232|P1|Overall Study|Lost to Follow-up|6
3091490|NCT00348933|10601232|P1|Overall Study|Withdrawal by Subject|10
3091491|NCT00348881|10601240|P2|Overall Study|Serious Adverse Event|2
3091492|NCT00348881|10601241|P1|Overall Study|Serious Adverse Event|0
3091493|NCT00348881|10601240|P2|Overall Study|Adverse Event|0
3091494|NCT00348881|10601241|P1|Overall Study|Adverse Event|2
3091495|NCT00348881|10601240|P2|Overall Study|Withdrawal by Subject|4
3091496|NCT00348881|10601241|P1|Overall Study|Withdrawal by Subject|3
3091497|NCT00348881|10601240|P2|Overall Study|Lost to Follow-up|6
3091498|NCT00348881|10601241|P1|Overall Study|Lost to Follow-up|12
3091499|NCT00348816|10601253|P1|Overall Study|Noncompliance with radiation treatment|1
3091500|NCT00348790|10601260|P1|Completed Treatment|Unable to travel to study site|1
3091501|NCT00348790|10601260|P1|Completed Treatment|Required surgery|2
3091502|NCT00348790|10601260|P1|Completed Treatment|Adverse Event|4
3091503|NCT00348790|10601260|P1|Completed Treatment|Disease progression|14
3091504|NCT00348790|10601260|P1|Completed Treatment|Withdrawal by Subject|4
3091505|NCT00348686|10601272|P1|Overall Study|Multiple Reasons|8
3091506|NCT00348686|10601272|P1|Overall Study|Lost to Follow-up|2
3091507|NCT00348686|10601272|P1|Overall Study|Protocol Violation|6
3091508|NCT00348686|10601272|P1|Overall Study|Adverse Event|5
3091509|NCT00348686|10601272|P1|Overall Study|Withdrawal by Subject|45
3091510|NCT00348673|10601289|P9|Stage 1|Randomized but not Treated|0
3091511|NCT00348673|10601290|P8|Stage 1|Randomized but not Treated|0
3091512|NCT00348673|10601291|P7|Stage 1|Randomized but not Treated|0
3091513|NCT00348673|10601292|P6|Stage 1|Randomized but not Treated|0
3091514|NCT00348673|10601293|P5|Stage 1|Randomized but not Treated|0
3091515|NCT00348673|10601294|P4|Stage 1|Randomized but not Treated|0
3091516|NCT00348673|10601295|P3|Stage 1|Randomized but not Treated|1
3091517|NCT00348673|10601296|P2|Stage 1|Randomized but not Treated|0
3091518|NCT00348673|10601297|P1|Stage 1|Randomized but not Treated|0
3091519|NCT00348595|10601346|P2|Overall Study|Adverse Event|8
3091520|NCT00348595|10601347|P1|Overall Study|Adverse Event|5
3091521|NCT00348556|10601359|P1|Overall Study|Adverse Event|1
3091522|NCT00348374|10601366|P2|Overall Study|randomized but did not receive treatment|7
3091523|NCT00348374|10601367|P1|Overall Study|randomized but did not receive treatment|0
3091524|NCT00348374|10601366|P2|Overall Study|ongoing at date of cutoff|1
3091525|NCT00348374|10601367|P1|Overall Study|ongoing at date of cutoff|1
3091526|NCT00348374|10601366|P2|Overall Study|Other|12
3091527|NCT00348374|10601367|P1|Overall Study|Other|11
3091528|NCT00348374|10601366|P2|Overall Study|Withdrawal by Subject|5
3091529|NCT00348374|10601367|P1|Overall Study|Withdrawal by Subject|5
3091530|NCT00348374|10601366|P2|Overall Study|Lost to Follow-up|3
3091531|NCT00348374|10601367|P1|Overall Study|Lost to Follow-up|1
3091532|NCT00348374|10601366|P2|Overall Study|Adverse Event|4
3091533|NCT00348374|10601367|P1|Overall Study|Adverse Event|1
3091534|NCT00348348|10601414|P2|Overall Study|Adverse event probably related to study|0
3091535|NCT00348348|10601415|P1|Overall Study|Adverse event probably related to study|1
3091536|NCT00348348|10601414|P2|Overall Study|Worsening of BC - Unlikely related|2
3091537|NCT00348348|10601415|P1|Overall Study|Worsening of BC - Unlikely related|1
3091538|NCT00348348|10601414|P2|Overall Study|Worsening of BC - Unrelated to study|3
3091539|NCT00348348|10601415|P1|Overall Study|Worsening of BC - Unrelated to study|0
3091540|NCT00348348|10601414|P2|Overall Study|Dissallowed Meds - possibly releated|1
3091541|NCT00348348|10601415|P1|Overall Study|Dissallowed Meds - possibly releated|1
3091542|NCT00348348|10601414|P2|Overall Study|Dissallowed Meds - unlikley related|1
3091543|NCT00348348|10601415|P1|Overall Study|Dissallowed Meds - unlikley related|1
3091544|NCT00348348|10601414|P2|Overall Study|Dissallowed Meds - unrelated to study|3
3091545|NCT00348348|10601415|P1|Overall Study|Dissallowed Meds - unrelated to study|1
3091546|NCT00348348|10601414|P2|Overall Study|Other|4
3091547|NCT00348348|10601415|P1|Overall Study|Other|7
3091548|NCT00348348|10601414|P2|Overall Study|Withdrawal by Subject|1
3091549|NCT00348348|10601415|P1|Overall Study|Withdrawal by Subject|4
3091550|NCT00348348|10601414|P2|Overall Study|Lost to Follow-up|10
3091551|NCT00348348|10601415|P1|Overall Study|Lost to Follow-up|8
3091552|NCT00348348|10601414|P2|Overall Study|Lack of Efficacy|1
3091553|NCT00348348|10601415|P1|Overall Study|Lack of Efficacy|1
3091554|NCT00348348|10601414|P2|Overall Study|Adverse event - unrelated to study drug|1
3091555|NCT00348348|10601415|P1|Overall Study|Adverse event - unrelated to study drug|0
3091556|NCT00348309|10601430|P3|Overall Study|HCV career|1
3091557|NCT00348309|10601431|P2|Overall Study|HCV career|0
3091558|NCT00348309|10601432|P1|Overall Study|HCV career|0
3091559|NCT00348309|10601430|P3|Overall Study|Cardiologist recommendations|1
3091560|NCT00348309|10601431|P2|Overall Study|Cardiologist recommendations|0
3091561|NCT00348309|10601432|P1|Overall Study|Cardiologist recommendations|0
3091562|NCT00348309|10601430|P3|Overall Study|ECG abnormal|2
3091563|NCT00348309|10601431|P2|Overall Study|ECG abnormal|0
3091564|NCT00348309|10601432|P1|Overall Study|ECG abnormal|0
3091565|NCT00348309|10601430|P3|Overall Study|Adverse event not attended|1
3091566|NCT00348309|10601431|P2|Overall Study|Adverse event not attended|0
3091567|NCT00348309|10601432|P1|Overall Study|Adverse event not attended|0
3091568|NCT00348309|10601430|P3|Overall Study|Site closure|1
3091569|NCT00348309|10601431|P2|Overall Study|Site closure|0
3091570|NCT00348309|10601432|P1|Overall Study|Site closure|0
3091571|NCT00348309|10601430|P3|Overall Study|Increased dose of Aricept|1
3091572|NCT00348309|10601431|P2|Overall Study|Increased dose of Aricept|0
3091573|NCT00348309|10601432|P1|Overall Study|Increased dose of Aricept|0
3091574|NCT00348309|10601430|P3|Overall Study|Medical Monitor decision|1
3091575|NCT00348309|10601431|P2|Overall Study|Medical Monitor decision|0
3091576|NCT00348309|10601432|P1|Overall Study|Medical Monitor decision|0
3091577|NCT00348309|10601430|P3|Overall Study|Forgot often medication|0
3091578|NCT00348309|10601431|P2|Overall Study|Forgot often medication|1
3091579|NCT00348309|10601432|P1|Overall Study|Forgot often medication|0
3091580|NCT00348309|10601430|P3|Overall Study|Sponsor refuseal|1
3091581|NCT00348309|10601431|P2|Overall Study|Sponsor refuseal|1
3091582|NCT00348309|10601432|P1|Overall Study|Sponsor refuseal|0
3091583|NCT00348309|10601430|P3|Overall Study|Participant was hospitalized|0
3091584|NCT00348309|10601431|P2|Overall Study|Participant was hospitalized|1
3091585|NCT00348309|10601432|P1|Overall Study|Participant was hospitalized|0
3091586|NCT00348309|10601430|P3|Overall Study|A foul of exclusion criteria|0
3091587|NCT00348309|10601431|P2|Overall Study|A foul of exclusion criteria|1
3091588|NCT00348309|10601432|P1|Overall Study|A foul of exclusion criteria|0
3091589|NCT00348309|10601430|P3|Overall Study|Ineffectiveness of treatment|0
3091590|NCT00348309|10601431|P2|Overall Study|Ineffectiveness of treatment|1
3091591|NCT00348309|10601432|P1|Overall Study|Ineffectiveness of treatment|0
3091592|NCT00348309|10601430|P3|Overall Study|Decision of sponsor|0
3091593|NCT00348309|10601431|P2|Overall Study|Decision of sponsor|0
3091594|NCT00348309|10601432|P1|Overall Study|Decision of sponsor|1
3091595|NCT00348309|10601430|P3|Overall Study|Participant died|1
3091596|NCT00348309|10601431|P2|Overall Study|Participant died|1
3091597|NCT00348309|10601432|P1|Overall Study|Participant died|2
3091598|NCT00348309|10601430|P3|Overall Study|Did not appear in time for Visit 3|0
3091599|NCT00348309|10601431|P2|Overall Study|Did not appear in time for Visit 3|0
3091600|NCT00348309|10601432|P1|Overall Study|Did not appear in time for Visit 3|1
3091601|NCT00348309|10601430|P3|Overall Study|Worsening of alzheimer|1
3091602|NCT00348309|10601431|P2|Overall Study|Worsening of alzheimer|0
3091603|NCT00348309|10601432|P1|Overall Study|Worsening of alzheimer|1
3091604|NCT00348309|10601430|P3|Overall Study|Cognitive and behaviour worsening|0
3091605|NCT00348309|10601431|P2|Overall Study|Cognitive and behaviour worsening|0
3091606|NCT00348309|10601432|P1|Overall Study|Cognitive and behaviour worsening|2
3091607|NCT00348309|10601430|P3|Overall Study|Worsened neurodegenerative disease|0
3091608|NCT00348309|10601431|P2|Overall Study|Worsened neurodegenerative disease|0
3091609|NCT00348309|10601432|P1|Overall Study|Worsened neurodegenerative disease|1
3091610|NCT00348309|10601430|P3|Overall Study|No disponibility of medication|0
3091611|NCT00348309|10601431|P2|Overall Study|No disponibility of medication|0
3091612|NCT00348309|10601432|P1|Overall Study|No disponibility of medication|1
3091613|NCT00348309|10601430|P3|Overall Study|Principal investigator's decision|0
3091614|NCT00348309|10601431|P2|Overall Study|Principal investigator's decision|0
3091615|NCT00348309|10601432|P1|Overall Study|Principal investigator's decision|1
3091616|NCT00348309|10601430|P3|Overall Study|PI closing medical practice|0
3091617|NCT00348309|10601431|P2|Overall Study|PI closing medical practice|0
3091618|NCT00348309|10601432|P1|Overall Study|PI closing medical practice|1
3091619|NCT00348309|10601430|P3|Overall Study|Unable to complete ET visit|0
3091620|NCT00348309|10601431|P2|Overall Study|Unable to complete ET visit|0
3091621|NCT00348309|10601432|P1|Overall Study|Unable to complete ET visit|1
3091622|NCT00348309|10601430|P3|Overall Study|Caregiver withdrawal|7
3091623|NCT00348309|10601431|P2|Overall Study|Caregiver withdrawal|0
3091624|NCT00348309|10601432|P1|Overall Study|Caregiver withdrawal|3
3091625|NCT00348309|10601430|P3|Overall Study|Use of prohibited medication|2
3091626|NCT00348309|10601431|P2|Overall Study|Use of prohibited medication|2
3091627|NCT00348309|10601432|P1|Overall Study|Use of prohibited medication|5
3091628|NCT00348309|10601430|P3|Overall Study|Caregiver sick|0
3091629|NCT00348309|10601431|P2|Overall Study|Caregiver sick|0
3091630|NCT00348309|10601432|P1|Overall Study|Caregiver sick|1
3091631|NCT00348309|10601430|P3|Overall Study|Wrong bottle allocated|0
3091632|NCT00348309|10601431|P2|Overall Study|Wrong bottle allocated|0
3091633|NCT00348309|10601432|P1|Overall Study|Wrong bottle allocated|1
3091634|NCT00348309|10601430|P3|Overall Study|Lack of insight, dementia|0
3091635|NCT00348309|10601431|P2|Overall Study|Lack of insight, dementia|0
3091636|NCT00348309|10601432|P1|Overall Study|Lack of insight, dementia|1
3091637|NCT00348309|10601430|P3|Overall Study|Death of caregiver|1
3091638|NCT00348309|10601431|P2|Overall Study|Death of caregiver|0
3091639|NCT00348309|10601432|P1|Overall Study|Death of caregiver|1
3091640|NCT00348309|10601430|P3|Overall Study|Non-compliance|8
3091641|NCT00348309|10601431|P2|Overall Study|Non-compliance|6
3091642|NCT00348309|10601432|P1|Overall Study|Non-compliance|8
3091643|NCT00348309|10601430|P3|Overall Study|Withdrawal by Subject|40
3091644|NCT00348309|10601431|P2|Overall Study|Withdrawal by Subject|37
3091645|NCT00348309|10601432|P1|Overall Study|Withdrawal by Subject|33
3091646|NCT00348309|10601430|P3|Overall Study|Protocol Violation|7
3091647|NCT00348309|10601431|P2|Overall Study|Protocol Violation|12
3091648|NCT00348309|10601432|P1|Overall Study|Protocol Violation|7
3091649|NCT00348309|10601430|P3|Overall Study|Lost to Follow-up|4
3091650|NCT00348309|10601431|P2|Overall Study|Lost to Follow-up|7
3091651|NCT00348309|10601432|P1|Overall Study|Lost to Follow-up|6
3091652|NCT00348309|10601430|P3|Overall Study|Adverse Event|63
3091653|NCT00348309|10601431|P2|Overall Study|Adverse Event|28
3091654|NCT00348309|10601432|P1|Overall Study|Adverse Event|56
3091655|NCT00348283|10601505|P2|Open Label|Sponsor decision|1
3091656|NCT00348283|10601506|P1|Open Label|Sponsor decision|0
3091657|NCT00348283|10601505|P2|Open Label|Pregnancy|1
3091658|NCT00348283|10601506|P1|Open Label|Pregnancy|0
3091659|NCT00348283|10601505|P2|Open Label|Subject moved to the United States|1
3091660|NCT00348283|10601506|P1|Open Label|Subject moved to the United States|0
3091661|NCT00348283|10601505|P2|Open Label|Administrative reasons|5
3091662|NCT00348283|10601506|P1|Open Label|Administrative reasons|0
3091663|NCT00348283|10601505|P2|Open Label|Lack of Efficacy|13
3091664|NCT00348283|10601506|P1|Open Label|Lack of Efficacy|0
3091665|NCT00348283|10601505|P2|Open Label|Lost to Follow-up|1
3091666|NCT00348283|10601506|P1|Open Label|Lost to Follow-up|0
3091667|NCT00348283|10601505|P2|Open Label|Withdrawal by Subject|4
3091668|NCT00348283|10601506|P1|Open Label|Withdrawal by Subject|0
3091669|NCT00348283|10601505|P2|Open Label|Adverse Event|8
3091670|NCT00348283|10601506|P1|Open Label|Adverse Event|0
3091671|NCT00348283|10601505|P2|Double Blind|Pregnancy|1
3091672|NCT00348283|10601506|P1|Double Blind|Pregnancy|0
3091673|NCT00348283|10601505|P2|Double Blind|Lack of Efficacy|2
3091674|NCT00348283|10601506|P1|Double Blind|Lack of Efficacy|2
3091675|NCT00348283|10601505|P2|Double Blind|Protocol Violation|1
3091676|NCT00348283|10601506|P1|Double Blind|Protocol Violation|0
3091677|NCT00348283|10601505|P2|Double Blind|Withdrawal by Subject|1
3091678|NCT00348283|10601506|P1|Double Blind|Withdrawal by Subject|1
3091679|NCT00348283|10601505|P2|Double Blind|Adverse Event|5
3091680|NCT00348283|10601506|P1|Double Blind|Adverse Event|2
3091681|NCT00348283|10601505|P2|Induction|Protocol Violation|4
3091682|NCT00348283|10601506|P1|Induction|Protocol Violation|0
3091683|NCT00348283|10601505|P2|Induction|Adverse Event|2
3091684|NCT00348283|10601506|P1|Induction|Adverse Event|0
3091685|NCT00348140|10601525|P3|Overall Study|Memory declined|1
3091686|NCT00348140|10601526|P2|Overall Study|Memory declined|0
3091687|NCT00348140|10601527|P1|Overall Study|Memory declined|0
3091688|NCT00348140|10601525|P3|Overall Study|Exclusion criteria met|1
3091689|NCT00348140|10601526|P2|Overall Study|Exclusion criteria met|0
3091690|NCT00348140|10601527|P1|Overall Study|Exclusion criteria met|0
3091691|NCT00348140|10601525|P3|Overall Study|Participant died|0
3091692|NCT00348140|10601526|P2|Overall Study|Participant died|1
3091693|NCT00348140|10601527|P1|Overall Study|Participant died|0
3091694|NCT00348140|10601525|P3|Overall Study|Abnormal ECG|3
3091695|NCT00348140|10601526|P2|Overall Study|Abnormal ECG|1
3091696|NCT00348140|10601527|P1|Overall Study|Abnormal ECG|0
3091697|NCT00348140|10601525|P3|Overall Study|Serious adverse event|0
3091698|NCT00348140|10601526|P2|Overall Study|Serious adverse event|1
3091699|NCT00348140|10601527|P1|Overall Study|Serious adverse event|0
3091700|NCT00348140|10601525|P3|Overall Study|Increased risk of cardiac infarction|0
3091701|NCT00348140|10601526|P2|Overall Study|Increased risk of cardiac infarction|1
3091702|NCT00348140|10601527|P1|Overall Study|Increased risk of cardiac infarction|0
3091703|NCT00348140|10601525|P3|Overall Study|Disease progression|5
3091704|NCT00348140|10601526|P2|Overall Study|Disease progression|2
3091705|NCT00348140|10601527|P1|Overall Study|Disease progression|1
3091706|NCT00348140|10601525|P3|Overall Study|Use of prohibited drug|2
3091707|NCT00348140|10601526|P2|Overall Study|Use of prohibited drug|0
3091708|NCT00348140|10601527|P1|Overall Study|Use of prohibited drug|1
3091709|NCT00348140|10601525|P3|Overall Study|Decided to discontinue on their own|1
3091710|NCT00348140|10601526|P2|Overall Study|Decided to discontinue on their own|4
3091711|NCT00348140|10601527|P1|Overall Study|Decided to discontinue on their own|1
3091712|NCT00348140|10601525|P3|Overall Study|Investigator decided to discontinue|4
3091713|NCT00348140|10601526|P2|Overall Study|Investigator decided to discontinue|1
3091714|NCT00348140|10601527|P1|Overall Study|Investigator decided to discontinue|4
3091715|NCT00348140|10601525|P3|Overall Study|Screen failure|0
3091716|NCT00348140|10601526|P2|Overall Study|Screen failure|0
3091717|NCT00348140|10601527|P1|Overall Study|Screen failure|1
3091718|NCT00348140|10601525|P3|Overall Study|Participant unwell|0
3091719|NCT00348140|10601526|P2|Overall Study|Participant unwell|0
3091720|NCT00348140|10601527|P1|Overall Study|Participant unwell|1
3091721|NCT00348140|10601525|P3|Overall Study|Unmet inclusion-exclusion criteria|1
3091722|NCT00348140|10601526|P2|Overall Study|Unmet inclusion-exclusion criteria|0
3091723|NCT00348140|10601527|P1|Overall Study|Unmet inclusion-exclusion criteria|1
3091724|NCT00348140|10601525|P3|Overall Study|Administration related|1
3091725|NCT00348140|10601526|P2|Overall Study|Administration related|1
3091726|NCT00348140|10601527|P1|Overall Study|Administration related|3
3091727|NCT00348140|10601525|P3|Overall Study|Efficacy related|0
3091728|NCT00348140|10601526|P2|Overall Study|Efficacy related|1
3091729|NCT00348140|10601527|P1|Overall Study|Efficacy related|1
3091730|NCT00348140|10601525|P3|Overall Study|Participant hospitalised|0
3091731|NCT00348140|10601526|P2|Overall Study|Participant hospitalised|0
3091732|NCT00348140|10601527|P1|Overall Study|Participant hospitalised|3
3091733|NCT00348140|10601525|P3|Overall Study|Caregiver related|3
3091734|NCT00348140|10601526|P2|Overall Study|Caregiver related|7
3091735|NCT00348140|10601527|P1|Overall Study|Caregiver related|4
3091736|NCT00348140|10601525|P3|Overall Study|Conditional medication increased dose|0
3091737|NCT00348140|10601526|P2|Overall Study|Conditional medication increased dose|0
3091738|NCT00348140|10601527|P1|Overall Study|Conditional medication increased dose|1
3091739|NCT00348140|10601525|P3|Overall Study|Participant at risk due to study drug|0
3091740|NCT00348140|10601526|P2|Overall Study|Participant at risk due to study drug|0
3091741|NCT00348140|10601527|P1|Overall Study|Participant at risk due to study drug|2
3091742|NCT00348140|10601525|P3|Overall Study|Non-compliance|5
3091743|NCT00348140|10601526|P2|Overall Study|Non-compliance|13
3091744|NCT00348140|10601527|P1|Overall Study|Non-compliance|8
3091745|NCT00348140|10601525|P3|Overall Study|Withdrawal by Subject|40
3091746|NCT00348140|10601526|P2|Overall Study|Withdrawal by Subject|40
3091747|NCT00348140|10601527|P1|Overall Study|Withdrawal by Subject|32
3091748|NCT00348140|10601525|P3|Overall Study|Protocol Violation|14
3091749|NCT00348140|10601526|P2|Overall Study|Protocol Violation|13
3091750|NCT00348140|10601527|P1|Overall Study|Protocol Violation|12
3091751|NCT00348140|10601525|P3|Overall Study|Lost to Follow-up|4
3091752|NCT00348140|10601526|P2|Overall Study|Lost to Follow-up|4
3091753|NCT00348140|10601527|P1|Overall Study|Lost to Follow-up|4
3091754|NCT00348140|10601525|P3|Overall Study|Adverse Event|78
3091755|NCT00348140|10601526|P2|Overall Study|Adverse Event|49
3091756|NCT00348140|10601527|P1|Overall Study|Adverse Event|46
3091757|NCT00347958|10601625|P1|Overall Study|Withdrawal by Subject|1
3091758|NCT00347958|10601625|P1|Overall Study|Protocol Violation|2
3091759|NCT00347958|10601625|P1|Overall Study|Adverse Event|1
3091760|NCT00347932|10601634|P2|Overall Study|Did not meet inclusion criteria|8
3091761|NCT00347932|10601635|P1|Overall Study|Did not meet inclusion criteria|4
3091762|NCT00347932|10601634|P2|Overall Study|Withdrawal by Subject|16
3091763|NCT00347932|10601635|P1|Overall Study|Withdrawal by Subject|10
3091764|NCT00347932|10601634|P2|Overall Study|Lost to Follow-up|9
3091765|NCT00347932|10601635|P1|Overall Study|Lost to Follow-up|10
3091766|NCT00347932|10601634|P2|Overall Study|Lack of Efficacy|14
3091767|NCT00347932|10601635|P1|Overall Study|Lack of Efficacy|3
3091768|NCT00347932|10601634|P2|Overall Study|Adverse Event|5
3091769|NCT00347932|10601635|P1|Overall Study|Adverse Event|4
3091770|NCT00347919|10601650|P3|Overall Study|Missing|2
3091771|NCT00347919|10601651|P2|Overall Study|Missing|1
3091772|NCT00347919|10601652|P1|Overall Study|Missing|2
3091773|NCT00347919|10601650|P3|Overall Study|Par. Started Other Treatment|1
3091774|NCT00347919|10601651|P2|Overall Study|Par. Started Other Treatment|1
3091775|NCT00347919|10601652|P1|Overall Study|Par. Started Other Treatment|1
3091776|NCT00347919|10601650|P3|Overall Study|Death|19
3091777|NCT00347919|10601651|P2|Overall Study|Death|42
3091778|NCT00347919|10601652|P1|Overall Study|Death|35
3091779|NCT00347919|10601650|P3|Overall Study|Sponsor terminated study|16
3091780|NCT00347919|10601651|P2|Overall Study|Sponsor terminated study|10
3091781|NCT00347919|10601652|P1|Overall Study|Sponsor terminated study|15
3091782|NCT00347919|10601650|P3|Overall Study|Physician Decision|0
3091783|NCT00347919|10601651|P2|Overall Study|Physician Decision|1
3091784|NCT00347919|10601652|P1|Overall Study|Physician Decision|1
3091785|NCT00347919|10601650|P3|Overall Study|Withdrawal by Subject|0
3091786|NCT00347919|10601651|P2|Overall Study|Withdrawal by Subject|8
3091787|NCT00347919|10601652|P1|Overall Study|Withdrawal by Subject|6
3091788|NCT00347919|10601650|P3|Overall Study|Lost to Follow-up|0
3091789|NCT00347919|10601651|P2|Overall Study|Lost to Follow-up|13
3091790|NCT00347919|10601652|P1|Overall Study|Lost to Follow-up|11
3091791|NCT00347776|10601675|P3|12 Month Follow-up|Reached endpoint|9
3091792|NCT00347776|10601676|P2|12 Month Follow-up|Reached endpoint|6
3091793|NCT00347776|10601677|P1|12 Month Follow-up|Reached endpoint|13
3091794|NCT00347776|10601675|P3|12 Month Follow-up|Death|4
3091795|NCT00347776|10601676|P2|12 Month Follow-up|Death|4
3091796|NCT00347776|10601677|P1|12 Month Follow-up|Death|3
3091797|NCT00347776|10601675|P3|12 Month Follow-up|Lost to Follow-up|6
3091798|NCT00347776|10601676|P2|12 Month Follow-up|Lost to Follow-up|6
3091799|NCT00347776|10601677|P1|12 Month Follow-up|Lost to Follow-up|7
3091800|NCT00347776|10601675|P3|6 Month Follow-up|reached endpont|15
3091801|NCT00347776|10601676|P2|6 Month Follow-up|reached endpont|12
3091802|NCT00347776|10601677|P1|6 Month Follow-up|reached endpont|20
3091803|NCT00347776|10601675|P3|6 Month Follow-up|Death|3
3091804|NCT00347776|10601676|P2|6 Month Follow-up|Death|1
3091805|NCT00347776|10601677|P1|6 Month Follow-up|Death|2
3091806|NCT00347776|10601675|P3|1.5 Month Follow-up|reached the endpoint|12
3091807|NCT00347776|10601676|P2|1.5 Month Follow-up|reached the endpoint|8
3091808|NCT00347776|10601677|P1|1.5 Month Follow-up|reached the endpoint|12
3091809|NCT00347776|10601675|P3|1.5 Month Follow-up|Death|0
3091810|NCT00347776|10601676|P2|1.5 Month Follow-up|Death|0
3091811|NCT00347776|10601677|P1|1.5 Month Follow-up|Death|2
3091812|NCT00347438|10601689|P1|Overall Study|Physician Decision|1
3091813|NCT00347438|10601689|P1|Overall Study|Withdrawal by Subject|1
3091814|NCT00347360|10601711|P15|Overall Study|Visits conflicted with new job|0
3091815|NCT00347360|10601712|P14|Overall Study|Visits conflicted with new job|0
3091816|NCT00347360|10601713|P13|Overall Study|Visits conflicted with new job|0
3091817|NCT00347360|10601714|P12|Overall Study|Visits conflicted with new job|0
3091894|NCT00347360|10601716|P10|Overall Study|Randomized in error|0
3091818|NCT00347360|10601715|P11|Overall Study|Visits conflicted with new job|0
3091819|NCT00347360|10601716|P10|Overall Study|Visits conflicted with new job|0
3091820|NCT00347360|10601717|P9|Overall Study|Visits conflicted with new job|0
3091821|NCT00347360|10601718|P8|Overall Study|Visits conflicted with new job|0
3091822|NCT00347360|10601719|P7|Overall Study|Visits conflicted with new job|1
3091823|NCT00347360|10601720|P6|Overall Study|Visits conflicted with new job|0
3091824|NCT00347360|10601721|P5|Overall Study|Visits conflicted with new job|0
3091825|NCT00347360|10601722|P4|Overall Study|Visits conflicted with new job|0
3091826|NCT00347360|10601723|P3|Overall Study|Visits conflicted with new job|0
3091827|NCT00347360|10601724|P2|Overall Study|Visits conflicted with new job|0
3091828|NCT00347360|10601725|P1|Overall Study|Visits conflicted with new job|0
3091829|NCT00347360|10601711|P15|Overall Study|Subject refuse to sign updated consent|1
3091830|NCT00347360|10601712|P14|Overall Study|Subject refuse to sign updated consent|0
3091831|NCT00347360|10601713|P13|Overall Study|Subject refuse to sign updated consent|0
3091832|NCT00347360|10601714|P12|Overall Study|Subject refuse to sign updated consent|0
3091833|NCT00347360|10601715|P11|Overall Study|Subject refuse to sign updated consent|0
3091834|NCT00347360|10601716|P10|Overall Study|Subject refuse to sign updated consent|0
3091835|NCT00347360|10601717|P9|Overall Study|Subject refuse to sign updated consent|0
3091836|NCT00347360|10601718|P8|Overall Study|Subject refuse to sign updated consent|0
3091837|NCT00347360|10601719|P7|Overall Study|Subject refuse to sign updated consent|0
3091838|NCT00347360|10601720|P6|Overall Study|Subject refuse to sign updated consent|0
3091839|NCT00347360|10601721|P5|Overall Study|Subject refuse to sign updated consent|0
3091840|NCT00347360|10601722|P4|Overall Study|Subject refuse to sign updated consent|0
3091841|NCT00347360|10601723|P3|Overall Study|Subject refuse to sign updated consent|0
3091842|NCT00347360|10601724|P2|Overall Study|Subject refuse to sign updated consent|0
3091843|NCT00347360|10601725|P1|Overall Study|Subject refuse to sign updated consent|0
3091844|NCT00347360|10601711|P15|Overall Study|Subject left town, ran out of study drug|0
3091845|NCT00347360|10601712|P14|Overall Study|Subject left town, ran out of study drug|1
3091846|NCT00347360|10601713|P13|Overall Study|Subject left town, ran out of study drug|0
3091847|NCT00347360|10601714|P12|Overall Study|Subject left town, ran out of study drug|0
3091848|NCT00347360|10601715|P11|Overall Study|Subject left town, ran out of study drug|0
3091849|NCT00347360|10601716|P10|Overall Study|Subject left town, ran out of study drug|0
3091850|NCT00347360|10601717|P9|Overall Study|Subject left town, ran out of study drug|0
3091851|NCT00347360|10601718|P8|Overall Study|Subject left town, ran out of study drug|0
3091852|NCT00347360|10601719|P7|Overall Study|Subject left town, ran out of study drug|0
3091853|NCT00347360|10601720|P6|Overall Study|Subject left town, ran out of study drug|0
3091854|NCT00347360|10601721|P5|Overall Study|Subject left town, ran out of study drug|0
3091855|NCT00347360|10601722|P4|Overall Study|Subject left town, ran out of study drug|0
3091856|NCT00347360|10601723|P3|Overall Study|Subject left town, ran out of study drug|0
3091857|NCT00347360|10601724|P2|Overall Study|Subject left town, ran out of study drug|0
3091858|NCT00347360|10601725|P1|Overall Study|Subject left town, ran out of study drug|0
3091859|NCT00347360|10601711|P15|Overall Study|Prolonged duration between visits|0
3091860|NCT00347360|10601712|P14|Overall Study|Prolonged duration between visits|0
3091861|NCT00347360|10601713|P13|Overall Study|Prolonged duration between visits|1
3091862|NCT00347360|10601714|P12|Overall Study|Prolonged duration between visits|0
3091863|NCT00347360|10601715|P11|Overall Study|Prolonged duration between visits|0
3091864|NCT00347360|10601716|P10|Overall Study|Prolonged duration between visits|0
3091865|NCT00347360|10601717|P9|Overall Study|Prolonged duration between visits|0
3091866|NCT00347360|10601718|P8|Overall Study|Prolonged duration between visits|0
3091867|NCT00347360|10601719|P7|Overall Study|Prolonged duration between visits|0
3091868|NCT00347360|10601720|P6|Overall Study|Prolonged duration between visits|0
3091869|NCT00347360|10601721|P5|Overall Study|Prolonged duration between visits|0
3091870|NCT00347360|10601722|P4|Overall Study|Prolonged duration between visits|0
3091871|NCT00347360|10601723|P3|Overall Study|Prolonged duration between visits|0
3091872|NCT00347360|10601724|P2|Overall Study|Prolonged duration between visits|0
3091873|NCT00347360|10601725|P1|Overall Study|Prolonged duration between visits|0
3091874|NCT00347360|10601711|P15|Overall Study|Failed inclusion criteria #4|0
3091875|NCT00347360|10601712|P14|Overall Study|Failed inclusion criteria #4|0
3091876|NCT00347360|10601713|P13|Overall Study|Failed inclusion criteria #4|0
3091877|NCT00347360|10601714|P12|Overall Study|Failed inclusion criteria #4|1
3091878|NCT00347360|10601715|P11|Overall Study|Failed inclusion criteria #4|0
3091879|NCT00347360|10601716|P10|Overall Study|Failed inclusion criteria #4|0
3091880|NCT00347360|10601717|P9|Overall Study|Failed inclusion criteria #4|0
3091881|NCT00347360|10601718|P8|Overall Study|Failed inclusion criteria #4|0
3091882|NCT00347360|10601719|P7|Overall Study|Failed inclusion criteria #4|0
3091883|NCT00347360|10601720|P6|Overall Study|Failed inclusion criteria #4|0
3091884|NCT00347360|10601721|P5|Overall Study|Failed inclusion criteria #4|0
3091885|NCT00347360|10601722|P4|Overall Study|Failed inclusion criteria #4|0
3091886|NCT00347360|10601723|P3|Overall Study|Failed inclusion criteria #4|0
3091887|NCT00347360|10601724|P2|Overall Study|Failed inclusion criteria #4|0
3091888|NCT00347360|10601725|P1|Overall Study|Failed inclusion criteria #4|0
3091889|NCT00347360|10601711|P15|Overall Study|Randomized in error|0
3091890|NCT00347360|10601712|P14|Overall Study|Randomized in error|0
3091891|NCT00347360|10601713|P13|Overall Study|Randomized in error|0
3091892|NCT00347360|10601714|P12|Overall Study|Randomized in error|1
3091893|NCT00347360|10601715|P11|Overall Study|Randomized in error|0
3091895|NCT00347360|10601717|P9|Overall Study|Randomized in error|0
3091896|NCT00347360|10601718|P8|Overall Study|Randomized in error|0
3091897|NCT00347360|10601719|P7|Overall Study|Randomized in error|0
3091898|NCT00347360|10601720|P6|Overall Study|Randomized in error|0
3091899|NCT00347360|10601721|P5|Overall Study|Randomized in error|0
3091900|NCT00347360|10601722|P4|Overall Study|Randomized in error|0
3091901|NCT00347360|10601723|P3|Overall Study|Randomized in error|0
3091902|NCT00347360|10601724|P2|Overall Study|Randomized in error|0
3091903|NCT00347360|10601725|P1|Overall Study|Randomized in error|0
3091904|NCT00347360|10601711|P15|Overall Study|Did not meet criteria before ABPM|0
3091905|NCT00347360|10601712|P14|Overall Study|Did not meet criteria before ABPM|0
3091906|NCT00347360|10601713|P13|Overall Study|Did not meet criteria before ABPM|0
3091907|NCT00347360|10601714|P12|Overall Study|Did not meet criteria before ABPM|0
3091908|NCT00347360|10601715|P11|Overall Study|Did not meet criteria before ABPM|1
3091909|NCT00347360|10601716|P10|Overall Study|Did not meet criteria before ABPM|0
3091910|NCT00347360|10601717|P9|Overall Study|Did not meet criteria before ABPM|0
3091911|NCT00347360|10601718|P8|Overall Study|Did not meet criteria before ABPM|0
3091912|NCT00347360|10601719|P7|Overall Study|Did not meet criteria before ABPM|0
3091913|NCT00347360|10601720|P6|Overall Study|Did not meet criteria before ABPM|0
3091914|NCT00347360|10601721|P5|Overall Study|Did not meet criteria before ABPM|0
3091915|NCT00347360|10601722|P4|Overall Study|Did not meet criteria before ABPM|0
3091916|NCT00347360|10601723|P3|Overall Study|Did not meet criteria before ABPM|0
3091917|NCT00347360|10601724|P2|Overall Study|Did not meet criteria before ABPM|0
3091918|NCT00347360|10601725|P1|Overall Study|Did not meet criteria before ABPM|0
3091919|NCT00347360|10601711|P15|Overall Study|PI recommended early withdrawal|0
3091920|NCT00347360|10601712|P14|Overall Study|PI recommended early withdrawal|0
3091921|NCT00347360|10601713|P13|Overall Study|PI recommended early withdrawal|0
3091922|NCT00347360|10601714|P12|Overall Study|PI recommended early withdrawal|0
3091923|NCT00347360|10601715|P11|Overall Study|PI recommended early withdrawal|0
3091924|NCT00347360|10601716|P10|Overall Study|PI recommended early withdrawal|1
3091925|NCT00347360|10601717|P9|Overall Study|PI recommended early withdrawal|0
3091926|NCT00347360|10601718|P8|Overall Study|PI recommended early withdrawal|0
3091927|NCT00347360|10601719|P7|Overall Study|PI recommended early withdrawal|0
3091928|NCT00347360|10601720|P6|Overall Study|PI recommended early withdrawal|0
3091929|NCT00347360|10601721|P5|Overall Study|PI recommended early withdrawal|0
3091930|NCT00347360|10601722|P4|Overall Study|PI recommended early withdrawal|0
3091931|NCT00347360|10601723|P3|Overall Study|PI recommended early withdrawal|0
3091932|NCT00347360|10601724|P2|Overall Study|PI recommended early withdrawal|0
3091933|NCT00347360|10601725|P1|Overall Study|PI recommended early withdrawal|0
3091934|NCT00347360|10601711|P15|Overall Study|Abnormal lab values|0
3091935|NCT00347360|10601712|P14|Overall Study|Abnormal lab values|0
3091936|NCT00347360|10601713|P13|Overall Study|Abnormal lab values|0
3091937|NCT00347360|10601714|P12|Overall Study|Abnormal lab values|0
3091938|NCT00347360|10601715|P11|Overall Study|Abnormal lab values|0
3091939|NCT00347360|10601716|P10|Overall Study|Abnormal lab values|0
3091940|NCT00347360|10601717|P9|Overall Study|Abnormal lab values|0
3091941|NCT00347360|10601718|P8|Overall Study|Abnormal lab values|0
3091942|NCT00347360|10601719|P7|Overall Study|Abnormal lab values|1
3091943|NCT00347360|10601720|P6|Overall Study|Abnormal lab values|0
3091944|NCT00347360|10601721|P5|Overall Study|Abnormal lab values|0
3091945|NCT00347360|10601722|P4|Overall Study|Abnormal lab values|0
3091946|NCT00347360|10601723|P3|Overall Study|Abnormal lab values|0
3091947|NCT00347360|10601724|P2|Overall Study|Abnormal lab values|0
3091948|NCT00347360|10601725|P1|Overall Study|Abnormal lab values|0
3091949|NCT00347360|10601711|P15|Overall Study|Subject did not meet end of study ABPM|0
3091950|NCT00347360|10601712|P14|Overall Study|Subject did not meet end of study ABPM|1
3091951|NCT00347360|10601713|P13|Overall Study|Subject did not meet end of study ABPM|1
3091952|NCT00347360|10601714|P12|Overall Study|Subject did not meet end of study ABPM|0
3091953|NCT00347360|10601715|P11|Overall Study|Subject did not meet end of study ABPM|1
3091954|NCT00347360|10601716|P10|Overall Study|Subject did not meet end of study ABPM|0
3091955|NCT00347360|10601717|P9|Overall Study|Subject did not meet end of study ABPM|0
3091956|NCT00347360|10601718|P8|Overall Study|Subject did not meet end of study ABPM|0
3091957|NCT00347360|10601719|P7|Overall Study|Subject did not meet end of study ABPM|1
3091958|NCT00347360|10601720|P6|Overall Study|Subject did not meet end of study ABPM|0
3091959|NCT00347360|10601721|P5|Overall Study|Subject did not meet end of study ABPM|0
3091960|NCT00347360|10601722|P4|Overall Study|Subject did not meet end of study ABPM|0
3091961|NCT00347360|10601723|P3|Overall Study|Subject did not meet end of study ABPM|0
3091962|NCT00347360|10601724|P2|Overall Study|Subject did not meet end of study ABPM|0
3091963|NCT00347360|10601725|P1|Overall Study|Subject did not meet end of study ABPM|0
3091964|NCT00347360|10601711|P15|Overall Study|P.I. recommended due to blood pressure|0
3091965|NCT00347360|10601712|P14|Overall Study|P.I. recommended due to blood pressure|0
3091966|NCT00347360|10601713|P13|Overall Study|P.I. recommended due to blood pressure|0
3091967|NCT00347360|10601714|P12|Overall Study|P.I. recommended due to blood pressure|0
3091968|NCT00347360|10601715|P11|Overall Study|P.I. recommended due to blood pressure|0
3091969|NCT00347360|10601716|P10|Overall Study|P.I. recommended due to blood pressure|0
3091970|NCT00347360|10601717|P9|Overall Study|P.I. recommended due to blood pressure|0
3091971|NCT00347360|10601718|P8|Overall Study|P.I. recommended due to blood pressure|0
3091972|NCT00347360|10601719|P7|Overall Study|P.I. recommended due to blood pressure|0
3091973|NCT00347360|10601720|P6|Overall Study|P.I. recommended due to blood pressure|0
3091974|NCT00347360|10601721|P5|Overall Study|P.I. recommended due to blood pressure|1
3091975|NCT00347360|10601722|P4|Overall Study|P.I. recommended due to blood pressure|0
3091976|NCT00347360|10601723|P3|Overall Study|P.I. recommended due to blood pressure|0
3091977|NCT00347360|10601724|P2|Overall Study|P.I. recommended due to blood pressure|0
3091978|NCT00347360|10601725|P1|Overall Study|P.I. recommended due to blood pressure|0
3091979|NCT00347360|10601711|P15|Overall Study|Per sponsors instruction|0
3091980|NCT00347360|10601712|P14|Overall Study|Per sponsors instruction|0
3091981|NCT00347360|10601713|P13|Overall Study|Per sponsors instruction|0
3091982|NCT00347360|10601714|P12|Overall Study|Per sponsors instruction|0
3091983|NCT00347360|10601715|P11|Overall Study|Per sponsors instruction|0
3091984|NCT00347360|10601716|P10|Overall Study|Per sponsors instruction|0
3091985|NCT00347360|10601717|P9|Overall Study|Per sponsors instruction|0
3091986|NCT00347360|10601718|P8|Overall Study|Per sponsors instruction|0
3091987|NCT00347360|10601719|P7|Overall Study|Per sponsors instruction|0
3091988|NCT00347360|10601720|P6|Overall Study|Per sponsors instruction|0
3091989|NCT00347360|10601721|P5|Overall Study|Per sponsors instruction|0
3091990|NCT00347360|10601722|P4|Overall Study|Per sponsors instruction|0
3091991|NCT00347360|10601723|P3|Overall Study|Per sponsors instruction|0
3091992|NCT00347360|10601724|P2|Overall Study|Per sponsors instruction|1
3091993|NCT00347360|10601725|P1|Overall Study|Per sponsors instruction|0
3091994|NCT00347360|10601711|P15|Overall Study|Reason not listed/blank|0
3091995|NCT00347360|10601712|P14|Overall Study|Reason not listed/blank|1
3091996|NCT00347360|10601713|P13|Overall Study|Reason not listed/blank|0
3091997|NCT00347360|10601714|P12|Overall Study|Reason not listed/blank|0
3091998|NCT00347360|10601715|P11|Overall Study|Reason not listed/blank|0
3091999|NCT00347360|10601716|P10|Overall Study|Reason not listed/blank|0
3092000|NCT00347360|10601717|P9|Overall Study|Reason not listed/blank|0
3092001|NCT00347360|10601718|P8|Overall Study|Reason not listed/blank|0
3092002|NCT00347360|10601719|P7|Overall Study|Reason not listed/blank|1
3092003|NCT00347360|10601720|P6|Overall Study|Reason not listed/blank|0
3092004|NCT00347360|10601721|P5|Overall Study|Reason not listed/blank|0
3092005|NCT00347360|10601722|P4|Overall Study|Reason not listed/blank|0
3092006|NCT00347360|10601723|P3|Overall Study|Reason not listed/blank|0
3092007|NCT00347360|10601724|P2|Overall Study|Reason not listed/blank|0
3092008|NCT00347360|10601725|P1|Overall Study|Reason not listed/blank|1
3092009|NCT00347360|10601711|P15|Overall Study|Lack of Efficacy|0
3092010|NCT00347360|10601712|P14|Overall Study|Lack of Efficacy|0
3092011|NCT00347360|10601713|P13|Overall Study|Lack of Efficacy|0
3092012|NCT00347360|10601714|P12|Overall Study|Lack of Efficacy|0
3092013|NCT00347360|10601715|P11|Overall Study|Lack of Efficacy|0
3092014|NCT00347360|10601716|P10|Overall Study|Lack of Efficacy|0
3092015|NCT00347360|10601717|P9|Overall Study|Lack of Efficacy|1
3092016|NCT00347360|10601718|P8|Overall Study|Lack of Efficacy|1
3092017|NCT00347360|10601719|P7|Overall Study|Lack of Efficacy|0
3092018|NCT00347360|10601720|P6|Overall Study|Lack of Efficacy|1
3092019|NCT00347360|10601721|P5|Overall Study|Lack of Efficacy|0
3092020|NCT00347360|10601722|P4|Overall Study|Lack of Efficacy|1
3092021|NCT00347360|10601723|P3|Overall Study|Lack of Efficacy|3
3092022|NCT00347360|10601724|P2|Overall Study|Lack of Efficacy|1
3092023|NCT00347360|10601725|P1|Overall Study|Lack of Efficacy|1
3092024|NCT00347360|10601711|P15|Overall Study|Withdrawal by Subject|1
3092025|NCT00347360|10601712|P14|Overall Study|Withdrawal by Subject|2
3092026|NCT00347360|10601713|P13|Overall Study|Withdrawal by Subject|4
3092027|NCT00347360|10601714|P12|Overall Study|Withdrawal by Subject|3
3092028|NCT00347360|10601715|P11|Overall Study|Withdrawal by Subject|0
3092029|NCT00347360|10601716|P10|Overall Study|Withdrawal by Subject|1
3092030|NCT00347360|10601717|P9|Overall Study|Withdrawal by Subject|1
3092031|NCT00347360|10601718|P8|Overall Study|Withdrawal by Subject|1
3092032|NCT00347360|10601719|P7|Overall Study|Withdrawal by Subject|1
3092033|NCT00347360|10601720|P6|Overall Study|Withdrawal by Subject|2
3092034|NCT00347360|10601721|P5|Overall Study|Withdrawal by Subject|1
3092035|NCT00347360|10601722|P4|Overall Study|Withdrawal by Subject|4
3092036|NCT00347360|10601723|P3|Overall Study|Withdrawal by Subject|2
3092037|NCT00347360|10601724|P2|Overall Study|Withdrawal by Subject|1
3092038|NCT00347360|10601725|P1|Overall Study|Withdrawal by Subject|0
3092039|NCT00347360|10601711|P15|Overall Study|Protocol Violation|0
3092040|NCT00347360|10601712|P14|Overall Study|Protocol Violation|1
3092041|NCT00347360|10601713|P13|Overall Study|Protocol Violation|0
3092042|NCT00347360|10601714|P12|Overall Study|Protocol Violation|0
3092043|NCT00347360|10601715|P11|Overall Study|Protocol Violation|0
3092044|NCT00347360|10601716|P10|Overall Study|Protocol Violation|2
3092045|NCT00347360|10601717|P9|Overall Study|Protocol Violation|1
3092046|NCT00347360|10601718|P8|Overall Study|Protocol Violation|0
3092047|NCT00347360|10601719|P7|Overall Study|Protocol Violation|0
3092048|NCT00347360|10601720|P6|Overall Study|Protocol Violation|2
3092049|NCT00347360|10601721|P5|Overall Study|Protocol Violation|1
3092050|NCT00347360|10601722|P4|Overall Study|Protocol Violation|2
3092051|NCT00347360|10601723|P3|Overall Study|Protocol Violation|1
3092052|NCT00347360|10601724|P2|Overall Study|Protocol Violation|3
3092053|NCT00347360|10601725|P1|Overall Study|Protocol Violation|2
3092054|NCT00347360|10601711|P15|Overall Study|Lost to Follow-up|0
3092055|NCT00347360|10601712|P14|Overall Study|Lost to Follow-up|0
3092056|NCT00347360|10601713|P13|Overall Study|Lost to Follow-up|1
3092057|NCT00347360|10601714|P12|Overall Study|Lost to Follow-up|0
3092058|NCT00347360|10601715|P11|Overall Study|Lost to Follow-up|0
3092059|NCT00347360|10601716|P10|Overall Study|Lost to Follow-up|2
3092060|NCT00347360|10601717|P9|Overall Study|Lost to Follow-up|1
3092061|NCT00347360|10601718|P8|Overall Study|Lost to Follow-up|1
3092062|NCT00347360|10601719|P7|Overall Study|Lost to Follow-up|0
3092063|NCT00347360|10601720|P6|Overall Study|Lost to Follow-up|1
3092064|NCT00347360|10601721|P5|Overall Study|Lost to Follow-up|1
3092065|NCT00347360|10601722|P4|Overall Study|Lost to Follow-up|2
3092066|NCT00347360|10601723|P3|Overall Study|Lost to Follow-up|0
3092067|NCT00347360|10601724|P2|Overall Study|Lost to Follow-up|0
3092068|NCT00347360|10601725|P1|Overall Study|Lost to Follow-up|0
3092069|NCT00347360|10601711|P15|Overall Study|Adverse Event|2
3092070|NCT00347360|10601712|P14|Overall Study|Adverse Event|2
3092071|NCT00347360|10601713|P13|Overall Study|Adverse Event|3
3092072|NCT00347360|10601714|P12|Overall Study|Adverse Event|1
3092073|NCT00347360|10601715|P11|Overall Study|Adverse Event|3
3092074|NCT00347360|10601716|P10|Overall Study|Adverse Event|3
3092075|NCT00347360|10601717|P9|Overall Study|Adverse Event|2
3092076|NCT00347360|10601718|P8|Overall Study|Adverse Event|0
3092077|NCT00347360|10601719|P7|Overall Study|Adverse Event|2
3092078|NCT00347360|10601720|P6|Overall Study|Adverse Event|2
3092079|NCT00347360|10601721|P5|Overall Study|Adverse Event|1
3092080|NCT00347360|10601722|P4|Overall Study|Adverse Event|4
3092081|NCT00347360|10601723|P3|Overall Study|Adverse Event|0
3092082|NCT00347360|10601724|P2|Overall Study|Adverse Event|2
3092083|NCT00347360|10601725|P1|Overall Study|Adverse Event|1
3092084|NCT00347269|10601913|P2|Overall Study|Death|3
3092085|NCT00347269|10601914|P1|Overall Study|Death|2
3092086|NCT00347269|10601913|P2|Overall Study|Withdrawal by Subject|38
3092087|NCT00347269|10601914|P1|Overall Study|Withdrawal by Subject|18
3092088|NCT00347269|10601913|P2|Overall Study|Lost to Follow-up|65
3092089|NCT00347269|10601914|P1|Overall Study|Lost to Follow-up|74
3092090|NCT00347009|10601929|P1|Overall Study|Serious Adverse Event|1
3092091|NCT00347009|10601929|P1|Overall Study|Increased ALT/HBV DNA|1
3092092|NCT00347009|10601929|P1|Overall Study|Insufficient Viral Suppression|3
3092093|NCT00347009|10601929|P1|Overall Study|Adverse Laboratory Experience|1
3092094|NCT00347009|10601929|P1|Overall Study|Protocol Violation|2
3092095|NCT00347009|10601929|P1|Overall Study|Lost to Follow-up|4
3092096|NCT00347009|10601929|P1|Overall Study|Physician Decision|5
3092097|NCT00347009|10601929|P1|Overall Study|Withdrawal by Subject|3
3092098|NCT00347009|10601929|P1|Overall Study|Adverse Event|6
3092099|NCT00347009|10601929|P1|Overall Study|Death|1
3092100|NCT00346775|10601950|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
3092101|NCT00346775|10601951|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
3092102|NCT00346775|10601950|P2|Period 1: Intervention Period 1|Protocol Violation|2
3092103|NCT00346775|10601951|P1|Period 1: Intervention Period 1|Protocol Violation|3
3092104|NCT00346775|10601950|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
3092105|NCT00346775|10601951|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
3092106|NCT00346697|10601963|P2|Overall Study|Lost to Follow-up|1
3092107|NCT00346697|10601964|P1|Overall Study|Lost to Follow-up|0
3092108|NCT00346632|10602000|P10|Overall Study|Not Stated|1
3092109|NCT00346632|10602001|P9|Overall Study|Not Stated|2
3092110|NCT00346632|10602002|P8|Overall Study|Not Stated|2
3092111|NCT00346632|10602003|P7|Overall Study|Not Stated|0
3092112|NCT00346632|10602004|P6|Overall Study|Not Stated|0
3092113|NCT00346632|10602005|P5|Overall Study|Not Stated|0
3092114|NCT00346632|10602006|P4|Overall Study|Not Stated|0
3092115|NCT00346632|10602007|P3|Overall Study|Not Stated|0
3092116|NCT00346632|10602008|P2|Overall Study|Not Stated|1
3092117|NCT00346632|10602009|P1|Overall Study|Not Stated|1
3092118|NCT00346632|10602000|P10|Overall Study|Switched to alternative treatment|0
3092119|NCT00346632|10602001|P9|Overall Study|Switched to alternative treatment|0
3092120|NCT00346632|10602002|P8|Overall Study|Switched to alternative treatment|0
3092121|NCT00346632|10602003|P7|Overall Study|Switched to alternative treatment|0
3092122|NCT00346632|10602004|P6|Overall Study|Switched to alternative treatment|0
3092123|NCT00346632|10602005|P5|Overall Study|Switched to alternative treatment|0
3092124|NCT00346632|10602006|P4|Overall Study|Switched to alternative treatment|0
3092125|NCT00346632|10602007|P3|Overall Study|Switched to alternative treatment|1
3092126|NCT00346632|10602008|P2|Overall Study|Switched to alternative treatment|0
3092127|NCT00346632|10602009|P1|Overall Study|Switched to alternative treatment|0
3092128|NCT00346632|10602000|P10|Overall Study|Withdrawal by Subject|0
3092129|NCT00346632|10602001|P9|Overall Study|Withdrawal by Subject|0
3092130|NCT00346632|10602002|P8|Overall Study|Withdrawal by Subject|0
3092131|NCT00346632|10602003|P7|Overall Study|Withdrawal by Subject|1
3092132|NCT00346632|10602004|P6|Overall Study|Withdrawal by Subject|0
3092133|NCT00346632|10602005|P5|Overall Study|Withdrawal by Subject|0
3092134|NCT00346632|10602006|P4|Overall Study|Withdrawal by Subject|0
3092135|NCT00346632|10602007|P3|Overall Study|Withdrawal by Subject|0
3092136|NCT00346632|10602008|P2|Overall Study|Withdrawal by Subject|0
3092137|NCT00346632|10602009|P1|Overall Study|Withdrawal by Subject|0
3092138|NCT00346632|10602000|P10|Overall Study|Protocol Violation|0
3092139|NCT00346632|10602001|P9|Overall Study|Protocol Violation|0
3092140|NCT00346632|10602002|P8|Overall Study|Protocol Violation|0
3092141|NCT00346632|10602003|P7|Overall Study|Protocol Violation|1
3092142|NCT00346632|10602004|P6|Overall Study|Protocol Violation|0
3092143|NCT00346632|10602005|P5|Overall Study|Protocol Violation|0
3092144|NCT00346632|10602006|P4|Overall Study|Protocol Violation|0
3092145|NCT00346632|10602007|P3|Overall Study|Protocol Violation|0
3092146|NCT00346632|10602008|P2|Overall Study|Protocol Violation|0
3092147|NCT00346632|10602009|P1|Overall Study|Protocol Violation|0
3092148|NCT00346632|10602000|P10|Overall Study|Death|0
3092149|NCT00346632|10602001|P9|Overall Study|Death|0
3092150|NCT00346632|10602002|P8|Overall Study|Death|0
3092151|NCT00346632|10602003|P7|Overall Study|Death|0
3092152|NCT00346632|10602004|P6|Overall Study|Death|0
3092153|NCT00346632|10602005|P5|Overall Study|Death|0
3092154|NCT00346632|10602006|P4|Overall Study|Death|0
3092155|NCT00346632|10602007|P3|Overall Study|Death|1
3092156|NCT00346632|10602008|P2|Overall Study|Death|0
3092157|NCT00346632|10602009|P1|Overall Study|Death|0
3092158|NCT00346632|10602000|P10|Overall Study|Adverse Event|0
3092159|NCT00346632|10602001|P9|Overall Study|Adverse Event|0
3092160|NCT00346632|10602002|P8|Overall Study|Adverse Event|0
3092161|NCT00346632|10602003|P7|Overall Study|Adverse Event|1
3092162|NCT00346632|10602004|P6|Overall Study|Adverse Event|1
3092163|NCT00346632|10602005|P5|Overall Study|Adverse Event|1
3092164|NCT00346632|10602006|P4|Overall Study|Adverse Event|0
3092165|NCT00346632|10602007|P3|Overall Study|Adverse Event|0
3092166|NCT00346632|10602008|P2|Overall Study|Adverse Event|0
3092167|NCT00346632|10602009|P1|Overall Study|Adverse Event|0
3092168|NCT00346632|10602000|P10|Overall Study|Progressive Disease|2
3092169|NCT00346632|10602001|P9|Overall Study|Progressive Disease|2
3092170|NCT00346632|10602002|P8|Overall Study|Progressive Disease|2
3092171|NCT00346632|10602003|P7|Overall Study|Progressive Disease|2
3092172|NCT00346632|10602004|P6|Overall Study|Progressive Disease|1
3092173|NCT00346632|10602005|P5|Overall Study|Progressive Disease|3
3092174|NCT00346632|10602006|P4|Overall Study|Progressive Disease|3
3092175|NCT00346632|10602007|P3|Overall Study|Progressive Disease|4
3092176|NCT00346632|10602008|P2|Overall Study|Progressive Disease|2
3092177|NCT00346632|10602009|P1|Overall Study|Progressive Disease|2
3092178|NCT00346398|10602159|P2|Overall Study|Withdrawal by Subject|2
3092179|NCT00346398|10602160|P1|Overall Study|Withdrawal by Subject|0
3092180|NCT00346398|10602159|P2|Overall Study|Lost to Follow-up|0
3092181|NCT00346398|10602160|P1|Overall Study|Lost to Follow-up|3
3092182|NCT00346333|10602172|P2|Overall Study|unwilling or unable to continue|8
3092183|NCT00346333|10602173|P1|Overall Study|unwilling or unable to continue|4
3092184|NCT00346333|10602172|P2|Overall Study|Death|0
3092185|NCT00346333|10602173|P1|Overall Study|Death|1
3092186|NCT00346268|10602189|P2|Overall Study|Participant refused|3
3092187|NCT00346268|10602190|P1|Overall Study|Participant refused|0
3092188|NCT00346268|10602189|P2|Overall Study|Protocol Violation|0
3092189|NCT00346268|10602190|P1|Overall Study|Protocol Violation|1
3092190|NCT00346268|10602189|P2|Overall Study|Adverse Event|0
3092191|NCT00346268|10602190|P1|Overall Study|Adverse Event|1
3092192|NCT00346216|10602225|P3|Overall Study|Missing Subject Summary Status|62
3092193|NCT00346216|10602226|P2|Overall Study|Missing Subject Summary Status|61
3092194|NCT00346216|10602227|P1|Overall Study|Missing Subject Summary Status|62
3092195|NCT00346216|10602225|P3|Overall Study|Study terminated by sponsor|8
3092196|NCT00346216|10602226|P2|Overall Study|Study terminated by sponsor|4
3092197|NCT00346216|10602227|P1|Overall Study|Study terminated by sponsor|11
3092198|NCT00346216|10602225|P3|Overall Study|Death|228
3092199|NCT00346216|10602226|P2|Overall Study|Death|192
3092200|NCT00346216|10602227|P1|Overall Study|Death|189
3092201|NCT00346216|10602225|P3|Overall Study|Does not meet entrance criteria|8
3092202|NCT00346216|10602226|P2|Overall Study|Does not meet entrance criteria|10
3092203|NCT00346216|10602227|P1|Overall Study|Does not meet entrance criteria|13
3092204|NCT00346216|10602225|P3|Overall Study|Physician Decision|59
3092205|NCT00346216|10602226|P2|Overall Study|Physician Decision|76
3092206|NCT00346216|10602227|P1|Overall Study|Physician Decision|80
3092207|NCT00346216|10602225|P3|Overall Study|Lost to Follow-up|542
3092208|NCT00346216|10602226|P2|Overall Study|Lost to Follow-up|588
3092209|NCT00346216|10602227|P1|Overall Study|Lost to Follow-up|611
3092210|NCT00346216|10602225|P3|Overall Study|Withdrawal by Subject|651
3092211|NCT00346216|10602226|P2|Overall Study|Withdrawal by Subject|692
3092212|NCT00346216|10602227|P1|Overall Study|Withdrawal by Subject|661
3092213|NCT00346216|10602225|P3|Overall Study|No longer willing to participate|585
3092214|NCT00346216|10602226|P2|Overall Study|No longer willing to participate|606
3092215|NCT00346216|10602227|P1|Overall Study|No longer willing to participate|600
3092216|NCT00346216|10602225|P3|Overall Study|Other|205
3092217|NCT00346216|10602226|P2|Overall Study|Other|231
3092218|NCT00346216|10602227|P1|Overall Study|Other|181
3092219|NCT00346164|10602248|P4|Overall Study|Inability to start week 16 tx on time|11
3092220|NCT00346164|10602249|P3|Overall Study|Inability to start week 16 tx on time|0
3092221|NCT00346164|10602250|P2|Overall Study|Inability to start week 16 tx on time|0
3092222|NCT00346164|10602251|P1|Overall Study|Inability to start week 16 tx on time|0
3092223|NCT00346164|10602248|P4|Overall Study|Refusal of further protocol therapy|15
3092224|NCT00346164|10602249|P3|Overall Study|Refusal of further protocol therapy|3
3092225|NCT00346164|10602250|P2|Overall Study|Refusal of further protocol therapy|1
3092226|NCT00346164|10602251|P1|Overall Study|Refusal of further protocol therapy|0
3092227|NCT00346164|10602248|P4|Overall Study|Ineligible|23
3092228|NCT00346164|10602249|P3|Overall Study|Ineligible|2
3092229|NCT00346164|10602250|P2|Overall Study|Ineligible|2
3092230|NCT00346164|10602251|P1|Overall Study|Ineligible|11
3092231|NCT00346164|10602248|P4|Overall Study|Withdrawal by Subject|0
3092232|NCT00346164|10602249|P3|Overall Study|Withdrawal by Subject|2
3092233|NCT00346164|10602250|P2|Overall Study|Withdrawal by Subject|0
3092234|NCT00346164|10602251|P1|Overall Study|Withdrawal by Subject|0
3092235|NCT00346164|10602248|P4|Overall Study|Protocol Violation|4
3092236|NCT00346164|10602249|P3|Overall Study|Protocol Violation|10
3092237|NCT00346164|10602250|P2|Overall Study|Protocol Violation|2
3092238|NCT00346164|10602251|P1|Overall Study|Protocol Violation|6
3092239|NCT00346164|10602248|P4|Overall Study|Physician Decision|27
3092240|NCT00346164|10602249|P3|Overall Study|Physician Decision|2
3092241|NCT00346164|10602250|P2|Overall Study|Physician Decision|1
3092242|NCT00346164|10602251|P1|Overall Study|Physician Decision|0
3092243|NCT00346164|10602248|P4|Overall Study|Lack of Efficacy|25
3092244|NCT00346164|10602249|P3|Overall Study|Lack of Efficacy|7
3092245|NCT00346164|10602250|P2|Overall Study|Lack of Efficacy|1
3092246|NCT00346164|10602251|P1|Overall Study|Lack of Efficacy|0
3092247|NCT00346164|10602248|P4|Overall Study|Adverse Event|1
3092248|NCT00346164|10602249|P3|Overall Study|Adverse Event|0
3092249|NCT00346164|10602250|P2|Overall Study|Adverse Event|0
3092250|NCT00346164|10602251|P1|Overall Study|Adverse Event|0
3092251|NCT00346151|10602286|P1|Overall Study|Withdrawal by Subject|3
3092252|NCT00346073|10602306|P2|Overall Study|Lost to Follow-up|24
3092253|NCT00346073|10602307|P1|Overall Study|Lost to Follow-up|39
3092254|NCT00346073|10602306|P2|Overall Study|Serious Adverse Event|0
3092255|NCT00346073|10602307|P1|Overall Study|Serious Adverse Event|2
3092256|NCT00346034|10602341|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
3092257|NCT00346034|10602341|P1|Overall Study|Patient Stopped Taking Study Drug|1
3092258|NCT00346034|10602341|P1|Overall Study|Withdrawal by Subject|13
3092259|NCT00346034|10602341|P1|Overall Study|Lack of Efficacy|8
3092260|NCT00346034|10602341|P1|Overall Study|Adverse Event|34
3092261|NCT00345878|10602381|P2|Overall Study|Other|0
3092262|NCT00345878|10602382|P1|Overall Study|Other|1
3092263|NCT00345878|10602381|P2|Overall Study|Lost to Follow-up|1
3092264|NCT00345878|10602382|P1|Overall Study|Lost to Follow-up|2
3092265|NCT00345878|10602381|P2|Overall Study|Adverse Event|0
3092266|NCT00345878|10602382|P1|Overall Study|Adverse Event|1
3092267|NCT00345839|10602400|P2|Overall Study|Lost to Follow-up|61
3092268|NCT00345839|10602401|P1|Overall Study|Lost to Follow-up|58
3092269|NCT00345839|10602400|P2|Overall Study|Withdrawal by Subject|98
3092270|NCT00345839|10602401|P1|Overall Study|Withdrawal by Subject|91
3092271|NCT00345683|10602427|P2|Overall Study|Other|2
3092272|NCT00345683|10602428|P1|Overall Study|Other|6
3092273|NCT00345683|10602427|P2|Overall Study|Lost to Follow-up|7
3092274|NCT00345683|10602428|P1|Overall Study|Lost to Follow-up|19
3092275|NCT00345631|10602451|P3|Overall Study|Other reasons|1
3092276|NCT00345631|10602452|P2|Overall Study|Other reasons|0
3092277|NCT00345631|10602453|P1|Overall Study|Other reasons|0
3092278|NCT00345631|10602451|P3|Overall Study|Lost to Follow-up|4
3092279|NCT00345631|10602452|P2|Overall Study|Lost to Follow-up|7
3092280|NCT00345631|10602453|P1|Overall Study|Lost to Follow-up|3
3092281|NCT00345631|10602451|P3|Overall Study|Adverse Event|0
3092282|NCT00345631|10602452|P2|Overall Study|Adverse Event|1
3092283|NCT00345631|10602453|P1|Overall Study|Adverse Event|0
3092284|NCT00345631|10602451|P3|Overall Study|Withdrawal by Subject|1
3092285|NCT00345631|10602452|P2|Overall Study|Withdrawal by Subject|0
3092286|NCT00345631|10602453|P1|Overall Study|Withdrawal by Subject|1
3092287|NCT00345605|10602485|P2|Arm 2, Opposite Treatment|Adverse Event|0
3092288|NCT00345605|10602486|P1|Arm 2, Opposite Treatment|Adverse Event|1
3092289|NCT00345605|10602485|P2|Arm 1|Adverse Event|1
3092290|NCT00345605|10602486|P1|Arm 1|Adverse Event|0
3092291|NCT00345592|10602506|P2|Overall Study|Withdrawal by Subject|8
3092292|NCT00345592|10602507|P1|Overall Study|Withdrawal by Subject|11
3092293|NCT00345592|10602506|P2|Overall Study|Death|16
3092294|NCT00345592|10602507|P1|Overall Study|Death|14
3092295|NCT00345579|10602515|P2|Overall Study|Other|1
3092296|NCT00345579|10602516|P1|Overall Study|Other|9
3092297|NCT00345579|10602515|P2|Overall Study|Lost to Follow-up|36
3092298|NCT00345579|10602516|P1|Overall Study|Lost to Follow-up|82
3092299|NCT00345579|10602515|P2|Overall Study|Withdrawal by Subject|17
3092300|NCT00345579|10602516|P1|Overall Study|Withdrawal by Subject|50
3092301|NCT00345579|10602515|P2|Overall Study|Protocol Violation|5
3092302|NCT00345579|10602516|P1|Overall Study|Protocol Violation|14
3092303|NCT00345579|10602515|P2|Overall Study|Adverse Event|6
3092304|NCT00345579|10602516|P1|Overall Study|Adverse Event|9
3092305|NCT00345540|10602536|P1|Overall Study|Withdrawal by Subject|1
3092306|NCT00345397|10602542|P1|Overall Study|Death|1
3092307|NCT00345358|10602573|P4|Booster Vaccination Phase|Lost to Follow-up|0
3092308|NCT00345358|10602574|P3|Booster Vaccination Phase|Lost to Follow-up|0
3092309|NCT00345358|10602575|P2|Booster Vaccination Phase|Lost to Follow-up|0
3092310|NCT00345358|10602576|P1|Booster Vaccination Phase|Lost to Follow-up|3
3092311|NCT00345358|10602573|P4|Booster Vaccination Phase|Withdrawal by Subject|0
3092312|NCT00345358|10602574|P3|Booster Vaccination Phase|Withdrawal by Subject|0
3092313|NCT00345358|10602575|P2|Booster Vaccination Phase|Withdrawal by Subject|0
3092314|NCT00345358|10602576|P1|Booster Vaccination Phase|Withdrawal by Subject|1
3092315|NCT00345358|10602573|P4|Primary Vaccination Phase|Lost to Follow-up|2
3092316|NCT00345358|10602574|P3|Primary Vaccination Phase|Lost to Follow-up|2
3092317|NCT00345358|10602575|P2|Primary Vaccination Phase|Lost to Follow-up|0
3092318|NCT00345358|10602576|P1|Primary Vaccination Phase|Lost to Follow-up|1
3092319|NCT00345358|10602573|P4|Primary Vaccination Phase|Withdrawal by Subject|0
3092320|NCT00345358|10602574|P3|Primary Vaccination Phase|Withdrawal by Subject|4
3092321|NCT00345358|10602575|P2|Primary Vaccination Phase|Withdrawal by Subject|2
3092322|NCT00345358|10602576|P1|Primary Vaccination Phase|Withdrawal by Subject|1
3092323|NCT00345358|10602573|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
3092324|NCT00345358|10602574|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
3092325|NCT00345358|10602575|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
3092326|NCT00345358|10602576|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
3092327|NCT00345358|10602573|P4|Primary Vaccination Phase|Other|0
3092328|NCT00345358|10602574|P3|Primary Vaccination Phase|Other|1
3092329|NCT00345358|10602575|P2|Primary Vaccination Phase|Other|1
3092330|NCT00345358|10602576|P1|Primary Vaccination Phase|Other|0
3092331|NCT00345293|10602666|P2|Overall Study|Withdrawal by Subject|0
3092332|NCT00345293|10602667|P1|Overall Study|Withdrawal by Subject|1
3092333|NCT00345293|10602666|P2|Overall Study|Unable to access line for sample|0
3092334|NCT00345293|10602667|P1|Overall Study|Unable to access line for sample|1
3092335|NCT00345046|10602713|P3|Overall Study|Protocol Violation|2
3092336|NCT00345046|10602714|P2|Overall Study|Protocol Violation|1
3092337|NCT00345046|10602715|P1|Overall Study|Protocol Violation|1
3092338|NCT00344968|10602745|P3|Overall Study|Other|0
3092339|NCT00344968|10602746|P2|Overall Study|Other|1
3092340|NCT00344968|10602747|P1|Overall Study|Other|0
3092341|NCT00344968|10602745|P3|Overall Study|Death|31
3092342|NCT00344968|10602746|P2|Overall Study|Death|27
3092343|NCT00344968|10602747|P1|Overall Study|Death|11
3092344|NCT00344968|10602745|P3|Overall Study|Lost to Follow-up|37
3092345|NCT00344968|10602746|P2|Overall Study|Lost to Follow-up|37
3092346|NCT00344968|10602747|P1|Overall Study|Lost to Follow-up|24
3092347|NCT00344968|10602745|P3|Overall Study|Withdrawal by Subject|27
3092348|NCT00344968|10602746|P2|Overall Study|Withdrawal by Subject|31
3092349|NCT00344968|10602747|P1|Overall Study|Withdrawal by Subject|14
3092350|NCT00344968|10602745|P3|Overall Study|Protocol Violation|5
3092351|NCT00344968|10602746|P2|Overall Study|Protocol Violation|2
3092352|NCT00344968|10602747|P1|Overall Study|Protocol Violation|2
3092353|NCT00344968|10602745|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
3092354|NCT00344968|10602746|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
3092355|NCT00344968|10602747|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
3092356|NCT00344968|10602745|P3|Overall Study|Adverse Event|15
3092357|NCT00344968|10602746|P2|Overall Study|Adverse Event|4
3092358|NCT00344968|10602747|P1|Overall Study|Adverse Event|5
3092359|NCT00344773|10602758|P1|Overall Study|Not Eligible for the study|2
3092360|NCT00344773|10602758|P1|Overall Study|Withdrawal by Subject|1
3092361|NCT00344773|10602758|P1|Overall Study|Objective Disease Progression|16
3092362|NCT00344773|10602758|P1|Overall Study|Adverse Event|2
3092363|NCT00344500|10602781|P3|Overall Study|Not Noted|0
3092364|NCT00344500|10602782|P2|Overall Study|Not Noted|3
3092365|NCT00344500|10602783|P1|Overall Study|Not Noted|1
3092366|NCT00344500|10602781|P3|Overall Study|Protocol Violation|1
3092367|NCT00344500|10602782|P2|Overall Study|Protocol Violation|7
3092368|NCT00344500|10602783|P1|Overall Study|Protocol Violation|4
3092369|NCT00344500|10602781|P3|Overall Study|Withdrawal by Subject|0
3092370|NCT00344500|10602782|P2|Overall Study|Withdrawal by Subject|10
3092371|NCT00344500|10602783|P1|Overall Study|Withdrawal by Subject|7
3092372|NCT00344500|10602781|P3|Overall Study|Lost to Follow-up|1
3092373|NCT00344500|10602782|P2|Overall Study|Lost to Follow-up|13
3092374|NCT00344500|10602783|P1|Overall Study|Lost to Follow-up|5
3092375|NCT00344500|10602781|P3|Overall Study|Adverse Event|0
3092376|NCT00344500|10602782|P2|Overall Study|Adverse Event|2
3092377|NCT00344500|10602783|P1|Overall Study|Adverse Event|6
3092378|NCT00344487|10602794|P1|Overall Study|immunologic failure|1
3092379|NCT00344461|10602798|P1|Overall Study|Withdrawal by Subject|2
3092380|NCT00344461|10602798|P1|Overall Study|Protocol Violation|6
3092381|NCT00344461|10602798|P1|Overall Study|Physician Decision|2
3092382|NCT00344461|10602798|P1|Overall Study|Lost to Follow-up|2
3092383|NCT00344461|10602798|P1|Overall Study|Lack of Efficacy|2
3092384|NCT00344461|10602798|P1|Overall Study|Death|1
3092385|NCT00344461|10602798|P1|Overall Study|Adverse Event|6
3092386|NCT00344448|10602809|P2|Open Label|Study terminated|0
3092387|NCT00344448|10602810|P1|Open Label|Study terminated|1
3092388|NCT00344448|10602809|P2|Open Label|Withdrawal by Subject|1
3092389|NCT00344448|10602810|P1|Open Label|Withdrawal by Subject|1
3092390|NCT00344448|10602809|P2|Double Blind, Placebo Controlled|Study terminated|0
3092391|NCT00344448|10602810|P1|Double Blind, Placebo Controlled|Study terminated|1
3092392|NCT00344448|10602809|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
3092393|NCT00344448|10602810|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
3092394|NCT00344448|10602809|P2|Screening|Withdrawal by Subject|1
3092395|NCT00344448|10602810|P1|Screening|Withdrawal by Subject|0
3092396|NCT00344318|10602831|P4|Overall Study|Lost to Follow-up|0
3092397|NCT00344318|10602832|P3|Overall Study|Lost to Follow-up|1
3092398|NCT00344318|10602833|P2|Overall Study|Lost to Follow-up|0
3092399|NCT00344318|10602834|P1|Overall Study|Lost to Follow-up|2
3092400|NCT00344318|10602831|P4|Overall Study|Withdrawal by Subject|2
3092401|NCT00344318|10602832|P3|Overall Study|Withdrawal by Subject|0
3092402|NCT00344318|10602833|P2|Overall Study|Withdrawal by Subject|2
3092403|NCT00344318|10602834|P1|Overall Study|Withdrawal by Subject|2
3092404|NCT00344318|10602831|P4|Overall Study|Adverse Event|1
3092405|NCT00344318|10602832|P3|Overall Study|Adverse Event|0
3092406|NCT00344318|10602833|P2|Overall Study|Adverse Event|3
3092407|NCT00344318|10602834|P1|Overall Study|Adverse Event|0
3092408|NCT00344305|10602956|P2|Overall Study|Participant was not contacted in window|1
3092409|NCT00344305|10602957|P1|Overall Study|Participant was not contacted in window|0
3092410|NCT00344305|10602956|P2|Overall Study|Lost to Follow-up|0
3092411|NCT00344305|10602957|P1|Overall Study|Lost to Follow-up|2
3092412|NCT00344032|10603007|P2|Overall Study|Physician Decision|1
3092413|NCT00344032|10603008|P1|Overall Study|Physician Decision|4
3092414|NCT00344032|10603007|P2|Overall Study|Lost to Follow-up|6
3092415|NCT00344032|10603008|P1|Overall Study|Lost to Follow-up|4
3092416|NCT00344032|10603007|P2|Overall Study|Withdrawal by Subject|2
3092417|NCT00344032|10603008|P1|Overall Study|Withdrawal by Subject|6
3092418|NCT00344032|10603007|P2|Overall Study|Adverse Event|1
3092419|NCT00344032|10603008|P1|Overall Study|Adverse Event|0
3092420|NCT00344019|10603027|P3|Overall Study|did not meet final inclusion criteria|74
3092421|NCT00344019|10603028|P2|Overall Study|did not meet final inclusion criteria|0
3092422|NCT00344019|10603029|P1|Overall Study|did not meet final inclusion criteria|0
3092423|NCT00343915|10603047|P2|Primary Study|Other|0
3092424|NCT00343915|10603048|P1|Primary Study|Other|1
3092425|NCT00343915|10603047|P2|Primary Study|Lost to Follow-up|3
3092426|NCT00343915|10603048|P1|Primary Study|Lost to Follow-up|2
3092427|NCT00343915|10603047|P2|Primary Study|Withdrawal by Subject|0
3092428|NCT00343915|10603048|P1|Primary Study|Withdrawal by Subject|1
3092429|NCT00343889|10603074|P2|Overall Study|Protocol Violation|0
3092430|NCT00343889|10603075|P1|Overall Study|Protocol Violation|1
3092431|NCT00343889|10603074|P2|Overall Study|Withdrawal by Subject|1
3092432|NCT00343889|10603075|P1|Overall Study|Withdrawal by Subject|0
3092433|NCT00343889|10603074|P2|Overall Study|Lost to Follow-up|0
3092434|NCT00343889|10603075|P1|Overall Study|Lost to Follow-up|2
3092435|NCT00343512|10603239|P1|Overall Study|Withdrawal by Subject|2
3092436|NCT00343382|10603327|P3|Overall Study|Other Reason Not Specified|4
3092437|NCT00343382|10603328|P2|Overall Study|Other Reason Not Specified|2
3092438|NCT00343382|10603329|P1|Overall Study|Other Reason Not Specified|1
3092439|NCT00343382|10603327|P3|Overall Study|Withdrawal by Subject|6
3092440|NCT00343382|10603328|P2|Overall Study|Withdrawal by Subject|2
3092441|NCT00343382|10603329|P1|Overall Study|Withdrawal by Subject|1
3092442|NCT00343382|10603327|P3|Overall Study|Adverse Event|7
3092443|NCT00343382|10603328|P2|Overall Study|Adverse Event|10
3092444|NCT00343382|10603329|P1|Overall Study|Adverse Event|2
3092445|NCT00343291|10603348|P2|Overall Study|Other|5
3092446|NCT00343291|10603349|P1|Overall Study|Other|8
3092447|NCT00343291|10603348|P2|Overall Study|Withdrawal by Subject|2
3092448|NCT00343291|10603349|P1|Overall Study|Withdrawal by Subject|0
3092449|NCT00343291|10603348|P2|Overall Study|Progressive disease|34
3092450|NCT00343291|10603349|P1|Overall Study|Progressive disease|33
3092451|NCT00343291|10603348|P2|Overall Study|Death|2
3092452|NCT00343291|10603349|P1|Overall Study|Death|3
3092453|NCT00343291|10603348|P2|Overall Study|Adverse Event|13
3092454|NCT00343291|10603349|P1|Overall Study|Adverse Event|13
3092455|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
3092456|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
3092457|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Sponsor Decision|5
3092458|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Sponsor Decision|8
3092459|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Protocol Violation|3
3092460|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Protocol Violation|3
3092461|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Physician Decision|7
3092462|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Physician Decision|4
3092463|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
3092464|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
3092465|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
3092466|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
3092467|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
3092468|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
3092469|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Death|5
3092470|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Death|4
3092471|NCT00343252|10603365|P2|18 Months (All Treated Participants)|Adverse Event|23
3092472|NCT00343252|10603366|P1|18 Months (All Treated Participants)|Adverse Event|31
3092473|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
3092474|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
3092475|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Sponsor Decision|6
3092476|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Sponsor Decision|9
3092477|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Protocol Violation|2
3092478|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Protocol Violation|3
3092479|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Physician Decision|5
3092480|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Physician Decision|4
3092481|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
3092482|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
3092483|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
3092484|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
3092485|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
3092486|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
3092487|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Death|3
3092488|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Death|3
3092489|NCT00343252|10603365|P2|12 Months (All Treated Participants)|Adverse Event|20
3092490|NCT00343252|10603366|P1|12 Months (All Treated Participants)|Adverse Event|22
3092491|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
3092492|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
3092493|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Sponsor Decision|4
3092494|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Sponsor Decision|7
3092495|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Protocol Violation|2
3092496|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Protocol Violation|2
3092497|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Physician Decision|3
3092498|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Physician Decision|1
3092499|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
3092500|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
3092501|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
3092502|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
3092503|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
3092504|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
3092505|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Death|2
3092506|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Death|0
3092507|NCT00343252|10603365|P2|6 Months (All Treated Participants)|Adverse Event|11
3092508|NCT00343252|10603366|P1|6 Months (All Treated Participants)|Adverse Event|17
3092509|NCT00342628|10603431|P3|Overall Study|moved residence|1
3092510|NCT00342628|10603432|P2|Overall Study|moved residence|1
3092511|NCT00342628|10603433|P1|Overall Study|moved residence|0
3092512|NCT00342628|10603431|P3|Overall Study|Death|0
3092513|NCT00342628|10603432|P2|Overall Study|Death|1
3092514|NCT00342628|10603433|P1|Overall Study|Death|1
3092515|NCT00342628|10603431|P3|Overall Study|Withdrawal by Subject|18
3092516|NCT00342628|10603432|P2|Overall Study|Withdrawal by Subject|19
3092517|NCT00342628|10603433|P1|Overall Study|Withdrawal by Subject|19
3092518|NCT00340834|10603499|P5|Extension Phase of Study|Death|1
3092519|NCT00340834|10603500|P4|Extension Phase of Study|Death|0
3092520|NCT00340834|10603501|P3|Extension Phase of Study|Death|0
3092521|NCT00340834|10603502|P2|Extension Phase of Study|Death|0
3092522|NCT00340834|10603503|P1|Extension Phase of Study|Death|0
3092523|NCT00340834|10603499|P5|Extension Phase of Study|Protocol Violation|0
3092524|NCT00340834|10603500|P4|Extension Phase of Study|Protocol Violation|0
3092525|NCT00340834|10603501|P3|Extension Phase of Study|Protocol Violation|0
3092526|NCT00340834|10603502|P2|Extension Phase of Study|Protocol Violation|0
3092527|NCT00340834|10603503|P1|Extension Phase of Study|Protocol Violation|3
3092528|NCT00340834|10603499|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
3092529|NCT00340834|10603500|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
3092530|NCT00340834|10603501|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
3092531|NCT00340834|10603502|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
3092532|NCT00340834|10603503|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
3092533|NCT00340834|10603499|P5|Extension Phase of Study|Administrative problems|1
3092534|NCT00340834|10603500|P4|Extension Phase of Study|Administrative problems|1
3092535|NCT00340834|10603501|P3|Extension Phase of Study|Administrative problems|0
3092536|NCT00340834|10603502|P2|Extension Phase of Study|Administrative problems|0
3092537|NCT00340834|10603503|P1|Extension Phase of Study|Administrative problems|3
3092538|NCT00340834|10603499|P5|Extension Phase of Study|Subject no longer requires study drug|2
3092539|NCT00340834|10603500|P4|Extension Phase of Study|Subject no longer requires study drug|0
3092540|NCT00340834|10603501|P3|Extension Phase of Study|Subject no longer requires study drug|0
3092541|NCT00340834|10603502|P2|Extension Phase of Study|Subject no longer requires study drug|0
3092542|NCT00340834|10603503|P1|Extension Phase of Study|Subject no longer requires study drug|4
3092543|NCT00340834|10603499|P5|Extension Phase of Study|Lost to Follow-up|3
3092544|NCT00340834|10603500|P4|Extension Phase of Study|Lost to Follow-up|2
3092545|NCT00340834|10603501|P3|Extension Phase of Study|Lost to Follow-up|0
3092546|NCT00340834|10603502|P2|Extension Phase of Study|Lost to Follow-up|1
3092547|NCT00340834|10603503|P1|Extension Phase of Study|Lost to Follow-up|1
3092548|NCT00340834|10603499|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
3092549|NCT00340834|10603500|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
3092550|NCT00340834|10603501|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
3092551|NCT00340834|10603502|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
3092552|NCT00340834|10603503|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
3092553|NCT00340834|10603499|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
3092554|NCT00340834|10603500|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
3092555|NCT00340834|10603501|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
3092556|NCT00340834|10603502|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
3092557|NCT00340834|10603503|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
3092558|NCT00340834|10603499|P5|Extension Phase of Study|Adverse Event|7
3092559|NCT00340834|10603500|P4|Extension Phase of Study|Adverse Event|19
3092560|NCT00340834|10603501|P3|Extension Phase of Study|Adverse Event|0
3092561|NCT00340834|10603502|P2|Extension Phase of Study|Adverse Event|22
3092562|NCT00340834|10603503|P1|Extension Phase of Study|Adverse Event|21
3092563|NCT00340834|10603499|P5|Extension Phase of Study|Subject withdrew consent|15
3092564|NCT00340834|10603500|P4|Extension Phase of Study|Subject withdrew consent|12
3092565|NCT00340834|10603501|P3|Extension Phase of Study|Subject withdrew consent|0
3092566|NCT00340834|10603502|P2|Extension Phase of Study|Subject withdrew consent|31
3092567|NCT00340834|10603503|P1|Extension Phase of Study|Subject withdrew consent|26
3092568|NCT00340834|10603499|P5|Extension Phase of Study|Subject did not receive study drug|0
3092569|NCT00340834|10603500|P4|Extension Phase of Study|Subject did not receive study drug|2
3092570|NCT00340834|10603501|P3|Extension Phase of Study|Subject did not receive study drug|0
3092571|NCT00340834|10603502|P2|Extension Phase of Study|Subject did not receive study drug|1
3092572|NCT00340834|10603503|P1|Extension Phase of Study|Subject did not receive study drug|0
3092573|NCT00340834|10603499|P5|Core Phase of Study|Protocol Violation|0
3092574|NCT00340834|10603500|P4|Core Phase of Study|Protocol Violation|0
3092575|NCT00340834|10603501|P3|Core Phase of Study|Protocol Violation|2
3092576|NCT00340834|10603502|P2|Core Phase of Study|Protocol Violation|0
3092577|NCT00340834|10603503|P1|Core Phase of Study|Protocol Violation|0
3092578|NCT00340834|10603499|P5|Core Phase of Study|Death|0
3092579|NCT00340834|10603500|P4|Core Phase of Study|Death|0
3092580|NCT00340834|10603501|P3|Core Phase of Study|Death|0
3092581|NCT00340834|10603502|P2|Core Phase of Study|Death|0
3092582|NCT00340834|10603503|P1|Core Phase of Study|Death|2
3092583|NCT00340834|10603499|P5|Core Phase of Study|Lost to Follow-up|0
3092584|NCT00340834|10603500|P4|Core Phase of Study|Lost to Follow-up|0
3092585|NCT00340834|10603501|P3|Core Phase of Study|Lost to Follow-up|4
3092586|NCT00340834|10603502|P2|Core Phase of Study|Lost to Follow-up|1
3092587|NCT00340834|10603503|P1|Core Phase of Study|Lost to Follow-up|1
3092588|NCT00340834|10603499|P5|Core Phase of Study|Abnormal test procedure result(s)|0
3092589|NCT00340834|10603500|P4|Core Phase of Study|Abnormal test procedure result(s)|0
3092590|NCT00340834|10603501|P3|Core Phase of Study|Abnormal test procedure result(s)|3
3092591|NCT00340834|10603502|P2|Core Phase of Study|Abnormal test procedure result(s)|3
3092592|NCT00340834|10603503|P1|Core Phase of Study|Abnormal test procedure result(s)|4
3092593|NCT00340834|10603499|P5|Core Phase of Study|Abnormal laboratory value(s)|0
3092594|NCT00340834|10603500|P4|Core Phase of Study|Abnormal laboratory value(s)|0
3092595|NCT00340834|10603501|P3|Core Phase of Study|Abnormal laboratory value(s)|1
3092596|NCT00340834|10603502|P2|Core Phase of Study|Abnormal laboratory value(s)|6
3092597|NCT00340834|10603503|P1|Core Phase of Study|Abnormal laboratory value(s)|4
3092598|NCT00340834|10603499|P5|Core Phase of Study|Lack of Efficacy|0
3092599|NCT00340834|10603500|P4|Core Phase of Study|Lack of Efficacy|0
3092600|NCT00340834|10603501|P3|Core Phase of Study|Lack of Efficacy|7
3092601|NCT00340834|10603502|P2|Core Phase of Study|Lack of Efficacy|3
3092602|NCT00340834|10603503|P1|Core Phase of Study|Lack of Efficacy|3
3092603|NCT00340834|10603499|P5|Core Phase of Study|Administrative Problems|0
3092604|NCT00340834|10603500|P4|Core Phase of Study|Administrative Problems|0
3092605|NCT00340834|10603501|P3|Core Phase of Study|Administrative Problems|7
3092606|NCT00340834|10603502|P2|Core Phase of Study|Administrative Problems|2
3092607|NCT00340834|10603503|P1|Core Phase of Study|Administrative Problems|6
3092608|NCT00340834|10603499|P5|Core Phase of Study|Withdrawal by Subject|0
3092609|NCT00340834|10603500|P4|Core Phase of Study|Withdrawal by Subject|0
3092610|NCT00340834|10603501|P3|Core Phase of Study|Withdrawal by Subject|16
3092611|NCT00340834|10603502|P2|Core Phase of Study|Withdrawal by Subject|9
3092612|NCT00340834|10603503|P1|Core Phase of Study|Withdrawal by Subject|11
3092613|NCT00340834|10603499|P5|Core Phase of Study|Adverse Event|0
3092614|NCT00340834|10603500|P4|Core Phase of Study|Adverse Event|0
3092615|NCT00340834|10603501|P3|Core Phase of Study|Adverse Event|9
3092616|NCT00340834|10603502|P2|Core Phase of Study|Adverse Event|9
3092617|NCT00340834|10603503|P1|Core Phase of Study|Adverse Event|26
3092618|NCT00340704|10603537|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
3092619|NCT00340704|10603538|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
3092620|NCT00340704|10603539|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
3092621|NCT00340704|10603540|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
3092622|NCT00340704|10603541|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
3092623|NCT00340704|10603542|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
3092624|NCT00340704|10603543|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
3092625|NCT00340704|10603544|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
3092626|NCT00340704|10603545|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
3092627|NCT00340704|10603537|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092628|NCT00340704|10603538|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092629|NCT00340704|10603539|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092630|NCT00340704|10603540|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
3092631|NCT00340704|10603541|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
3092632|NCT00340704|10603542|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092633|NCT00340704|10603543|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092634|NCT00340704|10603544|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092635|NCT00340704|10603545|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
3092636|NCT00340704|10603537|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092637|NCT00340704|10603538|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092638|NCT00340704|10603539|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092639|NCT00340704|10603540|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
3092640|NCT00340704|10603541|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092641|NCT00340704|10603542|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092642|NCT00340704|10603543|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092643|NCT00340704|10603544|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092644|NCT00340704|10603545|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
3092645|NCT00340704|10603537|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
3092646|NCT00340704|10603538|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
3092647|NCT00340704|10603539|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
3092648|NCT00340704|10603540|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
3092649|NCT00340704|10603541|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
3092650|NCT00340704|10603542|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
3092651|NCT00340704|10603543|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
3092652|NCT00340704|10603544|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
3092653|NCT00340704|10603545|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
3092654|NCT00340704|10603537|P9|PK Study|Not treated|0
3092655|NCT00340704|10603538|P8|PK Study|Not treated|0
3092656|NCT00340704|10603539|P7|PK Study|Not treated|0
3092657|NCT00340704|10603540|P6|PK Study|Not treated|0
3092658|NCT00340704|10603541|P5|PK Study|Not treated|0
3092659|NCT00340704|10603542|P4|PK Study|Not treated|0
3092660|NCT00340704|10603543|P3|PK Study|Not treated|1
3092661|NCT00340704|10603544|P2|PK Study|Not treated|0
3092662|NCT00340704|10603545|P1|PK Study|Not treated|0
3092663|NCT00340704|10603537|P9|PK Study|Adverse Event|0
3092664|NCT00340704|10603538|P8|PK Study|Adverse Event|0
3092665|NCT00340704|10603539|P7|PK Study|Adverse Event|0
3092666|NCT00340704|10603540|P6|PK Study|Adverse Event|0
3092667|NCT00340704|10603541|P5|PK Study|Adverse Event|0
3092668|NCT00340704|10603542|P4|PK Study|Adverse Event|0
3092669|NCT00340704|10603543|P3|PK Study|Adverse Event|0
3092670|NCT00340704|10603544|P2|PK Study|Adverse Event|1
3092671|NCT00340704|10603545|P1|PK Study|Adverse Event|0
3092672|NCT00340678|10603651|P4|Overall Study|Lost to Follow-up|0
3092673|NCT00340678|10603652|P3|Overall Study|Lost to Follow-up|0
3092674|NCT00340678|10603653|P2|Overall Study|Lost to Follow-up|0
3092675|NCT00340678|10603654|P1|Overall Study|Lost to Follow-up|1
3092676|NCT00339833|10603681|P2|Overall Study|Error in data records|0
3092677|NCT00339833|10603682|P1|Overall Study|Error in data records|1
3092678|NCT00339833|10603681|P2|Overall Study|anaemia or excess drop in glycaemia|0
3092679|NCT00339833|10603682|P1|Overall Study|anaemia or excess drop in glycaemia|2
3092680|NCT00339833|10603681|P2|Overall Study|Poor venous access|2
3092681|NCT00339833|10603682|P1|Overall Study|Poor venous access|2
3092682|NCT00339833|10603681|P2|Overall Study|minor infection|1
3092683|NCT00339833|10603682|P1|Overall Study|minor infection|0
3092684|NCT00339833|10603681|P2|Overall Study|Chest pain|1
3092685|NCT00339833|10603682|P1|Overall Study|Chest pain|0
3092686|NCT00339833|10603681|P2|Overall Study|indigestion|1
3092687|NCT00339833|10603682|P1|Overall Study|indigestion|0
3092688|NCT00339833|10603681|P2|Overall Study|toothache|1
3092689|NCT00339833|10603682|P1|Overall Study|toothache|0
3092690|NCT00339833|10603681|P2|Overall Study|Withdrawal by Subject|2
3092691|NCT00339833|10603682|P1|Overall Study|Withdrawal by Subject|1
3092692|NCT00339183|10603692|P2|Overall Study|Ongoing|13
3092693|NCT00339183|10603693|P1|Overall Study|Ongoing|20
3092694|NCT00339183|10603692|P2|Overall Study|Other|40
3092695|NCT00339183|10603693|P1|Overall Study|Other|46
3092696|NCT00339183|10603692|P2|Overall Study|Missing reason|1
3092697|NCT00339183|10603693|P1|Overall Study|Missing reason|3
3092698|NCT00339183|10603692|P2|Overall Study|Protocol-specified criteria|8
3092699|NCT00339183|10603693|P1|Overall Study|Protocol-specified criteria|12
3092700|NCT00339183|10603692|P2|Overall Study|Lost to Follow-up|17
3092701|NCT00339183|10603693|P1|Overall Study|Lost to Follow-up|17
3092702|NCT00339183|10603692|P2|Overall Study|Physician Decision|4
3092703|NCT00339183|10603693|P1|Overall Study|Physician Decision|2
3092704|NCT00339183|10603692|P2|Overall Study|Withdrawal by Subject|19
3092705|NCT00339183|10603693|P1|Overall Study|Withdrawal by Subject|16
3092706|NCT00339183|10603692|P2|Overall Study|Adverse Event|3
3092707|NCT00339183|10603693|P1|Overall Study|Adverse Event|5
3092708|NCT00339144|10603722|P3|Overall Study|Participant's request to discontinuation|1
3092709|NCT00339144|10603723|P2|Overall Study|Participant's request to discontinuation|0
3092710|NCT00339144|10603724|P1|Overall Study|Participant's request to discontinuation|1
3092711|NCT00339144|10603722|P3|Overall Study|Study drug toxicity|1
3092712|NCT00339144|10603723|P2|Overall Study|Study drug toxicity|1
3092713|NCT00339144|10603724|P1|Overall Study|Study drug toxicity|3
3092714|NCT00339144|10603722|P3|Overall Study|Disease progression|2
3092715|NCT00339144|10603723|P2|Overall Study|Disease progression|2
3092716|NCT00339144|10603724|P1|Overall Study|Disease progression|5
3092717|NCT00339040|10603829|P2|Stage II|Site closing|0
3092718|NCT00339040|10603830|P1|Stage II|Site closing|2
3092719|NCT00339040|10603829|P2|Stage II|Not able to attend clinic|0
3092720|NCT00339040|10603830|P1|Stage II|Not able to attend clinic|1
3092721|NCT00339040|10603829|P2|Stage II|Protocol Violation|0
3092722|NCT00339040|10603830|P1|Stage II|Protocol Violation|3
3092723|NCT00339040|10603829|P2|Stage II|Withdrawal by Subject|2
3092724|NCT00339040|10603830|P1|Stage II|Withdrawal by Subject|1
3092725|NCT00339040|10603829|P2|Stage II|Lost to Follow-up|0
3092726|NCT00339040|10603830|P1|Stage II|Lost to Follow-up|3
3092727|NCT00339040|10603829|P2|Stage I|Protocol Violation|1
3092728|NCT00339040|10603830|P1|Stage I|Protocol Violation|1
3092729|NCT00339040|10603829|P2|Stage I|Not able to attend clinic|0
3092730|NCT00339040|10603830|P1|Stage I|Not able to attend clinic|1
3092731|NCT00338962|10603857|P4|Overall Study|Poor Compliance|0
3092732|NCT00338962|10603858|P3|Overall Study|Poor Compliance|2
3092733|NCT00338962|10603859|P2|Overall Study|Poor Compliance|0
3092734|NCT00338962|10603860|P1|Overall Study|Poor Compliance|0
3092735|NCT00338962|10603857|P4|Overall Study|Adverse Event|0
3092736|NCT00338962|10603858|P3|Overall Study|Adverse Event|2
3092737|NCT00338962|10603859|P2|Overall Study|Adverse Event|0
3092738|NCT00338962|10603860|P1|Overall Study|Adverse Event|0
3092739|NCT00338962|10603857|P4|Overall Study|Moved|0
3092740|NCT00338962|10603858|P3|Overall Study|Moved|0
3092741|NCT00338962|10603859|P2|Overall Study|Moved|1
3092742|NCT00338962|10603860|P1|Overall Study|Moved|0
3092743|NCT00338962|10603857|P4|Overall Study|Time Constraint|0
3092744|NCT00338962|10603858|P3|Overall Study|Time Constraint|0
3092745|NCT00338962|10603859|P2|Overall Study|Time Constraint|0
3092746|NCT00338962|10603860|P1|Overall Study|Time Constraint|2
3092747|NCT00338962|10603857|P4|Overall Study|No Transportation|0
3092748|NCT00338962|10603858|P3|Overall Study|No Transportation|0
3092749|NCT00338962|10603859|P2|Overall Study|No Transportation|0
3092750|NCT00338962|10603860|P1|Overall Study|No Transportation|2
3092751|NCT00338962|10603857|P4|Overall Study|Withdrawal by Subject|0
3092752|NCT00338962|10603858|P3|Overall Study|Withdrawal by Subject|0
3092753|NCT00338962|10603859|P2|Overall Study|Withdrawal by Subject|0
3092754|NCT00338962|10603860|P1|Overall Study|Withdrawal by Subject|1
3092755|NCT00338962|10603857|P4|Overall Study|Lost to Follow-up|3
3092756|NCT00338962|10603858|P3|Overall Study|Lost to Follow-up|2
3092757|NCT00338962|10603859|P2|Overall Study|Lost to Follow-up|3
3092758|NCT00338962|10603860|P1|Overall Study|Lost to Follow-up|3
3092759|NCT00338884|10603882|P1|Overall Study|Randomized But Did Not Receive Treatment|1
3092760|NCT00338884|10603882|P1|Overall Study|Lost to Follow-up|1
3092761|NCT00338884|10603882|P1|Overall Study|Withdrawal by Subject|3
3092762|NCT00338884|10603882|P1|Overall Study|Global Deterioration of Health Status|3
3092763|NCT00338884|10603882|P1|Overall Study|Other|4
3092764|NCT00338884|10603882|P1|Overall Study|Death|8
3092765|NCT00338884|10603882|P1|Overall Study|Adverse Event|14
3092766|NCT00338884|10603882|P1|Overall Study|Objective Disease Progression or Relapse|44
3092767|NCT00338806|10603916|P2|Follow-up|Lost to Follow-up|3
3092768|NCT00338806|10603917|P1|Follow-up|Lost to Follow-up|1
3092769|NCT00338806|10603916|P2|Acute Phase|Withdrawal by Subject|1
3092770|NCT00338806|10603917|P1|Acute Phase|Withdrawal by Subject|0
3092771|NCT00338741|10603979|P2|Overall Study|Lost to Follow-up|0
3092772|NCT00338741|10603980|P1|Overall Study|Lost to Follow-up|2
3092773|NCT00338728|10603988|P1|Overall Study|Screen Failure|14
3092774|NCT00338455|10604016|P2|Overall Study|Physician Decision|0
3092775|NCT00338455|10604017|P1|Overall Study|Physician Decision|1
3092776|NCT00338455|10604016|P2|Overall Study|Death|1
3092777|NCT00338455|10604017|P1|Overall Study|Death|2
3092778|NCT00338286|10604031|P2|Overall Study|Other|93
3092779|NCT00338286|10604032|P1|Overall Study|Other|103
3092780|NCT00338286|10604031|P2|Overall Study|Lost to Follow-up|66
3092781|NCT00338286|10604032|P1|Overall Study|Lost to Follow-up|80
3092782|NCT00338286|10604031|P2|Overall Study|Withdrawal by Subject|54
3092783|NCT00338286|10604032|P1|Overall Study|Withdrawal by Subject|50
3092784|NCT00338104|10604049|P3|Overall Study|Protocol Violation|3
3092785|NCT00338104|10604050|P2|Overall Study|Protocol Violation|1
3092786|NCT00338104|10604051|P1|Overall Study|Protocol Violation|2
3092787|NCT00337935|10604074|P2|Overall Study|Lack of Efficacy|1
3092788|NCT00337935|10604075|P1|Overall Study|Lack of Efficacy|0
3092789|NCT00337935|10604074|P2|Overall Study|Other|1
3092790|NCT00337935|10604075|P1|Overall Study|Other|0
3092791|NCT00337935|10604074|P2|Overall Study|Withdrawal by Subject|7
3092792|NCT00337935|10604075|P1|Overall Study|Withdrawal by Subject|1
3092793|NCT00337935|10604074|P2|Overall Study|Protocol Violation|3
3092794|NCT00337935|10604075|P1|Overall Study|Protocol Violation|4
3092795|NCT00337935|10604074|P2|Overall Study|Lost to Follow-up|1
3092796|NCT00337935|10604075|P1|Overall Study|Lost to Follow-up|0
3092797|NCT00337935|10604074|P2|Overall Study|Physician Decision|1
3092798|NCT00337935|10604075|P1|Overall Study|Physician Decision|1
3092799|NCT00337935|10604074|P2|Overall Study|Death|8
3092800|NCT00337935|10604075|P1|Overall Study|Death|2
3092801|NCT00337935|10604074|P2|Overall Study|Adverse Event|5
3092802|NCT00337935|10604075|P1|Overall Study|Adverse Event|2
3092803|NCT00337818|10604088|P3|Overall Study|Lost to Follow-up|107
3092804|NCT00337818|10604089|P2|Overall Study|Lost to Follow-up|91
3092805|NCT00337818|10604090|P1|Overall Study|Lost to Follow-up|289
3092806|NCT00337779|10604112|P2|Overall Study|Death|1
3092807|NCT00337779|10604113|P1|Overall Study|Death|0
3092808|NCT00337779|10604112|P2|Overall Study|Pregnancy|2
3092809|NCT00337779|10604113|P1|Overall Study|Pregnancy|3
3092810|NCT00337779|10604112|P2|Overall Study|Adverse Event|51
3092811|NCT00337779|10604113|P1|Overall Study|Adverse Event|28
3092812|NCT00337779|10604112|P2|Overall Study|Lost to Follow-up|5
3092813|NCT00337779|10604113|P1|Overall Study|Lost to Follow-up|6
3092814|NCT00337779|10604112|P2|Overall Study|Protocol Violation|1
3092815|NCT00337779|10604113|P1|Overall Study|Protocol Violation|1
3092816|NCT00337779|10604112|P2|Overall Study|Physician Decision|6
3092817|NCT00337779|10604113|P1|Overall Study|Physician Decision|3
3092818|NCT00337779|10604112|P2|Overall Study|Sponsor decision|1
3092819|NCT00337779|10604113|P1|Overall Study|Sponsor decision|1
3092820|NCT00337779|10604112|P2|Overall Study|Withdrawal by Subject|12
3092821|NCT00337779|10604113|P1|Overall Study|Withdrawal by Subject|10
3092822|NCT00337727|10604125|P2|Overall Study|Withdrawal by Subject|5
3092823|NCT00337727|10604126|P1|Overall Study|Withdrawal by Subject|3
3092824|NCT00337727|10604125|P2|Overall Study|Protocol Violation|0
3092825|NCT00337727|10604126|P1|Overall Study|Protocol Violation|4
3092826|NCT00337727|10604125|P2|Overall Study|Physician Decision|0
3092827|NCT00337727|10604126|P1|Overall Study|Physician Decision|1
3092828|NCT00337727|10604125|P2|Overall Study|Lost to Follow-up|4
3092829|NCT00337727|10604126|P1|Overall Study|Lost to Follow-up|5
3092830|NCT00337727|10604125|P2|Overall Study|Adverse Event|3
3092831|NCT00337727|10604126|P1|Overall Study|Adverse Event|5
3092832|NCT00337675|10604137|P3|Overall Study|Trial Terminated|2
3092833|NCT00337675|10604138|P2|Overall Study|Trial Terminated|0
3092834|NCT00337675|10604139|P1|Overall Study|Trial Terminated|0
3092835|NCT00337675|10604137|P3|Overall Study|Progressive Disease|0
3092836|NCT00337675|10604138|P2|Overall Study|Progressive Disease|2
3092837|NCT00337675|10604139|P1|Overall Study|Progressive Disease|0
3092838|NCT00337675|10604137|P3|Overall Study|Withdrawal by Subject|19
3092839|NCT00337675|10604138|P2|Overall Study|Withdrawal by Subject|25
3092840|NCT00337675|10604139|P1|Overall Study|Withdrawal by Subject|25
3092841|NCT00337675|10604137|P3|Overall Study|Protocol Violation|19
3092842|NCT00337675|10604138|P2|Overall Study|Protocol Violation|24
3092843|NCT00337675|10604139|P1|Overall Study|Protocol Violation|21
3092844|NCT00337675|10604137|P3|Overall Study|Physician Decision|14
3092845|NCT00337675|10604138|P2|Overall Study|Physician Decision|17
3092846|NCT00337675|10604139|P1|Overall Study|Physician Decision|9
3092847|NCT00337675|10604137|P3|Overall Study|Lost to Follow-up|17
3092848|NCT00337675|10604138|P2|Overall Study|Lost to Follow-up|19
3092849|NCT00337675|10604139|P1|Overall Study|Lost to Follow-up|22
3092850|NCT00337675|10604137|P3|Overall Study|Lack of Efficacy|9
3092851|NCT00337675|10604138|P2|Overall Study|Lack of Efficacy|7
3092852|NCT00337675|10604139|P1|Overall Study|Lack of Efficacy|10
3092853|NCT00337675|10604137|P3|Overall Study|Adverse Event|19
3092854|NCT00337675|10604138|P2|Overall Study|Adverse Event|9
3092855|NCT00337675|10604139|P1|Overall Study|Adverse Event|10
3092856|NCT00337662|10604156|P4|Study Period III|Clinical Relapse|0
3092857|NCT00337662|10604157|P3|Study Period III|Clinical Relapse|0
3092858|NCT00337662|10604158|P2|Study Period III|Clinical Relapse|0
3092859|NCT00337662|10604159|P1|Study Period III|Clinical Relapse|1
3092860|NCT00337662|10604156|P4|Study Period III|Sponsor Decision|0
3092861|NCT00337662|10604157|P3|Study Period III|Sponsor Decision|1
3092862|NCT00337662|10604158|P2|Study Period III|Sponsor Decision|0
3092863|NCT00337662|10604159|P1|Study Period III|Sponsor Decision|1
3092864|NCT00337662|10604156|P4|Study Period III|Parent/Caregiver Decision|0
3092865|NCT00337662|10604157|P3|Study Period III|Parent/Caregiver Decision|2
3092866|NCT00337662|10604158|P2|Study Period III|Parent/Caregiver Decision|0
3092867|NCT00337662|10604159|P1|Study Period III|Parent/Caregiver Decision|0
3092868|NCT00337662|10604156|P4|Study Period III|Lack of Efficacy|0
3092869|NCT00337662|10604157|P3|Study Period III|Lack of Efficacy|2
3092870|NCT00337662|10604158|P2|Study Period III|Lack of Efficacy|4
3092871|NCT00337662|10604159|P1|Study Period III|Lack of Efficacy|4
3092872|NCT00337662|10604156|P4|Study Period III|Entry Criteria Not Met|0
3092873|NCT00337662|10604157|P3|Study Period III|Entry Criteria Not Met|3
3092874|NCT00337662|10604158|P2|Study Period III|Entry Criteria Not Met|1
3092875|NCT00337662|10604159|P1|Study Period III|Entry Criteria Not Met|4
3092876|NCT00337662|10604156|P4|Study Period III|Physician Decision|0
3092877|NCT00337662|10604157|P3|Study Period III|Physician Decision|0
3092878|NCT00337662|10604158|P2|Study Period III|Physician Decision|5
3092879|NCT00337662|10604159|P1|Study Period III|Physician Decision|6
3092880|NCT00337662|10604156|P4|Study Period III|Protocol Violation|0
3092881|NCT00337662|10604157|P3|Study Period III|Protocol Violation|2
3092882|NCT00337662|10604158|P2|Study Period III|Protocol Violation|8
3092883|NCT00337662|10604159|P1|Study Period III|Protocol Violation|3
3092884|NCT00337662|10604156|P4|Study Period III|Adverse Event|0
3092885|NCT00337662|10604157|P3|Study Period III|Adverse Event|8
3092886|NCT00337662|10604158|P2|Study Period III|Adverse Event|10
3092887|NCT00337662|10604159|P1|Study Period III|Adverse Event|9
3092888|NCT00337662|10604156|P4|Study Period III|Withdrawal by Subject|0
3092889|NCT00337662|10604157|P3|Study Period III|Withdrawal by Subject|12
3092890|NCT00337662|10604158|P2|Study Period III|Withdrawal by Subject|14
3092891|NCT00337662|10604159|P1|Study Period III|Withdrawal by Subject|18
3092892|NCT00337662|10604156|P4|Study Period III|Lost to Follow-up|0
3092893|NCT00337662|10604157|P3|Study Period III|Lost to Follow-up|14
3092894|NCT00337662|10604158|P2|Study Period III|Lost to Follow-up|16
3092895|NCT00337662|10604159|P1|Study Period III|Lost to Follow-up|14
3092896|NCT00337662|10604156|P4|Study Period II|Parent/Caregiver Decision|1
3092897|NCT00337662|10604157|P3|Study Period II|Parent/Caregiver Decision|0
3092898|NCT00337662|10604158|P2|Study Period II|Parent/Caregiver Decision|0
3092899|NCT00337662|10604159|P1|Study Period II|Parent/Caregiver Decision|0
3092900|NCT00337662|10604156|P4|Study Period II|Sponsor Decision|2
3092901|NCT00337662|10604157|P3|Study Period II|Sponsor Decision|0
3092902|NCT00337662|10604158|P2|Study Period II|Sponsor Decision|0
3092903|NCT00337662|10604159|P1|Study Period II|Sponsor Decision|0
3092904|NCT00337662|10604156|P4|Study Period II|Lack of Efficacy|7
3092905|NCT00337662|10604157|P3|Study Period II|Lack of Efficacy|0
3092906|NCT00337662|10604158|P2|Study Period II|Lack of Efficacy|0
3092907|NCT00337662|10604159|P1|Study Period II|Lack of Efficacy|0
3092908|NCT00337662|10604156|P4|Study Period II|Protocol Violation|6
3092909|NCT00337662|10604157|P3|Study Period II|Protocol Violation|0
3092910|NCT00337662|10604158|P2|Study Period II|Protocol Violation|0
3092911|NCT00337662|10604159|P1|Study Period II|Protocol Violation|0
3092912|NCT00337662|10604156|P4|Study Period II|Entry Criteria Not Met|6
3092913|NCT00337662|10604157|P3|Study Period II|Entry Criteria Not Met|0
3092914|NCT00337662|10604158|P2|Study Period II|Entry Criteria Not Met|0
3092915|NCT00337662|10604159|P1|Study Period II|Entry Criteria Not Met|0
3092916|NCT00337662|10604156|P4|Study Period II|Physician Decision|13
3092917|NCT00337662|10604157|P3|Study Period II|Physician Decision|0
3092918|NCT00337662|10604158|P2|Study Period II|Physician Decision|0
3092919|NCT00337662|10604159|P1|Study Period II|Physician Decision|0
3092920|NCT00337662|10604156|P4|Study Period II|Adverse Event|16
3092921|NCT00337662|10604157|P3|Study Period II|Adverse Event|0
3092922|NCT00337662|10604158|P2|Study Period II|Adverse Event|0
3092923|NCT00337662|10604159|P1|Study Period II|Adverse Event|0
3092924|NCT00337662|10604156|P4|Study Period II|Withdrawal by Subject|20
3092925|NCT00337662|10604157|P3|Study Period II|Withdrawal by Subject|0
3092926|NCT00337662|10604158|P2|Study Period II|Withdrawal by Subject|0
3092927|NCT00337662|10604159|P1|Study Period II|Withdrawal by Subject|0
3092928|NCT00337662|10604156|P4|Study Period II|Lost to Follow-up|35
3092929|NCT00337662|10604157|P3|Study Period II|Lost to Follow-up|0
3092930|NCT00337662|10604158|P2|Study Period II|Lost to Follow-up|0
3092931|NCT00337662|10604159|P1|Study Period II|Lost to Follow-up|0
3092932|NCT00337610|10604213|P2|Overall Study|Withdrawal by Subject|5
3092933|NCT00337610|10604214|P1|Overall Study|Withdrawal by Subject|6
3092934|NCT00337610|10604213|P2|Overall Study|Lost to Follow-up|3
3092935|NCT00337610|10604214|P1|Overall Study|Lost to Follow-up|3
3092936|NCT00337610|10604213|P2|Overall Study|Lack of Efficacy|3
3092937|NCT00337610|10604214|P1|Overall Study|Lack of Efficacy|6
3092938|NCT00337610|10604213|P2|Overall Study|Death|1
3092939|NCT00337610|10604214|P1|Overall Study|Death|0
3092940|NCT00337610|10604213|P2|Overall Study|Adverse Event|2
3092941|NCT00337610|10604214|P1|Overall Study|Adverse Event|2
3092942|NCT00337571|10604230|P4|Overall Study|High Potassium level|1
3092943|NCT00337571|10604231|P3|Overall Study|High Potassium level|0
3092944|NCT00337571|10604232|P2|Overall Study|High Potassium level|0
3092945|NCT00337571|10604233|P1|Overall Study|High Potassium level|0
3092946|NCT00337571|10604230|P4|Overall Study|No longer met study criteria|0
3092947|NCT00337571|10604231|P3|Overall Study|No longer met study criteria|0
3092948|NCT00337571|10604232|P2|Overall Study|No longer met study criteria|0
3092949|NCT00337571|10604233|P1|Overall Study|No longer met study criteria|1
3092950|NCT00337571|10604230|P4|Overall Study|Poor/noncompliance|1
3092951|NCT00337571|10604231|P3|Overall Study|Poor/noncompliance|1
3092952|NCT00337571|10604232|P2|Overall Study|Poor/noncompliance|1
3092953|NCT00337571|10604233|P1|Overall Study|Poor/noncompliance|1
3092954|NCT00337571|10604230|P4|Overall Study|Lost to Follow-up|1
3092955|NCT00337571|10604231|P3|Overall Study|Lost to Follow-up|0
3092956|NCT00337571|10604232|P2|Overall Study|Lost to Follow-up|1
3092957|NCT00337571|10604233|P1|Overall Study|Lost to Follow-up|3
3092958|NCT00337571|10604230|P4|Overall Study|Withdrawal by Subject|0
3092959|NCT00337571|10604231|P3|Overall Study|Withdrawal by Subject|1
3092960|NCT00337571|10604232|P2|Overall Study|Withdrawal by Subject|2
3092961|NCT00337571|10604233|P1|Overall Study|Withdrawal by Subject|2
3092962|NCT00337571|10604230|P4|Overall Study|Adverse Event|4
3092963|NCT00337571|10604231|P3|Overall Study|Adverse Event|8
3092964|NCT00337571|10604232|P2|Overall Study|Adverse Event|5
3092965|NCT00337571|10604233|P1|Overall Study|Adverse Event|4
3092966|NCT00337571|10604230|P4|Overall Study|Lack of Efficacy|0
3092967|NCT00337571|10604231|P3|Overall Study|Lack of Efficacy|0
3092968|NCT00337571|10604232|P2|Overall Study|Lack of Efficacy|0
3092969|NCT00337571|10604233|P1|Overall Study|Lack of Efficacy|3
3092970|NCT00337467|10604271|P1|Overall Study|Subject No Longer Met Study Criteria|2
3092971|NCT00337467|10604271|P1|Overall Study|Lost to Follow-up|2
3092972|NCT00337467|10604271|P1|Overall Study|Pregnancy|1
3092973|NCT00337467|10604271|P1|Overall Study|Subject Withdrew Consent|2
3092974|NCT00337467|10604271|P1|Overall Study|Adverse Event|3
3092975|NCT00337428|10604290|P2|Overall Study|Anorexia|0
3092976|NCT00337428|10604291|P1|Overall Study|Anorexia|1
3092977|NCT00337428|10604290|P2|Overall Study|Unwilling to Continue|0
3092978|NCT00337428|10604291|P1|Overall Study|Unwilling to Continue|1
3092979|NCT00337428|10604290|P2|Overall Study|Lack of Time|1
3092980|NCT00337428|10604291|P1|Overall Study|Lack of Time|1
3092981|NCT00337428|10604290|P2|Overall Study|Withdrawal by Subject|2
3092982|NCT00337428|10604291|P1|Overall Study|Withdrawal by Subject|1
3092983|NCT00337285|10604342|P1|Overall Study|Lack of protocol compliance|7
3092984|NCT00337285|10604342|P1|Overall Study|Physician Decision|1
3092985|NCT00337285|10604342|P1|Overall Study|Death|1
3092986|NCT00337285|10604342|P1|Overall Study|Lack of Efficacy|11
3092987|NCT00337285|10604342|P1|Overall Study|Protocol Violation|27
3092988|NCT00337285|10604342|P1|Overall Study|Adverse Event|28
3092989|NCT00337285|10604342|P1|Overall Study|Lost to Follow-up|41
3092990|NCT00337285|10604342|P1|Overall Study|Withdrawal by Subject|42
3092991|NCT00337272|10604350|P2|Withdrawal Period|Non-compliance|1
3092992|NCT00337272|10604351|P1|Withdrawal Period|Non-compliance|0
3092993|NCT00337272|10604350|P2|Treatment Period|Withdrawal by Subject|1
3092994|NCT00337272|10604351|P1|Treatment Period|Withdrawal by Subject|0
3092995|NCT00337272|10604350|P2|Treatment Period|Non-compliance|1
3092996|NCT00337272|10604351|P1|Treatment Period|Non-compliance|1
3092997|NCT00337272|10604350|P2|Screening Period (Pre-randomization)|Screen failure|0
3092998|NCT00337272|10604351|P1|Screening Period (Pre-randomization)|Screen failure|3
3092999|NCT00337272|10604350|P2|Screening Period (Pre-randomization)|Non-compliance|0
3093000|NCT00337272|10604351|P1|Screening Period (Pre-randomization)|Non-compliance|1
3093001|NCT00337272|10604350|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
3093002|NCT00337272|10604351|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
3093003|NCT00337207|10604371|P1|Overall Study|Withdrawal by Subject|3
3093004|NCT00337194|10604379|P2|Overall Study|Subsequent non-protocol therapy|1
3093005|NCT00337194|10604380|P1|Overall Study|Subsequent non-protocol therapy|3
3093006|NCT00337194|10604379|P2|Overall Study|Disease progression|2
3093007|NCT00337194|10604380|P1|Overall Study|Disease progression|1
3093008|NCT00337194|10604379|P2|Overall Study|Withdrawal by Subject|0
3093009|NCT00337194|10604380|P1|Overall Study|Withdrawal by Subject|1
3093010|NCT00337194|10604379|P2|Overall Study|Death|0
3093011|NCT00337194|10604380|P1|Overall Study|Death|2
3093012|NCT00337194|10604379|P2|Overall Study|Adverse Event|1
3093013|NCT00337194|10604380|P1|Overall Study|Adverse Event|5
3093014|NCT00337168|10604404|P1|Overall Study|Did not start therapy|1
3093015|NCT00337168|10604404|P1|Overall Study|Not protocol specified|2
3093016|NCT00337168|10604404|P1|Overall Study|Death|5
3093017|NCT00337129|10604411|P1|Overall Study|not protocol specified|1
3093018|NCT00337129|10604411|P1|Overall Study|Death|2
3093019|NCT00337129|10604411|P1|Overall Study|Lack of Efficacy|32
3093020|NCT00337129|10604411|P1|Overall Study|Withdrawal by Subject|1
3093021|NCT00337129|10604411|P1|Overall Study|Adverse Event|4
3093022|NCT00337103|10604420|P2|Overall Study|Death|0
3093023|NCT00337103|10604421|P1|Overall Study|Death|1
3093024|NCT00337103|10604420|P2|Overall Study|Lost to Follow-up|2
3093025|NCT00337103|10604421|P1|Overall Study|Lost to Follow-up|1
3093026|NCT00337103|10604420|P2|Overall Study|Entry Criteria Not Met|1
3093027|NCT00337103|10604421|P1|Overall Study|Entry Criteria Not Met|4
3093028|NCT00337103|10604420|P2|Overall Study|Other|6
3093029|NCT00337103|10604421|P1|Overall Study|Other|5
3093030|NCT00337103|10604420|P2|Overall Study|Withdrawal by Subject|5
3093031|NCT00337103|10604421|P1|Overall Study|Withdrawal by Subject|8
3093032|NCT00337103|10604420|P2|Overall Study|Physician Decision|14
3093033|NCT00337103|10604421|P1|Overall Study|Physician Decision|15
3093034|NCT00337103|10604420|P2|Overall Study|Clinical Progression|24
3093035|NCT00337103|10604421|P1|Overall Study|Clinical Progression|27
3093036|NCT00337103|10604420|P2|Overall Study|Subject Choice|27
3093037|NCT00337103|10604421|P1|Overall Study|Subject Choice|34
3093038|NCT00337103|10604420|P2|Overall Study|Adverse Event|59
3093039|NCT00337103|10604421|P1|Overall Study|Adverse Event|45
3093040|NCT00337103|10604420|P2|Overall Study|Progressive Disease|405
3093041|NCT00337103|10604421|P1|Overall Study|Progressive Disease|409
3093042|NCT00337077|10604432|P3|Overall Study|Ineligible|1
3093043|NCT00337077|10604433|P2|Overall Study|Ineligible|1
3093044|NCT00337077|10604434|P1|Overall Study|Ineligible|1
3093045|NCT00337077|10604432|P3|Overall Study|Never started treatment|0
3093046|NCT00337077|10604433|P2|Overall Study|Never started treatment|1
3093047|NCT00337077|10604434|P1|Overall Study|Never started treatment|1
3093048|NCT00337077|10604432|P3|Overall Study|Physician Decision|2
3093049|NCT00337077|10604433|P2|Overall Study|Physician Decision|4
3093050|NCT00337077|10604434|P1|Overall Study|Physician Decision|1
3093051|NCT00337077|10604432|P3|Overall Study|Alternative therapy|0
3093052|NCT00337077|10604433|P2|Overall Study|Alternative therapy|0
3093053|NCT00337077|10604434|P1|Overall Study|Alternative therapy|1
3093054|NCT00337077|10604432|P3|Overall Study|Withdrawal by Subject|2
3093055|NCT00337077|10604433|P2|Overall Study|Withdrawal by Subject|2
3093056|NCT00337077|10604434|P1|Overall Study|Withdrawal by Subject|7
3093057|NCT00337077|10604432|P3|Overall Study|Death|0
3093058|NCT00337077|10604433|P2|Overall Study|Death|1
3093059|NCT00337077|10604434|P1|Overall Study|Death|0
3093060|NCT00337077|10604432|P3|Overall Study|Adverse Event|1
3093061|NCT00337077|10604433|P2|Overall Study|Adverse Event|7
3093062|NCT00337077|10604434|P1|Overall Study|Adverse Event|7
3093063|NCT00337077|10604432|P3|Overall Study|Progressive disease|19
3093064|NCT00337077|10604433|P2|Overall Study|Progressive disease|37
3093065|NCT00337077|10604434|P1|Overall Study|Progressive disease|25
3093066|NCT00336895|10604449|P1|Overall Study|screen failed|1
3093067|NCT00336895|10604449|P1|Overall Study|Physician Decision|1
3093068|NCT00336895|10604449|P1|Overall Study|nausea and upset stomach|1
3093069|NCT00336895|10604449|P1|Overall Study|diarrhea|1
3093070|NCT00336856|10604455|P1|Overall Study|Found ineligible at time of analysis|1
3093071|NCT00336856|10604455|P1|Overall Study|Withdrawal by Subject|3
3093072|NCT00336583|10604503|P1|Overall Study|Death|1
3093073|NCT00336583|10604503|P1|Overall Study|Lost to Follow-up|1
3093074|NCT00336544|10604510|P2|Overall Study|Other|5
3093075|NCT00336544|10604511|P1|Overall Study|Other|3
3093076|NCT00336544|10604510|P2|Overall Study|Withdrawal by Subject|3
3093077|NCT00336544|10604511|P1|Overall Study|Withdrawal by Subject|4
3093078|NCT00336544|10604510|P2|Overall Study|Adverse Event|9
3093079|NCT00336544|10604511|P1|Overall Study|Adverse Event|4
3093080|NCT00336544|10604510|P2|Overall Study|Lack of Efficacy|5
3093081|NCT00336544|10604511|P1|Overall Study|Lack of Efficacy|8
3093082|NCT00336505|10604525|P2|Overall Study|Other|7
3093083|NCT00336505|10604526|P1|Overall Study|Other|7
3093084|NCT00336505|10604525|P2|Overall Study|Withdrawal by Subject|3
3093085|NCT00336505|10604526|P1|Overall Study|Withdrawal by Subject|5
3093086|NCT00336505|10604525|P2|Overall Study|Lost to Follow-up|4
3093087|NCT00336505|10604526|P1|Overall Study|Lost to Follow-up|7
3093088|NCT00336505|10604525|P2|Overall Study|Lack of Efficacy|4
3093089|NCT00336505|10604526|P1|Overall Study|Lack of Efficacy|8
3093090|NCT00336505|10604525|P2|Overall Study|Adverse Event|9
3093091|NCT00336505|10604526|P1|Overall Study|Adverse Event|10
3093092|NCT00336492|10604541|P3|Overall Study|Other|1
3093093|NCT00336492|10604542|P2|Overall Study|Other|0
3093094|NCT00336492|10604543|P1|Overall Study|Other|5
3093095|NCT00336492|10604541|P3|Overall Study|Lack of Efficacy|4
3093096|NCT00336492|10604542|P2|Overall Study|Lack of Efficacy|1
3093097|NCT00336492|10604543|P1|Overall Study|Lack of Efficacy|6
3093098|NCT00336492|10604541|P3|Overall Study|Adverse Event|6
3093099|NCT00336492|10604542|P2|Overall Study|Adverse Event|3
3093100|NCT00336492|10604543|P1|Overall Study|Adverse Event|4
3093101|NCT00336479|10604555|P4|Overall Study|Virologic Stopping Rule|0
3093102|NCT00336479|10604556|P3|Overall Study|Virologic Stopping Rule|0
3093103|NCT00336479|10604557|P2|Overall Study|Virologic Stopping Rule|0
3093104|NCT00336479|10604558|P1|Overall Study|Virologic Stopping Rule|20
3093105|NCT00336479|10604555|P4|Overall Study|Other|0
3093106|NCT00336479|10604556|P3|Overall Study|Other|1
3093107|NCT00336479|10604557|P2|Overall Study|Other|0
3093108|NCT00336479|10604558|P1|Overall Study|Other|0
3093109|NCT00336479|10604555|P4|Overall Study|Withdrawal by Subject|0
3093110|NCT00336479|10604556|P3|Overall Study|Withdrawal by Subject|3
3093111|NCT00336479|10604557|P2|Overall Study|Withdrawal by Subject|2
3093112|NCT00336479|10604558|P1|Overall Study|Withdrawal by Subject|3
3093113|NCT00336479|10604555|P4|Overall Study|Lost to Follow-up|0
3093114|NCT00336479|10604556|P3|Overall Study|Lost to Follow-up|0
3093115|NCT00336479|10604557|P2|Overall Study|Lost to Follow-up|2
3093116|NCT00336479|10604558|P1|Overall Study|Lost to Follow-up|3
3093117|NCT00336479|10604555|P4|Overall Study|Physician Decision|0
3093118|NCT00336479|10604556|P3|Overall Study|Physician Decision|1
3093119|NCT00336479|10604557|P2|Overall Study|Physician Decision|3
3093120|NCT00336479|10604558|P1|Overall Study|Physician Decision|2
3093121|NCT00336479|10604555|P4|Overall Study|Noncompliant|0
3093122|NCT00336479|10604556|P3|Overall Study|Noncompliant|3
3093123|NCT00336479|10604557|P2|Overall Study|Noncompliant|7
3093124|NCT00336479|10604558|P1|Overall Study|Noncompliant|1
3093125|NCT00336479|10604555|P4|Overall Study|Adverse Event|4
3093126|NCT00336479|10604556|P3|Overall Study|Adverse Event|18
3093127|NCT00336479|10604557|P2|Overall Study|Adverse Event|11
3093128|NCT00336479|10604558|P1|Overall Study|Adverse Event|8
3093129|NCT00336284|10604647|P2|Overall Study|Withdrawal by Physician or Subject|64
3093130|NCT00336284|10604648|P1|Overall Study|Withdrawal by Physician or Subject|102
3093131|NCT00336284|10604647|P2|Overall Study|Lost to Follow-up|61
3093132|NCT00336284|10604648|P1|Overall Study|Lost to Follow-up|82
3093133|NCT00336284|10604647|P2|Overall Study|Death|26
3093134|NCT00336284|10604648|P1|Overall Study|Death|52
3093135|NCT00336024|10604666|P2|Overall Study|Ineligible|7
3093136|NCT00336024|10604667|P1|Overall Study|Ineligible|7
3093137|NCT00336024|10604666|P2|Overall Study|Progressive Disease|7
3093138|NCT00336024|10604667|P1|Overall Study|Progressive Disease|4
3093139|NCT00336024|10604666|P2|Overall Study|Failure to fulfill consolidation|1
3093140|NCT00336024|10604667|P1|Overall Study|Failure to fulfill consolidation|1
3093141|NCT00336024|10604666|P2|Overall Study|Withdrawal by Subject|2
3093142|NCT00336024|10604667|P1|Overall Study|Withdrawal by Subject|1
3093143|NCT00336024|10604666|P2|Overall Study|Protocol Violation|0
3093144|NCT00336024|10604667|P1|Overall Study|Protocol Violation|1
3093145|NCT00336024|10604666|P2|Overall Study|Physician Decision|1
3093146|NCT00336024|10604667|P1|Overall Study|Physician Decision|4
3093147|NCT00336024|10604666|P2|Overall Study|Death|1
3093148|NCT00336024|10604667|P1|Overall Study|Death|2
3093149|NCT00335972|10604703|P2|Overall Study|not given treatments|3
3093150|NCT00335972|10604704|P1|Overall Study|not given treatments|0
3093151|NCT00335959|10604714|P1|Overall Study|Ineligible|1
3093152|NCT00335959|10604714|P1|Overall Study|Adverse Event|2
3093153|NCT00335829|10604719|P1|Overall Study|Adverse Event|1
3093154|NCT00335829|10604719|P1|Overall Study|Lost to Follow-up|1
3093155|NCT00335829|10604719|P1|Overall Study|Withdrawal by Subject|1
3093156|NCT00335777|10604733|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
3093157|NCT00335777|10604733|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
3093158|NCT00335777|10604733|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
3093159|NCT00335777|10604733|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
3093160|NCT00335777|10604733|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
3093161|NCT00335764|10604743|P5|Overall Study|wrong histology|1
3093162|NCT00335764|10604744|P4|Overall Study|wrong histology|0
3093163|NCT00335764|10604745|P3|Overall Study|wrong histology|0
3093164|NCT00335764|10604746|P2|Overall Study|wrong histology|0
3093165|NCT00335764|10604747|P1|Overall Study|wrong histology|1
3093166|NCT00335738|10604796|P2|Overall Study|Ineligible|4
3093167|NCT00335738|10604797|P1|Overall Study|Ineligible|3
3093168|NCT00335738|10604796|P2|Overall Study|Withdrawal by Subject|0
3093169|NCT00335738|10604797|P1|Overall Study|Withdrawal by Subject|2
3093170|NCT00335738|10604796|P2|Overall Study|Physician Decision|0
3093171|NCT00335738|10604797|P1|Overall Study|Physician Decision|6
3093172|NCT00335556|10604829|P6|Overall Study|Refusal of further protocol therapy|0
3093173|NCT00335556|10604830|P5|Overall Study|Refusal of further protocol therapy|0
3093174|NCT00335556|10604831|P4|Overall Study|Refusal of further protocol therapy|1
3093175|NCT00335556|10604832|P3|Overall Study|Refusal of further protocol therapy|0
3093176|NCT00335556|10604833|P2|Overall Study|Refusal of further protocol therapy|4
3093177|NCT00335556|10604834|P1|Overall Study|Refusal of further protocol therapy|0
3093178|NCT00335556|10604829|P6|Overall Study|Ineligible|0
3093179|NCT00335556|10604830|P5|Overall Study|Ineligible|0
3093180|NCT00335556|10604831|P4|Overall Study|Ineligible|0
3093181|NCT00335556|10604832|P3|Overall Study|Ineligible|0
3093182|NCT00335556|10604833|P2|Overall Study|Ineligible|0
3093183|NCT00335556|10604834|P1|Overall Study|Ineligible|2
3093184|NCT00335556|10604829|P6|Overall Study|Physician Decision|0
3093185|NCT00335556|10604830|P5|Overall Study|Physician Decision|0
3093186|NCT00335556|10604831|P4|Overall Study|Physician Decision|1
3093187|NCT00335556|10604832|P3|Overall Study|Physician Decision|2
3093188|NCT00335556|10604833|P2|Overall Study|Physician Decision|6
3093189|NCT00335556|10604834|P1|Overall Study|Physician Decision|0
3093190|NCT00335556|10604829|P6|Overall Study|Lack of Efficacy|1
3093191|NCT00335556|10604830|P5|Overall Study|Lack of Efficacy|0
3093192|NCT00335556|10604831|P4|Overall Study|Lack of Efficacy|3
3093193|NCT00335556|10604832|P3|Overall Study|Lack of Efficacy|3
3093194|NCT00335556|10604833|P2|Overall Study|Lack of Efficacy|19
3093195|NCT00335556|10604834|P1|Overall Study|Lack of Efficacy|0
3093196|NCT00335556|10604829|P6|Overall Study|Death|0
3093197|NCT00335556|10604830|P5|Overall Study|Death|1
3093198|NCT00335556|10604831|P4|Overall Study|Death|0
3093199|NCT00335556|10604832|P3|Overall Study|Death|0
3093200|NCT00335556|10604833|P2|Overall Study|Death|5
3093201|NCT00335556|10604834|P1|Overall Study|Death|0
3093202|NCT00335452|10604896|P4|Overall Study|Lost to Follow-up|2
3093203|NCT00335452|10604897|P3|Overall Study|Lost to Follow-up|1
3093204|NCT00335452|10604898|P2|Overall Study|Lost to Follow-up|3
3093205|NCT00335452|10604899|P1|Overall Study|Lost to Follow-up|2
3093206|NCT00335452|10604896|P4|Overall Study|Death|129
3093207|NCT00335452|10604897|P3|Overall Study|Death|158
3093208|NCT00335452|10604898|P2|Overall Study|Death|144
3093209|NCT00335452|10604899|P1|Overall Study|Death|156
3093210|NCT00335322|10604924|P3|Overall Study|Randomised but withdrew prior to ART sta|2
3093211|NCT00335322|10604925|P2|Overall Study|Randomised but withdrew prior to ART sta|2
3093212|NCT00335322|10604926|P1|Overall Study|Randomised but withdrew prior to ART sta|1
3093213|NCT00335153|10604974|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
3093214|NCT00335153|10604974|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
3093215|NCT00335153|10604974|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
3093216|NCT00335153|10604974|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
3093217|NCT00335153|10604974|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
3093218|NCT00335153|10604974|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
3093219|NCT00335153|10604974|P1|Nasojejunal (NJ) Test Period|Administrative|1
3093220|NCT00335153|10604974|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
3093221|NCT00335153|10604974|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
3093222|NCT00335153|10604974|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
3093223|NCT00335140|10605011|P1|Overall Study|Ineligible|1
3093224|NCT00334958|10605017|P2|Overall Study|Other|2
3093225|NCT00334958|10605018|P1|Overall Study|Other|1
3093226|NCT00334958|10605017|P2|Overall Study|Adverse Event|12
3093227|NCT00334958|10605018|P1|Overall Study|Adverse Event|27
3093228|NCT00334958|10605017|P2|Overall Study|Withdrawal by Subject|4
3093229|NCT00334958|10605018|P1|Overall Study|Withdrawal by Subject|7
3093230|NCT00334958|10605017|P2|Overall Study|Request of the investigator or sponsor|1
3093231|NCT00334958|10605018|P1|Overall Study|Request of the investigator or sponsor|0
3093232|NCT00334958|10605017|P2|Overall Study|Protocol Violation|2
3093233|NCT00334958|10605018|P1|Overall Study|Protocol Violation|2
3093234|NCT00334958|10605017|P2|Overall Study|Medication Noncompliance|3
3093235|NCT00334958|10605018|P1|Overall Study|Medication Noncompliance|0
3093236|NCT00334893|10605032|P2|Overall Study|Not Treated|0
3093237|NCT00334893|10605033|P1|Overall Study|Not Treated|1
3093238|NCT00334815|10605043|P2|Overall Study|Physician Decision|4
3093239|NCT00334815|10605044|P1|Overall Study|Physician Decision|2
3093240|NCT00334815|10605043|P2|Overall Study|patient refused treatment|1
3093241|NCT00334815|10605044|P1|Overall Study|patient refused treatment|0
3093242|NCT00334815|10605043|P2|Overall Study|ineligible|1
3093243|NCT00334815|10605044|P1|Overall Study|ineligible|1
3093244|NCT00334815|10605043|P2|Overall Study|Progression|0
3093245|NCT00334815|10605044|P1|Overall Study|Progression|1
3093246|NCT00334815|10605043|P2|Overall Study|Death|2
3093247|NCT00334815|10605044|P1|Overall Study|Death|0
3093248|NCT00334815|10605043|P2|Overall Study|Adverse Event|2
3093249|NCT00334815|10605044|P1|Overall Study|Adverse Event|3
3093250|NCT00334802|10605058|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
3093251|NCT00334802|10605059|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
3093252|NCT00334802|10605058|P2|Overall Study|Adverse Event|3
3093253|NCT00334802|10605059|P1|Overall Study|Adverse Event|0
3093254|NCT00334802|10605058|P2|Overall Study|Withdrawal by Subject|4
3093255|NCT00334802|10605059|P1|Overall Study|Withdrawal by Subject|0
3093256|NCT00334802|10605058|P2|Overall Study|Physician Decision|0
3093257|NCT00334802|10605059|P1|Overall Study|Physician Decision|1
3093258|NCT00334802|10605058|P2|Overall Study|Patient Condition Aggrevated|0
3093259|NCT00334802|10605059|P1|Overall Study|Patient Condition Aggrevated|1
3093260|NCT00334802|10605058|P2|Overall Study|Lack of Efficacy|3
3093261|NCT00334802|10605059|P1|Overall Study|Lack of Efficacy|1
3093262|NCT00334802|10605058|P2|Overall Study|Toxicity|5
3093263|NCT00334802|10605059|P1|Overall Study|Toxicity|1
3093264|NCT00334802|10605058|P2|Overall Study|Progressive Disease|24
3093265|NCT00334802|10605059|P1|Overall Study|Progressive Disease|2
3093266|NCT00334737|10605079|P3|Follow up Phase|Lost to Follow-up|6
3093267|NCT00334737|10605080|P2|Follow up Phase|Lost to Follow-up|3
3093268|NCT00334737|10605081|P1|Follow up Phase|Lost to Follow-up|5
3093269|NCT00334737|10605079|P3|Hospital Phase|Did not receive study drug|0
3093270|NCT00334737|10605080|P2|Hospital Phase|Did not receive study drug|0
3093271|NCT00334737|10605081|P1|Hospital Phase|Did not receive study drug|1
3093272|NCT00334737|10605079|P3|Hospital Phase|Withdrawal by Subject|1
3093273|NCT00334737|10605080|P2|Hospital Phase|Withdrawal by Subject|0
3093274|NCT00334737|10605081|P1|Hospital Phase|Withdrawal by Subject|0
3093275|NCT00334737|10605079|P3|Hospital Phase|Death|3
3093276|NCT00334737|10605080|P2|Hospital Phase|Death|2
3093277|NCT00334737|10605081|P1|Hospital Phase|Death|1
3093278|NCT00334542|10605129|P1|Overall Study|New cancer diagnosis|1
3093279|NCT00334542|10605129|P1|Overall Study|Withdrawal by Subject|1
3093280|NCT00334542|10605129|P1|Overall Study|Adverse Event|3
3093281|NCT00334295|10605136|P1|Overall Study|Patients received fewer than 3 injection|5
3093282|NCT00334282|10605146|P2|Overall Study|Death|100
3093283|NCT00334282|10605147|P1|Overall Study|Death|194
3093284|NCT00334282|10605146|P2|Overall Study|Withdrawal by Subject|3
3093285|NCT00334282|10605147|P1|Overall Study|Withdrawal by Subject|17
3093286|NCT00334282|10605146|P2|Overall Study|Lost to Follow-up|5
3093287|NCT00334282|10605147|P1|Overall Study|Lost to Follow-up|11
3093288|NCT00334113|10605178|P2|Overall Study|Withdrawal by Subject|1
3093289|NCT00334113|10605179|P1|Overall Study|Withdrawal by Subject|0
3093290|NCT00334113|10605178|P2|Overall Study|Lost to Follow-up|2
3093291|NCT00334113|10605179|P1|Overall Study|Lost to Follow-up|2
3093292|NCT00333983|10605202|P3|Overall Study|Withdrawal by Subject|1
3093293|NCT00333983|10605203|P2|Overall Study|Withdrawal by Subject|3
3093294|NCT00333983|10605204|P1|Overall Study|Withdrawal by Subject|0
3093295|NCT00333983|10605202|P3|Overall Study|Adverse Event|1
3093296|NCT00333983|10605203|P2|Overall Study|Adverse Event|1
3093297|NCT00333983|10605204|P1|Overall Study|Adverse Event|1
3093298|NCT00333983|10605202|P3|Overall Study|Lost to Follow-up|0
3093299|NCT00333983|10605203|P2|Overall Study|Lost to Follow-up|1
3093300|NCT00333983|10605204|P1|Overall Study|Lost to Follow-up|2
3093301|NCT00333970|10605214|P2|Overall Study|Withdrawal by Subject|7
3093302|NCT00333970|10605215|P1|Overall Study|Withdrawal by Subject|13
3093303|NCT00333866|10605230|P4|Overall Study|Randomized but not Treated|1
3093304|NCT00333866|10605231|P3|Overall Study|Randomized but not Treated|2
3093305|NCT00333866|10605232|P2|Overall Study|Randomized but not Treated|3
3093306|NCT00333866|10605233|P1|Overall Study|Randomized but not Treated|5
3093307|NCT00333866|10605230|P4|Overall Study|Withdrawal by Subject|9
3093308|NCT00333866|10605231|P3|Overall Study|Withdrawal by Subject|4
3093309|NCT00333866|10605232|P2|Overall Study|Withdrawal by Subject|14
3093310|NCT00333866|10605233|P1|Overall Study|Withdrawal by Subject|8
3093311|NCT00333866|10605230|P4|Overall Study|Lost to Follow-up|2
3093312|NCT00333866|10605231|P3|Overall Study|Lost to Follow-up|2
3093313|NCT00333866|10605232|P2|Overall Study|Lost to Follow-up|2
3093314|NCT00333866|10605233|P1|Overall Study|Lost to Follow-up|1
3093315|NCT00333866|10605230|P4|Overall Study|Lack of Efficacy|5
3093316|NCT00333866|10605231|P3|Overall Study|Lack of Efficacy|3
3093317|NCT00333866|10605232|P2|Overall Study|Lack of Efficacy|6
3093318|NCT00333866|10605233|P1|Overall Study|Lack of Efficacy|8
3093319|NCT00333866|10605230|P4|Overall Study|Other|2
3093320|NCT00333866|10605231|P3|Overall Study|Other|2
3093321|NCT00333866|10605232|P2|Overall Study|Other|2
3093322|NCT00333866|10605233|P1|Overall Study|Other|3
3093323|NCT00333866|10605230|P4|Overall Study|Adverse Event|47
3093324|NCT00333866|10605231|P3|Overall Study|Adverse Event|38
3093325|NCT00333866|10605232|P2|Overall Study|Adverse Event|37
3093326|NCT00333866|10605233|P1|Overall Study|Adverse Event|23
3093327|NCT00333840|10605293|P4|Second-line Treatment Period|Death|9
3093328|NCT00333840|10605294|P3|Second-line Treatment Period|Death|0
3093329|NCT00333840|10605295|P2|Second-line Treatment Period|Death|0
3093330|NCT00333840|10605296|P1|Second-line Treatment Period|Death|0
3093331|NCT00333840|10605293|P4|Second-line Treatment Period|Administrative problems|7
3093332|NCT00333840|10605294|P3|Second-line Treatment Period|Administrative problems|0
3093333|NCT00333840|10605295|P2|Second-line Treatment Period|Administrative problems|0
3093334|NCT00333840|10605296|P1|Second-line Treatment Period|Administrative problems|0
3093335|NCT00333840|10605293|P4|Second-line Treatment Period|Lost to Follow-up|6
3093336|NCT00333840|10605294|P3|Second-line Treatment Period|Lost to Follow-up|0
3093337|NCT00333840|10605295|P2|Second-line Treatment Period|Lost to Follow-up|0
3093338|NCT00333840|10605296|P1|Second-line Treatment Period|Lost to Follow-up|0
3093339|NCT00333840|10605293|P4|Second-line Treatment Period|Subject withdrew consent|34
3093340|NCT00333840|10605294|P3|Second-line Treatment Period|Subject withdrew consent|0
3093341|NCT00333840|10605295|P2|Second-line Treatment Period|Subject withdrew consent|0
3093342|NCT00333840|10605296|P1|Second-line Treatment Period|Subject withdrew consent|0
3093343|NCT00333840|10605293|P4|Second-line Treatment Period|Protocol Violation|10
3093344|NCT00333840|10605294|P3|Second-line Treatment Period|Protocol Violation|1
3093345|NCT00333840|10605295|P2|Second-line Treatment Period|Protocol Violation|0
3093346|NCT00333840|10605296|P1|Second-line Treatment Period|Protocol Violation|0
3093347|NCT00333840|10605293|P4|Second-line Treatment Period|No longer required study drug|14
3093348|NCT00333840|10605294|P3|Second-line Treatment Period|No longer required study drug|1
3093349|NCT00333840|10605295|P2|Second-line Treatment Period|No longer required study drug|0
3093350|NCT00333840|10605296|P1|Second-line Treatment Period|No longer required study drug|0
3093351|NCT00333840|10605293|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
3093352|NCT00333840|10605294|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
3093353|NCT00333840|10605295|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
3093354|NCT00333840|10605296|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
3093355|NCT00333840|10605293|P4|Second-line Treatment Period|Abnormal procedure|1
3093356|NCT00333840|10605294|P3|Second-line Treatment Period|Abnormal procedure|0
3093357|NCT00333840|10605295|P2|Second-line Treatment Period|Abnormal procedure|0
3093358|NCT00333840|10605296|P1|Second-line Treatment Period|Abnormal procedure|0
3093359|NCT00333840|10605293|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
3093360|NCT00333840|10605294|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
3093361|NCT00333840|10605295|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
3093362|NCT00333840|10605296|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
3093363|NCT00333840|10605293|P4|Second-line Treatment Period|Adverse Event|34
3093364|NCT00333840|10605294|P3|Second-line Treatment Period|Adverse Event|3
3093365|NCT00333840|10605295|P2|Second-line Treatment Period|Adverse Event|0
3093366|NCT00333840|10605296|P1|Second-line Treatment Period|Adverse Event|0
3093367|NCT00333840|10605293|P4|First-line Treatment Period|Crossed over to other treatment arm|0
3093368|NCT00333840|10605294|P3|First-line Treatment Period|Crossed over to other treatment arm|0
3093369|NCT00333840|10605295|P2|First-line Treatment Period|Crossed over to other treatment arm|363
3093370|NCT00333840|10605296|P1|First-line Treatment Period|Crossed over to other treatment arm|14
3093371|NCT00333840|10605293|P4|First-line Treatment Period|Death|0
3093372|NCT00333840|10605294|P3|First-line Treatment Period|Death|0
3093373|NCT00333840|10605295|P2|First-line Treatment Period|Death|2
3093374|NCT00333840|10605296|P1|First-line Treatment Period|Death|19
3093375|NCT00333840|10605293|P4|First-line Treatment Period|Administrative problems|0
3093376|NCT00333840|10605294|P3|First-line Treatment Period|Administrative problems|0
3093377|NCT00333840|10605295|P2|First-line Treatment Period|Administrative problems|6
3093378|NCT00333840|10605296|P1|First-line Treatment Period|Administrative problems|12
3093379|NCT00333840|10605293|P4|First-line Treatment Period|Lost to Follow-up|0
3093380|NCT00333840|10605294|P3|First-line Treatment Period|Lost to Follow-up|0
3093381|NCT00333840|10605295|P2|First-line Treatment Period|Lost to Follow-up|6
3093382|NCT00333840|10605296|P1|First-line Treatment Period|Lost to Follow-up|15
3093383|NCT00333840|10605293|P4|First-line Treatment Period|Subject withdrew consent|0
3093384|NCT00333840|10605294|P3|First-line Treatment Period|Subject withdrew consent|0
3093385|NCT00333840|10605295|P2|First-line Treatment Period|Subject withdrew consent|77
3093386|NCT00333840|10605296|P1|First-line Treatment Period|Subject withdrew consent|57
3093387|NCT00333840|10605293|P4|First-line Treatment Period|Protocol Violation|0
3093388|NCT00333840|10605294|P3|First-line Treatment Period|Protocol Violation|0
3093389|NCT00333840|10605295|P2|First-line Treatment Period|Protocol Violation|17
3093390|NCT00333840|10605296|P1|First-line Treatment Period|Protocol Violation|17
3093391|NCT00333840|10605293|P4|First-line Treatment Period|No longer required study drug|0
3093392|NCT00333840|10605294|P3|First-line Treatment Period|No longer required study drug|0
3093393|NCT00333840|10605295|P2|First-line Treatment Period|No longer required study drug|8
3093394|NCT00333840|10605296|P1|First-line Treatment Period|No longer required study drug|21
3093395|NCT00333840|10605293|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
3093396|NCT00333840|10605294|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
3093397|NCT00333840|10605295|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
3093398|NCT00333840|10605296|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
3093399|NCT00333840|10605293|P4|First-line Treatment Period|Abnormal procedure|0
3093400|NCT00333840|10605294|P3|First-line Treatment Period|Abnormal procedure|0
3093401|NCT00333840|10605295|P2|First-line Treatment Period|Abnormal procedure|0
3093402|NCT00333840|10605296|P1|First-line Treatment Period|Abnormal procedure|2
3093403|NCT00333840|10605293|P4|First-line Treatment Period|Abnormal laboratory values|0
3093404|NCT00333840|10605294|P3|First-line Treatment Period|Abnormal laboratory values|0
3093405|NCT00333840|10605295|P2|First-line Treatment Period|Abnormal laboratory values|1
3093406|NCT00333840|10605296|P1|First-line Treatment Period|Abnormal laboratory values|3
3093407|NCT00333840|10605293|P4|First-line Treatment Period|Adverse Event|0
3093408|NCT00333840|10605294|P3|First-line Treatment Period|Adverse Event|0
3093409|NCT00333840|10605295|P2|First-line Treatment Period|Adverse Event|37
3093410|NCT00333840|10605296|P1|First-line Treatment Period|Adverse Event|38
3093411|NCT00333801|10605342|P2|Overall Study|Withdrawal by Subject|1
3093412|NCT00333801|10605343|P1|Overall Study|Withdrawal by Subject|0
3093413|NCT00333801|10605342|P2|Overall Study|Incarcerated|2
3093414|NCT00333801|10605343|P1|Overall Study|Incarcerated|1
3093415|NCT00333801|10605342|P2|Overall Study|Lost to Follow-up|0
3093416|NCT00333801|10605343|P1|Overall Study|Lost to Follow-up|2
3093417|NCT00333801|10605342|P2|Overall Study|Moved to another state|3
3093418|NCT00333801|10605343|P1|Overall Study|Moved to another state|5
3093419|NCT00333788|10605361|P1|Overall Study|Other: Signed consent for another study|1
3093420|NCT00333788|10605361|P1|Overall Study|Other: Physician decision|1
3093421|NCT00333788|10605361|P1|Overall Study|Other: Medical monitor decision|1
3093422|NCT00333788|10605361|P1|Overall Study|Other: Subject in need of an Entocort|1
3093423|NCT00333788|10605361|P1|Overall Study|Other: Sponsor decision|1
3093424|NCT00333788|10605361|P1|Overall Study|Other: Quality of life concern|1
3093425|NCT00333788|10605361|P1|Overall Study|Other: Investigator decision|1
3093426|NCT00333788|10605361|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
3093427|NCT00333788|10605361|P1|Overall Study|Other: Moved|2
3093428|NCT00333788|10605361|P1|Overall Study|Other: Non-compliance|2
3093429|NCT00333788|10605361|P1|Overall Study|Withdrawal by Subject|24
3093430|NCT00333788|10605361|P1|Overall Study|Lost to Follow-up|2
3093431|NCT00333788|10605361|P1|Overall Study|Lack of Efficacy|80
3093432|NCT00333788|10605361|P1|Overall Study|Adverse Event|44
3093433|NCT00333775|10605391|P3|Overall Study|Lost to Follow-up|8
3093434|NCT00333775|10605392|P2|Overall Study|Lost to Follow-up|7
3093435|NCT00333775|10605393|P1|Overall Study|Lost to Follow-up|10
3093436|NCT00333775|10605391|P3|Overall Study|In Follow−up When Study Stopped|96
3093437|NCT00333775|10605392|P2|Overall Study|In Follow−up When Study Stopped|92
3093438|NCT00333775|10605393|P1|Overall Study|In Follow−up When Study Stopped|87
3093439|NCT00333775|10605391|P3|Overall Study|Death|143
3093440|NCT00333775|10605392|P2|Overall Study|Death|149
3093441|NCT00333775|10605393|P1|Overall Study|Death|144
3093442|NCT00333619|10605432|P2|Overall Study|Lost to Follow-up|3
3093443|NCT00333619|10605433|P1|Overall Study|Lost to Follow-up|3
3093444|NCT00333619|10605432|P2|Overall Study|Withdrawal by Subject|1
3093445|NCT00333619|10605433|P1|Overall Study|Withdrawal by Subject|6
3093446|NCT00333619|10605432|P2|Overall Study|Death|6
3093447|NCT00333619|10605433|P1|Overall Study|Death|12
3093448|NCT00333359|10605462|P2|Overall Study|Withdrew before Receiving One Dose|6
3093449|NCT00333359|10605463|P1|Overall Study|Withdrew before Receiving One Dose|2
3093450|NCT00333359|10605462|P2|Overall Study|Treatment Failure|8
3093451|NCT00333359|10605463|P1|Overall Study|Treatment Failure|3
3093452|NCT00333359|10605462|P2|Overall Study|Termination or Withdrawal by Sponsor|1
3093453|NCT00333359|10605463|P1|Overall Study|Termination or Withdrawal by Sponsor|1
3093454|NCT00333359|10605462|P2|Overall Study|Lost to Follow-up|25
3093455|NCT00333359|10605463|P1|Overall Study|Lost to Follow-up|15
3093456|NCT00333359|10605462|P2|Overall Study|Protocol Non-compliance|8
3093457|NCT00333359|10605463|P1|Overall Study|Protocol Non-compliance|2
3093458|NCT00333359|10605462|P2|Overall Study|Physician Decision|2
3093459|NCT00333359|10605463|P1|Overall Study|Physician Decision|2
3093460|NCT00333359|10605462|P2|Overall Study|Withdrawal by Subject|37
3093461|NCT00333359|10605463|P1|Overall Study|Withdrawal by Subject|19
3093462|NCT00333359|10605462|P2|Overall Study|Adverse Event|35
3093463|NCT00333359|10605463|P1|Overall Study|Adverse Event|29
3093464|NCT00333229|10605506|P2|Overall Study|Lack of Efficacy|1
3093465|NCT00333229|10605507|P1|Overall Study|Lack of Efficacy|0
3093466|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Death|0
3093467|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Death|1
3093468|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Death|0
3093469|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
3093470|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
3093471|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
3093472|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
3093473|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
3093474|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
3093475|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
3093476|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
3093477|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
3093478|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
3093479|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
3093480|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
3093481|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
3093482|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
3093483|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
3093484|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
3093485|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
3093486|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
3093487|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
3093488|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
3093489|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
3093490|NCT00333138|10605577|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
3093491|NCT00333138|10605578|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
3093492|NCT00333138|10605579|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
3093493|NCT00333138|10605577|P3|Core Study (6 Months)|Laboratory abnormality|1
3093494|NCT00333138|10605578|P2|Core Study (6 Months)|Laboratory abnormality|0
3093495|NCT00333138|10605579|P1|Core Study (6 Months)|Laboratory abnormality|0
3093496|NCT00333138|10605577|P3|Core Study (6 Months)|Protocol Violation|1
3093497|NCT00333138|10605578|P2|Core Study (6 Months)|Protocol Violation|0
3093498|NCT00333138|10605579|P1|Core Study (6 Months)|Protocol Violation|1
3093499|NCT00333138|10605577|P3|Core Study (6 Months)|Lack of Efficacy|0
3093500|NCT00333138|10605578|P2|Core Study (6 Months)|Lack of Efficacy|0
3093501|NCT00333138|10605579|P1|Core Study (6 Months)|Lack of Efficacy|1
3093502|NCT00333138|10605577|P3|Core Study (6 Months)|Withdrawal by Subject|2
3093503|NCT00333138|10605578|P2|Core Study (6 Months)|Withdrawal by Subject|1
3093504|NCT00333138|10605579|P1|Core Study (6 Months)|Withdrawal by Subject|1
3093505|NCT00333138|10605577|P3|Core Study (6 Months)|Adverse Event|8
3093506|NCT00333138|10605578|P2|Core Study (6 Months)|Adverse Event|5
3093507|NCT00333138|10605579|P1|Core Study (6 Months)|Adverse Event|4
3093508|NCT00332839|10605618|P2|Follow-up (Months 12 - 60)|Death|1
3093509|NCT00332839|10605619|P1|Follow-up (Months 12 - 60)|Death|1
3093510|NCT00332839|10605618|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
3093511|NCT00332839|10605619|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
3093512|NCT00332839|10605618|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
3093513|NCT00332839|10605619|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
3093514|NCT00332839|10605618|P2|Core (Months 0 - 12)|Adverse Event|15
3093515|NCT00332839|10605619|P1|Core (Months 0 - 12)|Adverse Event|5
3093516|NCT00332839|10605618|P2|Core (Months 0 - 12)|Protocol deviation|1
3093517|NCT00332839|10605619|P1|Core (Months 0 - 12)|Protocol deviation|1
3093518|NCT00332839|10605618|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
3093519|NCT00332839|10605619|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
3093520|NCT00332839|10605618|P2|Core (Months 0 - 12)|Administrative problems|1
3093521|NCT00332839|10605619|P1|Core (Months 0 - 12)|Administrative problems|1
3093522|NCT00332709|10605650|P2|Overall Study|Abnormal test procedure result|0
3093523|NCT00332709|10605651|P1|Overall Study|Abnormal test procedure result|1
3093524|NCT00332709|10605650|P2|Overall Study|Administrative Problems|3
3093525|NCT00332709|10605651|P1|Overall Study|Administrative Problems|0
3093526|NCT00332709|10605650|P2|Overall Study|Lost to Follow-up|0
3093527|NCT00332709|10605651|P1|Overall Study|Lost to Follow-up|2
3093528|NCT00332709|10605650|P2|Overall Study|Withdrawal by Subject|3
3093529|NCT00332709|10605651|P1|Overall Study|Withdrawal by Subject|2
3093530|NCT00332709|10605650|P2|Overall Study|Adverse Event|14
3093531|NCT00332709|10605651|P1|Overall Study|Adverse Event|11
3093532|NCT00332696|10605675|P2|Overall Study|Withdrawal by Subject|0
3093533|NCT00332696|10605676|P1|Overall Study|Withdrawal by Subject|1
3093534|NCT00332696|10605675|P2|Overall Study|Lost to Follow-up|1
3093535|NCT00332696|10605676|P1|Overall Study|Lost to Follow-up|0
3093536|NCT00332696|10605675|P2|Overall Study|Condition does not justify treatment|2
3093537|NCT00332696|10605676|P1|Overall Study|Condition does not justify treatment|0
3093538|NCT00332696|10605675|P2|Overall Study|Adverse Event|2
3093539|NCT00332696|10605676|P1|Overall Study|Adverse Event|1
3093540|NCT00332696|10605675|P2|Overall Study|Insufficient therapeutic effect|11
3093541|NCT00332696|10605676|P1|Overall Study|Insufficient therapeutic effect|4
3093542|NCT00332696|10605675|P2|Overall Study|Death|14
3093543|NCT00332696|10605676|P1|Overall Study|Death|24
3093544|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
3093545|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
3093546|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
3093547|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
3093548|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
3093549|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
3093550|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
3093551|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
3093552|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
3093553|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
3093554|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
3093555|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
3093556|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
3093557|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
3093558|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
3093559|NCT00332488|10605752|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
3093560|NCT00332488|10605753|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
3093561|NCT00332488|10605754|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
3093562|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
3093563|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
3093564|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
3093565|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
3093566|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
3093567|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
3093568|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
3093569|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
3093570|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
3093571|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
3093572|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
3093573|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
3093574|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
3093575|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
3093576|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
3093577|NCT00332488|10605752|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
3093578|NCT00332488|10605753|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
3093579|NCT00332488|10605754|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
3093580|NCT00332462|10605766|P1|Overall Study|Graft Loss|2
3093581|NCT00332462|10605766|P1|Overall Study|Death|3
3093582|NCT00332462|10605766|P1|Overall Study|no longer requires study drug|1
3093583|NCT00332462|10605766|P1|Overall Study|Unsatisfactory therapeutic effect|4
3093584|NCT00332462|10605766|P1|Overall Study|Abnormal Lab Value|1
3093585|NCT00332462|10605766|P1|Overall Study|Adverse Event|5
3093586|NCT00332332|10605773|P1|Overall Study|Did not receive study treatment|16
3093587|NCT00332332|10605773|P1|Overall Study|Other|18
3093588|NCT00332332|10605773|P1|Overall Study|Disease progression|2
3093589|NCT00332332|10605773|P1|Overall Study|Noncompliance|2
3093590|NCT00332332|10605773|P1|Overall Study|Protocol deviation|4
3093591|NCT00332332|10605773|P1|Overall Study|Lost to Follow-up|3
3093592|NCT00332332|10605773|P1|Overall Study|Physician Decision|1
3093593|NCT00332332|10605773|P1|Overall Study|Withdrawal by Subject|8
3093594|NCT00332332|10605773|P1|Overall Study|Death|1
3093595|NCT00332332|10605773|P1|Overall Study|Adverse Event|13
3093596|NCT00332241|10605782|P2|Overall Study|Lost to Follow-up|1
3093597|NCT00332241|10605783|P1|Overall Study|Lost to Follow-up|4
3093598|NCT00332241|10605782|P2|Overall Study|Withdrawal by Subject|1
3093599|NCT00332241|10605783|P1|Overall Study|Withdrawal by Subject|2
3093600|NCT00332241|10605782|P2|Overall Study|Adverse Event|5
3093601|NCT00332241|10605783|P1|Overall Study|Adverse Event|3
3093602|NCT00332241|10605782|P2|Overall Study|Lack of Efficacy|1
3093603|NCT00332241|10605783|P1|Overall Study|Lack of Efficacy|6
3093604|NCT00332202|10605805|P2|Overall Study|Death|2
3093605|NCT00332202|10605806|P1|Overall Study|Death|5
3093606|NCT00332202|10605805|P2|Overall Study|Progressive Disease|60
3093607|NCT00332202|10605806|P1|Overall Study|Progressive Disease|106
3093608|NCT00332202|10605805|P2|Overall Study|Withdrawal by Subject|17
3093609|NCT00332202|10605806|P1|Overall Study|Withdrawal by Subject|36
3093610|NCT00332202|10605805|P2|Overall Study|Sponsor Decision|2
3093611|NCT00332202|10605806|P1|Overall Study|Sponsor Decision|1
3093612|NCT00332202|10605805|P2|Overall Study|Protocol Violation|2
3093613|NCT00332202|10605806|P1|Overall Study|Protocol Violation|7
3093614|NCT00332202|10605805|P2|Overall Study|Protocol Entry Criteria Not Met|5
3093615|NCT00332202|10605806|P1|Overall Study|Protocol Entry Criteria Not Met|6
3093616|NCT00332202|10605805|P2|Overall Study|Physician Decision|8
3093617|NCT00332202|10605806|P1|Overall Study|Physician Decision|6
3093618|NCT00332202|10605805|P2|Overall Study|Lost to Follow-up|1
3093619|NCT00332202|10605806|P1|Overall Study|Lost to Follow-up|2
3093620|NCT00332202|10605805|P2|Overall Study|Adverse Event|28
3093621|NCT00332202|10605806|P1|Overall Study|Adverse Event|72
3093622|NCT00332189|10605835|P1|Overall Study|Moved out of country|2
3093623|NCT00332189|10605835|P1|Overall Study|Lack of Efficacy|4
3093624|NCT00332189|10605835|P1|Overall Study|Withdrawal by Subject|9
3093625|NCT00332189|10605835|P1|Overall Study|Uncooperative/Noncompliant|3
3093626|NCT00332189|10605835|P1|Overall Study|Adverse Event|3
3093627|NCT00331864|10605877|P2|Overall Study|Death|0
3093628|NCT00331864|10605878|P1|Overall Study|Death|6
3093629|NCT00331864|10605877|P2|Overall Study|Administrative Problems|0
3093630|NCT00331864|10605878|P1|Overall Study|Administrative Problems|1
3093631|NCT00331864|10605877|P2|Overall Study|Lost to Follow-up|3
3093632|NCT00331864|10605878|P1|Overall Study|Lost to Follow-up|4
3093633|NCT00331864|10605877|P2|Overall Study|Withdrawal by Subject|0
3093634|NCT00331864|10605878|P1|Overall Study|Withdrawal by Subject|10
3093635|NCT00331864|10605877|P2|Overall Study|Protocol Violation|0
3093636|NCT00331864|10605878|P1|Overall Study|Protocol Violation|3
3093637|NCT00331864|10605877|P2|Overall Study|Lack of Efficacy|0
3093638|NCT00331864|10605878|P1|Overall Study|Lack of Efficacy|4
3093639|NCT00331864|10605877|P2|Overall Study|Adverse Event|1
3093640|NCT00331864|10605878|P1|Overall Study|Adverse Event|30
3093641|NCT00331799|10605897|P1|Overall Study|Sedation|1
3093642|NCT00331799|10605897|P1|Overall Study|Withdrawal by Subject|2
3093643|NCT00331773|10605903|P2|Overall Study|Protocol Violation|3
3093644|NCT00331773|10605904|P1|Overall Study|Protocol Violation|10
3093645|NCT00331773|10605903|P2|Overall Study|Withdrawal by Subject|4
3093646|NCT00331773|10605904|P1|Overall Study|Withdrawal by Subject|6
3093647|NCT00331760|10605934|P2|Overall Study|Ineligible / no protocol treatment|8
3093648|NCT00331760|10605935|P1|Overall Study|Ineligible / no protocol treatment|15
3093649|NCT00331682|10605956|P1|Overall Study|Adverse Event|1
3093650|NCT00331630|10605962|P1|Follow up for 5 Years|Data collection was stopped|24
3093651|NCT00331630|10605962|P1|Follow up for 5 Years|Death|5
3093652|NCT00331630|10605962|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
3093653|NCT00331630|10605962|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
3093654|NCT00331552|10605974|P2|Period 3: Phase II|Severe Nausea|0
3093655|NCT00331552|10605975|P1|Period 3: Phase II|Severe Nausea|1
3093656|NCT00331552|10605974|P2|Period 3: Phase II|Neurological Symptoms|0
3093657|NCT00331552|10605975|P1|Period 3: Phase II|Neurological Symptoms|1
3093658|NCT00331422|10605989|P1|Overall Study|Did not receive entire study regimen|5
3093659|NCT00331409|10605998|P1|Overall Study|Lack of Efficacy|4
3093660|NCT00331344|10606006|P9|Phase II|Death|4
3093661|NCT00331344|10606007|P8|Phase II|Death|0
3093662|NCT00331344|10606008|P7|Phase II|Death|0
3093663|NCT00331344|10606009|P6|Phase II|Death|0
3093664|NCT00331344|10606010|P5|Phase II|Death|0
3093665|NCT00331344|10606011|P4|Phase II|Death|0
3093666|NCT00331344|10606012|P3|Phase II|Death|0
3093667|NCT00331344|10606013|P2|Phase II|Death|0
3093668|NCT00331344|10606014|P1|Phase II|Death|0
3093669|NCT00331344|10606006|P9|Phase I|Adverse Event|0
3093670|NCT00331344|10606007|P8|Phase I|Adverse Event|1
3093671|NCT00331344|10606008|P7|Phase I|Adverse Event|0
3093672|NCT00331344|10606009|P6|Phase I|Adverse Event|2
3093673|NCT00331344|10606010|P5|Phase I|Adverse Event|2
3093674|NCT00331344|10606011|P4|Phase I|Adverse Event|1
3093675|NCT00331344|10606012|P3|Phase I|Adverse Event|0
3093676|NCT00331344|10606013|P2|Phase I|Adverse Event|0
3093677|NCT00331344|10606014|P1|Phase I|Adverse Event|0
3093678|NCT00331006|10606051|P1|Follow-Up Phase II|Lost to Follow-up|3
3093679|NCT00331006|10606051|P1|Follow-Up Phase I|Lost to Follow-up|1
3093680|NCT00331006|10606051|P1|Treatment Phase|Withdrawal by Subject|1
3093681|NCT00331006|10606051|P1|Screening Phase|Ineligible for treatment phase|4
3093682|NCT00331006|10606051|P1|Screening Phase|Lost to Follow-up|1
3093683|NCT00331006|10606051|P1|Screening Phase|enrollment halted|1
3093684|NCT00331006|10606051|P1|Screening Phase|Withdrawal by Subject|1
3093685|NCT00330967|10606064|P2|Overall Study|Physician Decision|9
3093686|NCT00330967|10606065|P1|Overall Study|Physician Decision|0
3093687|NCT00330967|10606064|P2|Overall Study|Withdrawal by Subject|5
3093688|NCT00330967|10606065|P1|Overall Study|Withdrawal by Subject|0
3093689|NCT00330928|10606076|P1|Overall Study|IVUS could not be performed.|1
3093690|NCT00330928|10606076|P1|Overall Study|Death|1
3093691|NCT00330928|10606076|P1|Overall Study|Physician Decision|9
3093692|NCT00330928|10606076|P1|Overall Study|Lost to Follow-up|6
3093693|NCT00330759|10606118|P2|Overall Study|Other|44
3093694|NCT00330759|10606119|P1|Overall Study|Other|36
3093695|NCT00330759|10606118|P2|Overall Study|Ineligibility determined|1
3093696|NCT00330759|10606119|P1|Overall Study|Ineligibility determined|2
3093697|NCT00330759|10606118|P2|Overall Study|Protocol deviation|2
3093698|NCT00330759|10606119|P1|Overall Study|Protocol deviation|0
3093699|NCT00330759|10606118|P2|Overall Study|Physician Decision|2
3093700|NCT00330759|10606119|P1|Overall Study|Physician Decision|1
3093701|NCT00330759|10606118|P2|Overall Study|Noncompliance|17
3093702|NCT00330759|10606119|P1|Overall Study|Noncompliance|15
3093703|NCT00330759|10606118|P2|Overall Study|Lost to Follow-up|22
3093704|NCT00330759|10606119|P1|Overall Study|Lost to Follow-up|16
3093705|NCT00330759|10606118|P2|Overall Study|Participant request|22
3093706|NCT00330759|10606119|P1|Overall Study|Participant request|31
3093707|NCT00330759|10606118|P2|Overall Study|Adverse Event|36
3093708|NCT00330759|10606119|P1|Overall Study|Adverse Event|48
3093709|NCT00330759|10606118|P2|Overall Study|Withdrawal by Subject|124
3093710|NCT00330759|10606119|P1|Overall Study|Withdrawal by Subject|143
3093711|NCT00330759|10606118|P2|Overall Study|Disease progression|126
3093712|NCT00330759|10606119|P1|Overall Study|Disease progression|104
3093713|NCT00330759|10606118|P2|Overall Study|Death|310
3093714|NCT00330759|10606119|P1|Overall Study|Death|316
3093715|NCT00330681|10606152|P2|Overall Study|Tracheotomy due to worsening of ALS|2
3093716|NCT00330681|10606153|P1|Overall Study|Tracheotomy due to worsening of ALS|1
3093717|NCT00330681|10606152|P2|Overall Study|Withdrawal by Subject|5
3093718|NCT00330681|10606153|P1|Overall Study|Withdrawal by Subject|5
3093719|NCT00330681|10606152|P2|Overall Study|Protocol Violation|1
3093720|NCT00330681|10606153|P1|Overall Study|Protocol Violation|0
3093721|NCT00330681|10606152|P2|Overall Study|Adverse Event|6
3093722|NCT00330681|10606153|P1|Overall Study|Adverse Event|3
3093723|NCT00330668|10606175|P1|Overall Study|Patient started Lupron|1
3093724|NCT00330668|10606175|P1|Overall Study|Use of exclusionary medication|1
3093725|NCT00330668|10606175|P1|Overall Study|Lack of Efficacy|1
3093726|NCT00330668|10606175|P1|Overall Study|Sponsor's decision|76
3093727|NCT00330668|10606175|P1|Overall Study|Withdrawal by Subject|20
3093728|NCT00330668|10606175|P1|Overall Study|Non-Compliance|5
3093729|NCT00330668|10606175|P1|Overall Study|Lost to Follow-up|9
3093730|NCT00330668|10606175|P1|Overall Study|Adverse Event|1
3093731|NCT00330616|10606182|P1|Overall Study|Other|1
3093732|NCT00330616|10606182|P1|Overall Study|Withdrawal by Subject|4
3093733|NCT00330616|10606182|P1|Overall Study|Lost to Follow-up|2
3093734|NCT00330616|10606182|P1|Overall Study|Lack of Efficacy|1
3093735|NCT00330616|10606182|P1|Overall Study|Adverse Event|13
3093736|NCT00330460|10606233|P2|Overall Study|Other|0
3093737|NCT00330460|10606234|P1|Overall Study|Other|1
3093738|NCT00330460|10606233|P2|Overall Study|Noncompliance|1
3093739|NCT00330460|10606234|P1|Overall Study|Noncompliance|2
3093740|NCT00330460|10606233|P2|Overall Study|Lost to Follow-up|3
3093741|NCT00330460|10606234|P1|Overall Study|Lost to Follow-up|8
3093742|NCT00330460|10606233|P2|Overall Study|Ineligibility determined|3
3093743|NCT00330460|10606234|P1|Overall Study|Ineligibility determined|1
3093744|NCT00330460|10606233|P2|Overall Study|Death|1
3093745|NCT00330460|10606234|P1|Overall Study|Death|1
3093746|NCT00330460|10606233|P2|Overall Study|Withdrawal by Subject|17
3093747|NCT00330460|10606234|P1|Overall Study|Withdrawal by Subject|18
3093748|NCT00330460|10606233|P2|Overall Study|Adverse Event|8
3093749|NCT00330460|10606234|P1|Overall Study|Adverse Event|10
3093750|NCT00330460|10606233|P2|Overall Study|Physician Decision|0
3093751|NCT00330460|10606234|P1|Overall Study|Physician Decision|1
3093752|NCT00330343|10606277|P1|Overall Study|Lost to Follow-up|5
3093753|NCT00330187|10606285|P4|Overall Study|Withdrawal by Subject|4
3093754|NCT00330187|10606286|P3|Overall Study|Withdrawal by Subject|4
3093755|NCT00330187|10606287|P2|Overall Study|Withdrawal by Subject|5
3093756|NCT00330187|10606288|P1|Overall Study|Withdrawal by Subject|8
3093757|NCT00330187|10606285|P4|Overall Study|Lost to Follow-up|10
3093758|NCT00330187|10606286|P3|Overall Study|Lost to Follow-up|14
3093759|NCT00330187|10606287|P2|Overall Study|Lost to Follow-up|13
3093760|NCT00330187|10606288|P1|Overall Study|Lost to Follow-up|12
3093761|NCT00330174|10606300|P2|Overall Study|Miscellaneous reasons|1
3093762|NCT00330174|10606301|P1|Overall Study|Miscellaneous reasons|7
3093763|NCT00330174|10606300|P2|Overall Study|Excessive missed visits|8
3093764|NCT00330174|10606301|P1|Overall Study|Excessive missed visits|3
3093765|NCT00330174|10606300|P2|Overall Study|Clinical deterioration|2
3093766|NCT00330174|10606301|P1|Overall Study|Clinical deterioration|1
3093767|NCT00330174|10606300|P2|Overall Study|Lost to Follow-up|1
3093768|NCT00330174|10606301|P1|Overall Study|Lost to Follow-up|4
3093769|NCT00330174|10606300|P2|Overall Study|Withdrawal by Subject|7
3093770|NCT00330174|10606301|P1|Overall Study|Withdrawal by Subject|7
3093771|NCT00329901|10606325|P3|Overall Study|Unable to classify|0
3093772|NCT00329901|10606326|P2|Overall Study|Unable to classify|2
3093773|NCT00329901|10606327|P1|Overall Study|Unable to classify|2
3093774|NCT00329901|10606325|P3|Overall Study|Protocol Violation|1
3093775|NCT00329901|10606326|P2|Overall Study|Protocol Violation|0
3093776|NCT00329901|10606327|P1|Overall Study|Protocol Violation|1
3093777|NCT00329901|10606325|P3|Overall Study|Lost to Follow-up|1
3093778|NCT00329901|10606326|P2|Overall Study|Lost to Follow-up|0
3093779|NCT00329901|10606327|P1|Overall Study|Lost to Follow-up|2
3093780|NCT00329901|10606325|P3|Overall Study|Withdrawal by Subject|2
3093781|NCT00329901|10606326|P2|Overall Study|Withdrawal by Subject|3
3093782|NCT00329901|10606327|P1|Overall Study|Withdrawal by Subject|4
3093783|NCT00329849|10606357|P2|Overall Study|Withdrawal by Subject|4
3093784|NCT00329849|10606358|P1|Overall Study|Withdrawal by Subject|6
3093785|NCT00329797|10606384|P2|Overall Study|Withdrawal by Subject|6
3093786|NCT00329797|10606385|P1|Overall Study|Withdrawal by Subject|6
3093787|NCT00329797|10606384|P2|Overall Study|Protocol Violation|0
3093788|NCT00329797|10606385|P1|Overall Study|Protocol Violation|1
3093789|NCT00329784|10606401|P4|Overall Study|Other|0
3093790|NCT00329784|10606402|P3|Overall Study|Other|0
3093791|NCT00329784|10606403|P2|Overall Study|Other|2
3093792|NCT00329784|10606404|P1|Overall Study|Other|1
3093793|NCT00329784|10606401|P4|Overall Study|Withdrawal by Subject|0
3093794|NCT00329784|10606402|P3|Overall Study|Withdrawal by Subject|0
3093795|NCT00329784|10606403|P2|Overall Study|Withdrawal by Subject|2
3093796|NCT00329784|10606404|P1|Overall Study|Withdrawal by Subject|4
3093797|NCT00329784|10606401|P4|Overall Study|Lost to Follow-up|0
3093798|NCT00329784|10606402|P3|Overall Study|Lost to Follow-up|0
3093799|NCT00329784|10606403|P2|Overall Study|Lost to Follow-up|1
3093800|NCT00329784|10606404|P1|Overall Study|Lost to Follow-up|0
3093801|NCT00329745|10606432|P2|Overall Study|Lost to Follow-up|101
3093802|NCT00329745|10606433|P1|Overall Study|Lost to Follow-up|86
3093803|NCT00329745|10606432|P2|Overall Study|Withdrawal by Subject|1
3093804|NCT00329745|10606433|P1|Overall Study|Withdrawal by Subject|0
3093805|NCT00329745|10606432|P2|Overall Study|Protocol Violation|0
3093806|NCT00329745|10606433|P1|Overall Study|Protocol Violation|1
3093807|NCT00329719|10606453|P4|Overall Study|Lost to Follow-up|1
3093808|NCT00329719|10606454|P3|Overall Study|Lost to Follow-up|0
3093809|NCT00329719|10606455|P2|Overall Study|Lost to Follow-up|0
3093810|NCT00329719|10606456|P1|Overall Study|Lost to Follow-up|0
3093811|NCT00329641|10606478|P1|Overall Study|Other reason, not protocol specified|1
3093812|NCT00329641|10606478|P1|Overall Study|Adverse Event|3
3093813|NCT00329641|10606478|P1|Overall Study|Not eligible|1
3093814|NCT00329641|10606478|P1|Overall Study|Did not start treatment|1
3093815|NCT00329602|10606487|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
3093816|NCT00329602|10606488|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
3093817|NCT00329602|10606489|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
3093818|NCT00329602|10606487|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
3093819|NCT00329602|10606488|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
3093820|NCT00329602|10606489|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
3093821|NCT00329602|10606487|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
3093822|NCT00329602|10606488|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
3093823|NCT00329602|10606489|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
3093824|NCT00329602|10606487|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
3093825|NCT00329602|10606488|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
3093826|NCT00329602|10606489|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
3093827|NCT00329602|10606487|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
3093828|NCT00329602|10606488|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
3093829|NCT00329602|10606489|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
3093830|NCT00329602|10606487|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
3093831|NCT00329602|10606488|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
3093832|NCT00329602|10606489|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
3093833|NCT00329550|10606527|P3|Overall Study|Due to Relocation|1
3093834|NCT00329550|10606528|P2|Overall Study|Due to Relocation|0
3093835|NCT00329550|10606529|P1|Overall Study|Due to Relocation|0
3093836|NCT00329550|10606527|P3|Overall Study|Withdrawal of Consent|1
3093837|NCT00329550|10606528|P2|Overall Study|Withdrawal of Consent|0
3093838|NCT00329550|10606529|P1|Overall Study|Withdrawal of Consent|1
3093839|NCT00329550|10606527|P3|Overall Study|Adverse Event|2
3093840|NCT00329550|10606528|P2|Overall Study|Adverse Event|4
3093841|NCT00329550|10606529|P1|Overall Study|Adverse Event|3
3093842|NCT00329420|10606798|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
3093843|NCT00329420|10606799|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
3093844|NCT00329420|10606800|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
3093845|NCT00329420|10606798|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
3093846|NCT00329420|10606799|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
3093847|NCT00329420|10606800|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
3093848|NCT00329420|10606798|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
3093849|NCT00329420|10606799|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
3093850|NCT00329420|10606800|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
3093851|NCT00329420|10606798|P3|Re-induction Phase|Did not respond to re-induction|7
3093852|NCT00329420|10606799|P2|Re-induction Phase|Did not respond to re-induction|5
3093853|NCT00329420|10606800|P1|Re-induction Phase|Did not respond to re-induction|6
3093854|NCT00329420|10606798|P3|Re-induction Phase|Withdrawal of Consent|1
3093855|NCT00329420|10606799|P2|Re-induction Phase|Withdrawal of Consent|0
3093856|NCT00329420|10606800|P1|Re-induction Phase|Withdrawal of Consent|0
3093857|NCT00329420|10606798|P3|Re-induction Phase|Lack of Efficacy|0
3093858|NCT00329420|10606799|P2|Re-induction Phase|Lack of Efficacy|1
3093859|NCT00329420|10606800|P1|Re-induction Phase|Lack of Efficacy|0
3093860|NCT00329407|10607179|P1|Overall Study|Withdrawal by Subject|1
3093861|NCT00329303|10607186|P2|Overall Study|Patient relocated|1
3093862|NCT00329303|10607187|P1|Overall Study|Patient relocated|0
3093863|NCT00329303|10607186|P2|Overall Study|Patient no longer available|0
3093864|NCT00329303|10607187|P1|Overall Study|Patient no longer available|1
3093865|NCT00329303|10607186|P2|Overall Study|Decision of the sponsor|1
3093866|NCT00329303|10607187|P1|Overall Study|Decision of the sponsor|0
3093867|NCT00329303|10607186|P2|Overall Study|Lack of Efficacy|0
3093868|NCT00329303|10607187|P1|Overall Study|Lack of Efficacy|1
3093869|NCT00329238|10607349|P2|Overall Study|Other reason (not specified)|54
3093870|NCT00329238|10607350|P1|Overall Study|Other reason (not specified)|40
3093871|NCT00329238|10607349|P2|Overall Study|Withdrawal by Subject|58
3093872|NCT00329238|10607350|P1|Overall Study|Withdrawal by Subject|64
3093873|NCT00329238|10607349|P2|Overall Study|Lost to Follow-up|6
3093874|NCT00329238|10607350|P1|Overall Study|Lost to Follow-up|2
3093875|NCT00329238|10607349|P2|Overall Study|Protocol Violation|34
3093876|NCT00329238|10607350|P1|Overall Study|Protocol Violation|23
3093877|NCT00329238|10607349|P2|Overall Study|Adverse Event|129
3093878|NCT00329238|10607350|P1|Overall Study|Adverse Event|147
3093879|NCT00329160|10607386|P1|Overall Study|Incomplete IVUS|45
3093880|NCT00329160|10607386|P1|Overall Study|Did not Receive Study Drug|1
3093881|NCT00329160|10607386|P1|Overall Study|Protocol Violation|2
3093882|NCT00329160|10607386|P1|Overall Study|Withdrawal by Subject|13
3093883|NCT00329160|10607386|P1|Overall Study|Adverse Event|27
3093884|NCT00329108|10607395|P2|Overall Study|Protocol Violation|2
3093885|NCT00329108|10607396|P1|Overall Study|Protocol Violation|0
3093886|NCT00329108|10607395|P2|Overall Study|withdrew patient after SAE resolved|0
3093887|NCT00329108|10607396|P1|Overall Study|withdrew patient after SAE resolved|1
3093888|NCT00329108|10607395|P2|Overall Study|study terminated by sponsor|0
3093889|NCT00329108|10607396|P1|Overall Study|study terminated by sponsor|1
3093890|NCT00329108|10607395|P2|Overall Study|Subject no longer willing to participate|2
3093891|NCT00329108|10607396|P1|Overall Study|Subject no longer willing to participate|2
3093892|NCT00329108|10607395|P2|Overall Study|symptomatic deterioration|1
3093893|NCT00329108|10607396|P1|Overall Study|symptomatic deterioration|1
3093894|NCT00329108|10607395|P2|Overall Study|Withdrawal by Subject|2
3093895|NCT00329108|10607396|P1|Overall Study|Withdrawal by Subject|0
3093896|NCT00329108|10607395|P2|Overall Study|Lack of Efficacy|3
3093897|NCT00329108|10607396|P1|Overall Study|Lack of Efficacy|3
3093898|NCT00329108|10607395|P2|Overall Study|Adverse Event|2
3093899|NCT00329108|10607396|P1|Overall Study|Adverse Event|2
3093900|NCT00329030|10607404|P2|Overall Study|Ineligible Pathology|1
3093901|NCT00329030|10607405|P1|Overall Study|Ineligible Pathology|1
3093902|NCT00329030|10607404|P2|Overall Study|Progressive Disease|2
3093903|NCT00329030|10607405|P1|Overall Study|Progressive Disease|6
3093904|NCT00329030|10607404|P2|Overall Study|Withdrawal by Subject|3
3093905|NCT00329030|10607405|P1|Overall Study|Withdrawal by Subject|1
3093906|NCT00328926|10607436|P3|Overall Study|Lack of ovarian response|0
3093907|NCT00328926|10607437|P2|Overall Study|Lack of ovarian response|1
3093908|NCT00328926|10607438|P1|Overall Study|Lack of ovarian response|0
3093909|NCT00328926|10607436|P3|Overall Study|In vitro fertilization treatment|1
3093910|NCT00328926|10607437|P2|Overall Study|In vitro fertilization treatment|0
3093911|NCT00328926|10607438|P1|Overall Study|In vitro fertilization treatment|0
3093912|NCT00328926|10607436|P3|Overall Study|Death|1
3093913|NCT00328926|10607437|P2|Overall Study|Death|0
3093914|NCT00328926|10607438|P1|Overall Study|Death|0
3093915|NCT00328926|10607436|P3|Overall Study|Lost to Follow-up|0
3093916|NCT00328926|10607437|P2|Overall Study|Lost to Follow-up|1
3093917|NCT00328926|10607438|P1|Overall Study|Lost to Follow-up|0
3093918|NCT00328926|10607436|P3|Overall Study|Pregnancy|0
3093919|NCT00328926|10607437|P2|Overall Study|Pregnancy|1
3093920|NCT00328926|10607438|P1|Overall Study|Pregnancy|2
3093921|NCT00328783|10607463|P1|Overall Study|Withdrawal by Subject|1
3093922|NCT00328783|10607463|P1|Overall Study|No heart in RT field|4
3093923|NCT00328783|10607463|P1|Overall Study|Could not tolerate ABC|21
3093924|NCT00328627|10607489|P12|Overall Study|Other|0
3093925|NCT00328627|10607490|P11|Overall Study|Other|1
3093926|NCT00328627|10607491|P10|Overall Study|Other|1
3093927|NCT00328627|10607492|P9|Overall Study|Other|0
3093928|NCT00328627|10607493|P8|Overall Study|Other|0
3093929|NCT00328627|10607494|P7|Overall Study|Other|1
3093930|NCT00328627|10607495|P6|Overall Study|Other|0
3093931|NCT00328627|10607496|P5|Overall Study|Other|0
3093932|NCT00328627|10607497|P4|Overall Study|Other|1
3093933|NCT00328627|10607498|P3|Overall Study|Other|0
3093934|NCT00328627|10607499|P2|Overall Study|Other|0
3093935|NCT00328627|10607500|P1|Overall Study|Other|0
3093936|NCT00328627|10607489|P12|Overall Study|Physician Decision|0
3093937|NCT00328627|10607490|P11|Overall Study|Physician Decision|1
3093938|NCT00328627|10607491|P10|Overall Study|Physician Decision|2
3093939|NCT00328627|10607492|P9|Overall Study|Physician Decision|3
3093940|NCT00328627|10607493|P8|Overall Study|Physician Decision|0
3093941|NCT00328627|10607494|P7|Overall Study|Physician Decision|1
3093942|NCT00328627|10607495|P6|Overall Study|Physician Decision|1
3093943|NCT00328627|10607496|P5|Overall Study|Physician Decision|1
3093944|NCT00328627|10607497|P4|Overall Study|Physician Decision|2
3093945|NCT00328627|10607498|P3|Overall Study|Physician Decision|1
3093946|NCT00328627|10607499|P2|Overall Study|Physician Decision|3
3093947|NCT00328627|10607500|P1|Overall Study|Physician Decision|4
3093948|NCT00328627|10607489|P12|Overall Study|Pregnancy|0
3093949|NCT00328627|10607490|P11|Overall Study|Pregnancy|0
3093950|NCT00328627|10607491|P10|Overall Study|Pregnancy|0
3093951|NCT00328627|10607492|P9|Overall Study|Pregnancy|0
3093952|NCT00328627|10607493|P8|Overall Study|Pregnancy|0
3093953|NCT00328627|10607494|P7|Overall Study|Pregnancy|0
3093954|NCT00328627|10607495|P6|Overall Study|Pregnancy|0
3093955|NCT00328627|10607496|P5|Overall Study|Pregnancy|0
3093956|NCT00328627|10607497|P4|Overall Study|Pregnancy|0
3093957|NCT00328627|10607498|P3|Overall Study|Pregnancy|0
3093958|NCT00328627|10607499|P2|Overall Study|Pregnancy|1
3093959|NCT00328627|10607500|P1|Overall Study|Pregnancy|0
3093960|NCT00328627|10607489|P12|Overall Study|Withdrawal by Subject|7
3093961|NCT00328627|10607490|P11|Overall Study|Withdrawal by Subject|2
3093962|NCT00328627|10607491|P10|Overall Study|Withdrawal by Subject|5
3093963|NCT00328627|10607492|P9|Overall Study|Withdrawal by Subject|4
3093964|NCT00328627|10607493|P8|Overall Study|Withdrawal by Subject|4
3093965|NCT00328627|10607494|P7|Overall Study|Withdrawal by Subject|4
3093966|NCT00328627|10607495|P6|Overall Study|Withdrawal by Subject|5
3093967|NCT00328627|10607496|P5|Overall Study|Withdrawal by Subject|2
3093968|NCT00328627|10607497|P4|Overall Study|Withdrawal by Subject|6
3093969|NCT00328627|10607498|P3|Overall Study|Withdrawal by Subject|5
3093970|NCT00328627|10607499|P2|Overall Study|Withdrawal by Subject|4
3093971|NCT00328627|10607500|P1|Overall Study|Withdrawal by Subject|5
3093972|NCT00328627|10607489|P12|Overall Study|Lost to Follow-up|1
3093973|NCT00328627|10607490|P11|Overall Study|Lost to Follow-up|0
3093974|NCT00328627|10607491|P10|Overall Study|Lost to Follow-up|2
3093975|NCT00328627|10607492|P9|Overall Study|Lost to Follow-up|3
3093976|NCT00328627|10607493|P8|Overall Study|Lost to Follow-up|0
3093977|NCT00328627|10607494|P7|Overall Study|Lost to Follow-up|3
3093978|NCT00328627|10607495|P6|Overall Study|Lost to Follow-up|2
3093979|NCT00328627|10607496|P5|Overall Study|Lost to Follow-up|0
3093980|NCT00328627|10607497|P4|Overall Study|Lost to Follow-up|4
3093981|NCT00328627|10607498|P3|Overall Study|Lost to Follow-up|2
3093982|NCT00328627|10607499|P2|Overall Study|Lost to Follow-up|2
3093983|NCT00328627|10607500|P1|Overall Study|Lost to Follow-up|4
3093984|NCT00328627|10607489|P12|Overall Study|Protocol Violation|2
3093985|NCT00328627|10607490|P11|Overall Study|Protocol Violation|6
3093986|NCT00328627|10607491|P10|Overall Study|Protocol Violation|4
3093987|NCT00328627|10607492|P9|Overall Study|Protocol Violation|1
3093988|NCT00328627|10607493|P8|Overall Study|Protocol Violation|2
3093989|NCT00328627|10607494|P7|Overall Study|Protocol Violation|6
3093990|NCT00328627|10607495|P6|Overall Study|Protocol Violation|5
3093991|NCT00328627|10607496|P5|Overall Study|Protocol Violation|5
3093992|NCT00328627|10607497|P4|Overall Study|Protocol Violation|8
3093993|NCT00328627|10607498|P3|Overall Study|Protocol Violation|2
3093994|NCT00328627|10607499|P2|Overall Study|Protocol Violation|2
3093995|NCT00328627|10607500|P1|Overall Study|Protocol Violation|2
3093996|NCT00328627|10607489|P12|Overall Study|Adverse Event|4
3093997|NCT00328627|10607490|P11|Overall Study|Adverse Event|5
3093998|NCT00328627|10607491|P10|Overall Study|Adverse Event|7
3093999|NCT00328627|10607492|P9|Overall Study|Adverse Event|0
3094000|NCT00328627|10607493|P8|Overall Study|Adverse Event|2
3094001|NCT00328627|10607494|P7|Overall Study|Adverse Event|1
3094002|NCT00328627|10607495|P6|Overall Study|Adverse Event|2
3094003|NCT00328627|10607496|P5|Overall Study|Adverse Event|1
3094004|NCT00328627|10607497|P4|Overall Study|Adverse Event|3
3094005|NCT00328627|10607498|P3|Overall Study|Adverse Event|2
3094006|NCT00328627|10607499|P2|Overall Study|Adverse Event|1
3094007|NCT00328627|10607500|P1|Overall Study|Adverse Event|3
3094008|NCT00328627|10607489|P12|Overall Study|Hyperglycemic Rescue|2
3094009|NCT00328627|10607490|P11|Overall Study|Hyperglycemic Rescue|3
3094010|NCT00328627|10607491|P10|Overall Study|Hyperglycemic Rescue|11
3094011|NCT00328627|10607492|P9|Overall Study|Hyperglycemic Rescue|6
3094012|NCT00328627|10607493|P8|Overall Study|Hyperglycemic Rescue|6
3094013|NCT00328627|10607494|P7|Overall Study|Hyperglycemic Rescue|19
3094014|NCT00328627|10607495|P6|Overall Study|Hyperglycemic Rescue|5
3094015|NCT00328627|10607496|P5|Overall Study|Hyperglycemic Rescue|6
3094016|NCT00328627|10607497|P4|Overall Study|Hyperglycemic Rescue|13
3094017|NCT00328627|10607498|P3|Overall Study|Hyperglycemic Rescue|16
3094018|NCT00328627|10607499|P2|Overall Study|Hyperglycemic Rescue|18
3094019|NCT00328627|10607500|P1|Overall Study|Hyperglycemic Rescue|41
3094020|NCT00328562|10609037|P1|Overall Study|Disease progression|1
3094021|NCT00328510|10609046|P2|Overall Study|Treatment changed to a single fraction|1
3094022|NCT00328510|10609047|P1|Overall Study|Treatment changed to a single fraction|1
3094023|NCT00328510|10609046|P2|Overall Study|Severe kyphosis, could not use mask|1
3094024|NCT00328510|10609047|P1|Overall Study|Severe kyphosis, could not use mask|0
3094025|NCT00328510|10609046|P2|Overall Study|Withdrawal by Subject|2
3094026|NCT00328510|10609047|P1|Overall Study|Withdrawal by Subject|4
3094027|NCT00328510|10609046|P2|Overall Study|Dentition problems, could not use frame|0
3094028|NCT00328510|10609047|P1|Overall Study|Dentition problems, could not use frame|1
3094029|NCT00328510|10609046|P2|Overall Study|Gag disorder, could not use frame|0
3094030|NCT00328510|10609047|P1|Overall Study|Gag disorder, could not use frame|4
3094031|NCT00328198|10609062|P1|Follow-up|Death|31
3094032|NCT00328198|10609062|P1|Follow-up|Lost to Follow-up|4
3094033|NCT00328198|10609062|P1|Treatment|Confirmed complete response, MRD -|3
3094034|NCT00328198|10609062|P1|Treatment|Non-compliance|1
3094035|NCT00328198|10609062|P1|Treatment|Evidence of disease progression|2
3094036|NCT00328198|10609062|P1|Treatment|Withdrawal by Subject|5
3094037|NCT00328198|10609062|P1|Treatment|Physician Decision|5
3094038|NCT00328198|10609062|P1|Treatment|Death|1
3094039|NCT00328198|10609062|P1|Treatment|Adverse Event|21
3094040|NCT00328172|10609077|P5|Overall Study|Other reason (not specified)|0
3094041|NCT00328172|10609078|P4|Overall Study|Other reason (not specified)|0
3094042|NCT00328172|10609079|P3|Overall Study|Other reason (not specified)|1
3094043|NCT00328172|10609080|P2|Overall Study|Other reason (not specified)|0
3094044|NCT00328172|10609081|P1|Overall Study|Other reason (not specified)|3
3094045|NCT00328172|10609077|P5|Overall Study|Lack of Efficacy|3
3094046|NCT00328172|10609078|P4|Overall Study|Lack of Efficacy|4
3094047|NCT00328172|10609079|P3|Overall Study|Lack of Efficacy|4
3094048|NCT00328172|10609080|P2|Overall Study|Lack of Efficacy|9
3094049|NCT00328172|10609081|P1|Overall Study|Lack of Efficacy|14
3094050|NCT00328172|10609077|P5|Overall Study|Withdrawal by Subject|0
3094051|NCT00328172|10609078|P4|Overall Study|Withdrawal by Subject|6
3094052|NCT00328172|10609079|P3|Overall Study|Withdrawal by Subject|1
3094053|NCT00328172|10609080|P2|Overall Study|Withdrawal by Subject|1
3094054|NCT00328172|10609081|P1|Overall Study|Withdrawal by Subject|1
3094055|NCT00328172|10609077|P5|Overall Study|Lost to Follow-up|1
3094056|NCT00328172|10609078|P4|Overall Study|Lost to Follow-up|1
3094057|NCT00328172|10609079|P3|Overall Study|Lost to Follow-up|2
3094058|NCT00328172|10609080|P2|Overall Study|Lost to Follow-up|1
3094059|NCT00328172|10609081|P1|Overall Study|Lost to Follow-up|1
3094060|NCT00328172|10609077|P5|Overall Study|Protocol Violation|0
3094061|NCT00328172|10609078|P4|Overall Study|Protocol Violation|0
3094062|NCT00328172|10609079|P3|Overall Study|Protocol Violation|1
3094063|NCT00328172|10609080|P2|Overall Study|Protocol Violation|1
3094064|NCT00328172|10609081|P1|Overall Study|Protocol Violation|0
3094065|NCT00328172|10609077|P5|Overall Study|Adverse Event|1
3094066|NCT00328172|10609078|P4|Overall Study|Adverse Event|2
3094067|NCT00328172|10609079|P3|Overall Study|Adverse Event|1
3094068|NCT00328172|10609080|P2|Overall Study|Adverse Event|2
3094069|NCT00328172|10609081|P1|Overall Study|Adverse Event|3
3094070|NCT00328094|10609105|P2|Overall Study|Physician Decision|3
3094071|NCT00328094|10609106|P1|Overall Study|Physician Decision|3
3094072|NCT00327717|10609140|P2|Overall Study|Withdrawal by Subject|7
3094073|NCT00327717|10609141|P1|Overall Study|Withdrawal by Subject|3
3094074|NCT00327717|10609140|P2|Overall Study|Lack of Efficacy|1
3094075|NCT00327717|10609141|P1|Overall Study|Lack of Efficacy|0
3094076|NCT00327717|10609140|P2|Overall Study|Adverse Event|6
3094077|NCT00327717|10609141|P1|Overall Study|Adverse Event|6
3094078|NCT00327470|10609167|P2|Overall Study|Death|4
3094079|NCT00327470|10609168|P1|Overall Study|Death|1
3094080|NCT00327470|10609167|P2|Overall Study|Withdrawal by Subject|12
3094081|NCT00327470|10609168|P1|Overall Study|Withdrawal by Subject|6
3094082|NCT00327470|10609167|P2|Overall Study|Lost to Follow-up|3
3094083|NCT00327470|10609168|P1|Overall Study|Lost to Follow-up|1
3094084|NCT00327470|10609167|P2|Overall Study|Other|9
3094085|NCT00327470|10609168|P1|Overall Study|Other|5
3094086|NCT00327470|10609167|P2|Overall Study|Lack of Efficacy|19
3094087|NCT00327470|10609168|P1|Overall Study|Lack of Efficacy|7
3094088|NCT00327470|10609167|P2|Overall Study|Adverse Event|14
3094089|NCT00327470|10609168|P1|Overall Study|Adverse Event|9
3094090|NCT00327470|10609167|P2|Overall Study|Randomized, but not treated|2
3094091|NCT00327470|10609168|P1|Overall Study|Randomized, but not treated|0
3094092|NCT00327444|10609188|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
3094093|NCT00327444|10609189|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
3094094|NCT00327444|10609188|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
3094095|NCT00327444|10609189|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
3094096|NCT00327444|10609188|P2|Open Label Treatment (OL) Period|Adverse Event|2
3094097|NCT00327444|10609189|P1|Open Label Treatment (OL) Period|Adverse Event|2
3094098|NCT00327444|10609188|P2|Open Label Treatment (OL) Period|Disease progression|7
3094099|NCT00327444|10609189|P1|Open Label Treatment (OL) Period|Disease progression|8
3094100|NCT00327444|10609188|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
3094101|NCT00327444|10609189|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
3094102|NCT00327444|10609188|P2|Double Blind Treatment (DB) Period|Subject request|1
3094103|NCT00327444|10609189|P1|Double Blind Treatment (DB) Period|Subject request|0
3094104|NCT00327444|10609188|P2|Double Blind Treatment (DB) Period|Adverse Event|5
3094105|NCT00327444|10609189|P1|Double Blind Treatment (DB) Period|Adverse Event|5
3094106|NCT00327444|10609188|P2|Double Blind Treatment (DB) Period|Disease progression|13
3094107|NCT00327444|10609189|P1|Double Blind Treatment (DB) Period|Disease progression|10
3094108|NCT00327340|10609207|P2|Overall Study|Adverse Event|3
3094109|NCT00327340|10609208|P1|Overall Study|Adverse Event|3
3094110|NCT00327340|10609207|P2|Overall Study|Symptomatic Disease|2
3094111|NCT00327340|10609208|P1|Overall Study|Symptomatic Disease|0
3094112|NCT00327340|10609207|P2|Overall Study|Disease Progression|19
3094113|NCT00327340|10609208|P1|Overall Study|Disease Progression|10
3094114|NCT00327340|10609207|P2|Overall Study|Physician Decision|1
3094115|NCT00327340|10609208|P1|Overall Study|Physician Decision|1
3094116|NCT00327340|10609207|P2|Overall Study|Withdrawal by Subject|5
3094117|NCT00327340|10609208|P1|Overall Study|Withdrawal by Subject|1
3094118|NCT00327171|10609222|P2|Overall Study|Other|0
3094119|NCT00327171|10609223|P1|Overall Study|Other|1
3094120|NCT00327171|10609222|P2|Overall Study|Undisclosed history of ischemia|1
3094121|NCT00327171|10609223|P1|Overall Study|Undisclosed history of ischemia|0
3094122|NCT00327171|10609222|P2|Overall Study|Clinical progression|8
3094123|NCT00327171|10609223|P1|Overall Study|Clinical progression|12
3094124|NCT00327171|10609222|P2|Overall Study|Investigator/participant request|8
3094125|NCT00327171|10609223|P1|Overall Study|Investigator/participant request|1
3094126|NCT00327171|10609222|P2|Overall Study|Disease progression/lack of efficacy|69
3094127|NCT00327171|10609223|P1|Overall Study|Disease progression/lack of efficacy|68
3094128|NCT00327171|10609222|P2|Overall Study|Adverse Event|23
3094129|NCT00327171|10609223|P1|Overall Study|Adverse Event|23
3094130|NCT00327171|10609222|P2|Overall Study|Did not receive study medication|0
3094131|NCT00327171|10609223|P1|Overall Study|Did not receive study medication|3
3094132|NCT00327015|10609255|P4|Overall Study|Administrative Reason by Sponsor|1
3094133|NCT00327015|10609256|P3|Overall Study|Administrative Reason by Sponsor|2
3094134|NCT00327015|10609257|P2|Overall Study|Administrative Reason by Sponsor|2
3094135|NCT00327015|10609258|P1|Overall Study|Administrative Reason by Sponsor|1
3094136|NCT00327015|10609255|P4|Overall Study|Pregnancy|1
3094137|NCT00327015|10609256|P3|Overall Study|Pregnancy|1
3094138|NCT00327015|10609257|P2|Overall Study|Pregnancy|2
3094139|NCT00327015|10609258|P1|Overall Study|Pregnancy|0
3094140|NCT00327015|10609255|P4|Overall Study|Death|3
3094141|NCT00327015|10609256|P3|Overall Study|Death|2
3094142|NCT00327015|10609257|P2|Overall Study|Death|2
3094143|NCT00327015|10609258|P1|Overall Study|Death|1
3094144|NCT00327015|10609255|P4|Overall Study|Physician Decision|2
3094145|NCT00327015|10609256|P3|Overall Study|Physician Decision|3
3094146|NCT00327015|10609257|P2|Overall Study|Physician Decision|1
3094147|NCT00327015|10609258|P1|Overall Study|Physician Decision|0
3094148|NCT00327015|10609255|P4|Overall Study|Poor/Noncompliance|5
3094149|NCT00327015|10609256|P3|Overall Study|Poor/Noncompliance|4
3094150|NCT00327015|10609257|P2|Overall Study|Poor/Noncompliance|8
3094151|NCT00327015|10609258|P1|Overall Study|Poor/Noncompliance|11
3094152|NCT00327015|10609255|P4|Overall Study|Subject no longer meets study criteria|7
3094153|NCT00327015|10609256|P3|Overall Study|Subject no longer meets study criteria|8
3094154|NCT00327015|10609257|P2|Overall Study|Subject no longer meets study criteria|2
3094155|NCT00327015|10609258|P1|Overall Study|Subject no longer meets study criteria|4
3094156|NCT00327015|10609255|P4|Overall Study|Adverse Event|14
3094157|NCT00327015|10609256|P3|Overall Study|Adverse Event|14
3094158|NCT00327015|10609257|P2|Overall Study|Adverse Event|10
3094159|NCT00327015|10609258|P1|Overall Study|Adverse Event|14
3094160|NCT00327015|10609255|P4|Overall Study|Lost to Follow-up|22
3094161|NCT00327015|10609256|P3|Overall Study|Lost to Follow-up|29
3094162|NCT00327015|10609257|P2|Overall Study|Lost to Follow-up|23
3094163|NCT00327015|10609258|P1|Overall Study|Lost to Follow-up|22
3094164|NCT00327015|10609255|P4|Overall Study|Withdrawal of Consent by Subject|25
3094165|NCT00327015|10609256|P3|Overall Study|Withdrawal of Consent by Subject|28
3094166|NCT00327015|10609257|P2|Overall Study|Withdrawal of Consent by Subject|24
3094167|NCT00327015|10609258|P1|Overall Study|Withdrawal of Consent by Subject|20
3094168|NCT00327015|10609255|P4|Overall Study|Lack of Efficacy|29
3094169|NCT00327015|10609256|P3|Overall Study|Lack of Efficacy|35
3094170|NCT00327015|10609257|P2|Overall Study|Lack of Efficacy|18
3094171|NCT00327015|10609258|P1|Overall Study|Lack of Efficacy|18
3094172|NCT00326963|10609300|P1|Overall Study|Administrative / other|1
3094173|NCT00326963|10609300|P1|Overall Study|Other protocol violation|1
3094174|NCT00326963|10609300|P1|Overall Study|Violation of selection criteria at entry|2
3094175|NCT00326963|10609300|P1|Overall Study|Refused treatment / did not cooperate|5
3094176|NCT00326963|10609300|P1|Overall Study|Withdrawal by Subject|10
3094177|NCT00326963|10609300|P1|Overall Study|Failure to return|10
3094178|NCT00326963|10609300|P1|Overall Study|Death|1
3094179|NCT00326963|10609300|P1|Overall Study|Injection site reaction|1
3094180|NCT00326963|10609300|P1|Overall Study|Adverse Event|2
3094181|NCT00326950|10609320|P1|Overall Study|Progressive Disease|1
3094182|NCT00326911|10609342|P2|Overall Study|Withdrawal by subject prior to treatment|1
3094183|NCT00326911|10609343|P1|Overall Study|Withdrawal by subject prior to treatment|0
3094184|NCT00326911|10609342|P2|Overall Study|Physician decision prior to treatment|0
3094185|NCT00326911|10609343|P1|Overall Study|Physician decision prior to treatment|1
3094186|NCT00326911|10609342|P2|Overall Study|Hospitalization prior to treatment|1
3094187|NCT00326911|10609343|P1|Overall Study|Hospitalization prior to treatment|0
3094188|NCT00326898|10609396|P3|Overall Study|Other/Missing/Unknown|32
3094189|NCT00326898|10609397|P2|Overall Study|Other/Missing/Unknown|28
3094190|NCT00326898|10609398|P1|Overall Study|Other/Missing/Unknown|33
3094191|NCT00326898|10609396|P3|Overall Study|Other complicating disease|4
3094192|NCT00326898|10609397|P2|Overall Study|Other complicating disease|5
3094193|NCT00326898|10609398|P1|Overall Study|Other complicating disease|5
3094194|NCT00326898|10609396|P3|Overall Study|Alternative therapy|0
3094195|NCT00326898|10609397|P2|Overall Study|Alternative therapy|0
3094196|NCT00326898|10609398|P1|Overall Study|Alternative therapy|1
3094197|NCT00326898|10609396|P3|Overall Study|Withdrawal by Subject|32
3094198|NCT00326898|10609397|P2|Overall Study|Withdrawal by Subject|128
3094199|NCT00326898|10609398|P1|Overall Study|Withdrawal by Subject|134
3094200|NCT00326898|10609396|P3|Overall Study|Death|0
3094201|NCT00326898|10609397|P2|Overall Study|Death|0
3094202|NCT00326898|10609398|P1|Overall Study|Death|2
3094203|NCT00326898|10609396|P3|Overall Study|Adverse Event|33
3094204|NCT00326898|10609397|P2|Overall Study|Adverse Event|128
3094205|NCT00326898|10609398|P1|Overall Study|Adverse Event|124
3094206|NCT00326898|10609396|P3|Overall Study|Disease progression|102
3094207|NCT00326898|10609397|P2|Overall Study|Disease progression|54
3094208|NCT00326898|10609398|P1|Overall Study|Disease progression|52
3094209|NCT00326885|10609415|P1|Overall Study|Hospice withdrew consent|2
3094210|NCT00326885|10609415|P1|Overall Study|Physician Decision|1
3094211|NCT00326885|10609415|P1|Overall Study|Withdrawal by Subject|3
3094212|NCT00326885|10609415|P1|Overall Study|Adverse Event|1
3094213|NCT00326716|10609446|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
3094214|NCT00326716|10609447|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
3094215|NCT00326716|10609448|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
3094216|NCT00326716|10609449|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
3094217|NCT00326612|10609521|P2|Overall Study|They did not have a seizure requiring tx|137
3094218|NCT00326612|10609522|P1|Overall Study|They did not have a seizure requiring tx|129
3094219|NCT00326599|10609544|P4|Overall Study|Other Unspecified Reason|1
3094220|NCT00326599|10609545|P3|Overall Study|Other Unspecified Reason|2
3094221|NCT00326599|10609546|P2|Overall Study|Other Unspecified Reason|0
3094222|NCT00326599|10609547|P1|Overall Study|Other Unspecified Reason|0
3094223|NCT00326599|10609544|P4|Overall Study|Death|2
3094224|NCT00326599|10609545|P3|Overall Study|Death|1
3094225|NCT00326599|10609546|P2|Overall Study|Death|0
3094226|NCT00326599|10609547|P1|Overall Study|Death|0
3094227|NCT00326599|10609544|P4|Overall Study|Alternate Treatment|0
3094228|NCT00326599|10609545|P3|Overall Study|Alternate Treatment|0
3094229|NCT00326599|10609546|P2|Overall Study|Alternate Treatment|0
3094230|NCT00326599|10609547|P1|Overall Study|Alternate Treatment|1
3094231|NCT00326599|10609544|P4|Overall Study|Disease Progression|11
3094232|NCT00326599|10609545|P3|Overall Study|Disease Progression|13
3094233|NCT00326599|10609546|P2|Overall Study|Disease Progression|1
3094234|NCT00326599|10609547|P1|Overall Study|Disease Progression|3
3094235|NCT00326599|10609544|P4|Overall Study|Adverse Event|3
3094236|NCT00326599|10609545|P3|Overall Study|Adverse Event|32
3094237|NCT00326599|10609546|P2|Overall Study|Adverse Event|0
3094238|NCT00326599|10609547|P1|Overall Study|Adverse Event|1
3094239|NCT00326599|10609544|P4|Overall Study|Withdrawal by Subject|2
3094240|NCT00326599|10609545|P3|Overall Study|Withdrawal by Subject|5
3094241|NCT00326599|10609546|P2|Overall Study|Withdrawal by Subject|0
3094242|NCT00326599|10609547|P1|Overall Study|Withdrawal by Subject|1
3094243|NCT00326495|10609566|P1|Overall Study|Subject off study before assessment|1
3094244|NCT00326495|10609566|P1|Overall Study|Refused further treatment|2
3094245|NCT00326495|10609566|P1|Overall Study|Disease progression before treatment|1
3094246|NCT00326495|10609566|P1|Overall Study|Switched to alternative treatment|1
3094247|NCT00326417|10609573|P4|Overall Study|Death|0
3094248|NCT00326417|10609574|P3|Overall Study|Death|0
3094249|NCT00326417|10609575|P2|Overall Study|Death|0
3094250|NCT00326417|10609576|P1|Overall Study|Death|7
3094251|NCT00326417|10609573|P4|Overall Study|Arm Closed|3
3094252|NCT00326417|10609574|P3|Overall Study|Arm Closed|0
3094253|NCT00326417|10609575|P2|Overall Study|Arm Closed|0
3094254|NCT00326417|10609576|P1|Overall Study|Arm Closed|7
3094255|NCT00326417|10609573|P4|Overall Study|Withdrawal by Subject|0
3094256|NCT00326417|10609574|P3|Overall Study|Withdrawal by Subject|1
3094257|NCT00326417|10609575|P2|Overall Study|Withdrawal by Subject|0
3094258|NCT00326417|10609576|P1|Overall Study|Withdrawal by Subject|0
3094259|NCT00326209|10609592|P1|Overall Study|Pregnancy|1
3094260|NCT00326209|10609592|P1|Overall Study|Withdrawn in error|1
3094261|NCT00326209|10609592|P1|Overall Study|Violation of entry criteria|1
3094262|NCT00326209|10609592|P1|Overall Study|Prohibited medication use|1
3094263|NCT00326209|10609592|P1|Overall Study|Sponsor closed study|173
3094264|NCT00326209|10609592|P1|Overall Study|Participant non-compliant|6
3094265|NCT00326209|10609592|P1|Overall Study|Lost to Follow-up|18
3094266|NCT00326209|10609592|P1|Overall Study|Lack of Efficacy|31
3094267|NCT00326209|10609592|P1|Overall Study|Withdrawal by Subject|22
3094268|NCT00326209|10609592|P1|Overall Study|Adverse Event|28
3094269|NCT00326183|10609610|P2|Overall Study|Adverse Event|0
3094270|NCT00326183|10609611|P1|Overall Study|Adverse Event|1
3094271|NCT00326183|10609610|P2|Overall Study|Other|13
3094272|NCT00326183|10609611|P1|Overall Study|Other|47
3094273|NCT00326183|10609610|P2|Overall Study|Subject Moved|4
3094274|NCT00326183|10609611|P1|Overall Study|Subject Moved|7
3094275|NCT00326183|10609610|P2|Overall Study|Withdrawal by Subject|7
3094276|NCT00326183|10609611|P1|Overall Study|Withdrawal by Subject|35
3094277|NCT00326183|10609610|P2|Overall Study|Protocol Violation|3
3094278|NCT00326183|10609611|P1|Overall Study|Protocol Violation|6
3094279|NCT00326183|10609610|P2|Overall Study|Lost to Follow-up|56
3094280|NCT00326183|10609611|P1|Overall Study|Lost to Follow-up|104
3094281|NCT00326118|10609643|P2|Active Phase|Withdrawal by Subject|1
3094282|NCT00326118|10609644|P1|Active Phase|Withdrawal by Subject|4
3094283|NCT00326001|10609680|P2|Overall Study|Physician Decision|3
3094284|NCT00326001|10609681|P1|Overall Study|Physician Decision|3
3094285|NCT00326001|10609680|P2|Overall Study|Adverse Event|5
3094286|NCT00326001|10609681|P1|Overall Study|Adverse Event|4
3094287|NCT00325897|10609695|P2|Overall Study|Lost to Follow-up|13
3094288|NCT00325897|10609696|P1|Overall Study|Lost to Follow-up|12
3094289|NCT00325819|10609716|P2|Overall Study|Lost to Follow-up|3
3094290|NCT00325819|10609717|P1|Overall Study|Lost to Follow-up|3
3094291|NCT00325819|10609716|P2|Overall Study|Did not take a dose of study product|9
3094292|NCT00325819|10609717|P1|Overall Study|Did not take a dose of study product|4
3094293|NCT00325819|10609716|P2|Overall Study|Study product lost in mail|1
3094294|NCT00325819|10609717|P1|Overall Study|Study product lost in mail|2
3094295|NCT00325754|10609744|P2|Overall Study|Adverse Event|1
3094296|NCT00325754|10609745|P1|Overall Study|Adverse Event|4
3094297|NCT00325468|10609800|P5|Overall Study|site closure etc|1
3094298|NCT00325468|10609801|P4|Overall Study|site closure etc|8
3094299|NCT00325468|10609802|P3|Overall Study|site closure etc|1
3094300|NCT00325468|10609803|P2|Overall Study|site closure etc|2
3094301|NCT00325468|10609804|P1|Overall Study|site closure etc|4
3094302|NCT00325468|10609800|P5|Overall Study|Withdrawal by Subject|4
3094303|NCT00325468|10609801|P4|Overall Study|Withdrawal by Subject|14
3094304|NCT00325468|10609802|P3|Overall Study|Withdrawal by Subject|0
3094305|NCT00325468|10609803|P2|Overall Study|Withdrawal by Subject|1
3094306|NCT00325468|10609804|P1|Overall Study|Withdrawal by Subject|3
3094307|NCT00325468|10609800|P5|Overall Study|Physician Decision|0
3094308|NCT00325468|10609801|P4|Overall Study|Physician Decision|1
3094309|NCT00325468|10609802|P3|Overall Study|Physician Decision|0
3094310|NCT00325468|10609803|P2|Overall Study|Physician Decision|1
3094311|NCT00325468|10609804|P1|Overall Study|Physician Decision|1
3094312|NCT00325468|10609800|P5|Overall Study|Lost to Follow-up|2
3094313|NCT00325468|10609801|P4|Overall Study|Lost to Follow-up|2
3094314|NCT00325468|10609802|P3|Overall Study|Lost to Follow-up|1
3094315|NCT00325468|10609803|P2|Overall Study|Lost to Follow-up|0
3094316|NCT00325468|10609804|P1|Overall Study|Lost to Follow-up|0
3094317|NCT00325468|10609800|P5|Overall Study|Death|0
3094318|NCT00325468|10609801|P4|Overall Study|Death|4
3094319|NCT00325468|10609802|P3|Overall Study|Death|2
3094320|NCT00325468|10609803|P2|Overall Study|Death|0
3094321|NCT00325468|10609804|P1|Overall Study|Death|2
3094322|NCT00325468|10609800|P5|Overall Study|Adverse Event|1
3094323|NCT00325468|10609801|P4|Overall Study|Adverse Event|5
3094324|NCT00325468|10609802|P3|Overall Study|Adverse Event|0
3094325|NCT00325468|10609803|P2|Overall Study|Adverse Event|1
3094326|NCT00325468|10609804|P1|Overall Study|Adverse Event|1
3094327|NCT00325416|10609887|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
3094328|NCT00325416|10609888|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
3094329|NCT00325416|10609887|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
3094330|NCT00325416|10609888|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
3094331|NCT00325416|10609887|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
3094332|NCT00325416|10609888|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
3094333|NCT00325416|10609887|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
3094334|NCT00325416|10609888|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
3094335|NCT00325416|10609887|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
3094336|NCT00325416|10609888|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
3094337|NCT00325416|10609887|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
3094338|NCT00325416|10609888|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
3094339|NCT00325234|10609941|P2|Overall Study|Progressive Disease|37
3094340|NCT00325234|10609942|P1|Overall Study|Progressive Disease|34
3094341|NCT00325234|10609941|P2|Overall Study|Physician Decision|12
3094342|NCT00325234|10609942|P1|Overall Study|Physician Decision|17
3094343|NCT00325234|10609941|P2|Overall Study|Subject Decision|8
3094344|NCT00325234|10609942|P1|Overall Study|Subject Decision|6
3094345|NCT00325234|10609941|P2|Overall Study|Entry Criteria Not Met|2
3094346|NCT00325234|10609942|P1|Overall Study|Entry Criteria Not Met|1
3094347|NCT00325234|10609941|P2|Overall Study|Death due to Study Disease|0
3094348|NCT00325234|10609942|P1|Overall Study|Death due to Study Disease|1
3094349|NCT00325234|10609941|P2|Overall Study|Adverse Event|7
3094350|NCT00325234|10609942|P1|Overall Study|Adverse Event|10
3094351|NCT00325195|10609961|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
3094352|NCT00325195|10609962|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
3094353|NCT00325195|10609963|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
3094354|NCT00325195|10609961|P3|Received Intervention: ITT Population|Lost to Follow-up|2
3094355|NCT00325195|10609962|P2|Received Intervention: ITT Population|Lost to Follow-up|0
3094356|NCT00325195|10609963|P1|Received Intervention: ITT Population|Lost to Follow-up|0
3094357|NCT00325195|10609961|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
3094358|NCT00325195|10609962|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
3094359|NCT00325195|10609963|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
3094360|NCT00325195|10609961|P3|Received Intervention: ITT Population|Death|0
3094361|NCT00325195|10609962|P2|Received Intervention: ITT Population|Death|1
3094362|NCT00325195|10609963|P1|Received Intervention: ITT Population|Death|3
3094363|NCT00325195|10609961|P3|Received Intervention: ITT Population|Adverse Event|1
3094364|NCT00325195|10609962|P2|Received Intervention: ITT Population|Adverse Event|17
3094365|NCT00325195|10609963|P1|Received Intervention: ITT Population|Adverse Event|15
3094366|NCT00325195|10609961|P3|Randomized|Not dosed|3
3094367|NCT00325195|10609962|P2|Randomized|Not dosed|5
3094368|NCT00325195|10609963|P1|Randomized|Not dosed|5
3094369|NCT00325156|10609986|P1|Overall Study|Withdrawal by Subject|31
3094370|NCT00325156|10609986|P1|Overall Study|Other|1
3094371|NCT00325156|10609986|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
3094372|NCT00325156|10609986|P1|Overall Study|Adverse event, non-fatal|3
3094373|NCT00325156|10609986|P1|Overall Study|Migrated/moved from study area|12
3094374|NCT00325156|10609986|P1|Overall Study|Lost to follow-up (complete vaccination)|41
3094375|NCT00325156|10609986|P1|Overall Study|Protocol Violation|8
3094376|NCT00325143|10609993|P1|Overall Study|Withdrawal by Subject|8
3094377|NCT00325143|10609993|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
3094378|NCT00325143|10609993|P1|Overall Study|Migrated/moved from study area|1
3094379|NCT00325143|10609993|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
3094380|NCT00325130|10610003|P2|Overall Study|Patient Discontinued for Other|0
3094381|NCT00325130|10610004|P1|Overall Study|Patient Discontinued for Other|1
3094382|NCT00325130|10610003|P2|Overall Study|Moved|1
3094383|NCT00325130|10610004|P1|Overall Study|Moved|0
3094384|NCT00325130|10610003|P2|Overall Study|Protocol Deviation|1
3094385|NCT00325130|10610004|P1|Overall Study|Protocol Deviation|0
3094386|NCT00325130|10610003|P2|Overall Study|Withdrawal by Subject|14
3094387|NCT00325130|10610004|P1|Overall Study|Withdrawal by Subject|12
3094388|NCT00325130|10610003|P2|Overall Study|Lost to Follow-up|14
3094389|NCT00325130|10610004|P1|Overall Study|Lost to Follow-up|6
3094390|NCT00325039|10610061|P2|Overall Study|Lost to Follow-up|14
3094391|NCT00325039|10610062|P1|Overall Study|Lost to Follow-up|18
3094392|NCT00324987|10610078|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
3094393|NCT00324987|10610079|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
3094394|NCT00324987|10610078|P2|Overall Study|Progression|1
3094395|NCT00324987|10610079|P1|Overall Study|Progression|1
3094396|NCT00324987|10610078|P2|Overall Study|Withdrawal by Subject|1
3094397|NCT00324987|10610079|P1|Overall Study|Withdrawal by Subject|1
3094398|NCT00324987|10610078|P2|Overall Study|Adverse Event|1
3094399|NCT00324987|10610079|P1|Overall Study|Adverse Event|2
3094400|NCT00324961|10610093|P1|Overall Study|Other|2
3094401|NCT00324961|10610093|P1|Overall Study|Protocol Violation|3
3094402|NCT00324961|10610093|P1|Overall Study|Lost to Follow-up|22
3094403|NCT00324961|10610093|P1|Overall Study|Consent Withdrawn|11
3094404|NCT00324961|10610093|P1|Overall Study|Adverse Event|5
3094405|NCT00324805|10610144|P2|Overall Study|Did not start therapy|17
3094406|NCT00324805|10610145|P1|Overall Study|Did not start therapy|12
3094407|NCT00324805|10610144|P2|Overall Study|Other|2
3094408|NCT00324805|10610145|P1|Overall Study|Other|0
3094409|NCT00324805|10610144|P2|Overall Study|Other reasons|26
3094410|NCT00324805|10610145|P1|Overall Study|Other reasons|7
3094411|NCT00324805|10610144|P2|Overall Study|Other complicating disease|9
3094412|NCT00324805|10610145|P1|Overall Study|Other complicating disease|1
3094413|NCT00324805|10610144|P2|Overall Study|Alternative therapy|8
3094414|NCT00324805|10610145|P1|Overall Study|Alternative therapy|4
3094415|NCT00324805|10610144|P2|Overall Study|Death|9
3094416|NCT00324805|10610145|P1|Overall Study|Death|6
3094417|NCT00324805|10610144|P2|Overall Study|Withdrawal by Subject|174
3094418|NCT00324805|10610145|P1|Overall Study|Withdrawal by Subject|51
3094419|NCT00324805|10610144|P2|Overall Study|Progression|35
3094420|NCT00324805|10610145|P1|Overall Study|Progression|7
3094421|NCT00324805|10610144|P2|Overall Study|Adverse Event|203
3094422|NCT00324805|10610145|P1|Overall Study|Adverse Event|62
3094423|NCT00324740|10610170|P3|Overall Study|Withdrawal by Subject|1
3094424|NCT00324740|10610171|P2|Overall Study|Withdrawal by Subject|0
3094425|NCT00324740|10610172|P1|Overall Study|Withdrawal by Subject|1
3094426|NCT00324675|10610192|P2|Overall Study|Adverse Event|0
3094427|NCT00324675|10610193|P1|Overall Study|Adverse Event|1
3094428|NCT00324649|10610201|P2|Overall Study|Noncompliance|0
3094429|NCT00324649|10610202|P1|Overall Study|Noncompliance|1
3094430|NCT00324649|10610201|P2|Overall Study|Withdrawal by Subject|1
3094431|NCT00324649|10610202|P1|Overall Study|Withdrawal by Subject|0
3094432|NCT00324649|10610201|P2|Overall Study|Adverse Event|4
3094433|NCT00324649|10610202|P1|Overall Study|Adverse Event|1
3094434|NCT00324233|10610333|P2|Second Period|Protocol Violation|6
3094435|NCT00324233|10610334|P1|Second Period|Protocol Violation|4
3094436|NCT00324233|10610333|P2|Second Period|unable to insert catheter|1
3094437|NCT00324233|10610334|P1|Second Period|unable to insert catheter|1
3094438|NCT00324233|10610333|P2|First Period|unable to insert catheter|0
3094439|NCT00324233|10610334|P1|First Period|unable to insert catheter|1
3094440|NCT00324168|10610342|P2|Overall Study|Patient did not visit in f/u window|9
3094441|NCT00324168|10610343|P1|Overall Study|Patient did not visit in f/u window|6
3094442|NCT00324168|10610342|P2|Overall Study|Death|3
3094443|NCT00324168|10610343|P1|Overall Study|Death|3
3094444|NCT00324168|10610342|P2|Overall Study|Lost to Follow-up|18
3094445|NCT00324168|10610343|P1|Overall Study|Lost to Follow-up|19
3094446|NCT00324155|10610371|P2|Follow-up Phase|On-going participants still on drug|6
3094447|NCT00324155|10610372|P1|Follow-up Phase|On-going participants still on drug|11
3094448|NCT00324155|10610371|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
3094449|NCT00324155|10610372|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
3094450|NCT00324155|10610371|P2|Received Treatment in Maintenance Phase|Adverse Event|3
3094451|NCT00324155|10610372|P1|Received Treatment in Maintenance Phase|Adverse Event|0
3094452|NCT00324155|10610371|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
3094453|NCT00324155|10610372|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
3094454|NCT00324155|10610371|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
3094455|NCT00324155|10610372|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
3094456|NCT00324155|10610371|P2|Received Treatment in Maintenance Phase|Disease Progression|41
3094457|NCT00324155|10610372|P1|Received Treatment in Maintenance Phase|Disease Progression|26
3094458|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Physician Decision|0
3094459|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Physician Decision|2
3094460|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
3094461|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
3094462|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Adverse Event|7
3094463|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Adverse Event|6
3094464|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
3094465|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
3094466|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Death|15
3094467|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Death|8
3094468|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
3094469|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
3094470|NCT00324155|10610371|P2|Received Treatment in Induction Phase|Disease Progression|152
3094471|NCT00324155|10610372|P1|Received Treatment in Induction Phase|Disease Progression|88
3094472|NCT00324155|10610371|P2|Enrolled and Randomized|Lost to Follow-up|1
3094473|NCT00324155|10610372|P1|Enrolled and Randomized|Lost to Follow-up|0
3094474|NCT00324155|10610371|P2|Enrolled and Randomized|No longer met study criteria|0
3094475|NCT00324155|10610372|P1|Enrolled and Randomized|No longer met study criteria|3
3094476|NCT00324116|10610402|P1|Overall Study|Other|5
3094477|NCT00324116|10610402|P1|Overall Study|Withdrawal by Subject|5
3094478|NCT00324116|10610402|P1|Overall Study|Lack of Efficacy|17
3094479|NCT00324116|10610402|P1|Overall Study|Adverse Event|5
3094480|NCT00324038|10610414|P2|Overall Study|Other|13
3094481|NCT00324038|10610415|P1|Overall Study|Other|6
3094482|NCT00324038|10610414|P2|Overall Study|Lost to Follow-up|2
3094483|NCT00324038|10610415|P1|Overall Study|Lost to Follow-up|0
3094484|NCT00324038|10610414|P2|Overall Study|Lack of Efficacy|13
3094485|NCT00324038|10610415|P1|Overall Study|Lack of Efficacy|5
3094486|NCT00324038|10610414|P2|Overall Study|Adverse Event|23
3094487|NCT00324038|10610415|P1|Overall Study|Adverse Event|38
3094488|NCT00323882|10610426|P5|Overall Study|Other|1
3094489|NCT00323882|10610427|P4|Overall Study|Other|1
3094490|NCT00323882|10610428|P3|Overall Study|Other|0
3094491|NCT00323882|10610429|P2|Overall Study|Other|0
3094492|NCT00323882|10610430|P1|Overall Study|Other|0
3094493|NCT00323882|10610426|P5|Overall Study|Lost to Follow-up|1
3094494|NCT00323882|10610427|P4|Overall Study|Lost to Follow-up|0
3094495|NCT00323882|10610428|P3|Overall Study|Lost to Follow-up|1
3094496|NCT00323882|10610429|P2|Overall Study|Lost to Follow-up|0
3094497|NCT00323882|10610430|P1|Overall Study|Lost to Follow-up|0
3094498|NCT00323882|10610426|P5|Overall Study|Death|5
3094499|NCT00323882|10610427|P4|Overall Study|Death|0
3094500|NCT00323882|10610428|P3|Overall Study|Death|1
3094501|NCT00323882|10610429|P2|Overall Study|Death|1
3094502|NCT00323882|10610430|P1|Overall Study|Death|0
3094503|NCT00323882|10610426|P5|Overall Study|Disease Progression|22
3094504|NCT00323882|10610427|P4|Overall Study|Disease Progression|5
3094505|NCT00323882|10610428|P3|Overall Study|Disease Progression|10
3094506|NCT00323882|10610429|P2|Overall Study|Disease Progression|4
3094507|NCT00323882|10610430|P1|Overall Study|Disease Progression|6
3094508|NCT00323882|10610426|P5|Overall Study|Adverse Event|3
3094509|NCT00323882|10610427|P4|Overall Study|Adverse Event|1
3094510|NCT00323882|10610428|P3|Overall Study|Adverse Event|1
3094511|NCT00323882|10610429|P2|Overall Study|Adverse Event|1
3094512|NCT00323882|10610430|P1|Overall Study|Adverse Event|2
3094513|NCT00323869|10610501|P1|Overall Study|Death|1
3094514|NCT00323622|10610557|P8|Overall Study|Death|2
3094515|NCT00323622|10610558|P7|Overall Study|Death|0
3094516|NCT00323622|10610559|P6|Overall Study|Death|0
3094517|NCT00323622|10610560|P5|Overall Study|Death|7
3094518|NCT00323622|10610561|P4|Overall Study|Death|0
3094519|NCT00323622|10610562|P3|Overall Study|Death|0
3094520|NCT00323622|10610563|P2|Overall Study|Death|1
3094521|NCT00323622|10610564|P1|Overall Study|Death|1
3094522|NCT00323622|10610557|P8|Overall Study|Other|13
3094523|NCT00323622|10610558|P7|Overall Study|Other|5
3094524|NCT00323622|10610559|P6|Overall Study|Other|74
3094525|NCT00323622|10610560|P5|Overall Study|Other|32
3094526|NCT00323622|10610561|P4|Overall Study|Other|12
3094527|NCT00323622|10610562|P3|Overall Study|Other|4
3094528|NCT00323622|10610563|P2|Overall Study|Other|91
3094529|NCT00323622|10610564|P1|Overall Study|Other|30
3094530|NCT00323609|10610606|P4|Overall Study|Other reason|9
3094531|NCT00323609|10610607|P3|Overall Study|Other reason|4
3094532|NCT00323609|10610608|P2|Overall Study|Other reason|8
3094533|NCT00323609|10610609|P1|Overall Study|Other reason|11
3094534|NCT00323609|10610606|P4|Overall Study|Logistical withdrawal|1
3094535|NCT00323609|10610607|P3|Overall Study|Logistical withdrawal|0
3094536|NCT00323609|10610608|P2|Overall Study|Logistical withdrawal|5
3094537|NCT00323609|10610609|P1|Overall Study|Logistical withdrawal|9
3094538|NCT00323609|10610606|P4|Overall Study|Unrelenting or severe back pain|0
3094539|NCT00323609|10610607|P3|Overall Study|Unrelenting or severe back pain|0
3094540|NCT00323609|10610608|P2|Overall Study|Unrelenting or severe back pain|1
3094541|NCT00323609|10610609|P1|Overall Study|Unrelenting or severe back pain|1
3094542|NCT00323609|10610606|P4|Overall Study|Sponsor discontinued trial|0
3094543|NCT00323609|10610607|P3|Overall Study|Sponsor discontinued trial|0
3094544|NCT00323609|10610608|P2|Overall Study|Sponsor discontinued trial|29
3094545|NCT00323609|10610609|P1|Overall Study|Sponsor discontinued trial|29
3094546|NCT00323609|10610606|P4|Overall Study|Other non-VCF-related medical condition|0
3094547|NCT00323609|10610607|P3|Overall Study|Other non-VCF-related medical condition|0
3094548|NCT00323609|10610608|P2|Overall Study|Other non-VCF-related medical condition|2
3094549|NCT00323609|10610609|P1|Overall Study|Other non-VCF-related medical condition|3
3094550|NCT00323609|10610606|P4|Overall Study|Withdrawal by Subject|4
3094551|NCT00323609|10610607|P3|Overall Study|Withdrawal by Subject|4
3094552|NCT00323609|10610608|P2|Overall Study|Withdrawal by Subject|23
3094553|NCT00323609|10610609|P1|Overall Study|Withdrawal by Subject|11
3094554|NCT00323609|10610606|P4|Overall Study|Physician Decision|1
3094555|NCT00323609|10610607|P3|Overall Study|Physician Decision|0
3094556|NCT00323609|10610608|P2|Overall Study|Physician Decision|0
3094557|NCT00323609|10610609|P1|Overall Study|Physician Decision|2
3094558|NCT00323609|10610606|P4|Overall Study|Lost to Follow-up|0
3094559|NCT00323609|10610607|P3|Overall Study|Lost to Follow-up|0
3094560|NCT00323609|10610608|P2|Overall Study|Lost to Follow-up|10
3094561|NCT00323609|10610609|P1|Overall Study|Lost to Follow-up|9
3094562|NCT00323609|10610606|P4|Overall Study|Death|0
3094563|NCT00323609|10610607|P3|Overall Study|Death|0
3094564|NCT00323609|10610608|P2|Overall Study|Death|21
3094565|NCT00323609|10610609|P1|Overall Study|Death|16
3094566|NCT00323557|10610645|P2|Overall Study|Physician Decision|0
3094567|NCT00323557|10610646|P1|Overall Study|Physician Decision|1
3094568|NCT00323492|10610655|P3|Study Phase 2|Protocol Violation|0
3094569|NCT00323492|10610656|P2|Study Phase 2|Protocol Violation|0
3094570|NCT00323492|10610657|P1|Study Phase 2|Protocol Violation|1
3094571|NCT00323492|10610655|P3|Study Phase 2|Noncompliance with study schedule|1
3094572|NCT00323492|10610656|P2|Study Phase 2|Noncompliance with study schedule|0
3094573|NCT00323492|10610657|P1|Study Phase 2|Noncompliance with study schedule|0
3094574|NCT00323492|10610655|P3|Study Phase 2|Withdrawal by Subject|0
3094575|NCT00323492|10610656|P2|Study Phase 2|Withdrawal by Subject|1
3094576|NCT00323492|10610657|P1|Study Phase 2|Withdrawal by Subject|0
3094577|NCT00323492|10610655|P3|Study Phase 2|Lost to Follow-up|0
3094578|NCT00323492|10610656|P2|Study Phase 2|Lost to Follow-up|0
3094579|NCT00323492|10610657|P1|Study Phase 2|Lost to Follow-up|1
3094580|NCT00323492|10610655|P3|Study Phase 2|Physician Decision|0
3094581|NCT00323492|10610656|P2|Study Phase 2|Physician Decision|0
3094582|NCT00323492|10610657|P1|Study Phase 2|Physician Decision|1
3094583|NCT00323492|10610655|P3|Study Phase 2|Adverse Event|0
3094584|NCT00323492|10610656|P2|Study Phase 2|Adverse Event|0
3094585|NCT00323492|10610657|P1|Study Phase 2|Adverse Event|1
3094586|NCT00323492|10610655|P3|Study Phase 1|Adverse Event|0
3094587|NCT00323492|10610656|P2|Study Phase 1|Adverse Event|0
3094588|NCT00323492|10610657|P1|Study Phase 1|Adverse Event|2
3094589|NCT00323479|10610688|P1|Overall Study|house moving|1
3094590|NCT00323479|10610688|P1|Overall Study|Protocol Violation|3
3094591|NCT00323479|10610688|P1|Overall Study|Withdrawal by Subject|2
3094592|NCT00323479|10610688|P1|Overall Study|Adverse Event|2
3094593|NCT00323414|10610721|P2|Overall Study|Withdrawal by Subject|1
3094594|NCT00323414|10610722|P1|Overall Study|Withdrawal by Subject|0
3094595|NCT00323310|10610744|P1|Overall Study|did not complete the 24-hr f-up visit|1
3094596|NCT00323310|10610744|P1|Overall Study|a parent refused blood draw|1
3094597|NCT00323310|10610744|P1|Overall Study|Withdrawal by Subject|1
3094598|NCT00323297|10610759|P2|Part B (Open-label)|Protocol Violation|1
3094599|NCT00323297|10610760|P1|Part B (Open-label)|Protocol Violation|0
3094600|NCT00323297|10610759|P2|Part B (Open-label)|Adverse Event|5
3094601|NCT00323297|10610760|P1|Part B (Open-label)|Adverse Event|5
3094602|NCT00323297|10610759|P2|Part B (Open-label)|Lack of Efficacy|1
3094603|NCT00323297|10610760|P1|Part B (Open-label)|Lack of Efficacy|3
3094604|NCT00323297|10610759|P2|Part B (Open-label)|Withdrawal by Subject|3
3094605|NCT00323297|10610760|P1|Part B (Open-label)|Withdrawal by Subject|1
3094606|NCT00323297|10610759|P2|Part B (Open-label)|Reason unspecified|1
3094607|NCT00323297|10610760|P1|Part B (Open-label)|Reason unspecified|0
3094608|NCT00323297|10610759|P2|Part B (Open-label)|Death|1
3094609|NCT00323297|10610760|P1|Part B (Open-label)|Death|0
3094610|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Related adverse event|2
3094611|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Related adverse event|2
3094612|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
3094613|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
3094614|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
3094615|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
3094616|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Protocol Violation|3
3094617|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Protocol Violation|1
3094618|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Death|1
3094619|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Death|0
3094620|NCT00323297|10610759|P2|Part A (Double Blind Randomized)|Reason unspecified|1
3094621|NCT00323297|10610760|P1|Part A (Double Blind Randomized)|Reason unspecified|0
3094622|NCT00323258|10610800|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
3094623|NCT00323258|10610801|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
3094624|NCT00323258|10610800|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
3094625|NCT00323258|10610801|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
3094626|NCT00323258|10610800|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
3094627|NCT00323258|10610801|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
3094628|NCT00323258|10610800|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
3094629|NCT00323258|10610801|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
3094630|NCT00323258|10610800|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
3094631|NCT00323258|10610801|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
3094632|NCT00323258|10610800|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
3094633|NCT00323258|10610801|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
3094634|NCT00323258|10610800|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
3094635|NCT00323258|10610801|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
3094636|NCT00323115|10610826|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
3094637|NCT00323115|10610826|P1|Vaccine Administration|Adverse Event|1
3094638|NCT00323063|10610853|P2|Overall Study|brain mets discovered prior to treatment|0
3094639|NCT00323063|10610854|P1|Overall Study|brain mets discovered prior to treatment|1
3094640|NCT00323063|10610853|P2|Overall Study|Adverse Event|0
3094641|NCT00323063|10610854|P1|Overall Study|Adverse Event|1
3094642|NCT00322881|10610871|P1|Overall Study|Disease Progression|2
3094643|NCT00322881|10610871|P1|Overall Study|Adverse Event|1
3094644|NCT00322881|10610871|P1|Overall Study|Death|2
3094645|NCT00322868|10610875|P1|Overall Study|disease progression|1
3094646|NCT00322842|10610900|P2|Overall Study|Death|0
3094647|NCT00322842|10610901|P1|Overall Study|Death|1
3094648|NCT00322842|10610900|P2|Overall Study|Refused transplant|0
3094649|NCT00322842|10610901|P1|Overall Study|Refused transplant|1
3094650|NCT00322842|10610900|P2|Overall Study|Lost to Follow-up|1
3094651|NCT00322842|10610901|P1|Overall Study|Lost to Follow-up|0
3094652|NCT00322842|10610900|P2|Overall Study|Withdrawal by Subject|1
3094653|NCT00322842|10610901|P1|Overall Study|Withdrawal by Subject|0
3094654|NCT00322712|10610939|P1|Overall Study|treated with bevacizumab not cetuximab|1
3094655|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
3094656|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
3094657|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
3094658|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Death|0
3094659|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Death|1
3094660|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Death|0
3094661|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
3094662|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
3094663|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
3094664|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
3094665|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
3094666|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
3094667|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
3094668|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
3094669|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
3094670|NCT00322621|10610943|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
3094671|NCT00322621|10610944|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
3094672|NCT00322621|10610945|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
3094673|NCT00322621|10610943|P3|Period II - Acute Therapy Phase|Physician Decision|0
3094674|NCT00322621|10610944|P2|Period II - Acute Therapy Phase|Physician Decision|0
3094675|NCT00322621|10610945|P1|Period II - Acute Therapy Phase|Physician Decision|1
3094676|NCT00322621|10610943|P3|Period II - Acute Therapy Phase|Protocol Violation|0
3094677|NCT00322621|10610944|P2|Period II - Acute Therapy Phase|Protocol Violation|0
3094678|NCT00322621|10610945|P1|Period II - Acute Therapy Phase|Protocol Violation|2
3094679|NCT00322621|10610943|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
3094680|NCT00322621|10610944|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
3094681|NCT00322621|10610945|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
3094682|NCT00322621|10610943|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
3094683|NCT00322621|10610944|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
3094684|NCT00322621|10610945|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
3094685|NCT00322621|10610943|P3|Period II - Acute Therapy Phase|Adverse Event|0
3094686|NCT00322621|10610944|P2|Period II - Acute Therapy Phase|Adverse Event|0
3094687|NCT00322621|10610945|P1|Period II - Acute Therapy Phase|Adverse Event|20
3094688|NCT00322556|10610997|P1|Overall Study|Other Reason|7
3094689|NCT00322556|10610997|P1|Overall Study|Lost to Follow-up|3
3094690|NCT00322556|10610997|P1|Overall Study|Withdrawal by Subject|1
3094691|NCT00322556|10610997|P1|Overall Study|Adverse Event|1
3094692|NCT00322491|10611013|P2|Overall Study|Death|2
3094693|NCT00322491|10611014|P1|Overall Study|Death|1
3094694|NCT00322491|10611013|P2|Overall Study|Adverse Event|0
3094695|NCT00322491|10611014|P1|Overall Study|Adverse Event|1
3094696|NCT00322452|10611104|P2|Overall Study|Death|227
3094697|NCT00322452|10611105|P1|Overall Study|Death|223
3094698|NCT00322452|10611104|P2|Overall Study|Withdrawal by Subject|46
3094699|NCT00322452|10611105|P1|Overall Study|Withdrawal by Subject|19
3094700|NCT00322452|10611104|P2|Overall Study|Lost to Follow-up|2
3094701|NCT00322452|10611105|P1|Overall Study|Lost to Follow-up|5
3094702|NCT00322452|10611104|P2|Overall Study|Eligibility criteria not fulfilled|1
3094703|NCT00322452|10611105|P1|Overall Study|Eligibility criteria not fulfilled|0
3094704|NCT00322387|10611156|P2|Follow-up Period|Death|0
3094705|NCT00322387|10611157|P1|Follow-up Period|Death|1
3094706|NCT00322387|10611156|P2|Follow-up Period|Final assessment not done|3
3094707|NCT00322387|10611157|P1|Follow-up Period|Final assessment not done|1
3094708|NCT00322387|10611156|P2|Treatment Period|Adverse Event|1
3094709|NCT00322387|10611157|P1|Treatment Period|Adverse Event|0
3094710|NCT00322374|10611191|P4|Second Escalation|Study Drug Toxicity|0
3094711|NCT00322374|10611192|P3|Second Escalation|Study Drug Toxicity|1
3094712|NCT00322374|10611193|P2|Second Escalation|Study Drug Toxicity|0
3094713|NCT00322374|10611194|P1|Second Escalation|Study Drug Toxicity|0
3094714|NCT00322374|10611191|P4|Second Escalation|Physician Decision|0
3094715|NCT00322374|10611192|P3|Second Escalation|Physician Decision|5
3094716|NCT00322374|10611193|P2|Second Escalation|Physician Decision|0
3094717|NCT00322374|10611194|P1|Second Escalation|Physician Decision|0
3094718|NCT00322374|10611191|P4|First Escalation|Participant Request|0
3094719|NCT00322374|10611192|P3|First Escalation|Participant Request|0
3094720|NCT00322374|10611193|P2|First Escalation|Participant Request|1
3094721|NCT00322374|10611194|P1|First Escalation|Participant Request|0
3094722|NCT00322374|10611191|P4|First Escalation|Study Drug Toxicity|0
3094723|NCT00322374|10611192|P3|First Escalation|Study Drug Toxicity|0
3094724|NCT00322374|10611193|P2|First Escalation|Study Drug Toxicity|11
3094725|NCT00322374|10611194|P1|First Escalation|Study Drug Toxicity|0
3094726|NCT00322374|10611191|P4|First Escalation|Physician Decision|0
3094727|NCT00322374|10611192|P3|First Escalation|Physician Decision|0
3094728|NCT00322374|10611193|P2|First Escalation|Physician Decision|12
3094729|NCT00322374|10611194|P1|First Escalation|Physician Decision|0
3094730|NCT00322374|10611191|P4|First Escalation|Documented Disease Progression|0
3094731|NCT00322374|10611192|P3|First Escalation|Documented Disease Progression|0
3094732|NCT00322374|10611193|P2|First Escalation|Documented Disease Progression|6
3094733|NCT00322374|10611194|P1|First Escalation|Documented Disease Progression|0
3094734|NCT00322374|10611191|P4|Starting Dose|Study Drug Toxicity|0
3094735|NCT00322374|10611192|P3|Starting Dose|Study Drug Toxicity|0
3094736|NCT00322374|10611193|P2|Starting Dose|Study Drug Toxicity|0
3094737|NCT00322374|10611194|P1|Starting Dose|Study Drug Toxicity|4
3094738|NCT00322374|10611191|P4|Starting Dose|Physician Decision|0
3094739|NCT00322374|10611192|P3|Starting Dose|Physician Decision|0
3094740|NCT00322374|10611193|P2|Starting Dose|Physician Decision|0
3094741|NCT00322374|10611194|P1|Starting Dose|Physician Decision|2
3094742|NCT00322348|10611244|P2|Overall Study|Reasons not specified|1
3094743|NCT00322348|10611245|P1|Overall Study|Reasons not specified|5
3094744|NCT00322348|10611244|P2|Overall Study|Disease Progression|25
3094745|NCT00322348|10611245|P1|Overall Study|Disease Progression|30
3094746|NCT00322348|10611244|P2|Overall Study|Death|2
3094747|NCT00322348|10611245|P1|Overall Study|Death|0
3094748|NCT00322348|10611244|P2|Overall Study|Lost to Follow-up|0
3094749|NCT00322348|10611245|P1|Overall Study|Lost to Follow-up|1
3094750|NCT00322348|10611244|P2|Overall Study|Withdrawal by Subject|4
3094751|NCT00322348|10611245|P1|Overall Study|Withdrawal by Subject|1
3094752|NCT00322348|10611244|P2|Overall Study|Adverse Event|1
3094753|NCT00322348|10611245|P1|Overall Study|Adverse Event|0
3094754|NCT00322153|10611336|P2|Overall Study|Withdrawn for other reasons|4
3094755|NCT00322153|10611337|P1|Overall Study|Withdrawn for other reasons|5
3094756|NCT00322153|10611336|P2|Overall Study|Lost to Follow-up|4
3094757|NCT00322153|10611337|P1|Overall Study|Lost to Follow-up|5
3094758|NCT00322153|10611336|P2|Overall Study|Lack of Efficacy|3
3094759|NCT00322153|10611337|P1|Overall Study|Lack of Efficacy|8
3094760|NCT00322153|10611336|P2|Overall Study|Withdrawal by Subject|10
3094761|NCT00322153|10611337|P1|Overall Study|Withdrawal by Subject|18
3094762|NCT00322153|10611336|P2|Overall Study|Protocol Violation|14
3094763|NCT00322153|10611337|P1|Overall Study|Protocol Violation|6
3094764|NCT00322153|10611336|P2|Overall Study|Adverse Event|34
3094765|NCT00322153|10611337|P1|Overall Study|Adverse Event|21
3094766|NCT00322049|10611370|P4|Overall Study|Infected with Dengue during study|0
3094767|NCT00322049|10611371|P3|Overall Study|Infected with Dengue during study|0
3094768|NCT00322049|10611372|P2|Overall Study|Infected with Dengue during study|1
3094769|NCT00322049|10611373|P1|Overall Study|Infected with Dengue during study|0
3094770|NCT00322049|10611370|P4|Overall Study|Moved out of area|1
3094771|NCT00322049|10611371|P3|Overall Study|Moved out of area|0
3094772|NCT00322049|10611372|P2|Overall Study|Moved out of area|0
3094773|NCT00322049|10611373|P1|Overall Study|Moved out of area|0
3094774|NCT00321984|10611406|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
3094775|NCT00321984|10611407|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
3094776|NCT00321984|10611408|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
3094777|NCT00321984|10611406|P3|Overall Study|Per Investigator Request|0
3094778|NCT00321984|10611407|P2|Overall Study|Per Investigator Request|0
3094779|NCT00321984|10611408|P1|Overall Study|Per Investigator Request|1
3094780|NCT00321984|10611406|P3|Overall Study|Per Subject Request|0
3094781|NCT00321984|10611407|P2|Overall Study|Per Subject Request|0
3094782|NCT00321984|10611408|P1|Overall Study|Per Subject Request|1
3094783|NCT00321984|10611406|P3|Overall Study|Pregnancy|0
3094784|NCT00321984|10611407|P2|Overall Study|Pregnancy|1
3094785|NCT00321984|10611408|P1|Overall Study|Pregnancy|0
3094786|NCT00321984|10611406|P3|Overall Study|Noncompliant|2
3094787|NCT00321984|10611407|P2|Overall Study|Noncompliant|0
3094788|NCT00321984|10611408|P1|Overall Study|Noncompliant|0
3094789|NCT00321984|10611406|P3|Overall Study|Lack of Efficacy|3
3094790|NCT00321984|10611407|P2|Overall Study|Lack of Efficacy|1
3094791|NCT00321984|10611408|P1|Overall Study|Lack of Efficacy|3
3094792|NCT00321984|10611406|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
3094793|NCT00321984|10611407|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
3094794|NCT00321984|10611408|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
3094795|NCT00321984|10611406|P3|Overall Study|Withdrawal by Subject|5
3094796|NCT00321984|10611407|P2|Overall Study|Withdrawal by Subject|6
3094797|NCT00321984|10611408|P1|Overall Study|Withdrawal by Subject|8
3094798|NCT00321984|10611406|P3|Overall Study|Lost to Follow-up|2
3094799|NCT00321984|10611407|P2|Overall Study|Lost to Follow-up|4
3094800|NCT00321984|10611408|P1|Overall Study|Lost to Follow-up|2
3094801|NCT00321984|10611406|P3|Overall Study|Protocol Violation|1
3094802|NCT00321984|10611407|P2|Overall Study|Protocol Violation|1
3094803|NCT00321984|10611408|P1|Overall Study|Protocol Violation|0
3094804|NCT00321984|10611406|P3|Overall Study|Adverse Event|8
3094805|NCT00321984|10611407|P2|Overall Study|Adverse Event|6
3094806|NCT00321984|10611408|P1|Overall Study|Adverse Event|9
3094807|NCT00321932|10611436|P2|Overall Study|Missing data|1
3094808|NCT00321932|10611437|P1|Overall Study|Missing data|2
3094809|NCT00321932|10611436|P2|Overall Study|Early relapse|8
3094810|NCT00321932|10611437|P1|Overall Study|Early relapse|2
3094811|NCT00321932|10611436|P2|Overall Study|Withdrawal by Subject|6
3094812|NCT00321932|10611437|P1|Overall Study|Withdrawal by Subject|3
3094813|NCT00321932|10611436|P2|Overall Study|Death|6
3094814|NCT00321932|10611437|P1|Overall Study|Death|3
3094815|NCT00321919|10611461|P2|Overall Study|Other withdrawal reason|6
3094816|NCT00321919|10611462|P1|Overall Study|Other withdrawal reason|7
3094817|NCT00321919|10611461|P2|Overall Study|Failure to Return|1
3094818|NCT00321919|10611462|P1|Overall Study|Failure to Return|3
3094819|NCT00321919|10611461|P2|Overall Study|Other Protocol Violation|3
3094820|NCT00321919|10611462|P1|Overall Study|Other Protocol Violation|2
3094821|NCT00321919|10611461|P2|Overall Study|Refused Treatment|14
3094822|NCT00321919|10611462|P1|Overall Study|Refused Treatment|23
3094823|NCT00321919|10611461|P2|Overall Study|Violation of Selection Criteria at Entry|1
3094824|NCT00321919|10611462|P1|Overall Study|Violation of Selection Criteria at Entry|1
3094825|NCT00321919|10611461|P2|Overall Study|Insufficient Therapeutic Response|0
3094826|NCT00321919|10611462|P1|Overall Study|Insufficient Therapeutic Response|1
3094827|NCT00321919|10611461|P2|Overall Study|Death|17
3094828|NCT00321919|10611462|P1|Overall Study|Death|21
3094829|NCT00321919|10611461|P2|Overall Study|Adverse Event|10
3094830|NCT00321919|10611462|P1|Overall Study|Adverse Event|17
3094831|NCT00321906|10611504|P2|Overall Study|Withdrawal by Subject|4
3094832|NCT00321906|10611505|P1|Overall Study|Withdrawal by Subject|0
3094833|NCT00321906|10611504|P2|Overall Study|Lost to Follow-up|2
3094834|NCT00321906|10611505|P1|Overall Study|Lost to Follow-up|1
3094835|NCT00321906|10611504|P2|Overall Study|Death|6
3094836|NCT00321906|10611505|P1|Overall Study|Death|9
3094837|NCT00321906|10611504|P2|Overall Study|Adverse Event|44
3094838|NCT00321906|10611505|P1|Overall Study|Adverse Event|36
3094839|NCT00321893|10611527|P2|Overall Study|Adverse Event|3
3094840|NCT00321893|10611528|P1|Overall Study|Adverse Event|6
3094841|NCT00321893|10611527|P2|Overall Study|Lost to Follow-up|1
3094842|NCT00321893|10611528|P1|Overall Study|Lost to Follow-up|2
3094843|NCT00321893|10611527|P2|Overall Study|Non-Compliance/Refusal|10
3094844|NCT00321893|10611528|P1|Overall Study|Non-Compliance/Refusal|16
3094845|NCT00321854|10611542|P2|Overall Study|Other|1
3094846|NCT00321854|10611543|P1|Overall Study|Other|1
3094847|NCT00321854|10611542|P2|Overall Study|Withdrawal by Subject|17
3094848|NCT00321854|10611543|P1|Overall Study|Withdrawal by Subject|6
3094849|NCT00321854|10611542|P2|Overall Study|Lost to Follow-up|2
3094850|NCT00321854|10611543|P1|Overall Study|Lost to Follow-up|0
3094851|NCT00321854|10611542|P2|Overall Study|Protocol Violation|5
3094852|NCT00321854|10611543|P1|Overall Study|Protocol Violation|6
3094853|NCT00321854|10611542|P2|Overall Study|Lack of Efficacy|14
3094854|NCT00321854|10611543|P1|Overall Study|Lack of Efficacy|9
3094855|NCT00321854|10611542|P2|Overall Study|Adverse Event|43
3094856|NCT00321854|10611543|P1|Overall Study|Adverse Event|41
3094857|NCT00321828|10611661|P1|Overall Study|No follow up data|1
3094858|NCT00321828|10611661|P1|Overall Study|Ineligible|3
3094859|NCT00321789|10611667|P2|Overall Study|Protocol Violation|3
3094860|NCT00321789|10611668|P1|Overall Study|Protocol Violation|5
3094861|NCT00321789|10611667|P2|Overall Study|Withdrawal by Subject|6
3094862|NCT00321789|10611668|P1|Overall Study|Withdrawal by Subject|6
3094863|NCT00321789|10611667|P2|Overall Study|Lost to Follow-up|7
3094864|NCT00321789|10611668|P1|Overall Study|Lost to Follow-up|4
3094865|NCT00321763|10611700|P4|Overall Study|Lost to Follow-up|4
3094866|NCT00321763|10611701|P3|Overall Study|Lost to Follow-up|5
3094867|NCT00321763|10611702|P2|Overall Study|Lost to Follow-up|1
3094868|NCT00321763|10611703|P1|Overall Study|Lost to Follow-up|3
3094869|NCT00321763|10611700|P4|Overall Study|Withdrawal by Subject|0
3094870|NCT00321763|10611701|P3|Overall Study|Withdrawal by Subject|1
3094871|NCT00321763|10611702|P2|Overall Study|Withdrawal by Subject|0
3094872|NCT00321763|10611703|P1|Overall Study|Withdrawal by Subject|2
3094873|NCT00321763|10611700|P4|Overall Study|Adverse Event|1
3094874|NCT00321763|10611701|P3|Overall Study|Adverse Event|0
3094875|NCT00321763|10611702|P2|Overall Study|Adverse Event|1
3094876|NCT00321763|10611703|P1|Overall Study|Adverse Event|1
3094877|NCT00321737|10611763|P3|Overall Study|Subject Request/ Subject Unavailable|2
3094878|NCT00321737|10611764|P2|Overall Study|Subject Request/ Subject Unavailable|0
3094879|NCT00321737|10611765|P1|Overall Study|Subject Request/ Subject Unavailable|0
3094880|NCT00321737|10611763|P3|Overall Study|Noncompliance|0
3094881|NCT00321737|10611764|P2|Overall Study|Noncompliance|0
3094882|NCT00321737|10611765|P1|Overall Study|Noncompliance|2
3094883|NCT00321737|10611763|P3|Overall Study|Pregnancy|0
3094884|NCT00321737|10611764|P2|Overall Study|Pregnancy|2
3094885|NCT00321737|10611765|P1|Overall Study|Pregnancy|0
3094886|NCT00321737|10611763|P3|Overall Study|Therapeutic Failure|2
3094887|NCT00321737|10611764|P2|Overall Study|Therapeutic Failure|0
3094888|NCT00321737|10611765|P1|Overall Study|Therapeutic Failure|6
3094889|NCT00321737|10611763|P3|Overall Study|Possible Barrett's Esophagus|1
3094890|NCT00321737|10611764|P2|Overall Study|Possible Barrett's Esophagus|1
3094891|NCT00321737|10611765|P1|Overall Study|Possible Barrett's Esophagus|2
3094892|NCT00321737|10611763|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
3094893|NCT00321737|10611764|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
3094894|NCT00321737|10611765|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
3094895|NCT00321737|10611763|P3|Overall Study|Protocol Violation|1
3094896|NCT00321737|10611764|P2|Overall Study|Protocol Violation|0
3094897|NCT00321737|10611765|P1|Overall Study|Protocol Violation|0
3094898|NCT00321737|10611763|P3|Overall Study|Withdrawal by Subject|17
3094899|NCT00321737|10611764|P2|Overall Study|Withdrawal by Subject|12
3094900|NCT00321737|10611765|P1|Overall Study|Withdrawal by Subject|19
3094901|NCT00321737|10611763|P3|Overall Study|Lost to Follow-up|6
3094902|NCT00321737|10611764|P2|Overall Study|Lost to Follow-up|5
3094903|NCT00321737|10611765|P1|Overall Study|Lost to Follow-up|5
3094904|NCT00321737|10611763|P3|Overall Study|Adverse Event|6
3094905|NCT00321737|10611764|P2|Overall Study|Adverse Event|3
3094906|NCT00321737|10611765|P1|Overall Study|Adverse Event|11
3094907|NCT00321737|10611763|P3|Overall Study|Relapse of Erosive Esophagitis|19
3094908|NCT00321737|10611764|P2|Overall Study|Relapse of Erosive Esophagitis|25
3094909|NCT00321737|10611765|P1|Overall Study|Relapse of Erosive Esophagitis|76
3094910|NCT00321711|10611793|P5|Part B|Death|1
3094911|NCT00321711|10611794|P4|Part B|Death|2
3094912|NCT00321711|10611795|P3|Part B|Death|0
3094913|NCT00321711|10611796|P2|Part B|Death|0
3094914|NCT00321711|10611797|P1|Part B|Death|0
3094915|NCT00321711|10611793|P5|Part B|Physician Decision|2
3094916|NCT00321711|10611794|P4|Part B|Physician Decision|1
3094917|NCT00321711|10611795|P3|Part B|Physician Decision|0
3094918|NCT00321711|10611796|P2|Part B|Physician Decision|0
3094919|NCT00321711|10611797|P1|Part B|Physician Decision|0
3094920|NCT00321711|10611793|P5|Part B|Disease progression|0
3094921|NCT00321711|10611794|P4|Part B|Disease progression|1
3094922|NCT00321711|10611795|P3|Part B|Disease progression|0
3094923|NCT00321711|10611796|P2|Part B|Disease progression|0
3094924|NCT00321711|10611797|P1|Part B|Disease progression|0
3094925|NCT00321711|10611793|P5|Part B|Adverse Event|1
3094926|NCT00321711|10611794|P4|Part B|Adverse Event|2
3094927|NCT00321711|10611795|P3|Part B|Adverse Event|0
3094928|NCT00321711|10611796|P2|Part B|Adverse Event|0
3094929|NCT00321711|10611797|P1|Part B|Adverse Event|0
3094930|NCT00321711|10611793|P5|Part B|Noncompliance|1
3094931|NCT00321711|10611794|P4|Part B|Noncompliance|0
3094932|NCT00321711|10611795|P3|Part B|Noncompliance|0
3094933|NCT00321711|10611796|P2|Part B|Noncompliance|0
3094934|NCT00321711|10611797|P1|Part B|Noncompliance|0
3094935|NCT00321711|10611793|P5|Part A|Protocol deviation|0
3094936|NCT00321711|10611794|P4|Part A|Protocol deviation|0
3094937|NCT00321711|10611795|P3|Part A|Protocol deviation|1
3094938|NCT00321711|10611796|P2|Part A|Protocol deviation|0
3094939|NCT00321711|10611797|P1|Part A|Protocol deviation|0
3094940|NCT00321711|10611793|P5|Part A|Other|0
3094941|NCT00321711|10611794|P4|Part A|Other|0
3094942|NCT00321711|10611795|P3|Part A|Other|3
3094943|NCT00321711|10611796|P2|Part A|Other|2
3094944|NCT00321711|10611797|P1|Part A|Other|1
3094945|NCT00321711|10611793|P5|Part A|Physician Decision|0
3094946|NCT00321711|10611794|P4|Part A|Physician Decision|0
3094947|NCT00321711|10611795|P3|Part A|Physician Decision|3
3094948|NCT00321711|10611796|P2|Part A|Physician Decision|1
3094949|NCT00321711|10611797|P1|Part A|Physician Decision|0
3094950|NCT00321711|10611793|P5|Part A|Requirement for alternative therapy|0
3094951|NCT00321711|10611794|P4|Part A|Requirement for alternative therapy|0
3094952|NCT00321711|10611795|P3|Part A|Requirement for alternative therapy|1
3094953|NCT00321711|10611796|P2|Part A|Requirement for alternative therapy|2
3094954|NCT00321711|10611797|P1|Part A|Requirement for alternative therapy|0
3094955|NCT00321711|10611793|P5|Part A|Disease progression|0
3094956|NCT00321711|10611794|P4|Part A|Disease progression|0
3094957|NCT00321711|10611795|P3|Part A|Disease progression|0
3094958|NCT00321711|10611796|P2|Part A|Disease progression|1
3094959|NCT00321711|10611797|P1|Part A|Disease progression|0
3094960|NCT00321711|10611793|P5|Part A|Withdrawal by Subject|0
3094961|NCT00321711|10611794|P4|Part A|Withdrawal by Subject|0
3094962|NCT00321711|10611795|P3|Part A|Withdrawal by Subject|1
3094963|NCT00321711|10611796|P2|Part A|Withdrawal by Subject|1
3094964|NCT00321711|10611797|P1|Part A|Withdrawal by Subject|1
3094965|NCT00321711|10611793|P5|Part A|Adverse Event|0
3094966|NCT00321711|10611794|P4|Part A|Adverse Event|0
3094967|NCT00321711|10611795|P3|Part A|Adverse Event|2
3094968|NCT00321711|10611796|P2|Part A|Adverse Event|3
3094969|NCT00321711|10611797|P1|Part A|Adverse Event|3
3094970|NCT00321685|10611847|P1|Overall Study|Ineligible|2
3094971|NCT00321685|10611847|P1|Overall Study|Not start protocol therapy|2
3094972|NCT00321685|10611847|P1|Overall Study|Other|5
3094973|NCT00321685|10611847|P1|Overall Study|Complicating disese|1
3094974|NCT00321685|10611847|P1|Overall Study|Alternative therapy|1
3094975|NCT00321685|10611847|P1|Overall Study|Withdrawal by Subject|8
3094976|NCT00321685|10611847|P1|Overall Study|Death|2
3094977|NCT00321685|10611847|P1|Overall Study|Adverse Event|18
3094978|NCT00321672|10611859|P4|Overall Study|Extensive travel required for new job|0
3094979|NCT00321672|10611860|P3|Overall Study|Extensive travel required for new job|0
3094980|NCT00321672|10611861|P2|Overall Study|Extensive travel required for new job|1
3094981|NCT00321672|10611862|P1|Overall Study|Extensive travel required for new job|0
3094982|NCT00321672|10611859|P4|Overall Study|Diagnosis of testicular cancer|0
3094983|NCT00321672|10611860|P3|Overall Study|Diagnosis of testicular cancer|0
3094984|NCT00321672|10611861|P2|Overall Study|Diagnosis of testicular cancer|1
3094985|NCT00321672|10611862|P1|Overall Study|Diagnosis of testicular cancer|0
3094986|NCT00321672|10611859|P4|Overall Study|Protocol Violation|0
3094987|NCT00321672|10611860|P3|Overall Study|Protocol Violation|1
3094988|NCT00321672|10611861|P2|Overall Study|Protocol Violation|0
3094989|NCT00321672|10611862|P1|Overall Study|Protocol Violation|0
3094990|NCT00321672|10611859|P4|Overall Study|Moved out of state|0
3094991|NCT00321672|10611860|P3|Overall Study|Moved out of state|1
3094992|NCT00321672|10611861|P2|Overall Study|Moved out of state|1
3094993|NCT00321672|10611862|P1|Overall Study|Moved out of state|0
3094994|NCT00321672|10611859|P4|Overall Study|Incarcerated|0
3094995|NCT00321672|10611860|P3|Overall Study|Incarcerated|2
3094996|NCT00321672|10611861|P2|Overall Study|Incarcerated|0
3094997|NCT00321672|10611862|P1|Overall Study|Incarcerated|0
3094998|NCT00321672|10611859|P4|Overall Study|Too far to travel for visits|0
3094999|NCT00321672|10611860|P3|Overall Study|Too far to travel for visits|0
3095000|NCT00321672|10611861|P2|Overall Study|Too far to travel for visits|0
3095001|NCT00321672|10611862|P1|Overall Study|Too far to travel for visits|1
3095002|NCT00321672|10611859|P4|Overall Study|Death|0
3095003|NCT00321672|10611860|P3|Overall Study|Death|0
3095004|NCT00321672|10611861|P2|Overall Study|Death|0
3095005|NCT00321672|10611862|P1|Overall Study|Death|1
3095006|NCT00321672|10611859|P4|Overall Study|Lost to Follow-up|2
3095007|NCT00321672|10611860|P3|Overall Study|Lost to Follow-up|4
3095008|NCT00321672|10611861|P2|Overall Study|Lost to Follow-up|0
3095009|NCT00321672|10611862|P1|Overall Study|Lost to Follow-up|2
3095010|NCT00321672|10611859|P4|Overall Study|Lack of Efficacy|0
3095011|NCT00321672|10611860|P3|Overall Study|Lack of Efficacy|0
3095012|NCT00321672|10611861|P2|Overall Study|Lack of Efficacy|1
3095013|NCT00321672|10611862|P1|Overall Study|Lack of Efficacy|1
3095014|NCT00321672|10611859|P4|Overall Study|Adverse Event|0
3095015|NCT00321672|10611860|P3|Overall Study|Adverse Event|0
3095016|NCT00321672|10611861|P2|Overall Study|Adverse Event|1
3095017|NCT00321672|10611862|P1|Overall Study|Adverse Event|1
3095018|NCT00321672|10611859|P4|Overall Study|Noncompliance|0
3095019|NCT00321672|10611860|P3|Overall Study|Noncompliance|1
3095020|NCT00321672|10611861|P2|Overall Study|Noncompliance|2
3095021|NCT00321672|10611862|P1|Overall Study|Noncompliance|1
3095022|NCT00321672|10611859|P4|Overall Study|Withdrawal by Subject|0
3095023|NCT00321672|10611860|P3|Overall Study|Withdrawal by Subject|2
3095024|NCT00321672|10611861|P2|Overall Study|Withdrawal by Subject|1
3095025|NCT00321672|10611862|P1|Overall Study|Withdrawal by Subject|5
3095026|NCT00321646|10611888|P1|Neoadjuvant Chemotherapy|Disease progression|1
3095027|NCT00321646|10611888|P1|Neoadjuvant Chemotherapy|Adverse Event|2
3095028|NCT00321646|10611888|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
3095029|NCT00321620|10611895|P2|Overall Study|Other|33
3095030|NCT00321620|10611896|P1|Overall Study|Other|42
3095031|NCT00321620|10611895|P2|Overall Study|Participant request|52
3095032|NCT00321620|10611896|P1|Overall Study|Participant request|75
3095033|NCT00321620|10611895|P2|Overall Study|Ineligibility determined|3
3095034|NCT00321620|10611896|P1|Overall Study|Ineligibility determined|2
3095035|NCT00321620|10611895|P2|Overall Study|Protocol deviation|3
3095036|NCT00321620|10611896|P1|Overall Study|Protocol deviation|4
3095037|NCT00321620|10611895|P2|Overall Study|Noncompliance|7
3095038|NCT00321620|10611896|P1|Overall Study|Noncompliance|14
3095039|NCT00321620|10611895|P2|Overall Study|Physician Decision|1
3095040|NCT00321620|10611896|P1|Overall Study|Physician Decision|4
3095041|NCT00321620|10611895|P2|Overall Study|Lost to Follow-up|9
3095042|NCT00321620|10611896|P1|Overall Study|Lost to Follow-up|13
3095043|NCT00321620|10611895|P2|Overall Study|Adverse Event|56
3095044|NCT00321620|10611896|P1|Overall Study|Adverse Event|43
3095045|NCT00321620|10611895|P2|Overall Study|Disease progression|117
3095046|NCT00321620|10611896|P1|Overall Study|Disease progression|113
3095047|NCT00321620|10611895|P2|Overall Study|Withdrawal by Subject|147
3095048|NCT00321620|10611896|P1|Overall Study|Withdrawal by Subject|164
3095049|NCT00321620|10611895|P2|Overall Study|Death|294
3095050|NCT00321620|10611896|P1|Overall Study|Death|269
3095051|NCT00321555|10611924|P1|Overall Study|Disease progression on study|1
3095052|NCT00321555|10611924|P1|Overall Study|Physician Decision|1
3095053|NCT00321555|10611924|P1|Overall Study|Switched to alternative treatment|3
3095054|NCT00321555|10611924|P1|Overall Study|Developed antibodies|1
3095055|NCT00321464|10611932|P2|Overall Study|Other|18
3095056|NCT00321464|10611933|P1|Overall Study|Other|21
3095057|NCT00321464|10611932|P2|Overall Study|Ineligibility determined|1
3095058|NCT00321464|10611933|P1|Overall Study|Ineligibility determined|2
3095059|NCT00321464|10611932|P2|Overall Study|Protocol deviation|2
3095060|NCT00321464|10611933|P1|Overall Study|Protocol deviation|0
3095061|NCT00321464|10611932|P2|Overall Study|Lost to Follow-up|8
3095062|NCT00321464|10611933|P1|Overall Study|Lost to Follow-up|7
3095063|NCT00321464|10611932|P2|Overall Study|Noncompliance|10
3095064|NCT00321464|10611933|P1|Overall Study|Noncompliance|4
3095065|NCT00321464|10611932|P2|Overall Study|Physician Decision|14
3095066|NCT00321464|10611933|P1|Overall Study|Physician Decision|15
3095067|NCT00321464|10611932|P2|Overall Study|Adverse Event|28
3095068|NCT00321464|10611933|P1|Overall Study|Adverse Event|43
3095069|NCT00321464|10611932|P2|Overall Study|Participant request|61
3095070|NCT00321464|10611933|P1|Overall Study|Participant request|57
3095071|NCT00321464|10611932|P2|Overall Study|Withdrawal by Subject|118
3095072|NCT00321464|10611933|P1|Overall Study|Withdrawal by Subject|117
3095073|NCT00321464|10611932|P2|Overall Study|Disease progression|124
3095074|NCT00321464|10611933|P1|Overall Study|Disease progression|124
3095075|NCT00321464|10611932|P2|Overall Study|Death|174
3095076|NCT00321464|10611933|P1|Overall Study|Death|169
3095077|NCT00321373|10611946|P3|Overall Study|Other|1
3095078|NCT00321373|10611947|P2|Overall Study|Other|0
3095079|NCT00321373|10611948|P1|Overall Study|Other|0
3095080|NCT00321373|10611946|P3|Overall Study|Withdrawal by Subject|0
3095081|NCT00321373|10611947|P2|Overall Study|Withdrawal by Subject|0
3095082|NCT00321373|10611948|P1|Overall Study|Withdrawal by Subject|1
3095083|NCT00321373|10611946|P3|Overall Study|Lost to Follow-up|1
3095084|NCT00321373|10611947|P2|Overall Study|Lost to Follow-up|0
3095085|NCT00321373|10611948|P1|Overall Study|Lost to Follow-up|1
3095086|NCT00321373|10611946|P3|Overall Study|Adverse Event|1
3095087|NCT00321373|10611947|P2|Overall Study|Adverse Event|0
3095088|NCT00321373|10611948|P1|Overall Study|Adverse Event|0
3095089|NCT00321048|10611988|P2|Overall Study|Withdrawal by Subject|8
3095090|NCT00321048|10611989|P1|Overall Study|Withdrawal by Subject|6
3095091|NCT00320801|10611997|P4|Extension Phase|Lost to Follow-up|3
3095092|NCT00320801|10611998|P3|Extension Phase|Lost to Follow-up|0
3095093|NCT00320801|10611999|P2|Extension Phase|Lost to Follow-up|0
3095094|NCT00320801|10612000|P1|Extension Phase|Lost to Follow-up|0
3095095|NCT00320801|10611997|P4|Extension Phase|Lack of Efficacy|2
3095096|NCT00320801|10611998|P3|Extension Phase|Lack of Efficacy|0
3095097|NCT00320801|10611999|P2|Extension Phase|Lack of Efficacy|0
3095098|NCT00320801|10612000|P1|Extension Phase|Lack of Efficacy|0
3095099|NCT00320801|10611997|P4|Extension Phase|Administrative|29
3095100|NCT00320801|10611998|P3|Extension Phase|Administrative|0
3095101|NCT00320801|10611999|P2|Extension Phase|Administrative|0
3095102|NCT00320801|10612000|P1|Extension Phase|Administrative|0
3095103|NCT00320801|10611997|P4|Extension Phase|Adverse Event|8
3095104|NCT00320801|10611998|P3|Extension Phase|Adverse Event|0
3095105|NCT00320801|10611999|P2|Extension Phase|Adverse Event|0
3095106|NCT00320801|10612000|P1|Extension Phase|Adverse Event|0
3095107|NCT00320801|10611997|P4|Extension Phase|Withdrawal by Subject|6
3095108|NCT00320801|10611998|P3|Extension Phase|Withdrawal by Subject|0
3095109|NCT00320801|10611999|P2|Extension Phase|Withdrawal by Subject|0
3095110|NCT00320801|10612000|P1|Extension Phase|Withdrawal by Subject|0
3095111|NCT00320801|10611997|P4|Double-blind Phase|Lack of Efficacy|0
3095112|NCT00320801|10611998|P3|Double-blind Phase|Lack of Efficacy|1
3095113|NCT00320801|10611999|P2|Double-blind Phase|Lack of Efficacy|9
3095114|NCT00320801|10612000|P1|Double-blind Phase|Lack of Efficacy|0
3095115|NCT00320801|10611997|P4|Double-blind Phase|Administrative|0
3095116|NCT00320801|10611998|P3|Double-blind Phase|Administrative|4
3095117|NCT00320801|10611999|P2|Double-blind Phase|Administrative|0
3095118|NCT00320801|10612000|P1|Double-blind Phase|Administrative|0
3095119|NCT00320801|10611997|P4|Double-blind Phase|Adverse Event|0
3095120|NCT00320801|10611998|P3|Double-blind Phase|Adverse Event|8
3095121|NCT00320801|10611999|P2|Double-blind Phase|Adverse Event|2
3095122|NCT00320801|10612000|P1|Double-blind Phase|Adverse Event|0
3095123|NCT00320801|10611997|P4|Double-blind Phase|Withdrawal by Subject|0
3095124|NCT00320801|10611998|P3|Double-blind Phase|Withdrawal by Subject|1
3095125|NCT00320801|10611999|P2|Double-blind Phase|Withdrawal by Subject|0
3095126|NCT00320801|10612000|P1|Double-blind Phase|Withdrawal by Subject|0
3095127|NCT00320801|10611997|P4|Open-label Run-in Period|Did not qualify|0
3095128|NCT00320801|10611998|P3|Open-label Run-in Period|Did not qualify|0
3095129|NCT00320801|10611999|P2|Open-label Run-in Period|Did not qualify|0
3095130|NCT00320801|10612000|P1|Open-label Run-in Period|Did not qualify|1
3095131|NCT00320801|10611997|P4|Open-label Run-in Period|Lost to Follow-up|0
3095132|NCT00320801|10611998|P3|Open-label Run-in Period|Lost to Follow-up|0
3095133|NCT00320801|10611999|P2|Open-label Run-in Period|Lost to Follow-up|0
3095134|NCT00320801|10612000|P1|Open-label Run-in Period|Lost to Follow-up|2
3095135|NCT00320801|10611997|P4|Open-label Run-in Period|Lack of Efficacy|0
3095136|NCT00320801|10611998|P3|Open-label Run-in Period|Lack of Efficacy|0
3095137|NCT00320801|10611999|P2|Open-label Run-in Period|Lack of Efficacy|0
3095138|NCT00320801|10612000|P1|Open-label Run-in Period|Lack of Efficacy|44
3095139|NCT00320801|10611997|P4|Open-label Run-in Period|Administrative|0
3095140|NCT00320801|10611998|P3|Open-label Run-in Period|Administrative|0
3095141|NCT00320801|10611999|P2|Open-label Run-in Period|Administrative|0
3095142|NCT00320801|10612000|P1|Open-label Run-in Period|Administrative|10
3095143|NCT00320801|10611997|P4|Open-label Run-in Period|Adverse Event|0
3095144|NCT00320801|10611998|P3|Open-label Run-in Period|Adverse Event|0
3095145|NCT00320801|10611999|P2|Open-label Run-in Period|Adverse Event|0
3095146|NCT00320801|10612000|P1|Open-label Run-in Period|Adverse Event|33
3095147|NCT00320801|10611997|P4|Open-label Run-in Period|Withdrawal by Subject|0
3095148|NCT00320801|10611998|P3|Open-label Run-in Period|Withdrawal by Subject|0
3095149|NCT00320801|10611999|P2|Open-label Run-in Period|Withdrawal by Subject|0
3095150|NCT00320801|10612000|P1|Open-label Run-in Period|Withdrawal by Subject|2
3095151|NCT00320788|10612015|P5|Overall Study|Withdrawal by Subject|1
3095152|NCT00320788|10612016|P4|Overall Study|Withdrawal by Subject|3
3095153|NCT00320788|10612017|P3|Overall Study|Withdrawal by Subject|0
3095154|NCT00320788|10612018|P2|Overall Study|Withdrawal by Subject|0
3095155|NCT00320788|10612019|P1|Overall Study|Withdrawal by Subject|3
3095156|NCT00320788|10612015|P5|Overall Study|Protocol Violation|1
3095157|NCT00320788|10612016|P4|Overall Study|Protocol Violation|0
3095158|NCT00320788|10612017|P3|Overall Study|Protocol Violation|0
3095159|NCT00320788|10612018|P2|Overall Study|Protocol Violation|0
3095160|NCT00320788|10612019|P1|Overall Study|Protocol Violation|0
3095161|NCT00320788|10612015|P5|Overall Study|Physician Decision|0
3095162|NCT00320788|10612016|P4|Overall Study|Physician Decision|0
3095163|NCT00320788|10612017|P3|Overall Study|Physician Decision|0
3095164|NCT00320788|10612018|P2|Overall Study|Physician Decision|1
3095165|NCT00320788|10612019|P1|Overall Study|Physician Decision|1
3095166|NCT00320788|10612015|P5|Overall Study|Other|1
3095167|NCT00320788|10612016|P4|Overall Study|Other|1
3095168|NCT00320788|10612017|P3|Overall Study|Other|1
3095169|NCT00320788|10612018|P2|Overall Study|Other|2
3095170|NCT00320788|10612019|P1|Overall Study|Other|1
3095171|NCT00320788|10612015|P5|Overall Study|Decision by the Sponsor|1
3095172|NCT00320788|10612016|P4|Overall Study|Decision by the Sponsor|0
3095173|NCT00320788|10612017|P3|Overall Study|Decision by the Sponsor|0
3095174|NCT00320788|10612018|P2|Overall Study|Decision by the Sponsor|1
3095175|NCT00320788|10612019|P1|Overall Study|Decision by the Sponsor|1
3095176|NCT00320788|10612015|P5|Overall Study|Lost to Follow-up|0
3095177|NCT00320788|10612016|P4|Overall Study|Lost to Follow-up|0
3095178|NCT00320788|10612017|P3|Overall Study|Lost to Follow-up|1
3095179|NCT00320788|10612018|P2|Overall Study|Lost to Follow-up|2
3095180|NCT00320788|10612019|P1|Overall Study|Lost to Follow-up|0
3095181|NCT00320788|10612015|P5|Overall Study|Death|1
3095182|NCT00320788|10612016|P4|Overall Study|Death|0
3095183|NCT00320788|10612017|P3|Overall Study|Death|1
3095184|NCT00320788|10612018|P2|Overall Study|Death|0
3095185|NCT00320788|10612019|P1|Overall Study|Death|0
3095186|NCT00320788|10612015|P5|Overall Study|Adverse Event|0
3095187|NCT00320788|10612016|P4|Overall Study|Adverse Event|1
3095188|NCT00320788|10612017|P3|Overall Study|Adverse Event|0
3095189|NCT00320788|10612018|P2|Overall Study|Adverse Event|0
3095190|NCT00320788|10612019|P1|Overall Study|Adverse Event|0
3095191|NCT00320710|10612073|P3|Overall Study|Lost to Follow-up|0
3095192|NCT00320710|10612074|P2|Overall Study|Lost to Follow-up|0
3095193|NCT00320710|10612075|P1|Overall Study|Lost to Follow-up|1
3095194|NCT00320710|10612073|P3|Overall Study|Adverse Event|1
3095195|NCT00320710|10612074|P2|Overall Study|Adverse Event|14
3095196|NCT00320710|10612075|P1|Overall Study|Adverse Event|18
3095197|NCT00320710|10612073|P3|Overall Study|Abnormal laboratory value(s)|0
3095198|NCT00320710|10612074|P2|Overall Study|Abnormal laboratory value(s)|3
3095199|NCT00320710|10612075|P1|Overall Study|Abnormal laboratory value(s)|12
3095200|NCT00320710|10612073|P3|Overall Study|Abnormal test procedure result(s)|0
3095201|NCT00320710|10612074|P2|Overall Study|Abnormal test procedure result(s)|0
3095202|NCT00320710|10612075|P1|Overall Study|Abnormal test procedure result(s)|2
3095203|NCT00320710|10612073|P3|Overall Study|Protocol Violation|0
3095204|NCT00320710|10612074|P2|Overall Study|Protocol Violation|5
3095205|NCT00320710|10612075|P1|Overall Study|Protocol Violation|6
3095206|NCT00320710|10612073|P3|Overall Study|Withdrawal by Subject|1
3095207|NCT00320710|10612074|P2|Overall Study|Withdrawal by Subject|26
3095208|NCT00320710|10612075|P1|Overall Study|Withdrawal by Subject|20
3095209|NCT00320710|10612073|P3|Overall Study|Administrative problems|0
3095210|NCT00320710|10612074|P2|Overall Study|Administrative problems|2
3095211|NCT00320710|10612075|P1|Overall Study|Administrative problems|1
3095212|NCT00320710|10612073|P3|Overall Study|Death|1
3095213|NCT00320710|10612074|P2|Overall Study|Death|7
3095214|NCT00320710|10612075|P1|Overall Study|Death|10
3095215|NCT00320710|10612073|P3|Overall Study|Disease progression|2
3095216|NCT00320710|10612074|P2|Overall Study|Disease progression|19
3095217|NCT00320710|10612075|P1|Overall Study|Disease progression|24
3095218|NCT00320606|10612105|P1|Overall Study|Withdrawal by Subject|1
3095219|NCT00320606|10612105|P1|Overall Study|Protocol Violation|1
3095220|NCT00320606|10612105|P1|Overall Study|Adverse Event|1
3095221|NCT00320593|10612121|P2|Overall Study|Withdrawal by clinical center|0
3095222|NCT00320593|10612122|P1|Overall Study|Withdrawal by clinical center|1
3095223|NCT00320593|10612121|P2|Overall Study|Withdrawal by Subject|1
3095224|NCT00320593|10612122|P1|Overall Study|Withdrawal by Subject|2
3095225|NCT00320593|10612121|P2|Overall Study|Moved to another state|0
3095226|NCT00320593|10612122|P1|Overall Study|Moved to another state|1
3095227|NCT00320593|10612121|P2|Overall Study|Lost to Follow-up|0
3095228|NCT00320593|10612122|P1|Overall Study|Lost to Follow-up|3
3095229|NCT00320541|10612146|P2|Overall Study|Protocol Entry Criterion Not Met|0
3095230|NCT00320541|10612147|P1|Overall Study|Protocol Entry Criterion Not Met|1
3095231|NCT00320541|10612146|P2|Overall Study|Death due to Adverse Event(s)|0
3095232|NCT00320541|10612147|P1|Overall Study|Death due to Adverse Event(s)|1
3095233|NCT00320541|10612146|P2|Overall Study|Death due to Study Disease|3
3095234|NCT00320541|10612147|P1|Overall Study|Death due to Study Disease|1
3095235|NCT00320541|10612146|P2|Overall Study|Sponsor Decision|1
3095236|NCT00320541|10612147|P1|Overall Study|Sponsor Decision|2
3095237|NCT00320541|10612146|P2|Overall Study|Other|4
3095238|NCT00320541|10612147|P1|Overall Study|Other|3
3095239|NCT00320541|10612146|P2|Overall Study|Physician Decision|13
3095240|NCT00320541|10612147|P1|Overall Study|Physician Decision|9
3095241|NCT00320541|10612146|P2|Overall Study|Withdrawal by Subject|16
3095242|NCT00320541|10612147|P1|Overall Study|Withdrawal by Subject|12
3095243|NCT00320541|10612146|P2|Overall Study|Protocol Violation|1
3095244|NCT00320541|10612147|P1|Overall Study|Protocol Violation|0
3095245|NCT00320541|10612146|P2|Overall Study|Adverse Event|19
3095246|NCT00320541|10612147|P1|Overall Study|Adverse Event|21
3095247|NCT00320528|10612174|P3|Study Period III|Atomoxetine Commercially Available|90
3095248|NCT00320528|10612175|P2|Study Period III|Atomoxetine Commercially Available|25
3095249|NCT00320528|10612176|P1|Study Period III|Atomoxetine Commercially Available|68
3095250|NCT00320528|10612174|P3|Study Period III|Sponsor Decision|1
3095251|NCT00320528|10612175|P2|Study Period III|Sponsor Decision|0
3095252|NCT00320528|10612176|P1|Study Period III|Sponsor Decision|0
3095253|NCT00320528|10612174|P3|Study Period III|Physician Decision|2
3095254|NCT00320528|10612175|P2|Study Period III|Physician Decision|1
3095255|NCT00320528|10612176|P1|Study Period III|Physician Decision|0
3095256|NCT00320528|10612174|P3|Study Period III|Protocol Violation|0
3095257|NCT00320528|10612175|P2|Study Period III|Protocol Violation|1
3095258|NCT00320528|10612176|P1|Study Period III|Protocol Violation|0
3095259|NCT00320528|10612174|P3|Study Period III|Parent/Caregiver Decision|11
3095260|NCT00320528|10612175|P2|Study Period III|Parent/Caregiver Decision|3
3095261|NCT00320528|10612176|P1|Study Period III|Parent/Caregiver Decision|14
3095262|NCT00320528|10612174|P3|Study Period III|Lack of Efficacy|0
3095263|NCT00320528|10612175|P2|Study Period III|Lack of Efficacy|0
3095264|NCT00320528|10612176|P1|Study Period III|Lack of Efficacy|2
3095265|NCT00320528|10612174|P3|Study Period III|Withdrawal by Subject|2
3095266|NCT00320528|10612175|P2|Study Period III|Withdrawal by Subject|1
3095267|NCT00320528|10612176|P1|Study Period III|Withdrawal by Subject|1
3095268|NCT00320528|10612174|P3|Study Period III|Lost to Follow-up|0
3095269|NCT00320528|10612175|P2|Study Period III|Lost to Follow-up|0
3095270|NCT00320528|10612176|P1|Study Period III|Lost to Follow-up|1
3095271|NCT00320528|10612174|P3|Study Period III|Adverse Event|0
3095272|NCT00320528|10612175|P2|Study Period III|Adverse Event|0
3095273|NCT00320528|10612176|P1|Study Period III|Adverse Event|1
3095274|NCT00320528|10612174|P3|Study Period II|Entry Criteria Exclusion|2
3095275|NCT00320528|10612175|P2|Study Period II|Entry Criteria Exclusion|2
3095276|NCT00320528|10612176|P1|Study Period II|Entry Criteria Exclusion|0
3095277|NCT00320528|10612174|P3|Study Period II|Withdrawal by Subject|1
3095278|NCT00320528|10612175|P2|Study Period II|Withdrawal by Subject|1
3095279|NCT00320528|10612176|P1|Study Period II|Withdrawal by Subject|0
3095280|NCT00320528|10612174|P3|Study Period II|Parent/Caregiver Decision|11
3095281|NCT00320528|10612175|P2|Study Period II|Parent/Caregiver Decision|3
3095282|NCT00320528|10612176|P1|Study Period II|Parent/Caregiver Decision|8
3095283|NCT00320528|10612174|P3|Study Period II|Adverse Event|8
3095284|NCT00320528|10612175|P2|Study Period II|Adverse Event|4
3095285|NCT00320528|10612176|P1|Study Period II|Adverse Event|3
3095286|NCT00320515|10612211|P1|Overall Study|Withdrawal by Subject|8
3095287|NCT00320515|10612211|P1|Overall Study|Physician Decision|2
3095288|NCT00320515|10612211|P1|Overall Study|Lost to Follow-up|6
3095289|NCT00320515|10612211|P1|Overall Study|Death|33
3095290|NCT00320489|10612220|P2|Overall Study|Withdrawal by Subject|41
3095291|NCT00320489|10612221|P1|Overall Study|Withdrawal by Subject|39
3095292|NCT00320489|10612220|P2|Overall Study|Sponsor Decision|3
3095293|NCT00320489|10612221|P1|Overall Study|Sponsor Decision|3
3095294|NCT00320489|10612220|P2|Overall Study|Protocol Violation|4
3095295|NCT00320489|10612221|P1|Overall Study|Protocol Violation|4
3095296|NCT00320489|10612220|P2|Overall Study|Physician Decision|8
3095297|NCT00320489|10612221|P1|Overall Study|Physician Decision|8
3095298|NCT00320489|10612220|P2|Overall Study|Lost to Follow-up|22
3095299|NCT00320489|10612221|P1|Overall Study|Lost to Follow-up|21
3095300|NCT00320489|10612220|P2|Overall Study|Lack of Efficacy|7
3095301|NCT00320489|10612221|P1|Overall Study|Lack of Efficacy|16
3095302|NCT00320489|10612220|P2|Overall Study|Entry Criteria Exclusion|4
3095303|NCT00320489|10612221|P1|Overall Study|Entry Criteria Exclusion|2
3095304|NCT00320489|10612220|P2|Overall Study|Death|2
3095305|NCT00320489|10612221|P1|Overall Study|Death|0
3095306|NCT00320489|10612220|P2|Overall Study|Clinical Relapse|20
3095307|NCT00320489|10612221|P1|Overall Study|Clinical Relapse|26
3095308|NCT00320489|10612220|P2|Overall Study|Adverse Event|25
3095309|NCT00320489|10612221|P1|Overall Study|Adverse Event|26
3095310|NCT00320424|10612277|P1|Overall Study|Other|3
3095311|NCT00320424|10612277|P1|Overall Study|Adverse Event|3
3095312|NCT00320411|10612291|P1|Overall Study|No investigational product admin.|4
3095313|NCT00320398|10612314|P2|Overall Study|Other|0
3095314|NCT00320398|10612315|P1|Overall Study|Other|1
3095315|NCT00320398|10612314|P2|Overall Study|Adverse Event|4
3095316|NCT00320398|10612315|P1|Overall Study|Adverse Event|1
3095317|NCT00320385|10612343|P2|Overall Study|Adverse Event|1
3095318|NCT00320385|10612344|P1|Overall Study|Adverse Event|0
3095319|NCT00320385|10612343|P2|Overall Study|Withdrew Consent|0
3095320|NCT00320385|10612344|P1|Overall Study|Withdrew Consent|1
3095321|NCT00320385|10612343|P2|Overall Study|Serious Adverse Event|0
3095322|NCT00320385|10612344|P1|Overall Study|Serious Adverse Event|1
3095323|NCT00320385|10612343|P2|Overall Study|Death|2
3095324|NCT00320385|10612344|P1|Overall Study|Death|1
3095325|NCT00320385|10612343|P2|Overall Study|Investigator Decision|1
3095326|NCT00320385|10612344|P1|Overall Study|Investigator Decision|0
3095327|NCT00320385|10612343|P2|Overall Study|Sponsor Terminated Study|1
3095328|NCT00320385|10612344|P1|Overall Study|Sponsor Terminated Study|2
3095329|NCT00320385|10612343|P2|Overall Study|Withdrawal by Subject|7
3095330|NCT00320385|10612344|P1|Overall Study|Withdrawal by Subject|6
3095331|NCT00320385|10612343|P2|Overall Study|Lost to Follow-up|10
3095332|NCT00320385|10612344|P1|Overall Study|Lost to Follow-up|7
3095333|NCT00320372|10612367|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
3095334|NCT00320372|10612368|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
3095335|NCT00320372|10612367|P2|Overall Study|Did not Meet (I/E)|1
3095336|NCT00320372|10612368|P1|Overall Study|Did not Meet (I/E)|3
3095337|NCT00320372|10612367|P2|Overall Study|Non-Compliance|39
3095338|NCT00320372|10612368|P1|Overall Study|Non-Compliance|40
3095339|NCT00320372|10612367|P2|Overall Study|Withdrawal by Subject|37
3095340|NCT00320372|10612368|P1|Overall Study|Withdrawal by Subject|55
3095341|NCT00320372|10612367|P2|Overall Study|Death|8
3095342|NCT00320372|10612368|P1|Overall Study|Death|7
3095343|NCT00320372|10612367|P2|Overall Study|Physician Decision|7
3095344|NCT00320372|10612368|P1|Overall Study|Physician Decision|4
3095345|NCT00320255|10612408|P6|Overall Study|Other|0
3095346|NCT00320255|10612409|P5|Overall Study|Other|0
3095347|NCT00320255|10612410|P4|Overall Study|Other|0
3095348|NCT00320255|10612411|P3|Overall Study|Other|1
3095349|NCT00320255|10612412|P2|Overall Study|Other|2
3095350|NCT00320255|10612413|P1|Overall Study|Other|3
3095351|NCT00320255|10612408|P6|Overall Study|No longer meets study criteria|0
3095352|NCT00320255|10612409|P5|Overall Study|No longer meets study criteria|0
3095353|NCT00320255|10612410|P4|Overall Study|No longer meets study criteria|1
3095354|NCT00320255|10612411|P3|Overall Study|No longer meets study criteria|0
3095355|NCT00320255|10612412|P2|Overall Study|No longer meets study criteria|0
3095356|NCT00320255|10612413|P1|Overall Study|No longer meets study criteria|0
3095357|NCT00320255|10612408|P6|Overall Study|Poor compliance/noncompliance|0
3095358|NCT00320255|10612409|P5|Overall Study|Poor compliance/noncompliance|0
3095359|NCT00320255|10612410|P4|Overall Study|Poor compliance/noncompliance|1
3095360|NCT00320255|10612411|P3|Overall Study|Poor compliance/noncompliance|0
3095361|NCT00320255|10612412|P2|Overall Study|Poor compliance/noncompliance|1
3095362|NCT00320255|10612413|P1|Overall Study|Poor compliance/noncompliance|1
3095363|NCT00320255|10612408|P6|Overall Study|Withdrawal by Subject|0
3095364|NCT00320255|10612409|P5|Overall Study|Withdrawal by Subject|0
3095365|NCT00320255|10612410|P4|Overall Study|Withdrawal by Subject|4
3095366|NCT00320255|10612411|P3|Overall Study|Withdrawal by Subject|2
3095367|NCT00320255|10612412|P2|Overall Study|Withdrawal by Subject|2
3095368|NCT00320255|10612413|P1|Overall Study|Withdrawal by Subject|1
3095369|NCT00320255|10612408|P6|Overall Study|Adverse Event|0
3095370|NCT00320255|10612409|P5|Overall Study|Adverse Event|0
3095371|NCT00320255|10612410|P4|Overall Study|Adverse Event|2
3095372|NCT00320255|10612411|P3|Overall Study|Adverse Event|3
3095373|NCT00320255|10612412|P2|Overall Study|Adverse Event|2
3095374|NCT00320255|10612413|P1|Overall Study|Adverse Event|5
3095375|NCT00320255|10612408|P6|Overall Study|Lack of Efficacy|0
3095376|NCT00320255|10612409|P5|Overall Study|Lack of Efficacy|0
3095377|NCT00320255|10612410|P4|Overall Study|Lack of Efficacy|0
3095378|NCT00320255|10612411|P3|Overall Study|Lack of Efficacy|0
3095379|NCT00320255|10612412|P2|Overall Study|Lack of Efficacy|0
3095380|NCT00320255|10612413|P1|Overall Study|Lack of Efficacy|1
3095381|NCT00320216|10612506|P5|Overall Study|Other|3
3095382|NCT00320216|10612507|P4|Overall Study|Other|1
3095383|NCT00320216|10612508|P3|Overall Study|Other|5
3095384|NCT00320216|10612509|P2|Overall Study|Other|2
3095385|NCT00320216|10612510|P1|Overall Study|Other|7
3095386|NCT00320216|10612506|P5|Overall Study|Lost to Follow-up|0
3095387|NCT00320216|10612507|P4|Overall Study|Lost to Follow-up|0
3095388|NCT00320216|10612508|P3|Overall Study|Lost to Follow-up|0
3095389|NCT00320216|10612509|P2|Overall Study|Lost to Follow-up|0
3095390|NCT00320216|10612510|P1|Overall Study|Lost to Follow-up|3
3095391|NCT00320216|10612506|P5|Overall Study|Lack of Efficacy|1
3095392|NCT00320216|10612507|P4|Overall Study|Lack of Efficacy|0
3095393|NCT00320216|10612508|P3|Overall Study|Lack of Efficacy|1
3095394|NCT00320216|10612509|P2|Overall Study|Lack of Efficacy|2
3095395|NCT00320216|10612510|P1|Overall Study|Lack of Efficacy|6
3095396|NCT00320216|10612506|P5|Overall Study|Adverse Event|2
3095397|NCT00320216|10612507|P4|Overall Study|Adverse Event|2
3095398|NCT00320216|10612508|P3|Overall Study|Adverse Event|0
3095399|NCT00320216|10612509|P2|Overall Study|Adverse Event|6
3095400|NCT00320216|10612510|P1|Overall Study|Adverse Event|0
3095401|NCT00320190|10612544|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
3095402|NCT00320190|10612545|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
3095403|NCT00320190|10612544|P2|Long-term (12-month) Extension|Lack of major molecular response|2
3095404|NCT00320190|10612545|P1|Long-term (12-month) Extension|Lack of major molecular response|1
3095405|NCT00320190|10612544|P2|Long-term (12-month) Extension|Sponsor terminated study|0
3095406|NCT00320190|10612545|P1|Long-term (12-month) Extension|Sponsor terminated study|7
3095407|NCT00320190|10612544|P2|First 12 Months|Withdrawal by Subject|1
3095408|NCT00320190|10612545|P1|First 12 Months|Withdrawal by Subject|0
3095409|NCT00320190|10612544|P2|First 12 Months|Study drug toxicity|1
3095410|NCT00320190|10612545|P1|First 12 Months|Study drug toxicity|0
3095411|NCT00320190|10612544|P2|First 12 Months|Investigator request|1
3095412|NCT00320190|10612545|P1|First 12 Months|Investigator request|0
3095413|NCT00320190|10612544|P2|First 12 Months|Adverse event unrelated to study drug|0
3095414|NCT00320190|10612545|P1|First 12 Months|Adverse event unrelated to study drug|1
3095415|NCT00320190|10612544|P2|First 12 Months|Enrollment failure|1
3095416|NCT00320190|10612545|P1|First 12 Months|Enrollment failure|0
3095417|NCT00320190|10612544|P2|First 12 Months|Lost to Follow-up|1
3095418|NCT00320190|10612545|P1|First 12 Months|Lost to Follow-up|0
3095419|NCT00320190|10612544|P2|First 12 Months|Sponsor terminated study|2
3095420|NCT00320190|10612545|P1|First 12 Months|Sponsor terminated study|2
3095421|NCT00320190|10612544|P2|First 12 Months|Completed but did not enter extension|3
3095422|NCT00320190|10612545|P1|First 12 Months|Completed but did not enter extension|5
3095423|NCT00320112|10612565|P2|Overall Study|Death|1
3095424|NCT00320112|10612566|P1|Overall Study|Death|2
3095425|NCT00320112|10612565|P2|Overall Study|Withdrawal by Subject|0
3095426|NCT00320112|10612566|P1|Overall Study|Withdrawal by Subject|3
3095427|NCT00320112|10612565|P2|Overall Study|Lost to Follow-up|4
3095428|NCT00320112|10612566|P1|Overall Study|Lost to Follow-up|3
3095429|NCT00319982|10612580|P2|Overall Study|Withdrawal by Subject|0
3095430|NCT00319982|10612581|P1|Overall Study|Withdrawal by Subject|1
3095431|NCT00319956|10612601|P2|Overall Study|Death|24
3095432|NCT00319956|10612602|P1|Overall Study|Death|20
3095433|NCT00319839|10612614|P1|Overall Study|Withdrawal by Subject|1
3095434|NCT00319839|10612614|P1|Overall Study|Adverse Event|5
3095435|NCT00319735|10612630|P1|Overall Study|Death|2
3095436|NCT00319696|10612643|P1|Overall Study|Lost to Follow-up|3
3095437|NCT00319696|10612643|P1|Overall Study|administrative|7
3095438|NCT00319696|10612643|P1|Overall Study|withdrawal of consent|14
3095439|NCT00319696|10612643|P1|Overall Study|Adverse Event|36
3095440|NCT00319592|10612680|P2|Overall Study|Physician Decision|1
3095441|NCT00319592|10612681|P1|Overall Study|Physician Decision|0
3095442|NCT00319592|10612680|P2|Overall Study|Protocol Violation|0
3095443|NCT00319592|10612681|P1|Overall Study|Protocol Violation|1
3095444|NCT00319553|10612697|P2|Overall Study|Withdrawal by Subject|1
3095445|NCT00319553|10612698|P1|Overall Study|Withdrawal by Subject|1
3095446|NCT00319553|10612697|P2|Overall Study|Lost to Follow-up|1
3095447|NCT00319553|10612698|P1|Overall Study|Lost to Follow-up|2
3095448|NCT00319553|10612697|P2|Overall Study|Protocol Violation|2
3095449|NCT00319553|10612698|P1|Overall Study|Protocol Violation|1
3095450|NCT00319501|10612712|P2|Open-label Extension Period|Withdrawal by Subject|0
3095451|NCT00319501|10612713|P1|Open-label Extension Period|Withdrawal by Subject|2
3095452|NCT00319501|10612712|P2|Open-label Extension Period|Sponsor request|0
3095453|NCT00319501|10612713|P1|Open-label Extension Period|Sponsor request|26
3095454|NCT00319501|10612712|P2|Open-label Extension Period|Principal investigator decision|0
3095455|NCT00319501|10612713|P1|Open-label Extension Period|Principal investigator decision|2
3095456|NCT00319501|10612712|P2|Open-label Extension Period|Other|0
3095457|NCT00319501|10612713|P1|Open-label Extension Period|Other|1
3095458|NCT00319501|10612712|P2|Open-label Extension Period|Did not receive treatment|0
3095459|NCT00319501|10612713|P1|Open-label Extension Period|Did not receive treatment|18
3095460|NCT00319501|10612712|P2|Open-label Extension Period|Adverse Event|0
3095461|NCT00319501|10612713|P1|Open-label Extension Period|Adverse Event|2
3095462|NCT00319501|10612712|P2|Open-label Period|Other|0
3095463|NCT00319501|10612713|P1|Open-label Period|Other|11
3095464|NCT00319501|10612712|P2|Open-label Period|Did not receive treatment|0
3095465|NCT00319501|10612713|P1|Open-label Period|Did not receive treatment|33
3095466|NCT00319501|10612712|P2|Open-label Period|Lost to Follow-up|0
3095467|NCT00319501|10612713|P1|Open-label Period|Lost to Follow-up|5
3095468|NCT00319501|10612712|P2|Open-label Period|Sponsor request|0
3095469|NCT00319501|10612713|P1|Open-label Period|Sponsor request|12
3095470|NCT00319501|10612712|P2|Open-label Period|Principal Investigator decision|0
3095471|NCT00319501|10612713|P1|Open-label Period|Principal Investigator decision|6
3095472|NCT00319501|10612712|P2|Open-label Period|Withdrawal by Subject|0
3095473|NCT00319501|10612713|P1|Open-label Period|Withdrawal by Subject|38
3095474|NCT00319501|10612712|P2|Open-label Period|Protocol Violation|0
3095475|NCT00319501|10612713|P1|Open-label Period|Protocol Violation|6
3095476|NCT00319501|10612712|P2|Open-label Period|Adverse Event|0
3095477|NCT00319501|10612713|P1|Open-label Period|Adverse Event|5
3095478|NCT00319501|10612712|P2|Double-blind Period|Did not receive treatment|29
3095479|NCT00319501|10612713|P1|Double-blind Period|Did not receive treatment|42
3095480|NCT00319501|10612712|P2|Double-blind Period|Sponsor Request|0
3095481|NCT00319501|10612713|P1|Double-blind Period|Sponsor Request|1
3095482|NCT00319501|10612712|P2|Double-blind Period|Withdrawal by Subject|3
3095483|NCT00319501|10612713|P1|Double-blind Period|Withdrawal by Subject|0
3095484|NCT00319449|10612739|P2|Overall Study|Noncompliance with the protocol|0
3095485|NCT00319449|10612740|P1|Overall Study|Noncompliance with the protocol|1
3095486|NCT00319449|10612739|P2|Overall Study|Subject did not wish to continue|0
3095487|NCT00319449|10612740|P1|Overall Study|Subject did not wish to continue|1
3095488|NCT00319436|10612752|P2|Overall Study|Withdrawal by Subject|7
3095489|NCT00319436|10612753|P1|Overall Study|Withdrawal by Subject|6
3095490|NCT00319254|10612771|P1|Overall Study|Enrolled, Not Treated|2
3095491|NCT00319254|10612771|P1|Overall Study|Lost to Follow-up|2
3095492|NCT00319254|10612771|P1|Overall Study|Death|46
3095493|NCT00319254|10612771|P1|Overall Study|Withdrawal by Subject|4
3095494|NCT00319111|10612784|P1|Overall Study|Treatment failure|1
3095495|NCT00319111|10612784|P1|Overall Study|Administrative|2
3095496|NCT00319111|10612784|P1|Overall Study|Lack of clinical improvement|4
3095497|NCT00319111|10612784|P1|Overall Study|Death|9
3095498|NCT00319111|10612784|P1|Overall Study|Withdrawal of consent|11
3095499|NCT00319111|10612784|P1|Overall Study|Adverse Event|20
3095500|NCT00319098|10612798|P2|Overall Study|Protocol Violation|1
3095501|NCT00319098|10612799|P1|Overall Study|Protocol Violation|3
3095502|NCT00319098|10612798|P2|Overall Study|Others|8
3095503|NCT00319098|10612799|P1|Overall Study|Others|33
3095504|NCT00319098|10612798|P2|Overall Study|Lost to Follow-up|13
3095505|NCT00319098|10612799|P1|Overall Study|Lost to Follow-up|37
3095506|NCT00319098|10612798|P2|Overall Study|Migrated/moved from study area|1
3095507|NCT00319098|10612799|P1|Overall Study|Migrated/moved from study area|2
3095508|NCT00319098|10612798|P2|Overall Study|Withdrawal by Subject|8
3095509|NCT00319098|10612799|P1|Overall Study|Withdrawal by Subject|37
3095510|NCT00319098|10612798|P2|Overall Study|Adverse Event|1
3095511|NCT00319098|10612799|P1|Overall Study|Adverse Event|20
3095512|NCT00319098|10612798|P2|Overall Study|Serious adverse event|0
3095513|NCT00319098|10612799|P1|Overall Study|Serious adverse event|3
3095514|NCT00319046|10612857|P1|Overall Study|administrative reason|1
3095515|NCT00319046|10612857|P1|Overall Study|withdrawal of subject's consent|7
3095516|NCT00319020|10612866|P2|Overall Study|Adverse Event|1
3095517|NCT00319020|10612867|P1|Overall Study|Adverse Event|0
3095518|NCT00319020|10612866|P2|Overall Study|Treatment failure|1
3095519|NCT00319020|10612867|P1|Overall Study|Treatment failure|0
3095520|NCT00319020|10612866|P2|Overall Study|Transplant|1
3095521|NCT00319020|10612867|P1|Overall Study|Transplant|0
3095522|NCT00319020|10612866|P2|Overall Study|Disease progression|2
3095523|NCT00319020|10612867|P1|Overall Study|Disease progression|0
3095524|NCT00319020|10612866|P2|Overall Study|Administrative reason|5
3095525|NCT00319020|10612867|P1|Overall Study|Administrative reason|0
3095526|NCT00319020|10612866|P2|Overall Study|F-1 completed but not enrolled in F-2|0
3095527|NCT00319020|10612867|P1|Overall Study|F-1 completed but not enrolled in F-2|1
3095528|NCT00319020|10612866|P2|Overall Study|Withdrawal by Subject|1
3095529|NCT00319020|10612867|P1|Overall Study|Withdrawal by Subject|4
3095530|NCT00319020|10612866|P2|Overall Study|Death|2
3095531|NCT00319020|10612867|P1|Overall Study|Death|2
3095532|NCT00318656|10612939|P2|Overall Study|Did not receive any treatment|1
3095533|NCT00318656|10612940|P1|Overall Study|Did not receive any treatment|0
3095534|NCT00318656|10612939|P2|Overall Study|Took Avandamet instead of Glim/Met|1
3095535|NCT00318656|10612940|P1|Overall Study|Took Avandamet instead of Glim/Met|0
3095536|NCT00318565|10612997|P1|Overall Study|Excluded per protocol|24
3095537|NCT00318474|10613004|P2|Overall Study|Trial terminated|7
3095538|NCT00318474|10613005|P1|Overall Study|Trial terminated|10
3095539|NCT00318474|10613004|P2|Overall Study|Post-therapy hyperflycemia|1
3095540|NCT00318474|10613005|P1|Overall Study|Post-therapy hyperflycemia|0
3095541|NCT00318474|10613004|P2|Overall Study|Fall in GFR|3
3095542|NCT00318474|10613005|P1|Overall Study|Fall in GFR|3
3095543|NCT00318474|10613004|P2|Overall Study|Withdrawal by Subject|2
3095544|NCT00318474|10613005|P1|Overall Study|Withdrawal by Subject|3
3095545|NCT00318474|10613004|P2|Overall Study|Protocol Violation|0
3095546|NCT00318474|10613005|P1|Overall Study|Protocol Violation|1
3095547|NCT00318474|10613004|P2|Overall Study|Pregnancy|2
3095548|NCT00318474|10613005|P1|Overall Study|Pregnancy|0
3095549|NCT00318474|10613004|P2|Overall Study|Lost to Follow-up|1
3095550|NCT00318474|10613005|P1|Overall Study|Lost to Follow-up|0
3095551|NCT00318474|10613004|P2|Overall Study|Adverse Event|1
3095552|NCT00318474|10613005|P1|Overall Study|Adverse Event|1
3095553|NCT00318461|10613016|P5|Open-Label Extension, 18 Months|Protocol Violation|6
3095554|NCT00318461|10613017|P4|Open-Label Extension, 18 Months|Protocol Violation|4
3095555|NCT00318461|10613018|P3|Open-Label Extension, 18 Months|Protocol Violation|3
3095556|NCT00318461|10613019|P2|Open-Label Extension, 18 Months|Protocol Violation|5
3095557|NCT00318461|10613020|P1|Open-Label Extension, 18 Months|Protocol Violation|7
3095558|NCT00318461|10613016|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
3095559|NCT00318461|10613017|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
3095560|NCT00318461|10613018|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
3095561|NCT00318461|10613019|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
3095562|NCT00318461|10613020|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
3095563|NCT00318461|10613016|P5|Open-Label Extension, 18 Months|Adverse Event|6
3095564|NCT00318461|10613017|P4|Open-Label Extension, 18 Months|Adverse Event|1
3095565|NCT00318461|10613018|P3|Open-Label Extension, 18 Months|Adverse Event|6
3095566|NCT00318461|10613019|P2|Open-Label Extension, 18 Months|Adverse Event|8
3095567|NCT00318461|10613020|P1|Open-Label Extension, 18 Months|Adverse Event|11
3095568|NCT00318461|10613016|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
3095569|NCT00318461|10613017|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
3095570|NCT00318461|10613018|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
3095571|NCT00318461|10613019|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
3095572|NCT00318461|10613020|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
3095573|NCT00318461|10613016|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
3095574|NCT00318461|10613017|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
3095575|NCT00318461|10613018|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
3095576|NCT00318461|10613019|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
3095577|NCT00318461|10613020|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
3095578|NCT00318461|10613016|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
3095579|NCT00318461|10613017|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
3095580|NCT00318461|10613018|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
3095581|NCT00318461|10613019|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
3095582|NCT00318461|10613020|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
3095583|NCT00318461|10613016|P5|Double-Blind, 6 Months|Hyperglicaemia|0
3095584|NCT00318461|10613017|P4|Double-Blind, 6 Months|Hyperglicaemia|1
3095585|NCT00318461|10613018|P3|Double-Blind, 6 Months|Hyperglicaemia|0
3095586|NCT00318461|10613019|P2|Double-Blind, 6 Months|Hyperglicaemia|0
3095587|NCT00318461|10613020|P1|Double-Blind, 6 Months|Hyperglicaemia|0
3095588|NCT00318461|10613016|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
3095589|NCT00318461|10613017|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
3095590|NCT00318461|10613018|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
3095591|NCT00318461|10613019|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
3095592|NCT00318461|10613020|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
3095593|NCT00318461|10613016|P5|Double-Blind, 6 Months|Lack of time|0
3095594|NCT00318461|10613017|P4|Double-Blind, 6 Months|Lack of time|0
3095595|NCT00318461|10613018|P3|Double-Blind, 6 Months|Lack of time|0
3095596|NCT00318461|10613019|P2|Double-Blind, 6 Months|Lack of time|0
3095597|NCT00318461|10613020|P1|Double-Blind, 6 Months|Lack of time|1
3095598|NCT00318461|10613016|P5|Double-Blind, 6 Months|Investigator decision|1
3095599|NCT00318461|10613017|P4|Double-Blind, 6 Months|Investigator decision|0
3095600|NCT00318461|10613018|P3|Double-Blind, 6 Months|Investigator decision|0
3095601|NCT00318461|10613019|P2|Double-Blind, 6 Months|Investigator decision|0
3095602|NCT00318461|10613020|P1|Double-Blind, 6 Months|Investigator decision|0
3095603|NCT00318461|10613016|P5|Double-Blind, 6 Months|Work commitment|1
3095604|NCT00318461|10613017|P4|Double-Blind, 6 Months|Work commitment|0
3095605|NCT00318461|10613018|P3|Double-Blind, 6 Months|Work commitment|0
3095606|NCT00318461|10613019|P2|Double-Blind, 6 Months|Work commitment|0
3095607|NCT00318461|10613020|P1|Double-Blind, 6 Months|Work commitment|0
3095608|NCT00318461|10613016|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
3095609|NCT00318461|10613017|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
3095610|NCT00318461|10613018|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
3095611|NCT00318461|10613019|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
3095612|NCT00318461|10613020|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
3095613|NCT00318461|10613016|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
3095614|NCT00318461|10613017|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
3095615|NCT00318461|10613018|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
3095616|NCT00318461|10613019|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
3095617|NCT00318461|10613020|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
3095618|NCT00318461|10613016|P5|Double-Blind, 6 Months|Move|0
3095619|NCT00318461|10613017|P4|Double-Blind, 6 Months|Move|0
3095620|NCT00318461|10613018|P3|Double-Blind, 6 Months|Move|0
3095621|NCT00318461|10613019|P2|Double-Blind, 6 Months|Move|1
3095622|NCT00318461|10613020|P1|Double-Blind, 6 Months|Move|0
3095623|NCT00318461|10613016|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
3095624|NCT00318461|10613017|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
3095625|NCT00318461|10613018|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
3095626|NCT00318461|10613019|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
3095627|NCT00318461|10613020|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
3095628|NCT00318461|10613016|P5|Double-Blind, 6 Months|Consent withdrawn|4
3095629|NCT00318461|10613017|P4|Double-Blind, 6 Months|Consent withdrawn|10
3095630|NCT00318461|10613018|P3|Double-Blind, 6 Months|Consent withdrawn|4
3095631|NCT00318461|10613019|P2|Double-Blind, 6 Months|Consent withdrawn|3
3095632|NCT00318461|10613020|P1|Double-Blind, 6 Months|Consent withdrawn|0
3095633|NCT00318461|10613016|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
3095634|NCT00318461|10613017|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
3095635|NCT00318461|10613018|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
3095636|NCT00318461|10613019|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
3095637|NCT00318461|10613020|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
3095638|NCT00318461|10613016|P5|Double-Blind, 6 Months|Lost to follow up|0
3095639|NCT00318461|10613017|P4|Double-Blind, 6 Months|Lost to follow up|0
3095640|NCT00318461|10613018|P3|Double-Blind, 6 Months|Lost to follow up|0
3095641|NCT00318461|10613019|P2|Double-Blind, 6 Months|Lost to follow up|1
3095642|NCT00318461|10613020|P1|Double-Blind, 6 Months|Lost to follow up|0
3095643|NCT00318461|10613016|P5|Double-Blind, 6 Months|Protocol Violation|5
3095644|NCT00318461|10613017|P4|Double-Blind, 6 Months|Protocol Violation|4
3095645|NCT00318461|10613018|P3|Double-Blind, 6 Months|Protocol Violation|4
3095646|NCT00318461|10613019|P2|Double-Blind, 6 Months|Protocol Violation|4
3095647|NCT00318461|10613020|P1|Double-Blind, 6 Months|Protocol Violation|2
3095648|NCT00318461|10613016|P5|Double-Blind, 6 Months|Lack of Efficacy|9
3095649|NCT00318461|10613017|P4|Double-Blind, 6 Months|Lack of Efficacy|29
3095650|NCT00318461|10613018|P3|Double-Blind, 6 Months|Lack of Efficacy|13
3095651|NCT00318461|10613019|P2|Double-Blind, 6 Months|Lack of Efficacy|8
3095652|NCT00318461|10613020|P1|Double-Blind, 6 Months|Lack of Efficacy|19
3095653|NCT00318461|10613016|P5|Double-Blind, 6 Months|Adverse Event|8
3095654|NCT00318461|10613017|P4|Double-Blind, 6 Months|Adverse Event|2
3095655|NCT00318461|10613018|P3|Double-Blind, 6 Months|Adverse Event|29
3095656|NCT00318461|10613019|P2|Double-Blind, 6 Months|Adverse Event|23
3095657|NCT00318461|10613020|P1|Double-Blind, 6 Months|Adverse Event|11
3095658|NCT00318370|10613119|P3|Period 3|Other|3
3095659|NCT00318370|10613120|P2|Period 3|Other|0
3095660|NCT00318370|10613121|P1|Period 3|Other|0
3095661|NCT00318370|10613119|P3|Period 3|Withdrawal by Subject|3
3095662|NCT00318370|10613120|P2|Period 3|Withdrawal by Subject|0
3095663|NCT00318370|10613121|P1|Period 3|Withdrawal by Subject|0
3095664|NCT00318370|10613119|P3|Period 3|Physician Decision|1
3095665|NCT00318370|10613120|P2|Period 3|Physician Decision|0
3095666|NCT00318370|10613121|P1|Period 3|Physician Decision|0
3095667|NCT00318370|10613119|P3|Period 3|Death|1
3095668|NCT00318370|10613120|P2|Period 3|Death|0
3095669|NCT00318370|10613121|P1|Period 3|Death|0
3095670|NCT00318370|10613119|P3|Period 3|Lack of Efficacy|24
3095671|NCT00318370|10613120|P2|Period 3|Lack of Efficacy|0
3095672|NCT00318370|10613121|P1|Period 3|Lack of Efficacy|0
3095673|NCT00318370|10613119|P3|Period 3|Adverse Event|1
3095674|NCT00318370|10613120|P2|Period 3|Adverse Event|0
3095675|NCT00318370|10613121|P1|Period 3|Adverse Event|0
3095676|NCT00318370|10613119|P3|Period 2|Other|0
3095677|NCT00318370|10613120|P2|Period 2|Other|1
3095678|NCT00318370|10613121|P1|Period 2|Other|0
3095679|NCT00318370|10613119|P3|Period 2|Withdrawal by Subject|0
3095680|NCT00318370|10613120|P2|Period 2|Withdrawal by Subject|1
3095681|NCT00318370|10613121|P1|Period 2|Withdrawal by Subject|0
3095682|NCT00318370|10613119|P3|Period 2|Physician Decision|0
3095683|NCT00318370|10613120|P2|Period 2|Physician Decision|1
3095684|NCT00318370|10613121|P1|Period 2|Physician Decision|0
3095685|NCT00318370|10613119|P3|Period 2|Lack of Efficacy|0
3095686|NCT00318370|10613120|P2|Period 2|Lack of Efficacy|5
3095687|NCT00318370|10613121|P1|Period 2|Lack of Efficacy|0
3095688|NCT00318370|10613119|P3|Period 2|Adverse Event|0
3095689|NCT00318370|10613120|P2|Period 2|Adverse Event|3
3095690|NCT00318370|10613121|P1|Period 2|Adverse Event|0
3095691|NCT00318370|10613119|P3|Period 1|Withdrawal by Subject|0
3095692|NCT00318370|10613120|P2|Period 1|Withdrawal by Subject|0
3095693|NCT00318370|10613121|P1|Period 1|Withdrawal by Subject|1
3095694|NCT00318370|10613119|P3|Period 1|Physician Decision|0
3095695|NCT00318370|10613120|P2|Period 1|Physician Decision|0
3095696|NCT00318370|10613121|P1|Period 1|Physician Decision|1
3095697|NCT00318370|10613119|P3|Period 1|Lack of Efficacy|0
3095698|NCT00318370|10613120|P2|Period 1|Lack of Efficacy|0
3095699|NCT00318370|10613121|P1|Period 1|Lack of Efficacy|5
3095700|NCT00318149|10613155|P6|Overall Study|Adverse Event|2
3095701|NCT00318149|10613156|P5|Overall Study|Adverse Event|0
3095702|NCT00318149|10613157|P4|Overall Study|Adverse Event|0
3095703|NCT00318149|10613158|P3|Overall Study|Adverse Event|0
3095704|NCT00318149|10613159|P2|Overall Study|Adverse Event|0
3095705|NCT00318149|10613160|P1|Overall Study|Adverse Event|0
3095706|NCT00317642|10613306|P2|Overall Study|AML Not Centrally Confirmed|5
3095707|NCT00317642|10613307|P1|Overall Study|AML Not Centrally Confirmed|1
3095708|NCT00317642|10613306|P2|Overall Study|Referred For Transplantation|0
3095709|NCT00317642|10613307|P1|Overall Study|Referred For Transplantation|1
3095710|NCT00317642|10613306|P2|Overall Study|Withdrawal by Subject|1
3095711|NCT00317642|10613307|P1|Overall Study|Withdrawal by Subject|0
3095712|NCT00317642|10613306|P2|Overall Study|Not Continue to Consolidation|0
3095713|NCT00317642|10613307|P1|Overall Study|Not Continue to Consolidation|2
3095714|NCT00317642|10613306|P2|Overall Study|Death|7
3095715|NCT00317642|10613307|P1|Overall Study|Death|14
3095716|NCT00317642|10613306|P2|Overall Study|Disease Recurrence|2
3095717|NCT00317642|10613307|P1|Overall Study|Disease Recurrence|1
3095718|NCT00317642|10613306|P2|Overall Study|Treatment Failure|102
3095719|NCT00317642|10613307|P1|Overall Study|Treatment Failure|56
3095720|NCT00317642|10613306|P2|Overall Study|Adverse Event|5
3095721|NCT00317642|10613307|P1|Overall Study|Adverse Event|17
3095722|NCT00317642|10613306|P2|Overall Study|Participant declined treatment|3
3095723|NCT00317642|10613307|P1|Overall Study|Participant declined treatment|14
3095724|NCT00317642|10613306|P2|Overall Study|Physician Decision|7
3095725|NCT00317642|10613307|P1|Overall Study|Physician Decision|15
3095726|NCT00317642|10613306|P2|Overall Study|Not Received Either Study Drug|3
3095727|NCT00317642|10613307|P1|Overall Study|Not Received Either Study Drug|1
3095728|NCT00317473|10613386|P6|Overall Study|Other|0
3095729|NCT00317473|10613387|P5|Overall Study|Other|0
3095730|NCT00317473|10613388|P4|Overall Study|Other|0
3095731|NCT00317473|10613389|P3|Overall Study|Other|0
3095732|NCT00317473|10613390|P2|Overall Study|Other|2
3095733|NCT00317473|10613391|P1|Overall Study|Other|0
3095734|NCT00317473|10613386|P6|Overall Study|Death|0
3095735|NCT00317473|10613387|P5|Overall Study|Death|0
3095736|NCT00317473|10613388|P4|Overall Study|Death|0
3095737|NCT00317473|10613389|P3|Overall Study|Death|0
3095738|NCT00317473|10613390|P2|Overall Study|Death|0
3095739|NCT00317473|10613391|P1|Overall Study|Death|1
3095740|NCT00317473|10613386|P6|Overall Study|Relocation|2
3095741|NCT00317473|10613387|P5|Overall Study|Relocation|5
3095742|NCT00317473|10613388|P4|Overall Study|Relocation|1
3095743|NCT00317473|10613389|P3|Overall Study|Relocation|1
3095744|NCT00317473|10613390|P2|Overall Study|Relocation|0
3095745|NCT00317473|10613391|P1|Overall Study|Relocation|1
3095746|NCT00317473|10613386|P6|Overall Study|Withdrawal by Subject|1
3095747|NCT00317473|10613387|P5|Overall Study|Withdrawal by Subject|3
3095748|NCT00317473|10613388|P4|Overall Study|Withdrawal by Subject|1
3095749|NCT00317473|10613389|P3|Overall Study|Withdrawal by Subject|2
3095750|NCT00317473|10613390|P2|Overall Study|Withdrawal by Subject|1
3095751|NCT00317473|10613391|P1|Overall Study|Withdrawal by Subject|2
3095752|NCT00317109|10613430|P2|Overall Study|Migated/moved from study area|0
3095753|NCT00317109|10613431|P1|Overall Study|Migated/moved from study area|1
3095754|NCT00317109|10613430|P2|Overall Study|Withdrawal by Subject|0
3095755|NCT00317109|10613431|P1|Overall Study|Withdrawal by Subject|2
3095756|NCT00317044|10613468|P3|Overall Study|Multiple Reasons|6
3095757|NCT00317044|10613469|P2|Overall Study|Multiple Reasons|2
3095758|NCT00317044|10613470|P1|Overall Study|Multiple Reasons|6
3095759|NCT00317044|10613468|P3|Overall Study|Lost to Follow-up|3
3095760|NCT00317044|10613469|P2|Overall Study|Lost to Follow-up|2
3095761|NCT00317044|10613470|P1|Overall Study|Lost to Follow-up|0
3095762|NCT00317044|10613468|P3|Overall Study|Withdrawal by Subject|12
3095763|NCT00317044|10613469|P2|Overall Study|Withdrawal by Subject|7
3095764|NCT00317044|10613470|P1|Overall Study|Withdrawal by Subject|10
3095765|NCT00317044|10613468|P3|Overall Study|Adverse Event|4
3095766|NCT00317044|10613469|P2|Overall Study|Adverse Event|7
3095767|NCT00317044|10613470|P1|Overall Study|Adverse Event|4
3095768|NCT00317044|10613468|P3|Overall Study|Protocol Violation|20
3095769|NCT00317044|10613469|P2|Overall Study|Protocol Violation|22
3095770|NCT00317044|10613470|P1|Overall Study|Protocol Violation|28
3095771|NCT00316914|10613516|P2|Overall Study|Missing end of treatment documentation|15
3095772|NCT00316914|10613517|P1|Overall Study|Missing end of treatment documentation|14
3095773|NCT00316914|10613516|P2|Overall Study|Other Problems|11
3095774|NCT00316914|10613517|P1|Overall Study|Other Problems|6
3095775|NCT00316914|10613516|P2|Overall Study|Adverse Event|7
3095776|NCT00316914|10613517|P1|Overall Study|Adverse Event|8
3095777|NCT00316914|10613516|P2|Overall Study|Withdrawal by Subject|3
3095778|NCT00316914|10613517|P1|Overall Study|Withdrawal by Subject|5
3095779|NCT00316888|10613547|P2|Overall Study|Not start protocol therapy|1
3095780|NCT00316888|10613548|P1|Overall Study|Not start protocol therapy|0
3095781|NCT00316888|10613547|P2|Overall Study|Withdrawal by Subject|2
3095782|NCT00316888|10613548|P1|Overall Study|Withdrawal by Subject|2
3095783|NCT00316888|10613547|P2|Overall Study|Adverse Event|5
3095784|NCT00316888|10613548|P1|Overall Study|Adverse Event|4
3095785|NCT00316719|10613570|P2|Overall Study|Consent withdrawn|0
3095786|NCT00316719|10613571|P1|Overall Study|Consent withdrawn|2
3095787|NCT00316719|10613570|P2|Overall Study|Adverse Event|6
3095788|NCT00316719|10613571|P1|Overall Study|Adverse Event|0
3095789|NCT00316706|10613597|P2|Overall Study|Lost to Follow-up|48
3095790|NCT00316706|10613598|P1|Overall Study|Lost to Follow-up|38
3095791|NCT00316693|10613614|P2|Overall Study|Other|44
3095792|NCT00316693|10613615|P1|Overall Study|Other|38
3095793|NCT00316693|10613614|P2|Overall Study|Lost to Follow-up|34
3095794|NCT00316693|10613615|P1|Overall Study|Lost to Follow-up|26
3095795|NCT00316693|10613614|P2|Overall Study|Withdrawal by Subject|6
3095796|NCT00316693|10613615|P1|Overall Study|Withdrawal by Subject|6
3095797|NCT00316693|10613614|P2|Overall Study|Protocol Violation|0
3095798|NCT00316693|10613615|P1|Overall Study|Protocol Violation|1
3095799|NCT00316693|10613614|P2|Overall Study|Adverse Event|1
3095800|NCT00316693|10613615|P1|Overall Study|Adverse Event|6
3095801|NCT00316602|10613657|P2|Overall Study|Other|6
3095802|NCT00316602|10613658|P1|Overall Study|Other|3
3095803|NCT00316602|10613657|P2|Overall Study|Adverse Event|0
3095804|NCT00316602|10613658|P1|Overall Study|Adverse Event|1
3095805|NCT00316602|10613657|P2|Overall Study|Subject unwilling/unable to comply with|17
3095806|NCT00316602|10613658|P1|Overall Study|Subject unwilling/unable to comply with|3
3095807|NCT00316602|10613657|P2|Overall Study|Withdrawal by Subject|2
3095808|NCT00316602|10613658|P1|Overall Study|Withdrawal by Subject|3
3095809|NCT00316589|10613690|P4|Overall Study|Other reason|1
3095810|NCT00316589|10613691|P3|Overall Study|Other reason|1
3095811|NCT00316589|10613692|P2|Overall Study|Other reason|12
3095812|NCT00316589|10613693|P1|Overall Study|Other reason|0
3095813|NCT00316589|10613690|P4|Overall Study|Physician Decision|0
3095814|NCT00316589|10613691|P3|Overall Study|Physician Decision|0
3095815|NCT00316589|10613692|P2|Overall Study|Physician Decision|1
3095816|NCT00316589|10613693|P1|Overall Study|Physician Decision|0
3095817|NCT00316589|10613690|P4|Overall Study|Adverse Event|1
3095818|NCT00316589|10613691|P3|Overall Study|Adverse Event|0
3095819|NCT00316589|10613692|P2|Overall Study|Adverse Event|0
3095820|NCT00316589|10613693|P1|Overall Study|Adverse Event|1
3095821|NCT00316589|10613690|P4|Overall Study|Subject unwilling/unable to comply|2
3095822|NCT00316589|10613691|P3|Overall Study|Subject unwilling/unable to comply|0
3095823|NCT00316589|10613692|P2|Overall Study|Subject unwilling/unable to comply|6
3095824|NCT00316589|10613693|P1|Overall Study|Subject unwilling/unable to comply|0
3095825|NCT00316589|10613690|P4|Overall Study|Withdrawal by Subject|1
3095826|NCT00316589|10613691|P3|Overall Study|Withdrawal by Subject|0
3095827|NCT00316589|10613692|P2|Overall Study|Withdrawal by Subject|5
3095828|NCT00316589|10613693|P1|Overall Study|Withdrawal by Subject|0
3095829|NCT00316303|10613827|P2|Overall Study|Lost to Follow-up|16
3095830|NCT00316303|10613828|P1|Overall Study|Lost to Follow-up|11
3095831|NCT00316277|10613844|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
3095832|NCT00316277|10613845|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
3095833|NCT00316277|10613844|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
3095834|NCT00316277|10613845|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
3095835|NCT00316277|10613844|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
3095836|NCT00316277|10613845|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
3095837|NCT00316277|10613844|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
3095838|NCT00316277|10613845|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
3095839|NCT00316277|10613844|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
3095840|NCT00316277|10613845|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
3095841|NCT00316264|10613866|P3|Overall Study|Other|0
3095842|NCT00316264|10613867|P2|Overall Study|Other|1
3095843|NCT00316264|10613868|P1|Overall Study|Other|1
3095844|NCT00316264|10613866|P3|Overall Study|Death|0
3095845|NCT00316264|10613867|P2|Overall Study|Death|0
3095846|NCT00316264|10613868|P1|Overall Study|Death|2
3095847|NCT00316264|10613866|P3|Overall Study|Withdrawal of Consent|6
3095848|NCT00316264|10613867|P2|Overall Study|Withdrawal of Consent|5
3095849|NCT00316264|10613868|P1|Overall Study|Withdrawal of Consent|3
3095850|NCT00316264|10613866|P3|Overall Study|Lost to Follow-up|0
3095851|NCT00316264|10613867|P2|Overall Study|Lost to Follow-up|1
3095852|NCT00316264|10613868|P1|Overall Study|Lost to Follow-up|0
3095853|NCT00316225|10613936|P1|Overall Study|Death|2
3095854|NCT00316225|10613936|P1|Overall Study|Withdrawal by Subject|3
3095855|NCT00316225|10613936|P1|Overall Study|Progressive Disease|15
3095856|NCT00316225|10613936|P1|Overall Study|Physician Decision|3
3095857|NCT00316225|10613936|P1|Overall Study|Adverse Event|2
3095858|NCT00316199|10613945|P1|Overall Study|Lost to Follow-up|2
3095859|NCT00316199|10613945|P1|Overall Study|Death|8
3095860|NCT00316199|10613945|P1|Overall Study|Adverse Event|2
3095861|NCT00316186|10613953|P1|Overall Study|Other|1
3095862|NCT00316186|10613953|P1|Overall Study|Lost to Follow-up|1
3095863|NCT00316186|10613953|P1|Overall Study|Disease Progression|4
3095864|NCT00316186|10613953|P1|Overall Study|Adverse Event|6
3095865|NCT00316173|10613967|P2|Treatment Phase|Study Follow-up Stopped|34
3095866|NCT00316173|10613968|P1|Treatment Phase|Study Follow-up Stopped|0
3095867|NCT00316173|10613967|P2|Treatment Phase|Withdrawal by Subject|1
3095868|NCT00316173|10613968|P1|Treatment Phase|Withdrawal by Subject|0
3095869|NCT00316173|10613967|P2|Treatment Phase|Lost to Follow-up|3
3095870|NCT00316173|10613968|P1|Treatment Phase|Lost to Follow-up|0
3095871|NCT00316173|10613967|P2|Treatment Phase|Lack of Efficacy|3
3095872|NCT00316173|10613968|P1|Treatment Phase|Lack of Efficacy|0
3095873|NCT00316173|10613967|P2|Treatment Phase|Adverse Event|1
3095874|NCT00316173|10613968|P1|Treatment Phase|Adverse Event|0
3095875|NCT00316173|10613967|P2|Run-in Phase|Study Follow-up Stopped|0
3095876|NCT00316173|10613968|P1|Run-in Phase|Study Follow-up Stopped|5
3095877|NCT00316173|10613967|P2|Run-in Phase|Protocol Violation|0
3095878|NCT00316173|10613968|P1|Run-in Phase|Protocol Violation|1
3095879|NCT00316173|10613967|P2|Run-in Phase|Adverse Event|0
3095880|NCT00316173|10613968|P1|Run-in Phase|Adverse Event|1
3095881|NCT00316121|10613981|P2|Overall Study|Subject did not have 24 month visit|0
3095882|NCT00316121|10613982|P1|Overall Study|Subject did not have 24 month visit|1
3095883|NCT00316121|10613981|P2|Overall Study|Subject no show for visit x 3|0
3095884|NCT00316121|10613982|P1|Overall Study|Subject no show for visit x 3|1
3095885|NCT00316121|10613981|P2|Overall Study|Subject refused to return|0
3095886|NCT00316121|10613982|P1|Overall Study|Subject refused to return|1
3095887|NCT00316121|10613981|P2|Overall Study|Subject relocated|1
3095888|NCT00316121|10613982|P1|Overall Study|Subject relocated|1
3095889|NCT00316121|10613981|P2|Overall Study|Reason is missing|0
3095890|NCT00316121|10613982|P1|Overall Study|Reason is missing|1
3095891|NCT00316121|10613981|P2|Overall Study|Withdrawal by Subject|0
3095892|NCT00316121|10613982|P1|Overall Study|Withdrawal by Subject|2
3095893|NCT00316121|10613981|P2|Overall Study|Lost to Follow-up|8
3095894|NCT00316121|10613982|P1|Overall Study|Lost to Follow-up|14
3095895|NCT00316121|10613981|P2|Overall Study|Death|0
3095896|NCT00316121|10613982|P1|Overall Study|Death|1
3095897|NCT00316082|10613993|P5|Overall Study|Administrative reason by sponsor|0
3095898|NCT00316082|10613994|P4|Overall Study|Administrative reason by sponsor|0
3095899|NCT00316082|10613995|P3|Overall Study|Administrative reason by sponsor|1
3095900|NCT00316082|10613996|P2|Overall Study|Administrative reason by sponsor|0
3095901|NCT00316082|10613997|P1|Overall Study|Administrative reason by sponsor|0
3095902|NCT00316082|10613993|P5|Overall Study|Death|0
3095903|NCT00316082|10613994|P4|Overall Study|Death|0
3095904|NCT00316082|10613995|P3|Overall Study|Death|1
3095905|NCT00316082|10613996|P2|Overall Study|Death|0
3095906|NCT00316082|10613997|P1|Overall Study|Death|0
3095907|NCT00316082|10613993|P5|Overall Study|Physician Decision|1
3095908|NCT00316082|10613994|P4|Overall Study|Physician Decision|1
3095909|NCT00316082|10613995|P3|Overall Study|Physician Decision|2
3095910|NCT00316082|10613996|P2|Overall Study|Physician Decision|1
3095911|NCT00316082|10613997|P1|Overall Study|Physician Decision|1
3095912|NCT00316082|10613993|P5|Overall Study|Subject no longer meets study criteria|1
3095913|NCT00316082|10613994|P4|Overall Study|Subject no longer meets study criteria|2
3095914|NCT00316082|10613995|P3|Overall Study|Subject no longer meets study criteria|2
3095915|NCT00316082|10613996|P2|Overall Study|Subject no longer meets study criteria|1
3095916|NCT00316082|10613997|P1|Overall Study|Subject no longer meets study criteria|3
3095917|NCT00316082|10613993|P5|Overall Study|Adverse Event|3
3095918|NCT00316082|10613994|P4|Overall Study|Adverse Event|1
3095919|NCT00316082|10613995|P3|Overall Study|Adverse Event|5
3095920|NCT00316082|10613996|P2|Overall Study|Adverse Event|2
3095921|NCT00316082|10613997|P1|Overall Study|Adverse Event|4
3095922|NCT00316082|10613993|P5|Overall Study|Poor/noncompliance|4
3095923|NCT00316082|10613994|P4|Overall Study|Poor/noncompliance|1
3095924|NCT00316082|10613995|P3|Overall Study|Poor/noncompliance|4
3095925|NCT00316082|10613996|P2|Overall Study|Poor/noncompliance|1
3095926|NCT00316082|10613997|P1|Overall Study|Poor/noncompliance|6
3095927|NCT00316082|10613993|P5|Overall Study|Lost to Follow-up|6
3095928|NCT00316082|10613994|P4|Overall Study|Lost to Follow-up|8
3095929|NCT00316082|10613995|P3|Overall Study|Lost to Follow-up|7
3095930|NCT00316082|10613996|P2|Overall Study|Lost to Follow-up|6
3095931|NCT00316082|10613997|P1|Overall Study|Lost to Follow-up|7
3095932|NCT00316082|10613993|P5|Overall Study|Withdrawal of Consent by Subject|5
3095933|NCT00316082|10613994|P4|Overall Study|Withdrawal of Consent by Subject|9
3095934|NCT00316082|10613995|P3|Overall Study|Withdrawal of Consent by Subject|2
3096025|NCT00314574|10614623|P1|Overall Study|Lost to Follow-up|19
3095935|NCT00316082|10613996|P2|Overall Study|Withdrawal of Consent by Subject|8
3095936|NCT00316082|10613997|P1|Overall Study|Withdrawal of Consent by Subject|10
3095937|NCT00316082|10613993|P5|Overall Study|Lack of Efficacy|6
3095938|NCT00316082|10613994|P4|Overall Study|Lack of Efficacy|4
3095939|NCT00316082|10613995|P3|Overall Study|Lack of Efficacy|3
3095940|NCT00316082|10613996|P2|Overall Study|Lack of Efficacy|3
3095941|NCT00316082|10613997|P1|Overall Study|Lack of Efficacy|2
3095942|NCT00316017|10614028|P3|Overall Study|Protocol Violation|19
3095943|NCT00316017|10614029|P2|Overall Study|Protocol Violation|13
3095944|NCT00316017|10614030|P1|Overall Study|Protocol Violation|11
3095945|NCT00316004|10614104|P3|Overall Study|Subject was not given study fluid.|21
3095946|NCT00316004|10614105|P2|Overall Study|Subject was not given study fluid.|14
3095947|NCT00316004|10614106|P1|Overall Study|Subject was not given study fluid.|14
3095948|NCT00315731|10614177|P1|Overall Study|Death|5
3095949|NCT00315731|10614177|P1|Overall Study|Lost to Follow-up|1
3095950|NCT00315705|10614205|P1|Phase 2|Death|7
3095951|NCT00315705|10614205|P1|Phase 2|Other|1
3095952|NCT00315705|10614205|P1|Phase 2|Scheduled for transplant|8
3095953|NCT00315705|10614205|P1|Phase 2|Disease relapse|1
3095954|NCT00315705|10614205|P1|Phase 2|Failure to achieve response|3
3095955|NCT00315705|10614205|P1|Phase 2|Adverse Event|1
3095956|NCT00315705|10614205|P1|Phase 2|Physician Decision|4
3095957|NCT00315705|10614205|P1|Phase 1|Death|3
3095958|NCT00315705|10614205|P1|Phase 1|Scheduled for transplant|9
3095959|NCT00315705|10614205|P1|Phase 1|Disease relapse|4
3095960|NCT00315705|10614205|P1|Phase 1|Failure to achieve response|8
3095961|NCT00315705|10614205|P1|Phase 1|Refused further treatment|1
3095962|NCT00315458|10614266|P4|Overall Study|Did not qualify|0
3095963|NCT00315458|10614267|P3|Overall Study|Did not qualify|1
3095964|NCT00315458|10614268|P2|Overall Study|Did not qualify|0
3095965|NCT00315458|10614269|P1|Overall Study|Did not qualify|0
3095966|NCT00315458|10614266|P4|Overall Study|Lack of Efficacy|1
3095967|NCT00315458|10614267|P3|Overall Study|Lack of Efficacy|20
3095968|NCT00315458|10614268|P2|Overall Study|Lack of Efficacy|0
3095969|NCT00315458|10614269|P1|Overall Study|Lack of Efficacy|0
3095970|NCT00315458|10614266|P4|Overall Study|Withdrawal by Subject|2
3095971|NCT00315458|10614267|P3|Overall Study|Withdrawal by Subject|0
3095972|NCT00315458|10614268|P2|Overall Study|Withdrawal by Subject|3
3095973|NCT00315458|10614269|P1|Overall Study|Withdrawal by Subject|0
3095974|NCT00315458|10614266|P4|Overall Study|Lost to Follow-up|2
3095975|NCT00315458|10614267|P3|Overall Study|Lost to Follow-up|0
3095976|NCT00315458|10614268|P2|Overall Study|Lost to Follow-up|2
3095977|NCT00315458|10614269|P1|Overall Study|Lost to Follow-up|1
3095978|NCT00315458|10614266|P4|Overall Study|Adverse Event|3
3095979|NCT00315458|10614267|P3|Overall Study|Adverse Event|23
3095980|NCT00315458|10614268|P2|Overall Study|Adverse Event|4
3095981|NCT00315458|10614269|P1|Overall Study|Adverse Event|2
3095982|NCT00315458|10614266|P4|Overall Study|Administrative|21
3095983|NCT00315458|10614267|P3|Overall Study|Administrative|8
3095984|NCT00315458|10614268|P2|Overall Study|Administrative|3
3095985|NCT00315458|10614269|P1|Overall Study|Administrative|0
3095986|NCT00315445|10614282|P3|Overall Study|Other|0
3095987|NCT00315445|10614283|P2|Overall Study|Other|3
3095988|NCT00315445|10614284|P1|Overall Study|Other|1
3095989|NCT00315445|10614282|P3|Overall Study|Protocol Violation|1
3095990|NCT00315445|10614283|P2|Overall Study|Protocol Violation|0
3095991|NCT00315445|10614284|P1|Overall Study|Protocol Violation|2
3095992|NCT00315445|10614282|P3|Overall Study|Lost to Follow-up|1
3095993|NCT00315445|10614283|P2|Overall Study|Lost to Follow-up|0
3095994|NCT00315445|10614284|P1|Overall Study|Lost to Follow-up|1
3095995|NCT00315445|10614282|P3|Overall Study|Lack of Efficacy|7
3095996|NCT00315445|10614283|P2|Overall Study|Lack of Efficacy|1
3095997|NCT00315445|10614284|P1|Overall Study|Lack of Efficacy|16
3095998|NCT00315445|10614282|P3|Overall Study|Adverse Event|15
3095999|NCT00315445|10614283|P2|Overall Study|Adverse Event|12
3096000|NCT00315445|10614284|P1|Overall Study|Adverse Event|7
3096001|NCT00315055|10614574|P2|Overall Study|Lost to Follow-up|1
3096002|NCT00315055|10614575|P1|Overall Study|Lost to Follow-up|1
3096003|NCT00315055|10614574|P2|Overall Study|Protocol Violation|4
3096004|NCT00315055|10614575|P1|Overall Study|Protocol Violation|2
3096005|NCT00314951|10614593|P2|Follow-up|mITT failure|34
3096006|NCT00314951|10614594|P1|Follow-up|mITT failure|44
3096007|NCT00314951|10614593|P2|Treatment|Didn't meet criteria for mITT population|11
3096008|NCT00314951|10614594|P1|Treatment|Didn't meet criteria for mITT population|16
3096009|NCT00314808|10614604|P1|Overall Study|Withdrawal by Subject/PI without AE|4
3096010|NCT00314808|10614604|P1|Overall Study|Disease Progression without AE|4
3096011|NCT00314795|10614612|P1|Overall Study|Participants Withdrew Consent|2
3096012|NCT00314795|10614612|P1|Overall Study|Renal Transplant|3
3096013|NCT00314795|10614612|P1|Overall Study|Reason not Specified|3
3096014|NCT00314795|10614612|P1|Overall Study|Death|4
3096015|NCT00314795|10614612|P1|Overall Study|Adverse Event|8
3096016|NCT00314574|10614622|P2|Overall Study|Data unknown at database lock|1
3096017|NCT00314574|10614623|P1|Overall Study|Data unknown at database lock|0
3096018|NCT00314574|10614622|P2|Overall Study|Pregnancy|4
3096019|NCT00314574|10614623|P1|Overall Study|Pregnancy|6
3096020|NCT00314574|10614622|P2|Overall Study|Physician Decision|15
3096021|NCT00314574|10614623|P1|Overall Study|Physician Decision|22
3096022|NCT00314574|10614622|P2|Overall Study|Withdrawal by Subject|22
3096023|NCT00314574|10614623|P1|Overall Study|Withdrawal by Subject|33
3096024|NCT00314574|10614622|P2|Overall Study|Lost to Follow-up|25
3096026|NCT00314574|10614622|P2|Overall Study|Adverse Event|16
3096027|NCT00314574|10614623|P1|Overall Study|Adverse Event|11
3096028|NCT00314574|10614622|P2|Overall Study|Death|0
3096029|NCT00314574|10614623|P1|Overall Study|Death|3
3096030|NCT00314366|10614639|P2|Overall Study|not treated due to patient medical condi|0
3096031|NCT00314366|10614640|P1|Overall Study|not treated due to patient medical condi|1
3096032|NCT00314340|10614685|P1|Overall Study|lost interest|1
3096033|NCT00314327|10614691|P1|Overall Study|Withdrawal by Subject|1
3096034|NCT00314262|10614696|P1|Overall Study|Physician Decision|1
3096035|NCT00314262|10614696|P1|Overall Study|Withdrawal by Subject|2
3096036|NCT00314262|10614696|P1|Overall Study|Adverse Event|2
3096037|NCT00314249|10614704|P2|Overall Study|Non-Compliant|6
3096038|NCT00314249|10614705|P1|Overall Study|Non-Compliant|5
3096039|NCT00314249|10614704|P2|Overall Study|Withdrawn for other reasons|1
3096040|NCT00314249|10614705|P1|Overall Study|Withdrawn for other reasons|4
3096041|NCT00314249|10614704|P2|Overall Study|Physician Decision|1
3096042|NCT00314249|10614705|P1|Overall Study|Physician Decision|1
3096043|NCT00314249|10614704|P2|Overall Study|Lost to Follow-up|9
3096044|NCT00314249|10614705|P1|Overall Study|Lost to Follow-up|15
3096045|NCT00314249|10614704|P2|Overall Study|Withdrawal by Subject|28
3096046|NCT00314249|10614705|P1|Overall Study|Withdrawal by Subject|21
3096047|NCT00314249|10614704|P2|Overall Study|Lack of Efficacy|24
3096048|NCT00314249|10614705|P1|Overall Study|Lack of Efficacy|33
3096049|NCT00314249|10614704|P2|Overall Study|Adverse Event|94
3096050|NCT00314249|10614705|P1|Overall Study|Adverse Event|73
3096051|NCT00314145|10614738|P2|Overall Study|Sponsor Decision|0
3096052|NCT00314145|10614739|P1|Overall Study|Sponsor Decision|2
3096053|NCT00314145|10614738|P2|Overall Study|Protocol Violation|0
3096054|NCT00314145|10614739|P1|Overall Study|Protocol Violation|3
3096055|NCT00314145|10614738|P2|Overall Study|Adverse Event|3
3096056|NCT00314145|10614739|P1|Overall Study|Adverse Event|0
3096057|NCT00314145|10614738|P2|Overall Study|Physician Decision|4
3096058|NCT00314145|10614739|P1|Overall Study|Physician Decision|3
3096059|NCT00314145|10614738|P2|Overall Study|Lost to Follow-up|12
3096060|NCT00314145|10614739|P1|Overall Study|Lost to Follow-up|5
3096061|NCT00314145|10614738|P2|Overall Study|Withdrawal by Subject|10
3096062|NCT00314145|10614739|P1|Overall Study|Withdrawal by Subject|8
3096063|NCT00314132|10614753|P2|Overall Study|Physician Decision|0
3096064|NCT00314132|10614754|P1|Overall Study|Physician Decision|1
3096065|NCT00314132|10614753|P2|Overall Study|Adverse Event|0
3096066|NCT00314132|10614754|P1|Overall Study|Adverse Event|1
3096067|NCT00314132|10614753|P2|Overall Study|Withdrawal by Subject|5
3096068|NCT00314132|10614754|P1|Overall Study|Withdrawal by Subject|3
3096069|NCT00314132|10614753|P2|Overall Study|Lost to Follow-up|13
3096070|NCT00314132|10614754|P1|Overall Study|Lost to Follow-up|3
3096071|NCT00313911|10614781|P2|Overall Study|Did not meet age criteria|1
3096072|NCT00313911|10614782|P1|Overall Study|Did not meet age criteria|1
3096073|NCT00313911|10614781|P2|Overall Study|Withdrawal by Subject|12
3096074|NCT00313911|10614782|P1|Overall Study|Withdrawal by Subject|39
3096075|NCT00313911|10614781|P2|Overall Study|Lost to Follow-up|14
3096076|NCT00313911|10614782|P1|Overall Study|Lost to Follow-up|27
3096077|NCT00313911|10614781|P2|Overall Study|Protocol Violation|10
3096078|NCT00313911|10614782|P1|Overall Study|Protocol Violation|19
3096079|NCT00313911|10614781|P2|Overall Study|Adverse Event|3
3096080|NCT00313911|10614782|P1|Overall Study|Adverse Event|2
3096081|NCT00313911|10614781|P2|Overall Study|Serious adverse event|1
3096082|NCT00313911|10614782|P1|Overall Study|Serious adverse event|6
3096083|NCT00313846|10614796|P2|Overall Study|Administrative|3
3096084|NCT00313846|10614797|P1|Overall Study|Administrative|2
3096085|NCT00313846|10614796|P2|Overall Study|Adverse Event|8
3096086|NCT00313846|10614797|P1|Overall Study|Adverse Event|1
3096087|NCT00313846|10614796|P2|Overall Study|Withdrawal by Subject|0
3096088|NCT00313846|10614797|P1|Overall Study|Withdrawal by Subject|2
3096089|NCT00313820|10614808|P2|Pregabalin or Placebo Treatment Period|Other|3
3096090|NCT00313820|10614809|P1|Pregabalin or Placebo Treatment Period|Other|2
3096091|NCT00313820|10614808|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
3096092|NCT00313820|10614809|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
3096093|NCT00313820|10614808|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
3096094|NCT00313820|10614809|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
3096095|NCT00313820|10614808|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
3096096|NCT00313820|10614809|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
3096097|NCT00313820|10614808|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
3096098|NCT00313820|10614809|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
3096099|NCT00313820|10614808|P2|Assigned to Treatment|Other|0
3096100|NCT00313820|10614809|P1|Assigned to Treatment|Other|1
3096101|NCT00313781|10614847|P3|After Crossover|Other|18
3096102|NCT00313781|10614848|P2|After Crossover|Other|0
3096103|NCT00313781|10614849|P1|After Crossover|Other|0
3096104|NCT00313781|10614847|P3|After Crossover|Withdrawal by Subject|3
3096105|NCT00313781|10614848|P2|After Crossover|Withdrawal by Subject|0
3096106|NCT00313781|10614849|P1|After Crossover|Withdrawal by Subject|0
3096107|NCT00313781|10614847|P3|After Crossover|Death|6
3096108|NCT00313781|10614848|P2|After Crossover|Death|0
3096109|NCT00313781|10614849|P1|After Crossover|Death|0
3096110|NCT00313781|10614847|P3|Before Crossover|Randomized, not treated|0
3096111|NCT00313781|10614848|P2|Before Crossover|Randomized, not treated|0
3096112|NCT00313781|10614849|P1|Before Crossover|Randomized, not treated|5
3096113|NCT00313781|10614847|P3|Before Crossover|Crossover|0
3096114|NCT00313781|10614848|P2|Before Crossover|Crossover|37
3096115|NCT00313781|10614849|P1|Before Crossover|Crossover|0
3096116|NCT00313781|10614847|P3|Before Crossover|Other|0
3096117|NCT00313781|10614848|P2|Before Crossover|Other|30
3096118|NCT00313781|10614849|P1|Before Crossover|Other|45
3096119|NCT00313781|10614847|P3|Before Crossover|Withdrawal by Subject|0
3096120|NCT00313781|10614848|P2|Before Crossover|Withdrawal by Subject|1
3096121|NCT00313781|10614849|P1|Before Crossover|Withdrawal by Subject|3
3096122|NCT00313781|10614847|P3|Before Crossover|Lost to Follow-up|0
3096123|NCT00313781|10614848|P2|Before Crossover|Lost to Follow-up|3
3096124|NCT00313781|10614849|P1|Before Crossover|Lost to Follow-up|0
3096125|NCT00313781|10614847|P3|Before Crossover|Death|0
3096126|NCT00313781|10614848|P2|Before Crossover|Death|8
3096127|NCT00313781|10614849|P1|Before Crossover|Death|22
3096128|NCT00313716|10614895|P6|Overall Study|Withdrawal by Subject|0
3096129|NCT00313716|10614896|P5|Overall Study|Withdrawal by Subject|1
3096130|NCT00313716|10614897|P4|Overall Study|Withdrawal by Subject|0
3096131|NCT00313716|10614898|P3|Overall Study|Withdrawal by Subject|1
3096132|NCT00313716|10614899|P2|Overall Study|Withdrawal by Subject|1
3096133|NCT00313716|10614900|P1|Overall Study|Withdrawal by Subject|0
3096134|NCT00313716|10614895|P6|Overall Study|Lost to Follow-up|4
3096135|NCT00313716|10614896|P5|Overall Study|Lost to Follow-up|0
3096136|NCT00313716|10614897|P4|Overall Study|Lost to Follow-up|1
3096137|NCT00313716|10614898|P3|Overall Study|Lost to Follow-up|2
3096138|NCT00313716|10614899|P2|Overall Study|Lost to Follow-up|5
3096139|NCT00313716|10614900|P1|Overall Study|Lost to Follow-up|2
3096140|NCT00313716|10614895|P6|Overall Study|Death|9
3096141|NCT00313716|10614896|P5|Overall Study|Death|5
3096142|NCT00313716|10614897|P4|Overall Study|Death|3
3096143|NCT00313716|10614898|P3|Overall Study|Death|9
3096144|NCT00313716|10614899|P2|Overall Study|Death|2
3096145|NCT00313716|10614900|P1|Overall Study|Death|3
3096146|NCT00313703|10614927|P4|Overall Study|Lost to Follow-up|12
3096147|NCT00313703|10614928|P3|Overall Study|Lost to Follow-up|5
3096148|NCT00313703|10614929|P2|Overall Study|Lost to Follow-up|2
3096149|NCT00313703|10614930|P1|Overall Study|Lost to Follow-up|11
3096150|NCT00313612|10614946|P2|Overall Study|Patient never received treatment|1
3096151|NCT00313612|10614947|P1|Overall Study|Patient never received treatment|0
3096152|NCT00313586|10614959|P4|Overall Study|Death before starting treatment|0
3096153|NCT00313586|10614960|P3|Overall Study|Death before starting treatment|0
3096154|NCT00313586|10614961|P2|Overall Study|Death before starting treatment|0
3096155|NCT00313586|10614962|P1|Overall Study|Death before starting treatment|1
3096156|NCT00313586|10614959|P4|Overall Study|Moved|0
3096157|NCT00313586|10614960|P3|Overall Study|Moved|0
3096158|NCT00313586|10614961|P2|Overall Study|Moved|1
3096159|NCT00313586|10614962|P1|Overall Study|Moved|0
3096160|NCT00313586|10614959|P4|Overall Study|Lost insurance|0
3096161|NCT00313586|10614960|P3|Overall Study|Lost insurance|0
3096162|NCT00313586|10614961|P2|Overall Study|Lost insurance|1
3096163|NCT00313586|10614962|P1|Overall Study|Lost insurance|0
3096164|NCT00313586|10614959|P4|Overall Study|Absolute neutrophil count not recovered|0
3096165|NCT00313586|10614960|P3|Overall Study|Absolute neutrophil count not recovered|0
3096166|NCT00313586|10614961|P2|Overall Study|Absolute neutrophil count not recovered|1
3096167|NCT00313586|10614962|P1|Overall Study|Absolute neutrophil count not recovered|2
3096168|NCT00313586|10614959|P4|Overall Study|Physician Decision|0
3096169|NCT00313586|10614960|P3|Overall Study|Physician Decision|0
3096170|NCT00313586|10614961|P2|Overall Study|Physician Decision|1
3096171|NCT00313586|10614962|P1|Overall Study|Physician Decision|2
3096172|NCT00313586|10614959|P4|Overall Study|Did not achieve HI-major/better response|1
3096173|NCT00313586|10614960|P3|Overall Study|Did not achieve HI-major/better response|2
3096174|NCT00313586|10614961|P2|Overall Study|Did not achieve HI-major/better response|7
3096175|NCT00313586|10614962|P1|Overall Study|Did not achieve HI-major/better response|10
3096176|NCT00313586|10614959|P4|Overall Study|Other complicating disease|0
3096177|NCT00313586|10614960|P3|Overall Study|Other complicating disease|0
3096178|NCT00313586|10614961|P2|Overall Study|Other complicating disease|2
3096179|NCT00313586|10614962|P1|Overall Study|Other complicating disease|2
3096180|NCT00313586|10614959|P4|Overall Study|Alternative therapy|0
3096181|NCT00313586|10614960|P3|Overall Study|Alternative therapy|2
3096182|NCT00313586|10614961|P2|Overall Study|Alternative therapy|6
3096183|NCT00313586|10614962|P1|Overall Study|Alternative therapy|3
3096184|NCT00313586|10614959|P4|Overall Study|Withdrawal by Subject|2
3096185|NCT00313586|10614960|P3|Overall Study|Withdrawal by Subject|6
3096186|NCT00313586|10614961|P2|Overall Study|Withdrawal by Subject|6
3096187|NCT00313586|10614962|P1|Overall Study|Withdrawal by Subject|13
3096188|NCT00313586|10614959|P4|Overall Study|Death|7
3096189|NCT00313586|10614960|P3|Overall Study|Death|1
3096190|NCT00313586|10614961|P2|Overall Study|Death|8
3096191|NCT00313586|10614962|P1|Overall Study|Death|11
3096192|NCT00313586|10614959|P4|Overall Study|Adverse Event|10
3096193|NCT00313586|10614960|P3|Overall Study|Adverse Event|3
3096194|NCT00313586|10614961|P2|Overall Study|Adverse Event|18
3096195|NCT00313586|10614962|P1|Overall Study|Adverse Event|12
3096196|NCT00313586|10614959|P4|Overall Study|Disease progression|3
3096197|NCT00313586|10614960|P3|Overall Study|Disease progression|10
3096198|NCT00313586|10614961|P2|Overall Study|Disease progression|19
3096199|NCT00313586|10614962|P1|Overall Study|Disease progression|14
3096200|NCT00313313|10614985|P3|Overall Study|Subject No Longer Meets Study Criteria|2
3096201|NCT00313313|10614986|P2|Overall Study|Subject No Longer Meets Study Criteria|3
3096202|NCT00313313|10614987|P1|Overall Study|Subject No Longer Meets Study Criteria|0
3096203|NCT00313313|10614985|P3|Overall Study|Death|2
3096204|NCT00313313|10614986|P2|Overall Study|Death|0
3096205|NCT00313313|10614987|P1|Overall Study|Death|0
3096206|NCT00313313|10614985|P3|Overall Study|Pregnancy|0
3096207|NCT00313313|10614986|P2|Overall Study|Pregnancy|2
3096208|NCT00313313|10614987|P1|Overall Study|Pregnancy|1
3096209|NCT00313313|10614985|P3|Overall Study|Poor/Noncompliance|2
3096210|NCT00313313|10614986|P2|Overall Study|Poor/Noncompliance|6
3096211|NCT00313313|10614987|P1|Overall Study|Poor/Noncompliance|3
3096212|NCT00313313|10614985|P3|Overall Study|Physician Decision|4
3096213|NCT00313313|10614986|P2|Overall Study|Physician Decision|6
3096214|NCT00313313|10614987|P1|Overall Study|Physician Decision|2
3096215|NCT00313313|10614985|P3|Overall Study|Adverse Event|12
3096216|NCT00313313|10614986|P2|Overall Study|Adverse Event|16
3096217|NCT00313313|10614987|P1|Overall Study|Adverse Event|15
3096218|NCT00313313|10614985|P3|Overall Study|Lost to Follow-up|9
3096219|NCT00313313|10614986|P2|Overall Study|Lost to Follow-up|7
3096220|NCT00313313|10614987|P1|Overall Study|Lost to Follow-up|10
3096221|NCT00313313|10614985|P3|Overall Study|Withdrawal of consent by subject|31
3096222|NCT00313313|10614986|P2|Overall Study|Withdrawal of consent by subject|17
3096223|NCT00313313|10614987|P1|Overall Study|Withdrawal of consent by subject|18
3096224|NCT00313313|10614985|P3|Overall Study|Lack of Efficacy|20
3096225|NCT00313313|10614986|P2|Overall Study|Lack of Efficacy|9
3096226|NCT00313313|10614987|P1|Overall Study|Lack of Efficacy|14
3096227|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
3096228|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
3096229|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
3096230|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
3096231|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
3096232|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
3096233|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
3096234|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
3096235|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
3096236|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
3096237|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase B|Death|0
3096238|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase B|Death|0
3096239|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase B|Death|0
3096240|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase B|Death|0
3096241|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase B|Death|1
3096242|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
3096243|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
3096244|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
3096245|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
3096246|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
3096247|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase A|Death|0
3096248|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase A|Death|0
3096249|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase A|Death|0
3096250|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase A|Death|1
3096251|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase A|Death|0
3096252|NCT00313300|10615009|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
3096253|NCT00313300|10615010|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
3096254|NCT00313300|10615011|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
3096255|NCT00313300|10615012|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
3096256|NCT00313300|10615013|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
3096257|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|non-specified|0
3096258|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|non-specified|0
3096259|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|non-specified|0
3096260|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|non-specified|0
3096261|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|non-specified|1
3096262|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
3096263|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
3096264|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
3096265|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
3096266|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
3096267|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
3096268|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
3096269|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
3096270|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
3096271|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
3096272|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
3096273|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
3096274|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
3096275|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
3096276|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
3096277|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
3096278|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
3096279|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
3096280|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
3096281|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
3096282|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|Death|1
3096283|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|Death|0
3096284|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|Death|1
3096285|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|Death|3
3096286|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|Death|5
3096287|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
3096288|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
3096289|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
3096290|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
3096291|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
3096292|NCT00313300|10615009|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
3096293|NCT00313300|10615010|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
3096294|NCT00313300|10615011|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
3096295|NCT00313300|10615012|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
3096296|NCT00313300|10615013|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
3096297|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
3096298|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
3096299|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
3096300|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
3096301|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
3096302|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
3096303|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
3096304|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
3096305|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
3096306|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
3096307|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
3096308|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
3096309|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
3096310|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
3096311|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
3096312|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
3096313|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
3096314|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
3096315|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
3096316|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
3096317|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Death|0
3096318|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Death|0
3096319|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Death|0
3096320|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Death|4
3096321|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Death|3
3096322|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
3096323|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
3096324|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
3096325|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
3096326|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
3096327|NCT00313300|10615009|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
3096328|NCT00313300|10615010|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
3096329|NCT00313300|10615011|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
3096330|NCT00313300|10615012|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
3096331|NCT00313300|10615013|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
3096332|NCT00313170|10615083|P3|Overall Study|Progression (investigators opinion)|0
3096333|NCT00313170|10615084|P2|Overall Study|Progression (investigators opinion)|0
3096334|NCT00313170|10615085|P1|Overall Study|Progression (investigators opinion)|1
3096335|NCT00313170|10615083|P3|Overall Study|Lost to Follow-up|1
3096336|NCT00313170|10615084|P2|Overall Study|Lost to Follow-up|0
3096337|NCT00313170|10615085|P1|Overall Study|Lost to Follow-up|0
3096338|NCT00313170|10615083|P3|Overall Study|Incorrect enrollment|1
3096339|NCT00313170|10615084|P2|Overall Study|Incorrect enrollment|2
3096340|NCT00313170|10615085|P1|Overall Study|Incorrect enrollment|0
3096341|NCT00313170|10615083|P3|Overall Study|Withdrawal by Subject|1
3096342|NCT00313170|10615084|P2|Overall Study|Withdrawal by Subject|0
3096343|NCT00313170|10615085|P1|Overall Study|Withdrawal by Subject|1
3096344|NCT00313170|10615083|P3|Overall Study|Disease progression|27
3096345|NCT00313170|10615084|P2|Overall Study|Disease progression|26
3096346|NCT00313170|10615085|P1|Overall Study|Disease progression|31
3096347|NCT00313170|10615083|P3|Overall Study|Adverse Event|0
3096348|NCT00313170|10615084|P2|Overall Study|Adverse Event|2
3096349|NCT00313170|10615085|P1|Overall Study|Adverse Event|1
3096350|NCT00313170|10615083|P3|Overall Study|Death|2
3096351|NCT00313170|10615084|P2|Overall Study|Death|4
3096352|NCT00313170|10615085|P1|Overall Study|Death|2
3096353|NCT00313144|10615104|P1|Overall Study|Due to termination of the study|66
3096354|NCT00313144|10615104|P1|Overall Study|Change to different product|1
3096355|NCT00313144|10615104|P1|Overall Study|Insurance (homecare provider) change|1
3096356|NCT00313144|10615104|P1|Overall Study|Liver transplant|1
3096357|NCT00313144|10615104|P1|Overall Study|Adverse event - transient|5
3096358|NCT00313144|10615104|P1|Overall Study|Physician Decision|4
3096359|NCT00313144|10615104|P1|Overall Study|Terminated by sponsor/ homecare provider|4
3096360|NCT00313144|10615104|P1|Overall Study|Withdrawal by Subject|4
3096361|NCT00313144|10615104|P1|Overall Study|Lost to Follow-up|5
3096362|NCT00313144|10615104|P1|Overall Study|Death|7
3096363|NCT00313144|10615104|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
3096364|NCT00313014|10615191|P3|Overall Study|Lack of Efficacy|16
3096365|NCT00313014|10615192|P2|Overall Study|Lack of Efficacy|25
3096366|NCT00313014|10615193|P1|Overall Study|Lack of Efficacy|52
3096367|NCT00313014|10615191|P3|Overall Study|Administrative|14
3096368|NCT00313014|10615192|P2|Overall Study|Administrative|6
3096369|NCT00313014|10615193|P1|Overall Study|Administrative|9
3096370|NCT00313014|10615191|P3|Overall Study|Lost to Follow-up|10
3096371|NCT00313014|10615192|P2|Overall Study|Lost to Follow-up|6
3096372|NCT00313014|10615193|P1|Overall Study|Lost to Follow-up|7
3096373|NCT00313014|10615191|P3|Overall Study|Adverse Event|16
3096374|NCT00313014|10615192|P2|Overall Study|Adverse Event|29
3096375|NCT00313014|10615193|P1|Overall Study|Adverse Event|14
3096376|NCT00313014|10615191|P3|Overall Study|Withdrawal by Subject|5
3096377|NCT00313014|10615192|P2|Overall Study|Withdrawal by Subject|7
3096378|NCT00313014|10615193|P1|Overall Study|Withdrawal by Subject|11
3096379|NCT00312897|10615224|P2|Overall Study|discontinued prior to getting treatment|3
3096380|NCT00312897|10615225|P1|Overall Study|discontinued prior to getting treatment|0
3096381|NCT00312897|10615224|P2|Overall Study|Pregnancy|0
3096382|NCT00312897|10615225|P1|Overall Study|Pregnancy|1
3096383|NCT00312897|10615224|P2|Overall Study|Withdrawal by Subject|3
3096384|NCT00312897|10615225|P1|Overall Study|Withdrawal by Subject|1
3096385|NCT00312897|10615224|P2|Overall Study|Physician Decision|0
3096386|NCT00312897|10615225|P1|Overall Study|Physician Decision|1
3096387|NCT00312897|10615224|P2|Overall Study|Lost to Follow-up|0
3096388|NCT00312897|10615225|P1|Overall Study|Lost to Follow-up|2
3096389|NCT00312897|10615224|P2|Overall Study|Adverse Event|0
3096390|NCT00312897|10615225|P1|Overall Study|Adverse Event|1
3096391|NCT00312858|10615250|P2|Overall Study|Other|12
3096392|NCT00312858|10615251|P1|Overall Study|Other|9
3096393|NCT00312858|10615250|P2|Overall Study|Participant Moved|10
3096394|NCT00312858|10615251|P1|Overall Study|Participant Moved|11
3096395|NCT00312858|10615250|P2|Overall Study|Withdraw by Participant|20
3096396|NCT00312858|10615251|P1|Overall Study|Withdraw by Participant|20
3096397|NCT00312858|10615250|P2|Overall Study|Protocol Violation|8
3096398|NCT00312858|10615251|P1|Overall Study|Protocol Violation|3
3096399|NCT00312858|10615250|P2|Overall Study|Lost to Follow-up|42
3096400|NCT00312858|10615251|P1|Overall Study|Lost to Follow-up|25
3096401|NCT00312858|10615250|P2|Overall Study|Adverse Event|1
3096402|NCT00312858|10615251|P1|Overall Study|Adverse Event|0
3096403|NCT00312845|10615305|P2|Overall Study|Other|5
3096404|NCT00312845|10615306|P1|Overall Study|Other|6
3096405|NCT00312845|10615305|P2|Overall Study|Lost to Follow-up|0
3096406|NCT00312845|10615306|P1|Overall Study|Lost to Follow-up|2
3096407|NCT00312845|10615305|P2|Overall Study|Disease Progression|77
3096408|NCT00312845|10615306|P1|Overall Study|Disease Progression|56
3096409|NCT00312845|10615305|P2|Overall Study|Withdrawal by Subject|6
3096410|NCT00312845|10615306|P1|Overall Study|Withdrawal by Subject|14
3096411|NCT00312845|10615305|P2|Overall Study|Death|2
3096412|NCT00312845|10615306|P1|Overall Study|Death|2
3096413|NCT00312845|10615305|P2|Overall Study|Adverse Event|5
3096414|NCT00312845|10615306|P1|Overall Study|Adverse Event|19
3096415|NCT00312728|10615314|P1|Overall Study|Other|1
3096416|NCT00312728|10615314|P1|Overall Study|Other|10
3096417|NCT00312728|10615314|P1|Overall Study|Protocol Violation|2
3096418|NCT00312728|10615314|P1|Overall Study|Required non-protocol cancer treatment|2
3096419|NCT00312728|10615314|P1|Overall Study|Withdrawal by Subject|10
3096420|NCT00312728|10615314|P1|Overall Study|Adverse Event|32
3096421|NCT00312728|10615314|P1|Overall Study|Progressive disease|53
3096422|NCT00312702|10615326|P3|Immunization Phase|Lost to Follow-up|0
3096423|NCT00312702|10615327|P2|Immunization Phase|Lost to Follow-up|1
3096424|NCT00312702|10615328|P1|Immunization Phase|Lost to Follow-up|0
3096425|NCT00312663|10615341|P3|Immunization Phase|Adverse Event|0
3096426|NCT00312663|10615342|P2|Immunization Phase|Adverse Event|1
3096427|NCT00312663|10615343|P1|Immunization Phase|Adverse Event|0
3096428|NCT00312572|10615356|P2|Overall Study|Lack of Efficacy|2
3096429|NCT00312572|10615357|P1|Overall Study|Lack of Efficacy|1
3096430|NCT00312572|10615356|P2|Overall Study|Administrative|2
3096431|NCT00312572|10615357|P1|Overall Study|Administrative|4
3096432|NCT00312572|10615356|P2|Overall Study|Lost to Follow-up|1
3096433|NCT00312572|10615357|P1|Overall Study|Lost to Follow-up|1
3096434|NCT00312572|10615356|P2|Overall Study|Adverse Event|16
3096435|NCT00312572|10615357|P1|Overall Study|Adverse Event|10
3096436|NCT00312494|10615368|P3|Overall Study|Other|1
3096437|NCT00312494|10615369|P2|Overall Study|Other|10
3096438|NCT00312494|10615370|P1|Overall Study|Other|10
3096439|NCT00312494|10615368|P3|Overall Study|Withdrawal by Subject|10
3096440|NCT00312494|10615369|P2|Overall Study|Withdrawal by Subject|9
3096441|NCT00312494|10615370|P1|Overall Study|Withdrawal by Subject|6
3096442|NCT00312494|10615368|P3|Overall Study|Lost to Follow-up|8
3096443|NCT00312494|10615369|P2|Overall Study|Lost to Follow-up|8
3096444|NCT00312494|10615370|P1|Overall Study|Lost to Follow-up|8
3096445|NCT00312494|10615368|P3|Overall Study|Laboratory abnormality|0
3096446|NCT00312494|10615369|P2|Overall Study|Laboratory abnormality|0
3096447|NCT00312494|10615370|P1|Overall Study|Laboratory abnormality|1
3096448|NCT00312494|10615368|P3|Overall Study|Lack of Efficacy|8
3096449|NCT00312494|10615369|P2|Overall Study|Lack of Efficacy|6
3096450|NCT00312494|10615370|P1|Overall Study|Lack of Efficacy|4
3096451|NCT00312494|10615368|P3|Overall Study|Adverse Event|11
3096452|NCT00312494|10615369|P2|Overall Study|Adverse Event|15
3096453|NCT00312494|10615370|P1|Overall Study|Adverse Event|33
3096454|NCT00312494|10615368|P3|Overall Study|Randomized; not treated with study drug|5
3096455|NCT00312494|10615369|P2|Overall Study|Randomized; not treated with study drug|10
3096456|NCT00312494|10615370|P1|Overall Study|Randomized; not treated with study drug|9
3096457|NCT00312377|10615404|P2|Overall Study|Site ended participation in study|0
3096458|NCT00312377|10615405|P1|Overall Study|Site ended participation in study|1
3096459|NCT00312377|10615404|P2|Overall Study|Discontinue treatment survival follow up|200
3096460|NCT00312377|10615405|P1|Overall Study|Discontinue treatment survival follow up|202
3096461|NCT00312377|10615404|P2|Overall Study|Randomised but never received treatment|6
3096462|NCT00312377|10615405|P1|Overall Study|Randomised but never received treatment|6
3096463|NCT00312377|10615404|P2|Overall Study|Non-compliance|2
3096464|NCT00312377|10615405|P1|Overall Study|Non-compliance|0
3096465|NCT00312377|10615404|P2|Overall Study|Lost to Follow-up|12
3096466|NCT00312377|10615405|P1|Overall Study|Lost to Follow-up|9
3096467|NCT00312377|10615404|P2|Overall Study|Withdrawal by Subject|30
3096468|NCT00312377|10615405|P1|Overall Study|Withdrawal by Subject|23
3096469|NCT00312377|10615404|P2|Overall Study|Death|418
3096470|NCT00312377|10615405|P1|Overall Study|Death|403
3096471|NCT00312338|10615429|P2|Overall Study|Subsequent infection|0
3096472|NCT00312338|10615430|P1|Overall Study|Subsequent infection|2
3096473|NCT00312338|10615429|P2|Overall Study|Withdrawal by Subject|0
3096474|NCT00312338|10615430|P1|Overall Study|Withdrawal by Subject|4
3096475|NCT00312338|10615429|P2|Overall Study|Lost to Follow-up|1
3096476|NCT00312338|10615430|P1|Overall Study|Lost to Follow-up|9
3096477|NCT00312338|10615429|P2|Overall Study|Adverse Event|2
3096478|NCT00312338|10615430|P1|Overall Study|Adverse Event|7
3096479|NCT00312221|10615443|P4|Double-blind Phase|Lack of Efficacy|10
3096480|NCT00312221|10615444|P3|Double-blind Phase|Lack of Efficacy|6
3096481|NCT00312221|10615445|P2|Double-blind Phase|Lack of Efficacy|17
3096482|NCT00312221|10615446|P1|Double-blind Phase|Lack of Efficacy|0
3096483|NCT00312221|10615443|P4|Double-blind Phase|Administrative|33
3096484|NCT00312221|10615444|P3|Double-blind Phase|Administrative|37
3096485|NCT00312221|10615445|P2|Double-blind Phase|Administrative|26
3096486|NCT00312221|10615446|P1|Double-blind Phase|Administrative|0
3096487|NCT00312221|10615443|P4|Double-blind Phase|Lost to Follow-up|2
3096488|NCT00312221|10615444|P3|Double-blind Phase|Lost to Follow-up|2
3096489|NCT00312221|10615445|P2|Double-blind Phase|Lost to Follow-up|0
3096490|NCT00312221|10615446|P1|Double-blind Phase|Lost to Follow-up|0
3096491|NCT00312221|10615443|P4|Double-blind Phase|Adverse Event|18
3096492|NCT00312221|10615444|P3|Double-blind Phase|Adverse Event|19
3096493|NCT00312221|10615445|P2|Double-blind Phase|Adverse Event|10
3096494|NCT00312221|10615446|P1|Double-blind Phase|Adverse Event|0
3096495|NCT00312221|10615443|P4|Double-blind Phase|Withdrawal by Subject|7
3096496|NCT00312221|10615444|P3|Double-blind Phase|Withdrawal by Subject|8
3096497|NCT00312221|10615445|P2|Double-blind Phase|Withdrawal by Subject|6
3096498|NCT00312221|10615446|P1|Double-blind Phase|Withdrawal by Subject|0
3096499|NCT00312221|10615443|P4|Open-label Run-in Period|Did not qualify|0
3096500|NCT00312221|10615444|P3|Open-label Run-in Period|Did not qualify|0
3096501|NCT00312221|10615445|P2|Open-label Run-in Period|Did not qualify|0
3096502|NCT00312221|10615446|P1|Open-label Run-in Period|Did not qualify|5
3096503|NCT00312221|10615443|P4|Open-label Run-in Period|Lack of Efficacy|0
3096504|NCT00312221|10615444|P3|Open-label Run-in Period|Lack of Efficacy|0
3096505|NCT00312221|10615445|P2|Open-label Run-in Period|Lack of Efficacy|0
3096506|NCT00312221|10615446|P1|Open-label Run-in Period|Lack of Efficacy|102
3096507|NCT00312221|10615443|P4|Open-label Run-in Period|Administrative|0
3096508|NCT00312221|10615444|P3|Open-label Run-in Period|Administrative|0
3096509|NCT00312221|10615445|P2|Open-label Run-in Period|Administrative|0
3096510|NCT00312221|10615446|P1|Open-label Run-in Period|Administrative|42
3096511|NCT00312221|10615443|P4|Open-label Run-in Period|Lost to Follow-up|0
3096512|NCT00312221|10615444|P3|Open-label Run-in Period|Lost to Follow-up|0
3096513|NCT00312221|10615445|P2|Open-label Run-in Period|Lost to Follow-up|0
3096514|NCT00312221|10615446|P1|Open-label Run-in Period|Lost to Follow-up|5
3096515|NCT00312221|10615443|P4|Open-label Run-in Period|Adverse Event|0
3096516|NCT00312221|10615444|P3|Open-label Run-in Period|Adverse Event|0
3096517|NCT00312221|10615445|P2|Open-label Run-in Period|Adverse Event|0
3096518|NCT00312221|10615446|P1|Open-label Run-in Period|Adverse Event|74
3096519|NCT00312221|10615443|P4|Open-label Run-in Period|Withdrawal by Subject|0
3096520|NCT00312221|10615444|P3|Open-label Run-in Period|Withdrawal by Subject|0
3096521|NCT00312221|10615445|P2|Open-label Run-in Period|Withdrawal by Subject|0
3096522|NCT00312221|10615446|P1|Open-label Run-in Period|Withdrawal by Subject|6
3096523|NCT00312208|10615466|P2|Overall Study|Other|7
3096524|NCT00312208|10615467|P1|Overall Study|Other|5
3096525|NCT00312208|10615466|P2|Overall Study|Withdrawal by Subject|42
3096526|NCT00312208|10615467|P1|Overall Study|Withdrawal by Subject|53
3096527|NCT00312208|10615466|P2|Overall Study|Lost to Follow-up|5
3096528|NCT00312208|10615467|P1|Overall Study|Lost to Follow-up|3
3096529|NCT00312208|10615466|P2|Overall Study|Lack of Efficacy|4
3096530|NCT00312208|10615467|P1|Overall Study|Lack of Efficacy|7
3096531|NCT00312208|10615466|P2|Overall Study|Death|1
3096532|NCT00312208|10615467|P1|Overall Study|Death|2
3096533|NCT00312208|10615466|P2|Overall Study|Protocol Violation|3
3096534|NCT00312208|10615467|P1|Overall Study|Protocol Violation|5
3096535|NCT00312208|10615466|P2|Overall Study|Adverse Event|61
3096536|NCT00312208|10615467|P1|Overall Study|Adverse Event|97
3096537|NCT00312195|10615477|P2|Overall Study|Protocol Violation|0
3096538|NCT00312195|10615478|P1|Overall Study|Protocol Violation|1
3096539|NCT00312195|10615477|P2|Overall Study|Lost to Follow-up|0
3096540|NCT00312195|10615478|P1|Overall Study|Lost to Follow-up|1
3096541|NCT00312195|10615477|P2|Overall Study|Adverse Event|6
3096542|NCT00312195|10615478|P1|Overall Study|Adverse Event|4
3096543|NCT00311623|10615506|P3|Overall Study|Physician Decision|2
3096544|NCT00311623|10615507|P2|Overall Study|Physician Decision|0
3096545|NCT00311623|10615508|P1|Overall Study|Physician Decision|0
3096546|NCT00311584|10615550|P2|Overall Study|ineligible|2
3096547|NCT00311584|10615551|P1|Overall Study|ineligible|2
3096548|NCT00311584|10615550|P2|Overall Study|Withdrawal by Subject|1
3096549|NCT00311584|10615551|P1|Overall Study|Withdrawal by Subject|1
3096550|NCT00311584|10615550|P2|Overall Study|Physician Decision|5
3096551|NCT00311584|10615551|P1|Overall Study|Physician Decision|4
3096552|NCT00311584|10615550|P2|Overall Study|Lack of Efficacy|15
3096553|NCT00311584|10615551|P1|Overall Study|Lack of Efficacy|12
3096554|NCT00311584|10615550|P2|Overall Study|Death|0
3096555|NCT00311584|10615551|P1|Overall Study|Death|1
3096556|NCT00311402|10615559|P2|Overall Study|IRB's rejection etc.|3
3096557|NCT00311402|10615560|P1|Overall Study|IRB's rejection etc.|10
3096558|NCT00311402|10615559|P2|Overall Study|Protocol Violation|6
3096559|NCT00311402|10615560|P1|Overall Study|Protocol Violation|7
3096560|NCT00311402|10615559|P2|Overall Study|Lack of Efficacy|42
3096561|NCT00311402|10615560|P1|Overall Study|Lack of Efficacy|58
3096562|NCT00311402|10615559|P2|Overall Study|Withdrawal by Subject|18
3096563|NCT00311402|10615560|P1|Overall Study|Withdrawal by Subject|17
3096564|NCT00311402|10615559|P2|Overall Study|Lost to Follow-up|3
3096565|NCT00311402|10615560|P1|Overall Study|Lost to Follow-up|0
3096566|NCT00311402|10615559|P2|Overall Study|Adverse Event|105
3096567|NCT00311402|10615560|P1|Overall Study|Adverse Event|118
3096568|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
3096569|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
3096570|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
3096571|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
3096572|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
3096573|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
3096574|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
3096575|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
3096576|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
3096577|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
3096578|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
3096579|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
3096580|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
3096581|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
3096582|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
3096583|NCT00311363|10615609|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
3096584|NCT00311363|10615610|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
3096585|NCT00311363|10615611|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
3096586|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Death|0
3096587|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Death|0
3096588|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Death|1
3096589|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
3096590|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
3096591|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
3096592|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
3096593|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
3096594|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
3096595|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
3096596|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
3096597|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
3096598|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
3096599|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
3096600|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
3096601|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
3096602|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
3096603|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
3096604|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
3096605|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
3096606|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
3096607|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
3096608|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
3096609|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
3096610|NCT00311363|10615609|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
3096611|NCT00311363|10615610|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
3096612|NCT00311363|10615611|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
3096613|NCT00311311|10615671|P2|Overall Study|Lack of ancillary assistance|1
3096614|NCT00311311|10615672|P1|Overall Study|Lack of ancillary assistance|0
3096615|NCT00311311|10615671|P2|Overall Study|Death|0
3096616|NCT00311311|10615672|P1|Overall Study|Death|1
3096617|NCT00311311|10615671|P2|Overall Study|Study Termination by Sponsor|4
3096618|NCT00311311|10615672|P1|Overall Study|Study Termination by Sponsor|3
3096619|NCT00311311|10615671|P2|Overall Study|Noncompliance|1
3096620|NCT00311311|10615672|P1|Overall Study|Noncompliance|0
3096621|NCT00311311|10615671|P2|Overall Study|Withdrawal by Subject|1
3096622|NCT00311311|10615672|P1|Overall Study|Withdrawal by Subject|1
3096623|NCT00311311|10615671|P2|Overall Study|Adverse Event|2
3096624|NCT00311311|10615672|P1|Overall Study|Adverse Event|3
3096625|NCT00311181|10615722|P1|Overall Study|Final DFTs were not obtained|96
3096626|NCT00311155|10615728|P1|Overall Study|Did not meet entry criteria|55
3096627|NCT00311155|10615728|P1|Overall Study|Withdrawal by Subject|17
3096628|NCT00311155|10615728|P1|Overall Study|Adverse Event|21
3096629|NCT00310856|10615740|P3|Overall Study|Unable to classify|0
3096630|NCT00310856|10615741|P2|Overall Study|Unable to classify|0
3096631|NCT00310856|10615742|P1|Overall Study|Unable to classify|1
3096632|NCT00310856|10615740|P3|Overall Study|Inappropriate enrollment|0
3096633|NCT00310856|10615741|P2|Overall Study|Inappropriate enrollment|1
3096634|NCT00310856|10615742|P1|Overall Study|Inappropriate enrollment|1
3096635|NCT00310856|10615740|P3|Overall Study|Lost to Follow-up|6
3096636|NCT00310856|10615741|P2|Overall Study|Lost to Follow-up|2
3096637|NCT00310856|10615742|P1|Overall Study|Lost to Follow-up|1
3096638|NCT00310856|10615740|P3|Overall Study|Withdrawal by Subject|2
3096639|NCT00310856|10615741|P2|Overall Study|Withdrawal by Subject|2
3096640|NCT00310856|10615742|P1|Overall Study|Withdrawal by Subject|2
3096641|NCT00310817|10615766|P4|Overall Study|Unable to classify|0
3096642|NCT00310817|10615767|P3|Overall Study|Unable to classify|0
3096643|NCT00310817|10615768|P2|Overall Study|Unable to classify|1
3096644|NCT00310817|10615769|P1|Overall Study|Unable to classify|3
3096645|NCT00310817|10615766|P4|Overall Study|Protocol Violation|1
3096646|NCT00310817|10615767|P3|Overall Study|Protocol Violation|1
3096647|NCT00310817|10615768|P2|Overall Study|Protocol Violation|1
3096648|NCT00310817|10615769|P1|Overall Study|Protocol Violation|1
3096649|NCT00310817|10615766|P4|Overall Study|Inappropriate Enrollment|0
3096650|NCT00310817|10615767|P3|Overall Study|Inappropriate Enrollment|1
3096651|NCT00310817|10615768|P2|Overall Study|Inappropriate Enrollment|0
3096652|NCT00310817|10615769|P1|Overall Study|Inappropriate Enrollment|1
3096653|NCT00310817|10615766|P4|Overall Study|Lost to Follow-up|0
3096654|NCT00310817|10615767|P3|Overall Study|Lost to Follow-up|0
3096655|NCT00310817|10615768|P2|Overall Study|Lost to Follow-up|1
3096656|NCT00310817|10615769|P1|Overall Study|Lost to Follow-up|2
3096657|NCT00310817|10615766|P4|Overall Study|Withdrawal by Subject|7
3096658|NCT00310817|10615767|P3|Overall Study|Withdrawal by Subject|6
3096659|NCT00310817|10615768|P2|Overall Study|Withdrawal by Subject|4
3096660|NCT00310817|10615769|P1|Overall Study|Withdrawal by Subject|1
3096661|NCT00310817|10615766|P4|Overall Study|AE or Death|0
3096662|NCT00310817|10615767|P3|Overall Study|AE or Death|0
3096663|NCT00310817|10615768|P2|Overall Study|AE or Death|1
3096664|NCT00310817|10615769|P1|Overall Study|AE or Death|3
3096665|NCT00310804|10615857|P2|Overall Study|Withdrawal by Subject|0
3096666|NCT00310804|10615858|P1|Overall Study|Withdrawal by Subject|3
3096667|NCT00310804|10615857|P2|Overall Study|Lost to Follow-up|0
3096668|NCT00310804|10615858|P1|Overall Study|Lost to Follow-up|2
3096669|NCT00310440|10615917|P2|Overall Study|Missed 12 Month Visit|4
3096670|NCT00310440|10615918|P1|Overall Study|Missed 12 Month Visit|7
3096671|NCT00310440|10615917|P2|Overall Study|Withdrawal by Subject|1
3096672|NCT00310440|10615918|P1|Overall Study|Withdrawal by Subject|2
3096673|NCT00310440|10615917|P2|Overall Study|Lost to Follow-up|8
3096674|NCT00310440|10615918|P1|Overall Study|Lost to Follow-up|17
3096675|NCT00310388|10615982|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
3096676|NCT00310388|10615983|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
3096677|NCT00310388|10615982|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
3096678|NCT00310388|10615983|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
3096679|NCT00310388|10615982|P2|Safety Follow-up Continuation Phase|Adverse Event|1
3096680|NCT00310388|10615983|P1|Safety Follow-up Continuation Phase|Adverse Event|0
3096681|NCT00310388|10615982|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
3096682|NCT00310388|10615983|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
3096683|NCT00310388|10615982|P2|Primary Reporting Phase|Other|0
3096684|NCT00310388|10615983|P1|Primary Reporting Phase|Other|1
3096685|NCT00310388|10615982|P2|Primary Reporting Phase|Missing|0
3096686|NCT00310388|10615983|P1|Primary Reporting Phase|Missing|1
3096687|NCT00310388|10615982|P2|Primary Reporting Phase|Participant retired the informed consent|0
3096688|NCT00310388|10615983|P1|Primary Reporting Phase|Participant retired the informed consent|1
3096689|NCT00310388|10615982|P2|Primary Reporting Phase|Participant passed away|0
3096690|NCT00310388|10615983|P1|Primary Reporting Phase|Participant passed away|1
3096691|NCT00310388|10615982|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
3096692|NCT00310388|10615983|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
3096693|NCT00310388|10615982|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
3096694|NCT00310388|10615983|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
3096695|NCT00310388|10615982|P2|Primary Reporting Phase|Termination of study at sponsor request|0
3096696|NCT00310388|10615983|P1|Primary Reporting Phase|Termination of study at sponsor request|3
3096697|NCT00310388|10615982|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
3096698|NCT00310388|10615983|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
3096699|NCT00310388|10615982|P2|Primary Reporting Phase|Discontinuation of study|0
3096700|NCT00310388|10615983|P1|Primary Reporting Phase|Discontinuation of study|1
3096701|NCT00310388|10615982|P2|Primary Reporting Phase|Ministry of Health decision|0
3096702|NCT00310388|10615983|P1|Primary Reporting Phase|Ministry of Health decision|25
3096703|NCT00310388|10615982|P2|Primary Reporting Phase|Participant request|0
3096704|NCT00310388|10615983|P1|Primary Reporting Phase|Participant request|2
3096705|NCT00310388|10615982|P2|Primary Reporting Phase|Participant request unrelated to study|0
3096706|NCT00310388|10615983|P1|Primary Reporting Phase|Participant request unrelated to study|2
3096707|NCT00310388|10615982|P2|Primary Reporting Phase|Failed to return|0
3096708|NCT00310388|10615983|P1|Primary Reporting Phase|Failed to return|8
3096709|NCT00310388|10615982|P2|Primary Reporting Phase|Request of the sponsor|0
3096710|NCT00310388|10615983|P1|Primary Reporting Phase|Request of the sponsor|19
3096711|NCT00310388|10615982|P2|Primary Reporting Phase|Physician Decision|0
3096712|NCT00310388|10615983|P1|Primary Reporting Phase|Physician Decision|2
3096713|NCT00310388|10615982|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
3096714|NCT00310388|10615983|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
3096715|NCT00310388|10615982|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
3096716|NCT00310388|10615983|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
3096717|NCT00310388|10615982|P2|Primary Reporting Phase|Change in participant medical condition|0
3096718|NCT00310388|10615983|P1|Primary Reporting Phase|Change in participant medical condition|3
3096719|NCT00310388|10615982|P2|Primary Reporting Phase|Pregnancy|0
3096720|NCT00310388|10615983|P1|Primary Reporting Phase|Pregnancy|3
3096721|NCT00310388|10615982|P2|Primary Reporting Phase|Protocol Violation|0
3096722|NCT00310388|10615983|P1|Primary Reporting Phase|Protocol Violation|10
3096723|NCT00310388|10615982|P2|Primary Reporting Phase|Withdrawal by Subject|0
3096724|NCT00310388|10615983|P1|Primary Reporting Phase|Withdrawal by Subject|97
3096725|NCT00310388|10615982|P2|Primary Reporting Phase|Lack of Efficacy|0
3096726|NCT00310388|10615983|P1|Primary Reporting Phase|Lack of Efficacy|56
3096727|NCT00310388|10615982|P2|Primary Reporting Phase|Adverse Event|0
3096728|NCT00310388|10615983|P1|Primary Reporting Phase|Adverse Event|101
3096729|NCT00310375|10616025|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
3096730|NCT00310375|10616026|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
3096731|NCT00310375|10616027|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
3096732|NCT00310375|10616025|P3|Primary Reporting Phase|Request of Ethics Committee|0
3096733|NCT00310375|10616026|P2|Primary Reporting Phase|Request of Ethics Committee|1
3096734|NCT00310375|10616027|P1|Primary Reporting Phase|Request of Ethics Committee|0
3096735|NCT00310375|10616025|P3|Primary Reporting Phase|Par. switched to commercial product|0
3096736|NCT00310375|10616026|P2|Primary Reporting Phase|Par. switched to commercial product|1
3096737|NCT00310375|10616027|P1|Primary Reporting Phase|Par. switched to commercial product|0
3096738|NCT00310375|10616025|P3|Primary Reporting Phase|Missed study drug for 2 months|0
3096739|NCT00310375|10616026|P2|Primary Reporting Phase|Missed study drug for 2 months|0
3096740|NCT00310375|10616027|P1|Primary Reporting Phase|Missed study drug for 2 months|1
3096741|NCT00310375|10616025|P3|Primary Reporting Phase|Site closure|0
3096742|NCT00310375|10616026|P2|Primary Reporting Phase|Site closure|0
3096743|NCT00310375|10616027|P1|Primary Reporting Phase|Site closure|3
3096744|NCT00310375|10616025|P3|Primary Reporting Phase|Missed study drug >5 days|0
3096745|NCT00310375|10616026|P2|Primary Reporting Phase|Missed study drug >5 days|0
3096746|NCT00310375|10616027|P1|Primary Reporting Phase|Missed study drug >5 days|1
3096747|NCT00310375|10616025|P3|Primary Reporting Phase|Going for temporal lobectomy|0
3096748|NCT00310375|10616026|P2|Primary Reporting Phase|Going for temporal lobectomy|0
3096749|NCT00310375|10616027|P1|Primary Reporting Phase|Going for temporal lobectomy|1
3096750|NCT00310375|10616025|P3|Primary Reporting Phase|Participant request unrelated to study|0
3096751|NCT00310375|10616026|P2|Primary Reporting Phase|Participant request unrelated to study|2
3096752|NCT00310375|10616027|P1|Primary Reporting Phase|Participant request unrelated to study|1
3096753|NCT00310375|10616025|P3|Primary Reporting Phase|Failed to return|0
3096754|NCT00310375|10616026|P2|Primary Reporting Phase|Failed to return|3
3096755|NCT00310375|10616027|P1|Primary Reporting Phase|Failed to return|1
3096756|NCT00310375|10616025|P3|Primary Reporting Phase|Request of the sponsor|0
3096757|NCT00310375|10616026|P2|Primary Reporting Phase|Request of the sponsor|2
3096758|NCT00310375|10616027|P1|Primary Reporting Phase|Request of the sponsor|2
3096759|NCT00310375|10616025|P3|Primary Reporting Phase|Physician Decision|0
3096760|NCT00310375|10616026|P2|Primary Reporting Phase|Physician Decision|3
3096761|NCT00310375|10616027|P1|Primary Reporting Phase|Physician Decision|5
3096762|NCT00310375|10616025|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
3096763|NCT00310375|10616026|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
3096764|NCT00310375|10616027|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
3096765|NCT00310375|10616025|P3|Primary Reporting Phase|Change in Par medical condition|0
3096766|NCT00310375|10616026|P2|Primary Reporting Phase|Change in Par medical condition|0
3096767|NCT00310375|10616027|P1|Primary Reporting Phase|Change in Par medical condition|2
3096768|NCT00310375|10616025|P3|Primary Reporting Phase|Protocol Violation|0
3096769|NCT00310375|10616026|P2|Primary Reporting Phase|Protocol Violation|5
3096770|NCT00310375|10616027|P1|Primary Reporting Phase|Protocol Violation|8
3096771|NCT00310375|10616025|P3|Primary Reporting Phase|Withdrawal by Subject|0
3096772|NCT00310375|10616026|P2|Primary Reporting Phase|Withdrawal by Subject|7
3096773|NCT00310375|10616027|P1|Primary Reporting Phase|Withdrawal by Subject|10
3096774|NCT00310375|10616025|P3|Primary Reporting Phase|Pregnancy|0
3096775|NCT00310375|10616026|P2|Primary Reporting Phase|Pregnancy|2
3096776|NCT00310375|10616027|P1|Primary Reporting Phase|Pregnancy|2
3096777|NCT00310375|10616025|P3|Primary Reporting Phase|Lack of Efficacy|0
3096778|NCT00310375|10616026|P2|Primary Reporting Phase|Lack of Efficacy|19
3096779|NCT00310375|10616027|P1|Primary Reporting Phase|Lack of Efficacy|24
3096780|NCT00310375|10616025|P3|Primary Reporting Phase|Adverse Event|0
3096781|NCT00310375|10616026|P2|Primary Reporting Phase|Adverse Event|22
3096782|NCT00310375|10616027|P1|Primary Reporting Phase|Adverse Event|28
3096783|NCT00310037|10616163|P2|Overall Study|Non-protocol treatment|0
3096784|NCT00310037|10616164|P1|Overall Study|Non-protocol treatment|1
3096785|NCT00310037|10616163|P2|Overall Study|Progression|0
3096786|NCT00310037|10616164|P1|Overall Study|Progression|6
3096787|NCT00310037|10616163|P2|Overall Study|Withdrawal by Subject|3
3096788|NCT00310037|10616164|P1|Overall Study|Withdrawal by Subject|4
3096789|NCT00310037|10616163|P2|Overall Study|Adverse Event|14
3096790|NCT00310037|10616164|P1|Overall Study|Adverse Event|7
3096791|NCT00309985|10616178|P2|Overall Study|Chemotherapy discontinued only|0
3096792|NCT00309985|10616179|P1|Overall Study|Chemotherapy discontinued only|1
3096793|NCT00309985|10616178|P2|Overall Study|Non-compliance|0
3096794|NCT00309985|10616179|P1|Overall Study|Non-compliance|1
3096795|NCT00309985|10616178|P2|Overall Study|Complicating disease|0
3096796|NCT00309985|10616179|P1|Overall Study|Complicating disease|1
3096797|NCT00309985|10616178|P2|Overall Study|Never started treatment|0
3096798|NCT00309985|10616179|P1|Overall Study|Never started treatment|7
3096799|NCT00309985|10616178|P2|Overall Study|Physician Decision|0
3096800|NCT00309985|10616179|P1|Overall Study|Physician Decision|3
3096801|NCT00309985|10616178|P2|Overall Study|Withdrawal by Subject|1
3096802|NCT00309985|10616179|P1|Overall Study|Withdrawal by Subject|5
3096803|NCT00309985|10616178|P2|Overall Study|Death|0
3096804|NCT00309985|10616179|P1|Overall Study|Death|2
3096805|NCT00309985|10616178|P2|Overall Study|Adverse Event|0
3096806|NCT00309985|10616179|P1|Overall Study|Adverse Event|30
3096807|NCT00309985|10616178|P2|Overall Study|Disease progression|0
3096808|NCT00309985|10616179|P1|Overall Study|Disease progression|12
3096809|NCT00309959|10616195|P1|Overall Study|Ineligible - no prior chemotherapy|2
3096810|NCT00309946|10616204|P1|Overall Study|Withdrawal by Subject|1
3096811|NCT00309907|10616210|P1|Overall Study|Major infectious event|4
3096812|NCT00309907|10616210|P1|Overall Study|Ineligible|11
3096813|NCT00309907|10616210|P1|Overall Study|Physician Decision|1
3096814|NCT00309907|10616210|P1|Overall Study|Death|4
3096815|NCT00309777|10616223|P4|Overall Study|Death|0
3096816|NCT00309777|10616224|P3|Overall Study|Death|0
3096817|NCT00309777|10616225|P2|Overall Study|Death|1
3096818|NCT00309777|10616226|P1|Overall Study|Death|0
3096819|NCT00309777|10616223|P4|Overall Study|Lost to Follow-up|0
3096820|NCT00309777|10616224|P3|Overall Study|Lost to Follow-up|1
3096821|NCT00309777|10616225|P2|Overall Study|Lost to Follow-up|0
3096822|NCT00309777|10616226|P1|Overall Study|Lost to Follow-up|0
3096823|NCT00309777|10616223|P4|Overall Study|Withdrawal by Subject|2
3096824|NCT00309777|10616224|P3|Overall Study|Withdrawal by Subject|7
3096825|NCT00309777|10616225|P2|Overall Study|Withdrawal by Subject|5
3096826|NCT00309777|10616226|P1|Overall Study|Withdrawal by Subject|6
3096827|NCT00309777|10616223|P4|Overall Study|Protocol Violation|1
3096828|NCT00309777|10616224|P3|Overall Study|Protocol Violation|3
3096829|NCT00309777|10616225|P2|Overall Study|Protocol Violation|1
3096830|NCT00309777|10616226|P1|Overall Study|Protocol Violation|4
3096831|NCT00309777|10616223|P4|Overall Study|Adverse Event|1
3096832|NCT00309777|10616224|P3|Overall Study|Adverse Event|8
3096833|NCT00309777|10616225|P2|Overall Study|Adverse Event|2
3096834|NCT00309777|10616226|P1|Overall Study|Adverse Event|13
3096835|NCT00309608|10616267|P5|Overall Study|Other incl. Lack of efficacy|0
3096836|NCT00309608|10616268|P4|Overall Study|Other incl. Lack of efficacy|4
3096837|NCT00309608|10616269|P3|Overall Study|Other incl. Lack of efficacy|3
3096838|NCT00309608|10616270|P2|Overall Study|Other incl. Lack of efficacy|4
3096839|NCT00309608|10616271|P1|Overall Study|Other incl. Lack of efficacy|10
3096840|NCT00309608|10616267|P5|Overall Study|Withdrawal by Subject|0
3096841|NCT00309608|10616268|P4|Overall Study|Withdrawal by Subject|0
3096842|NCT00309608|10616269|P3|Overall Study|Withdrawal by Subject|2
3096843|NCT00309608|10616270|P2|Overall Study|Withdrawal by Subject|4
3096844|NCT00309608|10616271|P1|Overall Study|Withdrawal by Subject|1
3096845|NCT00309608|10616267|P5|Overall Study|Lost to Follow-up|1
3096846|NCT00309608|10616268|P4|Overall Study|Lost to Follow-up|0
3096847|NCT00309608|10616269|P3|Overall Study|Lost to Follow-up|2
3096848|NCT00309608|10616270|P2|Overall Study|Lost to Follow-up|0
3096849|NCT00309608|10616271|P1|Overall Study|Lost to Follow-up|0
3096850|NCT00309608|10616267|P5|Overall Study|Protocol Violation|0
3096851|NCT00309608|10616268|P4|Overall Study|Protocol Violation|0
3096852|NCT00309608|10616269|P3|Overall Study|Protocol Violation|0
3096853|NCT00309608|10616270|P2|Overall Study|Protocol Violation|0
3096854|NCT00309608|10616271|P1|Overall Study|Protocol Violation|2
3096855|NCT00309608|10616267|P5|Overall Study|Adverse Event|3
3096856|NCT00309608|10616268|P4|Overall Study|Adverse Event|2
3096857|NCT00309608|10616269|P3|Overall Study|Adverse Event|3
3096858|NCT00309608|10616270|P2|Overall Study|Adverse Event|5
3096859|NCT00309608|10616271|P1|Overall Study|Adverse Event|1
3096860|NCT00309452|10616319|P2|Overall Study|Withdrawal by Subject|0
3096861|NCT00309452|10616320|P1|Overall Study|Withdrawal by Subject|3
3096862|NCT00309387|10616348|P2|Overall Study|Lost to Follow-up|86
3096863|NCT00309387|10616349|P1|Overall Study|Lost to Follow-up|70
3096864|NCT00309387|10616348|P2|Overall Study|Death|73
3096865|NCT00309387|10616349|P1|Overall Study|Death|72
3096866|NCT00309244|10616367|P2|Overall Study|Death|1
3096867|NCT00309244|10616368|P1|Overall Study|Death|4
3096868|NCT00309244|10616367|P2|Overall Study|Randomized but not dosed|12
3096869|NCT00309244|10616368|P1|Overall Study|Randomized but not dosed|11
3096870|NCT00309244|10616367|P2|Overall Study|Various|7
3096871|NCT00309244|10616368|P1|Overall Study|Various|7
3096872|NCT00309244|10616367|P2|Overall Study|Withdrawal by Subject|32
3096873|NCT00309244|10616368|P1|Overall Study|Withdrawal by Subject|50
3096874|NCT00309244|10616367|P2|Overall Study|Protocol Violation|3
3096875|NCT00309244|10616368|P1|Overall Study|Protocol Violation|6
3096876|NCT00309244|10616367|P2|Overall Study|Physician Decision|8
3096877|NCT00309244|10616368|P1|Overall Study|Physician Decision|5
3096878|NCT00309244|10616367|P2|Overall Study|Lost to Follow-up|22
3096879|NCT00309244|10616368|P1|Overall Study|Lost to Follow-up|6
3096880|NCT00309244|10616367|P2|Overall Study|Adverse Event|12
3096881|NCT00309244|10616368|P1|Overall Study|Adverse Event|29
3096882|NCT00309166|10616390|P2|Overall Study|Withdrawal by Subject|3
3096883|NCT00309166|10616391|P1|Overall Study|Withdrawal by Subject|4
3096884|NCT00309166|10616390|P2|Overall Study|Adverse event, non-fatal|0
3096885|NCT00309166|10616391|P1|Overall Study|Adverse event, non-fatal|1
3096886|NCT00308997|10616419|P2|Overall Study|Unable to tolerate intervention|0
3096887|NCT00308997|10616420|P1|Overall Study|Unable to tolerate intervention|1
3096888|NCT00308997|10616419|P2|Overall Study|Subject feigned clinical data|1
3096889|NCT00308997|10616420|P1|Overall Study|Subject feigned clinical data|0
3096890|NCT00308737|10616439|P3|Overall Study|Various|8
3096891|NCT00308737|10616440|P2|Overall Study|Various|20
3096892|NCT00308737|10616441|P1|Overall Study|Various|32
3096893|NCT00308737|10616439|P3|Overall Study|Withdrawal by Subject|18
3096894|NCT00308737|10616440|P2|Overall Study|Withdrawal by Subject|166
3096895|NCT00308737|10616441|P1|Overall Study|Withdrawal by Subject|218
3096896|NCT00308737|10616439|P3|Overall Study|Protocol Violation|5
3096897|NCT00308737|10616440|P2|Overall Study|Protocol Violation|9
3096898|NCT00308737|10616441|P1|Overall Study|Protocol Violation|34
3096899|NCT00308737|10616439|P3|Overall Study|Physician Decision|1
3096900|NCT00308737|10616440|P2|Overall Study|Physician Decision|2
3096901|NCT00308737|10616441|P1|Overall Study|Physician Decision|15
3096902|NCT00308737|10616439|P3|Overall Study|Lost to Follow-up|5
3096903|NCT00308737|10616440|P2|Overall Study|Lost to Follow-up|80
3096904|NCT00308737|10616441|P1|Overall Study|Lost to Follow-up|56
3096905|NCT00308737|10616439|P3|Overall Study|Death|0
3096906|NCT00308737|10616440|P2|Overall Study|Death|3
3096907|NCT00308737|10616441|P1|Overall Study|Death|4
3096908|NCT00308737|10616439|P3|Overall Study|Adverse Event|0
3096909|NCT00308737|10616440|P2|Overall Study|Adverse Event|9
3096910|NCT00308737|10616441|P1|Overall Study|Adverse Event|104
3096911|NCT00308711|10616481|P3|Overall Study|Subject incarcerated, data not allowed|1
3096912|NCT00308711|10616482|P2|Overall Study|Subject incarcerated, data not allowed|0
3096913|NCT00308711|10616483|P1|Overall Study|Subject incarcerated, data not allowed|0
3096914|NCT00308711|10616481|P3|Overall Study|Baby not born within 7 days of treatment|2
3096915|NCT00308711|10616482|P2|Overall Study|Baby not born within 7 days of treatment|2
3096916|NCT00308711|10616483|P1|Overall Study|Baby not born within 7 days of treatment|1
3096917|NCT00308711|10616481|P3|Overall Study|Lost to Follow-up|0
3096918|NCT00308711|10616482|P2|Overall Study|Lost to Follow-up|1
3096919|NCT00308711|10616483|P1|Overall Study|Lost to Follow-up|0
3096920|NCT00308711|10616481|P3|Overall Study|Protocol Violation|1
3096921|NCT00308711|10616482|P2|Overall Study|Protocol Violation|1
3096922|NCT00308711|10616483|P1|Overall Study|Protocol Violation|0
3096923|NCT00308711|10616481|P3|Overall Study|Withdrawal by Subject|1
3096924|NCT00308711|10616482|P2|Overall Study|Withdrawal by Subject|0
3096925|NCT00308711|10616483|P1|Overall Study|Withdrawal by Subject|1
3096926|NCT00308620|10616518|P3|Overall Study|Lost to Follow-up|1
3096927|NCT00308620|10616519|P2|Overall Study|Lost to Follow-up|0
3096928|NCT00308620|10616520|P1|Overall Study|Lost to Follow-up|0
3096929|NCT00308620|10616518|P3|Overall Study|Death|0
3096930|NCT00308620|10616519|P2|Overall Study|Death|1
3096931|NCT00308620|10616520|P1|Overall Study|Death|1
3096932|NCT00308581|10616529|P3|Randomized Maintenance Phase|Unknown reason|0
3096933|NCT00308581|10616530|P2|Randomized Maintenance Phase|Unknown reason|0
3096934|NCT00308581|10616531|P1|Randomized Maintenance Phase|Unknown reason|3
3096935|NCT00308581|10616529|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
3096936|NCT00308581|10616530|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
3096937|NCT00308581|10616531|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
3096938|NCT00308581|10616529|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
3096939|NCT00308581|10616530|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
3096940|NCT00308581|10616531|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
3096941|NCT00308581|10616529|P3|Randomized Maintenance Phase|Lost to Follow-up|0
3096942|NCT00308581|10616530|P2|Randomized Maintenance Phase|Lost to Follow-up|2
3096943|NCT00308581|10616531|P1|Randomized Maintenance Phase|Lost to Follow-up|0
3096944|NCT00308581|10616529|P3|Randomized Maintenance Phase|Lack of Efficacy|0
3096945|NCT00308581|10616530|P2|Randomized Maintenance Phase|Lack of Efficacy|21
3096946|NCT00308581|10616531|P1|Randomized Maintenance Phase|Lack of Efficacy|9
3096947|NCT00308581|10616529|P3|Randomized Maintenance Phase|Adverse Event|0
3096948|NCT00308581|10616530|P2|Randomized Maintenance Phase|Adverse Event|17
3096949|NCT00308581|10616531|P1|Randomized Maintenance Phase|Adverse Event|10
3096950|NCT00308581|10616529|P3|Induction Phase|Unknown reason|3
3096951|NCT00308581|10616530|P2|Induction Phase|Unknown reason|0
3096952|NCT00308581|10616531|P1|Induction Phase|Unknown reason|0
3096953|NCT00308581|10616529|P3|Induction Phase|Withdrawal by Subject|5
3096954|NCT00308581|10616530|P2|Induction Phase|Withdrawal by Subject|0
3096955|NCT00308581|10616531|P1|Induction Phase|Withdrawal by Subject|0
3096956|NCT00308581|10616529|P3|Induction Phase|Lack of Efficacy|121
3096957|NCT00308581|10616530|P2|Induction Phase|Lack of Efficacy|0
3096958|NCT00308581|10616531|P1|Induction Phase|Lack of Efficacy|0
3096959|NCT00308581|10616529|P3|Induction Phase|Adverse Event|37
3096960|NCT00308581|10616530|P2|Induction Phase|Adverse Event|0
3096961|NCT00308581|10616531|P1|Induction Phase|Adverse Event|0
3096962|NCT00308555|10616657|P2|Overall Study|Physician Decision|0
3096963|NCT00308555|10616658|P1|Overall Study|Physician Decision|2
3096964|NCT00308555|10616657|P2|Overall Study|Withdrawal by Subject|0
3096965|NCT00308555|10616658|P1|Overall Study|Withdrawal by Subject|1
3096966|NCT00308308|10616675|P2|Overall Study|Other|0
3096967|NCT00308308|10616676|P1|Overall Study|Other|1
3096968|NCT00308308|10616675|P2|Overall Study|Randomized but not dosed|16
3096969|NCT00308308|10616676|P1|Overall Study|Randomized but not dosed|8
3096970|NCT00308308|10616675|P2|Overall Study|Various|5
3096971|NCT00308308|10616676|P1|Overall Study|Various|7
3096972|NCT00308308|10616675|P2|Overall Study|Withdrawal by Subject|19
3096973|NCT00308308|10616676|P1|Overall Study|Withdrawal by Subject|47
3096974|NCT00308308|10616675|P2|Overall Study|Protocol Violation|14
3096975|NCT00308308|10616676|P1|Overall Study|Protocol Violation|3
3096976|NCT00308308|10616675|P2|Overall Study|Physician Decision|7
3096977|NCT00308308|10616676|P1|Overall Study|Physician Decision|15
3096978|NCT00308308|10616675|P2|Overall Study|Lost to Follow-up|5
3096979|NCT00308308|10616676|P1|Overall Study|Lost to Follow-up|5
3096980|NCT00308308|10616675|P2|Overall Study|Adverse Event|2
3096981|NCT00308308|10616676|P1|Overall Study|Adverse Event|17
3096982|NCT00308139|10616755|P2|Overall Study|Other|0
3096983|NCT00308139|10616756|P1|Overall Study|Other|1
3096984|NCT00308139|10616755|P2|Overall Study|Administrative|4
3096985|NCT00308139|10616756|P1|Overall Study|Administrative|1
3096986|NCT00308139|10616755|P2|Overall Study|Loss of Glucose Control|7
3096987|NCT00308139|10616756|P1|Overall Study|Loss of Glucose Control|5
3096988|NCT00308139|10616755|P2|Overall Study|Investigator Decision|10
3096989|NCT00308139|10616756|P1|Overall Study|Investigator Decision|11
3096990|NCT00308139|10616755|P2|Overall Study|Withdrawal of Consent|42
3096991|NCT00308139|10616756|P1|Overall Study|Withdrawal of Consent|40
3096992|NCT00308139|10616755|P2|Overall Study|Protocol Violation|2
3096993|NCT00308139|10616756|P1|Overall Study|Protocol Violation|3
3096994|NCT00308139|10616755|P2|Overall Study|Lost to Follow-up|8
3096995|NCT00308139|10616756|P1|Overall Study|Lost to Follow-up|13
3096996|NCT00308139|10616755|P2|Overall Study|Adverse Event|14
3096997|NCT00308139|10616756|P1|Overall Study|Adverse Event|20
3096998|NCT00308113|10616830|P4|Overall Study|Protocol closure|1
3096999|NCT00308113|10616831|P3|Overall Study|Protocol closure|0
3097000|NCT00308113|10616832|P2|Overall Study|Protocol closure|0
3097001|NCT00308113|10616833|P1|Overall Study|Protocol closure|0
3097002|NCT00308087|10616853|P2|Overall Study|Other|3
3097003|NCT00308087|10616854|P1|Overall Study|Other|4
3097004|NCT00308087|10616853|P2|Overall Study|Withdrawal by Subject|1
3097005|NCT00308087|10616854|P1|Overall Study|Withdrawal by Subject|2
3097006|NCT00308087|10616853|P2|Overall Study|Study Closure|12
3097007|NCT00308087|10616854|P1|Overall Study|Study Closure|11
3097008|NCT00308087|10616853|P2|Overall Study|Progressive Disease|21
3097009|NCT00308087|10616854|P1|Overall Study|Progressive Disease|19
3097010|NCT00308074|10616870|P1|Overall Study|Withdrawal by Subject|1
3097011|NCT00307931|10616887|P1|Overall Study|Adverse Event|1
3097012|NCT00307801|10616904|P2|Overall Study|Pregnancy|1
3097013|NCT00307801|10616905|P1|Overall Study|Pregnancy|0
3097014|NCT00307801|10616904|P2|Overall Study|No reason specified|0
3097015|NCT00307801|10616905|P1|Overall Study|No reason specified|2
3097016|NCT00307801|10616904|P2|Overall Study|Protocol Violation|2
3097017|NCT00307801|10616905|P1|Overall Study|Protocol Violation|3
3097018|NCT00307801|10616904|P2|Overall Study|Frustration with e-diary|0
3097019|NCT00307801|10616905|P1|Overall Study|Frustration with e-diary|1
3097020|NCT00307801|10616904|P2|Overall Study|Lost to Follow-up, moved abroad|1
3097021|NCT00307801|10616905|P1|Overall Study|Lost to Follow-up, moved abroad|1
3097022|NCT00307801|10616904|P2|Overall Study|Lack of Efficacy|2
3097023|NCT00307801|10616905|P1|Overall Study|Lack of Efficacy|0
3097024|NCT00307801|10616904|P2|Overall Study|Wrong Randomization|0
3097025|NCT00307801|10616905|P1|Overall Study|Wrong Randomization|1
3097026|NCT00307801|10616904|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
3097027|NCT00307801|10616905|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
3097028|NCT00307801|10616904|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
3097029|NCT00307801|10616905|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
3097030|NCT00307801|10616904|P2|Overall Study|Non-compliance, not taken all tablets|2
3097031|NCT00307801|10616905|P1|Overall Study|Non-compliance, not taken all tablets|1
3097032|NCT00307801|10616904|P2|Overall Study|Withdrawal by Subject|4
3097033|NCT00307801|10616905|P1|Overall Study|Withdrawal by Subject|9
3097034|NCT00307801|10616904|P2|Overall Study|Adverse Event|4
3097035|NCT00307801|10616905|P1|Overall Study|Adverse Event|12
3097036|NCT00307736|10617017|P4|Overall Study|Withdrawal by Subject|0
3097037|NCT00307736|10617018|P3|Overall Study|Withdrawal by Subject|2
3097038|NCT00307736|10617019|P2|Overall Study|Withdrawal by Subject|0
3097039|NCT00307736|10617020|P1|Overall Study|Withdrawal by Subject|0
3097040|NCT00307736|10617017|P4|Overall Study|Adverse Event|3
3097041|NCT00307736|10617018|P3|Overall Study|Adverse Event|1
3097042|NCT00307736|10617019|P2|Overall Study|Adverse Event|0
3097043|NCT00307736|10617020|P1|Overall Study|Adverse Event|0
3097044|NCT00307684|10617031|P3|Double Blind Phase|Lack of Efficacy|0
3097045|NCT00307684|10617032|P2|Double Blind Phase|Lack of Efficacy|5
3097046|NCT00307684|10617033|P1|Double Blind Phase|Lack of Efficacy|2
3097047|NCT00307684|10617031|P3|Open Label Phase|other|6
3097048|NCT00307684|10617032|P2|Open Label Phase|other|0
3097049|NCT00307684|10617033|P1|Open Label Phase|other|0
3097050|NCT00307684|10617031|P3|Open Label Phase|non compliance|5
3097051|NCT00307684|10617032|P2|Open Label Phase|non compliance|0
3097052|NCT00307684|10617033|P1|Open Label Phase|non compliance|0
3097053|NCT00307684|10617031|P3|Open Label Phase|Lost to Follow-up|11
3097054|NCT00307684|10617032|P2|Open Label Phase|Lost to Follow-up|0
3097055|NCT00307684|10617033|P1|Open Label Phase|Lost to Follow-up|0
3097056|NCT00307684|10617031|P3|Open Label Phase|Withdrawal by Subject|15
3097057|NCT00307684|10617032|P2|Open Label Phase|Withdrawal by Subject|0
3097058|NCT00307684|10617033|P1|Open Label Phase|Withdrawal by Subject|0
3097059|NCT00307684|10617031|P3|Open Label Phase|Adverse Event|16
3097060|NCT00307684|10617032|P2|Open Label Phase|Adverse Event|0
3097061|NCT00307684|10617033|P1|Open Label Phase|Adverse Event|0
3097062|NCT00307684|10617031|P3|Open Label Phase|Lack of Efficacy|3
3097063|NCT00307684|10617032|P2|Open Label Phase|Lack of Efficacy|0
3097064|NCT00307684|10617033|P1|Open Label Phase|Lack of Efficacy|0
3097065|NCT00307489|10617061|P2|Week 48 Through Week 168|Seroconversion|0
3097066|NCT00307489|10617062|P1|Week 48 Through Week 168|Seroconversion|1
3097067|NCT00307489|10617061|P2|Week 48 Through Week 168|Lost to Follow-up|1
3097068|NCT00307489|10617062|P1|Week 48 Through Week 168|Lost to Follow-up|0
3097069|NCT00307489|10617061|P2|Week 48 Through Week 168|Death|1
3097070|NCT00307489|10617062|P1|Week 48 Through Week 168|Death|0
3097071|NCT00307489|10617061|P2|Week 48 Through Week 168|Lack of Efficacy|2
3097072|NCT00307489|10617062|P1|Week 48 Through Week 168|Lack of Efficacy|2
3097073|NCT00307489|10617061|P2|Week 48 Through Week 168|Withdrawal by Subject|2
3097074|NCT00307489|10617062|P1|Week 48 Through Week 168|Withdrawal by Subject|1
3097075|NCT00307489|10617061|P2|Week 48 Through Week 168|Physician Decision|0
3097076|NCT00307489|10617062|P1|Week 48 Through Week 168|Physician Decision|1
3097077|NCT00307489|10617061|P2|Week 48 Through Week 168|Adverse Event|0
3097078|NCT00307489|10617062|P1|Week 48 Through Week 168|Adverse Event|1
3097079|NCT00307489|10617061|P2|Baseline Through Week 48|Withdrawal by Subject|1
3097080|NCT00307489|10617062|P1|Baseline Through Week 48|Withdrawal by Subject|0
3097081|NCT00307489|10617061|P2|Baseline Through Week 48|Physician Decision|0
3097082|NCT00307489|10617062|P1|Baseline Through Week 48|Physician Decision|1
3097083|NCT00307489|10617061|P2|Baseline Through Week 48|Lost to Follow-up|1
3097084|NCT00307489|10617062|P1|Baseline Through Week 48|Lost to Follow-up|0
3097085|NCT00307437|10617107|P7|After Controlled Period|Other|28
3097086|NCT00307437|10617108|P6|After Controlled Period|Other|40
3097087|NCT00307437|10617109|P5|After Controlled Period|Other|9
3097088|NCT00307437|10617110|P4|After Controlled Period|Other|15
3097089|NCT00307437|10617111|P3|After Controlled Period|Other|0
3097090|NCT00307437|10617112|P2|After Controlled Period|Other|0
3097091|NCT00307437|10617113|P1|After Controlled Period|Other|0
3097092|NCT00307437|10617107|P7|After Controlled Period|Lost to Follow-up|18
3097093|NCT00307437|10617108|P6|After Controlled Period|Lost to Follow-up|13
3097094|NCT00307437|10617109|P5|After Controlled Period|Lost to Follow-up|12
3097095|NCT00307437|10617110|P4|After Controlled Period|Lost to Follow-up|7
3097096|NCT00307437|10617111|P3|After Controlled Period|Lost to Follow-up|0
3097097|NCT00307437|10617112|P2|After Controlled Period|Lost to Follow-up|0
3097098|NCT00307437|10617113|P1|After Controlled Period|Lost to Follow-up|0
3097099|NCT00307437|10617107|P7|After Controlled Period|Lack of Efficacy|24
3097100|NCT00307437|10617108|P6|After Controlled Period|Lack of Efficacy|37
3097101|NCT00307437|10617109|P5|After Controlled Period|Lack of Efficacy|17
3097102|NCT00307437|10617110|P4|After Controlled Period|Lack of Efficacy|15
3097103|NCT00307437|10617111|P3|After Controlled Period|Lack of Efficacy|0
3097104|NCT00307437|10617112|P2|After Controlled Period|Lack of Efficacy|0
3097105|NCT00307437|10617113|P1|After Controlled Period|Lack of Efficacy|0
3097106|NCT00307437|10617107|P7|After Controlled Period|Death|3
3097107|NCT00307437|10617108|P6|After Controlled Period|Death|1
3097108|NCT00307437|10617109|P5|After Controlled Period|Death|1
3097109|NCT00307437|10617110|P4|After Controlled Period|Death|3
3097110|NCT00307437|10617111|P3|After Controlled Period|Death|0
3097111|NCT00307437|10617112|P2|After Controlled Period|Death|0
3097112|NCT00307437|10617113|P1|After Controlled Period|Death|0
3097113|NCT00307437|10617107|P7|After Controlled Period|Adverse Event|40
3097114|NCT00307437|10617108|P6|After Controlled Period|Adverse Event|31
3097115|NCT00307437|10617109|P5|After Controlled Period|Adverse Event|16
3097116|NCT00307437|10617110|P4|After Controlled Period|Adverse Event|18
3097117|NCT00307437|10617111|P3|After Controlled Period|Adverse Event|0
3097118|NCT00307437|10617112|P2|After Controlled Period|Adverse Event|0
3097119|NCT00307437|10617113|P1|After Controlled Period|Adverse Event|0
3097120|NCT00307437|10617107|P7|Controlled Period|Other|0
3097121|NCT00307437|10617108|P6|Controlled Period|Other|0
3097122|NCT00307437|10617109|P5|Controlled Period|Other|0
3097123|NCT00307437|10617110|P4|Controlled Period|Other|0
3097124|NCT00307437|10617111|P3|Controlled Period|Other|3
3097125|NCT00307437|10617112|P2|Controlled Period|Other|1
3097126|NCT00307437|10617113|P1|Controlled Period|Other|5
3097127|NCT00307437|10617107|P7|Controlled Period|Lost to Follow-up|0
3097128|NCT00307437|10617108|P6|Controlled Period|Lost to Follow-up|0
3097129|NCT00307437|10617109|P5|Controlled Period|Lost to Follow-up|0
3097130|NCT00307437|10617110|P4|Controlled Period|Lost to Follow-up|0
3097131|NCT00307437|10617111|P3|Controlled Period|Lost to Follow-up|0
3097132|NCT00307437|10617112|P2|Controlled Period|Lost to Follow-up|3
3097133|NCT00307437|10617113|P1|Controlled Period|Lost to Follow-up|2
3097134|NCT00307437|10617107|P7|Controlled Period|Lack of Efficacy|0
3097135|NCT00307437|10617108|P6|Controlled Period|Lack of Efficacy|0
3097136|NCT00307437|10617109|P5|Controlled Period|Lack of Efficacy|0
3097137|NCT00307437|10617110|P4|Controlled Period|Lack of Efficacy|0
3097138|NCT00307437|10617111|P3|Controlled Period|Lack of Efficacy|0
3097139|NCT00307437|10617112|P2|Controlled Period|Lack of Efficacy|0
3097140|NCT00307437|10617113|P1|Controlled Period|Lack of Efficacy|2
3097141|NCT00307437|10617107|P7|Controlled Period|Death|0
3097142|NCT00307437|10617108|P6|Controlled Period|Death|0
3097143|NCT00307437|10617109|P5|Controlled Period|Death|0
3097144|NCT00307437|10617110|P4|Controlled Period|Death|0
3097145|NCT00307437|10617111|P3|Controlled Period|Death|1
3097146|NCT00307437|10617112|P2|Controlled Period|Death|0
3097147|NCT00307437|10617113|P1|Controlled Period|Death|0
3097148|NCT00307437|10617107|P7|Controlled Period|Adverse Event|0
3097149|NCT00307437|10617108|P6|Controlled Period|Adverse Event|0
3097150|NCT00307437|10617109|P5|Controlled Period|Adverse Event|0
3097151|NCT00307437|10617110|P4|Controlled Period|Adverse Event|0
3097152|NCT00307437|10617111|P3|Controlled Period|Adverse Event|5
3097153|NCT00307437|10617112|P2|Controlled Period|Adverse Event|2
3097154|NCT00307437|10617113|P1|Controlled Period|Adverse Event|7
3097155|NCT00307333|10617139|P2|Overall Study|Lost to Follow-up|3
3097156|NCT00307333|10617140|P1|Overall Study|Lost to Follow-up|11
3097157|NCT00307294|10617152|P1|Overall Study|Withdrawal by Subject|1
3097158|NCT00307164|10617161|P2|Overall Study|Lost to Follow-up|1
3097159|NCT00307164|10617162|P1|Overall Study|Lost to Follow-up|6
3097160|NCT00307164|10617161|P2|Overall Study|Not compliant with requirements|4
3097161|NCT00307164|10617162|P1|Overall Study|Not compliant with requirements|4
3097162|NCT00307164|10617161|P2|Overall Study|Withdrawal by Subject|8
3097163|NCT00307164|10617162|P1|Overall Study|Withdrawal by Subject|1
3097164|NCT00307164|10617161|P2|Overall Study|Subject/parent not able to get to clinic|1
3097165|NCT00307164|10617162|P1|Overall Study|Subject/parent not able to get to clinic|2
3097166|NCT00307164|10617161|P2|Overall Study|Severe debilitation, unable to continue|0
3097167|NCT00307164|10617162|P1|Overall Study|Severe debilitation, unable to continue|1
3097168|NCT00307164|10617161|P2|Overall Study|Death|0
3097169|NCT00307164|10617162|P1|Overall Study|Death|1
3097170|NCT00307151|10617202|P4|Overall Study|Clinic unable to contact subject|1
3097171|NCT00307151|10617203|P3|Overall Study|Clinic unable to contact subject|1
3097172|NCT00307151|10617204|P2|Overall Study|Clinic unable to contact subject|3
3097173|NCT00307151|10617205|P1|Overall Study|Clinic unable to contact subject|3
3097174|NCT00307151|10617202|P4|Overall Study|Not willing to adhere to study reqs|2
3097175|NCT00307151|10617203|P3|Overall Study|Not willing to adhere to study reqs|2
3097176|NCT00307151|10617204|P2|Overall Study|Not willing to adhere to study reqs|0
3097177|NCT00307151|10617205|P1|Overall Study|Not willing to adhere to study reqs|2
3097178|NCT00307151|10617202|P4|Overall Study|Withdrew consent|3
3097179|NCT00307151|10617203|P3|Overall Study|Withdrew consent|1
3097180|NCT00307151|10617204|P2|Overall Study|Withdrew consent|1
3097181|NCT00307151|10617205|P1|Overall Study|Withdrew consent|0
3097182|NCT00307151|10617202|P4|Overall Study|Subject unable to get to clinic|2
3097183|NCT00307151|10617203|P3|Overall Study|Subject unable to get to clinic|6
3097184|NCT00307151|10617204|P2|Overall Study|Subject unable to get to clinic|0
3097185|NCT00307151|10617205|P1|Overall Study|Subject unable to get to clinic|1
3097186|NCT00307151|10617202|P4|Overall Study|Severe debilitation, unable to continue|0
3097187|NCT00307151|10617203|P3|Overall Study|Severe debilitation, unable to continue|0
3097188|NCT00307151|10617204|P2|Overall Study|Severe debilitation, unable to continue|0
3097189|NCT00307151|10617205|P1|Overall Study|Severe debilitation, unable to continue|1
3097190|NCT00307151|10617202|P4|Overall Study|Death|3
3097191|NCT00307151|10617203|P3|Overall Study|Death|10
3097192|NCT00307151|10617204|P2|Overall Study|Death|3
3097193|NCT00307151|10617205|P1|Overall Study|Death|4
3097194|NCT00307125|10617249|P3|Pilot Phase|Withdrawal by Subject|1
3097195|NCT00307125|10617250|P2|Pilot Phase|Withdrawal by Subject|1
3097196|NCT00307125|10617251|P1|Pilot Phase|Withdrawal by Subject|0
3097197|NCT00307125|10617249|P3|Pilot Phase|Lost to Follow-up|0
3097198|NCT00307125|10617250|P2|Pilot Phase|Lost to Follow-up|1
3097199|NCT00307125|10617251|P1|Pilot Phase|Lost to Follow-up|0
3097200|NCT00307125|10617249|P3|Screening Phase|Coronary artery bypass|0
3097201|NCT00307125|10617250|P2|Screening Phase|Coronary artery bypass|0
3097202|NCT00307125|10617251|P1|Screening Phase|Coronary artery bypass|1
3097203|NCT00307125|10617249|P3|Screening Phase|AMR and treated with rituximab|0
3097204|NCT00307125|10617250|P2|Screening Phase|AMR and treated with rituximab|0
3097205|NCT00307125|10617251|P1|Screening Phase|AMR and treated with rituximab|1
3097206|NCT00307125|10617249|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
3097207|NCT00307125|10617250|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
3097208|NCT00307125|10617251|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
3097209|NCT00307125|10617249|P3|Screening Phase|Screen Error|0
3097210|NCT00307125|10617250|P2|Screening Phase|Screen Error|0
3097211|NCT00307125|10617251|P1|Screening Phase|Screen Error|1
3097212|NCT00307125|10617249|P3|Screening Phase|Ineligible|0
3097213|NCT00307125|10617250|P2|Screening Phase|Ineligible|0
3097214|NCT00307125|10617251|P1|Screening Phase|Ineligible|1
3097215|NCT00307125|10617249|P3|Screening Phase|PAK|0
3097216|NCT00307125|10617250|P2|Screening Phase|PAK|0
3097217|NCT00307125|10617251|P1|Screening Phase|PAK|1
3097218|NCT00307125|10617249|P3|Screening Phase|Malignancy|0
3097219|NCT00307125|10617250|P2|Screening Phase|Malignancy|0
3097220|NCT00307125|10617251|P1|Screening Phase|Malignancy|1
3097221|NCT00307125|10617249|P3|Screening Phase|Metastatic colon cancer|0
3097222|NCT00307125|10617250|P2|Screening Phase|Metastatic colon cancer|0
3097223|NCT00307125|10617251|P1|Screening Phase|Metastatic colon cancer|1
3097224|NCT00307125|10617249|P3|Screening Phase|Developed acute leukemia|0
3097225|NCT00307125|10617250|P2|Screening Phase|Developed acute leukemia|0
3097226|NCT00307125|10617251|P1|Screening Phase|Developed acute leukemia|1
3097227|NCT00307125|10617249|P3|Screening Phase|Try to get pregnant|0
3097228|NCT00307125|10617250|P2|Screening Phase|Try to get pregnant|0
3097229|NCT00307125|10617251|P1|Screening Phase|Try to get pregnant|1
3097230|NCT00307125|10617249|P3|Screening Phase|Ineligible for pilot|0
3097231|NCT00307125|10617250|P2|Screening Phase|Ineligible for pilot|0
3097232|NCT00307125|10617251|P1|Screening Phase|Ineligible for pilot|4
3097233|NCT00307125|10617249|P3|Screening Phase|Received Pancreas Transplant|0
3097234|NCT00307125|10617250|P2|Screening Phase|Received Pancreas Transplant|0
3097235|NCT00307125|10617251|P1|Screening Phase|Received Pancreas Transplant|8
3097236|NCT00307125|10617249|P3|Screening Phase|Moved or transferred facilities|0
3097237|NCT00307125|10617250|P2|Screening Phase|Moved or transferred facilities|0
3097238|NCT00307125|10617251|P1|Screening Phase|Moved or transferred facilities|34
3097239|NCT00307125|10617249|P3|Screening Phase|Scheduling issues/Non-compliance|0
3097240|NCT00307125|10617250|P2|Screening Phase|Scheduling issues/Non-compliance|0
3097241|NCT00307125|10617251|P1|Screening Phase|Scheduling issues/Non-compliance|55
3097242|NCT00307125|10617249|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
3097243|NCT00307125|10617250|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
3097244|NCT00307125|10617251|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
3097245|NCT00307125|10617249|P3|Screening Phase|Graft Failure|0
3097246|NCT00307125|10617250|P2|Screening Phase|Graft Failure|0
3097247|NCT00307125|10617251|P1|Screening Phase|Graft Failure|8
3097248|NCT00307125|10617249|P3|Screening Phase|Graft Loss|0
3097249|NCT00307125|10617250|P2|Screening Phase|Graft Loss|0
3097250|NCT00307125|10617251|P1|Screening Phase|Graft Loss|3
3097251|NCT00307125|10617249|P3|Screening Phase|Study Terminated|0
3097252|NCT00307125|10617250|P2|Screening Phase|Study Terminated|0
3097253|NCT00307125|10617251|P1|Screening Phase|Study Terminated|17
3097254|NCT00307125|10617249|P3|Screening Phase|Sponsor Decision|0
3097255|NCT00307125|10617250|P2|Screening Phase|Sponsor Decision|0
3097256|NCT00307125|10617251|P1|Screening Phase|Sponsor Decision|4
3097257|NCT00307125|10617249|P3|Screening Phase|Physician Decision|0
3097258|NCT00307125|10617250|P2|Screening Phase|Physician Decision|0
3097259|NCT00307125|10617251|P1|Screening Phase|Physician Decision|26
3097260|NCT00307125|10617249|P3|Screening Phase|Withdrawal by Subject|0
3097261|NCT00307125|10617250|P2|Screening Phase|Withdrawal by Subject|0
3097262|NCT00307125|10617251|P1|Screening Phase|Withdrawal by Subject|77
3097263|NCT00307125|10617249|P3|Screening Phase|Death|0
3097264|NCT00307125|10617250|P2|Screening Phase|Death|0
3097265|NCT00307125|10617251|P1|Screening Phase|Death|10
3097266|NCT00307125|10617249|P3|Screening Phase|Lost to Follow-up|0
3097267|NCT00307125|10617250|P2|Screening Phase|Lost to Follow-up|0
3097268|NCT00307125|10617251|P1|Screening Phase|Lost to Follow-up|87
3097269|NCT00307125|10617249|P3|Screening Phase|Protocol Violation|0
3097270|NCT00307125|10617250|P2|Screening Phase|Protocol Violation|0
3097271|NCT00307125|10617251|P1|Screening Phase|Protocol Violation|27
3097272|NCT00307125|10617249|P3|Screening Phase|Adverse Event|0
3097273|NCT00307125|10617250|P2|Screening Phase|Adverse Event|0
3097274|NCT00307125|10617251|P1|Screening Phase|Adverse Event|1
3097275|NCT00307086|10617273|P1|Overall Study|ineligible|5
3097276|NCT00307047|10617279|P2|Overall Study|All death, all MI, all Revascularization|16
3097277|NCT00307047|10617280|P1|Overall Study|All death, all MI, all Revascularization|27
3097278|NCT00307047|10617279|P2|Overall Study|Lost to follow-up for other reasons|1
3097279|NCT00307047|10617280|P1|Overall Study|Lost to follow-up for other reasons|0
3097280|NCT00307047|10617279|P2|Overall Study|Physician Decision|2
3097281|NCT00307047|10617280|P1|Overall Study|Physician Decision|1
3097282|NCT00307047|10617279|P2|Overall Study|Withdrawal by Subject|6
3097283|NCT00307047|10617280|P1|Overall Study|Withdrawal by Subject|6
3097284|NCT00307047|10617279|P2|Overall Study|Lost to Follow-up|24
3097285|NCT00307047|10617280|P1|Overall Study|Lost to Follow-up|35
3097286|NCT00307034|10617418|P2|Overall Study|Lost to Follow-up|3
3097287|NCT00307034|10617419|P1|Overall Study|Lost to Follow-up|0
3097288|NCT00307034|10617418|P2|Overall Study|Withdrawal by Subject|2
3097289|NCT00307034|10617419|P1|Overall Study|Withdrawal by Subject|1
3097290|NCT00307034|10617418|P2|Overall Study|Adverse Event|2
3097291|NCT00307034|10617419|P1|Overall Study|Adverse Event|1
3097292|NCT00306995|10617464|P7|Study Part II for Subset 2|Serious Adverse Event|0
3097293|NCT00306995|10617465|P6|Study Part II for Subset 2|Serious Adverse Event|0
3097294|NCT00306995|10617466|P5|Study Part II for Subset 2|Serious Adverse Event|0
3097295|NCT00306995|10617467|P4|Study Part II for Subset 2|Serious Adverse Event|0
3097296|NCT00306995|10617468|P3|Study Part II for Subset 2|Serious Adverse Event|0
3097297|NCT00306995|10617469|P2|Study Part II for Subset 2|Serious Adverse Event|1
3097298|NCT00306995|10617470|P1|Study Part II for Subset 2|Serious Adverse Event|0
3097299|NCT00306995|10617464|P7|Study Part I|Withdrawal by Subject|1
3097300|NCT00306995|10617465|P6|Study Part I|Withdrawal by Subject|0
3097301|NCT00306995|10617466|P5|Study Part I|Withdrawal by Subject|0
3097302|NCT00306995|10617467|P4|Study Part I|Withdrawal by Subject|0
3097303|NCT00306995|10617468|P3|Study Part I|Withdrawal by Subject|0
3097304|NCT00306995|10617469|P2|Study Part I|Withdrawal by Subject|0
3097305|NCT00306995|10617470|P1|Study Part I|Withdrawal by Subject|0
3097306|NCT00306891|10617863|P4|Part B|Development of study specific disc crit.|1
3097307|NCT00306891|10617864|P3|Part B|Development of study specific disc crit.|0
3097308|NCT00306891|10617865|P2|Part B|Development of study specific disc crit.|0
3097309|NCT00306891|10617866|P1|Part B|Development of study specific disc crit.|0
3097310|NCT00306891|10617863|P4|Part B|Condition under investigation worsened|8
3097311|NCT00306891|10617864|P3|Part B|Condition under investigation worsened|2
3097312|NCT00306891|10617865|P2|Part B|Condition under investigation worsened|0
3097313|NCT00306891|10617866|P1|Part B|Condition under investigation worsened|0
3097314|NCT00306891|10617863|P4|Part B|Withdrawal by Subject|1
3097315|NCT00306891|10617864|P3|Part B|Withdrawal by Subject|3
3097316|NCT00306891|10617865|P2|Part B|Withdrawal by Subject|0
3097317|NCT00306891|10617866|P1|Part B|Withdrawal by Subject|0
3097318|NCT00306891|10617863|P4|Part B|Adverse Event|5
3097319|NCT00306891|10617864|P3|Part B|Adverse Event|5
3097320|NCT00306891|10617865|P2|Part B|Adverse Event|0
3097321|NCT00306891|10617866|P1|Part B|Adverse Event|0
3097322|NCT00306891|10617863|P4|Part B|Death|2
3097323|NCT00306891|10617864|P3|Part B|Death|1
3097324|NCT00306891|10617865|P2|Part B|Death|0
3097325|NCT00306891|10617866|P1|Part B|Death|0
3097326|NCT00306891|10617863|P4|Part A|QTC interval outwith elig. criteria|0
3097327|NCT00306891|10617864|P3|Part A|QTC interval outwith elig. criteria|0
3097328|NCT00306891|10617865|P2|Part A|QTC interval outwith elig. criteria|0
3097329|NCT00306891|10617866|P1|Part A|QTC interval outwith elig. criteria|1
3097330|NCT00306891|10617863|P4|Part A|Suspicion of second malignancy|0
3097331|NCT00306891|10617864|P3|Part A|Suspicion of second malignancy|0
3097332|NCT00306891|10617865|P2|Part A|Suspicion of second malignancy|1
3097333|NCT00306891|10617866|P1|Part A|Suspicion of second malignancy|0
3097334|NCT00306891|10617863|P4|Part A|Reaccumul. of ascites following drainage|0
3097335|NCT00306891|10617864|P3|Part A|Reaccumul. of ascites following drainage|0
3097336|NCT00306891|10617865|P2|Part A|Reaccumul. of ascites following drainage|1
3097337|NCT00306891|10617866|P1|Part A|Reaccumul. of ascites following drainage|0
3097338|NCT00306891|10617863|P4|Part A|Partial bowel obstruction|0
3097339|NCT00306891|10617864|P3|Part A|Partial bowel obstruction|0
3097340|NCT00306891|10617865|P2|Part A|Partial bowel obstruction|0
3097341|NCT00306891|10617866|P1|Part A|Partial bowel obstruction|1
3097342|NCT00306891|10617863|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
3097343|NCT00306891|10617864|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
3097344|NCT00306891|10617865|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
3097345|NCT00306891|10617866|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
3097346|NCT00306891|10617863|P4|Part A|Condition under investigation worsened|0
3097347|NCT00306891|10617864|P3|Part A|Condition under investigation worsened|0
3097348|NCT00306891|10617865|P2|Part A|Condition under investigation worsened|2
3097349|NCT00306891|10617866|P1|Part A|Condition under investigation worsened|2
3097350|NCT00306891|10617863|P4|Part A|Withdrawal by Subject|0
3097351|NCT00306891|10617864|P3|Part A|Withdrawal by Subject|0
3097352|NCT00306891|10617865|P2|Part A|Withdrawal by Subject|1
3097353|NCT00306891|10617866|P1|Part A|Withdrawal by Subject|1
3097354|NCT00306852|10617889|P2|Overall Study|Lost to Follow-up|24
3097355|NCT00306852|10617890|P1|Overall Study|Lost to Follow-up|15
3097356|NCT00306852|10617889|P2|Overall Study|Death|14
3097357|NCT00306852|10617890|P1|Overall Study|Death|14
3097358|NCT00306787|10617908|P2|Overall Study|Abnormal laboratory value(s)|0
3097359|NCT00306787|10617909|P1|Overall Study|Abnormal laboratory value(s)|1
3097360|NCT00306787|10617908|P2|Overall Study|Administrative problems|0
3097361|NCT00306787|10617909|P1|Overall Study|Administrative problems|4
3097362|NCT00306787|10617908|P2|Overall Study|Lost to Follow-up|6
3097363|NCT00306787|10617909|P1|Overall Study|Lost to Follow-up|9
3097364|NCT00306787|10617908|P2|Overall Study|Withdrawal by Subject|9
3097365|NCT00306787|10617909|P1|Overall Study|Withdrawal by Subject|2
3097366|NCT00306787|10617908|P2|Overall Study|Protocol Violation|10
3097367|NCT00306787|10617909|P1|Overall Study|Protocol Violation|8
3097368|NCT00306787|10617908|P2|Overall Study|Lack of Efficacy|0
3097369|NCT00306787|10617909|P1|Overall Study|Lack of Efficacy|1
3097370|NCT00306787|10617908|P2|Overall Study|Adverse Event|1
3097371|NCT00306787|10617909|P1|Overall Study|Adverse Event|1
3097372|NCT00306787|10617908|P2|Overall Study|Discontinued without taking study drug|215
3097373|NCT00306787|10617909|P1|Overall Study|Discontinued without taking study drug|208
3097374|NCT00306670|10617927|P2|Overall Study|patients recruited; Genentech, the st|2
3097375|NCT00306670|10617928|P1|Overall Study|patients recruited; Genentech, the st|0
3097376|NCT00306592|10617934|P2|Overall Study|48-week Treatment Period Ongoing|20
3097377|NCT00306592|10617935|P1|Overall Study|48-week Treatment Period Ongoing|0
3097378|NCT00306592|10617934|P2|Overall Study|Other|2
3097379|NCT00306592|10617935|P1|Overall Study|Other|1
3097380|NCT00306592|10617934|P2|Overall Study|Other|10
3097381|NCT00306592|10617935|P1|Overall Study|Other|5
3097382|NCT00306592|10617934|P2|Overall Study|Voluntary|6
3097383|NCT00306592|10617935|P1|Overall Study|Voluntary|10
3097384|NCT00306592|10617934|P2|Overall Study|Persistent Antibodies|3
3097385|NCT00306592|10617935|P1|Overall Study|Persistent Antibodies|6
3097386|NCT00306592|10617934|P2|Overall Study|Noncompliance|2
3097387|NCT00306592|10617935|P1|Overall Study|Noncompliance|0
3097388|NCT00306592|10617934|P2|Overall Study|Lost to Follow-up|0
3097389|NCT00306592|10617935|P1|Overall Study|Lost to Follow-up|1
3097390|NCT00306592|10617934|P2|Overall Study|Adverse Event|15
3097391|NCT00306592|10617935|P1|Overall Study|Adverse Event|8
3097392|NCT00306527|10617945|P4|Overall Study|Death|2
3097393|NCT00306527|10617946|P3|Overall Study|Death|1
3097394|NCT00306527|10617947|P2|Overall Study|Death|0
3097395|NCT00306527|10617948|P1|Overall Study|Death|1
3097396|NCT00306527|10617945|P4|Overall Study|Adverse Event|1
3097397|NCT00306527|10617946|P3|Overall Study|Adverse Event|1
3097398|NCT00306527|10617947|P2|Overall Study|Adverse Event|0
3097399|NCT00306527|10617948|P1|Overall Study|Adverse Event|0
3097400|NCT00306527|10617945|P4|Overall Study|Withdrawal by Subject|3
3097401|NCT00306527|10617946|P3|Overall Study|Withdrawal by Subject|0
3097402|NCT00306527|10617947|P2|Overall Study|Withdrawal by Subject|3
3097403|NCT00306527|10617948|P1|Overall Study|Withdrawal by Subject|2
3097404|NCT00306527|10617945|P4|Overall Study|Lost to Follow-up|0
3097405|NCT00306527|10617946|P3|Overall Study|Lost to Follow-up|3
3097406|NCT00306527|10617947|P2|Overall Study|Lost to Follow-up|4
3097407|NCT00306527|10617948|P1|Overall Study|Lost to Follow-up|3
3097408|NCT00306384|10618017|P3|Overall Study|Site closure|0
3097409|NCT00306384|10618018|P2|Overall Study|Site closure|0
3097410|NCT00306384|10618019|P1|Overall Study|Site closure|2
3097411|NCT00306384|10618017|P3|Overall Study|Other|32
3097412|NCT00306384|10618018|P2|Overall Study|Other|70
3097413|NCT00306384|10618019|P1|Overall Study|Other|80
3097414|NCT00306384|10618017|P3|Overall Study|Investigator discretion|21
3097415|NCT00306384|10618018|P2|Overall Study|Investigator discretion|31
3097416|NCT00306384|10618019|P1|Overall Study|Investigator discretion|28
3097417|NCT00306384|10618017|P3|Overall Study|Lack of Efficacy|38
3097418|NCT00306384|10618018|P2|Overall Study|Lack of Efficacy|40
3097419|NCT00306384|10618019|P1|Overall Study|Lack of Efficacy|26
3097420|NCT00306384|10618017|P3|Overall Study|Pregnancy|1
3097421|NCT00306384|10618018|P2|Overall Study|Pregnancy|1
3097422|NCT00306384|10618019|P1|Overall Study|Pregnancy|3
3097423|NCT00306384|10618017|P3|Overall Study|Study termination|1
3097424|NCT00306384|10618018|P2|Overall Study|Study termination|0
3097425|NCT00306384|10618019|P1|Overall Study|Study termination|1
3097426|NCT00306384|10618017|P3|Overall Study|Voluntary withdrawal|91
3097427|NCT00306384|10618018|P2|Overall Study|Voluntary withdrawal|187
3097428|NCT00306384|10618019|P1|Overall Study|Voluntary withdrawal|199
3097429|NCT00306384|10618017|P3|Overall Study|Lost to Follow-up|35
3097430|NCT00306384|10618018|P2|Overall Study|Lost to Follow-up|41
3097431|NCT00306384|10618019|P1|Overall Study|Lost to Follow-up|57
3097432|NCT00306384|10618017|P3|Overall Study|Major protocol deviation|18
3097433|NCT00306384|10618018|P2|Overall Study|Major protocol deviation|51
3097434|NCT00306384|10618019|P1|Overall Study|Major protocol deviation|43
3097435|NCT00306384|10618017|P3|Overall Study|Adverse Event|40
3097436|NCT00306384|10618018|P2|Overall Study|Adverse Event|87
3097437|NCT00306384|10618019|P1|Overall Study|Adverse Event|103
3097438|NCT00306293|10618051|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
3097439|NCT00306293|10618052|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
3097440|NCT00306293|10618051|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
3097441|NCT00306293|10618052|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
3097442|NCT00306293|10618051|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
3097443|NCT00306293|10618052|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
3097444|NCT00306293|10618051|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
3097445|NCT00306293|10618052|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
3097446|NCT00306293|10618051|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
3097447|NCT00306293|10618052|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
3097448|NCT00306293|10618051|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
3097449|NCT00306293|10618052|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
3097450|NCT00306293|10618051|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
3097451|NCT00306293|10618052|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
3097452|NCT00306293|10618051|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
3097453|NCT00306293|10618052|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
3097454|NCT00306202|10618073|P3|Overall Study|Still on treatment|0
3097455|NCT00306202|10618074|P2|Overall Study|Still on treatment|1
3097456|NCT00306202|10618075|P1|Overall Study|Still on treatment|6
3097457|NCT00306189|10618235|P4|Overall Study|Other|0
3097458|NCT00306189|10618236|P3|Overall Study|Other|0
3097459|NCT00306189|10618237|P2|Overall Study|Other|0
3097460|NCT00306189|10618238|P1|Overall Study|Other|1
3097461|NCT00306189|10618235|P4|Overall Study|Ineligibility determined|1
3097462|NCT00306189|10618236|P3|Overall Study|Ineligibility determined|1
3097463|NCT00306189|10618237|P2|Overall Study|Ineligibility determined|1
3097464|NCT00306189|10618238|P1|Overall Study|Ineligibility determined|1
3097465|NCT00306189|10618235|P4|Overall Study|Withdrawal by Subject|1
3097466|NCT00306189|10618236|P3|Overall Study|Withdrawal by Subject|8
3097467|NCT00306189|10618237|P2|Overall Study|Withdrawal by Subject|2
3097468|NCT00306189|10618238|P1|Overall Study|Withdrawal by Subject|4
3097469|NCT00306189|10618235|P4|Overall Study|Adverse Event|2
3097470|NCT00306189|10618236|P3|Overall Study|Adverse Event|2
3097471|NCT00306189|10618237|P2|Overall Study|Adverse Event|3
3097472|NCT00306189|10618238|P1|Overall Study|Adverse Event|3
3097473|NCT00306189|10618235|P4|Overall Study|Physician Decision|1
3097474|NCT00306189|10618236|P3|Overall Study|Physician Decision|0
3097475|NCT00306189|10618237|P2|Overall Study|Physician Decision|0
3097476|NCT00306189|10618238|P1|Overall Study|Physician Decision|0
3097477|NCT00305877|10618265|P2|Overall Study|Transportation issue with daily RT|1
3097478|NCT00305877|10618266|P1|Overall Study|Transportation issue with daily RT|0
3097479|NCT00305877|10618265|P2|Overall Study|Ineligible|1
3097480|NCT00305877|10618266|P1|Overall Study|Ineligible|2
3097481|NCT00305877|10618265|P2|Overall Study|Never start treatment|5
3097482|NCT00305877|10618266|P1|Overall Study|Never start treatment|2
3097483|NCT00305877|10618265|P2|Overall Study|Physician Decision|1
3097484|NCT00305877|10618266|P1|Overall Study|Physician Decision|1
3097485|NCT00305877|10618265|P2|Overall Study|Withdrawal by Subject|2
3097486|NCT00305877|10618266|P1|Overall Study|Withdrawal by Subject|4
3097487|NCT00305877|10618265|P2|Overall Study|Death|1
3097488|NCT00305877|10618266|P1|Overall Study|Death|0
3097489|NCT00305877|10618265|P2|Overall Study|Adverse Event|14
3097490|NCT00305877|10618266|P1|Overall Study|Adverse Event|9
3097491|NCT00305877|10618265|P2|Overall Study|Lack of Efficacy|9
3097492|NCT00305877|10618266|P1|Overall Study|Lack of Efficacy|6
3097493|NCT00305864|10618280|P4|Overall Study|Ineligible / No protocol treatment|13
3097494|NCT00305864|10618281|P3|Overall Study|Ineligible / No protocol treatment|1
3097495|NCT00305864|10618282|P2|Overall Study|Ineligible / No protocol treatment|1
3097496|NCT00305864|10618283|P1|Overall Study|Ineligible / No protocol treatment|0
3097497|NCT00305773|10618296|P2|Overall Study|All other reasons|2
3097498|NCT00305773|10618297|P1|Overall Study|All other reasons|3
3097499|NCT00305773|10618296|P2|Overall Study|Disease Progression|3
3097500|NCT00305773|10618297|P1|Overall Study|Disease Progression|1
3097501|NCT00305773|10618296|P2|Overall Study|Withdrawal by Subject|4
3097502|NCT00305773|10618297|P1|Overall Study|Withdrawal by Subject|1
3097503|NCT00305773|10618296|P2|Overall Study|Physician Decision|1
3097504|NCT00305773|10618297|P1|Overall Study|Physician Decision|1
3097505|NCT00305773|10618296|P2|Overall Study|Alternative Treatment|4
3097506|NCT00305773|10618297|P1|Overall Study|Alternative Treatment|4
3097507|NCT00305773|10618296|P2|Overall Study|Adverse Event|2
3097508|NCT00305773|10618297|P1|Overall Study|Adverse Event|1
3097509|NCT00305773|10618296|P2|Overall Study|Death|2
3097510|NCT00305773|10618297|P1|Overall Study|Death|3
3097511|NCT00305695|10618317|P2|Overall Study|Did not have baseline scan|1
3097512|NCT00305695|10618318|P1|Overall Study|Did not have baseline scan|1
3097513|NCT00305695|10618317|P2|Overall Study|Withdrawal by subject prior to 18 month|26
3097514|NCT00305695|10618318|P1|Overall Study|Withdrawal by subject prior to 18 month|40
3097515|NCT00305604|10618343|P2|Overall Study|Patient moved|0
3097516|NCT00305604|10618344|P1|Overall Study|Patient moved|1
3097517|NCT00305604|10618343|P2|Overall Study|Withdrawal by Subject|21
3097518|NCT00305604|10618344|P1|Overall Study|Withdrawal by Subject|12
3097519|NCT00305604|10618343|P2|Overall Study|Protocol Violation|1
3097520|NCT00305604|10618344|P1|Overall Study|Protocol Violation|2
3097521|NCT00305604|10618343|P2|Overall Study|Lost to Follow-up|4
3097522|NCT00305604|10618344|P1|Overall Study|Lost to Follow-up|0
3097523|NCT00305604|10618343|P2|Overall Study|Lack of Efficacy|18
3097524|NCT00305604|10618344|P1|Overall Study|Lack of Efficacy|11
3097525|NCT00305604|10618343|P2|Overall Study|Adverse Event|3
3097526|NCT00305604|10618344|P1|Overall Study|Adverse Event|6
3097527|NCT00305448|10618488|P3|Overall Study|Tumor Marker Elevation|1
3097528|NCT00305448|10618489|P2|Overall Study|Tumor Marker Elevation|0
3097529|NCT00305448|10618490|P1|Overall Study|Tumor Marker Elevation|0
3097530|NCT00305448|10618488|P3|Overall Study|Subjective Disease Progression|2
3097531|NCT00305448|10618489|P2|Overall Study|Subjective Disease Progression|2
3097532|NCT00305448|10618490|P1|Overall Study|Subjective Disease Progression|1
3097533|NCT00305448|10618488|P3|Overall Study|Disease Progression|28
3097534|NCT00305448|10618489|P2|Overall Study|Disease Progression|31
3097535|NCT00305448|10618490|P1|Overall Study|Disease Progression|27
3097536|NCT00305448|10618488|P3|Overall Study|Adverse Event|1
3097537|NCT00305448|10618489|P2|Overall Study|Adverse Event|0
3097538|NCT00305448|10618490|P1|Overall Study|Adverse Event|1
3097539|NCT00305448|10618488|P3|Overall Study|Withdrawal by Subject|1
3097540|NCT00305448|10618489|P2|Overall Study|Withdrawal by Subject|0
3097541|NCT00305448|10618490|P1|Overall Study|Withdrawal by Subject|2
3097542|NCT00305448|10618488|P3|Overall Study|Protocol Violation|0
3097543|NCT00305448|10618489|P2|Overall Study|Protocol Violation|1
3097544|NCT00305448|10618490|P1|Overall Study|Protocol Violation|0
3097545|NCT00305253|10618512|P2|Overall Study|Withdrawal by Subject|1
3097546|NCT00305253|10618513|P1|Overall Study|Withdrawal by Subject|0
3097547|NCT00305227|10618525|P2|Overall Study|Lost to Follow-up|6
3097548|NCT00305227|10618526|P1|Overall Study|Lost to Follow-up|7
3097549|NCT00305110|10618573|P1|Overall Study|Missing data|29
3097550|NCT00305058|10618646|P2|Overall Study|Missing outcome data|2
3097551|NCT00305058|10618647|P1|Overall Study|Missing outcome data|3
3097552|NCT00305058|10618646|P2|Overall Study|Missing data collection instrument|2
3097553|NCT00305058|10618647|P1|Overall Study|Missing data collection instrument|3
3097554|NCT00305058|10618646|P2|Overall Study|Participant too young|0
3097555|NCT00305058|10618647|P1|Overall Study|Participant too young|1
3097556|NCT00304954|10618663|P4|Overall Study|Adverse Event|0
3097557|NCT00304954|10618664|P3|Overall Study|Adverse Event|0
3097558|NCT00304954|10618665|P2|Overall Study|Adverse Event|0
3097559|NCT00304954|10618666|P1|Overall Study|Adverse Event|1
3097560|NCT00304954|10618663|P4|Overall Study|Withdrawal by Subject|0
3097561|NCT00304954|10618664|P3|Overall Study|Withdrawal by Subject|1
3097562|NCT00304954|10618665|P2|Overall Study|Withdrawal by Subject|0
3097563|NCT00304954|10618666|P1|Overall Study|Withdrawal by Subject|0
3097564|NCT00304915|10618686|P2|Overall Study|Withdrawal by Subject|0
3097565|NCT00304915|10618687|P1|Overall Study|Withdrawal by Subject|3
3097566|NCT00304915|10618686|P2|Overall Study|Death|5
3097567|NCT00304915|10618687|P1|Overall Study|Death|4
3097568|NCT00304915|10618686|P2|Overall Study|Lost to Follow-up|11
3097569|NCT00304915|10618687|P1|Overall Study|Lost to Follow-up|11
3097570|NCT00304356|10618732|P1|Nitazoxanide|Physician Decision|1
3097571|NCT00304356|10618732|P1|Nitazoxanide|Physician Decision|1
3097572|NCT00304356|10618732|P1|Nitazoxanide|Physician Decision|1
3097573|NCT00304356|10618732|P1|Nitazoxanide|number is 0|1
3097574|NCT00304356|10618732|P1|Nitazoxanide|Physician Decision|1
3097575|NCT00304356|10618732|P1|Nitazoxanide|Physician Decision|5
3097576|NCT00304278|10618736|P1|Overall Study|PT had medical condition preventing TX|1
3097577|NCT00304278|10618736|P1|Overall Study|lack of insurance coverage for chemoRT|1
3097578|NCT00304083|10618785|P2|Overall Study|Other|2
3097579|NCT00304083|10618786|P1|Overall Study|Other|5
3097580|NCT00304083|10618785|P2|Overall Study|Disease Progression|1
3097581|NCT00304083|10618786|P1|Overall Study|Disease Progression|5
3097582|NCT00304083|10618785|P2|Overall Study|Physician Decision|3
3097583|NCT00304083|10618786|P1|Overall Study|Physician Decision|8
3097584|NCT00304083|10618785|P2|Overall Study|Withdrawal by Subject|2
3097585|NCT00304083|10618786|P1|Overall Study|Withdrawal by Subject|4
3097586|NCT00304070|10618805|P3|Overall Study|Progressive Disease|4
3097587|NCT00304070|10618806|P2|Overall Study|Progressive Disease|7
3097588|NCT00304070|10618807|P1|Overall Study|Progressive Disease|3
3097589|NCT00304070|10618805|P3|Overall Study|Withdrawal by Subject|1
3097590|NCT00304070|10618806|P2|Overall Study|Withdrawal by Subject|0
3097591|NCT00304070|10618807|P1|Overall Study|Withdrawal by Subject|0
3097592|NCT00304070|10618805|P3|Overall Study|Physician Decision|3
3097593|NCT00304070|10618806|P2|Overall Study|Physician Decision|0
3097594|NCT00304070|10618807|P1|Overall Study|Physician Decision|0
3097595|NCT00304070|10618805|P3|Overall Study|Lost to Follow-up|1
3097596|NCT00304070|10618806|P2|Overall Study|Lost to Follow-up|0
3097597|NCT00304070|10618807|P1|Overall Study|Lost to Follow-up|0
3097598|NCT00304070|10618805|P3|Overall Study|Death|3
3097599|NCT00304070|10618806|P2|Overall Study|Death|0
3097600|NCT00304070|10618807|P1|Overall Study|Death|0
3097601|NCT00304031|10618822|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
3097602|NCT00304031|10618823|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
3097603|NCT00304031|10618824|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
3097604|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
3097605|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
3097606|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
3097607|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
3097608|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
3097609|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
3097610|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
3097611|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
3097612|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
3097613|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
3097614|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
3097615|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
3097616|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Death|0
3097617|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Death|0
3097618|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Death|18
3097619|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
3097620|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
3097621|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
3097622|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
3097623|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
3097624|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
3097625|NCT00304031|10618822|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
3097626|NCT00304031|10618823|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
3097627|NCT00304031|10618824|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
3097628|NCT00304031|10618822|P3|Registration|Ineligible|0
3097629|NCT00304031|10618823|P2|Registration|Ineligible|0
3097630|NCT00304031|10618824|P1|Registration|Ineligible|48
3097631|NCT00303953|10618863|P1|Overall Study|Physician Decision|1
3097632|NCT00303953|10618863|P1|Overall Study|Lack of Efficacy|12
3097633|NCT00303953|10618863|P1|Overall Study|Adverse Event|4
3097634|NCT00303953|10618863|P1|Overall Study|Death|1
3097635|NCT00303953|10618863|P1|Overall Study|Ineligible|1
3097636|NCT00303719|10618898|P2|Overall Study|Lost to Follow-up|7
3097637|NCT00303719|10618899|P1|Overall Study|Lost to Follow-up|0
3097638|NCT00303719|10618898|P2|Overall Study|Not evaluable, prior therapies|30
3097639|NCT00303719|10618899|P1|Overall Study|Not evaluable, prior therapies|0
3097640|NCT00303667|10618915|P2|Overall Study|Death|4
3097641|NCT00303667|10618916|P1|Overall Study|Death|0
3097642|NCT00303628|10618940|P2|Overall Study|Other|9
3097643|NCT00303628|10618941|P1|Overall Study|Other|8
3097644|NCT00303628|10618940|P2|Overall Study|Not start protocol therapy|5
3097645|NCT00303628|10618941|P1|Overall Study|Not start protocol therapy|3
3097646|NCT00303628|10618940|P2|Overall Study|Other complicating disease|1
3097647|NCT00303628|10618941|P1|Overall Study|Other complicating disease|0
3097648|NCT00303628|10618940|P2|Overall Study|Alternative therapy|0
3097649|NCT00303628|10618941|P1|Overall Study|Alternative therapy|2
3097650|NCT00303628|10618940|P2|Overall Study|Withdrawal by Subject|20
3097651|NCT00303628|10618941|P1|Overall Study|Withdrawal by Subject|11
3097652|NCT00303628|10618940|P2|Overall Study|Death|1
3097653|NCT00303628|10618941|P1|Overall Study|Death|0
3097654|NCT00303628|10618940|P2|Overall Study|Adverse Event|36
3097655|NCT00303628|10618941|P1|Overall Study|Adverse Event|26
3097656|NCT00303628|10618940|P2|Overall Study|Disease progression|1
3097657|NCT00303628|10618941|P1|Overall Study|Disease progression|0
3097658|NCT00303602|10618959|P2|Overall Study|Protocol Violation|0
3097659|NCT00303602|10618960|P1|Overall Study|Protocol Violation|1
3097660|NCT00303602|10618959|P2|Overall Study|Noncompliance|2
3097661|NCT00303602|10618960|P1|Overall Study|Noncompliance|2
3097662|NCT00303602|10618959|P2|Overall Study|Physician Decision|1
3097663|NCT00303602|10618960|P1|Overall Study|Physician Decision|2
3097664|NCT00303602|10618959|P2|Overall Study|Protocol entry criteria not met|2
3097665|NCT00303602|10618960|P1|Overall Study|Protocol entry criteria not met|2
3097666|NCT00303602|10618959|P2|Overall Study|Lost to Follow-up|2
3097667|NCT00303602|10618960|P1|Overall Study|Lost to Follow-up|5
3097668|NCT00303602|10618959|P2|Overall Study|Withdrawal by Subject|6
3097669|NCT00303602|10618960|P1|Overall Study|Withdrawal by Subject|5
3097670|NCT00303602|10618959|P2|Overall Study|Adverse Event|2
3097671|NCT00303602|10618960|P1|Overall Study|Adverse Event|2
3097672|NCT00303485|10619006|P2|Overall Study|Withdrawal by Subject|0
3097673|NCT00303485|10619007|P1|Overall Study|Withdrawal by Subject|1
3097674|NCT00303485|10619006|P2|Overall Study|Failure to return|1
3097675|NCT00303485|10619007|P1|Overall Study|Failure to return|0
3097676|NCT00303485|10619006|P2|Overall Study|Adverse Event/Intercurrent Illness|1
3097677|NCT00303485|10619007|P1|Overall Study|Adverse Event/Intercurrent Illness|0
3097678|NCT00303472|10619038|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
3097679|NCT00303472|10619039|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
3097680|NCT00303472|10619040|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
3097681|NCT00303472|10619041|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
3097682|NCT00303472|10619042|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
3097683|NCT00303472|10619043|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
3097684|NCT00303472|10619044|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
3097685|NCT00303472|10619038|P7|Treatment Extension (Optional)|Other|0
3097686|NCT00303472|10619039|P6|Treatment Extension (Optional)|Other|0
3097687|NCT00303472|10619040|P5|Treatment Extension (Optional)|Other|1
3097688|NCT00303472|10619041|P4|Treatment Extension (Optional)|Other|2
3097689|NCT00303472|10619042|P3|Treatment Extension (Optional)|Other|4
3097690|NCT00303472|10619043|P2|Treatment Extension (Optional)|Other|2
3097691|NCT00303472|10619044|P1|Treatment Extension (Optional)|Other|0
3097692|NCT00303472|10619038|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
3097693|NCT00303472|10619039|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
3097694|NCT00303472|10619040|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
3097695|NCT00303472|10619041|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
3097696|NCT00303472|10619042|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
3097697|NCT00303472|10619043|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
3097698|NCT00303472|10619044|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
3097699|NCT00303472|10619038|P7|Treatment Extension (Optional)|Physician Decision|0
3097700|NCT00303472|10619039|P6|Treatment Extension (Optional)|Physician Decision|0
3097701|NCT00303472|10619040|P5|Treatment Extension (Optional)|Physician Decision|2
3097702|NCT00303472|10619041|P4|Treatment Extension (Optional)|Physician Decision|3
3097703|NCT00303472|10619042|P3|Treatment Extension (Optional)|Physician Decision|2
3097704|NCT00303472|10619043|P2|Treatment Extension (Optional)|Physician Decision|4
3097705|NCT00303472|10619044|P1|Treatment Extension (Optional)|Physician Decision|0
3097706|NCT00303472|10619038|P7|Treatment Extension (Optional)|Lost to Follow-up|0
3097707|NCT00303472|10619039|P6|Treatment Extension (Optional)|Lost to Follow-up|0
3097708|NCT00303472|10619040|P5|Treatment Extension (Optional)|Lost to Follow-up|0
3097709|NCT00303472|10619041|P4|Treatment Extension (Optional)|Lost to Follow-up|1
3097710|NCT00303472|10619042|P3|Treatment Extension (Optional)|Lost to Follow-up|0
3097711|NCT00303472|10619043|P2|Treatment Extension (Optional)|Lost to Follow-up|0
3097712|NCT00303472|10619044|P1|Treatment Extension (Optional)|Lost to Follow-up|0
3097713|NCT00303472|10619038|P7|Treatment Extension (Optional)|Death|0
3097714|NCT00303472|10619039|P6|Treatment Extension (Optional)|Death|0
3097715|NCT00303472|10619040|P5|Treatment Extension (Optional)|Death|0
3097716|NCT00303472|10619041|P4|Treatment Extension (Optional)|Death|0
3097717|NCT00303472|10619042|P3|Treatment Extension (Optional)|Death|1
3097718|NCT00303472|10619043|P2|Treatment Extension (Optional)|Death|0
3097719|NCT00303472|10619044|P1|Treatment Extension (Optional)|Death|2
3097720|NCT00303472|10619038|P7|Treatment Extension (Optional)|Adverse Event|0
3097721|NCT00303472|10619039|P6|Treatment Extension (Optional)|Adverse Event|0
3097722|NCT00303472|10619040|P5|Treatment Extension (Optional)|Adverse Event|0
3097723|NCT00303472|10619041|P4|Treatment Extension (Optional)|Adverse Event|0
3097724|NCT00303472|10619042|P3|Treatment Extension (Optional)|Adverse Event|1
3097725|NCT00303472|10619043|P2|Treatment Extension (Optional)|Adverse Event|0
3097726|NCT00303472|10619044|P1|Treatment Extension (Optional)|Adverse Event|1
3097727|NCT00303472|10619038|P7|Treatment Period|Disease Progression (to AML)|0
3097728|NCT00303472|10619039|P6|Treatment Period|Disease Progression (to AML)|0
3097729|NCT00303472|10619040|P5|Treatment Period|Disease Progression (to AML)|1
3097730|NCT00303472|10619041|P4|Treatment Period|Disease Progression (to AML)|0
3097731|NCT00303472|10619042|P3|Treatment Period|Disease Progression (to AML)|0
3097732|NCT00303472|10619043|P2|Treatment Period|Disease Progression (to AML)|0
3097733|NCT00303472|10619044|P1|Treatment Period|Disease Progression (to AML)|0
3097734|NCT00303472|10619038|P7|Treatment Period|Other|1
3097735|NCT00303472|10619039|P6|Treatment Period|Other|0
3097736|NCT00303472|10619040|P5|Treatment Period|Other|1
3097737|NCT00303472|10619041|P4|Treatment Period|Other|0
3097738|NCT00303472|10619042|P3|Treatment Period|Other|0
3097739|NCT00303472|10619043|P2|Treatment Period|Other|0
3097740|NCT00303472|10619044|P1|Treatment Period|Other|0
3097741|NCT00303472|10619038|P7|Treatment Period|Withdrawal by Subject|0
3097742|NCT00303472|10619039|P6|Treatment Period|Withdrawal by Subject|1
3097743|NCT00303472|10619040|P5|Treatment Period|Withdrawal by Subject|0
3097744|NCT00303472|10619041|P4|Treatment Period|Withdrawal by Subject|1
3097745|NCT00303472|10619042|P3|Treatment Period|Withdrawal by Subject|0
3097746|NCT00303472|10619043|P2|Treatment Period|Withdrawal by Subject|0
3097747|NCT00303472|10619044|P1|Treatment Period|Withdrawal by Subject|0
3097748|NCT00303472|10619038|P7|Treatment Period|Death|1
3097749|NCT00303472|10619039|P6|Treatment Period|Death|0
3097750|NCT00303472|10619040|P5|Treatment Period|Death|0
3097751|NCT00303472|10619041|P4|Treatment Period|Death|1
3097752|NCT00303472|10619042|P3|Treatment Period|Death|0
3097753|NCT00303472|10619043|P2|Treatment Period|Death|0
3097754|NCT00303472|10619044|P1|Treatment Period|Death|0
3097755|NCT00303472|10619038|P7|Treatment Period|Adverse Event|0
3097756|NCT00303472|10619039|P6|Treatment Period|Adverse Event|0
3097757|NCT00303472|10619040|P5|Treatment Period|Adverse Event|1
3097758|NCT00303472|10619041|P4|Treatment Period|Adverse Event|0
3097759|NCT00303472|10619042|P3|Treatment Period|Adverse Event|0
3097760|NCT00303472|10619043|P2|Treatment Period|Adverse Event|0
3097761|NCT00303472|10619044|P1|Treatment Period|Adverse Event|0
3097762|NCT00303459|10619104|P2|Overall Study|Lung transplantation|1
3097763|NCT00303459|10619105|P1|Overall Study|Lung transplantation|1
3097764|NCT00303459|10619104|P2|Overall Study|Decision by the investigator|7
3097765|NCT00303459|10619105|P1|Overall Study|Decision by the investigator|5
3097766|NCT00303459|10619104|P2|Overall Study|Administrative reason|7
3097767|NCT00303459|10619105|P1|Overall Study|Administrative reason|7
3097768|NCT00303459|10619104|P2|Overall Study|Lost to Follow-up|4
3097769|NCT00303459|10619105|P1|Overall Study|Lost to Follow-up|5
3097770|NCT00303459|10619104|P2|Overall Study|Withdrawal of consent|26
3097771|NCT00303459|10619105|P1|Overall Study|Withdrawal of consent|32
3097772|NCT00303459|10619104|P2|Overall Study|Death|44
3097773|NCT00303459|10619105|P1|Overall Study|Death|33
3097774|NCT00303446|10619131|P2|Overall Study|Physician Decision|1
3097775|NCT00303446|10619132|P1|Overall Study|Physician Decision|0
3097776|NCT00303446|10619131|P2|Overall Study|Death|1
3097777|NCT00303446|10619132|P1|Overall Study|Death|0
3097778|NCT00303446|10619131|P2|Overall Study|Withdrawal by Subject|2
3097779|NCT00303446|10619132|P1|Overall Study|Withdrawal by Subject|2
3097780|NCT00303329|10619168|P2|Overall Study|Stopped at end of extension 1|0
3097781|NCT00303329|10619169|P1|Overall Study|Stopped at end of extension 1|1
3097782|NCT00303329|10619168|P2|Overall Study|Stopped at end of core|9
3097783|NCT00303329|10619169|P1|Overall Study|Stopped at end of core|3
3097784|NCT00303329|10619168|P2|Overall Study|Death|12
3097785|NCT00303329|10619169|P1|Overall Study|Death|2
3097786|NCT00303329|10619168|P2|Overall Study|Administrative problems|0
3097787|NCT00303329|10619169|P1|Overall Study|Administrative problems|1
3097788|NCT00303329|10619168|P2|Overall Study|Lost to Follow-up|1
3097789|NCT00303329|10619169|P1|Overall Study|Lost to Follow-up|0
3097790|NCT00303329|10619168|P2|Overall Study|Withdrawal by Subject|15
3097791|NCT00303329|10619169|P1|Overall Study|Withdrawal by Subject|9
3097792|NCT00303329|10619168|P2|Overall Study|Protocol Violation|0
3097793|NCT00303329|10619169|P1|Overall Study|Protocol Violation|3
3097794|NCT00303329|10619168|P2|Overall Study|Condition no longer requires study drug|8
3097795|NCT00303329|10619169|P1|Overall Study|Condition no longer requires study drug|0
3097796|NCT00303329|10619168|P2|Overall Study|Unsatisfactory therapeutic effect|2
3097797|NCT00303329|10619169|P1|Overall Study|Unsatisfactory therapeutic effect|9
3097798|NCT00303329|10619168|P2|Overall Study|Abnormal Laboratory Values|1
3097799|NCT00303329|10619169|P1|Overall Study|Abnormal Laboratory Values|0
3097800|NCT00303329|10619168|P2|Overall Study|Adverse Event|14
3097801|NCT00303329|10619169|P1|Overall Study|Adverse Event|7
3097802|NCT00303316|10619183|P2|Overall Study|Withdrawal by Subject|2
3097803|NCT00303316|10619184|P1|Overall Study|Withdrawal by Subject|1
3097804|NCT00303316|10619183|P2|Overall Study|Lost to Follow-up|1
3097805|NCT00303316|10619184|P1|Overall Study|Lost to Follow-up|0
3097806|NCT00303316|10619183|P2|Overall Study|Protocol Violation|0
3097807|NCT00303316|10619184|P1|Overall Study|Protocol Violation|1
3097808|NCT00303186|10619196|P1|Overall Study|Other|52
3097809|NCT00303108|10619230|P3|Overall Study|ineligible|0
3097810|NCT00303108|10619231|P2|Overall Study|ineligible|1
3097811|NCT00303108|10619232|P1|Overall Study|ineligible|2
3097812|NCT00303108|10619230|P3|Overall Study|Failed Entry|1
3097813|NCT00303108|10619231|P2|Overall Study|Failed Entry|0
3097814|NCT00303108|10619232|P1|Overall Study|Failed Entry|1
3097815|NCT00303108|10619230|P3|Overall Study|Patient Request|8
3097816|NCT00303108|10619231|P2|Overall Study|Patient Request|2
3097817|NCT00303108|10619232|P1|Overall Study|Patient Request|4
3097818|NCT00303108|10619230|P3|Overall Study|Adverse Event|7
3097819|NCT00303108|10619231|P2|Overall Study|Adverse Event|6
3097820|NCT00303108|10619232|P1|Overall Study|Adverse Event|5
3097821|NCT00303069|10619252|P4|Overall Study|Recruitment into Army Reserves|0
3097822|NCT00303069|10619253|P3|Overall Study|Recruitment into Army Reserves|1
3097823|NCT00303069|10619254|P2|Overall Study|Recruitment into Army Reserves|0
3097824|NCT00303069|10619255|P1|Overall Study|Recruitment into Army Reserves|0
3097825|NCT00303069|10619252|P4|Overall Study|subject moved|0
3097826|NCT00303069|10619253|P3|Overall Study|subject moved|0
3097827|NCT00303069|10619254|P2|Overall Study|subject moved|0
3097828|NCT00303069|10619255|P1|Overall Study|subject moved|1
3097829|NCT00303069|10619252|P4|Overall Study|Lost to Follow-up|2
3097830|NCT00303069|10619253|P3|Overall Study|Lost to Follow-up|0
3097831|NCT00303069|10619254|P2|Overall Study|Lost to Follow-up|0
3097832|NCT00303069|10619255|P1|Overall Study|Lost to Follow-up|1
3097833|NCT00302952|10619275|P2|Overall Study|Elevated SGOT (AST) lab value|1
3097834|NCT00302952|10619276|P1|Overall Study|Elevated SGOT (AST) lab value|0
3097835|NCT00302952|10619275|P2|Overall Study|Withdrawal by Subject|3
3097836|NCT00302952|10619276|P1|Overall Study|Withdrawal by Subject|2
3097837|NCT00302952|10619275|P2|Overall Study|Physician Decision|1
3097838|NCT00302952|10619276|P1|Overall Study|Physician Decision|1
3097839|NCT00302731|10619326|P4|Overall Study|cancer unrelated to study discovered|0
3097840|NCT00302731|10619327|P3|Overall Study|cancer unrelated to study discovered|1
3097841|NCT00302731|10619328|P2|Overall Study|cancer unrelated to study discovered|0
3097842|NCT00302731|10619329|P1|Overall Study|cancer unrelated to study discovered|1
3097843|NCT00302731|10619326|P4|Overall Study|Protocol Violation|0
3097844|NCT00302731|10619327|P3|Overall Study|Protocol Violation|0
3097845|NCT00302731|10619328|P2|Overall Study|Protocol Violation|0
3097846|NCT00302731|10619329|P1|Overall Study|Protocol Violation|1
3097847|NCT00302731|10619326|P4|Overall Study|Withdrawal by Subject|0
3097848|NCT00302731|10619327|P3|Overall Study|Withdrawal by Subject|0
3097849|NCT00302731|10619328|P2|Overall Study|Withdrawal by Subject|1
3097850|NCT00302731|10619329|P1|Overall Study|Withdrawal by Subject|1
3097851|NCT00302731|10619326|P4|Overall Study|Adverse Event|0
3097852|NCT00302731|10619327|P3|Overall Study|Adverse Event|2
3097853|NCT00302731|10619328|P2|Overall Study|Adverse Event|2
3097854|NCT00302731|10619329|P1|Overall Study|Adverse Event|0
3097855|NCT00302731|10619326|P4|Overall Study|Lost to Follow-up|0
3097856|NCT00302731|10619327|P3|Overall Study|Lost to Follow-up|0
3097857|NCT00302731|10619328|P2|Overall Study|Lost to Follow-up|2
3097858|NCT00302731|10619329|P1|Overall Study|Lost to Follow-up|1
3097859|NCT00302718|10619355|P4|Overall Study|Participant left primary care setting|1
3097860|NCT00302718|10619356|P3|Overall Study|Participant left primary care setting|2
3097861|NCT00302718|10619357|P2|Overall Study|Participant left primary care setting|0
3097862|NCT00302718|10619358|P1|Overall Study|Participant left primary care setting|0
3097863|NCT00302718|10619355|P4|Overall Study|Withdrawal by Subject|0
3097864|NCT00302718|10619356|P3|Overall Study|Withdrawal by Subject|0
3097865|NCT00302718|10619357|P2|Overall Study|Withdrawal by Subject|1
3097866|NCT00302718|10619358|P1|Overall Study|Withdrawal by Subject|0
3097867|NCT00302718|10619355|P4|Overall Study|Participant left the hospital|1
3097868|NCT00302718|10619356|P3|Overall Study|Participant left the hospital|0
3097869|NCT00302718|10619357|P2|Overall Study|Participant left the hospital|0
3097870|NCT00302718|10619358|P1|Overall Study|Participant left the hospital|1
3097871|NCT00302458|10619424|P1|Overall Study|Withdrawal by Subject|1
3097872|NCT00302458|10619424|P1|Overall Study|Ineligible after screening|1
3097873|NCT00302458|10619424|P1|Overall Study|Lost to Follow-up|1
3097874|NCT00302328|10619435|P3|Overall Study|Physician Decision|0
3097875|NCT00302328|10619436|P2|Overall Study|Physician Decision|1
3097876|NCT00302328|10619437|P1|Overall Study|Physician Decision|0
3097877|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
3097878|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
3097879|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
3097880|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
3097881|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
3097882|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
3097883|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
3097884|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
3097885|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
3097963|NCT00302081|10619518|P1|Overall Study|Withdrawal by Subject|8
3097886|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
3097887|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
3097888|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
3097889|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
3097890|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
3097891|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
3097892|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Death|1
3097893|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Death|1
3097894|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Death|0
3097895|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Death|0
3097896|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Death|0
3097897|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Disease progression|2
3097898|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Disease progression|1
3097899|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Disease progression|0
3097900|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Disease progression|0
3097901|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Disease progression|0
3097902|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
3097903|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
3097904|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
3097905|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
3097906|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
3097907|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Adverse Event|0
3097908|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Adverse Event|1
3097909|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Adverse Event|0
3097910|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Adverse Event|0
3097911|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Adverse Event|0
3097912|NCT00302211|10619454|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
3097913|NCT00302211|10619455|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
3097914|NCT00302211|10619456|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
3097915|NCT00302211|10619457|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
3097916|NCT00302211|10619458|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
3097917|NCT00302211|10619454|P5|Double Blind Period (New Patients)|Disease progression|0
3097918|NCT00302211|10619455|P4|Double Blind Period (New Patients)|Disease progression|0
3097919|NCT00302211|10619456|P3|Double Blind Period (New Patients)|Disease progression|1
3097920|NCT00302211|10619457|P2|Double Blind Period (New Patients)|Disease progression|1
3097921|NCT00302211|10619458|P1|Double Blind Period (New Patients)|Disease progression|0
3097922|NCT00302211|10619454|P5|Double Blind Period (New Patients)|Investigator's judgement|0
3097923|NCT00302211|10619455|P4|Double Blind Period (New Patients)|Investigator's judgement|0
3097924|NCT00302211|10619456|P3|Double Blind Period (New Patients)|Investigator's judgement|0
3097925|NCT00302211|10619457|P2|Double Blind Period (New Patients)|Investigator's judgement|0
3097926|NCT00302211|10619458|P1|Double Blind Period (New Patients)|Investigator's judgement|1
3097927|NCT00302211|10619454|P5|Double Blind Period (New Patients)|Adverse Event|0
3097928|NCT00302211|10619455|P4|Double Blind Period (New Patients)|Adverse Event|0
3097929|NCT00302211|10619456|P3|Double Blind Period (New Patients)|Adverse Event|3
3097930|NCT00302211|10619457|P2|Double Blind Period (New Patients)|Adverse Event|0
3097931|NCT00302211|10619458|P1|Double Blind Period (New Patients)|Adverse Event|0
3097932|NCT00302211|10619454|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
3097933|NCT00302211|10619455|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
3097934|NCT00302211|10619456|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
3097935|NCT00302211|10619457|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
3097936|NCT00302211|10619458|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
3097937|NCT00302159|10619484|P1|Overall Study|pt started Avastin|1
3097938|NCT00302159|10619484|P1|Overall Study|pt declined before treatment started|1
3097939|NCT00302107|10619506|P2|Overall Study|Adverse Event|0
3097940|NCT00302107|10619507|P1|Overall Study|Adverse Event|1
3097941|NCT00302107|10619506|P2|Overall Study|Withdrawal by Subject|3
3097942|NCT00302107|10619507|P1|Overall Study|Withdrawal by Subject|0
3097943|NCT00302107|10619506|P2|Overall Study|Relocation|1
3097944|NCT00302107|10619507|P1|Overall Study|Relocation|0
3097945|NCT00302107|10619506|P2|Overall Study|Protocol Violation|0
3097946|NCT00302107|10619507|P1|Overall Study|Protocol Violation|1
3097947|NCT00302107|10619506|P2|Overall Study|Lost to Follow-up|5
3097948|NCT00302107|10619507|P1|Overall Study|Lost to Follow-up|6
3097949|NCT00302081|10619516|P3|Overall Study|Other|5
3097950|NCT00302081|10619517|P2|Overall Study|Other|6
3097951|NCT00302081|10619518|P1|Overall Study|Other|13
3097952|NCT00302081|10619516|P3|Overall Study|Death|0
3097953|NCT00302081|10619517|P2|Overall Study|Death|1
3097954|NCT00302081|10619518|P1|Overall Study|Death|2
3097955|NCT00302081|10619516|P3|Overall Study|Lack of Efficacy|5
3097956|NCT00302081|10619517|P2|Overall Study|Lack of Efficacy|0
3097957|NCT00302081|10619518|P1|Overall Study|Lack of Efficacy|1
3097958|NCT00302081|10619516|P3|Overall Study|Protocol Violation|2
3097959|NCT00302081|10619517|P2|Overall Study|Protocol Violation|1
3097960|NCT00302081|10619518|P1|Overall Study|Protocol Violation|5
3097961|NCT00302081|10619516|P3|Overall Study|Withdrawal by Subject|8
3097962|NCT00302081|10619517|P2|Overall Study|Withdrawal by Subject|12
3097964|NCT00302081|10619516|P3|Overall Study|Lost to Follow-up|28
3097965|NCT00302081|10619517|P2|Overall Study|Lost to Follow-up|18
3097966|NCT00302081|10619518|P1|Overall Study|Lost to Follow-up|21
3097967|NCT00302081|10619516|P3|Overall Study|Adverse Event|4
3097968|NCT00302081|10619517|P2|Overall Study|Adverse Event|5
3097969|NCT00302081|10619518|P1|Overall Study|Adverse Event|6
3097970|NCT00302003|10619575|P1|Overall Study|Protocol Violation|1
3097971|NCT00302003|10619575|P1|Overall Study|Ineligible|9
3097972|NCT00302003|10619575|P1|Overall Study|Withdrawal by Subject|5
3097973|NCT00302003|10619575|P1|Overall Study|Physician Decision|2
3097974|NCT00302003|10619575|P1|Overall Study|Lost to Follow-up|1
3097975|NCT00302003|10619575|P1|Overall Study|Lack of Efficacy|62
3097976|NCT00301964|10619582|P1|Overall Study|Inadequate pathology|1
3097977|NCT00301964|10619582|P1|Overall Study|Wrong primary|1
3097978|NCT00301964|10619582|P1|Overall Study|Second primary|2
3097979|NCT00301834|10619603|P1|Overall Study|Death|1
3097980|NCT00301821|10619612|P1|Overall Study|Cancel|1
3097981|NCT00301821|10619612|P1|Overall Study|Ineligible|25
3097982|NCT00301808|10619619|P1|Overall Study|Lack of Efficacy|4
3097983|NCT00301808|10619619|P1|Overall Study|Death|3
3097984|NCT00301808|10619619|P1|Overall Study|Adverse Event|5
3097985|NCT00301366|10619644|P1|Overall Study|Adverse Event|1
3097986|NCT00301262|10619650|P2|Open Label Phase (OL)|Other|0
3097987|NCT00301262|10619651|P1|Open Label Phase (OL)|Other|2
3097988|NCT00301262|10619650|P2|Open Label Phase (OL)|Lost to Follow-up|2
3097989|NCT00301262|10619651|P1|Open Label Phase (OL)|Lost to Follow-up|1
3097990|NCT00301262|10619650|P2|Open Label Phase (OL)|Adverse Event|0
3097991|NCT00301262|10619651|P1|Open Label Phase (OL)|Adverse Event|1
3097992|NCT00301262|10619650|P2|Double Blind Phase (DB)|Other|4
3097993|NCT00301262|10619651|P1|Double Blind Phase (DB)|Other|1
3097994|NCT00301262|10619650|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
3097995|NCT00301262|10619651|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
3097996|NCT00301262|10619650|P2|Double Blind Phase (DB)|Lost to Follow-up|3
3097997|NCT00301262|10619651|P1|Double Blind Phase (DB)|Lost to Follow-up|3
3097998|NCT00301262|10619650|P2|Double Blind Phase (DB)|Lack of Efficacy|1
3097999|NCT00301262|10619651|P1|Double Blind Phase (DB)|Lack of Efficacy|0
3098000|NCT00301262|10619650|P2|Double Blind Phase (DB)|Adverse Event|0
3098001|NCT00301262|10619651|P1|Double Blind Phase (DB)|Adverse Event|1
3098002|NCT00301080|10619809|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
3098003|NCT00301080|10619810|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
3098004|NCT00301080|10619811|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
3098005|NCT00301080|10619812|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
3098006|NCT00301080|10619813|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
3098007|NCT00301067|10619842|P4|Follow up Until Death|Alive at last data cut point|1
3098008|NCT00301067|10619843|P3|Follow up Until Death|Alive at last data cut point|0
3098009|NCT00301067|10619844|P2|Follow up Until Death|Alive at last data cut point|0
3098010|NCT00301067|10619845|P1|Follow up Until Death|Alive at last data cut point|1
3098011|NCT00301067|10619842|P4|Completed 12 Cycles of Treatment|Adverse Event|1
3098012|NCT00301067|10619843|P3|Completed 12 Cycles of Treatment|Adverse Event|0
3098013|NCT00301067|10619844|P2|Completed 12 Cycles of Treatment|Adverse Event|0
3098014|NCT00301067|10619845|P1|Completed 12 Cycles of Treatment|Adverse Event|0
3098015|NCT00301067|10619842|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
3098016|NCT00301067|10619843|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
3098017|NCT00301067|10619844|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
3098018|NCT00301067|10619845|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
3098019|NCT00301067|10619842|P4|Completed 4 Cycles of Treatment|Progressive disease|5
3098020|NCT00301067|10619843|P3|Completed 4 Cycles of Treatment|Progressive disease|2
3098021|NCT00301067|10619844|P2|Completed 4 Cycles of Treatment|Progressive disease|1
3098022|NCT00301067|10619845|P1|Completed 4 Cycles of Treatment|Progressive disease|1
3098023|NCT00301067|10619842|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
3098024|NCT00301067|10619843|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
3098025|NCT00301067|10619844|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
3098026|NCT00301067|10619845|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
3098027|NCT00301067|10619842|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
3098028|NCT00301067|10619843|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
3098029|NCT00301067|10619844|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
3098030|NCT00301067|10619845|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
3098031|NCT00300885|10619870|P2|Follow-up|Withdrawal by Subject|25
3098032|NCT00300885|10619871|P1|Follow-up|Withdrawal by Subject|26
3098033|NCT00300885|10619870|P2|Follow-up|Lost to Follow-up|7
3098034|NCT00300885|10619871|P1|Follow-up|Lost to Follow-up|11
3098035|NCT00300885|10619870|P2|Follow-up|Death|163
3098036|NCT00300885|10619871|P1|Follow-up|Death|141
3098037|NCT00300885|10619870|P2|Treatment|Non-compliant with study medication|4
3098038|NCT00300885|10619871|P1|Treatment|Non-compliant with study medication|3
3098039|NCT00300885|10619870|P2|Treatment|Random code broken (subject died)|1
3098040|NCT00300885|10619871|P1|Treatment|Random code broken (subject died)|0
3098041|NCT00300885|10619870|P2|Treatment|Disease progression|238
3098042|NCT00300885|10619871|P1|Treatment|Disease progression|171
3098043|NCT00300885|10619870|P2|Treatment|Withdrawal by Subject|23
3098044|NCT00300885|10619871|P1|Treatment|Withdrawal by Subject|26
3098045|NCT00300885|10619870|P2|Treatment|Protocol Violation|11
3098046|NCT00300885|10619871|P1|Treatment|Protocol Violation|11
3098047|NCT00300885|10619870|P2|Treatment|Physician Decision|5
3098048|NCT00300885|10619871|P1|Treatment|Physician Decision|4
3098049|NCT00300885|10619870|P2|Treatment|Lost to Follow-up|2
3098050|NCT00300885|10619871|P1|Treatment|Lost to Follow-up|3
3098051|NCT00300885|10619870|P2|Treatment|Lack of Efficacy|1
3098052|NCT00300885|10619871|P1|Treatment|Lack of Efficacy|1
3098053|NCT00300885|10619870|P2|Treatment|Death|7
3098054|NCT00300885|10619871|P1|Treatment|Death|20
3098055|NCT00300885|10619870|P2|Treatment|Adverse Event|82
3098056|NCT00300885|10619871|P1|Treatment|Adverse Event|134
3098057|NCT00300781|10619889|P2|Overall Study|Lost to Follow-up|1
3098058|NCT00300781|10619890|P1|Overall Study|Lost to Follow-up|0
3098059|NCT00300781|10619889|P2|Overall Study|Symptomatic Deterioration|0
3098060|NCT00300781|10619890|P1|Overall Study|Symptomatic Deterioration|1
3098061|NCT00300781|10619889|P2|Overall Study|Not Recorded|1
3098062|NCT00300781|10619890|P1|Overall Study|Not Recorded|0
3098063|NCT00300781|10619889|P2|Overall Study|Physician Decision|0
3098064|NCT00300781|10619890|P1|Overall Study|Physician Decision|1
3098065|NCT00300781|10619889|P2|Overall Study|Withdrawal by Subject|2
3098066|NCT00300781|10619890|P1|Overall Study|Withdrawal by Subject|1
3098067|NCT00300781|10619889|P2|Overall Study|Adverse Event|6
3098068|NCT00300781|10619890|P1|Overall Study|Adverse Event|5
3098069|NCT00300781|10619889|P2|Overall Study|Disease Progression|52
3098070|NCT00300781|10619890|P1|Overall Study|Disease Progression|55
3098071|NCT00300755|10619905|P3|Overall Study|Protocol Violation|1
3098072|NCT00300755|10619906|P2|Overall Study|Protocol Violation|0
3098073|NCT00300755|10619907|P1|Overall Study|Protocol Violation|0
3098074|NCT00300755|10619905|P3|Overall Study|Withdrawal by Subject|0
3098075|NCT00300755|10619906|P2|Overall Study|Withdrawal by Subject|2
3098076|NCT00300755|10619907|P1|Overall Study|Withdrawal by Subject|0
3098077|NCT00300755|10619905|P3|Overall Study|Adverse Event|1
3098078|NCT00300755|10619906|P2|Overall Study|Adverse Event|2
3098079|NCT00300755|10619907|P1|Overall Study|Adverse Event|1
3098080|NCT00300495|10619941|P2|Overall Study|Protocol Violation|1
3098081|NCT00300495|10619942|P1|Overall Study|Protocol Violation|4
3098082|NCT00300365|10620209|P2|Overall Study|Adverse Event|2
3098083|NCT00300365|10620210|P1|Overall Study|Adverse Event|0
3098084|NCT00300365|10620209|P2|Overall Study|Withdrawal by Subject|0
3098085|NCT00300365|10620210|P1|Overall Study|Withdrawal by Subject|1
3098086|NCT00300365|10620209|P2|Overall Study|Physician Decision|0
3098087|NCT00300365|10620210|P1|Overall Study|Physician Decision|2
3098088|NCT00300365|10620209|P2|Overall Study|Lost to Follow-up|0
3098089|NCT00300365|10620210|P1|Overall Study|Lost to Follow-up|1
3098090|NCT00300274|10620219|P3|Overall Study|Re-transplant|1
3098091|NCT00300274|10620220|P2|Overall Study|Re-transplant|0
3098092|NCT00300274|10620221|P1|Overall Study|Re-transplant|0
3098093|NCT00300274|10620219|P3|Overall Study|Death|25
3098094|NCT00300274|10620220|P2|Overall Study|Death|20
3098095|NCT00300274|10620221|P1|Overall Study|Death|31
3098096|NCT00300274|10620219|P3|Overall Study|Lost to Follow-up|5
3098097|NCT00300274|10620220|P2|Overall Study|Lost to Follow-up|4
3098098|NCT00300274|10620221|P1|Overall Study|Lost to Follow-up|3
3098099|NCT00300274|10620219|P3|Overall Study|Withdrawal by Subject|14
3098100|NCT00300274|10620220|P2|Overall Study|Withdrawal by Subject|3
3098101|NCT00300274|10620221|P1|Overall Study|Withdrawal by Subject|12
3098102|NCT00299975|10620291|P3|Overall Study|Physician Decision|1
3098103|NCT00299975|10620292|P2|Overall Study|Physician Decision|0
3098104|NCT00299975|10620293|P1|Overall Study|Physician Decision|0
3098105|NCT00299975|10620291|P3|Overall Study|Withdrawal by Subject|3
3098106|NCT00299975|10620292|P2|Overall Study|Withdrawal by Subject|1
3098107|NCT00299975|10620293|P1|Overall Study|Withdrawal by Subject|0
3098108|NCT00299975|10620291|P3|Overall Study|Lost to Follow-up|0
3098109|NCT00299975|10620292|P2|Overall Study|Lost to Follow-up|0
3098110|NCT00299975|10620293|P1|Overall Study|Lost to Follow-up|1
3098111|NCT00299975|10620291|P3|Overall Study|Lack of Efficacy|1
3098112|NCT00299975|10620292|P2|Overall Study|Lack of Efficacy|0
3098113|NCT00299975|10620293|P1|Overall Study|Lack of Efficacy|1
3098114|NCT00299975|10620291|P3|Overall Study|Pregnancy|1
3098115|NCT00299975|10620292|P2|Overall Study|Pregnancy|0
3098116|NCT00299975|10620293|P1|Overall Study|Pregnancy|0
3098117|NCT00299975|10620291|P3|Overall Study|Adverse Event|2
3098118|NCT00299975|10620292|P2|Overall Study|Adverse Event|0
3098119|NCT00299975|10620293|P1|Overall Study|Adverse Event|1
3098120|NCT00299702|10620350|P2|Overall Study|Admin issues, sponsor decision, etc.|9
3098121|NCT00299702|10620351|P1|Overall Study|Admin issues, sponsor decision, etc.|5
3098122|NCT00299702|10620350|P2|Overall Study|Insufficient Response|3
3098123|NCT00299702|10620351|P1|Overall Study|Insufficient Response|4
3098124|NCT00299702|10620350|P2|Overall Study|Pregnancy|1
3098125|NCT00299702|10620351|P1|Overall Study|Pregnancy|0
3098126|NCT00299702|10620350|P2|Overall Study|Withdrawal by Subject|23
3098127|NCT00299702|10620351|P1|Overall Study|Withdrawal by Subject|25
3098128|NCT00299702|10620350|P2|Overall Study|Lost to Follow-up|10
3098129|NCT00299702|10620351|P1|Overall Study|Lost to Follow-up|18
3098130|NCT00299702|10620350|P2|Overall Study|Adverse Event|4
3098131|NCT00299702|10620351|P1|Overall Study|Adverse Event|0
3098132|NCT00299702|10620350|P2|Overall Study|Death|0
3098133|NCT00299702|10620351|P1|Overall Study|Death|1
3098134|NCT00299546|10620366|P3|Overall Study|Not treated|1
3098135|NCT00299546|10620367|P2|Overall Study|Not treated|1
3098136|NCT00299546|10620368|P1|Overall Study|Not treated|0
3098137|NCT00299546|10620366|P3|Overall Study|Other|19
3098138|NCT00299546|10620367|P2|Overall Study|Other|26
3098139|NCT00299546|10620368|P1|Overall Study|Other|24
3098140|NCT00299546|10620366|P3|Overall Study|Unsatisfactory therapeutic effect|34
3098141|NCT00299546|10620367|P2|Overall Study|Unsatisfactory therapeutic effect|39
3098142|NCT00299546|10620368|P1|Overall Study|Unsatisfactory therapeutic effect|34
3098143|NCT00299546|10620366|P3|Overall Study|Adverse Event|27
3098144|NCT00299546|10620367|P2|Overall Study|Adverse Event|22
3098145|NCT00299546|10620368|P1|Overall Study|Adverse Event|37
3098146|NCT00299546|10620366|P3|Overall Study|Lost to Follow-up|5
3098147|NCT00299546|10620367|P2|Overall Study|Lost to Follow-up|2
3098148|NCT00299546|10620368|P1|Overall Study|Lost to Follow-up|2
3098149|NCT00299546|10620366|P3|Overall Study|Death|0
3098150|NCT00299546|10620367|P2|Overall Study|Death|2
3098151|NCT00299546|10620368|P1|Overall Study|Death|3
3098152|NCT00299494|10620399|P6|Overall Study|Other - site closure|1
3098153|NCT00299494|10620400|P5|Overall Study|Other - site closure|1
3098154|NCT00299494|10620401|P4|Overall Study|Other - site closure|1
3098155|NCT00299494|10620402|P3|Overall Study|Other - site closure|0
3098156|NCT00299494|10620403|P2|Overall Study|Other - site closure|0
3098157|NCT00299494|10620404|P1|Overall Study|Other - site closure|0
3098158|NCT00299494|10620399|P6|Overall Study|Other - Unspecified|1
3098159|NCT00299494|10620400|P5|Overall Study|Other - Unspecified|3
3098160|NCT00299494|10620401|P4|Overall Study|Other - Unspecified|0
3098161|NCT00299494|10620402|P3|Overall Study|Other - Unspecified|0
3098162|NCT00299494|10620403|P2|Overall Study|Other - Unspecified|0
3098163|NCT00299494|10620404|P1|Overall Study|Other - Unspecified|0
3098164|NCT00299494|10620399|P6|Overall Study|Lost to Follow-up|1
3098165|NCT00299494|10620400|P5|Overall Study|Lost to Follow-up|3
3098166|NCT00299494|10620401|P4|Overall Study|Lost to Follow-up|0
3098167|NCT00299494|10620402|P3|Overall Study|Lost to Follow-up|0
3098168|NCT00299494|10620403|P2|Overall Study|Lost to Follow-up|0
3098169|NCT00299494|10620404|P1|Overall Study|Lost to Follow-up|0
3098170|NCT00299494|10620399|P6|Overall Study|Death|19
3098171|NCT00299494|10620400|P5|Overall Study|Death|18
3098172|NCT00299494|10620401|P4|Overall Study|Death|6
3098173|NCT00299494|10620402|P3|Overall Study|Death|4
3098174|NCT00299494|10620403|P2|Overall Study|Death|1
3098175|NCT00299494|10620404|P1|Overall Study|Death|3
3098176|NCT00299494|10620399|P6|Overall Study|Physician Decision|0
3098177|NCT00299494|10620400|P5|Overall Study|Physician Decision|1
3098178|NCT00299494|10620401|P4|Overall Study|Physician Decision|0
3098179|NCT00299494|10620402|P3|Overall Study|Physician Decision|0
3098180|NCT00299494|10620403|P2|Overall Study|Physician Decision|0
3098181|NCT00299494|10620404|P1|Overall Study|Physician Decision|0
3098182|NCT00299494|10620399|P6|Overall Study|Withdrawal by Subject|4
3098183|NCT00299494|10620400|P5|Overall Study|Withdrawal by Subject|1
3098184|NCT00299494|10620401|P4|Overall Study|Withdrawal by Subject|3
3098185|NCT00299494|10620402|P3|Overall Study|Withdrawal by Subject|0
3098186|NCT00299494|10620403|P2|Overall Study|Withdrawal by Subject|0
3098187|NCT00299494|10620404|P1|Overall Study|Withdrawal by Subject|0
3098188|NCT00299156|10620533|P3|Period 2 (Randomized)|Screen Failure|0
3098189|NCT00299156|10620534|P2|Period 2 (Randomized)|Screen Failure|1
3098190|NCT00299156|10620535|P1|Period 2 (Randomized)|Screen Failure|0
3098191|NCT00299130|10620546|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
3098192|NCT00299130|10620547|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
3098193|NCT00299130|10620548|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
3098194|NCT00299130|10620546|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
3098195|NCT00299130|10620547|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
3098196|NCT00299130|10620548|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
3098197|NCT00299130|10620546|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
3098198|NCT00299130|10620547|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
3098199|NCT00299130|10620548|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
3098200|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
3098201|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
3098202|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
3098203|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
3098204|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
3098205|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
3098206|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
3098207|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
3098208|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
3098209|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
3098210|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
3098211|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
3098212|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
3098213|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
3098214|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
3098215|NCT00299130|10620546|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
3098216|NCT00299130|10620547|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
3098217|NCT00299130|10620548|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
3098218|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
3098219|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
3098220|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
3098221|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
3098222|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
3098223|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
3098224|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Failure to Return|6
3098225|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Failure to Return|6
3098226|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Failure to Return|4
3098227|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
3098228|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
3098229|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
3098230|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
3098231|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
3098232|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
3098233|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
3098234|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
3098235|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
3098236|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Death|1
3098237|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Death|3
3098238|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Death|1
3098239|NCT00299130|10620546|P3|Treatment Period (up to 5 Years)|Adverse Event|13
3098240|NCT00299130|10620547|P2|Treatment Period (up to 5 Years)|Adverse Event|8
3098241|NCT00299130|10620548|P1|Treatment Period (up to 5 Years)|Adverse Event|13
3098242|NCT00299104|10620653|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
3098243|NCT00299104|10620654|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
3098244|NCT00299104|10620655|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
3098245|NCT00299104|10620653|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
3098246|NCT00299104|10620654|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
3098247|NCT00299104|10620655|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
3098248|NCT00299104|10620653|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
3098249|NCT00299104|10620654|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
3098250|NCT00299104|10620655|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
3098251|NCT00299104|10620653|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
3098252|NCT00299104|10620654|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
3098253|NCT00299104|10620655|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
3098254|NCT00299104|10620653|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
3098255|NCT00299104|10620654|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
3098256|NCT00299104|10620655|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
3098257|NCT00299104|10620653|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
3098258|NCT00299104|10620654|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
3098259|NCT00299104|10620655|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
3098260|NCT00299104|10620653|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
3098261|NCT00299104|10620654|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
3098262|NCT00299104|10620655|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
3098263|NCT00299104|10620653|P3|Safety Follow-Up (SFU) Period|Death|1
3098264|NCT00299104|10620654|P2|Safety Follow-Up (SFU) Period|Death|2
3098265|NCT00299104|10620655|P1|Safety Follow-Up (SFU) Period|Death|3
3098266|NCT00299104|10620653|P3|Treatment Period|Administrative reasons|137
3098267|NCT00299104|10620654|P2|Treatment Period|Administrative reasons|120
3098268|NCT00299104|10620655|P1|Treatment Period|Administrative reasons|106
3098269|NCT00299104|10620653|P3|Treatment Period|Withdrew consent|9
3098270|NCT00299104|10620654|P2|Treatment Period|Withdrew consent|19
3098271|NCT00299104|10620655|P1|Treatment Period|Withdrew consent|14
3098272|NCT00299104|10620653|P3|Treatment Period|Refused treatment|2
3098273|NCT00299104|10620654|P2|Treatment Period|Refused treatment|2
3098274|NCT00299104|10620655|P1|Treatment Period|Refused treatment|9
3098275|NCT00299104|10620653|P3|Treatment Period|Protocol Violation|0
3098276|NCT00299104|10620654|P2|Treatment Period|Protocol Violation|1
3098277|NCT00299104|10620655|P1|Treatment Period|Protocol Violation|1
3098278|NCT00299104|10620653|P3|Treatment Period|Violation of selection criteria|0
3098279|NCT00299104|10620654|P2|Treatment Period|Violation of selection criteria|2
3098280|NCT00299104|10620655|P1|Treatment Period|Violation of selection criteria|1
3098281|NCT00299104|10620653|P3|Treatment Period|Failure to return|8
3098282|NCT00299104|10620654|P2|Treatment Period|Failure to return|8
3098283|NCT00299104|10620655|P1|Treatment Period|Failure to return|9
3098284|NCT00299104|10620653|P3|Treatment Period|Insufficient therapeutic response|8
3098285|NCT00299104|10620654|P2|Treatment Period|Insufficient therapeutic response|13
3098286|NCT00299104|10620655|P1|Treatment Period|Insufficient therapeutic response|34
3098287|NCT00299104|10620653|P3|Treatment Period|Death|1
3098288|NCT00299104|10620654|P2|Treatment Period|Death|1
3098289|NCT00299104|10620655|P1|Treatment Period|Death|1
3098290|NCT00299104|10620653|P3|Treatment Period|Adverse Event|7
3098291|NCT00299104|10620654|P2|Treatment Period|Adverse Event|9
3098292|NCT00299104|10620655|P1|Treatment Period|Adverse Event|14
3098293|NCT00298896|10620765|P1|Overall Study|Assigned to treatment in error|1
3098294|NCT00298896|10620765|P1|Overall Study|Withdrawal by Subject|2
3098295|NCT00298896|10620765|P1|Overall Study|Disease Progression|41
3098296|NCT00298896|10620765|P1|Overall Study|Intercurrent Illness|1
3098297|NCT00298896|10620765|P1|Overall Study|Physician Decision|2
3098298|NCT00298896|10620765|P1|Overall Study|Death|3
3098299|NCT00298831|10620770|P1|Overall Study|Participants did not receive treatment|27
3098300|NCT00298831|10620770|P1|Overall Study|Withdrawal by Subject|1
3098301|NCT00298831|10620770|P1|Overall Study|Lost to Follow-up|3
3098302|NCT00298831|10620770|P1|Overall Study|Adverse Event|1
3098303|NCT00298766|10620779|P1|Overall Study|Other|4
3098304|NCT00298766|10620779|P1|Overall Study|Subjects overall condition deterioration|4
3098305|NCT00298766|10620779|P1|Overall Study|Deterioration in KPS and organ function|1
3098306|NCT00298766|10620779|P1|Overall Study|Progression of amyloid markers|4
3098307|NCT00298766|10620779|P1|Overall Study|Treatment ongoing|4
3098308|NCT00298766|10620779|P1|Overall Study|Withdrawal by Subject|9
3098309|NCT00298766|10620779|P1|Overall Study|Death|2
3098310|NCT00298766|10620779|P1|Overall Study|Adverse Event|18
3098311|NCT00298740|10620788|P1|Overall Study|Withdrawal by Subject|3
3098312|NCT00298740|10620788|P1|Overall Study|Lack of Efficacy|6
3098313|NCT00298363|10620858|P3|Overall Study|Lack of Efficacy|0
3098314|NCT00298363|10620859|P2|Overall Study|Lack of Efficacy|3
3098315|NCT00298363|10620860|P1|Overall Study|Lack of Efficacy|2
3098316|NCT00298363|10620858|P3|Overall Study|Adverse Event|2
3098317|NCT00298363|10620859|P2|Overall Study|Adverse Event|2
3098318|NCT00298363|10620860|P1|Overall Study|Adverse Event|5
3098319|NCT00298363|10620858|P3|Overall Study|Withdrawal by Subject|3
3098320|NCT00298363|10620859|P2|Overall Study|Withdrawal by Subject|1
3098321|NCT00298363|10620860|P1|Overall Study|Withdrawal by Subject|5
3098322|NCT00298363|10620858|P3|Overall Study|Protocol Violation|0
3098323|NCT00298363|10620859|P2|Overall Study|Protocol Violation|1
3098324|NCT00298363|10620860|P1|Overall Study|Protocol Violation|1
3098325|NCT00298363|10620858|P3|Overall Study|Physician Decision|0
3098326|NCT00298363|10620859|P2|Overall Study|Physician Decision|1
3098327|NCT00298363|10620860|P1|Overall Study|Physician Decision|4
3098328|NCT00298363|10620858|P3|Overall Study|Lost to Follow-up|1
3098329|NCT00298363|10620859|P2|Overall Study|Lost to Follow-up|0
3098330|NCT00298363|10620860|P1|Overall Study|Lost to Follow-up|0
3098331|NCT00298272|10621018|P2|Safety Follow-up Phase|Administrative/Other Reason|1
3098332|NCT00298272|10621019|P1|Safety Follow-up Phase|Administrative/Other Reason|1
3098333|NCT00298272|10621018|P2|Safety Follow-up Phase|Withdrawal by Subject|2
3098334|NCT00298272|10621019|P1|Safety Follow-up Phase|Withdrawal by Subject|2
3098335|NCT00298272|10621018|P2|Safety Follow-up Phase|Failure to Return|1
3098336|NCT00298272|10621019|P1|Safety Follow-up Phase|Failure to Return|1
3098337|NCT00298272|10621018|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
3098338|NCT00298272|10621019|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
3098339|NCT00298272|10621018|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
3098340|NCT00298272|10621019|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
3098341|NCT00298272|10621018|P2|Open Label Retreatment Phase|Protocol Violation|1
3098342|NCT00298272|10621019|P1|Open Label Retreatment Phase|Protocol Violation|2
3098343|NCT00298272|10621018|P2|Open Label Retreatment Phase|Failure to Return|0
3098344|NCT00298272|10621019|P1|Open Label Retreatment Phase|Failure to Return|1
3098345|NCT00298272|10621018|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
3098346|NCT00298272|10621019|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
3098347|NCT00298272|10621018|P2|Open Label Retreatment Phase|Adverse Event|2
3098348|NCT00298272|10621019|P1|Open Label Retreatment Phase|Adverse Event|1
3098349|NCT00298272|10621018|P2|Double-blind Phase|Withdrawal by Subject|0
3098350|NCT00298272|10621019|P1|Double-blind Phase|Withdrawal by Subject|2
3098351|NCT00298272|10621018|P2|Double-blind Phase|Protocol Violation|0
3098352|NCT00298272|10621019|P1|Double-blind Phase|Protocol Violation|2
3098353|NCT00298272|10621018|P2|Double-blind Phase|Failure to Return|0
3098354|NCT00298272|10621019|P1|Double-blind Phase|Failure to Return|2
3098355|NCT00298272|10621018|P2|Double-blind Phase|Adverse Event|0
3098356|NCT00298272|10621019|P1|Double-blind Phase|Adverse Event|2
3098357|NCT00298038|10621083|P2|Overall Study|Severe Gastrointestinal Bleed|0
3098358|NCT00298038|10621084|P1|Overall Study|Severe Gastrointestinal Bleed|1
3098359|NCT00298038|10621083|P2|Overall Study|Cocaine Abuse|0
3098360|NCT00298038|10621084|P1|Overall Study|Cocaine Abuse|1
3098361|NCT00298038|10621083|P2|Overall Study|Noncompliance|0
3098362|NCT00298038|10621084|P1|Overall Study|Noncompliance|1
3098363|NCT00298038|10621083|P2|Overall Study|Breakthrough overt HE episode|69
3098364|NCT00298038|10621084|P1|Overall Study|Breakthrough overt HE episode|28
3098365|NCT00298038|10621083|P2|Overall Study|Adverse Event|7
3098366|NCT00298038|10621084|P1|Overall Study|Adverse Event|8
3098367|NCT00298038|10621083|P2|Overall Study|Withdrawal by Subject|9
3098368|NCT00298038|10621084|P1|Overall Study|Withdrawal by Subject|6
3098369|NCT00298038|10621083|P2|Overall Study|Death|3
3098370|NCT00298038|10621084|P1|Overall Study|Death|6
3098371|NCT00298038|10621083|P2|Overall Study|Protocol Violation|3
3098372|NCT00298038|10621084|P1|Overall Study|Protocol Violation|1
3098373|NCT00298038|10621083|P2|Overall Study|Liver Transplant|1
3098374|NCT00298038|10621084|P1|Overall Study|Liver Transplant|0
3098375|NCT00298038|10621083|P2|Overall Study|Lost to Follow-up|1
3098376|NCT00298038|10621084|P1|Overall Study|Lost to Follow-up|0
3098377|NCT00297830|10621103|P3|12 Month Visit|Withdrawal by Subject|0
3098378|NCT00297830|10621104|P2|12 Month Visit|Withdrawal by Subject|3
3098379|NCT00297830|10621105|P1|12 Month Visit|Withdrawal by Subject|0
3098380|NCT00297830|10621103|P3|12 Month Visit|Adverse Event|0
3098381|NCT00297830|10621104|P2|12 Month Visit|Adverse Event|3
3098382|NCT00297830|10621105|P1|12 Month Visit|Adverse Event|0
3098383|NCT00297830|10621103|P3|12 Month Visit|Lost to Follow-up|0
3098384|NCT00297830|10621104|P2|12 Month Visit|Lost to Follow-up|0
3098385|NCT00297830|10621105|P1|12 Month Visit|Lost to Follow-up|1
3098386|NCT00297830|10621103|P3|6 Month Visit|Adverse Event|0
3098387|NCT00297830|10621104|P2|6 Month Visit|Adverse Event|1
3098388|NCT00297830|10621105|P1|6 Month Visit|Adverse Event|0
3098389|NCT00297830|10621103|P3|6 Month Visit|Withdrawal by Subject|1
3098390|NCT00297830|10621104|P2|6 Month Visit|Withdrawal by Subject|1
3098391|NCT00297830|10621105|P1|6 Month Visit|Withdrawal by Subject|2
3098392|NCT00297830|10621103|P3|6 Month Visit|Death|2
3098393|NCT00297830|10621104|P2|6 Month Visit|Death|0
3098394|NCT00297830|10621105|P1|6 Month Visit|Death|1
3098395|NCT00297778|10621124|P2|Overall Study|Other|1
3098396|NCT00297778|10621125|P1|Overall Study|Other|0
3098397|NCT00297778|10621124|P2|Overall Study|Non-compliant with trial protocol|3
3098398|NCT00297778|10621125|P1|Overall Study|Non-compliant with trial protocol|0
3098399|NCT00297778|10621124|P2|Overall Study|Lack of Efficacy|1
3098400|NCT00297778|10621125|P1|Overall Study|Lack of Efficacy|2
3098401|NCT00297778|10621124|P2|Overall Study|Withdrawal by Subject|5
3098402|NCT00297778|10621125|P1|Overall Study|Withdrawal by Subject|1
3098403|NCT00297778|10621124|P2|Overall Study|Adverse Event|10
3098404|NCT00297778|10621125|P1|Overall Study|Adverse Event|16
3098405|NCT00297648|10621159|P1|Overall Study|Other: Incompliance|1
3098406|NCT00297648|10621159|P1|Overall Study|Withdrawal by Subject|3
3098407|NCT00297648|10621159|P1|Overall Study|Lost to Follow-up|1
3098408|NCT00297648|10621159|P1|Overall Study|Lack of Efficacy|18
3098409|NCT00297648|10621159|P1|Overall Study|Adverse Event|13
3098410|NCT00297492|10621205|P3|6 Month Follow-up|Lost to Follow-up|27
3098411|NCT00297492|10621206|P2|6 Month Follow-up|Lost to Follow-up|49
3098412|NCT00297492|10621207|P1|6 Month Follow-up|Lost to Follow-up|63
3098413|NCT00297492|10621205|P3|Set Quit Date|Lost to Follow-up|5
3098414|NCT00297492|10621206|P2|Set Quit Date|Lost to Follow-up|13
3098415|NCT00297492|10621207|P1|Set Quit Date|Lost to Follow-up|7
3098416|NCT00297427|10621217|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
3098417|NCT00297427|10621218|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
3098418|NCT00297427|10621217|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
3098419|NCT00297427|10621218|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
3098420|NCT00297427|10621217|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
3098421|NCT00297427|10621218|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
3098422|NCT00297427|10621217|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
3098423|NCT00297427|10621218|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
3098424|NCT00297427|10621217|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
3098425|NCT00297427|10621218|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
3098426|NCT00297427|10621217|P2|Phase 1: Initial Intervention|Death|1
3098427|NCT00297427|10621218|P1|Phase 1: Initial Intervention|Death|0
3098428|NCT00297427|10621217|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
3098429|NCT00297427|10621218|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
3098430|NCT00297427|10621217|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
3098431|NCT00297427|10621218|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
3098432|NCT00297258|10621259|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
3098433|NCT00297258|10621259|P1|Overall Study|Switch to Commercial Treatment|1
3098434|NCT00297258|10621259|P1|Overall Study|Surgery Performed on Target Lesion|1
3098435|NCT00297258|10621259|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
3098436|NCT00297258|10621259|P1|Overall Study|Deteriorization of General Condition|1
3098437|NCT00297258|10621259|P1|Overall Study|Intercurrent Death|2
3098438|NCT00297258|10621259|P1|Overall Study|Intercurrent Illness|3
3098439|NCT00297258|10621259|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
3098440|NCT00297258|10621259|P1|Overall Study|Toxicity (or Toxic Death)|10
3098441|NCT00297258|10621259|P1|Overall Study|Disease Progression, Relapse, Death|120
3098442|NCT00297232|10621278|P1|Overall Study|Other|1
3098443|NCT00297232|10621278|P1|Overall Study|No data available after Week 264|161
3098444|NCT00297232|10621278|P1|Overall Study|Did Not Enroll to Week 480|17
3098445|NCT00297232|10621278|P1|Overall Study|Did Not Enroll to Week 264|34
3098446|NCT00297232|10621278|P1|Overall Study|Investigator Withdrew From Program|19
3098447|NCT00297232|10621278|P1|Overall Study|Persistently Positive Antibodies|11
3098448|NCT00297232|10621278|P1|Overall Study|Subject Withdrew Consent|37
3098449|NCT00297232|10621278|P1|Overall Study|Subject Relocated|7
3098450|NCT00297232|10621278|P1|Overall Study|Sponsor Decision|34
3098451|NCT00297232|10621278|P1|Overall Study|Miscellaneous|5
3098452|NCT00297232|10621278|P1|Overall Study|Anti-JCV Antibody Positive|13
3098453|NCT00297232|10621278|P1|Overall Study|Fear of PML|10
3098454|NCT00297232|10621278|P1|Overall Study|Disease Progression|8
3098455|NCT00297232|10621278|P1|Overall Study|Switched to Commercial Tysabri|22
3098456|NCT00297232|10621278|P1|Overall Study|Anti-natalizumab Positive|8
3098457|NCT00297232|10621278|P1|Overall Study|Death|9
3098458|NCT00297232|10621278|P1|Overall Study|Subject was Noncompliant|9
3098459|NCT00297232|10621278|P1|Overall Study|Voluntary Withdrawal|120
3098460|NCT00297232|10621278|P1|Overall Study|Adverse Event|63
3098461|NCT00297232|10621278|P1|Overall Study|Lost to Follow-up|10
3098462|NCT00297232|10621278|P1|Overall Study|Lack of Efficacy|7
3098463|NCT00297167|10621284|P3|Second Double-blind Intervention Period|Protocol Violation|0
3098464|NCT00297167|10621285|P2|Second Double-blind Intervention Period|Protocol Violation|0
3098465|NCT00297167|10621286|P1|Second Double-blind Intervention Period|Protocol Violation|1
3098466|NCT00297167|10621284|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
3098467|NCT00297167|10621285|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
3098468|NCT00297167|10621286|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
3098469|NCT00297037|10621350|P2|Overall Study|Withdrawal by Subject|0
3098470|NCT00297037|10621351|P1|Overall Study|Withdrawal by Subject|2
3098471|NCT00296816|10621363|P1|Overall Study|ineligibility due to radiation treatment|1
3098472|NCT00296816|10621363|P1|Overall Study|Proteinuria|1
3098473|NCT00296816|10621363|P1|Overall Study|Neuropathy/patient preference|1
3098474|NCT00296816|10621363|P1|Overall Study|Urine protein/creatinine ratio delay|1
3098475|NCT00296816|10621363|P1|Overall Study|Noncompliance/decision to discontinue|1
3098476|NCT00296816|10621363|P1|Overall Study|Relocation to Florida|1
3098477|NCT00296816|10621363|P1|Overall Study|Poor performance status|1
3098478|NCT00296816|10621363|P1|Overall Study|Progression based on CA-125 (biomarker)|2
3098479|NCT00296816|10621363|P1|Overall Study|Missing for end of treatment|4
3098480|NCT00296816|10621363|P1|Overall Study|Non-compliance|1
3098481|NCT00296816|10621363|P1|Overall Study|Investigator/Participant request|5
3098482|NCT00296816|10621363|P1|Overall Study|Adverse Event|18
3098483|NCT00296816|10621363|P1|Overall Study|Disease Progression|37
3098484|NCT00296725|10621375|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
3098485|NCT00296725|10621375|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
3098486|NCT00296725|10621375|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
3098487|NCT00296647|10621388|P5|Overall Study|Withdrawal by Subject|19
3098488|NCT00296647|10621389|P4|Overall Study|Withdrawal by Subject|16
3098489|NCT00296647|10621390|P3|Overall Study|Withdrawal by Subject|32
3098490|NCT00296647|10621391|P2|Overall Study|Withdrawal by Subject|27
3098491|NCT00296647|10621392|P1|Overall Study|Withdrawal by Subject|28
3098492|NCT00296647|10621388|P5|Overall Study|Death|1
3098493|NCT00296647|10621389|P4|Overall Study|Death|1
3098494|NCT00296647|10621390|P3|Overall Study|Death|2
3098495|NCT00296647|10621391|P2|Overall Study|Death|1
3098496|NCT00296647|10621392|P1|Overall Study|Death|4
3098497|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Other|2
3098498|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Other|0
3098499|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
3098500|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
3098501|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
3098502|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
3098503|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
3098504|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
3098505|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
3098506|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
3098507|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
3098508|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
3098509|NCT00296517|10621406|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
3098510|NCT00296517|10621407|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
3098511|NCT00296517|10621406|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
3098512|NCT00296517|10621407|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
3098513|NCT00296517|10621406|P2|Dose Level 2 - Week 2|Adverse Event|5
3098514|NCT00296517|10621407|P1|Dose Level 2 - Week 2|Adverse Event|1
3098515|NCT00296504|10621443|P9|Final Analysis|Poor Adherence|1
3098516|NCT00296504|10621444|P8|Final Analysis|Poor Adherence|0
3098517|NCT00296504|10621445|P7|Final Analysis|Poor Adherence|0
3098518|NCT00296504|10621446|P6|Final Analysis|Poor Adherence|0
3098519|NCT00296504|10621447|P5|Final Analysis|Poor Adherence|0
3098520|NCT00296504|10621448|P4|Final Analysis|Poor Adherence|0
3098521|NCT00296504|10621449|P3|Final Analysis|Poor Adherence|0
3098522|NCT00296504|10621450|P2|Final Analysis|Poor Adherence|0
3098523|NCT00296504|10621451|P1|Final Analysis|Poor Adherence|0
3098524|NCT00296504|10621443|P9|Final Analysis|Participant Moved to Another Country|1
3098525|NCT00296504|10621444|P8|Final Analysis|Participant Moved to Another Country|0
3098526|NCT00296504|10621445|P7|Final Analysis|Participant Moved to Another Country|0
3098527|NCT00296504|10621446|P6|Final Analysis|Participant Moved to Another Country|0
3098528|NCT00296504|10621447|P5|Final Analysis|Participant Moved to Another Country|0
3098529|NCT00296504|10621448|P4|Final Analysis|Participant Moved to Another Country|0
3098530|NCT00296504|10621449|P3|Final Analysis|Participant Moved to Another Country|0
3098531|NCT00296504|10621450|P2|Final Analysis|Participant Moved to Another Country|0
3098532|NCT00296504|10621451|P1|Final Analysis|Participant Moved to Another Country|0
3098533|NCT00296504|10621443|P9|Final Analysis|Tuberculosis|1
3098534|NCT00296504|10621444|P8|Final Analysis|Tuberculosis|0
3098535|NCT00296504|10621445|P7|Final Analysis|Tuberculosis|0
3098536|NCT00296504|10621446|P6|Final Analysis|Tuberculosis|0
3098537|NCT00296504|10621447|P5|Final Analysis|Tuberculosis|0
3098538|NCT00296504|10621448|P4|Final Analysis|Tuberculosis|0
3098539|NCT00296504|10621449|P3|Final Analysis|Tuberculosis|0
3098540|NCT00296504|10621450|P2|Final Analysis|Tuberculosis|0
3098541|NCT00296504|10621451|P1|Final Analysis|Tuberculosis|0
3098542|NCT00296504|10621443|P9|Final Analysis|Pregnancy|4
3098543|NCT00296504|10621444|P8|Final Analysis|Pregnancy|0
3098544|NCT00296504|10621445|P7|Final Analysis|Pregnancy|0
3098545|NCT00296504|10621446|P6|Final Analysis|Pregnancy|0
3098546|NCT00296504|10621447|P5|Final Analysis|Pregnancy|0
3098547|NCT00296504|10621448|P4|Final Analysis|Pregnancy|0
3098548|NCT00296504|10621449|P3|Final Analysis|Pregnancy|0
3098549|NCT00296504|10621450|P2|Final Analysis|Pregnancy|0
3098550|NCT00296504|10621451|P1|Final Analysis|Pregnancy|0
3098551|NCT00296504|10621443|P9|Final Analysis|Adverse Event|2
3098552|NCT00296504|10621444|P8|Final Analysis|Adverse Event|0
3098553|NCT00296504|10621445|P7|Final Analysis|Adverse Event|0
3098554|NCT00296504|10621446|P6|Final Analysis|Adverse Event|0
3098555|NCT00296504|10621447|P5|Final Analysis|Adverse Event|0
3098556|NCT00296504|10621448|P4|Final Analysis|Adverse Event|0
3098557|NCT00296504|10621449|P3|Final Analysis|Adverse Event|0
3098558|NCT00296504|10621450|P2|Final Analysis|Adverse Event|0
3098559|NCT00296504|10621451|P1|Final Analysis|Adverse Event|0
3098560|NCT00296504|10621443|P9|Final Analysis|Insufficient Viral Load Response|6
3098561|NCT00296504|10621444|P8|Final Analysis|Insufficient Viral Load Response|0
3098562|NCT00296504|10621445|P7|Final Analysis|Insufficient Viral Load Response|0
3098563|NCT00296504|10621446|P6|Final Analysis|Insufficient Viral Load Response|0
3098564|NCT00296504|10621447|P5|Final Analysis|Insufficient Viral Load Response|0
3098565|NCT00296504|10621448|P4|Final Analysis|Insufficient Viral Load Response|0
3098566|NCT00296504|10621449|P3|Final Analysis|Insufficient Viral Load Response|0
3098567|NCT00296504|10621450|P2|Final Analysis|Insufficient Viral Load Response|0
3098568|NCT00296504|10621451|P1|Final Analysis|Insufficient Viral Load Response|0
3098569|NCT00296504|10621443|P9|Final Analysis|Lost to Follow-up|5
3098570|NCT00296504|10621444|P8|Final Analysis|Lost to Follow-up|0
3098571|NCT00296504|10621445|P7|Final Analysis|Lost to Follow-up|0
3098572|NCT00296504|10621446|P6|Final Analysis|Lost to Follow-up|0
3098573|NCT00296504|10621447|P5|Final Analysis|Lost to Follow-up|0
3098574|NCT00296504|10621448|P4|Final Analysis|Lost to Follow-up|0
3098575|NCT00296504|10621449|P3|Final Analysis|Lost to Follow-up|0
3098576|NCT00296504|10621450|P2|Final Analysis|Lost to Follow-up|0
3098577|NCT00296504|10621451|P1|Final Analysis|Lost to Follow-up|0
3098578|NCT00296504|10621443|P9|Final Analysis|Withdrawal by Subject|1
3098579|NCT00296504|10621444|P8|Final Analysis|Withdrawal by Subject|0
3098580|NCT00296504|10621445|P7|Final Analysis|Withdrawal by Subject|0
3098581|NCT00296504|10621446|P6|Final Analysis|Withdrawal by Subject|0
3098582|NCT00296504|10621447|P5|Final Analysis|Withdrawal by Subject|0
3098583|NCT00296504|10621448|P4|Final Analysis|Withdrawal by Subject|0
3098584|NCT00296504|10621449|P3|Final Analysis|Withdrawal by Subject|0
3098585|NCT00296504|10621450|P2|Final Analysis|Withdrawal by Subject|0
3098586|NCT00296504|10621451|P1|Final Analysis|Withdrawal by Subject|0
3098587|NCT00296504|10621443|P9|Interim Analysis|Ongoing|0
3098588|NCT00296504|10621444|P8|Interim Analysis|Ongoing|1
3098589|NCT00296504|10621445|P7|Interim Analysis|Ongoing|30
3098590|NCT00296504|10621446|P6|Interim Analysis|Ongoing|0
3098591|NCT00296504|10621447|P5|Interim Analysis|Ongoing|0
3098592|NCT00296504|10621448|P4|Interim Analysis|Ongoing|22
3098593|NCT00296504|10621449|P3|Interim Analysis|Ongoing|16
3098594|NCT00296504|10621450|P2|Interim Analysis|Ongoing|12
3098595|NCT00296504|10621451|P1|Interim Analysis|Ongoing|32
3098596|NCT00296504|10621443|P9|Interim Analysis|Participant Needed Interferon|0
3098597|NCT00296504|10621444|P8|Interim Analysis|Participant Needed Interferon|1
3098598|NCT00296504|10621445|P7|Interim Analysis|Participant Needed Interferon|0
3098599|NCT00296504|10621446|P6|Interim Analysis|Participant Needed Interferon|0
3098600|NCT00296504|10621447|P5|Interim Analysis|Participant Needed Interferon|0
3098601|NCT00296504|10621448|P4|Interim Analysis|Participant Needed Interferon|0
3098602|NCT00296504|10621449|P3|Interim Analysis|Participant Needed Interferon|0
3098603|NCT00296504|10621450|P2|Interim Analysis|Participant Needed Interferon|0
3098604|NCT00296504|10621451|P1|Interim Analysis|Participant Needed Interferon|0
3098605|NCT00296504|10621443|P9|Interim Analysis|Study Ended|0
3098606|NCT00296504|10621444|P8|Interim Analysis|Study Ended|0
3098607|NCT00296504|10621445|P7|Interim Analysis|Study Ended|1
3098608|NCT00296504|10621446|P6|Interim Analysis|Study Ended|0
3098609|NCT00296504|10621447|P5|Interim Analysis|Study Ended|0
3098610|NCT00296504|10621448|P4|Interim Analysis|Study Ended|0
3098611|NCT00296504|10621449|P3|Interim Analysis|Study Ended|0
3098612|NCT00296504|10621450|P2|Interim Analysis|Study Ended|0
3098613|NCT00296504|10621451|P1|Interim Analysis|Study Ended|0
3098614|NCT00296504|10621443|P9|Interim Analysis|Participant Stopped HIV Medications|0
3098615|NCT00296504|10621444|P8|Interim Analysis|Participant Stopped HIV Medications|0
3098616|NCT00296504|10621445|P7|Interim Analysis|Participant Stopped HIV Medications|1
3098617|NCT00296504|10621446|P6|Interim Analysis|Participant Stopped HIV Medications|0
3098618|NCT00296504|10621447|P5|Interim Analysis|Participant Stopped HIV Medications|0
3098619|NCT00296504|10621448|P4|Interim Analysis|Participant Stopped HIV Medications|0
3098620|NCT00296504|10621449|P3|Interim Analysis|Participant Stopped HIV Medications|0
3098621|NCT00296504|10621450|P2|Interim Analysis|Participant Stopped HIV Medications|0
3098622|NCT00296504|10621451|P1|Interim Analysis|Participant Stopped HIV Medications|0
3098623|NCT00296504|10621443|P9|Interim Analysis|Physician and Participant Decision|0
3098624|NCT00296504|10621444|P8|Interim Analysis|Physician and Participant Decision|0
3098625|NCT00296504|10621445|P7|Interim Analysis|Physician and Participant Decision|0
3098626|NCT00296504|10621446|P6|Interim Analysis|Physician and Participant Decision|1
3098627|NCT00296504|10621447|P5|Interim Analysis|Physician and Participant Decision|0
3098628|NCT00296504|10621448|P4|Interim Analysis|Physician and Participant Decision|0
3098629|NCT00296504|10621449|P3|Interim Analysis|Physician and Participant Decision|0
3098630|NCT00296504|10621450|P2|Interim Analysis|Physician and Participant Decision|0
3098631|NCT00296504|10621451|P1|Interim Analysis|Physician and Participant Decision|0
3098632|NCT00296504|10621443|P9|Interim Analysis|Participant Stopped|0
3098633|NCT00296504|10621444|P8|Interim Analysis|Participant Stopped|0
3098634|NCT00296504|10621445|P7|Interim Analysis|Participant Stopped|0
3098635|NCT00296504|10621446|P6|Interim Analysis|Participant Stopped|0
3098636|NCT00296504|10621447|P5|Interim Analysis|Participant Stopped|1
3098637|NCT00296504|10621448|P4|Interim Analysis|Participant Stopped|0
3098638|NCT00296504|10621449|P3|Interim Analysis|Participant Stopped|0
3098639|NCT00296504|10621450|P2|Interim Analysis|Participant Stopped|0
3098640|NCT00296504|10621451|P1|Interim Analysis|Participant Stopped|0
3098641|NCT00296504|10621443|P9|Interim Analysis|Inclusion in Other Protocol|0
3098642|NCT00296504|10621444|P8|Interim Analysis|Inclusion in Other Protocol|0
3098643|NCT00296504|10621445|P7|Interim Analysis|Inclusion in Other Protocol|0
3098644|NCT00296504|10621446|P6|Interim Analysis|Inclusion in Other Protocol|0
3098645|NCT00296504|10621447|P5|Interim Analysis|Inclusion in Other Protocol|0
3098646|NCT00296504|10621448|P4|Interim Analysis|Inclusion in Other Protocol|1
3098647|NCT00296504|10621449|P3|Interim Analysis|Inclusion in Other Protocol|0
3098648|NCT00296504|10621450|P2|Interim Analysis|Inclusion in Other Protocol|0
3098649|NCT00296504|10621451|P1|Interim Analysis|Inclusion in Other Protocol|0
3098650|NCT00296504|10621443|P9|Interim Analysis|Missed Schedule Date|0
3098651|NCT00296504|10621444|P8|Interim Analysis|Missed Schedule Date|0
3098652|NCT00296504|10621445|P7|Interim Analysis|Missed Schedule Date|0
3098653|NCT00296504|10621446|P6|Interim Analysis|Missed Schedule Date|0
3098654|NCT00296504|10621447|P5|Interim Analysis|Missed Schedule Date|0
3098655|NCT00296504|10621448|P4|Interim Analysis|Missed Schedule Date|0
3098656|NCT00296504|10621449|P3|Interim Analysis|Missed Schedule Date|0
3098657|NCT00296504|10621450|P2|Interim Analysis|Missed Schedule Date|0
3098658|NCT00296504|10621451|P1|Interim Analysis|Missed Schedule Date|1
3098659|NCT00296504|10621443|P9|Interim Analysis|Lack of Personnel at Site|0
3098660|NCT00296504|10621444|P8|Interim Analysis|Lack of Personnel at Site|0
3098661|NCT00296504|10621445|P7|Interim Analysis|Lack of Personnel at Site|0
3098662|NCT00296504|10621446|P6|Interim Analysis|Lack of Personnel at Site|0
3098663|NCT00296504|10621447|P5|Interim Analysis|Lack of Personnel at Site|0
3098664|NCT00296504|10621448|P4|Interim Analysis|Lack of Personnel at Site|0
3098665|NCT00296504|10621449|P3|Interim Analysis|Lack of Personnel at Site|0
3098666|NCT00296504|10621450|P2|Interim Analysis|Lack of Personnel at Site|0
3098667|NCT00296504|10621451|P1|Interim Analysis|Lack of Personnel at Site|1
3098668|NCT00296504|10621443|P9|Interim Analysis|Site Closing|0
3098669|NCT00296504|10621444|P8|Interim Analysis|Site Closing|0
3098670|NCT00296504|10621445|P7|Interim Analysis|Site Closing|2
3098671|NCT00296504|10621446|P6|Interim Analysis|Site Closing|1
3098672|NCT00296504|10621447|P5|Interim Analysis|Site Closing|0
3098673|NCT00296504|10621448|P4|Interim Analysis|Site Closing|0
3098674|NCT00296504|10621449|P3|Interim Analysis|Site Closing|0
3098675|NCT00296504|10621450|P2|Interim Analysis|Site Closing|0
3098676|NCT00296504|10621451|P1|Interim Analysis|Site Closing|1
3098677|NCT00296504|10621443|P9|Interim Analysis|Non-adherence|0
3098678|NCT00296504|10621444|P8|Interim Analysis|Non-adherence|1
3098679|NCT00296504|10621445|P7|Interim Analysis|Non-adherence|0
3098680|NCT00296504|10621446|P6|Interim Analysis|Non-adherence|0
3098681|NCT00296504|10621447|P5|Interim Analysis|Non-adherence|1
3098682|NCT00296504|10621448|P4|Interim Analysis|Non-adherence|0
3098683|NCT00296504|10621449|P3|Interim Analysis|Non-adherence|0
3098684|NCT00296504|10621450|P2|Interim Analysis|Non-adherence|0
3098685|NCT00296504|10621451|P1|Interim Analysis|Non-adherence|2
3098686|NCT00296504|10621443|P9|Interim Analysis|Principle Investigator Terminated Study|0
3098687|NCT00296504|10621444|P8|Interim Analysis|Principle Investigator Terminated Study|0
3098688|NCT00296504|10621445|P7|Interim Analysis|Principle Investigator Terminated Study|0
3098689|NCT00296504|10621446|P6|Interim Analysis|Principle Investigator Terminated Study|0
3098690|NCT00296504|10621447|P5|Interim Analysis|Principle Investigator Terminated Study|0
3098691|NCT00296504|10621448|P4|Interim Analysis|Principle Investigator Terminated Study|0
3098692|NCT00296504|10621449|P3|Interim Analysis|Principle Investigator Terminated Study|1
3098693|NCT00296504|10621450|P2|Interim Analysis|Principle Investigator Terminated Study|0
3098694|NCT00296504|10621451|P1|Interim Analysis|Principle Investigator Terminated Study|0
3098695|NCT00296504|10621443|P9|Interim Analysis|Principle Investigator Discretion|0
3098696|NCT00296504|10621444|P8|Interim Analysis|Principle Investigator Discretion|0
3098697|NCT00296504|10621445|P7|Interim Analysis|Principle Investigator Discretion|0
3098698|NCT00296504|10621446|P6|Interim Analysis|Principle Investigator Discretion|0
3098699|NCT00296504|10621447|P5|Interim Analysis|Principle Investigator Discretion|0
3098700|NCT00296504|10621448|P4|Interim Analysis|Principle Investigator Discretion|1
3098701|NCT00296504|10621449|P3|Interim Analysis|Principle Investigator Discretion|1
3098702|NCT00296504|10621450|P2|Interim Analysis|Principle Investigator Discretion|0
3098703|NCT00296504|10621451|P1|Interim Analysis|Principle Investigator Discretion|2
3098704|NCT00296504|10621443|P9|Interim Analysis|Physician Decision|0
3098705|NCT00296504|10621444|P8|Interim Analysis|Physician Decision|0
3098706|NCT00296504|10621445|P7|Interim Analysis|Physician Decision|0
3098707|NCT00296504|10621446|P6|Interim Analysis|Physician Decision|0
3098708|NCT00296504|10621447|P5|Interim Analysis|Physician Decision|0
3098709|NCT00296504|10621448|P4|Interim Analysis|Physician Decision|0
3098710|NCT00296504|10621449|P3|Interim Analysis|Physician Decision|1
3098711|NCT00296504|10621450|P2|Interim Analysis|Physician Decision|0
3098712|NCT00296504|10621451|P1|Interim Analysis|Physician Decision|0
3098713|NCT00296504|10621443|P9|Interim Analysis|Resistance to FPV|0
3098714|NCT00296504|10621444|P8|Interim Analysis|Resistance to FPV|0
3098715|NCT00296504|10621445|P7|Interim Analysis|Resistance to FPV|0
3098716|NCT00296504|10621446|P6|Interim Analysis|Resistance to FPV|0
3098717|NCT00296504|10621447|P5|Interim Analysis|Resistance to FPV|0
3098718|NCT00296504|10621448|P4|Interim Analysis|Resistance to FPV|0
3098719|NCT00296504|10621449|P3|Interim Analysis|Resistance to FPV|1
3098720|NCT00296504|10621450|P2|Interim Analysis|Resistance to FPV|0
3098721|NCT00296504|10621451|P1|Interim Analysis|Resistance to FPV|0
3098722|NCT00296504|10621443|P9|Interim Analysis|Participant Was Incarcerated|0
3098723|NCT00296504|10621444|P8|Interim Analysis|Participant Was Incarcerated|0
3098724|NCT00296504|10621445|P7|Interim Analysis|Participant Was Incarcerated|0
3098725|NCT00296504|10621446|P6|Interim Analysis|Participant Was Incarcerated|0
3098726|NCT00296504|10621447|P5|Interim Analysis|Participant Was Incarcerated|0
3098727|NCT00296504|10621448|P4|Interim Analysis|Participant Was Incarcerated|0
3098728|NCT00296504|10621449|P3|Interim Analysis|Participant Was Incarcerated|1
3098729|NCT00296504|10621450|P2|Interim Analysis|Participant Was Incarcerated|0
3098730|NCT00296504|10621451|P1|Interim Analysis|Participant Was Incarcerated|2
3098731|NCT00296504|10621443|P9|Interim Analysis|Participant Moved|0
3098732|NCT00296504|10621444|P8|Interim Analysis|Participant Moved|0
3098733|NCT00296504|10621445|P7|Interim Analysis|Participant Moved|1
3098734|NCT00296504|10621446|P6|Interim Analysis|Participant Moved|1
3098735|NCT00296504|10621447|P5|Interim Analysis|Participant Moved|0
3098736|NCT00296504|10621448|P4|Interim Analysis|Participant Moved|0
3098737|NCT00296504|10621449|P3|Interim Analysis|Participant Moved|1
3098738|NCT00296504|10621450|P2|Interim Analysis|Participant Moved|0
3098739|NCT00296504|10621451|P1|Interim Analysis|Participant Moved|1
3098740|NCT00296504|10621443|P9|Interim Analysis|Participant Had Problems with Alcohol|0
3098741|NCT00296504|10621444|P8|Interim Analysis|Participant Had Problems with Alcohol|0
3098742|NCT00296504|10621445|P7|Interim Analysis|Participant Had Problems with Alcohol|0
3098743|NCT00296504|10621446|P6|Interim Analysis|Participant Had Problems with Alcohol|0
3098744|NCT00296504|10621447|P5|Interim Analysis|Participant Had Problems with Alcohol|0
3098745|NCT00296504|10621448|P4|Interim Analysis|Participant Had Problems with Alcohol|0
3098746|NCT00296504|10621449|P3|Interim Analysis|Participant Had Problems with Alcohol|1
3098747|NCT00296504|10621450|P2|Interim Analysis|Participant Had Problems with Alcohol|0
3098748|NCT00296504|10621451|P1|Interim Analysis|Participant Had Problems with Alcohol|0
3098749|NCT00296504|10621443|P9|Interim Analysis|To Simplify Treatment|0
3098750|NCT00296504|10621444|P8|Interim Analysis|To Simplify Treatment|0
3098751|NCT00296504|10621445|P7|Interim Analysis|To Simplify Treatment|2
3098752|NCT00296504|10621446|P6|Interim Analysis|To Simplify Treatment|0
3098753|NCT00296504|10621447|P5|Interim Analysis|To Simplify Treatment|0
3098754|NCT00296504|10621448|P4|Interim Analysis|To Simplify Treatment|0
3098755|NCT00296504|10621449|P3|Interim Analysis|To Simplify Treatment|1
3098756|NCT00296504|10621450|P2|Interim Analysis|To Simplify Treatment|0
3098757|NCT00296504|10621451|P1|Interim Analysis|To Simplify Treatment|0
3098758|NCT00296504|10621443|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
3098759|NCT00296504|10621444|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
3098760|NCT00296504|10621445|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
3098761|NCT00296504|10621446|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
3098762|NCT00296504|10621447|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
3098763|NCT00296504|10621448|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
3098764|NCT00296504|10621449|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
3098765|NCT00296504|10621450|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
3098766|NCT00296504|10621451|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
3098767|NCT00296504|10621443|P9|Interim Analysis|Participant Non-compliant|0
3098768|NCT00296504|10621444|P8|Interim Analysis|Participant Non-compliant|2
3098769|NCT00296504|10621445|P7|Interim Analysis|Participant Non-compliant|6
3098770|NCT00296504|10621446|P6|Interim Analysis|Participant Non-compliant|3
3098771|NCT00296504|10621447|P5|Interim Analysis|Participant Non-compliant|1
3098772|NCT00296504|10621448|P4|Interim Analysis|Participant Non-compliant|1
3098773|NCT00296504|10621449|P3|Interim Analysis|Participant Non-compliant|2
3098774|NCT00296504|10621450|P2|Interim Analysis|Participant Non-compliant|1
3098775|NCT00296504|10621451|P1|Interim Analysis|Participant Non-compliant|0
3098776|NCT00296504|10621443|P9|Interim Analysis|Death|0
3098777|NCT00296504|10621444|P8|Interim Analysis|Death|0
3098778|NCT00296504|10621445|P7|Interim Analysis|Death|0
3098779|NCT00296504|10621446|P6|Interim Analysis|Death|0
3098780|NCT00296504|10621447|P5|Interim Analysis|Death|0
3098781|NCT00296504|10621448|P4|Interim Analysis|Death|0
3098782|NCT00296504|10621449|P3|Interim Analysis|Death|3
3098783|NCT00296504|10621450|P2|Interim Analysis|Death|0
3098784|NCT00296504|10621451|P1|Interim Analysis|Death|1
3098785|NCT00296504|10621443|P9|Interim Analysis|Pregnancy|0
3098786|NCT00296504|10621444|P8|Interim Analysis|Pregnancy|1
3098787|NCT00296504|10621445|P7|Interim Analysis|Pregnancy|1
3098788|NCT00296504|10621446|P6|Interim Analysis|Pregnancy|1
3098789|NCT00296504|10621447|P5|Interim Analysis|Pregnancy|0
3098790|NCT00296504|10621448|P4|Interim Analysis|Pregnancy|2
3098791|NCT00296504|10621449|P3|Interim Analysis|Pregnancy|4
3098792|NCT00296504|10621450|P2|Interim Analysis|Pregnancy|1
3098793|NCT00296504|10621451|P1|Interim Analysis|Pregnancy|4
3098794|NCT00296504|10621443|P9|Interim Analysis|Switched to Commercially Available Drug|0
3098795|NCT00296504|10621444|P8|Interim Analysis|Switched to Commercially Available Drug|4
3098796|NCT00296504|10621445|P7|Interim Analysis|Switched to Commercially Available Drug|3
3098797|NCT00296504|10621446|P6|Interim Analysis|Switched to Commercially Available Drug|5
3098798|NCT00296504|10621447|P5|Interim Analysis|Switched to Commercially Available Drug|0
3098799|NCT00296504|10621448|P4|Interim Analysis|Switched to Commercially Available Drug|1
3098800|NCT00296504|10621449|P3|Interim Analysis|Switched to Commercially Available Drug|4
3098801|NCT00296504|10621450|P2|Interim Analysis|Switched to Commercially Available Drug|0
3098802|NCT00296504|10621451|P1|Interim Analysis|Switched to Commercially Available Drug|2
3098803|NCT00296504|10621443|P9|Interim Analysis|Insufficient CD4 Response|0
3098804|NCT00296504|10621444|P8|Interim Analysis|Insufficient CD4 Response|0
3098805|NCT00296504|10621445|P7|Interim Analysis|Insufficient CD4 Response|0
3098806|NCT00296504|10621446|P6|Interim Analysis|Insufficient CD4 Response|1
3098807|NCT00296504|10621447|P5|Interim Analysis|Insufficient CD4 Response|1
3098808|NCT00296504|10621448|P4|Interim Analysis|Insufficient CD4 Response|0
3098809|NCT00296504|10621449|P3|Interim Analysis|Insufficient CD4 Response|0
3098810|NCT00296504|10621450|P2|Interim Analysis|Insufficient CD4 Response|0
3098811|NCT00296504|10621451|P1|Interim Analysis|Insufficient CD4 Response|0
3098812|NCT00296504|10621443|P9|Interim Analysis|Protocol Violation|0
3098813|NCT00296504|10621444|P8|Interim Analysis|Protocol Violation|1
3098814|NCT00296504|10621445|P7|Interim Analysis|Protocol Violation|0
3098815|NCT00296504|10621446|P6|Interim Analysis|Protocol Violation|0
3098816|NCT00296504|10621447|P5|Interim Analysis|Protocol Violation|1
3098817|NCT00296504|10621448|P4|Interim Analysis|Protocol Violation|0
3098818|NCT00296504|10621449|P3|Interim Analysis|Protocol Violation|2
3098819|NCT00296504|10621450|P2|Interim Analysis|Protocol Violation|0
3098820|NCT00296504|10621451|P1|Interim Analysis|Protocol Violation|0
3098821|NCT00296504|10621443|P9|Interim Analysis|Adverse Event|0
3098822|NCT00296504|10621444|P8|Interim Analysis|Adverse Event|5
3098823|NCT00296504|10621445|P7|Interim Analysis|Adverse Event|4
3098824|NCT00296504|10621446|P6|Interim Analysis|Adverse Event|3
3098825|NCT00296504|10621447|P5|Interim Analysis|Adverse Event|6
3098826|NCT00296504|10621448|P4|Interim Analysis|Adverse Event|4
3098827|NCT00296504|10621449|P3|Interim Analysis|Adverse Event|13
3098828|NCT00296504|10621450|P2|Interim Analysis|Adverse Event|0
3098829|NCT00296504|10621451|P1|Interim Analysis|Adverse Event|0
3098830|NCT00296504|10621443|P9|Interim Analysis|Insufficient Viral Load Response|0
3098831|NCT00296504|10621444|P8|Interim Analysis|Insufficient Viral Load Response|24
3098832|NCT00296504|10621445|P7|Interim Analysis|Insufficient Viral Load Response|2
3098833|NCT00296504|10621446|P6|Interim Analysis|Insufficient Viral Load Response|9
3098834|NCT00296504|10621447|P5|Interim Analysis|Insufficient Viral Load Response|7
3098835|NCT00296504|10621448|P4|Interim Analysis|Insufficient Viral Load Response|2
3098836|NCT00296504|10621449|P3|Interim Analysis|Insufficient Viral Load Response|12
3098837|NCT00296504|10621450|P2|Interim Analysis|Insufficient Viral Load Response|1
3098838|NCT00296504|10621451|P1|Interim Analysis|Insufficient Viral Load Response|5
3098839|NCT00296504|10621443|P9|Interim Analysis|Clinical Progression|0
3098840|NCT00296504|10621444|P8|Interim Analysis|Clinical Progression|2
3098841|NCT00296504|10621445|P7|Interim Analysis|Clinical Progression|1
3098842|NCT00296504|10621446|P6|Interim Analysis|Clinical Progression|2
3098843|NCT00296504|10621447|P5|Interim Analysis|Clinical Progression|0
3098844|NCT00296504|10621448|P4|Interim Analysis|Clinical Progression|1
3098845|NCT00296504|10621449|P3|Interim Analysis|Clinical Progression|1
3098846|NCT00296504|10621450|P2|Interim Analysis|Clinical Progression|0
3098847|NCT00296504|10621451|P1|Interim Analysis|Clinical Progression|1
3098848|NCT00296504|10621443|P9|Interim Analysis|Lost to Follow-up|0
3098849|NCT00296504|10621444|P8|Interim Analysis|Lost to Follow-up|4
3098850|NCT00296504|10621445|P7|Interim Analysis|Lost to Follow-up|11
3098851|NCT00296504|10621446|P6|Interim Analysis|Lost to Follow-up|4
3098852|NCT00296504|10621447|P5|Interim Analysis|Lost to Follow-up|14
3098853|NCT00296504|10621448|P4|Interim Analysis|Lost to Follow-up|8
3098854|NCT00296504|10621449|P3|Interim Analysis|Lost to Follow-up|26
3098855|NCT00296504|10621450|P2|Interim Analysis|Lost to Follow-up|3
3098856|NCT00296504|10621451|P1|Interim Analysis|Lost to Follow-up|13
3098857|NCT00296504|10621443|P9|Interim Analysis|Withdrawal by Subject|0
3098858|NCT00296504|10621444|P8|Interim Analysis|Withdrawal by Subject|3
3098859|NCT00296504|10621445|P7|Interim Analysis|Withdrawal by Subject|9
3098860|NCT00296504|10621446|P6|Interim Analysis|Withdrawal by Subject|5
3098861|NCT00296504|10621447|P5|Interim Analysis|Withdrawal by Subject|5
3098862|NCT00296504|10621448|P4|Interim Analysis|Withdrawal by Subject|0
3098863|NCT00296504|10621449|P3|Interim Analysis|Withdrawal by Subject|12
3098864|NCT00296504|10621450|P2|Interim Analysis|Withdrawal by Subject|0
3098865|NCT00296504|10621451|P1|Interim Analysis|Withdrawal by Subject|8
3098866|NCT00296491|10621544|P4|Overall Study|Lost to Follow-up|0
3098867|NCT00296491|10621545|P3|Overall Study|Lost to Follow-up|2
3098868|NCT00296491|10621546|P2|Overall Study|Lost to Follow-up|2
3098869|NCT00296491|10621547|P1|Overall Study|Lost to Follow-up|0
3098870|NCT00296491|10621544|P4|Overall Study|Non-Compliance|14
3098871|NCT00296491|10621545|P3|Overall Study|Non-Compliance|10
3098872|NCT00296491|10621546|P2|Overall Study|Non-Compliance|13
3098873|NCT00296491|10621547|P1|Overall Study|Non-Compliance|12
3098874|NCT00296491|10621544|P4|Overall Study|Withdrawal by Subject|2
3098875|NCT00296491|10621545|P3|Overall Study|Withdrawal by Subject|3
3098876|NCT00296491|10621546|P2|Overall Study|Withdrawal by Subject|3
3098877|NCT00296491|10621547|P1|Overall Study|Withdrawal by Subject|7
3098878|NCT00296491|10621544|P4|Overall Study|Withdrawn due to Asthma|4
3098879|NCT00296491|10621545|P3|Overall Study|Withdrawn due to Asthma|0
3098880|NCT00296491|10621546|P2|Overall Study|Withdrawn due to Asthma|0
3098881|NCT00296491|10621547|P1|Overall Study|Withdrawn due to Asthma|0
3098882|NCT00296491|10621544|P4|Overall Study|Adverse Event|4
3098883|NCT00296491|10621545|P3|Overall Study|Adverse Event|1
3098884|NCT00296491|10621546|P2|Overall Study|Adverse Event|3
3098885|NCT00296491|10621547|P1|Overall Study|Adverse Event|1
3098886|NCT00296491|10621544|P4|Overall Study|Protocol Violation|3
3098887|NCT00296491|10621545|P3|Overall Study|Protocol Violation|2
3098888|NCT00296491|10621546|P2|Overall Study|Protocol Violation|6
3098889|NCT00296491|10621547|P1|Overall Study|Protocol Violation|4
3098890|NCT00296491|10621544|P4|Overall Study|Low Pollen Counts|16
3098891|NCT00296491|10621545|P3|Overall Study|Low Pollen Counts|25
3098892|NCT00296491|10621546|P2|Overall Study|Low Pollen Counts|26
3098893|NCT00296491|10621547|P1|Overall Study|Low Pollen Counts|18
3098894|NCT00296400|10621576|P3|Overall Study|Pregnancy|0
3098895|NCT00296400|10621577|P2|Overall Study|Pregnancy|2
3098896|NCT00296400|10621578|P1|Overall Study|Pregnancy|1
3098897|NCT00296400|10621576|P3|Overall Study|Visit 10 was performed earlier|0
3098898|NCT00296400|10621577|P2|Overall Study|Visit 10 was performed earlier|1
3098899|NCT00296400|10621578|P1|Overall Study|Visit 10 was performed earlier|0
3098900|NCT00296400|10621576|P3|Overall Study|Study specific discontinuation criteria|1
3098901|NCT00296400|10621577|P2|Overall Study|Study specific discontinuation criteria|0
3098902|NCT00296400|10621578|P1|Overall Study|Study specific discontinuation criteria|0
3098903|NCT00296400|10621576|P3|Overall Study|Lost to Follow-up|2
3098904|NCT00296400|10621577|P2|Overall Study|Lost to Follow-up|1
3098905|NCT00296400|10621578|P1|Overall Study|Lost to Follow-up|1
3098906|NCT00296400|10621576|P3|Overall Study|Protocol Violation|1
3098907|NCT00296400|10621577|P2|Overall Study|Protocol Violation|1
3098908|NCT00296400|10621578|P1|Overall Study|Protocol Violation|1
3098909|NCT00296400|10621576|P3|Overall Study|Incorrect enrollment|0
3098910|NCT00296400|10621577|P2|Overall Study|Incorrect enrollment|0
3098911|NCT00296400|10621578|P1|Overall Study|Incorrect enrollment|2
3098912|NCT00296400|10621576|P3|Overall Study|Withdrawal by Subject|2
3098913|NCT00296400|10621577|P2|Overall Study|Withdrawal by Subject|6
3098914|NCT00296400|10621578|P1|Overall Study|Withdrawal by Subject|5
3098915|NCT00296400|10621576|P3|Overall Study|Adverse Event|7
3098916|NCT00296400|10621577|P2|Overall Study|Adverse Event|7
3098917|NCT00296400|10621578|P1|Overall Study|Adverse Event|7
3098918|NCT00296374|10621802|P3|Overall Study|Other|1
3098919|NCT00296374|10621803|P2|Overall Study|Other|0
3098920|NCT00296374|10621804|P1|Overall Study|Other|0
3098921|NCT00296374|10621802|P3|Overall Study|Pregnancy|2
3098922|NCT00296374|10621803|P2|Overall Study|Pregnancy|0
3098923|NCT00296374|10621804|P1|Overall Study|Pregnancy|0
3098924|NCT00296374|10621802|P3|Overall Study|Nephrologist introduced ACE|0
3098925|NCT00296374|10621803|P2|Overall Study|Nephrologist introduced ACE|1
3098926|NCT00296374|10621804|P1|Overall Study|Nephrologist introduced ACE|0
3098927|NCT00296374|10621802|P3|Overall Study|Stopped drug before end of study visit|0
3098928|NCT00296374|10621803|P2|Overall Study|Stopped drug before end of study visit|1
3098929|NCT00296374|10621804|P1|Overall Study|Stopped drug before end of study visit|0
3098930|NCT00296374|10621802|P3|Overall Study|Relocated to another state|0
3098931|NCT00296374|10621803|P2|Overall Study|Relocated to another state|0
3098932|NCT00296374|10621804|P1|Overall Study|Relocated to another state|1
3098933|NCT00296374|10621802|P3|Overall Study|Lost to Follow-up|1
3098934|NCT00296374|10621803|P2|Overall Study|Lost to Follow-up|1
3098935|NCT00296374|10621804|P1|Overall Study|Lost to Follow-up|3
3098936|NCT00296374|10621802|P3|Overall Study|Protocol Violation|3
3098937|NCT00296374|10621803|P2|Overall Study|Protocol Violation|2
3098938|NCT00296374|10621804|P1|Overall Study|Protocol Violation|1
3098939|NCT00296374|10621802|P3|Overall Study|Incorrect enrollment|4
3098940|NCT00296374|10621803|P2|Overall Study|Incorrect enrollment|3
3098941|NCT00296374|10621804|P1|Overall Study|Incorrect enrollment|3
3098942|NCT00296374|10621802|P3|Overall Study|Withdrawal by Subject|11
3098943|NCT00296374|10621803|P2|Overall Study|Withdrawal by Subject|5
3098944|NCT00296374|10621804|P1|Overall Study|Withdrawal by Subject|3
3098945|NCT00296374|10621802|P3|Overall Study|Adverse Event|7
3098946|NCT00296374|10621803|P2|Overall Study|Adverse Event|10
3098947|NCT00296374|10621804|P1|Overall Study|Adverse Event|14
3098948|NCT00296335|10622027|P2|Overall Study|Physician Decision|11
3098949|NCT00296335|10622028|P1|Overall Study|Physician Decision|3
3098950|NCT00296335|10622027|P2|Overall Study|Lost to Follow-up|33
3098951|NCT00296335|10622028|P1|Overall Study|Lost to Follow-up|7
3098952|NCT00296335|10622027|P2|Overall Study|Adverse Event|27
3098953|NCT00296335|10622028|P1|Overall Study|Adverse Event|17
3098954|NCT00296335|10622027|P2|Overall Study|Recurrence|51
3098955|NCT00296335|10622028|P1|Overall Study|Recurrence|3
3098956|NCT00296244|10622068|P2|Overall Study|Underwent retransplant|1
3098957|NCT00296244|10622069|P1|Overall Study|Underwent retransplant|0
3098958|NCT00296140|10622133|P2|Overall Study|Discharge to Nursing Home|0
3098959|NCT00296140|10622134|P1|Overall Study|Discharge to Nursing Home|1
3098960|NCT00296140|10622133|P2|Overall Study|Withdrawal by Subject|0
3098961|NCT00296140|10622134|P1|Overall Study|Withdrawal by Subject|1
3098962|NCT00296140|10622133|P2|Overall Study|Lost to Follow-up|0
3098963|NCT00296140|10622134|P1|Overall Study|Lost to Follow-up|1
3098964|NCT00296036|10622146|P6|Overall Study|Protocol Violation|3
3098965|NCT00296036|10622147|P5|Overall Study|Protocol Violation|0
3098966|NCT00296036|10622148|P4|Overall Study|Protocol Violation|0
3098967|NCT00296036|10622149|P3|Overall Study|Protocol Violation|0
3098968|NCT00296036|10622150|P2|Overall Study|Protocol Violation|0
3098969|NCT00296036|10622151|P1|Overall Study|Protocol Violation|0
3098970|NCT00296036|10622146|P6|Overall Study|Withdrawal by Subject|1
3098971|NCT00296036|10622147|P5|Overall Study|Withdrawal by Subject|2
3098972|NCT00296036|10622148|P4|Overall Study|Withdrawal by Subject|1
3098973|NCT00296036|10622149|P3|Overall Study|Withdrawal by Subject|2
3098974|NCT00296036|10622150|P2|Overall Study|Withdrawal by Subject|0
3098975|NCT00296036|10622151|P1|Overall Study|Withdrawal by Subject|1
3098976|NCT00295932|10622188|P11|Overall Study|Not Treated|1
3098977|NCT00295932|10622189|P10|Overall Study|Not Treated|0
3098978|NCT00295932|10622190|P9|Overall Study|Not Treated|0
3098979|NCT00295932|10622191|P8|Overall Study|Not Treated|0
3098980|NCT00295932|10622192|P7|Overall Study|Not Treated|0
3098981|NCT00295932|10622193|P6|Overall Study|Not Treated|0
3098982|NCT00295932|10622194|P5|Overall Study|Not Treated|0
3098983|NCT00295932|10622195|P4|Overall Study|Not Treated|0
3098984|NCT00295932|10622196|P3|Overall Study|Not Treated|0
3098985|NCT00295932|10622197|P2|Overall Study|Not Treated|0
3098986|NCT00295932|10622198|P1|Overall Study|Not Treated|0
3098987|NCT00295880|10622232|P1|Overall Study|Unit randomization did not occur|1
3098988|NCT00295880|10622232|P1|Overall Study|IBMI unit could not be volume reduced|1
3098989|NCT00295854|10622252|P3|Overall Study|Other|1
3098990|NCT00295854|10622253|P2|Overall Study|Other|5
3098991|NCT00295854|10622254|P1|Overall Study|Other|3
3098992|NCT00295854|10622252|P3|Overall Study|required a prohibited medication|0
3098993|NCT00295854|10622253|P2|Overall Study|required a prohibited medication|0
3098994|NCT00295854|10622254|P1|Overall Study|required a prohibited medication|1
3098995|NCT00295854|10622252|P3|Overall Study|did not continue to meet criteria|2
3098996|NCT00295854|10622253|P2|Overall Study|did not continue to meet criteria|1
3098997|NCT00295854|10622254|P1|Overall Study|did not continue to meet criteria|1
3098998|NCT00295854|10622252|P3|Overall Study|Withdrawal by Subject|4
3098999|NCT00295854|10622253|P2|Overall Study|Withdrawal by Subject|7
3099000|NCT00295854|10622254|P1|Overall Study|Withdrawal by Subject|3
3099001|NCT00295854|10622252|P3|Overall Study|Lost to Follow-up|1
3099002|NCT00295854|10622253|P2|Overall Study|Lost to Follow-up|0
3099003|NCT00295854|10622254|P1|Overall Study|Lost to Follow-up|2
3099004|NCT00295854|10622252|P3|Overall Study|Protocol Violation|1
3099005|NCT00295854|10622253|P2|Overall Study|Protocol Violation|1
3099006|NCT00295854|10622254|P1|Overall Study|Protocol Violation|1
3099007|NCT00295854|10622252|P3|Overall Study|Adverse Event|6
3099008|NCT00295854|10622253|P2|Overall Study|Adverse Event|7
3099009|NCT00295854|10622254|P1|Overall Study|Adverse Event|7
3099010|NCT00295750|10622268|P3|Overall Study|Protocol Violation|2
3099011|NCT00295750|10622269|P2|Overall Study|Protocol Violation|4
3099012|NCT00295750|10622270|P1|Overall Study|Protocol Violation|2
3099013|NCT00295750|10622268|P3|Overall Study|Withdrawal by Subject|7
3099014|NCT00295750|10622269|P2|Overall Study|Withdrawal by Subject|4
3099015|NCT00295750|10622270|P1|Overall Study|Withdrawal by Subject|9
3099016|NCT00295750|10622268|P3|Overall Study|Randomized but never received trial drug|3
3099017|NCT00295750|10622269|P2|Overall Study|Randomized but never received trial drug|3
3099018|NCT00295750|10622270|P1|Overall Study|Randomized but never received trial drug|4
3099019|NCT00295750|10622268|P3|Overall Study|Personal reasons|0
3099020|NCT00295750|10622269|P2|Overall Study|Personal reasons|1
3099021|NCT00295750|10622270|P1|Overall Study|Personal reasons|0
3099022|NCT00295750|10622268|P3|Overall Study|Disease progression|0
3099023|NCT00295750|10622269|P2|Overall Study|Disease progression|1
3099024|NCT00295750|10622270|P1|Overall Study|Disease progression|2
3099025|NCT00295750|10622268|P3|Overall Study|Trial drug errors|0
3099026|NCT00295750|10622269|P2|Overall Study|Trial drug errors|1
3099027|NCT00295750|10622270|P1|Overall Study|Trial drug errors|1
3099028|NCT00295750|10622268|P3|Overall Study|Administrative errors|5
3099029|NCT00295750|10622269|P2|Overall Study|Administrative errors|4
3099030|NCT00295750|10622270|P1|Overall Study|Administrative errors|2
3099031|NCT00295750|10622268|P3|Overall Study|Taking prohibited therapy|2
3099032|NCT00295750|10622269|P2|Overall Study|Taking prohibited therapy|3
3099033|NCT00295750|10622270|P1|Overall Study|Taking prohibited therapy|2
3099034|NCT00295750|10622268|P3|Overall Study|Lost to Follow-up|1
3099035|NCT00295750|10622269|P2|Overall Study|Lost to Follow-up|4
3099036|NCT00295750|10622270|P1|Overall Study|Lost to Follow-up|1
3099037|NCT00295750|10622268|P3|Overall Study|Lack of Efficacy|0
3099038|NCT00295750|10622269|P2|Overall Study|Lack of Efficacy|1
3099039|NCT00295750|10622270|P1|Overall Study|Lack of Efficacy|1
3099040|NCT00295750|10622268|P3|Overall Study|Adverse Event|12
3099041|NCT00295750|10622269|P2|Overall Study|Adverse Event|15
3099042|NCT00295750|10622270|P1|Overall Study|Adverse Event|19
3099043|NCT00295633|10622305|P3|Overall Study|Administrative reason by sponsor|1
3099044|NCT00295633|10622306|P2|Overall Study|Administrative reason by sponsor|0
3099045|NCT00295633|10622307|P1|Overall Study|Administrative reason by sponsor|0
3099046|NCT00295633|10622305|P3|Overall Study|Death|0
3099047|NCT00295633|10622306|P2|Overall Study|Death|1
3099048|NCT00295633|10622307|P1|Overall Study|Death|1
3099049|NCT00295633|10622305|P3|Overall Study|Subject No Longer Meets Study Criteria|3
3099050|NCT00295633|10622306|P2|Overall Study|Subject No Longer Meets Study Criteria|3
3099051|NCT00295633|10622307|P1|Overall Study|Subject No Longer Meets Study Criteria|0
3099052|NCT00295633|10622305|P3|Overall Study|Poor/Noncompliance|6
3099053|NCT00295633|10622306|P2|Overall Study|Poor/Noncompliance|2
3099054|NCT00295633|10622307|P1|Overall Study|Poor/Noncompliance|2
3099055|NCT00295633|10622305|P3|Overall Study|Physician Decision|8
3099056|NCT00295633|10622306|P2|Overall Study|Physician Decision|10
3099057|NCT00295633|10622307|P1|Overall Study|Physician Decision|9
3099058|NCT00295633|10622305|P3|Overall Study|Lost to Follow-up|7
3099059|NCT00295633|10622306|P2|Overall Study|Lost to Follow-up|11
3099060|NCT00295633|10622307|P1|Overall Study|Lost to Follow-up|6
3099061|NCT00295633|10622305|P3|Overall Study|Adverse Event|9
3099062|NCT00295633|10622306|P2|Overall Study|Adverse Event|17
3099063|NCT00295633|10622307|P1|Overall Study|Adverse Event|9
3099064|NCT00295633|10622305|P3|Overall Study|Withdrawal of consent by subject|26
3099065|NCT00295633|10622306|P2|Overall Study|Withdrawal of consent by subject|16
3099066|NCT00295633|10622307|P1|Overall Study|Withdrawal of consent by subject|16
3099067|NCT00295633|10622305|P3|Overall Study|Lack of Efficacy|16
3099068|NCT00295633|10622306|P2|Overall Study|Lack of Efficacy|7
3099069|NCT00295633|10622307|P1|Overall Study|Lack of Efficacy|19
3099070|NCT00295620|10622326|P2|Overall Study|Protocol Violation|32
3099071|NCT00295620|10622327|P1|Overall Study|Protocol Violation|30
3099072|NCT00295620|10622326|P2|Overall Study|Discontinuation by sponsor|593
3099073|NCT00295620|10622327|P1|Overall Study|Discontinuation by sponsor|580
3099074|NCT00295620|10622326|P2|Overall Study|Other reasons|9
3099075|NCT00295620|10622327|P1|Overall Study|Other reasons|10
3099076|NCT00295620|10622326|P2|Overall Study|Death|207
3099077|NCT00295620|10622327|P1|Overall Study|Death|206
3099078|NCT00295620|10622326|P2|Overall Study|Withdrawal by Subject|50
3099079|NCT00295620|10622327|P1|Overall Study|Withdrawal by Subject|37
3099080|NCT00295620|10622326|P2|Overall Study|Lost to Follow-up|5
3099081|NCT00295620|10622327|P1|Overall Study|Lost to Follow-up|9
3099082|NCT00295490|10622351|P4|Overall Study|Other|1
3099083|NCT00295490|10622352|P3|Overall Study|Other|0
3099084|NCT00295490|10622353|P2|Overall Study|Other|2
3099085|NCT00295490|10622354|P1|Overall Study|Other|0
3099086|NCT00295490|10622351|P4|Overall Study|Adverse Event|0
3099087|NCT00295490|10622352|P3|Overall Study|Adverse Event|0
3099088|NCT00295490|10622353|P2|Overall Study|Adverse Event|0
3099089|NCT00295490|10622354|P1|Overall Study|Adverse Event|1
3099090|NCT00295490|10622351|P4|Overall Study|Lost to Follow-up|0
3099091|NCT00295490|10622352|P3|Overall Study|Lost to Follow-up|1
3099092|NCT00295490|10622353|P2|Overall Study|Lost to Follow-up|0
3099093|NCT00295490|10622354|P1|Overall Study|Lost to Follow-up|0
3099094|NCT00295490|10622351|P4|Overall Study|Withdrawal by Subject|1
3099095|NCT00295490|10622352|P3|Overall Study|Withdrawal by Subject|0
3099096|NCT00295490|10622353|P2|Overall Study|Withdrawal by Subject|2
3099097|NCT00295490|10622354|P1|Overall Study|Withdrawal by Subject|0
3099098|NCT00295490|10622351|P4|Overall Study|Protocol Violation|3
3099099|NCT00295490|10622352|P3|Overall Study|Protocol Violation|3
3099100|NCT00295490|10622353|P2|Overall Study|Protocol Violation|0
3099101|NCT00295490|10622354|P1|Overall Study|Protocol Violation|0
3099102|NCT00295022|10622404|P3|Overall Study|Withdrawal by Subject|2
3099103|NCT00295022|10622405|P2|Overall Study|Withdrawal by Subject|0
3099104|NCT00295022|10622406|P1|Overall Study|Withdrawal by Subject|0
3099105|NCT00295022|10622404|P3|Overall Study|Lost to Follow-up|1
3099106|NCT00295022|10622405|P2|Overall Study|Lost to Follow-up|0
3099107|NCT00295022|10622406|P1|Overall Study|Lost to Follow-up|0
3099108|NCT00295022|10622404|P3|Overall Study|Adverse Event|2
3099109|NCT00295022|10622405|P2|Overall Study|Adverse Event|1
3099110|NCT00295022|10622406|P1|Overall Study|Adverse Event|1
3099111|NCT00294762|10622522|P2|Overall Study|Did not receive study treatment|3
3099112|NCT00294762|10622523|P1|Overall Study|Did not receive study treatment|3
3099113|NCT00294723|10622542|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
3099114|NCT00294723|10622543|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
3099115|NCT00294723|10622544|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
3099116|NCT00294723|10622542|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
3099117|NCT00294723|10622543|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
3099118|NCT00294723|10622544|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
3099119|NCT00294723|10622542|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
3099120|NCT00294723|10622543|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
3099121|NCT00294723|10622544|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
3099122|NCT00294723|10622542|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
3099123|NCT00294723|10622543|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
3099124|NCT00294723|10622544|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
3099125|NCT00294723|10622542|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
3099126|NCT00294723|10622543|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
3099127|NCT00294723|10622544|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
3099128|NCT00294723|10622542|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
3099129|NCT00294723|10622543|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
3099130|NCT00294723|10622544|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
3099131|NCT00294723|10622542|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
3099132|NCT00294723|10622543|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
3099133|NCT00294723|10622544|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
3099134|NCT00294723|10622542|P3|Open-Label Extension 52 Weeks|Adverse Event|2
3099135|NCT00294723|10622543|P2|Open-Label Extension 52 Weeks|Adverse Event|5
3099136|NCT00294723|10622544|P1|Open-Label Extension 52 Weeks|Adverse Event|5
3099137|NCT00294723|10622542|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
3099138|NCT00294723|10622543|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
3099139|NCT00294723|10622544|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
3099140|NCT00294723|10622542|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
3099229|NCT00294047|10622819|P1|Month 84|Withdrawal by Subject|33
3099141|NCT00294723|10622543|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
3099142|NCT00294723|10622544|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
3099143|NCT00294723|10622542|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
3099144|NCT00294723|10622543|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
3099145|NCT00294723|10622544|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
3099146|NCT00294723|10622542|P3|Double-Blind Period 52 Weeks|Adverse Event|15
3099147|NCT00294723|10622543|P2|Double-Blind Period 52 Weeks|Adverse Event|25
3099148|NCT00294723|10622544|P1|Double-Blind Period 52 Weeks|Adverse Event|18
3099149|NCT00294684|10622605|P2|Overall Study|Lost to Follow-up|8
3099150|NCT00294684|10622606|P1|Overall Study|Lost to Follow-up|5
3099151|NCT00294671|10622646|P2|Overall Study|Death|1
3099152|NCT00294671|10622647|P1|Overall Study|Death|0
3099153|NCT00294671|10622646|P2|Overall Study|Non-compliance|0
3099154|NCT00294671|10622647|P1|Overall Study|Non-compliance|1
3099155|NCT00294671|10622646|P2|Overall Study|Lost to Follow-up|3
3099156|NCT00294671|10622647|P1|Overall Study|Lost to Follow-up|1
3099157|NCT00294671|10622646|P2|Overall Study|Non-drug related AE|2
3099158|NCT00294671|10622647|P1|Overall Study|Non-drug related AE|3
3099159|NCT00294671|10622646|P2|Overall Study|Drug related adverse event (AE)|2
3099160|NCT00294671|10622647|P1|Overall Study|Drug related adverse event (AE)|4
3099161|NCT00294671|10622646|P2|Overall Study|Liver transplant|9
3099162|NCT00294671|10622647|P1|Overall Study|Liver transplant|7
3099163|NCT00294671|10622646|P2|Overall Study|Lack of Efficacy|23
3099164|NCT00294671|10622647|P1|Overall Study|Lack of Efficacy|11
3099165|NCT00294658|10622663|P2|Overall Study|Patient and family were not satisfied|1
3099166|NCT00294658|10622664|P1|Overall Study|Patient and family were not satisfied|0
3099167|NCT00294658|10622663|P2|Overall Study|Found to have invasive thymoma|0
3099168|NCT00294658|10622664|P1|Overall Study|Found to have invasive thymoma|1
3099169|NCT00294658|10622663|P2|Overall Study|Withdrawal by Subject|4
3099170|NCT00294658|10622664|P1|Overall Study|Withdrawal by Subject|0
3099171|NCT00294658|10622663|P2|Overall Study|Pregnancy|1
3099172|NCT00294658|10622664|P1|Overall Study|Pregnancy|0
3099173|NCT00294658|10622663|P2|Overall Study|Physician Decision|2
3099174|NCT00294658|10622664|P1|Overall Study|Physician Decision|1
3099175|NCT00294658|10622663|P2|Overall Study|Lost to Follow-up|0
3099176|NCT00294658|10622664|P1|Overall Study|Lost to Follow-up|4
3099177|NCT00294658|10622663|P2|Overall Study|Death|1
3099178|NCT00294658|10622664|P1|Overall Study|Death|0
3099179|NCT00294645|10622728|P2|Overall Study|Other|10
3099180|NCT00294645|10622729|P1|Overall Study|Other|4
3099181|NCT00294645|10622728|P2|Overall Study|Physician Decision|20
3099182|NCT00294645|10622729|P1|Overall Study|Physician Decision|15
3099183|NCT00294645|10622728|P2|Overall Study|Withdrawal by Subject|34
3099184|NCT00294645|10622729|P1|Overall Study|Withdrawal by Subject|18
3099185|NCT00294645|10622728|P2|Overall Study|Lost to Follow-up|10
3099186|NCT00294645|10622729|P1|Overall Study|Lost to Follow-up|1
3099187|NCT00294645|10622728|P2|Overall Study|Death|18
3099188|NCT00294645|10622729|P1|Overall Study|Death|10
3099189|NCT00294554|10622773|P2|Overall Study|Physician Decision|1
3099190|NCT00294554|10622774|P1|Overall Study|Physician Decision|0
3099191|NCT00294554|10622773|P2|Overall Study|Lack of Efficacy|1
3099192|NCT00294554|10622774|P1|Overall Study|Lack of Efficacy|0
3099193|NCT00294398|10622801|P2|Overall Study|Lost to Follow-up|26
3099194|NCT00294398|10622802|P1|Overall Study|Lost to Follow-up|21
3099195|NCT00294060|10622810|P1|Overall Study|Device explanted/not replaced|23
3099196|NCT00294060|10622810|P1|Overall Study|Medical condition|3
3099197|NCT00294060|10622810|P1|Overall Study|Physician Decision|797
3099198|NCT00294060|10622810|P1|Overall Study|Withdrawal by Subject|11
3099199|NCT00294060|10622810|P1|Overall Study|Lost to Follow-up|55
3099200|NCT00294060|10622810|P1|Overall Study|Other|59
3099201|NCT00294060|10622810|P1|Overall Study|Death|225
3099202|NCT00294047|10622818|P2|Month 84|No consent for Month 84 Follow-up|754
3099203|NCT00294047|10622819|P1|Month 84|No consent for Month 84 Follow-up|731
3099204|NCT00294047|10622818|P2|Month 84|Visit missed|1
3099205|NCT00294047|10622819|P1|Month 84|Visit missed|0
3099206|NCT00294047|10622818|P2|Month 84|Under investigation locally|0
3099207|NCT00294047|10622819|P1|Month 84|Under investigation locally|1
3099208|NCT00294047|10622818|P2|Month 84|Unable to reach study site|0
3099209|NCT00294047|10622819|P1|Month 84|Unable to reach study site|1
3099210|NCT00294047|10622818|P2|Month 84|Transport reimbursement delayed|1
3099211|NCT00294047|10622819|P1|Month 84|Transport reimbursement delayed|0
3099212|NCT00294047|10622818|P2|Month 84|Subject does not want male physician|0
3099213|NCT00294047|10622819|P1|Month 84|Subject does not want male physician|1
3099214|NCT00294047|10622818|P2|Month 84|Personal reason|4
3099215|NCT00294047|10622819|P1|Month 84|Personal reason|2
3099216|NCT00294047|10622818|P2|Month 84|Lack of time|1
3099217|NCT00294047|10622819|P1|Month 84|Lack of time|3
3099218|NCT00294047|10622818|P2|Month 84|Family problems|2
3099219|NCT00294047|10622819|P1|Month 84|Family problems|2
3099220|NCT00294047|10622818|P2|Month 84|Center closed, subject did not transfer|0
3099221|NCT00294047|10622819|P1|Month 84|Center closed, subject did not transfer|1
3099222|NCT00294047|10622818|P2|Month 84|Work related reasons|2
3099223|NCT00294047|10622819|P1|Month 84|Work related reasons|4
3099224|NCT00294047|10622818|P2|Month 84|Absent Cervix|0
3099225|NCT00294047|10622819|P1|Month 84|Absent Cervix|2
3099226|NCT00294047|10622818|P2|Month 84|Lost to Follow-up|190
3099227|NCT00294047|10622819|P1|Month 84|Lost to Follow-up|187
3099228|NCT00294047|10622818|P2|Month 84|Withdrawal by Subject|31
3099230|NCT00294047|10622818|P2|Month 84|Protocol Violation|1
3099231|NCT00294047|10622819|P1|Month 84|Protocol Violation|1
3099232|NCT00294047|10622818|P2|Month 84|Adverse Event|2
3099233|NCT00294047|10622819|P1|Month 84|Adverse Event|4
3099234|NCT00294047|10622818|P2|Month 48|Other|14
3099235|NCT00294047|10622819|P1|Month 48|Other|10
3099236|NCT00294047|10622818|P2|Month 48|Lost to Follow-up|287
3099237|NCT00294047|10622819|P1|Month 48|Lost to Follow-up|272
3099238|NCT00294047|10622818|P2|Month 48|Withdrawal by Subject|115
3099239|NCT00294047|10622819|P1|Month 48|Withdrawal by Subject|111
3099240|NCT00294047|10622818|P2|Month 48|Protocol Violation|4
3099241|NCT00294047|10622819|P1|Month 48|Protocol Violation|4
3099242|NCT00294047|10622818|P2|Month 48|Adverse Event|13
3099243|NCT00294047|10622819|P1|Month 48|Adverse Event|28
3099244|NCT00293813|10622924|P3|Overall Study|Noncompliance|0
3099245|NCT00293813|10622925|P2|Overall Study|Noncompliance|1
3099246|NCT00293813|10622926|P1|Overall Study|Noncompliance|0
3099247|NCT00293813|10622924|P3|Overall Study|Lost to Follow-up|3
3099248|NCT00293813|10622925|P2|Overall Study|Lost to Follow-up|2
3099249|NCT00293813|10622926|P1|Overall Study|Lost to Follow-up|3
3099250|NCT00293813|10622924|P3|Overall Study|Withdrawal by Subject|4
3099251|NCT00293813|10622925|P2|Overall Study|Withdrawal by Subject|4
3099252|NCT00293813|10622926|P1|Overall Study|Withdrawal by Subject|7
3099253|NCT00293813|10622924|P3|Overall Study|Adverse Event|1
3099254|NCT00293813|10622925|P2|Overall Study|Adverse Event|1
3099255|NCT00293813|10622926|P1|Overall Study|Adverse Event|3
3099256|NCT00293813|10622924|P3|Overall Study|Physician Decision|0
3099257|NCT00293813|10622925|P2|Overall Study|Physician Decision|1
3099258|NCT00293813|10622926|P1|Overall Study|Physician Decision|0
3099259|NCT00293722|10622937|P1|Overall Study|Other|427
3099260|NCT00293709|10622951|P1|Overall Study|Other|47
3099261|NCT00293579|10622965|P1|Overall Study|Withdrawal by Subject|1
3099262|NCT00293462|10622984|P3|Overall Study|Physician Decision|0
3099263|NCT00293462|10622985|P2|Overall Study|Physician Decision|1
3099264|NCT00293462|10622986|P1|Overall Study|Physician Decision|0
3099265|NCT00293462|10622984|P3|Overall Study|Low radiation dose in oral cavity|0
3099266|NCT00293462|10622985|P2|Overall Study|Low radiation dose in oral cavity|1
3099267|NCT00293462|10622986|P1|Overall Study|Low radiation dose in oral cavity|0
3099268|NCT00293462|10622984|P3|Overall Study|Possible Tracheostomy leakage|0
3099269|NCT00293462|10622985|P2|Overall Study|Possible Tracheostomy leakage|1
3099270|NCT00293462|10622986|P1|Overall Study|Possible Tracheostomy leakage|0
3099271|NCT00293462|10622984|P3|Overall Study|Ischemic stroke after chemotherapy|1
3099272|NCT00293462|10622985|P2|Overall Study|Ischemic stroke after chemotherapy|0
3099273|NCT00293462|10622986|P1|Overall Study|Ischemic stroke after chemotherapy|0
3099274|NCT00293462|10622984|P3|Overall Study|Blood clot after chemotherapy|1
3099275|NCT00293462|10622985|P2|Overall Study|Blood clot after chemotherapy|0
3099276|NCT00293462|10622986|P1|Overall Study|Blood clot after chemotherapy|0
3099277|NCT00293462|10622984|P3|Overall Study|Went back to his home country|1
3099278|NCT00293462|10622985|P2|Overall Study|Went back to his home country|0
3099279|NCT00293462|10622986|P1|Overall Study|Went back to his home country|0
3099280|NCT00293462|10622984|P3|Overall Study|No Show|1
3099281|NCT00293462|10622985|P2|Overall Study|No Show|0
3099282|NCT00293462|10622986|P1|Overall Study|No Show|0
3099283|NCT00293462|10622984|P3|Overall Study|Refuse Radiation Treatment|0
3099284|NCT00293462|10622985|P2|Overall Study|Refuse Radiation Treatment|0
3099285|NCT00293462|10622986|P1|Overall Study|Refuse Radiation Treatment|1
3099286|NCT00293462|10622984|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
3099287|NCT00293462|10622985|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
3099288|NCT00293462|10622986|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
3099289|NCT00293462|10622984|P3|Overall Study|Change Treatment Regimen (ineligible)|0
3099290|NCT00293462|10622985|P2|Overall Study|Change Treatment Regimen (ineligible)|0
3099291|NCT00293462|10622986|P1|Overall Study|Change Treatment Regimen (ineligible)|1
3099292|NCT00293462|10622984|P3|Overall Study|Lost to Follow-up|0
3099293|NCT00293462|10622985|P2|Overall Study|Lost to Follow-up|1
3099294|NCT00293462|10622986|P1|Overall Study|Lost to Follow-up|0
3099295|NCT00293462|10622984|P3|Overall Study|Death|0
3099296|NCT00293462|10622985|P2|Overall Study|Death|0
3099297|NCT00293462|10622986|P1|Overall Study|Death|1
3099298|NCT00293462|10622984|P3|Overall Study|Withdrawal by Subject|6
3099299|NCT00293462|10622985|P2|Overall Study|Withdrawal by Subject|3
3099300|NCT00293462|10622986|P1|Overall Study|Withdrawal by Subject|4
3099301|NCT00293397|10623005|P1|Overall Study|Death|2
3099302|NCT00293384|10623015|P1|Overall Study|Ineligible|2
3099303|NCT00293384|10623015|P1|Overall Study|Missed dosage/study drug|1
3099304|NCT00293384|10623015|P1|Overall Study|Non-compliance|2
3099305|NCT00293293|10623024|P2|Overall Study|Patient discontinued chemotherapy|1
3099306|NCT00293293|10623025|P1|Overall Study|Patient discontinued chemotherapy|0
3099307|NCT00293293|10623024|P2|Overall Study|"Patient too anxious to complete trial"|0
3099308|NCT00293293|10623025|P1|Overall Study|"Patient too anxious to complete trial"|1
3099309|NCT00293293|10623024|P2|Overall Study|Withdrawal by Subject|1
3099310|NCT00293293|10623025|P1|Overall Study|Withdrawal by Subject|1
3099311|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
3099312|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
3099313|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
3099314|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
3099315|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
3099316|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
3099317|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
3099318|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
3099319|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
3099320|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
3099321|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
3099322|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
3099323|NCT00293267|10623053|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
3099324|NCT00293267|10623054|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
3099325|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Other Reason|1
3099326|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Other Reason|3
3099327|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
3099328|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
3099329|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
3099330|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
3099331|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
3099332|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
3099333|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
3099334|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
3099335|NCT00293267|10623053|P2|Extension - Open-Label Week 157-240|Adverse Event|0
3099336|NCT00293267|10623054|P1|Extension - Open-Label Week 157-240|Adverse Event|5
3099337|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
3099338|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
3099339|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Other Reason|0
3099340|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Other Reason|7
3099341|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
3099342|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
3099343|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Death|0
3099344|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Death|3
3099345|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
3099346|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
3099347|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
3099348|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
3099349|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
3099350|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
3099351|NCT00293267|10623053|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
3099352|NCT00293267|10623054|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
3099353|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
3099354|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
3099355|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
3099356|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
3099357|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
3099358|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
3099359|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
3099360|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
3099361|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Death|3
3099362|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Death|3
3099363|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
3099364|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
3099365|NCT00293267|10623053|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
3099366|NCT00293267|10623054|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
3099367|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
3099368|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
3099369|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
3099370|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
3099371|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
3099372|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
3099373|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
3099374|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
3099375|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
3099376|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
3099377|NCT00293254|10623094|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
3099378|NCT00293254|10623095|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
3099379|NCT00293254|10623094|P2|Extension - Open-Label Week 157-240|Other Reason|0
3099380|NCT00293254|10623095|P1|Extension - Open-Label Week 157-240|Other Reason|4
3099381|NCT00293254|10623094|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
3099382|NCT00293254|10623095|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
3099383|NCT00293254|10623094|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
3099384|NCT00293254|10623095|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
3099385|NCT00293254|10623094|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
3099386|NCT00293254|10623095|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
3099387|NCT00293254|10623094|P2|Extension - Open-Label Week 157-240|Adverse Event|1
3099388|NCT00293254|10623095|P1|Extension - Open-Label Week 157-240|Adverse Event|2
3099389|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
3099390|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
3099391|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Other Reason|2
3099392|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Other Reason|10
3099393|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
3099394|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
3099395|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
3099396|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
3099397|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
3099398|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
3099399|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
3099400|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
3099401|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Death|1
3099402|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Death|4
3099403|NCT00293254|10623094|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
3099404|NCT00293254|10623095|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
3099405|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
3099406|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
3099407|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
3099408|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
3099409|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
3099410|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
3099411|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
3099412|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
3099413|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
3099414|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
3099415|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Death|2
3099416|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Death|5
3099417|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
3099418|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
3099419|NCT00293254|10623094|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
3099420|NCT00293254|10623095|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
3099421|NCT00293241|10623135|P2|Overall Study|Withdrawal by Subject|8
3099422|NCT00293241|10623136|P1|Overall Study|Withdrawal by Subject|4
3099423|NCT00293241|10623135|P2|Overall Study|Physician Decision|17
3099424|NCT00293241|10623136|P1|Overall Study|Physician Decision|23
3099425|NCT00293241|10623135|P2|Overall Study|Lost to Follow-up|16
3099426|NCT00293241|10623136|P1|Overall Study|Lost to Follow-up|9
3099427|NCT00293059|10623180|P2|Overall Study|missing|5
3099428|NCT00293059|10623181|P1|Overall Study|missing|3
3099429|NCT00293059|10623180|P2|Overall Study|Noncompliant - sanitary pads collection|1
3099430|NCT00293059|10623181|P1|Overall Study|Noncompliant - sanitary pads collection|0
3099431|NCT00293059|10623180|P2|Overall Study|Participant stopped study drug|0
3099432|NCT00293059|10623181|P1|Overall Study|Participant stopped study drug|1
3099433|NCT00293059|10623180|P2|Overall Study|Participant moved out of state|0
3099434|NCT00293059|10623181|P1|Overall Study|Participant moved out of state|1
3099435|NCT00293059|10623180|P2|Overall Study|Withdrawal by Subject|5
3099436|NCT00293059|10623181|P1|Overall Study|Withdrawal by Subject|11
3099437|NCT00293059|10623180|P2|Overall Study|Protocol Violation|0
3099438|NCT00293059|10623181|P1|Overall Study|Protocol Violation|2
3099439|NCT00293059|10623180|P2|Overall Study|Pregnancy|1
3099440|NCT00293059|10623181|P1|Overall Study|Pregnancy|1
3099441|NCT00293059|10623180|P2|Overall Study|Lost to Follow-up|3
3099442|NCT00293059|10623181|P1|Overall Study|Lost to Follow-up|2
3099443|NCT00293059|10623180|P2|Overall Study|Lack of Efficacy|0
3099444|NCT00293059|10623181|P1|Overall Study|Lack of Efficacy|2
3099445|NCT00293059|10623180|P2|Overall Study|Adverse Event|4
3099446|NCT00293059|10623181|P1|Overall Study|Adverse Event|12
3099447|NCT00293033|10623293|P1|Double-blind Treatment Period|Noncompliance|4
3099448|NCT00293033|10623293|P1|Double-blind Treatment Period|Withdrawal by Subject|4
3099449|NCT00293033|10623293|P1|Double-blind Treatment Period|Lack of Efficacy|1
3099450|NCT00293033|10623293|P1|Double-blind Treatment Period|Adverse Event|3
3099451|NCT00293033|10623293|P1|Open-label Titration Period|Noncompliance and other|27
3099452|NCT00293033|10623293|P1|Open-label Titration Period|Withdrawal by Subject|22
3099453|NCT00293033|10623293|P1|Open-label Titration Period|Protocol Violation|2
3099454|NCT00293033|10623293|P1|Open-label Titration Period|Lack of Efficacy|5
3099455|NCT00293033|10623293|P1|Open-label Titration Period|Death|3
3099456|NCT00293033|10623293|P1|Open-label Titration Period|Adverse Event|10
3099457|NCT00293020|10623396|P1|Overall Study|No dose taken|1
3099458|NCT00293020|10623396|P1|Overall Study|Other Reason|22
3099459|NCT00293020|10623396|P1|Overall Study|Physician Decision|21
3099460|NCT00293020|10623396|P1|Overall Study|Protocol Violation|6
3099461|NCT00293020|10623396|P1|Overall Study|Lost to Follow-up|4
3099462|NCT00293020|10623396|P1|Overall Study|Lack of Efficacy|12
3099463|NCT00293020|10623396|P1|Overall Study|Death|32
3099464|NCT00293020|10623396|P1|Overall Study|Adverse Event|30
3099465|NCT00293020|10623396|P1|Overall Study|Withdrawal by Subject|34
3099466|NCT00292981|10623400|P1|Overall Study|Other|3
3099467|NCT00292981|10623400|P1|Overall Study|Withdrawal by Subject|22
3099468|NCT00292981|10623400|P1|Overall Study|Lost to Follow-up|13
3099469|NCT00292981|10623400|P1|Overall Study|Adverse Event|1
3099470|NCT00292942|10623411|P4|Overall Study|Adverse Event|1
3099471|NCT00292942|10623412|P3|Overall Study|Adverse Event|0
3099472|NCT00292942|10623413|P2|Overall Study|Adverse Event|0
3099473|NCT00292942|10623414|P1|Overall Study|Adverse Event|0
3099474|NCT00292942|10623411|P4|Overall Study|Withdrawal by Subject|0
3099475|NCT00292942|10623412|P3|Overall Study|Withdrawal by Subject|1
3099476|NCT00292942|10623413|P2|Overall Study|Withdrawal by Subject|0
3099477|NCT00292942|10623414|P1|Overall Study|Withdrawal by Subject|0
3099478|NCT00292461|10623460|P2|Overall Study|Lost to Follow-up|0
3099479|NCT00292461|10623461|P1|Overall Study|Lost to Follow-up|1
3099480|NCT00292461|10623460|P2|Overall Study|Protocol Violation|3
3099481|NCT00292461|10623461|P1|Overall Study|Protocol Violation|4
3099482|NCT00292461|10623460|P2|Overall Study|Withdrawal by Subject|1
3099483|NCT00292461|10623461|P1|Overall Study|Withdrawal by Subject|0
3099484|NCT00292461|10623460|P2|Overall Study|Lack of Efficacy|0
3099485|NCT00292461|10623461|P1|Overall Study|Lack of Efficacy|1
3099486|NCT00292461|10623460|P2|Overall Study|Adverse Event|2
3099487|NCT00292461|10623461|P1|Overall Study|Adverse Event|4
3099488|NCT00292370|10623476|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
3099489|NCT00292370|10623477|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
3099490|NCT00292370|10623478|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
3099491|NCT00292370|10623476|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
3099492|NCT00292370|10623477|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
3099493|NCT00292370|10623478|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
3099494|NCT00292370|10623476|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
3099495|NCT00292370|10623477|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
3099496|NCT00292370|10623478|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
3099497|NCT00292370|10623476|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
3099498|NCT00292370|10623477|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
3099499|NCT00292370|10623478|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
3099500|NCT00292370|10623476|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
3099501|NCT00292370|10623477|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
3099502|NCT00292370|10623478|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
3099503|NCT00292370|10623476|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
3099504|NCT00292370|10623477|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
3099505|NCT00292370|10623478|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
3099506|NCT00292318|10623503|P2|Overall Study|Study terminated by officials|1
3099507|NCT00292318|10623504|P1|Overall Study|Study terminated by officials|2
3099508|NCT00292227|10623514|P3|Patch Period|Withdrawal by Subject|1
3099509|NCT00292227|10623515|P2|Patch Period|Withdrawal by Subject|0
3099510|NCT00292227|10623516|P1|Patch Period|Withdrawal by Subject|0
3099511|NCT00292227|10623514|P3|Patch Period|Adverse Event|2
3099512|NCT00292227|10623515|P2|Patch Period|Adverse Event|0
3099513|NCT00292227|10623516|P1|Patch Period|Adverse Event|1
3099514|NCT00292188|10623598|P3|Double-Blind|Laboratory Abnormality|1
3099515|NCT00292188|10623599|P2|Double-Blind|Laboratory Abnormality|0
3099516|NCT00292188|10623600|P1|Double-Blind|Laboratory Abnormality|0
3099517|NCT00292188|10623598|P3|Double-Blind|Withdrawal by Subject|3
3099518|NCT00292188|10623599|P2|Double-Blind|Withdrawal by Subject|0
3099519|NCT00292188|10623600|P1|Double-Blind|Withdrawal by Subject|0
3099520|NCT00292188|10623598|P3|Double-Blind|Other|4
3099521|NCT00292188|10623599|P2|Double-Blind|Other|3
3099522|NCT00292188|10623600|P1|Double-Blind|Other|0
3099523|NCT00292188|10623598|P3|Double-Blind|Lost to Follow-up|0
3099524|NCT00292188|10623599|P2|Double-Blind|Lost to Follow-up|1
3099525|NCT00292188|10623600|P1|Double-Blind|Lost to Follow-up|0
3099526|NCT00292188|10623598|P3|Double-Blind|Lack of Efficacy|12
3099527|NCT00292188|10623599|P2|Double-Blind|Lack of Efficacy|2
3099528|NCT00292188|10623600|P1|Double-Blind|Lack of Efficacy|0
3099529|NCT00292188|10623598|P3|Double-Blind|Adverse Event|9
3099530|NCT00292188|10623599|P2|Double-Blind|Adverse Event|25
3099531|NCT00292188|10623600|P1|Double-Blind|Adverse Event|0
3099532|NCT00292188|10623598|P3|Single-Blind|Did not receive treatment|0
3099533|NCT00292188|10623599|P2|Single-Blind|Did not receive treatment|0
3099534|NCT00292188|10623600|P1|Single-Blind|Did not receive treatment|1
3099535|NCT00292188|10623598|P3|Single-Blind|Withdrawal by Subject|0
3099536|NCT00292188|10623599|P2|Single-Blind|Withdrawal by Subject|0
3099537|NCT00292188|10623600|P1|Single-Blind|Withdrawal by Subject|12
3099538|NCT00292188|10623598|P3|Single-Blind|Other|0
3099539|NCT00292188|10623599|P2|Single-Blind|Other|0
3099540|NCT00292188|10623600|P1|Single-Blind|Other|77
3099541|NCT00292188|10623598|P3|Single-Blind|Lost to Follow-up|0
3099542|NCT00292188|10623599|P2|Single-Blind|Lost to Follow-up|0
3099543|NCT00292188|10623600|P1|Single-Blind|Lost to Follow-up|3
3099544|NCT00292188|10623598|P3|Single-Blind|Laboratory Abnormality|0
3099545|NCT00292188|10623599|P2|Single-Blind|Laboratory Abnormality|0
3099546|NCT00292188|10623600|P1|Single-Blind|Laboratory Abnormality|5
3099547|NCT00292188|10623598|P3|Single-Blind|Lack of Efficacy|0
3099548|NCT00292188|10623599|P2|Single-Blind|Lack of Efficacy|0
3099549|NCT00292188|10623600|P1|Single-Blind|Lack of Efficacy|2
3099550|NCT00292188|10623598|P3|Single-Blind|Adverse Event|0
3099551|NCT00292188|10623599|P2|Single-Blind|Adverse Event|0
3099552|NCT00292188|10623600|P1|Single-Blind|Adverse Event|14
3099553|NCT00291642|10623717|P5|Overall Study|Intake of prohibited medication|0
3099554|NCT00291642|10623718|P4|Overall Study|Intake of prohibited medication|0
3099555|NCT00291642|10623719|P3|Overall Study|Intake of prohibited medication|0
3099556|NCT00291642|10623720|P2|Overall Study|Intake of prohibited medication|0
3099557|NCT00291642|10623721|P1|Overall Study|Intake of prohibited medication|1
3099558|NCT00291642|10623717|P5|Overall Study|Patient missed visit|0
3099559|NCT00291642|10623718|P4|Overall Study|Patient missed visit|0
3099560|NCT00291642|10623719|P3|Overall Study|Patient missed visit|1
3099561|NCT00291642|10623720|P2|Overall Study|Patient missed visit|0
3099562|NCT00291642|10623721|P1|Overall Study|Patient missed visit|0
3099563|NCT00291642|10623717|P5|Overall Study|Adverse Event|1
3099564|NCT00291642|10623718|P4|Overall Study|Adverse Event|0
3099565|NCT00291642|10623719|P3|Overall Study|Adverse Event|1
3099566|NCT00291642|10623720|P2|Overall Study|Adverse Event|0
3099567|NCT00291642|10623721|P1|Overall Study|Adverse Event|1
3099568|NCT00291577|10623773|P1|Overall Study|Lack of Efficacy|14
3099569|NCT00291577|10623773|P1|Overall Study|Withdrawal by Subject|2
3099570|NCT00291577|10623773|P1|Overall Study|Other|4
3099571|NCT00291577|10623773|P1|Overall Study|Adverse Event|1
3099572|NCT00291551|10623792|P1|Overall Study|Withdrawal by Subject|6
3099573|NCT00291551|10623792|P1|Overall Study|Death|7
3099574|NCT00291330|10623840|P2|Overall Study|Other|1
3099575|NCT00291330|10623841|P1|Overall Study|Other|3
3099576|NCT00291330|10623840|P2|Overall Study|Withdrawal by Subject|25
3099577|NCT00291330|10623841|P1|Overall Study|Withdrawal by Subject|22
3099578|NCT00291330|10623840|P2|Overall Study|Lost to Follow-up|11
3099579|NCT00291330|10623841|P1|Overall Study|Lost to Follow-up|16
3099580|NCT00291330|10623840|P2|Overall Study|Protocol Violation|20
3099581|NCT00291330|10623841|P1|Overall Study|Protocol Violation|13
3099582|NCT00291330|10623840|P2|Overall Study|Adverse Event|40
3099583|NCT00291330|10623841|P1|Overall Study|Adverse Event|47
3099584|NCT00291187|10623883|P4|Overall Study|Protocol Violation- No Drug Administered|0
3099585|NCT00291187|10623884|P3|Overall Study|Protocol Violation- No Drug Administered|1
3099586|NCT00291187|10623885|P2|Overall Study|Protocol Violation- No Drug Administered|0
3099587|NCT00291187|10623886|P1|Overall Study|Protocol Violation- No Drug Administered|0
3099588|NCT00291018|10623930|P3|Overall Study|Lost to Follow-up|18
3099589|NCT00291018|10623931|P2|Overall Study|Lost to Follow-up|4
3099590|NCT00291018|10623932|P1|Overall Study|Lost to Follow-up|3
3099591|NCT00291018|10623930|P3|Overall Study|Failures|5
3099592|NCT00291018|10623931|P2|Overall Study|Failures|12
3099593|NCT00291018|10623932|P1|Overall Study|Failures|5
3099594|NCT00291018|10623930|P3|Overall Study|Withdrawal by Subject|1
3099595|NCT00291018|10623931|P2|Overall Study|Withdrawal by Subject|8
3099596|NCT00291018|10623932|P1|Overall Study|Withdrawal by Subject|2
3099597|NCT00291018|10623930|P3|Overall Study|Death|4
3099598|NCT00291018|10623931|P2|Overall Study|Death|3
3099599|NCT00291018|10623932|P1|Overall Study|Death|3
3099600|NCT00291018|10623930|P3|Overall Study|Not Consented or Declined PAS|15
3099601|NCT00291018|10623931|P2|Overall Study|Not Consented or Declined PAS|15
3099602|NCT00291018|10623932|P1|Overall Study|Not Consented or Declined PAS|12
3099603|NCT00290888|10623972|P2|Overall Study|Physician Decision|1
3099604|NCT00290888|10623973|P1|Overall Study|Physician Decision|3
3099605|NCT00290771|10623990|P2|Overall Study|Lost to Follow-up|1
3099606|NCT00290771|10623991|P1|Overall Study|Lost to Follow-up|0
3099607|NCT00290771|10623990|P2|Overall Study|Protocol Violation|0
3099608|NCT00290771|10623991|P1|Overall Study|Protocol Violation|2
3099609|NCT00290771|10623990|P2|Overall Study|Administrative problems|1
3099610|NCT00290771|10623991|P1|Overall Study|Administrative problems|2
3099611|NCT00290771|10623990|P2|Overall Study|Withdrawal by Subject|6
3099612|NCT00290771|10623991|P1|Overall Study|Withdrawal by Subject|5
3099613|NCT00290771|10623990|P2|Overall Study|Adverse Event|6
3099614|NCT00290771|10623991|P1|Overall Study|Adverse Event|12
3099615|NCT00290771|10623990|P2|Overall Study|Death|10
3099616|NCT00290771|10623991|P1|Overall Study|Death|11
3099617|NCT00290771|10623990|P2|Overall Study|Disease progression|73
3099618|NCT00290771|10623991|P1|Overall Study|Disease progression|95
3099619|NCT00290758|10624015|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
3099620|NCT00290758|10624016|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
3099621|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
3099622|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
3099623|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
3099624|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
3099625|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
3099626|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
3099627|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
3099628|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
3099629|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
3099630|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
3099631|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
3099632|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
3099633|NCT00290758|10624015|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
3099634|NCT00290758|10624016|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
3099635|NCT00290732|10624038|P5|Overall Study|Inability to instill drug intraductally.|0
3099636|NCT00290732|10624039|P4|Overall Study|Inability to instill drug intraductally.|0
3099637|NCT00290732|10624040|P3|Overall Study|Inability to instill drug intraductally.|1
3099638|NCT00290732|10624041|P2|Overall Study|Inability to instill drug intraductally.|1
3099639|NCT00290732|10624042|P1|Overall Study|Inability to instill drug intraductally.|0
3099640|NCT00290706|10624064|P4|Overall Study|Physician Decision|1
3099641|NCT00290706|10624065|P3|Overall Study|Physician Decision|0
3099642|NCT00290706|10624066|P2|Overall Study|Physician Decision|0
3099643|NCT00290706|10624067|P1|Overall Study|Physician Decision|0
3099644|NCT00290706|10624064|P4|Overall Study|Receive auto transplant or radiation|1
3099645|NCT00290706|10624065|P3|Overall Study|Receive auto transplant or radiation|0
3099646|NCT00290706|10624066|P2|Overall Study|Receive auto transplant or radiation|0
3099647|NCT00290706|10624067|P1|Overall Study|Receive auto transplant or radiation|0
3099648|NCT00290706|10624064|P4|Overall Study|Adverse Event|0
3099649|NCT00290706|10624065|P3|Overall Study|Adverse Event|2
3099650|NCT00290706|10624066|P2|Overall Study|Adverse Event|1
3099651|NCT00290706|10624067|P1|Overall Study|Adverse Event|0
3099652|NCT00290706|10624064|P4|Overall Study|Progressive Disease|10
3099653|NCT00290706|10624065|P3|Overall Study|Progressive Disease|4
3099654|NCT00290706|10624066|P2|Overall Study|Progressive Disease|5
3099655|NCT00290706|10624067|P1|Overall Study|Progressive Disease|3
3099656|NCT00290706|10624064|P4|Overall Study|Withdrawal by Subject|0
3099657|NCT00290706|10624065|P3|Overall Study|Withdrawal by Subject|0
3099658|NCT00290706|10624066|P2|Overall Study|Withdrawal by Subject|0
3099659|NCT00290706|10624067|P1|Overall Study|Withdrawal by Subject|2
3099660|NCT00290693|10624086|P1|Overall Study|Withdrawal by Subject|2
3099661|NCT00290589|10624114|P2|Overall Study|Lost to Follow-up|2
3099662|NCT00290589|10624115|P1|Overall Study|Lost to Follow-up|2
3099663|NCT00290407|10624148|P1|Overall Study|Physician Decision|2
3099664|NCT00290355|10624155|P2|Overall Study|Other|0
3099665|NCT00290355|10624156|P1|Overall Study|Other|2
3099666|NCT00290355|10624155|P2|Overall Study|Lost to Follow-up|1
3099667|NCT00290355|10624156|P1|Overall Study|Lost to Follow-up|3
3099668|NCT00290355|10624155|P2|Overall Study|Migrated / moved from the study area|0
3099669|NCT00290355|10624156|P1|Overall Study|Migrated / moved from the study area|1
3099670|NCT00290355|10624155|P2|Overall Study|Withdrawal by Subject|0
3099671|NCT00290355|10624156|P1|Overall Study|Withdrawal by Subject|2
3099672|NCT00290355|10624155|P2|Overall Study|Protocol Violation|0
3099673|NCT00290355|10624156|P1|Overall Study|Protocol Violation|1
3099674|NCT00290355|10624155|P2|Overall Study|Study product reactogenicity|0
3099675|NCT00290355|10624156|P1|Overall Study|Study product reactogenicity|1
3099676|NCT00290355|10624155|P2|Overall Study|Serious adverse event|4
3099677|NCT00290355|10624156|P1|Overall Study|Serious adverse event|7
3099678|NCT00290342|10624200|P2|Overall Study|Lost to Follow-up|0
3099679|NCT00290342|10624201|P1|Overall Study|Lost to Follow-up|1
3099680|NCT00290342|10624200|P2|Overall Study|Withdrawal by Subject|4
3099681|NCT00290342|10624201|P1|Overall Study|Withdrawal by Subject|6
3099682|NCT00290342|10624200|P2|Overall Study|Other|1
3099683|NCT00290342|10624201|P1|Overall Study|Other|0
3099684|NCT00290290|10624256|P2|Overall Study|Underwent clean surgical procedure|12
3099685|NCT00290290|10624257|P1|Overall Study|Underwent clean surgical procedure|13
3099686|NCT00290290|10624256|P2|Overall Study|Withdrawal by Subject|2
3099687|NCT00290290|10624257|P1|Overall Study|Withdrawal by Subject|2
3099688|NCT00290290|10624256|P2|Overall Study|Death|4
3099689|NCT00290290|10624257|P1|Overall Study|Death|3
3099690|NCT00290251|10624263|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
3099691|NCT00290251|10624264|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
3099692|NCT00290251|10624265|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
3099693|NCT00290251|10624263|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
3099694|NCT00290251|10624264|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
3099695|NCT00290251|10624265|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
3099696|NCT00290251|10624263|P3|Treatment 1 (Months 1 - 3)|headache|0
3099697|NCT00290251|10624264|P2|Treatment 1 (Months 1 - 3)|headache|1
3099698|NCT00290251|10624265|P1|Treatment 1 (Months 1 - 3)|headache|0
3099699|NCT00290251|10624263|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
3099700|NCT00290251|10624264|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
3099701|NCT00290251|10624265|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
3099702|NCT00290238|10624277|P2|Overall Study|Withdrawal by Subject|13
3099703|NCT00290238|10624278|P1|Overall Study|Withdrawal by Subject|15
3099704|NCT00290238|10624277|P2|Overall Study|Lost to Follow-up|1
3099705|NCT00290238|10624278|P1|Overall Study|Lost to Follow-up|0
3099706|NCT00290238|10624277|P2|Overall Study|Study terminated|27
3099707|NCT00290238|10624278|P1|Overall Study|Study terminated|27
3099708|NCT00290186|10624303|P2|Overall Study|Withdrawal by Subject|1
3099709|NCT00290186|10624304|P1|Overall Study|Withdrawal by Subject|0
3099710|NCT00290186|10624303|P2|Overall Study|Study was terminated prior to 3-month te|1
3099711|NCT00290186|10624304|P1|Overall Study|Study was terminated prior to 3-month te|1
3099712|NCT00290186|10624303|P2|Overall Study|Lost to Follow-up|2
3099713|NCT00290186|10624304|P1|Overall Study|Lost to Follow-up|3
3099714|NCT00290186|10624303|P2|Overall Study|Adverse Event|1
3099715|NCT00290186|10624304|P1|Overall Study|Adverse Event|1
3099716|NCT00289991|10624355|P2|Overall Study|Other|14
3099717|NCT00289991|10624356|P1|Overall Study|Other|5
3099718|NCT00289991|10624355|P2|Overall Study|Withdrawal by Subject|12
3099719|NCT00289991|10624356|P1|Overall Study|Withdrawal by Subject|2
3099720|NCT00289991|10624355|P2|Overall Study|Lost to Follow-up|1
3099721|NCT00289991|10624356|P1|Overall Study|Lost to Follow-up|0
3099722|NCT00289991|10624355|P2|Overall Study|Fungal breakthrough infection|1
3099723|NCT00289991|10624356|P1|Overall Study|Fungal breakthrough infection|0
3099724|NCT00289991|10624355|P2|Overall Study|Failure of prophylaxis|1
3099725|NCT00289991|10624356|P1|Overall Study|Failure of prophylaxis|1
3099726|NCT00289991|10624355|P2|Overall Study|Adverse Event|13
3099727|NCT00289991|10624356|P1|Overall Study|Adverse Event|15
3099728|NCT00289991|10624355|P2|Overall Study|Death|38
3099729|NCT00289991|10624356|P1|Overall Study|Death|35
3099730|NCT00289978|10624381|P3|Overall Study|Death|2
3099731|NCT00289978|10624382|P2|Overall Study|Death|0
3099732|NCT00289978|10624383|P1|Overall Study|Death|1
3099733|NCT00289978|10624381|P3|Overall Study|Abnormal test procedure result(s)|1
3099734|NCT00289978|10624382|P2|Overall Study|Abnormal test procedure result(s)|1
3099735|NCT00289978|10624383|P1|Overall Study|Abnormal test procedure result(s)|2
3099736|NCT00289978|10624381|P3|Overall Study|Protocol Violation|4
3099737|NCT00289978|10624382|P2|Overall Study|Protocol Violation|5
3099738|NCT00289978|10624383|P1|Overall Study|Protocol Violation|5
3099739|NCT00289978|10624381|P3|Overall Study|Lost to Follow-up|7
3099740|NCT00289978|10624382|P2|Overall Study|Lost to Follow-up|5
3099741|NCT00289978|10624383|P1|Overall Study|Lost to Follow-up|3
3099742|NCT00289978|10624381|P3|Overall Study|Abnormal laboratory value(s)|1
3099743|NCT00289978|10624382|P2|Overall Study|Abnormal laboratory value(s)|9
3099744|NCT00289978|10624383|P1|Overall Study|Abnormal laboratory value(s)|20
3099745|NCT00289978|10624381|P3|Overall Study|Lack of Efficacy|25
3099746|NCT00289978|10624382|P2|Overall Study|Lack of Efficacy|6
3099747|NCT00289978|10624383|P1|Overall Study|Lack of Efficacy|13
3099748|NCT00289978|10624381|P3|Overall Study|Adverse Event|18
3099749|NCT00289978|10624382|P2|Overall Study|Adverse Event|13
3099750|NCT00289978|10624383|P1|Overall Study|Adverse Event|22
3099751|NCT00289978|10624381|P3|Overall Study|Withdrawal by Subject|28
3099752|NCT00289978|10624382|P2|Overall Study|Withdrawal by Subject|17
3099753|NCT00289978|10624383|P1|Overall Study|Withdrawal by Subject|31
3099754|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
3099755|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
3099756|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
3099757|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
3099758|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
3099759|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
3099760|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
3099761|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
3099762|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
3099763|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
3099764|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
3099765|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
3099766|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
3099767|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
3099768|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
3099769|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
3099770|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
3099771|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
3099772|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
3099773|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
3099774|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
3099775|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
3099776|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
3099777|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
3099778|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
3099779|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099780|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
3099781|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099782|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099783|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099784|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
3099785|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
3099786|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
3099787|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
3099788|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
3099789|NCT00289913|10624402|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099790|NCT00289913|10624403|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099791|NCT00289913|10624404|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099792|NCT00289913|10624405|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
3099793|NCT00289913|10624406|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099794|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
3099795|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
3099796|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
3099941|NCT00289900|10624439|P4|Overall Study|Other|5
3099797|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
3099798|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
3099799|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
3099800|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
3099801|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
3099802|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
3099803|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
3099804|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
3099805|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
3099806|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
3099807|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
3099808|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
3099809|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
3099810|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
3099811|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
3099812|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
3099813|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
3099814|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
3099815|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
3099816|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
3099817|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
3099818|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
3099819|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
3099820|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
3099821|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
3099822|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
3099823|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
3099824|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
3099825|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
3099826|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
3099827|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
3099828|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
3099829|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
3099830|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
3099831|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
3099832|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
3099833|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
3099834|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
3099835|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
3099836|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
3099837|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
3099838|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
3099839|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
3099840|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
3099841|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
3099842|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
3099843|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
3099844|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099845|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099846|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
3099847|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
3099848|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
3099849|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
3099850|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
3099851|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
3099852|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
3099853|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
3099854|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
3099855|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
3099856|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
3099857|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
3099858|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
3099859|NCT00289913|10624402|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099860|NCT00289913|10624403|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099861|NCT00289913|10624404|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
3099862|NCT00289913|10624405|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099863|NCT00289913|10624406|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099864|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
3099942|NCT00289900|10624440|P3|Overall Study|Other|0
3099865|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
3099866|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
3099867|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
3099868|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
3099869|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
3099870|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
3099871|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
3099872|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
3099873|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
3099874|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
3099875|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
3099876|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
3099877|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
3099878|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
3099879|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
3099880|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
3099881|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
3099882|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
3099883|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
3099884|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
3099885|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
3099886|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
3099887|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
3099888|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
3099889|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
3099890|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
3099891|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
3099892|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
3099893|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
3099894|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
3099895|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
3099896|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
3099897|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
3099898|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
3099899|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
3099900|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
3099901|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
3099902|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
3099903|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
3099904|NCT00289913|10624402|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099905|NCT00289913|10624403|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099906|NCT00289913|10624404|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099907|NCT00289913|10624405|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
3099908|NCT00289913|10624406|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
3099909|NCT00289900|10624437|P6|Overall Study|Not treated|0
3099910|NCT00289900|10624438|P5|Overall Study|Not treated|0
3099911|NCT00289900|10624439|P4|Overall Study|Not treated|0
3099912|NCT00289900|10624440|P3|Overall Study|Not treated|0
3099913|NCT00289900|10624441|P2|Overall Study|Not treated|1
3099914|NCT00289900|10624442|P1|Overall Study|Not treated|0
3099915|NCT00289900|10624437|P6|Overall Study|site terminated|0
3099916|NCT00289900|10624438|P5|Overall Study|site terminated|0
3099917|NCT00289900|10624439|P4|Overall Study|site terminated|0
3099918|NCT00289900|10624440|P3|Overall Study|site terminated|1
3099919|NCT00289900|10624441|P2|Overall Study|site terminated|0
3099920|NCT00289900|10624442|P1|Overall Study|site terminated|1
3099921|NCT00289900|10624437|P6|Overall Study|Protocol Violation|4
3099922|NCT00289900|10624438|P5|Overall Study|Protocol Violation|7
3099923|NCT00289900|10624439|P4|Overall Study|Protocol Violation|6
3099924|NCT00289900|10624440|P3|Overall Study|Protocol Violation|2
3099925|NCT00289900|10624441|P2|Overall Study|Protocol Violation|9
3099926|NCT00289900|10624442|P1|Overall Study|Protocol Violation|3
3099927|NCT00289900|10624437|P6|Overall Study|Withdrawal by Subject|11
3099928|NCT00289900|10624438|P5|Overall Study|Withdrawal by Subject|12
3099929|NCT00289900|10624439|P4|Overall Study|Withdrawal by Subject|18
3099930|NCT00289900|10624440|P3|Overall Study|Withdrawal by Subject|8
3099931|NCT00289900|10624441|P2|Overall Study|Withdrawal by Subject|21
3099932|NCT00289900|10624442|P1|Overall Study|Withdrawal by Subject|10
3099933|NCT00289900|10624437|P6|Overall Study|Participant moved|1
3099934|NCT00289900|10624438|P5|Overall Study|Participant moved|1
3099935|NCT00289900|10624439|P4|Overall Study|Participant moved|1
3099936|NCT00289900|10624440|P3|Overall Study|Participant moved|0
3099937|NCT00289900|10624441|P2|Overall Study|Participant moved|0
3099938|NCT00289900|10624442|P1|Overall Study|Participant moved|1
3099939|NCT00289900|10624437|P6|Overall Study|Other|0
3099940|NCT00289900|10624438|P5|Overall Study|Other|1
3099943|NCT00289900|10624441|P2|Overall Study|Other|0
3099944|NCT00289900|10624442|P1|Overall Study|Other|0
3099945|NCT00289900|10624437|P6|Overall Study|Participant had flushing|4
3099946|NCT00289900|10624438|P5|Overall Study|Participant had flushing|0
3099947|NCT00289900|10624439|P4|Overall Study|Participant had flushing|2
3099948|NCT00289900|10624440|P3|Overall Study|Participant had flushing|1
3099949|NCT00289900|10624441|P2|Overall Study|Participant had flushing|42
3099950|NCT00289900|10624442|P1|Overall Study|Participant had flushing|18
3099951|NCT00289900|10624437|P6|Overall Study|Lost to Follow-up|8
3099952|NCT00289900|10624438|P5|Overall Study|Lost to Follow-up|4
3099953|NCT00289900|10624439|P4|Overall Study|Lost to Follow-up|8
3099954|NCT00289900|10624440|P3|Overall Study|Lost to Follow-up|8
3099955|NCT00289900|10624441|P2|Overall Study|Lost to Follow-up|7
3099956|NCT00289900|10624442|P1|Overall Study|Lost to Follow-up|7
3099957|NCT00289900|10624437|P6|Overall Study|Adverse Event|33
3099958|NCT00289900|10624438|P5|Overall Study|Adverse Event|20
3099959|NCT00289900|10624439|P4|Overall Study|Adverse Event|19
3099960|NCT00289900|10624440|P3|Overall Study|Adverse Event|13
3099961|NCT00289900|10624441|P2|Overall Study|Adverse Event|40
3099962|NCT00289900|10624442|P1|Overall Study|Adverse Event|28
3099963|NCT00289887|10624546|P2|Overall Study|Other|3
3099964|NCT00289887|10624547|P1|Overall Study|Other|7
3099965|NCT00289887|10624546|P2|Overall Study|Withdrawal by Subject|8
3099966|NCT00289887|10624547|P1|Overall Study|Withdrawal by Subject|3
3099967|NCT00289887|10624546|P2|Overall Study|Protocol Violation|1
3099968|NCT00289887|10624547|P1|Overall Study|Protocol Violation|3
3099969|NCT00289887|10624546|P2|Overall Study|Lost to Follow-up|3
3099970|NCT00289887|10624547|P1|Overall Study|Lost to Follow-up|3
3099971|NCT00289887|10624546|P2|Overall Study|Lack of Efficacy|11
3099972|NCT00289887|10624547|P1|Overall Study|Lack of Efficacy|3
3099973|NCT00289887|10624546|P2|Overall Study|Adverse Event|3
3099974|NCT00289887|10624547|P1|Overall Study|Adverse Event|3
3099975|NCT00289874|10624565|P2|Overall Study|Did not meet eligibility|0
3099976|NCT00289874|10624566|P1|Overall Study|Did not meet eligibility|1
3099977|NCT00289874|10624565|P2|Overall Study|Protocol Violation|2
3099978|NCT00289874|10624566|P1|Overall Study|Protocol Violation|3
3099979|NCT00289874|10624565|P2|Overall Study|Lost to Follow-up|1
3099980|NCT00289874|10624566|P1|Overall Study|Lost to Follow-up|1
3099981|NCT00289874|10624565|P2|Overall Study|Adverse Event|5
3099982|NCT00289874|10624566|P1|Overall Study|Adverse Event|1
3099983|NCT00289848|10624576|P2|Overall Study|Open-Label AHA Treatment Requested|1
3099984|NCT00289848|10624577|P1|Overall Study|Open-Label AHA Treatment Requested|0
3099985|NCT00289848|10624576|P2|Overall Study|Patient Moved|2
3099986|NCT00289848|10624577|P1|Overall Study|Patient Moved|6
3099987|NCT00289848|10624576|P2|Overall Study|Withdrawal by Subject|11
3099988|NCT00289848|10624577|P1|Overall Study|Withdrawal by Subject|5
3099989|NCT00289848|10624576|P2|Overall Study|Protocol Violation|2
3099990|NCT00289848|10624577|P1|Overall Study|Protocol Violation|5
3099991|NCT00289848|10624576|P2|Overall Study|Lost to Follow-up|1
3099992|NCT00289848|10624577|P1|Overall Study|Lost to Follow-up|3
3099993|NCT00289848|10624576|P2|Overall Study|Lack of Efficacy|24
3099994|NCT00289848|10624577|P1|Overall Study|Lack of Efficacy|20
3099995|NCT00289848|10624576|P2|Overall Study|Death|0
3099996|NCT00289848|10624577|P1|Overall Study|Death|1
3099997|NCT00289848|10624576|P2|Overall Study|Adverse Event|4
3099998|NCT00289848|10624577|P1|Overall Study|Adverse Event|6
3099999|NCT00289783|10624589|P2|Fourth Dose Phase|Other|10
3100000|NCT00289783|10624590|P1|Fourth Dose Phase|Other|22
3100001|NCT00289783|10624589|P2|Fourth Dose Phase|Migration from the study area|1
3100002|NCT00289783|10624590|P1|Fourth Dose Phase|Migration from the study area|1
3100003|NCT00289783|10624589|P2|Fourth Dose Phase|Lost to Follow-up|12
3100004|NCT00289783|10624590|P1|Fourth Dose Phase|Lost to Follow-up|53
3100005|NCT00289783|10624589|P2|Fourth Dose Phase|Withdrawal by Subject|1
3100006|NCT00289783|10624590|P1|Fourth Dose Phase|Withdrawal by Subject|10
3100007|NCT00289783|10624589|P2|Fourth Dose Phase|Adverse Event|0
3100008|NCT00289783|10624590|P1|Fourth Dose Phase|Adverse Event|1
3100009|NCT00289783|10624589|P2|Primary Phase|Other|12
3100010|NCT00289783|10624590|P1|Primary Phase|Other|32
3100011|NCT00289783|10624589|P2|Primary Phase|Migration from the study area|10
3100012|NCT00289783|10624590|P1|Primary Phase|Migration from the study area|26
3100013|NCT00289783|10624589|P2|Primary Phase|Lost to Follow-up|14
3100014|NCT00289783|10624590|P1|Primary Phase|Lost to Follow-up|60
3100015|NCT00289783|10624589|P2|Primary Phase|Withdrawal by Subject|40
3100016|NCT00289783|10624590|P1|Primary Phase|Withdrawal by Subject|93
3100017|NCT00289783|10624589|P2|Primary Phase|Protocol Violation|6
3100018|NCT00289783|10624590|P1|Primary Phase|Protocol Violation|27
3100019|NCT00289783|10624589|P2|Primary Phase|Adverse Event|1
3100020|NCT00289783|10624590|P1|Primary Phase|Adverse Event|10
3100021|NCT00289770|10624768|P1|Year 15|Withdrawal by Subject|1
3100022|NCT00289731|10624814|P3|Overall Study|Other|0
3100023|NCT00289731|10624815|P2|Overall Study|Other|0
3100024|NCT00289731|10624816|P1|Overall Study|Other|1
3100025|NCT00289731|10624814|P3|Overall Study|Adverse Event|2
3100026|NCT00289731|10624815|P2|Overall Study|Adverse Event|2
3100027|NCT00289731|10624816|P1|Overall Study|Adverse Event|1
3100028|NCT00289536|10624928|P3|Period 3|Lost to Follow-up|1
3100029|NCT00289536|10624929|P2|Period 3|Lost to Follow-up|0
3100030|NCT00289536|10624930|P1|Period 3|Lost to Follow-up|0
3100031|NCT00289458|10624976|P3|Overall Study|Withdrawal by Subject|4
3100032|NCT00289458|10624977|P2|Overall Study|Withdrawal by Subject|2
3100033|NCT00289458|10624978|P1|Overall Study|Withdrawal by Subject|2
3100034|NCT00289458|10624976|P3|Overall Study|Physician Decision|2
3100035|NCT00289458|10624977|P2|Overall Study|Physician Decision|4
3100036|NCT00289458|10624978|P1|Overall Study|Physician Decision|3
3100037|NCT00289458|10624976|P3|Overall Study|Death|0
3100038|NCT00289458|10624977|P2|Overall Study|Death|0
3100039|NCT00289458|10624978|P1|Overall Study|Death|1
3100040|NCT00289289|10625039|P3|Overall Study|Other Exit Reason|12
3100041|NCT00289289|10625040|P2|Overall Study|Other Exit Reason|4
3100042|NCT00289289|10625041|P1|Overall Study|Other Exit Reason|6
3100043|NCT00289289|10625039|P3|Overall Study|Did not meet inclusion/exclusion|6
3100044|NCT00289289|10625040|P2|Overall Study|Did not meet inclusion/exclusion|0
3100045|NCT00289289|10625041|P1|Overall Study|Did not meet inclusion/exclusion|0
3100046|NCT00289289|10625039|P3|Overall Study|Non-study device implanted|3
3100047|NCT00289289|10625040|P2|Overall Study|Non-study device implanted|1
3100048|NCT00289289|10625041|P1|Overall Study|Non-study device implanted|2
3100049|NCT00289289|10625039|P3|Overall Study|Physician Decision|6
3100050|NCT00289289|10625040|P2|Overall Study|Physician Decision|0
3100051|NCT00289289|10625041|P1|Overall Study|Physician Decision|1
3100052|NCT00289289|10625039|P3|Overall Study|No implant attempted|1
3100053|NCT00289289|10625040|P2|Overall Study|No implant attempted|0
3100054|NCT00289289|10625041|P1|Overall Study|No implant attempted|0
3100055|NCT00289289|10625039|P3|Overall Study|Death|5
3100056|NCT00289289|10625040|P2|Overall Study|Death|2
3100057|NCT00289289|10625041|P1|Overall Study|Death|4
3100058|NCT00289289|10625039|P3|Overall Study|Lost to Follow-up|1
3100059|NCT00289289|10625040|P2|Overall Study|Lost to Follow-up|0
3100060|NCT00289289|10625041|P1|Overall Study|Lost to Follow-up|1
3100061|NCT00289289|10625039|P3|Overall Study|Withdrawal by Subject|15
3100062|NCT00289289|10625040|P2|Overall Study|Withdrawal by Subject|3
3100063|NCT00289289|10625041|P1|Overall Study|Withdrawal by Subject|5
3100064|NCT00289276|10625056|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
3100065|NCT00289276|10625057|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
3100066|NCT00289276|10625056|P2|Second Part of FAST Study (Expansion)|Death|2
3100067|NCT00289276|10625057|P1|Second Part of FAST Study (Expansion)|Death|0
3100068|NCT00289198|10625092|P2|Overall Study|Other: Impossible to come on visit|1
3100069|NCT00289198|10625093|P1|Overall Study|Other: Impossible to come on visit|0
3100070|NCT00289198|10625092|P2|Overall Study|Other: Miscalculation of the visit date|22
3100071|NCT00289198|10625093|P1|Overall Study|Other: Miscalculation of the visit date|21
3100072|NCT00289198|10625092|P2|Overall Study|Other: Unable to attend on schedule|1
3100073|NCT00289198|10625093|P1|Overall Study|Other: Unable to attend on schedule|2
3100074|NCT00289198|10625092|P2|Overall Study|Other: Physician's decision|1
3100075|NCT00289198|10625093|P1|Overall Study|Other: Physician's decision|0
3100076|NCT00289198|10625092|P2|Overall Study|Other: Low compliance|1
3100077|NCT00289198|10625093|P1|Overall Study|Other: Low compliance|0
3100078|NCT00289198|10625092|P2|Overall Study|Lack of Efficacy|0
3100079|NCT00289198|10625093|P1|Overall Study|Lack of Efficacy|2
3100080|NCT00289198|10625092|P2|Overall Study|Withdrawal by Subject|1
3100081|NCT00289198|10625093|P1|Overall Study|Withdrawal by Subject|4
3100082|NCT00289198|10625092|P2|Overall Study|Protocol Violation|1
3100083|NCT00289198|10625093|P1|Overall Study|Protocol Violation|2
3100084|NCT00289198|10625092|P2|Overall Study|Adverse Event|2
3100085|NCT00289198|10625093|P1|Overall Study|Adverse Event|0
3100086|NCT00289185|10625143|P2|Overall Study|Death|1
3100087|NCT00289185|10625144|P1|Overall Study|Death|1
3100088|NCT00289185|10625143|P2|Overall Study|Lost to Follow-up|17
3100089|NCT00289185|10625144|P1|Overall Study|Lost to Follow-up|23
3100090|NCT00289185|10625143|P2|Overall Study|Withdrawal by Subject|8
3100091|NCT00289185|10625144|P1|Overall Study|Withdrawal by Subject|4
3100092|NCT00289133|10625191|P2|Overall Study|Lost to Follow-up|115
3100093|NCT00289133|10625192|P1|Overall Study|Lost to Follow-up|92
3100094|NCT00289133|10625191|P2|Overall Study|Revision|6
3100095|NCT00289133|10625192|P1|Overall Study|Revision|8
3100096|NCT00289133|10625191|P2|Overall Study|Physician Decision|45
3100097|NCT00289133|10625192|P1|Overall Study|Physician Decision|41
3100098|NCT00289133|10625191|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
3100099|NCT00289133|10625192|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
3100100|NCT00289133|10625191|P2|Overall Study|Death|10
3100101|NCT00289133|10625192|P1|Overall Study|Death|5
3100102|NCT00289133|10625191|P2|Overall Study|Withdrawal by Subject|10
3100103|NCT00289133|10625192|P1|Overall Study|Withdrawal by Subject|9
3100104|NCT00289133|10625191|P2|Overall Study|Protocol Violation|38
3100105|NCT00289133|10625192|P1|Overall Study|Protocol Violation|32
3100106|NCT00289133|10625191|P2|Overall Study|Non-study device implanted|0
3100107|NCT00289133|10625192|P1|Overall Study|Non-study device implanted|12
3100108|NCT00289016|10625248|P1|Overall Study|Other|1
3100109|NCT00289016|10625248|P1|Overall Study|Adverse Event|1
3100110|NCT00289016|10625248|P1|Overall Study|Withdrawal by Subject|2
3100111|NCT00289016|10625248|P1|Overall Study|Unrelated Medical Condition or Accident|2
3100112|NCT00289016|10625248|P1|Overall Study|Death|2
3100113|NCT00289016|10625248|P1|Overall Study|Disease Progression|29
3100114|NCT00288912|10625260|P3|Overall Study|Withdrawal by Subject|12
3100115|NCT00288912|10625261|P2|Overall Study|Withdrawal by Subject|5
3100116|NCT00288912|10625262|P1|Overall Study|Withdrawal by Subject|4
3100117|NCT00288912|10625260|P3|Overall Study|Lost to Follow-up|9
3100118|NCT00288912|10625261|P2|Overall Study|Lost to Follow-up|6
3100119|NCT00288912|10625262|P1|Overall Study|Lost to Follow-up|9
3100120|NCT00288912|10625260|P3|Overall Study|Developed exclusion criterion|7
3100121|NCT00288912|10625261|P2|Overall Study|Developed exclusion criterion|6
3100122|NCT00288912|10625262|P1|Overall Study|Developed exclusion criterion|4
3100123|NCT00288860|10625302|P2|Overall Study|Lost to Follow-up|71
3100124|NCT00288860|10625303|P1|Overall Study|Lost to Follow-up|74
3100125|NCT00288860|10625302|P2|Overall Study|Withdrawal by Subject|15
3100126|NCT00288860|10625303|P1|Overall Study|Withdrawal by Subject|20
3100127|NCT00288860|10625302|P2|Overall Study|Death|3
3100128|NCT00288860|10625303|P1|Overall Study|Death|4
3100129|NCT00288860|10625302|P2|Overall Study|Did not complete intake|8
3100130|NCT00288860|10625303|P1|Overall Study|Did not complete intake|4
3100131|NCT00288704|10625316|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
3100132|NCT00288704|10625317|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
3100133|NCT00288704|10625318|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
3100134|NCT00288704|10625316|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
3100135|NCT00288704|10625317|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
3100136|NCT00288704|10625318|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
3100137|NCT00288704|10625316|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
3100138|NCT00288704|10625317|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
3100139|NCT00288704|10625318|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
3100140|NCT00288704|10625316|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
3100141|NCT00288704|10625317|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
3100142|NCT00288704|10625318|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
3100143|NCT00288704|10625316|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
3100144|NCT00288704|10625317|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
3100145|NCT00288704|10625318|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
3100146|NCT00288704|10625316|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
3100147|NCT00288704|10625317|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
3100148|NCT00288704|10625318|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
3100149|NCT00288704|10625316|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
3100150|NCT00288704|10625317|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
3100151|NCT00288704|10625318|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
3100152|NCT00288639|10625345|P1|Overall Study|Other|1
3100153|NCT00288639|10625345|P1|Overall Study|Withdrawal by Subject|2
3100154|NCT00288639|10625345|P1|Overall Study|Lack of Efficacy|4
3100155|NCT00288639|10625345|P1|Overall Study|Adverse Event|5
3100156|NCT00288626|10625362|P1|Overall Study|Withdrawal by Subject|4
3100157|NCT00288626|10625362|P1|Overall Study|Death|3
3100158|NCT00288587|10625396|P2|Overall Study|Severe Aortic Stenosis|0
3100159|NCT00288587|10625397|P1|Overall Study|Severe Aortic Stenosis|1
3100160|NCT00288587|10625396|P2|Overall Study|Physician Decision|2
3100161|NCT00288587|10625397|P1|Overall Study|Physician Decision|0
3100162|NCT00288587|10625396|P2|Overall Study|Adverse Event|1
3100163|NCT00288587|10625397|P1|Overall Study|Adverse Event|0
3100164|NCT00288587|10625396|P2|Overall Study|Transplant|3
3100165|NCT00288587|10625397|P1|Overall Study|Transplant|0
3100166|NCT00288587|10625396|P2|Overall Study|Death|4
3100167|NCT00288587|10625397|P1|Overall Study|Death|4
3100168|NCT00288509|10625440|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
3100169|NCT00288509|10625440|P1|Treatment Cycle 4|Physician Decision|4
3100170|NCT00288509|10625440|P1|Treatment Cycle 4|Withdrawal by Subject|3
3100171|NCT00288509|10625440|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
3100172|NCT00288509|10625440|P1|Treatment Cycle 3|Lost to Follow-up|2
3100173|NCT00288509|10625440|P1|Treatment Cycle 3|Withdrawal by Subject|1
3100174|NCT00288509|10625440|P1|Treatment Cycle 3|Lack of Efficacy|1
3100175|NCT00288509|10625440|P1|Treatment Cycle 2|Withdrawal by Subject|2
3100176|NCT00288509|10625440|P1|Treatment Cycle 2|Lack of Efficacy|1
3100177|NCT00288509|10625440|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
3100178|NCT00288509|10625440|P1|Treatment Cycle 1|Lost to Follow-up|2
3100179|NCT00288509|10625440|P1|Treatment Cycle 1|Withdrawal by Subject|1
3100180|NCT00288509|10625440|P1|Treatment Cycle 1|Lack of Efficacy|1
3100181|NCT00288509|10625440|P1|Treatment Cycle 1|Adverse Event|1
3100182|NCT00288080|10625458|P2|Overall Study|Protocol Violation|20
3100183|NCT00288080|10625459|P1|Overall Study|Protocol Violation|25
3100184|NCT00288080|10625458|P2|Overall Study|Withdrawal by Subject|3
3100185|NCT00288080|10625459|P1|Overall Study|Withdrawal by Subject|1
3100186|NCT00288054|10625481|P1|Overall Study|Not protocol specified|2
3100187|NCT00288054|10625481|P1|Overall Study|Withdrawal by Subject|1
3100188|NCT00288054|10625481|P1|Overall Study|Adverse Event|3
3100189|NCT00288054|10625481|P1|Overall Study|Lack of Efficacy|16
3100190|NCT00288054|10625481|P1|Overall Study|Protocol Violation|2
3100191|NCT00288015|10625489|P1|Follow up for Survival x 2 Years|Other|9
3100192|NCT00288015|10625489|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
3100193|NCT00288015|10625489|P1|Follow up for Survival x 2 Years|Death|13
3100194|NCT00288015|10625489|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
3100195|NCT00288015|10625489|P1|First Response Assessment|Physician Decision|2
3100196|NCT00288015|10625489|P1|First Response Assessment|Death|1
3100197|NCT00288015|10625489|P1|First Response Assessment|Withdrawal by Subject|1
3100198|NCT00288015|10625489|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
3100199|NCT00288015|10625489|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
3100200|NCT00287690|10625581|P2|Overall Study|Protocol Violation|26
3100201|NCT00287690|10625582|P1|Overall Study|Protocol Violation|20
3100202|NCT00287586|10625594|P2|Overall Study|Recurrent Melanoma|1
3100203|NCT00287586|10625595|P1|Overall Study|Recurrent Melanoma|0
3100204|NCT00287586|10625594|P2|Overall Study|Itchy Swollen Eyes|1
3100205|NCT00287586|10625595|P1|Overall Study|Itchy Swollen Eyes|0
3100206|NCT00287586|10625594|P2|Overall Study|Bradycardia|1
3100207|NCT00287586|10625595|P1|Overall Study|Bradycardia|0
3100208|NCT00287586|10625594|P2|Overall Study|Mood Swings and Irritability|1
3100209|NCT00287586|10625595|P1|Overall Study|Mood Swings and Irritability|0
3100210|NCT00287586|10625594|P2|Overall Study|Mastodynia and Gynecomastia|1
3100211|NCT00287586|10625595|P1|Overall Study|Mastodynia and Gynecomastia|0
3100212|NCT00287586|10625594|P2|Overall Study|Retroperitoneal Cancer|1
3100213|NCT00287586|10625595|P1|Overall Study|Retroperitoneal Cancer|0
3100214|NCT00287586|10625594|P2|Overall Study|Elevated IPSS Score|1
3100215|NCT00287586|10625595|P1|Overall Study|Elevated IPSS Score|0
3100216|NCT00287586|10625594|P2|Overall Study|Lung Cancer|2
3100217|NCT00287586|10625595|P1|Overall Study|Lung Cancer|0
3100218|NCT00287586|10625594|P2|Overall Study|Major Depression|2
3100219|NCT00287586|10625595|P1|Overall Study|Major Depression|0
3100220|NCT00287586|10625594|P2|Overall Study|Enrolled in Another Study|0
3100221|NCT00287586|10625595|P1|Overall Study|Enrolled in Another Study|1
3100222|NCT00287586|10625594|P2|Overall Study|Nonadherence|1
3100223|NCT00287586|10625595|P1|Overall Study|Nonadherence|1
3100224|NCT00287586|10625594|P2|Overall Study|Inappropriate Behaviour with Staff|0
3100225|NCT00287586|10625595|P1|Overall Study|Inappropriate Behaviour with Staff|1
3100226|NCT00287586|10625594|P2|Overall Study|Shoulder Pain|0
3100227|NCT00287586|10625595|P1|Overall Study|Shoulder Pain|1
3100228|NCT00287586|10625594|P2|Overall Study|Sleep Apnea|0
3100229|NCT00287586|10625595|P1|Overall Study|Sleep Apnea|1
3100230|NCT00287586|10625594|P2|Overall Study|Pancreatic Cancer|3
3100231|NCT00287586|10625595|P1|Overall Study|Pancreatic Cancer|1
3100232|NCT00287586|10625594|P2|Overall Study|Cognitive Impairment|0
3100233|NCT00287586|10625595|P1|Overall Study|Cognitive Impairment|1
3100234|NCT00287586|10625594|P2|Overall Study|Lower Urinary Tract Symptoms|0
3100235|NCT00287586|10625595|P1|Overall Study|Lower Urinary Tract Symptoms|1
3100236|NCT00287586|10625594|P2|Overall Study|Myocardial Infarction|0
3100237|NCT00287586|10625595|P1|Overall Study|Myocardial Infarction|1
3100238|NCT00287586|10625594|P2|Overall Study|Stroke|0
3100239|NCT00287586|10625595|P1|Overall Study|Stroke|2
3100240|NCT00287586|10625594|P2|Overall Study|Elevated Prostate Specific Antigen|0
3100241|NCT00287586|10625595|P1|Overall Study|Elevated Prostate Specific Antigen|2
3100242|NCT00287586|10625594|P2|Overall Study|Rash|0
3100243|NCT00287586|10625595|P1|Overall Study|Rash|3
3100244|NCT00287586|10625594|P2|Overall Study|Elevated Hematocrit|0
3100245|NCT00287586|10625595|P1|Overall Study|Elevated Hematocrit|3
3100246|NCT00287586|10625594|P2|Overall Study|Death|3
3100247|NCT00287586|10625595|P1|Overall Study|Death|2
3100248|NCT00287586|10625594|P2|Overall Study|Lost to Follow-up|4
3100249|NCT00287586|10625595|P1|Overall Study|Lost to Follow-up|5
3100250|NCT00287586|10625594|P2|Overall Study|Withdrew Consent|30
3100251|NCT00287586|10625595|P1|Overall Study|Withdrew Consent|19
3100252|NCT00287469|10625633|P2|Overall Study|Lost to Follow-up|69
3100253|NCT00287469|10625634|P1|Overall Study|Lost to Follow-up|74
3100254|NCT00287469|10625633|P2|Overall Study|moved from area|138
3100255|NCT00287469|10625634|P1|Overall Study|moved from area|144
3100256|NCT00287469|10625633|P2|Overall Study|Adverse Event|1
3100257|NCT00287469|10625634|P1|Overall Study|Adverse Event|1
3100258|NCT00287469|10625633|P2|Overall Study|serious adverse event|6
3100259|NCT00287469|10625634|P1|Overall Study|serious adverse event|1
3100260|NCT00287365|10625644|P1|Overall Study|sample not acquired|13
3100261|NCT00287118|10625666|P1|Overall Study|Other|7
3100262|NCT00287118|10625666|P1|Overall Study|Protocol Violation|2
3100263|NCT00287118|10625666|P1|Overall Study|Lost to Follow-up|1
3100264|NCT00287118|10625666|P1|Overall Study|Lack of Efficacy|11
3100265|NCT00287118|10625666|P1|Overall Study|Death|1
3100266|NCT00287118|10625666|P1|Overall Study|Adverse Event|30
3100267|NCT00287079|10625672|P2|Overall Study|Other|0
3100268|NCT00287079|10625673|P1|Overall Study|Other|3
3100269|NCT00287079|10625672|P2|Overall Study|Protocol Violation|0
3100270|NCT00287079|10625673|P1|Overall Study|Protocol Violation|1
3100271|NCT00287079|10625672|P2|Overall Study|Adverse Event|0
3100272|NCT00287079|10625673|P1|Overall Study|Adverse Event|5
3100273|NCT00287079|10625672|P2|Overall Study|Non-qualifying relapse|0
3100274|NCT00287079|10625673|P1|Overall Study|Non-qualifying relapse|1
3100275|NCT00287079|10625672|P2|Overall Study|Qualifying relapse|1
3100276|NCT00287079|10625673|P1|Overall Study|Qualifying relapse|12
3100277|NCT00286754|10625701|P3|Overall Study|Moved out of state|1
3100278|NCT00286754|10625702|P2|Overall Study|Moved out of state|0
3100279|NCT00286754|10625703|P1|Overall Study|Moved out of state|0
3100280|NCT00286754|10625701|P3|Overall Study|Lost to Follow-up|6
3100281|NCT00286754|10625702|P2|Overall Study|Lost to Follow-up|14
3100282|NCT00286754|10625703|P1|Overall Study|Lost to Follow-up|12
3100283|NCT00286754|10625701|P3|Overall Study|Withdrawal by Subject|0
3100284|NCT00286754|10625702|P2|Overall Study|Withdrawal by Subject|2
3100285|NCT00286754|10625703|P1|Overall Study|Withdrawal by Subject|6
3100286|NCT00286754|10625701|P3|Overall Study|Adverse Event|3
3100287|NCT00286754|10625702|P2|Overall Study|Adverse Event|2
3100288|NCT00286754|10625703|P1|Overall Study|Adverse Event|2
3100289|NCT00286494|10625762|P3|Overall Study|Protocol Violation|2
3100290|NCT00286494|10625763|P2|Overall Study|Protocol Violation|1
3100291|NCT00286494|10625764|P1|Overall Study|Protocol Violation|1
3100292|NCT00286494|10625762|P3|Overall Study|Lost to Follow-up|3
3100293|NCT00286494|10625763|P2|Overall Study|Lost to Follow-up|1
3100294|NCT00286494|10625764|P1|Overall Study|Lost to Follow-up|3
3100295|NCT00286494|10625762|P3|Overall Study|Physician Decision|1
3100296|NCT00286494|10625763|P2|Overall Study|Physician Decision|5
3100297|NCT00286494|10625764|P1|Overall Study|Physician Decision|5
3100298|NCT00286494|10625762|P3|Overall Study|Adverse Event|6
3100299|NCT00286494|10625763|P2|Overall Study|Adverse Event|8
3100300|NCT00286494|10625764|P1|Overall Study|Adverse Event|3
3100301|NCT00286494|10625762|P3|Overall Study|Withdrawal by Subject|9
3100302|NCT00286494|10625763|P2|Overall Study|Withdrawal by Subject|10
3100303|NCT00286494|10625764|P1|Overall Study|Withdrawal by Subject|2
3100304|NCT00286494|10625762|P3|Overall Study|Hyperglycemic rescue|18
3100305|NCT00286494|10625763|P2|Overall Study|Hyperglycemic rescue|19
3100306|NCT00286494|10625764|P1|Overall Study|Hyperglycemic rescue|12
3100307|NCT00286468|10625925|P3|Overall Study|Physician Decision|1
3100308|NCT00286468|10625926|P2|Overall Study|Physician Decision|2
3100309|NCT00286468|10625927|P1|Overall Study|Physician Decision|3
3100310|NCT00286468|10625925|P3|Overall Study|Withdrawal by Subject|11
3100311|NCT00286468|10625926|P2|Overall Study|Withdrawal by Subject|8
3100312|NCT00286468|10625927|P1|Overall Study|Withdrawal by Subject|3
3100313|NCT00286468|10625925|P3|Overall Study|Lost to Follow-up|2
3100314|NCT00286468|10625926|P2|Overall Study|Lost to Follow-up|1
3100315|NCT00286468|10625927|P1|Overall Study|Lost to Follow-up|1
3100316|NCT00286468|10625925|P3|Overall Study|Protocol Violation|1
3100317|NCT00286468|10625926|P2|Overall Study|Protocol Violation|3
3100318|NCT00286468|10625927|P1|Overall Study|Protocol Violation|0
3100319|NCT00286468|10625925|P3|Overall Study|Adverse Event|4
3100320|NCT00286468|10625926|P2|Overall Study|Adverse Event|6
3100321|NCT00286468|10625927|P1|Overall Study|Adverse Event|2
3100322|NCT00286468|10625925|P3|Overall Study|Hyperglycemic Rescue|31
3100323|NCT00286468|10625926|P2|Overall Study|Hyperglycemic Rescue|30
3100324|NCT00286468|10625927|P1|Overall Study|Hyperglycemic Rescue|28
3100325|NCT00286455|10626088|P3|Overall Study|Withdrawal by Subject|7
3100326|NCT00286455|10626089|P2|Overall Study|Withdrawal by Subject|8
3100327|NCT00286455|10626090|P1|Overall Study|Withdrawal by Subject|0
3100328|NCT00286455|10626088|P3|Overall Study|Participant Non-compliance|0
3100329|NCT00286455|10626089|P2|Overall Study|Participant Non-compliance|0
3100330|NCT00286455|10626090|P1|Overall Study|Participant Non-compliance|1
3100331|NCT00286455|10626088|P3|Overall Study|Protocol Violation|0
3100332|NCT00286455|10626089|P2|Overall Study|Protocol Violation|1
3100333|NCT00286455|10626090|P1|Overall Study|Protocol Violation|1
3100334|NCT00286455|10626088|P3|Overall Study|Physician Decision|2
3100335|NCT00286455|10626089|P2|Overall Study|Physician Decision|0
3100336|NCT00286455|10626090|P1|Overall Study|Physician Decision|3
3100337|NCT00286455|10626088|P3|Overall Study|Lost to Follow-up|3
3100338|NCT00286455|10626089|P2|Overall Study|Lost to Follow-up|3
3100339|NCT00286455|10626090|P1|Overall Study|Lost to Follow-up|0
3100340|NCT00286455|10626088|P3|Overall Study|Adverse Event|2
3100341|NCT00286455|10626089|P2|Overall Study|Adverse Event|3
3100342|NCT00286455|10626090|P1|Overall Study|Adverse Event|1
3100343|NCT00286455|10626088|P3|Overall Study|Hyperglycemia rescue|10
3100344|NCT00286455|10626089|P2|Overall Study|Hyperglycemia rescue|13
3100345|NCT00286455|10626090|P1|Overall Study|Hyperglycemia rescue|19
3100346|NCT00286442|10626269|P3|Overall Study|Withdrawal by Subject|2
3100347|NCT00286442|10626270|P2|Overall Study|Withdrawal by Subject|14
3100348|NCT00286442|10626271|P1|Overall Study|Withdrawal by Subject|2
3100349|NCT00286442|10626269|P3|Overall Study|Administrative Error|0
3100350|NCT00286442|10626270|P2|Overall Study|Administrative Error|1
3100351|NCT00286442|10626271|P1|Overall Study|Administrative Error|1
3100352|NCT00286442|10626269|P3|Overall Study|Physician Decision|1
3100353|NCT00286442|10626270|P2|Overall Study|Physician Decision|1
3100354|NCT00286442|10626271|P1|Overall Study|Physician Decision|1
3100355|NCT00286442|10626269|P3|Overall Study|Lost to Follow-up|1
3100356|NCT00286442|10626270|P2|Overall Study|Lost to Follow-up|2
3100357|NCT00286442|10626271|P1|Overall Study|Lost to Follow-up|5
3100358|NCT00286442|10626269|P3|Overall Study|Protocol Violation|2
3100359|NCT00286442|10626270|P2|Overall Study|Protocol Violation|4
3100360|NCT00286442|10626271|P1|Overall Study|Protocol Violation|2
3100361|NCT00286442|10626269|P3|Overall Study|Adverse Event|1
3100362|NCT00286442|10626270|P2|Overall Study|Adverse Event|6
3100363|NCT00286442|10626271|P1|Overall Study|Adverse Event|7
3100364|NCT00286442|10626269|P3|Overall Study|Hyperglycemic Rescue|25
3100365|NCT00286442|10626270|P2|Overall Study|Hyperglycemic Rescue|17
3100366|NCT00286442|10626271|P1|Overall Study|Hyperglycemic Rescue|19
3100367|NCT00286429|10626432|P3|Overall Study|Administrative Decision|0
3100368|NCT00286429|10626433|P2|Overall Study|Administrative Decision|1
3100369|NCT00286429|10626434|P1|Overall Study|Administrative Decision|0
3100370|NCT00286429|10626432|P3|Overall Study|Administrative Error|1
3100371|NCT00286429|10626433|P2|Overall Study|Administrative Error|1
3100372|NCT00286429|10626434|P1|Overall Study|Administrative Error|1
3100373|NCT00286429|10626432|P3|Overall Study|Withdrawal by Subject|6
3100374|NCT00286429|10626433|P2|Overall Study|Withdrawal by Subject|2
3100375|NCT00286429|10626434|P1|Overall Study|Withdrawal by Subject|3
3100376|NCT00286429|10626432|P3|Overall Study|Protocol Violation|4
3100377|NCT00286429|10626433|P2|Overall Study|Protocol Violation|5
3100378|NCT00286429|10626434|P1|Overall Study|Protocol Violation|3
3100379|NCT00286429|10626432|P3|Overall Study|Physician Decision|7
3100380|NCT00286429|10626433|P2|Overall Study|Physician Decision|7
3100381|NCT00286429|10626434|P1|Overall Study|Physician Decision|10
3100382|NCT00286429|10626432|P3|Overall Study|Lost to Follow-up|3
3100383|NCT00286429|10626433|P2|Overall Study|Lost to Follow-up|4
3100384|NCT00286429|10626434|P1|Overall Study|Lost to Follow-up|2
3100385|NCT00286429|10626432|P3|Overall Study|Lack of Efficacy|25
3100386|NCT00286429|10626433|P2|Overall Study|Lack of Efficacy|27
3100387|NCT00286429|10626434|P1|Overall Study|Lack of Efficacy|52
3100388|NCT00286429|10626432|P3|Overall Study|Adverse Event|6
3100389|NCT00286429|10626433|P2|Overall Study|Adverse Event|1
3100390|NCT00286429|10626434|P1|Overall Study|Adverse Event|4
3100391|NCT00286221|10626550|P4|Overall Study|Unrecognized exclusion criteria met|0
3100392|NCT00286221|10626551|P3|Overall Study|Unrecognized exclusion criteria met|0
3100393|NCT00286221|10626552|P2|Overall Study|Unrecognized exclusion criteria met|1
3100394|NCT00286221|10626553|P1|Overall Study|Unrecognized exclusion criteria met|0
3100395|NCT00286221|10626550|P4|Overall Study|Inability to trigger PCA|0
3100396|NCT00286221|10626551|P3|Overall Study|Inability to trigger PCA|0
3100397|NCT00286221|10626552|P2|Overall Study|Inability to trigger PCA|0
3100398|NCT00286221|10626553|P1|Overall Study|Inability to trigger PCA|2
3100399|NCT00286221|10626550|P4|Overall Study|Unanticipated Neurosurgical Complication|2
3100400|NCT00286221|10626551|P3|Overall Study|Unanticipated Neurosurgical Complication|3
3100401|NCT00286221|10626552|P2|Overall Study|Unanticipated Neurosurgical Complication|3
3100402|NCT00286221|10626553|P1|Overall Study|Unanticipated Neurosurgical Complication|6
3100403|NCT00286221|10626550|P4|Overall Study|Protocol Violation|4
3100404|NCT00286221|10626551|P3|Overall Study|Protocol Violation|6
3100405|NCT00286221|10626552|P2|Overall Study|Protocol Violation|1
3100406|NCT00286221|10626553|P1|Overall Study|Protocol Violation|2
3100407|NCT00286156|10626579|P3|Overall Study|AE: pneumonia|0
3100408|NCT00286156|10626580|P2|Overall Study|AE: pneumonia|0
3100409|NCT00286156|10626581|P1|Overall Study|AE: pneumonia|1
3100410|NCT00286156|10626579|P3|Overall Study|AE: nephrotic-range proteinuruia|0
3100411|NCT00286156|10626580|P2|Overall Study|AE: nephrotic-range proteinuruia|0
3100412|NCT00286156|10626581|P1|Overall Study|AE: nephrotic-range proteinuruia|1
3100413|NCT00286156|10626579|P3|Overall Study|AE: pulmonary embolus|0
3100414|NCT00286156|10626580|P2|Overall Study|AE: pulmonary embolus|1
3100415|NCT00286156|10626581|P1|Overall Study|AE: pulmonary embolus|0
3100416|NCT00286156|10626579|P3|Overall Study|Missed 12 month visit|1
3100417|NCT00286156|10626580|P2|Overall Study|Missed 12 month visit|0
3100418|NCT00286156|10626581|P1|Overall Study|Missed 12 month visit|0
3100419|NCT00286091|10626594|P2|Open-label Treatment Phase|Missing End of Study Information|1
3100420|NCT00286091|10626595|P1|Open-label Treatment Phase|Missing End of Study Information|0
3100421|NCT00286091|10626594|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
3100422|NCT00286091|10626595|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
3100423|NCT00286091|10626594|P2|Open-label Treatment Phase|Lost to Follow-up|1
3100424|NCT00286091|10626595|P1|Open-label Treatment Phase|Lost to Follow-up|0
3100425|NCT00286091|10626594|P2|Open-label Treatment Phase|Noncompliance|1
3100426|NCT00286091|10626595|P1|Open-label Treatment Phase|Noncompliance|3
3100427|NCT00286091|10626594|P2|Open-label Treatment Phase|Disease Progression|3
3100428|NCT00286091|10626595|P1|Open-label Treatment Phase|Disease Progression|9
3100429|NCT00286091|10626594|P2|Open-label Treatment Phase|Death|7
3100430|NCT00286091|10626595|P1|Open-label Treatment Phase|Death|10
3100431|NCT00286091|10626594|P2|Open-label Treatment Phase|Withdrawal by Subject|10
3100432|NCT00286091|10626595|P1|Open-label Treatment Phase|Withdrawal by Subject|14
3100433|NCT00286091|10626594|P2|Open-label Treatment Phase|Other|11
3100434|NCT00286091|10626595|P1|Open-label Treatment Phase|Other|11
3100435|NCT00286091|10626594|P2|Open-label Treatment Phase|Adverse Event|16
3100436|NCT00286091|10626595|P1|Open-label Treatment Phase|Adverse Event|5
3100437|NCT00286091|10626594|P2|Open-label Treatment Phase|Physician Decision|21
3100438|NCT00286091|10626595|P1|Open-label Treatment Phase|Physician Decision|24
3100439|NCT00286091|10626594|P2|Double-blind Treatment Phase|Ineligibility Determined|2
3100440|NCT00286091|10626595|P1|Double-blind Treatment Phase|Ineligibility Determined|1
3100441|NCT00286091|10626594|P2|Double-blind Treatment Phase|Protocol Deviation|3
3100442|NCT00286091|10626595|P1|Double-blind Treatment Phase|Protocol Deviation|1
3100443|NCT00286091|10626594|P2|Double-blind Treatment Phase|Lost to Follow-up|4
3100444|NCT00286091|10626595|P1|Double-blind Treatment Phase|Lost to Follow-up|11
3100445|NCT00286091|10626594|P2|Double-blind Treatment Phase|Noncompliance|8
3100446|NCT00286091|10626595|P1|Double-blind Treatment Phase|Noncompliance|8
3100447|NCT00286091|10626594|P2|Double-blind Treatment Phase|Administrative Decision|21
3100448|NCT00286091|10626595|P1|Double-blind Treatment Phase|Administrative Decision|20
3100449|NCT00286091|10626594|P2|Double-blind Treatment Phase|Other|33
3100450|NCT00286091|10626595|P1|Double-blind Treatment Phase|Other|25
3100451|NCT00286091|10626594|P2|Double-blind Treatment Phase|Disease Progression|35
3100452|NCT00286091|10626595|P1|Double-blind Treatment Phase|Disease Progression|22
3100453|NCT00286091|10626594|P2|Double-blind Treatment Phase|Adverse Event|40
3100454|NCT00286091|10626595|P1|Double-blind Treatment Phase|Adverse Event|28
3100455|NCT00286091|10626594|P2|Double-blind Treatment Phase|Death|65
3100456|NCT00286091|10626595|P1|Double-blind Treatment Phase|Death|58
3100457|NCT00286091|10626594|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
3100458|NCT00286091|10626595|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
3100459|NCT00286091|10626594|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
3100460|NCT00286091|10626595|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
3100461|NCT00285857|10626618|P1|Overall Study|Adverse Event|1
3100462|NCT00285857|10626618|P1|Overall Study|Inadequate initial breast cytology|1
3100463|NCT00285857|10626618|P1|Overall Study|Withdrawal by Subject|2
3100464|NCT00285818|10626631|P2|Overall Study|Lost to Follow-up|0
3100465|NCT00285818|10626632|P1|Overall Study|Lost to Follow-up|1
3100466|NCT00285818|10626631|P2|Overall Study|Withdrawal by Subject|2
3100467|NCT00285818|10626632|P1|Overall Study|Withdrawal by Subject|3
3100468|NCT00285649|10626677|P3|Overall Study|Withdrawal by Subject|2
3100469|NCT00285649|10626678|P2|Overall Study|Withdrawal by Subject|2
3100470|NCT00285649|10626679|P1|Overall Study|Withdrawal by Subject|3
3100471|NCT00285649|10626677|P3|Overall Study|Lost to Follow-up|4
3100472|NCT00285649|10626678|P2|Overall Study|Lost to Follow-up|4
3100473|NCT00285649|10626679|P1|Overall Study|Lost to Follow-up|6
3100474|NCT00285584|10626689|P2|Month 6|Lost to Follow-up|1
3100475|NCT00285584|10626690|P1|Month 6|Lost to Follow-up|0
3100476|NCT00285584|10626689|P2|Month 3|Withdrawal by Subject|0
3100477|NCT00285584|10626690|P1|Month 3|Withdrawal by Subject|1
3100478|NCT00285584|10626689|P2|Month 3|Lost to Follow-up|3
3100479|NCT00285584|10626690|P1|Month 3|Lost to Follow-up|3
3100480|NCT00285207|10626722|P2|Overall Study|non-compliance|1
3100481|NCT00285207|10626723|P1|Overall Study|non-compliance|0
3100482|NCT00285207|10626722|P2|Overall Study|Pregnancy|1
3100483|NCT00285207|10626723|P1|Overall Study|Pregnancy|1
3100484|NCT00285207|10626722|P2|Overall Study|Withdrawal by Subject|2
3100485|NCT00285207|10626723|P1|Overall Study|Withdrawal by Subject|5
3100486|NCT00285207|10626722|P2|Overall Study|Lost to Follow-up|2
3100487|NCT00285207|10626723|P1|Overall Study|Lost to Follow-up|3
3100488|NCT00285012|10626731|P2|Received Study Tx|Other|5
3100489|NCT00285012|10626732|P1|Received Study Tx|Other|5
3100490|NCT00285012|10626731|P2|Received Study Tx|Withdrawal by Subject|43
3100491|NCT00285012|10626732|P1|Received Study Tx|Withdrawal by Subject|31
3100492|NCT00285012|10626731|P2|Received Study Tx|Lost to Follow-up|31
3100493|NCT00285012|10626732|P1|Received Study Tx|Lost to Follow-up|29
3100494|NCT00285012|10626731|P2|Received Study Tx|Lack of Efficacy|3
3100495|NCT00285012|10626732|P1|Received Study Tx|Lack of Efficacy|0
3100496|NCT00285012|10626731|P2|Received Study Tx|Adverse Event|11
3100497|NCT00285012|10626732|P1|Received Study Tx|Adverse Event|5
3100498|NCT00285012|10626731|P2|Received Study Tx|Death|1
3100499|NCT00285012|10626732|P1|Received Study Tx|Death|2
3100500|NCT00285012|10626731|P2|Assigned to Study Treatment (Tx)|Other|3
3100501|NCT00285012|10626732|P1|Assigned to Study Treatment (Tx)|Other|2
3100502|NCT00284934|10626758|P2|Overall Study|Other reasons|1
3100503|NCT00284934|10626759|P1|Overall Study|Other reasons|3
3100504|NCT00284934|10626758|P2|Overall Study|Adverse Event|2
3100505|NCT00284934|10626759|P1|Overall Study|Adverse Event|1
3100506|NCT00284856|10626774|P3|Overall Study|Other|4
3100507|NCT00284856|10626775|P2|Overall Study|Other|5
3100508|NCT00284856|10626776|P1|Overall Study|Other|4
3100509|NCT00284856|10626774|P3|Overall Study|Withdrawal by Subject|18
3100510|NCT00284856|10626775|P2|Overall Study|Withdrawal by Subject|16
3100511|NCT00284856|10626776|P1|Overall Study|Withdrawal by Subject|12
3100512|NCT00284856|10626774|P3|Overall Study|Protocol Violation|5
3100513|NCT00284856|10626775|P2|Overall Study|Protocol Violation|4
3100514|NCT00284856|10626776|P1|Overall Study|Protocol Violation|5
3100515|NCT00284856|10626774|P3|Overall Study|Lost to Follow-up|22
3100516|NCT00284856|10626775|P2|Overall Study|Lost to Follow-up|21
3100517|NCT00284856|10626776|P1|Overall Study|Lost to Follow-up|25
3100518|NCT00284856|10626774|P3|Overall Study|Lack of Efficacy|8
3100519|NCT00284856|10626775|P2|Overall Study|Lack of Efficacy|1
3100520|NCT00284856|10626776|P1|Overall Study|Lack of Efficacy|2
3100521|NCT00284856|10626774|P3|Overall Study|Adverse Event|3
3100522|NCT00284856|10626775|P2|Overall Study|Adverse Event|3
3100523|NCT00284856|10626776|P1|Overall Study|Adverse Event|3
3100524|NCT00284141|10626875|P1|Overall Study|Ongoing treatment|2
3100525|NCT00284141|10626875|P1|Overall Study|Did not take study medication|2
3100526|NCT00284141|10626875|P1|Overall Study|Pneumonia|1
3100527|NCT00284141|10626875|P1|Overall Study|General decline|1
3100528|NCT00284141|10626875|P1|Overall Study|Clinical deterioration / death|2
3100529|NCT00284141|10626875|P1|Overall Study|Symptomatic / Clinical Progression|11
3100530|NCT00284141|10626875|P1|Overall Study|Participant's request|9
3100531|NCT00284141|10626875|P1|Overall Study|Adverse Event|19
3100532|NCT00284141|10626875|P1|Overall Study|Disease Progression / Lack of efficacy|51
3100533|NCT00284089|10626898|P4|Extension Phase|Withdrawal by Subject|3
3100534|NCT00284089|10626899|P3|Extension Phase|Withdrawal by Subject|1
3100535|NCT00284089|10626900|P2|Extension Phase|Withdrawal by Subject|0
3100536|NCT00284089|10626901|P1|Extension Phase|Withdrawal by Subject|0
3100537|NCT00284089|10626898|P4|Extension Phase|Protocol Violation|0
3100538|NCT00284089|10626899|P3|Extension Phase|Protocol Violation|1
3100539|NCT00284089|10626900|P2|Extension Phase|Protocol Violation|0
3100540|NCT00284089|10626901|P1|Extension Phase|Protocol Violation|0
3100541|NCT00284089|10626898|P4|Extension Phase|condition no longer requires study drug|7
3100542|NCT00284089|10626899|P3|Extension Phase|condition no longer requires study drug|2
3100543|NCT00284089|10626900|P2|Extension Phase|condition no longer requires study drug|0
3100544|NCT00284089|10626901|P1|Extension Phase|condition no longer requires study drug|2
3100545|NCT00284089|10626898|P4|Extension Phase|Adverse Event|2
3100546|NCT00284089|10626899|P3|Extension Phase|Adverse Event|2
3100547|NCT00284089|10626900|P2|Extension Phase|Adverse Event|0
3100548|NCT00284089|10626901|P1|Extension Phase|Adverse Event|0
3100549|NCT00284089|10626898|P4|Multiple Dose Phase|Death|1
3100550|NCT00284089|10626899|P3|Multiple Dose Phase|Death|1
3100551|NCT00284089|10626900|P2|Multiple Dose Phase|Death|0
3100552|NCT00284089|10626901|P1|Multiple Dose Phase|Death|0
3100553|NCT00284089|10626898|P4|Multiple Dose Phase|Withdrawal by Subject|2
3100554|NCT00284089|10626899|P3|Multiple Dose Phase|Withdrawal by Subject|1
3100555|NCT00284089|10626900|P2|Multiple Dose Phase|Withdrawal by Subject|0
3100556|NCT00284089|10626901|P1|Multiple Dose Phase|Withdrawal by Subject|0
3100557|NCT00284089|10626898|P4|Multiple Dose Phase|Protocol Violation|0
3100558|NCT00284089|10626899|P3|Multiple Dose Phase|Protocol Violation|1
3100559|NCT00284089|10626900|P2|Multiple Dose Phase|Protocol Violation|0
3100560|NCT00284089|10626901|P1|Multiple Dose Phase|Protocol Violation|0
3100561|NCT00284089|10626898|P4|Multiple Dose Phase|Adverse Event|1
3100562|NCT00284089|10626899|P3|Multiple Dose Phase|Adverse Event|1
3100563|NCT00284089|10626900|P2|Multiple Dose Phase|Adverse Event|0
3100564|NCT00284089|10626901|P1|Multiple Dose Phase|Adverse Event|1
3100565|NCT00284050|10626930|P3|Overall Study|Death|0
3100566|NCT00284050|10626931|P2|Overall Study|Death|0
3100567|NCT00284050|10626932|P1|Overall Study|Death|1
3100568|NCT00284050|10626930|P3|Overall Study|Lost to Follow-up|1
3100569|NCT00284050|10626931|P2|Overall Study|Lost to Follow-up|0
3100570|NCT00284050|10626932|P1|Overall Study|Lost to Follow-up|1
3100571|NCT00284050|10626930|P3|Overall Study|Withdrawal by Subject|2
3100572|NCT00284050|10626931|P2|Overall Study|Withdrawal by Subject|2
3100573|NCT00284050|10626932|P1|Overall Study|Withdrawal by Subject|2
3100574|NCT00284050|10626930|P3|Overall Study|Protocol Violation|2
3100575|NCT00284050|10626931|P2|Overall Study|Protocol Violation|1
3100576|NCT00284050|10626932|P1|Overall Study|Protocol Violation|0
3100577|NCT00284050|10626930|P3|Overall Study|Lack of Efficacy|3
3100578|NCT00284050|10626931|P2|Overall Study|Lack of Efficacy|1
3100579|NCT00284050|10626932|P1|Overall Study|Lack of Efficacy|0
3100580|NCT00284050|10626930|P3|Overall Study|Adverse Event|1
3100581|NCT00284050|10626931|P2|Overall Study|Adverse Event|1
3100582|NCT00284050|10626932|P1|Overall Study|Adverse Event|1
3100583|NCT00283959|10626946|P1|Extension Period|Low Compliance|1
3100584|NCT00283868|10626958|P2|Overall Study|Lost to Follow-up|8
3100585|NCT00283868|10626959|P1|Overall Study|Lost to Follow-up|7
3100586|NCT00283842|10626976|P5|Overall Study|Lost to Follow-up|1
3100587|NCT00283842|10626977|P4|Overall Study|Lost to Follow-up|1
3100588|NCT00283842|10626978|P3|Overall Study|Lost to Follow-up|4
3100589|NCT00283842|10626979|P2|Overall Study|Lost to Follow-up|2
3100590|NCT00283842|10626980|P1|Overall Study|Lost to Follow-up|0
3100591|NCT00283842|10626976|P5|Overall Study|Lack of Efficacy|3
3100592|NCT00283842|10626977|P4|Overall Study|Lack of Efficacy|0
3100593|NCT00283842|10626978|P3|Overall Study|Lack of Efficacy|1
3100594|NCT00283842|10626979|P2|Overall Study|Lack of Efficacy|3
3100595|NCT00283842|10626980|P1|Overall Study|Lack of Efficacy|1
3100596|NCT00283842|10626976|P5|Overall Study|Withdrawal by Subject|4
3100597|NCT00283842|10626977|P4|Overall Study|Withdrawal by Subject|5
3100598|NCT00283842|10626978|P3|Overall Study|Withdrawal by Subject|1
3100599|NCT00283842|10626979|P2|Overall Study|Withdrawal by Subject|1
3100600|NCT00283842|10626980|P1|Overall Study|Withdrawal by Subject|2
3100601|NCT00283842|10626976|P5|Overall Study|Protocol deviation|2
3100602|NCT00283842|10626977|P4|Overall Study|Protocol deviation|0
3100603|NCT00283842|10626978|P3|Overall Study|Protocol deviation|0
3100604|NCT00283842|10626979|P2|Overall Study|Protocol deviation|0
3100605|NCT00283842|10626980|P1|Overall Study|Protocol deviation|0
3100606|NCT00283842|10626976|P5|Overall Study|Protocol Violation|0
3100607|NCT00283842|10626977|P4|Overall Study|Protocol Violation|0
3100608|NCT00283842|10626978|P3|Overall Study|Protocol Violation|4
3100609|NCT00283842|10626979|P2|Overall Study|Protocol Violation|5
3100610|NCT00283842|10626980|P1|Overall Study|Protocol Violation|1
3100611|NCT00283842|10626976|P5|Overall Study|Adverse Event|5
3100612|NCT00283842|10626977|P4|Overall Study|Adverse Event|21
3100613|NCT00283842|10626978|P3|Overall Study|Adverse Event|21
3100614|NCT00283842|10626979|P2|Overall Study|Adverse Event|7
3100615|NCT00283842|10626980|P1|Overall Study|Adverse Event|8
3100616|NCT00283803|10627012|P1|Overall Study|Withdrawal by Subject|4
3100617|NCT00283803|10627012|P1|Overall Study|Physician Decision|9
3100618|NCT00283712|10627020|P2|Overall Study|Death|1
3100619|NCT00283712|10627021|P1|Overall Study|Death|0
3100620|NCT00283686|10627059|P4|Overall Study|Less than full participation|12
3100621|NCT00283686|10627060|P3|Overall Study|Less than full participation|6
3100622|NCT00283686|10627061|P2|Overall Study|Less than full participation|9
3100623|NCT00283686|10627062|P1|Overall Study|Less than full participation|7
3100624|NCT00283686|10627059|P4|Overall Study|Lost to Follow-up|20
3100625|NCT00283686|10627060|P3|Overall Study|Lost to Follow-up|26
3100626|NCT00283686|10627061|P2|Overall Study|Lost to Follow-up|31
3100627|NCT00283686|10627062|P1|Overall Study|Lost to Follow-up|21
3100628|NCT00283686|10627059|P4|Overall Study|Death|0
3100629|NCT00283686|10627060|P3|Overall Study|Death|1
3100630|NCT00283686|10627061|P2|Overall Study|Death|1
3100631|NCT00283686|10627062|P1|Overall Study|Death|1
3100632|NCT00283595|10627106|P2|Overall Study|Withdrawal by Subject|2
3100633|NCT00283595|10627107|P1|Overall Study|Withdrawal by Subject|1
3100634|NCT00283439|10627132|P4|Overall Study|Other|0
3100635|NCT00283439|10627133|P3|Overall Study|Other|0
3100636|NCT00283439|10627134|P2|Overall Study|Other|0
3100637|NCT00283439|10627135|P1|Overall Study|Other|1
3100638|NCT00283439|10627132|P4|Overall Study|Treatment discontinued|3
3100639|NCT00283439|10627133|P3|Overall Study|Treatment discontinued|1
3100640|NCT00283439|10627134|P2|Overall Study|Treatment discontinued|2
3100641|NCT00283439|10627135|P1|Overall Study|Treatment discontinued|0
3100642|NCT00283439|10627132|P4|Overall Study|Stem cell transplant|3
3100643|NCT00283439|10627133|P3|Overall Study|Stem cell transplant|4
3100644|NCT00283439|10627134|P2|Overall Study|Stem cell transplant|6
3100645|NCT00283439|10627135|P1|Overall Study|Stem cell transplant|6
3100646|NCT00283439|10627132|P4|Overall Study|Requirement for alternative therapy|2
3100647|NCT00283439|10627133|P3|Overall Study|Requirement for alternative therapy|5
3100648|NCT00283439|10627134|P2|Overall Study|Requirement for alternative therapy|2
3100649|NCT00283439|10627135|P1|Overall Study|Requirement for alternative therapy|1
3100650|NCT00283439|10627132|P4|Overall Study|Disease progression|0
3100651|NCT00283439|10627133|P3|Overall Study|Disease progression|0
3100652|NCT00283439|10627134|P2|Overall Study|Disease progression|1
3100653|NCT00283439|10627135|P1|Overall Study|Disease progression|0
3100654|NCT00283439|10627132|P4|Overall Study|Death|0
3100655|NCT00283439|10627133|P3|Overall Study|Death|1
3100656|NCT00283439|10627134|P2|Overall Study|Death|0
3100657|NCT00283439|10627135|P1|Overall Study|Death|0
3100658|NCT00283439|10627132|P4|Overall Study|Adverse Event|1
3100659|NCT00283439|10627133|P3|Overall Study|Adverse Event|0
3100660|NCT00283439|10627134|P2|Overall Study|Adverse Event|0
3100661|NCT00283439|10627135|P1|Overall Study|Adverse Event|0
3100662|NCT00283400|10627161|P4|Overall Study|Death|0
3100663|NCT00283400|10627162|P3|Overall Study|Death|1
3100664|NCT00283400|10627163|P2|Overall Study|Death|0
3100665|NCT00283400|10627164|P1|Overall Study|Death|1
3100666|NCT00283400|10627161|P4|Overall Study|Withdrawal by Subject|0
3100667|NCT00283400|10627162|P3|Overall Study|Withdrawal by Subject|0
3100668|NCT00283400|10627163|P2|Overall Study|Withdrawal by Subject|1
3100669|NCT00283400|10627164|P1|Overall Study|Withdrawal by Subject|1
3100670|NCT00283387|10627182|P2|First Intervention|Withdrawal by Subject|1
3100671|NCT00283387|10627183|P1|First Intervention|Withdrawal by Subject|0
3100672|NCT00283387|10627182|P2|First Intervention|Subject non-compliant|1
3100673|NCT00283387|10627183|P1|First Intervention|Subject non-compliant|1
3100674|NCT00283296|10627189|P1|Overall Study|in-home trial not completed|5
3100675|NCT00283244|10627198|P3|Overall Study|Clinical deterioration|3
3100676|NCT00283244|10627199|P2|Overall Study|Clinical deterioration|3
3100677|NCT00283244|10627200|P1|Overall Study|Clinical deterioration|1
3100678|NCT00283244|10627198|P3|Overall Study|Medical illness (other complicating dz)|6
3100679|NCT00283244|10627199|P2|Overall Study|Medical illness (other complicating dz)|3
3100680|NCT00283244|10627200|P1|Overall Study|Medical illness (other complicating dz)|4
3100681|NCT00283244|10627198|P3|Overall Study|Physician Decision|1
3100682|NCT00283244|10627199|P2|Overall Study|Physician Decision|0
3100683|NCT00283244|10627200|P1|Overall Study|Physician Decision|0
3100684|NCT00283244|10627198|P3|Overall Study|Withdrawal by Subject|2
3100685|NCT00283244|10627199|P2|Overall Study|Withdrawal by Subject|2
3100686|NCT00283244|10627200|P1|Overall Study|Withdrawal by Subject|1
3100687|NCT00283244|10627198|P3|Overall Study|Lack of Efficacy|26
3100688|NCT00283244|10627199|P2|Overall Study|Lack of Efficacy|32
3100689|NCT00283244|10627200|P1|Overall Study|Lack of Efficacy|8
3100690|NCT00283244|10627198|P3|Overall Study|Death|2
3100691|NCT00283244|10627199|P2|Overall Study|Death|3
3100692|NCT00283244|10627200|P1|Overall Study|Death|4
3100693|NCT00283244|10627198|P3|Overall Study|Adverse Event|11
3100694|NCT00283244|10627199|P2|Overall Study|Adverse Event|8
3100695|NCT00283244|10627200|P1|Overall Study|Adverse Event|0
3100696|NCT00283062|10627236|P4|Overall Study|chemotherapy not completed (cycle 6)|0
3100697|NCT00283062|10627237|P3|Overall Study|chemotherapy not completed (cycle 6)|0
3100698|NCT00283062|10627238|P2|Overall Study|chemotherapy not completed (cycle 6)|0
3100699|NCT00283062|10627239|P1|Overall Study|chemotherapy not completed (cycle 6)|1
3100700|NCT00283062|10627236|P4|Overall Study|Undefined|4
3100701|NCT00283062|10627237|P3|Overall Study|Undefined|1
3100702|NCT00283062|10627238|P2|Overall Study|Undefined|1
3100703|NCT00283062|10627239|P1|Overall Study|Undefined|0
3100704|NCT00283062|10627236|P4|Overall Study|Participant did not wish to continue|0
3100705|NCT00283062|10627237|P3|Overall Study|Participant did not wish to continue|1
3100706|NCT00283062|10627238|P2|Overall Study|Participant did not wish to continue|2
3100707|NCT00283062|10627239|P1|Overall Study|Participant did not wish to continue|3
3100708|NCT00283062|10627236|P4|Overall Study|Progressive disease|0
3100709|NCT00283062|10627237|P3|Overall Study|Progressive disease|1
3100710|NCT00283062|10627238|P2|Overall Study|Progressive disease|0
3100711|NCT00283062|10627239|P1|Overall Study|Progressive disease|0
3100712|NCT00283062|10627236|P4|Overall Study|Lost to Follow-up|0
3100713|NCT00283062|10627237|P3|Overall Study|Lost to Follow-up|1
3100714|NCT00283062|10627238|P2|Overall Study|Lost to Follow-up|0
3100715|NCT00283062|10627239|P1|Overall Study|Lost to Follow-up|1
3100716|NCT00283062|10627236|P4|Overall Study|Adverse Event|0
3100717|NCT00283062|10627237|P3|Overall Study|Adverse Event|1
3100718|NCT00283062|10627238|P2|Overall Study|Adverse Event|0
3100719|NCT00283062|10627239|P1|Overall Study|Adverse Event|2
3100720|NCT00283062|10627236|P4|Overall Study|Did not receive any study medication|45
3100721|NCT00283062|10627237|P3|Overall Study|Did not receive any study medication|36
3100722|NCT00283062|10627238|P2|Overall Study|Did not receive any study medication|4
3100723|NCT00283062|10627239|P1|Overall Study|Did not receive any study medication|5
3100724|NCT00283049|10627272|P3|Overall Study|No longer requires study treatment|1
3100725|NCT00283049|10627273|P2|Overall Study|No longer requires study treatment|0
3100726|NCT00283049|10627274|P1|Overall Study|No longer requires study treatment|0
3100727|NCT00283049|10627272|P3|Overall Study|Discontinuation of Study|20
3100728|NCT00283049|10627273|P2|Overall Study|Discontinuation of Study|16
3100729|NCT00283049|10627274|P1|Overall Study|Discontinuation of Study|18
3100730|NCT00283049|10627272|P3|Overall Study|Withdrawal by Subject|19
3100731|NCT00283049|10627273|P2|Overall Study|Withdrawal by Subject|24
3100732|NCT00283049|10627274|P1|Overall Study|Withdrawal by Subject|26
3100733|NCT00283049|10627272|P3|Overall Study|Lost to Follow-up|5
3100734|NCT00283049|10627273|P2|Overall Study|Lost to Follow-up|2
3100735|NCT00283049|10627274|P1|Overall Study|Lost to Follow-up|4
3100736|NCT00283049|10627272|P3|Overall Study|Lack of Efficacy|1
3100737|NCT00283049|10627273|P2|Overall Study|Lack of Efficacy|1
3100738|NCT00283049|10627274|P1|Overall Study|Lack of Efficacy|0
3100739|NCT00283049|10627272|P3|Overall Study|Death|1
3100740|NCT00283049|10627273|P2|Overall Study|Death|1
3100741|NCT00283049|10627274|P1|Overall Study|Death|1
3100742|NCT00283049|10627272|P3|Overall Study|Protocol Violation|3
3100743|NCT00283049|10627273|P2|Overall Study|Protocol Violation|0
3100744|NCT00283049|10627274|P1|Overall Study|Protocol Violation|3
3100745|NCT00283049|10627272|P3|Overall Study|Adverse Event|4
3100746|NCT00283049|10627273|P2|Overall Study|Adverse Event|1
3100747|NCT00283049|10627274|P1|Overall Study|Adverse Event|6
3100748|NCT00282984|10627302|P2|Overall Study|Protocol Violation|0
3100749|NCT00282984|10627303|P1|Overall Study|Protocol Violation|2
3100750|NCT00282984|10627302|P2|Overall Study|in prison|1
3100751|NCT00282984|10627303|P1|Overall Study|in prison|0
3100752|NCT00282984|10627302|P2|Overall Study|lack of motivation|0
3100753|NCT00282984|10627303|P1|Overall Study|lack of motivation|1
3100754|NCT00282984|10627302|P2|Overall Study|Participant used antipsychosis meds|1
3100755|NCT00282984|10627303|P1|Overall Study|Participant used antipsychosis meds|0
3100756|NCT00282984|10627302|P2|Overall Study|Participant only allowed phone follow-up|1
3100757|NCT00282984|10627303|P1|Overall Study|Participant only allowed phone follow-up|0
3100758|NCT00282984|10627302|P2|Overall Study|Participant stopped study medication|2
3100759|NCT00282984|10627303|P1|Overall Study|Participant stopped study medication|2
3100760|NCT00282984|10627302|P2|Overall Study|Withdrawal by Participant|34
3100761|NCT00282984|10627303|P1|Overall Study|Withdrawal by Participant|22
3100762|NCT00282984|10627302|P2|Overall Study|Lost to Follow-up|10
3100763|NCT00282984|10627303|P1|Overall Study|Lost to Follow-up|14
3100764|NCT00282984|10627302|P2|Overall Study|Lack of Efficacy|2
3100765|NCT00282984|10627303|P1|Overall Study|Lack of Efficacy|0
3100766|NCT00282984|10627302|P2|Overall Study|Adverse Event|5
3100767|NCT00282984|10627303|P1|Overall Study|Adverse Event|8
3100768|NCT00282984|10627302|P2|Overall Study|Death|5
3100769|NCT00282984|10627303|P1|Overall Study|Death|2
3100770|NCT00282919|10627340|P1|Overall Study|Asymptomatic Parasitemia|2
3100771|NCT00282919|10627340|P1|Overall Study|Withdrawal by Subject|1
3100772|NCT00282919|10627340|P1|Overall Study|Lack of Efficacy|4
3100773|NCT00282867|10627355|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
3100774|NCT00282867|10627356|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
3100775|NCT00282867|10627357|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
3100776|NCT00282568|10627459|P1|Extended Treatment Period|Lost to Follow-up|2
3100777|NCT00282568|10627459|P1|Extended Treatment Period|Physician Decision|1
3100778|NCT00282568|10627459|P1|Extended Treatment Period|Non-compliance|4
3100779|NCT00282568|10627459|P1|Extended Treatment Period|Adverse Event|17
3100780|NCT00282568|10627459|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
3100781|NCT00282568|10627459|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
3100782|NCT00282464|10627485|P2|Overall Study|dropped due to missed visits|1
3100783|NCT00282464|10627486|P1|Overall Study|dropped due to missed visits|0
3100784|NCT00282464|10627485|P2|Overall Study|dispensed wrong kit|1
3100785|NCT00282464|10627486|P1|Overall Study|dispensed wrong kit|0
3100786|NCT00282464|10627485|P2|Overall Study|family crisis|1
3100787|NCT00282464|10627486|P1|Overall Study|family crisis|0
3100788|NCT00282464|10627485|P2|Overall Study|patient incarcerated|1
3100789|NCT00282464|10627486|P1|Overall Study|patient incarcerated|0
3100790|NCT00282464|10627485|P2|Overall Study|patient no show|1
3100791|NCT00282464|10627486|P1|Overall Study|patient no show|0
3100792|NCT00282464|10627485|P2|Overall Study|patient non-compliant|0
3100793|NCT00282464|10627486|P1|Overall Study|patient non-compliant|3
3100794|NCT00282464|10627485|P2|Overall Study|Patient moved|0
3100795|NCT00282464|10627486|P1|Overall Study|Patient moved|1
3100796|NCT00282464|10627485|P2|Overall Study|Protocol Violation|7
3100797|NCT00282464|10627486|P1|Overall Study|Protocol Violation|0
3100798|NCT00282464|10627485|P2|Overall Study|laboratory abnormality|2
3100799|NCT00282464|10627486|P1|Overall Study|laboratory abnormality|1
3100800|NCT00282464|10627485|P2|Overall Study|Withdrawal by Subject|10
3100801|NCT00282464|10627486|P1|Overall Study|Withdrawal by Subject|24
3100802|NCT00282464|10627485|P2|Overall Study|Lost to Follow-up|10
3100803|NCT00282464|10627486|P1|Overall Study|Lost to Follow-up|10
3100804|NCT00282464|10627485|P2|Overall Study|Lack of Efficacy|8
3100805|NCT00282464|10627486|P1|Overall Study|Lack of Efficacy|8
3100806|NCT00282464|10627485|P2|Overall Study|Adverse Event|20
3100807|NCT00282464|10627486|P1|Overall Study|Adverse Event|26
3100808|NCT00282438|10627536|P2|Overall Study|Death|1
3100809|NCT00282438|10627537|P1|Overall Study|Death|0
3100810|NCT00282438|10627536|P2|Overall Study|Lack of Efficacy|0
3100811|NCT00282438|10627537|P1|Overall Study|Lack of Efficacy|1
3100812|NCT00282412|10627547|P1|Overall Study|Death|2
3100813|NCT00282347|10627553|P2|B Cell Follow-up Period|Reason Not Specified|0
3100814|NCT00282347|10627554|P1|B Cell Follow-up Period|Reason Not Specified|2
3100815|NCT00282347|10627553|P2|B Cell Follow-up Period|Physician Decision|0
3100816|NCT00282347|10627554|P1|B Cell Follow-up Period|Physician Decision|1
3100817|NCT00282347|10627553|P2|B Cell Follow-up Period|Withdrawal by Subject|0
3100818|NCT00282347|10627554|P1|B Cell Follow-up Period|Withdrawal by Subject|2
3100819|NCT00282347|10627553|P2|Safety Follow-up Period|Protocol Deviation|2
3100820|NCT00282347|10627554|P1|Safety Follow-up Period|Protocol Deviation|0
3100821|NCT00282347|10627553|P2|Safety Follow-up Period|Physician Decision|1
3100822|NCT00282347|10627554|P1|Safety Follow-up Period|Physician Decision|1
3100823|NCT00282347|10627553|P2|Safety Follow-up Period|Withdrawal by Subject|1
3100824|NCT00282347|10627554|P1|Safety Follow-up Period|Withdrawal by Subject|2
3100825|NCT00282347|10627553|P2|Safety Follow-up Period|Lost to Follow-up|2
3100826|NCT00282347|10627554|P1|Safety Follow-up Period|Lost to Follow-up|0
3100827|NCT00282347|10627553|P2|Treatment Period|Physician Decision|1
3100828|NCT00282347|10627554|P1|Treatment Period|Physician Decision|0
3100829|NCT00282347|10627553|P2|Treatment Period|Withdrawal by Subject|3
3100830|NCT00282347|10627554|P1|Treatment Period|Withdrawal by Subject|1
3100831|NCT00282347|10627553|P2|Treatment Period|Lost to Follow-up|5
3100832|NCT00282347|10627554|P1|Treatment Period|Lost to Follow-up|2
3100833|NCT00282347|10627553|P2|Treatment Period|Death|0
3100834|NCT00282347|10627554|P1|Treatment Period|Death|2
3100835|NCT00282334|10627580|P2|Overall Study|Withdrawal by Subject|5
3100836|NCT00282334|10627581|P1|Overall Study|Withdrawal by Subject|8
3100837|NCT00282308|10627589|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
3100838|NCT00282308|10627590|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
3100839|NCT00282308|10627591|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
3100840|NCT00282308|10627589|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
3100841|NCT00282308|10627590|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
3100842|NCT00282308|10627591|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
3100843|NCT00282308|10627589|P3|Safety Follow-up Period|Lost to Follow-up|5
3100844|NCT00282308|10627590|P2|Safety Follow-up Period|Lost to Follow-up|0
3100845|NCT00282308|10627591|P1|Safety Follow-up Period|Lost to Follow-up|0
3100846|NCT00282308|10627589|P3|Safety Follow-up Period|Adverse Event|1
3100847|NCT00282308|10627590|P2|Safety Follow-up Period|Adverse Event|0
3100848|NCT00282308|10627591|P1|Safety Follow-up Period|Adverse Event|0
3100849|NCT00282308|10627589|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
3100850|NCT00282308|10627590|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
3100851|NCT00282308|10627591|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
3100852|NCT00282308|10627589|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
3100853|NCT00282308|10627590|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
3100854|NCT00282308|10627591|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
3100855|NCT00282308|10627589|P3|Optional Extension Re-treatment Period|Adverse Event|4
3100856|NCT00282308|10627590|P2|Optional Extension Re-treatment Period|Adverse Event|0
3100857|NCT00282308|10627591|P1|Optional Extension Re-treatment Period|Adverse Event|0
3100858|NCT00282308|10627589|P3|Treatment Period|Not Treated with Study Drug|0
3100859|NCT00282308|10627590|P2|Treatment Period|Not Treated with Study Drug|0
3100860|NCT00282308|10627591|P1|Treatment Period|Not Treated with Study Drug|1
3100861|NCT00282308|10627589|P3|Treatment Period|Adverse Event|0
3100862|NCT00282308|10627590|P2|Treatment Period|Adverse Event|2
3100863|NCT00282308|10627591|P1|Treatment Period|Adverse Event|0
3100864|NCT00282308|10627589|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
3100865|NCT00282308|10627590|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
3100866|NCT00282308|10627591|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
3100867|NCT00282308|10627589|P3|Treatment Period|Lost to Follow-up|0
3100868|NCT00282308|10627590|P2|Treatment Period|Lost to Follow-up|0
3100869|NCT00282308|10627591|P1|Treatment Period|Lost to Follow-up|1
3100870|NCT00282295|10627621|P3|Overall Study|Other|0
3100871|NCT00282295|10627622|P2|Overall Study|Other|1
3100872|NCT00282295|10627623|P1|Overall Study|Other|0
3100873|NCT00282295|10627621|P3|Overall Study|Lost to Follow-up|2
3100874|NCT00282295|10627622|P2|Overall Study|Lost to Follow-up|7
3100875|NCT00282295|10627623|P1|Overall Study|Lost to Follow-up|1
3100876|NCT00282295|10627621|P3|Overall Study|Withdrawal by Subject|4
3100877|NCT00282295|10627622|P2|Overall Study|Withdrawal by Subject|6
3100878|NCT00282295|10627623|P1|Overall Study|Withdrawal by Subject|2
3100879|NCT00282295|10627621|P3|Overall Study|Protocol Violation|1
3100880|NCT00282295|10627622|P2|Overall Study|Protocol Violation|2
3100881|NCT00282295|10627623|P1|Overall Study|Protocol Violation|0
3100882|NCT00282295|10627621|P3|Overall Study|Serious Adverse Events|1
3100883|NCT00282295|10627622|P2|Overall Study|Serious Adverse Events|0
3100884|NCT00282295|10627623|P1|Overall Study|Serious Adverse Events|0
3100885|NCT00282295|10627621|P3|Overall Study|Adverse Event|0
3100886|NCT00282295|10627622|P2|Overall Study|Adverse Event|1
3100887|NCT00282295|10627623|P1|Overall Study|Adverse Event|0
3100888|NCT00282256|10627678|P1|Extension Treatment Period|Adverse Event|2
3100889|NCT00282256|10627678|P1|Pharmacokinetic Treatment Period|Poor venous access|1
3100890|NCT00282243|10627699|P1|Extension Treatment Period|Physician Decision|1
3100891|NCT00282243|10627699|P1|Extension Treatment Period|Non-compliance|2
3100892|NCT00282243|10627699|P1|Extension Treatment Period|Withdrawal by Subject|4
3100893|NCT00282243|10627699|P1|Extension Treatment Period|Adverse Event|15
3100894|NCT00282243|10627699|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
3100895|NCT00282243|10627699|P1|Pharmacokinetic Treatment Period|Adverse Event|3
3100896|NCT00282152|10627725|P2|Overall Study|Withdrawal by Subject|0
3100897|NCT00282152|10627726|P1|Overall Study|Withdrawal by Subject|1
3100898|NCT00282113|10627747|P3|Overall Study|Removed at parents request|0
3100899|NCT00282113|10627748|P2|Overall Study|Removed at parents request|0
3100900|NCT00282113|10627749|P1|Overall Study|Removed at parents request|1
3100901|NCT00282087|10627763|P1|Overall Study|Death|1
3100902|NCT00282048|10627776|P1|Overall Study|Ongoing|1
3100903|NCT00282048|10627776|P1|Overall Study|Other|8
3100904|NCT00282048|10627776|P1|Overall Study|Withdrawal by Subject|1
3100905|NCT00282048|10627776|P1|Overall Study|Adverse Event|22
3100906|NCT00282048|10627776|P1|Overall Study|Lack of Efficacy|30
3100907|NCT00281957|10627790|P2|Overall Study|Refusal unrelated to adverse events|1
3100908|NCT00281957|10627791|P1|Overall Study|Refusal unrelated to adverse events|0
3100909|NCT00281957|10627790|P2|Overall Study|Did not start treatment|1
3100910|NCT00281957|10627791|P1|Overall Study|Did not start treatment|3
3100911|NCT00281957|10627790|P2|Overall Study|Not eligible|2
3100912|NCT00281957|10627791|P1|Overall Study|Not eligible|1
3100913|NCT00281957|10627790|P2|Overall Study|Not protocol specified|1
3100914|NCT00281957|10627791|P1|Overall Study|Not protocol specified|8
3100915|NCT00281957|10627790|P2|Overall Study|Progression/relapse|35
3100916|NCT00281957|10627791|P1|Overall Study|Progression/relapse|47
3100917|NCT00281957|10627790|P2|Overall Study|Death|0
3100918|NCT00281957|10627791|P1|Overall Study|Death|1
3100919|NCT00281957|10627790|P2|Overall Study|Adverse Event|2
3100920|NCT00281957|10627791|P1|Overall Study|Adverse Event|7
3100921|NCT00281840|10627865|P1|Overall Study|Complicating Disease|1
3100922|NCT00281840|10627865|P1|Overall Study|exceed maximum delay in treatment|1
3100923|NCT00281840|10627865|P1|Overall Study|Disease Progression|2
3100924|NCT00281840|10627865|P1|Overall Study|Withdrawal by Subject|3
3100925|NCT00281840|10627865|P1|Overall Study|Physician Decision|6
3100926|NCT00281840|10627865|P1|Overall Study|Adverse Event|12
3100927|NCT00281697|10627881|P2|Overall Study|Did not receive study drug|2
3100928|NCT00281697|10627882|P1|Overall Study|Did not receive study drug|3
3100929|NCT00281697|10627881|P2|Overall Study|Subject/guardian's decision to withdraw|6
3100930|NCT00281697|10627882|P1|Overall Study|Subject/guardian's decision to withdraw|33
3100931|NCT00281697|10627881|P2|Overall Study|Physician's decision to withdraw|12
3100932|NCT00281697|10627882|P1|Overall Study|Physician's decision to withdraw|15
3100933|NCT00281697|10627881|P2|Overall Study|Other|6
3100934|NCT00281697|10627882|P1|Overall Study|Other|5
3100935|NCT00281697|10627881|P2|Overall Study|Disease progression|149
3100936|NCT00281697|10627882|P1|Overall Study|Disease progression|279
3100937|NCT00281697|10627881|P2|Overall Study|Death|3
3100938|NCT00281697|10627882|P1|Overall Study|Death|8
3100939|NCT00281697|10627881|P2|Overall Study|Adverse Event|15
3100940|NCT00281697|10627882|P1|Overall Study|Adverse Event|54
3100941|NCT00281697|10627881|P2|Overall Study|> 60 days since last dose of study drug|4
3100942|NCT00281697|10627882|P1|Overall Study|> 60 days since last dose of study drug|4
3100943|NCT00281684|10627902|P4|Overall Study|Withdrawal by Subject|0
3100944|NCT00281684|10627903|P3|Overall Study|Withdrawal by Subject|0
3100945|NCT00281684|10627904|P2|Overall Study|Withdrawal by Subject|0
3100946|NCT00281684|10627905|P1|Overall Study|Withdrawal by Subject|1
3100947|NCT00281684|10627902|P4|Overall Study|Lost to Follow-up|0
3100948|NCT00281684|10627903|P3|Overall Study|Lost to Follow-up|1
3100949|NCT00281684|10627904|P2|Overall Study|Lost to Follow-up|0
3100950|NCT00281684|10627905|P1|Overall Study|Lost to Follow-up|0
3100951|NCT00281658|10627979|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
3100952|NCT00281658|10627980|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
3100953|NCT00281658|10627981|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
3100954|NCT00281658|10627979|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
3100955|NCT00281658|10627980|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
3100956|NCT00281658|10627981|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
3100957|NCT00281658|10627979|P3|Open-label Monotherapy Extension Phase|Death|97
3100958|NCT00281658|10627980|P2|Open-label Monotherapy Extension Phase|Death|0
3100959|NCT00281658|10627981|P1|Open-label Monotherapy Extension Phase|Death|0
3100960|NCT00281658|10627979|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
3100961|NCT00281658|10627980|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
3100962|NCT00281658|10627981|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
3100963|NCT00281658|10627979|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
3100964|NCT00281658|10627980|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
3100965|NCT00281658|10627981|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
3100966|NCT00281658|10627979|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
3100967|NCT00281658|10627980|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
3100968|NCT00281658|10627981|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
3100969|NCT00281658|10627979|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
3100970|NCT00281658|10627980|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
3100971|NCT00281658|10627981|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
3100972|NCT00281658|10627979|P3|Double-blind, Randomized Phase|Death|0
3100973|NCT00281658|10627980|P2|Double-blind, Randomized Phase|Death|46
3100974|NCT00281658|10627981|P1|Double-blind, Randomized Phase|Death|120
3100975|NCT00281632|10627998|P1|Overall Study|Ongoing|3
3100976|NCT00281632|10627998|P1|Overall Study|Physician Decision|1
3100977|NCT00281632|10627998|P1|Overall Study|Death|1
3100978|NCT00281632|10627998|P1|Overall Study|Disease Progression|22
3100979|NCT00281632|10627998|P1|Overall Study|Withdrawal by Subject|2
3100980|NCT00281632|10627998|P1|Overall Study|Adverse Event|7
3100981|NCT00281580|10628040|P16|Overall Study|Randomised in error; pregnancy; moving|2
3100982|NCT00281580|10628041|P15|Overall Study|Randomised in error; pregnancy; moving|1
3100983|NCT00281580|10628042|P14|Overall Study|Randomised in error; pregnancy; moving|0
3100984|NCT00281580|10628043|P13|Overall Study|Randomised in error; pregnancy; moving|2
3100985|NCT00281580|10628044|P12|Overall Study|Randomised in error; pregnancy; moving|1
3100986|NCT00281580|10628045|P11|Overall Study|Randomised in error; pregnancy; moving|1
3100987|NCT00281580|10628046|P10|Overall Study|Randomised in error; pregnancy; moving|1
3100988|NCT00281580|10628047|P9|Overall Study|Randomised in error; pregnancy; moving|2
3100989|NCT00281580|10628048|P8|Overall Study|Randomised in error; pregnancy; moving|0
3100990|NCT00281580|10628049|P7|Overall Study|Randomised in error; pregnancy; moving|1
3100991|NCT00281580|10628050|P6|Overall Study|Randomised in error; pregnancy; moving|0
3100992|NCT00281580|10628051|P5|Overall Study|Randomised in error; pregnancy; moving|0
3100993|NCT00281580|10628052|P4|Overall Study|Randomised in error; pregnancy; moving|2
3100994|NCT00281580|10628053|P3|Overall Study|Randomised in error; pregnancy; moving|0
3100995|NCT00281580|10628054|P2|Overall Study|Randomised in error; pregnancy; moving|0
3100996|NCT00281580|10628055|P1|Overall Study|Randomised in error; pregnancy; moving|0
3100997|NCT00281580|10628040|P16|Overall Study|Lost to Follow-up|0
3100998|NCT00281580|10628041|P15|Overall Study|Lost to Follow-up|0
3100999|NCT00281580|10628042|P14|Overall Study|Lost to Follow-up|0
3101000|NCT00281580|10628043|P13|Overall Study|Lost to Follow-up|1
3101001|NCT00281580|10628044|P12|Overall Study|Lost to Follow-up|0
3101002|NCT00281580|10628045|P11|Overall Study|Lost to Follow-up|1
3101003|NCT00281580|10628046|P10|Overall Study|Lost to Follow-up|1
3101004|NCT00281580|10628047|P9|Overall Study|Lost to Follow-up|2
3101005|NCT00281580|10628048|P8|Overall Study|Lost to Follow-up|1
3101006|NCT00281580|10628049|P7|Overall Study|Lost to Follow-up|0
3101007|NCT00281580|10628050|P6|Overall Study|Lost to Follow-up|1
3101008|NCT00281580|10628051|P5|Overall Study|Lost to Follow-up|0
3101009|NCT00281580|10628052|P4|Overall Study|Lost to Follow-up|3
3101010|NCT00281580|10628053|P3|Overall Study|Lost to Follow-up|0
3101011|NCT00281580|10628054|P2|Overall Study|Lost to Follow-up|0
3101012|NCT00281580|10628055|P1|Overall Study|Lost to Follow-up|0
3101013|NCT00281580|10628040|P16|Overall Study|Lack of Efficacy|0
3101014|NCT00281580|10628041|P15|Overall Study|Lack of Efficacy|1
3101015|NCT00281580|10628042|P14|Overall Study|Lack of Efficacy|2
3101016|NCT00281580|10628043|P13|Overall Study|Lack of Efficacy|0
3101017|NCT00281580|10628044|P12|Overall Study|Lack of Efficacy|1
3101018|NCT00281580|10628045|P11|Overall Study|Lack of Efficacy|0
3101019|NCT00281580|10628046|P10|Overall Study|Lack of Efficacy|0
3101020|NCT00281580|10628047|P9|Overall Study|Lack of Efficacy|0
3101021|NCT00281580|10628048|P8|Overall Study|Lack of Efficacy|0
3101022|NCT00281580|10628049|P7|Overall Study|Lack of Efficacy|0
3101023|NCT00281580|10628050|P6|Overall Study|Lack of Efficacy|0
3101024|NCT00281580|10628051|P5|Overall Study|Lack of Efficacy|2
3101025|NCT00281580|10628052|P4|Overall Study|Lack of Efficacy|6
3101026|NCT00281580|10628053|P3|Overall Study|Lack of Efficacy|1
3101027|NCT00281580|10628054|P2|Overall Study|Lack of Efficacy|1
3101028|NCT00281580|10628055|P1|Overall Study|Lack of Efficacy|2
3101029|NCT00281580|10628040|P16|Overall Study|Withdrawal by Subject|5
3101030|NCT00281580|10628041|P15|Overall Study|Withdrawal by Subject|1
3101031|NCT00281580|10628042|P14|Overall Study|Withdrawal by Subject|2
3101032|NCT00281580|10628043|P13|Overall Study|Withdrawal by Subject|2
3101033|NCT00281580|10628044|P12|Overall Study|Withdrawal by Subject|1
3101034|NCT00281580|10628045|P11|Overall Study|Withdrawal by Subject|1
3101035|NCT00281580|10628046|P10|Overall Study|Withdrawal by Subject|4
3101036|NCT00281580|10628047|P9|Overall Study|Withdrawal by Subject|1
3101037|NCT00281580|10628048|P8|Overall Study|Withdrawal by Subject|0
3101038|NCT00281580|10628049|P7|Overall Study|Withdrawal by Subject|2
3101039|NCT00281580|10628050|P6|Overall Study|Withdrawal by Subject|2
3101040|NCT00281580|10628051|P5|Overall Study|Withdrawal by Subject|1
3101041|NCT00281580|10628052|P4|Overall Study|Withdrawal by Subject|1
3101042|NCT00281580|10628053|P3|Overall Study|Withdrawal by Subject|1
3101043|NCT00281580|10628054|P2|Overall Study|Withdrawal by Subject|0
3101044|NCT00281580|10628055|P1|Overall Study|Withdrawal by Subject|3
3101045|NCT00281580|10628040|P16|Overall Study|Protocol Violation|3
3101046|NCT00281580|10628041|P15|Overall Study|Protocol Violation|1
3101047|NCT00281580|10628042|P14|Overall Study|Protocol Violation|1
3101048|NCT00281580|10628043|P13|Overall Study|Protocol Violation|0
3101049|NCT00281580|10628044|P12|Overall Study|Protocol Violation|2
3101050|NCT00281580|10628045|P11|Overall Study|Protocol Violation|1
3101051|NCT00281580|10628046|P10|Overall Study|Protocol Violation|0
3101052|NCT00281580|10628047|P9|Overall Study|Protocol Violation|2
3101053|NCT00281580|10628048|P8|Overall Study|Protocol Violation|0
3101054|NCT00281580|10628049|P7|Overall Study|Protocol Violation|1
3101055|NCT00281580|10628050|P6|Overall Study|Protocol Violation|0
3101056|NCT00281580|10628051|P5|Overall Study|Protocol Violation|0
3101057|NCT00281580|10628052|P4|Overall Study|Protocol Violation|1
3101058|NCT00281580|10628053|P3|Overall Study|Protocol Violation|1
3101059|NCT00281580|10628054|P2|Overall Study|Protocol Violation|0
3101060|NCT00281580|10628055|P1|Overall Study|Protocol Violation|0
3101061|NCT00281580|10628040|P16|Overall Study|Adverse Event|3
3101062|NCT00281580|10628041|P15|Overall Study|Adverse Event|3
3101063|NCT00281580|10628042|P14|Overall Study|Adverse Event|2
3101064|NCT00281580|10628043|P13|Overall Study|Adverse Event|8
3101065|NCT00281580|10628044|P12|Overall Study|Adverse Event|5
3101066|NCT00281580|10628045|P11|Overall Study|Adverse Event|0
3101067|NCT00281580|10628046|P10|Overall Study|Adverse Event|6
3101068|NCT00281580|10628047|P9|Overall Study|Adverse Event|1
3101069|NCT00281580|10628048|P8|Overall Study|Adverse Event|0
3101070|NCT00281580|10628049|P7|Overall Study|Adverse Event|1
3101071|NCT00281580|10628050|P6|Overall Study|Adverse Event|0
3101072|NCT00281580|10628051|P5|Overall Study|Adverse Event|1
3101073|NCT00281580|10628052|P4|Overall Study|Adverse Event|4
3101074|NCT00281580|10628053|P3|Overall Study|Adverse Event|2
3101075|NCT00281580|10628054|P2|Overall Study|Adverse Event|0
3101076|NCT00281580|10628055|P1|Overall Study|Adverse Event|2
3101077|NCT00281528|10628402|P3|Overall Study|Other|5
3101078|NCT00281528|10628403|P2|Overall Study|Other|3
3101079|NCT00281528|10628404|P1|Overall Study|Other|6
3101080|NCT00281528|10628402|P3|Overall Study|Withdrawal by Subject|7
3101081|NCT00281528|10628403|P2|Overall Study|Withdrawal by Subject|5
3101082|NCT00281528|10628404|P1|Overall Study|Withdrawal by Subject|5
3101083|NCT00281528|10628402|P3|Overall Study|Protocol Violation|1
3101084|NCT00281528|10628403|P2|Overall Study|Protocol Violation|0
3101085|NCT00281528|10628404|P1|Overall Study|Protocol Violation|1
3101086|NCT00281528|10628402|P3|Overall Study|Physician Decision|5
3101087|NCT00281528|10628403|P2|Overall Study|Physician Decision|4
3101088|NCT00281528|10628404|P1|Overall Study|Physician Decision|11
3101089|NCT00281528|10628402|P3|Overall Study|Adverse Event-unrelated to treatment|2
3101090|NCT00281528|10628403|P2|Overall Study|Adverse Event-unrelated to treatment|0
3101091|NCT00281528|10628404|P1|Overall Study|Adverse Event-unrelated to treatment|3
3101092|NCT00281528|10628402|P3|Overall Study|Unacceptable Toxicity-related to trt|32
3101093|NCT00281528|10628403|P2|Overall Study|Unacceptable Toxicity-related to trt|24
3101094|NCT00281528|10628404|P1|Overall Study|Unacceptable Toxicity-related to trt|21
3101095|NCT00281528|10628402|P3|Overall Study|Progressive Disease|27
3101096|NCT00281528|10628403|P2|Overall Study|Progressive Disease|18
3101097|NCT00281528|10628404|P1|Overall Study|Progressive Disease|28
3101098|NCT00281320|10628455|P2|Overall Study|Other|1
3101099|NCT00281320|10628456|P1|Overall Study|Other|3
3101100|NCT00281320|10628455|P2|Overall Study|Lost to Follow-up|2
3101101|NCT00281320|10628456|P1|Overall Study|Lost to Follow-up|1
3101102|NCT00281320|10628455|P2|Overall Study|Withdrawal by Subject|6
3101103|NCT00281320|10628456|P1|Overall Study|Withdrawal by Subject|5
3101104|NCT00281320|10628455|P2|Overall Study|Lack of Efficacy|3
3101105|NCT00281320|10628456|P1|Overall Study|Lack of Efficacy|4
3101106|NCT00281320|10628455|P2|Overall Study|Adverse Event|9
3101107|NCT00281320|10628456|P1|Overall Study|Adverse Event|12
3101108|NCT00281099|10628478|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
3101109|NCT00281099|10628479|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
3101110|NCT00281099|10628478|P2|Overall Study|Physician Decision|72
3101111|NCT00281099|10628479|P1|Overall Study|Physician Decision|79
3101112|NCT00281099|10628478|P2|Overall Study|Withdrawal by Subject|70
3101113|NCT00281099|10628479|P1|Overall Study|Withdrawal by Subject|65
3101114|NCT00281099|10628478|P2|Overall Study|Lost to Follow-up|19
3101115|NCT00281099|10628479|P1|Overall Study|Lost to Follow-up|10
3101116|NCT00281099|10628478|P2|Overall Study|Death|57
3101117|NCT00281099|10628479|P1|Overall Study|Death|46
3101118|NCT00280917|10628528|P4|Overall Study|Noncompliance|0
3101119|NCT00280917|10628529|P3|Overall Study|Noncompliance|2
3101120|NCT00280917|10628530|P2|Overall Study|Noncompliance|1
3101121|NCT00280917|10628531|P1|Overall Study|Noncompliance|0
3101122|NCT00280917|10628528|P4|Overall Study|Withdrawal by Subject|1
3101123|NCT00280917|10628529|P3|Overall Study|Withdrawal by Subject|0
3101124|NCT00280917|10628530|P2|Overall Study|Withdrawal by Subject|2
3101125|NCT00280917|10628531|P1|Overall Study|Withdrawal by Subject|0
3101126|NCT00280917|10628528|P4|Overall Study|Change Therapy|0
3101127|NCT00280917|10628529|P3|Overall Study|Change Therapy|0
3101128|NCT00280917|10628530|P2|Overall Study|Change Therapy|2
3101129|NCT00280917|10628531|P1|Overall Study|Change Therapy|1
3101130|NCT00280917|10628528|P4|Overall Study|Adverse Event|1
3101131|NCT00280917|10628529|P3|Overall Study|Adverse Event|4
3101132|NCT00280917|10628530|P2|Overall Study|Adverse Event|1
3101133|NCT00280917|10628531|P1|Overall Study|Adverse Event|1
3101134|NCT00280748|10628554|P1|Overall Study|Extra-cranial disease progression|1
3101135|NCT00280748|10628554|P1|Overall Study|Decline in performance|3
3101136|NCT00280735|10628564|P1|Overall Study|Intercurrent Illness|2
3101137|NCT00280735|10628564|P1|Overall Study|Withdrawal by Subject|8
3101138|NCT00280735|10628564|P1|Overall Study|Lack of Efficacy|3
3101139|NCT00280735|10628564|P1|Overall Study|Adverse Event|5
3101140|NCT00280683|10628576|P2|Overall Study|Adverse Event|1
3101141|NCT00280683|10628577|P1|Overall Study|Adverse Event|1
3101142|NCT00280683|10628576|P2|Overall Study|Withdrawal by Subject|2
3101143|NCT00280683|10628577|P1|Overall Study|Withdrawal by Subject|1
3101144|NCT00280566|10628587|P3|Period 2 Double Blind|miscellaneous|5
3101145|NCT00280566|10628588|P2|Period 2 Double Blind|miscellaneous|10
3101146|NCT00280566|10628589|P1|Period 2 Double Blind|miscellaneous|0
3101147|NCT00280566|10628587|P3|Period 2 Double Blind|Withdrawal by Subject|9
3101148|NCT00280566|10628588|P2|Period 2 Double Blind|Withdrawal by Subject|9
3101149|NCT00280566|10628589|P1|Period 2 Double Blind|Withdrawal by Subject|0
3101150|NCT00280566|10628587|P3|Period 2 Double Blind|Lost to Follow-up|6
3101151|NCT00280566|10628588|P2|Period 2 Double Blind|Lost to Follow-up|3
3101152|NCT00280566|10628589|P1|Period 2 Double Blind|Lost to Follow-up|0
3101153|NCT00280566|10628587|P3|Period 2 Double Blind|Adverse Event|15
3101154|NCT00280566|10628588|P2|Period 2 Double Blind|Adverse Event|11
3101155|NCT00280566|10628589|P1|Period 2 Double Blind|Adverse Event|0
3101156|NCT00280566|10628587|P3|Period 2 Double Blind|Laboratory Abnormality|0
3101157|NCT00280566|10628588|P2|Period 2 Double Blind|Laboratory Abnormality|1
3101158|NCT00280566|10628589|P1|Period 2 Double Blind|Laboratory Abnormality|0
3101159|NCT00280566|10628587|P3|Period 2 Double Blind|Lack of Efficacy|22
3101160|NCT00280566|10628588|P2|Period 2 Double Blind|Lack of Efficacy|9
3101161|NCT00280566|10628589|P1|Period 2 Double Blind|Lack of Efficacy|0
3101162|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
3101163|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
3101164|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
3101165|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
3101166|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
3101167|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
3101168|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
3101169|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
3101170|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
3101171|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
3101172|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
3101173|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
3101174|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
3101175|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
3101176|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
3101177|NCT00280566|10628587|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
3101178|NCT00280566|10628588|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
3101179|NCT00280566|10628589|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
3101180|NCT00280397|10628614|P1|Overall Study|Adverse Event|1
3101181|NCT00280293|10628680|P2|Overall Study|Adverse Event|1
3101182|NCT00280293|10628681|P1|Overall Study|Adverse Event|0
3101183|NCT00280293|10628680|P2|Overall Study|Incarceration/Legal Reasons|1
3101184|NCT00280293|10628681|P1|Overall Study|Incarceration/Legal Reasons|1
3101185|NCT00280293|10628680|P2|Overall Study|Withdrawal by Subject|5
3101186|NCT00280293|10628681|P1|Overall Study|Withdrawal by Subject|3
3101187|NCT00280293|10628680|P2|Overall Study|Lost to Follow-up|12
3101188|NCT00280293|10628681|P1|Overall Study|Lost to Follow-up|14
3101189|NCT00280293|10628680|P2|Overall Study|Physician Decision|4
3101190|NCT00280293|10628681|P1|Overall Study|Physician Decision|5
3101191|NCT00280293|10628680|P2|Overall Study|Protocol Violation|0
3101192|NCT00280293|10628681|P1|Overall Study|Protocol Violation|3
3101193|NCT00280150|10628704|P4|Overall Study|Declining Performance Status|1
3101194|NCT00280150|10628705|P3|Overall Study|Declining Performance Status|0
3101195|NCT00280150|10628706|P2|Overall Study|Declining Performance Status|0
3101196|NCT00280150|10628707|P1|Overall Study|Declining Performance Status|0
3101197|NCT00280150|10628704|P4|Overall Study|Did not get consolidation therapy|0
3101198|NCT00280150|10628705|P3|Overall Study|Did not get consolidation therapy|3
3101199|NCT00280150|10628706|P2|Overall Study|Did not get consolidation therapy|0
3101200|NCT00280150|10628707|P1|Overall Study|Did not get consolidation therapy|3
3101201|NCT00280150|10628704|P4|Overall Study|Withdrawal by Subject|1
3101202|NCT00280150|10628705|P3|Overall Study|Withdrawal by Subject|0
3101203|NCT00280150|10628706|P2|Overall Study|Withdrawal by Subject|0
3101204|NCT00280150|10628707|P1|Overall Study|Withdrawal by Subject|0
3101205|NCT00280150|10628704|P4|Overall Study|Protocol Violation|1
3101206|NCT00280150|10628705|P3|Overall Study|Protocol Violation|0
3101207|NCT00280150|10628706|P2|Overall Study|Protocol Violation|0
3101208|NCT00280150|10628707|P1|Overall Study|Protocol Violation|0
3101209|NCT00280150|10628704|P4|Overall Study|Physician Decision|1
3101210|NCT00280150|10628705|P3|Overall Study|Physician Decision|0
3101211|NCT00280150|10628706|P2|Overall Study|Physician Decision|0
3101212|NCT00280150|10628707|P1|Overall Study|Physician Decision|0
3101213|NCT00280150|10628704|P4|Overall Study|Lack of Efficacy|3
3101214|NCT00280150|10628705|P3|Overall Study|Lack of Efficacy|0
3101215|NCT00280150|10628706|P2|Overall Study|Lack of Efficacy|0
3101216|NCT00280150|10628707|P1|Overall Study|Lack of Efficacy|0
3101217|NCT00280150|10628704|P4|Overall Study|Adverse Event|3
3101218|NCT00280150|10628705|P3|Overall Study|Adverse Event|2
3101219|NCT00280150|10628706|P2|Overall Study|Adverse Event|1
3101220|NCT00280150|10628707|P1|Overall Study|Adverse Event|0
3101221|NCT00280059|10628722|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
3101222|NCT00280059|10628723|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
3101223|NCT00280059|10628722|P2|Efficacy Assessment Phase|Other|8
3101224|NCT00280059|10628723|P1|Efficacy Assessment Phase|Other|7
3101225|NCT00280059|10628722|P2|Efficacy Assessment Phase|Lost to Follow-up|13
3101226|NCT00280059|10628723|P1|Efficacy Assessment Phase|Lost to Follow-up|6
3101227|NCT00280059|10628722|P2|Efficacy Assessment Phase|Lack of Efficacy|3
3101228|NCT00280059|10628723|P1|Efficacy Assessment Phase|Lack of Efficacy|19
3101229|NCT00280059|10628722|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
3101230|NCT00280059|10628723|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
3101231|NCT00280059|10628722|P2|Efficacy Assessment Phase|Adverse Event|31
3101232|NCT00280059|10628723|P1|Efficacy Assessment Phase|Adverse Event|33
3101233|NCT00280059|10628722|P2|Efficacy Assessment Phase|Death|0
3101234|NCT00280059|10628723|P1|Efficacy Assessment Phase|Death|2
3101235|NCT00279916|10628787|P2|Overall Study|Lost to Follow-up|2
3101236|NCT00279916|10628788|P1|Overall Study|Lost to Follow-up|3
3101237|NCT00279916|10628787|P2|Overall Study|Withdrawal by Subject|3
3101238|NCT00279916|10628788|P1|Overall Study|Withdrawal by Subject|4
3101239|NCT00279812|10628814|P6|Overall Study|Adverse Event|1
3101240|NCT00279812|10628815|P5|Overall Study|Adverse Event|2
3101241|NCT00279812|10628816|P4|Overall Study|Adverse Event|0
3101242|NCT00279812|10628817|P3|Overall Study|Adverse Event|1
3101243|NCT00279812|10628818|P2|Overall Study|Adverse Event|1
3101244|NCT00279812|10628819|P1|Overall Study|Adverse Event|0
3101245|NCT00279812|10628814|P6|Overall Study|Withdrawal by Subject|0
3101246|NCT00279812|10628815|P5|Overall Study|Withdrawal by Subject|0
3101247|NCT00279812|10628816|P4|Overall Study|Withdrawal by Subject|0
3101248|NCT00279812|10628817|P3|Overall Study|Withdrawal by Subject|2
3101249|NCT00279812|10628818|P2|Overall Study|Withdrawal by Subject|4
3101250|NCT00279812|10628819|P1|Overall Study|Withdrawal by Subject|0
3101251|NCT00279812|10628814|P6|Overall Study|Protocol Violation|0
3101252|NCT00279812|10628815|P5|Overall Study|Protocol Violation|1
3101253|NCT00279812|10628816|P4|Overall Study|Protocol Violation|0
3101254|NCT00279812|10628817|P3|Overall Study|Protocol Violation|0
3101255|NCT00279812|10628818|P2|Overall Study|Protocol Violation|1
3101256|NCT00279812|10628819|P1|Overall Study|Protocol Violation|1
3101257|NCT00279708|10628847|P2|Overall Study|Adverse Event|1
3101258|NCT00279708|10628848|P1|Overall Study|Adverse Event|1
3101259|NCT00279708|10628847|P2|Overall Study|Withdrawal by Subject|3
3101260|NCT00279708|10628848|P1|Overall Study|Withdrawal by Subject|2
3101261|NCT00279305|10628877|P2|Overall Study|FDA Safety Alert|1
3101262|NCT00279305|10628878|P1|Overall Study|FDA Safety Alert|4
3101263|NCT00279305|10628877|P2|Overall Study|Dificulting establishing IV|0
3101264|NCT00279305|10628878|P1|Overall Study|Dificulting establishing IV|1
3101265|NCT00279305|10628877|P2|Overall Study|Withdrawal by Subject|0
3101266|NCT00279305|10628878|P1|Overall Study|Withdrawal by Subject|2
3101267|NCT00279305|10628877|P2|Overall Study|Pregnancy|0
3101268|NCT00279305|10628878|P1|Overall Study|Pregnancy|1
3101269|NCT00279214|10628886|P2|Overall Study|Physician Decision|2
3101270|NCT00279214|10628887|P1|Overall Study|Physician Decision|3
3101271|NCT00279201|10628917|P6|Intensification Addendum|Death|0
3101272|NCT00279201|10628918|P5|Intensification Addendum|Death|1
3101273|NCT00279201|10628919|P4|Intensification Addendum|Death|0
3101274|NCT00279201|10628920|P3|Intensification Addendum|Death|0
3101275|NCT00279201|10628921|P2|Intensification Addendum|Death|0
3101276|NCT00279201|10628922|P1|Intensification Addendum|Death|0
3101277|NCT00279201|10628917|P6|Intensification Addendum|Lack of Efficacy|0
3101278|NCT00279201|10628918|P5|Intensification Addendum|Lack of Efficacy|1
3101279|NCT00279201|10628919|P4|Intensification Addendum|Lack of Efficacy|1
3101280|NCT00279201|10628920|P3|Intensification Addendum|Lack of Efficacy|0
3101281|NCT00279201|10628921|P2|Intensification Addendum|Lack of Efficacy|0
3101282|NCT00279201|10628922|P1|Intensification Addendum|Lack of Efficacy|0
3101283|NCT00279201|10628917|P6|Intensification Addendum|Entry Criteria Exclusion|0
3101284|NCT00279201|10628918|P5|Intensification Addendum|Entry Criteria Exclusion|0
3101285|NCT00279201|10628919|P4|Intensification Addendum|Entry Criteria Exclusion|0
3101286|NCT00279201|10628920|P3|Intensification Addendum|Entry Criteria Exclusion|1
3101287|NCT00279201|10628921|P2|Intensification Addendum|Entry Criteria Exclusion|0
3101288|NCT00279201|10628922|P1|Intensification Addendum|Entry Criteria Exclusion|0
3101289|NCT00279201|10628917|P6|Intensification Addendum|Sponsor Decision|1
3101290|NCT00279201|10628918|P5|Intensification Addendum|Sponsor Decision|1
3101291|NCT00279201|10628919|P4|Intensification Addendum|Sponsor Decision|0
3101292|NCT00279201|10628920|P3|Intensification Addendum|Sponsor Decision|0
3101293|NCT00279201|10628921|P2|Intensification Addendum|Sponsor Decision|0
3101294|NCT00279201|10628922|P1|Intensification Addendum|Sponsor Decision|0
3101295|NCT00279201|10628917|P6|Intensification Addendum|Physician Decision|2
3101296|NCT00279201|10628918|P5|Intensification Addendum|Physician Decision|3
3101297|NCT00279201|10628919|P4|Intensification Addendum|Physician Decision|1
3101298|NCT00279201|10628920|P3|Intensification Addendum|Physician Decision|4
3101299|NCT00279201|10628921|P2|Intensification Addendum|Physician Decision|0
3101300|NCT00279201|10628922|P1|Intensification Addendum|Physician Decision|0
3101301|NCT00279201|10628917|P6|Intensification Addendum|Adverse Event|3
3101302|NCT00279201|10628918|P5|Intensification Addendum|Adverse Event|1
3101303|NCT00279201|10628919|P4|Intensification Addendum|Adverse Event|4
3101304|NCT00279201|10628920|P3|Intensification Addendum|Adverse Event|0
3101305|NCT00279201|10628921|P2|Intensification Addendum|Adverse Event|0
3101306|NCT00279201|10628922|P1|Intensification Addendum|Adverse Event|0
3101307|NCT00279201|10628917|P6|Intensification Addendum|Protocol Violation|6
3101308|NCT00279201|10628918|P5|Intensification Addendum|Protocol Violation|6
3101309|NCT00279201|10628919|P4|Intensification Addendum|Protocol Violation|2
3101310|NCT00279201|10628920|P3|Intensification Addendum|Protocol Violation|2
3101311|NCT00279201|10628921|P2|Intensification Addendum|Protocol Violation|0
3101312|NCT00279201|10628922|P1|Intensification Addendum|Protocol Violation|0
3101313|NCT00279201|10628917|P6|Intensification Addendum|Lost to Follow-up|7
3101314|NCT00279201|10628918|P5|Intensification Addendum|Lost to Follow-up|7
3101315|NCT00279201|10628919|P4|Intensification Addendum|Lost to Follow-up|6
3101316|NCT00279201|10628920|P3|Intensification Addendum|Lost to Follow-up|4
3101317|NCT00279201|10628921|P2|Intensification Addendum|Lost to Follow-up|0
3101318|NCT00279201|10628922|P1|Intensification Addendum|Lost to Follow-up|0
3101319|NCT00279201|10628917|P6|Intensification Addendum|Withdrawal by Subject|18
3101320|NCT00279201|10628918|P5|Intensification Addendum|Withdrawal by Subject|9
3101321|NCT00279201|10628919|P4|Intensification Addendum|Withdrawal by Subject|14
3101322|NCT00279201|10628920|P3|Intensification Addendum|Withdrawal by Subject|12
3101323|NCT00279201|10628921|P2|Intensification Addendum|Withdrawal by Subject|0
3101324|NCT00279201|10628922|P1|Intensification Addendum|Withdrawal by Subject|0
3101325|NCT00279201|10628917|P6|Maintenance|HbA1c>7.5%|0
3101326|NCT00279201|10628918|P5|Maintenance|HbA1c>7.5%|0
3101327|NCT00279201|10628919|P4|Maintenance|HbA1c>7.5%|0
3101328|NCT00279201|10628920|P3|Maintenance|HbA1c>7.5%|0
3101329|NCT00279201|10628921|P2|Maintenance|HbA1c>7.5%|126
3101330|NCT00279201|10628922|P1|Maintenance|HbA1c>7.5%|123
3101331|NCT00279201|10628917|P6|Maintenance|Sponsor Decision|0
3101332|NCT00279201|10628918|P5|Maintenance|Sponsor Decision|0
3101333|NCT00279201|10628919|P4|Maintenance|Sponsor Decision|0
3101334|NCT00279201|10628920|P3|Maintenance|Sponsor Decision|0
3101335|NCT00279201|10628921|P2|Maintenance|Sponsor Decision|0
3101336|NCT00279201|10628922|P1|Maintenance|Sponsor Decision|4
3101337|NCT00279201|10628917|P6|Maintenance|Physician Decision|0
3101338|NCT00279201|10628918|P5|Maintenance|Physician Decision|0
3101339|NCT00279201|10628919|P4|Maintenance|Physician Decision|0
3101340|NCT00279201|10628920|P3|Maintenance|Physician Decision|0
3101341|NCT00279201|10628921|P2|Maintenance|Physician Decision|9
3101342|NCT00279201|10628922|P1|Maintenance|Physician Decision|9
3101343|NCT00279201|10628917|P6|Maintenance|Withdrawal by Subject|0
3101344|NCT00279201|10628918|P5|Maintenance|Withdrawal by Subject|0
3101345|NCT00279201|10628919|P4|Maintenance|Withdrawal by Subject|0
3101346|NCT00279201|10628920|P3|Maintenance|Withdrawal by Subject|0
3101347|NCT00279201|10628921|P2|Maintenance|Withdrawal by Subject|18
3101348|NCT00279201|10628922|P1|Maintenance|Withdrawal by Subject|18
3101349|NCT00279201|10628917|P6|Maintenance|Protocol Violation|0
3101350|NCT00279201|10628918|P5|Maintenance|Protocol Violation|0
3101351|NCT00279201|10628919|P4|Maintenance|Protocol Violation|0
3101352|NCT00279201|10628920|P3|Maintenance|Protocol Violation|0
3101353|NCT00279201|10628921|P2|Maintenance|Protocol Violation|24
3101354|NCT00279201|10628922|P1|Maintenance|Protocol Violation|16
3101355|NCT00279201|10628917|P6|Maintenance|Entry Criteria Exclusion|0
3101356|NCT00279201|10628918|P5|Maintenance|Entry Criteria Exclusion|0
3101357|NCT00279201|10628919|P4|Maintenance|Entry Criteria Exclusion|0
3101358|NCT00279201|10628920|P3|Maintenance|Entry Criteria Exclusion|0
3101359|NCT00279201|10628921|P2|Maintenance|Entry Criteria Exclusion|4
3101360|NCT00279201|10628922|P1|Maintenance|Entry Criteria Exclusion|1
3101361|NCT00279201|10628917|P6|Maintenance|Lost to Follow-up|0
3101362|NCT00279201|10628918|P5|Maintenance|Lost to Follow-up|0
3101363|NCT00279201|10628919|P4|Maintenance|Lost to Follow-up|0
3101364|NCT00279201|10628920|P3|Maintenance|Lost to Follow-up|0
3101365|NCT00279201|10628921|P2|Maintenance|Lost to Follow-up|13
3101366|NCT00279201|10628922|P1|Maintenance|Lost to Follow-up|17
3101367|NCT00279201|10628917|P6|Maintenance|Death|0
3101368|NCT00279201|10628918|P5|Maintenance|Death|0
3101369|NCT00279201|10628919|P4|Maintenance|Death|0
3101370|NCT00279201|10628920|P3|Maintenance|Death|0
3101371|NCT00279201|10628921|P2|Maintenance|Death|4
3101372|NCT00279201|10628922|P1|Maintenance|Death|4
3101373|NCT00279201|10628917|P6|Maintenance|Adverse Event|0
3101374|NCT00279201|10628918|P5|Maintenance|Adverse Event|0
3101375|NCT00279201|10628919|P4|Maintenance|Adverse Event|0
3101376|NCT00279201|10628920|P3|Maintenance|Adverse Event|0
3101377|NCT00279201|10628921|P2|Maintenance|Adverse Event|4
3101378|NCT00279201|10628922|P1|Maintenance|Adverse Event|4
3101379|NCT00279201|10628917|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
3101380|NCT00279201|10628918|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
3101381|NCT00279201|10628919|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
3101382|NCT00279201|10628920|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
3101383|NCT00279201|10628921|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
3101384|NCT00279201|10628922|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
3101385|NCT00279201|10628917|P6|Maintenance|Lack of Efficacy|0
3101386|NCT00279201|10628918|P5|Maintenance|Lack of Efficacy|0
3101387|NCT00279201|10628919|P4|Maintenance|Lack of Efficacy|0
3101388|NCT00279201|10628920|P3|Maintenance|Lack of Efficacy|0
3101389|NCT00279201|10628921|P2|Maintenance|Lack of Efficacy|30
3101390|NCT00279201|10628922|P1|Maintenance|Lack of Efficacy|32
3101391|NCT00279201|10628917|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
3101392|NCT00279201|10628918|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
3101393|NCT00279201|10628919|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
3101394|NCT00279201|10628920|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
3101395|NCT00279201|10628921|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
3101396|NCT00279201|10628922|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
3101397|NCT00279201|10628917|P6|Initiation|Sponsor Decision|0
3101398|NCT00279201|10628918|P5|Initiation|Sponsor Decision|0
3101399|NCT00279201|10628919|P4|Initiation|Sponsor Decision|0
3101400|NCT00279201|10628920|P3|Initiation|Sponsor Decision|0
3101401|NCT00279201|10628921|P2|Initiation|Sponsor Decision|5
3101402|NCT00279201|10628922|P1|Initiation|Sponsor Decision|13
3101403|NCT00279201|10628917|P6|Initiation|Physician Decision|0
3101404|NCT00279201|10628918|P5|Initiation|Physician Decision|0
3101405|NCT00279201|10628919|P4|Initiation|Physician Decision|0
3101406|NCT00279201|10628920|P3|Initiation|Physician Decision|0
3101407|NCT00279201|10628921|P2|Initiation|Physician Decision|18
3101408|NCT00279201|10628922|P1|Initiation|Physician Decision|15
3101409|NCT00279201|10628917|P6|Initiation|Withdrawal by Subject|0
3101410|NCT00279201|10628918|P5|Initiation|Withdrawal by Subject|0
3101411|NCT00279201|10628919|P4|Initiation|Withdrawal by Subject|0
3101412|NCT00279201|10628920|P3|Initiation|Withdrawal by Subject|0
3101413|NCT00279201|10628921|P2|Initiation|Withdrawal by Subject|41
3101414|NCT00279201|10628922|P1|Initiation|Withdrawal by Subject|35
3101415|NCT00279201|10628917|P6|Initiation|Protocol Violation|0
3101416|NCT00279201|10628918|P5|Initiation|Protocol Violation|0
3101417|NCT00279201|10628919|P4|Initiation|Protocol Violation|0
3101418|NCT00279201|10628920|P3|Initiation|Protocol Violation|0
3101419|NCT00279201|10628921|P2|Initiation|Protocol Violation|10
3101420|NCT00279201|10628922|P1|Initiation|Protocol Violation|9
3101421|NCT00279201|10628917|P6|Initiation|Entry Criteria Exclusion|0
3101422|NCT00279201|10628918|P5|Initiation|Entry Criteria Exclusion|0
3101423|NCT00279201|10628919|P4|Initiation|Entry Criteria Exclusion|0
3101424|NCT00279201|10628920|P3|Initiation|Entry Criteria Exclusion|0
3101425|NCT00279201|10628921|P2|Initiation|Entry Criteria Exclusion|9
3101426|NCT00279201|10628922|P1|Initiation|Entry Criteria Exclusion|7
3101427|NCT00279201|10628917|P6|Initiation|Lost to Follow-up|0
3101428|NCT00279201|10628918|P5|Initiation|Lost to Follow-up|0
3101429|NCT00279201|10628919|P4|Initiation|Lost to Follow-up|0
3101430|NCT00279201|10628920|P3|Initiation|Lost to Follow-up|0
3101431|NCT00279201|10628921|P2|Initiation|Lost to Follow-up|41
3101432|NCT00279201|10628922|P1|Initiation|Lost to Follow-up|42
3101433|NCT00279201|10628917|P6|Initiation|Adverse Event|0
3101434|NCT00279201|10628918|P5|Initiation|Adverse Event|0
3101435|NCT00279201|10628919|P4|Initiation|Adverse Event|0
3101436|NCT00279201|10628920|P3|Initiation|Adverse Event|0
3101437|NCT00279201|10628921|P2|Initiation|Adverse Event|15
3101438|NCT00279201|10628922|P1|Initiation|Adverse Event|6
3101439|NCT00279201|10628917|P6|Initiation|Death|0
3101440|NCT00279201|10628918|P5|Initiation|Death|0
3101441|NCT00279201|10628919|P4|Initiation|Death|0
3101442|NCT00279201|10628920|P3|Initiation|Death|0
3101443|NCT00279201|10628921|P2|Initiation|Death|5
3101444|NCT00279201|10628922|P1|Initiation|Death|1
3101445|NCT00278993|10629066|P1|Overall Study|Not Otherwise Specified|4
3101446|NCT00278993|10629066|P1|Overall Study|Physician Decision|9
3101447|NCT00278993|10629066|P1|Overall Study|Progressive Disease|65
3101448|NCT00278993|10629066|P1|Overall Study|Withdrawal by Subject|5
3101449|NCT00278993|10629066|P1|Overall Study|Adverse Event|24
3101450|NCT00278954|10629074|P1|Overall Study|Withdrawal by Subject|1
3101451|NCT00278954|10629074|P1|Overall Study|Lost to Follow-up|1
3101452|NCT00278954|10629074|P1|Overall Study|Adverse Event|3
3101453|NCT00278915|10629082|P1|Overall Study|Lack of Efficacy|1
3101454|NCT00278889|10629118|P3|Overall Study|Death|17
3101455|NCT00278889|10629119|P2|Overall Study|Death|21
3101456|NCT00278889|10629120|P1|Overall Study|Death|24
3101457|NCT00278889|10629118|P3|Overall Study|Lost to Follow-up|0
3101458|NCT00278889|10629119|P2|Overall Study|Lost to Follow-up|1
3101459|NCT00278889|10629120|P1|Overall Study|Lost to Follow-up|1
3101460|NCT00278889|10629118|P3|Overall Study|Withdrawal by Subject|3
3101461|NCT00278889|10629119|P2|Overall Study|Withdrawal by Subject|5
3101462|NCT00278889|10629120|P1|Overall Study|Withdrawal by Subject|0
3101463|NCT00278564|10629168|P1|Overall Study|Lack of Efficacy|4
3101464|NCT00278512|10629189|P2|Overall Study|Death|0
3101465|NCT00278512|10629190|P1|Overall Study|Death|1
3101466|NCT00278473|10629198|P2|Overall Study|drop out|3
3101467|NCT00278473|10629199|P1|Overall Study|drop out|4
3101468|NCT00278395|10629215|P1|Overall Study|Nonevaluable|1
3101469|NCT00278395|10629215|P1|Overall Study|Adverse Event|2
3101470|NCT00278200|10629233|P2|Overall Study|Physician Decision|1
3101471|NCT00278200|10629234|P1|Overall Study|Physician Decision|0
3101472|NCT00278200|10629233|P2|Overall Study|Death|3
3101473|NCT00278200|10629234|P1|Overall Study|Death|1
3101474|NCT00278161|10629243|P1|Overall Study|Death|11
3101475|NCT00278109|10629249|P1|Overall Study|social circumstances|1
3101476|NCT00278109|10629249|P1|Overall Study|Adverse Event|3
3101477|NCT00277355|10629295|P2|Overall Study|Physician Decision|0
3101478|NCT00277355|10629296|P1|Overall Study|Physician Decision|1
3101479|NCT00277355|10629295|P2|Overall Study|Death|0
3101480|NCT00277355|10629296|P1|Overall Study|Death|3
3101481|NCT00277355|10629295|P2|Overall Study|Adverse Event|0
3101482|NCT00277355|10629296|P1|Overall Study|Adverse Event|5
3101483|NCT00277355|10629295|P2|Overall Study|Lost to Follow-up|2
3101484|NCT00277355|10629296|P1|Overall Study|Lost to Follow-up|2
3101485|NCT00277355|10629295|P2|Overall Study|Withdrawal by Subject|3
3101486|NCT00277355|10629296|P1|Overall Study|Withdrawal by Subject|3
3101487|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
3101488|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
3101489|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
3101490|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
3101491|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
3101492|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
3101493|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
3101494|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
3101495|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
3101496|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
3101497|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
3101498|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
3101499|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
3101500|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
3101501|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
3101502|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
3101503|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
3101504|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
3101505|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
3101506|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
3101507|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
3101508|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
3101509|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
3101510|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
3101511|NCT00277212|10629304|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
3101512|NCT00277212|10629305|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
3101513|NCT00277212|10629306|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
3101514|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
3101515|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
3101516|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
3101517|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
3101518|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
3101519|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
3101520|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
3101521|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
3101522|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
3101523|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
3101524|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
3101525|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
3101526|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
3101527|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
3101528|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
3101529|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
3101530|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
3101531|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
3101532|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
3101533|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
3101534|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
3101535|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
3101536|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
3101537|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
3101538|NCT00277212|10629304|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
3101539|NCT00277212|10629305|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
3101540|NCT00277212|10629306|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
3101541|NCT00277095|10629344|P1|Overall Study|Physician Decision|1
3101542|NCT00277095|10629344|P1|Overall Study|Missed Follow-up|9
3101543|NCT00277095|10629344|P1|Overall Study|Lost to Follow-up|2
3101544|NCT00277095|10629344|P1|Overall Study|Explanted|7
3101545|NCT00277095|10629344|P1|Overall Study|Death|2
3101546|NCT00276744|10629353|P1|PART A|Reason unknown|98
3101547|NCT00276614|10629357|P1|Overall Study|Progression of disease under study|3
3101548|NCT00276484|10629368|P2|Overall Study|Could not take time off work|1
3101549|NCT00276484|10629369|P1|Overall Study|Could not take time off work|0
3101550|NCT00276484|10629368|P2|Overall Study|Withdrawal by Subject|3
3101551|NCT00276484|10629369|P1|Overall Study|Withdrawal by Subject|4
3101552|NCT00276484|10629368|P2|Overall Study|Protocol Violation|1
3101553|NCT00276484|10629369|P1|Overall Study|Protocol Violation|0
3101554|NCT00276484|10629368|P2|Overall Study|Lost to Follow-up|1
3101555|NCT00276484|10629369|P1|Overall Study|Lost to Follow-up|1
3101556|NCT00276484|10629368|P2|Overall Study|Adverse Event|7
3101557|NCT00276484|10629369|P1|Overall Study|Adverse Event|4
3101558|NCT00276458|10629401|P2|Overall Study|Protocol Violation|3
3101559|NCT00276458|10629402|P1|Overall Study|Protocol Violation|4
3101560|NCT00276458|10629401|P2|Overall Study|Lost to Follow-up|2
3101561|NCT00276458|10629402|P1|Overall Study|Lost to Follow-up|2
3101562|NCT00276458|10629401|P2|Overall Study|Adverse Event|2
3101563|NCT00276458|10629402|P1|Overall Study|Adverse Event|0
3101564|NCT00276419|10629436|P2|First Intervention|Withdrawal by Subject|2
3101565|NCT00276419|10629437|P1|First Intervention|Withdrawal by Subject|0
3101566|NCT00276419|10629436|P2|First Intervention|Adverse Event|0
3101567|NCT00276419|10629437|P1|First Intervention|Adverse Event|1
3101568|NCT00276380|10629480|P2|Overall Study|Abnormal aPPT Levels|1
3101569|NCT00276380|10629481|P1|Overall Study|Abnormal aPPT Levels|0
3101570|NCT00276380|10629480|P2|Overall Study|Death|3
3101571|NCT00276380|10629481|P1|Overall Study|Death|5
3101572|NCT00276380|10629480|P2|Overall Study|Withdrawal by Subject|6
3101573|NCT00276380|10629481|P1|Overall Study|Withdrawal by Subject|3
3101574|NCT00276380|10629480|P2|Overall Study|Lost to Follow-up|1
3101575|NCT00276380|10629481|P1|Overall Study|Lost to Follow-up|1
3101576|NCT00276380|10629480|P2|Overall Study|Adverse Event|3
3101577|NCT00276380|10629481|P1|Overall Study|Adverse Event|5
3101578|NCT00276159|10629536|P1|Overall Study|Did not receive all 24 doses of 852A|6
3101579|NCT00276094|10629546|P3|Overall Study|Other-Study medication lost|1
3101580|NCT00276094|10629547|P2|Overall Study|Other-Study medication lost|0
3101581|NCT00276094|10629548|P1|Overall Study|Other-Study medication lost|0
3101582|NCT00276094|10629546|P3|Overall Study|Other-Relocation|0
3101583|NCT00276094|10629547|P2|Overall Study|Other-Relocation|1
3101584|NCT00276094|10629548|P1|Overall Study|Other-Relocation|0
3101585|NCT00276094|10629546|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
3101586|NCT00276094|10629547|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
3101587|NCT00276094|10629548|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
3101588|NCT00276094|10629546|P3|Overall Study|Other-Refused follow-up visit|0
3101589|NCT00276094|10629547|P2|Overall Study|Other-Refused follow-up visit|0
3101590|NCT00276094|10629548|P1|Overall Study|Other-Refused follow-up visit|1
3101591|NCT00276094|10629546|P3|Overall Study|Other-Lack of efficacy|0
3101592|NCT00276094|10629547|P2|Overall Study|Other-Lack of efficacy|0
3101593|NCT00276094|10629548|P1|Overall Study|Other-Lack of efficacy|1
3101594|NCT00276094|10629546|P3|Overall Study|Other-Scheduled gastroplasty|0
3101595|NCT00276094|10629547|P2|Overall Study|Other-Scheduled gastroplasty|0
3101596|NCT00276094|10629548|P1|Overall Study|Other-Scheduled gastroplasty|1
3101597|NCT00276094|10629546|P3|Overall Study|Other-Subject moved out of country|0
3101598|NCT00276094|10629547|P2|Overall Study|Other-Subject moved out of country|0
3101599|NCT00276094|10629548|P1|Overall Study|Other-Subject moved out of country|1
3101600|NCT00276094|10629546|P3|Overall Study|Lost to Follow-up|4
3101601|NCT00276094|10629547|P2|Overall Study|Lost to Follow-up|6
3101602|NCT00276094|10629548|P1|Overall Study|Lost to Follow-up|8
3101603|NCT00276094|10629546|P3|Overall Study|Protocol Violation|10
3101604|NCT00276094|10629547|P2|Overall Study|Protocol Violation|7
3101605|NCT00276094|10629548|P1|Overall Study|Protocol Violation|16
3101606|NCT00276094|10629546|P3|Overall Study|Withdrawal by Subject|12
3101607|NCT00276094|10629547|P2|Overall Study|Withdrawal by Subject|14
3101608|NCT00276094|10629548|P1|Overall Study|Withdrawal by Subject|14
3101609|NCT00276094|10629546|P3|Overall Study|Adverse Event|11
3101610|NCT00276094|10629547|P2|Overall Study|Adverse Event|13
3101611|NCT00276094|10629548|P1|Overall Study|Adverse Event|15
3101612|NCT00276016|10629601|P6|Intervention 1|Withdrawal by Subject|0
3101613|NCT00276016|10629602|P5|Intervention 1|Withdrawal by Subject|0
3101614|NCT00276016|10629603|P4|Intervention 1|Withdrawal by Subject|0
3101615|NCT00276016|10629604|P3|Intervention 1|Withdrawal by Subject|0
3101616|NCT00276016|10629605|P2|Intervention 1|Withdrawal by Subject|1
3101617|NCT00276016|10629606|P1|Intervention 1|Withdrawal by Subject|0
3101618|NCT00275821|10629652|P3|Overall Study|Protocol Violation|0
3101619|NCT00275821|10629653|P2|Overall Study|Protocol Violation|1
3101620|NCT00275821|10629654|P1|Overall Study|Protocol Violation|5
3101621|NCT00275821|10629652|P3|Overall Study|Lack of Efficacy|0
3101622|NCT00275821|10629653|P2|Overall Study|Lack of Efficacy|1
3101623|NCT00275821|10629654|P1|Overall Study|Lack of Efficacy|2
3101624|NCT00275821|10629652|P3|Overall Study|Death|1
3101625|NCT00275821|10629653|P2|Overall Study|Death|2
3101626|NCT00275821|10629654|P1|Overall Study|Death|0
3101627|NCT00275821|10629652|P3|Overall Study|Lost to Follow-up|1
3101628|NCT00275821|10629653|P2|Overall Study|Lost to Follow-up|1
3101629|NCT00275821|10629654|P1|Overall Study|Lost to Follow-up|0
3101630|NCT00275821|10629652|P3|Overall Study|Withdrawal by Subject|1
3101631|NCT00275821|10629653|P2|Overall Study|Withdrawal by Subject|2
3101632|NCT00275821|10629654|P1|Overall Study|Withdrawal by Subject|0
3101633|NCT00275821|10629652|P3|Overall Study|Administrative problems|4
3101634|NCT00275821|10629653|P2|Overall Study|Administrative problems|4
3101635|NCT00275821|10629654|P1|Overall Study|Administrative problems|3
3101636|NCT00275821|10629652|P3|Overall Study|Adverse Event|5
3101637|NCT00275821|10629653|P2|Overall Study|Adverse Event|12
3101638|NCT00275821|10629654|P1|Overall Study|Adverse Event|4
3101639|NCT00275561|10629673|P2|Overall Study|Family Issues|2
3101640|NCT00275561|10629674|P1|Overall Study|Family Issues|0
3101641|NCT00275561|10629673|P2|Overall Study|Scheduling|2
3101642|NCT00275561|10629674|P1|Overall Study|Scheduling|1
3101643|NCT00275561|10629673|P2|Overall Study|Travel|1
3101644|NCT00275561|10629674|P1|Overall Study|Travel|1
3101645|NCT00275561|10629673|P2|Overall Study|Withdrawal by Subject|1
3101646|NCT00275561|10629674|P1|Overall Study|Withdrawal by Subject|0
3101647|NCT00275509|10629686|P2|Overall Study|graft thrombosis, post-operative day #8|1
3101648|NCT00275509|10629687|P1|Overall Study|graft thrombosis, post-operative day #8|0
3101649|NCT00275340|10629710|P2|Overall Study|Lost to Follow-up|4
3101650|NCT00275340|10629711|P1|Overall Study|Lost to Follow-up|2
3101651|NCT00275301|10629715|P1|Overall Study|Adverse Event|5
3101652|NCT00275262|10629734|P2|Overall Study|Started Chemotherapy|0
3101653|NCT00275262|10629735|P1|Overall Study|Started Chemotherapy|1
3101654|NCT00275262|10629734|P2|Overall Study|Death|0
3101655|NCT00275262|10629735|P1|Overall Study|Death|1
3101656|NCT00275262|10629734|P2|Overall Study|Protocol Violation|2
3101657|NCT00275262|10629735|P1|Overall Study|Protocol Violation|0
3101658|NCT00275262|10629734|P2|Overall Study|Lost to Follow-up|2
3101659|NCT00275262|10629735|P1|Overall Study|Lost to Follow-up|0
3101660|NCT00275262|10629734|P2|Overall Study|Disease progression|5
3101661|NCT00275262|10629735|P1|Overall Study|Disease progression|2
3101662|NCT00275262|10629734|P2|Overall Study|Adverse Event|0
3101663|NCT00275262|10629735|P1|Overall Study|Adverse Event|2
3101664|NCT00275028|10629749|P1|Overall Study|Physician Decision|2
3101665|NCT00275028|10629749|P1|Overall Study|Progressive Disease|30
3101666|NCT00275028|10629749|P1|Overall Study|Adverse Event|9
3101667|NCT00275028|10629749|P1|Overall Study|Withdrawal by Subject|5
3101668|NCT00275028|10629749|P1|Overall Study|Withdrew consent before treatment began|1
3101669|NCT00275002|10629756|P2|Overall Study|Adverse Event|1
3101670|NCT00275002|10629757|P1|Overall Study|Adverse Event|0
3101671|NCT00275002|10629756|P2|Overall Study|Disease progression|15
3101672|NCT00275002|10629757|P1|Overall Study|Disease progression|21
3101673|NCT00275002|10629756|P2|Overall Study|Death|0
3101674|NCT00275002|10629757|P1|Overall Study|Death|1
3101675|NCT00274937|10629765|P1|Overall Study|Progressive Disease|4
3101676|NCT00274937|10629765|P1|Overall Study|Withdrawal by Subject|6
3101677|NCT00274937|10629765|P1|Overall Study|Physician Decision|10
3101678|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
3101679|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
3101680|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
3101681|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
3101682|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
3101683|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
3101684|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
3101685|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
3101686|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
3101687|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
3101688|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
3101689|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
3101690|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
3101691|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
3101692|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
3101693|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
3101694|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
3101695|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
3101696|NCT00274924|10629777|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
3101697|NCT00274924|10629778|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
3101698|NCT00274924|10629779|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
3101699|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
3101700|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
3101701|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
3101702|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
3101703|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
3101704|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
3101705|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
3101706|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
3101707|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
3101708|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
3101709|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
3101710|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
3101711|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
3101712|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
3101713|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
3101714|NCT00274924|10629777|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
3101715|NCT00274924|10629778|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
3101716|NCT00274924|10629779|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
3101717|NCT00274846|10629788|P1|Overall Study|Did not receive adequate NK cells|1
3101718|NCT00274742|10629817|P6|Overall Study|Other|0
3101719|NCT00274742|10629818|P5|Overall Study|Other|2
3101720|NCT00274742|10629819|P4|Overall Study|Other|0
3101721|NCT00274742|10629820|P3|Overall Study|Other|0
3101722|NCT00274742|10629821|P2|Overall Study|Other|3
3101723|NCT00274742|10629822|P1|Overall Study|Other|0
3101724|NCT00274742|10629817|P6|Overall Study|Disease Progression|0
3101725|NCT00274742|10629818|P5|Overall Study|Disease Progression|1
3101726|NCT00274742|10629819|P4|Overall Study|Disease Progression|0
3101727|NCT00274742|10629820|P3|Overall Study|Disease Progression|1
3101728|NCT00274742|10629821|P2|Overall Study|Disease Progression|1
3101729|NCT00274742|10629822|P1|Overall Study|Disease Progression|0
3101730|NCT00274742|10629817|P6|Overall Study|End of Study|0
3101731|NCT00274742|10629818|P5|Overall Study|End of Study|0
3101732|NCT00274742|10629819|P4|Overall Study|End of Study|1
3101733|NCT00274742|10629820|P3|Overall Study|End of Study|0
3101734|NCT00274742|10629821|P2|Overall Study|End of Study|0
3101735|NCT00274742|10629822|P1|Overall Study|End of Study|0
3101736|NCT00274742|10629817|P6|Overall Study|Lost to Follow-up|0
3101737|NCT00274742|10629818|P5|Overall Study|Lost to Follow-up|1
3101738|NCT00274742|10629819|P4|Overall Study|Lost to Follow-up|0
3101739|NCT00274742|10629820|P3|Overall Study|Lost to Follow-up|0
3101740|NCT00274742|10629821|P2|Overall Study|Lost to Follow-up|0
3101741|NCT00274742|10629822|P1|Overall Study|Lost to Follow-up|0
3101742|NCT00274742|10629817|P6|Overall Study|Adverse Event|3
3101743|NCT00274742|10629818|P5|Overall Study|Adverse Event|12
3101744|NCT00274742|10629819|P4|Overall Study|Adverse Event|4
3101745|NCT00274742|10629820|P3|Overall Study|Adverse Event|1
3101746|NCT00274742|10629821|P2|Overall Study|Adverse Event|4
3101747|NCT00274742|10629822|P1|Overall Study|Adverse Event|0
3101748|NCT00274716|10629860|P6|Phase B|Lost to Follow-up|0
3101749|NCT00274716|10629861|P5|Phase B|Lost to Follow-up|0
3101750|NCT00274716|10629862|P4|Phase B|Lost to Follow-up|0
3101751|NCT00274716|10629863|P3|Phase B|Lost to Follow-up|0
3101752|NCT00274716|10629864|P2|Phase B|Lost to Follow-up|1
3101753|NCT00274716|10629865|P1|Phase B|Lost to Follow-up|0
3101754|NCT00274716|10629860|P6|Phase B|Other non-reported reason|0
3101755|NCT00274716|10629861|P5|Phase B|Other non-reported reason|0
3101756|NCT00274716|10629862|P4|Phase B|Other non-reported reason|1
3101757|NCT00274716|10629863|P3|Phase B|Other non-reported reason|1
3101758|NCT00274716|10629864|P2|Phase B|Other non-reported reason|0
3101759|NCT00274716|10629865|P1|Phase B|Other non-reported reason|0
3101760|NCT00274716|10629860|P6|Phase B|Participant moved|0
3101761|NCT00274716|10629861|P5|Phase B|Participant moved|0
3101762|NCT00274716|10629862|P4|Phase B|Participant moved|0
3101763|NCT00274716|10629863|P3|Phase B|Participant moved|0
3101764|NCT00274716|10629864|P2|Phase B|Participant moved|0
3101765|NCT00274716|10629865|P1|Phase B|Participant moved|1
3101766|NCT00274716|10629860|P6|Phase B|Withdrawal by Subject|0
3101767|NCT00274716|10629861|P5|Phase B|Withdrawal by Subject|0
3101768|NCT00274716|10629862|P4|Phase B|Withdrawal by Subject|0
3101769|NCT00274716|10629863|P3|Phase B|Withdrawal by Subject|0
3101770|NCT00274716|10629864|P2|Phase B|Withdrawal by Subject|1
3101771|NCT00274716|10629865|P1|Phase B|Withdrawal by Subject|0
3101772|NCT00274716|10629860|P6|Phase B|Protocol Violation|0
3101773|NCT00274716|10629861|P5|Phase B|Protocol Violation|0
3101774|NCT00274716|10629862|P4|Phase B|Protocol Violation|0
3101775|NCT00274716|10629863|P3|Phase B|Protocol Violation|0
3101776|NCT00274716|10629864|P2|Phase B|Protocol Violation|2
3101777|NCT00274716|10629865|P1|Phase B|Protocol Violation|0
3101778|NCT00274716|10629860|P6|Phase B|Adverse Event|1
3101779|NCT00274716|10629861|P5|Phase B|Adverse Event|0
3101780|NCT00274716|10629862|P4|Phase B|Adverse Event|0
3101781|NCT00274716|10629863|P3|Phase B|Adverse Event|2
3101782|NCT00274716|10629864|P2|Phase B|Adverse Event|0
3101783|NCT00274716|10629865|P1|Phase B|Adverse Event|0
3101784|NCT00274716|10629860|P6|Phase A|Completed but did not enter Phase B|1
3101785|NCT00274716|10629861|P5|Phase A|Completed but did not enter Phase B|1
3101786|NCT00274716|10629862|P4|Phase A|Completed but did not enter Phase B|2
3101787|NCT00274716|10629863|P3|Phase A|Completed but did not enter Phase B|2
3101788|NCT00274716|10629864|P2|Phase A|Completed but did not enter Phase B|2
3101789|NCT00274716|10629865|P1|Phase A|Completed but did not enter Phase B|1
3101790|NCT00274716|10629860|P6|Phase A|Adverse Event|0
3101791|NCT00274716|10629861|P5|Phase A|Adverse Event|2
3101792|NCT00274716|10629862|P4|Phase A|Adverse Event|0
3101793|NCT00274716|10629863|P3|Phase A|Adverse Event|3
3101794|NCT00274716|10629864|P2|Phase A|Adverse Event|3
3101795|NCT00274716|10629865|P1|Phase A|Adverse Event|2
3101796|NCT00274716|10629860|P6|Phase A|Withdrawal by Subject|1
3101797|NCT00274716|10629861|P5|Phase A|Withdrawal by Subject|0
3101798|NCT00274716|10629862|P4|Phase A|Withdrawal by Subject|3
3101799|NCT00274716|10629863|P3|Phase A|Withdrawal by Subject|1
3101800|NCT00274716|10629864|P2|Phase A|Withdrawal by Subject|2
3101801|NCT00274716|10629865|P1|Phase A|Withdrawal by Subject|2
3101802|NCT00274716|10629860|P6|Phase A|Met criteria for discontinuation|0
3101803|NCT00274716|10629861|P5|Phase A|Met criteria for discontinuation|0
3101804|NCT00274716|10629862|P4|Phase A|Met criteria for discontinuation|0
3101805|NCT00274716|10629863|P3|Phase A|Met criteria for discontinuation|0
3101806|NCT00274716|10629864|P2|Phase A|Met criteria for discontinuation|1
3101807|NCT00274716|10629865|P1|Phase A|Met criteria for discontinuation|1
3101808|NCT00274716|10629860|P6|Phase A|Protocol Violation|0
3101809|NCT00274716|10629861|P5|Phase A|Protocol Violation|0
3101810|NCT00274716|10629862|P4|Phase A|Protocol Violation|1
3101811|NCT00274716|10629863|P3|Phase A|Protocol Violation|0
3101812|NCT00274716|10629864|P2|Phase A|Protocol Violation|0
3101813|NCT00274716|10629865|P1|Phase A|Protocol Violation|1
3101814|NCT00274716|10629860|P6|Phase A|Site Terminated|0
3101815|NCT00274716|10629861|P5|Phase A|Site Terminated|0
3101816|NCT00274716|10629862|P4|Phase A|Site Terminated|1
3101817|NCT00274716|10629863|P3|Phase A|Site Terminated|0
3101818|NCT00274716|10629864|P2|Phase A|Site Terminated|0
3101819|NCT00274716|10629865|P1|Phase A|Site Terminated|0
3101820|NCT00274716|10629860|P6|Phase A|Participant moved|1
3101821|NCT00274716|10629861|P5|Phase A|Participant moved|0
3101822|NCT00274716|10629862|P4|Phase A|Participant moved|0
3101823|NCT00274716|10629863|P3|Phase A|Participant moved|1
3101824|NCT00274716|10629864|P2|Phase A|Participant moved|0
3101825|NCT00274716|10629865|P1|Phase A|Participant moved|0
3101826|NCT00274716|10629860|P6|Phase A|Other non-reported reason|1
3101827|NCT00274716|10629861|P5|Phase A|Other non-reported reason|0
3101828|NCT00274716|10629862|P4|Phase A|Other non-reported reason|2
3101829|NCT00274716|10629863|P3|Phase A|Other non-reported reason|1
3101830|NCT00274716|10629864|P2|Phase A|Other non-reported reason|2
3101831|NCT00274716|10629865|P1|Phase A|Other non-reported reason|4
3101832|NCT00274651|10629927|P2|Overall Study|Physician Decision|7
3101833|NCT00274651|10629928|P1|Overall Study|Physician Decision|8
3101834|NCT00274651|10629927|P2|Overall Study|Withdrawal by Subject|1
3101835|NCT00274651|10629928|P1|Overall Study|Withdrawal by Subject|0
3101836|NCT00274651|10629927|P2|Overall Study|Death|3
3101837|NCT00274651|10629928|P1|Overall Study|Death|1
3101838|NCT00274651|10629927|P2|Overall Study|Lack of Efficacy|6
3101839|NCT00274651|10629928|P1|Overall Study|Lack of Efficacy|13
3101840|NCT00274651|10629927|P2|Overall Study|Adverse Event|3
3101841|NCT00274651|10629928|P1|Overall Study|Adverse Event|6
3101842|NCT00274625|10629943|P2|Overall Study|Excluded from analysis|8
3101843|NCT00274625|10629944|P1|Overall Study|Excluded from analysis|14
3101844|NCT00274625|10629943|P2|Overall Study|Lost to Follow-up|54
3101845|NCT00274625|10629944|P1|Overall Study|Lost to Follow-up|46
3101846|NCT00274469|10629952|P2|Overall Study|Did not consent to OS follow-up|19
3101847|NCT00274469|10629953|P1|Overall Study|Did not consent to OS follow-up|16
3101848|NCT00274469|10629952|P2|Overall Study|Death|74
3101849|NCT00274469|10629953|P1|Overall Study|Death|63
3101850|NCT00274456|10629973|P4|Overall Study|Withdrawal by Subject|13
3101851|NCT00274456|10629974|P3|Overall Study|Withdrawal by Subject|9
3101852|NCT00274456|10629975|P2|Overall Study|Withdrawal by Subject|13
3101853|NCT00274456|10629976|P1|Overall Study|Withdrawal by Subject|18
3101854|NCT00274456|10629973|P4|Overall Study|Lost to Follow-up|0
3101855|NCT00274456|10629974|P3|Overall Study|Lost to Follow-up|1
3101856|NCT00274456|10629975|P2|Overall Study|Lost to Follow-up|0
3101857|NCT00274456|10629976|P1|Overall Study|Lost to Follow-up|0
3101858|NCT00274456|10629973|P4|Overall Study|Physician Decision|13
3101859|NCT00274456|10629974|P3|Overall Study|Physician Decision|6
3101860|NCT00274456|10629975|P2|Overall Study|Physician Decision|5
3101861|NCT00274456|10629976|P1|Overall Study|Physician Decision|7
3101862|NCT00274456|10629973|P4|Overall Study|Adverse Event|2
3101863|NCT00274456|10629974|P3|Overall Study|Adverse Event|2
3101864|NCT00274456|10629975|P2|Overall Study|Adverse Event|1
3101865|NCT00274456|10629976|P1|Overall Study|Adverse Event|0
3101866|NCT00274456|10629973|P4|Overall Study|Unacceptable toxicity|16
3101867|NCT00274456|10629974|P3|Overall Study|Unacceptable toxicity|12
3101868|NCT00274456|10629975|P2|Overall Study|Unacceptable toxicity|5
3101869|NCT00274456|10629976|P1|Overall Study|Unacceptable toxicity|10
3101870|NCT00274456|10629973|P4|Overall Study|Still on treatment|1
3101871|NCT00274456|10629974|P3|Overall Study|Still on treatment|5
3101872|NCT00274456|10629975|P2|Overall Study|Still on treatment|3
3101873|NCT00274456|10629976|P1|Overall Study|Still on treatment|2
3101874|NCT00274287|10630018|P1|Overall Study|subject non-compliance|1
3101875|NCT00274287|10630018|P1|Overall Study|Withdrawal by Subject|1
3101876|NCT00274261|10630028|P2|Overall Study|Lost to Follow-up|75
3101877|NCT00274261|10630029|P1|Overall Study|Lost to Follow-up|106
3101878|NCT00274261|10630028|P2|Overall Study|Protocol Violation|42
3101879|NCT00274261|10630029|P1|Overall Study|Protocol Violation|71
3101880|NCT00274261|10630028|P2|Overall Study|Withdrawal by Subject|126
3101881|NCT00274261|10630029|P1|Overall Study|Withdrawal by Subject|179
3101882|NCT00274261|10630028|P2|Overall Study|Pregnancy|83
3101883|NCT00274261|10630029|P1|Overall Study|Pregnancy|114
3101884|NCT00274261|10630028|P2|Overall Study|Adverse Event|11
3101885|NCT00274261|10630029|P1|Overall Study|Adverse Event|19
3101886|NCT00273858|10630068|P1|Overall Study|Adverse Event|81
3101887|NCT00273858|10630068|P1|Overall Study|Withdrawal by Subject|21
3101888|NCT00273858|10630068|P1|Overall Study|Lost to Follow-up|101
3101889|NCT00273858|10630068|P1|Overall Study|Not completed 24 month observation time|334
3101890|NCT00273182|10630127|P1|Overall Study|Site exit, system change, 36 m FU missed|36
3101891|NCT00273182|10630127|P1|Overall Study|Device/System Explant|154
3101892|NCT00273182|10630127|P1|Overall Study|Withdrawal by Subject|257
3101893|NCT00273182|10630127|P1|Overall Study|Lost to Follow-up|88
3101894|NCT00273182|10630127|P1|Overall Study|Death|450
3101895|NCT00273052|10630137|P2|Overall Study|Worsening serum lipid levels|2
3101896|NCT00273052|10630138|P1|Overall Study|Worsening serum lipid levels|0
3101897|NCT00273052|10630137|P2|Overall Study|Other|0
3101898|NCT00273052|10630138|P1|Overall Study|Other|2
3101899|NCT00273052|10630137|P2|Overall Study|Non-Compliance|1
3101900|NCT00273052|10630138|P1|Overall Study|Non-Compliance|3
3101901|NCT00273052|10630137|P2|Overall Study|Lack of Efficacy|4
3101902|NCT00273052|10630138|P1|Overall Study|Lack of Efficacy|6
3101903|NCT00273052|10630137|P2|Overall Study|Lost to Follow-up|25
3101904|NCT00273052|10630138|P1|Overall Study|Lost to Follow-up|7
3101905|NCT00273052|10630137|P2|Overall Study|Protocol Violation|18
3101906|NCT00273052|10630138|P1|Overall Study|Protocol Violation|14
3101907|NCT00273052|10630137|P2|Overall Study|Adverse Event|19
3101908|NCT00273052|10630138|P1|Overall Study|Adverse Event|21
3101909|NCT00273052|10630137|P2|Overall Study|Withdrawal by Subject|19
3101910|NCT00273052|10630138|P1|Overall Study|Withdrawal by Subject|16
3101911|NCT00272987|10630173|P3|Overall Study|Ongoing|15
3101912|NCT00272987|10630174|P2|Overall Study|Ongoing|14
3101913|NCT00272987|10630175|P1|Overall Study|Ongoing|20
3101914|NCT00272987|10630173|P3|Overall Study|Missed >3 Visits|1
3101915|NCT00272987|10630174|P2|Overall Study|Missed >3 Visits|0
3101916|NCT00272987|10630175|P1|Overall Study|Missed >3 Visits|0
3101917|NCT00272987|10630173|P3|Overall Study|Withdrawal by Subject|3
3101918|NCT00272987|10630174|P2|Overall Study|Withdrawal by Subject|0
3101919|NCT00272987|10630175|P1|Overall Study|Withdrawal by Subject|0
3101920|NCT00272987|10630173|P3|Overall Study|Adverse Event|0
3101921|NCT00272987|10630174|P2|Overall Study|Adverse Event|0
3101922|NCT00272987|10630175|P1|Overall Study|Adverse Event|1
3101923|NCT00272961|10630239|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
3101924|NCT00272961|10630240|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
3101925|NCT00272961|10630241|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
3101926|NCT00272961|10630242|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
3101927|NCT00272961|10630243|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
3101928|NCT00272961|10630239|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
3101929|NCT00272961|10630240|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
3101930|NCT00272961|10630241|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
3101931|NCT00272961|10630242|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
3101932|NCT00272961|10630243|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
3101933|NCT00272961|10630239|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
3101934|NCT00272961|10630240|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
3101935|NCT00272961|10630241|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
3101936|NCT00272961|10630242|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
3101937|NCT00272961|10630243|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
3101938|NCT00272961|10630239|P5|Placebo Run-in Phase: Up to Week 2|Other|0
3101939|NCT00272961|10630240|P4|Placebo Run-in Phase: Up to Week 2|Other|0
3101940|NCT00272961|10630241|P3|Placebo Run-in Phase: Up to Week 2|Other|0
3101941|NCT00272961|10630242|P2|Placebo Run-in Phase: Up to Week 2|Other|0
3101942|NCT00272961|10630243|P1|Placebo Run-in Phase: Up to Week 2|Other|2
3101943|NCT00272961|10630239|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
3101944|NCT00272961|10630240|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
3101945|NCT00272961|10630241|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
3101946|NCT00272961|10630242|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
3101947|NCT00272961|10630243|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
3101948|NCT00272961|10630239|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
3101949|NCT00272961|10630240|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
3101950|NCT00272961|10630241|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
3101951|NCT00272961|10630242|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
3101952|NCT00272961|10630243|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
3101953|NCT00272961|10630239|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
3101954|NCT00272961|10630240|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
3101955|NCT00272961|10630241|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
3101956|NCT00272961|10630242|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
3101957|NCT00272961|10630243|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
3101958|NCT00272961|10630239|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
3101959|NCT00272961|10630240|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
3101960|NCT00272961|10630241|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
3101961|NCT00272961|10630242|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
3101962|NCT00272961|10630243|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
3101963|NCT00272844|10630300|P1|Overall Study|Withdrawal by Subject|5
3101964|NCT00272792|10630308|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
3101965|NCT00272792|10630309|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
3101966|NCT00272792|10630308|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
3101967|NCT00272792|10630309|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
3101968|NCT00272792|10630308|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
3101969|NCT00272792|10630309|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
3101970|NCT00272792|10630308|P2|Part 1: Responsiveness|Lost to Follow-up|0
3101971|NCT00272792|10630309|P1|Part 1: Responsiveness|Lost to Follow-up|1
3101972|NCT00272779|10630319|P2|Baseline Through Week 96|Continuing on treatment|38
3101973|NCT00272779|10630320|P1|Baseline Through Week 96|Continuing on treatment|61
3101974|NCT00272779|10630319|P2|Baseline Through Week 96|Never treated|3
3101975|NCT00272779|10630320|P1|Baseline Through Week 96|Never treated|2
3101976|NCT00272779|10630319|P2|Baseline Through Week 96|Pregnancy at Week 96|0
3101977|NCT00272779|10630320|P1|Baseline Through Week 96|Pregnancy at Week 96|1
3101978|NCT00272779|10630319|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
3101979|NCT00272779|10630320|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
3101980|NCT00272779|10630319|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
3101981|NCT00272779|10630320|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
3101982|NCT00272779|10630319|P2|Baseline Through Week 96|Changed address before Week 96|1
3101983|NCT00272779|10630320|P1|Baseline Through Week 96|Changed address before Week 96|0
3101984|NCT00272779|10630319|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
3101985|NCT00272779|10630320|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
3101986|NCT00272779|10630319|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
3101987|NCT00272779|10630320|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
3101988|NCT00272779|10630319|P2|Baseline Through Week 96|Pregnancy before Week 96|7
3101989|NCT00272779|10630320|P1|Baseline Through Week 96|Pregnancy before Week 96|5
3101990|NCT00272779|10630319|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
3101991|NCT00272779|10630320|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
3101992|NCT00272779|10630319|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
3101993|NCT00272779|10630320|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
3101994|NCT00272779|10630319|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
3101995|NCT00272779|10630320|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
3101996|NCT00272779|10630319|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
3101997|NCT00272779|10630320|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
3101998|NCT00272779|10630319|P2|Baseline Through Week 96|Death before Week 96|5
3101999|NCT00272779|10630320|P1|Baseline Through Week 96|Death before Week 96|6
3102000|NCT00272779|10630319|P2|Baseline Through Week 96|Adverse event before Week 96|22
3102001|NCT00272779|10630320|P1|Baseline Through Week 96|Adverse event before Week 96|13
3102002|NCT00272779|10630319|P2|Baseline Through Week 48|Never treated|3
3102003|NCT00272779|10630320|P1|Baseline Through Week 48|Never treated|2
3102004|NCT00272779|10630319|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
3102005|NCT00272779|10630320|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
3102006|NCT00272779|10630319|P2|Baseline Through Week 48|Continuing treatment|368
3102007|NCT00272779|10630320|P1|Baseline Through Week 48|Continuing treatment|385
3102008|NCT00272779|10630319|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
3102009|NCT00272779|10630320|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
3102010|NCT00272779|10630319|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
3102011|NCT00272779|10630320|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
3102012|NCT00272779|10630319|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
3102013|NCT00272779|10630320|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
3102014|NCT00272779|10630319|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
3102015|NCT00272779|10630320|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
3102016|NCT00272779|10630319|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
3102017|NCT00272779|10630320|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
3102018|NCT00272779|10630319|P2|Baseline Through Week 48|Death on/after Week 48|1
3102019|NCT00272779|10630320|P1|Baseline Through Week 48|Death on/after Week 48|1
3102020|NCT00272779|10630319|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
3102021|NCT00272779|10630320|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
3102022|NCT00272779|10630319|P2|Baseline Through Week 48|Chose different site before wk 48|1
3102023|NCT00272779|10630320|P1|Baseline Through Week 48|Chose different site before wk 48|0
3102024|NCT00272779|10630319|P2|Baseline Through Week 48|Participant's decision before wk 48|1
3102025|NCT00272779|10630320|P1|Baseline Through Week 48|Participant's decision before wk 48|0
3102026|NCT00272779|10630319|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
3102027|NCT00272779|10630320|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
3102028|NCT00272779|10630319|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
3102029|NCT00272779|10630320|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
3102030|NCT00272779|10630319|P2|Baseline Through Week 48|Pregnancy before Week 48|2
3102031|NCT00272779|10630320|P1|Baseline Through Week 48|Pregnancy before Week 48|2
3102032|NCT00272779|10630319|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
3102033|NCT00272779|10630320|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
3102034|NCT00272779|10630319|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
3102035|NCT00272779|10630320|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
3102036|NCT00272779|10630319|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
3102037|NCT00272779|10630320|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
3102038|NCT00272779|10630319|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
3102039|NCT00272779|10630320|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
3102040|NCT00272779|10630319|P2|Baseline Through Week 48|Death before Week 48|4
3102041|NCT00272779|10630320|P1|Baseline Through Week 48|Death before Week 48|4
3102042|NCT00272779|10630319|P2|Baseline Through Week 48|Adverse event before Week 48|14
3102043|NCT00272779|10630320|P1|Baseline Through Week 48|Adverse event before Week 48|10
3102044|NCT00272038|10630580|P1|Overall Study|withdrew before they received 2 cycles|7
3102045|NCT00271947|10630586|P1|Overall Study|Lost to Follow-up|1
3102046|NCT00271856|10630592|P2|Overall Study|Lost to Follow-up|11
3102047|NCT00271856|10630593|P1|Overall Study|Lost to Follow-up|10
3102048|NCT00271856|10630592|P2|Overall Study|Withdrawal by Subject|7
3102049|NCT00271856|10630593|P1|Overall Study|Withdrawal by Subject|1
3102050|NCT00271817|10630612|P3|Part 2|LDL < 50 mg/dL|4
3102051|NCT00271817|10630613|P2|Part 2|LDL < 50 mg/dL|3
3102052|NCT00271817|10630614|P1|Part 2|LDL < 50 mg/dL|0
3102053|NCT00271817|10630612|P3|Part 2|Withdrawal by Subject|13
3102054|NCT00271817|10630613|P2|Part 2|Withdrawal by Subject|2
3102055|NCT00271817|10630614|P1|Part 2|Withdrawal by Subject|0
3102056|NCT00271817|10630612|P3|Part 2|Patient Moved|5
3102057|NCT00271817|10630613|P2|Part 2|Patient Moved|0
3102058|NCT00271817|10630614|P1|Part 2|Patient Moved|0
3102059|NCT00271817|10630612|P3|Part 2|Protocol Violation|5
3102060|NCT00271817|10630613|P2|Part 2|Protocol Violation|3
3102061|NCT00271817|10630614|P1|Part 2|Protocol Violation|0
3102062|NCT00271817|10630612|P3|Part 2|Lost to Follow-up|18
3102063|NCT00271817|10630613|P2|Part 2|Lost to Follow-up|6
3102064|NCT00271817|10630614|P1|Part 2|Lost to Follow-up|0
3102065|NCT00271817|10630612|P3|Part 2|Lack of Efficacy|6
3102066|NCT00271817|10630613|P2|Part 2|Lack of Efficacy|1
3102067|NCT00271817|10630614|P1|Part 2|Lack of Efficacy|0
3102068|NCT00271817|10630612|P3|Part 2|Adverse Event|33
3102069|NCT00271817|10630613|P2|Part 2|Adverse Event|17
3102070|NCT00271817|10630614|P1|Part 2|Adverse Event|0
3102071|NCT00271817|10630612|P3|Part 1|LDL < 50 mg/dL|48
3102072|NCT00271817|10630613|P2|Part 1|LDL < 50 mg/dL|4
3102073|NCT00271817|10630614|P1|Part 1|LDL < 50 mg/dL|1
3102074|NCT00271817|10630612|P3|Part 1|Withdrawal by Subject|45
3102075|NCT00271817|10630613|P2|Part 1|Withdrawal by Subject|17
3102076|NCT00271817|10630614|P1|Part 1|Withdrawal by Subject|23
3102077|NCT00271817|10630612|P3|Part 1|Patient Moved|5
3102078|NCT00271817|10630613|P2|Part 1|Patient Moved|1
3102079|NCT00271817|10630614|P1|Part 1|Patient Moved|3
3102080|NCT00271817|10630612|P3|Part 1|Protocol Violation|7
3102081|NCT00271817|10630613|P2|Part 1|Protocol Violation|4
3102082|NCT00271817|10630614|P1|Part 1|Protocol Violation|5
3102083|NCT00271817|10630612|P3|Part 1|Lost to Follow-up|24
3102084|NCT00271817|10630613|P2|Part 1|Lost to Follow-up|8
3102085|NCT00271817|10630614|P1|Part 1|Lost to Follow-up|6
3102086|NCT00271817|10630612|P3|Part 1|Adverse Event|156
3102087|NCT00271817|10630613|P2|Part 1|Adverse Event|25
3102088|NCT00271817|10630614|P1|Part 1|Adverse Event|68
3102089|NCT00271609|10630656|P2|Overall Study|Withdrawal by Subject|0
3102090|NCT00271609|10630657|P1|Overall Study|Withdrawal by Subject|2
3102091|NCT00271609|10630656|P2|Overall Study|Adverse Event|3
3102092|NCT00271609|10630657|P1|Overall Study|Adverse Event|11
3102093|NCT00271596|10630667|P2|Overall Study|Withdrawal by Subject|1
3102094|NCT00271596|10630668|P1|Overall Study|Withdrawal by Subject|0
3102095|NCT00271596|10630667|P2|Overall Study|Protocol Violation|0
3102096|NCT00271596|10630668|P1|Overall Study|Protocol Violation|1
3102097|NCT00271544|10630703|P1|Overall Study|Implant not attempted|4
3102098|NCT00271544|10630703|P1|Overall Study|Model 4196 lead not attempted|9
3102099|NCT00271544|10630703|P1|Overall Study|Subjects did not receive a 4196 lead|7
3102100|NCT00271505|10630724|P1|Overall Study|Death|1
3102101|NCT00271505|10630724|P1|Overall Study|Adverse Event|1
3102102|NCT00271505|10630724|P1|Overall Study|Screen Failure|3
3102103|NCT00271024|10630823|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
3102104|NCT00271024|10630824|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
3102105|NCT00271024|10630825|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
3102106|NCT00271024|10630826|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
3102107|NCT00271024|10630823|P4|Overall Study|Unpleasant Reaction To Tablet|2
3102108|NCT00271024|10630824|P3|Overall Study|Unpleasant Reaction To Tablet|4
3102109|NCT00271024|10630825|P2|Overall Study|Unpleasant Reaction To Tablet|3
3102110|NCT00271024|10630826|P1|Overall Study|Unpleasant Reaction To Tablet|1
3102111|NCT00271024|10630823|P4|Overall Study|Protocol Violation|11
3102112|NCT00271024|10630824|P3|Overall Study|Protocol Violation|5
3102113|NCT00271024|10630825|P2|Overall Study|Protocol Violation|6
3102114|NCT00271024|10630826|P1|Overall Study|Protocol Violation|1
3102115|NCT00271024|10630823|P4|Overall Study|Unknown/Unspecified|4
3102116|NCT00271024|10630824|P3|Overall Study|Unknown/Unspecified|8
3102117|NCT00271024|10630825|P2|Overall Study|Unknown/Unspecified|11
3102118|NCT00271024|10630826|P1|Overall Study|Unknown/Unspecified|11
3102119|NCT00271024|10630823|P4|Overall Study|Lost Interest|3
3102120|NCT00271024|10630824|P3|Overall Study|Lost Interest|2
3102121|NCT00271024|10630825|P2|Overall Study|Lost Interest|4
3102122|NCT00271024|10630826|P1|Overall Study|Lost Interest|3
3102123|NCT00270998|10630876|P3|12 Month Follow-up|Received/desired alternate treatment|1
3102124|NCT00270998|10630877|P2|12 Month Follow-up|Received/desired alternate treatment|4
3102125|NCT00270998|10630878|P1|12 Month Follow-up|Received/desired alternate treatment|1
3102126|NCT00270998|10630876|P3|12 Month Follow-up|Personal/family health|1
3102127|NCT00270998|10630877|P2|12 Month Follow-up|Personal/family health|5
3102128|NCT00270998|10630878|P1|12 Month Follow-up|Personal/family health|0
3102129|NCT00270998|10630876|P3|12 Month Follow-up|Pessary did not fit|0
3102130|NCT00270998|10630877|P2|12 Month Follow-up|Pessary did not fit|0
3102131|NCT00270998|10630878|P1|12 Month Follow-up|Pessary did not fit|1
3102132|NCT00270998|10630876|P3|12 Month Follow-up|Withdrawal by Subject|16
3102133|NCT00270998|10630877|P2|12 Month Follow-up|Withdrawal by Subject|12
3102134|NCT00270998|10630878|P1|12 Month Follow-up|Withdrawal by Subject|7
3102135|NCT00270998|10630876|P3|12 Month Follow-up|Lack of Efficacy|3
3102136|NCT00270998|10630877|P2|12 Month Follow-up|Lack of Efficacy|4
3102137|NCT00270998|10630878|P1|12 Month Follow-up|Lack of Efficacy|5
3102138|NCT00270998|10630876|P3|3 Month Follow-up|Received/desired alternate treatment|2
3102139|NCT00270998|10630877|P2|3 Month Follow-up|Received/desired alternate treatment|5
3102140|NCT00270998|10630878|P1|3 Month Follow-up|Received/desired alternate treatment|13
3102141|NCT00270998|10630876|P3|3 Month Follow-up|Personal/family health|0
3102142|NCT00270998|10630877|P2|3 Month Follow-up|Personal/family health|1
3102143|NCT00270998|10630878|P1|3 Month Follow-up|Personal/family health|1
3102144|NCT00270998|10630876|P3|3 Month Follow-up|Pessary did not fit|0
3102145|NCT00270998|10630877|P2|3 Month Follow-up|Pessary did not fit|0
3102146|NCT00270998|10630878|P1|3 Month Follow-up|Pessary did not fit|12
3102147|NCT00270998|10630876|P3|3 Month Follow-up|Withdrawal by Subject|15
3102148|NCT00270998|10630877|P2|3 Month Follow-up|Withdrawal by Subject|14
3102149|NCT00270998|10630878|P1|3 Month Follow-up|Withdrawal by Subject|11
3102150|NCT00270998|10630876|P3|3 Month Follow-up|Lack of Efficacy|1
3102151|NCT00270998|10630877|P2|3 Month Follow-up|Lack of Efficacy|2
3102152|NCT00270998|10630878|P1|3 Month Follow-up|Lack of Efficacy|1
3102153|NCT00270998|10630876|P3|3 Month Follow-up|Adverse Event|0
3102154|NCT00270998|10630877|P2|3 Month Follow-up|Adverse Event|0
3102155|NCT00270998|10630878|P1|3 Month Follow-up|Adverse Event|1
3102156|NCT00270894|10630907|P1|Overall Study|Withdrawal by Subject|1
3102157|NCT00270894|10630907|P1|Overall Study|Adverse Event|1
3102158|NCT00270855|10630919|P2|Overall Study|Withdrawal by Subject|8
3102159|NCT00270855|10630920|P1|Overall Study|Withdrawal by Subject|8
3102160|NCT00270257|10631056|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
3102161|NCT00270257|10631057|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
3102162|NCT00270231|10631075|P2|Second Intervention|Lost to Follow-up|1
3102163|NCT00270231|10631076|P1|Second Intervention|Lost to Follow-up|0
3102164|NCT00270231|10631075|P2|Washout Period|Lost to Follow-up|0
3102165|NCT00270231|10631076|P1|Washout Period|Lost to Follow-up|1
3102166|NCT00270231|10631075|P2|First Intervention|Lost to Follow-up|1
3102167|NCT00270231|10631076|P1|First Intervention|Lost to Follow-up|1
3102168|NCT00270205|10631086|P4|Overall Study|Lost to Follow-up|1
3102169|NCT00270205|10631087|P3|Overall Study|Lost to Follow-up|0
3102170|NCT00270205|10631088|P2|Overall Study|Lost to Follow-up|0
3102171|NCT00270205|10631089|P1|Overall Study|Lost to Follow-up|1
3102172|NCT00269919|10631207|P1|Overall Study|Started but not treated|1
3102173|NCT00269919|10631207|P1|Overall Study|Other|26
3102174|NCT00269633|10631226|P2|Overall Study|Withdrawal by Subject|0
3102175|NCT00269633|10631227|P1|Overall Study|Withdrawal by Subject|1
3102176|NCT00269477|10631237|P4|Overall Study|Missed post-vaccination blood draw|0
3102177|NCT00269477|10631238|P3|Overall Study|Missed post-vaccination blood draw|0
3102178|NCT00269477|10631239|P2|Overall Study|Missed post-vaccination blood draw|1
3102179|NCT00269477|10631240|P1|Overall Study|Missed post-vaccination blood draw|0
3102180|NCT00269477|10631237|P4|Overall Study|Protocol Violation|0
3102181|NCT00269477|10631238|P3|Overall Study|Protocol Violation|1
3102182|NCT00269477|10631239|P2|Overall Study|Protocol Violation|5
3102183|NCT00269477|10631240|P1|Overall Study|Protocol Violation|5
3102184|NCT00269399|10631256|P2|Overall Study|Development of exclusion criteria|1
3102185|NCT00269399|10631257|P1|Overall Study|Development of exclusion criteria|0
3102186|NCT00269399|10631256|P2|Overall Study|Other|4
3102187|NCT00269399|10631257|P1|Overall Study|Other|0
3102188|NCT00269399|10631256|P2|Overall Study|Negative Lab Result for C. difficile|3
3102189|NCT00269399|10631257|P1|Overall Study|Negative Lab Result for C. difficile|2
3102190|NCT00269399|10631256|P2|Overall Study|Withdrawal by Subject|5
3102191|NCT00269399|10631257|P1|Overall Study|Withdrawal by Subject|2
3102192|NCT00269399|10631256|P2|Overall Study|Adverse Event|4
3102193|NCT00269399|10631257|P1|Overall Study|Adverse Event|10
3102194|NCT00269399|10631256|P2|Overall Study|Lack of Efficacy|10
3102195|NCT00269399|10631257|P1|Overall Study|Lack of Efficacy|27
3102196|NCT00269152|10631267|P2|Overall Study|Protocol Violation|1
3102197|NCT00269152|10631268|P1|Overall Study|Protocol Violation|0
3102198|NCT00269152|10631267|P2|Overall Study|Physician Decision|3
3102199|NCT00269152|10631268|P1|Overall Study|Physician Decision|2
3102200|NCT00269152|10631267|P2|Overall Study|Withdrawal by Subject|3
3102201|NCT00269152|10631268|P1|Overall Study|Withdrawal by Subject|7
3102202|NCT00269152|10631267|P2|Overall Study|Adverse Event|3
3102203|NCT00269152|10631268|P1|Overall Study|Adverse Event|9
3102204|NCT00269113|10631284|P2|Overall Study|Other|2
3102205|NCT00269113|10631285|P1|Overall Study|Other|0
3102206|NCT00269113|10631284|P2|Overall Study|Protocol Violation|5
3102207|NCT00269113|10631285|P1|Overall Study|Protocol Violation|15
3102208|NCT00269113|10631284|P2|Overall Study|Lost to Follow-up|1
3102209|NCT00269113|10631285|P1|Overall Study|Lost to Follow-up|2
3102210|NCT00269113|10631284|P2|Overall Study|Death|2
3102211|NCT00269113|10631285|P1|Overall Study|Death|6
3102212|NCT00269113|10631284|P2|Overall Study|Withdrawal by Subject|2
3102213|NCT00269113|10631285|P1|Overall Study|Withdrawal by Subject|0
3102214|NCT00269113|10631284|P2|Overall Study|Early Improvement|0
3102215|NCT00269113|10631285|P1|Overall Study|Early Improvement|2
3102216|NCT00269113|10631284|P2|Overall Study|Lack of Efficacy|18
3102217|NCT00269113|10631285|P1|Overall Study|Lack of Efficacy|35
3102218|NCT00269113|10631284|P2|Overall Study|Adverse Event|7
3102219|NCT00269113|10631285|P1|Overall Study|Adverse Event|14
3102220|NCT00269087|10631303|P1|Overall Study|Exacerbation of COPD|13
3102221|NCT00269087|10631303|P1|Overall Study|Withdrawal by Subject|1
3102222|NCT00269087|10631303|P1|Overall Study|Adverse Event|20
3102223|NCT00268996|10631333|P2|Overall Study|Other|1
3102224|NCT00268996|10631334|P1|Overall Study|Other|1
3102225|NCT00268996|10631333|P2|Overall Study|Non-compliance|0
3102226|NCT00268996|10631334|P1|Overall Study|Non-compliance|1
3102227|NCT00268996|10631333|P2|Overall Study|Withdrawal by Subject|11
3102228|NCT00268996|10631334|P1|Overall Study|Withdrawal by Subject|5
3102229|NCT00268996|10631333|P2|Overall Study|Lost to Follow-up|1
3102230|NCT00268996|10631334|P1|Overall Study|Lost to Follow-up|3
3102231|NCT00268996|10631333|P2|Overall Study|Adverse Event|7
3102232|NCT00268996|10631334|P1|Overall Study|Adverse Event|11
3102233|NCT00268983|10631378|P2|Overall Study|Death|0
3102234|NCT00268983|10631379|P1|Overall Study|Death|3
3102235|NCT00268905|10631422|P3|Overall Study|Clinical Progression|1
3102236|NCT00268905|10631423|P2|Overall Study|Clinical Progression|4
3102237|NCT00268905|10631424|P1|Overall Study|Clinical Progression|9
3102238|NCT00268905|10631422|P3|Overall Study|Physician Decision|1
3102239|NCT00268905|10631423|P2|Overall Study|Physician Decision|0
3102240|NCT00268905|10631424|P1|Overall Study|Physician Decision|3
3102241|NCT00268905|10631422|P3|Overall Study|Progressive Disease|3
3102242|NCT00268905|10631423|P2|Overall Study|Progressive Disease|4
3102243|NCT00268905|10631424|P1|Overall Study|Progressive Disease|28
3102244|NCT00268905|10631422|P3|Overall Study|Withdrawal by Subject|3
3102245|NCT00268905|10631423|P2|Overall Study|Withdrawal by Subject|0
3102246|NCT00268905|10631424|P1|Overall Study|Withdrawal by Subject|0
3102247|NCT00268905|10631422|P3|Overall Study|Lost to Follow-up|0
3102248|NCT00268905|10631423|P2|Overall Study|Lost to Follow-up|1
3102249|NCT00268905|10631424|P1|Overall Study|Lost to Follow-up|0
3102250|NCT00268905|10631422|P3|Overall Study|Adverse Event|4
3102251|NCT00268905|10631423|P2|Overall Study|Adverse Event|0
3102252|NCT00268905|10631424|P1|Overall Study|Adverse Event|3
3102253|NCT00268892|10631441|P3|Overall Study|Trial Site Closed|2
3102254|NCT00268892|10631442|P2|Overall Study|Trial Site Closed|2
3102255|NCT00268892|10631443|P1|Overall Study|Trial Site Closed|4
3102256|NCT00268892|10631441|P3|Overall Study|Disease Progression|0
3102257|NCT00268892|10631442|P2|Overall Study|Disease Progression|1
3102258|NCT00268892|10631443|P1|Overall Study|Disease Progression|1
3102259|NCT00268892|10631441|P3|Overall Study|Protocol Violation|0
3102260|NCT00268892|10631442|P2|Overall Study|Protocol Violation|1
3102261|NCT00268892|10631443|P1|Overall Study|Protocol Violation|0
3102262|NCT00268892|10631441|P3|Overall Study|Lost to Follow-up|4
3102263|NCT00268892|10631442|P2|Overall Study|Lost to Follow-up|2
3102264|NCT00268892|10631443|P1|Overall Study|Lost to Follow-up|5
3102265|NCT00268892|10631441|P3|Overall Study|Physician Decision|0
3102266|NCT00268892|10631442|P2|Overall Study|Physician Decision|1
3102267|NCT00268892|10631443|P1|Overall Study|Physician Decision|0
3102268|NCT00268892|10631441|P3|Overall Study|Withdrawal by Subject|13
3102269|NCT00268892|10631442|P2|Overall Study|Withdrawal by Subject|15
3102270|NCT00268892|10631443|P1|Overall Study|Withdrawal by Subject|14
3102271|NCT00268892|10631441|P3|Overall Study|Lack of Efficacy|0
3102272|NCT00268892|10631442|P2|Overall Study|Lack of Efficacy|3
3102273|NCT00268892|10631443|P1|Overall Study|Lack of Efficacy|1
3102274|NCT00268892|10631441|P3|Overall Study|Adverse Event|20
3102275|NCT00268892|10631442|P2|Overall Study|Adverse Event|17
3102276|NCT00268892|10631443|P1|Overall Study|Adverse Event|14
3102277|NCT00268463|10631462|P2|Overall Study|study terminated due to low accrual|12
3102278|NCT00268463|10631463|P1|Overall Study|study terminated due to low accrual|10
3102279|NCT00268437|10631479|P1|Overall Study|Ineligible|1
3102280|NCT00268346|10631486|P2|Overall Study|Withdrawal by Subject|1
3102281|NCT00268346|10631487|P1|Overall Study|Withdrawal by Subject|0
3102282|NCT00268346|10631486|P2|Overall Study|Death|1
3102283|NCT00268346|10631487|P1|Overall Study|Death|0
3102284|NCT00268346|10631486|P2|Overall Study|Adverse Event|1
3102285|NCT00268346|10631487|P1|Overall Study|Adverse Event|0
3102286|NCT00268242|10631493|P1|Overall Study|Death|1
3102287|NCT00268203|10631502|P1|Overall Study|Completed 2 Years of Follow-up|62
3102288|NCT00268203|10631502|P1|Overall Study|Reason Not Specified|34
3102289|NCT00268203|10631502|P1|Overall Study|Death|84
3102290|NCT00268203|10631502|P1|Overall Study|Progressive Disease|359
3102291|NCT00268203|10631502|P1|Overall Study|Received Other NHL Therapy|7
3102292|NCT00268203|10631502|P1|Overall Study|Withdrawal by Subject|9
3102293|NCT00268203|10631502|P1|Overall Study|Lost to Follow-up|92
3102294|NCT00267969|10631516|P7|After Controlled Period|Other|25
3102295|NCT00267969|10631517|P6|After Controlled Period|Other|22
3102296|NCT00267969|10631518|P5|After Controlled Period|Other|11
3102297|NCT00267969|10631519|P4|After Controlled Period|Other|13
3102298|NCT00267969|10631520|P3|After Controlled Period|Other|0
3102299|NCT00267969|10631521|P2|After Controlled Period|Other|0
3102300|NCT00267969|10631522|P1|After Controlled Period|Other|0
3102301|NCT00267969|10631516|P7|After Controlled Period|Lost to Follow-up|10
3102302|NCT00267969|10631517|P6|After Controlled Period|Lost to Follow-up|9
3102303|NCT00267969|10631518|P5|After Controlled Period|Lost to Follow-up|8
3102304|NCT00267969|10631519|P4|After Controlled Period|Lost to Follow-up|5
3102305|NCT00267969|10631520|P3|After Controlled Period|Lost to Follow-up|0
3102306|NCT00267969|10631521|P2|After Controlled Period|Lost to Follow-up|0
3102307|NCT00267969|10631522|P1|After Controlled Period|Lost to Follow-up|0
3102308|NCT00267969|10631516|P7|After Controlled Period|Lack of Efficacy|15
3102309|NCT00267969|10631517|P6|After Controlled Period|Lack of Efficacy|28
3102310|NCT00267969|10631518|P5|After Controlled Period|Lack of Efficacy|6
3102311|NCT00267969|10631519|P4|After Controlled Period|Lack of Efficacy|10
3102312|NCT00267969|10631520|P3|After Controlled Period|Lack of Efficacy|0
3102313|NCT00267969|10631521|P2|After Controlled Period|Lack of Efficacy|0
3102314|NCT00267969|10631522|P1|After Controlled Period|Lack of Efficacy|0
3102315|NCT00267969|10631516|P7|After Controlled Period|Death|1
3102316|NCT00267969|10631517|P6|After Controlled Period|Death|0
3102317|NCT00267969|10631518|P5|After Controlled Period|Death|2
3102318|NCT00267969|10631519|P4|After Controlled Period|Death|1
3102319|NCT00267969|10631520|P3|After Controlled Period|Death|0
3102320|NCT00267969|10631521|P2|After Controlled Period|Death|0
3102321|NCT00267969|10631522|P1|After Controlled Period|Death|0
3102322|NCT00267969|10631516|P7|After Controlled Period|Adverse Event|21
3102323|NCT00267969|10631517|P6|After Controlled Period|Adverse Event|23
3102324|NCT00267969|10631518|P5|After Controlled Period|Adverse Event|8
3102325|NCT00267969|10631519|P4|After Controlled Period|Adverse Event|7
3102326|NCT00267969|10631520|P3|After Controlled Period|Adverse Event|0
3102327|NCT00267969|10631521|P2|After Controlled Period|Adverse Event|0
3102328|NCT00267969|10631522|P1|After Controlled Period|Adverse Event|0
3102329|NCT00267969|10631516|P7|Controlled Period|Other|0
3102330|NCT00267969|10631517|P6|Controlled Period|Other|0
3102331|NCT00267969|10631518|P5|Controlled Period|Other|0
3102332|NCT00267969|10631519|P4|Controlled Period|Other|0
3102333|NCT00267969|10631520|P3|Controlled Period|Other|6
3102334|NCT00267969|10631521|P2|Controlled Period|Other|1
3102335|NCT00267969|10631522|P1|Controlled Period|Other|2
3102336|NCT00267969|10631516|P7|Controlled Period|Randomized but not treated|0
3102337|NCT00267969|10631517|P6|Controlled Period|Randomized but not treated|0
3102338|NCT00267969|10631518|P5|Controlled Period|Randomized but not treated|0
3102339|NCT00267969|10631519|P4|Controlled Period|Randomized but not treated|0
3102340|NCT00267969|10631520|P3|Controlled Period|Randomized but not treated|1
3102341|NCT00267969|10631521|P2|Controlled Period|Randomized but not treated|0
3102342|NCT00267969|10631522|P1|Controlled Period|Randomized but not treated|0
3102343|NCT00267969|10631516|P7|Controlled Period|Lost to Follow-up|0
3102344|NCT00267969|10631517|P6|Controlled Period|Lost to Follow-up|0
3102345|NCT00267969|10631518|P5|Controlled Period|Lost to Follow-up|0
3102346|NCT00267969|10631519|P4|Controlled Period|Lost to Follow-up|0
3102347|NCT00267969|10631520|P3|Controlled Period|Lost to Follow-up|1
3102348|NCT00267969|10631521|P2|Controlled Period|Lost to Follow-up|0
3102349|NCT00267969|10631522|P1|Controlled Period|Lost to Follow-up|1
3102350|NCT00267969|10631516|P7|Controlled Period|Lack of Efficacy|0
3102351|NCT00267969|10631517|P6|Controlled Period|Lack of Efficacy|0
3102352|NCT00267969|10631518|P5|Controlled Period|Lack of Efficacy|0
3102353|NCT00267969|10631519|P4|Controlled Period|Lack of Efficacy|0
3102354|NCT00267969|10631520|P3|Controlled Period|Lack of Efficacy|1
3102355|NCT00267969|10631521|P2|Controlled Period|Lack of Efficacy|0
3102356|NCT00267969|10631522|P1|Controlled Period|Lack of Efficacy|3
3102357|NCT00267969|10631516|P7|Controlled Period|Adverse Event|0
3102358|NCT00267969|10631517|P6|Controlled Period|Adverse Event|0
3102359|NCT00267969|10631518|P5|Controlled Period|Adverse Event|0
3102360|NCT00267969|10631519|P4|Controlled Period|Adverse Event|0
3102361|NCT00267969|10631520|P3|Controlled Period|Adverse Event|2
3102362|NCT00267969|10631521|P2|Controlled Period|Adverse Event|0
3102363|NCT00267969|10631522|P1|Controlled Period|Adverse Event|6
3102364|NCT00267956|10631548|P4|After Controlled Period|Withdrew consent|0
3102365|NCT00267956|10631549|P3|After Controlled Period|Withdrew consent|1
3102366|NCT00267956|10631550|P2|After Controlled Period|Withdrew consent|0
3102367|NCT00267956|10631551|P1|After Controlled Period|Withdrew consent|0
3102368|NCT00267956|10631548|P4|After Controlled Period|Lost to Follow-up|0
3102369|NCT00267956|10631549|P3|After Controlled Period|Lost to Follow-up|1
3102370|NCT00267956|10631550|P2|After Controlled Period|Lost to Follow-up|0
3102371|NCT00267956|10631551|P1|After Controlled Period|Lost to Follow-up|0
3102372|NCT00267956|10631548|P4|After Controlled Period|Lack of Efficacy|1
3102373|NCT00267956|10631549|P3|After Controlled Period|Lack of Efficacy|1
3102374|NCT00267956|10631550|P2|After Controlled Period|Lack of Efficacy|0
3102375|NCT00267956|10631551|P1|After Controlled Period|Lack of Efficacy|0
3102376|NCT00267956|10631548|P4|After Controlled Period|Adverse Event|1
3102377|NCT00267956|10631549|P3|After Controlled Period|Adverse Event|2
3102378|NCT00267956|10631550|P2|After Controlled Period|Adverse Event|0
3102379|NCT00267956|10631551|P1|After Controlled Period|Adverse Event|0
3102380|NCT00267956|10631548|P4|Controlled Period|Withdrew consent|0
3102381|NCT00267956|10631549|P3|Controlled Period|Withdrew consent|0
3102382|NCT00267956|10631550|P2|Controlled Period|Withdrew consent|1
3102383|NCT00267956|10631551|P1|Controlled Period|Withdrew consent|3
3102384|NCT00267956|10631548|P4|Controlled Period|Lost to Follow-up|0
3102385|NCT00267956|10631549|P3|Controlled Period|Lost to Follow-up|0
3102386|NCT00267956|10631550|P2|Controlled Period|Lost to Follow-up|0
3102387|NCT00267956|10631551|P1|Controlled Period|Lost to Follow-up|2
3102388|NCT00267956|10631548|P4|Controlled Period|Lack of Efficacy|0
3102389|NCT00267956|10631549|P3|Controlled Period|Lack of Efficacy|0
3102390|NCT00267956|10631550|P2|Controlled Period|Lack of Efficacy|2
3102391|NCT00267956|10631551|P1|Controlled Period|Lack of Efficacy|4
3102392|NCT00267956|10631548|P4|Controlled Period|Adverse Event|0
3102393|NCT00267956|10631549|P3|Controlled Period|Adverse Event|0
3102394|NCT00267956|10631550|P2|Controlled Period|Adverse Event|1
3102395|NCT00267956|10631551|P1|Controlled Period|Adverse Event|4
3102396|NCT00267865|10631569|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
3102397|NCT00267865|10631569|P1|Induction Treatment|Died before completing.|2
3102398|NCT00267748|10631592|P3|Randomized Period|randomized but not treated|3
3102399|NCT00267748|10631593|P2|Randomized Period|randomized but not treated|0
3102400|NCT00267748|10631594|P1|Randomized Period|randomized but not treated|0
3102401|NCT00267748|10631592|P3|Randomized Period|Other|6
3102402|NCT00267748|10631593|P2|Randomized Period|Other|9
3102403|NCT00267748|10631594|P1|Randomized Period|Other|0
3102404|NCT00267748|10631592|P3|Randomized Period|Withdrawal by Subject|2
3102405|NCT00267748|10631593|P2|Randomized Period|Withdrawal by Subject|9
3102406|NCT00267748|10631594|P1|Randomized Period|Withdrawal by Subject|0
3102407|NCT00267748|10631592|P3|Randomized Period|Objective progression or relapse|86
3102408|NCT00267748|10631593|P2|Randomized Period|Objective progression or relapse|77
3102409|NCT00267748|10631594|P1|Randomized Period|Objective progression or relapse|0
3102410|NCT00267748|10631592|P3|Randomized Period|Lost to Follow-up|0
3102411|NCT00267748|10631593|P2|Randomized Period|Lost to Follow-up|1
3102412|NCT00267748|10631594|P1|Randomized Period|Lost to Follow-up|0
3102413|NCT00267748|10631592|P3|Randomized Period|Global deterioration of health status|7
3102414|NCT00267748|10631593|P2|Randomized Period|Global deterioration of health status|6
3102415|NCT00267748|10631594|P1|Randomized Period|Global deterioration of health status|0
3102416|NCT00267748|10631592|P3|Randomized Period|Adverse Event|25
3102417|NCT00267748|10631593|P2|Randomized Period|Adverse Event|23
3102418|NCT00267748|10631594|P1|Randomized Period|Adverse Event|0
3102419|NCT00267748|10631592|P3|Randomized Period|Death|3
3102420|NCT00267748|10631593|P2|Randomized Period|Death|2
3102421|NCT00267748|10631594|P1|Randomized Period|Death|0
3102422|NCT00267748|10631592|P3|Non-randomized Period|Other|0
3102423|NCT00267748|10631593|P2|Non-randomized Period|Other|0
3102424|NCT00267748|10631594|P1|Non-randomized Period|Other|3
3102425|NCT00267748|10631592|P3|Non-randomized Period|Participant not willing to participate|0
3102426|NCT00267748|10631593|P2|Non-randomized Period|Participant not willing to participate|0
3102427|NCT00267748|10631594|P1|Non-randomized Period|Participant not willing to participate|1
3102428|NCT00267748|10631592|P3|Non-randomized Period|Death|0
3102429|NCT00267748|10631593|P2|Non-randomized Period|Death|0
3102430|NCT00267748|10631594|P1|Non-randomized Period|Death|1
3102431|NCT00267748|10631592|P3|Non-randomized Period|Adverse Event|0
3102432|NCT00267748|10631593|P2|Non-randomized Period|Adverse Event|0
3102433|NCT00267748|10631594|P1|Non-randomized Period|Adverse Event|8
3102434|NCT00267748|10631592|P3|Non-randomized Period|Progressive disease|0
3102435|NCT00267748|10631593|P2|Non-randomized Period|Progressive disease|0
3102436|NCT00267748|10631594|P1|Non-randomized Period|Progressive disease|10
3102437|NCT00267488|10631651|P1|Overall Study|Other (Disease Progression)|1
3102438|NCT00267488|10631651|P1|Overall Study|Protocol Violation|1
3102439|NCT00267488|10631651|P1|Overall Study|Sponsor Terminated Study|9
3102440|NCT00267202|10631675|P2|Overall Study|Lost to Follow-up|0
3102441|NCT00267202|10631676|P1|Overall Study|Lost to Follow-up|3
3102442|NCT00267202|10631675|P2|Overall Study|Administrative problems|1
3102443|NCT00267202|10631676|P1|Overall Study|Administrative problems|2
3102444|NCT00267202|10631675|P2|Overall Study|Protocol Violation|3
3102445|NCT00267202|10631676|P1|Overall Study|Protocol Violation|2
3102446|NCT00267202|10631675|P2|Overall Study|Adverse Event|7
3102447|NCT00267202|10631676|P1|Overall Study|Adverse Event|13
3102448|NCT00267202|10631675|P2|Overall Study|Withdrawal by Subject|15
3102449|NCT00267202|10631676|P1|Overall Study|Withdrawal by Subject|12
3102450|NCT00267202|10631675|P2|Overall Study|Unsatisfactory therapeutic effect|8
3102451|NCT00267202|10631676|P1|Overall Study|Unsatisfactory therapeutic effect|21
3102452|NCT00267189|10631697|P2|Overall Study|Missing|0
3102453|NCT00267189|10631698|P1|Overall Study|Missing|3
3102454|NCT00267189|10631697|P2|Overall Study|Death|0
3102455|NCT00267189|10631698|P1|Overall Study|Death|1
3102456|NCT00267189|10631697|P2|Overall Study|Patient withdrew consent|1
3102457|NCT00267189|10631698|P1|Overall Study|Patient withdrew consent|1
3102458|NCT00267150|10631708|P1|Overall Study|Adverse Event|1
3102459|NCT00267098|10631732|P8|Overall Study|Sponsor withdrew subject|0
3102460|NCT00267098|10631733|P7|Overall Study|Sponsor withdrew subject|0
3102461|NCT00267098|10631734|P6|Overall Study|Sponsor withdrew subject|0
3102462|NCT00267098|10631735|P5|Overall Study|Sponsor withdrew subject|0
3102463|NCT00267098|10631736|P4|Overall Study|Sponsor withdrew subject|1
3102464|NCT00267098|10631737|P3|Overall Study|Sponsor withdrew subject|0
3102465|NCT00267098|10631738|P2|Overall Study|Sponsor withdrew subject|0
3102466|NCT00267098|10631739|P1|Overall Study|Sponsor withdrew subject|0
3102467|NCT00267098|10631732|P8|Overall Study|Subject listed for heart transplant|0
3102468|NCT00267098|10631733|P7|Overall Study|Subject listed for heart transplant|1
3102469|NCT00267098|10631734|P6|Overall Study|Subject listed for heart transplant|0
3102470|NCT00267098|10631735|P5|Overall Study|Subject listed for heart transplant|0
3102471|NCT00267098|10631736|P4|Overall Study|Subject listed for heart transplant|0
3102472|NCT00267098|10631737|P3|Overall Study|Subject listed for heart transplant|0
3102473|NCT00267098|10631738|P2|Overall Study|Subject listed for heart transplant|0
3102474|NCT00267098|10631739|P1|Overall Study|Subject listed for heart transplant|0
3102475|NCT00267098|10631732|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
3102476|NCT00267098|10631733|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
3102477|NCT00267098|10631734|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
3102478|NCT00267098|10631735|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
3102479|NCT00267098|10631736|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
3102480|NCT00267098|10631737|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
3102481|NCT00267098|10631738|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
3102482|NCT00267098|10631739|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
3102483|NCT00267098|10631732|P8|Overall Study|Explanted Medtronic device|0
3102484|NCT00267098|10631733|P7|Overall Study|Explanted Medtronic device|0
3102485|NCT00267098|10631734|P6|Overall Study|Explanted Medtronic device|0
3102486|NCT00267098|10631735|P5|Overall Study|Explanted Medtronic device|0
3102487|NCT00267098|10631736|P4|Overall Study|Explanted Medtronic device|1
3102488|NCT00267098|10631737|P3|Overall Study|Explanted Medtronic device|0
3102489|NCT00267098|10631738|P2|Overall Study|Explanted Medtronic device|0
3102490|NCT00267098|10631739|P1|Overall Study|Explanted Medtronic device|0
3102491|NCT00267098|10631732|P8|Overall Study|Site closure|0
3102492|NCT00267098|10631733|P7|Overall Study|Site closure|1
3102493|NCT00267098|10631734|P6|Overall Study|Site closure|1
3102494|NCT00267098|10631735|P5|Overall Study|Site closure|0
3102495|NCT00267098|10631736|P4|Overall Study|Site closure|1
3102496|NCT00267098|10631737|P3|Overall Study|Site closure|0
3102497|NCT00267098|10631738|P2|Overall Study|Site closure|0
3102498|NCT00267098|10631739|P1|Overall Study|Site closure|0
3102499|NCT00267098|10631732|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102500|NCT00267098|10631733|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102501|NCT00267098|10631734|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102502|NCT00267098|10631735|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102503|NCT00267098|10631736|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102504|NCT00267098|10631737|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102505|NCT00267098|10631738|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
3102506|NCT00267098|10631739|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
3102507|NCT00267098|10631732|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102508|NCT00267098|10631733|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102509|NCT00267098|10631734|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102510|NCT00267098|10631735|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
3102511|NCT00267098|10631736|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102512|NCT00267098|10631737|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102513|NCT00267098|10631738|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
3102514|NCT00267098|10631739|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
3102515|NCT00267098|10631732|P8|Overall Study|Physician Decision|0
3102516|NCT00267098|10631733|P7|Overall Study|Physician Decision|3
3102517|NCT00267098|10631734|P6|Overall Study|Physician Decision|4
3102518|NCT00267098|10631735|P5|Overall Study|Physician Decision|5
3102519|NCT00267098|10631736|P4|Overall Study|Physician Decision|11
3102520|NCT00267098|10631737|P3|Overall Study|Physician Decision|7
3102521|NCT00267098|10631738|P2|Overall Study|Physician Decision|0
3102522|NCT00267098|10631739|P1|Overall Study|Physician Decision|5
3102523|NCT00267098|10631732|P8|Overall Study|Withdrawal by Subject|5
3102524|NCT00267098|10631733|P7|Overall Study|Withdrawal by Subject|12
3102525|NCT00267098|10631734|P6|Overall Study|Withdrawal by Subject|9
3102526|NCT00267098|10631735|P5|Overall Study|Withdrawal by Subject|12
3102527|NCT00267098|10631736|P4|Overall Study|Withdrawal by Subject|21
3102528|NCT00267098|10631737|P3|Overall Study|Withdrawal by Subject|24
3102529|NCT00267098|10631738|P2|Overall Study|Withdrawal by Subject|0
3102530|NCT00267098|10631739|P1|Overall Study|Withdrawal by Subject|8
3102531|NCT00267098|10631732|P8|Overall Study|Lost to Follow-up|1
3102532|NCT00267098|10631733|P7|Overall Study|Lost to Follow-up|1
3102533|NCT00267098|10631734|P6|Overall Study|Lost to Follow-up|3
3102534|NCT00267098|10631735|P5|Overall Study|Lost to Follow-up|2
3102535|NCT00267098|10631736|P4|Overall Study|Lost to Follow-up|5
3102536|NCT00267098|10631737|P3|Overall Study|Lost to Follow-up|6
3102537|NCT00267098|10631738|P2|Overall Study|Lost to Follow-up|0
3102538|NCT00267098|10631739|P1|Overall Study|Lost to Follow-up|0
3102539|NCT00267098|10631732|P8|Overall Study|Death|9
3102540|NCT00267098|10631733|P7|Overall Study|Death|28
3102541|NCT00267098|10631734|P6|Overall Study|Death|23
3102542|NCT00267098|10631735|P5|Overall Study|Death|14
3102543|NCT00267098|10631736|P4|Overall Study|Death|66
3102544|NCT00267098|10631737|P3|Overall Study|Death|57
3102545|NCT00267098|10631738|P2|Overall Study|Death|0
3102546|NCT00267098|10631739|P1|Overall Study|Death|0
3102547|NCT00267046|10631882|P2|Overall Study|Radiation|1
3102548|NCT00267046|10631883|P1|Overall Study|Radiation|0
3102549|NCT00267046|10631882|P2|Overall Study|Withdrawal by Subject|0
3102550|NCT00267046|10631883|P1|Overall Study|Withdrawal by Subject|1
3102551|NCT00267046|10631882|P2|Overall Study|Surgery|1
3102552|NCT00267046|10631883|P1|Overall Study|Surgery|3
3102553|NCT00267046|10631882|P2|Overall Study|Open-label palifermin|7
3102554|NCT00267046|10631883|P1|Overall Study|Open-label palifermin|2
3102555|NCT00267046|10631882|P2|Overall Study|Chemotoxicity|0
3102556|NCT00267046|10631883|P1|Overall Study|Chemotoxicity|2
3102557|NCT00267046|10631882|P2|Overall Study|Disease progression|2
3102558|NCT00267046|10631883|P1|Overall Study|Disease progression|4
3102559|NCT00267007|10631893|P2|Overall Study|Adverse Event|0
3102560|NCT00267007|10631894|P1|Overall Study|Adverse Event|1
3102561|NCT00267007|10631893|P2|Overall Study|Non-compliance|1
3102562|NCT00267007|10631894|P1|Overall Study|Non-compliance|0
3102563|NCT00267007|10631893|P2|Overall Study|Lost to Follow-up|0
3102564|NCT00267007|10631894|P1|Overall Study|Lost to Follow-up|1
3102565|NCT00267007|10631893|P2|Overall Study|Withdrawal by Subject|0
3102566|NCT00267007|10631894|P1|Overall Study|Withdrawal by Subject|6
3102567|NCT00266877|10631905|P3|Overall Study|Concomitant Radiotherapy|0
3102568|NCT00266877|10631906|P2|Overall Study|Concomitant Radiotherapy|1
3102569|NCT00266877|10631907|P1|Overall Study|Concomitant Radiotherapy|0
3102570|NCT00266877|10631905|P3|Overall Study|Hospitalization|0
3102571|NCT00266877|10631906|P2|Overall Study|Hospitalization|0
3102572|NCT00266877|10631907|P1|Overall Study|Hospitalization|1
3102573|NCT00266877|10631905|P3|Overall Study|Symptomatic Deterioration|1
3102574|NCT00266877|10631906|P2|Overall Study|Symptomatic Deterioration|3
3102575|NCT00266877|10631907|P1|Overall Study|Symptomatic Deterioration|6
3102576|NCT00266877|10631905|P3|Overall Study|Disease Progression|23
3102577|NCT00266877|10631906|P2|Overall Study|Disease Progression|37
3102578|NCT00266877|10631907|P1|Overall Study|Disease Progression|72
3102579|NCT00266877|10631905|P3|Overall Study|Withdrawal by Subject|1
3102580|NCT00266877|10631906|P2|Overall Study|Withdrawal by Subject|1
3102581|NCT00266877|10631907|P1|Overall Study|Withdrawal by Subject|3
3102582|NCT00266877|10631905|P3|Overall Study|Physician Decision|1
3102583|NCT00266877|10631906|P2|Overall Study|Physician Decision|1
3102584|NCT00266877|10631907|P1|Overall Study|Physician Decision|2
3102585|NCT00266877|10631905|P3|Overall Study|Adverse Event|1
3102586|NCT00266877|10631906|P2|Overall Study|Adverse Event|4
3102587|NCT00266877|10631907|P1|Overall Study|Adverse Event|6
3102588|NCT00266877|10631905|P3|Overall Study|Death|1
3102589|NCT00266877|10631906|P2|Overall Study|Death|1
3102590|NCT00266877|10631907|P1|Overall Study|Death|1
3102591|NCT00266864|10631926|P2|Overall Study|Withdrawal by Subject|1
3102592|NCT00266864|10631927|P1|Overall Study|Withdrawal by Subject|1
3102593|NCT00266864|10631926|P2|Overall Study|Lost to Follow-up|1
3102594|NCT00266864|10631927|P1|Overall Study|Lost to Follow-up|4
3102595|NCT00266825|10631958|P2|Completed Follow-Up|Withdrawal by Subject|5
3102596|NCT00266825|10631959|P1|Completed Follow-Up|Withdrawal by Subject|11
3102597|NCT00266825|10631958|P2|Completed Follow-Up|Lost to Follow-up|19
3102598|NCT00266825|10631959|P1|Completed Follow-Up|Lost to Follow-up|14
3102599|NCT00266812|10631985|P2|Overall Study|Discontinued before starting study drug|0
3102600|NCT00266812|10631986|P1|Overall Study|Discontinued before starting study drug|4
3102601|NCT00266812|10631985|P2|Overall Study|Withdrawal by Subject|2
3102602|NCT00266812|10631986|P1|Overall Study|Withdrawal by Subject|0
3102603|NCT00266812|10631985|P2|Overall Study|Protocol Violation|1
3102604|NCT00266812|10631986|P1|Overall Study|Protocol Violation|0
3102605|NCT00266812|10631985|P2|Overall Study|Adverse Event|1
3102606|NCT00266812|10631986|P1|Overall Study|Adverse Event|3
3102607|NCT00266812|10631985|P2|Overall Study|Death|4
3102608|NCT00266812|10631986|P1|Overall Study|Death|5
3102609|NCT00266812|10631985|P2|Overall Study|Disease Progression|3
3102610|NCT00266812|10631986|P1|Overall Study|Disease Progression|9
3102611|NCT00266708|10632011|P2|Overall Study|Asthma|2
3102612|NCT00266708|10632012|P1|Overall Study|Asthma|0
3102613|NCT00266708|10632011|P2|Overall Study|Refused biopsy|6
3102614|NCT00266708|10632012|P1|Overall Study|Refused biopsy|3
3102615|NCT00266708|10632011|P2|Overall Study|No renal function|1
3102616|NCT00266708|10632012|P1|Overall Study|No renal function|1
3102617|NCT00266695|10632052|P1|Overall Study|Withdrawal by Subject|15
3102618|NCT00266695|10632052|P1|Overall Study|Lost to Follow-up|3
3102619|NCT00266695|10632052|P1|Overall Study|Physician Decision|1
3102620|NCT00266695|10632052|P1|Overall Study|Death|9
3102621|NCT00266695|10632052|P1|Overall Study|Adverse Event|1
3102622|NCT00266656|10632064|P2|Overall Study|Parent/Caregiver Decision|2
3102623|NCT00266656|10632065|P1|Overall Study|Parent/Caregiver Decision|1
3102624|NCT00266656|10632064|P2|Overall Study|Did Not Reach Final Height|8
3102625|NCT00266656|10632065|P1|Overall Study|Did Not Reach Final Height|4
3102626|NCT00266656|10632064|P2|Overall Study|Withdrawal by Subject|2
3102627|NCT00266656|10632065|P1|Overall Study|Withdrawal by Subject|4
3102628|NCT00266656|10632064|P2|Overall Study|Lost to Follow-up|1
3102629|NCT00266656|10632065|P1|Overall Study|Lost to Follow-up|4
3102630|NCT00266656|10632064|P2|Overall Study|Death|0
3102631|NCT00266656|10632065|P1|Overall Study|Death|1
3102632|NCT00266630|10632089|P2|Overall Study|Other|11
3102633|NCT00266630|10632090|P1|Overall Study|Other|19
3102634|NCT00266630|10632089|P2|Overall Study|Lost to Follow-up|0
3102635|NCT00266630|10632090|P1|Overall Study|Lost to Follow-up|1
3102636|NCT00266630|10632089|P2|Overall Study|Withdrawal by Subject|2
3102637|NCT00266630|10632090|P1|Overall Study|Withdrawal by Subject|10
3102638|NCT00266630|10632089|P2|Overall Study|Physician Decision|2
3102639|NCT00266630|10632090|P1|Overall Study|Physician Decision|1
3102640|NCT00266630|10632089|P2|Overall Study|Protocol Violation|3
3102641|NCT00266630|10632090|P1|Overall Study|Protocol Violation|1
3102642|NCT00266630|10632089|P2|Overall Study|Entry Criteria not met|0
3102643|NCT00266630|10632090|P1|Overall Study|Entry Criteria not met|1
3102644|NCT00266630|10632089|P2|Overall Study|Lack of Efficacy|4
3102645|NCT00266630|10632090|P1|Overall Study|Lack of Efficacy|1
3102646|NCT00266630|10632089|P2|Overall Study|Adverse Event|6
3102647|NCT00266630|10632090|P1|Overall Study|Adverse Event|8
3102648|NCT00266409|10632132|P4|Overall Study|Other|0
3102649|NCT00266409|10632133|P3|Overall Study|Other|2
3102650|NCT00266409|10632134|P2|Overall Study|Other|4
3102651|NCT00266409|10632135|P1|Overall Study|Other|7
3102652|NCT00266409|10632132|P4|Overall Study|Protocol Violation|2
3102653|NCT00266409|10632133|P3|Overall Study|Protocol Violation|4
3102654|NCT00266409|10632134|P2|Overall Study|Protocol Violation|3
3102655|NCT00266409|10632135|P1|Overall Study|Protocol Violation|5
3102656|NCT00266409|10632132|P4|Overall Study|Withdrawal by Subject|9
3102657|NCT00266409|10632133|P3|Overall Study|Withdrawal by Subject|3
3102658|NCT00266409|10632134|P2|Overall Study|Withdrawal by Subject|10
3102659|NCT00266409|10632135|P1|Overall Study|Withdrawal by Subject|6
3102660|NCT00266409|10632132|P4|Overall Study|Lost to Follow-up|8
3102661|NCT00266409|10632133|P3|Overall Study|Lost to Follow-up|6
3102662|NCT00266409|10632134|P2|Overall Study|Lost to Follow-up|21
3102663|NCT00266409|10632135|P1|Overall Study|Lost to Follow-up|18
3102664|NCT00266409|10632132|P4|Overall Study|Adverse Event|1
3102665|NCT00266409|10632133|P3|Overall Study|Adverse Event|1
3102666|NCT00266409|10632134|P2|Overall Study|Adverse Event|2
3102667|NCT00266409|10632135|P1|Overall Study|Adverse Event|7
3102668|NCT00266409|10632132|P4|Overall Study|Lack of Efficacy|2
3102669|NCT00266409|10632133|P3|Overall Study|Lack of Efficacy|1
3102670|NCT00266409|10632134|P2|Overall Study|Lack of Efficacy|6
3102671|NCT00266409|10632135|P1|Overall Study|Lack of Efficacy|2
3102672|NCT00266227|10632423|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
3102673|NCT00266227|10632424|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
3102674|NCT00266227|10632425|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
3102675|NCT00266227|10632423|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
3102676|NCT00266227|10632424|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
3102677|NCT00266227|10632425|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
3102678|NCT00266227|10632423|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
3102679|NCT00266227|10632424|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
3102680|NCT00266227|10632425|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
3102681|NCT00266227|10632423|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
3102682|NCT00266227|10632424|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
3102683|NCT00266227|10632425|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
3102684|NCT00266227|10632423|P3|Retreatment: Week 48 to Week 72|Death|0
3102685|NCT00266227|10632424|P2|Retreatment: Week 48 to Week 72|Death|1
3102686|NCT00266227|10632425|P1|Retreatment: Week 48 to Week 72|Death|1
3102687|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Pregnancy|0
3102688|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Pregnancy|0
3102689|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Pregnancy|1
3102690|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
3102691|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
3102692|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
3102693|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
3102694|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
3102695|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
3102696|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
3102697|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
3102698|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
3102699|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Adverse Event|0
3102700|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Adverse Event|7
3102701|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Adverse Event|7
3102702|NCT00266227|10632423|P3|Retreatment: Up to Week 48|Death|0
3102703|NCT00266227|10632424|P2|Retreatment: Up to Week 48|Death|0
3102704|NCT00266227|10632425|P1|Retreatment: Up to Week 48|Death|1
3102705|NCT00266227|10632423|P3|Initial Treatment|Pregnancy|1
3102706|NCT00266227|10632424|P2|Initial Treatment|Pregnancy|0
3102707|NCT00266227|10632425|P1|Initial Treatment|Pregnancy|0
3102708|NCT00266227|10632423|P3|Initial Treatment|Physician decision to withdraw|12
3102709|NCT00266227|10632424|P2|Initial Treatment|Physician decision to withdraw|0
3102710|NCT00266227|10632425|P1|Initial Treatment|Physician decision to withdraw|0
3102711|NCT00266227|10632423|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
3102712|NCT00266227|10632424|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
3102713|NCT00266227|10632425|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
3102714|NCT00266227|10632423|P3|Initial Treatment|Lost to Follow-up|6
3102715|NCT00266227|10632424|P2|Initial Treatment|Lost to Follow-up|0
3102716|NCT00266227|10632425|P1|Initial Treatment|Lost to Follow-up|0
3102717|NCT00266227|10632423|P3|Initial Treatment|Adverse Event|13
3102718|NCT00266227|10632424|P2|Initial Treatment|Adverse Event|0
3102719|NCT00266227|10632425|P1|Initial Treatment|Adverse Event|0
3102720|NCT00266032|10632479|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
3102721|NCT00266032|10632480|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
3102722|NCT00266032|10632481|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
3102723|NCT00266032|10632479|P3|Open-label Safety Extension|Withdrawal by Subject|12
3102724|NCT00266032|10632480|P2|Open-label Safety Extension|Withdrawal by Subject|3
3102725|NCT00266032|10632481|P1|Open-label Safety Extension|Withdrawal by Subject|19
3102726|NCT00266032|10632479|P3|Open-label Safety Extension|Protocol Violation|2
3102727|NCT00266032|10632480|P2|Open-label Safety Extension|Protocol Violation|3
3102728|NCT00266032|10632481|P1|Open-label Safety Extension|Protocol Violation|1
3102729|NCT00266032|10632479|P3|Open-label Safety Extension|Pregnancy|2
3102730|NCT00266032|10632480|P2|Open-label Safety Extension|Pregnancy|1
3102731|NCT00266032|10632481|P1|Open-label Safety Extension|Pregnancy|4
3102732|NCT00266032|10632479|P3|Open-label Safety Extension|Lost to Follow-up|4
3102733|NCT00266032|10632480|P2|Open-label Safety Extension|Lost to Follow-up|5
3102734|NCT00266032|10632481|P1|Open-label Safety Extension|Lost to Follow-up|2
3102735|NCT00266032|10632479|P3|Open-label Safety Extension|Adverse Event|4
3102736|NCT00266032|10632480|P2|Open-label Safety Extension|Adverse Event|0
3102737|NCT00266032|10632481|P1|Open-label Safety Extension|Adverse Event|5
3102738|NCT00266032|10632479|P3|Treatment|patient moved/wish for pregnancy/no need|8
3102739|NCT00266032|10632480|P2|Treatment|patient moved/wish for pregnancy/no need|5
3102740|NCT00266032|10632481|P1|Treatment|patient moved/wish for pregnancy/no need|13
3102741|NCT00266032|10632479|P3|Treatment|Withdrawal by Subject|12
3102742|NCT00266032|10632480|P2|Treatment|Withdrawal by Subject|13
3102743|NCT00266032|10632481|P1|Treatment|Withdrawal by Subject|28
3102744|NCT00266032|10632479|P3|Treatment|Protocol Violation|13
3102745|NCT00266032|10632480|P2|Treatment|Protocol Violation|14
3102746|NCT00266032|10632481|P1|Treatment|Protocol Violation|6
3102747|NCT00266032|10632479|P3|Treatment|Pregnancy|2
3102748|NCT00266032|10632480|P2|Treatment|Pregnancy|2
3102749|NCT00266032|10632481|P1|Treatment|Pregnancy|3
3102750|NCT00266032|10632479|P3|Treatment|Lost to Follow-up|2
3102751|NCT00266032|10632480|P2|Treatment|Lost to Follow-up|4
3102752|NCT00266032|10632481|P1|Treatment|Lost to Follow-up|19
3102753|NCT00266032|10632479|P3|Treatment|Adverse Event|10
3102754|NCT00266032|10632480|P2|Treatment|Adverse Event|26
3102755|NCT00266032|10632481|P1|Treatment|Adverse Event|42
3102756|NCT00265941|10632516|P2|Overall Study|Lost to Follow-up|1
3102757|NCT00265941|10632517|P1|Overall Study|Lost to Follow-up|1
3102758|NCT00265941|10632516|P2|Overall Study|Protocol Violation|25
3102759|NCT00265941|10632517|P1|Overall Study|Protocol Violation|22
3102760|NCT00265889|10632549|P1|Overall Study|Insurance denied the request|3
3102761|NCT00265889|10632549|P1|Overall Study|Protocol Violation|1
3102762|NCT00265889|10632549|P1|Overall Study|Physician Decision|1
3102763|NCT00265785|10632576|P1|Overall Study|Did not receive protocol treatment|2
3102764|NCT00265785|10632576|P1|Overall Study|Ineligible|1
3102765|NCT00265785|10632576|P1|Overall Study|Not protocol specified|2
3102766|NCT00265785|10632576|P1|Overall Study|Progression/Relapse|15
3102767|NCT00265785|10632576|P1|Overall Study|Withdrawal by Subject|3
3102768|NCT00265785|10632576|P1|Overall Study|Adverse Event|4
3102769|NCT00265759|10632589|P4|Overall Study|Discontinued due to intolerability|1
3102770|NCT00265759|10632590|P3|Overall Study|Discontinued due to intolerability|0
3102771|NCT00265759|10632591|P2|Overall Study|Discontinued due to intolerability|0
3102772|NCT00265759|10632592|P1|Overall Study|Discontinued due to intolerability|0
3102773|NCT00265759|10632589|P4|Overall Study|Bilateral disease|2
3102774|NCT00265759|10632590|P3|Overall Study|Bilateral disease|0
3102775|NCT00265759|10632591|P2|Overall Study|Bilateral disease|0
3102776|NCT00265759|10632592|P1|Overall Study|Bilateral disease|0
3102777|NCT00265759|10632589|P4|Overall Study|Ineligible|1
3102778|NCT00265759|10632590|P3|Overall Study|Ineligible|0
3102779|NCT00265759|10632591|P2|Overall Study|Ineligible|0
3102780|NCT00265759|10632592|P1|Overall Study|Ineligible|0
3102781|NCT00265759|10632589|P4|Overall Study|Cancel|3
3102782|NCT00265759|10632590|P3|Overall Study|Cancel|0
3102783|NCT00265759|10632591|P2|Overall Study|Cancel|0
3102784|NCT00265759|10632592|P1|Overall Study|Cancel|0
3102785|NCT00265759|10632589|P4|Overall Study|Withdrawal by Subject|2
3102786|NCT00265759|10632590|P3|Overall Study|Withdrawal by Subject|2
3102787|NCT00265759|10632591|P2|Overall Study|Withdrawal by Subject|1
3102788|NCT00265759|10632592|P1|Overall Study|Withdrawal by Subject|0
3102789|NCT00265395|10632680|P2|Overall Study|Administrative|1
3102790|NCT00265395|10632681|P1|Overall Study|Administrative|0
3102791|NCT00265395|10632680|P2|Overall Study|Lack of Efficacy|1
3102792|NCT00265395|10632681|P1|Overall Study|Lack of Efficacy|0
3102793|NCT00265395|10632680|P2|Overall Study|Protocol Violation|2
3102794|NCT00265395|10632681|P1|Overall Study|Protocol Violation|2
3102795|NCT00265395|10632680|P2|Overall Study|Withdrawal by Subject|6
3102796|NCT00265395|10632681|P1|Overall Study|Withdrawal by Subject|1
3102797|NCT00265395|10632680|P2|Overall Study|Lost to Follow-up|1
3102798|NCT00265395|10632681|P1|Overall Study|Lost to Follow-up|2
3102799|NCT00265395|10632680|P2|Overall Study|Adverse Event|6
3102800|NCT00265395|10632681|P1|Overall Study|Adverse Event|3
3102801|NCT00265382|10632686|P1|Overall Study|Death|1
3102802|NCT00265382|10632686|P1|Overall Study|Study terminated by sponsor|94
3102803|NCT00265382|10632686|P1|Overall Study|Withdrawal by Subject|13
3102804|NCT00265382|10632686|P1|Overall Study|Miscellaneous|6
3102805|NCT00265382|10632686|P1|Overall Study|Lack of Efficacy|6
3102806|NCT00265382|10632686|P1|Overall Study|Lost to Follow-up|3
3102807|NCT00265382|10632686|P1|Overall Study|Laboratory Abnormality|1
3102808|NCT00265382|10632686|P1|Overall Study|Adverse Event|21
3102809|NCT00265343|10632706|P2|Overall Study|Other|3
3102810|NCT00265343|10632707|P1|Overall Study|Other|8
3102811|NCT00265343|10632706|P2|Overall Study|Withdrawal by Subject|9
3102812|NCT00265343|10632707|P1|Overall Study|Withdrawal by Subject|3
3102813|NCT00265343|10632706|P2|Overall Study|Adverse Event|7
3102814|NCT00265343|10632707|P1|Overall Study|Adverse Event|10
3102815|NCT00265330|10632715|P1|Overall Study|Protocol Violation|1
3102816|NCT00265330|10632715|P1|Overall Study|Withdrew Consent|1
3102817|NCT00265330|10632715|P1|Overall Study|Principal Investigators Request|1
3102818|NCT00265330|10632715|P1|Overall Study|Site Closed by Sponsor|1
3102819|NCT00265330|10632715|P1|Overall Study|Discharged from Unit for Long Term Care|1
3102820|NCT00265330|10632715|P1|Overall Study|Began Taking Formulary Geodon|1
3102821|NCT00265330|10632715|P1|Overall Study|Family Scheduling Conflicts|1
3102822|NCT00265330|10632715|P1|Overall Study|Lack of Efficacy|4
3102823|NCT00265330|10632715|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
3102824|NCT00265330|10632715|P1|Overall Study|Withdrawal by Subject|34
3102825|NCT00265330|10632715|P1|Overall Study|Lost to Follow-up|8
3102826|NCT00265330|10632715|P1|Overall Study|Adverse Event|41
3102827|NCT00265317|10632741|P4|Phase 2|Other|1
3102828|NCT00265317|10632742|P3|Phase 2|Other|1
3102829|NCT00265317|10632743|P2|Phase 2|Other|0
3102830|NCT00265317|10632744|P1|Phase 2|Other|0
3102831|NCT00265317|10632741|P4|Phase 2|Study terminated by sponsor|0
3102832|NCT00265317|10632742|P3|Phase 2|Study terminated by sponsor|1
3102833|NCT00265317|10632743|P2|Phase 2|Study terminated by sponsor|0
3102834|NCT00265317|10632744|P1|Phase 2|Study terminated by sponsor|0
3102835|NCT00265317|10632741|P4|Phase 2|Withdrawal/other than adverse event|1
3102836|NCT00265317|10632742|P3|Phase 2|Withdrawal/other than adverse event|2
3102837|NCT00265317|10632743|P2|Phase 2|Withdrawal/other than adverse event|0
3102838|NCT00265317|10632744|P1|Phase 2|Withdrawal/other than adverse event|0
3102839|NCT00265317|10632741|P4|Phase 2|Lost to Follow-up|1
3102840|NCT00265317|10632742|P3|Phase 2|Lost to Follow-up|0
3102841|NCT00265317|10632743|P2|Phase 2|Lost to Follow-up|0
3102842|NCT00265317|10632744|P1|Phase 2|Lost to Follow-up|0
3102843|NCT00265317|10632741|P4|Phase 2|Protocol Violation|4
3102844|NCT00265317|10632742|P3|Phase 2|Protocol Violation|1
3102845|NCT00265317|10632743|P2|Phase 2|Protocol Violation|0
3102846|NCT00265317|10632744|P1|Phase 2|Protocol Violation|0
3102847|NCT00265317|10632741|P4|Phase 2|Death|15
3102848|NCT00265317|10632742|P3|Phase 2|Death|12
3102849|NCT00265317|10632743|P2|Phase 2|Death|0
3102850|NCT00265317|10632744|P1|Phase 2|Death|0
3102851|NCT00265317|10632741|P4|Phase 2|Adverse Event|5
3102852|NCT00265317|10632742|P3|Phase 2|Adverse Event|7
3102853|NCT00265317|10632743|P2|Phase 2|Adverse Event|0
3102854|NCT00265317|10632744|P1|Phase 2|Adverse Event|0
3102855|NCT00265317|10632741|P4|Phase 2|Global deterioration of health status|0
3102856|NCT00265317|10632742|P3|Phase 2|Global deterioration of health status|3
3102857|NCT00265317|10632743|P2|Phase 2|Global deterioration of health status|0
3102858|NCT00265317|10632744|P1|Phase 2|Global deterioration of health status|0
3102859|NCT00265317|10632741|P4|Phase 2|Objective progression or relapse|38
3102860|NCT00265317|10632742|P3|Phase 2|Objective progression or relapse|37
3102861|NCT00265317|10632743|P2|Phase 2|Objective progression or relapse|0
3102862|NCT00265317|10632744|P1|Phase 2|Objective progression or relapse|0
3102863|NCT00265317|10632741|P4|Lead-In|Withdrawal/other than adverse event|0
3102864|NCT00265317|10632742|P3|Lead-In|Withdrawal/other than adverse event|0
3102865|NCT00265317|10632743|P2|Lead-In|Withdrawal/other than adverse event|0
3102866|NCT00265317|10632744|P1|Lead-In|Withdrawal/other than adverse event|1
3102867|NCT00265317|10632741|P4|Lead-In|Death|0
3102868|NCT00265317|10632742|P3|Lead-In|Death|0
3102869|NCT00265317|10632743|P2|Lead-In|Death|5
3102870|NCT00265317|10632744|P1|Lead-In|Death|3
3102871|NCT00265317|10632741|P4|Lead-In|Adverse Event|0
3102872|NCT00265317|10632742|P3|Lead-In|Adverse Event|0
3102873|NCT00265317|10632743|P2|Lead-In|Adverse Event|1
3102874|NCT00265317|10632744|P1|Lead-In|Adverse Event|2
3102875|NCT00265317|10632741|P4|Lead-In|Objective progression or relapse|0
3102876|NCT00265317|10632742|P3|Lead-In|Objective progression or relapse|0
3102877|NCT00265317|10632743|P2|Lead-In|Objective progression or relapse|11
3102878|NCT00265317|10632744|P1|Lead-In|Objective progression or relapse|6
3102879|NCT00265239|10632859|P2|Overall Study|Adverse Event|1
3102880|NCT00265239|10632860|P1|Overall Study|Adverse Event|2
3102881|NCT00265122|10632882|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
3102882|NCT00265122|10632883|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
3102883|NCT00265122|10632884|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
3102884|NCT00265122|10632885|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
3102885|NCT00265122|10632886|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
3102886|NCT00265122|10632887|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
3102887|NCT00265122|10632882|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
3102888|NCT00265122|10632883|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
3102889|NCT00265122|10632884|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
3102890|NCT00265122|10632885|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
3102891|NCT00265122|10632886|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
3102892|NCT00265122|10632887|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
3102893|NCT00265122|10632882|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
3102894|NCT00265122|10632883|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
3102895|NCT00265122|10632884|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
3102896|NCT00265122|10632885|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
3102897|NCT00265122|10632886|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
3102898|NCT00265122|10632887|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
3102899|NCT00265122|10632882|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
3102900|NCT00265122|10632883|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
3102901|NCT00265122|10632884|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
3102902|NCT00265122|10632885|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
3102903|NCT00265122|10632886|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
3102904|NCT00265122|10632887|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
3102905|NCT00265122|10632882|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
3102906|NCT00265122|10632883|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
3102907|NCT00265122|10632884|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
3102908|NCT00265122|10632885|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
3102909|NCT00265122|10632886|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
3102910|NCT00265122|10632887|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
3102911|NCT00265122|10632882|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
3102912|NCT00265122|10632883|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
3102913|NCT00265122|10632884|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
3102914|NCT00265122|10632885|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
3102915|NCT00265122|10632886|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
3102916|NCT00265122|10632887|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
3102917|NCT00265109|10632909|P1|Overall Study|Adverse Event|1
3102918|NCT00265109|10632909|P1|Overall Study|Withdrawal by Subject|5
3102919|NCT00265096|10632928|P3|Overall Study|Other|10
3102920|NCT00265096|10632929|P2|Overall Study|Other|19
3102921|NCT00265096|10632930|P1|Overall Study|Other|11
3102922|NCT00265096|10632928|P3|Overall Study|Unsatisfactory therapeutic effect|6
3102923|NCT00265096|10632929|P2|Overall Study|Unsatisfactory therapeutic effect|8
3102924|NCT00265096|10632930|P1|Overall Study|Unsatisfactory therapeutic effect|9
3102925|NCT00265096|10632928|P3|Overall Study|Death|2
3102926|NCT00265096|10632929|P2|Overall Study|Death|1
3102927|NCT00265096|10632930|P1|Overall Study|Death|0
3102928|NCT00265096|10632928|P3|Overall Study|Lost to Follow-up|3
3102929|NCT00265096|10632929|P2|Overall Study|Lost to Follow-up|5
3102930|NCT00265096|10632930|P1|Overall Study|Lost to Follow-up|2
3102931|NCT00265096|10632928|P3|Overall Study|Adverse Event|18
3102932|NCT00265096|10632929|P2|Overall Study|Adverse Event|18
3102933|NCT00265096|10632930|P1|Overall Study|Adverse Event|14
3102934|NCT00265083|10632962|P3|Overall Study|Other|9
3102935|NCT00265083|10632963|P2|Overall Study|Other|12
3102936|NCT00265083|10632964|P1|Overall Study|Other|1
3102937|NCT00265083|10632962|P3|Overall Study|Unsatisfactory therapeutic effect|14
3102938|NCT00265083|10632963|P2|Overall Study|Unsatisfactory therapeutic effect|13
3102939|NCT00265083|10632964|P1|Overall Study|Unsatisfactory therapeutic effect|8
3102940|NCT00265083|10632962|P3|Overall Study|Lost to Follow-up|4
3102941|NCT00265083|10632963|P2|Overall Study|Lost to Follow-up|4
3102942|NCT00265083|10632964|P1|Overall Study|Lost to Follow-up|3
3102943|NCT00265083|10632962|P3|Overall Study|Adverse Event|15
3102944|NCT00265083|10632963|P2|Overall Study|Adverse Event|13
3102945|NCT00265083|10632964|P1|Overall Study|Adverse Event|5
3102946|NCT00264875|10632985|P1|Overall Study|Withdrawal by Subject|7
3102947|NCT00264875|10632985|P1|Overall Study|Protocol Violation|11
3102948|NCT00264875|10632985|P1|Overall Study|Lost to Follow-up|6
3102949|NCT00264875|10632985|P1|Overall Study|Adverse Event|6
3102950|NCT00264849|10632991|P2|Overall Study|Administrative Problems|0
3102951|NCT00264849|10632992|P1|Overall Study|Administrative Problems|2
3102952|NCT00264849|10632991|P2|Overall Study|Death|1
3102953|NCT00264849|10632992|P1|Overall Study|Death|0
3102954|NCT00264849|10632991|P2|Overall Study|Lost to Follow-up|2
3102955|NCT00264849|10632992|P1|Overall Study|Lost to Follow-up|0
3102956|NCT00264849|10632991|P2|Overall Study|Lack of Efficacy|6
3102957|NCT00264849|10632992|P1|Overall Study|Lack of Efficacy|1
3102958|NCT00264849|10632991|P2|Overall Study|Protocol Violation|3
3102959|NCT00264849|10632992|P1|Overall Study|Protocol Violation|5
3102960|NCT00264849|10632991|P2|Overall Study|Withdrawal by Subject|11
3102961|NCT00264849|10632992|P1|Overall Study|Withdrawal by Subject|7
3102962|NCT00264849|10632991|P2|Overall Study|Adverse Event|2
3102963|NCT00264849|10632992|P1|Overall Study|Adverse Event|7
3102964|NCT00264810|10633026|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
3102965|NCT00264810|10633027|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
3102966|NCT00264810|10633026|P2|Open Label Evaluation Period|Death|2
3102967|NCT00264810|10633027|P1|Open Label Evaluation Period|Death|3
3102968|NCT00264810|10633026|P2|Open Label Evaluation Period|Explant due to infection|1
3102969|NCT00264810|10633027|P1|Open Label Evaluation Period|Explant due to infection|1
3102970|NCT00264810|10633026|P2|Blinded Evaluation Period|Explant due to infection|1
3102971|NCT00264810|10633027|P1|Blinded Evaluation Period|Explant due to infection|1
3102972|NCT00264810|10633026|P2|Stimulation Optimization Period|Death|1
3102973|NCT00264810|10633027|P1|Stimulation Optimization Period|Death|0
3102974|NCT00264810|10633026|P2|Stimulation Optimization Period|Withdrawal by Subject|0
3102975|NCT00264810|10633027|P1|Stimulation Optimization Period|Withdrawal by Subject|1
3102976|NCT00264810|10633026|P2|Baseline|Other|1
3102977|NCT00264810|10633027|P1|Baseline|Other|0
3102978|NCT00264810|10633026|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
3102979|NCT00264810|10633027|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
3102980|NCT00264810|10633026|P2|Baseline|Insufficient Seizure Frequency|2
3102981|NCT00264810|10633027|P1|Baseline|Insufficient Seizure Frequency|2
3102982|NCT00264810|10633026|P2|Baseline|Subject Compliance Failure|3
3102983|NCT00264810|10633027|P1|Baseline|Subject Compliance Failure|3
3102984|NCT00264810|10633026|P2|Baseline|Physician Decision|8
3102985|NCT00264810|10633027|P1|Baseline|Physician Decision|7
3102986|NCT00264810|10633026|P2|Baseline|Withdrawal by Subject|10
3102987|NCT00264810|10633027|P1|Baseline|Withdrawal by Subject|10
3102988|NCT00264797|10633037|P2|Overall Study|Other|4
3102989|NCT00264797|10633038|P1|Overall Study|Other|3
3102990|NCT00264797|10633037|P2|Overall Study|Feels treatment not necessary, not worki|1
3102991|NCT00264797|10633038|P1|Overall Study|Feels treatment not necessary, not worki|0
3102992|NCT00264797|10633037|P2|Overall Study|Pressure/advice from Outsiders|1
3102993|NCT00264797|10633038|P1|Overall Study|Pressure/advice from Outsiders|1
3102994|NCT00264797|10633037|P2|Overall Study|Incarceration|5
3102995|NCT00264797|10633038|P1|Overall Study|Incarceration|4
3102996|NCT00264797|10633037|P2|Overall Study|Practical Problems|3
3102997|NCT00264797|10633038|P1|Overall Study|Practical Problems|2
3102998|NCT00264797|10633037|P2|Overall Study|Moved from area|1
3102999|NCT00264797|10633038|P1|Overall Study|Moved from area|3
3103000|NCT00264797|10633037|P2|Overall Study|Lost to Follow-up|17
3103001|NCT00264797|10633038|P1|Overall Study|Lost to Follow-up|9
3103002|NCT00264797|10633037|P2|Overall Study|Withdrawal by Subject|11
3103003|NCT00264797|10633038|P1|Overall Study|Withdrawal by Subject|11
3103004|NCT00264576|10633060|P2|Overall Study|Lost to Follow-up|1
3103005|NCT00264576|10633061|P1|Overall Study|Lost to Follow-up|1
3103006|NCT00264550|10633085|P4|Overall Study|Other|9
3103007|NCT00264550|10633086|P3|Overall Study|Other|3
3103008|NCT00264550|10633087|P2|Overall Study|Other|7
3103009|NCT00264550|10633088|P1|Overall Study|Other|13
3103010|NCT00264550|10633085|P4|Overall Study|Discontinued oral study agent|0
3103011|NCT00264550|10633086|P3|Overall Study|Discontinued oral study agent|0
3103012|NCT00264550|10633087|P2|Overall Study|Discontinued oral study agent|1
3103013|NCT00264550|10633088|P1|Overall Study|Discontinued oral study agent|0
3103014|NCT00264550|10633085|P4|Overall Study|Unsatisfactory therapeutic effect|6
3103015|NCT00264550|10633086|P3|Overall Study|Unsatisfactory therapeutic effect|4
3103016|NCT00264550|10633087|P2|Overall Study|Unsatisfactory therapeutic effect|11
3103017|NCT00264550|10633088|P1|Overall Study|Unsatisfactory therapeutic effect|4
3103018|NCT00264550|10633085|P4|Overall Study|Adverse Event|14
3103019|NCT00264550|10633086|P3|Overall Study|Adverse Event|9
3103020|NCT00264550|10633087|P2|Overall Study|Adverse Event|18
3103021|NCT00264550|10633088|P1|Overall Study|Adverse Event|23
3103022|NCT00264550|10633085|P4|Overall Study|Lost to Follow-up|1
3103023|NCT00264550|10633086|P3|Overall Study|Lost to Follow-up|1
3103024|NCT00264550|10633087|P2|Overall Study|Lost to Follow-up|1
3103025|NCT00264550|10633088|P1|Overall Study|Lost to Follow-up|3
3103026|NCT00264550|10633085|P4|Overall Study|Death|0
3103027|NCT00264550|10633086|P3|Overall Study|Death|0
3103028|NCT00264550|10633087|P2|Overall Study|Death|3
3103029|NCT00264550|10633088|P1|Overall Study|Death|0
3103030|NCT00264537|10633127|P4|Overall Study|Not treated|0
3103031|NCT00264537|10633128|P3|Overall Study|Not treated|1
3103032|NCT00264537|10633129|P2|Overall Study|Not treated|2
3103033|NCT00264537|10633130|P1|Overall Study|Not treated|0
3103034|NCT00264537|10633127|P4|Overall Study|Other|11
3103035|NCT00264537|10633128|P3|Overall Study|Other|10
3103036|NCT00264537|10633129|P2|Overall Study|Other|11
3103037|NCT00264537|10633130|P1|Overall Study|Other|21
3103038|NCT00264537|10633127|P4|Overall Study|Unsatisfactory therapeutic effect|7
3103039|NCT00264537|10633128|P3|Overall Study|Unsatisfactory therapeutic effect|5
3103040|NCT00264537|10633129|P2|Overall Study|Unsatisfactory therapeutic effect|6
3103041|NCT00264537|10633130|P1|Overall Study|Unsatisfactory therapeutic effect|5
3103042|NCT00264537|10633127|P4|Overall Study|Adverse Event|34
3103043|NCT00264537|10633128|P3|Overall Study|Adverse Event|24
3103044|NCT00264537|10633129|P2|Overall Study|Adverse Event|32
3103045|NCT00264537|10633130|P1|Overall Study|Adverse Event|21
3103046|NCT00264537|10633127|P4|Overall Study|Lost to Follow-up|6
3103047|NCT00264537|10633128|P3|Overall Study|Lost to Follow-up|7
3103048|NCT00264537|10633129|P2|Overall Study|Lost to Follow-up|4
3103049|NCT00264537|10633130|P1|Overall Study|Lost to Follow-up|3
3103050|NCT00264537|10633127|P4|Overall Study|Death|2
3103051|NCT00264537|10633128|P3|Overall Study|Death|3
3103052|NCT00264537|10633129|P2|Overall Study|Death|3
3103053|NCT00264537|10633130|P1|Overall Study|Death|0
3103054|NCT00264498|10633162|P2|Crossover Treatment|Withdrawal by Subject|0
3103055|NCT00264498|10633163|P1|Crossover Treatment|Withdrawal by Subject|1
3103056|NCT00264498|10633162|P2|Crossover Treatment|Study closure|1
3103057|NCT00264498|10633163|P1|Crossover Treatment|Study closure|0
3103058|NCT00264498|10633162|P2|Crossover Treatment|Objective disease progression|5
3103059|NCT00264498|10633163|P1|Crossover Treatment|Objective disease progression|4
3103060|NCT00264498|10633162|P2|Crossover Treatment|Death|3
3103061|NCT00264498|10633163|P1|Crossover Treatment|Death|1
3103062|NCT00264498|10633162|P2|Randomized Treatment|Protocol Violation|0
3103063|NCT00264498|10633163|P1|Randomized Treatment|Protocol Violation|1
3103064|NCT00264498|10633162|P2|Randomized Treatment|Study Closure|0
3103065|NCT00264498|10633163|P1|Randomized Treatment|Study Closure|1
3103066|NCT00264498|10633162|P2|Randomized Treatment|Incorrectly randomized|0
3103067|NCT00264498|10633163|P1|Randomized Treatment|Incorrectly randomized|1
3103068|NCT00264498|10633162|P2|Randomized Treatment|Physician Decision|0
3103069|NCT00264498|10633163|P1|Randomized Treatment|Physician Decision|1
3103070|NCT00264498|10633162|P2|Randomized Treatment|Objective disease Progression|14
3103071|NCT00264498|10633163|P1|Randomized Treatment|Objective disease Progression|13
3103072|NCT00264498|10633162|P2|Randomized Treatment|Withdrawal by Subject|1
3103073|NCT00264498|10633163|P1|Randomized Treatment|Withdrawal by Subject|0
3103074|NCT00264498|10633162|P2|Randomized Treatment|Death|3
3103075|NCT00264498|10633163|P1|Randomized Treatment|Death|0
3103076|NCT00264303|10633186|P2|Overall Study|Various reasons listed in study report|7
3103077|NCT00264303|10633187|P1|Overall Study|Various reasons listed in study report|6
3103078|NCT00264303|10633186|P2|Overall Study|Withdrawal by Subject|3
3103079|NCT00264303|10633187|P1|Overall Study|Withdrawal by Subject|2
3103080|NCT00264303|10633186|P2|Overall Study|Lost to Follow-up|3
3103081|NCT00264303|10633187|P1|Overall Study|Lost to Follow-up|3
3103082|NCT00264303|10633186|P2|Overall Study|Lack of Efficacy|13
3103083|NCT00264303|10633187|P1|Overall Study|Lack of Efficacy|10
3103084|NCT00264303|10633186|P2|Overall Study|Adverse Event|3
3103085|NCT00264303|10633187|P1|Overall Study|Adverse Event|4
3103086|NCT00264290|10633205|P2|Intervention (8 Weeks)|Adverse Event|0
3103087|NCT00264290|10633206|P1|Intervention (8 Weeks)|Adverse Event|1
3103088|NCT00264238|10633212|P1|Overall Study|Protocol Violation|1
3103089|NCT00264147|10633224|P6|Treatment II Period|Pre-scheduled total hip replacement|1
3103090|NCT00264147|10633225|P5|Treatment II Period|Pre-scheduled total hip replacement|0
3103091|NCT00264147|10633226|P4|Treatment II Period|Pre-scheduled total hip replacement|0
3103092|NCT00264147|10633227|P3|Treatment II Period|Pre-scheduled total hip replacement|0
3103093|NCT00264147|10633228|P2|Treatment II Period|Pre-scheduled total hip replacement|0
3103094|NCT00264147|10633229|P1|Treatment II Period|Pre-scheduled total hip replacement|0
3103095|NCT00264147|10633224|P6|Treatment II Period|Withdrawal by Subject|2
3103096|NCT00264147|10633225|P5|Treatment II Period|Withdrawal by Subject|3
3103097|NCT00264147|10633226|P4|Treatment II Period|Withdrawal by Subject|0
3103098|NCT00264147|10633227|P3|Treatment II Period|Withdrawal by Subject|0
3103099|NCT00264147|10633228|P2|Treatment II Period|Withdrawal by Subject|0
3103100|NCT00264147|10633229|P1|Treatment II Period|Withdrawal by Subject|0
3103101|NCT00264147|10633224|P6|Treatment II Period|Lost to Follow-up|1
3103102|NCT00264147|10633225|P5|Treatment II Period|Lost to Follow-up|1
3103103|NCT00264147|10633226|P4|Treatment II Period|Lost to Follow-up|0
3103104|NCT00264147|10633227|P3|Treatment II Period|Lost to Follow-up|0
3103105|NCT00264147|10633228|P2|Treatment II Period|Lost to Follow-up|0
3103106|NCT00264147|10633229|P1|Treatment II Period|Lost to Follow-up|0
3103107|NCT00264147|10633224|P6|Treatment II Period|Lack of Efficacy|19
3103108|NCT00264147|10633225|P5|Treatment II Period|Lack of Efficacy|20
3103109|NCT00264147|10633226|P4|Treatment II Period|Lack of Efficacy|0
3103110|NCT00264147|10633227|P3|Treatment II Period|Lack of Efficacy|0
3103111|NCT00264147|10633228|P2|Treatment II Period|Lack of Efficacy|0
3103112|NCT00264147|10633229|P1|Treatment II Period|Lack of Efficacy|0
3103113|NCT00264147|10633224|P6|Treatment II Period|Laboratory Adverse Event|1
3103114|NCT00264147|10633225|P5|Treatment II Period|Laboratory Adverse Event|0
3103115|NCT00264147|10633226|P4|Treatment II Period|Laboratory Adverse Event|0
3103116|NCT00264147|10633227|P3|Treatment II Period|Laboratory Adverse Event|0
3103117|NCT00264147|10633228|P2|Treatment II Period|Laboratory Adverse Event|0
3103118|NCT00264147|10633229|P1|Treatment II Period|Laboratory Adverse Event|0
3103119|NCT00264147|10633224|P6|Treatment II Period|Adverse Event|9
3103120|NCT00264147|10633225|P5|Treatment II Period|Adverse Event|9
3103121|NCT00264147|10633226|P4|Treatment II Period|Adverse Event|0
3103122|NCT00264147|10633227|P3|Treatment II Period|Adverse Event|0
3103123|NCT00264147|10633228|P2|Treatment II Period|Adverse Event|0
3103124|NCT00264147|10633229|P1|Treatment II Period|Adverse Event|0
3103125|NCT00264147|10633224|P6|Treatment I Period|Reassigned to Treatment II Period|0
3103126|NCT00264147|10633225|P5|Treatment I Period|Reassigned to Treatment II Period|45
3103127|NCT00264147|10633226|P4|Treatment I Period|Reassigned to Treatment II Period|63
3103128|NCT00264147|10633227|P3|Treatment I Period|Reassigned to Treatment II Period|65
3103129|NCT00264147|10633228|P2|Treatment I Period|Reassigned to Treatment II Period|72
3103130|NCT00264147|10633229|P1|Treatment I Period|Reassigned to Treatment II Period|84
3103131|NCT00264147|10633224|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
3103132|NCT00264147|10633225|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
3103133|NCT00264147|10633226|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
3103134|NCT00264147|10633227|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
3103135|NCT00264147|10633228|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
3103136|NCT00264147|10633229|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
3103137|NCT00264147|10633224|P6|Treatment I Period|Patient out of town for an extended time|0
3103138|NCT00264147|10633225|P5|Treatment I Period|Patient out of town for an extended time|0
3103139|NCT00264147|10633226|P4|Treatment I Period|Patient out of town for an extended time|0
3103140|NCT00264147|10633227|P3|Treatment I Period|Patient out of town for an extended time|0
3103141|NCT00264147|10633228|P2|Treatment I Period|Patient out of town for an extended time|1
3103142|NCT00264147|10633229|P1|Treatment I Period|Patient out of town for an extended time|0
3103143|NCT00264147|10633224|P6|Treatment I Period|Withdrawal by Subject|0
3103144|NCT00264147|10633225|P5|Treatment I Period|Withdrawal by Subject|2
3103145|NCT00264147|10633226|P4|Treatment I Period|Withdrawal by Subject|2
3103146|NCT00264147|10633227|P3|Treatment I Period|Withdrawal by Subject|0
3103147|NCT00264147|10633228|P2|Treatment I Period|Withdrawal by Subject|0
3103148|NCT00264147|10633229|P1|Treatment I Period|Withdrawal by Subject|2
3103149|NCT00264147|10633224|P6|Treatment I Period|Protocol Violation|0
3103150|NCT00264147|10633225|P5|Treatment I Period|Protocol Violation|0
3103151|NCT00264147|10633226|P4|Treatment I Period|Protocol Violation|0
3103152|NCT00264147|10633227|P3|Treatment I Period|Protocol Violation|0
3103153|NCT00264147|10633228|P2|Treatment I Period|Protocol Violation|2
3103154|NCT00264147|10633229|P1|Treatment I Period|Protocol Violation|2
3103155|NCT00264147|10633224|P6|Treatment I Period|Lost to Follow-up|0
3103156|NCT00264147|10633225|P5|Treatment I Period|Lost to Follow-up|1
3103157|NCT00264147|10633226|P4|Treatment I Period|Lost to Follow-up|1
3103158|NCT00264147|10633227|P3|Treatment I Period|Lost to Follow-up|0
3103159|NCT00264147|10633228|P2|Treatment I Period|Lost to Follow-up|0
3103160|NCT00264147|10633229|P1|Treatment I Period|Lost to Follow-up|1
3103161|NCT00264147|10633224|P6|Treatment I Period|Lack of Efficacy|0
3103162|NCT00264147|10633225|P5|Treatment I Period|Lack of Efficacy|1
3103163|NCT00264147|10633226|P4|Treatment I Period|Lack of Efficacy|0
3103164|NCT00264147|10633227|P3|Treatment I Period|Lack of Efficacy|8
3103165|NCT00264147|10633228|P2|Treatment I Period|Lack of Efficacy|2
3103166|NCT00264147|10633229|P1|Treatment I Period|Lack of Efficacy|6
3103167|NCT00264147|10633224|P6|Treatment I Period|Laboratory Adverse Event|0
3103168|NCT00264147|10633225|P5|Treatment I Period|Laboratory Adverse Event|0
3103169|NCT00264147|10633226|P4|Treatment I Period|Laboratory Adverse Event|1
3103170|NCT00264147|10633227|P3|Treatment I Period|Laboratory Adverse Event|0
3103171|NCT00264147|10633228|P2|Treatment I Period|Laboratory Adverse Event|0
3103172|NCT00264147|10633229|P1|Treatment I Period|Laboratory Adverse Event|0
3103173|NCT00264147|10633224|P6|Treatment I Period|Adverse Event|0
3103174|NCT00264147|10633225|P5|Treatment I Period|Adverse Event|7
3103175|NCT00264147|10633226|P4|Treatment I Period|Adverse Event|5
3103176|NCT00264147|10633227|P3|Treatment I Period|Adverse Event|3
3103177|NCT00264147|10633228|P2|Treatment I Period|Adverse Event|6
3103178|NCT00264147|10633229|P1|Treatment I Period|Adverse Event|3
3103179|NCT00264004|10633272|P4|Overall Study|Not treated|2
3103180|NCT00264004|10633273|P3|Overall Study|Not treated|2
3103181|NCT00264004|10633274|P2|Overall Study|Not treated|0
3103182|NCT00264004|10633275|P1|Overall Study|Not treated|3
3103183|NCT00264004|10633272|P4|Overall Study|Cond. under inv. worsened|4
3103184|NCT00264004|10633273|P3|Overall Study|Cond. under inv. worsened|3
3103185|NCT00264004|10633274|P2|Overall Study|Cond. under inv. worsened|5
3103186|NCT00264004|10633275|P1|Overall Study|Cond. under inv. worsened|9
3103187|NCT00264004|10633272|P4|Overall Study|Development study specific disc. crit.|0
3103188|NCT00264004|10633273|P3|Overall Study|Development study specific disc. crit.|1
3103189|NCT00264004|10633274|P2|Overall Study|Development study specific disc. crit.|0
3103190|NCT00264004|10633275|P1|Overall Study|Development study specific disc. crit.|1
3103191|NCT00264004|10633272|P4|Overall Study|Other|3
3103192|NCT00264004|10633273|P3|Overall Study|Other|0
3103193|NCT00264004|10633274|P2|Overall Study|Other|2
3103194|NCT00264004|10633275|P1|Overall Study|Other|2
3103195|NCT00264004|10633272|P4|Overall Study|Withdrawal by Subject|2
3103196|NCT00264004|10633273|P3|Overall Study|Withdrawal by Subject|2
3103197|NCT00264004|10633274|P2|Overall Study|Withdrawal by Subject|1
3103198|NCT00264004|10633275|P1|Overall Study|Withdrawal by Subject|0
3103199|NCT00264004|10633272|P4|Overall Study|Adverse Event|4
3103200|NCT00264004|10633273|P3|Overall Study|Adverse Event|6
3103201|NCT00264004|10633274|P2|Overall Study|Adverse Event|3
3103202|NCT00264004|10633275|P1|Overall Study|Adverse Event|2
3103203|NCT00263887|10633303|P2|Overall Study|Lack of Efficacy|1
3103204|NCT00263887|10633304|P1|Overall Study|Lack of Efficacy|0
3103205|NCT00263887|10633303|P2|Overall Study|Disease progression|1
3103206|NCT00263887|10633304|P1|Overall Study|Disease progression|0
3103207|NCT00263887|10633303|P2|Overall Study|Adverse Event|2
3103208|NCT00263887|10633304|P1|Overall Study|Adverse Event|0
3103209|NCT00263887|10633303|P2|Overall Study|Too ill to attend visit|0
3103210|NCT00263887|10633304|P1|Overall Study|Too ill to attend visit|1
3103211|NCT00263887|10633303|P2|Overall Study|Lung transplantation|2
3103212|NCT00263887|10633304|P1|Overall Study|Lung transplantation|1
3103213|NCT00263887|10633303|P2|Overall Study|Withdrawal by Subject|1
3103214|NCT00263887|10633304|P1|Overall Study|Withdrawal by Subject|1
3103215|NCT00263757|10633312|P2|Overall Study|Adverse Event|3
3103216|NCT00263757|10633313|P1|Overall Study|Adverse Event|3
3103217|NCT00263757|10633312|P2|Overall Study|Screen failure|1
3103218|NCT00263757|10633313|P1|Overall Study|Screen failure|0
3103219|NCT00263757|10633312|P2|Overall Study|Withdrawal by Subject|4
3103220|NCT00263757|10633313|P1|Overall Study|Withdrawal by Subject|5
3103221|NCT00263666|10633325|P2|Overall Study|Withdrawal by Subject|1
3103222|NCT00263666|10633326|P1|Overall Study|Withdrawal by Subject|0
3103223|NCT00263666|10633325|P2|Overall Study|Lost to Follow-up|2
3103224|NCT00263666|10633326|P1|Overall Study|Lost to Follow-up|1
3103225|NCT00263666|10633325|P2|Overall Study|Adverse Event|8
3103226|NCT00263666|10633326|P1|Overall Study|Adverse Event|6
3103227|NCT00263588|10633379|P2|Overall Study|Sponsor terminated study|1
3103228|NCT00263588|10633380|P1|Overall Study|Sponsor terminated study|0
3103229|NCT00263588|10633379|P2|Overall Study|Investigator decision|15
3103230|NCT00263588|10633380|P1|Overall Study|Investigator decision|7
3103231|NCT00263588|10633379|P2|Overall Study|Protocol Violation|1
3103232|NCT00263588|10633380|P1|Overall Study|Protocol Violation|0
3103233|NCT00263588|10633379|P2|Overall Study|Withdrawal by Subject|4
3103234|NCT00263588|10633380|P1|Overall Study|Withdrawal by Subject|3
3103235|NCT00263588|10633379|P2|Overall Study|Lost to Follow-up|10
3103236|NCT00263588|10633380|P1|Overall Study|Lost to Follow-up|7
3103237|NCT00263588|10633379|P2|Overall Study|disease progression, coma, 1 unknown|11
3103238|NCT00263588|10633380|P1|Overall Study|disease progression, coma, 1 unknown|10
3103239|NCT00263588|10633379|P2|Overall Study|Death|90
3103240|NCT00263588|10633380|P1|Overall Study|Death|54
3103241|NCT00263328|10633406|P3|Overall Study|Adverse Event|4
3103242|NCT00263328|10633407|P2|Overall Study|Adverse Event|1
3103243|NCT00263328|10633408|P1|Overall Study|Adverse Event|1
3103244|NCT00263328|10633406|P3|Overall Study|Other|1
3103245|NCT00263328|10633407|P2|Overall Study|Other|0
3103246|NCT00263328|10633408|P1|Overall Study|Other|3
3103247|NCT00263328|10633406|P3|Overall Study|Withdrawal by Subject|1
3103248|NCT00263328|10633407|P2|Overall Study|Withdrawal by Subject|0
3103249|NCT00263328|10633408|P1|Overall Study|Withdrawal by Subject|3
3103250|NCT00263328|10633406|P3|Overall Study|Lost to Follow-up|0
3103251|NCT00263328|10633407|P2|Overall Study|Lost to Follow-up|1
3103252|NCT00263328|10633408|P1|Overall Study|Lost to Follow-up|1
3103253|NCT00263328|10633406|P3|Overall Study|Death|1
3103254|NCT00263328|10633407|P2|Overall Study|Death|0
3103255|NCT00263328|10633408|P1|Overall Study|Death|0
3103256|NCT00263211|10633566|P2|Overall Study|Disease Progression|1
3103257|NCT00263211|10633567|P1|Overall Study|Disease Progression|0
3103258|NCT00263211|10633566|P2|Overall Study|Protocol Violation|0
3103259|NCT00263211|10633567|P1|Overall Study|Protocol Violation|1
3103260|NCT00263211|10633566|P2|Overall Study|Withdrawal by Subject|0
3103261|NCT00263211|10633567|P1|Overall Study|Withdrawal by Subject|3
3103262|NCT00263211|10633566|P2|Overall Study|Death|0
3103263|NCT00263211|10633567|P1|Overall Study|Death|1
3103264|NCT00262951|10633618|P1|Overall Study|Off treatment for other disease|1
3103265|NCT00262951|10633618|P1|Overall Study|Alternative treatment|3
3103266|NCT00262951|10633618|P1|Overall Study|Withdrawal by Subject|1
3103267|NCT00262951|10633618|P1|Overall Study|Death|1
3103268|NCT00262951|10633618|P1|Overall Study|Adverse Event|7
3103269|NCT00262951|10633618|P1|Overall Study|Progressive disease/relapse|3
3103270|NCT00262925|10633623|P1|Overall Study|Other|1
3103271|NCT00262925|10633623|P1|Overall Study|alternative therapy|1
3103272|NCT00262925|10633623|P1|Overall Study|Death|2
3103273|NCT00262925|10633623|P1|Overall Study|Adverse Event|4
3103274|NCT00262925|10633623|P1|Overall Study|Lack of Efficacy|3
3103275|NCT00262873|10633629|P1|Overall Study|Withdrawal by Subject|5
3103276|NCT00262873|10633629|P1|Overall Study|Adverse Event|3
3103277|NCT00262860|10633640|P1|Overall Study|Adverse Event|2
3103278|NCT00262847|10633649|P3|Overall Study|Did not receive study treatment|4
3103279|NCT00262847|10633650|P2|Overall Study|Did not receive study treatment|1
3103280|NCT00262847|10633651|P1|Overall Study|Did not receive study treatment|4
3103281|NCT00262847|10633649|P3|Overall Study|Other Reasons|27
3103282|NCT00262847|10633650|P2|Overall Study|Other Reasons|88
3103283|NCT00262847|10633651|P1|Overall Study|Other Reasons|79
3103284|NCT00262847|10633649|P3|Overall Study|Concomitant disease|4
3103285|NCT00262847|10633650|P2|Overall Study|Concomitant disease|2
3103286|NCT00262847|10633651|P1|Overall Study|Concomitant disease|3
3103287|NCT00262847|10633649|P3|Overall Study|Death|11
3103288|NCT00262847|10633650|P2|Overall Study|Death|8
3103289|NCT00262847|10633651|P1|Overall Study|Death|8
3103290|NCT00262847|10633649|P3|Overall Study|Adverse Event|108
3103291|NCT00262847|10633650|P2|Overall Study|Adverse Event|88
3103292|NCT00262847|10633651|P1|Overall Study|Adverse Event|74
3103293|NCT00262847|10633649|P3|Overall Study|Patient Refusal|47
3103294|NCT00262847|10633650|P2|Overall Study|Patient Refusal|52
3103295|NCT00262847|10633651|P1|Overall Study|Patient Refusal|41
3103296|NCT00262847|10633649|P3|Overall Study|Disease Progression|195
3103297|NCT00262847|10633650|P2|Overall Study|Disease Progression|274
3103298|NCT00262847|10633651|P1|Overall Study|Disease Progression|309
3103299|NCT00262834|10633670|P2|Overall Study|Surgery delayed/tissue not collected|4
3103300|NCT00262834|10633671|P1|Overall Study|Surgery delayed/tissue not collected|1
3103301|NCT00262821|10633684|P2|Overall Study|Inevaluable - inadequate data|4
3103302|NCT00262821|10633685|P1|Overall Study|Inevaluable - inadequate data|0
3103303|NCT00262821|10633684|P2|Overall Study|Ineligible - required test not done|4
3103304|NCT00262821|10633685|P1|Overall Study|Ineligible - required test not done|1
3103305|NCT00262821|10633684|P2|Overall Study|Ineligible - elevated creatinine|2
3103306|NCT00262821|10633685|P1|Overall Study|Ineligible - elevated creatinine|0
3103307|NCT00262821|10633684|P2|Overall Study|Ineligible - inadequate pathology|3
3103308|NCT00262821|10633685|P1|Overall Study|Ineligible - inadequate pathology|1
3103309|NCT00262821|10633684|P2|Overall Study|Ineligible - wrong primary|1
3103310|NCT00262821|10633685|P1|Overall Study|Ineligible - wrong primary|0
3103311|NCT00262821|10633684|P2|Overall Study|Ineligible - wrong cell type|2
3103312|NCT00262821|10633685|P1|Overall Study|Ineligible - wrong cell type|2
3103313|NCT00262821|10633684|P2|Overall Study|Ineligible - wrong stage|3
3103314|NCT00262821|10633685|P1|Overall Study|Ineligible - wrong stage|0
3103315|NCT00262743|10633697|P2|Overall Study|Disease progression|3
3103316|NCT00262743|10633698|P1|Overall Study|Disease progression|0
3103317|NCT00262743|10633697|P2|Overall Study|Adverse Event|9
3103318|NCT00262743|10633698|P1|Overall Study|Adverse Event|0
3103319|NCT00262600|10633733|P3|Overall Study|Other|62
3103320|NCT00262600|10633734|P2|Overall Study|Other|59
3103321|NCT00262600|10633735|P1|Overall Study|Other|58
3103322|NCT00262600|10633733|P3|Overall Study|Not Treated|24
3103323|NCT00262600|10633734|P2|Overall Study|Not Treated|17
3103324|NCT00262600|10633735|P1|Overall Study|Not Treated|32
3103325|NCT00262600|10633733|P3|Overall Study|Withdrawal by Subject|139
3103326|NCT00262600|10633734|P2|Overall Study|Withdrawal by Subject|145
3103327|NCT00262600|10633735|P1|Overall Study|Withdrawal by Subject|128
3103328|NCT00262600|10633733|P3|Overall Study|Lost to Follow-up|41
3103329|NCT00262600|10633734|P2|Overall Study|Lost to Follow-up|31
3103330|NCT00262600|10633735|P1|Overall Study|Lost to Follow-up|17
3103331|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
3103332|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
3103333|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
3103334|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
3103335|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Virologic failure|0
3103336|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Virologic failure|8
3103337|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Virologic failure|0
3103338|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Virologic failure|5
3103339|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Death|0
3103340|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Death|2
3103341|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Death|0
3103342|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Death|2
3103343|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Noncompliance|0
3103344|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Noncompliance|11
3103345|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Noncompliance|0
3103346|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Noncompliance|6
3103347|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
3103348|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
3103349|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
3103350|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
3103351|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
3103352|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
3103353|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
3103354|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
3103355|NCT00262522|10633762|P4|Study Start Through 96 Weeks|Adverse Event|0
3103356|NCT00262522|10633763|P3|Study Start Through 96 Weeks|Adverse Event|16
3103357|NCT00262522|10633764|P2|Study Start Through 96 Weeks|Adverse Event|0
3103358|NCT00262522|10633765|P1|Study Start Through 96 Weeks|Adverse Event|20
3103359|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
3103360|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
3103361|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
3103362|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
3103363|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Virologic failure|0
3103364|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Virologic failure|4
3103365|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Virologic failure|0
3103366|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Virologic failure|2
3103367|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Death|0
3103368|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Death|1
3103369|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Death|0
3103370|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Death|2
3103371|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Noncompliance|0
3103372|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Noncompliance|8
3103373|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Noncompliance|0
3103374|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Noncompliance|3
3103375|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
3103376|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
3103377|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
3103378|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
3103379|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
3103380|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
3103381|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
3103382|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
3103383|NCT00262522|10633762|P4|Study Start Through 48 Weeks|Adverse Event|0
3103384|NCT00262522|10633763|P3|Study Start Through 48 Weeks|Adverse Event|10
3103385|NCT00262522|10633764|P2|Study Start Through 48 Weeks|Adverse Event|0
3103386|NCT00262522|10633765|P1|Study Start Through 48 Weeks|Adverse Event|16
3103387|NCT00262522|10633762|P4|Study Start Through 8 Weeks|Death|0
3103388|NCT00262522|10633763|P3|Study Start Through 8 Weeks|Death|0
3103389|NCT00262522|10633764|P2|Study Start Through 8 Weeks|Death|0
3103390|NCT00262522|10633765|P1|Study Start Through 8 Weeks|Death|1
3103391|NCT00262522|10633762|P4|Study Start Through 8 Weeks|Noncompliance|2
3103392|NCT00262522|10633763|P3|Study Start Through 8 Weeks|Noncompliance|2
3103393|NCT00262522|10633764|P2|Study Start Through 8 Weeks|Noncompliance|0
3103394|NCT00262522|10633765|P1|Study Start Through 8 Weeks|Noncompliance|0
3103395|NCT00262522|10633762|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
3103396|NCT00262522|10633763|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
3103397|NCT00262522|10633764|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
3103398|NCT00262522|10633765|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
3103399|NCT00262522|10633762|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
3103400|NCT00262522|10633763|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
3103401|NCT00262522|10633764|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
3103402|NCT00262522|10633765|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
3103403|NCT00262522|10633762|P4|Study Start Through 8 Weeks|Adverse Event|1
3103404|NCT00262522|10633763|P3|Study Start Through 8 Weeks|Adverse Event|3
3103405|NCT00262522|10633764|P2|Study Start Through 8 Weeks|Adverse Event|2
3103406|NCT00262522|10633765|P1|Study Start Through 8 Weeks|Adverse Event|1
3103407|NCT00262314|10633794|P1|Overall Study|Administrative withdrawal|30
3103408|NCT00262314|10633794|P1|Overall Study|Lost to Follow-up|70
3103409|NCT00262314|10633794|P1|Overall Study|Other|95
3103410|NCT00262314|10633794|P1|Overall Study|Patient's decision|92
3103411|NCT00262314|10633794|P1|Overall Study|Death|12
3103412|NCT00262314|10633794|P1|Overall Study|Changing physicians|38
3103413|NCT00262301|10633812|P3|Double-blind Phase|"worsening of HAE symptoms"|0
3103414|NCT00262301|10633813|P2|Double-blind Phase|"worsening of HAE symptoms"|1
3103415|NCT00262301|10633814|P1|Double-blind Phase|"worsening of HAE symptoms"|0
3103416|NCT00262301|10633812|P3|Double-blind Phase|Lost to Follow-up|0
3103417|NCT00262301|10633813|P2|Double-blind Phase|Lost to Follow-up|0
3103418|NCT00262301|10633814|P1|Double-blind Phase|Lost to Follow-up|1
3103419|NCT00262223|10633827|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
3103420|NCT00262223|10633828|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
3103421|NCT00262223|10633827|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
3103422|NCT00262223|10633828|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
3103423|NCT00262223|10633827|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
3103424|NCT00262223|10633828|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
3103425|NCT00262223|10633827|P2|Treatment Phase|Adverse Event|2
3103426|NCT00262223|10633828|P1|Treatment Phase|Adverse Event|1
3103427|NCT00262223|10633827|P2|Treatment Phase|Withdrawal by Subject|6
3103428|NCT00262223|10633828|P1|Treatment Phase|Withdrawal by Subject|3
3103429|NCT00262119|10633839|P3|Overall Study|Death|16
3103430|NCT00262119|10633840|P2|Overall Study|Death|19
3103431|NCT00262119|10633841|P1|Overall Study|Death|20
3103432|NCT00262119|10633839|P3|Overall Study|Lost to Follow-up|42
3103433|NCT00262119|10633840|P2|Overall Study|Lost to Follow-up|51
3103434|NCT00262119|10633841|P1|Overall Study|Lost to Follow-up|38
3103435|NCT00262080|10633861|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
3103436|NCT00262080|10633862|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
3103437|NCT00262080|10633863|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
3103438|NCT00262080|10633861|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
3103439|NCT00262080|10633862|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
3103440|NCT00262080|10633863|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
3103441|NCT00262080|10633861|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
3103442|NCT00262080|10633862|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
3103443|NCT00262080|10633863|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
3103444|NCT00262080|10633861|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
3103445|NCT00262080|10633862|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
3103446|NCT00262080|10633863|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
3103447|NCT00262080|10633861|P3|Repeat Dose Treatment Period|Adverse Event|0
3103448|NCT00262080|10633862|P2|Repeat Dose Treatment Period|Adverse Event|0
3103449|NCT00262080|10633863|P1|Repeat Dose Treatment Period|Adverse Event|1
3103450|NCT00262080|10633861|P3|Double Blind Treatment Period|Lost to Follow-up|0
3103451|NCT00262080|10633862|P2|Double Blind Treatment Period|Lost to Follow-up|0
3103452|NCT00262080|10633863|P1|Double Blind Treatment Period|Lost to Follow-up|1
3103453|NCT00262067|10633883|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
3103454|NCT00262067|10633884|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
3103455|NCT00262067|10633885|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
3103456|NCT00262067|10633886|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
3103457|NCT00262067|10633883|P4|Overall Study|Sponsor's Decision to Terminate Study|0
3103458|NCT00262067|10633884|P3|Overall Study|Sponsor's Decision to Terminate Study|0
3103459|NCT00262067|10633885|P2|Overall Study|Sponsor's Decision to Terminate Study|0
3103460|NCT00262067|10633886|P1|Overall Study|Sponsor's Decision to Terminate Study|1
3103461|NCT00262067|10633883|P4|Overall Study|Lost to Follow-up|5
3103462|NCT00262067|10633884|P3|Overall Study|Lost to Follow-up|7
3103463|NCT00262067|10633885|P2|Overall Study|Lost to Follow-up|4
3103464|NCT00262067|10633886|P1|Overall Study|Lost to Follow-up|5
3103465|NCT00262067|10633883|P4|Overall Study|Death|99
3103466|NCT00262067|10633884|P3|Overall Study|Death|186
3103467|NCT00262067|10633885|P2|Overall Study|Death|89
3103468|NCT00262067|10633886|P1|Overall Study|Death|190
3103469|NCT00262041|10633920|P3|Overall Study|Unable to classify|0
3103470|NCT00262041|10633921|P2|Overall Study|Unable to classify|0
3103471|NCT00262041|10633922|P1|Overall Study|Unable to classify|1
3103472|NCT00262041|10633920|P3|Overall Study|Lost to Follow-up|5
3103473|NCT00262041|10633921|P2|Overall Study|Lost to Follow-up|1
3103474|NCT00262041|10633922|P1|Overall Study|Lost to Follow-up|1
3103475|NCT00262041|10633920|P3|Overall Study|Withdrawal by Subject|1
3103476|NCT00262041|10633921|P2|Overall Study|Withdrawal by Subject|3
3103477|NCT00262041|10633922|P1|Overall Study|Withdrawal by Subject|0
3103478|NCT00262028|10633951|P9|Overall Study|Unable to classify|1
3103479|NCT00262028|10633952|P8|Overall Study|Unable to classify|0
3103480|NCT00262028|10633953|P7|Overall Study|Unable to classify|0
3103481|NCT00262028|10633954|P6|Overall Study|Unable to classify|0
3103482|NCT00262028|10633955|P5|Overall Study|Unable to classify|0
3103483|NCT00262028|10633956|P4|Overall Study|Unable to classify|0
3103484|NCT00262028|10633957|P3|Overall Study|Unable to classify|0
3103485|NCT00262028|10633958|P2|Overall Study|Unable to classify|3
3103486|NCT00262028|10633959|P1|Overall Study|Unable to classify|0
3103487|NCT00262028|10633951|P9|Overall Study|Protocol Violation|0
3103488|NCT00262028|10633952|P8|Overall Study|Protocol Violation|0
3103489|NCT00262028|10633953|P7|Overall Study|Protocol Violation|0
3103490|NCT00262028|10633954|P6|Overall Study|Protocol Violation|0
3103491|NCT00262028|10633955|P5|Overall Study|Protocol Violation|0
3103492|NCT00262028|10633956|P4|Overall Study|Protocol Violation|1
3103493|NCT00262028|10633957|P3|Overall Study|Protocol Violation|0
3103494|NCT00262028|10633958|P2|Overall Study|Protocol Violation|0
3103495|NCT00262028|10633959|P1|Overall Study|Protocol Violation|0
3103496|NCT00262028|10633951|P9|Overall Study|Administrative Reason|10
3103497|NCT00262028|10633952|P8|Overall Study|Administrative Reason|6
3103498|NCT00262028|10633953|P7|Overall Study|Administrative Reason|4
3103499|NCT00262028|10633954|P6|Overall Study|Administrative Reason|7
3103500|NCT00262028|10633955|P5|Overall Study|Administrative Reason|6
3103501|NCT00262028|10633956|P4|Overall Study|Administrative Reason|12
3103502|NCT00262028|10633957|P3|Overall Study|Administrative Reason|9
3103503|NCT00262028|10633958|P2|Overall Study|Administrative Reason|14
3103504|NCT00262028|10633959|P1|Overall Study|Administrative Reason|11
3103505|NCT00262028|10633951|P9|Overall Study|Lost to Follow-up|6
3103506|NCT00262028|10633952|P8|Overall Study|Lost to Follow-up|5
3103507|NCT00262028|10633953|P7|Overall Study|Lost to Follow-up|3
3103508|NCT00262028|10633954|P6|Overall Study|Lost to Follow-up|3
3103509|NCT00262028|10633955|P5|Overall Study|Lost to Follow-up|4
3103510|NCT00262028|10633956|P4|Overall Study|Lost to Follow-up|5
3103511|NCT00262028|10633957|P3|Overall Study|Lost to Follow-up|5
3103512|NCT00262028|10633958|P2|Overall Study|Lost to Follow-up|7
3103513|NCT00262028|10633959|P1|Overall Study|Lost to Follow-up|7
3103514|NCT00262028|10633951|P9|Overall Study|Withdrawal by Subject|2
3103515|NCT00262028|10633952|P8|Overall Study|Withdrawal by Subject|7
3103516|NCT00262028|10633953|P7|Overall Study|Withdrawal by Subject|5
3103517|NCT00262028|10633954|P6|Overall Study|Withdrawal by Subject|3
3103518|NCT00262028|10633955|P5|Overall Study|Withdrawal by Subject|2
3103519|NCT00262028|10633956|P4|Overall Study|Withdrawal by Subject|5
3103520|NCT00262028|10633957|P3|Overall Study|Withdrawal by Subject|6
3103521|NCT00262028|10633958|P2|Overall Study|Withdrawal by Subject|3
3103522|NCT00262028|10633959|P1|Overall Study|Withdrawal by Subject|6
3103523|NCT00262002|10634021|P7|Overall Study|Unable to classify|2
3103524|NCT00262002|10634022|P6|Overall Study|Unable to classify|0
3103525|NCT00262002|10634023|P5|Overall Study|Unable to classify|0
3103526|NCT00262002|10634024|P4|Overall Study|Unable to classify|0
3103527|NCT00262002|10634025|P3|Overall Study|Unable to classify|0
3103528|NCT00262002|10634026|P2|Overall Study|Unable to classify|0
3103529|NCT00262002|10634027|P1|Overall Study|Unable to classify|0
3103530|NCT00262002|10634021|P7|Overall Study|Protocol Violation|2
3103531|NCT00262002|10634022|P6|Overall Study|Protocol Violation|3
3103532|NCT00262002|10634023|P5|Overall Study|Protocol Violation|5
3103533|NCT00262002|10634024|P4|Overall Study|Protocol Violation|2
3103534|NCT00262002|10634025|P3|Overall Study|Protocol Violation|0
3103535|NCT00262002|10634026|P2|Overall Study|Protocol Violation|2
3103536|NCT00262002|10634027|P1|Overall Study|Protocol Violation|3
3103537|NCT00262002|10634021|P7|Overall Study|Inapropriate enrollment|0
3103538|NCT00262002|10634022|P6|Overall Study|Inapropriate enrollment|0
3103539|NCT00262002|10634023|P5|Overall Study|Inapropriate enrollment|0
3103540|NCT00262002|10634024|P4|Overall Study|Inapropriate enrollment|0
3103541|NCT00262002|10634025|P3|Overall Study|Inapropriate enrollment|0
3103542|NCT00262002|10634026|P2|Overall Study|Inapropriate enrollment|1
3103543|NCT00262002|10634027|P1|Overall Study|Inapropriate enrollment|0
3103544|NCT00262002|10634021|P7|Overall Study|Lost to Follow-up|0
3103545|NCT00262002|10634022|P6|Overall Study|Lost to Follow-up|1
3103546|NCT00262002|10634023|P5|Overall Study|Lost to Follow-up|0
3103547|NCT00262002|10634024|P4|Overall Study|Lost to Follow-up|2
3103548|NCT00262002|10634025|P3|Overall Study|Lost to Follow-up|0
3103549|NCT00262002|10634026|P2|Overall Study|Lost to Follow-up|0
3103550|NCT00262002|10634027|P1|Overall Study|Lost to Follow-up|2
3103551|NCT00262002|10634021|P7|Overall Study|Withdrawal by Subject|2
3103552|NCT00262002|10634022|P6|Overall Study|Withdrawal by Subject|2
3103553|NCT00262002|10634023|P5|Overall Study|Withdrawal by Subject|2
3103554|NCT00262002|10634024|P4|Overall Study|Withdrawal by Subject|1
3103555|NCT00262002|10634025|P3|Overall Study|Withdrawal by Subject|0
3103556|NCT00262002|10634026|P2|Overall Study|Withdrawal by Subject|2
3103557|NCT00262002|10634027|P1|Overall Study|Withdrawal by Subject|4
3103558|NCT00262002|10634021|P7|Overall Study|Adverse Event|0
3103559|NCT00262002|10634022|P6|Overall Study|Adverse Event|1
3103560|NCT00262002|10634023|P5|Overall Study|Adverse Event|0
3103561|NCT00262002|10634024|P4|Overall Study|Adverse Event|0
3103562|NCT00262002|10634025|P3|Overall Study|Adverse Event|0
3103563|NCT00262002|10634026|P2|Overall Study|Adverse Event|1
3103564|NCT00262002|10634027|P1|Overall Study|Adverse Event|2
3103565|NCT00261950|10634120|P1|Overall Study|Protocol specified Criteria|11
3103566|NCT00261950|10634120|P1|Overall Study|Physician Decision|1
3103567|NCT00261950|10634120|P1|Overall Study|Other|1
3103568|NCT00261950|10634120|P1|Overall Study|Withdrawal by Subject|5
3103569|NCT00261950|10634120|P1|Overall Study|Death|6
3103570|NCT00261950|10634120|P1|Overall Study|Lost to Follow-up|2
3103571|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Extension study|1
3103572|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Extension study|1
3103573|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Extension study|9
3103574|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Extension study|5
3103575|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Extension study|9
3103576|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Extension study|4
3103577|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Extension study|0
3103578|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Extension study|27
3103579|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Extension study|61
3103580|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Extension study|0
3103581|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Extension study|0
3103582|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Extension study|0
3103583|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Death|22
3103584|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Death|44
3103585|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Death|30
3103586|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Death|3
3103587|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Death|12
3103588|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Death|10
3103589|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Death|1
3103590|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Death|7
3103591|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Death|37
3103592|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Death|0
3103593|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Death|0
3103594|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Death|0
3103595|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Other|0
3103596|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Other|0
3103597|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Other|4
3103598|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Other|4
3103599|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Other|5
3103600|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Other|1
3103601|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Other|0
3103602|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Other|4
3103603|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Other|15
3103604|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Other|0
3103605|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Other|0
3103606|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Other|0
3103607|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103608|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
3103609|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
3103610|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
3103611|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103612|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
3103613|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103614|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
3103615|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
3103616|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103617|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103618|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
3103619|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103620|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103621|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
3103622|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103623|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
3103624|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
3103625|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
3103859|NCT00259649|10635052|P1|Overall Study|irregular menses|3
3103626|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
3103627|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
3103628|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103629|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103630|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
3103631|NCT00261846|10634145|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103632|NCT00261846|10634146|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103633|NCT00261846|10634147|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103634|NCT00261846|10634148|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
3103635|NCT00261846|10634149|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103636|NCT00261846|10634150|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103637|NCT00261846|10634151|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103638|NCT00261846|10634152|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103639|NCT00261846|10634153|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
3103640|NCT00261846|10634154|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103641|NCT00261846|10634155|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103642|NCT00261846|10634156|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
3103643|NCT00261846|10634145|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103644|NCT00261846|10634146|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103645|NCT00261846|10634147|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103646|NCT00261846|10634148|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103647|NCT00261846|10634149|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103648|NCT00261846|10634150|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103649|NCT00261846|10634151|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103650|NCT00261846|10634152|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103651|NCT00261846|10634153|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
3103652|NCT00261846|10634154|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
3103653|NCT00261846|10634155|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
3103654|NCT00261846|10634156|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
3103655|NCT00261833|10634415|P2|Overall Study|Not interested in being participant|1
3103656|NCT00261833|10634416|P1|Overall Study|Not interested in being participant|0
3103657|NCT00261833|10634415|P2|Overall Study|Missing reason|0
3103658|NCT00261833|10634416|P1|Overall Study|Missing reason|1
3103659|NCT00261833|10634415|P2|Overall Study|Lung transplantation|1
3103660|NCT00261833|10634416|P1|Overall Study|Lung transplantation|1
3103661|NCT00261833|10634415|P2|Overall Study|Suspicion of pulmonary cancer|1
3103662|NCT00261833|10634416|P1|Overall Study|Suspicion of pulmonary cancer|0
3103663|NCT00261833|10634415|P2|Overall Study|Protocol Violation|1
3103664|NCT00261833|10634416|P1|Overall Study|Protocol Violation|0
3103665|NCT00261833|10634415|P2|Overall Study|Withdrawal by Subject|7
3103666|NCT00261833|10634416|P1|Overall Study|Withdrawal by Subject|5
3103667|NCT00261833|10634415|P2|Overall Study|Adverse Event|4
3103668|NCT00261833|10634416|P1|Overall Study|Adverse Event|1
3103669|NCT00261833|10634415|P2|Overall Study|Death|3
3103670|NCT00261833|10634416|P1|Overall Study|Death|1
3103671|NCT00261716|10634450|P2|Overall Study|Lost to Follow-up|2
3103672|NCT00261716|10634451|P1|Overall Study|Lost to Follow-up|0
3103673|NCT00261716|10634450|P2|Overall Study|Withdrawal by Subject|8
3103674|NCT00261716|10634451|P1|Overall Study|Withdrawal by Subject|6
3103675|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
3103676|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
3103677|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
3103678|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
3103679|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
3103680|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
3103681|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
3103682|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
3103683|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
3103684|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
3103685|NCT00261495|10634471|P2|Extension Phase (Weeks 24 to 52)|Other|2
3103686|NCT00261495|10634472|P1|Extension Phase (Weeks 24 to 52)|Other|4
3103687|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
3103688|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
3103689|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
3103690|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
3103691|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
3103692|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
3103693|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
3103694|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
3103695|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
3103696|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
3103697|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
3103698|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
3103699|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
3103700|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
3103701|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
3103702|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
3103703|NCT00261495|10634471|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
3103704|NCT00261495|10634472|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
3103705|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
3103706|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
3103707|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
3103708|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
3103709|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
3103710|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
3103711|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
3103712|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
3103713|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
3103714|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
3103715|NCT00261495|10634471|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
3103716|NCT00261495|10634472|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
3103717|NCT00261443|10634636|P3|4: Extension Phase|Lost to Follow-up|0
3103718|NCT00261443|10634637|P2|4: Extension Phase|Lost to Follow-up|1
3103719|NCT00261443|10634638|P1|4: Extension Phase|Lost to Follow-up|0
3103720|NCT00261443|10634636|P3|4: Extension Phase|Withdrawal by Subject|2
3103721|NCT00261443|10634637|P2|4: Extension Phase|Withdrawal by Subject|1
3103722|NCT00261443|10634638|P1|4: Extension Phase|Withdrawal by Subject|0
3103723|NCT00261443|10634636|P3|4: Extension Phase|Adverse Event|0
3103724|NCT00261443|10634637|P2|4: Extension Phase|Adverse Event|1
3103725|NCT00261443|10634638|P1|4: Extension Phase|Adverse Event|0
3103726|NCT00261443|10634636|P3|3: Assessment of Relapse|Other Reasons|3
3103727|NCT00261443|10634637|P2|3: Assessment of Relapse|Other Reasons|4
3103728|NCT00261443|10634638|P1|3: Assessment of Relapse|Other Reasons|0
3103729|NCT00261443|10634636|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
3103730|NCT00261443|10634637|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
3103731|NCT00261443|10634638|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
3103732|NCT00261443|10634636|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
3103733|NCT00261443|10634637|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
3103734|NCT00261443|10634638|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
3103735|NCT00261443|10634636|P3|3: Assessment of Relapse|Pregnancy|1
3103736|NCT00261443|10634637|P2|3: Assessment of Relapse|Pregnancy|2
3103737|NCT00261443|10634638|P1|3: Assessment of Relapse|Pregnancy|0
3103738|NCT00261443|10634636|P3|3: Assessment of Relapse|Poor/Noncompliance|3
3103739|NCT00261443|10634637|P2|3: Assessment of Relapse|Poor/Noncompliance|5
3103740|NCT00261443|10634638|P1|3: Assessment of Relapse|Poor/Noncompliance|0
3103741|NCT00261443|10634636|P3|3: Assessment of Relapse|Lost to Follow-up|6
3103742|NCT00261443|10634637|P2|3: Assessment of Relapse|Lost to Follow-up|7
3103743|NCT00261443|10634638|P1|3: Assessment of Relapse|Lost to Follow-up|0
3103744|NCT00261443|10634636|P3|3: Assessment of Relapse|Death|1
3103745|NCT00261443|10634637|P2|3: Assessment of Relapse|Death|0
3103746|NCT00261443|10634638|P1|3: Assessment of Relapse|Death|0
3103747|NCT00261443|10634636|P3|3: Assessment of Relapse|Withdrawal by Subject|15
3103748|NCT00261443|10634637|P2|3: Assessment of Relapse|Withdrawal by Subject|14
3103749|NCT00261443|10634638|P1|3: Assessment of Relapse|Withdrawal by Subject|0
3103750|NCT00261443|10634636|P3|3: Assessment of Relapse|Adverse Event|19
3103751|NCT00261443|10634637|P2|3: Assessment of Relapse|Adverse Event|15
3103752|NCT00261443|10634638|P1|3: Assessment of Relapse|Adverse Event|0
3103753|NCT00261443|10634636|P3|3: Assessment of Relapse|Lack of Efficacy|14
3103754|NCT00261443|10634637|P2|3: Assessment of Relapse|Lack of Efficacy|31
3103755|NCT00261443|10634638|P1|3: Assessment of Relapse|Lack of Efficacy|0
3103756|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Other Reasons|0
3103757|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Other Reasons|0
3103758|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Other Reasons|13
3103759|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
3103760|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
3103761|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
3103762|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
3103763|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
3103764|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
3103765|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Pregnancy|0
3103766|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Pregnancy|0
3103767|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Pregnancy|1
3103768|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
3103769|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
3103770|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
3103771|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
3103772|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
3103773|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
3103774|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
3103775|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
3103860|NCT00259649|10635052|P1|Overall Study|Lost to Follow-up|7
3103776|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
3103777|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Adverse Event|0
3103778|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Adverse Event|0
3103779|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Adverse Event|93
3103780|NCT00261443|10634636|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
3103781|NCT00261443|10634637|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
3103782|NCT00261443|10634638|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
3103783|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
3103784|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
3103785|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
3103786|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
3103787|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
3103788|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
3103789|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
3103790|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
3103791|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
3103792|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
3103793|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
3103794|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
3103795|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
3103796|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
3103797|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
3103798|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
3103799|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
3103800|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
3103801|NCT00261443|10634636|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
3103802|NCT00261443|10634637|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
3103803|NCT00261443|10634638|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
3103804|NCT00260832|10634923|P2|Overall Study|Protocol Violation|1
3103805|NCT00260832|10634924|P1|Overall Study|Protocol Violation|3
3103806|NCT00260832|10634923|P2|Overall Study|Other|7
3103807|NCT00260832|10634924|P1|Overall Study|Other|10
3103808|NCT00260832|10634923|P2|Overall Study|Death|62
3103809|NCT00260832|10634924|P1|Overall Study|Death|43
3103810|NCT00260832|10634923|P2|Overall Study|Physician Decision|9
3103811|NCT00260832|10634924|P1|Overall Study|Physician Decision|15
3103812|NCT00260832|10634923|P2|Overall Study|Withdrawal by Subject|17
3103813|NCT00260832|10634924|P1|Overall Study|Withdrawal by Subject|15
3103814|NCT00260832|10634923|P2|Overall Study|Progression|96
3103815|NCT00260832|10634924|P1|Overall Study|Progression|116
3103816|NCT00260832|10634923|P2|Overall Study|Adverse Event|19
3103817|NCT00260832|10634924|P1|Overall Study|Adverse Event|26
3103818|NCT00260533|10634953|P2|Overall Study|Other|3
3103819|NCT00260533|10634954|P1|Overall Study|Other|3
3103820|NCT00260429|10634962|P2|Overall Study|scheduled hand surgery|0
3103821|NCT00260429|10634963|P1|Overall Study|scheduled hand surgery|1
3103822|NCT00260429|10634962|P2|Overall Study|failure to follow appointments|0
3103823|NCT00260429|10634963|P1|Overall Study|failure to follow appointments|1
3103824|NCT00260208|10634971|P2|Overall Study|Missing|16
3103825|NCT00260208|10634972|P1|Overall Study|Missing|18
3103826|NCT00260208|10634971|P2|Overall Study|Death|10
3103827|NCT00260208|10634972|P1|Overall Study|Death|12
3103828|NCT00260208|10634971|P2|Overall Study|Lost to Follow-up|1
3103829|NCT00260208|10634972|P1|Overall Study|Lost to Follow-up|6
3103830|NCT00260208|10634971|P2|Overall Study|Subject withdrew consent|7
3103831|NCT00260208|10634972|P1|Overall Study|Subject withdrew consent|11
3103832|NCT00260065|10635015|P1|Overall Study|Medication Noncompliance|1
3103833|NCT00260065|10635015|P1|Overall Study|Not otherwise specified|8
3103834|NCT00260065|10635015|P1|Overall Study|Physician Decision|19
3103835|NCT00260065|10635015|P1|Overall Study|Withdrawal by Subject|13
3103836|NCT00260065|10635015|P1|Overall Study|Death|13
3103837|NCT00260065|10635015|P1|Overall Study|Adverse Event|17
3103838|NCT00260065|10635015|P1|Overall Study|Progressive Disease|22
3103839|NCT00259857|10635022|P2|24 Months Treatment|Lost to Follow-up|3
3103840|NCT00259857|10635023|P1|24 Months Treatment|Lost to Follow-up|0
3103841|NCT00259857|10635022|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
3103842|NCT00259857|10635023|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
3103843|NCT00259740|10635041|P2|Overall Study|Requirement for alternative therapy|4
3103844|NCT00259740|10635042|P1|Overall Study|Requirement for alternative therapy|0
3103845|NCT00259740|10635041|P2|Overall Study|Other|0
3103846|NCT00259740|10635042|P1|Overall Study|Other|3
3103847|NCT00259740|10635041|P2|Overall Study|Ongoing|3
3103848|NCT00259740|10635042|P1|Overall Study|Ongoing|17
3103849|NCT00259740|10635041|P2|Overall Study|Disease progression|36
3103850|NCT00259740|10635042|P1|Overall Study|Disease progression|19
3103851|NCT00259740|10635041|P2|Overall Study|Death|1
3103852|NCT00259740|10635042|P1|Overall Study|Death|1
3103853|NCT00259740|10635041|P2|Overall Study|Withdrawal by Subject|6
3103854|NCT00259740|10635042|P1|Overall Study|Withdrawal by Subject|2
3103855|NCT00259740|10635041|P2|Overall Study|Adverse Event|2
3103856|NCT00259740|10635042|P1|Overall Study|Adverse Event|0
3103857|NCT00259740|10635041|P2|Overall Study|Physician Decision|1
3103858|NCT00259740|10635042|P1|Overall Study|Physician Decision|1
3103861|NCT00259610|10635060|P4|Overall Study|Serious Adverse Event|2
3103862|NCT00259610|10635061|P3|Overall Study|Serious Adverse Event|2
3103863|NCT00259610|10635062|P2|Overall Study|Serious Adverse Event|2
3103864|NCT00259610|10635063|P1|Overall Study|Serious Adverse Event|8
3103865|NCT00259610|10635060|P4|Overall Study|Adverse Event|2
3103866|NCT00259610|10635061|P3|Overall Study|Adverse Event|5
3103867|NCT00259610|10635062|P2|Overall Study|Adverse Event|4
3103868|NCT00259610|10635063|P1|Overall Study|Adverse Event|3
3103869|NCT00259610|10635060|P4|Overall Study|non medical reason|3
3103870|NCT00259610|10635061|P3|Overall Study|non medical reason|10
3103871|NCT00259610|10635062|P2|Overall Study|non medical reason|2
3103872|NCT00259610|10635063|P1|Overall Study|non medical reason|6
3103873|NCT00259610|10635060|P4|Overall Study|Death|0
3103874|NCT00259610|10635061|P3|Overall Study|Death|2
3103875|NCT00259610|10635062|P2|Overall Study|Death|1
3103876|NCT00259610|10635063|P1|Overall Study|Death|1
3103877|NCT00259610|10635060|P4|Overall Study|Physician Decision|2
3103878|NCT00259610|10635061|P3|Overall Study|Physician Decision|7
3103879|NCT00259610|10635062|P2|Overall Study|Physician Decision|4
3103880|NCT00259610|10635063|P1|Overall Study|Physician Decision|6
3103881|NCT00259610|10635060|P4|Overall Study|Lost to Follow-up|15
3103882|NCT00259610|10635061|P3|Overall Study|Lost to Follow-up|18
3103883|NCT00259610|10635062|P2|Overall Study|Lost to Follow-up|8
3103884|NCT00259610|10635063|P1|Overall Study|Lost to Follow-up|19
3103885|NCT00259610|10635060|P4|Overall Study|Withdrawal by Subject|19
3103886|NCT00259610|10635061|P3|Overall Study|Withdrawal by Subject|29
3103887|NCT00259610|10635062|P2|Overall Study|Withdrawal by Subject|25
3103888|NCT00259610|10635063|P1|Overall Study|Withdrawal by Subject|33
3103889|NCT00259298|10635077|P1|Overall Study|Physician Decision|2
3103890|NCT00259298|10635077|P1|Overall Study|Withdrawal by Subject|1
3103891|NCT00259272|10635095|P4|Overall Study|Lost to Follow-up|1
3103892|NCT00259272|10635096|P3|Overall Study|Lost to Follow-up|0
3103893|NCT00259272|10635097|P2|Overall Study|Lost to Follow-up|0
3103894|NCT00259272|10635098|P1|Overall Study|Lost to Follow-up|1
3103895|NCT00259272|10635095|P4|Overall Study|Withdrawal by Subject|7
3103896|NCT00259272|10635096|P3|Overall Study|Withdrawal by Subject|2
3103897|NCT00259272|10635097|P2|Overall Study|Withdrawal by Subject|2
3103898|NCT00259272|10635098|P1|Overall Study|Withdrawal by Subject|4
3103899|NCT00259272|10635095|P4|Overall Study|Sponsor Decision|0
3103900|NCT00259272|10635096|P3|Overall Study|Sponsor Decision|0
3103901|NCT00259272|10635097|P2|Overall Study|Sponsor Decision|1
3103902|NCT00259272|10635098|P1|Overall Study|Sponsor Decision|0
3103903|NCT00259272|10635095|P4|Overall Study|Protocol Violation|1
3103904|NCT00259272|10635096|P3|Overall Study|Protocol Violation|0
3103905|NCT00259272|10635097|P2|Overall Study|Protocol Violation|0
3103906|NCT00259272|10635098|P1|Overall Study|Protocol Violation|2
3103907|NCT00259272|10635095|P4|Overall Study|Physician Decision|3
3103908|NCT00259272|10635096|P3|Overall Study|Physician Decision|1
3103909|NCT00259272|10635097|P2|Overall Study|Physician Decision|2
3103910|NCT00259272|10635098|P1|Overall Study|Physician Decision|1
3103911|NCT00259272|10635095|P4|Overall Study|Lack of Efficacy|6
3103912|NCT00259272|10635096|P3|Overall Study|Lack of Efficacy|2
3103913|NCT00259272|10635097|P2|Overall Study|Lack of Efficacy|1
3103914|NCT00259272|10635098|P1|Overall Study|Lack of Efficacy|5
3103915|NCT00259272|10635095|P4|Overall Study|Adverse Event|3
3103916|NCT00259272|10635096|P3|Overall Study|Adverse Event|0
3103917|NCT00259272|10635097|P2|Overall Study|Adverse Event|1
3103918|NCT00259272|10635098|P1|Overall Study|Adverse Event|2
3103919|NCT00259012|10635194|P2|Overall Study|Protocol Violation|1
3103920|NCT00259012|10635195|P1|Overall Study|Protocol Violation|1
3103921|NCT00259012|10635194|P2|Overall Study|Lost to Follow-up|1
3103922|NCT00259012|10635195|P1|Overall Study|Lost to Follow-up|0
3103923|NCT00259012|10635194|P2|Overall Study|Physician Decision|1
3103924|NCT00259012|10635195|P1|Overall Study|Physician Decision|0
3103925|NCT00259012|10635194|P2|Overall Study|Withdrawal by Subject|0
3103926|NCT00259012|10635195|P1|Overall Study|Withdrawal by Subject|1
3103927|NCT00259012|10635194|P2|Overall Study|Adverse Event|1
3103928|NCT00259012|10635195|P1|Overall Study|Adverse Event|0
3103929|NCT00258960|10635227|P1|Overall Study|Mistake|2
3103930|NCT00258960|10635227|P1|Overall Study|Withdrawal by Subject|1
3103931|NCT00258960|10635227|P1|Overall Study|Physician Decision|1
3103932|NCT00258960|10635227|P1|Overall Study|Adverse Event|4
3103933|NCT00258960|10635227|P1|Overall Study|Disease Progression|7
3103934|NCT00258960|10635227|P1|Overall Study|Death|2
3103935|NCT00258895|10635243|P2|Overall Study|Withdrawal by Subject|0
3103936|NCT00258895|10635244|P1|Overall Study|Withdrawal by Subject|1
3103937|NCT00258895|10635243|P2|Overall Study|Protocol Violation|2
3103938|NCT00258895|10635244|P1|Overall Study|Protocol Violation|6
3103939|NCT00258895|10635243|P2|Overall Study|Lost to Follow-up|1
3103940|NCT00258895|10635244|P1|Overall Study|Lost to Follow-up|3
3103941|NCT00258856|10635280|P4|Overall Study|Non-compliance|1
3103942|NCT00258856|10635281|P3|Overall Study|Non-compliance|0
3103943|NCT00258856|10635282|P2|Overall Study|Non-compliance|0
3103944|NCT00258856|10635283|P1|Overall Study|Non-compliance|2
3103945|NCT00258856|10635280|P4|Overall Study|Lost to Follow-up|0
3103946|NCT00258856|10635281|P3|Overall Study|Lost to Follow-up|2
3103947|NCT00258856|10635282|P2|Overall Study|Lost to Follow-up|0
3103948|NCT00258856|10635283|P1|Overall Study|Lost to Follow-up|1
3103949|NCT00258674|10635324|P3|Overall Study|Death|34
3103950|NCT00258674|10635325|P2|Overall Study|Death|53
3103951|NCT00258674|10635326|P1|Overall Study|Death|32
3103952|NCT00258440|10635385|P3|Overall Study|Withdrawal by Subject|1
3103953|NCT00258440|10635386|P2|Overall Study|Withdrawal by Subject|0
3103954|NCT00258440|10635387|P1|Overall Study|Withdrawal by Subject|0
3103955|NCT00258154|10635425|P2|Overall Study|Patient Moved|1
3103956|NCT00258154|10635426|P1|Overall Study|Patient Moved|3
3103957|NCT00258154|10635425|P2|Overall Study|Withdrawal by Subject|4
3103958|NCT00258154|10635426|P1|Overall Study|Withdrawal by Subject|3
3103959|NCT00258154|10635425|P2|Overall Study|Protocol Violation|1
3103960|NCT00258154|10635426|P1|Overall Study|Protocol Violation|2
3103961|NCT00258154|10635425|P2|Overall Study|Lost to Follow-up|1
3103962|NCT00258154|10635426|P1|Overall Study|Lost to Follow-up|0
3103963|NCT00258154|10635425|P2|Overall Study|Adverse Event|0
3103964|NCT00258154|10635426|P1|Overall Study|Adverse Event|1
3103965|NCT00257920|10635521|P2|Period: Second Intervention|Other|1
3103966|NCT00257920|10635522|P1|Period: Second Intervention|Other|2
3103967|NCT00257920|10635521|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
3103968|NCT00257920|10635522|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
3103969|NCT00257660|10635578|P2|Overall Study|No longer wanted to do blood draws|0
3103970|NCT00257660|10635579|P1|Overall Study|No longer wanted to do blood draws|1
3103971|NCT00257660|10635578|P2|Overall Study|PI & Subject Schedule Conflicts|0
3103972|NCT00257660|10635579|P1|Overall Study|PI & Subject Schedule Conflicts|1
3103973|NCT00257660|10635578|P2|Overall Study|Lost to Follow-up|0
3103974|NCT00257660|10635579|P1|Overall Study|Lost to Follow-up|1
3103975|NCT00257660|10635578|P2|Overall Study|Withdrawal by Subject|0
3103976|NCT00257660|10635579|P1|Overall Study|Withdrawal by Subject|2
3103977|NCT00257660|10635578|P2|Overall Study|Lack of Efficacy|23
3103978|NCT00257660|10635579|P1|Overall Study|Lack of Efficacy|5
3103979|NCT00257608|10635609|P3|Post Chemotherapy Phase|Not treated|7
3103980|NCT00257608|10635610|P2|Post Chemotherapy Phase|Not treated|4
3103981|NCT00257608|10635611|P1|Post Chemotherapy Phase|Not treated|0
3103982|NCT00257608|10635609|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
3103983|NCT00257608|10635610|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
3103984|NCT00257608|10635611|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
3103985|NCT00257608|10635609|P3|Post Chemotherapy Phase|Physician Decision|11
3103986|NCT00257608|10635610|P2|Post Chemotherapy Phase|Physician Decision|8
3103987|NCT00257608|10635611|P1|Post Chemotherapy Phase|Physician Decision|0
3103988|NCT00257608|10635609|P3|Post Chemotherapy Phase|Lost to Follow-up|1
3103989|NCT00257608|10635610|P2|Post Chemotherapy Phase|Lost to Follow-up|0
3103990|NCT00257608|10635611|P1|Post Chemotherapy Phase|Lost to Follow-up|0
3103991|NCT00257608|10635609|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
3103992|NCT00257608|10635610|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
3103993|NCT00257608|10635611|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
3103994|NCT00257608|10635609|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
3103995|NCT00257608|10635610|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
3103996|NCT00257608|10635611|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
3103997|NCT00257608|10635609|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
3103998|NCT00257608|10635610|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
3103999|NCT00257608|10635611|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
3104000|NCT00257608|10635609|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
3104001|NCT00257608|10635610|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
3104002|NCT00257608|10635611|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
3104003|NCT00257608|10635609|P3|Post Chemotherapy Phase|Disease progression|168
3104004|NCT00257608|10635610|P2|Post Chemotherapy Phase|Disease progression|204
3104005|NCT00257608|10635611|P1|Post Chemotherapy Phase|Disease progression|0
3104006|NCT00257608|10635609|P3|Post Chemotherapy Phase|Adverse Event|38
3104007|NCT00257608|10635610|P2|Post Chemotherapy Phase|Adverse Event|34
3104008|NCT00257608|10635611|P1|Post Chemotherapy Phase|Adverse Event|0
3104009|NCT00257608|10635609|P3|Chemotherapy Phase|Physician Decision|0
3104010|NCT00257608|10635610|P2|Chemotherapy Phase|Physician Decision|0
3104011|NCT00257608|10635611|P1|Chemotherapy Phase|Physician Decision|28
3104012|NCT00257608|10635609|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
3104013|NCT00257608|10635610|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
3104014|NCT00257608|10635611|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
3104015|NCT00257608|10635609|P3|Chemotherapy Phase|Patient's decision to discontinue|0
3104016|NCT00257608|10635610|P2|Chemotherapy Phase|Patient's decision to discontinue|0
3104017|NCT00257608|10635611|P1|Chemotherapy Phase|Patient's decision to discontinue|35
3104018|NCT00257608|10635609|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
3104019|NCT00257608|10635610|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
3104020|NCT00257608|10635611|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
3104021|NCT00257608|10635609|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
3104022|NCT00257608|10635610|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
3104023|NCT00257608|10635611|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
3104024|NCT00257608|10635609|P3|Chemotherapy Phase|Disease progression|0
3104025|NCT00257608|10635610|P2|Chemotherapy Phase|Disease progression|0
3104026|NCT00257608|10635611|P1|Chemotherapy Phase|Disease progression|139
3104027|NCT00257608|10635609|P3|Chemotherapy Phase|Adverse Event|0
3104028|NCT00257608|10635610|P2|Chemotherapy Phase|Adverse Event|0
3104029|NCT00257608|10635611|P1|Chemotherapy Phase|Adverse Event|138
3104030|NCT00257556|10635637|P2|Overall Study|other reason|6
3104031|NCT00257556|10635638|P1|Overall Study|other reason|4
3104032|NCT00257556|10635637|P2|Overall Study|Did not meet hCG criterion|0
3104033|NCT00257556|10635638|P1|Overall Study|Did not meet hCG criterion|3
3104034|NCT00257556|10635637|P2|Overall Study|Physician Decision|0
3104035|NCT00257556|10635638|P1|Overall Study|Physician Decision|6
3104036|NCT00257556|10635637|P2|Overall Study|Adverse Event|4
3104037|NCT00257556|10635638|P1|Overall Study|Adverse Event|1
3104038|NCT00257192|10635682|P2|Overall Study|Miscellaneous|4
3104039|NCT00257192|10635683|P1|Overall Study|Miscellaneous|0
3104040|NCT00257192|10635682|P2|Overall Study|Study terminated by sponsor|0
3104041|NCT00257192|10635683|P1|Overall Study|Study terminated by sponsor|1
3104042|NCT00257192|10635682|P2|Overall Study|Randomized but not treated|1
3104043|NCT00257192|10635683|P1|Overall Study|Randomized but not treated|0
3104044|NCT00257192|10635682|P2|Overall Study|Withdrawal by Subject|2
3104045|NCT00257192|10635683|P1|Overall Study|Withdrawal by Subject|14
3104046|NCT00257192|10635682|P2|Overall Study|Insufficient clinical response|18
3104047|NCT00257192|10635683|P1|Overall Study|Insufficient clinical response|18
3104048|NCT00257192|10635682|P2|Overall Study|Lost to Follow-up|3
3104049|NCT00257192|10635683|P1|Overall Study|Lost to Follow-up|3
3104050|NCT00257192|10635682|P2|Overall Study|Laboratory abnormality|1
3104051|NCT00257192|10635683|P1|Overall Study|Laboratory abnormality|1
3104052|NCT00257192|10635682|P2|Overall Study|Adverse Event|10
3104053|NCT00257192|10635683|P1|Overall Study|Adverse Event|21
3104054|NCT00257166|10635727|P2|Overall Study|Randomized, but not treated|0
3104055|NCT00257166|10635728|P1|Overall Study|Randomized, but not treated|1
3104056|NCT00257166|10635727|P2|Overall Study|Other|21
3104057|NCT00257166|10635728|P1|Overall Study|Other|16
3104058|NCT00257166|10635727|P2|Overall Study|Withdrawal by Subject|2
3104059|NCT00257166|10635728|P1|Overall Study|Withdrawal by Subject|9
3104060|NCT00257166|10635727|P2|Overall Study|Lost to Follow-up|1
3104061|NCT00257166|10635728|P1|Overall Study|Lost to Follow-up|8
3104062|NCT00257166|10635727|P2|Overall Study|Laboratory abnormality|0
3104063|NCT00257166|10635728|P1|Overall Study|Laboratory abnormality|1
3104064|NCT00257166|10635727|P2|Overall Study|Adverse Event|13
3104065|NCT00257166|10635728|P1|Overall Study|Adverse Event|18
3104066|NCT00257010|10635740|P1|Overall Study|no headache reported|9
3104067|NCT00257010|10635740|P1|Overall Study|various|11
3104068|NCT00257010|10635740|P1|Overall Study|Adverse Event|10
3104069|NCT00257010|10635740|P1|Overall Study|Withdrawal by Subject|34
3104070|NCT00257010|10635740|P1|Overall Study|Lost to Follow-up|53
3104071|NCT00257010|10635740|P1|Overall Study|Lack of Efficacy|11
3104072|NCT00256997|10635751|P2|Overall Study|Investigator Withdrew Participant|1
3104073|NCT00256997|10635752|P1|Overall Study|Investigator Withdrew Participant|2
3104074|NCT00256997|10635751|P2|Overall Study|Participant Non-compliant|6
3104075|NCT00256997|10635752|P1|Overall Study|Participant Non-compliant|3
3104076|NCT00256997|10635751|P2|Overall Study|End of Study (As Per Sponsor)|24
3104077|NCT00256997|10635752|P1|Overall Study|End of Study (As Per Sponsor)|12
3104078|NCT00256997|10635751|P2|Overall Study|Other|8
3104079|NCT00256997|10635752|P1|Overall Study|Other|5
3104080|NCT00256997|10635751|P2|Overall Study|Started but not treated|0
3104081|NCT00256997|10635752|P1|Overall Study|Started but not treated|2
3104082|NCT00256997|10635751|P2|Overall Study|Withdrawal by Subject|3
3104083|NCT00256997|10635752|P1|Overall Study|Withdrawal by Subject|13
3104084|NCT00256997|10635751|P2|Overall Study|Lost to Follow-up|5
3104085|NCT00256997|10635752|P1|Overall Study|Lost to Follow-up|3
3104086|NCT00256997|10635751|P2|Overall Study|Adverse Event|0
3104087|NCT00256997|10635752|P1|Overall Study|Adverse Event|4
3104088|NCT00256997|10635751|P2|Overall Study|Death|0
3104089|NCT00256997|10635752|P1|Overall Study|Death|2
3104090|NCT00256997|10635751|P2|Overall Study|Lack of Efficacy|4
3104091|NCT00256997|10635752|P1|Overall Study|Lack of Efficacy|1
3104092|NCT00256997|10635751|P2|Overall Study|Protocol Violation|4
3104093|NCT00256997|10635752|P1|Overall Study|Protocol Violation|1
3104094|NCT00256867|10635794|P8|Overall Study|Withdrawal by participant|0
3104095|NCT00256867|10635795|P7|Overall Study|Withdrawal by participant|0
3104096|NCT00256867|10635796|P6|Overall Study|Withdrawal by participant|1
3104097|NCT00256867|10635797|P5|Overall Study|Withdrawal by participant|0
3104098|NCT00256867|10635798|P4|Overall Study|Withdrawal by participant|0
3104099|NCT00256867|10635799|P3|Overall Study|Withdrawal by participant|0
3104100|NCT00256867|10635800|P2|Overall Study|Withdrawal by participant|0
3104101|NCT00256867|10635801|P1|Overall Study|Withdrawal by participant|0
3104102|NCT00256867|10635794|P8|Overall Study|Participant out of assessment window|0
3104103|NCT00256867|10635795|P7|Overall Study|Participant out of assessment window|0
3104104|NCT00256867|10635796|P6|Overall Study|Participant out of assessment window|0
3104105|NCT00256867|10635797|P5|Overall Study|Participant out of assessment window|0
3104106|NCT00256867|10635798|P4|Overall Study|Participant out of assessment window|0
3104107|NCT00256867|10635799|P3|Overall Study|Participant out of assessment window|1
3104108|NCT00256867|10635800|P2|Overall Study|Participant out of assessment window|0
3104109|NCT00256867|10635801|P1|Overall Study|Participant out of assessment window|0
3104110|NCT00256867|10635794|P8|Overall Study|Participant travelled Overseas|0
3104111|NCT00256867|10635795|P7|Overall Study|Participant travelled Overseas|0
3104112|NCT00256867|10635796|P6|Overall Study|Participant travelled Overseas|0
3104113|NCT00256867|10635797|P5|Overall Study|Participant travelled Overseas|0
3104114|NCT00256867|10635798|P4|Overall Study|Participant travelled Overseas|0
3104115|NCT00256867|10635799|P3|Overall Study|Participant travelled Overseas|0
3104116|NCT00256867|10635800|P2|Overall Study|Participant travelled Overseas|1
3104117|NCT00256867|10635801|P1|Overall Study|Participant travelled Overseas|0
3104118|NCT00256867|10635794|P8|Overall Study|Non-compliance with study medication|1
3104119|NCT00256867|10635795|P7|Overall Study|Non-compliance with study medication|0
3104120|NCT00256867|10635796|P6|Overall Study|Non-compliance with study medication|0
3104121|NCT00256867|10635797|P5|Overall Study|Non-compliance with study medication|0
3104122|NCT00256867|10635798|P4|Overall Study|Non-compliance with study medication|0
3104123|NCT00256867|10635799|P3|Overall Study|Non-compliance with study medication|0
3104124|NCT00256867|10635800|P2|Overall Study|Non-compliance with study medication|0
3104125|NCT00256867|10635801|P1|Overall Study|Non-compliance with study medication|0
3104126|NCT00256867|10635794|P8|Overall Study|Investigator's Decision|0
3104127|NCT00256867|10635795|P7|Overall Study|Investigator's Decision|0
3104128|NCT00256867|10635796|P6|Overall Study|Investigator's Decision|0
3104129|NCT00256867|10635797|P5|Overall Study|Investigator's Decision|1
3104130|NCT00256867|10635798|P4|Overall Study|Investigator's Decision|0
3104131|NCT00256867|10635799|P3|Overall Study|Investigator's Decision|0
3104132|NCT00256867|10635800|P2|Overall Study|Investigator's Decision|0
3104133|NCT00256867|10635801|P1|Overall Study|Investigator's Decision|0
3104134|NCT00256867|10635794|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
3104135|NCT00256867|10635795|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
3104136|NCT00256867|10635796|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
3104137|NCT00256867|10635797|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
3104138|NCT00256867|10635798|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
3104139|NCT00256867|10635799|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
3104140|NCT00256867|10635800|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
3104141|NCT00256867|10635801|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
3104142|NCT00256867|10635794|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104143|NCT00256867|10635795|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104144|NCT00256867|10635796|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104145|NCT00256867|10635797|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104146|NCT00256867|10635798|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104147|NCT00256867|10635799|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104148|NCT00256867|10635800|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
3104149|NCT00256867|10635801|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
3104150|NCT00256867|10635794|P8|Overall Study|Withdrawal by Subject|2
3104151|NCT00256867|10635795|P7|Overall Study|Withdrawal by Subject|3
3104152|NCT00256867|10635796|P6|Overall Study|Withdrawal by Subject|2
3104153|NCT00256867|10635797|P5|Overall Study|Withdrawal by Subject|2
3104154|NCT00256867|10635798|P4|Overall Study|Withdrawal by Subject|1
3104155|NCT00256867|10635799|P3|Overall Study|Withdrawal by Subject|1
3104156|NCT00256867|10635800|P2|Overall Study|Withdrawal by Subject|0
3104157|NCT00256867|10635801|P1|Overall Study|Withdrawal by Subject|0
3104158|NCT00256867|10635794|P8|Overall Study|Protocol Violation|1
3104159|NCT00256867|10635795|P7|Overall Study|Protocol Violation|0
3104160|NCT00256867|10635796|P6|Overall Study|Protocol Violation|1
3104161|NCT00256867|10635797|P5|Overall Study|Protocol Violation|0
3104162|NCT00256867|10635798|P4|Overall Study|Protocol Violation|1
3104163|NCT00256867|10635799|P3|Overall Study|Protocol Violation|0
3104164|NCT00256867|10635800|P2|Overall Study|Protocol Violation|0
3104165|NCT00256867|10635801|P1|Overall Study|Protocol Violation|0
3104166|NCT00256867|10635794|P8|Overall Study|Lost to Follow-up|2
3104167|NCT00256867|10635795|P7|Overall Study|Lost to Follow-up|1
3104168|NCT00256867|10635796|P6|Overall Study|Lost to Follow-up|0
3104169|NCT00256867|10635797|P5|Overall Study|Lost to Follow-up|2
3104170|NCT00256867|10635798|P4|Overall Study|Lost to Follow-up|3
3104171|NCT00256867|10635799|P3|Overall Study|Lost to Follow-up|2
3104172|NCT00256867|10635800|P2|Overall Study|Lost to Follow-up|2
3104173|NCT00256867|10635801|P1|Overall Study|Lost to Follow-up|2
3104174|NCT00256867|10635794|P8|Overall Study|Adverse Event|4
3104175|NCT00256867|10635795|P7|Overall Study|Adverse Event|1
3104176|NCT00256867|10635796|P6|Overall Study|Adverse Event|2
3104177|NCT00256867|10635797|P5|Overall Study|Adverse Event|2
3104178|NCT00256867|10635798|P4|Overall Study|Adverse Event|1
3104179|NCT00256867|10635799|P3|Overall Study|Adverse Event|1
3104180|NCT00256867|10635800|P2|Overall Study|Adverse Event|1
3104181|NCT00256867|10635801|P1|Overall Study|Adverse Event|0
3104182|NCT00256854|10635891|P6|Overall Study|Not compliant with the study drug|0
3104183|NCT00256854|10635892|P5|Overall Study|Not compliant with the study drug|1
3104184|NCT00256854|10635893|P4|Overall Study|Not compliant with the study drug|0
3104185|NCT00256854|10635894|P3|Overall Study|Not compliant with the study drug|0
3104186|NCT00256854|10635895|P2|Overall Study|Not compliant with the study drug|0
3104187|NCT00256854|10635896|P1|Overall Study|Not compliant with the study drug|0
3104188|NCT00256854|10635891|P6|Overall Study|Adverse Event|1
3104189|NCT00256854|10635892|P5|Overall Study|Adverse Event|0
3104190|NCT00256854|10635893|P4|Overall Study|Adverse Event|2
3104191|NCT00256854|10635894|P3|Overall Study|Adverse Event|2
3104192|NCT00256854|10635895|P2|Overall Study|Adverse Event|0
3104193|NCT00256854|10635896|P1|Overall Study|Adverse Event|0
3104194|NCT00256854|10635891|P6|Overall Study|Protocol Violation|0
3104195|NCT00256854|10635892|P5|Overall Study|Protocol Violation|0
3104196|NCT00256854|10635893|P4|Overall Study|Protocol Violation|1
3104197|NCT00256854|10635894|P3|Overall Study|Protocol Violation|1
3104198|NCT00256854|10635895|P2|Overall Study|Protocol Violation|1
3104199|NCT00256854|10635896|P1|Overall Study|Protocol Violation|0
3104200|NCT00256854|10635891|P6|Overall Study|Lack of Efficacy|0
3104201|NCT00256854|10635892|P5|Overall Study|Lack of Efficacy|0
3104202|NCT00256854|10635893|P4|Overall Study|Lack of Efficacy|0
3104203|NCT00256854|10635894|P3|Overall Study|Lack of Efficacy|0
3104204|NCT00256854|10635895|P2|Overall Study|Lack of Efficacy|0
3104205|NCT00256854|10635896|P1|Overall Study|Lack of Efficacy|1
3104206|NCT00256854|10635891|P6|Overall Study|Withdrawal by Subject|0
3104207|NCT00256854|10635892|P5|Overall Study|Withdrawal by Subject|0
3104208|NCT00256854|10635893|P4|Overall Study|Withdrawal by Subject|0
3104209|NCT00256854|10635894|P3|Overall Study|Withdrawal by Subject|0
3104210|NCT00256854|10635895|P2|Overall Study|Withdrawal by Subject|3
3104211|NCT00256854|10635896|P1|Overall Study|Withdrawal by Subject|2
3104212|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Other|5
3104213|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Other|4
3104214|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Other|5
3104215|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
3104216|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
3104217|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
3104218|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
3104219|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
3104220|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
3104221|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
3104222|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
3104223|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
3104224|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
3104225|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
3104226|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
3104227|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Death|4
3104228|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Death|4
3104229|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Death|9
3104230|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
3104231|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
3104232|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
3104233|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
3104234|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
3104235|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
3104236|NCT00256750|10635955|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
3104237|NCT00256750|10635956|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
3104238|NCT00256750|10635957|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
3104239|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Other|1
3104240|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Other|1
3104241|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Other|0
3104242|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
3104243|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
3104244|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
3104245|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
3104246|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
3104247|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
3104248|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
3104249|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
3104250|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
3104251|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Death|1
3104252|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Death|2
3104253|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Death|0
3104254|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
3104255|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
3104256|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
3104257|NCT00256750|10635955|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
3104258|NCT00256750|10635956|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
3104259|NCT00256750|10635957|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
3104260|NCT00256750|10635955|P3|Post-Transplant Treated (24 Months)|Other|1
3104261|NCT00256750|10635956|P2|Post-Transplant Treated (24 Months)|Other|0
3104262|NCT00256750|10635957|P1|Post-Transplant Treated (24 Months)|Other|2
3104263|NCT00256750|10635955|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
3104264|NCT00256750|10635956|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
3104265|NCT00256750|10635957|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
3104266|NCT00256750|10635955|P3|Post-Transplant Treated (24 Months)|Death|0
3104267|NCT00256750|10635956|P2|Post-Transplant Treated (24 Months)|Death|0
3104268|NCT00256750|10635957|P1|Post-Transplant Treated (24 Months)|Death|3
3104269|NCT00256750|10635955|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
3104270|NCT00256750|10635956|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
3104271|NCT00256750|10635957|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
3104272|NCT00256750|10635955|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
3104273|NCT00256750|10635956|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
3104274|NCT00256750|10635957|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
3104275|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
3104276|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
3104277|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
3104278|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
3104279|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
3104280|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
3104281|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Other|2
3104282|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Other|4
3104283|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Other|5
3104284|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
3104285|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
3104286|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
3104287|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
3104288|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
3104289|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
3104290|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Death|4
3104291|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Death|2
3104292|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Death|3
3104293|NCT00256750|10635955|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
3104294|NCT00256750|10635956|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
3104295|NCT00256750|10635957|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
3104296|NCT00256750|10635955|P3|Transplanted Pre-Treatment|Death|0
3104297|NCT00256750|10635956|P2|Transplanted Pre-Treatment|Death|0
3104298|NCT00256750|10635957|P1|Transplanted Pre-Treatment|Death|1
3104299|NCT00256750|10635955|P3|Transplanted Pre-Treatment|Other|0
3104300|NCT00256750|10635956|P2|Transplanted Pre-Treatment|Other|0
3104301|NCT00256750|10635957|P1|Transplanted Pre-Treatment|Other|2
3104302|NCT00256750|10635955|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
3104303|NCT00256750|10635956|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
3104304|NCT00256750|10635957|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
3104305|NCT00256724|10636093|P2|Overall Study|Protocol Violation|3
3104306|NCT00256724|10636094|P1|Overall Study|Protocol Violation|3
3104307|NCT00256724|10636093|P2|Overall Study|Physician Decision|5
3104308|NCT00256724|10636094|P1|Overall Study|Physician Decision|2
3104309|NCT00256698|10636104|P2|Overall Study|Prematurely Discontinued|0
3104310|NCT00256698|10636105|P1|Overall Study|Prematurely Discontinued|1
3104311|NCT00256698|10636104|P2|Overall Study|withdrawn due to osteoporosis|0
3104312|NCT00256698|10636105|P1|Overall Study|withdrawn due to osteoporosis|1
3104313|NCT00256698|10636104|P2|Overall Study|still ongoing at data cut-off|46
3104314|NCT00256698|10636105|P1|Overall Study|still ongoing at data cut-off|41
3104315|NCT00256698|10636104|P2|Overall Study|disease progression|105
3104316|NCT00256698|10636105|P1|Overall Study|disease progression|97
3104317|NCT00256698|10636104|P2|Overall Study|Lost to Follow-up|3
3104318|NCT00256698|10636105|P1|Overall Study|Lost to Follow-up|1
3104319|NCT00256698|10636104|P2|Overall Study|Protocol Violation|5
3104320|NCT00256698|10636105|P1|Overall Study|Protocol Violation|6
3104321|NCT00256698|10636104|P2|Overall Study|Adverse Event|6
3104322|NCT00256698|10636105|P1|Overall Study|Adverse Event|13
3104323|NCT00256698|10636104|P2|Overall Study|Withdrawal by Subject|7
3104324|NCT00256698|10636105|P1|Overall Study|Withdrawal by Subject|7
3104325|NCT00256308|10636152|P1|Overall Study|Death|2
3104326|NCT00256295|10636160|P1|Overall Study|Death|1
3104327|NCT00256295|10636160|P1|Overall Study|Withdrawal by Subject|3
3104328|NCT00256282|10636166|P1|Overall Study|Physician Decision|1
3104329|NCT00256282|10636166|P1|Overall Study|Adverse Event|3
3104330|NCT00256282|10636166|P1|Overall Study|Disease progression, relapse during acti|12
3104331|NCT00256243|10636171|P1|Overall Study|Not treated|1
3104332|NCT00256243|10636171|P1|Overall Study|Death|7
3104333|NCT00256243|10636171|P1|Overall Study|Lost to Follow-up|2
3104334|NCT00256204|10636180|P4|Overall Study|Need for additional prohibited treatment|25
3104335|NCT00256204|10636181|P3|Overall Study|Need for additional prohibited treatment|27
3104336|NCT00256204|10636182|P2|Overall Study|Need for additional prohibited treatment|28
3104337|NCT00256204|10636183|P1|Overall Study|Need for additional prohibited treatment|38
3104338|NCT00256204|10636180|P4|Overall Study|Withdrawal by Subject|5
3104339|NCT00256204|10636181|P3|Overall Study|Withdrawal by Subject|7
3104340|NCT00256204|10636182|P2|Overall Study|Withdrawal by Subject|6
3104341|NCT00256204|10636183|P1|Overall Study|Withdrawal by Subject|17
3104342|NCT00256204|10636180|P4|Overall Study|Physician Decision|2
3104343|NCT00256204|10636181|P3|Overall Study|Physician Decision|1
3104344|NCT00256204|10636182|P2|Overall Study|Physician Decision|0
3104345|NCT00256204|10636183|P1|Overall Study|Physician Decision|0
3104346|NCT00256204|10636180|P4|Overall Study|Protocol Violation|1
3104347|NCT00256204|10636181|P3|Overall Study|Protocol Violation|2
3104348|NCT00256204|10636182|P2|Overall Study|Protocol Violation|0
3104349|NCT00256204|10636183|P1|Overall Study|Protocol Violation|1
3104350|NCT00256204|10636180|P4|Overall Study|Lost to Follow-up|2
3104351|NCT00256204|10636181|P3|Overall Study|Lost to Follow-up|1
3104352|NCT00256204|10636182|P2|Overall Study|Lost to Follow-up|1
3104353|NCT00256204|10636183|P1|Overall Study|Lost to Follow-up|1
3104354|NCT00256204|10636180|P4|Overall Study|Death|0
3104355|NCT00256204|10636181|P3|Overall Study|Death|0
3104356|NCT00256204|10636182|P2|Overall Study|Death|1
3104357|NCT00256204|10636183|P1|Overall Study|Death|0
3104358|NCT00256204|10636180|P4|Overall Study|Adverse Event|14
3104359|NCT00256204|10636181|P3|Overall Study|Adverse Event|16
3104360|NCT00256204|10636182|P2|Overall Study|Adverse Event|14
3104361|NCT00256204|10636183|P1|Overall Study|Adverse Event|10
3104362|NCT00256126|10636198|P2|Overall Study|Other|2
3104363|NCT00256126|10636199|P1|Overall Study|Other|1
3104364|NCT00256126|10636198|P2|Overall Study|Adverse Event|0
3104365|NCT00256126|10636199|P1|Overall Study|Adverse Event|1
3104366|NCT00255840|10636238|P2|Overall Study|Discontinued intervention|56
3104367|NCT00255840|10636239|P1|Overall Study|Discontinued intervention|53
3104368|NCT00255840|10636238|P2|Overall Study|Lost to Follow-up|14
3104369|NCT00255840|10636239|P1|Overall Study|Lost to Follow-up|10
3104370|NCT00255723|10636252|P2|Overall Study|Response Data Not Available|0
3104371|NCT00255723|10636253|P1|Overall Study|Response Data Not Available|1
3104372|NCT00255723|10636252|P2|Overall Study|Death|1
3104373|NCT00255723|10636253|P1|Overall Study|Death|0
3104374|NCT00255723|10636252|P2|Overall Study|Adverse Event|1
3104375|NCT00255723|10636253|P1|Overall Study|Adverse Event|1
3104376|NCT00255346|10636269|P5|Overall Study|Adverse Event|0
3104377|NCT00255346|10636270|P4|Overall Study|Adverse Event|0
3104378|NCT00255346|10636271|P3|Overall Study|Adverse Event|0
3104379|NCT00255346|10636272|P2|Overall Study|Adverse Event|0
3104380|NCT00255346|10636273|P1|Overall Study|Adverse Event|1
3104381|NCT00255190|10636288|P2|Overall Study|Various|23
3104382|NCT00255190|10636289|P1|Overall Study|Various|4
3104383|NCT00255190|10636288|P2|Overall Study|Erosive esophagitis not healed|20
3104384|NCT00255190|10636289|P1|Overall Study|Erosive esophagitis not healed|0
3104385|NCT00255190|10636288|P2|Overall Study|Inclusion/Exclusion criteria not met|1
3104386|NCT00255190|10636289|P1|Overall Study|Inclusion/Exclusion criteria not met|0
3104387|NCT00255190|10636288|P2|Overall Study|Withdrew Consent|48
3104388|NCT00255190|10636289|P1|Overall Study|Withdrew Consent|17
3104389|NCT00255190|10636288|P2|Overall Study|Lost to Follow-up|27
3104390|NCT00255190|10636289|P1|Overall Study|Lost to Follow-up|10
3104391|NCT00255190|10636288|P2|Overall Study|Protocol Violation|2
3104392|NCT00255190|10636289|P1|Overall Study|Protocol Violation|2
3104393|NCT00255190|10636288|P2|Overall Study|Adverse Event|36
3104394|NCT00255190|10636289|P1|Overall Study|Adverse Event|17
3104395|NCT00255164|10636373|P3|Overall Study|Therapeutic Failure|3
3104396|NCT00255164|10636374|P2|Overall Study|Therapeutic Failure|2
3104397|NCT00255164|10636375|P1|Overall Study|Therapeutic Failure|11
3104398|NCT00255164|10636373|P3|Overall Study|Esophageal Stricture|1
3104399|NCT00255164|10636374|P2|Overall Study|Esophageal Stricture|0
3104400|NCT00255164|10636375|P1|Overall Study|Esophageal Stricture|0
3104401|NCT00255164|10636373|P3|Overall Study|Possible Barrett's Esophagus|8
3104402|NCT00255164|10636374|P2|Overall Study|Possible Barrett's Esophagus|3
3104403|NCT00255164|10636375|P1|Overall Study|Possible Barrett's Esophagus|1
3104404|NCT00255164|10636373|P3|Overall Study|Relapse of Erosive Esophagitis|12
3104405|NCT00255164|10636374|P2|Overall Study|Relapse of Erosive Esophagitis|16
3104406|NCT00255164|10636375|P1|Overall Study|Relapse of Erosive Esophagitis|78
3104407|NCT00255164|10636373|P3|Overall Study|Subject Request/Subject Unavailable|2
3104408|NCT00255164|10636374|P2|Overall Study|Subject Request/Subject Unavailable|1
3104409|NCT00255164|10636375|P1|Overall Study|Subject Request/Subject Unavailable|1
3104410|NCT00255164|10636373|P3|Overall Study|Noncompliance|2
3104411|NCT00255164|10636374|P2|Overall Study|Noncompliance|1
3104412|NCT00255164|10636375|P1|Overall Study|Noncompliance|0
3104413|NCT00255164|10636373|P3|Overall Study|Withdrawal by Subject|8
3104414|NCT00255164|10636374|P2|Overall Study|Withdrawal by Subject|17
3104415|NCT00255164|10636375|P1|Overall Study|Withdrawal by Subject|18
3104416|NCT00255164|10636373|P3|Overall Study|Lost to Follow-up|4
3104417|NCT00255164|10636374|P2|Overall Study|Lost to Follow-up|3
3104418|NCT00255164|10636375|P1|Overall Study|Lost to Follow-up|4
3104419|NCT00255164|10636373|P3|Overall Study|Adverse Event|9
3104420|NCT00255164|10636374|P2|Overall Study|Adverse Event|6
3104421|NCT00255164|10636375|P1|Overall Study|Adverse Event|10
3104422|NCT00255151|10636401|P3|Overall Study|Therapeutic Failure|3
3104423|NCT00255151|10636402|P2|Overall Study|Therapeutic Failure|2
3104424|NCT00255151|10636403|P1|Overall Study|Therapeutic Failure|11
3104425|NCT00255151|10636401|P3|Overall Study|Esophageal Stricture|1
3104426|NCT00255151|10636402|P2|Overall Study|Esophageal Stricture|0
3104427|NCT00255151|10636403|P1|Overall Study|Esophageal Stricture|0
3104428|NCT00255151|10636401|P3|Overall Study|Possible Barrett's Esophagus|8
3104429|NCT00255151|10636402|P2|Overall Study|Possible Barrett's Esophagus|3
3104430|NCT00255151|10636403|P1|Overall Study|Possible Barrett's Esophagus|1
3104431|NCT00255151|10636401|P3|Overall Study|Relapse of Erosive Esophagitis|12
3104432|NCT00255151|10636402|P2|Overall Study|Relapse of Erosive Esophagitis|16
3104433|NCT00255151|10636403|P1|Overall Study|Relapse of Erosive Esophagitis|78
3104434|NCT00255151|10636401|P3|Overall Study|Subject Request/Subject Unavailable|2
3104435|NCT00255151|10636402|P2|Overall Study|Subject Request/Subject Unavailable|1
3104436|NCT00255151|10636403|P1|Overall Study|Subject Request/Subject Unavailable|1
3104437|NCT00255151|10636401|P3|Overall Study|Noncompliance|2
3104438|NCT00255151|10636402|P2|Overall Study|Noncompliance|1
3104439|NCT00255151|10636403|P1|Overall Study|Noncompliance|0
3104440|NCT00255151|10636401|P3|Overall Study|Withdrawal by Subject|8
3104441|NCT00255151|10636402|P2|Overall Study|Withdrawal by Subject|17
3104442|NCT00255151|10636403|P1|Overall Study|Withdrawal by Subject|18
3104443|NCT00255151|10636401|P3|Overall Study|Lost to Follow-up|4
3104444|NCT00255151|10636402|P2|Overall Study|Lost to Follow-up|3
3104445|NCT00255151|10636403|P1|Overall Study|Lost to Follow-up|4
3104446|NCT00255151|10636401|P3|Overall Study|Adverse Event|9
3104447|NCT00255151|10636402|P2|Overall Study|Adverse Event|6
3104448|NCT00255151|10636403|P1|Overall Study|Adverse Event|10
3104449|NCT00255086|10636441|P2|Overall Study|Protocol Violation|1
3104450|NCT00255086|10636442|P1|Overall Study|Protocol Violation|1
3104451|NCT00255086|10636441|P2|Overall Study|Adverse Event|1
3104452|NCT00255086|10636442|P1|Overall Study|Adverse Event|1
3104453|NCT00255047|10636454|P4|Overall Study|Withdrawal by Subject|18
3104454|NCT00255047|10636455|P3|Overall Study|Withdrawal by Subject|25
3104455|NCT00255047|10636456|P2|Overall Study|Withdrawal by Subject|23
3104456|NCT00255047|10636457|P1|Overall Study|Withdrawal by Subject|24
3104457|NCT00255047|10636454|P4|Overall Study|Lost to Follow-up|6
3104458|NCT00255047|10636455|P3|Overall Study|Lost to Follow-up|5
3104459|NCT00255047|10636456|P2|Overall Study|Lost to Follow-up|8
3104460|NCT00255047|10636457|P1|Overall Study|Lost to Follow-up|9
3104461|NCT00255047|10636454|P4|Overall Study|Protocol Violation|20
3104462|NCT00255047|10636455|P3|Overall Study|Protocol Violation|16
3104463|NCT00255047|10636456|P2|Overall Study|Protocol Violation|13
3104464|NCT00255047|10636457|P1|Overall Study|Protocol Violation|13
3104465|NCT00255047|10636454|P4|Overall Study|Adverse Event|1
3104466|NCT00255047|10636455|P3|Overall Study|Adverse Event|2
3104467|NCT00255047|10636456|P2|Overall Study|Adverse Event|3
3104468|NCT00255047|10636457|P1|Overall Study|Adverse Event|0
3104469|NCT00255047|10636454|P4|Overall Study|Serious Adverse Events|1
3104470|NCT00255047|10636455|P3|Overall Study|Serious Adverse Events|2
3104471|NCT00255047|10636456|P2|Overall Study|Serious Adverse Events|1
3104472|NCT00255047|10636457|P1|Overall Study|Serious Adverse Events|2
3104473|NCT00255034|10636481|P2|Overall Study|Withdrawal by Subject|38
3104474|NCT00255034|10636482|P1|Overall Study|Withdrawal by Subject|15
3104475|NCT00255008|10636492|P4|Overall Study|Other|2
3104476|NCT00255008|10636493|P3|Overall Study|Other|3
3104477|NCT00255008|10636494|P2|Overall Study|Other|0
3104478|NCT00255008|10636495|P1|Overall Study|Other|7
3104479|NCT00255008|10636492|P4|Overall Study|Adverse lab experience|0
3104480|NCT00255008|10636493|P3|Overall Study|Adverse lab experience|0
3104481|NCT00255008|10636494|P2|Overall Study|Adverse lab experience|0
3104482|NCT00255008|10636495|P1|Overall Study|Adverse lab experience|1
3104483|NCT00255008|10636492|P4|Overall Study|Sponsor request|17
3104484|NCT00255008|10636493|P3|Overall Study|Sponsor request|8
3104485|NCT00255008|10636494|P2|Overall Study|Sponsor request|3
3104486|NCT00255008|10636495|P1|Overall Study|Sponsor request|18
3104487|NCT00255008|10636492|P4|Overall Study|Withdrew consent|0
3104488|NCT00255008|10636493|P3|Overall Study|Withdrew consent|2
3104489|NCT00255008|10636494|P2|Overall Study|Withdrew consent|0
3104490|NCT00255008|10636495|P1|Overall Study|Withdrew consent|0
3104491|NCT00255008|10636492|P4|Overall Study|Did not meet viral reduction criteria|1
3104492|NCT00255008|10636493|P3|Overall Study|Did not meet viral reduction criteria|0
3104493|NCT00255008|10636494|P2|Overall Study|Did not meet viral reduction criteria|5
3104494|NCT00255008|10636495|P1|Overall Study|Did not meet viral reduction criteria|4
3104495|NCT00255008|10636492|P4|Overall Study|Lost to Follow-up|2
3104496|NCT00255008|10636493|P3|Overall Study|Lost to Follow-up|1
3104497|NCT00255008|10636494|P2|Overall Study|Lost to Follow-up|0
3104498|NCT00255008|10636495|P1|Overall Study|Lost to Follow-up|1
3104499|NCT00255008|10636492|P4|Overall Study|Adverse Event|0
3104500|NCT00255008|10636493|P3|Overall Study|Adverse Event|2
3104501|NCT00255008|10636494|P2|Overall Study|Adverse Event|1
3104502|NCT00255008|10636495|P1|Overall Study|Adverse Event|1
3104503|NCT00254982|10636531|P2|Overall Study|Abnormal liver function tests|1
3104504|NCT00254982|10636532|P1|Overall Study|Abnormal liver function tests|2
3104505|NCT00254982|10636531|P2|Overall Study|Opportunistic infection|0
3104506|NCT00254982|10636532|P1|Overall Study|Opportunistic infection|1
3104507|NCT00254982|10636531|P2|Overall Study|Malignancy|2
3104508|NCT00254982|10636532|P1|Overall Study|Malignancy|0
3104509|NCT00254982|10636531|P2|Overall Study|Diagnosis of Tuberculosis|1
3104510|NCT00254982|10636532|P1|Overall Study|Diagnosis of Tuberculosis|1
3104511|NCT00254982|10636531|P2|Overall Study|Protocol deviation|1
3104512|NCT00254982|10636532|P1|Overall Study|Protocol deviation|1
3104513|NCT00254982|10636531|P2|Overall Study|Inclusion/exclusion criteria violation|2
3104514|NCT00254982|10636532|P1|Overall Study|Inclusion/exclusion criteria violation|0
3104515|NCT00254982|10636531|P2|Overall Study|Withdrawal by Subject|1
3104516|NCT00254982|10636532|P1|Overall Study|Withdrawal by Subject|1
3104517|NCT00254982|10636531|P2|Overall Study|Adverse Event|16
3104518|NCT00254982|10636532|P1|Overall Study|Adverse Event|18
3104519|NCT00254982|10636531|P2|Overall Study|Lost to Follow-up|3
3104520|NCT00254982|10636532|P1|Overall Study|Lost to Follow-up|5
3104521|NCT00254982|10636531|P2|Overall Study|Lack of Efficacy|3
3104522|NCT00254982|10636532|P1|Overall Study|Lack of Efficacy|5
3104523|NCT00254982|10636531|P2|Overall Study|Other|1
3104524|NCT00254982|10636532|P1|Overall Study|Other|2
3104525|NCT00254566|10636544|P2|Overall Study|Lost to Follow-up|2
3104526|NCT00254566|10636545|P1|Overall Study|Lost to Follow-up|7
3104527|NCT00254566|10636544|P2|Overall Study|Withdrawal by Subject|6
3104528|NCT00254566|10636545|P1|Overall Study|Withdrawal by Subject|5
3104529|NCT00254566|10636544|P2|Overall Study|Other|5
3104530|NCT00254566|10636545|P1|Overall Study|Other|1
3104531|NCT00254566|10636544|P2|Overall Study|Lack of Efficacy|9
3104532|NCT00254566|10636545|P1|Overall Study|Lack of Efficacy|12
3104533|NCT00254566|10636544|P2|Overall Study|Adverse Event|4
3104534|NCT00254566|10636545|P1|Overall Study|Adverse Event|5
3104535|NCT00254566|10636544|P2|Overall Study|Death|0
3104536|NCT00254566|10636545|P1|Overall Study|Death|1
3104537|NCT00254540|10636569|P2|Overall Study|Laboratory Test Abnormality|1
3104538|NCT00254540|10636570|P1|Overall Study|Laboratory Test Abnormality|0
3104539|NCT00254540|10636569|P2|Overall Study|Death|1
3104540|NCT00254540|10636570|P1|Overall Study|Death|0
3104541|NCT00254540|10636569|P2|Overall Study|Lack of Efficacy|13
3104542|NCT00254540|10636570|P1|Overall Study|Lack of Efficacy|13
3104543|NCT00254540|10636569|P2|Overall Study|Adverse Event|7
3104544|NCT00254540|10636570|P1|Overall Study|Adverse Event|6
3104545|NCT00254501|10636599|P2|Overall Study|Lost to Follow-up|1
3104546|NCT00254501|10636600|P1|Overall Study|Lost to Follow-up|1
3104547|NCT00254397|10636645|P4|Overall Study|Adverse Event|1
3104548|NCT00254397|10636646|P3|Overall Study|Adverse Event|3
3104549|NCT00254397|10636647|P2|Overall Study|Adverse Event|0
3104550|NCT00254397|10636648|P1|Overall Study|Adverse Event|2
3104551|NCT00254397|10636645|P4|Overall Study|Non-Compliant|1
3104552|NCT00254397|10636646|P3|Overall Study|Non-Compliant|0
3104553|NCT00254397|10636647|P2|Overall Study|Non-Compliant|0
3104554|NCT00254397|10636648|P1|Overall Study|Non-Compliant|0
3104555|NCT00254397|10636645|P4|Overall Study|Disease Progression|23
3104556|NCT00254397|10636646|P3|Overall Study|Disease Progression|16
3104557|NCT00254397|10636647|P2|Overall Study|Disease Progression|1
3104558|NCT00254397|10636648|P1|Overall Study|Disease Progression|4
3104559|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Other|1
3104560|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Other|0
3104561|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Other|0
3104562|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Other|0
3104563|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Other|0
3104564|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Other|0
3104565|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Other|0
3104566|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
3104567|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104568|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104569|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104570|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104571|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104572|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
3104573|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
3104574|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104575|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104576|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104577|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104578|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104579|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
3104580|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
3104581|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104582|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104583|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104584|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104585|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104586|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
3104587|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
3104588|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104589|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104590|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104591|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104592|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104593|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
3104594|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Adverse Event|1
3104595|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Adverse Event|0
3104596|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Adverse Event|0
3104597|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Adverse Event|0
3104598|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Adverse Event|0
3104599|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Adverse Event|0
3104600|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Adverse Event|0
3104601|NCT00254293|10636672|P7|LTE Open Label Fixed Dosing|Death|3
3104602|NCT00254293|10636673|P6|LTE Open Label Fixed Dosing|Death|0
3104603|NCT00254293|10636674|P5|LTE Open Label Fixed Dosing|Death|0
3104604|NCT00254293|10636675|P4|LTE Open Label Fixed Dosing|Death|0
3104605|NCT00254293|10636676|P3|LTE Open Label Fixed Dosing|Death|0
3104606|NCT00254293|10636677|P2|LTE Open Label Fixed Dosing|Death|0
3104607|NCT00254293|10636678|P1|LTE Open Label Fixed Dosing|Death|0
3104608|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Other|0
3104609|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Other|0
3104610|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Other|0
3104611|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Other|0
3104612|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Other|2
3104613|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Other|0
3104614|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Other|0
3104615|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104616|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104617|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104618|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104619|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
3104696|NCT00253747|10636813|P2|Overall Study|Lost to Follow-up|14
3104620|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104621|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
3104622|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104623|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104624|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104625|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104626|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
3104627|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104628|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
3104629|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104630|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104631|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104632|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104633|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
3104634|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104635|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
3104636|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
3104637|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
3104638|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
3104639|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
3104640|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
3104641|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
3104642|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
3104643|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
3104644|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
3104645|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
3104646|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
3104647|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
3104648|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
3104649|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
3104650|NCT00254293|10636672|P7|LTE Open Label Variable SC Dosing|Death|0
3104651|NCT00254293|10636673|P6|LTE Open Label Variable SC Dosing|Death|0
3104652|NCT00254293|10636674|P5|LTE Open Label Variable SC Dosing|Death|0
3104653|NCT00254293|10636675|P4|LTE Open Label Variable SC Dosing|Death|0
3104654|NCT00254293|10636676|P3|LTE Open Label Variable SC Dosing|Death|1
3104655|NCT00254293|10636677|P2|LTE Open Label Variable SC Dosing|Death|0
3104656|NCT00254293|10636678|P1|LTE Open Label Variable SC Dosing|Death|0
3104657|NCT00254293|10636672|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104658|NCT00254293|10636673|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104659|NCT00254293|10636674|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104660|NCT00254293|10636675|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104661|NCT00254293|10636676|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
3104662|NCT00254293|10636677|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104663|NCT00254293|10636678|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
3104664|NCT00254293|10636672|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104665|NCT00254293|10636673|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104666|NCT00254293|10636674|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104667|NCT00254293|10636675|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104668|NCT00254293|10636676|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
3104669|NCT00254293|10636677|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104670|NCT00254293|10636678|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
3104671|NCT00254293|10636672|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
3104672|NCT00254293|10636673|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
3104673|NCT00254293|10636674|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
3104674|NCT00254293|10636675|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
3104675|NCT00254293|10636676|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
3104676|NCT00254293|10636677|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
3104677|NCT00254293|10636678|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
3104678|NCT00254163|10636761|P2|Overall Study|Other|8
3104679|NCT00254163|10636762|P1|Overall Study|Other|8
3104680|NCT00254163|10636761|P2|Overall Study|Death|1
3104681|NCT00254163|10636762|P1|Overall Study|Death|0
3104682|NCT00254163|10636761|P2|Overall Study|Progressive disease|1
3104683|NCT00254163|10636762|P1|Overall Study|Progressive disease|0
3104684|NCT00254163|10636761|P2|Overall Study|Failed entry|3
3104685|NCT00254163|10636762|P1|Overall Study|Failed entry|1
3104686|NCT00254163|10636761|P2|Overall Study|Investigator request|3
3104687|NCT00254163|10636762|P1|Overall Study|Investigator request|1
3104688|NCT00254163|10636761|P2|Overall Study|Patient request/withdrew consent|4
3104689|NCT00254163|10636762|P1|Overall Study|Patient request/withdrew consent|6
3104690|NCT00254163|10636761|P2|Overall Study|Adverse Event|26
3104691|NCT00254163|10636762|P1|Overall Study|Adverse Event|29
3104692|NCT00253747|10636813|P2|Overall Study|Administrative Discharge (1), Other (2)|2
3104693|NCT00253747|10636814|P1|Overall Study|Administrative Discharge (1), Other (2)|1
3104694|NCT00253747|10636813|P2|Overall Study|Withdrawal by Subject|11
3104695|NCT00253747|10636814|P1|Overall Study|Withdrawal by Subject|10
3104697|NCT00253747|10636814|P1|Overall Study|Lost to Follow-up|13
3104698|NCT00253643|10636867|P4|Overall Study|Non-Compliance|2
3104699|NCT00253643|10636868|P3|Overall Study|Non-Compliance|0
3104700|NCT00253643|10636869|P2|Overall Study|Non-Compliance|0
3104701|NCT00253643|10636870|P1|Overall Study|Non-Compliance|0
3104702|NCT00253643|10636867|P4|Overall Study|Withdrawal by Subject|1
3104703|NCT00253643|10636868|P3|Overall Study|Withdrawal by Subject|1
3104704|NCT00253643|10636869|P2|Overall Study|Withdrawal by Subject|0
3104705|NCT00253643|10636870|P1|Overall Study|Withdrawal by Subject|0
3104706|NCT00253630|10636884|P1|Overall Study|ineligible|2
3104707|NCT00253448|10636900|P1|Overall Study|Withdrawal by Subject|1
3104708|NCT00253370|10636919|P1|Overall Study|Abdominal pain due to disease|1
3104709|NCT00253370|10636919|P1|Overall Study|Protocol Violation|1
3104710|NCT00253370|10636919|P1|Overall Study|Physician Decision|1
3104711|NCT00253370|10636919|P1|Overall Study|Non-protocol therapy|1
3104712|NCT00253370|10636919|P1|Overall Study|Withdrawal by Subject|6
3104713|NCT00253370|10636919|P1|Overall Study|Death|2
3104714|NCT00253370|10636919|P1|Overall Study|Disease progression|13
3104715|NCT00253370|10636919|P1|Overall Study|Adverse Event|18
3104716|NCT00252733|10636965|P2|Overall Study|Multiple Reasons|14
3104717|NCT00252733|10636966|P1|Overall Study|Multiple Reasons|14
3104718|NCT00252733|10636965|P2|Overall Study|Lost to Follow-up|6
3104719|NCT00252733|10636966|P1|Overall Study|Lost to Follow-up|12
3104720|NCT00252733|10636965|P2|Overall Study|Death|5
3104721|NCT00252733|10636966|P1|Overall Study|Death|7
3104722|NCT00252733|10636965|P2|Overall Study|Withdrawal by Subject|67
3104723|NCT00252733|10636966|P1|Overall Study|Withdrawal by Subject|73
3104724|NCT00252720|10636976|P2|Overall Study|Mainly patients lost to follow-up|18
3104725|NCT00252720|10636977|P1|Overall Study|Mainly patients lost to follow-up|7
3104726|NCT00252720|10636976|P2|Overall Study|Moving|42
3104727|NCT00252720|10636977|P1|Overall Study|Moving|23
3104728|NCT00252720|10636976|P2|Overall Study|Death|8
3104729|NCT00252720|10636977|P1|Overall Study|Death|7
3104730|NCT00252720|10636976|P2|Overall Study|Withdrawal by Subject|97
3104731|NCT00252720|10636977|P1|Overall Study|Withdrawal by Subject|95
3104732|NCT00252694|10636991|P2|Overall Study|Patient Moving|16
3104733|NCT00252694|10636992|P1|Overall Study|Patient Moving|17
3104734|NCT00252694|10636991|P2|Overall Study|Mostly Lost to Follow Up|13
3104735|NCT00252694|10636992|P1|Overall Study|Mostly Lost to Follow Up|8
3104736|NCT00252694|10636991|P2|Overall Study|Death|34
3104737|NCT00252694|10636992|P1|Overall Study|Death|36
3104738|NCT00252694|10636991|P2|Overall Study|Withdrawal by Subject|91
3104739|NCT00252694|10636992|P1|Overall Study|Withdrawal by Subject|83
3104740|NCT00252577|10637038|P1|Overall Study|Lost to Follow-up|20
3104741|NCT00252564|10637044|P2|Overall Study|Withdrawal by Subject|2
3104742|NCT00252564|10637045|P1|Overall Study|Withdrawal by Subject|0
3104743|NCT00252564|10637044|P2|Overall Study|Patient Request|5
3104744|NCT00252564|10637045|P1|Overall Study|Patient Request|4
3104745|NCT00252564|10637044|P2|Overall Study|Lost to Follow-up|0
3104746|NCT00252564|10637045|P1|Overall Study|Lost to Follow-up|1
3104747|NCT00252564|10637044|P2|Overall Study|Physician Decision|0
3104748|NCT00252564|10637045|P1|Overall Study|Physician Decision|1
3104749|NCT00252564|10637044|P2|Overall Study|Death|3
3104750|NCT00252564|10637045|P1|Overall Study|Death|0
3104751|NCT00252564|10637044|P2|Overall Study|Disease Progression|20
3104752|NCT00252564|10637045|P1|Overall Study|Disease Progression|14
3104753|NCT00252564|10637044|P2|Overall Study|Unrelated Complication|1
3104754|NCT00252564|10637045|P1|Overall Study|Unrelated Complication|2
3104755|NCT00252564|10637044|P2|Overall Study|Adverse Event|13
3104756|NCT00252564|10637045|P1|Overall Study|Adverse Event|17
3104757|NCT00252499|10637085|P3|Overall Study|Lost to Follow-up|0
3104758|NCT00252499|10637086|P2|Overall Study|Lost to Follow-up|0
3104759|NCT00252499|10637087|P1|Overall Study|Lost to Follow-up|1
3104760|NCT00252239|10637119|P4|Overall Study|Lost to Follow-up|0
3104761|NCT00252239|10637120|P3|Overall Study|Lost to Follow-up|2
3104762|NCT00252239|10637121|P2|Overall Study|Lost to Follow-up|0
3104763|NCT00252239|10637122|P1|Overall Study|Lost to Follow-up|0
3104764|NCT00252239|10637119|P4|Overall Study|Withdrawal by Subject|1
3104765|NCT00252239|10637120|P3|Overall Study|Withdrawal by Subject|0
3104766|NCT00252239|10637121|P2|Overall Study|Withdrawal by Subject|0
3104767|NCT00252239|10637122|P1|Overall Study|Withdrawal by Subject|1
3104768|NCT00252187|10637134|P2|Overall Study|Withdrawal by Subject|0
3104769|NCT00252187|10637135|P1|Overall Study|Withdrawal by Subject|1
3104770|NCT00252187|10637134|P2|Overall Study|Adverse Event|1
3104771|NCT00252187|10637135|P1|Overall Study|Adverse Event|3
3104772|NCT00252174|10637158|P3|Overall Study|Withdrawal by Subject|0
3104773|NCT00252174|10637159|P2|Overall Study|Withdrawal by Subject|1
3104774|NCT00252174|10637160|P1|Overall Study|Withdrawal by Subject|0
3104775|NCT00252057|10637200|P2|Overall Study|Participant previously enrolled|1
3104776|NCT00252057|10637201|P1|Overall Study|Participant previously enrolled|0
3104777|NCT00252057|10637200|P2|Overall Study|Death|2
3104778|NCT00252057|10637201|P1|Overall Study|Death|1
3104779|NCT00252057|10637200|P2|Overall Study|Withdrawal by Subject|5
3104780|NCT00252057|10637201|P1|Overall Study|Withdrawal by Subject|2
3104781|NCT00251979|10637209|P2|Overall Study|Death|5
3104782|NCT00251979|10637210|P1|Overall Study|Death|3
3104783|NCT00251979|10637209|P2|Overall Study|Lost to Follow-up|6
3104784|NCT00251979|10637210|P1|Overall Study|Lost to Follow-up|8
3104785|NCT00251979|10637209|P2|Overall Study|Withdrawal by Subject|7
3104786|NCT00251979|10637210|P1|Overall Study|Withdrawal by Subject|13
3104787|NCT00251979|10637209|P2|Overall Study|Adverse Event|17
3104788|NCT00251979|10637210|P1|Overall Study|Adverse Event|11
3104789|NCT00251979|10637209|P2|Overall Study|Protocol Violation|5
3104790|NCT00251979|10637210|P1|Overall Study|Protocol Violation|3
3104791|NCT00251927|10637242|P2|Overall Study|Study procedure non-compliance|6
3104792|NCT00251927|10637243|P1|Overall Study|Study procedure non-compliance|5
3104793|NCT00251927|10637242|P2|Overall Study|Study-specific discont. achieved|2
3104794|NCT00251927|10637243|P1|Overall Study|Study-specific discont. achieved|13
3104795|NCT00251927|10637242|P2|Overall Study|Withdrawal by Subject|25
3104796|NCT00251927|10637243|P1|Overall Study|Withdrawal by Subject|40
3104797|NCT00251927|10637242|P2|Overall Study|Pregnancy|0
3104798|NCT00251927|10637243|P1|Overall Study|Pregnancy|2
3104799|NCT00251927|10637242|P2|Overall Study|Protocol Violation|2
3104800|NCT00251927|10637243|P1|Overall Study|Protocol Violation|1
3104801|NCT00251927|10637242|P2|Overall Study|Lost to Follow-up|8
3104802|NCT00251927|10637243|P1|Overall Study|Lost to Follow-up|22
3104803|NCT00251927|10637242|P2|Overall Study|Lack of Efficacy|16
3104804|NCT00251927|10637243|P1|Overall Study|Lack of Efficacy|22
3104805|NCT00251927|10637242|P2|Overall Study|Adverse Event|15
3104806|NCT00251927|10637243|P1|Overall Study|Adverse Event|3
3104807|NCT00251758|10637295|P3|Overall Study|Per Investigator Request|0
3104808|NCT00251758|10637296|P2|Overall Study|Per Investigator Request|0
3104809|NCT00251758|10637297|P1|Overall Study|Per Investigator Request|1
3104810|NCT00251758|10637295|P3|Overall Study|Per Subject Request|1
3104811|NCT00251758|10637296|P2|Overall Study|Per Subject Request|0
3104812|NCT00251758|10637297|P1|Overall Study|Per Subject Request|0
3104813|NCT00251758|10637295|P3|Overall Study|Pregnancy|0
3104814|NCT00251758|10637296|P2|Overall Study|Pregnancy|1
3104815|NCT00251758|10637297|P1|Overall Study|Pregnancy|0
3104816|NCT00251758|10637295|P3|Overall Study|Noncompliant|2
3104817|NCT00251758|10637296|P2|Overall Study|Noncompliant|2
3104818|NCT00251758|10637297|P1|Overall Study|Noncompliant|0
3104819|NCT00251758|10637295|P3|Overall Study|Lack of Efficacy|0
3104820|NCT00251758|10637296|P2|Overall Study|Lack of Efficacy|0
3104821|NCT00251758|10637297|P1|Overall Study|Lack of Efficacy|3
3104822|NCT00251758|10637295|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
3104823|NCT00251758|10637296|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
3104824|NCT00251758|10637297|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
3104825|NCT00251758|10637295|P3|Overall Study|Withdrawal by Subject|3
3104826|NCT00251758|10637296|P2|Overall Study|Withdrawal by Subject|7
3104827|NCT00251758|10637297|P1|Overall Study|Withdrawal by Subject|13
3104828|NCT00251758|10637295|P3|Overall Study|Lost to Follow-up|5
3104829|NCT00251758|10637296|P2|Overall Study|Lost to Follow-up|2
3104830|NCT00251758|10637297|P1|Overall Study|Lost to Follow-up|4
3104831|NCT00251758|10637295|P3|Overall Study|Adverse Event|11
3104832|NCT00251758|10637296|P2|Overall Study|Adverse Event|9
3104833|NCT00251758|10637297|P1|Overall Study|Adverse Event|7
3104834|NCT00251745|10637317|P3|Overall Study|Per Investigator Request|0
3104835|NCT00251745|10637318|P2|Overall Study|Per Investigator Request|0
3104836|NCT00251745|10637319|P1|Overall Study|Per Investigator Request|1
3104837|NCT00251745|10637317|P3|Overall Study|Per Subject Request|1
3104838|NCT00251745|10637318|P2|Overall Study|Per Subject Request|0
3104839|NCT00251745|10637319|P1|Overall Study|Per Subject Request|0
3104840|NCT00251745|10637317|P3|Overall Study|Pregnancy|0
3104841|NCT00251745|10637318|P2|Overall Study|Pregnancy|1
3104842|NCT00251745|10637319|P1|Overall Study|Pregnancy|0
3104843|NCT00251745|10637317|P3|Overall Study|Noncompliant|2
3104844|NCT00251745|10637318|P2|Overall Study|Noncompliant|2
3104845|NCT00251745|10637319|P1|Overall Study|Noncompliant|0
3104846|NCT00251745|10637317|P3|Overall Study|Lack of Efficacy|0
3104847|NCT00251745|10637318|P2|Overall Study|Lack of Efficacy|0
3104848|NCT00251745|10637319|P1|Overall Study|Lack of Efficacy|3
3104849|NCT00251745|10637317|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
3104850|NCT00251745|10637318|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
3104851|NCT00251745|10637319|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
3104852|NCT00251745|10637317|P3|Overall Study|Withdrawal by Subject|3
3104853|NCT00251745|10637318|P2|Overall Study|Withdrawal by Subject|7
3104854|NCT00251745|10637319|P1|Overall Study|Withdrawal by Subject|13
3104855|NCT00251745|10637317|P3|Overall Study|Lost to Follow-up|5
3104856|NCT00251745|10637318|P2|Overall Study|Lost to Follow-up|2
3104857|NCT00251745|10637319|P1|Overall Study|Lost to Follow-up|4
3104858|NCT00251745|10637317|P3|Overall Study|Adverse Event|11
3104859|NCT00251745|10637318|P2|Overall Study|Adverse Event|9
3104860|NCT00251745|10637319|P1|Overall Study|Adverse Event|7
3104861|NCT00251719|10637339|P3|Overall Study|Barrett's esophagus|0
3104862|NCT00251719|10637340|P2|Overall Study|Barrett's esophagus|2
3104863|NCT00251719|10637341|P1|Overall Study|Barrett's esophagus|2
3104864|NCT00251719|10637339|P3|Overall Study|Noncompliance|1
3104865|NCT00251719|10637340|P2|Overall Study|Noncompliance|3
3104866|NCT00251719|10637341|P1|Overall Study|Noncompliance|2
3104867|NCT00251719|10637339|P3|Overall Study|Investigator decision|0
3104868|NCT00251719|10637340|P2|Overall Study|Investigator decision|1
3104869|NCT00251719|10637341|P1|Overall Study|Investigator decision|1
3104870|NCT00251719|10637339|P3|Overall Study|Inclusion/exclusion criteria not met|2
3104871|NCT00251719|10637340|P2|Overall Study|Inclusion/exclusion criteria not met|6
3104872|NCT00251719|10637341|P1|Overall Study|Inclusion/exclusion criteria not met|12
3104873|NCT00251719|10637339|P3|Overall Study|Lack of Efficacy|0
3104874|NCT00251719|10637340|P2|Overall Study|Lack of Efficacy|1
3104875|NCT00251719|10637341|P1|Overall Study|Lack of Efficacy|2
3104876|NCT00251719|10637339|P3|Overall Study|Withdrawal by Subject|11
3104877|NCT00251719|10637340|P2|Overall Study|Withdrawal by Subject|12
3104878|NCT00251719|10637341|P1|Overall Study|Withdrawal by Subject|14
3104879|NCT00251719|10637339|P3|Overall Study|Lost to Follow-up|8
3104880|NCT00251719|10637340|P2|Overall Study|Lost to Follow-up|11
3104881|NCT00251719|10637341|P1|Overall Study|Lost to Follow-up|5
3104882|NCT00251719|10637339|P3|Overall Study|Protocol Violation|1
3104883|NCT00251719|10637340|P2|Overall Study|Protocol Violation|1
3104884|NCT00251719|10637341|P1|Overall Study|Protocol Violation|1
3104885|NCT00251719|10637339|P3|Overall Study|Adverse Event|7
3104886|NCT00251719|10637340|P2|Overall Study|Adverse Event|8
3104887|NCT00251719|10637341|P1|Overall Study|Adverse Event|14
3104888|NCT00251693|10637367|P3|Overall Study|Abnormal laboratory findings|1
3104889|NCT00251693|10637368|P2|Overall Study|Abnormal laboratory findings|0
3104890|NCT00251693|10637369|P1|Overall Study|Abnormal laboratory findings|0
3104891|NCT00251693|10637367|P3|Overall Study|Subject request/subject unavailable|0
3104892|NCT00251693|10637368|P2|Overall Study|Subject request/subject unavailable|2
3104893|NCT00251693|10637369|P1|Overall Study|Subject request/subject unavailable|1
3104894|NCT00251693|10637367|P3|Overall Study|Possible Barrett's esophagus|2
3104895|NCT00251693|10637368|P2|Overall Study|Possible Barrett's esophagus|5
3104896|NCT00251693|10637369|P1|Overall Study|Possible Barrett's esophagus|3
3104897|NCT00251693|10637367|P3|Overall Study|Noncompliant|2
3104898|NCT00251693|10637368|P2|Overall Study|Noncompliant|0
3104899|NCT00251693|10637369|P1|Overall Study|Noncompliant|0
3104900|NCT00251693|10637367|P3|Overall Study|Inclusion/exclusion criteria not met|8
3104901|NCT00251693|10637368|P2|Overall Study|Inclusion/exclusion criteria not met|3
3104902|NCT00251693|10637369|P1|Overall Study|Inclusion/exclusion criteria not met|5
3104903|NCT00251693|10637367|P3|Overall Study|Lack of Efficacy|0
3104904|NCT00251693|10637368|P2|Overall Study|Lack of Efficacy|1
3104905|NCT00251693|10637369|P1|Overall Study|Lack of Efficacy|0
3104906|NCT00251693|10637367|P3|Overall Study|Withdrawal by Subject|14
3104907|NCT00251693|10637368|P2|Overall Study|Withdrawal by Subject|17
3104908|NCT00251693|10637369|P1|Overall Study|Withdrawal by Subject|11
3104909|NCT00251693|10637367|P3|Overall Study|Lost to Follow-up|8
3104910|NCT00251693|10637368|P2|Overall Study|Lost to Follow-up|7
3104911|NCT00251693|10637369|P1|Overall Study|Lost to Follow-up|12
3104912|NCT00251693|10637367|P3|Overall Study|Protocol Violation|2
3104913|NCT00251693|10637368|P2|Overall Study|Protocol Violation|0
3104914|NCT00251693|10637369|P1|Overall Study|Protocol Violation|2
3104915|NCT00251693|10637367|P3|Overall Study|Adverse Event|9
3104916|NCT00251693|10637368|P2|Overall Study|Adverse Event|9
3104917|NCT00251693|10637369|P1|Overall Study|Adverse Event|17
3104918|NCT00251641|10637394|P2|Overall Study|Switched Treatment|63
3104919|NCT00251641|10637395|P1|Overall Study|Switched Treatment|9
3104920|NCT00251641|10637394|P2|Overall Study|Did not Meet protocol Eligibility|1
3104921|NCT00251641|10637395|P1|Overall Study|Did not Meet protocol Eligibility|2
3104922|NCT00251641|10637394|P2|Overall Study|Protocol Violation|2
3104923|NCT00251641|10637395|P1|Overall Study|Protocol Violation|10
3104924|NCT00251641|10637394|P2|Overall Study|Withdrawal by Subject|8
3104925|NCT00251641|10637395|P1|Overall Study|Withdrawal by Subject|6
3104926|NCT00251641|10637394|P2|Overall Study|Lost to Follow-up|3
3104927|NCT00251641|10637395|P1|Overall Study|Lost to Follow-up|3
3104928|NCT00251641|10637394|P2|Overall Study|Progression of Disease|2
3104929|NCT00251641|10637395|P1|Overall Study|Progression of Disease|0
3104930|NCT00251641|10637394|P2|Overall Study|Lack of Efficacy|1
3104931|NCT00251641|10637395|P1|Overall Study|Lack of Efficacy|2
3104932|NCT00251641|10637394|P2|Overall Study|Adverse Event|8
3104933|NCT00251641|10637395|P1|Overall Study|Adverse Event|80
3104934|NCT00251589|10637413|P4|Overall Study|Discontinued due to progressive disease|1
3104935|NCT00251589|10637414|P3|Overall Study|Discontinued due to progressive disease|0
3104936|NCT00251589|10637415|P2|Overall Study|Discontinued due to progressive disease|1
3104937|NCT00251589|10637416|P1|Overall Study|Discontinued due to progressive disease|9
3104938|NCT00251589|10637413|P4|Overall Study|Withdrawal by Subject|0
3104939|NCT00251589|10637414|P3|Overall Study|Withdrawal by Subject|0
3104940|NCT00251589|10637415|P2|Overall Study|Withdrawal by Subject|1
3104941|NCT00251589|10637416|P1|Overall Study|Withdrawal by Subject|1
3104942|NCT00251589|10637413|P4|Overall Study|Adverse Event|1
3104943|NCT00251589|10637414|P3|Overall Study|Adverse Event|2
3104944|NCT00251589|10637415|P2|Overall Study|Adverse Event|1
3104945|NCT00251589|10637416|P1|Overall Study|Adverse Event|5
3104946|NCT00251316|10637453|P2|Overall Study|Physician Decision|3
3104947|NCT00251316|10637454|P1|Overall Study|Physician Decision|2
3104948|NCT00251004|10637493|P3|Overall Study|Graft Loss|8
3104949|NCT00251004|10637494|P2|Overall Study|Graft Loss|13
3104950|NCT00251004|10637495|P1|Overall Study|Graft Loss|12
3104951|NCT00251004|10637493|P3|Overall Study|Lost to Follow-up|1
3104952|NCT00251004|10637494|P2|Overall Study|Lost to Follow-up|2
3104953|NCT00251004|10637495|P1|Overall Study|Lost to Follow-up|1
3104954|NCT00251004|10637493|P3|Overall Study|Death|8
3104955|NCT00251004|10637494|P2|Overall Study|Death|10
3104956|NCT00251004|10637495|P1|Overall Study|Death|9
3104957|NCT00251004|10637493|P3|Overall Study|Withdrawal by Subject|14
3104958|NCT00251004|10637494|P2|Overall Study|Withdrawal by Subject|16
3104959|NCT00251004|10637495|P1|Overall Study|Withdrawal by Subject|23
3104960|NCT00250835|10637519|P1|Overall Study|Withdrawal by Subject|1
3104961|NCT00250718|10637528|P1|Overall Study|Withdrawal by Subject|1
3104962|NCT00250718|10637528|P1|Overall Study|Adverse Event|1
3104963|NCT00250718|10637528|P1|Overall Study|Death|1
3104964|NCT00250705|10637533|P1|Overall Study|Lack of Efficacy|2
3104965|NCT00250679|10637544|P3|Overall Study|various single events: hip surgery,diary|1
3104966|NCT00250679|10637545|P2|Overall Study|various single events: hip surgery,diary|1
3104967|NCT00250679|10637546|P1|Overall Study|various single events: hip surgery,diary|3
3104968|NCT00250679|10637544|P3|Overall Study|Non-compliance|0
3104969|NCT00250679|10637545|P2|Overall Study|Non-compliance|1
3104970|NCT00250679|10637546|P1|Overall Study|Non-compliance|1
3104971|NCT00250679|10637544|P3|Overall Study|Moved|0
3104972|NCT00250679|10637545|P2|Overall Study|Moved|1
3104973|NCT00250679|10637546|P1|Overall Study|Moved|1
3104974|NCT00250679|10637544|P3|Overall Study|Technical Holter issues|2
3104975|NCT00250679|10637545|P2|Overall Study|Technical Holter issues|0
3104976|NCT00250679|10637546|P1|Overall Study|Technical Holter issues|1
3104977|NCT00250679|10637544|P3|Overall Study|Lack of Efficacy|3
3104978|NCT00250679|10637545|P2|Overall Study|Lack of Efficacy|1
3104979|NCT00250679|10637546|P1|Overall Study|Lack of Efficacy|0
3104980|NCT00250679|10637544|P3|Overall Study|Does Not Meet Entry Criteria|2
3104981|NCT00250679|10637545|P2|Overall Study|Does Not Meet Entry Criteria|4
3104982|NCT00250679|10637546|P1|Overall Study|Does Not Meet Entry Criteria|1
3104983|NCT00250679|10637544|P3|Overall Study|Lost to Follow-up|2
3104984|NCT00250679|10637545|P2|Overall Study|Lost to Follow-up|4
3104985|NCT00250679|10637546|P1|Overall Study|Lost to Follow-up|3
3104986|NCT00250679|10637544|P3|Overall Study|Withdrawal by Subject|15
3104987|NCT00250679|10637545|P2|Overall Study|Withdrawal by Subject|18
3104988|NCT00250679|10637546|P1|Overall Study|Withdrawal by Subject|15
3104989|NCT00250679|10637544|P3|Overall Study|Protocol Violation|3
3104990|NCT00250679|10637545|P2|Overall Study|Protocol Violation|4
3104991|NCT00250679|10637546|P1|Overall Study|Protocol Violation|2
3104992|NCT00250679|10637544|P3|Overall Study|Adverse Event|16
3104993|NCT00250679|10637545|P2|Overall Study|Adverse Event|15
3104994|NCT00250679|10637546|P1|Overall Study|Adverse Event|12
3104995|NCT00250588|10637647|P3|Overall Study|Lost to Follow-up|13
3104996|NCT00250588|10637648|P2|Overall Study|Lost to Follow-up|13
3104997|NCT00250588|10637649|P1|Overall Study|Lost to Follow-up|6
3104998|NCT00250588|10637647|P3|Overall Study|Withdrawal by Subject|0
3104999|NCT00250588|10637648|P2|Overall Study|Withdrawal by Subject|6
3105000|NCT00250588|10637649|P1|Overall Study|Withdrawal by Subject|3
3105001|NCT00250458|10637697|P2|Overall Study|Other|0
3105002|NCT00250458|10637698|P1|Overall Study|Other|1
3105003|NCT00250458|10637697|P2|Overall Study|Qualifying migraine but did not treat|3
3105004|NCT00250458|10637698|P1|Overall Study|Qualifying migraine but did not treat|3
3105005|NCT00250458|10637697|P2|Overall Study|Lack of Migraine Attack|9
3105006|NCT00250458|10637698|P1|Overall Study|Lack of Migraine Attack|20
3105007|NCT00250458|10637697|P2|Overall Study|Withdrawal by Subject|2
3105008|NCT00250458|10637698|P1|Overall Study|Withdrawal by Subject|4
3105009|NCT00250458|10637697|P2|Overall Study|Protocol Violation|1
3105010|NCT00250458|10637698|P1|Overall Study|Protocol Violation|0
3105011|NCT00250458|10637697|P2|Overall Study|Lost to Follow-up|2
3105012|NCT00250458|10637698|P1|Overall Study|Lost to Follow-up|4
3105013|NCT00250432|10637708|P2|Overall Study|Pt was considered untreatable|1
3105014|NCT00250432|10637709|P1|Overall Study|Pt was considered untreatable|0
3105015|NCT00250432|10637708|P2|Overall Study|Pt died out of posttherapy report period|5
3105016|NCT00250432|10637709|P1|Overall Study|Pt died out of posttherapy report period|6
3105017|NCT00250432|10637708|P2|Overall Study|Withdrawal by Subject|2
3105018|NCT00250432|10637709|P1|Overall Study|Withdrawal by Subject|6
3105019|NCT00250432|10637708|P2|Overall Study|Protocol Violation|3
3105020|NCT00250432|10637709|P1|Overall Study|Protocol Violation|0
3105021|NCT00250432|10637708|P2|Overall Study|Patient Moved|1
3105022|NCT00250432|10637709|P1|Overall Study|Patient Moved|0
3105023|NCT00250432|10637708|P2|Overall Study|Lost to Follow-up|5
3105024|NCT00250432|10637709|P1|Overall Study|Lost to Follow-up|6
3105025|NCT00250432|10637708|P2|Overall Study|Lack of Efficacy|1
3105026|NCT00250432|10637709|P1|Overall Study|Lack of Efficacy|2
3105027|NCT00250432|10637708|P2|Overall Study|Adverse Event|29
3105028|NCT00250432|10637709|P1|Overall Study|Adverse Event|25
3105029|NCT00250276|10637721|P4|Overall Study|Lost to Follow-up|8
3105030|NCT00250276|10637722|P3|Overall Study|Lost to Follow-up|13
3105031|NCT00250276|10637723|P2|Overall Study|Lost to Follow-up|18
3105032|NCT00250276|10637724|P1|Overall Study|Lost to Follow-up|11
3105033|NCT00250276|10637721|P4|Overall Study|Migrated/moved from study area|7
3105034|NCT00250276|10637722|P3|Overall Study|Migrated/moved from study area|2
3105035|NCT00250276|10637723|P2|Overall Study|Migrated/moved from study area|0
3105036|NCT00250276|10637724|P1|Overall Study|Migrated/moved from study area|3
3105037|NCT00250276|10637721|P4|Overall Study|Withdrawal by Subject|2
3105038|NCT00250276|10637722|P3|Overall Study|Withdrawal by Subject|3
3105039|NCT00250276|10637723|P2|Overall Study|Withdrawal by Subject|2
3105040|NCT00250276|10637724|P1|Overall Study|Withdrawal by Subject|1
3105041|NCT00250276|10637721|P4|Overall Study|Protocol Violation|0
3105042|NCT00250276|10637722|P3|Overall Study|Protocol Violation|0
3105043|NCT00250276|10637723|P2|Overall Study|Protocol Violation|1
3105044|NCT00250276|10637724|P1|Overall Study|Protocol Violation|0
3105045|NCT00250276|10637721|P4|Overall Study|Non-serious Adverse Event|2
3105046|NCT00250276|10637722|P3|Overall Study|Non-serious Adverse Event|0
3105047|NCT00250276|10637723|P2|Overall Study|Non-serious Adverse Event|0
3105048|NCT00250276|10637724|P1|Overall Study|Non-serious Adverse Event|2
3105049|NCT00250276|10637721|P4|Overall Study|Serious Adverse Event|0
3105050|NCT00250276|10637722|P3|Overall Study|Serious Adverse Event|1
3105051|NCT00250276|10637723|P2|Overall Study|Serious Adverse Event|0
3105052|NCT00250276|10637724|P1|Overall Study|Serious Adverse Event|0
3105053|NCT00249873|10637804|P2|Overall Study|Thromboembolic/outcome event|122
3105054|NCT00249873|10637805|P1|Overall Study|Thromboembolic/outcome event|82
3105055|NCT00249873|10637804|P2|Overall Study|Event related to cardiac condition|21
3105056|NCT00249873|10637805|P1|Overall Study|Event related to cardiac condition|12
3105057|NCT00249873|10637804|P2|Overall Study|Surgery/ procedure|9
3105058|NCT00249873|10637805|P1|Overall Study|Surgery/ procedure|9
3105059|NCT00249873|10637804|P2|Overall Study|Study drug intolerance|0
3105060|NCT00249873|10637805|P1|Overall Study|Study drug intolerance|5
3105061|NCT00249873|10637804|P2|Overall Study|Oral anticoagulant required|157
3105062|NCT00249873|10637805|P1|Overall Study|Oral anticoagulant required|159
3105063|NCT00249873|10637804|P2|Overall Study|Angiotensin II receptor blocker required|0
3105064|NCT00249873|10637805|P1|Overall Study|Angiotensin II receptor blocker required|1
3105065|NCT00249873|10637804|P2|Overall Study|Open label clopidogrel required|42
3105066|NCT00249873|10637805|P1|Overall Study|Open label clopidogrel required|31
3105067|NCT00249873|10637804|P2|Overall Study|Physician withdrew consent|60
3105068|NCT00249873|10637805|P1|Overall Study|Physician withdrew consent|59
3105069|NCT00249873|10637804|P2|Overall Study|Patient not wish to continue after May08|4
3105070|NCT00249873|10637805|P1|Overall Study|Patient not wish to continue after May08|3
3105071|NCT00249873|10637804|P2|Overall Study|Other contraindicated medication|0
3105072|NCT00249873|10637805|P1|Overall Study|Other contraindicated medication|1
3105073|NCT00249873|10637804|P2|Overall Study|Other non serious Adverse Event|108
3105074|NCT00249873|10637805|P1|Overall Study|Other non serious Adverse Event|112
3105075|NCT00249873|10637804|P2|Overall Study|Non-compliance|46
3105076|NCT00249873|10637805|P1|Overall Study|Non-compliance|41
3105077|NCT00249873|10637804|P2|Overall Study|Minor bleeding|37
3105078|NCT00249873|10637805|P1|Overall Study|Minor bleeding|99
3105079|NCT00249873|10637804|P2|Overall Study|Lost to Follow-up|7
3105080|NCT00249873|10637805|P1|Overall Study|Lost to Follow-up|4
3105081|NCT00249873|10637804|P2|Overall Study|Withdrawal by Subject|466
3105082|NCT00249873|10637805|P1|Overall Study|Withdrawal by Subject|504
3105083|NCT00249873|10637804|P2|Overall Study|Contraindication to oral anticoagulant|8
3105084|NCT00249873|10637805|P1|Overall Study|Contraindication to oral anticoagulant|4
3105085|NCT00249873|10637804|P2|Overall Study|Qualifying condition not present|23
3105086|NCT00249873|10637805|P1|Overall Study|Qualifying condition not present|20
3105087|NCT00249873|10637804|P2|Overall Study|Other Serious Adverse Event|97
3105088|NCT00249873|10637805|P1|Overall Study|Other Serious Adverse Event|86
3105089|NCT00249873|10637804|P2|Overall Study|Serious haemorrhagic Adverse Event|30
3105090|NCT00249873|10637805|P1|Overall Study|Serious haemorrhagic Adverse Event|74
3105091|NCT00249873|10637804|P2|Overall Study|Severe allergic reaction|1
3105092|NCT00249873|10637805|P1|Overall Study|Severe allergic reaction|8
3105093|NCT00249873|10637804|P2|Overall Study|Significant thrombocytopenia|8
3105094|NCT00249873|10637805|P1|Overall Study|Significant thrombocytopenia|9
3105095|NCT00249873|10637804|P2|Overall Study|Not treated|8
3105096|NCT00249873|10637805|P1|Overall Study|Not treated|7
3105097|NCT00249834|10637825|P8|Overall Study|Protocol Violation|0
3105098|NCT00249834|10637826|P7|Overall Study|Protocol Violation|0
3105099|NCT00249834|10637827|P6|Overall Study|Protocol Violation|2
3105100|NCT00249834|10637828|P5|Overall Study|Protocol Violation|5
3105101|NCT00249834|10637829|P4|Overall Study|Protocol Violation|8
3105102|NCT00249834|10637830|P3|Overall Study|Protocol Violation|14
3105103|NCT00249834|10637831|P2|Overall Study|Protocol Violation|19
3105104|NCT00249834|10637832|P1|Overall Study|Protocol Violation|0
3105105|NCT00249834|10637825|P8|Overall Study|Failure of down-regulation|0
3105106|NCT00249834|10637826|P7|Overall Study|Failure of down-regulation|1
3105107|NCT00249834|10637827|P6|Overall Study|Failure of down-regulation|0
3105108|NCT00249834|10637828|P5|Overall Study|Failure of down-regulation|0
3105109|NCT00249834|10637829|P4|Overall Study|Failure of down-regulation|0
3105110|NCT00249834|10637830|P3|Overall Study|Failure of down-regulation|0
3105111|NCT00249834|10637831|P2|Overall Study|Failure of down-regulation|0
3105112|NCT00249834|10637832|P1|Overall Study|Failure of down-regulation|0
3105113|NCT00249834|10637825|P8|Overall Study|Ovarian stimulation failed|0
3105114|NCT00249834|10637826|P7|Overall Study|Ovarian stimulation failed|0
3105115|NCT00249834|10637827|P6|Overall Study|Ovarian stimulation failed|0
3105116|NCT00249834|10637828|P5|Overall Study|Ovarian stimulation failed|0
3105117|NCT00249834|10637829|P4|Overall Study|Ovarian stimulation failed|0
3105118|NCT00249834|10637830|P3|Overall Study|Ovarian stimulation failed|0
3105119|NCT00249834|10637831|P2|Overall Study|Ovarian stimulation failed|0
3105120|NCT00249834|10637832|P1|Overall Study|Ovarian stimulation failed|1
3105121|NCT00249821|10637881|P2|Overall Study|Technical problem|1
3105122|NCT00249821|10637882|P1|Overall Study|Technical problem|0
3105123|NCT00249808|10637902|P1|Overall Study|Did Not Provide Post-Baseline Data|11
3105124|NCT00249808|10637902|P1|Overall Study|Lack of Efficacy|52
3105125|NCT00249808|10637902|P1|Overall Study|Adverse Event|81
3105126|NCT00249808|10637902|P1|Overall Study|Lost to Follow-up|8
3105127|NCT00249808|10637902|P1|Overall Study|Protocol Violation|3
3105128|NCT00249808|10637902|P1|Overall Study|Other|27
3105129|NCT00249795|10637910|P2|Overall Study|Missing|1
3105130|NCT00249795|10637911|P1|Overall Study|Missing|0
3105131|NCT00249795|10637910|P2|Overall Study|Lost to Follow-up|2
3105132|NCT00249795|10637911|P1|Overall Study|Lost to Follow-up|0
3105133|NCT00249795|10637910|P2|Overall Study|Site not agree to continue after May08|1
3105134|NCT00249795|10637911|P1|Overall Study|Site not agree to continue after May08|1
3105135|NCT00249795|10637910|P2|Overall Study|Patient not wish to continue after May08|6
3105136|NCT00249795|10637911|P1|Overall Study|Patient not wish to continue after May08|4
3105137|NCT00249795|10637910|P2|Overall Study|Event related to cardiac condition|16
3105138|NCT00249795|10637911|P1|Overall Study|Event related to cardiac condition|17
3105139|NCT00249795|10637910|P2|Overall Study|Other contraindicated medication|1
3105140|NCT00249795|10637911|P1|Overall Study|Other contraindicated medication|1
3105141|NCT00249795|10637910|P2|Overall Study|Hypotension (non-symptomatic)|5
3105142|NCT00249795|10637911|P1|Overall Study|Hypotension (non-symptomatic)|5
3105143|NCT00249795|10637910|P2|Overall Study|Lightheadedness / dizziness|11
3105144|NCT00249795|10637911|P1|Overall Study|Lightheadedness / dizziness|15
3105145|NCT00249795|10637910|P2|Overall Study|Angiotensin II receptor blocker required|58
3105146|NCT00249795|10637911|P1|Overall Study|Angiotensin II receptor blocker required|35
3105147|NCT00249795|10637910|P2|Overall Study|Surgery / procedure|5
3105148|NCT00249795|10637911|P1|Overall Study|Surgery / procedure|4
3105149|NCT00249795|10637910|P2|Overall Study|Physician withdrew consent|63
3105150|NCT00249795|10637911|P1|Overall Study|Physician withdrew consent|71
3105151|NCT00249795|10637910|P2|Overall Study|Other adverse events (non-serious)|159
3105152|NCT00249795|10637911|P1|Overall Study|Other adverse events (non-serious)|188
3105153|NCT00249795|10637910|P2|Overall Study|Study drug intolerance|3
3105154|NCT00249795|10637911|P1|Overall Study|Study drug intolerance|3
3105155|NCT00249795|10637910|P2|Overall Study|Non-compliance|69
3105156|NCT00249795|10637911|P1|Overall Study|Non-compliance|71
3105157|NCT00249795|10637910|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
3105158|NCT00249795|10637911|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
3105159|NCT00249795|10637910|P2|Overall Study|Oral anticoagulant required|0
3105160|NCT00249795|10637911|P1|Overall Study|Oral anticoagulant required|2
3105161|NCT00249795|10637910|P2|Overall Study|Thromboembolic / outcome event|45
3105162|NCT00249795|10637911|P1|Overall Study|Thromboembolic / outcome event|39
3105163|NCT00249795|10637910|P2|Overall Study|Withdrawal by Subject|742
3105164|NCT00249795|10637911|P1|Overall Study|Withdrawal by Subject|678
3105165|NCT00249795|10637910|P2|Overall Study|Qualifying condition not present|29
3105166|NCT00249795|10637911|P1|Overall Study|Qualifying condition not present|26
3105167|NCT00249795|10637910|P2|Overall Study|Other Serious Adverse Event|93
3105168|NCT00249795|10637911|P1|Overall Study|Other Serious Adverse Event|84
3105169|NCT00249795|10637910|P2|Overall Study|Symptomatic hypotension|64
3105170|NCT00249795|10637911|P1|Overall Study|Symptomatic hypotension|127
3105171|NCT00249795|10637910|P2|Overall Study|Not treated|14
3105172|NCT00249795|10637911|P1|Overall Study|Not treated|16
3105173|NCT00249769|10637932|P3|Overall Study|Lost to Follow-up|3
3105174|NCT00249769|10637933|P2|Overall Study|Lost to Follow-up|0
3105175|NCT00249769|10637934|P1|Overall Study|Lost to Follow-up|0
3105176|NCT00249769|10637932|P3|Overall Study|Physician Decision|2
3105177|NCT00249769|10637933|P2|Overall Study|Physician Decision|0
3105178|NCT00249769|10637934|P1|Overall Study|Physician Decision|0
3105179|NCT00249769|10637932|P3|Overall Study|Adverse Event|1
3105180|NCT00249769|10637933|P2|Overall Study|Adverse Event|0
3105181|NCT00249769|10637934|P1|Overall Study|Adverse Event|0
3105182|NCT00249769|10637932|P3|Overall Study|Miscellaneous|2
3105183|NCT00249769|10637933|P2|Overall Study|Miscellaneous|2
3105184|NCT00249769|10637934|P1|Overall Study|Miscellaneous|0
3105185|NCT00249769|10637932|P3|Overall Study|Migration from Study Area|14
3105186|NCT00249769|10637933|P2|Overall Study|Migration from Study Area|3
3105187|NCT00249769|10637934|P1|Overall Study|Migration from Study Area|1
3105188|NCT00249769|10637932|P3|Overall Study|Withdrawal by Subject|6
3105189|NCT00249769|10637933|P2|Overall Study|Withdrawal by Subject|10
3105190|NCT00249769|10637934|P1|Overall Study|Withdrawal by Subject|1
3105191|NCT00249613|10637962|P2|12 Month Follow-up|Lost to Follow-up|8
3105192|NCT00249613|10637963|P1|12 Month Follow-up|Lost to Follow-up|10
3105193|NCT00249613|10637962|P2|12 Month Follow-up|Withdrawal by Subject|6
3105194|NCT00249613|10637963|P1|12 Month Follow-up|Withdrawal by Subject|6
3105195|NCT00249613|10637962|P2|12 Month Follow-up|Death|1
3105196|NCT00249613|10637963|P1|12 Month Follow-up|Death|1
3105197|NCT00249444|10638004|P2|Overall Study|life event|1
3105198|NCT00249444|10638005|P1|Overall Study|life event|0
3105199|NCT00249444|10638004|P2|Overall Study|Adverse Event|1
3105200|NCT00249444|10638005|P1|Overall Study|Adverse Event|1
3105201|NCT00249444|10638004|P2|Overall Study|non-compliant|11
3105202|NCT00249444|10638005|P1|Overall Study|non-compliant|9
3105203|NCT00249444|10638004|P2|Overall Study|Lost to Follow-up|2
3105204|NCT00249444|10638005|P1|Overall Study|Lost to Follow-up|2
3105205|NCT00249288|10638030|P2|Overall Study|Withdrawal by Subject|2
3105206|NCT00249288|10638031|P1|Overall Study|Withdrawal by Subject|2
3105207|NCT00249288|10638030|P2|Overall Study|Lost to Follow-up|3
3105208|NCT00249288|10638031|P1|Overall Study|Lost to Follow-up|3
3105209|NCT00249002|10638123|P1|Overall Study|Other|2
3105210|NCT00249002|10638123|P1|Overall Study|Study cancellation|3
3105211|NCT00249002|10638123|P1|Overall Study|Adverse Event|2
3105212|NCT00248833|10638142|P3|Overall Study|Other|0
3105213|NCT00248833|10638143|P2|Overall Study|Other|1
3105214|NCT00248833|10638144|P1|Overall Study|Other|0
3105215|NCT00248833|10638142|P3|Overall Study|Lost to Follow-up|1
3105216|NCT00248833|10638143|P2|Overall Study|Lost to Follow-up|1
3105217|NCT00248833|10638144|P1|Overall Study|Lost to Follow-up|1
3105218|NCT00248833|10638142|P3|Overall Study|Withdrawal by Subject|1
3105219|NCT00248833|10638143|P2|Overall Study|Withdrawal by Subject|1
3105220|NCT00248833|10638144|P1|Overall Study|Withdrawal by Subject|0
3105221|NCT00248833|10638142|P3|Overall Study|Adverse Event|0
3105222|NCT00248833|10638143|P2|Overall Study|Adverse Event|0
3105223|NCT00248833|10638144|P1|Overall Study|Adverse Event|2
3105224|NCT00248794|10638180|P3|Overall Study|Lost to Follow-up|3
3105225|NCT00248794|10638181|P2|Overall Study|Lost to Follow-up|8
3105226|NCT00248794|10638182|P1|Overall Study|Lost to Follow-up|6
3105227|NCT00248651|10638232|P3|Overall Study|Withdrawal by Subject|32
3105228|NCT00248651|10638233|P2|Overall Study|Withdrawal by Subject|40
3105229|NCT00248651|10638234|P1|Overall Study|Withdrawal by Subject|28
3105230|NCT00248625|10638270|P2|Overall Study|Withdrawal by Subject|2
3105231|NCT00248625|10638271|P1|Overall Study|Withdrawal by Subject|0
3105232|NCT00248495|10638363|P1|Overall Study|Withdrawal by Subject|1
3105233|NCT00248287|10638374|P2|Overall Study|Other|2
3105234|NCT00248287|10638375|P1|Overall Study|Other|3
3105235|NCT00248287|10638374|P2|Overall Study|Patient Request|3
3105236|NCT00248287|10638375|P1|Overall Study|Patient Request|5
3105237|NCT00248287|10638374|P2|Overall Study|Investigator Request|3
3105238|NCT00248287|10638375|P1|Overall Study|Investigator Request|4
3105239|NCT00248287|10638374|P2|Overall Study|Lost to Follow-up|1
3105240|NCT00248287|10638375|P1|Overall Study|Lost to Follow-up|0
3105241|NCT00248287|10638374|P2|Overall Study|Death|0
3105242|NCT00248287|10638375|P1|Overall Study|Death|1
3105243|NCT00248287|10638374|P2|Overall Study|Adverse Event|10
3105244|NCT00248287|10638375|P1|Overall Study|Adverse Event|11
3105245|NCT00248170|10638389|P2|Overall Study|Protocol deviation|19
3105246|NCT00248170|10638390|P1|Overall Study|Protocol deviation|17
3105247|NCT00248170|10638389|P2|Overall Study|Abnormal laboratory values|0
3105248|NCT00248170|10638390|P1|Overall Study|Abnormal laboratory values|4
3105249|NCT00248170|10638389|P2|Overall Study|Abnormal test procedure(s) result|61
3105250|NCT00248170|10638390|P1|Overall Study|Abnormal test procedure(s) result|49
3105251|NCT00248170|10638389|P2|Overall Study|Administrative problems|25
3105252|NCT00248170|10638390|P1|Overall Study|Administrative problems|22
3105253|NCT00248170|10638389|P2|Overall Study|Adverse Event|296
3105254|NCT00248170|10638390|P1|Overall Study|Adverse Event|311
3105255|NCT00248170|10638389|P2|Overall Study|Death|47
3105256|NCT00248170|10638390|P1|Overall Study|Death|28
3105257|NCT00248170|10638389|P2|Overall Study|Disease progression|216
3105258|NCT00248170|10638390|P1|Overall Study|Disease progression|196
3105259|NCT00248170|10638389|P2|Overall Study|Lost to Follow-up|35
3105260|NCT00248170|10638390|P1|Overall Study|Lost to Follow-up|28
3105261|NCT00248170|10638389|P2|Overall Study|Protocol Violation|30
3105262|NCT00248170|10638390|P1|Overall Study|Protocol Violation|35
3105263|NCT00248170|10638389|P2|Overall Study|Withdrawal by Subject|79
3105264|NCT00248170|10638390|P1|Overall Study|Withdrawal by Subject|71
3105265|NCT00248040|10638413|P3|Overall Study|Death|1
3105266|NCT00248040|10638414|P2|Overall Study|Death|0
3105267|NCT00248040|10638415|P1|Overall Study|Death|0
3105268|NCT00248040|10638413|P3|Overall Study|transplant cancelled post treat start|0
3105269|NCT00248040|10638414|P2|Overall Study|transplant cancelled post treat start|0
3105270|NCT00248040|10638415|P1|Overall Study|transplant cancelled post treat start|1
3105271|NCT00248040|10638413|P3|Overall Study|transplantectomy|3
3105272|NCT00248040|10638414|P2|Overall Study|transplantectomy|1
3105273|NCT00248040|10638415|P1|Overall Study|transplantectomy|2
3105274|NCT00247962|10638464|P2|Overall Study|Lack of Efficacy|2
3105275|NCT00247962|10638465|P1|Overall Study|Lack of Efficacy|4
3105276|NCT00247962|10638464|P2|Overall Study|Withdrawal by Subject|2
3105277|NCT00247962|10638465|P1|Overall Study|Withdrawal by Subject|3
3105278|NCT00247962|10638464|P2|Overall Study|Protocol Violation|1
3105279|NCT00247962|10638465|P1|Overall Study|Protocol Violation|1
3105280|NCT00247962|10638464|P2|Overall Study|Physician Decision|1
3105281|NCT00247962|10638465|P1|Overall Study|Physician Decision|0
3105282|NCT00247962|10638464|P2|Overall Study|Lost to Follow-up|1
3105283|NCT00247962|10638465|P1|Overall Study|Lost to Follow-up|3
3105284|NCT00247962|10638464|P2|Overall Study|Adverse Event|12
3105285|NCT00247962|10638465|P1|Overall Study|Adverse Event|15
3105286|NCT00247676|10638473|P1|Overall Study|Withdrawal by Subject|2
3105287|NCT00247676|10638473|P1|Overall Study|Other|3
3105288|NCT00247676|10638473|P1|Overall Study|Lack of Efficacy|15
3105289|NCT00247676|10638473|P1|Overall Study|Adverse Event|11
3105290|NCT00247676|10638473|P1|Overall Study|Death|5
3105291|NCT00247611|10638518|P2|Baselined|Completed baseline only|8
3105292|NCT00247611|10638519|P1|Baselined|Completed baseline only|9
3105293|NCT00247611|10638518|P2|Baselined|Completed baseline, never placed on ARVs|5
3105294|NCT00247611|10638519|P1|Baselined|Completed baseline, never placed on ARVs|8
3105295|NCT00247416|10638537|P2|Overall Study|3 patients were found to be ineligible|2
3105296|NCT00247416|10638538|P1|Overall Study|3 patients were found to be ineligible|1
3105297|NCT00247273|10638579|P2|Overall Study|Did not take any study drug|0
3105298|NCT00247273|10638580|P1|Overall Study|Did not take any study drug|2
3105299|NCT00247273|10638579|P2|Overall Study|Withdrawal by Subject|47
3105300|NCT00247273|10638580|P1|Overall Study|Withdrawal by Subject|46
3105301|NCT00247273|10638579|P2|Overall Study|Lost to Follow-up|7
3105302|NCT00247273|10638580|P1|Overall Study|Lost to Follow-up|7
3105303|NCT00247273|10638579|P2|Overall Study|Physician Decision|3
3105304|NCT00247273|10638580|P1|Overall Study|Physician Decision|6
3105305|NCT00247273|10638579|P2|Overall Study|Adverse Event|80
3105306|NCT00247273|10638580|P1|Overall Study|Adverse Event|85
3105307|NCT00246805|10638626|P2|Phase 1|Lost to Follow-up|0
3105308|NCT00246805|10638627|P1|Phase 1|Lost to Follow-up|1
3105309|NCT00246753|10638633|P1|Overall Study|Unacceptable toxicity|2
3105310|NCT00246753|10638633|P1|Overall Study|Adverse Event|2
3105311|NCT00246753|10638633|P1|Overall Study|Physician Decision|2
3105312|NCT00246753|10638633|P1|Overall Study|Withdrawal by Subject|2
3105313|NCT00246740|10638641|P2|Initial Enrollment|Other|2
3105314|NCT00246740|10638642|P1|Initial Enrollment|Other|1
3105315|NCT00246740|10638641|P2|Initial Enrollment|Surgery schedule change|4
3105316|NCT00246740|10638642|P1|Initial Enrollment|Surgery schedule change|4
3105317|NCT00246740|10638641|P2|Initial Enrollment|Additional surgery scheduled|2
3105318|NCT00246740|10638642|P1|Initial Enrollment|Additional surgery scheduled|0
3105319|NCT00246740|10638641|P2|Initial Enrollment|Death|0
3105320|NCT00246740|10638642|P1|Initial Enrollment|Death|1
3105321|NCT00246571|10638666|P2|Overall Study|Crossover participants|74
3105322|NCT00246571|10638667|P1|Overall Study|Crossover participants|0
3105323|NCT00246571|10638666|P2|Overall Study|Laboratory abnormalities|0
3105324|NCT00246571|10638667|P1|Overall Study|Laboratory abnormalities|1
3105325|NCT00246571|10638666|P2|Overall Study|Did not meet entrance criteria|1
3105326|NCT00246571|10638667|P1|Overall Study|Did not meet entrance criteria|2
3105327|NCT00246571|10638666|P2|Overall Study|Sponsor|1
3105328|NCT00246571|10638667|P1|Overall Study|Sponsor|0
3105329|NCT00246571|10638666|P2|Overall Study|Death|3
3105330|NCT00246571|10638667|P1|Overall Study|Death|17
3105331|NCT00246571|10638666|P2|Overall Study|Lack of Efficacy|21
3105332|NCT00246571|10638667|P1|Overall Study|Lack of Efficacy|84
3105333|NCT00246571|10638666|P2|Overall Study|Withdrawal by Subject|3
3105334|NCT00246571|10638667|P1|Overall Study|Withdrawal by Subject|2
3105335|NCT00246571|10638666|P2|Overall Study|Protocol Violation|1
3105336|NCT00246571|10638667|P1|Overall Study|Protocol Violation|0
3105337|NCT00246571|10638666|P2|Overall Study|Adverse Event|0
3105338|NCT00246571|10638667|P1|Overall Study|Adverse Event|7
3105339|NCT00246376|10638732|P5|Overall Study|Lost to Follow-up|13
3105340|NCT00246376|10638733|P4|Overall Study|Lost to Follow-up|16
3105341|NCT00246376|10638734|P3|Overall Study|Lost to Follow-up|11
3105342|NCT00246376|10638735|P2|Overall Study|Lost to Follow-up|11
3105343|NCT00246376|10638736|P1|Overall Study|Lost to Follow-up|2
3105344|NCT00246376|10638732|P5|Overall Study|Adverse Event|1
3105345|NCT00246376|10638733|P4|Overall Study|Adverse Event|3
3105346|NCT00246376|10638734|P3|Overall Study|Adverse Event|1
3105347|NCT00246376|10638735|P2|Overall Study|Adverse Event|3
3105348|NCT00246376|10638736|P1|Overall Study|Adverse Event|2
3105349|NCT00246376|10638732|P5|Overall Study|Dropped/withdrew during dietary run-in|3
3105350|NCT00246376|10638733|P4|Overall Study|Dropped/withdrew during dietary run-in|7
3105351|NCT00246376|10638734|P3|Overall Study|Dropped/withdrew during dietary run-in|4
3105352|NCT00246376|10638735|P2|Overall Study|Dropped/withdrew during dietary run-in|5
3105353|NCT00246376|10638736|P1|Overall Study|Dropped/withdrew during dietary run-in|11
3105354|NCT00246337|10638787|P9|Overall Study|Reported as completing trial in error|0
3105355|NCT00246337|10638788|P8|Overall Study|Reported as completing trial in error|1
3105356|NCT00246337|10638789|P7|Overall Study|Reported as completing trial in error|0
3105357|NCT00246337|10638790|P6|Overall Study|Reported as completing trial in error|0
3105358|NCT00246337|10638791|P5|Overall Study|Reported as completing trial in error|0
3105359|NCT00246337|10638792|P4|Overall Study|Reported as completing trial in error|0
3105360|NCT00246337|10638793|P3|Overall Study|Reported as completing trial in error|0
3105361|NCT00246337|10638794|P2|Overall Study|Reported as completing trial in error|0
3105362|NCT00246337|10638795|P1|Overall Study|Reported as completing trial in error|0
3105363|NCT00246337|10638787|P9|Overall Study|Protocol Violator|0
3105364|NCT00246337|10638788|P8|Overall Study|Protocol Violator|0
3105365|NCT00246337|10638789|P7|Overall Study|Protocol Violator|0
3105366|NCT00246337|10638790|P6|Overall Study|Protocol Violator|0
3105367|NCT00246337|10638791|P5|Overall Study|Protocol Violator|0
3105368|NCT00246337|10638792|P4|Overall Study|Protocol Violator|0
3105369|NCT00246337|10638793|P3|Overall Study|Protocol Violator|0
3105370|NCT00246337|10638794|P2|Overall Study|Protocol Violator|0
3105371|NCT00246337|10638795|P1|Overall Study|Protocol Violator|1
3105372|NCT00246337|10638787|P9|Overall Study|Overwhelmed|0
3105373|NCT00246337|10638788|P8|Overall Study|Overwhelmed|0
3105374|NCT00246337|10638789|P7|Overall Study|Overwhelmed|0
3105375|NCT00246337|10638790|P6|Overall Study|Overwhelmed|1
3105376|NCT00246337|10638791|P5|Overall Study|Overwhelmed|0
3105377|NCT00246337|10638792|P4|Overall Study|Overwhelmed|0
3105378|NCT00246337|10638793|P3|Overall Study|Overwhelmed|0
3105379|NCT00246337|10638794|P2|Overall Study|Overwhelmed|0
3105380|NCT00246337|10638795|P1|Overall Study|Overwhelmed|0
3105381|NCT00246337|10638787|P9|Overall Study|Abnormal baseline lab values|4
3105382|NCT00246337|10638788|P8|Overall Study|Abnormal baseline lab values|0
3105383|NCT00246337|10638789|P7|Overall Study|Abnormal baseline lab values|2
3105384|NCT00246337|10638790|P6|Overall Study|Abnormal baseline lab values|2
3105385|NCT00246337|10638791|P5|Overall Study|Abnormal baseline lab values|0
3105386|NCT00246337|10638792|P4|Overall Study|Abnormal baseline lab values|0
3105387|NCT00246337|10638793|P3|Overall Study|Abnormal baseline lab values|2
3105388|NCT00246337|10638794|P2|Overall Study|Abnormal baseline lab values|0
3105389|NCT00246337|10638795|P1|Overall Study|Abnormal baseline lab values|7
3105390|NCT00246337|10638787|P9|Overall Study|Site Terminated|2
3105391|NCT00246337|10638788|P8|Overall Study|Site Terminated|6
3105392|NCT00246337|10638789|P7|Overall Study|Site Terminated|1
3105393|NCT00246337|10638790|P6|Overall Study|Site Terminated|7
3105394|NCT00246337|10638791|P5|Overall Study|Site Terminated|0
3105395|NCT00246337|10638792|P4|Overall Study|Site Terminated|0
3105396|NCT00246337|10638793|P3|Overall Study|Site Terminated|0
3105397|NCT00246337|10638794|P2|Overall Study|Site Terminated|0
3105398|NCT00246337|10638795|P1|Overall Study|Site Terminated|10
3105399|NCT00246337|10638787|P9|Overall Study|Lack of Qualifying Event|5
3105400|NCT00246337|10638788|P8|Overall Study|Lack of Qualifying Event|2
3105401|NCT00246337|10638789|P7|Overall Study|Lack of Qualifying Event|3
3105402|NCT00246337|10638790|P6|Overall Study|Lack of Qualifying Event|3
3105403|NCT00246337|10638791|P5|Overall Study|Lack of Qualifying Event|1
3105404|NCT00246337|10638792|P4|Overall Study|Lack of Qualifying Event|1
3105405|NCT00246337|10638793|P3|Overall Study|Lack of Qualifying Event|1
3105406|NCT00246337|10638794|P2|Overall Study|Lack of Qualifying Event|2
3105407|NCT00246337|10638795|P1|Overall Study|Lack of Qualifying Event|8
3105408|NCT00246337|10638787|P9|Overall Study|Withdrawal by Subject|0
3105409|NCT00246337|10638788|P8|Overall Study|Withdrawal by Subject|1
3105410|NCT00246337|10638789|P7|Overall Study|Withdrawal by Subject|1
3105411|NCT00246337|10638790|P6|Overall Study|Withdrawal by Subject|0
3105412|NCT00246337|10638791|P5|Overall Study|Withdrawal by Subject|0
3105413|NCT00246337|10638792|P4|Overall Study|Withdrawal by Subject|0
3105414|NCT00246337|10638793|P3|Overall Study|Withdrawal by Subject|0
3105415|NCT00246337|10638794|P2|Overall Study|Withdrawal by Subject|0
3105416|NCT00246337|10638795|P1|Overall Study|Withdrawal by Subject|2
3105417|NCT00246337|10638787|P9|Overall Study|Protocol Violation|0
3105418|NCT00246337|10638788|P8|Overall Study|Protocol Violation|1
3105419|NCT00246337|10638789|P7|Overall Study|Protocol Violation|1
3105420|NCT00246337|10638790|P6|Overall Study|Protocol Violation|0
3105421|NCT00246337|10638791|P5|Overall Study|Protocol Violation|1
3105422|NCT00246337|10638792|P4|Overall Study|Protocol Violation|0
3105423|NCT00246337|10638793|P3|Overall Study|Protocol Violation|0
3105424|NCT00246337|10638794|P2|Overall Study|Protocol Violation|0
3105425|NCT00246337|10638795|P1|Overall Study|Protocol Violation|1
3105426|NCT00246337|10638787|P9|Overall Study|Lost to Follow-up|0
3105427|NCT00246337|10638788|P8|Overall Study|Lost to Follow-up|2
3105428|NCT00246337|10638789|P7|Overall Study|Lost to Follow-up|1
3105429|NCT00246337|10638790|P6|Overall Study|Lost to Follow-up|2
3105430|NCT00246337|10638791|P5|Overall Study|Lost to Follow-up|2
3105431|NCT00246337|10638792|P4|Overall Study|Lost to Follow-up|0
3105432|NCT00246337|10638793|P3|Overall Study|Lost to Follow-up|0
3105433|NCT00246337|10638794|P2|Overall Study|Lost to Follow-up|0
3105434|NCT00246337|10638795|P1|Overall Study|Lost to Follow-up|3
3105435|NCT00246324|10638842|P1|Overall Study|Withdrawal by Subject|1
3105436|NCT00246259|10638849|P2|Overall Study|randomly assigned, not eligible for ITT|6
3105437|NCT00246259|10638850|P1|Overall Study|randomly assigned, not eligible for ITT|2
3105438|NCT00246259|10638849|P2|Overall Study|Withdrawal by Subject|1
3105439|NCT00246259|10638850|P1|Overall Study|Withdrawal by Subject|5
3105440|NCT00246259|10638849|P2|Overall Study|Lost to Follow-up|4
3105441|NCT00246259|10638850|P1|Overall Study|Lost to Follow-up|3
3105442|NCT00246259|10638849|P2|Overall Study|Adverse Event|0
3105443|NCT00246259|10638850|P1|Overall Study|Adverse Event|5
3105444|NCT00246259|10638849|P2|Overall Study|Investigator withdrew participant|0
3105445|NCT00246259|10638850|P1|Overall Study|Investigator withdrew participant|2
3105446|NCT00246259|10638849|P2|Overall Study|Lack of Efficacy|2
3105447|NCT00246259|10638850|P1|Overall Study|Lack of Efficacy|2
3105448|NCT00246259|10638849|P2|Overall Study|Participant non-compliant|9
3105449|NCT00246259|10638850|P1|Overall Study|Participant non-compliant|4
3105450|NCT00246259|10638849|P2|Overall Study|Not stable by Week 18|1
3105451|NCT00246259|10638850|P1|Overall Study|Not stable by Week 18|2
3105452|NCT00246259|10638849|P2|Overall Study|Other|3
3105453|NCT00246259|10638850|P1|Overall Study|Other|3
3105454|NCT00246090|10638884|P1|Overall Study|Not Otherwise Specified|10
3105455|NCT00246090|10638884|P1|Overall Study|Physician Decision|11
3105456|NCT00246090|10638884|P1|Overall Study|Clinical Progression|30
3105457|NCT00246090|10638884|P1|Overall Study|Progressive Disease|212
3105458|NCT00246090|10638884|P1|Overall Study|Withdrawal by Subject|7
3105459|NCT00246090|10638884|P1|Overall Study|Adverse Event|25
3105460|NCT00246025|10638893|P4|Overall Study|unsuitable medical history was found|1
3105461|NCT00246025|10638894|P3|Overall Study|unsuitable medical history was found|0
3105462|NCT00246025|10638895|P2|Overall Study|unsuitable medical history was found|0
3105463|NCT00246025|10638896|P1|Overall Study|unsuitable medical history was found|0
3105464|NCT00246025|10638893|P4|Overall Study|Withdrawal by Subject|2
3105465|NCT00246025|10638894|P3|Overall Study|Withdrawal by Subject|1
3105466|NCT00246025|10638895|P2|Overall Study|Withdrawal by Subject|0
3105467|NCT00246025|10638896|P1|Overall Study|Withdrawal by Subject|3
3105468|NCT00246025|10638893|P4|Overall Study|Adverse Event|10
3105469|NCT00246025|10638894|P3|Overall Study|Adverse Event|9
3105470|NCT00246025|10638895|P2|Overall Study|Adverse Event|9
3105471|NCT00246025|10638896|P1|Overall Study|Adverse Event|7
3105472|NCT00246012|10638955|P9|Overall Study|Randomly assigned but not treated|0
3105473|NCT00246012|10638956|P8|Overall Study|Randomly assigned but not treated|0
3105474|NCT00246012|10638957|P7|Overall Study|Randomly assigned but not treated|1
3105475|NCT00246012|10638958|P6|Overall Study|Randomly assigned but not treated|1
3105476|NCT00246012|10638959|P5|Overall Study|Randomly assigned but not treated|0
3105477|NCT00246012|10638960|P4|Overall Study|Randomly assigned but not treated|0
3105478|NCT00246012|10638961|P3|Overall Study|Randomly assigned but not treated|0
3105479|NCT00246012|10638962|P2|Overall Study|Randomly assigned but not treated|0
3105480|NCT00246012|10638963|P1|Overall Study|Randomly assigned but not treated|0
3105481|NCT00246012|10638955|P9|Overall Study|Other|0
3105482|NCT00246012|10638956|P8|Overall Study|Other|1
3105483|NCT00246012|10638957|P7|Overall Study|Other|0
3105484|NCT00246012|10638958|P6|Overall Study|Other|0
3105485|NCT00246012|10638959|P5|Overall Study|Other|0
3105486|NCT00246012|10638960|P4|Overall Study|Other|0
3105487|NCT00246012|10638961|P3|Overall Study|Other|0
3105488|NCT00246012|10638962|P2|Overall Study|Other|0
3105489|NCT00246012|10638963|P1|Overall Study|Other|0
3105490|NCT00246012|10638955|P9|Overall Study|Disease progression|26
3105491|NCT00246012|10638956|P8|Overall Study|Disease progression|27
3105492|NCT00246012|10638957|P7|Overall Study|Disease progression|30
3105493|NCT00246012|10638958|P6|Overall Study|Disease progression|25
3105494|NCT00246012|10638959|P5|Overall Study|Disease progression|3
3105495|NCT00246012|10638960|P4|Overall Study|Disease progression|3
3105496|NCT00246012|10638961|P3|Overall Study|Disease progression|2
3105497|NCT00246012|10638962|P2|Overall Study|Disease progression|1
3105498|NCT00246012|10638963|P1|Overall Study|Disease progression|3
3105499|NCT00246012|10638955|P9|Overall Study|Withdrawal by Subject|0
3105500|NCT00246012|10638956|P8|Overall Study|Withdrawal by Subject|0
3105501|NCT00246012|10638957|P7|Overall Study|Withdrawal by Subject|0
3105502|NCT00246012|10638958|P6|Overall Study|Withdrawal by Subject|1
3105503|NCT00246012|10638959|P5|Overall Study|Withdrawal by Subject|0
3105504|NCT00246012|10638960|P4|Overall Study|Withdrawal by Subject|0
3105505|NCT00246012|10638961|P3|Overall Study|Withdrawal by Subject|0
3105506|NCT00246012|10638962|P2|Overall Study|Withdrawal by Subject|0
3105507|NCT00246012|10638963|P1|Overall Study|Withdrawal by Subject|0
3105508|NCT00246012|10638955|P9|Overall Study|Adverse Event|2
3105509|NCT00246012|10638956|P8|Overall Study|Adverse Event|0
3105510|NCT00246012|10638957|P7|Overall Study|Adverse Event|0
3105511|NCT00246012|10638958|P6|Overall Study|Adverse Event|1
3105512|NCT00246012|10638959|P5|Overall Study|Adverse Event|0
3105513|NCT00246012|10638960|P4|Overall Study|Adverse Event|0
3105514|NCT00246012|10638961|P3|Overall Study|Adverse Event|0
3105515|NCT00246012|10638962|P2|Overall Study|Adverse Event|0
3105516|NCT00246012|10638963|P1|Overall Study|Adverse Event|0
3105517|NCT00245960|10639058|P2|Overall Study|Lack of Efficacy|6
3105518|NCT00245960|10639059|P1|Overall Study|Lack of Efficacy|4
3105519|NCT00245960|10639058|P2|Overall Study|Withdrawal by Subject|7
3105520|NCT00245960|10639059|P1|Overall Study|Withdrawal by Subject|5
3105521|NCT00245960|10639058|P2|Overall Study|Protocol Violation|3
3105522|NCT00245960|10639059|P1|Overall Study|Protocol Violation|4
3105523|NCT00245960|10639058|P2|Overall Study|Lost to Follow-up|2
3105524|NCT00245960|10639059|P1|Overall Study|Lost to Follow-up|2
3105525|NCT00245960|10639058|P2|Overall Study|Adverse Event|10
3105526|NCT00245960|10639059|P1|Overall Study|Adverse Event|14
3105527|NCT00245856|10639067|P2|Period Two|Withdrawal by Subject|1
3105528|NCT00245856|10639068|P1|Period Two|Withdrawal by Subject|0
3105529|NCT00245765|10639078|P3|Overall Study|Other|4
3105530|NCT00245765|10639079|P2|Overall Study|Other|4
3105531|NCT00245765|10639080|P1|Overall Study|Other|13
3105532|NCT00245765|10639078|P3|Overall Study|Other reason|1
3105533|NCT00245765|10639079|P2|Overall Study|Other reason|0
3105534|NCT00245765|10639080|P1|Overall Study|Other reason|2
3105535|NCT00245765|10639078|P3|Overall Study|Withdrawal by Subject|3
3105536|NCT00245765|10639079|P2|Overall Study|Withdrawal by Subject|0
3105537|NCT00245765|10639080|P1|Overall Study|Withdrawal by Subject|1
3105538|NCT00245765|10639078|P3|Overall Study|Lost to Follow-up|0
3105539|NCT00245765|10639079|P2|Overall Study|Lost to Follow-up|2
3105540|NCT00245765|10639080|P1|Overall Study|Lost to Follow-up|1
3105541|NCT00245765|10639078|P3|Overall Study|Lack of Efficacy|0
3105542|NCT00245765|10639079|P2|Overall Study|Lack of Efficacy|7
3105543|NCT00245765|10639080|P1|Overall Study|Lack of Efficacy|14
3105544|NCT00245765|10639078|P3|Overall Study|Adverse Event|0
3105545|NCT00245765|10639079|P2|Overall Study|Adverse Event|1
3105546|NCT00245765|10639080|P1|Overall Study|Adverse Event|1
3105547|NCT00245583|10639129|P2|Overall Study|Withdrawal by Subject|3
3105548|NCT00245583|10639130|P1|Overall Study|Withdrawal by Subject|2
3105549|NCT00245583|10639129|P2|Overall Study|Lack of Efficacy|0
3105550|NCT00245583|10639130|P1|Overall Study|Lack of Efficacy|1
3105551|NCT00245583|10639129|P2|Overall Study|Adverse Event|1
3105552|NCT00245583|10639130|P1|Overall Study|Adverse Event|2
3105553|NCT00245583|10639129|P2|Overall Study|Lost to Follow-up|5
3105554|NCT00245583|10639130|P1|Overall Study|Lost to Follow-up|1
3105555|NCT00245570|10639150|P6|Washout Between Periods III and IV|Adverse Event|0
3105556|NCT00245570|10639151|P5|Washout Between Periods III and IV|Adverse Event|0
3105557|NCT00245570|10639152|P4|Washout Between Periods III and IV|Adverse Event|0
3105558|NCT00245570|10639153|P3|Washout Between Periods III and IV|Adverse Event|0
3105559|NCT00245570|10639154|P2|Washout Between Periods III and IV|Adverse Event|1
3105560|NCT00245570|10639155|P1|Washout Between Periods III and IV|Adverse Event|0
3105561|NCT00245466|10639289|P3|Overall Study|Administrative reasons|0
3105562|NCT00245466|10639290|P2|Overall Study|Administrative reasons|1
3105563|NCT00245466|10639291|P1|Overall Study|Administrative reasons|0
3105564|NCT00245466|10639289|P3|Overall Study|Death|0
3105565|NCT00245466|10639290|P2|Overall Study|Death|2
3105566|NCT00245466|10639291|P1|Overall Study|Death|0
3105567|NCT00245466|10639289|P3|Overall Study|Protocol Violation|2
3105568|NCT00245466|10639290|P2|Overall Study|Protocol Violation|2
3105569|NCT00245466|10639291|P1|Overall Study|Protocol Violation|1
3105570|NCT00245466|10639289|P3|Overall Study|Disease progression|1
3105571|NCT00245466|10639290|P2|Overall Study|Disease progression|3
3105572|NCT00245466|10639291|P1|Overall Study|Disease progression|0
3105573|NCT00245466|10639289|P3|Overall Study|Lost to Follow-up|0
3105574|NCT00245466|10639290|P2|Overall Study|Lost to Follow-up|0
3105575|NCT00245466|10639291|P1|Overall Study|Lost to Follow-up|3
3105576|NCT00245466|10639289|P3|Overall Study|Withdrawal by Subject|1
3105577|NCT00245466|10639290|P2|Overall Study|Withdrawal by Subject|2
3105578|NCT00245466|10639291|P1|Overall Study|Withdrawal by Subject|2
3105579|NCT00245466|10639289|P3|Overall Study|Insufficient PSA and testosterone suppr|3
3105580|NCT00245466|10639290|P2|Overall Study|Insufficient PSA and testosterone suppr|0
3105581|NCT00245466|10639291|P1|Overall Study|Insufficient PSA and testosterone suppr|0
3105582|NCT00245466|10639289|P3|Overall Study|Insufficient testosterone suppr|21
3105583|NCT00245466|10639290|P2|Overall Study|Insufficient testosterone suppr|12
3105584|NCT00245466|10639291|P1|Overall Study|Insufficient testosterone suppr|12
3105585|NCT00245466|10639289|P3|Overall Study|Low prostate specific antigen suppr|5
3105586|NCT00245466|10639290|P2|Overall Study|Low prostate specific antigen suppr|14
3105587|NCT00245466|10639291|P1|Overall Study|Low prostate specific antigen suppr|16
3105588|NCT00245466|10639289|P3|Overall Study|Adverse Event|4
3105589|NCT00245466|10639290|P2|Overall Study|Adverse Event|8
3105590|NCT00245466|10639291|P1|Overall Study|Adverse Event|2
3105591|NCT00245102|10639334|P6|Overall Study|Clinical progression|0
3105592|NCT00245102|10639335|P5|Overall Study|Clinical progression|0
3105593|NCT00245102|10639336|P4|Overall Study|Clinical progression|0
3105594|NCT00245102|10639337|P3|Overall Study|Clinical progression|0
3105595|NCT00245102|10639338|P2|Overall Study|Clinical progression|0
3105596|NCT00245102|10639339|P1|Overall Study|Clinical progression|1
3105597|NCT00245102|10639334|P6|Overall Study|Participant needed surgery|0
3105598|NCT00245102|10639335|P5|Overall Study|Participant needed surgery|0
3105599|NCT00245102|10639336|P4|Overall Study|Participant needed surgery|0
3105600|NCT00245102|10639337|P3|Overall Study|Participant needed surgery|1
3105601|NCT00245102|10639338|P2|Overall Study|Participant needed surgery|0
3105602|NCT00245102|10639339|P1|Overall Study|Participant needed surgery|0
3105603|NCT00245102|10639334|P6|Overall Study|Decline in performance|2
3105604|NCT00245102|10639335|P5|Overall Study|Decline in performance|0
3105605|NCT00245102|10639336|P4|Overall Study|Decline in performance|1
3105606|NCT00245102|10639337|P3|Overall Study|Decline in performance|0
3105607|NCT00245102|10639338|P2|Overall Study|Decline in performance|2
3105608|NCT00245102|10639339|P1|Overall Study|Decline in performance|0
3105609|NCT00245102|10639334|P6|Overall Study|Adverse Event|2
3105610|NCT00245102|10639335|P5|Overall Study|Adverse Event|0
3105611|NCT00245102|10639336|P4|Overall Study|Adverse Event|1
3105612|NCT00245102|10639337|P3|Overall Study|Adverse Event|5
3105613|NCT00245102|10639338|P2|Overall Study|Adverse Event|2
3105614|NCT00245102|10639339|P1|Overall Study|Adverse Event|4
3105615|NCT00245102|10639334|P6|Overall Study|Death|0
3105616|NCT00245102|10639335|P5|Overall Study|Death|0
3105617|NCT00245102|10639336|P4|Overall Study|Death|1
3105618|NCT00245102|10639337|P3|Overall Study|Death|0
3105619|NCT00245102|10639338|P2|Overall Study|Death|0
3105620|NCT00245102|10639339|P1|Overall Study|Death|0
3105621|NCT00245102|10639334|P6|Overall Study|Protocol Violation|0
3105622|NCT00245102|10639335|P5|Overall Study|Protocol Violation|0
3105623|NCT00245102|10639336|P4|Overall Study|Protocol Violation|0
3105624|NCT00245102|10639337|P3|Overall Study|Protocol Violation|0
3105625|NCT00245102|10639338|P2|Overall Study|Protocol Violation|0
3105626|NCT00245102|10639339|P1|Overall Study|Protocol Violation|1
3105627|NCT00245102|10639334|P6|Overall Study|Not Treated|0
3105628|NCT00245102|10639335|P5|Overall Study|Not Treated|0
3105629|NCT00245102|10639336|P4|Overall Study|Not Treated|0
3105630|NCT00245102|10639337|P3|Overall Study|Not Treated|1
3105631|NCT00245102|10639338|P2|Overall Study|Not Treated|0
3105632|NCT00245102|10639339|P1|Overall Study|Not Treated|1
3105633|NCT00245063|10639355|P2|Overall Study|Death|0
3105634|NCT00245063|10639356|P1|Overall Study|Death|1
3105635|NCT00245063|10639355|P2|Overall Study|Adverse Event|5
3105636|NCT00245063|10639356|P1|Overall Study|Adverse Event|6
3105637|NCT00245050|10639364|P2|Overall Study|Adverse Event|2
3105638|NCT00245050|10639365|P1|Overall Study|Adverse Event|3
3105639|NCT00245037|10639373|P1|Overall Study|Death|17
3105640|NCT00245011|10639383|P1|Overall Study|Lack of Efficacy|1
3105641|NCT00244933|10639400|P1|Overall Study|Not response evaluable|2
3105642|NCT00244881|10639404|P1|Overall Study|Withdrawal by Subject|3
3105643|NCT00244855|10639412|P2|Overall Study|Withdrawal by Subject|1
3105644|NCT00244855|10639413|P1|Overall Study|Withdrawal by Subject|0
3105645|NCT00244764|10639421|P1|Overall Study|Developed Secondary Malignancy|1
3105646|NCT00244764|10639421|P1|Overall Study|Sponsor Terminated Study|2
3105647|NCT00244764|10639421|P1|Overall Study|Primary Investigator Discretion|2
3105648|NCT00244764|10639421|P1|Overall Study|Participant was Hospitalized until Death|1
3105649|NCT00244764|10639421|P1|Overall Study|Declining Performance Status|1
3105650|NCT00244764|10639421|P1|Overall Study|Off Study Medication for >21 Days|1
3105651|NCT00244764|10639421|P1|Overall Study|Death|1
3105652|NCT00244764|10639421|P1|Overall Study|Protocol Violation|2
3105653|NCT00244764|10639421|P1|Overall Study|Disease Progression|13
3105654|NCT00244764|10639421|P1|Overall Study|Withdrawal by Subject|12
3105655|NCT00244764|10639421|P1|Overall Study|Lost to Follow-up|23
3105656|NCT00244764|10639421|P1|Overall Study|Adverse Event|37
3105657|NCT00244751|10639431|P3|Overall Study|Participant randomized by mistake|1
3105658|NCT00244751|10639432|P2|Overall Study|Participant randomized by mistake|0
3105659|NCT00244751|10639433|P1|Overall Study|Participant randomized by mistake|0
3105660|NCT00244751|10639431|P3|Overall Study|Safety reasons|0
3105661|NCT00244751|10639432|P2|Overall Study|Safety reasons|1
3105662|NCT00244751|10639433|P1|Overall Study|Safety reasons|0
3105663|NCT00244751|10639431|P3|Overall Study|Lack of compliance with protocol|0
3105664|NCT00244751|10639432|P2|Overall Study|Lack of compliance with protocol|1
3105665|NCT00244751|10639433|P1|Overall Study|Lack of compliance with protocol|0
3105666|NCT00244751|10639431|P3|Overall Study|Elevated liver enzymes|0
3105667|NCT00244751|10639432|P2|Overall Study|Elevated liver enzymes|0
3105668|NCT00244751|10639433|P1|Overall Study|Elevated liver enzymes|1
3105669|NCT00244751|10639431|P3|Overall Study|Withdrawal by Subject|3
3105670|NCT00244751|10639432|P2|Overall Study|Withdrawal by Subject|5
3105671|NCT00244751|10639433|P1|Overall Study|Withdrawal by Subject|7
3105672|NCT00244751|10639431|P3|Overall Study|Protocol Violation|1
3105673|NCT00244751|10639432|P2|Overall Study|Protocol Violation|0
3105674|NCT00244751|10639433|P1|Overall Study|Protocol Violation|1
3105675|NCT00244751|10639431|P3|Overall Study|Lost to Follow-up|0
3105676|NCT00244751|10639432|P2|Overall Study|Lost to Follow-up|1
3105677|NCT00244751|10639433|P1|Overall Study|Lost to Follow-up|0
3105678|NCT00244751|10639431|P3|Overall Study|Adverse Event|5
3105679|NCT00244751|10639432|P2|Overall Study|Adverse Event|7
3105680|NCT00244751|10639433|P1|Overall Study|Adverse Event|7
3105681|NCT00244725|10639534|P4|Overall Study|Failed to follow-up|1
3105682|NCT00244725|10639535|P3|Overall Study|Failed to follow-up|1
3105683|NCT00244725|10639536|P2|Overall Study|Failed to follow-up|0
3105684|NCT00244725|10639537|P1|Overall Study|Failed to follow-up|0
3105685|NCT00244725|10639534|P4|Overall Study|Vomit|0
3105686|NCT00244725|10639535|P3|Overall Study|Vomit|1
3105687|NCT00244725|10639536|P2|Overall Study|Vomit|0
3105688|NCT00244725|10639537|P1|Overall Study|Vomit|0
3105689|NCT00244725|10639534|P4|Overall Study|Administrative reason|0
3105690|NCT00244725|10639535|P3|Overall Study|Administrative reason|1
3105691|NCT00244725|10639536|P2|Overall Study|Administrative reason|0
3105692|NCT00244725|10639537|P1|Overall Study|Administrative reason|0
3105693|NCT00244725|10639534|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
3105694|NCT00244725|10639535|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
3105695|NCT00244725|10639536|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
3105696|NCT00244725|10639537|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
3105697|NCT00244725|10639534|P4|Overall Study|Received prohibited medication|1
3105698|NCT00244725|10639535|P3|Overall Study|Received prohibited medication|0
3105699|NCT00244725|10639536|P2|Overall Study|Received prohibited medication|1
3105700|NCT00244725|10639537|P1|Overall Study|Received prohibited medication|0
3105701|NCT00244725|10639534|P4|Overall Study|Headache|0
3105702|NCT00244725|10639535|P3|Overall Study|Headache|0
3105703|NCT00244725|10639536|P2|Overall Study|Headache|1
3105704|NCT00244725|10639537|P1|Overall Study|Headache|0
3105705|NCT00244725|10639534|P4|Overall Study|Rehab Refused to allow participantion|0
3105706|NCT00244725|10639535|P3|Overall Study|Rehab Refused to allow participantion|0
3105707|NCT00244725|10639536|P2|Overall Study|Rehab Refused to allow participantion|1
3105708|NCT00244725|10639537|P1|Overall Study|Rehab Refused to allow participantion|0
3105709|NCT00244725|10639534|P4|Overall Study|Mediciation Error|0
3105710|NCT00244725|10639535|P3|Overall Study|Mediciation Error|0
3105711|NCT00244725|10639536|P2|Overall Study|Mediciation Error|1
3105712|NCT00244725|10639537|P1|Overall Study|Mediciation Error|0
3105713|NCT00244725|10639534|P4|Overall Study|Sponsor withdrew the participant|1
3105714|NCT00244725|10639535|P3|Overall Study|Sponsor withdrew the participant|0
3105715|NCT00244725|10639536|P2|Overall Study|Sponsor withdrew the participant|0
3105716|NCT00244725|10639537|P1|Overall Study|Sponsor withdrew the participant|1
3105717|NCT00244725|10639534|P4|Overall Study|Liver function test abnormality|1
3105718|NCT00244725|10639535|P3|Overall Study|Liver function test abnormality|0
3105719|NCT00244725|10639536|P2|Overall Study|Liver function test abnormality|0
3105720|NCT00244725|10639537|P1|Overall Study|Liver function test abnormality|2
3105721|NCT00244725|10639534|P4|Overall Study|Withdrwal by participant|1
3105722|NCT00244725|10639535|P3|Overall Study|Withdrwal by participant|0
3105723|NCT00244725|10639536|P2|Overall Study|Withdrwal by participant|0
3105724|NCT00244725|10639537|P1|Overall Study|Withdrwal by participant|1
3105725|NCT00244725|10639534|P4|Overall Study|Adverse Events|4
3105726|NCT00244725|10639535|P3|Overall Study|Adverse Events|4
3105727|NCT00244725|10639536|P2|Overall Study|Adverse Events|1
3105728|NCT00244725|10639537|P1|Overall Study|Adverse Events|3
3105729|NCT00244725|10639534|P4|Overall Study|Physician Decision|2
3105730|NCT00244725|10639535|P3|Overall Study|Physician Decision|1
3105731|NCT00244725|10639536|P2|Overall Study|Physician Decision|0
3105732|NCT00244725|10639537|P1|Overall Study|Physician Decision|3
3105733|NCT00244725|10639534|P4|Overall Study|Not meet treatment eligibility criteria|0
3105734|NCT00244725|10639535|P3|Overall Study|Not meet treatment eligibility criteria|0
3105735|NCT00244725|10639536|P2|Overall Study|Not meet treatment eligibility criteria|2
3105736|NCT00244725|10639537|P1|Overall Study|Not meet treatment eligibility criteria|1
3105737|NCT00244725|10639534|P4|Overall Study|Withdrawal by Subject|8
3105738|NCT00244725|10639535|P3|Overall Study|Withdrawal by Subject|7
3105739|NCT00244725|10639536|P2|Overall Study|Withdrawal by Subject|7
3105740|NCT00244725|10639537|P1|Overall Study|Withdrawal by Subject|9
3105741|NCT00244725|10639534|P4|Overall Study|Lost to Follow-up|2
3105742|NCT00244725|10639535|P3|Overall Study|Lost to Follow-up|9
3105743|NCT00244725|10639536|P2|Overall Study|Lost to Follow-up|4
3105744|NCT00244725|10639537|P1|Overall Study|Lost to Follow-up|3
3105745|NCT00244712|10639593|P2|Overall Study|Protocol Violation, disease progression|11
3105746|NCT00244712|10639594|P1|Overall Study|Protocol Violation, disease progression|13
3105747|NCT00244712|10639593|P2|Overall Study|Withdrawal by Subject|23
3105748|NCT00244712|10639594|P1|Overall Study|Withdrawal by Subject|13
3105749|NCT00244712|10639593|P2|Overall Study|Lost to Follow-up|52
3105750|NCT00244712|10639594|P1|Overall Study|Lost to Follow-up|45
3105751|NCT00244712|10639593|P2|Overall Study|Lack of Compliance|11
3105752|NCT00244712|10639594|P1|Overall Study|Lack of Compliance|10
3105753|NCT00244712|10639593|P2|Overall Study|Protocol-Defined Virologic Failure|6
3105754|NCT00244712|10639594|P1|Overall Study|Protocol-Defined Virologic Failure|8
3105755|NCT00244712|10639593|P2|Overall Study|Adverse Event|21
3105756|NCT00244712|10639594|P1|Overall Study|Adverse Event|20
3105757|NCT00244621|10639629|P3|Open-label Treatment Period|Moved abroad|1
3105758|NCT00244621|10639630|P2|Open-label Treatment Period|Moved abroad|0
3105759|NCT00244621|10639631|P1|Open-label Treatment Period|Moved abroad|0
3105760|NCT00244621|10639629|P3|Open-label Treatment Period|Adverse Event|1
3105761|NCT00244621|10639630|P2|Open-label Treatment Period|Adverse Event|0
3105762|NCT00244621|10639631|P1|Open-label Treatment Period|Adverse Event|0
3105763|NCT00244621|10639629|P3|Open-label Treatment Period|Withdrawal by Subject|0
3105764|NCT00244621|10639630|P2|Open-label Treatment Period|Withdrawal by Subject|0
3105765|NCT00244621|10639631|P1|Open-label Treatment Period|Withdrawal by Subject|1
3105766|NCT00244621|10639629|P3|Open-label Treatment Period|Lost to Follow-up|0
3105767|NCT00244621|10639630|P2|Open-label Treatment Period|Lost to Follow-up|1
3105768|NCT00244621|10639631|P1|Open-label Treatment Period|Lost to Follow-up|0
3105769|NCT00244621|10639629|P3|Double-blind Treatment Period|Multiple Reasons|1
3105770|NCT00244621|10639630|P2|Double-blind Treatment Period|Multiple Reasons|1
3105771|NCT00244621|10639631|P1|Double-blind Treatment Period|Multiple Reasons|2
3105772|NCT00244621|10639629|P3|Double-blind Treatment Period|Lack of Efficacy|0
3105773|NCT00244621|10639630|P2|Double-blind Treatment Period|Lack of Efficacy|1
3105774|NCT00244621|10639631|P1|Double-blind Treatment Period|Lack of Efficacy|0
3105775|NCT00244621|10639629|P3|Double-blind Treatment Period|Withdrawal by Subject|0
3105776|NCT00244621|10639630|P2|Double-blind Treatment Period|Withdrawal by Subject|1
3105777|NCT00244621|10639631|P1|Double-blind Treatment Period|Withdrawal by Subject|0
3105778|NCT00244621|10639629|P3|Double-blind Treatment Period|Lost to Follow-up|1
3105779|NCT00244621|10639630|P2|Double-blind Treatment Period|Lost to Follow-up|0
3105780|NCT00244621|10639631|P1|Double-blind Treatment Period|Lost to Follow-up|0
3105781|NCT00244374|10639648|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
3105782|NCT00244374|10639649|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
3105783|NCT00244374|10639650|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
3105784|NCT00244374|10639651|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
3105785|NCT00244374|10639652|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
3105786|NCT00244374|10639648|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
3105787|NCT00244374|10639649|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
3105788|NCT00244374|10639650|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
3105789|NCT00244374|10639651|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
3105790|NCT00244374|10639652|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
3105791|NCT00244374|10639648|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
3105792|NCT00244374|10639649|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
3105793|NCT00244374|10639650|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
3105794|NCT00244374|10639651|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
3105795|NCT00244374|10639652|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
3105796|NCT00244374|10639648|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
3105797|NCT00244374|10639649|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
3105798|NCT00244374|10639650|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
3105799|NCT00244374|10639651|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
3105800|NCT00244374|10639652|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
3105801|NCT00244374|10639648|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
3105802|NCT00244374|10639649|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
3105803|NCT00244374|10639650|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
3105804|NCT00244374|10639651|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
3105805|NCT00244374|10639652|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
3105806|NCT00244374|10639648|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
3105807|NCT00244374|10639649|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
3105808|NCT00244374|10639650|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
3105809|NCT00244374|10639651|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
3105810|NCT00244374|10639652|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
3105811|NCT00244374|10639648|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
3105812|NCT00244374|10639649|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
3105813|NCT00244374|10639650|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
3105814|NCT00244374|10639651|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
3105815|NCT00244374|10639652|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
3105816|NCT00244374|10639648|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
3105817|NCT00244374|10639649|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
3105818|NCT00244374|10639650|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
3105819|NCT00244374|10639651|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
3105820|NCT00244374|10639652|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
3105821|NCT00244374|10639648|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
3105822|NCT00244374|10639649|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
3105823|NCT00244374|10639650|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
3105824|NCT00244374|10639651|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
3105825|NCT00244374|10639652|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
3105826|NCT00243932|10639708|P3|Stage 1: Dose Selection|Lost to Follow-up|0
3105827|NCT00243932|10639709|P2|Stage 1: Dose Selection|Lost to Follow-up|0
3105828|NCT00243932|10639710|P1|Stage 1: Dose Selection|Lost to Follow-up|2
3105829|NCT00243919|10639721|P3|Overall Study|Physician Decision|0
3105830|NCT00243919|10639722|P2|Overall Study|Physician Decision|1
3105831|NCT00243919|10639723|P1|Overall Study|Physician Decision|1
3105832|NCT00243919|10639721|P3|Overall Study|Administrative Error|0
3105833|NCT00243919|10639722|P2|Overall Study|Administrative Error|0
3105834|NCT00243919|10639723|P1|Overall Study|Administrative Error|1
3105835|NCT00243919|10639721|P3|Overall Study|Lost to Follow-up|3
3105836|NCT00243919|10639722|P2|Overall Study|Lost to Follow-up|7
3105837|NCT00243919|10639723|P1|Overall Study|Lost to Follow-up|6
3105838|NCT00243919|10639721|P3|Overall Study|Withdrawal by Subject|2
3105839|NCT00243919|10639722|P2|Overall Study|Withdrawal by Subject|6
3105840|NCT00243919|10639723|P1|Overall Study|Withdrawal by Subject|6
3105841|NCT00243919|10639721|P3|Overall Study|Death|6
3105842|NCT00243919|10639722|P2|Overall Study|Death|4
3105843|NCT00243919|10639723|P1|Overall Study|Death|3
3105844|NCT00243841|10639767|P6|Overall Study|Physician Decision|2
3105845|NCT00243841|10639768|P5|Overall Study|Physician Decision|0
3105846|NCT00243841|10639769|P4|Overall Study|Physician Decision|0
3105847|NCT00243841|10639770|P3|Overall Study|Physician Decision|1
3105848|NCT00243841|10639771|P2|Overall Study|Physician Decision|0
3105849|NCT00243841|10639772|P1|Overall Study|Physician Decision|0
3105850|NCT00243659|10639794|P2|Overall Study|Protocol Violation|2
3105851|NCT00243659|10639795|P1|Overall Study|Protocol Violation|1
3105852|NCT00243659|10639794|P2|Overall Study|Withdrawal by Subject|1
3105853|NCT00243659|10639795|P1|Overall Study|Withdrawal by Subject|1
3105854|NCT00243503|10639803|P1|Overall Study|Other|1
3105855|NCT00243503|10639803|P1|Overall Study|Death|1
3105856|NCT00243503|10639803|P1|Overall Study|Lack of Efficacy|44
3105857|NCT00243503|10639803|P1|Overall Study|Withdrawal by Subject|1
3105858|NCT00243503|10639803|P1|Overall Study|Adverse Event|11
3105859|NCT00243412|10639820|P2|Overall Study|Other|1
3105860|NCT00243412|10639821|P1|Overall Study|Other|1
3105861|NCT00243412|10639820|P2|Overall Study|Withdrawal by Subject|5
3105862|NCT00243412|10639821|P1|Overall Study|Withdrawal by Subject|4
3105863|NCT00243412|10639820|P2|Overall Study|Physician Decision|1
3105864|NCT00243412|10639821|P1|Overall Study|Physician Decision|1
3105865|NCT00243412|10639820|P2|Overall Study|Lost to Follow-up|1
3105866|NCT00243412|10639821|P1|Overall Study|Lost to Follow-up|0
3105867|NCT00243412|10639820|P2|Overall Study|Adverse Event|2
3105868|NCT00243412|10639821|P1|Overall Study|Adverse Event|4
3105869|NCT00243412|10639820|P2|Overall Study|Death|1
3105870|NCT00243412|10639821|P1|Overall Study|Death|0
3105871|NCT00243386|10639847|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
3105872|NCT00243386|10639848|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
3105873|NCT00243386|10639849|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
3105874|NCT00243386|10639847|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
3105875|NCT00243386|10639848|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
3105876|NCT00243386|10639849|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
3105877|NCT00243386|10639847|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
3105878|NCT00243386|10639848|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
3105879|NCT00243386|10639849|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
3105880|NCT00243386|10639847|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
3105881|NCT00243386|10639848|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
3105882|NCT00243386|10639849|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
3105883|NCT00243386|10639847|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
3105884|NCT00243386|10639848|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
3105885|NCT00243386|10639849|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
3105886|NCT00243386|10639847|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
3105887|NCT00243386|10639848|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
3105888|NCT00243386|10639849|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
3105889|NCT00243386|10639847|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
3105890|NCT00243386|10639848|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
3105891|NCT00243386|10639849|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
3105892|NCT00243386|10639847|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
3105893|NCT00243386|10639848|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
3105894|NCT00243386|10639849|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
3105895|NCT00243347|10639914|P1|Overall Study|Condition worsened|7
3105896|NCT00243347|10639914|P1|Overall Study|Withdrawal by Subject|5
3105897|NCT00243347|10639914|P1|Overall Study|Death|1
3105898|NCT00243347|10639914|P1|Overall Study|Adverse Event|2
3105899|NCT00243347|10639914|P1|Overall Study|Lack of Efficacy|4
3105900|NCT00243269|10639923|P4|Overall Study|Lost to Follow-up|3
3105901|NCT00243269|10639924|P3|Overall Study|Lost to Follow-up|1
3105902|NCT00243269|10639925|P2|Overall Study|Lost to Follow-up|0
3105903|NCT00243269|10639926|P1|Overall Study|Lost to Follow-up|1
3105904|NCT00243269|10639923|P4|Overall Study|Protocol Violation|1
3105905|NCT00243269|10639924|P3|Overall Study|Protocol Violation|0
3105906|NCT00243269|10639925|P2|Overall Study|Protocol Violation|1
3105907|NCT00243269|10639926|P1|Overall Study|Protocol Violation|2
3105908|NCT00243074|10639961|P1|Overall Study|Did not receive any treatment|1
3105909|NCT00243074|10639961|P1|Overall Study|not protocol specified|1
3105910|NCT00243074|10639961|P1|Overall Study|Death|2
3105911|NCT00243074|10639961|P1|Overall Study|Lack of Efficacy|36
3105912|NCT00243074|10639961|P1|Overall Study|Withdrawal by Subject|2
3105913|NCT00243074|10639961|P1|Overall Study|Adverse Event|6
3105914|NCT00243074|10639961|P1|Overall Study|Ineligible|6
3105915|NCT00243022|10639987|P2|Overall Study|Difficult Travel Distance|1
3105916|NCT00243022|10639988|P1|Overall Study|Difficult Travel Distance|0
3105917|NCT00243022|10639987|P2|Overall Study|Death|0
3105918|NCT00243022|10639988|P1|Overall Study|Death|1
3105919|NCT00243022|10639987|P2|Overall Study|Withdrawal by Subject|0
3105920|NCT00243022|10639988|P1|Overall Study|Withdrawal by Subject|1
3105921|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
3105922|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
3105923|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
3105924|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
3105925|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Protocol Violation|1
3105926|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Protocol Violation|0
3105927|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Protocol Violation|2
3105928|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Protocol Violation|0
3105929|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Other|3
3105930|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Other|4
3105931|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Other|5
3105932|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Other|3
3105933|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
3105934|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
3105935|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
3105936|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
3105937|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Death|1
3105938|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Death|0
3105939|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Death|0
3105940|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Death|0
3105941|NCT00242710|10640012|P4|Study Extension (up to Year 2)|Adverse Event|4
3105942|NCT00242710|10640013|P3|Study Extension (up to Year 2)|Adverse Event|2
3105943|NCT00242710|10640014|P2|Study Extension (up to Year 2)|Adverse Event|9
3105944|NCT00242710|10640015|P1|Study Extension (up to Year 2)|Adverse Event|7
3105945|NCT00242710|10640012|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
3105946|NCT00242710|10640013|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
3105947|NCT00242710|10640014|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
3105948|NCT00242710|10640015|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
3105949|NCT00242710|10640012|P4|Period Between Core Study and Extension|Protocol Violation|1
3105950|NCT00242710|10640013|P3|Period Between Core Study and Extension|Protocol Violation|2
3105951|NCT00242710|10640014|P2|Period Between Core Study and Extension|Protocol Violation|0
3105952|NCT00242710|10640015|P1|Period Between Core Study and Extension|Protocol Violation|0
3105953|NCT00242710|10640012|P4|Period Between Core Study and Extension|Extension not Available|7
3105954|NCT00242710|10640013|P3|Period Between Core Study and Extension|Extension not Available|8
3105955|NCT00242710|10640014|P2|Period Between Core Study and Extension|Extension not Available|21
3105956|NCT00242710|10640015|P1|Period Between Core Study and Extension|Extension not Available|17
3105957|NCT00242710|10640012|P4|Period Between Core Study and Extension|Other|11
3105958|NCT00242710|10640013|P3|Period Between Core Study and Extension|Other|9
3105959|NCT00242710|10640014|P2|Period Between Core Study and Extension|Other|24
3105960|NCT00242710|10640015|P1|Period Between Core Study and Extension|Other|24
3105961|NCT00242710|10640012|P4|Period Between Core Study and Extension|Physician Decision|0
3105962|NCT00242710|10640013|P3|Period Between Core Study and Extension|Physician Decision|0
3105963|NCT00242710|10640014|P2|Period Between Core Study and Extension|Physician Decision|1
3105964|NCT00242710|10640015|P1|Period Between Core Study and Extension|Physician Decision|1
3105965|NCT00242710|10640012|P4|Period Between Core Study and Extension|Adverse Event|2
3105966|NCT00242710|10640013|P3|Period Between Core Study and Extension|Adverse Event|5
3105967|NCT00242710|10640014|P2|Period Between Core Study and Extension|Adverse Event|3
3105968|NCT00242710|10640015|P1|Period Between Core Study and Extension|Adverse Event|2
3105969|NCT00242710|10640012|P4|Core Study (up to Year 1)|Randomized but not Treated|2
3105970|NCT00242710|10640013|P3|Core Study (up to Year 1)|Randomized but not Treated|4
3105971|NCT00242710|10640014|P2|Core Study (up to Year 1)|Randomized but not Treated|4
3105972|NCT00242710|10640015|P1|Core Study (up to Year 1)|Randomized but not Treated|12
3105973|NCT00242710|10640012|P4|Core Study (up to Year 1)|Lack of Efficacy|0
3105974|NCT00242710|10640013|P3|Core Study (up to Year 1)|Lack of Efficacy|0
3105975|NCT00242710|10640014|P2|Core Study (up to Year 1)|Lack of Efficacy|0
3105976|NCT00242710|10640015|P1|Core Study (up to Year 1)|Lack of Efficacy|1
3105977|NCT00242710|10640012|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
3105978|NCT00242710|10640013|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
3105979|NCT00242710|10640014|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
3105980|NCT00242710|10640015|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
3105981|NCT00242710|10640012|P4|Core Study (up to Year 1)|Protocol Violation|3
3105982|NCT00242710|10640013|P3|Core Study (up to Year 1)|Protocol Violation|1
3105983|NCT00242710|10640014|P2|Core Study (up to Year 1)|Protocol Violation|9
3105984|NCT00242710|10640015|P1|Core Study (up to Year 1)|Protocol Violation|2
3105985|NCT00242710|10640012|P4|Core Study (up to Year 1)|Other|2
3105986|NCT00242710|10640013|P3|Core Study (up to Year 1)|Other|0
3105987|NCT00242710|10640014|P2|Core Study (up to Year 1)|Other|1
3105988|NCT00242710|10640015|P1|Core Study (up to Year 1)|Other|6
3105989|NCT00242710|10640012|P4|Core Study (up to Year 1)|Lost to Follow-up|3
3105990|NCT00242710|10640013|P3|Core Study (up to Year 1)|Lost to Follow-up|7
3105991|NCT00242710|10640014|P2|Core Study (up to Year 1)|Lost to Follow-up|8
3105992|NCT00242710|10640015|P1|Core Study (up to Year 1)|Lost to Follow-up|8
3105993|NCT00242710|10640012|P4|Core Study (up to Year 1)|Physician Decision|1
3105994|NCT00242710|10640013|P3|Core Study (up to Year 1)|Physician Decision|0
3105995|NCT00242710|10640014|P2|Core Study (up to Year 1)|Physician Decision|1
3105996|NCT00242710|10640015|P1|Core Study (up to Year 1)|Physician Decision|0
3105997|NCT00242710|10640012|P4|Core Study (up to Year 1)|Death|0
3105998|NCT00242710|10640013|P3|Core Study (up to Year 1)|Death|1
3105999|NCT00242710|10640014|P2|Core Study (up to Year 1)|Death|0
3106000|NCT00242710|10640015|P1|Core Study (up to Year 1)|Death|0
3106001|NCT00242710|10640012|P4|Core Study (up to Year 1)|Adverse Event|14
3106002|NCT00242710|10640013|P3|Core Study (up to Year 1)|Adverse Event|23
3106003|NCT00242710|10640014|P2|Core Study (up to Year 1)|Adverse Event|25
3106004|NCT00242710|10640015|P1|Core Study (up to Year 1)|Adverse Event|30
3106005|NCT00242658|10640072|P2|Overall Study|Lost to Follow-up|19
3106006|NCT00242658|10640073|P1|Overall Study|Lost to Follow-up|22
3106007|NCT00242580|10640104|P3|Overall Study|Death|1
3106008|NCT00242580|10640105|P2|Overall Study|Death|2
3106009|NCT00242580|10640106|P1|Overall Study|Death|1
3106010|NCT00242580|10640104|P3|Overall Study|Lost to Follow-up|0
3106011|NCT00242580|10640105|P2|Overall Study|Lost to Follow-up|3
3106012|NCT00242580|10640106|P1|Overall Study|Lost to Follow-up|0
3106013|NCT00242580|10640104|P3|Overall Study|Subject withdrew consent|5
3106014|NCT00242580|10640105|P2|Overall Study|Subject withdrew consent|2
3106015|NCT00242580|10640106|P1|Overall Study|Subject withdrew consent|2
3106016|NCT00242580|10640104|P3|Overall Study|Protocol Violation|1
3106017|NCT00242580|10640105|P2|Overall Study|Protocol Violation|0
3106018|NCT00242580|10640106|P1|Overall Study|Protocol Violation|0
3106019|NCT00242580|10640104|P3|Overall Study|Unsatisfactory therapeutic effect|5
3106020|NCT00242580|10640105|P2|Overall Study|Unsatisfactory therapeutic effect|5
3106021|NCT00242580|10640106|P1|Overall Study|Unsatisfactory therapeutic effect|4
3106022|NCT00242580|10640104|P3|Overall Study|Adverse Event|2
3106023|NCT00242580|10640105|P2|Overall Study|Adverse Event|0
3106024|NCT00242580|10640106|P1|Overall Study|Adverse Event|3
3106025|NCT00242567|10640131|P2|Overall Study|Other|9
3106026|NCT00242567|10640132|P1|Overall Study|Other|14
3106027|NCT00242567|10640131|P2|Overall Study|Use of an inhibitor of bone resorption|2
3106028|NCT00242567|10640132|P1|Overall Study|Use of an inhibitor of bone resorption|0
3106029|NCT00242567|10640131|P2|Overall Study|Protocol Violation|12
3106030|NCT00242567|10640132|P1|Overall Study|Protocol Violation|12
3106031|NCT00242567|10640131|P2|Overall Study|Withdrawal by Subject|28
3106032|NCT00242567|10640132|P1|Overall Study|Withdrawal by Subject|33
3106033|NCT00242567|10640131|P2|Overall Study|Lost to Follow-up|19
3106034|NCT00242567|10640132|P1|Overall Study|Lost to Follow-up|9
3106035|NCT00242567|10640131|P2|Overall Study|Lack of Efficacy|2
3106036|NCT00242567|10640132|P1|Overall Study|Lack of Efficacy|2
3106037|NCT00242567|10640131|P2|Overall Study|Symptomatic deterioration|3
3106038|NCT00242567|10640132|P1|Overall Study|Symptomatic deterioration|9
3106039|NCT00242567|10640131|P2|Overall Study|Disease Progression|22
3106040|NCT00242567|10640132|P1|Overall Study|Disease Progression|17
3106041|NCT00242567|10640131|P2|Overall Study|Adverse Event|43
3106042|NCT00242567|10640132|P1|Overall Study|Adverse Event|70
3106043|NCT00242216|10640179|P2|Overall Study|no medicaiton dispensed|1
3106044|NCT00242216|10640180|P1|Overall Study|no medicaiton dispensed|1
3106045|NCT00242216|10640179|P2|Overall Study|Lack of Efficacy|2
3106046|NCT00242216|10640180|P1|Overall Study|Lack of Efficacy|1
3106047|NCT00242216|10640179|P2|Overall Study|Death|2
3106048|NCT00242216|10640180|P1|Overall Study|Death|4
3106049|NCT00242216|10640179|P2|Overall Study|Lost to Follow-up|17
3106050|NCT00242216|10640180|P1|Overall Study|Lost to Follow-up|12
3106051|NCT00241839|10640218|P2|Overall Study|Adverse Event|1
3106052|NCT00241839|10640219|P1|Overall Study|Adverse Event|1
3106053|NCT00241839|10640218|P2|Overall Study|Withdrawal by Subject|17
3106054|NCT00241839|10640219|P1|Overall Study|Withdrawal by Subject|18
3106055|NCT00241644|10640235|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
3106056|NCT00241644|10640236|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
3106057|NCT00241644|10640237|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
3106058|NCT00241644|10640238|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
3106059|NCT00241644|10640235|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
3106060|NCT00241644|10640236|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
3106061|NCT00241644|10640237|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
3106062|NCT00241644|10640238|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
3106063|NCT00241644|10640235|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
3106064|NCT00241644|10640236|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
3106065|NCT00241644|10640237|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
3106066|NCT00241644|10640238|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
3106067|NCT00241644|10640235|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
3106068|NCT00241644|10640236|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
3106069|NCT00241644|10640237|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
3106070|NCT00241644|10640238|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
3106071|NCT00241644|10640235|P4|Second Efficacy Period (Year 2)|Adverse Event|20
3106072|NCT00241644|10640236|P3|Second Efficacy Period (Year 2)|Adverse Event|12
3106073|NCT00241644|10640237|P2|Second Efficacy Period (Year 2)|Adverse Event|9
3106074|NCT00241644|10640238|P1|Second Efficacy Period (Year 2)|Adverse Event|11
3106075|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
3106076|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
3106077|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
3106078|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
3106079|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
3106080|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
3106081|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
3106082|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
3106083|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
3106084|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
3106085|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
3106086|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
3106087|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Non-compliance|3
3106088|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Non-compliance|2
3106089|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Non-compliance|1
3106090|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Non-compliance|2
3106091|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
3106092|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
3106093|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
3106094|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
3106095|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
3106096|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
3106097|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
3106098|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
3106099|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Protocol Violation|8
3106100|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Protocol Violation|4
3106101|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Protocol Violation|5
3106102|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Protocol Violation|3
3106103|NCT00241644|10640235|P4|First Efficacy Period (Year 1)|Adverse Event|91
3106104|NCT00241644|10640236|P3|First Efficacy Period (Year 1)|Adverse Event|45
3106105|NCT00241644|10640237|P2|First Efficacy Period (Year 1)|Adverse Event|45
3106106|NCT00241644|10640238|P1|First Efficacy Period (Year 1)|Adverse Event|46
3106107|NCT00241631|10640322|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
3106108|NCT00241631|10640323|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
3106109|NCT00241631|10640322|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
3106110|NCT00241631|10640323|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
3106111|NCT00241631|10640322|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
3106112|NCT00241631|10640323|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
3106113|NCT00241631|10640322|P2|Phase 1 (4 Weeks)|sore throat|0
3106114|NCT00241631|10640323|P1|Phase 1 (4 Weeks)|sore throat|1
3106115|NCT00241631|10640322|P2|Run in (2 Weeks)|Physician Decision|3
3106116|NCT00241631|10640323|P1|Run in (2 Weeks)|Physician Decision|3
3106117|NCT00241358|10640336|P3|Overall Study|Determined to be not ineligible|1
3106118|NCT00241358|10640337|P2|Overall Study|Determined to be not ineligible|1
3106119|NCT00241358|10640338|P1|Overall Study|Determined to be not ineligible|0
3106120|NCT00241280|10640371|P2|Overall Study|Excessive Dryness|1
3106121|NCT00241280|10640372|P1|Overall Study|Excessive Dryness|0
3106122|NCT00241280|10640371|P2|Overall Study|Coating on Lens|0
3106123|NCT00241280|10640372|P1|Overall Study|Coating on Lens|1
3106124|NCT00241280|10640371|P2|Overall Study|History of Ocular Surgery|1
3106125|NCT00241280|10640372|P1|Overall Study|History of Ocular Surgery|0
3106126|NCT00241280|10640371|P2|Overall Study|Scheduling Conflict|2
3106127|NCT00241280|10640372|P1|Overall Study|Scheduling Conflict|0
3106128|NCT00241280|10640371|P2|Overall Study|Unacceptable Fit|1
3106129|NCT00241280|10640372|P1|Overall Study|Unacceptable Fit|0
3106130|NCT00241280|10640371|P2|Overall Study|Dispensed incorrect test article|2
3106131|NCT00241280|10640372|P1|Overall Study|Dispensed incorrect test article|1
3106132|NCT00241280|10640371|P2|Overall Study|Subject Ineligible/Dispensed|6
3106133|NCT00241280|10640372|P1|Overall Study|Subject Ineligible/Dispensed|9
3106134|NCT00241280|10640371|P2|Overall Study|Diabetic|0
3106135|NCT00241280|10640372|P1|Overall Study|Diabetic|1
3106136|NCT00241280|10640371|P2|Overall Study|Unsatisfactory Visual Response|1
3106137|NCT00241280|10640372|P1|Overall Study|Unsatisfactory Visual Response|1
3106138|NCT00241280|10640371|P2|Overall Study|Unsatisfactory Physiological Response|1
3106139|NCT00241280|10640372|P1|Overall Study|Unsatisfactory Physiological Response|1
3106140|NCT00241280|10640371|P2|Overall Study|Relocation|4
3106141|NCT00241280|10640372|P1|Overall Study|Relocation|4
3106142|NCT00241280|10640371|P2|Overall Study|Protocol Violation|10
3106143|NCT00241280|10640372|P1|Overall Study|Protocol Violation|4
3106144|NCT00241280|10640371|P2|Overall Study|Withdrawal by Subject|4
3106145|NCT00241280|10640372|P1|Overall Study|Withdrawal by Subject|7
3106146|NCT00241280|10640371|P2|Overall Study|Lost to Follow-up|8
3106147|NCT00241280|10640372|P1|Overall Study|Lost to Follow-up|5
3106148|NCT00241280|10640371|P2|Overall Study|Pregnancy|5
3106149|NCT00241280|10640372|P1|Overall Study|Pregnancy|1
3106150|NCT00241280|10640371|P2|Overall Study|Discomfort|16
3106151|NCT00241280|10640372|P1|Overall Study|Discomfort|11
3106152|NCT00241280|10640371|P2|Overall Study|Adverse Event|6
3106153|NCT00241280|10640372|P1|Overall Study|Adverse Event|2
3106154|NCT00240994|10640387|P1|Overall Study|Graft failure|1
3106155|NCT00240994|10640387|P1|Overall Study|Protocol Violation|1
3106156|NCT00240994|10640387|P1|Overall Study|Lost to Follow-up|1
3106157|NCT00240331|10640522|P2|Overall Study|Option selected by investigator|2
3106158|NCT00240331|10640523|P1|Overall Study|Option selected by investigator|1
3106159|NCT00240331|10640522|P2|Overall Study|Withdrawal by Subject|132
3106160|NCT00240331|10640523|P1|Overall Study|Withdrawal by Subject|125
3106161|NCT00240110|10640566|P2|Overall Study|Lost to Follow-up|7
3106162|NCT00240110|10640567|P1|Overall Study|Lost to Follow-up|6
3106163|NCT00240097|10640575|P1|Part II|did not continue from Part I|23
3106164|NCT00240097|10640575|P1|Part I|unevaluable|1
3106165|NCT00240097|10640575|P1|Part I|histology|1
3106166|NCT00240097|10640575|P1|Part I|Death|1
3106167|NCT00240097|10640575|P1|Part I|Adverse Event|1
3106168|NCT00240071|10640585|P1|Overall Study|Withdrawal by Subject|3
3106169|NCT00239928|10640590|P1|Overall Study|Withdrawal by Subject|2
3106170|NCT00239928|10640590|P1|Overall Study|Not need to continue study|3
3106171|NCT00239928|10640590|P1|Overall Study|Adverse Event|4
3106172|NCT00239928|10640590|P1|Overall Study|Lack of Efficacy|1
3106173|NCT00239837|10640602|P2|Overall Study|Lost to Follow-up|7
3106174|NCT00239837|10640603|P1|Overall Study|Lost to Follow-up|3
3106175|NCT00239720|10640630|P2|Overall Study|Lost to Follow-up|1
3106176|NCT00239720|10640631|P1|Overall Study|Lost to Follow-up|0
3106177|NCT00239720|10640630|P2|Overall Study|Adverse Event|0
3106178|NCT00239720|10640631|P1|Overall Study|Adverse Event|1
3106179|NCT00239681|10640639|P2|Overall Study|No information chacked on CaseReportForm|84
3106180|NCT00239681|10640640|P1|Overall Study|No information chacked on CaseReportForm|90
3106181|NCT00239681|10640639|P2|Overall Study|Physician Decision|17
3106182|NCT00239681|10640640|P1|Overall Study|Physician Decision|13
3106183|NCT00239681|10640639|P2|Overall Study|Protocol Violation|4
3106184|NCT00239681|10640640|P1|Overall Study|Protocol Violation|4
3106185|NCT00239681|10640639|P2|Overall Study|Lost to Follow-up|22
3106186|NCT00239681|10640640|P1|Overall Study|Lost to Follow-up|28
3106187|NCT00239681|10640639|P2|Overall Study|Withdrawal by Subject|489
3106188|NCT00239681|10640640|P1|Overall Study|Withdrawal by Subject|458
3106189|NCT00239681|10640639|P2|Overall Study|Adverse Event|99
3106190|NCT00239681|10640640|P1|Overall Study|Adverse Event|100
3106191|NCT00239590|10640693|P2|Completed Study Protocol|Withdrawal by Subject|1
3106192|NCT00239590|10640694|P1|Completed Study Protocol|Withdrawal by Subject|0
3106193|NCT00239590|10640693|P2|Completed Study Protocol|Adverse Event|1
3106194|NCT00239590|10640694|P1|Completed Study Protocol|Adverse Event|1
3106195|NCT00239590|10640693|P2|Randomized|Withdrawal by Subject|1
3106196|NCT00239590|10640694|P1|Randomized|Withdrawal by Subject|0
3106197|NCT00239590|10640693|P2|Randomized|Lost to Follow-up|1
3106198|NCT00239590|10640694|P1|Randomized|Lost to Follow-up|0
3106199|NCT00239577|10640706|P4|Primary Phase|Other|0
3106200|NCT00239577|10640707|P3|Primary Phase|Other|2
3106201|NCT00239577|10640708|P2|Primary Phase|Other|3
3106202|NCT00239577|10640709|P1|Primary Phase|Other|5
3106203|NCT00239577|10640706|P4|Primary Phase|Adverse Event|0
3106204|NCT00239577|10640707|P3|Primary Phase|Adverse Event|1
3106205|NCT00239577|10640708|P2|Primary Phase|Adverse Event|0
3106206|NCT00239577|10640709|P1|Primary Phase|Adverse Event|0
3106207|NCT00239356|10640813|P2|Overall Study|Drug available on market|2
3106208|NCT00239356|10640814|P1|Overall Study|Drug available on market|11
3106209|NCT00239356|10640813|P2|Overall Study|Administrative reason|1
3106210|NCT00239356|10640814|P1|Overall Study|Administrative reason|0
3106211|NCT00239356|10640813|P2|Overall Study|Pregnancy|0
3106212|NCT00239356|10640814|P1|Overall Study|Pregnancy|1
3106213|NCT00239356|10640813|P2|Overall Study|poor/non-compliance|0
3106214|NCT00239356|10640814|P1|Overall Study|poor/non-compliance|2
3106215|NCT00239356|10640813|P2|Overall Study|Lost to Follow-up|0
3106216|NCT00239356|10640814|P1|Overall Study|Lost to Follow-up|3
3106217|NCT00239356|10640813|P2|Overall Study|Withdrawal by Subject|6
3106218|NCT00239356|10640814|P1|Overall Study|Withdrawal by Subject|15
3106219|NCT00239356|10640813|P2|Overall Study|Adverse Event|0
3106220|NCT00239356|10640814|P1|Overall Study|Adverse Event|6
3106221|NCT00239356|10640813|P2|Overall Study|Lack of Efficacy|0
3106222|NCT00239356|10640814|P1|Overall Study|Lack of Efficacy|1
3106223|NCT00239226|10640836|P4|Overall Study|Lost to Follow-up|0
3106224|NCT00239226|10640837|P3|Overall Study|Lost to Follow-up|1
3106225|NCT00239226|10640838|P2|Overall Study|Lost to Follow-up|0
3106226|NCT00239226|10640839|P1|Overall Study|Lost to Follow-up|1
3106227|NCT00239226|10640836|P4|Overall Study|permAF during stabilization period|3
3106228|NCT00239226|10640837|P3|Overall Study|permAF during stabilization period|0
3106229|NCT00239226|10640838|P2|Overall Study|permAF during stabilization period|0
3106230|NCT00239226|10640839|P1|Overall Study|permAF during stabilization period|0
3106231|NCT00239005|10640851|P2|Overall Study|Lost to Follow-up|1
3106232|NCT00239005|10640852|P1|Overall Study|Lost to Follow-up|0
3106233|NCT00239005|10640851|P2|Overall Study|Subj. cond. no longer needs study drug|1
3106234|NCT00239005|10640852|P1|Overall Study|Subj. cond. no longer needs study drug|0
3106235|NCT00239005|10640851|P2|Overall Study|Protocol Violation|0
3106236|NCT00239005|10640852|P1|Overall Study|Protocol Violation|1
3106237|NCT00239005|10640851|P2|Overall Study|Unsatisfactory Therapeutic effect|0
3106238|NCT00239005|10640852|P1|Overall Study|Unsatisfactory Therapeutic effect|2
3106239|NCT00239005|10640851|P2|Overall Study|Withdrawal by Subject|4
3106240|NCT00239005|10640852|P1|Overall Study|Withdrawal by Subject|3
3106241|NCT00239005|10640851|P2|Overall Study|Adverse Event|6
3106242|NCT00239005|10640852|P1|Overall Study|Adverse Event|6
3106243|NCT00238433|10640868|P1|Overall Study|Death|1
3106244|NCT00238433|10640868|P1|Overall Study|Lost to Follow-up|1
3106245|NCT00238433|10640868|P1|Overall Study|Screen failure|1
3106246|NCT00238420|10640875|P2|Overall Study|Protocol Violation|1
3106247|NCT00238420|10640876|P1|Overall Study|Protocol Violation|1
3106248|NCT00238303|10640893|P3|Overall Study|Adverse Event|3
3106249|NCT00238303|10640894|P2|Overall Study|Adverse Event|1
3106250|NCT00238303|10640895|P1|Overall Study|Adverse Event|0
3106251|NCT00238303|10640893|P3|Overall Study|Poor tolerance of study treatment|1
3106252|NCT00238303|10640894|P2|Overall Study|Poor tolerance of study treatment|0
3106253|NCT00238303|10640895|P1|Overall Study|Poor tolerance of study treatment|1
3106254|NCT00238303|10640893|P3|Overall Study|Other Medical Problems|2
3106255|NCT00238303|10640894|P2|Overall Study|Other Medical Problems|0
3106256|NCT00238303|10640895|P1|Overall Study|Other Medical Problems|2
3106257|NCT00238303|10640893|P3|Overall Study|Death|1
3106258|NCT00238303|10640894|P2|Overall Study|Death|0
3106259|NCT00238303|10640895|P1|Overall Study|Death|1
3106260|NCT00238303|10640893|P3|Overall Study|Withdrawal by Subject|2
3106261|NCT00238303|10640894|P2|Overall Study|Withdrawal by Subject|1
3106262|NCT00238303|10640895|P1|Overall Study|Withdrawal by Subject|11
3106263|NCT00238264|10640912|P1|Overall Study|Ineligible|7
3106264|NCT00238264|10640912|P1|Overall Study|Withdrawal by Subject|4
3106265|NCT00238264|10640912|P1|Overall Study|Lost to Follow-up|18
3106266|NCT00238264|10640912|P1|Overall Study|Death|7
3106267|NCT00238238|10640925|P3|Overall Study|Withdrawal by Subject|0
3106268|NCT00238238|10640926|P2|Overall Study|Withdrawal by Subject|3
3106269|NCT00238238|10640927|P1|Overall Study|Withdrawal by Subject|0
3106270|NCT00238121|10640940|P2|Overall Study|Adverse Event|1
3106271|NCT00238121|10640941|P1|Overall Study|Adverse Event|2
3106272|NCT00238121|10640940|P2|Overall Study|Withdrawal by Subject|1
3106273|NCT00238121|10640941|P1|Overall Study|Withdrawal by Subject|1
3106274|NCT00237809|10640967|P4|Overall Study|Lost to Follow-up|9
3106275|NCT00237809|10640968|P3|Overall Study|Lost to Follow-up|9
3106276|NCT00237809|10640969|P2|Overall Study|Lost to Follow-up|10
3106277|NCT00237809|10640970|P1|Overall Study|Lost to Follow-up|11
3106278|NCT00237796|10641006|P2|Overall Study|Baseline and one other ILSS required|5
3106279|NCT00237796|10641007|P1|Overall Study|Baseline and one other ILSS required|10
3106280|NCT00237744|10641041|P3|Overall Study|Withdrawal by Subject|0
3106281|NCT00237744|10641042|P2|Overall Study|Withdrawal by Subject|1
3106282|NCT00237744|10641043|P1|Overall Study|Withdrawal by Subject|3
3106283|NCT00237692|10641069|P4|Overall Study|Withdrawal by Subject|4
3106284|NCT00237692|10641070|P3|Overall Study|Withdrawal by Subject|10
3106285|NCT00237692|10641071|P2|Overall Study|Withdrawal by Subject|6
3106286|NCT00237692|10641072|P1|Overall Study|Withdrawal by Subject|4
3106287|NCT00237692|10641069|P4|Overall Study|Excluded - did not meet criteria|9
3106288|NCT00237692|10641070|P3|Overall Study|Excluded - did not meet criteria|5
3106289|NCT00237692|10641071|P2|Overall Study|Excluded - did not meet criteria|3
3106290|NCT00237692|10641072|P1|Overall Study|Excluded - did not meet criteria|4
3106291|NCT00237692|10641069|P4|Overall Study|Death|3
3106292|NCT00237692|10641070|P3|Overall Study|Death|2
3106293|NCT00237692|10641071|P2|Overall Study|Death|2
3106294|NCT00237692|10641072|P1|Overall Study|Death|1
3106295|NCT00237692|10641069|P4|Overall Study|Lost to Follow-up|3
3106296|NCT00237692|10641070|P3|Overall Study|Lost to Follow-up|5
3106297|NCT00237692|10641071|P2|Overall Study|Lost to Follow-up|3
3106298|NCT00237692|10641072|P1|Overall Study|Lost to Follow-up|9
3106299|NCT00237458|10641112|P1|Overall Study|Withdrawal by Subject|1
3106300|NCT00237458|10641112|P1|Overall Study|Adverse Event|1
3106301|NCT00237458|10641112|P1|Overall Study|Lack of Efficacy|1
3106302|NCT00237185|10641130|P2|Extension|Death|1
3106303|NCT00237185|10641131|P1|Extension|Death|1
3106304|NCT00237185|10641130|P2|Extension|Administrative problems|0
3106305|NCT00237185|10641131|P1|Extension|Administrative problems|1
3106306|NCT00237185|10641130|P2|Extension|Lost to Follow-up|0
3106307|NCT00237185|10641131|P1|Extension|Lost to Follow-up|1
3106308|NCT00237185|10641130|P2|Extension|Withdrawal by Subject|2
3106309|NCT00237185|10641131|P1|Extension|Withdrawal by Subject|3
3106310|NCT00237185|10641130|P2|Extension|Condition no longer required study drug|1
3106311|NCT00237185|10641131|P1|Extension|Condition no longer required study drug|0
3106312|NCT00237185|10641130|P2|Extension|Lack of Efficacy|14
3106313|NCT00237185|10641131|P1|Extension|Lack of Efficacy|9
3106314|NCT00237185|10641130|P2|Extension|Abnormal laboratory value|1
3106315|NCT00237185|10641131|P1|Extension|Abnormal laboratory value|0
3106316|NCT00237185|10641130|P2|Extension|Adverse Event|0
3106317|NCT00237185|10641131|P1|Extension|Adverse Event|1
3106318|NCT00237185|10641130|P2|Core|Determined ineligible post randomization|0
3106319|NCT00237185|10641131|P1|Core|Determined ineligible post randomization|1
3106320|NCT00237185|10641130|P2|Core|Death|0
3106321|NCT00237185|10641131|P1|Core|Death|4
3106322|NCT00237185|10641130|P2|Core|Administrative problems|1
3106323|NCT00237185|10641131|P1|Core|Administrative problems|0
3106324|NCT00237185|10641130|P2|Core|Withdrawal by Subject|4
3106325|NCT00237185|10641131|P1|Core|Withdrawal by Subject|4
3106326|NCT00237185|10641130|P2|Core|Protocol Violation|1
3106327|NCT00237185|10641131|P1|Core|Protocol Violation|1
3106328|NCT00237185|10641130|P2|Core|Lack of Efficacy|23
3106329|NCT00237185|10641131|P1|Core|Lack of Efficacy|30
3106330|NCT00237185|10641130|P2|Core|Abnormal test procedure results|0
3106331|NCT00237185|10641131|P1|Core|Abnormal test procedure results|1
3106332|NCT00237185|10641130|P2|Core|Abnormal laboratory value|4
3106333|NCT00237185|10641131|P1|Core|Abnormal laboratory value|0
3106334|NCT00237185|10641130|P2|Core|Adverse Event|4
3106335|NCT00237185|10641131|P1|Core|Adverse Event|3
3106336|NCT00237042|10641162|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
3106337|NCT00237042|10641163|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
3106338|NCT00237042|10641164|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
3106339|NCT00237042|10641162|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
3106340|NCT00237042|10641163|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
3106341|NCT00237042|10641164|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
3106342|NCT00237042|10641162|P3|Treatment|Completed no treatment|21
3106343|NCT00237042|10641163|P2|Treatment|Completed no treatment|5
3106344|NCT00237042|10641164|P1|Treatment|Completed no treatment|5
3106345|NCT00237042|10641162|P3|Treatment|Moved out of state|1
3106346|NCT00237042|10641163|P2|Treatment|Moved out of state|1
3106347|NCT00237042|10641164|P1|Treatment|Moved out of state|1
3106348|NCT00237042|10641162|P3|Treatment|Became ineligible post-randomization|16
3106349|NCT00237042|10641163|P2|Treatment|Became ineligible post-randomization|1
3106350|NCT00237042|10641164|P1|Treatment|Became ineligible post-randomization|0
3106351|NCT00236899|10641238|P4|Overall Study|Lack of Efficacy|23
3106352|NCT00236899|10641239|P3|Overall Study|Lack of Efficacy|25
3106353|NCT00236899|10641240|P2|Overall Study|Lack of Efficacy|18
3106354|NCT00236899|10641241|P1|Overall Study|Lack of Efficacy|18
3106355|NCT00236899|10641238|P4|Overall Study|Satisfactory Response|1
3106356|NCT00236899|10641239|P3|Overall Study|Satisfactory Response|0
3106357|NCT00236899|10641240|P2|Overall Study|Satisfactory Response|0
3106358|NCT00236899|10641241|P1|Overall Study|Satisfactory Response|2
3106359|NCT00236899|10641238|P4|Overall Study|Physician Decision|6
3106360|NCT00236899|10641239|P3|Overall Study|Physician Decision|7
3106361|NCT00236899|10641240|P2|Overall Study|Physician Decision|8
3106362|NCT00236899|10641241|P1|Overall Study|Physician Decision|7
3106363|NCT00236899|10641238|P4|Overall Study|Withdrawal by Subject|2
3106364|NCT00236899|10641239|P3|Overall Study|Withdrawal by Subject|5
3106365|NCT00236899|10641240|P2|Overall Study|Withdrawal by Subject|4
3106366|NCT00236899|10641241|P1|Overall Study|Withdrawal by Subject|6
3106367|NCT00236899|10641238|P4|Overall Study|Protocol Violation|0
3106368|NCT00236899|10641239|P3|Overall Study|Protocol Violation|0
3106369|NCT00236899|10641240|P2|Overall Study|Protocol Violation|0
3106370|NCT00236899|10641241|P1|Overall Study|Protocol Violation|1
3106371|NCT00236899|10641238|P4|Overall Study|Entry Criteria Exclusion|0
3106372|NCT00236899|10641239|P3|Overall Study|Entry Criteria Exclusion|1
3106373|NCT00236899|10641240|P2|Overall Study|Entry Criteria Exclusion|1
3106374|NCT00236899|10641241|P1|Overall Study|Entry Criteria Exclusion|0
3106375|NCT00236899|10641238|P4|Overall Study|Lost to Follow-up|0
3106376|NCT00236899|10641239|P3|Overall Study|Lost to Follow-up|0
3106377|NCT00236899|10641240|P2|Overall Study|Lost to Follow-up|1
3106378|NCT00236899|10641241|P1|Overall Study|Lost to Follow-up|0
3106379|NCT00236899|10641238|P4|Overall Study|Death (Study Drug Toxicity)|0
3106380|NCT00236899|10641239|P3|Overall Study|Death (Study Drug Toxicity)|0
3106381|NCT00236899|10641240|P2|Overall Study|Death (Study Drug Toxicity)|0
3106382|NCT00236899|10641241|P1|Overall Study|Death (Study Drug Toxicity)|1
3106383|NCT00236899|10641238|P4|Overall Study|Death (Not Study Related)|0
3106384|NCT00236899|10641239|P3|Overall Study|Death (Not Study Related)|0
3106385|NCT00236899|10641240|P2|Overall Study|Death (Not Study Related)|0
3106386|NCT00236899|10641241|P1|Overall Study|Death (Not Study Related)|2
3106387|NCT00236899|10641238|P4|Overall Study|Death (Study Disease)|0
3106388|NCT00236899|10641239|P3|Overall Study|Death (Study Disease)|0
3106389|NCT00236899|10641240|P2|Overall Study|Death (Study Disease)|4
3106390|NCT00236899|10641241|P1|Overall Study|Death (Study Disease)|1
3106391|NCT00236899|10641238|P4|Overall Study|Adverse Event (Not Study Related)|7
3106392|NCT00236899|10641239|P3|Overall Study|Adverse Event (Not Study Related)|4
3106393|NCT00236899|10641240|P2|Overall Study|Adverse Event (Not Study Related)|3
3106394|NCT00236899|10641241|P1|Overall Study|Adverse Event (Not Study Related)|3
3106395|NCT00236899|10641238|P4|Overall Study|Adverse Event (Study Related)|1
3106396|NCT00236899|10641239|P3|Overall Study|Adverse Event (Study Related)|2
3106397|NCT00236899|10641240|P2|Overall Study|Adverse Event (Study Related)|1
3106398|NCT00236899|10641241|P1|Overall Study|Adverse Event (Study Related)|1
3106399|NCT00236197|10641273|P2|Overall Study|Other|2
3106400|NCT00236197|10641274|P1|Overall Study|Other|0
3106401|NCT00236197|10641273|P2|Overall Study|Medication non-compliance|2
3106402|NCT00236197|10641274|P1|Overall Study|Medication non-compliance|1
3106403|NCT00236197|10641273|P2|Overall Study|Protocol Violation|3
3106404|NCT00236197|10641274|P1|Overall Study|Protocol Violation|0
3106405|NCT00236197|10641273|P2|Overall Study|Lost to Follow-up|5
3106406|NCT00236197|10641274|P1|Overall Study|Lost to Follow-up|1
3106407|NCT00236197|10641273|P2|Overall Study|Withdrawal by Subject|2
3106408|NCT00236197|10641274|P1|Overall Study|Withdrawal by Subject|3
3106409|NCT00236184|10641282|P2|Overall Study|other|2
3106410|NCT00236184|10641283|P1|Overall Study|other|1
3106411|NCT00236184|10641282|P2|Overall Study|non-compliance with study drug|1
3106412|NCT00236184|10641283|P1|Overall Study|non-compliance with study drug|2
3106413|NCT00236184|10641282|P2|Overall Study|Protocol Violation|0
3106414|NCT00236184|10641283|P1|Overall Study|Protocol Violation|3
3106415|NCT00236184|10641282|P2|Overall Study|Withdrawal by Subject|0
3106416|NCT00236184|10641283|P1|Overall Study|Withdrawal by Subject|3
3106417|NCT00236184|10641282|P2|Overall Study|Physician Decision|1
3106418|NCT00236184|10641283|P1|Overall Study|Physician Decision|1
3106419|NCT00236184|10641282|P2|Overall Study|Lost to Follow-up|4
3106420|NCT00236184|10641283|P1|Overall Study|Lost to Follow-up|3
3106421|NCT00236184|10641282|P2|Overall Study|Lack of Efficacy|1
3106422|NCT00236184|10641283|P1|Overall Study|Lack of Efficacy|0
3106423|NCT00236184|10641282|P2|Overall Study|Adverse Event|2
3106424|NCT00236184|10641283|P1|Overall Study|Adverse Event|5
3106425|NCT00236080|10641294|P5|Overall Study|Miscellaneous|0
3106426|NCT00236080|10641295|P4|Overall Study|Miscellaneous|0
3106427|NCT00236080|10641296|P3|Overall Study|Miscellaneous|1
3106428|NCT00236080|10641297|P2|Overall Study|Miscellaneous|0
3106429|NCT00236080|10641298|P1|Overall Study|Miscellaneous|0
3106430|NCT00236080|10641294|P5|Overall Study|Withdrawal by Subject|0
3106431|NCT00236080|10641295|P4|Overall Study|Withdrawal by Subject|0
3106432|NCT00236080|10641296|P3|Overall Study|Withdrawal by Subject|0
3106433|NCT00236080|10641297|P2|Overall Study|Withdrawal by Subject|0
3106434|NCT00236080|10641298|P1|Overall Study|Withdrawal by Subject|1
3106435|NCT00236080|10641294|P5|Overall Study|Physician Decision|1
3106436|NCT00236080|10641295|P4|Overall Study|Physician Decision|1
3106437|NCT00236080|10641296|P3|Overall Study|Physician Decision|1
3106438|NCT00236080|10641297|P2|Overall Study|Physician Decision|0
3106439|NCT00236080|10641298|P1|Overall Study|Physician Decision|1
3106440|NCT00236080|10641294|P5|Overall Study|Lost to Follow-up|0
3106441|NCT00236080|10641295|P4|Overall Study|Lost to Follow-up|0
3106442|NCT00236080|10641296|P3|Overall Study|Lost to Follow-up|0
3106443|NCT00236080|10641297|P2|Overall Study|Lost to Follow-up|1
3106444|NCT00236080|10641298|P1|Overall Study|Lost to Follow-up|0
3106445|NCT00236080|10641294|P5|Overall Study|Adverse Event|0
3106446|NCT00236080|10641295|P4|Overall Study|Adverse Event|1
3106447|NCT00236080|10641296|P3|Overall Study|Adverse Event|3
3106448|NCT00236080|10641297|P2|Overall Study|Adverse Event|0
3106449|NCT00236080|10641298|P1|Overall Study|Adverse Event|0
3106450|NCT00235989|10641319|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
3106451|NCT00235989|10641320|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
3106452|NCT00235989|10641321|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
3106453|NCT00235989|10641322|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
3106454|NCT00235989|10641323|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
3106455|NCT00235989|10641324|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
3106456|NCT00235989|10641319|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
3106457|NCT00235989|10641320|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
3106458|NCT00235989|10641321|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
3106459|NCT00235989|10641322|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
3106460|NCT00235989|10641323|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
3106461|NCT00235989|10641324|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
3106462|NCT00235989|10641319|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
3106463|NCT00235989|10641320|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
3106464|NCT00235989|10641321|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
3106465|NCT00235989|10641322|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
3106466|NCT00235989|10641323|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
3106467|NCT00235989|10641324|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
3106468|NCT00235989|10641319|P6|Extension Treatment Period (ET)|Adverse Event|0
3106469|NCT00235989|10641320|P5|Extension Treatment Period (ET)|Adverse Event|0
3106470|NCT00235989|10641321|P4|Extension Treatment Period (ET)|Adverse Event|0
3106471|NCT00235989|10641322|P3|Extension Treatment Period (ET)|Adverse Event|2
3106472|NCT00235989|10641323|P2|Extension Treatment Period (ET)|Adverse Event|0
3106473|NCT00235989|10641324|P1|Extension Treatment Period (ET)|Adverse Event|3
3106474|NCT00235989|10641319|P6|Core Treatment Period (CT)|Lost to Follow-up|2
3106475|NCT00235989|10641320|P5|Core Treatment Period (CT)|Lost to Follow-up|0
3106476|NCT00235989|10641321|P4|Core Treatment Period (CT)|Lost to Follow-up|0
3106477|NCT00235989|10641322|P3|Core Treatment Period (CT)|Lost to Follow-up|0
3106478|NCT00235989|10641323|P2|Core Treatment Period (CT)|Lost to Follow-up|0
3106479|NCT00235989|10641324|P1|Core Treatment Period (CT)|Lost to Follow-up|0
3106480|NCT00235872|10641338|P1|Overall Study|Administrative reason|61
3106481|NCT00235872|10641338|P1|Overall Study|Withdrawal by Subject|50
3106482|NCT00235872|10641338|P1|Overall Study|Lost to Follow-up|1
3106483|NCT00235872|10641338|P1|Overall Study|Death|1
3106484|NCT00235872|10641338|P1|Overall Study|Adverse Event|34
3106485|NCT00235755|10641369|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
3106486|NCT00235755|10641370|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
3106487|NCT00235755|10641371|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
3106488|NCT00235755|10641369|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
3106489|NCT00235755|10641370|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
3106490|NCT00235755|10641371|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
3106491|NCT00235755|10641369|P3|12-Week Maintenance Phase|Protocol Violation|2
3106492|NCT00235755|10641370|P2|12-Week Maintenance Phase|Protocol Violation|4
3106493|NCT00235755|10641371|P1|12-Week Maintenance Phase|Protocol Violation|0
3106494|NCT00235755|10641369|P3|12-Week Maintenance Phase|Lack of Efficacy|0
3106495|NCT00235755|10641370|P2|12-Week Maintenance Phase|Lack of Efficacy|0
3106496|NCT00235755|10641371|P1|12-Week Maintenance Phase|Lack of Efficacy|5
3106497|NCT00235755|10641369|P3|12-Week Maintenance Phase|Lost to Follow-up|0
3106498|NCT00235755|10641370|P2|12-Week Maintenance Phase|Lost to Follow-up|3
3106499|NCT00235755|10641371|P1|12-Week Maintenance Phase|Lost to Follow-up|2
3106500|NCT00235755|10641369|P3|12-Week Maintenance Phase|Adverse Event|26
3106501|NCT00235755|10641370|P2|12-Week Maintenance Phase|Adverse Event|12
3106502|NCT00235755|10641371|P1|12-Week Maintenance Phase|Adverse Event|8
3106503|NCT00235755|10641369|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
3106504|NCT00235755|10641370|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
3106505|NCT00235755|10641371|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
3106506|NCT00235755|10641369|P3|4-Week Titration Phase|Randomization Occurred in Error|0
3106507|NCT00235755|10641370|P2|4-Week Titration Phase|Randomization Occurred in Error|0
3106508|NCT00235755|10641371|P1|4-Week Titration Phase|Randomization Occurred in Error|1
3106509|NCT00235755|10641369|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
3106510|NCT00235755|10641370|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
3106511|NCT00235755|10641371|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
3106512|NCT00235755|10641369|P3|4-Week Titration Phase|Withdrawal by Subject|3
3106513|NCT00235755|10641370|P2|4-Week Titration Phase|Withdrawal by Subject|2
3106514|NCT00235755|10641371|P1|4-Week Titration Phase|Withdrawal by Subject|1
3106515|NCT00235755|10641369|P3|4-Week Titration Phase|Protocol Violation|1
3106516|NCT00235755|10641370|P2|4-Week Titration Phase|Protocol Violation|2
3106517|NCT00235755|10641371|P1|4-Week Titration Phase|Protocol Violation|2
3106518|NCT00235755|10641369|P3|4-Week Titration Phase|Lost to Follow-up|1
3106519|NCT00235755|10641370|P2|4-Week Titration Phase|Lost to Follow-up|1
3106520|NCT00235755|10641371|P1|4-Week Titration Phase|Lost to Follow-up|0
3106521|NCT00235755|10641369|P3|4-Week Titration Phase|Adverse Event|20
3106522|NCT00235755|10641370|P2|4-Week Titration Phase|Adverse Event|14
3106523|NCT00235755|10641371|P1|4-Week Titration Phase|Adverse Event|6
3106524|NCT00235716|10641449|P4|Overall Study|Physician Decision|3
3106525|NCT00235716|10641450|P3|Overall Study|Physician Decision|1
3106526|NCT00235716|10641451|P2|Overall Study|Physician Decision|1
3106527|NCT00235716|10641452|P1|Overall Study|Physician Decision|0
3106528|NCT00235716|10641449|P4|Overall Study|Adverse Event|0
3106529|NCT00235716|10641450|P3|Overall Study|Adverse Event|1
3106530|NCT00235716|10641451|P2|Overall Study|Adverse Event|1
3106531|NCT00235716|10641452|P1|Overall Study|Adverse Event|1
3106532|NCT00235716|10641449|P4|Overall Study|Lost to Follow-up|10
3106533|NCT00235716|10641450|P3|Overall Study|Lost to Follow-up|14
3106534|NCT00235716|10641451|P2|Overall Study|Lost to Follow-up|7
3106535|NCT00235716|10641452|P1|Overall Study|Lost to Follow-up|12
3106536|NCT00235716|10641449|P4|Overall Study|Withdrawal by Subject|18
3106537|NCT00235716|10641450|P3|Overall Study|Withdrawal by Subject|17
3106538|NCT00235716|10641451|P2|Overall Study|Withdrawal by Subject|19
3106539|NCT00235716|10641452|P1|Overall Study|Withdrawal by Subject|23
3106540|NCT00235716|10641449|P4|Overall Study|Death|31
3106541|NCT00235716|10641450|P3|Overall Study|Death|32
3106542|NCT00235716|10641451|P2|Overall Study|Death|39
3106543|NCT00235716|10641452|P1|Overall Study|Death|26
3106544|NCT00235495|10641503|P2|Overall Study|Visit/assessmen outside window/missing|10
3106545|NCT00235495|10641504|P1|Overall Study|Visit/assessmen outside window/missing|0
3106546|NCT00235495|10641503|P2|Overall Study|Lost to Follow-up|13
3106547|NCT00235495|10641504|P1|Overall Study|Lost to Follow-up|11
3106548|NCT00235495|10641503|P2|Overall Study|Withdrawal by Subject|3
3106549|NCT00235495|10641504|P1|Overall Study|Withdrawal by Subject|5
3106550|NCT00235495|10641503|P2|Overall Study|Death|42
3106551|NCT00235495|10641504|P1|Overall Study|Death|52
3106552|NCT00235443|10641577|P6|Overall Study|Other reasons for premature termination|6
3106553|NCT00235443|10641578|P5|Overall Study|Other reasons for premature termination|3
3106554|NCT00235443|10641579|P4|Overall Study|Other reasons for premature termination|7
3106555|NCT00235443|10641580|P3|Overall Study|Other reasons for premature termination|6
3106556|NCT00235443|10641581|P2|Overall Study|Other reasons for premature termination|6
3106557|NCT00235443|10641582|P1|Overall Study|Other reasons for premature termination|1
3106558|NCT00235443|10641577|P6|Overall Study|Unsatisfactory compliance|0
3106559|NCT00235443|10641578|P5|Overall Study|Unsatisfactory compliance|1
3106560|NCT00235443|10641579|P4|Overall Study|Unsatisfactory compliance|4
3106561|NCT00235443|10641580|P3|Overall Study|Unsatisfactory compliance|3
3106562|NCT00235443|10641581|P2|Overall Study|Unsatisfactory compliance|2
3106563|NCT00235443|10641582|P1|Overall Study|Unsatisfactory compliance|0
3106564|NCT00235443|10641577|P6|Overall Study|Lost to Follow-up|3
3106565|NCT00235443|10641578|P5|Overall Study|Lost to Follow-up|4
3106566|NCT00235443|10641579|P4|Overall Study|Lost to Follow-up|6
3106567|NCT00235443|10641580|P3|Overall Study|Lost to Follow-up|6
3106568|NCT00235443|10641581|P2|Overall Study|Lost to Follow-up|8
3106569|NCT00235443|10641582|P1|Overall Study|Lost to Follow-up|0
3106570|NCT00235443|10641577|P6|Overall Study|Withdrawal by Subject|12
3106571|NCT00235443|10641578|P5|Overall Study|Withdrawal by Subject|10
3106572|NCT00235443|10641579|P4|Overall Study|Withdrawal by Subject|24
3106573|NCT00235443|10641580|P3|Overall Study|Withdrawal by Subject|25
3106574|NCT00235443|10641581|P2|Overall Study|Withdrawal by Subject|9
3106575|NCT00235443|10641582|P1|Overall Study|Withdrawal by Subject|3
3106576|NCT00235443|10641577|P6|Overall Study|Lack of Efficacy|9
3106577|NCT00235443|10641578|P5|Overall Study|Lack of Efficacy|2
3106578|NCT00235443|10641579|P4|Overall Study|Lack of Efficacy|12
3106579|NCT00235443|10641580|P3|Overall Study|Lack of Efficacy|5
3106580|NCT00235443|10641581|P2|Overall Study|Lack of Efficacy|1
3106581|NCT00235443|10641582|P1|Overall Study|Lack of Efficacy|0
3106582|NCT00235443|10641577|P6|Overall Study|Adverse Event|15
3106583|NCT00235443|10641578|P5|Overall Study|Adverse Event|10
3106584|NCT00235443|10641579|P4|Overall Study|Adverse Event|44
3106585|NCT00235443|10641580|P3|Overall Study|Adverse Event|17
3106586|NCT00235443|10641581|P2|Overall Study|Adverse Event|12
3106587|NCT00235443|10641582|P1|Overall Study|Adverse Event|4
3106588|NCT00235391|10641723|P6|Overall Study|Death|0
3106589|NCT00235391|10641724|P5|Overall Study|Death|0
3106590|NCT00235391|10641725|P4|Overall Study|Death|4
3106591|NCT00235391|10641726|P3|Overall Study|Death|1
3106592|NCT00235391|10641727|P2|Overall Study|Death|0
3106593|NCT00235391|10641728|P1|Overall Study|Death|0
3106594|NCT00235391|10641723|P6|Overall Study|Administrative problems|0
3106595|NCT00235391|10641724|P5|Overall Study|Administrative problems|0
3106596|NCT00235391|10641725|P4|Overall Study|Administrative problems|1
3106597|NCT00235391|10641726|P3|Overall Study|Administrative problems|0
3106598|NCT00235391|10641727|P2|Overall Study|Administrative problems|0
3106599|NCT00235391|10641728|P1|Overall Study|Administrative problems|0
3106600|NCT00235391|10641723|P6|Overall Study|Lost to Follow-up|0
3106601|NCT00235391|10641724|P5|Overall Study|Lost to Follow-up|0
3106602|NCT00235391|10641725|P4|Overall Study|Lost to Follow-up|16
3106603|NCT00235391|10641726|P3|Overall Study|Lost to Follow-up|3
3106604|NCT00235391|10641727|P2|Overall Study|Lost to Follow-up|3
3106605|NCT00235391|10641728|P1|Overall Study|Lost to Follow-up|0
3106606|NCT00235391|10641723|P6|Overall Study|Withdrawal by Subject|0
3106607|NCT00235391|10641724|P5|Overall Study|Withdrawal by Subject|5
3106608|NCT00235391|10641725|P4|Overall Study|Withdrawal by Subject|61
3106609|NCT00235391|10641726|P3|Overall Study|Withdrawal by Subject|3
3106610|NCT00235391|10641727|P2|Overall Study|Withdrawal by Subject|3
3106611|NCT00235391|10641728|P1|Overall Study|Withdrawal by Subject|2
3106612|NCT00235391|10641723|P6|Overall Study|Protocol deviation|0
3106613|NCT00235391|10641724|P5|Overall Study|Protocol deviation|0
3106614|NCT00235391|10641725|P4|Overall Study|Protocol deviation|11
3106615|NCT00235391|10641726|P3|Overall Study|Protocol deviation|1
3106616|NCT00235391|10641727|P2|Overall Study|Protocol deviation|0
3106617|NCT00235391|10641728|P1|Overall Study|Protocol deviation|0
3106618|NCT00235391|10641723|P6|Overall Study|Condition no longer requires treatment|0
3106619|NCT00235391|10641724|P5|Overall Study|Condition no longer requires treatment|1
3106620|NCT00235391|10641725|P4|Overall Study|Condition no longer requires treatment|11
3106621|NCT00235391|10641726|P3|Overall Study|Condition no longer requires treatment|0
3106622|NCT00235391|10641727|P2|Overall Study|Condition no longer requires treatment|0
3106623|NCT00235391|10641728|P1|Overall Study|Condition no longer requires treatment|3
3106624|NCT00235391|10641723|P6|Overall Study|Unsatisfactory therapeutic effect|0
3106625|NCT00235391|10641724|P5|Overall Study|Unsatisfactory therapeutic effect|0
3106626|NCT00235391|10641725|P4|Overall Study|Unsatisfactory therapeutic effect|17
3106627|NCT00235391|10641726|P3|Overall Study|Unsatisfactory therapeutic effect|2
3106628|NCT00235391|10641727|P2|Overall Study|Unsatisfactory therapeutic effect|2
3106629|NCT00235391|10641728|P1|Overall Study|Unsatisfactory therapeutic effect|0
3106630|NCT00235391|10641723|P6|Overall Study|Abnormal laboratory value(s)|2
3106631|NCT00235391|10641724|P5|Overall Study|Abnormal laboratory value(s)|1
3106632|NCT00235391|10641725|P4|Overall Study|Abnormal laboratory value(s)|27
3106633|NCT00235391|10641726|P3|Overall Study|Abnormal laboratory value(s)|4
3106634|NCT00235391|10641727|P2|Overall Study|Abnormal laboratory value(s)|5
3106635|NCT00235391|10641728|P1|Overall Study|Abnormal laboratory value(s)|3
3106636|NCT00235391|10641723|P6|Overall Study|Adverse Event|2
3106637|NCT00235391|10641724|P5|Overall Study|Adverse Event|5
3106638|NCT00235391|10641725|P4|Overall Study|Adverse Event|72
3106639|NCT00235391|10641726|P3|Overall Study|Adverse Event|10
3106640|NCT00235391|10641727|P2|Overall Study|Adverse Event|5
3106641|NCT00235391|10641728|P1|Overall Study|Adverse Event|4
3106642|NCT00235326|10641745|P2|Overall Study|Lost to Follow-up|1400
3106643|NCT00235326|10641746|P1|Overall Study|Lost to Follow-up|746
3106644|NCT00234533|10641786|P1|Overall Study|Enrolled but not treated|3
3106645|NCT00234533|10641786|P1|Overall Study|Adverse Event|2
3106646|NCT00234533|10641786|P1|Overall Study|Withdrawal by Subject|6
3106647|NCT00234494|10641805|P1|Overall Study|Protocol Violation|2
3106648|NCT00234104|10641851|P4|Overall Study|Physician Decision|2
3106649|NCT00234104|10641852|P3|Overall Study|Physician Decision|2
3106650|NCT00234104|10641853|P2|Overall Study|Physician Decision|1
3106651|NCT00234104|10641854|P1|Overall Study|Physician Decision|0
3106652|NCT00234104|10641851|P4|Overall Study|Protocol Violation|1
3106653|NCT00234104|10641852|P3|Overall Study|Protocol Violation|0
3106654|NCT00234104|10641853|P2|Overall Study|Protocol Violation|0
3106655|NCT00234104|10641854|P1|Overall Study|Protocol Violation|0
3106656|NCT00234104|10641851|P4|Overall Study|Adverse Event|5
3106657|NCT00234104|10641852|P3|Overall Study|Adverse Event|3
3106658|NCT00234104|10641853|P2|Overall Study|Adverse Event|0
3106659|NCT00234104|10641854|P1|Overall Study|Adverse Event|4
3106660|NCT00234065|10641895|P2|Overall Study|Not Classified|112
3106661|NCT00234065|10641896|P1|Overall Study|Not Classified|111
3106662|NCT00234065|10641895|P2|Overall Study|Physician Decision|22
3106663|NCT00234065|10641896|P1|Overall Study|Physician Decision|23
3106664|NCT00234065|10641895|P2|Overall Study|Withdrawal by Subject|56
3106665|NCT00234065|10641896|P1|Overall Study|Withdrawal by Subject|73
3106666|NCT00234065|10641895|P2|Overall Study|Adverse Event|166
3106667|NCT00234065|10641896|P1|Overall Study|Adverse Event|268
3106668|NCT00234052|10641912|P1|Follow-up for 5 Years|Other|7
3106669|NCT00234052|10641912|P1|Follow-up for 5 Years|Lost to Follow-up|1
3106670|NCT00234052|10641912|P1|Follow-up for 5 Years|Death|41
3106671|NCT00234052|10641912|P1|Treatment|Progressive Disease|11
3106672|NCT00234052|10641912|P1|Treatment|Death|2
3106673|NCT00234052|10641912|P1|Treatment|Adverse Event|5
3106674|NCT00234052|10641912|P1|Treatment|Withdrawal by Subject|3
3106675|NCT00234039|10641922|P1|Overall Study|No Protocol Treatment Received|2
3106676|NCT00234039|10641922|P1|Overall Study|Ineligible|9
3106677|NCT00234039|10641922|P1|Overall Study|Other - Not Protocol Specified|3
3106678|NCT00234039|10641922|P1|Overall Study|Progression/relapse|34
3106679|NCT00234039|10641922|P1|Overall Study|Adverse Event|2
3106680|NCT00233987|10641929|P1|Overall Study|Ineligible|4
3106681|NCT00233987|10641929|P1|Overall Study|Eligible but No Treatment Received|2
3106682|NCT00233987|10641929|P1|Overall Study|Other - Not Protocol Specified|5
3106683|NCT00233987|10641929|P1|Overall Study|Reason Under Review|1
3106684|NCT00233987|10641929|P1|Overall Study|Lack of Efficacy|2
3106685|NCT00233987|10641929|P1|Overall Study|Withdrawal by Subject|1
3106686|NCT00233948|10641938|P6|Overall Study|Adverse Event|0
3106687|NCT00233948|10641939|P5|Overall Study|Adverse Event|0
3106688|NCT00233948|10641940|P4|Overall Study|Adverse Event|0
3106689|NCT00233948|10641941|P3|Overall Study|Adverse Event|0
3106690|NCT00233948|10641942|P2|Overall Study|Adverse Event|0
3106691|NCT00233948|10641943|P1|Overall Study|Adverse Event|1
3106692|NCT00233480|10641969|P2|Overall Study|Underwent status II heart transplant|1
3106693|NCT00233480|10641970|P1|Overall Study|Underwent status II heart transplant|0
3106694|NCT00233454|10641986|P1|Overall Study|Death|6
3106695|NCT00233402|10641994|P2|Overall Study|Lost to follow up etc|21
3106696|NCT00233402|10641995|P1|Overall Study|Lost to follow up etc|3
3106697|NCT00233402|10641994|P2|Overall Study|No Ta/T1|94
3106698|NCT00233402|10641995|P1|Overall Study|No Ta/T1|89
3106699|NCT00233402|10641994|P2|Overall Study|No pathology data|9
3106700|NCT00233402|10641995|P1|Overall Study|No pathology data|12
3106701|NCT00233324|10642010|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
3106702|NCT00233324|10642011|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
3106703|NCT00233324|10642012|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
3106704|NCT00233324|10642013|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
3106705|NCT00233324|10642010|P4|Follow up at 18-22 Months Corrected Age|Death|4
3106706|NCT00233324|10642011|P3|Follow up at 18-22 Months Corrected Age|Death|5
3106707|NCT00233324|10642012|P2|Follow up at 18-22 Months Corrected Age|Death|7
3106708|NCT00233324|10642013|P1|Follow up at 18-22 Months Corrected Age|Death|5
3106709|NCT00233324|10642010|P4|Main Study|Death|47
3106710|NCT00233324|10642011|P3|Main Study|Death|62
3106711|NCT00233324|10642012|P2|Main Study|Death|60
3106712|NCT00233324|10642013|P1|Main Study|Death|68
3106713|NCT00233064|10642135|P2|Overall Study|Moved to Dom. Republic|0
3106714|NCT00233064|10642136|P1|Overall Study|Moved to Dom. Republic|1
3106715|NCT00233064|10642135|P2|Overall Study|Protocol Violation|0
3106716|NCT00233064|10642136|P1|Overall Study|Protocol Violation|1
3106717|NCT00233064|10642135|P2|Overall Study|Relocation|1
3106718|NCT00233064|10642136|P1|Overall Study|Relocation|0
3106719|NCT00233064|10642135|P2|Overall Study|Death|1
3106720|NCT00233064|10642136|P1|Overall Study|Death|0
3106721|NCT00233064|10642135|P2|Overall Study|Withdrawal by Subject|3
3106722|NCT00233064|10642136|P1|Overall Study|Withdrawal by Subject|5
3106723|NCT00233064|10642135|P2|Overall Study|Lost to Follow-up|7
3106724|NCT00233064|10642136|P1|Overall Study|Lost to Follow-up|7
3106725|NCT00232596|10642162|P2|12-Week Maintenance Phase|Other|3
3106726|NCT00232596|10642163|P1|12-Week Maintenance Phase|Other|1
3106727|NCT00232596|10642162|P2|12-Week Maintenance Phase|Protocol Violation|1
3106728|NCT00232596|10642163|P1|12-Week Maintenance Phase|Protocol Violation|3
3106729|NCT00232596|10642162|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
3106730|NCT00232596|10642163|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
3106731|NCT00232596|10642162|P2|12-Week Maintenance Phase|Adverse Event|22
3106732|NCT00232596|10642163|P1|12-Week Maintenance Phase|Adverse Event|7
3106733|NCT00232596|10642162|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
3106734|NCT00232596|10642163|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
3106735|NCT00232596|10642162|P2|6-Week Titration Phase|Other|3
3106736|NCT00232596|10642163|P1|6-Week Titration Phase|Other|3
3106737|NCT00232596|10642162|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
3106738|NCT00232596|10642163|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
3106739|NCT00232596|10642162|P2|6-Week Titration Phase|Protocol Violation|3
3106740|NCT00232596|10642163|P1|6-Week Titration Phase|Protocol Violation|1
3106741|NCT00232596|10642162|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
3106742|NCT00232596|10642163|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
3106743|NCT00232596|10642162|P2|6-Week Titration Phase|Failed to Return|1
3106744|NCT00232596|10642163|P1|6-Week Titration Phase|Failed to Return|2
3106745|NCT00232596|10642162|P2|6-Week Titration Phase|Adverse Event|19
3106746|NCT00232596|10642163|P1|6-Week Titration Phase|Adverse Event|6
3106747|NCT00232557|10642254|P2|Overall Study|Lost to Follow-up|5
3106748|NCT00232557|10642255|P1|Overall Study|Lost to Follow-up|3
3106749|NCT00232544|10642265|P2|Overall Study|Lost to Follow-up|15
3106750|NCT00232544|10642266|P1|Overall Study|Lost to Follow-up|20
3106751|NCT00232180|10642297|P3|Open Label Phase|Randomized but not treated|1
3106752|NCT00232180|10642298|P2|Open Label Phase|Randomized but not treated|0
3106753|NCT00232180|10642299|P1|Open Label Phase|Randomized but not treated|0
3106754|NCT00232180|10642297|P3|Open Label Phase|Laboratory abnormality|10
3106755|NCT00232180|10642298|P2|Open Label Phase|Laboratory abnormality|0
3106756|NCT00232180|10642299|P1|Open Label Phase|Laboratory abnormality|0
3106757|NCT00232180|10642297|P3|Open Label Phase|Adverse Event|25
3106758|NCT00232180|10642298|P2|Open Label Phase|Adverse Event|0
3106759|NCT00232180|10642299|P1|Open Label Phase|Adverse Event|0
3106760|NCT00232180|10642297|P3|Open Label Phase|Other|16
3106761|NCT00232180|10642298|P2|Open Label Phase|Other|0
3106762|NCT00232180|10642299|P1|Open Label Phase|Other|0
3106763|NCT00232180|10642297|P3|Open Label Phase|Withdrawal by Subject|37
3106764|NCT00232180|10642298|P2|Open Label Phase|Withdrawal by Subject|0
3106765|NCT00232180|10642299|P1|Open Label Phase|Withdrawal by Subject|0
3106766|NCT00232180|10642297|P3|Open Label Phase|Study terminated by sponsor|3
3106767|NCT00232180|10642298|P2|Open Label Phase|Study terminated by sponsor|0
3106768|NCT00232180|10642299|P1|Open Label Phase|Study terminated by sponsor|0
3106769|NCT00232180|10642297|P3|Open Label Phase|Protocol Violation|3
3106770|NCT00232180|10642298|P2|Open Label Phase|Protocol Violation|0
3106771|NCT00232180|10642299|P1|Open Label Phase|Protocol Violation|0
3106772|NCT00232180|10642297|P3|Open Label Phase|Lost to Follow-up|5
3106773|NCT00232180|10642298|P2|Open Label Phase|Lost to Follow-up|0
3106774|NCT00232180|10642299|P1|Open Label Phase|Lost to Follow-up|0
3106775|NCT00232180|10642297|P3|Open Label Phase|Death|48
3106776|NCT00232180|10642298|P2|Open Label Phase|Death|0
3106777|NCT00232180|10642299|P1|Open Label Phase|Death|0
3106778|NCT00232180|10642297|P3|Double-blind (DB) Phase|Laboratory abnormality|0
3106779|NCT00232180|10642298|P2|Double-blind (DB) Phase|Laboratory abnormality|7
3106780|NCT00232180|10642299|P1|Double-blind (DB) Phase|Laboratory abnormality|6
3106781|NCT00232180|10642297|P3|Double-blind (DB) Phase|Randomized but not treated|0
3106782|NCT00232180|10642298|P2|Double-blind (DB) Phase|Randomized but not treated|4
3106783|NCT00232180|10642299|P1|Double-blind (DB) Phase|Randomized but not treated|3
3106784|NCT00232180|10642297|P3|Double-blind (DB) Phase|Other|0
3106785|NCT00232180|10642298|P2|Double-blind (DB) Phase|Other|75
3106786|NCT00232180|10642299|P1|Double-blind (DB) Phase|Other|70
3106787|NCT00232180|10642297|P3|Double-blind (DB) Phase|Adverse Event|0
3106788|NCT00232180|10642298|P2|Double-blind (DB) Phase|Adverse Event|100
3106789|NCT00232180|10642299|P1|Double-blind (DB) Phase|Adverse Event|83
3106790|NCT00232180|10642297|P3|Double-blind (DB) Phase|Protocol Violation|0
3106791|NCT00232180|10642298|P2|Double-blind (DB) Phase|Protocol Violation|21
3106792|NCT00232180|10642299|P1|Double-blind (DB) Phase|Protocol Violation|28
3106793|NCT00232180|10642297|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
3106794|NCT00232180|10642298|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
3106795|NCT00232180|10642299|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
3106796|NCT00232180|10642297|P3|Double-blind (DB) Phase|Lost to Follow-up|0
3106797|NCT00232180|10642298|P2|Double-blind (DB) Phase|Lost to Follow-up|28
3106798|NCT00232180|10642299|P1|Double-blind (DB) Phase|Lost to Follow-up|34
3106799|NCT00232180|10642297|P3|Double-blind (DB) Phase|Death|0
3106800|NCT00232180|10642298|P2|Double-blind (DB) Phase|Death|222
3106801|NCT00232180|10642299|P1|Double-blind (DB) Phase|Death|186
3106802|NCT00232141|10642344|P2|Overall Study|Withdrawal by Subject|3
3106803|NCT00232141|10642345|P1|Overall Study|Withdrawal by Subject|5
3106804|NCT00232141|10642344|P2|Overall Study|Other|10
3106805|NCT00232141|10642345|P1|Overall Study|Other|8
3106806|NCT00232141|10642344|P2|Overall Study|Lost to Follow-up|6
3106807|NCT00232141|10642345|P1|Overall Study|Lost to Follow-up|9
3106808|NCT00232141|10642344|P2|Overall Study|Lack of Efficacy|3
3106809|NCT00232141|10642345|P1|Overall Study|Lack of Efficacy|0
3106810|NCT00232141|10642344|P2|Overall Study|Adverse Event|4
3106811|NCT00232141|10642345|P1|Overall Study|Adverse Event|9
3106812|NCT00231894|10642415|P2|Overall Study|Withdrawal by Subject|1
3106813|NCT00231894|10642416|P1|Overall Study|Withdrawal by Subject|1
3106814|NCT00231842|10642438|P1|Overall Study|Did not complete the last 3 cycle|8
3106815|NCT00231842|10642438|P1|Overall Study|Withdrawal by Subject|3
3106816|NCT00231816|10642445|P2|Overall Study|Other|1
3106817|NCT00231816|10642446|P1|Overall Study|Other|2
3106818|NCT00231816|10642445|P2|Overall Study|Withdrawal by Subject|3
3106819|NCT00231816|10642446|P1|Overall Study|Withdrawal by Subject|3
3106820|NCT00231816|10642445|P2|Overall Study|Protocol Violation|3
3106821|NCT00231816|10642446|P1|Overall Study|Protocol Violation|2
3106822|NCT00231816|10642445|P2|Overall Study|Lost to Follow-up|5
3106823|NCT00231816|10642446|P1|Overall Study|Lost to Follow-up|8
3106824|NCT00231816|10642445|P2|Overall Study|Adverse Event|0
3106825|NCT00231816|10642446|P1|Overall Study|Adverse Event|1
3106826|NCT00231777|10642461|P2|Overall Study|Other|2
3106827|NCT00231777|10642462|P1|Overall Study|Other|3
3106828|NCT00231777|10642461|P2|Overall Study|Lost to Follow-up|0
3106829|NCT00231777|10642462|P1|Overall Study|Lost to Follow-up|3
3106830|NCT00231478|10642476|P2|Overall Study|Administrative|2
3106831|NCT00231478|10642477|P1|Overall Study|Administrative|3
3106832|NCT00231478|10642476|P2|Overall Study|Adverse Event|1
3106833|NCT00231478|10642477|P1|Overall Study|Adverse Event|0
3106834|NCT00231478|10642476|P2|Overall Study|Withdrawal by Subject|0
3106835|NCT00231478|10642477|P1|Overall Study|Withdrawal by Subject|1
3106836|NCT00231478|10642476|P2|Overall Study|Refused Treatment|1
3106837|NCT00231478|10642477|P1|Overall Study|Refused Treatment|1
3106838|NCT00231478|10642476|P2|Overall Study|Protocol Violation|2
3106839|NCT00231478|10642477|P1|Overall Study|Protocol Violation|3
3106840|NCT00231465|10642489|P1|Overall Study|Did not have follow up CT scans|1
3106841|NCT00231465|10642489|P1|Overall Study|Completed only one cycle|1
3106842|NCT00231413|10642502|P7|Overall Study|Pregnancy|0
3106843|NCT00231413|10642503|P6|Overall Study|Pregnancy|0
3106844|NCT00231413|10642504|P5|Overall Study|Pregnancy|0
3106845|NCT00231413|10642505|P4|Overall Study|Pregnancy|0
3106846|NCT00231413|10642506|P3|Overall Study|Pregnancy|0
3106847|NCT00231413|10642507|P2|Overall Study|Pregnancy|0
3106848|NCT00231413|10642508|P1|Overall Study|Pregnancy|1
3106849|NCT00231413|10642502|P7|Overall Study|Lost to Follow-up|0
3106850|NCT00231413|10642503|P6|Overall Study|Lost to Follow-up|4
3106851|NCT00231413|10642504|P5|Overall Study|Lost to Follow-up|1
3106852|NCT00231413|10642505|P4|Overall Study|Lost to Follow-up|1
3106853|NCT00231413|10642506|P3|Overall Study|Lost to Follow-up|1
3106854|NCT00231413|10642507|P2|Overall Study|Lost to Follow-up|4
3106855|NCT00231413|10642508|P1|Overall Study|Lost to Follow-up|4
3106856|NCT00231413|10642502|P7|Overall Study|Migrated/moved from study area|0
3106857|NCT00231413|10642503|P6|Overall Study|Migrated/moved from study area|1
3106858|NCT00231413|10642504|P5|Overall Study|Migrated/moved from study area|0
3106859|NCT00231413|10642505|P4|Overall Study|Migrated/moved from study area|0
3106860|NCT00231413|10642506|P3|Overall Study|Migrated/moved from study area|1
3106861|NCT00231413|10642507|P2|Overall Study|Migrated/moved from study area|0
3106862|NCT00231413|10642508|P1|Overall Study|Migrated/moved from study area|0
3106863|NCT00231413|10642502|P7|Overall Study|Withdrawal by Subject|3
3106864|NCT00231413|10642503|P6|Overall Study|Withdrawal by Subject|0
3106865|NCT00231413|10642504|P5|Overall Study|Withdrawal by Subject|2
3106866|NCT00231413|10642505|P4|Overall Study|Withdrawal by Subject|2
3106867|NCT00231413|10642506|P3|Overall Study|Withdrawal by Subject|4
3106868|NCT00231413|10642507|P2|Overall Study|Withdrawal by Subject|1
3106869|NCT00231413|10642508|P1|Overall Study|Withdrawal by Subject|3
3106870|NCT00231413|10642502|P7|Overall Study|Non-serious AE|1
3106871|NCT00231413|10642503|P6|Overall Study|Non-serious AE|0
3106872|NCT00231413|10642504|P5|Overall Study|Non-serious AE|0
3106873|NCT00231413|10642505|P4|Overall Study|Non-serious AE|0
3106874|NCT00231413|10642506|P3|Overall Study|Non-serious AE|1
3106875|NCT00231413|10642507|P2|Overall Study|Non-serious AE|0
3106876|NCT00231413|10642508|P1|Overall Study|Non-serious AE|0
3106877|NCT00231179|10642678|P2|Overall Study|Withdrawal by Subject|3
3106878|NCT00231179|10642679|P1|Overall Study|Withdrawal by Subject|3
3106879|NCT00231179|10642678|P2|Overall Study|Lost to Follow-up|21
3106880|NCT00231179|10642679|P1|Overall Study|Lost to Follow-up|21
3106881|NCT00231114|10642706|P2|Post-Treatment Period|Withdrawal by Subject|0
3106882|NCT00231114|10642707|P1|Post-Treatment Period|Withdrawal by Subject|1
3106883|NCT00231114|10642706|P2|Post-Treatment Period|Physician Decision|0
3106884|NCT00231114|10642707|P1|Post-Treatment Period|Physician Decision|1
3106885|NCT00231114|10642706|P2|Post-Treatment Period|Lost to Follow-up|1
3106886|NCT00231114|10642707|P1|Post-Treatment Period|Lost to Follow-up|6
3106887|NCT00231114|10642706|P2|Treatment Period|Death: Motor Vehicle Accident|0
3106888|NCT00231114|10642707|P1|Treatment Period|Death: Motor Vehicle Accident|1
3106889|NCT00231114|10642706|P2|Randomized|Withdrawal by Subject|3
3106890|NCT00231114|10642707|P1|Randomized|Withdrawal by Subject|6
3106891|NCT00231062|10642743|P1|Overall Study|Physician Decision|6
3106892|NCT00230971|10642751|P2|Baseline Participants|Reintervention|0
3106893|NCT00230971|10642752|P1|Baseline Participants|Reintervention|1
3106894|NCT00230971|10642751|P2|Baseline Participants|Failure to return|1
3106895|NCT00230971|10642752|P1|Baseline Participants|Failure to return|1
3106896|NCT00230971|10642751|P2|Baseline Participants|No bacteria observed|0
3106897|NCT00230971|10642752|P1|Baseline Participants|No bacteria observed|1
3106898|NCT00230971|10642751|P2|Baseline Participants|Adverse Event|0
3106899|NCT00230971|10642752|P1|Baseline Participants|Adverse Event|1
3106900|NCT00230971|10642751|P2|Baseline Participants|Withdrawal by Subject|1
3106901|NCT00230971|10642752|P1|Baseline Participants|Withdrawal by Subject|7
3106902|NCT00230971|10642751|P2|Baseline Participants|Death|5
3106903|NCT00230971|10642752|P1|Baseline Participants|Death|6
3106904|NCT00230971|10642751|P2|Baseline Participants|Lost to Follow-up|12
3106905|NCT00230971|10642752|P1|Baseline Participants|Lost to Follow-up|5
3106906|NCT00230971|10642751|P2|Randomization|No study drug administered|3
3106907|NCT00230971|10642752|P1|Randomization|No study drug administered|3
3106908|NCT00230282|10642790|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
3106995|NCT00229723|10642932|P2|Concomitant Phase|Informed consent withdrawn|2
3106909|NCT00230282|10642790|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
3106910|NCT00230282|10642790|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
3106911|NCT00230282|10642790|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
3106912|NCT00230178|10642798|P3|Overall Study|Various other reasons|4
3106913|NCT00230178|10642799|P2|Overall Study|Various other reasons|2
3106914|NCT00230178|10642800|P1|Overall Study|Various other reasons|3
3106915|NCT00230178|10642798|P3|Overall Study|Withdrawal by Subject|1
3106916|NCT00230178|10642799|P2|Overall Study|Withdrawal by Subject|0
3106917|NCT00230178|10642800|P1|Overall Study|Withdrawal by Subject|0
3106918|NCT00230178|10642798|P3|Overall Study|Adverse Event|2
3106919|NCT00230178|10642799|P2|Overall Study|Adverse Event|5
3106920|NCT00230178|10642800|P1|Overall Study|Adverse Event|1
3106921|NCT00230048|10642852|P2|Overall Study|Lost to Follow-up|18
3106922|NCT00230048|10642853|P1|Overall Study|Lost to Follow-up|13
3106923|NCT00229931|10642911|P2|Overall Study|Lost to Follow-up|2
3106924|NCT00229931|10642912|P1|Overall Study|Lost to Follow-up|3
3106925|NCT00229931|10642911|P2|Overall Study|Death|0
3106926|NCT00229931|10642912|P1|Overall Study|Death|1
3106927|NCT00229723|10642927|P7|Maintenance Phase|Other|1
3106928|NCT00229723|10642928|P6|Maintenance Phase|Other|3
3106929|NCT00229723|10642929|P5|Maintenance Phase|Other|3
3106930|NCT00229723|10642930|P4|Maintenance Phase|Other|2
3106931|NCT00229723|10642931|P3|Maintenance Phase|Other|1
3106932|NCT00229723|10642932|P2|Maintenance Phase|Other|4
3106933|NCT00229723|10642933|P1|Maintenance Phase|Other|5
3106934|NCT00229723|10642927|P7|Maintenance Phase|Severe non-compliance|0
3106935|NCT00229723|10642928|P6|Maintenance Phase|Severe non-compliance|0
3106936|NCT00229723|10642929|P5|Maintenance Phase|Severe non-compliance|1
3106937|NCT00229723|10642930|P4|Maintenance Phase|Severe non-compliance|0
3106938|NCT00229723|10642931|P3|Maintenance Phase|Severe non-compliance|0
3106939|NCT00229723|10642932|P2|Maintenance Phase|Severe non-compliance|1
3106940|NCT00229723|10642933|P1|Maintenance Phase|Severe non-compliance|3
3106941|NCT00229723|10642927|P7|Maintenance Phase|Informed consent withdrawn|0
3106942|NCT00229723|10642928|P6|Maintenance Phase|Informed consent withdrawn|1
3106943|NCT00229723|10642929|P5|Maintenance Phase|Informed consent withdrawn|1
3106944|NCT00229723|10642930|P4|Maintenance Phase|Informed consent withdrawn|1
3106945|NCT00229723|10642931|P3|Maintenance Phase|Informed consent withdrawn|0
3106946|NCT00229723|10642932|P2|Maintenance Phase|Informed consent withdrawn|0
3106947|NCT00229723|10642933|P1|Maintenance Phase|Informed consent withdrawn|1
3106948|NCT00229723|10642927|P7|Maintenance Phase|Lost to Follow-up|1
3106949|NCT00229723|10642928|P6|Maintenance Phase|Lost to Follow-up|0
3106950|NCT00229723|10642929|P5|Maintenance Phase|Lost to Follow-up|0
3106951|NCT00229723|10642930|P4|Maintenance Phase|Lost to Follow-up|2
3106952|NCT00229723|10642931|P3|Maintenance Phase|Lost to Follow-up|2
3106953|NCT00229723|10642932|P2|Maintenance Phase|Lost to Follow-up|1
3106954|NCT00229723|10642933|P1|Maintenance Phase|Lost to Follow-up|0
3106955|NCT00229723|10642927|P7|Maintenance Phase|Clinical progression|1
3106956|NCT00229723|10642928|P6|Maintenance Phase|Clinical progression|1
3106957|NCT00229723|10642929|P5|Maintenance Phase|Clinical progression|1
3106958|NCT00229723|10642930|P4|Maintenance Phase|Clinical progression|2
3106959|NCT00229723|10642931|P3|Maintenance Phase|Clinical progression|2
3106960|NCT00229723|10642932|P2|Maintenance Phase|Clinical progression|1
3106961|NCT00229723|10642933|P1|Maintenance Phase|Clinical progression|4
3106962|NCT00229723|10642927|P7|Maintenance Phase|Objective disease progression|5
3106963|NCT00229723|10642928|P6|Maintenance Phase|Objective disease progression|9
3106964|NCT00229723|10642929|P5|Maintenance Phase|Objective disease progression|2
3106965|NCT00229723|10642930|P4|Maintenance Phase|Objective disease progression|6
3106966|NCT00229723|10642931|P3|Maintenance Phase|Objective disease progression|3
3106967|NCT00229723|10642932|P2|Maintenance Phase|Objective disease progression|5
3106968|NCT00229723|10642933|P1|Maintenance Phase|Objective disease progression|5
3106969|NCT00229723|10642927|P7|Maintenance Phase|Adverse Event|2
3106970|NCT00229723|10642928|P6|Maintenance Phase|Adverse Event|5
3106971|NCT00229723|10642929|P5|Maintenance Phase|Adverse Event|7
3106972|NCT00229723|10642930|P4|Maintenance Phase|Adverse Event|4
3106973|NCT00229723|10642931|P3|Maintenance Phase|Adverse Event|1
3106974|NCT00229723|10642932|P2|Maintenance Phase|Adverse Event|2
3106975|NCT00229723|10642933|P1|Maintenance Phase|Adverse Event|7
3106976|NCT00229723|10642927|P7|Concomitant Phase|Other|0
3106977|NCT00229723|10642928|P6|Concomitant Phase|Other|2
3106978|NCT00229723|10642929|P5|Concomitant Phase|Other|0
3106979|NCT00229723|10642930|P4|Concomitant Phase|Other|1
3106980|NCT00229723|10642931|P3|Concomitant Phase|Other|1
3106981|NCT00229723|10642932|P2|Concomitant Phase|Other|0
3106982|NCT00229723|10642933|P1|Concomitant Phase|Other|3
3106983|NCT00229723|10642927|P7|Concomitant Phase|Severe non-compliance|0
3106984|NCT00229723|10642928|P6|Concomitant Phase|Severe non-compliance|0
3106985|NCT00229723|10642929|P5|Concomitant Phase|Severe non-compliance|1
3106986|NCT00229723|10642930|P4|Concomitant Phase|Severe non-compliance|0
3106987|NCT00229723|10642931|P3|Concomitant Phase|Severe non-compliance|0
3106988|NCT00229723|10642932|P2|Concomitant Phase|Severe non-compliance|1
3106989|NCT00229723|10642933|P1|Concomitant Phase|Severe non-compliance|0
3106990|NCT00229723|10642927|P7|Concomitant Phase|Informed consent withdrawn|0
3106991|NCT00229723|10642928|P6|Concomitant Phase|Informed consent withdrawn|0
3106992|NCT00229723|10642929|P5|Concomitant Phase|Informed consent withdrawn|0
3106993|NCT00229723|10642930|P4|Concomitant Phase|Informed consent withdrawn|2
3106994|NCT00229723|10642931|P3|Concomitant Phase|Informed consent withdrawn|0
3106996|NCT00229723|10642933|P1|Concomitant Phase|Informed consent withdrawn|3
3106997|NCT00229723|10642927|P7|Concomitant Phase|Lost to Follow-up|0
3106998|NCT00229723|10642928|P6|Concomitant Phase|Lost to Follow-up|0
3106999|NCT00229723|10642929|P5|Concomitant Phase|Lost to Follow-up|1
3107000|NCT00229723|10642930|P4|Concomitant Phase|Lost to Follow-up|0
3107001|NCT00229723|10642931|P3|Concomitant Phase|Lost to Follow-up|0
3107002|NCT00229723|10642932|P2|Concomitant Phase|Lost to Follow-up|0
3107003|NCT00229723|10642933|P1|Concomitant Phase|Lost to Follow-up|0
3107004|NCT00229723|10642927|P7|Concomitant Phase|Clinical progression|1
3107005|NCT00229723|10642928|P6|Concomitant Phase|Clinical progression|0
3107006|NCT00229723|10642929|P5|Concomitant Phase|Clinical progression|0
3107007|NCT00229723|10642930|P4|Concomitant Phase|Clinical progression|0
3107008|NCT00229723|10642931|P3|Concomitant Phase|Clinical progression|0
3107009|NCT00229723|10642932|P2|Concomitant Phase|Clinical progression|0
3107010|NCT00229723|10642933|P1|Concomitant Phase|Clinical progression|0
3107011|NCT00229723|10642927|P7|Concomitant Phase|Objective disease progression|0
3107012|NCT00229723|10642928|P6|Concomitant Phase|Objective disease progression|0
3107013|NCT00229723|10642929|P5|Concomitant Phase|Objective disease progression|0
3107014|NCT00229723|10642930|P4|Concomitant Phase|Objective disease progression|0
3107015|NCT00229723|10642931|P3|Concomitant Phase|Objective disease progression|0
3107016|NCT00229723|10642932|P2|Concomitant Phase|Objective disease progression|0
3107017|NCT00229723|10642933|P1|Concomitant Phase|Objective disease progression|0
3107018|NCT00229723|10642927|P7|Concomitant Phase|Adverse Event|2
3107019|NCT00229723|10642928|P6|Concomitant Phase|Adverse Event|1
3107020|NCT00229723|10642929|P5|Concomitant Phase|Adverse Event|0
3107021|NCT00229723|10642930|P4|Concomitant Phase|Adverse Event|2
3107022|NCT00229723|10642931|P3|Concomitant Phase|Adverse Event|5
3107023|NCT00229723|10642932|P2|Concomitant Phase|Adverse Event|2
3107024|NCT00229723|10642933|P1|Concomitant Phase|Adverse Event|4
3107025|NCT00229658|10642986|P2|Overall Study|Withdrawal of consent|39
3107026|NCT00229658|10642987|P1|Overall Study|Withdrawal of consent|46
3107027|NCT00229658|10642986|P2|Overall Study|Serious Adverse Event|2
3107028|NCT00229658|10642987|P1|Overall Study|Serious Adverse Event|2
3107029|NCT00229658|10642986|P2|Overall Study|Lost to Follow-up|55
3107030|NCT00229658|10642987|P1|Overall Study|Lost to Follow-up|82
3107031|NCT00229658|10642986|P2|Overall Study|Other|60
3107032|NCT00229658|10642987|P1|Overall Study|Other|80
3107033|NCT00229658|10642986|P2|Overall Study|Investigator decision|10
3107034|NCT00229658|10642987|P1|Overall Study|Investigator decision|13
3107035|NCT00229658|10642986|P2|Overall Study|Administrative|1
3107036|NCT00229658|10642987|P1|Overall Study|Administrative|2
3107037|NCT00229203|10643023|P2|Overall Study|Withdrawal by Subject|4
3107038|NCT00229203|10643024|P1|Overall Study|Withdrawal by Subject|1
3107039|NCT00229203|10643023|P2|Overall Study|Other|3
3107040|NCT00229203|10643024|P1|Overall Study|Other|3
3107041|NCT00229203|10643023|P2|Overall Study|Death|2
3107042|NCT00229203|10643024|P1|Overall Study|Death|4
3107043|NCT00229203|10643023|P2|Overall Study|Toxicity|1
3107044|NCT00229203|10643024|P1|Overall Study|Toxicity|6
3107045|NCT00229203|10643023|P2|Overall Study|Progressive disease|9
3107046|NCT00229203|10643024|P1|Overall Study|Progressive disease|18
3107047|NCT00228917|10643052|P8|Overall Study|Migrated/moved from study area|0
3107048|NCT00228917|10643053|P7|Overall Study|Migrated/moved from study area|0
3107049|NCT00228917|10643054|P6|Overall Study|Migrated/moved from study area|2
3107050|NCT00228917|10643055|P5|Overall Study|Migrated/moved from study area|0
3107051|NCT00228917|10643056|P4|Overall Study|Migrated/moved from study area|0
3107052|NCT00228917|10643057|P3|Overall Study|Migrated/moved from study area|0
3107053|NCT00228917|10643058|P2|Overall Study|Migrated/moved from study area|0
3107054|NCT00228917|10643059|P1|Overall Study|Migrated/moved from study area|0
3107055|NCT00228813|10643105|P1|Overall Study|Death|4
3107056|NCT00228566|10643111|P1|Overall Study|Miscellaneous|1
3107057|NCT00228566|10643111|P1|Overall Study|Withdrawal by Subject|4
3107058|NCT00228566|10643111|P1|Overall Study|Physician Decision|5
3107059|NCT00228566|10643111|P1|Overall Study|Lost to Follow-up|16
3107060|NCT00228566|10643111|P1|Overall Study|Lack of Efficacy|14
3107061|NCT00228566|10643111|P1|Overall Study|Adverse Event|31
3107062|NCT00228553|10643115|P1|Overall Study|Miscellaneous|46
3107063|NCT00228553|10643115|P1|Overall Study|Pregnancy|2
3107064|NCT00228553|10643115|P1|Overall Study|Withdrawal by Subject|115
3107065|NCT00228553|10643115|P1|Overall Study|Protocol Violation|6
3107066|NCT00228553|10643115|P1|Overall Study|Physician Decision|48
3107067|NCT00228553|10643115|P1|Overall Study|Lost to Follow-up|67
3107068|NCT00228553|10643115|P1|Overall Study|Lack of Efficacy|34
3107069|NCT00228553|10643115|P1|Overall Study|Adverse Event|112
3107070|NCT00228384|10643121|P2|Overall Study|Physician Decision|1
3107071|NCT00228384|10643122|P1|Overall Study|Physician Decision|0
3107072|NCT00228384|10643121|P2|Overall Study|Withdrawal by Subject|10
3107073|NCT00228384|10643122|P1|Overall Study|Withdrawal by Subject|9
3107074|NCT00228384|10643121|P2|Overall Study|Surgical Intervention (bypass)|5
3107075|NCT00228384|10643122|P1|Overall Study|Surgical Intervention (bypass)|5
3107076|NCT00228384|10643121|P2|Overall Study|Lost to Follow-up|10
3107077|NCT00228384|10643122|P1|Overall Study|Lost to Follow-up|6
3107078|NCT00228384|10643121|P2|Overall Study|Death|3
3107079|NCT00228384|10643122|P1|Overall Study|Death|9
3107080|NCT00227903|10643173|P2|Overall Study|Miscarriage|0
3107081|NCT00227903|10643174|P1|Overall Study|Miscarriage|1
3107082|NCT00227903|10643173|P2|Overall Study|Lost to Follow-up|3
3107083|NCT00227903|10643174|P1|Overall Study|Lost to Follow-up|1
3107084|NCT00227903|10643173|P2|Overall Study|Subject moved out of area|2
3107085|NCT00227903|10643174|P1|Overall Study|Subject moved out of area|1
3107086|NCT00227903|10643173|P2|Overall Study|Withdrawal by Subject|5
3107087|NCT00227903|10643174|P1|Overall Study|Withdrawal by Subject|2
3107088|NCT00227877|10643238|P4|12-months Follow-up|Lost to Follow-up|26
3107089|NCT00227877|10643239|P3|12-months Follow-up|Lost to Follow-up|30
3107090|NCT00227877|10643240|P2|12-months Follow-up|Lost to Follow-up|189
3107091|NCT00227877|10643241|P1|12-months Follow-up|Lost to Follow-up|232
3107092|NCT00227877|10643238|P4|12-months Follow-up|Completed late|0
3107093|NCT00227877|10643239|P3|12-months Follow-up|Completed late|1
3107094|NCT00227877|10643240|P2|12-months Follow-up|Completed late|74
3107095|NCT00227877|10643241|P1|12-months Follow-up|Completed late|78
3107096|NCT00227877|10643238|P4|3-months Follow-up|Lost to Follow-up|13
3107097|NCT00227877|10643239|P3|3-months Follow-up|Lost to Follow-up|18
3107098|NCT00227877|10643240|P2|3-months Follow-up|Lost to Follow-up|139
3107099|NCT00227877|10643241|P1|3-months Follow-up|Lost to Follow-up|178
3107100|NCT00227877|10643238|P4|3-months Follow-up|Completed late|8
3107101|NCT00227877|10643239|P3|3-months Follow-up|Completed late|34
3107102|NCT00227877|10643240|P2|3-months Follow-up|Completed late|128
3107103|NCT00227877|10643241|P1|3-months Follow-up|Completed late|135
3107104|NCT00227877|10643238|P4|Post-visit Checklist|Lost to Follow-up|0
3107105|NCT00227877|10643239|P3|Post-visit Checklist|Lost to Follow-up|1
3107106|NCT00227877|10643240|P2|Post-visit Checklist|Lost to Follow-up|13
3107107|NCT00227877|10643241|P1|Post-visit Checklist|Lost to Follow-up|24
3107108|NCT00227877|10643238|P4|Pre-visit Assessment|Technical difficulties|0
3107109|NCT00227877|10643239|P3|Pre-visit Assessment|Technical difficulties|0
3107110|NCT00227877|10643240|P2|Pre-visit Assessment|Technical difficulties|3
3107111|NCT00227877|10643241|P1|Pre-visit Assessment|Technical difficulties|7
3107112|NCT00227721|10643277|P1|Overall Study|On study, but never treated.|1
3107113|NCT00227591|10643299|P1|Overall Study|Withdrawal by Subject|1
3107114|NCT00227539|10643303|P1|Overall Study|Protocol Violation|1
3107115|NCT00227370|10643311|P2|Overall Study|Other reasons|1
3107116|NCT00227370|10643312|P1|Overall Study|Other reasons|2
3107117|NCT00227370|10643311|P2|Overall Study|Physician Decision|6
3107118|NCT00227370|10643312|P1|Overall Study|Physician Decision|9
3107119|NCT00227370|10643311|P2|Overall Study|Adverse Event|11
3107120|NCT00227370|10643312|P1|Overall Study|Adverse Event|6
3107121|NCT00227370|10643311|P2|Overall Study|Death|4
3107122|NCT00227370|10643312|P1|Overall Study|Death|3
3107123|NCT00227370|10643311|P2|Overall Study|Withdrawal by Subject|2
3107124|NCT00227370|10643312|P1|Overall Study|Withdrawal by Subject|1
3107125|NCT00227344|10643332|P2|Overall Study|study terminated early|5
3107126|NCT00227344|10643333|P1|Overall Study|study terminated early|12
3107127|NCT00227305|10643353|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
3107128|NCT00227305|10643353|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
3107129|NCT00227305|10643353|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
3107130|NCT00227305|10643353|P1|Overall Study|Physician Decision|3
3107131|NCT00227305|10643353|P1|Overall Study|Lack of Efficacy|7
3107132|NCT00227305|10643353|P1|Overall Study|MOVED OUT OF AREA|3
3107133|NCT00227305|10643353|P1|Overall Study|Study specific discontinuation|13
3107134|NCT00227305|10643353|P1|Overall Study|Lost to Follow-up|33
3107135|NCT00227305|10643353|P1|Overall Study|Withdrawal by Subject|42
3107136|NCT00227305|10643353|P1|Overall Study|Adverse Event|40
3107137|NCT00227266|10643370|P3|Overall Study|Excessive weight gain|2
3107138|NCT00227266|10643371|P2|Overall Study|Excessive weight gain|0
3107139|NCT00227266|10643372|P1|Overall Study|Excessive weight gain|0
3107140|NCT00227266|10643370|P3|Overall Study|Protocol Violation|1
3107141|NCT00227266|10643371|P2|Overall Study|Protocol Violation|0
3107142|NCT00227266|10643372|P1|Overall Study|Protocol Violation|1
3107143|NCT00227266|10643370|P3|Overall Study|Withdrawal by Subject|1
3107144|NCT00227266|10643371|P2|Overall Study|Withdrawal by Subject|0
3107145|NCT00227266|10643372|P1|Overall Study|Withdrawal by Subject|0
3107146|NCT00226941|10643402|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
3107147|NCT00226941|10643403|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
3107148|NCT00226941|10643404|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
3107149|NCT00226941|10643405|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
3107150|NCT00226941|10643402|P4|Overall Study|Withdrawal by subject - toxicity|1
3107151|NCT00226941|10643403|P3|Overall Study|Withdrawal by subject - toxicity|0
3107152|NCT00226941|10643404|P2|Overall Study|Withdrawal by subject - toxicity|0
3107153|NCT00226941|10643405|P1|Overall Study|Withdrawal by subject - toxicity|0
3107154|NCT00226811|10643439|P1|Overall Study|Withdrawal by Subject|2
3107155|NCT00226811|10643439|P1|Overall Study|Lack of Efficacy|55
3107156|NCT00226811|10643439|P1|Overall Study|Adverse Event|11
3107157|NCT00226811|10643439|P1|Overall Study|Death|8
3107158|NCT00226655|10643449|P1|Overall Study|Clinical deterioration|10
3107159|NCT00226655|10643449|P1|Overall Study|Physician Decision|6
3107160|NCT00226655|10643449|P1|Overall Study|Adverse Event|35
3107161|NCT00226655|10643449|P1|Overall Study|Withdrawal by Subject|15
3107162|NCT00226655|10643449|P1|Overall Study|Death|13
3107163|NCT00226499|10643471|P3|Overall Study|Others|356
3107164|NCT00226499|10643472|P2|Overall Study|Others|1066
3107165|NCT00226499|10643473|P1|Overall Study|Others|1064
3107166|NCT00226499|10643471|P3|Overall Study|Adverse Event|3
3107167|NCT00226499|10643472|P2|Overall Study|Adverse Event|6
3107168|NCT00226499|10643473|P1|Overall Study|Adverse Event|10
3107169|NCT00225758|10643608|P1|Overall Study|Adverse Event|4
3107170|NCT00225277|10643640|P2|Overall Study|Other|9
3107171|NCT00225277|10643641|P1|Overall Study|Other|7
3107172|NCT00225277|10643640|P2|Overall Study|Withdrawal by Subject|34
3107173|NCT00225277|10643641|P1|Overall Study|Withdrawal by Subject|40
3107174|NCT00225277|10643640|P2|Overall Study|Protocol Violation|3
3107175|NCT00225277|10643641|P1|Overall Study|Protocol Violation|6
3107176|NCT00225277|10643640|P2|Overall Study|Physician Decision|8
3107177|NCT00225277|10643641|P1|Overall Study|Physician Decision|6
3107178|NCT00225277|10643640|P2|Overall Study|Lost to Follow-up|6
3107179|NCT00225277|10643641|P1|Overall Study|Lost to Follow-up|4
3107180|NCT00225277|10643640|P2|Overall Study|Lack of Efficacy|1
3107181|NCT00225277|10643641|P1|Overall Study|Lack of Efficacy|4
3107182|NCT00225277|10643640|P2|Overall Study|Adverse Event|34
3107183|NCT00225277|10643641|P1|Overall Study|Adverse Event|30
3107184|NCT00225251|10643659|P2|Overall Study|Withdrawal by Subject|1
3107185|NCT00225251|10643660|P1|Overall Study|Withdrawal by Subject|1
3107186|NCT00225212|10643674|P1|Overall Study|Intercurrent illness|1
3107187|NCT00225212|10643674|P1|Overall Study|Adverse Event|2
3107188|NCT00225212|10643674|P1|Overall Study|Death|1
3107189|NCT00225212|10643674|P1|Overall Study|Disease progression|2
3107190|NCT00225147|10643683|P4|Open-label Phase|Withdrawal by Subject|6
3107191|NCT00225147|10643684|P3|Open-label Phase|Withdrawal by Subject|0
3107192|NCT00225147|10643685|P2|Open-label Phase|Withdrawal by Subject|0
3107193|NCT00225147|10643686|P1|Open-label Phase|Withdrawal by Subject|0
3107194|NCT00225147|10643683|P4|Open-label Phase|Lost to Follow-up|4
3107195|NCT00225147|10643684|P3|Open-label Phase|Lost to Follow-up|0
3107196|NCT00225147|10643685|P2|Open-label Phase|Lost to Follow-up|0
3107197|NCT00225147|10643686|P1|Open-label Phase|Lost to Follow-up|0
3107198|NCT00224874|10643733|P4|Overall Study|Withdrawal by Subject|0
3107199|NCT00224874|10643734|P3|Overall Study|Withdrawal by Subject|1
3107200|NCT00224874|10643735|P2|Overall Study|Withdrawal by Subject|0
3107201|NCT00224874|10643736|P1|Overall Study|Withdrawal by Subject|0
3107202|NCT00224770|10643781|P3|Overall Study|Lost to Follow-up|0
3107203|NCT00224770|10643782|P2|Overall Study|Lost to Follow-up|2
3107204|NCT00224770|10643783|P1|Overall Study|Lost to Follow-up|4
3107205|NCT00224484|10643818|P3|Overall Study|Reason not specified|2
3107206|NCT00224484|10643819|P2|Overall Study|Reason not specified|4
3107207|NCT00224484|10643820|P1|Overall Study|Reason not specified|5
3107208|NCT00224484|10643818|P3|Overall Study|Lost to Follow-up|36
3107209|NCT00224484|10643819|P2|Overall Study|Lost to Follow-up|28
3107210|NCT00224484|10643820|P1|Overall Study|Lost to Follow-up|66
3107211|NCT00224484|10643818|P3|Overall Study|Migrated/moved from study area|5
3107212|NCT00224484|10643819|P2|Overall Study|Migrated/moved from study area|5
3107213|NCT00224484|10643820|P1|Overall Study|Migrated/moved from study area|18
3107214|NCT00224484|10643818|P3|Overall Study|Withdrawal by Subject|16
3107215|NCT00224484|10643819|P2|Overall Study|Withdrawal by Subject|18
3107216|NCT00224484|10643820|P1|Overall Study|Withdrawal by Subject|49
3107217|NCT00224484|10643818|P3|Overall Study|Protocol Violation|0
3107218|NCT00224484|10643819|P2|Overall Study|Protocol Violation|2
3107219|NCT00224484|10643820|P1|Overall Study|Protocol Violation|2
3107220|NCT00224484|10643818|P3|Overall Study|Non-Serious Adverse Event|3
3107221|NCT00224484|10643819|P2|Overall Study|Non-Serious Adverse Event|7
3107222|NCT00224484|10643820|P1|Overall Study|Non-Serious Adverse Event|5
3107223|NCT00224484|10643818|P3|Overall Study|Serious Adverse Event|0
3107224|NCT00224484|10643819|P2|Overall Study|Serious Adverse Event|1
3107225|NCT00224484|10643820|P1|Overall Study|Serious Adverse Event|1
3107226|NCT00224133|10643884|P1|Overall Study|Other|14
3107227|NCT00224133|10643884|P1|Overall Study|Physician Decision|1
3107228|NCT00224133|10643884|P1|Overall Study|Lost to Follow-up|21
3107229|NCT00224133|10643884|P1|Overall Study|Lack of Efficacy|58
3107230|NCT00224133|10643884|P1|Overall Study|Withdrawal by Subject|33
3107231|NCT00224133|10643884|P1|Overall Study|Protocol Violation|6
3107232|NCT00224133|10643884|P1|Overall Study|Adverse Event|93
3107233|NCT00224120|10643890|P2|Overall Study|Other|5
3107234|NCT00224120|10643891|P1|Overall Study|Other|4
3107235|NCT00224120|10643890|P2|Overall Study|Lost to Follow-up|3
3107236|NCT00224120|10643891|P1|Overall Study|Lost to Follow-up|2
3107237|NCT00224120|10643890|P2|Overall Study|Lack of Efficacy|2
3107238|NCT00224120|10643891|P1|Overall Study|Lack of Efficacy|0
3107239|NCT00224120|10643890|P2|Overall Study|Withdrawal by Subject|10
3107240|NCT00224120|10643891|P1|Overall Study|Withdrawal by Subject|5
3107241|NCT00224120|10643890|P2|Overall Study|Protocol Violation|0
3107242|NCT00224120|10643891|P1|Overall Study|Protocol Violation|1
3107243|NCT00224120|10643890|P2|Overall Study|Adverse Event|4
3107244|NCT00224120|10643891|P1|Overall Study|Adverse Event|10
3107245|NCT00224107|10643901|P2|Overall Study|Other|1
3107246|NCT00224107|10643902|P1|Overall Study|Other|1
3107247|NCT00224107|10643901|P2|Overall Study|Physician Decision|0
3107248|NCT00224107|10643902|P1|Overall Study|Physician Decision|1
3107249|NCT00224107|10643901|P2|Overall Study|Lost to Follow-up|0
3107250|NCT00224107|10643902|P1|Overall Study|Lost to Follow-up|4
3107251|NCT00224107|10643901|P2|Overall Study|Lack of Efficacy|0
3107252|NCT00224107|10643902|P1|Overall Study|Lack of Efficacy|2
3107253|NCT00224107|10643901|P2|Overall Study|Withdrawal by Subject|4
3107254|NCT00224107|10643902|P1|Overall Study|Withdrawal by Subject|1
3107255|NCT00224107|10643901|P2|Overall Study|Protocol Violation|3
3107256|NCT00224107|10643902|P1|Overall Study|Protocol Violation|2
3107257|NCT00224107|10643901|P2|Overall Study|Adverse Event|6
3107258|NCT00224107|10643902|P1|Overall Study|Adverse Event|20
3107259|NCT00224055|10643912|P2|Overall Study|Other|0
3107260|NCT00224055|10643913|P1|Overall Study|Other|1
3107261|NCT00224055|10643912|P2|Overall Study|Withdrawal by Subject|2
3107262|NCT00224055|10643913|P1|Overall Study|Withdrawal by Subject|0
3107263|NCT00224055|10643912|P2|Overall Study|Inclusion Violation|6
3107264|NCT00224055|10643913|P1|Overall Study|Inclusion Violation|3
3107265|NCT00224055|10643912|P2|Overall Study|Protocol Violation|1
3107266|NCT00224055|10643913|P1|Overall Study|Protocol Violation|1
3107267|NCT00224055|10643912|P2|Overall Study|Lost to Follow-up|2
3107268|NCT00224055|10643913|P1|Overall Study|Lost to Follow-up|1
3107269|NCT00224055|10643912|P2|Overall Study|Adverse Event|3
3107270|NCT00224055|10643913|P1|Overall Study|Adverse Event|9
3107271|NCT00224042|10643923|P2|Overall Study|Other|0
3107272|NCT00224042|10643924|P1|Overall Study|Other|2
3107273|NCT00224042|10643923|P2|Overall Study|Did not meet lab incusion criteria|3
3107274|NCT00224042|10643924|P1|Overall Study|Did not meet lab incusion criteria|2
3107275|NCT00224042|10643923|P2|Overall Study|Physician Decision|1
3107276|NCT00224042|10643924|P1|Overall Study|Physician Decision|0
3107277|NCT00224042|10643923|P2|Overall Study|Protocol Violation|1
3107278|NCT00224042|10643924|P1|Overall Study|Protocol Violation|0
3107279|NCT00224042|10643923|P2|Overall Study|Adverse Event|1
3107280|NCT00224042|10643924|P1|Overall Study|Adverse Event|2
3107281|NCT00224029|10643936|P1|Overall Study|Other|1
3107282|NCT00224029|10643936|P1|Overall Study|Withdrawal by Subject|4
3107283|NCT00224029|10643936|P1|Overall Study|Lost to Follow-up|1
3107284|NCT00224016|10643942|P2|Maintenance Period|Lost to Follow-up|1
3107285|NCT00224016|10643943|P1|Maintenance Period|Lost to Follow-up|0
3107286|NCT00224016|10643942|P2|Maintenance Period|Withdrawal by Subject|0
3107287|NCT00224016|10643943|P1|Maintenance Period|Withdrawal by Subject|2
3107288|NCT00224016|10643942|P2|Titration Period|Lost to Follow-up|0
3107289|NCT00224016|10643943|P1|Titration Period|Lost to Follow-up|1
3107290|NCT00224016|10643942|P2|Titration Period|Withdrawal by Subject|1
3107291|NCT00224016|10643943|P1|Titration Period|Withdrawal by Subject|0
3107292|NCT00224003|10643951|P1|Overall Study|unk|3
3107293|NCT00224003|10643951|P1|Overall Study|Withdrawal by Subject|1
3107294|NCT00224003|10643951|P1|Overall Study|Protocol Violation|2
3107295|NCT00224003|10643951|P1|Overall Study|Adverse Event|1
3107296|NCT00223990|10643957|P2|Overall Study|Lost to Follow-up|0
3107297|NCT00223990|10643958|P1|Overall Study|Lost to Follow-up|1
3107298|NCT00223990|10643957|P2|Overall Study|Withdrawal by Subject|8
3107299|NCT00223990|10643958|P1|Overall Study|Withdrawal by Subject|4
3107300|NCT00223990|10643957|P2|Overall Study|Moved from area|1
3107301|NCT00223990|10643958|P1|Overall Study|Moved from area|2
3107302|NCT00223977|10643983|P3|Overall Study|Other|0
3107303|NCT00223977|10643984|P2|Overall Study|Other|0
3107304|NCT00223977|10643985|P1|Overall Study|Other|1
3107305|NCT00223977|10643983|P3|Overall Study|Withdrawal by Subject|2
3107306|NCT00223977|10643984|P2|Overall Study|Withdrawal by Subject|1
3107307|NCT00223977|10643985|P1|Overall Study|Withdrawal by Subject|1
3107308|NCT00223977|10643983|P3|Overall Study|Protocol Violation|1
3107309|NCT00223977|10643984|P2|Overall Study|Protocol Violation|0
3107310|NCT00223977|10643985|P1|Overall Study|Protocol Violation|0
3107311|NCT00223977|10643983|P3|Overall Study|Adverse Event|0
3107312|NCT00223977|10643984|P2|Overall Study|Adverse Event|10
3107313|NCT00223977|10643985|P1|Overall Study|Adverse Event|7
3107314|NCT00223808|10644019|P3|Overall Study|<5 hrs therapy before discharge|5
3107315|NCT00223808|10644020|P2|Overall Study|<5 hrs therapy before discharge|5
3107316|NCT00223808|10644021|P1|Overall Study|<5 hrs therapy before discharge|3
3107317|NCT00223795|10644038|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
3107318|NCT00223795|10644039|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
3107319|NCT00223795|10644038|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
3107320|NCT00223795|10644039|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
3107321|NCT00223496|10644117|P1|Overall Study|Physician Decision|2
3107322|NCT00223496|10644117|P1|Overall Study|Withdrawal by Subject|1
3107323|NCT00223496|10644117|P1|Overall Study|Lack of Efficacy|6
3107324|NCT00223496|10644117|P1|Overall Study|Lost to Follow-up|4
3107325|NCT00223496|10644117|P1|Overall Study|screen failure|9
3107326|NCT00223080|10644147|P2|Overall Study|Adverse Event|1
3107327|NCT00223080|10644148|P1|Overall Study|Adverse Event|0
3107328|NCT00223080|10644147|P2|Overall Study|Reason not provided|140
3107329|NCT00223080|10644148|P1|Overall Study|Reason not provided|141
3107330|NCT00223080|10644147|P2|Overall Study|Other|11
3107331|NCT00223080|10644148|P1|Overall Study|Other|14
3107332|NCT00223080|10644147|P2|Overall Study|Death|74
3107333|NCT00223080|10644148|P1|Overall Study|Death|85
3107334|NCT00223080|10644147|P2|Overall Study|Lost to Follow-up|284
3107335|NCT00223080|10644148|P1|Overall Study|Lost to Follow-up|259
3107336|NCT00223080|10644147|P2|Overall Study|Moved from study area|47
3107337|NCT00223080|10644148|P1|Overall Study|Moved from study area|37
3107338|NCT00223080|10644147|P2|Overall Study|Non-compliant|7
3107339|NCT00223080|10644148|P1|Overall Study|Non-compliant|7
3107340|NCT00223080|10644147|P2|Overall Study|Required contraindicated med|1
3107341|NCT00223080|10644148|P1|Overall Study|Required contraindicated med|0
3107342|NCT00223080|10644147|P2|Overall Study|Withdrawal by Subject|232
3107343|NCT00223080|10644148|P1|Overall Study|Withdrawal by Subject|253
3107344|NCT00222729|10644166|P1|Overall Study|Adverse Event|3
3107345|NCT00222105|10644184|P1|Overall Study|Death|2
3107346|NCT00222105|10644184|P1|Overall Study|Treatment delays|2
3107347|NCT00222105|10644184|P1|Overall Study|Adverse Event|8
3107348|NCT00222105|10644184|P1|Overall Study|Withdrawal by Subject|1
3107349|NCT00222105|10644184|P1|Overall Study|Removed due to wrong diagnosis|1
3107350|NCT00221195|10644205|P2|Therapy 2 (Months 10-15)|Adverse Event|0
3107351|NCT00221195|10644206|P1|Therapy 2 (Months 10-15)|Adverse Event|1
3107352|NCT00221195|10644205|P2|Therapy 2 (Months 10-15)|Death|0
3107353|NCT00221195|10644206|P1|Therapy 2 (Months 10-15)|Death|1
3107354|NCT00221195|10644205|P2|Washout Period (Months 7-9)|Death|1
3107355|NCT00221195|10644206|P1|Washout Period (Months 7-9)|Death|0
3107356|NCT00221195|10644205|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
3107357|NCT00221195|10644206|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
3107358|NCT00221195|10644205|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
3107359|NCT00221195|10644206|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
3107360|NCT00221104|10644228|P2|Overall Study|Others|47
3107361|NCT00221104|10644229|P1|Overall Study|Others|37
3107362|NCT00221104|10644228|P2|Overall Study|Withdrawal by Subject|29
3107363|NCT00221104|10644229|P1|Overall Study|Withdrawal by Subject|42
3107364|NCT00221104|10644228|P2|Overall Study|Protocol Violation|0
3107365|NCT00221104|10644229|P1|Overall Study|Protocol Violation|2
3107366|NCT00221104|10644228|P2|Overall Study|Physician Decision|0
3107367|NCT00221104|10644229|P1|Overall Study|Physician Decision|1
3107368|NCT00221104|10644228|P2|Overall Study|Adverse Event|0
3107369|NCT00221104|10644229|P1|Overall Study|Adverse Event|1
3107370|NCT00220805|10644262|P2|Overall Study|Develop. of choroidal neovascularization|8
3107371|NCT00220805|10644263|P1|Overall Study|Develop. of choroidal neovascularization|3
3107372|NCT00220805|10644262|P2|Overall Study|Lack of Efficacy|0
3107373|NCT00220805|10644263|P1|Overall Study|Lack of Efficacy|1
3107374|NCT00220805|10644262|P2|Overall Study|Withdrawal by Subject|0
3107375|NCT00220805|10644263|P1|Overall Study|Withdrawal by Subject|3
3107376|NCT00220805|10644262|P2|Overall Study|Adverse Event|3
3107377|NCT00220805|10644263|P1|Overall Study|Adverse Event|1
3107378|NCT00220779|10644284|P3|Overall Study|Lack of Efficacy|1
3107379|NCT00220779|10644285|P2|Overall Study|Lack of Efficacy|0
3107380|NCT00220779|10644286|P1|Overall Study|Lack of Efficacy|3
3107381|NCT00220779|10644284|P3|Overall Study|Pregnancy|2
3107382|NCT00220779|10644285|P2|Overall Study|Pregnancy|0
3107383|NCT00220779|10644286|P1|Overall Study|Pregnancy|0
3107384|NCT00220779|10644284|P3|Overall Study|Too time consuming|0
3107385|NCT00220779|10644285|P2|Overall Study|Too time consuming|0
3107386|NCT00220779|10644286|P1|Overall Study|Too time consuming|1
3107387|NCT00220779|10644284|P3|Overall Study|Non-compliance|0
3107388|NCT00220779|10644285|P2|Overall Study|Non-compliance|0
3107389|NCT00220779|10644286|P1|Overall Study|Non-compliance|1
3107390|NCT00220779|10644284|P3|Overall Study|Withdrawal by Subject|1
3107391|NCT00220779|10644285|P2|Overall Study|Withdrawal by Subject|4
3107392|NCT00220779|10644286|P1|Overall Study|Withdrawal by Subject|1
3107393|NCT00220779|10644284|P3|Overall Study|Adverse Event|0
3107394|NCT00220779|10644285|P2|Overall Study|Adverse Event|0
3107395|NCT00220779|10644286|P1|Overall Study|Adverse Event|1
3107396|NCT00220740|10644296|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
3107397|NCT00220740|10644297|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
3107398|NCT00220740|10644296|P2|Efficacy Period|Protocol Violation|0
3107399|NCT00220740|10644297|P1|Efficacy Period|Protocol Violation|1
3107400|NCT00220740|10644296|P2|Efficacy Period|Withdrawal by Subject|0
3107401|NCT00220740|10644297|P1|Efficacy Period|Withdrawal by Subject|1
3107402|NCT00220740|10644296|P2|Efficacy Period|Adverse Event|1
3107403|NCT00220740|10644297|P1|Efficacy Period|Adverse Event|1
3107404|NCT00220740|10644296|P2|Efficacy Period|Entered rescue treatment with placebo|0
3107405|NCT00220740|10644297|P1|Efficacy Period|Entered rescue treatment with placebo|23
3107406|NCT00220727|10644311|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
3107407|NCT00220727|10644312|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
3107408|NCT00220701|10644328|P2|Overall Study|Lost to Follow-up|4
3107409|NCT00220701|10644329|P1|Overall Study|Lost to Follow-up|5
3107410|NCT00220636|10644345|P1|Overall Study|Withdrawal by Subject|4
3107411|NCT00219557|10644355|P3|Phase 2|Treatment not received|3
3107412|NCT00219557|10644356|P2|Phase 2|Treatment not received|1
3107413|NCT00219557|10644357|P1|Phase 2|Treatment not received|0
3107414|NCT00219557|10644355|P3|Phase 2|Withdrawal by Subject|5
3107415|NCT00219557|10644356|P2|Phase 2|Withdrawal by Subject|9
3107416|NCT00219557|10644357|P1|Phase 2|Withdrawal by Subject|0
3107417|NCT00219557|10644355|P3|Phase 2|Other|6
3107418|NCT00219557|10644356|P2|Phase 2|Other|8
3107419|NCT00219557|10644357|P1|Phase 2|Other|0
3107420|NCT00219557|10644355|P3|Phase 2|Death|2
3107421|NCT00219557|10644356|P2|Phase 2|Death|8
3107422|NCT00219557|10644357|P1|Phase 2|Death|0
3107423|NCT00219557|10644355|P3|Phase 2|Adverse Event|2
3107424|NCT00219557|10644356|P2|Phase 2|Adverse Event|22
3107425|NCT00219557|10644357|P1|Phase 2|Adverse Event|0
3107426|NCT00219557|10644355|P3|Phase 2|Lack of Efficacy|15
3107427|NCT00219557|10644356|P2|Phase 2|Lack of Efficacy|21
3107428|NCT00219557|10644357|P1|Phase 2|Lack of Efficacy|0
3107429|NCT00219557|10644355|P3|Phase 1|Started chemotherapy at other institute|0
3107430|NCT00219557|10644356|P2|Phase 1|Started chemotherapy at other institute|0
3107431|NCT00219557|10644357|P1|Phase 1|Started chemotherapy at other institute|1
3107432|NCT00219557|10644355|P3|Phase 1|Withdrawal by Subject|0
3107433|NCT00219557|10644356|P2|Phase 1|Withdrawal by Subject|0
3107434|NCT00219557|10644357|P1|Phase 1|Withdrawal by Subject|1
3107435|NCT00219557|10644355|P3|Phase 1|Adverse Event|0
3107436|NCT00219557|10644356|P2|Phase 1|Adverse Event|0
3107437|NCT00219557|10644357|P1|Phase 1|Adverse Event|2
3107438|NCT00219557|10644355|P3|Phase 1|Lack of Efficacy|0
3107439|NCT00219557|10644356|P2|Phase 1|Lack of Efficacy|0
3107440|NCT00219557|10644357|P1|Phase 1|Lack of Efficacy|3
3107441|NCT00219544|10644385|P2|Single Blind Treatment Period|Withdrawal by Subject|0
3107442|NCT00219544|10644386|P1|Single Blind Treatment Period|Withdrawal by Subject|1
3107443|NCT00219544|10644385|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
3107444|NCT00219544|10644386|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
3107445|NCT00219544|10644385|P2|Single Blind Treatment Period|Lost to Follow-up|0
3107446|NCT00219544|10644386|P1|Single Blind Treatment Period|Lost to Follow-up|2
3107447|NCT00219544|10644385|P2|Single Blind Treatment Period|Protocol Violation|0
3107448|NCT00219544|10644386|P1|Single Blind Treatment Period|Protocol Violation|4
3107449|NCT00219544|10644385|P2|Single Blind Treatment Period|Adverse Event|0
3107450|NCT00219544|10644386|P1|Single Blind Treatment Period|Adverse Event|9
3107451|NCT00219544|10644385|P2|Single Blind Treatment Period|Lack of Efficacy|0
3107452|NCT00219544|10644386|P1|Single Blind Treatment Period|Lack of Efficacy|5
3107453|NCT00219349|10644424|P1|Escitalopram Phase|Withdrawal by Subject|3
3107454|NCT00219349|10644424|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
3107455|NCT00219349|10644424|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
3107456|NCT00219349|10644424|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
3107457|NCT00219284|10644437|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
3107458|NCT00219284|10644438|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
3107459|NCT00219284|10644437|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
3107460|NCT00219284|10644438|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
3107461|NCT00219284|10644437|P2|Extension Phase - 8 Weeks|Adverse Event|3
3107462|NCT00219284|10644438|P1|Extension Phase - 8 Weeks|Adverse Event|2
3107463|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
3107464|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
3107465|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
3107466|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
3107467|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
3107468|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
3107469|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
3107470|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
3107471|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
3107472|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
3107473|NCT00219284|10644437|P2|Treatment Phase - 16 Weeks|Adverse Event|24
3107474|NCT00219284|10644438|P1|Treatment Phase - 16 Weeks|Adverse Event|26
3107475|NCT00219141|10644463|P3|Overall Study|Condition no longer requires study drug|0
3107476|NCT00219141|10644464|P2|Overall Study|Condition no longer requires study drug|0
3107477|NCT00219141|10644465|P1|Overall Study|Condition no longer requires study drug|1
3107478|NCT00219141|10644463|P3|Overall Study|Withdrawal by Subject|5
3107479|NCT00219141|10644464|P2|Overall Study|Withdrawal by Subject|3
3107480|NCT00219141|10644465|P1|Overall Study|Withdrawal by Subject|1
3107481|NCT00219141|10644463|P3|Overall Study|Protocol Violation|1
3107482|NCT00219141|10644464|P2|Overall Study|Protocol Violation|1
3107483|NCT00219141|10644465|P1|Overall Study|Protocol Violation|3
3107484|NCT00219141|10644463|P3|Overall Study|Lost to Follow-up|1
3107485|NCT00219141|10644464|P2|Overall Study|Lost to Follow-up|4
3107486|NCT00219141|10644465|P1|Overall Study|Lost to Follow-up|2
3107487|NCT00219141|10644463|P3|Overall Study|Administrative problems|0
3107488|NCT00219141|10644464|P2|Overall Study|Administrative problems|1
3107489|NCT00219141|10644465|P1|Overall Study|Administrative problems|0
3107490|NCT00219141|10644463|P3|Overall Study|Lack of Efficacy|0
3107491|NCT00219141|10644464|P2|Overall Study|Lack of Efficacy|2
3107492|NCT00219141|10644465|P1|Overall Study|Lack of Efficacy|3
3107493|NCT00219141|10644463|P3|Overall Study|Adverse Event|5
3107494|NCT00219141|10644464|P2|Overall Study|Adverse Event|10
3107495|NCT00219141|10644465|P1|Overall Study|Adverse Event|4
3107496|NCT00218634|10644511|P2|Overall Study|Lost to Follow-up|15
3107497|NCT00218634|10644512|P1|Overall Study|Lost to Follow-up|8
3107498|NCT00218543|10644532|P1|Overall Study|Adverse Event|2
3107499|NCT00218543|10644532|P1|Overall Study|Physician Decision|3
3107500|NCT00218543|10644532|P1|Overall Study|Withdrawal by Subject|1
3107501|NCT00218543|10644532|P1|Overall Study|relocated|1
3107502|NCT00218543|10644532|P1|Overall Study|Lost to Follow-up|8
3107503|NCT00218296|10644710|P2|Overall Study|Randomized but did not enter treatment|67
3107504|NCT00218296|10644711|P1|Overall Study|Randomized but did not enter treatment|66
3107505|NCT00218296|10644710|P2|Overall Study|Withdrawal by Subject|47
3107506|NCT00218296|10644711|P1|Overall Study|Withdrawal by Subject|36
3107507|NCT00218296|10644710|P2|Overall Study|Lost to Follow-up|7
3107508|NCT00218296|10644711|P1|Overall Study|Lost to Follow-up|9
3107509|NCT00217971|10644814|P2|Overall Study|non compliant|0
3107510|NCT00217971|10644815|P1|Overall Study|non compliant|1
3107511|NCT00217971|10644814|P2|Overall Study|Withdrawal by Subject|12
3107512|NCT00217971|10644815|P1|Overall Study|Withdrawal by Subject|7
3107513|NCT00217971|10644814|P2|Overall Study|Physician Decision|1
3107514|NCT00217971|10644815|P1|Overall Study|Physician Decision|0
3107515|NCT00217971|10644814|P2|Overall Study|Lost to Follow-up|19
3107516|NCT00217971|10644815|P1|Overall Study|Lost to Follow-up|15
3107517|NCT00217971|10644814|P2|Overall Study|Adverse Event|1
3107518|NCT00217971|10644815|P1|Overall Study|Adverse Event|1
3107519|NCT00217672|10644830|P2|Follow-up|Lost to Follow-up|0
3107520|NCT00217672|10644831|P1|Follow-up|Lost to Follow-up|1
3107521|NCT00217672|10644830|P2|Follow-up|Withdrawal by Subject|0
3107522|NCT00217672|10644831|P1|Follow-up|Withdrawal by Subject|4
3107523|NCT00217672|10644830|P2|Treatment|secondary malignancy|0
3107524|NCT00217672|10644831|P1|Treatment|secondary malignancy|1
3107525|NCT00217672|10644830|P2|Treatment|Death|0
3107526|NCT00217672|10644831|P1|Treatment|Death|2
3107527|NCT00217672|10644830|P2|Treatment|insurance issues|1
3107528|NCT00217672|10644831|P1|Treatment|insurance issues|1
3107529|NCT00217672|10644830|P2|Treatment|Physician Decision|0
3107530|NCT00217672|10644831|P1|Treatment|Physician Decision|6
3107531|NCT00217672|10644830|P2|Treatment|reqd treatment not permitted by protocol|0
3107532|NCT00217672|10644831|P1|Treatment|reqd treatment not permitted by protocol|6
3107533|NCT00217672|10644830|P2|Treatment|Adverse Event|2
3107534|NCT00217672|10644831|P1|Treatment|Adverse Event|18
3107535|NCT00217672|10644830|P2|Treatment|disease progression|4
3107536|NCT00217672|10644831|P1|Treatment|disease progression|33
3107537|NCT00217672|10644830|P2|Allocation|Ineligible|0
3107538|NCT00217672|10644831|P1|Allocation|Ineligible|2
3107539|NCT00217620|10644837|P1|Overall Study|Never received treatment|1
3107540|NCT00217620|10644837|P1|Overall Study|Ineligible|13
3107541|NCT00217620|10644837|P1|Overall Study|Not Protocol Specified|4
3107542|NCT00217620|10644837|P1|Overall Study|Progression|31
3107543|NCT00217620|10644837|P1|Overall Study|Adverse Event|2
3107544|NCT00217581|10644852|P1|Overall Study|Withdrawal by Subject|1
3107545|NCT00217464|10644881|P1|Overall Study|Other|2
3107546|NCT00217464|10644881|P1|Overall Study|Progression|15
3107547|NCT00217425|10644897|P1|Overall Study|Other|4
3107548|NCT00217425|10644897|P1|Overall Study|Other complicating disease|1
3107549|NCT00217425|10644897|P1|Overall Study|Withdrawal by Subject|4
3107550|NCT00217425|10644897|P1|Overall Study|Adverse Event|8
3107551|NCT00217425|10644897|P1|Overall Study|Lack of Efficacy|13
3107552|NCT00217425|10644897|P1|Overall Study|Patient ineligible|5
3107553|NCT00217425|10644897|P1|Overall Study|Never started treatment|2
3107554|NCT00217087|10644911|P2|Overall Study|completed less than 12 months return|18
3107555|NCT00217087|10644912|P1|Overall Study|completed less than 12 months return|10
3107556|NCT00217087|10644911|P2|Overall Study|decided to have esophagectomy|2
3107557|NCT00217087|10644912|P1|Overall Study|decided to have esophagectomy|1
3107558|NCT00217022|10644926|P2|Overall Study|Withdrawal by Subject|1
3107559|NCT00217022|10644927|P1|Overall Study|Withdrawal by Subject|1
3107560|NCT00216736|10644937|P2|Overall Study|Lost to Follow-up|1
3107561|NCT00216736|10644938|P1|Overall Study|Lost to Follow-up|1
3107562|NCT00216671|10644952|P2|Overall Study|Insufficient Response Adverse Event|1
3107563|NCT00216671|10644953|P1|Overall Study|Insufficient Response Adverse Event|2
3107564|NCT00216671|10644952|P2|Overall Study|Ineligible, no efficacy data|2
3107565|NCT00216671|10644953|P1|Overall Study|Ineligible, no efficacy data|2
3107566|NCT00216671|10644952|P2|Overall Study|Patient Moved|1
3107567|NCT00216671|10644953|P1|Overall Study|Patient Moved|0
3107568|NCT00216671|10644952|P2|Overall Study|Investigator Illness|1
3107569|NCT00216671|10644953|P1|Overall Study|Investigator Illness|0
3107570|NCT00216671|10644952|P2|Overall Study|Relapse|0
3107571|NCT00216671|10644953|P1|Overall Study|Relapse|1
3107572|NCT00216671|10644952|P2|Overall Study|Protocol Violation|5
3107573|NCT00216671|10644953|P1|Overall Study|Protocol Violation|3
3107574|NCT00216671|10644952|P2|Overall Study|Physician Decision|1
3107575|NCT00216671|10644953|P1|Overall Study|Physician Decision|1
3107576|NCT00216671|10644952|P2|Overall Study|Ineligible|2
3107577|NCT00216671|10644953|P1|Overall Study|Ineligible|0
3107578|NCT00216671|10644952|P2|Overall Study|Non compliant|2
3107579|NCT00216671|10644953|P1|Overall Study|Non compliant|2
3107580|NCT00216671|10644952|P2|Overall Study|Lost to Follow-up|5
3107581|NCT00216671|10644953|P1|Overall Study|Lost to Follow-up|3
3107582|NCT00216671|10644952|P2|Overall Study|Insufficient Response|4
3107583|NCT00216671|10644953|P1|Overall Study|Insufficient Response|9
3107584|NCT00216671|10644952|P2|Overall Study|No Need to Continue Medication|1
3107585|NCT00216671|10644953|P1|Overall Study|No Need to Continue Medication|1
3107586|NCT00216671|10644952|P2|Overall Study|Refused Injections|13
3107587|NCT00216671|10644953|P1|Overall Study|Refused Injections|3
3107588|NCT00216671|10644952|P2|Overall Study|Withdrawal by Subject|2
3107589|NCT00216671|10644953|P1|Overall Study|Withdrawal by Subject|4
3107590|NCT00216671|10644952|P2|Overall Study|Pregnancy|1
3107591|NCT00216671|10644953|P1|Overall Study|Pregnancy|0
3107592|NCT00216671|10644952|P2|Overall Study|Adverse Event|9
3107593|NCT00216671|10644953|P1|Overall Study|Adverse Event|4
3107594|NCT00216476|10644971|P3|Overall Study|Patient Moved|0
3107595|NCT00216476|10644972|P2|Overall Study|Patient Moved|2
3107596|NCT00216476|10644973|P1|Overall Study|Patient Moved|2
3107597|NCT00216476|10644971|P3|Overall Study|Protocol Deviation|0
3107598|NCT00216476|10644972|P2|Overall Study|Protocol Deviation|1
3107599|NCT00216476|10644973|P1|Overall Study|Protocol Deviation|5
3107600|NCT00216476|10644971|P3|Overall Study|Administrative Reasons|0
3107601|NCT00216476|10644972|P2|Overall Study|Administrative Reasons|1
3107602|NCT00216476|10644973|P1|Overall Study|Administrative Reasons|1
3107603|NCT00216476|10644971|P3|Overall Study|Higher dose/Extra Medication Required|2
3107604|NCT00216476|10644972|P2|Overall Study|Higher dose/Extra Medication Required|0
3107605|NCT00216476|10644973|P1|Overall Study|Higher dose/Extra Medication Required|2
3107606|NCT00216476|10644971|P3|Overall Study|Non-compliance|1
3107607|NCT00216476|10644972|P2|Overall Study|Non-compliance|4
3107608|NCT00216476|10644973|P1|Overall Study|Non-compliance|0
3107609|NCT00216476|10644971|P3|Overall Study|No Further Need for Treatment|1
3107610|NCT00216476|10644972|P2|Overall Study|No Further Need for Treatment|4
3107611|NCT00216476|10644973|P1|Overall Study|No Further Need for Treatment|3
3107612|NCT00216476|10644971|P3|Overall Study|Refuses Injection|0
3107613|NCT00216476|10644972|P2|Overall Study|Refuses Injection|0
3107614|NCT00216476|10644973|P1|Overall Study|Refuses Injection|11
3107615|NCT00216476|10644971|P3|Overall Study|Other|1
3107616|NCT00216476|10644972|P2|Overall Study|Other|0
3107617|NCT00216476|10644973|P1|Overall Study|Other|0
3107618|NCT00216476|10644971|P3|Overall Study|Pregnancy|1
3107619|NCT00216476|10644972|P2|Overall Study|Pregnancy|1
3107620|NCT00216476|10644973|P1|Overall Study|Pregnancy|0
3107621|NCT00216476|10644971|P3|Overall Study|Death|0
3107622|NCT00216476|10644972|P2|Overall Study|Death|0
3107623|NCT00216476|10644973|P1|Overall Study|Death|2
3107624|NCT00216476|10644971|P3|Overall Study|Lack of Efficacy|0
3107625|NCT00216476|10644972|P2|Overall Study|Lack of Efficacy|3
3107626|NCT00216476|10644973|P1|Overall Study|Lack of Efficacy|4
3107627|NCT00216476|10644971|P3|Overall Study|Adverse Event|1
3107628|NCT00216476|10644972|P2|Overall Study|Adverse Event|10
3107629|NCT00216476|10644973|P1|Overall Study|Adverse Event|6
3107630|NCT00216476|10644971|P3|Overall Study|Lost to Follow-up|1
3107631|NCT00216476|10644972|P2|Overall Study|Lost to Follow-up|9
3107632|NCT00216476|10644973|P1|Overall Study|Lost to Follow-up|10
3107633|NCT00216476|10644971|P3|Overall Study|Withdrawal by Subject|9
3107634|NCT00216476|10644972|P2|Overall Study|Withdrawal by Subject|72
3107635|NCT00216476|10644973|P1|Overall Study|Withdrawal by Subject|59
3107636|NCT00216203|10645010|P1|Overall Study|Withdrawal by Subject|2
3107637|NCT00216086|10645040|P1|Overall Study|Social Reasons|2
3107638|NCT00216086|10645040|P1|Overall Study|Diagnosis of Metastatic Disease|1
3107639|NCT00216086|10645040|P1|Overall Study|Protocol Violation|1
3107640|NCT00215943|10645072|P2|Overall Study|Other complications|1
3107641|NCT00215943|10645073|P1|Overall Study|Other complications|3
3107642|NCT00215943|10645072|P2|Overall Study|Other disease|1
3107643|NCT00215943|10645073|P1|Overall Study|Other disease|0
3107644|NCT00215943|10645072|P2|Overall Study|Adverse Event|6
3107645|NCT00215943|10645073|P1|Overall Study|Adverse Event|3
3107646|NCT00215943|10645072|P2|Overall Study|Alternate therapy|1
3107647|NCT00215943|10645073|P1|Overall Study|Alternate therapy|0
3107648|NCT00215943|10645072|P2|Overall Study|Disease Progression|5
3107649|NCT00215943|10645073|P1|Overall Study|Disease Progression|3
3107650|NCT00215683|10645098|P3|Overall Study|Intermittent therapy required|0
3107651|NCT00215683|10645099|P2|Overall Study|Intermittent therapy required|1
3107652|NCT00215683|10645100|P1|Overall Study|Intermittent therapy required|0
3107653|NCT00215683|10645098|P3|Overall Study|No study drug available|0
3107654|NCT00215683|10645099|P2|Overall Study|No study drug available|1
3107655|NCT00215683|10645100|P1|Overall Study|No study drug available|0
3107656|NCT00215683|10645098|P3|Overall Study|Difficult to attend visits|0
3107657|NCT00215683|10645099|P2|Overall Study|Difficult to attend visits|1
3107658|NCT00215683|10645100|P1|Overall Study|Difficult to attend visits|0
3107659|NCT00215683|10645098|P3|Overall Study|Physician Decision|1
3107660|NCT00215683|10645099|P2|Overall Study|Physician Decision|0
3107661|NCT00215683|10645100|P1|Overall Study|Physician Decision|0
3107662|NCT00215683|10645098|P3|Overall Study|Withdrawal by Subject|13
3107663|NCT00215683|10645099|P2|Overall Study|Withdrawal by Subject|4
3107664|NCT00215683|10645100|P1|Overall Study|Withdrawal by Subject|9
3107665|NCT00215683|10645098|P3|Overall Study|Lost to Follow-up|1
3107666|NCT00215683|10645099|P2|Overall Study|Lost to Follow-up|2
3107667|NCT00215683|10645100|P1|Overall Study|Lost to Follow-up|0
3107668|NCT00215683|10645098|P3|Overall Study|Lack of Efficacy|2
3107669|NCT00215683|10645099|P2|Overall Study|Lack of Efficacy|1
3107670|NCT00215683|10645100|P1|Overall Study|Lack of Efficacy|5
3107671|NCT00215683|10645098|P3|Overall Study|Adverse Event|15
3107672|NCT00215683|10645099|P2|Overall Study|Adverse Event|16
3107673|NCT00215683|10645100|P1|Overall Study|Adverse Event|15
3107674|NCT00215657|10645119|P8|Overall Study|Other|1
3107675|NCT00215657|10645120|P7|Overall Study|Other|6
3107676|NCT00215657|10645121|P6|Overall Study|Other|4
3107677|NCT00215657|10645122|P5|Overall Study|Other|5
3107678|NCT00215657|10645123|P4|Overall Study|Other|3
3107679|NCT00215657|10645124|P3|Overall Study|Other|2
3107680|NCT00215657|10645125|P2|Overall Study|Other|1
3107681|NCT00215657|10645126|P1|Overall Study|Other|3
3107682|NCT00215657|10645119|P8|Overall Study|Insufficient testosterone response|7
3107683|NCT00215657|10645120|P7|Overall Study|Insufficient testosterone response|4
3107684|NCT00215657|10645121|P6|Overall Study|Insufficient testosterone response|12
3107685|NCT00215657|10645122|P5|Overall Study|Insufficient testosterone response|8
3107686|NCT00215657|10645123|P4|Overall Study|Insufficient testosterone response|12
3107687|NCT00215657|10645124|P3|Overall Study|Insufficient testosterone response|1
3107688|NCT00215657|10645125|P2|Overall Study|Insufficient testosterone response|4
3107689|NCT00215657|10645126|P1|Overall Study|Insufficient testosterone response|5
3107690|NCT00215657|10645119|P8|Overall Study|Insuff prostate specific antigen resp|2
3107691|NCT00215657|10645120|P7|Overall Study|Insuff prostate specific antigen resp|3
3107692|NCT00215657|10645121|P6|Overall Study|Insuff prostate specific antigen resp|2
3107693|NCT00215657|10645122|P5|Overall Study|Insuff prostate specific antigen resp|1
3107694|NCT00215657|10645123|P4|Overall Study|Insuff prostate specific antigen resp|2
3107695|NCT00215657|10645124|P3|Overall Study|Insuff prostate specific antigen resp|2
3107696|NCT00215657|10645125|P2|Overall Study|Insuff prostate specific antigen resp|2
3107697|NCT00215657|10645126|P1|Overall Study|Insuff prostate specific antigen resp|3
3107698|NCT00215657|10645119|P8|Overall Study|Withdrawal by Subject|3
3107699|NCT00215657|10645120|P7|Overall Study|Withdrawal by Subject|10
3107700|NCT00215657|10645121|P6|Overall Study|Withdrawal by Subject|1
3107701|NCT00215657|10645122|P5|Overall Study|Withdrawal by Subject|6
3107702|NCT00215657|10645123|P4|Overall Study|Withdrawal by Subject|1
3107703|NCT00215657|10645124|P3|Overall Study|Withdrawal by Subject|3
3107704|NCT00215657|10645125|P2|Overall Study|Withdrawal by Subject|3
3107705|NCT00215657|10645126|P1|Overall Study|Withdrawal by Subject|6
3107706|NCT00215657|10645119|P8|Overall Study|Adverse Event|3
3107707|NCT00215657|10645120|P7|Overall Study|Adverse Event|0
3107708|NCT00215657|10645121|P6|Overall Study|Adverse Event|1
3107709|NCT00215657|10645122|P5|Overall Study|Adverse Event|3
3107710|NCT00215657|10645123|P4|Overall Study|Adverse Event|0
3107711|NCT00215657|10645124|P3|Overall Study|Adverse Event|3
3107712|NCT00215657|10645125|P2|Overall Study|Adverse Event|1
3107713|NCT00215657|10645126|P1|Overall Study|Adverse Event|5
3107714|NCT00215644|10645154|P2|Overall Study|Randomized but Not Treated|0
3107715|NCT00215644|10645155|P1|Overall Study|Randomized but Not Treated|1
3107716|NCT00215644|10645154|P2|Overall Study|Other|15
3107717|NCT00215644|10645155|P1|Overall Study|Other|3
3107718|NCT00215644|10645154|P2|Overall Study|Withdrawal by Subject|0
3107719|NCT00215644|10645155|P1|Overall Study|Withdrawal by Subject|1
3107720|NCT00215644|10645154|P2|Overall Study|Death|2
3107721|NCT00215644|10645155|P1|Overall Study|Death|1
3107722|NCT00215644|10645154|P2|Overall Study|Adverse Event|9
3107723|NCT00215644|10645155|P1|Overall Study|Adverse Event|2
3107724|NCT00215644|10645154|P2|Overall Study|Disease Progression|10
3107725|NCT00215644|10645155|P1|Overall Study|Disease Progression|28
3107726|NCT00215553|10645182|P7|Overall Study|Adverse Event|0
3107727|NCT00215553|10645183|P6|Overall Study|Adverse Event|6
3107728|NCT00215553|10645184|P5|Overall Study|Adverse Event|2
3107729|NCT00215553|10645185|P4|Overall Study|Adverse Event|1
3107730|NCT00215553|10645186|P3|Overall Study|Adverse Event|2
3107731|NCT00215553|10645187|P2|Overall Study|Adverse Event|1
3107732|NCT00215553|10645188|P1|Overall Study|Adverse Event|0
3107733|NCT00215540|10645221|P3|Overall Study|Withdrew from study medication|0
3107734|NCT00215540|10645222|P2|Overall Study|Withdrew from study medication|0
3107735|NCT00215540|10645223|P1|Overall Study|Withdrew from study medication|1
3107736|NCT00215150|10645258|P1|Randomization Phase Placebo|Withdrawal by Subject|1
3107737|NCT00215150|10645258|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
3107738|NCT00215150|10645258|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
3107739|NCT00215150|10645258|P1|Open Label Phase|Did not meet randomization criteria|9
3107740|NCT00215150|10645258|P1|Open Label Phase|Did not complete a post base visit|13
3107741|NCT00215150|10645258|P1|Open Label Phase|Withdrawal by Subject|1
3107742|NCT00215150|10645258|P1|Open Label Phase|Lost to Follow-up|7
3107743|NCT00215137|10645266|P3|Randomization Period|Withdrawal by Subject|0
3107744|NCT00215137|10645267|P2|Randomization Period|Withdrawal by Subject|1
3107745|NCT00215137|10645268|P1|Randomization Period|Withdrawal by Subject|0
3107746|NCT00215137|10645266|P3|Randomization Period|Lost to Follow-up|0
3107747|NCT00215137|10645267|P2|Randomization Period|Lost to Follow-up|1
3107748|NCT00215137|10645268|P1|Randomization Period|Lost to Follow-up|0
3107749|NCT00215137|10645266|P3|Open Label Escitalopram|Lack of Efficacy|0
3107750|NCT00215137|10645267|P2|Open Label Escitalopram|Lack of Efficacy|0
3107751|NCT00215137|10645268|P1|Open Label Escitalopram|Lack of Efficacy|1
3107752|NCT00214500|10645366|P1|Extension Period|Withdrawal by Subject|2
3107753|NCT00214500|10645366|P1|Treatment Period|Adverse Event|1
3107754|NCT00214461|10645387|P4|Overall Study|Withdrawal by Subject|0
3107755|NCT00214461|10645388|P3|Overall Study|Withdrawal by Subject|1
3107756|NCT00214461|10645389|P2|Overall Study|Withdrawal by Subject|0
3107757|NCT00214461|10645390|P1|Overall Study|Withdrawal by Subject|0
3107758|NCT00214461|10645387|P4|Overall Study|Adverse Event|1
3107759|NCT00214461|10645388|P3|Overall Study|Adverse Event|1
3107760|NCT00214461|10645389|P2|Overall Study|Adverse Event|0
3107761|NCT00214461|10645390|P1|Overall Study|Adverse Event|0
3107762|NCT00214422|10645407|P3|Overall Study|Unable to make a radiation treatment|1
3107763|NCT00214422|10645408|P2|Overall Study|Unable to make a radiation treatment|0
3107764|NCT00214422|10645409|P1|Overall Study|Unable to make a radiation treatment|0
3107765|NCT00214422|10645407|P3|Overall Study|Disease progression on study|0
3107766|NCT00214422|10645408|P2|Overall Study|Disease progression on study|0
3107767|NCT00214422|10645409|P1|Overall Study|Disease progression on study|1
3107768|NCT00214422|10645407|P3|Overall Study|Pt taken off study|0
3107769|NCT00214422|10645408|P2|Overall Study|Pt taken off study|1
3107770|NCT00214422|10645409|P1|Overall Study|Pt taken off study|1
3107771|NCT00214422|10645407|P3|Overall Study|Developed esophageal ca|0
3107772|NCT00214422|10645408|P2|Overall Study|Developed esophageal ca|0
3107773|NCT00214422|10645409|P1|Overall Study|Developed esophageal ca|1
3107774|NCT00214422|10645407|P3|Overall Study|Physician Decision|0
3107775|NCT00214422|10645408|P2|Overall Study|Physician Decision|0
3107776|NCT00214422|10645409|P1|Overall Study|Physician Decision|2
3107777|NCT00214383|10645432|P2|Overall Study|Lost to Follow-up|26
3107778|NCT00214383|10645433|P1|Overall Study|Lost to Follow-up|16
3107779|NCT00214201|10645445|P2|Overall Study|Death|2
3107780|NCT00214201|10645446|P1|Overall Study|Death|0
3107781|NCT00214201|10645445|P2|Overall Study|Withdrawal by Subject|0
3107782|NCT00214201|10645446|P1|Overall Study|Withdrawal by Subject|2
3107783|NCT00214136|10645461|P1|Overall Study|Death|5
3107784|NCT00214019|10645506|P1|Overall Study|Screen Failed prior to randomization|17
3107785|NCT00214019|10645506|P1|Overall Study|Withdrawal by Subject|2
3107786|NCT00214019|10645506|P1|Overall Study|Lost to Follow-up|11
3107787|NCT00213980|10645515|P2|Overall Study|Failed to obtain all 3 DXAs|3
3107788|NCT00213980|10645516|P1|Overall Study|Failed to obtain all 3 DXAs|1
3107789|NCT00213980|10645515|P2|Overall Study|Developed ovarian cancer|0
3107790|NCT00213980|10645516|P1|Overall Study|Developed ovarian cancer|1
3107791|NCT00213980|10645515|P2|Overall Study|Disease progression|2
3107792|NCT00213980|10645516|P1|Overall Study|Disease progression|0
3107793|NCT00213980|10645515|P2|Overall Study|Adverse Event|1
3107794|NCT00213980|10645516|P1|Overall Study|Adverse Event|1
3107795|NCT00213980|10645515|P2|Overall Study|Withdrawal by Subject|1
3107796|NCT00213980|10645516|P1|Overall Study|Withdrawal by Subject|3
3107797|NCT00213148|10645543|P5|Cycle 3 (1 Month)|Other|0
3107798|NCT00213148|10645544|P4|Cycle 3 (1 Month)|Other|1
3107799|NCT00213148|10645545|P3|Cycle 3 (1 Month)|Other|1
3107800|NCT00213148|10645546|P2|Cycle 3 (1 Month)|Other|0
3107801|NCT00213148|10645547|P1|Cycle 3 (1 Month)|Other|0
3107802|NCT00213148|10645543|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
3107803|NCT00213148|10645544|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
3107804|NCT00213148|10645545|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
3107805|NCT00213148|10645546|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
3107806|NCT00213148|10645547|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
3107807|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
3107808|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
3107809|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
3107810|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
3107811|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
3107812|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
3107813|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
3107814|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
3107815|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
3107816|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
3107817|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
3107818|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
3107819|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
3107820|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
3107821|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
3107822|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Other|7
3107823|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Other|8
3107824|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Other|2
3107825|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Other|1
3107826|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Other|2
3107827|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
3107828|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
3107829|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
3107830|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
3107831|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
3107832|NCT00213148|10645543|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
3107833|NCT00213148|10645544|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
3107834|NCT00213148|10645545|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
3107835|NCT00213148|10645546|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
3107836|NCT00213148|10645547|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
3107837|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
3107838|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
3107839|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
3107840|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
3107841|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
3107842|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
3107843|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
3107844|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
3107845|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
3107846|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
3107847|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
3107848|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
3107849|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
3107850|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
3107851|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
3107852|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Other|7
3107853|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Other|2
3107854|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Other|2
3107855|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Other|0
3107856|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Other|3
3107857|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Protocol Violation|0
3107858|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Protocol Violation|0
3107859|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Protocol Violation|1
3107860|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Protocol Violation|0
3107861|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Protocol Violation|1
3107862|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
3107863|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
3107864|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
3107865|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
3107866|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
3107867|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Adverse Event|0
3107868|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Adverse Event|0
3107869|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Adverse Event|1
3107870|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Adverse Event|0
3107871|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Adverse Event|0
3107872|NCT00213148|10645543|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
3107873|NCT00213148|10645544|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
3107874|NCT00213148|10645545|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
3107875|NCT00213148|10645546|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
3107876|NCT00213148|10645547|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
3107877|NCT00213135|10645574|P3|Overall Study|Other|15
3107878|NCT00213135|10645575|P2|Overall Study|Other|12
3107879|NCT00213135|10645576|P1|Overall Study|Other|21
3107880|NCT00213135|10645574|P3|Overall Study|Disease progression|21
3107881|NCT00213135|10645575|P2|Overall Study|Disease progression|5
3107882|NCT00213135|10645576|P1|Overall Study|Disease progression|4
3107883|NCT00213135|10645574|P3|Overall Study|Death|2
3107884|NCT00213135|10645575|P2|Overall Study|Death|1
3107885|NCT00213135|10645576|P1|Overall Study|Death|1
3107886|NCT00213135|10645574|P3|Overall Study|Protocol Violation|10
3107887|NCT00213135|10645575|P2|Overall Study|Protocol Violation|4
3107888|NCT00213135|10645576|P1|Overall Study|Protocol Violation|4
3107889|NCT00213135|10645574|P3|Overall Study|Lost to Follow-up|4
3107890|NCT00213135|10645575|P2|Overall Study|Lost to Follow-up|8
3107891|NCT00213135|10645576|P1|Overall Study|Lost to Follow-up|11
3107892|NCT00213135|10645574|P3|Overall Study|Adverse Event|5
3107893|NCT00213135|10645575|P2|Overall Study|Adverse Event|5
3107894|NCT00213135|10645576|P1|Overall Study|Adverse Event|9
3107895|NCT00212758|10645619|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
3107896|NCT00212758|10645620|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
3107897|NCT00212758|10645619|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
3107898|NCT00212758|10645620|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
3107899|NCT00212355|10645636|P1|Overall Study|A change of address|1
3107900|NCT00212355|10645636|P1|Overall Study|Withdrawal by Subject|1
3107901|NCT00212355|10645636|P1|Overall Study|Adverse Event|1
3107902|NCT00212134|10645657|P2|Phase 3 (Age 10 Years)|On Going|21
3107903|NCT00212134|10645658|P1|Phase 3 (Age 10 Years)|On Going|21
3107904|NCT00211887|10645679|P3|Overall Study|Side effects|5
3107905|NCT00211887|10645680|P2|Overall Study|Side effects|13
3107906|NCT00211887|10645681|P1|Overall Study|Side effects|19
3107907|NCT00211887|10645679|P3|Overall Study|Other medical reason|7
3107908|NCT00211887|10645680|P2|Overall Study|Other medical reason|11
3107909|NCT00211887|10645681|P1|Overall Study|Other medical reason|15
3107910|NCT00211887|10645679|P3|Overall Study|Non-medical reason|8
3107911|NCT00211887|10645680|P2|Overall Study|Non-medical reason|14
3107912|NCT00211887|10645681|P1|Overall Study|Non-medical reason|31
3107913|NCT00211887|10645679|P3|Overall Study|Lost to Follow-up|9
3107914|NCT00211887|10645680|P2|Overall Study|Lost to Follow-up|13
3107915|NCT00211887|10645681|P1|Overall Study|Lost to Follow-up|28
3107916|NCT00211887|10645679|P3|Overall Study|Death|1
3107917|NCT00211887|10645680|P2|Overall Study|Death|1
3107918|NCT00211887|10645681|P1|Overall Study|Death|1
3107919|NCT00211887|10645679|P3|Overall Study|Adverse Event|6
3107920|NCT00211887|10645680|P2|Overall Study|Adverse Event|4
3107921|NCT00211887|10645681|P1|Overall Study|Adverse Event|8
3107922|NCT00211809|10645698|P1|Overall Study|side effects|2
3107923|NCT00211809|10645698|P1|Overall Study|Pregnancy|1
3107924|NCT00211809|10645698|P1|Overall Study|Lost to Follow-up|2
3107925|NCT00211809|10645698|P1|Overall Study|Lack of Efficacy|1
3107926|NCT00211757|10645714|P2|Overall Study|Lack of Efficacy|1
3107927|NCT00211757|10645715|P1|Overall Study|Lack of Efficacy|0
3107928|NCT00211757|10645714|P2|Overall Study|Withdrawal by Subject|1
3107929|NCT00211757|10645715|P1|Overall Study|Withdrawal by Subject|1
3107930|NCT00211536|10645736|P2|Overall Study|Adverse Event|0
3107931|NCT00211536|10645737|P1|Overall Study|Adverse Event|2
3107932|NCT00211536|10645736|P2|Overall Study|Physician Decision|5
3107933|NCT00211536|10645737|P1|Overall Study|Physician Decision|0
3107934|NCT00211536|10645736|P2|Overall Study|Withdrawal by Subject|2
3107935|NCT00211536|10645737|P1|Overall Study|Withdrawal by Subject|2
3107936|NCT00211510|10645753|P2|Overall Study|Withdrawal by Subject|1
3107937|NCT00211510|10645754|P1|Overall Study|Withdrawal by Subject|3
3107938|NCT00211510|10645753|P2|Overall Study|Physician Decision|1
3107939|NCT00211510|10645754|P1|Overall Study|Physician Decision|3
3107940|NCT00211237|10645772|P3|12 Months|unrelated medical problem|1
3107941|NCT00211237|10645773|P2|12 Months|unrelated medical problem|0
3107942|NCT00211237|10645774|P1|12 Months|unrelated medical problem|0
3107943|NCT00211237|10645772|P3|12 Months|Withdrew|1
3107944|NCT00211237|10645773|P2|12 Months|Withdrew|0
3107945|NCT00211237|10645774|P1|12 Months|Withdrew|0
3107946|NCT00211237|10645772|P3|12 Months|Lost to Follow-up|1
3107947|NCT00211237|10645773|P2|12 Months|Lost to Follow-up|0
3107948|NCT00211237|10645774|P1|12 Months|Lost to Follow-up|1
3107949|NCT00211237|10645772|P3|12 Months|Death|3
3107950|NCT00211237|10645773|P2|12 Months|Death|2
3107951|NCT00211237|10645774|P1|12 Months|Death|8
3107952|NCT00211237|10645772|P3|6 Months|Could not comply with protocol|0
3107953|NCT00211237|10645773|P2|6 Months|Could not comply with protocol|2
3107954|NCT00211237|10645774|P1|6 Months|Could not comply with protocol|0
3107955|NCT00211237|10645772|P3|6 Months|Lost to Follow-up|0
3107956|NCT00211237|10645773|P2|6 Months|Lost to Follow-up|0
3107957|NCT00211237|10645774|P1|6 Months|Lost to Follow-up|2
3107958|NCT00211237|10645772|P3|6 Months|Death|3
3107959|NCT00211237|10645773|P2|6 Months|Death|0
3107960|NCT00211237|10645774|P1|6 Months|Death|6
3107961|NCT00211237|10645772|P3|3 Months|Non-medical problem|1
3107962|NCT00211237|10645773|P2|3 Months|Non-medical problem|0
3107963|NCT00211237|10645774|P1|3 Months|Non-medical problem|0
3107964|NCT00211237|10645772|P3|3 Months|Withdrew|0
3107965|NCT00211237|10645773|P2|3 Months|Withdrew|1
3107966|NCT00211237|10645774|P1|3 Months|Withdrew|0
3107967|NCT00211237|10645772|P3|3 Months|Could not comply with protocol|0
3107968|NCT00211237|10645773|P2|3 Months|Could not comply with protocol|0
3107969|NCT00211237|10645774|P1|3 Months|Could not comply with protocol|1
3107970|NCT00211237|10645772|P3|3 Months|Death|0
3107971|NCT00211237|10645773|P2|3 Months|Death|3
3107972|NCT00211237|10645774|P1|3 Months|Death|7
3107973|NCT00211237|10645772|P3|1 Month|Non-medical problem|0
3107974|NCT00211237|10645773|P2|1 Month|Non-medical problem|2
3107975|NCT00211237|10645774|P1|1 Month|Non-medical problem|0
3107976|NCT00211237|10645772|P3|1 Month|Additional surgery needed|0
3107977|NCT00211237|10645773|P2|1 Month|Additional surgery needed|0
3107978|NCT00211237|10645774|P1|1 Month|Additional surgery needed|1
3107979|NCT00211237|10645772|P3|1 Month|Withdrew|0
3107980|NCT00211237|10645773|P2|1 Month|Withdrew|4
3107981|NCT00211237|10645774|P1|1 Month|Withdrew|0
3107982|NCT00211237|10645772|P3|1 Month|Lost to Follow-up|0
3107983|NCT00211237|10645773|P2|1 Month|Lost to Follow-up|2
3107984|NCT00211237|10645774|P1|1 Month|Lost to Follow-up|0
3107985|NCT00211237|10645772|P3|1 Month|Death|0
3107986|NCT00211237|10645773|P2|1 Month|Death|1
3107987|NCT00211237|10645774|P1|1 Month|Death|2
3107988|NCT00211237|10645772|P3|Baseline|Refused random assignment|0
3107989|NCT00211237|10645773|P2|Baseline|Refused random assignment|0
3107990|NCT00211237|10645774|P1|Baseline|Refused random assignment|1
3107991|NCT00211237|10645772|P3|Baseline|Withdrew|0
3107992|NCT00211237|10645773|P2|Baseline|Withdrew|3
3107993|NCT00211237|10645774|P1|Baseline|Withdrew|1
3107994|NCT00211185|10645864|P1|Overall Study|Physician Decision|5
3107995|NCT00211185|10645864|P1|Overall Study|Withdrawal by Subject|6
3107996|NCT00211185|10645864|P1|Overall Study|Disease progression|7
3107997|NCT00211185|10645864|P1|Overall Study|Death|2
3107998|NCT00211172|10645878|P2|Overall Study|Died or lost health plan eligibility|32
3107999|NCT00211172|10645879|P1|Overall Study|Died or lost health plan eligibility|39
3108000|NCT00211081|10645885|P1|Overall Study|Withdrawal by Subject|2
3108001|NCT00210639|10645897|P2|Overall Study|Other|12
3108002|NCT00210639|10645898|P1|Overall Study|Other|18
3108003|NCT00210639|10645897|P2|Overall Study|Withdrawal by Subject|1
3108004|NCT00210639|10645898|P1|Overall Study|Withdrawal by Subject|8
3108005|NCT00210639|10645897|P2|Overall Study|Lost to Follow-up|29
3108006|NCT00210639|10645898|P1|Overall Study|Lost to Follow-up|37
3108007|NCT00210626|10645906|P2|Overall Study|Other|5
3108008|NCT00210626|10645907|P1|Overall Study|Other|4
3108009|NCT00210626|10645906|P2|Overall Study|Sponser Request|0
3108010|NCT00210626|10645907|P1|Overall Study|Sponser Request|1
3108011|NCT00210626|10645906|P2|Overall Study|Physician Decision|2
3108012|NCT00210626|10645907|P1|Overall Study|Physician Decision|0
3108013|NCT00210626|10645906|P2|Overall Study|Withdrawal by Subject|20
3108014|NCT00210626|10645907|P1|Overall Study|Withdrawal by Subject|29
3108015|NCT00210626|10645906|P2|Overall Study|Death|0
3108016|NCT00210626|10645907|P1|Overall Study|Death|1
3108017|NCT00210626|10645906|P2|Overall Study|Lost to Follow-up|11
3108018|NCT00210626|10645907|P1|Overall Study|Lost to Follow-up|11
3108019|NCT00210626|10645906|P2|Overall Study|Protocol Violation|5
3108020|NCT00210626|10645907|P1|Overall Study|Protocol Violation|1
3108021|NCT00210626|10645906|P2|Overall Study|Adverse Event|2
3108022|NCT00210626|10645907|P1|Overall Study|Adverse Event|1
3108023|NCT00210470|10645915|P1|Overall Study|Subject did not continue to surgery|1
3108024|NCT00209560|10645946|P2|Overall Study|Lack of Efficacy|0
3108025|NCT00209560|10645947|P1|Overall Study|Lack of Efficacy|1
3108026|NCT00209339|10645966|P1|At 5 Years Follow-up|Death|1
3108027|NCT00209339|10645966|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
3108028|NCT00209339|10645966|P1|At 5 Years Follow-up|Withdrawal by Subject|2
3108029|NCT00209339|10645966|P1|At 4 Years Follow-up|Death|1
3108030|NCT00209339|10645966|P1|At 4 Years Follow-up|Withdrawal by Subject|4
3108031|NCT00209339|10645966|P1|At 3 Years Follow-up|Withdrawal by Subject|1
3108032|NCT00209339|10645966|P1|At 24 Months Follow-up|Death|1
3108033|NCT00209339|10645966|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
3108034|NCT00209339|10645966|P1|At 24 Months Follow-up|Withdrawal by Subject|4
3108035|NCT00209339|10645966|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
3108036|NCT00209339|10645966|P1|At 12 Months Follow-up|Death|1
3108037|NCT00209339|10645966|P1|At 12 Months Follow-up|Withdrawal by Subject|8
3108038|NCT00209274|10646050|P2|Overall Study|Randomized not treated (RNT)|15
3108039|NCT00209274|10646051|P1|Overall Study|Randomized not treated (RNT)|6
3108040|NCT00209274|10646050|P2|Overall Study|Withdrawal by Subject|15
3108041|NCT00209274|10646051|P1|Overall Study|Withdrawal by Subject|30
3108042|NCT00209274|10646050|P2|Overall Study|Death|15
3108043|NCT00209274|10646051|P1|Overall Study|Death|32
3108044|NCT00209274|10646050|P2|Overall Study|Missed visit|2
3108045|NCT00209274|10646051|P1|Overall Study|Missed visit|3
3108046|NCT00209170|10646371|P2|Overall Study|Lack of Efficacy|1
3108047|NCT00209170|10646372|P1|Overall Study|Lack of Efficacy|0
3108048|NCT00209170|10646371|P2|Overall Study|Withdrawal by Subject|1
3108049|NCT00209170|10646372|P1|Overall Study|Withdrawal by Subject|2
3108050|NCT00209170|10646371|P2|Overall Study|Adverse Event|1
3108051|NCT00209170|10646372|P1|Overall Study|Adverse Event|0
3108052|NCT00209131|10646380|P2|Overall Study|Lack of personnel due to turnovers.|11
3108053|NCT00209131|10646381|P1|Overall Study|Lack of personnel due to turnovers.|15
3108054|NCT00209092|10646391|P2|Overall Study|Withdrawal by Subject|0
3108055|NCT00209092|10646392|P1|Overall Study|Withdrawal by Subject|1
3108056|NCT00209092|10646391|P2|Overall Study|Adverse Event|1
3108057|NCT00209092|10646392|P1|Overall Study|Adverse Event|0
3108058|NCT00209092|10646391|P2|Overall Study|Progression of disease|1
3108059|NCT00209092|10646392|P1|Overall Study|Progression of disease|7
3108060|NCT00209027|10646402|P2|Overall Study|study terminated|0
3108061|NCT00209027|10646403|P1|Overall Study|study terminated|10
3108062|NCT00208767|10646427|P2|Overall Study|Lost to Follow-up|3
3108063|NCT00208767|10646428|P1|Overall Study|Lost to Follow-up|3
3108064|NCT00208767|10646427|P2|Overall Study|Death|0
3108065|NCT00208767|10646428|P1|Overall Study|Death|1
3108066|NCT00208767|10646427|P2|Overall Study|Withdrawal by Subject|3
3108067|NCT00208767|10646428|P1|Overall Study|Withdrawal by Subject|14
3108068|NCT00208767|10646427|P2|Overall Study|Adverse Event|1
3108069|NCT00208767|10646428|P1|Overall Study|Adverse Event|9
3108070|NCT00208325|10646456|P4|Overall Study|Mis-Randomized|0
3108071|NCT00208325|10646457|P3|Overall Study|Mis-Randomized|0
3108072|NCT00208325|10646458|P2|Overall Study|Mis-Randomized|20
3108073|NCT00208325|10646459|P1|Overall Study|Mis-Randomized|17
3108074|NCT00208325|10646456|P4|Overall Study|Other|0
3108075|NCT00208325|10646457|P3|Overall Study|Other|1
3108076|NCT00208325|10646458|P2|Overall Study|Other|1
3108077|NCT00208325|10646459|P1|Overall Study|Other|2
3108078|NCT00208325|10646456|P4|Overall Study|Does not wish to Continue in Study|2
3108079|NCT00208325|10646457|P3|Overall Study|Does not wish to Continue in Study|3
3108080|NCT00208325|10646458|P2|Overall Study|Does not wish to Continue in Study|8
3108081|NCT00208325|10646459|P1|Overall Study|Does not wish to Continue in Study|5
3108082|NCT00208325|10646456|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
3108083|NCT00208325|10646457|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
3108084|NCT00208325|10646458|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
3108085|NCT00208325|10646459|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
3108086|NCT00208325|10646456|P4|Overall Study|Lost to Follow-up|0
3108087|NCT00208325|10646457|P3|Overall Study|Lost to Follow-up|2
3108088|NCT00208325|10646458|P2|Overall Study|Lost to Follow-up|0
3108089|NCT00208325|10646459|P1|Overall Study|Lost to Follow-up|1
3108090|NCT00208325|10646456|P4|Overall Study|Revision|4
3108091|NCT00208325|10646457|P3|Overall Study|Revision|0
3108092|NCT00208325|10646458|P2|Overall Study|Revision|1
3108093|NCT00208325|10646459|P1|Overall Study|Revision|4
3108094|NCT00208325|10646456|P4|Overall Study|Withdrawal by Subject|0
3108095|NCT00208325|10646457|P3|Overall Study|Withdrawal by Subject|0
3108096|NCT00208325|10646458|P2|Overall Study|Withdrawal by Subject|1
3108097|NCT00208325|10646459|P1|Overall Study|Withdrawal by Subject|0
3108098|NCT00208325|10646456|P4|Overall Study|Death|5
3108099|NCT00208325|10646457|P3|Overall Study|Death|7
3108100|NCT00208325|10646458|P2|Overall Study|Death|19
3108101|NCT00208325|10646459|P1|Overall Study|Death|18
3108102|NCT00207740|10646596|P4|Overall Study|Other|5
3108103|NCT00207740|10646597|P3|Overall Study|Other|7
3108104|NCT00207740|10646598|P2|Overall Study|Other|10
3108105|NCT00207740|10646599|P1|Overall Study|Other|2
3108106|NCT00207740|10646596|P4|Overall Study|Sponsor Directive|21
3108107|NCT00207740|10646597|P3|Overall Study|Sponsor Directive|16
3108108|NCT00207740|10646598|P2|Overall Study|Sponsor Directive|15
3108109|NCT00207740|10646599|P1|Overall Study|Sponsor Directive|22
3108110|NCT00207740|10646596|P4|Overall Study|Death|1
3108111|NCT00207740|10646597|P3|Overall Study|Death|0
3108112|NCT00207740|10646598|P2|Overall Study|Death|0
3108113|NCT00207740|10646599|P1|Overall Study|Death|0
3108114|NCT00207740|10646596|P4|Overall Study|Lost to Follow-up|1
3108115|NCT00207740|10646597|P3|Overall Study|Lost to Follow-up|1
3108116|NCT00207740|10646598|P2|Overall Study|Lost to Follow-up|2
3108117|NCT00207740|10646599|P1|Overall Study|Lost to Follow-up|0
3108118|NCT00207740|10646596|P4|Overall Study|Unsatisfactory therapeutic effect|4
3108119|NCT00207740|10646597|P3|Overall Study|Unsatisfactory therapeutic effect|2
3108120|NCT00207740|10646598|P2|Overall Study|Unsatisfactory therapeutic effect|0
3108121|NCT00207740|10646599|P1|Overall Study|Unsatisfactory therapeutic effect|1
3108122|NCT00207740|10646596|P4|Overall Study|Adverse Event|11
3108123|NCT00207740|10646597|P3|Overall Study|Adverse Event|14
3108124|NCT00207740|10646598|P2|Overall Study|Adverse Event|14
3108125|NCT00207740|10646599|P1|Overall Study|Adverse Event|4
3108126|NCT00207727|10646645|P5|Overall Study|Other|33
3108127|NCT00207727|10646646|P4|Overall Study|Other|37
3108128|NCT00207727|10646647|P3|Overall Study|Other|41
3108129|NCT00207727|10646648|P2|Overall Study|Other|41
3108130|NCT00207727|10646649|P1|Overall Study|Other|38
3108131|NCT00207727|10646645|P5|Overall Study|Lost to Follow-up|0
3108132|NCT00207727|10646646|P4|Overall Study|Lost to Follow-up|0
3108133|NCT00207727|10646647|P3|Overall Study|Lost to Follow-up|0
3108134|NCT00207727|10646648|P2|Overall Study|Lost to Follow-up|1
3108135|NCT00207727|10646649|P1|Overall Study|Lost to Follow-up|0
3108136|NCT00207727|10646645|P5|Overall Study|Withdrawal by Subject|1
3108137|NCT00207727|10646646|P4|Overall Study|Withdrawal by Subject|0
3108138|NCT00207727|10646647|P3|Overall Study|Withdrawal by Subject|0
3108139|NCT00207727|10646648|P2|Overall Study|Withdrawal by Subject|0
3108140|NCT00207727|10646649|P1|Overall Study|Withdrawal by Subject|0
3108141|NCT00207714|10646676|P5|Overall Study|Other|0
3108142|NCT00207714|10646677|P4|Overall Study|Other|1
3108143|NCT00207714|10646678|P3|Overall Study|Other|5
3108144|NCT00207714|10646679|P2|Overall Study|Other|2
3108145|NCT00207714|10646680|P1|Overall Study|Other|3
3108146|NCT00207714|10646676|P5|Overall Study|Unsatisfactory therapeutic effect|4
3108147|NCT00207714|10646677|P4|Overall Study|Unsatisfactory therapeutic effect|4
3108148|NCT00207714|10646678|P3|Overall Study|Unsatisfactory therapeutic effect|1
3108149|NCT00207714|10646679|P2|Overall Study|Unsatisfactory therapeutic effect|3
3108150|NCT00207714|10646680|P1|Overall Study|Unsatisfactory therapeutic effect|5
3108151|NCT00207714|10646676|P5|Overall Study|Adverse Event|1
3108152|NCT00207714|10646677|P4|Overall Study|Adverse Event|3
3108153|NCT00207714|10646678|P3|Overall Study|Adverse Event|4
3108154|NCT00207714|10646679|P2|Overall Study|Adverse Event|2
3108155|NCT00207714|10646680|P1|Overall Study|Adverse Event|6
3108156|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
3108157|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
3108158|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
3108159|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
3108160|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Death|1
3108161|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Death|0
3108162|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Death|0
3108163|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Death|0
3108164|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
3108165|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
3108166|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
3108167|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
3108168|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
3108169|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
3108170|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
3108171|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
3108172|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
3108173|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
3108174|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
3108175|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
3108176|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
3108177|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
3108178|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
3108179|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
3108180|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
3108181|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
3108182|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
3108183|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
3108184|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
3108185|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
3108186|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
3108187|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
3108188|NCT00207142|10646702|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
3108189|NCT00207142|10646703|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
3108190|NCT00207142|10646704|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
3108191|NCT00207142|10646705|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
3108192|NCT00207142|10646702|P4|Induction Phase|Missing lab data|0
3108193|NCT00207142|10646703|P3|Induction Phase|Missing lab data|0
3108194|NCT00207142|10646704|P2|Induction Phase|Missing lab data|0
3108195|NCT00207142|10646705|P1|Induction Phase|Missing lab data|1
3108196|NCT00207142|10646702|P4|Induction Phase|Incarceration|0
3108197|NCT00207142|10646703|P3|Induction Phase|Incarceration|0
3108198|NCT00207142|10646704|P2|Induction Phase|Incarceration|0
3108199|NCT00207142|10646705|P1|Induction Phase|Incarceration|1
3108200|NCT00207142|10646702|P4|Induction Phase|Withdrawal by Subject|0
3108201|NCT00207142|10646703|P3|Induction Phase|Withdrawal by Subject|0
3108202|NCT00207142|10646704|P2|Induction Phase|Withdrawal by Subject|0
3108203|NCT00207142|10646705|P1|Induction Phase|Withdrawal by Subject|4
3108204|NCT00207142|10646702|P4|Induction Phase|Subject no longer meets study criteria|0
3108205|NCT00207142|10646703|P3|Induction Phase|Subject no longer meets study criteria|0
3108206|NCT00207142|10646704|P2|Induction Phase|Subject no longer meets study criteria|0
3108207|NCT00207142|10646705|P1|Induction Phase|Subject no longer meets study criteria|3
3108208|NCT00207142|10646702|P4|Induction Phase|Pregnancy|0
3108209|NCT00207142|10646703|P3|Induction Phase|Pregnancy|0
3108210|NCT00207142|10646704|P2|Induction Phase|Pregnancy|0
3108211|NCT00207142|10646705|P1|Induction Phase|Pregnancy|1
3108212|NCT00207142|10646702|P4|Induction Phase|Poor/noncompliance|0
3108213|NCT00207142|10646703|P3|Induction Phase|Poor/noncompliance|0
3108214|NCT00207142|10646704|P2|Induction Phase|Poor/noncompliance|0
3108215|NCT00207142|10646705|P1|Induction Phase|Poor/noncompliance|2
3108216|NCT00207142|10646702|P4|Induction Phase|Physician Decision|0
3108217|NCT00207142|10646703|P3|Induction Phase|Physician Decision|0
3108218|NCT00207142|10646704|P2|Induction Phase|Physician Decision|0
3108219|NCT00207142|10646705|P1|Induction Phase|Physician Decision|2
3108220|NCT00207142|10646702|P4|Induction Phase|Lost to Follow-up|0
3108221|NCT00207142|10646703|P3|Induction Phase|Lost to Follow-up|0
3108222|NCT00207142|10646704|P2|Induction Phase|Lost to Follow-up|0
3108223|NCT00207142|10646705|P1|Induction Phase|Lost to Follow-up|5
3108224|NCT00207142|10646702|P4|Induction Phase|Lack of Efficacy|0
3108225|NCT00207142|10646703|P3|Induction Phase|Lack of Efficacy|0
3108226|NCT00207142|10646704|P2|Induction Phase|Lack of Efficacy|0
3108227|NCT00207142|10646705|P1|Induction Phase|Lack of Efficacy|1
3108228|NCT00207142|10646702|P4|Induction Phase|Death|0
3108229|NCT00207142|10646703|P3|Induction Phase|Death|0
3108230|NCT00207142|10646704|P2|Induction Phase|Death|0
3108231|NCT00207142|10646705|P1|Induction Phase|Death|1
3108232|NCT00207142|10646702|P4|Induction Phase|Adverse Event|0
3108233|NCT00207142|10646703|P3|Induction Phase|Adverse Event|0
3108234|NCT00207142|10646704|P2|Induction Phase|Adverse Event|0
3108235|NCT00207142|10646705|P1|Induction Phase|Adverse Event|9
3108236|NCT00207090|10646742|P1|Overall Study|Physician Decision|1
3108237|NCT00207090|10646742|P1|Overall Study|Disease progression/relapse|2
3108238|NCT00207090|10646742|P1|Overall Study|Chest wall mass larger|1
3108239|NCT00207090|10646742|P1|Overall Study|Study drug toxicity|3
3108240|NCT00206726|10646771|P1|Overall Study|Withdrawal by Subject|8
3108241|NCT00206726|10646771|P1|Overall Study|Protocol Violation|1
3108242|NCT00206726|10646771|P1|Overall Study|Death|4
3108243|NCT00206726|10646771|P1|Overall Study|Adverse Event|17
3108244|NCT00206726|10646771|P1|Overall Study|Bone marrow transplant|1
3108245|NCT00206726|10646771|P1|Overall Study|Placed on new protocol|1
3108246|NCT00206726|10646771|P1|Overall Study|Progressive disease or relapsed disease|18
3108247|NCT00206726|10646771|P1|Overall Study|Delayed recovery of blood counts|1
3108248|NCT00206518|10646782|P2|Overall Study|Protocol Violation|1
3108249|NCT00206518|10646783|P1|Overall Study|Protocol Violation|1
3108250|NCT00206518|10646782|P2|Overall Study|Physician Decision|0
3108251|NCT00206518|10646783|P1|Overall Study|Physician Decision|1
3108252|NCT00206518|10646782|P2|Overall Study|Adverse Event|1
3108253|NCT00206518|10646783|P1|Overall Study|Adverse Event|2
3108254|NCT00206518|10646782|P2|Overall Study|Lack of Efficacy|4
3108255|NCT00206518|10646783|P1|Overall Study|Lack of Efficacy|6
3108256|NCT00206440|10646795|P2|Overall Study|Adverse Event|2
3108257|NCT00206440|10646796|P1|Overall Study|Adverse Event|4
3108258|NCT00206440|10646795|P2|Overall Study|Protocol Violation|2
3108259|NCT00206440|10646796|P1|Overall Study|Protocol Violation|1
3108260|NCT00206427|10646802|P1|Overall Study|Adverse Event|2
3108261|NCT00206323|10646812|P2|Overall Study|Lost to Follow-up|1
3108262|NCT00206323|10646813|P1|Overall Study|Lost to Follow-up|1
3108263|NCT00206323|10646812|P2|Overall Study|Adverse Event|1
3108264|NCT00206323|10646813|P1|Overall Study|Adverse Event|1
3108265|NCT00206323|10646812|P2|Overall Study|Lack of Efficacy|1
3108266|NCT00206323|10646813|P1|Overall Study|Lack of Efficacy|4
3108267|NCT00206102|10646821|P2|Overall Study|None of those categories|36
3108268|NCT00206102|10646822|P1|Overall Study|None of those categories|42
3108269|NCT00206102|10646821|P2|Overall Study|Study-specific discontinuation criteria|17
3108270|NCT00206102|10646822|P1|Overall Study|Study-specific discontinuation criteria|18
3108271|NCT00206102|10646821|P2|Overall Study|Withdrawal by Subject|101
3108272|NCT00206102|10646822|P1|Overall Study|Withdrawal by Subject|118
3108273|NCT00206102|10646821|P2|Overall Study|Lost to Follow-up|66
3108274|NCT00206102|10646822|P1|Overall Study|Lost to Follow-up|95
3108275|NCT00206102|10646821|P2|Overall Study|Lack of therapeutic response|11
3108276|NCT00206102|10646822|P1|Overall Study|Lack of therapeutic response|16
3108277|NCT00206102|10646821|P2|Overall Study|Protocol Violation|2
3108278|NCT00206102|10646822|P1|Overall Study|Protocol Violation|0
3108279|NCT00206102|10646821|P2|Overall Study|Adverse Event|82
3108280|NCT00206102|10646822|P1|Overall Study|Adverse Event|119
3108281|NCT00206076|10646858|P2|Overall Study|Withdrawal by Subject|1
3108282|NCT00206076|10646859|P1|Overall Study|Withdrawal by Subject|1
3108283|NCT00206076|10646858|P2|Overall Study|Physician Decision|0
3108284|NCT00206076|10646859|P1|Overall Study|Physician Decision|2
3108285|NCT00205881|10646869|P1|Overall Study|Withdrawal by Subject|16
3108286|NCT00205855|10646874|P1|Overall Study|Withdrawal by Subject|5
3108287|NCT00205855|10646874|P1|Overall Study|Only received temporary implants|16
3108288|NCT00205803|10646880|P2|Toddler Dose|Lost to Follow-up|3
3108289|NCT00205803|10646881|P1|Toddler Dose|Lost to Follow-up|2
3108290|NCT00205803|10646880|P2|After Infant Series|Other|4
3108291|NCT00205803|10646881|P1|After Infant Series|Other|10
3108292|NCT00205803|10646880|P2|After Infant Series|Withdrawal by Subject|4
3108293|NCT00205803|10646881|P1|After Infant Series|Withdrawal by Subject|1
3108294|NCT00205803|10646880|P2|After Infant Series|Physician Decision|2
3108295|NCT00205803|10646881|P1|After Infant Series|Physician Decision|3
3108296|NCT00205803|10646880|P2|After Infant Series|Lost to Follow-up|1
3108297|NCT00205803|10646881|P1|After Infant Series|Lost to Follow-up|2
3108298|NCT00205803|10646880|P2|After Infant Series|Protocol Violation|1
3108299|NCT00205803|10646881|P1|After Infant Series|Protocol Violation|1
3108300|NCT00205803|10646880|P2|After Infant Series|Adverse Event|1
3108301|NCT00205803|10646881|P1|After Infant Series|Adverse Event|1
3108302|NCT00205803|10646880|P2|Infant Series|Sponsor request|0
3108303|NCT00205803|10646881|P1|Infant Series|Sponsor request|1
3108304|NCT00205803|10646880|P2|Infant Series|Non-compliant|0
3108305|NCT00205803|10646881|P1|Infant Series|Non-compliant|1
3108306|NCT00205803|10646880|P2|Infant Series|Lost Kaiser coverage|1
3108307|NCT00205803|10646881|P1|Infant Series|Lost Kaiser coverage|0
3108308|NCT00205803|10646880|P2|Infant Series|Protocol Violation|0
3108309|NCT00205803|10646881|P1|Infant Series|Protocol Violation|1
3108310|NCT00205803|10646880|P2|Infant Series|Physician Decision|1
3108311|NCT00205803|10646881|P1|Infant Series|Physician Decision|3
3108312|NCT00205803|10646880|P2|Infant Series|Withdrawal by Subject|5
3108313|NCT00205803|10646881|P1|Infant Series|Withdrawal by Subject|2
3108314|NCT00205803|10646880|P2|Infant Series|Lost to Follow-up|4
3108315|NCT00205803|10646881|P1|Infant Series|Lost to Follow-up|10
3108316|NCT00205777|10646937|P6|Study Extension II|Enrolled but not treated|131
3108317|NCT00205777|10646938|P5|Study Extension II|Enrolled but not treated|0
3108318|NCT00205777|10646939|P4|Study Extension II|Enrolled but not treated|71
3108319|NCT00205777|10646940|P3|Study Extension II|Enrolled but not treated|0
3108320|NCT00205777|10646941|P2|Study Extension II|Enrolled but not treated|0
3108321|NCT00205777|10646942|P1|Study Extension II|Enrolled but not treated|0
3108322|NCT00205777|10646937|P6|Study Extension II|Other Event|20
3108323|NCT00205777|10646938|P5|Study Extension II|Other Event|0
3108324|NCT00205777|10646939|P4|Study Extension II|Other Event|12
3108325|NCT00205777|10646940|P3|Study Extension II|Other Event|0
3108326|NCT00205777|10646941|P2|Study Extension II|Other Event|0
3108327|NCT00205777|10646942|P1|Study Extension II|Other Event|0
3108328|NCT00205777|10646937|P6|Study Extension II|Failed to return|26
3108329|NCT00205777|10646938|P5|Study Extension II|Failed to return|0
3108330|NCT00205777|10646939|P4|Study Extension II|Failed to return|14
3108331|NCT00205777|10646940|P3|Study Extension II|Failed to return|0
3108332|NCT00205777|10646941|P2|Study Extension II|Failed to return|0
3108333|NCT00205777|10646942|P1|Study Extension II|Failed to return|0
3108334|NCT00205777|10646937|P6|Study Extension II|Lack of Efficacy|1
3108335|NCT00205777|10646938|P5|Study Extension II|Lack of Efficacy|0
3108336|NCT00205777|10646939|P4|Study Extension II|Lack of Efficacy|0
3108337|NCT00205777|10646940|P3|Study Extension II|Lack of Efficacy|0
3108338|NCT00205777|10646941|P2|Study Extension II|Lack of Efficacy|0
3108339|NCT00205777|10646942|P1|Study Extension II|Lack of Efficacy|0
3108340|NCT00205777|10646937|P6|Study Extension II|Protocol Violation|10
3108341|NCT00205777|10646938|P5|Study Extension II|Protocol Violation|0
3108342|NCT00205777|10646939|P4|Study Extension II|Protocol Violation|1
3108343|NCT00205777|10646940|P3|Study Extension II|Protocol Violation|0
3108344|NCT00205777|10646941|P2|Study Extension II|Protocol Violation|0
3108345|NCT00205777|10646942|P1|Study Extension II|Protocol Violation|0
3108346|NCT00205777|10646937|P6|Study Extension II|Withdrawal by Subject|59
3108347|NCT00205777|10646938|P5|Study Extension II|Withdrawal by Subject|0
3108348|NCT00205777|10646939|P4|Study Extension II|Withdrawal by Subject|35
3108349|NCT00205777|10646940|P3|Study Extension II|Withdrawal by Subject|0
3108350|NCT00205777|10646941|P2|Study Extension II|Withdrawal by Subject|0
3108351|NCT00205777|10646942|P1|Study Extension II|Withdrawal by Subject|0
3108352|NCT00205777|10646937|P6|Study Extension II|Death|5
3108353|NCT00205777|10646938|P5|Study Extension II|Death|0
3108354|NCT00205777|10646939|P4|Study Extension II|Death|2
3108355|NCT00205777|10646940|P3|Study Extension II|Death|0
3108356|NCT00205777|10646941|P2|Study Extension II|Death|0
3108357|NCT00205777|10646942|P1|Study Extension II|Death|0
3108358|NCT00205777|10646937|P6|Study Extension II|Adverse Event|30
3108359|NCT00205777|10646938|P5|Study Extension II|Adverse Event|0
3108360|NCT00205777|10646939|P4|Study Extension II|Adverse Event|14
3108361|NCT00205777|10646940|P3|Study Extension II|Adverse Event|0
3108362|NCT00205777|10646941|P2|Study Extension II|Adverse Event|0
3108363|NCT00205777|10646942|P1|Study Extension II|Adverse Event|0
3108364|NCT00205777|10646937|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
3108365|NCT00205777|10646938|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
3108366|NCT00205777|10646939|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
3108367|NCT00205777|10646940|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
3108368|NCT00205777|10646941|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
3108369|NCT00205777|10646942|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
3108370|NCT00205777|10646937|P6|Study Extension I|Withdrawn as per protocol|0
3108371|NCT00205777|10646938|P5|Study Extension I|Withdrawn as per protocol|0
3108372|NCT00205777|10646939|P4|Study Extension I|Withdrawn as per protocol|0
3108373|NCT00205777|10646940|P3|Study Extension I|Withdrawn as per protocol|1070
3108374|NCT00205777|10646941|P2|Study Extension I|Withdrawn as per protocol|0
3108375|NCT00205777|10646942|P1|Study Extension I|Withdrawn as per protocol|0
3108376|NCT00205777|10646937|P6|Study Extension I|Other Event|0
3108377|NCT00205777|10646938|P5|Study Extension I|Other Event|29
3108378|NCT00205777|10646939|P4|Study Extension I|Other Event|34
3108379|NCT00205777|10646940|P3|Study Extension I|Other Event|0
3108380|NCT00205777|10646941|P2|Study Extension I|Other Event|0
3108381|NCT00205777|10646942|P1|Study Extension I|Other Event|34
3108382|NCT00205777|10646937|P6|Study Extension I|Failed to return|0
3108383|NCT00205777|10646938|P5|Study Extension I|Failed to return|13
3108384|NCT00205777|10646939|P4|Study Extension I|Failed to return|17
3108385|NCT00205777|10646940|P3|Study Extension I|Failed to return|0
3108386|NCT00205777|10646941|P2|Study Extension I|Failed to return|0
3108387|NCT00205777|10646942|P1|Study Extension I|Failed to return|15
3108388|NCT00205777|10646937|P6|Study Extension I|Lack of Efficacy|0
3108389|NCT00205777|10646938|P5|Study Extension I|Lack of Efficacy|2
3108390|NCT00205777|10646939|P4|Study Extension I|Lack of Efficacy|1
3108391|NCT00205777|10646940|P3|Study Extension I|Lack of Efficacy|0
3108392|NCT00205777|10646941|P2|Study Extension I|Lack of Efficacy|0
3108393|NCT00205777|10646942|P1|Study Extension I|Lack of Efficacy|0
3108394|NCT00205777|10646937|P6|Study Extension I|Protocol Violation|0
3108395|NCT00205777|10646938|P5|Study Extension I|Protocol Violation|8
3108396|NCT00205777|10646939|P4|Study Extension I|Protocol Violation|8
3108397|NCT00205777|10646940|P3|Study Extension I|Protocol Violation|0
3108398|NCT00205777|10646941|P2|Study Extension I|Protocol Violation|0
3108399|NCT00205777|10646942|P1|Study Extension I|Protocol Violation|4
3108400|NCT00205777|10646937|P6|Study Extension I|Withdrawal by Subject|0
3108401|NCT00205777|10646938|P5|Study Extension I|Withdrawal by Subject|89
3108402|NCT00205777|10646939|P4|Study Extension I|Withdrawal by Subject|106
3108403|NCT00205777|10646940|P3|Study Extension I|Withdrawal by Subject|0
3108404|NCT00205777|10646941|P2|Study Extension I|Withdrawal by Subject|0
3108405|NCT00205777|10646942|P1|Study Extension I|Withdrawal by Subject|99
3108406|NCT00205777|10646937|P6|Study Extension I|Death|0
3108407|NCT00205777|10646938|P5|Study Extension I|Death|2
3108408|NCT00205777|10646939|P4|Study Extension I|Death|1
3108409|NCT00205777|10646940|P3|Study Extension I|Death|0
3108410|NCT00205777|10646941|P2|Study Extension I|Death|0
3108411|NCT00205777|10646942|P1|Study Extension I|Death|5
3108412|NCT00205777|10646937|P6|Study Extension I|Adverse Event|0
3108413|NCT00205777|10646938|P5|Study Extension I|Adverse Event|58
3108414|NCT00205777|10646939|P4|Study Extension I|Adverse Event|61
3108415|NCT00205777|10646940|P3|Study Extension I|Adverse Event|0
3108416|NCT00205777|10646941|P2|Study Extension I|Adverse Event|0
3108417|NCT00205777|10646942|P1|Study Extension I|Adverse Event|57
3108418|NCT00205777|10646937|P6|Completed Core Study, Entered SE I|Other Event|0
3108419|NCT00205777|10646938|P5|Completed Core Study, Entered SE I|Other Event|0
3108420|NCT00205777|10646939|P4|Completed Core Study, Entered SE I|Other Event|50
3108421|NCT00205777|10646940|P3|Completed Core Study, Entered SE I|Other Event|47
3108422|NCT00205777|10646941|P2|Completed Core Study, Entered SE I|Other Event|46
3108423|NCT00205777|10646942|P1|Completed Core Study, Entered SE I|Other Event|52
3108424|NCT00205777|10646937|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
3108425|NCT00205777|10646938|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
3108426|NCT00205777|10646939|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
3108427|NCT00205777|10646940|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
3108428|NCT00205777|10646941|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
3108429|NCT00205777|10646942|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
3108430|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
3108431|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
3108432|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
3108433|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
3108434|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
3108435|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
3108436|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
3108437|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
3108438|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
3108439|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
3108440|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
3108441|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
3108442|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Protocol Violation|0
3108443|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Protocol Violation|0
3108444|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Protocol Violation|42
3108445|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Protocol Violation|50
3108446|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Protocol Violation|55
3108447|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Protocol Violation|53
3108448|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
3108449|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
3108450|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
3108451|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
3108452|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
3108453|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
3108454|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Other Event|0
3108455|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Other Event|0
3108456|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Other Event|58
3108457|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Other Event|41
3108458|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Other Event|52
3108459|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Other Event|49
3108460|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Failed to return|0
3108461|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Failed to return|0
3108462|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Failed to return|27
3108463|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Failed to return|27
3108464|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Failed to return|25
3108465|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Failed to return|40
3108466|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Death|0
3108467|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Death|0
3108468|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Death|7
3108469|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Death|14
3108470|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Death|7
3108471|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Death|9
3108472|NCT00205777|10646937|P6|Core Study (Up to 3 Years)|Adverse Event|0
3108473|NCT00205777|10646938|P5|Core Study (Up to 3 Years)|Adverse Event|0
3108474|NCT00205777|10646939|P4|Core Study (Up to 3 Years)|Adverse Event|232
3108475|NCT00205777|10646940|P3|Core Study (Up to 3 Years)|Adverse Event|252
3108476|NCT00205777|10646941|P2|Core Study (Up to 3 Years)|Adverse Event|267
3108477|NCT00205777|10646942|P1|Core Study (Up to 3 Years)|Adverse Event|260
3108478|NCT00205712|10647151|P2|Overall Study|Lost to Follow-up|1
3108479|NCT00205712|10647152|P1|Overall Study|Lost to Follow-up|0
3108480|NCT00205699|10647165|P3|Overall Study|Lack of Efficacy|0
3108481|NCT00205699|10647166|P2|Overall Study|Lack of Efficacy|1
3108482|NCT00205699|10647167|P1|Overall Study|Lack of Efficacy|0
3108483|NCT00205699|10647165|P3|Overall Study|Withdrawal by Subject|1
3108484|NCT00205699|10647166|P2|Overall Study|Withdrawal by Subject|2
3108485|NCT00205699|10647167|P1|Overall Study|Withdrawal by Subject|1
3108486|NCT00205699|10647165|P3|Overall Study|Adverse Event|0
3108487|NCT00205699|10647166|P2|Overall Study|Adverse Event|0
3108488|NCT00205699|10647167|P1|Overall Study|Adverse Event|1
3108489|NCT00205699|10647165|P3|Overall Study|Lost to Follow-up|5
3108490|NCT00205699|10647166|P2|Overall Study|Lost to Follow-up|3
3108491|NCT00205699|10647167|P1|Overall Study|Lost to Follow-up|1
3108492|NCT00205179|10647247|P2|Overall Study|Adverse Event|1
3108493|NCT00205179|10647248|P1|Overall Study|Adverse Event|1
3108494|NCT00205179|10647247|P2|Overall Study|Physician Decision|1
3108495|NCT00205179|10647248|P1|Overall Study|Physician Decision|1
3108496|NCT00205179|10647247|P2|Overall Study|Death|2
3108497|NCT00205179|10647248|P1|Overall Study|Death|0
3108498|NCT00203996|10647366|P10|Overall Study|Scheduling issue|0
3108499|NCT00203996|10647367|P9|Overall Study|Scheduling issue|0
3108500|NCT00203996|10647368|P8|Overall Study|Scheduling issue|2
3108501|NCT00203996|10647369|P7|Overall Study|Scheduling issue|0
3108502|NCT00203996|10647370|P6|Overall Study|Scheduling issue|0
3108503|NCT00203996|10647371|P5|Overall Study|Scheduling issue|0
3108504|NCT00203996|10647372|P4|Overall Study|Scheduling issue|0
3108505|NCT00203996|10647373|P3|Overall Study|Scheduling issue|0
3108506|NCT00203996|10647374|P2|Overall Study|Scheduling issue|0
3108507|NCT00203996|10647375|P1|Overall Study|Scheduling issue|0
3108508|NCT00203996|10647366|P10|Overall Study|CPAP machine malfunction|0
3108509|NCT00203996|10647367|P9|Overall Study|CPAP machine malfunction|0
3108510|NCT00203996|10647368|P8|Overall Study|CPAP machine malfunction|0
3108511|NCT00203996|10647369|P7|Overall Study|CPAP machine malfunction|0
3108512|NCT00203996|10647370|P6|Overall Study|CPAP machine malfunction|0
3108513|NCT00203996|10647371|P5|Overall Study|CPAP machine malfunction|0
3108514|NCT00203996|10647372|P4|Overall Study|CPAP machine malfunction|1
3108515|NCT00203996|10647373|P3|Overall Study|CPAP machine malfunction|0
3108516|NCT00203996|10647374|P2|Overall Study|CPAP machine malfunction|0
3108517|NCT00203996|10647375|P1|Overall Study|CPAP machine malfunction|0
3108518|NCT00203996|10647366|P10|Overall Study|Physician Decision|1
3108519|NCT00203996|10647367|P9|Overall Study|Physician Decision|0
3108520|NCT00203996|10647368|P8|Overall Study|Physician Decision|0
3108521|NCT00203996|10647369|P7|Overall Study|Physician Decision|0
3108522|NCT00203996|10647370|P6|Overall Study|Physician Decision|0
3108523|NCT00203996|10647371|P5|Overall Study|Physician Decision|0
3108524|NCT00203996|10647372|P4|Overall Study|Physician Decision|2
3108525|NCT00203996|10647373|P3|Overall Study|Physician Decision|0
3108526|NCT00203996|10647374|P2|Overall Study|Physician Decision|0
3108527|NCT00203996|10647375|P1|Overall Study|Physician Decision|0
3108528|NCT00203996|10647366|P10|Overall Study|Protocol Violation|0
3108529|NCT00203996|10647367|P9|Overall Study|Protocol Violation|0
3108530|NCT00203996|10647368|P8|Overall Study|Protocol Violation|0
3108531|NCT00203996|10647369|P7|Overall Study|Protocol Violation|0
3108532|NCT00203996|10647370|P6|Overall Study|Protocol Violation|0
3108533|NCT00203996|10647371|P5|Overall Study|Protocol Violation|1
3108534|NCT00203996|10647372|P4|Overall Study|Protocol Violation|6
3108535|NCT00203996|10647373|P3|Overall Study|Protocol Violation|0
3108536|NCT00203996|10647374|P2|Overall Study|Protocol Violation|0
3108537|NCT00203996|10647375|P1|Overall Study|Protocol Violation|0
3108538|NCT00203996|10647366|P10|Overall Study|Lost to Follow-up|0
3108539|NCT00203996|10647367|P9|Overall Study|Lost to Follow-up|0
3108540|NCT00203996|10647368|P8|Overall Study|Lost to Follow-up|0
3108541|NCT00203996|10647369|P7|Overall Study|Lost to Follow-up|0
3108542|NCT00203996|10647370|P6|Overall Study|Lost to Follow-up|0
3108543|NCT00203996|10647371|P5|Overall Study|Lost to Follow-up|0
3108544|NCT00203996|10647372|P4|Overall Study|Lost to Follow-up|1
3108545|NCT00203996|10647373|P3|Overall Study|Lost to Follow-up|0
3108546|NCT00203996|10647374|P2|Overall Study|Lost to Follow-up|0
3108547|NCT00203996|10647375|P1|Overall Study|Lost to Follow-up|0
3108548|NCT00203892|10647442|P3|Overall Study|Death|0
3108549|NCT00203892|10647443|P2|Overall Study|Death|0
3108550|NCT00203892|10647444|P1|Overall Study|Death|1
3108551|NCT00203892|10647442|P3|Overall Study|Physician Decision|0
3108552|NCT00203892|10647443|P2|Overall Study|Physician Decision|2
3108553|NCT00203892|10647444|P1|Overall Study|Physician Decision|1
3108554|NCT00203502|10647455|P1|Overall Study|Death|1
3108555|NCT00203476|10647466|P3|Overall Study|Withdrawal by Subject|0
3108556|NCT00203476|10647467|P2|Overall Study|Withdrawal by Subject|1
3108557|NCT00203476|10647468|P1|Overall Study|Withdrawal by Subject|0
3108558|NCT00203476|10647466|P3|Overall Study|Lost to Follow-up|0
3108559|NCT00203476|10647467|P2|Overall Study|Lost to Follow-up|0
3108560|NCT00203476|10647468|P1|Overall Study|Lost to Follow-up|1
3108561|NCT00203424|10647485|P1|Follow-up Period|Lost to Follow-up|1
3108562|NCT00203424|10647485|P1|Follow-up Period|progressive disease|4
3108563|NCT00203424|10647485|P1|Follow-up Period|Withdrawal by Subject|1
3108564|NCT00203424|10647485|P1|Treatment Period|progressive disease|2
3108565|NCT00203424|10647485|P1|Treatment Period|Adverse Event|5
3108566|NCT00203424|10647485|P1|Treatment Period|Withdrawal by Subject|4
3108567|NCT00203411|10647492|P1|Follow-up|Progressive Disease|4
3108568|NCT00203307|10647501|P2|First Intervention|Adverse Event|0
3108569|NCT00203307|10647502|P1|First Intervention|Adverse Event|2
3108570|NCT00203294|10647510|P2|Overall Study|Withdrawal by Subject|13
3108571|NCT00203294|10647511|P1|Overall Study|Withdrawal by Subject|8
3108572|NCT00203268|10647517|P1|Early Treatment|Withdrawal by Subject|1
3108573|NCT00203268|10647517|P1|Early Treatment|Lost to Follow-up|1
3108574|NCT00203268|10647517|P1|Early Treatment|only treated one headache|2
3108575|NCT00203242|10647523|P1|Overall Study|Lost to Follow-up|1
3108576|NCT00203047|10647575|P2|Overall Study|Other|5
3108577|NCT00203047|10647576|P1|Overall Study|Other|5
3108578|NCT00203047|10647575|P2|Overall Study|Pregnancy|0
3108579|NCT00203047|10647576|P1|Overall Study|Pregnancy|3
3108580|NCT00203047|10647575|P2|Overall Study|Death|2
3108581|NCT00203047|10647576|P1|Overall Study|Death|1
3108582|NCT00203047|10647575|P2|Overall Study|Adverse Event|18
3108583|NCT00203047|10647576|P1|Overall Study|Adverse Event|8
3108584|NCT00203047|10647575|P2|Overall Study|Lost to Follow-up|5
3108585|NCT00203047|10647576|P1|Overall Study|Lost to Follow-up|11
3108586|NCT00203047|10647575|P2|Overall Study|Protocol Violation|0
3108587|NCT00203047|10647576|P1|Overall Study|Protocol Violation|1
3108588|NCT00203047|10647575|P2|Overall Study|Non-compliance|8
3108589|NCT00203047|10647576|P1|Overall Study|Non-compliance|4
3108590|NCT00203047|10647575|P2|Overall Study|Physician Decision|7
3108591|NCT00203047|10647576|P1|Overall Study|Physician Decision|8
3108592|NCT00203047|10647575|P2|Overall Study|Teva requested participant withdrawal|1
3108593|NCT00203047|10647576|P1|Overall Study|Teva requested participant withdrawal|1
3108594|NCT00203047|10647575|P2|Overall Study|Withdrawal by Subject|47
3108595|NCT00203047|10647576|P1|Overall Study|Withdrawal by Subject|13
3108596|NCT00203047|10647575|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
3108597|NCT00203047|10647576|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
3108598|NCT00203047|10647575|P2|Overall Study|Ongoing: in database - January 29, 2009|109
3108599|NCT00203047|10647576|P1|Overall Study|Ongoing: in database - January 29, 2009|131
3108600|NCT00203021|10647590|P2|Overall Study|Other than specified|16
3108601|NCT00203021|10647591|P1|Overall Study|Other than specified|11
3108602|NCT00203021|10647590|P2|Overall Study|Lost to Follow-up|7
3108603|NCT00203021|10647591|P1|Overall Study|Lost to Follow-up|9
3108604|NCT00203021|10647590|P2|Overall Study|Withdrawal by Subject|48
3108605|NCT00203021|10647591|P1|Overall Study|Withdrawal by Subject|45
3108606|NCT00203021|10647590|P2|Overall Study|Adverse Event|5
3108607|NCT00203021|10647591|P1|Overall Study|Adverse Event|10
3108608|NCT00203021|10647590|P2|Overall Study|Death|1
3108609|NCT00203021|10647591|P1|Overall Study|Death|4
3108610|NCT00202878|10647601|P2|Overall Study|Withdrawal by Subject|808
3108611|NCT00202878|10647602|P1|Overall Study|Withdrawal by Subject|795
3108612|NCT00202878|10647601|P2|Overall Study|Site Closure|36
3108613|NCT00202878|10647602|P1|Overall Study|Site Closure|39
3108614|NCT00202878|10647601|P2|Overall Study|Lost to Follow-up|49
3108615|NCT00202878|10647602|P1|Overall Study|Lost to Follow-up|44
3108616|NCT00202878|10647601|P2|Overall Study|Only Vital Status Known|356
3108617|NCT00202878|10647602|P1|Overall Study|Only Vital Status Known|357
3108618|NCT00202878|10647601|P2|Overall Study|Death|968
3108619|NCT00202878|10647602|P1|Overall Study|Death|964
3108620|NCT00202839|10647616|P2|Overall Study|Lost to Follow-up|2
3108621|NCT00202839|10647617|P1|Overall Study|Lost to Follow-up|3
3108622|NCT00202839|10647616|P2|Overall Study|Protocol Violation|1
3108623|NCT00202839|10647617|P1|Overall Study|Protocol Violation|2
3108624|NCT00202839|10647616|P2|Overall Study|Withdrawal by Subject|2
3108625|NCT00202839|10647617|P1|Overall Study|Withdrawal by Subject|6
3108626|NCT00202839|10647616|P2|Overall Study|Physician Decision|0
3108627|NCT00202839|10647617|P1|Overall Study|Physician Decision|12
3108628|NCT00202839|10647616|P2|Overall Study|Adverse Event|5
3108629|NCT00202839|10647617|P1|Overall Study|Adverse Event|1
3108630|NCT00202644|10647632|P2|Overall Study|Other|1
3108631|NCT00202644|10647633|P1|Overall Study|Other|9
3108632|NCT00202644|10647632|P2|Overall Study|Lost to Follow-up|1
3108633|NCT00202644|10647633|P1|Overall Study|Lost to Follow-up|0
3108634|NCT00202644|10647632|P2|Overall Study|Lack of Efficacy|6
3108635|NCT00202644|10647633|P1|Overall Study|Lack of Efficacy|6
3108636|NCT00202644|10647632|P2|Overall Study|Withdrawal by Subject|6
3108637|NCT00202644|10647633|P1|Overall Study|Withdrawal by Subject|8
3108638|NCT00202644|10647632|P2|Overall Study|Adverse Event|13
3108639|NCT00202644|10647633|P1|Overall Study|Adverse Event|12
3108640|NCT00201851|10647694|P3|Overall Study|Ineligible post enrollment|1
3108641|NCT00201851|10647695|P2|Overall Study|Ineligible post enrollment|1
3108642|NCT00201851|10647696|P1|Overall Study|Ineligible post enrollment|6
3108643|NCT00201851|10647694|P3|Overall Study|Lost to Follow-up|0
3108644|NCT00201851|10647695|P2|Overall Study|Lost to Follow-up|1
3108645|NCT00201851|10647696|P1|Overall Study|Lost to Follow-up|2
3108646|NCT00201643|10647768|P2|Overall Study|Withdrawal by Subject|4
3108647|NCT00201643|10647769|P1|Overall Study|Withdrawal by Subject|5
3108648|NCT00201201|10647833|P2|Overall Study|Withdrawal by Subject|5
3108649|NCT00201201|10647834|P1|Overall Study|Withdrawal by Subject|5
3108650|NCT00201201|10647833|P2|Overall Study|Death|2
3108651|NCT00201201|10647834|P1|Overall Study|Death|0
3108652|NCT00201006|10647872|P3|Overall Study|Adverse Event|1
3108653|NCT00201006|10647873|P2|Overall Study|Adverse Event|0
3108654|NCT00201006|10647874|P1|Overall Study|Adverse Event|1
3108655|NCT00201006|10647872|P3|Overall Study|Withdrawal by Subject|3
3108656|NCT00201006|10647873|P2|Overall Study|Withdrawal by Subject|2
3108657|NCT00201006|10647874|P1|Overall Study|Withdrawal by Subject|7
3108658|NCT00200967|10647884|P2|Run-out Period|Lost to Follow-up|0
3108659|NCT00200967|10647885|P1|Run-out Period|Lost to Follow-up|1
3108660|NCT00200967|10647884|P2|Second Treatment Period|Withdrawal by Subject|2
3108661|NCT00200967|10647885|P1|Second Treatment Period|Withdrawal by Subject|1
3108662|NCT00200967|10647884|P2|Wash-out Period|Lost to Follow-up|1
3108663|NCT00200967|10647885|P1|Wash-out Period|Lost to Follow-up|0
3108664|NCT00200967|10647884|P2|First Treatment Period|Pregnancy|0
3108665|NCT00200967|10647885|P1|First Treatment Period|Pregnancy|1
3108666|NCT00200967|10647884|P2|First Treatment Period|Withdrawal by Subject|1
3108667|NCT00200967|10647885|P1|First Treatment Period|Withdrawal by Subject|5
3108668|NCT00200850|10647935|P3|Overall Study|Adverse Event|2
3108669|NCT00200850|10647936|P2|Overall Study|Adverse Event|1
3108670|NCT00200850|10647937|P1|Overall Study|Adverse Event|1
3108671|NCT00200850|10647935|P3|Overall Study|optic neuritis|1
3108672|NCT00200850|10647936|P2|Overall Study|optic neuritis|0
3108673|NCT00200850|10647937|P1|Overall Study|optic neuritis|0
3108674|NCT00200850|10647935|P3|Overall Study|Poor adherence|1
3108675|NCT00200850|10647936|P2|Overall Study|Poor adherence|0
3108676|NCT00200850|10647937|P1|Overall Study|Poor adherence|0
3108677|NCT00200850|10647935|P3|Overall Study|Pregnancy|1
3108678|NCT00200850|10647936|P2|Overall Study|Pregnancy|0
3108679|NCT00200850|10647937|P1|Overall Study|Pregnancy|0
3108680|NCT00200850|10647935|P3|Overall Study|too busy|0
3108681|NCT00200850|10647936|P2|Overall Study|too busy|0
3108682|NCT00200850|10647937|P1|Overall Study|too busy|1
3108683|NCT00200850|10647935|P3|Overall Study|relocation|1
3108684|NCT00200850|10647936|P2|Overall Study|relocation|0
3108685|NCT00200850|10647937|P1|Overall Study|relocation|1
3108686|NCT00200356|10647958|P2|Overall Study|Nontreatment|0
3108687|NCT00200356|10647959|P1|Overall Study|Nontreatment|1
3108688|NCT00200356|10647958|P2|Overall Study|Protocol Violation|4
3108689|NCT00200356|10647959|P1|Overall Study|Protocol Violation|4
3108690|NCT00200356|10647958|P2|Overall Study|Lack of Efficacy|3
3108691|NCT00200356|10647959|P1|Overall Study|Lack of Efficacy|3
3108692|NCT00200057|10648026|P1|Overall Study|Death|1
3108693|NCT00200057|10648026|P1|Overall Study|Infection|1
3108694|NCT00200057|10648026|P1|Overall Study|Change in medical condition|1
3108695|NCT00200057|10648026|P1|Overall Study|Withdrawal by Subject|1
3108696|NCT00200057|10648026|P1|Overall Study|Exited due to terminal illness of PI|2
3108697|NCT00200057|10648026|P1|Overall Study|Lack of Efficacy|3
3108698|NCT00199875|10648050|P5|Overall Study|Withdrawal by Subject|1
3108699|NCT00199875|10648051|P4|Overall Study|Withdrawal by Subject|0
3108700|NCT00199875|10648052|P3|Overall Study|Withdrawal by Subject|0
3108701|NCT00199875|10648053|P2|Overall Study|Withdrawal by Subject|0
3108702|NCT00199875|10648054|P1|Overall Study|Withdrawal by Subject|0
3108703|NCT00199381|10648076|P1|Overall Study|Study termination by Sponsor|323
3108704|NCT00199381|10648076|P1|Overall Study|Not including due to early termination|37
3108705|NCT00199381|10648076|P1|Overall Study|Lack of Efficacy|27
3108706|NCT00199381|10648076|P1|Overall Study|Protocol Violation|6
3108707|NCT00199381|10648076|P1|Overall Study|Adverse Event|73
3108708|NCT00199381|10648076|P1|Overall Study|Withdrawal by Subject|38
3108709|NCT00198822|10648083|P3|Overall Study|Lost to Follow-up|21
3108710|NCT00198822|10648084|P2|Overall Study|Lost to Follow-up|20
3108711|NCT00198822|10648085|P1|Overall Study|Lost to Follow-up|14
3108712|NCT00198133|10648104|P2|Overall Study|Physician Decision|0
3108713|NCT00198133|10648105|P1|Overall Study|Physician Decision|1
3108714|NCT00198133|10648104|P2|Overall Study|Withdrawal by Subject|0
3108715|NCT00198133|10648105|P1|Overall Study|Withdrawal by Subject|1
3108716|NCT00198133|10648104|P2|Overall Study|Adverse Event|3
3108717|NCT00198133|10648105|P1|Overall Study|Adverse Event|1
3108718|NCT00198133|10648104|P2|Overall Study|Disease progression|5
3108719|NCT00198133|10648105|P1|Overall Study|Disease progression|2
3108720|NCT00198107|10648117|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
3108721|NCT00198107|10648118|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
3108722|NCT00198107|10648119|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
3108723|NCT00198107|10648117|P3|Double-Blind Period|Withdrawal by Subject|0
3108724|NCT00198107|10648118|P2|Double-Blind Period|Withdrawal by Subject|1
3108725|NCT00198107|10648119|P1|Double-Blind Period|Withdrawal by Subject|0
3108726|NCT00198107|10648117|P3|Double-Blind Period|Physician Decision|0
3108727|NCT00198107|10648118|P2|Double-Blind Period|Physician Decision|0
3108728|NCT00198107|10648119|P1|Double-Blind Period|Physician Decision|1
3108729|NCT00198107|10648117|P3|Double-Blind Period|Lost to Follow-up|0
3108730|NCT00198107|10648118|P2|Double-Blind Period|Lost to Follow-up|1
3108731|NCT00198107|10648119|P1|Double-Blind Period|Lost to Follow-up|2
3108732|NCT00198107|10648117|P3|Double-Blind Period|Lack of Efficacy|0
3108733|NCT00198107|10648118|P2|Double-Blind Period|Lack of Efficacy|0
3108734|NCT00198107|10648119|P1|Double-Blind Period|Lack of Efficacy|2
3108735|NCT00198107|10648117|P3|Double-Blind Period|Adverse Event|0
3108736|NCT00198107|10648118|P2|Double-Blind Period|Adverse Event|1
3108737|NCT00198107|10648119|P1|Double-Blind Period|Adverse Event|1
3108738|NCT00198029|10648187|P1|Overall Study|Withdrawal by Subject|4
3108739|NCT00197496|10648194|P2|Follow-up|Lost to Follow-up|1
3108740|NCT00197496|10648195|P1|Follow-up|Lost to Follow-up|2
3108741|NCT00197496|10648194|P2|Baseline to Discharge|Protocol Violation|1
3108742|NCT00197496|10648195|P1|Baseline to Discharge|Protocol Violation|0
3108743|NCT00197496|10648194|P2|Baseline to Discharge|Physician Decision|1
3108744|NCT00197496|10648195|P1|Baseline to Discharge|Physician Decision|0
3108745|NCT00197496|10648194|P2|Baseline to Discharge|MRSA|0
3108746|NCT00197496|10648195|P1|Baseline to Discharge|MRSA|1
3108747|NCT00197496|10648194|P2|Baseline to Discharge|not interested|0
3108748|NCT00197496|10648195|P1|Baseline to Discharge|not interested|1
3108749|NCT00197236|10648243|P3|Overall Study|Returned out of specified time window|1
3108750|NCT00197236|10648244|P2|Overall Study|Returned out of specified time window|0
3108751|NCT00197236|10648245|P1|Overall Study|Returned out of specified time window|0
3108752|NCT00197236|10648243|P3|Overall Study|Study drug/medication expiration|3
3108753|NCT00197236|10648244|P2|Overall Study|Study drug/medication expiration|0
3108754|NCT00197236|10648245|P1|Overall Study|Study drug/medication expiration|1
3108755|NCT00197236|10648243|P3|Overall Study|Withdrawal by Subject|11
3108756|NCT00197236|10648244|P2|Overall Study|Withdrawal by Subject|3
3108757|NCT00197236|10648245|P1|Overall Study|Withdrawal by Subject|7
3108758|NCT00197236|10648243|P3|Overall Study|Protocol Violation|1
3108759|NCT00197236|10648244|P2|Overall Study|Protocol Violation|0
3108760|NCT00197236|10648245|P1|Overall Study|Protocol Violation|0
3108761|NCT00197236|10648243|P3|Overall Study|Lost to Follow-up|6
3108762|NCT00197236|10648244|P2|Overall Study|Lost to Follow-up|14
3108763|NCT00197236|10648245|P1|Overall Study|Lost to Follow-up|5
3108764|NCT00197236|10648243|P3|Overall Study|Adverse Event|1
3108765|NCT00197236|10648244|P2|Overall Study|Adverse Event|0
3108766|NCT00197236|10648245|P1|Overall Study|Adverse Event|1
3108767|NCT00197145|10648319|P2|Period 2 : Open Label Phase|Other|0
3108768|NCT00197145|10648320|P1|Period 2 : Open Label Phase|Other|1
3108769|NCT00197145|10648319|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
3108770|NCT00197145|10648320|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
3108771|NCT00197145|10648319|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
3108772|NCT00197145|10648320|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
3108773|NCT00197145|10648319|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
3108774|NCT00197145|10648320|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
3108775|NCT00197145|10648319|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
3108776|NCT00197145|10648320|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
3108777|NCT00197145|10648319|P2|Period 1: Randomized Treatment Phase|Other|2
3108778|NCT00197145|10648320|P1|Period 1: Randomized Treatment Phase|Other|2
3108779|NCT00197145|10648319|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
3108780|NCT00197145|10648320|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
3108781|NCT00197145|10648319|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
3108782|NCT00197145|10648320|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
3108783|NCT00197106|10648391|P3|Overall Treatment Period|Withdrawal by Subject|2
3108784|NCT00197106|10648392|P2|Overall Treatment Period|Withdrawal by Subject|0
3108785|NCT00197106|10648393|P1|Overall Treatment Period|Withdrawal by Subject|0
3108786|NCT00197106|10648391|P3|Overall Treatment Period|Protocol Violation|2
3108787|NCT00197106|10648392|P2|Overall Treatment Period|Protocol Violation|0
3108788|NCT00197106|10648393|P1|Overall Treatment Period|Protocol Violation|0
3108789|NCT00197106|10648391|P3|Overall Treatment Period|Lost to Follow-up|2
3108790|NCT00197106|10648392|P2|Overall Treatment Period|Lost to Follow-up|0
3108791|NCT00197106|10648393|P1|Overall Treatment Period|Lost to Follow-up|0
3108792|NCT00197106|10648391|P3|Overall Treatment Period|Lack of Efficacy|0
3108793|NCT00197106|10648392|P2|Overall Treatment Period|Lack of Efficacy|1
3108794|NCT00197106|10648393|P1|Overall Treatment Period|Lack of Efficacy|0
3108795|NCT00197106|10648391|P3|4-Week Run-In Period|Did not meet entry criteria|0
3108796|NCT00197106|10648392|P2|4-Week Run-In Period|Did not meet entry criteria|0
3108797|NCT00197106|10648393|P1|4-Week Run-In Period|Did not meet entry criteria|99
3108798|NCT00197028|10648429|P2|Overall Study|Other|6
3108799|NCT00197028|10648430|P1|Overall Study|Other|3
3108800|NCT00197028|10648429|P2|Overall Study|Lost to Follow-up|0
3108801|NCT00197028|10648430|P1|Overall Study|Lost to Follow-up|1
3108802|NCT00197028|10648429|P2|Overall Study|Withdrawal by Subject|12
3108803|NCT00197028|10648430|P1|Overall Study|Withdrawal by Subject|8
3108804|NCT00197028|10648429|P2|Overall Study|Protocol Violation|1
3108805|NCT00197028|10648430|P1|Overall Study|Protocol Violation|2
3108806|NCT00197028|10648429|P2|Overall Study|Adverse Event|2
3108807|NCT00197028|10648430|P1|Overall Study|Adverse Event|2
3108808|NCT00197015|10648473|P3|Overall Study|Other|2
3108809|NCT00197015|10648474|P2|Overall Study|Other|3
3108810|NCT00197015|10648475|P1|Overall Study|Other|2
3108811|NCT00197015|10648473|P3|Overall Study|Lost to Follow-up|37
3108812|NCT00197015|10648474|P2|Overall Study|Lost to Follow-up|46
3108813|NCT00197015|10648475|P1|Overall Study|Lost to Follow-up|28
3108814|NCT00197015|10648473|P3|Overall Study|Withdrawal by Subject|34
3108815|NCT00197015|10648474|P2|Overall Study|Withdrawal by Subject|37
3108816|NCT00197015|10648475|P1|Overall Study|Withdrawal by Subject|17
3108817|NCT00197015|10648473|P3|Overall Study|Protocol Violation|3
3108818|NCT00197015|10648474|P2|Overall Study|Protocol Violation|3
3108819|NCT00197015|10648475|P1|Overall Study|Protocol Violation|0
3108820|NCT00197015|10648473|P3|Overall Study|Adverse Event|1
3108821|NCT00197015|10648474|P2|Overall Study|Adverse Event|0
3108822|NCT00197015|10648475|P1|Overall Study|Adverse Event|3
3108823|NCT00197002|10648534|P3|Overall Study|Others|1
3108824|NCT00197002|10648535|P2|Overall Study|Others|1
3108825|NCT00197002|10648536|P1|Overall Study|Others|3
3108826|NCT00197002|10648534|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
3108827|NCT00197002|10648535|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
3108828|NCT00197002|10648536|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
3108829|NCT00197002|10648534|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
3108830|NCT00197002|10648535|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
3108831|NCT00197002|10648536|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
3108832|NCT00197002|10648534|P3|Overall Study|Migrated/moved from study area|1
3108833|NCT00197002|10648535|P2|Overall Study|Migrated/moved from study area|5
3108834|NCT00197002|10648536|P1|Overall Study|Migrated/moved from study area|3
3108835|NCT00197002|10648534|P3|Overall Study|Withdrawal by Subject|7
3108836|NCT00197002|10648535|P2|Overall Study|Withdrawal by Subject|5
3108837|NCT00197002|10648536|P1|Overall Study|Withdrawal by Subject|9
3108838|NCT00197002|10648534|P3|Overall Study|Protocol Violation|2
3108839|NCT00197002|10648535|P2|Overall Study|Protocol Violation|0
3108840|NCT00197002|10648536|P1|Overall Study|Protocol Violation|1
3108841|NCT00197002|10648534|P3|Overall Study|Adverse Event|0
3108842|NCT00197002|10648535|P2|Overall Study|Adverse Event|1
3108843|NCT00197002|10648536|P1|Overall Study|Adverse Event|0
3108844|NCT00196976|10648587|P14|Booster Study|Lost to Follow-up|0
3108845|NCT00196976|10648588|P13|Booster Study|Lost to Follow-up|0
3108846|NCT00196976|10648589|P12|Booster Study|Lost to Follow-up|2
3108847|NCT00196976|10648590|P11|Booster Study|Lost to Follow-up|1
3108848|NCT00196976|10648591|P10|Booster Study|Lost to Follow-up|0
3108849|NCT00196976|10648592|P9|Booster Study|Lost to Follow-up|0
3108850|NCT00196976|10648593|P8|Booster Study|Lost to Follow-up|0
3108851|NCT00196976|10648594|P7|Booster Study|Lost to Follow-up|0
3108852|NCT00196976|10648595|P6|Booster Study|Lost to Follow-up|0
3108853|NCT00196976|10648596|P5|Booster Study|Lost to Follow-up|0
3108854|NCT00196976|10648597|P4|Booster Study|Lost to Follow-up|0
3108855|NCT00196976|10648598|P3|Booster Study|Lost to Follow-up|0
3108856|NCT00196976|10648599|P2|Booster Study|Lost to Follow-up|0
3108857|NCT00196976|10648600|P1|Booster Study|Lost to Follow-up|0
3108858|NCT00196976|10648587|P14|Booster Study|Withdrawal by Subject|0
3108859|NCT00196976|10648588|P13|Booster Study|Withdrawal by Subject|0
3108860|NCT00196976|10648589|P12|Booster Study|Withdrawal by Subject|0
3108861|NCT00196976|10648590|P11|Booster Study|Withdrawal by Subject|1
3108862|NCT00196976|10648591|P10|Booster Study|Withdrawal by Subject|0
3108863|NCT00196976|10648592|P9|Booster Study|Withdrawal by Subject|0
3108864|NCT00196976|10648593|P8|Booster Study|Withdrawal by Subject|0
3108865|NCT00196976|10648594|P7|Booster Study|Withdrawal by Subject|0
3108866|NCT00196976|10648595|P6|Booster Study|Withdrawal by Subject|0
3108867|NCT00196976|10648596|P5|Booster Study|Withdrawal by Subject|0
3108868|NCT00196976|10648597|P4|Booster Study|Withdrawal by Subject|0
3108869|NCT00196976|10648598|P3|Booster Study|Withdrawal by Subject|0
3108870|NCT00196976|10648599|P2|Booster Study|Withdrawal by Subject|0
3108871|NCT00196976|10648600|P1|Booster Study|Withdrawal by Subject|0
3108872|NCT00196976|10648587|P14|Primary Study|Other|0
3108873|NCT00196976|10648588|P13|Primary Study|Other|0
3108874|NCT00196976|10648589|P12|Primary Study|Other|0
3108875|NCT00196976|10648590|P11|Primary Study|Other|0
3108876|NCT00196976|10648591|P10|Primary Study|Other|0
3108877|NCT00196976|10648592|P9|Primary Study|Other|0
3108878|NCT00196976|10648593|P8|Primary Study|Other|0
3108879|NCT00196976|10648594|P7|Primary Study|Other|0
3108880|NCT00196976|10648595|P6|Primary Study|Other|0
3108881|NCT00196976|10648596|P5|Primary Study|Other|0
3108882|NCT00196976|10648597|P4|Primary Study|Other|0
3108883|NCT00196976|10648598|P3|Primary Study|Other|2
3108884|NCT00196976|10648599|P2|Primary Study|Other|0
3108885|NCT00196976|10648600|P1|Primary Study|Other|0
3108886|NCT00196976|10648587|P14|Primary Study|Lost to Follow-up|0
3108887|NCT00196976|10648588|P13|Primary Study|Lost to Follow-up|0
3108888|NCT00196976|10648589|P12|Primary Study|Lost to Follow-up|0
3108889|NCT00196976|10648590|P11|Primary Study|Lost to Follow-up|0
3108890|NCT00196976|10648591|P10|Primary Study|Lost to Follow-up|0
3108891|NCT00196976|10648592|P9|Primary Study|Lost to Follow-up|0
3108892|NCT00196976|10648593|P8|Primary Study|Lost to Follow-up|2
3108893|NCT00196976|10648594|P7|Primary Study|Lost to Follow-up|0
3108894|NCT00196976|10648595|P6|Primary Study|Lost to Follow-up|1
3108895|NCT00196976|10648596|P5|Primary Study|Lost to Follow-up|1
3108896|NCT00196976|10648597|P4|Primary Study|Lost to Follow-up|0
3108897|NCT00196976|10648598|P3|Primary Study|Lost to Follow-up|0
3108898|NCT00196976|10648599|P2|Primary Study|Lost to Follow-up|0
3108899|NCT00196976|10648600|P1|Primary Study|Lost to Follow-up|0
3108900|NCT00196976|10648587|P14|Primary Study|Withdrawal by Subject|0
3108901|NCT00196976|10648588|P13|Primary Study|Withdrawal by Subject|0
3108902|NCT00196976|10648589|P12|Primary Study|Withdrawal by Subject|0
3108903|NCT00196976|10648590|P11|Primary Study|Withdrawal by Subject|0
3108904|NCT00196976|10648591|P10|Primary Study|Withdrawal by Subject|1
3108905|NCT00196976|10648592|P9|Primary Study|Withdrawal by Subject|0
3108906|NCT00196976|10648593|P8|Primary Study|Withdrawal by Subject|0
3108907|NCT00196976|10648594|P7|Primary Study|Withdrawal by Subject|0
3108908|NCT00196976|10648595|P6|Primary Study|Withdrawal by Subject|1
3108909|NCT00196976|10648596|P5|Primary Study|Withdrawal by Subject|2
3108910|NCT00196976|10648597|P4|Primary Study|Withdrawal by Subject|1
3108911|NCT00196976|10648598|P3|Primary Study|Withdrawal by Subject|1
3108912|NCT00196976|10648599|P2|Primary Study|Withdrawal by Subject|0
3108913|NCT00196976|10648600|P1|Primary Study|Withdrawal by Subject|1
3108914|NCT00196976|10648587|P14|Primary Study|Protocol Violation|0
3108915|NCT00196976|10648588|P13|Primary Study|Protocol Violation|0
3108916|NCT00196976|10648589|P12|Primary Study|Protocol Violation|0
3108917|NCT00196976|10648590|P11|Primary Study|Protocol Violation|0
3108918|NCT00196976|10648591|P10|Primary Study|Protocol Violation|0
3108919|NCT00196976|10648592|P9|Primary Study|Protocol Violation|0
3108920|NCT00196976|10648593|P8|Primary Study|Protocol Violation|0
3108921|NCT00196976|10648594|P7|Primary Study|Protocol Violation|0
3108922|NCT00196976|10648595|P6|Primary Study|Protocol Violation|0
3108923|NCT00196976|10648596|P5|Primary Study|Protocol Violation|0
3108924|NCT00196976|10648597|P4|Primary Study|Protocol Violation|0
3108925|NCT00196976|10648598|P3|Primary Study|Protocol Violation|1
3108926|NCT00196976|10648599|P2|Primary Study|Protocol Violation|1
3108927|NCT00196976|10648600|P1|Primary Study|Protocol Violation|0
3108928|NCT00196976|10648587|P14|Primary Study|Migrated from study area|0
3108929|NCT00196976|10648588|P13|Primary Study|Migrated from study area|0
3108930|NCT00196976|10648589|P12|Primary Study|Migrated from study area|0
3108931|NCT00196976|10648590|P11|Primary Study|Migrated from study area|0
3108932|NCT00196976|10648591|P10|Primary Study|Migrated from study area|0
3108933|NCT00196976|10648592|P9|Primary Study|Migrated from study area|0
3108934|NCT00196976|10648593|P8|Primary Study|Migrated from study area|1
3108935|NCT00196976|10648594|P7|Primary Study|Migrated from study area|0
3108936|NCT00196976|10648595|P6|Primary Study|Migrated from study area|0
3108937|NCT00196976|10648596|P5|Primary Study|Migrated from study area|0
3108938|NCT00196976|10648597|P4|Primary Study|Migrated from study area|0
3108939|NCT00196976|10648598|P3|Primary Study|Migrated from study area|0
3108940|NCT00196976|10648599|P2|Primary Study|Migrated from study area|0
3108941|NCT00196976|10648600|P1|Primary Study|Migrated from study area|0
3108942|NCT00196937|10648796|P3|Overall Study|Other|1
3108943|NCT00196937|10648797|P2|Overall Study|Other|1
3108944|NCT00196937|10648798|P1|Overall Study|Other|3
3108945|NCT00196937|10648796|P3|Overall Study|Lost to Follow-up|3
3108946|NCT00196937|10648797|P2|Overall Study|Lost to Follow-up|3
3108947|NCT00196937|10648798|P1|Overall Study|Lost to Follow-up|4
3108948|NCT00196937|10648796|P3|Overall Study|Withdrawal by Subject|2
3108949|NCT00196937|10648797|P2|Overall Study|Withdrawal by Subject|0
3108950|NCT00196937|10648798|P1|Overall Study|Withdrawal by Subject|0
3108951|NCT00196937|10648796|P3|Overall Study|Non-serious adverse event|1
3108952|NCT00196937|10648797|P2|Overall Study|Non-serious adverse event|1
3108953|NCT00196937|10648798|P1|Overall Study|Non-serious adverse event|1
3108954|NCT00196937|10648796|P3|Overall Study|Serious Adverse Event|0
3108955|NCT00196937|10648797|P2|Overall Study|Serious Adverse Event|0
3108956|NCT00196937|10648798|P1|Overall Study|Serious Adverse Event|1
3108957|NCT00196326|10648852|P1|Overall Study|Other|22
3108958|NCT00196326|10648852|P1|Overall Study|Lost to Follow-up|304
3108959|NCT00196326|10648852|P1|Overall Study|Pregnancy|34
3108960|NCT00196326|10648852|P1|Overall Study|Adverse Event|253
3108961|NCT00196326|10648852|P1|Overall Study|Withdrawal by Subject|225
3108962|NCT00196326|10648852|P1|Overall Study|Physician Decision|3
3108963|NCT00196326|10648852|P1|Overall Study|Non-compliance with the protocol|81
3108964|NCT00196326|10648852|P1|Overall Study|Did not meet protocol requirements|64
3108965|NCT00196313|10648860|P2|Overall Study|Lost to Follow-up|2
3108966|NCT00196313|10648861|P1|Overall Study|Lost to Follow-up|2
3108967|NCT00196313|10648860|P2|Overall Study|Subject Pregnant|1
3108968|NCT00196313|10648861|P1|Overall Study|Subject Pregnant|1
3108969|NCT00196313|10648860|P2|Overall Study|Adverse Event|1
3108970|NCT00196313|10648861|P1|Overall Study|Adverse Event|3
3108971|NCT00196313|10648860|P2|Overall Study|Withdrawal by Subject|1
3108972|NCT00196313|10648861|P1|Overall Study|Withdrawal by Subject|3
3108973|NCT00196313|10648860|P2|Overall Study|Protocol Violation|3
3108974|NCT00196313|10648861|P1|Overall Study|Protocol Violation|2
3108975|NCT00196196|10648875|P1|Overall Study|Did not have required condition (hydroce|5
3108976|NCT00196196|10648875|P1|Overall Study|Withdrawal by Subject|2
3108977|NCT00196105|10648883|P3|Overall Study|Lost to Follow-up|7
3108978|NCT00196105|10648884|P2|Overall Study|Lost to Follow-up|5
3108979|NCT00196105|10648885|P1|Overall Study|Lost to Follow-up|4
3108980|NCT00195819|10648905|P2|Open-label|Withdrawal by Subject|5
3108981|NCT00195819|10648906|P1|Open-label|Withdrawal by Subject|0
3108982|NCT00195819|10648905|P2|Open-label|Moved|1
3108983|NCT00195819|10648906|P1|Open-label|Moved|0
3108984|NCT00195819|10648905|P2|Open-label|Protocol Violation|2
3108985|NCT00195819|10648906|P1|Open-label|Protocol Violation|0
3108986|NCT00195819|10648905|P2|Open-label|Pregnancy|1
3108987|NCT00195819|10648906|P1|Open-label|Pregnancy|0
3108988|NCT00195819|10648905|P2|Open-label|Lack of Efficacy|2
3108989|NCT00195819|10648906|P1|Open-label|Lack of Efficacy|0
3108990|NCT00195819|10648905|P2|Open-label|Adverse Event|9
3108991|NCT00195819|10648906|P1|Open-label|Adverse Event|0
3108992|NCT00195819|10648905|P2|Double-Blind|Moved|0
3108993|NCT00195819|10648906|P1|Double-Blind|Moved|1
3108994|NCT00195819|10648905|P2|Double-Blind|Withdrawal by Subject|0
3108995|NCT00195819|10648906|P1|Double-Blind|Withdrawal by Subject|1
3108996|NCT00195715|10648956|P1|Overall Study|Sponsor discretion - trial ended early|1
3108997|NCT00195715|10648956|P1|Overall Study|Sponsor discontinued trial|1
3108998|NCT00195715|10648956|P1|Overall Study|Colonic stricture|1
3108999|NCT00195715|10648956|P1|Overall Study|Ineligible|1
3109000|NCT00195715|10648956|P1|Overall Study|Increased infection rate|1
3109001|NCT00195715|10648956|P1|Overall Study|Planned surgery|2
3109002|NCT00195715|10648956|P1|Overall Study|Use of prohibited medication|2
3109003|NCT00195715|10648956|P1|Overall Study|Subject wants to get pregnant|4
3109004|NCT00195715|10648956|P1|Overall Study|Investigator's decision|2
3109005|NCT00195715|10648956|P1|Overall Study|Administrative reasons|2
3109006|NCT00195715|10648956|P1|Overall Study|Sponsor stopped study|1
3109007|NCT00195715|10648956|P1|Overall Study|Loss of response/no improvement|3
3109008|NCT00195715|10648956|P1|Overall Study|Subject choice|3
3109009|NCT00195715|10648956|P1|Overall Study|Subject started commercial Humira|5
3109010|NCT00195715|10648956|P1|Overall Study|Subject non-compliance|6
3109011|NCT00195715|10648956|P1|Overall Study|Subject moved/relocated|7
3109012|NCT00195715|10648956|P1|Overall Study|Investigative site closure|8
3109013|NCT00195715|10648956|P1|Overall Study|Pregnancy|14
3109014|NCT00195715|10648956|P1|Overall Study|Lack of Efficacy|93
3109015|NCT00195715|10648956|P1|Overall Study|Protocol Violation|13
3109016|NCT00195715|10648956|P1|Overall Study|Lost to Follow-up|27
3109017|NCT00195715|10648956|P1|Overall Study|Withdrawal by Subject|58
3109018|NCT00195715|10648956|P1|Overall Study|Adverse Event|122
3109019|NCT00195676|10649056|P1|Period R - Retreatment 16 Weeks|Other reasons|6
3109020|NCT00195676|10649056|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
3109021|NCT00195676|10649056|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
3109022|NCT00195676|10649056|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
3109023|NCT00195676|10649056|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
3109024|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
3109025|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
3109026|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
3109027|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
3109028|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
3109029|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
3109030|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Death|2
3109031|NCT00195676|10649056|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
3109032|NCT00195676|10649056|P1|Period O - Open-label Treatment|Other reasons|68
3109033|NCT00195676|10649056|P1|Period O - Open-label Treatment|Administrative reasons|2
3109034|NCT00195676|10649056|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
3109035|NCT00195676|10649056|P1|Period O - Open-label Treatment|Protocol Violation|12
3109036|NCT00195676|10649056|P1|Period O - Open-label Treatment|Lost to Follow-up|91
3109037|NCT00195676|10649056|P1|Period O - Open-label Treatment|Lack of Efficacy|198
3109038|NCT00195676|10649056|P1|Period O - Open-label Treatment|Death|6
3109039|NCT00195676|10649056|P1|Period O - Open-label Treatment|Adverse Event|82
3109040|NCT00195663|10649070|P3|Open-Label Extension Period|Administrative reasons|13
3109041|NCT00195663|10649071|P2|Open-Label Extension Period|Administrative reasons|11
3109042|NCT00195663|10649072|P1|Open-Label Extension Period|Administrative reasons|11
3109043|NCT00195663|10649070|P3|Open-Label Extension Period|Lack of Efficacy|12
3109044|NCT00195663|10649071|P2|Open-Label Extension Period|Lack of Efficacy|6
3109045|NCT00195663|10649072|P1|Open-Label Extension Period|Lack of Efficacy|14
3109046|NCT00195663|10649070|P3|Open-Label Extension Period|Withdrawal by Subject|22
3109047|NCT00195663|10649071|P2|Open-Label Extension Period|Withdrawal by Subject|15
3109048|NCT00195663|10649072|P1|Open-Label Extension Period|Withdrawal by Subject|16
3109049|NCT00195663|10649070|P3|Open-Label Extension Period|Death|2
3109050|NCT00195663|10649071|P2|Open-Label Extension Period|Death|2
3109051|NCT00195663|10649072|P1|Open-Label Extension Period|Death|2
3109052|NCT00195663|10649070|P3|Open-Label Extension Period|Protocol Violation|4
3109053|NCT00195663|10649071|P2|Open-Label Extension Period|Protocol Violation|4
3109054|NCT00195663|10649072|P1|Open-Label Extension Period|Protocol Violation|3
3109055|NCT00195663|10649070|P3|Open-Label Extension Period|Recovery|2
3109056|NCT00195663|10649071|P2|Open-Label Extension Period|Recovery|2
3109057|NCT00195663|10649072|P1|Open-Label Extension Period|Recovery|0
3109058|NCT00195663|10649070|P3|Open-Label Extension Period|Lost to Follow-up|6
3109059|NCT00195663|10649071|P2|Open-Label Extension Period|Lost to Follow-up|2
3109060|NCT00195663|10649072|P1|Open-Label Extension Period|Lost to Follow-up|9
3109061|NCT00195663|10649070|P3|Open-Label Extension Period|Adverse Event|36
3109062|NCT00195663|10649071|P2|Open-Label Extension Period|Adverse Event|32
3109063|NCT00195663|10649072|P1|Open-Label Extension Period|Adverse Event|21
3109064|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Administrative reasons|9
3109065|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Administrative reasons|2
3109066|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Administrative reasons|3
3109067|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Recovery|1
3109068|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Recovery|0
3109069|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Recovery|1
3109070|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
3109071|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
3109072|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
3109073|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Protocol Violation|4
3109074|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Protocol Violation|6
3109075|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Protocol Violation|6
3109076|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
3109077|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
3109078|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
3109079|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
3109080|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
3109081|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
3109082|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
3109083|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
3109084|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
3109085|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Death|0
3109086|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Death|2
3109087|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Death|0
3109088|NCT00195663|10649070|P3|2-year Double-blind Treatment Period|Adverse Event|32
3109089|NCT00195663|10649071|P2|2-year Double-blind Treatment Period|Adverse Event|27
3109090|NCT00195663|10649072|P1|2-year Double-blind Treatment Period|Adverse Event|21
3109091|NCT00195650|10649166|P1|Overall Study|Administrative reasons|83
3109092|NCT00195650|10649166|P1|Overall Study|Protocol Violation|15
3109093|NCT00195650|10649166|P1|Overall Study|Death|23
3109094|NCT00195650|10649166|P1|Overall Study|Lost to Follow-up|44
3109095|NCT00195650|10649166|P1|Overall Study|Withdrawal by Subject|67
3109096|NCT00195650|10649166|P1|Overall Study|Lack of Efficacy|99
3109097|NCT00195650|10649166|P1|Overall Study|Adverse Event|194
3109098|NCT00195507|10649191|P2|Overall Study|Protocol Deviation|3
3109099|NCT00195507|10649192|P1|Overall Study|Protocol Deviation|6
3109100|NCT00195507|10649191|P2|Overall Study|Withdrawal by Subject|23
3109101|NCT00195507|10649192|P1|Overall Study|Withdrawal by Subject|16
3109102|NCT00195507|10649191|P2|Overall Study|Lack of Efficacy|67
3109103|NCT00195507|10649192|P1|Overall Study|Lack of Efficacy|40
3109104|NCT00195507|10649191|P2|Overall Study|Protocol Violation|4
3109105|NCT00195507|10649192|P1|Overall Study|Protocol Violation|5
3109106|NCT00195507|10649191|P2|Overall Study|Lost to Follow-up|2
3109107|NCT00195507|10649192|P1|Overall Study|Lost to Follow-up|3
3109108|NCT00195507|10649191|P2|Overall Study|Physician Decision|2
3109109|NCT00195507|10649192|P1|Overall Study|Physician Decision|1
3109110|NCT00195507|10649191|P2|Overall Study|Failed to Return|3
3109111|NCT00195507|10649192|P1|Overall Study|Failed to Return|4
3109112|NCT00195507|10649191|P2|Overall Study|Death|1
3109113|NCT00195507|10649192|P1|Overall Study|Death|0
3109114|NCT00195507|10649191|P2|Overall Study|Adverse Event|13
3109115|NCT00195507|10649192|P1|Overall Study|Adverse Event|24
3109116|NCT00195494|10649206|P6|Year 2|System toxicity|0
3109117|NCT00195494|10649207|P5|Year 2|System toxicity|0
3109118|NCT00195494|10649208|P4|Year 2|System toxicity|1
3109119|NCT00195494|10649209|P3|Year 2|System toxicity|0
3109120|NCT00195494|10649210|P2|Year 2|System toxicity|0
3109121|NCT00195494|10649211|P1|Year 2|System toxicity|0
3109122|NCT00195494|10649206|P6|Year 2|Withdrawal by Subject|0
3109123|NCT00195494|10649207|P5|Year 2|Withdrawal by Subject|0
3109124|NCT00195494|10649208|P4|Year 2|Withdrawal by Subject|3
3109125|NCT00195494|10649209|P3|Year 2|Withdrawal by Subject|4
3109126|NCT00195494|10649210|P2|Year 2|Withdrawal by Subject|5
3109127|NCT00195494|10649211|P1|Year 2|Withdrawal by Subject|1
3109128|NCT00195494|10649206|P6|Year 2|Physician Decision|0
3109129|NCT00195494|10649207|P5|Year 2|Physician Decision|0
3109130|NCT00195494|10649208|P4|Year 2|Physician Decision|0
3109131|NCT00195494|10649209|P3|Year 2|Physician Decision|0
3109132|NCT00195494|10649210|P2|Year 2|Physician Decision|1
3109133|NCT00195494|10649211|P1|Year 2|Physician Decision|1
3109134|NCT00195494|10649206|P6|Year 2|Protocol deviation|0
3109135|NCT00195494|10649207|P5|Year 2|Protocol deviation|0
3109136|NCT00195494|10649208|P4|Year 2|Protocol deviation|0
3109137|NCT00195494|10649209|P3|Year 2|Protocol deviation|0
3109138|NCT00195494|10649210|P2|Year 2|Protocol deviation|1
3109139|NCT00195494|10649211|P1|Year 2|Protocol deviation|0
3109140|NCT00195494|10649206|P6|Year 2|Missed >4 consecutive doses|0
3109141|NCT00195494|10649207|P5|Year 2|Missed >4 consecutive doses|0
3109142|NCT00195494|10649208|P4|Year 2|Missed >4 consecutive doses|0
3109143|NCT00195494|10649209|P3|Year 2|Missed >4 consecutive doses|1
3109144|NCT00195494|10649210|P2|Year 2|Missed >4 consecutive doses|1
3109145|NCT00195494|10649211|P1|Year 2|Missed >4 consecutive doses|1
3109146|NCT00195494|10649206|P6|Year 2|Lost to Follow-up|0
3109147|NCT00195494|10649207|P5|Year 2|Lost to Follow-up|0
3109148|NCT00195494|10649208|P4|Year 2|Lost to Follow-up|1
3109149|NCT00195494|10649209|P3|Year 2|Lost to Follow-up|1
3109150|NCT00195494|10649210|P2|Year 2|Lost to Follow-up|0
3109151|NCT00195494|10649211|P1|Year 2|Lost to Follow-up|0
3109152|NCT00195494|10649206|P6|Year 2|Compliance|0
3109153|NCT00195494|10649207|P5|Year 2|Compliance|0
3109154|NCT00195494|10649208|P4|Year 2|Compliance|2
3109155|NCT00195494|10649209|P3|Year 2|Compliance|0
3109156|NCT00195494|10649210|P2|Year 2|Compliance|0
3109157|NCT00195494|10649211|P1|Year 2|Compliance|1
3109158|NCT00195494|10649206|P6|Year 2|Lack of Efficacy|0
3109159|NCT00195494|10649207|P5|Year 2|Lack of Efficacy|0
3109160|NCT00195494|10649208|P4|Year 2|Lack of Efficacy|7
3109161|NCT00195494|10649209|P3|Year 2|Lack of Efficacy|7
3109162|NCT00195494|10649210|P2|Year 2|Lack of Efficacy|1
3109163|NCT00195494|10649211|P1|Year 2|Lack of Efficacy|0
3109164|NCT00195494|10649206|P6|Year 2|Adverse Event|0
3109165|NCT00195494|10649207|P5|Year 2|Adverse Event|0
3109166|NCT00195494|10649208|P4|Year 2|Adverse Event|9
3109167|NCT00195494|10649209|P3|Year 2|Adverse Event|5
3109168|NCT00195494|10649210|P2|Year 2|Adverse Event|7
3109169|NCT00195494|10649211|P1|Year 2|Adverse Event|3
3109170|NCT00195494|10649206|P6|Year 1|Protocol Violation|1
3109171|NCT00195494|10649207|P5|Year 1|Protocol Violation|1
3109172|NCT00195494|10649208|P4|Year 1|Protocol Violation|0
3109173|NCT00195494|10649209|P3|Year 1|Protocol Violation|0
3109174|NCT00195494|10649210|P2|Year 1|Protocol Violation|0
3109175|NCT00195494|10649211|P1|Year 1|Protocol Violation|0
3109176|NCT00195494|10649206|P6|Year 1|Withdrawal by Subject|9
3109177|NCT00195494|10649207|P5|Year 1|Withdrawal by Subject|8
3109178|NCT00195494|10649208|P4|Year 1|Withdrawal by Subject|0
3109179|NCT00195494|10649209|P3|Year 1|Withdrawal by Subject|0
3109180|NCT00195494|10649210|P2|Year 1|Withdrawal by Subject|0
3109181|NCT00195494|10649211|P1|Year 1|Withdrawal by Subject|0
3109182|NCT00195494|10649206|P6|Year 1|Physician Decision|0
3109183|NCT00195494|10649207|P5|Year 1|Physician Decision|1
3109184|NCT00195494|10649208|P4|Year 1|Physician Decision|0
3109185|NCT00195494|10649209|P3|Year 1|Physician Decision|0
3109186|NCT00195494|10649210|P2|Year 1|Physician Decision|0
3109187|NCT00195494|10649211|P1|Year 1|Physician Decision|0
3109188|NCT00195494|10649206|P6|Year 1|Protocol deviation|3
3109189|NCT00195494|10649207|P5|Year 1|Protocol deviation|2
3109190|NCT00195494|10649208|P4|Year 1|Protocol deviation|0
3109191|NCT00195494|10649209|P3|Year 1|Protocol deviation|0
3109192|NCT00195494|10649210|P2|Year 1|Protocol deviation|0
3109193|NCT00195494|10649211|P1|Year 1|Protocol deviation|0
3109194|NCT00195494|10649206|P6|Year 1|Missed >4 consecutive doses|2
3109195|NCT00195494|10649207|P5|Year 1|Missed >4 consecutive doses|3
3109196|NCT00195494|10649208|P4|Year 1|Missed >4 consecutive doses|0
3109197|NCT00195494|10649209|P3|Year 1|Missed >4 consecutive doses|0
3109198|NCT00195494|10649210|P2|Year 1|Missed >4 consecutive doses|0
3109199|NCT00195494|10649211|P1|Year 1|Missed >4 consecutive doses|0
3109200|NCT00195494|10649206|P6|Year 1|Lost to Follow-up|0
3109201|NCT00195494|10649207|P5|Year 1|Lost to Follow-up|1
3109202|NCT00195494|10649208|P4|Year 1|Lost to Follow-up|0
3109203|NCT00195494|10649209|P3|Year 1|Lost to Follow-up|0
3109204|NCT00195494|10649210|P2|Year 1|Lost to Follow-up|0
3109205|NCT00195494|10649211|P1|Year 1|Lost to Follow-up|0
3109206|NCT00195494|10649206|P6|Year 1|Compliance|1
3109207|NCT00195494|10649207|P5|Year 1|Compliance|5
3109208|NCT00195494|10649208|P4|Year 1|Compliance|0
3109209|NCT00195494|10649209|P3|Year 1|Compliance|0
3109210|NCT00195494|10649210|P2|Year 1|Compliance|0
3109211|NCT00195494|10649211|P1|Year 1|Compliance|0
3109212|NCT00195494|10649206|P6|Year 1|Lack of Efficacy|9
3109213|NCT00195494|10649207|P5|Year 1|Lack of Efficacy|24
3109214|NCT00195494|10649208|P4|Year 1|Lack of Efficacy|0
3109215|NCT00195494|10649209|P3|Year 1|Lack of Efficacy|0
3109216|NCT00195494|10649210|P2|Year 1|Lack of Efficacy|0
3109217|NCT00195494|10649211|P1|Year 1|Lack of Efficacy|0
3109218|NCT00195494|10649206|P6|Year 1|System Toxicity|1
3109219|NCT00195494|10649207|P5|Year 1|System Toxicity|0
3109220|NCT00195494|10649208|P4|Year 1|System Toxicity|0
3109221|NCT00195494|10649209|P3|Year 1|System Toxicity|0
3109222|NCT00195494|10649210|P2|Year 1|System Toxicity|0
3109223|NCT00195494|10649211|P1|Year 1|System Toxicity|0
3109224|NCT00195494|10649206|P6|Year 1|Adverse Event|27
3109225|NCT00195494|10649207|P5|Year 1|Adverse Event|34
3109226|NCT00195494|10649208|P4|Year 1|Adverse Event|0
3109227|NCT00195494|10649209|P3|Year 1|Adverse Event|0
3109228|NCT00195494|10649210|P2|Year 1|Adverse Event|0
3109229|NCT00195494|10649211|P1|Year 1|Adverse Event|0
3109230|NCT00195442|10649229|P1|Overall Study|Other|14
3109231|NCT00195442|10649229|P1|Overall Study|Poor cooperation|2
3109232|NCT00195442|10649229|P1|Overall Study|No reason specified|4
3109233|NCT00195442|10649229|P1|Overall Study|Death|7
3109234|NCT00195442|10649229|P1|Overall Study|Intermittent product shortage|21
3109235|NCT00195442|10649229|P1|Overall Study|Switch to other Factor VIII preparation|23
3109236|NCT00195442|10649229|P1|Overall Study|Lost to Follow-up|27
3109237|NCT00195442|10649229|P1|Overall Study|Less than expected therapeutic effect|38
3109238|NCT00195429|10649248|P2|Overall Study|Lost to Follow-up|0
3109239|NCT00195429|10649249|P1|Overall Study|Lost to Follow-up|1
3109240|NCT00195429|10649248|P2|Overall Study|Lack of Efficacy|1
3109241|NCT00195429|10649249|P1|Overall Study|Lack of Efficacy|2
3109242|NCT00195429|10649248|P2|Overall Study|Adverse Event|4
3109243|NCT00195429|10649249|P1|Overall Study|Adverse Event|2
3109244|NCT00195351|10649265|P2|Overall Study|Lack of Efficacy|1
3109245|NCT00195351|10649266|P1|Overall Study|Lack of Efficacy|0
3109246|NCT00195351|10649265|P2|Overall Study|Death|1
3109247|NCT00195351|10649266|P1|Overall Study|Death|3
3109248|NCT00195351|10649265|P2|Overall Study|Protocol Deviation|2
3109249|NCT00195351|10649266|P1|Overall Study|Protocol Deviation|3
3109250|NCT00195351|10649265|P2|Overall Study|Withdrawal by Subject|3
3109251|NCT00195351|10649266|P1|Overall Study|Withdrawal by Subject|6
3109252|NCT00195351|10649265|P2|Overall Study|Lost to Follow-up|9
3109253|NCT00195351|10649266|P1|Overall Study|Lost to Follow-up|9
3109254|NCT00195338|10649276|P1|Overall Study|Early closure of the site|4
3109255|NCT00195338|10649276|P1|Overall Study|Lack of Efficacy|1
3109256|NCT00195338|10649276|P1|Overall Study|Adverse Event|5
3109257|NCT00195338|10649276|P1|Overall Study|Lost to Follow-up|2
3109258|NCT00195273|10649286|P2|Overall Study|Procedural complications|3
3109259|NCT00195273|10649287|P1|Overall Study|Procedural complications|9
3109260|NCT00195273|10649286|P2|Overall Study|Lack of Efficacy|1
3109261|NCT00195273|10649287|P1|Overall Study|Lack of Efficacy|3
3109262|NCT00195273|10649286|P2|Overall Study|Protocol deviation|1
3109263|NCT00195273|10649287|P1|Overall Study|Protocol deviation|0
3109264|NCT00195273|10649286|P2|Overall Study|Adverse Event|9
3109265|NCT00195273|10649287|P1|Overall Study|Adverse Event|9
3109266|NCT00195260|10649301|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
3109267|NCT00195260|10649302|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
3109268|NCT00195260|10649303|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
3109269|NCT00195260|10649304|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109270|NCT00195260|10649305|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109271|NCT00195260|10649306|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109272|NCT00195260|10649307|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109273|NCT00195260|10649308|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109274|NCT00195260|10649309|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109275|NCT00195260|10649310|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109276|NCT00195260|10649311|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
3109277|NCT00195260|10649301|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
3109278|NCT00195260|10649302|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
3109279|NCT00195260|10649303|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
3109280|NCT00195260|10649304|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109281|NCT00195260|10649305|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109282|NCT00195260|10649306|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109283|NCT00195260|10649307|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109284|NCT00195260|10649308|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109285|NCT00195260|10649309|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109286|NCT00195260|10649310|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109287|NCT00195260|10649311|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
3109288|NCT00195260|10649301|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
3109289|NCT00195260|10649302|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
3109290|NCT00195260|10649303|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
3109291|NCT00195260|10649304|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109292|NCT00195260|10649305|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109293|NCT00195260|10649306|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109294|NCT00195260|10649307|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109295|NCT00195260|10649308|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109296|NCT00195260|10649309|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109297|NCT00195260|10649310|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109298|NCT00195260|10649311|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
3109299|NCT00195260|10649301|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
3109300|NCT00195260|10649302|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
3109301|NCT00195260|10649303|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
3109302|NCT00195260|10649304|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109303|NCT00195260|10649305|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109304|NCT00195260|10649306|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109305|NCT00195260|10649307|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109306|NCT00195260|10649308|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109307|NCT00195260|10649309|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109308|NCT00195260|10649310|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109309|NCT00195260|10649311|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
3109310|NCT00195260|10649301|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109311|NCT00195260|10649302|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109312|NCT00195260|10649303|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109313|NCT00195260|10649304|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109314|NCT00195260|10649305|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109315|NCT00195260|10649306|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
3109316|NCT00195260|10649307|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109317|NCT00195260|10649308|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
3109318|NCT00195260|10649309|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
3109319|NCT00195260|10649310|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
3109320|NCT00195260|10649311|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
3109321|NCT00195260|10649301|P11|Part 1: Dose Escalation|Disease Progression|0
3109322|NCT00195260|10649302|P10|Part 1: Dose Escalation|Disease Progression|0
3109323|NCT00195260|10649303|P9|Part 1: Dose Escalation|Disease Progression|0
3109324|NCT00195260|10649304|P8|Part 1: Dose Escalation|Disease Progression|4
3109325|NCT00195260|10649305|P7|Part 1: Dose Escalation|Disease Progression|7
3109326|NCT00195260|10649306|P6|Part 1: Dose Escalation|Disease Progression|6
3109327|NCT00195260|10649307|P5|Part 1: Dose Escalation|Disease Progression|4
3109328|NCT00195260|10649308|P4|Part 1: Dose Escalation|Disease Progression|6
3109329|NCT00195260|10649309|P3|Part 1: Dose Escalation|Disease Progression|5
3109330|NCT00195260|10649310|P2|Part 1: Dose Escalation|Disease Progression|2
3109331|NCT00195260|10649311|P1|Part 1: Dose Escalation|Disease Progression|3
3109332|NCT00195260|10649301|P11|Part 1: Dose Escalation|Death|0
3109333|NCT00195260|10649302|P10|Part 1: Dose Escalation|Death|0
3109334|NCT00195260|10649303|P9|Part 1: Dose Escalation|Death|0
3109335|NCT00195260|10649304|P8|Part 1: Dose Escalation|Death|1
3109336|NCT00195260|10649305|P7|Part 1: Dose Escalation|Death|0
3109337|NCT00195260|10649306|P6|Part 1: Dose Escalation|Death|0
3109338|NCT00195260|10649307|P5|Part 1: Dose Escalation|Death|0
3109339|NCT00195260|10649308|P4|Part 1: Dose Escalation|Death|0
3109340|NCT00195260|10649309|P3|Part 1: Dose Escalation|Death|0
3109341|NCT00195260|10649310|P2|Part 1: Dose Escalation|Death|0
3109342|NCT00195260|10649311|P1|Part 1: Dose Escalation|Death|0
3109343|NCT00195260|10649301|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
3109344|NCT00195260|10649302|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
3109345|NCT00195260|10649303|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
3109346|NCT00195260|10649304|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
3109347|NCT00195260|10649305|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
3109348|NCT00195260|10649306|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
3109349|NCT00195260|10649307|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
3109350|NCT00195260|10649308|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
3109351|NCT00195260|10649309|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
3109352|NCT00195260|10649310|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
3109353|NCT00195260|10649311|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
3109354|NCT00195260|10649301|P11|Part 1: Dose Escalation|Adverse Event|0
3109355|NCT00195260|10649302|P10|Part 1: Dose Escalation|Adverse Event|0
3109356|NCT00195260|10649303|P9|Part 1: Dose Escalation|Adverse Event|0
3109357|NCT00195260|10649304|P8|Part 1: Dose Escalation|Adverse Event|0
3109358|NCT00195260|10649305|P7|Part 1: Dose Escalation|Adverse Event|3
3109359|NCT00195260|10649306|P6|Part 1: Dose Escalation|Adverse Event|0
3109360|NCT00195260|10649307|P5|Part 1: Dose Escalation|Adverse Event|1
3109361|NCT00195260|10649308|P4|Part 1: Dose Escalation|Adverse Event|1
3109362|NCT00195260|10649309|P3|Part 1: Dose Escalation|Adverse Event|0
3109363|NCT00195260|10649310|P2|Part 1: Dose Escalation|Adverse Event|1
3109364|NCT00195260|10649311|P1|Part 1: Dose Escalation|Adverse Event|0
3109365|NCT00194987|10649479|P2|Overall Study|Withdrawal by Subject|3
3109366|NCT00194987|10649480|P1|Overall Study|Withdrawal by Subject|0
3109367|NCT00194792|10649513|P1|Overall Study|Withdrawal by Subject|1
3109368|NCT00194675|10649537|P2|Overall Study|Death|0
3109369|NCT00194675|10649538|P1|Overall Study|Death|1
3109370|NCT00194675|10649537|P2|Overall Study|Protocol Violation|0
3109371|NCT00194675|10649538|P1|Overall Study|Protocol Violation|1
3109372|NCT00194675|10649537|P2|Overall Study|"withdrew due to edgy feeling"|0
3109373|NCT00194675|10649538|P1|Overall Study|"withdrew due to edgy feeling"|1
3109374|NCT00194675|10649537|P2|Overall Study|lack of interest|1
3109375|NCT00194675|10649538|P1|Overall Study|lack of interest|1
3109376|NCT00194675|10649537|P2|Overall Study|Lost to Follow-up|1
3109377|NCT00194675|10649538|P1|Overall Study|Lost to Follow-up|1
3109378|NCT00194077|10649613|P2|Overall Study|Withdrawal by Subject|1
3109379|NCT00194077|10649614|P1|Overall Study|Withdrawal by Subject|1
3109380|NCT00194077|10649613|P2|Overall Study|Study nonadherence|0
3109381|NCT00194077|10649614|P1|Overall Study|Study nonadherence|1
3109382|NCT00194077|10649613|P2|Overall Study|Lack of Efficacy|29
3109383|NCT00194077|10649614|P1|Overall Study|Lack of Efficacy|22
3109384|NCT00194025|10649620|P1|Overall Study|non-adherence with study medication|4
3109385|NCT00194025|10649620|P1|Overall Study|Adverse Event|1
3109386|NCT00194012|10649635|P2|Open Label Extension (OLE)|Lack of Efficacy|0
3109387|NCT00194012|10649636|P1|Open Label Extension (OLE)|Lack of Efficacy|1
3109388|NCT00194012|10649635|P2|Open Label Extension (OLE)|Lost to Follow-up|5
3109389|NCT00194012|10649636|P1|Open Label Extension (OLE)|Lost to Follow-up|3
3109390|NCT00194012|10649635|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
3109391|NCT00194012|10649636|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
3109392|NCT00194012|10649635|P2|Open Label Extension (OLE)|Weight Gain|0
3109393|NCT00194012|10649636|P1|Open Label Extension (OLE)|Weight Gain|1
3109394|NCT00194012|10649635|P2|Randomized Phase|Oral/nasal twitching|1
3109395|NCT00194012|10649636|P1|Randomized Phase|Oral/nasal twitching|0
3109396|NCT00194012|10649635|P2|Randomized Phase|Emesis and enuresis|1
3109397|NCT00194012|10649636|P1|Randomized Phase|Emesis and enuresis|0
3109398|NCT00194012|10649635|P2|Randomized Phase|Participant reported having a rash|0
3109399|NCT00194012|10649636|P1|Randomized Phase|Participant reported having a rash|1
3109400|NCT00194012|10649635|P2|Randomized Phase|Adverse Event|1
3109401|NCT00194012|10649636|P1|Randomized Phase|Adverse Event|2
3109402|NCT00194012|10649635|P2|Randomized Phase|Withdrawal by Subject|3
3109403|NCT00194012|10649636|P1|Randomized Phase|Withdrawal by Subject|3
3109404|NCT00194012|10649635|P2|Randomized Phase|Study nonadherence|1
3109405|NCT00194012|10649636|P1|Randomized Phase|Study nonadherence|2
3109406|NCT00194012|10649635|P2|Randomized Phase|Lack of Efficacy|18
3109407|NCT00194012|10649636|P1|Randomized Phase|Lack of Efficacy|8
3109408|NCT00193609|10649672|P1|Overall Study|Adverse Event|2
3109409|NCT00193609|10649672|P1|Overall Study|Lack of Efficacy|2
3109410|NCT00193479|10649699|P1|Induction Chemotherapy|Disease Progression|1
3109411|NCT00193479|10649699|P1|Induction Chemotherapy|Adverse Event|2
3109412|NCT00193206|10649740|P1|Postoperative Therapy|Protocol Violation|1
3109413|NCT00193206|10649740|P1|Postoperative Therapy|Lack of Efficacy|1
3109414|NCT00193206|10649740|P1|Postoperative Therapy|Intercurrent Illness|2
3109415|NCT00193206|10649740|P1|Postoperative Therapy|Physician Decision|3
3109416|NCT00193206|10649740|P1|Postoperative Therapy|Withdrawal by Subject|7
3109417|NCT00193206|10649740|P1|Preoperative Therapy|False Positive Pregnancy Test|1
3109418|NCT00193206|10649740|P1|Preoperative Therapy|Withdrawal by Subject|2
3109419|NCT00193206|10649740|P1|Preoperative Therapy|Adverse Event|2
3109420|NCT00193206|10649740|P1|Preoperative Therapy|Lack of Efficacy|2
3109421|NCT00193180|10649744|P1|Overall Study|Protocol Violation|1
3109422|NCT00193180|10649744|P1|Overall Study|Adverse Event|8
3109423|NCT00193180|10649744|P1|Overall Study|Lack of Efficacy|1
3109424|NCT00193063|10649759|P1|Overall Study|Adverse Event|1
3109425|NCT00193063|10649759|P1|Overall Study|Lack of Efficacy|3
3109426|NCT00193050|10649765|P1|Adjuvant|Lack of Efficacy|2
3109427|NCT00193050|10649765|P1|Adjuvant|Intercurrent Hospitalization|3
3109428|NCT00193050|10649765|P1|Adjuvant|Physician Decision|5
3109429|NCT00193050|10649765|P1|Neoadjuvant Treatment|Adverse Event|2
3109430|NCT00193050|10649765|P1|Neoadjuvant Treatment|Physician Decision|2
3109431|NCT00193050|10649765|P1|Neoadjuvant Treatment|Intercurrent Illness|3
3109432|NCT00193050|10649765|P1|Neoadjuvant Treatment|Lack of Efficacy|2
3109433|NCT00192647|10649782|P2|Overall Study|Other/Administrative|3
3109434|NCT00192647|10649783|P1|Overall Study|Other/Administrative|5
3109435|NCT00192647|10649782|P2|Overall Study|Failure to Return|13
3109436|NCT00192647|10649783|P1|Overall Study|Failure to Return|11
3109437|NCT00192647|10649782|P2|Overall Study|Refused Treatment/Did not Cooperate|8
3109438|NCT00192647|10649783|P1|Overall Study|Refused Treatment/Did not Cooperate|10
3109439|NCT00192647|10649782|P2|Overall Study|Protocol Violation|1
3109440|NCT00192647|10649783|P1|Overall Study|Protocol Violation|3
3109441|NCT00192647|10649782|P2|Overall Study|Entry Criteria Violation|6
3109442|NCT00192647|10649783|P1|Overall Study|Entry Criteria Violation|6
3109443|NCT00192647|10649782|P2|Overall Study|Insufficient Therapeutic Response|83
3109444|NCT00192647|10649783|P1|Overall Study|Insufficient Therapeutic Response|53
3109445|NCT00192647|10649782|P2|Overall Study|Laboratory Test Abnormality|2
3109446|NCT00192647|10649783|P1|Overall Study|Laboratory Test Abnormality|4
3109447|NCT00192647|10649782|P2|Overall Study|Adverse Event|29
3109448|NCT00192647|10649783|P1|Overall Study|Adverse Event|35
3109449|NCT00192647|10649782|P2|Overall Study|Death|1
3109450|NCT00192647|10649783|P1|Overall Study|Death|1
3109451|NCT00192296|10649803|P4|Overall Study|Withdrawal by Subject|0
3109452|NCT00192296|10649804|P3|Overall Study|Withdrawal by Subject|0
3109453|NCT00192296|10649805|P2|Overall Study|Withdrawal by Subject|1
3109454|NCT00192296|10649806|P1|Overall Study|Withdrawal by Subject|0
3109455|NCT00192075|10649862|P2|Overall Study|Other|2
3109456|NCT00192075|10649863|P1|Overall Study|Other|5
3109457|NCT00192075|10649862|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
3109458|NCT00192075|10649863|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
3109459|NCT00192075|10649862|P2|Overall Study|Patient Non-Compliance|1
3109460|NCT00192075|10649863|P1|Overall Study|Patient Non-Compliance|0
3109461|NCT00192075|10649862|P2|Overall Study|Withdrawal by Subject|5
3109462|NCT00192075|10649863|P1|Overall Study|Withdrawal by Subject|5
3109463|NCT00192075|10649862|P2|Overall Study|Physician Decision|0
3109464|NCT00192075|10649863|P1|Overall Study|Physician Decision|3
3109465|NCT00192075|10649862|P2|Overall Study|Lack of Efficacy|0
3109466|NCT00192075|10649863|P1|Overall Study|Lack of Efficacy|0
3109467|NCT00192075|10649862|P2|Overall Study|Death|1
3109468|NCT00192075|10649863|P1|Overall Study|Death|0
3109469|NCT00192075|10649862|P2|Overall Study|Adverse Event|3
3109470|NCT00192075|10649863|P1|Overall Study|Adverse Event|1
3109471|NCT00192075|10649862|P2|Overall Study|Disease Progression|6
3109472|NCT00192075|10649863|P1|Overall Study|Disease Progression|23
3109473|NCT00192036|10649888|P1|Overall Study|Unknown or Not Specified|5
3109474|NCT00192036|10649888|P1|Overall Study|Death|1
3109475|NCT00192036|10649888|P1|Overall Study|Clinical Disease Progression|1
3109476|NCT00192036|10649888|P1|Overall Study|Objective Tumor Progression|4
3109477|NCT00192036|10649888|P1|Overall Study|Patient/Physician Perception|1
3109478|NCT00192036|10649888|P1|Overall Study|Adverse Event|6
3109479|NCT00192036|10649888|P1|Overall Study|Protocol Violation|3
3109480|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Physician Decision|0
3109481|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Physician Decision|9
3109482|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
3109483|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
3109484|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Protocol Violation|0
3109485|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Protocol Violation|1
3109486|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
3109487|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
3109488|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
3109489|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
3109490|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
3109491|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
3109492|NCT00192023|10649898|P2|Period IV - Optional Open-Label|Adverse Event|0
3109493|NCT00192023|10649899|P1|Period IV - Optional Open-Label|Adverse Event|6
3109494|NCT00192023|10649898|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
3109495|NCT00192023|10649899|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
3109496|NCT00192023|10649898|P2|Period III - Double-Blind|Physician Decision|0
3109497|NCT00192023|10649899|P1|Period III - Double-Blind|Physician Decision|2
3109498|NCT00192023|10649898|P2|Period III - Double-Blind|Adverse Event|0
3109499|NCT00192023|10649899|P1|Period III - Double-Blind|Adverse Event|3
3109500|NCT00191984|10649921|P1|Overall Study|Physician Decision|4
3109501|NCT00191984|10649921|P1|Overall Study|Withdrawal by Subject|7
3109502|NCT00191984|10649921|P1|Overall Study|Entry Criteria Exclusion|1
3109503|NCT00191984|10649921|P1|Overall Study|Death|2
3109504|NCT00191984|10649921|P1|Overall Study|Adverse Event|4
3109505|NCT00191984|10649921|P1|Overall Study|Disease Progression|21
3109506|NCT00191945|10649931|P2|Double-Blind Acute Treatment|Physician Decision|2
3109507|NCT00191945|10649932|P1|Double-Blind Acute Treatment|Physician Decision|0
3109508|NCT00191945|10649931|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
3109509|NCT00191945|10649932|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
3109510|NCT00191945|10649931|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
3109511|NCT00191945|10649932|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
3109512|NCT00191945|10649931|P2|Double-Blind Acute Treatment|Parent's Decision|0
3109513|NCT00191945|10649932|P1|Double-Blind Acute Treatment|Parent's Decision|3
3109514|NCT00191906|10649968|P4|Study Period III|Lack of Efficacy|0
3109515|NCT00191906|10649969|P3|Study Period III|Lack of Efficacy|0
3109516|NCT00191906|10649970|P2|Study Period III|Lack of Efficacy|3
3109517|NCT00191906|10649971|P1|Study Period III|Lack of Efficacy|3
3109518|NCT00191906|10649968|P4|Study Period III|Parent/Caregiver Decision|0
3109519|NCT00191906|10649969|P3|Study Period III|Parent/Caregiver Decision|0
3109520|NCT00191906|10649970|P2|Study Period III|Parent/Caregiver Decision|0
3109521|NCT00191906|10649971|P1|Study Period III|Parent/Caregiver Decision|1
3109522|NCT00191906|10649968|P4|Study Period III|Lost to Follow-up|0
3109523|NCT00191906|10649969|P3|Study Period III|Lost to Follow-up|0
3109524|NCT00191906|10649970|P2|Study Period III|Lost to Follow-up|1
3109525|NCT00191906|10649971|P1|Study Period III|Lost to Follow-up|0
3109526|NCT00191906|10649968|P4|Study Period III|Adverse Event|0
3109527|NCT00191906|10649969|P3|Study Period III|Adverse Event|0
3109528|NCT00191906|10649970|P2|Study Period III|Adverse Event|0
3109529|NCT00191906|10649971|P1|Study Period III|Adverse Event|1
3109530|NCT00191906|10649968|P4|Study Period II|Entry Criteria Exclusion|0
3109531|NCT00191906|10649969|P3|Study Period II|Entry Criteria Exclusion|1
3109532|NCT00191906|10649970|P2|Study Period II|Entry Criteria Exclusion|0
3109533|NCT00191906|10649971|P1|Study Period II|Entry Criteria Exclusion|0
3109534|NCT00191906|10649968|P4|Study Period II|Parent/Caregiver Decision|0
3109535|NCT00191906|10649969|P3|Study Period II|Parent/Caregiver Decision|0
3109536|NCT00191906|10649970|P2|Study Period II|Parent/Caregiver Decision|1
3109537|NCT00191906|10649971|P1|Study Period II|Parent/Caregiver Decision|0
3109538|NCT00191906|10649968|P4|Study Period II|Withdrawal by Subject|0
3109539|NCT00191906|10649969|P3|Study Period II|Withdrawal by Subject|0
3109540|NCT00191906|10649970|P2|Study Period II|Withdrawal by Subject|3
3109541|NCT00191906|10649971|P1|Study Period II|Withdrawal by Subject|0
3109542|NCT00191906|10649968|P4|Study Period II|Adverse Event|0
3109543|NCT00191906|10649969|P3|Study Period II|Adverse Event|0
3109544|NCT00191906|10649970|P2|Study Period II|Adverse Event|1
3109545|NCT00191906|10649971|P1|Study Period II|Adverse Event|0
3109546|NCT00191854|10650014|P3|Overall Study|Screen Failure|1
3109547|NCT00191854|10650015|P2|Overall Study|Screen Failure|0
3109548|NCT00191854|10650016|P1|Overall Study|Screen Failure|0
3109549|NCT00191854|10650014|P3|Overall Study|Sponsor Decision|1
3109550|NCT00191854|10650015|P2|Overall Study|Sponsor Decision|0
3109551|NCT00191854|10650016|P1|Overall Study|Sponsor Decision|0
3109552|NCT00191854|10650014|P3|Overall Study|Withdrawal by Subject|3
3109553|NCT00191854|10650015|P2|Overall Study|Withdrawal by Subject|2
3109554|NCT00191854|10650016|P1|Overall Study|Withdrawal by Subject|4
3109555|NCT00191854|10650014|P3|Overall Study|Lost to Follow-up|5
3109556|NCT00191854|10650015|P2|Overall Study|Lost to Follow-up|5
3109557|NCT00191854|10650016|P1|Overall Study|Lost to Follow-up|7
3109558|NCT00191854|10650014|P3|Overall Study|Death|29
3109559|NCT00191854|10650015|P2|Overall Study|Death|23
3109560|NCT00191854|10650016|P1|Overall Study|Death|26
3109561|NCT00191815|10650036|P1|Overall Study|Withdrawal by Subject|7
3109562|NCT00191815|10650036|P1|Overall Study|Physician Decision|2
3109563|NCT00191815|10650036|P1|Overall Study|Protocol Violation|3
3109564|NCT00191815|10650036|P1|Overall Study|Death|2
3109565|NCT00191815|10650036|P1|Overall Study|Disease progression or relapse|24
3109566|NCT00191815|10650036|P1|Overall Study|Adverse Event|2
3109567|NCT00191789|10650048|P1|Overall Study|Death - Not Study-Drug Related|1
3109568|NCT00191789|10650048|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
3109569|NCT00191789|10650048|P1|Overall Study|Death - Possibly Study Drug Related|4
3109570|NCT00191789|10650048|P1|Overall Study|Withdrawal by Subject|4
3109571|NCT00191789|10650048|P1|Overall Study|Patient/Physician: Satisfactory Response|4
3109572|NCT00191789|10650048|P1|Overall Study|Patient: Satisfactory Response|5
3109573|NCT00191789|10650048|P1|Overall Study|Adverse Event|5
3109574|NCT00191724|10650065|P5|Overall Study|Withdrawal by Subject|0
3109575|NCT00191724|10650066|P4|Overall Study|Withdrawal by Subject|1
3109576|NCT00191724|10650067|P3|Overall Study|Withdrawal by Subject|0
3109577|NCT00191724|10650068|P2|Overall Study|Withdrawal by Subject|0
3109578|NCT00191724|10650069|P1|Overall Study|Withdrawal by Subject|0
3109579|NCT00191724|10650065|P5|Overall Study|Lost to Follow-up|3
3109580|NCT00191724|10650066|P4|Overall Study|Lost to Follow-up|2
3109581|NCT00191724|10650067|P3|Overall Study|Lost to Follow-up|0
3109582|NCT00191724|10650068|P2|Overall Study|Lost to Follow-up|1
3109583|NCT00191724|10650069|P1|Overall Study|Lost to Follow-up|1
3109584|NCT00191724|10650065|P5|Overall Study|Adverse Event|0
3109585|NCT00191724|10650066|P4|Overall Study|Adverse Event|0
3109586|NCT00191724|10650067|P3|Overall Study|Adverse Event|1
3109587|NCT00191724|10650068|P2|Overall Study|Adverse Event|0
3109588|NCT00191724|10650069|P1|Overall Study|Adverse Event|0
3109589|NCT00191646|10650098|P2|Overall Study|Missing Data|11
3109590|NCT00191646|10650099|P1|Overall Study|Missing Data|18
3109591|NCT00191646|10650098|P2|Overall Study|Other|34
3109592|NCT00191646|10650099|P1|Overall Study|Other|33
3109593|NCT00191646|10650098|P2|Overall Study|Death|8
3109594|NCT00191646|10650099|P1|Overall Study|Death|6
3109595|NCT00191646|10650098|P2|Overall Study|Protocol Violation|7
3109596|NCT00191646|10650099|P1|Overall Study|Protocol Violation|5
3109597|NCT00191646|10650098|P2|Overall Study|Withdrawal by Subject|39
3109598|NCT00191646|10650099|P1|Overall Study|Withdrawal by Subject|58
3109599|NCT00191646|10650098|P2|Overall Study|Physician Decision|11
3109600|NCT00191646|10650099|P1|Overall Study|Physician Decision|20
3109601|NCT00191646|10650098|P2|Overall Study|Disease Progression|6
3109602|NCT00191646|10650099|P1|Overall Study|Disease Progression|5
3109603|NCT00191646|10650098|P2|Overall Study|Toxicity|37
3109604|NCT00191646|10650099|P1|Overall Study|Toxicity|26
3109605|NCT00191477|10650119|P2|Overall Study|Discontinued Prior to Instillation|14
3109606|NCT00191477|10650120|P1|Overall Study|Discontinued Prior to Instillation|13
3109607|NCT00191477|10650119|P2|Overall Study|Pathological Specimen Lost|0
3109608|NCT00191477|10650120|P1|Overall Study|Pathological Specimen Lost|1
3109609|NCT00191477|10650119|P2|Overall Study|Not Eligible|38
3109610|NCT00191477|10650120|P1|Overall Study|Not Eligible|41
3109611|NCT00191477|10650119|P2|Overall Study|Other|0
3109612|NCT00191477|10650120|P1|Overall Study|Other|2
3109613|NCT00191477|10650119|P2|Overall Study|Withdrawal by Subject|0
3109614|NCT00191477|10650120|P1|Overall Study|Withdrawal by Subject|2
3109615|NCT00191477|10650119|P2|Overall Study|Treatment Change|0
3109616|NCT00191477|10650120|P1|Overall Study|Treatment Change|2
3109617|NCT00191477|10650119|P2|Overall Study|Protocol Violation|1
3109618|NCT00191477|10650120|P1|Overall Study|Protocol Violation|1
3109619|NCT00191477|10650119|P2|Overall Study|Lost to Follow-up|21
3109620|NCT00191477|10650120|P1|Overall Study|Lost to Follow-up|23
3109621|NCT00191477|10650119|P2|Overall Study|Death, Other Cause|6
3109622|NCT00191477|10650120|P1|Overall Study|Death, Other Cause|3
3109623|NCT00191477|10650119|P2|Overall Study|Death, Study Disease|1
3109624|NCT00191477|10650120|P1|Overall Study|Death, Study Disease|1
3109625|NCT00191477|10650119|P2|Overall Study|Tumor Recurrence|48
3109626|NCT00191477|10650120|P1|Overall Study|Tumor Recurrence|49
3109627|NCT00191451|10650139|P3|Overall Study|Reason Not Specified|3
3109628|NCT00191451|10650140|P2|Overall Study|Reason Not Specified|1
3109629|NCT00191451|10650141|P1|Overall Study|Reason Not Specified|2
3109630|NCT00191451|10650139|P3|Overall Study|Ineligible|0
3109631|NCT00191451|10650140|P2|Overall Study|Ineligible|1
3109632|NCT00191451|10650141|P1|Overall Study|Ineligible|0
3109633|NCT00191451|10650139|P3|Overall Study|Sponsor Decision|0
3109634|NCT00191451|10650140|P2|Overall Study|Sponsor Decision|0
3109635|NCT00191451|10650141|P1|Overall Study|Sponsor Decision|1
3109636|NCT00191451|10650139|P3|Overall Study|Physician Decision|6
3109637|NCT00191451|10650140|P2|Overall Study|Physician Decision|9
3109638|NCT00191451|10650141|P1|Overall Study|Physician Decision|2
3109639|NCT00191451|10650139|P3|Overall Study|Withdrawal by Subject|5
3109640|NCT00191451|10650140|P2|Overall Study|Withdrawal by Subject|3
3109641|NCT00191451|10650141|P1|Overall Study|Withdrawal by Subject|2
3109642|NCT00191386|10650161|P1|Overall Study|Lack of Efficacy|15
3109643|NCT00191386|10650161|P1|Overall Study|Physician Decision|11
3109644|NCT00191386|10650161|P1|Overall Study|Withdrawal by Subject|96
3109645|NCT00191386|10650161|P1|Overall Study|Protocol Violation|18
3109646|NCT00191386|10650161|P1|Overall Study|Entry Criteria Exclusion|3
3109647|NCT00191386|10650161|P1|Overall Study|Lost to Follow-up|1
3109648|NCT00191386|10650161|P1|Overall Study|Adverse Event|16
3109649|NCT00191334|10650168|P1|Overall Study|Withdrawal by Subject|4
3109650|NCT00191334|10650168|P1|Overall Study|Physician Decision|1
3109651|NCT00191334|10650168|P1|Overall Study|Disease Progression or Relapse|8
3109652|NCT00191334|10650168|P1|Overall Study|Adverse Event|4
3109653|NCT00191308|10650176|P1|Overall Study|Adverse Event|1
3109654|NCT00191282|10650186|P2|Overall Study|Lost to Follow-up|31
3109655|NCT00191282|10650187|P1|Overall Study|Lost to Follow-up|24
3109656|NCT00191282|10650186|P2|Overall Study|Sponsor's decision|2
3109657|NCT00191282|10650187|P1|Overall Study|Sponsor's decision|2
3109658|NCT00191282|10650186|P2|Overall Study|Severity of outcome|5
3109659|NCT00191282|10650187|P1|Overall Study|Severity of outcome|2
3109660|NCT00191282|10650186|P2|Overall Study|Protocol Violation|12
3109661|NCT00191282|10650187|P1|Overall Study|Protocol Violation|9
3109662|NCT00191282|10650186|P2|Overall Study|Protocol entry criteria not met|9
3109663|NCT00191282|10650187|P1|Overall Study|Protocol entry criteria not met|14
3109664|NCT00191282|10650186|P2|Overall Study|Physician Decision|15
3109665|NCT00191282|10650187|P1|Overall Study|Physician Decision|18
3109666|NCT00191282|10650186|P2|Overall Study|Withdrawal by Subject|44
3109667|NCT00191282|10650187|P1|Overall Study|Withdrawal by Subject|59
3109668|NCT00191282|10650186|P2|Overall Study|Patient moved|14
3109669|NCT00191282|10650187|P1|Overall Study|Patient moved|11
3109670|NCT00191282|10650186|P2|Overall Study|Noncompliance|17
3109671|NCT00191282|10650187|P1|Overall Study|Noncompliance|14
3109672|NCT00191282|10650186|P2|Overall Study|Lack of Efficacy|6
3109673|NCT00191282|10650187|P1|Overall Study|Lack of Efficacy|11
3109674|NCT00191282|10650186|P2|Overall Study|Death|51
3109675|NCT00191282|10650187|P1|Overall Study|Death|51
3109676|NCT00191282|10650186|P2|Overall Study|Adverse Event|6
3109677|NCT00191282|10650187|P1|Overall Study|Adverse Event|5
3109678|NCT00191269|10650247|P2|Overall Study|Physician Decision|3
3109679|NCT00191269|10650248|P1|Overall Study|Physician Decision|0
3109680|NCT00191269|10650247|P2|Overall Study|Pathologic Aggrevation|1
3109681|NCT00191269|10650248|P1|Overall Study|Pathologic Aggrevation|0
3109682|NCT00191269|10650247|P2|Overall Study|Withdrawal by Subject|1
3109683|NCT00191269|10650248|P1|Overall Study|Withdrawal by Subject|0
3109684|NCT00191269|10650247|P2|Overall Study|Lack of Efficacy|5
3109685|NCT00191269|10650248|P1|Overall Study|Lack of Efficacy|1
3109686|NCT00191269|10650247|P2|Overall Study|Progression of Disease|42
3109687|NCT00191269|10650248|P1|Overall Study|Progression of Disease|4
3109688|NCT00191269|10650247|P2|Overall Study|Adverse Event|4
3109689|NCT00191269|10650248|P1|Overall Study|Adverse Event|1
3109690|NCT00191269|10650247|P2|Overall Study|Protocol Violation|2
3109691|NCT00191269|10650248|P1|Overall Study|Protocol Violation|0
3109692|NCT00191191|10650264|P2|Overall Study|Good Clinical Practice Violation|1
3109693|NCT00191191|10650265|P1|Overall Study|Good Clinical Practice Violation|0
3109694|NCT00191191|10650264|P2|Overall Study|Physician Decision|2
3109695|NCT00191191|10650265|P1|Overall Study|Physician Decision|3
3109696|NCT00191191|10650264|P2|Overall Study|Lost to Follow-up|0
3109697|NCT00191191|10650265|P1|Overall Study|Lost to Follow-up|1
3109698|NCT00191191|10650264|P2|Overall Study|Family/Caregiver Decision|7
3109699|NCT00191191|10650265|P1|Overall Study|Family/Caregiver Decision|5
3109700|NCT00191191|10650264|P2|Overall Study|Toxicity After Dose Reduction|8
3109701|NCT00191191|10650265|P1|Overall Study|Toxicity After Dose Reduction|7
3109702|NCT00191191|10650264|P2|Overall Study|Progressive Disease|72
3109703|NCT00191191|10650265|P1|Overall Study|Progressive Disease|84
3109704|NCT00191191|10650264|P2|Overall Study|Adverse Event|21
3109705|NCT00191191|10650265|P1|Overall Study|Adverse Event|11
3109706|NCT00191191|10650264|P2|Overall Study|Treated with Another Systemic Agent|1
3109707|NCT00191191|10650265|P1|Overall Study|Treated with Another Systemic Agent|1
3109708|NCT00191191|10650264|P2|Overall Study|Entry Criteria Exclusion|0
3109709|NCT00191191|10650265|P1|Overall Study|Entry Criteria Exclusion|2
3109710|NCT00191165|10650281|P2|Overall Study|Participant Moved Away|1
3109711|NCT00191165|10650282|P1|Overall Study|Participant Moved Away|0
3109712|NCT00191165|10650281|P2|Overall Study|Protocol Violation|1
3109713|NCT00191165|10650282|P1|Overall Study|Protocol Violation|0
3109714|NCT00191165|10650281|P2|Overall Study|Adverse Event|0
3109715|NCT00191165|10650282|P1|Overall Study|Adverse Event|2
3109716|NCT00191152|10650294|P2|Crossover Treatment|Other|3
3109717|NCT00191152|10650295|P1|Crossover Treatment|Other|4
3109718|NCT00191152|10650294|P2|Crossover Treatment|Lost to Follow-up|1
3109719|NCT00191152|10650295|P1|Crossover Treatment|Lost to Follow-up|2
3109720|NCT00191152|10650294|P2|Crossover Treatment|Withdrawal by Subject|9
3109721|NCT00191152|10650295|P1|Crossover Treatment|Withdrawal by Subject|6
3109722|NCT00191152|10650294|P2|Crossover Treatment|Physician Decision|7
3109723|NCT00191152|10650295|P1|Crossover Treatment|Physician Decision|7
3109724|NCT00191152|10650294|P2|Crossover Treatment|Adverse Event|8
3109725|NCT00191152|10650295|P1|Crossover Treatment|Adverse Event|8
3109726|NCT00191152|10650294|P2|Initial Treatment|Other|21
3109727|NCT00191152|10650295|P1|Initial Treatment|Other|18
3109728|NCT00191152|10650294|P2|Initial Treatment|Lost to Follow-up|6
3109729|NCT00191152|10650295|P1|Initial Treatment|Lost to Follow-up|0
3109730|NCT00191152|10650294|P2|Initial Treatment|Withdrawal by Subject|28
3109731|NCT00191152|10650295|P1|Initial Treatment|Withdrawal by Subject|40
3109732|NCT00191152|10650294|P2|Initial Treatment|Physician Decision|31
3109733|NCT00191152|10650295|P1|Initial Treatment|Physician Decision|40
3109734|NCT00191152|10650294|P2|Initial Treatment|Adverse Event|67
3109735|NCT00191152|10650295|P1|Initial Treatment|Adverse Event|43
3109736|NCT00191139|10650327|P2|Overall Study|Other|2
3109737|NCT00191139|10650328|P1|Overall Study|Other|1
3109738|NCT00191139|10650327|P2|Overall Study|Disease Progression|1
3109739|NCT00191139|10650328|P1|Overall Study|Disease Progression|0
3109740|NCT00191139|10650327|P2|Overall Study|Withdrawal by Subject|3
3109741|NCT00191139|10650328|P1|Overall Study|Withdrawal by Subject|0
3109742|NCT00191139|10650327|P2|Overall Study|Death|0
3109743|NCT00191139|10650328|P1|Overall Study|Death|2
3109744|NCT00191139|10650327|P2|Overall Study|Adverse Event|6
3109745|NCT00191139|10650328|P1|Overall Study|Adverse Event|2
3109746|NCT00191113|10650344|P2|Core Study|Death|0
3109747|NCT00191113|10650345|P1|Core Study|Death|1
3109748|NCT00191113|10650344|P2|Core Study|Lack of Efficacy|2
3109749|NCT00191113|10650345|P1|Core Study|Lack of Efficacy|0
3109750|NCT00191113|10650344|P2|Core Study|Adverse Event|2
3109751|NCT00191113|10650345|P1|Core Study|Adverse Event|0
3109752|NCT00191113|10650344|P2|Core Study|Lost to Follow-up|0
3109753|NCT00191113|10650345|P1|Core Study|Lost to Follow-up|3
3109754|NCT00191113|10650344|P2|Core Study|Protocol Violation|2
3109755|NCT00191113|10650345|P1|Core Study|Protocol Violation|6
3109756|NCT00191113|10650344|P2|Core Study|Withdrawal by Subject|9
3109757|NCT00191113|10650345|P1|Core Study|Withdrawal by Subject|25
3109758|NCT00191100|10650387|P2|Overall Study|Reason Not Specified|1
3109759|NCT00191100|10650388|P1|Overall Study|Reason Not Specified|0
3109760|NCT00191100|10650387|P2|Overall Study|Death from Other Cause|0
3109761|NCT00191100|10650388|P1|Overall Study|Death from Other Cause|1
3109762|NCT00191100|10650387|P2|Overall Study|Protocol Violation|1
3109763|NCT00191100|10650388|P1|Overall Study|Protocol Violation|1
3109764|NCT00191100|10650387|P2|Overall Study|Death from Study Drug Toxicity|0
3109765|NCT00191100|10650388|P1|Overall Study|Death from Study Drug Toxicity|2
3109766|NCT00191100|10650387|P2|Overall Study|Physician Decision|1
3109767|NCT00191100|10650388|P1|Overall Study|Physician Decision|3
3109768|NCT00191100|10650387|P2|Overall Study|Lack of Efficacy, Stable Disease|0
3109769|NCT00191100|10650388|P1|Overall Study|Lack of Efficacy, Stable Disease|1
3109770|NCT00191100|10650387|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
3109771|NCT00191100|10650388|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
3109772|NCT00191100|10650387|P2|Overall Study|Clinical Relapse|1
3109773|NCT00191100|10650388|P1|Overall Study|Clinical Relapse|2
3109774|NCT00191100|10650387|P2|Overall Study|Protocol Entry Criteria Not Met|1
3109775|NCT00191100|10650388|P1|Overall Study|Protocol Entry Criteria Not Met|2
3109776|NCT00191100|10650387|P2|Overall Study|Withdrawal by Subject|3
3109777|NCT00191100|10650388|P1|Overall Study|Withdrawal by Subject|9
3109778|NCT00191100|10650387|P2|Overall Study|Patient Moved|1
3109779|NCT00191100|10650388|P1|Overall Study|Patient Moved|0
3109780|NCT00191100|10650387|P2|Overall Study|Lost to Follow-up|0
3109781|NCT00191100|10650388|P1|Overall Study|Lost to Follow-up|2
3109782|NCT00191100|10650387|P2|Overall Study|Adverse Event|1
3109783|NCT00191100|10650388|P1|Overall Study|Adverse Event|18
3109784|NCT00190983|10650404|P1|Overall Study|Inevaluable (never treated)|2
3109785|NCT00190775|10650413|P2|Overall Study|Exclusion Criteria Met|3
3109786|NCT00190775|10650414|P1|Overall Study|Exclusion Criteria Met|1
3109787|NCT00190775|10650413|P2|Overall Study|Protocol Violation|1
3109788|NCT00190775|10650414|P1|Overall Study|Protocol Violation|0
3109789|NCT00190775|10650413|P2|Overall Study|Noncompliance|5
3109790|NCT00190775|10650414|P1|Overall Study|Noncompliance|3
3109791|NCT00190775|10650413|P2|Overall Study|Physician Decision|0
3109792|NCT00190775|10650414|P1|Overall Study|Physician Decision|3
3109793|NCT00190775|10650413|P2|Overall Study|Sponsor Decision|0
3109794|NCT00190775|10650414|P1|Overall Study|Sponsor Decision|1
3109795|NCT00190775|10650413|P2|Overall Study|Withdrawal by Subject|13
3109796|NCT00190775|10650414|P1|Overall Study|Withdrawal by Subject|24
3109797|NCT00190775|10650413|P2|Overall Study|Participant Moved|1
3109798|NCT00190775|10650414|P1|Overall Study|Participant Moved|0
3109799|NCT00190775|10650413|P2|Overall Study|Lost to Follow-up|23
3109800|NCT00190775|10650414|P1|Overall Study|Lost to Follow-up|31
3109801|NCT00190775|10650413|P2|Overall Study|Lack of Efficacy|32
3109802|NCT00190775|10650414|P1|Overall Study|Lack of Efficacy|28
3109803|NCT00190775|10650413|P2|Overall Study|Satisfactory Response|0
3109804|NCT00190775|10650414|P1|Overall Study|Satisfactory Response|1
3109805|NCT00190775|10650413|P2|Overall Study|Adverse Event|22
3109806|NCT00190775|10650414|P1|Overall Study|Adverse Event|57
3109807|NCT00190749|10650485|P2|Overall Study|Sponsor Decision|0
3109808|NCT00190749|10650486|P1|Overall Study|Sponsor Decision|1
3109809|NCT00190749|10650485|P2|Overall Study|Reason Not Specified|2
3109810|NCT00190749|10650486|P1|Overall Study|Reason Not Specified|0
3109811|NCT00190749|10650485|P2|Overall Study|Lack of Efficacy|3
3109812|NCT00190749|10650486|P1|Overall Study|Lack of Efficacy|2
3109813|NCT00190749|10650485|P2|Overall Study|Adverse Event|5
3109814|NCT00190749|10650486|P1|Overall Study|Adverse Event|0
3109815|NCT00190749|10650485|P2|Overall Study|Protocol Violation|4
3109816|NCT00190749|10650486|P1|Overall Study|Protocol Violation|5
3109817|NCT00190749|10650485|P2|Overall Study|Withdrawal by Subject|6
3109818|NCT00190749|10650486|P1|Overall Study|Withdrawal by Subject|10
3109819|NCT00190749|10650485|P2|Overall Study|Lost to Follow-up|11
3109820|NCT00190749|10650486|P1|Overall Study|Lost to Follow-up|8
3109821|NCT00190684|10650550|P1|Overall Study|Study Period V Completed|1
3109822|NCT00190684|10650550|P1|Overall Study|Study Period III Completed|103
3109823|NCT00190684|10650550|P1|Overall Study|Protocol Violation|123
3109824|NCT00190684|10650550|P1|Overall Study|Physician Decision|84
3109825|NCT00190684|10650550|P1|Overall Study|Sponsor's decision|17
3109826|NCT00190684|10650550|P1|Overall Study|Clinical relapse|67
3109827|NCT00190684|10650550|P1|Overall Study|Patient Decision|432
3109828|NCT00190684|10650550|P1|Overall Study|Patient moved|60
3109829|NCT00190684|10650550|P1|Overall Study|Lost to Follow-up|232
3109830|NCT00190684|10650550|P1|Overall Study|Lack of efficacy|204
3109831|NCT00190684|10650550|P1|Overall Study|Satisfactory response|80
3109832|NCT00190684|10650550|P1|Overall Study|Adverse Event|86
3109833|NCT00190671|10650571|P2|Overall Study|Withdrawal by Subject|2
3109834|NCT00190671|10650572|P1|Overall Study|Withdrawal by Subject|0
3109835|NCT00190671|10650571|P2|Overall Study|Protocol Violation|1
3109836|NCT00190671|10650572|P1|Overall Study|Protocol Violation|0
3109837|NCT00190671|10650571|P2|Overall Study|Death from Other Causes|2
3109838|NCT00190671|10650572|P1|Overall Study|Death from Other Causes|0
3109839|NCT00190671|10650571|P2|Overall Study|Death from Study-Drug Toxicity|2
3109840|NCT00190671|10650572|P1|Overall Study|Death from Study-Drug Toxicity|0
3109841|NCT00190671|10650571|P2|Overall Study|Clinical Relapse|1
3109842|NCT00190671|10650572|P1|Overall Study|Clinical Relapse|0
3109843|NCT00190671|10650571|P2|Overall Study|Adverse Event|2
3109844|NCT00190671|10650572|P1|Overall Study|Adverse Event|3
3109845|NCT00190671|10650571|P2|Overall Study|Death from Study Disease|1
3109846|NCT00190671|10650572|P1|Overall Study|Death from Study Disease|1
3109847|NCT00190671|10650571|P2|Overall Study|Lack of Efficacy|24
3109848|NCT00190671|10650572|P1|Overall Study|Lack of Efficacy|19
3109849|NCT00190671|10650571|P2|Overall Study|Satisfactory Response|7
3109850|NCT00190671|10650572|P1|Overall Study|Satisfactory Response|4
3109851|NCT00189540|10650592|P2|Overall Study|Death|1
3109852|NCT00189540|10650593|P1|Overall Study|Death|4
3109853|NCT00189540|10650592|P2|Overall Study|Withdrawal by Subject|0
3109854|NCT00189540|10650593|P1|Overall Study|Withdrawal by Subject|3
3109855|NCT00189488|10650611|P2|Overall Study|Other|0
3109856|NCT00189488|10650612|P1|Overall Study|Other|1
3109857|NCT00189488|10650611|P2|Overall Study|Death|8
3109858|NCT00189488|10650612|P1|Overall Study|Death|5
3109859|NCT00189488|10650611|P2|Overall Study|Administrative Decision|2
3109860|NCT00189488|10650612|P1|Overall Study|Administrative Decision|0
3109861|NCT00189488|10650611|P2|Overall Study|Disease progression|4
3109862|NCT00189488|10650612|P1|Overall Study|Disease progression|2
3109863|NCT00189488|10650611|P2|Overall Study|Withdrawal by Subject|6
3109864|NCT00189488|10650612|P1|Overall Study|Withdrawal by Subject|2
3109865|NCT00189488|10650611|P2|Overall Study|Adverse Event|1
3109866|NCT00189488|10650612|P1|Overall Study|Adverse Event|2
3109867|NCT00189488|10650611|P2|Overall Study|Protocol deviation|1
3109868|NCT00189488|10650612|P1|Overall Study|Protocol deviation|2
3109869|NCT00189488|10650611|P2|Overall Study|Ineligibility determined|0
3109870|NCT00189488|10650612|P1|Overall Study|Ineligibility determined|1
3109871|NCT00189462|10650643|P2|Overall Study|Lost to Follow-up|20
3109872|NCT00189462|10650644|P1|Overall Study|Lost to Follow-up|18
3109873|NCT00189462|10650643|P2|Overall Study|Lack of Efficacy|1
3109874|NCT00189462|10650644|P1|Overall Study|Lack of Efficacy|5
3109875|NCT00189423|10650661|P2|Overall Study|Lost to Follow-up|10
3109876|NCT00189423|10650662|P1|Overall Study|Lost to Follow-up|10
3109877|NCT00189423|10650661|P2|Overall Study|Withdrawal by Subject|9
3109878|NCT00189423|10650662|P1|Overall Study|Withdrawal by Subject|9
3109879|NCT00189423|10650661|P2|Overall Study|Death|747
3109880|NCT00189423|10650662|P1|Overall Study|Death|746
3109881|NCT00189306|10650684|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
3109882|NCT00189306|10650684|P1|Long-Term Follow-up|Lost to Follow-up|9
3109883|NCT00189306|10650684|P1|Long-Term Follow-up|Intercurrent disease|2
3109884|NCT00189306|10650684|P1|Long-Term Follow-up|Withdrawal by Subject|1
3109885|NCT00189306|10650684|P1|Long-Term Follow-up|Death|4
3109886|NCT00189306|10650684|P1|Long-Term Follow-up|Adverse Event|2
3109887|NCT00189306|10650684|P1|Posttreatment Period|Local skin reaction/sign|1
3109888|NCT00189306|10650684|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
3109889|NCT00189306|10650684|P1|Posttreatment Period|Protocol Violation|1
3109890|NCT00189306|10650684|P1|Posttreatment Period|Target lesion excised|1
3109891|NCT00189306|10650684|P1|Posttreatment Period|Noncompliance|1
3109892|NCT00189306|10650684|P1|Posttreatment Period|Withdrawal by Subject|2
3109893|NCT00189306|10650684|P1|Posttreatment Period|Death|1
3109894|NCT00189306|10650684|P1|Treatment Period|Protocol Violation|1
3109895|NCT00189306|10650684|P1|Treatment Period|Adverse Event|2
3109896|NCT00189306|10650684|P1|Treatment Period|Withdrawal by Subject|2
3109897|NCT00189202|10650693|P1|Overall Study|Physician Decision|5
3109898|NCT00187889|10650734|P2|Overall Study|Withdrawal by Subject|4
3109899|NCT00187889|10650735|P1|Overall Study|Withdrawal by Subject|6
3109900|NCT00187486|10650777|P1|Overall Study|Protocol Violation|1
3109901|NCT00187135|10650857|P6|Visit Three|Study Discontinued|6
3109902|NCT00187135|10650858|P5|Visit Three|Study Discontinued|7
3109903|NCT00187135|10650859|P4|Visit Three|Study Discontinued|7
3109904|NCT00187135|10650860|P3|Visit Three|Study Discontinued|7
3109905|NCT00187135|10650861|P2|Visit Three|Study Discontinued|6
3109906|NCT00187135|10650862|P1|Visit Three|Study Discontinued|7
3109907|NCT00187135|10650857|P6|Visit Three|Withdrawal by Subject|0
3109908|NCT00187135|10650858|P5|Visit Three|Withdrawal by Subject|0
3109909|NCT00187135|10650859|P4|Visit Three|Withdrawal by Subject|2
3109910|NCT00187135|10650860|P3|Visit Three|Withdrawal by Subject|1
3109911|NCT00187135|10650861|P2|Visit Three|Withdrawal by Subject|1
3109912|NCT00187135|10650862|P1|Visit Three|Withdrawal by Subject|0
3109913|NCT00187135|10650857|P6|Visit Three|Death|0
3109914|NCT00187135|10650858|P5|Visit Three|Death|1
3109915|NCT00187135|10650859|P4|Visit Three|Death|0
3109916|NCT00187135|10650860|P3|Visit Three|Death|1
3109917|NCT00187135|10650861|P2|Visit Three|Death|0
3109918|NCT00187135|10650862|P1|Visit Three|Death|0
3109919|NCT00187135|10650857|P6|Visit Two|Study Discontinued|6
3109920|NCT00187135|10650858|P5|Visit Two|Study Discontinued|5
3109921|NCT00187135|10650859|P4|Visit Two|Study Discontinued|7
3109922|NCT00187135|10650860|P3|Visit Two|Study Discontinued|1
3109923|NCT00187135|10650861|P2|Visit Two|Study Discontinued|2
3109924|NCT00187135|10650862|P1|Visit Two|Study Discontinued|3
3109925|NCT00187135|10650857|P6|Visit Two|Withdrawal by Subject|1
3109926|NCT00187135|10650858|P5|Visit Two|Withdrawal by Subject|1
3109927|NCT00187135|10650859|P4|Visit Two|Withdrawal by Subject|0
3109928|NCT00187135|10650860|P3|Visit Two|Withdrawal by Subject|1
3109929|NCT00187135|10650861|P2|Visit Two|Withdrawal by Subject|1
3109930|NCT00187135|10650862|P1|Visit Two|Withdrawal by Subject|1
3109931|NCT00187135|10650857|P6|Visit Two|Physician Decision|0
3109932|NCT00187135|10650858|P5|Visit Two|Physician Decision|0
3109933|NCT00187135|10650859|P4|Visit Two|Physician Decision|0
3109934|NCT00187135|10650860|P3|Visit Two|Physician Decision|0
3109935|NCT00187135|10650861|P2|Visit Two|Physician Decision|0
3109936|NCT00187135|10650862|P1|Visit Two|Physician Decision|1
3109937|NCT00187135|10650857|P6|Visit Two|Death|1
3109938|NCT00187135|10650858|P5|Visit Two|Death|0
3109939|NCT00187135|10650859|P4|Visit Two|Death|1
3109940|NCT00187135|10650860|P3|Visit Two|Death|0
3109941|NCT00187135|10650861|P2|Visit Two|Death|0
3109942|NCT00187135|10650862|P1|Visit Two|Death|0
3109943|NCT00187135|10650857|P6|Visit One|Physician Decision|1
3109944|NCT00187135|10650858|P5|Visit One|Physician Decision|0
3109945|NCT00187135|10650859|P4|Visit One|Physician Decision|0
3109946|NCT00187135|10650860|P3|Visit One|Physician Decision|0
3109947|NCT00187135|10650861|P2|Visit One|Physician Decision|1
3109948|NCT00187135|10650862|P1|Visit One|Physician Decision|3
3109949|NCT00187135|10650857|P6|Visit One|Withdrawal by Subject|1
3109950|NCT00187135|10650858|P5|Visit One|Withdrawal by Subject|0
3109951|NCT00187135|10650859|P4|Visit One|Withdrawal by Subject|0
3109952|NCT00187135|10650860|P3|Visit One|Withdrawal by Subject|0
3109953|NCT00187135|10650861|P2|Visit One|Withdrawal by Subject|0
3109954|NCT00187135|10650862|P1|Visit One|Withdrawal by Subject|1
3109955|NCT00187096|10650885|P3|Overall Study|unacceptable toxicity|1
3109956|NCT00187096|10650886|P2|Overall Study|unacceptable toxicity|0
3109957|NCT00187096|10650887|P1|Overall Study|unacceptable toxicity|0
3109958|NCT00186901|10650925|P3|Overall Study|Bone Mineral Density > 0|149
3109959|NCT00186901|10650926|P2|Overall Study|Bone Mineral Density > 0|0
3109960|NCT00186901|10650927|P1|Overall Study|Bone Mineral Density > 0|0
3109961|NCT00186901|10650925|P3|Overall Study|Limited adherence to study requirements|0
3109962|NCT00186901|10650926|P2|Overall Study|Limited adherence to study requirements|23
3109963|NCT00186901|10650927|P1|Overall Study|Limited adherence to study requirements|20
3109964|NCT00186901|10650925|P3|Overall Study|Open label|0
3109965|NCT00186901|10650926|P2|Overall Study|Open label|2
3109966|NCT00186901|10650927|P1|Overall Study|Open label|3
3109967|NCT00186901|10650925|P3|Overall Study|Withdrawal by Subject|0
3109968|NCT00186901|10650926|P2|Overall Study|Withdrawal by Subject|5
3109969|NCT00186901|10650927|P1|Overall Study|Withdrawal by Subject|4
3109970|NCT00186901|10650925|P3|Overall Study|ALL relapse or second malignancy|0
3109971|NCT00186901|10650926|P2|Overall Study|ALL relapse or second malignancy|2
3109972|NCT00186901|10650927|P1|Overall Study|ALL relapse or second malignancy|1
3109973|NCT00186901|10650925|P3|Overall Study|Bone Mineral Density dropped > 5%|0
3109974|NCT00186901|10650926|P2|Overall Study|Bone Mineral Density dropped > 5%|7
3109975|NCT00186901|10650927|P1|Overall Study|Bone Mineral Density dropped > 5%|9
3109976|NCT00186901|10650925|P3|Overall Study|Lost to Follow-up|0
3109977|NCT00186901|10650926|P2|Overall Study|Lost to Follow-up|3
3109978|NCT00186901|10650927|P1|Overall Study|Lost to Follow-up|6
3109979|NCT00186901|10650925|P3|Overall Study|Pregnancy|0
3109980|NCT00186901|10650926|P2|Overall Study|Pregnancy|3
3109981|NCT00186901|10650927|P1|Overall Study|Pregnancy|6
3109982|NCT00186888|10650967|P3|Overall Study|Relapse or progression of disease|0
3109983|NCT00186888|10650968|P2|Overall Study|Relapse or progression of disease|2
3109984|NCT00186888|10650969|P1|Overall Study|Relapse or progression of disease|4
3109985|NCT00186888|10650967|P3|Overall Study|Toxicity|0
3109986|NCT00186888|10650968|P2|Overall Study|Toxicity|1
3109987|NCT00186888|10650969|P1|Overall Study|Toxicity|0
3109988|NCT00186628|10651061|P1|Overall Study|Withdrawal by subject (before treatment)|1
3109989|NCT00186628|10651061|P1|Overall Study|Death|2
3109990|NCT00186537|10651072|P3|Overall Study|ALT > 1.5 x ULN|0
3109991|NCT00186537|10651073|P2|Overall Study|ALT > 1.5 x ULN|0
3109992|NCT00186537|10651074|P1|Overall Study|ALT > 1.5 x ULN|3
3109993|NCT00186537|10651072|P3|Overall Study|Withdrawal by Subject|3
3109994|NCT00186537|10651073|P2|Overall Study|Withdrawal by Subject|0
3109995|NCT00186537|10651074|P1|Overall Study|Withdrawal by Subject|4
3109996|NCT00186485|10651097|P1|Overall Study|Lost to Follow-up|3
3109997|NCT00186186|10651109|P1|Overall Study|Not reported as to reason|2
3109998|NCT00186186|10651109|P1|Overall Study|Withdrawal by Subject|3
3109999|NCT00186186|10651109|P1|Overall Study|Lack of Efficacy|3
3110000|NCT00186121|10651114|P1|Overall Study|Not eligible (no treatment)|1
3110001|NCT00186121|10651114|P1|Overall Study|Underwent oophorectomy (no treatment)|1
3110002|NCT00186121|10651114|P1|Overall Study|Subject withdrawal (no treatment)|1
3110003|NCT00186043|10651148|P2|Overall Study|Protocol Violation|1
3110004|NCT00186043|10651149|P1|Overall Study|Protocol Violation|2
3110005|NCT00186043|10651148|P2|Overall Study|Adverse Event|3
3110006|NCT00186043|10651149|P1|Overall Study|Adverse Event|7
3110007|NCT00186043|10651148|P2|Overall Study|Withdrawal by Subject|0
3110008|NCT00186043|10651149|P1|Overall Study|Withdrawal by Subject|1
3110009|NCT00186043|10651148|P2|Overall Study|Lost to Follow-up|6
3110010|NCT00186043|10651149|P1|Overall Study|Lost to Follow-up|4
3110011|NCT00186043|10651148|P2|Overall Study|Lack of Efficacy|3
3110012|NCT00186043|10651149|P1|Overall Study|Lack of Efficacy|1
3110013|NCT00185965|10651176|P2|Overall Study|Adverse Event|1
3110014|NCT00185965|10651177|P1|Overall Study|Adverse Event|0
3110015|NCT00185731|10651202|P1|Overall Study|Not Eligible|1
3110016|NCT00185731|10651202|P1|Overall Study|Withdrawal by Subject|1
3110017|NCT00185640|10651219|P1|Overall Study|Death|138
3110018|NCT00185640|10651219|P1|Overall Study|Withdrawal by Subject|3
3110019|NCT00185640|10651219|P1|Overall Study|Not Eligible|4
3110020|NCT00185614|10651228|P1|Inter-treatment Period|Lack of allogenic donor|1
3110021|NCT00185614|10651228|P1|Inter-treatment Period|Relapse|2
3110022|NCT00185614|10651228|P1|Inter-treatment Period|Physician Decision|1
3110023|NCT00185588|10651240|P4|Overall Study|Physician Decision|0
3110024|NCT00185588|10651241|P3|Overall Study|Physician Decision|1
3110025|NCT00185588|10651242|P2|Overall Study|Physician Decision|0
3110026|NCT00185588|10651243|P1|Overall Study|Physician Decision|0
3110027|NCT00185588|10651240|P4|Overall Study|Withdrawal by Subject|0
3110028|NCT00185588|10651241|P3|Overall Study|Withdrawal by Subject|0
3110029|NCT00185588|10651242|P2|Overall Study|Withdrawal by Subject|1
3110030|NCT00185588|10651243|P1|Overall Study|Withdrawal by Subject|0
3110031|NCT00185588|10651240|P4|Overall Study|Lost to Follow-up|2
3110032|NCT00185588|10651241|P3|Overall Study|Lost to Follow-up|1
3110033|NCT00185588|10651242|P2|Overall Study|Lost to Follow-up|0
3110034|NCT00185588|10651243|P1|Overall Study|Lost to Follow-up|0
3110035|NCT00185588|10651240|P4|Overall Study|Adverse Event|2
3110036|NCT00185588|10651241|P3|Overall Study|Adverse Event|4
3110037|NCT00185588|10651242|P2|Overall Study|Adverse Event|1
3110038|NCT00185588|10651243|P1|Overall Study|Adverse Event|3
3110039|NCT00185458|10651257|P1|HRT Phase|Withdrawal by Subject|3
3110040|NCT00185458|10651257|P1|HRT Phase|Protocol Violation|2
3110041|NCT00185458|10651257|P1|HRT Phase|Lost to Follow-up|4
3110042|NCT00185458|10651257|P1|HRT Phase|Adverse Event|18
3110043|NCT00185458|10651257|P1|Contraception Phase|Withdrawal by Subject|7
3110044|NCT00185458|10651257|P1|Contraception Phase|Physician Decision|2
3110045|NCT00185458|10651257|P1|Contraception Phase|Protocol Violation|2
3110046|NCT00185458|10651257|P1|Contraception Phase|Lost to Follow-up|10
3110047|NCT00185458|10651257|P1|Contraception Phase|Adverse Event|37
3110048|NCT00185380|10651320|P3|Overall Study|personal reason|1
3110049|NCT00185380|10651321|P2|Overall Study|personal reason|1
3110050|NCT00185380|10651322|P1|Overall Study|personal reason|6
3110051|NCT00185380|10651320|P3|Overall Study|Could not attend visits|4
3110052|NCT00185380|10651321|P2|Overall Study|Could not attend visits|0
3110053|NCT00185380|10651322|P1|Overall Study|Could not attend visits|2
3110054|NCT00185380|10651320|P3|Overall Study|No need for contraception|3
3110055|NCT00185380|10651321|P2|Overall Study|No need for contraception|3
3110056|NCT00185380|10651322|P1|Overall Study|No need for contraception|3
3110057|NCT00185380|10651320|P3|Overall Study|Planned pregnancy|12
3110058|NCT00185380|10651321|P2|Overall Study|Planned pregnancy|12
3110059|NCT00185380|10651322|P1|Overall Study|Planned pregnancy|9
3110060|NCT00185380|10651320|P3|Overall Study|Failed insertion|2
3110061|NCT00185380|10651321|P2|Overall Study|Failed insertion|1
3110062|NCT00185380|10651322|P1|Overall Study|Failed insertion|1
3110063|NCT00185380|10651320|P3|Overall Study|Withdrawal by Subject|0
3110064|NCT00185380|10651321|P2|Overall Study|Withdrawal by Subject|2
3110065|NCT00185380|10651322|P1|Overall Study|Withdrawal by Subject|1
3110066|NCT00185380|10651320|P3|Overall Study|Protocol Violation|1
3110067|NCT00185380|10651321|P2|Overall Study|Protocol Violation|2
3110068|NCT00185380|10651322|P1|Overall Study|Protocol Violation|2
3110069|NCT00185380|10651320|P3|Overall Study|Pregnancy|0
3110070|NCT00185380|10651321|P2|Overall Study|Pregnancy|4
3110071|NCT00185380|10651322|P1|Overall Study|Pregnancy|1
3110072|NCT00185380|10651320|P3|Overall Study|Lost to Follow-up|3
3110073|NCT00185380|10651321|P2|Overall Study|Lost to Follow-up|4
3110074|NCT00185380|10651322|P1|Overall Study|Lost to Follow-up|0
3110075|NCT00185380|10651320|P3|Overall Study|Adverse Event|48
3110076|NCT00185380|10651321|P2|Overall Study|Adverse Event|43
3110077|NCT00185380|10651322|P1|Overall Study|Adverse Event|41
3110078|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
3110079|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
3110080|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
3110081|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
3110082|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
3110083|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
3110084|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
3110085|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
3110086|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
3110087|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
3110088|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
3110089|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
3110090|NCT00185211|10651350|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
3110091|NCT00185211|10651351|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
3110092|NCT00185211|10651350|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
3110093|NCT00185211|10651351|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
3110094|NCT00185211|10651350|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
3110095|NCT00185211|10651351|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
3110096|NCT00185211|10651350|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
3110097|NCT00185211|10651351|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
3110098|NCT00185211|10651350|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
3110099|NCT00185211|10651351|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
3110100|NCT00185211|10651350|P2|Placebo-controlled Study (92012)|Adverse Event|0
3110101|NCT00185211|10651351|P1|Placebo-controlled Study (92012)|Adverse Event|8
3110102|NCT00184600|10651424|P3|Overall Study|Unclassified|3
3110103|NCT00184600|10651425|P2|Overall Study|Unclassified|5
3110104|NCT00184600|10651426|P1|Overall Study|Unclassified|4
3110105|NCT00184600|10651424|P3|Overall Study|Withdrawal by Subject|12
3110106|NCT00184600|10651425|P2|Overall Study|Withdrawal by Subject|28
3110107|NCT00184600|10651426|P1|Overall Study|Withdrawal by Subject|20
3110108|NCT00184600|10651424|P3|Overall Study|Protocol Violation|3
3110109|NCT00184600|10651425|P2|Overall Study|Protocol Violation|2
3110110|NCT00184600|10651426|P1|Overall Study|Protocol Violation|2
3110111|NCT00184600|10651424|P3|Overall Study|Lost to Follow-up|1
3110112|NCT00184600|10651425|P2|Overall Study|Lost to Follow-up|6
3110113|NCT00184600|10651426|P1|Overall Study|Lost to Follow-up|4
3110114|NCT00184600|10651424|P3|Overall Study|Lack of Efficacy|3
3110115|NCT00184600|10651425|P2|Overall Study|Lack of Efficacy|1
3110116|NCT00184600|10651426|P1|Overall Study|Lack of Efficacy|3
3110117|NCT00184600|10651424|P3|Overall Study|Death|7
3110118|NCT00184600|10651425|P2|Overall Study|Death|9
3110119|NCT00184600|10651426|P1|Overall Study|Death|3
3110120|NCT00184600|10651424|P3|Overall Study|Adverse Event|5
3110121|NCT00184600|10651425|P2|Overall Study|Adverse Event|0
3110122|NCT00184600|10651426|P1|Overall Study|Adverse Event|9
3110123|NCT00184093|10651517|P1|Overall Study|Withdrawal by Subject|2
3110124|NCT00184093|10651517|P1|Overall Study|Physician Decision|1
3110125|NCT00184093|10651517|P1|Overall Study|Lost to Follow-up|3
3110126|NCT00184093|10651517|P1|Overall Study|Adverse Event|3
3110127|NCT00184054|10651522|P1|Overall Study|Adverse Event|1
3110128|NCT00184028|10651527|P1|Overall Study|Non-compliance|2
3110129|NCT00184028|10651527|P1|Overall Study|Withdrawal by Subject|1
3110130|NCT00184028|10651527|P1|Overall Study|Adverse Event|2
3110131|NCT00184028|10651527|P1|Overall Study|Lack of Efficacy|4
3110132|NCT00184028|10651527|P1|Overall Study|Death|1
3110133|NCT00184002|10651532|P1|Overall Study|Withdrawal by Subject|4
3110134|NCT00184002|10651532|P1|Overall Study|Physician Decision|1
3110135|NCT00184002|10651532|P1|Overall Study|Death|3
3110136|NCT00184002|10651532|P1|Overall Study|Adverse Event|9
3110137|NCT00183872|10651558|P1|Overall Study|Drug delayed more than 28 days|2
3110138|NCT00183872|10651558|P1|Overall Study|Withdrawal by Subject|2
3110139|NCT00183872|10651558|P1|Overall Study|Adverse Event|9
3110140|NCT00183872|10651558|P1|Overall Study|Death|3
3110141|NCT00183625|10651587|P4|Overall Study|Withdrawal by Subject|14
3110142|NCT00183625|10651588|P3|Overall Study|Withdrawal by Subject|19
3110143|NCT00183625|10651589|P2|Overall Study|Withdrawal by Subject|18
3110144|NCT00183625|10651590|P1|Overall Study|Withdrawal by Subject|18
3110145|NCT00183430|10651687|P2|Overall Study|Withdrawal by Subject|0
3110146|NCT00183430|10651688|P1|Overall Study|Withdrawal by Subject|1
3110147|NCT00183430|10651687|P2|Overall Study|did not meet inclusion criteria|0
3110148|NCT00183430|10651688|P1|Overall Study|did not meet inclusion criteria|1
3110149|NCT00183430|10651687|P2|Overall Study|Lost to Follow-up|0
3110150|NCT00183430|10651688|P1|Overall Study|Lost to Follow-up|3
3110151|NCT00183430|10651687|P2|Overall Study|Adverse Event|0
3110152|NCT00183430|10651688|P1|Overall Study|Adverse Event|1
3110153|NCT00183391|10651700|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
3110154|NCT00183391|10651701|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
3110155|NCT00183391|10651700|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
3110156|NCT00183391|10651701|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
3110157|NCT00183274|10651774|P6|Phase 3: Double-Blind|Relapsed|2
3110158|NCT00183274|10651775|P5|Phase 3: Double-Blind|Relapsed|11
3110159|NCT00183274|10651776|P4|Phase 3: Double-Blind|Relapsed|1
3110160|NCT00183274|10651777|P3|Phase 3: Double-Blind|Relapsed|0
3110161|NCT00183274|10651778|P2|Phase 3: Double-Blind|Relapsed|0
3110162|NCT00183274|10651779|P1|Phase 3: Double-Blind|Relapsed|0
3110163|NCT00183274|10651774|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
3110164|NCT00183274|10651775|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
3110165|NCT00183274|10651776|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
3110166|NCT00183274|10651777|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
3110167|NCT00183274|10651778|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
3110168|NCT00183274|10651779|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
3110169|NCT00183274|10651774|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
3110170|NCT00183274|10651775|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
3110171|NCT00183274|10651776|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
3110172|NCT00183274|10651777|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
3110173|NCT00183274|10651778|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
3110174|NCT00183274|10651779|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
3110175|NCT00183274|10651774|P6|Phase 2: Double-Blind|Relapsed|0
3110176|NCT00183274|10651775|P5|Phase 2: Double-Blind|Relapsed|0
3110177|NCT00183274|10651776|P4|Phase 2: Double-Blind|Relapsed|0
3110178|NCT00183274|10651777|P3|Phase 2: Double-Blind|Relapsed|29
3110179|NCT00183274|10651778|P2|Phase 2: Double-Blind|Relapsed|8
3110180|NCT00183274|10651779|P1|Phase 2: Double-Blind|Relapsed|0
3110181|NCT00183274|10651774|P6|Phase 1: Open-Label|Other|0
3110182|NCT00183274|10651775|P5|Phase 1: Open-Label|Other|0
3110183|NCT00183274|10651776|P4|Phase 1: Open-Label|Other|0
3110184|NCT00183274|10651777|P3|Phase 1: Open-Label|Other|0
3110185|NCT00183274|10651778|P2|Phase 1: Open-Label|Other|0
3110186|NCT00183274|10651779|P1|Phase 1: Open-Label|Other|9
3110187|NCT00183274|10651774|P6|Phase 1: Open-Label|Lost to Follow-up|0
3110188|NCT00183274|10651775|P5|Phase 1: Open-Label|Lost to Follow-up|0
3110189|NCT00183274|10651776|P4|Phase 1: Open-Label|Lost to Follow-up|0
3110190|NCT00183274|10651777|P3|Phase 1: Open-Label|Lost to Follow-up|0
3110191|NCT00183274|10651778|P2|Phase 1: Open-Label|Lost to Follow-up|0
3110192|NCT00183274|10651779|P1|Phase 1: Open-Label|Lost to Follow-up|33
3110193|NCT00183274|10651774|P6|Phase 1: Open-Label|Withdrawal by Subject|0
3110194|NCT00183274|10651775|P5|Phase 1: Open-Label|Withdrawal by Subject|0
3110195|NCT00183274|10651776|P4|Phase 1: Open-Label|Withdrawal by Subject|0
3110196|NCT00183274|10651777|P3|Phase 1: Open-Label|Withdrawal by Subject|0
3110197|NCT00183274|10651778|P2|Phase 1: Open-Label|Withdrawal by Subject|0
3110198|NCT00183274|10651779|P1|Phase 1: Open-Label|Withdrawal by Subject|13
3110199|NCT00183274|10651774|P6|Phase 1: Open-Label|Protocol Violation|0
3110200|NCT00183274|10651775|P5|Phase 1: Open-Label|Protocol Violation|0
3110201|NCT00183274|10651776|P4|Phase 1: Open-Label|Protocol Violation|0
3110202|NCT00183274|10651777|P3|Phase 1: Open-Label|Protocol Violation|0
3110203|NCT00183274|10651778|P2|Phase 1: Open-Label|Protocol Violation|0
3110204|NCT00183274|10651779|P1|Phase 1: Open-Label|Protocol Violation|11
3110205|NCT00183274|10651774|P6|Phase 1: Open-Label|Lack of Efficacy|0
3110206|NCT00183274|10651775|P5|Phase 1: Open-Label|Lack of Efficacy|0
3110207|NCT00183274|10651776|P4|Phase 1: Open-Label|Lack of Efficacy|0
3110208|NCT00183274|10651777|P3|Phase 1: Open-Label|Lack of Efficacy|0
3110209|NCT00183274|10651778|P2|Phase 1: Open-Label|Lack of Efficacy|0
3110210|NCT00183274|10651779|P1|Phase 1: Open-Label|Lack of Efficacy|13
3110211|NCT00183274|10651774|P6|Phase 1: Open-Label|Adverse Event|0
3110212|NCT00183274|10651775|P5|Phase 1: Open-Label|Adverse Event|0
3110213|NCT00183274|10651776|P4|Phase 1: Open-Label|Adverse Event|0
3110214|NCT00183274|10651777|P3|Phase 1: Open-Label|Adverse Event|0
3110215|NCT00183274|10651778|P2|Phase 1: Open-Label|Adverse Event|0
3110216|NCT00183274|10651779|P1|Phase 1: Open-Label|Adverse Event|31
3110217|NCT00183248|10651796|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
3110218|NCT00183248|10651797|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
3110219|NCT00183248|10651796|P2|Overall Study|Lost to Follow-up|1
3110220|NCT00183248|10651797|P1|Overall Study|Lost to Follow-up|0
3110221|NCT00183196|10651818|P3|Overall Study|Required more intensive care|2
3110222|NCT00183196|10651819|P2|Overall Study|Required more intensive care|1
3110223|NCT00183196|10651820|P1|Overall Study|Required more intensive care|0
3110224|NCT00183196|10651818|P3|Overall Study|Legal event|1
3110225|NCT00183196|10651819|P2|Overall Study|Legal event|1
3110226|NCT00183196|10651820|P1|Overall Study|Legal event|1
3110227|NCT00183196|10651818|P3|Overall Study|Adverse Event|2
3110228|NCT00183196|10651819|P2|Overall Study|Adverse Event|2
3110229|NCT00183196|10651820|P1|Overall Study|Adverse Event|1
3110230|NCT00183196|10651818|P3|Overall Study|Withdrawal by Subject|13
3110231|NCT00183196|10651819|P2|Overall Study|Withdrawal by Subject|11
3110232|NCT00183196|10651820|P1|Overall Study|Withdrawal by Subject|18
3110233|NCT00182689|10651903|P2|Overall Study|Never received treatment|0
3110234|NCT00182689|10651904|P1|Overall Study|Never received treatment|1
3110235|NCT00182689|10651903|P2|Overall Study|Ineligible|4
3110236|NCT00182689|10651904|P1|Overall Study|Ineligible|1
3110237|NCT00182689|10651903|P2|Overall Study|not protocol specified|3
3110238|NCT00182689|10651904|P1|Overall Study|not protocol specified|0
3110239|NCT00182689|10651903|P2|Overall Study|Death|0
3110240|NCT00182689|10651904|P1|Overall Study|Death|1
3110241|NCT00182689|10651903|P2|Overall Study|Progression|29
3110242|NCT00182689|10651904|P1|Overall Study|Progression|27
3110243|NCT00182689|10651903|P2|Overall Study|Withdrawal by Subject|2
3110244|NCT00182689|10651904|P1|Overall Study|Withdrawal by Subject|2
3110245|NCT00182689|10651903|P2|Overall Study|Adverse Event|11
3110246|NCT00182689|10651904|P1|Overall Study|Adverse Event|8
3110247|NCT00182637|10651914|P1|Overall Study|Disease Progression|1
3110248|NCT00182637|10651914|P1|Overall Study|Adverse Event|2
3110249|NCT00182325|10651922|P2|Overall Study|Did not complete survey|43
3110250|NCT00182325|10651923|P1|Overall Study|Did not complete survey|22
3110251|NCT00182325|10651922|P2|Overall Study|Miscarriage|3
3110252|NCT00182325|10651923|P1|Overall Study|Miscarriage|5
3110253|NCT00182325|10651922|P2|Overall Study|Lost to Follow-up|7
3110254|NCT00182325|10651923|P1|Overall Study|Lost to Follow-up|7
3110255|NCT00182091|10651951|P4|Overall Study|Withdrawal by Subject|0
3110256|NCT00182091|10651952|P3|Overall Study|Withdrawal by Subject|0
3110257|NCT00182091|10651953|P2|Overall Study|Withdrawal by Subject|0
3110258|NCT00182091|10651954|P1|Overall Study|Withdrawal by Subject|1
3110259|NCT00182078|10651970|P2|Overall Study|Withdrawal by Subject|0
3110260|NCT00182078|10651971|P1|Overall Study|Withdrawal by Subject|1
3110261|NCT00181883|10651999|P1|Overall Study|Lost to Follow-up|1
3110262|NCT00181883|10651999|P1|Overall Study|Withdrawal by Subject|4
3110263|NCT00181883|10651999|P1|Overall Study|Treatment Limiting AEs|3
3110264|NCT00181883|10651999|P1|Overall Study|Lack of Efficacy|2
3110265|NCT00181844|10652003|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
3110266|NCT00181844|10652003|P1|Exposed to Study Medication|Withdrawal by Subject|1
3110267|NCT00181844|10652003|P1|Exposed to Study Medication|Non-compliance|2
3110268|NCT00181844|10652003|P1|Exposed to Study Medication|Lack of Efficacy|2
3110269|NCT00181844|10652003|P1|Exposed to Study Medication|Adverse Event|10
3110270|NCT00181844|10652003|P1|Signed Consent|Did not meet entrance criteria|7
3110271|NCT00181844|10652003|P1|Signed Consent|Withdrawal by Subject|5
3110272|NCT00181766|10652007|P1|Overall Study|non-compliance|2
3110273|NCT00181766|10652007|P1|Overall Study|Adverse Event|4
3110274|NCT00181766|10652007|P1|Overall Study|Lost to Follow-up|6
3110275|NCT00181155|10652081|P2|Overall Study|Withdrawal by Subject|0
3110276|NCT00181155|10652082|P1|Overall Study|Withdrawal by Subject|1
3110277|NCT00181155|10652081|P2|Overall Study|Physician Decision|0
3110278|NCT00181155|10652082|P1|Overall Study|Physician Decision|1
3110279|NCT00180713|10652092|P2|Overall Study|Adverse Event|3
3110280|NCT00180713|10652093|P1|Overall Study|Adverse Event|3
3110281|NCT00180713|10652092|P2|Overall Study|Withdrawal by Subject|0
3110282|NCT00180713|10652093|P1|Overall Study|Withdrawal by Subject|2
3110283|NCT00180479|10652157|P2|Overall Study|Informed consent not signed|1
3110284|NCT00180479|10652158|P1|Overall Study|Informed consent not signed|0
3110285|NCT00180479|10652157|P2|Overall Study|Withdrawal by Subject|3
3110286|NCT00180479|10652158|P1|Overall Study|Withdrawal by Subject|3
3110287|NCT00180479|10652157|P2|Overall Study|Lost to Follow-up|7
3110288|NCT00180479|10652158|P1|Overall Study|Lost to Follow-up|9
3110289|NCT00180479|10652157|P2|Overall Study|Death|2
3110290|NCT00180479|10652158|P1|Overall Study|Death|4
3110291|NCT00179959|10652283|P2|Overall Study|Withdrawal by Subject|2
3110292|NCT00179959|10652284|P1|Overall Study|Withdrawal by Subject|3
3110293|NCT00179959|10652283|P2|Overall Study|Lost to Follow-up|1
3110294|NCT00179959|10652284|P1|Overall Study|Lost to Follow-up|3
3110295|NCT00179673|10652290|P1|Overall Study|Other Observations and options|14
3110296|NCT00179673|10652290|P1|Overall Study|Death|4
3110297|NCT00179673|10652290|P1|Overall Study|Withdrawal by Subject|3
3110298|NCT00179673|10652290|P1|Overall Study|Lack of Efficacy|15
3110299|NCT00179673|10652290|P1|Overall Study|Adverse Event|7
3110300|NCT00179660|10652298|P1|Overall Study|Other - Unspecified|9
3110301|NCT00179660|10652298|P1|Overall Study|Death|3
3110302|NCT00179660|10652298|P1|Overall Study|Lost to Follow-up|1
3110303|NCT00179660|10652298|P1|Overall Study|Withdrawal by Subject|2
3110304|NCT00179660|10652298|P1|Overall Study|Lack of therapeutic effect|28
3110305|NCT00179660|10652298|P1|Overall Study|Adverse Event|7
3110306|NCT00179647|10652307|P1|Overall Study|Other|960
3110307|NCT00179647|10652307|P1|Overall Study|Death|94
3110308|NCT00179647|10652307|P1|Overall Study|Lost to Follow-up|4
3110309|NCT00179647|10652307|P1|Overall Study|Withdrawal by Subject|83
3110310|NCT00179647|10652307|P1|Overall Study|Lack of Efficacy|478
3110311|NCT00179647|10652307|P1|Overall Study|Adverse Event|294
3110312|NCT00179621|10652314|P4|Open-Label Period|Other|2
3110313|NCT00179621|10652315|P3|Open-Label Period|Other|1
3110314|NCT00179621|10652316|P2|Open-Label Period|Other|1
3110315|NCT00179621|10652317|P1|Open-Label Period|Other|0
3110316|NCT00179621|10652314|P4|Open-Label Period|Death|2
3110317|NCT00179621|10652315|P3|Open-Label Period|Death|1
3110318|NCT00179621|10652316|P2|Open-Label Period|Death|0
3110319|NCT00179621|10652317|P1|Open-Label Period|Death|0
3110320|NCT00179621|10652314|P4|Open-Label Period|Withdrawal by Subject|2
3110321|NCT00179621|10652315|P3|Open-Label Period|Withdrawal by Subject|2
3110322|NCT00179621|10652316|P2|Open-Label Period|Withdrawal by Subject|2
3110323|NCT00179621|10652317|P1|Open-Label Period|Withdrawal by Subject|0
3110324|NCT00179621|10652314|P4|Open-Label Period|Adverse Event|6
3110325|NCT00179621|10652315|P3|Open-Label Period|Adverse Event|5
3110326|NCT00179621|10652316|P2|Open-Label Period|Adverse Event|6
3110327|NCT00179621|10652317|P1|Open-Label Period|Adverse Event|0
3110328|NCT00179621|10652314|P4|Open-Label Period|Lack of Therapeutic Effect|31
3110329|NCT00179621|10652315|P3|Open-Label Period|Lack of Therapeutic Effect|19
3110330|NCT00179621|10652316|P2|Open-Label Period|Lack of Therapeutic Effect|19
3110331|NCT00179621|10652317|P1|Open-Label Period|Lack of Therapeutic Effect|0
3110332|NCT00179621|10652314|P4|Double-Blind Period|Other|0
3110333|NCT00179621|10652315|P3|Double-Blind Period|Other|2
3110334|NCT00179621|10652316|P2|Double-Blind Period|Other|2
3110335|NCT00179621|10652317|P1|Double-Blind Period|Other|0
3110336|NCT00179621|10652314|P4|Double-Blind Period|Protocol Violation|0
3110337|NCT00179621|10652315|P3|Double-Blind Period|Protocol Violation|0
3110338|NCT00179621|10652316|P2|Double-Blind Period|Protocol Violation|0
3110339|NCT00179621|10652317|P1|Double-Blind Period|Protocol Violation|1
3110340|NCT00179621|10652314|P4|Double-Blind Period|Death|0
3110341|NCT00179621|10652315|P3|Double-Blind Period|Death|2
3110342|NCT00179621|10652316|P2|Double-Blind Period|Death|1
3110343|NCT00179621|10652317|P1|Double-Blind Period|Death|0
3110344|NCT00179621|10652314|P4|Double-Blind Period|Withdrawal by Subject|0
3110345|NCT00179621|10652315|P3|Double-Blind Period|Withdrawal by Subject|3
3110346|NCT00179621|10652316|P2|Double-Blind Period|Withdrawal by Subject|1
3110347|NCT00179621|10652317|P1|Double-Blind Period|Withdrawal by Subject|2
3110348|NCT00179621|10652314|P4|Double-Blind Period|Adverse Event|0
3110349|NCT00179621|10652315|P3|Double-Blind Period|Adverse Event|4
3110350|NCT00179621|10652316|P2|Double-Blind Period|Adverse Event|7
3110351|NCT00179621|10652317|P1|Double-Blind Period|Adverse Event|2
3110352|NCT00179621|10652314|P4|Double-Blind Period|Lack of Therapeutic Effect|0
3110353|NCT00179621|10652315|P3|Double-Blind Period|Lack of Therapeutic Effect|19
3110354|NCT00179621|10652316|P2|Double-Blind Period|Lack of Therapeutic Effect|35
3110355|NCT00179621|10652317|P1|Double-Blind Period|Lack of Therapeutic Effect|59
3110356|NCT00179517|10652370|P2|Overall Study|Withdrawal by Subject|1
3110357|NCT00179517|10652371|P1|Overall Study|Withdrawal by Subject|2
3110358|NCT00179413|10652409|P2|Overall Study|Withdrawal by Subject|95
3110359|NCT00179413|10652410|P1|Overall Study|Withdrawal by Subject|87
3110360|NCT00179413|10652409|P2|Overall Study|Adverse Event|20
3110361|NCT00179413|10652410|P1|Overall Study|Adverse Event|38
3110362|NCT00179309|10652422|P2|Treatment|Allergy|0
3110363|NCT00179309|10652423|P1|Treatment|Allergy|1
3110364|NCT00179309|10652422|P2|Treatment|Withdrawal by Subject|2
3110365|NCT00179309|10652423|P1|Treatment|Withdrawal by Subject|1
3110366|NCT00179309|10652422|P2|Treatment|Toxicity|3
3110367|NCT00179309|10652423|P1|Treatment|Toxicity|2
3110368|NCT00179010|10652446|P2|Overall Study|Failure to place arterial line|1
3110369|NCT00179010|10652447|P1|Overall Study|Failure to place arterial line|0
3110370|NCT00179010|10652446|P2|Overall Study|Muscle probe defective|1
3110371|NCT00179010|10652447|P1|Overall Study|Muscle probe defective|1
3110372|NCT00178685|10652486|P3|Overall Study|Withdrawal by Subject|7
3110373|NCT00178685|10652487|P2|Overall Study|Withdrawal by Subject|14
3110374|NCT00178685|10652488|P1|Overall Study|Withdrawal by Subject|8
3110375|NCT00178685|10652486|P3|Overall Study|Lost to Follow-up|183
3110376|NCT00178685|10652487|P2|Overall Study|Lost to Follow-up|187
3110377|NCT00178685|10652488|P1|Overall Study|Lost to Follow-up|100
3110378|NCT00178685|10652486|P3|Overall Study|Death|6
3110379|NCT00178685|10652487|P2|Overall Study|Death|3
3110380|NCT00178685|10652488|P1|Overall Study|Death|3
3110381|NCT00178633|10652499|P1|Overall Study|Lost to Follow-up|6
3110382|NCT00178464|10652529|P1|Overall Study|Physician Decision|1
3110383|NCT00178464|10652529|P1|Overall Study|Withdrawal by Subject|1
3110384|NCT00178399|10652534|P1|Overall Study|Lost to Follow-up|1
3110385|NCT00178399|10652534|P1|Overall Study|Withdrawal by Subject|8
3110386|NCT00178399|10652534|P1|Overall Study|Physician Decision|4
3110387|NCT00178256|10652541|P4|Overall Study|Cancer progression|1
3110388|NCT00178256|10652542|P3|Overall Study|Cancer progression|0
3110389|NCT00178256|10652543|P2|Overall Study|Cancer progression|0
3110390|NCT00178256|10652544|P1|Overall Study|Cancer progression|2
3110391|NCT00178256|10652541|P4|Overall Study|Death|1
3110392|NCT00178256|10652542|P3|Overall Study|Death|0
3110393|NCT00178256|10652543|P2|Overall Study|Death|1
3110394|NCT00178256|10652544|P1|Overall Study|Death|0
3110395|NCT00178256|10652541|P4|Overall Study|Adverse Event|0
3110396|NCT00178256|10652542|P3|Overall Study|Adverse Event|0
3110397|NCT00178256|10652543|P2|Overall Study|Adverse Event|0
3110398|NCT00178256|10652544|P1|Overall Study|Adverse Event|2
3110399|NCT00178126|10652583|P2|Overall Study|did not receive intervention|6
3110400|NCT00178126|10652584|P1|Overall Study|did not receive intervention|4
3110401|NCT00178126|10652583|P2|Overall Study|Lost to Follow-up|21
3110402|NCT00178126|10652584|P1|Overall Study|Lost to Follow-up|21
3110403|NCT00177671|10652626|P2|Overall Study|Physician Decision|8
3110404|NCT00177671|10652627|P1|Overall Study|Physician Decision|12
3110405|NCT00177671|10652626|P2|Overall Study|Adverse Event|0
3110406|NCT00177671|10652627|P1|Overall Study|Adverse Event|6
3110407|NCT00177671|10652626|P2|Overall Study|medical complications|0
3110408|NCT00177671|10652627|P1|Overall Study|medical complications|2
3110409|NCT00177671|10652626|P2|Overall Study|Withdrawal by Subject|6
3110410|NCT00177671|10652627|P1|Overall Study|Withdrawal by Subject|5
3110411|NCT00177307|10652639|P1|Overall Study|Withdrawal by Subject|1
3110412|NCT00177294|10652648|P2|Overall Study|Withdrawal by Subject|5
3110413|NCT00177294|10652649|P1|Overall Study|Withdrawal by Subject|7
3110414|NCT00177216|10652663|P3|Overall Study|Withdrawal by Subject|1
3110415|NCT00177216|10652664|P2|Overall Study|Withdrawal by Subject|3
3110416|NCT00177216|10652665|P1|Overall Study|Withdrawal by Subject|6
3110417|NCT00177164|10652681|P2|Overall Study|Pregnancy|1
3110418|NCT00177164|10652682|P1|Overall Study|Pregnancy|0
3110419|NCT00177164|10652681|P2|Overall Study|Lack of Efficacy|1
3110420|NCT00177164|10652682|P1|Overall Study|Lack of Efficacy|2
3110421|NCT00177164|10652681|P2|Overall Study|discharge from hospital|0
3110422|NCT00177164|10652682|P1|Overall Study|discharge from hospital|1
3110423|NCT00177164|10652681|P2|Overall Study|Adverse Event|0
3110424|NCT00177164|10652682|P1|Overall Study|Adverse Event|1
3110425|NCT00177164|10652681|P2|Overall Study|increase in alcohol and drug use|2
3110426|NCT00177164|10652682|P1|Overall Study|increase in alcohol and drug use|1
3110427|NCT00177164|10652681|P2|Overall Study|Lost to Follow-up|5
3110428|NCT00177164|10652682|P1|Overall Study|Lost to Follow-up|4
3110429|NCT00177164|10652681|P2|Overall Study|Protocol Violation|7
3110430|NCT00177164|10652682|P1|Overall Study|Protocol Violation|0
3110431|NCT00176644|10652855|P1|Overall Study|Withdrawal by Subject|1
3110432|NCT00176605|10652868|P1|Overall Study|Withdrawal by Subject|2
3110433|NCT00176488|10652879|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
3110434|NCT00176462|10652887|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
3110435|NCT00176462|10652888|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
3110436|NCT00176462|10652887|P2|Intensive Continuation (8X8-week Cycles)|Death|0
3110437|NCT00176462|10652888|P1|Intensive Continuation (8X8-week Cycles)|Death|1
3110438|NCT00176462|10652887|P2|Consolidation (12 Weeks)|Not documented|1
3110439|NCT00176462|10652888|P1|Consolidation (12 Weeks)|Not documented|0
3110440|NCT00176462|10652887|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
3110441|NCT00176462|10652888|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
3110442|NCT00176462|10652887|P2|Consolidation (12 Weeks)|Adverse Event|1
3110443|NCT00176462|10652888|P1|Consolidation (12 Weeks)|Adverse Event|0
3110444|NCT00176462|10652887|P2|Consolidation (12 Weeks)|Patient moved to another state|1
3110445|NCT00176462|10652888|P1|Consolidation (12 Weeks)|Patient moved to another state|0
3110446|NCT00176462|10652887|P2|Induction (4 Weeks)|Lack of Efficacy|1
3110447|NCT00176462|10652888|P1|Induction (4 Weeks)|Lack of Efficacy|0
3110448|NCT00176462|10652887|P2|Induction (4 Weeks)|Death|2
3110449|NCT00176462|10652888|P1|Induction (4 Weeks)|Death|1
3110450|NCT00176462|10652887|P2|Induction (4 Weeks)|Withdrawal by Subject|2
3110451|NCT00176462|10652888|P1|Induction (4 Weeks)|Withdrawal by Subject|0
3110452|NCT00176254|10652908|P1|Overall Study|Lost to Follow-up|1
3110453|NCT00175877|10652936|P1|Overall Study|Withdrawal by subject & Other|1
3110454|NCT00175877|10652936|P1|Overall Study|AE & Other|1
3110455|NCT00175877|10652936|P1|Overall Study|Other Reason|20
3110456|NCT00175877|10652936|P1|Overall Study|Protocol Violation|15
3110457|NCT00175877|10652936|P1|Overall Study|Lack of Efficacy|26
3110458|NCT00175877|10652936|P1|Overall Study|Lost to Follow-up|9
3110459|NCT00175877|10652936|P1|Overall Study|Withdrawal by Subject|141
3110460|NCT00175877|10652936|P1|Overall Study|Adverse Event|136
3110461|NCT00175825|10652971|P4|Overall Study|Withdrawal by Subject|0
3110462|NCT00175825|10652972|P3|Overall Study|Withdrawal by Subject|0
3110463|NCT00175825|10652973|P2|Overall Study|Withdrawal by Subject|0
3110464|NCT00175825|10652974|P1|Overall Study|Withdrawal by Subject|1
3110465|NCT00175825|10652971|P4|Overall Study|Lost to Follow-up|0
3110466|NCT00175825|10652972|P3|Overall Study|Lost to Follow-up|0
3110467|NCT00175825|10652973|P2|Overall Study|Lost to Follow-up|2
3110468|NCT00175825|10652974|P1|Overall Study|Lost to Follow-up|1
3110469|NCT00175825|10652971|P4|Overall Study|Adverse Event|1
3110470|NCT00175825|10652972|P3|Overall Study|Adverse Event|1
3110471|NCT00175825|10652973|P2|Overall Study|Adverse Event|2
3110472|NCT00175825|10652974|P1|Overall Study|Adverse Event|3
3110473|NCT00175019|10653027|P3|Overall Study|Reason Not Specified|11
3110474|NCT00175019|10653028|P2|Overall Study|Reason Not Specified|34
3110475|NCT00175019|10653029|P1|Overall Study|Reason Not Specified|40
3110476|NCT00175019|10653027|P3|Overall Study|Gout Flare|0
3110477|NCT00175019|10653028|P2|Overall Study|Gout Flare|3
3110478|NCT00175019|10653029|P1|Overall Study|Gout Flare|2
3110479|NCT00175019|10653027|P3|Overall Study|Therapeutic Failure|22
3110480|NCT00175019|10653028|P2|Overall Study|Therapeutic Failure|38
3110481|NCT00175019|10653029|P1|Overall Study|Therapeutic Failure|10
3110482|NCT00175019|10653027|P3|Overall Study|Personal Reason(s)|8
3110483|NCT00175019|10653028|P2|Overall Study|Personal Reason(s)|31
3110484|NCT00175019|10653029|P1|Overall Study|Personal Reason(s)|39
3110485|NCT00175019|10653027|P3|Overall Study|Did not continue under Amendment 4|2
3110486|NCT00175019|10653028|P2|Overall Study|Did not continue under Amendment 4|1
3110487|NCT00175019|10653029|P1|Overall Study|Did not continue under Amendment 4|1
3110488|NCT00175019|10653027|P3|Overall Study|Lost to Follow-up|9
3110489|NCT00175019|10653028|P2|Overall Study|Lost to Follow-up|39
3110490|NCT00175019|10653029|P1|Overall Study|Lost to Follow-up|42
3110491|NCT00175019|10653027|P3|Overall Study|Protocol Violation|3
3110492|NCT00175019|10653028|P2|Overall Study|Protocol Violation|3
3110493|NCT00175019|10653029|P1|Overall Study|Protocol Violation|6
3110494|NCT00175019|10653027|P3|Overall Study|Adverse Event|2
3110495|NCT00175019|10653028|P2|Overall Study|Adverse Event|22
3110496|NCT00175019|10653029|P1|Overall Study|Adverse Event|54
3110497|NCT00174967|10653082|P4|Overall Study|Other|0
3110498|NCT00174967|10653083|P3|Overall Study|Other|0
3110499|NCT00174967|10653084|P2|Overall Study|Other|1
3110500|NCT00174967|10653085|P1|Overall Study|Other|0
3110501|NCT00174967|10653082|P4|Overall Study|Gout Flare|1
3110502|NCT00174967|10653083|P3|Overall Study|Gout Flare|0
3110503|NCT00174967|10653084|P2|Overall Study|Gout Flare|0
3110504|NCT00174967|10653085|P1|Overall Study|Gout Flare|0
3110505|NCT00174967|10653082|P4|Overall Study|Adverse Event|1
3110506|NCT00174967|10653083|P3|Overall Study|Adverse Event|2
3110507|NCT00174967|10653084|P2|Overall Study|Adverse Event|2
3110508|NCT00174967|10653085|P1|Overall Study|Adverse Event|1
3110509|NCT00174954|10653131|P1|Overall Study|Physician Decision|1
3110510|NCT00174954|10653131|P1|Overall Study|No tophi found in MRI|1
3110511|NCT00174954|10653131|P1|Overall Study|Adverse Event|2
3110512|NCT00174941|10653139|P4|Overall Study|Reason Not Specified|9
3110513|NCT00174941|10653140|P3|Overall Study|Reason Not Specified|2
3110514|NCT00174941|10653141|P2|Overall Study|Reason Not Specified|6
3110515|NCT00174941|10653142|P1|Overall Study|Reason Not Specified|1
3110516|NCT00174941|10653139|P4|Overall Study|Gout Flare|8
3110517|NCT00174941|10653140|P3|Overall Study|Gout Flare|4
3110518|NCT00174941|10653141|P2|Overall Study|Gout Flare|4
3110519|NCT00174941|10653142|P1|Overall Study|Gout Flare|0
3110520|NCT00174941|10653139|P4|Overall Study|Personal Reason(s)|22
3110521|NCT00174941|10653140|P3|Overall Study|Personal Reason(s)|8
3110522|NCT00174941|10653141|P2|Overall Study|Personal Reason(s)|14
3110523|NCT00174941|10653142|P1|Overall Study|Personal Reason(s)|0
3110524|NCT00174941|10653139|P4|Overall Study|Lost to Follow-up|5
3110525|NCT00174941|10653140|P3|Overall Study|Lost to Follow-up|2
3110526|NCT00174941|10653141|P2|Overall Study|Lost to Follow-up|3
3110527|NCT00174941|10653142|P1|Overall Study|Lost to Follow-up|0
3110528|NCT00174941|10653139|P4|Overall Study|Protocol Violation|1
3110529|NCT00174941|10653140|P3|Overall Study|Protocol Violation|0
3110530|NCT00174941|10653141|P2|Overall Study|Protocol Violation|1
3110531|NCT00174941|10653142|P1|Overall Study|Protocol Violation|0
3110532|NCT00174941|10653139|P4|Overall Study|Adverse Event|13
3110533|NCT00174941|10653140|P3|Overall Study|Adverse Event|2
3110534|NCT00174941|10653141|P2|Overall Study|Adverse Event|10
3110535|NCT00174941|10653142|P1|Overall Study|Adverse Event|1
3110536|NCT00174915|10653217|P5|Overall Study|Therapeutic Failure|3
3110537|NCT00174915|10653218|P4|Overall Study|Therapeutic Failure|1
3110538|NCT00174915|10653219|P3|Overall Study|Therapeutic Failure|2
3110539|NCT00174915|10653220|P2|Overall Study|Therapeutic Failure|3
3110540|NCT00174915|10653221|P1|Overall Study|Therapeutic Failure|6
3110541|NCT00174915|10653217|P5|Overall Study|Protocol Violation|3
3110542|NCT00174915|10653218|P4|Overall Study|Protocol Violation|6
3110543|NCT00174915|10653219|P3|Overall Study|Protocol Violation|3
3110544|NCT00174915|10653220|P2|Overall Study|Protocol Violation|3
3110545|NCT00174915|10653221|P1|Overall Study|Protocol Violation|6
3110546|NCT00174915|10653217|P5|Overall Study|Gout Flare|0
3110547|NCT00174915|10653218|P4|Overall Study|Gout Flare|1
3110548|NCT00174915|10653219|P3|Overall Study|Gout Flare|8
3110549|NCT00174915|10653220|P2|Overall Study|Gout Flare|6
3110550|NCT00174915|10653221|P1|Overall Study|Gout Flare|13
3110551|NCT00174915|10653217|P5|Overall Study|Other|3
3110552|NCT00174915|10653218|P4|Overall Study|Other|5
3110553|NCT00174915|10653219|P3|Overall Study|Other|6
3110554|NCT00174915|10653220|P2|Overall Study|Other|8
3110555|NCT00174915|10653221|P1|Overall Study|Other|15
3110556|NCT00174915|10653217|P5|Overall Study|Personal Reason(s)|9
3110557|NCT00174915|10653218|P4|Overall Study|Personal Reason(s)|9
3110558|NCT00174915|10653219|P3|Overall Study|Personal Reason(s)|9
3110559|NCT00174915|10653220|P2|Overall Study|Personal Reason(s)|16
3110560|NCT00174915|10653221|P1|Overall Study|Personal Reason(s)|16
3110561|NCT00174915|10653217|P5|Overall Study|Adverse Event|5
3110562|NCT00174915|10653218|P4|Overall Study|Adverse Event|18
3110563|NCT00174915|10653219|P3|Overall Study|Adverse Event|11
3110564|NCT00174915|10653220|P2|Overall Study|Adverse Event|16
3110565|NCT00174915|10653221|P1|Overall Study|Adverse Event|18
3110566|NCT00174915|10653217|P5|Overall Study|Lost to Follow-up|10
3110567|NCT00174915|10653218|P4|Overall Study|Lost to Follow-up|17
3110568|NCT00174915|10653219|P3|Overall Study|Lost to Follow-up|9
3110569|NCT00174915|10653220|P2|Overall Study|Lost to Follow-up|17
3110570|NCT00174915|10653221|P1|Overall Study|Lost to Follow-up|19
3110571|NCT00174785|10653280|P2|Overall Study|Not pre-specified/Not coded|70
3110572|NCT00174785|10653281|P1|Overall Study|Not pre-specified/Not coded|56
3110573|NCT00174785|10653280|P2|Overall Study|Family request|8
3110574|NCT00174785|10653281|P1|Overall Study|Family request|6
3110575|NCT00174785|10653280|P2|Overall Study|Other prohibited medication|3
3110576|NCT00174785|10653281|P1|Overall Study|Other prohibited medication|5
3110577|NCT00174785|10653280|P2|Overall Study|Prohibited antiarrhythmic medication|88
3110578|NCT00174785|10653281|P1|Overall Study|Prohibited antiarrhythmic medication|39
3110579|NCT00174785|10653280|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
3110580|NCT00174785|10653281|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
3110581|NCT00174785|10653280|P2|Overall Study|Withdrawal by Subject|175
3110582|NCT00174785|10653281|P1|Overall Study|Withdrawal by Subject|173
3110583|NCT00174785|10653280|P2|Overall Study|Protocol Violation|14
3110584|NCT00174785|10653281|P1|Overall Study|Protocol Violation|14
3110585|NCT00174785|10653280|P2|Overall Study|Adverse Event|191
3110586|NCT00174785|10653281|P1|Overall Study|Adverse Event|293
3110587|NCT00174460|10653297|P2|Overall Study|Withdrawal by Subject|1
3110588|NCT00174460|10653298|P1|Overall Study|Withdrawal by Subject|0
3110589|NCT00174447|10653344|P1|Overall Study|Administrative reason/Other|2
3110590|NCT00174447|10653344|P1|Overall Study|Lack of Efficacy|1
3110591|NCT00174447|10653344|P1|Overall Study|Protocol Violation|1
3110592|NCT00174447|10653344|P1|Overall Study|Withdrawal by Subject|15
3110593|NCT00174447|10653344|P1|Overall Study|Adverse Event|19
3110594|NCT00174382|10653353|P1|Overall Study|Lost to Follow-up|1
3110595|NCT00174382|10653353|P1|Overall Study|Subject felt pill not effective enough|1
3110596|NCT00174382|10653353|P1|Overall Study|Arrived early for last visit in error|1
3110597|NCT00174382|10653353|P1|Overall Study|Protocol Violation|3
3110598|NCT00174382|10653353|P1|Overall Study|Withdrawal by Subject|6
3110599|NCT00174382|10653353|P1|Overall Study|Adverse Event|19
3110600|NCT00174382|10653353|P1|Overall Study|Death|2
3110601|NCT00174291|10653372|P2|Overall Study|Withdrawal by Subject|3
3110602|NCT00174291|10653373|P1|Overall Study|Withdrawal by Subject|3
3110603|NCT00174291|10653372|P2|Overall Study|Study terminated by sponsor|0
3110604|NCT00174291|10653373|P1|Overall Study|Study terminated by sponsor|1
3110605|NCT00174291|10653372|P2|Overall Study|Protocol Violation|2
3110606|NCT00174291|10653373|P1|Overall Study|Protocol Violation|0
3110607|NCT00174291|10653372|P2|Overall Study|Lost to Follow-up|1
3110608|NCT00174291|10653373|P1|Overall Study|Lost to Follow-up|1
3110609|NCT00174265|10653403|P2|Overall Study|Other (Not specified)|10
3110610|NCT00174265|10653404|P1|Overall Study|Other (Not specified)|16
3110611|NCT00174265|10653403|P2|Overall Study|Lost to Follow-up|0
3110612|NCT00174265|10653404|P1|Overall Study|Lost to Follow-up|1
3110613|NCT00174265|10653403|P2|Overall Study|Withdrawal by Subject|5
3110614|NCT00174265|10653404|P1|Overall Study|Withdrawal by Subject|3
3110615|NCT00174265|10653403|P2|Overall Study|Lack of Efficacy|2
3110616|NCT00174265|10653404|P1|Overall Study|Lack of Efficacy|2
3110617|NCT00174265|10653403|P2|Overall Study|Adverse Event|4
3110618|NCT00174265|10653404|P1|Overall Study|Adverse Event|7
3110619|NCT00174252|10653412|P1|Overall Study|Protocol Violation|2
3110620|NCT00174187|10653447|P3|Period 2 (After 3 Years)|Other|5
3110621|NCT00174187|10653448|P2|Period 2 (After 3 Years)|Other|0
3110622|NCT00174187|10653449|P1|Period 2 (After 3 Years)|Other|0
3110623|NCT00174187|10653447|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
3110624|NCT00174187|10653448|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
3110625|NCT00174187|10653449|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
3110626|NCT00174187|10653447|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
3110627|NCT00174187|10653448|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
3110628|NCT00174187|10653449|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
3110629|NCT00174187|10653447|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
3110630|NCT00174187|10653448|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
3110631|NCT00174187|10653449|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
3110632|NCT00174187|10653447|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
3110633|NCT00174187|10653448|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
3110634|NCT00174187|10653449|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
3110635|NCT00174187|10653447|P3|Period 1 (up to 3 Years)|Other|0
3110636|NCT00174187|10653448|P2|Period 1 (up to 3 Years)|Other|1
3110637|NCT00174187|10653449|P1|Period 1 (up to 3 Years)|Other|0
3110638|NCT00174187|10653447|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
3110639|NCT00174187|10653448|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
3110640|NCT00174187|10653449|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
3110641|NCT00174187|10653447|P3|Period 1 (up to 3 Years)|Non compliance|0
3110642|NCT00174187|10653448|P2|Period 1 (up to 3 Years)|Non compliance|1
3110643|NCT00174187|10653449|P1|Period 1 (up to 3 Years)|Non compliance|0
3110644|NCT00174187|10653447|P3|Period 1 (up to 3 Years)|Serious adverse event|0
3110645|NCT00174187|10653448|P2|Period 1 (up to 3 Years)|Serious adverse event|1
3110646|NCT00174187|10653449|P1|Period 1 (up to 3 Years)|Serious adverse event|0
3110647|NCT00172185|10653514|P4|Overall Study|Withdrawal by Subject|0
3110648|NCT00172185|10653515|P3|Overall Study|Withdrawal by Subject|1
3110649|NCT00172185|10653516|P2|Overall Study|Withdrawal by Subject|0
3110650|NCT00172185|10653517|P1|Overall Study|Withdrawal by Subject|0
3110651|NCT00172185|10653514|P4|Overall Study|SPONSOR Decision|0
3110652|NCT00172185|10653515|P3|Overall Study|SPONSOR Decision|0
3110653|NCT00172185|10653516|P2|Overall Study|SPONSOR Decision|1
3110654|NCT00172185|10653517|P1|Overall Study|SPONSOR Decision|0
3110655|NCT00172185|10653514|P4|Overall Study|Physician Decision|0
3110656|NCT00172185|10653515|P3|Overall Study|Physician Decision|1
3110657|NCT00172185|10653516|P2|Overall Study|Physician Decision|0
3110658|NCT00172185|10653517|P1|Overall Study|Physician Decision|0
3110659|NCT00172185|10653514|P4|Overall Study|Adverse Event|4
3110660|NCT00172185|10653515|P3|Overall Study|Adverse Event|3
3110661|NCT00172185|10653516|P2|Overall Study|Adverse Event|1
3110662|NCT00172185|10653517|P1|Overall Study|Adverse Event|0
3110663|NCT00172042|10653533|P2|Overall Study|Death|42
3110664|NCT00172042|10653534|P1|Overall Study|Death|42
3110665|NCT00172042|10653533|P2|Overall Study|Administrative problems|10
3110666|NCT00172042|10653534|P1|Overall Study|Administrative problems|13
3110667|NCT00172042|10653533|P2|Overall Study|Lost to Follow-up|5
3110668|NCT00172042|10653534|P1|Overall Study|Lost to Follow-up|3
3110669|NCT00172042|10653533|P2|Overall Study|Withdrawal by Subject|25
3110670|NCT00172042|10653534|P1|Overall Study|Withdrawal by Subject|37
3110671|NCT00172042|10653533|P2|Overall Study|Protocol Violation|7
3110672|NCT00172042|10653534|P1|Overall Study|Protocol Violation|8
3110673|NCT00172042|10653533|P2|Overall Study|Patient no longer requires study drug|8
3110674|NCT00172042|10653534|P1|Overall Study|Patient no longer requires study drug|10
3110675|NCT00172042|10653533|P2|Overall Study|Unsatisfactory therapeutic effect|11
3110676|NCT00172042|10653534|P1|Overall Study|Unsatisfactory therapeutic effect|13
3110677|NCT00172042|10653533|P2|Overall Study|Abnormal test procedure(s)|3
3110678|NCT00172042|10653534|P1|Overall Study|Abnormal test procedure(s)|0
3110679|NCT00172042|10653533|P2|Overall Study|Abnormal laboratory value(s)|1
3110680|NCT00172042|10653534|P1|Overall Study|Abnormal laboratory value(s)|5
3110681|NCT00172042|10653533|P2|Overall Study|Adverse Event|13
3110682|NCT00172042|10653534|P1|Overall Study|Adverse Event|27
3110683|NCT00171925|10653556|P2|Overall Study|Death|2
3110684|NCT00171925|10653557|P1|Overall Study|Death|1
3110685|NCT00171925|10653556|P2|Overall Study|Administrative problems|11
3110686|NCT00171925|10653557|P1|Overall Study|Administrative problems|10
3110687|NCT00171925|10653556|P2|Overall Study|Lost to Follow-up|2
3110688|NCT00171925|10653557|P1|Overall Study|Lost to Follow-up|2
3110689|NCT00171925|10653556|P2|Overall Study|Withdrawal by Subject|9
3110690|NCT00171925|10653557|P1|Overall Study|Withdrawal by Subject|6
3110691|NCT00171925|10653556|P2|Overall Study|Protocol Violation|1
3110692|NCT00171925|10653557|P1|Overall Study|Protocol Violation|1
3110693|NCT00171925|10653556|P2|Overall Study|Adverse Event|6
3110694|NCT00171925|10653557|P1|Overall Study|Adverse Event|10
3110695|NCT00171873|10653569|P2|Overall Study|Switched to Octreotide|1
3110696|NCT00171873|10653570|P1|Overall Study|Switched to Octreotide|0
3110697|NCT00171873|10653569|P2|Overall Study|Adverse Event|0
3110698|NCT00171873|10653570|P1|Overall Study|Adverse Event|5
3110699|NCT00171873|10653569|P2|Overall Study|Withdrawal by Subject|2
3110700|NCT00171873|10653570|P1|Overall Study|Withdrawal by Subject|4
3110701|NCT00171834|10653583|P7|Overall Study|Treatment Duration Completed|0
3110702|NCT00171834|10653584|P6|Overall Study|Treatment Duration Completed|1
3110703|NCT00171834|10653585|P5|Overall Study|Treatment Duration Completed|2
3110704|NCT00171834|10653586|P4|Overall Study|Treatment Duration Completed|0
3110705|NCT00171834|10653587|P3|Overall Study|Treatment Duration Completed|1
3110706|NCT00171834|10653588|P2|Overall Study|Treatment Duration Completed|0
3110707|NCT00171834|10653589|P1|Overall Study|Treatment Duration Completed|0
3110708|NCT00171834|10653583|P7|Overall Study|Disease Progression|3
3110709|NCT00171834|10653584|P6|Overall Study|Disease Progression|18
3110710|NCT00171834|10653585|P5|Overall Study|Disease Progression|2
3110711|NCT00171834|10653586|P4|Overall Study|Disease Progression|9
3110712|NCT00171834|10653587|P3|Overall Study|Disease Progression|8
3110713|NCT00171834|10653588|P2|Overall Study|Disease Progression|8
3110714|NCT00171834|10653589|P1|Overall Study|Disease Progression|4
3110715|NCT00171834|10653583|P7|Overall Study|Death from study indication|0
3110716|NCT00171834|10653584|P6|Overall Study|Death from study indication|0
3110717|NCT00171834|10653585|P5|Overall Study|Death from study indication|1
3110718|NCT00171834|10653586|P4|Overall Study|Death from study indication|0
3110719|NCT00171834|10653587|P3|Overall Study|Death from study indication|0
3110720|NCT00171834|10653588|P2|Overall Study|Death from study indication|1
3110721|NCT00171834|10653589|P1|Overall Study|Death from study indication|0
3110722|NCT00171834|10653583|P7|Overall Study|Withdrawal by Subject|0
3110723|NCT00171834|10653584|P6|Overall Study|Withdrawal by Subject|1
3110724|NCT00171834|10653585|P5|Overall Study|Withdrawal by Subject|1
3110725|NCT00171834|10653586|P4|Overall Study|Withdrawal by Subject|1
3110726|NCT00171834|10653587|P3|Overall Study|Withdrawal by Subject|0
3110727|NCT00171834|10653588|P2|Overall Study|Withdrawal by Subject|2
3110728|NCT00171834|10653589|P1|Overall Study|Withdrawal by Subject|0
3110729|NCT00171834|10653583|P7|Overall Study|Adverse Event|1
3110730|NCT00171834|10653584|P6|Overall Study|Adverse Event|15
3110731|NCT00171834|10653585|P5|Overall Study|Adverse Event|2
3110732|NCT00171834|10653586|P4|Overall Study|Adverse Event|2
3110733|NCT00171834|10653587|P3|Overall Study|Adverse Event|3
3110734|NCT00171834|10653588|P2|Overall Study|Adverse Event|1
3110735|NCT00171834|10653589|P1|Overall Study|Adverse Event|2
3110736|NCT00171704|10653629|P2|Overall Study|Protocol Violation|1
3110737|NCT00171704|10653630|P1|Overall Study|Protocol Violation|0
3110738|NCT00171704|10653629|P2|Overall Study|Withdrawal by Subject|3
3110739|NCT00171704|10653630|P1|Overall Study|Withdrawal by Subject|1
3110740|NCT00171704|10653629|P2|Overall Study|Death|2
3110741|NCT00171704|10653630|P1|Overall Study|Death|2
3110742|NCT00171704|10653629|P2|Overall Study|Administrative Problems|1
3110743|NCT00171704|10653630|P1|Overall Study|Administrative Problems|2
3110744|NCT00171704|10653629|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
3110745|NCT00171704|10653630|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
3110746|NCT00171704|10653629|P2|Overall Study|Disease Progression|9
3110747|NCT00171704|10653630|P1|Overall Study|Disease Progression|14
3110748|NCT00171704|10653629|P2|Overall Study|Adverse Event|33
3110749|NCT00171704|10653630|P1|Overall Study|Adverse Event|24
3110750|NCT00171340|10653652|P2|Overall Study|Death|6
3110751|NCT00171340|10653653|P1|Overall Study|Death|6
3110752|NCT00171340|10653652|P2|Overall Study|Administrative Problems|2
3110753|NCT00171340|10653653|P1|Overall Study|Administrative Problems|5
3110754|NCT00171340|10653652|P2|Overall Study|No Longer Required Study Drug|1
3110755|NCT00171340|10653653|P1|Overall Study|No Longer Required Study Drug|1
3110756|NCT00171340|10653652|P2|Overall Study|Abnormal Test Procedure Results|11
3110757|NCT00171340|10653653|P1|Overall Study|Abnormal Test Procedure Results|6
3110758|NCT00171340|10653652|P2|Overall Study|Abnormal Laboratory Results|0
3110759|NCT00171340|10653653|P1|Overall Study|Abnormal Laboratory Results|2
3110760|NCT00171340|10653652|P2|Overall Study|Lost to Follow-up|5
3110761|NCT00171340|10653653|P1|Overall Study|Lost to Follow-up|0
3110762|NCT00171340|10653652|P2|Overall Study|Withdrawal by Subject|19
3110763|NCT00171340|10653653|P1|Overall Study|Withdrawal by Subject|22
3110764|NCT00171340|10653652|P2|Overall Study|Protocol Violation|8
3110765|NCT00171340|10653653|P1|Overall Study|Protocol Violation|7
3110766|NCT00171340|10653652|P2|Overall Study|Lack of Efficacy|41
3110767|NCT00171340|10653653|P1|Overall Study|Lack of Efficacy|29
3110768|NCT00171340|10653652|P2|Overall Study|Adverse Event|42
3110769|NCT00171340|10653653|P1|Overall Study|Adverse Event|46
3110770|NCT00171314|10653669|P2|Overall Study|Death|1
3110771|NCT00171314|10653670|P1|Overall Study|Death|2
3110772|NCT00171314|10653669|P2|Overall Study|Lost to Follow-up|3
3110773|NCT00171314|10653670|P1|Overall Study|Lost to Follow-up|1
3110774|NCT00171314|10653669|P2|Overall Study|Administrative Problems|3
3110775|NCT00171314|10653670|P1|Overall Study|Administrative Problems|4
3110776|NCT00171314|10653669|P2|Overall Study|Protocol Violation|7
3110777|NCT00171314|10653670|P1|Overall Study|Protocol Violation|3
3110778|NCT00171314|10653669|P2|Overall Study|Abnormal Test Procedure Results|3
3110779|NCT00171314|10653670|P1|Overall Study|Abnormal Test Procedure Results|9
3110780|NCT00171314|10653669|P2|Overall Study|Withdrawal by Subject|6
3110781|NCT00171314|10653670|P1|Overall Study|Withdrawal by Subject|9
3110782|NCT00171314|10653669|P2|Overall Study|Lack of Efficacy|14
3110783|NCT00171314|10653670|P1|Overall Study|Lack of Efficacy|19
3110784|NCT00171314|10653669|P2|Overall Study|Adverse Event|41
3110785|NCT00171314|10653670|P1|Overall Study|Adverse Event|44
3110786|NCT00171301|10653686|P2|Overall Study|Withdrawal by Subject|1
3110787|NCT00171301|10653687|P1|Overall Study|Withdrawal by Subject|0
3110788|NCT00171301|10653686|P2|Overall Study|Protocol Violation|2
3110789|NCT00171301|10653687|P1|Overall Study|Protocol Violation|0
3110790|NCT00171301|10653686|P2|Overall Study|Lost to Follow-up|2
3110791|NCT00171301|10653687|P1|Overall Study|Lost to Follow-up|6
3110792|NCT00171301|10653686|P2|Overall Study|Adverse Event|2
3110793|NCT00171301|10653687|P1|Overall Study|Adverse Event|1
3110794|NCT00171301|10653686|P2|Overall Study|Death|2
3110795|NCT00171301|10653687|P1|Overall Study|Death|1
3110796|NCT00171210|10653700|P2|Overall Study|Stopped at end of extension 1|1
3110797|NCT00171210|10653701|P1|Overall Study|Stopped at end of extension 1|0
3110798|NCT00171210|10653700|P2|Overall Study|Stopped at end of core|32
3110799|NCT00171210|10653701|P1|Overall Study|Stopped at end of core|0
3110800|NCT00171210|10653700|P2|Overall Study|Death|3
3110801|NCT00171210|10653701|P1|Overall Study|Death|2
3110802|NCT00171210|10653700|P2|Overall Study|Administrative problems|1
3110803|NCT00171210|10653701|P1|Overall Study|Administrative problems|1
3110804|NCT00171210|10653700|P2|Overall Study|Lost to Follow-up|0
3110805|NCT00171210|10653701|P1|Overall Study|Lost to Follow-up|1
3110806|NCT00171210|10653700|P2|Overall Study|Withdrawal by Subject|30
3110807|NCT00171210|10653701|P1|Overall Study|Withdrawal by Subject|32
3110808|NCT00171210|10653700|P2|Overall Study|Protocol Violation|2
3110809|NCT00171210|10653701|P1|Overall Study|Protocol Violation|0
3110810|NCT00171210|10653700|P2|Overall Study|Unsatisfactory therapeutic effect|15
3110811|NCT00171210|10653701|P1|Overall Study|Unsatisfactory therapeutic effect|11
3110812|NCT00171210|10653700|P2|Overall Study|Abnormal test procedure result(s)|1
3110813|NCT00171210|10653701|P1|Overall Study|Abnormal test procedure result(s)|0
3110814|NCT00171210|10653700|P2|Overall Study|Abnormal laboratory value(s)|3
3110815|NCT00171210|10653701|P1|Overall Study|Abnormal laboratory value(s)|6
3110816|NCT00171210|10653700|P2|Overall Study|Adverse Event|27
3110817|NCT00171210|10653701|P1|Overall Study|Adverse Event|16
3110818|NCT00171054|10653731|P2|Overall Study|Condition no longer required study drug|1
3110819|NCT00171054|10653732|P1|Overall Study|Condition no longer required study drug|0
3110820|NCT00171054|10653731|P2|Overall Study|Adverse Event|8
3110821|NCT00171054|10653732|P1|Overall Study|Adverse Event|8
3110822|NCT00171054|10653731|P2|Overall Study|Lost to Follow-up|1
3110823|NCT00171054|10653732|P1|Overall Study|Lost to Follow-up|0
3110824|NCT00171054|10653731|P2|Overall Study|Patient withdrew consent|0
3110825|NCT00171054|10653732|P1|Overall Study|Patient withdrew consent|1
3110826|NCT00171054|10653731|P2|Overall Study|Protocol Violation|2
3110827|NCT00171054|10653732|P1|Overall Study|Protocol Violation|1
3110828|NCT00170950|10653764|P2|Overall Study|Termination Data Not Recorded|22
3110829|NCT00170950|10653765|P1|Overall Study|Termination Data Not Recorded|17
3110830|NCT00170950|10653764|P2|Overall Study|Missing|1
3110831|NCT00170950|10653765|P1|Overall Study|Missing|2
3110832|NCT00170950|10653764|P2|Overall Study|Lost to Follow-up|115
3110833|NCT00170950|10653765|P1|Overall Study|Lost to Follow-up|134
3110834|NCT00170950|10653764|P2|Overall Study|Withdrawal by Subject|498
3110835|NCT00170950|10653765|P1|Overall Study|Withdrawal by Subject|496
3110836|NCT00170950|10653764|P2|Overall Study|Death|274
3110837|NCT00170950|10653765|P1|Overall Study|Death|236
3110838|NCT00170846|10653778|P3|Overall Study|Reason Missing|0
3110839|NCT00170846|10653779|P2|Overall Study|Reason Missing|1
3110840|NCT00170846|10653780|P1|Overall Study|Reason Missing|0
3110841|NCT00170846|10653778|P3|Overall Study|Death|3
3110842|NCT00170846|10653779|P2|Overall Study|Death|3
3110843|NCT00170846|10653780|P1|Overall Study|Death|0
3110844|NCT00170846|10653778|P3|Overall Study|Lost to Follow-up|2
3110845|NCT00170846|10653779|P2|Overall Study|Lost to Follow-up|3
3110846|NCT00170846|10653780|P1|Overall Study|Lost to Follow-up|6
3110847|NCT00170846|10653778|P3|Overall Study|Subject withdrew Informed Consent|8
3110848|NCT00170846|10653779|P2|Overall Study|Subject withdrew Informed Consent|12
3110849|NCT00170846|10653780|P1|Overall Study|Subject withdrew Informed Consent|5
3110850|NCT00169442|10653812|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
3110851|NCT00169442|10653813|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
3110852|NCT00169442|10653814|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
3110853|NCT00169442|10653815|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
3110854|NCT00169442|10653816|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
3110855|NCT00169442|10653817|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
3110856|NCT00169442|10653812|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
3110857|NCT00169442|10653813|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
3110858|NCT00169442|10653814|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
3110859|NCT00169442|10653815|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
3110860|NCT00169442|10653816|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
3110861|NCT00169442|10653817|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
3110862|NCT00169442|10653812|P6|Overall Study|Migrated/moved from study area|2
3110863|NCT00169442|10653813|P5|Overall Study|Migrated/moved from study area|0
3110864|NCT00169442|10653814|P4|Overall Study|Migrated/moved from study area|0
3110865|NCT00169442|10653815|P3|Overall Study|Migrated/moved from study area|0
3110866|NCT00169442|10653816|P2|Overall Study|Migrated/moved from study area|0
3110867|NCT00169442|10653817|P1|Overall Study|Migrated/moved from study area|0
3110868|NCT00169442|10653812|P6|Overall Study|Withdrawal by Subject|0
3110869|NCT00169442|10653813|P5|Overall Study|Withdrawal by Subject|0
3110870|NCT00169442|10653814|P4|Overall Study|Withdrawal by Subject|0
3110871|NCT00169442|10653815|P3|Overall Study|Withdrawal by Subject|1
3110872|NCT00169442|10653816|P2|Overall Study|Withdrawal by Subject|0
3110873|NCT00169442|10653817|P1|Overall Study|Withdrawal by Subject|0
3110874|NCT00169104|10653926|P2|Overall Study|Physician Decision|1
3110875|NCT00169104|10653927|P1|Overall Study|Physician Decision|0
3110876|NCT00169104|10653926|P2|Overall Study|Protocol Violation|1
3110877|NCT00169104|10653927|P1|Overall Study|Protocol Violation|0
3110878|NCT00169104|10653926|P2|Overall Study|Withdrawal by Subject|0
3110879|NCT00169104|10653927|P1|Overall Study|Withdrawal by Subject|2
3110880|NCT00168844|10653941|P3|Overall Study|Other|9
3110881|NCT00168844|10653942|P2|Overall Study|Other|7
3110882|NCT00168844|10653943|P1|Overall Study|Other|6
3110883|NCT00168844|10653941|P3|Overall Study|Protocol Violation|4
3110884|NCT00168844|10653942|P2|Overall Study|Protocol Violation|2
3110885|NCT00168844|10653943|P1|Overall Study|Protocol Violation|2
3110886|NCT00168844|10653941|P3|Overall Study|Withdrawal by Subject|19
3110887|NCT00168844|10653942|P2|Overall Study|Withdrawal by Subject|9
3110888|NCT00168844|10653943|P1|Overall Study|Withdrawal by Subject|12
3110889|NCT00168844|10653941|P3|Overall Study|Lost to Follow-up|11
3110890|NCT00168844|10653942|P2|Overall Study|Lost to Follow-up|5
3110891|NCT00168844|10653943|P1|Overall Study|Lost to Follow-up|4
3110892|NCT00168844|10653941|P3|Overall Study|Adverse Event|48
3110893|NCT00168844|10653942|P2|Overall Study|Adverse Event|32
3110894|NCT00168844|10653943|P1|Overall Study|Adverse Event|31
3110895|NCT00168831|10654125|P3|Overall Study|Other|6
3110896|NCT00168831|10654126|P2|Overall Study|Other|3
3110897|NCT00168831|10654127|P1|Overall Study|Other|6
3110898|NCT00168831|10654125|P3|Overall Study|Protocol Violation|11
3110899|NCT00168831|10654126|P2|Overall Study|Protocol Violation|11
3110900|NCT00168831|10654127|P1|Overall Study|Protocol Violation|6
3110901|NCT00168831|10654125|P3|Overall Study|Withdrawal by Subject|19
3110902|NCT00168831|10654126|P2|Overall Study|Withdrawal by Subject|14
3110903|NCT00168831|10654127|P1|Overall Study|Withdrawal by Subject|7
3110904|NCT00168831|10654125|P3|Overall Study|Lost to Follow-up|4
3110905|NCT00168831|10654126|P2|Overall Study|Lost to Follow-up|6
3110906|NCT00168831|10654127|P1|Overall Study|Lost to Follow-up|5
3110907|NCT00168831|10654125|P3|Overall Study|Adverse Event|74
3110908|NCT00168831|10654126|P2|Overall Study|Adverse Event|47
3110909|NCT00168831|10654127|P1|Overall Study|Adverse Event|36
3110910|NCT00168818|10654309|P3|Treatment|Other|31
3110911|NCT00168818|10654310|P2|Treatment|Other|29
3110912|NCT00168818|10654311|P1|Treatment|Other|23
3110913|NCT00168818|10654309|P3|Treatment|Withdrawal by Subject|22
3110914|NCT00168818|10654310|P2|Treatment|Withdrawal by Subject|20
3110915|NCT00168818|10654311|P1|Treatment|Withdrawal by Subject|25
3110916|NCT00168818|10654309|P3|Treatment|Lost to Follow-up|1
3110917|NCT00168818|10654310|P2|Treatment|Lost to Follow-up|2
3110918|NCT00168818|10654311|P1|Treatment|Lost to Follow-up|0
3110919|NCT00168818|10654309|P3|Treatment|Protocol Violation|11
3110920|NCT00168818|10654310|P2|Treatment|Protocol Violation|11
3110921|NCT00168818|10654311|P1|Treatment|Protocol Violation|8
3110922|NCT00168818|10654309|P3|Treatment|Adverse Event|68
3110923|NCT00168818|10654310|P2|Treatment|Adverse Event|89
3110924|NCT00168818|10654311|P1|Treatment|Adverse Event|77
3110925|NCT00168818|10654309|P3|Overall Study|Other|30
3110926|NCT00168818|10654310|P2|Overall Study|Other|24
3110927|NCT00168818|10654311|P1|Overall Study|Other|22
3110928|NCT00168818|10654309|P3|Overall Study|Withdrawal by Subject|37
3110929|NCT00168818|10654310|P2|Overall Study|Withdrawal by Subject|41
3110930|NCT00168818|10654311|P1|Overall Study|Withdrawal by Subject|43
3110931|NCT00168818|10654309|P3|Overall Study|Lost to Follow-up|15
3110932|NCT00168818|10654310|P2|Overall Study|Lost to Follow-up|4
3110933|NCT00168818|10654311|P1|Overall Study|Lost to Follow-up|13
3110934|NCT00168818|10654309|P3|Overall Study|Protocol Violation|11
3110935|NCT00168818|10654310|P2|Overall Study|Protocol Violation|11
3110936|NCT00168818|10654311|P1|Overall Study|Protocol Violation|16
3110937|NCT00168818|10654309|P3|Overall Study|Adverse Event|31
3110938|NCT00168818|10654310|P2|Overall Study|Adverse Event|29
3110939|NCT00168818|10654311|P1|Overall Study|Adverse Event|23
3110940|NCT00168805|10654355|P3|Treatment|Other|17
3110941|NCT00168805|10654356|P2|Treatment|Other|18
3110942|NCT00168805|10654357|P1|Treatment|Other|18
3110943|NCT00168805|10654355|P3|Treatment|Withdrawal by Subject|8
3110944|NCT00168805|10654356|P2|Treatment|Withdrawal by Subject|7
3110945|NCT00168805|10654357|P1|Treatment|Withdrawal by Subject|3
3110946|NCT00168805|10654355|P3|Treatment|Protocol Violation|5
3110947|NCT00168805|10654356|P2|Treatment|Protocol Violation|5
3110948|NCT00168805|10654357|P1|Treatment|Protocol Violation|3
3110949|NCT00168805|10654355|P3|Treatment|Adverse Event|32
3110950|NCT00168805|10654356|P2|Treatment|Adverse Event|26
3110951|NCT00168805|10654357|P1|Treatment|Adverse Event|25
3110952|NCT00168805|10654355|P3|Overall Study|Other|22
3110953|NCT00168805|10654356|P2|Overall Study|Other|21
3110954|NCT00168805|10654357|P1|Overall Study|Other|24
3110955|NCT00168805|10654355|P3|Overall Study|Withdrawal by Subject|21
3110956|NCT00168805|10654356|P2|Overall Study|Withdrawal by Subject|18
3110957|NCT00168805|10654357|P1|Overall Study|Withdrawal by Subject|16
3110958|NCT00168805|10654355|P3|Overall Study|Lost to Follow-up|11
3110959|NCT00168805|10654356|P2|Overall Study|Lost to Follow-up|17
3110960|NCT00168805|10654357|P1|Overall Study|Lost to Follow-up|12
3110961|NCT00168805|10654355|P3|Overall Study|Protocol Violation|8
3110962|NCT00168805|10654356|P2|Overall Study|Protocol Violation|11
3110963|NCT00168805|10654357|P1|Overall Study|Protocol Violation|12
3110964|NCT00168805|10654355|P3|Overall Study|Adverse Event|16
3110965|NCT00168805|10654356|P2|Overall Study|Adverse Event|11
3110966|NCT00168805|10654357|P1|Overall Study|Adverse Event|7
3110967|NCT00168103|10654593|P4|Overall Study|Lost to Follow-up|0
3110968|NCT00168103|10654594|P3|Overall Study|Lost to Follow-up|0
3110969|NCT00168103|10654595|P2|Overall Study|Lost to Follow-up|3
3110970|NCT00168103|10654596|P1|Overall Study|Lost to Follow-up|1
3110971|NCT00168103|10654593|P4|Overall Study|Withdrawal by Subject|0
3110972|NCT00168103|10654594|P3|Overall Study|Withdrawal by Subject|1
3110973|NCT00168103|10654595|P2|Overall Study|Withdrawal by Subject|2
3110974|NCT00168103|10654596|P1|Overall Study|Withdrawal by Subject|1
3110975|NCT00168064|10654618|P2|Overall Study|Various|3
3110976|NCT00168064|10654619|P1|Overall Study|Various|4
3110977|NCT00168064|10654618|P2|Overall Study|Subject's Best interest|2
3110978|NCT00168064|10654619|P1|Overall Study|Subject's Best interest|2
3110979|NCT00168064|10654618|P2|Overall Study|Concurrent Illness|3
3110980|NCT00168064|10654619|P1|Overall Study|Concurrent Illness|4
3110981|NCT00168064|10654618|P2|Overall Study|Non-compliance|3
3110982|NCT00168064|10654619|P1|Overall Study|Non-compliance|2
3110983|NCT00168064|10654618|P2|Overall Study|Lost to Follow-up|3
3110984|NCT00168064|10654619|P1|Overall Study|Lost to Follow-up|4
3110985|NCT00168064|10654618|P2|Overall Study|Lack of Efficacy|4
3110986|NCT00168064|10654619|P1|Overall Study|Lack of Efficacy|4
3110987|NCT00168064|10654618|P2|Overall Study|Withdrawal by Subject|4
3110988|NCT00168064|10654619|P1|Overall Study|Withdrawal by Subject|3
3110989|NCT00168064|10654618|P2|Overall Study|Adverse Event|22
3110990|NCT00168064|10654619|P1|Overall Study|Adverse Event|26
3110991|NCT00168038|10654627|P1|Overall Study|Therapy failure|1
3110992|NCT00168038|10654627|P1|Overall Study|Adverse Event|1
3110993|NCT00167778|10654650|P1|Overall Study|Withdrawal by Subject|1
3110994|NCT00167414|10654716|P1|Overall Study|Death|10
3110995|NCT00167310|10654741|P2|Overall Study|Withdrawal by Subject|7
3110996|NCT00167310|10654742|P1|Overall Study|Withdrawal by Subject|3
3110997|NCT00167310|10654741|P2|Overall Study|Protocol Violation|3
3110998|NCT00167310|10654742|P1|Overall Study|Protocol Violation|5
3110999|NCT00167245|10654752|P2|Overall Study|Drowsy|0
3111000|NCT00167245|10654753|P1|Overall Study|Drowsy|1
3111001|NCT00167245|10654752|P2|Overall Study|Incarcerated|2
3111002|NCT00167245|10654753|P1|Overall Study|Incarcerated|3
3111003|NCT00167245|10654752|P2|Overall Study|Withdrawal by Subject|8
3111004|NCT00167245|10654753|P1|Overall Study|Withdrawal by Subject|5
3111005|NCT00167245|10654752|P2|Overall Study|Lost to Follow-up|31
3111006|NCT00167245|10654753|P1|Overall Study|Lost to Follow-up|20
3111007|NCT00166712|10654803|P2|Overall Study|Physician Decision|2
3111008|NCT00166712|10654804|P1|Overall Study|Physician Decision|0
3111009|NCT00166712|10654803|P2|Overall Study|Withdrawal by Subject|2
3111010|NCT00166712|10654804|P1|Overall Study|Withdrawal by Subject|1
3111011|NCT00166712|10654803|P2|Overall Study|Adverse Event|0
3111012|NCT00166712|10654804|P1|Overall Study|Adverse Event|1
3111013|NCT00166712|10654803|P2|Overall Study|Death|1
3111014|NCT00166712|10654804|P1|Overall Study|Death|0
3111015|NCT00166517|10654821|P2|Overall Study|Withdrawal by Subject|1
3111016|NCT00166517|10654822|P1|Overall Study|Withdrawal by Subject|0
3111017|NCT00166517|10654821|P2|Overall Study|Protocol Violation|1
3111018|NCT00166517|10654822|P1|Overall Study|Protocol Violation|4
3111019|NCT00166517|10654821|P2|Overall Study|Lost to Follow-up|0
3111020|NCT00166517|10654822|P1|Overall Study|Lost to Follow-up|1
3111021|NCT00166504|10654832|P2|Overall Study|Withdrawal by Subject|0
3111022|NCT00166504|10654833|P1|Overall Study|Withdrawal by Subject|1
3111023|NCT00166504|10654832|P2|Overall Study|Lost to Follow-up|1
3111024|NCT00166504|10654833|P1|Overall Study|Lost to Follow-up|1
3111025|NCT00166504|10654832|P2|Overall Study|Adverse Event|3
3111026|NCT00166504|10654833|P1|Overall Study|Adverse Event|3
3111027|NCT00166439|10654839|P1|Overall Study|Ineligible|5
3111028|NCT00166296|10654856|P2|Overall Study|Lost to Follow-up|2
3111029|NCT00166296|10654857|P1|Overall Study|Lost to Follow-up|4
3111030|NCT00166296|10654856|P2|Overall Study|Adverse Event|4
3111031|NCT00166296|10654857|P1|Overall Study|Adverse Event|2
3111032|NCT00166296|10654856|P2|Overall Study|Withdrawal by Subject|3
3111033|NCT00166296|10654857|P1|Overall Study|Withdrawal by Subject|1
3111034|NCT00166114|10654909|P2|Overall Study|Adverse Event|1
3111035|NCT00166114|10654910|P1|Overall Study|Adverse Event|2
3111036|NCT00166114|10654909|P2|Overall Study|Withdrawal by Subject|4
3111037|NCT00166114|10654910|P1|Overall Study|Withdrawal by Subject|10
3111038|NCT00166114|10654909|P2|Overall Study|Protocol Violation|1
3111039|NCT00166114|10654910|P1|Overall Study|Protocol Violation|2
3111040|NCT00165984|10654927|P1|Overall Study|Death|15
3111041|NCT00165841|10654945|P2|Overall Study|Medication Noncompliance|1
3111042|NCT00165841|10654946|P1|Overall Study|Medication Noncompliance|1
3111043|NCT00165841|10654945|P2|Overall Study|Other|5
3111044|NCT00165841|10654946|P1|Overall Study|Other|3
3111045|NCT00165841|10654945|P2|Overall Study|Protocol Violation|8
3111046|NCT00165841|10654946|P1|Overall Study|Protocol Violation|6
3111047|NCT00165841|10654945|P2|Overall Study|Physician Decision|0
3111048|NCT00165841|10654946|P1|Overall Study|Physician Decision|1
3111049|NCT00165841|10654945|P2|Overall Study|Withdrawal by Subject|8
3111050|NCT00165841|10654946|P1|Overall Study|Withdrawal by Subject|7
3111051|NCT00165841|10654945|P2|Overall Study|Lost to Follow-up|4
3111052|NCT00165841|10654946|P1|Overall Study|Lost to Follow-up|4
3111053|NCT00165841|10654945|P2|Overall Study|Lack of Efficacy|33
3111054|NCT00165841|10654946|P1|Overall Study|Lack of Efficacy|6
3111055|NCT00165841|10654945|P2|Overall Study|Adverse Event|3
3111056|NCT00165841|10654946|P1|Overall Study|Adverse Event|2
3111057|NCT00165789|10654956|P4|Overall Study|Withdrawal by Subject|2
3111058|NCT00165789|10654957|P3|Overall Study|Withdrawal by Subject|1
3111059|NCT00165789|10654958|P2|Overall Study|Withdrawal by Subject|1
3111060|NCT00165789|10654959|P1|Overall Study|Withdrawal by Subject|0
3111061|NCT00165789|10654956|P4|Overall Study|Adverse Event|12
3111062|NCT00165789|10654957|P3|Overall Study|Adverse Event|0
3111063|NCT00165789|10654958|P2|Overall Study|Adverse Event|3
3111064|NCT00165789|10654959|P1|Overall Study|Adverse Event|0
3111065|NCT00165776|10655013|P4|Overall Study|Worsening of Cervical Dystonia|1
3111066|NCT00165776|10655014|P3|Overall Study|Worsening of Cervical Dystonia|0
3111067|NCT00165776|10655015|P2|Overall Study|Worsening of Cervical Dystonia|0
3111068|NCT00165776|10655016|P1|Overall Study|Worsening of Cervical Dystonia|0
3111069|NCT00165776|10655013|P4|Overall Study|Withdrawal by Subject|0
3111070|NCT00165776|10655014|P3|Overall Study|Withdrawal by Subject|2
3111071|NCT00165776|10655015|P2|Overall Study|Withdrawal by Subject|1
3111072|NCT00165776|10655016|P1|Overall Study|Withdrawal by Subject|4
3111073|NCT00165776|10655013|P4|Overall Study|Lack of Efficacy|1
3111074|NCT00165776|10655014|P3|Overall Study|Lack of Efficacy|0
3111075|NCT00165776|10655015|P2|Overall Study|Lack of Efficacy|0
3111076|NCT00165776|10655016|P1|Overall Study|Lack of Efficacy|0
3111077|NCT00165698|10655052|P2|Overall Study|Not Taken/Lost the medicine|2
3111078|NCT00165698|10655053|P1|Overall Study|Not Taken/Lost the medicine|1
3111079|NCT00165698|10655052|P2|Overall Study|Protocol Violation|0
3111080|NCT00165698|10655053|P1|Overall Study|Protocol Violation|1
3111081|NCT00165698|10655052|P2|Overall Study|Withdrawal by Subject|1
3111082|NCT00165698|10655053|P1|Overall Study|Withdrawal by Subject|2
3111083|NCT00165698|10655052|P2|Overall Study|Lost to Follow-up|2
3111084|NCT00165698|10655053|P1|Overall Study|Lost to Follow-up|2
3111085|NCT00165698|10655052|P2|Overall Study|Adverse Event|10
3111086|NCT00165698|10655053|P1|Overall Study|Adverse Event|2
3111087|NCT00165672|10655079|P2|Overall Study|Adverse Event|1
3111088|NCT00165672|10655080|P1|Overall Study|Adverse Event|0
3111089|NCT00165646|10655089|P3|Overall Study|Protocol Violation|0
3111090|NCT00165646|10655090|P2|Overall Study|Protocol Violation|0
3111091|NCT00165646|10655091|P1|Overall Study|Protocol Violation|1
3111092|NCT00165646|10655089|P3|Overall Study|Physician Decision|2
3111093|NCT00165646|10655090|P2|Overall Study|Physician Decision|0
3111094|NCT00165646|10655091|P1|Overall Study|Physician Decision|2
3111095|NCT00165646|10655089|P3|Overall Study|Withdrawal by Subject|1
3111096|NCT00165646|10655090|P2|Overall Study|Withdrawal by Subject|2
3111097|NCT00165646|10655091|P1|Overall Study|Withdrawal by Subject|0
3111098|NCT00165646|10655089|P3|Overall Study|Lack of Efficacy|0
3111099|NCT00165646|10655090|P2|Overall Study|Lack of Efficacy|2
3111100|NCT00165646|10655091|P1|Overall Study|Lack of Efficacy|1
3111101|NCT00165646|10655089|P3|Overall Study|Adverse Event|1
3111102|NCT00165646|10655090|P2|Overall Study|Adverse Event|1
3111103|NCT00165646|10655091|P1|Overall Study|Adverse Event|1
3111104|NCT00165503|10655099|P1|Overall Study|Unresectable|3
3111105|NCT00165503|10655099|P1|Overall Study|Lost to Follow-up|12
3111106|NCT00165503|10655099|P1|Overall Study|Death|1
3111107|NCT00163657|10655106|P3|Overall Study|Other reason|3
3111108|NCT00163657|10655107|P2|Overall Study|Other reason|1
3111109|NCT00163657|10655108|P1|Overall Study|Other reason|0
3111110|NCT00163657|10655106|P3|Overall Study|Lost to Follow-up|10
3111111|NCT00163657|10655107|P2|Overall Study|Lost to Follow-up|3
3111112|NCT00163657|10655108|P1|Overall Study|Lost to Follow-up|1
3111113|NCT00163657|10655106|P3|Overall Study|Non Compliance|0
3111114|NCT00163657|10655107|P2|Overall Study|Non Compliance|0
3111115|NCT00163657|10655108|P1|Overall Study|Non Compliance|1
3111116|NCT00163657|10655106|P3|Overall Study|Physician Decision|1
3111117|NCT00163657|10655107|P2|Overall Study|Physician Decision|1
3111118|NCT00163657|10655108|P1|Overall Study|Physician Decision|0
3111119|NCT00163657|10655106|P3|Overall Study|Withdrawal by Subject|2
3111120|NCT00163657|10655107|P2|Overall Study|Withdrawal by Subject|3
3111121|NCT00163657|10655108|P1|Overall Study|Withdrawal by Subject|2
3111122|NCT00163657|10655106|P3|Overall Study|graft loss|2
3111123|NCT00163657|10655107|P2|Overall Study|graft loss|1
3111124|NCT00163657|10655108|P1|Overall Study|graft loss|4
3111125|NCT00163657|10655106|P3|Overall Study|Death|19
3111126|NCT00163657|10655107|P2|Overall Study|Death|14
3111127|NCT00163657|10655108|P1|Overall Study|Death|12
3111128|NCT00163215|10655198|P1|Overall Study|Other|7
3111129|NCT00163215|10655198|P1|Overall Study|Withdrawal by Subject|5
3111130|NCT00163215|10655198|P1|Overall Study|Lack of Efficacy|3
3111131|NCT00163189|10655218|P1|Overall Study|Did not meet continuation criterion|16
3111132|NCT00163189|10655218|P1|Overall Study|Withdrawal by Subject|11
3111133|NCT00163189|10655218|P1|Overall Study|Study terminated by sponsor|11
3111134|NCT00163189|10655218|P1|Overall Study|Lack of Efficacy|7
3111135|NCT00163189|10655218|P1|Overall Study|Adverse Event|6
3111136|NCT00163189|10655218|P1|Overall Study|Death|3
3111137|NCT00163189|10655218|P1|Overall Study|Protocol Violation|2
3111138|NCT00163189|10655218|P1|Overall Study|Lost to Follow-up|1
3111139|NCT00163189|10655218|P1|Overall Study|Other|6
3111140|NCT00163020|10655242|P2|Overall Study|Lost to Follow-up|2
3111141|NCT00163020|10655243|P1|Overall Study|Lost to Follow-up|0
3111142|NCT00162981|10655283|P2|Overall Study|Physician Decision|0
3111143|NCT00162981|10655284|P1|Overall Study|Physician Decision|1
3111144|NCT00162981|10655283|P2|Overall Study|Withdrawal by Subject|1
3111145|NCT00162981|10655284|P1|Overall Study|Withdrawal by Subject|1
3111146|NCT00162981|10655283|P2|Overall Study|Adverse Event|5
3111147|NCT00162981|10655284|P1|Overall Study|Adverse Event|2
3111148|NCT00162942|10655300|P2|Overall Study|2 or more consecutive treatments missed|0
3111149|NCT00162942|10655301|P1|Overall Study|2 or more consecutive treatments missed|1
3111150|NCT00162942|10655300|P2|Overall Study|Flare During Active Treatment|3
3111151|NCT00162942|10655301|P1|Overall Study|Flare During Active Treatment|7
3111152|NCT00162942|10655300|P2|Overall Study|Lack of Efficacy|0
3111153|NCT00162942|10655301|P1|Overall Study|Lack of Efficacy|1
3111154|NCT00162942|10655300|P2|Overall Study|Alternate Therapy|2
3111155|NCT00162942|10655301|P1|Overall Study|Alternate Therapy|6
3111156|NCT00162942|10655300|P2|Overall Study|Enter Open-Label Study|35
3111157|NCT00162942|10655301|P1|Overall Study|Enter Open-Label Study|76
3111158|NCT00162942|10655300|P2|Overall Study|Physician Decision|0
3111159|NCT00162942|10655301|P1|Overall Study|Physician Decision|1
3111160|NCT00162942|10655300|P2|Overall Study|Withdrawal by Subject|6
3111161|NCT00162942|10655301|P1|Overall Study|Withdrawal by Subject|3
3111162|NCT00162942|10655300|P2|Overall Study|Death|0
3111163|NCT00162942|10655301|P1|Overall Study|Death|1
3111164|NCT00162942|10655300|P2|Overall Study|Adverse Event|6
3111165|NCT00162942|10655301|P1|Overall Study|Adverse Event|10
3111166|NCT00162773|10655349|P1|Overall Study|P.I, Left institution. Study terminated|22
3111167|NCT00162370|10655353|P1|Efficacy Population|Lost to Follow-up|51
3111168|NCT00162266|10655361|P4|Open-Label Period|Other Reasons|15
3111169|NCT00162266|10655362|P3|Open-Label Period|Other Reasons|0
3111170|NCT00162266|10655363|P2|Open-Label Period|Other Reasons|0
3111171|NCT00162266|10655364|P1|Open-Label Period|Other Reasons|0
3111172|NCT00162266|10655361|P4|Open-Label Period|Administrative Reason By Sponsor|9
3111173|NCT00162266|10655362|P3|Open-Label Period|Administrative Reason By Sponsor|0
3111174|NCT00162266|10655363|P2|Open-Label Period|Administrative Reason By Sponsor|0
3111175|NCT00162266|10655364|P1|Open-Label Period|Administrative Reason By Sponsor|0
3111176|NCT00162266|10655361|P4|Open-Label Period|Withdrawal by Subject|31
3111177|NCT00162266|10655362|P3|Open-Label Period|Withdrawal by Subject|0
3111178|NCT00162266|10655363|P2|Open-Label Period|Withdrawal by Subject|0
3111179|NCT00162266|10655364|P1|Open-Label Period|Withdrawal by Subject|0
3111180|NCT00162266|10655361|P4|Open-Label Period|Lost to Follow-up|3
3111181|NCT00162266|10655362|P3|Open-Label Period|Lost to Follow-up|0
3111182|NCT00162266|10655363|P2|Open-Label Period|Lost to Follow-up|0
3111183|NCT00162266|10655364|P1|Open-Label Period|Lost to Follow-up|0
3111184|NCT00162266|10655361|P4|Open-Label Period|Lack of Efficacy|26
3111185|NCT00162266|10655362|P3|Open-Label Period|Lack of Efficacy|0
3111186|NCT00162266|10655363|P2|Open-Label Period|Lack of Efficacy|0
3111187|NCT00162266|10655364|P1|Open-Label Period|Lack of Efficacy|0
3111188|NCT00162266|10655361|P4|Open-Label Period|Adverse Event|46
3111189|NCT00162266|10655362|P3|Open-Label Period|Adverse Event|0
3111190|NCT00162266|10655363|P2|Open-Label Period|Adverse Event|0
3111191|NCT00162266|10655364|P1|Open-Label Period|Adverse Event|0
3111192|NCT00162266|10655361|P4|Open-Label Period|Death|7
3111193|NCT00162266|10655362|P3|Open-Label Period|Death|0
3111194|NCT00162266|10655363|P2|Open-Label Period|Death|0
3111195|NCT00162266|10655364|P1|Open-Label Period|Death|0
3111196|NCT00162266|10655361|P4|Double-Blind Period|Withdrawal by Subject|0
3111197|NCT00162266|10655362|P3|Double-Blind Period|Withdrawal by Subject|6
3111198|NCT00162266|10655363|P2|Double-Blind Period|Withdrawal by Subject|2
3111199|NCT00162266|10655364|P1|Double-Blind Period|Withdrawal by Subject|5
3111200|NCT00162266|10655361|P4|Double-Blind Period|Lack of Efficacy|0
3111201|NCT00162266|10655362|P3|Double-Blind Period|Lack of Efficacy|30
3111202|NCT00162266|10655363|P2|Double-Blind Period|Lack of Efficacy|17
3111203|NCT00162266|10655364|P1|Double-Blind Period|Lack of Efficacy|13
3111204|NCT00162266|10655361|P4|Double-Blind Period|Other Reason|0
3111205|NCT00162266|10655362|P3|Double-Blind Period|Other Reason|1
3111206|NCT00162266|10655363|P2|Double-Blind Period|Other Reason|0
3111207|NCT00162266|10655364|P1|Double-Blind Period|Other Reason|1
3111208|NCT00162266|10655361|P4|Double-Blind Period|Lost to Follow-up|0
3111209|NCT00162266|10655362|P3|Double-Blind Period|Lost to Follow-up|0
3111210|NCT00162266|10655363|P2|Double-Blind Period|Lost to Follow-up|2
3111211|NCT00162266|10655364|P1|Double-Blind Period|Lost to Follow-up|1
3111212|NCT00162266|10655361|P4|Double-Blind Period|Death|0
3111213|NCT00162266|10655362|P3|Double-Blind Period|Death|0
3111214|NCT00162266|10655363|P2|Double-Blind Period|Death|1
3111215|NCT00162266|10655364|P1|Double-Blind Period|Death|0
3111216|NCT00162266|10655361|P4|Double-Blind Period|Adverse Event|0
3111217|NCT00162266|10655362|P3|Double-Blind Period|Adverse Event|11
3111218|NCT00162266|10655363|P2|Double-Blind Period|Adverse Event|9
3111219|NCT00162266|10655364|P1|Double-Blind Period|Adverse Event|5
3111220|NCT00162136|10655565|P1|Overall Study|Withdrawal by Subject|1
3111221|NCT00162136|10655565|P1|Overall Study|Study Drug Toxicity|4
3111222|NCT00162136|10655565|P1|Overall Study|Investigator Request|5
3111223|NCT00162136|10655565|P1|Overall Study|Disease Progression/Relapse|23
3111224|NCT00162136|10655565|P1|Overall Study|Death|1
3111225|NCT00162136|10655565|P1|Overall Study|Adverse Event|1
3111226|NCT00162123|10655597|P8|Overall Study|Follow-up only (not treated or assessed)|57
3111227|NCT00162123|10655598|P7|Overall Study|Follow-up only (not treated or assessed)|0
3111228|NCT00162123|10655599|P6|Overall Study|Follow-up only (not treated or assessed)|0
3111229|NCT00162123|10655600|P5|Overall Study|Follow-up only (not treated or assessed)|0
3111230|NCT00162123|10655601|P4|Overall Study|Follow-up only (not treated or assessed)|0
3111231|NCT00162123|10655602|P3|Overall Study|Follow-up only (not treated or assessed)|0
3111232|NCT00162123|10655603|P2|Overall Study|Follow-up only (not treated or assessed)|0
3111233|NCT00162123|10655604|P1|Overall Study|Follow-up only (not treated or assessed)|0
3111234|NCT00162123|10655597|P8|Overall Study|Tumor assessment only (not treated)|1
3111235|NCT00162123|10655598|P7|Overall Study|Tumor assessment only (not treated)|0
3111236|NCT00162123|10655599|P6|Overall Study|Tumor assessment only (not treated)|0
3111237|NCT00162123|10655600|P5|Overall Study|Tumor assessment only (not treated)|0
3111238|NCT00162123|10655601|P4|Overall Study|Tumor assessment only (not treated)|0
3111239|NCT00162123|10655602|P3|Overall Study|Tumor assessment only (not treated)|0
3111240|NCT00162123|10655603|P2|Overall Study|Tumor assessment only (not treated)|0
3111241|NCT00162123|10655604|P1|Overall Study|Tumor assessment only (not treated)|0
3111242|NCT00162123|10655597|P8|Overall Study|Physician Decision|0
3111243|NCT00162123|10655598|P7|Overall Study|Physician Decision|1
3111244|NCT00162123|10655599|P6|Overall Study|Physician Decision|1
3111245|NCT00162123|10655600|P5|Overall Study|Physician Decision|0
3111246|NCT00162123|10655601|P4|Overall Study|Physician Decision|0
3111247|NCT00162123|10655602|P3|Overall Study|Physician Decision|0
3111248|NCT00162123|10655603|P2|Overall Study|Physician Decision|2
3111249|NCT00162123|10655604|P1|Overall Study|Physician Decision|1
3111250|NCT00162123|10655597|P8|Overall Study|Not specified (after start of treatment)|0
3111251|NCT00162123|10655598|P7|Overall Study|Not specified (after start of treatment)|0
3111252|NCT00162123|10655599|P6|Overall Study|Not specified (after start of treatment)|0
3111253|NCT00162123|10655600|P5|Overall Study|Not specified (after start of treatment)|3
3111254|NCT00162123|10655601|P4|Overall Study|Not specified (after start of treatment)|0
3111255|NCT00162123|10655602|P3|Overall Study|Not specified (after start of treatment)|0
3111256|NCT00162123|10655603|P2|Overall Study|Not specified (after start of treatment)|0
3111257|NCT00162123|10655604|P1|Overall Study|Not specified (after start of treatment)|0
3111258|NCT00162123|10655597|P8|Overall Study|Not specified (before treatment)|0
3111259|NCT00162123|10655598|P7|Overall Study|Not specified (before treatment)|0
3111260|NCT00162123|10655599|P6|Overall Study|Not specified (before treatment)|1
3111261|NCT00162123|10655600|P5|Overall Study|Not specified (before treatment)|12
3111262|NCT00162123|10655601|P4|Overall Study|Not specified (before treatment)|0
3111263|NCT00162123|10655602|P3|Overall Study|Not specified (before treatment)|0
3111264|NCT00162123|10655603|P2|Overall Study|Not specified (before treatment)|0
3111265|NCT00162123|10655604|P1|Overall Study|Not specified (before treatment)|2
3111266|NCT00162123|10655597|P8|Overall Study|Adverse Event|0
3111267|NCT00162123|10655598|P7|Overall Study|Adverse Event|0
3111268|NCT00162123|10655599|P6|Overall Study|Adverse Event|0
3111269|NCT00162123|10655600|P5|Overall Study|Adverse Event|1
3111270|NCT00162123|10655601|P4|Overall Study|Adverse Event|2
3111271|NCT00162123|10655602|P3|Overall Study|Adverse Event|0
3111272|NCT00162123|10655603|P2|Overall Study|Adverse Event|2
3111273|NCT00162123|10655604|P1|Overall Study|Adverse Event|1
3111274|NCT00162123|10655597|P8|Overall Study|Deterioration without progression|0
3111275|NCT00162123|10655598|P7|Overall Study|Deterioration without progression|0
3111276|NCT00162123|10655599|P6|Overall Study|Deterioration without progression|0
3111277|NCT00162123|10655600|P5|Overall Study|Deterioration without progression|1
3111278|NCT00162123|10655601|P4|Overall Study|Deterioration without progression|0
3111279|NCT00162123|10655602|P3|Overall Study|Deterioration without progression|3
3111280|NCT00162123|10655603|P2|Overall Study|Deterioration without progression|2
3111281|NCT00162123|10655604|P1|Overall Study|Deterioration without progression|2
3111282|NCT00162123|10655597|P8|Overall Study|Withdrawal by Subject|0
3111283|NCT00162123|10655598|P7|Overall Study|Withdrawal by Subject|1
3111284|NCT00162123|10655599|P6|Overall Study|Withdrawal by Subject|2
3111285|NCT00162123|10655600|P5|Overall Study|Withdrawal by Subject|1
3111286|NCT00162123|10655601|P4|Overall Study|Withdrawal by Subject|1
3111287|NCT00162123|10655602|P3|Overall Study|Withdrawal by Subject|2
3111288|NCT00162123|10655603|P2|Overall Study|Withdrawal by Subject|0
3111289|NCT00162123|10655604|P1|Overall Study|Withdrawal by Subject|2
3111290|NCT00162123|10655597|P8|Overall Study|Death|0
3111291|NCT00162123|10655598|P7|Overall Study|Death|0
3111292|NCT00162123|10655599|P6|Overall Study|Death|1
3111293|NCT00162123|10655600|P5|Overall Study|Death|1
3111294|NCT00162123|10655601|P4|Overall Study|Death|1
3111295|NCT00162123|10655602|P3|Overall Study|Death|1
3111296|NCT00162123|10655603|P2|Overall Study|Death|3
3111297|NCT00162123|10655604|P1|Overall Study|Death|3
3111298|NCT00162123|10655597|P8|Overall Study|Study drug toxicity|0
3111299|NCT00162123|10655598|P7|Overall Study|Study drug toxicity|1
3111300|NCT00162123|10655599|P6|Overall Study|Study drug toxicity|1
3111301|NCT00162123|10655600|P5|Overall Study|Study drug toxicity|4
3111302|NCT00162123|10655601|P4|Overall Study|Study drug toxicity|0
3111303|NCT00162123|10655602|P3|Overall Study|Study drug toxicity|5
3111304|NCT00162123|10655603|P2|Overall Study|Study drug toxicity|1
3111305|NCT00162123|10655604|P1|Overall Study|Study drug toxicity|6
3111306|NCT00162123|10655597|P8|Overall Study|Disease progression|0
3111307|NCT00162123|10655598|P7|Overall Study|Disease progression|1
3111308|NCT00162123|10655599|P6|Overall Study|Disease progression|3
3111309|NCT00162123|10655600|P5|Overall Study|Disease progression|8
3111310|NCT00162123|10655601|P4|Overall Study|Disease progression|4
3111311|NCT00162123|10655602|P3|Overall Study|Disease progression|10
3111312|NCT00162123|10655603|P2|Overall Study|Disease progression|19
3111313|NCT00162123|10655604|P1|Overall Study|Disease progression|27
3111314|NCT00162097|10655637|P4|Overall Study|Participant no longer met study criteria|1
3111315|NCT00162097|10655638|P3|Overall Study|Participant no longer met study criteria|0
3111316|NCT00162097|10655639|P2|Overall Study|Participant no longer met study criteria|0
3111317|NCT00162097|10655640|P1|Overall Study|Participant no longer met study criteria|0
3111318|NCT00162032|10655702|P2|Overall Study|Reason not specified|0
3111319|NCT00162032|10655703|P1|Overall Study|Reason not specified|1
3111320|NCT00162032|10655702|P2|Overall Study|Lost to Follow-up|2
3111321|NCT00162032|10655703|P1|Overall Study|Lost to Follow-up|4
3111322|NCT00161616|10655724|P2|Overall Study|Protocol deviation|0
3111323|NCT00161616|10655725|P1|Overall Study|Protocol deviation|1
3111324|NCT00161616|10655724|P2|Overall Study|Lost to Follow-up|13
3111325|NCT00161616|10655725|P1|Overall Study|Lost to Follow-up|17
3111326|NCT00161616|10655724|P2|Overall Study|Death|1
3111327|NCT00161616|10655725|P1|Overall Study|Death|1
3111328|NCT00161616|10655724|P2|Overall Study|Physician Decision|0
3111329|NCT00161616|10655725|P1|Overall Study|Physician Decision|1
3111330|NCT00161616|10655724|P2|Overall Study|Withdrawal by Subject|5
3111331|NCT00161616|10655725|P1|Overall Study|Withdrawal by Subject|6
3111332|NCT00161213|10655757|P1|Overall Study|Evaluable for toxicity but not response|1
3111333|NCT00161213|10655757|P1|Overall Study|Withdrawal by Subject|1
3111334|NCT00160706|10655764|P1|Overall Study|Other Reason|11
3111335|NCT00160706|10655764|P1|Overall Study|Lack of Efficacy and Other|1
3111336|NCT00160706|10655764|P1|Overall Study|Lack of Efficacy|42
3111337|NCT00160706|10655764|P1|Overall Study|Lost to Follow-up and Other|1
3111338|NCT00160706|10655764|P1|Overall Study|Lost to Follow-up|4
3111339|NCT00160706|10655764|P1|Overall Study|Physician Decision and Other|3
3111340|NCT00160706|10655764|P1|Overall Study|Physician Decision|10
3111341|NCT00160706|10655764|P1|Overall Study|Withdrawal by Subject and Other|12
3111342|NCT00160706|10655764|P1|Overall Study|Withdrawal by Subject|41
3111343|NCT00160706|10655764|P1|Overall Study|Protocol Violation|3
3111344|NCT00160706|10655764|P1|Overall Study|Adverse Event and Other Reason|105
3111345|NCT00160706|10655764|P1|Overall Study|Adverse Event|53
3111346|NCT00160693|10655776|P1|Overall Study|Study terminated by sponsor|15
3111347|NCT00160693|10655776|P1|Overall Study|Withdrawal by Subject|54
3111348|NCT00160693|10655776|P1|Overall Study|Lost to Follow-up|15
3111349|NCT00160693|10655776|P1|Overall Study|Protocol Violation|24
3111350|NCT00160693|10655776|P1|Overall Study|Lack of Efficacy|30
3111351|NCT00160693|10655776|P1|Overall Study|Adverse Event|97
3111352|NCT00160680|10655795|P2|Overall Study|Withdrawal by Subject|9
3111353|NCT00160680|10655796|P1|Overall Study|Withdrawal by Subject|4
3111354|NCT00160680|10655795|P2|Overall Study|Lost to Follow-up|2
3111355|NCT00160680|10655796|P1|Overall Study|Lost to Follow-up|3
3111356|NCT00160680|10655795|P2|Overall Study|Lack of Efficacy|1
3111357|NCT00160680|10655796|P1|Overall Study|Lack of Efficacy|2
3111358|NCT00160680|10655795|P2|Overall Study|Adverse Event|1
3111359|NCT00160680|10655796|P1|Overall Study|Adverse Event|0
3111360|NCT00160667|10655831|P3|Overall Study|Patient decision|1
3111361|NCT00160667|10655832|P2|Overall Study|Patient decision|0
3111362|NCT00160667|10655833|P1|Overall Study|Patient decision|0
3111363|NCT00160667|10655831|P3|Overall Study|Protocol Violation|0
3111364|NCT00160667|10655832|P2|Overall Study|Protocol Violation|1
3111365|NCT00160667|10655833|P1|Overall Study|Protocol Violation|0
3111366|NCT00160667|10655831|P3|Overall Study|Lack of Efficacy|0
3111367|NCT00160667|10655832|P2|Overall Study|Lack of Efficacy|1
3111368|NCT00160667|10655833|P1|Overall Study|Lack of Efficacy|0
3111369|NCT00160667|10655831|P3|Overall Study|Withdrawal by Subject|1
3111370|NCT00160667|10655832|P2|Overall Study|Withdrawal by Subject|0
3111371|NCT00160667|10655833|P1|Overall Study|Withdrawal by Subject|2
3111372|NCT00160667|10655831|P3|Overall Study|Adverse Event|4
3111373|NCT00160667|10655832|P2|Overall Study|Adverse Event|1
3111374|NCT00160667|10655833|P1|Overall Study|Adverse Event|3
3111375|NCT00160641|10655880|P1|Overall Study|Other|9
3111376|NCT00160641|10655880|P1|Overall Study|Protocol Violation|3
3111377|NCT00160641|10655880|P1|Overall Study|Lack of Efficacy|12
3111378|NCT00160641|10655880|P1|Overall Study|Lost to Follow-up|8
3111379|NCT00160641|10655880|P1|Overall Study|Withdrawal by Subject|87
3111380|NCT00160641|10655880|P1|Overall Study|Adverse Event|102
3111381|NCT00160615|10655913|P2|Overall Study|Poor compliance|1
3111382|NCT00160615|10655914|P1|Overall Study|Poor compliance|0
3111383|NCT00160615|10655913|P2|Overall Study|Non-compliance was suspected|1
3111384|NCT00160615|10655914|P1|Overall Study|Non-compliance was suspected|0
3111385|NCT00160615|10655913|P2|Overall Study|Switch to surgical treatment|2
3111386|NCT00160615|10655914|P1|Overall Study|Switch to surgical treatment|0
3111387|NCT00160615|10655913|P2|Overall Study|AE agents had to be discontinued (exam.)|1
3111388|NCT00160615|10655914|P1|Overall Study|AE agents had to be discontinued (exam.)|0
3111389|NCT00160615|10655913|P2|Overall Study|Investigator decision|1
3111390|NCT00160615|10655914|P1|Overall Study|Investigator decision|1
3111391|NCT00160615|10655913|P2|Overall Study|Patient decision|2
3111392|NCT00160615|10655914|P1|Overall Study|Patient decision|1
3111393|NCT00160615|10655913|P2|Overall Study|Lack of Efficacy|23
3111394|NCT00160615|10655914|P1|Overall Study|Lack of Efficacy|11
3111395|NCT00160615|10655913|P2|Overall Study|Withdrawal by Subject|2
3111396|NCT00160615|10655914|P1|Overall Study|Withdrawal by Subject|0
3111397|NCT00160615|10655913|P2|Overall Study|Adverse Event|12
3111398|NCT00160615|10655914|P1|Overall Study|Adverse Event|5
3111399|NCT00160563|10655937|P3|Overall Study|Missing reason|0
3111400|NCT00160563|10655938|P2|Overall Study|Missing reason|1
3111401|NCT00160563|10655939|P1|Overall Study|Missing reason|0
3111402|NCT00160563|10655937|P3|Overall Study|Other (listed in the study report)|81
3111403|NCT00160563|10655938|P2|Overall Study|Other (listed in the study report)|40
3111404|NCT00160563|10655939|P1|Overall Study|Other (listed in the study report)|48
3111405|NCT00160563|10655937|P3|Overall Study|Withdrawal by Subject|3
3111406|NCT00160563|10655938|P2|Overall Study|Withdrawal by Subject|2
3111407|NCT00160563|10655939|P1|Overall Study|Withdrawal by Subject|1
3111408|NCT00160563|10655937|P3|Overall Study|Protocol Violation|3
3111409|NCT00160563|10655938|P2|Overall Study|Protocol Violation|0
3111410|NCT00160563|10655939|P1|Overall Study|Protocol Violation|0
3111411|NCT00160563|10655937|P3|Overall Study|Lost to Follow-up|2
3111412|NCT00160563|10655938|P2|Overall Study|Lost to Follow-up|1
3111413|NCT00160563|10655939|P1|Overall Study|Lost to Follow-up|1
3111414|NCT00160563|10655937|P3|Overall Study|Adverse Event|1
3111415|NCT00160563|10655938|P2|Overall Study|Adverse Event|1
3111416|NCT00160563|10655939|P1|Overall Study|Adverse Event|1
3111417|NCT00160524|10655951|P1|Overall Study|Other|20
3111418|NCT00160524|10655951|P1|Overall Study|Lack of Efficacy and Other|1
3111419|NCT00160524|10655951|P1|Overall Study|Lack of Efficacy|21
3111420|NCT00160524|10655951|P1|Overall Study|Lost to Follow-up and Other|1
3111421|NCT00160524|10655951|P1|Overall Study|Lost to Follow-up|13
3111422|NCT00160524|10655951|P1|Overall Study|Physician Decision and Other|6
3111423|NCT00160524|10655951|P1|Overall Study|Physician Decision|27
3111424|NCT00160524|10655951|P1|Overall Study|Withdrawal by Subject and Other|17
3111425|NCT00160524|10655951|P1|Overall Study|Withdrawal by Subject|141
3111426|NCT00160524|10655951|P1|Overall Study|Protocol Violation and Other|2
3111427|NCT00160524|10655951|P1|Overall Study|Protocol Violation|16
3111428|NCT00160524|10655951|P1|Overall Study|Adverse Event and Other|94
3111429|NCT00160524|10655951|P1|Overall Study|Adverse Event|119
3111430|NCT00160251|10655968|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
3111431|NCT00160251|10655969|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111432|NCT00160251|10655970|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111433|NCT00160251|10655971|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111434|NCT00160251|10655972|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111435|NCT00160251|10655973|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111436|NCT00160251|10655974|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111437|NCT00160251|10655975|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
3111438|NCT00160251|10655968|P8|Post-amendment 2|Lack of Efficacy|24
3111439|NCT00160251|10655969|P7|Post-amendment 2|Lack of Efficacy|0
3111440|NCT00160251|10655970|P6|Post-amendment 2|Lack of Efficacy|0
3111441|NCT00160251|10655971|P5|Post-amendment 2|Lack of Efficacy|0
3111442|NCT00160251|10655972|P4|Post-amendment 2|Lack of Efficacy|0
3111443|NCT00160251|10655973|P3|Post-amendment 2|Lack of Efficacy|0
3111444|NCT00160251|10655974|P2|Post-amendment 2|Lack of Efficacy|0
3111445|NCT00160251|10655975|P1|Post-amendment 2|Lack of Efficacy|0
3111446|NCT00160251|10655968|P8|Post-amendment 2|Adverse Event|20
3111447|NCT00160251|10655969|P7|Post-amendment 2|Adverse Event|0
3111448|NCT00160251|10655970|P6|Post-amendment 2|Adverse Event|0
3111449|NCT00160251|10655971|P5|Post-amendment 2|Adverse Event|0
3111450|NCT00160251|10655972|P4|Post-amendment 2|Adverse Event|0
3111451|NCT00160251|10655973|P3|Post-amendment 2|Adverse Event|0
3111452|NCT00160251|10655974|P2|Post-amendment 2|Adverse Event|0
3111453|NCT00160251|10655975|P1|Post-amendment 2|Adverse Event|0
3111454|NCT00160251|10655968|P8|Prior to Amendment 2|Completed Treatment Phase|0
3111455|NCT00160251|10655969|P7|Prior to Amendment 2|Completed Treatment Phase|0
3111456|NCT00160251|10655970|P6|Prior to Amendment 2|Completed Treatment Phase|23
3111457|NCT00160251|10655971|P5|Prior to Amendment 2|Completed Treatment Phase|0
3111458|NCT00160251|10655972|P4|Prior to Amendment 2|Completed Treatment Phase|0
3111459|NCT00160251|10655973|P3|Prior to Amendment 2|Completed Treatment Phase|0
3111460|NCT00160251|10655974|P2|Prior to Amendment 2|Completed Treatment Phase|0
3111461|NCT00160251|10655975|P1|Prior to Amendment 2|Completed Treatment Phase|3
3111462|NCT00160251|10655968|P8|Prior to Amendment 2|Noncompliance with protocol|0
3111463|NCT00160251|10655969|P7|Prior to Amendment 2|Noncompliance with protocol|0
3111464|NCT00160251|10655970|P6|Prior to Amendment 2|Noncompliance with protocol|0
3111465|NCT00160251|10655971|P5|Prior to Amendment 2|Noncompliance with protocol|0
3111466|NCT00160251|10655972|P4|Prior to Amendment 2|Noncompliance with protocol|0
3111467|NCT00160251|10655973|P3|Prior to Amendment 2|Noncompliance with protocol|0
3111468|NCT00160251|10655974|P2|Prior to Amendment 2|Noncompliance with protocol|0
3111469|NCT00160251|10655975|P1|Prior to Amendment 2|Noncompliance with protocol|1
3111470|NCT00160251|10655968|P8|Prior to Amendment 2|Withdrawal by Subject|0
3111471|NCT00160251|10655969|P7|Prior to Amendment 2|Withdrawal by Subject|3
3111472|NCT00160251|10655970|P6|Prior to Amendment 2|Withdrawal by Subject|3
3111473|NCT00160251|10655971|P5|Prior to Amendment 2|Withdrawal by Subject|2
3111474|NCT00160251|10655972|P4|Prior to Amendment 2|Withdrawal by Subject|4
3111475|NCT00160251|10655973|P3|Prior to Amendment 2|Withdrawal by Subject|3
3111476|NCT00160251|10655974|P2|Prior to Amendment 2|Withdrawal by Subject|1
3111477|NCT00160251|10655975|P1|Prior to Amendment 2|Withdrawal by Subject|3
3111478|NCT00160251|10655968|P8|Prior to Amendment 2|Lost to Follow-up|0
3111479|NCT00160251|10655969|P7|Prior to Amendment 2|Lost to Follow-up|0
3111480|NCT00160251|10655970|P6|Prior to Amendment 2|Lost to Follow-up|1
3111481|NCT00160251|10655971|P5|Prior to Amendment 2|Lost to Follow-up|1
3111482|NCT00160251|10655972|P4|Prior to Amendment 2|Lost to Follow-up|0
3111483|NCT00160251|10655973|P3|Prior to Amendment 2|Lost to Follow-up|1
3111484|NCT00160251|10655974|P2|Prior to Amendment 2|Lost to Follow-up|0
3111485|NCT00160251|10655975|P1|Prior to Amendment 2|Lost to Follow-up|0
3111486|NCT00160251|10655968|P8|Prior to Amendment 2|Lack of Efficacy|0
3111487|NCT00160251|10655969|P7|Prior to Amendment 2|Lack of Efficacy|0
3111488|NCT00160251|10655970|P6|Prior to Amendment 2|Lack of Efficacy|55
3111489|NCT00160251|10655971|P5|Prior to Amendment 2|Lack of Efficacy|24
3111490|NCT00160251|10655972|P4|Prior to Amendment 2|Lack of Efficacy|35
3111491|NCT00160251|10655973|P3|Prior to Amendment 2|Lack of Efficacy|37
3111492|NCT00160251|10655974|P2|Prior to Amendment 2|Lack of Efficacy|4
3111493|NCT00160251|10655975|P1|Prior to Amendment 2|Lack of Efficacy|0
3111494|NCT00160251|10655968|P8|Prior to Amendment 2|Adverse Event|0
3111495|NCT00160251|10655969|P7|Prior to Amendment 2|Adverse Event|1
3111496|NCT00160251|10655970|P6|Prior to Amendment 2|Adverse Event|1
3111497|NCT00160251|10655971|P5|Prior to Amendment 2|Adverse Event|1
3111498|NCT00160251|10655972|P4|Prior to Amendment 2|Adverse Event|1
3111499|NCT00160251|10655973|P3|Prior to Amendment 2|Adverse Event|3
3111500|NCT00160251|10655974|P2|Prior to Amendment 2|Adverse Event|1
3111501|NCT00160251|10655975|P1|Prior to Amendment 2|Adverse Event|2
3111502|NCT00160199|10656051|P2|Overall Study|Protocol Violation|8
3111503|NCT00160199|10656052|P1|Overall Study|Protocol Violation|8
3111504|NCT00160199|10656051|P2|Overall Study|Administrative|1
3111505|NCT00160199|10656052|P1|Overall Study|Administrative|0
3111506|NCT00160199|10656051|P2|Overall Study|Withdrawal by Subject|6
3111507|NCT00160199|10656052|P1|Overall Study|Withdrawal by Subject|4
3111508|NCT00160199|10656051|P2|Overall Study|Lost to Follow-up|7
3111509|NCT00160199|10656052|P1|Overall Study|Lost to Follow-up|7
3111510|NCT00160199|10656051|P2|Overall Study|Lack of Efficacy|1
3111511|NCT00160199|10656052|P1|Overall Study|Lack of Efficacy|0
3111512|NCT00160199|10656051|P2|Overall Study|Adverse Event|14
3111513|NCT00160199|10656052|P1|Overall Study|Adverse Event|5
3111514|NCT00159913|10656109|P4|Overall Study|Protocol Violation|0
3111515|NCT00159913|10656110|P3|Overall Study|Protocol Violation|1
3111516|NCT00159913|10656111|P2|Overall Study|Protocol Violation|0
3111517|NCT00159913|10656112|P1|Overall Study|Protocol Violation|1
3111518|NCT00159913|10656109|P4|Overall Study|Lost to Follow-up|1
3111519|NCT00159913|10656110|P3|Overall Study|Lost to Follow-up|0
3111520|NCT00159913|10656111|P2|Overall Study|Lost to Follow-up|0
3111521|NCT00159913|10656112|P1|Overall Study|Lost to Follow-up|0
3111522|NCT00159913|10656109|P4|Overall Study|Withdrawal by Subject|1
3111523|NCT00159913|10656110|P3|Overall Study|Withdrawal by Subject|0
3111524|NCT00159913|10656111|P2|Overall Study|Withdrawal by Subject|0
3111525|NCT00159913|10656112|P1|Overall Study|Withdrawal by Subject|0
3111526|NCT00159913|10656109|P4|Overall Study|Adverse Event|0
3111527|NCT00159913|10656110|P3|Overall Study|Adverse Event|1
3111528|NCT00159913|10656111|P2|Overall Study|Adverse Event|0
3111529|NCT00159913|10656112|P1|Overall Study|Adverse Event|1
3111530|NCT00159874|10656186|P7|Overall Study|Pregnancy|0
3111531|NCT00159874|10656187|P6|Overall Study|Pregnancy|0
3111532|NCT00159874|10656188|P5|Overall Study|Pregnancy|0
3111533|NCT00159874|10656189|P4|Overall Study|Pregnancy|0
3111534|NCT00159874|10656190|P3|Overall Study|Pregnancy|0
3111535|NCT00159874|10656191|P2|Overall Study|Pregnancy|1
3111536|NCT00159874|10656192|P1|Overall Study|Pregnancy|1
3111537|NCT00159874|10656186|P7|Overall Study|Withdrawal by Subject|1
3111538|NCT00159874|10656187|P6|Overall Study|Withdrawal by Subject|2
3111539|NCT00159874|10656188|P5|Overall Study|Withdrawal by Subject|3
3111540|NCT00159874|10656189|P4|Overall Study|Withdrawal by Subject|4
3111541|NCT00159874|10656190|P3|Overall Study|Withdrawal by Subject|8
3111542|NCT00159874|10656191|P2|Overall Study|Withdrawal by Subject|6
3111543|NCT00159874|10656192|P1|Overall Study|Withdrawal by Subject|2
3111544|NCT00159874|10656186|P7|Overall Study|Death|0
3111545|NCT00159874|10656187|P6|Overall Study|Death|2
3111546|NCT00159874|10656188|P5|Overall Study|Death|1
3111547|NCT00159874|10656189|P4|Overall Study|Death|0
3111548|NCT00159874|10656190|P3|Overall Study|Death|15
3111549|NCT00159874|10656191|P2|Overall Study|Death|8
3111550|NCT00159874|10656192|P1|Overall Study|Death|3
3111551|NCT00159874|10656186|P7|Overall Study|Protocol Violation|0
3111552|NCT00159874|10656187|P6|Overall Study|Protocol Violation|0
3111553|NCT00159874|10656188|P5|Overall Study|Protocol Violation|0
3111554|NCT00159874|10656189|P4|Overall Study|Protocol Violation|0
3111555|NCT00159874|10656190|P3|Overall Study|Protocol Violation|2
3111556|NCT00159874|10656191|P2|Overall Study|Protocol Violation|5
3111557|NCT00159874|10656192|P1|Overall Study|Protocol Violation|0
3111558|NCT00159874|10656186|P7|Overall Study|Other|3
3111559|NCT00159874|10656187|P6|Overall Study|Other|1
3111560|NCT00159874|10656188|P5|Overall Study|Other|2
3111561|NCT00159874|10656189|P4|Overall Study|Other|0
3111562|NCT00159874|10656190|P3|Overall Study|Other|8
3111563|NCT00159874|10656191|P2|Overall Study|Other|8
3111564|NCT00159874|10656192|P1|Overall Study|Other|8
3111565|NCT00159874|10656186|P7|Overall Study|Lost to Follow-up|1
3111566|NCT00159874|10656187|P6|Overall Study|Lost to Follow-up|2
3111567|NCT00159874|10656188|P5|Overall Study|Lost to Follow-up|1
3111568|NCT00159874|10656189|P4|Overall Study|Lost to Follow-up|0
3111569|NCT00159874|10656190|P3|Overall Study|Lost to Follow-up|3
3111570|NCT00159874|10656191|P2|Overall Study|Lost to Follow-up|0
3111571|NCT00159874|10656192|P1|Overall Study|Lost to Follow-up|1
3111572|NCT00159874|10656186|P7|Overall Study|Lack of Efficacy|0
3111573|NCT00159874|10656187|P6|Overall Study|Lack of Efficacy|3
3111574|NCT00159874|10656188|P5|Overall Study|Lack of Efficacy|0
3111575|NCT00159874|10656189|P4|Overall Study|Lack of Efficacy|1
3111576|NCT00159874|10656190|P3|Overall Study|Lack of Efficacy|1
3111577|NCT00159874|10656191|P2|Overall Study|Lack of Efficacy|0
3111578|NCT00159874|10656192|P1|Overall Study|Lack of Efficacy|2
3111579|NCT00159874|10656186|P7|Overall Study|Does Not Meet Entrance Criteria|0
3111580|NCT00159874|10656187|P6|Overall Study|Does Not Meet Entrance Criteria|0
3111581|NCT00159874|10656188|P5|Overall Study|Does Not Meet Entrance Criteria|0
3111582|NCT00159874|10656189|P4|Overall Study|Does Not Meet Entrance Criteria|0
3111583|NCT00159874|10656190|P3|Overall Study|Does Not Meet Entrance Criteria|1
3111584|NCT00159874|10656191|P2|Overall Study|Does Not Meet Entrance Criteria|0
3111585|NCT00159874|10656192|P1|Overall Study|Does Not Meet Entrance Criteria|1
3111586|NCT00159874|10656186|P7|Overall Study|Adverse Event|0
3111587|NCT00159874|10656187|P6|Overall Study|Adverse Event|2
3111588|NCT00159874|10656188|P5|Overall Study|Adverse Event|1
3111589|NCT00159874|10656189|P4|Overall Study|Adverse Event|1
3111590|NCT00159874|10656190|P3|Overall Study|Adverse Event|5
3111591|NCT00159874|10656191|P2|Overall Study|Adverse Event|2
3111592|NCT00159874|10656192|P1|Overall Study|Adverse Event|2
3111593|NCT00159861|10656362|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
3111594|NCT00159861|10656363|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
3111595|NCT00159861|10656362|P2|Extension Study - up to 3 Years|Reason Unspecified|19
3111596|NCT00159861|10656363|P1|Extension Study - up to 3 Years|Reason Unspecified|12
3111597|NCT00159861|10656362|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
3111598|NCT00159861|10656363|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
3111599|NCT00159861|10656362|P2|Extension Study - up to 3 Years|Adverse Event|14
3111600|NCT00159861|10656363|P1|Extension Study - up to 3 Years|Adverse Event|14
3111601|NCT00159861|10656362|P2|Extension Study - up to 3 Years|Death|28
3111602|NCT00159861|10656363|P1|Extension Study - up to 3 Years|Death|24
3111603|NCT00159861|10656362|P2|Core Study - 16 Weeks|Randomized but not Treated|0
3111604|NCT00159861|10656363|P1|Core Study - 16 Weeks|Randomized but not Treated|2
3111605|NCT00159861|10656362|P2|Core Study - 16 Weeks|Subject Defaulted|0
3111606|NCT00159861|10656363|P1|Core Study - 16 Weeks|Subject Defaulted|1
3111607|NCT00159861|10656362|P2|Core Study - 16 Weeks|Reason Unspecified|3
3111608|NCT00159861|10656363|P1|Core Study - 16 Weeks|Reason Unspecified|5
3111609|NCT00159861|10656362|P2|Core Study - 16 Weeks|Lack of Efficacy|3
3111610|NCT00159861|10656363|P1|Core Study - 16 Weeks|Lack of Efficacy|2
3111611|NCT00159861|10656362|P2|Core Study - 16 Weeks|Adverse Event|6
3111612|NCT00159861|10656363|P1|Core Study - 16 Weeks|Adverse Event|12
3111613|NCT00159861|10656362|P2|Core Study - 16 Weeks|Death|0
3111614|NCT00159861|10656363|P1|Core Study - 16 Weeks|Death|3
3111615|NCT00159822|10656384|P1|Post-treatment Follow-up Period|Reason unspecified|1
3111616|NCT00159822|10656384|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
3111617|NCT00159822|10656384|P1|Post-treatment Follow-up Period|Death|1
3111618|NCT00159822|10656384|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
3111619|NCT00159822|10656384|P1|Voriconazole Treatment Period|Lost to Follow-up|2
3111620|NCT00159822|10656384|P1|Voriconazole Treatment Period|Protocol Violation|2
3111621|NCT00159822|10656384|P1|Voriconazole Treatment Period|Death|4
3111622|NCT00159822|10656384|P1|Voriconazole Treatment Period|Adverse Event|9
3111623|NCT00159822|10656384|P1|Voriconazole Treatment Period|Lack of Efficacy|3
3111624|NCT00159783|10656402|P3|Overall Study|Other|4
3111625|NCT00159783|10656403|P2|Overall Study|Other|2
3111626|NCT00159783|10656404|P1|Overall Study|Other|0
3111627|NCT00159783|10656402|P3|Overall Study|Lost to Follow-up|11
3111628|NCT00159783|10656403|P2|Overall Study|Lost to Follow-up|5
3111629|NCT00159783|10656404|P1|Overall Study|Lost to Follow-up|6
3111630|NCT00159783|10656402|P3|Overall Study|Withdrawal by Subject|12
3111631|NCT00159783|10656403|P2|Overall Study|Withdrawal by Subject|11
3111632|NCT00159783|10656404|P1|Overall Study|Withdrawal by Subject|7
3111633|NCT00159783|10656402|P3|Overall Study|Lack of Efficacy|3
3111634|NCT00159783|10656403|P2|Overall Study|Lack of Efficacy|2
3111635|NCT00159783|10656404|P1|Overall Study|Lack of Efficacy|1
3111636|NCT00159783|10656402|P3|Overall Study|Adverse Event|9
3111637|NCT00159783|10656403|P2|Overall Study|Adverse Event|7
3111638|NCT00159783|10656404|P1|Overall Study|Adverse Event|5
3111639|NCT00159432|10656434|P1|Overall Study|Lack of Efficacy|8
3111640|NCT00159432|10656434|P1|Overall Study|Death|1
3111641|NCT00159432|10656434|P1|Overall Study|Adverse Event|1
3111642|NCT00158860|10656508|P2|Overall Study|Closed per sponsor|1
3111643|NCT00158860|10656509|P1|Overall Study|Closed per sponsor|0
3111644|NCT00158860|10656508|P2|Overall Study|Lost to Follow up but returned per GSK|1
3111645|NCT00158860|10656509|P1|Overall Study|Lost to Follow up but returned per GSK|0
3111646|NCT00158860|10656508|P2|Overall Study|SPONSOR REQUEST|1
3111647|NCT00158860|10656509|P1|Overall Study|SPONSOR REQUEST|0
3111648|NCT00158860|10656508|P2|Overall Study|SPONSOR STOPPED STUDY|2
3111649|NCT00158860|10656509|P1|Overall Study|SPONSOR STOPPED STUDY|2
3111650|NCT00158860|10656508|P2|Overall Study|Pregnancy|3
3111651|NCT00158860|10656509|P1|Overall Study|Pregnancy|3
3111652|NCT00158860|10656508|P2|Overall Study|MOVING OUT OF STATE|0
3111653|NCT00158860|10656509|P1|Overall Study|MOVING OUT OF STATE|1
3111654|NCT00158860|10656508|P2|Overall Study|Withdrawal by Subject|17
3111655|NCT00158860|10656509|P1|Overall Study|Withdrawal by Subject|7
3111656|NCT00158860|10656508|P2|Overall Study|Protocol Violation|23
3111657|NCT00158860|10656509|P1|Overall Study|Protocol Violation|8
3111658|NCT00158860|10656508|P2|Overall Study|Lost to Follow-up|17
3111659|NCT00158860|10656509|P1|Overall Study|Lost to Follow-up|11
3111660|NCT00158860|10656508|P2|Overall Study|Adverse Event|6
3111661|NCT00158860|10656509|P1|Overall Study|Adverse Event|3
3111662|NCT00158756|10656528|P5|Overall Study|Serious adverse event|0
3111663|NCT00158756|10656529|P4|Overall Study|Serious adverse event|0
3111664|NCT00158756|10656530|P3|Overall Study|Serious adverse event|1
3111665|NCT00158756|10656531|P2|Overall Study|Serious adverse event|0
3111666|NCT00158756|10656532|P1|Overall Study|Serious adverse event|0
3111667|NCT00158756|10656528|P5|Overall Study|Adverse Event|0
3111668|NCT00158756|10656529|P4|Overall Study|Adverse Event|0
3111669|NCT00158756|10656530|P3|Overall Study|Adverse Event|1
3111670|NCT00158756|10656531|P2|Overall Study|Adverse Event|0
3111671|NCT00158756|10656532|P1|Overall Study|Adverse Event|0
3111672|NCT00158756|10656528|P5|Overall Study|Withdrawal by Subject|3
3111673|NCT00158756|10656529|P4|Overall Study|Withdrawal by Subject|1
3111674|NCT00158756|10656530|P3|Overall Study|Withdrawal by Subject|6
3111675|NCT00158756|10656531|P2|Overall Study|Withdrawal by Subject|0
3111676|NCT00158756|10656532|P1|Overall Study|Withdrawal by Subject|5
3111677|NCT00158600|10656638|P2|Overall Study|Withdrawal by Subject|2
3111678|NCT00158600|10656639|P1|Overall Study|Withdrawal by Subject|2
3111679|NCT00158600|10656638|P2|Overall Study|Death|0
3111680|NCT00158600|10656639|P1|Overall Study|Death|1
3111681|NCT00158600|10656638|P2|Overall Study|Adverse Event|1
3111682|NCT00158600|10656639|P1|Overall Study|Adverse Event|2
3111683|NCT00158600|10656638|P2|Overall Study|unable to commit time to study|1
3111684|NCT00158600|10656639|P1|Overall Study|unable to commit time to study|0
3111685|NCT00158262|10656664|P2|Overall Study|Lost to Follow-up|1
3111686|NCT00158262|10656665|P1|Overall Study|Lost to Follow-up|1
3111687|NCT00158184|10656726|P2|Overall Study|Adverse Event|1
3111688|NCT00158184|10656727|P1|Overall Study|Adverse Event|1
3111689|NCT00158184|10656726|P2|Overall Study|failed for follow unit/study rules|0
3111690|NCT00158184|10656727|P1|Overall Study|failed for follow unit/study rules|2
3111691|NCT00158184|10656726|P2|Overall Study|personal issues|1
3111692|NCT00158184|10656727|P1|Overall Study|personal issues|3
3111693|NCT00158054|10656737|P2|Overall Study|Unavailable for follow up|3
3111694|NCT00158054|10656738|P1|Overall Study|Unavailable for follow up|7
3111695|NCT00158054|10656737|P2|Overall Study|Refused to continue|0
3111696|NCT00158054|10656738|P1|Overall Study|Refused to continue|3
3111697|NCT00157950|10656752|P2|Overall Study|Death|0
3111698|NCT00157950|10656753|P1|Overall Study|Death|1
3111699|NCT00157820|10656770|P3|2nd 8 Months|Premature cross-over|9
3111700|NCT00157820|10656771|P2|2nd 8 Months|Premature cross-over|7
3111701|NCT00157820|10656772|P1|2nd 8 Months|Premature cross-over|1
3111702|NCT00157820|10656770|P3|2nd 8 Months|Lost to Follow-up|2
3111703|NCT00157820|10656771|P2|2nd 8 Months|Lost to Follow-up|5
3111704|NCT00157820|10656772|P1|2nd 8 Months|Lost to Follow-up|1
3111705|NCT00157820|10656770|P3|2nd 8 Months|Death|3
3111706|NCT00157820|10656771|P2|2nd 8 Months|Death|1
3111707|NCT00157820|10656772|P1|2nd 8 Months|Death|3
3111708|NCT00157820|10656770|P3|1st 8 Month|Premature cross-over|2
3111709|NCT00157820|10656771|P2|1st 8 Month|Premature cross-over|2
3111710|NCT00157820|10656772|P1|1st 8 Month|Premature cross-over|0
3111711|NCT00157820|10656770|P3|1st 8 Month|Lost to Follow-up|1
3111712|NCT00157820|10656771|P2|1st 8 Month|Lost to Follow-up|2
3111713|NCT00157820|10656772|P1|1st 8 Month|Lost to Follow-up|1
3111714|NCT00157820|10656770|P3|1st 8 Month|Death|3
3111715|NCT00157820|10656771|P2|1st 8 Month|Death|8
3111716|NCT00157820|10656772|P1|1st 8 Month|Death|7
3111717|NCT00157820|10656770|P3|Randomized|Protocol Violation|2
3111718|NCT00157820|10656771|P2|Randomized|Protocol Violation|1
3111719|NCT00157820|10656772|P1|Randomized|Protocol Violation|2
3111720|NCT00157820|10656770|P3|Randomized|Withdrawal by Subject|3
3111721|NCT00157820|10656771|P2|Randomized|Withdrawal by Subject|2
3111722|NCT00157820|10656772|P1|Randomized|Withdrawal by Subject|1
3111723|NCT00157820|10656770|P3|Randomized|Physician Decision|3
3111724|NCT00157820|10656771|P2|Randomized|Physician Decision|2
3111725|NCT00157820|10656772|P1|Randomized|Physician Decision|4
3111726|NCT00157755|10656785|P6|Overall Study|Study completion|2
3111727|NCT00157755|10656786|P5|Overall Study|Study completion|1
3111728|NCT00157755|10656787|P4|Overall Study|Study completion|0
3111729|NCT00157755|10656788|P3|Overall Study|Study completion|0
3111730|NCT00157755|10656789|P2|Overall Study|Study completion|0
3111731|NCT00157755|10656790|P1|Overall Study|Study completion|0
3111732|NCT00157755|10656785|P6|Overall Study|Subject non-compliance|1
3111733|NCT00157755|10656786|P5|Overall Study|Subject non-compliance|0
3111734|NCT00157755|10656787|P4|Overall Study|Subject non-compliance|0
3111735|NCT00157755|10656788|P3|Overall Study|Subject non-compliance|0
3111736|NCT00157755|10656789|P2|Overall Study|Subject non-compliance|0
3111737|NCT00157755|10656790|P1|Overall Study|Subject non-compliance|0
3111738|NCT00157755|10656785|P6|Overall Study|Study site closure|0
3111739|NCT00157755|10656786|P5|Overall Study|Study site closure|0
3111740|NCT00157755|10656787|P4|Overall Study|Study site closure|0
3111741|NCT00157755|10656788|P3|Overall Study|Study site closure|0
3111742|NCT00157755|10656789|P2|Overall Study|Study site closure|1
3111743|NCT00157755|10656790|P1|Overall Study|Study site closure|0
3111744|NCT00157755|10656785|P6|Overall Study|Medical reason|0
3111745|NCT00157755|10656786|P5|Overall Study|Medical reason|0
3111746|NCT00157755|10656787|P4|Overall Study|Medical reason|1
3111747|NCT00157755|10656788|P3|Overall Study|Medical reason|1
3111748|NCT00157755|10656789|P2|Overall Study|Medical reason|0
3111749|NCT00157755|10656790|P1|Overall Study|Medical reason|0
3111750|NCT00157755|10656785|P6|Overall Study|Explant due to infection|0
3111751|NCT00157755|10656786|P5|Overall Study|Explant due to infection|0
3111752|NCT00157755|10656787|P4|Overall Study|Explant due to infection|0
3111753|NCT00157755|10656788|P3|Overall Study|Explant due to infection|1
3111754|NCT00157755|10656789|P2|Overall Study|Explant due to infection|0
3111755|NCT00157755|10656790|P1|Overall Study|Explant due to infection|0
3111756|NCT00157755|10656785|P6|Overall Study|Withdrawal by Subject|2
3111757|NCT00157755|10656786|P5|Overall Study|Withdrawal by Subject|1
3111758|NCT00157755|10656787|P4|Overall Study|Withdrawal by Subject|1
3111759|NCT00157755|10656788|P3|Overall Study|Withdrawal by Subject|1
3111760|NCT00157755|10656789|P2|Overall Study|Withdrawal by Subject|0
3111761|NCT00157755|10656790|P1|Overall Study|Withdrawal by Subject|0
3111762|NCT00157755|10656785|P6|Overall Study|Lost to Follow-up|0
3111763|NCT00157755|10656786|P5|Overall Study|Lost to Follow-up|0
3111764|NCT00157755|10656787|P4|Overall Study|Lost to Follow-up|0
3111765|NCT00157755|10656788|P3|Overall Study|Lost to Follow-up|1
3111766|NCT00157755|10656789|P2|Overall Study|Lost to Follow-up|0
3111767|NCT00157755|10656790|P1|Overall Study|Lost to Follow-up|0
3111768|NCT00157755|10656785|P6|Overall Study|Death|0
3111769|NCT00157755|10656786|P5|Overall Study|Death|0
3111770|NCT00157755|10656787|P4|Overall Study|Death|2
3111771|NCT00157755|10656788|P3|Overall Study|Death|3
3111772|NCT00157755|10656789|P2|Overall Study|Death|3
3111773|NCT00157755|10656790|P1|Overall Study|Death|2
3111774|NCT00157248|10656826|P4|Overall Study|site closures, subject moving|9
3111775|NCT00157248|10656827|P3|Overall Study|site closures, subject moving|3
3111776|NCT00157248|10656828|P2|Overall Study|site closures, subject moving|7
3111777|NCT00157248|10656829|P1|Overall Study|site closures, subject moving|7
3111778|NCT00157248|10656826|P4|Overall Study|Withdrawal by Subject|3
3111779|NCT00157248|10656827|P3|Overall Study|Withdrawal by Subject|3
3111780|NCT00157248|10656828|P2|Overall Study|Withdrawal by Subject|4
3111781|NCT00157248|10656829|P1|Overall Study|Withdrawal by Subject|1
3111782|NCT00157248|10656826|P4|Overall Study|Lost to Follow-up|0
3111783|NCT00157248|10656827|P3|Overall Study|Lost to Follow-up|0
3111784|NCT00157248|10656828|P2|Overall Study|Lost to Follow-up|1
3111785|NCT00157248|10656829|P1|Overall Study|Lost to Follow-up|0
3111786|NCT00157248|10656826|P4|Overall Study|Protocol Violation|2
3111787|NCT00157248|10656827|P3|Overall Study|Protocol Violation|2
3111788|NCT00157248|10656828|P2|Overall Study|Protocol Violation|0
3111789|NCT00157248|10656829|P1|Overall Study|Protocol Violation|4
3111790|NCT00157248|10656826|P4|Overall Study|Adverse Event|33
3111791|NCT00157248|10656827|P3|Overall Study|Adverse Event|13
3111792|NCT00157248|10656828|P2|Overall Study|Adverse Event|25
3111793|NCT00157248|10656829|P1|Overall Study|Adverse Event|36
3111794|NCT00157209|10656935|P2|Overall Study|Ongoing at data cut-off|0
3111795|NCT00157209|10656936|P1|Overall Study|Ongoing at data cut-off|10
3111796|NCT00157196|10656950|P1|Overall Study|Ongoing at data cut-off|9
3111797|NCT00157157|10656956|P1|Overall Study|Inclusion not met- baseline FVIII value|1
3111798|NCT00157157|10656956|P1|Overall Study|Met exclusion criteria|1
3111799|NCT00157157|10656956|P1|Overall Study|Enrolled in another study|1
3111800|NCT00157157|10656956|P1|Overall Study|Lost to Follow-up|1
3111801|NCT00157157|10656956|P1|Overall Study|Physician Decision|1
3111802|NCT00157157|10656956|P1|Overall Study|Withdrawal by Subject|6
3111803|NCT00157014|10656983|P4|Overall Study|Withdrawal by Subject|0
3111804|NCT00157014|10656984|P3|Overall Study|Withdrawal by Subject|0
3111805|NCT00157014|10656985|P2|Overall Study|Withdrawal by Subject|0
3111806|NCT00157014|10656986|P1|Overall Study|Withdrawal by Subject|1
3111807|NCT00157014|10656983|P4|Overall Study|Patient would not receive transplant|0
3111808|NCT00157014|10656984|P3|Overall Study|Patient would not receive transplant|0
3111809|NCT00157014|10656985|P2|Overall Study|Patient would not receive transplant|1
3111810|NCT00157014|10656986|P1|Overall Study|Patient would not receive transplant|0
3111811|NCT00157014|10656983|P4|Overall Study|Patient unable to return in nursing home|0
3111812|NCT00157014|10656984|P3|Overall Study|Patient unable to return in nursing home|0
3111813|NCT00157014|10656985|P2|Overall Study|Patient unable to return in nursing home|0
3111814|NCT00157014|10656986|P1|Overall Study|Patient unable to return in nursing home|1
3111815|NCT00157014|10656983|P4|Overall Study|Patient withdrawn by investigator|0
3111816|NCT00157014|10656984|P3|Overall Study|Patient withdrawn by investigator|0
3111817|NCT00157014|10656985|P2|Overall Study|Patient withdrawn by investigator|0
3111818|NCT00157014|10656986|P1|Overall Study|Patient withdrawn by investigator|1
3111819|NCT00157014|10656983|P4|Overall Study|Medications withdrawn on family request|0
3111820|NCT00157014|10656984|P3|Overall Study|Medications withdrawn on family request|0
3111821|NCT00157014|10656985|P2|Overall Study|Medications withdrawn on family request|1
3111822|NCT00157014|10656986|P1|Overall Study|Medications withdrawn on family request|0
3111823|NCT00157014|10656983|P4|Overall Study|Physician Decision|0
3111824|NCT00157014|10656984|P3|Overall Study|Physician Decision|0
3111825|NCT00157014|10656985|P2|Overall Study|Physician Decision|1
3111826|NCT00157014|10656986|P1|Overall Study|Physician Decision|0
3111827|NCT00157014|10656983|P4|Overall Study|Death|1
3111828|NCT00157014|10656984|P3|Overall Study|Death|1
3111829|NCT00157014|10656985|P2|Overall Study|Death|2
3111830|NCT00157014|10656986|P1|Overall Study|Death|4
3111831|NCT00156819|10657102|P3|Overall Study|Lost to Follow-up|3
3111832|NCT00156819|10657103|P2|Overall Study|Lost to Follow-up|1
3111833|NCT00156819|10657104|P1|Overall Study|Lost to Follow-up|1
3111834|NCT00156533|10657121|P4|Overall Study|Failed Screening|1
3111835|NCT00156533|10657122|P3|Overall Study|Failed Screening|1
3111836|NCT00156533|10657123|P2|Overall Study|Failed Screening|0
3111837|NCT00156533|10657124|P1|Overall Study|Failed Screening|1
3111838|NCT00156533|10657121|P4|Overall Study|Withdrawal by Subject|1
3111839|NCT00156533|10657122|P3|Overall Study|Withdrawal by Subject|0
3111840|NCT00156533|10657123|P2|Overall Study|Withdrawal by Subject|0
3111841|NCT00156533|10657124|P1|Overall Study|Withdrawal by Subject|1
3111842|NCT00156533|10657121|P4|Overall Study|Withdrawn - Medication Expiration|0
3111843|NCT00156533|10657122|P3|Overall Study|Withdrawn - Medication Expiration|1
3111844|NCT00156533|10657123|P2|Overall Study|Withdrawn - Medication Expiration|2
3111845|NCT00156533|10657124|P1|Overall Study|Withdrawn - Medication Expiration|0
3111846|NCT00156065|10657158|P3|Overall Study|Other|3
3111847|NCT00156065|10657159|P2|Overall Study|Other|9
3111848|NCT00156065|10657160|P1|Overall Study|Other|2
3111849|NCT00156065|10657158|P3|Overall Study|Lost to Follow-up|1
3111850|NCT00156065|10657159|P2|Overall Study|Lost to Follow-up|7
3111851|NCT00156065|10657160|P1|Overall Study|Lost to Follow-up|5
3111852|NCT00156065|10657158|P3|Overall Study|Withdrawal by Subject|16
3111853|NCT00156065|10657159|P2|Overall Study|Withdrawal by Subject|26
3111854|NCT00156065|10657160|P1|Overall Study|Withdrawal by Subject|13
3111855|NCT00156065|10657158|P3|Overall Study|Lack of Efficacy|3
3111856|NCT00156065|10657159|P2|Overall Study|Lack of Efficacy|9
3111857|NCT00156065|10657160|P1|Overall Study|Lack of Efficacy|2
3111858|NCT00156065|10657158|P3|Overall Study|Adverse Event|4
3111859|NCT00156065|10657159|P2|Overall Study|Adverse Event|11
3111860|NCT00156065|10657160|P1|Overall Study|Adverse Event|8
3111861|NCT00156065|10657158|P3|Overall Study|Enrolled But Never Received Treatment|0
3111862|NCT00156065|10657159|P2|Overall Study|Enrolled But Never Received Treatment|1
3111863|NCT00156065|10657160|P1|Overall Study|Enrolled But Never Received Treatment|1
3111864|NCT00154375|10657194|P2|Overall Study|Suspected progression of disease|30
3111865|NCT00154375|10657195|P1|Overall Study|Suspected progression of disease|44
3111866|NCT00154375|10657194|P2|Overall Study|Protocol Violation|1
3111867|NCT00154375|10657195|P1|Overall Study|Protocol Violation|0
3111868|NCT00154375|10657194|P2|Overall Study|Abnormal laboratory value(s)|2
3111869|NCT00154375|10657195|P1|Overall Study|Abnormal laboratory value(s)|0
3111870|NCT00154375|10657194|P2|Overall Study|Lost to Follow-up|1
3111871|NCT00154375|10657195|P1|Overall Study|Lost to Follow-up|2
3111872|NCT00154375|10657194|P2|Overall Study|Study drug no longer required|3
3111873|NCT00154375|10657195|P1|Overall Study|Study drug no longer required|5
3111874|NCT00154375|10657194|P2|Overall Study|Death|13
3111875|NCT00154375|10657195|P1|Overall Study|Death|5
3111876|NCT00154375|10657194|P2|Overall Study|Withdrawal by Subject|10
3111877|NCT00154375|10657195|P1|Overall Study|Withdrawal by Subject|14
3111878|NCT00154375|10657194|P2|Overall Study|Adverse Event|20
3111879|NCT00154375|10657195|P1|Overall Study|Adverse Event|18
3111880|NCT00154375|10657194|P2|Overall Study|Unsatisfactory therapeutic effect|26
3111881|NCT00154375|10657195|P1|Overall Study|Unsatisfactory therapeutic effect|25
3111882|NCT00154310|10657206|P2|Overall Study|Death|1
3111883|NCT00154310|10657207|P1|Overall Study|Death|0
3111884|NCT00154310|10657206|P2|Overall Study|Administrative problems|1
3111885|NCT00154310|10657207|P1|Overall Study|Administrative problems|0
3111886|NCT00154310|10657206|P2|Overall Study|Lost to Follow-up|8
3111887|NCT00154310|10657207|P1|Overall Study|Lost to Follow-up|0
3111888|NCT00154310|10657206|P2|Overall Study|Withdrawal by Subject|3
3111889|NCT00154310|10657207|P1|Overall Study|Withdrawal by Subject|9
3111890|NCT00154310|10657206|P2|Overall Study|Protocol Violation|2
3111891|NCT00154310|10657207|P1|Overall Study|Protocol Violation|4
3111892|NCT00154310|10657206|P2|Overall Study|Lack of Efficacy|4
3111893|NCT00154310|10657207|P1|Overall Study|Lack of Efficacy|5
3111894|NCT00154310|10657206|P2|Overall Study|Adverse Event|9
3111895|NCT00154310|10657207|P1|Overall Study|Adverse Event|19
3111896|NCT00154297|10657223|P2|Overall Study|Lost to Follow-up|0
3111897|NCT00154297|10657224|P1|Overall Study|Lost to Follow-up|3
3111898|NCT00154297|10657223|P2|Overall Study|Withdrawal by Subject|5
3111899|NCT00154297|10657224|P1|Overall Study|Withdrawal by Subject|0
3111900|NCT00154297|10657223|P2|Overall Study|Death|2
3111901|NCT00154297|10657224|P1|Overall Study|Death|5
3111902|NCT00154284|10657242|P2|Overall Study|Protocol Violation|1
3111903|NCT00154284|10657243|P1|Overall Study|Protocol Violation|0
3111904|NCT00154284|10657242|P2|Overall Study|Lack of Efficacy|2
3111905|NCT00154284|10657243|P1|Overall Study|Lack of Efficacy|1
3111906|NCT00154284|10657242|P2|Overall Study|Abnormal laboratory value(s)|1
3111907|NCT00154284|10657243|P1|Overall Study|Abnormal laboratory value(s)|0
3111908|NCT00154284|10657242|P2|Overall Study|Adverse Event|9
3111909|NCT00154284|10657243|P1|Overall Study|Adverse Event|6
3111910|NCT00154102|10657257|P2|Overall Study|investigational study phase ongoing|2
3111911|NCT00154102|10657258|P1|Overall Study|investigational study phase ongoing|7
3111912|NCT00154063|10657294|P2|Overall Study|Other|3
3111913|NCT00154063|10657295|P1|Overall Study|Other|3
3111914|NCT00154063|10657294|P2|Overall Study|Withdrawal by Subject|9
3111915|NCT00154063|10657295|P1|Overall Study|Withdrawal by Subject|4
3111916|NCT00154063|10657294|P2|Overall Study|Investigator or Sponsor Request|1
3111917|NCT00154063|10657295|P1|Overall Study|Investigator or Sponsor Request|0
3111918|NCT00154063|10657294|P2|Overall Study|Protocol Violation|1
3111919|NCT00154063|10657295|P1|Overall Study|Protocol Violation|1
3111920|NCT00154063|10657294|P2|Overall Study|Adverse Event|8
3111921|NCT00154063|10657295|P1|Overall Study|Adverse Event|4
3111922|NCT00153920|10657357|P1|Overall Study|Progressive Disease before Trt|1
3111923|NCT00153920|10657357|P1|Overall Study|Withdrawal of Consent before Trt|1
3111924|NCT00153920|10657357|P1|Overall Study|Non-Protocol Therapy|1
3111925|NCT00153920|10657357|P1|Overall Study|Withdrawal by Subject|1
3111926|NCT00153920|10657357|P1|Overall Study|Death|2
3111927|NCT00153920|10657357|P1|Overall Study|Lack of Response|3
3111928|NCT00153920|10657357|P1|Overall Study|Physician Decision|3
3111929|NCT00153920|10657357|P1|Overall Study|Progressive Disease|9
3111930|NCT00153920|10657357|P1|Overall Study|Adverse Event|9
3111931|NCT00153816|10657383|P6|Overall Study|Follow-up exam done, histology missing|2
3111932|NCT00153816|10657384|P5|Overall Study|Follow-up exam done, histology missing|1
3111933|NCT00153816|10657385|P4|Overall Study|Follow-up exam done, histology missing|3
3111934|NCT00153816|10657386|P3|Overall Study|Follow-up exam done, histology missing|3
3111935|NCT00153816|10657387|P2|Overall Study|Follow-up exam done, histology missing|3
3111936|NCT00153816|10657388|P1|Overall Study|Follow-up exam done, histology missing|2
3111937|NCT00153816|10657383|P6|Overall Study|Follow-up exam not done|9
3111938|NCT00153816|10657384|P5|Overall Study|Follow-up exam not done|8
3111939|NCT00153816|10657385|P4|Overall Study|Follow-up exam not done|10
3111940|NCT00153816|10657386|P3|Overall Study|Follow-up exam not done|11
3111941|NCT00153816|10657387|P2|Overall Study|Follow-up exam not done|7
3111942|NCT00153816|10657388|P1|Overall Study|Follow-up exam not done|8
3111943|NCT00153816|10657383|P6|Overall Study|Withdrawal by Subject|5
3111944|NCT00153816|10657384|P5|Overall Study|Withdrawal by Subject|1
3111945|NCT00153816|10657385|P4|Overall Study|Withdrawal by Subject|4
3111946|NCT00153816|10657386|P3|Overall Study|Withdrawal by Subject|9
3111947|NCT00153816|10657387|P2|Overall Study|Withdrawal by Subject|9
3111948|NCT00153816|10657388|P1|Overall Study|Withdrawal by Subject|9
3111949|NCT00153816|10657383|P6|Overall Study|Lost to Follow-up|9
3111950|NCT00153816|10657384|P5|Overall Study|Lost to Follow-up|7
3111951|NCT00153816|10657385|P4|Overall Study|Lost to Follow-up|8
3111952|NCT00153816|10657386|P3|Overall Study|Lost to Follow-up|5
3111953|NCT00153816|10657387|P2|Overall Study|Lost to Follow-up|8
3111954|NCT00153816|10657388|P1|Overall Study|Lost to Follow-up|7
3111955|NCT00153816|10657383|P6|Overall Study|Death|2
3111956|NCT00153816|10657384|P5|Overall Study|Death|0
3111957|NCT00153816|10657385|P4|Overall Study|Death|6
3111958|NCT00153816|10657386|P3|Overall Study|Death|4
3111959|NCT00153816|10657387|P2|Overall Study|Death|5
3111960|NCT00153816|10657388|P1|Overall Study|Death|6
3111961|NCT00153179|10657429|P4|Study Visit Day 2|Withdrawal by Subject|2
3111962|NCT00153179|10657430|P3|Study Visit Day 2|Withdrawal by Subject|2
3111963|NCT00153179|10657431|P2|Study Visit Day 2|Withdrawal by Subject|0
3111964|NCT00153179|10657432|P1|Study Visit Day 2|Withdrawal by Subject|1
3111965|NCT00153101|10657464|P5|Overall Study|Withdrawal by Subject|5
3111966|NCT00153101|10657465|P4|Overall Study|Withdrawal by Subject|3
3111967|NCT00153101|10657466|P3|Overall Study|Withdrawal by Subject|3
3111968|NCT00153101|10657467|P2|Overall Study|Withdrawal by Subject|4
3111969|NCT00153101|10657468|P1|Overall Study|Withdrawal by Subject|3
3111970|NCT00153101|10657464|P5|Overall Study|Lost to Follow-up|5
3111971|NCT00153101|10657465|P4|Overall Study|Lost to Follow-up|5
3111972|NCT00153101|10657466|P3|Overall Study|Lost to Follow-up|12
3111973|NCT00153101|10657467|P2|Overall Study|Lost to Follow-up|14
3111974|NCT00153101|10657468|P1|Overall Study|Lost to Follow-up|14
3111975|NCT00153062|10657576|P4|Overall Study|Other|0
3111976|NCT00153062|10657577|P3|Overall Study|Other|1
3111977|NCT00153062|10657578|P2|Overall Study|Other|0
3111978|NCT00153062|10657579|P1|Overall Study|Other|0
3111979|NCT00153062|10657576|P4|Overall Study|No disposition data available|1
3111980|NCT00153062|10657577|P3|Overall Study|No disposition data available|1
3111981|NCT00153062|10657578|P2|Overall Study|No disposition data available|1
3111982|NCT00153062|10657579|P1|Overall Study|No disposition data available|1
3111983|NCT00153062|10657576|P4|Overall Study|Protocol Violation|1
3111984|NCT00153062|10657577|P3|Overall Study|Protocol Violation|1
3111985|NCT00153062|10657578|P2|Overall Study|Protocol Violation|2
3111986|NCT00153062|10657579|P1|Overall Study|Protocol Violation|0
3111987|NCT00153062|10657576|P4|Overall Study|Adverse Event|0
3111988|NCT00153062|10657577|P3|Overall Study|Adverse Event|1
3111989|NCT00153062|10657578|P2|Overall Study|Adverse Event|1
3111990|NCT00153062|10657579|P1|Overall Study|Adverse Event|0
3111991|NCT00153062|10657576|P4|Overall Study|Lost to Follow-up|16
3111992|NCT00153062|10657577|P3|Overall Study|Lost to Follow-up|15
3111993|NCT00153062|10657578|P2|Overall Study|Lost to Follow-up|20
3111994|NCT00153062|10657579|P1|Overall Study|Lost to Follow-up|12
3111995|NCT00153062|10657576|P4|Overall Study|Withdrawal by Subject|28
3111996|NCT00153062|10657577|P3|Overall Study|Withdrawal by Subject|27
3111997|NCT00153062|10657578|P2|Overall Study|Withdrawal by Subject|30
3111998|NCT00153062|10657579|P1|Overall Study|Withdrawal by Subject|14
3111999|NCT00153062|10657576|P4|Overall Study|Death|365
3112000|NCT00153062|10657577|P3|Overall Study|Death|369
3112001|NCT00153062|10657578|P2|Overall Study|Death|352
3112002|NCT00153062|10657579|P1|Overall Study|Death|360
3112003|NCT00152971|10657598|P3|Treatment|Other|10
3112004|NCT00152971|10657599|P2|Treatment|Other|11
3112005|NCT00152971|10657600|P1|Treatment|Other|9
3112006|NCT00152971|10657598|P3|Treatment|Withdrawal by Subject|5
3112007|NCT00152971|10657599|P2|Treatment|Withdrawal by Subject|4
3112008|NCT00152971|10657600|P1|Treatment|Withdrawal by Subject|4
3112009|NCT00152971|10657598|P3|Treatment|Lost to Follow-up|1
3112010|NCT00152971|10657599|P2|Treatment|Lost to Follow-up|2
3112011|NCT00152971|10657600|P1|Treatment|Lost to Follow-up|1
3112012|NCT00152971|10657598|P3|Treatment|Protocol Violation|10
3112013|NCT00152971|10657599|P2|Treatment|Protocol Violation|6
3112014|NCT00152971|10657600|P1|Treatment|Protocol Violation|8
3112015|NCT00152971|10657598|P3|Treatment|Adverse Event|54
3112016|NCT00152971|10657599|P2|Treatment|Adverse Event|40
3112017|NCT00152971|10657600|P1|Treatment|Adverse Event|49
3112018|NCT00152971|10657598|P3|Overall Study|Other|5
3112019|NCT00152971|10657599|P2|Overall Study|Other|5
3112020|NCT00152971|10657600|P1|Overall Study|Other|3
3112021|NCT00152971|10657598|P3|Overall Study|Withdrawal by Subject|14
3112022|NCT00152971|10657599|P2|Overall Study|Withdrawal by Subject|8
3112023|NCT00152971|10657600|P1|Overall Study|Withdrawal by Subject|9
3112024|NCT00152971|10657598|P3|Overall Study|Lost to Follow-up|13
3112025|NCT00152971|10657599|P2|Overall Study|Lost to Follow-up|14
3112026|NCT00152971|10657600|P1|Overall Study|Lost to Follow-up|17
3112027|NCT00152971|10657598|P3|Overall Study|Protocol Violation|8
3112028|NCT00152971|10657599|P2|Overall Study|Protocol Violation|11
3112029|NCT00152971|10657600|P1|Overall Study|Protocol Violation|10
3112030|NCT00152971|10657598|P3|Overall Study|Adverse Event|9
3112031|NCT00152971|10657599|P2|Overall Study|Adverse Event|10
3112032|NCT00152971|10657600|P1|Overall Study|Adverse Event|12
3112033|NCT00152763|10657636|P4|Overall Study|Lost to Follow-up|13
3112034|NCT00152763|10657637|P3|Overall Study|Lost to Follow-up|2
3112035|NCT00152763|10657638|P2|Overall Study|Lost to Follow-up|4
3112036|NCT00152763|10657639|P1|Overall Study|Lost to Follow-up|6
3112037|NCT00152763|10657636|P4|Overall Study|Death|1
3112038|NCT00152763|10657637|P3|Overall Study|Death|2
3112039|NCT00152763|10657638|P2|Overall Study|Death|1
3112040|NCT00152763|10657639|P1|Overall Study|Death|4
3112041|NCT00152516|10657755|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
3112042|NCT00152516|10657755|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
3112043|NCT00152516|10657755|P1|Overall Study|Other: Moved Out Of State|1
3112044|NCT00152516|10657755|P1|Overall Study|Other: Primary Care Physician's Decision|1
3112045|NCT00152516|10657755|P1|Overall Study|Other: Non-Compliance|2
3112046|NCT00152516|10657755|P1|Overall Study|Other: Parents Withdrew Consent|2
3112047|NCT00152516|10657755|P1|Overall Study|Other: Given Commercial Drug in Error|2
3112048|NCT00152516|10657755|P1|Overall Study|Other: Mother Refused To Cooperate|1
3112049|NCT00152516|10657755|P1|Overall Study|Protocol Violation|3
3112050|NCT00152516|10657755|P1|Overall Study|Withdrawal by Subject|8
3112051|NCT00152516|10657755|P1|Overall Study|Lost to Follow-up|5
3112052|NCT00152516|10657755|P1|Overall Study|Lack and Loss of Efficacy|30
3112053|NCT00152516|10657755|P1|Overall Study|Adverse Event|18
3112054|NCT00152464|10657781|P2|Overall Study|Patient relocated|0
3112055|NCT00152464|10657782|P1|Overall Study|Patient relocated|1
3112056|NCT00152464|10657781|P2|Overall Study|Eczema poorly controlled|0
3112057|NCT00152464|10657782|P1|Overall Study|Eczema poorly controlled|1
3112058|NCT00152464|10657781|P2|Overall Study|Lack of Efficacy|0
3112059|NCT00152464|10657782|P1|Overall Study|Lack of Efficacy|1
3112060|NCT00152464|10657781|P2|Overall Study|Investigator decision|0
3112061|NCT00152464|10657782|P1|Overall Study|Investigator decision|1
3112062|NCT00152464|10657781|P2|Overall Study|Parent decision|1
3112063|NCT00152464|10657782|P1|Overall Study|Parent decision|1
3112064|NCT00152464|10657781|P2|Overall Study|Eczema deterioration|1
3112065|NCT00152464|10657782|P1|Overall Study|Eczema deterioration|0
3112066|NCT00152464|10657781|P2|Overall Study|Atopic dermatitis poorly controlled|1
3112067|NCT00152464|10657782|P1|Overall Study|Atopic dermatitis poorly controlled|0
3112068|NCT00152464|10657781|P2|Overall Study|Withdrawal by Subject|22
3112069|NCT00152464|10657782|P1|Overall Study|Withdrawal by Subject|21
3112070|NCT00152464|10657781|P2|Overall Study|Protocol Violation|1
3112071|NCT00152464|10657782|P1|Overall Study|Protocol Violation|3
3112072|NCT00152464|10657781|P2|Overall Study|Lost to Follow-up|4
3112073|NCT00152464|10657782|P1|Overall Study|Lost to Follow-up|8
3112074|NCT00152464|10657781|P2|Overall Study|Adverse Event|6
3112075|NCT00152464|10657782|P1|Overall Study|Adverse Event|3
3112076|NCT00152009|10657810|P4|Overall Study|Sponsor's decision|3
3112077|NCT00152009|10657811|P3|Overall Study|Sponsor's decision|1
3112078|NCT00152009|10657812|P2|Overall Study|Sponsor's decision|3
3112079|NCT00152009|10657813|P1|Overall Study|Sponsor's decision|3
3112080|NCT00152009|10657810|P4|Overall Study|ECG abnormalities|1
3112081|NCT00152009|10657811|P3|Overall Study|ECG abnormalities|2
3112082|NCT00152009|10657812|P2|Overall Study|ECG abnormalities|2
3112083|NCT00152009|10657813|P1|Overall Study|ECG abnormalities|2
3112084|NCT00152009|10657810|P4|Overall Study|Lack of Efficacy|15
3112085|NCT00152009|10657811|P3|Overall Study|Lack of Efficacy|7
3112086|NCT00152009|10657812|P2|Overall Study|Lack of Efficacy|6
3112087|NCT00152009|10657813|P1|Overall Study|Lack of Efficacy|8
3112088|NCT00152009|10657810|P4|Overall Study|Lost to Follow-up|3
3112089|NCT00152009|10657811|P3|Overall Study|Lost to Follow-up|3
3112090|NCT00152009|10657812|P2|Overall Study|Lost to Follow-up|4
3112091|NCT00152009|10657813|P1|Overall Study|Lost to Follow-up|2
3112092|NCT00152009|10657810|P4|Overall Study|Withdrawal by Subject|9
3112093|NCT00152009|10657811|P3|Overall Study|Withdrawal by Subject|4
3112094|NCT00152009|10657812|P2|Overall Study|Withdrawal by Subject|3
3112095|NCT00152009|10657813|P1|Overall Study|Withdrawal by Subject|2
3112096|NCT00152009|10657810|P4|Overall Study|Protocol Violation|1
3112097|NCT00152009|10657811|P3|Overall Study|Protocol Violation|0
3112098|NCT00152009|10657812|P2|Overall Study|Protocol Violation|0
3112099|NCT00152009|10657813|P1|Overall Study|Protocol Violation|3
3112100|NCT00152009|10657810|P4|Overall Study|Adverse Event|1
3112101|NCT00152009|10657811|P3|Overall Study|Adverse Event|20
3112102|NCT00152009|10657812|P2|Overall Study|Adverse Event|13
3112103|NCT00152009|10657813|P1|Overall Study|Adverse Event|9
3112104|NCT00151996|10657845|P2|Overall Study|Sponsor's decision|2
3112105|NCT00151996|10657846|P1|Overall Study|Sponsor's decision|0
3112106|NCT00151996|10657845|P2|Overall Study|Protocol Violation|2
3112107|NCT00151996|10657846|P1|Overall Study|Protocol Violation|1
3112108|NCT00151996|10657845|P2|Overall Study|Withdrawal by Subject|1
3112109|NCT00151996|10657846|P1|Overall Study|Withdrawal by Subject|1
3112110|NCT00151996|10657845|P2|Overall Study|Adverse Event|2
3112111|NCT00151996|10657846|P1|Overall Study|Adverse Event|3
3112112|NCT00151892|10657862|P2|Overall Study|Lack of study medication at center|1
3112113|NCT00151892|10657863|P1|Overall Study|Lack of study medication at center|0
3112114|NCT00151892|10657862|P2|Overall Study|Used prohibited corticosteroids|0
3112115|NCT00151892|10657863|P1|Overall Study|Used prohibited corticosteroids|1
3112116|NCT00151892|10657862|P2|Overall Study|Did not return for a visit|0
3112117|NCT00151892|10657863|P1|Overall Study|Did not return for a visit|1
3112118|NCT00151892|10657862|P2|Overall Study|Pregnancy|1
3112119|NCT00151892|10657863|P1|Overall Study|Pregnancy|0
3112120|NCT00151892|10657862|P2|Overall Study|Non-compliance|1
3112121|NCT00151892|10657863|P1|Overall Study|Non-compliance|0
3112122|NCT00151892|10657862|P2|Overall Study|Protocol Violation|3
3112123|NCT00151892|10657863|P1|Overall Study|Protocol Violation|3
3112124|NCT00151892|10657862|P2|Overall Study|Adverse Event|3
3112125|NCT00151892|10657863|P1|Overall Study|Adverse Event|6
3112126|NCT00151892|10657862|P2|Overall Study|Lost to Follow-up|10
3112127|NCT00151892|10657863|P1|Overall Study|Lost to Follow-up|5
3112128|NCT00151892|10657862|P2|Overall Study|Patient request|7
3112129|NCT00151892|10657863|P1|Overall Study|Patient request|10
3112130|NCT00151892|10657862|P2|Overall Study|Lack of Efficacy|57
3112131|NCT00151892|10657863|P1|Overall Study|Lack of Efficacy|50
3112132|NCT00151775|10657908|P12|Period 4: Open Label|Protocol Violation|0
3112133|NCT00151775|10657909|P11|Period 4: Open Label|Protocol Violation|0
3112134|NCT00151775|10657910|P10|Period 4: Open Label|Protocol Violation|0
3112135|NCT00151775|10657911|P9|Period 4: Open Label|Protocol Violation|0
3112136|NCT00151775|10657912|P8|Period 4: Open Label|Protocol Violation|0
3112137|NCT00151775|10657913|P7|Period 4: Open Label|Protocol Violation|0
3112138|NCT00151775|10657914|P6|Period 4: Open Label|Protocol Violation|0
3112139|NCT00151775|10657915|P5|Period 4: Open Label|Protocol Violation|1
3112140|NCT00151775|10657916|P4|Period 4: Open Label|Protocol Violation|0
3112141|NCT00151775|10657917|P3|Period 4: Open Label|Protocol Violation|0
3112142|NCT00151775|10657918|P2|Period 4: Open Label|Protocol Violation|0
3112143|NCT00151775|10657919|P1|Period 4: Open Label|Protocol Violation|0
3112144|NCT00151775|10657908|P12|Period 4: Open Label|Physician Decision|0
3112145|NCT00151775|10657909|P11|Period 4: Open Label|Physician Decision|0
3112146|NCT00151775|10657910|P10|Period 4: Open Label|Physician Decision|2
3112147|NCT00151775|10657911|P9|Period 4: Open Label|Physician Decision|0
3112148|NCT00151775|10657912|P8|Period 4: Open Label|Physician Decision|0
3112149|NCT00151775|10657913|P7|Period 4: Open Label|Physician Decision|0
3112150|NCT00151775|10657914|P6|Period 4: Open Label|Physician Decision|0
3112151|NCT00151775|10657915|P5|Period 4: Open Label|Physician Decision|0
3112152|NCT00151775|10657916|P4|Period 4: Open Label|Physician Decision|0
3112153|NCT00151775|10657917|P3|Period 4: Open Label|Physician Decision|0
3112154|NCT00151775|10657918|P2|Period 4: Open Label|Physician Decision|0
3112155|NCT00151775|10657919|P1|Period 4: Open Label|Physician Decision|0
3112156|NCT00151775|10657908|P12|Period 4: Open Label|Other|0
3112157|NCT00151775|10657909|P11|Period 4: Open Label|Other|0
3112158|NCT00151775|10657910|P10|Period 4: Open Label|Other|3
3112159|NCT00151775|10657911|P9|Period 4: Open Label|Other|0
3112160|NCT00151775|10657912|P8|Period 4: Open Label|Other|0
3112161|NCT00151775|10657913|P7|Period 4: Open Label|Other|0
3112162|NCT00151775|10657914|P6|Period 4: Open Label|Other|0
3112163|NCT00151775|10657915|P5|Period 4: Open Label|Other|1
3112164|NCT00151775|10657916|P4|Period 4: Open Label|Other|0
3112165|NCT00151775|10657917|P3|Period 4: Open Label|Other|0
3112166|NCT00151775|10657918|P2|Period 4: Open Label|Other|0
3112167|NCT00151775|10657919|P1|Period 4: Open Label|Other|0
3112168|NCT00151775|10657908|P12|Period 4: Open Label|Non-compliance with protocol|0
3112169|NCT00151775|10657909|P11|Period 4: Open Label|Non-compliance with protocol|0
3112170|NCT00151775|10657910|P10|Period 4: Open Label|Non-compliance with protocol|4
3112171|NCT00151775|10657911|P9|Period 4: Open Label|Non-compliance with protocol|0
3112172|NCT00151775|10657912|P8|Period 4: Open Label|Non-compliance with protocol|0
3112173|NCT00151775|10657913|P7|Period 4: Open Label|Non-compliance with protocol|0
3112174|NCT00151775|10657914|P6|Period 4: Open Label|Non-compliance with protocol|0
3112175|NCT00151775|10657915|P5|Period 4: Open Label|Non-compliance with protocol|4
3112176|NCT00151775|10657916|P4|Period 4: Open Label|Non-compliance with protocol|0
3112177|NCT00151775|10657917|P3|Period 4: Open Label|Non-compliance with protocol|0
3112178|NCT00151775|10657918|P2|Period 4: Open Label|Non-compliance with protocol|0
3112179|NCT00151775|10657919|P1|Period 4: Open Label|Non-compliance with protocol|0
3112180|NCT00151775|10657908|P12|Period 4: Open Label|Lost to Follow-up|0
3112181|NCT00151775|10657909|P11|Period 4: Open Label|Lost to Follow-up|0
3112182|NCT00151775|10657910|P10|Period 4: Open Label|Lost to Follow-up|7
3112183|NCT00151775|10657911|P9|Period 4: Open Label|Lost to Follow-up|0
3112184|NCT00151775|10657912|P8|Period 4: Open Label|Lost to Follow-up|0
3112185|NCT00151775|10657913|P7|Period 4: Open Label|Lost to Follow-up|0
3112186|NCT00151775|10657914|P6|Period 4: Open Label|Lost to Follow-up|0
3112187|NCT00151775|10657915|P5|Period 4: Open Label|Lost to Follow-up|17
3112188|NCT00151775|10657916|P4|Period 4: Open Label|Lost to Follow-up|0
3112189|NCT00151775|10657917|P3|Period 4: Open Label|Lost to Follow-up|0
3112190|NCT00151775|10657918|P2|Period 4: Open Label|Lost to Follow-up|0
3112191|NCT00151775|10657919|P1|Period 4: Open Label|Lost to Follow-up|0
3112192|NCT00151775|10657908|P12|Period 4: Open Label|Adverse Event|0
3112193|NCT00151775|10657909|P11|Period 4: Open Label|Adverse Event|0
3112194|NCT00151775|10657910|P10|Period 4: Open Label|Adverse Event|2
3112195|NCT00151775|10657911|P9|Period 4: Open Label|Adverse Event|0
3112196|NCT00151775|10657912|P8|Period 4: Open Label|Adverse Event|0
3112197|NCT00151775|10657913|P7|Period 4: Open Label|Adverse Event|0
3112198|NCT00151775|10657914|P6|Period 4: Open Label|Adverse Event|0
3112199|NCT00151775|10657915|P5|Period 4: Open Label|Adverse Event|1
3112200|NCT00151775|10657916|P4|Period 4: Open Label|Adverse Event|0
3112201|NCT00151775|10657917|P3|Period 4: Open Label|Adverse Event|0
3112202|NCT00151775|10657918|P2|Period 4: Open Label|Adverse Event|0
3112203|NCT00151775|10657919|P1|Period 4: Open Label|Adverse Event|0
3112204|NCT00151775|10657908|P12|Period 4: Open Label|Withdrawal by Subject|0
3112205|NCT00151775|10657909|P11|Period 4: Open Label|Withdrawal by Subject|0
3112206|NCT00151775|10657910|P10|Period 4: Open Label|Withdrawal by Subject|2
3112207|NCT00151775|10657911|P9|Period 4: Open Label|Withdrawal by Subject|0
3112208|NCT00151775|10657912|P8|Period 4: Open Label|Withdrawal by Subject|0
3112209|NCT00151775|10657913|P7|Period 4: Open Label|Withdrawal by Subject|0
3112210|NCT00151775|10657914|P6|Period 4: Open Label|Withdrawal by Subject|0
3112211|NCT00151775|10657915|P5|Period 4: Open Label|Withdrawal by Subject|5
3112212|NCT00151775|10657916|P4|Period 4: Open Label|Withdrawal by Subject|0
3112213|NCT00151775|10657917|P3|Period 4: Open Label|Withdrawal by Subject|0
3112214|NCT00151775|10657918|P2|Period 4: Open Label|Withdrawal by Subject|0
3112215|NCT00151775|10657919|P1|Period 4: Open Label|Withdrawal by Subject|0
3112216|NCT00151775|10657908|P12|Period 4: Open Label|Increased blood pressure|0
3112217|NCT00151775|10657909|P11|Period 4: Open Label|Increased blood pressure|0
3112218|NCT00151775|10657910|P10|Period 4: Open Label|Increased blood pressure|1
3112219|NCT00151775|10657911|P9|Period 4: Open Label|Increased blood pressure|0
3112220|NCT00151775|10657912|P8|Period 4: Open Label|Increased blood pressure|0
3112221|NCT00151775|10657913|P7|Period 4: Open Label|Increased blood pressure|0
3112222|NCT00151775|10657914|P6|Period 4: Open Label|Increased blood pressure|0
3112223|NCT00151775|10657915|P5|Period 4: Open Label|Increased blood pressure|1
3112224|NCT00151775|10657916|P4|Period 4: Open Label|Increased blood pressure|0
3112225|NCT00151775|10657917|P3|Period 4: Open Label|Increased blood pressure|0
3112226|NCT00151775|10657918|P2|Period 4: Open Label|Increased blood pressure|0
3112227|NCT00151775|10657919|P1|Period 4: Open Label|Increased blood pressure|0
3112228|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
3112229|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112230|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112231|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112232|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112233|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112234|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112235|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112236|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112237|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112238|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112239|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
3112240|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112241|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112242|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112243|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112244|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112245|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112246|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112247|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112248|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112249|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
3112250|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112251|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
3112252|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112253|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112254|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112255|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112256|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112257|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112258|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112259|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112260|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112261|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
3112262|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112263|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
3112264|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112265|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112266|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112267|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112268|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112269|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
3112270|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112271|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112272|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112273|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112274|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112275|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
3112276|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Other|0
3112277|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Other|0
3112278|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Other|0
3112279|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Other|0
3112280|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Other|1
3112281|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Other|0
3112282|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Other|0
3112283|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Other|0
3112284|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Other|0
3112285|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Other|1
3112286|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Other|0
3112287|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Other|0
3112288|NCT00151775|10657908|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112289|NCT00151775|10657909|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112290|NCT00151775|10657910|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112291|NCT00151775|10657911|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112292|NCT00151775|10657912|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112293|NCT00151775|10657913|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112294|NCT00151775|10657914|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
3112295|NCT00151775|10657915|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112296|NCT00151775|10657916|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112297|NCT00151775|10657917|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112298|NCT00151775|10657918|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112299|NCT00151775|10657919|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
3112300|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112301|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112302|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112460|NCT00150618|10658113|P2|Overall Study|Sponsor's decision|0
3112303|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112304|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112305|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
3112306|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112307|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112308|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112309|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112310|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112311|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
3112312|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112313|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112314|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112315|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112316|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112317|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112318|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
3112319|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112320|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112321|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112322|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112323|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
3112324|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
3112325|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
3112326|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
3112327|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
3112328|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
3112329|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
3112330|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
3112331|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
3112332|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
3112333|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
3112334|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
3112335|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
3112336|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|Other|0
3112337|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|Other|0
3112338|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|Other|0
3112339|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|Other|0
3112340|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|Other|0
3112341|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|Other|1
3112342|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|Other|0
3112343|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|Other|0
3112344|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|Other|0
3112345|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|Other|0
3112346|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|Other|0
3112347|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|Other|0
3112348|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112349|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112350|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112351|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112352|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112353|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112354|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112355|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112356|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112357|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112358|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
3112359|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
3112360|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112361|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
3112362|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112363|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112364|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112365|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
3112366|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112367|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112368|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112369|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112370|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
3112371|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
3112372|NCT00151775|10657908|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112373|NCT00151775|10657909|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112374|NCT00151775|10657910|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112375|NCT00151775|10657911|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112376|NCT00151775|10657912|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112377|NCT00151775|10657913|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112378|NCT00151775|10657914|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112379|NCT00151775|10657915|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112380|NCT00151775|10657916|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112381|NCT00151775|10657917|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
3112382|NCT00151775|10657918|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
3112383|NCT00151775|10657919|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
3112384|NCT00151476|10657963|P2|FAP Analyzed Subjects|Other study participation|1
3112385|NCT00151476|10657964|P1|FAP Analyzed Subjects|Other study participation|0
3112386|NCT00151476|10657963|P2|FAP Analyzed Subjects|Lost to Follow-up|2
3112387|NCT00151476|10657964|P1|FAP Analyzed Subjects|Lost to Follow-up|0
3112388|NCT00151476|10657963|P2|FAP Identified Subjects|Protocol Violation|1
3112389|NCT00151476|10657964|P1|FAP Identified Subjects|Protocol Violation|0
3112390|NCT00151411|10658021|P2|Overall Study|Pregnancy|4
3112391|NCT00151411|10658022|P1|Overall Study|Pregnancy|0
3112392|NCT00151411|10658021|P2|Overall Study|Adverse Event|0
3112393|NCT00151411|10658022|P1|Overall Study|Adverse Event|6
3112394|NCT00151411|10658021|P2|Overall Study|Withdrawal by Subject|20
3112395|NCT00151411|10658022|P1|Overall Study|Withdrawal by Subject|12
3112396|NCT00151411|10658021|P2|Overall Study|Lost to Follow-up|19
3112397|NCT00151411|10658022|P1|Overall Study|Lost to Follow-up|15
3112398|NCT00151372|10658034|P2|Overall Study|Withdrawal by Subject|7
3112399|NCT00151372|10658035|P1|Overall Study|Withdrawal by Subject|7
3112400|NCT00151372|10658034|P2|Overall Study|Too sick medically to continue|6
3112401|NCT00151372|10658035|P1|Overall Study|Too sick medically to continue|5
3112402|NCT00151372|10658034|P2|Overall Study|Lost to Follow-up|5
3112403|NCT00151372|10658035|P1|Overall Study|Lost to Follow-up|5
3112404|NCT00151372|10658034|P2|Overall Study|Death|11
3112405|NCT00151372|10658035|P1|Overall Study|Death|12
3112406|NCT00151281|10658050|P1|Overall Study|Not evaluable|3
3112407|NCT00150969|10658059|P2|24-48 Month Extension|Other Reason|91
3112408|NCT00150969|10658060|P1|24-48 Month Extension|Other Reason|81
3112409|NCT00150969|10658059|P2|24-48 Month Extension|Adverse Event|3
3112410|NCT00150969|10658060|P1|24-48 Month Extension|Adverse Event|1
3112411|NCT00150969|10658059|P2|24-48 Month Extension|Lack of Efficacy|1
3112412|NCT00150969|10658060|P1|24-48 Month Extension|Lack of Efficacy|0
3112413|NCT00150969|10658059|P2|24-48 Month Extension|Withdrawal by Subject|5
3112414|NCT00150969|10658060|P1|24-48 Month Extension|Withdrawal by Subject|6
3112415|NCT00150969|10658059|P2|24 Month Main Study|Withdrawal by Subject|4
3112416|NCT00150969|10658060|P1|24 Month Main Study|Withdrawal by Subject|7
3112417|NCT00150969|10658059|P2|24 Month Main Study|Protocol Violation|2
3112418|NCT00150969|10658060|P1|24 Month Main Study|Protocol Violation|4
3112419|NCT00150969|10658059|P2|24 Month Main Study|Lost to Follow-up|2
3112420|NCT00150969|10658060|P1|24 Month Main Study|Lost to Follow-up|3
3112421|NCT00150969|10658059|P2|24 Month Main Study|Lack of Efficacy|8
3112422|NCT00150969|10658060|P1|24 Month Main Study|Lack of Efficacy|1
3112423|NCT00150969|10658059|P2|24 Month Main Study|Death|1
3112424|NCT00150969|10658060|P1|24 Month Main Study|Death|1
3112425|NCT00150969|10658059|P2|24 Month Main Study|Adverse Event|4
3112426|NCT00150969|10658060|P1|24 Month Main Study|Adverse Event|3
3112427|NCT00150813|10658092|P1|Overall Study|Switch to commercially available LEV|2
3112428|NCT00150813|10658092|P1|Overall Study|Planned pregancy|1
3112429|NCT00150813|10658092|P1|Overall Study|Remission|3
3112430|NCT00150813|10658092|P1|Overall Study|Withdrawal by Subject|5
3112431|NCT00150813|10658092|P1|Overall Study|Lost to Follow-up|5
3112432|NCT00150813|10658092|P1|Overall Study|Lack of Efficacy|1
3112433|NCT00150813|10658092|P1|Overall Study|Adverse Event|1
3112434|NCT00150800|10658096|P1|Overall Study|PI discontinuation request|1
3112435|NCT00150800|10658096|P1|Overall Study|Pregnancy planned|1
3112436|NCT00150800|10658096|P1|Overall Study|Surgical intervention|4
3112437|NCT00150800|10658096|P1|Overall Study|Patient insurance|1
3112438|NCT00150800|10658096|P1|Overall Study|PI leaving site|2
3112439|NCT00150800|10658096|P1|Overall Study|PI retiring|2
3112440|NCT00150800|10658096|P1|Overall Study|Moved from area/country|8
3112441|NCT00150800|10658096|P1|Overall Study|Generalized Epilepsy|1
3112442|NCT00150800|10658096|P1|Overall Study|Sponsor's request|2
3112443|NCT00150800|10658096|P1|Overall Study|Visit refusal|3
3112444|NCT00150800|10658096|P1|Overall Study|BRV monotherapy|1
3112445|NCT00150800|10658096|P1|Overall Study|Neurosurgery|2
3112446|NCT00150800|10658096|P1|Overall Study|Distance too long for patient|1
3112447|NCT00150800|10658096|P1|Overall Study|Nobody to accompany patient|1
3112448|NCT00150800|10658096|P1|Overall Study|Protocol non-adherence|2
3112449|NCT00150800|10658096|P1|Overall Study|Site closure|24
3112450|NCT00150800|10658096|P1|Overall Study|IP misshandling|1
3112451|NCT00150800|10658096|P1|Overall Study|No compliance|18
3112452|NCT00150800|10658096|P1|Overall Study|Subject's choice|90
3112453|NCT00150800|10658096|P1|Overall Study|Lost to Follow-up|58
3112454|NCT00150800|10658096|P1|Overall Study|Lack of Efficacy|166
3112455|NCT00150800|10658096|P1|Overall Study|Death|18
3112456|NCT00150800|10658096|P1|Overall Study|Adverse Event|89
3112457|NCT00150618|10658110|P5|Overall Study|Sponsor's decision|0
3112458|NCT00150618|10658111|P4|Overall Study|Sponsor's decision|1
3112459|NCT00150618|10658112|P3|Overall Study|Sponsor's decision|0
3112461|NCT00150618|10658114|P1|Overall Study|Sponsor's decision|0
3112462|NCT00150618|10658110|P5|Overall Study|Abnormal ECG|0
3112463|NCT00150618|10658111|P4|Overall Study|Abnormal ECG|0
3112464|NCT00150618|10658112|P3|Overall Study|Abnormal ECG|0
3112465|NCT00150618|10658113|P2|Overall Study|Abnormal ECG|0
3112466|NCT00150618|10658114|P1|Overall Study|Abnormal ECG|1
3112467|NCT00150618|10658110|P5|Overall Study|Lack of compliance|1
3112468|NCT00150618|10658111|P4|Overall Study|Lack of compliance|0
3112469|NCT00150618|10658112|P3|Overall Study|Lack of compliance|1
3112470|NCT00150618|10658113|P2|Overall Study|Lack of compliance|1
3112471|NCT00150618|10658114|P1|Overall Study|Lack of compliance|2
3112472|NCT00150618|10658110|P5|Overall Study|Physician Decision|1
3112473|NCT00150618|10658111|P4|Overall Study|Physician Decision|0
3112474|NCT00150618|10658112|P3|Overall Study|Physician Decision|0
3112475|NCT00150618|10658113|P2|Overall Study|Physician Decision|2
3112476|NCT00150618|10658114|P1|Overall Study|Physician Decision|0
3112477|NCT00150618|10658110|P5|Overall Study|No study meds|2
3112478|NCT00150618|10658111|P4|Overall Study|No study meds|0
3112479|NCT00150618|10658112|P3|Overall Study|No study meds|0
3112480|NCT00150618|10658113|P2|Overall Study|No study meds|0
3112481|NCT00150618|10658114|P1|Overall Study|No study meds|0
3112482|NCT00150618|10658110|P5|Overall Study|Lack of Efficacy|6
3112483|NCT00150618|10658111|P4|Overall Study|Lack of Efficacy|4
3112484|NCT00150618|10658112|P3|Overall Study|Lack of Efficacy|7
3112485|NCT00150618|10658113|P2|Overall Study|Lack of Efficacy|4
3112486|NCT00150618|10658114|P1|Overall Study|Lack of Efficacy|1
3112487|NCT00150618|10658110|P5|Overall Study|Protocol Violation|1
3112488|NCT00150618|10658111|P4|Overall Study|Protocol Violation|0
3112489|NCT00150618|10658112|P3|Overall Study|Protocol Violation|0
3112490|NCT00150618|10658113|P2|Overall Study|Protocol Violation|0
3112491|NCT00150618|10658114|P1|Overall Study|Protocol Violation|1
3112492|NCT00150618|10658110|P5|Overall Study|Lost to Follow-up|4
3112493|NCT00150618|10658111|P4|Overall Study|Lost to Follow-up|8
3112494|NCT00150618|10658112|P3|Overall Study|Lost to Follow-up|5
3112495|NCT00150618|10658113|P2|Overall Study|Lost to Follow-up|1
3112496|NCT00150618|10658114|P1|Overall Study|Lost to Follow-up|4
3112497|NCT00150618|10658110|P5|Overall Study|Withdrawal by Subject|5
3112498|NCT00150618|10658111|P4|Overall Study|Withdrawal by Subject|4
3112499|NCT00150618|10658112|P3|Overall Study|Withdrawal by Subject|8
3112500|NCT00150618|10658113|P2|Overall Study|Withdrawal by Subject|8
3112501|NCT00150618|10658114|P1|Overall Study|Withdrawal by Subject|6
3112502|NCT00150618|10658110|P5|Overall Study|Adverse Event|5
3112503|NCT00150618|10658111|P4|Overall Study|Adverse Event|9
3112504|NCT00150618|10658112|P3|Overall Study|Adverse Event|6
3112505|NCT00150618|10658113|P2|Overall Study|Adverse Event|2
3112506|NCT00150618|10658114|P1|Overall Study|Adverse Event|2
3112507|NCT00150592|10658148|P2|Overall Study|Non-compliance|0
3112508|NCT00150592|10658149|P1|Overall Study|Non-compliance|1
3112509|NCT00150592|10658148|P2|Overall Study|Withdrawal by Subject|2
3112510|NCT00150592|10658149|P1|Overall Study|Withdrawal by Subject|1
3112511|NCT00150592|10658148|P2|Overall Study|Protocol Violation|0
3112512|NCT00150592|10658149|P1|Overall Study|Protocol Violation|1
3112513|NCT00150592|10658148|P2|Overall Study|Adverse Event|1
3112514|NCT00150592|10658149|P1|Overall Study|Adverse Event|4
3112515|NCT00150462|10658180|P11|Overall Study|Other|1
3112516|NCT00150462|10658181|P10|Overall Study|Other|1
3112517|NCT00150462|10658182|P9|Overall Study|Other|0
3112518|NCT00150462|10658183|P8|Overall Study|Other|0
3112519|NCT00150462|10658184|P7|Overall Study|Other|0
3112520|NCT00150462|10658185|P6|Overall Study|Other|0
3112521|NCT00150462|10658186|P5|Overall Study|Other|0
3112522|NCT00150462|10658187|P4|Overall Study|Other|0
3112523|NCT00150462|10658188|P3|Overall Study|Other|0
3112524|NCT00150462|10658189|P2|Overall Study|Other|0
3112525|NCT00150462|10658190|P1|Overall Study|Other|0
3112526|NCT00150462|10658180|P11|Overall Study|Physician Decision|0
3112527|NCT00150462|10658181|P10|Overall Study|Physician Decision|0
3112528|NCT00150462|10658182|P9|Overall Study|Physician Decision|0
3112529|NCT00150462|10658183|P8|Overall Study|Physician Decision|0
3112530|NCT00150462|10658184|P7|Overall Study|Physician Decision|0
3112531|NCT00150462|10658185|P6|Overall Study|Physician Decision|0
3112532|NCT00150462|10658186|P5|Overall Study|Physician Decision|0
3112533|NCT00150462|10658187|P4|Overall Study|Physician Decision|1
3112534|NCT00150462|10658188|P3|Overall Study|Physician Decision|1
3112535|NCT00150462|10658189|P2|Overall Study|Physician Decision|0
3112536|NCT00150462|10658190|P1|Overall Study|Physician Decision|0
3112537|NCT00150462|10658180|P11|Overall Study|Adverse Event|0
3112538|NCT00150462|10658181|P10|Overall Study|Adverse Event|1
3112539|NCT00150462|10658182|P9|Overall Study|Adverse Event|0
3112540|NCT00150462|10658183|P8|Overall Study|Adverse Event|2
3112541|NCT00150462|10658184|P7|Overall Study|Adverse Event|0
3112542|NCT00150462|10658185|P6|Overall Study|Adverse Event|0
3112543|NCT00150462|10658186|P5|Overall Study|Adverse Event|0
3112544|NCT00150462|10658187|P4|Overall Study|Adverse Event|1
3112545|NCT00150462|10658188|P3|Overall Study|Adverse Event|0
3112546|NCT00150462|10658189|P2|Overall Study|Adverse Event|0
3112547|NCT00150462|10658190|P1|Overall Study|Adverse Event|0
3112548|NCT00150462|10658180|P11|Overall Study|Death|0
3112549|NCT00150462|10658181|P10|Overall Study|Death|0
3112550|NCT00150462|10658182|P9|Overall Study|Death|1
3112551|NCT00150462|10658183|P8|Overall Study|Death|0
3112552|NCT00150462|10658184|P7|Overall Study|Death|0
3112553|NCT00150462|10658185|P6|Overall Study|Death|0
3112554|NCT00150462|10658186|P5|Overall Study|Death|0
3112555|NCT00150462|10658187|P4|Overall Study|Death|0
3112556|NCT00150462|10658188|P3|Overall Study|Death|0
3112557|NCT00150462|10658189|P2|Overall Study|Death|1
3112558|NCT00150462|10658190|P1|Overall Study|Death|0
3112559|NCT00150462|10658180|P11|Overall Study|Withdrawal by Subject|0
3112560|NCT00150462|10658181|P10|Overall Study|Withdrawal by Subject|1
3112561|NCT00150462|10658182|P9|Overall Study|Withdrawal by Subject|0
3112562|NCT00150462|10658183|P8|Overall Study|Withdrawal by Subject|1
3112563|NCT00150462|10658184|P7|Overall Study|Withdrawal by Subject|0
3112564|NCT00150462|10658185|P6|Overall Study|Withdrawal by Subject|2
3112565|NCT00150462|10658186|P5|Overall Study|Withdrawal by Subject|1
3112566|NCT00150462|10658187|P4|Overall Study|Withdrawal by Subject|0
3112567|NCT00150462|10658188|P3|Overall Study|Withdrawal by Subject|1
3112568|NCT00150462|10658189|P2|Overall Study|Withdrawal by Subject|1
3112569|NCT00150462|10658190|P1|Overall Study|Withdrawal by Subject|0
3112570|NCT00150462|10658180|P11|Overall Study|Disease Progression or Relapse|2
3112571|NCT00150462|10658181|P10|Overall Study|Disease Progression or Relapse|3
3112572|NCT00150462|10658182|P9|Overall Study|Disease Progression or Relapse|5
3112573|NCT00150462|10658183|P8|Overall Study|Disease Progression or Relapse|5
3112574|NCT00150462|10658184|P7|Overall Study|Disease Progression or Relapse|3
3112575|NCT00150462|10658185|P6|Overall Study|Disease Progression or Relapse|2
3112576|NCT00150462|10658186|P5|Overall Study|Disease Progression or Relapse|2
3112577|NCT00150462|10658187|P4|Overall Study|Disease Progression or Relapse|1
3112578|NCT00150462|10658188|P3|Overall Study|Disease Progression or Relapse|2
3112579|NCT00150462|10658189|P2|Overall Study|Disease Progression or Relapse|1
3112580|NCT00150462|10658190|P1|Overall Study|Disease Progression or Relapse|3
3112581|NCT00150345|10658300|P2|Overall Study|Other|14
3112582|NCT00150345|10658301|P1|Overall Study|Other|12
3112583|NCT00150345|10658300|P2|Overall Study|Laboratory abnormality|2
3112584|NCT00150345|10658301|P1|Overall Study|Laboratory abnormality|1
3112585|NCT00150345|10658300|P2|Overall Study|Withdrawal by Subject|4
3112586|NCT00150345|10658301|P1|Overall Study|Withdrawal by Subject|3
3112587|NCT00150345|10658300|P2|Overall Study|Lack of Efficacy|4
3112588|NCT00150345|10658301|P1|Overall Study|Lack of Efficacy|5
3112589|NCT00150345|10658300|P2|Overall Study|Adverse Event|6
3112590|NCT00150345|10658301|P1|Overall Study|Adverse Event|8
3112591|NCT00150345|10658300|P2|Overall Study|Death|2
3112592|NCT00150345|10658301|P1|Overall Study|Death|5
3112593|NCT00150176|10658365|P2|Overall Study|OTHER|13
3112594|NCT00150176|10658366|P1|Overall Study|OTHER|11
3112595|NCT00150176|10658365|P2|Overall Study|Lost to Follow-up|3
3112596|NCT00150176|10658366|P1|Overall Study|Lost to Follow-up|3
3112597|NCT00150176|10658365|P2|Overall Study|Withdrawal by Subject|12
3112598|NCT00150176|10658366|P1|Overall Study|Withdrawal by Subject|19
3112599|NCT00150176|10658365|P2|Overall Study|Relapse/Impending relapse, non-AE|39
3112600|NCT00150176|10658366|P1|Overall Study|Relapse/Impending relapse, non-AE|10
3112601|NCT00150176|10658365|P2|Overall Study|Adverse Event|53
3112602|NCT00150176|10658366|P1|Overall Study|Adverse Event|16
3112603|NCT00149994|10658377|P2|Overall Study|Protocol Violation|1
3112604|NCT00149994|10658378|P1|Overall Study|Protocol Violation|0
3112605|NCT00149994|10658377|P2|Overall Study|Administrative problems:|0
3112606|NCT00149994|10658378|P1|Overall Study|Administrative problems:|1
3112607|NCT00149890|10658386|P2|Overall Study|Graft Loss|1
3112608|NCT00149890|10658387|P1|Overall Study|Graft Loss|2
3112609|NCT00149890|10658386|P2|Overall Study|Lost to Follow-up|0
3112610|NCT00149890|10658387|P1|Overall Study|Lost to Follow-up|1
3112611|NCT00149890|10658386|P2|Overall Study|Protocol Violation|0
3112612|NCT00149890|10658387|P1|Overall Study|Protocol Violation|1
3112613|NCT00149890|10658386|P2|Overall Study|Lack of Efficacy|9
3112614|NCT00149890|10658387|P1|Overall Study|Lack of Efficacy|8
3112615|NCT00149890|10658386|P2|Overall Study|Adverse Event|8
3112616|NCT00149890|10658387|P1|Overall Study|Adverse Event|1
3112617|NCT00149825|10658422|P2|Overall Study|Other|0
3112618|NCT00149825|10658423|P1|Overall Study|Other|1
3112619|NCT00149825|10658422|P2|Overall Study|Not liking insomnia therapy|0
3112620|NCT00149825|10658423|P1|Overall Study|Not liking insomnia therapy|1
3112621|NCT00149825|10658422|P2|Overall Study|Time commitments|1
3112622|NCT00149825|10658423|P1|Overall Study|Time commitments|2
3112623|NCT00149825|10658422|P2|Overall Study|Intolerance to medication side effects|2
3112624|NCT00149825|10658423|P1|Overall Study|Intolerance to medication side effects|1
3112625|NCT00149747|10658451|P2|Overall Study|Withdrawal by Subject|3
3112626|NCT00149747|10658452|P1|Overall Study|Withdrawal by Subject|3
3112627|NCT00149747|10658451|P2|Overall Study|Death|0
3112628|NCT00149747|10658452|P1|Overall Study|Death|1
3112629|NCT00149630|10658498|P2|Overall Study|Adverse Event|0
3112630|NCT00149630|10658499|P1|Overall Study|Adverse Event|2
3112631|NCT00149630|10658498|P2|Overall Study|Treatment Programs|5
3112632|NCT00149630|10658499|P1|Overall Study|Treatment Programs|4
3112633|NCT00149630|10658498|P2|Overall Study|Incarceration|0
3112634|NCT00149630|10658499|P1|Overall Study|Incarceration|2
3112635|NCT00149396|10658509|P1|Overall Study|other treatment|5
3112636|NCT00149396|10658509|P1|Overall Study|Subject noncompliance|2
3112637|NCT00149396|10658509|P1|Overall Study|Withdrawal by Subject|1
3112638|NCT00149396|10658509|P1|Overall Study|Death|15
3112639|NCT00149214|10658579|P2|Overall Study|Progressive Disease|3
3112640|NCT00149214|10658580|P1|Overall Study|Progressive Disease|7
3112641|NCT00149214|10658579|P2|Overall Study|Sponsor Decision|1
3112642|NCT00149214|10658580|P1|Overall Study|Sponsor Decision|0
3112643|NCT00149214|10658579|P2|Overall Study|Physician Decision|3
3112644|NCT00149214|10658580|P1|Overall Study|Physician Decision|3
3112645|NCT00149214|10658579|P2|Overall Study|Withdrawal by Subject|1
3112646|NCT00149214|10658580|P1|Overall Study|Withdrawal by Subject|4
3112647|NCT00149214|10658579|P2|Overall Study|Adverse Event|9
3112648|NCT00149214|10658580|P1|Overall Study|Adverse Event|12
3112649|NCT00148941|10658607|P4|Overall Study|Other|2
3112650|NCT00148941|10658608|P3|Overall Study|Other|1
3112651|NCT00148941|10658609|P2|Overall Study|Other|0
3112652|NCT00148941|10658610|P1|Overall Study|Other|0
3112653|NCT00148941|10658607|P4|Overall Study|Withdrawal by Subject|0
3112654|NCT00148941|10658608|P3|Overall Study|Withdrawal by Subject|1
3112655|NCT00148941|10658609|P2|Overall Study|Withdrawal by Subject|0
3112656|NCT00148941|10658610|P1|Overall Study|Withdrawal by Subject|1
3112657|NCT00148941|10658607|P4|Overall Study|Lost to Follow-up|22
3112658|NCT00148941|10658608|P3|Overall Study|Lost to Follow-up|18
3112659|NCT00148941|10658609|P2|Overall Study|Lost to Follow-up|24
3112660|NCT00148941|10658610|P1|Overall Study|Lost to Follow-up|17
3112661|NCT00148759|10658725|P2|Overall Study|Lost to Follow-up|0
3112662|NCT00148759|10658726|P1|Overall Study|Lost to Follow-up|1
3112663|NCT00148759|10658725|P2|Overall Study|Withdrawal by Subject|1
3112664|NCT00148759|10658726|P1|Overall Study|Withdrawal by Subject|1
3112665|NCT00148343|10658754|P2|Overall Study|Physician Decision|4
3112666|NCT00148343|10658755|P1|Overall Study|Physician Decision|3
3112667|NCT00148343|10658754|P2|Overall Study|Withdrawal by Subject|7
3112668|NCT00148343|10658755|P1|Overall Study|Withdrawal by Subject|12
3112669|NCT00148317|10658769|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
3112670|NCT00148317|10658769|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
3112671|NCT00148317|10658769|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
3112672|NCT00148122|10658776|P1|Overall Study|Withdrawal by Subject|2
3112673|NCT00148109|10658784|P2|Overall Study|Withdrawal by Subject|0
3112674|NCT00148109|10658785|P1|Overall Study|Withdrawal by Subject|2
3112675|NCT00148109|10658784|P2|Overall Study|Adverse Event|2
3112676|NCT00148109|10658785|P1|Overall Study|Adverse Event|0
3112677|NCT00148109|10658784|P2|Overall Study|Lack of Efficacy|18
3112678|NCT00148109|10658785|P1|Overall Study|Lack of Efficacy|10
3112679|NCT00147823|10658801|P2|Overall Study|Did not receive vitoss due to infection|2
3112680|NCT00147823|10658802|P1|Overall Study|Did not receive vitoss due to infection|6
3112681|NCT00147823|10658801|P2|Overall Study|Withdrawal by Subject|1
3112682|NCT00147823|10658802|P1|Overall Study|Withdrawal by Subject|0
3112683|NCT00147823|10658801|P2|Overall Study|Physician Decision|0
3112684|NCT00147823|10658802|P1|Overall Study|Physician Decision|1
3112685|NCT00147823|10658801|P2|Overall Study|Lost to Follow-up|12
3112686|NCT00147823|10658802|P1|Overall Study|Lost to Follow-up|6
3112687|NCT00147745|10658833|P3|Overall Study|Withdrawal by Subject|0
3112688|NCT00147745|10658834|P2|Overall Study|Withdrawal by Subject|0
3112689|NCT00147745|10658835|P1|Overall Study|Withdrawal by Subject|1
3112690|NCT00147537|10658857|P11|Phase 2|Randomized but not treated|1
3112691|NCT00147537|10658858|P10|Phase 2|Randomized but not treated|1
3112692|NCT00147537|10658859|P9|Phase 2|Randomized but not treated|0
3112693|NCT00147537|10658860|P8|Phase 2|Randomized but not treated|0
3112694|NCT00147537|10658861|P7|Phase 2|Randomized but not treated|0
3112695|NCT00147537|10658862|P6|Phase 2|Randomized but not treated|0
3112696|NCT00147537|10658863|P5|Phase 2|Randomized but not treated|0
3112697|NCT00147537|10658864|P4|Phase 2|Randomized but not treated|0
3112698|NCT00147537|10658865|P3|Phase 2|Randomized but not treated|0
3112699|NCT00147537|10658866|P2|Phase 2|Randomized but not treated|0
3112700|NCT00147537|10658867|P1|Phase 2|Randomized but not treated|0
3112701|NCT00147537|10658857|P11|Phase 2|Withdrawal by Subject|4
3112702|NCT00147537|10658858|P10|Phase 2|Withdrawal by Subject|16
3112703|NCT00147537|10658859|P9|Phase 2|Withdrawal by Subject|0
3112704|NCT00147537|10658860|P8|Phase 2|Withdrawal by Subject|0
3112705|NCT00147537|10658861|P7|Phase 2|Withdrawal by Subject|0
3112706|NCT00147537|10658862|P6|Phase 2|Withdrawal by Subject|0
3112707|NCT00147537|10658863|P5|Phase 2|Withdrawal by Subject|0
3112708|NCT00147537|10658864|P4|Phase 2|Withdrawal by Subject|0
3112709|NCT00147537|10658865|P3|Phase 2|Withdrawal by Subject|0
3112710|NCT00147537|10658866|P2|Phase 2|Withdrawal by Subject|0
3112711|NCT00147537|10658867|P1|Phase 2|Withdrawal by Subject|0
3112712|NCT00147537|10658857|P11|Phase 2|Other|12
3112713|NCT00147537|10658858|P10|Phase 2|Other|47
3112714|NCT00147537|10658859|P9|Phase 2|Other|0
3112715|NCT00147537|10658860|P8|Phase 2|Other|0
3112716|NCT00147537|10658861|P7|Phase 2|Other|0
3112717|NCT00147537|10658862|P6|Phase 2|Other|0
3112718|NCT00147537|10658863|P5|Phase 2|Other|0
3112719|NCT00147537|10658864|P4|Phase 2|Other|0
3112720|NCT00147537|10658865|P3|Phase 2|Other|0
3112721|NCT00147537|10658866|P2|Phase 2|Other|0
3112722|NCT00147537|10658867|P1|Phase 2|Other|0
3112723|NCT00147537|10658857|P11|Phase 2|Lost to Follow-up|4
3112724|NCT00147537|10658858|P10|Phase 2|Lost to Follow-up|12
3112725|NCT00147537|10658859|P9|Phase 2|Lost to Follow-up|0
3112726|NCT00147537|10658860|P8|Phase 2|Lost to Follow-up|0
3112727|NCT00147537|10658861|P7|Phase 2|Lost to Follow-up|0
3112728|NCT00147537|10658862|P6|Phase 2|Lost to Follow-up|0
3112729|NCT00147537|10658863|P5|Phase 2|Lost to Follow-up|0
3112730|NCT00147537|10658864|P4|Phase 2|Lost to Follow-up|0
3112731|NCT00147537|10658865|P3|Phase 2|Lost to Follow-up|0
3112732|NCT00147537|10658866|P2|Phase 2|Lost to Follow-up|0
3112733|NCT00147537|10658867|P1|Phase 2|Lost to Follow-up|0
3112734|NCT00147537|10658857|P11|Phase 2|Death|31
3112735|NCT00147537|10658858|P10|Phase 2|Death|85
3112736|NCT00147537|10658859|P9|Phase 2|Death|0
3112737|NCT00147537|10658860|P8|Phase 2|Death|0
3112738|NCT00147537|10658861|P7|Phase 2|Death|0
3112739|NCT00147537|10658862|P6|Phase 2|Death|0
3112740|NCT00147537|10658863|P5|Phase 2|Death|0
3112741|NCT00147537|10658864|P4|Phase 2|Death|0
3112742|NCT00147537|10658865|P3|Phase 2|Death|0
3112743|NCT00147537|10658866|P2|Phase 2|Death|0
3112744|NCT00147537|10658867|P1|Phase 2|Death|0
3112745|NCT00147537|10658857|P11|Phase 1b|Randomized but not treated|0
3112746|NCT00147537|10658858|P10|Phase 1b|Randomized but not treated|0
3112747|NCT00147537|10658859|P9|Phase 1b|Randomized but not treated|1
3112748|NCT00147537|10658860|P8|Phase 1b|Randomized but not treated|0
3112749|NCT00147537|10658861|P7|Phase 1b|Randomized but not treated|1
3112750|NCT00147537|10658862|P6|Phase 1b|Randomized but not treated|0
3112751|NCT00147537|10658863|P5|Phase 1b|Randomized but not treated|0
3112752|NCT00147537|10658864|P4|Phase 1b|Randomized but not treated|0
3112753|NCT00147537|10658865|P3|Phase 1b|Randomized but not treated|0
3112754|NCT00147537|10658866|P2|Phase 1b|Randomized but not treated|0
3112755|NCT00147537|10658867|P1|Phase 1b|Randomized but not treated|0
3112756|NCT00147537|10658857|P11|Phase 1b|Withdrawal by Subject|0
3112757|NCT00147537|10658858|P10|Phase 1b|Withdrawal by Subject|0
3112758|NCT00147537|10658859|P9|Phase 1b|Withdrawal by Subject|2
3112759|NCT00147537|10658860|P8|Phase 1b|Withdrawal by Subject|0
3112760|NCT00147537|10658861|P7|Phase 1b|Withdrawal by Subject|0
3112761|NCT00147537|10658862|P6|Phase 1b|Withdrawal by Subject|0
3112762|NCT00147537|10658863|P5|Phase 1b|Withdrawal by Subject|0
3112763|NCT00147537|10658864|P4|Phase 1b|Withdrawal by Subject|0
3112764|NCT00147537|10658865|P3|Phase 1b|Withdrawal by Subject|0
3112765|NCT00147537|10658866|P2|Phase 1b|Withdrawal by Subject|0
3112766|NCT00147537|10658867|P1|Phase 1b|Withdrawal by Subject|0
3112767|NCT00147537|10658857|P11|Phase 1b|Other|0
3112768|NCT00147537|10658858|P10|Phase 1b|Other|0
3112769|NCT00147537|10658859|P9|Phase 1b|Other|4
3112770|NCT00147537|10658860|P8|Phase 1b|Other|4
3112771|NCT00147537|10658861|P7|Phase 1b|Other|14
3112772|NCT00147537|10658862|P6|Phase 1b|Other|1
3112773|NCT00147537|10658863|P5|Phase 1b|Other|1
3112774|NCT00147537|10658864|P4|Phase 1b|Other|1
3112775|NCT00147537|10658865|P3|Phase 1b|Other|2
3112776|NCT00147537|10658866|P2|Phase 1b|Other|0
3112777|NCT00147537|10658867|P1|Phase 1b|Other|0
3112778|NCT00147537|10658857|P11|Phase 1b|Lost to Follow-up|0
3112779|NCT00147537|10658858|P10|Phase 1b|Lost to Follow-up|0
3112780|NCT00147537|10658859|P9|Phase 1b|Lost to Follow-up|1
3112781|NCT00147537|10658860|P8|Phase 1b|Lost to Follow-up|0
3112782|NCT00147537|10658861|P7|Phase 1b|Lost to Follow-up|2
3112783|NCT00147537|10658862|P6|Phase 1b|Lost to Follow-up|0
3112784|NCT00147537|10658863|P5|Phase 1b|Lost to Follow-up|0
3112785|NCT00147537|10658864|P4|Phase 1b|Lost to Follow-up|0
3112786|NCT00147537|10658865|P3|Phase 1b|Lost to Follow-up|0
3112787|NCT00147537|10658866|P2|Phase 1b|Lost to Follow-up|1
3112788|NCT00147537|10658867|P1|Phase 1b|Lost to Follow-up|2
3112789|NCT00147537|10658857|P11|Phase 1b|Death|0
3112790|NCT00147537|10658858|P10|Phase 1b|Death|0
3112791|NCT00147537|10658859|P9|Phase 1b|Death|9
3112792|NCT00147537|10658860|P8|Phase 1b|Death|3
3112793|NCT00147537|10658861|P7|Phase 1b|Death|1
3112794|NCT00147537|10658862|P6|Phase 1b|Death|2
3112795|NCT00147537|10658863|P5|Phase 1b|Death|2
3112796|NCT00147537|10658864|P4|Phase 1b|Death|1
3112797|NCT00147537|10658865|P3|Phase 1b|Death|2
3112798|NCT00147537|10658866|P2|Phase 1b|Death|1
3112799|NCT00147537|10658867|P1|Phase 1b|Death|0
3112800|NCT00147498|10659050|P4|Overall Study|Other|3
3112801|NCT00147498|10659051|P3|Overall Study|Other|3
3112802|NCT00147498|10659052|P2|Overall Study|Other|1
3112803|NCT00147498|10659053|P1|Overall Study|Other|1
3112804|NCT00147498|10659050|P4|Overall Study|Participant defaulted|3
3112805|NCT00147498|10659051|P3|Overall Study|Participant defaulted|4
3112806|NCT00147498|10659052|P2|Overall Study|Participant defaulted|1
3112807|NCT00147498|10659053|P1|Overall Study|Participant defaulted|0
3112808|NCT00147498|10659050|P4|Overall Study|Laboratory abnormality|0
3112809|NCT00147498|10659051|P3|Overall Study|Laboratory abnormality|2
3112810|NCT00147498|10659052|P2|Overall Study|Laboratory abnormality|0
3112811|NCT00147498|10659053|P1|Overall Study|Laboratory abnormality|0
3112812|NCT00147498|10659050|P4|Overall Study|Lack of Efficacy|8
3112813|NCT00147498|10659051|P3|Overall Study|Lack of Efficacy|1
3112814|NCT00147498|10659052|P2|Overall Study|Lack of Efficacy|1
3112815|NCT00147498|10659053|P1|Overall Study|Lack of Efficacy|1
3112816|NCT00147498|10659050|P4|Overall Study|Adverse Event|3
3112817|NCT00147498|10659051|P3|Overall Study|Adverse Event|7
3112818|NCT00147498|10659052|P2|Overall Study|Adverse Event|6
3112819|NCT00147498|10659053|P1|Overall Study|Adverse Event|1
3112820|NCT00147238|10659177|P1|Overall Study|Inevaluable|8
3112821|NCT00147225|10659187|P6|Overall Study|Chemotherapy Changed|1
3112822|NCT00147225|10659188|P5|Overall Study|Chemotherapy Changed|0
3112823|NCT00147225|10659189|P4|Overall Study|Chemotherapy Changed|0
3112824|NCT00147225|10659190|P3|Overall Study|Chemotherapy Changed|0
3112825|NCT00147225|10659191|P2|Overall Study|Chemotherapy Changed|0
3112826|NCT00147225|10659192|P1|Overall Study|Chemotherapy Changed|0
3112827|NCT00147225|10659187|P6|Overall Study|Screen Failure|0
3112828|NCT00147225|10659188|P5|Overall Study|Screen Failure|1
3112829|NCT00147225|10659189|P4|Overall Study|Screen Failure|0
3112830|NCT00147225|10659190|P3|Overall Study|Screen Failure|0
3112831|NCT00147225|10659191|P2|Overall Study|Screen Failure|0
3112832|NCT00147225|10659192|P1|Overall Study|Screen Failure|0
3112833|NCT00147225|10659187|P6|Overall Study|Adverse Event|0
3112834|NCT00147225|10659188|P5|Overall Study|Adverse Event|0
3112835|NCT00147225|10659189|P4|Overall Study|Adverse Event|1
3112836|NCT00147225|10659190|P3|Overall Study|Adverse Event|1
3112837|NCT00147225|10659191|P2|Overall Study|Adverse Event|0
3112838|NCT00147225|10659192|P1|Overall Study|Adverse Event|0
3112839|NCT00147225|10659187|P6|Overall Study|Withdrawal by Subject|1
3112840|NCT00147225|10659188|P5|Overall Study|Withdrawal by Subject|0
3112841|NCT00147225|10659189|P4|Overall Study|Withdrawal by Subject|0
3112842|NCT00147225|10659190|P3|Overall Study|Withdrawal by Subject|1
3112843|NCT00147225|10659191|P2|Overall Study|Withdrawal by Subject|0
3112844|NCT00147225|10659192|P1|Overall Study|Withdrawal by Subject|1
3112845|NCT00146848|10659367|P3|Post-randomization|Withdrawn|27
3112846|NCT00146848|10659368|P2|Post-randomization|Withdrawn|32
3112847|NCT00146848|10659369|P1|Post-randomization|Withdrawn|26
3112848|NCT00146848|10659367|P3|Post-randomization|Lost to Follow-up|12
3112849|NCT00146848|10659368|P2|Post-randomization|Lost to Follow-up|15
3112850|NCT00146848|10659369|P1|Post-randomization|Lost to Follow-up|12
3112851|NCT00146848|10659367|P3|Pre-randomization|Withdrawal by Subject|0
3112852|NCT00146848|10659368|P2|Pre-randomization|Withdrawal by Subject|0
3112853|NCT00146848|10659369|P1|Pre-randomization|Withdrawal by Subject|40
3112854|NCT00146848|10659367|P3|Pre-randomization|Protocol Violation|0
3112855|NCT00146848|10659368|P2|Pre-randomization|Protocol Violation|0
3112856|NCT00146848|10659369|P1|Pre-randomization|Protocol Violation|172
3112857|NCT00146848|10659367|P3|Pre-randomization|Physician Decision|0
3112858|NCT00146848|10659368|P2|Pre-randomization|Physician Decision|0
3112859|NCT00146848|10659369|P1|Pre-randomization|Physician Decision|8
3112860|NCT00146848|10659367|P3|Pre-randomization|Lost to Follow-up|0
3112861|NCT00146848|10659368|P2|Pre-randomization|Lost to Follow-up|0
3112862|NCT00146848|10659369|P1|Pre-randomization|Lost to Follow-up|70
3112863|NCT00146848|10659367|P3|Pre-randomization|Death|0
3112864|NCT00146848|10659368|P2|Pre-randomization|Death|0
3112865|NCT00146848|10659369|P1|Pre-randomization|Death|19
3112866|NCT00146770|10659385|P2|Overall Study|Withdrawal by Subject|0
3112867|NCT00146770|10659386|P1|Overall Study|Withdrawal by Subject|2
3112868|NCT00146770|10659385|P2|Overall Study|Pregnancy|0
3112869|NCT00146770|10659386|P1|Overall Study|Pregnancy|1
3112870|NCT00146770|10659385|P2|Overall Study|Adverse Event|0
3112871|NCT00146770|10659386|P1|Overall Study|Adverse Event|2
3112872|NCT00146757|10659404|P2|Overall Study|Adverse Event|0
3112873|NCT00146757|10659405|P1|Overall Study|Adverse Event|1
3112874|NCT00146757|10659404|P2|Overall Study|Death|0
3112875|NCT00146757|10659405|P1|Overall Study|Death|1
3112876|NCT00146640|10659424|P2|Overall Study|Non-Medical Reasons|4
3112877|NCT00146640|10659425|P1|Overall Study|Non-Medical Reasons|8
3112878|NCT00146640|10659424|P2|Overall Study|Medical Reasons|0
3112879|NCT00146640|10659425|P1|Overall Study|Medical Reasons|3
3112880|NCT00146640|10659424|P2|Overall Study|Adverse Event|10
3112881|NCT00146640|10659425|P1|Overall Study|Adverse Event|12
3112882|NCT00146328|10659448|P3|Overall Study|Interaction with other medication|1
3112883|NCT00146328|10659449|P2|Overall Study|Interaction with other medication|0
3112884|NCT00146328|10659450|P1|Overall Study|Interaction with other medication|2
3112885|NCT00146328|10659448|P3|Overall Study|Moved|0
3112886|NCT00146328|10659449|P2|Overall Study|Moved|0
3112887|NCT00146328|10659450|P1|Overall Study|Moved|2
3112888|NCT00146328|10659448|P3|Overall Study|Death|1
3112889|NCT00146328|10659449|P2|Overall Study|Death|1
3112890|NCT00146328|10659450|P1|Overall Study|Death|0
3112891|NCT00146328|10659448|P3|Overall Study|Enroll into other trial|2
3112892|NCT00146328|10659449|P2|Overall Study|Enroll into other trial|4
3112893|NCT00146328|10659450|P1|Overall Study|Enroll into other trial|2
3112894|NCT00146328|10659448|P3|Overall Study|Patient decision to end|6
3112895|NCT00146328|10659449|P2|Overall Study|Patient decision to end|1
3112896|NCT00146328|10659450|P1|Overall Study|Patient decision to end|0
3112897|NCT00146328|10659448|P3|Overall Study|Trial ended/site closed|19
3112898|NCT00146328|10659449|P2|Overall Study|Trial ended/site closed|2
3112899|NCT00146328|10659450|P1|Overall Study|Trial ended/site closed|8
3112900|NCT00146328|10659448|P3|Overall Study|Virologic Failure/lack of efficacy|142
3112901|NCT00146328|10659449|P2|Overall Study|Virologic Failure/lack of efficacy|72
3112902|NCT00146328|10659450|P1|Overall Study|Virologic Failure/lack of efficacy|54
3112903|NCT00146328|10659448|P3|Overall Study|Withdrawal by Subject|22
3112904|NCT00146328|10659449|P2|Overall Study|Withdrawal by Subject|16
3112905|NCT00146328|10659450|P1|Overall Study|Withdrawal by Subject|16
3112906|NCT00146328|10659448|P3|Overall Study|Lost to Follow-up|7
3112907|NCT00146328|10659449|P2|Overall Study|Lost to Follow-up|4
3112908|NCT00146328|10659450|P1|Overall Study|Lost to Follow-up|7
3112909|NCT00146328|10659448|P3|Overall Study|Protocol Violation|12
3112910|NCT00146328|10659449|P2|Overall Study|Protocol Violation|6
3112911|NCT00146328|10659450|P1|Overall Study|Protocol Violation|11
3112912|NCT00146328|10659448|P3|Overall Study|Adverse Event|79
3112913|NCT00146328|10659449|P2|Overall Study|Adverse Event|48
3112914|NCT00146328|10659450|P1|Overall Study|Adverse Event|39
3112915|NCT00146172|10659541|P8|Overall Study|Symptomatic Deterioration|2
3112916|NCT00146172|10659542|P7|Overall Study|Symptomatic Deterioration|0
3112917|NCT00146172|10659543|P6|Overall Study|Symptomatic Deterioration|2
3112918|NCT00146172|10659544|P5|Overall Study|Symptomatic Deterioration|1
3112919|NCT00146172|10659545|P4|Overall Study|Symptomatic Deterioration|0
3112920|NCT00146172|10659546|P3|Overall Study|Symptomatic Deterioration|1
3112921|NCT00146172|10659547|P2|Overall Study|Symptomatic Deterioration|0
3112922|NCT00146172|10659548|P1|Overall Study|Symptomatic Deterioration|1
3112923|NCT00146172|10659541|P8|Overall Study|Withdrawal by Subject|4
3112924|NCT00146172|10659542|P7|Overall Study|Withdrawal by Subject|1
3112925|NCT00146172|10659543|P6|Overall Study|Withdrawal by Subject|1
3112926|NCT00146172|10659544|P5|Overall Study|Withdrawal by Subject|0
3112927|NCT00146172|10659545|P4|Overall Study|Withdrawal by Subject|0
3112928|NCT00146172|10659546|P3|Overall Study|Withdrawal by Subject|0
3112929|NCT00146172|10659547|P2|Overall Study|Withdrawal by Subject|0
3112930|NCT00146172|10659548|P1|Overall Study|Withdrawal by Subject|0
3112931|NCT00146172|10659541|P8|Overall Study|Physician Decision|1
3112932|NCT00146172|10659542|P7|Overall Study|Physician Decision|0
3112933|NCT00146172|10659543|P6|Overall Study|Physician Decision|0
3112934|NCT00146172|10659544|P5|Overall Study|Physician Decision|0
3112935|NCT00146172|10659545|P4|Overall Study|Physician Decision|0
3112936|NCT00146172|10659546|P3|Overall Study|Physician Decision|0
3112937|NCT00146172|10659547|P2|Overall Study|Physician Decision|0
3112938|NCT00146172|10659548|P1|Overall Study|Physician Decision|0
3112939|NCT00146172|10659541|P8|Overall Study|Death|0
3112940|NCT00146172|10659542|P7|Overall Study|Death|1
3112941|NCT00146172|10659543|P6|Overall Study|Death|0
3112942|NCT00146172|10659544|P5|Overall Study|Death|0
3112943|NCT00146172|10659545|P4|Overall Study|Death|0
3112944|NCT00146172|10659546|P3|Overall Study|Death|0
3112945|NCT00146172|10659547|P2|Overall Study|Death|0
3112946|NCT00146172|10659548|P1|Overall Study|Death|0
3112947|NCT00146172|10659541|P8|Overall Study|Disease Progression|22
3112948|NCT00146172|10659542|P7|Overall Study|Disease Progression|1
3112949|NCT00146172|10659543|P6|Overall Study|Disease Progression|2
3112950|NCT00146172|10659544|P5|Overall Study|Disease Progression|2
3112951|NCT00146172|10659545|P4|Overall Study|Disease Progression|5
3112952|NCT00146172|10659546|P3|Overall Study|Disease Progression|2
3112953|NCT00146172|10659547|P2|Overall Study|Disease Progression|4
3112954|NCT00146172|10659548|P1|Overall Study|Disease Progression|2
3112955|NCT00146172|10659541|P8|Overall Study|Lost to Follow-up|1
3112956|NCT00146172|10659542|P7|Overall Study|Lost to Follow-up|0
3112957|NCT00146172|10659543|P6|Overall Study|Lost to Follow-up|0
3112958|NCT00146172|10659544|P5|Overall Study|Lost to Follow-up|0
3112959|NCT00146172|10659545|P4|Overall Study|Lost to Follow-up|0
3112960|NCT00146172|10659546|P3|Overall Study|Lost to Follow-up|0
3112961|NCT00146172|10659547|P2|Overall Study|Lost to Follow-up|0
3112962|NCT00146172|10659548|P1|Overall Study|Lost to Follow-up|0
3112963|NCT00146172|10659541|P8|Overall Study|Adverse Event|10
3112964|NCT00146172|10659542|P7|Overall Study|Adverse Event|3
3112965|NCT00146172|10659543|P6|Overall Study|Adverse Event|2
3112966|NCT00146172|10659544|P5|Overall Study|Adverse Event|0
3112967|NCT00146172|10659545|P4|Overall Study|Adverse Event|1
3112968|NCT00146172|10659546|P3|Overall Study|Adverse Event|1
3112969|NCT00146172|10659547|P2|Overall Study|Adverse Event|0
3112970|NCT00146172|10659548|P1|Overall Study|Adverse Event|0
3112971|NCT00145977|10659583|P2|Overall Study|Withdrawal by Subject|0
3112972|NCT00145977|10659584|P1|Overall Study|Withdrawal by Subject|1
3112973|NCT00145977|10659583|P2|Overall Study|Lost to Follow-up|0
3112974|NCT00145977|10659584|P1|Overall Study|Lost to Follow-up|1
3112975|NCT00145977|10659583|P2|Overall Study|Lack of Efficacy|4
3112976|NCT00145977|10659584|P1|Overall Study|Lack of Efficacy|0
3112977|NCT00145795|10659610|P2|Overall Study|Adverse Event|0
3112978|NCT00145795|10659611|P1|Overall Study|Adverse Event|1
3112979|NCT00145626|10659646|P1|Overall Study|Withdrawal by Subject|1
3112980|NCT00145626|10659646|P1|Overall Study|Death|1
3112981|NCT00145626|10659646|P1|Overall Study|Turned 2 years old before treatment|1
3112982|NCT00145626|10659646|P1|Overall Study|Did not have NK infusions|2
3112983|NCT00145600|10659692|P4|Overall Study|Withdrawal by Subject|1
3112984|NCT00145600|10659693|P3|Overall Study|Withdrawal by Subject|0
3112985|NCT00145600|10659694|P2|Overall Study|Withdrawal by Subject|2
3112986|NCT00145600|10659695|P1|Overall Study|Withdrawal by Subject|1
3112987|NCT00145600|10659692|P4|Overall Study|Noncompliance|0
3112988|NCT00145600|10659693|P3|Overall Study|Noncompliance|0
3112989|NCT00145600|10659694|P2|Overall Study|Noncompliance|0
3112990|NCT00145600|10659695|P1|Overall Study|Noncompliance|1
3112991|NCT00145600|10659692|P4|Overall Study|Lost to Follow-up|4
3112992|NCT00145600|10659693|P3|Overall Study|Lost to Follow-up|2
3112993|NCT00145600|10659694|P2|Overall Study|Lost to Follow-up|6
3112994|NCT00145600|10659695|P1|Overall Study|Lost to Follow-up|2
3112995|NCT00145600|10659692|P4|Overall Study|Ineligible|5
3112996|NCT00145600|10659693|P3|Overall Study|Ineligible|1
3112997|NCT00145600|10659694|P2|Overall Study|Ineligible|0
3112998|NCT00145600|10659695|P1|Overall Study|Ineligible|3
3112999|NCT00145600|10659692|P4|Overall Study|Death|6
3113000|NCT00145600|10659693|P3|Overall Study|Death|2
3113001|NCT00145600|10659694|P2|Overall Study|Death|2
3113002|NCT00145600|10659695|P1|Overall Study|Death|1
3113003|NCT00145574|10659819|P3|Open Label Long-term Extension|required restricted medicine|1
3113004|NCT00145574|10659820|P2|Open Label Long-term Extension|required restricted medicine|0
3113005|NCT00145574|10659821|P1|Open Label Long-term Extension|required restricted medicine|0
3113006|NCT00145574|10659819|P3|Open Label Long-term Extension|Withdrawal by Subject|4
3113007|NCT00145574|10659820|P2|Open Label Long-term Extension|Withdrawal by Subject|0
3113008|NCT00145574|10659821|P1|Open Label Long-term Extension|Withdrawal by Subject|0
3113009|NCT00145574|10659819|P3|Open Label Long-term Extension|Lost to Follow-up|1
3113010|NCT00145574|10659820|P2|Open Label Long-term Extension|Lost to Follow-up|0
3113011|NCT00145574|10659821|P1|Open Label Long-term Extension|Lost to Follow-up|0
3113012|NCT00145574|10659819|P3|Open Label Long-term Extension|Adverse Event|5
3113013|NCT00145574|10659820|P2|Open Label Long-term Extension|Adverse Event|0
3113014|NCT00145574|10659821|P1|Open Label Long-term Extension|Adverse Event|0
3113015|NCT00145574|10659819|P3|Double Blind|required restricted medicine|0
3113016|NCT00145574|10659820|P2|Double Blind|required restricted medicine|1
3113017|NCT00145574|10659821|P1|Double Blind|required restricted medicine|0
3113018|NCT00145574|10659819|P3|Double Blind|Withdrawal by Subject|1
3113019|NCT00145574|10659820|P2|Double Blind|Withdrawal by Subject|1
3113020|NCT00145574|10659821|P1|Double Blind|Withdrawal by Subject|1
3113021|NCT00145574|10659819|P3|Double Blind|Adverse Event|1
3113022|NCT00145574|10659820|P2|Double Blind|Adverse Event|3
3113023|NCT00145574|10659821|P1|Double Blind|Adverse Event|0
3113024|NCT00145509|10659878|P2|Overall Study|Reason not provided|1
3113025|NCT00145509|10659879|P1|Overall Study|Reason not provided|2
3113026|NCT00145509|10659878|P2|Overall Study|Withdrew Consent|7
3113027|NCT00145509|10659879|P1|Overall Study|Withdrew Consent|2
3113028|NCT00145509|10659878|P2|Overall Study|Lost to Follow-up|9
3113029|NCT00145509|10659879|P1|Overall Study|Lost to Follow-up|5
3113030|NCT00145509|10659878|P2|Overall Study|Lack of Efficacy|1
3113031|NCT00145509|10659879|P1|Overall Study|Lack of Efficacy|3
3113032|NCT00145509|10659878|P2|Overall Study|Adverse Event|3
3113033|NCT00145509|10659879|P1|Overall Study|Adverse Event|10
3113034|NCT00145496|10659893|P2|Overall Study|Other|13
3113035|NCT00145496|10659894|P1|Overall Study|Other|25
3113036|NCT00145496|10659893|P2|Overall Study|Lost to Follow-up|5
3113037|NCT00145496|10659894|P1|Overall Study|Lost to Follow-up|12
3113038|NCT00145496|10659893|P2|Overall Study|Withdrawal by Subject|26
3113039|NCT00145496|10659894|P1|Overall Study|Withdrawal by Subject|32
3113040|NCT00145496|10659893|P2|Overall Study|Lack of Efficacy|7
3113041|NCT00145496|10659894|P1|Overall Study|Lack of Efficacy|12
3113042|NCT00145496|10659893|P2|Overall Study|Adverse Event|30
3113043|NCT00145496|10659894|P1|Overall Study|Adverse Event|42
3113044|NCT00145470|10659906|P2|Overall Study|Reason Not Reported|9
3113045|NCT00145470|10659907|P1|Overall Study|Reason Not Reported|9
3113046|NCT00145470|10659906|P2|Overall Study|Lost to Follow-up|17
3113047|NCT00145470|10659907|P1|Overall Study|Lost to Follow-up|21
3113048|NCT00145470|10659906|P2|Overall Study|Withdrawal by Subject|34
3113049|NCT00145470|10659907|P1|Overall Study|Withdrawal by Subject|36
3113050|NCT00145470|10659906|P2|Overall Study|Lack of Efficacy|13
3113051|NCT00145470|10659907|P1|Overall Study|Lack of Efficacy|27
3113052|NCT00145470|10659906|P2|Overall Study|Adverse Event|25
3113053|NCT00145470|10659907|P1|Overall Study|Adverse Event|19
3113054|NCT00145327|10659977|P3|Overall Study|Missing – not stated|1
3113055|NCT00145327|10659978|P2|Overall Study|Missing – not stated|0
3113056|NCT00145327|10659979|P1|Overall Study|Missing – not stated|1
3113057|NCT00145327|10659977|P3|Overall Study|Abnormal laboratory value(s)|2
3113058|NCT00145327|10659978|P2|Overall Study|Abnormal laboratory value(s)|0
3113059|NCT00145327|10659979|P1|Overall Study|Abnormal laboratory value(s)|1
3113060|NCT00145327|10659977|P3|Overall Study|Protocol Violation|2
3113061|NCT00145327|10659978|P2|Overall Study|Protocol Violation|0
3113062|NCT00145327|10659979|P1|Overall Study|Protocol Violation|2
3113063|NCT00145327|10659977|P3|Overall Study|Administrative problems|13
3113064|NCT00145327|10659978|P2|Overall Study|Administrative problems|9
3113065|NCT00145327|10659979|P1|Overall Study|Administrative problems|12
3113066|NCT00145327|10659977|P3|Overall Study|Lost to Follow-up|14
3113067|NCT00145327|10659978|P2|Overall Study|Lost to Follow-up|14
3113068|NCT00145327|10659979|P1|Overall Study|Lost to Follow-up|9
3113069|NCT00145327|10659977|P3|Overall Study|Adverse Event|22
3113070|NCT00145327|10659978|P2|Overall Study|Adverse Event|11
3113071|NCT00145327|10659979|P1|Overall Study|Adverse Event|14
3113072|NCT00145327|10659977|P3|Overall Study|Death|30
3113073|NCT00145327|10659978|P2|Overall Study|Death|18
3113074|NCT00145327|10659979|P1|Overall Study|Death|26
3113075|NCT00145327|10659977|P3|Overall Study|Withdrawal by Subject|164
3113076|NCT00145327|10659978|P2|Overall Study|Withdrawal by Subject|72
3113077|NCT00145327|10659979|P1|Overall Study|Withdrawal by Subject|77
3113078|NCT00145119|10660078|P1|Overall Study|Death|45
3113079|NCT00144781|10660096|P4|Overall Study|Non-compliant|0
3113080|NCT00144781|10660097|P3|Overall Study|Non-compliant|0
3113081|NCT00144781|10660098|P2|Overall Study|Non-compliant|1
3113082|NCT00144781|10660099|P1|Overall Study|Non-compliant|0
3113083|NCT00144781|10660096|P4|Overall Study|Adverse Event|0
3113084|NCT00144781|10660097|P3|Overall Study|Adverse Event|0
3113085|NCT00144781|10660098|P2|Overall Study|Adverse Event|1
3113086|NCT00144781|10660099|P1|Overall Study|Adverse Event|0
3113087|NCT00144339|10660128|P2|Overall Study|Other|60
3113088|NCT00144339|10660129|P1|Overall Study|Other|58
3113089|NCT00144339|10660128|P2|Overall Study|Lost to Follow-up|64
3113090|NCT00144339|10660129|P1|Overall Study|Lost to Follow-up|76
3113091|NCT00144339|10660128|P2|Overall Study|Withdrawal by Subject|300
3113092|NCT00144339|10660129|P1|Overall Study|Withdrawal by Subject|403
3113093|NCT00144339|10660128|P2|Overall Study|Protocol Violation|48
3113094|NCT00144339|10660129|P1|Overall Study|Protocol Violation|75
3113095|NCT00144339|10660128|P2|Overall Study|Adverse Event|627
3113096|NCT00144339|10660129|P1|Overall Study|Adverse Event|746
3113097|NCT00144300|10660337|P2|Overall Study|Other reason (not specified)|3
3113098|NCT00144300|10660338|P1|Overall Study|Other reason (not specified)|1
3113099|NCT00144300|10660337|P2|Overall Study|Withdrawal by Subject|6
3113100|NCT00144300|10660338|P1|Overall Study|Withdrawal by Subject|6
3113101|NCT00144300|10660337|P2|Overall Study|Lost to Follow-up|0
3113102|NCT00144300|10660338|P1|Overall Study|Lost to Follow-up|3
3113103|NCT00144300|10660337|P2|Overall Study|Protocol Violation|3
3113104|NCT00144300|10660338|P1|Overall Study|Protocol Violation|1
3113105|NCT00144300|10660337|P2|Overall Study|Adverse Event|16
3113106|NCT00144300|10660338|P1|Overall Study|Adverse Event|18
3113107|NCT00144170|10660386|P2|Overall Study|Other reason not defined above|316
3113108|NCT00144170|10660387|P1|Overall Study|Other reason not defined above|211
3113109|NCT00144170|10660386|P2|Overall Study|Withdrawal by Subject|13
3113110|NCT00144170|10660387|P1|Overall Study|Withdrawal by Subject|29
3113111|NCT00144170|10660386|P2|Overall Study|Lost to Follow-up|10
3113112|NCT00144170|10660387|P1|Overall Study|Lost to Follow-up|5
3113113|NCT00144170|10660386|P2|Overall Study|Protocol Violation|16
3113114|NCT00144170|10660387|P1|Overall Study|Protocol Violation|23
3113115|NCT00144170|10660386|P2|Overall Study|Adverse Event|41
3113116|NCT00144170|10660387|P1|Overall Study|Adverse Event|84
3113117|NCT00144027|10660577|P2|Overall Study|did not complete baseline assessment|6
3113118|NCT00144027|10660578|P1|Overall Study|did not complete baseline assessment|0
3113119|NCT00144027|10660577|P2|Overall Study|Withdrawal by Subject|2
3113120|NCT00144027|10660578|P1|Overall Study|Withdrawal by Subject|2
3113121|NCT00144027|10660577|P2|Overall Study|Lost to Follow-up|3
3113122|NCT00144027|10660578|P1|Overall Study|Lost to Follow-up|1
3113123|NCT00143598|10660608|P2|Overall Study|Death|36
3113124|NCT00143598|10660609|P1|Overall Study|Death|36
3113125|NCT00143598|10660608|P2|Overall Study|Withdrawal by Subject|37
3113126|NCT00143598|10660609|P1|Overall Study|Withdrawal by Subject|33
3113127|NCT00143598|10660608|P2|Overall Study|Lost to Follow-up|21
3113128|NCT00143598|10660609|P1|Overall Study|Lost to Follow-up|23
3113129|NCT00143507|10660623|P2|Overall Study|Withdrawn by sponsor's decision|3
3113130|NCT00143507|10660624|P1|Overall Study|Withdrawn by sponsor's decision|0
3113131|NCT00143507|10660623|P2|Overall Study|Lost to Follow-up|0
3113132|NCT00143507|10660624|P1|Overall Study|Lost to Follow-up|1
3113133|NCT00143507|10660623|P2|Overall Study|Withdrawal by Subject|102
3113134|NCT00143507|10660624|P1|Overall Study|Withdrawal by Subject|114
3113135|NCT00143507|10660623|P2|Overall Study|Death|547
3113136|NCT00143507|10660624|P1|Overall Study|Death|572
3113137|NCT00143455|10660658|P4|Cohort 2|Randomized But Not Treated|1
3113138|NCT00143455|10660659|P3|Cohort 2|Randomized But Not Treated|1
3113139|NCT00143455|10660660|P2|Cohort 2|Randomized But Not Treated|0
3113140|NCT00143455|10660661|P1|Cohort 2|Randomized But Not Treated|0
3113141|NCT00143455|10660658|P4|Cohort 2|Other|6
3113142|NCT00143455|10660659|P3|Cohort 2|Other|7
3113143|NCT00143455|10660660|P2|Cohort 2|Other|0
3113144|NCT00143455|10660661|P1|Cohort 2|Other|0
3113145|NCT00143455|10660658|P4|Cohort 2|Withdrawal by Subject|12
3113146|NCT00143455|10660659|P3|Cohort 2|Withdrawal by Subject|13
3113147|NCT00143455|10660660|P2|Cohort 2|Withdrawal by Subject|0
3113148|NCT00143455|10660661|P1|Cohort 2|Withdrawal by Subject|0
3113149|NCT00143455|10660658|P4|Cohort 2|Progressive Disease|27
3113150|NCT00143455|10660659|P3|Cohort 2|Progressive Disease|20
3113151|NCT00143455|10660660|P2|Cohort 2|Progressive Disease|0
3113152|NCT00143455|10660661|P1|Cohort 2|Progressive Disease|0
3113153|NCT00143455|10660658|P4|Cohort 2|Death|12
3113154|NCT00143455|10660659|P3|Cohort 2|Death|20
3113155|NCT00143455|10660660|P2|Cohort 2|Death|0
3113156|NCT00143455|10660661|P1|Cohort 2|Death|0
3113157|NCT00143455|10660658|P4|Cohort 2|Lost to Follow-up|4
3113158|NCT00143455|10660659|P3|Cohort 2|Lost to Follow-up|1
3113159|NCT00143455|10660660|P2|Cohort 2|Lost to Follow-up|0
3113160|NCT00143455|10660661|P1|Cohort 2|Lost to Follow-up|0
3113161|NCT00143455|10660658|P4|Cohort 2|Protocol Violation|1
3113162|NCT00143455|10660659|P3|Cohort 2|Protocol Violation|1
3113163|NCT00143455|10660660|P2|Cohort 2|Protocol Violation|0
3113164|NCT00143455|10660661|P1|Cohort 2|Protocol Violation|0
3113165|NCT00143455|10660658|P4|Cohort 2|No Longer Required Study Treatment|0
3113166|NCT00143455|10660659|P3|Cohort 2|No Longer Required Study Treatment|1
3113167|NCT00143455|10660660|P2|Cohort 2|No Longer Required Study Treatment|0
3113168|NCT00143455|10660661|P1|Cohort 2|No Longer Required Study Treatment|0
3113169|NCT00143455|10660658|P4|Cohort 2|Adverse Event|30
3113170|NCT00143455|10660659|P3|Cohort 2|Adverse Event|42
3113171|NCT00143455|10660660|P2|Cohort 2|Adverse Event|0
3113172|NCT00143455|10660661|P1|Cohort 2|Adverse Event|0
3113173|NCT00143455|10660658|P4|Cohort 1|Randomized But Not Treated|0
3113174|NCT00143455|10660659|P3|Cohort 1|Randomized But Not Treated|0
3113175|NCT00143455|10660660|P2|Cohort 1|Randomized But Not Treated|1
3113176|NCT00143455|10660661|P1|Cohort 1|Randomized But Not Treated|0
3113177|NCT00143455|10660658|P4|Cohort 1|Withdrawal by Subject|0
3113178|NCT00143455|10660659|P3|Cohort 1|Withdrawal by Subject|0
3113179|NCT00143455|10660660|P2|Cohort 1|Withdrawal by Subject|4
3113180|NCT00143455|10660661|P1|Cohort 1|Withdrawal by Subject|1
3113181|NCT00143455|10660658|P4|Cohort 1|Progressive Disease|0
3113182|NCT00143455|10660659|P3|Cohort 1|Progressive Disease|0
3113183|NCT00143455|10660660|P2|Cohort 1|Progressive Disease|6
3113184|NCT00143455|10660661|P1|Cohort 1|Progressive Disease|0
3113185|NCT00143455|10660658|P4|Cohort 1|Death|0
3113186|NCT00143455|10660659|P3|Cohort 1|Death|0
3113187|NCT00143455|10660660|P2|Cohort 1|Death|2
3113188|NCT00143455|10660661|P1|Cohort 1|Death|5
3113189|NCT00143455|10660658|P4|Cohort 1|Adverse Event|0
3113190|NCT00143455|10660659|P3|Cohort 1|Adverse Event|0
3113191|NCT00143455|10660660|P2|Cohort 1|Adverse Event|4
3113192|NCT00143455|10660661|P1|Cohort 1|Adverse Event|8
3113193|NCT00143403|10660695|P2|Overall Study|Randomized Not Treated|8
3113194|NCT00143403|10660696|P1|Overall Study|Randomized Not Treated|7
3113195|NCT00143403|10660695|P2|Overall Study|specified by site|9
3113196|NCT00143403|10660696|P1|Overall Study|specified by site|4
3113197|NCT00143403|10660695|P2|Overall Study|Protocol Violation|2
3113198|NCT00143403|10660696|P1|Overall Study|Protocol Violation|2
3113199|NCT00143403|10660695|P2|Overall Study|Relapse|7
3113200|NCT00143403|10660696|P1|Overall Study|Relapse|15
3113201|NCT00143403|10660695|P2|Overall Study|Withdrawal by Subject|12
3113202|NCT00143403|10660696|P1|Overall Study|Withdrawal by Subject|3
3113203|NCT00143403|10660695|P2|Overall Study|Death|0
3113204|NCT00143403|10660696|P1|Overall Study|Death|1
3113205|NCT00143403|10660695|P2|Overall Study|Adverse Event|8
3113206|NCT00143403|10660696|P1|Overall Study|Adverse Event|3
3113207|NCT00143390|10660706|P2|Overall Study|Other|2
3113208|NCT00143390|10660707|P1|Overall Study|Other|1
3113209|NCT00143390|10660706|P2|Overall Study|Adverse Event|8
3113210|NCT00143390|10660707|P1|Overall Study|Adverse Event|9
3113211|NCT00143390|10660706|P2|Overall Study|Study termination|15
3113212|NCT00143390|10660707|P1|Overall Study|Study termination|10
3113213|NCT00143390|10660706|P2|Overall Study|Protocol Violation|0
3113214|NCT00143390|10660707|P1|Overall Study|Protocol Violation|2
3113215|NCT00143390|10660706|P2|Overall Study|Progressive disease|115
3113216|NCT00143390|10660707|P1|Overall Study|Progressive disease|119
3113217|NCT00143390|10660706|P2|Overall Study|Withdrawal by Subject|4
3113218|NCT00143390|10660707|P1|Overall Study|Withdrawal by Subject|4
3113219|NCT00143390|10660706|P2|Overall Study|Not meeting entry criteria|5
3113220|NCT00143390|10660707|P1|Overall Study|Not meeting entry criteria|2
3113221|NCT00143390|10660706|P2|Overall Study|Death|0
3113222|NCT00143390|10660707|P1|Overall Study|Death|2
3113223|NCT00143312|10660723|P1|Overall Study|Withdrawal by Subject|1
3113224|NCT00143312|10660723|P1|Overall Study|Other|1
3113225|NCT00143312|10660723|P1|Overall Study|Lost to Follow-up|1
3113226|NCT00143312|10660723|P1|Overall Study|Adverse Event|2
3113227|NCT00143312|10660723|P1|Overall Study|Death|11
3113228|NCT00143247|10660733|P1|Overall Study|Other|12
3113229|NCT00143247|10660733|P1|Overall Study|following inaccurate lab adverse event|1
3113230|NCT00143247|10660733|P1|Overall Study|Lost to Follow-up|12
3113231|NCT00143247|10660733|P1|Overall Study|Protocol Violation|15
3113232|NCT00143247|10660733|P1|Overall Study|Study terminated by sponsor|31
3113233|NCT00143247|10660733|P1|Overall Study|Withdrawal by Subject|55
3113234|NCT00143247|10660733|P1|Overall Study|Lack of Efficacy|3
3113235|NCT00143247|10660733|P1|Overall Study|Adverse Event|19
3113236|NCT00143247|10660733|P1|Overall Study|Death|8
3113237|NCT00142935|10660750|P3|Overall Study|Death|1
3113238|NCT00142935|10660751|P2|Overall Study|Death|2
3113239|NCT00142935|10660752|P1|Overall Study|Death|0
3113240|NCT00142935|10660750|P3|Overall Study|Lost to Follow-up|5
3113241|NCT00142935|10660751|P2|Overall Study|Lost to Follow-up|5
3113242|NCT00142935|10660752|P1|Overall Study|Lost to Follow-up|2
3113243|NCT00142935|10660750|P3|Overall Study|Other reason|1
3113244|NCT00142935|10660751|P2|Overall Study|Other reason|1
3113245|NCT00142935|10660752|P1|Overall Study|Other reason|1
3113246|NCT00142909|10660777|P2|Medications Begin|Withdrawal by Subject|0
3113247|NCT00142909|10660778|P1|Medications Begin|Withdrawal by Subject|2
3113248|NCT00142909|10660777|P2|Medications Begin|Withdrawal by Subject|3
3113249|NCT00142909|10660778|P1|Medications Begin|Withdrawal by Subject|5
3113250|NCT00142909|10660777|P2|Medications Begin|Protocol Violation|0
3113251|NCT00142909|10660778|P1|Medications Begin|Protocol Violation|2
3113252|NCT00142909|10660777|P2|Randomization|Various Reasons|10
3113253|NCT00142909|10660778|P1|Randomization|Various Reasons|7
3113254|NCT00142792|10660814|P3|Overall Study|No category|1
3113255|NCT00142792|10660815|P2|Overall Study|No category|2
3113256|NCT00142792|10660816|P1|Overall Study|No category|1
3113257|NCT00142792|10660814|P3|Overall Study|Lost to Follow-up|7
3113258|NCT00142792|10660815|P2|Overall Study|Lost to Follow-up|11
3113259|NCT00142792|10660816|P1|Overall Study|Lost to Follow-up|8
3113260|NCT00142792|10660814|P3|Overall Study|Withdrawal by Subject|3
3113261|NCT00142792|10660815|P2|Overall Study|Withdrawal by Subject|2
3113262|NCT00142792|10660816|P1|Overall Study|Withdrawal by Subject|3
3113263|NCT00142792|10660814|P3|Overall Study|Death|1
3113264|NCT00142792|10660815|P2|Overall Study|Death|0
3113265|NCT00142792|10660816|P1|Overall Study|Death|0
3113266|NCT00142519|10660838|P2|Overall Study|Withdrawal by Subject|7
3113267|NCT00142519|10660839|P1|Overall Study|Withdrawal by Subject|10
3113268|NCT00142519|10660838|P2|Overall Study|Protocol Violation|0
3113269|NCT00142519|10660839|P1|Overall Study|Protocol Violation|1
3113270|NCT00142519|10660838|P2|Overall Study|Not Treated|9
3113271|NCT00142519|10660839|P1|Overall Study|Not Treated|7
3113272|NCT00142415|10660862|P6|Overall Study|Physician Decision|2
3113273|NCT00142415|10660863|P5|Overall Study|Physician Decision|1
3113274|NCT00142415|10660864|P4|Overall Study|Physician Decision|0
3113275|NCT00142415|10660865|P3|Overall Study|Physician Decision|0
3113276|NCT00142415|10660866|P2|Overall Study|Physician Decision|0
3113277|NCT00142415|10660867|P1|Overall Study|Physician Decision|0
3113278|NCT00142298|10660905|P10|Overall Study|Treatment Failure|0
3113279|NCT00142298|10660906|P9|Overall Study|Treatment Failure|0
3113280|NCT00142298|10660907|P8|Overall Study|Treatment Failure|0
3113281|NCT00142298|10660908|P7|Overall Study|Treatment Failure|2
3113282|NCT00142298|10660909|P6|Overall Study|Treatment Failure|2
3113283|NCT00142298|10660910|P5|Overall Study|Treatment Failure|0
3113284|NCT00142298|10660911|P4|Overall Study|Treatment Failure|0
3113285|NCT00142298|10660912|P3|Overall Study|Treatment Failure|0
3113286|NCT00142298|10660913|P2|Overall Study|Treatment Failure|0
3113287|NCT00142298|10660914|P1|Overall Study|Treatment Failure|0
3113288|NCT00142298|10660905|P10|Overall Study|Lost to Follow-up|0
3113289|NCT00142298|10660906|P9|Overall Study|Lost to Follow-up|0
3113290|NCT00142298|10660907|P8|Overall Study|Lost to Follow-up|0
3113291|NCT00142298|10660908|P7|Overall Study|Lost to Follow-up|2
3113292|NCT00142298|10660909|P6|Overall Study|Lost to Follow-up|0
3113293|NCT00142298|10660910|P5|Overall Study|Lost to Follow-up|0
3113294|NCT00142298|10660911|P4|Overall Study|Lost to Follow-up|0
3113295|NCT00142298|10660912|P3|Overall Study|Lost to Follow-up|0
3113296|NCT00142298|10660913|P2|Overall Study|Lost to Follow-up|0
3113297|NCT00142298|10660914|P1|Overall Study|Lost to Follow-up|0
3113298|NCT00142298|10660905|P10|Overall Study|Other- not specified|0
3113299|NCT00142298|10660906|P9|Overall Study|Other- not specified|0
3113300|NCT00142298|10660907|P8|Overall Study|Other- not specified|0
3113301|NCT00142298|10660908|P7|Overall Study|Other- not specified|0
3113302|NCT00142298|10660909|P6|Overall Study|Other- not specified|0
3113303|NCT00142298|10660910|P5|Overall Study|Other- not specified|0
3113304|NCT00142298|10660911|P4|Overall Study|Other- not specified|1
3113305|NCT00142298|10660912|P3|Overall Study|Other- not specified|0
3113306|NCT00142298|10660913|P2|Overall Study|Other- not specified|3
3113307|NCT00142298|10660914|P1|Overall Study|Other- not specified|0
3113308|NCT00142298|10660905|P10|Overall Study|Virologic breakthrough|0
3113309|NCT00142298|10660906|P9|Overall Study|Virologic breakthrough|0
3113310|NCT00142298|10660907|P8|Overall Study|Virologic breakthrough|0
3113311|NCT00142298|10660908|P7|Overall Study|Virologic breakthrough|3
3113312|NCT00142298|10660909|P6|Overall Study|Virologic breakthrough|3
3113313|NCT00142298|10660910|P5|Overall Study|Virologic breakthrough|2
3113314|NCT00142298|10660911|P4|Overall Study|Virologic breakthrough|7
3113315|NCT00142298|10660912|P3|Overall Study|Virologic breakthrough|9
3113316|NCT00142298|10660913|P2|Overall Study|Virologic breakthrough|23
3113317|NCT00142298|10660914|P1|Overall Study|Virologic breakthrough|19
3113318|NCT00142298|10660905|P10|Overall Study|Pregnancy|0
3113319|NCT00142298|10660906|P9|Overall Study|Pregnancy|1
3113320|NCT00142298|10660907|P8|Overall Study|Pregnancy|0
3113321|NCT00142298|10660908|P7|Overall Study|Pregnancy|0
3113322|NCT00142298|10660909|P6|Overall Study|Pregnancy|0
3113323|NCT00142298|10660910|P5|Overall Study|Pregnancy|0
3113324|NCT00142298|10660911|P4|Overall Study|Pregnancy|3
3113325|NCT00142298|10660912|P3|Overall Study|Pregnancy|2
3113326|NCT00142298|10660913|P2|Overall Study|Pregnancy|4
3113327|NCT00142298|10660914|P1|Overall Study|Pregnancy|4
3113328|NCT00142298|10660905|P10|Overall Study|Patient, Investigator,or Sponsor request|0
3113329|NCT00142298|10660906|P9|Overall Study|Patient, Investigator,or Sponsor request|1
3113330|NCT00142298|10660907|P8|Overall Study|Patient, Investigator,or Sponsor request|4
3113331|NCT00142298|10660908|P7|Overall Study|Patient, Investigator,or Sponsor request|1
3113332|NCT00142298|10660909|P6|Overall Study|Patient, Investigator,or Sponsor request|3
3113333|NCT00142298|10660910|P5|Overall Study|Patient, Investigator,or Sponsor request|4
3113334|NCT00142298|10660911|P4|Overall Study|Patient, Investigator,or Sponsor request|51
3113335|NCT00142298|10660912|P3|Overall Study|Patient, Investigator,or Sponsor request|11
3113336|NCT00142298|10660913|P2|Overall Study|Patient, Investigator,or Sponsor request|60
3113337|NCT00142298|10660914|P1|Overall Study|Patient, Investigator,or Sponsor request|66
3113338|NCT00142298|10660905|P10|Overall Study|Non-compliance|0
3113339|NCT00142298|10660906|P9|Overall Study|Non-compliance|3
3113340|NCT00142298|10660907|P8|Overall Study|Non-compliance|3
3113341|NCT00142298|10660908|P7|Overall Study|Non-compliance|0
3113342|NCT00142298|10660909|P6|Overall Study|Non-compliance|0
3113343|NCT00142298|10660910|P5|Overall Study|Non-compliance|1
3113344|NCT00142298|10660911|P4|Overall Study|Non-compliance|6
3113345|NCT00142298|10660912|P3|Overall Study|Non-compliance|0
3113346|NCT00142298|10660913|P2|Overall Study|Non-compliance|13
3113347|NCT00142298|10660914|P1|Overall Study|Non-compliance|15
3113348|NCT00142298|10660905|P10|Overall Study|Lack of Efficacy|0
3113349|NCT00142298|10660906|P9|Overall Study|Lack of Efficacy|0
3113350|NCT00142298|10660907|P8|Overall Study|Lack of Efficacy|1
3113351|NCT00142298|10660908|P7|Overall Study|Lack of Efficacy|0
3113352|NCT00142298|10660909|P6|Overall Study|Lack of Efficacy|0
3113353|NCT00142298|10660910|P5|Overall Study|Lack of Efficacy|1
3113354|NCT00142298|10660911|P4|Overall Study|Lack of Efficacy|12
3113355|NCT00142298|10660912|P3|Overall Study|Lack of Efficacy|9
3113356|NCT00142298|10660913|P2|Overall Study|Lack of Efficacy|62
3113357|NCT00142298|10660914|P1|Overall Study|Lack of Efficacy|44
3113358|NCT00142298|10660905|P10|Overall Study|Death|0
3113359|NCT00142298|10660906|P9|Overall Study|Death|0
3113360|NCT00142298|10660907|P8|Overall Study|Death|0
3113361|NCT00142298|10660908|P7|Overall Study|Death|0
3113362|NCT00142298|10660909|P6|Overall Study|Death|6
3113363|NCT00142298|10660910|P5|Overall Study|Death|0
3113364|NCT00142298|10660911|P4|Overall Study|Death|0
3113365|NCT00142298|10660912|P3|Overall Study|Death|1
3113366|NCT00142298|10660913|P2|Overall Study|Death|1
3113367|NCT00142298|10660914|P1|Overall Study|Death|1
3113368|NCT00142298|10660905|P10|Overall Study|Clinical disease progression|0
3113369|NCT00142298|10660906|P9|Overall Study|Clinical disease progression|0
3113370|NCT00142298|10660907|P8|Overall Study|Clinical disease progression|0
3113371|NCT00142298|10660908|P7|Overall Study|Clinical disease progression|0
3113372|NCT00142298|10660909|P6|Overall Study|Clinical disease progression|0
3113373|NCT00142298|10660910|P5|Overall Study|Clinical disease progression|0
3113374|NCT00142298|10660911|P4|Overall Study|Clinical disease progression|0
3113375|NCT00142298|10660912|P3|Overall Study|Clinical disease progression|0
3113376|NCT00142298|10660913|P2|Overall Study|Clinical disease progression|0
3113377|NCT00142298|10660914|P1|Overall Study|Clinical disease progression|1
3113378|NCT00142298|10660905|P10|Overall Study|Adverse Event|0
3113379|NCT00142298|10660906|P9|Overall Study|Adverse Event|0
3113380|NCT00142298|10660907|P8|Overall Study|Adverse Event|0
3113381|NCT00142298|10660908|P7|Overall Study|Adverse Event|0
3113382|NCT00142298|10660909|P6|Overall Study|Adverse Event|2
3113383|NCT00142298|10660910|P5|Overall Study|Adverse Event|2
3113384|NCT00142298|10660911|P4|Overall Study|Adverse Event|5
3113385|NCT00142298|10660912|P3|Overall Study|Adverse Event|1
3113386|NCT00142298|10660913|P2|Overall Study|Adverse Event|10
3113387|NCT00142298|10660914|P1|Overall Study|Adverse Event|10
3113388|NCT00141921|10660948|P1|Overall Study|Other|8
3113389|NCT00141921|10660948|P1|Overall Study|Ineligibility Determined|2
3113390|NCT00141921|10660948|P1|Overall Study|Pregnancy|4
3113391|NCT00141921|10660948|P1|Overall Study|Administrative Decision|2
3113392|NCT00141921|10660948|P1|Overall Study|Adverse Event|5
3113393|NCT00141921|10660948|P1|Overall Study|Protocol Deviation|7
3113394|NCT00141921|10660948|P1|Overall Study|Disease Progression|7
3113395|NCT00141921|10660948|P1|Overall Study|Noncompliance|17
3113396|NCT00141921|10660948|P1|Overall Study|Lost to Follow-up|19
3113397|NCT00141921|10660948|P1|Overall Study|Withdrawal by Subject|42
3113398|NCT00141921|10660948|P1|Overall Study|Remain on Study|28
3113399|NCT00141817|10660974|P4|Overall Study|Parent request|0
3113400|NCT00141817|10660975|P3|Overall Study|Parent request|0
3113401|NCT00141817|10660976|P2|Overall Study|Parent request|0
3113402|NCT00141817|10660977|P1|Overall Study|Parent request|1
3113403|NCT00141817|10660974|P4|Overall Study|Protocol Violation|0
3113404|NCT00141817|10660975|P3|Overall Study|Protocol Violation|1
3113405|NCT00141817|10660976|P2|Overall Study|Protocol Violation|0
3113406|NCT00141817|10660977|P1|Overall Study|Protocol Violation|0
3113407|NCT00141778|10661018|P3|Started Study Medication|Chest Discomfort|1
3113408|NCT00141778|10661019|P2|Started Study Medication|Chest Discomfort|0
3113409|NCT00141778|10661020|P1|Started Study Medication|Chest Discomfort|0
3113410|NCT00141778|10661018|P3|Started Study Medication|Difficulty Swallowing|0
3113411|NCT00141778|10661019|P2|Started Study Medication|Difficulty Swallowing|1
3113412|NCT00141778|10661020|P1|Started Study Medication|Difficulty Swallowing|0
3113413|NCT00141778|10661018|P3|Started Study Medication|Withdrawal by Subject|0
3113414|NCT00141778|10661019|P2|Started Study Medication|Withdrawal by Subject|2
3113415|NCT00141778|10661020|P1|Started Study Medication|Withdrawal by Subject|0
3113416|NCT00141778|10661018|P3|Started Study Medication|Met safety criteria for discontinuation|3
3113417|NCT00141778|10661019|P2|Started Study Medication|Met safety criteria for discontinuation|4
3113418|NCT00141778|10661020|P1|Started Study Medication|Met safety criteria for discontinuation|2
3113419|NCT00141778|10661018|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
3113420|NCT00141778|10661019|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
3113421|NCT00141778|10661020|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
3113422|NCT00141726|10661073|P1|Overall Study|Completed <50% Scheduled Dosing|3
3113423|NCT00141518|10661081|P3|Overall Study|Lack of Efficacy|0
3113424|NCT00141518|10661082|P2|Overall Study|Lack of Efficacy|0
3113425|NCT00141518|10661083|P1|Overall Study|Lack of Efficacy|5
3113426|NCT00141518|10661081|P3|Overall Study|Protocol Violation|2
3113427|NCT00141518|10661082|P2|Overall Study|Protocol Violation|1
3113428|NCT00141518|10661083|P1|Overall Study|Protocol Violation|1
3113429|NCT00141518|10661081|P3|Overall Study|Withdrawal by Subject|2
3113430|NCT00141518|10661082|P2|Overall Study|Withdrawal by Subject|0
3113431|NCT00141518|10661083|P1|Overall Study|Withdrawal by Subject|2
3113432|NCT00141518|10661081|P3|Overall Study|Adverse Event|2
3113433|NCT00141518|10661082|P2|Overall Study|Adverse Event|5
3113434|NCT00141518|10661083|P1|Overall Study|Adverse Event|7
3113435|NCT00141518|10661081|P3|Overall Study|Withdrew Consent Prior to Treatment|0
3113436|NCT00141518|10661082|P2|Overall Study|Withdrew Consent Prior to Treatment|0
3113437|NCT00141518|10661083|P1|Overall Study|Withdrew Consent Prior to Treatment|1
3113438|NCT00141453|10661272|P2|Overall Study|Protocol Violation|5
3113439|NCT00141453|10661273|P1|Overall Study|Protocol Violation|6
3113440|NCT00141297|10661287|P10|Overall Study|Transitioned|0
3113441|NCT00141297|10661288|P9|Overall Study|Transitioned|0
3113442|NCT00141297|10661289|P8|Overall Study|Transitioned|0
3113443|NCT00141297|10661290|P7|Overall Study|Transitioned|0
3113444|NCT00141297|10661291|P6|Overall Study|Transitioned|0
3113445|NCT00141297|10661292|P5|Overall Study|Transitioned|1
3113446|NCT00141297|10661293|P4|Overall Study|Transitioned|0
3113447|NCT00141297|10661294|P3|Overall Study|Transitioned|0
3113448|NCT00141297|10661295|P2|Overall Study|Transitioned|0
3113449|NCT00141297|10661296|P1|Overall Study|Transitioned|0
3113450|NCT00141297|10661287|P10|Overall Study|Progressive Disease|6
3113451|NCT00141297|10661288|P9|Overall Study|Progressive Disease|15
3113452|NCT00141297|10661289|P8|Overall Study|Progressive Disease|3
3113453|NCT00141297|10661290|P7|Overall Study|Progressive Disease|3
3113454|NCT00141297|10661291|P6|Overall Study|Progressive Disease|2
3113455|NCT00141297|10661292|P5|Overall Study|Progressive Disease|15
3113456|NCT00141297|10661293|P4|Overall Study|Progressive Disease|2
3113457|NCT00141297|10661294|P3|Overall Study|Progressive Disease|6
3113458|NCT00141297|10661295|P2|Overall Study|Progressive Disease|3
3113459|NCT00141297|10661296|P1|Overall Study|Progressive Disease|2
3113460|NCT00141297|10661287|P10|Overall Study|Other|0
3113461|NCT00141297|10661288|P9|Overall Study|Other|2
3113462|NCT00141297|10661289|P8|Overall Study|Other|0
3113463|NCT00141297|10661290|P7|Overall Study|Other|0
3113464|NCT00141297|10661291|P6|Overall Study|Other|0
3113465|NCT00141297|10661292|P5|Overall Study|Other|5
3113466|NCT00141297|10661293|P4|Overall Study|Other|1
3113467|NCT00141297|10661294|P3|Overall Study|Other|0
3113468|NCT00141297|10661295|P2|Overall Study|Other|0
3113469|NCT00141297|10661296|P1|Overall Study|Other|0
3113470|NCT00141297|10661287|P10|Overall Study|Withdrawal by Subject|0
3113471|NCT00141297|10661288|P9|Overall Study|Withdrawal by Subject|1
3113472|NCT00141297|10661289|P8|Overall Study|Withdrawal by Subject|0
3113473|NCT00141297|10661290|P7|Overall Study|Withdrawal by Subject|0
3113474|NCT00141297|10661291|P6|Overall Study|Withdrawal by Subject|0
3113475|NCT00141297|10661292|P5|Overall Study|Withdrawal by Subject|0
3113476|NCT00141297|10661293|P4|Overall Study|Withdrawal by Subject|0
3113477|NCT00141297|10661294|P3|Overall Study|Withdrawal by Subject|0
3113478|NCT00141297|10661295|P2|Overall Study|Withdrawal by Subject|0
3113479|NCT00141297|10661296|P1|Overall Study|Withdrawal by Subject|0
3113480|NCT00141297|10661287|P10|Overall Study|Death|0
3113481|NCT00141297|10661288|P9|Overall Study|Death|1
3113482|NCT00141297|10661289|P8|Overall Study|Death|0
3113483|NCT00141297|10661290|P7|Overall Study|Death|0
3113484|NCT00141297|10661291|P6|Overall Study|Death|0
3113485|NCT00141297|10661292|P5|Overall Study|Death|0
3113486|NCT00141297|10661293|P4|Overall Study|Death|0
3113487|NCT00141297|10661294|P3|Overall Study|Death|0
3113488|NCT00141297|10661295|P2|Overall Study|Death|0
3113489|NCT00141297|10661296|P1|Overall Study|Death|1
3113490|NCT00141297|10661287|P10|Overall Study|Adverse Event|0
3113491|NCT00141297|10661288|P9|Overall Study|Adverse Event|1
3113492|NCT00141297|10661289|P8|Overall Study|Adverse Event|1
3113493|NCT00141297|10661290|P7|Overall Study|Adverse Event|0
3113494|NCT00141297|10661291|P6|Overall Study|Adverse Event|1
3113495|NCT00141297|10661292|P5|Overall Study|Adverse Event|1
3113496|NCT00141297|10661293|P4|Overall Study|Adverse Event|0
3113497|NCT00141297|10661294|P3|Overall Study|Adverse Event|1
3113498|NCT00141297|10661295|P2|Overall Study|Adverse Event|0
3113499|NCT00141297|10661296|P1|Overall Study|Adverse Event|0
3113500|NCT00141271|10661574|P3|Overall Study|Other|5
3113501|NCT00141271|10661575|P2|Overall Study|Other|12
3113502|NCT00141271|10661576|P1|Overall Study|Other|11
3113503|NCT00141271|10661574|P3|Overall Study|Withdrawal by Subject|10
3113504|NCT00141271|10661575|P2|Overall Study|Withdrawal by Subject|9
3113505|NCT00141271|10661576|P1|Overall Study|Withdrawal by Subject|14
3113506|NCT00141271|10661574|P3|Overall Study|Lost to Follow-up|21
3113507|NCT00141271|10661575|P2|Overall Study|Lost to Follow-up|15
3113508|NCT00141271|10661576|P1|Overall Study|Lost to Follow-up|15
3113509|NCT00141271|10661574|P3|Overall Study|Lack of Efficacy|3
3113510|NCT00141271|10661575|P2|Overall Study|Lack of Efficacy|7
3113511|NCT00141271|10661576|P1|Overall Study|Lack of Efficacy|7
3113512|NCT00141271|10661574|P3|Overall Study|Laboratory Abnormality|1
3113513|NCT00141271|10661575|P2|Overall Study|Laboratory Abnormality|1
3113514|NCT00141271|10661576|P1|Overall Study|Laboratory Abnormality|2
3113515|NCT00141271|10661574|P3|Overall Study|Adverse Event|17
3113516|NCT00141271|10661575|P2|Overall Study|Adverse Event|19
3113517|NCT00141271|10661576|P1|Overall Study|Adverse Event|31
3113518|NCT00141219|10661697|P2|Overall Study|Withdrawal by Subject|2
3113519|NCT00141219|10661698|P1|Overall Study|Withdrawal by Subject|6
3113520|NCT00141219|10661697|P2|Overall Study|Lack of Efficacy|4
3113521|NCT00141219|10661698|P1|Overall Study|Lack of Efficacy|5
3113522|NCT00141219|10661697|P2|Overall Study|Adverse Event|6
3113523|NCT00141219|10661698|P1|Overall Study|Adverse Event|8
3113524|NCT00141219|10661697|P2|Overall Study|Protocol violations|4
3113525|NCT00141219|10661698|P1|Overall Study|Protocol violations|5
3113526|NCT00141102|10661755|P2|Overall Study|Death|2
3113527|NCT00141102|10661756|P1|Overall Study|Death|2
3113528|NCT00141102|10661755|P2|Overall Study|Randomized But Did Not Receive Treatment|9
3113529|NCT00141102|10661756|P1|Overall Study|Randomized But Did Not Receive Treatment|15
3113530|NCT00141102|10661755|P2|Overall Study|Withdrawal by Subject|142
3113531|NCT00141102|10661756|P1|Overall Study|Withdrawal by Subject|112
3113532|NCT00141102|10661755|P2|Overall Study|Other|76
3113533|NCT00141102|10661756|P1|Overall Study|Other|87
3113534|NCT00141102|10661755|P2|Overall Study|Lost to Follow-up|32
3113535|NCT00141102|10661756|P1|Overall Study|Lost to Follow-up|29
3113536|NCT00141102|10661755|P2|Overall Study|Lack of Efficacy|26
3113537|NCT00141102|10661756|P1|Overall Study|Lack of Efficacy|21
3113538|NCT00141102|10661755|P2|Overall Study|Laboratory Abnormality|33
3113539|NCT00141102|10661756|P1|Overall Study|Laboratory Abnormality|9
3113540|NCT00141102|10661755|P2|Overall Study|Adverse Event|305
3113541|NCT00141102|10661756|P1|Overall Study|Adverse Event|233
3113542|NCT00141037|10661796|P2|Overall Study|Graft Failure|4
3113543|NCT00141037|10661797|P1|Overall Study|Graft Failure|3
3113544|NCT00141037|10661796|P2|Overall Study|Moved from area|7
3113545|NCT00141037|10661797|P1|Overall Study|Moved from area|1
3113546|NCT00141037|10661796|P2|Overall Study|Other|1
3113547|NCT00141037|10661797|P1|Overall Study|Other|0
3113548|NCT00141037|10661796|P2|Overall Study|Withdrawal by Subject|1
3113549|NCT00141037|10661797|P1|Overall Study|Withdrawal by Subject|2
3113550|NCT00141037|10661796|P2|Overall Study|Protocol Violation|2
3113551|NCT00141037|10661797|P1|Overall Study|Protocol Violation|0
3113552|NCT00141037|10661796|P2|Overall Study|Lost to Follow-up|1
3113553|NCT00141037|10661797|P1|Overall Study|Lost to Follow-up|3
3113554|NCT00141037|10661796|P2|Overall Study|Physician Decision|2
3113555|NCT00141037|10661797|P1|Overall Study|Physician Decision|1
3113556|NCT00140426|10661832|P2|Overall Study|Withdrawal by Subject|3
3113557|NCT00140426|10661833|P1|Overall Study|Withdrawal by Subject|0
3113558|NCT00140413|10661866|P2|Overall Study|Withdrawal by Subject|0
3113559|NCT00140413|10661867|P1|Overall Study|Withdrawal by Subject|2
3113560|NCT00140413|10661866|P2|Overall Study|Lost to Follow-up|0
3113561|NCT00140413|10661867|P1|Overall Study|Lost to Follow-up|1
3113562|NCT00140140|10661998|P3|Overall Study|Physician Decision|0
3113563|NCT00140140|10661999|P2|Overall Study|Physician Decision|1
3113564|NCT00140140|10662000|P1|Overall Study|Physician Decision|1
3113565|NCT00140140|10661998|P3|Overall Study|Unacceptable toxicity|2
3113566|NCT00140140|10661999|P2|Overall Study|Unacceptable toxicity|1
3113567|NCT00140140|10662000|P1|Overall Study|Unacceptable toxicity|1
3113568|NCT00139776|10662050|P4|Period III|Withdrawal by Subject|21
3113569|NCT00139776|10662051|P3|Period III|Withdrawal by Subject|16
3113570|NCT00139776|10662052|P2|Period III|Withdrawal by Subject|0
3113571|NCT00139776|10662053|P1|Period III|Withdrawal by Subject|0
3113572|NCT00139776|10662050|P4|Period III|Lost to Follow-up|4
3113573|NCT00139776|10662051|P3|Period III|Lost to Follow-up|5
3113574|NCT00139776|10662052|P2|Period III|Lost to Follow-up|0
3113575|NCT00139776|10662053|P1|Period III|Lost to Follow-up|0
3113576|NCT00139776|10662050|P4|Period III|Lack of Efficacy|24
3113577|NCT00139776|10662051|P3|Period III|Lack of Efficacy|10
3113578|NCT00139776|10662052|P2|Period III|Lack of Efficacy|0
3113579|NCT00139776|10662053|P1|Period III|Lack of Efficacy|0
3113580|NCT00139776|10662050|P4|Period III|Other|34
3113581|NCT00139776|10662051|P3|Period III|Other|23
3113582|NCT00139776|10662052|P2|Period III|Other|0
3113583|NCT00139776|10662053|P1|Period III|Other|0
3113584|NCT00139776|10662050|P4|Period III|Adverse Event|23
3113585|NCT00139776|10662051|P3|Period III|Adverse Event|22
3113586|NCT00139776|10662052|P2|Period III|Adverse Event|0
3113587|NCT00139776|10662053|P1|Period III|Adverse Event|0
3113588|NCT00139776|10662050|P4|Period II|Not Randomized into Period III|0
3113589|NCT00139776|10662051|P3|Period II|Not Randomized into Period III|0
3113590|NCT00139776|10662052|P2|Period II|Not Randomized into Period III|322
3113591|NCT00139776|10662053|P1|Period II|Not Randomized into Period III|0
3113592|NCT00139776|10662050|P4|Period I|Did not enter Period II|0
3113593|NCT00139776|10662051|P3|Period I|Did not enter Period II|0
3113594|NCT00139776|10662052|P2|Period I|Did not enter Period II|0
3113595|NCT00139776|10662053|P1|Period I|Did not enter Period II|575
3113596|NCT00139737|10662088|P1|Overall Study|Screened, Not Treated|13
3113597|NCT00139737|10662088|P1|Overall Study|Did Not Meet Entrance Criteria|1
3113598|NCT00139737|10662088|P1|Overall Study|Withdrew During Screening Phase|8
3113599|NCT00139737|10662088|P1|Overall Study|Protocol Violation|18
3113600|NCT00139737|10662088|P1|Overall Study|Laboratory Abnormality|2
3113601|NCT00139737|10662088|P1|Overall Study|Death|3
3113602|NCT00139737|10662088|P1|Overall Study|Lost to Follow-up|8
3113603|NCT00139737|10662088|P1|Overall Study|Lack of Efficacy|40
3113604|NCT00139737|10662088|P1|Overall Study|Adverse Event|58
3113605|NCT00139737|10662088|P1|Overall Study|Withdrawal by Subject|190
3113606|NCT00139659|10662094|P2|Overall Study|Withdrawal by Subject|10
3113607|NCT00139659|10662095|P1|Overall Study|Withdrawal by Subject|14
3113608|NCT00139659|10662094|P2|Overall Study|Reason not Specified|3
3113609|NCT00139659|10662095|P1|Overall Study|Reason not Specified|6
3113610|NCT00139659|10662094|P2|Overall Study|Lost to Follow-up|3
3113611|NCT00139659|10662095|P1|Overall Study|Lost to Follow-up|7
3113612|NCT00139659|10662094|P2|Overall Study|Lack of Efficacy|1
3113613|NCT00139659|10662095|P1|Overall Study|Lack of Efficacy|1
3113614|NCT00139659|10662094|P2|Overall Study|Adverse Event|1
3113615|NCT00139659|10662095|P1|Overall Study|Adverse Event|12
3113616|NCT00139477|10662173|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
3113617|NCT00139477|10662174|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
3113618|NCT00139477|10662173|P2|Second Intervention -6Months to 12Months|Relocation|0
3113619|NCT00139477|10662174|P1|Second Intervention -6Months to 12Months|Relocation|1
3113620|NCT00139477|10662173|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
3113621|NCT00139477|10662174|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
3113622|NCT00139477|10662173|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
3113623|NCT00139477|10662174|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
3113624|NCT00139477|10662173|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
3113625|NCT00139477|10662174|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
3113626|NCT00139477|10662173|P2|First Intervention -Baseline to 6Months|Relocation|2
3113627|NCT00139477|10662174|P1|First Intervention -Baseline to 6Months|Relocation|1
3113628|NCT00139477|10662173|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
3113629|NCT00139477|10662174|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
3113630|NCT00138671|10662209|P2|Overall Study|Other|3
3113631|NCT00138671|10662210|P1|Overall Study|Other|3
3113632|NCT00138671|10662209|P2|Overall Study|Withdrawal by Subject|5
3113633|NCT00138671|10662210|P1|Overall Study|Withdrawal by Subject|3
3113634|NCT00138671|10662209|P2|Overall Study|Lost to Follow-up|2
3113635|NCT00138671|10662210|P1|Overall Study|Lost to Follow-up|1
3113636|NCT00138671|10662209|P2|Overall Study|Adverse Event|3
3113637|NCT00138671|10662210|P1|Overall Study|Adverse Event|6
3113638|NCT00138671|10662209|P2|Overall Study|Death|3
3113639|NCT00138671|10662210|P1|Overall Study|Death|0
3113640|NCT00138658|10662260|P1|Overall Study|Withdrawal by Subject|5
3113641|NCT00138658|10662260|P1|Overall Study|Physician Decision|11
3113642|NCT00138658|10662260|P1|Overall Study|Disease Progression|21
3113643|NCT00138658|10662260|P1|Overall Study|Death|1
3113644|NCT00138658|10662260|P1|Overall Study|Adverse Event|23
3113645|NCT00138424|10662283|P4|Overall Study|Physician Decision|0
3113646|NCT00138424|10662284|P3|Overall Study|Physician Decision|0
3113647|NCT00138424|10662285|P2|Overall Study|Physician Decision|1
3113648|NCT00138424|10662286|P1|Overall Study|Physician Decision|0
3113649|NCT00138151|10662369|P1|Overall Study|Physician Decision|1
3113650|NCT00138151|10662369|P1|Overall Study|Withdrawal by Subject|3
3113651|NCT00138073|10662379|P1|Overall Study|lack of resources|55
3113652|NCT00137839|10662418|P1|Overall Study|Prolonged Treatment Delay|1
3113653|NCT00137839|10662418|P1|Overall Study|Not Start Treatment|1
3113654|NCT00137839|10662418|P1|Overall Study|Disease Progression|60
3113655|NCT00137839|10662418|P1|Overall Study|Death|8
3113656|NCT00137839|10662418|P1|Overall Study|Physician Decision|7
3113657|NCT00137839|10662418|P1|Overall Study|Adverse Event|7
3113658|NCT00137631|10662431|P2|Overall Study|Lost to Follow-up|41
3113659|NCT00137631|10662432|P1|Overall Study|Lost to Follow-up|37
3113660|NCT00137449|10662448|P2|Overall Study|Withdrawal by Subject|1
3113661|NCT00137449|10662449|P1|Overall Study|Withdrawal by Subject|1
3113662|NCT00137449|10662448|P2|Overall Study|Adverse Event|1
3113663|NCT00137449|10662449|P1|Overall Study|Adverse Event|3
3113664|NCT00137449|10662448|P2|Overall Study|Death|3
3113665|NCT00137449|10662449|P1|Overall Study|Death|4
3113666|NCT00137449|10662448|P2|Overall Study|Disease Progression|13
3113667|NCT00137449|10662449|P1|Overall Study|Disease Progression|8
3113668|NCT00137436|10662486|P1|Overall Study|Other|5
3113669|NCT00137436|10662486|P1|Overall Study|Withdrawal by Subject|6
3113670|NCT00137436|10662486|P1|Overall Study|Lack of Efficacy|17
3113671|NCT00137436|10662486|P1|Overall Study|Death|2
3113672|NCT00137436|10662486|P1|Overall Study|Adverse Event|13
3113673|NCT00137423|10662505|P2|Overall Study|Death|1
3113674|NCT00137423|10662506|P1|Overall Study|Death|0
3113675|NCT00137423|10662505|P2|Overall Study|Lack of Efficacy|33
3113676|NCT00137423|10662506|P1|Overall Study|Lack of Efficacy|31
3113677|NCT00137423|10662505|P2|Overall Study|consent withdrawn|1
3113678|NCT00137423|10662506|P1|Overall Study|consent withdrawn|1
3113679|NCT00137423|10662505|P2|Overall Study|Adverse Event|9
3113680|NCT00137423|10662506|P1|Overall Study|Adverse Event|7
3113681|NCT00137267|10662543|P2|Overall Study|Lost to Follow-up|21
3113682|NCT00137267|10662544|P1|Overall Study|Lost to Follow-up|15
3113683|NCT00137111|10662556|P4|Total Therapy|Non Compliance|0
3113684|NCT00137111|10662557|P3|Total Therapy|Non Compliance|0
3113685|NCT00137111|10662558|P2|Total Therapy|Non Compliance|0
3113686|NCT00137111|10662559|P1|Total Therapy|Non Compliance|5
3113687|NCT00137111|10662556|P4|Total Therapy|Death|0
3113688|NCT00137111|10662557|P3|Total Therapy|Death|0
3113689|NCT00137111|10662558|P2|Total Therapy|Death|0
3113690|NCT00137111|10662559|P1|Total Therapy|Death|35
3113691|NCT00137046|10662573|P2|Overall Study|Withdrew prior to study treatment|1
3113692|NCT00137046|10662574|P1|Overall Study|Withdrew prior to study treatment|1
3113693|NCT00137046|10662573|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
3113694|NCT00137046|10662574|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
3113695|NCT00137046|10662573|P2|Overall Study|Withdrawal by Subject|42
3113696|NCT00137046|10662574|P1|Overall Study|Withdrawal by Subject|33
3113697|NCT00137046|10662573|P2|Overall Study|Other|19
3113698|NCT00137046|10662574|P1|Overall Study|Other|23
3113699|NCT00137046|10662573|P2|Overall Study|Lost to Follow-up|24
3113700|NCT00137046|10662574|P1|Overall Study|Lost to Follow-up|8
3113701|NCT00137046|10662573|P2|Overall Study|Lack of Efficacy|1
3113702|NCT00137046|10662574|P1|Overall Study|Lack of Efficacy|13
3113703|NCT00137046|10662573|P2|Overall Study|Laboratory Abnormality|0
3113704|NCT00137046|10662574|P1|Overall Study|Laboratory Abnormality|2
3113705|NCT00137046|10662573|P2|Overall Study|Adverse Event|5
3113706|NCT00137046|10662574|P1|Overall Study|Adverse Event|16
3113707|NCT00137046|10662573|P2|Overall Study|Death|1
3113708|NCT00137046|10662574|P1|Overall Study|Death|2
3113709|NCT00136955|10662622|P1|Overall Study|Incl. prog. disease, protocol violation|12
3113710|NCT00136955|10662622|P1|Overall Study|Withdrawal by Subject|2
3113711|NCT00136955|10662622|P1|Overall Study|Lost to Follow-up|1
3113712|NCT00136955|10662622|P1|Overall Study|Adverse Event|8
3113713|NCT00136916|10662631|P2|Overall Study|Discontinued in follow up period|0
3113714|NCT00136916|10662632|P1|Overall Study|Discontinued in follow up period|3
3113715|NCT00136916|10662631|P2|Overall Study|Other|24
3113716|NCT00136916|10662632|P1|Overall Study|Other|22
3113717|NCT00136916|10662631|P2|Overall Study|Withdrawal by Subject|46
3113718|NCT00136916|10662632|P1|Overall Study|Withdrawal by Subject|44
3113719|NCT00136916|10662631|P2|Overall Study|Lost to Follow-up|14
3113720|NCT00136916|10662632|P1|Overall Study|Lost to Follow-up|12
3113721|NCT00136916|10662631|P2|Overall Study|Lack of Efficacy|3
3113722|NCT00136916|10662632|P1|Overall Study|Lack of Efficacy|13
3113723|NCT00136916|10662631|P2|Overall Study|Laboratory abnormality|1
3113724|NCT00136916|10662632|P1|Overall Study|Laboratory abnormality|0
3113725|NCT00136916|10662631|P2|Overall Study|Adverse Event|8
3113726|NCT00136916|10662632|P1|Overall Study|Adverse Event|27
3113727|NCT00136916|10662631|P2|Overall Study|Death|3
3113728|NCT00136916|10662632|P1|Overall Study|Death|1
3113729|NCT00136916|10662631|P2|Overall Study|Never received study treatment|5
3113730|NCT00136916|10662632|P1|Overall Study|Never received study treatment|3
3113731|NCT00136604|10662739|P5|Overall Study|Migrated/moved from study area|0
3113732|NCT00136604|10662740|P4|Overall Study|Migrated/moved from study area|0
3113733|NCT00136604|10662741|P3|Overall Study|Migrated/moved from study area|0
3113734|NCT00136604|10662742|P2|Overall Study|Migrated/moved from study area|1
3113735|NCT00136604|10662743|P1|Overall Study|Migrated/moved from study area|0
3113736|NCT00136604|10662739|P5|Overall Study|Lost to Follow-up|1
3113737|NCT00136604|10662740|P4|Overall Study|Lost to Follow-up|0
3113738|NCT00136604|10662741|P3|Overall Study|Lost to Follow-up|0
3113739|NCT00136604|10662742|P2|Overall Study|Lost to Follow-up|0
3113740|NCT00136604|10662743|P1|Overall Study|Lost to Follow-up|1
3113741|NCT00136357|10662851|P2|Overall Study|Withdrawal by Subject|2
3113742|NCT00136357|10662852|P1|Overall Study|Withdrawal by Subject|3
3113743|NCT00136318|10662860|P2|Overall Study|Withdrawal by Subject|2
3113744|NCT00136318|10662861|P1|Overall Study|Withdrawal by Subject|2
3113745|NCT00136318|10662860|P2|Overall Study|Adverse Event|5
3113746|NCT00136318|10662861|P1|Overall Study|Adverse Event|5
3113747|NCT00136084|10662888|P2|Overall Study|Withdrawal by Subject|1
3113748|NCT00136084|10662889|P1|Overall Study|Withdrawal by Subject|5
3113749|NCT00136084|10662888|P2|Overall Study|No Response|2
3113750|NCT00136084|10662889|P1|Overall Study|No Response|1
3113751|NCT00136084|10662888|P2|Overall Study|Lost to Follow-up|0
3113752|NCT00136084|10662889|P1|Overall Study|Lost to Follow-up|2
3113753|NCT00136084|10662888|P2|Overall Study|Relapse|23
3113754|NCT00136084|10662889|P1|Overall Study|Relapse|20
3113755|NCT00136084|10662888|P2|Overall Study|Unacceptable toxicity|11
3113756|NCT00136084|10662889|P1|Overall Study|Unacceptable toxicity|8
3113757|NCT00136084|10662888|P2|Overall Study|Death|5
3113758|NCT00136084|10662889|P1|Overall Study|Death|12
3113759|NCT00135707|10662925|P2|Overall Study|Institutional review board request|0
3113760|NCT00135707|10662926|P1|Overall Study|Institutional review board request|1
3113761|NCT00135707|10662925|P2|Overall Study|Withdrawal by Subject|1
3113762|NCT00135707|10662926|P1|Overall Study|Withdrawal by Subject|0
3113763|NCT00135707|10662925|P2|Overall Study|Lost to Follow-up|89
3113764|NCT00135707|10662926|P1|Overall Study|Lost to Follow-up|94
3113765|NCT00135694|10663009|P3|Overall Study|Ineligible for Random assignment|0
3113766|NCT00135694|10663010|P2|Overall Study|Ineligible for Random assignment|0
3113767|NCT00135694|10663011|P1|Overall Study|Ineligible for Random assignment|42
3113768|NCT00135694|10663009|P3|Overall Study|Hepatitis C related reasons|0
3113769|NCT00135694|10663010|P2|Overall Study|Hepatitis C related reasons|1
3113770|NCT00135694|10663011|P1|Overall Study|Hepatitis C related reasons|39
3113771|NCT00135694|10663009|P3|Overall Study|Protocol Violation|0
3113772|NCT00135694|10663010|P2|Overall Study|Protocol Violation|1
3113773|NCT00135694|10663011|P1|Overall Study|Protocol Violation|19
3113774|NCT00135694|10663009|P3|Overall Study|Withdrawal by Subject|4
3113775|NCT00135694|10663010|P2|Overall Study|Withdrawal by Subject|7
3113776|NCT00135694|10663011|P1|Overall Study|Withdrawal by Subject|41
3113777|NCT00135694|10663009|P3|Overall Study|Lost to Follow-up|1
3113778|NCT00135694|10663010|P2|Overall Study|Lost to Follow-up|7
3113779|NCT00135694|10663011|P1|Overall Study|Lost to Follow-up|8
3113780|NCT00135694|10663009|P3|Overall Study|Death|2
3113781|NCT00135694|10663010|P2|Overall Study|Death|1
3113782|NCT00135694|10663011|P1|Overall Study|Death|14
3113783|NCT00135694|10663009|P3|Overall Study|Adverse Event|0
3113784|NCT00135694|10663010|P2|Overall Study|Adverse Event|4
3113785|NCT00135694|10663011|P1|Overall Study|Adverse Event|17
3113786|NCT00135512|10663029|P1|Overall Study|Other|42
3113787|NCT00135512|10663029|P1|Overall Study|Lack of Efficacy|25
3113788|NCT00135512|10663029|P1|Overall Study|Adverse Event|56
3113789|NCT00135356|10663041|P2|Overall Study|Withdrawal by Subject|4
3113790|NCT00135356|10663042|P1|Overall Study|Withdrawal by Subject|2
3113791|NCT00135356|10663041|P2|Overall Study|No longer meets study criteria|0
3113792|NCT00135356|10663042|P1|Overall Study|No longer meets study criteria|2
3113793|NCT00135356|10663041|P2|Overall Study|Poor/noncompliance|1
3113794|NCT00135356|10663042|P1|Overall Study|Poor/noncompliance|1
3113795|NCT00135356|10663041|P2|Overall Study|Change in antiviral regimen|1
3113796|NCT00135356|10663042|P1|Overall Study|Change in antiviral regimen|0
3113797|NCT00135356|10663041|P2|Overall Study|Surgery for abdominal fat|0
3113798|NCT00135356|10663042|P1|Overall Study|Surgery for abdominal fat|1
3113799|NCT00135356|10663041|P2|Overall Study|Lost to Follow-up|1
3113800|NCT00135356|10663042|P1|Overall Study|Lost to Follow-up|3
3113801|NCT00135356|10663041|P2|Overall Study|Lack of Efficacy|0
3113802|NCT00135356|10663042|P1|Overall Study|Lack of Efficacy|2
3113803|NCT00135356|10663041|P2|Overall Study|Adverse Event|2
3113804|NCT00135356|10663042|P1|Overall Study|Adverse Event|6
3113805|NCT00135330|10663085|P3|Overall Study|Sponsor Decision|0
3113806|NCT00135330|10663086|P2|Overall Study|Sponsor Decision|1
3113807|NCT00135330|10663087|P1|Overall Study|Sponsor Decision|0
3113808|NCT00135330|10663085|P3|Overall Study|Patient Decision|4
3113809|NCT00135330|10663086|P2|Overall Study|Patient Decision|1
3113810|NCT00135330|10663087|P1|Overall Study|Patient Decision|5
3113811|NCT00135330|10663085|P3|Overall Study|Protocol Violation|3
3113812|NCT00135330|10663086|P2|Overall Study|Protocol Violation|3
3113813|NCT00135330|10663087|P1|Overall Study|Protocol Violation|4
3113814|NCT00135330|10663085|P3|Overall Study|Physician Decision|0
3113815|NCT00135330|10663086|P2|Overall Study|Physician Decision|1
3113816|NCT00135330|10663087|P1|Overall Study|Physician Decision|1
3113817|NCT00135330|10663085|P3|Overall Study|Lost to Follow-up|3
3113818|NCT00135330|10663086|P2|Overall Study|Lost to Follow-up|2
3113819|NCT00135330|10663087|P1|Overall Study|Lost to Follow-up|0
3113820|NCT00135330|10663085|P3|Overall Study|Adverse Event|1
3113821|NCT00135330|10663086|P2|Overall Study|Adverse Event|5
3113822|NCT00135330|10663087|P1|Overall Study|Adverse Event|2
3113823|NCT00134901|10663285|P2|Overall Study|discontinued intervention|10
3113824|NCT00134901|10663286|P1|Overall Study|discontinued intervention|12
3113825|NCT00134901|10663285|P2|Overall Study|Lost to Follow-up|5
3113826|NCT00134901|10663286|P1|Overall Study|Lost to Follow-up|5
3113827|NCT00134784|10663298|P4|Overall Study|Withdrawal by Subject|1
3113828|NCT00134784|10663299|P3|Overall Study|Withdrawal by Subject|2
3113829|NCT00134784|10663300|P2|Overall Study|Withdrawal by Subject|2
3113830|NCT00134784|10663301|P1|Overall Study|Withdrawal by Subject|2
3113831|NCT00134719|10663311|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
3113832|NCT00134719|10663312|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
3113833|NCT00134719|10663313|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
3113834|NCT00134719|10663311|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
3113835|NCT00134719|10663312|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
3113836|NCT00134719|10663313|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
3113837|NCT00134719|10663311|P3|Primary Vaccination Phase|Lost to Follow-up|3
3113838|NCT00134719|10663312|P2|Primary Vaccination Phase|Lost to Follow-up|3
3113839|NCT00134719|10663313|P1|Primary Vaccination Phase|Lost to Follow-up|7
3113840|NCT00134719|10663311|P3|Primary Vaccination Phase|Withdrawal by Subject|2
3113841|NCT00134719|10663312|P2|Primary Vaccination Phase|Withdrawal by Subject|3
3113842|NCT00134719|10663313|P1|Primary Vaccination Phase|Withdrawal by Subject|2
3113843|NCT00134719|10663311|P3|Primary Vaccination Phase|Protocol Violation|0
3113844|NCT00134719|10663312|P2|Primary Vaccination Phase|Protocol Violation|0
3113845|NCT00134719|10663313|P1|Primary Vaccination Phase|Protocol Violation|1
3113846|NCT00134719|10663311|P3|Primary Vaccination Phase|Adverse Event|0
3113847|NCT00134719|10663312|P2|Primary Vaccination Phase|Adverse Event|0
3113848|NCT00134719|10663313|P1|Primary Vaccination Phase|Adverse Event|4
3113849|NCT00134563|10663444|P3|Overall Study|Reason other than above|5
3113850|NCT00134563|10663445|P2|Overall Study|Reason other than above|2
3113851|NCT00134563|10663446|P1|Overall Study|Reason other than above|0
3113852|NCT00134563|10663444|P3|Overall Study|did not wish to continue|26
3113853|NCT00134563|10663445|P2|Overall Study|did not wish to continue|32
3113854|NCT00134563|10663446|P1|Overall Study|did not wish to continue|33
3113855|NCT00134563|10663444|P3|Overall Study|progressive disease|2
3113856|NCT00134563|10663445|P2|Overall Study|progressive disease|4
3113857|NCT00134563|10663446|P1|Overall Study|progressive disease|11
3113858|NCT00134563|10663444|P3|Overall Study|Lost to Follow-up|2
3113859|NCT00134563|10663445|P2|Overall Study|Lost to Follow-up|0
3113860|NCT00134563|10663446|P1|Overall Study|Lost to Follow-up|4
3113861|NCT00134563|10663444|P3|Overall Study|Protocol Violation|5
3113862|NCT00134563|10663445|P2|Overall Study|Protocol Violation|2
3113863|NCT00134563|10663446|P1|Overall Study|Protocol Violation|3
3113864|NCT00134563|10663444|P3|Overall Study|Lack of Efficacy|17
3113865|NCT00134563|10663445|P2|Overall Study|Lack of Efficacy|14
3113866|NCT00134563|10663446|P1|Overall Study|Lack of Efficacy|24
3113867|NCT00134563|10663444|P3|Overall Study|Adverse Event|38
3113868|NCT00134563|10663445|P2|Overall Study|Adverse Event|37
3113869|NCT00134563|10663446|P1|Overall Study|Adverse Event|29
3113870|NCT00134563|10663444|P3|Overall Study|Not treated due to protocol violation|1
3113871|NCT00134563|10663445|P2|Overall Study|Not treated due to protocol violation|1
3113872|NCT00134563|10663446|P1|Overall Study|Not treated due to protocol violation|0
3113873|NCT00134082|10663507|P1|Overall Study|Death|1
3113874|NCT00134082|10663507|P1|Overall Study|Adverse Event|2
3113875|NCT00134056|10663516|P2|Eligible for Protocol Assigned Treatment|Other|56
3113876|NCT00134056|10663517|P1|Eligible for Protocol Assigned Treatment|Other|55
3113877|NCT00134056|10663516|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
3113878|NCT00134056|10663517|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
3113879|NCT00134056|10663516|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
3113880|NCT00134056|10663517|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
3113881|NCT00134056|10663516|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
3113882|NCT00134056|10663517|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
3113883|NCT00134056|10663516|P2|Randomization|Not eligible for assigned treatment|20
3113884|NCT00134056|10663517|P1|Randomization|Not eligible for assigned treatment|22
3113885|NCT00133991|10663561|P1|Overall Study|Death|4
3113886|NCT00133952|10663600|P2|Overall Study|Sponsor Decision|1
3113887|NCT00133952|10663601|P1|Overall Study|Sponsor Decision|0
3113888|NCT00133952|10663600|P2|Overall Study|Physician Decision|3
3113889|NCT00133952|10663601|P1|Overall Study|Physician Decision|4
3113890|NCT00133952|10663600|P2|Overall Study|Withdrawal by Subject|4
3113891|NCT00133952|10663601|P1|Overall Study|Withdrawal by Subject|20
3113892|NCT00133952|10663600|P2|Overall Study|Protocol Violation|1
3113893|NCT00133952|10663601|P1|Overall Study|Protocol Violation|1
3113894|NCT00133952|10663600|P2|Overall Study|Protocol Entry Criteria Exclusion|1
3113895|NCT00133952|10663601|P1|Overall Study|Protocol Entry Criteria Exclusion|4
3113896|NCT00133952|10663600|P2|Overall Study|Lost to Follow-up|14
3113897|NCT00133952|10663601|P1|Overall Study|Lost to Follow-up|9
3113898|NCT00133952|10663600|P2|Overall Study|Death|2
3113899|NCT00133952|10663601|P1|Overall Study|Death|3
3113900|NCT00133952|10663600|P2|Overall Study|Adverse Event|2
3113901|NCT00133952|10663601|P1|Overall Study|Adverse Event|1
3113902|NCT00133705|10663632|P2|Overall Study|Withdrawal by Subject|3
3113903|NCT00133705|10663633|P1|Overall Study|Withdrawal by Subject|2
3113904|NCT00132873|10663768|P1|Overall Study|Planned Pregnancy|1
3113905|NCT00132873|10663768|P1|Overall Study|Withdrawal by Subject|3
3113906|NCT00132873|10663768|P1|Overall Study|Lack of Efficacy|1
3113907|NCT00132873|10663768|P1|Overall Study|Lost to Follow-up|1
3113908|NCT00132873|10663768|P1|Overall Study|Adverse Event|3
3113909|NCT00132808|10663776|P3|Stratum II|Withdrawal by Subject|6
3113910|NCT00132808|10663777|P2|Stratum II|Withdrawal by Subject|9
3113911|NCT00132808|10663778|P1|Stratum II|Withdrawal by Subject|4
3113912|NCT00132808|10663776|P3|Stratum II|Protocol Violation|1
3113913|NCT00132808|10663777|P2|Stratum II|Protocol Violation|2
3113914|NCT00132808|10663778|P1|Stratum II|Protocol Violation|0
3113915|NCT00132808|10663776|P3|Stratum II|Lost to Follow-up|1
3113916|NCT00132808|10663777|P2|Stratum II|Lost to Follow-up|2
3113917|NCT00132808|10663778|P1|Stratum II|Lost to Follow-up|2
3113918|NCT00132808|10663776|P3|Stratum II|Death|0
3113919|NCT00132808|10663777|P2|Stratum II|Death|0
3113920|NCT00132808|10663778|P1|Stratum II|Death|1
3113921|NCT00132808|10663776|P3|Stratum II|Adverse Event|1
3113922|NCT00132808|10663777|P2|Stratum II|Adverse Event|2
3113923|NCT00132808|10663778|P1|Stratum II|Adverse Event|1
3113924|NCT00132808|10663776|P3|Stratum I|Abnormal test procedure result (s)|1
3113925|NCT00132808|10663777|P2|Stratum I|Abnormal test procedure result (s)|0
3113926|NCT00132808|10663778|P1|Stratum I|Abnormal test procedure result (s)|0
3113927|NCT00132808|10663776|P3|Stratum I|Withdrawal by Subject|3
3113928|NCT00132808|10663777|P2|Stratum I|Withdrawal by Subject|7
3113929|NCT00132808|10663778|P1|Stratum I|Withdrawal by Subject|4
3113930|NCT00132808|10663776|P3|Stratum I|Lost to Follow-up|1
3113931|NCT00132808|10663777|P2|Stratum I|Lost to Follow-up|4
3113932|NCT00132808|10663778|P1|Stratum I|Lost to Follow-up|3
3113933|NCT00132808|10663776|P3|Stratum I|Adverse Event|0
3113934|NCT00132808|10663777|P2|Stratum I|Adverse Event|1
3113935|NCT00132808|10663778|P1|Stratum I|Adverse Event|2
3113936|NCT00132769|10663803|P2|Overall Study|Protocol Violation|1
3113937|NCT00132769|10663804|P1|Overall Study|Protocol Violation|1
3113938|NCT00132769|10663803|P2|Overall Study|Adverse Event|1
3113939|NCT00132769|10663804|P1|Overall Study|Adverse Event|2
3113940|NCT00132769|10663803|P2|Overall Study|Lack of Efficacy|6
3113941|NCT00132769|10663804|P1|Overall Study|Lack of Efficacy|7
3113942|NCT00132769|10663803|P2|Overall Study|Withdrawal by Subject|3
3113943|NCT00132769|10663804|P1|Overall Study|Withdrawal by Subject|1
3113944|NCT00132730|10663830|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
3113945|NCT00132730|10663831|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
3113946|NCT00132730|10663832|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
3113947|NCT00132730|10663833|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
3113948|NCT00132730|10663834|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
3113949|NCT00132730|10663835|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
3113950|NCT00132730|10663830|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
3113951|NCT00132730|10663831|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
3113952|NCT00132730|10663832|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
3113953|NCT00132730|10663833|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
3113954|NCT00132730|10663834|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
3113955|NCT00132730|10663835|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
3113956|NCT00132730|10663830|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
3113957|NCT00132730|10663831|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
3113958|NCT00132730|10663832|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
3113959|NCT00132730|10663833|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
3113960|NCT00132730|10663834|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
3113961|NCT00132730|10663835|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
3113962|NCT00132730|10663830|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
3113963|NCT00132730|10663831|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
3113964|NCT00132730|10663832|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
3113965|NCT00132730|10663833|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
3113966|NCT00132730|10663834|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
3113967|NCT00132730|10663835|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
3113968|NCT00132730|10663830|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
3113969|NCT00132730|10663831|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
3113970|NCT00132730|10663832|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
3113971|NCT00132730|10663833|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
3113972|NCT00132730|10663834|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
3113973|NCT00132730|10663835|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
3113974|NCT00132730|10663830|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
3113975|NCT00132730|10663831|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
3113976|NCT00132730|10663832|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
3113977|NCT00132730|10663833|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
3113978|NCT00132730|10663834|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
3113979|NCT00132730|10663835|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
3113980|NCT00132730|10663830|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
3113981|NCT00132730|10663831|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
3113982|NCT00132730|10663832|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
3113983|NCT00132730|10663833|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
3113984|NCT00132730|10663834|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
3113985|NCT00132730|10663835|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
3113986|NCT00132730|10663830|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
3113987|NCT00132730|10663831|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
3113988|NCT00132730|10663832|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
3113989|NCT00132730|10663833|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
3113990|NCT00132730|10663834|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
3113991|NCT00132730|10663835|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
3113992|NCT00132730|10663830|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
3113993|NCT00132730|10663831|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
3113994|NCT00132730|10663832|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
3113995|NCT00132730|10663833|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
3113996|NCT00132730|10663834|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
3113997|NCT00132730|10663835|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
3113998|NCT00132730|10663830|P6|Period II - 12-week Treatment (Base)|Other reasons|0
3113999|NCT00132730|10663831|P5|Period II - 12-week Treatment (Base)|Other reasons|0
3114000|NCT00132730|10663832|P4|Period II - 12-week Treatment (Base)|Other reasons|13
3114001|NCT00132730|10663833|P3|Period II - 12-week Treatment (Base)|Other reasons|9
3114002|NCT00132730|10663834|P2|Period II - 12-week Treatment (Base)|Other reasons|10
3114003|NCT00132730|10663835|P1|Period II - 12-week Treatment (Base)|Other reasons|11
3114004|NCT00132730|10663830|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
3114005|NCT00132730|10663831|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
3114006|NCT00132730|10663832|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
3114007|NCT00132730|10663833|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
3114008|NCT00132730|10663834|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
3114009|NCT00132730|10663835|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
3114010|NCT00132730|10663830|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
3114011|NCT00132730|10663831|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
3114012|NCT00132730|10663832|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
3114013|NCT00132730|10663833|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
3114014|NCT00132730|10663834|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
3114015|NCT00132730|10663835|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
3114016|NCT00132691|10663879|P2|Overall Study|Death|0
3114017|NCT00132691|10663880|P1|Overall Study|Death|2
3114018|NCT00132691|10663879|P2|Overall Study|Missed 2-year visit|4
3114019|NCT00132691|10663880|P1|Overall Study|Missed 2-year visit|4
3114020|NCT00132691|10663879|P2|Overall Study|Lost to Follow-up|8
3114021|NCT00132691|10663880|P1|Overall Study|Lost to Follow-up|5
3114022|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
3114023|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
3114024|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
3114025|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
3114026|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
3114027|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
3114028|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
3114029|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
3114030|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
3114031|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
3114032|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
3114033|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
3114034|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
3114035|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
3114036|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
3114037|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
3114038|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
3114039|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
3114040|NCT00132678|10663920|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
3114041|NCT00132678|10663921|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
3114042|NCT00132678|10663922|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
3114043|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Pregnancy|0
3114044|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Pregnancy|0
3114045|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Pregnancy|2
3114046|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Physician Decision|0
3114047|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Physician Decision|0
3114048|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Physician Decision|1
3114049|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
3114050|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
3114051|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
3114052|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
3114053|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
3114054|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
3114055|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
3114056|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
3114057|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
3114058|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
3114059|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
3114060|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
3114061|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Non responder|0
3114062|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Non responder|0
3114063|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Non responder|107
3114064|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Adverse Event|0
3114065|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Adverse Event|0
3114066|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Adverse Event|12
3114067|NCT00132678|10663920|P3|Period III (Open-Label Stabilization)|Death|0
3114068|NCT00132678|10663921|P2|Period III (Open-Label Stabilization)|Death|0
3114069|NCT00132678|10663922|P1|Period III (Open-Label Stabilization)|Death|2
3114070|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
3114071|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
3114072|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
3114073|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
3114074|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
3114075|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
3114076|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
3114077|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
3114078|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
3114079|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
3114080|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
3114081|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
3114082|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
3114083|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
3114084|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
3114085|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
3114086|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
3114087|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
3114088|NCT00132678|10663920|P3|Period II (Open-Label Oral Risperidone)|Death|1
3114089|NCT00132678|10663921|P2|Period II (Open-Label Oral Risperidone)|Death|0
3114090|NCT00132678|10663922|P1|Period II (Open-Label Oral Risperidone)|Death|0
3114091|NCT00132496|10663936|P2|Overall Study|Physician Decision|0
3114092|NCT00132496|10663937|P1|Overall Study|Physician Decision|1
3114093|NCT00132496|10663936|P2|Overall Study|Withdrawal by Subject|2
3114094|NCT00132496|10663937|P1|Overall Study|Withdrawal by Subject|1
3114095|NCT00132314|10663945|P2|Overall Study|Refused intervention at baseline|7
3114096|NCT00132314|10663946|P1|Overall Study|Refused intervention at baseline|2
3114097|NCT00132314|10663945|P2|Overall Study|Lacked SSN|3
3114098|NCT00132314|10663946|P1|Overall Study|Lacked SSN|1
3114099|NCT00132314|10663945|P2|Overall Study|Lost to Follow-up|62
3114100|NCT00132314|10663946|P1|Overall Study|Lost to Follow-up|70
3114101|NCT00132301|10663956|P2|Overall Study|Excluded by Data Monitoring Committee|0
3114102|NCT00132301|10663957|P1|Overall Study|Excluded by Data Monitoring Committee|1
3114103|NCT00132301|10663956|P2|Overall Study|Other|1
3114104|NCT00132301|10663957|P1|Overall Study|Other|1
3114105|NCT00132301|10663956|P2|Overall Study|Lost to Follow-up|3
3114106|NCT00132301|10663957|P1|Overall Study|Lost to Follow-up|5
3114107|NCT00132301|10663956|P2|Overall Study|Physician Decision|1
3114108|NCT00132301|10663957|P1|Overall Study|Physician Decision|1
3114109|NCT00132301|10663956|P2|Overall Study|Withdrawal by Subject|2
3114110|NCT00132301|10663957|P1|Overall Study|Withdrawal by Subject|5
3114111|NCT00132301|10663956|P2|Overall Study|Death|6
3114112|NCT00132301|10663957|P1|Overall Study|Death|7
3114113|NCT00132132|10663965|P2|Overall Study|Lost to Follow-up|2
3114114|NCT00132132|10663966|P1|Overall Study|Lost to Follow-up|7
3114115|NCT00132028|10663974|P1|Overall Study|Physician Decision|3
3114116|NCT00132028|10663974|P1|Overall Study|not eligible|2
3114117|NCT00132028|10663974|P1|Overall Study|Withdrawal by Subject|2
3114118|NCT00132028|10663974|P1|Overall Study|Lack of Efficacy|11
3114119|NCT00132028|10663974|P1|Overall Study|Death|2
3114120|NCT00132028|10663974|P1|Overall Study|Adverse Event|7
3114121|NCT00131937|10663986|P1|Overall Study|Alternative therapy|1
3114122|NCT00131937|10663986|P1|Overall Study|Disease Progression|7
3114123|NCT00131937|10663986|P1|Overall Study|Physician Decision|1
3114124|NCT00131937|10663986|P1|Overall Study|Withdrawal by Subject|2
3114125|NCT00131937|10663986|P1|Overall Study|Adverse Event|3
3114126|NCT00131911|10663994|P2|Overall Study|Withdrawal by Subject|0
3114127|NCT00131911|10663995|P1|Overall Study|Withdrawal by Subject|1
3114128|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Administrative reasons|0
3114129|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Administrative reasons|1
3114130|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Administrative reasons|0
3114131|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Administrative reasons|0
3114293|NCT00130520|10664344|P1|Overall Study|Physician Decision|1
3114132|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Administrative reasons|2
3114133|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Administrative reasons|4
3114134|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
3114135|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
3114136|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
3114137|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
3114138|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
3114139|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
3114140|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Adverse Event|1
3114141|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Adverse Event|0
3114142|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Adverse Event|0
3114143|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Adverse Event|0
3114144|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Adverse Event|1
3114145|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Adverse Event|0
3114146|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
3114147|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
3114148|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
3114149|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
3114150|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
3114151|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
3114152|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Protocol Violation|0
3114153|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Protocol Violation|0
3114154|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Protocol Violation|0
3114155|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Protocol Violation|1
3114156|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Protocol Violation|1
3114157|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Protocol Violation|0
3114158|NCT00131664|10664065|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
3114159|NCT00131664|10664066|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
3114160|NCT00131664|10664067|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
3114161|NCT00131664|10664068|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
3114162|NCT00131664|10664069|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
3114163|NCT00131664|10664070|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
3114164|NCT00131664|10664065|P6|First Period (First 6 Months)|Administrative reasons|0
3114165|NCT00131664|10664066|P5|First Period (First 6 Months)|Administrative reasons|0
3114166|NCT00131664|10664067|P4|First Period (First 6 Months)|Administrative reasons|0
3114167|NCT00131664|10664068|P3|First Period (First 6 Months)|Administrative reasons|5
3114168|NCT00131664|10664069|P2|First Period (First 6 Months)|Administrative reasons|0
3114169|NCT00131664|10664070|P1|First Period (First 6 Months)|Administrative reasons|2
3114170|NCT00131664|10664065|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
3114171|NCT00131664|10664066|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
3114172|NCT00131664|10664067|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
3114173|NCT00131664|10664068|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
3114174|NCT00131664|10664069|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
3114175|NCT00131664|10664070|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
3114176|NCT00131664|10664065|P6|First Period (First 6 Months)|Adverse Event|0
3114177|NCT00131664|10664066|P5|First Period (First 6 Months)|Adverse Event|0
3114178|NCT00131664|10664067|P4|First Period (First 6 Months)|Adverse Event|0
3114179|NCT00131664|10664068|P3|First Period (First 6 Months)|Adverse Event|5
3114180|NCT00131664|10664069|P2|First Period (First 6 Months)|Adverse Event|4
3114181|NCT00131664|10664070|P1|First Period (First 6 Months)|Adverse Event|9
3114182|NCT00131664|10664065|P6|First Period (First 6 Months)|Withdrawal by Subject|0
3114183|NCT00131664|10664066|P5|First Period (First 6 Months)|Withdrawal by Subject|0
3114184|NCT00131664|10664067|P4|First Period (First 6 Months)|Withdrawal by Subject|0
3114185|NCT00131664|10664068|P3|First Period (First 6 Months)|Withdrawal by Subject|2
3114186|NCT00131664|10664069|P2|First Period (First 6 Months)|Withdrawal by Subject|6
3114187|NCT00131664|10664070|P1|First Period (First 6 Months)|Withdrawal by Subject|4
3114188|NCT00131664|10664065|P6|First Period (First 6 Months)|Protocol Violation|0
3114189|NCT00131664|10664066|P5|First Period (First 6 Months)|Protocol Violation|0
3114190|NCT00131664|10664067|P4|First Period (First 6 Months)|Protocol Violation|0
3114191|NCT00131664|10664068|P3|First Period (First 6 Months)|Protocol Violation|1
3114192|NCT00131664|10664069|P2|First Period (First 6 Months)|Protocol Violation|2
3114193|NCT00131664|10664070|P1|First Period (First 6 Months)|Protocol Violation|2
3114194|NCT00131664|10664065|P6|First Period (First 6 Months)|Death|0
3114195|NCT00131664|10664066|P5|First Period (First 6 Months)|Death|0
3114196|NCT00131664|10664067|P4|First Period (First 6 Months)|Death|0
3114197|NCT00131664|10664068|P3|First Period (First 6 Months)|Death|0
3114198|NCT00131664|10664069|P2|First Period (First 6 Months)|Death|1
3114199|NCT00131664|10664070|P1|First Period (First 6 Months)|Death|0
3114200|NCT00131664|10664065|P6|First Period (First 6 Months)|Lost to Follow-up|0
3114201|NCT00131664|10664066|P5|First Period (First 6 Months)|Lost to Follow-up|0
3114202|NCT00131664|10664067|P4|First Period (First 6 Months)|Lost to Follow-up|0
3114203|NCT00131664|10664068|P3|First Period (First 6 Months)|Lost to Follow-up|3
3114204|NCT00131664|10664069|P2|First Period (First 6 Months)|Lost to Follow-up|3
3114205|NCT00131664|10664070|P1|First Period (First 6 Months)|Lost to Follow-up|7
3114206|NCT00131508|10664142|P2|Overall Study|Withdrawal by Subject|2
3114207|NCT00131508|10664143|P1|Overall Study|Withdrawal by Subject|1
3114208|NCT00131508|10664142|P2|Overall Study|Non-Compliance|4
3114209|NCT00131508|10664143|P1|Overall Study|Non-Compliance|2
3114210|NCT00131508|10664142|P2|Overall Study|Disease progression|2
3114211|NCT00131508|10664143|P1|Overall Study|Disease progression|0
3114212|NCT00131469|10664167|P2|Overall Study|scan not analyzable|6
3114213|NCT00131469|10664168|P1|Overall Study|scan not analyzable|3
3114214|NCT00131469|10664167|P2|Overall Study|Lost to Follow-up|1
3114215|NCT00131469|10664168|P1|Overall Study|Lost to Follow-up|0
3114216|NCT00131469|10664167|P2|Overall Study|Death|1
3114217|NCT00131469|10664168|P1|Overall Study|Death|0
3114218|NCT00131469|10664167|P2|Overall Study|Protocol Violation|1
3114219|NCT00131469|10664168|P1|Overall Study|Protocol Violation|3
3114220|NCT00131469|10664167|P2|Overall Study|Withdrawal by Subject|4
3114221|NCT00131469|10664168|P1|Overall Study|Withdrawal by Subject|3
3114222|NCT00131365|10664214|P1|Overall Study|Alternative treatment|3
3114223|NCT00131365|10664214|P1|Overall Study|Withdrawal by Subject|1
3114224|NCT00131352|10664221|P2|Repeat Treatment Period|Other|0
3114225|NCT00131352|10664222|P1|Repeat Treatment Period|Other|1
3114226|NCT00131352|10664221|P2|Repeat Treatment Period|Adverse Event|0
3114227|NCT00131352|10664222|P1|Repeat Treatment Period|Adverse Event|1
3114228|NCT00131352|10664221|P2|Initial Treatment Period|Other|2
3114229|NCT00131352|10664222|P1|Initial Treatment Period|Other|0
3114230|NCT00131352|10664221|P2|Initial Treatment Period|Lack of Efficacy|4
3114231|NCT00131352|10664222|P1|Initial Treatment Period|Lack of Efficacy|6
3114232|NCT00131352|10664221|P2|Initial Treatment Period|Withdrawal by Subject|1
3114233|NCT00131352|10664222|P1|Initial Treatment Period|Withdrawal by Subject|1
3114234|NCT00131352|10664221|P2|Initial Treatment Period|Non-compliant|2
3114235|NCT00131352|10664222|P1|Initial Treatment Period|Non-compliant|1
3114236|NCT00131352|10664221|P2|Initial Treatment Period|Adverse Event|3
3114237|NCT00131352|10664222|P1|Initial Treatment Period|Adverse Event|1
3114238|NCT00131248|10664244|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
3114239|NCT00131248|10664245|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
3114240|NCT00130832|10664272|P2|Overall Study|Other|3
3114241|NCT00130832|10664273|P1|Overall Study|Other|0
3114242|NCT00130832|10664272|P2|Overall Study|Moved|2
3114243|NCT00130832|10664273|P1|Overall Study|Moved|2
3114244|NCT00130832|10664272|P2|Overall Study|Withdrawal by Subject|1
3114245|NCT00130832|10664273|P1|Overall Study|Withdrawal by Subject|6
3114246|NCT00130832|10664272|P2|Overall Study|Protocol Violation|8
3114247|NCT00130832|10664273|P1|Overall Study|Protocol Violation|6
3114248|NCT00130832|10664272|P2|Overall Study|Lost to Follow-up|2
3114249|NCT00130832|10664273|P1|Overall Study|Lost to Follow-up|1
3114250|NCT00130832|10664272|P2|Overall Study|Adverse Event|1
3114251|NCT00130832|10664273|P1|Overall Study|Adverse Event|1
3114252|NCT00130793|10664285|P2|Overall Study|Withdrew consent|0
3114253|NCT00130793|10664286|P1|Overall Study|Withdrew consent|2
3114254|NCT00130793|10664285|P2|Overall Study|Lost to Follow-up|4
3114255|NCT00130793|10664286|P1|Overall Study|Lost to Follow-up|1
3114256|NCT00130728|10664307|P2|Overall Study|Withdrawal by Subject|2
3114257|NCT00130728|10664308|P1|Overall Study|Withdrawal by Subject|0
3114258|NCT00130728|10664307|P2|Overall Study|Lost to Follow-up|0
3114259|NCT00130728|10664308|P1|Overall Study|Lost to Follow-up|4
3114260|NCT00130728|10664307|P2|Overall Study|Death|211
3114261|NCT00130728|10664308|P1|Overall Study|Death|207
3114262|NCT00130689|10664320|P1|Overall Study|Ineligible|6
3114263|NCT00130689|10664320|P1|Overall Study|Withdrawal by Subject|3
3114264|NCT00130689|10664320|P1|Overall Study|Clinical Deterioration|4
3114265|NCT00130689|10664320|P1|Overall Study|Death|1
3114266|NCT00130689|10664320|P1|Overall Study|Progressive Disease|29
3114267|NCT00130637|10664324|P1|Overall Study|Withdrawal by Subject|1
3114268|NCT00130637|10664324|P1|Overall Study|Adverse Event|2
3114269|NCT00130533|10664331|P2|Overall Study|Other|5
3114270|NCT00130533|10664332|P1|Overall Study|Other|12
3114271|NCT00130533|10664331|P2|Overall Study|Second Primary Malignancy|1
3114272|NCT00130533|10664332|P1|Overall Study|Second Primary Malignancy|0
3114273|NCT00130533|10664331|P2|Overall Study|Sponsor´s decision|0
3114274|NCT00130533|10664332|P1|Overall Study|Sponsor´s decision|2
3114275|NCT00130533|10664331|P2|Overall Study|Lost to Follow-up|1
3114276|NCT00130533|10664332|P1|Overall Study|Lost to Follow-up|1
3114277|NCT00130533|10664331|P2|Overall Study|Protocol Violation|1
3114278|NCT00130533|10664332|P1|Overall Study|Protocol Violation|5
3114279|NCT00130533|10664331|P2|Overall Study|Death|2
3114280|NCT00130533|10664332|P1|Overall Study|Death|4
3114281|NCT00130533|10664331|P2|Overall Study|Interruption of treatment > 3 weeks|0
3114282|NCT00130533|10664332|P1|Overall Study|Interruption of treatment > 3 weeks|11
3114283|NCT00130533|10664331|P2|Overall Study|Disease relapse|13
3114284|NCT00130533|10664332|P1|Overall Study|Disease relapse|9
3114285|NCT00130533|10664331|P2|Overall Study|Adverse Event|1
3114286|NCT00130533|10664332|P1|Overall Study|Adverse Event|34
3114287|NCT00130533|10664331|P2|Overall Study|Withdrawal by Subject|6
3114288|NCT00130533|10664332|P1|Overall Study|Withdrawal by Subject|33
3114289|NCT00130520|10664344|P1|Overall Study|Did not meet re-treatment criteria|1
3114290|NCT00130520|10664344|P1|Overall Study|Protocol non-compliance|1
3114291|NCT00130520|10664344|P1|Overall Study|Disease Progression|23
3114292|NCT00130520|10664344|P1|Overall Study|Withdrawal by Subject|1
3114294|NCT00130520|10664344|P1|Overall Study|Death|1
3114295|NCT00130520|10664344|P1|Overall Study|Adverse Event|11
3114296|NCT00130286|10664354|P4|Overall Study|Missing lab specimens|0
3114297|NCT00130286|10664355|P3|Overall Study|Missing lab specimens|0
3114298|NCT00130286|10664356|P2|Overall Study|Missing lab specimens|2
3114299|NCT00130286|10664357|P1|Overall Study|Missing lab specimens|0
3114300|NCT00130286|10664354|P4|Overall Study|Adverse Event|0
3114301|NCT00130286|10664355|P3|Overall Study|Adverse Event|2
3114302|NCT00130286|10664356|P2|Overall Study|Adverse Event|0
3114303|NCT00130286|10664357|P1|Overall Study|Adverse Event|0
3114304|NCT00130286|10664354|P4|Overall Study|Withdrawal by Subject|2
3114305|NCT00130286|10664355|P3|Overall Study|Withdrawal by Subject|2
3114306|NCT00130286|10664356|P2|Overall Study|Withdrawal by Subject|1
3114307|NCT00130286|10664357|P1|Overall Study|Withdrawal by Subject|0
3114308|NCT00130247|10664377|P2|Overall Study|Not compliant with DOT|2
3114309|NCT00130247|10664378|P1|Overall Study|Not compliant with DOT|0
3114310|NCT00130247|10664377|P2|Overall Study|Post-randomization exclusion|2
3114311|NCT00130247|10664378|P1|Overall Study|Post-randomization exclusion|1
3114312|NCT00130247|10664377|P2|Overall Study|Pregnancy|0
3114313|NCT00130247|10664378|P1|Overall Study|Pregnancy|1
3114314|NCT00130208|10664396|P2|Washout Period (8 Weeks)|Other|1
3114315|NCT00130208|10664397|P1|Washout Period (8 Weeks)|Other|1
3114316|NCT00130208|10664396|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
3114317|NCT00130208|10664397|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
3114318|NCT00130208|10664396|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
3114319|NCT00130208|10664397|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
3114320|NCT00130208|10664396|P2|Washout Period (8 Weeks)|Adverse Event|6
3114321|NCT00130208|10664397|P1|Washout Period (8 Weeks)|Adverse Event|3
3114322|NCT00130208|10664396|P2|Maintenance Period (26 Weeks)|Other|1
3114323|NCT00130208|10664397|P1|Maintenance Period (26 Weeks)|Other|1
3114324|NCT00130208|10664396|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
3114325|NCT00130208|10664397|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
3114326|NCT00130208|10664396|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
3114327|NCT00130208|10664397|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
3114328|NCT00130208|10664396|P2|Maintenance Period (26 Weeks)|Physician Decision|2
3114329|NCT00130208|10664397|P1|Maintenance Period (26 Weeks)|Physician Decision|0
3114330|NCT00130208|10664396|P2|Maintenance Period (26 Weeks)|Adverse Event|12
3114331|NCT00130208|10664397|P1|Maintenance Period (26 Weeks)|Adverse Event|10
3114332|NCT00130039|10664433|P2|Overall Study|clinical events without follow up MRI|4
3114333|NCT00130039|10664434|P1|Overall Study|clinical events without follow up MRI|5
3114334|NCT00130039|10664433|P2|Overall Study|Physician Decision|0
3114335|NCT00130039|10664434|P1|Overall Study|Physician Decision|3
3114336|NCT00130039|10664433|P2|Overall Study|Adverse Event|2
3114337|NCT00130039|10664434|P1|Overall Study|Adverse Event|4
3114338|NCT00130039|10664433|P2|Overall Study|Lost to Follow-up|1
3114339|NCT00130039|10664434|P1|Overall Study|Lost to Follow-up|3
3114340|NCT00130039|10664433|P2|Overall Study|Withdrawal by Subject|11
3114341|NCT00130039|10664434|P1|Overall Study|Withdrawal by Subject|15
3114342|NCT00129987|10664452|P2|1 Year|Withdrawal by Subject|21
3114343|NCT00129987|10664453|P1|1 Year|Withdrawal by Subject|32
3114344|NCT00129987|10664452|P2|1st Educational Session|Withdrawal by Subject|109
3114345|NCT00129987|10664453|P1|1st Educational Session|Withdrawal by Subject|141
3114346|NCT00129974|10664465|P1|Overall Study|Other|1
3114347|NCT00129961|10664472|P2|Overall Study|Missing Record|1
3114348|NCT00129961|10664473|P1|Overall Study|Missing Record|0
3114349|NCT00129961|10664472|P2|Overall Study|Withdrawal by Subject|1
3114350|NCT00129961|10664473|P1|Overall Study|Withdrawal by Subject|2
3114351|NCT00129961|10664472|P2|Overall Study|Physician Decision|0
3114352|NCT00129961|10664473|P1|Overall Study|Physician Decision|1
3114353|NCT00129961|10664472|P2|Overall Study|Withdrawal by Sponsor|20
3114354|NCT00129961|10664473|P1|Overall Study|Withdrawal by Sponsor|14
3114355|NCT00129961|10664472|P2|Overall Study|Death|1
3114356|NCT00129961|10664473|P1|Overall Study|Death|1
3114357|NCT00129961|10664472|P2|Overall Study|Adverse Event|0
3114358|NCT00129961|10664473|P1|Overall Study|Adverse Event|1
3114359|NCT00129935|10664509|P2|Overall Study|Incorrect study treatment|0
3114360|NCT00129935|10664510|P1|Overall Study|Incorrect study treatment|1
3114361|NCT00129935|10664509|P2|Overall Study|Crossed to the other arm|1
3114362|NCT00129935|10664510|P1|Overall Study|Crossed to the other arm|2
3114363|NCT00129935|10664509|P2|Overall Study|Other|2
3114364|NCT00129935|10664510|P1|Overall Study|Other|3
3114365|NCT00129935|10664509|P2|Overall Study|Second primary|1
3114366|NCT00129935|10664510|P1|Overall Study|Second primary|0
3114367|NCT00129935|10664509|P2|Overall Study|Recurrence|3
3114368|NCT00129935|10664510|P1|Overall Study|Recurrence|1
3114369|NCT00129935|10664509|P2|Overall Study|Physician Decision|4
3114370|NCT00129935|10664510|P1|Overall Study|Physician Decision|3
3114371|NCT00129935|10664509|P2|Overall Study|Protocol Violation|4
3114372|NCT00129935|10664510|P1|Overall Study|Protocol Violation|0
3114373|NCT00129935|10664509|P2|Overall Study|Withdrawal by Subject|20
3114374|NCT00129935|10664510|P1|Overall Study|Withdrawal by Subject|7
3114375|NCT00129935|10664509|P2|Overall Study|Death|1
3114376|NCT00129935|10664510|P1|Overall Study|Death|1
3114377|NCT00129935|10664509|P2|Overall Study|Adverse Event|56
3114378|NCT00129935|10664510|P1|Overall Study|Adverse Event|18
3114379|NCT00129766|10664528|P2|Overall Study|Lost to Follow-up|21
3114380|NCT00129766|10664529|P1|Overall Study|Lost to Follow-up|26
3114381|NCT00129766|10664528|P2|Overall Study|Withdrawal of consent|30
3114382|NCT00129766|10664529|P1|Overall Study|Withdrawal of consent|31
3114383|NCT00129766|10664528|P2|Overall Study|Death|8
3114384|NCT00129766|10664529|P1|Overall Study|Death|3
3114385|NCT00129701|10664578|P1|Overall Study|Withdrawal by Subject|33
3114386|NCT00129649|10664587|P2|Overall Study|Withdrawal by Subject|65
3114387|NCT00129649|10664588|P1|Overall Study|Withdrawal by Subject|76
3114388|NCT00129623|10664596|P2|Overall Study|Uncertainty to return|1
3114389|NCT00129623|10664597|P1|Overall Study|Uncertainty to return|0
3114390|NCT00129623|10664596|P2|Overall Study|Relocated job out of state|0
3114391|NCT00129623|10664597|P1|Overall Study|Relocated job out of state|1
3114392|NCT00129623|10664596|P2|Overall Study|Failure to Return|1
3114393|NCT00129623|10664597|P1|Overall Study|Failure to Return|1
3114394|NCT00129623|10664596|P2|Overall Study|Refused Treatment|3
3114395|NCT00129623|10664597|P1|Overall Study|Refused Treatment|5
3114396|NCT00129623|10664596|P2|Overall Study|Adverse Event|7
3114397|NCT00129623|10664597|P1|Overall Study|Adverse Event|3
3114398|NCT00129545|10664622|P3|Overall Study|Device not implanted|0
3114399|NCT00129545|10664623|P2|Overall Study|Device not implanted|61
3114400|NCT00129545|10664624|P1|Overall Study|Device not implanted|16
3114401|NCT00129545|10664622|P3|Overall Study|Physician Decision|10
3114402|NCT00129545|10664623|P2|Overall Study|Physician Decision|3
3114403|NCT00129545|10664624|P1|Overall Study|Physician Decision|0
3114404|NCT00129545|10664622|P3|Overall Study|Lost to Follow-up|13
3114405|NCT00129545|10664623|P2|Overall Study|Lost to Follow-up|22
3114406|NCT00129545|10664624|P1|Overall Study|Lost to Follow-up|2
3114407|NCT00129545|10664622|P3|Overall Study|Withdrawal by Subject|44
3114408|NCT00129545|10664623|P2|Overall Study|Withdrawal by Subject|18
3114409|NCT00129545|10664624|P1|Overall Study|Withdrawal by Subject|3
3114410|NCT00129545|10664622|P3|Overall Study|Death|44
3114411|NCT00129545|10664623|P2|Overall Study|Death|60
3114412|NCT00129545|10664624|P1|Overall Study|Death|5
3114413|NCT00129467|10664653|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
3114414|NCT00129467|10664654|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
3114415|NCT00129467|10664653|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
3114416|NCT00129467|10664654|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
3114417|NCT00129467|10664653|P2|Received Intervention|Dizzyness, fatigue|1
3114418|NCT00129467|10664654|P1|Received Intervention|Dizzyness, fatigue|0
3114419|NCT00129467|10664653|P2|Received Intervention|Intolerance to citalopram|1
3114420|NCT00129467|10664654|P1|Received Intervention|Intolerance to citalopram|0
3114421|NCT00129467|10664653|P2|Received Intervention|Nausea|0
3114422|NCT00129467|10664654|P1|Received Intervention|Nausea|1
3114423|NCT00129467|10664653|P2|Received Intervention|Withdrawal by Subject|0
3114424|NCT00129467|10664654|P1|Received Intervention|Withdrawal by Subject|1
3114425|NCT00129467|10664653|P2|Received Intervention|Delirium|0
3114426|NCT00129467|10664654|P1|Received Intervention|Delirium|2
3114427|NCT00129467|10664653|P2|Received Intervention|Cardiac SAE (hypertension)|1
3114428|NCT00129467|10664654|P1|Received Intervention|Cardiac SAE (hypertension)|1
3114429|NCT00129467|10664653|P2|Received Intervention|Death|1
3114430|NCT00129467|10664654|P1|Received Intervention|Death|1
3114431|NCT00129402|10664685|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
3114432|NCT00129402|10664686|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114433|NCT00129402|10664687|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114434|NCT00129402|10664688|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114435|NCT00129402|10664689|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114436|NCT00129402|10664690|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114437|NCT00129402|10664691|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
3114438|NCT00129402|10664685|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
3114439|NCT00129402|10664686|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114440|NCT00129402|10664687|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114441|NCT00129402|10664688|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114442|NCT00129402|10664689|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114443|NCT00129402|10664690|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114444|NCT00129402|10664691|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
3114445|NCT00129402|10664685|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
3114446|NCT00129402|10664686|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114447|NCT00129402|10664687|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114448|NCT00129402|10664688|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114449|NCT00129402|10664689|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114450|NCT00129402|10664690|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114451|NCT00129402|10664691|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
3114452|NCT00129402|10664685|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
3114453|NCT00129402|10664686|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114454|NCT00129402|10664687|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114455|NCT00129402|10664688|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114456|NCT00129402|10664689|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114457|NCT00129402|10664690|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114458|NCT00129402|10664691|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
3114459|NCT00129402|10664685|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
3114460|NCT00129402|10664686|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
3114461|NCT00129402|10664687|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
3114462|NCT00129402|10664688|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
3114463|NCT00129402|10664689|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
3114464|NCT00129402|10664690|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
3114465|NCT00129402|10664691|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
3114466|NCT00129402|10664685|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
3114467|NCT00129402|10664686|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
3114468|NCT00129402|10664687|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
3114469|NCT00129402|10664688|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
3114470|NCT00129402|10664689|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
3114471|NCT00129402|10664690|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
3114472|NCT00129402|10664691|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
3114473|NCT00129402|10664685|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114474|NCT00129402|10664686|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114475|NCT00129402|10664687|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114476|NCT00129402|10664688|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114477|NCT00129402|10664689|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
3114478|NCT00129402|10664690|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114479|NCT00129402|10664691|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
3114480|NCT00129402|10664685|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
3114481|NCT00129402|10664686|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
3114482|NCT00129402|10664687|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
3114483|NCT00129402|10664688|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
3114484|NCT00129402|10664689|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
3114485|NCT00129402|10664690|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
3114486|NCT00129402|10664691|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
3114487|NCT00129402|10664685|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114488|NCT00129402|10664686|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114489|NCT00129402|10664687|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114490|NCT00129402|10664688|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114491|NCT00129402|10664689|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
3114492|NCT00129402|10664690|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114493|NCT00129402|10664691|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
3114494|NCT00129402|10664685|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
3114495|NCT00129402|10664686|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
3114496|NCT00129402|10664687|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
3114497|NCT00129402|10664688|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
3114498|NCT00129402|10664689|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
3114499|NCT00129402|10664690|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
3114500|NCT00129402|10664691|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
3114501|NCT00129402|10664685|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114502|NCT00129402|10664686|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114503|NCT00129402|10664687|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114504|NCT00129402|10664688|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
3114505|NCT00129402|10664689|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114506|NCT00129402|10664690|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114507|NCT00129402|10664691|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
3114508|NCT00129402|10664685|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114509|NCT00129402|10664686|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
3114510|NCT00129402|10664687|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114511|NCT00129402|10664688|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114512|NCT00129402|10664689|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114513|NCT00129402|10664690|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114514|NCT00129402|10664691|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
3114515|NCT00129402|10664685|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
3114516|NCT00129402|10664686|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
3114517|NCT00129402|10664687|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
3114518|NCT00129402|10664688|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
3114519|NCT00129402|10664689|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
3114520|NCT00129402|10664690|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
3114521|NCT00129402|10664691|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
3114522|NCT00129389|10664710|P2|Overall Study|Crossed to the other arm|16
3114523|NCT00129389|10664711|P1|Overall Study|Crossed to the other arm|1
3114524|NCT00129389|10664710|P2|Overall Study|Not eligible|2
3114525|NCT00129389|10664711|P1|Overall Study|Not eligible|1
3114526|NCT00129389|10664710|P2|Overall Study|Relapse|0
3114527|NCT00129389|10664711|P1|Overall Study|Relapse|1
3114528|NCT00129389|10664710|P2|Overall Study|Withdrawal by Subject|23
3114529|NCT00129389|10664711|P1|Overall Study|Withdrawal by Subject|9
3114530|NCT00129389|10664710|P2|Overall Study|Protocol Violation|6
3114531|NCT00129389|10664711|P1|Overall Study|Protocol Violation|0
3114532|NCT00129389|10664710|P2|Overall Study|Physician Decision|4
3114533|NCT00129389|10664711|P1|Overall Study|Physician Decision|0
3114534|NCT00129389|10664710|P2|Overall Study|Lost to Follow-up|1
3114535|NCT00129389|10664711|P1|Overall Study|Lost to Follow-up|2
3114536|NCT00129389|10664710|P2|Overall Study|Death|1
3114537|NCT00129389|10664711|P1|Overall Study|Death|0
3114538|NCT00129389|10664710|P2|Overall Study|Adverse Event|87
3114539|NCT00129389|10664711|P1|Overall Study|Adverse Event|19
3114540|NCT00129376|10664719|P1|Overall Study|Lack of Efficacy|1
3114541|NCT00129376|10664719|P1|Overall Study|Adverse Event|1
3114542|NCT00129311|10664729|P2|Overall Study|Withdrawal by Subject|19
3114543|NCT00129311|10664730|P1|Overall Study|Withdrawal by Subject|12
3114544|NCT00129272|10664759|P2|Overall Study|Withdrawal by Subject|11
3114545|NCT00129272|10664760|P1|Overall Study|Withdrawal by Subject|5
3114546|NCT00129272|10664759|P2|Overall Study|Lost to Follow-up|11
3114547|NCT00129272|10664760|P1|Overall Study|Lost to Follow-up|12
3114548|NCT00129259|10664770|P2|Overall Study|Only available minimal phone assessments|1
3114549|NCT00129259|10664771|P1|Overall Study|Only available minimal phone assessments|0
3114550|NCT00129259|10664770|P2|Overall Study|Withdrawal by Subject|1
3114551|NCT00129259|10664771|P1|Overall Study|Withdrawal by Subject|2
3114552|NCT00129259|10664770|P2|Overall Study|Lost to Follow-up|1
3114553|NCT00129259|10664771|P1|Overall Study|Lost to Follow-up|1
3114554|NCT00129220|10664799|P3|Study Period III|Reason Not Specified|2
3114555|NCT00129220|10664800|P2|Study Period III|Reason Not Specified|0
3114556|NCT00129220|10664801|P1|Study Period III|Reason Not Specified|9
3114557|NCT00129220|10664799|P3|Study Period III|Sponsor Decision|0
3114558|NCT00129220|10664800|P2|Study Period III|Sponsor Decision|0
3114559|NCT00129220|10664801|P1|Study Period III|Sponsor Decision|1
3114560|NCT00129220|10664799|P3|Study Period III|Withdrawal by Subject|3
3114561|NCT00129220|10664800|P2|Study Period III|Withdrawal by Subject|0
3114562|NCT00129220|10664801|P1|Study Period III|Withdrawal by Subject|1
3114563|NCT00129220|10664799|P3|Study Period III|Protocol Violation|2
3114564|NCT00129220|10664800|P2|Study Period III|Protocol Violation|1
3114565|NCT00129220|10664801|P1|Study Period III|Protocol Violation|1
3114566|NCT00129220|10664799|P3|Study Period III|Adverse Event|3
3114567|NCT00129220|10664800|P2|Study Period III|Adverse Event|0
3114568|NCT00129220|10664801|P1|Study Period III|Adverse Event|1
3114569|NCT00129220|10664799|P3|Study Period II|Reason Not Specified|5
3114570|NCT00129220|10664800|P2|Study Period II|Reason Not Specified|0
3114571|NCT00129220|10664801|P1|Study Period II|Reason Not Specified|2
3114572|NCT00129220|10664799|P3|Study Period II|Withdrawal by Subject|4
3114573|NCT00129220|10664800|P2|Study Period II|Withdrawal by Subject|3
3114574|NCT00129220|10664801|P1|Study Period II|Withdrawal by Subject|1
3114575|NCT00129220|10664799|P3|Study Period II|Physician Decision|0
3114576|NCT00129220|10664800|P2|Study Period II|Physician Decision|1
3114577|NCT00129220|10664801|P1|Study Period II|Physician Decision|0
3114578|NCT00129220|10664799|P3|Study Period II|Protocol Violation|1
3114579|NCT00129220|10664800|P2|Study Period II|Protocol Violation|2
3114580|NCT00129220|10664801|P1|Study Period II|Protocol Violation|4
3114581|NCT00129220|10664799|P3|Study Period II|Entry Criteria Not Met|2
3114582|NCT00129220|10664800|P2|Study Period II|Entry Criteria Not Met|0
3114583|NCT00129220|10664801|P1|Study Period II|Entry Criteria Not Met|2
3114584|NCT00129220|10664799|P3|Study Period II|Lack of Efficacy|28
3114585|NCT00129220|10664800|P2|Study Period II|Lack of Efficacy|1
3114586|NCT00129220|10664801|P1|Study Period II|Lack of Efficacy|15
3114587|NCT00129220|10664799|P3|Study Period II|Adverse Event|7
3114588|NCT00129220|10664800|P2|Study Period II|Adverse Event|5
3114589|NCT00129220|10664801|P1|Study Period II|Adverse Event|9
3114590|NCT00129129|10664841|P5|Fourth Dose Phase|Protocol Violation|0
3114591|NCT00129129|10664842|P4|Fourth Dose Phase|Protocol Violation|1
3114592|NCT00129129|10664843|P3|Fourth Dose Phase|Protocol Violation|0
3114593|NCT00129129|10664844|P2|Fourth Dose Phase|Protocol Violation|0
3114594|NCT00129129|10664845|P1|Fourth Dose Phase|Protocol Violation|0
3114595|NCT00129129|10664841|P5|Fourth Dose Phase|Other|1
3114596|NCT00129129|10664842|P4|Fourth Dose Phase|Other|1
3114597|NCT00129129|10664843|P3|Fourth Dose Phase|Other|0
3114598|NCT00129129|10664844|P2|Fourth Dose Phase|Other|0
3114599|NCT00129129|10664845|P1|Fourth Dose Phase|Other|0
3114600|NCT00129129|10664841|P5|Fourth Dose Phase|Migration from study area|2
3114601|NCT00129129|10664842|P4|Fourth Dose Phase|Migration from study area|0
3114602|NCT00129129|10664843|P3|Fourth Dose Phase|Migration from study area|0
3114603|NCT00129129|10664844|P2|Fourth Dose Phase|Migration from study area|0
3114604|NCT00129129|10664845|P1|Fourth Dose Phase|Migration from study area|0
3114605|NCT00129129|10664841|P5|Fourth Dose Phase|Withdrawal by Subject|1
3114606|NCT00129129|10664842|P4|Fourth Dose Phase|Withdrawal by Subject|0
3114607|NCT00129129|10664843|P3|Fourth Dose Phase|Withdrawal by Subject|0
3114608|NCT00129129|10664844|P2|Fourth Dose Phase|Withdrawal by Subject|0
3114609|NCT00129129|10664845|P1|Fourth Dose Phase|Withdrawal by Subject|0
3114610|NCT00129129|10664841|P5|Fourth Dose Phase|Lost to Follow-up|2
3114611|NCT00129129|10664842|P4|Fourth Dose Phase|Lost to Follow-up|2
3114612|NCT00129129|10664843|P3|Fourth Dose Phase|Lost to Follow-up|0
3114613|NCT00129129|10664844|P2|Fourth Dose Phase|Lost to Follow-up|0
3114614|NCT00129129|10664845|P1|Fourth Dose Phase|Lost to Follow-up|4
3114615|NCT00129129|10664841|P5|Primary Phase|Other|0
3114616|NCT00129129|10664842|P4|Primary Phase|Other|0
3114617|NCT00129129|10664843|P3|Primary Phase|Other|0
3114618|NCT00129129|10664844|P2|Primary Phase|Other|5
3114619|NCT00129129|10664845|P1|Primary Phase|Other|2
3114620|NCT00129129|10664841|P5|Primary Phase|Lost to Follow-up|0
3114621|NCT00129129|10664842|P4|Primary Phase|Lost to Follow-up|0
3114622|NCT00129129|10664843|P3|Primary Phase|Lost to Follow-up|0
3114623|NCT00129129|10664844|P2|Primary Phase|Lost to Follow-up|6
3114624|NCT00129129|10664845|P1|Primary Phase|Lost to Follow-up|8
3114625|NCT00129129|10664841|P5|Primary Phase|Migration from study area|0
3114626|NCT00129129|10664842|P4|Primary Phase|Migration from study area|0
3114627|NCT00129129|10664843|P3|Primary Phase|Migration from study area|0
3114628|NCT00129129|10664844|P2|Primary Phase|Migration from study area|3
3114629|NCT00129129|10664845|P1|Primary Phase|Migration from study area|1
3114630|NCT00129129|10664841|P5|Primary Phase|Withdrawal by Subject|0
3114631|NCT00129129|10664842|P4|Primary Phase|Withdrawal by Subject|0
3114632|NCT00129129|10664843|P3|Primary Phase|Withdrawal by Subject|0
3114633|NCT00129129|10664844|P2|Primary Phase|Withdrawal by Subject|10
3114634|NCT00129129|10664845|P1|Primary Phase|Withdrawal by Subject|12
3114635|NCT00129129|10664841|P5|Primary Phase|Adverse Event|0
3114636|NCT00129129|10664842|P4|Primary Phase|Adverse Event|0
3114637|NCT00129129|10664843|P3|Primary Phase|Adverse Event|0
3114638|NCT00129129|10664844|P2|Primary Phase|Adverse Event|1
3114639|NCT00129129|10664845|P1|Primary Phase|Adverse Event|2
3114640|NCT00129116|10665052|P5|Booster Phase|Lost to Follow-up|1
3114641|NCT00129116|10665053|P4|Booster Phase|Lost to Follow-up|0
3114642|NCT00129116|10665054|P3|Booster Phase|Lost to Follow-up|0
3114643|NCT00129116|10665055|P2|Booster Phase|Lost to Follow-up|0
3114644|NCT00129116|10665056|P1|Booster Phase|Lost to Follow-up|2
3114645|NCT00129116|10665052|P5|Primary Phase|Other|0
3114646|NCT00129116|10665053|P4|Primary Phase|Other|0
3114647|NCT00129116|10665054|P3|Primary Phase|Other|1
3114648|NCT00129116|10665055|P2|Primary Phase|Other|0
3114649|NCT00129116|10665056|P1|Primary Phase|Other|0
3114650|NCT00129116|10665052|P5|Primary Phase|Withdrawal by Subject|0
3114651|NCT00129116|10665053|P4|Primary Phase|Withdrawal by Subject|0
3114652|NCT00129116|10665054|P3|Primary Phase|Withdrawal by Subject|0
3114653|NCT00129116|10665055|P2|Primary Phase|Withdrawal by Subject|1
3114654|NCT00129116|10665056|P1|Primary Phase|Withdrawal by Subject|0
3114655|NCT00129116|10665052|P5|Primary Phase|Adverse Event|0
3114656|NCT00129116|10665053|P4|Primary Phase|Adverse Event|0
3114657|NCT00129116|10665054|P3|Primary Phase|Adverse Event|0
3114658|NCT00129116|10665055|P2|Primary Phase|Adverse Event|1
3114659|NCT00129116|10665056|P1|Primary Phase|Adverse Event|1
3114660|NCT00129116|10665052|P5|Primary Phase|Protocol Violation|0
3114661|NCT00129116|10665053|P4|Primary Phase|Protocol Violation|0
3114662|NCT00129116|10665054|P3|Primary Phase|Protocol Violation|0
3114663|NCT00129116|10665055|P2|Primary Phase|Protocol Violation|1
3114664|NCT00129116|10665056|P1|Primary Phase|Protocol Violation|0
3114665|NCT00129116|10665052|P5|Primary Phase|Lost to Follow-up|1
3114666|NCT00129116|10665053|P4|Primary Phase|Lost to Follow-up|1
3114667|NCT00129116|10665054|P3|Primary Phase|Lost to Follow-up|0
3114668|NCT00129116|10665055|P2|Primary Phase|Lost to Follow-up|1
3114669|NCT00129116|10665056|P1|Primary Phase|Lost to Follow-up|1
3114670|NCT00128830|10665340|P1|Overall Study|Other|9
3114671|NCT00128830|10665340|P1|Overall Study|Discontinued or ineligible for study|2
3114672|NCT00128830|10665340|P1|Overall Study|Non-compliant|4
3114673|NCT00128830|10665340|P1|Overall Study|Reached a virologic endpoint|29
3114674|NCT00128830|10665340|P1|Overall Study|Lost to Follow-up|4
3114675|NCT00128830|10665340|P1|Overall Study|Withdrawal by Subject|14
3114676|NCT00128830|10665340|P1|Overall Study|Adverse Event|10
3114677|NCT00128661|10665382|P2|Overall Study|Other|8
3114678|NCT00128661|10665383|P1|Overall Study|Other|7
3114679|NCT00128661|10665382|P2|Overall Study|Withdrawal by Subject|232
3114680|NCT00128661|10665383|P1|Overall Study|Withdrawal by Subject|243
3114681|NCT00128661|10665382|P2|Overall Study|Lost to Follow-up|7
3114682|NCT00128661|10665383|P1|Overall Study|Lost to Follow-up|10
3114683|NCT00128661|10665382|P2|Overall Study|Adverse Event|11
3114684|NCT00128661|10665383|P1|Overall Study|Adverse Event|14
3114685|NCT00128492|10665429|P2|Overall Study|Pregnancy|1
3114686|NCT00128492|10665430|P1|Overall Study|Pregnancy|0
3114687|NCT00128492|10665429|P2|Overall Study|Withdrawal by Subject|5
3114688|NCT00128492|10665430|P1|Overall Study|Withdrawal by Subject|3
3114689|NCT00128492|10665429|P2|Overall Study|Personal or administrative|22
3114690|NCT00128492|10665430|P1|Overall Study|Personal or administrative|10
3114691|NCT00128492|10665429|P2|Overall Study|Noncompliance|5
3114692|NCT00128492|10665430|P1|Overall Study|Noncompliance|0
3114693|NCT00128492|10665429|P2|Overall Study|Lost to Follow-up|5
3114694|NCT00128492|10665430|P1|Overall Study|Lost to Follow-up|1
3114695|NCT00128492|10665429|P2|Overall Study|Death|0
3114696|NCT00128492|10665430|P1|Overall Study|Death|1
3114697|NCT00128492|10665429|P2|Overall Study|AE related to study|4
3114698|NCT00128492|10665430|P1|Overall Study|AE related to study|1
3114699|NCT00128492|10665429|P2|Overall Study|Study drug intolerance (AE)|8
3114700|NCT00128492|10665430|P1|Overall Study|Study drug intolerance (AE)|2
3114701|NCT00128492|10665429|P2|Overall Study|AE unrelated to study|9
3114702|NCT00128492|10665430|P1|Overall Study|AE unrelated to study|2
3114703|NCT00128206|10665587|P2|Overall Study|Adverse Event|2
3114704|NCT00128206|10665588|P1|Overall Study|Adverse Event|0
3114705|NCT00128206|10665587|P2|Overall Study|Lost to Follow-up|118
3114706|NCT00128206|10665588|P1|Overall Study|Lost to Follow-up|137
3114707|NCT00127933|10665880|P2|Overall Study|Randomized but not dosed|0
3114708|NCT00127933|10665881|P1|Overall Study|Randomized but not dosed|1
3114709|NCT00127855|10665902|P5|Primary Vaccination Course|Other|1
3114710|NCT00127855|10665903|P4|Primary Vaccination Course|Other|0
3114711|NCT00127855|10665904|P3|Primary Vaccination Course|Other|0
3114712|NCT00127855|10665905|P2|Primary Vaccination Course|Other|0
3114713|NCT00127855|10665906|P1|Primary Vaccination Course|Other|0
3114714|NCT00127855|10665902|P5|Primary Vaccination Course|Lost to Follow-up|2
3114715|NCT00127855|10665903|P4|Primary Vaccination Course|Lost to Follow-up|0
3114716|NCT00127855|10665904|P3|Primary Vaccination Course|Lost to Follow-up|1
3114717|NCT00127855|10665905|P2|Primary Vaccination Course|Lost to Follow-up|1
3114718|NCT00127855|10665906|P1|Primary Vaccination Course|Lost to Follow-up|1
3114719|NCT00127855|10665902|P5|Primary Vaccination Course|Withdrawal by Subject|1
3114720|NCT00127855|10665903|P4|Primary Vaccination Course|Withdrawal by Subject|0
3114721|NCT00127855|10665904|P3|Primary Vaccination Course|Withdrawal by Subject|0
3114722|NCT00127855|10665905|P2|Primary Vaccination Course|Withdrawal by Subject|0
3114723|NCT00127855|10665906|P1|Primary Vaccination Course|Withdrawal by Subject|1
3114724|NCT00127855|10665902|P5|Primary Vaccination Course|Adverse Event|0
3114725|NCT00127855|10665903|P4|Primary Vaccination Course|Adverse Event|0
3114726|NCT00127855|10665904|P3|Primary Vaccination Course|Adverse Event|1
3114727|NCT00127855|10665905|P2|Primary Vaccination Course|Adverse Event|0
3114728|NCT00127855|10665906|P1|Primary Vaccination Course|Adverse Event|0
3114729|NCT00127842|10666088|P1|Overall Study|Other|5
3114730|NCT00127842|10666088|P1|Overall Study|Protocol Violation|1
3114731|NCT00127842|10666088|P1|Overall Study|Noncompliance|2
3114732|NCT00127842|10666088|P1|Overall Study|Lack of Efficacy|12
3114733|NCT00127842|10666088|P1|Overall Study|Lost to Follow-up|1
3114734|NCT00127842|10666088|P1|Overall Study|Withdrawal by Subject|3
3114735|NCT00127842|10666088|P1|Overall Study|Adverse Event|15
3114736|NCT00127803|10666106|P4|Overall Study|Lost to Follow-up|1
3114737|NCT00127803|10666107|P3|Overall Study|Lost to Follow-up|0
3114738|NCT00127803|10666108|P2|Overall Study|Lost to Follow-up|0
3114739|NCT00127803|10666109|P1|Overall Study|Lost to Follow-up|0
3114740|NCT00127803|10666106|P4|Overall Study|Withdrawal by Subject|0
3114741|NCT00127803|10666107|P3|Overall Study|Withdrawal by Subject|0
3114742|NCT00127803|10666108|P2|Overall Study|Withdrawal by Subject|0
3114743|NCT00127803|10666109|P1|Overall Study|Withdrawal by Subject|1
3114744|NCT00127803|10666106|P4|Overall Study|Adverse Event|0
3114745|NCT00127803|10666107|P3|Overall Study|Adverse Event|0
3114746|NCT00127803|10666108|P2|Overall Study|Adverse Event|0
3114747|NCT00127803|10666109|P1|Overall Study|Adverse Event|2
3114748|NCT00127712|10666158|P2|Overall Study|Lack of GI access to continue|0
3114749|NCT00127712|10666159|P1|Overall Study|Lack of GI access to continue|2
3114750|NCT00127712|10666158|P2|Overall Study|Adverse Event|0
3114751|NCT00127712|10666159|P1|Overall Study|Adverse Event|3
3114752|NCT00127660|10666175|P4|Overall Study|Protocol Violation|0
3114753|NCT00127660|10666176|P3|Overall Study|Protocol Violation|5
3114754|NCT00127660|10666177|P2|Overall Study|Protocol Violation|3
3114755|NCT00127660|10666178|P1|Overall Study|Protocol Violation|3
3114756|NCT00127608|10666188|P1|Overall Study|VZV DNA negative|1
3114757|NCT00127413|10666232|P4|Overall Study|Lost to Follow-up|2
3114758|NCT00127413|10666233|P3|Overall Study|Lost to Follow-up|8
3114759|NCT00127413|10666234|P2|Overall Study|Lost to Follow-up|4
3114760|NCT00127413|10666235|P1|Overall Study|Lost to Follow-up|6
3114761|NCT00127205|10666276|P3|Overall Study|Progression|84
3114762|NCT00127205|10666277|P2|Overall Study|Progression|130
3114763|NCT00127205|10666278|P1|Overall Study|Progression|127
3114764|NCT00127205|10666276|P3|Overall Study|Under Review|6
3114765|NCT00127205|10666277|P2|Overall Study|Under Review|21
3114766|NCT00127205|10666278|P1|Overall Study|Under Review|13
3114767|NCT00127205|10666276|P3|Overall Study|Other-non protocol specified|77
3114768|NCT00127205|10666277|P2|Overall Study|Other-non protocol specified|129
3114769|NCT00127205|10666278|P1|Overall Study|Other-non protocol specified|141
3114770|NCT00127205|10666276|P3|Overall Study|Withdrawal by Subject|172
3114771|NCT00127205|10666277|P2|Overall Study|Withdrawal by Subject|308
3114772|NCT00127205|10666278|P1|Overall Study|Withdrawal by Subject|318
3114773|NCT00127205|10666276|P3|Overall Study|Death|6
3114774|NCT00127205|10666277|P2|Overall Study|Death|6
3114775|NCT00127205|10666278|P1|Overall Study|Death|8
3114776|NCT00127205|10666276|P3|Overall Study|Adverse Event|272
3114777|NCT00127205|10666277|P2|Overall Study|Adverse Event|386
3114778|NCT00127205|10666278|P1|Overall Study|Adverse Event|228
3114779|NCT00127192|10666300|P5|Overall Study|Adverse event in pre-treatment period|0
3114780|NCT00127192|10666301|P4|Overall Study|Adverse event in pre-treatment period|0
3114781|NCT00127192|10666302|P3|Overall Study|Adverse event in pre-treatment period|0
3114782|NCT00127192|10666303|P2|Overall Study|Adverse event in pre-treatment period|0
3114783|NCT00127192|10666304|P1|Overall Study|Adverse event in pre-treatment period|1
3114784|NCT00127192|10666300|P5|Overall Study|Withdrawal by Subject|3
3114785|NCT00127192|10666301|P4|Overall Study|Withdrawal by Subject|0
3114786|NCT00127192|10666302|P3|Overall Study|Withdrawal by Subject|1
3114787|NCT00127192|10666303|P2|Overall Study|Withdrawal by Subject|0
3114788|NCT00127192|10666304|P1|Overall Study|Withdrawal by Subject|0
3114789|NCT00127192|10666300|P5|Overall Study|Lack of Efficacy|2
3114790|NCT00127192|10666301|P4|Overall Study|Lack of Efficacy|0
3114791|NCT00127192|10666302|P3|Overall Study|Lack of Efficacy|0
3114792|NCT00127192|10666303|P2|Overall Study|Lack of Efficacy|0
3114793|NCT00127192|10666304|P1|Overall Study|Lack of Efficacy|2
3114794|NCT00127192|10666300|P5|Overall Study|Adverse Event|0
3114795|NCT00127192|10666301|P4|Overall Study|Adverse Event|1
3114796|NCT00127192|10666302|P3|Overall Study|Adverse Event|1
3114797|NCT00127192|10666303|P2|Overall Study|Adverse Event|1
3114798|NCT00127192|10666304|P1|Overall Study|Adverse Event|0
3114799|NCT00127166|10666328|P2|Period II|Patient did not perform Visit 6 exercise|0
3114800|NCT00127166|10666329|P1|Period II|Patient did not perform Visit 6 exercise|1
3114801|NCT00127166|10666328|P2|Period II|Withdrawal by Subject|0
3114802|NCT00127166|10666329|P1|Period II|Withdrawal by Subject|2
3114803|NCT00127166|10666328|P2|Washout Period|Patient did not meet inclusion criteria|1
3114804|NCT00127166|10666329|P1|Washout Period|Patient did not meet inclusion criteria|0
3114805|NCT00127166|10666328|P2|Period I|Patient did not meet inclusion criteria|0
3114806|NCT00127166|10666329|P1|Period I|Patient did not meet inclusion criteria|1
3114807|NCT00127166|10666328|P2|Period I|Withdrawal by Subject|0
3114808|NCT00127166|10666329|P1|Period I|Withdrawal by Subject|2
3114809|NCT00127166|10666328|P2|Period I|Protocol Violation|2
3114810|NCT00127166|10666329|P1|Period I|Protocol Violation|0
3114811|NCT00127101|10666349|P6|Continuation Phase|Withdrawal by Subject|1
3114812|NCT00127101|10666350|P5|Continuation Phase|Withdrawal by Subject|2
3114813|NCT00127101|10666351|P4|Continuation Phase|Withdrawal by Subject|0
3114814|NCT00127101|10666352|P3|Continuation Phase|Withdrawal by Subject|1
3114815|NCT00127101|10666353|P2|Continuation Phase|Withdrawal by Subject|0
3114816|NCT00127101|10666354|P1|Continuation Phase|Withdrawal by Subject|0
3114817|NCT00127101|10666349|P6|Continuation Phase|Lack of Efficacy|1
3114818|NCT00127101|10666350|P5|Continuation Phase|Lack of Efficacy|0
3114819|NCT00127101|10666351|P4|Continuation Phase|Lack of Efficacy|0
3114820|NCT00127101|10666352|P3|Continuation Phase|Lack of Efficacy|0
3114821|NCT00127101|10666353|P2|Continuation Phase|Lack of Efficacy|0
3114822|NCT00127101|10666354|P1|Continuation Phase|Lack of Efficacy|0
3114823|NCT00127101|10666349|P6|Continuation Phase|Adverse Event|1
3114824|NCT00127101|10666350|P5|Continuation Phase|Adverse Event|1
3114825|NCT00127101|10666351|P4|Continuation Phase|Adverse Event|0
3114826|NCT00127101|10666352|P3|Continuation Phase|Adverse Event|0
3114827|NCT00127101|10666353|P2|Continuation Phase|Adverse Event|0
3114828|NCT00127101|10666354|P1|Continuation Phase|Adverse Event|0
3114829|NCT00127101|10666349|P6|Base Protocol|Withdrawal by Subject|1
3114830|NCT00127101|10666350|P5|Base Protocol|Withdrawal by Subject|0
3114831|NCT00127101|10666351|P4|Base Protocol|Withdrawal by Subject|0
3114832|NCT00127101|10666352|P3|Base Protocol|Withdrawal by Subject|1
3114833|NCT00127101|10666353|P2|Base Protocol|Withdrawal by Subject|2
3114834|NCT00127101|10666354|P1|Base Protocol|Withdrawal by Subject|1
3114835|NCT00127101|10666349|P6|Base Protocol|Lack of Efficacy|0
3114836|NCT00127101|10666350|P5|Base Protocol|Lack of Efficacy|2
3114837|NCT00127101|10666351|P4|Base Protocol|Lack of Efficacy|0
3114838|NCT00127101|10666352|P3|Base Protocol|Lack of Efficacy|0
3114839|NCT00127101|10666353|P2|Base Protocol|Lack of Efficacy|0
3114840|NCT00127101|10666354|P1|Base Protocol|Lack of Efficacy|1
3114841|NCT00127101|10666349|P6|Base Protocol|Adverse Event|0
3114842|NCT00127101|10666350|P5|Base Protocol|Adverse Event|0
3114843|NCT00127101|10666351|P4|Base Protocol|Adverse Event|0
3114844|NCT00127101|10666352|P3|Base Protocol|Adverse Event|1
3114845|NCT00127101|10666353|P2|Base Protocol|Adverse Event|2
3114846|NCT00127101|10666354|P1|Base Protocol|Adverse Event|0
3114847|NCT00127036|10666389|P2|Overall Study|Screen Failure|0
3114848|NCT00127036|10666390|P1|Overall Study|Screen Failure|2
3114849|NCT00127036|10666389|P2|Overall Study|Insufficient Data for Analysis|11
3114850|NCT00127036|10666390|P1|Overall Study|Insufficient Data for Analysis|6
3114851|NCT00126776|10666402|P2|Overall Study|follow up complete on all patients|0
3114852|NCT00126776|10666403|P1|Overall Study|follow up complete on all patients|0
3114853|NCT00126659|10666452|P3|Overall Study|Adverse Event|2
3114854|NCT00126659|10666453|P2|Overall Study|Adverse Event|0
3114855|NCT00126659|10666454|P1|Overall Study|Adverse Event|0
3114856|NCT00126594|10666462|P2|Overall Study|Disease Progression|24
3114857|NCT00126594|10666463|P1|Overall Study|Disease Progression|29
3114858|NCT00126594|10666462|P2|Overall Study|Non-compliance|1
3114859|NCT00126594|10666463|P1|Overall Study|Non-compliance|0
3114860|NCT00126594|10666462|P2|Overall Study|Adverse Event|5
3114861|NCT00126594|10666463|P1|Overall Study|Adverse Event|7
3114862|NCT00126594|10666462|P2|Overall Study|Physician Decision|3
3114863|NCT00126594|10666463|P1|Overall Study|Physician Decision|1
3114864|NCT00126594|10666462|P2|Overall Study|Withdrawal by Subject|4
3114865|NCT00126594|10666463|P1|Overall Study|Withdrawal by Subject|0
3114866|NCT00126594|10666462|P2|Overall Study|Ineligible|0
3114867|NCT00126594|10666463|P1|Overall Study|Ineligible|2
3114868|NCT00126581|10666480|P2|Overall Study|Other illness/MD discretion|4
3114869|NCT00126581|10666481|P1|Overall Study|Other illness/MD discretion|3
3114870|NCT00126581|10666480|P2|Overall Study|Alternative therapy|3
3114871|NCT00126581|10666481|P1|Overall Study|Alternative therapy|3
3114872|NCT00126581|10666480|P2|Overall Study|Withdrawal by Subject|4
3114873|NCT00126581|10666481|P1|Overall Study|Withdrawal by Subject|1
3114874|NCT00126581|10666480|P2|Overall Study|Death|2
3114875|NCT00126581|10666481|P1|Overall Study|Death|3
3114876|NCT00126581|10666480|P2|Overall Study|Adverse Event|7
3114877|NCT00126581|10666481|P1|Overall Study|Adverse Event|3
3114878|NCT00126568|10666501|P1|Overall Study|Death|2
3114879|NCT00126555|10666508|P1|Overall Study|Progressive Disease|3
3114880|NCT00126555|10666508|P1|Overall Study|Adverse Event|2
3114881|NCT00126555|10666508|P1|Overall Study|Withdrawal by Subject|1
3114882|NCT00126503|10666530|P2|Overall Study|Physician Decision|1
3114883|NCT00126503|10666531|P1|Overall Study|Physician Decision|2
3114884|NCT00126503|10666530|P2|Overall Study|non-compliant|0
3114885|NCT00126503|10666531|P1|Overall Study|non-compliant|1
3114886|NCT00126503|10666530|P2|Overall Study|Adverse Event|3
3114887|NCT00126503|10666531|P1|Overall Study|Adverse Event|13
3114888|NCT00126503|10666530|P2|Overall Study|Death|0
3114889|NCT00126503|10666531|P1|Overall Study|Death|3
3114890|NCT00126503|10666530|P2|Overall Study|other complicating disease|1
3114891|NCT00126503|10666531|P1|Overall Study|other complicating disease|4
3114892|NCT00126503|10666530|P2|Overall Study|alternative therapy|1
3114893|NCT00126503|10666531|P1|Overall Study|alternative therapy|1
3114894|NCT00126503|10666530|P2|Overall Study|Withdrawal by Subject|1
3114895|NCT00126503|10666531|P1|Overall Study|Withdrawal by Subject|0
3114896|NCT00126503|10666530|P2|Overall Study|disease progression|14
3114897|NCT00126503|10666531|P1|Overall Study|disease progression|23
3114898|NCT00126490|10666543|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
3114899|NCT00126438|10666553|P2|Overall Study|Withdrawal by Subject|2
3114900|NCT00126438|10666554|P1|Overall Study|Withdrawal by Subject|3
3114901|NCT00126438|10666553|P2|Overall Study|Protocol Violation|8
3114902|NCT00126438|10666554|P1|Overall Study|Protocol Violation|8
3114903|NCT00126438|10666553|P2|Overall Study|Lost to Follow-up|0
3114904|NCT00126438|10666554|P1|Overall Study|Lost to Follow-up|22
3114905|NCT00126438|10666553|P2|Overall Study|Withdrawal due to adverse event|0
3114906|NCT00126438|10666554|P1|Overall Study|Withdrawal due to adverse event|1
3114907|NCT00126425|10666562|P2|Overall Study|Other|0
3114908|NCT00126425|10666563|P1|Overall Study|Other|5
3114909|NCT00126425|10666562|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
3114910|NCT00126425|10666563|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
3114911|NCT00126425|10666562|P2|Overall Study|Adverse Event|0
3114912|NCT00126425|10666563|P1|Overall Study|Adverse Event|1
3114913|NCT00126425|10666562|P2|Overall Study|Protocol Violation|6
3114914|NCT00126425|10666563|P1|Overall Study|Protocol Violation|9
3114915|NCT00126425|10666562|P2|Overall Study|Lost to Follow-up|4
3114916|NCT00126425|10666563|P1|Overall Study|Lost to Follow-up|8
3114917|NCT00126425|10666562|P2|Overall Study|Withdrawal by Subject|1
3114918|NCT00126425|10666563|P1|Overall Study|Withdrawal by Subject|17
3114919|NCT00126191|10666571|P2|Overall Study|Death|1
3114920|NCT00126191|10666572|P1|Overall Study|Death|0
3114921|NCT00126191|10666571|P2|Overall Study|Physician Decision|1
3114922|NCT00126191|10666572|P1|Overall Study|Physician Decision|0
3114923|NCT00126126|10666582|P2|Overall Study|Lost to Follow-up|2
3114924|NCT00126126|10666583|P1|Overall Study|Lost to Follow-up|0
3114925|NCT00125853|10666622|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
3114926|NCT00125853|10666623|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
3114927|NCT00125359|10666737|P1|Overall Study|Physician Decision|14
3114928|NCT00125359|10666737|P1|Overall Study|Adverse Event|5
3114929|NCT00125359|10666737|P1|Overall Study|Death|4
3114930|NCT00125268|10666746|P2|Overall Study|Withdrawal by Subject|1
3114931|NCT00125268|10666747|P1|Overall Study|Withdrawal by Subject|1
3114932|NCT00125242|10666759|P2|Overall Study|did not qualify|2
3114933|NCT00125242|10666760|P1|Overall Study|did not qualify|7
3114934|NCT00125190|10666765|P1|Overall Study|Non-compliance|2
3114935|NCT00125190|10666765|P1|Overall Study|other|1
3114936|NCT00125190|10666765|P1|Overall Study|Patient/Parent Decision|7
3114937|NCT00125190|10666765|P1|Overall Study|Lost to Follow-up|4
3114938|NCT00125190|10666765|P1|Overall Study|Adverse Event|1
3114939|NCT00125164|10666783|P4|Overall Study|Withdrawal by Subject|1
3114940|NCT00125164|10666784|P3|Overall Study|Withdrawal by Subject|1
3114941|NCT00125164|10666785|P2|Overall Study|Withdrawal by Subject|0
3114942|NCT00125164|10666786|P1|Overall Study|Withdrawal by Subject|2
3114943|NCT00125164|10666783|P4|Overall Study|Lost to Follow-up|1
3114944|NCT00125164|10666784|P3|Overall Study|Lost to Follow-up|1
3114945|NCT00125164|10666785|P2|Overall Study|Lost to Follow-up|0
3114946|NCT00125164|10666786|P1|Overall Study|Lost to Follow-up|0
3114947|NCT00125164|10666783|P4|Overall Study|Adverse Event|4
3114948|NCT00125164|10666784|P3|Overall Study|Adverse Event|2
3114949|NCT00125164|10666785|P2|Overall Study|Adverse Event|0
3114950|NCT00125164|10666786|P1|Overall Study|Adverse Event|0
3114951|NCT00125138|10666840|P4|Overall Study|Sponsor decision-pt moved to assist care|1
3114952|NCT00125138|10666841|P3|Overall Study|Sponsor decision-pt moved to assist care|0
3114953|NCT00125138|10666842|P2|Overall Study|Sponsor decision-pt moved to assist care|0
3114954|NCT00125138|10666843|P1|Overall Study|Sponsor decision-pt moved to assist care|0
3114955|NCT00125138|10666840|P4|Overall Study|Lack of Efficacy|1
3114956|NCT00125138|10666841|P3|Overall Study|Lack of Efficacy|0
3114957|NCT00125138|10666842|P2|Overall Study|Lack of Efficacy|0
3114958|NCT00125138|10666843|P1|Overall Study|Lack of Efficacy|0
3114959|NCT00125138|10666840|P4|Overall Study|Withdrawal by Subject|1
3114960|NCT00125138|10666841|P3|Overall Study|Withdrawal by Subject|1
3114961|NCT00125138|10666842|P2|Overall Study|Withdrawal by Subject|3
3114962|NCT00125138|10666843|P1|Overall Study|Withdrawal by Subject|2
3114963|NCT00125138|10666840|P4|Overall Study|Adverse Event|2
3114964|NCT00125138|10666841|P3|Overall Study|Adverse Event|3
3114965|NCT00125138|10666842|P2|Overall Study|Adverse Event|0
3114966|NCT00125138|10666843|P1|Overall Study|Adverse Event|1
3114967|NCT00124982|10666892|P3|Long-term Period|Neurologist Recommendation|1
3114968|NCT00124982|10666893|P2|Long-term Period|Neurologist Recommendation|0
3114969|NCT00124982|10666894|P1|Long-term Period|Neurologist Recommendation|0
3114970|NCT00124982|10666892|P3|Long-term Period|Administrative Reason by Sponsor|1
3114971|NCT00124982|10666893|P2|Long-term Period|Administrative Reason by Sponsor|0
3114972|NCT00124982|10666894|P1|Long-term Period|Administrative Reason by Sponsor|0
3114973|NCT00124982|10666892|P3|Long-term Period|Poor/Non-compliance|2
3114974|NCT00124982|10666893|P2|Long-term Period|Poor/Non-compliance|0
3114975|NCT00124982|10666894|P1|Long-term Period|Poor/Non-compliance|0
3114976|NCT00124982|10666892|P3|Long-term Period|Pregnancy|1
3114977|NCT00124982|10666893|P2|Long-term Period|Pregnancy|0
3114978|NCT00124982|10666894|P1|Long-term Period|Pregnancy|0
3114979|NCT00124982|10666892|P3|Long-term Period|Withdrawal by Subject|16
3114980|NCT00124982|10666893|P2|Long-term Period|Withdrawal by Subject|0
3114981|NCT00124982|10666894|P1|Long-term Period|Withdrawal by Subject|0
3114982|NCT00124982|10666892|P3|Long-term Period|Lost to Follow-up|4
3114983|NCT00124982|10666893|P2|Long-term Period|Lost to Follow-up|0
3114984|NCT00124982|10666894|P1|Long-term Period|Lost to Follow-up|0
3114985|NCT00124982|10666892|P3|Long-term Period|Lack of Efficacy|46
3114986|NCT00124982|10666893|P2|Long-term Period|Lack of Efficacy|0
3114987|NCT00124982|10666894|P1|Long-term Period|Lack of Efficacy|0
3114988|NCT00124982|10666892|P3|Long-term Period|Adverse Event|17
3114989|NCT00124982|10666893|P2|Long-term Period|Adverse Event|0
3114990|NCT00124982|10666894|P1|Long-term Period|Adverse Event|0
3114991|NCT00124982|10666892|P3|Long-term Period|Death|1
3114992|NCT00124982|10666893|P2|Long-term Period|Death|0
3114993|NCT00124982|10666894|P1|Long-term Period|Death|0
3114994|NCT00124982|10666892|P3|Short-term Period|Participant Had Lymphopenia|0
3114995|NCT00124982|10666893|P2|Short-term Period|Participant Had Lymphopenia|0
3114996|NCT00124982|10666894|P1|Short-term Period|Participant Had Lymphopenia|1
3114997|NCT00124982|10666892|P3|Short-term Period|Investigator Decision-No Specific AE|0
3114998|NCT00124982|10666893|P2|Short-term Period|Investigator Decision-No Specific AE|0
3114999|NCT00124982|10666894|P1|Short-term Period|Investigator Decision-No Specific AE|1
3115000|NCT00124982|10666892|P3|Short-term Period|Participant Chose Own Doctor|0
3115001|NCT00124982|10666893|P2|Short-term Period|Participant Chose Own Doctor|1
3115002|NCT00124982|10666894|P1|Short-term Period|Participant Chose Own Doctor|0
3115003|NCT00124982|10666892|P3|Short-term Period|Participant Decision|0
3115004|NCT00124982|10666893|P2|Short-term Period|Participant Decision|0
3115005|NCT00124982|10666894|P1|Short-term Period|Participant Decision|1
3115006|NCT00124982|10666892|P3|Short-term Period|No Longer Meets Study Criteria|0
3115007|NCT00124982|10666893|P2|Short-term Period|No Longer Meets Study Criteria|2
3115008|NCT00124982|10666894|P1|Short-term Period|No Longer Meets Study Criteria|1
3115009|NCT00124982|10666892|P3|Short-term Period|Poor/Non-compliance|0
3115010|NCT00124982|10666893|P2|Short-term Period|Poor/Non-compliance|1
3115011|NCT00124982|10666894|P1|Short-term Period|Poor/Non-compliance|3
3115012|NCT00124982|10666892|P3|Short-term Period|Withdrawal of Consent|0
3115013|NCT00124982|10666893|P2|Short-term Period|Withdrawal of Consent|9
3115014|NCT00124982|10666894|P1|Short-term Period|Withdrawal of Consent|7
3115015|NCT00124982|10666892|P3|Short-term Period|Lost to Follow-up|0
3115016|NCT00124982|10666893|P2|Short-term Period|Lost to Follow-up|5
3115017|NCT00124982|10666894|P1|Short-term Period|Lost to Follow-up|8
3115018|NCT00124982|10666892|P3|Short-term Period|Lack of Efficacy|0
3115019|NCT00124982|10666893|P2|Short-term Period|Lack of Efficacy|73
3115020|NCT00124982|10666894|P1|Short-term Period|Lack of Efficacy|32
3115021|NCT00124982|10666892|P3|Short-term Period|Adverse Event|0
3115022|NCT00124982|10666893|P2|Short-term Period|Adverse Event|22
3115023|NCT00124982|10666894|P1|Short-term Period|Adverse Event|17
3115024|NCT00124982|10666892|P3|Short-term Period|Death|0
3115025|NCT00124982|10666893|P2|Short-term Period|Death|1
3115026|NCT00124982|10666894|P1|Short-term Period|Death|1
3115027|NCT00124943|10666976|P4|Phase II|Withdrawal by Subject|2
3115028|NCT00124943|10666977|P3|Phase II|Withdrawal by Subject|0
3115029|NCT00124943|10666978|P2|Phase II|Withdrawal by Subject|0
3115030|NCT00124943|10666979|P1|Phase II|Withdrawal by Subject|0
3115031|NCT00124943|10666976|P4|Phase II|Lost to Follow-up|1
3115032|NCT00124943|10666977|P3|Phase II|Lost to Follow-up|0
3115033|NCT00124943|10666978|P2|Phase II|Lost to Follow-up|0
3115034|NCT00124943|10666979|P1|Phase II|Lost to Follow-up|0
3115035|NCT00124943|10666976|P4|Phase II|Protocol Violation|1
3115036|NCT00124943|10666977|P3|Phase II|Protocol Violation|0
3115037|NCT00124943|10666978|P2|Phase II|Protocol Violation|0
3115038|NCT00124943|10666979|P1|Phase II|Protocol Violation|0
3115039|NCT00124943|10666976|P4|Phase II|Adverse Event|1
3115040|NCT00124943|10666977|P3|Phase II|Adverse Event|0
3115041|NCT00124943|10666978|P2|Phase II|Adverse Event|2
3115042|NCT00124943|10666979|P1|Phase II|Adverse Event|0
3115043|NCT00124917|10667017|P1|Overall Study|Physician Decision|3
3115044|NCT00124748|10667027|P2|Overall Study|Death|3
3115045|NCT00124748|10667028|P1|Overall Study|Death|1
3115046|NCT00124748|10667027|P2|Overall Study|Administrative Problem(Study Terminated)|174
3115047|NCT00124748|10667028|P1|Overall Study|Administrative Problem(Study Terminated)|101
3115048|NCT00124748|10667027|P2|Overall Study|Lost to Follow-up|7
3115049|NCT00124748|10667028|P1|Overall Study|Lost to Follow-up|2
3115050|NCT00124748|10667027|P2|Overall Study|Withdrawal by Subject|15
3115051|NCT00124748|10667028|P1|Overall Study|Withdrawal by Subject|5
3115052|NCT00124748|10667027|P2|Overall Study|Protocol Violation|1
3115053|NCT00124748|10667028|P1|Overall Study|Protocol Violation|3
3115054|NCT00124748|10667027|P2|Overall Study|No longer requires study drug|1
3115055|NCT00124748|10667028|P1|Overall Study|No longer requires study drug|1
3115056|NCT00124748|10667027|P2|Overall Study|Lack of Efficacy|41
3115057|NCT00124748|10667028|P1|Overall Study|Lack of Efficacy|20
3115058|NCT00124748|10667027|P2|Overall Study|Abnormal Procedure|1
3115059|NCT00124748|10667028|P1|Overall Study|Abnormal Procedure|0
3115060|NCT00124748|10667027|P2|Overall Study|Abnormal laboratory Value|2
3115061|NCT00124748|10667028|P1|Overall Study|Abnormal laboratory Value|2
3115062|NCT00124748|10667027|P2|Overall Study|Adverse Event|39
3115063|NCT00124748|10667028|P1|Overall Study|Adverse Event|8
3115064|NCT00124709|10667135|P2|Overall Study|Lost to Follow-up|120
3115065|NCT00124709|10667136|P1|Overall Study|Lost to Follow-up|114
3115066|NCT00124709|10667135|P2|Overall Study|Withdrawal by Subject|136
3115067|NCT00124709|10667136|P1|Overall Study|Withdrawal by Subject|127
3115068|NCT00124709|10667135|P2|Overall Study|Protocol Violation|5
3115069|NCT00124709|10667136|P1|Overall Study|Protocol Violation|3
3115070|NCT00124709|10667135|P2|Overall Study|Lack of Efficacy|10
3115071|NCT00124709|10667136|P1|Overall Study|Lack of Efficacy|5
3115072|NCT00124709|10667135|P2|Overall Study|Adverse Event|0
3115073|NCT00124709|10667136|P1|Overall Study|Adverse Event|3
3115074|NCT00124709|10667135|P2|Overall Study|Randomized but did not take medication|1
3115075|NCT00124709|10667136|P1|Overall Study|Randomized but did not take medication|3
3115076|NCT00124657|10667153|P3|Overall Study|Intercurrent illness|0
3115077|NCT00124657|10667154|P2|Overall Study|Intercurrent illness|0
3115078|NCT00124657|10667155|P1|Overall Study|Intercurrent illness|1
3115079|NCT00124657|10667153|P3|Overall Study|Progressive disease|27
3115080|NCT00124657|10667154|P2|Overall Study|Progressive disease|5
3115081|NCT00124657|10667155|P1|Overall Study|Progressive disease|14
3115082|NCT00124657|10667153|P3|Overall Study|Non-compliance|4
3115083|NCT00124657|10667154|P2|Overall Study|Non-compliance|0
3115084|NCT00124657|10667155|P1|Overall Study|Non-compliance|1
3115085|NCT00124657|10667153|P3|Overall Study|Toxicity|1
3115086|NCT00124657|10667154|P2|Overall Study|Toxicity|0
3115087|NCT00124657|10667155|P1|Overall Study|Toxicity|0
3115088|NCT00124618|10667190|P1|Overall Study|Ineligible|1
3115089|NCT00124462|10667205|P2|Overall Study|Device fitting, n=2, other hlth issues|1
3115090|NCT00124462|10667206|P1|Overall Study|Device fitting, n=2, other hlth issues|1
3115091|NCT00124462|10667205|P2|Overall Study|Withdrawal by Subject|5
3115092|NCT00124462|10667206|P1|Overall Study|Withdrawal by Subject|4
3115093|NCT00124462|10667205|P2|Overall Study|Physician Decision|4
3115094|NCT00124462|10667206|P1|Overall Study|Physician Decision|3
3115095|NCT00124462|10667205|P2|Overall Study|Lost to Follow-up|3
3115096|NCT00124462|10667206|P1|Overall Study|Lost to Follow-up|3
3115097|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Relocated|0
3115098|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Relocated|1
3115099|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
3115100|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
3115101|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Pregnancy|0
3115102|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Pregnancy|1
3115103|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
3115104|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
3115105|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
3115106|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
3115107|NCT00124449|10667216|P2|18-Month Untreated Observation Period|Adverse Event|1
3115108|NCT00124449|10667217|P1|18-Month Untreated Observation Period|Adverse Event|0
3115109|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
3115110|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
3115111|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Sponsor request|1
3115112|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Sponsor request|0
3115113|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
3115114|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
3115115|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
3115116|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
3115117|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
3115118|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
3115119|NCT00124449|10667216|P2|6-month Double-Blind Treatment Period|Adverse Event|0
3115120|NCT00124449|10667217|P1|6-month Double-Blind Treatment Period|Adverse Event|1
3115121|NCT00124072|10667271|P4|Overall Study|Death|480
3115122|NCT00124072|10667272|P3|Overall Study|Death|471
3115123|NCT00124072|10667273|P2|Overall Study|Death|484
3115124|NCT00124072|10667274|P1|Overall Study|Death|499
3115125|NCT00124072|10667271|P4|Overall Study|Lost to Follow-up for Morbidity|18
3115126|NCT00124072|10667272|P3|Overall Study|Lost to Follow-up for Morbidity|19
3115127|NCT00124072|10667273|P2|Overall Study|Lost to Follow-up for Morbidity|25
3115128|NCT00124072|10667274|P1|Overall Study|Lost to Follow-up for Morbidity|15
3115129|NCT00124072|10667271|P4|Overall Study|Lost to Follow-up for Mortality|2
3115130|NCT00124072|10667272|P3|Overall Study|Lost to Follow-up for Mortality|2
3115131|NCT00124072|10667273|P2|Overall Study|Lost to Follow-up for Mortality|3
3115132|NCT00124072|10667274|P1|Overall Study|Lost to Follow-up for Mortality|0
3115133|NCT00124020|10667286|P2|Overall Study|Transfer to another hospital|0
3115134|NCT00124020|10667287|P1|Overall Study|Transfer to another hospital|2
3115135|NCT00124020|10667286|P2|Overall Study|Other|1
3115136|NCT00124020|10667287|P1|Overall Study|Other|1
3115137|NCT00124020|10667286|P2|Overall Study|Lost to Follow-up|8
3115138|NCT00124020|10667287|P1|Overall Study|Lost to Follow-up|5
3115139|NCT00124020|10667286|P2|Overall Study|Withdrawal by Subject|11
3115140|NCT00124020|10667287|P1|Overall Study|Withdrawal by Subject|13
3115141|NCT00124020|10667286|P2|Overall Study|Death|71
3115142|NCT00124020|10667287|P1|Overall Study|Death|67
3115143|NCT00123955|10667295|P2|Overall Study|Death|1
3115144|NCT00123955|10667296|P1|Overall Study|Death|0
3115145|NCT00123955|10667295|P2|Overall Study|Withdrawal by Subject|3
3115146|NCT00123955|10667296|P1|Overall Study|Withdrawal by Subject|4
3115147|NCT00123955|10667295|P2|Overall Study|Adverse Event|0
3115148|NCT00123955|10667296|P1|Overall Study|Adverse Event|1
3115149|NCT00123734|10667308|P1|Overall Study|Withdrawal by Subject|1
3115150|NCT00123734|10667308|P1|Overall Study|Dropout|1
3115151|NCT00123734|10667308|P1|Overall Study|Lost to Follow-up|3
3115152|NCT00123734|10667308|P1|Overall Study|Death|3
3115153|NCT00123487|10667393|P2|Treated With Study Drug|Unknown (case report form lost)|1
3115154|NCT00123487|10667394|P1|Treated With Study Drug|Unknown (case report form lost)|0
3115155|NCT00123487|10667393|P2|Treated With Study Drug|Withdrawal by Subject|13
3115156|NCT00123487|10667394|P1|Treated With Study Drug|Withdrawal by Subject|11
3115157|NCT00123487|10667393|P2|Treated With Study Drug|Study Drug Toxicity|80
3115158|NCT00123487|10667394|P1|Treated With Study Drug|Study Drug Toxicity|62
3115159|NCT00123487|10667393|P2|Treated With Study Drug|Other|58
3115160|NCT00123487|10667394|P1|Treated With Study Drug|Other|59
3115161|NCT00123487|10667393|P2|Treated With Study Drug|Physician Decision|9
3115162|NCT00123487|10667394|P1|Treated With Study Drug|Physician Decision|8
3115163|NCT00123487|10667393|P2|Treated With Study Drug|Disease Progression|122
3115164|NCT00123487|10667394|P1|Treated With Study Drug|Disease Progression|141
3115165|NCT00123487|10667393|P2|Treated With Study Drug|Adverse Event|22
3115166|NCT00123487|10667394|P1|Treated With Study Drug|Adverse Event|23
3115167|NCT00123487|10667393|P2|Randomized|SAE prior to starting treatment|0
3115168|NCT00123487|10667394|P1|Randomized|SAE prior to starting treatment|1
3115169|NCT00123487|10667393|P2|Randomized|Death prior to starting treatment|1
3115170|NCT00123487|10667394|P1|Randomized|Death prior to starting treatment|0
3115171|NCT00123474|10667438|P4|As Treated at Study Closure|Withdrawal by Subject|16
3115172|NCT00123474|10667439|P3|As Treated at Study Closure|Withdrawal by Subject|18
3115173|NCT00123474|10667440|P2|As Treated at Study Closure|Withdrawal by Subject|19
3115174|NCT00123474|10667441|P1|As Treated at Study Closure|Withdrawal by Subject|14
3115175|NCT00123474|10667438|P4|As Treated at Study Closure|Study Drug Toxicity|51
3115176|NCT00123474|10667439|P3|As Treated at Study Closure|Study Drug Toxicity|45
3115177|NCT00123474|10667440|P2|As Treated at Study Closure|Study Drug Toxicity|45
3115178|NCT00123474|10667441|P1|As Treated at Study Closure|Study Drug Toxicity|39
3115179|NCT00123474|10667438|P4|As Treated at Study Closure|non-specified|60
3115180|NCT00123474|10667439|P3|As Treated at Study Closure|non-specified|57
3115181|NCT00123474|10667440|P2|As Treated at Study Closure|non-specified|47
3115182|NCT00123474|10667441|P1|As Treated at Study Closure|non-specified|54
3115183|NCT00123474|10667438|P4|As Treated at Study Closure|Investigator Request|5
3115184|NCT00123474|10667439|P3|As Treated at Study Closure|Investigator Request|7
3115185|NCT00123474|10667440|P2|As Treated at Study Closure|Investigator Request|6
3115186|NCT00123474|10667441|P1|As Treated at Study Closure|Investigator Request|12
3115187|NCT00123474|10667438|P4|As Treated at Study Closure|Disease Progression|27
3115188|NCT00123474|10667439|P3|As Treated at Study Closure|Disease Progression|29
3115189|NCT00123474|10667440|P2|As Treated at Study Closure|Disease Progression|42
3115190|NCT00123474|10667441|P1|As Treated at Study Closure|Disease Progression|35
3115191|NCT00123474|10667438|P4|As Treated at Study Closure|Adverse Event|8
3115192|NCT00123474|10667439|P3|As Treated at Study Closure|Adverse Event|10
3115193|NCT00123474|10667440|P2|As Treated at Study Closure|Adverse Event|4
3115194|NCT00123474|10667441|P1|As Treated at Study Closure|Adverse Event|10
3115195|NCT00123474|10667438|P4|As Treated at Study Closure|not reported when site closed|0
3115196|NCT00123474|10667439|P3|As Treated at Study Closure|not reported when site closed|1
3115197|NCT00123474|10667440|P2|As Treated at Study Closure|not reported when site closed|0
3115198|NCT00123474|10667441|P1|As Treated at Study Closure|not reported when site closed|1
3115199|NCT00123474|10667438|P4|Randomized to Treatment|Randomized, never treated|1
3115200|NCT00123474|10667439|P3|Randomized to Treatment|Randomized, never treated|2
3115201|NCT00123474|10667440|P2|Randomized to Treatment|Randomized, never treated|4
3115202|NCT00123474|10667441|P1|Randomized to Treatment|Randomized, never treated|1
3115203|NCT00123422|10667535|P3|Overall Study|Lost to Follow-up|2
3115204|NCT00123422|10667536|P2|Overall Study|Lost to Follow-up|2
3115205|NCT00123422|10667537|P1|Overall Study|Lost to Follow-up|1
3115206|NCT00123422|10667535|P3|Overall Study|Withdrawal by Subject|2
3115207|NCT00123422|10667536|P2|Overall Study|Withdrawal by Subject|2
3115208|NCT00123422|10667537|P1|Overall Study|Withdrawal by Subject|1
3115209|NCT00123422|10667535|P3|Overall Study|Physician Decision|6
3115210|NCT00123422|10667536|P2|Overall Study|Physician Decision|2
3115211|NCT00123422|10667537|P1|Overall Study|Physician Decision|2
3115212|NCT00122980|10667625|P2|Overall Study|Study termination|35
3115213|NCT00122980|10667626|P1|Overall Study|Study termination|27
3115214|NCT00122980|10667625|P2|Overall Study|Adjudicated stroke (study endpoint)|0
3115215|NCT00122980|10667626|P1|Overall Study|Adjudicated stroke (study endpoint)|7
3115216|NCT00122980|10667625|P2|Overall Study|Withdrawal by Subject|3
3115217|NCT00122980|10667626|P1|Overall Study|Withdrawal by Subject|2
3115218|NCT00122980|10667625|P2|Overall Study|Protocol Violation|1
3115219|NCT00122980|10667626|P1|Overall Study|Protocol Violation|5
3115220|NCT00122980|10667625|P2|Overall Study|Physician Decision|0
3115221|NCT00122980|10667626|P1|Overall Study|Physician Decision|2
3115222|NCT00122980|10667625|P2|Overall Study|Death|1
3115223|NCT00122980|10667626|P1|Overall Study|Death|0
3115224|NCT00122954|10667650|P2|Overall Study|Protocol Violation|1
3115225|NCT00122954|10667651|P1|Overall Study|Protocol Violation|0
3115226|NCT00122954|10667650|P2|Overall Study|Withdrawal by Subject|2
3115227|NCT00122954|10667651|P1|Overall Study|Withdrawal by Subject|2
3115228|NCT00122681|10667661|P2|Overall Study|Personal reasons|147
3115229|NCT00122681|10667662|P1|Overall Study|Personal reasons|150
3115230|NCT00122681|10667661|P2|Overall Study|Withdrawal by Subject|251
3115231|NCT00122681|10667662|P1|Overall Study|Withdrawal by Subject|257
3115232|NCT00122681|10667661|P2|Overall Study|Protocol Violation|10
3115233|NCT00122681|10667662|P1|Overall Study|Protocol Violation|7
3115234|NCT00122681|10667661|P2|Overall Study|Lost to Follow-up|1097
3115235|NCT00122681|10667662|P1|Overall Study|Lost to Follow-up|1080
3115236|NCT00122681|10667661|P2|Overall Study|Adverse Event|16
3115237|NCT00122681|10667662|P1|Overall Study|Adverse Event|20
3115238|NCT00122460|10667736|P2|Overall Study|investigational study phase ongoing|1
3115239|NCT00122460|10667737|P1|Overall Study|investigational study phase ongoing|7
3115240|NCT00122382|10667786|P3|Open-Label Study|Withdrawal of Consent|4
3115241|NCT00122382|10667787|P2|Open-Label Study|Withdrawal of Consent|0
3115242|NCT00122382|10667788|P1|Open-Label Study|Withdrawal of Consent|0
3115243|NCT00122382|10667786|P3|Open-Label Study|Poor/Non-Compliance|1
3115244|NCT00122382|10667787|P2|Open-Label Study|Poor/Non-Compliance|0
3115245|NCT00122382|10667788|P1|Open-Label Study|Poor/Non-Compliance|0
3115246|NCT00122382|10667786|P3|Open-Label Study|Pregnancy|2
3115247|NCT00122382|10667787|P2|Open-Label Study|Pregnancy|0
3115248|NCT00122382|10667788|P1|Open-Label Study|Pregnancy|0
3115249|NCT00122382|10667786|P3|Open-Label Study|Lost to Follow-up|3
3115250|NCT00122382|10667787|P2|Open-Label Study|Lost to Follow-up|0
3115251|NCT00122382|10667788|P1|Open-Label Study|Lost to Follow-up|0
3115252|NCT00122382|10667786|P3|Open-Label Study|Lack of Efficacy|3
3115253|NCT00122382|10667787|P2|Open-Label Study|Lack of Efficacy|0
3115254|NCT00122382|10667788|P1|Open-Label Study|Lack of Efficacy|0
3115255|NCT00122382|10667786|P3|Open-Label Study|Death|2
3115256|NCT00122382|10667787|P2|Open-Label Study|Death|0
3115257|NCT00122382|10667788|P1|Open-Label Study|Death|0
3115258|NCT00122382|10667786|P3|Open-Label Study|Adverse Event|11
3115259|NCT00122382|10667787|P2|Open-Label Study|Adverse Event|0
3115260|NCT00122382|10667788|P1|Open-Label Study|Adverse Event|0
3115261|NCT00122382|10667786|P3|Double-Blind Study|Randomized but not treated|0
3115262|NCT00122382|10667787|P2|Double-Blind Study|Randomized but not treated|2
3115263|NCT00122382|10667788|P1|Double-Blind Study|Randomized but not treated|0
3115264|NCT00122382|10667786|P3|Double-Blind Study|Methotrexate Discontinued|0
3115265|NCT00122382|10667787|P2|Double-Blind Study|Methotrexate Discontinued|1
3115266|NCT00122382|10667788|P1|Double-Blind Study|Methotrexate Discontinued|0
3115267|NCT00122382|10667786|P3|Double-Blind Study|Protocol Violation|0
3115268|NCT00122382|10667787|P2|Double-Blind Study|Protocol Violation|0
3115269|NCT00122382|10667788|P1|Double-Blind Study|Protocol Violation|1
3115270|NCT00122382|10667786|P3|Double-Blind Study|Withdrawal of Consent|0
3115271|NCT00122382|10667787|P2|Double-Blind Study|Withdrawal of Consent|3
3115272|NCT00122382|10667788|P1|Double-Blind Study|Withdrawal of Consent|7
3115273|NCT00122382|10667786|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
3115274|NCT00122382|10667787|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
3115275|NCT00122382|10667788|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
3115276|NCT00122382|10667786|P3|Double-Blind Study|Pregnancy|0
3115277|NCT00122382|10667787|P2|Double-Blind Study|Pregnancy|0
3115278|NCT00122382|10667788|P1|Double-Blind Study|Pregnancy|2
3115279|NCT00122382|10667786|P3|Double-Blind Study|Lost to Follow-up|0
3115280|NCT00122382|10667787|P2|Double-Blind Study|Lost to Follow-up|1
3115281|NCT00122382|10667788|P1|Double-Blind Study|Lost to Follow-up|2
3115282|NCT00122382|10667786|P3|Double-Blind Study|Lack of Efficacy|0
3115283|NCT00122382|10667787|P2|Double-Blind Study|Lack of Efficacy|8
3115284|NCT00122382|10667788|P1|Double-Blind Study|Lack of Efficacy|0
3115285|NCT00122382|10667786|P3|Double-Blind Study|Death|0
3115286|NCT00122382|10667787|P2|Double-Blind Study|Death|2
3115287|NCT00122382|10667788|P1|Double-Blind Study|Death|2
3115288|NCT00122382|10667786|P3|Double-Blind Study|Adverse Event|0
3115289|NCT00122382|10667787|P2|Double-Blind Study|Adverse Event|11
3115290|NCT00122382|10667788|P1|Double-Blind Study|Adverse Event|9
3115291|NCT00122317|10667932|P1|Overall Study|Withdrawal by Subject|1
3115292|NCT00122317|10667932|P1|Overall Study|patient non-compliance|1
3115293|NCT00122317|10667932|P1|Overall Study|Physician Decision|2
3115294|NCT00122317|10667932|P1|Overall Study|Adverse Event|4
3115295|NCT00122317|10667932|P1|Overall Study|Death|3
3115296|NCT00122278|10667941|P2|Overall Study|Lost to Follow-up|0
3115297|NCT00122278|10667942|P1|Overall Study|Lost to Follow-up|2
3115298|NCT00122187|10667952|P2|Overall Study|Withdrew because of resource limitations|2
3115299|NCT00122187|10667953|P1|Overall Study|Withdrew because of resource limitations|2
3115300|NCT00122135|10667967|P2|Overall Study|Withdrawal by Subject|0
3115301|NCT00122135|10667968|P1|Overall Study|Withdrawal by Subject|3
3115302|NCT00122109|10667976|P2|Overall Study|Did not meet criteria|7
3115303|NCT00122109|10667977|P1|Overall Study|Did not meet criteria|6
3115304|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Death|2
3115305|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Death|0
3115306|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Death|0
3115307|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Death|1
3115308|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
3115309|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
3115310|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
3115311|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
3115312|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
3115313|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
3115314|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
3115315|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
3115316|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
3115317|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
3115318|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
3115319|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
3115320|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
3115321|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
3115322|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
3115323|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
3115324|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
3115325|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
3115326|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
3115327|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
3115328|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
3115329|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
3115330|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
3115331|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
3115332|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
3115333|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
3115334|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
3115335|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
3115336|NCT00121667|10668243|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
3115337|NCT00121667|10668244|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
3115338|NCT00121667|10668245|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
3115339|NCT00121667|10668246|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
3115340|NCT00121667|10668243|P4|Short Term (ST) Period|Pregnancy|1
3115341|NCT00121667|10668244|P3|Short Term (ST) Period|Pregnancy|0
3115342|NCT00121667|10668245|P2|Short Term (ST) Period|Pregnancy|0
3115343|NCT00121667|10668246|P1|Short Term (ST) Period|Pregnancy|0
3115344|NCT00121667|10668243|P4|Short Term (ST) Period|Death|1
3115345|NCT00121667|10668244|P3|Short Term (ST) Period|Death|0
3115346|NCT00121667|10668245|P2|Short Term (ST) Period|Death|0
3115347|NCT00121667|10668246|P1|Short Term (ST) Period|Death|0
3115348|NCT00121667|10668243|P4|Short Term (ST) Period|Other Reason|0
3115349|NCT00121667|10668244|P3|Short Term (ST) Period|Other Reason|0
3115350|NCT00121667|10668245|P2|Short Term (ST) Period|Other Reason|0
3115351|NCT00121667|10668246|P1|Short Term (ST) Period|Other Reason|3
3115352|NCT00121667|10668243|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
3115353|NCT00121667|10668244|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
3115354|NCT00121667|10668245|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
3115355|NCT00121667|10668246|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
3115356|NCT00121667|10668243|P4|Short Term (ST) Period|Poor / Non-compliance|2
3115357|NCT00121667|10668244|P3|Short Term (ST) Period|Poor / Non-compliance|1
3115358|NCT00121667|10668245|P2|Short Term (ST) Period|Poor / Non-compliance|1
3115359|NCT00121667|10668246|P1|Short Term (ST) Period|Poor / Non-compliance|0
3115360|NCT00121667|10668243|P4|Short Term (ST) Period|Lost to Follow-up|3
3115361|NCT00121667|10668244|P3|Short Term (ST) Period|Lost to Follow-up|4
3115362|NCT00121667|10668245|P2|Short Term (ST) Period|Lost to Follow-up|4
3115363|NCT00121667|10668246|P1|Short Term (ST) Period|Lost to Follow-up|3
3115364|NCT00121667|10668243|P4|Short Term (ST) Period|Adverse Event|3
3115365|NCT00121667|10668244|P3|Short Term (ST) Period|Adverse Event|5
3115366|NCT00121667|10668245|P2|Short Term (ST) Period|Adverse Event|6
3115367|NCT00121667|10668246|P1|Short Term (ST) Period|Adverse Event|5
3115368|NCT00121667|10668243|P4|Short Term (ST) Period|Subject Withdrew Consent|11
3115369|NCT00121667|10668244|P3|Short Term (ST) Period|Subject Withdrew Consent|4
3115370|NCT00121667|10668245|P2|Short Term (ST) Period|Subject Withdrew Consent|13
3115371|NCT00121667|10668246|P1|Short Term (ST) Period|Subject Withdrew Consent|8
3115372|NCT00121667|10668243|P4|Short Term (ST) Period|Lack of Efficacy|44
3115373|NCT00121667|10668244|P3|Short Term (ST) Period|Lack of Efficacy|27
3115374|NCT00121667|10668245|P2|Short Term (ST) Period|Lack of Efficacy|22
3115375|NCT00121667|10668246|P1|Short Term (ST) Period|Lack of Efficacy|25
3115376|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Other Reason|1
3115377|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Other Reason|0
3115378|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Other Reason|2
3115379|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Other Reason|3
3115380|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Other Reason|5
3115381|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Missing|0
3115382|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Missing|0
3115383|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Missing|1
3115384|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Missing|0
3115385|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Missing|0
3115386|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Death|0
3115387|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Death|1
3115388|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Death|0
3115389|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Death|0
3115390|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Death|0
3115391|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
3115392|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
3115393|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
3115394|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
3115395|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
3115396|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Pregnancy|0
3115397|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Pregnancy|1
3115398|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Pregnancy|0
3115399|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Pregnancy|1
3115400|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Pregnancy|0
3115401|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
3115402|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
3115403|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
3115404|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
3115405|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
3115406|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
3115407|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
3115408|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
3115409|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
3115410|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
3115411|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
3115412|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
3115413|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
3115414|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
3115415|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
3115416|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Adverse Event|5
3115417|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Adverse Event|5
3115418|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Adverse Event|10
3115419|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Adverse Event|10
3115420|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Adverse Event|9
3115421|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
3115422|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
3115423|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
3115424|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
3115425|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
3115426|NCT00121641|10668344|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
3115427|NCT00121641|10668345|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
3115428|NCT00121641|10668346|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
3115429|NCT00121641|10668347|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
3115430|NCT00121641|10668348|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
3115431|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Other Reason|0
3115432|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Other Reason|0
3115433|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Other Reason|0
3115434|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Other Reason|0
3115435|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Other Reason|1
3115436|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
3115437|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
3115438|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
3115439|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
3115440|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
3115441|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
3115442|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
3115443|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
3115444|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
3115445|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
3115446|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
3115447|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
3115448|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
3115449|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
3115450|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
3115451|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Adverse Event|2
3115452|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Adverse Event|0
3115453|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Adverse Event|4
3115454|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Adverse Event|3
3115455|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Adverse Event|3
3115456|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
3115457|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
3115458|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
3115459|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
3115460|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
3115461|NCT00121641|10668344|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
3115462|NCT00121641|10668345|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
3115463|NCT00121641|10668346|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
3115464|NCT00121641|10668347|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
3115465|NCT00121641|10668348|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
3115466|NCT00121485|10668461|P2|Overall Study|Crossover|2
3115467|NCT00121485|10668462|P1|Overall Study|Crossover|0
3115468|NCT00121485|10668461|P2|Overall Study|Not implanted|5
3115469|NCT00121485|10668462|P1|Overall Study|Not implanted|1
3115470|NCT00121238|10668507|P1|Overall Study|Protocol Violation|2
3115471|NCT00121238|10668507|P1|Overall Study|disease progression before intervention|1
3115472|NCT00121199|10668523|P1|Overall Study|Ineligible|9
3115473|NCT00121199|10668523|P1|Overall Study|Other - Not Protocol Specified|3
3115474|NCT00121199|10668523|P1|Overall Study|Death|3
3115475|NCT00121199|10668523|P1|Overall Study|Progression/Relapse|1
3115476|NCT00121199|10668523|P1|Overall Study|Refusal Unrelated to Adverse Event|1
3115477|NCT00121199|10668523|P1|Overall Study|Adverse Event|11
3115478|NCT00121134|10668567|P4|Overall Study|Patient Personal Reasons|0
3115479|NCT00121134|10668568|P3|Overall Study|Patient Personal Reasons|0
3115480|NCT00121134|10668569|P2|Overall Study|Patient Personal Reasons|1
3115481|NCT00121134|10668570|P1|Overall Study|Patient Personal Reasons|0
3115482|NCT00121134|10668567|P4|Overall Study|Intercurrent Illness|1
3115483|NCT00121134|10668568|P3|Overall Study|Intercurrent Illness|0
3115484|NCT00121134|10668569|P2|Overall Study|Intercurrent Illness|0
3115485|NCT00121134|10668570|P1|Overall Study|Intercurrent Illness|0
3115486|NCT00121134|10668567|P4|Overall Study|Treatment Delay|0
3115487|NCT00121134|10668568|P3|Overall Study|Treatment Delay|0
3115488|NCT00121134|10668569|P2|Overall Study|Treatment Delay|0
3115489|NCT00121134|10668570|P1|Overall Study|Treatment Delay|1
3115490|NCT00121134|10668567|P4|Overall Study|Physician Decision|1
3115491|NCT00121134|10668568|P3|Overall Study|Physician Decision|4
3115492|NCT00121134|10668569|P2|Overall Study|Physician Decision|4
3115493|NCT00121134|10668570|P1|Overall Study|Physician Decision|6
3115494|NCT00121134|10668567|P4|Overall Study|Toxicity|5
3115495|NCT00121134|10668568|P3|Overall Study|Toxicity|13
3115496|NCT00121134|10668569|P2|Overall Study|Toxicity|7
3115497|NCT00121134|10668570|P1|Overall Study|Toxicity|4
3115498|NCT00121134|10668567|P4|Overall Study|Progression of Disease|2
3115499|NCT00121134|10668568|P3|Overall Study|Progression of Disease|4
3115500|NCT00121134|10668569|P2|Overall Study|Progression of Disease|3
3115501|NCT00121134|10668570|P1|Overall Study|Progression of Disease|5
3115502|NCT00120874|10668582|P2|Overall Study|Death|1
3115503|NCT00120874|10668583|P1|Overall Study|Death|0
3115504|NCT00120627|10668621|P2|Overall Study|Withdrawal by Subject|5
3115505|NCT00120627|10668622|P1|Overall Study|Withdrawal by Subject|5
3115506|NCT00120406|10668673|P2|Overall Study|patient moved but has not withdrawn|1
3115507|NCT00120406|10668674|P1|Overall Study|patient moved but has not withdrawn|0
3115508|NCT00120406|10668673|P2|Overall Study|received non-study stent|2
3115509|NCT00120406|10668674|P1|Overall Study|received non-study stent|0
3115510|NCT00120406|10668673|P2|Overall Study|Lost to Follow-up|2
3115511|NCT00120406|10668674|P1|Overall Study|Lost to Follow-up|5
3115512|NCT00120406|10668673|P2|Overall Study|Withdrawal by Subject|7
3115513|NCT00120406|10668674|P1|Overall Study|Withdrawal by Subject|5
3115514|NCT00120406|10668673|P2|Overall Study|Death|4
3115515|NCT00120406|10668674|P1|Overall Study|Death|9
3115516|NCT00120289|10668684|P2|Overall Study|Withdrawal by Subject|13
3115517|NCT00120289|10668685|P1|Overall Study|Withdrawal by Subject|14
3115518|NCT00120289|10668684|P2|Overall Study|Lost to Follow-up|14
3115519|NCT00120289|10668685|P1|Overall Study|Lost to Follow-up|11
3115520|NCT00120289|10668684|P2|Overall Study|Death|82
3115521|NCT00120289|10668685|P1|Overall Study|Death|96
3115522|NCT00120250|10668697|P2|Overall Study|Protocol Violation|1
3115523|NCT00120250|10668698|P1|Overall Study|Protocol Violation|0
3115524|NCT00120250|10668697|P2|Overall Study|Lost to Follow-up|1
3115525|NCT00120250|10668698|P1|Overall Study|Lost to Follow-up|1
3115526|NCT00120042|10668714|P3|Overall Study|all completed protocl|0
3115527|NCT00120042|10668715|P2|Overall Study|all completed protocl|0
3115528|NCT00120042|10668716|P1|Overall Study|all completed protocl|0
3115529|NCT00119678|10668739|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
3115530|NCT00119678|10668740|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
3115531|NCT00119678|10668739|P2|Open-label Treatment Period|Pregnancy|0
3115532|NCT00119678|10668740|P1|Open-label Treatment Period|Pregnancy|1
3115533|NCT00119678|10668739|P2|Open-label Treatment Period|Participants not meeting study criteria|0
3115534|NCT00119678|10668740|P1|Open-label Treatment Period|Participants not meeting study criteria|2
3115535|NCT00119678|10668739|P2|Open-label Treatment Period|Participant withdrew consent|0
3115536|NCT00119678|10668740|P1|Open-label Treatment Period|Participant withdrew consent|4
3115537|NCT00119678|10668739|P2|Open-label Treatment Period|Lost to Follow-up|0
3115538|NCT00119678|10668740|P1|Open-label Treatment Period|Lost to Follow-up|3
3115539|NCT00119678|10668739|P2|Open-label Treatment Period|Lack of Efficacy|0
3115540|NCT00119678|10668740|P1|Open-label Treatment Period|Lack of Efficacy|9
3115541|NCT00119678|10668739|P2|Open-label Treatment Period|Adverse Event|0
3115542|NCT00119678|10668740|P1|Open-label Treatment Period|Adverse Event|3
3115543|NCT00119678|10668739|P2|Open-label Treatment Period|Death|0
3115544|NCT00119678|10668740|P1|Open-label Treatment Period|Death|1
3115545|NCT00119678|10668739|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
3115546|NCT00119678|10668740|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
3115547|NCT00119678|10668739|P2|Double-blind Treatment Period|Not treated|2
3115548|NCT00119678|10668740|P1|Double-blind Treatment Period|Not treated|1
3115549|NCT00119678|10668739|P2|Double-blind Treatment Period|Pregnancy|2
3115550|NCT00119678|10668740|P1|Double-blind Treatment Period|Pregnancy|0
3115551|NCT00119678|10668739|P2|Double-blind Treatment Period|Poor/Non-compliance|0
3115552|NCT00119678|10668740|P1|Double-blind Treatment Period|Poor/Non-compliance|3
3115553|NCT00119678|10668739|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
3115554|NCT00119678|10668740|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
3115555|NCT00119678|10668739|P2|Double-blind Treatment Period|Participant withdrew consent|4
3115556|NCT00119678|10668740|P1|Double-blind Treatment Period|Participant withdrew consent|4
3115557|NCT00119678|10668739|P2|Double-blind Treatment Period|Lost to Follow-up|2
3115558|NCT00119678|10668740|P1|Double-blind Treatment Period|Lost to Follow-up|1
3115559|NCT00119678|10668739|P2|Double-blind Treatment Period|Lack of Efficacy|12
3115560|NCT00119678|10668740|P1|Double-blind Treatment Period|Lack of Efficacy|21
3115561|NCT00119678|10668739|P2|Double-blind Treatment Period|Adverse Event|1
3115562|NCT00119678|10668740|P1|Double-blind Treatment Period|Adverse Event|7
3115563|NCT00119678|10668739|P2|Double-blind Treatment Period|Death|0
3115564|NCT00119678|10668740|P1|Double-blind Treatment Period|Death|1
3115565|NCT00119405|10668786|P1|Overall Study|Withdrawal by Subject|1
3115566|NCT00119379|10668800|P2|Overall Study|Adverse Event|1
3115567|NCT00119379|10668801|P1|Overall Study|Adverse Event|4
3115568|NCT00119262|10668819|P2|Overall Study|others|5
3115569|NCT00119262|10668820|P1|Overall Study|others|0
3115570|NCT00119262|10668819|P2|Overall Study|ineligble|2
3115571|NCT00119262|10668820|P1|Overall Study|ineligble|1
3115572|NCT00119262|10668819|P2|Overall Study|other disease|2
3115573|NCT00119262|10668820|P1|Overall Study|other disease|0
3115574|NCT00119262|10668819|P2|Overall Study|Adverse Event|35
3115575|NCT00119262|10668820|P1|Overall Study|Adverse Event|33
3115576|NCT00119262|10668819|P2|Overall Study|Withdrawal by Subject|11
3115577|NCT00119262|10668820|P1|Overall Study|Withdrawal by Subject|12
3115578|NCT00119262|10668819|P2|Overall Study|Lack of Efficacy|3
3115579|NCT00119262|10668820|P1|Overall Study|Lack of Efficacy|0
3115580|NCT00119015|10668857|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
3115581|NCT00119015|10668858|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
3115582|NCT00119015|10668859|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
3115583|NCT00118911|10668875|P2|Overall Study|Withdrawal by Subject|5
3115584|NCT00118911|10668876|P1|Overall Study|Withdrawal by Subject|2
3115585|NCT00118898|10668888|P4|Overall Study|Not able to get to clinic|40
3115586|NCT00118898|10668889|P3|Overall Study|Not able to get to clinic|31
3115587|NCT00118898|10668890|P2|Overall Study|Not able to get to clinic|43
3115588|NCT00118898|10668891|P1|Overall Study|Not able to get to clinic|34
3115589|NCT00118898|10668888|P4|Overall Study|Not compliant with requirements|11
3115590|NCT00118898|10668889|P3|Overall Study|Not compliant with requirements|11
3115591|NCT00118898|10668890|P2|Overall Study|Not compliant with requirements|13
3115592|NCT00118898|10668891|P1|Overall Study|Not compliant with requirements|11
3115593|NCT00118898|10668888|P4|Overall Study|Severe debilitation|4
3115594|NCT00118898|10668889|P3|Overall Study|Severe debilitation|6
3115595|NCT00118898|10668890|P2|Overall Study|Severe debilitation|4
3115596|NCT00118898|10668891|P1|Overall Study|Severe debilitation|1
3115597|NCT00118898|10668888|P4|Overall Study|Site Closure|37
3115598|NCT00118898|10668889|P3|Overall Study|Site Closure|28
3115599|NCT00118898|10668890|P2|Overall Study|Site Closure|31
3115600|NCT00118898|10668891|P1|Overall Study|Site Closure|33
3115601|NCT00118898|10668888|P4|Overall Study|Withdrawal by Subject|8
3115602|NCT00118898|10668889|P3|Overall Study|Withdrawal by Subject|8
3115603|NCT00118898|10668890|P2|Overall Study|Withdrawal by Subject|5
3115604|NCT00118898|10668891|P1|Overall Study|Withdrawal by Subject|10
3115605|NCT00118898|10668888|P4|Overall Study|Lost to Follow-up|33
3115606|NCT00118898|10668889|P3|Overall Study|Lost to Follow-up|33
3115607|NCT00118898|10668890|P2|Overall Study|Lost to Follow-up|34
3115608|NCT00118898|10668891|P1|Overall Study|Lost to Follow-up|26
3115609|NCT00118898|10668888|P4|Overall Study|Death|8
3115610|NCT00118898|10668889|P3|Overall Study|Death|6
3115611|NCT00118898|10668890|P2|Overall Study|Death|11
3115612|NCT00118898|10668891|P1|Overall Study|Death|6
3115613|NCT00118716|10669017|P2|Overall Study|Investigator discretion|1
3115614|NCT00118716|10669018|P1|Overall Study|Investigator discretion|0
3115615|NCT00118716|10669017|P2|Overall Study|Expired drug use|2
3115616|NCT00118716|10669018|P1|Overall Study|Expired drug use|1
3115617|NCT00118716|10669017|P2|Overall Study|misrandomized|1
3115618|NCT00118716|10669018|P1|Overall Study|misrandomized|1
3115619|NCT00118716|10669017|P2|Overall Study|Non-compliance|3
3115620|NCT00118716|10669018|P1|Overall Study|Non-compliance|1
3115621|NCT00118716|10669017|P2|Overall Study|Discontinued by sponsor|1
3115622|NCT00118716|10669018|P1|Overall Study|Discontinued by sponsor|1
3115623|NCT00118716|10669017|P2|Overall Study|Exacerbation|2
3115624|NCT00118716|10669018|P1|Overall Study|Exacerbation|2
3115625|NCT00118716|10669017|P2|Overall Study|Withdrawal by Subject|1
3115626|NCT00118716|10669018|P1|Overall Study|Withdrawal by Subject|0
3115627|NCT00118716|10669017|P2|Overall Study|Protocol Violation|4
3115628|NCT00118716|10669018|P1|Overall Study|Protocol Violation|5
3115629|NCT00118716|10669017|P2|Overall Study|Adverse Event|7
3115630|NCT00118716|10669018|P1|Overall Study|Adverse Event|2
3115631|NCT00118703|10669038|P2|Overall Study|Lost to Follow-up|2
3115632|NCT00118703|10669039|P1|Overall Study|Lost to Follow-up|1
3115633|NCT00118703|10669038|P2|Overall Study|Withdrawal by Subject|5
3115634|NCT00118703|10669039|P1|Overall Study|Withdrawal by Subject|2
3115635|NCT00118703|10669038|P2|Overall Study|Participant took two different treatment|1
3115636|NCT00118703|10669039|P1|Overall Study|Participant took two different treatment|0
3115637|NCT00118703|10669038|P2|Overall Study|Adverse Event|1
3115638|NCT00118703|10669039|P1|Overall Study|Adverse Event|1
3115639|NCT00118703|10669038|P2|Overall Study|Protocol Violation|0
3115640|NCT00118703|10669039|P1|Overall Study|Protocol Violation|1
3115641|NCT00118482|10669136|P2|Overall Study|Withdrawal by Subject|22
3115642|NCT00118482|10669137|P1|Overall Study|Withdrawal by Subject|23
3115643|NCT00118482|10669136|P2|Overall Study|Lost to Follow-up|7
3115644|NCT00118482|10669137|P1|Overall Study|Lost to Follow-up|7
3115645|NCT00118430|10669152|P3|Overall Study|Lost to Follow-up|28
3115646|NCT00118430|10669153|P2|Overall Study|Lost to Follow-up|22
3115647|NCT00118430|10669154|P1|Overall Study|Lost to Follow-up|15
3115648|NCT00118430|10669152|P3|Overall Study|Withdrawal by Subject|0
3115649|NCT00118430|10669153|P2|Overall Study|Withdrawal by Subject|2
3115650|NCT00118430|10669154|P1|Overall Study|Withdrawal by Subject|6
3115651|NCT00118417|10669169|P2|Phase II (Weeks 6 to 12)|Remission|2
3115652|NCT00118417|10669170|P1|Phase II (Weeks 6 to 12)|Remission|1
3115653|NCT00118417|10669169|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
3115654|NCT00118417|10669170|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
3115655|NCT00118417|10669169|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
3115656|NCT00118417|10669170|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
3115657|NCT00118417|10669169|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
3115658|NCT00118417|10669170|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
3115659|NCT00118417|10669169|P2|Phase I (Weeks 0 to 6)|Remission|0
3115660|NCT00118417|10669170|P1|Phase I (Weeks 0 to 6)|Remission|8
3115661|NCT00118287|10669314|P1|Overall Study|Muscle pain|1
3115662|NCT00118287|10669314|P1|Overall Study|Intracranial haemorrhage|1
3115663|NCT00118157|10669347|P1|Overall Study|Withdrawal by Subject|2
3115664|NCT00118157|10669347|P1|Overall Study|Death|8
3115665|NCT00118157|10669347|P1|Overall Study|Adverse Event|2
3115666|NCT00118092|10669365|P1|Overall Study|Protocol Violation|1
3115667|NCT00118092|10669365|P1|Overall Study|Withdrawal by Subject|1
3115668|NCT00118040|10669383|P3|Overall Study|Other|1
3115669|NCT00118040|10669384|P2|Overall Study|Other|0
3115670|NCT00118040|10669385|P1|Overall Study|Other|0
3115671|NCT00118040|10669383|P3|Overall Study|Non-Compliant Participant|2
3115672|NCT00118040|10669384|P2|Overall Study|Non-Compliant Participant|1
3115673|NCT00118040|10669385|P1|Overall Study|Non-Compliant Participant|1
3115674|NCT00118040|10669383|P3|Overall Study|Medical Contraindication|1
3115675|NCT00118040|10669384|P2|Overall Study|Medical Contraindication|0
3115676|NCT00118040|10669385|P1|Overall Study|Medical Contraindication|0
3115677|NCT00118040|10669383|P3|Overall Study|Withdrawal by Subject|2
3115678|NCT00118040|10669384|P2|Overall Study|Withdrawal by Subject|0
3115679|NCT00118040|10669385|P1|Overall Study|Withdrawal by Subject|0
3115680|NCT00118040|10669383|P3|Overall Study|Adverse Event|0
3115681|NCT00118040|10669384|P2|Overall Study|Adverse Event|1
3115682|NCT00118040|10669385|P1|Overall Study|Adverse Event|0
3115683|NCT00117988|10669446|P1|Overall Study|Adverse Event|1
3115684|NCT00117988|10669446|P1|Overall Study|Death|3
3115685|NCT00117949|10669469|P4|Overall Study|Hepatic abnormalities|1
3115686|NCT00117949|10669470|P3|Overall Study|Hepatic abnormalities|0
3115687|NCT00117949|10669471|P2|Overall Study|Hepatic abnormalities|1
3115688|NCT00117949|10669472|P1|Overall Study|Hepatic abnormalities|0
3115689|NCT00117949|10669469|P4|Overall Study|PSA reduction <=50%|4
3115690|NCT00117949|10669470|P3|Overall Study|PSA reduction <=50%|2
3115691|NCT00117949|10669471|P2|Overall Study|PSA reduction <=50%|2
3115692|NCT00117949|10669472|P1|Overall Study|PSA reduction <=50%|0
3115693|NCT00117949|10669469|P4|Overall Study|PSA increase >=10ng/mL|0
3115694|NCT00117949|10669470|P3|Overall Study|PSA increase >=10ng/mL|1
3115695|NCT00117949|10669471|P2|Overall Study|PSA increase >=10ng/mL|1
3115696|NCT00117949|10669472|P1|Overall Study|PSA increase >=10ng/mL|0
3115697|NCT00117949|10669469|P4|Overall Study|Prostate-specific antigen increase >=25%|2
3115698|NCT00117949|10669470|P3|Overall Study|Prostate-specific antigen increase >=25%|1
3115699|NCT00117949|10669471|P2|Overall Study|Prostate-specific antigen increase >=25%|1
3115700|NCT00117949|10669472|P1|Overall Study|Prostate-specific antigen increase >=25%|0
3115701|NCT00117949|10669469|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
3115702|NCT00117949|10669470|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
3115703|NCT00117949|10669471|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
3115704|NCT00117949|10669472|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
3115705|NCT00117949|10669469|P4|Overall Study|Testosterone >1.0 ng/mL|15
3115706|NCT00117949|10669470|P3|Overall Study|Testosterone >1.0 ng/mL|17
3115707|NCT00117949|10669471|P2|Overall Study|Testosterone >1.0 ng/mL|18
3115708|NCT00117949|10669472|P1|Overall Study|Testosterone >1.0 ng/mL|10
3115709|NCT00117845|10669506|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
3115710|NCT00117793|10669524|P1|Overall Study|Withdrawal by Subject|12
3115711|NCT00117676|10669547|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
3115712|NCT00117676|10669548|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
3115713|NCT00117676|10669547|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
3115714|NCT00117676|10669548|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
3115715|NCT00117676|10669547|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
3115716|NCT00117676|10669548|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
3115717|NCT00117676|10669547|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
3115718|NCT00117676|10669548|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
3115719|NCT00117676|10669547|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
3115720|NCT00117676|10669548|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
3115721|NCT00117676|10669547|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
3115722|NCT00117676|10669548|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
3115723|NCT00117676|10669547|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
3115724|NCT00117676|10669548|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
3115725|NCT00117676|10669547|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
3115726|NCT00117676|10669548|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
3115727|NCT00117676|10669547|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
3115728|NCT00117676|10669548|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
3115729|NCT00117676|10669547|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
3115730|NCT00117676|10669548|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
3115731|NCT00117676|10669547|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
3115732|NCT00117676|10669548|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
3115733|NCT00117676|10669547|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
3115734|NCT00117676|10669548|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
3115735|NCT00117676|10669547|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
3115736|NCT00117676|10669548|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
3115737|NCT00117676|10669547|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
3115738|NCT00117676|10669548|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
3115739|NCT00117676|10669547|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
3115740|NCT00117676|10669548|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
3115741|NCT00117676|10669547|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
3115742|NCT00117676|10669548|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
3115743|NCT00117676|10669547|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
3115744|NCT00117676|10669548|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
3115745|NCT00117676|10669547|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
3115746|NCT00117676|10669548|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
3115747|NCT00117676|10669547|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
3115748|NCT00117676|10669548|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
3115749|NCT00117676|10669547|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
3115750|NCT00117676|10669548|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
3115751|NCT00117676|10669547|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
3115752|NCT00117676|10669548|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
3115753|NCT00117676|10669547|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
3115754|NCT00117676|10669548|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
3115755|NCT00117676|10669547|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
3115756|NCT00117676|10669548|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
3115757|NCT00117676|10669547|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
3115758|NCT00117676|10669548|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
3115759|NCT00117676|10669547|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
3115760|NCT00117676|10669548|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
3115761|NCT00117676|10669547|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
3115762|NCT00117676|10669548|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
3115763|NCT00117676|10669547|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
3115764|NCT00117676|10669548|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
3115765|NCT00117676|10669547|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
3115766|NCT00117676|10669548|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
3115767|NCT00117676|10669547|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
3115768|NCT00117676|10669548|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
3115769|NCT00117676|10669547|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
3115770|NCT00117676|10669548|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
3115771|NCT00117676|10669547|P2|Double-blind Period Through Week 48|Withdrew Consent|1
3115772|NCT00117676|10669548|P1|Double-blind Period Through Week 48|Withdrew Consent|0
3115773|NCT00117676|10669547|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
3115774|NCT00117676|10669548|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
3115775|NCT00117676|10669547|P2|Double-blind Period Through Week 48|Protocol Violation|1
3115776|NCT00117676|10669548|P1|Double-blind Period Through Week 48|Protocol Violation|0
3115777|NCT00117676|10669547|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
3115778|NCT00117676|10669548|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
3115779|NCT00117676|10669547|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
3115780|NCT00117676|10669548|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
3115781|NCT00117637|10669637|P2|Second Intervention (Period 2)|reason not reported|0
3115782|NCT00117637|10669638|P1|Second Intervention (Period 2)|reason not reported|1
3115783|NCT00117637|10669637|P2|Second Intervention (Period 2)|non compliant with study medication|1
3115784|NCT00117637|10669638|P1|Second Intervention (Period 2)|non compliant with study medication|1
3115785|NCT00117637|10669637|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
3115786|NCT00117637|10669638|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
3115787|NCT00117637|10669637|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
3115788|NCT00117637|10669638|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
3115789|NCT00117637|10669637|P2|Second Intervention (Period 2)|Protocol Violation|0
3115790|NCT00117637|10669638|P1|Second Intervention (Period 2)|Protocol Violation|1
3115791|NCT00117637|10669637|P2|Second Intervention (Period 2)|Lost to Follow-up|0
3115792|NCT00117637|10669638|P1|Second Intervention (Period 2)|Lost to Follow-up|1
3115793|NCT00117637|10669637|P2|Second Intervention (Period 2)|Adverse Event|9
3115794|NCT00117637|10669638|P1|Second Intervention (Period 2)|Adverse Event|0
3115795|NCT00117637|10669637|P2|First Intervention (Period 1)|reason not reported|1
3115796|NCT00117637|10669638|P1|First Intervention (Period 1)|reason not reported|0
3115797|NCT00117637|10669637|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
3115798|NCT00117637|10669638|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
3115799|NCT00117637|10669637|P2|First Intervention (Period 1)|protocol driven decision point|0
3115800|NCT00117637|10669638|P1|First Intervention (Period 1)|protocol driven decision point|1
3115801|NCT00117637|10669637|P2|First Intervention (Period 1)|study terminated by the sponsor|1
3115802|NCT00117637|10669638|P1|First Intervention (Period 1)|study terminated by the sponsor|3
3115803|NCT00117637|10669637|P2|First Intervention (Period 1)|Withdrawal by Subject|4
3115804|NCT00117637|10669638|P1|First Intervention (Period 1)|Withdrawal by Subject|2
3115805|NCT00117637|10669637|P2|First Intervention (Period 1)|Protocol Violation|0
3115806|NCT00117637|10669638|P1|First Intervention (Period 1)|Protocol Violation|1
3115807|NCT00117637|10669637|P2|First Intervention (Period 1)|Lost to Follow-up|2
3115808|NCT00117637|10669638|P1|First Intervention (Period 1)|Lost to Follow-up|0
3115809|NCT00117637|10669637|P2|First Intervention (Period 1)|Adverse Event|16
3115810|NCT00117637|10669638|P1|First Intervention (Period 1)|Adverse Event|11
3115811|NCT00117598|10669713|P5|After Treament Cross Over|Other|2
3115812|NCT00117598|10669714|P4|After Treament Cross Over|Other|1
3115813|NCT00117598|10669715|P3|After Treament Cross Over|Other|0
3115814|NCT00117598|10669716|P2|After Treament Cross Over|Other|0
3115815|NCT00117598|10669717|P1|After Treament Cross Over|Other|0
3115816|NCT00117598|10669713|P5|After Treament Cross Over|Withdrawal by Subject|0
3115817|NCT00117598|10669714|P4|After Treament Cross Over|Withdrawal by Subject|1
3115818|NCT00117598|10669715|P3|After Treament Cross Over|Withdrawal by Subject|0
3115819|NCT00117598|10669716|P2|After Treament Cross Over|Withdrawal by Subject|0
3115820|NCT00117598|10669717|P1|After Treament Cross Over|Withdrawal by Subject|0
3115821|NCT00117598|10669713|P5|After Treament Cross Over|Death|2
3115822|NCT00117598|10669714|P4|After Treament Cross Over|Death|1
3115823|NCT00117598|10669715|P3|After Treament Cross Over|Death|0
3115824|NCT00117598|10669716|P2|After Treament Cross Over|Death|0
3115825|NCT00117598|10669717|P1|After Treament Cross Over|Death|0
3115826|NCT00117598|10669713|P5|Prior to Treatment Cross Over|Other|0
3115827|NCT00117598|10669714|P4|Prior to Treatment Cross Over|Other|0
3115828|NCT00117598|10669715|P3|Prior to Treatment Cross Over|Other|9
3115829|NCT00117598|10669716|P2|Prior to Treatment Cross Over|Other|9
3115830|NCT00117598|10669717|P1|Prior to Treatment Cross Over|Other|15
3115831|NCT00117598|10669713|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
3115832|NCT00117598|10669714|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
3115833|NCT00117598|10669715|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
3115834|NCT00117598|10669716|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
3115835|NCT00117598|10669717|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
3115836|NCT00117598|10669713|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
3115837|NCT00117598|10669714|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
3115838|NCT00117598|10669715|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
3115839|NCT00117598|10669716|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
3115840|NCT00117598|10669717|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
3115841|NCT00117598|10669713|P5|Prior to Treatment Cross Over|Death|0
3115842|NCT00117598|10669714|P4|Prior to Treatment Cross Over|Death|0
3115843|NCT00117598|10669715|P3|Prior to Treatment Cross Over|Death|37
3115844|NCT00117598|10669716|P2|Prior to Treatment Cross Over|Death|41
3115845|NCT00117598|10669717|P1|Prior to Treatment Cross Over|Death|40
3115846|NCT00117572|10669751|P2|Overall Study|Protocol Violation|0
3115847|NCT00117572|10669752|P1|Overall Study|Protocol Violation|1
3115848|NCT00117572|10669751|P2|Overall Study|Withdrawal by Subject|3
3115849|NCT00117572|10669752|P1|Overall Study|Withdrawal by Subject|3
3115850|NCT00117572|10669751|P2|Overall Study|Site withdrew before starting treatment|3
3115851|NCT00117572|10669752|P1|Overall Study|Site withdrew before starting treatment|2
3115852|NCT00117338|10669793|P2|Overall Study|Lack of Efficacy|1
3115853|NCT00117338|10669794|P1|Overall Study|Lack of Efficacy|0
3115854|NCT00117338|10669793|P2|Overall Study|Did not meet Inclusion Criteria|0
3115855|NCT00117338|10669794|P1|Overall Study|Did not meet Inclusion Criteria|1
3115856|NCT00117338|10669793|P2|Overall Study|Withdrawal by Subject|0
3115857|NCT00117338|10669794|P1|Overall Study|Withdrawal by Subject|1
3115858|NCT00117338|10669793|P2|Overall Study|Protocol Violation|2
3115859|NCT00117338|10669794|P1|Overall Study|Protocol Violation|3
3115860|NCT00117338|10669793|P2|Overall Study|Adverse Event|1
3115861|NCT00117338|10669794|P1|Overall Study|Adverse Event|0
3115862|NCT00117325|10669814|P2|Overall Study|Admisnitrative|0
3115863|NCT00117325|10669815|P1|Overall Study|Admisnitrative|1
3115864|NCT00117325|10669814|P2|Overall Study|Early termination|1
3115865|NCT00117325|10669815|P1|Overall Study|Early termination|1
3115866|NCT00117325|10669814|P2|Overall Study|Use of prohibited medicine|2
3115867|NCT00117325|10669815|P1|Overall Study|Use of prohibited medicine|1
3115868|NCT00117325|10669814|P2|Overall Study|Lack of Efficacy|0
3115869|NCT00117325|10669815|P1|Overall Study|Lack of Efficacy|1
3115870|NCT00117325|10669814|P2|Overall Study|Withdrawal by Subject|2
3115871|NCT00117325|10669815|P1|Overall Study|Withdrawal by Subject|3
3115872|NCT00117325|10669814|P2|Overall Study|Protocol Violation|3
3115873|NCT00117325|10669815|P1|Overall Study|Protocol Violation|2
3115874|NCT00117325|10669814|P2|Overall Study|Lost to Follow-up|1
3115875|NCT00117325|10669815|P1|Overall Study|Lost to Follow-up|1
3115876|NCT00117325|10669814|P2|Overall Study|Adverse Event|3
3115877|NCT00117325|10669815|P1|Overall Study|Adverse Event|3
3115878|NCT00117312|10669847|P4|Overall Study|Withdrawal by Subject|0
3115879|NCT00117312|10669848|P3|Overall Study|Withdrawal by Subject|0
3115880|NCT00117312|10669849|P2|Overall Study|Withdrawal by Subject|2
3115881|NCT00117312|10669850|P1|Overall Study|Withdrawal by Subject|0
3115882|NCT00117312|10669847|P4|Overall Study|Hepatic abnormality|1
3115883|NCT00117312|10669848|P3|Overall Study|Hepatic abnormality|0
3115884|NCT00117312|10669849|P2|Overall Study|Hepatic abnormality|1
3115885|NCT00117312|10669850|P1|Overall Study|Hepatic abnormality|0
3115886|NCT00117312|10669847|P4|Overall Study|PSA increase >= 10ng/mL|0
3115887|NCT00117312|10669848|P3|Overall Study|PSA increase >= 10ng/mL|1
3115888|NCT00117312|10669849|P2|Overall Study|PSA increase >= 10ng/mL|1
3115889|NCT00117312|10669850|P1|Overall Study|PSA increase >= 10ng/mL|0
3115890|NCT00117312|10669847|P4|Overall Study|PSA decrease <=50%|4
3115891|NCT00117312|10669848|P3|Overall Study|PSA decrease <=50%|2
3115892|NCT00117312|10669849|P2|Overall Study|PSA decrease <=50%|2
3115893|NCT00117312|10669850|P1|Overall Study|PSA decrease <=50%|0
3115894|NCT00117312|10669847|P4|Overall Study|Protocol Violation|0
3115895|NCT00117312|10669848|P3|Overall Study|Protocol Violation|3
3115896|NCT00117312|10669849|P2|Overall Study|Protocol Violation|1
3115897|NCT00117312|10669850|P1|Overall Study|Protocol Violation|0
3115898|NCT00117312|10669847|P4|Overall Study|Adverse Event|0
3115899|NCT00117312|10669848|P3|Overall Study|Adverse Event|0
3115900|NCT00117312|10669849|P2|Overall Study|Adverse Event|2
3115901|NCT00117312|10669850|P1|Overall Study|Adverse Event|0
3115902|NCT00117312|10669847|P4|Overall Study|Patient choice|1
3115903|NCT00117312|10669848|P3|Overall Study|Patient choice|2
3115904|NCT00117312|10669849|P2|Overall Study|Patient choice|0
3115905|NCT00117312|10669850|P1|Overall Study|Patient choice|0
3115906|NCT00117312|10669847|P4|Overall Study|Other|1
3115907|NCT00117312|10669848|P3|Overall Study|Other|3
3115908|NCT00117312|10669849|P2|Overall Study|Other|1
3115909|NCT00117312|10669850|P1|Overall Study|Other|0
3115910|NCT00117312|10669847|P4|Overall Study|Prostate-specific antigen increase >=25%|3
3115911|NCT00117312|10669848|P3|Overall Study|Prostate-specific antigen increase >=25%|5
3115912|NCT00117312|10669849|P2|Overall Study|Prostate-specific antigen increase >=25%|1
3115913|NCT00117312|10669850|P1|Overall Study|Prostate-specific antigen increase >=25%|0
3115914|NCT00117312|10669847|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
3115915|NCT00117312|10669848|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
3115916|NCT00117312|10669849|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
3115917|NCT00117312|10669850|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
3115918|NCT00117312|10669847|P4|Overall Study|Testosterone >1.0 ng/mL|9
3115919|NCT00117312|10669848|P3|Overall Study|Testosterone >1.0 ng/mL|5
3115920|NCT00117312|10669849|P2|Overall Study|Testosterone >1.0 ng/mL|9
3115921|NCT00117312|10669850|P1|Overall Study|Testosterone >1.0 ng/mL|9
3115922|NCT00117286|10669866|P2|Overall Study|Research site closing|2
3115923|NCT00117286|10669867|P1|Overall Study|Research site closing|0
3115924|NCT00117286|10669866|P2|Overall Study|Lack of Efficacy|1
3115925|NCT00117286|10669867|P1|Overall Study|Lack of Efficacy|2
3115926|NCT00117286|10669866|P2|Overall Study|Physician Decision|7
3115927|NCT00117286|10669867|P1|Overall Study|Physician Decision|3
3115928|NCT00117286|10669866|P2|Overall Study|Withdrawal by Subject|2
3115929|NCT00117286|10669867|P1|Overall Study|Withdrawal by Subject|6
3115930|NCT00117286|10669866|P2|Overall Study|Protocol Violation|3
3115931|NCT00117286|10669867|P1|Overall Study|Protocol Violation|3
3115932|NCT00117286|10669866|P2|Overall Study|Lost to Follow-up|0
3115933|NCT00117286|10669867|P1|Overall Study|Lost to Follow-up|2
3115934|NCT00117286|10669866|P2|Overall Study|Adverse Event|6
3115935|NCT00117286|10669867|P1|Overall Study|Adverse Event|12
3115936|NCT00117156|10669875|P1|Overall Study|Trt for Pre-Exist Second Primary|1
3115937|NCT00117156|10669875|P1|Overall Study|Physician Decision|1
3115938|NCT00117156|10669875|P1|Overall Study|Adverse Event|9
3115939|NCT00116844|10669943|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
3115940|NCT00116844|10669944|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
3115941|NCT00116844|10669943|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
3115942|NCT00116844|10669944|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
3115943|NCT00116844|10669943|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
3115944|NCT00116844|10669944|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
3115945|NCT00116844|10669943|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
3115946|NCT00116844|10669944|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
3115947|NCT00116844|10669943|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
3115948|NCT00116844|10669944|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
3115949|NCT00116844|10669943|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
3115950|NCT00116844|10669944|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
3115951|NCT00116844|10669943|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
3115952|NCT00116844|10669944|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
3115953|NCT00116844|10669943|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
3115954|NCT00116844|10669944|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
3115955|NCT00116844|10669943|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
3115956|NCT00116844|10669944|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
3115957|NCT00116831|10669962|P2|Overall Study|Missing data for participant|0
3115958|NCT00116831|10669963|P1|Overall Study|Missing data for participant|1
3115959|NCT00116831|10669962|P2|Overall Study|Insufficient therapeutic effect|1
3115960|NCT00116831|10669963|P1|Overall Study|Insufficient therapeutic effect|0
3115961|NCT00116831|10669962|P2|Overall Study|Withdrawal by Subject|32
3115962|NCT00116831|10669963|P1|Overall Study|Withdrawal by Subject|32
3115963|NCT00116831|10669962|P2|Overall Study|Withdrawn investigational product|0
3115964|NCT00116831|10669963|P1|Overall Study|Withdrawn investigational product|1
3115965|NCT00116831|10669962|P2|Overall Study|Low haemoglobin on screening|0
3115966|NCT00116831|10669963|P1|Overall Study|Low haemoglobin on screening|1
3115967|NCT00116831|10669962|P2|Overall Study|Hypoglycaemic events|0
3115968|NCT00116831|10669963|P1|Overall Study|Hypoglycaemic events|1
3115969|NCT00116831|10669962|P2|Overall Study|Protocol Violation|6
3115970|NCT00116831|10669963|P1|Overall Study|Protocol Violation|3
3115971|NCT00116831|10669962|P2|Overall Study|Lost to Follow-up|6
3115972|NCT00116831|10669963|P1|Overall Study|Lost to Follow-up|8
3115973|NCT00116831|10669962|P2|Overall Study|Baseline IVUS determined unevaluable|11
3115974|NCT00116831|10669963|P1|Overall Study|Baseline IVUS determined unevaluable|12
3115975|NCT00116831|10669962|P2|Overall Study|Adverse Event|16
3115976|NCT00116831|10669963|P1|Overall Study|Adverse Event|14
3115977|NCT00116805|10670041|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
3115978|NCT00116805|10670042|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
3115979|NCT00116805|10670041|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
3115980|NCT00116805|10670042|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
3115981|NCT00116805|10670041|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
3115982|NCT00116805|10670042|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
3115983|NCT00116805|10670041|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
3115984|NCT00116805|10670042|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
3115985|NCT00116805|10670041|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
3115986|NCT00116805|10670042|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
3115987|NCT00116805|10670041|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
3115988|NCT00116805|10670042|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
3115989|NCT00116805|10670041|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
3115990|NCT00116805|10670042|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
3115991|NCT00116805|10670041|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
3115992|NCT00116805|10670042|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
3115993|NCT00116805|10670041|P2|Open-label Period Weeks 337 - 384|Completed Study|0
3115994|NCT00116805|10670042|P1|Open-label Period Weeks 337 - 384|Completed Study|1
3115995|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
3115996|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
3115997|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
3115998|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
3115999|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
3116000|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
3116001|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
3116002|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
3116003|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
3116004|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
3116005|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
3116006|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
3116007|NCT00116805|10670041|P2|Open-label Period Weeks 289 - 336|Completed Study|1
3116008|NCT00116805|10670042|P1|Open-label Period Weeks 289 - 336|Completed Study|0
3116009|NCT00116805|10670041|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
3116010|NCT00116805|10670042|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
3116011|NCT00116805|10670041|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
3116012|NCT00116805|10670042|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
3116013|NCT00116805|10670041|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
3116014|NCT00116805|10670042|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
3116015|NCT00116805|10670041|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
3116016|NCT00116805|10670042|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
3116017|NCT00116805|10670041|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
3116018|NCT00116805|10670042|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
3116019|NCT00116805|10670041|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
3116020|NCT00116805|10670042|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
3116021|NCT00116805|10670041|P2|Open-label Period Weeks 193 - 240|Completed Study|1
3116022|NCT00116805|10670042|P1|Open-label Period Weeks 193 - 240|Completed Study|0
3116023|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
3116024|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
3116025|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
3116026|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
3116027|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
3116028|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
3116029|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
3116030|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
3116031|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
3116032|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
3116033|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
3116034|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
3116035|NCT00116805|10670041|P2|Open-label Period Weeks 145 - 192|Completed Study|1
3116036|NCT00116805|10670042|P1|Open-label Period Weeks 145 - 192|Completed Study|1
3116037|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
3116038|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
3116039|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
3116040|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
3116041|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
3116042|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
3116043|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
3116044|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
3116045|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
3116046|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
3116047|NCT00116805|10670041|P2|Open-label Period Weeks 97 - 144|Completed Study|0
3116048|NCT00116805|10670042|P1|Open-label Period Weeks 97 - 144|Completed Study|1
3116049|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
3116050|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
3116051|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
3116052|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
3116053|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
3116054|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
3116055|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
3116056|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
3116057|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
3116058|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
3116059|NCT00116805|10670041|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
3116060|NCT00116805|10670042|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
3116061|NCT00116805|10670041|P2|Double-blind Period Through Week 48|Withdrew Consent|2
3116062|NCT00116805|10670042|P1|Double-blind Period Through Week 48|Withdrew Consent|4
3116063|NCT00116805|10670041|P2|Double-blind Period Through Week 48|Protocol Violation|1
3116064|NCT00116805|10670042|P1|Double-blind Period Through Week 48|Protocol Violation|1
3116065|NCT00116805|10670041|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
3116066|NCT00116805|10670042|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
3116067|NCT00116779|10670135|P2|Overall Study|Elevated PSA levels|2
3116068|NCT00116779|10670136|P1|Overall Study|Elevated PSA levels|2
3116069|NCT00116779|10670135|P2|Overall Study|Physician Decision|1
3116070|NCT00116779|10670136|P1|Overall Study|Physician Decision|3
3116071|NCT00116779|10670135|P2|Overall Study|Inadequate testosterone suppression|9
3116072|NCT00116779|10670136|P1|Overall Study|Inadequate testosterone suppression|7
3116073|NCT00116779|10670135|P2|Overall Study|Withdrawal by Subject|1
3116074|NCT00116779|10670136|P1|Overall Study|Withdrawal by Subject|4
3116075|NCT00116779|10670135|P2|Overall Study|Protocol Violation|4
3116076|NCT00116779|10670136|P1|Overall Study|Protocol Violation|1
3116077|NCT00116779|10670135|P2|Overall Study|Adverse Event|2
3116078|NCT00116779|10670136|P1|Overall Study|Adverse Event|4
3116079|NCT00116753|10670169|P3|Overall Study|Dosing Error|0
3116080|NCT00116753|10670170|P2|Overall Study|Dosing Error|1
3116081|NCT00116753|10670171|P1|Overall Study|Dosing Error|0
3116082|NCT00116753|10670169|P3|Overall Study|Progressive Parkinson's Disease|0
3116083|NCT00116753|10670170|P2|Overall Study|Progressive Parkinson's Disease|0
3116084|NCT00116753|10670171|P1|Overall Study|Progressive Parkinson's Disease|1
3116085|NCT00116753|10670169|P3|Overall Study|Abnormal Echocardiogram|1
3116086|NCT00116753|10670170|P2|Overall Study|Abnormal Echocardiogram|0
3116087|NCT00116753|10670171|P1|Overall Study|Abnormal Echocardiogram|0
3116088|NCT00116753|10670169|P3|Overall Study|Disease Progression|3
3116089|NCT00116753|10670170|P2|Overall Study|Disease Progression|4
3116090|NCT00116753|10670171|P1|Overall Study|Disease Progression|3
3116091|NCT00116753|10670169|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
3116092|NCT00116753|10670170|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
3116093|NCT00116753|10670171|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
3116094|NCT00116753|10670169|P3|Overall Study|Protocol Violation|1
3116095|NCT00116753|10670170|P2|Overall Study|Protocol Violation|0
3116096|NCT00116753|10670171|P1|Overall Study|Protocol Violation|0
3116097|NCT00116753|10670169|P3|Overall Study|Lost to Follow-up|1
3116098|NCT00116753|10670170|P2|Overall Study|Lost to Follow-up|2
3116099|NCT00116753|10670171|P1|Overall Study|Lost to Follow-up|0
3116100|NCT00116753|10670169|P3|Overall Study|Withdrawal by Subject|8
3116101|NCT00116753|10670170|P2|Overall Study|Withdrawal by Subject|12
3116102|NCT00116753|10670171|P1|Overall Study|Withdrawal by Subject|11
3116103|NCT00116753|10670169|P3|Overall Study|Adverse Event|7
3116104|NCT00116753|10670170|P2|Overall Study|Adverse Event|10
3116105|NCT00116753|10670171|P1|Overall Study|Adverse Event|16
3116106|NCT00116688|10670193|P2|Overall Study|Other|0
3116107|NCT00116688|10670194|P1|Overall Study|Other|11
3116108|NCT00116688|10670193|P2|Overall Study|Pregnancy|0
3116109|NCT00116688|10670194|P1|Overall Study|Pregnancy|1
3116110|NCT00116688|10670193|P2|Overall Study|Protocol-specified criteria|0
3116111|NCT00116688|10670194|P1|Overall Study|Protocol-specified criteria|3
3116112|NCT00116688|10670193|P2|Overall Study|Death|0
3116113|NCT00116688|10670194|P1|Overall Study|Death|15
3116114|NCT00116688|10670193|P2|Overall Study|Lost to Follow-up|0
3116115|NCT00116688|10670194|P1|Overall Study|Lost to Follow-up|3
3116116|NCT00116688|10670193|P2|Overall Study|Physician Decision|0
3116117|NCT00116688|10670194|P1|Overall Study|Physician Decision|7
3116118|NCT00116688|10670193|P2|Overall Study|Requirement for alternative therapy|1
3116119|NCT00116688|10670194|P1|Overall Study|Requirement for alternative therapy|11
3116120|NCT00116688|10670193|P2|Overall Study|Withdrawal by Subject|2
3116121|NCT00116688|10670194|P1|Overall Study|Withdrawal by Subject|26
3116122|NCT00116688|10670193|P2|Overall Study|Adverse Event|0
3116123|NCT00116688|10670194|P1|Overall Study|Adverse Event|11
3116124|NCT00116688|10670193|P2|Overall Study|Noncompliance|1
3116125|NCT00116688|10670194|P1|Overall Study|Noncompliance|3
3116126|NCT00116688|10670193|P2|Overall Study|Protocol deviation|0
3116127|NCT00116688|10670194|P1|Overall Study|Protocol deviation|1
3116128|NCT00116649|10670209|P1|Overall Study|Protocol Specified|7
3116129|NCT00116649|10670209|P1|Overall Study|Various Reasons|18
3116130|NCT00116649|10670209|P1|Overall Study|Local Skin Reaction|9
3116131|NCT00116649|10670209|P1|Overall Study|Withdrawal by Subject|68
3116132|NCT00116649|10670209|P1|Overall Study|Lost to Follow-up|32
3116133|NCT00116649|10670209|P1|Overall Study|Lack of Efficacy|1
3116134|NCT00116649|10670209|P1|Overall Study|Adverse Event|20
3116135|NCT00116584|10670216|P2|Overall Study|Protocol Violation|1
3116136|NCT00116584|10670217|P1|Overall Study|Protocol Violation|1
3116137|NCT00116584|10670216|P2|Overall Study|Withdrawal by Subject|0
3116138|NCT00116584|10670217|P1|Overall Study|Withdrawal by Subject|1
3116139|NCT00116558|10670230|P3|Overall Study|disease progression|18
3116140|NCT00116558|10670231|P2|Overall Study|disease progression|7
3116141|NCT00116558|10670232|P1|Overall Study|disease progression|3
3116142|NCT00116558|10670230|P3|Overall Study|Withdrawal by Subject|12
3116143|NCT00116558|10670231|P2|Overall Study|Withdrawal by Subject|3
3116144|NCT00116558|10670232|P1|Overall Study|Withdrawal by Subject|17
3116145|NCT00116558|10670230|P3|Overall Study|Death|3
3116146|NCT00116558|10670231|P2|Overall Study|Death|5
3116147|NCT00116558|10670232|P1|Overall Study|Death|11
3116148|NCT00116428|10670243|P2|Overall Study|Did not meet inclusion criteria|0
3116149|NCT00116428|10670244|P1|Overall Study|Did not meet inclusion criteria|1
3116150|NCT00116428|10670243|P2|Overall Study|Withdrawal by Subject|5
3116151|NCT00116428|10670244|P1|Overall Study|Withdrawal by Subject|2
3116152|NCT00116272|10670273|P2|Overall Study|Lost to Follow-up|6
3116153|NCT00116272|10670274|P1|Overall Study|Lost to Follow-up|11
3116154|NCT00116168|10670343|P4|Overall Study|Lost to Follow-up|0
3116155|NCT00116168|10670344|P3|Overall Study|Lost to Follow-up|0
3116156|NCT00116168|10670345|P2|Overall Study|Lost to Follow-up|5
3116157|NCT00116168|10670346|P1|Overall Study|Lost to Follow-up|6
3116158|NCT00115934|10670410|P2|Overall Study|Did not receive intervention|2
3116159|NCT00115934|10670411|P1|Overall Study|Did not receive intervention|3
3116160|NCT00115934|10670410|P2|Overall Study|Lost to Follow-up|0
3116161|NCT00115934|10670411|P1|Overall Study|Lost to Follow-up|1
3116162|NCT00115804|10670460|P1|Overall Study|Adverse Event|2
3116163|NCT00115778|10670471|P2|Overall Study|Withdrawal by Subject|1
3116164|NCT00115778|10670472|P1|Overall Study|Withdrawal by Subject|0
3116165|NCT00115765|10670492|P4|Overall Study|Other|2
3116166|NCT00115765|10670493|P3|Overall Study|Other|9
3116167|NCT00115765|10670494|P2|Overall Study|Other|12
3116168|NCT00115765|10670495|P1|Overall Study|Other|6
3116169|NCT00115765|10670492|P4|Overall Study|Lost to Follow-up|1
3116170|NCT00115765|10670493|P3|Overall Study|Lost to Follow-up|18
3116171|NCT00115765|10670494|P2|Overall Study|Lost to Follow-up|20
3116172|NCT00115765|10670495|P1|Overall Study|Lost to Follow-up|3
3116173|NCT00115765|10670492|P4|Overall Study|Physician Decision|13
3116174|NCT00115765|10670493|P3|Overall Study|Physician Decision|18
3116175|NCT00115765|10670494|P2|Overall Study|Physician Decision|15
3116176|NCT00115765|10670495|P1|Overall Study|Physician Decision|4
3116177|NCT00115765|10670492|P4|Overall Study|Withdrawal by Subject|15
3116178|NCT00115765|10670493|P3|Overall Study|Withdrawal by Subject|76
3116179|NCT00115765|10670494|P2|Overall Study|Withdrawal by Subject|53
3116180|NCT00115765|10670495|P1|Overall Study|Withdrawal by Subject|22
3116181|NCT00115739|10670533|P1|Overall Study|Lost to Follow-up|3
3116182|NCT00115349|10670542|P2|Overall Study|Study closed due to low enrollment.|9
3116183|NCT00115349|10670543|P1|Overall Study|Study closed due to low enrollment.|11
3116184|NCT00115063|10670564|P2|Overall Study|Death|0
3116185|NCT00115063|10670565|P1|Overall Study|Death|1
3116186|NCT00115063|10670564|P2|Overall Study|Lost to Follow-up|104
3116187|NCT00115063|10670565|P1|Overall Study|Lost to Follow-up|98
3116188|NCT00115037|10670583|P6|Phase2|Lost to Follow-up|10
3116189|NCT00115037|10670584|P5|Phase2|Lost to Follow-up|4
3116190|NCT00115037|10670585|P4|Phase2|Lost to Follow-up|14
3116191|NCT00115037|10670586|P3|Phase2|Lost to Follow-up|12
3116192|NCT00115037|10670587|P2|Phase2|Lost to Follow-up|0
3116193|NCT00115037|10670588|P1|Phase2|Lost to Follow-up|0
3116194|NCT00115037|10670583|P6|Phase2|Withdrawal by Subject|1
3116195|NCT00115037|10670584|P5|Phase2|Withdrawal by Subject|2
3116196|NCT00115037|10670585|P4|Phase2|Withdrawal by Subject|1
3116197|NCT00115037|10670586|P3|Phase2|Withdrawal by Subject|2
3116198|NCT00115037|10670587|P2|Phase2|Withdrawal by Subject|0
3116199|NCT00115037|10670588|P1|Phase2|Withdrawal by Subject|0
3116200|NCT00115037|10670583|P6|Phase2|Death|1
3116201|NCT00115037|10670584|P5|Phase2|Death|0
3116202|NCT00115037|10670585|P4|Phase2|Death|0
3116203|NCT00115037|10670586|P3|Phase2|Death|1
3116204|NCT00115037|10670587|P2|Phase2|Death|0
3116205|NCT00115037|10670588|P1|Phase2|Death|0
3116206|NCT00115037|10670583|P6|Phase1|Withdrawal by Subject|0
3116207|NCT00115037|10670584|P5|Phase1|Withdrawal by Subject|0
3116208|NCT00115037|10670585|P4|Phase1|Withdrawal by Subject|0
3116209|NCT00115037|10670586|P3|Phase1|Withdrawal by Subject|0
3116210|NCT00115037|10670587|P2|Phase1|Withdrawal by Subject|4
3116211|NCT00115037|10670588|P1|Phase1|Withdrawal by Subject|9
3116212|NCT00115037|10670583|P6|Phase1|Lost to Follow-up|0
3116213|NCT00115037|10670584|P5|Phase1|Lost to Follow-up|0
3116214|NCT00115037|10670585|P4|Phase1|Lost to Follow-up|0
3116215|NCT00115037|10670586|P3|Phase1|Lost to Follow-up|0
3116216|NCT00115037|10670587|P2|Phase1|Lost to Follow-up|23
3116217|NCT00115037|10670588|P1|Phase1|Lost to Follow-up|16
3116218|NCT00114972|10670604|P2|Overall Study|Lost to Follow-up|5
3116219|NCT00114972|10670605|P1|Overall Study|Lost to Follow-up|8
3116220|NCT00114972|10670604|P2|Overall Study|Withdrawal by Subject|7
3116221|NCT00114972|10670605|P1|Overall Study|Withdrawal by Subject|40
3116222|NCT00114959|10670625|P1|Overall Study|Death|1
3116223|NCT00114959|10670625|P1|Overall Study|Physician Decision|1
3116224|NCT00114959|10670625|P1|Overall Study|Lack of Efficacy|6
3116225|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Other|2
3116226|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Other|0
3116227|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Other|2
3116228|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
3116229|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
3116230|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
3116231|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
3116232|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
3116233|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
3116234|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
3116235|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
3116236|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
3116237|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Adverse Event|7
3116238|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Adverse Event|14
3116239|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Adverse Event|15
3116240|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
3116241|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
3116242|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
3116243|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
3116244|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
3116245|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
3116246|NCT00114777|10670635|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
3116247|NCT00114777|10670636|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
3116248|NCT00114777|10670637|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
3116249|NCT00114777|10670635|P3|Long-Term Extension to Month 84|Death|7
3116250|NCT00114777|10670636|P2|Long-Term Extension to Month 84|Death|13
3116251|NCT00114777|10670637|P1|Long-Term Extension to Month 84|Death|8
3116252|NCT00114777|10670635|P3|Randomization to Month 36|Other|12
3116253|NCT00114777|10670636|P2|Randomization to Month 36|Other|3
3116254|NCT00114777|10670637|P1|Randomization to Month 36|Other|9
3116255|NCT00114777|10670635|P3|Randomization to Month 36|Withdrawal by Subject|5
3116256|NCT00114777|10670636|P2|Randomization to Month 36|Withdrawal by Subject|4
3116257|NCT00114777|10670637|P1|Randomization to Month 36|Withdrawal by Subject|3
3116258|NCT00114777|10670635|P3|Randomization to Month 36|Adverse Event|44
3116259|NCT00114777|10670636|P2|Randomization to Month 36|Adverse Event|35
3116260|NCT00114777|10670637|P1|Randomization to Month 36|Adverse Event|34
3116261|NCT00114777|10670635|P3|Randomization to Month 36|Poor or Non-Compliance|1
3116262|NCT00114777|10670636|P2|Randomization to Month 36|Poor or Non-Compliance|0
3116263|NCT00114777|10670637|P1|Randomization to Month 36|Poor or Non-Compliance|0
3116264|NCT00114777|10670635|P3|Randomization to Month 36|Lack of Efficacy|17
3116265|NCT00114777|10670636|P2|Randomization to Month 36|Lack of Efficacy|15
3116266|NCT00114777|10670637|P1|Randomization to Month 36|Lack of Efficacy|19
3116267|NCT00114777|10670635|P3|Randomization to Month 36|No Longer Met Study Criteria|2
3116268|NCT00114777|10670636|P2|Randomization to Month 36|No Longer Met Study Criteria|0
3116269|NCT00114777|10670637|P1|Randomization to Month 36|No Longer Met Study Criteria|0
3116270|NCT00114777|10670635|P3|Randomization to Month 36|Death|3
3116271|NCT00114777|10670636|P2|Randomization to Month 36|Death|4
3116272|NCT00114777|10670637|P1|Randomization to Month 36|Death|10
3116273|NCT00114738|10670711|P3|Screening for Randomization|Other|0
3116274|NCT00114738|10670712|P2|Screening for Randomization|Other|0
3116275|NCT00114738|10670713|P1|Screening for Randomization|Other|1
3116276|NCT00114738|10670711|P3|Screening for Randomization|CNS Hemorrhage|0
3116277|NCT00114738|10670712|P2|Screening for Randomization|CNS Hemorrhage|0
3116278|NCT00114738|10670713|P1|Screening for Randomization|CNS Hemorrhage|1
3116279|NCT00114738|10670711|P3|Screening for Randomization|Progressive disease|0
3116280|NCT00114738|10670712|P2|Screening for Randomization|Progressive disease|0
3116281|NCT00114738|10670713|P1|Screening for Randomization|Progressive disease|2
3116282|NCT00114738|10670711|P3|Screening for Randomization|Neuropathy|0
3116283|NCT00114738|10670712|P2|Screening for Randomization|Neuropathy|0
3116284|NCT00114738|10670713|P1|Screening for Randomization|Neuropathy|17
3116285|NCT00114738|10670711|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
3116286|NCT00114738|10670712|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
3116287|NCT00114738|10670713|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
3116288|NCT00114738|10670711|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
3116289|NCT00114738|10670712|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
3116290|NCT00114738|10670713|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
3116291|NCT00114634|10670726|P1|Overall Study|failure to return forms|3
3116292|NCT00114530|10670742|P2|Overall Study|Ineligible|0
3116293|NCT00114530|10670743|P1|Overall Study|Ineligible|1
3116294|NCT00114530|10670742|P2|Overall Study|Subject decision after endpoint failure|1
3116295|NCT00114530|10670743|P1|Overall Study|Subject decision after endpoint failure|0
3116296|NCT00114530|10670742|P2|Overall Study|Breast Cancer|0
3116297|NCT00114530|10670743|P1|Overall Study|Breast Cancer|1
3116298|NCT00114530|10670742|P2|Overall Study|Withdrawal by Subject|6
3116299|NCT00114530|10670743|P1|Overall Study|Withdrawal by Subject|2
3116300|NCT00114530|10670742|P2|Overall Study|Physician Decision|1
3116301|NCT00114530|10670743|P1|Overall Study|Physician Decision|1
3116302|NCT00114530|10670742|P2|Overall Study|Lost to Follow-up|1
3116303|NCT00114530|10670743|P1|Overall Study|Lost to Follow-up|1
3116304|NCT00114530|10670742|P2|Overall Study|Death|11
3116305|NCT00114530|10670743|P1|Overall Study|Death|3
3116306|NCT00114244|10670880|P2|Overall Study|Withdrawal by Subject|2
3116307|NCT00114244|10670881|P1|Overall Study|Withdrawal by Subject|0
3116308|NCT00114244|10670880|P2|Overall Study|Adverse Event|5
3116309|NCT00114244|10670881|P1|Overall Study|Adverse Event|2
3116310|NCT00114231|10670893|P2|Overall Study|Biopsy done after registration|0
3116311|NCT00114231|10670894|P1|Overall Study|Biopsy done after registration|1
3116312|NCT00114231|10670893|P2|Overall Study|No Absolute Neutrophil Count|0
3116313|NCT00114231|10670894|P1|Overall Study|No Absolute Neutrophil Count|2
3116314|NCT00114231|10670893|P2|Overall Study|Tumor fixed on digital exam|1
3116315|NCT00114231|10670894|P1|Overall Study|Tumor fixed on digital exam|0
3116316|NCT00114231|10670893|P2|Overall Study|Tumor size > 4cm|0
3116317|NCT00114231|10670894|P1|Overall Study|Tumor size > 4cm|1
3116318|NCT00114231|10670893|P2|Overall Study|Low creatinine clearance|1
3116319|NCT00114231|10670894|P1|Overall Study|Low creatinine clearance|0
3116320|NCT00114231|10670893|P2|Overall Study|No adenocarcinoma|0
3116321|NCT00114231|10670894|P1|Overall Study|No adenocarcinoma|1
3116322|NCT00114231|10670893|P2|Overall Study|Suspected metastatic disease|0
3116323|NCT00114231|10670894|P1|Overall Study|Suspected metastatic disease|1
3116324|NCT00114231|10670893|P2|Overall Study|QARC requirement not met|0
3116325|NCT00114231|10670894|P1|Overall Study|QARC requirement not met|1
3116326|NCT00114231|10670893|P2|Overall Study|No consent|0
3116327|NCT00114231|10670894|P1|Overall Study|No consent|2
3116328|NCT00114218|10670903|P1|Overall Study|Never Treated|1
3116329|NCT00114218|10670903|P1|Overall Study|Wrong Primary|1
3116330|NCT00114218|10670903|P1|Overall Study|Wrong Cell Type|2
3116331|NCT00114166|10670910|P2|Overall Study|Wrong primary|1
3116332|NCT00114166|10670911|P1|Overall Study|Wrong primary|0
3116333|NCT00114140|10670921|P1|Overall Study|Protocol Violation|7
3116334|NCT00114127|10670935|P2|Overall Study|Withdrawal by Subject|3
3116335|NCT00114127|10670936|P1|Overall Study|Withdrawal by Subject|1
3116336|NCT00114127|10670935|P2|Overall Study|Lost to Follow-up|0
3116337|NCT00114127|10670936|P1|Overall Study|Lost to Follow-up|1
3116338|NCT00114127|10670935|P2|Overall Study|Adverse Event|1
3116339|NCT00114127|10670936|P1|Overall Study|Adverse Event|2
3116340|NCT00113919|10671008|P1|Overall Study|Death|6
3116341|NCT00113919|10671008|P1|Overall Study|Physician Decision|8
3116342|NCT00113841|10671076|P2|Overall Study|Non-compliant|0
3116343|NCT00113841|10671077|P1|Overall Study|Non-compliant|1
3116344|NCT00113841|10671076|P2|Overall Study|Disease progression|2
3116345|NCT00113841|10671077|P1|Overall Study|Disease progression|0
3116346|NCT00113763|10671085|P2|Overall Study|Ongoing|0
3116347|NCT00113763|10671086|P1|Overall Study|Ongoing|1
3116348|NCT00113763|10671085|P2|Overall Study|Non-compliance|0
3116349|NCT00113763|10671086|P1|Overall Study|Non-compliance|1
3116350|NCT00113763|10671085|P2|Overall Study|Other|6
3116351|NCT00113763|10671086|P1|Overall Study|Other|27
3116352|NCT00113763|10671085|P2|Overall Study|Withdrawal by Subject|4
3116353|NCT00113763|10671086|P1|Overall Study|Withdrawal by Subject|1
3116354|NCT00113763|10671085|P2|Overall Study|Lost to Follow-up|0
3116355|NCT00113763|10671086|P1|Overall Study|Lost to Follow-up|10
3116356|NCT00113763|10671085|P2|Overall Study|Disease Progression|14
3116357|NCT00113763|10671086|P1|Overall Study|Disease Progression|28
3116358|NCT00113763|10671085|P2|Overall Study|Adverse Event|2
3116359|NCT00113763|10671086|P1|Overall Study|Adverse Event|5
3116360|NCT00113607|10671112|P2|Overall Study|Other|32
3116361|NCT00113607|10671113|P1|Overall Study|Other|43
3116362|NCT00113607|10671112|P2|Overall Study|Complete Response (Confirmed)|24
3116363|NCT00113607|10671113|P1|Overall Study|Complete Response (Confirmed)|14
3116364|NCT00113607|10671112|P2|Overall Study|Disease Progression|142
3116365|NCT00113607|10671113|P1|Overall Study|Disease Progression|180
3116366|NCT00113607|10671112|P2|Overall Study|Lost to Follow-up|2
3116367|NCT00113607|10671113|P1|Overall Study|Lost to Follow-up|0
3116368|NCT00113607|10671112|P2|Overall Study|Withdrawal by Subject|58
3116369|NCT00113607|10671113|P1|Overall Study|Withdrawal by Subject|50
3116370|NCT00113607|10671112|P2|Overall Study|Death|8
3116371|NCT00113607|10671113|P1|Overall Study|Death|8
3116372|NCT00113607|10671112|P2|Overall Study|Adverse Event|71
3116373|NCT00113607|10671113|P1|Overall Study|Adverse Event|40
3116374|NCT00113568|10671127|P1|Overall Study|Other|112
3116375|NCT00113568|10671127|P1|Overall Study|Withdrawal by Subject|117
3116376|NCT00113568|10671127|P1|Overall Study|Protocol Violation|32
3116377|NCT00113568|10671127|P1|Overall Study|Lost to Follow-up|156
3116378|NCT00113568|10671127|P1|Overall Study|Lack of Efficacy|30
3116379|NCT00113568|10671127|P1|Overall Study|Death|1
3116380|NCT00113568|10671127|P1|Overall Study|Adverse Event|97
3116381|NCT00113555|10671139|P1|Overall Study|Lost to Follow-up|8
3116382|NCT00113555|10671139|P1|Overall Study|Missed Followup|4
3116383|NCT00113555|10671139|P1|Overall Study|Death|1
3116384|NCT00113555|10671139|P1|Overall Study|Permanently Explanted|7
3116385|NCT00113555|10671139|P1|Overall Study|Baseline Failure|59
3116386|NCT00113529|10671149|P1|Overall Study|Withdrawal by Subject|4
3116387|NCT00113529|10671149|P1|Overall Study|Decision of sponsor|6
3116388|NCT00113529|10671149|P1|Overall Study|Lack of Efficacy|20
3116389|NCT00113529|10671149|P1|Overall Study|Adverse Event|4
3116390|NCT00113516|10671182|P2|Part 2|Ongoing|1
3116391|NCT00113516|10671183|P1|Part 2|Ongoing|0
3116392|NCT00113516|10671182|P2|Part 2|Laboratory Abnormality|1
3116393|NCT00113516|10671183|P1|Part 2|Laboratory Abnormality|0
3116394|NCT00113516|10671182|P2|Part 2|Other|3
3116395|NCT00113516|10671183|P1|Part 2|Other|0
3116396|NCT00113516|10671182|P2|Part 2|Withdrawal by Subject|3
3116397|NCT00113516|10671183|P1|Part 2|Withdrawal by Subject|0
3116398|NCT00113516|10671182|P2|Part 2|Lack of Efficacy|37
3116399|NCT00113516|10671183|P1|Part 2|Lack of Efficacy|0
3116400|NCT00113516|10671182|P2|Part 2|Death|5
3116401|NCT00113516|10671183|P1|Part 2|Death|0
3116402|NCT00113516|10671182|P2|Part 2|Adverse Event|16
3116403|NCT00113516|10671183|P1|Part 2|Adverse Event|0
3116404|NCT00113516|10671182|P2|Part 1|Missing|0
3116405|NCT00113516|10671183|P1|Part 1|Missing|65
3116406|NCT00113516|10671182|P2|Part 1|Ongoing|0
3116407|NCT00113516|10671183|P1|Part 1|Ongoing|1
3116408|NCT00113516|10671182|P2|Part 1|Laboratory Abnormality|0
3116409|NCT00113516|10671183|P1|Part 1|Laboratory Abnormality|1
3116410|NCT00113516|10671182|P2|Part 1|Did Not Meet Entrance Criteria|0
3116411|NCT00113516|10671183|P1|Part 1|Did Not Meet Entrance Criteria|1
3116412|NCT00113516|10671182|P2|Part 1|Lack of Efficacy|0
3116413|NCT00113516|10671183|P1|Part 1|Lack of Efficacy|2
3116414|NCT00113516|10671182|P2|Part 1|Withdrawal by Subject|0
3116415|NCT00113516|10671183|P1|Part 1|Withdrawal by Subject|2
3116416|NCT00113516|10671182|P2|Part 1|Other|0
3116417|NCT00113516|10671183|P1|Part 1|Other|3
3116418|NCT00113516|10671182|P2|Part 1|Death|0
3116419|NCT00113516|10671183|P1|Part 1|Death|3
3116420|NCT00113516|10671182|P2|Part 1|Adverse Event|0
3116421|NCT00113516|10671183|P1|Part 1|Adverse Event|6
3116422|NCT00113490|10671226|P2|Overall Study|Lost to Follow-up|0
3116423|NCT00113490|10671227|P1|Overall Study|Lost to Follow-up|1
3116424|NCT00113490|10671226|P2|Overall Study|Withdrawal by Subject|3
3116425|NCT00113490|10671227|P1|Overall Study|Withdrawal by Subject|1
3116426|NCT00113399|10671260|P2|Overall Study|Other|1
3116427|NCT00113399|10671261|P1|Overall Study|Other|0
3116428|NCT00113399|10671260|P2|Overall Study|Complete Response|1
3116429|NCT00113399|10671261|P1|Overall Study|Complete Response|0
3116430|NCT00113399|10671260|P2|Overall Study|Withdrawal by Subject|2
3116431|NCT00113399|10671261|P1|Overall Study|Withdrawal by Subject|1
3116432|NCT00113399|10671260|P2|Overall Study|Death|1
3116433|NCT00113399|10671261|P1|Overall Study|Death|1
3116434|NCT00113386|10671269|P2|Overall Study|Unknown - Lost to Follow-Up|1
3116435|NCT00113386|10671270|P1|Overall Study|Unknown - Lost to Follow-Up|2
3116436|NCT00113386|10671269|P2|Overall Study|Ineligible|2
3116437|NCT00113386|10671270|P1|Overall Study|Ineligible|1
3116438|NCT00113386|10671269|P2|Overall Study|Toxicity|0
3116439|NCT00113386|10671270|P1|Overall Study|Toxicity|3
3116440|NCT00113386|10671269|P2|Overall Study|Physician Decision|1
3116441|NCT00113386|10671270|P1|Overall Study|Physician Decision|0
3116442|NCT00113386|10671269|P2|Overall Study|Withdrawal by Subject|0
3116443|NCT00113386|10671270|P1|Overall Study|Withdrawal by Subject|1
3116444|NCT00113373|10671276|P1|Overall Study|Never Treated|1
3116445|NCT00113373|10671276|P1|Overall Study|Ineligible: second primary|1
3116446|NCT00113373|10671276|P1|Overall Study|Ineligible: wrong primary|1
3116447|NCT00113360|10671291|P1|Overall Study|Did not meet eligibility criteria|3
3116448|NCT00113360|10671291|P1|Overall Study|Subject required surgery|1
3116449|NCT00113360|10671291|P1|Overall Study|Adverse Event|3
3116450|NCT00113295|10671305|P2|Overall Study|Unrelated Medical Illness|0
3116451|NCT00113295|10671306|P1|Overall Study|Unrelated Medical Illness|1
3116452|NCT00113295|10671305|P2|Overall Study|Adverse Event|1
3116453|NCT00113295|10671306|P1|Overall Study|Adverse Event|4
3116454|NCT00113269|10671325|P4|Overall Study|Unable to return for follow up|0
3116455|NCT00113269|10671326|P3|Overall Study|Unable to return for follow up|0
3116456|NCT00113269|10671327|P2|Overall Study|Unable to return for follow up|1
3116457|NCT00113269|10671328|P1|Overall Study|Unable to return for follow up|2
3116458|NCT00113269|10671325|P4|Overall Study|Did not meet eligibility criteria|1
3116459|NCT00113269|10671326|P3|Overall Study|Did not meet eligibility criteria|0
3116460|NCT00113269|10671327|P2|Overall Study|Did not meet eligibility criteria|0
3116461|NCT00113269|10671328|P1|Overall Study|Did not meet eligibility criteria|1
3116462|NCT00113269|10671325|P4|Overall Study|Withdrew consent, Prednisone initiated|1
3116463|NCT00113269|10671326|P3|Overall Study|Withdrew consent, Prednisone initiated|0
3116464|NCT00113269|10671327|P2|Overall Study|Withdrew consent, Prednisone initiated|0
3116465|NCT00113269|10671328|P1|Overall Study|Withdrew consent, Prednisone initiated|0
3116466|NCT00113269|10671325|P4|Overall Study|Received pancreas transplant|2
3116467|NCT00113269|10671326|P3|Overall Study|Received pancreas transplant|0
3116468|NCT00113269|10671327|P2|Overall Study|Received pancreas transplant|0
3116469|NCT00113269|10671328|P1|Overall Study|Received pancreas transplant|0
3116470|NCT00113269|10671325|P4|Overall Study|Moved|3
3116471|NCT00113269|10671326|P3|Overall Study|Moved|0
3116472|NCT00113269|10671327|P2|Overall Study|Moved|1
3116473|NCT00113269|10671328|P1|Overall Study|Moved|0
3116474|NCT00113269|10671325|P4|Overall Study|Discontinued due to rejection|0
3116475|NCT00113269|10671326|P3|Overall Study|Discontinued due to rejection|1
3116476|NCT00113269|10671327|P2|Overall Study|Discontinued due to rejection|0
3116477|NCT00113269|10671328|P1|Overall Study|Discontinued due to rejection|0
3116478|NCT00113269|10671325|P4|Overall Study|Sponsor elected to discontinue patient|1
3116479|NCT00113269|10671326|P3|Overall Study|Sponsor elected to discontinue patient|0
3116480|NCT00113269|10671327|P2|Overall Study|Sponsor elected to discontinue patient|0
3116481|NCT00113269|10671328|P1|Overall Study|Sponsor elected to discontinue patient|1
3116482|NCT00113269|10671325|P4|Overall Study|Lost to Follow-up|3
3116483|NCT00113269|10671326|P3|Overall Study|Lost to Follow-up|6
3116484|NCT00113269|10671327|P2|Overall Study|Lost to Follow-up|3
3116485|NCT00113269|10671328|P1|Overall Study|Lost to Follow-up|2
3116486|NCT00113269|10671325|P4|Overall Study|Protocol Violation|2
3116487|NCT00113269|10671326|P3|Overall Study|Protocol Violation|4
3116488|NCT00113269|10671327|P2|Overall Study|Protocol Violation|0
3116489|NCT00113269|10671328|P1|Overall Study|Protocol Violation|1
3116490|NCT00113269|10671325|P4|Overall Study|Graft loss|9
3116491|NCT00113269|10671326|P3|Overall Study|Graft loss|4
3116492|NCT00113269|10671327|P2|Overall Study|Graft loss|6
3116493|NCT00113269|10671328|P1|Overall Study|Graft loss|6
3116494|NCT00113269|10671325|P4|Overall Study|Withdrawal by Subject|2
3116495|NCT00113269|10671326|P3|Overall Study|Withdrawal by Subject|4
3116496|NCT00113269|10671327|P2|Overall Study|Withdrawal by Subject|3
3116497|NCT00113269|10671328|P1|Overall Study|Withdrawal by Subject|4
3116498|NCT00113269|10671325|P4|Overall Study|Adverse Event|7
3116499|NCT00113269|10671326|P3|Overall Study|Adverse Event|11
3116500|NCT00113269|10671327|P2|Overall Study|Adverse Event|7
3116501|NCT00113269|10671328|P1|Overall Study|Adverse Event|2
3116502|NCT00113269|10671325|P4|Overall Study|Did not meet eligibility – pre-treatment|2
3116503|NCT00113269|10671326|P3|Overall Study|Did not meet eligibility – pre-treatment|0
3116504|NCT00113269|10671327|P2|Overall Study|Did not meet eligibility – pre-treatment|0
3116505|NCT00113269|10671328|P1|Overall Study|Did not meet eligibility – pre-treatment|0
3116506|NCT00113269|10671325|P4|Overall Study|Death in operating room|1
3116507|NCT00113269|10671326|P3|Overall Study|Death in operating room|0
3116508|NCT00113269|10671327|P2|Overall Study|Death in operating room|0
3116509|NCT00113269|10671328|P1|Overall Study|Death in operating room|0
3116510|NCT00113269|10671325|P4|Overall Study|Early graft loss, technical|0
3116511|NCT00113269|10671326|P3|Overall Study|Early graft loss, technical|2
3116512|NCT00113269|10671327|P2|Overall Study|Early graft loss, technical|0
3116513|NCT00113269|10671328|P1|Overall Study|Early graft loss, technical|0
3116514|NCT00113269|10671325|P4|Overall Study|Not transplanted, recipient issues|4
3116515|NCT00113269|10671326|P3|Overall Study|Not transplanted, recipient issues|7
3116516|NCT00113269|10671327|P2|Overall Study|Not transplanted, recipient issues|1
3116517|NCT00113269|10671328|P1|Overall Study|Not transplanted, recipient issues|2
3116518|NCT00113269|10671325|P4|Overall Study|Not transplanted, donor issues|2
3116519|NCT00113269|10671326|P3|Overall Study|Not transplanted, donor issues|2
3116520|NCT00113269|10671327|P2|Overall Study|Not transplanted, donor issues|0
3116521|NCT00113269|10671328|P1|Overall Study|Not transplanted, donor issues|4
3116522|NCT00113087|10671388|P2|Overall Study|Family or MD withdrew subject|5
3116523|NCT00113087|10671389|P1|Overall Study|Family or MD withdrew subject|10
3116524|NCT00113087|10671388|P2|Overall Study|Death or Transplant|16
3116525|NCT00113087|10671389|P1|Overall Study|Death or Transplant|14
3116526|NCT00112957|10671460|P1|Overall Study|Physician Decision|1
3116527|NCT00112957|10671460|P1|Overall Study|Progressive disease|18
3116528|NCT00112905|10671500|P1|Overall Study|performance status was deteiorating|1
3116529|NCT00112905|10671500|P1|Overall Study|Alternative treatment|1
3116530|NCT00112905|10671500|P1|Overall Study|Ineligibility|5
3116531|NCT00112905|10671500|P1|Overall Study|Death|1
3116532|NCT00112905|10671500|P1|Overall Study|Adverse Event|4
3116533|NCT00112866|10671509|P2|Overall Study|did not start treatment post-op|2
3116534|NCT00112866|10671510|P1|Overall Study|did not start treatment post-op|1
3116535|NCT00112866|10671509|P2|Overall Study|Protocol Violation|0
3116536|NCT00112866|10671510|P1|Overall Study|Protocol Violation|1
3116537|NCT00112840|10671532|P3|Overall Study|Protocol Violation|5
3116538|NCT00112840|10671533|P2|Overall Study|Protocol Violation|0
3116539|NCT00112840|10671534|P1|Overall Study|Protocol Violation|0
3116540|NCT00112840|10671532|P3|Overall Study|Withdrawal by Subject|1
3116541|NCT00112840|10671533|P2|Overall Study|Withdrawal by Subject|0
3116542|NCT00112840|10671534|P1|Overall Study|Withdrawal by Subject|1
3116543|NCT00112840|10671532|P3|Overall Study|Physician Decision|0
3116544|NCT00112840|10671533|P2|Overall Study|Physician Decision|0
3116545|NCT00112840|10671534|P1|Overall Study|Physician Decision|1
3116546|NCT00112736|10671553|P2|Overall Study|1 pt never had had RX due rapid decline|0
3116547|NCT00112736|10671554|P1|Overall Study|1 pt never had had RX due rapid decline|1
3116548|NCT00112489|10671611|P1|Overall Study|Ineligible|7
3116549|NCT00112489|10671611|P1|Overall Study|Patient never treated|2
3116550|NCT00112489|10671611|P1|Overall Study|Other, Not Specified|9
3116551|NCT00112489|10671611|P1|Overall Study|Death|2
3116552|NCT00112489|10671611|P1|Overall Study|Adverse Event|12
3116553|NCT00112489|10671611|P1|Overall Study|Refused further treatment|8
3116554|NCT00112463|10671621|P1|Overall Study|Never started treatment|2
3116555|NCT00112463|10671621|P1|Overall Study|Withdrawal by Subject|2
3116556|NCT00112463|10671621|P1|Overall Study|Toxicity|3
3116557|NCT00112463|10671621|P1|Overall Study|Second Primary|1
3116558|NCT00112463|10671621|P1|Overall Study|Progression|30
3116559|NCT00112463|10671621|P1|Overall Study|Physician Decision|1
3116560|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
3116561|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116562|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
3116563|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
3116564|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116565|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116566|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116567|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116568|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116569|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116570|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116571|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116572|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116573|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116574|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116575|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116576|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116577|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116578|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116579|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116580|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116581|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116582|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116583|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116584|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116585|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
3116586|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
3116587|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
3116588|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
3116589|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
3116590|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
3116591|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
3116592|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
3116593|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
3116594|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
3116595|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
3116596|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
3116597|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
3116598|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
3116599|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
3116600|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
3116601|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
3116602|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
3116603|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
3116604|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
3116605|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
3116606|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
3116607|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
3116608|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
3116609|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
3116610|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
3116611|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
3116612|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Other|0
3116613|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Other|1
3116614|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Other|0
3116615|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Other|0
3116616|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Other|0
3116617|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Other|0
3116618|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Other|0
3116619|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Other|0
3116620|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Other|0
3116621|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Other|0
3116622|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Other|0
3116623|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Other|0
3116624|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Other|0
3116625|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Other|0
3116626|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Other|0
3116627|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Other|0
3116628|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Other|0
3116629|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Other|0
3116630|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Other|0
3116631|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Other|0
3116632|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Other|0
3116633|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Other|0
3116634|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Other|0
3116635|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Other|0
3116636|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Other|0
3116637|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Other|0
3116638|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
3116639|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116640|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116641|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116642|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116643|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116644|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116645|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116646|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116647|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116648|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116649|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116650|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116651|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116652|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116653|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116654|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116655|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116656|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116657|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116658|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116659|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116660|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116661|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116662|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116663|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
3116664|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Death|0
3116665|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Death|0
3116666|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Death|2
3116667|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Death|0
3116668|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Death|0
3116669|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Death|0
3116670|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Death|0
3116671|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Death|0
3116672|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Death|0
3116673|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Death|0
3116674|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Death|0
3116675|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Death|0
3116676|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Death|0
3116677|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Death|0
3116678|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Death|0
3116679|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Death|0
3116680|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Death|0
3116681|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Death|0
3116682|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Death|0
3116683|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Death|0
3116684|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Death|0
3116685|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Death|0
3116686|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Death|0
3116687|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Death|0
3116688|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Death|0
3116689|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Death|0
3116690|NCT00112437|10671633|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
3116691|NCT00112437|10671634|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
3116692|NCT00112437|10671635|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
3116693|NCT00112437|10671636|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
3116694|NCT00112437|10671637|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
3116695|NCT00112437|10671638|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
3116696|NCT00112437|10671639|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
3116697|NCT00112437|10671640|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
3116698|NCT00112437|10671641|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
3116699|NCT00112437|10671642|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
3116700|NCT00112437|10671643|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
3116701|NCT00112437|10671644|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
3116702|NCT00112437|10671645|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
3116703|NCT00112437|10671646|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
3116704|NCT00112437|10671647|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
3116705|NCT00112437|10671648|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
3116706|NCT00112437|10671649|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
3116707|NCT00112437|10671650|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
3116708|NCT00112437|10671651|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
3116709|NCT00112437|10671652|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
3116710|NCT00112437|10671653|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
3116711|NCT00112437|10671654|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
3116712|NCT00112437|10671655|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
3116713|NCT00112437|10671656|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
3116714|NCT00112437|10671657|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
3116715|NCT00112437|10671658|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
3116716|NCT00112437|10671633|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116717|NCT00112437|10671634|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116718|NCT00112437|10671635|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116719|NCT00112437|10671636|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116720|NCT00112437|10671637|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
3116721|NCT00112437|10671638|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
3116722|NCT00112437|10671639|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116723|NCT00112437|10671640|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116724|NCT00112437|10671641|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116725|NCT00112437|10671642|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116726|NCT00112437|10671643|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116727|NCT00112437|10671644|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116728|NCT00112437|10671645|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116729|NCT00112437|10671646|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116730|NCT00112437|10671647|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116731|NCT00112437|10671648|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116732|NCT00112437|10671649|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116733|NCT00112437|10671650|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116734|NCT00112437|10671651|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116735|NCT00112437|10671652|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116736|NCT00112437|10671653|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116737|NCT00112437|10671654|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116738|NCT00112437|10671655|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116739|NCT00112437|10671656|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116740|NCT00112437|10671657|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116741|NCT00112437|10671658|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
3116742|NCT00112437|10671633|P26|Years 4-5 (24-Month Extension)|Participant moved|0
3116743|NCT00112437|10671634|P25|Years 4-5 (24-Month Extension)|Participant moved|0
3116744|NCT00112437|10671635|P24|Years 4-5 (24-Month Extension)|Participant moved|0
3116745|NCT00112437|10671636|P23|Years 4-5 (24-Month Extension)|Participant moved|0
3116746|NCT00112437|10671637|P22|Years 4-5 (24-Month Extension)|Participant moved|1
3116747|NCT00112437|10671638|P21|Years 4-5 (24-Month Extension)|Participant moved|0
3116748|NCT00112437|10671639|P20|Years 4-5 (24-Month Extension)|Participant moved|0
3116749|NCT00112437|10671640|P19|Years 4-5 (24-Month Extension)|Participant moved|0
3116750|NCT00112437|10671641|P18|Years 4-5 (24-Month Extension)|Participant moved|0
3116751|NCT00112437|10671642|P17|Years 4-5 (24-Month Extension)|Participant moved|0
3116752|NCT00112437|10671643|P16|Years 4-5 (24-Month Extension)|Participant moved|0
3116753|NCT00112437|10671644|P15|Years 4-5 (24-Month Extension)|Participant moved|0
3116754|NCT00112437|10671645|P14|Years 4-5 (24-Month Extension)|Participant moved|0
3116755|NCT00112437|10671646|P13|Years 4-5 (24-Month Extension)|Participant moved|0
3116756|NCT00112437|10671647|P12|Years 4-5 (24-Month Extension)|Participant moved|0
3116757|NCT00112437|10671648|P11|Years 4-5 (24-Month Extension)|Participant moved|0
3116758|NCT00112437|10671649|P10|Years 4-5 (24-Month Extension)|Participant moved|0
3116759|NCT00112437|10671650|P9|Years 4-5 (24-Month Extension)|Participant moved|0
3116760|NCT00112437|10671651|P8|Years 4-5 (24-Month Extension)|Participant moved|0
3116761|NCT00112437|10671652|P7|Years 4-5 (24-Month Extension)|Participant moved|0
3116762|NCT00112437|10671653|P6|Years 4-5 (24-Month Extension)|Participant moved|0
3116763|NCT00112437|10671654|P5|Years 4-5 (24-Month Extension)|Participant moved|0
3116764|NCT00112437|10671655|P4|Years 4-5 (24-Month Extension)|Participant moved|0
3116765|NCT00112437|10671656|P3|Years 4-5 (24-Month Extension)|Participant moved|0
3116766|NCT00112437|10671657|P2|Years 4-5 (24-Month Extension)|Participant moved|0
3116767|NCT00112437|10671658|P1|Years 4-5 (24-Month Extension)|Participant moved|0
3116768|NCT00112437|10671633|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
3116769|NCT00112437|10671634|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
3116770|NCT00112437|10671635|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
3116771|NCT00112437|10671636|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
3116772|NCT00112437|10671637|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
3116773|NCT00112437|10671638|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
3116774|NCT00112437|10671639|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
3116775|NCT00112437|10671640|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
3116776|NCT00112437|10671641|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
3116777|NCT00112437|10671642|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
3116778|NCT00112437|10671643|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
3116779|NCT00112437|10671644|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
3116780|NCT00112437|10671645|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
3116781|NCT00112437|10671646|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
3116782|NCT00112437|10671647|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
3116783|NCT00112437|10671648|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
3116784|NCT00112437|10671649|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
3116785|NCT00112437|10671650|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
3116786|NCT00112437|10671651|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
3116787|NCT00112437|10671652|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
3116788|NCT00112437|10671653|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
3116789|NCT00112437|10671654|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
3116790|NCT00112437|10671655|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
3116791|NCT00112437|10671656|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
3116792|NCT00112437|10671657|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
3116793|NCT00112437|10671658|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
3116794|NCT00112437|10671633|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116795|NCT00112437|10671634|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116796|NCT00112437|10671635|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116797|NCT00112437|10671636|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116798|NCT00112437|10671637|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116799|NCT00112437|10671638|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
3116800|NCT00112437|10671639|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116801|NCT00112437|10671640|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116802|NCT00112437|10671641|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116803|NCT00112437|10671642|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116804|NCT00112437|10671643|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116805|NCT00112437|10671644|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116806|NCT00112437|10671645|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116807|NCT00112437|10671646|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116808|NCT00112437|10671647|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116809|NCT00112437|10671648|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116810|NCT00112437|10671649|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116811|NCT00112437|10671650|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116812|NCT00112437|10671651|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116813|NCT00112437|10671652|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116814|NCT00112437|10671653|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116815|NCT00112437|10671654|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116816|NCT00112437|10671655|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116817|NCT00112437|10671656|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116818|NCT00112437|10671657|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116819|NCT00112437|10671658|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
3116820|NCT00112437|10671633|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116821|NCT00112437|10671634|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116822|NCT00112437|10671635|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116823|NCT00112437|10671636|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116824|NCT00112437|10671637|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
3116825|NCT00112437|10671638|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
3116826|NCT00112437|10671639|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116827|NCT00112437|10671640|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116828|NCT00112437|10671641|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116829|NCT00112437|10671642|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116830|NCT00112437|10671643|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116831|NCT00112437|10671644|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116832|NCT00112437|10671645|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116833|NCT00112437|10671646|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116834|NCT00112437|10671647|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116835|NCT00112437|10671648|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116836|NCT00112437|10671649|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116837|NCT00112437|10671650|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116838|NCT00112437|10671651|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116839|NCT00112437|10671652|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116840|NCT00112437|10671653|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116841|NCT00112437|10671654|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116842|NCT00112437|10671655|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116843|NCT00112437|10671656|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116844|NCT00112437|10671657|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116845|NCT00112437|10671658|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
3116846|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116847|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116848|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116849|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116850|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116851|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116852|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116853|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116854|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116855|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116856|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116857|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116858|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116859|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116860|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
3116861|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
3116862|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116863|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116864|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116865|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116866|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116867|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116868|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116869|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116870|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116871|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
3116872|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116873|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116874|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116875|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116876|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116877|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116878|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116879|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116880|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116881|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116882|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116883|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
3116884|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116885|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116886|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
3116887|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116888|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116889|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116890|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116891|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116892|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116893|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116894|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116895|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116896|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116897|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
3116898|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|Protocol Violation|0
3116899|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|Protocol Violation|0
3116900|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|Protocol Violation|0
3116901|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|Protocol Violation|0
3116902|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|Protocol Violation|0
3116903|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|Protocol Violation|0
3116904|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|Protocol Violation|0
3116905|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|Protocol Violation|0
3116906|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|Protocol Violation|0
3116907|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|Protocol Violation|0
3116908|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|Protocol Violation|1
3116909|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|Protocol Violation|0
3116910|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|Protocol Violation|0
3116911|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|Protocol Violation|0
3116912|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|Protocol Violation|0
3116913|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|Protocol Violation|0
3116914|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|Protocol Violation|0
3116915|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|Protocol Violation|0
3116916|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|Protocol Violation|0
3116917|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|Protocol Violation|0
3116918|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|Protocol Violation|0
3116919|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|Protocol Violation|0
3116920|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|Protocol Violation|0
3116921|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|Protocol Violation|0
3116922|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|Protocol Violation|0
3116923|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|Protocol Violation|0
3116924|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116925|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116926|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116927|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116928|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116929|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116930|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116931|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116932|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116933|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116934|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
3116935|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116936|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116937|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116938|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116939|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116940|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116941|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116942|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116943|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116944|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116945|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116946|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116947|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116948|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116949|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
3116950|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116951|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116952|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116953|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116954|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116955|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116956|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116957|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
3116958|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116959|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116960|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
3116961|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116962|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
3116963|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116964|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
3116965|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116966|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116967|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116968|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116969|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116970|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116971|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116972|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116973|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116974|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116975|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
3116976|NCT00112437|10671633|P26|Year 3 (12-Month Extension)|Adverse Event|0
3116977|NCT00112437|10671634|P25|Year 3 (12-Month Extension)|Adverse Event|0
3116978|NCT00112437|10671635|P24|Year 3 (12-Month Extension)|Adverse Event|0
3116979|NCT00112437|10671636|P23|Year 3 (12-Month Extension)|Adverse Event|0
3116980|NCT00112437|10671637|P22|Year 3 (12-Month Extension)|Adverse Event|0
3116981|NCT00112437|10671638|P21|Year 3 (12-Month Extension)|Adverse Event|0
3116982|NCT00112437|10671639|P20|Year 3 (12-Month Extension)|Adverse Event|1
3116983|NCT00112437|10671640|P19|Year 3 (12-Month Extension)|Adverse Event|0
3116984|NCT00112437|10671641|P18|Year 3 (12-Month Extension)|Adverse Event|1
3116985|NCT00112437|10671642|P17|Year 3 (12-Month Extension)|Adverse Event|3
3116986|NCT00112437|10671643|P16|Year 3 (12-Month Extension)|Adverse Event|1
3116987|NCT00112437|10671644|P15|Year 3 (12-Month Extension)|Adverse Event|0
3116988|NCT00112437|10671645|P14|Year 3 (12-Month Extension)|Adverse Event|0
3116989|NCT00112437|10671646|P13|Year 3 (12-Month Extension)|Adverse Event|0
3116990|NCT00112437|10671647|P12|Year 3 (12-Month Extension)|Adverse Event|0
3116991|NCT00112437|10671648|P11|Year 3 (12-Month Extension)|Adverse Event|1
3116992|NCT00112437|10671649|P10|Year 3 (12-Month Extension)|Adverse Event|0
3116993|NCT00112437|10671650|P9|Year 3 (12-Month Extension)|Adverse Event|0
3116994|NCT00112437|10671651|P8|Year 3 (12-Month Extension)|Adverse Event|0
3116995|NCT00112437|10671652|P7|Year 3 (12-Month Extension)|Adverse Event|0
3116996|NCT00112437|10671653|P6|Year 3 (12-Month Extension)|Adverse Event|0
3116997|NCT00112437|10671654|P5|Year 3 (12-Month Extension)|Adverse Event|0
3116998|NCT00112437|10671655|P4|Year 3 (12-Month Extension)|Adverse Event|0
3116999|NCT00112437|10671656|P3|Year 3 (12-Month Extension)|Adverse Event|0
3117000|NCT00112437|10671657|P2|Year 3 (12-Month Extension)|Adverse Event|0
3117001|NCT00112437|10671658|P1|Year 3 (12-Month Extension)|Adverse Event|0
3117002|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Moved|0
3117003|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Moved|0
3117004|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Moved|0
3117005|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Moved|0
3117006|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Moved|0
3117007|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Moved|0
3117008|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Moved|0
3117009|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Moved|0
3117010|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Moved|0
3117011|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Moved|0
3117012|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Moved|0
3117013|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Moved|0
3117014|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Moved|0
3117015|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Moved|0
3117016|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Moved|0
3117017|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Moved|0
3117018|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Moved|1
3117019|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Moved|0
3117020|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Moved|0
3117021|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Moved|0
3117022|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Moved|0
3117023|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Moved|0
3117024|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Moved|0
3117025|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Moved|0
3117026|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Moved|0
3117027|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Moved|0
3117028|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|patient was out of windows|0
3117029|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|patient was out of windows|0
3117030|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|patient was out of windows|0
3117031|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|patient was out of windows|0
3117032|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|patient was out of windows|0
3117033|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|patient was out of windows|0
3117034|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|patient was out of windows|0
3117035|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|patient was out of windows|0
3117036|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|patient was out of windows|0
3117037|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|patient was out of windows|0
3117038|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|patient was out of windows|0
3117039|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|patient was out of windows|0
3117040|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|patient was out of windows|0
3117041|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|patient was out of windows|0
3117042|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|patient was out of windows|0
3117043|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|patient was out of windows|0
3117044|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|patient was out of windows|1
3117045|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|patient was out of windows|0
3117046|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|patient was out of windows|0
3117047|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|patient was out of windows|0
3117048|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|patient was out of windows|0
3117049|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|patient was out of windows|0
3117050|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|patient was out of windows|0
3117051|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|patient was out of windows|0
3117052|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|patient was out of windows|0
3117053|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|patient was out of windows|0
3117054|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117055|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117056|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117057|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117058|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117059|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117060|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117061|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117062|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117063|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117064|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117065|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117066|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117067|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117068|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117069|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117070|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
3117071|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117072|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117073|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117074|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117075|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117076|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117077|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117078|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117079|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
3117080|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117081|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117082|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117083|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117084|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117085|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117086|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117087|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117088|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117089|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117090|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117091|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117092|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117093|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117094|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117095|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117096|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
3117097|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
3117098|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
3117099|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
3117100|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
3117101|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117102|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117103|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117104|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117105|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
3117106|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Protocol Violation|0
3117107|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Protocol Violation|0
3117108|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Protocol Violation|0
3117109|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Protocol Violation|0
3117110|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Protocol Violation|0
3117111|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Protocol Violation|0
3117112|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Protocol Violation|0
3117113|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Protocol Violation|0
3117114|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Protocol Violation|0
3117115|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Protocol Violation|0
3117116|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Protocol Violation|0
3117117|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Protocol Violation|0
3117118|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Protocol Violation|0
3117119|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Protocol Violation|0
3117120|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Protocol Violation|0
3117121|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Protocol Violation|0
3117122|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Protocol Violation|0
3117123|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Protocol Violation|1
3117124|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Protocol Violation|0
3117125|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Protocol Violation|0
3117126|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Protocol Violation|0
3117127|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Protocol Violation|0
3117128|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Protocol Violation|0
3117129|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Protocol Violation|0
3117130|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Protocol Violation|0
3117131|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Protocol Violation|0
3117132|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117133|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117134|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117135|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117136|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117137|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117138|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117139|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117140|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117141|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117142|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117143|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117144|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117145|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117146|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117147|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117148|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117149|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
3117150|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117151|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117152|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117153|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117154|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117155|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117156|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117157|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
3117158|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117159|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117160|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117161|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117162|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117163|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117164|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117165|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117166|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117167|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117168|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117169|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117170|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117171|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117172|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117173|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117174|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
3117175|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117176|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117177|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
3117178|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
3117179|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117180|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117181|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117182|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117183|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
3117184|NCT00112437|10671633|P26|Year 2 (12-Month Extension)|Adverse Event|0
3117185|NCT00112437|10671634|P25|Year 2 (12-Month Extension)|Adverse Event|0
3117186|NCT00112437|10671635|P24|Year 2 (12-Month Extension)|Adverse Event|0
3117187|NCT00112437|10671636|P23|Year 2 (12-Month Extension)|Adverse Event|0
3117188|NCT00112437|10671637|P22|Year 2 (12-Month Extension)|Adverse Event|0
3117189|NCT00112437|10671638|P21|Year 2 (12-Month Extension)|Adverse Event|0
3117190|NCT00112437|10671639|P20|Year 2 (12-Month Extension)|Adverse Event|0
3117191|NCT00112437|10671640|P19|Year 2 (12-Month Extension)|Adverse Event|0
3117192|NCT00112437|10671641|P18|Year 2 (12-Month Extension)|Adverse Event|0
3117193|NCT00112437|10671642|P17|Year 2 (12-Month Extension)|Adverse Event|0
3117194|NCT00112437|10671643|P16|Year 2 (12-Month Extension)|Adverse Event|0
3117195|NCT00112437|10671644|P15|Year 2 (12-Month Extension)|Adverse Event|0
3117196|NCT00112437|10671645|P14|Year 2 (12-Month Extension)|Adverse Event|0
3117197|NCT00112437|10671646|P13|Year 2 (12-Month Extension)|Adverse Event|0
3117198|NCT00112437|10671647|P12|Year 2 (12-Month Extension)|Adverse Event|0
3117199|NCT00112437|10671648|P11|Year 2 (12-Month Extension)|Adverse Event|0
3117200|NCT00112437|10671649|P10|Year 2 (12-Month Extension)|Adverse Event|7
3117201|NCT00112437|10671650|P9|Year 2 (12-Month Extension)|Adverse Event|1
3117202|NCT00112437|10671651|P8|Year 2 (12-Month Extension)|Adverse Event|6
3117203|NCT00112437|10671652|P7|Year 2 (12-Month Extension)|Adverse Event|2
3117204|NCT00112437|10671653|P6|Year 2 (12-Month Extension)|Adverse Event|1
3117205|NCT00112437|10671654|P5|Year 2 (12-Month Extension)|Adverse Event|0
3117206|NCT00112437|10671655|P4|Year 2 (12-Month Extension)|Adverse Event|0
3117207|NCT00112437|10671656|P3|Year 2 (12-Month Extension)|Adverse Event|0
3117208|NCT00112437|10671657|P2|Year 2 (12-Month Extension)|Adverse Event|0
3117209|NCT00112437|10671658|P1|Year 2 (12-Month Extension)|Adverse Event|0
3117210|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117211|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117212|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117213|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117285|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|moved|1
3117214|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117215|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117216|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117217|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117218|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117219|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117220|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117221|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117222|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117223|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117224|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117225|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117226|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117227|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117228|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117229|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117230|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117231|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
3117232|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117233|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117234|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117235|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
3117236|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117237|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117238|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117239|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117240|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117241|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117242|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117243|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117244|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117245|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117246|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117247|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117248|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117249|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117250|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117251|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117252|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117253|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117254|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117255|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117256|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117257|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117258|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
3117259|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117260|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117261|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
3117262|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|moved|0
3117263|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|moved|0
3117264|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|moved|0
3117265|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|moved|0
3117266|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|moved|0
3117267|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|moved|0
3117268|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|moved|0
3117269|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|moved|0
3117270|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|moved|0
3117271|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|moved|0
3117272|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|moved|0
3117273|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|moved|0
3117274|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|moved|0
3117275|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|moved|0
3117276|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|moved|0
3117277|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|moved|0
3117278|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|moved|0
3117279|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|moved|0
3117280|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|moved|0
3117281|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|moved|0
3117282|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|moved|0
3117283|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|moved|0
3117284|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|moved|0
3117286|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|moved|1
3117287|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|moved|0
3117288|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117289|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117290|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117291|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117292|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117293|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117294|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117295|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117296|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117297|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117298|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117299|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117300|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117301|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117302|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117303|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117304|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117305|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117306|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117307|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117308|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
3117309|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
3117310|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
3117311|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
3117312|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
3117313|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
3117314|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
3117315|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
3117316|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
3117317|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
3117318|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
3117319|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
3117320|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
3117321|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
3117322|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
3117323|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
3117324|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
3117325|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
3117326|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
3117327|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
3117328|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
3117329|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
3117330|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
3117331|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
3117332|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
3117333|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
3117334|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
3117335|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
3117336|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
3117337|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
3117338|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
3117339|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
3117340|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117341|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117342|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117343|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117344|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117345|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117346|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117347|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117348|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117349|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117350|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117351|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117352|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117353|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117354|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117355|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117356|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117357|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117358|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117359|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117360|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117442|NCT00112047|10672280|P2|Atripla Phase|Withdrew consent|7
3117361|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117362|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117363|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117364|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
3117365|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
3117366|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117367|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117368|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117369|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117370|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117371|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117372|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117373|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117374|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117375|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117376|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117377|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117378|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117379|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117380|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117381|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117382|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117383|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117384|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117385|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117386|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117387|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117388|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117389|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117390|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
3117391|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
3117392|NCT00112437|10671633|P26|Year 1 (12-Month Base Study)|Adverse Event|0
3117393|NCT00112437|10671634|P25|Year 1 (12-Month Base Study)|Adverse Event|0
3117394|NCT00112437|10671635|P24|Year 1 (12-Month Base Study)|Adverse Event|0
3117395|NCT00112437|10671636|P23|Year 1 (12-Month Base Study)|Adverse Event|0
3117396|NCT00112437|10671637|P22|Year 1 (12-Month Base Study)|Adverse Event|0
3117397|NCT00112437|10671638|P21|Year 1 (12-Month Base Study)|Adverse Event|0
3117398|NCT00112437|10671639|P20|Year 1 (12-Month Base Study)|Adverse Event|0
3117399|NCT00112437|10671640|P19|Year 1 (12-Month Base Study)|Adverse Event|0
3117400|NCT00112437|10671641|P18|Year 1 (12-Month Base Study)|Adverse Event|0
3117401|NCT00112437|10671642|P17|Year 1 (12-Month Base Study)|Adverse Event|0
3117402|NCT00112437|10671643|P16|Year 1 (12-Month Base Study)|Adverse Event|0
3117403|NCT00112437|10671644|P15|Year 1 (12-Month Base Study)|Adverse Event|0
3117404|NCT00112437|10671645|P14|Year 1 (12-Month Base Study)|Adverse Event|0
3117405|NCT00112437|10671646|P13|Year 1 (12-Month Base Study)|Adverse Event|0
3117406|NCT00112437|10671647|P12|Year 1 (12-Month Base Study)|Adverse Event|0
3117407|NCT00112437|10671648|P11|Year 1 (12-Month Base Study)|Adverse Event|0
3117408|NCT00112437|10671649|P10|Year 1 (12-Month Base Study)|Adverse Event|0
3117409|NCT00112437|10671650|P9|Year 1 (12-Month Base Study)|Adverse Event|0
3117410|NCT00112437|10671651|P8|Year 1 (12-Month Base Study)|Adverse Event|0
3117411|NCT00112437|10671652|P7|Year 1 (12-Month Base Study)|Adverse Event|0
3117412|NCT00112437|10671653|P6|Year 1 (12-Month Base Study)|Adverse Event|0
3117413|NCT00112437|10671654|P5|Year 1 (12-Month Base Study)|Adverse Event|3
3117414|NCT00112437|10671655|P4|Year 1 (12-Month Base Study)|Adverse Event|4
3117415|NCT00112437|10671656|P3|Year 1 (12-Month Base Study)|Adverse Event|6
3117416|NCT00112437|10671657|P2|Year 1 (12-Month Base Study)|Adverse Event|10
3117417|NCT00112437|10671658|P1|Year 1 (12-Month Base Study)|Adverse Event|9
3117418|NCT00112385|10671938|P2|Overall Study|Withdrawal by Subject|1
3117419|NCT00112385|10671939|P1|Overall Study|Withdrawal by Subject|0
3117420|NCT00112385|10671938|P2|Overall Study|Lost to Follow-up|0
3117421|NCT00112385|10671939|P1|Overall Study|Lost to Follow-up|1
3117422|NCT00112359|10672029|P2|Overall Study|Other|0
3117423|NCT00112359|10672030|P1|Overall Study|Other|3
3117424|NCT00112359|10672029|P2|Overall Study|Personal/administrative|1
3117425|NCT00112359|10672030|P1|Overall Study|Personal/administrative|1
3117426|NCT00112359|10672029|P2|Overall Study|Lost to Follow-up|1
3117427|NCT00112359|10672030|P1|Overall Study|Lost to Follow-up|0
3117428|NCT00112359|10672029|P2|Overall Study|Related adverse event|3
3117429|NCT00112359|10672030|P1|Overall Study|Related adverse event|5
3117430|NCT00112359|10672029|P2|Overall Study|Trial drug intolerance (adverse event)|0
3117431|NCT00112359|10672030|P1|Overall Study|Trial drug intolerance (adverse event)|2
3117432|NCT00112359|10672029|P2|Overall Study|Unrelated adverse event|8
3117433|NCT00112359|10672030|P1|Overall Study|Unrelated adverse event|16
3117434|NCT00112294|10672056|P2|Overall Study|Still on study|0
3117435|NCT00112294|10672057|P1|Overall Study|Still on study|5
3117436|NCT00112047|10672280|P2|Atripla Phase|Other|1
3117437|NCT00112047|10672281|P1|Atripla Phase|Other|3
3117438|NCT00112047|10672280|P2|Atripla Phase|Non-compliance|0
3117439|NCT00112047|10672281|P1|Atripla Phase|Non-compliance|1
3117440|NCT00112047|10672280|P2|Atripla Phase|Sub-optimal virological response|1
3117441|NCT00112047|10672281|P1|Atripla Phase|Sub-optimal virological response|0
3117443|NCT00112047|10672281|P1|Atripla Phase|Withdrew consent|7
3117444|NCT00112047|10672280|P2|Atripla Phase|Death|2
3117445|NCT00112047|10672281|P1|Atripla Phase|Death|0
3117446|NCT00112047|10672280|P2|Atripla Phase|Pregnancy|1
3117447|NCT00112047|10672281|P1|Atripla Phase|Pregnancy|0
3117448|NCT00112047|10672280|P2|Atripla Phase|Lost to Follow-up|7
3117449|NCT00112047|10672281|P1|Atripla Phase|Lost to Follow-up|5
3117450|NCT00112047|10672280|P2|Atripla Phase|Adverse Event|1
3117451|NCT00112047|10672281|P1|Atripla Phase|Adverse Event|2
3117452|NCT00112047|10672280|P2|Randomized Phase|High Hepatitis B DNA|1
3117453|NCT00112047|10672281|P1|Randomized Phase|High Hepatitis B DNA|0
3117454|NCT00112047|10672280|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
3117455|NCT00112047|10672281|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
3117456|NCT00112047|10672280|P2|Randomized Phase|Moved out of State|1
3117457|NCT00112047|10672281|P1|Randomized Phase|Moved out of State|0
3117458|NCT00112047|10672280|P2|Randomized Phase|Incarceration|2
3117459|NCT00112047|10672281|P1|Randomized Phase|Incarceration|3
3117460|NCT00112047|10672280|P2|Randomized Phase|Inability to swallow pills|1
3117461|NCT00112047|10672281|P1|Randomized Phase|Inability to swallow pills|0
3117462|NCT00112047|10672280|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
3117463|NCT00112047|10672281|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
3117464|NCT00112047|10672280|P2|Randomized Phase|Death|3
3117465|NCT00112047|10672281|P1|Randomized Phase|Death|1
3117466|NCT00112047|10672280|P2|Randomized Phase|Pregnancy|1
3117467|NCT00112047|10672281|P1|Randomized Phase|Pregnancy|3
3117468|NCT00112047|10672280|P2|Randomized Phase|Protocol Violation|0
3117469|NCT00112047|10672281|P1|Randomized Phase|Protocol Violation|2
3117470|NCT00112047|10672280|P2|Randomized Phase|Noncompliance|4
3117471|NCT00112047|10672281|P1|Randomized Phase|Noncompliance|8
3117472|NCT00112047|10672280|P2|Randomized Phase|Sub-optimal virological response|13
3117473|NCT00112047|10672281|P1|Randomized Phase|Sub-optimal virological response|3
3117474|NCT00112047|10672280|P2|Randomized Phase|Withrawal of consent|18
3117475|NCT00112047|10672281|P1|Randomized Phase|Withrawal of consent|10
3117476|NCT00112047|10672280|P2|Randomized Phase|Adverse Event|10
3117477|NCT00112047|10672281|P1|Randomized Phase|Adverse Event|10
3117478|NCT00112047|10672280|P2|Randomized Phase|Lost to Follow-up|33
3117479|NCT00112047|10672281|P1|Randomized Phase|Lost to Follow-up|26
3117480|NCT00111917|10672381|P2|Overall Study|Withdrawal by Subject|1
3117481|NCT00111917|10672382|P1|Overall Study|Withdrawal by Subject|1
3117482|NCT00111839|10672397|P3|Overall Study|Randomized but Not Treated|2
3117483|NCT00111839|10672398|P2|Overall Study|Randomized but Not Treated|0
3117484|NCT00111839|10672399|P1|Overall Study|Randomized but Not Treated|0
3117485|NCT00111839|10672397|P3|Overall Study|Other|3
3117486|NCT00111839|10672398|P2|Overall Study|Other|3
3117487|NCT00111839|10672399|P1|Overall Study|Other|6
3117488|NCT00111839|10672397|P3|Overall Study|Logistical Constraint|0
3117489|NCT00111839|10672398|P2|Overall Study|Logistical Constraint|0
3117490|NCT00111839|10672399|P1|Overall Study|Logistical Constraint|1
3117491|NCT00111839|10672397|P3|Overall Study|Lost to Follow-up|0
3117492|NCT00111839|10672398|P2|Overall Study|Lost to Follow-up|0
3117493|NCT00111839|10672399|P1|Overall Study|Lost to Follow-up|1
3117494|NCT00111839|10672397|P3|Overall Study|Withdrawal by Subject|2
3117495|NCT00111839|10672398|P2|Overall Study|Withdrawal by Subject|2
3117496|NCT00111839|10672399|P1|Overall Study|Withdrawal by Subject|2
3117497|NCT00111839|10672397|P3|Overall Study|Death|6
3117498|NCT00111839|10672398|P2|Overall Study|Death|1
3117499|NCT00111839|10672399|P1|Overall Study|Death|1
3117500|NCT00111839|10672397|P3|Overall Study|Protocol Violation|2
3117501|NCT00111839|10672398|P2|Overall Study|Protocol Violation|4
3117502|NCT00111839|10672399|P1|Overall Study|Protocol Violation|2
3117503|NCT00111839|10672397|P3|Overall Study|Adverse Event|1
3117504|NCT00111839|10672398|P2|Overall Study|Adverse Event|3
3117505|NCT00111839|10672399|P1|Overall Study|Adverse Event|5
3117506|NCT00111839|10672397|P3|Overall Study|Disease Progression|33
3117507|NCT00111839|10672398|P2|Overall Study|Disease Progression|33
3117508|NCT00111839|10672399|P1|Overall Study|Disease Progression|30
3117509|NCT00111813|10672419|P6|Overall Study|Other|0
3117510|NCT00111813|10672420|P5|Overall Study|Other|0
3117511|NCT00111813|10672421|P4|Overall Study|Other|0
3117512|NCT00111813|10672422|P3|Overall Study|Other|1
3117513|NCT00111813|10672423|P2|Overall Study|Other|0
3117514|NCT00111813|10672424|P1|Overall Study|Other|0
3117515|NCT00111813|10672419|P6|Overall Study|Lack of Efficacy|1
3117516|NCT00111813|10672420|P5|Overall Study|Lack of Efficacy|0
3117517|NCT00111813|10672421|P4|Overall Study|Lack of Efficacy|0
3117518|NCT00111813|10672422|P3|Overall Study|Lack of Efficacy|0
3117519|NCT00111813|10672423|P2|Overall Study|Lack of Efficacy|0
3117520|NCT00111813|10672424|P1|Overall Study|Lack of Efficacy|0
3117521|NCT00111813|10672419|P6|Overall Study|Progressive disease|3
3117522|NCT00111813|10672420|P5|Overall Study|Progressive disease|4
3117523|NCT00111813|10672421|P4|Overall Study|Progressive disease|3
3117524|NCT00111813|10672422|P3|Overall Study|Progressive disease|5
3117525|NCT00111813|10672423|P2|Overall Study|Progressive disease|1
3117526|NCT00111813|10672424|P1|Overall Study|Progressive disease|2
3117527|NCT00111813|10672419|P6|Overall Study|Adverse Event|2
3117528|NCT00111813|10672420|P5|Overall Study|Adverse Event|2
3117529|NCT00111813|10672421|P4|Overall Study|Adverse Event|2
3117530|NCT00111813|10672422|P3|Overall Study|Adverse Event|4
3117531|NCT00111813|10672423|P2|Overall Study|Adverse Event|2
3117532|NCT00111813|10672424|P1|Overall Study|Adverse Event|1
3117533|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
3117534|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
3117535|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
3117536|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
3117537|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
3117538|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
3117539|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
3117540|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
3117541|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
3117542|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
3117543|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
3117544|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
3117545|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
3117546|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
3117547|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
3117548|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
3117549|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
3117550|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
3117551|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
3117552|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
3117553|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
3117554|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
3117555|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
3117556|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
3117557|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
3117558|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
3117559|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
3117560|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
3117561|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
3117562|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
3117563|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
3117564|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
3117565|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
3117566|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
3117567|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
3117568|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
3117569|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
3117570|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
3117571|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
3117572|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
3117573|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
3117574|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
3117575|NCT00111800|10672463|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
3117576|NCT00111800|10672464|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
3117577|NCT00111800|10672465|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
3117578|NCT00111800|10672466|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
3117579|NCT00111800|10672467|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
3117580|NCT00111800|10672468|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
3117581|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
3117582|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
3117583|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
3117584|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
3117585|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
3117586|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
3117587|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
3117588|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
3117589|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
3117590|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
3117591|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
3117592|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
3117593|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
3117594|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
3117595|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
3117596|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
3117597|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
3117598|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
3117599|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
3117834|NCT00110617|10672939|P2|Overall Study|Administrative problems|5
3117600|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
3117601|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
3117602|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
3117603|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
3117604|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
3117605|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
3117606|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
3117607|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
3117608|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
3117609|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
3117610|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
3117611|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
3117612|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
3117613|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
3117614|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
3117615|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
3117616|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
3117617|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
3117618|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
3117619|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
3117620|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
3117621|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
3117622|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
3117623|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
3117624|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
3117625|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
3117626|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
3117627|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
3117628|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
3117629|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
3117630|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
3117631|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
3117632|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
3117633|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
3117634|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
3117635|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
3117636|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
3117637|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
3117638|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
3117639|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
3117640|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
3117641|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
3117642|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
3117643|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
3117644|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
3117645|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
3117646|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
3117647|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
3117648|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
3117649|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
3117650|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
3117651|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
3117652|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
3117653|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
3117654|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
3117655|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
3117656|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
3117657|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
3117658|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
3117659|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
3117660|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
3117661|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
3117662|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
3117663|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
3117664|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
3117835|NCT00110617|10672940|P1|Overall Study|Administrative problems|6
3117665|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
3117666|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
3117667|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
3117668|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
3117669|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
3117670|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
3117671|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
3117672|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
3117673|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
3117674|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
3117675|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
3117676|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
3117677|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
3117678|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
3117679|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
3117680|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
3117681|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
3117682|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
3117683|NCT00111800|10672463|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
3117684|NCT00111800|10672464|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
3117685|NCT00111800|10672465|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
3117686|NCT00111800|10672466|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
3117687|NCT00111800|10672467|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
3117688|NCT00111800|10672468|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
3117689|NCT00111761|10672638|P2|Part 2|Other|0
3117690|NCT00111761|10672639|P1|Part 2|Other|1
3117691|NCT00111761|10672638|P2|Part 2|Protocol-specified criteria|0
3117692|NCT00111761|10672639|P1|Part 2|Protocol-specified criteria|1
3117693|NCT00111761|10672638|P2|Part 2|Disease progression|0
3117694|NCT00111761|10672639|P1|Part 2|Disease progression|3
3117695|NCT00111761|10672638|P2|Part 2|Death|0
3117696|NCT00111761|10672639|P1|Part 2|Death|1
3117697|NCT00111761|10672638|P2|Part 2|Physician Decision|0
3117698|NCT00111761|10672639|P1|Part 2|Physician Decision|1
3117699|NCT00111761|10672638|P2|Part 2|Adverse Event|0
3117700|NCT00111761|10672639|P1|Part 2|Adverse Event|1
3117701|NCT00111761|10672638|P2|Part 1|Withdrawal by Subject|1
3117702|NCT00111761|10672639|P1|Part 1|Withdrawal by Subject|0
3117703|NCT00111761|10672638|P2|Part 1|Other|1
3117704|NCT00111761|10672639|P1|Part 1|Other|0
3117705|NCT00111761|10672638|P2|Part 1|Death|2
3117706|NCT00111761|10672639|P1|Part 1|Death|0
3117707|NCT00111761|10672638|P2|Part 1|Physician Decision|1
3117708|NCT00111761|10672639|P1|Part 1|Physician Decision|0
3117709|NCT00111475|10672676|P10|Overall Study|Lost to Follow-up|0
3117710|NCT00111475|10672677|P9|Overall Study|Lost to Follow-up|0
3117711|NCT00111475|10672678|P8|Overall Study|Lost to Follow-up|0
3117712|NCT00111475|10672679|P7|Overall Study|Lost to Follow-up|0
3117713|NCT00111475|10672680|P6|Overall Study|Lost to Follow-up|1
3117714|NCT00111475|10672681|P5|Overall Study|Lost to Follow-up|0
3117715|NCT00111475|10672682|P4|Overall Study|Lost to Follow-up|0
3117716|NCT00111475|10672683|P3|Overall Study|Lost to Follow-up|0
3117717|NCT00111475|10672684|P2|Overall Study|Lost to Follow-up|0
3117718|NCT00111475|10672685|P1|Overall Study|Lost to Follow-up|0
3117719|NCT00111241|10672803|P2|Overall Study|Adverse Event|0
3117720|NCT00111241|10672804|P1|Overall Study|Adverse Event|1
3117721|NCT00111241|10672803|P2|Overall Study|Protocol Violation|8
3117722|NCT00111241|10672804|P1|Overall Study|Protocol Violation|9
3117723|NCT00111241|10672803|P2|Overall Study|Withdrawal by Subject|0
3117724|NCT00111241|10672804|P1|Overall Study|Withdrawal by Subject|4
3117725|NCT00111241|10672803|P2|Overall Study|Lost to Follow-up|0
3117726|NCT00111241|10672804|P1|Overall Study|Lost to Follow-up|1
3117727|NCT00111228|10672815|P3|Overall Study|Withdrawal by Subject|0
3117728|NCT00111228|10672816|P2|Overall Study|Withdrawal by Subject|1
3117729|NCT00111228|10672817|P1|Overall Study|Withdrawal by Subject|5
3117730|NCT00111007|10672830|P2|Long Term Follow-up|Missing|3
3117731|NCT00111007|10672831|P1|Long Term Follow-up|Missing|10
3117732|NCT00111007|10672830|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
3117733|NCT00111007|10672831|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
3117734|NCT00111007|10672830|P2|Long Term Follow-up|Withdrawal by Subject|1
3117735|NCT00111007|10672831|P1|Long Term Follow-up|Withdrawal by Subject|0
3117736|NCT00111007|10672830|P2|Long Term Follow-up|Lost to Follow-up|1
3117737|NCT00111007|10672831|P1|Long Term Follow-up|Lost to Follow-up|1
3117738|NCT00111007|10672830|P2|Long Term Follow-up|Death|39
3117739|NCT00111007|10672831|P1|Long Term Follow-up|Death|34
3117740|NCT00111007|10672830|P2|Active Follow-up|Disease progression/recurrence/relapse|2
3117741|NCT00111007|10672831|P1|Active Follow-up|Disease progression/recurrence/relapse|3
3117742|NCT00111007|10672830|P2|Active Follow-up|Death|0
3117743|NCT00111007|10672831|P1|Active Follow-up|Death|2
3117744|NCT00111007|10672830|P2|Active Follow-up|Adverse Event|0
3117745|NCT00111007|10672831|P1|Active Follow-up|Adverse Event|1
3117746|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Primary reason with other category|1
3117747|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Primary reason with other category|0
3117748|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
3117749|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
3117750|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
3117751|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
3117752|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Relapse|0
3117753|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Relapse|1
3117754|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
3117755|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
3117756|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
3117757|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
3117758|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Protocol Violation|1
3117759|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Protocol Violation|0
3117760|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Death|2
3117761|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Death|5
3117762|NCT00111007|10672830|P2|Double-blind (DB) Treatment|Adverse Event|4
3117763|NCT00111007|10672831|P1|Double-blind (DB) Treatment|Adverse Event|12
3117764|NCT00110994|10672847|P2|Long Term Follow-up|Death|17
3117765|NCT00110994|10672848|P1|Long Term Follow-up|Death|19
3117766|NCT00110994|10672847|P2|Active Follow-up|Other reasons|2
3117767|NCT00110994|10672848|P1|Active Follow-up|Other reasons|0
3117768|NCT00110994|10672847|P2|Active Follow-up|Disease progression/recurrence/replace|0
3117769|NCT00110994|10672848|P1|Active Follow-up|Disease progression/recurrence/replace|1
3117770|NCT00110994|10672847|P2|Double-blind (DB) Treatment|other reasons|3
3117771|NCT00110994|10672848|P1|Double-blind (DB) Treatment|other reasons|2
3117772|NCT00110994|10672847|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
3117773|NCT00110994|10672848|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
3117774|NCT00110994|10672847|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
3117775|NCT00110994|10672848|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
3117776|NCT00110994|10672847|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
3117777|NCT00110994|10672848|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
3117778|NCT00110994|10672847|P2|Double-blind (DB) Treatment|Death|0
3117779|NCT00110994|10672848|P1|Double-blind (DB) Treatment|Death|1
3117780|NCT00110994|10672847|P2|Double-blind (DB) Treatment|Adverse Event|0
3117781|NCT00110994|10672848|P1|Double-blind (DB) Treatment|Adverse Event|3
3117782|NCT00110890|10672874|P2|Overall Study|Did not enter follow-up phase|4
3117783|NCT00110890|10672875|P1|Overall Study|Did not enter follow-up phase|10
3117784|NCT00110890|10672874|P2|Overall Study|Parathyroidectomy|1
3117785|NCT00110890|10672875|P1|Overall Study|Parathyroidectomy|0
3117786|NCT00110890|10672874|P2|Overall Study|Disease progression|1
3117787|NCT00110890|10672875|P1|Overall Study|Disease progression|0
3117788|NCT00110890|10672874|P2|Overall Study|Requirement for alternative therapy|1
3117789|NCT00110890|10672875|P1|Overall Study|Requirement for alternative therapy|0
3117790|NCT00110890|10672874|P2|Overall Study|Ineligibility determined|0
3117791|NCT00110890|10672875|P1|Overall Study|Ineligibility determined|3
3117792|NCT00110890|10672874|P2|Overall Study|Other|23
3117793|NCT00110890|10672875|P1|Overall Study|Other|34
3117794|NCT00110890|10672874|P2|Overall Study|Invest. Product Commercially Available|110
3117795|NCT00110890|10672875|P1|Overall Study|Invest. Product Commercially Available|217
3117796|NCT00110890|10672874|P2|Overall Study|Kidney Transplant|12
3117797|NCT00110890|10672875|P1|Overall Study|Kidney Transplant|16
3117798|NCT00110890|10672874|P2|Overall Study|Noncompliance|0
3117799|NCT00110890|10672875|P1|Overall Study|Noncompliance|10
3117800|NCT00110890|10672874|P2|Overall Study|Protocol Deviation|0
3117801|NCT00110890|10672875|P1|Overall Study|Protocol Deviation|1
3117802|NCT00110890|10672874|P2|Overall Study|Withdrawal by Subject|5
3117803|NCT00110890|10672875|P1|Overall Study|Withdrawal by Subject|17
3117804|NCT00110890|10672874|P2|Overall Study|Physician Decision|5
3117805|NCT00110890|10672875|P1|Overall Study|Physician Decision|4
3117806|NCT00110890|10672874|P2|Overall Study|Lost to Follow-up|1
3117807|NCT00110890|10672875|P1|Overall Study|Lost to Follow-up|3
3117808|NCT00110890|10672874|P2|Overall Study|Death|9
3117809|NCT00110890|10672875|P1|Overall Study|Death|16
3117810|NCT00110890|10672874|P2|Overall Study|Adverse Event|7
3117811|NCT00110890|10672875|P1|Overall Study|Adverse Event|30
3117812|NCT00110812|10672892|P3|Extended Follow-up|Lost to Follow-up|1
3117813|NCT00110812|10672893|P2|Extended Follow-up|Lost to Follow-up|3
3117814|NCT00110812|10672894|P1|Extended Follow-up|Lost to Follow-up|1
3117815|NCT00110812|10672892|P3|Extended Follow-up|Withdrawal by Subject|0
3117816|NCT00110812|10672893|P2|Extended Follow-up|Withdrawal by Subject|1
3117817|NCT00110812|10672894|P1|Extended Follow-up|Withdrawal by Subject|0
3117818|NCT00110812|10672892|P3|Extended Follow-up|Death|3
3117819|NCT00110812|10672893|P2|Extended Follow-up|Death|0
3117820|NCT00110812|10672894|P1|Extended Follow-up|Death|1
3117821|NCT00110812|10672892|P3|Main Study|Lost to Follow-up|10
3117822|NCT00110812|10672893|P2|Main Study|Lost to Follow-up|11
3117823|NCT00110812|10672894|P1|Main Study|Lost to Follow-up|8
3117824|NCT00110812|10672892|P3|Main Study|Withdrawal by Subject|1
3117825|NCT00110812|10672893|P2|Main Study|Withdrawal by Subject|0
3117826|NCT00110812|10672894|P1|Main Study|Withdrawal by Subject|0
3117827|NCT00110812|10672892|P3|Main Study|Death|2
3117828|NCT00110812|10672893|P2|Main Study|Death|0
3117829|NCT00110812|10672894|P1|Main Study|Death|0
3117830|NCT00110617|10672939|P2|Overall Study|Did not receive study drug|12
3117831|NCT00110617|10672940|P1|Overall Study|Did not receive study drug|0
3117832|NCT00110617|10672939|P2|Overall Study|Death|1
3117833|NCT00110617|10672940|P1|Overall Study|Death|1
3117836|NCT00110617|10672939|P2|Overall Study|Lost to Follow-up|1
3117837|NCT00110617|10672940|P1|Overall Study|Lost to Follow-up|9
3117838|NCT00110617|10672939|P2|Overall Study|Withdrawal by Subject|4
3117839|NCT00110617|10672940|P1|Overall Study|Withdrawal by Subject|10
3117840|NCT00110617|10672939|P2|Overall Study|Protocol Violation|0
3117841|NCT00110617|10672940|P1|Overall Study|Protocol Violation|5
3117842|NCT00110617|10672939|P2|Overall Study|Patient no longer requires study drug|0
3117843|NCT00110617|10672940|P1|Overall Study|Patient no longer requires study drug|1
3117844|NCT00110617|10672939|P2|Overall Study|Lack of Efficacy|0
3117845|NCT00110617|10672940|P1|Overall Study|Lack of Efficacy|1
3117846|NCT00110617|10672939|P2|Overall Study|Abnormal Laboratory Value|2
3117847|NCT00110617|10672940|P1|Overall Study|Abnormal Laboratory Value|4
3117848|NCT00110617|10672939|P2|Overall Study|Adverse Event|4
3117849|NCT00110617|10672940|P1|Overall Study|Adverse Event|2
3117850|NCT00110396|10673057|P1|Overall Study|Patient is to be administered copaxone|1
3117851|NCT00110396|10673057|P1|Overall Study|The patient has refused to visit site|1
3117852|NCT00110396|10673057|P1|Overall Study|The patient has refused|2
3117853|NCT00110396|10673057|P1|Overall Study|Patient refused to come back|1
3117854|NCT00110396|10673057|P1|Overall Study|Protocol Violation|2
3117855|NCT00110396|10673057|P1|Overall Study|Pregnancy (Protocol violation)|2
3117856|NCT00110396|10673057|P1|Overall Study|Pregnancy|1
3117857|NCT00110396|10673057|P1|Overall Study|Participation in MS vaccine study|1
3117858|NCT00110396|10673057|P1|Overall Study|Patient's decision|1
3117859|NCT00110396|10673057|P1|Overall Study|Patient will|1
3117860|NCT00110396|10673057|P1|Overall Study|Patient refused to participate|1
3117861|NCT00110396|10673057|P1|Overall Study|Patient refused to continue|1
3117862|NCT00110396|10673057|P1|Overall Study|Patient non-compliance|1
3117863|NCT00110396|10673057|P1|Overall Study|Decided not to continue treatment|1
3117864|NCT00110396|10673057|P1|Overall Study|Lack of Efficacy|1
3117865|NCT00110396|10673057|P1|Overall Study|Initiated mitoxantrone therapy|1
3117866|NCT00110396|10673057|P1|Overall Study|Administration of plasmapheresis|1
3117867|NCT00110396|10673057|P1|Overall Study|Lost to Follow-up|1
3117868|NCT00110396|10673057|P1|Overall Study|Adverse Event|15
3117869|NCT00110357|10673065|P2|Overall Study|Withdrawal by Subject|1
3117870|NCT00110357|10673066|P1|Overall Study|Withdrawal by Subject|3
3117871|NCT00110357|10673065|P2|Overall Study|Study Drug Toxicity|3
3117872|NCT00110357|10673066|P1|Overall Study|Study Drug Toxicity|1
3117873|NCT00110357|10673065|P2|Overall Study|Study Closure|0
3117874|NCT00110357|10673066|P1|Overall Study|Study Closure|1
3117875|NCT00110357|10673065|P2|Overall Study|Disease progression/relapse|15
3117876|NCT00110357|10673066|P1|Overall Study|Disease progression/relapse|20
3117877|NCT00110357|10673065|P2|Overall Study|Deterioration without progression|0
3117878|NCT00110357|10673066|P1|Overall Study|Deterioration without progression|2
3117879|NCT00110305|10673154|P2|Overall Study|Other|2
3117880|NCT00110305|10673155|P1|Overall Study|Other|8
3117881|NCT00110305|10673154|P2|Overall Study|Lost to Follow-up|3
3117882|NCT00110305|10673155|P1|Overall Study|Lost to Follow-up|20
3117883|NCT00110305|10673154|P2|Overall Study|Withdrawal by Subject|7
3117884|NCT00110305|10673155|P1|Overall Study|Withdrawal by Subject|7
3117885|NCT00110305|10673154|P2|Overall Study|Protocol Violation|1
3117886|NCT00110305|10673155|P1|Overall Study|Protocol Violation|0
3117887|NCT00110305|10673154|P2|Overall Study|Subject Reached A Virologic Endpoint|3
3117888|NCT00110305|10673155|P1|Overall Study|Subject Reached A Virologic Endpoint|21
3117889|NCT00110305|10673154|P2|Overall Study|Subject Ineligible To Continue The Trial|1
3117890|NCT00110305|10673155|P1|Overall Study|Subject Ineligible To Continue The Trial|2
3117891|NCT00110305|10673154|P2|Overall Study|Subject Non-Compliant|2
3117892|NCT00110305|10673155|P1|Overall Study|Subject Non-Compliant|9
3117893|NCT00110305|10673154|P2|Overall Study|Sponsors Decision|0
3117894|NCT00110305|10673155|P1|Overall Study|Sponsors Decision|1
3117895|NCT00110305|10673154|P2|Overall Study|Adverse Event|13
3117896|NCT00110305|10673155|P1|Overall Study|Adverse Event|46
3117897|NCT00110214|10673208|P2|Overall Study|Other (not specified)|75
3117898|NCT00110214|10673209|P1|Overall Study|Other (not specified)|61
3117899|NCT00110214|10673208|P2|Overall Study|Refused further treatment|65
3117900|NCT00110214|10673209|P1|Overall Study|Refused further treatment|52
3117901|NCT00110214|10673208|P2|Overall Study|Adverse Event|192
3117902|NCT00110214|10673209|P1|Overall Study|Adverse Event|115
3117903|NCT00110214|10673208|P2|Overall Study|Disease progression or death|151
3117904|NCT00110214|10673209|P1|Overall Study|Disease progression or death|260
3117905|NCT00110214|10673208|P2|Overall Study|Never started treatment|20
3117906|NCT00110214|10673209|P1|Overall Study|Never started treatment|21
3117907|NCT00110149|10673221|P1|Overall Study|Physician Decision|3
3117908|NCT00110084|10673235|P1|Overall Study|Other|2
3117909|NCT00110084|10673235|P1|Overall Study|Intercurrent Illness|1
3117910|NCT00110084|10673235|P1|Overall Study|Alternate Therapy|5
3117911|NCT00110084|10673235|P1|Overall Study|Patient Refusal|10
3117912|NCT00110084|10673235|P1|Overall Study|Death|1
3117913|NCT00110084|10673235|P1|Overall Study|Adverse Event|9
3117914|NCT00110019|10673244|P2|Overall Study|other reasons|30
3117915|NCT00110019|10673245|P1|Overall Study|other reasons|22
3117916|NCT00110019|10673244|P2|Overall Study|Not start protocol therapy|16
3117917|NCT00110019|10673245|P1|Overall Study|Not start protocol therapy|17
3117918|NCT00110019|10673244|P2|Overall Study|symptom deterioration|16
3117919|NCT00110019|10673245|P1|Overall Study|symptom deterioration|13
3117920|NCT00110019|10673244|P2|Overall Study|complicating disease|1
3117921|NCT00110019|10673245|P1|Overall Study|complicating disease|1
3117922|NCT00110019|10673244|P2|Overall Study|alternative therapy|1
3117923|NCT00110019|10673245|P1|Overall Study|alternative therapy|5
3117924|NCT00110019|10673244|P2|Overall Study|Withdrawal by Subject|9
3117925|NCT00110019|10673245|P1|Overall Study|Withdrawal by Subject|21
3117926|NCT00110019|10673244|P2|Overall Study|Death|15
3117927|NCT00110019|10673245|P1|Overall Study|Death|13
3117928|NCT00110019|10673244|P2|Overall Study|Adverse Event|40
3117929|NCT00110019|10673245|P1|Overall Study|Adverse Event|61
3117930|NCT00110019|10673244|P2|Overall Study|Lack of Efficacy|285
3117931|NCT00110019|10673245|P1|Overall Study|Lack of Efficacy|253
3117932|NCT00109967|10673257|P2|Overall Study|Death|2
3117933|NCT00109967|10673258|P1|Overall Study|Death|0
3117934|NCT00109967|10673257|P2|Overall Study|Physician Decision|3
3117935|NCT00109967|10673258|P1|Overall Study|Physician Decision|1
3117936|NCT00109967|10673257|P2|Overall Study|Withdrawal by Subject|0
3117937|NCT00109967|10673258|P1|Overall Study|Withdrawal by Subject|5
3117938|NCT00109967|10673257|P2|Overall Study|Adverse Event|1
3117939|NCT00109967|10673258|P1|Overall Study|Adverse Event|12
3117940|NCT00109967|10673257|P2|Overall Study|Cancel Prior to Treatment|0
3117941|NCT00109967|10673258|P1|Overall Study|Cancel Prior to Treatment|2
3117942|NCT00109928|10673272|P1|Overall Study|not eligible|1
3117943|NCT00109928|10673272|P1|Overall Study|not protocol specified|2
3117944|NCT00109928|10673272|P1|Overall Study|Death|2
3117945|NCT00109928|10673272|P1|Overall Study|Progression|6
3117946|NCT00109928|10673272|P1|Overall Study|Adverse Event|2
3117947|NCT00109850|10673289|P1|Overall Study|Ineligible|1
3117948|NCT00109850|10673289|P1|Overall Study|Death|2
3117949|NCT00109850|10673289|P1|Overall Study|Adverse Event|1
3117950|NCT00109837|10673296|P1|Overall Study|Ineligible|1
3117951|NCT00109837|10673296|P1|Overall Study|Not treated|1
3117952|NCT00109837|10673296|P1|Overall Study|BCR/ABL+ or Ph+|17
3117953|NCT00109837|10673296|P1|Overall Study|Death|1
3117954|NCT00109837|10673296|P1|Overall Study|Refusal unrelated to adverse effects|1
3117955|NCT00109837|10673296|P1|Overall Study|Adverse Event|2
3117956|NCT00109772|10673306|P2|Open-label Extension|Other|10
3117957|NCT00109772|10673307|P1|Open-label Extension|Other|4
3117958|NCT00109772|10673306|P2|Open-label Extension|Protocol Violation|2
3117959|NCT00109772|10673307|P1|Open-label Extension|Protocol Violation|2
3117960|NCT00109772|10673306|P2|Open-label Extension|Death|1
3117961|NCT00109772|10673307|P1|Open-label Extension|Death|0
3117962|NCT00109772|10673306|P2|Open-label Extension|Lost to Follow-up|0
3117963|NCT00109772|10673307|P1|Open-label Extension|Lost to Follow-up|1
3117964|NCT00109772|10673306|P2|Open-label Extension|Withdrawal by Subject|6
3117965|NCT00109772|10673307|P1|Open-label Extension|Withdrawal by Subject|9
3117966|NCT00109772|10673306|P2|Open-label Extension|Lack of Efficacy|11
3117967|NCT00109772|10673307|P1|Open-label Extension|Lack of Efficacy|19
3117968|NCT00109772|10673306|P2|Open-label Extension|Adverse Event|19
3117969|NCT00109772|10673307|P1|Open-label Extension|Adverse Event|10
3117970|NCT00109772|10673306|P2|Double-blind Treatment|Withdrew prior to treatment|1
3117971|NCT00109772|10673307|P1|Double-blind Treatment|Withdrew prior to treatment|3
3117972|NCT00109772|10673306|P2|Double-blind Treatment|Other|4
3117973|NCT00109772|10673307|P1|Double-blind Treatment|Other|0
3117974|NCT00109772|10673306|P2|Double-blind Treatment|Protocol Violation|1
3117975|NCT00109772|10673307|P1|Double-blind Treatment|Protocol Violation|0
3117976|NCT00109772|10673306|P2|Double-blind Treatment|Lost to Follow-up|3
3117977|NCT00109772|10673307|P1|Double-blind Treatment|Lost to Follow-up|2
3117978|NCT00109772|10673306|P2|Double-blind Treatment|Withdrawal by Subject|1
3117979|NCT00109772|10673307|P1|Double-blind Treatment|Withdrawal by Subject|2
3117980|NCT00109772|10673306|P2|Double-blind Treatment|Lack of Efficacy|0
3117981|NCT00109772|10673307|P1|Double-blind Treatment|Lack of Efficacy|1
3117982|NCT00109772|10673306|P2|Double-blind Treatment|Adverse Event|5
3117983|NCT00109772|10673307|P1|Double-blind Treatment|Adverse Event|14
3117984|NCT00109733|10673347|P2|Overall Study|Could not commit time for study|1
3117985|NCT00109733|10673348|P1|Overall Study|Could not commit time for study|1
3117986|NCT00109733|10673347|P2|Overall Study|Non-compliant|1
3117987|NCT00109733|10673348|P1|Overall Study|Non-compliant|0
3117988|NCT00109733|10673347|P2|Overall Study|Stopped taking study drug|1
3117989|NCT00109733|10673348|P1|Overall Study|Stopped taking study drug|1
3117990|NCT00109733|10673347|P2|Overall Study|Protocol Violation|1
3117991|NCT00109733|10673348|P1|Overall Study|Protocol Violation|0
3117992|NCT00109590|10673365|P3|Overall Study|Never Started Treatment|3
3117993|NCT00109590|10673366|P2|Overall Study|Never Started Treatment|2
3117994|NCT00109590|10673367|P1|Overall Study|Never Started Treatment|1
3117995|NCT00109590|10673365|P3|Overall Study|Lost to Follow-up|1
3117996|NCT00109590|10673366|P2|Overall Study|Lost to Follow-up|0
3117997|NCT00109590|10673367|P1|Overall Study|Lost to Follow-up|1
3117998|NCT00109577|10673409|P2|Overall Study|Withdrawal by Subject|3
3117999|NCT00109577|10673410|P1|Overall Study|Withdrawal by Subject|3
3118000|NCT00109343|10673441|P3|Overall Study|Other|1
3118001|NCT00109343|10673442|P2|Overall Study|Other|2
3118002|NCT00109343|10673443|P1|Overall Study|Other|5
3118003|NCT00109343|10673441|P3|Overall Study|Subject Moved|1
3118004|NCT00109343|10673442|P2|Overall Study|Subject Moved|2
3118005|NCT00109343|10673443|P1|Overall Study|Subject Moved|6
3118006|NCT00109343|10673441|P3|Overall Study|Withdrawal by Subject|10
3118007|NCT00109343|10673442|P2|Overall Study|Withdrawal by Subject|11
3118008|NCT00109343|10673443|P1|Overall Study|Withdrawal by Subject|15
3118009|NCT00109343|10673441|P3|Overall Study|Protocol Violation|2
3118010|NCT00109343|10673442|P2|Overall Study|Protocol Violation|2
3118011|NCT00109343|10673443|P1|Overall Study|Protocol Violation|1
3118012|NCT00109343|10673441|P3|Overall Study|Lost to Follow-up|14
3118013|NCT00109343|10673442|P2|Overall Study|Lost to Follow-up|20
3118014|NCT00109343|10673443|P1|Overall Study|Lost to Follow-up|35
3118015|NCT00109343|10673441|P3|Overall Study|Lack of Efficacy|0
3118016|NCT00109343|10673442|P2|Overall Study|Lack of Efficacy|0
3118017|NCT00109343|10673443|P1|Overall Study|Lack of Efficacy|1
3118018|NCT00109343|10673441|P3|Overall Study|Adverse Event|2
3118019|NCT00109343|10673442|P2|Overall Study|Adverse Event|0
3118020|NCT00109343|10673443|P1|Overall Study|Adverse Event|1
3118021|NCT00109031|10673488|P4|Overall Study|Protocol Violation|0
3118022|NCT00109031|10673489|P3|Overall Study|Protocol Violation|1
3118023|NCT00109031|10673490|P2|Overall Study|Protocol Violation|0
3118024|NCT00109031|10673491|P1|Overall Study|Protocol Violation|0
3118025|NCT00109031|10673488|P4|Overall Study|Physician Decision|0
3118026|NCT00109031|10673489|P3|Overall Study|Physician Decision|0
3118027|NCT00109031|10673490|P2|Overall Study|Physician Decision|1
3118028|NCT00109031|10673491|P1|Overall Study|Physician Decision|0
3118029|NCT00109031|10673488|P4|Overall Study|Withdrawal by Subject|0
3118030|NCT00109031|10673489|P3|Overall Study|Withdrawal by Subject|0
3118031|NCT00109031|10673490|P2|Overall Study|Withdrawal by Subject|1
3118032|NCT00109031|10673491|P1|Overall Study|Withdrawal by Subject|0
3118033|NCT00109031|10673488|P4|Overall Study|Adverse Event|0
3118034|NCT00109031|10673489|P3|Overall Study|Adverse Event|1
3118035|NCT00109031|10673490|P2|Overall Study|Adverse Event|0
3118036|NCT00109031|10673491|P1|Overall Study|Adverse Event|0
3118037|NCT00108953|10673542|P2|Follow-up|Study terminated by sponsor|6
3118038|NCT00108953|10673543|P1|Follow-up|Study terminated by sponsor|10
3118039|NCT00108953|10673542|P2|Follow-up|Lost to Follow-up|1
3118040|NCT00108953|10673543|P1|Follow-up|Lost to Follow-up|1
3118041|NCT00108953|10673542|P2|Follow-up|Death|26
3118042|NCT00108953|10673543|P1|Follow-up|Death|18
3118043|NCT00108862|10673565|P2|Overall Study|Lost to Follow-up|19
3118044|NCT00108862|10673566|P1|Overall Study|Lost to Follow-up|27
3118045|NCT00108862|10673565|P2|Overall Study|Withdrawal by Subject|6
3118046|NCT00108862|10673566|P1|Overall Study|Withdrawal by Subject|10
3118047|NCT00108862|10673565|P2|Overall Study|Death|37
3118048|NCT00108862|10673566|P1|Overall Study|Death|31
3118049|NCT00108732|10673594|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
3118050|NCT00108732|10673594|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
3118051|NCT00108732|10673594|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
3118052|NCT00108732|10673594|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
3118053|NCT00108732|10673594|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
3118054|NCT00108732|10673594|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
3118055|NCT00108732|10673594|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
3118056|NCT00108628|10673603|P2|Overall Study|Death|0
3118057|NCT00108628|10673604|P1|Overall Study|Death|1
3118058|NCT00108628|10673603|P2|Overall Study|Lack of Efficacy|1
3118059|NCT00108628|10673604|P1|Overall Study|Lack of Efficacy|2
3118060|NCT00108628|10673603|P2|Overall Study|Withdrawal by Subject|9
3118061|NCT00108628|10673604|P1|Overall Study|Withdrawal by Subject|17
3118062|NCT00108485|10673654|P2|Overall Study|Lost to Follow-up|2
3118063|NCT00108485|10673655|P1|Overall Study|Lost to Follow-up|0
3118064|NCT00108485|10673654|P2|Overall Study|Withdrawal by Subject|0
3118065|NCT00108485|10673655|P1|Overall Study|Withdrawal by Subject|3
3118066|NCT00108433|10673663|P2|Overall Study|Other|14
3118067|NCT00108433|10673664|P1|Overall Study|Other|14
3118068|NCT00108433|10673663|P2|Overall Study|Adverse Event|1
3118069|NCT00108433|10673664|P1|Overall Study|Adverse Event|3
3118070|NCT00108433|10673663|P2|Overall Study|Death|0
3118071|NCT00108433|10673664|P1|Overall Study|Death|3
3118072|NCT00108433|10673663|P2|Overall Study|Lack of Efficacy|2
3118073|NCT00108433|10673664|P1|Overall Study|Lack of Efficacy|1
3118074|NCT00108355|10673680|P2|Overall Study|Loculated ascites, limiting paracentesis|1
3118075|NCT00108355|10673681|P1|Overall Study|Loculated ascites, limiting paracentesis|1
3118076|NCT00108355|10673680|P2|Overall Study|Peritonitis at index paracentesis|1
3118077|NCT00108355|10673681|P1|Overall Study|Peritonitis at index paracentesis|1
3118078|NCT00108160|10673730|P2|Overall Study|Protocol Violation|5
3118079|NCT00108160|10673731|P1|Overall Study|Protocol Violation|9
3118080|NCT00108160|10673730|P2|Overall Study|Withdrawal by Subject|2
3118081|NCT00108160|10673731|P1|Overall Study|Withdrawal by Subject|4
3118082|NCT00108160|10673730|P2|Overall Study|Death|2
3118083|NCT00108160|10673731|P1|Overall Study|Death|1
3118084|NCT00108160|10673730|P2|Overall Study|Lost to Follow-up|12
3118085|NCT00108160|10673731|P1|Overall Study|Lost to Follow-up|25
3118086|NCT00108082|10673744|P3|Overall Study|Blood Pressure Not Controlled|0
3118087|NCT00108082|10673745|P2|Overall Study|Blood Pressure Not Controlled|0
3118088|NCT00108082|10673746|P1|Overall Study|Blood Pressure Not Controlled|1
3118089|NCT00108082|10673744|P3|Overall Study|Investigator Not at Site|0
3118090|NCT00108082|10673745|P2|Overall Study|Investigator Not at Site|0
3118091|NCT00108082|10673746|P1|Overall Study|Investigator Not at Site|1
3118092|NCT00108082|10673744|P3|Overall Study|Subject Left Site Location|0
3118093|NCT00108082|10673745|P2|Overall Study|Subject Left Site Location|0
3118094|NCT00108082|10673746|P1|Overall Study|Subject Left Site Location|1
3118095|NCT00108082|10673744|P3|Overall Study|Study Medication Not Tapered|0
3118096|NCT00108082|10673745|P2|Overall Study|Study Medication Not Tapered|1
3118097|NCT00108082|10673746|P1|Overall Study|Study Medication Not Tapered|0
3118098|NCT00108082|10673744|P3|Overall Study|Protocol Amendment|0
3118099|NCT00108082|10673745|P2|Overall Study|Protocol Amendment|1
3118100|NCT00108082|10673746|P1|Overall Study|Protocol Amendment|0
3118101|NCT00108082|10673744|P3|Overall Study|Site Closed Study|0
3118102|NCT00108082|10673745|P2|Overall Study|Site Closed Study|2
3118103|NCT00108082|10673746|P1|Overall Study|Site Closed Study|0
3118104|NCT00108082|10673744|P3|Overall Study|Stopped Study Medication|1
3118105|NCT00108082|10673745|P2|Overall Study|Stopped Study Medication|0
3118106|NCT00108082|10673746|P1|Overall Study|Stopped Study Medication|0
3118107|NCT00108082|10673744|P3|Overall Study|Non-compliance|2
3118108|NCT00108082|10673745|P2|Overall Study|Non-compliance|0
3118109|NCT00108082|10673746|P1|Overall Study|Non-compliance|1
3118110|NCT00108082|10673744|P3|Overall Study|Incorrectly Randomized|2
3118111|NCT00108082|10673745|P2|Overall Study|Incorrectly Randomized|0
3118112|NCT00108082|10673746|P1|Overall Study|Incorrectly Randomized|0
3118113|NCT00108082|10673744|P3|Overall Study|Woman of Child-bearing Potential|2
3118114|NCT00108082|10673745|P2|Overall Study|Woman of Child-bearing Potential|0
3118115|NCT00108082|10673746|P1|Overall Study|Woman of Child-bearing Potential|2
3118116|NCT00108082|10673744|P3|Overall Study|Amendment 4: > Month 12|5
3118117|NCT00108082|10673745|P2|Overall Study|Amendment 4: > Month 12|7
3118118|NCT00108082|10673746|P1|Overall Study|Amendment 4: > Month 12|5
3118119|NCT00108082|10673744|P3|Overall Study|Lack of Efficacy|2
3118120|NCT00108082|10673745|P2|Overall Study|Lack of Efficacy|1
3118121|NCT00108082|10673746|P1|Overall Study|Lack of Efficacy|3
3118122|NCT00108082|10673744|P3|Overall Study|Protocol Violation|0
3118123|NCT00108082|10673745|P2|Overall Study|Protocol Violation|2
3118124|NCT00108082|10673746|P1|Overall Study|Protocol Violation|1
3118125|NCT00108082|10673744|P3|Overall Study|Consent Withdrawn|5
3118126|NCT00108082|10673745|P2|Overall Study|Consent Withdrawn|3
3118127|NCT00108082|10673746|P1|Overall Study|Consent Withdrawn|3
3118128|NCT00108082|10673744|P3|Overall Study|Lost to Follow-up|7
3118129|NCT00108082|10673745|P2|Overall Study|Lost to Follow-up|3
3118130|NCT00108082|10673746|P1|Overall Study|Lost to Follow-up|6
3118131|NCT00108082|10673744|P3|Overall Study|Adverse Event|17
3118132|NCT00108082|10673745|P2|Overall Study|Adverse Event|12
3118133|NCT00108082|10673746|P1|Overall Study|Adverse Event|14
3118134|NCT00108069|10673795|P2|Overall Study|Progessive disease|11
3118135|NCT00108069|10673796|P1|Overall Study|Progessive disease|27
3118136|NCT00108069|10673795|P2|Overall Study|Death|0
3118137|NCT00108069|10673796|P1|Overall Study|Death|1
3118138|NCT00108069|10673795|P2|Overall Study|Withdrawal by Subject|0
3118139|NCT00108069|10673796|P1|Overall Study|Withdrawal by Subject|1
3118140|NCT00108069|10673795|P2|Overall Study|Adverse Event|1
3118141|NCT00108069|10673796|P1|Overall Study|Adverse Event|1
3118142|NCT00108069|10673795|P2|Overall Study|Never rec'd study drug|1
3118143|NCT00108069|10673796|P1|Overall Study|Never rec'd study drug|0
3118144|NCT00107991|10673810|P1|18-Week Post Treatment Assessment|Adverse Event|2
3118145|NCT00107991|10673810|P1|12 Week Treatment Period|Incarcerated|1
3118146|NCT00107991|10673810|P1|12 Week Treatment Period|Protocol Violation|1
3118147|NCT00107991|10673810|P1|12 Week Treatment Period|Adverse Event|1
3118148|NCT00107991|10673810|P1|12 Week Treatment Period|Lack of Efficacy|2
3118149|NCT00107991|10673810|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
3118150|NCT00107991|10673810|P1|Eligibility Assessment|chronic uncontrolled asthma|1
3118151|NCT00107991|10673810|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
3118152|NCT00107991|10673810|P1|Eligibility Assessment|Abnormal labs|2
3118153|NCT00107991|10673810|P1|Eligibility Assessment|Positive purified protein derivative|4
3118154|NCT00107991|10673810|P1|Eligibility Assessment|Unwilling to participate|7
3118155|NCT00107991|10673810|P1|Eligibility Assessment|Disease not severe enough|7
3118156|NCT00107978|10673820|P2|Overall Study|Other|4
3118157|NCT00107978|10673821|P1|Overall Study|Other|5
3118158|NCT00107978|10673820|P2|Overall Study|Protocol Violation|1
3118159|NCT00107978|10673821|P1|Overall Study|Protocol Violation|0
3118160|NCT00107978|10673820|P2|Overall Study|Withdrawal by Subject|9
3118161|NCT00107978|10673821|P1|Overall Study|Withdrawal by Subject|4
3118162|NCT00107978|10673820|P2|Overall Study|Lost to Follow-up|28
3118163|NCT00107978|10673821|P1|Overall Study|Lost to Follow-up|20
3118164|NCT00107978|10673820|P2|Overall Study|Death|3
3118165|NCT00107978|10673821|P1|Overall Study|Death|3
3118166|NCT00107978|10673820|P2|Overall Study|Adverse Event|5
3118167|NCT00107978|10673821|P1|Overall Study|Adverse Event|1
3118168|NCT00107952|10673829|P2|Overall Study|Never received study treatment|6
3118169|NCT00107952|10673830|P1|Overall Study|Never received study treatment|9
3118170|NCT00107952|10673829|P2|Overall Study|Other|5
3118171|NCT00107952|10673830|P1|Overall Study|Other|2
3118172|NCT00107952|10673829|P2|Overall Study|Withdrawal by Subject|6
3118173|NCT00107952|10673830|P1|Overall Study|Withdrawal by Subject|9
3118174|NCT00107952|10673829|P2|Overall Study|Lost to Follow-up|3
3118175|NCT00107952|10673830|P1|Overall Study|Lost to Follow-up|0
3118176|NCT00107952|10673829|P2|Overall Study|Death|61
3118177|NCT00107952|10673830|P1|Overall Study|Death|75
3118178|NCT00107900|10673842|P6|Overall Study|Administrative Reasons|0
3118179|NCT00107900|10673843|P5|Overall Study|Administrative Reasons|2
3118180|NCT00107900|10673844|P4|Overall Study|Administrative Reasons|2
3118181|NCT00107900|10673845|P3|Overall Study|Administrative Reasons|2
3118182|NCT00107900|10673846|P2|Overall Study|Administrative Reasons|0
3118183|NCT00107900|10673847|P1|Overall Study|Administrative Reasons|1
3118184|NCT00107900|10673842|P6|Overall Study|Withdrawal by Subject|1
3118185|NCT00107900|10673843|P5|Overall Study|Withdrawal by Subject|1
3118186|NCT00107900|10673844|P4|Overall Study|Withdrawal by Subject|0
3118187|NCT00107900|10673845|P3|Overall Study|Withdrawal by Subject|5
3118188|NCT00107900|10673846|P2|Overall Study|Withdrawal by Subject|0
3118189|NCT00107900|10673847|P1|Overall Study|Withdrawal by Subject|1
3118190|NCT00107900|10673842|P6|Overall Study|Protocol Violation|0
3118191|NCT00107900|10673843|P5|Overall Study|Protocol Violation|7
3118192|NCT00107900|10673844|P4|Overall Study|Protocol Violation|5
3118193|NCT00107900|10673845|P3|Overall Study|Protocol Violation|5
3118194|NCT00107900|10673846|P2|Overall Study|Protocol Violation|0
3118195|NCT00107900|10673847|P1|Overall Study|Protocol Violation|1
3118196|NCT00107900|10673842|P6|Overall Study|Lost to Follow-up|5
3118197|NCT00107900|10673843|P5|Overall Study|Lost to Follow-up|5
3118198|NCT00107900|10673844|P4|Overall Study|Lost to Follow-up|2
3118199|NCT00107900|10673845|P3|Overall Study|Lost to Follow-up|3
3118200|NCT00107900|10673846|P2|Overall Study|Lost to Follow-up|1
3118201|NCT00107900|10673847|P1|Overall Study|Lost to Follow-up|4
3118202|NCT00107900|10673842|P6|Overall Study|Death|0
3118203|NCT00107900|10673843|P5|Overall Study|Death|1
3118204|NCT00107900|10673844|P4|Overall Study|Death|0
3118205|NCT00107900|10673845|P3|Overall Study|Death|0
3118206|NCT00107900|10673846|P2|Overall Study|Death|0
3118207|NCT00107900|10673847|P1|Overall Study|Death|0
3118208|NCT00107900|10673842|P6|Overall Study|Adverse Event|3
3118209|NCT00107900|10673843|P5|Overall Study|Adverse Event|5
3118210|NCT00107900|10673844|P4|Overall Study|Adverse Event|3
3118211|NCT00107900|10673845|P3|Overall Study|Adverse Event|10
3118212|NCT00107900|10673846|P2|Overall Study|Adverse Event|2
3118213|NCT00107900|10673847|P1|Overall Study|Adverse Event|3
3118214|NCT00107783|10673881|P2|Overall Study|Second hip replacement|1
3118215|NCT00107783|10673882|P1|Overall Study|Second hip replacement|1
3118216|NCT00107783|10673881|P2|Overall Study|Withdrawal by Subject|0
3118217|NCT00107783|10673882|P1|Overall Study|Withdrawal by Subject|2
3118218|NCT00107783|10673881|P2|Overall Study|Death|1
3118219|NCT00107783|10673882|P1|Overall Study|Death|0
3118220|NCT00107783|10673881|P2|Overall Study|Adverse Event|2
3118221|NCT00107783|10673882|P1|Overall Study|Adverse Event|0
3118222|NCT00107653|10673917|P2|Overall Study|Administrative Reasons|3
3118223|NCT00107653|10673918|P1|Overall Study|Administrative Reasons|3
3118224|NCT00107653|10673917|P2|Overall Study|Lost to Follow-up|5
3118225|NCT00107653|10673918|P1|Overall Study|Lost to Follow-up|13
3118226|NCT00107653|10673917|P2|Overall Study|Withdrawal by Subject|13
3118227|NCT00107653|10673918|P1|Overall Study|Withdrawal by Subject|12
3118228|NCT00107653|10673917|P2|Overall Study|Protocol Violation|0
3118229|NCT00107653|10673918|P1|Overall Study|Protocol Violation|1
3118230|NCT00107653|10673917|P2|Overall Study|Violation of Selection Criteria at Entry|1
3118231|NCT00107653|10673918|P1|Overall Study|Violation of Selection Criteria at Entry|1
3118232|NCT00107653|10673917|P2|Overall Study|Insufficient Therapeutic Response|11
3118233|NCT00107653|10673918|P1|Overall Study|Insufficient Therapeutic Response|25
3118234|NCT00107653|10673917|P2|Overall Study|Adverse Event|43
3118235|NCT00107653|10673918|P1|Overall Study|Adverse Event|24
3118236|NCT00107614|10673964|P1|Overall Study|Death|2
3118237|NCT00107614|10673964|P1|Overall Study|Physician Decision|10
3118238|NCT00107380|10673995|P1|Overall Study|Ineligible|2
3118239|NCT00107380|10673995|P1|Overall Study|Other - not protocol specified|7
3118240|NCT00107380|10673995|P1|Overall Study|Death|3
3118241|NCT00107380|10673995|P1|Overall Study|Progression/relapse|4
3118242|NCT00107380|10673995|P1|Overall Study|Refusal Unrelated to Adverse Event|7
3118243|NCT00107380|10673995|P1|Overall Study|Adverse Event|7
3118244|NCT00107315|10674001|P1|Overall Study|Withdrawal by Subject|2
3118245|NCT00107315|10674001|P1|Overall Study|Adverse Event|4
3118246|NCT00107315|10674001|P1|Overall Study|Disease Progression|9
3118247|NCT00107276|10674008|P1|Overall Study|Ineligible|16
3118248|NCT00107276|10674008|P1|Overall Study|Death|1
3118249|NCT00107276|10674008|P1|Overall Study|Patient refusal|1
3118250|NCT00107276|10674008|P1|Overall Study|M.D. decision|2
3118251|NCT00107276|10674008|P1|Overall Study|Adverse Event|6
3118252|NCT00107276|10674008|P1|Overall Study|Progression|46
3118253|NCT00107198|10674014|P1|Overall Study|Ineligible|5
3118254|NCT00107198|10674014|P1|Overall Study|Withdrawal by Subject|6
3118255|NCT00107198|10674014|P1|Overall Study|Protocol Violation|1
3118256|NCT00107198|10674014|P1|Overall Study|Lost to Follow-up|12
3118257|NCT00107198|10674014|P1|Overall Study|Lack of Efficacy|28
3118258|NCT00107172|10674024|P2|Overall Study|Other Reason|3
3118259|NCT00107172|10674025|P1|Overall Study|Other Reason|4
3118260|NCT00107172|10674024|P2|Overall Study|Death|2
3118261|NCT00107172|10674025|P1|Overall Study|Death|0
3118262|NCT00107172|10674024|P2|Overall Study|Withdrawal by Subject|0
3118263|NCT00107172|10674025|P1|Overall Study|Withdrawal by Subject|1
3118264|NCT00107120|10674055|P2|Overall Study|death of parent|1
3118265|NCT00107120|10674056|P1|Overall Study|death of parent|0
3118266|NCT00107120|10674055|P2|Overall Study|moving away from site|1
3118267|NCT00107120|10674056|P1|Overall Study|moving away from site|1
3118268|NCT00107120|10674055|P2|Overall Study|Pregnancy|1
3118269|NCT00107120|10674056|P1|Overall Study|Pregnancy|0
3118270|NCT00107120|10674055|P2|Overall Study|Lost to Follow-up|6
3118271|NCT00107120|10674056|P1|Overall Study|Lost to Follow-up|8
3118272|NCT00107120|10674055|P2|Overall Study|Withdrawal by Subject|9
3118273|NCT00107120|10674056|P1|Overall Study|Withdrawal by Subject|8
3118274|NCT00107120|10674055|P2|Overall Study|Protocol Violation|0
3118275|NCT00107120|10674056|P1|Overall Study|Protocol Violation|3
3118276|NCT00107120|10674055|P2|Overall Study|Lack of Efficacy|5
3118277|NCT00107120|10674056|P1|Overall Study|Lack of Efficacy|5
3118278|NCT00107120|10674055|P2|Overall Study|Adverse Event|1
3118279|NCT00107120|10674056|P1|Overall Study|Adverse Event|4
3118280|NCT00107042|10674068|P2|Overall Study|Disallowed medications|2
3118281|NCT00107042|10674069|P1|Overall Study|Disallowed medications|0
3118282|NCT00107042|10674068|P2|Overall Study|vaccinated outside window|1
3118283|NCT00107042|10674069|P1|Overall Study|vaccinated outside window|1
3118284|NCT00107042|10674068|P2|Overall Study|Inadvertent enrollment|1
3118285|NCT00107042|10674069|P1|Overall Study|Inadvertent enrollment|0
3118286|NCT00107042|10674068|P2|Overall Study|Pregnancy|1
3118287|NCT00107042|10674069|P1|Overall Study|Pregnancy|1
3118288|NCT00107042|10674068|P2|Overall Study|Moved out of area|3
3118289|NCT00107042|10674069|P1|Overall Study|Moved out of area|5
3118290|NCT00107042|10674068|P2|Overall Study|Withdrawal by Subject|1
3118291|NCT00107042|10674069|P1|Overall Study|Withdrawal by Subject|6
3118292|NCT00107042|10674068|P2|Overall Study|Lost to Follow-up|7
3118293|NCT00107042|10674069|P1|Overall Study|Lost to Follow-up|9
3118294|NCT00106964|10674135|P3|Overall Study|Required disallowed medication|0
3118295|NCT00106964|10674136|P2|Overall Study|Required disallowed medication|1
3118296|NCT00106964|10674137|P1|Overall Study|Required disallowed medication|0
3118297|NCT00106964|10674135|P3|Overall Study|Did not meet eligibility criteria|2
3118298|NCT00106964|10674136|P2|Overall Study|Did not meet eligibility criteria|2
3118299|NCT00106964|10674137|P1|Overall Study|Did not meet eligibility criteria|0
3118300|NCT00106964|10674135|P3|Overall Study|Failure to adhere|0
3118301|NCT00106964|10674136|P2|Overall Study|Failure to adhere|0
3118302|NCT00106964|10674137|P1|Overall Study|Failure to adhere|2
3118303|NCT00106964|10674135|P3|Overall Study|Site Funding Terminated|1
3118304|NCT00106964|10674136|P2|Overall Study|Site Funding Terminated|1
3118305|NCT00106964|10674137|P1|Overall Study|Site Funding Terminated|0
3118306|NCT00106964|10674135|P3|Overall Study|Incarceration|0
3118307|NCT00106964|10674136|P2|Overall Study|Incarceration|1
3118308|NCT00106964|10674137|P1|Overall Study|Incarceration|0
3118309|NCT00106964|10674135|P3|Overall Study|Death|0
3118310|NCT00106964|10674136|P2|Overall Study|Death|1
3118311|NCT00106964|10674137|P1|Overall Study|Death|1
3118312|NCT00106964|10674135|P3|Overall Study|Pregnancy|2
3118313|NCT00106964|10674136|P2|Overall Study|Pregnancy|3
3118314|NCT00106964|10674137|P1|Overall Study|Pregnancy|2
3118315|NCT00106964|10674135|P3|Overall Study|Lost to Follow-up|2
3118316|NCT00106964|10674136|P2|Overall Study|Lost to Follow-up|6
3118317|NCT00106964|10674137|P1|Overall Study|Lost to Follow-up|8
3118318|NCT00106704|10674232|P2|Overall Study|Laboratory test|1
3118319|NCT00106704|10674233|P1|Overall Study|Laboratory test|1
3118320|NCT00106704|10674232|P2|Overall Study|Unable to re-enter US|0
3118321|NCT00106704|10674233|P1|Overall Study|Unable to re-enter US|1
3118322|NCT00106704|10674232|P2|Overall Study|Patient Received Glycemic Medication|41
3118323|NCT00106704|10674233|P1|Overall Study|Patient Received Glycemic Medication|22
3118324|NCT00106704|10674232|P2|Overall Study|Planned major surgery|0
3118325|NCT00106704|10674233|P1|Overall Study|Planned major surgery|1
3118326|NCT00106704|10674232|P2|Overall Study|Site terminated|1
3118327|NCT00106704|10674233|P1|Overall Study|Site terminated|0
3118328|NCT00106704|10674232|P2|Overall Study|Patient moved|0
3118329|NCT00106704|10674233|P1|Overall Study|Patient moved|1
3118330|NCT00106704|10674232|P2|Overall Study|Withdrawal by Subject|21
3118331|NCT00106704|10674233|P1|Overall Study|Withdrawal by Subject|14
3118332|NCT00106704|10674232|P2|Overall Study|Protocol Violation|7
3118333|NCT00106704|10674233|P1|Overall Study|Protocol Violation|4
3118334|NCT00106704|10674232|P2|Overall Study|Pregnancy|0
3118335|NCT00106704|10674233|P1|Overall Study|Pregnancy|1
3118336|NCT00106704|10674232|P2|Overall Study|Lost to Follow-up|3
3118337|NCT00106704|10674233|P1|Overall Study|Lost to Follow-up|7
3118338|NCT00106704|10674232|P2|Overall Study|Lack of Efficacy|69
3118339|NCT00106704|10674233|P1|Overall Study|Lack of Efficacy|67
3118340|NCT00106704|10674232|P2|Overall Study|Death|1
3118341|NCT00106704|10674233|P1|Overall Study|Death|2
3118342|NCT00106704|10674232|P2|Overall Study|Adverse Event|7
3118343|NCT00106704|10674233|P1|Overall Study|Adverse Event|10
3118344|NCT00106639|10674244|P3|Overall Study|Participant defaulted|1
3118345|NCT00106639|10674245|P2|Overall Study|Participant defaulted|1
3118346|NCT00106639|10674246|P1|Overall Study|Participant defaulted|0
3118347|NCT00106639|10674244|P3|Overall Study|Withdrawal by Subject|0
3118348|NCT00106639|10674245|P2|Overall Study|Withdrawal by Subject|1
3118349|NCT00106639|10674246|P1|Overall Study|Withdrawal by Subject|0
3118350|NCT00106639|10674244|P3|Overall Study|Protocol Violation|0
3118351|NCT00106639|10674245|P2|Overall Study|Protocol Violation|1
3118352|NCT00106639|10674246|P1|Overall Study|Protocol Violation|0
3118353|NCT00106639|10674244|P3|Overall Study|Adverse Event|1
3118354|NCT00106639|10674245|P2|Overall Study|Adverse Event|4
3118355|NCT00106639|10674246|P1|Overall Study|Adverse Event|3
3118356|NCT00106626|10674373|P4|Overall Study|> 14 day delay in therapy start|0
3118357|NCT00106626|10674374|P3|Overall Study|> 14 day delay in therapy start|0
3118358|NCT00106626|10674375|P2|Overall Study|> 14 day delay in therapy start|1
3118359|NCT00106626|10674376|P1|Overall Study|> 14 day delay in therapy start|0
3118360|NCT00106626|10674373|P4|Overall Study|Received radiation on new therapy|0
3118361|NCT00106626|10674374|P3|Overall Study|Received radiation on new therapy|0
3118362|NCT00106626|10674375|P2|Overall Study|Received radiation on new therapy|0
3118363|NCT00106626|10674376|P1|Overall Study|Received radiation on new therapy|1
3118364|NCT00106626|10674373|P4|Overall Study|Progressive Disease|10
3118365|NCT00106626|10674374|P3|Overall Study|Progressive Disease|9
3118366|NCT00106626|10674375|P2|Overall Study|Progressive Disease|1
3118367|NCT00106626|10674376|P1|Overall Study|Progressive Disease|4
3118368|NCT00106626|10674373|P4|Overall Study|Adverse Event|3
3118369|NCT00106626|10674374|P3|Overall Study|Adverse Event|3
3118370|NCT00106626|10674375|P2|Overall Study|Adverse Event|4
3118371|NCT00106626|10674376|P1|Overall Study|Adverse Event|5
3118372|NCT00106353|10674721|P7|Part 2|Physician Decision|0
3118373|NCT00106353|10674722|P6|Part 2|Physician Decision|1
3118374|NCT00106353|10674723|P5|Part 2|Physician Decision|0
3118375|NCT00106353|10674724|P4|Part 2|Physician Decision|0
3118376|NCT00106353|10674725|P3|Part 2|Physician Decision|0
3118377|NCT00106353|10674726|P2|Part 2|Physician Decision|0
3118378|NCT00106353|10674727|P1|Part 2|Physician Decision|0
3118379|NCT00106353|10674721|P7|Part 2|Withdrawal by Subject|0
3118380|NCT00106353|10674722|P6|Part 2|Withdrawal by Subject|0
3118381|NCT00106353|10674723|P5|Part 2|Withdrawal by Subject|1
3118382|NCT00106353|10674724|P4|Part 2|Withdrawal by Subject|0
3118383|NCT00106353|10674725|P3|Part 2|Withdrawal by Subject|0
3118384|NCT00106353|10674726|P2|Part 2|Withdrawal by Subject|0
3118385|NCT00106353|10674727|P1|Part 2|Withdrawal by Subject|0
3118386|NCT00106353|10674721|P7|Part 2|Other|1
3118387|NCT00106353|10674722|P6|Part 2|Other|1
3118388|NCT00106353|10674723|P5|Part 2|Other|1
3118389|NCT00106353|10674724|P4|Part 2|Other|0
3118390|NCT00106353|10674725|P3|Part 2|Other|0
3118391|NCT00106353|10674726|P2|Part 2|Other|0
3118392|NCT00106353|10674727|P1|Part 2|Other|0
3118393|NCT00106353|10674721|P7|Part 2|Adverse Event|1
3118394|NCT00106353|10674722|P6|Part 2|Adverse Event|2
3118395|NCT00106353|10674723|P5|Part 2|Adverse Event|0
3118396|NCT00106353|10674724|P4|Part 2|Adverse Event|0
3118397|NCT00106353|10674725|P3|Part 2|Adverse Event|0
3118398|NCT00106353|10674726|P2|Part 2|Adverse Event|0
3118399|NCT00106353|10674727|P1|Part 2|Adverse Event|0
3118400|NCT00106353|10674721|P7|Part 2|Symptomatic deterioration|0
3118401|NCT00106353|10674722|P6|Part 2|Symptomatic deterioration|0
3118402|NCT00106353|10674723|P5|Part 2|Symptomatic deterioration|3
3118403|NCT00106353|10674724|P4|Part 2|Symptomatic deterioration|0
3118404|NCT00106353|10674725|P3|Part 2|Symptomatic deterioration|0
3118405|NCT00106353|10674726|P2|Part 2|Symptomatic deterioration|0
3118406|NCT00106353|10674727|P1|Part 2|Symptomatic deterioration|0
3118407|NCT00106353|10674721|P7|Part 2|Death|1
3118408|NCT00106353|10674722|P6|Part 2|Death|0
3118409|NCT00106353|10674723|P5|Part 2|Death|3
3118410|NCT00106353|10674724|P4|Part 2|Death|0
3118411|NCT00106353|10674725|P3|Part 2|Death|0
3118412|NCT00106353|10674726|P2|Part 2|Death|0
3118413|NCT00106353|10674727|P1|Part 2|Death|0
3118414|NCT00106353|10674721|P7|Part 2|Disease progression|13
3118415|NCT00106353|10674722|P6|Part 2|Disease progression|14
3118416|NCT00106353|10674723|P5|Part 2|Disease progression|8
3118417|NCT00106353|10674724|P4|Part 2|Disease progression|0
3118418|NCT00106353|10674725|P3|Part 2|Disease progression|0
3118419|NCT00106353|10674726|P2|Part 2|Disease progression|0
3118420|NCT00106353|10674727|P1|Part 2|Disease progression|0
3118421|NCT00106353|10674721|P7|Part 1|Adverse Event|0
3118422|NCT00106353|10674722|P6|Part 1|Adverse Event|0
3118423|NCT00106353|10674723|P5|Part 1|Adverse Event|0
3118424|NCT00106353|10674724|P4|Part 1|Adverse Event|1
3118425|NCT00106353|10674725|P3|Part 1|Adverse Event|0
3118426|NCT00106353|10674726|P2|Part 1|Adverse Event|0
3118427|NCT00106353|10674727|P1|Part 1|Adverse Event|0
3118428|NCT00106353|10674721|P7|Part 1|Entered follow-up phase|0
3118429|NCT00106353|10674722|P6|Part 1|Entered follow-up phase|0
3118430|NCT00106353|10674723|P5|Part 1|Entered follow-up phase|0
3118431|NCT00106353|10674724|P4|Part 1|Entered follow-up phase|1
3118432|NCT00106353|10674725|P3|Part 1|Entered follow-up phase|0
3118433|NCT00106353|10674726|P2|Part 1|Entered follow-up phase|1
3118434|NCT00106353|10674727|P1|Part 1|Entered follow-up phase|1
3118435|NCT00106353|10674721|P7|Part 1|Symptomatic deterioration|0
3118436|NCT00106353|10674722|P6|Part 1|Symptomatic deterioration|0
3118437|NCT00106353|10674723|P5|Part 1|Symptomatic deterioration|0
3118438|NCT00106353|10674724|P4|Part 1|Symptomatic deterioration|0
3118439|NCT00106353|10674725|P3|Part 1|Symptomatic deterioration|1
3118440|NCT00106353|10674726|P2|Part 1|Symptomatic deterioration|0
3118441|NCT00106353|10674727|P1|Part 1|Symptomatic deterioration|0
3118442|NCT00106353|10674721|P7|Part 1|Withdrawal by Subject|0
3118443|NCT00106353|10674722|P6|Part 1|Withdrawal by Subject|0
3118444|NCT00106353|10674723|P5|Part 1|Withdrawal by Subject|0
3118445|NCT00106353|10674724|P4|Part 1|Withdrawal by Subject|2
3118446|NCT00106353|10674725|P3|Part 1|Withdrawal by Subject|1
3118447|NCT00106353|10674726|P2|Part 1|Withdrawal by Subject|0
3118448|NCT00106353|10674727|P1|Part 1|Withdrawal by Subject|0
3118449|NCT00106353|10674721|P7|Part 1|Disease progression|0
3118450|NCT00106353|10674722|P6|Part 1|Disease progression|0
3118451|NCT00106353|10674723|P5|Part 1|Disease progression|0
3118452|NCT00106353|10674724|P4|Part 1|Disease progression|3
3118453|NCT00106353|10674725|P3|Part 1|Disease progression|1
3118454|NCT00106353|10674726|P2|Part 1|Disease progression|4
3118455|NCT00106353|10674727|P1|Part 1|Disease progression|3
3118456|NCT00106249|10674854|P2|Overall Study|Lost to Follow-up|2
3118457|NCT00106249|10674855|P1|Overall Study|Lost to Follow-up|3
3118458|NCT00106184|10674867|P2|Overall Study|Withdrawal by Subject|2
3118459|NCT00106184|10674868|P1|Overall Study|Withdrawal by Subject|3
3118460|NCT00106080|10674910|P2|Overall Study|Withdrew/Loss to follow-up|27
3118461|NCT00106080|10674911|P1|Overall Study|Withdrew/Loss to follow-up|43
3118462|NCT00106028|10674921|P2|Overall Study|Lost to Follow-up|1
3118463|NCT00106028|10674922|P1|Overall Study|Lost to Follow-up|0
3118464|NCT00106028|10674921|P2|Overall Study|Withdrawal by Subject|8
3118465|NCT00106028|10674922|P1|Overall Study|Withdrawal by Subject|2
3118466|NCT00106028|10674921|P2|Overall Study|Protocol Violation|1
3118467|NCT00106028|10674922|P1|Overall Study|Protocol Violation|1
3118468|NCT00106028|10674921|P2|Overall Study|Adverse Event|2
3118469|NCT00106028|10674922|P1|Overall Study|Adverse Event|3
3118470|NCT00106002|10675016|P1|Overall Study|Ineligible after Registration|1
3118471|NCT00106002|10675016|P1|Overall Study|Did not take any study drug|1
3118472|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
3118473|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
3118474|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
3118475|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
3118476|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Death|0
3118477|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Death|0
3118478|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
3118479|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
3118480|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
3118481|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
3118482|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
3118483|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
3118484|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
3118485|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
3118486|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
3118487|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
3118488|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
3118489|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
3118490|NCT00105989|10675024|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
3118491|NCT00105989|10675025|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
3118492|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
3118493|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
3118494|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
3118495|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
3118496|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Death|0
3118497|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Death|0
3118498|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
3118499|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
3118500|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
3118501|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
3118502|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
3118503|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
3118504|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
3118505|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
3118506|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
3118507|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
3118508|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
3118509|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
3118510|NCT00105989|10675024|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
3118511|NCT00105989|10675025|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
3118512|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
3118513|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
3118514|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
3118515|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
3118516|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Death|0
3118517|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Death|1
3118518|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Physician Decision|0
3118519|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Physician Decision|0
3118520|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
3118521|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
3118522|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
3118523|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
3118524|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
3118525|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
3118526|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
3118527|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
3118528|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
3118529|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
3118530|NCT00105989|10675024|P2|Acute - Open Label: Week 0-10|Adverse Event|0
3118531|NCT00105989|10675025|P1|Acute - Open Label: Week 0-10|Adverse Event|33
3118532|NCT00105586|10675141|P2|Overall Study|Physician Decision|13
3118533|NCT00105586|10675142|P1|Overall Study|Physician Decision|13
3118534|NCT00105586|10675141|P2|Overall Study|Adverse Event|3
3118535|NCT00105586|10675142|P1|Overall Study|Adverse Event|4
3118536|NCT00105560|10675150|P1|Overall Study|Lost to Follow-up|1
3118537|NCT00105534|10675172|P2|Overall Study|Other Reason|2
3118538|NCT00105534|10675173|P1|Overall Study|Other Reason|0
3118539|NCT00105534|10675172|P2|Overall Study|Treatment unmasked|0
3118540|NCT00105534|10675173|P1|Overall Study|Treatment unmasked|1
3118541|NCT00105534|10675172|P2|Overall Study|Lack of Efficacy|15
3118542|NCT00105534|10675173|P1|Overall Study|Lack of Efficacy|7
3118543|NCT00105534|10675172|P2|Overall Study|Lost to Follow-up|1
3118544|NCT00105534|10675173|P1|Overall Study|Lost to Follow-up|5
3118545|NCT00105534|10675172|P2|Overall Study|Withdrawal by Subject|6
3118546|NCT00105534|10675173|P1|Overall Study|Withdrawal by Subject|6
3118547|NCT00105534|10675172|P2|Overall Study|Protocol Violation|4
3118548|NCT00105534|10675173|P1|Overall Study|Protocol Violation|1
3118549|NCT00105534|10675172|P2|Overall Study|Adverse Event|5
3118550|NCT00105534|10675173|P1|Overall Study|Adverse Event|2
3118551|NCT00105521|10675185|P4|Overall Study|Lost to Follow-up|0
3118552|NCT00105521|10675186|P3|Overall Study|Lost to Follow-up|0
3118553|NCT00105521|10675187|P2|Overall Study|Lost to Follow-up|1
3118554|NCT00105521|10675188|P1|Overall Study|Lost to Follow-up|0
3118555|NCT00105521|10675185|P4|Overall Study|Protocol Violation|4
3118556|NCT00105521|10675186|P3|Overall Study|Protocol Violation|4
3118557|NCT00105521|10675187|P2|Overall Study|Protocol Violation|5
3118558|NCT00105521|10675188|P1|Overall Study|Protocol Violation|3
3118559|NCT00105521|10675185|P4|Overall Study|Lack of Efficacy|1
3118560|NCT00105521|10675186|P3|Overall Study|Lack of Efficacy|0
3118561|NCT00105521|10675187|P2|Overall Study|Lack of Efficacy|0
3118562|NCT00105521|10675188|P1|Overall Study|Lack of Efficacy|0
3118563|NCT00105521|10675185|P4|Overall Study|Withdrawal by Subject|4
3118564|NCT00105521|10675186|P3|Overall Study|Withdrawal by Subject|1
3118565|NCT00105521|10675187|P2|Overall Study|Withdrawal by Subject|0
3118566|NCT00105521|10675188|P1|Overall Study|Withdrawal by Subject|1
3118567|NCT00105521|10675185|P4|Overall Study|Adverse Event|8
3118568|NCT00105521|10675186|P3|Overall Study|Adverse Event|10
3118569|NCT00105521|10675187|P2|Overall Study|Adverse Event|4
3118570|NCT00105521|10675188|P1|Overall Study|Adverse Event|10
3118571|NCT00105521|10675185|P4|Overall Study|Other|0
3118572|NCT00105521|10675186|P3|Overall Study|Other|2
3118573|NCT00105521|10675187|P2|Overall Study|Other|1
3118574|NCT00105521|10675188|P1|Overall Study|Other|1
3118575|NCT00105508|10675212|P2|Overall Study|Other|9
3118576|NCT00105508|10675213|P1|Overall Study|Other|8
3118577|NCT00105508|10675212|P2|Overall Study|Protocol Violation|2
3118578|NCT00105508|10675213|P1|Overall Study|Protocol Violation|1
3118579|NCT00105508|10675212|P2|Overall Study|Lost to Follow-up|0
3118580|NCT00105508|10675213|P1|Overall Study|Lost to Follow-up|3
3118581|NCT00105508|10675212|P2|Overall Study|Withdrawal by Subject|6
3118582|NCT00105508|10675213|P1|Overall Study|Withdrawal by Subject|10
3118583|NCT00105508|10675212|P2|Overall Study|Insufficient Efficacy|0
3118584|NCT00105508|10675213|P1|Overall Study|Insufficient Efficacy|1
3118585|NCT00105508|10675212|P2|Overall Study|Adverse Event|19
3118586|NCT00105508|10675213|P1|Overall Study|Adverse Event|16
3118587|NCT00105508|10675212|P2|Overall Study|Prephase Dropout|0
3118588|NCT00105508|10675213|P1|Overall Study|Prephase Dropout|1
3118589|NCT00105482|10675227|P2|Overall Study|Withdrawn by PI|1
3118590|NCT00105482|10675228|P1|Overall Study|Withdrawn by PI|1
3118591|NCT00105482|10675227|P2|Overall Study|Scheduling Conflict|3
3118592|NCT00105482|10675228|P1|Overall Study|Scheduling Conflict|2
3118593|NCT00105482|10675227|P2|Overall Study|Lost Interest|32
3118594|NCT00105482|10675228|P1|Overall Study|Lost Interest|29
3118595|NCT00105482|10675227|P2|Overall Study|Withdrawal by Subject|1
3118596|NCT00105482|10675228|P1|Overall Study|Withdrawal by Subject|0
3118597|NCT00105482|10675227|P2|Overall Study|Lost to Follow-up|17
3118598|NCT00105482|10675228|P1|Overall Study|Lost to Follow-up|26
3118599|NCT00105482|10675227|P2|Overall Study|Adverse Event|1
3118600|NCT00105482|10675228|P1|Overall Study|Adverse Event|1
3118601|NCT00105469|10675244|P2|Overall Study|Other Reason|0
3118602|NCT00105469|10675245|P1|Overall Study|Other Reason|4
3118603|NCT00105469|10675244|P2|Overall Study|Lack of Efficacy|0
3118604|NCT00105469|10675245|P1|Overall Study|Lack of Efficacy|2
3118605|NCT00105469|10675244|P2|Overall Study|Lost to Follow-up|0
3118606|NCT00105469|10675245|P1|Overall Study|Lost to Follow-up|1
3118607|NCT00105469|10675244|P2|Overall Study|Withdrawal by Subject|3
3118608|NCT00105469|10675245|P1|Overall Study|Withdrawal by Subject|2
3118609|NCT00105469|10675244|P2|Overall Study|Protocol Violation|0
3118610|NCT00105469|10675245|P1|Overall Study|Protocol Violation|4
3118611|NCT00105469|10675244|P2|Overall Study|Adverse Event|8
3118612|NCT00105469|10675245|P1|Overall Study|Adverse Event|9
3118613|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
3118614|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
3118615|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
3118616|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
3118617|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
3118618|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
3118619|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
3118620|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
3118621|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
3118622|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
3118623|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
3118624|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
3118625|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
3118626|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
3118627|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
3118628|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
3118629|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
3118630|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
3118631|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
3118632|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
3118633|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
3118634|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
3118635|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
3118636|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
3118637|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
3118638|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
3118639|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
3118640|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
3118641|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
3118642|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
3118643|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
3118644|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
3118645|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
3118646|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
3118647|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
3118648|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
3118649|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
3118650|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
3118651|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
3118652|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
3118653|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
3118654|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
3118655|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
3118656|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
3118657|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
3118658|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
3118659|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
3118660|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
3118661|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
3118662|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
3118663|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
3118664|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
3118665|NCT00105443|10675255|P4|Follow-up and/or Open Label Nexavar|Death|4
3118666|NCT00105443|10675256|P3|Follow-up and/or Open Label Nexavar|Death|219
3118667|NCT00105443|10675257|P2|Follow-up and/or Open Label Nexavar|Death|7
3118668|NCT00105443|10675258|P1|Follow-up and/or Open Label Nexavar|Death|180
3118669|NCT00105443|10675255|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
3118670|NCT00105443|10675256|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
3118671|NCT00105443|10675257|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
3118672|NCT00105443|10675258|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
3118673|NCT00105443|10675255|P4|Double-Blind Treatment|Physician Decision|0
3118674|NCT00105443|10675256|P3|Double-Blind Treatment|Physician Decision|2
3118675|NCT00105443|10675257|P2|Double-Blind Treatment|Physician Decision|0
3118676|NCT00105443|10675258|P1|Double-Blind Treatment|Physician Decision|1
3118677|NCT00105443|10675255|P4|Double-Blind Treatment|Withdrawal by Subject|0
3118678|NCT00105443|10675256|P3|Double-Blind Treatment|Withdrawal by Subject|7
3118679|NCT00105443|10675257|P2|Double-Blind Treatment|Withdrawal by Subject|0
3118680|NCT00105443|10675258|P1|Double-Blind Treatment|Withdrawal by Subject|8
3118681|NCT00105443|10675255|P4|Double-Blind Treatment|Lost to Follow-up|0
3118682|NCT00105443|10675256|P3|Double-Blind Treatment|Lost to Follow-up|1
3118683|NCT00105443|10675257|P2|Double-Blind Treatment|Lost to Follow-up|0
3118684|NCT00105443|10675258|P1|Double-Blind Treatment|Lost to Follow-up|0
3118685|NCT00105443|10675255|P4|Double-Blind Treatment|Adverse Event|0
3118686|NCT00105443|10675256|P3|Double-Blind Treatment|Adverse Event|0
3118687|NCT00105443|10675257|P2|Double-Blind Treatment|Adverse Event|0
3118688|NCT00105443|10675258|P1|Double-Blind Treatment|Adverse Event|1
3118689|NCT00105235|10675285|P1|Overall Study|Withdrawal by Subject|2
3118690|NCT00105235|10675285|P1|Overall Study|Physician Decision|1
3118691|NCT00105235|10675285|P1|Overall Study|Death|4
3118692|NCT00105196|10675298|P2|Overall Study|Subject became unblinded|1
3118693|NCT00105196|10675299|P1|Overall Study|Subject became unblinded|0
3118694|NCT00105196|10675298|P2|Overall Study|marijuana use|1
3118695|NCT00105196|10675299|P1|Overall Study|marijuana use|0
3118696|NCT00105196|10675298|P2|Overall Study|pending surgery|1
3118697|NCT00105196|10675299|P1|Overall Study|pending surgery|0
3118698|NCT00105196|10675298|P2|Overall Study|Protocol Violation|2
3118699|NCT00105196|10675299|P1|Overall Study|Protocol Violation|5
3118700|NCT00105196|10675298|P2|Overall Study|Poor/noncompliance|4
3118701|NCT00105196|10675299|P1|Overall Study|Poor/noncompliance|3
3118702|NCT00105196|10675298|P2|Overall Study|Lost to Follow-up|2
3118703|NCT00105196|10675299|P1|Overall Study|Lost to Follow-up|3
3118704|NCT00105196|10675298|P2|Overall Study|Withdrawal by Subject|6
3118705|NCT00105196|10675299|P1|Overall Study|Withdrawal by Subject|6
3118706|NCT00105196|10675298|P2|Overall Study|Adverse Event|3
3118707|NCT00105196|10675299|P1|Overall Study|Adverse Event|11
3118708|NCT00105196|10675298|P2|Overall Study|Lack of Efficacy|3
3118709|NCT00105196|10675299|P1|Overall Study|Lack of Efficacy|2
3118710|NCT00105183|10675322|P3|Overall Study|Other reason|0
3118711|NCT00105183|10675323|P2|Overall Study|Other reason|2
3118712|NCT00105183|10675324|P1|Overall Study|Other reason|1
3118713|NCT00105183|10675322|P3|Overall Study|Lost to Follow-up|1
3118714|NCT00105183|10675323|P2|Overall Study|Lost to Follow-up|1
3118715|NCT00105183|10675324|P1|Overall Study|Lost to Follow-up|0
3118716|NCT00105183|10675322|P3|Overall Study|Physician Decision|3
3118717|NCT00105183|10675323|P2|Overall Study|Physician Decision|2
3118718|NCT00105183|10675324|P1|Overall Study|Physician Decision|1
3118719|NCT00105183|10675322|P3|Overall Study|Withdrawal by Subject|4
3118720|NCT00105183|10675323|P2|Overall Study|Withdrawal by Subject|1
3118721|NCT00105183|10675324|P1|Overall Study|Withdrawal by Subject|1
3118722|NCT00105183|10675322|P3|Overall Study|Death|15
3118723|NCT00105183|10675323|P2|Overall Study|Death|13
3118724|NCT00105183|10675324|P1|Overall Study|Death|19
3118725|NCT00105157|10675360|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
3118726|NCT00105157|10675361|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
3118727|NCT00105157|10675362|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
3118728|NCT00105157|10675363|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
3118729|NCT00105157|10675360|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
3118730|NCT00105157|10675361|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
3118731|NCT00105157|10675362|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
3118732|NCT00105157|10675363|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
3118733|NCT00105157|10675360|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
3118734|NCT00105157|10675361|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
3118735|NCT00105157|10675362|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
3118736|NCT00105157|10675363|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
3118737|NCT00105157|10675360|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
3118738|NCT00105157|10675361|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
3118739|NCT00105157|10675362|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
3118740|NCT00105157|10675363|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
3118741|NCT00105157|10675360|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
3118742|NCT00105157|10675361|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
3118743|NCT00105157|10675362|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
3118744|NCT00105157|10675363|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
3118745|NCT00105157|10675360|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
3118746|NCT00105157|10675361|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
3118747|NCT00105157|10675362|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
3118748|NCT00105157|10675363|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
3118749|NCT00105157|10675360|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
3118750|NCT00105157|10675361|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
3118751|NCT00105157|10675362|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
3118752|NCT00105157|10675363|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
3118753|NCT00105157|10675360|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
3118754|NCT00105157|10675361|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
3118755|NCT00105157|10675362|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
3118756|NCT00105157|10675363|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
3118757|NCT00105157|10675360|P4|Open-Label Continuation of DB|Lost to Follow-up|0
3118758|NCT00105157|10675361|P3|Open-Label Continuation of DB|Lost to Follow-up|1
3118759|NCT00105157|10675362|P2|Open-Label Continuation of DB|Lost to Follow-up|1
3118760|NCT00105157|10675363|P1|Open-Label Continuation of DB|Lost to Follow-up|1
3118761|NCT00105157|10675360|P4|Open-Label Continuation of DB|Lack of Efficacy|1
3118762|NCT00105157|10675361|P3|Open-Label Continuation of DB|Lack of Efficacy|3
3118763|NCT00105157|10675362|P2|Open-Label Continuation of DB|Lack of Efficacy|4
3118764|NCT00105157|10675363|P1|Open-Label Continuation of DB|Lack of Efficacy|1
3118765|NCT00105157|10675360|P4|Open-Label Continuation of DB|Adverse Event|0
3118766|NCT00105157|10675361|P3|Open-Label Continuation of DB|Adverse Event|0
3118767|NCT00105157|10675362|P2|Open-Label Continuation of DB|Adverse Event|1
3118768|NCT00105157|10675363|P1|Open-Label Continuation of DB|Adverse Event|3
3118769|NCT00105157|10675360|P4|Double-Blind (DB)|Lack of Efficacy|38
3118770|NCT00105157|10675361|P3|Double-Blind (DB)|Lack of Efficacy|11
3118771|NCT00105157|10675362|P2|Double-Blind (DB)|Lack of Efficacy|14
3118772|NCT00105157|10675363|P1|Double-Blind (DB)|Lack of Efficacy|11
3118773|NCT00105157|10675360|P4|Double-Blind (DB)|Adverse Event|1
3118774|NCT00105157|10675361|P3|Double-Blind (DB)|Adverse Event|1
3118775|NCT00105157|10675362|P2|Double-Blind (DB)|Adverse Event|0
3118776|NCT00105157|10675363|P1|Double-Blind (DB)|Adverse Event|2
3118777|NCT00105157|10675360|P4|Double-Blind (DB)|Never Treated|0
3118778|NCT00105157|10675361|P3|Double-Blind (DB)|Never Treated|0
3118779|NCT00105157|10675362|P2|Double-Blind (DB)|Never Treated|0
3118780|NCT00105157|10675363|P1|Double-Blind (DB)|Never Treated|1
3118781|NCT00105079|10675557|P2|Overall Study|Other|1
3118782|NCT00105079|10675558|P1|Overall Study|Other|3
3118783|NCT00105079|10675557|P2|Overall Study|Protocol Violation|0
3118784|NCT00105079|10675558|P1|Overall Study|Protocol Violation|1
3118785|NCT00105079|10675557|P2|Overall Study|Violation of selection criteria at entry|2
3118786|NCT00105079|10675558|P1|Overall Study|Violation of selection criteria at entry|0
3118787|NCT00105079|10675557|P2|Overall Study|Refused treatment|4
3118788|NCT00105079|10675558|P1|Overall Study|Refused treatment|6
3118789|NCT00105079|10675557|P2|Overall Study|Lack of Efficacy|3
3118790|NCT00105079|10675558|P1|Overall Study|Lack of Efficacy|9
3118791|NCT00105079|10675557|P2|Overall Study|Lost to Follow-up|12
3118792|NCT00105079|10675558|P1|Overall Study|Lost to Follow-up|12
3118793|NCT00105079|10675557|P2|Overall Study|Death|1
3118794|NCT00105079|10675558|P1|Overall Study|Death|3
3118795|NCT00105079|10675557|P2|Overall Study|Adverse Event|12
3118796|NCT00105079|10675558|P1|Overall Study|Adverse Event|5
3118797|NCT00105066|10675576|P2|Overall Study|Adverse Event|5
3118798|NCT00105066|10675577|P1|Overall Study|Adverse Event|2
3118799|NCT00104884|10675655|P1|Overall Study|Disease progression|4
3118800|NCT00104871|10675659|P1|Overall Study|Not evaluable|1
3118801|NCT00104728|10675680|P1|Overall Study|screen failures|19
3118802|NCT00104650|10675688|P3|Follow-up Period|Other|0
3118803|NCT00104650|10675689|P2|Follow-up Period|Other|1
3118804|NCT00104650|10675690|P1|Follow-up Period|Other|0
3118805|NCT00104650|10675688|P3|Follow-up Period|Lost to Follow-up|2
3118806|NCT00104650|10675689|P2|Follow-up Period|Lost to Follow-up|1
3118807|NCT00104650|10675690|P1|Follow-up Period|Lost to Follow-up|0
3118808|NCT00104650|10675688|P3|Follow-up Period|Disease progression|0
3118809|NCT00104650|10675689|P2|Follow-up Period|Disease progression|1
3118810|NCT00104650|10675690|P1|Follow-up Period|Disease progression|3
3118811|NCT00104650|10675688|P3|Follow-up Period|Death|4
3118812|NCT00104650|10675689|P2|Follow-up Period|Death|6
3118813|NCT00104650|10675690|P1|Follow-up Period|Death|6
3118814|NCT00104650|10675688|P3|Follow-up Period|Withdrawal by Subject|3
3118815|NCT00104650|10675689|P2|Follow-up Period|Withdrawal by Subject|3
3118816|NCT00104650|10675690|P1|Follow-up Period|Withdrawal by Subject|0
3118817|NCT00104650|10675688|P3|Follow-up Period|Adverse Event|1
3118818|NCT00104650|10675689|P2|Follow-up Period|Adverse Event|0
3118819|NCT00104650|10675690|P1|Follow-up Period|Adverse Event|1
3118820|NCT00104650|10675688|P3|Follow-up Period|Physician Decision|0
3118821|NCT00104650|10675689|P2|Follow-up Period|Physician Decision|1
3118822|NCT00104650|10675690|P1|Follow-up Period|Physician Decision|1
3118823|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Protocol deviation|0
3118824|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Protocol deviation|1
3118825|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Protocol deviation|0
3118826|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Other|0
3118827|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Other|0
3118828|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Other|1
3118829|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
3118830|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
3118831|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
3118832|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Disease progression|2
3118833|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Disease progression|3
3118834|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Disease progression|2
3118835|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Death|6
3118836|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Death|5
3118837|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Death|7
3118838|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
3118839|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
3118840|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
3118841|NCT00104650|10675688|P3|Treatment Period (25 Weeks)|Physician Decision|1
3118842|NCT00104650|10675689|P2|Treatment Period (25 Weeks)|Physician Decision|0
3118843|NCT00104650|10675690|P1|Treatment Period (25 Weeks)|Physician Decision|0
3118844|NCT00104637|10675722|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
3118845|NCT00104637|10675723|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
3118846|NCT00104572|10675752|P3|Overall Study|Withdrawal by Subject|0
3118847|NCT00104572|10675753|P2|Overall Study|Withdrawal by Subject|3
3118848|NCT00104572|10675754|P1|Overall Study|Withdrawal by Subject|3
3118849|NCT00104520|10675773|P2|Overall Study|Other|5
3118850|NCT00104520|10675774|P1|Overall Study|Other|1
3118851|NCT00104520|10675773|P2|Overall Study|Personal/administrative|1
3118852|NCT00104520|10675774|P1|Overall Study|Personal/administrative|1
3118853|NCT00104520|10675773|P2|Overall Study|Noncompliance|2
3118854|NCT00104520|10675774|P1|Overall Study|Noncompliance|0
3118855|NCT00104520|10675773|P2|Overall Study|Lost to Follow-up|0
3118856|NCT00104520|10675774|P1|Overall Study|Lost to Follow-up|1
3118857|NCT00104520|10675773|P2|Overall Study|Related adverse event|15
3118858|NCT00104520|10675774|P1|Overall Study|Related adverse event|13
3118859|NCT00104520|10675773|P2|Overall Study|Study drug intolerance|1
3118860|NCT00104520|10675774|P1|Overall Study|Study drug intolerance|0
3118861|NCT00104520|10675773|P2|Overall Study|Unrelated adverse event|47
3118862|NCT00104520|10675774|P1|Overall Study|Unrelated adverse event|34
3118863|NCT00104416|10675794|P5|Continuation Phase|Non-compliance|1
3118864|NCT00104416|10675795|P4|Continuation Phase|Non-compliance|0
3118865|NCT00104416|10675796|P3|Continuation Phase|Non-compliance|0
3118866|NCT00104416|10675797|P2|Continuation Phase|Non-compliance|0
3118867|NCT00104416|10675798|P1|Continuation Phase|Non-compliance|0
3118868|NCT00104416|10675794|P5|Continuation Phase|Pregnancy|0
3118869|NCT00104416|10675795|P4|Continuation Phase|Pregnancy|1
3118870|NCT00104416|10675796|P3|Continuation Phase|Pregnancy|1
3118871|NCT00104416|10675797|P2|Continuation Phase|Pregnancy|0
3118872|NCT00104416|10675798|P1|Continuation Phase|Pregnancy|0
3118873|NCT00104416|10675794|P5|Continuation Phase|Withdrawal by Subject|1
3118874|NCT00104416|10675795|P4|Continuation Phase|Withdrawal by Subject|1
3118875|NCT00104416|10675796|P3|Continuation Phase|Withdrawal by Subject|2
3118876|NCT00104416|10675797|P2|Continuation Phase|Withdrawal by Subject|0
3118877|NCT00104416|10675798|P1|Continuation Phase|Withdrawal by Subject|0
3118878|NCT00104416|10675794|P5|Continuation Phase|Lost to Follow-up|1
3118879|NCT00104416|10675795|P4|Continuation Phase|Lost to Follow-up|0
3118880|NCT00104416|10675796|P3|Continuation Phase|Lost to Follow-up|1
3118881|NCT00104416|10675797|P2|Continuation Phase|Lost to Follow-up|0
3118882|NCT00104416|10675798|P1|Continuation Phase|Lost to Follow-up|0
3118883|NCT00104416|10675794|P5|Continuation Phase|Adverse Event|2
3118884|NCT00104416|10675795|P4|Continuation Phase|Adverse Event|0
3118885|NCT00104416|10675796|P3|Continuation Phase|Adverse Event|2
3118886|NCT00104416|10675797|P2|Continuation Phase|Adverse Event|0
3118887|NCT00104416|10675798|P1|Continuation Phase|Adverse Event|0
3118888|NCT00104416|10675794|P5|Double-Blind Phase|Participant Did Not Take Drug|0
3118889|NCT00104416|10675795|P4|Double-Blind Phase|Participant Did Not Take Drug|0
3118890|NCT00104416|10675796|P3|Double-Blind Phase|Participant Did Not Take Drug|0
3118891|NCT00104416|10675797|P2|Double-Blind Phase|Participant Did Not Take Drug|4
3118892|NCT00104416|10675798|P1|Double-Blind Phase|Participant Did Not Take Drug|3
3118893|NCT00104416|10675794|P5|Double-Blind Phase|Pregnancy|0
3118894|NCT00104416|10675795|P4|Double-Blind Phase|Pregnancy|0
3118895|NCT00104416|10675796|P3|Double-Blind Phase|Pregnancy|0
3118896|NCT00104416|10675797|P2|Double-Blind Phase|Pregnancy|0
3118897|NCT00104416|10675798|P1|Double-Blind Phase|Pregnancy|1
3118898|NCT00104416|10675794|P5|Double-Blind Phase|Withdrawal by Subject|0
3118899|NCT00104416|10675795|P4|Double-Blind Phase|Withdrawal by Subject|0
3118900|NCT00104416|10675796|P3|Double-Blind Phase|Withdrawal by Subject|0
3118901|NCT00104416|10675797|P2|Double-Blind Phase|Withdrawal by Subject|3
3118902|NCT00104416|10675798|P1|Double-Blind Phase|Withdrawal by Subject|2
3118903|NCT00104416|10675794|P5|Double-Blind Phase|Protocol Violation|0
3118904|NCT00104416|10675795|P4|Double-Blind Phase|Protocol Violation|0
3118905|NCT00104416|10675796|P3|Double-Blind Phase|Protocol Violation|0
3118906|NCT00104416|10675797|P2|Double-Blind Phase|Protocol Violation|1
3118907|NCT00104416|10675798|P1|Double-Blind Phase|Protocol Violation|0
3118908|NCT00104416|10675794|P5|Double-Blind Phase|Lost to Follow-up|0
3118909|NCT00104416|10675795|P4|Double-Blind Phase|Lost to Follow-up|0
3118910|NCT00104416|10675796|P3|Double-Blind Phase|Lost to Follow-up|0
3118911|NCT00104416|10675797|P2|Double-Blind Phase|Lost to Follow-up|1
3118912|NCT00104416|10675798|P1|Double-Blind Phase|Lost to Follow-up|0
3118913|NCT00104416|10675794|P5|Double-Blind Phase|Adverse Event|0
3118914|NCT00104416|10675795|P4|Double-Blind Phase|Adverse Event|0
3118915|NCT00104416|10675796|P3|Double-Blind Phase|Adverse Event|0
3118916|NCT00104416|10675797|P2|Double-Blind Phase|Adverse Event|1
3118917|NCT00104416|10675798|P1|Double-Blind Phase|Adverse Event|2
3118918|NCT00104299|10675843|P2|Overall Study|To have renal transplant|0
3118919|NCT00104299|10675844|P1|Overall Study|To have renal transplant|1
3118920|NCT00104299|10675843|P2|Overall Study|Physician Decision|1
3118921|NCT00104299|10675844|P1|Overall Study|Physician Decision|1
3118922|NCT00104299|10675843|P2|Overall Study|Withdrawal by Subject|6
3118923|NCT00104299|10675844|P1|Overall Study|Withdrawal by Subject|2
3118924|NCT00104299|10675843|P2|Overall Study|Death|2
3118925|NCT00104299|10675844|P1|Overall Study|Death|2
3118926|NCT00104299|10675843|P2|Overall Study|Adverse Event|1
3118927|NCT00104299|10675844|P1|Overall Study|Adverse Event|3
3118928|NCT00104247|10675866|P2|Overall Study|Noncompliant with dosing|1
3118929|NCT00104247|10675867|P1|Overall Study|Noncompliant with dosing|0
3118930|NCT00104247|10675866|P2|Overall Study|Withdrawal by Subject|0
3118931|NCT00104247|10675867|P1|Overall Study|Withdrawal by Subject|1
3118932|NCT00104104|10675886|P2|Overall Study|Death|6
3118933|NCT00104104|10675887|P1|Overall Study|Death|9
3118934|NCT00104104|10675886|P2|Overall Study|Administrative problems|13
3118935|NCT00104104|10675887|P1|Overall Study|Administrative problems|12
3118936|NCT00104104|10675886|P2|Overall Study|Lost to Follow-up|7
3118937|NCT00104104|10675887|P1|Overall Study|Lost to Follow-up|3
3118938|NCT00104104|10675886|P2|Overall Study|Withdrawal by Subject|15
3118939|NCT00104104|10675887|P1|Overall Study|Withdrawal by Subject|11
3118940|NCT00104104|10675886|P2|Overall Study|Protocol Violation|2
3118941|NCT00104104|10675887|P1|Overall Study|Protocol Violation|5
3118942|NCT00104104|10675886|P2|Overall Study|Condition no longer requires study drug|4
3118943|NCT00104104|10675887|P1|Overall Study|Condition no longer requires study drug|7
3118944|NCT00104104|10675886|P2|Overall Study|Lack of Efficacy|3
3118945|NCT00104104|10675887|P1|Overall Study|Lack of Efficacy|0
3118946|NCT00104104|10675886|P2|Overall Study|Abnormal laboratory value(s)|14
3118947|NCT00104104|10675887|P1|Overall Study|Abnormal laboratory value(s)|20
3118948|NCT00104104|10675886|P2|Overall Study|Adverse Event|8
3118949|NCT00104104|10675887|P1|Overall Study|Adverse Event|8
3118950|NCT00104052|10675901|P1|Overall Study|Discontinuation unrelated to treatment|2
3118951|NCT00104052|10675901|P1|Overall Study|Lack of Efficacy|26
3118952|NCT00104052|10675901|P1|Overall Study|Adverse Event|1
3118953|NCT00103857|10675912|P7|50-Week Extension Study|reason unspecified|0
3118954|NCT00103857|10675913|P6|50-Week Extension Study|reason unspecified|0
3118955|NCT00103857|10675914|P5|50-Week Extension Study|reason unspecified|1
3118956|NCT00103857|10675915|P4|50-Week Extension Study|reason unspecified|0
3118957|NCT00103857|10675916|P3|50-Week Extension Study|reason unspecified|0
3118958|NCT00103857|10675917|P2|50-Week Extension Study|reason unspecified|0
3118959|NCT00103857|10675918|P1|50-Week Extension Study|reason unspecified|0
3118960|NCT00103857|10675912|P7|50-Week Extension Study|patient scheduled for elective surgery|0
3118961|NCT00103857|10675913|P6|50-Week Extension Study|patient scheduled for elective surgery|0
3118962|NCT00103857|10675914|P5|50-Week Extension Study|patient scheduled for elective surgery|0
3118963|NCT00103857|10675915|P4|50-Week Extension Study|patient scheduled for elective surgery|0
3118964|NCT00103857|10675916|P3|50-Week Extension Study|patient scheduled for elective surgery|1
3118965|NCT00103857|10675917|P2|50-Week Extension Study|patient scheduled for elective surgery|0
3118966|NCT00103857|10675918|P1|50-Week Extension Study|patient scheduled for elective surgery|0
3118967|NCT00103857|10675912|P7|50-Week Extension Study|patient moved|0
3118968|NCT00103857|10675913|P6|50-Week Extension Study|patient moved|0
3118969|NCT00103857|10675914|P5|50-Week Extension Study|patient moved|0
3118970|NCT00103857|10675915|P4|50-Week Extension Study|patient moved|2
3118971|NCT00103857|10675916|P3|50-Week Extension Study|patient moved|1
3118972|NCT00103857|10675917|P2|50-Week Extension Study|patient moved|0
3118973|NCT00103857|10675918|P1|50-Week Extension Study|patient moved|0
3118974|NCT00103857|10675912|P7|50-Week Extension Study|non-compliance with study procedures|0
3118975|NCT00103857|10675913|P6|50-Week Extension Study|non-compliance with study procedures|0
3118976|NCT00103857|10675914|P5|50-Week Extension Study|non-compliance with study procedures|1
3118977|NCT00103857|10675915|P4|50-Week Extension Study|non-compliance with study procedures|1
3118978|NCT00103857|10675916|P3|50-Week Extension Study|non-compliance with study procedures|0
3118979|NCT00103857|10675917|P2|50-Week Extension Study|non-compliance with study procedures|0
3118980|NCT00103857|10675918|P1|50-Week Extension Study|non-compliance with study procedures|1
3118981|NCT00103857|10675912|P7|50-Week Extension Study|protocol discontinuation criteria|0
3118982|NCT00103857|10675913|P6|50-Week Extension Study|protocol discontinuation criteria|3
3118983|NCT00103857|10675914|P5|50-Week Extension Study|protocol discontinuation criteria|3
3118984|NCT00103857|10675915|P4|50-Week Extension Study|protocol discontinuation criteria|2
3118985|NCT00103857|10675916|P3|50-Week Extension Study|protocol discontinuation criteria|3
3118986|NCT00103857|10675917|P2|50-Week Extension Study|protocol discontinuation criteria|2
3118987|NCT00103857|10675918|P1|50-Week Extension Study|protocol discontinuation criteria|2
3118988|NCT00103857|10675912|P7|50-Week Extension Study|Withdrawal by Subject|0
3118989|NCT00103857|10675913|P6|50-Week Extension Study|Withdrawal by Subject|3
3118990|NCT00103857|10675914|P5|50-Week Extension Study|Withdrawal by Subject|3
3118991|NCT00103857|10675915|P4|50-Week Extension Study|Withdrawal by Subject|8
3118992|NCT00103857|10675916|P3|50-Week Extension Study|Withdrawal by Subject|2
3118993|NCT00103857|10675917|P2|50-Week Extension Study|Withdrawal by Subject|5
3118994|NCT00103857|10675918|P1|50-Week Extension Study|Withdrawal by Subject|2
3118995|NCT00103857|10675912|P7|50-Week Extension Study|Protocol Violation|0
3118996|NCT00103857|10675913|P6|50-Week Extension Study|Protocol Violation|1
3118997|NCT00103857|10675914|P5|50-Week Extension Study|Protocol Violation|0
3118998|NCT00103857|10675915|P4|50-Week Extension Study|Protocol Violation|2
3118999|NCT00103857|10675916|P3|50-Week Extension Study|Protocol Violation|1
3119000|NCT00103857|10675917|P2|50-Week Extension Study|Protocol Violation|1
3119001|NCT00103857|10675918|P1|50-Week Extension Study|Protocol Violation|1
3119002|NCT00103857|10675912|P7|50-Week Extension Study|Pregnancy|0
3119003|NCT00103857|10675913|P6|50-Week Extension Study|Pregnancy|0
3119004|NCT00103857|10675914|P5|50-Week Extension Study|Pregnancy|1
3119005|NCT00103857|10675915|P4|50-Week Extension Study|Pregnancy|0
3119006|NCT00103857|10675916|P3|50-Week Extension Study|Pregnancy|1
3119007|NCT00103857|10675917|P2|50-Week Extension Study|Pregnancy|0
3119008|NCT00103857|10675918|P1|50-Week Extension Study|Pregnancy|0
3119009|NCT00103857|10675912|P7|50-Week Extension Study|Physician Decision|0
3119010|NCT00103857|10675913|P6|50-Week Extension Study|Physician Decision|0
3119011|NCT00103857|10675914|P5|50-Week Extension Study|Physician Decision|0
3119012|NCT00103857|10675915|P4|50-Week Extension Study|Physician Decision|0
3119013|NCT00103857|10675916|P3|50-Week Extension Study|Physician Decision|1
3119014|NCT00103857|10675917|P2|50-Week Extension Study|Physician Decision|1
3119015|NCT00103857|10675918|P1|50-Week Extension Study|Physician Decision|0
3119016|NCT00103857|10675912|P7|50-Week Extension Study|Lost to Follow-up|0
3119017|NCT00103857|10675913|P6|50-Week Extension Study|Lost to Follow-up|3
3119018|NCT00103857|10675914|P5|50-Week Extension Study|Lost to Follow-up|3
3119019|NCT00103857|10675915|P4|50-Week Extension Study|Lost to Follow-up|4
3119020|NCT00103857|10675916|P3|50-Week Extension Study|Lost to Follow-up|1
3119021|NCT00103857|10675917|P2|50-Week Extension Study|Lost to Follow-up|0
3119022|NCT00103857|10675918|P1|50-Week Extension Study|Lost to Follow-up|4
3119023|NCT00103857|10675912|P7|50-Week Extension Study|Lack of Efficacy|0
3119024|NCT00103857|10675913|P6|50-Week Extension Study|Lack of Efficacy|8
3119025|NCT00103857|10675914|P5|50-Week Extension Study|Lack of Efficacy|8
3119026|NCT00103857|10675915|P4|50-Week Extension Study|Lack of Efficacy|16
3119027|NCT00103857|10675916|P3|50-Week Extension Study|Lack of Efficacy|13
3119028|NCT00103857|10675917|P2|50-Week Extension Study|Lack of Efficacy|15
3119029|NCT00103857|10675918|P1|50-Week Extension Study|Lack of Efficacy|26
3119030|NCT00103857|10675912|P7|50-Week Extension Study|Death|0
3119031|NCT00103857|10675913|P6|50-Week Extension Study|Death|1
3119032|NCT00103857|10675914|P5|50-Week Extension Study|Death|0
3119033|NCT00103857|10675915|P4|50-Week Extension Study|Death|1
3119034|NCT00103857|10675916|P3|50-Week Extension Study|Death|0
3119035|NCT00103857|10675917|P2|50-Week Extension Study|Death|0
3119036|NCT00103857|10675918|P1|50-Week Extension Study|Death|0
3119037|NCT00103857|10675912|P7|50-Week Extension Study|Adverse Event|0
3119038|NCT00103857|10675913|P6|50-Week Extension Study|Adverse Event|1
3119039|NCT00103857|10675914|P5|50-Week Extension Study|Adverse Event|1
3119040|NCT00103857|10675915|P4|50-Week Extension Study|Adverse Event|0
3119041|NCT00103857|10675916|P3|50-Week Extension Study|Adverse Event|2
3119042|NCT00103857|10675917|P2|50-Week Extension Study|Adverse Event|3
3119043|NCT00103857|10675918|P1|50-Week Extension Study|Adverse Event|2
3119044|NCT00103857|10675912|P7|54-Week Base Study|patient intolerance to rescue therapy|0
3119045|NCT00103857|10675913|P6|54-Week Base Study|patient intolerance to rescue therapy|0
3119046|NCT00103857|10675914|P5|54-Week Base Study|patient intolerance to rescue therapy|0
3119047|NCT00103857|10675915|P4|54-Week Base Study|patient intolerance to rescue therapy|0
3119048|NCT00103857|10675916|P3|54-Week Base Study|patient intolerance to rescue therapy|0
3119049|NCT00103857|10675917|P2|54-Week Base Study|patient intolerance to rescue therapy|0
3119050|NCT00103857|10675918|P1|54-Week Base Study|patient intolerance to rescue therapy|1
3119051|NCT00103857|10675912|P7|54-Week Base Study|site error|0
3119052|NCT00103857|10675913|P6|54-Week Base Study|site error|1
3119053|NCT00103857|10675914|P5|54-Week Base Study|site error|0
3119054|NCT00103857|10675915|P4|54-Week Base Study|site error|0
3119055|NCT00103857|10675916|P3|54-Week Base Study|site error|0
3119056|NCT00103857|10675917|P2|54-Week Base Study|site error|0
3119057|NCT00103857|10675918|P1|54-Week Base Study|site error|0
3119058|NCT00103857|10675912|P7|54-Week Base Study|laboratory reporting error|0
3119059|NCT00103857|10675913|P6|54-Week Base Study|laboratory reporting error|0
3119060|NCT00103857|10675914|P5|54-Week Base Study|laboratory reporting error|1
3119061|NCT00103857|10675915|P4|54-Week Base Study|laboratory reporting error|0
3119062|NCT00103857|10675916|P3|54-Week Base Study|laboratory reporting error|0
3119063|NCT00103857|10675917|P2|54-Week Base Study|laboratory reporting error|0
3119064|NCT00103857|10675918|P1|54-Week Base Study|laboratory reporting error|0
3119065|NCT00103857|10675912|P7|54-Week Base Study|patient incarcerated|0
3119066|NCT00103857|10675913|P6|54-Week Base Study|patient incarcerated|1
3119067|NCT00103857|10675914|P5|54-Week Base Study|patient incarcerated|1
3119068|NCT00103857|10675915|P4|54-Week Base Study|patient incarcerated|0
3119069|NCT00103857|10675916|P3|54-Week Base Study|patient incarcerated|0
3119070|NCT00103857|10675917|P2|54-Week Base Study|patient incarcerated|0
3119071|NCT00103857|10675918|P1|54-Week Base Study|patient incarcerated|0
3119072|NCT00103857|10675912|P7|54-Week Base Study|non-compliance with study procedures|0
3119073|NCT00103857|10675913|P6|54-Week Base Study|non-compliance with study procedures|2
3119074|NCT00103857|10675914|P5|54-Week Base Study|non-compliance with study procedures|0
3119075|NCT00103857|10675915|P4|54-Week Base Study|non-compliance with study procedures|0
3119076|NCT00103857|10675916|P3|54-Week Base Study|non-compliance with study procedures|0
3119077|NCT00103857|10675917|P2|54-Week Base Study|non-compliance with study procedures|2
3119078|NCT00103857|10675918|P1|54-Week Base Study|non-compliance with study procedures|1
3119079|NCT00103857|10675912|P7|54-Week Base Study|patient moved|0
3119080|NCT00103857|10675913|P6|54-Week Base Study|patient moved|1
3119081|NCT00103857|10675914|P5|54-Week Base Study|patient moved|3
3119082|NCT00103857|10675915|P4|54-Week Base Study|patient moved|2
3119083|NCT00103857|10675916|P3|54-Week Base Study|patient moved|1
3119084|NCT00103857|10675917|P2|54-Week Base Study|patient moved|1
3119085|NCT00103857|10675918|P1|54-Week Base Study|patient moved|0
3119086|NCT00103857|10675912|P7|54-Week Base Study|protocol discontinuation criteria|5
3119087|NCT00103857|10675913|P6|54-Week Base Study|protocol discontinuation criteria|3
3119088|NCT00103857|10675914|P5|54-Week Base Study|protocol discontinuation criteria|5
3119089|NCT00103857|10675915|P4|54-Week Base Study|protocol discontinuation criteria|6
3119090|NCT00103857|10675916|P3|54-Week Base Study|protocol discontinuation criteria|2
3119091|NCT00103857|10675917|P2|54-Week Base Study|protocol discontinuation criteria|5
3119092|NCT00103857|10675918|P1|54-Week Base Study|protocol discontinuation criteria|2
3119093|NCT00103857|10675912|P7|54-Week Base Study|Withdrawal by Subject|4
3119094|NCT00103857|10675913|P6|54-Week Base Study|Withdrawal by Subject|15
3119095|NCT00103857|10675914|P5|54-Week Base Study|Withdrawal by Subject|10
3119096|NCT00103857|10675915|P4|54-Week Base Study|Withdrawal by Subject|15
3119097|NCT00103857|10675916|P3|54-Week Base Study|Withdrawal by Subject|16
3119098|NCT00103857|10675917|P2|54-Week Base Study|Withdrawal by Subject|16
3119099|NCT00103857|10675918|P1|54-Week Base Study|Withdrawal by Subject|17
3119100|NCT00103857|10675912|P7|54-Week Base Study|Protocol Violation|3
3119101|NCT00103857|10675913|P6|54-Week Base Study|Protocol Violation|3
3119102|NCT00103857|10675914|P5|54-Week Base Study|Protocol Violation|0
3119103|NCT00103857|10675915|P4|54-Week Base Study|Protocol Violation|4
3119104|NCT00103857|10675916|P3|54-Week Base Study|Protocol Violation|2
3119105|NCT00103857|10675917|P2|54-Week Base Study|Protocol Violation|4
3119106|NCT00103857|10675918|P1|54-Week Base Study|Protocol Violation|6
3119107|NCT00103857|10675912|P7|54-Week Base Study|Pregnancy|1
3119108|NCT00103857|10675913|P6|54-Week Base Study|Pregnancy|0
3119109|NCT00103857|10675914|P5|54-Week Base Study|Pregnancy|1
3119110|NCT00103857|10675915|P4|54-Week Base Study|Pregnancy|0
3119111|NCT00103857|10675916|P3|54-Week Base Study|Pregnancy|0
3119112|NCT00103857|10675917|P2|54-Week Base Study|Pregnancy|0
3119113|NCT00103857|10675918|P1|54-Week Base Study|Pregnancy|1
3119114|NCT00103857|10675912|P7|54-Week Base Study|Physician Decision|0
3119115|NCT00103857|10675913|P6|54-Week Base Study|Physician Decision|0
3119116|NCT00103857|10675914|P5|54-Week Base Study|Physician Decision|1
3119117|NCT00103857|10675915|P4|54-Week Base Study|Physician Decision|0
3119118|NCT00103857|10675916|P3|54-Week Base Study|Physician Decision|0
3119119|NCT00103857|10675917|P2|54-Week Base Study|Physician Decision|1
3119120|NCT00103857|10675918|P1|54-Week Base Study|Physician Decision|1
3119121|NCT00103857|10675912|P7|54-Week Base Study|Lost to Follow-up|3
3119122|NCT00103857|10675913|P6|54-Week Base Study|Lost to Follow-up|9
3119123|NCT00103857|10675914|P5|54-Week Base Study|Lost to Follow-up|10
3119124|NCT00103857|10675915|P4|54-Week Base Study|Lost to Follow-up|5
3119125|NCT00103857|10675916|P3|54-Week Base Study|Lost to Follow-up|7
3119126|NCT00103857|10675917|P2|54-Week Base Study|Lost to Follow-up|4
3119127|NCT00103857|10675918|P1|54-Week Base Study|Lost to Follow-up|5
3119128|NCT00103857|10675912|P7|54-Week Base Study|Lack of Efficacy|19
3119129|NCT00103857|10675913|P6|54-Week Base Study|Lack of Efficacy|14
3119130|NCT00103857|10675914|P5|54-Week Base Study|Lack of Efficacy|3
3119131|NCT00103857|10675915|P4|54-Week Base Study|Lack of Efficacy|4
3119132|NCT00103857|10675916|P3|54-Week Base Study|Lack of Efficacy|8
3119133|NCT00103857|10675917|P2|54-Week Base Study|Lack of Efficacy|14
3119134|NCT00103857|10675918|P1|54-Week Base Study|Lack of Efficacy|11
3119135|NCT00103857|10675912|P7|54-Week Base Study|Death|0
3119136|NCT00103857|10675913|P6|54-Week Base Study|Death|1
3119137|NCT00103857|10675914|P5|54-Week Base Study|Death|1
3119138|NCT00103857|10675915|P4|54-Week Base Study|Death|0
3119139|NCT00103857|10675916|P3|54-Week Base Study|Death|0
3119140|NCT00103857|10675917|P2|54-Week Base Study|Death|0
3119141|NCT00103857|10675918|P1|54-Week Base Study|Death|0
3119142|NCT00103857|10675912|P7|54-Week Base Study|Adverse Event|3
3119143|NCT00103857|10675913|P6|54-Week Base Study|Adverse Event|11
3119144|NCT00103857|10675914|P5|54-Week Base Study|Adverse Event|5
3119145|NCT00103857|10675915|P4|54-Week Base Study|Adverse Event|6
3119146|NCT00103857|10675916|P3|54-Week Base Study|Adverse Event|11
3119147|NCT00103857|10675917|P2|54-Week Base Study|Adverse Event|9
3119148|NCT00103857|10675918|P1|54-Week Base Study|Adverse Event|12
3119149|NCT00103740|10676017|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
3119150|NCT00103740|10676018|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
3119151|NCT00103740|10676017|P2|Period 2 - Extended Observation Period|Death|2
3119152|NCT00103740|10676018|P1|Period 2 - Extended Observation Period|Death|6
3119153|NCT00103740|10676017|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
3119154|NCT00103740|10676018|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
3119155|NCT00103740|10676017|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
3119156|NCT00103740|10676018|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
3119157|NCT00103740|10676017|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
3119158|NCT00103740|10676018|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
3119159|NCT00103740|10676017|P2|Period 1 - Core|Patient withdrew consent|2
3119160|NCT00103740|10676018|P1|Period 1 - Core|Patient withdrew consent|3
3119161|NCT00103740|10676017|P2|Period 1 - Core|Protocol Violation|2
3119162|NCT00103740|10676018|P1|Period 1 - Core|Protocol Violation|3
3119163|NCT00103740|10676017|P2|Period 1 - Core|Adverse Event|0
3119164|NCT00103740|10676018|P1|Period 1 - Core|Adverse Event|1
3119165|NCT00103662|10676046|P2|Overall Study|Intercurrent illness|0
3119166|NCT00103662|10676047|P1|Overall Study|Intercurrent illness|1
3119167|NCT00103662|10676046|P2|Overall Study|Failed mobilization|4
3119168|NCT00103662|10676047|P1|Overall Study|Failed mobilization|0
3119169|NCT00103662|10676046|P2|Overall Study|Other|9
3119170|NCT00103662|10676047|P1|Overall Study|Other|6
3119171|NCT00103662|10676046|P2|Overall Study|Lost to Follow-up|1
3119172|NCT00103662|10676047|P1|Overall Study|Lost to Follow-up|0
3119173|NCT00103662|10676046|P2|Overall Study|Elective Withdrawal|5
3119174|NCT00103662|10676047|P1|Overall Study|Elective Withdrawal|5
3119175|NCT00103662|10676046|P2|Overall Study|Death|7
3119176|NCT00103662|10676047|P1|Overall Study|Death|7
3119177|NCT00103662|10676046|P2|Overall Study|Entered Rescue Procedure|7
3119178|NCT00103662|10676047|P1|Overall Study|Entered Rescue Procedure|0
3119179|NCT00103610|10676073|P2|Overall Study|Noncompliance|1
3119180|NCT00103610|10676074|P1|Overall Study|Noncompliance|0
3119181|NCT00103610|10676073|P2|Overall Study|Failed mobilization|5
3119182|NCT00103610|10676074|P1|Overall Study|Failed mobilization|1
3119183|NCT00103610|10676073|P2|Overall Study|Other|7
3119184|NCT00103610|10676074|P1|Overall Study|Other|2
3119185|NCT00103610|10676073|P2|Overall Study|Adverse Event|2
3119186|NCT00103610|10676074|P1|Overall Study|Adverse Event|2
3119187|NCT00103610|10676073|P2|Overall Study|Lost to Follow-up|1
3119188|NCT00103610|10676074|P1|Overall Study|Lost to Follow-up|3
3119189|NCT00103610|10676073|P2|Overall Study|Elective Withdrawal|0
3119190|NCT00103610|10676074|P1|Overall Study|Elective Withdrawal|4
3119191|NCT00103610|10676073|P2|Overall Study|Death|12
3119192|NCT00103610|10676074|P1|Overall Study|Death|16
3119193|NCT00103610|10676073|P2|Overall Study|Entered Rescue Procedure|52
3119194|NCT00103610|10676074|P1|Overall Study|Entered Rescue Procedure|10
3119195|NCT00103506|10676098|P2|Overall Study|Withdrawal by Subject|21
3119196|NCT00103506|10676099|P1|Overall Study|Withdrawal by Subject|18
3119197|NCT00103506|10676098|P2|Overall Study|Lost to Follow-up|13
3119198|NCT00103506|10676099|P1|Overall Study|Lost to Follow-up|13
3119199|NCT00103506|10676098|P2|Overall Study|Death|253
3119200|NCT00103506|10676099|P1|Overall Study|Death|257
3119201|NCT00103506|10676098|P2|Overall Study|Study closed by sponsor|37
3119202|NCT00103506|10676099|P1|Overall Study|Study closed by sponsor|34
3119203|NCT00103311|10676130|P2|Overall Study|Adverse Event|0
3119204|NCT00103311|10676131|P1|Overall Study|Adverse Event|1
3119205|NCT00103311|10676130|P2|Overall Study|Withdrawal by Subject|1
3119206|NCT00103311|10676131|P1|Overall Study|Withdrawal by Subject|2
3119207|NCT00103311|10676130|P2|Overall Study|Lost to Follow-up|0
3119208|NCT00103311|10676131|P1|Overall Study|Lost to Follow-up|1
3119209|NCT00103285|10676141|P8|Response Assignment|Other|53
3119210|NCT00103285|10676142|P7|Response Assignment|Other|11
3119211|NCT00103285|10676143|P6|Response Assignment|Other|17
3119212|NCT00103285|10676144|P5|Response Assignment|Other|37
3119213|NCT00103285|10676145|P4|Response Assignment|Other|38
3119214|NCT00103285|10676146|P3|Response Assignment|Other|48
3119215|NCT00103285|10676147|P2|Response Assignment|Other|30
3119216|NCT00103285|10676148|P1|Response Assignment|Other|0
3119217|NCT00103285|10676141|P8|Response Assignment|Refusal|10
3119218|NCT00103285|10676142|P7|Response Assignment|Refusal|30
3119219|NCT00103285|10676143|P6|Response Assignment|Refusal|15
3119220|NCT00103285|10676144|P5|Response Assignment|Refusal|25
3119221|NCT00103285|10676145|P4|Response Assignment|Refusal|3
3119222|NCT00103285|10676146|P3|Response Assignment|Refusal|5
3119223|NCT00103285|10676147|P2|Response Assignment|Refusal|53
3119224|NCT00103285|10676148|P1|Response Assignment|Refusal|0
3119225|NCT00103285|10676141|P8|Response Assignment|Ineligible|5
3119226|NCT00103285|10676142|P7|Response Assignment|Ineligible|1
3119227|NCT00103285|10676143|P6|Response Assignment|Ineligible|3
3119228|NCT00103285|10676144|P5|Response Assignment|Ineligible|0
3119229|NCT00103285|10676145|P4|Response Assignment|Ineligible|2
3119230|NCT00103285|10676146|P3|Response Assignment|Ineligible|6
3119231|NCT00103285|10676147|P2|Response Assignment|Ineligible|8
3119232|NCT00103285|10676148|P1|Response Assignment|Ineligible|0
3119233|NCT00103285|10676141|P8|Response Assignment|Withdrawal by Subject|2
3119234|NCT00103285|10676142|P7|Response Assignment|Withdrawal by Subject|0
3119235|NCT00103285|10676143|P6|Response Assignment|Withdrawal by Subject|2
3119236|NCT00103285|10676144|P5|Response Assignment|Withdrawal by Subject|2
3119237|NCT00103285|10676145|P4|Response Assignment|Withdrawal by Subject|1
3119238|NCT00103285|10676146|P3|Response Assignment|Withdrawal by Subject|1
3119239|NCT00103285|10676147|P2|Response Assignment|Withdrawal by Subject|4
3119240|NCT00103285|10676148|P1|Response Assignment|Withdrawal by Subject|0
3119241|NCT00103285|10676141|P8|Response Assignment|Protocol Violation|0
3119242|NCT00103285|10676142|P7|Response Assignment|Protocol Violation|0
3119243|NCT00103285|10676143|P6|Response Assignment|Protocol Violation|0
3119244|NCT00103285|10676144|P5|Response Assignment|Protocol Violation|0
3119245|NCT00103285|10676145|P4|Response Assignment|Protocol Violation|0
3119246|NCT00103285|10676146|P3|Response Assignment|Protocol Violation|0
3119247|NCT00103285|10676147|P2|Response Assignment|Protocol Violation|2
3119248|NCT00103285|10676148|P1|Response Assignment|Protocol Violation|0
3119249|NCT00103285|10676141|P8|Response Assignment|Physician Decision|35
3119250|NCT00103285|10676142|P7|Response Assignment|Physician Decision|4
3119251|NCT00103285|10676143|P6|Response Assignment|Physician Decision|7
3119252|NCT00103285|10676144|P5|Response Assignment|Physician Decision|13
3119253|NCT00103285|10676145|P4|Response Assignment|Physician Decision|9
3119254|NCT00103285|10676146|P3|Response Assignment|Physician Decision|14
3119255|NCT00103285|10676147|P2|Response Assignment|Physician Decision|13
3119256|NCT00103285|10676148|P1|Response Assignment|Physician Decision|0
3119257|NCT00103285|10676141|P8|Response Assignment|Lost to Follow-up|5
3119258|NCT00103285|10676142|P7|Response Assignment|Lost to Follow-up|2
3119259|NCT00103285|10676143|P6|Response Assignment|Lost to Follow-up|2
3119260|NCT00103285|10676144|P5|Response Assignment|Lost to Follow-up|1
3119261|NCT00103285|10676145|P4|Response Assignment|Lost to Follow-up|5
3119262|NCT00103285|10676146|P3|Response Assignment|Lost to Follow-up|5
3119263|NCT00103285|10676147|P2|Response Assignment|Lost to Follow-up|9
3119264|NCT00103285|10676148|P1|Response Assignment|Lost to Follow-up|0
3119265|NCT00103285|10676141|P8|Response Assignment|Death|8
3119266|NCT00103285|10676142|P7|Response Assignment|Death|0
3119267|NCT00103285|10676143|P6|Response Assignment|Death|1
3119268|NCT00103285|10676144|P5|Response Assignment|Death|3
3119269|NCT00103285|10676145|P4|Response Assignment|Death|2
3119270|NCT00103285|10676146|P3|Response Assignment|Death|2
3119271|NCT00103285|10676147|P2|Response Assignment|Death|5
3119272|NCT00103285|10676148|P1|Response Assignment|Death|0
3119273|NCT00103285|10676141|P8|Response Assignment|Adverse Event|2
3119274|NCT00103285|10676142|P7|Response Assignment|Adverse Event|1
3119275|NCT00103285|10676143|P6|Response Assignment|Adverse Event|1
3119276|NCT00103285|10676144|P5|Response Assignment|Adverse Event|3
3119277|NCT00103285|10676145|P4|Response Assignment|Adverse Event|2
3119278|NCT00103285|10676146|P3|Response Assignment|Adverse Event|3
3119279|NCT00103285|10676147|P2|Response Assignment|Adverse Event|8
3119280|NCT00103285|10676148|P1|Response Assignment|Adverse Event|0
3119281|NCT00103285|10676141|P8|Induction|Other|0
3119282|NCT00103285|10676142|P7|Induction|Other|0
3119283|NCT00103285|10676143|P6|Induction|Other|0
3119284|NCT00103285|10676144|P5|Induction|Other|0
3119285|NCT00103285|10676145|P4|Induction|Other|0
3119286|NCT00103285|10676146|P3|Induction|Other|0
3119287|NCT00103285|10676147|P2|Induction|Other|0
3119288|NCT00103285|10676148|P1|Induction|Other|258
3119289|NCT00103285|10676141|P8|Induction|Refusal|0
3119290|NCT00103285|10676142|P7|Induction|Refusal|0
3119291|NCT00103285|10676143|P6|Induction|Refusal|0
3119292|NCT00103285|10676144|P5|Induction|Refusal|0
3119293|NCT00103285|10676145|P4|Induction|Refusal|0
3119294|NCT00103285|10676146|P3|Induction|Refusal|0
3119295|NCT00103285|10676147|P2|Induction|Refusal|0
3119296|NCT00103285|10676148|P1|Induction|Refusal|906
3119297|NCT00103285|10676141|P8|Induction|Ineligible|0
3119298|NCT00103285|10676142|P7|Induction|Ineligible|0
3119299|NCT00103285|10676143|P6|Induction|Ineligible|0
3119300|NCT00103285|10676144|P5|Induction|Ineligible|0
3119301|NCT00103285|10676145|P4|Induction|Ineligible|0
3119302|NCT00103285|10676146|P3|Induction|Ineligible|0
3119303|NCT00103285|10676147|P2|Induction|Ineligible|0
3119304|NCT00103285|10676148|P1|Induction|Ineligible|43
3119305|NCT00103285|10676141|P8|Induction|Withdrawal by Subject|0
3119306|NCT00103285|10676142|P7|Induction|Withdrawal by Subject|0
3119307|NCT00103285|10676143|P6|Induction|Withdrawal by Subject|0
3119308|NCT00103285|10676144|P5|Induction|Withdrawal by Subject|0
3119309|NCT00103285|10676145|P4|Induction|Withdrawal by Subject|0
3119310|NCT00103285|10676146|P3|Induction|Withdrawal by Subject|0
3119311|NCT00103285|10676147|P2|Induction|Withdrawal by Subject|0
3119312|NCT00103285|10676148|P1|Induction|Withdrawal by Subject|1
3119313|NCT00103285|10676141|P8|Induction|Physician Decision|0
3119314|NCT00103285|10676142|P7|Induction|Physician Decision|0
3119315|NCT00103285|10676143|P6|Induction|Physician Decision|0
3119316|NCT00103285|10676144|P5|Induction|Physician Decision|0
3119317|NCT00103285|10676145|P4|Induction|Physician Decision|0
3119318|NCT00103285|10676146|P3|Induction|Physician Decision|0
3119319|NCT00103285|10676147|P2|Induction|Physician Decision|0
3119320|NCT00103285|10676148|P1|Induction|Physician Decision|103
3119321|NCT00103285|10676141|P8|Induction|Death|0
3119322|NCT00103285|10676142|P7|Induction|Death|0
3119323|NCT00103285|10676143|P6|Induction|Death|0
3119324|NCT00103285|10676144|P5|Induction|Death|0
3119325|NCT00103285|10676145|P4|Induction|Death|0
3119326|NCT00103285|10676146|P3|Induction|Death|0
3119327|NCT00103285|10676147|P2|Induction|Death|0
3119328|NCT00103285|10676148|P1|Induction|Death|24
3119329|NCT00103285|10676141|P8|Induction|Adverse Event|0
3119330|NCT00103285|10676142|P7|Induction|Adverse Event|0
3119331|NCT00103285|10676143|P6|Induction|Adverse Event|0
3119332|NCT00103285|10676144|P5|Induction|Adverse Event|0
3119333|NCT00103285|10676145|P4|Induction|Adverse Event|0
3119334|NCT00103285|10676146|P3|Induction|Adverse Event|0
3119335|NCT00103285|10676147|P2|Induction|Adverse Event|0
3119336|NCT00103285|10676148|P1|Induction|Adverse Event|14
3119337|NCT00103259|10676177|P2|Overall Study|ineligible/no protocol therapy|6
3119338|NCT00103259|10676178|P1|Overall Study|ineligible/no protocol therapy|4
3119339|NCT00103259|10676177|P2|Overall Study|other (reasons were not specified)|1
3119340|NCT00103259|10676178|P1|Overall Study|other (reasons were not specified)|2
3119341|NCT00103259|10676177|P2|Overall Study|alternative therapy|0
3119342|NCT00103259|10676178|P1|Overall Study|alternative therapy|1
3119343|NCT00103259|10676177|P2|Overall Study|Withdrawal by Subject|3
3119344|NCT00103259|10676178|P1|Overall Study|Withdrawal by Subject|2
3119345|NCT00103259|10676177|P2|Overall Study|Death|2
3119346|NCT00103259|10676178|P1|Overall Study|Death|3
3119347|NCT00103207|10676190|P1|Overall Study|Diagnosis of BAC not confirmed|27
3119348|NCT00103207|10676190|P1|Overall Study|Ineligible|4
3119349|NCT00103207|10676190|P1|Overall Study|Other complicating disease|1
3119350|NCT00103207|10676190|P1|Overall Study|Withdrawal by Subject|2
3119351|NCT00103207|10676190|P1|Overall Study|Death|1
3119352|NCT00103207|10676190|P1|Overall Study|Adverse Event|3
3119353|NCT00103142|10676209|P2|Overall Study|Progression of disease|1
3119354|NCT00103142|10676210|P1|Overall Study|Progression of disease|2
3119355|NCT00103142|10676209|P2|Overall Study|Adverse Event|0
3119356|NCT00103142|10676210|P1|Overall Study|Adverse Event|1
3119357|NCT00103012|10676226|P3|Overall Study|Subject non-compliant with medications|1
3119358|NCT00103012|10676227|P2|Overall Study|Subject non-compliant with medications|0
3119359|NCT00103012|10676228|P1|Overall Study|Subject non-compliant with medications|0
3119360|NCT00103012|10676226|P3|Overall Study|Adverse Event|1
3119361|NCT00103012|10676227|P2|Overall Study|Adverse Event|0
3119362|NCT00103012|10676228|P1|Overall Study|Adverse Event|0
3119363|NCT00103012|10676226|P3|Overall Study|Pregnancy|0
3119364|NCT00103012|10676227|P2|Overall Study|Pregnancy|0
3119365|NCT00103012|10676228|P1|Overall Study|Pregnancy|1
3119366|NCT00103012|10676226|P3|Overall Study|Withdrawal by Subject|2
3119367|NCT00103012|10676227|P2|Overall Study|Withdrawal by Subject|1
3119368|NCT00103012|10676228|P1|Overall Study|Withdrawal by Subject|2
3119369|NCT00102960|10676239|P3|Overall Study|Withdrawal by Subject|1
3119370|NCT00102960|10676240|P2|Overall Study|Withdrawal by Subject|0
3119371|NCT00102960|10676241|P1|Overall Study|Withdrawal by Subject|1
3119372|NCT00102960|10676239|P3|Overall Study|Lost to Follow-up|16
3119373|NCT00102960|10676240|P2|Overall Study|Lost to Follow-up|12
3119374|NCT00102960|10676241|P1|Overall Study|Lost to Follow-up|6
3119375|NCT00102960|10676239|P3|Overall Study|Death|11
3119376|NCT00102960|10676240|P2|Overall Study|Death|11
3119377|NCT00102960|10676241|P1|Overall Study|Death|23
3119378|NCT00102804|10676290|P2|Overall Study|Alive, Receiving Treatment|2
3119379|NCT00102804|10676291|P1|Overall Study|Alive, Receiving Treatment|7
3119380|NCT00102804|10676290|P2|Overall Study|Sponsor Decision|0
3119381|NCT00102804|10676291|P1|Overall Study|Sponsor Decision|1
3119382|NCT00102804|10676290|P2|Overall Study|Satisfactory Response|0
3119383|NCT00102804|10676291|P1|Overall Study|Satisfactory Response|2
3119384|NCT00102804|10676290|P2|Overall Study|Protocol Violation|1
3119385|NCT00102804|10676291|P1|Overall Study|Protocol Violation|2
3119386|NCT00102804|10676290|P2|Overall Study|Lost to Follow-up|1
3119387|NCT00102804|10676291|P1|Overall Study|Lost to Follow-up|4
3119388|NCT00102804|10676290|P2|Overall Study|Enrollment Criteria Not Met|0
3119389|NCT00102804|10676291|P1|Overall Study|Enrollment Criteria Not Met|6
3119390|NCT00102804|10676290|P2|Overall Study|Death|6
3119391|NCT00102804|10676291|P1|Overall Study|Death|5
3119392|NCT00102804|10676290|P2|Overall Study|Physician Decision|6
3119393|NCT00102804|10676291|P1|Overall Study|Physician Decision|24
3119394|NCT00102804|10676290|P2|Overall Study|Adverse Event|3
3119395|NCT00102804|10676291|P1|Overall Study|Adverse Event|37
3119396|NCT00102804|10676290|P2|Overall Study|Withdrawal by Subject|7
3119397|NCT00102804|10676291|P1|Overall Study|Withdrawal by Subject|46
3119398|NCT00102804|10676290|P2|Overall Study|Progressive Disease (PD)|196
3119399|NCT00102804|10676291|P1|Overall Study|Progressive Disease (PD)|307
3119400|NCT00102687|10676312|P5|Maintenance Period|Physician Decision|4
3119401|NCT00102687|10676313|P4|Maintenance Period|Physician Decision|0
3119402|NCT00102687|10676314|P3|Maintenance Period|Physician Decision|3
3119403|NCT00102687|10676315|P2|Maintenance Period|Physician Decision|2
3119404|NCT00102687|10676316|P1|Maintenance Period|Physician Decision|1
3119405|NCT00102687|10676312|P5|Maintenance Period|Death|1
3119406|NCT00102687|10676313|P4|Maintenance Period|Death|1
3119407|NCT00102687|10676314|P3|Maintenance Period|Death|0
3119408|NCT00102687|10676315|P2|Maintenance Period|Death|0
3119409|NCT00102687|10676316|P1|Maintenance Period|Death|0
3119410|NCT00102687|10676312|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
3119411|NCT00102687|10676313|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
3119412|NCT00102687|10676314|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
3119413|NCT00102687|10676315|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
3119414|NCT00102687|10676316|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
3119415|NCT00102687|10676312|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
3119416|NCT00102687|10676313|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
3119417|NCT00102687|10676314|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
3119418|NCT00102687|10676315|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
3119419|NCT00102687|10676316|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
3119420|NCT00102687|10676312|P5|Maintenance Period|Adverse Event|3
3119421|NCT00102687|10676313|P4|Maintenance Period|Adverse Event|1
3119422|NCT00102687|10676314|P3|Maintenance Period|Adverse Event|0
3119423|NCT00102687|10676315|P2|Maintenance Period|Adverse Event|0
3119424|NCT00102687|10676316|P1|Maintenance Period|Adverse Event|1
3119425|NCT00102687|10676312|P5|Maintenance Period|Withdrawal by Subject|1
3119426|NCT00102687|10676313|P4|Maintenance Period|Withdrawal by Subject|3
3119427|NCT00102687|10676314|P3|Maintenance Period|Withdrawal by Subject|2
3119428|NCT00102687|10676315|P2|Maintenance Period|Withdrawal by Subject|0
3119429|NCT00102687|10676316|P1|Maintenance Period|Withdrawal by Subject|4
3119430|NCT00102687|10676312|P5|Initial Period|Death|0
3119431|NCT00102687|10676313|P4|Initial Period|Death|0
3119432|NCT00102687|10676314|P3|Initial Period|Death|1
3119433|NCT00102687|10676315|P2|Initial Period|Death|1
3119434|NCT00102687|10676316|P1|Initial Period|Death|1
3119435|NCT00102687|10676312|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
3119436|NCT00102687|10676313|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
3119437|NCT00102687|10676314|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
3119438|NCT00102687|10676315|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
3119439|NCT00102687|10676316|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
3119440|NCT00102687|10676312|P5|Initial Period|Sponsor's decision|0
3119441|NCT00102687|10676313|P4|Initial Period|Sponsor's decision|0
3119442|NCT00102687|10676314|P3|Initial Period|Sponsor's decision|1
3119443|NCT00102687|10676315|P2|Initial Period|Sponsor's decision|1
3119444|NCT00102687|10676316|P1|Initial Period|Sponsor's decision|0
3119445|NCT00102687|10676312|P5|Initial Period|Physician Decision|0
3119446|NCT00102687|10676313|P4|Initial Period|Physician Decision|0
3119447|NCT00102687|10676314|P3|Initial Period|Physician Decision|6
3119448|NCT00102687|10676315|P2|Initial Period|Physician Decision|9
3119449|NCT00102687|10676316|P1|Initial Period|Physician Decision|2
3119450|NCT00102687|10676312|P5|Initial Period|Protocol Violation|0
3119451|NCT00102687|10676313|P4|Initial Period|Protocol Violation|0
3119452|NCT00102687|10676314|P3|Initial Period|Protocol Violation|2
3119453|NCT00102687|10676315|P2|Initial Period|Protocol Violation|0
3119454|NCT00102687|10676316|P1|Initial Period|Protocol Violation|0
3119455|NCT00102687|10676312|P5|Initial Period|Transformation to AML (blast > 30%)|0
3119456|NCT00102687|10676313|P4|Initial Period|Transformation to AML (blast > 30%)|0
3119457|NCT00102687|10676314|P3|Initial Period|Transformation to AML (blast > 30%)|0
3119458|NCT00102687|10676315|P2|Initial Period|Transformation to AML (blast > 30%)|3
3119459|NCT00102687|10676316|P1|Initial Period|Transformation to AML (blast > 30%)|1
3119460|NCT00102687|10676312|P5|Initial Period|Adverse Event|0
3119461|NCT00102687|10676313|P4|Initial Period|Adverse Event|0
3119462|NCT00102687|10676314|P3|Initial Period|Adverse Event|9
3119463|NCT00102687|10676315|P2|Initial Period|Adverse Event|7
3119464|NCT00102687|10676316|P1|Initial Period|Adverse Event|4
3119465|NCT00102687|10676312|P5|Initial Period|Withdrawal by Subject|0
3119466|NCT00102687|10676313|P4|Initial Period|Withdrawal by Subject|0
3119467|NCT00102687|10676314|P3|Initial Period|Withdrawal by Subject|5
3119468|NCT00102687|10676315|P2|Initial Period|Withdrawal by Subject|3
3119469|NCT00102687|10676316|P1|Initial Period|Withdrawal by Subject|6
3119470|NCT00102596|10676380|P2|Part A|Adverse Event|0
3119471|NCT00102596|10676381|P1|Part A|Adverse Event|1
3119472|NCT00102596|10676380|P2|Part A|Screen failures|0
3119473|NCT00102596|10676381|P1|Part A|Screen failures|6
3119474|NCT00102531|10676392|P2|Overall Study|Physician Decision|1
3119475|NCT00102531|10676393|P1|Overall Study|Physician Decision|0
3119476|NCT00102531|10676392|P2|Overall Study|Disease Progression|9
3119477|NCT00102531|10676393|P1|Overall Study|Disease Progression|5
3119478|NCT00102531|10676392|P2|Overall Study|Adverse Event|1
3119479|NCT00102531|10676393|P1|Overall Study|Adverse Event|0
3119480|NCT00102440|10676408|P3|Overall Study|Protocol Violation|1
3119481|NCT00102440|10676409|P2|Overall Study|Protocol Violation|2
3119482|NCT00102440|10676410|P1|Overall Study|Protocol Violation|7
3119483|NCT00102440|10676408|P3|Overall Study|Other|14
3119484|NCT00102440|10676409|P2|Overall Study|Other|14
3119485|NCT00102440|10676410|P1|Overall Study|Other|11
3119486|NCT00102440|10676408|P3|Overall Study|Personal Reason(s)|13
3119487|NCT00102440|10676409|P2|Overall Study|Personal Reason(s)|13
3119488|NCT00102440|10676410|P1|Overall Study|Personal Reason(s)|19
3119489|NCT00102440|10676408|P3|Overall Study|Gout Flare|9
3119490|NCT00102440|10676409|P2|Overall Study|Gout Flare|28
3119491|NCT00102440|10676410|P1|Overall Study|Gout Flare|10
3119492|NCT00102440|10676408|P3|Overall Study|Adverse Event|8
3119493|NCT00102440|10676409|P2|Overall Study|Adverse Event|23
3119494|NCT00102440|10676410|P1|Overall Study|Adverse Event|16
3119495|NCT00102440|10676408|P3|Overall Study|Lost to Follow-up|21
3119496|NCT00102440|10676409|P2|Overall Study|Lost to Follow-up|18
3119497|NCT00102440|10676410|P1|Overall Study|Lost to Follow-up|25
3119498|NCT00102063|10676460|P3|Overall Study|Protocol Violation|1
3119499|NCT00102063|10676461|P2|Overall Study|Protocol Violation|1
3119500|NCT00102063|10676462|P1|Overall Study|Protocol Violation|0
3119501|NCT00102063|10676460|P3|Overall Study|Lost to Follow-up|1
3119502|NCT00102063|10676461|P2|Overall Study|Lost to Follow-up|0
3119503|NCT00102063|10676462|P1|Overall Study|Lost to Follow-up|0
3119504|NCT00102063|10676460|P3|Overall Study|Withdrawal by Subject|5
3119505|NCT00102063|10676461|P2|Overall Study|Withdrawal by Subject|12
3119506|NCT00102063|10676462|P1|Overall Study|Withdrawal by Subject|4
3119507|NCT00102063|10676460|P3|Overall Study|Adverse Event|2
3119508|NCT00102063|10676461|P2|Overall Study|Adverse Event|4
3119509|NCT00102063|10676462|P1|Overall Study|Adverse Event|7
3119510|NCT00102063|10676460|P3|Overall Study|Lack of Efficacy|1
3119511|NCT00102063|10676461|P2|Overall Study|Lack of Efficacy|1
3119512|NCT00102063|10676462|P1|Overall Study|Lack of Efficacy|5
3119513|NCT00101907|10676520|P6|Overall Study|Withdrawal by Subject|0
3119514|NCT00101907|10676521|P5|Overall Study|Withdrawal by Subject|1
3119515|NCT00101907|10676522|P4|Overall Study|Withdrawal by Subject|0
3119516|NCT00101907|10676523|P3|Overall Study|Withdrawal by Subject|1
3119517|NCT00101907|10676524|P2|Overall Study|Withdrawal by Subject|0
3119518|NCT00101907|10676525|P1|Overall Study|Withdrawal by Subject|1
3119519|NCT00101907|10676520|P6|Overall Study|Physician Decision|0
3119520|NCT00101907|10676521|P5|Overall Study|Physician Decision|1
3119521|NCT00101907|10676522|P4|Overall Study|Physician Decision|1
3119522|NCT00101907|10676523|P3|Overall Study|Physician Decision|0
3119523|NCT00101907|10676524|P2|Overall Study|Physician Decision|0
3119524|NCT00101907|10676525|P1|Overall Study|Physician Decision|0
3119525|NCT00101907|10676520|P6|Overall Study|Death|0
3119526|NCT00101907|10676521|P5|Overall Study|Death|3
3119527|NCT00101907|10676522|P4|Overall Study|Death|0
3119528|NCT00101907|10676523|P3|Overall Study|Death|0
3119529|NCT00101907|10676524|P2|Overall Study|Death|1
3119530|NCT00101907|10676525|P1|Overall Study|Death|0
3119531|NCT00101907|10676520|P6|Overall Study|Adverse Event|0
3119532|NCT00101907|10676521|P5|Overall Study|Adverse Event|0
3119533|NCT00101907|10676522|P4|Overall Study|Adverse Event|0
3119534|NCT00101907|10676523|P3|Overall Study|Adverse Event|0
3119535|NCT00101907|10676524|P2|Overall Study|Adverse Event|0
3119536|NCT00101907|10676525|P1|Overall Study|Adverse Event|1
3119537|NCT00101868|10676567|P2|Overall Study|Lost to Follow-up|13
3119538|NCT00101868|10676568|P1|Overall Study|Lost to Follow-up|8
3119539|NCT00101868|10676567|P2|Overall Study|Protocol Violation|0
3119540|NCT00101868|10676568|P1|Overall Study|Protocol Violation|3
3119541|NCT00101868|10676567|P2|Overall Study|Withdrawal by Subject|9
3119542|NCT00101868|10676568|P1|Overall Study|Withdrawal by Subject|8
3119543|NCT00101868|10676567|P2|Overall Study|Death|10
3119544|NCT00101868|10676568|P1|Overall Study|Death|10
3119545|NCT00101686|10676638|P10|Overall Study|Withdrawal by Subject|9
3119546|NCT00101686|10676639|P9|Overall Study|Withdrawal by Subject|8
3119547|NCT00101686|10676640|P8|Overall Study|Withdrawal by Subject|7
3119548|NCT00101686|10676641|P7|Overall Study|Withdrawal by Subject|7
3119549|NCT00101686|10676642|P6|Overall Study|Withdrawal by Subject|7
3119550|NCT00101686|10676643|P5|Overall Study|Withdrawal by Subject|8
3119551|NCT00101686|10676644|P4|Overall Study|Withdrawal by Subject|8
3119552|NCT00101686|10676645|P3|Overall Study|Withdrawal by Subject|6
3119553|NCT00101686|10676646|P2|Overall Study|Withdrawal by Subject|8
3119554|NCT00101686|10676647|P1|Overall Study|Withdrawal by Subject|9
3119555|NCT00101686|10676638|P10|Overall Study|Other|3
3119556|NCT00101686|10676639|P9|Overall Study|Other|3
3119557|NCT00101686|10676640|P8|Overall Study|Other|5
3119558|NCT00101686|10676641|P7|Overall Study|Other|1
3119559|NCT00101686|10676642|P6|Overall Study|Other|12
3119560|NCT00101686|10676643|P5|Overall Study|Other|2
3119561|NCT00101686|10676644|P4|Overall Study|Other|6
3119562|NCT00101686|10676645|P3|Overall Study|Other|1
3119563|NCT00101686|10676646|P2|Overall Study|Other|4
3119564|NCT00101686|10676647|P1|Overall Study|Other|1
3119565|NCT00101686|10676638|P10|Overall Study|Physician Decision|1
3119566|NCT00101686|10676639|P9|Overall Study|Physician Decision|1
3119567|NCT00101686|10676640|P8|Overall Study|Physician Decision|5
3119568|NCT00101686|10676641|P7|Overall Study|Physician Decision|5
3119569|NCT00101686|10676642|P6|Overall Study|Physician Decision|9
3119570|NCT00101686|10676643|P5|Overall Study|Physician Decision|8
3119571|NCT00101686|10676644|P4|Overall Study|Physician Decision|7
3119572|NCT00101686|10676645|P3|Overall Study|Physician Decision|6
3119573|NCT00101686|10676646|P2|Overall Study|Physician Decision|13
3119574|NCT00101686|10676647|P1|Overall Study|Physician Decision|10
3119575|NCT00101686|10676638|P10|Overall Study|intercurrent non-cancer related illness|1
3119576|NCT00101686|10676639|P9|Overall Study|intercurrent non-cancer related illness|1
3119577|NCT00101686|10676640|P8|Overall Study|intercurrent non-cancer related illness|0
3119578|NCT00101686|10676641|P7|Overall Study|intercurrent non-cancer related illness|1
3119579|NCT00101686|10676642|P6|Overall Study|intercurrent non-cancer related illness|3
3119580|NCT00101686|10676643|P5|Overall Study|intercurrent non-cancer related illness|1
3119581|NCT00101686|10676644|P4|Overall Study|intercurrent non-cancer related illness|0
3119582|NCT00101686|10676645|P3|Overall Study|intercurrent non-cancer related illness|2
3119583|NCT00101686|10676646|P2|Overall Study|intercurrent non-cancer related illness|0
3119584|NCT00101686|10676647|P1|Overall Study|intercurrent non-cancer related illness|0
3119585|NCT00101686|10676638|P10|Overall Study|Randomized but did not receive treament|1
3119586|NCT00101686|10676639|P9|Overall Study|Randomized but did not receive treament|0
3119587|NCT00101686|10676640|P8|Overall Study|Randomized but did not receive treament|1
3119588|NCT00101686|10676641|P7|Overall Study|Randomized but did not receive treament|0
3119589|NCT00101686|10676642|P6|Overall Study|Randomized but did not receive treament|2
3119590|NCT00101686|10676643|P5|Overall Study|Randomized but did not receive treament|2
3119591|NCT00101686|10676644|P4|Overall Study|Randomized but did not receive treament|2
3119592|NCT00101686|10676645|P3|Overall Study|Randomized but did not receive treament|2
3119593|NCT00101686|10676646|P2|Overall Study|Randomized but did not receive treament|6
3119594|NCT00101686|10676647|P1|Overall Study|Randomized but did not receive treament|1
3119595|NCT00101686|10676638|P10|Overall Study|unacceptable toxicity|4
3119596|NCT00101686|10676639|P9|Overall Study|unacceptable toxicity|1
3119597|NCT00101686|10676640|P8|Overall Study|unacceptable toxicity|2
3119598|NCT00101686|10676641|P7|Overall Study|unacceptable toxicity|4
3119599|NCT00101686|10676642|P6|Overall Study|unacceptable toxicity|10
3119600|NCT00101686|10676643|P5|Overall Study|unacceptable toxicity|16
3119601|NCT00101686|10676644|P4|Overall Study|unacceptable toxicity|6
3119602|NCT00101686|10676645|P3|Overall Study|unacceptable toxicity|10
3119603|NCT00101686|10676646|P2|Overall Study|unacceptable toxicity|9
3119604|NCT00101686|10676647|P1|Overall Study|unacceptable toxicity|3
3119605|NCT00101686|10676638|P10|Overall Study|>3 week delay treatment due toxicity|0
3119606|NCT00101686|10676639|P9|Overall Study|>3 week delay treatment due toxicity|3
3119607|NCT00101686|10676640|P8|Overall Study|>3 week delay treatment due toxicity|1
3119608|NCT00101686|10676641|P7|Overall Study|>3 week delay treatment due toxicity|2
3119609|NCT00101686|10676642|P6|Overall Study|>3 week delay treatment due toxicity|3
3119610|NCT00101686|10676643|P5|Overall Study|>3 week delay treatment due toxicity|7
3119611|NCT00101686|10676644|P4|Overall Study|>3 week delay treatment due toxicity|2
3119612|NCT00101686|10676645|P3|Overall Study|>3 week delay treatment due toxicity|1
3119613|NCT00101686|10676646|P2|Overall Study|>3 week delay treatment due toxicity|2
3119614|NCT00101686|10676647|P1|Overall Study|>3 week delay treatment due toxicity|6
3119615|NCT00101686|10676638|P10|Overall Study|initiation other anti-cancer treatment|3
3119616|NCT00101686|10676639|P9|Overall Study|initiation other anti-cancer treatment|3
3119617|NCT00101686|10676640|P8|Overall Study|initiation other anti-cancer treatment|2
3119618|NCT00101686|10676641|P7|Overall Study|initiation other anti-cancer treatment|2
3119619|NCT00101686|10676642|P6|Overall Study|initiation other anti-cancer treatment|1
3119620|NCT00101686|10676643|P5|Overall Study|initiation other anti-cancer treatment|1
3119621|NCT00101686|10676644|P4|Overall Study|initiation other anti-cancer treatment|3
3119622|NCT00101686|10676645|P3|Overall Study|initiation other anti-cancer treatment|4
3119623|NCT00101686|10676646|P2|Overall Study|initiation other anti-cancer treatment|3
3119624|NCT00101686|10676647|P1|Overall Study|initiation other anti-cancer treatment|4
3119625|NCT00101686|10676638|P10|Overall Study|Progressive Disease|8
3119626|NCT00101686|10676639|P9|Overall Study|Progressive Disease|10
3119627|NCT00101686|10676640|P8|Overall Study|Progressive Disease|7
3119628|NCT00101686|10676641|P7|Overall Study|Progressive Disease|5
3119629|NCT00101686|10676642|P6|Overall Study|Progressive Disease|25
3119630|NCT00101686|10676643|P5|Overall Study|Progressive Disease|28
3119631|NCT00101686|10676644|P4|Overall Study|Progressive Disease|38
3119632|NCT00101686|10676645|P3|Overall Study|Progressive Disease|37
3119633|NCT00101686|10676646|P2|Overall Study|Progressive Disease|28
3119634|NCT00101686|10676647|P1|Overall Study|Progressive Disease|37
3119635|NCT00101582|10676764|P2|Overall Study|Other|1
3119636|NCT00101582|10676765|P1|Overall Study|Other|0
3119637|NCT00101582|10676764|P2|Overall Study|Death|5
3119638|NCT00101582|10676765|P1|Overall Study|Death|3
3119639|NCT00101582|10676764|P2|Overall Study|Physician Decision|0
3119640|NCT00101582|10676765|P1|Overall Study|Physician Decision|1
3119641|NCT00101582|10676764|P2|Overall Study|Withdrawal by Subject|4
3119642|NCT00101582|10676765|P1|Overall Study|Withdrawal by Subject|6
3119643|NCT00101582|10676764|P2|Overall Study|Adverse Event|4
3119644|NCT00101582|10676765|P1|Overall Study|Adverse Event|1
3119645|NCT00101582|10676764|P2|Overall Study|Ineligibility determined|1
3119646|NCT00101582|10676765|P1|Overall Study|Ineligibility determined|0
3119647|NCT00101452|10676788|P3|Overall Study|Other|12
3119648|NCT00101452|10676789|P2|Overall Study|Other|16
3119649|NCT00101452|10676790|P1|Overall Study|Other|15
3119650|NCT00101452|10676788|P3|Overall Study|Protocol Violation|3
3119651|NCT00101452|10676789|P2|Overall Study|Protocol Violation|1
3119652|NCT00101452|10676790|P1|Overall Study|Protocol Violation|2
3119653|NCT00101452|10676788|P3|Overall Study|Physician Decision|2
3119654|NCT00101452|10676789|P2|Overall Study|Physician Decision|3
3119655|NCT00101452|10676790|P1|Overall Study|Physician Decision|0
3119656|NCT00101452|10676788|P3|Overall Study|Baseline Fail|2
3119657|NCT00101452|10676789|P2|Overall Study|Baseline Fail|1
3119658|NCT00101452|10676790|P1|Overall Study|Baseline Fail|2
3119659|NCT00101452|10676788|P3|Overall Study|Withdrawal by Subject|9
3119660|NCT00101452|10676789|P2|Overall Study|Withdrawal by Subject|14
3119661|NCT00101452|10676790|P1|Overall Study|Withdrawal by Subject|10
3119662|NCT00101452|10676788|P3|Overall Study|Lost to Follow-up|14
3119663|NCT00101452|10676789|P2|Overall Study|Lost to Follow-up|8
3119664|NCT00101452|10676790|P1|Overall Study|Lost to Follow-up|13
3119665|NCT00101452|10676788|P3|Overall Study|Adverse Event|1
3119666|NCT00101452|10676789|P2|Overall Study|Adverse Event|0
3119667|NCT00101452|10676790|P1|Overall Study|Adverse Event|2
3119668|NCT00101439|10676804|P2|Period 2|Withdrawal by Subject|2
3119669|NCT00101439|10676805|P1|Period 2|Withdrawal by Subject|0
3119670|NCT00101400|10676821|P1|Survival Follow-Up|Alive|7
3119671|NCT00101283|10676841|P2|Overall Study|Prostate Cancer Recurrence|1
3119672|NCT00101283|10676842|P1|Overall Study|Prostate Cancer Recurrence|0
3119673|NCT00101283|10676841|P2|Overall Study|Insurance Refusal|1
3119674|NCT00101283|10676842|P1|Overall Study|Insurance Refusal|0
3119675|NCT00101283|10676841|P2|Overall Study|Withdrawal by Subject|1
3119676|NCT00101283|10676842|P1|Overall Study|Withdrawal by Subject|0
3119677|NCT00101192|10676852|P1|Overall Study|Inevaluable|1
3119678|NCT00101192|10676852|P1|Overall Study|Ineligible|6
3119679|NCT00101166|10676856|P1|Overall Study|progressive disease|10
3119680|NCT00101101|10676864|P1|Overall Study|never received vaccine|20
3119681|NCT00100932|10676887|P2|Overall Study|Other|2
3119682|NCT00100932|10676888|P1|Overall Study|Other|5
3119683|NCT00100932|10676887|P2|Overall Study|Physician Decision|5
3119684|NCT00100932|10676888|P1|Overall Study|Physician Decision|7
3119685|NCT00100932|10676887|P2|Overall Study|Progressive Disease|18
3119686|NCT00100932|10676888|P1|Overall Study|Progressive Disease|44
3119687|NCT00100932|10676887|P2|Overall Study|Withdrawal by Subject|0
3119688|NCT00100932|10676888|P1|Overall Study|Withdrawal by Subject|6
3119689|NCT00100932|10676887|P2|Overall Study|Adverse Event|2
3119690|NCT00100932|10676888|P1|Overall Study|Adverse Event|11
3119691|NCT00100828|10676903|P1|Overall Study|Physician Decision|6
3119692|NCT00100815|10676907|P1|Overall Study|Other|3
3119693|NCT00100815|10676907|P1|Overall Study|Death|4
3119694|NCT00100815|10676907|P1|Overall Study|Adverse Event|18
3119695|NCT00100815|10676907|P1|Overall Study|Progression|24
3119696|NCT00100802|10676915|P1|Overall Study|Ineligible|12
3119697|NCT00100802|10676915|P1|Overall Study|Withdrawal by Subject|5
3119698|NCT00100802|10676915|P1|Overall Study|Protocol Violation|1
3119699|NCT00100802|10676915|P1|Overall Study|Physician Decision|5
3119700|NCT00100802|10676915|P1|Overall Study|Lack of Efficacy|47
3119701|NCT00100802|10676915|P1|Overall Study|Death|1
3119702|NCT00100802|10676915|P1|Overall Study|Adverse Event|9
3119703|NCT00100789|10676920|P1|Overall Study|Never received treatment|1
3119704|NCT00100789|10676920|P1|Overall Study|Ineligible|3
3119705|NCT00100789|10676920|P1|Overall Study|Not protocol specified|5
3119706|NCT00100789|10676920|P1|Overall Study|Death|2
3119707|NCT00100789|10676920|P1|Overall Study|Progression/relapse|42
3119708|NCT00100789|10676920|P1|Overall Study|Withdrawal by Subject|1
3119709|NCT00100789|10676920|P1|Overall Study|Adverse Event|10
3119710|NCT00100178|10676997|P3|Overall Study|Physician Decision|3
3119711|NCT00100178|10676998|P2|Overall Study|Physician Decision|1
3119712|NCT00100178|10676999|P1|Overall Study|Physician Decision|6
3119713|NCT00100178|10676997|P3|Overall Study|Withdrawal by Subject|1
3119714|NCT00100178|10676998|P2|Overall Study|Withdrawal by Subject|1
3119715|NCT00100178|10676999|P1|Overall Study|Withdrawal by Subject|1
3119716|NCT00100178|10676997|P3|Overall Study|Adverse Event|1
3119717|NCT00100178|10676998|P2|Overall Study|Adverse Event|2
3119718|NCT00100178|10676999|P1|Overall Study|Adverse Event|2
3119719|NCT00100178|10676997|P3|Overall Study|Lost to Follow-up|5
3119720|NCT00100178|10676998|P2|Overall Study|Lost to Follow-up|6
3119721|NCT00100178|10676999|P1|Overall Study|Lost to Follow-up|0
3119722|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
3119723|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
3119724|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
3119799|NCT00099632|10677156|P5|Overall Study|Withdrawal by Subject|0
3119725|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
3119726|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
3119727|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
3119728|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
3119729|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
3119730|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
3119731|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
3119732|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
3119733|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
3119734|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
3119735|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
3119736|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
3119737|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
3119738|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
3119739|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
3119740|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
3119741|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
3119742|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
3119743|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
3119744|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
3119745|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
3119746|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
3119747|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
3119748|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
3119749|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
3119750|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
3119751|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
3119752|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
3119753|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
3119754|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
3119755|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
3119756|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
3119757|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
3119758|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
3119759|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
3119760|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
3119761|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
3119762|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
3119763|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
3119764|NCT00100048|10677028|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
3119765|NCT00100048|10677029|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
3119766|NCT00100048|10677030|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
3119767|NCT00100048|10677031|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
3119768|NCT00100048|10677032|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
3119769|NCT00100048|10677033|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
3119770|NCT00099983|10677142|P2|Overall Study|Other issue|0
3119771|NCT00099983|10677143|P1|Overall Study|Other issue|1
3119772|NCT00099983|10677142|P2|Overall Study|Intolerant of burden of visits|1
3119773|NCT00099983|10677143|P1|Overall Study|Intolerant of burden of visits|0
3119774|NCT00099983|10677142|P2|Overall Study|Incarcerated|1
3119775|NCT00099983|10677143|P1|Overall Study|Incarcerated|0
3119776|NCT00099983|10677142|P2|Overall Study|Other psychiatric problem|0
3119777|NCT00099983|10677143|P1|Overall Study|Other psychiatric problem|1
3119778|NCT00099983|10677142|P2|Overall Study|Moved|0
3119779|NCT00099983|10677143|P1|Overall Study|Moved|1
3119780|NCT00099983|10677142|P2|Overall Study|Unable to return for appointments|1
3119781|NCT00099983|10677143|P1|Overall Study|Unable to return for appointments|1
3119782|NCT00099983|10677142|P2|Overall Study|Lack of Efficacy|1
3119783|NCT00099983|10677143|P1|Overall Study|Lack of Efficacy|0
3119784|NCT00099983|10677142|P2|Overall Study|Adverse Event|1
3119785|NCT00099983|10677143|P1|Overall Study|Adverse Event|1
3119786|NCT00099983|10677142|P2|Overall Study|Withdrawal by Subject|2
3119787|NCT00099983|10677143|P1|Overall Study|Withdrawal by Subject|3
3119788|NCT00099983|10677142|P2|Overall Study|Missing Source Documents|15
3119789|NCT00099983|10677143|P1|Overall Study|Missing Source Documents|14
3119790|NCT00099983|10677142|P2|Overall Study|Lost to Follow-up|3
3119791|NCT00099983|10677143|P1|Overall Study|Lost to Follow-up|2
3119792|NCT00099632|10677155|P6|Overall Study|Protocol Violation|1
3119793|NCT00099632|10677156|P5|Overall Study|Protocol Violation|0
3119794|NCT00099632|10677157|P4|Overall Study|Protocol Violation|0
3119795|NCT00099632|10677158|P3|Overall Study|Protocol Violation|0
3119796|NCT00099632|10677159|P2|Overall Study|Protocol Violation|0
3119797|NCT00099632|10677160|P1|Overall Study|Protocol Violation|0
3119798|NCT00099632|10677155|P6|Overall Study|Withdrawal by Subject|1
3119800|NCT00099632|10677157|P4|Overall Study|Withdrawal by Subject|0
3119801|NCT00099632|10677158|P3|Overall Study|Withdrawal by Subject|0
3119802|NCT00099632|10677159|P2|Overall Study|Withdrawal by Subject|1
3119803|NCT00099632|10677160|P1|Overall Study|Withdrawal by Subject|0
3119804|NCT00099632|10677155|P6|Overall Study|Lost to Follow-up|0
3119805|NCT00099632|10677156|P5|Overall Study|Lost to Follow-up|1
3119806|NCT00099632|10677157|P4|Overall Study|Lost to Follow-up|1
3119807|NCT00099632|10677158|P3|Overall Study|Lost to Follow-up|3
3119808|NCT00099632|10677159|P2|Overall Study|Lost to Follow-up|0
3119809|NCT00099632|10677160|P1|Overall Study|Lost to Follow-up|1
3119810|NCT00099437|10677200|P2|Overall Study|Ongoing in FU but not on treatment|45
3119811|NCT00099437|10677201|P1|Overall Study|Ongoing in FU but not on treatment|37
3119812|NCT00099437|10677200|P2|Overall Study|Withdrawal by Subject|10
3119813|NCT00099437|10677201|P1|Overall Study|Withdrawal by Subject|6
3119814|NCT00099437|10677200|P2|Overall Study|Death|261
3119815|NCT00099437|10677201|P1|Overall Study|Death|293
3119816|NCT00099437|10677200|P2|Overall Study|Lost to Follow-up|33
3119817|NCT00099437|10677201|P1|Overall Study|Lost to Follow-up|30
3119818|NCT00099359|10677224|P3|Overall Study|moved out of area|4
3119819|NCT00099359|10677225|P2|Overall Study|moved out of area|7
3119820|NCT00099359|10677226|P1|Overall Study|moved out of area|9
3119821|NCT00099359|10677224|P3|Overall Study|Lost to Follow-up|24
3119822|NCT00099359|10677225|P2|Overall Study|Lost to Follow-up|24
3119823|NCT00099359|10677226|P1|Overall Study|Lost to Follow-up|15
3119824|NCT00099359|10677224|P3|Overall Study|Withdrawal by Subject|23
3119825|NCT00099359|10677225|P2|Overall Study|Withdrawal by Subject|19
3119826|NCT00099359|10677226|P1|Overall Study|Withdrawal by Subject|19
3119827|NCT00099359|10677224|P3|Overall Study|Death|17
3119828|NCT00099359|10677225|P2|Overall Study|Death|15
3119829|NCT00099359|10677226|P1|Overall Study|Death|11
3119830|NCT00099268|10677249|P2|Overall Study|Death|1
3119831|NCT00099268|10677250|P1|Overall Study|Death|3
3119832|NCT00099268|10677249|P2|Overall Study|Administrative problems|4
3119833|NCT00099268|10677250|P1|Overall Study|Administrative problems|4
3119834|NCT00099268|10677249|P2|Overall Study|Lack of Efficacy|18
3119835|NCT00099268|10677250|P1|Overall Study|Lack of Efficacy|5
3119836|NCT00099268|10677249|P2|Overall Study|Lost to Follow-up|4
3119837|NCT00099268|10677250|P1|Overall Study|Lost to Follow-up|6
3119838|NCT00099268|10677249|P2|Overall Study|Protocol Violation|8
3119839|NCT00099268|10677250|P1|Overall Study|Protocol Violation|9
3119840|NCT00099268|10677249|P2|Overall Study|Adverse Event|19
3119841|NCT00099268|10677250|P1|Overall Study|Adverse Event|19
3119842|NCT00099268|10677249|P2|Overall Study|Withdrawal by Subject|28
3119843|NCT00099268|10677250|P1|Overall Study|Withdrawal by Subject|46
3119844|NCT00098865|10677290|P1|Overall Study|Alternative Therapy|1
3119845|NCT00098865|10677290|P1|Overall Study|Adverse Event|2
3119846|NCT00098865|10677290|P1|Overall Study|Progressive Disease|6
3119847|NCT00098839|10677298|P2|Overall Study|Ineligible|0
3119848|NCT00098839|10677299|P1|Overall Study|Ineligible|2
3119849|NCT00098839|10677298|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
3119850|NCT00098839|10677299|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
3119851|NCT00098839|10677298|P2|Overall Study|Relapse|3
3119852|NCT00098839|10677299|P1|Overall Study|Relapse|6
3119853|NCT00098839|10677298|P2|Overall Study|Refusal of further protocol therapy|1
3119854|NCT00098839|10677299|P1|Overall Study|Refusal of further protocol therapy|3
3119855|NCT00098839|10677298|P2|Overall Study|Withdrawal by Subject|0
3119856|NCT00098839|10677299|P1|Overall Study|Withdrawal by Subject|1
3119857|NCT00098839|10677298|P2|Overall Study|Physician Decision|14
3119858|NCT00098839|10677299|P1|Overall Study|Physician Decision|4
3119859|NCT00098839|10677298|P2|Overall Study|Death|2
3119860|NCT00098839|10677299|P1|Overall Study|Death|1
3119861|NCT00098839|10677298|P2|Overall Study|Adverse Event|2
3119862|NCT00098839|10677299|P1|Overall Study|Adverse Event|5
3119863|NCT00098813|10677310|P1|Overall Study|Reversal of RAI resistance|1
3119864|NCT00098813|10677310|P1|Overall Study|Other complicating disease|1
3119865|NCT00098813|10677310|P1|Overall Study|Progression of Disease|1
3119866|NCT00098813|10677310|P1|Overall Study|Withdrawal by Subject|7
3119867|NCT00098813|10677310|P1|Overall Study|Protocol Violation|1
3119868|NCT00098813|10677310|P1|Overall Study|Death|8
3119869|NCT00098787|10677317|P3|Overall Study|Other|9
3119870|NCT00098787|10677318|P2|Overall Study|Other|6
3119871|NCT00098787|10677319|P1|Overall Study|Other|7
3119872|NCT00098787|10677317|P3|Overall Study|Alternative therapy|13
3119873|NCT00098787|10677318|P2|Overall Study|Alternative therapy|13
3119874|NCT00098787|10677319|P1|Overall Study|Alternative therapy|8
3119875|NCT00098787|10677317|P3|Overall Study|Withdrawal by Subject|6
3119876|NCT00098787|10677318|P2|Overall Study|Withdrawal by Subject|12
3119877|NCT00098787|10677319|P1|Overall Study|Withdrawal by Subject|4
3119878|NCT00098787|10677317|P3|Overall Study|Death|0
3119879|NCT00098787|10677318|P2|Overall Study|Death|1
3119880|NCT00098787|10677319|P1|Overall Study|Death|6
3119881|NCT00098787|10677317|P3|Overall Study|Adverse Event|8
3119882|NCT00098787|10677318|P2|Overall Study|Adverse Event|17
3119883|NCT00098787|10677319|P1|Overall Study|Adverse Event|8
3119884|NCT00098787|10677317|P3|Overall Study|Disease progression|23
3119885|NCT00098787|10677318|P2|Overall Study|Disease progression|17
3119886|NCT00098787|10677319|P1|Overall Study|Disease progression|28
3119887|NCT00098787|10677317|P3|Overall Study|Ineligible|3
3119888|NCT00098787|10677318|P2|Overall Study|Ineligible|7
3119889|NCT00098787|10677319|P1|Overall Study|Ineligible|9
3119890|NCT00098787|10677317|P3|Overall Study|Never started treatment|1
3119891|NCT00098787|10677318|P2|Overall Study|Never started treatment|2
3119892|NCT00098787|10677319|P1|Overall Study|Never started treatment|3
3119893|NCT00098774|10677333|P1|Overall Study|Physician Decision|2
3119894|NCT00098774|10677333|P1|Overall Study|Failed (to respond) during induction|4
3119895|NCT00098774|10677333|P1|Overall Study|Withdrawal by Subject|1
3119896|NCT00098774|10677333|P1|Overall Study|Disease Progression|9
3119897|NCT00098774|10677333|P1|Overall Study|Adverse Event|2
3119898|NCT00098748|10677343|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
3119899|NCT00098748|10677344|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
3119900|NCT00098748|10677345|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
3119901|NCT00098748|10677343|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
3119902|NCT00098748|10677344|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
3119903|NCT00098748|10677345|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
3119904|NCT00098748|10677343|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
3119905|NCT00098748|10677344|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
3119906|NCT00098748|10677345|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
3119907|NCT00098748|10677343|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
3119908|NCT00098748|10677344|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
3119909|NCT00098748|10677345|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
3119910|NCT00098748|10677343|P3|Continued on Open-Label Treatment|Adverse Event|0
3119911|NCT00098748|10677344|P2|Continued on Open-Label Treatment|Adverse Event|1
3119912|NCT00098748|10677345|P1|Continued on Open-Label Treatment|Adverse Event|0
3119913|NCT00098748|10677343|P3|Received Study Treatment|Subject defaulted|4
3119914|NCT00098748|10677344|P2|Received Study Treatment|Subject defaulted|4
3119915|NCT00098748|10677345|P1|Received Study Treatment|Subject defaulted|3
3119916|NCT00098748|10677343|P3|Received Study Treatment|Other|6
3119917|NCT00098748|10677344|P2|Received Study Treatment|Other|2
3119918|NCT00098748|10677345|P1|Received Study Treatment|Other|2
3119919|NCT00098748|10677343|P3|Received Study Treatment|Lack of Efficacy|27
3119920|NCT00098748|10677344|P2|Received Study Treatment|Lack of Efficacy|27
3119921|NCT00098748|10677345|P1|Received Study Treatment|Lack of Efficacy|40
3119922|NCT00098748|10677343|P3|Received Study Treatment|Adverse Event|5
3119923|NCT00098748|10677344|P2|Received Study Treatment|Adverse Event|2
3119924|NCT00098748|10677345|P1|Received Study Treatment|Adverse Event|1
3119925|NCT00098748|10677343|P3|Received Study Treatment|Death|2
3119926|NCT00098748|10677344|P2|Received Study Treatment|Death|1
3119927|NCT00098748|10677345|P1|Received Study Treatment|Death|2
3119928|NCT00098748|10677343|P3|Assigned to Study Treatment|Randomized, but not treated|2
3119929|NCT00098748|10677344|P2|Assigned to Study Treatment|Randomized, but not treated|2
3119930|NCT00098748|10677345|P1|Assigned to Study Treatment|Randomized, but not treated|0
3119931|NCT00098722|10677401|P7|Observation Phase|Other|10
3119932|NCT00098722|10677402|P6|Observation Phase|Other|21
3119933|NCT00098722|10677403|P5|Observation Phase|Other|0
3119934|NCT00098722|10677404|P4|Observation Phase|Other|0
3119935|NCT00098722|10677405|P3|Observation Phase|Other|0
3119936|NCT00098722|10677406|P2|Observation Phase|Other|0
3119937|NCT00098722|10677407|P1|Observation Phase|Other|0
3119938|NCT00098722|10677401|P7|Observation Phase|Participant defaulted|4
3119939|NCT00098722|10677402|P6|Observation Phase|Participant defaulted|17
3119940|NCT00098722|10677403|P5|Observation Phase|Participant defaulted|0
3119941|NCT00098722|10677404|P4|Observation Phase|Participant defaulted|0
3119942|NCT00098722|10677405|P3|Observation Phase|Participant defaulted|0
3119943|NCT00098722|10677406|P2|Observation Phase|Participant defaulted|0
3119944|NCT00098722|10677407|P1|Observation Phase|Participant defaulted|0
3119945|NCT00098722|10677401|P7|Observation Phase|Lack of Efficacy|0
3119946|NCT00098722|10677402|P6|Observation Phase|Lack of Efficacy|2
3119947|NCT00098722|10677403|P5|Observation Phase|Lack of Efficacy|0
3119948|NCT00098722|10677404|P4|Observation Phase|Lack of Efficacy|0
3119949|NCT00098722|10677405|P3|Observation Phase|Lack of Efficacy|0
3119950|NCT00098722|10677406|P2|Observation Phase|Lack of Efficacy|0
3119951|NCT00098722|10677407|P1|Observation Phase|Lack of Efficacy|0
3119952|NCT00098722|10677401|P7|Observation Phase|Death|3
3119953|NCT00098722|10677402|P6|Observation Phase|Death|5
3119954|NCT00098722|10677403|P5|Observation Phase|Death|0
3119955|NCT00098722|10677404|P4|Observation Phase|Death|0
3119956|NCT00098722|10677405|P3|Observation Phase|Death|0
3119957|NCT00098722|10677406|P2|Observation Phase|Death|0
3119958|NCT00098722|10677407|P1|Observation Phase|Death|0
3119959|NCT00098722|10677401|P7|Open Label Phase|Other|0
3119960|NCT00098722|10677402|P6|Open Label Phase|Other|0
3119961|NCT00098722|10677403|P5|Open Label Phase|Other|0
3119962|NCT00098722|10677404|P4|Open Label Phase|Other|18
3119963|NCT00098722|10677405|P3|Open Label Phase|Other|0
3119964|NCT00098722|10677406|P2|Open Label Phase|Other|0
3119965|NCT00098722|10677407|P1|Open Label Phase|Other|0
3119966|NCT00098722|10677401|P7|Open Label Phase|Ongoing at cut-off date|0
3119967|NCT00098722|10677402|P6|Open Label Phase|Ongoing at cut-off date|0
3119968|NCT00098722|10677403|P5|Open Label Phase|Ongoing at cut-off date|50
3119969|NCT00098722|10677404|P4|Open Label Phase|Ongoing at cut-off date|220
3119970|NCT00098722|10677405|P3|Open Label Phase|Ongoing at cut-off date|0
3119971|NCT00098722|10677406|P2|Open Label Phase|Ongoing at cut-off date|0
3119972|NCT00098722|10677407|P1|Open Label Phase|Ongoing at cut-off date|0
3119973|NCT00098722|10677401|P7|Open Label Phase|Participant defaulted|0
3119974|NCT00098722|10677402|P6|Open Label Phase|Participant defaulted|0
3119975|NCT00098722|10677403|P5|Open Label Phase|Participant defaulted|0
3119976|NCT00098722|10677404|P4|Open Label Phase|Participant defaulted|18
3119977|NCT00098722|10677405|P3|Open Label Phase|Participant defaulted|0
3119978|NCT00098722|10677406|P2|Open Label Phase|Participant defaulted|0
3119979|NCT00098722|10677407|P1|Open Label Phase|Participant defaulted|0
3119980|NCT00098722|10677401|P7|Open Label Phase|Pregnancy|0
3119981|NCT00098722|10677402|P6|Open Label Phase|Pregnancy|0
3119982|NCT00098722|10677403|P5|Open Label Phase|Pregnancy|0
3119983|NCT00098722|10677404|P4|Open Label Phase|Pregnancy|1
3119984|NCT00098722|10677405|P3|Open Label Phase|Pregnancy|0
3119985|NCT00098722|10677406|P2|Open Label Phase|Pregnancy|0
3119986|NCT00098722|10677407|P1|Open Label Phase|Pregnancy|0
3119987|NCT00098722|10677401|P7|Open Label Phase|Lack of Efficacy|0
3119988|NCT00098722|10677402|P6|Open Label Phase|Lack of Efficacy|0
3119989|NCT00098722|10677403|P5|Open Label Phase|Lack of Efficacy|0
3119990|NCT00098722|10677404|P4|Open Label Phase|Lack of Efficacy|8
3119991|NCT00098722|10677405|P3|Open Label Phase|Lack of Efficacy|0
3119992|NCT00098722|10677406|P2|Open Label Phase|Lack of Efficacy|0
3119993|NCT00098722|10677407|P1|Open Label Phase|Lack of Efficacy|0
3119994|NCT00098722|10677401|P7|Open Label Phase|Death|0
3119995|NCT00098722|10677402|P6|Open Label Phase|Death|0
3119996|NCT00098722|10677403|P5|Open Label Phase|Death|0
3119997|NCT00098722|10677404|P4|Open Label Phase|Death|2
3119998|NCT00098722|10677405|P3|Open Label Phase|Death|0
3119999|NCT00098722|10677406|P2|Open Label Phase|Death|0
3120000|NCT00098722|10677407|P1|Open Label Phase|Death|0
3120001|NCT00098722|10677401|P7|Open Label Phase|Adverse Event|0
3120002|NCT00098722|10677402|P6|Open Label Phase|Adverse Event|0
3120003|NCT00098722|10677403|P5|Open Label Phase|Adverse Event|0
3120004|NCT00098722|10677404|P4|Open Label Phase|Adverse Event|5
3120005|NCT00098722|10677405|P3|Open Label Phase|Adverse Event|0
3120006|NCT00098722|10677406|P2|Open Label Phase|Adverse Event|0
3120007|NCT00098722|10677407|P1|Open Label Phase|Adverse Event|0
3120008|NCT00098722|10677401|P7|Double Blind Phase|Other|0
3120009|NCT00098722|10677402|P6|Double Blind Phase|Other|0
3120010|NCT00098722|10677403|P5|Double Blind Phase|Other|0
3120011|NCT00098722|10677404|P4|Double Blind Phase|Other|0
3120012|NCT00098722|10677405|P3|Double Blind Phase|Other|7
3120013|NCT00098722|10677406|P2|Double Blind Phase|Other|8
3120014|NCT00098722|10677407|P1|Double Blind Phase|Other|7
3120015|NCT00098722|10677401|P7|Double Blind Phase|Ongoing at cut-off date|0
3120016|NCT00098722|10677402|P6|Double Blind Phase|Ongoing at cut-off date|0
3120017|NCT00098722|10677403|P5|Double Blind Phase|Ongoing at cut-off date|0
3120018|NCT00098722|10677404|P4|Double Blind Phase|Ongoing at cut-off date|0
3120019|NCT00098722|10677405|P3|Double Blind Phase|Ongoing at cut-off date|57
3120020|NCT00098722|10677406|P2|Double Blind Phase|Ongoing at cut-off date|137
3120021|NCT00098722|10677407|P1|Double Blind Phase|Ongoing at cut-off date|128
3120022|NCT00098722|10677401|P7|Double Blind Phase|Randomized, not treated|0
3120023|NCT00098722|10677402|P6|Double Blind Phase|Randomized, not treated|0
3120024|NCT00098722|10677403|P5|Double Blind Phase|Randomized, not treated|0
3120025|NCT00098722|10677404|P4|Double Blind Phase|Randomized, not treated|0
3120026|NCT00098722|10677405|P3|Double Blind Phase|Randomized, not treated|3
3120027|NCT00098722|10677406|P2|Double Blind Phase|Randomized, not treated|3
3120028|NCT00098722|10677407|P1|Double Blind Phase|Randomized, not treated|4
3120029|NCT00098722|10677401|P7|Double Blind Phase|Pregnancy|0
3120030|NCT00098722|10677402|P6|Double Blind Phase|Pregnancy|0
3120031|NCT00098722|10677403|P5|Double Blind Phase|Pregnancy|0
3120032|NCT00098722|10677404|P4|Double Blind Phase|Pregnancy|0
3120033|NCT00098722|10677405|P3|Double Blind Phase|Pregnancy|0
3120034|NCT00098722|10677406|P2|Double Blind Phase|Pregnancy|0
3120035|NCT00098722|10677407|P1|Double Blind Phase|Pregnancy|1
3120036|NCT00098722|10677401|P7|Double Blind Phase|Participant defaulted|0
3120037|NCT00098722|10677402|P6|Double Blind Phase|Participant defaulted|0
3120038|NCT00098722|10677403|P5|Double Blind Phase|Participant defaulted|0
3120039|NCT00098722|10677404|P4|Double Blind Phase|Participant defaulted|0
3120040|NCT00098722|10677405|P3|Double Blind Phase|Participant defaulted|9
3120041|NCT00098722|10677406|P2|Double Blind Phase|Participant defaulted|11
3120042|NCT00098722|10677407|P1|Double Blind Phase|Participant defaulted|16
3120043|NCT00098722|10677401|P7|Double Blind Phase|Lack of Efficacy|0
3120044|NCT00098722|10677402|P6|Double Blind Phase|Lack of Efficacy|0
3120045|NCT00098722|10677403|P5|Double Blind Phase|Lack of Efficacy|0
3120046|NCT00098722|10677404|P4|Double Blind Phase|Lack of Efficacy|0
3120047|NCT00098722|10677405|P3|Double Blind Phase|Lack of Efficacy|15
3120048|NCT00098722|10677406|P2|Double Blind Phase|Lack of Efficacy|23
3120049|NCT00098722|10677407|P1|Double Blind Phase|Lack of Efficacy|21
3120050|NCT00098722|10677401|P7|Double Blind Phase|Death|0
3120051|NCT00098722|10677402|P6|Double Blind Phase|Death|0
3120052|NCT00098722|10677403|P5|Double Blind Phase|Death|0
3120053|NCT00098722|10677404|P4|Double Blind Phase|Death|0
3120054|NCT00098722|10677405|P3|Double Blind Phase|Death|0
3120055|NCT00098722|10677406|P2|Double Blind Phase|Death|5
3120056|NCT00098722|10677407|P1|Double Blind Phase|Death|2
3120057|NCT00098722|10677401|P7|Double Blind Phase|Adverse Event|0
3120058|NCT00098722|10677402|P6|Double Blind Phase|Adverse Event|0
3120059|NCT00098722|10677403|P5|Double Blind Phase|Adverse Event|0
3120060|NCT00098722|10677404|P4|Double Blind Phase|Adverse Event|0
3120061|NCT00098722|10677405|P3|Double Blind Phase|Adverse Event|3
3120062|NCT00098722|10677406|P2|Double Blind Phase|Adverse Event|7
3120063|NCT00098722|10677407|P1|Double Blind Phase|Adverse Event|7
3120064|NCT00098475|10677481|P4|Step 2|Never started treatment|0
3120065|NCT00098475|10677482|P3|Step 2|Never started treatment|0
3120066|NCT00098475|10677483|P2|Step 2|Never started treatment|1
3120067|NCT00098475|10677484|P1|Step 2|Never started treatment|1
3120068|NCT00098475|10677481|P4|Step 2|Alternative therapy|0
3120069|NCT00098475|10677482|P3|Step 2|Alternative therapy|0
3120070|NCT00098475|10677483|P2|Step 2|Alternative therapy|2
3120071|NCT00098475|10677484|P1|Step 2|Alternative therapy|1
3120072|NCT00098475|10677481|P4|Step 2|Physician Decision|0
3120073|NCT00098475|10677482|P3|Step 2|Physician Decision|0
3120074|NCT00098475|10677483|P2|Step 2|Physician Decision|1
3120075|NCT00098475|10677484|P1|Step 2|Physician Decision|0
3120076|NCT00098475|10677481|P4|Step 2|Withdrawal by Subject|0
3120077|NCT00098475|10677482|P3|Step 2|Withdrawal by Subject|0
3120078|NCT00098475|10677483|P2|Step 2|Withdrawal by Subject|2
3120079|NCT00098475|10677484|P1|Step 2|Withdrawal by Subject|0
3120080|NCT00098475|10677481|P4|Step 2|Adverse Event|0
3120081|NCT00098475|10677482|P3|Step 2|Adverse Event|0
3120082|NCT00098475|10677483|P2|Step 2|Adverse Event|0
3120083|NCT00098475|10677484|P1|Step 2|Adverse Event|2
3120084|NCT00098475|10677481|P4|Step 2|Disease progression|0
3120085|NCT00098475|10677482|P3|Step 2|Disease progression|0
3120086|NCT00098475|10677483|P2|Step 2|Disease progression|4
3120087|NCT00098475|10677484|P1|Step 2|Disease progression|1
3120088|NCT00098475|10677481|P4|Step 1|Not documented|0
3120089|NCT00098475|10677482|P3|Step 1|Not documented|0
3120090|NCT00098475|10677483|P2|Step 1|Not documented|1
3120091|NCT00098475|10677484|P1|Step 1|Not documented|0
3120092|NCT00098475|10677481|P4|Step 1|Patient fell with fracture|0
3120093|NCT00098475|10677482|P3|Step 1|Patient fell with fracture|0
3120094|NCT00098475|10677483|P2|Step 1|Patient fell with fracture|0
3120095|NCT00098475|10677484|P1|Step 1|Patient fell with fracture|1
3120096|NCT00098475|10677481|P4|Step 1|Misinterpretation of lab data|0
3120097|NCT00098475|10677482|P3|Step 1|Misinterpretation of lab data|0
3120098|NCT00098475|10677483|P2|Step 1|Misinterpretation of lab data|1
3120099|NCT00098475|10677484|P1|Step 1|Misinterpretation of lab data|0
3120100|NCT00098475|10677481|P4|Step 1|Criteria to continue treatment not met|0
3120101|NCT00098475|10677482|P3|Step 1|Criteria to continue treatment not met|0
3120102|NCT00098475|10677483|P2|Step 1|Criteria to continue treatment not met|1
3120103|NCT00098475|10677484|P1|Step 1|Criteria to continue treatment not met|0
3120104|NCT00098475|10677481|P4|Step 1|Referred to other physicians|0
3120105|NCT00098475|10677482|P3|Step 1|Referred to other physicians|0
3120106|NCT00098475|10677483|P2|Step 1|Referred to other physicians|1
3120107|NCT00098475|10677484|P1|Step 1|Referred to other physicians|0
3120108|NCT00098475|10677481|P4|Step 1|Rising paraprotein|0
3120109|NCT00098475|10677482|P3|Step 1|Rising paraprotein|0
3120110|NCT00098475|10677483|P2|Step 1|Rising paraprotein|1
3120111|NCT00098475|10677484|P1|Step 1|Rising paraprotein|0
3120112|NCT00098475|10677481|P4|Step 1|Insurance issue|0
3120113|NCT00098475|10677482|P3|Step 1|Insurance issue|0
3120114|NCT00098475|10677483|P2|Step 1|Insurance issue|1
3120115|NCT00098475|10677484|P1|Step 1|Insurance issue|0
3120116|NCT00098475|10677481|P4|Step 1|Declining performance status|0
3120117|NCT00098475|10677482|P3|Step 1|Declining performance status|0
3120118|NCT00098475|10677483|P2|Step 1|Declining performance status|1
3120119|NCT00098475|10677484|P1|Step 1|Declining performance status|0
3120120|NCT00098475|10677481|P4|Step 1|Off treatment for > specified timeframe|0
3120121|NCT00098475|10677482|P3|Step 1|Off treatment for > specified timeframe|0
3120122|NCT00098475|10677483|P2|Step 1|Off treatment for > specified timeframe|1
3120123|NCT00098475|10677484|P1|Step 1|Off treatment for > specified timeframe|1
3120124|NCT00098475|10677481|P4|Step 1|Incorrect disease assessment|0
3120125|NCT00098475|10677482|P3|Step 1|Incorrect disease assessment|0
3120126|NCT00098475|10677483|P2|Step 1|Incorrect disease assessment|0
3120127|NCT00098475|10677484|P1|Step 1|Incorrect disease assessment|2
3120128|NCT00098475|10677481|P4|Step 1|Both patient and physician's decision|0
3120129|NCT00098475|10677482|P3|Step 1|Both patient and physician's decision|0
3120130|NCT00098475|10677483|P2|Step 1|Both patient and physician's decision|1
3120131|NCT00098475|10677484|P1|Step 1|Both patient and physician's decision|2
3120132|NCT00098475|10677481|P4|Step 1|Cannot comply due to other tx|0
3120133|NCT00098475|10677482|P3|Step 1|Cannot comply due to other tx|0
3120134|NCT00098475|10677483|P2|Step 1|Cannot comply due to other tx|1
3120135|NCT00098475|10677484|P1|Step 1|Cannot comply due to other tx|0
3120136|NCT00098475|10677481|P4|Step 1|Complications|0
3120137|NCT00098475|10677482|P3|Step 1|Complications|0
3120138|NCT00098475|10677483|P2|Step 1|Complications|0
3120139|NCT00098475|10677484|P1|Step 1|Complications|1
3120140|NCT00098475|10677481|P4|Step 1|Knee surgery|0
3120141|NCT00098475|10677482|P3|Step 1|Knee surgery|0
3120142|NCT00098475|10677483|P2|Step 1|Knee surgery|0
3120143|NCT00098475|10677484|P1|Step 1|Knee surgery|1
3120144|NCT00098475|10677481|P4|Step 1|Still on treatment as of this analysis|0
3120145|NCT00098475|10677482|P3|Step 1|Still on treatment as of this analysis|0
3120146|NCT00098475|10677483|P2|Step 1|Still on treatment as of this analysis|27
3120147|NCT00098475|10677484|P1|Step 1|Still on treatment as of this analysis|14
3120148|NCT00098475|10677481|P4|Step 1|Never started treatment|0
3120149|NCT00098475|10677482|P3|Step 1|Never started treatment|0
3120150|NCT00098475|10677483|P2|Step 1|Never started treatment|2
3120151|NCT00098475|10677484|P1|Step 1|Never started treatment|0
3120152|NCT00098475|10677481|P4|Step 1|Other disease|0
3120153|NCT00098475|10677482|P3|Step 1|Other disease|1
3120154|NCT00098475|10677483|P2|Step 1|Other disease|1
3120155|NCT00098475|10677484|P1|Step 1|Other disease|2
3120156|NCT00098475|10677481|P4|Step 1|Alternative therapy|0
3120157|NCT00098475|10677482|P3|Step 1|Alternative therapy|1
3120158|NCT00098475|10677483|P2|Step 1|Alternative therapy|43
3120159|NCT00098475|10677484|P1|Step 1|Alternative therapy|31
3120160|NCT00098475|10677481|P4|Step 1|Physician Decision|0
3120161|NCT00098475|10677482|P3|Step 1|Physician Decision|0
3120162|NCT00098475|10677483|P2|Step 1|Physician Decision|2
3120163|NCT00098475|10677484|P1|Step 1|Physician Decision|5
3120164|NCT00098475|10677481|P4|Step 1|Withdrawal by Subject|0
3120165|NCT00098475|10677482|P3|Step 1|Withdrawal by Subject|0
3120166|NCT00098475|10677483|P2|Step 1|Withdrawal by Subject|11
3120167|NCT00098475|10677484|P1|Step 1|Withdrawal by Subject|14
3120168|NCT00098475|10677481|P4|Step 1|Death|1
3120169|NCT00098475|10677482|P3|Step 1|Death|0
3120170|NCT00098475|10677483|P2|Step 1|Death|5
3120171|NCT00098475|10677484|P1|Step 1|Death|8
3120172|NCT00098475|10677481|P4|Step 1|Adverse Event|1
3120173|NCT00098475|10677482|P3|Step 1|Adverse Event|0
3120174|NCT00098475|10677483|P2|Step 1|Adverse Event|37
3120175|NCT00098475|10677484|P1|Step 1|Adverse Event|56
3120176|NCT00098475|10677481|P4|Step 1|Progressive disease|1
3120177|NCT00098475|10677482|P3|Step 1|Progressive disease|2
3120178|NCT00098475|10677483|P2|Step 1|Progressive disease|35
3120179|NCT00098475|10677484|P1|Step 1|Progressive disease|33
3120180|NCT00098345|10677521|P1|Overall Study|progression|4
3120181|NCT00098345|10677521|P1|Overall Study|Withdrawal by Subject|2
3120182|NCT00098345|10677521|P1|Overall Study|Adverse Event|7
3120183|NCT00098306|10677534|P7|Observational Phase|Un-specified|4
3120184|NCT00098306|10677535|P6|Observational Phase|Un-specified|7
3120185|NCT00098306|10677536|P5|Observational Phase|Un-specified|0
3120186|NCT00098306|10677537|P4|Observational Phase|Un-specified|0
3120187|NCT00098306|10677538|P3|Observational Phase|Un-specified|0
3120188|NCT00098306|10677539|P2|Observational Phase|Un-specified|0
3120189|NCT00098306|10677540|P1|Observational Phase|Un-specified|0
3120190|NCT00098306|10677534|P7|Observational Phase|Participant defaulted|18
3120191|NCT00098306|10677535|P6|Observational Phase|Participant defaulted|34
3120192|NCT00098306|10677536|P5|Observational Phase|Participant defaulted|0
3120193|NCT00098306|10677537|P4|Observational Phase|Participant defaulted|0
3120194|NCT00098306|10677538|P3|Observational Phase|Participant defaulted|0
3120195|NCT00098306|10677539|P2|Observational Phase|Participant defaulted|0
3120196|NCT00098306|10677540|P1|Observational Phase|Participant defaulted|0
3120197|NCT00098306|10677534|P7|Observational Phase|Death|4
3120198|NCT00098306|10677535|P6|Observational Phase|Death|5
3120199|NCT00098306|10677536|P5|Observational Phase|Death|0
3120200|NCT00098306|10677537|P4|Observational Phase|Death|0
3120201|NCT00098306|10677538|P3|Observational Phase|Death|0
3120202|NCT00098306|10677539|P2|Observational Phase|Death|0
3120203|NCT00098306|10677540|P1|Observational Phase|Death|0
3120204|NCT00098306|10677534|P7|Open Label|Ongoing at cut-off date|0
3120205|NCT00098306|10677535|P6|Open Label|Ongoing at cut-off date|0
3120206|NCT00098306|10677536|P5|Open Label|Ongoing at cut-off date|62
3120207|NCT00098306|10677537|P4|Open Label|Ongoing at cut-off date|269
3120208|NCT00098306|10677538|P3|Open Label|Ongoing at cut-off date|0
3120209|NCT00098306|10677539|P2|Open Label|Ongoing at cut-off date|0
3120210|NCT00098306|10677540|P1|Open Label|Ongoing at cut-off date|0
3120211|NCT00098306|10677534|P7|Open Label|Un-specified|0
3120212|NCT00098306|10677535|P6|Open Label|Un-specified|0
3120213|NCT00098306|10677536|P5|Open Label|Un-specified|0
3120214|NCT00098306|10677537|P4|Open Label|Un-specified|15
3120215|NCT00098306|10677538|P3|Open Label|Un-specified|0
3120216|NCT00098306|10677539|P2|Open Label|Un-specified|0
3120217|NCT00098306|10677540|P1|Open Label|Un-specified|0
3120218|NCT00098306|10677534|P7|Open Label|Participant defaulted|0
3120219|NCT00098306|10677535|P6|Open Label|Participant defaulted|0
3120220|NCT00098306|10677536|P5|Open Label|Participant defaulted|0
3120221|NCT00098306|10677537|P4|Open Label|Participant defaulted|24
3120222|NCT00098306|10677538|P3|Open Label|Participant defaulted|0
3120223|NCT00098306|10677539|P2|Open Label|Participant defaulted|0
3120224|NCT00098306|10677540|P1|Open Label|Participant defaulted|0
3120225|NCT00098306|10677534|P7|Open Label|Death|0
3120226|NCT00098306|10677535|P6|Open Label|Death|0
3120227|NCT00098306|10677536|P5|Open Label|Death|0
3120228|NCT00098306|10677537|P4|Open Label|Death|4
3120229|NCT00098306|10677538|P3|Open Label|Death|0
3120230|NCT00098306|10677539|P2|Open Label|Death|0
3120231|NCT00098306|10677540|P1|Open Label|Death|0
3120232|NCT00098306|10677534|P7|Open Label|Adverse Event|0
3120233|NCT00098306|10677535|P6|Open Label|Adverse Event|0
3120234|NCT00098306|10677536|P5|Open Label|Adverse Event|0
3120235|NCT00098306|10677537|P4|Open Label|Adverse Event|2
3120236|NCT00098306|10677538|P3|Open Label|Adverse Event|0
3120237|NCT00098306|10677539|P2|Open Label|Adverse Event|0
3120238|NCT00098306|10677540|P1|Open Label|Adverse Event|0
3120239|NCT00098306|10677534|P7|Open Label|Lack of Efficacy|0
3120240|NCT00098306|10677535|P6|Open Label|Lack of Efficacy|0
3120241|NCT00098306|10677536|P5|Open Label|Lack of Efficacy|0
3120242|NCT00098306|10677537|P4|Open Label|Lack of Efficacy|13
3120243|NCT00098306|10677538|P3|Open Label|Lack of Efficacy|0
3120244|NCT00098306|10677539|P2|Open Label|Lack of Efficacy|0
3120245|NCT00098306|10677540|P1|Open Label|Lack of Efficacy|0
3120246|NCT00098306|10677534|P7|Double Blind|Un-specified|0
3120247|NCT00098306|10677535|P6|Double Blind|Un-specified|0
3120248|NCT00098306|10677536|P5|Double Blind|Un-specified|0
3120249|NCT00098306|10677537|P4|Double Blind|Un-specified|0
3120250|NCT00098306|10677538|P3|Double Blind|Un-specified|11
3120251|NCT00098306|10677539|P2|Double Blind|Un-specified|3
3120252|NCT00098306|10677540|P1|Double Blind|Un-specified|7
3120253|NCT00098306|10677534|P7|Double Blind|Participant defaulted|0
3120254|NCT00098306|10677535|P6|Double Blind|Participant defaulted|0
3120255|NCT00098306|10677536|P5|Double Blind|Participant defaulted|0
3120256|NCT00098306|10677537|P4|Double Blind|Participant defaulted|0
3120257|NCT00098306|10677538|P3|Double Blind|Participant defaulted|11
3120258|NCT00098306|10677539|P2|Double Blind|Participant defaulted|18
3120259|NCT00098306|10677540|P1|Double Blind|Participant defaulted|19
3120260|NCT00098306|10677534|P7|Double Blind|Death|0
3120261|NCT00098306|10677535|P6|Double Blind|Death|0
3120262|NCT00098306|10677536|P5|Double Blind|Death|0
3120263|NCT00098306|10677537|P4|Double Blind|Death|0
3120264|NCT00098306|10677538|P3|Double Blind|Death|1
3120265|NCT00098306|10677539|P2|Double Blind|Death|4
3120266|NCT00098306|10677540|P1|Double Blind|Death|1
3120267|NCT00098306|10677534|P7|Double Blind|Lack of Efficacy|0
3120268|NCT00098306|10677535|P6|Double Blind|Lack of Efficacy|0
3120269|NCT00098306|10677536|P5|Double Blind|Lack of Efficacy|0
3120270|NCT00098306|10677537|P4|Double Blind|Lack of Efficacy|0
3120271|NCT00098306|10677538|P3|Double Blind|Lack of Efficacy|17
3120272|NCT00098306|10677539|P2|Double Blind|Lack of Efficacy|34
3120273|NCT00098306|10677540|P1|Double Blind|Lack of Efficacy|43
3120274|NCT00098306|10677534|P7|Double Blind|Adverse Event|0
3120275|NCT00098306|10677535|P6|Double Blind|Adverse Event|0
3120276|NCT00098306|10677536|P5|Double Blind|Adverse Event|0
3120277|NCT00098306|10677537|P4|Double Blind|Adverse Event|0
3120278|NCT00098306|10677538|P3|Double Blind|Adverse Event|6
3120279|NCT00098306|10677539|P2|Double Blind|Adverse Event|10
3120280|NCT00098306|10677540|P1|Double Blind|Adverse Event|11
3120281|NCT00098306|10677534|P7|Double Blind|Ongoing at cut-off date|0
3120282|NCT00098306|10677535|P6|Double Blind|Ongoing at cut-off date|0
3120283|NCT00098306|10677536|P5|Double Blind|Ongoing at cut-off date|0
3120284|NCT00098306|10677537|P4|Double Blind|Ongoing at cut-off date|0
3120285|NCT00098306|10677538|P3|Double Blind|Ongoing at cut-off date|72
3120286|NCT00098306|10677539|P2|Double Blind|Ongoing at cut-off date|166
3120287|NCT00098306|10677540|P1|Double Blind|Ongoing at cut-off date|151
3120288|NCT00098306|10677534|P7|Double Blind|Randomized, not treated|0
3120289|NCT00098306|10677535|P6|Double Blind|Randomized, not treated|0
3120290|NCT00098306|10677536|P5|Double Blind|Randomized, not treated|0
3120291|NCT00098306|10677537|P4|Double Blind|Randomized, not treated|0
3120292|NCT00098306|10677538|P3|Double Blind|Randomized, not treated|2
3120293|NCT00098306|10677539|P2|Double Blind|Randomized, not treated|5
3120294|NCT00098306|10677540|P1|Double Blind|Randomized, not treated|9
3120295|NCT00098293|10677606|P5|Supplemental Phase (SP)|Other|22
3120296|NCT00098293|10677607|P4|Supplemental Phase (SP)|Other|0
3120297|NCT00098293|10677608|P3|Supplemental Phase (SP)|Other|0
3120298|NCT00098293|10677609|P2|Supplemental Phase (SP)|Other|0
3120299|NCT00098293|10677610|P1|Supplemental Phase (SP)|Other|0
3120300|NCT00098293|10677606|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
3120301|NCT00098293|10677607|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
3120302|NCT00098293|10677608|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
3120303|NCT00098293|10677609|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
3120304|NCT00098293|10677610|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
3120305|NCT00098293|10677606|P5|Supplemental Phase (SP)|Lost to Follow-up|2
3120306|NCT00098293|10677607|P4|Supplemental Phase (SP)|Lost to Follow-up|0
3120307|NCT00098293|10677608|P3|Supplemental Phase (SP)|Lost to Follow-up|0
3120308|NCT00098293|10677609|P2|Supplemental Phase (SP)|Lost to Follow-up|0
3120309|NCT00098293|10677610|P1|Supplemental Phase (SP)|Lost to Follow-up|0
3120310|NCT00098293|10677606|P5|Supplemental Phase (SP)|Death|1
3120311|NCT00098293|10677607|P4|Supplemental Phase (SP)|Death|0
3120312|NCT00098293|10677608|P3|Supplemental Phase (SP)|Death|0
3120313|NCT00098293|10677609|P2|Supplemental Phase (SP)|Death|0
3120314|NCT00098293|10677610|P1|Supplemental Phase (SP)|Death|0
3120315|NCT00098293|10677606|P5|Open-label (OL) Phase|Death|0
3120316|NCT00098293|10677607|P4|Open-label (OL) Phase|Death|0
3120317|NCT00098293|10677608|P3|Open-label (OL) Phase|Death|3
3120318|NCT00098293|10677609|P2|Open-label (OL) Phase|Death|2
3120319|NCT00098293|10677610|P1|Open-label (OL) Phase|Death|0
3120320|NCT00098293|10677606|P5|Open-label (OL) Phase|Participant Defaulted|0
3120321|NCT00098293|10677607|P4|Open-label (OL) Phase|Participant Defaulted|20
3120322|NCT00098293|10677608|P3|Open-label (OL) Phase|Participant Defaulted|16
3120323|NCT00098293|10677609|P2|Open-label (OL) Phase|Participant Defaulted|6
3120324|NCT00098293|10677610|P1|Open-label (OL) Phase|Participant Defaulted|0
3120325|NCT00098293|10677606|P5|Open-label (OL) Phase|Protocol Violation|0
3120326|NCT00098293|10677607|P4|Open-label (OL) Phase|Protocol Violation|16
3120327|NCT00098293|10677608|P3|Open-label (OL) Phase|Protocol Violation|13
3120328|NCT00098293|10677609|P2|Open-label (OL) Phase|Protocol Violation|6
3120329|NCT00098293|10677610|P1|Open-label (OL) Phase|Protocol Violation|0
3120330|NCT00098293|10677606|P5|Open-label (OL) Phase|Pregnancy|0
3120331|NCT00098293|10677607|P4|Open-label (OL) Phase|Pregnancy|3
3120332|NCT00098293|10677608|P3|Open-label (OL) Phase|Pregnancy|0
3120333|NCT00098293|10677609|P2|Open-label (OL) Phase|Pregnancy|1
3120334|NCT00098293|10677610|P1|Open-label (OL) Phase|Pregnancy|0
3120335|NCT00098293|10677606|P5|Open-label (OL) Phase|Lack of Efficacy|0
3120336|NCT00098293|10677607|P4|Open-label (OL) Phase|Lack of Efficacy|20
3120337|NCT00098293|10677608|P3|Open-label (OL) Phase|Lack of Efficacy|2
3120338|NCT00098293|10677609|P2|Open-label (OL) Phase|Lack of Efficacy|7
3120339|NCT00098293|10677610|P1|Open-label (OL) Phase|Lack of Efficacy|0
3120340|NCT00098293|10677606|P5|Open-label (OL) Phase|Adverse Event|0
3120341|NCT00098293|10677607|P4|Open-label (OL) Phase|Adverse Event|6
3120342|NCT00098293|10677608|P3|Open-label (OL) Phase|Adverse Event|7
3120343|NCT00098293|10677609|P2|Open-label (OL) Phase|Adverse Event|3
3120344|NCT00098293|10677610|P1|Open-label (OL) Phase|Adverse Event|0
3120345|NCT00098293|10677606|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
3120346|NCT00098293|10677607|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
3120347|NCT00098293|10677608|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
3120348|NCT00098293|10677609|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
3120349|NCT00098293|10677610|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
3120350|NCT00098293|10677606|P5|Double-blind (DB) Phase|Terminated by sponsor|0
3120351|NCT00098293|10677607|P4|Double-blind (DB) Phase|Terminated by sponsor|0
3120352|NCT00098293|10677608|P3|Double-blind (DB) Phase|Terminated by sponsor|0
3120353|NCT00098293|10677609|P2|Double-blind (DB) Phase|Terminated by sponsor|0
3120354|NCT00098293|10677610|P1|Double-blind (DB) Phase|Terminated by sponsor|135
3120355|NCT00098293|10677606|P5|Double-blind (DB) Phase|Protocol Violation|0
3120356|NCT00098293|10677607|P4|Double-blind (DB) Phase|Protocol Violation|0
3120357|NCT00098293|10677608|P3|Double-blind (DB) Phase|Protocol Violation|22
3120358|NCT00098293|10677609|P2|Double-blind (DB) Phase|Protocol Violation|18
3120359|NCT00098293|10677610|P1|Double-blind (DB) Phase|Protocol Violation|2
3120360|NCT00098293|10677606|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
3120361|NCT00098293|10677607|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
3120362|NCT00098293|10677608|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
3120363|NCT00098293|10677609|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
3120364|NCT00098293|10677610|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
3120365|NCT00098293|10677606|P5|Double-blind (DB) Phase|Death|0
3120366|NCT00098293|10677607|P4|Double-blind (DB) Phase|Death|0
3120367|NCT00098293|10677608|P3|Double-blind (DB) Phase|Death|2
3120368|NCT00098293|10677609|P2|Double-blind (DB) Phase|Death|2
3120369|NCT00098293|10677610|P1|Double-blind (DB) Phase|Death|1
3120370|NCT00098293|10677606|P5|Double-blind (DB) Phase|Lack of Efficacy|0
3120371|NCT00098293|10677607|P4|Double-blind (DB) Phase|Lack of Efficacy|0
3120372|NCT00098293|10677608|P3|Double-blind (DB) Phase|Lack of Efficacy|30
3120373|NCT00098293|10677609|P2|Double-blind (DB) Phase|Lack of Efficacy|64
3120374|NCT00098293|10677610|P1|Double-blind (DB) Phase|Lack of Efficacy|11
3120375|NCT00098293|10677606|P5|Double-blind (DB) Phase|Participant Defaulted|0
3120376|NCT00098293|10677607|P4|Double-blind (DB) Phase|Participant Defaulted|0
3120377|NCT00098293|10677608|P3|Double-blind (DB) Phase|Participant Defaulted|36
3120378|NCT00098293|10677609|P2|Double-blind (DB) Phase|Participant Defaulted|40
3120379|NCT00098293|10677610|P1|Double-blind (DB) Phase|Participant Defaulted|11
3120380|NCT00098293|10677606|P5|Double-blind (DB) Phase|Pregnancy|0
3120381|NCT00098293|10677607|P4|Double-blind (DB) Phase|Pregnancy|0
3120382|NCT00098293|10677608|P3|Double-blind (DB) Phase|Pregnancy|9
3120383|NCT00098293|10677609|P2|Double-blind (DB) Phase|Pregnancy|7
3120384|NCT00098293|10677610|P1|Double-blind (DB) Phase|Pregnancy|0
3120385|NCT00098293|10677606|P5|Double-blind (DB) Phase|Adverse Event|0
3120386|NCT00098293|10677607|P4|Double-blind (DB) Phase|Adverse Event|0
3120387|NCT00098293|10677608|P3|Double-blind (DB) Phase|Adverse Event|60
3120388|NCT00098293|10677609|P2|Double-blind (DB) Phase|Adverse Event|27
3120389|NCT00098293|10677610|P1|Double-blind (DB) Phase|Adverse Event|14
3120390|NCT00098254|10677663|P1|Overall Study|Death|1
3120391|NCT00098254|10677663|P1|Overall Study|Adverse Event|2
3120392|NCT00098020|10677729|P1|Overall Study|Low epidermal growth factor receptor|1
3120393|NCT00098020|10677729|P1|Overall Study|Low urine PCR|1
3120394|NCT00098020|10677729|P1|Overall Study|elevated liver enzymes|1
3120395|NCT00098020|10677729|P1|Overall Study|Lost to Follow-up|1
3120396|NCT00098020|10677729|P1|Overall Study|Adverse Event|2
3120397|NCT00097981|10677736|P2|Overall Study|Other|13
3120398|NCT00097981|10677737|P1|Overall Study|Other|19
3120399|NCT00097981|10677736|P2|Overall Study|Transplant planned|27
3120400|NCT00097981|10677737|P1|Overall Study|Transplant planned|28
3120401|NCT00097981|10677736|P2|Overall Study|Disease Progression|2
3120402|NCT00097981|10677737|P1|Overall Study|Disease Progression|8
3120403|NCT00097981|10677736|P2|Overall Study|Physician Decision|1
3120404|NCT00097981|10677737|P1|Overall Study|Physician Decision|7
3120405|NCT00097981|10677736|P2|Overall Study|Death|4
3120406|NCT00097981|10677737|P1|Overall Study|Death|2
3120407|NCT00097981|10677736|P2|Overall Study|Protocol Violation|1
3120408|NCT00097981|10677737|P1|Overall Study|Protocol Violation|1
3120409|NCT00097981|10677736|P2|Overall Study|Withdrawal by Subject|8
3120410|NCT00097981|10677737|P1|Overall Study|Withdrawal by Subject|10
3120411|NCT00097981|10677736|P2|Overall Study|Adverse Event|44
3120412|NCT00097981|10677737|P1|Overall Study|Adverse Event|31
3120413|NCT00097786|10677759|P4|Overall Study|lost to follow-up for all-cause death|310
3120414|NCT00097786|10677760|P3|Overall Study|lost to follow-up for all-cause death|313
3120415|NCT00097786|10677761|P2|Overall Study|lost to follow-up for all-cause death|292
3120416|NCT00097786|10677762|P1|Overall Study|lost to follow-up for all-cause death|296
3120417|NCT00097773|10677784|P4|Overall Study|Other|0
3120418|NCT00097773|10677785|P3|Overall Study|Other|2
3120419|NCT00097773|10677786|P2|Overall Study|Other|0
3120420|NCT00097773|10677787|P1|Overall Study|Other|1
3120421|NCT00097773|10677784|P4|Overall Study|Adverse Event|0
3120422|NCT00097773|10677785|P3|Overall Study|Adverse Event|0
3120423|NCT00097773|10677786|P2|Overall Study|Adverse Event|1
3120424|NCT00097773|10677787|P1|Overall Study|Adverse Event|0
3120425|NCT00097773|10677784|P4|Overall Study|Withdrawal by Subject|1
3120426|NCT00097773|10677785|P3|Overall Study|Withdrawal by Subject|3
3120427|NCT00097773|10677786|P2|Overall Study|Withdrawal by Subject|3
3120428|NCT00097773|10677787|P1|Overall Study|Withdrawal by Subject|3
3120429|NCT00097773|10677784|P4|Overall Study|Physician Decision|1
3120430|NCT00097773|10677785|P3|Overall Study|Physician Decision|3
3120431|NCT00097773|10677786|P2|Overall Study|Physician Decision|2
3120432|NCT00097773|10677787|P1|Overall Study|Physician Decision|2
3120433|NCT00097773|10677784|P4|Overall Study|Lost to Follow-up|1
3120434|NCT00097773|10677785|P3|Overall Study|Lost to Follow-up|0
3120435|NCT00097773|10677786|P2|Overall Study|Lost to Follow-up|2
3120436|NCT00097773|10677787|P1|Overall Study|Lost to Follow-up|2
3120437|NCT00097721|10677807|P2|Overall Study|Reason not given|1
3120438|NCT00097721|10677808|P1|Overall Study|Reason not given|1
3120439|NCT00097721|10677807|P2|Overall Study|Physician Decision|3
3120440|NCT00097721|10677808|P1|Overall Study|Physician Decision|1
3120441|NCT00097721|10677807|P2|Overall Study|Progressive Disease|27
3120442|NCT00097721|10677808|P1|Overall Study|Progressive Disease|55
3120443|NCT00097721|10677807|P2|Overall Study|Withdrawal by Subject|1
3120444|NCT00097721|10677808|P1|Overall Study|Withdrawal by Subject|6
3120445|NCT00097721|10677807|P2|Overall Study|Adverse Event|1
3120446|NCT00097721|10677808|P1|Overall Study|Adverse Event|8
3120447|NCT00097591|10677858|P2|Overall Study|Other|3
3120448|NCT00097591|10677859|P1|Overall Study|Other|0
3120449|NCT00097591|10677858|P2|Overall Study|Lost to follow up|10
3120450|NCT00097591|10677859|P1|Overall Study|Lost to follow up|6
3120451|NCT00097591|10677858|P2|Overall Study|Unable to attend termination visit|51
3120452|NCT00097591|10677859|P1|Overall Study|Unable to attend termination visit|53
3120453|NCT00097591|10677858|P2|Overall Study|Less than 6 months on study drug|7
3120454|NCT00097591|10677859|P1|Overall Study|Less than 6 months on study drug|9
3120455|NCT00097591|10677858|P2|Overall Study|Withdrawal of consent|323
3120456|NCT00097591|10677859|P1|Overall Study|Withdrawal of consent|342
3120457|NCT00097539|10677882|P7|Overall Study|Reason not Specified|2
3120458|NCT00097539|10677883|P6|Overall Study|Reason not Specified|40
3120459|NCT00097539|10677884|P5|Overall Study|Reason not Specified|11
3120460|NCT00097539|10677885|P4|Overall Study|Reason not Specified|21
3120461|NCT00097539|10677886|P3|Overall Study|Reason not Specified|53
3120462|NCT00097539|10677887|P2|Overall Study|Reason not Specified|49
3120463|NCT00097539|10677888|P1|Overall Study|Reason not Specified|111
3120464|NCT00097539|10677882|P7|Overall Study|Reasons Other Than Above|34
3120465|NCT00097539|10677883|P6|Overall Study|Reasons Other Than Above|1244
3120466|NCT00097539|10677884|P5|Overall Study|Reasons Other Than Above|361
3120467|NCT00097539|10677885|P4|Overall Study|Reasons Other Than Above|692
3120468|NCT00097539|10677886|P3|Overall Study|Reasons Other Than Above|1757
3120469|NCT00097539|10677887|P2|Overall Study|Reasons Other Than Above|1382
3120470|NCT00097539|10677888|P1|Overall Study|Reasons Other Than Above|3602
3120471|NCT00097539|10677882|P7|Overall Study|Death|0
3120472|NCT00097539|10677883|P6|Overall Study|Death|3
3120473|NCT00097539|10677884|P5|Overall Study|Death|1
3120474|NCT00097539|10677885|P4|Overall Study|Death|0
3120475|NCT00097539|10677886|P3|Overall Study|Death|0
3120476|NCT00097539|10677887|P2|Overall Study|Death|7
3120477|NCT00097539|10677888|P1|Overall Study|Death|2
3120478|NCT00097539|10677882|P7|Overall Study|Adverse Event|1
3120479|NCT00097539|10677883|P6|Overall Study|Adverse Event|59
3120480|NCT00097539|10677884|P5|Overall Study|Adverse Event|30
3120481|NCT00097539|10677885|P4|Overall Study|Adverse Event|27
3120482|NCT00097539|10677886|P3|Overall Study|Adverse Event|37
3120483|NCT00097539|10677887|P2|Overall Study|Adverse Event|133
3120484|NCT00097539|10677888|P1|Overall Study|Adverse Event|78
3120485|NCT00097539|10677882|P7|Overall Study|Lack of Efficacy|5
3120486|NCT00097539|10677883|P6|Overall Study|Lack of Efficacy|228
3120487|NCT00097539|10677884|P5|Overall Study|Lack of Efficacy|45
3120488|NCT00097539|10677885|P4|Overall Study|Lack of Efficacy|105
3120489|NCT00097539|10677886|P3|Overall Study|Lack of Efficacy|202
3120490|NCT00097539|10677887|P2|Overall Study|Lack of Efficacy|122
3120491|NCT00097539|10677888|P1|Overall Study|Lack of Efficacy|249
3120492|NCT00097539|10677882|P7|Overall Study|Participant Non-compliant|18
3120493|NCT00097539|10677883|P6|Overall Study|Participant Non-compliant|543
3120494|NCT00097539|10677884|P5|Overall Study|Participant Non-compliant|136
3120495|NCT00097539|10677885|P4|Overall Study|Participant Non-compliant|353
3120496|NCT00097539|10677886|P3|Overall Study|Participant Non-compliant|1067
3120497|NCT00097539|10677887|P2|Overall Study|Participant Non-compliant|567
3120498|NCT00097539|10677888|P1|Overall Study|Participant Non-compliant|2140
3120499|NCT00097539|10677882|P7|Overall Study|Withdrawal by Subject|3
3120500|NCT00097539|10677883|P6|Overall Study|Withdrawal by Subject|229
3120501|NCT00097539|10677884|P5|Overall Study|Withdrawal by Subject|68
3120502|NCT00097539|10677885|P4|Overall Study|Withdrawal by Subject|217
3120503|NCT00097539|10677886|P3|Overall Study|Withdrawal by Subject|346
3120504|NCT00097539|10677887|P2|Overall Study|Withdrawal by Subject|323
3120505|NCT00097539|10677888|P1|Overall Study|Withdrawal by Subject|925
3120506|NCT00097539|10677882|P7|Overall Study|Status Unknown (Or no final evaluation)|108
3120507|NCT00097539|10677883|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
3120508|NCT00097539|10677884|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
3120509|NCT00097539|10677885|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
3120510|NCT00097539|10677886|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
3120511|NCT00097539|10677887|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
3120512|NCT00097539|10677888|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
3120513|NCT00097500|10677934|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
3120514|NCT00097500|10677935|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
3120515|NCT00097500|10677934|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
3120516|NCT00097500|10677935|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
3120517|NCT00097500|10677934|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
3120518|NCT00097500|10677935|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
3120519|NCT00097500|10677934|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
3120520|NCT00097500|10677935|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
3120521|NCT00097500|10677934|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
3120522|NCT00097500|10677935|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
3120523|NCT00097500|10677934|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
3120524|NCT00097500|10677935|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
3120525|NCT00097500|10677934|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
3120526|NCT00097500|10677935|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
3120527|NCT00097370|10677966|P1|Stage 3|Lost to Follow-up|1
3120528|NCT00097370|10677966|P1|Stage 3|Sponsor Terminated Study|52
3120529|NCT00097370|10677966|P1|Stage 3|Lack of Efficacy|1
3120530|NCT00097370|10677966|P1|Stage 3|Withdrawal by Subject|3
3120531|NCT00097370|10677966|P1|Stage 3|Adverse Event|2
3120532|NCT00097370|10677966|P1|Stage 2|Lost to Follow-up|1
3120533|NCT00097370|10677966|P1|Stage 2|Sponsor Terminated Study|2
3120534|NCT00097370|10677966|P1|Stage 2|Pregnancy|1
3120535|NCT00097370|10677966|P1|Stage 2|Lack of Efficacy|3
3120536|NCT00097370|10677966|P1|Stage 2|Withdrawal by Subject|1
3120537|NCT00097370|10677966|P1|Stage 2|Adverse Event|5
3120538|NCT00097370|10677966|P1|Stage 1|Lack of Efficacy|2
3120539|NCT00097370|10677966|P1|Stage 1|Withdrawal by Subject|1
3120540|NCT00097370|10677966|P1|Stage 1|Adverse Event|3
3120541|NCT00096993|10678000|P2|Overall Study|Other unspecified|1
3120542|NCT00096993|10678001|P1|Overall Study|Other unspecified|1
3120543|NCT00096993|10678000|P2|Overall Study|Non-compliance|1
3120544|NCT00096993|10678001|P1|Overall Study|Non-compliance|0
3120545|NCT00096993|10678000|P2|Overall Study|Physician Decision|1
3120546|NCT00096993|10678001|P1|Overall Study|Physician Decision|2
3120547|NCT00096993|10678000|P2|Overall Study|Subject's decision|1
3120548|NCT00096993|10678001|P1|Overall Study|Subject's decision|3
3120549|NCT00096993|10678000|P2|Overall Study|Adverse Event|8
3120550|NCT00096993|10678001|P1|Overall Study|Adverse Event|2
3120551|NCT00096993|10678000|P2|Overall Study|Disease progression|53
3120552|NCT00096993|10678001|P1|Overall Study|Disease progression|56
3120553|NCT00096993|10678000|P2|Overall Study|Death|0
3120554|NCT00096993|10678001|P1|Overall Study|Death|1
3120555|NCT00096954|10678017|P2|Overall Study|Lost to Follow-up|5
3120556|NCT00096954|10678018|P1|Overall Study|Lost to Follow-up|8
3120557|NCT00096954|10678017|P2|Overall Study|Non-compliance|3
3120558|NCT00096954|10678018|P1|Overall Study|Non-compliance|0
3120559|NCT00096954|10678017|P2|Overall Study|Initiation of immunotherapy|0
3120560|NCT00096954|10678018|P1|Overall Study|Initiation of immunotherapy|1
3120561|NCT00096954|10678017|P2|Overall Study|Pregnancy|1
3120562|NCT00096954|10678018|P1|Overall Study|Pregnancy|1
3120563|NCT00096954|10678017|P2|Overall Study|Sponsors Decision|1
3120564|NCT00096954|10678018|P1|Overall Study|Sponsors Decision|1
3120565|NCT00096954|10678017|P2|Overall Study|Physician Decision|1
3120566|NCT00096954|10678018|P1|Overall Study|Physician Decision|1
3120567|NCT00096954|10678017|P2|Overall Study|Withdrawal by Subject|8
3120568|NCT00096954|10678018|P1|Overall Study|Withdrawal by Subject|9
3120569|NCT00096954|10678017|P2|Overall Study|Adverse Event|1
3120570|NCT00096954|10678018|P1|Overall Study|Adverse Event|3
3120571|NCT00096941|10678030|P1|Overall Study|disease progression|3
3120572|NCT00096785|10678037|P2|Overall Study|Relocated|0
3120573|NCT00096785|10678038|P1|Overall Study|Relocated|1
3120574|NCT00096785|10678037|P2|Overall Study|Withdrawal by Subject|1
3120575|NCT00096785|10678038|P1|Overall Study|Withdrawal by Subject|0
3120576|NCT00096785|10678037|P2|Overall Study|Lost to Follow-up|0
3120577|NCT00096785|10678038|P1|Overall Study|Lost to Follow-up|1
3120578|NCT00096538|10678067|P1|Overall Study|Withdrawal by Subject|1
3120579|NCT00096486|10678075|P4|Overall Study|Not Treated|1
3120580|NCT00096486|10678076|P3|Overall Study|Not Treated|1
3120581|NCT00096486|10678077|P2|Overall Study|Not Treated|0
3120582|NCT00096486|10678078|P1|Overall Study|Not Treated|0
3120583|NCT00096486|10678075|P4|Overall Study|Withdrawal by Subject|1
3120584|NCT00096486|10678076|P3|Overall Study|Withdrawal by Subject|1
3120585|NCT00096486|10678077|P2|Overall Study|Withdrawal by Subject|0
3120586|NCT00096486|10678078|P1|Overall Study|Withdrawal by Subject|0
3120587|NCT00096447|10678097|P1|Overall Study|Never treated|1
3120588|NCT00096382|10678113|P2|Overall Study|Death during treatment|0
3120589|NCT00096382|10678114|P1|Overall Study|Death during treatment|1
3120590|NCT00096382|10678113|P2|Overall Study|Not treated|0
3120591|NCT00096382|10678114|P1|Overall Study|Not treated|1
3120592|NCT00096356|10678124|P2|Overall Study|multiple reasons|18
3120593|NCT00096356|10678125|P1|Overall Study|multiple reasons|10
3120594|NCT00096356|10678124|P2|Overall Study|Lack of Efficacy|0
3120595|NCT00096356|10678125|P1|Overall Study|Lack of Efficacy|1
3120596|NCT00096356|10678124|P2|Overall Study|Withdrawal by Subject|23
3120597|NCT00096356|10678125|P1|Overall Study|Withdrawal by Subject|17
3120598|NCT00096356|10678124|P2|Overall Study|Physician Decision|3
3120599|NCT00096356|10678125|P1|Overall Study|Physician Decision|5
3120600|NCT00096356|10678124|P2|Overall Study|Adverse Event|9
3120601|NCT00096356|10678125|P1|Overall Study|Adverse Event|11
3120602|NCT00096278|10678137|P2|Overall Study|Patient not at risk for primary endpoint|2
3120603|NCT00096278|10678138|P1|Overall Study|Patient not at risk for primary endpoint|3
3120604|NCT00096278|10678137|P2|Overall Study|No follow-up data|18
3120605|NCT00096278|10678138|P1|Overall Study|No follow-up data|15
3120606|NCT00096265|10678157|P3|Overall Study|Ineligible|0
3120607|NCT00096265|10678158|P2|Overall Study|Ineligible|0
3120608|NCT00096265|10678159|P1|Overall Study|Ineligible|1
3120609|NCT00096226|10678185|P1|Overall Study|Protocol treatment not started|1
3120610|NCT00096226|10678185|P1|Overall Study|Ineligible|2
3120611|NCT00096200|10678199|P3|Overall Study|Ineligible pathology|0
3120612|NCT00096200|10678200|P2|Overall Study|Ineligible pathology|1
3120613|NCT00096200|10678201|P1|Overall Study|Ineligible pathology|0
3120614|NCT00096200|10678199|P3|Overall Study|Withdrawal by Subject|0
3120615|NCT00096200|10678200|P2|Overall Study|Withdrawal by Subject|2
3120616|NCT00096200|10678201|P1|Overall Study|Withdrawal by Subject|1
3120617|NCT00096200|10678199|P3|Overall Study|Adverse Event|0
3120618|NCT00096200|10678200|P2|Overall Study|Adverse Event|4
3120619|NCT00096200|10678201|P1|Overall Study|Adverse Event|0
3120620|NCT00096174|10678215|P1|Overall Study|other reason|8
3120621|NCT00096174|10678215|P1|Overall Study|Ineligible|6
3120622|NCT00096174|10678215|P1|Overall Study|Not started protocol therapy|3
3120623|NCT00096174|10678215|P1|Overall Study|Withdrawal by Subject|15
3120624|NCT00096174|10678215|P1|Overall Study|Death|6
3120625|NCT00096174|10678215|P1|Overall Study|Adverse Event|15
3120626|NCT00096174|10678215|P1|Overall Study|Lack of Efficacy|9
3120627|NCT00096135|10678260|P2|Overall Study|Ineligible|0
3120628|NCT00096135|10678261|P1|Overall Study|Ineligible|2
3120629|NCT00096135|10678260|P2|Overall Study|Other, specify|3
3120630|NCT00096135|10678261|P1|Overall Study|Other, specify|15
3120631|NCT00096135|10678260|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
3120632|NCT00096135|10678261|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
3120633|NCT00096135|10678260|P2|Overall Study|Refusal of further protocol therapy|1
3120634|NCT00096135|10678261|P1|Overall Study|Refusal of further protocol therapy|4
3120635|NCT00096135|10678260|P2|Overall Study|Physician Decision|4
3120636|NCT00096135|10678261|P1|Overall Study|Physician Decision|20
3120637|NCT00096044|10678277|P1|Overall Study|Disease Progression|4
3120638|NCT00096044|10678277|P1|Overall Study|Adverse Event|21
3120639|NCT00096044|10678277|P1|Overall Study|Withdrawal by Subject|9
3120640|NCT00096031|10678286|P1|Overall Study|Not protocol specified|5
3120641|NCT00096031|10678286|P1|Overall Study|Ineligible|8
3120642|NCT00096031|10678286|P1|Overall Study|Withdrawal by Subject|1
3120643|NCT00096031|10678286|P1|Overall Study|Death|4
3120644|NCT00096031|10678286|P1|Overall Study|Lack of Efficacy|42
3120645|NCT00096031|10678286|P1|Overall Study|Adverse Event|3
3120646|NCT00096018|10678294|P2|Overall Study|Miscellaneous|1
3120647|NCT00096018|10678295|P1|Overall Study|Miscellaneous|2
3120648|NCT00096018|10678294|P2|Overall Study|Withdrawal by Subject|2
3120649|NCT00096018|10678295|P1|Overall Study|Withdrawal by Subject|0
3120650|NCT00096018|10678294|P2|Overall Study|Death|1
3120651|NCT00096018|10678295|P1|Overall Study|Death|0
3120652|NCT00096018|10678294|P2|Overall Study|Adverse Event|5
3120653|NCT00096018|10678295|P1|Overall Study|Adverse Event|0
3120654|NCT00096018|10678294|P2|Overall Study|Miscellaneous (not treated)|2
3120655|NCT00096018|10678295|P1|Overall Study|Miscellaneous (not treated)|0
3120656|NCT00096018|10678294|P2|Overall Study|Became Ineligible (not treated)|3
3120657|NCT00096018|10678295|P1|Overall Study|Became Ineligible (not treated)|0
3120658|NCT00095979|10678303|P1|Overall Study|Ineligible: Second primary cancer site|2
3120659|NCT00095940|10678321|P9|Lapatinib Continuation/Phase II|Adverse Event|0
3120660|NCT00095940|10678322|P8|Lapatinib Continuation/Phase II|Adverse Event|1
3120661|NCT00095940|10678323|P7|Lapatinib Continuation/Phase II|Adverse Event|0
3120662|NCT00095940|10678324|P6|Lapatinib Continuation/Phase II|Adverse Event|0
3120663|NCT00095940|10678325|P5|Lapatinib Continuation/Phase II|Adverse Event|0
3120664|NCT00095940|10678326|P4|Lapatinib Continuation/Phase II|Adverse Event|0
3120665|NCT00095940|10678327|P3|Lapatinib Continuation/Phase II|Adverse Event|0
3120666|NCT00095940|10678328|P2|Lapatinib Continuation/Phase II|Adverse Event|0
3120667|NCT00095940|10678329|P1|Lapatinib Continuation/Phase II|Adverse Event|0
3120668|NCT00095940|10678321|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
3120669|NCT00095940|10678322|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
3120670|NCT00095940|10678323|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
3120671|NCT00095940|10678324|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
3120672|NCT00095940|10678325|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
3120673|NCT00095940|10678326|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
3120674|NCT00095940|10678327|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
3120675|NCT00095940|10678328|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
3120676|NCT00095940|10678329|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
3120677|NCT00095940|10678321|P9|Lapatinib Continuation/Phase II|Disease Progression|12
3120678|NCT00095940|10678322|P8|Lapatinib Continuation/Phase II|Disease Progression|1
3120679|NCT00095940|10678323|P7|Lapatinib Continuation/Phase II|Disease Progression|2
3120680|NCT00095940|10678324|P6|Lapatinib Continuation/Phase II|Disease Progression|13
3120681|NCT00095940|10678325|P5|Lapatinib Continuation/Phase II|Disease Progression|0
3120682|NCT00095940|10678326|P4|Lapatinib Continuation/Phase II|Disease Progression|0
3120683|NCT00095940|10678327|P3|Lapatinib Continuation/Phase II|Disease Progression|15
3120684|NCT00095940|10678328|P2|Lapatinib Continuation/Phase II|Disease Progression|1
3120685|NCT00095940|10678329|P1|Lapatinib Continuation/Phase II|Disease Progression|1
3120686|NCT00095836|10678362|P1|Overall Study|Death|2
3120687|NCT00095836|10678362|P1|Overall Study|Adverse Event|1
3120688|NCT00095836|10678362|P1|Overall Study|Lost to Follow-up|1
3120689|NCT00095628|10678392|P1|Overall Study|Disease progression prior to treatment|1
3120690|NCT00095576|10678403|P2|Overall Study|Subject moved|36
3120691|NCT00095576|10678404|P1|Overall Study|Subject moved|30
3120692|NCT00095576|10678403|P2|Overall Study|Site terminated|67
3120693|NCT00095576|10678404|P1|Overall Study|Site terminated|75
3120694|NCT00095576|10678403|P2|Overall Study|Option to switch to a rollover study|1099
3120695|NCT00095576|10678404|P1|Overall Study|Option to switch to a rollover study|1097
3120696|NCT00095576|10678403|P2|Overall Study|Withdrawal by Subject|47
3120697|NCT00095576|10678404|P1|Overall Study|Withdrawal by Subject|34
3120698|NCT00095576|10678403|P2|Overall Study|Protocol Violation|0
3120699|NCT00095576|10678404|P1|Overall Study|Protocol Violation|1
3120700|NCT00095576|10678403|P2|Overall Study|Lost to Follow-up|229
3120701|NCT00095576|10678404|P1|Overall Study|Lost to Follow-up|233
3120702|NCT00095576|10678403|P2|Overall Study|Adverse Event|3
3120703|NCT00095576|10678404|P1|Overall Study|Adverse Event|5
3120704|NCT00095498|10678428|P3|Overall Study|Requirement for alternative therapy|2
3120705|NCT00095498|10678429|P2|Overall Study|Requirement for alternative therapy|0
3120706|NCT00095498|10678430|P1|Overall Study|Requirement for alternative therapy|1
3120707|NCT00095498|10678428|P3|Overall Study|Protocol Violation|1
3120708|NCT00095498|10678429|P2|Overall Study|Protocol Violation|0
3120709|NCT00095498|10678430|P1|Overall Study|Protocol Violation|0
3120710|NCT00095498|10678428|P3|Overall Study|Other|6
3120711|NCT00095498|10678429|P2|Overall Study|Other|7
3120712|NCT00095498|10678430|P1|Overall Study|Other|6
3120713|NCT00095498|10678428|P3|Overall Study|Noncompliance|1
3120714|NCT00095498|10678429|P2|Overall Study|Noncompliance|0
3120715|NCT00095498|10678430|P1|Overall Study|Noncompliance|1
3120716|NCT00095498|10678428|P3|Overall Study|Lost to Follow-up|2
3120717|NCT00095498|10678429|P2|Overall Study|Lost to Follow-up|1
3120718|NCT00095498|10678430|P1|Overall Study|Lost to Follow-up|1
3120719|NCT00095498|10678428|P3|Overall Study|Ineligibility determined|2
3120720|NCT00095498|10678429|P2|Overall Study|Ineligibility determined|0
3120721|NCT00095498|10678430|P1|Overall Study|Ineligibility determined|3
3120722|NCT00095498|10678428|P3|Overall Study|Disease progression|1
3120723|NCT00095498|10678429|P2|Overall Study|Disease progression|1
3120724|NCT00095498|10678430|P1|Overall Study|Disease progression|0
3120725|NCT00095498|10678428|P3|Overall Study|Withdrawal by Subject|15
3120726|NCT00095498|10678429|P2|Overall Study|Withdrawal by Subject|16
3120727|NCT00095498|10678430|P1|Overall Study|Withdrawal by Subject|15
3120728|NCT00095498|10678428|P3|Overall Study|Adverse Event|1
3120729|NCT00095498|10678429|P2|Overall Study|Adverse Event|0
3120730|NCT00095498|10678430|P1|Overall Study|Adverse Event|1
3120731|NCT00095498|10678428|P3|Overall Study|Physician Decision|8
3120732|NCT00095498|10678429|P2|Overall Study|Physician Decision|10
3120733|NCT00095498|10678430|P1|Overall Study|Physician Decision|9
3120734|NCT00095303|10678857|P2|Follow Up Study|Lost to Follow-up|58
3120735|NCT00095303|10678858|P1|Follow Up Study|Lost to Follow-up|59
3120736|NCT00095303|10678857|P2|Main Study|Lost to Follow-up|87
3120737|NCT00095303|10678858|P1|Main Study|Lost to Follow-up|91
3120738|NCT00095238|10678926|P2|Overall Study|Other Reasons|88
3120739|NCT00095238|10678927|P1|Overall Study|Other Reasons|87
3120740|NCT00095238|10678926|P2|Overall Study|Missing|0
3120741|NCT00095238|10678927|P1|Overall Study|Missing|1
3120742|NCT00095238|10678926|P2|Overall Study|Study terminated by sponsor|1
3120743|NCT00095238|10678927|P1|Overall Study|Study terminated by sponsor|0
3120744|NCT00095238|10678926|P2|Overall Study|No longer met study criteria|5
3120745|NCT00095238|10678927|P1|Overall Study|No longer met study criteria|4
3120746|NCT00095238|10678926|P2|Overall Study|Noncompliance|45
3120747|NCT00095238|10678927|P1|Overall Study|Noncompliance|44
3120748|NCT00095238|10678926|P2|Overall Study|Lost to Follow-up|24
3120749|NCT00095238|10678927|P1|Overall Study|Lost to Follow-up|19
3120750|NCT00095238|10678926|P2|Overall Study|Death|170
3120751|NCT00095238|10678927|P1|Overall Study|Death|154
3120752|NCT00095238|10678926|P2|Overall Study|Subject Withdrew Consent|223
3120753|NCT00095238|10678927|P1|Overall Study|Subject Withdrew Consent|208
3120754|NCT00095238|10678926|P2|Overall Study|Adverse Event|287
3120755|NCT00095238|10678927|P1|Overall Study|Adverse Event|331
3120756|NCT00095238|10678926|P2|Overall Study|Lack of Efficacy|9
3120757|NCT00095238|10678927|P1|Overall Study|Lack of Efficacy|9
3120758|NCT00095212|10678989|P2|Overall Study|Withdrawal by Subject|3
3120759|NCT00095212|10678990|P1|Overall Study|Withdrawal by Subject|1
3120760|NCT00095199|10679020|P4|Overall Study|Data inadvertently lost by site|0
3120761|NCT00095199|10679021|P3|Overall Study|Data inadvertently lost by site|0
3120762|NCT00095199|10679022|P2|Overall Study|Data inadvertently lost by site|0
3120763|NCT00095199|10679023|P1|Overall Study|Data inadvertently lost by site|1
3120764|NCT00095199|10679020|P4|Overall Study|Primary tumor removed in other surgery|0
3120765|NCT00095199|10679021|P3|Overall Study|Primary tumor removed in other surgery|0
3120766|NCT00095199|10679022|P2|Overall Study|Primary tumor removed in other surgery|1
3120767|NCT00095199|10679023|P1|Overall Study|Primary tumor removed in other surgery|0
3120768|NCT00095199|10679020|P4|Overall Study|Started radiotherapy regimen|0
3120769|NCT00095199|10679021|P3|Overall Study|Started radiotherapy regimen|0
3120770|NCT00095199|10679022|P2|Overall Study|Started radiotherapy regimen|1
3120771|NCT00095199|10679023|P1|Overall Study|Started radiotherapy regimen|0
3120772|NCT00095199|10679020|P4|Overall Study|Started Palliative Radiotherapy|0
3120773|NCT00095199|10679021|P3|Overall Study|Started Palliative Radiotherapy|0
3120774|NCT00095199|10679022|P2|Overall Study|Started Palliative Radiotherapy|0
3120775|NCT00095199|10679023|P1|Overall Study|Started Palliative Radiotherapy|1
3120776|NCT00095199|10679020|P4|Overall Study|Not eligible|1
3120777|NCT00095199|10679021|P3|Overall Study|Not eligible|0
3120778|NCT00095199|10679022|P2|Overall Study|Not eligible|7
3120779|NCT00095199|10679023|P1|Overall Study|Not eligible|1
3120780|NCT00095199|10679020|P4|Overall Study|Physician Decision|1
3120781|NCT00095199|10679021|P3|Overall Study|Physician Decision|1
3120782|NCT00095199|10679022|P2|Overall Study|Physician Decision|6
3120783|NCT00095199|10679023|P1|Overall Study|Physician Decision|5
3120784|NCT00095199|10679020|P4|Overall Study|Surgery needed could not start in 7 days|0
3120785|NCT00095199|10679021|P3|Overall Study|Surgery needed could not start in 7 days|1
3120786|NCT00095199|10679022|P2|Overall Study|Surgery needed could not start in 7 days|0
3120787|NCT00095199|10679023|P1|Overall Study|Surgery needed could not start in 7 days|0
3120788|NCT00095199|10679020|P4|Overall Study|Liver function test results elevated|1
3120789|NCT00095199|10679021|P3|Overall Study|Liver function test results elevated|1
3120790|NCT00095199|10679022|P2|Overall Study|Liver function test results elevated|0
3120791|NCT00095199|10679023|P1|Overall Study|Liver function test results elevated|0
3120792|NCT00095199|10679020|P4|Overall Study|Protocol Violation|0
3120793|NCT00095199|10679021|P3|Overall Study|Protocol Violation|2
3120794|NCT00095199|10679022|P2|Overall Study|Protocol Violation|4
3120795|NCT00095199|10679023|P1|Overall Study|Protocol Violation|4
3120796|NCT00095199|10679020|P4|Overall Study|Withdrawal by Subject|22
3120797|NCT00095199|10679021|P3|Overall Study|Withdrawal by Subject|13
3120798|NCT00095199|10679022|P2|Overall Study|Withdrawal by Subject|16
3120799|NCT00095199|10679023|P1|Overall Study|Withdrawal by Subject|21
3120800|NCT00095199|10679020|P4|Overall Study|Death|9
3120801|NCT00095199|10679021|P3|Overall Study|Death|11
3120802|NCT00095199|10679022|P2|Overall Study|Death|6
3120803|NCT00095199|10679023|P1|Overall Study|Death|10
3120804|NCT00095199|10679020|P4|Overall Study|Progressive disease|98
3120805|NCT00095199|10679021|P3|Overall Study|Progressive disease|105
3120806|NCT00095199|10679022|P2|Overall Study|Progressive disease|179
3120807|NCT00095199|10679023|P1|Overall Study|Progressive disease|213
3120808|NCT00095199|10679020|P4|Overall Study|Adverse Event|11
3120809|NCT00095199|10679021|P3|Overall Study|Adverse Event|26
3120810|NCT00095199|10679022|P2|Overall Study|Adverse Event|22
3120811|NCT00095199|10679023|P1|Overall Study|Adverse Event|40
3120812|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Other|8
3120813|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Other|6
3120814|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Other|4
3120815|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Other|0
3120816|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Other|0
3120817|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Other|0
3120818|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
3120819|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
3120820|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
3120821|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
3120822|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
3120823|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
3120824|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
3120825|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
3120826|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
3120827|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
3120828|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
3120829|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
3120830|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
3120831|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
3120832|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
3120833|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
3120834|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
3120835|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
3120836|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
3120837|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
3120838|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
3120839|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
3120840|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
3120841|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
3120842|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
3120843|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
3120844|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
3120845|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
3120846|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
3120847|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
3120848|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
3120849|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
3120850|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
3120851|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
3120852|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
3120853|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
3120854|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
3120855|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
3120856|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
3120857|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
3120858|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
3120859|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
3120860|NCT00095173|10679061|P6|Open-Label Extension Phase (Period C)|Death|1
3120861|NCT00095173|10679062|P5|Open-Label Extension Phase (Period C)|Death|0
3120862|NCT00095173|10679063|P4|Open-Label Extension Phase (Period C)|Death|0
3120863|NCT00095173|10679064|P3|Open-Label Extension Phase (Period C)|Death|0
3120864|NCT00095173|10679065|P2|Open-Label Extension Phase (Period C)|Death|0
3120865|NCT00095173|10679066|P1|Open-Label Extension Phase (Period C)|Death|0
3120866|NCT00095173|10679061|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
3120867|NCT00095173|10679062|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
3120868|NCT00095173|10679063|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
3120869|NCT00095173|10679064|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
3120870|NCT00095173|10679065|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
3120871|NCT00095173|10679066|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
3120872|NCT00095173|10679061|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
3120873|NCT00095173|10679062|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
3120874|NCT00095173|10679063|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
3120875|NCT00095173|10679064|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
3120876|NCT00095173|10679065|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
3120877|NCT00095173|10679066|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
3120878|NCT00095173|10679061|P6|Open-Label Lead-In Phase (Period A)|Other|0
3120879|NCT00095173|10679062|P5|Open-Label Lead-In Phase (Period A)|Other|0
3120880|NCT00095173|10679063|P4|Open-Label Lead-In Phase (Period A)|Other|0
3120881|NCT00095173|10679064|P3|Open-Label Lead-In Phase (Period A)|Other|0
3120882|NCT00095173|10679065|P2|Open-Label Lead-In Phase (Period A)|Other|0
3120883|NCT00095173|10679066|P1|Open-Label Lead-In Phase (Period A)|Other|1
3120884|NCT00095173|10679061|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
3120885|NCT00095173|10679062|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
3120886|NCT00095173|10679063|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
3120887|NCT00095173|10679064|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
3120888|NCT00095173|10679065|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
3120889|NCT00095173|10679066|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
3120890|NCT00095173|10679061|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
3120891|NCT00095173|10679062|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
3120892|NCT00095173|10679063|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
3120893|NCT00095173|10679064|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
3120894|NCT00095173|10679065|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
3120895|NCT00095173|10679066|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
3120896|NCT00095173|10679061|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
3120897|NCT00095173|10679062|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
3120898|NCT00095173|10679063|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
3120899|NCT00095173|10679064|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
3120900|NCT00095173|10679065|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
3120901|NCT00095173|10679066|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
3120902|NCT00095147|10679104|P5|Long-term Extension Period|Leaving country|1
3120903|NCT00095147|10679105|P4|Long-term Extension Period|Leaving country|0
3120904|NCT00095147|10679106|P3|Long-term Extension Period|Leaving country|0
3120905|NCT00095147|10679107|P2|Long-term Extension Period|Leaving country|0
3120906|NCT00095147|10679108|P1|Long-term Extension Period|Leaving country|0
3120907|NCT00095147|10679104|P5|Long-term Extension Period|Participant chose to use Revellex|1
3120908|NCT00095147|10679105|P4|Long-term Extension Period|Participant chose to use Revellex|0
3120909|NCT00095147|10679106|P3|Long-term Extension Period|Participant chose to use Revellex|0
3120910|NCT00095147|10679107|P2|Long-term Extension Period|Participant chose to use Revellex|0
3120911|NCT00095147|10679108|P1|Long-term Extension Period|Participant chose to use Revellex|0
3120912|NCT00095147|10679104|P5|Long-term Extension Period|No longer meets study criteria|1
3120913|NCT00095147|10679105|P4|Long-term Extension Period|No longer meets study criteria|0
3120914|NCT00095147|10679106|P3|Long-term Extension Period|No longer meets study criteria|0
3120915|NCT00095147|10679107|P2|Long-term Extension Period|No longer meets study criteria|0
3120916|NCT00095147|10679108|P1|Long-term Extension Period|No longer meets study criteria|0
3120917|NCT00095147|10679104|P5|Long-term Extension Period|Pregnancy|1
3120918|NCT00095147|10679105|P4|Long-term Extension Period|Pregnancy|0
3120919|NCT00095147|10679106|P3|Long-term Extension Period|Pregnancy|0
3120920|NCT00095147|10679107|P2|Long-term Extension Period|Pregnancy|0
3120921|NCT00095147|10679108|P1|Long-term Extension Period|Pregnancy|0
3120922|NCT00095147|10679104|P5|Long-term Extension Period|Withdrawal of consent|12
3120923|NCT00095147|10679105|P4|Long-term Extension Period|Withdrawal of consent|0
3120924|NCT00095147|10679106|P3|Long-term Extension Period|Withdrawal of consent|0
3120925|NCT00095147|10679107|P2|Long-term Extension Period|Withdrawal of consent|0
3120926|NCT00095147|10679108|P1|Long-term Extension Period|Withdrawal of consent|0
3120927|NCT00095147|10679104|P5|Long-term Extension Period|Lost to Follow-up|6
3120928|NCT00095147|10679105|P4|Long-term Extension Period|Lost to Follow-up|0
3120929|NCT00095147|10679106|P3|Long-term Extension Period|Lost to Follow-up|0
3120930|NCT00095147|10679107|P2|Long-term Extension Period|Lost to Follow-up|0
3120931|NCT00095147|10679108|P1|Long-term Extension Period|Lost to Follow-up|0
3120932|NCT00095147|10679104|P5|Long-term Extension Period|Lack of Efficacy|9
3120933|NCT00095147|10679105|P4|Long-term Extension Period|Lack of Efficacy|0
3120934|NCT00095147|10679106|P3|Long-term Extension Period|Lack of Efficacy|0
3120935|NCT00095147|10679107|P2|Long-term Extension Period|Lack of Efficacy|0
3120936|NCT00095147|10679108|P1|Long-term Extension Period|Lack of Efficacy|0
3120937|NCT00095147|10679104|P5|Long-term Extension Period|Adverse Event|11
3120938|NCT00095147|10679105|P4|Long-term Extension Period|Adverse Event|0
3120939|NCT00095147|10679106|P3|Long-term Extension Period|Adverse Event|0
3120940|NCT00095147|10679107|P2|Long-term Extension Period|Adverse Event|0
3120941|NCT00095147|10679108|P1|Long-term Extension Period|Adverse Event|0
3120942|NCT00095147|10679104|P5|Long-term Extension Period|Death|3
3120943|NCT00095147|10679105|P4|Long-term Extension Period|Death|0
3120944|NCT00095147|10679106|P3|Long-term Extension Period|Death|0
3120945|NCT00095147|10679107|P2|Long-term Extension Period|Death|0
3120946|NCT00095147|10679108|P1|Long-term Extension Period|Death|0
3120947|NCT00095147|10679104|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
3120948|NCT00095147|10679105|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
3120949|NCT00095147|10679106|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
3120950|NCT00095147|10679107|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
3120951|NCT00095147|10679108|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
3120952|NCT00095147|10679104|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
3120953|NCT00095147|10679105|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
3120954|NCT00095147|10679106|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
3120955|NCT00095147|10679107|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
3120956|NCT00095147|10679108|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
3120957|NCT00095147|10679104|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
3120958|NCT00095147|10679105|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
3120959|NCT00095147|10679106|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
3120960|NCT00095147|10679107|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
3120961|NCT00095147|10679108|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
3120962|NCT00095147|10679104|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
3120963|NCT00095147|10679105|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
3120964|NCT00095147|10679106|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
3120965|NCT00095147|10679107|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
3120966|NCT00095147|10679108|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
3120967|NCT00095147|10679104|P5|Double-blind Period 2 (Days 198-365)|Death|0
3120968|NCT00095147|10679105|P4|Double-blind Period 2 (Days 198-365)|Death|1
3120969|NCT00095147|10679106|P3|Double-blind Period 2 (Days 198-365)|Death|0
3120970|NCT00095147|10679107|P2|Double-blind Period 2 (Days 198-365)|Death|1
3120971|NCT00095147|10679108|P1|Double-blind Period 2 (Days 198-365)|Death|0
3120972|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
3120973|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
3120974|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
3120975|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
3120976|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
3120977|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
3120978|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
3120979|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
3120980|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
3120981|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
3120982|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
3120983|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
3120984|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
3120985|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
3120986|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
3120987|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
3120988|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
3120989|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
3120990|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
3120991|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
3120992|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
3120993|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
3120994|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
3120995|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
3120996|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
3120997|NCT00095147|10679104|P5|Double-blind Period 1 (Days 1-197)|Death|0
3120998|NCT00095147|10679105|P4|Double-blind Period 1 (Days 1-197)|Death|0
3120999|NCT00095147|10679106|P3|Double-blind Period 1 (Days 1-197)|Death|0
3121000|NCT00095147|10679107|P2|Double-blind Period 1 (Days 1-197)|Death|0
3121001|NCT00095147|10679108|P1|Double-blind Period 1 (Days 1-197)|Death|1
3121002|NCT00095121|10679303|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
3121003|NCT00095121|10679304|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
3121004|NCT00095121|10679303|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
3121005|NCT00095121|10679304|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
3121006|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Protocol Violation|1
3121007|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Protocol Violation|0
3121008|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
3121009|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
3121010|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Death|1
3121011|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Death|3
3121012|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Patient Moved|0
3121013|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Patient Moved|1
3121014|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
3121015|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
3121016|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
3121017|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
3121018|NCT00095056|10679350|P2|Phase B (Weeks 12-54)|Adverse Event|2
3121019|NCT00095056|10679351|P1|Phase B (Weeks 12-54)|Adverse Event|2
3121020|NCT00095056|10679350|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
3121021|NCT00095056|10679351|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
3121022|NCT00095056|10679350|P2|Phase A (Weeks 0-12)|Death|0
3121023|NCT00095056|10679351|P1|Phase A (Weeks 0-12)|Death|1
3121024|NCT00095056|10679350|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
3121025|NCT00095056|10679351|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
3121026|NCT00095056|10679350|P2|Phase A (Weeks 0-12)|Adverse Event|1
3121027|NCT00095056|10679351|P1|Phase A (Weeks 0-12)|Adverse Event|1
3121028|NCT00094861|10679480|P2|Overall Study|Other|0
3121029|NCT00094861|10679481|P1|Overall Study|Other|3
3121030|NCT00094861|10679480|P2|Overall Study|Death|2
3121031|NCT00094861|10679481|P1|Overall Study|Death|4
3121032|NCT00094861|10679480|P2|Overall Study|Lost to Follow-up|1
3121033|NCT00094861|10679481|P1|Overall Study|Lost to Follow-up|0
3121034|NCT00094861|10679480|P2|Overall Study|Physician Decision|1
3121035|NCT00094861|10679481|P1|Overall Study|Physician Decision|1
3121036|NCT00094861|10679480|P2|Overall Study|Withdrawal by Subject|3
3121037|NCT00094861|10679481|P1|Overall Study|Withdrawal by Subject|5
3121038|NCT00094861|10679480|P2|Overall Study|Adverse Event|2
3121039|NCT00094861|10679481|P1|Overall Study|Adverse Event|5
3121040|NCT00094835|10679508|P7|Overall Study|Other|0
3121041|NCT00094835|10679509|P6|Overall Study|Other|0
3121042|NCT00094835|10679510|P5|Overall Study|Other|0
3121043|NCT00094835|10679511|P4|Overall Study|Other|1
3121044|NCT00094835|10679512|P3|Overall Study|Other|1
3121045|NCT00094835|10679513|P2|Overall Study|Other|1
3121046|NCT00094835|10679514|P1|Overall Study|Other|1
3121047|NCT00094835|10679508|P7|Overall Study|Non-compliance|1
3121048|NCT00094835|10679509|P6|Overall Study|Non-compliance|2
3121049|NCT00094835|10679510|P5|Overall Study|Non-compliance|2
3121050|NCT00094835|10679511|P4|Overall Study|Non-compliance|0
3121051|NCT00094835|10679512|P3|Overall Study|Non-compliance|2
3121052|NCT00094835|10679513|P2|Overall Study|Non-compliance|2
3121053|NCT00094835|10679514|P1|Overall Study|Non-compliance|1
3121054|NCT00094835|10679508|P7|Overall Study|Death|0
3121055|NCT00094835|10679509|P6|Overall Study|Death|0
3121056|NCT00094835|10679510|P5|Overall Study|Death|1
3121057|NCT00094835|10679511|P4|Overall Study|Death|0
3121058|NCT00094835|10679512|P3|Overall Study|Death|0
3121059|NCT00094835|10679513|P2|Overall Study|Death|0
3121060|NCT00094835|10679514|P1|Overall Study|Death|1
3121061|NCT00094835|10679508|P7|Overall Study|Lost to Follow-up|0
3121062|NCT00094835|10679509|P6|Overall Study|Lost to Follow-up|0
3121063|NCT00094835|10679510|P5|Overall Study|Lost to Follow-up|1
3121064|NCT00094835|10679511|P4|Overall Study|Lost to Follow-up|0
3121065|NCT00094835|10679512|P3|Overall Study|Lost to Follow-up|0
3121066|NCT00094835|10679513|P2|Overall Study|Lost to Follow-up|0
3121067|NCT00094835|10679514|P1|Overall Study|Lost to Follow-up|0
3121068|NCT00094835|10679508|P7|Overall Study|Withdrawal by Subject|1
3121069|NCT00094835|10679509|P6|Overall Study|Withdrawal by Subject|0
3121070|NCT00094835|10679510|P5|Overall Study|Withdrawal by Subject|0
3121071|NCT00094835|10679511|P4|Overall Study|Withdrawal by Subject|0
3121072|NCT00094835|10679512|P3|Overall Study|Withdrawal by Subject|0
3121073|NCT00094835|10679513|P2|Overall Study|Withdrawal by Subject|0
3121074|NCT00094835|10679514|P1|Overall Study|Withdrawal by Subject|0
3121075|NCT00094835|10679508|P7|Overall Study|Physician Decision|0
3121076|NCT00094835|10679509|P6|Overall Study|Physician Decision|1
3121077|NCT00094835|10679510|P5|Overall Study|Physician Decision|0
3121078|NCT00094835|10679511|P4|Overall Study|Physician Decision|0
3121079|NCT00094835|10679512|P3|Overall Study|Physician Decision|0
3121080|NCT00094835|10679513|P2|Overall Study|Physician Decision|0
3121081|NCT00094835|10679514|P1|Overall Study|Physician Decision|1
3121082|NCT00094809|10679592|P2|Overall Study|Other|1
3121083|NCT00094809|10679593|P1|Overall Study|Other|1
3121084|NCT00094809|10679592|P2|Overall Study|Study drug not received|8
3121085|NCT00094809|10679593|P1|Overall Study|Study drug not received|2
3121086|NCT00094809|10679592|P2|Overall Study|Informed consent signed after treatment|0
3121087|NCT00094809|10679593|P1|Overall Study|Informed consent signed after treatment|1
3121088|NCT00094809|10679592|P2|Overall Study|Other|4
3121089|NCT00094809|10679593|P1|Overall Study|Other|2
3121090|NCT00094809|10679592|P2|Overall Study|Protocol-specified criteria|1
3121091|NCT00094809|10679593|P1|Overall Study|Protocol-specified criteria|1
3121092|NCT00094809|10679592|P2|Overall Study|Death|25
3121093|NCT00094809|10679593|P1|Overall Study|Death|19
3121094|NCT00094809|10679592|P2|Overall Study|Lost to Follow-up|6
3121095|NCT00094809|10679593|P1|Overall Study|Lost to Follow-up|6
3121096|NCT00094809|10679592|P2|Overall Study|Physician Decision|5
3121097|NCT00094809|10679593|P1|Overall Study|Physician Decision|3
3121098|NCT00094809|10679592|P2|Overall Study|Disease progression|3
3121099|NCT00094809|10679593|P1|Overall Study|Disease progression|3
3121100|NCT00094809|10679592|P2|Overall Study|Withdrawal by Subject|9
3121101|NCT00094809|10679593|P1|Overall Study|Withdrawal by Subject|8
3121102|NCT00094809|10679592|P2|Overall Study|Adverse Event|1
3121103|NCT00094809|10679593|P1|Overall Study|Adverse Event|3
3121104|NCT00094809|10679592|P2|Overall Study|Noncompliance|0
3121105|NCT00094809|10679593|P1|Overall Study|Noncompliance|1
3121106|NCT00094809|10679592|P2|Overall Study|Protocol deviation|2
3121107|NCT00094809|10679593|P1|Overall Study|Protocol deviation|2
3121108|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Other|23
3121109|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Other|15
3121110|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
3121111|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
3121112|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
3121113|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
3121114|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
3121115|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
3121116|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
3121117|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
3121118|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
3121119|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
3121120|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
3121121|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
3121122|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
3121123|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
3121124|NCT00094770|10679619|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
3121125|NCT00094770|10679620|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
3121126|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Other|11
3121127|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Other|10
3121128|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
3121129|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
3121130|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
3121131|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
3121132|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
3121133|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
3121134|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
3121135|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
3121136|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
3121137|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
3121138|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
3121139|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
3121140|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
3121141|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
3121142|NCT00094770|10679619|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
3121143|NCT00094770|10679620|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
3121144|NCT00094757|10679651|P3|Overall Study|Protocol specified discontinuation|0
3121145|NCT00094757|10679652|P2|Overall Study|Protocol specified discontinuation|3
3121146|NCT00094757|10679653|P1|Overall Study|Protocol specified discontinuation|1
3121147|NCT00094757|10679651|P3|Overall Study|Other|1
3121148|NCT00094757|10679652|P2|Overall Study|Other|3
3121149|NCT00094757|10679653|P1|Overall Study|Other|3
3121150|NCT00094757|10679651|P3|Overall Study|Withdrawal by Subject|5
3121151|NCT00094757|10679652|P2|Overall Study|Withdrawal by Subject|21
3121152|NCT00094757|10679653|P1|Overall Study|Withdrawal by Subject|14
3121153|NCT00094757|10679651|P3|Overall Study|Protocol Violation|3
3121154|NCT00094757|10679652|P2|Overall Study|Protocol Violation|5
3121155|NCT00094757|10679653|P1|Overall Study|Protocol Violation|8
3121156|NCT00094757|10679651|P3|Overall Study|Patient Moved|1
3121157|NCT00094757|10679652|P2|Overall Study|Patient Moved|1
3121158|NCT00094757|10679653|P1|Overall Study|Patient Moved|2
3121159|NCT00094757|10679651|P3|Overall Study|Lost to Follow-up|6
3121160|NCT00094757|10679652|P2|Overall Study|Lost to Follow-up|5
3121161|NCT00094757|10679653|P1|Overall Study|Lost to Follow-up|3
3121162|NCT00094757|10679651|P3|Overall Study|Lack of Efficacy|8
3121163|NCT00094757|10679652|P2|Overall Study|Lack of Efficacy|15
3121164|NCT00094757|10679653|P1|Overall Study|Lack of Efficacy|11
3121165|NCT00094757|10679651|P3|Overall Study|Adverse Event|6
3121166|NCT00094757|10679652|P2|Overall Study|Adverse Event|9
3121167|NCT00094757|10679653|P1|Overall Study|Adverse Event|11
3121168|NCT00094653|10679673|P3|Overall Study|Protocol Violation|1
3121169|NCT00094653|10679674|P2|Overall Study|Protocol Violation|0
3121170|NCT00094653|10679675|P1|Overall Study|Protocol Violation|0
3121171|NCT00094653|10679673|P3|Overall Study|Lost to Follow-up|1
3121172|NCT00094653|10679674|P2|Overall Study|Lost to Follow-up|2
3121173|NCT00094653|10679675|P1|Overall Study|Lost to Follow-up|3
3121174|NCT00094653|10679673|P3|Overall Study|Other|2
3121175|NCT00094653|10679674|P2|Overall Study|Other|2
3121176|NCT00094653|10679675|P1|Overall Study|Other|2
3121177|NCT00094653|10679673|P3|Overall Study|Subject Withdrew Consent|3
3121178|NCT00094653|10679674|P2|Overall Study|Subject Withdrew Consent|2
3121179|NCT00094653|10679675|P1|Overall Study|Subject Withdrew Consent|10
3121180|NCT00094653|10679673|P3|Overall Study|Death|119
3121181|NCT00094653|10679674|P2|Overall Study|Death|100
3121182|NCT00094653|10679675|P1|Overall Study|Death|306
3121183|NCT00094575|10679738|P2|Overall Study|Death|146
3121184|NCT00094575|10679739|P1|Overall Study|Death|146
3121185|NCT00094536|10679759|P1|Treatment and Follow-up|Unable to attend visits|1
3121186|NCT00094536|10679759|P1|Treatment and Follow-up|Subject non-compliance|9
3121187|NCT00094536|10679759|P1|Treatment and Follow-up|Withdrawal by Subject|1
3121188|NCT00094536|10679759|P1|Treatment and Follow-up|Lost to Follow-up|7
3121189|NCT00094536|10679759|P1|Treatment and Follow-up|Lack of Efficacy|9
3121190|NCT00094536|10679759|P1|Treatment and Follow-up|Adverse Event|4
3121191|NCT00094536|10679759|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
3121192|NCT00094458|10679783|P6|OLE: Open-Label Extension|Patient decision|0
3121193|NCT00094458|10679784|P5|OLE: Open-Label Extension|Patient decision|1
3121194|NCT00094458|10679785|P4|OLE: Open-Label Extension|Patient decision|0
3121195|NCT00094458|10679786|P3|OLE: Open-Label Extension|Patient decision|0
3121196|NCT00094458|10679787|P2|OLE: Open-Label Extension|Patient decision|0
3121197|NCT00094458|10679788|P1|OLE: Open-Label Extension|Patient decision|0
3121198|NCT00094458|10679783|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
3121199|NCT00094458|10679784|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
3121200|NCT00094458|10679785|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
3121201|NCT00094458|10679786|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
3121202|NCT00094458|10679787|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
3121203|NCT00094458|10679788|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
3121204|NCT00094458|10679783|P6|OLE: Open-Label Extension|Adverse Event|4
3121205|NCT00094458|10679784|P5|OLE: Open-Label Extension|Adverse Event|3
3121206|NCT00094458|10679785|P4|OLE: Open-Label Extension|Adverse Event|0
3121207|NCT00094458|10679786|P3|OLE: Open-Label Extension|Adverse Event|0
3121208|NCT00094458|10679787|P2|OLE: Open-Label Extension|Adverse Event|0
3121209|NCT00094458|10679788|P1|OLE: Open-Label Extension|Adverse Event|0
3121210|NCT00094458|10679783|P6|Study Extension: Week 30 Through Week 50|Other|0
3121211|NCT00094458|10679784|P5|Study Extension: Week 30 Through Week 50|Other|0
3121212|NCT00094458|10679785|P4|Study Extension: Week 30 Through Week 50|Other|0
3121213|NCT00094458|10679786|P3|Study Extension: Week 30 Through Week 50|Other|3
3121214|NCT00094458|10679787|P2|Study Extension: Week 30 Through Week 50|Other|2
3121215|NCT00094458|10679788|P1|Study Extension: Week 30 Through Week 50|Other|1
3121216|NCT00094458|10679783|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
3121217|NCT00094458|10679784|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
3121218|NCT00094458|10679785|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
3121219|NCT00094458|10679786|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
3121220|NCT00094458|10679787|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
3121221|NCT00094458|10679788|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
3121222|NCT00094458|10679783|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
3121223|NCT00094458|10679784|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
3121224|NCT00094458|10679785|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
3121225|NCT00094458|10679786|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
3121226|NCT00094458|10679787|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
3121227|NCT00094458|10679788|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
3121228|NCT00094458|10679783|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
3121229|NCT00094458|10679784|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
3121230|NCT00094458|10679785|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
3121231|NCT00094458|10679786|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
3121232|NCT00094458|10679787|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
3121233|NCT00094458|10679788|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
3121234|NCT00094458|10679783|P6|Main Study: Through Week 30|Other|0
3121235|NCT00094458|10679784|P5|Main Study: Through Week 30|Other|0
3121236|NCT00094458|10679785|P4|Main Study: Through Week 30|Other|0
3121237|NCT00094458|10679786|P3|Main Study: Through Week 30|Other|9
3121238|NCT00094458|10679787|P2|Main Study: Through Week 30|Other|16
3121239|NCT00094458|10679788|P1|Main Study: Through Week 30|Other|19
3121240|NCT00094458|10679783|P6|Main Study: Through Week 30|Death|0
3121241|NCT00094458|10679784|P5|Main Study: Through Week 30|Death|0
3121242|NCT00094458|10679785|P4|Main Study: Through Week 30|Death|0
3121243|NCT00094458|10679786|P3|Main Study: Through Week 30|Death|0
3121244|NCT00094458|10679787|P2|Main Study: Through Week 30|Death|0
3121245|NCT00094458|10679788|P1|Main Study: Through Week 30|Death|1
3121246|NCT00094458|10679783|P6|Main Study: Through Week 30|Adverse Event|0
3121247|NCT00094458|10679784|P5|Main Study: Through Week 30|Adverse Event|0
3121248|NCT00094458|10679785|P4|Main Study: Through Week 30|Adverse Event|0
3121249|NCT00094458|10679786|P3|Main Study: Through Week 30|Adverse Event|28
3121250|NCT00094458|10679787|P2|Main Study: Through Week 30|Adverse Event|20
3121251|NCT00094458|10679788|P1|Main Study: Through Week 30|Adverse Event|38
3121252|NCT00094458|10679783|P6|Main Study: Through Week 30|Withdrawal by Subject|0
3121253|NCT00094458|10679784|P5|Main Study: Through Week 30|Withdrawal by Subject|0
3121254|NCT00094458|10679785|P4|Main Study: Through Week 30|Withdrawal by Subject|0
3121255|NCT00094458|10679786|P3|Main Study: Through Week 30|Withdrawal by Subject|7
3121256|NCT00094458|10679787|P2|Main Study: Through Week 30|Withdrawal by Subject|9
3121257|NCT00094458|10679788|P1|Main Study: Through Week 30|Withdrawal by Subject|18
3121258|NCT00094458|10679783|P6|Main Study: Through Week 30|Lost to Follow-up|0
3121259|NCT00094458|10679784|P5|Main Study: Through Week 30|Lost to Follow-up|0
3121260|NCT00094458|10679785|P4|Main Study: Through Week 30|Lost to Follow-up|0
3121261|NCT00094458|10679786|P3|Main Study: Through Week 30|Lost to Follow-up|2
3121262|NCT00094458|10679787|P2|Main Study: Through Week 30|Lost to Follow-up|5
3121263|NCT00094458|10679788|P1|Main Study: Through Week 30|Lost to Follow-up|5
3121264|NCT00094458|10679783|P6|Main Study: Through Week 30|Eligibility criteria not met|0
3121265|NCT00094458|10679784|P5|Main Study: Through Week 30|Eligibility criteria not met|0
3121266|NCT00094458|10679785|P4|Main Study: Through Week 30|Eligibility criteria not met|0
3121267|NCT00094458|10679786|P3|Main Study: Through Week 30|Eligibility criteria not met|2
3121268|NCT00094458|10679787|P2|Main Study: Through Week 30|Eligibility criteria not met|8
3121269|NCT00094458|10679788|P1|Main Study: Through Week 30|Eligibility criteria not met|3
3121270|NCT00094328|10679826|P1|Overall Study|Lost to Follow-up|1
3121271|NCT00094302|10679840|P2|Overall Study|Death|246
3121272|NCT00094302|10679841|P1|Overall Study|Death|266
3121273|NCT00094302|10679840|P2|Overall Study|Withdrawal by Subject|111
3121274|NCT00094302|10679841|P1|Overall Study|Withdrawal by Subject|103
3121275|NCT00094302|10679840|P2|Overall Study|Physician Decision|8
3121276|NCT00094302|10679841|P1|Overall Study|Physician Decision|5
3121277|NCT00094302|10679840|P2|Overall Study|Lost to Follow-up|41
3121278|NCT00094302|10679841|P1|Overall Study|Lost to Follow-up|43
3121279|NCT00094172|10679930|P2|Overall Study|Started other MS therapy due to disease|0
3121280|NCT00094172|10679931|P1|Overall Study|Started other MS therapy due to disease|1
3121281|NCT00094172|10679930|P2|Overall Study|Primary endpoint met.|0
3121282|NCT00094172|10679931|P1|Overall Study|Primary endpoint met.|1
3121283|NCT00094172|10679930|P2|Overall Study|Withdrawal by Subject|5
3121284|NCT00094172|10679931|P1|Overall Study|Withdrawal by Subject|10
3121285|NCT00094172|10679930|P2|Overall Study|Protocol Violation|1
3121286|NCT00094172|10679931|P1|Overall Study|Protocol Violation|0
3121287|NCT00094172|10679930|P2|Overall Study|Lost to Follow-up|0
3121288|NCT00094172|10679931|P1|Overall Study|Lost to Follow-up|2
3121289|NCT00094172|10679930|P2|Overall Study|Adverse Event|1
3121290|NCT00094172|10679931|P1|Overall Study|Adverse Event|0
3121291|NCT00094107|10679941|P1|Overall Study|Withdrawal due to Disease Progression|1
3121292|NCT00094107|10679941|P1|Overall Study|Adverse Event|3
3121293|NCT00094107|10679941|P1|Overall Study|Death|5
3121294|NCT00094107|10679941|P1|Overall Study|Lack of Efficacy|23
3121295|NCT00094094|10679950|P1|Overall Study|Adverse Event|7
3121296|NCT00094094|10679950|P1|Overall Study|Lack of Efficacy|23
3121297|NCT00094094|10679950|P1|Overall Study|Death|2
3121298|NCT00094055|10679959|P1|Overall Study|Withdrawal by Subject|9
3121299|NCT00094055|10679959|P1|Overall Study|roll-over to another study|14
3121300|NCT00094055|10679959|P1|Overall Study|clinical progression|1
3121301|NCT00094055|10679959|P1|Overall Study|progressive disease|2
3121302|NCT00094055|10679959|P1|Overall Study|Lost to Follow-up|2
3121303|NCT00094055|10679959|P1|Overall Study|Lack of Efficacy|17
3121304|NCT00094055|10679959|P1|Overall Study|Death|4
3121305|NCT00094055|10679959|P1|Overall Study|Adverse Event|11
3121306|NCT00093808|10680016|P1|Overall Study|Protocol Violation|1
3121307|NCT00093808|10680016|P1|Overall Study|Cancel participation before receiving tx|1
3121308|NCT00093795|10680026|P3|Overall Study|No follow up data|17
3121309|NCT00093795|10680027|P2|Overall Study|No follow up data|16
3121310|NCT00093795|10680028|P1|Overall Study|No follow up data|20
3121311|NCT00093496|10680073|P2|Overall Study|Protocol Violation|3
3121312|NCT00093496|10680074|P1|Overall Study|Protocol Violation|1
3121313|NCT00093470|10680087|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
3121314|NCT00093470|10680088|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
3121315|NCT00093470|10680087|P2|Overall Study|Never started treatment|0
3121316|NCT00093470|10680088|P1|Overall Study|Never started treatment|1
3121317|NCT00093470|10680087|P2|Overall Study|Physician Decision|0
3121318|NCT00093470|10680088|P1|Overall Study|Physician Decision|2
3121319|NCT00093470|10680087|P2|Overall Study|Other complicating disease|0
3121320|NCT00093470|10680088|P1|Overall Study|Other complicating disease|3
3121321|NCT00093470|10680087|P2|Overall Study|Alternative therapy|0
3121322|NCT00093470|10680088|P1|Overall Study|Alternative therapy|2
3121323|NCT00093470|10680087|P2|Overall Study|Withdrawal by Subject|0
3121324|NCT00093470|10680088|P1|Overall Study|Withdrawal by Subject|8
3121325|NCT00093470|10680087|P2|Overall Study|Death|0
3121326|NCT00093470|10680088|P1|Overall Study|Death|2
3121327|NCT00093470|10680087|P2|Overall Study|Adverse Event|0
3121328|NCT00093470|10680088|P1|Overall Study|Adverse Event|15
3121329|NCT00093470|10680087|P2|Overall Study|Disease progression|0
3121330|NCT00093470|10680088|P1|Overall Study|Disease progression|39
3121331|NCT00093145|10680102|P1|Overall Study|Other|1
3121332|NCT00093145|10680102|P1|Overall Study|Withdrawal by Subject|9
3121333|NCT00093145|10680102|P1|Overall Study|Physician Decision|5
3121334|NCT00093145|10680102|P1|Overall Study|Unacceptable Toxicity Only|2
3121335|NCT00093015|10680144|P2|Overall Study|Death|385
3121336|NCT00093015|10680145|P1|Overall Study|Death|375
3121337|NCT00093015|10680144|P2|Overall Study|Lost to Follow-up|108
3121338|NCT00093015|10680145|P1|Overall Study|Lost to Follow-up|96
3121339|NCT00093015|10680144|P2|Overall Study|Withdrawal by Subject|171
3121340|NCT00093015|10680145|P1|Overall Study|Withdrawal by Subject|194
3121341|NCT00092677|10680173|P2|Overall Study|Adminstrative|9
3121342|NCT00092677|10680174|P1|Overall Study|Adminstrative|5
3121343|NCT00092677|10680173|P2|Overall Study|Lost to Follow-up|2
3121344|NCT00092677|10680174|P1|Overall Study|Lost to Follow-up|0
3121345|NCT00092547|10680218|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
3121346|NCT00092547|10680219|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
3121347|NCT00092547|10680220|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
3121348|NCT00092547|10680218|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
3121349|NCT00092547|10680219|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
3121350|NCT00092547|10680220|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
3121351|NCT00092547|10680218|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
3121352|NCT00092547|10680219|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
3121353|NCT00092547|10680220|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
3121354|NCT00092547|10680218|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
3121355|NCT00092547|10680219|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
3121356|NCT00092547|10680220|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
3121357|NCT00092547|10680218|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
3121358|NCT00092547|10680219|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
3121359|NCT00092547|10680220|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
3121360|NCT00092547|10680218|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
3121361|NCT00092547|10680219|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
3121362|NCT00092547|10680220|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
3121363|NCT00092547|10680218|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
3121364|NCT00092547|10680219|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
3121365|NCT00092547|10680220|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
3121366|NCT00092547|10680218|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
3121367|NCT00092547|10680219|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
3121368|NCT00092547|10680220|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
3121369|NCT00092547|10680218|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
3121370|NCT00092547|10680219|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
3121371|NCT00092547|10680220|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
3121372|NCT00092547|10680218|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
3121373|NCT00092547|10680219|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
3121374|NCT00092547|10680220|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
3121375|NCT00092547|10680218|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
3121376|NCT00092547|10680219|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
3121377|NCT00092547|10680220|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
3121378|NCT00092547|10680218|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
3121379|NCT00092547|10680219|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
3121380|NCT00092547|10680220|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
3121381|NCT00092547|10680218|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
3121382|NCT00092547|10680219|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
3121383|NCT00092547|10680220|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
3121384|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
3121385|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
3121386|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
3121387|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
3121388|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
3121389|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
3121390|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
3121391|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
3121392|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
3121393|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
3121394|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
3121395|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
3121396|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
3121397|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
3121398|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
3121399|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
3121400|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
3121401|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
3121402|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
3121403|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
3121404|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
3121405|NCT00092547|10680218|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
3121406|NCT00092547|10680219|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
3121407|NCT00092547|10680220|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
3121408|NCT00092534|10680264|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
3121409|NCT00092534|10680265|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
3121410|NCT00092534|10680266|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
3121411|NCT00092534|10680267|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
3121412|NCT00092534|10680268|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
3121413|NCT00092534|10680264|P5|Base Study EXT|Protocol Violation|0
3121414|NCT00092534|10680265|P4|Base Study EXT|Protocol Violation|0
3121415|NCT00092534|10680266|P3|Base Study EXT|Protocol Violation|15
3121416|NCT00092534|10680267|P2|Base Study EXT|Protocol Violation|0
3121417|NCT00092534|10680268|P1|Base Study EXT|Protocol Violation|0
3121418|NCT00092534|10680264|P5|Base Study EXT|Study ended|0
3121419|NCT00092534|10680265|P4|Base Study EXT|Study ended|0
3121420|NCT00092534|10680266|P3|Base Study EXT|Study ended|29
3121421|NCT00092534|10680267|P2|Base Study EXT|Study ended|0
3121422|NCT00092534|10680268|P1|Base Study EXT|Study ended|0
3121423|NCT00092534|10680264|P5|Base Study EXT|Site closed|0
3121424|NCT00092534|10680265|P4|Base Study EXT|Site closed|0
3121425|NCT00092534|10680266|P3|Base Study EXT|Site closed|21
3121426|NCT00092534|10680267|P2|Base Study EXT|Site closed|0
3121427|NCT00092534|10680268|P1|Base Study EXT|Site closed|0
3121428|NCT00092534|10680264|P5|Base Study EXT|Travel|0
3121429|NCT00092534|10680265|P4|Base Study EXT|Travel|0
3121430|NCT00092534|10680266|P3|Base Study EXT|Travel|2
3121431|NCT00092534|10680267|P2|Base Study EXT|Travel|0
3121432|NCT00092534|10680268|P1|Base Study EXT|Travel|0
3121433|NCT00092534|10680264|P5|Base Study EXT|Participant moved|0
3121434|NCT00092534|10680265|P4|Base Study EXT|Participant moved|0
3121435|NCT00092534|10680266|P3|Base Study EXT|Participant moved|6
3121436|NCT00092534|10680267|P2|Base Study EXT|Participant moved|0
3121437|NCT00092534|10680268|P1|Base Study EXT|Participant moved|0
3121438|NCT00092534|10680264|P5|Base Study EXT|Withdrawal by Subject|0
3121439|NCT00092534|10680265|P4|Base Study EXT|Withdrawal by Subject|0
3121440|NCT00092534|10680266|P3|Base Study EXT|Withdrawal by Subject|18
3121441|NCT00092534|10680267|P2|Base Study EXT|Withdrawal by Subject|0
3121442|NCT00092534|10680268|P1|Base Study EXT|Withdrawal by Subject|0
3121443|NCT00092534|10680264|P5|Base Study EXT|Pregnancy|0
3121444|NCT00092534|10680265|P4|Base Study EXT|Pregnancy|0
3121445|NCT00092534|10680266|P3|Base Study EXT|Pregnancy|12
3121446|NCT00092534|10680267|P2|Base Study EXT|Pregnancy|0
3121447|NCT00092534|10680268|P1|Base Study EXT|Pregnancy|0
3121448|NCT00092534|10680264|P5|Base Study EXT|Physician Decision|0
3121449|NCT00092534|10680265|P4|Base Study EXT|Physician Decision|0
3121450|NCT00092534|10680266|P3|Base Study EXT|Physician Decision|1
3121451|NCT00092534|10680267|P2|Base Study EXT|Physician Decision|0
3121452|NCT00092534|10680268|P1|Base Study EXT|Physician Decision|0
3121453|NCT00092534|10680264|P5|Base Study EXT|Lost to Follow-up|0
3121454|NCT00092534|10680265|P4|Base Study EXT|Lost to Follow-up|0
3121455|NCT00092534|10680266|P3|Base Study EXT|Lost to Follow-up|41
3121456|NCT00092534|10680267|P2|Base Study EXT|Lost to Follow-up|0
3121457|NCT00092534|10680268|P1|Base Study EXT|Lost to Follow-up|0
3121458|NCT00092534|10680264|P5|Base Study Follow-Up Period|Subjects in extension|0
3121459|NCT00092534|10680265|P4|Base Study Follow-Up Period|Subjects in extension|0
3121460|NCT00092534|10680266|P3|Base Study Follow-Up Period|Subjects in extension|0
3121461|NCT00092534|10680267|P2|Base Study Follow-Up Period|Subjects in extension|371
3121462|NCT00092534|10680268|P1|Base Study Follow-Up Period|Subjects in extension|15
3121463|NCT00092534|10680264|P5|Base Study Follow-Up Period|Subjects continuing|0
3121464|NCT00092534|10680265|P4|Base Study Follow-Up Period|Subjects continuing|0
3121465|NCT00092534|10680266|P3|Base Study Follow-Up Period|Subjects continuing|0
3121466|NCT00092534|10680267|P2|Base Study Follow-Up Period|Subjects continuing|31
3121467|NCT00092534|10680268|P1|Base Study Follow-Up Period|Subjects continuing|27
3121468|NCT00092534|10680264|P5|Base Study Follow-Up Period|Site Closed|0
3121469|NCT00092534|10680265|P4|Base Study Follow-Up Period|Site Closed|0
3121470|NCT00092534|10680266|P3|Base Study Follow-Up Period|Site Closed|0
3121471|NCT00092534|10680267|P2|Base Study Follow-Up Period|Site Closed|2
3121472|NCT00092534|10680268|P1|Base Study Follow-Up Period|Site Closed|0
3121473|NCT00092534|10680264|P5|Base Study Follow-Up Period|Travel|0
3121474|NCT00092534|10680265|P4|Base Study Follow-Up Period|Travel|0
3121475|NCT00092534|10680266|P3|Base Study Follow-Up Period|Travel|0
3121476|NCT00092534|10680267|P2|Base Study Follow-Up Period|Travel|7
3121477|NCT00092534|10680268|P1|Base Study Follow-Up Period|Travel|10
3121478|NCT00092534|10680264|P5|Base Study Follow-Up Period|Moved|0
3121479|NCT00092534|10680265|P4|Base Study Follow-Up Period|Moved|0
3121480|NCT00092534|10680266|P3|Base Study Follow-Up Period|Moved|0
3121481|NCT00092534|10680267|P2|Base Study Follow-Up Period|Moved|58
3121482|NCT00092534|10680268|P1|Base Study Follow-Up Period|Moved|62
3121483|NCT00092534|10680264|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
3121484|NCT00092534|10680265|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
3121485|NCT00092534|10680266|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
3121486|NCT00092534|10680267|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
3121487|NCT00092534|10680268|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
3121488|NCT00092534|10680264|P5|Base Study Follow-Up Period|Protocol Violation|0
3121489|NCT00092534|10680265|P4|Base Study Follow-Up Period|Protocol Violation|0
3121490|NCT00092534|10680266|P3|Base Study Follow-Up Period|Protocol Violation|0
3121491|NCT00092534|10680267|P2|Base Study Follow-Up Period|Protocol Violation|2
3121492|NCT00092534|10680268|P1|Base Study Follow-Up Period|Protocol Violation|1
3121493|NCT00092534|10680264|P5|Base Study Follow-Up Period|Pregnancy|0
3121494|NCT00092534|10680265|P4|Base Study Follow-Up Period|Pregnancy|0
3121495|NCT00092534|10680266|P3|Base Study Follow-Up Period|Pregnancy|0
3121496|NCT00092534|10680267|P2|Base Study Follow-Up Period|Pregnancy|10
3121497|NCT00092534|10680268|P1|Base Study Follow-Up Period|Pregnancy|6
3121498|NCT00092534|10680264|P5|Base Study Follow-Up Period|Lost to Follow-up|0
3121499|NCT00092534|10680265|P4|Base Study Follow-Up Period|Lost to Follow-up|0
3121500|NCT00092534|10680266|P3|Base Study Follow-Up Period|Lost to Follow-up|0
3121501|NCT00092534|10680267|P2|Base Study Follow-Up Period|Lost to Follow-up|146
3121502|NCT00092534|10680268|P1|Base Study Follow-Up Period|Lost to Follow-up|120
3121503|NCT00092534|10680264|P5|Base Study Follow-Up Period|Death|0
3121504|NCT00092534|10680265|P4|Base Study Follow-Up Period|Death|0
3121505|NCT00092534|10680266|P3|Base Study Follow-Up Period|Death|0
3121506|NCT00092534|10680267|P2|Base Study Follow-Up Period|Death|1
3121507|NCT00092534|10680268|P1|Base Study Follow-Up Period|Death|2
3121508|NCT00092534|10680264|P5|Base Study Follow-Up Period|Adverse Event|0
3121509|NCT00092534|10680265|P4|Base Study Follow-Up Period|Adverse Event|0
3121510|NCT00092534|10680266|P3|Base Study Follow-Up Period|Adverse Event|0
3121511|NCT00092534|10680267|P2|Base Study Follow-Up Period|Adverse Event|4
3121512|NCT00092534|10680268|P1|Base Study Follow-Up Period|Adverse Event|2
3121513|NCT00092534|10680264|P5|Base Study Vaccination Period|Site Closed|0
3121514|NCT00092534|10680265|P4|Base Study Vaccination Period|Site Closed|0
3121515|NCT00092534|10680266|P3|Base Study Vaccination Period|Site Closed|0
3121516|NCT00092534|10680267|P2|Base Study Vaccination Period|Site Closed|1
3121517|NCT00092534|10680268|P1|Base Study Vaccination Period|Site Closed|0
3121518|NCT00092534|10680264|P5|Base Study Vaccination Period|Travel|0
3121519|NCT00092534|10680265|P4|Base Study Vaccination Period|Travel|0
3121520|NCT00092534|10680266|P3|Base Study Vaccination Period|Travel|0
3121521|NCT00092534|10680267|P2|Base Study Vaccination Period|Travel|0
3121522|NCT00092534|10680268|P1|Base Study Vaccination Period|Travel|1
3121523|NCT00092534|10680264|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
3121524|NCT00092534|10680265|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
3121525|NCT00092534|10680266|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
3121526|NCT00092534|10680267|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
3121527|NCT00092534|10680268|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
3121528|NCT00092534|10680264|P5|Base Study Vaccination Period|Moved|0
3121529|NCT00092534|10680265|P4|Base Study Vaccination Period|Moved|0
3121530|NCT00092534|10680266|P3|Base Study Vaccination Period|Moved|0
3121531|NCT00092534|10680267|P2|Base Study Vaccination Period|Moved|12
3121532|NCT00092534|10680268|P1|Base Study Vaccination Period|Moved|14
3121533|NCT00092534|10680264|P5|Base Study Vaccination Period|Withdrawal by Subject|0
3121534|NCT00092534|10680265|P4|Base Study Vaccination Period|Withdrawal by Subject|0
3121535|NCT00092534|10680266|P3|Base Study Vaccination Period|Withdrawal by Subject|0
3121536|NCT00092534|10680267|P2|Base Study Vaccination Period|Withdrawal by Subject|58
3121537|NCT00092534|10680268|P1|Base Study Vaccination Period|Withdrawal by Subject|85
3121538|NCT00092534|10680264|P5|Base Study Vaccination Period|Protocol Violation|0
3121539|NCT00092534|10680265|P4|Base Study Vaccination Period|Protocol Violation|0
3121540|NCT00092534|10680266|P3|Base Study Vaccination Period|Protocol Violation|0
3121541|NCT00092534|10680267|P2|Base Study Vaccination Period|Protocol Violation|1
3121542|NCT00092534|10680268|P1|Base Study Vaccination Period|Protocol Violation|2
3121543|NCT00092534|10680264|P5|Base Study Vaccination Period|Pregnancy|0
3121544|NCT00092534|10680265|P4|Base Study Vaccination Period|Pregnancy|0
3121545|NCT00092534|10680266|P3|Base Study Vaccination Period|Pregnancy|0
3121546|NCT00092534|10680267|P2|Base Study Vaccination Period|Pregnancy|7
3121547|NCT00092534|10680268|P1|Base Study Vaccination Period|Pregnancy|9
3121548|NCT00092534|10680264|P5|Base Study Vaccination Period|Physician Decision|0
3121549|NCT00092534|10680265|P4|Base Study Vaccination Period|Physician Decision|0
3121550|NCT00092534|10680266|P3|Base Study Vaccination Period|Physician Decision|0
3121551|NCT00092534|10680267|P2|Base Study Vaccination Period|Physician Decision|0
3121552|NCT00092534|10680268|P1|Base Study Vaccination Period|Physician Decision|1
3121553|NCT00092534|10680264|P5|Base Study Vaccination Period|Lost to Follow-up|0
3121554|NCT00092534|10680265|P4|Base Study Vaccination Period|Lost to Follow-up|0
3121555|NCT00092534|10680266|P3|Base Study Vaccination Period|Lost to Follow-up|0
3121556|NCT00092534|10680267|P2|Base Study Vaccination Period|Lost to Follow-up|37
3121557|NCT00092534|10680268|P1|Base Study Vaccination Period|Lost to Follow-up|41
3121558|NCT00092534|10680264|P5|Base Study Vaccination Period|Death|0
3121559|NCT00092534|10680265|P4|Base Study Vaccination Period|Death|0
3121560|NCT00092534|10680266|P3|Base Study Vaccination Period|Death|0
3121561|NCT00092534|10680267|P2|Base Study Vaccination Period|Death|4
3121562|NCT00092534|10680268|P1|Base Study Vaccination Period|Death|5
3121563|NCT00092534|10680264|P5|Base Study Vaccination Period|Adverse Event|0
3121564|NCT00092534|10680265|P4|Base Study Vaccination Period|Adverse Event|0
3121565|NCT00092534|10680266|P3|Base Study Vaccination Period|Adverse Event|0
3121566|NCT00092534|10680267|P2|Base Study Vaccination Period|Adverse Event|1
3121567|NCT00092534|10680268|P1|Base Study Vaccination Period|Adverse Event|3
3121568|NCT00092534|10680264|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
3121569|NCT00092534|10680265|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
3121570|NCT00092534|10680266|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
3121571|NCT00092534|10680267|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
3121572|NCT00092534|10680268|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
3121573|NCT00092521|10680299|P4|Extension Study (Group 4)|Unable/unwilling to return|25
3121574|NCT00092521|10680300|P3|Extension Study (Group 4)|Unable/unwilling to return|0
3121575|NCT00092521|10680301|P2|Extension Study (Group 4)|Unable/unwilling to return|0
3121576|NCT00092521|10680302|P1|Extension Study (Group 4)|Unable/unwilling to return|0
3121577|NCT00092521|10680299|P4|Extension Study (Group 4)|Site Terminated|4
3121578|NCT00092521|10680300|P3|Extension Study (Group 4)|Site Terminated|0
3121579|NCT00092521|10680301|P2|Extension Study (Group 4)|Site Terminated|0
3121580|NCT00092521|10680302|P1|Extension Study (Group 4)|Site Terminated|0
3121581|NCT00092521|10680299|P4|Extension Study (Group 4)|Moved|16
3121582|NCT00092521|10680300|P3|Extension Study (Group 4)|Moved|0
3121583|NCT00092521|10680301|P2|Extension Study (Group 4)|Moved|0
3121584|NCT00092521|10680302|P1|Extension Study (Group 4)|Moved|0
3121585|NCT00092521|10680299|P4|Extension Study (Group 4)|Withdrawal by Subject|46
3121586|NCT00092521|10680300|P3|Extension Study (Group 4)|Withdrawal by Subject|0
3121587|NCT00092521|10680301|P2|Extension Study (Group 4)|Withdrawal by Subject|0
3121588|NCT00092521|10680302|P1|Extension Study (Group 4)|Withdrawal by Subject|0
3121589|NCT00092521|10680299|P4|Extension Study (Group 4)|Protocol Violation|2
3121590|NCT00092521|10680300|P3|Extension Study (Group 4)|Protocol Violation|0
3121591|NCT00092521|10680301|P2|Extension Study (Group 4)|Protocol Violation|0
3121592|NCT00092521|10680302|P1|Extension Study (Group 4)|Protocol Violation|0
3121593|NCT00092521|10680299|P4|Extension Study (Group 4)|Pregnancy|4
3121594|NCT00092521|10680300|P3|Extension Study (Group 4)|Pregnancy|0
3121595|NCT00092521|10680301|P2|Extension Study (Group 4)|Pregnancy|0
3121596|NCT00092521|10680302|P1|Extension Study (Group 4)|Pregnancy|0
3121597|NCT00092521|10680299|P4|Extension Study (Group 4)|Lost to Follow-up|87
3121598|NCT00092521|10680300|P3|Extension Study (Group 4)|Lost to Follow-up|0
3121599|NCT00092521|10680301|P2|Extension Study (Group 4)|Lost to Follow-up|0
3121600|NCT00092521|10680302|P1|Extension Study (Group 4)|Lost to Follow-up|0
3121601|NCT00092521|10680299|P4|Extension Study (Group 4)|Adverse Event|2
3121602|NCT00092521|10680300|P3|Extension Study (Group 4)|Adverse Event|0
3121603|NCT00092521|10680301|P2|Extension Study (Group 4)|Adverse Event|0
3121604|NCT00092521|10680302|P1|Extension Study (Group 4)|Adverse Event|0
3121605|NCT00092521|10680299|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
3121606|NCT00092521|10680300|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
3121607|NCT00092521|10680301|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
3121608|NCT00092521|10680302|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
3121609|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Visits Compressed|0
3121610|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Visits Compressed|5
3121611|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Visits Compressed|0
3121612|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Visits Compressed|5
3121613|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Travel|0
3121614|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Travel|0
3121615|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Travel|0
3121616|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Travel|2
3121617|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Site Terminated|0
3121618|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Site Terminated|3
3121619|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Site Terminated|0
3121620|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Site Terminated|3
3121621|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Moved|0
3121622|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Moved|28
3121623|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Moved|2
3121624|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Moved|32
3121625|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
3121626|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
3121627|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
3121628|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
3121629|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Protocol Violation|0
3121630|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Protocol Violation|5
3121631|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Protocol Violation|1
3121632|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Protocol Violation|1
3121633|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
3121634|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
3121635|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
3121636|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
3121637|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Death|0
3121638|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Death|1
3121639|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Death|0
3121640|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Death|2
3121641|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Adverse Event|0
3121642|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Adverse Event|0
3121643|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Adverse Event|0
3121644|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Adverse Event|1
3121645|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Subjects in Extension|0
3121646|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Subjects in Extension|412
3121647|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Subjects in Extension|109
3121648|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Subjects in Extension|13
3121649|NCT00092521|10680299|P4|Follow-Up (After Month 7)|Subjects Continuing|0
3121650|NCT00092521|10680300|P3|Follow-Up (After Month 7)|Subjects Continuing|35
3121651|NCT00092521|10680301|P2|Follow-Up (After Month 7)|Subjects Continuing|4
3121652|NCT00092521|10680302|P1|Follow-Up (After Month 7)|Subjects Continuing|34
3121728|NCT00092495|10680320|P1|Base Study Vaccination Period|Other|1
3121653|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
3121654|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
3121655|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
3121656|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
3121657|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
3121658|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
3121659|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
3121660|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
3121661|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Moved|0
3121662|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Moved|18
3121663|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Moved|1
3121664|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Moved|14
3121665|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
3121666|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
3121667|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
3121668|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
3121669|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
3121670|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
3121671|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
3121672|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
3121673|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
3121674|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
3121675|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
3121676|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
3121677|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Death|0
3121678|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Death|1
3121679|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Death|0
3121680|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Death|0
3121681|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
3121682|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
3121683|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
3121684|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
3121685|NCT00092521|10680299|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
3121686|NCT00092521|10680300|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
3121687|NCT00092521|10680301|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
3121688|NCT00092521|10680302|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
3121689|NCT00092495|10680316|P5|Base Study Follow-up Period|Withdrawal by Subject|0
3121690|NCT00092495|10680317|P4|Base Study Follow-up Period|Withdrawal by Subject|0
3121691|NCT00092495|10680318|P3|Base Study Follow-up Period|Withdrawal by Subject|0
3121692|NCT00092495|10680319|P2|Base Study Follow-up Period|Withdrawal by Subject|0
3121693|NCT00092495|10680320|P1|Base Study Follow-up Period|Withdrawal by Subject|2
3121694|NCT00092495|10680316|P5|Base Study Follow-up Period|Lost to Follow-up|0
3121695|NCT00092495|10680317|P4|Base Study Follow-up Period|Lost to Follow-up|12
3121696|NCT00092495|10680318|P3|Base Study Follow-up Period|Lost to Follow-up|3
3121697|NCT00092495|10680319|P2|Base Study Follow-up Period|Lost to Follow-up|3
3121698|NCT00092495|10680320|P1|Base Study Follow-up Period|Lost to Follow-up|1
3121699|NCT00092495|10680316|P5|Base Study Follow-up Period|Extended|0
3121700|NCT00092495|10680317|P4|Base Study Follow-up Period|Extended|2
3121701|NCT00092495|10680318|P3|Base Study Follow-up Period|Extended|1
3121702|NCT00092495|10680319|P2|Base Study Follow-up Period|Extended|0
3121703|NCT00092495|10680320|P1|Base Study Follow-up Period|Extended|0
3121704|NCT00092495|10680316|P5|Base Study Vaccination Period|Withdrawal by Subject|0
3121705|NCT00092495|10680317|P4|Base Study Vaccination Period|Withdrawal by Subject|25
3121706|NCT00092495|10680318|P3|Base Study Vaccination Period|Withdrawal by Subject|14
3121707|NCT00092495|10680319|P2|Base Study Vaccination Period|Withdrawal by Subject|10
3121708|NCT00092495|10680320|P1|Base Study Vaccination Period|Withdrawal by Subject|9
3121709|NCT00092495|10680316|P5|Base Study Vaccination Period|Protocol Violation|0
3121710|NCT00092495|10680317|P4|Base Study Vaccination Period|Protocol Violation|0
3121711|NCT00092495|10680318|P3|Base Study Vaccination Period|Protocol Violation|0
3121712|NCT00092495|10680319|P2|Base Study Vaccination Period|Protocol Violation|0
3121713|NCT00092495|10680320|P1|Base Study Vaccination Period|Protocol Violation|1
3121714|NCT00092495|10680316|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
3121715|NCT00092495|10680317|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
3121716|NCT00092495|10680318|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
3121717|NCT00092495|10680319|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
3121718|NCT00092495|10680320|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
3121719|NCT00092495|10680316|P5|Base Study Vaccination Period|Pregnancy|0
3121720|NCT00092495|10680317|P4|Base Study Vaccination Period|Pregnancy|0
3121721|NCT00092495|10680318|P3|Base Study Vaccination Period|Pregnancy|0
3121722|NCT00092495|10680319|P2|Base Study Vaccination Period|Pregnancy|0
3121723|NCT00092495|10680320|P1|Base Study Vaccination Period|Pregnancy|2
3121724|NCT00092495|10680316|P5|Base Study Vaccination Period|Other|0
3121725|NCT00092495|10680317|P4|Base Study Vaccination Period|Other|2
3121726|NCT00092495|10680318|P3|Base Study Vaccination Period|Other|0
3121727|NCT00092495|10680319|P2|Base Study Vaccination Period|Other|1
3121729|NCT00092495|10680316|P5|Base Study Vaccination Period|Moved|0
3121730|NCT00092495|10680317|P4|Base Study Vaccination Period|Moved|2
3121731|NCT00092495|10680318|P3|Base Study Vaccination Period|Moved|2
3121732|NCT00092495|10680319|P2|Base Study Vaccination Period|Moved|1
3121733|NCT00092495|10680320|P1|Base Study Vaccination Period|Moved|3
3121734|NCT00092495|10680316|P5|Base Study Vaccination Period|Lost to Follow-up|0
3121735|NCT00092495|10680317|P4|Base Study Vaccination Period|Lost to Follow-up|36
3121736|NCT00092495|10680318|P3|Base Study Vaccination Period|Lost to Follow-up|11
3121737|NCT00092495|10680319|P2|Base Study Vaccination Period|Lost to Follow-up|6
3121738|NCT00092495|10680320|P1|Base Study Vaccination Period|Lost to Follow-up|16
3121739|NCT00092495|10680316|P5|Base Study Vaccination Period|Adverse Event|0
3121740|NCT00092495|10680317|P4|Base Study Vaccination Period|Adverse Event|3
3121741|NCT00092495|10680318|P3|Base Study Vaccination Period|Adverse Event|0
3121742|NCT00092495|10680319|P2|Base Study Vaccination Period|Adverse Event|0
3121743|NCT00092495|10680320|P1|Base Study Vaccination Period|Adverse Event|1
3121744|NCT00092495|10680316|P5|Base Study Vaccination Period|*Pregnancy|0
3121745|NCT00092495|10680317|P4|Base Study Vaccination Period|*Pregnancy|7
3121746|NCT00092495|10680318|P3|Base Study Vaccination Period|*Pregnancy|5
3121747|NCT00092495|10680319|P2|Base Study Vaccination Period|*Pregnancy|2
3121748|NCT00092495|10680320|P1|Base Study Vaccination Period|*Pregnancy|0
3121749|NCT00092495|10680316|P5|Base Study Vaccination Period|*Other reasons|0
3121750|NCT00092495|10680317|P4|Base Study Vaccination Period|*Other reasons|1
3121751|NCT00092495|10680318|P3|Base Study Vaccination Period|*Other reasons|0
3121752|NCT00092495|10680319|P2|Base Study Vaccination Period|*Other reasons|0
3121753|NCT00092495|10680320|P1|Base Study Vaccination Period|*Other reasons|1
3121754|NCT00092495|10680316|P5|Base Study Vaccination Period|*Clinical AE|0
3121755|NCT00092495|10680317|P4|Base Study Vaccination Period|*Clinical AE|2
3121756|NCT00092495|10680318|P3|Base Study Vaccination Period|*Clinical AE|1
3121757|NCT00092495|10680319|P2|Base Study Vaccination Period|*Clinical AE|0
3121758|NCT00092495|10680320|P1|Base Study Vaccination Period|*Clinical AE|1
3121759|NCT00092495|10680316|P5|Base Study Vaccination Period|Extended|0
3121760|NCT00092495|10680317|P4|Base Study Vaccination Period|Extended|1
3121761|NCT00092495|10680318|P3|Base Study Vaccination Period|Extended|0
3121762|NCT00092495|10680319|P2|Base Study Vaccination Period|Extended|0
3121763|NCT00092495|10680320|P1|Base Study Vaccination Period|Extended|0
3121764|NCT00092495|10680316|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
3121765|NCT00092495|10680317|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
3121766|NCT00092495|10680318|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
3121767|NCT00092495|10680319|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
3121768|NCT00092495|10680320|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
3121769|NCT00092456|10680386|P4|Overall Study|Other|0
3121770|NCT00092456|10680387|P3|Overall Study|Other|3
3121771|NCT00092456|10680388|P2|Overall Study|Other|2
3121772|NCT00092456|10680389|P1|Overall Study|Other|4
3121773|NCT00092456|10680386|P4|Overall Study|Moved|1
3121774|NCT00092456|10680387|P3|Overall Study|Moved|0
3121775|NCT00092456|10680388|P2|Overall Study|Moved|1
3121776|NCT00092456|10680389|P1|Overall Study|Moved|1
3121777|NCT00092456|10680386|P4|Overall Study|Withdrawal by Subject|6
3121778|NCT00092456|10680387|P3|Overall Study|Withdrawal by Subject|16
3121779|NCT00092456|10680388|P2|Overall Study|Withdrawal by Subject|5
3121780|NCT00092456|10680389|P1|Overall Study|Withdrawal by Subject|13
3121781|NCT00092456|10680386|P4|Overall Study|Protocol Violation|6
3121782|NCT00092456|10680387|P3|Overall Study|Protocol Violation|8
3121783|NCT00092456|10680388|P2|Overall Study|Protocol Violation|7
3121784|NCT00092456|10680389|P1|Overall Study|Protocol Violation|5
3121785|NCT00092456|10680386|P4|Overall Study|Lost to Follow-up|2
3121786|NCT00092456|10680387|P3|Overall Study|Lost to Follow-up|1
3121787|NCT00092456|10680388|P2|Overall Study|Lost to Follow-up|2
3121788|NCT00092456|10680389|P1|Overall Study|Lost to Follow-up|2
3121789|NCT00092456|10680386|P4|Overall Study|Adverse Event|1
3121790|NCT00092456|10680387|P3|Overall Study|Adverse Event|1
3121791|NCT00092456|10680388|P2|Overall Study|Adverse Event|0
3121792|NCT00092456|10680389|P1|Overall Study|Adverse Event|0
3121793|NCT00092443|10680437|P2|Overall Study|Other|13
3121794|NCT00092443|10680438|P1|Overall Study|Other|17
3121795|NCT00092443|10680437|P2|Overall Study|Moved|5
3121796|NCT00092443|10680438|P1|Overall Study|Moved|5
3121797|NCT00092443|10680437|P2|Overall Study|Withdrawal by Subject|11
3121798|NCT00092443|10680438|P1|Overall Study|Withdrawal by Subject|9
3121799|NCT00092443|10680437|P2|Overall Study|Protocol Violation|9
3121800|NCT00092443|10680438|P1|Overall Study|Protocol Violation|11
3121801|NCT00092443|10680437|P2|Overall Study|Lost to Follow-up|3
3121802|NCT00092443|10680438|P1|Overall Study|Lost to Follow-up|7
3121803|NCT00092443|10680437|P2|Overall Study|Adverse Event|13
3121804|NCT00092443|10680438|P1|Overall Study|Adverse Event|9
3121805|NCT00092417|10680456|P2|Overall Study|Other|0
3121806|NCT00092417|10680457|P1|Overall Study|Other|1
3121807|NCT00092417|10680456|P2|Overall Study|Withdrawal by Subject|1
3121808|NCT00092417|10680457|P1|Overall Study|Withdrawal by Subject|2
3121809|NCT00092417|10680456|P2|Overall Study|Lost to Follow-up|0
3121810|NCT00092417|10680457|P1|Overall Study|Lost to Follow-up|2
3121811|NCT00092131|10680471|P2|Treatment Period II|Adverse Event|1
3121812|NCT00092131|10680472|P1|Treatment Period II|Adverse Event|0
3121813|NCT00092131|10680471|P2|Treatment Period I|Adverse Event|0
3121814|NCT00092131|10680472|P1|Treatment Period I|Adverse Event|1
3121815|NCT00092118|10680502|P2|Overall Study|Other|5
3121816|NCT00092118|10680503|P1|Overall Study|Other|6
3121817|NCT00092118|10680502|P2|Overall Study|Withdrawal by Subject|10
3121818|NCT00092118|10680503|P1|Overall Study|Withdrawal by Subject|4
3121819|NCT00092118|10680502|P2|Overall Study|Protocol Violation|25
3121820|NCT00092118|10680503|P1|Overall Study|Protocol Violation|23
3121821|NCT00092118|10680502|P2|Overall Study|Lost to Follow-up|3
3121822|NCT00092118|10680503|P1|Overall Study|Lost to Follow-up|4
3121823|NCT00092118|10680502|P2|Overall Study|Lack of Efficacy|14
3121824|NCT00092118|10680503|P1|Overall Study|Lack of Efficacy|12
3121825|NCT00092118|10680502|P2|Overall Study|Adverse Event|32
3121826|NCT00092118|10680503|P1|Overall Study|Adverse Event|35
3121827|NCT00091949|10680537|P2|Overall Study|Lost to Follow-up|41
3121828|NCT00091949|10680538|P1|Overall Study|Lost to Follow-up|58
3121829|NCT00091949|10680537|P2|Overall Study|Withdrawal by Subject|110
3121830|NCT00091949|10680538|P1|Overall Study|Withdrawal by Subject|117
3121831|NCT00091832|10680562|P6|Overall Study|Protocol Violation|1
3121832|NCT00091832|10680563|P5|Overall Study|Protocol Violation|0
3121833|NCT00091832|10680564|P4|Overall Study|Protocol Violation|0
3121834|NCT00091832|10680565|P3|Overall Study|Protocol Violation|1
3121835|NCT00091832|10680566|P2|Overall Study|Protocol Violation|0
3121836|NCT00091832|10680567|P1|Overall Study|Protocol Violation|0
3121837|NCT00091832|10680562|P6|Overall Study|Other|0
3121838|NCT00091832|10680563|P5|Overall Study|Other|0
3121839|NCT00091832|10680564|P4|Overall Study|Other|0
3121840|NCT00091832|10680565|P3|Overall Study|Other|2
3121841|NCT00091832|10680566|P2|Overall Study|Other|1
3121842|NCT00091832|10680567|P1|Overall Study|Other|0
3121843|NCT00091832|10680562|P6|Overall Study|Noncompliance|0
3121844|NCT00091832|10680563|P5|Overall Study|Noncompliance|0
3121845|NCT00091832|10680564|P4|Overall Study|Noncompliance|0
3121846|NCT00091832|10680565|P3|Overall Study|Noncompliance|0
3121847|NCT00091832|10680566|P2|Overall Study|Noncompliance|1
3121848|NCT00091832|10680567|P1|Overall Study|Noncompliance|0
3121849|NCT00091832|10680562|P6|Overall Study|Lost to Follow-up|1
3121850|NCT00091832|10680563|P5|Overall Study|Lost to Follow-up|2
3121851|NCT00091832|10680564|P4|Overall Study|Lost to Follow-up|3
3121852|NCT00091832|10680565|P3|Overall Study|Lost to Follow-up|3
3121853|NCT00091832|10680566|P2|Overall Study|Lost to Follow-up|0
3121854|NCT00091832|10680567|P1|Overall Study|Lost to Follow-up|1
3121855|NCT00091832|10680562|P6|Overall Study|Ineligibility Determined|0
3121856|NCT00091832|10680563|P5|Overall Study|Ineligibility Determined|1
3121857|NCT00091832|10680564|P4|Overall Study|Ineligibility Determined|0
3121858|NCT00091832|10680565|P3|Overall Study|Ineligibility Determined|1
3121859|NCT00091832|10680566|P2|Overall Study|Ineligibility Determined|0
3121860|NCT00091832|10680567|P1|Overall Study|Ineligibility Determined|0
3121861|NCT00091832|10680562|P6|Overall Study|Disease Progression|2
3121862|NCT00091832|10680563|P5|Overall Study|Disease Progression|1
3121863|NCT00091832|10680564|P4|Overall Study|Disease Progression|1
3121864|NCT00091832|10680565|P3|Overall Study|Disease Progression|0
3121865|NCT00091832|10680566|P2|Overall Study|Disease Progression|0
3121866|NCT00091832|10680567|P1|Overall Study|Disease Progression|2
3121867|NCT00091832|10680562|P6|Overall Study|Death|6
3121868|NCT00091832|10680563|P5|Overall Study|Death|5
3121869|NCT00091832|10680564|P4|Overall Study|Death|8
3121870|NCT00091832|10680565|P3|Overall Study|Death|5
3121871|NCT00091832|10680566|P2|Overall Study|Death|4
3121872|NCT00091832|10680567|P1|Overall Study|Death|6
3121873|NCT00091832|10680562|P6|Overall Study|Withdrawal by Subject|1
3121874|NCT00091832|10680563|P5|Overall Study|Withdrawal by Subject|3
3121875|NCT00091832|10680564|P4|Overall Study|Withdrawal by Subject|1
3121876|NCT00091832|10680565|P3|Overall Study|Withdrawal by Subject|0
3121877|NCT00091832|10680566|P2|Overall Study|Withdrawal by Subject|5
3121878|NCT00091832|10680567|P1|Overall Study|Withdrawal by Subject|4
3121879|NCT00091832|10680562|P6|Overall Study|Adverse Event|0
3121880|NCT00091832|10680563|P5|Overall Study|Adverse Event|3
3121881|NCT00091832|10680564|P4|Overall Study|Adverse Event|1
3121882|NCT00091832|10680565|P3|Overall Study|Adverse Event|0
3121883|NCT00091832|10680566|P2|Overall Study|Adverse Event|0
3121884|NCT00091832|10680567|P1|Overall Study|Adverse Event|0
3121885|NCT00091832|10680562|P6|Overall Study|Physician Decision|0
3121886|NCT00091832|10680563|P5|Overall Study|Physician Decision|0
3121887|NCT00091832|10680564|P4|Overall Study|Physician Decision|0
3121888|NCT00091832|10680565|P3|Overall Study|Physician Decision|0
3121889|NCT00091832|10680566|P2|Overall Study|Physician Decision|0
3121890|NCT00091832|10680567|P1|Overall Study|Physician Decision|1
3121891|NCT00091819|10680685|P2|Overall Study|Never received study treatment|4
3121892|NCT00091819|10680686|P1|Overall Study|Never received study treatment|3
3121893|NCT00091819|10680685|P2|Overall Study|Other|3
3121894|NCT00091819|10680686|P1|Overall Study|Other|2
3121895|NCT00091819|10680685|P2|Overall Study|Protocol Violation|2
3121896|NCT00091819|10680686|P1|Overall Study|Protocol Violation|1
3121897|NCT00091819|10680685|P2|Overall Study|Withdrawal by Subject|8
3121898|NCT00091819|10680686|P1|Overall Study|Withdrawal by Subject|5
3121899|NCT00091819|10680685|P2|Overall Study|Lost to Follow-up|23
3121900|NCT00091819|10680686|P1|Overall Study|Lost to Follow-up|26
3121901|NCT00091819|10680685|P2|Overall Study|Death|5
3121902|NCT00091819|10680686|P1|Overall Study|Death|4
3121903|NCT00091819|10680685|P2|Overall Study|Adverse Event|1
3121904|NCT00091819|10680686|P1|Overall Study|Adverse Event|1
3121905|NCT00091793|10680694|P2|Overall Study|Other|0
3121906|NCT00091793|10680695|P1|Overall Study|Other|2
3121907|NCT00091793|10680694|P2|Overall Study|Noncompliance|0
3121908|NCT00091793|10680695|P1|Overall Study|Noncompliance|2
3121909|NCT00091793|10680694|P2|Overall Study|Lost to Follow-up|5
3121910|NCT00091793|10680695|P1|Overall Study|Lost to Follow-up|7
3121911|NCT00091793|10680694|P2|Overall Study|Ineligibility determined|0
3121912|NCT00091793|10680695|P1|Overall Study|Ineligibility determined|2
3121913|NCT00091793|10680694|P2|Overall Study|Withdrawal by Subject|15
3121914|NCT00091793|10680695|P1|Overall Study|Withdrawal by Subject|10
3121915|NCT00091793|10680694|P2|Overall Study|Adverse Event|2
3121916|NCT00091793|10680695|P1|Overall Study|Adverse Event|1
3121917|NCT00091572|10680719|P2|Overall Study|Toxicity (Related AE)|9
3121918|NCT00091572|10680720|P1|Overall Study|Toxicity (Related AE)|53
3121919|NCT00091572|10680719|P2|Overall Study|Major Protocol Violation|0
3121920|NCT00091572|10680720|P1|Overall Study|Major Protocol Violation|2
3121921|NCT00091572|10680719|P2|Overall Study|Ongoing (still on treatment)|12
3121922|NCT00091572|10680720|P1|Overall Study|Ongoing (still on treatment)|8
3121923|NCT00091572|10680719|P2|Overall Study|Other Reason|13
3121924|NCT00091572|10680720|P1|Overall Study|Other Reason|6
3121925|NCT00091572|10680719|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
3121926|NCT00091572|10680720|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
3121927|NCT00091572|10680719|P2|Overall Study|Death not due to malignancy/toxicity|3
3121928|NCT00091572|10680720|P1|Overall Study|Death not due to malignancy/toxicity|1
3121929|NCT00091572|10680719|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
3121930|NCT00091572|10680720|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
3121931|NCT00091572|10680719|P2|Overall Study|Lost to Follow-up|1
3121932|NCT00091572|10680720|P1|Overall Study|Lost to Follow-up|1
3121933|NCT00091442|10680751|P2|Overall Study|Other|6
3121934|NCT00091442|10680752|P1|Overall Study|Other|2
3121935|NCT00091442|10680751|P2|Overall Study|Lost to Follow-up|3
3121936|NCT00091442|10680752|P1|Overall Study|Lost to Follow-up|1
3121937|NCT00091442|10680751|P2|Overall Study|Death|7
3121938|NCT00091442|10680752|P1|Overall Study|Death|9
3121939|NCT00091442|10680751|P2|Overall Study|2cycles therapy beyond Complete response|16
3121940|NCT00091442|10680752|P1|Overall Study|2cycles therapy beyond Complete response|9
3121941|NCT00091442|10680751|P2|Overall Study|Adverse Event|48
3121942|NCT00091442|10680752|P1|Overall Study|Adverse Event|29
3121943|NCT00091442|10680751|P2|Overall Study|Withdrawal by Subject|46
3121944|NCT00091442|10680752|P1|Overall Study|Withdrawal by Subject|38
3121945|NCT00091442|10680751|P2|Overall Study|Physician Decision|58
3121946|NCT00091442|10680752|P1|Overall Study|Physician Decision|61
3121947|NCT00091442|10680751|P2|Overall Study|Progressive Disease|189
3121948|NCT00091442|10680752|P1|Overall Study|Progressive Disease|220
3121949|NCT00091390|10680762|P1|Overall Study|Protocol Violation|2
3121950|NCT00091390|10680762|P1|Overall Study|Withdrawal by Subject|2
3121951|NCT00091169|10680780|P2|Overall Study|Not start protocol therapy|17
3121952|NCT00091169|10680781|P1|Overall Study|Not start protocol therapy|26
3121953|NCT00091169|10680780|P2|Overall Study|Other|4
3121954|NCT00091169|10680781|P1|Overall Study|Other|3
3121955|NCT00091169|10680780|P2|Overall Study|Withdrawal by Subject|13
3121956|NCT00091169|10680781|P1|Overall Study|Withdrawal by Subject|10
3121957|NCT00091169|10680780|P2|Overall Study|Death|1
3121958|NCT00091169|10680781|P1|Overall Study|Death|4
3121959|NCT00091169|10680780|P2|Overall Study|Adverse Event|17
3121960|NCT00091169|10680781|P1|Overall Study|Adverse Event|11
3121961|NCT00091169|10680780|P2|Overall Study|Disease progression|1
3121962|NCT00091169|10680781|P1|Overall Study|Disease progression|3
3121963|NCT00091026|10680799|P2|Overall Study|Unknown-never received treatment|1
3121964|NCT00091026|10680800|P1|Overall Study|Unknown-never received treatment|0
3121965|NCT00091026|10680799|P2|Overall Study|Patient withdrew and never received trea|2
3121966|NCT00091026|10680800|P1|Overall Study|Patient withdrew and never received trea|0
3121967|NCT00091026|10680799|P2|Overall Study|Patient deemed non eligible-never receiv|0
3121968|NCT00091026|10680800|P1|Overall Study|Patient deemed non eligible-never receiv|1
3121969|NCT00090987|10680810|P1|Overall Study|Incarcerated|1
3121970|NCT00090987|10680810|P1|Overall Study|Non-compliance|4
3121971|NCT00090987|10680810|P1|Overall Study|alternative therapy|1
3121972|NCT00090987|10680810|P1|Overall Study|Withdrawal by Subject|3
3121973|NCT00090987|10680810|P1|Overall Study|Lack of Efficacy|7
3121974|NCT00090987|10680810|P1|Overall Study|Adverse Event|5
3121975|NCT00090857|10680823|P2|Overall Study|Adverse Event|2
3121976|NCT00090857|10680824|P1|Overall Study|Adverse Event|2
3121977|NCT00090857|10680823|P2|Overall Study|Withdrawal by Subject|0
3121978|NCT00090857|10680824|P1|Overall Study|Withdrawal by Subject|2
3121979|NCT00090857|10680823|P2|Overall Study|Lost to Follow-up|1
3121980|NCT00090857|10680824|P1|Overall Study|Lost to Follow-up|0
3121981|NCT00090779|10680863|P2|Step 3|Off extended study due to study closure|3
3121982|NCT00090779|10680864|P1|Step 3|Off extended study due to study closure|4
3121983|NCT00090779|10680863|P2|Step 3|Initiation of ART and off extended study|2
3121984|NCT00090779|10680864|P1|Step 3|Initiation of ART and off extended study|3
3121985|NCT00090779|10680863|P2|Step 2|Non-compliance to study requirements|1
3121986|NCT00090779|10680864|P1|Step 2|Non-compliance to study requirements|0
3121987|NCT00090779|10680863|P2|Step 2|Subject relocated|1
3121988|NCT00090779|10680864|P1|Step 2|Subject relocated|0
3121989|NCT00090779|10680863|P2|Step 2|Off study per study closure|16
3121990|NCT00090779|10680864|P1|Step 2|Off study per study closure|6
3121991|NCT00090779|10680863|P2|Step 1|Subject relocated|8
3121992|NCT00090779|10680864|P1|Step 1|Subject relocated|2
3121993|NCT00090779|10680863|P2|Step 1|Non-compliance to study requirements|1
3121994|NCT00090779|10680864|P1|Step 1|Non-compliance to study requirements|0
3121995|NCT00090779|10680863|P2|Step 1|Pregnancy|0
3121996|NCT00090779|10680864|P1|Step 1|Pregnancy|1
3121997|NCT00090779|10680863|P2|Step 1|Physician Decision|0
3121998|NCT00090779|10680864|P1|Step 1|Physician Decision|1
3121999|NCT00090779|10680863|P2|Step 1|Death|2
3122000|NCT00090779|10680864|P1|Step 1|Death|0
3122001|NCT00090779|10680863|P2|Step 1|Lost to Follow-up|2
3122002|NCT00090779|10680864|P1|Step 1|Lost to Follow-up|3
3122003|NCT00090779|10680863|P2|Step 1|Withdrawal by Subject|2
3122004|NCT00090779|10680864|P1|Step 1|Withdrawal by Subject|4
3122005|NCT00090766|10680888|P3|Overall Study|Lost to Follow-up|2
3122006|NCT00090766|10680889|P2|Overall Study|Lost to Follow-up|0
3122007|NCT00090766|10680890|P1|Overall Study|Lost to Follow-up|2
3122008|NCT00090766|10680888|P3|Overall Study|Admin|0
3122009|NCT00090766|10680889|P2|Overall Study|Admin|2
3122010|NCT00090766|10680890|P1|Overall Study|Admin|0
3122011|NCT00090766|10680888|P3|Overall Study|Death|0
3122012|NCT00090766|10680889|P2|Overall Study|Death|0
3122013|NCT00090766|10680890|P1|Overall Study|Death|1
3122014|NCT00090766|10680888|P3|Overall Study|Nephrectomy Planned|1
3122015|NCT00090766|10680889|P2|Overall Study|Nephrectomy Planned|0
3122016|NCT00090766|10680890|P1|Overall Study|Nephrectomy Planned|0
3122017|NCT00090753|10680932|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
3122018|NCT00090753|10680933|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
3122019|NCT00090753|10680932|P2|Extended Treatment Period|Mircera Commercialization|93
3122020|NCT00090753|10680933|P1|Extended Treatment Period|Mircera Commercialization|188
3122021|NCT00090753|10680932|P2|Extended Treatment Period|Renal Transplant|12
3122022|NCT00090753|10680933|P1|Extended Treatment Period|Renal Transplant|15
3122023|NCT00090753|10680932|P2|Extended Treatment Period|Lost to Follow-up|1
3122024|NCT00090753|10680933|P1|Extended Treatment Period|Lost to Follow-up|3
3122025|NCT00090753|10680932|P2|Extended Treatment Period|Refused Treatment|12
3122026|NCT00090753|10680933|P1|Extended Treatment Period|Refused Treatment|18
3122027|NCT00090753|10680932|P2|Extended Treatment Period|Lack of Efficacy|0
3122028|NCT00090753|10680933|P1|Extended Treatment Period|Lack of Efficacy|1
3122029|NCT00090753|10680932|P2|Extended Treatment Period|Death|30
3122030|NCT00090753|10680933|P1|Extended Treatment Period|Death|58
3122031|NCT00090753|10680932|P2|Extended Treatment Period|Adverse Event|0
3122032|NCT00090753|10680933|P1|Extended Treatment Period|Adverse Event|11
3122033|NCT00090753|10680932|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
3122034|NCT00090753|10680933|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
3122035|NCT00090753|10680932|P2|First Treatment Period|Mircera Commercialization|0
3122036|NCT00090753|10680933|P1|First Treatment Period|Mircera Commercialization|1
3122037|NCT00090753|10680932|P2|First Treatment Period|Renal Transplant|50
3122038|NCT00090753|10680933|P1|First Treatment Period|Renal Transplant|70
3122039|NCT00090753|10680932|P2|First Treatment Period|Lost to Follow-up|4
3122040|NCT00090753|10680933|P1|First Treatment Period|Lost to Follow-up|4
3122041|NCT00090753|10680932|P2|First Treatment Period|Refused Treatment|25
3122042|NCT00090753|10680933|P1|First Treatment Period|Refused Treatment|32
3122043|NCT00090753|10680932|P2|First Treatment Period|Lack of Efficacy|1
3122044|NCT00090753|10680933|P1|First Treatment Period|Lack of Efficacy|2
3122045|NCT00090753|10680932|P2|First Treatment Period|Death|62
3122046|NCT00090753|10680933|P1|First Treatment Period|Death|88
3122047|NCT00090753|10680932|P2|First Treatment Period|Adverse Event|8
3122048|NCT00090753|10680933|P1|First Treatment Period|Adverse Event|20
3122049|NCT00090610|10680943|P2|Overall Study|Withdrawal by Subject|1
3122050|NCT00090610|10680944|P1|Overall Study|Withdrawal by Subject|1
3122051|NCT00090584|10680960|P2|Baseline to 8 Months|Lost to Follow-up|41
3122052|NCT00090584|10680961|P1|Baseline to 8 Months|Lost to Follow-up|44
3122053|NCT00090584|10680960|P2|Baseline to 10 Weeks|Lost to Follow-up|12
3122054|NCT00090584|10680961|P1|Baseline to 10 Weeks|Lost to Follow-up|15
3122055|NCT00090519|10680993|P2|Overall Study|Sponsor Decision|1
3122056|NCT00090519|10680994|P1|Overall Study|Sponsor Decision|3
3122057|NCT00090519|10680993|P2|Overall Study|Physician Decision|3
3122058|NCT00090519|10680994|P1|Overall Study|Physician Decision|2
3122059|NCT00090519|10680993|P2|Overall Study|Withdrawal by Subject|29
3122060|NCT00090519|10680994|P1|Overall Study|Withdrawal by Subject|28
3122061|NCT00090519|10680993|P2|Overall Study|Lost to Follow-up|29
3122062|NCT00090519|10680994|P1|Overall Study|Lost to Follow-up|26
3122063|NCT00090519|10680993|P2|Overall Study|Death|9
3122064|NCT00090519|10680994|P1|Overall Study|Death|9
3122065|NCT00090519|10680993|P2|Overall Study|Adverse Event|4
3122066|NCT00090519|10680994|P1|Overall Study|Adverse Event|5
3122067|NCT00090493|10681018|P1|Overall Study|Physician Decision|2
3122068|NCT00090363|10681025|P3|Overall Study|Continuing on study off treatment|16
3122069|NCT00090363|10681026|P2|Overall Study|Continuing on study off treatment|13
3122070|NCT00090363|10681027|P1|Overall Study|Continuing on study off treatment|14
3122071|NCT00090363|10681025|P3|Overall Study|Reasons not specified|1
3122072|NCT00090363|10681026|P2|Overall Study|Reasons not specified|1
3122073|NCT00090363|10681027|P1|Overall Study|Reasons not specified|2
3122074|NCT00090363|10681025|P3|Overall Study|Consent expired|9
3122075|NCT00090363|10681026|P2|Overall Study|Consent expired|10
3122076|NCT00090363|10681027|P1|Overall Study|Consent expired|7
3122077|NCT00090363|10681025|P3|Overall Study|Eligibility criteria not fulfilled|1
3122078|NCT00090363|10681026|P2|Overall Study|Eligibility criteria not fulfilled|0
3122079|NCT00090363|10681027|P1|Overall Study|Eligibility criteria not fulfilled|0
3122080|NCT00090363|10681025|P3|Overall Study|Study-specific discontinuation criteria|62
3122081|NCT00090363|10681026|P2|Overall Study|Study-specific discontinuation criteria|74
3122082|NCT00090363|10681027|P1|Overall Study|Study-specific discontinuation criteria|75
3122083|NCT00090363|10681025|P3|Overall Study|Withdrawal by Subject|6
3122084|NCT00090363|10681026|P2|Overall Study|Withdrawal by Subject|7
3122085|NCT00090363|10681027|P1|Overall Study|Withdrawal by Subject|7
3122086|NCT00090363|10681025|P3|Overall Study|Lost to Follow-up|1
3122087|NCT00090363|10681026|P2|Overall Study|Lost to Follow-up|2
3122088|NCT00090363|10681027|P1|Overall Study|Lost to Follow-up|1
3122089|NCT00090545|10681049|P2|Overall Study|Adverse Event|2
3122090|NCT00090545|10681050|P1|Overall Study|Adverse Event|0
3122091|NCT00090545|10681049|P2|Overall Study|Death|1
3122092|NCT00090545|10681050|P1|Overall Study|Death|0
3122093|NCT00090545|10681049|P2|Overall Study|Refused further treatment|4
3122094|NCT00090545|10681050|P1|Overall Study|Refused further treatment|1
3122095|NCT00090545|10681049|P2|Overall Study|Disease progression on study|17
3122096|NCT00090545|10681050|P1|Overall Study|Disease progression on study|21
3122097|NCT00090285|10681070|P6|Long-term Follow-up (EXT2)|Physician Decision|5
3122098|NCT00090285|10681071|P5|Long-term Follow-up (EXT2)|Physician Decision|6
3122099|NCT00090285|10681072|P4|Long-term Follow-up (EXT2)|Physician Decision|0
3122100|NCT00090285|10681073|P3|Long-term Follow-up (EXT2)|Physician Decision|0
3122101|NCT00090285|10681074|P2|Long-term Follow-up (EXT2)|Physician Decision|0
3122102|NCT00090285|10681075|P1|Long-term Follow-up (EXT2)|Physician Decision|0
3122103|NCT00090285|10681070|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
3122104|NCT00090285|10681071|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
3122105|NCT00090285|10681072|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122106|NCT00090285|10681073|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122107|NCT00090285|10681074|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122108|NCT00090285|10681075|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122109|NCT00090285|10681070|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
3122110|NCT00090285|10681071|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
3122111|NCT00090285|10681072|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122112|NCT00090285|10681073|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122113|NCT00090285|10681074|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122114|NCT00090285|10681075|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122115|NCT00090285|10681070|P6|Long-term Follow-up (EXT2)|Adverse Event|2
3122116|NCT00090285|10681071|P5|Long-term Follow-up (EXT2)|Adverse Event|5
3122117|NCT00090285|10681072|P4|Long-term Follow-up (EXT2)|Adverse Event|0
3122118|NCT00090285|10681073|P3|Long-term Follow-up (EXT2)|Adverse Event|0
3122119|NCT00090285|10681074|P2|Long-term Follow-up (EXT2)|Adverse Event|0
3122120|NCT00090285|10681075|P1|Long-term Follow-up (EXT2)|Adverse Event|0
3122121|NCT00090285|10681070|P6|Extension 1|Moved|0
3122122|NCT00090285|10681071|P5|Extension 1|Moved|0
3122123|NCT00090285|10681072|P4|Extension 1|Moved|0
3122124|NCT00090285|10681073|P3|Extension 1|Moved|3
3122125|NCT00090285|10681074|P2|Extension 1|Moved|0
3122126|NCT00090285|10681075|P1|Extension 1|Moved|0
3122127|NCT00090285|10681070|P6|Extension 1|Other|0
3122128|NCT00090285|10681071|P5|Extension 1|Other|0
3122129|NCT00090285|10681072|P4|Extension 1|Other|0
3122130|NCT00090285|10681073|P3|Extension 1|Other|4
3122131|NCT00090285|10681074|P2|Extension 1|Other|0
3122132|NCT00090285|10681075|P1|Extension 1|Other|0
3122133|NCT00090285|10681070|P6|Extension 1|Withdrawal by Subject|0
3122134|NCT00090285|10681071|P5|Extension 1|Withdrawal by Subject|0
3122135|NCT00090285|10681072|P4|Extension 1|Withdrawal by Subject|1
3122136|NCT00090285|10681073|P3|Extension 1|Withdrawal by Subject|13
3122137|NCT00090285|10681074|P2|Extension 1|Withdrawal by Subject|0
3122138|NCT00090285|10681075|P1|Extension 1|Withdrawal by Subject|0
3122139|NCT00090285|10681070|P6|Extension 1|Lost to Follow-up|0
3122140|NCT00090285|10681071|P5|Extension 1|Lost to Follow-up|0
3122141|NCT00090285|10681072|P4|Extension 1|Lost to Follow-up|0
3122142|NCT00090285|10681073|P3|Extension 1|Lost to Follow-up|35
3122143|NCT00090285|10681074|P2|Extension 1|Lost to Follow-up|0
3122144|NCT00090285|10681075|P1|Extension 1|Lost to Follow-up|0
3122145|NCT00090285|10681070|P6|Extension 1|Adverse Event|0
3122146|NCT00090285|10681071|P5|Extension 1|Adverse Event|0
3122147|NCT00090285|10681072|P4|Extension 1|Adverse Event|0
3122148|NCT00090285|10681073|P3|Extension 1|Adverse Event|2
3122149|NCT00090285|10681074|P2|Extension 1|Adverse Event|0
3122150|NCT00090285|10681075|P1|Extension 1|Adverse Event|0
3122151|NCT00090285|10681070|P6|Base Study Follow-up Period|Subject Incarcerated|0
3122152|NCT00090285|10681071|P5|Base Study Follow-up Period|Subject Incarcerated|0
3122153|NCT00090285|10681072|P4|Base Study Follow-up Period|Subject Incarcerated|0
3122154|NCT00090285|10681073|P3|Base Study Follow-up Period|Subject Incarcerated|0
3122155|NCT00090285|10681074|P2|Base Study Follow-up Period|Subject Incarcerated|2
3122156|NCT00090285|10681075|P1|Base Study Follow-up Period|Subject Incarcerated|0
3122157|NCT00090285|10681070|P6|Base Study Follow-up Period|Uncooperative|0
3122158|NCT00090285|10681071|P5|Base Study Follow-up Period|Uncooperative|0
3122159|NCT00090285|10681072|P4|Base Study Follow-up Period|Uncooperative|0
3122160|NCT00090285|10681073|P3|Base Study Follow-up Period|Uncooperative|0
3122161|NCT00090285|10681074|P2|Base Study Follow-up Period|Uncooperative|4
3122162|NCT00090285|10681075|P1|Base Study Follow-up Period|Uncooperative|3
3122163|NCT00090285|10681070|P6|Base Study Follow-up Period|Protocol Violation|0
3122164|NCT00090285|10681071|P5|Base Study Follow-up Period|Protocol Violation|0
3122165|NCT00090285|10681072|P4|Base Study Follow-up Period|Protocol Violation|0
3122166|NCT00090285|10681073|P3|Base Study Follow-up Period|Protocol Violation|0
3122167|NCT00090285|10681074|P2|Base Study Follow-up Period|Protocol Violation|0
3122168|NCT00090285|10681075|P1|Base Study Follow-up Period|Protocol Violation|1
3122169|NCT00090285|10681070|P6|Base Study Follow-up Period|Other|0
3122170|NCT00090285|10681071|P5|Base Study Follow-up Period|Other|0
3122171|NCT00090285|10681072|P4|Base Study Follow-up Period|Other|0
3122172|NCT00090285|10681073|P3|Base Study Follow-up Period|Other|0
3122173|NCT00090285|10681074|P2|Base Study Follow-up Period|Other|0
3122174|NCT00090285|10681075|P1|Base Study Follow-up Period|Other|2
3122175|NCT00090285|10681070|P6|Base Study Follow-up Period|Moved|0
3122176|NCT00090285|10681071|P5|Base Study Follow-up Period|Moved|0
3122177|NCT00090285|10681072|P4|Base Study Follow-up Period|Moved|0
3122178|NCT00090285|10681073|P3|Base Study Follow-up Period|Moved|0
3122179|NCT00090285|10681074|P2|Base Study Follow-up Period|Moved|36
3122180|NCT00090285|10681075|P1|Base Study Follow-up Period|Moved|41
3122181|NCT00090285|10681070|P6|Base Study Follow-up Period|Withdrawal by Subject|0
3122182|NCT00090285|10681071|P5|Base Study Follow-up Period|Withdrawal by Subject|0
3122183|NCT00090285|10681072|P4|Base Study Follow-up Period|Withdrawal by Subject|0
3122184|NCT00090285|10681073|P3|Base Study Follow-up Period|Withdrawal by Subject|0
3122185|NCT00090285|10681074|P2|Base Study Follow-up Period|Withdrawal by Subject|64
3122186|NCT00090285|10681075|P1|Base Study Follow-up Period|Withdrawal by Subject|53
3122187|NCT00090285|10681070|P6|Base Study Follow-up Period|Lost to Follow-up|0
3122188|NCT00090285|10681071|P5|Base Study Follow-up Period|Lost to Follow-up|0
3122189|NCT00090285|10681072|P4|Base Study Follow-up Period|Lost to Follow-up|0
3122190|NCT00090285|10681073|P3|Base Study Follow-up Period|Lost to Follow-up|0
3122191|NCT00090285|10681074|P2|Base Study Follow-up Period|Lost to Follow-up|226
3122192|NCT00090285|10681075|P1|Base Study Follow-up Period|Lost to Follow-up|232
3122193|NCT00090285|10681070|P6|Base Study Follow-up Period|Adverse Event|0
3122194|NCT00090285|10681071|P5|Base Study Follow-up Period|Adverse Event|0
3122195|NCT00090285|10681072|P4|Base Study Follow-up Period|Adverse Event|0
3122196|NCT00090285|10681073|P3|Base Study Follow-up Period|Adverse Event|0
3122197|NCT00090285|10681074|P2|Base Study Follow-up Period|Adverse Event|10
3122198|NCT00090285|10681075|P1|Base Study Follow-up Period|Adverse Event|3
3122199|NCT00090285|10681070|P6|Base Study Vaccination Period|HIV positive|0
3122200|NCT00090285|10681071|P5|Base Study Vaccination Period|HIV positive|0
3122201|NCT00090285|10681072|P4|Base Study Vaccination Period|HIV positive|0
3122202|NCT00090285|10681073|P3|Base Study Vaccination Period|HIV positive|0
3122203|NCT00090285|10681074|P2|Base Study Vaccination Period|HIV positive|1
3122204|NCT00090285|10681075|P1|Base Study Vaccination Period|HIV positive|1
3122205|NCT00090285|10681070|P6|Base Study Vaccination Period|Subject Incarcerated|0
3122206|NCT00090285|10681071|P5|Base Study Vaccination Period|Subject Incarcerated|0
3122207|NCT00090285|10681072|P4|Base Study Vaccination Period|Subject Incarcerated|0
3122208|NCT00090285|10681073|P3|Base Study Vaccination Period|Subject Incarcerated|0
3122209|NCT00090285|10681074|P2|Base Study Vaccination Period|Subject Incarcerated|2
3122210|NCT00090285|10681075|P1|Base Study Vaccination Period|Subject Incarcerated|2
3122211|NCT00090285|10681070|P6|Base Study Vaccination Period|Other|0
3122212|NCT00090285|10681071|P5|Base Study Vaccination Period|Other|0
3122213|NCT00090285|10681072|P4|Base Study Vaccination Period|Other|0
3122214|NCT00090285|10681073|P3|Base Study Vaccination Period|Other|0
3122215|NCT00090285|10681074|P2|Base Study Vaccination Period|Other|2
3122216|NCT00090285|10681075|P1|Base Study Vaccination Period|Other|2
3122217|NCT00090285|10681070|P6|Base Study Vaccination Period|Site Terminated|0
3122218|NCT00090285|10681071|P5|Base Study Vaccination Period|Site Terminated|0
3122219|NCT00090285|10681072|P4|Base Study Vaccination Period|Site Terminated|0
3122220|NCT00090285|10681073|P3|Base Study Vaccination Period|Site Terminated|0
3122221|NCT00090285|10681074|P2|Base Study Vaccination Period|Site Terminated|0
3122222|NCT00090285|10681075|P1|Base Study Vaccination Period|Site Terminated|1
3122223|NCT00090285|10681070|P6|Base Study Vaccination Period|Moved|0
3122224|NCT00090285|10681071|P5|Base Study Vaccination Period|Moved|0
3122225|NCT00090285|10681072|P4|Base Study Vaccination Period|Moved|0
3122226|NCT00090285|10681073|P3|Base Study Vaccination Period|Moved|0
3122227|NCT00090285|10681074|P2|Base Study Vaccination Period|Moved|21
3122228|NCT00090285|10681075|P1|Base Study Vaccination Period|Moved|20
3122229|NCT00090285|10681070|P6|Base Study Vaccination Period|Uncooperative|0
3122230|NCT00090285|10681071|P5|Base Study Vaccination Period|Uncooperative|0
3122231|NCT00090285|10681072|P4|Base Study Vaccination Period|Uncooperative|0
3122232|NCT00090285|10681073|P3|Base Study Vaccination Period|Uncooperative|0
3122233|NCT00090285|10681074|P2|Base Study Vaccination Period|Uncooperative|2
3122234|NCT00090285|10681075|P1|Base Study Vaccination Period|Uncooperative|2
3122235|NCT00090285|10681070|P6|Base Study Vaccination Period|Withdrawal by Subject|0
3122236|NCT00090285|10681071|P5|Base Study Vaccination Period|Withdrawal by Subject|0
3122237|NCT00090285|10681072|P4|Base Study Vaccination Period|Withdrawal by Subject|0
3122238|NCT00090285|10681073|P3|Base Study Vaccination Period|Withdrawal by Subject|0
3122239|NCT00090285|10681074|P2|Base Study Vaccination Period|Withdrawal by Subject|69
3122240|NCT00090285|10681075|P1|Base Study Vaccination Period|Withdrawal by Subject|64
3122241|NCT00090285|10681070|P6|Base Study Vaccination Period|Protocol Violation|0
3122242|NCT00090285|10681071|P5|Base Study Vaccination Period|Protocol Violation|0
3122243|NCT00090285|10681072|P4|Base Study Vaccination Period|Protocol Violation|0
3122244|NCT00090285|10681073|P3|Base Study Vaccination Period|Protocol Violation|0
3122245|NCT00090285|10681074|P2|Base Study Vaccination Period|Protocol Violation|3
3122246|NCT00090285|10681075|P1|Base Study Vaccination Period|Protocol Violation|2
3122247|NCT00090285|10681070|P6|Base Study Vaccination Period|Lost to Follow-up|0
3122248|NCT00090285|10681071|P5|Base Study Vaccination Period|Lost to Follow-up|0
3122249|NCT00090285|10681072|P4|Base Study Vaccination Period|Lost to Follow-up|0
3122250|NCT00090285|10681073|P3|Base Study Vaccination Period|Lost to Follow-up|0
3122251|NCT00090285|10681074|P2|Base Study Vaccination Period|Lost to Follow-up|112
3122252|NCT00090285|10681075|P1|Base Study Vaccination Period|Lost to Follow-up|111
3122253|NCT00090285|10681070|P6|Base Study Vaccination Period|Adverse Event|0
3122254|NCT00090285|10681071|P5|Base Study Vaccination Period|Adverse Event|0
3122255|NCT00090285|10681072|P4|Base Study Vaccination Period|Adverse Event|0
3122256|NCT00090285|10681073|P3|Base Study Vaccination Period|Adverse Event|0
3122257|NCT00090285|10681074|P2|Base Study Vaccination Period|Adverse Event|4
3122258|NCT00090285|10681075|P1|Base Study Vaccination Period|Adverse Event|2
3122259|NCT00090285|10681070|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
3122260|NCT00090285|10681071|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
3122261|NCT00090285|10681072|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
3122262|NCT00090285|10681073|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
3122263|NCT00090285|10681074|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
3122264|NCT00090285|10681075|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
3122265|NCT00090259|10681112|P2|Overall Study|Investigator site closed|7
3122266|NCT00090259|10681113|P1|Overall Study|Investigator site closed|11
3122267|NCT00090259|10681112|P2|Overall Study|Withdrawal by Subject|15
3122268|NCT00090259|10681113|P1|Overall Study|Withdrawal by Subject|21
3122269|NCT00090259|10681112|P2|Overall Study|Lost to Follow-up|26
3122270|NCT00090259|10681113|P1|Overall Study|Lost to Follow-up|30
3122271|NCT00090233|10681129|P2|Overall Study|Data not available at data cut-off point|1563
3122272|NCT00090233|10681130|P1|Overall Study|Data not available at data cut-off point|1552
3122273|NCT00090233|10681129|P2|Overall Study|Other|1160
3122274|NCT00090233|10681130|P1|Overall Study|Other|1211
3122275|NCT00090233|10681129|P2|Overall Study|Moved|189
3122276|NCT00090233|10681130|P1|Overall Study|Moved|203
3122277|NCT00090233|10681129|P2|Overall Study|Withdrawal by Subject|211
3122278|NCT00090233|10681130|P1|Overall Study|Withdrawal by Subject|182
3122279|NCT00090233|10681129|P2|Overall Study|Protocol Violation|1022
3122280|NCT00090233|10681130|P1|Overall Study|Protocol Violation|960
3122281|NCT00090233|10681129|P2|Overall Study|Lost to Follow-up|95
3122282|NCT00090233|10681130|P1|Overall Study|Lost to Follow-up|68
3122283|NCT00090233|10681129|P2|Overall Study|Adverse Event|198
3122284|NCT00090233|10681130|P1|Overall Study|Adverse Event|214
3122285|NCT00090233|10681129|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
3122286|NCT00090233|10681130|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
3122287|NCT00090220|10681154|P6|Long-term Follow-up (EXT2)|Other|0
3122288|NCT00090220|10681155|P5|Long-term Follow-up (EXT2)|Other|1
3122289|NCT00090220|10681156|P4|Long-term Follow-up (EXT2)|Other|0
3122290|NCT00090220|10681157|P3|Long-term Follow-up (EXT2)|Other|0
3122291|NCT00090220|10681158|P2|Long-term Follow-up (EXT2)|Other|0
3122292|NCT00090220|10681159|P1|Long-term Follow-up (EXT2)|Other|0
3122293|NCT00090220|10681154|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
3122294|NCT00090220|10681155|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
3122295|NCT00090220|10681156|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122296|NCT00090220|10681157|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122297|NCT00090220|10681158|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122298|NCT00090220|10681159|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
3122299|NCT00090220|10681154|P6|Long-term Follow-up (EXT2)|Death|1
3122300|NCT00090220|10681155|P5|Long-term Follow-up (EXT2)|Death|1
3122301|NCT00090220|10681156|P4|Long-term Follow-up (EXT2)|Death|0
3122302|NCT00090220|10681157|P3|Long-term Follow-up (EXT2)|Death|0
3122303|NCT00090220|10681158|P2|Long-term Follow-up (EXT2)|Death|0
3122304|NCT00090220|10681159|P1|Long-term Follow-up (EXT2)|Death|0
3122305|NCT00090220|10681154|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
3122306|NCT00090220|10681155|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
3122307|NCT00090220|10681156|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122308|NCT00090220|10681157|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122309|NCT00090220|10681158|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122310|NCT00090220|10681159|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
3122311|NCT00090220|10681154|P6|Extension 1 (EXT1)|Other reason|0
3122312|NCT00090220|10681155|P5|Extension 1 (EXT1)|Other reason|0
3122313|NCT00090220|10681156|P4|Extension 1 (EXT1)|Other reason|0
3122314|NCT00090220|10681157|P3|Extension 1 (EXT1)|Other reason|2
3122315|NCT00090220|10681158|P2|Extension 1 (EXT1)|Other reason|0
3122316|NCT00090220|10681159|P1|Extension 1 (EXT1)|Other reason|0
3122317|NCT00090220|10681154|P6|Extension 1 (EXT1)|Protocol Violation|0
3122318|NCT00090220|10681155|P5|Extension 1 (EXT1)|Protocol Violation|0
3122319|NCT00090220|10681156|P4|Extension 1 (EXT1)|Protocol Violation|1
3122320|NCT00090220|10681157|P3|Extension 1 (EXT1)|Protocol Violation|0
3122321|NCT00090220|10681158|P2|Extension 1 (EXT1)|Protocol Violation|0
3122322|NCT00090220|10681159|P1|Extension 1 (EXT1)|Protocol Violation|0
3122323|NCT00090220|10681154|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
3122324|NCT00090220|10681155|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
3122325|NCT00090220|10681156|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
3122326|NCT00090220|10681157|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
3122327|NCT00090220|10681158|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
3122328|NCT00090220|10681159|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
3122329|NCT00090220|10681154|P6|Extension 1 (EXT1)|Moved|0
3122330|NCT00090220|10681155|P5|Extension 1 (EXT1)|Moved|0
3122331|NCT00090220|10681156|P4|Extension 1 (EXT1)|Moved|1
3122332|NCT00090220|10681157|P3|Extension 1 (EXT1)|Moved|2
3122333|NCT00090220|10681158|P2|Extension 1 (EXT1)|Moved|0
3122334|NCT00090220|10681159|P1|Extension 1 (EXT1)|Moved|0
3122335|NCT00090220|10681154|P6|Extension 1 (EXT1)|Lost to Follow-up|0
3122336|NCT00090220|10681155|P5|Extension 1 (EXT1)|Lost to Follow-up|0
3122337|NCT00090220|10681156|P4|Extension 1 (EXT1)|Lost to Follow-up|0
3122338|NCT00090220|10681157|P3|Extension 1 (EXT1)|Lost to Follow-up|22
3122339|NCT00090220|10681158|P2|Extension 1 (EXT1)|Lost to Follow-up|0
3122340|NCT00090220|10681159|P1|Extension 1 (EXT1)|Lost to Follow-up|0
3122341|NCT00090220|10681154|P6|Extension 1 (EXT1)|Adverse Event|0
3122342|NCT00090220|10681155|P5|Extension 1 (EXT1)|Adverse Event|0
3122343|NCT00090220|10681156|P4|Extension 1 (EXT1)|Adverse Event|0
3122344|NCT00090220|10681157|P3|Extension 1 (EXT1)|Adverse Event|4
3122345|NCT00090220|10681158|P2|Extension 1 (EXT1)|Adverse Event|0
3122346|NCT00090220|10681159|P1|Extension 1 (EXT1)|Adverse Event|0
3122347|NCT00090220|10681154|P6|Base Study Follow-up Period|Other|0
3122348|NCT00090220|10681155|P5|Base Study Follow-up Period|Other|0
3122349|NCT00090220|10681156|P4|Base Study Follow-up Period|Other|0
3122350|NCT00090220|10681157|P3|Base Study Follow-up Period|Other|0
3122351|NCT00090220|10681158|P2|Base Study Follow-up Period|Other|21
3122352|NCT00090220|10681159|P1|Base Study Follow-up Period|Other|19
3122353|NCT00090220|10681154|P6|Base Study Follow-up Period|Patient Moved|0
3122354|NCT00090220|10681155|P5|Base Study Follow-up Period|Patient Moved|0
3122355|NCT00090220|10681156|P4|Base Study Follow-up Period|Patient Moved|0
3122356|NCT00090220|10681157|P3|Base Study Follow-up Period|Patient Moved|0
3122357|NCT00090220|10681158|P2|Base Study Follow-up Period|Patient Moved|28
3122358|NCT00090220|10681159|P1|Base Study Follow-up Period|Patient Moved|20
3122359|NCT00090220|10681154|P6|Base Study Follow-up Period|Withdrawal by Subject|0
3122360|NCT00090220|10681155|P5|Base Study Follow-up Period|Withdrawal by Subject|0
3122361|NCT00090220|10681156|P4|Base Study Follow-up Period|Withdrawal by Subject|0
3122362|NCT00090220|10681157|P3|Base Study Follow-up Period|Withdrawal by Subject|0
3122363|NCT00090220|10681158|P2|Base Study Follow-up Period|Withdrawal by Subject|36
3122364|NCT00090220|10681159|P1|Base Study Follow-up Period|Withdrawal by Subject|27
3122365|NCT00090220|10681154|P6|Base Study Follow-up Period|Lost to Follow-up|0
3122366|NCT00090220|10681155|P5|Base Study Follow-up Period|Lost to Follow-up|0
3122367|NCT00090220|10681156|P4|Base Study Follow-up Period|Lost to Follow-up|0
3122368|NCT00090220|10681157|P3|Base Study Follow-up Period|Lost to Follow-up|0
3122369|NCT00090220|10681158|P2|Base Study Follow-up Period|Lost to Follow-up|78
3122370|NCT00090220|10681159|P1|Base Study Follow-up Period|Lost to Follow-up|88
3122371|NCT00090220|10681154|P6|Base Study Follow-up Period|Adverse Event|0
3122372|NCT00090220|10681155|P5|Base Study Follow-up Period|Adverse Event|0
3122373|NCT00090220|10681156|P4|Base Study Follow-up Period|Adverse Event|0
3122374|NCT00090220|10681157|P3|Base Study Follow-up Period|Adverse Event|0
3122375|NCT00090220|10681158|P2|Base Study Follow-up Period|Adverse Event|1
3122376|NCT00090220|10681159|P1|Base Study Follow-up Period|Adverse Event|6
3122377|NCT00090220|10681154|P6|Base Study Vaccination Period|Other|0
3122378|NCT00090220|10681155|P5|Base Study Vaccination Period|Other|0
3122379|NCT00090220|10681156|P4|Base Study Vaccination Period|Other|0
3122380|NCT00090220|10681157|P3|Base Study Vaccination Period|Other|0
3122381|NCT00090220|10681158|P2|Base Study Vaccination Period|Other|4
3122382|NCT00090220|10681159|P1|Base Study Vaccination Period|Other|4
3122383|NCT00090220|10681154|P6|Base Study Vaccination Period|Patient Moved|0
3122384|NCT00090220|10681155|P5|Base Study Vaccination Period|Patient Moved|0
3122385|NCT00090220|10681156|P4|Base Study Vaccination Period|Patient Moved|0
3122386|NCT00090220|10681157|P3|Base Study Vaccination Period|Patient Moved|0
3122387|NCT00090220|10681158|P2|Base Study Vaccination Period|Patient Moved|2
3122388|NCT00090220|10681159|P1|Base Study Vaccination Period|Patient Moved|6
3122389|NCT00090220|10681154|P6|Base Study Vaccination Period|Withdrawal by Subject|0
3122390|NCT00090220|10681155|P5|Base Study Vaccination Period|Withdrawal by Subject|0
3122391|NCT00090220|10681156|P4|Base Study Vaccination Period|Withdrawal by Subject|0
3122392|NCT00090220|10681157|P3|Base Study Vaccination Period|Withdrawal by Subject|0
3122393|NCT00090220|10681158|P2|Base Study Vaccination Period|Withdrawal by Subject|27
3122394|NCT00090220|10681159|P1|Base Study Vaccination Period|Withdrawal by Subject|23
3122395|NCT00090220|10681154|P6|Base Study Vaccination Period|Lost to Follow-up|0
3122396|NCT00090220|10681155|P5|Base Study Vaccination Period|Lost to Follow-up|0
3122397|NCT00090220|10681156|P4|Base Study Vaccination Period|Lost to Follow-up|0
3122398|NCT00090220|10681157|P3|Base Study Vaccination Period|Lost to Follow-up|0
3122399|NCT00090220|10681158|P2|Base Study Vaccination Period|Lost to Follow-up|28
3122400|NCT00090220|10681159|P1|Base Study Vaccination Period|Lost to Follow-up|24
3122401|NCT00090220|10681154|P6|Base Study Vaccination Period|Adverse Event|0
3122402|NCT00090220|10681155|P5|Base Study Vaccination Period|Adverse Event|0
3122403|NCT00090220|10681156|P4|Base Study Vaccination Period|Adverse Event|0
3122404|NCT00090220|10681157|P3|Base Study Vaccination Period|Adverse Event|0
3122405|NCT00090220|10681158|P2|Base Study Vaccination Period|Adverse Event|1
3122406|NCT00090220|10681159|P1|Base Study Vaccination Period|Adverse Event|6
3122407|NCT00090220|10681154|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
3122408|NCT00090220|10681155|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
3122409|NCT00090220|10681156|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
3122410|NCT00090220|10681157|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
3122411|NCT00090220|10681158|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
3122412|NCT00090220|10681159|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
3122413|NCT00090402|10681254|P3|Overall Study|stopped taking study medication|1
3122414|NCT00090402|10681255|P2|Overall Study|stopped taking study medication|0
3122415|NCT00090402|10681256|P1|Overall Study|stopped taking study medication|1
3122416|NCT00090402|10681254|P3|Overall Study|subject moved|0
3122417|NCT00090402|10681255|P2|Overall Study|subject moved|1
3122418|NCT00090402|10681256|P1|Overall Study|subject moved|0
3122419|NCT00090402|10681254|P3|Overall Study|Death|0
3122420|NCT00090402|10681255|P2|Overall Study|Death|1
3122421|NCT00090402|10681256|P1|Overall Study|Death|1
3122422|NCT00090142|10681270|P2|Treatment Period II|Other|0
3122423|NCT00090142|10681271|P1|Treatment Period II|Other|1
3122424|NCT00090142|10681270|P2|Treatment Period I|Other|1
3122425|NCT00090142|10681271|P1|Treatment Period I|Other|0
3122426|NCT00090142|10681270|P2|Treatment Period I|Withdrawal by Subject|0
3122427|NCT00090142|10681271|P1|Treatment Period I|Withdrawal by Subject|2
3122428|NCT00090142|10681270|P2|Treatment Period I|Protocol Violation|0
3122429|NCT00090142|10681271|P1|Treatment Period I|Protocol Violation|2
3122430|NCT00090142|10681270|P2|Treatment Period I|Lost to Follow-up|2
3122431|NCT00090142|10681271|P1|Treatment Period I|Lost to Follow-up|1
3122432|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Other|0
3122433|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Other|1
3122434|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Other|0
3122435|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Jailed|0
3122436|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Jailed|1
3122437|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Jailed|0
3122438|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
3122439|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
3122440|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
3122441|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Depression|0
3122442|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Depression|1
3122443|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Depression|0
3122444|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
3122445|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
3122446|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
3122447|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
3122448|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
3122449|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
3122450|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Back Pain|0
3122451|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Back Pain|1
3122452|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Back Pain|0
3122453|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
3122454|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
3122455|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
3122456|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
3122457|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
3122458|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
3122459|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
3122460|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
3122461|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
3122462|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Gyneomastia|0
3122463|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Gyneomastia|0
3122464|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Gyneomastia|1
3122465|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Death|1
3122466|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Death|0
3122467|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Death|1
3122468|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
3122469|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
3122470|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
3122471|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Enrollment Error|2
3122472|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Enrollment Error|0
3122473|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Enrollment Error|1
3122474|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Loss of Libido|0
3122475|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Loss of Libido|0
3122476|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Loss of Libido|1
3122477|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
3122478|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
3122479|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
3122480|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
3122481|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
3122482|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
3122483|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
3122484|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
3122485|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
3122486|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
3122487|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
3122488|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
3122489|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Participant relocated|1
3122490|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Participant relocated|3
3122491|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Participant relocated|2
3122492|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
3122493|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
3122494|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
3122495|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Loss of Contact|2
3122496|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Loss of Contact|0
3122497|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Loss of Contact|4
3122498|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
3122499|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
3122500|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
3122501|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
3122502|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
3122503|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
3122504|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Protocol Violation|17
3122505|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Protocol Violation|18
3122506|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Protocol Violation|18
3122507|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
3122508|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
3122509|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
3122510|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
3122511|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
3122512|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
3122513|NCT00090103|10681302|P3|16-Week Safety Follow-up Period|Adverse Event|44
3122514|NCT00090103|10681303|P2|16-Week Safety Follow-up Period|Adverse Event|39
3122515|NCT00090103|10681304|P1|16-Week Safety Follow-up Period|Adverse Event|34
3122516|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
3122517|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
3122518|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
3122519|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
3122520|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
3122521|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
3122522|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
3122523|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
3122524|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
3122525|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
3122526|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
3122527|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
3122528|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
3122529|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
3122530|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
3122531|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
3122532|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
3122533|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
3122534|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
3122535|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
3122536|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
3122537|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
3122538|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
3122539|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
3122540|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
3122541|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
3122542|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
3122543|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
3122544|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
3122545|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
3122546|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
3122547|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
3122548|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
3122549|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
3122550|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
3122551|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
3122552|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
3122553|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
3122554|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
3122555|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
3122556|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
3122557|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
3122558|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
3122559|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
3122560|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
3122561|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
3122562|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
3122563|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
3122564|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
3122565|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
3122566|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
3122567|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
3122568|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
3122569|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
3122570|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
3122571|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
3122572|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
3122573|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
3122574|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
3122575|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
3122576|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
3122577|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
3122578|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
3122579|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
3122580|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
3122581|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
3122582|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
3122583|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
3122584|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
3122585|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
3122586|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
3122587|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
3122588|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
3122589|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
3122590|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
3122591|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
3122592|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
3122593|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
3122594|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
3122595|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
3122596|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
3122597|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
3122598|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
3122599|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
3122600|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
3122601|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
3122602|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
3122603|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
3122604|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
3122605|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
3122606|NCT00090103|10681302|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
3122607|NCT00090103|10681303|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
3122608|NCT00090103|10681304|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
3122609|NCT00089999|10681470|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
3122610|NCT00089999|10681471|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
3122611|NCT00089999|10681470|P2|Overall Study|Patient Underwent Surgery|0
3122612|NCT00089999|10681471|P1|Overall Study|Patient Underwent Surgery|2
3122613|NCT00089999|10681470|P2|Overall Study|Physician Decision|2
3122614|NCT00089999|10681471|P1|Overall Study|Physician Decision|2
3122615|NCT00089999|10681470|P2|Overall Study|Clinical Progression|2
3122616|NCT00089999|10681471|P1|Overall Study|Clinical Progression|1
3122617|NCT00089999|10681470|P2|Overall Study|Poor General Condition|0
3122618|NCT00089999|10681471|P1|Overall Study|Poor General Condition|1
3122619|NCT00089999|10681470|P2|Overall Study|Death|3
3122620|NCT00089999|10681471|P1|Overall Study|Death|3
3122621|NCT00089999|10681470|P2|Overall Study|Symptomatic Progression of Cancer|5
3122622|NCT00089999|10681471|P1|Overall Study|Symptomatic Progression of Cancer|2
3122623|NCT00089999|10681470|P2|Overall Study|Radiological Progression of Cancer|44
3122624|NCT00089999|10681471|P1|Overall Study|Radiological Progression of Cancer|52
3122625|NCT00089999|10681470|P2|Overall Study|Lost to Follow-up|1
3122626|NCT00089999|10681471|P1|Overall Study|Lost to Follow-up|2
3122627|NCT00089999|10681470|P2|Overall Study|Withdrawal by Subject|4
3122628|NCT00089999|10681471|P1|Overall Study|Withdrawal by Subject|0
3122629|NCT00089999|10681470|P2|Overall Study|Adverse Event|7
3122630|NCT00089999|10681471|P1|Overall Study|Adverse Event|4
3122631|NCT00089986|10681494|P3|Overall Study|Withdrawal by Subject|2
3122632|NCT00089986|10681495|P2|Overall Study|Withdrawal by Subject|6
3122633|NCT00089986|10681496|P1|Overall Study|Withdrawal by Subject|3
3122634|NCT00089986|10681494|P3|Overall Study|Do not resuscitate (DNR)|1
3122635|NCT00089986|10681495|P2|Overall Study|Do not resuscitate (DNR)|0
3122636|NCT00089986|10681496|P1|Overall Study|Do not resuscitate (DNR)|0
3122637|NCT00089986|10681494|P3|Overall Study|Family decision|0
3122638|NCT00089986|10681495|P2|Overall Study|Family decision|1
3122639|NCT00089986|10681496|P1|Overall Study|Family decision|0
3122640|NCT00089986|10681494|P3|Overall Study|Enrollment in another study|0
3122641|NCT00089986|10681495|P2|Overall Study|Enrollment in another study|1
3122642|NCT00089986|10681496|P1|Overall Study|Enrollment in another study|0
3122643|NCT00089986|10681494|P3|Overall Study|Investigator decision to withdrew|0
3122644|NCT00089986|10681495|P2|Overall Study|Investigator decision to withdrew|1
3122645|NCT00089986|10681496|P1|Overall Study|Investigator decision to withdrew|0
3122646|NCT00089986|10681494|P3|Overall Study|Hemohlobin stopping rule|0
3122647|NCT00089986|10681495|P2|Overall Study|Hemohlobin stopping rule|1
3122648|NCT00089986|10681496|P1|Overall Study|Hemohlobin stopping rule|0
3122649|NCT00089986|10681494|P3|Overall Study|Subject withdrew but agreed follow up|0
3122650|NCT00089986|10681495|P2|Overall Study|Subject withdrew but agreed follow up|2
3122651|NCT00089986|10681496|P1|Overall Study|Subject withdrew but agreed follow up|1
3122652|NCT00089986|10681494|P3|Overall Study|Patient transferred to another hospital|0
3122653|NCT00089986|10681495|P2|Overall Study|Patient transferred to another hospital|1
3122654|NCT00089986|10681496|P1|Overall Study|Patient transferred to another hospital|2
3122655|NCT00089986|10681494|P3|Overall Study|Protocol Violation|0
3122656|NCT00089986|10681495|P2|Overall Study|Protocol Violation|1
3122657|NCT00089986|10681496|P1|Overall Study|Protocol Violation|0
3122658|NCT00089986|10681494|P3|Overall Study|Lost to Follow-up|1
3122659|NCT00089986|10681495|P2|Overall Study|Lost to Follow-up|1
3122660|NCT00089986|10681496|P1|Overall Study|Lost to Follow-up|3
3122661|NCT00089986|10681494|P3|Overall Study|Adverse Event|6
3122662|NCT00089986|10681495|P2|Overall Study|Adverse Event|9
3122663|NCT00089986|10681496|P1|Overall Study|Adverse Event|6
3122664|NCT00089973|10681513|P1|Overall Study|Death|1
3122665|NCT00089973|10681513|P1|Overall Study|Disease progression|45
3122666|NCT00089973|10681513|P1|Overall Study|Withdrawal by Subject|1
3122667|NCT00089973|10681513|P1|Overall Study|Adverse Event|3
3122668|NCT00089895|10681528|P2|Overall Study|Missing|2
3122669|NCT00089895|10681529|P1|Overall Study|Missing|4
3122670|NCT00089895|10681528|P2|Overall Study|Not otherwise specified|8
3122671|NCT00089895|10681529|P1|Overall Study|Not otherwise specified|4
3122672|NCT00089895|10681528|P2|Overall Study|Exclusion criteria met|6
3122673|NCT00089895|10681529|P1|Overall Study|Exclusion criteria met|6
3122674|NCT00089895|10681528|P2|Overall Study|Physician Decision|7
3122675|NCT00089895|10681529|P1|Overall Study|Physician Decision|3
3122676|NCT00089895|10681528|P2|Overall Study|Bleeding|2
3122677|NCT00089895|10681529|P1|Overall Study|Bleeding|0
3122678|NCT00089895|10681528|P2|Overall Study|Surgery|1
3122679|NCT00089895|10681529|P1|Overall Study|Surgery|0
3122680|NCT00089895|10681528|P2|Overall Study|Technical reason|2
3122681|NCT00089895|10681529|P1|Overall Study|Technical reason|7
3122682|NCT00089895|10681528|P2|Overall Study|Consent Withdrawn|14
3122683|NCT00089895|10681529|P1|Overall Study|Consent Withdrawn|11
3122684|NCT00089843|10681541|P4|Overall Study|Physician Decision|1
3122685|NCT00089843|10681542|P3|Overall Study|Physician Decision|0
3122686|NCT00089843|10681543|P2|Overall Study|Physician Decision|0
3122687|NCT00089843|10681544|P1|Overall Study|Physician Decision|1
3122688|NCT00089843|10681541|P4|Overall Study|Withdrawal by Subject|6
3122689|NCT00089843|10681542|P3|Overall Study|Withdrawal by Subject|5
3122690|NCT00089843|10681543|P2|Overall Study|Withdrawal by Subject|4
3122691|NCT00089843|10681544|P1|Overall Study|Withdrawal by Subject|1
3122692|NCT00089791|10681556|P2|Overall Study|Requirement for alternative therapy|4
3122693|NCT00089791|10681557|P1|Overall Study|Requirement for alternative therapy|7
3122694|NCT00089791|10681556|P2|Overall Study|Protocol deviation|10
3122695|NCT00089791|10681557|P1|Overall Study|Protocol deviation|12
3122696|NCT00089791|10681556|P2|Overall Study|Other|32
3122697|NCT00089791|10681557|P1|Overall Study|Other|20
3122698|NCT00089791|10681556|P2|Overall Study|Noncompliance|13
3122699|NCT00089791|10681557|P1|Overall Study|Noncompliance|17
3122700|NCT00089791|10681556|P2|Overall Study|Lost to Follow-up|57
3122701|NCT00089791|10681557|P1|Overall Study|Lost to Follow-up|57
3122702|NCT00089791|10681556|P2|Overall Study|Ineligibility determined|9
3122703|NCT00089791|10681557|P1|Overall Study|Ineligibility determined|12
3122704|NCT00089791|10681556|P2|Overall Study|Disease progression|3
3122705|NCT00089791|10681557|P1|Overall Study|Disease progression|7
3122706|NCT00089791|10681556|P2|Overall Study|Death|62
3122707|NCT00089791|10681557|P1|Overall Study|Death|78
3122708|NCT00089791|10681556|P2|Overall Study|Withdrawal by Subject|344
3122709|NCT00089791|10681557|P1|Overall Study|Withdrawal by Subject|403
3122710|NCT00089791|10681556|P2|Overall Study|Adverse Event|93
3122711|NCT00089791|10681557|P1|Overall Study|Adverse Event|81
3122712|NCT00089791|10681556|P2|Overall Study|Physician Decision|3
3122713|NCT00089791|10681557|P1|Overall Study|Physician Decision|6
3122714|NCT00089778|10681591|P3|Overall Study|Protocol Violation|1
3122715|NCT00089778|10681592|P2|Overall Study|Protocol Violation|0
3122716|NCT00089778|10681593|P1|Overall Study|Protocol Violation|0
3122717|NCT00089674|10681606|P2|Overall Study|Requirement for alternative therapy|4
3122718|NCT00089674|10681607|P1|Overall Study|Requirement for alternative therapy|14
3122719|NCT00089674|10681606|P2|Overall Study|Other|9
3122720|NCT00089674|10681607|P1|Overall Study|Other|5
3122721|NCT00089674|10681606|P2|Overall Study|Noncompliance|3
3122722|NCT00089674|10681607|P1|Overall Study|Noncompliance|7
3122723|NCT00089674|10681606|P2|Overall Study|Lost to Follow-up|17
3122724|NCT00089674|10681607|P1|Overall Study|Lost to Follow-up|21
3122725|NCT00089674|10681606|P2|Overall Study|Ineligibility determined|10
3122726|NCT00089674|10681607|P1|Overall Study|Ineligibility determined|8
3122727|NCT00089674|10681606|P2|Overall Study|Disease progression|23
3122728|NCT00089674|10681607|P1|Overall Study|Disease progression|21
3122729|NCT00089674|10681606|P2|Overall Study|Death|43
3122730|NCT00089674|10681607|P1|Overall Study|Death|43
3122731|NCT00089674|10681606|P2|Overall Study|Withdrawal by Subject|127
3122732|NCT00089674|10681607|P1|Overall Study|Withdrawal by Subject|143
3122733|NCT00089674|10681606|P2|Overall Study|Adverse Event|29
3122734|NCT00089674|10681607|P1|Overall Study|Adverse Event|23
3122735|NCT00089674|10681606|P2|Overall Study|Physician Decision|2
3122736|NCT00089674|10681607|P1|Overall Study|Physician Decision|4
3122737|NCT00089661|10681633|P2|Overall Study|Other|1
3122738|NCT00089661|10681634|P1|Overall Study|Other|2
3122739|NCT00089661|10681633|P2|Overall Study|Noncompliance|4
3122740|NCT00089661|10681634|P1|Overall Study|Noncompliance|2
3122741|NCT00089661|10681633|P2|Overall Study|Ineligibility determined|4
3122742|NCT00089661|10681634|P1|Overall Study|Ineligibility determined|4
3122743|NCT00089661|10681633|P2|Overall Study|Disease progression|3
3122744|NCT00089661|10681634|P1|Overall Study|Disease progression|1
3122745|NCT00089661|10681633|P2|Overall Study|Withdrawal by Subject|9
3122746|NCT00089661|10681634|P1|Overall Study|Withdrawal by Subject|11
3122747|NCT00089661|10681633|P2|Overall Study|Lost to Follow-up|3
3122748|NCT00089661|10681634|P1|Overall Study|Lost to Follow-up|0
3122749|NCT00089661|10681633|P2|Overall Study|Death|0
3122750|NCT00089661|10681634|P1|Overall Study|Death|1
3122751|NCT00089661|10681633|P2|Overall Study|Adverse Event|2
3122752|NCT00089661|10681634|P1|Overall Study|Adverse Event|0
3122753|NCT00089648|10681650|P1|Overall Study|Lack of Efficacy|33
3122754|NCT00089648|10681650|P1|Overall Study|Withdrawal by Subject|1
3122755|NCT00089648|10681650|P1|Overall Study|Adverse Event|7
3122756|NCT00089635|10681666|P1|Overall Study|Other|2
3122757|NCT00089635|10681666|P1|Overall Study|Ineligibility determined|1
3122758|NCT00089635|10681666|P1|Overall Study|Withdrawal by Subject|6
3122759|NCT00089635|10681666|P1|Overall Study|Lost to Follow-up|3
3122760|NCT00089635|10681666|P1|Overall Study|Disease Progression|12
3122761|NCT00089635|10681666|P1|Overall Study|Death|17
3122762|NCT00089635|10681666|P1|Overall Study|Adverse Event|2
3122763|NCT00089583|10681680|P2|Overall Study|Participant Incarcerated|1
3122764|NCT00089583|10681681|P1|Overall Study|Participant Incarcerated|0
3122765|NCT00089583|10681680|P2|Overall Study|Necessity to Use Prohibited Drug|0
3122766|NCT00089583|10681681|P1|Overall Study|Necessity to Use Prohibited Drug|1
3122767|NCT00089583|10681680|P2|Overall Study|Start of Disallowed Medication|1
3122768|NCT00089583|10681681|P1|Overall Study|Start of Disallowed Medication|0
3122769|NCT00089583|10681680|P2|Overall Study|Principal Investigator Decision|10
3122770|NCT00089583|10681681|P1|Overall Study|Principal Investigator Decision|0
3122771|NCT00089583|10681680|P2|Overall Study|Protocol Violation|3
3122772|NCT00089583|10681681|P1|Overall Study|Protocol Violation|0
3122773|NCT00089583|10681680|P2|Overall Study|Reason Not Provided|1
3122774|NCT00089583|10681681|P1|Overall Study|Reason Not Provided|0
3122775|NCT00089583|10681680|P2|Overall Study|Participant Management Criteria Met|1
3122776|NCT00089583|10681681|P1|Overall Study|Participant Management Criteria Met|0
3122777|NCT00089583|10681680|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
3122778|NCT00089583|10681681|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
3122779|NCT00089583|10681680|P2|Overall Study|Non-Compliance|4
3122780|NCT00089583|10681681|P1|Overall Study|Non-Compliance|0
3122781|NCT00089583|10681680|P2|Overall Study|Participant Refused Study Medication|2
3122782|NCT00089583|10681681|P1|Overall Study|Participant Refused Study Medication|0
3122783|NCT00089583|10681680|P2|Overall Study|Participant (Par) Didn't Take Medication|0
3122784|NCT00089583|10681681|P1|Overall Study|Participant (Par) Didn't Take Medication|1
3122785|NCT00089583|10681680|P2|Overall Study|Withdrawal by Subject|4
3122786|NCT00089583|10681681|P1|Overall Study|Withdrawal by Subject|0
3122787|NCT00089583|10681680|P2|Overall Study|Insufficient Viral Load Response|5
3122788|NCT00089583|10681681|P1|Overall Study|Insufficient Viral Load Response|5
3122789|NCT00089583|10681680|P2|Overall Study|Adverse Event|3
3122790|NCT00089583|10681681|P1|Overall Study|Adverse Event|0
3122791|NCT00089609|10681775|P2|Overall Study|Withdrawal by Subject|1
3122792|NCT00089609|10681776|P1|Overall Study|Withdrawal by Subject|3
3122793|NCT00089544|10681795|P2|Overall Study|Ineligible|0
3122794|NCT00089544|10681796|P1|Overall Study|Ineligible|1
3122795|NCT00089505|10681810|P4|Overall Study|Protocol Violation|0
3122796|NCT00089505|10681811|P3|Overall Study|Protocol Violation|1
3122797|NCT00089505|10681812|P2|Overall Study|Protocol Violation|0
3122798|NCT00089505|10681813|P1|Overall Study|Protocol Violation|0
3122799|NCT00089505|10681810|P4|Overall Study|Physician Decision|0
3122800|NCT00089505|10681811|P3|Overall Study|Physician Decision|0
3122801|NCT00089505|10681812|P2|Overall Study|Physician Decision|0
3122802|NCT00089505|10681813|P1|Overall Study|Physician Decision|1
3122803|NCT00089505|10681810|P4|Overall Study|Lost to Follow-up|7
3122804|NCT00089505|10681811|P3|Overall Study|Lost to Follow-up|9
3122805|NCT00089505|10681812|P2|Overall Study|Lost to Follow-up|1
3122806|NCT00089505|10681813|P1|Overall Study|Lost to Follow-up|1
3122807|NCT00089505|10681810|P4|Overall Study|Withdrawal by Subject|6
3122808|NCT00089505|10681811|P3|Overall Study|Withdrawal by Subject|6
3122809|NCT00089505|10681812|P2|Overall Study|Withdrawal by Subject|0
3122810|NCT00089505|10681813|P1|Overall Study|Withdrawal by Subject|3
3122811|NCT00089505|10681810|P4|Overall Study|Death|8
3122812|NCT00089505|10681811|P3|Overall Study|Death|5
3122813|NCT00089505|10681812|P2|Overall Study|Death|1
3122814|NCT00089505|10681813|P1|Overall Study|Death|4
3122815|NCT00089479|10681857|P2|Overall Study|Lost to Follow-up|107
3122816|NCT00089479|10681858|P1|Overall Study|Lost to Follow-up|137
3122817|NCT00089479|10681857|P2|Overall Study|Withdrawal by Subject|107
3122818|NCT00089479|10681858|P1|Overall Study|Withdrawal by Subject|86
3122819|NCT00089479|10681857|P2|Overall Study|Death|75
3122820|NCT00089479|10681858|P1|Overall Study|Death|108
3122821|NCT00089297|10681901|P1|Overall Study|Non-compliance|1
3122822|NCT00089297|10681901|P1|Overall Study|IRB approval not ready|1
3122823|NCT00089297|10681901|P1|Overall Study|Secondary malignancy|1
3122824|NCT00089297|10681901|P1|Overall Study|Ineligible|11
3122825|NCT00089297|10681901|P1|Overall Study|Disease progression|2
3122826|NCT00089297|10681901|P1|Overall Study|Withdrawal by Subject|12
3122827|NCT00089297|10681901|P1|Overall Study|Death|1
3122828|NCT00089297|10681901|P1|Overall Study|Adverse Event|9
3122829|NCT00089284|10681913|P7|Overall Study|Adverse event before starting treatment|1
3122830|NCT00089284|10681914|P6|Overall Study|Adverse event before starting treatment|0
3122831|NCT00089284|10681915|P5|Overall Study|Adverse event before starting treatment|0
3122832|NCT00089284|10681916|P4|Overall Study|Adverse event before starting treatment|0
3122833|NCT00089284|10681917|P3|Overall Study|Adverse event before starting treatment|0
3122834|NCT00089284|10681918|P2|Overall Study|Adverse event before starting treatment|0
3122835|NCT00089284|10681919|P1|Overall Study|Adverse event before starting treatment|0
3122836|NCT00089141|10681956|P2|Overall Study|Termination of trial|24
3122837|NCT00089141|10681957|P1|Overall Study|Termination of trial|18
3122838|NCT00089076|10681993|P1|Overall Study|Progression|7
3122839|NCT00089076|10681993|P1|Overall Study|Withdrawal by Subject|2
3122840|NCT00089076|10681993|P1|Overall Study|Alternate Therapy|1
3122841|NCT00088907|10682050|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
3122842|NCT00088907|10682051|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
3122843|NCT00088907|10682050|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
3122844|NCT00088907|10682051|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
3122845|NCT00088907|10682050|P2|Single Gefitinib Treatment (Step 2)|Death|0
3122846|NCT00088907|10682051|P1|Single Gefitinib Treatment (Step 2)|Death|1
3122847|NCT00088907|10682050|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
3122848|NCT00088907|10682051|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
3122849|NCT00088907|10682050|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
3122850|NCT00088907|10682051|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
3122851|NCT00088907|10682050|P2|Randomized Study (Step 1)|unknown/not specify|13
3122852|NCT00088907|10682051|P1|Randomized Study (Step 1)|unknown/not specify|24
3122853|NCT00088907|10682050|P2|Randomized Study (Step 1)|complicating disease|1
3122854|NCT00088907|10682051|P1|Randomized Study (Step 1)|complicating disease|3
3122855|NCT00088907|10682050|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
3122856|NCT00088907|10682051|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
3122857|NCT00088907|10682050|P2|Randomized Study (Step 1)|Death|12
3122858|NCT00088907|10682051|P1|Randomized Study (Step 1)|Death|11
3122859|NCT00088907|10682050|P2|Randomized Study (Step 1)|Adverse Event|19
3122860|NCT00088907|10682051|P1|Randomized Study (Step 1)|Adverse Event|14
3122861|NCT00088907|10682050|P2|Randomized Study (Step 1)|Lack of Efficacy|62
3122862|NCT00088907|10682051|P1|Randomized Study (Step 1)|Lack of Efficacy|55
3122863|NCT00088881|10682062|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
3122864|NCT00088881|10682062|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
3122865|NCT00088881|10682062|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
3122866|NCT00088881|10682062|P1|Step 1 - R-CHOP|Physician Decision|1
3122867|NCT00088881|10682062|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
3122868|NCT00088881|10682062|P1|Step 1 - R-CHOP|Adverse Event|1
3122869|NCT00088881|10682062|P1|Step 1 - R-CHOP|Patient ineligible|9
3122870|NCT00088829|10682071|P1|Overall Study|PI left institution and study was close|22
3122871|NCT00088595|10682113|P1|Overall Study|New Cancer Therapy|2
3122872|NCT00088595|10682113|P1|Overall Study|Ongoing (After Core)|7
3122873|NCT00088595|10682113|P1|Overall Study|Withdrawal by Subject|8
3122874|NCT00088595|10682113|P1|Overall Study|Adverse Event|11
3122875|NCT00088530|10682131|P2|Overall Study|Patient never treated|0
3122876|NCT00088530|10682132|P1|Overall Study|Patient never treated|1
3122877|NCT00088530|10682131|P2|Overall Study|Sponsor decision|1
3122878|NCT00088530|10682132|P1|Overall Study|Sponsor decision|0
3122879|NCT00088530|10682131|P2|Overall Study|Physician Decision|0
3122880|NCT00088530|10682132|P1|Overall Study|Physician Decision|2
3122881|NCT00088530|10682131|P2|Overall Study|Lost to Follow-up|0
3122882|NCT00088530|10682132|P1|Overall Study|Lost to Follow-up|2
3122883|NCT00088530|10682131|P2|Overall Study|Withdrawal by Subject|5
3122884|NCT00088530|10682132|P1|Overall Study|Withdrawal by Subject|2
3122885|NCT00088530|10682131|P2|Overall Study|Adverse Event|9
3122886|NCT00088530|10682132|P1|Overall Study|Adverse Event|15
3122887|NCT00088530|10682131|P2|Overall Study|Progressive/Relapsed Disease|39
3122888|NCT00088530|10682132|P1|Overall Study|Progressive/Relapsed Disease|28
3122889|NCT00088465|10682144|P1|Overall Study|Death|11
3122890|NCT00088465|10682144|P1|Overall Study|Protocol Violation|17
3122891|NCT00088465|10682144|P1|Overall Study|Lack of Efficacy|27
3122892|NCT00088465|10682144|P1|Overall Study|Sponsor Decision|37
3122893|NCT00088465|10682144|P1|Overall Study|Physician Decision|45
3122894|NCT00088465|10682144|P1|Overall Study|Lost to Follow-up|57
3122895|NCT00088465|10682144|P1|Overall Study|Adverse Event|77
3122896|NCT00088465|10682144|P1|Overall Study|Withdrawal by Subject|290
3122897|NCT00088413|10682171|P4|Overall Study|Patient unevaluable due to adverse event|0
3122898|NCT00088413|10682172|P3|Overall Study|Patient unevaluable due to adverse event|1
3122899|NCT00088413|10682173|P2|Overall Study|Patient unevaluable due to adverse event|0
3122900|NCT00088413|10682174|P1|Overall Study|Patient unevaluable due to adverse event|0
3122901|NCT00088413|10682171|P4|Overall Study|Other|0
3122902|NCT00088413|10682172|P3|Overall Study|Other|0
3122903|NCT00088413|10682173|P2|Overall Study|Other|1
3122904|NCT00088413|10682174|P1|Overall Study|Other|0
3122905|NCT00088413|10682171|P4|Overall Study|Progressive disease|14
3122906|NCT00088413|10682172|P3|Overall Study|Progressive disease|8
3122907|NCT00088413|10682173|P2|Overall Study|Progressive disease|11
3122908|NCT00088413|10682174|P1|Overall Study|Progressive disease|9
3122909|NCT00088413|10682171|P4|Overall Study|Death|0
3122910|NCT00088413|10682172|P3|Overall Study|Death|0
3122911|NCT00088413|10682173|P2|Overall Study|Death|1
3122912|NCT00088413|10682174|P1|Overall Study|Death|0
3122913|NCT00088413|10682171|P4|Overall Study|Off study due to missing a vaccine dose|0
3122914|NCT00088413|10682172|P3|Overall Study|Off study due to missing a vaccine dose|0
3122915|NCT00088413|10682173|P2|Overall Study|Off study due to missing a vaccine dose|0
3122916|NCT00088413|10682174|P1|Overall Study|Off study due to missing a vaccine dose|1
3122917|NCT00088413|10682171|P4|Overall Study|Refused trmt Off-study per pt wishes|0
3122918|NCT00088413|10682172|P3|Overall Study|Refused trmt Off-study per pt wishes|1
3122919|NCT00088413|10682173|P2|Overall Study|Refused trmt Off-study per pt wishes|1
3122920|NCT00088413|10682174|P1|Overall Study|Refused trmt Off-study per pt wishes|0
3122921|NCT00088413|10682171|P4|Overall Study|Adverse Events/Side Effects|0
3122922|NCT00088413|10682172|P3|Overall Study|Adverse Events/Side Effects|1
3122923|NCT00088413|10682173|P2|Overall Study|Adverse Events/Side Effects|1
3122924|NCT00088413|10682174|P1|Overall Study|Adverse Events/Side Effects|0
3122925|NCT00088413|10682171|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
3122926|NCT00088413|10682172|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
3122927|NCT00088413|10682173|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
3122928|NCT00088413|10682174|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
3122929|NCT00088374|10682188|P1|Overall Study|patient received <1 cycle only of 17AAG|1
3122930|NCT00088374|10682188|P1|Overall Study|patient did not receive any 17AAG|1
3122931|NCT00088166|10682208|P2|Overall Study|Withdrawal by Subject|5
3122932|NCT00088166|10682209|P1|Overall Study|Withdrawal by Subject|5
3122933|NCT00088166|10682208|P2|Overall Study|Patient deterioration|39
3122934|NCT00088166|10682209|P1|Overall Study|Patient deterioration|29
3122935|NCT00088166|10682208|P2|Overall Study|Protocol Violation|5
3122936|NCT00088166|10682209|P1|Overall Study|Protocol Violation|1
3122937|NCT00088166|10682208|P2|Overall Study|Physician Decision|1
3122938|NCT00088166|10682209|P1|Overall Study|Physician Decision|4
3122939|NCT00088166|10682208|P2|Overall Study|Lost to Follow-up|1
3122940|NCT00088166|10682209|P1|Overall Study|Lost to Follow-up|0
3122941|NCT00088166|10682208|P2|Overall Study|Death|1
3122942|NCT00088166|10682209|P1|Overall Study|Death|3
3122943|NCT00088166|10682208|P2|Overall Study|Adverse Event|9
3122944|NCT00088166|10682209|P1|Overall Study|Adverse Event|11
3122945|NCT00088153|10682233|P2|Overall Study|Lost to Follow-up|12
3122946|NCT00088153|10682234|P1|Overall Study|Lost to Follow-up|11
3122947|NCT00088153|10682233|P2|Overall Study|Withdrawal by Subject|10
3122948|NCT00088153|10682234|P1|Overall Study|Withdrawal by Subject|10
3122949|NCT00088153|10682233|P2|Overall Study|Physician Decision|3
3122950|NCT00088153|10682234|P1|Overall Study|Physician Decision|3
3122951|NCT00087698|10682244|P1|Overall Study|Protocol Violation|1
3122952|NCT00087698|10682244|P1|Overall Study|Death from Study Drug Toxicity|2
3122953|NCT00087698|10682244|P1|Overall Study|Death from Study Disease|2
3122954|NCT00087698|10682244|P1|Overall Study|Clinical Relapse|1
3122955|NCT00087698|10682244|P1|Overall Study|Protocol Entry Criteria Not Met|2
3122956|NCT00087698|10682244|P1|Overall Study|Lack of Efficacy, Physician Perception|3
3122957|NCT00087698|10682244|P1|Overall Study|Withdrawal by Subject|4
3122958|NCT00087698|10682244|P1|Overall Study|Adverse Event|4
3122959|NCT00087698|10682244|P1|Overall Study|Death from Other Causes|3
3122960|NCT00087698|10682244|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
3122961|NCT00087685|10682253|P1|Overall Study|Withdrawal by Subject|3
3122962|NCT00087685|10682253|P1|Overall Study|Progressive Disease|5
3122963|NCT00087685|10682253|P1|Overall Study|Non-Compliance|1
3122964|NCT00087685|10682253|P1|Overall Study|Adverse Event|5
3123051|NCT00087555|10682413|P2|Overall Study|Pregnancy|1
3122965|NCT00087646|10682266|P4|Overall Study|Violation of Selection Criteria at Entry|1
3122966|NCT00087646|10682267|P3|Overall Study|Violation of Selection Criteria at Entry|0
3122967|NCT00087646|10682268|P2|Overall Study|Violation of Selection Criteria at Entry|0
3122968|NCT00087646|10682269|P1|Overall Study|Violation of Selection Criteria at Entry|1
3122969|NCT00087646|10682266|P4|Overall Study|Other Protocol Violation|0
3122970|NCT00087646|10682267|P3|Overall Study|Other Protocol Violation|0
3122971|NCT00087646|10682268|P2|Overall Study|Other Protocol Violation|1
3122972|NCT00087646|10682269|P1|Overall Study|Other Protocol Violation|3
3122973|NCT00087646|10682266|P4|Overall Study|Administrative/Other|2
3122974|NCT00087646|10682267|P3|Overall Study|Administrative/Other|1
3122975|NCT00087646|10682268|P2|Overall Study|Administrative/Other|1
3122976|NCT00087646|10682269|P1|Overall Study|Administrative/Other|6
3122977|NCT00087646|10682266|P4|Overall Study|Failure to Return|3
3122978|NCT00087646|10682267|P3|Overall Study|Failure to Return|2
3122979|NCT00087646|10682268|P2|Overall Study|Failure to Return|2
3122980|NCT00087646|10682269|P1|Overall Study|Failure to Return|5
3122981|NCT00087646|10682266|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
3122982|NCT00087646|10682267|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
3122983|NCT00087646|10682268|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
3122984|NCT00087646|10682269|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
3122985|NCT00087646|10682266|P4|Overall Study|Insufficient therapeutic response|51
3122986|NCT00087646|10682267|P3|Overall Study|Insufficient therapeutic response|38
3122987|NCT00087646|10682268|P2|Overall Study|Insufficient therapeutic response|24
3122988|NCT00087646|10682269|P1|Overall Study|Insufficient therapeutic response|64
3122989|NCT00087646|10682266|P4|Overall Study|Withdrawal by Subject|2
3122990|NCT00087646|10682267|P3|Overall Study|Withdrawal by Subject|2
3122991|NCT00087646|10682268|P2|Overall Study|Withdrawal by Subject|1
3122992|NCT00087646|10682269|P1|Overall Study|Withdrawal by Subject|6
3122993|NCT00087646|10682266|P4|Overall Study|Death|0
3122994|NCT00087646|10682267|P3|Overall Study|Death|0
3122995|NCT00087646|10682268|P2|Overall Study|Death|1
3122996|NCT00087646|10682269|P1|Overall Study|Death|0
3122997|NCT00087646|10682266|P4|Overall Study|Adverse Event|20
3122998|NCT00087646|10682267|P3|Overall Study|Adverse Event|18
3122999|NCT00087646|10682268|P2|Overall Study|Adverse Event|6
3123000|NCT00087646|10682269|P1|Overall Study|Adverse Event|37
3123001|NCT00087607|10682308|P2|Overall Study|Violation of Selection Criteria at Entry|1
3123002|NCT00087607|10682309|P1|Overall Study|Violation of Selection Criteria at Entry|0
3123003|NCT00087607|10682308|P2|Overall Study|Other Protocol Violation|2
3123004|NCT00087607|10682309|P1|Overall Study|Other Protocol Violation|5
3123005|NCT00087607|10682308|P2|Overall Study|Refused Treatment|7
3123006|NCT00087607|10682309|P1|Overall Study|Refused Treatment|5
3123007|NCT00087607|10682308|P2|Overall Study|Administrative|12
3123008|NCT00087607|10682309|P1|Overall Study|Administrative|12
3123009|NCT00087607|10682308|P2|Overall Study|Withdrew Consent|16
3123010|NCT00087607|10682309|P1|Overall Study|Withdrew Consent|12
3123011|NCT00087607|10682308|P2|Overall Study|Failure to return|17
3123012|NCT00087607|10682309|P1|Overall Study|Failure to return|21
3123013|NCT00087607|10682308|P2|Overall Study|Insufficient Therapeutic Response|42
3123014|NCT00087607|10682309|P1|Overall Study|Insufficient Therapeutic Response|53
3123015|NCT00087607|10682308|P2|Overall Study|Death|1
3123016|NCT00087607|10682309|P1|Overall Study|Death|0
3123017|NCT00087607|10682308|P2|Overall Study|Adverse Event|24
3123018|NCT00087607|10682309|P1|Overall Study|Adverse Event|14
3123019|NCT00087594|10682349|P2|Overall Study|Lack of Efficacy|5
3123020|NCT00087594|10682350|P1|Overall Study|Lack of Efficacy|2
3123021|NCT00087594|10682349|P2|Overall Study|Withdrawal by Subject|2
3123022|NCT00087594|10682350|P1|Overall Study|Withdrawal by Subject|4
3123023|NCT00087594|10682349|P2|Overall Study|Lost to Follow-up|2
3123024|NCT00087594|10682350|P1|Overall Study|Lost to Follow-up|0
3123025|NCT00087594|10682349|P2|Overall Study|Adverse Event|3
3123026|NCT00087594|10682350|P1|Overall Study|Adverse Event|2
3123027|NCT00087568|10682384|P2|Overall Study|Lack of Efficacy|1
3123028|NCT00087568|10682385|P1|Overall Study|Lack of Efficacy|24
3123029|NCT00087568|10682384|P2|Overall Study|Lost to Follow-up|0
3123030|NCT00087568|10682385|P1|Overall Study|Lost to Follow-up|1
3123031|NCT00087568|10682384|P2|Overall Study|Withdrawal by Subject|1
3123032|NCT00087568|10682385|P1|Overall Study|Withdrawal by Subject|1
3123033|NCT00087568|10682384|P2|Overall Study|Adverse Event|0
3123034|NCT00087568|10682385|P1|Overall Study|Adverse Event|4
3123035|NCT00087555|10682412|P3|Overall Study|Patient wanted to go back on Med|0
3123036|NCT00087555|10682413|P2|Overall Study|Patient wanted to go back on Med|0
3123037|NCT00087555|10682414|P1|Overall Study|Patient wanted to go back on Med|1
3123038|NCT00087555|10682412|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
3123039|NCT00087555|10682413|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
3123040|NCT00087555|10682414|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
3123041|NCT00087555|10682412|P3|Overall Study|Non Compliance|1
3123042|NCT00087555|10682413|P2|Overall Study|Non Compliance|0
3123043|NCT00087555|10682414|P1|Overall Study|Non Compliance|0
3123044|NCT00087555|10682412|P3|Overall Study|Lack of Efficacy|1
3123045|NCT00087555|10682413|P2|Overall Study|Lack of Efficacy|0
3123046|NCT00087555|10682414|P1|Overall Study|Lack of Efficacy|2
3123047|NCT00087555|10682412|P3|Overall Study|Withdrawal by Subject|1
3123048|NCT00087555|10682413|P2|Overall Study|Withdrawal by Subject|2
3123049|NCT00087555|10682414|P1|Overall Study|Withdrawal by Subject|3
3123050|NCT00087555|10682412|P3|Overall Study|Pregnancy|1
3123052|NCT00087555|10682414|P1|Overall Study|Pregnancy|0
3123053|NCT00087555|10682412|P3|Overall Study|Screen Failure|0
3123054|NCT00087555|10682413|P2|Overall Study|Screen Failure|1
3123055|NCT00087555|10682414|P1|Overall Study|Screen Failure|1
3123056|NCT00087555|10682412|P3|Overall Study|Protocol Violation|2
3123057|NCT00087555|10682413|P2|Overall Study|Protocol Violation|0
3123058|NCT00087555|10682414|P1|Overall Study|Protocol Violation|0
3123059|NCT00087555|10682412|P3|Overall Study|Non - Compliance|0
3123060|NCT00087555|10682413|P2|Overall Study|Non - Compliance|0
3123061|NCT00087555|10682414|P1|Overall Study|Non - Compliance|1
3123062|NCT00087555|10682412|P3|Overall Study|Lost to Follow-up|1
3123063|NCT00087555|10682413|P2|Overall Study|Lost to Follow-up|1
3123064|NCT00087555|10682414|P1|Overall Study|Lost to Follow-up|0
3123065|NCT00087555|10682412|P3|Overall Study|Adverse Event|14
3123066|NCT00087555|10682413|P2|Overall Study|Adverse Event|6
3123067|NCT00087555|10682414|P1|Overall Study|Adverse Event|3
3123068|NCT00087529|10682424|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
3123069|NCT00087529|10682425|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
3123070|NCT00087529|10682424|P2|Overall Study|Disease Progression|4
3123071|NCT00087529|10682425|P1|Overall Study|Disease Progression|5
3123072|NCT00087529|10682424|P2|Overall Study|Participant Noncompliance|1
3123073|NCT00087529|10682425|P1|Overall Study|Participant Noncompliance|0
3123074|NCT00087529|10682424|P2|Overall Study|Initiation of Excluded Therapy|1
3123075|NCT00087529|10682425|P1|Overall Study|Initiation of Excluded Therapy|0
3123076|NCT00087529|10682424|P2|Overall Study|Physician Decision|8
3123077|NCT00087529|10682425|P1|Overall Study|Physician Decision|4
3123078|NCT00087529|10682424|P2|Overall Study|Participant Decision|37
3123079|NCT00087529|10682425|P1|Overall Study|Participant Decision|14
3123080|NCT00087529|10682424|P2|Overall Study|Lost to Follow-up|3
3123081|NCT00087529|10682425|P1|Overall Study|Lost to Follow-up|2
3123082|NCT00087529|10682424|P2|Overall Study|Pregnancy|1
3123083|NCT00087529|10682425|P1|Overall Study|Pregnancy|0
3123084|NCT00087529|10682424|P2|Overall Study|Adverse Event|8
3123085|NCT00087529|10682425|P1|Overall Study|Adverse Event|0
3123086|NCT00087529|10682424|P2|Overall Study|Death|0
3123087|NCT00087529|10682425|P1|Overall Study|Death|1
3123088|NCT00087516|10682440|P4|Overall Study|Other|0
3123089|NCT00087516|10682441|P3|Overall Study|Other|1
3123090|NCT00087516|10682442|P2|Overall Study|Other|0
3123091|NCT00087516|10682443|P1|Overall Study|Other|0
3123092|NCT00087516|10682440|P4|Overall Study|Recommendation of Primary Care Physician|1
3123093|NCT00087516|10682441|P3|Overall Study|Recommendation of Primary Care Physician|0
3123094|NCT00087516|10682442|P2|Overall Study|Recommendation of Primary Care Physician|0
3123095|NCT00087516|10682443|P1|Overall Study|Recommendation of Primary Care Physician|0
3123096|NCT00087516|10682440|P4|Overall Study|Patient was non-compliant|0
3123097|NCT00087516|10682441|P3|Overall Study|Patient was non-compliant|0
3123098|NCT00087516|10682442|P2|Overall Study|Patient was non-compliant|1
3123099|NCT00087516|10682443|P1|Overall Study|Patient was non-compliant|3
3123100|NCT00087516|10682440|P4|Overall Study|Patient moved|0
3123101|NCT00087516|10682441|P3|Overall Study|Patient moved|1
3123102|NCT00087516|10682442|P2|Overall Study|Patient moved|2
3123103|NCT00087516|10682443|P1|Overall Study|Patient moved|3
3123104|NCT00087516|10682440|P4|Overall Study|Protocol specified discontinuation|26
3123105|NCT00087516|10682441|P3|Overall Study|Protocol specified discontinuation|33
3123106|NCT00087516|10682442|P2|Overall Study|Protocol specified discontinuation|33
3123107|NCT00087516|10682443|P1|Overall Study|Protocol specified discontinuation|35
3123108|NCT00087516|10682440|P4|Overall Study|Site terminated|0
3123109|NCT00087516|10682441|P3|Overall Study|Site terminated|1
3123110|NCT00087516|10682442|P2|Overall Study|Site terminated|2
3123111|NCT00087516|10682443|P1|Overall Study|Site terminated|0
3123112|NCT00087516|10682440|P4|Overall Study|Withdrawal by Subject|12
3123113|NCT00087516|10682441|P3|Overall Study|Withdrawal by Subject|11
3123114|NCT00087516|10682442|P2|Overall Study|Withdrawal by Subject|27
3123115|NCT00087516|10682443|P1|Overall Study|Withdrawal by Subject|16
3123116|NCT00087516|10682440|P4|Overall Study|Protocol Violation|6
3123117|NCT00087516|10682441|P3|Overall Study|Protocol Violation|3
3123118|NCT00087516|10682442|P2|Overall Study|Protocol Violation|8
3123119|NCT00087516|10682443|P1|Overall Study|Protocol Violation|4
3123120|NCT00087516|10682440|P4|Overall Study|Lost to Follow-up|5
3123121|NCT00087516|10682441|P3|Overall Study|Lost to Follow-up|5
3123122|NCT00087516|10682442|P2|Overall Study|Lost to Follow-up|6
3123123|NCT00087516|10682443|P1|Overall Study|Lost to Follow-up|8
3123124|NCT00087516|10682440|P4|Overall Study|Lack of Efficacy|29
3123125|NCT00087516|10682441|P3|Overall Study|Lack of Efficacy|39
3123126|NCT00087516|10682442|P2|Overall Study|Lack of Efficacy|80
3123127|NCT00087516|10682443|P1|Overall Study|Lack of Efficacy|82
3123128|NCT00087516|10682440|P4|Overall Study|Adverse Event|6
3123129|NCT00087516|10682441|P3|Overall Study|Adverse Event|3
3123130|NCT00087516|10682442|P2|Overall Study|Adverse Event|10
3123131|NCT00087516|10682443|P1|Overall Study|Adverse Event|10
3123132|NCT00087490|10682472|P2|Overall Study|Randomized but not treated|18
3123133|NCT00087490|10682473|P1|Overall Study|Randomized but not treated|7
3123134|NCT00087490|10682472|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
3123135|NCT00087490|10682473|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
3123136|NCT00087490|10682472|P2|Overall Study|Protocol Violation or (/) Unspecified|201
3123137|NCT00087490|10682473|P1|Overall Study|Protocol Violation or (/) Unspecified|214
3123138|NCT00087490|10682472|P2|Overall Study|Lack of Efficacy|2
3123139|NCT00087490|10682473|P1|Overall Study|Lack of Efficacy|0
3123140|NCT00087490|10682472|P2|Overall Study|Adverse Event|8
3123141|NCT00087490|10682473|P1|Overall Study|Adverse Event|3
3123142|NCT00087490|10682472|P2|Overall Study|Death|4
3123143|NCT00087490|10682473|P1|Overall Study|Death|6
3123144|NCT00087438|10682507|P1|Overall Study|Ineligible / No protocol treatment|4
3123145|NCT00087152|10682517|P1|Overall Study|Ineligible|6
3123146|NCT00087139|10682526|P3|Overall Study|Extradural disease|1
3123147|NCT00087139|10682527|P2|Overall Study|Extradural disease|0
3123148|NCT00087139|10682528|P1|Overall Study|Extradural disease|0
3123149|NCT00087139|10682526|P3|Overall Study|Response achieved|0
3123150|NCT00087139|10682527|P2|Overall Study|Response achieved|1
3123151|NCT00087139|10682528|P1|Overall Study|Response achieved|0
3123152|NCT00087139|10682526|P3|Overall Study|Use of coumadin|0
3123153|NCT00087139|10682527|P2|Overall Study|Use of coumadin|0
3123154|NCT00087139|10682528|P1|Overall Study|Use of coumadin|1
3123155|NCT00087139|10682526|P3|Overall Study|Symptomatic deterioration|3
3123156|NCT00087139|10682527|P2|Overall Study|Symptomatic deterioration|1
3123157|NCT00087139|10682528|P1|Overall Study|Symptomatic deterioration|1
3123158|NCT00087139|10682526|P3|Overall Study|Ineligible|4
3123159|NCT00087139|10682527|P2|Overall Study|Ineligible|7
3123160|NCT00087139|10682528|P1|Overall Study|Ineligible|4
3123161|NCT00087139|10682526|P3|Overall Study|Disease progression|12
3123162|NCT00087139|10682527|P2|Overall Study|Disease progression|19
3123163|NCT00087139|10682528|P1|Overall Study|Disease progression|9
3123164|NCT00087139|10682526|P3|Overall Study|Physician Decision|1
3123165|NCT00087139|10682527|P2|Overall Study|Physician Decision|1
3123166|NCT00087139|10682528|P1|Overall Study|Physician Decision|1
3123167|NCT00087139|10682526|P3|Overall Study|Withdrawal by Subject|2
3123168|NCT00087139|10682527|P2|Overall Study|Withdrawal by Subject|2
3123169|NCT00087139|10682528|P1|Overall Study|Withdrawal by Subject|3
3123170|NCT00087139|10682526|P3|Overall Study|Death|0
3123171|NCT00087139|10682527|P2|Overall Study|Death|1
3123172|NCT00087139|10682528|P1|Overall Study|Death|2
3123173|NCT00087139|10682526|P3|Overall Study|Adverse Event|13
3123174|NCT00087139|10682527|P2|Overall Study|Adverse Event|17
3123175|NCT00087139|10682528|P1|Overall Study|Adverse Event|18
3123176|NCT00087126|10682543|P1|Overall Study|Never treated|1
3123177|NCT00087126|10682543|P1|Overall Study|Ineligible - second primary|1
3123178|NCT00086996|10682568|P1|Overall Study|not eligible|5
3123179|NCT00086996|10682568|P1|Overall Study|Other|6
3123180|NCT00086996|10682568|P1|Overall Study|Withdrawal by Subject|13
3123181|NCT00086996|10682568|P1|Overall Study|progression/relapse|7
3123182|NCT00086996|10682568|P1|Overall Study|Death|4
3123183|NCT00086996|10682568|P1|Overall Study|Adverse Event|29
3123184|NCT00086684|10682590|P3|Overall Study|Other|3
3123185|NCT00086684|10682591|P2|Overall Study|Other|2
3123186|NCT00086684|10682592|P1|Overall Study|Other|4
3123187|NCT00086684|10682590|P3|Overall Study|WITHDRAWAL OF CONSENT|5
3123188|NCT00086684|10682591|P2|Overall Study|WITHDRAWAL OF CONSENT|7
3123189|NCT00086684|10682592|P1|Overall Study|WITHDRAWAL OF CONSENT|5
3123190|NCT00086684|10682590|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
3123191|NCT00086684|10682591|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
3123192|NCT00086684|10682592|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
3123193|NCT00086684|10682590|P3|Overall Study|NONCOMPLIANCE|6
3123194|NCT00086684|10682591|P2|Overall Study|NONCOMPLIANCE|7
3123195|NCT00086684|10682592|P1|Overall Study|NONCOMPLIANCE|5
3123196|NCT00086684|10682590|P3|Overall Study|Withdrawal by Subject|10
3123197|NCT00086684|10682591|P2|Overall Study|Withdrawal by Subject|4
3123198|NCT00086684|10682592|P1|Overall Study|Withdrawal by Subject|0
3123199|NCT00086684|10682590|P3|Overall Study|Protocol Violation|0
3123200|NCT00086684|10682591|P2|Overall Study|Protocol Violation|3
3123201|NCT00086684|10682592|P1|Overall Study|Protocol Violation|8
3123202|NCT00086684|10682590|P3|Overall Study|Lost to Follow-up|10
3123203|NCT00086684|10682591|P2|Overall Study|Lost to Follow-up|8
3123204|NCT00086684|10682592|P1|Overall Study|Lost to Follow-up|15
3123205|NCT00086684|10682590|P3|Overall Study|Lack of Efficacy|5
3123206|NCT00086684|10682591|P2|Overall Study|Lack of Efficacy|6
3123207|NCT00086684|10682592|P1|Overall Study|Lack of Efficacy|6
3123208|NCT00086684|10682590|P3|Overall Study|Adverse Event|14
3123209|NCT00086684|10682591|P2|Overall Study|Adverse Event|17
3123210|NCT00086684|10682592|P1|Overall Study|Adverse Event|12
3123211|NCT00086619|10682605|P2|Overall Study|Protocol Violation|1
3123212|NCT00086619|10682606|P1|Overall Study|Protocol Violation|1
3123213|NCT00086619|10682605|P2|Overall Study|Adverse Event|10
3123214|NCT00086619|10682606|P1|Overall Study|Adverse Event|8
3123215|NCT00086619|10682605|P2|Overall Study|Withdrawal by Subject|6
3123216|NCT00086619|10682606|P1|Overall Study|Withdrawal by Subject|6
3123217|NCT00086580|10682616|P2|Observation Period|Other|7
3123218|NCT00086580|10682617|P1|Observation Period|Other|8
3123219|NCT00086580|10682616|P2|Observation Period|Death|55
3123220|NCT00086580|10682617|P1|Observation Period|Death|33
3123221|NCT00086580|10682616|P2|Observation Period|Withdrawal by Subject|2
3123222|NCT00086580|10682617|P1|Observation Period|Withdrawal by Subject|4
3123223|NCT00086580|10682616|P2|Observation Period|Unable to comply with protocol|1
3123224|NCT00086580|10682617|P1|Observation Period|Unable to comply with protocol|1
3123225|NCT00086580|10682616|P2|Follow-up Period|Other|6
3123226|NCT00086580|10682617|P1|Follow-up Period|Other|7
3123227|NCT00086580|10682616|P2|Follow-up Period|Death|7
3123228|NCT00086580|10682617|P1|Follow-up Period|Death|13
3123229|NCT00086580|10682616|P2|Follow-up Period|AE - not related|0
3123230|NCT00086580|10682617|P1|Follow-up Period|AE - not related|1
3123231|NCT00086580|10682616|P2|Follow-up Period|Physician Decision|1
3123232|NCT00086580|10682617|P1|Follow-up Period|Physician Decision|0
3123233|NCT00086580|10682616|P2|Follow-up Period|Withdrawal by Subject|6
3123234|NCT00086580|10682617|P1|Follow-up Period|Withdrawal by Subject|6
3123235|NCT00086580|10682616|P2|Follow-up Period|Unable to comply with protocol|0
3123236|NCT00086580|10682617|P1|Follow-up Period|Unable to comply with protocol|5
3123237|NCT00086580|10682616|P2|Follow-up Period|Disease progression|99
3123238|NCT00086580|10682617|P1|Follow-up Period|Disease progression|72
3123239|NCT00086580|10682616|P2|Treatment Period|Other|3
3123240|NCT00086580|10682617|P1|Treatment Period|Other|5
3123241|NCT00086580|10682616|P2|Treatment Period|Death|7
3123242|NCT00086580|10682617|P1|Treatment Period|Death|5
3123243|NCT00086580|10682616|P2|Treatment Period|Anemia or thrombocytopenia|4
3123244|NCT00086580|10682617|P1|Treatment Period|Anemia or thrombocytopenia|1
3123245|NCT00086580|10682616|P2|Treatment Period|Toxicity - treatment related|15
3123246|NCT00086580|10682617|P1|Treatment Period|Toxicity - treatment related|15
3123247|NCT00086580|10682616|P2|Treatment Period|AE - not treatment related|7
3123248|NCT00086580|10682617|P1|Treatment Period|AE - not treatment related|7
3123249|NCT00086580|10682616|P2|Treatment Period|Physician Decision|7
3123250|NCT00086580|10682617|P1|Treatment Period|Physician Decision|13
3123251|NCT00086580|10682616|P2|Treatment Period|Withdrawal by Subject|8
3123252|NCT00086580|10682617|P1|Treatment Period|Withdrawal by Subject|7
3123253|NCT00086580|10682616|P2|Treatment Period|Unable to comply with protocol|1
3123254|NCT00086580|10682617|P1|Treatment Period|Unable to comply with protocol|3
3123255|NCT00086580|10682616|P2|Treatment Period|Disease progression|8
3123256|NCT00086580|10682617|P1|Treatment Period|Disease progression|9
3123257|NCT00086411|10682665|P4|Overall Study|Lost to Follow-up|12
3123258|NCT00086411|10682666|P3|Overall Study|Lost to Follow-up|13
3123259|NCT00086411|10682667|P2|Overall Study|Lost to Follow-up|11
3123260|NCT00086411|10682668|P1|Overall Study|Lost to Follow-up|11
3123261|NCT00086385|10682686|P4|Overall Study|Death|1
3123262|NCT00086385|10682687|P3|Overall Study|Death|1
3123263|NCT00086385|10682688|P2|Overall Study|Death|2
3123264|NCT00086385|10682689|P1|Overall Study|Death|2
3123265|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Discontinued in error|0
3123266|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Discontinued in error|1
3123267|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
3123268|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
3123269|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
3123270|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
3123271|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Patient Died|1
3123272|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Patient Died|3
3123273|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
3123274|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
3123275|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
3123276|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
3123277|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Patient Moved|2
3123278|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Patient Moved|2
3123279|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
3123280|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
3123281|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Protocol Violation|0
3123282|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Protocol Violation|1
3123283|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Physician Decision|0
3123284|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Physician Decision|3
3123285|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
3123286|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
3123287|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
3123288|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
3123289|NCT00086515|10682701|P2|Phase B (Weeks 24-104)|Adverse Event|10
3123290|NCT00086515|10682702|P1|Phase B (Weeks 24-104)|Adverse Event|16
3123291|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
3123292|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
3123293|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Poor compliance|0
3123294|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Poor compliance|1
3123295|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
3123296|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
3123297|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
3123298|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
3123299|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Protocol Violation|1
3123300|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Protocol Violation|0
3123301|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
3123302|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
3123303|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
3123304|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
3123305|NCT00086515|10682701|P2|Phase A to Phase B Transition Period|Adverse Event|1
3123306|NCT00086515|10682702|P1|Phase A to Phase B Transition Period|Adverse Event|2
3123307|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
3123308|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
3123309|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
3123310|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
3123311|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Poor compliance|0
3123312|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Poor compliance|1
3123313|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
3123314|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
3123315|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Patient Moved|3
3123316|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Patient Moved|2
3123317|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
3123318|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
3123319|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Protocol Violation|1
3123320|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Protocol Violation|3
3123321|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
3123322|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
3123323|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
3123324|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
3123325|NCT00086515|10682701|P2|Phase A (Weeks 0-24)|Adverse Event|9
3123326|NCT00086515|10682702|P1|Phase A (Weeks 0-24)|Adverse Event|17
3123327|NCT00086502|10682714|P2|Overall Study|Patient Accidentally Unblinded|0
3123328|NCT00086502|10682715|P1|Overall Study|Patient Accidentally Unblinded|1
3123329|NCT00086502|10682714|P2|Overall Study|Protocol Discontinuation Criteria|3
3123330|NCT00086502|10682715|P1|Overall Study|Protocol Discontinuation Criteria|1
3123331|NCT00086502|10682714|P2|Overall Study|Patient Moved|1
3123332|NCT00086502|10682715|P1|Overall Study|Patient Moved|1
3123333|NCT00086502|10682714|P2|Overall Study|Withdrawal by Subject|6
3123334|NCT00086502|10682715|P1|Overall Study|Withdrawal by Subject|5
3123335|NCT00086502|10682714|P2|Overall Study|Protocol Violation|3
3123336|NCT00086502|10682715|P1|Overall Study|Protocol Violation|3
3123337|NCT00086502|10682714|P2|Overall Study|Pregnancy|1
3123338|NCT00086502|10682715|P1|Overall Study|Pregnancy|0
3123339|NCT00086502|10682714|P2|Overall Study|Physician Decision|1
3123340|NCT00086502|10682715|P1|Overall Study|Physician Decision|1
3123341|NCT00086502|10682714|P2|Overall Study|Lost to Follow-up|1
3123342|NCT00086502|10682715|P1|Overall Study|Lost to Follow-up|3
3123343|NCT00086502|10682714|P2|Overall Study|Lack of Efficacy|2
3123344|NCT00086502|10682715|P1|Overall Study|Lack of Efficacy|0
3123345|NCT00086502|10682714|P2|Overall Study|Adverse Event|2
3123346|NCT00086502|10682715|P1|Overall Study|Adverse Event|11
3123347|NCT00086346|10682740|P2|Patients Dosed With Test Article|Lack of Efficacy|0
3123348|NCT00086346|10682741|P1|Patients Dosed With Test Article|Lack of Efficacy|11
3123349|NCT00086346|10682740|P2|Patients Dosed With Test Article|Protocol Violation|3
3123350|NCT00086346|10682741|P1|Patients Dosed With Test Article|Protocol Violation|11
3123351|NCT00086346|10682740|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
3123352|NCT00086346|10682741|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
3123353|NCT00086346|10682740|P2|Patients Dosed With Test Article|Nonmedical event|3
3123354|NCT00086346|10682741|P1|Patients Dosed With Test Article|Nonmedical event|7
3123355|NCT00086346|10682740|P2|Patients Dosed With Test Article|Lost to Follow-up|3
3123356|NCT00086346|10682741|P1|Patients Dosed With Test Article|Lost to Follow-up|1
3123357|NCT00086346|10682740|P2|Patients Dosed With Test Article|Adverse Event|11
3123358|NCT00086346|10682741|P1|Patients Dosed With Test Article|Adverse Event|94
3123359|NCT00086346|10682740|P2|Randomization|Did not receive test article|4
3123360|NCT00086346|10682741|P1|Randomization|Did not receive test article|4
3123361|NCT00086281|10682768|P15|Phase 2|Adverse Event|0
3123362|NCT00086281|10682769|P14|Phase 2|Adverse Event|1
3123363|NCT00086281|10682770|P13|Phase 2|Adverse Event|1
3123364|NCT00086281|10682771|P12|Phase 2|Adverse Event|0
3123365|NCT00086281|10682772|P11|Phase 2|Adverse Event|0
3123366|NCT00086281|10682773|P10|Phase 2|Adverse Event|0
3123367|NCT00086281|10682774|P9|Phase 2|Adverse Event|0
3123368|NCT00086281|10682775|P8|Phase 2|Adverse Event|0
3123369|NCT00086281|10682776|P7|Phase 2|Adverse Event|0
3123370|NCT00086281|10682777|P6|Phase 2|Adverse Event|0
3123371|NCT00086281|10682778|P5|Phase 2|Adverse Event|0
3123372|NCT00086281|10682779|P4|Phase 2|Adverse Event|0
3123373|NCT00086281|10682780|P3|Phase 2|Adverse Event|0
3123374|NCT00086281|10682781|P2|Phase 2|Adverse Event|0
3123375|NCT00086281|10682782|P1|Phase 2|Adverse Event|0
3123376|NCT00086281|10682768|P15|Phase 1|Serious Adverse Event|1
3123377|NCT00086281|10682769|P14|Phase 1|Serious Adverse Event|0
3123378|NCT00086281|10682770|P13|Phase 1|Serious Adverse Event|0
3123379|NCT00086281|10682771|P12|Phase 1|Serious Adverse Event|0
3123380|NCT00086281|10682772|P11|Phase 1|Serious Adverse Event|0
3123381|NCT00086281|10682773|P10|Phase 1|Serious Adverse Event|0
3123382|NCT00086281|10682774|P9|Phase 1|Serious Adverse Event|0
3123383|NCT00086281|10682775|P8|Phase 1|Serious Adverse Event|0
3123384|NCT00086281|10682776|P7|Phase 1|Serious Adverse Event|0
3123385|NCT00086281|10682777|P6|Phase 1|Serious Adverse Event|0
3123386|NCT00086281|10682778|P5|Phase 1|Serious Adverse Event|0
3123387|NCT00086281|10682779|P4|Phase 1|Serious Adverse Event|0
3123388|NCT00086281|10682780|P3|Phase 1|Serious Adverse Event|0
3123389|NCT00086281|10682781|P2|Phase 1|Serious Adverse Event|0
3123390|NCT00086281|10682782|P1|Phase 1|Serious Adverse Event|0
3123391|NCT00086281|10682768|P15|Phase 1|Protocol Violation|0
3123392|NCT00086281|10682769|P14|Phase 1|Protocol Violation|0
3123393|NCT00086281|10682770|P13|Phase 1|Protocol Violation|0
3123394|NCT00086281|10682771|P12|Phase 1|Protocol Violation|0
3123395|NCT00086281|10682772|P11|Phase 1|Protocol Violation|1
3123396|NCT00086281|10682773|P10|Phase 1|Protocol Violation|0
3123397|NCT00086281|10682774|P9|Phase 1|Protocol Violation|0
3123398|NCT00086281|10682775|P8|Phase 1|Protocol Violation|0
3123399|NCT00086281|10682776|P7|Phase 1|Protocol Violation|0
3123400|NCT00086281|10682777|P6|Phase 1|Protocol Violation|0
3123401|NCT00086281|10682778|P5|Phase 1|Protocol Violation|0
3123402|NCT00086281|10682779|P4|Phase 1|Protocol Violation|0
3123403|NCT00086281|10682780|P3|Phase 1|Protocol Violation|0
3123404|NCT00086281|10682781|P2|Phase 1|Protocol Violation|0
3123405|NCT00086281|10682782|P1|Phase 1|Protocol Violation|0
3123406|NCT00086281|10682768|P15|Phase 1|Adverse Event|2
3123407|NCT00086281|10682769|P14|Phase 1|Adverse Event|1
3123408|NCT00086281|10682770|P13|Phase 1|Adverse Event|1
3123409|NCT00086281|10682771|P12|Phase 1|Adverse Event|1
3123410|NCT00086281|10682772|P11|Phase 1|Adverse Event|2
3123411|NCT00086281|10682773|P10|Phase 1|Adverse Event|1
3123412|NCT00086281|10682774|P9|Phase 1|Adverse Event|0
3123413|NCT00086281|10682775|P8|Phase 1|Adverse Event|0
3123414|NCT00086281|10682776|P7|Phase 1|Adverse Event|0
3123415|NCT00086281|10682777|P6|Phase 1|Adverse Event|0
3123416|NCT00086281|10682778|P5|Phase 1|Adverse Event|0
3123417|NCT00086281|10682779|P4|Phase 1|Adverse Event|0
3123418|NCT00086281|10682780|P3|Phase 1|Adverse Event|0
3123419|NCT00086281|10682781|P2|Phase 1|Adverse Event|0
3123420|NCT00086281|10682782|P1|Phase 1|Adverse Event|0
3123421|NCT00086307|10682795|P3|Overall Study|Withdrawal by Subject|2
3123422|NCT00086307|10682796|P2|Overall Study|Withdrawal by Subject|0
3123423|NCT00086307|10682797|P1|Overall Study|Withdrawal by Subject|0
3123424|NCT00086307|10682795|P3|Overall Study|Fatigue and difficulty falling asleep|1
3123425|NCT00086307|10682796|P2|Overall Study|Fatigue and difficulty falling asleep|0
3123426|NCT00086307|10682797|P1|Overall Study|Fatigue and difficulty falling asleep|0
3123427|NCT00086307|10682795|P3|Overall Study|Suicidal ideation|1
3123428|NCT00086307|10682796|P2|Overall Study|Suicidal ideation|0
3123429|NCT00086307|10682797|P1|Overall Study|Suicidal ideation|0
3123430|NCT00086307|10682795|P3|Overall Study|Constipation and sleepiness|1
3123431|NCT00086307|10682796|P2|Overall Study|Constipation and sleepiness|0
3123432|NCT00086307|10682797|P1|Overall Study|Constipation and sleepiness|0
3123433|NCT00086307|10682795|P3|Overall Study|Nausea and headaches|1
3123434|NCT00086307|10682796|P2|Overall Study|Nausea and headaches|0
3123435|NCT00086307|10682797|P1|Overall Study|Nausea and headaches|0
3123436|NCT00086307|10682795|P3|Overall Study|Shortness of breath and muscle spasms|0
3123437|NCT00086307|10682796|P2|Overall Study|Shortness of breath and muscle spasms|0
3123438|NCT00086307|10682797|P1|Overall Study|Shortness of breath and muscle spasms|1
3123439|NCT00086307|10682795|P3|Overall Study|Lack of Efficacy|2
3123440|NCT00086307|10682796|P2|Overall Study|Lack of Efficacy|1
3123441|NCT00086307|10682797|P1|Overall Study|Lack of Efficacy|1
3123442|NCT00086190|10682808|P3|Overall Study|Worsening depression|2
3123443|NCT00086190|10682809|P2|Overall Study|Worsening depression|0
3123444|NCT00086190|10682810|P1|Overall Study|Worsening depression|0
3123445|NCT00086190|10682808|P3|Overall Study|Moved|0
3123446|NCT00086190|10682809|P2|Overall Study|Moved|0
3123447|NCT00086190|10682810|P1|Overall Study|Moved|1
3123448|NCT00086190|10682808|P3|Overall Study|Protocol Violation|0
3123449|NCT00086190|10682809|P2|Overall Study|Protocol Violation|0
3123450|NCT00086190|10682810|P1|Overall Study|Protocol Violation|1
3123451|NCT00086190|10682808|P3|Overall Study|Withdrawal by Subject|2
3123452|NCT00086190|10682809|P2|Overall Study|Withdrawal by Subject|2
3123453|NCT00086190|10682810|P1|Overall Study|Withdrawal by Subject|0
3123454|NCT00086190|10682808|P3|Overall Study|Adverse Event|2
3123455|NCT00086190|10682809|P2|Overall Study|Adverse Event|2
3123456|NCT00086190|10682810|P1|Overall Study|Adverse Event|6
3123457|NCT00086047|10682879|P2|Overall Study|Physician Decision|1
3123458|NCT00086047|10682880|P1|Overall Study|Physician Decision|0
3123459|NCT00086047|10682879|P2|Overall Study|Lost to Follow-up|6
3123460|NCT00086047|10682880|P1|Overall Study|Lost to Follow-up|7
3123461|NCT00085917|10682888|P2|Overall Study|Adverse Event|3
3123462|NCT00085917|10682889|P1|Overall Study|Adverse Event|4
3123463|NCT00085735|10682918|P6|Overall Study|Pt transferred to inst w/out study open|0
3123464|NCT00085735|10682919|P5|Overall Study|Pt transferred to inst w/out study open|0
3123465|NCT00085735|10682920|P4|Overall Study|Pt transferred to inst w/out study open|0
3123466|NCT00085735|10682921|P3|Overall Study|Pt transferred to inst w/out study open|0
3123467|NCT00085735|10682922|P2|Overall Study|Pt transferred to inst w/out study open|0
3123468|NCT00085735|10682923|P1|Overall Study|Pt transferred to inst w/out study open|1
3123469|NCT00085735|10682918|P6|Overall Study|Reason not documented|0
3123470|NCT00085735|10682919|P5|Overall Study|Reason not documented|1
3123471|NCT00085735|10682920|P4|Overall Study|Reason not documented|0
3123472|NCT00085735|10682921|P3|Overall Study|Reason not documented|1
3123473|NCT00085735|10682922|P2|Overall Study|Reason not documented|0
3123474|NCT00085735|10682923|P1|Overall Study|Reason not documented|1
3123475|NCT00085735|10682918|P6|Overall Study|Excess residual disease|4
3123476|NCT00085735|10682919|P5|Overall Study|Excess residual disease|1
3123477|NCT00085735|10682920|P4|Overall Study|Excess residual disease|1
3123478|NCT00085735|10682921|P3|Overall Study|Excess residual disease|1
3123479|NCT00085735|10682922|P2|Overall Study|Excess residual disease|2
3123480|NCT00085735|10682923|P1|Overall Study|Excess residual disease|2
3123481|NCT00085735|10682918|P6|Overall Study|Patient ineligible|8
3123482|NCT00085735|10682919|P5|Overall Study|Patient ineligible|17
3123483|NCT00085735|10682920|P4|Overall Study|Patient ineligible|7
3123484|NCT00085735|10682921|P3|Overall Study|Patient ineligible|3
3123485|NCT00085735|10682922|P2|Overall Study|Patient ineligible|0
3123486|NCT00085735|10682923|P1|Overall Study|Patient ineligible|1
3123487|NCT00085735|10682918|P6|Overall Study|Withdrawal by Subject|8
3123488|NCT00085735|10682919|P5|Overall Study|Withdrawal by Subject|7
3123489|NCT00085735|10682920|P4|Overall Study|Withdrawal by Subject|5
3123490|NCT00085735|10682921|P3|Overall Study|Withdrawal by Subject|4
3123491|NCT00085735|10682922|P2|Overall Study|Withdrawal by Subject|0
3123492|NCT00085735|10682923|P1|Overall Study|Withdrawal by Subject|1
3123493|NCT00085735|10682918|P6|Overall Study|Protocol Violation|0
3123494|NCT00085735|10682919|P5|Overall Study|Protocol Violation|0
3123495|NCT00085735|10682920|P4|Overall Study|Protocol Violation|0
3123496|NCT00085735|10682921|P3|Overall Study|Protocol Violation|0
3123497|NCT00085735|10682922|P2|Overall Study|Protocol Violation|0
3123498|NCT00085735|10682923|P1|Overall Study|Protocol Violation|1
3123499|NCT00085735|10682918|P6|Overall Study|Physician Decision|8
3123500|NCT00085735|10682919|P5|Overall Study|Physician Decision|11
3123501|NCT00085735|10682920|P4|Overall Study|Physician Decision|3
3123502|NCT00085735|10682921|P3|Overall Study|Physician Decision|2
3123503|NCT00085735|10682922|P2|Overall Study|Physician Decision|3
3123504|NCT00085735|10682923|P1|Overall Study|Physician Decision|2
3123505|NCT00085735|10682918|P6|Overall Study|Lost to Follow-up|0
3123506|NCT00085735|10682919|P5|Overall Study|Lost to Follow-up|1
3123507|NCT00085735|10682920|P4|Overall Study|Lost to Follow-up|0
3123508|NCT00085735|10682921|P3|Overall Study|Lost to Follow-up|0
3123509|NCT00085735|10682922|P2|Overall Study|Lost to Follow-up|1
3123510|NCT00085735|10682923|P1|Overall Study|Lost to Follow-up|0
3123511|NCT00085735|10682918|P6|Overall Study|Lack of Efficacy|3
3123512|NCT00085735|10682919|P5|Overall Study|Lack of Efficacy|4
3123513|NCT00085735|10682920|P4|Overall Study|Lack of Efficacy|3
3123514|NCT00085735|10682921|P3|Overall Study|Lack of Efficacy|6
3123515|NCT00085735|10682922|P2|Overall Study|Lack of Efficacy|4
3123516|NCT00085735|10682923|P1|Overall Study|Lack of Efficacy|2
3123517|NCT00085735|10682918|P6|Overall Study|Adverse Event|0
3123518|NCT00085735|10682919|P5|Overall Study|Adverse Event|0
3123519|NCT00085735|10682920|P4|Overall Study|Adverse Event|0
3123520|NCT00085735|10682921|P3|Overall Study|Adverse Event|0
3123521|NCT00085735|10682922|P2|Overall Study|Adverse Event|0
3123522|NCT00085735|10682923|P1|Overall Study|Adverse Event|1
3123523|NCT00085709|10682978|P2|Overall Study|Withdrawal by Subject|1
3123524|NCT00085709|10682979|P1|Overall Study|Withdrawal by Subject|2
3123525|NCT00085709|10682978|P2|Overall Study|Not eligible|19
3123526|NCT00085709|10682979|P1|Overall Study|Not eligible|19
3123527|NCT00085709|10682978|P2|Overall Study|Not protocol specified|22
3123528|NCT00085709|10682979|P1|Overall Study|Not protocol specified|12
3123529|NCT00085709|10682978|P2|Overall Study|Progression|4
3123530|NCT00085709|10682979|P1|Overall Study|Progression|3
3123531|NCT00085709|10682978|P2|Overall Study|Refusal unrelated to adverse events|2
3123532|NCT00085709|10682979|P1|Overall Study|Refusal unrelated to adverse events|1
3123533|NCT00085709|10682978|P2|Overall Study|Death|2
3123534|NCT00085709|10682979|P1|Overall Study|Death|8
3123535|NCT00085709|10682978|P2|Overall Study|Adverse Event|0
3123536|NCT00085709|10682979|P1|Overall Study|Adverse Event|8
3123537|NCT00085644|10682995|P3|Open-Label Period|Personal reason|4
3123538|NCT00085644|10682996|P2|Open-Label Period|Personal reason|0
3123539|NCT00085644|10682997|P1|Open-Label Period|Personal reason|0
3123540|NCT00085644|10682995|P3|Open-Label Period|Protocol Violation|4
3123541|NCT00085644|10682996|P2|Open-Label Period|Protocol Violation|0
3123542|NCT00085644|10682997|P1|Open-Label Period|Protocol Violation|0
3123543|NCT00085644|10682995|P3|Open-Label Period|Contemplating pregnancy|3
3123544|NCT00085644|10682996|P2|Open-Label Period|Contemplating pregnancy|0
3123545|NCT00085644|10682997|P1|Open-Label Period|Contemplating pregnancy|0
3123546|NCT00085644|10682995|P3|Open-Label Period|Pregnancy|3
3123547|NCT00085644|10682996|P2|Open-Label Period|Pregnancy|0
3123548|NCT00085644|10682997|P1|Open-Label Period|Pregnancy|0
3123549|NCT00085644|10682995|P3|Open-Label Period|Lack of Efficacy|15
3123550|NCT00085644|10682996|P2|Open-Label Period|Lack of Efficacy|0
3123551|NCT00085644|10682997|P1|Open-Label Period|Lack of Efficacy|0
3123552|NCT00085644|10682995|P3|Open-Label Period|Lost to Follow-up|13
3123553|NCT00085644|10682996|P2|Open-Label Period|Lost to Follow-up|0
3123554|NCT00085644|10682997|P1|Open-Label Period|Lost to Follow-up|0
3123555|NCT00085644|10682995|P3|Open-Label Period|Withdrawal by Subject|29
3123556|NCT00085644|10682996|P2|Open-Label Period|Withdrawal by Subject|0
3123557|NCT00085644|10682997|P1|Open-Label Period|Withdrawal by Subject|0
3123558|NCT00085644|10682995|P3|Open-Label Period|Adverse Event|38
3123559|NCT00085644|10682996|P2|Open-Label Period|Adverse Event|0
3123560|NCT00085644|10682997|P1|Open-Label Period|Adverse Event|0
3123561|NCT00085644|10682995|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
3123562|NCT00085644|10682996|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
3123563|NCT00085644|10682997|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
3123564|NCT00085644|10682995|P3|Double-Blind Period|Contemplating pregnancy|0
3123565|NCT00085644|10682996|P2|Double-Blind Period|Contemplating pregnancy|0
3123566|NCT00085644|10682997|P1|Double-Blind Period|Contemplating pregnancy|1
3123567|NCT00085644|10682995|P3|Double-Blind Period|Lack/loss of efficacy|0
3123568|NCT00085644|10682996|P2|Double-Blind Period|Lack/loss of efficacy|2
3123569|NCT00085644|10682997|P1|Double-Blind Period|Lack/loss of efficacy|2
3123570|NCT00085644|10682995|P3|Double-Blind Period|Lost to Follow-up|0
3123571|NCT00085644|10682996|P2|Double-Blind Period|Lost to Follow-up|1
3123572|NCT00085644|10682997|P1|Double-Blind Period|Lost to Follow-up|2
3123573|NCT00085644|10682995|P3|Double-Blind Period|Withdrawal by Subject|0
3123574|NCT00085644|10682996|P2|Double-Blind Period|Withdrawal by Subject|0
3123575|NCT00085644|10682997|P1|Double-Blind Period|Withdrawal by Subject|3
3123576|NCT00085644|10682995|P3|Double-Blind Period|Adverse Event|0
3123577|NCT00085644|10682996|P2|Double-Blind Period|Adverse Event|2
3123578|NCT00085644|10682997|P1|Double-Blind Period|Adverse Event|5
3123579|NCT00085631|10683038|P3|Overall Study|Missing Data|7
3123580|NCT00085631|10683039|P2|Overall Study|Missing Data|11
3123581|NCT00085631|10683040|P1|Overall Study|Missing Data|4
3123582|NCT00085566|10683050|P3|Overall Study|Clinical progression|1
3123583|NCT00085566|10683051|P2|Overall Study|Clinical progression|0
3123584|NCT00085566|10683052|P1|Overall Study|Clinical progression|0
3123585|NCT00085566|10683050|P3|Overall Study|Patient Not treated|3
3123586|NCT00085566|10683051|P2|Overall Study|Patient Not treated|0
3123587|NCT00085566|10683052|P1|Overall Study|Patient Not treated|0
3123588|NCT00085566|10683050|P3|Overall Study|Adverse Event|10
3123589|NCT00085566|10683051|P2|Overall Study|Adverse Event|0
3123590|NCT00085566|10683052|P1|Overall Study|Adverse Event|0
3123591|NCT00085540|10683062|P2|Overall Study|Protocol Violation|1
3123592|NCT00085540|10683063|P1|Overall Study|Protocol Violation|0
3123593|NCT00085540|10683062|P2|Overall Study|Withdrawal by Subject|1
3123594|NCT00085540|10683063|P1|Overall Study|Withdrawal by Subject|0
3123595|NCT00085423|10683075|P1|Overall Study|screen failure|1
3123596|NCT00085423|10683075|P1|Overall Study|Withdrawal by Subject|1
3123597|NCT00085202|10683126|P2|Overall Study|Progressive disease|11
3123598|NCT00085202|10683127|P1|Overall Study|Progressive disease|1
3123599|NCT00085202|10683126|P2|Overall Study|Physician Decision|1
3123600|NCT00085202|10683127|P1|Overall Study|Physician Decision|4
3123601|NCT00085202|10683126|P2|Overall Study|Withdrawal by Subject|1
3123602|NCT00085202|10683127|P1|Overall Study|Withdrawal by Subject|2
3123603|NCT00085202|10683126|P2|Overall Study|Non-specified|5
3123604|NCT00085202|10683127|P1|Overall Study|Non-specified|3
3123605|NCT00085202|10683126|P2|Overall Study|Excessive toxicity|5
3123606|NCT00085202|10683127|P1|Overall Study|Excessive toxicity|6
3123607|NCT00085202|10683126|P2|Overall Study|Bone involvement confirmed by bone scan|1
3123608|NCT00085202|10683127|P1|Overall Study|Bone involvement confirmed by bone scan|0
3123609|NCT00085202|10683126|P2|Overall Study|Still on therapy|0
3123610|NCT00085202|10683127|P1|Overall Study|Still on therapy|2
3123611|NCT00085098|10683148|P2|Overall Study|Ineligible|1
3123612|NCT00085098|10683149|P1|Overall Study|Ineligible|1
3123613|NCT00085098|10683148|P2|Overall Study|Withdrawal by Subject|1
3123614|NCT00085098|10683149|P1|Overall Study|Withdrawal by Subject|0
3123615|NCT00084864|10683163|P4|Overall Study|Adverse Event|0
3123616|NCT00084864|10683164|P3|Overall Study|Adverse Event|0
3123617|NCT00084864|10683165|P2|Overall Study|Adverse Event|0
3123618|NCT00084864|10683166|P1|Overall Study|Adverse Event|1
3123619|NCT00084838|10683192|P1|Overall Study|Ineligible|4
3123620|NCT00084838|10683192|P1|Overall Study|Pt Non-Compliance|1
3123621|NCT00084838|10683192|P1|Overall Study|Progressive Disease|4
3123622|NCT00084838|10683192|P1|Overall Study|Withdrawal by Subject|1
3123623|NCT00084838|10683192|P1|Overall Study|Adverse Event|2
3123624|NCT00084838|10683192|P1|Overall Study|Death|1
3123625|NCT00084747|10683214|P1|Overall Study|Withdrawal by Subject|2
3123626|NCT00084747|10683214|P1|Overall Study|Death|3
3123627|NCT00084747|10683214|P1|Overall Study|Relapsed|8
3123628|NCT00084682|10683219|P1|Overall Study|Withdrawal by Subject|1
3123629|NCT00084617|10683223|P1|Overall Study|Protocol Violation|1
3123630|NCT00084617|10683223|P1|Overall Study|Lack of Efficacy|1
3123631|NCT00084617|10683223|P1|Overall Study|Withdrawal by Subject|7
3123632|NCT00084487|10683229|P1|Overall Study|Death|1
3123633|NCT00084318|10683273|P2|Overall Study|No protocol treatment|0
3123634|NCT00084318|10683274|P1|Overall Study|No protocol treatment|2
3123635|NCT00084318|10683273|P2|Overall Study|Protocol Violation|11
3123636|NCT00084318|10683274|P1|Overall Study|Protocol Violation|15
3123637|NCT00084318|10683273|P2|Overall Study|Withdrawal by Subject|2
3123638|NCT00084318|10683274|P1|Overall Study|Withdrawal by Subject|5
3123639|NCT00084266|10683294|P2|Overall Study|Randomized not treated|20
3123640|NCT00084266|10683295|P1|Overall Study|Randomized not treated|21
3123641|NCT00084266|10683294|P2|Overall Study|Other|344
3123642|NCT00084266|10683295|P1|Overall Study|Other|360
3123643|NCT00084266|10683294|P2|Overall Study|Participant not willing to participate|8
3123644|NCT00084266|10683295|P1|Overall Study|Participant not willing to participate|3
3123645|NCT00084266|10683294|P2|Overall Study|Lost to Follow-up|3
3123646|NCT00084266|10683295|P1|Overall Study|Lost to Follow-up|5
3123647|NCT00084266|10683294|P2|Overall Study|Lack of Efficacy|4
3123648|NCT00084266|10683295|P1|Overall Study|Lack of Efficacy|2
3123649|NCT00084266|10683294|P2|Overall Study|Adverse Event|5
3123650|NCT00084266|10683295|P1|Overall Study|Adverse Event|8
3123651|NCT00084266|10683294|P2|Overall Study|Death|39
3123652|NCT00084266|10683295|P1|Overall Study|Death|42
3123653|NCT00084136|10683353|P3|NRTI Comparison|Not reason above|0
3123654|NCT00084136|10683354|P2|NRTI Comparison|Not reason above|0
3123655|NCT00084136|10683355|P1|NRTI Comparison|Not reason above|1
3123656|NCT00084136|10683353|P3|NRTI Comparison|Clinic site closed|14
3123657|NCT00084136|10683354|P2|NRTI Comparison|Clinic site closed|0
3123658|NCT00084136|10683355|P1|NRTI Comparison|Clinic site closed|12
3123659|NCT00084136|10683353|P3|NRTI Comparison|Withdrawal by Subject|38
3123660|NCT00084136|10683354|P2|NRTI Comparison|Withdrawal by Subject|0
3123661|NCT00084136|10683355|P1|NRTI Comparison|Withdrawal by Subject|54
3123662|NCT00084136|10683353|P3|NRTI Comparison|Lost to Follow-up|12
3123663|NCT00084136|10683354|P2|NRTI Comparison|Lost to Follow-up|0
3123664|NCT00084136|10683355|P1|NRTI Comparison|Lost to Follow-up|14
3123665|NCT00084136|10683353|P3|NRTI Comparison|Death|18
3123666|NCT00084136|10683354|P2|NRTI Comparison|Death|0
3123667|NCT00084136|10683355|P1|NRTI Comparison|Death|20
3123668|NCT00084136|10683353|P3|PI Comparison|Clinic site closed|0
3123669|NCT00084136|10683354|P2|PI Comparison|Clinic site closed|0
3123670|NCT00084136|10683355|P1|PI Comparison|Clinic site closed|1
3123671|NCT00084136|10683353|P3|PI Comparison|Withdrawal by Subject|0
3123672|NCT00084136|10683354|P2|PI Comparison|Withdrawal by Subject|30
3123673|NCT00084136|10683355|P1|PI Comparison|Withdrawal by Subject|33
3123674|NCT00084136|10683353|P3|PI Comparison|Lost to Follow-up|0
3123675|NCT00084136|10683354|P2|PI Comparison|Lost to Follow-up|8
3123676|NCT00084136|10683355|P1|PI Comparison|Lost to Follow-up|11
3123677|NCT00084136|10683353|P3|PI Comparison|Death|0
3123678|NCT00084136|10683354|P2|PI Comparison|Death|9
3123679|NCT00084136|10683355|P1|PI Comparison|Death|10
3123680|NCT00084084|10683414|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
3123681|NCT00084084|10683414|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
3123682|NCT00083915|10683424|P2|Overall Study|Insurance issues|1
3123683|NCT00083915|10683425|P1|Overall Study|Insurance issues|1
3123684|NCT00083915|10683424|P2|Overall Study|No response|1
3123685|NCT00083915|10683425|P1|Overall Study|No response|3
3123686|NCT00083915|10683424|P2|Overall Study|Failure to collect|0
3123687|NCT00083915|10683425|P1|Overall Study|Failure to collect|3
3123688|NCT00083915|10683424|P2|Overall Study|disease progression|23
3123689|NCT00083915|10683425|P1|Overall Study|disease progression|18
3123690|NCT00083915|10683424|P2|Overall Study|Withdrawal by Subject|3
3123691|NCT00083915|10683425|P1|Overall Study|Withdrawal by Subject|8
3123692|NCT00083915|10683424|P2|Overall Study|Physician Decision|6
3123693|NCT00083915|10683425|P1|Overall Study|Physician Decision|11
3123694|NCT00083915|10683424|P2|Overall Study|Death|3
3123695|NCT00083915|10683425|P1|Overall Study|Death|6
3123696|NCT00083889|10683433|P2|Overall Study|Crossover to SU011248|25
3123697|NCT00083889|10683434|P1|Overall Study|Crossover to SU011248|0
3123698|NCT00083889|10683433|P2|Overall Study|Completed on marketed sunitinub|0
3123699|NCT00083889|10683434|P1|Overall Study|Completed on marketed sunitinub|3
3123700|NCT00083889|10683433|P2|Overall Study|Randomized: did not take study drug|15
3123701|NCT00083889|10683434|P1|Overall Study|Randomized: did not take study drug|0
3123702|NCT00083889|10683433|P2|Overall Study|Decision of sponsor|4
3123703|NCT00083889|10683434|P1|Overall Study|Decision of sponsor|32
3123704|NCT00083889|10683433|P2|Overall Study|Lack of Efficacy|219
3123705|NCT00083889|10683434|P1|Overall Study|Lack of Efficacy|240
3123706|NCT00083889|10683433|P2|Overall Study|Withdrawal by Subject|24
3123707|NCT00083889|10683434|P1|Overall Study|Withdrawal by Subject|22
3123708|NCT00083889|10683433|P2|Overall Study|Protocol Violation|2
3123709|NCT00083889|10683434|P1|Overall Study|Protocol Violation|2
3123710|NCT00083889|10683433|P2|Overall Study|Adverse Event|86
3123711|NCT00083889|10683434|P1|Overall Study|Adverse Event|76
3123712|NCT00083759|10683492|P2|Overall Study|Other|13
3123713|NCT00083759|10683493|P1|Overall Study|Other|14
3123714|NCT00083759|10683492|P2|Overall Study|Sponsor's Discretion|29
3123715|NCT00083759|10683493|P1|Overall Study|Sponsor's Discretion|28
3123716|NCT00083759|10683492|P2|Overall Study|Non-Compliance|0
3123717|NCT00083759|10683493|P1|Overall Study|Non-Compliance|1
3123718|NCT00083759|10683492|P2|Overall Study|Subject Withdrew Consent|2
3123719|NCT00083759|10683493|P1|Overall Study|Subject Withdrew Consent|2
3123720|NCT00083759|10683492|P2|Overall Study|Inadequate Therapeutic Response|35
3123721|NCT00083759|10683493|P1|Overall Study|Inadequate Therapeutic Response|32
3123722|NCT00083759|10683492|P2|Overall Study|Death|1
3123723|NCT00083759|10683493|P1|Overall Study|Death|1
3123724|NCT00083759|10683492|P2|Overall Study|Lost to Follow-up|0
3123725|NCT00083759|10683493|P1|Overall Study|Lost to Follow-up|1
3123726|NCT00083759|10683492|P2|Overall Study|Adverse Event|3
3123727|NCT00083759|10683493|P1|Overall Study|Adverse Event|5
3123728|NCT00083616|10683511|P1|Overall Study|Other|6
3123729|NCT00083616|10683511|P1|Overall Study|Non-compliance|1
3123730|NCT00083616|10683511|P1|Overall Study|Ineligibility determined|2
3123731|NCT00083616|10683511|P1|Overall Study|Withdrawal by Subject|3
3123732|NCT00083616|10683511|P1|Overall Study|Physician Decision|2
3123733|NCT00083616|10683511|P1|Overall Study|Lost to Follow-up|1
3123734|NCT00083616|10683511|P1|Overall Study|Disease Progression|16
3123735|NCT00082888|10683539|P3|Overall Study|Ineligible|0
3123736|NCT00082888|10683540|P2|Overall Study|Ineligible|0
3123737|NCT00082888|10683541|P1|Overall Study|Ineligible|1
3123738|NCT00082810|10683561|P1|Overall Study|Withdrawal by Subject|4
3123739|NCT00082810|10683561|P1|Overall Study|Progressive disease|24
3123740|NCT00082810|10683561|P1|Overall Study|Adverse Event|3
3123741|NCT00082758|10683572|P3|Overall Study|Protocol Violation|0
3123742|NCT00082758|10683573|P2|Overall Study|Protocol Violation|1
3123743|NCT00082758|10683574|P1|Overall Study|Protocol Violation|0
3123744|NCT00082758|10683572|P3|Overall Study|Withdrawal by Subject|0
3123745|NCT00082758|10683573|P2|Overall Study|Withdrawal by Subject|0
3123746|NCT00082758|10683574|P1|Overall Study|Withdrawal by Subject|3
3123747|NCT00082758|10683572|P3|Overall Study|Physician Decision|0
3123748|NCT00082758|10683573|P2|Overall Study|Physician Decision|1
3123749|NCT00082758|10683574|P1|Overall Study|Physician Decision|0
3123750|NCT00082758|10683572|P3|Overall Study|Lack of Efficacy|0
3123751|NCT00082758|10683573|P2|Overall Study|Lack of Efficacy|13
3123752|NCT00082758|10683574|P1|Overall Study|Lack of Efficacy|12
3123753|NCT00082758|10683572|P3|Overall Study|Adverse Event|0
3123754|NCT00082758|10683573|P2|Overall Study|Adverse Event|2
3123755|NCT00082758|10683574|P1|Overall Study|Adverse Event|0
3123756|NCT00083226|10683594|P1|Overall Study|ineligible or not receiving treatment|4
3123757|NCT00083226|10683594|P1|Overall Study|Other|2
3123758|NCT00083226|10683594|P1|Overall Study|Withdrawal by Subject|4
3123759|NCT00083226|10683594|P1|Overall Study|Death|4
3123760|NCT00083226|10683594|P1|Overall Study|Adverse Event|9
3123761|NCT00083226|10683594|P1|Overall Study|Lack of Efficacy|19
3123762|NCT00082628|10683638|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
3123763|NCT00082628|10683639|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
3123764|NCT00082628|10683640|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
3123765|NCT00082628|10683641|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
3123766|NCT00082628|10683642|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
3123767|NCT00082628|10683638|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
3123768|NCT00082628|10683639|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
3123769|NCT00082628|10683640|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
3123770|NCT00082628|10683641|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
3123771|NCT00082628|10683642|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
3123772|NCT00082628|10683638|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
3123773|NCT00082628|10683639|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
3123774|NCT00082628|10683640|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
3123775|NCT00082628|10683641|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
3123776|NCT00082628|10683642|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
3123777|NCT00082628|10683638|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
3123778|NCT00082628|10683639|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
3123779|NCT00082628|10683640|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
3123780|NCT00082628|10683641|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
3123781|NCT00082628|10683642|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
3123782|NCT00082628|10683638|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
3123783|NCT00082628|10683639|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
3123784|NCT00082628|10683640|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
3123785|NCT00082628|10683641|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
3123786|NCT00082628|10683642|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
3123787|NCT00082628|10683638|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
3123788|NCT00082628|10683639|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
3123789|NCT00082628|10683640|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
3123790|NCT00082628|10683641|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
3123791|NCT00082628|10683642|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
3123792|NCT00082628|10683638|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
3123793|NCT00082628|10683639|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
3123794|NCT00082628|10683640|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
3123795|NCT00082628|10683641|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
3123796|NCT00082628|10683642|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
3123797|NCT00082433|10683662|P2|Overall Study|Impending surgery|1
3123798|NCT00082433|10683663|P1|Overall Study|Impending surgery|0
3123799|NCT00082433|10683662|P2|Overall Study|New primary cancer|0
3123800|NCT00082433|10683663|P1|Overall Study|New primary cancer|1
3123801|NCT00082433|10683662|P2|Overall Study|Noncompliance|1
3123802|NCT00082433|10683663|P1|Overall Study|Noncompliance|2
3123803|NCT00082433|10683662|P2|Overall Study|Ineligible|1
3123804|NCT00082433|10683663|P1|Overall Study|Ineligible|2
3123805|NCT00082433|10683662|P2|Overall Study|Not Treated|11
3123806|NCT00082433|10683663|P1|Overall Study|Not Treated|12
3123807|NCT00082433|10683662|P2|Overall Study|Still On Treatment|1
3123808|NCT00082433|10683663|P1|Overall Study|Still On Treatment|2
3123809|NCT00082433|10683662|P2|Overall Study|Withdrawal by Subject|30
3123810|NCT00082433|10683663|P1|Overall Study|Withdrawal by Subject|55
3123811|NCT00082433|10683662|P2|Overall Study|Study Drug Toxicity|66
3123812|NCT00082433|10683663|P1|Overall Study|Study Drug Toxicity|179
3123813|NCT00082433|10683662|P2|Overall Study|Lost to Follow-up|2
3123814|NCT00082433|10683663|P1|Overall Study|Lost to Follow-up|1
3123815|NCT00082433|10683662|P2|Overall Study|Physician Decision|61
3123816|NCT00082433|10683663|P1|Overall Study|Physician Decision|50
3123817|NCT00082433|10683662|P2|Overall Study|Disease Progression/Relapse|388
3123818|NCT00082433|10683663|P1|Overall Study|Disease Progression/Relapse|270
3123819|NCT00082433|10683662|P2|Overall Study|Death|18
3123820|NCT00082433|10683663|P1|Overall Study|Death|8
3123821|NCT00082433|10683662|P2|Overall Study|Adverse Event|17
3123822|NCT00082433|10683663|P1|Overall Study|Adverse Event|12
3123823|NCT00082381|10683683|P2|Overall Study|Loss of Glucose Control|0
3123824|NCT00082381|10683684|P1|Overall Study|Loss of Glucose Control|4
3123825|NCT00082381|10683683|P2|Overall Study|Protocol Violation|11
3123826|NCT00082381|10683684|P1|Overall Study|Protocol Violation|10
3123827|NCT00082381|10683683|P2|Overall Study|Physician Decision|2
3123828|NCT00082381|10683684|P1|Overall Study|Physician Decision|1
3123829|NCT00082381|10683683|P2|Overall Study|Patient Decision|4
3123830|NCT00082381|10683684|P1|Overall Study|Patient Decision|8
3123831|NCT00082381|10683683|P2|Overall Study|Lost to Follow-up|7
3123832|NCT00082381|10683684|P1|Overall Study|Lost to Follow-up|5
3123833|NCT00082381|10683683|P2|Overall Study|Adverse Event|2
3123834|NCT00082381|10683684|P1|Overall Study|Adverse Event|27
3123835|NCT00082407|10683704|P2|Overall Study|Lost to Follow-up|3
3123836|NCT00082407|10683705|P1|Overall Study|Lost to Follow-up|0
3123837|NCT00082407|10683704|P2|Overall Study|Death|1
3123838|NCT00082407|10683705|P1|Overall Study|Death|2
3123839|NCT00082407|10683704|P2|Overall Study|Loss of Glucose Control|2
3123840|NCT00082407|10683705|P1|Overall Study|Loss of Glucose Control|2
3123841|NCT00082407|10683704|P2|Overall Study|Physician Decision|3
3123842|NCT00082407|10683705|P1|Overall Study|Physician Decision|5
3123843|NCT00082407|10683704|P2|Overall Study|Patient Decision|6
3123844|NCT00082407|10683705|P1|Overall Study|Patient Decision|13
3123845|NCT00082407|10683704|P2|Overall Study|Protocol Violation|12
3123846|NCT00082407|10683705|P1|Overall Study|Protocol Violation|14
3123847|NCT00082407|10683704|P2|Overall Study|Adverse Event|0
3123848|NCT00082407|10683705|P1|Overall Study|Adverse Event|20
3123849|NCT00082368|10683723|P1|Overall Study|Not treated-pt had poor IV access|1
3123850|NCT00082355|10683728|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
3123851|NCT00082355|10683728|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
3123852|NCT00082355|10683728|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
3123853|NCT00082173|10683762|P2|Overall Study|Culture negative or resistant at baselin|6
3123854|NCT00082173|10683763|P1|Overall Study|Culture negative or resistant at baselin|5
3123855|NCT00082173|10683762|P2|Overall Study|Adverse Event|0
3123856|NCT00082173|10683763|P1|Overall Study|Adverse Event|1
3123857|NCT00082173|10683762|P2|Overall Study|Lost to Follow-up|0
3123858|NCT00082173|10683763|P1|Overall Study|Lost to Follow-up|1
3123859|NCT00082173|10683762|P2|Overall Study|Withdrawal by Subject|5
3123860|NCT00082173|10683763|P1|Overall Study|Withdrawal by Subject|3
3123861|NCT00081770|10683808|P3|Overall Study|Other|8
3123862|NCT00081770|10683809|P2|Overall Study|Other|7
3123863|NCT00081770|10683810|P1|Overall Study|Other|2
3123864|NCT00081770|10683808|P3|Overall Study|Administrative|1
3123865|NCT00081770|10683809|P2|Overall Study|Administrative|0
3123866|NCT00081770|10683810|P1|Overall Study|Administrative|1
3123867|NCT00081770|10683808|P3|Overall Study|Did not meet protocol eligibility|3
3123868|NCT00081770|10683809|P2|Overall Study|Did not meet protocol eligibility|0
3123869|NCT00081770|10683810|P1|Overall Study|Did not meet protocol eligibility|2
3123870|NCT00081770|10683808|P3|Overall Study|Withdrawal by Subject|42
3123871|NCT00081770|10683809|P2|Overall Study|Withdrawal by Subject|40
3123872|NCT00081770|10683810|P1|Overall Study|Withdrawal by Subject|45
3123873|NCT00081770|10683808|P3|Overall Study|Protocol Violation|10
3123874|NCT00081770|10683809|P2|Overall Study|Protocol Violation|10
3123875|NCT00081770|10683810|P1|Overall Study|Protocol Violation|15
3123876|NCT00081770|10683808|P3|Overall Study|Lost to Follow-up|45
3123877|NCT00081770|10683809|P2|Overall Study|Lost to Follow-up|34
3123878|NCT00081770|10683810|P1|Overall Study|Lost to Follow-up|45
3123879|NCT00081770|10683808|P3|Overall Study|Lack of Efficacy|211
3123880|NCT00081770|10683809|P2|Overall Study|Lack of Efficacy|357
3123881|NCT00081770|10683810|P1|Overall Study|Lack of Efficacy|262
3123882|NCT00081770|10683808|P3|Overall Study|Adverse Event|136
3123883|NCT00081770|10683809|P2|Overall Study|Adverse Event|98
3123884|NCT00081770|10683810|P1|Overall Study|Adverse Event|130
3123885|NCT00081731|10683829|P2|Overall Study|scientific integrity issue|8
3123886|NCT00081731|10683830|P1|Overall Study|scientific integrity issue|8
3123887|NCT00081653|10683850|P2|Overall Study|Loss of bone mass|2
3123888|NCT00081653|10683851|P1|Overall Study|Loss of bone mass|0
3123889|NCT00081653|10683850|P2|Overall Study|Participant leaving country|0
3123890|NCT00081653|10683851|P1|Overall Study|Participant leaving country|1
3123891|NCT00081653|10683850|P2|Overall Study|Bone loss|0
3123892|NCT00081653|10683851|P1|Overall Study|Bone loss|2
3123893|NCT00081653|10683850|P2|Overall Study|Low bone mineral density|0
3123894|NCT00081653|10683851|P1|Overall Study|Low bone mineral density|1
3123895|NCT00081653|10683850|P2|Overall Study|Refused Treatment|14
3123896|NCT00081653|10683851|P1|Overall Study|Refused Treatment|18
3123897|NCT00081653|10683850|P2|Overall Study|Lost to Follow-up|4
3123898|NCT00081653|10683851|P1|Overall Study|Lost to Follow-up|2
3123899|NCT00081653|10683850|P2|Overall Study|Adverse Event|17
3123900|NCT00081653|10683851|P1|Overall Study|Adverse Event|23
3123901|NCT00081497|10683869|P2|Overall Study|Non-compliance|1
3123902|NCT00081497|10683870|P1|Overall Study|Non-compliance|0
3123903|NCT00081497|10683869|P2|Overall Study|Withdrawal by Subject|0
3123904|NCT00081497|10683870|P1|Overall Study|Withdrawal by Subject|1
3123905|NCT00081497|10683869|P2|Overall Study|Death|1
3123906|NCT00081497|10683870|P1|Overall Study|Death|0
3123907|NCT00081497|10683869|P2|Overall Study|Adverse Event|0
3123908|NCT00081497|10683870|P1|Overall Study|Adverse Event|2
3123909|NCT00081458|10683888|P3|Overall Study|Randomized but not dosed|1
3123910|NCT00081458|10683889|P2|Overall Study|Randomized but not dosed|0
3123911|NCT00081458|10683890|P1|Overall Study|Randomized but not dosed|0
3123912|NCT00081458|10683888|P3|Overall Study|Withdrawal by Subject|1
3123913|NCT00081458|10683889|P2|Overall Study|Withdrawal by Subject|3
3123914|NCT00081458|10683890|P1|Overall Study|Withdrawal by Subject|0
3123915|NCT00081458|10683888|P3|Overall Study|Adverse Event|2
3123916|NCT00081458|10683889|P2|Overall Study|Adverse Event|5
3123917|NCT00081458|10683890|P1|Overall Study|Adverse Event|1
3123918|NCT00081289|10683946|P2|Overall Study|Ineligible / no protocol treatment|4
3123919|NCT00081289|10683947|P1|Overall Study|Ineligible / no protocol treatment|3
3123920|NCT00081289|10683946|P2|Overall Study|Accrued prior to chemotherapy amendment|17
3123921|NCT00081289|10683947|P1|Overall Study|Accrued prior to chemotherapy amendment|18
3123922|NCT00081263|10683991|P2|Overall Study|Inadequate data|10
3123923|NCT00081263|10683992|P1|Overall Study|Inadequate data|5
3123924|NCT00081263|10683991|P2|Overall Study|Never treated|5
3123925|NCT00081263|10683992|P1|Overall Study|Never treated|4
3123926|NCT00081263|10683991|P2|Overall Study|Inadequate pathology|1
3123927|NCT00081263|10683992|P1|Overall Study|Inadequate pathology|0
3123928|NCT00081263|10683991|P2|Overall Study|improper pre-protocol therapy|1
3123929|NCT00081263|10683992|P1|Overall Study|improper pre-protocol therapy|0
3123930|NCT00081263|10683991|P2|Overall Study|wrong cell type|5
3123931|NCT00081263|10683992|P1|Overall Study|wrong cell type|7
3123932|NCT00081263|10683991|P2|Overall Study|clerical error|0
3123933|NCT00081263|10683992|P1|Overall Study|clerical error|1
3123934|NCT00081159|10684002|P2|Overall Study|Lost to Follow-up|1
3123935|NCT00081159|10684003|P1|Overall Study|Lost to Follow-up|2
3123936|NCT00081159|10684002|P2|Overall Study|Myelosuppression prior to treatment|1
3123937|NCT00081159|10684003|P1|Overall Study|Myelosuppression prior to treatment|0
3123938|NCT00081159|10684002|P2|Overall Study|Withdrawal by Subject|3
3123939|NCT00081159|10684003|P1|Overall Study|Withdrawal by Subject|0
3123940|NCT00080938|10684013|P1|Overall Study|Ineligible|4
3123941|NCT00080938|10684013|P1|Overall Study|Not started protocol therapy|1
3123942|NCT00080938|10684013|P1|Overall Study|other disease|1
3123943|NCT00080938|10684013|P1|Overall Study|Lack of Efficacy|7
3123944|NCT00080938|10684013|P1|Overall Study|Death|2
3123945|NCT00080938|10684013|P1|Overall Study|Withdrawal by Subject|6
3123946|NCT00080938|10684013|P1|Overall Study|Adverse Event|3
3123947|NCT00080899|10684029|P1|Overall Study|Adverse Event|1
3123948|NCT00080483|10684041|P2|Overall Study|Physician Decision|1
3123949|NCT00080483|10684042|P1|Overall Study|Physician Decision|1
3123950|NCT00080483|10684041|P2|Overall Study|Lost to Follow-up|1
3123951|NCT00080483|10684042|P1|Overall Study|Lost to Follow-up|1
3123952|NCT00002525|10684050|P2|Overall Study|Never start protocol therapy|0
3123953|NCT00002525|10684051|P1|Overall Study|Never start protocol therapy|8
3123954|NCT00002525|10684050|P2|Overall Study|Other|0
3123955|NCT00002525|10684051|P1|Overall Study|Other|26
3123956|NCT00002525|10684050|P2|Overall Study|Error|0
3123957|NCT00002525|10684051|P1|Overall Study|Error|6
3123958|NCT00002525|10684050|P2|Overall Study|Duke's A, B1, D disease|0
3123959|NCT00002525|10684051|P1|Overall Study|Duke's A, B1, D disease|92
3123960|NCT00002525|10684050|P2|Overall Study|Other complicating disease|0
3123961|NCT00002525|10684051|P1|Overall Study|Other complicating disease|1
3123962|NCT00002525|10684050|P2|Overall Study|Start non-protocol therapy|0
3123963|NCT00002525|10684051|P1|Overall Study|Start non-protocol therapy|1
3123964|NCT00002525|10684050|P2|Overall Study|Withdrawal by Subject|0
3123965|NCT00002525|10684051|P1|Overall Study|Withdrawal by Subject|11
3123966|NCT00002525|10684050|P2|Overall Study|Death|0
3123967|NCT00002525|10684051|P1|Overall Study|Death|5
3123968|NCT00002525|10684050|P2|Overall Study|Adverse Event|0
3123969|NCT00002525|10684051|P1|Overall Study|Adverse Event|36
3123970|NCT00080301|10684078|P2|Overall Study|Still on Treatment as of CSR date|1
3123971|NCT00080301|10684079|P1|Overall Study|Still on Treatment as of CSR date|0
3123972|NCT00080301|10684078|P2|Overall Study|Randomized but Never Treated|10
3123973|NCT00080301|10684079|P1|Overall Study|Randomized but Never Treated|5
3123974|NCT00080288|10684099|P2|Overall Study|Miscellaneous|11
3123975|NCT00080288|10684100|P1|Overall Study|Miscellaneous|11
3123976|NCT00080288|10684099|P2|Overall Study|Withdrawal by Subject|16
3123977|NCT00080288|10684100|P1|Overall Study|Withdrawal by Subject|3
3123978|NCT00080288|10684099|P2|Overall Study|Physician Decision|2
3123979|NCT00080288|10684100|P1|Overall Study|Physician Decision|6
3123980|NCT00080288|10684099|P2|Overall Study|Lost to Follow-up|5
3123981|NCT00080288|10684100|P1|Overall Study|Lost to Follow-up|3
3123982|NCT00080288|10684099|P2|Overall Study|Adverse Event|4
3123983|NCT00080288|10684100|P1|Overall Study|Adverse Event|7
3123984|NCT00080223|10684108|P1|Overall Study|Physician Decision|1
3123985|NCT00080223|10684108|P1|Overall Study|Participant unwilling to continue|2
3123986|NCT00080223|10684108|P1|Overall Study|Non-compliance With Study Treatment|7
3123987|NCT00080223|10684108|P1|Overall Study|Lung Transplantation|9
3123988|NCT00080223|10684108|P1|Overall Study|Withdrawal by Subject|13
3123989|NCT00080223|10684108|P1|Overall Study|Death|21
3123990|NCT00080223|10684108|P1|Overall Study|Adverse Event|23
3123991|NCT00002540|10684118|P2|Overall Study|Refused Screen (Prostate Screening)|2433
3123992|NCT00002540|10684119|P1|Overall Study|Refused Screen (Prostate Screening)|0
3123993|NCT00002540|10684118|P2|Overall Study|Refused ASU (Control)|0
3123994|NCT00002540|10684119|P1|Overall Study|Refused ASU (Control)|597
3123995|NCT00002540|10684118|P2|Overall Study|Died Before ASU (Control)|0
3123996|NCT00002540|10684119|P1|Overall Study|Died Before ASU (Control)|202
3123997|NCT00002540|10684118|P2|Overall Study|Died Before Randomization|6
3123998|NCT00002540|10684119|P1|Overall Study|Died Before Randomization|2
3123999|NCT00002540|10684118|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
3124000|NCT00002540|10684119|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
3124001|NCT00080119|10684149|P4|Overall Study|Lost to Follow-up|14
3124002|NCT00080119|10684150|P3|Overall Study|Lost to Follow-up|19
3124003|NCT00080119|10684151|P2|Overall Study|Lost to Follow-up|19
3124004|NCT00080119|10684152|P1|Overall Study|Lost to Follow-up|16
3124005|NCT00080119|10684149|P4|Overall Study|Unwilling to adhere to study requirement|1
3124006|NCT00080119|10684150|P3|Overall Study|Unwilling to adhere to study requirement|5
3124007|NCT00080119|10684151|P2|Overall Study|Unwilling to adhere to study requirement|2
3124008|NCT00080119|10684152|P1|Overall Study|Unwilling to adhere to study requirement|3
3124009|NCT00080119|10684149|P4|Overall Study|Consent withdrawn|6
3124010|NCT00080119|10684150|P3|Overall Study|Consent withdrawn|4
3124011|NCT00080119|10684151|P2|Overall Study|Consent withdrawn|17
3124012|NCT00080119|10684152|P1|Overall Study|Consent withdrawn|13
3124013|NCT00080119|10684149|P4|Overall Study|Unable to get to clinic|1
3124014|NCT00080119|10684150|P3|Overall Study|Unable to get to clinic|7
3124015|NCT00080119|10684151|P2|Overall Study|Unable to get to clinic|24
3124016|NCT00080119|10684152|P1|Overall Study|Unable to get to clinic|24
3124017|NCT00080119|10684149|P4|Overall Study|Discontinued because of study closure|141
3124018|NCT00080119|10684150|P3|Overall Study|Discontinued because of study closure|130
3124019|NCT00080119|10684151|P2|Overall Study|Discontinued because of study closure|0
3124020|NCT00080119|10684152|P1|Overall Study|Discontinued because of study closure|0
3124021|NCT00079937|10684186|P2|Overall Study|Administrative problems|11
3124022|NCT00079937|10684187|P1|Overall Study|Administrative problems|22
3124023|NCT00079937|10684186|P2|Overall Study|Lost to Follow-up|5
3124024|NCT00079937|10684187|P1|Overall Study|Lost to Follow-up|12
3124025|NCT00079937|10684186|P2|Overall Study|Withdrawal by Subject|7
3124026|NCT00079937|10684187|P1|Overall Study|Withdrawal by Subject|21
3124027|NCT00079937|10684186|P2|Overall Study|Protocol Violation|6
3124028|NCT00079937|10684187|P1|Overall Study|Protocol Violation|8
3124029|NCT00079937|10684186|P2|Overall Study|Subject no longer requires study drug|0
3124030|NCT00079937|10684187|P1|Overall Study|Subject no longer requires study drug|3
3124031|NCT00079937|10684186|P2|Overall Study|Unsatisfactory therapeutic effect|2
3124032|NCT00079937|10684187|P1|Overall Study|Unsatisfactory therapeutic effect|1
3124033|NCT00079937|10684186|P2|Overall Study|Adverse Event|1
3124034|NCT00079937|10684187|P1|Overall Study|Adverse Event|2
3124035|NCT00009737|10684205|P2|Overall Study|Administrative/Other Reasons|1
3124036|NCT00009737|10684206|P1|Overall Study|Administrative/Other Reasons|7
3124037|NCT00009737|10684205|P2|Overall Study|Lost to Follow-up|1
3124038|NCT00009737|10684206|P1|Overall Study|Lost to Follow-up|1
3124039|NCT00009737|10684205|P2|Overall Study|Refused Treatment|16
3124040|NCT00009737|10684206|P1|Overall Study|Refused Treatment|15
3124041|NCT00009737|10684205|P2|Overall Study|Other Protocol Violation|0
3124042|NCT00009737|10684206|P1|Overall Study|Other Protocol Violation|1
3124043|NCT00009737|10684205|P2|Overall Study|Violation of Selection Criteria at Entry|9
3124044|NCT00009737|10684206|P1|Overall Study|Violation of Selection Criteria at Entry|13
3124045|NCT00009737|10684205|P2|Overall Study|Lack of Efficacy|15
3124046|NCT00009737|10684206|P1|Overall Study|Lack of Efficacy|17
3124047|NCT00009737|10684205|P2|Overall Study|Death|6
3124048|NCT00009737|10684206|P1|Overall Study|Death|4
3124049|NCT00009737|10684205|P2|Overall Study|Adverse Event|75
3124050|NCT00009737|10684206|P1|Overall Study|Adverse Event|112
3124051|NCT00079781|10684225|P3|Follow-up Period|Death|1
3124052|NCT00079781|10684226|P2|Follow-up Period|Death|0
3124053|NCT00079781|10684227|P1|Follow-up Period|Death|0
3124054|NCT00079781|10684225|P3|Follow-up Period|Lost to Follow-up|0
3124055|NCT00079781|10684226|P2|Follow-up Period|Lost to Follow-up|0
3124056|NCT00079781|10684227|P1|Follow-up Period|Lost to Follow-up|1
3124057|NCT00079781|10684225|P3|Follow-up Period|Withdrawal by Subject|1
3124058|NCT00079781|10684226|P2|Follow-up Period|Withdrawal by Subject|0
3124059|NCT00079781|10684227|P1|Follow-up Period|Withdrawal by Subject|3
3124060|NCT00079781|10684225|P3|Pre-implant Period|Did not meet I/E criteria|1
3124061|NCT00079781|10684226|P2|Pre-implant Period|Did not meet I/E criteria|1
3124062|NCT00079781|10684227|P1|Pre-implant Period|Did not meet I/E criteria|1
3124063|NCT00079781|10684225|P3|Pre-implant Period|Withdrawal by Subject|0
3124064|NCT00079781|10684226|P2|Pre-implant Period|Withdrawal by Subject|0
3124065|NCT00079781|10684227|P1|Pre-implant Period|Withdrawal by Subject|2
3124066|NCT00079677|10684236|P2|Overall Study|Miscellaneous|0
3124067|NCT00079677|10684237|P1|Overall Study|Miscellaneous|2
3124068|NCT00079677|10684236|P2|Overall Study|Withdrawal by Subject|3
3124069|NCT00079677|10684237|P1|Overall Study|Withdrawal by Subject|5
3124070|NCT00079677|10684236|P2|Overall Study|Protocol Violation|3
3124071|NCT00079677|10684237|P1|Overall Study|Protocol Violation|2
3124072|NCT00079677|10684236|P2|Overall Study|Physician Decision|0
3124073|NCT00079677|10684237|P1|Overall Study|Physician Decision|3
3124074|NCT00079677|10684236|P2|Overall Study|Lost to Follow-up|2
3124075|NCT00079677|10684237|P1|Overall Study|Lost to Follow-up|2
3124076|NCT00079677|10684236|P2|Overall Study|Lack of Efficacy|0
3124077|NCT00079677|10684237|P1|Overall Study|Lack of Efficacy|1
3124078|NCT00079677|10684236|P2|Overall Study|Adverse Event|6
3124079|NCT00079677|10684237|P1|Overall Study|Adverse Event|5
3124080|NCT00079417|10684253|P1|Overall Study|Ineligible|7
3124081|NCT00079417|10684253|P1|Overall Study|Physician Decision|2
3124082|NCT00079391|10684261|P1|Overall Study|Withdrawal by Subject|1
3124083|NCT00079339|10684273|P3|Overall Study|Disease progression|2
3124084|NCT00079339|10684274|P2|Overall Study|Disease progression|28
3124085|NCT00079339|10684275|P1|Overall Study|Disease progression|3
3124086|NCT00079339|10684273|P3|Overall Study|Withdrawal by Subject|1
3124087|NCT00079339|10684274|P2|Overall Study|Withdrawal by Subject|4
3124088|NCT00079339|10684275|P1|Overall Study|Withdrawal by Subject|0
3124089|NCT00079339|10684273|P3|Overall Study|Non-compliance|1
3124090|NCT00079339|10684274|P2|Overall Study|Non-compliance|0
3124091|NCT00079339|10684275|P1|Overall Study|Non-compliance|0
3124092|NCT00079339|10684273|P3|Overall Study|Death|0
3124093|NCT00079339|10684274|P2|Overall Study|Death|0
3124094|NCT00079339|10684275|P1|Overall Study|Death|1
3124095|NCT00079339|10684273|P3|Overall Study|Adverse Event|2
3124096|NCT00079339|10684274|P2|Overall Study|Adverse Event|7
3124097|NCT00079339|10684275|P1|Overall Study|Adverse Event|1
3124098|NCT00079274|10684306|P7|Overall Study|Other|0
3124099|NCT00079274|10684307|P6|Overall Study|Other|2
3124100|NCT00079274|10684308|P5|Overall Study|Other|1
3124101|NCT00079274|10684309|P4|Overall Study|Other|55
3124102|NCT00079274|10684310|P3|Overall Study|Other|5
3124103|NCT00079274|10684311|P2|Overall Study|Other|7
3124104|NCT00079274|10684312|P1|Overall Study|Other|43
3124105|NCT00079274|10684306|P7|Overall Study|Cytogenetic resistance|0
3124106|NCT00079274|10684307|P6|Overall Study|Cytogenetic resistance|0
3124107|NCT00079274|10684308|P5|Overall Study|Cytogenetic resistance|0
3124108|NCT00079274|10684309|P4|Overall Study|Cytogenetic resistance|2
3124109|NCT00079274|10684310|P3|Overall Study|Cytogenetic resistance|0
3124110|NCT00079274|10684311|P2|Overall Study|Cytogenetic resistance|0
3124111|NCT00079274|10684312|P1|Overall Study|Cytogenetic resistance|0
3124112|NCT00079274|10684306|P7|Overall Study|Death|0
3124113|NCT00079274|10684307|P6|Overall Study|Death|0
3124114|NCT00079274|10684308|P5|Overall Study|Death|0
3124115|NCT00079274|10684309|P4|Overall Study|Death|15
3124116|NCT00079274|10684310|P3|Overall Study|Death|1
3124117|NCT00079274|10684311|P2|Overall Study|Death|0
3124118|NCT00079274|10684312|P1|Overall Study|Death|4
3124119|NCT00079274|10684306|P7|Overall Study|Other Medical Problems|0
3124120|NCT00079274|10684307|P6|Overall Study|Other Medical Problems|0
3124121|NCT00079274|10684308|P5|Overall Study|Other Medical Problems|0
3124122|NCT00079274|10684309|P4|Overall Study|Other Medical Problems|7
3124123|NCT00079274|10684310|P3|Overall Study|Other Medical Problems|0
3124124|NCT00079274|10684311|P2|Overall Study|Other Medical Problems|1
3124125|NCT00079274|10684312|P1|Overall Study|Other Medical Problems|6
3124126|NCT00079274|10684306|P7|Overall Study|Alternate Treatment|0
3124127|NCT00079274|10684307|P6|Overall Study|Alternate Treatment|0
3124128|NCT00079274|10684308|P5|Overall Study|Alternate Treatment|0
3124129|NCT00079274|10684309|P4|Overall Study|Alternate Treatment|3
3124130|NCT00079274|10684310|P3|Overall Study|Alternate Treatment|0
3124131|NCT00079274|10684311|P2|Overall Study|Alternate Treatment|1
3124132|NCT00079274|10684312|P1|Overall Study|Alternate Treatment|6
3124133|NCT00079274|10684306|P7|Overall Study|Recurrence|0
3124134|NCT00079274|10684307|P6|Overall Study|Recurrence|2
3124135|NCT00079274|10684308|P5|Overall Study|Recurrence|0
3124136|NCT00079274|10684309|P4|Overall Study|Recurrence|15
3124137|NCT00079274|10684310|P3|Overall Study|Recurrence|1
3124138|NCT00079274|10684311|P2|Overall Study|Recurrence|0
3124139|NCT00079274|10684312|P1|Overall Study|Recurrence|21
3124140|NCT00079274|10684306|P7|Overall Study|Adverse Event|0
3124141|NCT00079274|10684307|P6|Overall Study|Adverse Event|8
3124142|NCT00079274|10684308|P5|Overall Study|Adverse Event|7
3124143|NCT00079274|10684309|P4|Overall Study|Adverse Event|184
3124144|NCT00079274|10684310|P3|Overall Study|Adverse Event|8
3124145|NCT00079274|10684311|P2|Overall Study|Adverse Event|8
3124146|NCT00079274|10684312|P1|Overall Study|Adverse Event|130
3124147|NCT00079274|10684306|P7|Overall Study|Withdrawal by Subject|0
3124148|NCT00079274|10684307|P6|Overall Study|Withdrawal by Subject|8
3124149|NCT00079274|10684308|P5|Overall Study|Withdrawal by Subject|7
3124150|NCT00079274|10684309|P4|Overall Study|Withdrawal by Subject|163
3124151|NCT00079274|10684310|P3|Overall Study|Withdrawal by Subject|12
3124152|NCT00079274|10684311|P2|Overall Study|Withdrawal by Subject|10
3124153|NCT00079274|10684312|P1|Overall Study|Withdrawal by Subject|111
3124154|NCT00079183|10684333|P1|Overall Study|Specimen collection non-compliance|1
3124155|NCT00079183|10684333|P1|Overall Study|Study medication non-compliance|2
3124156|NCT00079183|10684333|P1|Overall Study|Withdrawal by Subject|4
3124157|NCT00079040|10684348|P1|Overall Study|Ineligible|1
3124158|NCT00079040|10684348|P1|Overall Study|Withdrew before treatment|1
3124159|NCT00078949|10684371|P4|Overall Study|No treated|3
3124160|NCT00078949|10684372|P3|Overall Study|No treated|3
3124161|NCT00078949|10684373|P2|Overall Study|No treated|5
3124162|NCT00078949|10684374|P1|Overall Study|No treated|4
3124163|NCT00078819|10684403|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
3124164|NCT00078819|10684404|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
3124165|NCT00078819|10684405|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
3124166|NCT00078819|10684406|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
3124167|NCT00078819|10684403|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
3124168|NCT00078819|10684404|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
3124169|NCT00078819|10684405|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
3124170|NCT00078819|10684406|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
3124171|NCT00078819|10684403|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
3124172|NCT00078819|10684404|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
3124173|NCT00078819|10684405|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
3124174|NCT00078819|10684406|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
3124175|NCT00078819|10684403|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
3124176|NCT00078819|10684404|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
3124177|NCT00078819|10684405|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
3124178|NCT00078819|10684406|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
3124179|NCT00078819|10684403|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
3124180|NCT00078819|10684404|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
3124181|NCT00078819|10684405|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
3124182|NCT00078819|10684406|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
3124183|NCT00078819|10684403|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
3124184|NCT00078819|10684404|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
3124185|NCT00078819|10684405|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
3124186|NCT00078819|10684406|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
3124187|NCT00078819|10684403|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
3124188|NCT00078819|10684404|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
3124189|NCT00078819|10684405|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
3124190|NCT00078819|10684406|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
3124191|NCT00078819|10684403|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
3124192|NCT00078819|10684404|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
3124193|NCT00078819|10684405|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
3124194|NCT00078819|10684406|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
3124195|NCT00078806|10684431|P4|Part 2|Adverse Event|0
3124196|NCT00078806|10684432|P3|Part 2|Adverse Event|0
3124197|NCT00078806|10684433|P2|Part 2|Adverse Event|1
3124198|NCT00078806|10684434|P1|Part 2|Adverse Event|0
3124199|NCT00078806|10684431|P4|Part 1B|Lack of Efficacy|0
3124200|NCT00078806|10684432|P3|Part 1B|Lack of Efficacy|0
3124201|NCT00078806|10684433|P2|Part 1B|Lack of Efficacy|0
3124202|NCT00078806|10684434|P1|Part 1B|Lack of Efficacy|7
3124203|NCT00078806|10684431|P4|Part 1B|Adverse Event|0
3124204|NCT00078806|10684432|P3|Part 1B|Adverse Event|0
3124205|NCT00078806|10684433|P2|Part 1B|Adverse Event|0
3124206|NCT00078806|10684434|P1|Part 1B|Adverse Event|1
3124207|NCT00078806|10684431|P4|Part 1A|Other|0
3124208|NCT00078806|10684432|P3|Part 1A|Other|0
3124209|NCT00078806|10684433|P2|Part 1A|Other|0
3124210|NCT00078806|10684434|P1|Part 1A|Other|1
3124211|NCT00078806|10684431|P4|Part 1A|Lack of Efficacy|0
3124212|NCT00078806|10684432|P3|Part 1A|Lack of Efficacy|0
3124213|NCT00078806|10684433|P2|Part 1A|Lack of Efficacy|0
3124214|NCT00078806|10684434|P1|Part 1A|Lack of Efficacy|7
3124215|NCT00078806|10684431|P4|Part 1A|Adverse Event|0
3124216|NCT00078806|10684432|P3|Part 1A|Adverse Event|0
3124217|NCT00078806|10684433|P2|Part 1A|Adverse Event|0
3124218|NCT00078806|10684434|P1|Part 1A|Adverse Event|2
3124219|NCT00078767|10684470|P2|Overall Study|Withdrawal by Subject|1
3124220|NCT00078767|10684471|P1|Overall Study|Withdrawal by Subject|1
3124221|NCT00005947|10684518|P2|Overall Study|Site Closure|0
3124222|NCT00005947|10684519|P1|Overall Study|Site Closure|1
3124223|NCT00005947|10684518|P2|Overall Study|Patient Refused to Continue|1
3124224|NCT00005947|10684519|P1|Overall Study|Patient Refused to Continue|2
3124225|NCT00005947|10684518|P2|Overall Study|Death|40
3124226|NCT00005947|10684519|P1|Overall Study|Death|54
3124227|NCT00002597|10684555|P2|Overall Study|Withdrawal by Subject|6
3124228|NCT00002597|10684556|P1|Overall Study|Withdrawal by Subject|7
3124229|NCT00002597|10684555|P2|Overall Study|Protocol Violation|17
3124230|NCT00002597|10684556|P1|Overall Study|Protocol Violation|19
3124231|NCT00078377|10684581|P3|Overall Study|Miscellaneous|1
3124232|NCT00078377|10684582|P2|Overall Study|Miscellaneous|6
3124233|NCT00078377|10684583|P1|Overall Study|Miscellaneous|2
3124234|NCT00078377|10684581|P3|Overall Study|Withdrawal by Subject|4
3124235|NCT00078377|10684582|P2|Overall Study|Withdrawal by Subject|4
3124236|NCT00078377|10684583|P1|Overall Study|Withdrawal by Subject|3
3124237|NCT00078377|10684581|P3|Overall Study|Physician Decision|0
3124238|NCT00078377|10684582|P2|Overall Study|Physician Decision|0
3124239|NCT00078377|10684583|P1|Overall Study|Physician Decision|2
3124240|NCT00078377|10684581|P3|Overall Study|Lost to Follow-up|1
3124241|NCT00078377|10684582|P2|Overall Study|Lost to Follow-up|1
3124242|NCT00078377|10684583|P1|Overall Study|Lost to Follow-up|0
3124243|NCT00078377|10684581|P3|Overall Study|Lack of Efficacy|2
3124244|NCT00078377|10684582|P2|Overall Study|Lack of Efficacy|0
3124245|NCT00078377|10684583|P1|Overall Study|Lack of Efficacy|2
3124246|NCT00078377|10684581|P3|Overall Study|Adverse Event|1
3124247|NCT00078377|10684582|P2|Overall Study|Adverse Event|5
3124248|NCT00078377|10684583|P1|Overall Study|Adverse Event|2
3124249|NCT00078338|10684598|P2|Overall Study|Subjects randomized, but not treated|3
3124250|NCT00078338|10684599|P1|Overall Study|Subjects randomized, but not treated|3
3124251|NCT00078338|10684598|P2|Overall Study|Other|16
3124252|NCT00078338|10684599|P1|Overall Study|Other|28
3124253|NCT00078338|10684598|P2|Overall Study|Disease Progression|7
3124254|NCT00078338|10684599|P1|Overall Study|Disease Progression|4
3124255|NCT00078338|10684598|P2|Overall Study|Protocol Violation|2
3124256|NCT00078338|10684599|P1|Overall Study|Protocol Violation|2
3124257|NCT00078338|10684598|P2|Overall Study|Lost to Follow-up|2
3124258|NCT00078338|10684599|P1|Overall Study|Lost to Follow-up|17
3124259|NCT00078338|10684598|P2|Overall Study|Adverse Event|24
3124260|NCT00078338|10684599|P1|Overall Study|Adverse Event|31
3124261|NCT00078325|10684692|P3|Overall Study|Miscellaneous|1
3124262|NCT00078325|10684693|P2|Overall Study|Miscellaneous|1
3124263|NCT00078325|10684694|P1|Overall Study|Miscellaneous|1
3124264|NCT00078325|10684692|P3|Overall Study|Physician Decision|1
3124265|NCT00078325|10684693|P2|Overall Study|Physician Decision|0
3124266|NCT00078325|10684694|P1|Overall Study|Physician Decision|2
3124267|NCT00078325|10684692|P3|Overall Study|Lost to Follow-up|1
3124268|NCT00078325|10684693|P2|Overall Study|Lost to Follow-up|1
3124269|NCT00078325|10684694|P1|Overall Study|Lost to Follow-up|0
3124270|NCT00078325|10684692|P3|Overall Study|Withdrawal by Subject|3
3124271|NCT00078325|10684693|P2|Overall Study|Withdrawal by Subject|5
3124272|NCT00078325|10684694|P1|Overall Study|Withdrawal by Subject|1
3124273|NCT00078325|10684692|P3|Overall Study|Protocol Violation|0
3124274|NCT00078325|10684693|P2|Overall Study|Protocol Violation|2
3124275|NCT00078325|10684694|P1|Overall Study|Protocol Violation|2
3124276|NCT00078325|10684692|P3|Overall Study|Adverse Event|5
3124277|NCT00078325|10684693|P2|Overall Study|Adverse Event|10
3124278|NCT00078325|10684694|P1|Overall Study|Adverse Event|15
3124279|NCT00078312|10684705|P1|Overall Study|Miscellaneous|33
3124280|NCT00078312|10684705|P1|Overall Study|Withdrawal by Subject|33
3124281|NCT00078312|10684705|P1|Overall Study|Protocol Violation|3
3124282|NCT00078312|10684705|P1|Overall Study|Physician Decision|9
3124283|NCT00078312|10684705|P1|Overall Study|Lost to Follow-up|41
3124284|NCT00078312|10684705|P1|Overall Study|Lack of Efficacy|15
3124285|NCT00078312|10684705|P1|Overall Study|Adverse Event|43
3124286|NCT00077974|10684720|P1|Overall Study|Decision of Sponsor|2
3124287|NCT00077974|10684720|P1|Overall Study|Lack of Efficacy|76
3124288|NCT00077974|10684720|P1|Overall Study|Withdrawal by Subject|3
3124289|NCT00077974|10684720|P1|Overall Study|Protocol Violation|1
3124290|NCT00077974|10684720|P1|Overall Study|Adverse Event|22
3124291|NCT00077857|10684737|P2|Overall Study|Other|13
3124292|NCT00077857|10684738|P1|Overall Study|Other|15
3124293|NCT00077857|10684737|P2|Overall Study|Failure to return|5
3124294|NCT00077857|10684738|P1|Overall Study|Failure to return|5
3124295|NCT00077857|10684737|P2|Overall Study|Refused treatment|21
3124296|NCT00077857|10684738|P1|Overall Study|Refused treatment|29
3124297|NCT00077857|10684737|P2|Overall Study|Other protocol violation|1
3124298|NCT00077857|10684738|P1|Overall Study|Other protocol violation|0
3124299|NCT00077857|10684737|P2|Overall Study|Violation of selection criteria at entry|1
3124300|NCT00077857|10684738|P1|Overall Study|Violation of selection criteria at entry|3
3124301|NCT00077857|10684737|P2|Overall Study|Insufficient therapeutic response|128
3124302|NCT00077857|10684738|P1|Overall Study|Insufficient therapeutic response|112
3124303|NCT00077857|10684737|P2|Overall Study|Death|3
3124304|NCT00077857|10684738|P1|Overall Study|Death|7
3124305|NCT00077857|10684737|P2|Overall Study|Adverse Event|32
3124306|NCT00077857|10684738|P1|Overall Study|Adverse Event|30
3124307|NCT00077766|10684758|P2|Overall Study|Participants Vacation|1
3124308|NCT00077766|10684759|P1|Overall Study|Participants Vacation|2
3124309|NCT00077766|10684758|P2|Overall Study|Stop Dialysis|1
3124310|NCT00077766|10684759|P1|Overall Study|Stop Dialysis|0
3124311|NCT00077766|10684758|P2|Overall Study|Started Nocturnal Dialysis|1
3124312|NCT00077766|10684759|P1|Overall Study|Started Nocturnal Dialysis|0
3124313|NCT00077766|10684758|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
3124314|NCT00077766|10684759|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
3124315|NCT00077766|10684758|P2|Overall Study|Dialysis|1
3124316|NCT00077766|10684759|P1|Overall Study|Dialysis|0
3124317|NCT00077766|10684758|P2|Overall Study|Dialysis Discontinued|0
3124318|NCT00077766|10684759|P1|Overall Study|Dialysis Discontinued|1
3124319|NCT00077766|10684758|P2|Overall Study|Participant's decision|0
3124320|NCT00077766|10684759|P1|Overall Study|Participant's decision|1
3124321|NCT00077766|10684758|P2|Overall Study|Investigators Discretion|0
3124322|NCT00077766|10684759|P1|Overall Study|Investigators Discretion|1
3124323|NCT00077766|10684758|P2|Overall Study|Transplantation|1
3124324|NCT00077766|10684759|P1|Overall Study|Transplantation|5
3124325|NCT00077766|10684758|P2|Overall Study|Kidney Transplantation|5
3124326|NCT00077766|10684759|P1|Overall Study|Kidney Transplantation|9
3124327|NCT00077766|10684758|P2|Overall Study|Protocol Violation|0
3124328|NCT00077766|10684759|P1|Overall Study|Protocol Violation|1
3124329|NCT00077766|10684758|P2|Overall Study|Lost to Follow-up|0
3124330|NCT00077766|10684759|P1|Overall Study|Lost to Follow-up|2
3124331|NCT00077766|10684758|P2|Overall Study|Death|10
3124332|NCT00077766|10684759|P1|Overall Study|Death|12
3124333|NCT00077766|10684758|P2|Overall Study|Withdrawal by Subject|3
3124334|NCT00077766|10684759|P1|Overall Study|Withdrawal by Subject|4
3124335|NCT00077766|10684758|P2|Overall Study|Adverse Event|1
3124336|NCT00077766|10684759|P1|Overall Study|Adverse Event|1
3124337|NCT00077675|10684784|P2|Overall Study|Never received study treatment|3
3124338|NCT00077675|10684785|P1|Overall Study|Never received study treatment|3
3124339|NCT00077675|10684784|P2|Overall Study|Other|1
3124340|NCT00077675|10684785|P1|Overall Study|Other|0
3124341|NCT00077675|10684784|P2|Overall Study|Withdrawal by Subject|0
3124342|NCT00077675|10684785|P1|Overall Study|Withdrawal by Subject|1
3124343|NCT00077675|10684784|P2|Overall Study|Lost to Follow-up|3
3124344|NCT00077675|10684785|P1|Overall Study|Lost to Follow-up|6
3124345|NCT00077675|10684784|P2|Overall Study|Adverse Event|2
3124346|NCT00077675|10684785|P1|Overall Study|Adverse Event|1
3124347|NCT00077649|10684795|P4|Overall Study|Randomized but never dosed|0
3124348|NCT00077649|10684796|P3|Overall Study|Randomized but never dosed|0
3124349|NCT00077649|10684797|P2|Overall Study|Randomized but never dosed|0
3124350|NCT00077649|10684798|P1|Overall Study|Randomized but never dosed|1
3124351|NCT00077649|10684795|P4|Overall Study|Abnormality of Laboratory Test|2
3124352|NCT00077649|10684796|P3|Overall Study|Abnormality of Laboratory Test|1
3124353|NCT00077649|10684797|P2|Overall Study|Abnormality of Laboratory Test|2
3124354|NCT00077649|10684798|P1|Overall Study|Abnormality of Laboratory Test|1
3124355|NCT00077649|10684795|P4|Overall Study|Lost to Follow-up|2
3124356|NCT00077649|10684796|P3|Overall Study|Lost to Follow-up|3
3124357|NCT00077649|10684797|P2|Overall Study|Lost to Follow-up|2
3124358|NCT00077649|10684798|P1|Overall Study|Lost to Follow-up|2
3124359|NCT00077649|10684795|P4|Overall Study|Withdrawal by Subject|2
3124360|NCT00077649|10684796|P3|Overall Study|Withdrawal by Subject|1
3124361|NCT00077649|10684797|P2|Overall Study|Withdrawal by Subject|1
3124362|NCT00077649|10684798|P1|Overall Study|Withdrawal by Subject|0
3124363|NCT00077649|10684795|P4|Overall Study|Lack of Efficacy|2
3124364|NCT00077649|10684796|P3|Overall Study|Lack of Efficacy|3
3124365|NCT00077649|10684797|P2|Overall Study|Lack of Efficacy|3
3124366|NCT00077649|10684798|P1|Overall Study|Lack of Efficacy|5
3124367|NCT00077649|10684795|P4|Overall Study|Adverse Event|9
3124368|NCT00077649|10684796|P3|Overall Study|Adverse Event|7
3124369|NCT00077649|10684797|P2|Overall Study|Adverse Event|1
3124370|NCT00077649|10684798|P1|Overall Study|Adverse Event|5
3124371|NCT00077636|10684846|P2|Overall Study|Abnormality Of Laboratory Test|2
3124372|NCT00077636|10684847|P1|Overall Study|Abnormality Of Laboratory Test|3
3124373|NCT00077636|10684846|P2|Overall Study|Lost to Follow-up|18
3124374|NCT00077636|10684847|P1|Overall Study|Lost to Follow-up|10
3124375|NCT00077636|10684846|P2|Overall Study|Protocol Violation|2
3124376|NCT00077636|10684847|P1|Overall Study|Protocol Violation|0
3124377|NCT00077636|10684846|P2|Overall Study|Adverse Event|34
3124378|NCT00077636|10684847|P1|Overall Study|Adverse Event|17
3124379|NCT00077636|10684846|P2|Overall Study|Withdrawal by Subject|2
3124380|NCT00077636|10684847|P1|Overall Study|Withdrawal by Subject|2
3124381|NCT00077636|10684846|P2|Overall Study|Admin|3
3124382|NCT00077636|10684847|P1|Overall Study|Admin|3
3124383|NCT00077636|10684846|P2|Overall Study|Refused Treatment|31
3124384|NCT00077636|10684847|P1|Overall Study|Refused Treatment|9
3124385|NCT00077623|10684868|P3|Overall Study|Failure to return|0
3124386|NCT00077623|10684869|P2|Overall Study|Failure to return|0
3124387|NCT00077623|10684870|P1|Overall Study|Failure to return|1
3124388|NCT00077623|10684868|P3|Overall Study|Death|11
3124389|NCT00077623|10684869|P2|Overall Study|Death|18
3124390|NCT00077623|10684870|P1|Overall Study|Death|12
3124391|NCT00077623|10684868|P3|Overall Study|Insufficient therapeutic response|0
3124392|NCT00077623|10684869|P2|Overall Study|Insufficient therapeutic response|0
3124393|NCT00077623|10684870|P1|Overall Study|Insufficient therapeutic response|2
3124394|NCT00077623|10684868|P3|Overall Study|Other-Non safety reason|19
3124395|NCT00077623|10684869|P2|Overall Study|Other-Non safety reason|15
3124396|NCT00077623|10684870|P1|Overall Study|Other-Non safety reason|18
3124397|NCT00077623|10684868|P3|Overall Study|Withdrawal by Subject|1
3124398|NCT00077623|10684869|P2|Overall Study|Withdrawal by Subject|10
3124399|NCT00077623|10684870|P1|Overall Study|Withdrawal by Subject|2
3124400|NCT00077623|10684868|P3|Overall Study|Adverse Event|1
3124401|NCT00077623|10684869|P2|Overall Study|Adverse Event|0
3124402|NCT00077623|10684870|P1|Overall Study|Adverse Event|1
3124403|NCT00077610|10684905|P3|Overall Study|Sponsors decision to withdraw|1
3124404|NCT00077610|10684906|P2|Overall Study|Sponsors decision to withdraw|0
3124405|NCT00077610|10684907|P1|Overall Study|Sponsors decision to withdraw|0
3124406|NCT00077610|10684905|P3|Overall Study|Financial issues|0
3124407|NCT00077610|10684906|P2|Overall Study|Financial issues|1
3124408|NCT00077610|10684907|P1|Overall Study|Financial issues|0
3124409|NCT00077610|10684905|P3|Overall Study|Relocation|5
3124410|NCT00077610|10684906|P2|Overall Study|Relocation|8
3124411|NCT00077610|10684907|P1|Overall Study|Relocation|0
3124412|NCT00077610|10684905|P3|Overall Study|Change in dialysis modality|0
3124413|NCT00077610|10684906|P2|Overall Study|Change in dialysis modality|0
3124414|NCT00077610|10684907|P1|Overall Study|Change in dialysis modality|1
3124415|NCT00077610|10684905|P3|Overall Study|Transfer to other center for surgery|0
3124416|NCT00077610|10684906|P2|Overall Study|Transfer to other center for surgery|0
3124417|NCT00077610|10684907|P1|Overall Study|Transfer to other center for surgery|1
3124418|NCT00077610|10684905|P3|Overall Study|Transfer to satellite unit|0
3124419|NCT00077610|10684906|P2|Overall Study|Transfer to satellite unit|0
3124420|NCT00077610|10684907|P1|Overall Study|Transfer to satellite unit|1
3124421|NCT00077610|10684905|P3|Overall Study|Transferred to nursing home|1
3124422|NCT00077610|10684906|P2|Overall Study|Transferred to nursing home|0
3124423|NCT00077610|10684907|P1|Overall Study|Transferred to nursing home|0
3124424|NCT00077610|10684905|P3|Overall Study|Transferred to other unit|1
3124425|NCT00077610|10684906|P2|Overall Study|Transferred to other unit|0
3124426|NCT00077610|10684907|P1|Overall Study|Transferred to other unit|0
3124427|NCT00077610|10684905|P3|Overall Study|Given Epogen in hospital|0
3124428|NCT00077610|10684906|P2|Overall Study|Given Epogen in hospital|0
3124429|NCT00077610|10684907|P1|Overall Study|Given Epogen in hospital|1
3124430|NCT00077610|10684905|P3|Overall Study|Worsening of health condition|0
3124431|NCT00077610|10684906|P2|Overall Study|Worsening of health condition|1
3124432|NCT00077610|10684907|P1|Overall Study|Worsening of health condition|1
3124433|NCT00077610|10684905|P3|Overall Study|Principal Investigator's decision|1
3124434|NCT00077610|10684906|P2|Overall Study|Principal Investigator's decision|0
3124435|NCT00077610|10684907|P1|Overall Study|Principal Investigator's decision|1
3124436|NCT00077610|10684905|P3|Overall Study|Multiple blood transfusions|1
3124437|NCT00077610|10684906|P2|Overall Study|Multiple blood transfusions|0
3124438|NCT00077610|10684907|P1|Overall Study|Multiple blood transfusions|0
3124439|NCT00077610|10684905|P3|Overall Study|Insufficient Therapeutic Response|0
3124440|NCT00077610|10684906|P2|Overall Study|Insufficient Therapeutic Response|0
3124441|NCT00077610|10684907|P1|Overall Study|Insufficient Therapeutic Response|1
3124442|NCT00077610|10684905|P3|Overall Study|Withdrew from dialysis care|3
3124443|NCT00077610|10684906|P2|Overall Study|Withdrew from dialysis care|0
3124444|NCT00077610|10684907|P1|Overall Study|Withdrew from dialysis care|5
3124445|NCT00077610|10684905|P3|Overall Study|Renal transplant|11
3124446|NCT00077610|10684906|P2|Overall Study|Renal transplant|15
3124447|NCT00077610|10684907|P1|Overall Study|Renal transplant|12
3124448|NCT00077610|10684905|P3|Overall Study|Death|13
3124449|NCT00077610|10684906|P2|Overall Study|Death|13
3124450|NCT00077610|10684907|P1|Overall Study|Death|17
3124451|NCT00077610|10684905|P3|Overall Study|Withdrawal by Subject|6
3124452|NCT00077610|10684906|P2|Overall Study|Withdrawal by Subject|10
3124453|NCT00077610|10684907|P1|Overall Study|Withdrawal by Subject|4
3124454|NCT00077610|10684905|P3|Overall Study|Lost to Follow-up|2
3124455|NCT00077610|10684906|P2|Overall Study|Lost to Follow-up|1
3124456|NCT00077610|10684907|P1|Overall Study|Lost to Follow-up|0
3124457|NCT00077610|10684905|P3|Overall Study|Adverse Event|1
3124458|NCT00077610|10684906|P2|Overall Study|Adverse Event|7
3124459|NCT00077610|10684907|P1|Overall Study|Adverse Event|9
3124460|NCT00077376|10684936|P1|Overall Study|Insurance ran out|1
3124461|NCT00077376|10684936|P1|Overall Study|Surgery|1
3124462|NCT00077376|10684936|P1|Overall Study|Symptomatic deterioration|1
3124463|NCT00077376|10684936|P1|Overall Study|Still on treatment|1
3124464|NCT00077376|10684936|P1|Overall Study|Complicating disease|1
3124465|NCT00077376|10684936|P1|Overall Study|Alternative therapy|5
3124466|NCT00077376|10684936|P1|Overall Study|Physician Decision|1
3124467|NCT00077376|10684936|P1|Overall Study|Death|1
3124468|NCT00077376|10684936|P1|Overall Study|Withdrawal by Subject|2
3124469|NCT00077376|10684936|P1|Overall Study|Adverse Event|8
3124470|NCT00077207|10684947|P1|Overall Study|Ineligible|1
3124471|NCT00077207|10684947|P1|Overall Study|Withdrawal by Subject|6
3124472|NCT00077207|10684947|P1|Overall Study|Physician Decision|6
3124473|NCT00077207|10684947|P1|Overall Study|Lack of Efficacy|12
3124474|NCT00077207|10684947|P1|Overall Study|Adverse Event|5
3124475|NCT00077064|10684959|P2|Overall Study|Patient refusal|2
3124476|NCT00077064|10684960|P1|Overall Study|Patient refusal|0
3124477|NCT00077064|10684959|P2|Overall Study|Adverse Event|4
3124478|NCT00077064|10684960|P1|Overall Study|Adverse Event|0
3124479|NCT00076999|10684976|P5|Overall Study|Other reason (not specified)|13
3124480|NCT00076999|10684977|P4|Overall Study|Other reason (not specified)|1
3124481|NCT00076999|10684978|P3|Overall Study|Other reason (not specified)|4
3124482|NCT00076999|10684979|P2|Overall Study|Other reason (not specified)|8
3124483|NCT00076999|10684980|P1|Overall Study|Other reason (not specified)|8
3124484|NCT00076999|10684976|P5|Overall Study|Withdrawal by Subject|1
3124485|NCT00076999|10684977|P4|Overall Study|Withdrawal by Subject|0
3124486|NCT00076999|10684978|P3|Overall Study|Withdrawal by Subject|3
3124487|NCT00076999|10684979|P2|Overall Study|Withdrawal by Subject|4
3124488|NCT00076999|10684980|P1|Overall Study|Withdrawal by Subject|0
3124489|NCT00076999|10684976|P5|Overall Study|Lost to Follow-up|0
3124490|NCT00076999|10684977|P4|Overall Study|Lost to Follow-up|0
3124491|NCT00076999|10684978|P3|Overall Study|Lost to Follow-up|0
3124492|NCT00076999|10684979|P2|Overall Study|Lost to Follow-up|1
3124493|NCT00076999|10684980|P1|Overall Study|Lost to Follow-up|2
3124494|NCT00076999|10684976|P5|Overall Study|Protocol Violation|9
3124495|NCT00076999|10684977|P4|Overall Study|Protocol Violation|0
3124496|NCT00076999|10684978|P3|Overall Study|Protocol Violation|4
3124497|NCT00076999|10684979|P2|Overall Study|Protocol Violation|3
3124498|NCT00076999|10684980|P1|Overall Study|Protocol Violation|0
3124499|NCT00076999|10684976|P5|Overall Study|Adverse Event|2
3124500|NCT00076999|10684977|P4|Overall Study|Adverse Event|0
3124501|NCT00076999|10684978|P3|Overall Study|Adverse Event|6
3124502|NCT00076999|10684979|P2|Overall Study|Adverse Event|8
3124503|NCT00076999|10684980|P1|Overall Study|Adverse Event|2
3124504|NCT00003222|10685099|P2|Overall Study|Physician Decision|1
3124505|NCT00003222|10685100|P1|Overall Study|Physician Decision|0
3124506|NCT00076804|10685112|P2|Overall Study|Early study Closure|32
3124507|NCT00076804|10685113|P1|Overall Study|Early study Closure|32
3124508|NCT00076804|10685112|P2|Overall Study|Withdrawal by Subject|8
3124509|NCT00076804|10685113|P1|Overall Study|Withdrawal by Subject|10
3124510|NCT00076804|10685112|P2|Overall Study|Lost to Follow-up|9
3124511|NCT00076804|10685113|P1|Overall Study|Lost to Follow-up|9
3124512|NCT00076804|10685112|P2|Overall Study|Death|20
3124513|NCT00076804|10685113|P1|Overall Study|Death|9
3124514|NCT00076752|10685125|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
3124515|NCT00076752|10685125|P1|Overall Study|Death|2
3124516|NCT00076570|10685171|P2|Overall Study|Drug intolerance|8
3124517|NCT00076570|10685172|P1|Overall Study|Drug intolerance|8
3124518|NCT00003298|10685180|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
3124519|NCT00003298|10685180|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
3124520|NCT00003298|10685180|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
3124521|NCT00003298|10685180|P1|Step 2 (Adjuvant Therapy)|Death|1
3124522|NCT00003298|10685180|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
3124523|NCT00003298|10685180|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
3124524|NCT00003298|10685180|P1|Re-register to Step 2 After Surgery|Reason unknown|1
3124525|NCT00003298|10685180|P1|Re-register to Step 2 After Surgery|Other complications|2
3124526|NCT00003298|10685180|P1|Re-register to Step 2 After Surgery|Positive margins|5
3124527|NCT00003298|10685180|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
3124528|NCT00003298|10685180|P1|Surgery|Unevaluable and off study|2
3124529|NCT00003298|10685180|P1|Surgery|Progression before surgery|2
3124530|NCT00003298|10685180|P1|Surgery|Unresectable at surgery|3
3124531|NCT00003298|10685180|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
3124532|NCT00003298|10685180|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
3124533|NCT00076336|10685190|P2|Overall Study|Treatment failure|5
3124534|NCT00076336|10685191|P1|Overall Study|Treatment failure|4
3124535|NCT00076336|10685190|P2|Overall Study|Virologic Breakthrough|16
3124536|NCT00076336|10685191|P1|Overall Study|Virologic Breakthrough|14
3124537|NCT00076336|10685190|P2|Overall Study|Liver Transplantation|3
3124538|NCT00076336|10685191|P1|Overall Study|Liver Transplantation|3
3124539|NCT00076336|10685190|P2|Overall Study|Patient, Investigator, Sponsor request|6
3124540|NCT00076336|10685191|P1|Overall Study|Patient, Investigator, Sponsor request|8
3124541|NCT00076336|10685190|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
3124542|NCT00076336|10685191|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
3124543|NCT00076336|10685190|P2|Overall Study|Non-Compliance|0
3124544|NCT00076336|10685191|P1|Overall Study|Non-Compliance|2
3124545|NCT00076336|10685190|P2|Overall Study|Lost to Follow-up|4
3124546|NCT00076336|10685191|P1|Overall Study|Lost to Follow-up|4
3124547|NCT00076336|10685190|P2|Overall Study|Adverse Event|4
3124548|NCT00076336|10685191|P1|Overall Study|Adverse Event|4
3124549|NCT00076336|10685190|P2|Overall Study|Death|17
3124550|NCT00076336|10685191|P1|Overall Study|Death|13
3124551|NCT00076102|10685244|P1|Overall Study|refusal of further therapy|2
3124552|NCT00076102|10685244|P1|Overall Study|plexiform neurofibroma surgery|1
3124553|NCT00076102|10685244|P1|Overall Study|Progression in pre-existing brain tumor|1
3124554|NCT00076102|10685244|P1|Overall Study|Clinical progression|1
3124555|NCT00076024|10685272|P4|Phase 2, Open-label|Other|2
3124556|NCT00076024|10685273|P3|Phase 2, Open-label|Other|0
3124557|NCT00076024|10685274|P2|Phase 2, Open-label|Other|0
3124558|NCT00076024|10685275|P1|Phase 2, Open-label|Other|0
3124559|NCT00076024|10685272|P4|Phase 2, Open-label|Withdrawal by Subject|1
3124560|NCT00076024|10685273|P3|Phase 2, Open-label|Withdrawal by Subject|0
3124561|NCT00076024|10685274|P2|Phase 2, Open-label|Withdrawal by Subject|0
3124562|NCT00076024|10685275|P1|Phase 2, Open-label|Withdrawal by Subject|0
3124563|NCT00076024|10685272|P4|Phase 2, Open-label|Lack of Efficacy|11
3124564|NCT00076024|10685273|P3|Phase 2, Open-label|Lack of Efficacy|0
3124565|NCT00076024|10685274|P2|Phase 2, Open-label|Lack of Efficacy|0
3124566|NCT00076024|10685275|P1|Phase 2, Open-label|Lack of Efficacy|0
3124567|NCT00076024|10685272|P4|Phase 2, Open-label|Adverse Event|2
3124568|NCT00076024|10685273|P3|Phase 2, Open-label|Adverse Event|0
3124569|NCT00076024|10685274|P2|Phase 2, Open-label|Adverse Event|0
3124570|NCT00076024|10685275|P1|Phase 2, Open-label|Adverse Event|0
3124571|NCT00076024|10685272|P4|Phase 2, Double-blind|Randomized but not treated|0
3124572|NCT00076024|10685273|P3|Phase 2, Double-blind|Randomized but not treated|0
3124573|NCT00076024|10685274|P2|Phase 2, Double-blind|Randomized but not treated|1
3124574|NCT00076024|10685275|P1|Phase 2, Double-blind|Randomized but not treated|0
3124575|NCT00076024|10685272|P4|Phase 2, Double-blind|Un-specified|0
3124576|NCT00076024|10685273|P3|Phase 2, Double-blind|Un-specified|6
3124577|NCT00076024|10685274|P2|Phase 2, Double-blind|Un-specified|14
3124578|NCT00076024|10685275|P1|Phase 2, Double-blind|Un-specified|0
3124579|NCT00076024|10685272|P4|Phase 2, Double-blind|Adverse Event|0
3124580|NCT00076024|10685273|P3|Phase 2, Double-blind|Adverse Event|6
3124581|NCT00076024|10685274|P2|Phase 2, Double-blind|Adverse Event|25
3124582|NCT00076024|10685275|P1|Phase 2, Double-blind|Adverse Event|0
3124583|NCT00076024|10685272|P4|Phase 2, Double-blind|Withdrawal by Subject|0
3124584|NCT00076024|10685273|P3|Phase 2, Double-blind|Withdrawal by Subject|4
3124585|NCT00076024|10685274|P2|Phase 2, Double-blind|Withdrawal by Subject|13
3124586|NCT00076024|10685275|P1|Phase 2, Double-blind|Withdrawal by Subject|0
3124587|NCT00076024|10685272|P4|Phase 2, Double-blind|Lack of Efficacy|0
3124588|NCT00076024|10685273|P3|Phase 2, Double-blind|Lack of Efficacy|40
3124589|NCT00076024|10685274|P2|Phase 2, Double-blind|Lack of Efficacy|59
3124590|NCT00076024|10685275|P1|Phase 2, Double-blind|Lack of Efficacy|0
3124591|NCT00076024|10685272|P4|Phase 1, Lead-in|Clinical progression|0
3124592|NCT00076024|10685273|P3|Phase 1, Lead-in|Clinical progression|0
3124593|NCT00076024|10685274|P2|Phase 1, Lead-in|Clinical progression|0
3124594|NCT00076024|10685275|P1|Phase 1, Lead-in|Clinical progression|1
3124595|NCT00076024|10685272|P4|Phase 1, Lead-in|Adverse Event|0
3124596|NCT00076024|10685273|P3|Phase 1, Lead-in|Adverse Event|0
3124597|NCT00076024|10685274|P2|Phase 1, Lead-in|Adverse Event|0
3124598|NCT00076024|10685275|P1|Phase 1, Lead-in|Adverse Event|1
3124599|NCT00076024|10685272|P4|Phase 1, Lead-in|Lack of Efficacy|0
3124600|NCT00076024|10685273|P3|Phase 1, Lead-in|Lack of Efficacy|0
3124601|NCT00076024|10685274|P2|Phase 1, Lead-in|Lack of Efficacy|0
3124602|NCT00076024|10685275|P1|Phase 1, Lead-in|Lack of Efficacy|4
3124603|NCT00076011|10685289|P1|Overall Study|Ongoing|1
3124604|NCT00076011|10685289|P1|Overall Study|Other|11
3124605|NCT00076011|10685289|P1|Overall Study|Study terminated by sponsor|3
3124606|NCT00076011|10685289|P1|Overall Study|Withdrawal by Subject|1
3124607|NCT00076011|10685289|P1|Overall Study|Lack of Efficacy|25
3124608|NCT00076011|10685289|P1|Overall Study|Adverse Event|10
3124609|NCT00076011|10685289|P1|Overall Study|Death|1
3124610|NCT00075946|10685301|P5|Overall Study|Other|0
3124611|NCT00075946|10685302|P4|Overall Study|Other|2
3124612|NCT00075946|10685303|P3|Overall Study|Other|0
3124613|NCT00075946|10685304|P2|Overall Study|Other|13
3124614|NCT00075946|10685305|P1|Overall Study|Other|5
3124615|NCT00075946|10685301|P5|Overall Study|Time to progression less than 6 months|0
3124616|NCT00075946|10685302|P4|Overall Study|Time to progression less than 6 months|3
3124617|NCT00075946|10685303|P3|Overall Study|Time to progression less than 6 months|8
3124618|NCT00075946|10685304|P2|Overall Study|Time to progression less than 6 months|30
3124619|NCT00075946|10685305|P1|Overall Study|Time to progression less than 6 months|15
3124620|NCT00075946|10685301|P5|Overall Study|No response to retreatment|0
3124621|NCT00075946|10685302|P4|Overall Study|No response to retreatment|0
3124622|NCT00075946|10685303|P3|Overall Study|No response to retreatment|2
3124623|NCT00075946|10685304|P2|Overall Study|No response to retreatment|0
3124624|NCT00075946|10685305|P1|Overall Study|No response to retreatment|23
3124625|NCT00075946|10685301|P5|Overall Study|Other complicating disease|0
3124626|NCT00075946|10685302|P4|Overall Study|Other complicating disease|4
3124627|NCT00075946|10685303|P3|Overall Study|Other complicating disease|1
3124628|NCT00075946|10685304|P2|Overall Study|Other complicating disease|13
3124629|NCT00075946|10685305|P1|Overall Study|Other complicating disease|7
3124630|NCT00075946|10685301|P5|Overall Study|Alternative therapy|0
3124631|NCT00075946|10685302|P4|Overall Study|Alternative therapy|0
3124632|NCT00075946|10685303|P3|Overall Study|Alternative therapy|5
3124633|NCT00075946|10685304|P2|Overall Study|Alternative therapy|2
3124634|NCT00075946|10685305|P1|Overall Study|Alternative therapy|16
3124635|NCT00075946|10685301|P5|Overall Study|Withdrawal by Subject|0
3124636|NCT00075946|10685302|P4|Overall Study|Withdrawal by Subject|9
3124637|NCT00075946|10685303|P3|Overall Study|Withdrawal by Subject|4
3124638|NCT00075946|10685304|P2|Overall Study|Withdrawal by Subject|58
3124639|NCT00075946|10685305|P1|Overall Study|Withdrawal by Subject|23
3124640|NCT00075946|10685301|P5|Overall Study|Death|0
3124641|NCT00075946|10685302|P4|Overall Study|Death|0
3124642|NCT00075946|10685303|P3|Overall Study|Death|0
3124643|NCT00075946|10685304|P2|Overall Study|Death|1
3124644|NCT00075946|10685305|P1|Overall Study|Death|0
3124645|NCT00075946|10685301|P5|Overall Study|Adverse Event|0
3124646|NCT00075946|10685302|P4|Overall Study|Adverse Event|2
3124647|NCT00075946|10685303|P3|Overall Study|Adverse Event|0
3124648|NCT00075946|10685304|P2|Overall Study|Adverse Event|10
3124649|NCT00075946|10685305|P1|Overall Study|Adverse Event|2
3124650|NCT00075946|10685301|P5|Overall Study|Still on treatment at time of analysis|0
3124651|NCT00075946|10685302|P4|Overall Study|Still on treatment at time of analysis|9
3124652|NCT00075946|10685303|P3|Overall Study|Still on treatment at time of analysis|3
3124653|NCT00075946|10685304|P2|Overall Study|Still on treatment at time of analysis|19
3124654|NCT00075946|10685305|P1|Overall Study|Still on treatment at time of analysis|52
3124655|NCT00075946|10685301|P5|Overall Study|Incorrectly randomized (no response)|0
3124656|NCT00075946|10685302|P4|Overall Study|Incorrectly randomized (no response)|1
3124657|NCT00075946|10685303|P3|Overall Study|Incorrectly randomized (no response)|5
3124658|NCT00075946|10685304|P2|Overall Study|Incorrectly randomized (no response)|5
3124659|NCT00075946|10685305|P1|Overall Study|Incorrectly randomized (no response)|5
3124660|NCT00075946|10685301|P5|Overall Study|Did not achieve response after induction|182
3124661|NCT00075946|10685302|P4|Overall Study|Did not achieve response after induction|0
3124662|NCT00075946|10685303|P3|Overall Study|Did not achieve response after induction|0
3124663|NCT00075946|10685304|P2|Overall Study|Did not achieve response after induction|0
3124664|NCT00075946|10685305|P1|Overall Study|Did not achieve response after induction|0
3124665|NCT00075946|10685301|P5|Overall Study|Path ineligible: undetermined histology|6
3124666|NCT00075946|10685302|P4|Overall Study|Path ineligible: undetermined histology|0
3124667|NCT00075946|10685303|P3|Overall Study|Path ineligible: undetermined histology|0
3124668|NCT00075946|10685304|P2|Overall Study|Path ineligible: undetermined histology|0
3124669|NCT00075946|10685305|P1|Overall Study|Path ineligible: undetermined histology|0
3124670|NCT00075881|10685320|P1|Overall Study|never start protocol therapy|1
3124671|NCT00075881|10685320|P1|Overall Study|Ineligible|1
3124672|NCT00075881|10685320|P1|Overall Study|missing data|2
3124673|NCT00075881|10685320|P1|Overall Study|other|4
3124674|NCT00075881|10685320|P1|Overall Study|other complicating disease|3
3124675|NCT00075881|10685320|P1|Overall Study|Protocol Violation|4
3124676|NCT00075881|10685320|P1|Overall Study|Withdrawal by Subject|2
3124677|NCT00075881|10685320|P1|Overall Study|Death|1
3124678|NCT00075881|10685320|P1|Overall Study|Adverse Event|7
3124679|NCT00075881|10685320|P1|Overall Study|Lack of Efficacy|18
3124680|NCT00075816|10685364|P2|Overall Study|Did not undergo transplantation|11
3124681|NCT00075816|10685365|P1|Overall Study|Did not undergo transplantation|14
3124682|NCT00075764|10685434|P2|Overall Study|Under review|1
3124683|NCT00075764|10685435|P1|Overall Study|Under review|0
3124684|NCT00075764|10685434|P2|Overall Study|Not protocol specified|19
3124685|NCT00075764|10685435|P1|Overall Study|Not protocol specified|27
3124686|NCT00075764|10685434|P2|Overall Study|Delinquent|2
3124687|NCT00075764|10685435|P1|Overall Study|Delinquent|4
3124688|NCT00075764|10685434|P2|Overall Study|Still on treatment|15
3124689|NCT00075764|10685435|P1|Overall Study|Still on treatment|8
3124690|NCT00075764|10685434|P2|Overall Study|Progression|274
3124691|NCT00075764|10685435|P1|Overall Study|Progression|269
3124692|NCT00075764|10685434|P2|Overall Study|Withdrawal by Subject|18
3124693|NCT00075764|10685435|P1|Overall Study|Withdrawal by Subject|28
3124694|NCT00075764|10685434|P2|Overall Study|Death|8
3124695|NCT00075764|10685435|P1|Overall Study|Death|4
3124696|NCT00075764|10685434|P2|Overall Study|Adverse Event|12
3124697|NCT00075764|10685435|P1|Overall Study|Adverse Event|5
3124698|NCT00075725|10685459|P12|Overall Study|Pt incarcerated|0
3124699|NCT00075725|10685460|P11|Overall Study|Pt incarcerated|0
3124700|NCT00075725|10685461|P10|Overall Study|Pt incarcerated|0
3124701|NCT00075725|10685462|P9|Overall Study|Pt incarcerated|0
3124702|NCT00075725|10685463|P8|Overall Study|Pt incarcerated|1
3124703|NCT00075725|10685464|P7|Overall Study|Pt incarcerated|0
3124704|NCT00075725|10685465|P6|Overall Study|Pt incarcerated|0
3124705|NCT00075725|10685466|P5|Overall Study|Pt incarcerated|0
3124706|NCT00075725|10685467|P4|Overall Study|Pt incarcerated|0
3124707|NCT00075725|10685468|P3|Overall Study|Pt incarcerated|0
3124708|NCT00075725|10685469|P2|Overall Study|Pt incarcerated|0
3124709|NCT00075725|10685470|P1|Overall Study|Pt incarcerated|0
3124710|NCT00075725|10685459|P12|Overall Study|Pt care terminated due to pt behavior|0
3124711|NCT00075725|10685460|P11|Overall Study|Pt care terminated due to pt behavior|0
3124712|NCT00075725|10685461|P10|Overall Study|Pt care terminated due to pt behavior|0
3124713|NCT00075725|10685462|P9|Overall Study|Pt care terminated due to pt behavior|0
3124714|NCT00075725|10685463|P8|Overall Study|Pt care terminated due to pt behavior|1
3124715|NCT00075725|10685464|P7|Overall Study|Pt care terminated due to pt behavior|0
3124716|NCT00075725|10685465|P6|Overall Study|Pt care terminated due to pt behavior|0
3124717|NCT00075725|10685466|P5|Overall Study|Pt care terminated due to pt behavior|0
3124718|NCT00075725|10685467|P4|Overall Study|Pt care terminated due to pt behavior|0
3124719|NCT00075725|10685468|P3|Overall Study|Pt care terminated due to pt behavior|0
3124720|NCT00075725|10685469|P2|Overall Study|Pt care terminated due to pt behavior|0
3124721|NCT00075725|10685470|P1|Overall Study|Pt care terminated due to pt behavior|0
3124722|NCT00075725|10685459|P12|Overall Study|Other complications|0
3124723|NCT00075725|10685460|P11|Overall Study|Other complications|0
3124724|NCT00075725|10685461|P10|Overall Study|Other complications|0
3124725|NCT00075725|10685462|P9|Overall Study|Other complications|0
3124726|NCT00075725|10685463|P8|Overall Study|Other complications|0
3124727|NCT00075725|10685464|P7|Overall Study|Other complications|0
3124728|NCT00075725|10685465|P6|Overall Study|Other complications|1
3124729|NCT00075725|10685466|P5|Overall Study|Other complications|0
3124730|NCT00075725|10685467|P4|Overall Study|Other complications|0
3124731|NCT00075725|10685468|P3|Overall Study|Other complications|0
3124732|NCT00075725|10685469|P2|Overall Study|Other complications|0
3124733|NCT00075725|10685470|P1|Overall Study|Other complications|0
3124734|NCT00075725|10685459|P12|Overall Study|Study Closure|0
3124735|NCT00075725|10685460|P11|Overall Study|Study Closure|0
3124736|NCT00075725|10685461|P10|Overall Study|Study Closure|0
3124737|NCT00075725|10685462|P9|Overall Study|Study Closure|0
3124738|NCT00075725|10685463|P8|Overall Study|Study Closure|1
3124739|NCT00075725|10685464|P7|Overall Study|Study Closure|0
3124740|NCT00075725|10685465|P6|Overall Study|Study Closure|3
3124741|NCT00075725|10685466|P5|Overall Study|Study Closure|1
3124742|NCT00075725|10685467|P4|Overall Study|Study Closure|0
3124743|NCT00075725|10685468|P3|Overall Study|Study Closure|0
3124744|NCT00075725|10685469|P2|Overall Study|Study Closure|0
3124745|NCT00075725|10685470|P1|Overall Study|Study Closure|1
3124746|NCT00075725|10685459|P12|Overall Study|Institution Terminated|0
3124747|NCT00075725|10685460|P11|Overall Study|Institution Terminated|0
3124748|NCT00075725|10685461|P10|Overall Study|Institution Terminated|0
3124749|NCT00075725|10685462|P9|Overall Study|Institution Terminated|0
3124750|NCT00075725|10685463|P8|Overall Study|Institution Terminated|3
3124751|NCT00075725|10685464|P7|Overall Study|Institution Terminated|0
3124752|NCT00075725|10685465|P6|Overall Study|Institution Terminated|0
3124753|NCT00075725|10685466|P5|Overall Study|Institution Terminated|1
3124754|NCT00075725|10685467|P4|Overall Study|Institution Terminated|0
3124755|NCT00075725|10685468|P3|Overall Study|Institution Terminated|0
3124756|NCT00075725|10685469|P2|Overall Study|Institution Terminated|0
3124757|NCT00075725|10685470|P1|Overall Study|Institution Terminated|0
3124758|NCT00075725|10685459|P12|Overall Study|Pt relocated|0
3124759|NCT00075725|10685460|P11|Overall Study|Pt relocated|0
3124760|NCT00075725|10685461|P10|Overall Study|Pt relocated|0
3124761|NCT00075725|10685462|P9|Overall Study|Pt relocated|1
3124762|NCT00075725|10685463|P8|Overall Study|Pt relocated|2
3124763|NCT00075725|10685464|P7|Overall Study|Pt relocated|1
3124764|NCT00075725|10685465|P6|Overall Study|Pt relocated|1
3124765|NCT00075725|10685466|P5|Overall Study|Pt relocated|0
3124766|NCT00075725|10685467|P4|Overall Study|Pt relocated|2
3124767|NCT00075725|10685468|P3|Overall Study|Pt relocated|0
3124768|NCT00075725|10685469|P2|Overall Study|Pt relocated|0
3124769|NCT00075725|10685470|P1|Overall Study|Pt relocated|0
3124770|NCT00075725|10685459|P12|Overall Study|Pt received additional steroids|0
3124771|NCT00075725|10685460|P11|Overall Study|Pt received additional steroids|0
3124772|NCT00075725|10685461|P10|Overall Study|Pt received additional steroids|0
3124773|NCT00075725|10685462|P9|Overall Study|Pt received additional steroids|0
3124774|NCT00075725|10685463|P8|Overall Study|Pt received additional steroids|0
3124775|NCT00075725|10685464|P7|Overall Study|Pt received additional steroids|0
3124776|NCT00075725|10685465|P6|Overall Study|Pt received additional steroids|0
3124777|NCT00075725|10685466|P5|Overall Study|Pt received additional steroids|0
3124778|NCT00075725|10685467|P4|Overall Study|Pt received additional steroids|1
3124779|NCT00075725|10685468|P3|Overall Study|Pt received additional steroids|0
3124780|NCT00075725|10685469|P2|Overall Study|Pt received additional steroids|0
3124781|NCT00075725|10685470|P1|Overall Study|Pt received additional steroids|0
3124782|NCT00075725|10685459|P12|Overall Study|Pt went to transplant|0
3124783|NCT00075725|10685460|P11|Overall Study|Pt went to transplant|0
3124784|NCT00075725|10685461|P10|Overall Study|Pt went to transplant|0
3124785|NCT00075725|10685462|P9|Overall Study|Pt went to transplant|0
3124786|NCT00075725|10685463|P8|Overall Study|Pt went to transplant|0
3124787|NCT00075725|10685464|P7|Overall Study|Pt went to transplant|0
3124788|NCT00075725|10685465|P6|Overall Study|Pt went to transplant|1
3124789|NCT00075725|10685466|P5|Overall Study|Pt went to transplant|0
3124790|NCT00075725|10685467|P4|Overall Study|Pt went to transplant|1
3124791|NCT00075725|10685468|P3|Overall Study|Pt went to transplant|0
3124792|NCT00075725|10685469|P2|Overall Study|Pt went to transplant|0
3124793|NCT00075725|10685470|P1|Overall Study|Pt went to transplant|0
3124794|NCT00075725|10685459|P12|Overall Study|specimen(s) not submitted|0
3124795|NCT00075725|10685460|P11|Overall Study|specimen(s) not submitted|0
3124796|NCT00075725|10685461|P10|Overall Study|specimen(s) not submitted|0
3124797|NCT00075725|10685462|P9|Overall Study|specimen(s) not submitted|0
3124798|NCT00075725|10685463|P8|Overall Study|specimen(s) not submitted|0
3124799|NCT00075725|10685464|P7|Overall Study|specimen(s) not submitted|0
3124800|NCT00075725|10685465|P6|Overall Study|specimen(s) not submitted|0
3124801|NCT00075725|10685466|P5|Overall Study|specimen(s) not submitted|0
3124802|NCT00075725|10685467|P4|Overall Study|specimen(s) not submitted|0
3124803|NCT00075725|10685468|P3|Overall Study|specimen(s) not submitted|2
3124804|NCT00075725|10685469|P2|Overall Study|specimen(s) not submitted|0
3124805|NCT00075725|10685470|P1|Overall Study|specimen(s) not submitted|0
3124806|NCT00075725|10685459|P12|Overall Study|Unsuccessful institutional transfer|0
3124807|NCT00075725|10685460|P11|Overall Study|Unsuccessful institutional transfer|0
3124808|NCT00075725|10685461|P10|Overall Study|Unsuccessful institutional transfer|1
3124809|NCT00075725|10685462|P9|Overall Study|Unsuccessful institutional transfer|0
3124810|NCT00075725|10685463|P8|Overall Study|Unsuccessful institutional transfer|0
3124811|NCT00075725|10685464|P7|Overall Study|Unsuccessful institutional transfer|0
3124812|NCT00075725|10685465|P6|Overall Study|Unsuccessful institutional transfer|0
3124813|NCT00075725|10685466|P5|Overall Study|Unsuccessful institutional transfer|0
3124814|NCT00075725|10685467|P4|Overall Study|Unsuccessful institutional transfer|0
3124815|NCT00075725|10685468|P3|Overall Study|Unsuccessful institutional transfer|2
3124816|NCT00075725|10685469|P2|Overall Study|Unsuccessful institutional transfer|0
3124817|NCT00075725|10685470|P1|Overall Study|Unsuccessful institutional transfer|0
3124818|NCT00075725|10685459|P12|Overall Study|Clinic chart lost unable to recreate|0
3124819|NCT00075725|10685460|P11|Overall Study|Clinic chart lost unable to recreate|0
3124820|NCT00075725|10685461|P10|Overall Study|Clinic chart lost unable to recreate|0
3124821|NCT00075725|10685462|P9|Overall Study|Clinic chart lost unable to recreate|0
3124822|NCT00075725|10685463|P8|Overall Study|Clinic chart lost unable to recreate|0
3124823|NCT00075725|10685464|P7|Overall Study|Clinic chart lost unable to recreate|0
3124824|NCT00075725|10685465|P6|Overall Study|Clinic chart lost unable to recreate|0
3124825|NCT00075725|10685466|P5|Overall Study|Clinic chart lost unable to recreate|0
3124826|NCT00075725|10685467|P4|Overall Study|Clinic chart lost unable to recreate|0
3124827|NCT00075725|10685468|P3|Overall Study|Clinic chart lost unable to recreate|1
3124828|NCT00075725|10685469|P2|Overall Study|Clinic chart lost unable to recreate|0
3124829|NCT00075725|10685470|P1|Overall Study|Clinic chart lost unable to recreate|0
3124830|NCT00075725|10685459|P12|Overall Study|Pt trying to find a BM donor|0
3124831|NCT00075725|10685460|P11|Overall Study|Pt trying to find a BM donor|0
3124832|NCT00075725|10685461|P10|Overall Study|Pt trying to find a BM donor|0
3124833|NCT00075725|10685462|P9|Overall Study|Pt trying to find a BM donor|0
3124834|NCT00075725|10685463|P8|Overall Study|Pt trying to find a BM donor|0
3124835|NCT00075725|10685464|P7|Overall Study|Pt trying to find a BM donor|0
3124836|NCT00075725|10685465|P6|Overall Study|Pt trying to find a BM donor|0
3124837|NCT00075725|10685466|P5|Overall Study|Pt trying to find a BM donor|0
3124838|NCT00075725|10685467|P4|Overall Study|Pt trying to find a BM donor|0
3124839|NCT00075725|10685468|P3|Overall Study|Pt trying to find a BM donor|0
3124840|NCT00075725|10685469|P2|Overall Study|Pt trying to find a BM donor|1
3124841|NCT00075725|10685470|P1|Overall Study|Pt trying to find a BM donor|0
3124842|NCT00075725|10685459|P12|Overall Study|Other|3
3124843|NCT00075725|10685460|P11|Overall Study|Other|0
3124844|NCT00075725|10685461|P10|Overall Study|Other|1
3124845|NCT00075725|10685462|P9|Overall Study|Other|2
3124846|NCT00075725|10685463|P8|Overall Study|Other|9
3124847|NCT00075725|10685464|P7|Overall Study|Other|2
3124848|NCT00075725|10685465|P6|Overall Study|Other|4
3124849|NCT00075725|10685466|P5|Overall Study|Other|1
3124850|NCT00075725|10685467|P4|Overall Study|Other|1
3124851|NCT00075725|10685468|P3|Overall Study|Other|1
3124852|NCT00075725|10685469|P2|Overall Study|Other|2
3124853|NCT00075725|10685470|P1|Overall Study|Other|4
3124854|NCT00075725|10685459|P12|Overall Study|Inevaluable|0
3124855|NCT00075725|10685460|P11|Overall Study|Inevaluable|1
3124856|NCT00075725|10685461|P10|Overall Study|Inevaluable|0
3124857|NCT00075725|10685462|P9|Overall Study|Inevaluable|2
3124858|NCT00075725|10685463|P8|Overall Study|Inevaluable|11
3124859|NCT00075725|10685464|P7|Overall Study|Inevaluable|1
3124860|NCT00075725|10685465|P6|Overall Study|Inevaluable|9
3124861|NCT00075725|10685466|P5|Overall Study|Inevaluable|2
3124862|NCT00075725|10685467|P4|Overall Study|Inevaluable|2
3124863|NCT00075725|10685468|P3|Overall Study|Inevaluable|4
3124864|NCT00075725|10685469|P2|Overall Study|Inevaluable|1
3124865|NCT00075725|10685470|P1|Overall Study|Inevaluable|1
3124866|NCT00075725|10685459|P12|Overall Study|Pt has very high risk ALL characteristic|3
3124867|NCT00075725|10685460|P11|Overall Study|Pt has very high risk ALL characteristic|0
3124868|NCT00075725|10685461|P10|Overall Study|Pt has very high risk ALL characteristic|1
3124869|NCT00075725|10685462|P9|Overall Study|Pt has very high risk ALL characteristic|29
3124870|NCT00075725|10685463|P8|Overall Study|Pt has very high risk ALL characteristic|74
3124871|NCT00075725|10685464|P7|Overall Study|Pt has very high risk ALL characteristic|23
3124872|NCT00075725|10685465|P6|Overall Study|Pt has very high risk ALL characteristic|75
3124873|NCT00075725|10685466|P5|Overall Study|Pt has very high risk ALL characteristic|11
3124874|NCT00075725|10685467|P4|Overall Study|Pt has very high risk ALL characteristic|18
3124875|NCT00075725|10685468|P3|Overall Study|Pt has very high risk ALL characteristic|26
3124876|NCT00075725|10685469|P2|Overall Study|Pt has very high risk ALL characteristic|11
3124877|NCT00075725|10685470|P1|Overall Study|Pt has very high risk ALL characteristic|15
3124878|NCT00075725|10685459|P12|Overall Study|MRD positive after extended ind|0
3124879|NCT00075725|10685460|P11|Overall Study|MRD positive after extended ind|0
3124880|NCT00075725|10685461|P10|Overall Study|MRD positive after extended ind|0
3124881|NCT00075725|10685462|P9|Overall Study|MRD positive after extended ind|0
3124882|NCT00075725|10685463|P8|Overall Study|MRD positive after extended ind|1
3124883|NCT00075725|10685464|P7|Overall Study|MRD positive after extended ind|0
3124884|NCT00075725|10685465|P6|Overall Study|MRD positive after extended ind|2
3124885|NCT00075725|10685466|P5|Overall Study|MRD positive after extended ind|1
3124886|NCT00075725|10685467|P4|Overall Study|MRD positive after extended ind|0
3124887|NCT00075725|10685468|P3|Overall Study|MRD positive after extended ind|1
3124888|NCT00075725|10685469|P2|Overall Study|MRD positive after extended ind|1
3124889|NCT00075725|10685470|P1|Overall Study|MRD positive after extended ind|0
3124890|NCT00075725|10685459|P12|Overall Study|Insurance issues|0
3124891|NCT00075725|10685460|P11|Overall Study|Insurance issues|0
3124892|NCT00075725|10685461|P10|Overall Study|Insurance issues|0
3124893|NCT00075725|10685462|P9|Overall Study|Insurance issues|0
3124894|NCT00075725|10685463|P8|Overall Study|Insurance issues|1
3124895|NCT00075725|10685464|P7|Overall Study|Insurance issues|0
3124896|NCT00075725|10685465|P6|Overall Study|Insurance issues|1
3124897|NCT00075725|10685466|P5|Overall Study|Insurance issues|1
3124898|NCT00075725|10685467|P4|Overall Study|Insurance issues|1
3124899|NCT00075725|10685468|P3|Overall Study|Insurance issues|0
3124900|NCT00075725|10685469|P2|Overall Study|Insurance issues|1
3124901|NCT00075725|10685470|P1|Overall Study|Insurance issues|0
3124902|NCT00075725|10685459|P12|Overall Study|Pt age out of range for treatment|0
3124903|NCT00075725|10685460|P11|Overall Study|Pt age out of range for treatment|0
3124904|NCT00075725|10685461|P10|Overall Study|Pt age out of range for treatment|0
3124905|NCT00075725|10685462|P9|Overall Study|Pt age out of range for treatment|0
3124906|NCT00075725|10685463|P8|Overall Study|Pt age out of range for treatment|1
3124907|NCT00075725|10685464|P7|Overall Study|Pt age out of range for treatment|0
3124908|NCT00075725|10685465|P6|Overall Study|Pt age out of range for treatment|1
3124909|NCT00075725|10685466|P5|Overall Study|Pt age out of range for treatment|0
3124910|NCT00075725|10685467|P4|Overall Study|Pt age out of range for treatment|0
3124911|NCT00075725|10685468|P3|Overall Study|Pt age out of range for treatment|0
3124912|NCT00075725|10685469|P2|Overall Study|Pt age out of range for treatment|1
3124913|NCT00075725|10685470|P1|Overall Study|Pt age out of range for treatment|0
3124914|NCT00075725|10685459|P12|Overall Study|Pt non compliant with therapy|0
3124915|NCT00075725|10685460|P11|Overall Study|Pt non compliant with therapy|0
3124916|NCT00075725|10685461|P10|Overall Study|Pt non compliant with therapy|0
3124917|NCT00075725|10685462|P9|Overall Study|Pt non compliant with therapy|3
3124918|NCT00075725|10685463|P8|Overall Study|Pt non compliant with therapy|5
3124919|NCT00075725|10685464|P7|Overall Study|Pt non compliant with therapy|2
3124920|NCT00075725|10685465|P6|Overall Study|Pt non compliant with therapy|14
3124921|NCT00075725|10685466|P5|Overall Study|Pt non compliant with therapy|2
3124922|NCT00075725|10685467|P4|Overall Study|Pt non compliant with therapy|0
3124923|NCT00075725|10685468|P3|Overall Study|Pt non compliant with therapy|1
3124924|NCT00075725|10685469|P2|Overall Study|Pt non compliant with therapy|1
3124925|NCT00075725|10685470|P1|Overall Study|Pt non compliant with therapy|2
3124926|NCT00075725|10685459|P12|Overall Study|Pt/Guardian refused RT therapy|0
3124927|NCT00075725|10685460|P11|Overall Study|Pt/Guardian refused RT therapy|0
3124928|NCT00075725|10685461|P10|Overall Study|Pt/Guardian refused RT therapy|0
3124929|NCT00075725|10685462|P9|Overall Study|Pt/Guardian refused RT therapy|0
3124930|NCT00075725|10685463|P8|Overall Study|Pt/Guardian refused RT therapy|0
3124931|NCT00075725|10685464|P7|Overall Study|Pt/Guardian refused RT therapy|0
3124932|NCT00075725|10685465|P6|Overall Study|Pt/Guardian refused RT therapy|0
3124933|NCT00075725|10685466|P5|Overall Study|Pt/Guardian refused RT therapy|1
3124934|NCT00075725|10685467|P4|Overall Study|Pt/Guardian refused RT therapy|2
3124935|NCT00075725|10685468|P3|Overall Study|Pt/Guardian refused RT therapy|1
3124936|NCT00075725|10685469|P2|Overall Study|Pt/Guardian refused RT therapy|0
3124937|NCT00075725|10685470|P1|Overall Study|Pt/Guardian refused RT therapy|1
3124938|NCT00075725|10685459|P12|Overall Study|Ineligible or wrong diagnosis|4
3124939|NCT00075725|10685460|P11|Overall Study|Ineligible or wrong diagnosis|2
3124940|NCT00075725|10685461|P10|Overall Study|Ineligible or wrong diagnosis|1
3124941|NCT00075725|10685462|P9|Overall Study|Ineligible or wrong diagnosis|10
3124942|NCT00075725|10685463|P8|Overall Study|Ineligible or wrong diagnosis|9
3124943|NCT00075725|10685464|P7|Overall Study|Ineligible or wrong diagnosis|6
3124944|NCT00075725|10685465|P6|Overall Study|Ineligible or wrong diagnosis|17
3124945|NCT00075725|10685466|P5|Overall Study|Ineligible or wrong diagnosis|3
3124946|NCT00075725|10685467|P4|Overall Study|Ineligible or wrong diagnosis|10
3124947|NCT00075725|10685468|P3|Overall Study|Ineligible or wrong diagnosis|3
3124948|NCT00075725|10685469|P2|Overall Study|Ineligible or wrong diagnosis|3
3124949|NCT00075725|10685470|P1|Overall Study|Ineligible or wrong diagnosis|8
3124950|NCT00075725|10685459|P12|Overall Study|Patient off treatment|0
3124951|NCT00075725|10685460|P11|Overall Study|Patient off treatment|0
3124952|NCT00075725|10685461|P10|Overall Study|Patient off treatment|0
3124953|NCT00075725|10685462|P9|Overall Study|Patient off treatment|1
3124954|NCT00075725|10685463|P8|Overall Study|Patient off treatment|2
3124955|NCT00075725|10685464|P7|Overall Study|Patient off treatment|0
3124956|NCT00075725|10685465|P6|Overall Study|Patient off treatment|0
3124957|NCT00075725|10685466|P5|Overall Study|Patient off treatment|1
3124958|NCT00075725|10685467|P4|Overall Study|Patient off treatment|2
3124959|NCT00075725|10685468|P3|Overall Study|Patient off treatment|1
3124960|NCT00075725|10685469|P2|Overall Study|Patient off treatment|0
3124961|NCT00075725|10685470|P1|Overall Study|Patient off treatment|0
3124962|NCT00075725|10685459|P12|Overall Study|Disease Progression, all other reasons|5
3124963|NCT00075725|10685460|P11|Overall Study|Disease Progression, all other reasons|0
3124964|NCT00075725|10685461|P10|Overall Study|Disease Progression, all other reasons|4
3124965|NCT00075725|10685462|P9|Overall Study|Disease Progression, all other reasons|21
3124966|NCT00075725|10685463|P8|Overall Study|Disease Progression, all other reasons|46
3124967|NCT00075725|10685464|P7|Overall Study|Disease Progression, all other reasons|20
3124968|NCT00075725|10685465|P6|Overall Study|Disease Progression, all other reasons|59
3124969|NCT00075725|10685466|P5|Overall Study|Disease Progression, all other reasons|21
3124970|NCT00075725|10685467|P4|Overall Study|Disease Progression, all other reasons|6
3124971|NCT00075725|10685468|P3|Overall Study|Disease Progression, all other reasons|33
3124972|NCT00075725|10685469|P2|Overall Study|Disease Progression, all other reasons|5
3124973|NCT00075725|10685470|P1|Overall Study|Disease Progression, all other reasons|17
3124974|NCT00075725|10685459|P12|Overall Study|Withdrawal by Subject|0
3124975|NCT00075725|10685460|P11|Overall Study|Withdrawal by Subject|0
3124976|NCT00075725|10685461|P10|Overall Study|Withdrawal by Subject|2
3124977|NCT00075725|10685462|P9|Overall Study|Withdrawal by Subject|10
3124978|NCT00075725|10685463|P8|Overall Study|Withdrawal by Subject|31
3124979|NCT00075725|10685464|P7|Overall Study|Withdrawal by Subject|7
3124980|NCT00075725|10685465|P6|Overall Study|Withdrawal by Subject|27
3124981|NCT00075725|10685466|P5|Overall Study|Withdrawal by Subject|6
3124982|NCT00075725|10685467|P4|Overall Study|Withdrawal by Subject|10
3124983|NCT00075725|10685468|P3|Overall Study|Withdrawal by Subject|6
3124984|NCT00075725|10685469|P2|Overall Study|Withdrawal by Subject|3
3124985|NCT00075725|10685470|P1|Overall Study|Withdrawal by Subject|12
3124986|NCT00075725|10685459|P12|Overall Study|Protocol Violation|1
3124987|NCT00075725|10685460|P11|Overall Study|Protocol Violation|0
3124988|NCT00075725|10685461|P10|Overall Study|Protocol Violation|0
3124989|NCT00075725|10685462|P9|Overall Study|Protocol Violation|3
3124990|NCT00075725|10685463|P8|Overall Study|Protocol Violation|2
3124991|NCT00075725|10685464|P7|Overall Study|Protocol Violation|1
3124992|NCT00075725|10685465|P6|Overall Study|Protocol Violation|2
3124993|NCT00075725|10685466|P5|Overall Study|Protocol Violation|3
3124994|NCT00075725|10685467|P4|Overall Study|Protocol Violation|3
3124995|NCT00075725|10685468|P3|Overall Study|Protocol Violation|0
3124996|NCT00075725|10685469|P2|Overall Study|Protocol Violation|1
3124997|NCT00075725|10685470|P1|Overall Study|Protocol Violation|1
3124998|NCT00075725|10685459|P12|Overall Study|Pregnancy|0
3124999|NCT00075725|10685460|P11|Overall Study|Pregnancy|0
3125000|NCT00075725|10685461|P10|Overall Study|Pregnancy|0
3125001|NCT00075725|10685462|P9|Overall Study|Pregnancy|0
3125002|NCT00075725|10685463|P8|Overall Study|Pregnancy|1
3125003|NCT00075725|10685464|P7|Overall Study|Pregnancy|0
3125004|NCT00075725|10685465|P6|Overall Study|Pregnancy|1
3125005|NCT00075725|10685466|P5|Overall Study|Pregnancy|0
3125006|NCT00075725|10685467|P4|Overall Study|Pregnancy|0
3125007|NCT00075725|10685468|P3|Overall Study|Pregnancy|0
3125008|NCT00075725|10685469|P2|Overall Study|Pregnancy|0
3125009|NCT00075725|10685470|P1|Overall Study|Pregnancy|0
3125010|NCT00075725|10685459|P12|Overall Study|Physician Decision|0
3125011|NCT00075725|10685460|P11|Overall Study|Physician Decision|1
3125012|NCT00075725|10685461|P10|Overall Study|Physician Decision|0
3125013|NCT00075725|10685462|P9|Overall Study|Physician Decision|5
3125014|NCT00075725|10685463|P8|Overall Study|Physician Decision|17
3125015|NCT00075725|10685464|P7|Overall Study|Physician Decision|3
3125016|NCT00075725|10685465|P6|Overall Study|Physician Decision|19
3125017|NCT00075725|10685466|P5|Overall Study|Physician Decision|4
3125018|NCT00075725|10685467|P4|Overall Study|Physician Decision|8
3125019|NCT00075725|10685468|P3|Overall Study|Physician Decision|5
3125020|NCT00075725|10685469|P2|Overall Study|Physician Decision|6
3125021|NCT00075725|10685470|P1|Overall Study|Physician Decision|2
3125022|NCT00075725|10685459|P12|Overall Study|Lost to Follow-up|0
3125023|NCT00075725|10685460|P11|Overall Study|Lost to Follow-up|0
3125024|NCT00075725|10685461|P10|Overall Study|Lost to Follow-up|0
3125025|NCT00075725|10685462|P9|Overall Study|Lost to Follow-up|1
3125026|NCT00075725|10685463|P8|Overall Study|Lost to Follow-up|4
3125027|NCT00075725|10685464|P7|Overall Study|Lost to Follow-up|2
3125028|NCT00075725|10685465|P6|Overall Study|Lost to Follow-up|13
3125029|NCT00075725|10685466|P5|Overall Study|Lost to Follow-up|0
3125030|NCT00075725|10685467|P4|Overall Study|Lost to Follow-up|1
3125031|NCT00075725|10685468|P3|Overall Study|Lost to Follow-up|4
3125032|NCT00075725|10685469|P2|Overall Study|Lost to Follow-up|1
3125033|NCT00075725|10685470|P1|Overall Study|Lost to Follow-up|1
3125034|NCT00075725|10685459|P12|Overall Study|Death|0
3125035|NCT00075725|10685460|P11|Overall Study|Death|3
3125036|NCT00075725|10685461|P10|Overall Study|Death|4
3125037|NCT00075725|10685462|P9|Overall Study|Death|14
3125038|NCT00075725|10685463|P8|Overall Study|Death|22
3125039|NCT00075725|10685464|P7|Overall Study|Death|4
3125040|NCT00075725|10685465|P6|Overall Study|Death|25
3125041|NCT00075725|10685466|P5|Overall Study|Death|3
3125042|NCT00075725|10685467|P4|Overall Study|Death|2
3125043|NCT00075725|10685468|P3|Overall Study|Death|10
3125044|NCT00075725|10685469|P2|Overall Study|Death|5
3125045|NCT00075725|10685470|P1|Overall Study|Death|3
3125046|NCT00075725|10685459|P12|Overall Study|Adverse Event|2
3125047|NCT00075725|10685460|P11|Overall Study|Adverse Event|2
3125048|NCT00075725|10685461|P10|Overall Study|Adverse Event|4
3125049|NCT00075725|10685462|P9|Overall Study|Adverse Event|15
3125050|NCT00075725|10685463|P8|Overall Study|Adverse Event|51
3125051|NCT00075725|10685464|P7|Overall Study|Adverse Event|3
3125052|NCT00075725|10685465|P6|Overall Study|Adverse Event|38
3125053|NCT00075725|10685466|P5|Overall Study|Adverse Event|4
3125054|NCT00075725|10685467|P4|Overall Study|Adverse Event|8
3125055|NCT00075725|10685468|P3|Overall Study|Adverse Event|20
3125056|NCT00075725|10685469|P2|Overall Study|Adverse Event|6
3125057|NCT00075725|10685470|P1|Overall Study|Adverse Event|6
3125058|NCT00075582|10685567|P2|Overall Study|Ineligible for study|16
3125059|NCT00075582|10685568|P1|Overall Study|Ineligible for study|36
3125060|NCT00075582|10685567|P2|Overall Study|Withdrawal by Subject|2
3125061|NCT00075582|10685568|P1|Overall Study|Withdrawal by Subject|2
3125062|NCT00075582|10685567|P2|Overall Study|Physician Decision|8
3125063|NCT00075582|10685568|P1|Overall Study|Physician Decision|5
3125064|NCT00075582|10685567|P2|Overall Study|Lack of Efficacy|8
3125065|NCT00075582|10685568|P1|Overall Study|Lack of Efficacy|4
3125066|NCT00075582|10685567|P2|Overall Study|Adverse Event|1
3125067|NCT00075582|10685568|P1|Overall Study|Adverse Event|3
3125068|NCT00075504|10685582|P2|Overall Study|Withdrawal by Subject|7
3125069|NCT00075504|10685583|P1|Overall Study|Withdrawal by Subject|9
3125070|NCT00075478|10685595|P2|Overall Study|Physician Decision|1
3125071|NCT00075478|10685596|P1|Overall Study|Physician Decision|0
3125072|NCT00075478|10685595|P2|Overall Study|not eligible|0
3125073|NCT00075478|10685596|P1|Overall Study|not eligible|1
3125074|NCT00075400|10685616|P1|Overall Study|Never treated|2
3125075|NCT00075400|10685616|P1|Overall Study|Ineligible: wrong primary|1
3125076|NCT00075270|10685637|P2|Overall Study|Missing|13
3125077|NCT00075270|10685638|P1|Overall Study|Missing|26
3125078|NCT00075270|10685637|P2|Overall Study|Other/Unknown|5
3125079|NCT00075270|10685638|P1|Overall Study|Other/Unknown|9
3125080|NCT00075270|10685637|P2|Overall Study|Death|215
3125081|NCT00075270|10685638|P1|Overall Study|Death|198
3125082|NCT00075270|10685637|P2|Overall Study|Protocol Violation|2
3125083|NCT00075270|10685638|P1|Overall Study|Protocol Violation|0
3125084|NCT00075270|10685637|P2|Overall Study|Lost to Follow-up|28
3125085|NCT00075270|10685638|P1|Overall Study|Lost to Follow-up|25
3125086|NCT00075270|10685637|P2|Overall Study|Withdrawal by Subject|21
3125087|NCT00075270|10685638|P1|Overall Study|Withdrawal by Subject|28
3125088|NCT00075218|10685684|P3|Open-Label Treatment|enrolled in a separate continuation|9
3125089|NCT00075218|10685685|P2|Open-Label Treatment|enrolled in a separate continuation|0
3125090|NCT00075218|10685686|P1|Open-Label Treatment|enrolled in a separate continuation|0
3125091|NCT00075218|10685684|P3|Open-Label Treatment|Protocol Violation|1
3125092|NCT00075218|10685685|P2|Open-Label Treatment|Protocol Violation|0
3125093|NCT00075218|10685686|P1|Open-Label Treatment|Protocol Violation|0
3125094|NCT00075218|10685684|P3|Open-Label Treatment|Decision of Sponsor|8
3125095|NCT00075218|10685685|P2|Open-Label Treatment|Decision of Sponsor|0
3125096|NCT00075218|10685686|P1|Open-Label Treatment|Decision of Sponsor|0
3125097|NCT00075218|10685684|P3|Open-Label Treatment|Withdrawal by Subject|12
3125098|NCT00075218|10685685|P2|Open-Label Treatment|Withdrawal by Subject|0
3125099|NCT00075218|10685686|P1|Open-Label Treatment|Withdrawal by Subject|0
3125100|NCT00075218|10685684|P3|Open-Label Treatment|Adverse Event|51
3125101|NCT00075218|10685685|P2|Open-Label Treatment|Adverse Event|0
3125102|NCT00075218|10685686|P1|Open-Label Treatment|Adverse Event|0
3125103|NCT00075218|10685684|P3|Open-Label Treatment|Lack of Efficacy|174
3125104|NCT00075218|10685685|P2|Open-Label Treatment|Lack of Efficacy|0
3125105|NCT00075218|10685686|P1|Open-Label Treatment|Lack of Efficacy|0
3125106|NCT00075218|10685684|P3|Double-Blind Treatment|No study medication taken|0
3125107|NCT00075218|10685685|P2|Double-Blind Treatment|No study medication taken|0
3125108|NCT00075218|10685686|P1|Double-Blind Treatment|No study medication taken|2
3125109|NCT00075218|10685684|P3|Double-Blind Treatment|Decision of Sponsor|0
3125110|NCT00075218|10685685|P2|Double-Blind Treatment|Decision of Sponsor|1
3125111|NCT00075218|10685686|P1|Double-Blind Treatment|Decision of Sponsor|0
3125112|NCT00075218|10685684|P3|Double-Blind Treatment|Lack of Efficacy|0
3125113|NCT00075218|10685685|P2|Double-Blind Treatment|Lack of Efficacy|6
3125114|NCT00075218|10685686|P1|Double-Blind Treatment|Lack of Efficacy|58
3125115|NCT00075218|10685684|P3|Double-Blind Treatment|Lost to Follow-up|0
3125116|NCT00075218|10685685|P2|Double-Blind Treatment|Lost to Follow-up|0
3125117|NCT00075218|10685686|P1|Double-Blind Treatment|Lost to Follow-up|1
3125118|NCT00075218|10685684|P3|Double-Blind Treatment|Withdrawal by Subject|0
3125119|NCT00075218|10685685|P2|Double-Blind Treatment|Withdrawal by Subject|4
3125120|NCT00075218|10685686|P1|Double-Blind Treatment|Withdrawal by Subject|7
3125121|NCT00075218|10685684|P3|Double-Blind Treatment|Adverse Event|0
3125122|NCT00075218|10685685|P2|Double-Blind Treatment|Adverse Event|4
3125123|NCT00075218|10685686|P1|Double-Blind Treatment|Adverse Event|23
3125124|NCT00075023|10685735|P2|Pilot Study|Withdrawal by Subject|0
3125125|NCT00075023|10685736|P1|Pilot Study|Withdrawal by Subject|1
3125126|NCT00075023|10685735|P2|Pilot Study|Physician Decision|2
3125127|NCT00075023|10685736|P1|Pilot Study|Physician Decision|1
3125128|NCT00074984|10685745|P2|Overall Study|Patient Withdrawn Per Protocol|3
3125129|NCT00074984|10685746|P1|Overall Study|Patient Withdrawn Per Protocol|0
3125130|NCT00074984|10685745|P2|Overall Study|Withdrawal by Subject|3
3125131|NCT00074984|10685746|P1|Overall Study|Withdrawal by Subject|2
3125132|NCT00074984|10685745|P2|Overall Study|Death|2
3125133|NCT00074984|10685746|P1|Overall Study|Death|1
3125134|NCT00074958|10685761|P1|Overall Study|Adverse Event|1
3125135|NCT00074711|10685802|P2|Overall Study|Participant stopped study drug|6
3125136|NCT00074711|10685803|P1|Overall Study|Participant stopped study drug|4
3125137|NCT00074711|10685802|P2|Overall Study|Lost to Follow-up|8
3125138|NCT00074711|10685803|P1|Overall Study|Lost to Follow-up|10
3125139|NCT00074711|10685802|P2|Overall Study|Withdrawal by Subject|1
3125140|NCT00074711|10685803|P1|Overall Study|Withdrawal by Subject|1
3125141|NCT00074581|10685821|P2|Overall Study|Other|19
3125142|NCT00074581|10685822|P1|Overall Study|Other|14
3125143|NCT00074581|10685821|P2|Overall Study|Ended relationship w. index participant|106
3125144|NCT00074581|10685822|P1|Overall Study|Ended relationship w. index participant|117
3125145|NCT00074581|10685821|P2|Overall Study|Lost to Follow-up|11
3125146|NCT00074581|10685822|P1|Overall Study|Lost to Follow-up|16
3125147|NCT00074581|10685821|P2|Overall Study|Were withdrawn by investigator|2
3125148|NCT00074581|10685822|P1|Overall Study|Were withdrawn by investigator|5
3125149|NCT00074581|10685821|P2|Overall Study|Relocated|9
3125150|NCT00074581|10685822|P1|Overall Study|Relocated|14
3125151|NCT00074581|10685821|P2|Overall Study|Unable to adhere to visit schedule|14
3125152|NCT00074581|10685822|P1|Overall Study|Unable to adhere to visit schedule|13
3125153|NCT00074581|10685821|P2|Overall Study|Withdrawal by Subject|49
3125154|NCT00074581|10685822|P1|Overall Study|Withdrawal by Subject|50
3125155|NCT00074581|10685821|P2|Overall Study|Death|16
3125156|NCT00074581|10685822|P1|Overall Study|Death|15
3125157|NCT00074490|10685835|P6|Overall Study|Progressive malignancy|0
3125158|NCT00074490|10685836|P5|Overall Study|Progressive malignancy|3
3125159|NCT00074490|10685837|P4|Overall Study|Progressive malignancy|0
3125160|NCT00074490|10685838|P3|Overall Study|Progressive malignancy|0
3125161|NCT00074490|10685839|P2|Overall Study|Progressive malignancy|7
3125162|NCT00074490|10685840|P1|Overall Study|Progressive malignancy|0
3125163|NCT00074412|10685874|P2|Overall Study|Lost to Follow-up|58
3125164|NCT00074412|10685875|P1|Overall Study|Lost to Follow-up|52
3125165|NCT00074412|10685874|P2|Overall Study|Death|26
3125166|NCT00074412|10685875|P1|Overall Study|Death|30
3125167|NCT00074282|10685906|P3|Step 2|Ineligible|1
3125168|NCT00074282|10685907|P2|Step 2|Ineligible|0
3125169|NCT00074282|10685908|P1|Step 2|Ineligible|0
3125170|NCT00074282|10685906|P3|Step 2|Physician Decision|1
3125171|NCT00074282|10685907|P2|Step 2|Physician Decision|0
3125172|NCT00074282|10685908|P1|Step 2|Physician Decision|0
3125173|NCT00074282|10685906|P3|Step 2|Withdrawal by Subject|2
3125174|NCT00074282|10685907|P2|Step 2|Withdrawal by Subject|0
3125175|NCT00074282|10685908|P1|Step 2|Withdrawal by Subject|0
3125176|NCT00074282|10685906|P3|Step 2|Death|3
3125177|NCT00074282|10685907|P2|Step 2|Death|0
3125178|NCT00074282|10685908|P1|Step 2|Death|0
3125179|NCT00074282|10685906|P3|Step 2|Disease progression|5
3125180|NCT00074282|10685907|P2|Step 2|Disease progression|0
3125181|NCT00074282|10685908|P1|Step 2|Disease progression|0
3125182|NCT00074282|10685906|P3|Step 2|Adverse Event|12
3125183|NCT00074282|10685907|P2|Step 2|Adverse Event|2
3125184|NCT00074282|10685908|P1|Step 2|Adverse Event|0
3125185|NCT00074282|10685906|P3|Step 1|Never started treatment|0
3125186|NCT00074282|10685907|P2|Step 1|Never started treatment|0
3125187|NCT00074282|10685908|P1|Step 1|Never started treatment|2
3125188|NCT00074282|10685906|P3|Step 1|Ineligible|0
3125189|NCT00074282|10685907|P2|Step 1|Ineligible|0
3125190|NCT00074282|10685908|P1|Step 1|Ineligible|4
3125191|NCT00074282|10685906|P3|Step 1|Physician Decision|0
3125192|NCT00074282|10685907|P2|Step 1|Physician Decision|0
3125193|NCT00074282|10685908|P1|Step 1|Physician Decision|1
3125194|NCT00074282|10685906|P3|Step 1|Other complicating disease|0
3125195|NCT00074282|10685907|P2|Step 1|Other complicating disease|0
3125196|NCT00074282|10685908|P1|Step 1|Other complicating disease|2
3125197|NCT00074282|10685906|P3|Step 1|Alternative therapy|0
3125198|NCT00074282|10685907|P2|Step 1|Alternative therapy|0
3125199|NCT00074282|10685908|P1|Step 1|Alternative therapy|2
3125200|NCT00074282|10685906|P3|Step 1|Disease progression|0
3125201|NCT00074282|10685907|P2|Step 1|Disease progression|0
3125202|NCT00074282|10685908|P1|Step 1|Disease progression|2
3125203|NCT00074282|10685906|P3|Step 1|Withdrawal by Subject|0
3125204|NCT00074282|10685907|P2|Step 1|Withdrawal by Subject|0
3125205|NCT00074282|10685908|P1|Step 1|Withdrawal by Subject|7
3125206|NCT00074282|10685906|P3|Step 1|Death|0
3125207|NCT00074282|10685907|P2|Step 1|Death|0
3125208|NCT00074282|10685908|P1|Step 1|Death|6
3125209|NCT00074282|10685906|P3|Step 1|Adverse Event|0
3125210|NCT00074282|10685907|P2|Step 1|Adverse Event|0
3125211|NCT00074282|10685908|P1|Step 1|Adverse Event|32
3125212|NCT00074152|10685934|P2|Overall Study|Lack of Efficacy|24
3125213|NCT00074152|10685935|P1|Overall Study|Lack of Efficacy|34
3125214|NCT00074152|10685934|P2|Overall Study|Death|9
3125215|NCT00074152|10685935|P1|Overall Study|Death|21
3125216|NCT00073983|10685952|P1|Overall Study|not evaluable|1
3125217|NCT00073918|10685973|P1|Overall Study|Eligibility requirement not met-low CD20|1
3125218|NCT00073918|10685973|P1|Overall Study|Rapid disease progression|2
3125219|NCT00073918|10685973|P1|Overall Study|Eligibility requirement not met - HAMA+|1
3125220|NCT00073749|10685987|P7|Overall Study|Other|0
3125221|NCT00073749|10685988|P6|Overall Study|Other|2
3125222|NCT00073749|10685989|P5|Overall Study|Other|0
3125223|NCT00073749|10685990|P4|Overall Study|Other|0
3125224|NCT00073749|10685991|P3|Overall Study|Other|0
3125225|NCT00073749|10685992|P2|Overall Study|Other|0
3125226|NCT00073749|10685993|P1|Overall Study|Other|0
3125227|NCT00073749|10685987|P7|Overall Study|Lost to Follow-up|2
3125228|NCT00073749|10685988|P6|Overall Study|Lost to Follow-up|0
3125229|NCT00073749|10685989|P5|Overall Study|Lost to Follow-up|0
3125230|NCT00073749|10685990|P4|Overall Study|Lost to Follow-up|0
3125231|NCT00073749|10685991|P3|Overall Study|Lost to Follow-up|0
3125232|NCT00073749|10685992|P2|Overall Study|Lost to Follow-up|0
3125233|NCT00073749|10685993|P1|Overall Study|Lost to Follow-up|0
3125234|NCT00073749|10685987|P7|Overall Study|Discontinuation of Study by Sponsor|4
3125235|NCT00073749|10685988|P6|Overall Study|Discontinuation of Study by Sponsor|0
3125236|NCT00073749|10685989|P5|Overall Study|Discontinuation of Study by Sponsor|0
3125237|NCT00073749|10685990|P4|Overall Study|Discontinuation of Study by Sponsor|0
3125238|NCT00073749|10685991|P3|Overall Study|Discontinuation of Study by Sponsor|0
3125239|NCT00073749|10685992|P2|Overall Study|Discontinuation of Study by Sponsor|0
3125240|NCT00073749|10685993|P1|Overall Study|Discontinuation of Study by Sponsor|0
3125241|NCT00073749|10685987|P7|Overall Study|Withdrawal by Subject|2
3125242|NCT00073749|10685988|P6|Overall Study|Withdrawal by Subject|0
3125243|NCT00073749|10685989|P5|Overall Study|Withdrawal by Subject|1
3125244|NCT00073749|10685990|P4|Overall Study|Withdrawal by Subject|0
3125245|NCT00073749|10685991|P3|Overall Study|Withdrawal by Subject|0
3125246|NCT00073749|10685992|P2|Overall Study|Withdrawal by Subject|1
3125247|NCT00073749|10685993|P1|Overall Study|Withdrawal by Subject|0
3125248|NCT00073749|10685987|P7|Overall Study|Physician Decision|0
3125249|NCT00073749|10685988|P6|Overall Study|Physician Decision|2
3125250|NCT00073749|10685989|P5|Overall Study|Physician Decision|0
3125251|NCT00073749|10685990|P4|Overall Study|Physician Decision|0
3125252|NCT00073749|10685991|P3|Overall Study|Physician Decision|1
3125253|NCT00073749|10685992|P2|Overall Study|Physician Decision|0
3125254|NCT00073749|10685993|P1|Overall Study|Physician Decision|0
3125255|NCT00073749|10685987|P7|Overall Study|Adverse Event|0
3125256|NCT00073749|10685988|P6|Overall Study|Adverse Event|1
3125257|NCT00073749|10685989|P5|Overall Study|Adverse Event|2
3125258|NCT00073749|10685990|P4|Overall Study|Adverse Event|4
3125259|NCT00073749|10685991|P3|Overall Study|Adverse Event|6
3125260|NCT00073749|10685992|P2|Overall Study|Adverse Event|3
3125261|NCT00073749|10685993|P1|Overall Study|Adverse Event|0
3125262|NCT00073749|10685987|P7|Overall Study|Death|29
3125263|NCT00073749|10685988|P6|Overall Study|Death|0
3125264|NCT00073749|10685989|P5|Overall Study|Death|0
3125265|NCT00073749|10685990|P4|Overall Study|Death|0
3125266|NCT00073749|10685991|P3|Overall Study|Death|1
3125267|NCT00073749|10685992|P2|Overall Study|Death|1
3125268|NCT00073749|10685993|P1|Overall Study|Death|0
3125269|NCT00073749|10685987|P7|Overall Study|Disease Progression|3
3125270|NCT00073749|10685988|P6|Overall Study|Disease Progression|1
3125271|NCT00073749|10685989|P5|Overall Study|Disease Progression|3
3125272|NCT00073749|10685990|P4|Overall Study|Disease Progression|2
3125273|NCT00073749|10685991|P3|Overall Study|Disease Progression|3
3125274|NCT00073749|10685992|P2|Overall Study|Disease Progression|0
3125275|NCT00073749|10685993|P1|Overall Study|Disease Progression|2
3125276|NCT00073528|10686024|P2|Overall Study|Ongoing|344
3125277|NCT00073528|10686025|P1|Overall Study|Ongoing|349
3125278|NCT00073528|10686024|P2|Overall Study|Non-compliance|1
3125279|NCT00073528|10686025|P1|Overall Study|Non-compliance|0
3125280|NCT00073528|10686024|P2|Overall Study|Enrolled in Error|1
3125281|NCT00073528|10686025|P1|Overall Study|Enrolled in Error|0
3125282|NCT00073528|10686024|P2|Overall Study|Participant Was Unblinded|1
3125283|NCT00073528|10686025|P1|Overall Study|Participant Was Unblinded|0
3125284|NCT00073528|10686024|P2|Overall Study|Progressive Disease|1
3125285|NCT00073528|10686025|P1|Overall Study|Progressive Disease|0
3125286|NCT00073528|10686024|P2|Overall Study|Randomized in Error; Not Treated|0
3125287|NCT00073528|10686025|P1|Overall Study|Randomized in Error; Not Treated|2
3125288|NCT00073528|10686024|P2|Overall Study|Mastectomy Intervention|0
3125289|NCT00073528|10686025|P1|Overall Study|Mastectomy Intervention|1
3125290|NCT00073528|10686024|P2|Overall Study|Death|238
3125291|NCT00073528|10686025|P1|Overall Study|Death|229
3125292|NCT00073528|10686024|P2|Overall Study|Protocol Violation|5
3125293|NCT00073528|10686025|P1|Overall Study|Protocol Violation|3
3125294|NCT00073528|10686024|P2|Overall Study|Lost to Follow-up|22
3125295|NCT00073528|10686025|P1|Overall Study|Lost to Follow-up|26
3125296|NCT00073528|10686024|P2|Overall Study|Withdrawal by Subject|29
3125297|NCT00073528|10686025|P1|Overall Study|Withdrawal by Subject|34
3125298|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
3125299|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
3125300|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
3125301|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
3125302|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
3125303|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
3125304|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
3125305|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
3125306|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
3125307|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
3125308|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
3125309|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
3125310|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
3125311|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
3125312|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
3125313|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
3125314|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
3125315|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
3125316|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
3125317|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
3125318|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
3125319|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
3125320|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
3125321|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
3125322|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
3125323|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
3125324|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
3125325|NCT00073307|10686114|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
3125326|NCT00073307|10686115|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
3125327|NCT00073307|10686116|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
3125328|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
3125329|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
3125330|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
3125331|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
3125332|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
3125333|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
3125334|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
3125335|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
3125336|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
3125337|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
3125338|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
3125339|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
3125340|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
3125341|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
3125342|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
3125343|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
3125344|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
3125345|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
3125346|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
3125347|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
3125348|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
3125349|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
3125350|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
3125351|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
3125352|NCT00073307|10686114|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
3125353|NCT00073307|10686115|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
3125354|NCT00073307|10686116|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
3125355|NCT00073021|10686147|P2|Overall Study|Lack of Efficacy|5
3125356|NCT00073021|10686148|P1|Overall Study|Lack of Efficacy|11
3125357|NCT00073021|10686147|P2|Overall Study|Physician Decision|1
3125358|NCT00073021|10686148|P1|Overall Study|Physician Decision|3
3125359|NCT00073021|10686147|P2|Overall Study|Withdrawal by Subject|5
3125360|NCT00073021|10686148|P1|Overall Study|Withdrawal by Subject|6
3125361|NCT00073021|10686147|P2|Overall Study|Adverse Event|4
3125362|NCT00073021|10686148|P1|Overall Study|Adverse Event|4
3125363|NCT00073021|10686147|P2|Overall Study|Protocol Violation|1
3125364|NCT00073021|10686148|P1|Overall Study|Protocol Violation|2
3125365|NCT00073008|10686178|P2|Overall Study|"Other selected on Case Report Form"|5
3125366|NCT00073008|10686179|P1|Overall Study|"Other selected on Case Report Form"|7
3125367|NCT00073008|10686178|P2|Overall Study|Death|47
3125368|NCT00073008|10686179|P1|Overall Study|Death|46
3125369|NCT00073008|10686178|P2|Overall Study|Lost to Follow-up|3
3125370|NCT00073008|10686179|P1|Overall Study|Lost to Follow-up|1
3125371|NCT00073008|10686178|P2|Overall Study|Withdrawal by Subject|2
3125372|NCT00073008|10686179|P1|Overall Study|Withdrawal by Subject|2
3125373|NCT00073008|10686178|P2|Overall Study|Missing|6
3125374|NCT00073008|10686179|P1|Overall Study|Missing|6
3125375|NCT00072475|10686218|P1|Overall Study|Patient/Investigator Decision|4
3125376|NCT00072475|10686218|P1|Overall Study|Withdrawal by Subject|46
3125377|NCT00072475|10686218|P1|Overall Study|Death|3
3125378|NCT00072475|10686218|P1|Overall Study|Adverse Event|44
3125379|NCT00072384|10686233|P1|Overall Study|Ineligible|8
3125380|NCT00072384|10686233|P1|Overall Study|Physician Decision|1
3125381|NCT00072293|10686246|P2|Overall Study|Withdrawal by Subject|1
3125382|NCT00072293|10686247|P1|Overall Study|Withdrawal by Subject|0
3125383|NCT00072293|10686246|P2|Overall Study|Lost to Follow-up|1
3125384|NCT00072293|10686247|P1|Overall Study|Lost to Follow-up|1
3125385|NCT00072280|10686259|P2|Follow-up|Early termination of study|2
3125386|NCT00072280|10686260|P1|Follow-up|Early termination of study|2
3125387|NCT00072280|10686259|P2|Treatment|Found ineligible|2
3125388|NCT00072280|10686260|P1|Treatment|Found ineligible|1
3125389|NCT00072189|10686265|P1|Overall Study|Withdrawal by Subject|1
3125390|NCT00072176|10686273|P2|Overall Study|Protocol Violation|1
3125391|NCT00072176|10686274|P1|Overall Study|Protocol Violation|0
3125392|NCT00072176|10686273|P2|Overall Study|Withdrawal by Subject|0
3125393|NCT00072176|10686274|P1|Overall Study|Withdrawal by Subject|1
3125394|NCT00071981|10686286|P4|Overall Study|others (not specified in the study)|0
3125395|NCT00071981|10686287|P3|Overall Study|others (not specified in the study)|2
3125396|NCT00071981|10686288|P2|Overall Study|others (not specified in the study)|2
3125397|NCT00071981|10686289|P1|Overall Study|others (not specified in the study)|0
3125398|NCT00071981|10686286|P4|Overall Study|No protocol therapy|0
3125399|NCT00071981|10686287|P3|Overall Study|No protocol therapy|1
3125400|NCT00071981|10686288|P2|Overall Study|No protocol therapy|5
3125401|NCT00071981|10686289|P1|Overall Study|No protocol therapy|2
3125402|NCT00071981|10686286|P4|Overall Study|Withdrawal by Subject|0
3125403|NCT00071981|10686287|P3|Overall Study|Withdrawal by Subject|0
3125404|NCT00071981|10686288|P2|Overall Study|Withdrawal by Subject|1
3125405|NCT00071981|10686289|P1|Overall Study|Withdrawal by Subject|3
3125406|NCT00071981|10686286|P4|Overall Study|Death|1
3125407|NCT00071981|10686287|P3|Overall Study|Death|1
3125408|NCT00071981|10686288|P2|Overall Study|Death|0
3125409|NCT00071981|10686289|P1|Overall Study|Death|0
3125410|NCT00071981|10686286|P4|Overall Study|Adverse Event|1
3125411|NCT00071981|10686287|P3|Overall Study|Adverse Event|3
3125412|NCT00071981|10686288|P2|Overall Study|Adverse Event|4
3125413|NCT00071981|10686289|P1|Overall Study|Adverse Event|4
3125414|NCT00071981|10686286|P4|Overall Study|Lack of Efficacy|43
3125415|NCT00071981|10686287|P3|Overall Study|Lack of Efficacy|30
3125416|NCT00071981|10686288|P2|Overall Study|Lack of Efficacy|29
3125417|NCT00071981|10686289|P1|Overall Study|Lack of Efficacy|37
3125418|NCT00071812|10686332|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
3125419|NCT00071812|10686333|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
3125420|NCT00071812|10686334|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
3125421|NCT00071812|10686335|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
3125422|NCT00071812|10686332|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
3125423|NCT00071812|10686333|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125424|NCT00071812|10686334|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125425|NCT00071812|10686335|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125426|NCT00071812|10686332|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
3125427|NCT00071812|10686333|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125428|NCT00071812|10686334|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125429|NCT00071812|10686335|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125430|NCT00071812|10686332|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
3125431|NCT00071812|10686333|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125432|NCT00071812|10686334|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125433|NCT00071812|10686335|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125434|NCT00071812|10686332|P4|24-Week Open-Label Extension Period|Adverse Event|7
3125435|NCT00071812|10686333|P3|24-Week Open-Label Extension Period|Adverse Event|0
3125436|NCT00071812|10686334|P2|24-Week Open-Label Extension Period|Adverse Event|0
3125437|NCT00071812|10686335|P1|24-Week Open-Label Extension Period|Adverse Event|0
3125438|NCT00071812|10686332|P4|24-Week Double-Blind Period|Protocol Violation|1
3125439|NCT00071812|10686333|P3|24-Week Double-Blind Period|Protocol Violation|0
3125440|NCT00071812|10686334|P2|24-Week Double-Blind Period|Protocol Violation|0
3125441|NCT00071812|10686335|P1|24-Week Double-Blind Period|Protocol Violation|0
3125442|NCT00071812|10686332|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
3125443|NCT00071812|10686333|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
3125444|NCT00071812|10686334|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
3125445|NCT00071812|10686335|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
3125446|NCT00071812|10686332|P4|24-Week Double-Blind Period|Lost to Follow-up|0
3125447|NCT00071812|10686333|P3|24-Week Double-Blind Period|Lost to Follow-up|1
3125448|NCT00071812|10686334|P2|24-Week Double-Blind Period|Lost to Follow-up|1
3125449|NCT00071812|10686335|P1|24-Week Double-Blind Period|Lost to Follow-up|0
3125450|NCT00071812|10686332|P4|24-Week Double-Blind Period|Lack of Efficacy|1
3125451|NCT00071812|10686333|P3|24-Week Double-Blind Period|Lack of Efficacy|2
3125452|NCT00071812|10686334|P2|24-Week Double-Blind Period|Lack of Efficacy|1
3125453|NCT00071812|10686335|P1|24-Week Double-Blind Period|Lack of Efficacy|3
3125454|NCT00071812|10686332|P4|24-Week Double-Blind Period|Adverse Event|4
3125455|NCT00071812|10686333|P3|24-Week Double-Blind Period|Adverse Event|4
3125456|NCT00071812|10686334|P2|24-Week Double-Blind Period|Adverse Event|3
3125457|NCT00071812|10686335|P1|24-Week Double-Blind Period|Adverse Event|2
3125458|NCT00071799|10686377|P2|Overall Study|Not Documented|2
3125459|NCT00071799|10686378|P1|Overall Study|Not Documented|0
3125460|NCT00071799|10686377|P2|Overall Study|Different Central+Local Pathology Review|1
3125461|NCT00071799|10686378|P1|Overall Study|Different Central+Local Pathology Review|0
3125462|NCT00071799|10686377|P2|Overall Study|Disease Progression|20
3125463|NCT00071799|10686378|P1|Overall Study|Disease Progression|23
3125464|NCT00071799|10686377|P2|Overall Study|Lack of Efficacy|18
3125465|NCT00071799|10686378|P1|Overall Study|Lack of Efficacy|11
3125466|NCT00071799|10686377|P2|Overall Study|Physician Decision|2
3125467|NCT00071799|10686378|P1|Overall Study|Physician Decision|0
3125468|NCT00071799|10686377|P2|Overall Study|Withdrawal by Subject|37
3125469|NCT00071799|10686378|P1|Overall Study|Withdrawal by Subject|15
3125470|NCT00071799|10686377|P2|Overall Study|Lost to Follow-up|1
3125471|NCT00071799|10686378|P1|Overall Study|Lost to Follow-up|1
3125472|NCT00071799|10686377|P2|Overall Study|Protocol Violation|7
3125473|NCT00071799|10686378|P1|Overall Study|Protocol Violation|1
3125474|NCT00071799|10686377|P2|Overall Study|Adverse Event|10
3125475|NCT00071799|10686378|P1|Overall Study|Adverse Event|19
3125476|NCT00071760|10686431|P1|Overall Study|Ongoing|25
3125477|NCT00071760|10686431|P1|Overall Study|Study Team Rec./Resistance|1
3125478|NCT00071760|10686431|P1|Overall Study|Investigator's Recommendation (Rec.)|4
3125479|NCT00071760|10686431|P1|Overall Study|Relocation|1
3125480|NCT00071760|10686431|P1|Overall Study|Unavailability of RTV|8
3125481|NCT00071760|10686431|P1|Overall Study|Pulmonary Tuberculosis|1
3125482|NCT00071760|10686431|P1|Overall Study|Insufficient Viral Load Response|3
3125483|NCT00071760|10686431|P1|Overall Study|Withdrawal by Subject|3
3125484|NCT00071760|10686431|P1|Overall Study|Protocol Violation|1
3125485|NCT00071760|10686431|P1|Overall Study|Lost to Follow-up|4
3125486|NCT00071760|10686431|P1|Overall Study|Adverse Event|3
3125487|NCT00071513|10686511|P2|Follow-up Assessment|Withdrawal by Subject|6
3125488|NCT00071513|10686512|P1|Follow-up Assessment|Withdrawal by Subject|6
3125489|NCT00071513|10686511|P2|Intervention Component|Withdrawal by Subject|3
3125490|NCT00071513|10686512|P1|Intervention Component|Withdrawal by Subject|2
3125491|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
3125492|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
3125493|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
3125494|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
3125495|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
3125496|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125497|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125498|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
3125499|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Pregnancy|1
3125500|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Pregnancy|0
3125501|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Pregnancy|0
3125502|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Pregnancy|0
3125503|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
3125504|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125505|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125506|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
3125507|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
3125508|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125509|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125510|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
3125511|NCT00071487|10686524|P4|24-Week Open-Label Extension Period|Adverse Event|6
3125512|NCT00071487|10686525|P3|24-Week Open-Label Extension Period|Adverse Event|1
3125513|NCT00071487|10686526|P2|24-Week Open-Label Extension Period|Adverse Event|0
3125514|NCT00071487|10686527|P1|24-Week Open-Label Extension Period|Adverse Event|0
3125515|NCT00071487|10686524|P4|52-Week Double-Blind Period|Lack of Compliance|3
3125516|NCT00071487|10686525|P3|52-Week Double-Blind Period|Lack of Compliance|3
3125517|NCT00071487|10686526|P2|52-Week Double-Blind Period|Lack of Compliance|3
3125518|NCT00071487|10686527|P1|52-Week Double-Blind Period|Lack of Compliance|6
3125519|NCT00071487|10686524|P4|52-Week Double-Blind Period|Death|0
3125520|NCT00071487|10686525|P3|52-Week Double-Blind Period|Death|0
3125521|NCT00071487|10686526|P2|52-Week Double-Blind Period|Death|1
3125522|NCT00071487|10686527|P1|52-Week Double-Blind Period|Death|0
3125523|NCT00071487|10686524|P4|52-Week Double-Blind Period|Protocol Violation|0
3125524|NCT00071487|10686525|P3|52-Week Double-Blind Period|Protocol Violation|1
3125525|NCT00071487|10686526|P2|52-Week Double-Blind Period|Protocol Violation|1
3125526|NCT00071487|10686527|P1|52-Week Double-Blind Period|Protocol Violation|0
3125527|NCT00071487|10686524|P4|52-Week Double-Blind Period|Pregnancy|0
3125528|NCT00071487|10686525|P3|52-Week Double-Blind Period|Pregnancy|0
3125529|NCT00071487|10686526|P2|52-Week Double-Blind Period|Pregnancy|1
3125530|NCT00071487|10686527|P1|52-Week Double-Blind Period|Pregnancy|0
3125531|NCT00071487|10686524|P4|52-Week Double-Blind Period|Lost to Follow-up|2
3125532|NCT00071487|10686525|P3|52-Week Double-Blind Period|Lost to Follow-up|2
3125533|NCT00071487|10686526|P2|52-Week Double-Blind Period|Lost to Follow-up|0
3125534|NCT00071487|10686527|P1|52-Week Double-Blind Period|Lost to Follow-up|0
3125535|NCT00071487|10686524|P4|52-Week Double-Blind Period|Physician Decision|0
3125536|NCT00071487|10686525|P3|52-Week Double-Blind Period|Physician Decision|0
3125537|NCT00071487|10686526|P2|52-Week Double-Blind Period|Physician Decision|0
3125538|NCT00071487|10686527|P1|52-Week Double-Blind Period|Physician Decision|1
3125539|NCT00071487|10686524|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
3125540|NCT00071487|10686525|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
3125541|NCT00071487|10686526|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
3125542|NCT00071487|10686527|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
3125543|NCT00071487|10686524|P4|52-Week Double-Blind Period|Lack of Efficacy|1
3125544|NCT00071487|10686525|P3|52-Week Double-Blind Period|Lack of Efficacy|0
3125545|NCT00071487|10686526|P2|52-Week Double-Blind Period|Lack of Efficacy|2
3125546|NCT00071487|10686527|P1|52-Week Double-Blind Period|Lack of Efficacy|1
3125547|NCT00071487|10686524|P4|52-Week Double-Blind Period|Adverse Event|8
3125548|NCT00071487|10686525|P3|52-Week Double-Blind Period|Adverse Event|4
3125549|NCT00071487|10686526|P2|52-Week Double-Blind Period|Adverse Event|8
3125550|NCT00071487|10686527|P1|52-Week Double-Blind Period|Adverse Event|5
3125551|NCT00071396|10686571|P1|Overall Study|Physician Decision|2
3125552|NCT00071396|10686571|P1|Overall Study|Withdrawal by Subject|1
3125553|NCT00071110|10686577|P2|Overall Study|Protocol Violation|4
3125554|NCT00071110|10686578|P1|Overall Study|Protocol Violation|0
3125555|NCT00071032|10686592|P2|Overall Study|Missing Primary Outcome|1
3125556|NCT00071032|10686593|P1|Overall Study|Missing Primary Outcome|0
3125557|NCT00071032|10686592|P2|Overall Study|Withdrawal by Subject|6
3125558|NCT00071032|10686593|P1|Overall Study|Withdrawal by Subject|8
3125559|NCT00071032|10686592|P2|Overall Study|Lost to Follow-up|1
3125560|NCT00071032|10686593|P1|Overall Study|Lost to Follow-up|1
3125561|NCT00071006|10686601|P1|Overall Study|Other|3
3125562|NCT00071006|10686601|P1|Overall Study|Withdrawal by Subject|1
3125563|NCT00071006|10686601|P1|Overall Study|Adverse Event|1
3125564|NCT00071006|10686601|P1|Overall Study|Lack of Efficacy|7
3125565|NCT00070941|10686614|P3|Overall Study|Adverse Event|4
3125566|NCT00070941|10686615|P2|Overall Study|Adverse Event|8
3125567|NCT00070941|10686616|P1|Overall Study|Adverse Event|10
3125568|NCT00071058|10686624|P1|Overall Study|brain tumor-removed from study|1
3125569|NCT00070707|10686631|P2|Overall Study|Unrelated to Study Medication|0
3125570|NCT00070707|10686632|P1|Overall Study|Unrelated to Study Medication|1
3125571|NCT00070707|10686631|P2|Overall Study|Protocol Violation|4
3125572|NCT00070707|10686632|P1|Overall Study|Protocol Violation|8
3125573|NCT00070707|10686631|P2|Overall Study|Lack of Efficacy|1
3125574|NCT00070707|10686632|P1|Overall Study|Lack of Efficacy|4
3125575|NCT00070707|10686631|P2|Overall Study|Adverse Event|2
3125576|NCT00070707|10686632|P1|Overall Study|Adverse Event|1
3125577|NCT00003907|10686680|P2|Overall Study|ineligible or not treated|2
3125578|NCT00003907|10686681|P1|Overall Study|ineligible or not treated|2
3125579|NCT00003907|10686680|P2|Overall Study|Other|3
3125580|NCT00003907|10686681|P1|Overall Study|Other|1
3125581|NCT00003907|10686680|P2|Overall Study|Complicating disease|0
3125582|NCT00003907|10686681|P1|Overall Study|Complicating disease|1
3125583|NCT00003907|10686680|P2|Overall Study|Progressive disease|4
3125584|NCT00003907|10686681|P1|Overall Study|Progressive disease|4
3125585|NCT00003907|10686680|P2|Overall Study|Withdrawal by Subject|3
3125586|NCT00003907|10686681|P1|Overall Study|Withdrawal by Subject|1
3125587|NCT00003907|10686680|P2|Overall Study|Death|0
3125588|NCT00003907|10686681|P1|Overall Study|Death|2
3125589|NCT00003907|10686680|P2|Overall Study|Adverse Event|11
3125590|NCT00003907|10686681|P1|Overall Study|Adverse Event|2
3125591|NCT00070564|10686697|P6|Overall Study|Not reported|0
3125592|NCT00070564|10686698|P5|Overall Study|Not reported|1
3125593|NCT00070564|10686699|P4|Overall Study|Not reported|0
3125594|NCT00070564|10686700|P3|Overall Study|Not reported|0
3125595|NCT00070564|10686701|P2|Overall Study|Not reported|0
3125596|NCT00070564|10686702|P1|Overall Study|Not reported|0
3125597|NCT00070564|10686697|P6|Overall Study|Withdrawal by Subject|8
3125598|NCT00070564|10686698|P5|Overall Study|Withdrawal by Subject|8
3125599|NCT00070564|10686699|P4|Overall Study|Withdrawal by Subject|30
3125600|NCT00070564|10686700|P3|Overall Study|Withdrawal by Subject|23
3125601|NCT00070564|10686701|P2|Overall Study|Withdrawal by Subject|37
3125602|NCT00070564|10686702|P1|Overall Study|Withdrawal by Subject|26
3125603|NCT00070564|10686697|P6|Overall Study|Other, not protocol specified|7
3125604|NCT00070564|10686698|P5|Overall Study|Other, not protocol specified|6
3125605|NCT00070564|10686699|P4|Overall Study|Other, not protocol specified|19
3125606|NCT00070564|10686700|P3|Overall Study|Other, not protocol specified|14
3125607|NCT00070564|10686701|P2|Overall Study|Other, not protocol specified|15
3125608|NCT00070564|10686702|P1|Overall Study|Other, not protocol specified|17
3125609|NCT00070564|10686697|P6|Overall Study|Death|1
3125610|NCT00070564|10686698|P5|Overall Study|Death|0
3125611|NCT00070564|10686699|P4|Overall Study|Death|3
3125612|NCT00070564|10686700|P3|Overall Study|Death|5
3125613|NCT00070564|10686701|P2|Overall Study|Death|1
3125614|NCT00070564|10686702|P1|Overall Study|Death|4
3125615|NCT00070564|10686697|P6|Overall Study|Adverse Event|36
3125616|NCT00070564|10686698|P5|Overall Study|Adverse Event|63
3125617|NCT00070564|10686699|P4|Overall Study|Adverse Event|108
3125618|NCT00070564|10686700|P3|Overall Study|Adverse Event|120
3125619|NCT00070564|10686701|P2|Overall Study|Adverse Event|142
3125620|NCT00070564|10686702|P1|Overall Study|Adverse Event|150
3125621|NCT00070564|10686697|P6|Overall Study|Delinquent|0
3125622|NCT00070564|10686698|P5|Overall Study|Delinquent|0
3125623|NCT00070564|10686699|P4|Overall Study|Delinquent|0
3125624|NCT00070564|10686700|P3|Overall Study|Delinquent|2
3125625|NCT00070564|10686701|P2|Overall Study|Delinquent|4
3125626|NCT00070564|10686702|P1|Overall Study|Delinquent|1
3125627|NCT00070564|10686697|P6|Overall Study|Progression|0
3125628|NCT00070564|10686698|P5|Overall Study|Progression|1
3125629|NCT00070564|10686699|P4|Overall Study|Progression|7
3125630|NCT00070564|10686700|P3|Overall Study|Progression|7
3125631|NCT00070564|10686701|P2|Overall Study|Progression|4
3125632|NCT00070564|10686702|P1|Overall Study|Progression|2
3125633|NCT00070499|10686756|P4|Overall Study|Not eligible|2
3125634|NCT00070499|10686757|P3|Overall Study|Not eligible|3
3125635|NCT00070499|10686758|P2|Overall Study|Not eligible|5
3125636|NCT00070499|10686759|P1|Overall Study|Not eligible|2
3125637|NCT00070499|10686756|P4|Overall Study|Did not start treatment|2
3125638|NCT00070499|10686757|P3|Overall Study|Did not start treatment|0
3125639|NCT00070499|10686758|P2|Overall Study|Did not start treatment|0
3125640|NCT00070499|10686759|P1|Overall Study|Did not start treatment|1
3125641|NCT00070499|10686756|P4|Overall Study|Still on protocol treatment|57
3125642|NCT00070499|10686757|P3|Overall Study|Still on protocol treatment|79
3125643|NCT00070499|10686758|P2|Overall Study|Still on protocol treatment|4
3125644|NCT00070499|10686759|P1|Overall Study|Still on protocol treatment|10
3125645|NCT00070499|10686756|P4|Overall Study|Other - not protocol specified|20
3125646|NCT00070499|10686757|P3|Overall Study|Other - not protocol specified|12
3125647|NCT00070499|10686758|P2|Overall Study|Other - not protocol specified|3
3125648|NCT00070499|10686759|P1|Overall Study|Other - not protocol specified|7
3125649|NCT00070499|10686756|P4|Overall Study|Death|2
3125650|NCT00070499|10686757|P3|Overall Study|Death|1
3125651|NCT00070499|10686758|P2|Overall Study|Death|1
3125652|NCT00070499|10686759|P1|Overall Study|Death|1
3125653|NCT00070499|10686756|P4|Overall Study|Progression/relapse|4
3125654|NCT00070499|10686757|P3|Overall Study|Progression/relapse|1
3125655|NCT00070499|10686758|P2|Overall Study|Progression/relapse|2
3125656|NCT00070499|10686759|P1|Overall Study|Progression/relapse|4
3125657|NCT00070499|10686756|P4|Overall Study|Refusal unrelated to adverse effects|8
3125658|NCT00070499|10686757|P3|Overall Study|Refusal unrelated to adverse effects|5
3125659|NCT00070499|10686758|P2|Overall Study|Refusal unrelated to adverse effects|5
3125660|NCT00070499|10686759|P1|Overall Study|Refusal unrelated to adverse effects|7
3125661|NCT00070499|10686756|P4|Overall Study|Adverse Event|15
3125662|NCT00070499|10686757|P3|Overall Study|Adverse Event|19
3125663|NCT00070499|10686758|P2|Overall Study|Adverse Event|6
3125664|NCT00070499|10686759|P1|Overall Study|Adverse Event|6
3125665|NCT00070317|10686785|P1|Overall Study|Ineligible-Inadequate pathology|6
3125666|NCT00070317|10686785|P1|Overall Study|Ineligible-Improper prior treatment|2
3125667|NCT00070317|10686785|P1|Overall Study|Ineligible required test not done|1
3125668|NCT00070317|10686785|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
3125669|NCT00070317|10686785|P1|Overall Study|Inevaluable (Never Treated)|1
3125670|NCT00070291|10686790|P1|Step 2|Adverse Event|1
3125671|NCT00070291|10686790|P1|Step 1|Adverse Event|1
3125672|NCT00070291|10686790|P1|Step 1|Withdrawal by Subject|1
3125673|NCT00070109|10686806|P5|Overall Study|removed from prot thpy prior to chemo|0
3125674|NCT00070109|10686807|P4|Overall Study|removed from prot thpy prior to chemo|1
3125675|NCT00070109|10686808|P3|Overall Study|removed from prot thpy prior to chemo|0
3125676|NCT00070109|10686809|P2|Overall Study|removed from prot thpy prior to chemo|0
3125677|NCT00070109|10686810|P1|Overall Study|removed from prot thpy prior to chemo|0
3125678|NCT00070109|10686806|P5|Overall Study|Adverse Event|2
3125679|NCT00070109|10686807|P4|Overall Study|Adverse Event|4
3125680|NCT00070109|10686808|P3|Overall Study|Adverse Event|2
3125681|NCT00070109|10686809|P2|Overall Study|Adverse Event|0
3125682|NCT00070109|10686810|P1|Overall Study|Adverse Event|0
3125683|NCT00070109|10686806|P5|Overall Study|Withdrawal by Subject|0
3125684|NCT00070109|10686807|P4|Overall Study|Withdrawal by Subject|0
3125685|NCT00070109|10686808|P3|Overall Study|Withdrawal by Subject|1
3125686|NCT00070109|10686809|P2|Overall Study|Withdrawal by Subject|1
3125687|NCT00070109|10686810|P1|Overall Study|Withdrawal by Subject|0
3125688|NCT00070109|10686806|P5|Overall Study|Physician Decision|0
3125689|NCT00070109|10686807|P4|Overall Study|Physician Decision|0
3125690|NCT00070109|10686808|P3|Overall Study|Physician Decision|0
3125691|NCT00070109|10686809|P2|Overall Study|Physician Decision|0
3125692|NCT00070109|10686810|P1|Overall Study|Physician Decision|1
3125693|NCT00070109|10686806|P5|Overall Study|Lack of Efficacy|5
3125694|NCT00070109|10686807|P4|Overall Study|Lack of Efficacy|15
3125695|NCT00070109|10686808|P3|Overall Study|Lack of Efficacy|5
3125696|NCT00070109|10686809|P2|Overall Study|Lack of Efficacy|4
3125697|NCT00070109|10686810|P1|Overall Study|Lack of Efficacy|6
3125698|NCT00070109|10686806|P5|Overall Study|Death|1
3125699|NCT00070109|10686807|P4|Overall Study|Death|0
3125700|NCT00070109|10686808|P3|Overall Study|Death|0
3125701|NCT00070109|10686809|P2|Overall Study|Death|1
3125702|NCT00070109|10686810|P1|Overall Study|Death|1
3125703|NCT00070018|10686838|P1|Overall Study|Withdrawal by Subject|1
3125704|NCT00070018|10686838|P1|Overall Study|Lack of Efficacy|1
3125705|NCT00070018|10686838|P1|Overall Study|Adverse Event|2
3125706|NCT00069953|10686842|P1|Overall Study|Protocol Violation|2
3125707|NCT00069784|10686848|P2|Overall Study|Other|0
3125708|NCT00069784|10686849|P1|Overall Study|Other|17
3125709|NCT00069784|10686848|P2|Overall Study|Withdrawal by Subject|0
3125710|NCT00069784|10686849|P1|Overall Study|Withdrawal by Subject|1090
3125711|NCT00069784|10686848|P2|Overall Study|Adverse Event|0
3125712|NCT00069784|10686849|P1|Overall Study|Adverse Event|105
3125713|NCT00069823|10686869|P2|Overall Study|Did not have follow-up diary cards|3
3125714|NCT00069823|10686870|P1|Overall Study|Did not have follow-up diary cards|6
3125715|NCT00069641|10686913|P3|Overall Study|Death|1
3125716|NCT00069641|10686914|P2|Overall Study|Death|0
3125717|NCT00069641|10686915|P1|Overall Study|Death|1
3125718|NCT00069576|10686942|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
3125719|NCT00069576|10686943|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
3125720|NCT00069576|10686942|P2|Original Trial|Lost to Follow-up|33
3125721|NCT00069576|10686943|P1|Original Trial|Lost to Follow-up|25
3125722|NCT00069277|10686993|P1|Overall Study|Physician Decision|2
3125723|NCT00069277|10686993|P1|Overall Study|Progressive Disease|15
3125724|NCT00069277|10686993|P1|Overall Study|Withdrawal by Subject|1
3125725|NCT00069277|10686993|P1|Overall Study|Adverse Event|3
3125726|NCT00069264|10686997|P1|Overall Study|Discon Therapy|3
3125727|NCT00069264|10686997|P1|Overall Study|Withdrawal by Subject|3
3125728|NCT00069264|10686997|P1|Overall Study|Progressive Disease|23
3125729|NCT00069264|10686997|P1|Overall Study|Adverse Event|3
3125730|NCT00069238|10687025|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
3125731|NCT00069238|10687026|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
3125732|NCT00069238|10687027|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
3125733|NCT00069238|10687025|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
3125734|NCT00069238|10687026|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
3125735|NCT00069238|10687027|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
3125736|NCT00069238|10687025|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
3125737|NCT00069238|10687026|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
3125738|NCT00069238|10687027|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
3125739|NCT00069121|10687035|P2|Overall Study|Lost to Follow-up|63
3125740|NCT00069121|10687036|P1|Overall Study|Lost to Follow-up|63
3125741|NCT00069121|10687035|P2|Overall Study|Withdrawal by Subject|20
3125742|NCT00069121|10687036|P1|Overall Study|Withdrawal by Subject|18
3125743|NCT00069121|10687035|P2|Overall Study|Death|242
3125744|NCT00069121|10687036|P1|Overall Study|Death|286
3125745|NCT00069108|10687058|P2|Overall Study|Refused treatment|10
3125746|NCT00069108|10687059|P1|Overall Study|Refused treatment|5
3125747|NCT00069108|10687058|P2|Overall Study|Violation criteria|4
3125748|NCT00069108|10687059|P1|Overall Study|Violation criteria|1
3125749|NCT00069108|10687058|P2|Overall Study|Insufficient therapy|144
3125750|NCT00069108|10687059|P1|Overall Study|Insufficient therapy|117
3125751|NCT00069108|10687058|P2|Overall Study|Administration|4
3125752|NCT00069108|10687059|P1|Overall Study|Administration|15
3125753|NCT00069108|10687058|P2|Overall Study|Death|6
3125754|NCT00069108|10687059|P1|Overall Study|Death|6
3125755|NCT00069108|10687058|P2|Overall Study|Adverse Event|42
3125756|NCT00069108|10687059|P1|Overall Study|Adverse Event|64
3125757|NCT00069108|10687058|P2|Overall Study|Withdrawal by Subject|9
3125758|NCT00069108|10687059|P1|Overall Study|Withdrawal by Subject|5
3125759|NCT00069095|10687091|P6|Follow-up Phase|Death|101
3125760|NCT00069095|10687092|P5|Follow-up Phase|Death|92
3125761|NCT00069095|10687093|P4|Follow-up Phase|Death|112
3125762|NCT00069095|10687094|P3|Follow-up Phase|Death|120
3125763|NCT00069095|10687095|P2|Follow-up Phase|Death|206
3125764|NCT00069095|10687096|P1|Follow-up Phase|Death|174
3125765|NCT00069095|10687091|P6|Post-study Treatment Phase|Investigator decision|1
3125766|NCT00069095|10687092|P5|Post-study Treatment Phase|Investigator decision|0
3125767|NCT00069095|10687093|P4|Post-study Treatment Phase|Investigator decision|0
3125768|NCT00069095|10687094|P3|Post-study Treatment Phase|Investigator decision|0
3125769|NCT00069095|10687095|P2|Post-study Treatment Phase|Investigator decision|0
3125770|NCT00069095|10687096|P1|Post-study Treatment Phase|Investigator decision|0
3125771|NCT00069095|10687091|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
3125772|NCT00069095|10687092|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
3125773|NCT00069095|10687093|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
3125774|NCT00069095|10687094|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
3125775|NCT00069095|10687095|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
3125776|NCT00069095|10687096|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
3125777|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
3125778|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
3125779|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
3125780|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
3125781|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
3125782|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
3125783|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant had progressive disease|0
3125784|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant had progressive disease|1
3125785|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant had progressive disease|0
3125786|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant had progressive disease|0
3125787|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant had progressive disease|0
3125788|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant had progressive disease|0
3125789|NCT00069095|10687091|P6|Post-study Treatment Phase|Death|0
3125790|NCT00069095|10687092|P5|Post-study Treatment Phase|Death|1
3125791|NCT00069095|10687093|P4|Post-study Treatment Phase|Death|0
3125792|NCT00069095|10687094|P3|Post-study Treatment Phase|Death|0
3125793|NCT00069095|10687095|P2|Post-study Treatment Phase|Death|0
3125794|NCT00069095|10687096|P1|Post-study Treatment Phase|Death|0
3125795|NCT00069095|10687091|P6|Post-study Treatment Phase|Surgery|0
3125796|NCT00069095|10687092|P5|Post-study Treatment Phase|Surgery|1
3125797|NCT00069095|10687093|P4|Post-study Treatment Phase|Surgery|1
3125798|NCT00069095|10687094|P3|Post-study Treatment Phase|Surgery|0
3125799|NCT00069095|10687095|P2|Post-study Treatment Phase|Surgery|0
3125800|NCT00069095|10687096|P1|Post-study Treatment Phase|Surgery|0
3125801|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant completed treatment|0
3125802|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant completed treatment|0
3125803|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant completed treatment|1
3125804|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant completed treatment|0
3125805|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant completed treatment|0
3125806|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant completed treatment|0
3125807|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
3125808|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
3125809|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
3125810|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
3125811|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
3125812|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
3125813|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant will start new treatment|0
3125814|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant will start new treatment|0
3125815|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant will start new treatment|0
3125816|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant will start new treatment|1
3125817|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant will start new treatment|0
3125818|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant will start new treatment|0
3125819|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant withdrew consent|0
3125820|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant withdrew consent|0
3125821|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant withdrew consent|0
3125822|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant withdrew consent|1
3125823|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant withdrew consent|0
3125824|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant withdrew consent|0
3125825|NCT00069095|10687091|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
3125826|NCT00069095|10687092|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
3125827|NCT00069095|10687093|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
3125828|NCT00069095|10687094|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
3125829|NCT00069095|10687095|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
3125830|NCT00069095|10687096|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
3125831|NCT00069095|10687091|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
3125832|NCT00069095|10687092|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
3125833|NCT00069095|10687093|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
3125834|NCT00069095|10687094|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
3125835|NCT00069095|10687095|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
3125836|NCT00069095|10687096|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
3125837|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant had complete response|0
3125838|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant had complete response|0
3125839|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant had complete response|0
3125840|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant had complete response|0
3125841|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant had complete response|1
3125842|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant had complete response|1
3125843|NCT00069095|10687091|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
3125844|NCT00069095|10687092|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
3125845|NCT00069095|10687093|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
3125846|NCT00069095|10687094|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
3125847|NCT00069095|10687095|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
3125848|NCT00069095|10687096|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
3125849|NCT00069095|10687091|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
3125850|NCT00069095|10687092|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
3125851|NCT00069095|10687093|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
3125852|NCT00069095|10687094|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
3125853|NCT00069095|10687095|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
3125854|NCT00069095|10687096|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
3125855|NCT00069095|10687091|P6|Post-study Treatment Phase|Eligible for surgery|0
3125856|NCT00069095|10687092|P5|Post-study Treatment Phase|Eligible for surgery|0
3125857|NCT00069095|10687093|P4|Post-study Treatment Phase|Eligible for surgery|0
3125858|NCT00069095|10687094|P3|Post-study Treatment Phase|Eligible for surgery|0
3125859|NCT00069095|10687095|P2|Post-study Treatment Phase|Eligible for surgery|0
3125860|NCT00069095|10687096|P1|Post-study Treatment Phase|Eligible for surgery|2
3125861|NCT00069095|10687091|P6|Post-study Treatment Phase|Adverse Event|1
3125862|NCT00069095|10687092|P5|Post-study Treatment Phase|Adverse Event|5
3125863|NCT00069095|10687093|P4|Post-study Treatment Phase|Adverse Event|0
3125864|NCT00069095|10687094|P3|Post-study Treatment Phase|Adverse Event|1
3125865|NCT00069095|10687095|P2|Post-study Treatment Phase|Adverse Event|3
3125866|NCT00069095|10687096|P1|Post-study Treatment Phase|Adverse Event|2
3125867|NCT00069095|10687091|P6|Post-study Treatment Phase|Missing reason|17
3125868|NCT00069095|10687092|P5|Post-study Treatment Phase|Missing reason|18
3125869|NCT00069095|10687093|P4|Post-study Treatment Phase|Missing reason|8
3125870|NCT00069095|10687094|P3|Post-study Treatment Phase|Missing reason|12
3125871|NCT00069095|10687095|P2|Post-study Treatment Phase|Missing reason|3
3125872|NCT00069095|10687096|P1|Post-study Treatment Phase|Missing reason|1
3125873|NCT00069095|10687091|P6|Primary Treatment Phase|Violation criteria|5
3125874|NCT00069095|10687092|P5|Primary Treatment Phase|Violation criteria|1
3125875|NCT00069095|10687093|P4|Primary Treatment Phase|Violation criteria|3
3125876|NCT00069095|10687094|P3|Primary Treatment Phase|Violation criteria|4
3125877|NCT00069095|10687095|P2|Primary Treatment Phase|Violation criteria|2
3125878|NCT00069095|10687096|P1|Primary Treatment Phase|Violation criteria|0
3125879|NCT00069095|10687091|P6|Primary Treatment Phase|Other Violation|1
3125880|NCT00069095|10687092|P5|Primary Treatment Phase|Other Violation|0
3125881|NCT00069095|10687093|P4|Primary Treatment Phase|Other Violation|1
3125882|NCT00069095|10687094|P3|Primary Treatment Phase|Other Violation|1
3125883|NCT00069095|10687095|P2|Primary Treatment Phase|Other Violation|1
3125884|NCT00069095|10687096|P1|Primary Treatment Phase|Other Violation|0
3125885|NCT00069095|10687091|P6|Primary Treatment Phase|Withdrew|9
3125886|NCT00069095|10687092|P5|Primary Treatment Phase|Withdrew|4
3125887|NCT00069095|10687093|P4|Primary Treatment Phase|Withdrew|2
3125888|NCT00069095|10687094|P3|Primary Treatment Phase|Withdrew|8
3125889|NCT00069095|10687095|P2|Primary Treatment Phase|Withdrew|3
3125890|NCT00069095|10687096|P1|Primary Treatment Phase|Withdrew|2
3125891|NCT00069095|10687091|P6|Primary Treatment Phase|Refused treatment|27
3125892|NCT00069095|10687092|P5|Primary Treatment Phase|Refused treatment|24
3125893|NCT00069095|10687093|P4|Primary Treatment Phase|Refused treatment|31
3125894|NCT00069095|10687094|P3|Primary Treatment Phase|Refused treatment|17
3125895|NCT00069095|10687095|P2|Primary Treatment Phase|Refused treatment|26
3125896|NCT00069095|10687096|P1|Primary Treatment Phase|Refused treatment|15
3125897|NCT00069095|10687091|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
3125898|NCT00069095|10687092|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
3125899|NCT00069095|10687093|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
3125900|NCT00069095|10687094|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
3125901|NCT00069095|10687095|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
3125902|NCT00069095|10687096|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
3125903|NCT00069095|10687091|P6|Primary Treatment Phase|Failure to return|2
3125904|NCT00069095|10687092|P5|Primary Treatment Phase|Failure to return|0
3125905|NCT00069095|10687093|P4|Primary Treatment Phase|Failure to return|0
3125906|NCT00069095|10687094|P3|Primary Treatment Phase|Failure to return|0
3125907|NCT00069095|10687095|P2|Primary Treatment Phase|Failure to return|5
3125908|NCT00069095|10687096|P1|Primary Treatment Phase|Failure to return|5
3125909|NCT00069095|10687091|P6|Primary Treatment Phase|Death|8
3125910|NCT00069095|10687092|P5|Primary Treatment Phase|Death|8
3125911|NCT00069095|10687093|P4|Primary Treatment Phase|Death|5
3125912|NCT00069095|10687094|P3|Primary Treatment Phase|Death|2
3125913|NCT00069095|10687095|P2|Primary Treatment Phase|Death|8
3125914|NCT00069095|10687096|P1|Primary Treatment Phase|Death|14
3125915|NCT00069095|10687091|P6|Primary Treatment Phase|Adverse Event|101
3125916|NCT00069095|10687092|P5|Primary Treatment Phase|Adverse Event|109
3125917|NCT00069095|10687093|P4|Primary Treatment Phase|Adverse Event|72
3125918|NCT00069095|10687094|P3|Primary Treatment Phase|Adverse Event|71
3125919|NCT00069095|10687095|P2|Primary Treatment Phase|Adverse Event|92
3125920|NCT00069095|10687096|P1|Primary Treatment Phase|Adverse Event|99
3125921|NCT00069095|10687091|P6|Primary Treatment Phase|Admin/Other|42
3125922|NCT00069095|10687092|P5|Primary Treatment Phase|Admin/Other|48
3125923|NCT00069095|10687093|P4|Primary Treatment Phase|Admin/Other|45
3125924|NCT00069095|10687094|P3|Primary Treatment Phase|Admin/Other|31
3125925|NCT00069095|10687095|P2|Primary Treatment Phase|Admin/Other|38
3125926|NCT00069095|10687096|P1|Primary Treatment Phase|Admin/Other|29
3125927|NCT00069095|10687091|P6|Primary Treatment Phase|Ongoing|4
3125928|NCT00069095|10687092|P5|Primary Treatment Phase|Ongoing|7
3125929|NCT00069095|10687093|P4|Primary Treatment Phase|Ongoing|7
3125930|NCT00069095|10687094|P3|Primary Treatment Phase|Ongoing|5
3125931|NCT00069095|10687095|P2|Primary Treatment Phase|Ongoing|0
3125932|NCT00069095|10687096|P1|Primary Treatment Phase|Ongoing|0
3125933|NCT00068822|10687166|P2|First Randomized Intervention|Lost to Follow-up|2
3125934|NCT00068822|10687167|P1|First Randomized Intervention|Lost to Follow-up|1
3125935|NCT00068692|10687201|P8|Step 2: Randomization|never start protocol therapy|0
3125936|NCT00068692|10687202|P7|Step 2: Randomization|never start protocol therapy|0
3125937|NCT00068692|10687203|P6|Step 2: Randomization|never start protocol therapy|0
3125938|NCT00068692|10687204|P5|Step 2: Randomization|never start protocol therapy|1
3125939|NCT00068692|10687205|P4|Step 2: Randomization|never start protocol therapy|0
3125940|NCT00068692|10687206|P3|Step 2: Randomization|never start protocol therapy|1
3125941|NCT00068692|10687207|P2|Step 2: Randomization|never start protocol therapy|0
3125942|NCT00068692|10687208|P1|Step 2: Randomization|never start protocol therapy|0
3125943|NCT00068692|10687201|P8|Step 2: Randomization|Other|0
3125944|NCT00068692|10687202|P7|Step 2: Randomization|Other|0
3125945|NCT00068692|10687203|P6|Step 2: Randomization|Other|1
3125946|NCT00068692|10687204|P5|Step 2: Randomization|Other|0
3125947|NCT00068692|10687205|P4|Step 2: Randomization|Other|1
3125948|NCT00068692|10687206|P3|Step 2: Randomization|Other|0
3125949|NCT00068692|10687207|P2|Step 2: Randomization|Other|0
3125950|NCT00068692|10687208|P1|Step 2: Randomization|Other|0
3125951|NCT00068692|10687201|P8|Step 2: Randomization|Physician Decision|0
3125952|NCT00068692|10687202|P7|Step 2: Randomization|Physician Decision|0
3125953|NCT00068692|10687203|P6|Step 2: Randomization|Physician Decision|0
3125954|NCT00068692|10687204|P5|Step 2: Randomization|Physician Decision|1
3125955|NCT00068692|10687205|P4|Step 2: Randomization|Physician Decision|1
3125956|NCT00068692|10687206|P3|Step 2: Randomization|Physician Decision|0
3125957|NCT00068692|10687207|P2|Step 2: Randomization|Physician Decision|0
3125958|NCT00068692|10687208|P1|Step 2: Randomization|Physician Decision|0
3125959|NCT00068692|10687201|P8|Step 2: Randomization|alternative therapy|0
3125960|NCT00068692|10687202|P7|Step 2: Randomization|alternative therapy|0
3125961|NCT00068692|10687203|P6|Step 2: Randomization|alternative therapy|0
3125962|NCT00068692|10687204|P5|Step 2: Randomization|alternative therapy|1
3125963|NCT00068692|10687205|P4|Step 2: Randomization|alternative therapy|1
3125964|NCT00068692|10687206|P3|Step 2: Randomization|alternative therapy|0
3125965|NCT00068692|10687207|P2|Step 2: Randomization|alternative therapy|0
3125966|NCT00068692|10687208|P1|Step 2: Randomization|alternative therapy|0
3125967|NCT00068692|10687201|P8|Step 2: Randomization|Withdrawal by Subject|3
3125968|NCT00068692|10687202|P7|Step 2: Randomization|Withdrawal by Subject|0
3125969|NCT00068692|10687203|P6|Step 2: Randomization|Withdrawal by Subject|2
3125970|NCT00068692|10687204|P5|Step 2: Randomization|Withdrawal by Subject|3
3125971|NCT00068692|10687205|P4|Step 2: Randomization|Withdrawal by Subject|6
3125972|NCT00068692|10687206|P3|Step 2: Randomization|Withdrawal by Subject|4
3125973|NCT00068692|10687207|P2|Step 2: Randomization|Withdrawal by Subject|0
3125974|NCT00068692|10687208|P1|Step 2: Randomization|Withdrawal by Subject|0
3125975|NCT00068692|10687201|P8|Step 2: Randomization|Death|1
3125976|NCT00068692|10687202|P7|Step 2: Randomization|Death|0
3125977|NCT00068692|10687203|P6|Step 2: Randomization|Death|0
3125978|NCT00068692|10687204|P5|Step 2: Randomization|Death|1
3125979|NCT00068692|10687205|P4|Step 2: Randomization|Death|0
3125980|NCT00068692|10687206|P3|Step 2: Randomization|Death|0
3125981|NCT00068692|10687207|P2|Step 2: Randomization|Death|0
3125982|NCT00068692|10687208|P1|Step 2: Randomization|Death|0
3125983|NCT00068692|10687201|P8|Step 2: Randomization|Adverse Event|4
3125984|NCT00068692|10687202|P7|Step 2: Randomization|Adverse Event|4
3125985|NCT00068692|10687203|P6|Step 2: Randomization|Adverse Event|3
3125986|NCT00068692|10687204|P5|Step 2: Randomization|Adverse Event|2
3125987|NCT00068692|10687205|P4|Step 2: Randomization|Adverse Event|2
3125988|NCT00068692|10687206|P3|Step 2: Randomization|Adverse Event|4
3125989|NCT00068692|10687207|P2|Step 2: Randomization|Adverse Event|0
3125990|NCT00068692|10687208|P1|Step 2: Randomization|Adverse Event|0
3125991|NCT00068692|10687201|P8|Step 2: Randomization|Disesae progression/replase|0
3125992|NCT00068692|10687202|P7|Step 2: Randomization|Disesae progression/replase|0
3125993|NCT00068692|10687203|P6|Step 2: Randomization|Disesae progression/replase|0
3125994|NCT00068692|10687204|P5|Step 2: Randomization|Disesae progression/replase|0
3125995|NCT00068692|10687205|P4|Step 2: Randomization|Disesae progression/replase|1
3125996|NCT00068692|10687206|P3|Step 2: Randomization|Disesae progression/replase|1
3125997|NCT00068692|10687207|P2|Step 2: Randomization|Disesae progression/replase|0
3125998|NCT00068692|10687208|P1|Step 2: Randomization|Disesae progression/replase|0
3125999|NCT00068692|10687201|P8|Step 1: Registration|Registered but not randomized|0
3126000|NCT00068692|10687202|P7|Step 1: Registration|Registered but not randomized|0
3126001|NCT00068692|10687203|P6|Step 1: Registration|Registered but not randomized|0
3126002|NCT00068692|10687204|P5|Step 1: Registration|Registered but not randomized|0
3126003|NCT00068692|10687205|P4|Step 1: Registration|Registered but not randomized|0
3126004|NCT00068692|10687206|P3|Step 1: Registration|Registered but not randomized|0
3126005|NCT00068692|10687207|P2|Step 1: Registration|Registered but not randomized|1
3126006|NCT00068692|10687208|P1|Step 1: Registration|Registered but not randomized|0
3126007|NCT00068692|10687201|P8|Step 1: Registration|Not start protocol therapy|0
3126008|NCT00068692|10687202|P7|Step 1: Registration|Not start protocol therapy|0
3126009|NCT00068692|10687203|P6|Step 1: Registration|Not start protocol therapy|0
3126010|NCT00068692|10687204|P5|Step 1: Registration|Not start protocol therapy|0
3126011|NCT00068692|10687205|P4|Step 1: Registration|Not start protocol therapy|0
3126012|NCT00068692|10687206|P3|Step 1: Registration|Not start protocol therapy|0
3126013|NCT00068692|10687207|P2|Step 1: Registration|Not start protocol therapy|0
3126014|NCT00068692|10687208|P1|Step 1: Registration|Not start protocol therapy|3
3126015|NCT00068692|10687201|P8|Step 1: Registration|Other|0
3126016|NCT00068692|10687202|P7|Step 1: Registration|Other|0
3126017|NCT00068692|10687203|P6|Step 1: Registration|Other|0
3126018|NCT00068692|10687204|P5|Step 1: Registration|Other|0
3126019|NCT00068692|10687205|P4|Step 1: Registration|Other|0
3126020|NCT00068692|10687206|P3|Step 1: Registration|Other|0
3126021|NCT00068692|10687207|P2|Step 1: Registration|Other|0
3126022|NCT00068692|10687208|P1|Step 1: Registration|Other|2
3126023|NCT00068692|10687201|P8|Step 1: Registration|Not eligible|0
3126024|NCT00068692|10687202|P7|Step 1: Registration|Not eligible|0
3126025|NCT00068692|10687203|P6|Step 1: Registration|Not eligible|0
3126026|NCT00068692|10687204|P5|Step 1: Registration|Not eligible|0
3126027|NCT00068692|10687205|P4|Step 1: Registration|Not eligible|0
3126028|NCT00068692|10687206|P3|Step 1: Registration|Not eligible|0
3126029|NCT00068692|10687207|P2|Step 1: Registration|Not eligible|0
3126030|NCT00068692|10687208|P1|Step 1: Registration|Not eligible|6
3126031|NCT00068692|10687201|P8|Step 1: Registration|Protocol Violation|0
3126032|NCT00068692|10687202|P7|Step 1: Registration|Protocol Violation|0
3126033|NCT00068692|10687203|P6|Step 1: Registration|Protocol Violation|0
3126034|NCT00068692|10687204|P5|Step 1: Registration|Protocol Violation|0
3126035|NCT00068692|10687205|P4|Step 1: Registration|Protocol Violation|0
3126036|NCT00068692|10687206|P3|Step 1: Registration|Protocol Violation|0
3126037|NCT00068692|10687207|P2|Step 1: Registration|Protocol Violation|0
3126038|NCT00068692|10687208|P1|Step 1: Registration|Protocol Violation|1
3126039|NCT00068692|10687201|P8|Step 1: Registration|Complicating disease|0
3126040|NCT00068692|10687202|P7|Step 1: Registration|Complicating disease|0
3126041|NCT00068692|10687203|P6|Step 1: Registration|Complicating disease|0
3126042|NCT00068692|10687204|P5|Step 1: Registration|Complicating disease|0
3126043|NCT00068692|10687205|P4|Step 1: Registration|Complicating disease|0
3126044|NCT00068692|10687206|P3|Step 1: Registration|Complicating disease|0
3126045|NCT00068692|10687207|P2|Step 1: Registration|Complicating disease|0
3126046|NCT00068692|10687208|P1|Step 1: Registration|Complicating disease|2
3126047|NCT00068692|10687201|P8|Step 1: Registration|Alternative therapy|0
3126048|NCT00068692|10687202|P7|Step 1: Registration|Alternative therapy|0
3126049|NCT00068692|10687203|P6|Step 1: Registration|Alternative therapy|0
3126050|NCT00068692|10687204|P5|Step 1: Registration|Alternative therapy|0
3126051|NCT00068692|10687205|P4|Step 1: Registration|Alternative therapy|0
3126052|NCT00068692|10687206|P3|Step 1: Registration|Alternative therapy|0
3126053|NCT00068692|10687207|P2|Step 1: Registration|Alternative therapy|0
3126054|NCT00068692|10687208|P1|Step 1: Registration|Alternative therapy|2
3126055|NCT00068692|10687201|P8|Step 1: Registration|Withdrawal by Subject|0
3126056|NCT00068692|10687202|P7|Step 1: Registration|Withdrawal by Subject|0
3126057|NCT00068692|10687203|P6|Step 1: Registration|Withdrawal by Subject|0
3126058|NCT00068692|10687204|P5|Step 1: Registration|Withdrawal by Subject|0
3126059|NCT00068692|10687205|P4|Step 1: Registration|Withdrawal by Subject|0
3126060|NCT00068692|10687206|P3|Step 1: Registration|Withdrawal by Subject|0
3126061|NCT00068692|10687207|P2|Step 1: Registration|Withdrawal by Subject|0
3126062|NCT00068692|10687208|P1|Step 1: Registration|Withdrawal by Subject|11
3126063|NCT00068692|10687201|P8|Step 1: Registration|Death|0
3126064|NCT00068692|10687202|P7|Step 1: Registration|Death|0
3126065|NCT00068692|10687203|P6|Step 1: Registration|Death|0
3126066|NCT00068692|10687204|P5|Step 1: Registration|Death|0
3126067|NCT00068692|10687205|P4|Step 1: Registration|Death|0
3126068|NCT00068692|10687206|P3|Step 1: Registration|Death|0
3126069|NCT00068692|10687207|P2|Step 1: Registration|Death|0
3126070|NCT00068692|10687208|P1|Step 1: Registration|Death|1
3126071|NCT00068692|10687201|P8|Step 1: Registration|Adverse Event|0
3126072|NCT00068692|10687202|P7|Step 1: Registration|Adverse Event|0
3126073|NCT00068692|10687203|P6|Step 1: Registration|Adverse Event|0
3126074|NCT00068692|10687204|P5|Step 1: Registration|Adverse Event|0
3126075|NCT00068692|10687205|P4|Step 1: Registration|Adverse Event|0
3126076|NCT00068692|10687206|P3|Step 1: Registration|Adverse Event|0
3126077|NCT00068692|10687207|P2|Step 1: Registration|Adverse Event|0
3126078|NCT00068692|10687208|P1|Step 1: Registration|Adverse Event|7
3126079|NCT00068692|10687201|P8|Step 1: Registration|Disese progression/relapse|0
3126080|NCT00068692|10687202|P7|Step 1: Registration|Disese progression/relapse|0
3126081|NCT00068692|10687203|P6|Step 1: Registration|Disese progression/relapse|0
3126082|NCT00068692|10687204|P5|Step 1: Registration|Disese progression/relapse|0
3126083|NCT00068692|10687205|P4|Step 1: Registration|Disese progression/relapse|0
3126084|NCT00068692|10687206|P3|Step 1: Registration|Disese progression/relapse|0
3126085|NCT00068692|10687207|P2|Step 1: Registration|Disese progression/relapse|0
3126086|NCT00068692|10687208|P1|Step 1: Registration|Disese progression/relapse|5
3126087|NCT00068601|10687231|P2|Overall Study|Missing primary outcome data|34
3126088|NCT00068601|10687232|P1|Overall Study|Missing primary outcome data|30
3126089|NCT00068601|10687231|P2|Overall Study|Lost to Follow-up|2
3126090|NCT00068601|10687232|P1|Overall Study|Lost to Follow-up|3
3126091|NCT00068601|10687231|P2|Overall Study|Death|3
3126092|NCT00068601|10687232|P1|Overall Study|Death|11
3126093|NCT00068601|10687231|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
3126094|NCT00068601|10687232|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
3126095|NCT00068601|10687231|P2|Overall Study|Not evaluable: withdrew consent|4
3126096|NCT00068601|10687232|P1|Overall Study|Not evaluable: withdrew consent|5
3126097|NCT00068601|10687231|P2|Overall Study|Ineligible|13
3126098|NCT00068601|10687232|P1|Overall Study|Ineligible|11
3126099|NCT00068588|10687245|P3|Overall Study|Poor KPS|1
3126100|NCT00068588|10687246|P2|Overall Study|Poor KPS|0
3126101|NCT00068588|10687247|P1|Overall Study|Poor KPS|0
3126102|NCT00068588|10687245|P3|Overall Study|Withdrawal by Subject|1
3126103|NCT00068588|10687246|P2|Overall Study|Withdrawal by Subject|0
3126104|NCT00068588|10687247|P1|Overall Study|Withdrawal by Subject|0
3126105|NCT00068588|10687245|P3|Overall Study|Adverse Event|2
3126106|NCT00068588|10687246|P2|Overall Study|Adverse Event|0
3126107|NCT00068588|10687247|P1|Overall Study|Adverse Event|0
3126108|NCT00068445|10687263|P2|Treatment|Other (Specifics not available)|5
3126109|NCT00068445|10687264|P1|Treatment|Other (Specifics not available)|9
3126110|NCT00068445|10687263|P2|Treatment|Adverse Event|1
3126111|NCT00068445|10687264|P1|Treatment|Adverse Event|7
3126112|NCT00068445|10687263|P2|Treatment|Refused Further Treatment|10
3126113|NCT00068445|10687264|P1|Treatment|Refused Further Treatment|13
3126114|NCT00068445|10687263|P2|Randomization|Ineligible|1
3126115|NCT00068445|10687264|P1|Randomization|Ineligible|1
3126116|NCT00068445|10687263|P2|Randomization|Cancel|3
3126117|NCT00068445|10687264|P1|Randomization|Cancel|1
3126118|NCT00068419|10687288|P1|Overall Study|Ineligible|11
3126119|NCT00068419|10687288|P1|Overall Study|Withdrawal by Subject|14
3126120|NCT00068419|10687288|P1|Overall Study|Physician Decision|7
3126121|NCT00068419|10687288|P1|Overall Study|Lost to Follow-up|1
3126122|NCT00068419|10687288|P1|Overall Study|Lack of Efficacy|24
3126123|NCT00068419|10687288|P1|Overall Study|Adverse Event|3
3126124|NCT00068406|10687297|P1|Overall Study|Ineligible-Inadequate Pathology|2
3126125|NCT00068406|10687297|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
3126126|NCT00068393|10687302|P1|Overall Study|Quality of life worsening|1
3126127|NCT00068393|10687302|P1|Overall Study|Alternative treatment|1
3126128|NCT00068393|10687302|P1|Overall Study|Withdrawal by Subject|3
3126129|NCT00068393|10687302|P1|Overall Study|Death|3
3126130|NCT00068393|10687302|P1|Overall Study|Adverse Event|2
3126131|NCT00068380|10687308|P1|Overall Study|Adverse Event|2
3126132|NCT00068380|10687308|P1|Overall Study|Withdrawal by Subject|3
3126133|NCT00068250|10687352|P4|Phase I: Dose Level 2|Protocol Violation|0
3126134|NCT00068250|10687353|P3|Phase I: Dose Level 2|Protocol Violation|0
3126135|NCT00068250|10687354|P2|Phase I: Dose Level 2|Protocol Violation|1
3126136|NCT00068250|10687355|P1|Phase I: Dose Level 2|Protocol Violation|0
3126137|NCT00068237|10687365|P1|Overall Study|No protocol treatment received|2
3126138|NCT00068237|10687365|P1|Overall Study|Ineligible|3
3126139|NCT00068107|10687377|P1|Overall Study|Withdrawal by Subject|1
3126140|NCT00068107|10687377|P1|Overall Study|Death|2
3126141|NCT00068107|10687377|P1|Overall Study|end-stage renal disease|6
3126142|NCT00067990|10687390|P2|Overall Study|Withdrawal by Subject|12
3126143|NCT00067990|10687391|P1|Overall Study|Withdrawal by Subject|4
3126144|NCT00067990|10687390|P2|Overall Study|ESRD, Non IF/TA|3
3126145|NCT00067990|10687391|P1|Overall Study|ESRD, Non IF/TA|1
3126146|NCT00067990|10687390|P2|Overall Study|Death|7
3126147|NCT00067990|10687391|P1|Overall Study|Death|5
3126148|NCT00067470|10687414|P2|Overall Study|Withdrawal by Subject|1
3126149|NCT00067470|10687415|P1|Overall Study|Withdrawal by Subject|0
3126150|NCT00067002|10687436|P2|Overall Study|Graft Failure|6
3126151|NCT00067002|10687437|P1|Overall Study|Graft Failure|5
3126152|NCT00067002|10687436|P2|Overall Study|Delayed|1
3126153|NCT00067002|10687437|P1|Overall Study|Delayed|1
3126154|NCT00067002|10687436|P2|Overall Study|Early Death|2
3126155|NCT00067002|10687437|P1|Overall Study|Early Death|1
3126156|NCT00066807|10687495|P2|Overall Study|Study was terminated early|15
3126157|NCT00066807|10687496|P1|Overall Study|Study was terminated early|14
3126158|NCT00066742|10687521|P1|Consolidation Chemotherapy|Ineligible|2
3126159|NCT00066742|10687521|P1|Consolidation Chemotherapy|not protocol specified|1
3126160|NCT00066742|10687521|P1|Induction Chemoradiotherapy|Ineligible|3
3126161|NCT00066742|10687521|P1|Induction Chemoradiotherapy|not protocol specified|2
3126162|NCT00066742|10687521|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
3126163|NCT00066742|10687521|P1|Induction Chemoradiotherapy|Adverse Event|21
3126164|NCT00066742|10687521|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
3126165|NCT00066703|10687530|P2|Overall Study|Treatment ongoing|311
3126166|NCT00066703|10687531|P1|Overall Study|Treatment ongoing|346
3126167|NCT00066703|10687530|P2|Overall Study|Withdrawal by Subject|63
3126168|NCT00066703|10687531|P1|Overall Study|Withdrawal by Subject|38
3126169|NCT00066703|10687530|P2|Overall Study|Lost to Follow-up|28
3126170|NCT00066703|10687531|P1|Overall Study|Lost to Follow-up|31
3126171|NCT00066703|10687530|P2|Overall Study|Lack of Efficacy|69
3126172|NCT00066703|10687531|P1|Overall Study|Lack of Efficacy|114
3126173|NCT00066703|10687530|P2|Overall Study|Death|0
3126174|NCT00066703|10687531|P1|Overall Study|Death|3
3126175|NCT00066703|10687530|P2|Overall Study|Adverse Event|111
3126176|NCT00066703|10687531|P1|Overall Study|Adverse Event|80
3126177|NCT00066690|10687546|P3|Overall Study|Treatment Ongoing|282
3126178|NCT00066690|10687547|P2|Overall Study|Treatment Ongoing|278
3126179|NCT00066690|10687548|P1|Overall Study|Treatment Ongoing|246
3126180|NCT00066690|10687546|P3|Overall Study|Withdrawal by Subject|49
3126181|NCT00066690|10687547|P2|Overall Study|Withdrawal by Subject|55
3126182|NCT00066690|10687548|P1|Overall Study|Withdrawal by Subject|50
3126183|NCT00066690|10687546|P3|Overall Study|Lost to Follow-up|29
3126184|NCT00066690|10687547|P2|Overall Study|Lost to Follow-up|21
3126185|NCT00066690|10687548|P1|Overall Study|Lost to Follow-up|40
3126186|NCT00066690|10687546|P3|Overall Study|Lack of Efficacy|76
3126187|NCT00066690|10687547|P2|Overall Study|Lack of Efficacy|110
3126188|NCT00066690|10687548|P1|Overall Study|Lack of Efficacy|114
3126189|NCT00066690|10687546|P3|Overall Study|Death|2
3126190|NCT00066690|10687547|P2|Overall Study|Death|0
3126191|NCT00066690|10687548|P1|Overall Study|Death|3
3126192|NCT00066690|10687546|P3|Overall Study|Adverse Event|126
3126193|NCT00066690|10687547|P2|Overall Study|Adverse Event|58
3126194|NCT00066690|10687548|P1|Overall Study|Adverse Event|145
3126195|NCT00066573|10687567|P2|Overall Study|Did not received protocol treatment|28
3126196|NCT00066573|10687568|P1|Overall Study|Did not received protocol treatment|28
3126197|NCT00066469|10687580|P1|Overall Study|ineligible|1
3126198|NCT00066469|10687580|P1|Overall Study|Withdrawal by Subject|1
3126199|NCT00066469|10687580|P1|Overall Study|Physician Decision|1
3126200|NCT00066469|10687580|P1|Overall Study|Lost to Follow-up|1
3126201|NCT00066469|10687580|P1|Overall Study|Lack of Efficacy|9
3126202|NCT00066469|10687580|P1|Overall Study|Death|3
3126203|NCT00066365|10687586|P2|Overall Study|Ineligible|2
3126204|NCT00066365|10687587|P1|Overall Study|Ineligible|4
3126205|NCT00066365|10687586|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
3126206|NCT00066365|10687587|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
3126207|NCT00066365|10687586|P2|Overall Study|Physician Decision|0
3126208|NCT00066365|10687587|P1|Overall Study|Physician Decision|1
3126209|NCT00066365|10687586|P2|Overall Study|Lack of Efficacy|12
3126210|NCT00066365|10687587|P1|Overall Study|Lack of Efficacy|15
3126211|NCT00066365|10687586|P2|Overall Study|Adverse Event|0
3126212|NCT00066365|10687587|P1|Overall Study|Adverse Event|1
3126213|NCT00066222|10687615|P1|Overall Study|No protocol treatment received|1
3126214|NCT00066170|10687628|P4|Overall Study|Other|0
3126215|NCT00066170|10687629|P3|Overall Study|Other|2
3126216|NCT00066170|10687630|P2|Overall Study|Other|5
3126217|NCT00066170|10687631|P1|Overall Study|Other|1
3126218|NCT00066170|10687628|P4|Overall Study|Protocol Violation|0
3126219|NCT00066170|10687629|P3|Overall Study|Protocol Violation|0
3126220|NCT00066170|10687630|P2|Overall Study|Protocol Violation|0
3126221|NCT00066170|10687631|P1|Overall Study|Protocol Violation|3
3126222|NCT00066170|10687628|P4|Overall Study|Non-Compliance with Trial Medicine|1
3126223|NCT00066170|10687629|P3|Overall Study|Non-Compliance with Trial Medicine|0
3126224|NCT00066170|10687630|P2|Overall Study|Non-Compliance with Trial Medicine|0
3126225|NCT00066170|10687631|P1|Overall Study|Non-Compliance with Trial Medicine|1
3126226|NCT00066170|10687628|P4|Overall Study|Lost to Follow-up|0
3126227|NCT00066170|10687629|P3|Overall Study|Lost to Follow-up|0
3126228|NCT00066170|10687630|P2|Overall Study|Lost to Follow-up|1
3126229|NCT00066170|10687631|P1|Overall Study|Lost to Follow-up|0
3126230|NCT00066170|10687628|P4|Overall Study|Serious Adverse Event|1
3126231|NCT00066170|10687629|P3|Overall Study|Serious Adverse Event|1
3126232|NCT00066170|10687630|P2|Overall Study|Serious Adverse Event|0
3126233|NCT00066170|10687631|P1|Overall Study|Serious Adverse Event|0
3126234|NCT00066170|10687628|P4|Overall Study|Adverse Event|7
3126235|NCT00066170|10687629|P3|Overall Study|Adverse Event|1
3126236|NCT00066170|10687630|P2|Overall Study|Adverse Event|4
3126237|NCT00066170|10687631|P1|Overall Study|Adverse Event|2
3126238|NCT00066066|10687644|P6|Overall Study|Lost to Follow-up|5
3126239|NCT00066066|10687645|P5|Overall Study|Lost to Follow-up|3
3126240|NCT00066066|10687646|P4|Overall Study|Lost to Follow-up|4
3126241|NCT00066066|10687647|P3|Overall Study|Lost to Follow-up|7
3126242|NCT00066066|10687648|P2|Overall Study|Lost to Follow-up|4
3126243|NCT00066066|10687649|P1|Overall Study|Lost to Follow-up|6
3126244|NCT00065507|10687727|P2|Overall Study|Subject No Longer Meets Study Criteria|0
3126245|NCT00065507|10687728|P1|Overall Study|Subject No Longer Meets Study Criteria|1
3126246|NCT00065507|10687727|P2|Overall Study|Subject Withdrew Consent|1
3126247|NCT00065507|10687728|P1|Overall Study|Subject Withdrew Consent|2
3126248|NCT00065507|10687727|P2|Overall Study|Lost to Follow-up|0
3126249|NCT00065507|10687728|P1|Overall Study|Lost to Follow-up|3
3126250|NCT00065507|10687727|P2|Overall Study|Poor/Non-compliance|2
3126251|NCT00065507|10687728|P1|Overall Study|Poor/Non-compliance|3
3126252|NCT00065507|10687727|P2|Overall Study|Lack of Efficacy|6
3126253|NCT00065507|10687728|P1|Overall Study|Lack of Efficacy|0
3126254|NCT00065507|10687727|P2|Overall Study|Adverse Event|3
3126255|NCT00065507|10687728|P1|Overall Study|Adverse Event|4
3126256|NCT00065507|10687727|P2|Overall Study|Death|17
3126257|NCT00065507|10687728|P1|Overall Study|Death|16
3126258|NCT00065468|10687793|P3|Overall Study|Other|18
3126259|NCT00065468|10687794|P2|Overall Study|Other|24
3126260|NCT00065468|10687795|P1|Overall Study|Other|14
3126261|NCT00065468|10687793|P3|Overall Study|Disease progression|1
3126262|NCT00065468|10687794|P2|Overall Study|Disease progression|0
3126263|NCT00065468|10687795|P1|Overall Study|Disease progression|0
3126264|NCT00065468|10687793|P3|Overall Study|Discontinuation of study by Sponsor|13
3126265|NCT00065468|10687794|P2|Overall Study|Discontinuation of study by Sponsor|9
3126266|NCT00065468|10687795|P1|Overall Study|Discontinuation of study by Sponsor|13
3126267|NCT00065468|10687793|P3|Overall Study|Lost to Follow-up|2
3126268|NCT00065468|10687794|P2|Overall Study|Lost to Follow-up|3
3126269|NCT00065468|10687795|P1|Overall Study|Lost to Follow-up|5
3126270|NCT00065468|10687793|P3|Overall Study|Withdrawal by Subject|5
3126271|NCT00065468|10687794|P2|Overall Study|Withdrawal by Subject|4
3126272|NCT00065468|10687795|P1|Overall Study|Withdrawal by Subject|3
3126273|NCT00065468|10687793|P3|Overall Study|Death|171
3126274|NCT00065468|10687794|P2|Overall Study|Death|169
3126275|NCT00065468|10687795|P1|Overall Study|Death|172
3126276|NCT00065442|10687826|P2|Overall Study|Withdrawal by Subject|9
3126277|NCT00065442|10687827|P1|Overall Study|Withdrawal by Subject|3
3126278|NCT00065442|10687826|P2|Overall Study|Death|210
3126279|NCT00065442|10687827|P1|Overall Study|Death|121
3126280|NCT00065442|10687826|P2|Overall Study|Lost to Follow-up|1
3126281|NCT00065442|10687827|P1|Overall Study|Lost to Follow-up|1
3126282|NCT00065429|10687842|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126283|NCT00065429|10687843|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126284|NCT00065429|10687844|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
3126285|NCT00065429|10687845|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126286|NCT00065429|10687846|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126287|NCT00065429|10687847|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126288|NCT00065429|10687848|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
3126289|NCT00065429|10687842|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126290|NCT00065429|10687843|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126291|NCT00065429|10687844|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
3126292|NCT00065429|10687845|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126293|NCT00065429|10687846|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126294|NCT00065429|10687847|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126295|NCT00065429|10687848|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
3126296|NCT00065429|10687842|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
3126297|NCT00065429|10687843|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
3126298|NCT00065429|10687844|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
3126299|NCT00065429|10687845|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
3126300|NCT00065429|10687846|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
3126301|NCT00065429|10687847|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
3126302|NCT00065429|10687848|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
3126303|NCT00065429|10687842|P7|Phase I - May 2001 - Oct 2002|Death|0
3126304|NCT00065429|10687843|P6|Phase I - May 2001 - Oct 2002|Death|0
3126305|NCT00065429|10687844|P5|Phase I - May 2001 - Oct 2002|Death|1
3126306|NCT00065429|10687845|P4|Phase I - May 2001 - Oct 2002|Death|0
3126307|NCT00065429|10687846|P3|Phase I - May 2001 - Oct 2002|Death|0
3126308|NCT00065429|10687847|P2|Phase I - May 2001 - Oct 2002|Death|0
3126309|NCT00065429|10687848|P1|Phase I - May 2001 - Oct 2002|Death|0
3126310|NCT00065429|10687842|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126311|NCT00065429|10687843|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126312|NCT00065429|10687844|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126313|NCT00065429|10687845|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126314|NCT00065429|10687846|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126315|NCT00065429|10687847|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
3126316|NCT00065429|10687848|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
3126317|NCT00065429|10687842|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126318|NCT00065429|10687843|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126319|NCT00065429|10687844|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126320|NCT00065429|10687845|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126321|NCT00065429|10687846|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
3126322|NCT00065429|10687847|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126323|NCT00065429|10687848|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
3126324|NCT00065429|10687842|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126325|NCT00065429|10687843|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
3126326|NCT00065429|10687844|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126327|NCT00065429|10687845|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126328|NCT00065429|10687846|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126329|NCT00065429|10687847|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126330|NCT00065429|10687848|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
3126331|NCT00065260|10687862|P2|Overall Study|Death|1
3126332|NCT00065260|10687863|P1|Overall Study|Death|0
3126333|NCT00065182|10687871|P2|Overall Study|Decline in Status|1
3126334|NCT00065182|10687872|P1|Overall Study|Decline in Status|0
3126335|NCT00065182|10687871|P2|Overall Study|Death|1
3126336|NCT00065182|10687872|P1|Overall Study|Death|0
3126337|NCT00065182|10687871|P2|Overall Study|No clinical benefit|0
3126338|NCT00065182|10687872|P1|Overall Study|No clinical benefit|1
3126339|NCT00065182|10687871|P2|Overall Study|Withdrawal by Subject|3
3126340|NCT00065182|10687872|P1|Overall Study|Withdrawal by Subject|8
3126341|NCT00065182|10687871|P2|Overall Study|Sponsor Decision|7
3126342|NCT00065182|10687872|P1|Overall Study|Sponsor Decision|11
3126343|NCT00065182|10687871|P2|Overall Study|Serious adverse events (SAE)|0
3126344|NCT00065182|10687872|P1|Overall Study|Serious adverse events (SAE)|1
3126345|NCT00065182|10687871|P2|Overall Study|Protocol Violation|4
3126346|NCT00065182|10687872|P1|Overall Study|Protocol Violation|3
3126347|NCT00065182|10687871|P2|Overall Study|Lost to Follow-up|4
3126348|NCT00065182|10687872|P1|Overall Study|Lost to Follow-up|0
3126349|NCT00065182|10687871|P2|Overall Study|Adverse Event|17
3126350|NCT00065182|10687872|P1|Overall Study|Adverse Event|24
3126351|NCT00065156|10687898|P1|Overall Study|Secondary Malign Disease|1
3126352|NCT00065156|10687898|P1|Overall Study|Loss of Response|1
3126353|NCT00065156|10687898|P1|Overall Study|Non-Compliance|2
3126354|NCT00065156|10687898|P1|Overall Study|Investigator Decision|2
3126355|NCT00065156|10687898|P1|Overall Study|Disease Progression|7
3126356|NCT00065156|10687898|P1|Overall Study|Study Closed by Sponsor|2
3126357|NCT00065156|10687898|P1|Overall Study|Death|11
3126358|NCT00065156|10687898|P1|Overall Study|Lost to Follow-up|1
3126359|NCT00065156|10687898|P1|Overall Study|Withdrawal by Subject|8
3126360|NCT00065156|10687898|P1|Overall Study|Lack of Efficacy|52
3126361|NCT00065156|10687898|P1|Overall Study|Adverse Event|37
3126362|NCT00065065|10687915|P2|Overall Study|Other|2
3126363|NCT00065065|10687916|P1|Overall Study|Other|2
3126364|NCT00065065|10687915|P2|Overall Study|Lack of Efficacy|11
3126365|NCT00065065|10687916|P1|Overall Study|Lack of Efficacy|4
3126366|NCT00065065|10687915|P2|Overall Study|Withdrawal by Subject|5
3126367|NCT00065065|10687916|P1|Overall Study|Withdrawal by Subject|1
3126368|NCT00065065|10687915|P2|Overall Study|Adverse Event|2
3126369|NCT00065065|10687916|P1|Overall Study|Adverse Event|3
3126370|NCT00003895|10687928|P2|Overall Study|Withdrawal by Subject|3
3126371|NCT00003895|10687929|P1|Overall Study|Withdrawal by Subject|0
3126372|NCT00003895|10687928|P2|Overall Study|Patient Vacation|0
3126373|NCT00003895|10687929|P1|Overall Study|Patient Vacation|2
3126374|NCT00003895|10687928|P2|Overall Study|Lack of Efficacy|1
3126375|NCT00003895|10687929|P1|Overall Study|Lack of Efficacy|1
3126376|NCT00003895|10687928|P2|Overall Study|Adverse Event|0
3126377|NCT00003895|10687929|P1|Overall Study|Adverse Event|4
3126378|NCT00064987|10687937|P2|Overall Study|Physician Decision|0
3126379|NCT00064987|10687938|P1|Overall Study|Physician Decision|3
3126380|NCT00064753|10687969|P2|Overall Study|Lost to Follow-up|235
3126381|NCT00064753|10687970|P1|Overall Study|Lost to Follow-up|225
3126382|NCT00064753|10687969|P2|Overall Study|Withdrawal by Subject|171
3126383|NCT00064753|10687970|P1|Overall Study|Withdrawal by Subject|198
3126384|NCT00064753|10687969|P2|Overall Study|Death|242
3126385|NCT00064753|10687970|P1|Overall Study|Death|251
3126386|NCT00003645|10688000|P2|Overall Study|Withdrawal by Subject|3
3126387|NCT00003645|10688001|P1|Overall Study|Withdrawal by Subject|1
3126388|NCT00003645|10688000|P2|Overall Study|Lost to Follow-up|8
3126389|NCT00003645|10688001|P1|Overall Study|Lost to Follow-up|7
3126390|NCT00003645|10688000|P2|Overall Study|Death|1
3126391|NCT00003645|10688001|P1|Overall Study|Death|4
3126392|NCT00064792|10688015|P2|Overall Study|Adverse Event|0
3126393|NCT00064792|10688016|P1|Overall Study|Adverse Event|3
3126394|NCT00064792|10688015|P2|Overall Study|Withdrawal by Subject|0
3126395|NCT00064792|10688016|P1|Overall Study|Withdrawal by Subject|2
3126396|NCT00064701|10688027|P3|Clinical Continuation Phase|Patient opted out|1
3126397|NCT00064701|10688028|P2|Clinical Continuation Phase|Patient opted out|0
3126398|NCT00064701|10688029|P1|Clinical Continuation Phase|Patient opted out|0
3126399|NCT00064701|10688027|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
3126400|NCT00064701|10688028|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
3126401|NCT00064701|10688029|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
3126402|NCT00064701|10688027|P3|Clinical Continuation Phase|Discharged to nursing home|0
3126403|NCT00064701|10688028|P2|Clinical Continuation Phase|Discharged to nursing home|1
3126404|NCT00064701|10688029|P1|Clinical Continuation Phase|Discharged to nursing home|0
3126405|NCT00064701|10688027|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
3126406|NCT00064701|10688028|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
3126407|NCT00064701|10688029|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
3126408|NCT00064701|10688027|P3|Clinical Continuation Phase|Pancreas transplant|0
3126409|NCT00064701|10688028|P2|Clinical Continuation Phase|Pancreas transplant|0
3126410|NCT00064701|10688029|P1|Clinical Continuation Phase|Pancreas transplant|1
3126411|NCT00064701|10688027|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
3126412|NCT00064701|10688028|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
3126413|NCT00064701|10688029|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
3126414|NCT00064701|10688027|P3|Clinical Continuation Phase|Physician Decision|0
3126415|NCT00064701|10688028|P2|Clinical Continuation Phase|Physician Decision|3
3126416|NCT00064701|10688029|P1|Clinical Continuation Phase|Physician Decision|1
3126417|NCT00064701|10688027|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
3126418|NCT00064701|10688028|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
3126419|NCT00064701|10688029|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
3126420|NCT00064701|10688027|P3|Clinical Continuation Phase|Sponsor discontinued study|79
3126421|NCT00064701|10688028|P2|Clinical Continuation Phase|Sponsor discontinued study|129
3126422|NCT00064701|10688029|P1|Clinical Continuation Phase|Sponsor discontinued study|113
3126423|NCT00064701|10688027|P3|Clinical Continuation Phase|Rejection|2
3126424|NCT00064701|10688028|P2|Clinical Continuation Phase|Rejection|2
3126425|NCT00064701|10688029|P1|Clinical Continuation Phase|Rejection|1
3126426|NCT00064701|10688027|P3|Clinical Continuation Phase|Graft Failure|2
3126427|NCT00064701|10688028|P2|Clinical Continuation Phase|Graft Failure|5
3126428|NCT00064701|10688029|P1|Clinical Continuation Phase|Graft Failure|5
3126429|NCT00064701|10688027|P3|Clinical Continuation Phase|Lost to Follow-up|6
3126430|NCT00064701|10688028|P2|Clinical Continuation Phase|Lost to Follow-up|3
3126431|NCT00064701|10688029|P1|Clinical Continuation Phase|Lost to Follow-up|6
3126432|NCT00064701|10688027|P3|Clinical Continuation Phase|Withdrawal by Subject|22
3126433|NCT00064701|10688028|P2|Clinical Continuation Phase|Withdrawal by Subject|3
3126434|NCT00064701|10688029|P1|Clinical Continuation Phase|Withdrawal by Subject|22
3126435|NCT00064701|10688027|P3|Clinical Continuation Phase|Non-compliance|7
3126436|NCT00064701|10688028|P2|Clinical Continuation Phase|Non-compliance|6
3126437|NCT00064701|10688029|P1|Clinical Continuation Phase|Non-compliance|8
3126438|NCT00064701|10688027|P3|Clinical Continuation Phase|Adverse Event|14
3126439|NCT00064701|10688028|P2|Clinical Continuation Phase|Adverse Event|21
3126440|NCT00064701|10688029|P1|Clinical Continuation Phase|Adverse Event|12
3126441|NCT00064701|10688027|P3|One Year Post-transplant|Pancreas transplant|1
3126442|NCT00064701|10688028|P2|One Year Post-transplant|Pancreas transplant|0
3126443|NCT00064701|10688029|P1|One Year Post-transplant|Pancreas transplant|0
3126444|NCT00064701|10688027|P3|One Year Post-transplant|Poor absorption|0
3126445|NCT00064701|10688028|P2|One Year Post-transplant|Poor absorption|1
3126446|NCT00064701|10688029|P1|One Year Post-transplant|Poor absorption|0
3126447|NCT00064701|10688027|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
3126448|NCT00064701|10688028|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
3126449|NCT00064701|10688029|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
3126450|NCT00064701|10688027|P3|One Year Post-transplant|Incorrect study drug dispensed|0
3126451|NCT00064701|10688028|P2|One Year Post-transplant|Incorrect study drug dispensed|1
3126452|NCT00064701|10688029|P1|One Year Post-transplant|Incorrect study drug dispensed|0
3126453|NCT00064701|10688027|P3|One Year Post-transplant|Acute tubular necrosis|0
3126454|NCT00064701|10688028|P2|One Year Post-transplant|Acute tubular necrosis|0
3126455|NCT00064701|10688029|P1|One Year Post-transplant|Acute tubular necrosis|1
3126456|NCT00064701|10688027|P3|One Year Post-transplant|Converted to rapamycin|0
3126457|NCT00064701|10688028|P2|One Year Post-transplant|Converted to rapamycin|0
3126458|NCT00064701|10688029|P1|One Year Post-transplant|Converted to rapamycin|1
3126459|NCT00064701|10688027|P3|One Year Post-transplant|Lost to Follow-up|0
3126460|NCT00064701|10688028|P2|One Year Post-transplant|Lost to Follow-up|0
3126461|NCT00064701|10688029|P1|One Year Post-transplant|Lost to Follow-up|1
3126462|NCT00064701|10688027|P3|One Year Post-transplant|Withdrawal by Subject|1
3126463|NCT00064701|10688028|P2|One Year Post-transplant|Withdrawal by Subject|4
3126464|NCT00064701|10688029|P1|One Year Post-transplant|Withdrawal by Subject|0
3126465|NCT00064701|10688027|P3|One Year Post-transplant|Graft Failure|1
3126466|NCT00064701|10688028|P2|One Year Post-transplant|Graft Failure|2
3126467|NCT00064701|10688029|P1|One Year Post-transplant|Graft Failure|3
3126468|NCT00064701|10688027|P3|One Year Post-transplant|Non-compliance|5
3126469|NCT00064701|10688028|P2|One Year Post-transplant|Non-compliance|2
3126470|NCT00064701|10688029|P1|One Year Post-transplant|Non-compliance|4
3126471|NCT00064701|10688027|P3|One Year Post-transplant|Rejection|16
3126472|NCT00064701|10688028|P2|One Year Post-transplant|Rejection|1
3126473|NCT00064701|10688029|P1|One Year Post-transplant|Rejection|0
3126474|NCT00064701|10688027|P3|One Year Post-transplant|Adverse Event|37
3126475|NCT00064701|10688028|P2|One Year Post-transplant|Adverse Event|19
3126476|NCT00064701|10688029|P1|One Year Post-transplant|Adverse Event|23
3126477|NCT00064701|10688027|P3|One Year Post-transplant|Did not receive study drug|11
3126478|NCT00064701|10688028|P2|One Year Post-transplant|Did not receive study drug|12
3126479|NCT00064701|10688029|P1|One Year Post-transplant|Did not receive study drug|7
3126480|NCT00064662|10688081|P2|Overall Study|Administratively withdrawn|2
3126481|NCT00064662|10688082|P1|Overall Study|Administratively withdrawn|2
3126482|NCT00064662|10688081|P2|Overall Study|Withdrawal by Subject|14
3126483|NCT00064662|10688082|P1|Overall Study|Withdrawal by Subject|14
3126484|NCT00064662|10688081|P2|Overall Study|Lost to Follow-up|44
3126485|NCT00064662|10688082|P1|Overall Study|Lost to Follow-up|57
3126486|NCT00064662|10688081|P2|Overall Study|Death|1
3126487|NCT00064662|10688082|P1|Overall Study|Death|1
3126488|NCT00064350|10688093|P3|Cross-Over|Other|0
3126489|NCT00064350|10688094|P2|Cross-Over|Other|2
3126490|NCT00064350|10688095|P1|Cross-Over|Other|0
3126491|NCT00064350|10688093|P3|Cross-Over|Ineligible or never started treatment|0
3126492|NCT00064350|10688094|P2|Cross-Over|Ineligible or never started treatment|6
3126493|NCT00064350|10688095|P1|Cross-Over|Ineligible or never started treatment|3
3126494|NCT00064350|10688093|P3|Cross-Over|Withdrawal by Subject|0
3126495|NCT00064350|10688094|P2|Cross-Over|Withdrawal by Subject|2
3126496|NCT00064350|10688095|P1|Cross-Over|Withdrawal by Subject|2
3126497|NCT00064350|10688093|P3|Cross-Over|Death|0
3126498|NCT00064350|10688094|P2|Cross-Over|Death|3
3126499|NCT00064350|10688095|P1|Cross-Over|Death|1
3126500|NCT00064350|10688093|P3|Cross-Over|Adverse Event|0
3126501|NCT00064350|10688094|P2|Cross-Over|Adverse Event|1
3126502|NCT00064350|10688095|P1|Cross-Over|Adverse Event|0
3126503|NCT00064350|10688093|P3|Randomization|Other|0
3126504|NCT00064350|10688094|P2|Randomization|Other|0
3126505|NCT00064350|10688095|P1|Randomization|Other|5
3126506|NCT00064350|10688093|P3|Randomization|Ineligible or never started treatment|0
3126507|NCT00064350|10688094|P2|Randomization|Ineligible or never started treatment|15
3126508|NCT00064350|10688095|P1|Randomization|Ineligible or never started treatment|9
3126509|NCT00064350|10688093|P3|Randomization|Withdrawal by Subject|0
3126510|NCT00064350|10688094|P2|Randomization|Withdrawal by Subject|0
3126511|NCT00064350|10688095|P1|Randomization|Withdrawal by Subject|1
3126512|NCT00064350|10688093|P3|Randomization|Death|0
3126513|NCT00064350|10688094|P2|Randomization|Death|0
3126514|NCT00064350|10688095|P1|Randomization|Death|3
3126515|NCT00064350|10688093|P3|Randomization|Adverse Event|0
3126516|NCT00064350|10688094|P2|Randomization|Adverse Event|3
3126517|NCT00064350|10688095|P1|Randomization|Adverse Event|8
3126518|NCT00064350|10688093|P3|Induction Treatment|Other|13
3126519|NCT00064350|10688094|P2|Induction Treatment|Other|0
3126520|NCT00064350|10688095|P1|Induction Treatment|Other|0
3126521|NCT00064350|10688093|P3|Induction Treatment|Ineligible or never started treatment|34
3126522|NCT00064350|10688094|P2|Induction Treatment|Ineligible or never started treatment|6
3126523|NCT00064350|10688095|P1|Induction Treatment|Ineligible or never started treatment|3
3126524|NCT00064350|10688093|P3|Induction Treatment|Withdrawal by Subject|21
3126525|NCT00064350|10688094|P2|Induction Treatment|Withdrawal by Subject|0
3126526|NCT00064350|10688095|P1|Induction Treatment|Withdrawal by Subject|0
3126527|NCT00064350|10688093|P3|Induction Treatment|Death|9
3126528|NCT00064350|10688094|P2|Induction Treatment|Death|0
3126529|NCT00064350|10688095|P1|Induction Treatment|Death|0
3126530|NCT00064350|10688093|P3|Induction Treatment|Adverse Event|49
3126531|NCT00064350|10688094|P2|Induction Treatment|Adverse Event|2
3126532|NCT00064350|10688095|P1|Induction Treatment|Adverse Event|0
3126533|NCT00064350|10688093|P3|Induction Treatment|Disease Progression|110
3126534|NCT00064350|10688094|P2|Induction Treatment|Disease Progression|1
3126535|NCT00064350|10688095|P1|Induction Treatment|Disease Progression|5
3126536|NCT00064337|10688110|P1|Maintenance|Death|1
3126537|NCT00064337|10688110|P1|Maintenance|Not protocol-specified|2
3126538|NCT00064337|10688110|P1|Maintenance|On treatment at time of analysis|2
3126539|NCT00064337|10688110|P1|Maintenance|Progression|2
3126540|NCT00064337|10688110|P1|Maintenance|Adverse Event|3
3126541|NCT00064337|10688110|P1|Transplant|Progression|2
3126542|NCT00064337|10688110|P1|Transplant|Patient Refusal|2
3126543|NCT00064337|10688110|P1|Transplant|Death|3
3126544|NCT00064337|10688110|P1|Transplant|Not protocol-specified|5
3126545|NCT00064337|10688110|P1|Transplant|Adverse Event|9
3126546|NCT00064337|10688110|P1|PBSCC or Induction/PBSCC|Death|2
3126547|NCT00064337|10688110|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
3126548|NCT00064337|10688110|P1|PBSCC or Induction/PBSCC|Progression|3
3126549|NCT00064337|10688110|P1|PBSCC or Induction/PBSCC|Adverse Event|6
3126550|NCT00064337|10688110|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
3126551|NCT00064298|10688119|P2|Overall Study|Disease Progression|1
3126552|NCT00064298|10688120|P1|Overall Study|Disease Progression|2
3126553|NCT00064298|10688119|P2|Overall Study|Death|1
3126554|NCT00064298|10688120|P1|Overall Study|Death|0
3126555|NCT00064298|10688119|P2|Overall Study|Lost to Follow-up|2
3126556|NCT00064298|10688120|P1|Overall Study|Lost to Follow-up|2
3126557|NCT00064298|10688119|P2|Overall Study|Withdrawal by Subject|1
3126558|NCT00064298|10688120|P1|Overall Study|Withdrawal by Subject|2
3126559|NCT00064259|10688128|P4|Overall Study|Adverse Event|1
3126560|NCT00064259|10688129|P3|Overall Study|Adverse Event|0
3126561|NCT00064259|10688130|P2|Overall Study|Adverse Event|0
3126562|NCT00064259|10688131|P1|Overall Study|Adverse Event|1
3126563|NCT00064077|10688139|P4|Overall Study|Other reasons|2
3126564|NCT00064077|10688140|P3|Overall Study|Other reasons|1
3126565|NCT00064077|10688141|P2|Overall Study|Other reasons|2
3126566|NCT00064077|10688142|P1|Overall Study|Other reasons|2
3126567|NCT00064077|10688139|P4|Overall Study|No tumor|0
3126568|NCT00064077|10688140|P3|Overall Study|No tumor|1
3126569|NCT00064077|10688141|P2|Overall Study|No tumor|0
3126570|NCT00064077|10688142|P1|Overall Study|No tumor|0
3126571|NCT00064077|10688139|P4|Overall Study|No surgery|0
3126572|NCT00064077|10688140|P3|Overall Study|No surgery|1
3126573|NCT00064077|10688141|P2|Overall Study|No surgery|0
3126574|NCT00064077|10688142|P1|Overall Study|No surgery|0
3126575|NCT00064077|10688139|P4|Overall Study|Pathology|4
3126576|NCT00064077|10688140|P3|Overall Study|Pathology|3
3126577|NCT00064077|10688141|P2|Overall Study|Pathology|7
3126578|NCT00064077|10688142|P1|Overall Study|Pathology|10
3126579|NCT00064077|10688139|P4|Overall Study|Poor risk|1
3126580|NCT00064077|10688140|P3|Overall Study|Poor risk|1
3126581|NCT00064077|10688141|P2|Overall Study|Poor risk|0
3126582|NCT00064077|10688142|P1|Overall Study|Poor risk|2
3126583|NCT00064077|10688139|P4|Overall Study|Improper prior treatment|0
3126584|NCT00064077|10688140|P3|Overall Study|Improper prior treatment|0
3126585|NCT00064077|10688141|P2|Overall Study|Improper prior treatment|0
3126586|NCT00064077|10688142|P1|Overall Study|Improper prior treatment|1
3126587|NCT00064025|10688186|P1|Overall Study|Inevaluable|3
3126588|NCT00064025|10688186|P1|Overall Study|Ineligible|4
3126589|NCT00063999|10688195|P2|Overall Study|Ineligible|24
3126590|NCT00063999|10688196|P1|Overall Study|Ineligible|44
3126591|NCT00063999|10688195|P2|Overall Study|Withdrawal by Subject|0
3126592|NCT00063999|10688196|P1|Overall Study|Withdrawal by Subject|1
3126593|NCT00063986|10688212|P1|Overall Study|Intra-operatively ineligible|4
3126594|NCT00063986|10688212|P1|Overall Study|Ineligible|1
3126595|NCT00063986|10688212|P1|Overall Study|Withdrawal by Subject|1
3126596|NCT00063934|10688224|P1|Overall Study|Ineligible|1
3126597|NCT00063882|10688233|P2|Overall Study|Withdrawal by Subject|1
3126598|NCT00063882|10688234|P1|Overall Study|Withdrawal by Subject|2
3126599|NCT00063882|10688233|P2|Overall Study|Protocol Violation|3
3126600|NCT00063882|10688234|P1|Overall Study|Protocol Violation|3
3126601|NCT00063258|10688361|P2|Overall Study|Lack of Efficacy|0
3126602|NCT00063258|10688362|P1|Overall Study|Lack of Efficacy|2
3126603|NCT00063258|10688361|P2|Overall Study|Physician Decision|0
3126604|NCT00063258|10688362|P1|Overall Study|Physician Decision|2
3126605|NCT00063154|10688368|P1|Overall Study|Did not receive treatment|8
3126606|NCT00063154|10688368|P1|Overall Study|Reason unspecified|1
3126607|NCT00063154|10688368|P1|Overall Study|Death|3
3126608|NCT00063154|10688368|P1|Overall Study|Physician Decision|10
3126609|NCT00063154|10688368|P1|Overall Study|Adverse Event|2
3126610|NCT00063154|10688368|P1|Overall Study|Disease progression|27
3126611|NCT00062868|10688402|P21|Dose Level 3|Withdrew|0
3126612|NCT00062868|10688403|P20|Dose Level 3|Withdrew|0
3126613|NCT00062868|10688404|P19|Dose Level 3|Withdrew|0
3126614|NCT00062868|10688405|P18|Dose Level 3|Withdrew|0
3126615|NCT00062868|10688406|P17|Dose Level 3|Withdrew|0
3126616|NCT00062868|10688407|P16|Dose Level 3|Withdrew|0
3126617|NCT00062868|10688408|P15|Dose Level 3|Withdrew|0
3126618|NCT00062868|10688409|P14|Dose Level 3|Withdrew|0
3126619|NCT00062868|10688410|P13|Dose Level 3|Withdrew|0
3126620|NCT00062868|10688411|P12|Dose Level 3|Withdrew|0
3126621|NCT00062868|10688412|P11|Dose Level 3|Withdrew|0
3126622|NCT00062868|10688413|P10|Dose Level 3|Withdrew|0
3126623|NCT00062868|10688414|P9|Dose Level 3|Withdrew|0
3126624|NCT00062868|10688415|P8|Dose Level 3|Withdrew|0
3126625|NCT00062868|10688416|P7|Dose Level 3|Withdrew|0
3126626|NCT00062868|10688417|P6|Dose Level 3|Withdrew|0
3126627|NCT00062868|10688418|P5|Dose Level 3|Withdrew|0
3126628|NCT00062868|10688419|P4|Dose Level 3|Withdrew|0
3126629|NCT00062868|10688420|P3|Dose Level 3|Withdrew|2
3126630|NCT00062868|10688421|P2|Dose Level 3|Withdrew|0
3126631|NCT00062868|10688422|P1|Dose Level 3|Withdrew|0
3126632|NCT00062868|10688402|P21|Dose Level 3|Lost to Follow-up|0
3126633|NCT00062868|10688403|P20|Dose Level 3|Lost to Follow-up|0
3126634|NCT00062868|10688404|P19|Dose Level 3|Lost to Follow-up|0
3126635|NCT00062868|10688405|P18|Dose Level 3|Lost to Follow-up|0
3126636|NCT00062868|10688406|P17|Dose Level 3|Lost to Follow-up|0
3126637|NCT00062868|10688407|P16|Dose Level 3|Lost to Follow-up|0
3126638|NCT00062868|10688408|P15|Dose Level 3|Lost to Follow-up|1
3126639|NCT00062868|10688409|P14|Dose Level 3|Lost to Follow-up|0
3126640|NCT00062868|10688410|P13|Dose Level 3|Lost to Follow-up|0
3126641|NCT00062868|10688411|P12|Dose Level 3|Lost to Follow-up|0
3126642|NCT00062868|10688412|P11|Dose Level 3|Lost to Follow-up|0
3126643|NCT00062868|10688413|P10|Dose Level 3|Lost to Follow-up|0
3126644|NCT00062868|10688414|P9|Dose Level 3|Lost to Follow-up|0
3126645|NCT00062868|10688415|P8|Dose Level 3|Lost to Follow-up|0
3126646|NCT00062868|10688416|P7|Dose Level 3|Lost to Follow-up|0
3126647|NCT00062868|10688417|P6|Dose Level 3|Lost to Follow-up|0
3126648|NCT00062868|10688418|P5|Dose Level 3|Lost to Follow-up|0
3126649|NCT00062868|10688419|P4|Dose Level 3|Lost to Follow-up|0
3126650|NCT00062868|10688420|P3|Dose Level 3|Lost to Follow-up|0
3126651|NCT00062868|10688421|P2|Dose Level 3|Lost to Follow-up|0
3126652|NCT00062868|10688422|P1|Dose Level 3|Lost to Follow-up|0
3126653|NCT00062868|10688402|P21|Dose Level 3|Death|0
3126654|NCT00062868|10688403|P20|Dose Level 3|Death|0
3126655|NCT00062868|10688404|P19|Dose Level 3|Death|0
3126656|NCT00062868|10688405|P18|Dose Level 3|Death|1
3126657|NCT00062868|10688406|P17|Dose Level 3|Death|0
3126658|NCT00062868|10688407|P16|Dose Level 3|Death|0
3126659|NCT00062868|10688408|P15|Dose Level 3|Death|0
3126660|NCT00062868|10688409|P14|Dose Level 3|Death|0
3126661|NCT00062868|10688410|P13|Dose Level 3|Death|0
3126662|NCT00062868|10688411|P12|Dose Level 3|Death|1
3126663|NCT00062868|10688412|P11|Dose Level 3|Death|0
3126664|NCT00062868|10688413|P10|Dose Level 3|Death|0
3126665|NCT00062868|10688414|P9|Dose Level 3|Death|0
3126666|NCT00062868|10688415|P8|Dose Level 3|Death|0
3126667|NCT00062868|10688416|P7|Dose Level 3|Death|0
3126668|NCT00062868|10688417|P6|Dose Level 3|Death|0
3126669|NCT00062868|10688418|P5|Dose Level 3|Death|0
3126670|NCT00062868|10688419|P4|Dose Level 3|Death|0
3126671|NCT00062868|10688420|P3|Dose Level 3|Death|0
3126672|NCT00062868|10688421|P2|Dose Level 3|Death|0
3126673|NCT00062868|10688422|P1|Dose Level 3|Death|0
3126674|NCT00062868|10688402|P21|Dose Level 2|Lost to Follow-up|0
3126675|NCT00062868|10688403|P20|Dose Level 2|Lost to Follow-up|0
3126676|NCT00062868|10688404|P19|Dose Level 2|Lost to Follow-up|0
3126677|NCT00062868|10688405|P18|Dose Level 2|Lost to Follow-up|0
3126678|NCT00062868|10688406|P17|Dose Level 2|Lost to Follow-up|1
3126679|NCT00062868|10688407|P16|Dose Level 2|Lost to Follow-up|0
3126680|NCT00062868|10688408|P15|Dose Level 2|Lost to Follow-up|0
3126681|NCT00062868|10688409|P14|Dose Level 2|Lost to Follow-up|1
3126682|NCT00062868|10688410|P13|Dose Level 2|Lost to Follow-up|0
3126683|NCT00062868|10688411|P12|Dose Level 2|Lost to Follow-up|0
3126684|NCT00062868|10688412|P11|Dose Level 2|Lost to Follow-up|0
3126685|NCT00062868|10688413|P10|Dose Level 2|Lost to Follow-up|0
3126686|NCT00062868|10688414|P9|Dose Level 2|Lost to Follow-up|0
3126687|NCT00062868|10688415|P8|Dose Level 2|Lost to Follow-up|0
3126688|NCT00062868|10688416|P7|Dose Level 2|Lost to Follow-up|0
3126689|NCT00062868|10688417|P6|Dose Level 2|Lost to Follow-up|0
3126690|NCT00062868|10688418|P5|Dose Level 2|Lost to Follow-up|0
3126691|NCT00062868|10688419|P4|Dose Level 2|Lost to Follow-up|0
3126692|NCT00062868|10688420|P3|Dose Level 2|Lost to Follow-up|0
3126693|NCT00062868|10688421|P2|Dose Level 2|Lost to Follow-up|0
3126694|NCT00062868|10688422|P1|Dose Level 2|Lost to Follow-up|0
3126695|NCT00062868|10688402|P21|Dose Level 2|Death|0
3126696|NCT00062868|10688403|P20|Dose Level 2|Death|0
3126697|NCT00062868|10688404|P19|Dose Level 2|Death|0
3126698|NCT00062868|10688405|P18|Dose Level 2|Death|0
3126699|NCT00062868|10688406|P17|Dose Level 2|Death|2
3126700|NCT00062868|10688407|P16|Dose Level 2|Death|0
3126701|NCT00062868|10688408|P15|Dose Level 2|Death|0
3126702|NCT00062868|10688409|P14|Dose Level 2|Death|0
3126703|NCT00062868|10688410|P13|Dose Level 2|Death|0
3126704|NCT00062868|10688411|P12|Dose Level 2|Death|0
3126705|NCT00062868|10688412|P11|Dose Level 2|Death|1
3126706|NCT00062868|10688413|P10|Dose Level 2|Death|0
3126707|NCT00062868|10688414|P9|Dose Level 2|Death|0
3126708|NCT00062868|10688415|P8|Dose Level 2|Death|0
3126709|NCT00062868|10688416|P7|Dose Level 2|Death|0
3126710|NCT00062868|10688417|P6|Dose Level 2|Death|0
3126711|NCT00062868|10688418|P5|Dose Level 2|Death|2
3126712|NCT00062868|10688419|P4|Dose Level 2|Death|0
3126713|NCT00062868|10688420|P3|Dose Level 2|Death|0
3126714|NCT00062868|10688421|P2|Dose Level 2|Death|3
3126715|NCT00062868|10688422|P1|Dose Level 2|Death|0
3126716|NCT00062868|10688402|P21|Dose Level 1|Lost to Follow-up|1
3126717|NCT00062868|10688403|P20|Dose Level 1|Lost to Follow-up|0
3126718|NCT00062868|10688404|P19|Dose Level 1|Lost to Follow-up|2
3126719|NCT00062868|10688405|P18|Dose Level 1|Lost to Follow-up|0
3126720|NCT00062868|10688406|P17|Dose Level 1|Lost to Follow-up|0
3126721|NCT00062868|10688407|P16|Dose Level 1|Lost to Follow-up|0
3126722|NCT00062868|10688408|P15|Dose Level 1|Lost to Follow-up|0
3126723|NCT00062868|10688409|P14|Dose Level 1|Lost to Follow-up|0
3126724|NCT00062868|10688410|P13|Dose Level 1|Lost to Follow-up|1
3126725|NCT00062868|10688411|P12|Dose Level 1|Lost to Follow-up|0
3126726|NCT00062868|10688412|P11|Dose Level 1|Lost to Follow-up|0
3126727|NCT00062868|10688413|P10|Dose Level 1|Lost to Follow-up|0
3126728|NCT00062868|10688414|P9|Dose Level 1|Lost to Follow-up|0
3126729|NCT00062868|10688415|P8|Dose Level 1|Lost to Follow-up|0
3126730|NCT00062868|10688416|P7|Dose Level 1|Lost to Follow-up|0
3126731|NCT00062868|10688417|P6|Dose Level 1|Lost to Follow-up|0
3126732|NCT00062868|10688418|P5|Dose Level 1|Lost to Follow-up|0
3126733|NCT00062868|10688419|P4|Dose Level 1|Lost to Follow-up|0
3126734|NCT00062868|10688420|P3|Dose Level 1|Lost to Follow-up|0
3126735|NCT00062868|10688421|P2|Dose Level 1|Lost to Follow-up|0
3126736|NCT00062868|10688422|P1|Dose Level 1|Lost to Follow-up|0
3126737|NCT00062868|10688402|P21|Dose Level 1|Death|1
3126738|NCT00062868|10688403|P20|Dose Level 1|Death|0
3126739|NCT00062868|10688404|P19|Dose Level 1|Death|7
3126740|NCT00062868|10688405|P18|Dose Level 1|Death|0
3126741|NCT00062868|10688406|P17|Dose Level 1|Death|0
3126742|NCT00062868|10688407|P16|Dose Level 1|Death|0
3126743|NCT00062868|10688408|P15|Dose Level 1|Death|0
3126744|NCT00062868|10688409|P14|Dose Level 1|Death|0
3126745|NCT00062868|10688410|P13|Dose Level 1|Death|0
3126746|NCT00062868|10688411|P12|Dose Level 1|Death|0
3126747|NCT00062868|10688412|P11|Dose Level 1|Death|0
3126748|NCT00062868|10688413|P10|Dose Level 1|Death|0
3126749|NCT00062868|10688414|P9|Dose Level 1|Death|0
3126750|NCT00062868|10688415|P8|Dose Level 1|Death|0
3126751|NCT00062868|10688416|P7|Dose Level 1|Death|3
3126752|NCT00062868|10688417|P6|Dose Level 1|Death|0
3126753|NCT00062868|10688418|P5|Dose Level 1|Death|0
3126754|NCT00062868|10688419|P4|Dose Level 1|Death|2
3126755|NCT00062868|10688420|P3|Dose Level 1|Death|0
3126756|NCT00062868|10688421|P2|Dose Level 1|Death|0
3126757|NCT00062868|10688422|P1|Dose Level 1|Death|2
3126758|NCT00062751|10688521|P5|Overall Study|Death|0
3126759|NCT00062751|10688522|P4|Overall Study|Death|0
3126760|NCT00062751|10688523|P3|Overall Study|Death|1
3126761|NCT00062751|10688524|P2|Overall Study|Death|0
3126762|NCT00062751|10688525|P1|Overall Study|Death|1
3126763|NCT00062751|10688521|P5|Overall Study|Symptomatic deterioration|1
3126764|NCT00062751|10688522|P4|Overall Study|Symptomatic deterioration|0
3126765|NCT00062751|10688523|P3|Overall Study|Symptomatic deterioration|0
3126766|NCT00062751|10688524|P2|Overall Study|Symptomatic deterioration|1
3126767|NCT00062751|10688525|P1|Overall Study|Symptomatic deterioration|1
3126768|NCT00062751|10688521|P5|Overall Study|Withdrawal by Subject|0
3126769|NCT00062751|10688522|P4|Overall Study|Withdrawal by Subject|1
3126770|NCT00062751|10688523|P3|Overall Study|Withdrawal by Subject|2
3126771|NCT00062751|10688524|P2|Overall Study|Withdrawal by Subject|2
3126772|NCT00062751|10688525|P1|Overall Study|Withdrawal by Subject|1
3126773|NCT00062751|10688521|P5|Overall Study|Other|1
3126774|NCT00062751|10688522|P4|Overall Study|Other|0
3126775|NCT00062751|10688523|P3|Overall Study|Other|1
3126776|NCT00062751|10688524|P2|Overall Study|Other|3
3126777|NCT00062751|10688525|P1|Overall Study|Other|2
3126778|NCT00062751|10688521|P5|Overall Study|Adverse Event|2
3126779|NCT00062751|10688522|P4|Overall Study|Adverse Event|2
3126780|NCT00062751|10688523|P3|Overall Study|Adverse Event|2
3126781|NCT00062751|10688524|P2|Overall Study|Adverse Event|7
3126782|NCT00062751|10688525|P1|Overall Study|Adverse Event|4
3126783|NCT00062751|10688521|P5|Overall Study|Disease progression|2
3126784|NCT00062751|10688522|P4|Overall Study|Disease progression|2
3126785|NCT00062751|10688523|P3|Overall Study|Disease progression|24
3126786|NCT00062751|10688524|P2|Overall Study|Disease progression|17
3126787|NCT00062751|10688525|P1|Overall Study|Disease progression|24
3126788|NCT00062647|10688611|P2|Overall Study|Never received study treatment|1
3126789|NCT00062647|10688612|P1|Overall Study|Never received study treatment|1
3126790|NCT00062647|10688611|P2|Overall Study|Other|4
3126791|NCT00062647|10688612|P1|Overall Study|Other|4
3126792|NCT00062647|10688611|P2|Overall Study|Failed continuation criteria|2
3126793|NCT00062647|10688612|P1|Overall Study|Failed continuation criteria|4
3126794|NCT00062647|10688611|P2|Overall Study|Lost to Follow-up|2
3126795|NCT00062647|10688612|P1|Overall Study|Lost to Follow-up|1
3126796|NCT00062647|10688611|P2|Overall Study|Protocol Violation|0
3126797|NCT00062647|10688612|P1|Overall Study|Protocol Violation|1
3126798|NCT00062647|10688611|P2|Overall Study|Withdrawal by Subject|1
3126799|NCT00062647|10688612|P1|Overall Study|Withdrawal by Subject|2
3126800|NCT00062647|10688611|P2|Overall Study|Adverse Event|1
3126801|NCT00062647|10688612|P1|Overall Study|Adverse Event|1
3126802|NCT00062647|10688611|P2|Overall Study|Death|2
3126803|NCT00062647|10688612|P1|Overall Study|Death|2
3126804|NCT00062439|10688618|P1|Consolidation Chemotherapy|Adverse Event|2
3126805|NCT00062439|10688618|P1|Surgery|Adverse Event|2
3126806|NCT00062439|10688618|P1|Surgery|Death|1
3126807|NCT00062439|10688618|P1|Surgery|Physician Decision|4
3126808|NCT00062439|10688618|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
3126809|NCT00062439|10688618|P1|Post Chemoradiation Assessment|Physician Decision|1
3126810|NCT00062439|10688618|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
3126811|NCT00062439|10688618|P1|Post Chemoradiation Assessment|Disease progression|2
3126812|NCT00062439|10688618|P1|Post Chemoradiation Assessment|Death|1
3126813|NCT00062439|10688618|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
3126814|NCT00062439|10688618|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
3126815|NCT00062439|10688618|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
3126816|NCT00062439|10688618|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
3126817|NCT00062374|10688630|P1|Overall Study|Not treated|12
3126818|NCT00062166|10688635|P1|Overall Study|Withdrawal by Subject|6
3126819|NCT00062010|10688643|P1|Overall Study|Ineligible|3
3126820|NCT00061945|10688651|P2|Course IV: Alemtuzumab|Early exits|15
3126821|NCT00061945|10688652|P1|Course IV: Alemtuzumab|Early exits|6
3126822|NCT00061945|10688651|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
3126823|NCT00061945|10688652|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
3126913|NCT00059215|10688869|P3|Overall Study|Death|3
3126824|NCT00061945|10688651|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
3126825|NCT00061945|10688652|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
3126826|NCT00061945|10688651|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
3126827|NCT00061945|10688652|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
3126828|NCT00061932|10688662|P2|Overall Study|Withdrawal by Subject|4
3126829|NCT00061932|10688663|P1|Overall Study|Withdrawal by Subject|13
3126830|NCT00061633|10688676|P2|Overall Study|Never received study treatment|2
3126831|NCT00061633|10688677|P1|Overall Study|Never received study treatment|0
3126832|NCT00061633|10688676|P2|Overall Study|Other|1
3126833|NCT00061633|10688677|P1|Overall Study|Other|1
3126834|NCT00061633|10688676|P2|Overall Study|Lost to Follow-up|4
3126835|NCT00061633|10688677|P1|Overall Study|Lost to Follow-up|1
3126836|NCT00061633|10688676|P2|Overall Study|Withdrawal by Subject|2
3126837|NCT00061633|10688677|P1|Overall Study|Withdrawal by Subject|2
3126838|NCT00061633|10688676|P2|Overall Study|Adverse Event|2
3126839|NCT00061633|10688677|P1|Overall Study|Adverse Event|1
3126840|NCT00061048|10688702|P1|Overall Study|disease progression|20
3126841|NCT00061048|10688702|P1|Overall Study|Adverse Event|2
3126842|NCT00060944|10688712|P2|Overall Study|randomized but not treated|4
3126843|NCT00060944|10688713|P1|Overall Study|randomized but not treated|6
3126844|NCT00060944|10688712|P2|Overall Study|Other|4
3126845|NCT00060944|10688713|P1|Overall Study|Other|2
3126846|NCT00060944|10688712|P2|Overall Study|Treatment Switch|13
3126847|NCT00060944|10688713|P1|Overall Study|Treatment Switch|0
3126848|NCT00060944|10688712|P2|Overall Study|Subject Ineligible To Continue|1
3126849|NCT00060944|10688713|P1|Overall Study|Subject Ineligible To Continue|2
3126850|NCT00060944|10688712|P2|Overall Study|Lost to Follow-up|0
3126851|NCT00060944|10688713|P1|Overall Study|Lost to Follow-up|1
3126852|NCT00060944|10688712|P2|Overall Study|Disease Progression|94
3126853|NCT00060944|10688713|P1|Overall Study|Disease Progression|93
3126854|NCT00060944|10688712|P2|Overall Study|Withdrawal by Subject|5
3126855|NCT00060944|10688713|P1|Overall Study|Withdrawal by Subject|18
3126856|NCT00060944|10688712|P2|Overall Study|Death|3
3126857|NCT00060944|10688713|P1|Overall Study|Death|2
3126858|NCT00060944|10688712|P2|Overall Study|Adverse Event|10
3126859|NCT00060944|10688713|P1|Overall Study|Adverse Event|12
3126860|NCT00060840|10688729|P2|Overall Study|Other|0
3126861|NCT00060840|10688730|P1|Overall Study|Other|1
3126862|NCT00060840|10688729|P2|Overall Study|Physician Decision|0
3126863|NCT00060840|10688730|P1|Overall Study|Physician Decision|1
3126864|NCT00060840|10688729|P2|Overall Study|Subinvestigator unavailable|1
3126865|NCT00060840|10688730|P1|Overall Study|Subinvestigator unavailable|0
3126866|NCT00060840|10688729|P2|Overall Study|Withdrawal by Subject|1
3126867|NCT00060840|10688730|P1|Overall Study|Withdrawal by Subject|0
3126868|NCT00060840|10688729|P2|Overall Study|Death|1
3126869|NCT00060840|10688730|P1|Overall Study|Death|0
3126870|NCT00060840|10688729|P2|Overall Study|Change in surgical plan|6
3126871|NCT00060840|10688730|P1|Overall Study|Change in surgical plan|2
3126872|NCT00059839|10688783|P2|Overall Study|Ineligible|3
3126873|NCT00059839|10688784|P1|Overall Study|Ineligible|1
3126874|NCT00059839|10688783|P2|Overall Study|Withdrawal by Subject|6
3126875|NCT00059839|10688784|P1|Overall Study|Withdrawal by Subject|1
3126876|NCT00059839|10688783|P2|Overall Study|Physician Decision|2
3126877|NCT00059839|10688784|P1|Overall Study|Physician Decision|1
3126878|NCT00059839|10688783|P2|Overall Study|Lost to Follow-up|0
3126879|NCT00059839|10688784|P1|Overall Study|Lost to Follow-up|2
3126880|NCT00059839|10688783|P2|Overall Study|Lack of Efficacy|5
3126881|NCT00059839|10688784|P1|Overall Study|Lack of Efficacy|6
3126882|NCT00059839|10688783|P2|Overall Study|Death|1
3126883|NCT00059839|10688784|P1|Overall Study|Death|1
3126884|NCT00059787|10688790|P1|Overall Study|Other|4
3126885|NCT00059787|10688790|P1|Overall Study|ineligible|1
3126886|NCT00059787|10688790|P1|Overall Study|disease progression|2
3126887|NCT00059787|10688790|P1|Overall Study|Adverse Event|13
3126888|NCT00059332|10688841|P2|Overall Study|Lost to Follow-up|1
3126889|NCT00059332|10688842|P1|Overall Study|Lost to Follow-up|1
3126890|NCT00059332|10688841|P2|Overall Study|Withdrawal by Subject|1
3126891|NCT00059332|10688842|P1|Overall Study|Withdrawal by Subject|2
3126892|NCT00059215|10688868|P4|Overall Study|Physician Decision|1
3126893|NCT00059215|10688869|P3|Overall Study|Physician Decision|1
3126894|NCT00059215|10688870|P2|Overall Study|Physician Decision|2
3126895|NCT00059215|10688871|P1|Overall Study|Physician Decision|1
3126896|NCT00059215|10688868|P4|Overall Study|Protocol entry criteria not met|2
3126897|NCT00059215|10688869|P3|Overall Study|Protocol entry criteria not met|0
3126898|NCT00059215|10688870|P2|Overall Study|Protocol entry criteria not met|1
3126899|NCT00059215|10688871|P1|Overall Study|Protocol entry criteria not met|1
3126900|NCT00059215|10688868|P4|Overall Study|Protocol Violation|0
3126901|NCT00059215|10688869|P3|Overall Study|Protocol Violation|1
3126902|NCT00059215|10688870|P2|Overall Study|Protocol Violation|0
3126903|NCT00059215|10688871|P1|Overall Study|Protocol Violation|1
3126904|NCT00059215|10688868|P4|Overall Study|Withdrawal by Subject|3
3126905|NCT00059215|10688869|P3|Overall Study|Withdrawal by Subject|1
3126906|NCT00059215|10688870|P2|Overall Study|Withdrawal by Subject|4
3126907|NCT00059215|10688871|P1|Overall Study|Withdrawal by Subject|4
3126908|NCT00059215|10688868|P4|Overall Study|Lost to Follow-up|0
3126909|NCT00059215|10688869|P3|Overall Study|Lost to Follow-up|0
3126910|NCT00059215|10688870|P2|Overall Study|Lost to Follow-up|2
3126911|NCT00059215|10688871|P1|Overall Study|Lost to Follow-up|1
3126912|NCT00059215|10688868|P4|Overall Study|Death|0
3126914|NCT00059215|10688870|P2|Overall Study|Death|0
3126915|NCT00059215|10688871|P1|Overall Study|Death|0
3126916|NCT00059215|10688868|P4|Overall Study|Adverse Event|9
3126917|NCT00059215|10688869|P3|Overall Study|Adverse Event|9
3126918|NCT00059215|10688870|P2|Overall Study|Adverse Event|5
3126919|NCT00059215|10688871|P1|Overall Study|Adverse Event|5
3126920|NCT00058825|10688908|P1|Overall Study|Death|3
3126921|NCT00058825|10688908|P1|Overall Study|Graft Failure|5
3126922|NCT00058825|10688908|P1|Overall Study|Progressive Disease|5
3126923|NCT00058825|10688908|P1|Overall Study|Relapse|9
3126924|NCT00058552|10688924|P2|Overall Study|Clinical disease progression|4
3126925|NCT00058552|10688925|P1|Overall Study|Clinical disease progression|0
3126926|NCT00058552|10688924|P2|Overall Study|Physician Decision|5
3126927|NCT00058552|10688925|P1|Overall Study|Physician Decision|2
3126928|NCT00058552|10688924|P2|Overall Study|Withdrawal by Subject|5
3126929|NCT00058552|10688925|P1|Overall Study|Withdrawal by Subject|3
3126930|NCT00058552|10688924|P2|Overall Study|Adverse Event|2
3126931|NCT00058552|10688925|P1|Overall Study|Adverse Event|4
3126932|NCT00058552|10688924|P2|Overall Study|Disease progression|44
3126933|NCT00058552|10688925|P1|Overall Study|Disease progression|52
3126934|NCT00058552|10688924|P2|Overall Study|Died prior to receiving treatment|2
3126935|NCT00058552|10688925|P1|Overall Study|Died prior to receiving treatment|4
3126936|NCT00058539|10688943|P1|Overall Study|Death|1
3126937|NCT00058539|10688943|P1|Overall Study|Physician Decision|9
3126938|NCT00058539|10688943|P1|Overall Study|Withdrawal by Subject|5
3126939|NCT00058539|10688943|P1|Overall Study|Adverse Event|3
3126940|NCT00058539|10688943|P1|Overall Study|Disease progression|24
3126941|NCT00058214|10688976|P1|Overall Study|Adverse Event|1
3126942|NCT00058123|10688981|P1|Overall Study|Received >3 prior treatments|1
3126943|NCT00058123|10688981|P1|Overall Study|Wrong histology|9
3126944|NCT00058058|10688988|P1|Overall Study|Poor positioning, illness,pain|3
3126945|NCT00058058|10688988|P1|Overall Study|technical issues|6
3126946|NCT00058058|10688988|P1|Overall Study|Claustrophobic|5
3126947|NCT00058058|10688988|P1|Overall Study|Ineligible|20
3126948|NCT00058058|10688988|P1|Overall Study|Withdrawal by Subject|4
3126949|NCT00057954|10689013|P1|Overall Study|Disease progression|1
3126950|NCT00057954|10689013|P1|Overall Study|Death|1
3126951|NCT00057941|10689021|P2|Overall Study|Ineligible|5
3126952|NCT00057941|10689022|P1|Overall Study|Ineligible|2
3126953|NCT00057941|10689021|P2|Overall Study|insurance, symptomatic deterioration|3
3126954|NCT00057941|10689022|P1|Overall Study|insurance, symptomatic deterioration|1
3126955|NCT00057941|10689021|P2|Overall Study|still on treatment|1
3126956|NCT00057941|10689022|P1|Overall Study|still on treatment|3
3126957|NCT00057941|10689021|P2|Overall Study|Withdrawal by Subject|1
3126958|NCT00057941|10689022|P1|Overall Study|Withdrawal by Subject|6
3126959|NCT00057941|10689021|P2|Overall Study|Lack of Efficacy|53
3126960|NCT00057941|10689022|P1|Overall Study|Lack of Efficacy|54
3126961|NCT00057941|10689021|P2|Overall Study|Adverse Event|9
3126962|NCT00057941|10689022|P1|Overall Study|Adverse Event|7
3126963|NCT00057941|10689021|P2|Overall Study|Death|2
3126964|NCT00057941|10689022|P1|Overall Study|Death|1
3126965|NCT00057876|10689030|P2|Overall Study|other complicating disease|0
3126966|NCT00057876|10689031|P1|Overall Study|other complicating disease|1
3126967|NCT00057876|10689030|P2|Overall Study|other reason|2
3126968|NCT00057876|10689031|P1|Overall Study|other reason|2
3126969|NCT00057876|10689030|P2|Overall Study|Ineligible|2
3126970|NCT00057876|10689031|P1|Overall Study|Ineligible|1
3126971|NCT00057876|10689030|P2|Overall Study|Lack of Efficacy|8
3126972|NCT00057876|10689031|P1|Overall Study|Lack of Efficacy|10
3126973|NCT00057876|10689030|P2|Overall Study|Withdrawal by Subject|6
3126974|NCT00057876|10689031|P1|Overall Study|Withdrawal by Subject|5
3126975|NCT00057876|10689030|P2|Overall Study|Death|1
3126976|NCT00057876|10689031|P1|Overall Study|Death|2
3126977|NCT00057876|10689030|P2|Overall Study|Adverse Event|8
3126978|NCT00057876|10689031|P1|Overall Study|Adverse Event|8
3126979|NCT00057863|10689041|P1|Overall Study|Withdrawal by Subject|2
3126980|NCT00057863|10689041|P1|Overall Study|Death|1
3126981|NCT00057837|10689050|P2|Overall Study|Never started treatment|1
3126982|NCT00057837|10689051|P1|Overall Study|Never started treatment|1
3126983|NCT00057837|10689050|P2|Overall Study|Ineligible|3
3126984|NCT00057837|10689051|P1|Overall Study|Ineligible|3
3126985|NCT00057837|10689050|P2|Overall Study|Physician Decision|0
3126986|NCT00057837|10689051|P1|Overall Study|Physician Decision|1
3126987|NCT00057837|10689050|P2|Overall Study|Other complicating disease|1
3126988|NCT00057837|10689051|P1|Overall Study|Other complicating disease|2
3126989|NCT00057837|10689050|P2|Overall Study|Alternative therapy|1
3126990|NCT00057837|10689051|P1|Overall Study|Alternative therapy|0
3126991|NCT00057837|10689050|P2|Overall Study|Withdrawal by Subject|3
3126992|NCT00057837|10689051|P1|Overall Study|Withdrawal by Subject|5
3126993|NCT00057837|10689050|P2|Overall Study|Death|4
3126994|NCT00057837|10689051|P1|Overall Study|Death|5
3126995|NCT00057837|10689050|P2|Overall Study|Adverse Event|12
3126996|NCT00057837|10689051|P1|Overall Study|Adverse Event|2
3126997|NCT00057837|10689050|P2|Overall Study|Progression/relapse|14
3126998|NCT00057837|10689051|P1|Overall Study|Progression/relapse|12
3126999|NCT00057811|10689063|P2|Overall Study|Inevaluable|2
3127000|NCT00057811|10689064|P1|Overall Study|Inevaluable|1
3127001|NCT00057811|10689063|P2|Overall Study|Ineligible|2
3127002|NCT00057811|10689064|P1|Overall Study|Ineligible|4
3127003|NCT00057811|10689063|P2|Overall Study|Withdrawal by Subject|4
3127004|NCT00057811|10689064|P1|Overall Study|Withdrawal by Subject|3
3127005|NCT00057811|10689063|P2|Overall Study|Physician Decision|0
3127006|NCT00057811|10689064|P1|Overall Study|Physician Decision|1
3127007|NCT00057811|10689063|P2|Overall Study|Lack of Efficacy|4
3127008|NCT00057811|10689064|P1|Overall Study|Lack of Efficacy|1
3127009|NCT00057746|10689083|P3|Overall Study|Withdrawal by Subject|1
3127010|NCT00057746|10689084|P2|Overall Study|Withdrawal by Subject|0
3127011|NCT00057746|10689085|P1|Overall Study|Withdrawal by Subject|0
3127012|NCT00023673|10689096|P4|Overall Study|Patient withdrew consent|1
3127013|NCT00023673|10689097|P3|Overall Study|Patient withdrew consent|0
3127014|NCT00023673|10689098|P2|Overall Study|Patient withdrew consent|0
3127015|NCT00023673|10689099|P1|Overall Study|Patient withdrew consent|0
3127016|NCT00023673|10689096|P4|Overall Study|Ineligible / no protocol treatment|1
3127017|NCT00023673|10689097|P3|Overall Study|Ineligible / no protocol treatment|0
3127018|NCT00023673|10689098|P2|Overall Study|Ineligible / no protocol treatment|0
3127019|NCT00023673|10689099|P1|Overall Study|Ineligible / no protocol treatment|0
3127020|NCT00057330|10689163|P2|Overall Study|Other|206
3127021|NCT00057330|10689164|P1|Overall Study|Other|260
3127022|NCT00057330|10689163|P2|Overall Study|Physician Decision|0
3127023|NCT00057330|10689164|P1|Overall Study|Physician Decision|1
3127024|NCT00057330|10689163|P2|Overall Study|Lost to Follow-up|617
3127025|NCT00057330|10689164|P1|Overall Study|Lost to Follow-up|745
3127026|NCT00057330|10689163|P2|Overall Study|Withdrawal by Subject|84
3127027|NCT00057330|10689164|P1|Overall Study|Withdrawal by Subject|115
3127028|NCT00057330|10689163|P2|Overall Study|Protocol Violation|1
3127029|NCT00057330|10689164|P1|Overall Study|Protocol Violation|1
3127030|NCT00057330|10689163|P2|Overall Study|Death|0
3127031|NCT00057330|10689164|P1|Overall Study|Death|1
3127032|NCT00057330|10689163|P2|Overall Study|Adverse Event|12
3127033|NCT00057330|10689164|P1|Overall Study|Adverse Event|9
3127034|NCT00056862|10689194|P2|Overall Study|Protocol Violation|0
3127035|NCT00056862|10689195|P1|Overall Study|Protocol Violation|1
3127036|NCT00056407|10689253|P2|Overall Study|Missing|34
3127037|NCT00056407|10689254|P1|Overall Study|Missing|25
3127038|NCT00056407|10689253|P2|Overall Study|"Listed as Other on Case Report Form"|60
3127039|NCT00056407|10689254|P1|Overall Study|"Listed as Other on Case Report Form"|98
3127040|NCT00056407|10689253|P2|Overall Study|Diagnosed with Prostate Cancer|166
3127041|NCT00056407|10689254|P1|Overall Study|Diagnosed with Prostate Cancer|202
3127042|NCT00056407|10689253|P2|Overall Study|Protocol Violation|95
3127043|NCT00056407|10689254|P1|Overall Study|Protocol Violation|104
3127044|NCT00056407|10689253|P2|Overall Study|Lost to Follow-up|113
3127045|NCT00056407|10689254|P1|Overall Study|Lost to Follow-up|123
3127046|NCT00056407|10689253|P2|Overall Study|Withdrawal by Subject|361
3127047|NCT00056407|10689254|P1|Overall Study|Withdrawal by Subject|377
3127048|NCT00056407|10689253|P2|Overall Study|Adverse Event|364
3127049|NCT00056407|10689254|P1|Overall Study|Adverse Event|282
3127050|NCT00056316|10689312|P2|Overall Study|Death/NH placement of pt|1
3127051|NCT00056316|10689313|P1|Overall Study|Death/NH placement of pt|1
3127052|NCT00056316|10689312|P2|Overall Study|Withdrawal by Subject|2
3127053|NCT00056316|10689313|P1|Overall Study|Withdrawal by Subject|2
3127054|NCT00056160|10689327|P2|Final Follow-up|Adverse Event|0
3127055|NCT00056160|10689328|P1|Final Follow-up|Adverse Event|1
3127056|NCT00056160|10689327|P2|Final Follow-up|Transferred into RevAssist Program|0
3127057|NCT00056160|10689328|P1|Final Follow-up|Transferred into RevAssist Program|2
3127058|NCT00056160|10689327|P2|Final Follow-up|Transferred into expanded access study.|0
3127059|NCT00056160|10689328|P1|Final Follow-up|Transferred into expanded access study.|3
3127060|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
3127061|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
3127062|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
3127063|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
3127064|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
3127065|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
3127066|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
3127067|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
3127068|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
3127069|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
3127070|NCT00056160|10689327|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
3127071|NCT00056160|10689328|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
3127072|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Other|7
3127073|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Other|8
3127074|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Death|1
3127075|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Death|2
3127076|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
3127077|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
3127078|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
3127079|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
3127080|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
3127081|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
3127082|NCT00056160|10689327|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
3127083|NCT00056160|10689328|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
3127084|NCT00055601|10689351|P2|Overall Study|No protocol treatment received|1
3127085|NCT00055601|10689352|P1|Overall Study|No protocol treatment received|1
3127086|NCT00055601|10689351|P2|Overall Study|Protocol Violation|1
3127087|NCT00055601|10689352|P1|Overall Study|Protocol Violation|1
3127088|NCT00055497|10689366|P4|Overall Study|Other|11
3127089|NCT00055497|10689367|P3|Overall Study|Other|0
3127090|NCT00055497|10689368|P2|Overall Study|Other|0
3127091|NCT00055497|10689369|P1|Overall Study|Other|0
3127092|NCT00055497|10689366|P4|Overall Study|Administrative Reasons|1
3127093|NCT00055497|10689367|P3|Overall Study|Administrative Reasons|0
3127094|NCT00055497|10689368|P2|Overall Study|Administrative Reasons|0
3127095|NCT00055497|10689369|P1|Overall Study|Administrative Reasons|0
3127096|NCT00055497|10689366|P4|Overall Study|Lack of Efficacy|27
3127097|NCT00055497|10689367|P3|Overall Study|Lack of Efficacy|0
3127098|NCT00055497|10689368|P2|Overall Study|Lack of Efficacy|0
3127099|NCT00055497|10689369|P1|Overall Study|Lack of Efficacy|1
3127100|NCT00055497|10689366|P4|Overall Study|Protocol Violation|3
3127101|NCT00055497|10689367|P3|Overall Study|Protocol Violation|0
3127102|NCT00055497|10689368|P2|Overall Study|Protocol Violation|0
3127103|NCT00055497|10689369|P1|Overall Study|Protocol Violation|0
3127104|NCT00055497|10689366|P4|Overall Study|Lost to Follow-up|5
3127105|NCT00055497|10689367|P3|Overall Study|Lost to Follow-up|0
3127106|NCT00055497|10689368|P2|Overall Study|Lost to Follow-up|1
3127107|NCT00055497|10689369|P1|Overall Study|Lost to Follow-up|0
3127108|NCT00055497|10689366|P4|Overall Study|Withdrawal by Subject|15
3127109|NCT00055497|10689367|P3|Overall Study|Withdrawal by Subject|1
3127110|NCT00055497|10689368|P2|Overall Study|Withdrawal by Subject|1
3127111|NCT00055497|10689369|P1|Overall Study|Withdrawal by Subject|3
3127112|NCT00055497|10689366|P4|Overall Study|Adverse Event|28
3127113|NCT00055497|10689367|P3|Overall Study|Adverse Event|1
3127114|NCT00055497|10689368|P2|Overall Study|Adverse Event|1
3127115|NCT00055497|10689369|P1|Overall Study|Adverse Event|1
3127116|NCT00055471|10689414|P3|Period 1: Dose Escalation Period|Disease progression|0
3127117|NCT00055471|10689415|P2|Period 1: Dose Escalation Period|Disease progression|1
3127118|NCT00055471|10689416|P1|Period 1: Dose Escalation Period|Disease progression|0
3127119|NCT00055471|10689414|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
3127120|NCT00055471|10689415|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
3127121|NCT00055471|10689416|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
3127122|NCT00055471|10689414|P3|Period 1: Dose Escalation Period|Adverse Event|2
3127123|NCT00055471|10689415|P2|Period 1: Dose Escalation Period|Adverse Event|1
3127124|NCT00055471|10689416|P1|Period 1: Dose Escalation Period|Adverse Event|0
3127125|NCT00054717|10689471|P2|Overall Study|Other reason not defined above|217
3127126|NCT00054717|10689472|P1|Overall Study|Other reason not defined above|117
3127127|NCT00054717|10689471|P2|Overall Study|Withdrawal by Subject|20
3127128|NCT00054717|10689472|P1|Overall Study|Withdrawal by Subject|32
3127129|NCT00054717|10689471|P2|Overall Study|Lost to Follow-up|13
3127130|NCT00054717|10689472|P1|Overall Study|Lost to Follow-up|23
3127131|NCT00054717|10689471|P2|Overall Study|Protocol Violation|19
3127132|NCT00054717|10689472|P1|Overall Study|Protocol Violation|18
3127133|NCT00054717|10689471|P2|Overall Study|Adverse Event|22
3127134|NCT00054717|10689472|P1|Overall Study|Adverse Event|70
3127135|NCT00054717|10689471|P2|Overall Study|Randomized but not treated|8
3127136|NCT00054717|10689472|P1|Overall Study|Randomized but not treated|2
3127137|NCT00054704|10689660|P2|Overall Study|Lost to Follow-up|1
3127138|NCT00054704|10689661|P1|Overall Study|Lost to Follow-up|0
3127139|NCT00054704|10689660|P2|Overall Study|Adverse Event|1
3127140|NCT00054704|10689661|P1|Overall Study|Adverse Event|3
3127141|NCT00054704|10689660|P2|Overall Study|Lack of Efficacy|3
3127142|NCT00054704|10689661|P1|Overall Study|Lack of Efficacy|2
3127143|NCT00054691|10689667|P1|Overall Study|Noncompliant|1
3127144|NCT00054691|10689667|P1|Overall Study|Unmeasurable Disease|2
3127145|NCT00054639|10689681|P1|Overall Study|Physician Decision|1
3127146|NCT00054639|10689681|P1|Overall Study|Lack of Efficacy|1
3127147|NCT00054327|10689714|P6|Overall Study|Engraftment failure|0
3127148|NCT00054327|10689715|P5|Overall Study|Engraftment failure|0
3127149|NCT00054327|10689716|P4|Overall Study|Engraftment failure|0
3127150|NCT00054327|10689717|P3|Overall Study|Engraftment failure|0
3127151|NCT00054327|10689718|P2|Overall Study|Engraftment failure|0
3127152|NCT00054327|10689719|P1|Overall Study|Engraftment failure|1
3127153|NCT00054275|10689757|P1|Overall Study|Physician Decision|1
3127154|NCT00054275|10689757|P1|Overall Study|Progressive disease in cycle 1|1
3127155|NCT00054275|10689757|P1|Overall Study|Adverse Event|5
3127156|NCT00054275|10689757|P1|Overall Study|Withdrawal by Subject|4
3127157|NCT00054132|10689763|P1|Overall Study|Not Treated|1
3127158|NCT00053898|10689790|P2|Overall Study|Follow-up from telephone contact only|1
3127159|NCT00053898|10689791|P1|Overall Study|Follow-up from telephone contact only|5
3127160|NCT00053898|10689790|P2|Overall Study|No follow-up data from any source|12
3127161|NCT00053898|10689791|P1|Overall Study|No follow-up data from any source|9
3127162|NCT00053846|10689817|P2|Overall Study|Pills too large|1
3127163|NCT00053846|10689818|P1|Overall Study|Pills too large|0
3127164|NCT00053846|10689817|P2|Overall Study|Quit due to side effects|3
3127165|NCT00053846|10689818|P1|Overall Study|Quit due to side effects|1
3127166|NCT00053846|10689817|P2|Overall Study|Did not return data|2
3127167|NCT00053846|10689818|P1|Overall Study|Did not return data|1
3127168|NCT00053846|10689817|P2|Overall Study|Became ineligible|1
3127169|NCT00053846|10689818|P1|Overall Study|Became ineligible|3
3127170|NCT00053846|10689817|P2|Overall Study|Expired|0
3127171|NCT00053846|10689818|P1|Overall Study|Expired|5
3127172|NCT00053846|10689817|P2|Overall Study|Became too ill|7
3127173|NCT00053846|10689818|P1|Overall Study|Became too ill|8
3127174|NCT00053846|10689817|P2|Overall Study|Changed mind|13
3127175|NCT00053846|10689818|P1|Overall Study|Changed mind|8
3127176|NCT00053417|10689977|P4|Overall Study|Lost to Follow-up|0
3127177|NCT00053417|10689978|P3|Overall Study|Lost to Follow-up|0
3127178|NCT00053417|10689979|P2|Overall Study|Lost to Follow-up|1
3127179|NCT00053417|10689980|P1|Overall Study|Lost to Follow-up|1
3127180|NCT00053417|10689977|P4|Overall Study|Withdrawal by Subject|0
3127181|NCT00053417|10689978|P3|Overall Study|Withdrawal by Subject|0
3127182|NCT00053417|10689979|P2|Overall Study|Withdrawal by Subject|1
3127183|NCT00053417|10689980|P1|Overall Study|Withdrawal by Subject|0
3127184|NCT00053417|10689977|P4|Overall Study|Non-Compliance|1
3127185|NCT00053417|10689978|P3|Overall Study|Non-Compliance|0
3127186|NCT00053417|10689979|P2|Overall Study|Non-Compliance|0
3127187|NCT00053417|10689980|P1|Overall Study|Non-Compliance|0
3127188|NCT00053417|10689977|P4|Overall Study|Adverse Event|5
3127189|NCT00053417|10689978|P3|Overall Study|Adverse Event|1
3127190|NCT00053417|10689979|P2|Overall Study|Adverse Event|0
3127191|NCT00053417|10689980|P1|Overall Study|Adverse Event|1
3127192|NCT00053365|10689990|P1|Overall Study|Never treated|4
3127193|NCT00053365|10689990|P1|Overall Study|Platinum-sensitive interval >12 months|1
3127194|NCT00053365|10689990|P1|Overall Study|Incorrect cell type|1
3127195|NCT00053352|10689999|P2|Overall Study|Disease at new site|0
3127196|NCT00053352|10690000|P1|Overall Study|Disease at new site|1
3127197|NCT00053352|10689999|P2|Overall Study|Ineligible|8
3127198|NCT00053352|10690000|P1|Overall Study|Ineligible|8
3127199|NCT00053352|10689999|P2|Overall Study|Withdrawal by Subject|0
3127200|NCT00053352|10690000|P1|Overall Study|Withdrawal by Subject|1
3127201|NCT00053352|10689999|P2|Overall Study|Physician Decision|1
3127202|NCT00053352|10690000|P1|Overall Study|Physician Decision|11
3127203|NCT00053352|10689999|P2|Overall Study|Lost to Follow-up|1
3127204|NCT00053352|10690000|P1|Overall Study|Lost to Follow-up|0
3127205|NCT00003830|10690016|P2|Overall Study|Sentinel node positive patients|793
3127206|NCT00003830|10690017|P1|Overall Study|Sentinel node positive patients|829
3127207|NCT00003830|10690016|P2|Overall Study|No follow up data|0
3127208|NCT00003830|10690017|P1|Overall Study|No follow up data|3
3127209|NCT00052962|10690043|P2|Overall Study|Not randomized/not evaluable|0
3127210|NCT00052962|10690044|P1|Overall Study|Not randomized/not evaluable|1
3127211|NCT00052962|10690043|P2|Overall Study|Not evaluable|2
3127212|NCT00052962|10690044|P1|Overall Study|Not evaluable|0
3127213|NCT00052715|10690063|P1|Overall Study|wrong histology|1
3127214|NCT00049543|10690079|P2|Overall Study|still on treatment|9
3127215|NCT00049543|10690080|P1|Overall Study|still on treatment|2
3127216|NCT00049530|10690090|P1|Overall Study|ineligible|3
3127217|NCT00049530|10690090|P1|Overall Study|symptomatic deterioration|1
3127218|NCT00049530|10690090|P1|Overall Study|Death|1
3127219|NCT00049530|10690090|P1|Overall Study|Adverse Event|2
3127220|NCT00049530|10690090|P1|Overall Study|Lack of Efficacy|25
3127221|NCT00049517|10690099|P6|Conditioning/Transplant|Reasons not reported|5
3127222|NCT00049517|10690100|P5|Conditioning/Transplant|Reasons not reported|5
3127223|NCT00049517|10690101|P4|Conditioning/Transplant|Reasons not reported|15
3127224|NCT00049517|10690102|P3|Conditioning/Transplant|Reasons not reported|18
3127225|NCT00049517|10690103|P2|Conditioning/Transplant|Reasons not reported|31
3127226|NCT00049517|10690104|P1|Conditioning/Transplant|Reasons not reported|25
3127227|NCT00049517|10690099|P6|Conditioning/Transplant|Other complicating disease|1
3127228|NCT00049517|10690100|P5|Conditioning/Transplant|Other complicating disease|0
3127229|NCT00049517|10690101|P4|Conditioning/Transplant|Other complicating disease|4
3127230|NCT00049517|10690102|P3|Conditioning/Transplant|Other complicating disease|0
3127231|NCT00049517|10690103|P2|Conditioning/Transplant|Other complicating disease|0
3127232|NCT00049517|10690104|P1|Conditioning/Transplant|Other complicating disease|2
3127233|NCT00049517|10690099|P6|Conditioning/Transplant|Alternative therapy|0
3127234|NCT00049517|10690100|P5|Conditioning/Transplant|Alternative therapy|1
3127235|NCT00049517|10690101|P4|Conditioning/Transplant|Alternative therapy|1
3127236|NCT00049517|10690102|P3|Conditioning/Transplant|Alternative therapy|2
3127237|NCT00049517|10690103|P2|Conditioning/Transplant|Alternative therapy|4
3127238|NCT00049517|10690104|P1|Conditioning/Transplant|Alternative therapy|4
3127239|NCT00049517|10690099|P6|Conditioning/Transplant|Withdrawal by Subject|0
3127240|NCT00049517|10690100|P5|Conditioning/Transplant|Withdrawal by Subject|0
3127241|NCT00049517|10690101|P4|Conditioning/Transplant|Withdrawal by Subject|7
3127242|NCT00049517|10690102|P3|Conditioning/Transplant|Withdrawal by Subject|4
3127243|NCT00049517|10690103|P2|Conditioning/Transplant|Withdrawal by Subject|8
3127244|NCT00049517|10690104|P1|Conditioning/Transplant|Withdrawal by Subject|4
3127245|NCT00049517|10690099|P6|Conditioning/Transplant|Death|0
3127246|NCT00049517|10690100|P5|Conditioning/Transplant|Death|0
3127247|NCT00049517|10690101|P4|Conditioning/Transplant|Death|2
3127248|NCT00049517|10690102|P3|Conditioning/Transplant|Death|0
3127249|NCT00049517|10690103|P2|Conditioning/Transplant|Death|0
3127250|NCT00049517|10690104|P1|Conditioning/Transplant|Death|1
3127251|NCT00049517|10690099|P6|Conditioning/Transplant|Adverse Event|0
3127252|NCT00049517|10690100|P5|Conditioning/Transplant|Adverse Event|0
3127253|NCT00049517|10690101|P4|Conditioning/Transplant|Adverse Event|8
3127254|NCT00049517|10690102|P3|Conditioning/Transplant|Adverse Event|4
3127255|NCT00049517|10690103|P2|Conditioning/Transplant|Adverse Event|1
3127256|NCT00049517|10690104|P1|Conditioning/Transplant|Adverse Event|2
3127257|NCT00049517|10690099|P6|Conditioning/Transplant|Disease progression|0
3127258|NCT00049517|10690100|P5|Conditioning/Transplant|Disease progression|0
3127259|NCT00049517|10690101|P4|Conditioning/Transplant|Disease progression|6
3127260|NCT00049517|10690102|P3|Conditioning/Transplant|Disease progression|10
3127261|NCT00049517|10690103|P2|Conditioning/Transplant|Disease progression|6
3127262|NCT00049517|10690104|P1|Conditioning/Transplant|Disease progression|14
3127263|NCT00049517|10690099|P6|Induction|Reasons not reported|25
3127264|NCT00049517|10690100|P5|Induction|Reasons not reported|22
3127265|NCT00049517|10690101|P4|Induction|Reasons not reported|0
3127266|NCT00049517|10690102|P3|Induction|Reasons not reported|0
3127267|NCT00049517|10690103|P2|Induction|Reasons not reported|0
3127268|NCT00049517|10690104|P1|Induction|Reasons not reported|0
3127269|NCT00049517|10690099|P6|Induction|Other complicating disease|0
3127270|NCT00049517|10690100|P5|Induction|Other complicating disease|3
3127271|NCT00049517|10690101|P4|Induction|Other complicating disease|0
3127272|NCT00049517|10690102|P3|Induction|Other complicating disease|0
3127273|NCT00049517|10690103|P2|Induction|Other complicating disease|0
3127274|NCT00049517|10690104|P1|Induction|Other complicating disease|0
3127275|NCT00049517|10690099|P6|Induction|Alternative therapy|2
3127276|NCT00049517|10690100|P5|Induction|Alternative therapy|2
3127277|NCT00049517|10690101|P4|Induction|Alternative therapy|0
3127278|NCT00049517|10690102|P3|Induction|Alternative therapy|0
3127279|NCT00049517|10690103|P2|Induction|Alternative therapy|0
3127280|NCT00049517|10690104|P1|Induction|Alternative therapy|0
3127281|NCT00049517|10690099|P6|Induction|Withdrawal by Subject|3
3127282|NCT00049517|10690100|P5|Induction|Withdrawal by Subject|1
3127283|NCT00049517|10690101|P4|Induction|Withdrawal by Subject|0
3127284|NCT00049517|10690102|P3|Induction|Withdrawal by Subject|0
3127285|NCT00049517|10690103|P2|Induction|Withdrawal by Subject|0
3127286|NCT00049517|10690104|P1|Induction|Withdrawal by Subject|0
3127287|NCT00049517|10690099|P6|Induction|Death|6
3127288|NCT00049517|10690100|P5|Induction|Death|9
3127289|NCT00049517|10690101|P4|Induction|Death|0
3127290|NCT00049517|10690102|P3|Induction|Death|0
3127291|NCT00049517|10690103|P2|Induction|Death|0
3127292|NCT00049517|10690104|P1|Induction|Death|0
3127293|NCT00049517|10690099|P6|Induction|Adverse Event|7
3127294|NCT00049517|10690100|P5|Induction|Adverse Event|5
3127295|NCT00049517|10690101|P4|Induction|Adverse Event|0
3127296|NCT00049517|10690102|P3|Induction|Adverse Event|0
3127297|NCT00049517|10690103|P2|Induction|Adverse Event|0
3127298|NCT00049517|10690104|P1|Induction|Adverse Event|0
3127299|NCT00049517|10690099|P6|Induction|Disease progression|11
3127300|NCT00049517|10690100|P5|Induction|Disease progression|18
3127301|NCT00049517|10690101|P4|Induction|Disease progression|0
3127302|NCT00049517|10690102|P3|Induction|Disease progression|0
3127303|NCT00049517|10690103|P2|Induction|Disease progression|0
3127304|NCT00049517|10690104|P1|Induction|Disease progression|0
3127305|NCT00049322|10690122|P2|Overall Study|refused angio|3
3127306|NCT00049322|10690123|P1|Overall Study|refused angio|0
3127307|NCT00049322|10690122|P2|Overall Study|Adverse Event|0
3127308|NCT00049322|10690123|P1|Overall Study|Adverse Event|1
3127309|NCT00049322|10690122|P2|Overall Study|disease burden|3
3127310|NCT00049322|10690123|P1|Overall Study|disease burden|0
3127311|NCT00049257|10690135|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
3127312|NCT00049257|10690135|P1|Carboplatin, Paclitaxel|Death|2
3127313|NCT00049257|10690135|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
3127314|NCT00049257|10690135|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
3127315|NCT00049127|10690147|P5|Overall Study|Withdrawal by Subject|0
3127316|NCT00049127|10690148|P4|Overall Study|Withdrawal by Subject|0
3127317|NCT00049127|10690149|P3|Overall Study|Withdrawal by Subject|1
3127318|NCT00049127|10690150|P2|Overall Study|Withdrawal by Subject|0
3127319|NCT00049127|10690151|P1|Overall Study|Withdrawal by Subject|0
3127320|NCT00048997|10690189|P2|Overall Study|Withdrawal by Subject|1
3127321|NCT00048997|10690190|P1|Overall Study|Withdrawal by Subject|6
3127322|NCT00048997|10690189|P2|Overall Study|Protocol Violation|2
3127323|NCT00048997|10690190|P1|Overall Study|Protocol Violation|7
3127324|NCT00047385|10690213|P2|Overall Study|Eligible for screening but had no screen|492
3127325|NCT00047385|10690214|P1|Overall Study|Eligible for screening but had no screen|260
3127326|NCT00047385|10690213|P2|Overall Study|Lung Cancer diagnosed before screening|3
3127327|NCT00047385|10690214|P1|Overall Study|Lung Cancer diagnosed before screening|5
3127328|NCT00047385|10690213|P2|Overall Study|Death before any screening|5
3127329|NCT00047385|10690214|P1|Overall Study|Death before any screening|2
3127330|NCT00047320|10690232|P1|Overall Study|Ineligible|2
3127331|NCT00047320|10690232|P1|Overall Study|Withdrawal by Subject|9
3127332|NCT00047320|10690232|P1|Overall Study|Physician Decision|8
3127333|NCT00047320|10690232|P1|Overall Study|Lost to Follow-up|1
3127334|NCT00047320|10690232|P1|Overall Study|Lack of Efficacy|8
3127335|NCT00047008|10690247|P2|Overall Study|Ineligible|8
3127336|NCT00047008|10690248|P1|Overall Study|Ineligible|9
3127337|NCT00047008|10690247|P2|Overall Study|Withdrawn consent|3
3127338|NCT00047008|10690248|P1|Overall Study|Withdrawn consent|2
3127339|NCT00046930|10690256|P2|Overall Study|Ineligible|4
3127340|NCT00046930|10690257|P1|Overall Study|Ineligible|12
3127341|NCT00046891|10690272|P2|Overall Study|Adverse Event|5
3127342|NCT00046891|10690273|P1|Overall Study|Adverse Event|5
3127343|NCT00046891|10690272|P2|Overall Study|Withdrawal by Subject|15
3127344|NCT00046891|10690273|P1|Overall Study|Withdrawal by Subject|18
3127345|NCT00046891|10690272|P2|Overall Study|Ineligible|1
3127346|NCT00046891|10690273|P1|Overall Study|Ineligible|1
3127347|NCT00046891|10690272|P2|Overall Study|Cancels|9
3127348|NCT00046891|10690273|P1|Overall Study|Cancels|5
3127349|NCT00046839|10690293|P2|Overall Study|Withdrawal of consent|0
3127350|NCT00046839|10690294|P1|Overall Study|Withdrawal of consent|1
3127351|NCT00046839|10690293|P2|Overall Study|Ineligible / No protocol treatment|2
3127352|NCT00046839|10690294|P1|Overall Study|Ineligible / No protocol treatment|0
3127353|NCT00045734|10690301|P1|Overall Study|Protocol Violation|1
3127354|NCT00045708|10690316|P3|Phase 1|early progressive disease|0
3127355|NCT00045708|10690317|P2|Phase 1|early progressive disease|1
3127356|NCT00045708|10690318|P1|Phase 1|early progressive disease|0
3127357|NCT00045630|10690343|P1|Overall Study|Ineligible|2
3127358|NCT00045630|10690343|P1|Overall Study|Death|1
3127359|NCT00045630|10690343|P1|Overall Study|Progression/relapse|1
3127360|NCT00045630|10690343|P1|Overall Study|Refusal unrelated to adverse event|1
3127361|NCT00045630|10690343|P1|Overall Study|Adverse Event|1
3127362|NCT00045305|10690362|P1|Overall Study|site error|2
3127363|NCT00045305|10690362|P1|Overall Study|Death|3
3127364|NCT00045305|10690362|P1|Overall Study|Adverse Event|3
3127365|NCT00045305|10690362|P1|Overall Study|Lack of Efficacy|6
3127366|NCT00045162|10690373|P2|Overall Study|Other|16
3127367|NCT00045162|10690374|P1|Overall Study|Other|21
3127368|NCT00045162|10690373|P2|Overall Study|Withdrawal by Subject|3
3127369|NCT00045162|10690374|P1|Overall Study|Withdrawal by Subject|5
3127370|NCT00045162|10690373|P2|Overall Study|Death|10
3127371|NCT00045162|10690374|P1|Overall Study|Death|10
3127372|NCT00045162|10690373|P2|Overall Study|Lack of Efficacy|29
3127373|NCT00045162|10690374|P1|Overall Study|Lack of Efficacy|32
3127374|NCT00045162|10690373|P2|Overall Study|Adverse Event|50
3127375|NCT00045162|10690374|P1|Overall Study|Adverse Event|55
3127376|NCT00045162|10690373|P2|Overall Study|Not treated|2
3127377|NCT00045162|10690374|P1|Overall Study|Not treated|7
3127378|NCT00045162|10690373|P2|Overall Study|Ineligible|8
3127379|NCT00045162|10690374|P1|Overall Study|Ineligible|12
3127380|NCT00045110|10690389|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
3127381|NCT00045110|10690390|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
3127382|NCT00045110|10690391|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
3127383|NCT00045110|10690389|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
3127384|NCT00045110|10690390|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
3127385|NCT00045110|10690391|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
3127386|NCT00045110|10690389|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
3127387|NCT00045110|10690390|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
3127388|NCT00045110|10690391|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
3127389|NCT00045032|10690440|P3|Overall Study|Other|105
3127390|NCT00045032|10690441|P2|Overall Study|Other|84
3127391|NCT00045032|10690442|P1|Overall Study|Other|93
3127392|NCT00045032|10690440|P3|Overall Study|Failure to Return|61
3127393|NCT00045032|10690441|P2|Overall Study|Failure to Return|62
3127394|NCT00045032|10690442|P1|Overall Study|Failure to Return|57
3127395|NCT00045032|10690440|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
3127396|NCT00045032|10690441|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
3127397|NCT00045032|10690442|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
3127398|NCT00045032|10690440|P3|Overall Study|Other Protocol Violation|1
3127399|NCT00045032|10690441|P2|Overall Study|Other Protocol Violation|0
3127400|NCT00045032|10690442|P1|Overall Study|Other Protocol Violation|2
3127401|NCT00045032|10690440|P3|Overall Study|Violation of Selection Criteria at Entry|6
3127402|NCT00045032|10690441|P2|Overall Study|Violation of Selection Criteria at Entry|6
3127403|NCT00045032|10690442|P1|Overall Study|Violation of Selection Criteria at Entry|3
3127404|NCT00045032|10690440|P3|Overall Study|Insufficient Therapeutic Response|445
3127405|NCT00045032|10690441|P2|Overall Study|Insufficient Therapeutic Response|437
3127406|NCT00045032|10690442|P1|Overall Study|Insufficient Therapeutic Response|542
3127407|NCT00045032|10690440|P3|Overall Study|Death|17
3127408|NCT00045032|10690441|P2|Overall Study|Death|24
3127409|NCT00045032|10690442|P1|Overall Study|Death|22
3127410|NCT00045032|10690440|P3|Overall Study|Adverse Event/Intercurrent Illness|7
3127411|NCT00045032|10690441|P2|Overall Study|Adverse Event/Intercurrent Illness|2
3127412|NCT00045032|10690442|P1|Overall Study|Adverse Event/Intercurrent Illness|2
3127413|NCT00042991|10690576|P7|Overall Study|Alternative Therapy|0
3127414|NCT00042991|10690577|P6|Overall Study|Alternative Therapy|0
3127415|NCT00042991|10690578|P5|Overall Study|Alternative Therapy|1
3127416|NCT00042991|10690579|P4|Overall Study|Alternative Therapy|0
3127417|NCT00042991|10690580|P3|Overall Study|Alternative Therapy|0
3127418|NCT00042991|10690581|P2|Overall Study|Alternative Therapy|0
3127419|NCT00042991|10690582|P1|Overall Study|Alternative Therapy|0
3127420|NCT00042991|10690576|P7|Overall Study|Disease Progression|2
3127421|NCT00042991|10690577|P6|Overall Study|Disease Progression|4
3127422|NCT00042991|10690578|P5|Overall Study|Disease Progression|1
3127423|NCT00042991|10690579|P4|Overall Study|Disease Progression|2
3127424|NCT00042991|10690580|P3|Overall Study|Disease Progression|2
3127425|NCT00042991|10690581|P2|Overall Study|Disease Progression|29
3127426|NCT00042991|10690582|P1|Overall Study|Disease Progression|5
3127427|NCT00042991|10690576|P7|Overall Study|Withdrawal by Subject|0
3127428|NCT00042991|10690577|P6|Overall Study|Withdrawal by Subject|0
3127429|NCT00042991|10690578|P5|Overall Study|Withdrawal by Subject|1
3127430|NCT00042991|10690579|P4|Overall Study|Withdrawal by Subject|0
3127431|NCT00042991|10690580|P3|Overall Study|Withdrawal by Subject|2
3127432|NCT00042991|10690581|P2|Overall Study|Withdrawal by Subject|7
3127433|NCT00042991|10690582|P1|Overall Study|Withdrawal by Subject|0
3127434|NCT00042991|10690576|P7|Overall Study|Adverse Event|0
3127435|NCT00042991|10690577|P6|Overall Study|Adverse Event|1
3127436|NCT00042991|10690578|P5|Overall Study|Adverse Event|0
3127437|NCT00042991|10690579|P4|Overall Study|Adverse Event|0
3127438|NCT00042991|10690580|P3|Overall Study|Adverse Event|2
3127439|NCT00042991|10690581|P2|Overall Study|Adverse Event|4
3127440|NCT00042991|10690582|P1|Overall Study|Adverse Event|1
3127441|NCT00042939|10690625|P2|Overall Study|Did not start treatment|1
3127442|NCT00042939|10690626|P1|Overall Study|Did not start treatment|2
3127443|NCT00042939|10690625|P2|Overall Study|Treatment break > 4 weeks|1
3127444|NCT00042939|10690626|P1|Overall Study|Treatment break > 4 weeks|0
3127445|NCT00042939|10690625|P2|Overall Study|Still on treatment|0
3127446|NCT00042939|10690626|P1|Overall Study|Still on treatment|1
3127447|NCT00042939|10690625|P2|Overall Study|Patient non-compliance|0
3127448|NCT00042939|10690626|P1|Overall Study|Patient non-compliance|1
3127449|NCT00042939|10690625|P2|Overall Study|Rising ca 19-9|0
3127450|NCT00042939|10690626|P1|Overall Study|Rising ca 19-9|1
3127451|NCT00042939|10690625|P2|Overall Study|QOL diminished|0
3127452|NCT00042939|10690626|P1|Overall Study|QOL diminished|1
3127453|NCT00042939|10690625|P2|Overall Study|Deterioration of health|4
3127454|NCT00042939|10690626|P1|Overall Study|Deterioration of health|3
3127455|NCT00042939|10690625|P2|Overall Study|Ineligible|2
3127456|NCT00042939|10690626|P1|Overall Study|Ineligible|2
3127457|NCT00042939|10690625|P2|Overall Study|Other disease|0
3127458|NCT00042939|10690626|P1|Overall Study|Other disease|1
3127459|NCT00042939|10690625|P2|Overall Study|Withdrawal by Subject|4
3127460|NCT00042939|10690626|P1|Overall Study|Withdrawal by Subject|3
3127461|NCT00042939|10690625|P2|Overall Study|Death|2
3127462|NCT00042939|10690626|P1|Overall Study|Death|3
3127463|NCT00042939|10690625|P2|Overall Study|Adverse Event|7
3127464|NCT00042939|10690626|P1|Overall Study|Adverse Event|6
3127465|NCT00041132|10690640|P1|Overall Study|Physician Decision|2
3127466|NCT00041132|10690640|P1|Overall Study|Withdrawal by Subject|1
3127467|NCT00041132|10690640|P1|Overall Study|Not Eligible|7
3127468|NCT00041132|10690640|P1|Overall Study|Death|1
3127469|NCT00041132|10690640|P1|Overall Study|Adverse Event|19
3127470|NCT00041080|10690675|P2|Overall Study|Ineligible|0
3127471|NCT00041080|10690676|P1|Overall Study|Ineligible|1
3127472|NCT00041080|10690675|P2|Overall Study|Did not start therapy|1
3127473|NCT00041080|10690676|P1|Overall Study|Did not start therapy|1
3127474|NCT00041080|10690675|P2|Overall Study|Concommitant Illness/Other|2
3127475|NCT00041080|10690676|P1|Overall Study|Concommitant Illness/Other|1
3127476|NCT00041080|10690675|P2|Overall Study|Withdrawal by Subject|6
3127477|NCT00041080|10690676|P1|Overall Study|Withdrawal by Subject|6
3127478|NCT00041080|10690675|P2|Overall Study|Adverse Event|1
3127479|NCT00041080|10690676|P1|Overall Study|Adverse Event|21
3127480|NCT00041067|10690682|P1|Overall Study|Ineligible|2
3127481|NCT00041067|10690682|P1|Overall Study|Other reasons|23
3127482|NCT00041067|10690682|P1|Overall Study|Patient refusal|12
3127483|NCT00041067|10690682|P1|Overall Study|Progression|19
3127484|NCT00041067|10690682|P1|Overall Study|Adverse Event|20
3127485|NCT00040742|10690749|P4|Overall Study|Other medical|5
3127486|NCT00040742|10690750|P3|Overall Study|Other medical|5
3127487|NCT00040742|10690751|P2|Overall Study|Other medical|5
3127488|NCT00040742|10690752|P1|Overall Study|Other medical|7
3127489|NCT00040742|10690749|P4|Overall Study|Incomplete Forms|5
3127490|NCT00040742|10690750|P3|Overall Study|Incomplete Forms|4
3127491|NCT00040742|10690751|P2|Overall Study|Incomplete Forms|10
3127492|NCT00040742|10690752|P1|Overall Study|Incomplete Forms|6
3127493|NCT00040742|10690749|P4|Overall Study|Chemotoxicity|2
3127494|NCT00040742|10690750|P3|Overall Study|Chemotoxicity|5
3127495|NCT00040742|10690751|P2|Overall Study|Chemotoxicity|3
3127496|NCT00040742|10690752|P1|Overall Study|Chemotoxicity|4
3127497|NCT00040742|10690749|P4|Overall Study|Withdrawal by Subject|13
3127498|NCT00040742|10690750|P3|Overall Study|Withdrawal by Subject|10
3127499|NCT00040742|10690751|P2|Overall Study|Withdrawal by Subject|15
3127500|NCT00040742|10690752|P1|Overall Study|Withdrawal by Subject|7
3127501|NCT00040742|10690749|P4|Overall Study|Adverse Event|9
3127502|NCT00040742|10690750|P3|Overall Study|Adverse Event|21
3127503|NCT00040742|10690751|P2|Overall Study|Adverse Event|16
3127504|NCT00040742|10690752|P1|Overall Study|Adverse Event|15
3127505|NCT00040742|10690749|P4|Overall Study|Death|0
3127506|NCT00040742|10690750|P3|Overall Study|Death|1
3127507|NCT00040742|10690751|P2|Overall Study|Death|0
3127508|NCT00040742|10690752|P1|Overall Study|Death|0
3127509|NCT00039377|10690766|P4|Initial Registration|Withdrawal by Subject|0
3127510|NCT00039377|10690767|P3|Initial Registration|Withdrawal by Subject|0
3127511|NCT00039377|10690768|P2|Initial Registration|Withdrawal by Subject|0
3127512|NCT00039377|10690769|P1|Initial Registration|Withdrawal by Subject|3
3127513|NCT00039377|10690766|P4|Initial Registration|Received non-protocol therapy|0
3127514|NCT00039377|10690767|P3|Initial Registration|Received non-protocol therapy|0
3127515|NCT00039377|10690768|P2|Initial Registration|Received non-protocol therapy|0
3127516|NCT00039377|10690769|P1|Initial Registration|Received non-protocol therapy|11
3127517|NCT00039377|10690766|P4|Initial Registration|Relapsed|0
3127518|NCT00039377|10690767|P3|Initial Registration|Relapsed|0
3127519|NCT00039377|10690768|P2|Initial Registration|Relapsed|0
3127520|NCT00039377|10690769|P1|Initial Registration|Relapsed|6
3127521|NCT00039377|10690766|P4|Initial Registration|Adverse Event|0
3127522|NCT00039377|10690767|P3|Initial Registration|Adverse Event|0
3127523|NCT00039377|10690768|P2|Initial Registration|Adverse Event|0
3127524|NCT00039377|10690769|P1|Initial Registration|Adverse Event|2
3127525|NCT00039130|10690785|P1|Overall Study|Physician Decision|3
3127526|NCT00039130|10690785|P1|Overall Study|Subsequent treatment|2
3127527|NCT00039130|10690785|P1|Overall Study|Progression|2
3127528|NCT00039130|10690785|P1|Overall Study|Withdrawal by Subject|3
3127529|NCT00039130|10690785|P1|Overall Study|Death|9
3127530|NCT00039130|10690785|P1|Overall Study|Adverse Event|11
3127531|NCT00033657|10690801|P2|Adjuvant Chemotherapy|Other|2
3127532|NCT00033657|10690802|P1|Adjuvant Chemotherapy|Other|0
3127533|NCT00033657|10690801|P2|Adjuvant Chemotherapy|alternative therapy|0
3127534|NCT00033657|10690802|P1|Adjuvant Chemotherapy|alternative therapy|1
3127535|NCT00033657|10690801|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
3127536|NCT00033657|10690802|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
3127537|NCT00033657|10690801|P2|Adjuvant Chemotherapy|Death|1
3127538|NCT00033657|10690802|P1|Adjuvant Chemotherapy|Death|2
3127539|NCT00033657|10690801|P2|Adjuvant Chemotherapy|Adverse Event|10
3127540|NCT00033657|10690802|P1|Adjuvant Chemotherapy|Adverse Event|7
3127541|NCT00033657|10690801|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
3127542|NCT00033657|10690802|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
3127543|NCT00033657|10690801|P2|Surgical Resection|not complete resection|3
3127544|NCT00033657|10690802|P1|Surgical Resection|not complete resection|0
3127545|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
3127546|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
3127547|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Ineligible|4
3127548|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Ineligible|8
3127549|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|other complicating disease|1
3127550|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|other complicating disease|0
3127551|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
3127552|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
3127553|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Death|1
3127554|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Death|1
3127555|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Adverse Event|2
3127556|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Adverse Event|0
3127557|NCT00033657|10690801|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
3127558|NCT00033657|10690802|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
3127559|NCT00033631|10690816|P2|Overall Study|Withdrawal by Subject|4
3127560|NCT00033631|10690817|P1|Overall Study|Withdrawal by Subject|4
3127561|NCT00033631|10690816|P2|Overall Study|Protocol Violation|11
3127562|NCT00033631|10690817|P1|Overall Study|Protocol Violation|14
3127563|NCT00033540|10690835|P1|Overall Study|Never received treatment|2
3127564|NCT00033540|10690835|P1|Overall Study|Ineligible|3
3127565|NCT00033540|10690835|P1|Overall Study|Other|5
3127566|NCT00033540|10690835|P1|Overall Study|Withdrawal by Subject|6
3127567|NCT00033540|10690835|P1|Overall Study|Progression|26
3127568|NCT00033540|10690835|P1|Overall Study|Death|1
3127569|NCT00033540|10690835|P1|Overall Study|Adverse Event|14
3127570|NCT00033514|10690845|P2|Overall Study|Withdrawal by Subject|3
3127571|NCT00033514|10690846|P1|Overall Study|Withdrawal by Subject|0
3127572|NCT00033514|10690845|P2|Overall Study|Lost to Follow-up|1
3127573|NCT00033514|10690846|P1|Overall Study|Lost to Follow-up|1
3127574|NCT00033371|10690856|P2|Overall Study|Disease Progression|1
3127575|NCT00033371|10690857|P1|Overall Study|Disease Progression|0
3127576|NCT00033371|10690856|P2|Overall Study|Withdrawal by Subject|3
3127577|NCT00033371|10690857|P1|Overall Study|Withdrawal by Subject|3
3127578|NCT00033371|10690856|P2|Overall Study|Lost to Follow-up|1
3127579|NCT00033371|10690857|P1|Overall Study|Lost to Follow-up|2
3127580|NCT00033371|10690856|P2|Overall Study|Adverse Event|5
3127581|NCT00033371|10690857|P1|Overall Study|Adverse Event|1
3127582|NCT00033293|10690865|P2|Overall Study|Treatment refused|6
3127583|NCT00033293|10690866|P1|Overall Study|Treatment refused|0
3127584|NCT00033293|10690865|P2|Overall Study|Could not be weaned from steroid therapy|1
3127585|NCT00033293|10690866|P1|Overall Study|Could not be weaned from steroid therapy|1
3127586|NCT00033293|10690865|P2|Overall Study|Withdrawal by Subject|0
3127587|NCT00033293|10690866|P1|Overall Study|Withdrawal by Subject|1
3127588|NCT00033293|10690865|P2|Overall Study|Physician Decision|1
3127589|NCT00033293|10690866|P1|Overall Study|Physician Decision|3
3127590|NCT00033293|10690865|P2|Overall Study|Lost to Follow-up|1
3127591|NCT00033293|10690866|P1|Overall Study|Lost to Follow-up|0
3127592|NCT00033293|10690865|P2|Overall Study|Lack of Efficacy|8
3127593|NCT00033293|10690866|P1|Overall Study|Lack of Efficacy|5
3127594|NCT00033293|10690865|P2|Overall Study|Death|1
3127595|NCT00033293|10690866|P1|Overall Study|Death|0
3127596|NCT00031694|10690884|P1|Overall Study|Withdrawal by Subject|5
3127597|NCT00031694|10690884|P1|Overall Study|Death|2
3127598|NCT00031694|10690884|P1|Overall Study|Adverse Event|12
3127599|NCT00031590|10690888|P1|Overall Study|Withdrawal by parents|2
3127600|NCT00031590|10690888|P1|Overall Study|Adverse Event|1
3127601|NCT00030901|10690895|P3|Randomization|Ineligible|14
3127602|NCT00030901|10690896|P2|Randomization|Ineligible|15
3127603|NCT00030901|10690897|P1|Randomization|Ineligible|0
3127604|NCT00030901|10690895|P3|Randomization|Other|33
3127605|NCT00030901|10690896|P2|Randomization|Other|36
3127606|NCT00030901|10690897|P1|Randomization|Other|0
3127607|NCT00030901|10690895|P3|Randomization|Death|3
3127608|NCT00030901|10690896|P2|Randomization|Death|1
3127609|NCT00030901|10690897|P1|Randomization|Death|0
3127610|NCT00030901|10690895|P3|Randomization|Progression/Relapse|21
3127611|NCT00030901|10690896|P2|Randomization|Progression/Relapse|22
3127612|NCT00030901|10690897|P1|Randomization|Progression/Relapse|0
3127613|NCT00030901|10690895|P3|Randomization|Refusal Unrelated to Adverse Event|10
3127614|NCT00030901|10690896|P2|Randomization|Refusal Unrelated to Adverse Event|16
3127615|NCT00030901|10690897|P1|Randomization|Refusal Unrelated to Adverse Event|0
3127616|NCT00030901|10690895|P3|Randomization|Adverse Event|7
3127617|NCT00030901|10690896|P2|Randomization|Adverse Event|11
3127618|NCT00030901|10690897|P1|Randomization|Adverse Event|0
3127619|NCT00030901|10690895|P3|Initial Registration|Ineligible|0
3127620|NCT00030901|10690896|P2|Initial Registration|Ineligible|0
3127621|NCT00030901|10690897|P1|Initial Registration|Ineligible|167
3127622|NCT00030823|10690905|P1|Overall Study|Withdrawal by Subject|1
3127623|NCT00028769|10690913|P1|Overall Study|Not Analyzable|1
3127624|NCT00028769|10690913|P1|Overall Study|Ineligible|5
3127625|NCT00028769|10690913|P1|Overall Study|Other - Not Protocol Specified|1
3127626|NCT00028769|10690913|P1|Overall Study|Progression or Death|31
3127627|NCT00028769|10690913|P1|Overall Study|Refusal Unrelated to Adverse Events|1
3127628|NCT00028769|10690913|P1|Overall Study|Adverse Event|2
3127629|NCT00028002|10690919|P1|Overall Study|Ineligible|8
3127630|NCT00028002|10690919|P1|Overall Study|Withdrawal by Subject|3
3127631|NCT00027846|10690929|P3|Overall Study|Neuraxis dissemination during/after ther|5
3127632|NCT00027846|10690930|P2|Overall Study|Neuraxis dissemination during/after ther|2
3127633|NCT00027846|10690931|P1|Overall Study|Neuraxis dissemination during/after ther|0
3127634|NCT00027846|10690929|P3|Overall Study|Entry into another COG therapeutic study|2
3127635|NCT00027846|10690930|P2|Overall Study|Entry into another COG therapeutic study|5
3127636|NCT00027846|10690931|P1|Overall Study|Entry into another COG therapeutic study|0
3127637|NCT00027846|10690929|P3|Overall Study|Ineligible for study|14
3127638|NCT00027846|10690930|P2|Overall Study|Ineligible for study|6
3127639|NCT00027846|10690931|P1|Overall Study|Ineligible for study|2
3127640|NCT00027846|10690929|P3|Overall Study|Withdrawal by Subject|7
3127641|NCT00027846|10690930|P2|Overall Study|Withdrawal by Subject|14
3127642|NCT00027846|10690931|P1|Overall Study|Withdrawal by Subject|0
3127643|NCT00027846|10690929|P3|Overall Study|Lost to Follow-up|9
3127644|NCT00027846|10690930|P2|Overall Study|Lost to Follow-up|41
3127645|NCT00027846|10690931|P1|Overall Study|Lost to Follow-up|0
3127646|NCT00027560|10690949|P1|Overall Study|Withdrawal by Subject|1
3127647|NCT00026494|10690962|P4|Overall Study|Clinical progression|0
3127648|NCT00026494|10690963|P3|Overall Study|Clinical progression|3
3127649|NCT00026494|10690964|P2|Overall Study|Clinical progression|0
3127650|NCT00026494|10690965|P1|Overall Study|Clinical progression|0
3127651|NCT00026494|10690962|P4|Overall Study|Patient not treated|0
3127652|NCT00026494|10690963|P3|Overall Study|Patient not treated|2
3127653|NCT00026494|10690964|P2|Overall Study|Patient not treated|0
3127654|NCT00026494|10690965|P1|Overall Study|Patient not treated|0
3127655|NCT00026494|10690962|P4|Overall Study|Patient non-compliance|0
3127656|NCT00026494|10690963|P3|Overall Study|Patient non-compliance|0
3127657|NCT00026494|10690964|P2|Overall Study|Patient non-compliance|0
3127658|NCT00026494|10690965|P1|Overall Study|Patient non-compliance|1
3127659|NCT00026494|10690962|P4|Overall Study|Withdrawal by Subject|0
3127660|NCT00026494|10690963|P3|Overall Study|Withdrawal by Subject|1
3127661|NCT00026494|10690964|P2|Overall Study|Withdrawal by Subject|0
3127662|NCT00026494|10690965|P1|Overall Study|Withdrawal by Subject|1
3127663|NCT00026312|10690977|P2|Overall Study|Refusal by patient/parent/guardian|59
3127664|NCT00026312|10690978|P1|Overall Study|Refusal by patient/parent/guardian|8
3127665|NCT00026312|10690977|P2|Overall Study|Entry onto another COG study|1
3127666|NCT00026312|10690978|P1|Overall Study|Entry onto another COG study|0
3127667|NCT00026312|10690977|P2|Overall Study|Ineligible|5
3127668|NCT00026312|10690978|P1|Overall Study|Ineligible|4
3127669|NCT00026312|10690977|P2|Overall Study|Withdrawal by Subject|6
3127670|NCT00026312|10690978|P1|Overall Study|Withdrawal by Subject|1
3127671|NCT00026312|10690977|P2|Overall Study|Protocol Violation|3
3127672|NCT00026312|10690978|P1|Overall Study|Protocol Violation|0
3127673|NCT00026312|10690977|P2|Overall Study|Physician Decision|37
3127674|NCT00026312|10690978|P1|Overall Study|Physician Decision|1
3127675|NCT00026312|10690977|P2|Overall Study|Lost to Follow-up|5
3127676|NCT00026312|10690978|P1|Overall Study|Lost to Follow-up|0
3127677|NCT00026312|10690977|P2|Overall Study|Lack of Efficacy|114
3127678|NCT00026312|10690978|P1|Overall Study|Lack of Efficacy|19
3127679|NCT00026312|10690977|P2|Overall Study|Death|7
3127680|NCT00026312|10690978|P1|Overall Study|Death|1
3127681|NCT00026312|10690977|P2|Overall Study|Adverse Event|32
3127682|NCT00026312|10690978|P1|Overall Study|Adverse Event|0
3127683|NCT00026208|10691017|P2|Overall Study|Complications of auto accident|0
3127684|NCT00026208|10691018|P1|Overall Study|Complications of auto accident|1
3127685|NCT00025662|10691036|P1|Overall Study|Technical failure of manipulation|1
3127686|NCT00025662|10691036|P1|Overall Study|Withdrawal by Subject|2
3127687|NCT00025506|10691044|P1|Overall Study|Never Treated|2
3127688|NCT00025506|10691044|P1|Overall Study|Ineligible: inadequate pathology|2
3127689|NCT00025506|10691044|P1|Overall Study|Ineligible: wrong cell type|5
3127690|NCT00025506|10691044|P1|Overall Study|Ineligible: clerical error|1
3127691|NCT00025259|10691065|P7|Overall Study|Adverse Event|0
3127692|NCT00025259|10691066|P6|Overall Study|Adverse Event|0
3127693|NCT00025259|10691067|P5|Overall Study|Adverse Event|0
3127694|NCT00025259|10691068|P4|Overall Study|Adverse Event|0
3127695|NCT00025259|10691069|P3|Overall Study|Adverse Event|0
3127696|NCT00025259|10691070|P2|Overall Study|Adverse Event|0
3127697|NCT00025259|10691071|P1|Overall Study|Adverse Event|1
3127698|NCT00025259|10691065|P7|Overall Study|Randomization error|2
3127699|NCT00025259|10691066|P6|Overall Study|Randomization error|7
3127700|NCT00025259|10691067|P5|Overall Study|Randomization error|1
3127701|NCT00025259|10691068|P4|Overall Study|Randomization error|0
3127702|NCT00025259|10691069|P3|Overall Study|Randomization error|0
3127703|NCT00025259|10691070|P2|Overall Study|Randomization error|0
3127704|NCT00025259|10691071|P1|Overall Study|Randomization error|1
3127705|NCT00025259|10691065|P7|Overall Study|Ineligible|1
3127706|NCT00025259|10691066|P6|Overall Study|Ineligible|0
3127707|NCT00025259|10691067|P5|Overall Study|Ineligible|6
3127708|NCT00025259|10691068|P4|Overall Study|Ineligible|0
3127709|NCT00025259|10691069|P3|Overall Study|Ineligible|0
3127710|NCT00025259|10691070|P2|Overall Study|Ineligible|1
3127711|NCT00025259|10691071|P1|Overall Study|Ineligible|14
3127712|NCT00025259|10691065|P7|Overall Study|Withdrawal by Subject|3
3127713|NCT00025259|10691066|P6|Overall Study|Withdrawal by Subject|8
3127714|NCT00025259|10691067|P5|Overall Study|Withdrawal by Subject|11
3127715|NCT00025259|10691068|P4|Overall Study|Withdrawal by Subject|14
3127716|NCT00025259|10691069|P3|Overall Study|Withdrawal by Subject|6
3127717|NCT00025259|10691070|P2|Overall Study|Withdrawal by Subject|27
3127718|NCT00025259|10691071|P1|Overall Study|Withdrawal by Subject|9
3127719|NCT00025259|10691065|P7|Overall Study|Protocol Violation|3
3127720|NCT00025259|10691066|P6|Overall Study|Protocol Violation|1
3127721|NCT00025259|10691067|P5|Overall Study|Protocol Violation|2
3127722|NCT00025259|10691068|P4|Overall Study|Protocol Violation|1
3127723|NCT00025259|10691069|P3|Overall Study|Protocol Violation|2
3127724|NCT00025259|10691070|P2|Overall Study|Protocol Violation|2
3127725|NCT00025259|10691071|P1|Overall Study|Protocol Violation|3
3127726|NCT00025259|10691065|P7|Overall Study|Physician Decision|1
3127727|NCT00025259|10691066|P6|Overall Study|Physician Decision|2
3127728|NCT00025259|10691067|P5|Overall Study|Physician Decision|4
3127729|NCT00025259|10691068|P4|Overall Study|Physician Decision|5
3127730|NCT00025259|10691069|P3|Overall Study|Physician Decision|0
3127731|NCT00025259|10691070|P2|Overall Study|Physician Decision|1
3127732|NCT00025259|10691071|P1|Overall Study|Physician Decision|12
3127733|NCT00025259|10691065|P7|Overall Study|Lost to Follow-up|1
3127734|NCT00025259|10691066|P6|Overall Study|Lost to Follow-up|3
3127735|NCT00025259|10691067|P5|Overall Study|Lost to Follow-up|1
3127736|NCT00025259|10691068|P4|Overall Study|Lost to Follow-up|13
3127737|NCT00025259|10691069|P3|Overall Study|Lost to Follow-up|13
3127738|NCT00025259|10691070|P2|Overall Study|Lost to Follow-up|9
3127739|NCT00025259|10691071|P1|Overall Study|Lost to Follow-up|2
3127740|NCT00025259|10691065|P7|Overall Study|Lack of Efficacy|38
3127741|NCT00025259|10691066|P6|Overall Study|Lack of Efficacy|30
3127742|NCT00025259|10691067|P5|Overall Study|Lack of Efficacy|11
3127743|NCT00025259|10691068|P4|Overall Study|Lack of Efficacy|78
3127744|NCT00025259|10691069|P3|Overall Study|Lack of Efficacy|60
3127745|NCT00025259|10691070|P2|Overall Study|Lack of Efficacy|46
3127746|NCT00025259|10691071|P1|Overall Study|Lack of Efficacy|2
3127747|NCT00025259|10691065|P7|Overall Study|Death|2
3127748|NCT00025259|10691066|P6|Overall Study|Death|1
3127749|NCT00025259|10691067|P5|Overall Study|Death|0
3127750|NCT00025259|10691068|P4|Overall Study|Death|3
3127751|NCT00025259|10691069|P3|Overall Study|Death|0
3127752|NCT00025259|10691070|P2|Overall Study|Death|3
3127753|NCT00025259|10691071|P1|Overall Study|Death|1
3127754|NCT00025233|10691107|P1|Overall Study|Never treated|1
3127755|NCT00025233|10691107|P1|Overall Study|Ineligible: improper prior treatment|1
3127756|NCT00025233|10691107|P1|Overall Study|Ineligible: wrong primary|1
3127757|NCT00025233|10691107|P1|Overall Study|Ineligible: wrong cell type|1
3127758|NCT00025155|10691122|P1|Overall Study|Ineligible: Second primary cancer site|1
3127759|NCT00025155|10691122|P1|Overall Study|Ineligible: Wrong primary cancer site|1
3127760|NCT00024258|10691133|P1|Overall Study|Disease Progression|8
3127761|NCT00024258|10691133|P1|Overall Study|Withdrawal by Subject|1
3127762|NCT00024167|10691140|P2|Overall Study|Death|47
3127763|NCT00024167|10691141|P1|Overall Study|Death|53
3127764|NCT00023764|10691165|P1|Overall Study|delay in obtaining staging images|1
3127765|NCT00023764|10691165|P1|Overall Study|patient received other treatment|1
3127766|NCT00023764|10691165|P1|Overall Study|Progression of disease|6
3127767|NCT00023764|10691165|P1|Overall Study|Withdrawal by Subject|1
3127768|NCT00023764|10691165|P1|Overall Study|Adverse Event|4
3127769|NCT00023764|10691165|P1|Overall Study|Other|1
3127770|NCT00023712|10691172|P2|Overall Study|Never treated|1
3127771|NCT00023712|10691173|P1|Overall Study|Never treated|1
3127772|NCT00023712|10691172|P2|Overall Study|Not platinum sensitive|0
3127773|NCT00023712|10691173|P1|Overall Study|Not platinum sensitive|1
3127774|NCT00022698|10691197|P2|Overall Study|Administrative /other|7
3127775|NCT00022698|10691198|P1|Overall Study|Administrative /other|1
3127776|NCT00022698|10691197|P2|Overall Study|Insufficient therapeutic response|14
3127777|NCT00022698|10691198|P1|Overall Study|Insufficient therapeutic response|2
3127778|NCT00022698|10691197|P2|Overall Study|Refused treatment|2
3127779|NCT00022698|10691198|P1|Overall Study|Refused treatment|0
3127780|NCT00022698|10691197|P2|Overall Study|Failure to return|1
3127781|NCT00022698|10691198|P1|Overall Study|Failure to return|0
3127782|NCT00022698|10691197|P2|Overall Study|Death|2
3127783|NCT00022698|10691198|P1|Overall Study|Death|0
3127784|NCT00022698|10691197|P2|Overall Study|Adverse Event|9
3127785|NCT00022698|10691198|P1|Overall Study|Adverse Event|5
3127786|NCT00022672|10691223|P2|Extension Phase|Other|1
3127787|NCT00022672|10691224|P1|Extension Phase|Other|1
3127788|NCT00022672|10691223|P2|Extension Phase|Refused Treatment|2
3127789|NCT00022672|10691224|P1|Extension Phase|Refused Treatment|0
3127790|NCT00022672|10691223|P2|Extension Phase|Insufficient Therapeutic Response|44
3127791|NCT00022672|10691224|P1|Extension Phase|Insufficient Therapeutic Response|1
3127792|NCT00022672|10691223|P2|Extension Phase|Death|1
3127793|NCT00022672|10691224|P1|Extension Phase|Death|0
3127794|NCT00022672|10691223|P2|Extension Phase|Adverse Event|3
3127795|NCT00022672|10691224|P1|Extension Phase|Adverse Event|1
3127796|NCT00022672|10691223|P2|Main Phase: 24 Months|Other|0
3127797|NCT00022672|10691224|P1|Main Phase: 24 Months|Other|1
3127798|NCT00022672|10691223|P2|Main Phase: 24 Months|Failure to Return|1
3127799|NCT00022672|10691224|P1|Main Phase: 24 Months|Failure to Return|1
3127800|NCT00022672|10691223|P2|Main Phase: 24 Months|Refused Treatment|4
3127801|NCT00022672|10691224|P1|Main Phase: 24 Months|Refused Treatment|3
3127802|NCT00022672|10691223|P2|Main Phase: 24 Months|Other Protocol Violation|0
3127803|NCT00022672|10691224|P1|Main Phase: 24 Months|Other Protocol Violation|1
3127804|NCT00022672|10691223|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
3127805|NCT00022672|10691224|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
3127806|NCT00022672|10691223|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
3127807|NCT00022672|10691224|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
3127808|NCT00022672|10691223|P2|Main Phase: 24 Months|Death|3
3127809|NCT00022672|10691224|P1|Main Phase: 24 Months|Death|0
3127810|NCT00022672|10691223|P2|Main Phase: 24 Months|Adverse Event|0
3127811|NCT00022672|10691224|P1|Main Phase: 24 Months|Adverse Event|6
3127812|NCT00022659|10691257|P1|Overall Study|Never treated|1
3127813|NCT00022659|10691257|P1|Overall Study|Ineligible: wrong primary|1
3127814|NCT00022633|10691270|P2|Overall Study|Ineligible|0
3127815|NCT00022633|10691271|P1|Overall Study|Ineligible|4
3127816|NCT00022633|10691270|P2|Overall Study|Other - not protocol specified|2
3127817|NCT00022633|10691271|P1|Overall Study|Other - not protocol specified|3
3127818|NCT00022633|10691270|P2|Overall Study|Death|0
3127819|NCT00022633|10691271|P1|Overall Study|Death|4
3127820|NCT00022633|10691270|P2|Overall Study|Progression/relapse|2
3127821|NCT00022633|10691271|P1|Overall Study|Progression/relapse|9
3127822|NCT00022633|10691270|P2|Overall Study|Refusal unrelated to adverse event|0
3127823|NCT00022633|10691271|P1|Overall Study|Refusal unrelated to adverse event|1
3127824|NCT00022633|10691270|P2|Overall Study|Adverse Event|1
3127825|NCT00022633|10691271|P1|Overall Study|Adverse Event|11
3127826|NCT00022516|10691284|P2|Overall Study|Incomplete documentation|27
3127827|NCT00022516|10691285|P1|Overall Study|Incomplete documentation|0
3127828|NCT00022516|10691284|P2|Overall Study|Withdrawal by Subject|113
3127829|NCT00022516|10691285|P1|Overall Study|Withdrawal by Subject|2
3127830|NCT00022516|10691284|P2|Overall Study|Protocol Violation|3
3127831|NCT00022516|10691285|P1|Overall Study|Protocol Violation|1
3127832|NCT00022516|10691284|P2|Overall Study|Physician Decision|1
3127833|NCT00022516|10691285|P1|Overall Study|Physician Decision|0
3127834|NCT00022516|10691284|P2|Overall Study|Lack of Efficacy|27
3127835|NCT00022516|10691285|P1|Overall Study|Lack of Efficacy|0
3127836|NCT00022516|10691284|P2|Overall Study|Adverse Event|59
3127837|NCT00022516|10691285|P1|Overall Study|Adverse Event|0
3127838|NCT00021255|10691304|P3|Overall Study|Randomized but not treated|18
3127839|NCT00021255|10691305|P2|Overall Study|Randomized but not treated|2
3127840|NCT00021255|10691306|P1|Overall Study|Randomized but not treated|28
3127841|NCT00021255|10691304|P3|Overall Study|Missing|13
3127842|NCT00021255|10691305|P2|Overall Study|Missing|27
3127843|NCT00021255|10691306|P1|Overall Study|Missing|0
3127844|NCT00021255|10691304|P3|Overall Study|Other than specified above|19
3127845|NCT00021255|10691305|P2|Overall Study|Other than specified above|38
3127846|NCT00021255|10691306|P1|Overall Study|Other than specified above|0
3127847|NCT00021255|10691304|P3|Overall Study|Protocol Violation|0
3127848|NCT00021255|10691305|P2|Overall Study|Protocol Violation|2
3127849|NCT00021255|10691306|P1|Overall Study|Protocol Violation|0
3127850|NCT00021255|10691304|P3|Overall Study|Adverse Event|18
3127851|NCT00021255|10691305|P2|Overall Study|Adverse Event|30
3127852|NCT00021255|10691306|P1|Overall Study|Adverse Event|46
3127853|NCT00021255|10691304|P3|Overall Study|Herceptin toxicity|6
3127854|NCT00021255|10691305|P2|Overall Study|Herceptin toxicity|22
3127855|NCT00021255|10691306|P1|Overall Study|Herceptin toxicity|0
3127856|NCT00021255|10691304|P3|Overall Study|Cardiac toxicity|32
3127857|NCT00021255|10691305|P2|Overall Study|Cardiac toxicity|61
3127858|NCT00021255|10691306|P1|Overall Study|Cardiac toxicity|0
3127859|NCT00021255|10691304|P3|Overall Study|Lost to Follow-up|3
3127860|NCT00021255|10691305|P2|Overall Study|Lost to Follow-up|2
3127861|NCT00021255|10691306|P1|Overall Study|Lost to Follow-up|0
3127862|NCT00021255|10691304|P3|Overall Study|Withdrawal by Subject|26
3127863|NCT00021255|10691305|P2|Overall Study|Withdrawal by Subject|64
3127864|NCT00021255|10691306|P1|Overall Study|Withdrawal by Subject|41
3127865|NCT00021255|10691304|P3|Overall Study|Second primary malignancy|1
3127866|NCT00021255|10691305|P2|Overall Study|Second primary malignancy|4
3127867|NCT00021255|10691306|P1|Overall Study|Second primary malignancy|0
3127868|NCT00021255|10691304|P3|Overall Study|Breast cancer relapse|11
3127869|NCT00021255|10691305|P2|Overall Study|Breast cancer relapse|18
3127870|NCT00021255|10691306|P1|Overall Study|Breast cancer relapse|5
3127871|NCT00021255|10691304|P3|Overall Study|Death|2
3127872|NCT00021255|10691305|P2|Overall Study|Death|0
3127873|NCT00021255|10691306|P1|Overall Study|Death|1
3127874|NCT00021229|10691323|P3|Overall Study|Punctate hemmorrhage post RT|0
3127875|NCT00021229|10691324|P2|Overall Study|Punctate hemmorrhage post RT|0
3127876|NCT00021229|10691325|P1|Overall Study|Punctate hemmorrhage post RT|2
3127877|NCT00021229|10691323|P3|Overall Study|Physician Decision|1
3127878|NCT00021229|10691324|P2|Overall Study|Physician Decision|0
3127879|NCT00021229|10691325|P1|Overall Study|Physician Decision|0
3127880|NCT00021229|10691323|P3|Overall Study|Protocol Violation|0
3127881|NCT00021229|10691324|P2|Overall Study|Protocol Violation|1
3127882|NCT00021229|10691325|P1|Overall Study|Protocol Violation|1
3127883|NCT00021229|10691323|P3|Overall Study|Progressive Disease|12
3127884|NCT00021229|10691324|P2|Overall Study|Progressive Disease|19
3127885|NCT00021229|10691325|P1|Overall Study|Progressive Disease|15
3127886|NCT00021229|10691323|P3|Overall Study|Withdrawal by Subject|1
3127887|NCT00021229|10691324|P2|Overall Study|Withdrawal by Subject|7
3127888|NCT00021229|10691325|P1|Overall Study|Withdrawal by Subject|7
3127889|NCT00021229|10691323|P3|Overall Study|Death|0
3127890|NCT00021229|10691324|P2|Overall Study|Death|1
3127891|NCT00021229|10691325|P1|Overall Study|Death|0
3127892|NCT00021229|10691323|P3|Overall Study|Adverse Event|2
3127893|NCT00021229|10691324|P2|Overall Study|Adverse Event|5
3127894|NCT00021229|10691325|P1|Overall Study|Adverse Event|10
3127895|NCT00019604|10691380|P1|Overall Study|Details for other not available|4
3127896|NCT00019604|10691380|P1|Overall Study|Unable to evaluate|1
3127897|NCT00019604|10691380|P1|Overall Study|Too much disease|1
3127898|NCT00019604|10691380|P1|Overall Study|Pt going to immunotherapy study|1
3127899|NCT00019604|10691380|P1|Overall Study|Started new chemo regimen|1
3127900|NCT00019604|10691380|P1|Overall Study|Resectable disease|1
3127901|NCT00019604|10691380|P1|Overall Study|Non compliant|1
3127902|NCT00019604|10691380|P1|Overall Study|Non compliant on systemic CH|1
3127903|NCT00019604|10691380|P1|Overall Study|Move to a different study|1
3127904|NCT00019604|10691380|P1|Overall Study|Going to have liver transplant|1
3127905|NCT00019604|10691380|P1|Overall Study|Carcinoid tumor, not treatable|1
3127906|NCT00019604|10691380|P1|Overall Study|Refused treatment|1
3127907|NCT00019604|10691380|P1|Overall Study|Progressive disease|23
3127908|NCT00019604|10691380|P1|Overall Study|Death|1
3127909|NCT00016354|10691403|P8|Overall Study|Lack of Efficacy|1
3127910|NCT00016354|10691404|P7|Overall Study|Lack of Efficacy|0
3127911|NCT00016354|10691405|P6|Overall Study|Lack of Efficacy|0
3127912|NCT00016354|10691406|P5|Overall Study|Lack of Efficacy|0
3127913|NCT00016354|10691407|P4|Overall Study|Lack of Efficacy|0
3127914|NCT00016354|10691408|P3|Overall Study|Lack of Efficacy|0
3127915|NCT00016354|10691409|P2|Overall Study|Lack of Efficacy|0
3127916|NCT00016354|10691410|P1|Overall Study|Lack of Efficacy|0
3127917|NCT00014495|10691424|P4|Overall Study|Clinical deterioration|1
3127918|NCT00014495|10691425|P3|Overall Study|Clinical deterioration|0
3127919|NCT00014495|10691426|P2|Overall Study|Clinical deterioration|0
3127920|NCT00014495|10691427|P1|Overall Study|Clinical deterioration|0
3127921|NCT00014495|10691424|P4|Overall Study|Death|0
3127922|NCT00014495|10691425|P3|Overall Study|Death|1
3127923|NCT00014495|10691426|P2|Overall Study|Death|0
3127924|NCT00014495|10691427|P1|Overall Study|Death|0
3127925|NCT00012012|10691493|P2|Overall Study|Withdrawal by Subject|2
3127926|NCT00012012|10691494|P1|Overall Study|Withdrawal by Subject|0
3127927|NCT00012012|10691493|P2|Overall Study|Protocol Violation|1
3127928|NCT00012012|10691494|P1|Overall Study|Protocol Violation|1
3127929|NCT00010257|10691533|P2|Overall Study|Withdrawal by Subject|0
3127930|NCT00010257|10691534|P1|Overall Study|Withdrawal by Subject|1
3127931|NCT00009945|10691544|P2|Overall Study|no follow up data|5
3127932|NCT00009945|10691545|P1|Overall Study|no follow up data|7
3127933|NCT00008385|10691561|P2|Overall Study|Not start protocol therapy|175
3127934|NCT00008385|10691562|P1|Overall Study|Not start protocol therapy|44
3127935|NCT00008385|10691561|P2|Overall Study|Other|212
3127936|NCT00008385|10691562|P1|Overall Study|Other|105
3127937|NCT00008385|10691561|P2|Overall Study|Maximum dose reached|2
3127938|NCT00008385|10691562|P1|Overall Study|Maximum dose reached|0
3127939|NCT00008385|10691561|P2|Overall Study|Other complicating disease|30
3127940|NCT00008385|10691562|P1|Overall Study|Other complicating disease|17
3127941|NCT00008385|10691561|P2|Overall Study|Start non-protocol therapy|1
3127942|NCT00008385|10691562|P1|Overall Study|Start non-protocol therapy|3
3127943|NCT00008385|10691561|P2|Overall Study|Withdrawal by Subject|157
3127944|NCT00008385|10691562|P1|Overall Study|Withdrawal by Subject|67
3127945|NCT00008385|10691561|P2|Overall Study|Death|18
3127946|NCT00008385|10691562|P1|Overall Study|Death|12
3127947|NCT00008385|10691561|P2|Overall Study|Adverse Event|20
3127948|NCT00008385|10691562|P1|Overall Study|Adverse Event|8
3127949|NCT00008385|10691561|P2|Overall Study|Progressive disease|117
3127950|NCT00008385|10691562|P1|Overall Study|Progressive disease|52
3127951|NCT00008385|10691561|P2|Overall Study|Off treatment reasons not reported|70
3127952|NCT00008385|10691562|P1|Overall Study|Off treatment reasons not reported|79
3127953|NCT00008138|10691572|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
3127954|NCT00008138|10691572|P1|Post-Cytoreduction Chemotherapy|Progression|1
3127955|NCT00008138|10691572|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
3127956|NCT00008138|10691572|P1|Interval Debulking|Withdrawal by Subject|2
3127957|NCT00008138|10691572|P1|Neoadjuvant Chemotherapy|not protocol specified|8
3127958|NCT00008138|10691572|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
3127959|NCT00008138|10691572|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
3127960|NCT00008138|10691572|P1|Neoadjuvant Chemotherapy|Adverse Event|3
3127961|NCT00006916|10691578|P1|Overall Study|Complication of device insertion|1
3127962|NCT00006916|10691578|P1|Overall Study|Device not inserted|4
3127963|NCT00006903|10691584|P3|Overall Study|Ineligible|2
3127964|NCT00006903|10691585|P2|Overall Study|Ineligible|1
3127965|NCT00006903|10691586|P1|Overall Study|Ineligible|10
3127966|NCT00006903|10691584|P3|Overall Study|Patient never treated|1
3127967|NCT00006903|10691585|P2|Overall Study|Patient never treated|0
3127968|NCT00006903|10691586|P1|Overall Study|Patient never treated|0
3127969|NCT00006903|10691584|P3|Overall Study|Death|0
3127970|NCT00006903|10691585|P2|Overall Study|Death|1
3127971|NCT00006903|10691586|P1|Overall Study|Death|0
3127972|NCT00006903|10691584|P3|Overall Study|Adverse Event|1
3127973|NCT00006903|10691585|P2|Overall Study|Adverse Event|0
3127974|NCT00006903|10691586|P1|Overall Study|Adverse Event|0
3127975|NCT00006903|10691584|P3|Overall Study|Refused further treatment|1
3127976|NCT00006903|10691585|P2|Overall Study|Refused further treatment|2
3127977|NCT00006903|10691586|P1|Overall Study|Refused further treatment|0
3127978|NCT00006903|10691584|P3|Overall Study|Still receiving treatment|1
3127979|NCT00006903|10691585|P2|Overall Study|Still receiving treatment|0
3127980|NCT00006903|10691586|P1|Overall Study|Still receiving treatment|0
3127981|NCT00006721|10691599|P3|Overall Study|Eligible but no Treatment Received|0
3127982|NCT00006721|10691600|P2|Overall Study|Eligible but no Treatment Received|0
3127983|NCT00006721|10691601|P1|Overall Study|Eligible but no Treatment Received|1
3127984|NCT00006721|10691599|P3|Overall Study|Ineligible|10
3127985|NCT00006721|10691600|P2|Overall Study|Ineligible|12
3127986|NCT00006721|10691601|P1|Overall Study|Ineligible|2
3127987|NCT00006721|10691599|P3|Overall Study|Other - Not Protocol Specified|7
3127988|NCT00006721|10691600|P2|Overall Study|Other - Not Protocol Specified|7
3127989|NCT00006721|10691601|P1|Overall Study|Other - Not Protocol Specified|0
3127990|NCT00006721|10691599|P3|Overall Study|Death|2
3127991|NCT00006721|10691600|P2|Overall Study|Death|1
3127992|NCT00006721|10691601|P1|Overall Study|Death|0
3127993|NCT00006721|10691599|P3|Overall Study|Progression/Relapse|2
3127994|NCT00006721|10691600|P2|Overall Study|Progression/Relapse|1
3127995|NCT00006721|10691601|P1|Overall Study|Progression/Relapse|0
3127996|NCT00006721|10691599|P3|Overall Study|Refusal Unrelated to Adverse Event|8
3127997|NCT00006721|10691600|P2|Overall Study|Refusal Unrelated to Adverse Event|0
3127998|NCT00006721|10691601|P1|Overall Study|Refusal Unrelated to Adverse Event|1
3127999|NCT00006721|10691599|P3|Overall Study|Adverse Event|4
3128000|NCT00006721|10691600|P2|Overall Study|Adverse Event|4
3128001|NCT00006721|10691601|P1|Overall Study|Adverse Event|0
3128002|NCT00006478|10691619|P1|Overall Study|Physician Decision|6
3128003|NCT00006478|10691619|P1|Overall Study|Vaccine could not be produced|1
3128004|NCT00006392|10691630|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
3128005|NCT00006392|10691631|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
3128006|NCT00006392|10691632|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
3128007|NCT00006392|10691633|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
3128008|NCT00006392|10691630|P4|Overall Study|Ineligible|5
3128009|NCT00006392|10691631|P3|Overall Study|Ineligible|5
3128010|NCT00006392|10691632|P2|Overall Study|Ineligible|3
3128011|NCT00006392|10691633|P1|Overall Study|Ineligible|11
3128012|NCT00006389|10691663|P1|Overall Study|Adverse Event|1
3128013|NCT00006237|10691680|P2|Overall Study|Not protocol specified|5
3128014|NCT00006237|10691681|P1|Overall Study|Not protocol specified|14
3128015|NCT00006237|10691680|P2|Overall Study|Withdrawal by Subject|1
3128016|NCT00006237|10691681|P1|Overall Study|Withdrawal by Subject|0
3128017|NCT00006237|10691680|P2|Overall Study|Not eligible|20
3128018|NCT00006237|10691681|P1|Overall Study|Not eligible|9
3128019|NCT00006237|10691680|P2|Overall Study|Progression/relapse|2
3128020|NCT00006237|10691681|P1|Overall Study|Progression/relapse|54
3128021|NCT00006237|10691680|P2|Overall Study|Refusal unrelated to adverse effects|4
3128022|NCT00006237|10691681|P1|Overall Study|Refusal unrelated to adverse effects|8
3128023|NCT00006237|10691680|P2|Overall Study|Death|0
3128024|NCT00006237|10691681|P1|Overall Study|Death|1
3128025|NCT00006237|10691680|P2|Overall Study|Adverse Event|29
3128026|NCT00006237|10691681|P1|Overall Study|Adverse Event|39
3128027|NCT00006011|10691724|P3|Overall Study|Ineligible|9
3128028|NCT00006011|10691725|P2|Overall Study|Ineligible|16
3128029|NCT00006011|10691726|P1|Overall Study|Ineligible|18
3128030|NCT00006011|10691724|P3|Overall Study|Other|5
3128031|NCT00006011|10691725|P2|Overall Study|Other|2
3128032|NCT00006011|10691726|P1|Overall Study|Other|4
3128033|NCT00006011|10691724|P3|Overall Study|Death|2
3128034|NCT00006011|10691725|P2|Overall Study|Death|1
3128035|NCT00006011|10691726|P1|Overall Study|Death|0
3128036|NCT00006011|10691724|P3|Overall Study|Adverse Event|5
3128037|NCT00006011|10691725|P2|Overall Study|Adverse Event|39
3128038|NCT00006011|10691726|P1|Overall Study|Adverse Event|15
3128039|NCT00006011|10691724|P3|Overall Study|Refused further treatment|26
3128040|NCT00006011|10691725|P2|Overall Study|Refused further treatment|13
3128041|NCT00006011|10691726|P1|Overall Study|Refused further treatment|15
3128042|NCT00006011|10691724|P3|Overall Study|Disease progression|26
3128043|NCT00006011|10691725|P2|Overall Study|Disease progression|6
3128044|NCT00006011|10691726|P1|Overall Study|Disease progression|13
3128045|NCT00005957|10691734|P2|Overall Study|Crossover to the other arm|19
3128046|NCT00005957|10691735|P1|Overall Study|Crossover to the other arm|5
3128047|NCT00005957|10691734|P2|Overall Study|No treated|9
3128048|NCT00005957|10691735|P1|Overall Study|No treated|3
3128049|NCT00005879|10691745|P2|Overall Study|Withdrawal by Subject|10
3128050|NCT00005879|10691746|P1|Overall Study|Withdrawal by Subject|8
3128051|NCT00005047|10691769|P4|Overall Study|Lack of Efficacy|0
3128052|NCT00005047|10691770|P3|Overall Study|Lack of Efficacy|0
3128053|NCT00005047|10691771|P2|Overall Study|Lack of Efficacy|0
3128054|NCT00005047|10691772|P1|Overall Study|Lack of Efficacy|1
3128055|NCT00005047|10691769|P4|Overall Study|Lost to Follow-up|0
3128056|NCT00005047|10691770|P3|Overall Study|Lost to Follow-up|0
3128057|NCT00005047|10691771|P2|Overall Study|Lost to Follow-up|0
3128058|NCT00005047|10691772|P1|Overall Study|Lost to Follow-up|1
3128059|NCT00005047|10691769|P4|Overall Study|Adverse Event|0
3128060|NCT00005047|10691770|P3|Overall Study|Adverse Event|0
3128061|NCT00005047|10691771|P2|Overall Study|Adverse Event|0
3128062|NCT00005047|10691772|P1|Overall Study|Adverse Event|5
3128063|NCT00005047|10691769|P4|Overall Study|Withdrawal by Subject|0
3128064|NCT00005047|10691770|P3|Overall Study|Withdrawal by Subject|0
3128065|NCT00005047|10691771|P2|Overall Study|Withdrawal by Subject|0
3128066|NCT00005047|10691772|P1|Overall Study|Withdrawal by Subject|12
3128067|NCT00005044|10691788|P2|Overall Study|No protocol treatment|1
3128068|NCT00005044|10691789|P1|Overall Study|No protocol treatment|0
3128069|NCT00005044|10691788|P2|Overall Study|Withdrawal by Subject|5
3128070|NCT00005044|10691789|P1|Overall Study|Withdrawal by Subject|1
3128071|NCT00005044|10691788|P2|Overall Study|Protocol Violation|46
3128072|NCT00005044|10691789|P1|Overall Study|Protocol Violation|37
3128073|NCT00004888|10691809|P2|Overall Study|Toxic death|0
3128074|NCT00004888|10691810|P1|Overall Study|Toxic death|1
3128075|NCT00004888|10691809|P2|Overall Study|Death without progressive disease|1
3128076|NCT00004888|10691810|P1|Overall Study|Death without progressive disease|0
3128077|NCT00004888|10691809|P2|Overall Study|Progressive Disease|9
3128078|NCT00004888|10691810|P1|Overall Study|Progressive Disease|4
3128079|NCT00004888|10691809|P2|Overall Study|Physician Decision|1
3128080|NCT00004888|10691810|P1|Overall Study|Physician Decision|1
3128081|NCT00004888|10691809|P2|Overall Study|Withdrawal by Subject|3
3128082|NCT00004888|10691810|P1|Overall Study|Withdrawal by Subject|0
3128083|NCT00004888|10691809|P2|Overall Study|Adverse Event|10
3128084|NCT00004888|10691810|P1|Overall Study|Adverse Event|5
3128085|NCT00004859|10691828|P2|Overall Study|Other|21
3128086|NCT00004859|10691829|P1|Overall Study|Other|13
3128087|NCT00004859|10691828|P2|Overall Study|missing data|11
3128088|NCT00004859|10691829|P1|Overall Study|missing data|14
3128089|NCT00004859|10691828|P2|Overall Study|error|1
3128090|NCT00004859|10691829|P1|Overall Study|error|3
3128091|NCT00004859|10691828|P2|Overall Study|other disease|3
3128092|NCT00004859|10691829|P1|Overall Study|other disease|0
3128093|NCT00004859|10691828|P2|Overall Study|Protocol Violation|2
3128094|NCT00004859|10691829|P1|Overall Study|Protocol Violation|2
3128095|NCT00004859|10691828|P2|Overall Study|Withdrawal by Subject|33
3128096|NCT00004859|10691829|P1|Overall Study|Withdrawal by Subject|7
3128097|NCT00004859|10691828|P2|Overall Study|Death|5
3128098|NCT00004859|10691829|P1|Overall Study|Death|5
3128099|NCT00004859|10691828|P2|Overall Study|Adverse Event|93
3128100|NCT00004859|10691829|P1|Overall Study|Adverse Event|31
3128101|NCT00004859|10691828|P2|Overall Study|Lack of Efficacy|113
3128102|NCT00004859|10691829|P1|Overall Study|Lack of Efficacy|43
3128103|NCT00004259|10691843|P4|Overall Study|Withdrawal by Subject|0
3128104|NCT00004259|10691844|P3|Overall Study|Withdrawal by Subject|0
3128105|NCT00004259|10691845|P2|Overall Study|Withdrawal by Subject|2
3128106|NCT00004259|10691846|P1|Overall Study|Withdrawal by Subject|0
3128107|NCT00004259|10691843|P4|Overall Study|Protocol Violation|0
3128108|NCT00004259|10691844|P3|Overall Study|Protocol Violation|0
3128109|NCT00004259|10691845|P2|Overall Study|Protocol Violation|2
3128110|NCT00004259|10691846|P1|Overall Study|Protocol Violation|1
3128111|NCT00004228|10691871|P7|Overall Study|ineligible|5
3128112|NCT00004228|10691872|P6|Overall Study|ineligible|2
3128113|NCT00004228|10691873|P5|Overall Study|ineligible|1
3128114|NCT00004228|10691874|P4|Overall Study|ineligible|1
3128115|NCT00004228|10691875|P3|Overall Study|ineligible|4
3128116|NCT00004228|10691876|P2|Overall Study|ineligible|2
3128117|NCT00004228|10691877|P1|Overall Study|ineligible|4
3128118|NCT00004228|10691871|P7|Overall Study|Other|0
3128119|NCT00004228|10691872|P6|Overall Study|Other|0
3128120|NCT00004228|10691873|P5|Overall Study|Other|0
3128121|NCT00004228|10691874|P4|Overall Study|Other|0
3128122|NCT00004228|10691875|P3|Overall Study|Other|1
3128123|NCT00004228|10691876|P2|Overall Study|Other|0
3128124|NCT00004228|10691877|P1|Overall Study|Other|0
3128125|NCT00004228|10691871|P7|Overall Study|Withdrawal by Subject|2
3128126|NCT00004228|10691872|P6|Overall Study|Withdrawal by Subject|1
3128127|NCT00004228|10691873|P5|Overall Study|Withdrawal by Subject|2
3128128|NCT00004228|10691874|P4|Overall Study|Withdrawal by Subject|0
3128129|NCT00004228|10691875|P3|Overall Study|Withdrawal by Subject|1
3128130|NCT00004228|10691876|P2|Overall Study|Withdrawal by Subject|0
3128131|NCT00004228|10691877|P1|Overall Study|Withdrawal by Subject|3
3128132|NCT00004228|10691871|P7|Overall Study|Protocol Violation|0
3128133|NCT00004228|10691872|P6|Overall Study|Protocol Violation|2
3128134|NCT00004228|10691873|P5|Overall Study|Protocol Violation|1
3128135|NCT00004228|10691874|P4|Overall Study|Protocol Violation|1
3128136|NCT00004228|10691875|P3|Overall Study|Protocol Violation|2
3128137|NCT00004228|10691876|P2|Overall Study|Protocol Violation|5
3128138|NCT00004228|10691877|P1|Overall Study|Protocol Violation|0
3128139|NCT00004228|10691871|P7|Overall Study|Physician Decision|1
3128140|NCT00004228|10691872|P6|Overall Study|Physician Decision|1
3128141|NCT00004228|10691873|P5|Overall Study|Physician Decision|1
3128142|NCT00004228|10691874|P4|Overall Study|Physician Decision|2
3128143|NCT00004228|10691875|P3|Overall Study|Physician Decision|3
3128144|NCT00004228|10691876|P2|Overall Study|Physician Decision|0
3128145|NCT00004228|10691877|P1|Overall Study|Physician Decision|1
3128146|NCT00004228|10691871|P7|Overall Study|Lost to Follow-up|0
3128147|NCT00004228|10691872|P6|Overall Study|Lost to Follow-up|0
3128148|NCT00004228|10691873|P5|Overall Study|Lost to Follow-up|0
3128149|NCT00004228|10691874|P4|Overall Study|Lost to Follow-up|0
3128150|NCT00004228|10691875|P3|Overall Study|Lost to Follow-up|1
3128151|NCT00004228|10691876|P2|Overall Study|Lost to Follow-up|0
3128152|NCT00004228|10691877|P1|Overall Study|Lost to Follow-up|0
3128153|NCT00004228|10691871|P7|Overall Study|Lack of Efficacy|4
3128154|NCT00004228|10691872|P6|Overall Study|Lack of Efficacy|8
3128155|NCT00004228|10691873|P5|Overall Study|Lack of Efficacy|9
3128156|NCT00004228|10691874|P4|Overall Study|Lack of Efficacy|3
3128157|NCT00004228|10691875|P3|Overall Study|Lack of Efficacy|5
3128158|NCT00004228|10691876|P2|Overall Study|Lack of Efficacy|6
3128159|NCT00004228|10691877|P1|Overall Study|Lack of Efficacy|1
3128160|NCT00004228|10691871|P7|Overall Study|Death|0
3128161|NCT00004228|10691872|P6|Overall Study|Death|0
3128162|NCT00004228|10691873|P5|Overall Study|Death|1
3128163|NCT00004228|10691874|P4|Overall Study|Death|0
3128164|NCT00004228|10691875|P3|Overall Study|Death|2
3128165|NCT00004228|10691876|P2|Overall Study|Death|1
3128166|NCT00004228|10691877|P1|Overall Study|Death|0
3128167|NCT00004228|10691871|P7|Overall Study|Adverse Event|0
3128168|NCT00004228|10691872|P6|Overall Study|Adverse Event|0
3128169|NCT00004228|10691873|P5|Overall Study|Adverse Event|1
3128170|NCT00004228|10691874|P4|Overall Study|Adverse Event|0
3128171|NCT00004228|10691875|P3|Overall Study|Adverse Event|0
3128172|NCT00004228|10691876|P2|Overall Study|Adverse Event|1
3128173|NCT00004228|10691877|P1|Overall Study|Adverse Event|0
3128174|NCT00004124|10691911|P2|Overall Study|Received no protocol therapy|20
3128175|NCT00004124|10691912|P1|Overall Study|Received no protocol therapy|12
3128176|NCT00004088|10691937|P1|Overall Study|Physician Decision|1
3128177|NCT00004088|10691937|P1|Overall Study|Protocol Violation|3
3128178|NCT00004088|10691937|P1|Overall Study|Withdrawal by Subject|1
3128179|NCT00004088|10691937|P1|Overall Study|No C2 given due to study on hold by IRB|4
3128180|NCT00003901|10691970|P1|Overall Study|Medical problems|6
3128181|NCT00003901|10691970|P1|Overall Study|Chest X-Ray not done prior registration|1
3128182|NCT00003901|10691970|P1|Overall Study|CT Scan not within protocol requirement|2
3128183|NCT00003901|10691970|P1|Overall Study|Ineligible|6
3128184|NCT00003901|10691970|P1|Overall Study|Withdrawal by Subject|1
3128185|NCT00003901|10691970|P1|Overall Study|Adverse Event|1
3128186|NCT00003896|10691981|P1|Overall Study|ineligible|5
3128187|NCT00003896|10691981|P1|Overall Study|not protocol specified|3
3128188|NCT00003896|10691981|P1|Overall Study|Death|3
3128189|NCT00003896|10691981|P1|Overall Study|Lack of Efficacy|1
3128190|NCT00003896|10691981|P1|Overall Study|Withdrawal by Subject|1
3128191|NCT00003896|10691981|P1|Overall Study|Adverse Event|16
3128192|NCT00003875|10691987|P1|Overall Study|Screen Failed|1
3128193|NCT00003869|10691996|P2|Overall Study|Alternative treatmnt, medical problems|4
3128194|NCT00003869|10691997|P1|Overall Study|Alternative treatmnt, medical problems|5
3128195|NCT00003869|10691996|P2|Overall Study|Death|2
3128196|NCT00003869|10691997|P1|Overall Study|Death|1
3128197|NCT00003869|10691996|P2|Overall Study|Withdrawal by Subject|3
3128198|NCT00003869|10691997|P1|Overall Study|Withdrawal by Subject|21
3128199|NCT00003869|10691996|P2|Overall Study|Adverse Event|3
3128200|NCT00003869|10691997|P1|Overall Study|Adverse Event|14
3128201|NCT00003782|10692023|P3|Overall Study|No follow up data|26
3128202|NCT00003782|10692024|P2|Overall Study|No follow up data|31
3128203|NCT00003782|10692025|P1|Overall Study|No follow up data|30
3128204|NCT00003702|10692035|P2|Overall Study|Inadequate documentation of disease|3
3128205|NCT00003702|10692036|P1|Overall Study|Inadequate documentation of disease|1
3128206|NCT00003702|10692035|P2|Overall Study|WHO score > 6|1
3128207|NCT00003702|10692036|P1|Overall Study|WHO score > 6|2
3128208|NCT00003702|10692035|P2|Overall Study|Did not meet criteria for persistence|5
3128209|NCT00003702|10692036|P1|Overall Study|Did not meet criteria for persistence|8
3128210|NCT00003702|10692035|P2|Overall Study|Ineligible cell types|2
3128211|NCT00003702|10692036|P1|Overall Study|Ineligible cell types|2
3128212|NCT00003659|10692045|P1|Overall Study|Withdrawal by Subject|3
3128213|NCT00003641|10692066|P2|Overall Study|Never started interferon|12
3128214|NCT00003641|10692067|P1|Overall Study|Never started interferon|567
3128215|NCT00003641|10692066|P2|Overall Study|Should not receive interferon therapy|0
3128216|NCT00003641|10692067|P1|Overall Study|Should not receive interferon therapy|2
3128217|NCT00003641|10692066|P2|Overall Study|Unknown/missing|22
3128218|NCT00003641|10692067|P1|Overall Study|Unknown/missing|0
3128219|NCT00003641|10692066|P2|Overall Study|Disease progression|2
3128220|NCT00003641|10692067|P1|Overall Study|Disease progression|0
3128221|NCT00003641|10692066|P2|Overall Study|Adverse Event|38
3128222|NCT00003641|10692067|P1|Overall Study|Adverse Event|0
3128223|NCT00003641|10692066|P2|Overall Study|Withdrawal by Subject|100
3128224|NCT00003641|10692067|P1|Overall Study|Withdrawal by Subject|0
3128225|NCT00003631|10692078|P3|Overall Study|Evaluable for toxicity only|2
3128226|NCT00003631|10692079|P2|Overall Study|Evaluable for toxicity only|0
3128227|NCT00003631|10692080|P1|Overall Study|Evaluable for toxicity only|0
3128228|NCT00003631|10692078|P3|Overall Study|Death|1
3128229|NCT00003631|10692079|P2|Overall Study|Death|0
3128230|NCT00003631|10692080|P1|Overall Study|Death|0
3128231|NCT00003631|10692078|P3|Overall Study|Adverse Event|5
3128232|NCT00003631|10692079|P2|Overall Study|Adverse Event|1
3128233|NCT00003631|10692080|P1|Overall Study|Adverse Event|1
3128234|NCT00003631|10692078|P3|Overall Study|Protocol Violation|0
3128235|NCT00003631|10692079|P2|Overall Study|Protocol Violation|0
3128236|NCT00003631|10692080|P1|Overall Study|Protocol Violation|1
3128237|NCT00003631|10692078|P3|Overall Study|Patient not treated|1
3128238|NCT00003631|10692079|P2|Overall Study|Patient not treated|0
3128239|NCT00003631|10692080|P1|Overall Study|Patient not treated|1
3128240|NCT00003590|10692088|P1|Overall Study|Physician Decision|1
3128241|NCT00003590|10692088|P1|Overall Study|Death|1
3128242|NCT00003590|10692088|P1|Overall Study|Lack of Efficacy|11
3128243|NCT00003590|10692088|P1|Overall Study|Withdrawal by Subject|1
3128244|NCT00003590|10692088|P1|Overall Study|Adverse Event|7
3128245|NCT00003590|10692088|P1|Overall Study|Ineligible Patient|1
3128246|NCT00003537|10692093|P1|Overall Study|Not evalauable|1
3128247|NCT00003535|10692098|P1|Overall Study|Not evaluable|5
3128248|NCT00003499|10692103|P1|Overall Study|Not evaluable|8
3128249|NCT00003483|10692108|P1|Overall Study|Not evaluable|1
3128250|NCT00003479|10692113|P1|Overall Study|Not evaluable|3
3128251|NCT00003477|10692118|P1|Overall Study|Not evalauable|4
3128252|NCT00003476|10692123|P1|Overall Study|Not evaluable|1
3128253|NCT00003475|10692128|P1|Overall Study|Not evaluable|13
3128254|NCT00003474|10692133|P1|Overall Study|Not Evaluable|14
3128255|NCT00003473|10692138|P1|Overall Study|Three patients were not evaluable.|3
3128256|NCT00003472|10692143|P1|Overall Study|Not evaluable|3
3128257|NCT00003471|10692148|P1|Overall Study|Not evaluable|4
3128258|NCT00003470|10692153|P1|Overall Study|Not evaluable|6
3128259|NCT00003458|10692178|P1|Overall Study|Not evaluable|4
3128260|NCT00003457|10692183|P1|Overall Study|Not evaluable|9
3128261|NCT00003456|10692188|P1|Overall Study|Not evaluable|8
3128262|NCT00003389|10692205|P2|Overall Study|Ineligible|27
3128263|NCT00003389|10692206|P1|Overall Study|Ineligible|33
3128264|NCT00003389|10692205|P2|Overall Study|Off-treatment reason missing|21
3128265|NCT00003389|10692206|P1|Overall Study|Off-treatment reason missing|31
3128266|NCT00003389|10692205|P2|Overall Study|Complicating disease|0
3128267|NCT00003389|10692206|P1|Overall Study|Complicating disease|1
3128268|NCT00003389|10692205|P2|Overall Study|Alternative therapy|1
3128269|NCT00003389|10692206|P1|Overall Study|Alternative therapy|2
3128270|NCT00003389|10692205|P2|Overall Study|Withdrawal by Subject|5
3128271|NCT00003389|10692206|P1|Overall Study|Withdrawal by Subject|12
3128272|NCT00003389|10692205|P2|Overall Study|Death|3
3128273|NCT00003389|10692206|P1|Overall Study|Death|0
3128274|NCT00003389|10692205|P2|Overall Study|Adverse Event|2
3128275|NCT00003389|10692206|P1|Overall Study|Adverse Event|13
3128276|NCT00003389|10692205|P2|Overall Study|Disease progression|1
3128277|NCT00003389|10692206|P1|Overall Study|Disease progression|6
3128278|NCT00003377|10692221|P5|Period II|Ureteral stent complications|1
3128279|NCT00003377|10692222|P4|Period II|Ureteral stent complications|0
3128280|NCT00003377|10692223|P3|Period II|Ureteral stent complications|0
3128281|NCT00003377|10692224|P2|Period II|Ureteral stent complications|0
3128282|NCT00003377|10692225|P1|Period II|Ureteral stent complications|0
3128283|NCT00003377|10692221|P5|Period I|Dose Limiting Toxicity(DLT)|0
3128284|NCT00003377|10692222|P4|Period I|Dose Limiting Toxicity(DLT)|1
3128285|NCT00003377|10692223|P3|Period I|Dose Limiting Toxicity(DLT)|1
3128286|NCT00003377|10692224|P2|Period I|Dose Limiting Toxicity(DLT)|0
3128287|NCT00003377|10692225|P1|Period I|Dose Limiting Toxicity(DLT)|0
3128288|NCT00003199|10692239|P1|Overall Study|Screen fail|15
3128289|NCT00003199|10692239|P1|Overall Study|Lack of insurance clearance|2
3128290|NCT00003199|10692239|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
3128291|NCT00003138|10692247|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
3128292|NCT00003138|10692248|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
3128293|NCT00003138|10692247|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
3128294|NCT00003138|10692248|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
3128295|NCT00003138|10692247|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
3128296|NCT00003138|10692248|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
3128297|NCT00003138|10692247|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
3128298|NCT00003138|10692248|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
3128299|NCT00003138|10692247|P2|Step 1|Never started treatment|0
3128300|NCT00003138|10692248|P1|Step 1|Never started treatment|1
3128301|NCT00003138|10692247|P2|Step 1|Reasons off treatment not documented|57
3128302|NCT00003138|10692248|P1|Step 1|Reasons off treatment not documented|60
3128303|NCT00002931|10692265|P1|Overall Study|rapidly progressing disease during|2
3128304|NCT00002874|10692273|P2|Overall Study|Protocol Violation|34
3128305|NCT00002874|10692274|P1|Overall Study|Protocol Violation|44
3128306|NCT00002874|10692273|P2|Overall Study|Withdrawal by Subject|1
3128307|NCT00002874|10692274|P1|Overall Study|Withdrawal by Subject|1
3128308|NCT00002850|10692299|P3|Overall Study|Withdrawal by Subject|0
3128309|NCT00002850|10692300|P2|Overall Study|Withdrawal by Subject|1
3128310|NCT00002850|10692301|P1|Overall Study|Withdrawal by Subject|0
3128311|NCT00002850|10692299|P3|Overall Study|Protocol Violation|1
3128312|NCT00002850|10692300|P2|Overall Study|Protocol Violation|0
3128313|NCT00002850|10692301|P1|Overall Study|Protocol Violation|1
3128314|NCT00002850|10692299|P3|Overall Study|Death|3
3128315|NCT00002850|10692300|P2|Overall Study|Death|1
3128316|NCT00002850|10692301|P1|Overall Study|Death|4
3128317|NCT00002842|10692309|P1|Overall Study|ineligible for surgical resection|27
3128318|NCT00002766|10692315|P2|Overall Study|Protocol Violation|0
3128319|NCT00002766|10692316|P1|Overall Study|Protocol Violation|1
3128320|NCT00002766|10692315|P2|Overall Study|Adverse Event|1
3128321|NCT00002766|10692316|P1|Overall Study|Adverse Event|1
3128322|NCT00002766|10692315|P2|Overall Study|Patient Not Treated|2
3128323|NCT00002766|10692316|P1|Overall Study|Patient Not Treated|1
3128324|NCT00002766|10692315|P2|Overall Study|Withdrawal by Subject|1
3128325|NCT00002766|10692316|P1|Overall Study|Withdrawal by Subject|0
3128326|NCT00002651|10692324|P3|Consolidation and Randomization|not eligible|112
3128327|NCT00002651|10692325|P2|Consolidation and Randomization|not eligible|102
3128328|NCT00002651|10692326|P1|Consolidation and Randomization|not eligible|0
3128329|NCT00002651|10692324|P3|Consolidation and Randomization|Other|313
3128330|NCT00002651|10692325|P2|Consolidation and Randomization|Other|314
3128331|NCT00002651|10692326|P1|Consolidation and Randomization|Other|0
3128332|NCT00002651|10692324|P3|Consolidation and Randomization|Death|48
3128333|NCT00002651|10692325|P2|Consolidation and Randomization|Death|38
3128334|NCT00002651|10692326|P1|Consolidation and Randomization|Death|0
3128335|NCT00002651|10692324|P3|Consolidation and Randomization|Progression/relapse|298
3128336|NCT00002651|10692325|P2|Consolidation and Randomization|Progression/relapse|295
3128337|NCT00002651|10692326|P1|Consolidation and Randomization|Progression/relapse|0
3128338|NCT00002651|10692324|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
3128339|NCT00002651|10692325|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
3128340|NCT00002651|10692326|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
3128341|NCT00002651|10692324|P3|Consolidation and Randomization|Adverse Event|14
3128342|NCT00002651|10692325|P2|Consolidation and Randomization|Adverse Event|36
3128343|NCT00002651|10692326|P1|Consolidation and Randomization|Adverse Event|0
3128344|NCT00002651|10692324|P3|Induction|not eligible|0
3128345|NCT00002651|10692325|P2|Induction|not eligible|0
3128346|NCT00002651|10692326|P1|Induction|not eligible|90
3128347|NCT00002651|10692324|P3|Induction|Other|0
3128348|NCT00002651|10692325|P2|Induction|Other|0
3128349|NCT00002651|10692326|P1|Induction|Other|823
3128350|NCT00002651|10692324|P3|Induction|Death|0
3128351|NCT00002651|10692325|P2|Induction|Death|0
3128352|NCT00002651|10692326|P1|Induction|Death|62
3128353|NCT00002651|10692324|P3|Induction|Progression/relapse|0
3128354|NCT00002651|10692325|P2|Induction|Progression/relapse|0
3128355|NCT00002651|10692326|P1|Induction|Progression/relapse|274
3128356|NCT00002651|10692324|P3|Induction|Refusal unrelated to adverse event|0
3128357|NCT00002651|10692325|P2|Induction|Refusal unrelated to adverse event|0
3128358|NCT00002651|10692326|P1|Induction|Refusal unrelated to adverse event|50
3128359|NCT00002651|10692324|P3|Induction|Adverse Event|0
3128360|NCT00002651|10692325|P2|Induction|Adverse Event|0
3128361|NCT00002651|10692326|P1|Induction|Adverse Event|44
3128362|NCT00002558|10692344|P2|Overall Study|Withdrawal by Subject|1
3128363|NCT00002558|10692345|P1|Overall Study|Withdrawal by Subject|0
3128364|NCT00051636|10692370|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
3128365|NCT00051636|10692371|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
3128366|NCT00051636|10692370|P2|Period 2- Extended Observation Period|Death|5
3128367|NCT00051636|10692371|P1|Period 2- Extended Observation Period|Death|4
3128368|NCT00051636|10692370|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
3128369|NCT00051636|10692371|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
3128370|NCT00051636|10692370|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
3128371|NCT00051636|10692371|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
3128372|NCT00051636|10692370|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
3128373|NCT00051636|10692371|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
3128374|NCT00051636|10692370|P2|Period 1 - Core|Lost to Follow-up|2
3128375|NCT00051636|10692371|P1|Period 1 - Core|Lost to Follow-up|0
3128376|NCT00051636|10692370|P2|Period 1 - Core|Withdrawal by Subject|2
3128377|NCT00051636|10692371|P1|Period 1 - Core|Withdrawal by Subject|1
3128378|NCT00051636|10692370|P2|Period 1 - Core|Protocol Violation|0
3128379|NCT00051636|10692371|P1|Period 1 - Core|Protocol Violation|1
3128380|NCT00051636|10692370|P2|Period 1 - Core|Adverse Event|2
3128381|NCT00051636|10692371|P1|Period 1 - Core|Adverse Event|2
3128382|NCT00051558|10692399|P2|Overall Study|Physician Decision|0
3128383|NCT00051558|10692400|P1|Overall Study|Physician Decision|5
3128384|NCT00051558|10692399|P2|Overall Study|Significant Lab Value|0
3128385|NCT00051558|10692400|P1|Overall Study|Significant Lab Value|2
3128386|NCT00051558|10692399|P2|Overall Study|Other|1
3128387|NCT00051558|10692400|P1|Overall Study|Other|2
3128388|NCT00051558|10692399|P2|Overall Study|Sponsor Decision|1
3128389|NCT00051558|10692400|P1|Overall Study|Sponsor Decision|6
3128390|NCT00051558|10692399|P2|Overall Study|Protocol Entry Criteria Unmet|2
3128391|NCT00051558|10692400|P1|Overall Study|Protocol Entry Criteria Unmet|1
3128392|NCT00051558|10692399|P2|Overall Study|Protocol Violation|4
3128393|NCT00051558|10692400|P1|Overall Study|Protocol Violation|3
3128394|NCT00051558|10692399|P2|Overall Study|Lost to Follow-up|13
3128395|NCT00051558|10692400|P1|Overall Study|Lost to Follow-up|4
3128396|NCT00051558|10692399|P2|Overall Study|Death|15
3128397|NCT00051558|10692400|P1|Overall Study|Death|9
3128398|NCT00051558|10692399|P2|Overall Study|Withdrawal by Subject|42
3128399|NCT00051558|10692400|P1|Overall Study|Withdrawal by Subject|29
3128400|NCT00051558|10692399|P2|Overall Study|Adverse Event|18
3128401|NCT00051558|10692400|P1|Overall Study|Adverse Event|30
3128402|NCT00051363|10692436|P2|Overall Study|Excluded Pre-Randomization|5
3128403|NCT00051363|10692437|P1|Overall Study|Excluded Pre-Randomization|2
3128404|NCT00051363|10692436|P2|Overall Study|Death|2
3128405|NCT00051363|10692437|P1|Overall Study|Death|2
3128406|NCT00051363|10692436|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
3128407|NCT00051363|10692437|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
3128408|NCT00051363|10692436|P2|Overall Study|Dropped Post-Rand for Any Reason|126
3128409|NCT00051363|10692437|P1|Overall Study|Dropped Post-Rand for Any Reason|102
3128410|NCT00051025|10692477|P2|Overall Study|Death|1
3128411|NCT00051025|10692478|P1|Overall Study|Death|0
3128412|NCT00051025|10692477|P2|Overall Study|Withdrawal by Subject|1
3128413|NCT00051025|10692478|P1|Overall Study|Withdrawal by Subject|0
3128414|NCT00051025|10692477|P2|Overall Study|Adverse Event|1
3128415|NCT00051025|10692478|P1|Overall Study|Adverse Event|1
3128416|NCT00051025|10692477|P2|Overall Study|Progressive Disease|1
3128417|NCT00051025|10692478|P1|Overall Study|Progressive Disease|1
3128418|NCT00050960|10692492|P2|Overall Study|Death|15
3128419|NCT00050960|10692493|P1|Overall Study|Death|13
3128420|NCT00050960|10692492|P2|Overall Study|Non-compliance|1
3128421|NCT00050960|10692493|P1|Overall Study|Non-compliance|3
3128422|NCT00050960|10692492|P2|Overall Study|Administrative|46
3128423|NCT00050960|10692493|P1|Overall Study|Administrative|31
3128424|NCT00050960|10692492|P2|Overall Study|Withdrawal by Subject|18
3128425|NCT00050960|10692493|P1|Overall Study|Withdrawal by Subject|23
3128426|NCT00050960|10692492|P2|Overall Study|Lost to Follow-up|1
3128427|NCT00050960|10692493|P1|Overall Study|Lost to Follow-up|0
3128428|NCT00050960|10692492|P2|Overall Study|Adverse Event|61
3128429|NCT00050960|10692493|P1|Overall Study|Adverse Event|62
3128430|NCT00050960|10692492|P2|Overall Study|Complete Response|2
3128431|NCT00050960|10692493|P1|Overall Study|Complete Response|0
3128432|NCT00050960|10692492|P2|Overall Study|Partial Response|19
3128433|NCT00050960|10692493|P1|Overall Study|Partial Response|14
3128434|NCT00050960|10692492|P2|Overall Study|Stable Disease|48
3128435|NCT00050960|10692493|P1|Overall Study|Stable Disease|19
3128436|NCT00050960|10692492|P2|Overall Study|Progressive Disease|93
3128437|NCT00050960|10692493|P1|Overall Study|Progressive Disease|137
3128438|NCT00050778|10692502|P3|Overall Study|Familial and personal reasons|0
3128439|NCT00050778|10692503|P2|Overall Study|Familial and personal reasons|0
3128440|NCT00050778|10692504|P1|Overall Study|Familial and personal reasons|1
3128441|NCT00050778|10692502|P3|Overall Study|Randomized but not treated|2
3128442|NCT00050778|10692503|P2|Overall Study|Randomized but not treated|5
3128443|NCT00050778|10692504|P1|Overall Study|Randomized but not treated|4
3128444|NCT00050778|10692502|P3|Overall Study|Withdrawal by Subject|4
3128445|NCT00050778|10692503|P2|Overall Study|Withdrawal by Subject|8
3128446|NCT00050778|10692504|P1|Overall Study|Withdrawal by Subject|6
3128447|NCT00050778|10692502|P3|Overall Study|Protocol Violation|1
3128448|NCT00050778|10692503|P2|Overall Study|Protocol Violation|0
3128449|NCT00050778|10692504|P1|Overall Study|Protocol Violation|2
3128450|NCT00050778|10692502|P3|Overall Study|Physician Decision|2
3128451|NCT00050778|10692503|P2|Overall Study|Physician Decision|0
3128452|NCT00050778|10692504|P1|Overall Study|Physician Decision|3
3128453|NCT00050778|10692502|P3|Overall Study|Lost to Follow-up|4
3128454|NCT00050778|10692503|P2|Overall Study|Lost to Follow-up|2
3128455|NCT00050778|10692504|P1|Overall Study|Lost to Follow-up|0
3128456|NCT00050778|10692502|P3|Overall Study|Lack of Efficacy|2
3128457|NCT00050778|10692503|P2|Overall Study|Lack of Efficacy|2
3128458|NCT00050778|10692504|P1|Overall Study|Lack of Efficacy|16
3128459|NCT00050778|10692502|P3|Overall Study|Death|1
3128460|NCT00050778|10692503|P2|Overall Study|Death|1
3128461|NCT00050778|10692504|P1|Overall Study|Death|0
3128462|NCT00050778|10692502|P3|Overall Study|Adverse Event|2
3128463|NCT00050778|10692503|P2|Overall Study|Adverse Event|3
3128464|NCT00050778|10692504|P1|Overall Study|Adverse Event|13
3128465|NCT00050622|10692530|P1|Overall Study|Adverse Event|1
3128466|NCT00050167|10692568|P2|Overall Study|not eligible not invasive|1
3128467|NCT00050167|10692569|P1|Overall Study|not eligible not invasive|1
3128468|NCT00050011|10692602|P2|Overall Study|Unknown - Reason is missing|2
3128469|NCT00050011|10692603|P1|Overall Study|Unknown - Reason is missing|0
3128470|NCT00050011|10692602|P2|Overall Study|Death|4
3128471|NCT00050011|10692603|P1|Overall Study|Death|7
3128472|NCT00050011|10692602|P2|Overall Study|Administrative problems|6
3128473|NCT00050011|10692603|P1|Overall Study|Administrative problems|10
3128474|NCT00050011|10692602|P2|Overall Study|Lost to Follow-up|9
3128475|NCT00050011|10692603|P1|Overall Study|Lost to Follow-up|7
3128476|NCT00050011|10692602|P2|Overall Study|Withdrawal by Subject|26
3128477|NCT00050011|10692603|P1|Overall Study|Withdrawal by Subject|34
3128478|NCT00050011|10692602|P2|Overall Study|Protocol Violation|10
3128479|NCT00050011|10692603|P1|Overall Study|Protocol Violation|4
3128480|NCT00050011|10692602|P2|Overall Study|Participant condition no longer required|0
3128481|NCT00050011|10692603|P1|Overall Study|Participant condition no longer required|1
3128482|NCT00050011|10692602|P2|Overall Study|Lack of Efficacy|21
3128483|NCT00050011|10692603|P1|Overall Study|Lack of Efficacy|16
3128484|NCT00050011|10692602|P2|Overall Study|Abnormal test procedure results|1
3128485|NCT00050011|10692603|P1|Overall Study|Abnormal test procedure results|0
3128486|NCT00050011|10692602|P2|Overall Study|Abnormal laboratory value(s)|1
3128487|NCT00050011|10692603|P1|Overall Study|Abnormal laboratory value(s)|1
3128488|NCT00050011|10692602|P2|Overall Study|Adverse Event|46
3128489|NCT00050011|10692603|P1|Overall Study|Adverse Event|41
3128490|NCT00049842|10692625|P2|Follow-up Phase|Other|4
3128491|NCT00049842|10692626|P1|Follow-up Phase|Other|1
3128492|NCT00049842|10692625|P2|Follow-up Phase|Adverse Event|1
3128493|NCT00049842|10692626|P1|Follow-up Phase|Adverse Event|6
3128494|NCT00049842|10692625|P2|Treatment Phase|Did not meet protocol eligibility|1
3128495|NCT00049842|10692626|P1|Treatment Phase|Did not meet protocol eligibility|0
3128496|NCT00049842|10692625|P2|Treatment Phase|Administrative|3
3128497|NCT00049842|10692626|P1|Treatment Phase|Administrative|0
3128498|NCT00049842|10692625|P2|Treatment Phase|Lost to Follow-up|8
3128499|NCT00049842|10692626|P1|Treatment Phase|Lost to Follow-up|4
3128500|NCT00049842|10692625|P2|Treatment Phase|Non-compliance with protocol|8
3128501|NCT00049842|10692626|P1|Treatment Phase|Non-compliance with protocol|7
3128502|NCT00049842|10692625|P2|Treatment Phase|Withdrawal by Subject|46
3128503|NCT00049842|10692626|P1|Treatment Phase|Withdrawal by Subject|35
3128504|NCT00049842|10692625|P2|Treatment Phase|Adverse Event|12
3128505|NCT00049842|10692626|P1|Treatment Phase|Adverse Event|47
3128506|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Surgery|1
3128507|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Surgery|0
3128508|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Surgery|0
3128509|NCT00048932|10692644|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
3128510|NCT00048932|10692645|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
3128511|NCT00048932|10692646|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
3128512|NCT00048932|10692644|P3|Open Label Period (OL)|Site Staff Issues|2
3128513|NCT00048932|10692645|P2|Open Label Period (OL)|Site Staff Issues|0
3128514|NCT00048932|10692646|P1|Open Label Period (OL)|Site Staff Issues|0
3128515|NCT00048932|10692644|P3|Open Label Period (OL)|Investigator Decision|4
3128516|NCT00048932|10692645|P2|Open Label Period (OL)|Investigator Decision|0
3128517|NCT00048932|10692646|P1|Open Label Period (OL)|Investigator Decision|0
3128518|NCT00048932|10692644|P3|Open Label Period (OL)|Medication Lost Efficacy|1
3128519|NCT00048932|10692645|P2|Open Label Period (OL)|Medication Lost Efficacy|0
3128520|NCT00048932|10692646|P1|Open Label Period (OL)|Medication Lost Efficacy|0
3128521|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
3128522|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
3128523|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
3128524|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
3128525|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
3128526|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
3128527|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
3128528|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
3128529|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
3128530|NCT00048932|10692644|P3|Open Label Period (OL)|Patient Decision|4
3128531|NCT00048932|10692645|P2|Open Label Period (OL)|Patient Decision|0
3128532|NCT00048932|10692646|P1|Open Label Period (OL)|Patient Decision|0
3128533|NCT00048932|10692644|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
3128534|NCT00048932|10692645|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
3128535|NCT00048932|10692646|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
3128536|NCT00048932|10692644|P3|Open Label Period (OL)|Trial Terminated|1
3128537|NCT00048932|10692645|P2|Open Label Period (OL)|Trial Terminated|0
3128538|NCT00048932|10692646|P1|Open Label Period (OL)|Trial Terminated|0
3128539|NCT00048932|10692644|P3|Open Label Period (OL)|Site Closure|3
3128540|NCT00048932|10692645|P2|Open Label Period (OL)|Site Closure|0
3128541|NCT00048932|10692646|P1|Open Label Period (OL)|Site Closure|0
3128542|NCT00048932|10692644|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
3128543|NCT00048932|10692645|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
3128544|NCT00048932|10692646|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
3128545|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Relocated|6
3128546|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Relocated|0
3128547|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Relocated|0
3128548|NCT00048932|10692644|P3|Open Label Period (OL)|Participant Transportation Issues|1
3128549|NCT00048932|10692645|P2|Open Label Period (OL)|Participant Transportation Issues|0
3128550|NCT00048932|10692646|P1|Open Label Period (OL)|Participant Transportation Issues|0
3128551|NCT00048932|10692644|P3|Open Label Period (OL)|Investigator Retiring|2
3128552|NCT00048932|10692645|P2|Open Label Period (OL)|Investigator Retiring|0
3128553|NCT00048932|10692646|P1|Open Label Period (OL)|Investigator Retiring|0
3128554|NCT00048932|10692644|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
3128555|NCT00048932|10692645|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
3128556|NCT00048932|10692646|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
3128557|NCT00048932|10692644|P3|Open Label Period (OL)|Pregnancy|6
3128558|NCT00048932|10692645|P2|Open Label Period (OL)|Pregnancy|0
3128559|NCT00048932|10692646|P1|Open Label Period (OL)|Pregnancy|0
3128560|NCT00048932|10692644|P3|Open Label Period (OL)|Poor/Non-Compliance|13
3128561|NCT00048932|10692645|P2|Open Label Period (OL)|Poor/Non-Compliance|0
3128562|NCT00048932|10692646|P1|Open Label Period (OL)|Poor/Non-Compliance|0
3128563|NCT00048932|10692644|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
3128564|NCT00048932|10692645|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
3128565|NCT00048932|10692646|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
3128566|NCT00048932|10692644|P3|Open Label Period (OL)|Withdrawal by Subject|117
3128567|NCT00048932|10692645|P2|Open Label Period (OL)|Withdrawal by Subject|0
3128568|NCT00048932|10692646|P1|Open Label Period (OL)|Withdrawal by Subject|0
3128569|NCT00048932|10692644|P3|Open Label Period (OL)|Lost to Follow-up|27
3128570|NCT00048932|10692645|P2|Open Label Period (OL)|Lost to Follow-up|0
3128571|NCT00048932|10692646|P1|Open Label Period (OL)|Lost to Follow-up|0
3128572|NCT00048932|10692644|P3|Open Label Period (OL)|Lack of Efficacy|81
3128573|NCT00048932|10692645|P2|Open Label Period (OL)|Lack of Efficacy|0
3128574|NCT00048932|10692646|P1|Open Label Period (OL)|Lack of Efficacy|0
3128575|NCT00048932|10692644|P3|Open Label Period (OL)|Adverse Event|103
3128576|NCT00048932|10692645|P2|Open Label Period (OL)|Adverse Event|0
3128577|NCT00048932|10692646|P1|Open Label Period (OL)|Adverse Event|0
3128578|NCT00048932|10692644|P3|Open Label Period (OL)|Death|25
3128579|NCT00048932|10692645|P2|Open Label Period (OL)|Death|0
3128580|NCT00048932|10692646|P1|Open Label Period (OL)|Death|0
3128581|NCT00048932|10692644|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
3128582|NCT00048932|10692645|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
3128583|NCT00048932|10692646|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
3128584|NCT00048932|10692644|P3|Double Blind Period (DB)|Withdrawal by Subject|0
3128585|NCT00048932|10692645|P2|Double Blind Period (DB)|Withdrawal by Subject|10
3128586|NCT00048932|10692646|P1|Double Blind Period (DB)|Withdrawal by Subject|24
3128587|NCT00048932|10692644|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
3128588|NCT00048932|10692645|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
3128589|NCT00048932|10692646|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
3128590|NCT00048932|10692644|P3|Double Blind Period (DB)|Pregnancy|0
3128591|NCT00048932|10692645|P2|Double Blind Period (DB)|Pregnancy|0
3128592|NCT00048932|10692646|P1|Double Blind Period (DB)|Pregnancy|1
3128593|NCT00048932|10692644|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
3128594|NCT00048932|10692645|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
3128595|NCT00048932|10692646|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
3128596|NCT00048932|10692644|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
3128597|NCT00048932|10692645|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
3128598|NCT00048932|10692646|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
3128599|NCT00048932|10692644|P3|Double Blind Period (DB)|Relocation|0
3128600|NCT00048932|10692645|P2|Double Blind Period (DB)|Relocation|0
3128601|NCT00048932|10692646|P1|Double Blind Period (DB)|Relocation|1
3128602|NCT00048932|10692644|P3|Double Blind Period (DB)|Lost to Follow-up|0
3128603|NCT00048932|10692645|P2|Double Blind Period (DB)|Lost to Follow-up|4
3128604|NCT00048932|10692646|P1|Double Blind Period (DB)|Lost to Follow-up|3
3128605|NCT00048932|10692644|P3|Double Blind Period (DB)|Lack of Efficacy|0
3128606|NCT00048932|10692645|P2|Double Blind Period (DB)|Lack of Efficacy|44
3128607|NCT00048932|10692646|P1|Double Blind Period (DB)|Lack of Efficacy|26
3128608|NCT00048932|10692644|P3|Double Blind Period (DB)|Death|0
3128609|NCT00048932|10692645|P2|Double Blind Period (DB)|Death|3
3128610|NCT00048932|10692646|P1|Double Blind Period (DB)|Death|5
3128611|NCT00048932|10692644|P3|Double Blind Period (DB)|Adverse Event|0
3128612|NCT00048932|10692645|P2|Double Blind Period (DB)|Adverse Event|19
3128613|NCT00048932|10692646|P1|Double Blind Period (DB)|Adverse Event|51
3128614|NCT00048932|10692644|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
3128615|NCT00048932|10692645|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
3128616|NCT00048932|10692646|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
3128617|NCT00048581|10692688|P3|Open-Label Period|Study Ended By Sponsor|1
3128618|NCT00048581|10692689|P2|Open-Label Period|Study Ended By Sponsor|0
3128619|NCT00048581|10692690|P1|Open-Label Period|Study Ended By Sponsor|0
3128620|NCT00048581|10692688|P3|Open-Label Period|Primary Investigator Retired|2
3128621|NCT00048581|10692689|P2|Open-Label Period|Primary Investigator Retired|0
3128622|NCT00048581|10692690|P1|Open-Label Period|Primary Investigator Retired|0
3128623|NCT00048581|10692688|P3|Open-Label Period|Problem With Transportation To Site|1
3128624|NCT00048581|10692689|P2|Open-Label Period|Problem With Transportation To Site|0
3128625|NCT00048581|10692690|P1|Open-Label Period|Problem With Transportation To Site|0
3128626|NCT00048581|10692688|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
3128627|NCT00048581|10692689|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
3128628|NCT00048581|10692690|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
3128629|NCT00048581|10692688|P3|Open-Label Period|Study Site Closure|2
3128630|NCT00048581|10692689|P2|Open-Label Period|Study Site Closure|0
3128631|NCT00048581|10692690|P1|Open-Label Period|Study Site Closure|0
3128632|NCT00048581|10692688|P3|Open-Label Period|Pregnancy|7
3128633|NCT00048581|10692689|P2|Open-Label Period|Pregnancy|0
3128634|NCT00048581|10692690|P1|Open-Label Period|Pregnancy|0
3128635|NCT00048581|10692688|P3|Open-Label Period|Poor/Non-compliance|5
3128636|NCT00048581|10692689|P2|Open-Label Period|Poor/Non-compliance|0
3128637|NCT00048581|10692690|P1|Open-Label Period|Poor/Non-compliance|0
3128638|NCT00048581|10692688|P3|Open-Label Period|No Longer Meets Study Criteria|2
3128639|NCT00048581|10692689|P2|Open-Label Period|No Longer Meets Study Criteria|0
3128640|NCT00048581|10692690|P1|Open-Label Period|No Longer Meets Study Criteria|0
3128641|NCT00048581|10692688|P3|Open-Label Period|Withdrawal by Subject|20
3128642|NCT00048581|10692689|P2|Open-Label Period|Withdrawal by Subject|0
3128643|NCT00048581|10692690|P1|Open-Label Period|Withdrawal by Subject|0
3128644|NCT00048581|10692688|P3|Open-Label Period|Lost to Follow-up|14
3128645|NCT00048581|10692689|P2|Open-Label Period|Lost to Follow-up|0
3128646|NCT00048581|10692690|P1|Open-Label Period|Lost to Follow-up|0
3128647|NCT00048581|10692688|P3|Open-Label Period|Lack of Efficacy|69
3128648|NCT00048581|10692689|P2|Open-Label Period|Lack of Efficacy|0
3128649|NCT00048581|10692690|P1|Open-Label Period|Lack of Efficacy|0
3128650|NCT00048581|10692688|P3|Open-Label Period|Adverse Event|37
3128651|NCT00048581|10692689|P2|Open-Label Period|Adverse Event|0
3128652|NCT00048581|10692690|P1|Open-Label Period|Adverse Event|0
3128653|NCT00048581|10692688|P3|Open-Label Period|Death|4
3128654|NCT00048581|10692689|P2|Open-Label Period|Death|0
3128655|NCT00048581|10692690|P1|Open-Label Period|Death|0
3128656|NCT00048581|10692688|P3|Double-Blind Period|Investigator Decision|0
3128657|NCT00048581|10692689|P2|Double-Blind Period|Investigator Decision|0
3128658|NCT00048581|10692690|P1|Double-Blind Period|Investigator Decision|1
3128659|NCT00048581|10692688|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
3128660|NCT00048581|10692689|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
3128661|NCT00048581|10692690|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
3128662|NCT00048581|10692688|P3|Double-Blind Period|Withdrawal by Subject|0
3128663|NCT00048581|10692689|P2|Double-Blind Period|Withdrawal by Subject|2
3128664|NCT00048581|10692690|P1|Double-Blind Period|Withdrawal by Subject|5
3128665|NCT00048581|10692688|P3|Double-Blind Period|Lost to Follow-up|0
3128666|NCT00048581|10692689|P2|Double-Blind Period|Lost to Follow-up|0
3128667|NCT00048581|10692690|P1|Double-Blind Period|Lost to Follow-up|5
3128668|NCT00048581|10692688|P3|Double-Blind Period|Lack of Efficacy|0
3128669|NCT00048581|10692689|P2|Double-Blind Period|Lack of Efficacy|27
3128670|NCT00048581|10692690|P1|Double-Blind Period|Lack of Efficacy|14
3128671|NCT00048581|10692688|P3|Double-Blind Period|Adverse Event|0
3128672|NCT00048581|10692689|P2|Double-Blind Period|Adverse Event|5
3128673|NCT00048581|10692690|P1|Double-Blind Period|Adverse Event|9
3128674|NCT00048568|10692857|P3|Open-Label Period|Lost to Follow-up|7
3128675|NCT00048568|10692858|P2|Open-Label Period|Lost to Follow-up|0
3128676|NCT00048568|10692859|P1|Open-Label Period|Lost to Follow-up|0
3128677|NCT00048568|10692857|P3|Open-Label Period|Unknown Reasons|25
3128678|NCT00048568|10692858|P2|Open-Label Period|Unknown Reasons|0
3128679|NCT00048568|10692859|P1|Open-Label Period|Unknown Reasons|0
3128680|NCT00048568|10692857|P3|Open-Label Period|Administrative Decision By Sponsor|1
3128681|NCT00048568|10692858|P2|Open-Label Period|Administrative Decision By Sponsor|0
3128682|NCT00048568|10692859|P1|Open-Label Period|Administrative Decision By Sponsor|0
3128683|NCT00048568|10692857|P3|Open-Label Period|No Longer Met Study Criteria|2
3128684|NCT00048568|10692858|P2|Open-Label Period|No Longer Met Study Criteria|0
3128685|NCT00048568|10692859|P1|Open-Label Period|No Longer Met Study Criteria|0
3128686|NCT00048568|10692857|P3|Open-Label Period|Pregnancy|5
3128687|NCT00048568|10692858|P2|Open-Label Period|Pregnancy|0
3128688|NCT00048568|10692859|P1|Open-Label Period|Pregnancy|0
3128689|NCT00048568|10692857|P3|Open-Label Period|Withdrawal by Subject|26
3128690|NCT00048568|10692858|P2|Open-Label Period|Withdrawal by Subject|0
3128691|NCT00048568|10692859|P1|Open-Label Period|Withdrawal by Subject|0
3128692|NCT00048568|10692857|P3|Open-Label Period|Lack of Efficacy|32
3128693|NCT00048568|10692858|P2|Open-Label Period|Lack of Efficacy|0
3128694|NCT00048568|10692859|P1|Open-Label Period|Lack of Efficacy|0
3128695|NCT00048568|10692857|P3|Open-Label Period|Adverse Event|49
3128696|NCT00048568|10692858|P2|Open-Label Period|Adverse Event|0
3128697|NCT00048568|10692859|P1|Open-Label Period|Adverse Event|0
3128698|NCT00048568|10692857|P3|Open-Label Period|Death|13
3128699|NCT00048568|10692858|P2|Open-Label Period|Death|0
3128700|NCT00048568|10692859|P1|Open-Label Period|Death|0
3128701|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
3128702|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
3128703|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
3128704|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
3128705|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
3128706|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
3128707|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
3128708|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
3128709|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
3128710|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
3128711|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
3128712|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
3128713|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
3128714|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
3128715|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
3128716|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
3128717|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
3128718|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
3128719|NCT00048568|10692857|P3|Double-Blind Period Days 170 to 365|Death|0
3128720|NCT00048568|10692858|P2|Double-Blind Period Days 170 to 365|Death|1
3128721|NCT00048568|10692859|P1|Double-Blind Period Days 170 to 365|Death|1
3128722|NCT00048568|10692857|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
3128723|NCT00048568|10692858|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
3128724|NCT00048568|10692859|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
3128725|NCT00048568|10692857|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
3128726|NCT00048568|10692858|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
3128727|NCT00048568|10692859|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
3128728|NCT00048568|10692857|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
3128729|NCT00048568|10692858|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
3128730|NCT00048568|10692859|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
3128731|NCT00048568|10692857|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
3128732|NCT00048568|10692858|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
3128733|NCT00048568|10692859|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
3128734|NCT00048568|10692857|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
3128735|NCT00048568|10692858|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
3128736|NCT00048568|10692859|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
3128737|NCT00048724|10693164|P2|Overall Study|Administrative|1
3128738|NCT00048724|10693165|P1|Overall Study|Administrative|1
3128739|NCT00048724|10693164|P2|Overall Study|Did Not Meet Protocol Eligibility|2
3128740|NCT00048724|10693165|P1|Overall Study|Did Not Meet Protocol Eligibility|2
3128741|NCT00048724|10693164|P2|Overall Study|Noncompliance With Protocol|12
3128742|NCT00048724|10693165|P1|Overall Study|Noncompliance With Protocol|4
3128743|NCT00048724|10693164|P2|Overall Study|Protocol-defined Clinical Event|32
3128744|NCT00048724|10693165|P1|Overall Study|Protocol-defined Clinical Event|17
3128745|NCT00048724|10693164|P2|Overall Study|Lost to Follow-up|5
3128746|NCT00048724|10693165|P1|Overall Study|Lost to Follow-up|5
3128747|NCT00048724|10693164|P2|Overall Study|Withdrawal by Subject|54
3128748|NCT00048724|10693165|P1|Overall Study|Withdrawal by Subject|34
3128749|NCT00048724|10693164|P2|Overall Study|Adverse Event|12
3128750|NCT00048724|10693165|P1|Overall Study|Adverse Event|53
3128751|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
3128752|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
3128753|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128754|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128755|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128756|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128757|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128758|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
3128759|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
3128760|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
3128761|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128762|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128763|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128764|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128765|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128766|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
3128767|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
3128768|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
3128769|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128770|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128771|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128772|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128773|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128774|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
3128775|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
3128776|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
3128777|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128778|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128779|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128780|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128781|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128782|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
3128783|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
3128784|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
3128785|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128786|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128787|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128788|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128789|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128790|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
3128791|NCT00048542|10693177|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
3128792|NCT00048542|10693178|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
3128793|NCT00048542|10693179|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128794|NCT00048542|10693180|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128795|NCT00048542|10693181|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128796|NCT00048542|10693182|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128797|NCT00048542|10693183|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128798|NCT00048542|10693184|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
3128799|NCT00048542|10693177|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128800|NCT00048542|10693178|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128801|NCT00048542|10693179|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
3128802|NCT00048542|10693180|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
3128803|NCT00048542|10693181|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128804|NCT00048542|10693182|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128805|NCT00048542|10693183|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128806|NCT00048542|10693184|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
3128807|NCT00048542|10693177|P8|Open-Label Extension BSA Phase|Adverse Event|0
3128808|NCT00048542|10693178|P7|Open-Label Extension BSA Phase|Adverse Event|0
3128809|NCT00048542|10693179|P6|Open-Label Extension BSA Phase|Adverse Event|1
3128810|NCT00048542|10693180|P5|Open-Label Extension BSA Phase|Adverse Event|1
3128811|NCT00048542|10693181|P4|Open-Label Extension BSA Phase|Adverse Event|0
3128812|NCT00048542|10693182|P3|Open-Label Extension BSA Phase|Adverse Event|0
3128813|NCT00048542|10693183|P2|Open-Label Extension BSA Phase|Adverse Event|0
3128814|NCT00048542|10693184|P1|Open-Label Extension BSA Phase|Adverse Event|0
3128815|NCT00048542|10693177|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128816|NCT00048542|10693178|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128817|NCT00048542|10693179|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
3128818|NCT00048542|10693180|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
3128819|NCT00048542|10693181|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128820|NCT00048542|10693182|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128821|NCT00048542|10693183|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128822|NCT00048542|10693184|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
3128823|NCT00048542|10693177|P8|Open-Label Extension BSA Phase|Protocol Violation|0
3128824|NCT00048542|10693178|P7|Open-Label Extension BSA Phase|Protocol Violation|0
3128825|NCT00048542|10693179|P6|Open-Label Extension BSA Phase|Protocol Violation|1
3128826|NCT00048542|10693180|P5|Open-Label Extension BSA Phase|Protocol Violation|0
3128827|NCT00048542|10693181|P4|Open-Label Extension BSA Phase|Protocol Violation|0
3128828|NCT00048542|10693182|P3|Open-Label Extension BSA Phase|Protocol Violation|0
3128829|NCT00048542|10693183|P2|Open-Label Extension BSA Phase|Protocol Violation|0
3128830|NCT00048542|10693184|P1|Open-Label Extension BSA Phase|Protocol Violation|0
3128831|NCT00048542|10693177|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128832|NCT00048542|10693178|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128833|NCT00048542|10693179|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
3128834|NCT00048542|10693180|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
3128835|NCT00048542|10693181|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128836|NCT00048542|10693182|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128837|NCT00048542|10693183|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128838|NCT00048542|10693184|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
3128839|NCT00048542|10693177|P8|Double-Blind Phase|Randomized in error|0
3128840|NCT00048542|10693178|P7|Double-Blind Phase|Randomized in error|0
3128841|NCT00048542|10693179|P6|Double-Blind Phase|Randomized in error|0
3128842|NCT00048542|10693180|P5|Double-Blind Phase|Randomized in error|0
3128843|NCT00048542|10693181|P4|Double-Blind Phase|Randomized in error|0
3128844|NCT00048542|10693182|P3|Double-Blind Phase|Randomized in error|0
3128845|NCT00048542|10693183|P2|Double-Blind Phase|Randomized in error|0
3128846|NCT00048542|10693184|P1|Double-Blind Phase|Randomized in error|1
3128847|NCT00048542|10693177|P8|Double-Blind Phase|Sponsor request or decision|0
3128848|NCT00048542|10693178|P7|Double-Blind Phase|Sponsor request or decision|0
3128849|NCT00048542|10693179|P6|Double-Blind Phase|Sponsor request or decision|0
3128850|NCT00048542|10693180|P5|Double-Blind Phase|Sponsor request or decision|0
3128851|NCT00048542|10693181|P4|Double-Blind Phase|Sponsor request or decision|0
3128852|NCT00048542|10693182|P3|Double-Blind Phase|Sponsor request or decision|0
3128853|NCT00048542|10693183|P2|Double-Blind Phase|Sponsor request or decision|0
3128854|NCT00048542|10693184|P1|Double-Blind Phase|Sponsor request or decision|2
3128855|NCT00048542|10693177|P8|Double-Blind Phase|Protocol Violation|0
3128856|NCT00048542|10693178|P7|Double-Blind Phase|Protocol Violation|0
3128857|NCT00048542|10693179|P6|Double-Blind Phase|Protocol Violation|0
3128858|NCT00048542|10693180|P5|Double-Blind Phase|Protocol Violation|0
3128859|NCT00048542|10693181|P4|Double-Blind Phase|Protocol Violation|0
3128860|NCT00048542|10693182|P3|Double-Blind Phase|Protocol Violation|1
3128861|NCT00048542|10693183|P2|Double-Blind Phase|Protocol Violation|0
3128862|NCT00048542|10693184|P1|Double-Blind Phase|Protocol Violation|0
3128863|NCT00048542|10693177|P8|Double-Blind Phase|Withdrawal by Subject|0
3128864|NCT00048542|10693178|P7|Double-Blind Phase|Withdrawal by Subject|0
3128865|NCT00048542|10693179|P6|Double-Blind Phase|Withdrawal by Subject|0
3128866|NCT00048542|10693180|P5|Double-Blind Phase|Withdrawal by Subject|0
3128867|NCT00048542|10693181|P4|Double-Blind Phase|Withdrawal by Subject|0
3128868|NCT00048542|10693182|P3|Double-Blind Phase|Withdrawal by Subject|0
3128869|NCT00048542|10693183|P2|Double-Blind Phase|Withdrawal by Subject|1
3128870|NCT00048542|10693184|P1|Double-Blind Phase|Withdrawal by Subject|0
3128871|NCT00048347|10693250|P1|Overall Study|Screen failure|2
3128872|NCT00048165|10693256|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
3128873|NCT00048165|10693257|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
3128874|NCT00048165|10693256|P2|Completed 12 Months Study|Death|1
3128875|NCT00048165|10693257|P1|Completed 12 Months Study|Death|2
3128876|NCT00048165|10693256|P2|Completed 12 Months Study|Administration/Other|2
3128877|NCT00048165|10693257|P1|Completed 12 Months Study|Administration/Other|0
3128878|NCT00048165|10693256|P2|Completed 6 Months Study|Did not receive study drug|6
3128879|NCT00048165|10693257|P1|Completed 6 Months Study|Did not receive study drug|6
3128880|NCT00048165|10693256|P2|Completed 6 Months Study|Violation criteria|2
3128881|NCT00048165|10693257|P1|Completed 6 Months Study|Violation criteria|0
3128882|NCT00048165|10693256|P2|Completed 6 Months Study|Refused treatment|5
3128883|NCT00048165|10693257|P1|Completed 6 Months Study|Refused treatment|5
3128884|NCT00048165|10693256|P2|Completed 6 Months Study|Other violation|6
3128885|NCT00048165|10693257|P1|Completed 6 Months Study|Other violation|4
3128886|NCT00048165|10693256|P2|Completed 6 Months Study|Insufficient therapy|4
3128887|NCT00048165|10693257|P1|Completed 6 Months Study|Insufficient therapy|1
3128888|NCT00048165|10693256|P2|Completed 6 Months Study|Death|6
3128889|NCT00048165|10693257|P1|Completed 6 Months Study|Death|12
3128890|NCT00048165|10693256|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
3128891|NCT00048165|10693257|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
3128892|NCT00048165|10693256|P2|Completed 6 Months Study|Abnormality of laboratory test|0
3128893|NCT00048165|10693257|P1|Completed 6 Months Study|Abnormality of laboratory test|1
3128894|NCT00048165|10693256|P2|Completed 6 Months Study|Administration/Other|8
3128895|NCT00048165|10693257|P1|Completed 6 Months Study|Administration/Other|8
3128896|NCT00048074|10693292|P3|Overall Study|Social reasons|0
3128897|NCT00048074|10693293|P2|Overall Study|Social reasons|0
3128898|NCT00048074|10693294|P1|Overall Study|Social reasons|1
3128899|NCT00048074|10693292|P3|Overall Study|Out of station|1
3128900|NCT00048074|10693293|P2|Overall Study|Out of station|1
3128901|NCT00048074|10693294|P1|Overall Study|Out of station|0
3128902|NCT00048074|10693292|P3|Overall Study|Poor compliance|0
3128903|NCT00048074|10693293|P2|Overall Study|Poor compliance|1
3128904|NCT00048074|10693294|P1|Overall Study|Poor compliance|0
3128905|NCT00048074|10693292|P3|Overall Study|Husband ill|0
3128906|NCT00048074|10693293|P2|Overall Study|Husband ill|1
3128907|NCT00048074|10693294|P1|Overall Study|Husband ill|0
3128908|NCT00048074|10693292|P3|Overall Study|Study participation was terminated|0
3128909|NCT00048074|10693293|P2|Overall Study|Study participation was terminated|1
3128910|NCT00048074|10693294|P1|Overall Study|Study participation was terminated|0
3128911|NCT00048074|10693292|P3|Overall Study|Protocol Violation|0
3128912|NCT00048074|10693293|P2|Overall Study|Protocol Violation|3
3128913|NCT00048074|10693294|P1|Overall Study|Protocol Violation|1
3128914|NCT00048074|10693292|P3|Overall Study|Withdrawal by Subject|35
3128915|NCT00048074|10693293|P2|Overall Study|Withdrawal by Subject|30
3128916|NCT00048074|10693294|P1|Overall Study|Withdrawal by Subject|28
3128917|NCT00048074|10693292|P3|Overall Study|Lost to Follow-up|6
3128918|NCT00048074|10693293|P2|Overall Study|Lost to Follow-up|6
3128919|NCT00048074|10693294|P1|Overall Study|Lost to Follow-up|2
3128920|NCT00048074|10693292|P3|Overall Study|Death|2
3128921|NCT00048074|10693293|P2|Overall Study|Death|3
3128922|NCT00048074|10693294|P1|Overall Study|Death|3
3128923|NCT00048074|10693292|P3|Overall Study|Adverse Event|53
3128924|NCT00048074|10693293|P2|Overall Study|Adverse Event|41
3128925|NCT00048074|10693294|P1|Overall Study|Adverse Event|46
3128926|NCT00048061|10693351|P4|Overall Study|Early improvement|0
3128927|NCT00048061|10693352|P3|Overall Study|Early improvement|3
3128928|NCT00048061|10693353|P2|Overall Study|Early improvement|5
3128929|NCT00048061|10693354|P1|Overall Study|Early improvement|6
3128930|NCT00048061|10693351|P4|Overall Study|Did not follow-up|5
3128931|NCT00048061|10693352|P3|Overall Study|Did not follow-up|4
3128932|NCT00048061|10693353|P2|Overall Study|Did not follow-up|5
3128933|NCT00048061|10693354|P1|Overall Study|Did not follow-up|5
3128934|NCT00048061|10693351|P4|Overall Study|Withdrawal by Subject|32
3128935|NCT00048061|10693352|P3|Overall Study|Withdrawal by Subject|29
3128936|NCT00048061|10693353|P2|Overall Study|Withdrawal by Subject|29
3128937|NCT00048061|10693354|P1|Overall Study|Withdrawal by Subject|20
3128938|NCT00048061|10693351|P4|Overall Study|Lost to Follow-up|5
3128939|NCT00048061|10693352|P3|Overall Study|Lost to Follow-up|4
3128940|NCT00048061|10693353|P2|Overall Study|Lost to Follow-up|2
3128941|NCT00048061|10693354|P1|Overall Study|Lost to Follow-up|3
3128942|NCT00048061|10693351|P4|Overall Study|Adverse Event|37
3128943|NCT00048061|10693352|P3|Overall Study|Adverse Event|44
3128944|NCT00048061|10693353|P2|Overall Study|Adverse Event|32
3128945|NCT00048061|10693354|P1|Overall Study|Adverse Event|41
3128946|NCT00048048|10693433|P12|Extension Year 2|Early withdrawals|2
3128947|NCT00048048|10693434|P11|Extension Year 2|Early withdrawals|4
3128948|NCT00048048|10693435|P10|Extension Year 2|Early withdrawals|0
3128949|NCT00048048|10693436|P9|Extension Year 2|Early withdrawals|0
3128950|NCT00048048|10693437|P8|Extension Year 2|Early withdrawals|0
3128951|NCT00048048|10693438|P7|Extension Year 2|Early withdrawals|0
3128952|NCT00048048|10693439|P6|Extension Year 2|Early withdrawals|0
3128953|NCT00048048|10693440|P5|Extension Year 2|Early withdrawals|0
3128954|NCT00048048|10693441|P4|Extension Year 2|Early withdrawals|0
3128955|NCT00048048|10693442|P3|Extension Year 2|Early withdrawals|0
3128956|NCT00048048|10693443|P2|Extension Year 2|Early withdrawals|0
3128957|NCT00048048|10693444|P1|Extension Year 2|Early withdrawals|0
3128958|NCT00048048|10693433|P12|Extension Year 1|Early withdrawals|4
3128959|NCT00048048|10693434|P11|Extension Year 1|Early withdrawals|2
3128960|NCT00048048|10693435|P10|Extension Year 1|Early withdrawals|2
3128961|NCT00048048|10693436|P9|Extension Year 1|Early withdrawals|0
3128962|NCT00048048|10693437|P8|Extension Year 1|Early withdrawals|0
3128963|NCT00048048|10693438|P7|Extension Year 1|Early withdrawals|0
3128964|NCT00048048|10693439|P6|Extension Year 1|Early withdrawals|0
3128965|NCT00048048|10693440|P5|Extension Year 1|Early withdrawals|0
3128966|NCT00048048|10693441|P4|Extension Year 1|Early withdrawals|0
3128967|NCT00048048|10693442|P3|Extension Year 1|Early withdrawals|0
3128968|NCT00048048|10693443|P2|Extension Year 1|Early withdrawals|0
3128969|NCT00048048|10693444|P1|Extension Year 1|Early withdrawals|0
3128970|NCT00048048|10693433|P12|Core Treatment|Adverse Event|0
3128971|NCT00048048|10693434|P11|Core Treatment|Adverse Event|0
3128972|NCT00048048|10693435|P10|Core Treatment|Adverse Event|0
3128973|NCT00048048|10693436|P9|Core Treatment|Adverse Event|0
3128974|NCT00048048|10693437|P8|Core Treatment|Adverse Event|1
3128975|NCT00048048|10693438|P7|Core Treatment|Adverse Event|0
3128976|NCT00048048|10693439|P6|Core Treatment|Adverse Event|0
3128977|NCT00048048|10693440|P5|Core Treatment|Adverse Event|0
3128978|NCT00048048|10693441|P4|Core Treatment|Adverse Event|0
3128979|NCT00048048|10693442|P3|Core Treatment|Adverse Event|0
3128980|NCT00048048|10693443|P2|Core Treatment|Adverse Event|0
3128981|NCT00048048|10693444|P1|Core Treatment|Adverse Event|0
3128982|NCT00048048|10693433|P12|Core Treatment|Withdrawal by Subject|0
3128983|NCT00048048|10693434|P11|Core Treatment|Withdrawal by Subject|0
3128984|NCT00048048|10693435|P10|Core Treatment|Withdrawal by Subject|0
3128985|NCT00048048|10693436|P9|Core Treatment|Withdrawal by Subject|0
3128986|NCT00048048|10693437|P8|Core Treatment|Withdrawal by Subject|0
3128987|NCT00048048|10693438|P7|Core Treatment|Withdrawal by Subject|0
3128988|NCT00048048|10693439|P6|Core Treatment|Withdrawal by Subject|0
3128989|NCT00048048|10693440|P5|Core Treatment|Withdrawal by Subject|0
3128990|NCT00048048|10693441|P4|Core Treatment|Withdrawal by Subject|0
3128991|NCT00048048|10693442|P3|Core Treatment|Withdrawal by Subject|1
3128992|NCT00048048|10693443|P2|Core Treatment|Withdrawal by Subject|0
3128993|NCT00048048|10693444|P1|Core Treatment|Withdrawal by Subject|0
3128994|NCT00048035|10693500|P8|Extension Year 2|Early Withdrawals|3
3128995|NCT00048035|10693501|P7|Extension Year 2|Early Withdrawals|3
3128996|NCT00048035|10693502|P6|Extension Year 2|Early Withdrawals|0
3128997|NCT00048035|10693503|P5|Extension Year 2|Early Withdrawals|0
3128998|NCT00048035|10693504|P4|Extension Year 2|Early Withdrawals|0
3128999|NCT00048035|10693505|P3|Extension Year 2|Early Withdrawals|0
3129000|NCT00048035|10693506|P2|Extension Year 2|Early Withdrawals|0
3129001|NCT00048035|10693507|P1|Extension Year 2|Early Withdrawals|0
3129002|NCT00048035|10693500|P8|Extension Year 1|Early Withdrawals|11
3129003|NCT00048035|10693501|P7|Extension Year 1|Early Withdrawals|11
3129004|NCT00048035|10693502|P6|Extension Year 1|Early Withdrawals|0
3129005|NCT00048035|10693503|P5|Extension Year 1|Early Withdrawals|0
3129006|NCT00048035|10693504|P4|Extension Year 1|Early Withdrawals|0
3129007|NCT00048035|10693505|P3|Extension Year 1|Early Withdrawals|0
3129008|NCT00048035|10693506|P2|Extension Year 1|Early Withdrawals|0
3129009|NCT00048035|10693507|P1|Extension Year 1|Early Withdrawals|0
3129010|NCT00048035|10693500|P8|Core Period|Early Withdrawals|0
3129011|NCT00048035|10693501|P7|Core Period|Early Withdrawals|0
3129012|NCT00048035|10693502|P6|Core Period|Early Withdrawals|1
3129013|NCT00048035|10693503|P5|Core Period|Early Withdrawals|1
3129014|NCT00048035|10693504|P4|Core Period|Early Withdrawals|1
3129015|NCT00048035|10693505|P3|Core Period|Early Withdrawals|1
3129016|NCT00048035|10693506|P2|Core Period|Early Withdrawals|2
3129017|NCT00048035|10693507|P1|Core Period|Early Withdrawals|4
3129018|NCT00047879|10693545|P2|Overall Study|Progressive disease|3
3129019|NCT00047879|10693546|P1|Overall Study|Progressive disease|4
3129020|NCT00047463|10693582|P2|Overall Study|Withdrawal by Subject|3
3129021|NCT00047463|10693583|P1|Overall Study|Withdrawal by Subject|0
3129022|NCT00045942|10693700|P9|PKC412A2104E2|Death|0
3129023|NCT00045942|10693701|P8|PKC412A2104E2|Death|0
3129024|NCT00045942|10693702|P7|PKC412A2104E2|Death|2
3129025|NCT00045942|10693703|P6|PKC412A2104E2|Death|1
3129026|NCT00045942|10693704|P5|PKC412A2104E2|Death|0
3129027|NCT00045942|10693705|P4|PKC412A2104E2|Death|0
3129028|NCT00045942|10693706|P3|PKC412A2104E2|Death|0
3129029|NCT00045942|10693707|P2|PKC412A2104E2|Death|0
3129030|NCT00045942|10693708|P1|PKC412A2104E2|Death|0
3129031|NCT00045942|10693700|P9|PKC412A2104E2|Adverse Event|0
3129032|NCT00045942|10693701|P8|PKC412A2104E2|Adverse Event|1
3129033|NCT00045942|10693702|P7|PKC412A2104E2|Adverse Event|3
3129034|NCT00045942|10693703|P6|PKC412A2104E2|Adverse Event|4
3129035|NCT00045942|10693704|P5|PKC412A2104E2|Adverse Event|0
3129036|NCT00045942|10693705|P4|PKC412A2104E2|Adverse Event|0
3129037|NCT00045942|10693706|P3|PKC412A2104E2|Adverse Event|0
3129038|NCT00045942|10693707|P2|PKC412A2104E2|Adverse Event|0
3129039|NCT00045942|10693708|P1|PKC412A2104E2|Adverse Event|0
3129040|NCT00045942|10693700|P9|PKC412A2104E2|Lack of Efficacy|6
3129041|NCT00045942|10693701|P8|PKC412A2104E2|Lack of Efficacy|2
3129042|NCT00045942|10693702|P7|PKC412A2104E2|Lack of Efficacy|2
3129043|NCT00045942|10693703|P6|PKC412A2104E2|Lack of Efficacy|3
3129044|NCT00045942|10693704|P5|PKC412A2104E2|Lack of Efficacy|0
3129045|NCT00045942|10693705|P4|PKC412A2104E2|Lack of Efficacy|0
3129046|NCT00045942|10693706|P3|PKC412A2104E2|Lack of Efficacy|0
3129047|NCT00045942|10693707|P2|PKC412A2104E2|Lack of Efficacy|0
3129048|NCT00045942|10693708|P1|PKC412A2104E2|Lack of Efficacy|0
3129049|NCT00045942|10693700|P9|PKC412A2104E2|Withdrawal by Subject|0
3129050|NCT00045942|10693701|P8|PKC412A2104E2|Withdrawal by Subject|1
3129051|NCT00045942|10693702|P7|PKC412A2104E2|Withdrawal by Subject|0
3129052|NCT00045942|10693703|P6|PKC412A2104E2|Withdrawal by Subject|1
3129053|NCT00045942|10693704|P5|PKC412A2104E2|Withdrawal by Subject|0
3129054|NCT00045942|10693705|P4|PKC412A2104E2|Withdrawal by Subject|0
3129055|NCT00045942|10693706|P3|PKC412A2104E2|Withdrawal by Subject|0
3129056|NCT00045942|10693707|P2|PKC412A2104E2|Withdrawal by Subject|0
3129057|NCT00045942|10693708|P1|PKC412A2104E2|Withdrawal by Subject|0
3129058|NCT00045942|10693700|P9|PKC412A2104E2|Lost to Follow-up|0
3129059|NCT00045942|10693701|P8|PKC412A2104E2|Lost to Follow-up|3
3129060|NCT00045942|10693702|P7|PKC412A2104E2|Lost to Follow-up|0
3129061|NCT00045942|10693703|P6|PKC412A2104E2|Lost to Follow-up|0
3129062|NCT00045942|10693704|P5|PKC412A2104E2|Lost to Follow-up|0
3129063|NCT00045942|10693705|P4|PKC412A2104E2|Lost to Follow-up|0
3129064|NCT00045942|10693706|P3|PKC412A2104E2|Lost to Follow-up|0
3129065|NCT00045942|10693707|P2|PKC412A2104E2|Lost to Follow-up|0
3129066|NCT00045942|10693708|P1|PKC412A2104E2|Lost to Follow-up|0
3129067|NCT00045942|10693700|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129068|NCT00045942|10693701|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129069|NCT00045942|10693702|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129070|NCT00045942|10693703|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129071|NCT00045942|10693704|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129072|NCT00045942|10693705|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
3129073|NCT00045942|10693706|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
3129074|NCT00045942|10693707|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129075|NCT00045942|10693708|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
3129076|NCT00045942|10693700|P9|PKC412A2104E1|Death|0
3129077|NCT00045942|10693701|P8|PKC412A2104E1|Death|0
3129078|NCT00045942|10693702|P7|PKC412A2104E1|Death|0
3129079|NCT00045942|10693703|P6|PKC412A2104E1|Death|0
3129080|NCT00045942|10693704|P5|PKC412A2104E1|Death|1
3129081|NCT00045942|10693705|P4|PKC412A2104E1|Death|1
3129082|NCT00045942|10693706|P3|PKC412A2104E1|Death|1
3129083|NCT00045942|10693707|P2|PKC412A2104E1|Death|4
3129084|NCT00045942|10693708|P1|PKC412A2104E1|Death|0
3129085|NCT00045942|10693700|P9|PKC412A2104E1|Adverse Event|0
3129086|NCT00045942|10693701|P8|PKC412A2104E1|Adverse Event|0
3129087|NCT00045942|10693702|P7|PKC412A2104E1|Adverse Event|0
3129088|NCT00045942|10693703|P6|PKC412A2104E1|Adverse Event|0
3129089|NCT00045942|10693704|P5|PKC412A2104E1|Adverse Event|6
3129090|NCT00045942|10693705|P4|PKC412A2104E1|Adverse Event|3
3129091|NCT00045942|10693706|P3|PKC412A2104E1|Adverse Event|1
3129092|NCT00045942|10693707|P2|PKC412A2104E1|Adverse Event|1
3129093|NCT00045942|10693708|P1|PKC412A2104E1|Adverse Event|0
3129094|NCT00045942|10693700|P9|PKC412A2104E1|Abnormal laboratory value|0
3129095|NCT00045942|10693701|P8|PKC412A2104E1|Abnormal laboratory value|0
3129096|NCT00045942|10693702|P7|PKC412A2104E1|Abnormal laboratory value|0
3129097|NCT00045942|10693703|P6|PKC412A2104E1|Abnormal laboratory value|0
3129098|NCT00045942|10693704|P5|PKC412A2104E1|Abnormal laboratory value|0
3129099|NCT00045942|10693705|P4|PKC412A2104E1|Abnormal laboratory value|0
3129100|NCT00045942|10693706|P3|PKC412A2104E1|Abnormal laboratory value|0
3129101|NCT00045942|10693707|P2|PKC412A2104E1|Abnormal laboratory value|1
3129102|NCT00045942|10693708|P1|PKC412A2104E1|Abnormal laboratory value|0
3129103|NCT00045942|10693700|P9|PKC412A2104E1|Lack of Efficacy|0
3129104|NCT00045942|10693701|P8|PKC412A2104E1|Lack of Efficacy|0
3129105|NCT00045942|10693702|P7|PKC412A2104E1|Lack of Efficacy|0
3129106|NCT00045942|10693703|P6|PKC412A2104E1|Lack of Efficacy|0
3129107|NCT00045942|10693704|P5|PKC412A2104E1|Lack of Efficacy|17
3129108|NCT00045942|10693705|P4|PKC412A2104E1|Lack of Efficacy|23
3129109|NCT00045942|10693706|P3|PKC412A2104E1|Lack of Efficacy|11
3129110|NCT00045942|10693707|P2|PKC412A2104E1|Lack of Efficacy|11
3129111|NCT00045942|10693708|P1|PKC412A2104E1|Lack of Efficacy|0
3129112|NCT00045942|10693700|P9|PKC412A2104E1|Condition no longer requires study drug|0
3129113|NCT00045942|10693701|P8|PKC412A2104E1|Condition no longer requires study drug|0
3129114|NCT00045942|10693702|P7|PKC412A2104E1|Condition no longer requires study drug|0
3129115|NCT00045942|10693703|P6|PKC412A2104E1|Condition no longer requires study drug|0
3129116|NCT00045942|10693704|P5|PKC412A2104E1|Condition no longer requires study drug|1
3129117|NCT00045942|10693705|P4|PKC412A2104E1|Condition no longer requires study drug|0
3129118|NCT00045942|10693706|P3|PKC412A2104E1|Condition no longer requires study drug|1
3129119|NCT00045942|10693707|P2|PKC412A2104E1|Condition no longer requires study drug|1
3129120|NCT00045942|10693708|P1|PKC412A2104E1|Condition no longer requires study drug|0
3129121|NCT00045942|10693700|P9|PKC412A2104E1|Withdrawal by Subject|0
3129122|NCT00045942|10693701|P8|PKC412A2104E1|Withdrawal by Subject|0
3129123|NCT00045942|10693702|P7|PKC412A2104E1|Withdrawal by Subject|0
3129124|NCT00045942|10693703|P6|PKC412A2104E1|Withdrawal by Subject|0
3129125|NCT00045942|10693704|P5|PKC412A2104E1|Withdrawal by Subject|2
3129126|NCT00045942|10693705|P4|PKC412A2104E1|Withdrawal by Subject|5
3129127|NCT00045942|10693706|P3|PKC412A2104E1|Withdrawal by Subject|2
3129128|NCT00045942|10693707|P2|PKC412A2104E1|Withdrawal by Subject|0
3129129|NCT00045942|10693708|P1|PKC412A2104E1|Withdrawal by Subject|0
3129130|NCT00045942|10693700|P9|PKC412A2104 (Core)|Death|0
3129131|NCT00045942|10693701|P8|PKC412A2104 (Core)|Death|0
3129132|NCT00045942|10693702|P7|PKC412A2104 (Core)|Death|0
3129133|NCT00045942|10693703|P6|PKC412A2104 (Core)|Death|0
3129134|NCT00045942|10693704|P5|PKC412A2104 (Core)|Death|0
3129135|NCT00045942|10693705|P4|PKC412A2104 (Core)|Death|0
3129136|NCT00045942|10693706|P3|PKC412A2104 (Core)|Death|0
3129137|NCT00045942|10693707|P2|PKC412A2104 (Core)|Death|0
3129138|NCT00045942|10693708|P1|PKC412A2104 (Core)|Death|1
3129139|NCT00045942|10693700|P9|PKC412A2104 (Core)|Lack of Efficacy|0
3129140|NCT00045942|10693701|P8|PKC412A2104 (Core)|Lack of Efficacy|0
3129141|NCT00045942|10693702|P7|PKC412A2104 (Core)|Lack of Efficacy|0
3129142|NCT00045942|10693703|P6|PKC412A2104 (Core)|Lack of Efficacy|0
3129143|NCT00045942|10693704|P5|PKC412A2104 (Core)|Lack of Efficacy|0
3129144|NCT00045942|10693705|P4|PKC412A2104 (Core)|Lack of Efficacy|0
3129145|NCT00045942|10693706|P3|PKC412A2104 (Core)|Lack of Efficacy|0
3129146|NCT00045942|10693707|P2|PKC412A2104 (Core)|Lack of Efficacy|0
3129147|NCT00045942|10693708|P1|PKC412A2104 (Core)|Lack of Efficacy|13
3129148|NCT00045942|10693700|P9|PKC412A2104 (Core)|Adverse Event|0
3129149|NCT00045942|10693701|P8|PKC412A2104 (Core)|Adverse Event|0
3129150|NCT00045942|10693702|P7|PKC412A2104 (Core)|Adverse Event|0
3129151|NCT00045942|10693703|P6|PKC412A2104 (Core)|Adverse Event|0
3129152|NCT00045942|10693704|P5|PKC412A2104 (Core)|Adverse Event|0
3129153|NCT00045942|10693705|P4|PKC412A2104 (Core)|Adverse Event|0
3129154|NCT00045942|10693706|P3|PKC412A2104 (Core)|Adverse Event|0
3129155|NCT00045942|10693707|P2|PKC412A2104 (Core)|Adverse Event|0
3129156|NCT00045942|10693708|P1|PKC412A2104 (Core)|Adverse Event|5
3129157|NCT00045942|10693700|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
3129158|NCT00045942|10693701|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
3129159|NCT00045942|10693702|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
3129160|NCT00045942|10693703|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
3129161|NCT00045942|10693704|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
3129162|NCT00045942|10693705|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
3129163|NCT00045942|10693706|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
3129164|NCT00045942|10693707|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
3129165|NCT00045942|10693708|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
3129166|NCT00044512|10693797|P1|Follow Up|Lost to Follow-up|2
3129167|NCT00044213|10693812|P4|Overall Study|Lost to Follow-up|4
3129168|NCT00044213|10693813|P3|Overall Study|Lost to Follow-up|5
3129169|NCT00044213|10693814|P2|Overall Study|Lost to Follow-up|5
3129170|NCT00044213|10693815|P1|Overall Study|Lost to Follow-up|8
3129171|NCT00044213|10693812|P4|Overall Study|Death|49
3129172|NCT00044213|10693813|P3|Overall Study|Death|42
3129173|NCT00044213|10693814|P2|Overall Study|Death|42
3129174|NCT00044213|10693815|P1|Overall Study|Death|42
3129175|NCT00044213|10693812|P4|Overall Study|Withdrawal by Subject|83
3129176|NCT00044213|10693813|P3|Overall Study|Withdrawal by Subject|91
3129177|NCT00044213|10693814|P2|Overall Study|Withdrawal by Subject|65
3129178|NCT00044213|10693815|P1|Overall Study|Withdrawal by Subject|50
3129179|NCT00044083|10693880|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
3129180|NCT00044083|10693881|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
3129181|NCT00044083|10693880|P2|First Intervention (One Week) Patients|Used illegal drug|0
3129182|NCT00044083|10693881|P1|First Intervention (One Week) Patients|Used illegal drug|1
3129183|NCT00044083|10693880|P2|First Intervention (One Week) Patients|Not follow directions|2
3129184|NCT00044083|10693881|P1|First Intervention (One Week) Patients|Not follow directions|0
3129185|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
3129186|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
3129187|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
3129188|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
3129189|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
3129190|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
3129191|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Pregnancy|0
3129192|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Pregnancy|1
3129193|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
3129194|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
3129195|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Not follow directions|2
3129196|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Not follow directions|2
3129197|NCT00044083|10693880|P2|First Intervention (One Week)- HV's|Adverse Event|0
3129198|NCT00044083|10693881|P1|First Intervention (One Week)- HV's|Adverse Event|1
3129199|NCT00043979|10693919|P3|Period 1|recipient with progressive disease|3
3129200|NCT00043979|10693920|P2|Period 1|recipient with progressive disease|4
3129201|NCT00043979|10693921|P1|Period 1|recipient with progressive disease|7
3129202|NCT00043550|10693942|P3|Overall Study|Withdrawal by Subject|20
3129203|NCT00043550|10693943|P2|Overall Study|Withdrawal by Subject|12
3129204|NCT00043550|10693944|P1|Overall Study|Withdrawal by Subject|22
3129205|NCT00043186|10693961|P9|Overall Study|Other|0
3129206|NCT00043186|10693962|P8|Overall Study|Other|0
3129207|NCT00043186|10693963|P7|Overall Study|Other|0
3129208|NCT00043186|10693964|P6|Overall Study|Other|0
3129209|NCT00043186|10693965|P5|Overall Study|Other|0
3129210|NCT00043186|10693966|P4|Overall Study|Other|1
3129211|NCT00043186|10693967|P3|Overall Study|Other|1
3129212|NCT00043186|10693968|P2|Overall Study|Other|0
3129213|NCT00043186|10693969|P1|Overall Study|Other|0
3129214|NCT00043186|10693961|P9|Overall Study|Noncompliance|0
3129215|NCT00043186|10693962|P8|Overall Study|Noncompliance|0
3129216|NCT00043186|10693963|P7|Overall Study|Noncompliance|0
3129217|NCT00043186|10693964|P6|Overall Study|Noncompliance|0
3129218|NCT00043186|10693965|P5|Overall Study|Noncompliance|0
3129219|NCT00043186|10693966|P4|Overall Study|Noncompliance|1
3129220|NCT00043186|10693967|P3|Overall Study|Noncompliance|1
3129221|NCT00043186|10693968|P2|Overall Study|Noncompliance|0
3129222|NCT00043186|10693969|P1|Overall Study|Noncompliance|0
3129223|NCT00043186|10693961|P9|Overall Study|Lost to Follow-up|2
3129224|NCT00043186|10693962|P8|Overall Study|Lost to Follow-up|1
3129225|NCT00043186|10693963|P7|Overall Study|Lost to Follow-up|1
3129226|NCT00043186|10693964|P6|Overall Study|Lost to Follow-up|1
3129227|NCT00043186|10693965|P5|Overall Study|Lost to Follow-up|1
3129228|NCT00043186|10693966|P4|Overall Study|Lost to Follow-up|1
3129229|NCT00043186|10693967|P3|Overall Study|Lost to Follow-up|1
3129230|NCT00043186|10693968|P2|Overall Study|Lost to Follow-up|5
3129231|NCT00043186|10693969|P1|Overall Study|Lost to Follow-up|3
3129232|NCT00043186|10693961|P9|Overall Study|Ineligibility determined|1
3129233|NCT00043186|10693962|P8|Overall Study|Ineligibility determined|0
3129234|NCT00043186|10693963|P7|Overall Study|Ineligibility determined|0
3129235|NCT00043186|10693964|P6|Overall Study|Ineligibility determined|0
3129236|NCT00043186|10693965|P5|Overall Study|Ineligibility determined|0
3129237|NCT00043186|10693966|P4|Overall Study|Ineligibility determined|0
3129238|NCT00043186|10693967|P3|Overall Study|Ineligibility determined|0
3129239|NCT00043186|10693968|P2|Overall Study|Ineligibility determined|0
3129240|NCT00043186|10693969|P1|Overall Study|Ineligibility determined|0
3129241|NCT00043186|10693961|P9|Overall Study|Disease progression|0
3129242|NCT00043186|10693962|P8|Overall Study|Disease progression|4
3129243|NCT00043186|10693963|P7|Overall Study|Disease progression|0
3129244|NCT00043186|10693964|P6|Overall Study|Disease progression|0
3129245|NCT00043186|10693965|P5|Overall Study|Disease progression|0
3129246|NCT00043186|10693966|P4|Overall Study|Disease progression|3
3129247|NCT00043186|10693967|P3|Overall Study|Disease progression|0
3129248|NCT00043186|10693968|P2|Overall Study|Disease progression|0
3129249|NCT00043186|10693969|P1|Overall Study|Disease progression|1
3129250|NCT00043186|10693961|P9|Overall Study|Death|0
3129251|NCT00043186|10693962|P8|Overall Study|Death|0
3129252|NCT00043186|10693963|P7|Overall Study|Death|2
3129253|NCT00043186|10693964|P6|Overall Study|Death|0
3129254|NCT00043186|10693965|P5|Overall Study|Death|0
3129255|NCT00043186|10693966|P4|Overall Study|Death|0
3129256|NCT00043186|10693967|P3|Overall Study|Death|1
3129257|NCT00043186|10693968|P2|Overall Study|Death|0
3129258|NCT00043186|10693969|P1|Overall Study|Death|0
3129259|NCT00043186|10693961|P9|Overall Study|Withdrawal by Subject|10
3129260|NCT00043186|10693962|P8|Overall Study|Withdrawal by Subject|9
3129261|NCT00043186|10693963|P7|Overall Study|Withdrawal by Subject|12
3129262|NCT00043186|10693964|P6|Overall Study|Withdrawal by Subject|6
3129263|NCT00043186|10693965|P5|Overall Study|Withdrawal by Subject|14
3129264|NCT00043186|10693966|P4|Overall Study|Withdrawal by Subject|13
3129265|NCT00043186|10693967|P3|Overall Study|Withdrawal by Subject|11
3129266|NCT00043186|10693968|P2|Overall Study|Withdrawal by Subject|8
3129267|NCT00043186|10693969|P1|Overall Study|Withdrawal by Subject|11
3129268|NCT00043186|10693961|P9|Overall Study|Adverse Event|3
3129269|NCT00043186|10693962|P8|Overall Study|Adverse Event|1
3129270|NCT00043186|10693963|P7|Overall Study|Adverse Event|2
3129271|NCT00043186|10693964|P6|Overall Study|Adverse Event|1
3129272|NCT00043186|10693965|P5|Overall Study|Adverse Event|2
3129273|NCT00043186|10693966|P4|Overall Study|Adverse Event|3
3129274|NCT00043186|10693967|P3|Overall Study|Adverse Event|2
3129275|NCT00043186|10693968|P2|Overall Study|Adverse Event|2
3129276|NCT00043186|10693969|P1|Overall Study|Adverse Event|2
3129277|NCT00043186|10693961|P9|Overall Study|Physician Decision|1
3129278|NCT00043186|10693962|P8|Overall Study|Physician Decision|1
3129279|NCT00043186|10693963|P7|Overall Study|Physician Decision|0
3129280|NCT00043186|10693964|P6|Overall Study|Physician Decision|0
3129281|NCT00043186|10693965|P5|Overall Study|Physician Decision|1
3129282|NCT00043186|10693966|P4|Overall Study|Physician Decision|0
3129283|NCT00043186|10693967|P3|Overall Study|Physician Decision|3
3129284|NCT00043186|10693968|P2|Overall Study|Physician Decision|0
3129285|NCT00043186|10693969|P1|Overall Study|Physician Decision|0
3129286|NCT00042432|10694297|P2|Overall Study|Other|0
3129287|NCT00042432|10694298|P1|Overall Study|Other|2
3129288|NCT00042432|10694297|P2|Overall Study|Initiation of maintenance dialysis|1
3129289|NCT00042432|10694298|P1|Overall Study|Initiation of maintenance dialysis|1
3129290|NCT00042432|10694297|P2|Overall Study|Ineligibility determined|0
3129291|NCT00042432|10694298|P1|Overall Study|Ineligibility determined|1
3129292|NCT00042432|10694297|P2|Overall Study|Death|2
3129293|NCT00042432|10694298|P1|Overall Study|Death|0
3129294|NCT00042432|10694297|P2|Overall Study|Withdrawal by Subject|3
3129295|NCT00042432|10694298|P1|Overall Study|Withdrawal by Subject|1
3129296|NCT00042432|10694297|P2|Overall Study|Adverse Event|1
3129297|NCT00042432|10694298|P1|Overall Study|Adverse Event|4
3129298|NCT00041756|10694351|P5|Overall Study|Data Monitoring Committee Recommendation|21
3129299|NCT00041756|10694352|P4|Overall Study|Data Monitoring Committee Recommendation|0
3129300|NCT00041756|10694353|P3|Overall Study|Data Monitoring Committee Recommendation|0
3129301|NCT00041756|10694354|P2|Overall Study|Data Monitoring Committee Recommendation|0
3129302|NCT00041756|10694355|P1|Overall Study|Data Monitoring Committee Recommendation|0
3129303|NCT00041756|10694351|P5|Overall Study|Unable to meet protocol criteria|1
3129304|NCT00041756|10694352|P4|Overall Study|Unable to meet protocol criteria|0
3129305|NCT00041756|10694353|P3|Overall Study|Unable to meet protocol criteria|1
3129306|NCT00041756|10694354|P2|Overall Study|Unable to meet protocol criteria|0
3129307|NCT00041756|10694355|P1|Overall Study|Unable to meet protocol criteria|0
3129308|NCT00041756|10694351|P5|Overall Study|Lost to Follow-up|0
3129309|NCT00041756|10694352|P4|Overall Study|Lost to Follow-up|1
3129310|NCT00041756|10694353|P3|Overall Study|Lost to Follow-up|0
3129311|NCT00041756|10694354|P2|Overall Study|Lost to Follow-up|1
3129312|NCT00041756|10694355|P1|Overall Study|Lost to Follow-up|0
3129313|NCT00041756|10694351|P5|Overall Study|Withdrawal by Subject|3
3129314|NCT00041756|10694352|P4|Overall Study|Withdrawal by Subject|2
3129315|NCT00041756|10694353|P3|Overall Study|Withdrawal by Subject|4
3129316|NCT00041756|10694354|P2|Overall Study|Withdrawal by Subject|3
3129317|NCT00041756|10694355|P1|Overall Study|Withdrawal by Subject|3
3129318|NCT00041756|10694351|P5|Overall Study|Protocol Violation|1
3129319|NCT00041756|10694352|P4|Overall Study|Protocol Violation|2
3129320|NCT00041756|10694353|P3|Overall Study|Protocol Violation|2
3129321|NCT00041756|10694354|P2|Overall Study|Protocol Violation|1
3129322|NCT00041756|10694355|P1|Overall Study|Protocol Violation|1
3129323|NCT00041756|10694351|P5|Overall Study|Adverse Event|34
3129324|NCT00041756|10694352|P4|Overall Study|Adverse Event|11
3129325|NCT00041756|10694353|P3|Overall Study|Adverse Event|6
3129326|NCT00041756|10694354|P2|Overall Study|Adverse Event|10
3129327|NCT00041756|10694355|P1|Overall Study|Adverse Event|4
3129328|NCT00041470|10694383|P1|Overall Study|Loss of Funding|38
3129329|NCT00040664|10694388|P4|Overall Study|Non-viability of oral suspension|0
3129330|NCT00040664|10694389|P3|Overall Study|Non-viability of oral suspension|1
3129331|NCT00040664|10694390|P2|Overall Study|Non-viability of oral suspension|0
3129332|NCT00040664|10694391|P1|Overall Study|Non-viability of oral suspension|1
3129333|NCT00040664|10694388|P4|Overall Study|Change of formulation|0
3129334|NCT00040664|10694389|P3|Overall Study|Change of formulation|0
3129335|NCT00040664|10694390|P2|Overall Study|Change of formulation|2
3129336|NCT00040664|10694391|P1|Overall Study|Change of formulation|2
3129337|NCT00040664|10694388|P4|Overall Study|Pharmacokinetic target not achieved|1
3129338|NCT00040664|10694389|P3|Overall Study|Pharmacokinetic target not achieved|0
3129339|NCT00040664|10694390|P2|Overall Study|Pharmacokinetic target not achieved|1
3129340|NCT00040664|10694391|P1|Overall Study|Pharmacokinetic target not achieved|2
3129341|NCT00040664|10694388|P4|Overall Study|Poor taste|0
3129342|NCT00040664|10694389|P3|Overall Study|Poor taste|2
3129343|NCT00040664|10694390|P2|Overall Study|Poor taste|0
3129344|NCT00040664|10694391|P1|Overall Study|Poor taste|2
3129345|NCT00040664|10694388|P4|Overall Study|Medication adherence/compliance problems|5
3129346|NCT00040664|10694389|P3|Overall Study|Medication adherence/compliance problems|1
3129347|NCT00040664|10694390|P2|Overall Study|Medication adherence/compliance problems|2
3129348|NCT00040664|10694391|P1|Overall Study|Medication adherence/compliance problems|8
3129349|NCT00040664|10694388|P4|Overall Study|Pregnancy|3
3129350|NCT00040664|10694389|P3|Overall Study|Pregnancy|0
3129351|NCT00040664|10694390|P2|Overall Study|Pregnancy|0
3129352|NCT00040664|10694391|P1|Overall Study|Pregnancy|3
3129353|NCT00040664|10694388|P4|Overall Study|Withdrawal by Subject|4
3129354|NCT00040664|10694389|P3|Overall Study|Withdrawal by Subject|3
3129355|NCT00040664|10694390|P2|Overall Study|Withdrawal by Subject|0
3129356|NCT00040664|10694391|P1|Overall Study|Withdrawal by Subject|7
3129357|NCT00040664|10694388|P4|Overall Study|Protocol Violation|1
3129358|NCT00040664|10694389|P3|Overall Study|Protocol Violation|0
3129359|NCT00040664|10694390|P2|Overall Study|Protocol Violation|1
3129360|NCT00040664|10694391|P1|Overall Study|Protocol Violation|2
3129361|NCT00040664|10694388|P4|Overall Study|Lost to Follow-up|2
3129362|NCT00040664|10694389|P3|Overall Study|Lost to Follow-up|0
3129363|NCT00040664|10694390|P2|Overall Study|Lost to Follow-up|2
3129364|NCT00040664|10694391|P1|Overall Study|Lost to Follow-up|4
3129365|NCT00040664|10694388|P4|Overall Study|Insufficient CD4 response|0
3129366|NCT00040664|10694389|P3|Overall Study|Insufficient CD4 response|1
3129367|NCT00040664|10694390|P2|Overall Study|Insufficient CD4 response|0
3129368|NCT00040664|10694391|P1|Overall Study|Insufficient CD4 response|1
3129369|NCT00040664|10694388|P4|Overall Study|Lack of Efficacy|4
3129370|NCT00040664|10694389|P3|Overall Study|Lack of Efficacy|3
3129371|NCT00040664|10694390|P2|Overall Study|Lack of Efficacy|2
3129372|NCT00040664|10694391|P1|Overall Study|Lack of Efficacy|9
3129373|NCT00040664|10694388|P4|Overall Study|Adverse Event|7
3129374|NCT00040664|10694389|P3|Overall Study|Adverse Event|2
3129375|NCT00040664|10694390|P2|Overall Study|Adverse Event|3
3129376|NCT00040664|10694391|P1|Overall Study|Adverse Event|12
3129377|NCT00040365|10694457|P1|Overall Study|Lost to Follow-up|3
3129378|NCT00040365|10694457|P1|Overall Study|Progressive disease|7
3129379|NCT00040365|10694457|P1|Overall Study|Death|1
3129380|NCT00039871|10694466|P1|Overall Study|Never entered follow-up|7
3129381|NCT00039871|10694466|P1|Overall Study|Discontinued at Week 12 per protocol|1061
3129382|NCT00039871|10694466|P1|Overall Study|Administrative|1
3129383|NCT00039871|10694466|P1|Overall Study|Did not meet eligibility criteria|11
3129384|NCT00039871|10694466|P1|Overall Study|Withdrawal by Subject|97
3129385|NCT00039871|10694466|P1|Overall Study|Protocol Violation|24
3129386|NCT00039871|10694466|P1|Overall Study|Lost to Follow-up|18
3129387|NCT00039871|10694466|P1|Overall Study|Adverse Event|165
3129388|NCT00039741|10694476|P4|Overall Study|Missed final visit|2
3129389|NCT00039741|10694477|P3|Overall Study|Missed final visit|2
3129390|NCT00039741|10694478|P2|Overall Study|Missed final visit|1
3129391|NCT00039741|10694479|P1|Overall Study|Missed final visit|2
3129392|NCT00039741|10694476|P4|Overall Study|Withdrew consent|1
3129393|NCT00039741|10694477|P3|Overall Study|Withdrew consent|0
3129394|NCT00039741|10694478|P2|Overall Study|Withdrew consent|5
3129395|NCT00039741|10694479|P1|Overall Study|Withdrew consent|0
3129396|NCT00039741|10694476|P4|Overall Study|Non-compliance with protocol|0
3129397|NCT00039741|10694477|P3|Overall Study|Non-compliance with protocol|1
3129398|NCT00039741|10694478|P2|Overall Study|Non-compliance with protocol|0
3129399|NCT00039741|10694479|P1|Overall Study|Non-compliance with protocol|1
3129400|NCT00039741|10694476|P4|Overall Study|Moved|6
3129401|NCT00039741|10694477|P3|Overall Study|Moved|3
3129402|NCT00039741|10694478|P2|Overall Study|Moved|2
3129403|NCT00039741|10694479|P1|Overall Study|Moved|3
3129404|NCT00039741|10694476|P4|Overall Study|Not able to get to clinic|3
3129405|NCT00039741|10694477|P3|Overall Study|Not able to get to clinic|0
3129406|NCT00039741|10694478|P2|Overall Study|Not able to get to clinic|2
3129407|NCT00039741|10694479|P1|Overall Study|Not able to get to clinic|5
3129408|NCT00039741|10694476|P4|Overall Study|Confounding medical condition|0
3129409|NCT00039741|10694477|P3|Overall Study|Confounding medical condition|0
3129410|NCT00039741|10694478|P2|Overall Study|Confounding medical condition|0
3129411|NCT00039741|10694479|P1|Overall Study|Confounding medical condition|1
3129412|NCT00039741|10694476|P4|Overall Study|Lost to Follow-up|2
3129413|NCT00039741|10694477|P3|Overall Study|Lost to Follow-up|5
3129414|NCT00039741|10694478|P2|Overall Study|Lost to Follow-up|1
3129415|NCT00039741|10694479|P1|Overall Study|Lost to Follow-up|3
3129416|NCT00039741|10694476|P4|Overall Study|Death|0
3129417|NCT00039741|10694477|P3|Overall Study|Death|0
3129418|NCT00039741|10694478|P2|Overall Study|Death|1
3129419|NCT00039741|10694479|P1|Overall Study|Death|0
3129420|NCT00038948|10694523|P2|Overall Study|Lack of Efficacy|6
3129421|NCT00038948|10694524|P1|Overall Study|Lack of Efficacy|3
3129422|NCT00038948|10694523|P2|Overall Study|Protocol Violation|7
3129423|NCT00038948|10694524|P1|Overall Study|Protocol Violation|3
3129424|NCT00038948|10694523|P2|Overall Study|Withdrawal by Subject|10
3129425|NCT00038948|10694524|P1|Overall Study|Withdrawal by Subject|23
3129426|NCT00038948|10694523|P2|Overall Study|Nonmedical event|7
3129427|NCT00038948|10694524|P1|Overall Study|Nonmedical event|5
3129428|NCT00038948|10694523|P2|Overall Study|Lost to Follow-up|4
3129429|NCT00038948|10694524|P1|Overall Study|Lost to Follow-up|4
3129430|NCT00038948|10694523|P2|Overall Study|Adverse Event|43
3129431|NCT00038948|10694524|P1|Overall Study|Adverse Event|131
3129432|NCT00038649|10694559|P1|Overall Study|Adverse Event|9
3129433|NCT00038467|10694572|P2|Overall Study|Other|28
3129434|NCT00038467|10694573|P1|Overall Study|Other|26
3129435|NCT00038467|10694572|P2|Overall Study|Randomized, but not treated|35
3129436|NCT00038467|10694573|P1|Overall Study|Randomized, but not treated|31
3129437|NCT00038467|10694572|P2|Overall Study|Recurrence|179
3129438|NCT00038467|10694573|P1|Overall Study|Recurrence|109
3129439|NCT00038467|10694572|P2|Overall Study|Lost to Follow-up|10
3129440|NCT00038467|10694573|P1|Overall Study|Lost to Follow-up|15
3129441|NCT00038467|10694572|P2|Overall Study|Death|16
3129442|NCT00038467|10694573|P1|Overall Study|Death|22
3129443|NCT00038467|10694572|P2|Overall Study|Protocol Violation|22
3129444|NCT00038467|10694573|P1|Overall Study|Protocol Violation|19
3129445|NCT00038467|10694572|P2|Overall Study|Withdrawal by Subject|107
3129446|NCT00038467|10694573|P1|Overall Study|Withdrawal by Subject|150
3129447|NCT00038467|10694572|P2|Overall Study|Adverse Event|145
3129448|NCT00038467|10694573|P1|Overall Study|Adverse Event|170
3129449|NCT00038142|10694635|P2|Overall Study|Unknown Reason|0
3129450|NCT00038142|10694636|P1|Overall Study|Unknown Reason|8
3129451|NCT00038142|10694635|P2|Overall Study|Adverse Event|0
3129452|NCT00038142|10694636|P1|Overall Study|Adverse Event|1
3129453|NCT00038142|10694635|P2|Overall Study|Death|0
3129454|NCT00038142|10694636|P1|Overall Study|Death|1
3129455|NCT00038142|10694635|P2|Overall Study|Progressive Disease|7
3129456|NCT00038142|10694636|P1|Overall Study|Progressive Disease|11
3129457|NCT00038142|10694635|P2|Overall Study|Ineligible|0
3129458|NCT00038142|10694636|P1|Overall Study|Ineligible|1
3129459|NCT00038103|10694644|P2|Overall Study|Randomized/never treated|0
3129460|NCT00038103|10694645|P1|Overall Study|Randomized/never treated|2
3129461|NCT00038103|10694644|P2|Overall Study|Sponsor Decision|1
3129462|NCT00038103|10694645|P1|Overall Study|Sponsor Decision|0
3129463|NCT00038103|10694644|P2|Overall Study|Protocol Violation|2
3129464|NCT00038103|10694645|P1|Overall Study|Protocol Violation|0
3129465|NCT00038103|10694644|P2|Overall Study|Lost to Follow-up|3
3129466|NCT00038103|10694645|P1|Overall Study|Lost to Follow-up|0
3129467|NCT00038103|10694644|P2|Overall Study|Withdrawal by Subject|3
3129468|NCT00038103|10694645|P1|Overall Study|Withdrawal by Subject|0
3129469|NCT00038103|10694644|P2|Overall Study|Lack of Efficacy|41
3129470|NCT00038103|10694645|P1|Overall Study|Lack of Efficacy|48
3129471|NCT00038103|10694644|P2|Overall Study|Adverse Event|6
3129472|NCT00038103|10694645|P1|Overall Study|Adverse Event|5
3129473|NCT00037830|10694668|P3|Overall Study|Unrelated Medical Problem|0
3129474|NCT00037830|10694669|P2|Overall Study|Unrelated Medical Problem|0
3129475|NCT00037830|10694670|P1|Overall Study|Unrelated Medical Problem|2
3129476|NCT00037830|10694668|P3|Overall Study|Protocol Violation|0
3129477|NCT00037830|10694669|P2|Overall Study|Protocol Violation|2
3129478|NCT00037830|10694670|P1|Overall Study|Protocol Violation|2
3129479|NCT00037830|10694668|P3|Overall Study|Withdrawal by Subject|1
3129480|NCT00037830|10694669|P2|Overall Study|Withdrawal by Subject|5
3129481|NCT00037830|10694670|P1|Overall Study|Withdrawal by Subject|4
3129482|NCT00037830|10694668|P3|Overall Study|Adverse Event|0
3129483|NCT00037830|10694669|P2|Overall Study|Adverse Event|0
3129484|NCT00037830|10694670|P1|Overall Study|Adverse Event|2
3129485|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
3129486|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
3129487|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Too early switch|103
3129488|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Too early switch|0
3129489|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
3129490|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
3129491|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Protocol Violation|91
3129492|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Protocol Violation|23
3129493|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
3129494|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
3129495|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Treatment refusal|208
3129496|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Treatment refusal|113
3129497|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Other|288
3129498|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Other|277
3129499|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Adverse Event|782
3129500|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Adverse Event|501
3129501|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
3129502|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
3129503|NCT00036270|10694702|P2|Study Treatment to 5 Year Report|Ongoing|736
3129504|NCT00036270|10694703|P1|Study Treatment to 5 Year Report|Ongoing|1081
3129505|NCT00036270|10694702|P2|Randomized to Study Treatment|Withdrawal by Subject|7
3129506|NCT00036270|10694703|P1|Randomized to Study Treatment|Withdrawal by Subject|6
3129507|NCT00035932|10694722|P3|Overall Study|Lack of Efficacy|28
3129508|NCT00035932|10694723|P2|Overall Study|Lack of Efficacy|33
3129509|NCT00035932|10694724|P1|Overall Study|Lack of Efficacy|33
3129510|NCT00035932|10694722|P3|Overall Study|Study Termination by Sponsor|0
3129511|NCT00035932|10694723|P2|Overall Study|Study Termination by Sponsor|0
3129512|NCT00035932|10694724|P1|Overall Study|Study Termination by Sponsor|1
3129513|NCT00035932|10694722|P3|Overall Study|Withdrawal by Subject|0
3129514|NCT00035932|10694723|P2|Overall Study|Withdrawal by Subject|5
3129515|NCT00035932|10694724|P1|Overall Study|Withdrawal by Subject|1
3129516|NCT00035932|10694722|P3|Overall Study|Protocol Violation While on Study|2
3129517|NCT00035932|10694723|P2|Overall Study|Protocol Violation While on Study|1
3129518|NCT00035932|10694724|P1|Overall Study|Protocol Violation While on Study|0
3129519|NCT00035932|10694722|P3|Overall Study|Noncompliance|6
3129520|NCT00035932|10694723|P2|Overall Study|Noncompliance|7
3129521|NCT00035932|10694724|P1|Overall Study|Noncompliance|6
3129522|NCT00035932|10694722|P3|Overall Study|Lost to Follow-up|3
3129523|NCT00035932|10694723|P2|Overall Study|Lost to Follow-up|4
3129524|NCT00035932|10694724|P1|Overall Study|Lost to Follow-up|4
3129525|NCT00035932|10694722|P3|Overall Study|Disease Progression / Relapse|0
3129526|NCT00035932|10694723|P2|Overall Study|Disease Progression / Relapse|1
3129527|NCT00035932|10694724|P1|Overall Study|Disease Progression / Relapse|1
3129528|NCT00035932|10694722|P3|Overall Study|Death|1
3129529|NCT00035932|10694723|P2|Overall Study|Death|0
3129530|NCT00035932|10694724|P1|Overall Study|Death|0
3129531|NCT00035932|10694722|P3|Overall Study|Adverse Event|9
3129532|NCT00035932|10694723|P2|Overall Study|Adverse Event|9
3129533|NCT00035932|10694724|P1|Overall Study|Adverse Event|10
3129534|NCT00035815|10694850|P2|Overall Study|Withdrawal by Subject|11
3129535|NCT00035815|10694851|P1|Overall Study|Withdrawal by Subject|17
3129536|NCT00035555|10694864|P3|Overall Study|Received cyclosporin in error|1
3129537|NCT00035555|10694865|P2|Overall Study|Received cyclosporin in error|0
3129538|NCT00035555|10694866|P1|Overall Study|Received cyclosporin in error|0
3129539|NCT00035555|10694864|P3|Overall Study|Investigator deemed not a good candidate|1
3129540|NCT00035555|10694865|P2|Overall Study|Investigator deemed not a good candidate|0
3129541|NCT00035555|10694866|P1|Overall Study|Investigator deemed not a good candidate|0
3129542|NCT00035555|10694864|P3|Overall Study|Withdrawal by Subject|2
3129543|NCT00035555|10694865|P2|Overall Study|Withdrawal by Subject|0
3129544|NCT00035555|10694866|P1|Overall Study|Withdrawal by Subject|2
3129545|NCT00035555|10694864|P3|Overall Study|Treatment failure/lack of efficacy|3
3129546|NCT00035555|10694865|P2|Overall Study|Treatment failure/lack of efficacy|5
3129547|NCT00035555|10694866|P1|Overall Study|Treatment failure/lack of efficacy|7
3129548|NCT00035555|10694864|P3|Overall Study|Prohibited medication|0
3129549|NCT00035555|10694865|P2|Overall Study|Prohibited medication|1
3129550|NCT00035555|10694866|P1|Overall Study|Prohibited medication|1
3129551|NCT00035555|10694864|P3|Overall Study|Noncompliance|1
3129552|NCT00035555|10694865|P2|Overall Study|Noncompliance|1
3129553|NCT00035555|10694866|P1|Overall Study|Noncompliance|0
3129554|NCT00035555|10694864|P3|Overall Study|Lost to Follow-up|1
3129555|NCT00035555|10694865|P2|Overall Study|Lost to Follow-up|0
3129556|NCT00035555|10694866|P1|Overall Study|Lost to Follow-up|0
3129557|NCT00035555|10694864|P3|Overall Study|Death|2
3129558|NCT00035555|10694865|P2|Overall Study|Death|0
3129559|NCT00035555|10694866|P1|Overall Study|Death|0
3129560|NCT00035555|10694864|P3|Overall Study|Allograft loss|2
3129561|NCT00035555|10694865|P2|Overall Study|Allograft loss|1
3129562|NCT00035555|10694866|P1|Overall Study|Allograft loss|1
3129563|NCT00035555|10694864|P3|Overall Study|Adverse Event|9
3129564|NCT00035555|10694865|P2|Overall Study|Adverse Event|8
3129565|NCT00035555|10694866|P1|Overall Study|Adverse Event|5
3129566|NCT00032487|10694950|P2|Overall Study|Had other reason|12
3129567|NCT00032487|10694951|P1|Overall Study|Had other reason|12
3129568|NCT00032487|10694950|P2|Overall Study|Lost to Follow-up|58
3129569|NCT00032487|10694951|P1|Overall Study|Lost to Follow-up|57
3129570|NCT00032487|10694950|P2|Overall Study|Adverse Event|7
3129571|NCT00032487|10694951|P1|Overall Study|Adverse Event|3
3129572|NCT00032487|10694950|P2|Overall Study|Withdrawal by Subject|43
3129573|NCT00032487|10694951|P1|Overall Study|Withdrawal by Subject|67
3129574|NCT00031551|10694961|P2|Overall Study|Withdrew due to chemotherapy effects|0
3129575|NCT00031551|10694962|P1|Overall Study|Withdrew due to chemotherapy effects|2
3129576|NCT00031486|10694974|P2|Overall Study|Other|1
3129577|NCT00031486|10694975|P1|Overall Study|Other|1
3129578|NCT00031486|10694974|P2|Overall Study|Did not meet eligibility requirement|1
3129579|NCT00031486|10694975|P1|Overall Study|Did not meet eligibility requirement|2
3129580|NCT00031486|10694974|P2|Overall Study|Non-compliant|4
3129581|NCT00031486|10694975|P1|Overall Study|Non-compliant|0
3129582|NCT00031486|10694974|P2|Overall Study|Death|3
3129583|NCT00031486|10694975|P1|Overall Study|Death|0
3129584|NCT00031486|10694974|P2|Overall Study|Withdrawal by Subject|2
3129585|NCT00031486|10694975|P1|Overall Study|Withdrawal by Subject|3
3129586|NCT00031486|10694974|P2|Overall Study|Lost to Follow-up|1
3129587|NCT00031486|10694975|P1|Overall Study|Lost to Follow-up|0
3129588|NCT00031486|10694974|P2|Overall Study|Adverse Event|0
3129589|NCT00031486|10694975|P1|Overall Study|Adverse Event|1
3129590|NCT00031460|10695001|P2|Overall Study|Confirmed unevaluable|1
3129591|NCT00031460|10695002|P1|Overall Study|Confirmed unevaluable|0
3129592|NCT00031460|10695001|P2|Overall Study|Disruption of blinded drug supply|0
3129593|NCT00031460|10695002|P1|Overall Study|Disruption of blinded drug supply|2
3129594|NCT00031460|10695001|P2|Overall Study|Reactivation of Disease|9
3129595|NCT00031460|10695002|P1|Overall Study|Reactivation of Disease|5
3129596|NCT00031460|10695001|P2|Overall Study|Death|1
3129597|NCT00031460|10695002|P1|Overall Study|Death|0
3129598|NCT00031460|10695001|P2|Overall Study|Non-Compliant|1
3129599|NCT00031460|10695002|P1|Overall Study|Non-Compliant|1
3129600|NCT00031460|10695001|P2|Overall Study|Withdrawal by Subject|1
3129601|NCT00031460|10695002|P1|Overall Study|Withdrawal by Subject|1
3129602|NCT00031460|10695001|P2|Overall Study|Lost to Follow-up|1
3129603|NCT00031460|10695002|P1|Overall Study|Lost to Follow-up|0
3129604|NCT00031447|10695016|P2|Overall Study|Disruption of blinded study drug supply|4
3129605|NCT00031447|10695017|P1|Overall Study|Disruption of blinded study drug supply|7
3129606|NCT00031447|10695016|P2|Overall Study|Re-activation of Disease|1
3129607|NCT00031447|10695017|P1|Overall Study|Re-activation of Disease|2
3129608|NCT00031447|10695016|P2|Overall Study|Non-compliant|1
3129609|NCT00031447|10695017|P1|Overall Study|Non-compliant|1
3129610|NCT00031447|10695016|P2|Overall Study|Lost to Follow-up|1
3129611|NCT00031447|10695017|P1|Overall Study|Lost to Follow-up|0
3129612|NCT00029146|10695092|P2|Overall Study|Lost to Follow-up|1
3129613|NCT00029146|10695093|P1|Overall Study|Lost to Follow-up|2
3129614|NCT00027378|10695144|P2|Overall Study|Physician Decision|3
3129615|NCT00027378|10695145|P1|Overall Study|Physician Decision|0
3129616|NCT00027027|10695158|P5|Overall Study|Withdrawal by Subject|1
3129617|NCT00027027|10695159|P4|Overall Study|Withdrawal by Subject|0
3129618|NCT00027027|10695160|P3|Overall Study|Withdrawal by Subject|0
3129619|NCT00027027|10695161|P2|Overall Study|Withdrawal by Subject|0
3129620|NCT00027027|10695162|P1|Overall Study|Withdrawal by Subject|0
3129621|NCT00027027|10695158|P5|Overall Study|Physician Decision Due To PD|5
3129622|NCT00027027|10695159|P4|Overall Study|Physician Decision Due To PD|3
3129623|NCT00027027|10695160|P3|Overall Study|Physician Decision Due To PD|2
3129624|NCT00027027|10695161|P2|Overall Study|Physician Decision Due To PD|3
3129625|NCT00027027|10695162|P1|Overall Study|Physician Decision Due To PD|2
3129626|NCT00027027|10695158|P5|Overall Study|PD Requiring Surgery|0
3129627|NCT00027027|10695159|P4|Overall Study|PD Requiring Surgery|0
3129628|NCT00027027|10695160|P3|Overall Study|PD Requiring Surgery|1
3129629|NCT00027027|10695161|P2|Overall Study|PD Requiring Surgery|0
3129630|NCT00027027|10695162|P1|Overall Study|PD Requiring Surgery|0
3129631|NCT00027027|10695158|P5|Overall Study|Clinical Symptoms Progression not PD|0
3129632|NCT00027027|10695159|P4|Overall Study|Clinical Symptoms Progression not PD|0
3129633|NCT00027027|10695160|P3|Overall Study|Clinical Symptoms Progression not PD|0
3129634|NCT00027027|10695161|P2|Overall Study|Clinical Symptoms Progression not PD|0
3129635|NCT00027027|10695162|P1|Overall Study|Clinical Symptoms Progression not PD|1
3129636|NCT00027027|10695158|P5|Overall Study|Admitted for Signs of PD|1
3129637|NCT00027027|10695159|P4|Overall Study|Admitted for Signs of PD|0
3129638|NCT00027027|10695160|P3|Overall Study|Admitted for Signs of PD|0
3129639|NCT00027027|10695161|P2|Overall Study|Admitted for Signs of PD|0
3129640|NCT00027027|10695162|P1|Overall Study|Admitted for Signs of PD|0
3129641|NCT00027027|10695158|P5|Overall Study|Adverse Event|1
3129642|NCT00027027|10695159|P4|Overall Study|Adverse Event|0
3129643|NCT00027027|10695160|P3|Overall Study|Adverse Event|1
3129644|NCT00027027|10695161|P2|Overall Study|Adverse Event|0
3129645|NCT00027027|10695162|P1|Overall Study|Adverse Event|0
3129646|NCT00025883|10695209|P1|Overall Study|didn't reach 6 months of Metreleptin|10
3129647|NCT00025883|10695209|P1|Overall Study|Adverse Event|1
3129648|NCT00025883|10695209|P1|Overall Study|Death|1
3129649|NCT00025883|10695209|P1|Overall Study|no baseline data|1
3129650|NCT00025883|10695209|P1|Overall Study|had atypical progeriod lipodystrophy|4
3129651|NCT00023595|10695221|P5|10 Year Follow up|Lost to Follow-up|0
3129652|NCT00023595|10695222|P4|10 Year Follow up|Lost to Follow-up|0
3129653|NCT00023595|10695223|P3|10 Year Follow up|Lost to Follow-up|3
3129654|NCT00023595|10695224|P2|10 Year Follow up|Lost to Follow-up|10
3129655|NCT00023595|10695225|P1|10 Year Follow up|Lost to Follow-up|12
3129656|NCT00023595|10695221|P5|5 Year Follow up|Lost to Follow-up|3
3129657|NCT00023595|10695222|P4|5 Year Follow up|Lost to Follow-up|7
3129658|NCT00023595|10695223|P3|5 Year Follow up|Lost to Follow-up|1
3129659|NCT00023595|10695224|P2|5 Year Follow up|Lost to Follow-up|2
3129660|NCT00023595|10695225|P1|5 Year Follow up|Lost to Follow-up|2
3129661|NCT00023452|10695436|P2|Overall Study|Other|69
3129662|NCT00023452|10695437|P1|Overall Study|Other|204
3129663|NCT00023452|10695436|P2|Overall Study|Pregnant|20
3129664|NCT00023452|10695437|P1|Overall Study|Pregnant|53
3129665|NCT00023452|10695436|P2|Overall Study|Refused Treatment (continued follow-up)|224
3129666|NCT00023452|10695437|P1|Overall Study|Refused Treatment (continued follow-up)|225
3129667|NCT00023452|10695436|P2|Overall Study|Physician Decision|21
3129668|NCT00023452|10695437|P1|Overall Study|Physician Decision|49
3129669|NCT00023452|10695436|P2|Overall Study|Lost to Follow-up|60
3129670|NCT00023452|10695437|P1|Overall Study|Lost to Follow-up|293
3129671|NCT00023452|10695436|P2|Overall Study|Adverse Event|196
3129672|NCT00023452|10695437|P1|Overall Study|Adverse Event|139
3129673|NCT00023452|10695436|P2|Overall Study|Withdrawal by Subject|54
3129674|NCT00023452|10695437|P1|Overall Study|Withdrawal by Subject|66
3129675|NCT00023452|10695436|P2|Overall Study|Death|0
3129676|NCT00023452|10695437|P1|Overall Study|Death|2
3129677|NCT00023452|10695436|P2|Overall Study|Out of Window|69
3129678|NCT00023452|10695437|P1|Overall Study|Out of Window|129
3129679|NCT00023452|10695436|P2|Overall Study|Ineligible for Study|159
3129680|NCT00023452|10695437|P1|Overall Study|Ineligible for Study|163
3129681|NCT00023322|10695461|P1|Overall Study|Lost to Follow-up|1
3129682|NCT00022763|10695485|P2|Overall Study|Admin|2
3129683|NCT00022763|10695486|P1|Overall Study|Admin|3
3129684|NCT00022763|10695485|P2|Overall Study|Insufficient Therapy|0
3129685|NCT00022763|10695486|P1|Overall Study|Insufficient Therapy|1
3129686|NCT00022763|10695485|P2|Overall Study|Withdrawal by Subject|7
3129687|NCT00022763|10695486|P1|Overall Study|Withdrawal by Subject|4
3129688|NCT00022763|10695485|P2|Overall Study|Lost to Follow-up|3
3129689|NCT00022763|10695486|P1|Overall Study|Lost to Follow-up|0
3129690|NCT00022763|10695485|P2|Overall Study|Death|1
3129691|NCT00022763|10695486|P1|Overall Study|Death|0
3129692|NCT00022763|10695485|P2|Overall Study|Injection Site Reactions|2
3129693|NCT00022763|10695486|P1|Overall Study|Injection Site Reactions|0
3129694|NCT00022763|10695485|P2|Overall Study|Adverse Event|2
3129695|NCT00022763|10695486|P1|Overall Study|Adverse Event|1
3129696|NCT00014911|10695528|P1|Overall Study|Immunosuppression-related Side Effects|1
3129697|NCT00014911|10695528|P1|Overall Study|Unknown Reasons|2
3129698|NCT00014911|10695528|P1|Overall Study|Withdrawal by Subject|6
3129699|NCT00014911|10695528|P1|Overall Study|Lost to Follow-up|1
3129700|NCT00014911|10695528|P1|Overall Study|Adverse Event|1
3129701|NCT00006604|10695544|P17|Overall Study|Other Reason|0
3129702|NCT00006604|10695545|P16|Overall Study|Other Reason|0
3129703|NCT00006604|10695546|P15|Overall Study|Other Reason|0
3129704|NCT00006604|10695547|P14|Overall Study|Other Reason|0
3129705|NCT00006604|10695548|P13|Overall Study|Other Reason|0
3129706|NCT00006604|10695549|P12|Overall Study|Other Reason|0
3129707|NCT00006604|10695550|P11|Overall Study|Other Reason|0
3129708|NCT00006604|10695551|P10|Overall Study|Other Reason|1
3129709|NCT00006604|10695552|P9|Overall Study|Other Reason|0
3129710|NCT00006604|10695553|P8|Overall Study|Other Reason|0
3129711|NCT00006604|10695554|P7|Overall Study|Other Reason|0
3129712|NCT00006604|10695555|P6|Overall Study|Other Reason|1
3129713|NCT00006604|10695556|P5|Overall Study|Other Reason|0
3129714|NCT00006604|10695557|P4|Overall Study|Other Reason|0
3129715|NCT00006604|10695558|P3|Overall Study|Other Reason|0
3129716|NCT00006604|10695559|P2|Overall Study|Other Reason|0
3129717|NCT00006604|10695560|P1|Overall Study|Other Reason|0
3129718|NCT00006604|10695544|P17|Overall Study|Lost to Follow-up|3
3129719|NCT00006604|10695545|P16|Overall Study|Lost to Follow-up|1
3129720|NCT00006604|10695546|P15|Overall Study|Lost to Follow-up|0
3129721|NCT00006604|10695547|P14|Overall Study|Lost to Follow-up|0
3129722|NCT00006604|10695548|P13|Overall Study|Lost to Follow-up|0
3129723|NCT00006604|10695549|P12|Overall Study|Lost to Follow-up|0
3129724|NCT00006604|10695550|P11|Overall Study|Lost to Follow-up|0
3129725|NCT00006604|10695551|P10|Overall Study|Lost to Follow-up|2
3129726|NCT00006604|10695552|P9|Overall Study|Lost to Follow-up|0
3129727|NCT00006604|10695553|P8|Overall Study|Lost to Follow-up|1
3129728|NCT00006604|10695554|P7|Overall Study|Lost to Follow-up|0
3129729|NCT00006604|10695555|P6|Overall Study|Lost to Follow-up|0
3129730|NCT00006604|10695556|P5|Overall Study|Lost to Follow-up|0
3129731|NCT00006604|10695557|P4|Overall Study|Lost to Follow-up|0
3129732|NCT00006604|10695558|P3|Overall Study|Lost to Follow-up|0
3129733|NCT00006604|10695559|P2|Overall Study|Lost to Follow-up|0
3129734|NCT00006604|10695560|P1|Overall Study|Lost to Follow-up|0
3129735|NCT00006604|10695544|P17|Overall Study|Subj/parent not willing to adhere to req|4
3129736|NCT00006604|10695545|P16|Overall Study|Subj/parent not willing to adhere to req|3
3129737|NCT00006604|10695546|P15|Overall Study|Subj/parent not willing to adhere to req|3
3129738|NCT00006604|10695547|P14|Overall Study|Subj/parent not willing to adhere to req|2
3129739|NCT00006604|10695548|P13|Overall Study|Subj/parent not willing to adhere to req|0
3129740|NCT00006604|10695549|P12|Overall Study|Subj/parent not willing to adhere to req|0
3129741|NCT00006604|10695550|P11|Overall Study|Subj/parent not willing to adhere to req|3
3129742|NCT00006604|10695551|P10|Overall Study|Subj/parent not willing to adhere to req|6
3129743|NCT00006604|10695552|P9|Overall Study|Subj/parent not willing to adhere to req|0
3129744|NCT00006604|10695553|P8|Overall Study|Subj/parent not willing to adhere to req|1
3129745|NCT00006604|10695554|P7|Overall Study|Subj/parent not willing to adhere to req|3
3129746|NCT00006604|10695555|P6|Overall Study|Subj/parent not willing to adhere to req|0
3129747|NCT00006604|10695556|P5|Overall Study|Subj/parent not willing to adhere to req|0
3129748|NCT00006604|10695557|P4|Overall Study|Subj/parent not willing to adhere to req|3
3129749|NCT00006604|10695558|P3|Overall Study|Subj/parent not willing to adhere to req|1
3129750|NCT00006604|10695559|P2|Overall Study|Subj/parent not willing to adhere to req|0
3129751|NCT00006604|10695560|P1|Overall Study|Subj/parent not willing to adhere to req|0
3129752|NCT00006604|10695544|P17|Overall Study|Withdrawal by Subject|1
3129753|NCT00006604|10695545|P16|Overall Study|Withdrawal by Subject|0
3129754|NCT00006604|10695546|P15|Overall Study|Withdrawal by Subject|1
3129755|NCT00006604|10695547|P14|Overall Study|Withdrawal by Subject|2
3129756|NCT00006604|10695548|P13|Overall Study|Withdrawal by Subject|1
3129757|NCT00006604|10695549|P12|Overall Study|Withdrawal by Subject|0
3129758|NCT00006604|10695550|P11|Overall Study|Withdrawal by Subject|2
3129759|NCT00006604|10695551|P10|Overall Study|Withdrawal by Subject|3
3129760|NCT00006604|10695552|P9|Overall Study|Withdrawal by Subject|1
3129761|NCT00006604|10695553|P8|Overall Study|Withdrawal by Subject|0
3129762|NCT00006604|10695554|P7|Overall Study|Withdrawal by Subject|2
3129763|NCT00006604|10695555|P6|Overall Study|Withdrawal by Subject|2
3129764|NCT00006604|10695556|P5|Overall Study|Withdrawal by Subject|1
3129765|NCT00006604|10695557|P4|Overall Study|Withdrawal by Subject|0
3129766|NCT00006604|10695558|P3|Overall Study|Withdrawal by Subject|2
3129767|NCT00006604|10695559|P2|Overall Study|Withdrawal by Subject|0
3129768|NCT00006604|10695560|P1|Overall Study|Withdrawal by Subject|1
3129769|NCT00006604|10695544|P17|Overall Study|Site closing|1
3129770|NCT00006604|10695545|P16|Overall Study|Site closing|0
3129771|NCT00006604|10695546|P15|Overall Study|Site closing|0
3129772|NCT00006604|10695547|P14|Overall Study|Site closing|1
3129773|NCT00006604|10695548|P13|Overall Study|Site closing|1
3129774|NCT00006604|10695549|P12|Overall Study|Site closing|1
3129775|NCT00006604|10695550|P11|Overall Study|Site closing|0
3129776|NCT00006604|10695551|P10|Overall Study|Site closing|0
3129777|NCT00006604|10695552|P9|Overall Study|Site closing|0
3129778|NCT00006604|10695553|P8|Overall Study|Site closing|1
3129779|NCT00006604|10695554|P7|Overall Study|Site closing|0
3129780|NCT00006604|10695555|P6|Overall Study|Site closing|0
3129781|NCT00006604|10695556|P5|Overall Study|Site closing|0
3129782|NCT00006604|10695557|P4|Overall Study|Site closing|1
3129783|NCT00006604|10695558|P3|Overall Study|Site closing|1
3129784|NCT00006604|10695559|P2|Overall Study|Site closing|0
3129785|NCT00006604|10695560|P1|Overall Study|Site closing|0
3129786|NCT00006604|10695544|P17|Overall Study|Subj/Parent not able to get to clinic|0
3129787|NCT00006604|10695545|P16|Overall Study|Subj/Parent not able to get to clinic|0
3129788|NCT00006604|10695546|P15|Overall Study|Subj/Parent not able to get to clinic|3
3129789|NCT00006604|10695547|P14|Overall Study|Subj/Parent not able to get to clinic|1
3129790|NCT00006604|10695548|P13|Overall Study|Subj/Parent not able to get to clinic|1
3129791|NCT00006604|10695549|P12|Overall Study|Subj/Parent not able to get to clinic|1
3129792|NCT00006604|10695550|P11|Overall Study|Subj/Parent not able to get to clinic|2
3129793|NCT00006604|10695551|P10|Overall Study|Subj/Parent not able to get to clinic|1
3129794|NCT00006604|10695552|P9|Overall Study|Subj/Parent not able to get to clinic|0
3129795|NCT00006604|10695553|P8|Overall Study|Subj/Parent not able to get to clinic|0
3129796|NCT00006604|10695554|P7|Overall Study|Subj/Parent not able to get to clinic|1
3129797|NCT00006604|10695555|P6|Overall Study|Subj/Parent not able to get to clinic|0
3129798|NCT00006604|10695556|P5|Overall Study|Subj/Parent not able to get to clinic|1
3129799|NCT00006604|10695557|P4|Overall Study|Subj/Parent not able to get to clinic|1
3129800|NCT00006604|10695558|P3|Overall Study|Subj/Parent not able to get to clinic|0
3129801|NCT00006604|10695559|P2|Overall Study|Subj/Parent not able to get to clinic|0
3129802|NCT00006604|10695560|P1|Overall Study|Subj/Parent not able to get to clinic|0
3129803|NCT00006604|10695544|P17|Overall Study|Severe debilitation, unable to continue|0
3129804|NCT00006604|10695545|P16|Overall Study|Severe debilitation, unable to continue|0
3129805|NCT00006604|10695546|P15|Overall Study|Severe debilitation, unable to continue|2
3129806|NCT00006604|10695547|P14|Overall Study|Severe debilitation, unable to continue|0
3129807|NCT00006604|10695548|P13|Overall Study|Severe debilitation, unable to continue|1
3129808|NCT00006604|10695549|P12|Overall Study|Severe debilitation, unable to continue|2
3129809|NCT00006604|10695550|P11|Overall Study|Severe debilitation, unable to continue|0
3129810|NCT00006604|10695551|P10|Overall Study|Severe debilitation, unable to continue|5
3129811|NCT00006604|10695552|P9|Overall Study|Severe debilitation, unable to continue|0
3129812|NCT00006604|10695553|P8|Overall Study|Severe debilitation, unable to continue|0
3129813|NCT00006604|10695554|P7|Overall Study|Severe debilitation, unable to continue|3
3129814|NCT00006604|10695555|P6|Overall Study|Severe debilitation, unable to continue|0
3129815|NCT00006604|10695556|P5|Overall Study|Severe debilitation, unable to continue|0
3129816|NCT00006604|10695557|P4|Overall Study|Severe debilitation, unable to continue|0
3129817|NCT00006604|10695558|P3|Overall Study|Severe debilitation, unable to continue|0
3129818|NCT00006604|10695559|P2|Overall Study|Severe debilitation, unable to continue|0
3129819|NCT00006604|10695560|P1|Overall Study|Severe debilitation, unable to continue|0
3129820|NCT00006604|10695544|P17|Overall Study|Death|0
3129821|NCT00006604|10695545|P16|Overall Study|Death|0
3129822|NCT00006604|10695546|P15|Overall Study|Death|0
3129823|NCT00006604|10695547|P14|Overall Study|Death|0
3129824|NCT00006604|10695548|P13|Overall Study|Death|0
3129825|NCT00006604|10695549|P12|Overall Study|Death|1
3129826|NCT00006604|10695550|P11|Overall Study|Death|1
3129827|NCT00006604|10695551|P10|Overall Study|Death|1
3129828|NCT00006604|10695552|P9|Overall Study|Death|0
3129829|NCT00006604|10695553|P8|Overall Study|Death|0
3129830|NCT00006604|10695554|P7|Overall Study|Death|0
3129831|NCT00006604|10695555|P6|Overall Study|Death|0
3129832|NCT00006604|10695556|P5|Overall Study|Death|0
3129833|NCT00006604|10695557|P4|Overall Study|Death|0
3129834|NCT00006604|10695558|P3|Overall Study|Death|0
3129835|NCT00006604|10695559|P2|Overall Study|Death|0
3129836|NCT00006604|10695560|P1|Overall Study|Death|0
3129837|NCT00006604|10695544|P17|Overall Study|Randomization entry error-no RX, no FU|0
3129838|NCT00006604|10695545|P16|Overall Study|Randomization entry error-no RX, no FU|0
3129839|NCT00006604|10695546|P15|Overall Study|Randomization entry error-no RX, no FU|0
3129840|NCT00006604|10695547|P14|Overall Study|Randomization entry error-no RX, no FU|0
3129841|NCT00006604|10695548|P13|Overall Study|Randomization entry error-no RX, no FU|0
3129842|NCT00006604|10695549|P12|Overall Study|Randomization entry error-no RX, no FU|1
3129843|NCT00006604|10695550|P11|Overall Study|Randomization entry error-no RX, no FU|0
3129844|NCT00006604|10695551|P10|Overall Study|Randomization entry error-no RX, no FU|0
3129845|NCT00006604|10695552|P9|Overall Study|Randomization entry error-no RX, no FU|0
3129846|NCT00006604|10695553|P8|Overall Study|Randomization entry error-no RX, no FU|0
3129847|NCT00006604|10695554|P7|Overall Study|Randomization entry error-no RX, no FU|0
3129848|NCT00006604|10695555|P6|Overall Study|Randomization entry error-no RX, no FU|0
3129849|NCT00006604|10695556|P5|Overall Study|Randomization entry error-no RX, no FU|0
3129850|NCT00006604|10695557|P4|Overall Study|Randomization entry error-no RX, no FU|0
3129851|NCT00006604|10695558|P3|Overall Study|Randomization entry error-no RX, no FU|0
3129852|NCT00006604|10695559|P2|Overall Study|Randomization entry error-no RX, no FU|0
3129853|NCT00006604|10695560|P1|Overall Study|Randomization entry error-no RX, no FU|0
3129854|NCT00006604|10695544|P17|Overall Study|Met study objective - no further FU|0
3129855|NCT00006604|10695545|P16|Overall Study|Met study objective - no further FU|1
3129856|NCT00006604|10695546|P15|Overall Study|Met study objective - no further FU|1
3129857|NCT00006604|10695547|P14|Overall Study|Met study objective - no further FU|0
3129858|NCT00006604|10695548|P13|Overall Study|Met study objective - no further FU|0
3129859|NCT00006604|10695549|P12|Overall Study|Met study objective - no further FU|0
3129860|NCT00006604|10695550|P11|Overall Study|Met study objective - no further FU|0
3129861|NCT00006604|10695551|P10|Overall Study|Met study objective - no further FU|0
3129862|NCT00006604|10695552|P9|Overall Study|Met study objective - no further FU|0
3129863|NCT00006604|10695553|P8|Overall Study|Met study objective - no further FU|0
3129864|NCT00006604|10695554|P7|Overall Study|Met study objective - no further FU|0
3129865|NCT00006604|10695555|P6|Overall Study|Met study objective - no further FU|0
3129866|NCT00006604|10695556|P5|Overall Study|Met study objective - no further FU|0
3129867|NCT00006604|10695557|P4|Overall Study|Met study objective - no further FU|0
3129868|NCT00006604|10695558|P3|Overall Study|Met study objective - no further FU|0
3129869|NCT00006604|10695559|P2|Overall Study|Met study objective - no further FU|0
3129870|NCT00006604|10695560|P1|Overall Study|Met study objective - no further FU|1
3129871|NCT00004978|10695676|P2|Overall Study|site closure - not in analysis cohort|20
3129872|NCT00004978|10695677|P1|Overall Study|site closure - not in analysis cohort|19
3129873|NCT00004978|10695676|P2|Overall Study|Withdrawal by Subject|26
3129874|NCT00004978|10695677|P1|Overall Study|Withdrawal by Subject|17
3129875|NCT00004978|10695676|P2|Overall Study|Lost to Follow-up|108
3129876|NCT00004978|10695677|P1|Overall Study|Lost to Follow-up|101
3129877|NCT00004978|10695676|P2|Overall Study|Death|116
3129878|NCT00004978|10695677|P1|Overall Study|Death|107
3129879|NCT00021541|10695703|P2|Period 2-crossover|Pts that did not progress|3
3129880|NCT00021541|10695704|P1|Period 2-crossover|Pts that did not progress|2
3129881|NCT00021541|10695703|P2|Period 2-crossover|non-adherence|0
3129882|NCT00021541|10695704|P1|Period 2-crossover|non-adherence|1
3129883|NCT00021541|10695703|P2|Period 2-crossover|Adverse Event|2
3129884|NCT00021541|10695704|P1|Period 2-crossover|Adverse Event|2
3129885|NCT00021541|10695703|P2|Period 2-crossover|Withdrawal by Subject|4
3129886|NCT00021541|10695704|P1|Period 2-crossover|Withdrawal by Subject|3
3129887|NCT00021541|10695703|P2|Period 2-crossover|refused phase B|2
3129888|NCT00021541|10695704|P1|Period 2-crossover|refused phase B|2
3129889|NCT00021541|10695703|P2|Period 1-First Treatment|Ineligible|2
3129890|NCT00021541|10695704|P1|Period 1-First Treatment|Ineligible|0
3129891|NCT00021541|10695703|P2|Period 1-First Treatment|Pts that did not progress|2
3129892|NCT00021541|10695704|P1|Period 1-First Treatment|Pts that did not progress|2
3129893|NCT00021541|10695703|P2|Period 1-First Treatment|Death|0
3129894|NCT00021541|10695704|P1|Period 1-First Treatment|Death|1
3129895|NCT00021541|10695703|P2|Period 1-First Treatment|non-adherence|0
3129896|NCT00021541|10695704|P1|Period 1-First Treatment|non-adherence|3
3129897|NCT00021541|10695703|P2|Period 1-First Treatment|Adverse Event|1
3129898|NCT00021541|10695704|P1|Period 1-First Treatment|Adverse Event|2
3129899|NCT00021541|10695703|P2|Period 1-First Treatment|Withdrawal by Subject|3
3129900|NCT00021541|10695704|P1|Period 1-First Treatment|Withdrawal by Subject|3
3129901|NCT00015457|10695718|P2|Second Intervention|Withdrawal by Subject|0
3129902|NCT00015457|10695719|P1|Second Intervention|Withdrawal by Subject|1
3129903|NCT00015457|10695718|P2|First Intervention|Lack of Efficacy|1
3129904|NCT00015457|10695719|P1|First Intervention|Lack of Efficacy|0
3129905|NCT00015457|10695718|P2|First Intervention|Adverse Event|2
3129906|NCT00015457|10695719|P1|First Intervention|Adverse Event|0
3129907|NCT00013611|10695729|P2|Overall Study|Lost to Follow-up|100
3129908|NCT00013611|10695730|P1|Overall Study|Lost to Follow-up|91
3129909|NCT00010803|10695748|P2|Overall Study|Withdrawal by Subject|98
3129910|NCT00010803|10695749|P1|Overall Study|Withdrawal by Subject|97
3129911|NCT00007475|10695776|P4|Overall Study|Adverse Event|0
3129912|NCT00007475|10695777|P3|Overall Study|Adverse Event|0
3129913|NCT00007475|10695778|P2|Overall Study|Adverse Event|0
3129914|NCT00007475|10695779|P1|Overall Study|Adverse Event|3
3129915|NCT00007475|10695776|P4|Overall Study|Withdrawal by Subject|0
3129916|NCT00007475|10695777|P3|Overall Study|Withdrawal by Subject|0
3129917|NCT00007475|10695778|P2|Overall Study|Withdrawal by Subject|0
3129918|NCT00007475|10695779|P1|Overall Study|Withdrawal by Subject|1
3129919|NCT00007345|10695801|P2|Overall Study|Death on study|1
3129920|NCT00007345|10695802|P1|Overall Study|Death on study|1
3129921|NCT00007345|10695801|P2|Overall Study|Intercurrent illness|0
3129922|NCT00007345|10695802|P1|Overall Study|Intercurrent illness|1
3129923|NCT00007345|10695801|P2|Overall Study|Switched to alternative treatment|3
3129924|NCT00007345|10695802|P1|Overall Study|Switched to alternative treatment|0
3129925|NCT00007345|10695801|P2|Overall Study|Refused further treatment|7
3129926|NCT00007345|10695802|P1|Overall Study|Refused further treatment|0
3129927|NCT00006489|10695824|P4|Overall Study|Death|1
3129928|NCT00006489|10695825|P3|Overall Study|Death|0
3129929|NCT00006489|10695826|P2|Overall Study|Death|0
3129930|NCT00006489|10695827|P1|Overall Study|Death|0
3129931|NCT00006489|10695824|P4|Overall Study|Scheduling Conflict|1
3129932|NCT00006489|10695825|P3|Overall Study|Scheduling Conflict|2
3129933|NCT00006489|10695826|P2|Overall Study|Scheduling Conflict|3
3129934|NCT00006489|10695827|P1|Overall Study|Scheduling Conflict|0
3129935|NCT00006489|10695824|P4|Overall Study|Withdrawal by Subject|6
3129936|NCT00006489|10695825|P3|Overall Study|Withdrawal by Subject|9
3129937|NCT00006489|10695826|P2|Overall Study|Withdrawal by Subject|9
3129938|NCT00006489|10695827|P1|Overall Study|Withdrawal by Subject|10
3129939|NCT00006489|10695824|P4|Overall Study|Adverse Event|3
3129940|NCT00006489|10695825|P3|Overall Study|Adverse Event|4
3129941|NCT00006489|10695826|P2|Overall Study|Adverse Event|2
3129942|NCT00006489|10695827|P1|Overall Study|Adverse Event|3
3129943|NCT00006409|10695862|P6|Post-3 Year Intervention|Protocol Violation|62
3129944|NCT00006409|10695863|P5|Post-3 Year Intervention|Protocol Violation|62
3129945|NCT00006409|10695864|P4|Post-3 Year Intervention|Protocol Violation|0
3129946|NCT00006409|10695865|P3|Post-3 Year Intervention|Protocol Violation|0
3129947|NCT00006409|10695866|P2|Post-3 Year Intervention|Protocol Violation|0
3129948|NCT00006409|10695867|P1|Post-3 Year Intervention|Protocol Violation|0
3129949|NCT00006409|10695862|P6|Post-2 Year Intervention|Protocol Violation|0
3129950|NCT00006409|10695863|P5|Post-2 Year Intervention|Protocol Violation|0
3129951|NCT00006409|10695864|P4|Post-2 Year Intervention|Protocol Violation|168
3129952|NCT00006409|10695865|P3|Post-2 Year Intervention|Protocol Violation|251
3129953|NCT00006409|10695866|P2|Post-2 Year Intervention|Protocol Violation|0
3129954|NCT00006409|10695867|P1|Post-2 Year Intervention|Protocol Violation|0
3129955|NCT00006409|10695862|P6|Baseline|Protocol Violation|0
3129956|NCT00006409|10695863|P5|Baseline|Protocol Violation|0
3129957|NCT00006409|10695864|P4|Baseline|Protocol Violation|0
3129958|NCT00006409|10695865|P3|Baseline|Protocol Violation|0
3129959|NCT00006409|10695866|P2|Baseline|Protocol Violation|70
3129960|NCT00006409|10695867|P1|Baseline|Protocol Violation|48
3129961|NCT00006305|10695891|P4|Overall Study|Withdrawal by Subject|14
3129962|NCT00006305|10695892|P3|Overall Study|Withdrawal by Subject|15
3129963|NCT00006305|10695893|P2|Overall Study|Withdrawal by Subject|10
3129964|NCT00006305|10695894|P1|Overall Study|Withdrawal by Subject|17
3129965|NCT00006289|10695910|P2|Second Intervention (5 Weeks)|Protocol Violation|1
3129966|NCT00006289|10695911|P1|Second Intervention (5 Weeks)|Protocol Violation|1
3129967|NCT00006289|10695910|P2|First Intervention (5 Weeks)|Adverse Event|0
3129968|NCT00006289|10695911|P1|First Intervention (5 Weeks)|Adverse Event|1
3129969|NCT00006184|10695929|P2|Overall Study|Death|0
3129970|NCT00006184|10695930|P1|Overall Study|Death|1
3129971|NCT00006164|10695981|P2|Overall Study|Withdrew or lost to follow-up|81
3129972|NCT00006164|10695982|P1|Overall Study|Withdrew or lost to follow-up|70
3129973|NCT00005937|10696025|P1|Overall Study|Lack of Efficacy|5
3129974|NCT00005908|10696029|P2|Overall Study|Withdrawal by Subject|0
3129975|NCT00005908|10696030|P1|Overall Study|Withdrawal by Subject|1
3129976|NCT00005906|10696039|P1|Overall Study|Lack of Efficacy|3
3129977|NCT00004980|10696083|P2|Overall Study|Physician Decision|1
3129978|NCT00004980|10696084|P1|Overall Study|Physician Decision|0
3129979|NCT00004980|10696083|P2|Overall Study|memory difficulties|1
3129980|NCT00004980|10696084|P1|Overall Study|memory difficulties|1
3129981|NCT00004980|10696083|P2|Overall Study|Withdrawal by Subject|0
3129982|NCT00004980|10696084|P1|Overall Study|Withdrawal by Subject|1
3129983|NCT00004732|10696098|P2|Overall Study|Lost to Follow-up|47
3129984|NCT00004732|10696099|P1|Overall Study|Lost to Follow-up|33
3129985|NCT00004732|10696098|P2|Overall Study|Withdrawal by Subject|64
3129986|NCT00004732|10696099|P1|Overall Study|Withdrawal by Subject|36
3129987|NCT00004635|10696109|P2|Period Two|discrepancy in data entry|1
3129988|NCT00004635|10696110|P1|Period Two|discrepancy in data entry|0
3129989|NCT00004635|10696109|P2|Period Two|Lost to Follow-up|0
3129990|NCT00004635|10696110|P1|Period Two|Lost to Follow-up|1
3129991|NCT00004635|10696109|P2|Period Two|secondary malignancy|1
3129992|NCT00004635|10696110|P1|Period Two|secondary malignancy|1
3129993|NCT00004635|10696109|P2|Period Two|travel issues|1
3129994|NCT00004635|10696110|P1|Period Two|travel issues|0
3129995|NCT00004635|10696109|P2|Period Two|health problem|1
3129996|NCT00004635|10696110|P1|Period Two|health problem|1
3129997|NCT00004635|10696109|P2|Period Two|refused|2
3129998|NCT00004635|10696110|P1|Period Two|refused|0
3129999|NCT00004635|10696109|P2|Period Two|Adverse Event|0
3130000|NCT00004635|10696110|P1|Period Two|Adverse Event|1
3130001|NCT00004635|10696109|P2|Period Two|progression|3
3130002|NCT00004635|10696110|P1|Period Two|progression|2
3130003|NCT00004635|10696109|P2|Period One|discrepancy in data entry|1
3130004|NCT00004635|10696110|P1|Period One|discrepancy in data entry|0
3130005|NCT00004635|10696109|P2|Period One|health problem|1
3130006|NCT00004635|10696110|P1|Period One|health problem|0
3130007|NCT00004635|10696109|P2|Period One|progressed|2
3130008|NCT00004635|10696110|P1|Period One|progressed|0
3130009|NCT00004635|10696109|P2|Period One|second malignancy|0
3130010|NCT00004635|10696110|P1|Period One|second malignancy|1
3130011|NCT00004635|10696109|P2|Period One|PSA did not go <5 ng/mL|0
3130012|NCT00004635|10696110|P1|Period One|PSA did not go <5 ng/mL|1
3130013|NCT00004635|10696109|P2|Period One|Protocol Violation|0
3130014|NCT00004635|10696110|P1|Period One|Protocol Violation|1
3130015|NCT00004635|10696109|P2|Period One|Withdrawal by Subject|1
3130016|NCT00004635|10696110|P1|Period One|Withdrawal by Subject|1
3130017|NCT00004635|10696109|P2|Period One|refused|1
3130018|NCT00004635|10696110|P1|Period One|refused|2
3130019|NCT00004563|10696122|P2|Overall Study|Death|3
3130020|NCT00004563|10696123|P1|Overall Study|Death|2
3130021|NCT00004563|10696122|P2|Overall Study|Lack of Efficacy|5
3130022|NCT00004563|10696123|P1|Overall Study|Lack of Efficacy|3
3130023|NCT00004563|10696122|P2|Overall Study|Withdrawal by Subject|16
3130024|NCT00004563|10696123|P1|Overall Study|Withdrawal by Subject|20
3130025|NCT00004562|10696135|P2|Overall Study|Lost to Follow-up|91
3130026|NCT00004562|10696136|P1|Overall Study|Lost to Follow-up|102
3130027|NCT00001962|10696177|P1|Overall Study|Adverse Event|1
3130028|NCT00001962|10696177|P1|Overall Study|Lost to Follow-up|2
3130029|NCT00001962|10696177|P1|Overall Study|Death|1
3130030|NCT00001962|10696177|P1|Overall Study|Lack of Accrual|6
3130031|NCT00001962|10696177|P1|Overall Study|Lack of Efficacy|18
3130032|NCT00001959|10696181|P1|Overall Study|non-compliance|1
3130033|NCT00001959|10696181|P1|Overall Study|disabling sedation|1
3130034|NCT00001959|10696181|P1|Overall Study|newly diagnosed colon cancer|1
3130035|NCT00001941|10696187|P5|Overall Study|not treated- rapidly progressing disease|1
3130036|NCT00001941|10696188|P4|Overall Study|not treated- rapidly progressing disease|0
3130037|NCT00001941|10696189|P3|Overall Study|not treated- rapidly progressing disease|0
3130038|NCT00001941|10696190|P2|Overall Study|not treated- rapidly progressing disease|0
3130039|NCT00001941|10696191|P1|Overall Study|not treated- rapidly progressing disease|0
3130040|NCT00001832|10696223|P15|Treatment Period|Not treated|0
3130041|NCT00001832|10696224|P14|Treatment Period|Not treated|0
3130042|NCT00001832|10696225|P13|Treatment Period|Not treated|0
3130043|NCT00001832|10696226|P12|Treatment Period|Not treated|0
3130044|NCT00001832|10696227|P11|Treatment Period|Not treated|0
3130045|NCT00001832|10696228|P10|Treatment Period|Not treated|0
3130046|NCT00001832|10696229|P9|Treatment Period|Not treated|0
3130047|NCT00001832|10696230|P8|Treatment Period|Not treated|1
3130048|NCT00001832|10696231|P7|Treatment Period|Not treated|0
3130049|NCT00001832|10696232|P6|Treatment Period|Not treated|0
3130050|NCT00001832|10696233|P5|Treatment Period|Not treated|0
3130051|NCT00001832|10696234|P4|Treatment Period|Not treated|0
3130052|NCT00001832|10696235|P3|Treatment Period|Not treated|0
3130053|NCT00001832|10696236|P2|Treatment Period|Not treated|0
3130054|NCT00001832|10696237|P1|Treatment Period|Not treated|0
3130055|NCT00001832|10696223|P15|Treatment Period|Death during treatment|0
3130056|NCT00001832|10696224|P14|Treatment Period|Death during treatment|0
3130057|NCT00001832|10696225|P13|Treatment Period|Death during treatment|0
3130058|NCT00001832|10696226|P12|Treatment Period|Death during treatment|0
3130059|NCT00001832|10696227|P11|Treatment Period|Death during treatment|0
3130060|NCT00001832|10696228|P10|Treatment Period|Death during treatment|0
3130061|NCT00001832|10696229|P9|Treatment Period|Death during treatment|0
3130062|NCT00001832|10696230|P8|Treatment Period|Death during treatment|0
3130063|NCT00001832|10696231|P7|Treatment Period|Death during treatment|0
3130064|NCT00001832|10696232|P6|Treatment Period|Death during treatment|1
3130065|NCT00001832|10696233|P5|Treatment Period|Death during treatment|0
3130066|NCT00001832|10696234|P4|Treatment Period|Death during treatment|0
3130067|NCT00001832|10696235|P3|Treatment Period|Death during treatment|0
3130068|NCT00001832|10696236|P2|Treatment Period|Death during treatment|0
3130069|NCT00001832|10696237|P1|Treatment Period|Death during treatment|0
3130070|NCT00001832|10696223|P15|Apheresis Period|not able to manufacture treatment cells|0
3130071|NCT00001832|10696224|P14|Apheresis Period|not able to manufacture treatment cells|0
3130072|NCT00001832|10696225|P13|Apheresis Period|not able to manufacture treatment cells|0
3130073|NCT00001832|10696226|P12|Apheresis Period|not able to manufacture treatment cells|0
3130074|NCT00001832|10696227|P11|Apheresis Period|not able to manufacture treatment cells|0
3130075|NCT00001832|10696228|P10|Apheresis Period|not able to manufacture treatment cells|0
3130076|NCT00001832|10696229|P9|Apheresis Period|not able to manufacture treatment cells|0
3130077|NCT00001832|10696230|P8|Apheresis Period|not able to manufacture treatment cells|0
3130078|NCT00001832|10696231|P7|Apheresis Period|not able to manufacture treatment cells|0
3130079|NCT00001832|10696232|P6|Apheresis Period|not able to manufacture treatment cells|0
3130080|NCT00001832|10696233|P5|Apheresis Period|not able to manufacture treatment cells|0
3130081|NCT00001832|10696234|P4|Apheresis Period|not able to manufacture treatment cells|0
3130082|NCT00001832|10696235|P3|Apheresis Period|not able to manufacture treatment cells|0
3130083|NCT00001832|10696236|P2|Apheresis Period|not able to manufacture treatment cells|0
3130084|NCT00001832|10696237|P1|Apheresis Period|not able to manufacture treatment cells|60
3130085|NCT00001723|10696283|P2|Overall Study|medication intolerance|2
3130086|NCT00001723|10696284|P1|Overall Study|medication intolerance|1
3130087|NCT00001723|10696283|P2|Overall Study|Lost to Follow-up|2
3130088|NCT00001723|10696284|P1|Overall Study|Lost to Follow-up|2
3130089|NCT00001723|10696283|P2|Overall Study|Lack of family interest|5
3130090|NCT00001723|10696284|P1|Overall Study|Lack of family interest|4
3130091|NCT00001723|10696283|P2|Overall Study|Lack of Efficacy|7
3130092|NCT00001723|10696284|P1|Overall Study|Lack of Efficacy|6
3130093|NCT00001703|10696300|P1|Overall Study|recurrent disease|2
3130094|NCT00001703|10696300|P1|Overall Study|No evidence of disease|1
3130095|NCT00001703|10696300|P1|Overall Study|progressed disease|2
3130096|NCT00001596|10696338|P2|Overall Study|Adverse Event|0
3130097|NCT00001596|10696339|P1|Overall Study|Adverse Event|1
3130098|NCT00001596|10696338|P2|Overall Study|Study Termination|9
3130099|NCT00001596|10696339|P1|Overall Study|Study Termination|12
3130100|NCT00001596|10696338|P2|Overall Study|Withdrawal by Subject|1
3130101|NCT00001596|10696339|P1|Overall Study|Withdrawal by Subject|3
3130102|NCT00001596|10696338|P2|Overall Study|Death|0
3130103|NCT00001596|10696339|P1|Overall Study|Death|1
3130104|NCT00001575|10696370|P1|Overall Study|Withdrawn/deaths|23
3130105|NCT00001575|10696370|P1|Overall Study|Screening failures-Ph I portion|22
3130106|NCT00001566|10696376|P1|Overall Study|unable to complete initial apheresis|1
3130107|NCT00001566|10696376|P1|Overall Study|Lost to Follow-up|1
3130108|NCT00001566|10696376|P1|Overall Study|Death|13
3130109|NCT00001566|10696376|P1|Overall Study|stopped after C3 due to symptomatic PD|1
3130110|NCT00001566|10696376|P1|Overall Study|patients' choice to discontinue protocol|3
3130111|NCT00001262|10696416|P3|Overall Study|Withdrawal by Subject|0
3130112|NCT00001262|10696417|P2|Overall Study|Withdrawal by Subject|3
3130113|NCT00001262|10696418|P1|Overall Study|Withdrawal by Subject|0
3130114|NCT00001262|10696416|P3|Overall Study|Death|0
3130115|NCT00001262|10696417|P2|Overall Study|Death|11
3130116|NCT00001262|10696418|P1|Overall Study|Death|10
3130117|NCT00001213|10696444|P1|Overall Study|Death|18
3130118|NCT00000378|10696455|P2|Overall Study|Lack of Efficacy|14
3130119|NCT00000378|10696456|P1|Overall Study|Lack of Efficacy|16
3130120|NCT00000620|10696473|P8|Overall Study|missed closeout visit|16
3130121|NCT00000620|10696474|P7|Overall Study|missed closeout visit|13
3130122|NCT00000620|10696475|P6|Overall Study|missed closeout visit|28
3130123|NCT00000620|10696476|P5|Overall Study|missed closeout visit|26
3130124|NCT00000620|10696477|P4|Overall Study|missed closeout visit|11
3130125|NCT00000620|10696478|P3|Overall Study|missed closeout visit|16
3130126|NCT00000620|10696479|P2|Overall Study|missed closeout visit|28
3130127|NCT00000620|10696480|P1|Overall Study|missed closeout visit|22
3130128|NCT00000620|10696473|P8|Overall Study|Withdrawal by Subject|21
3130129|NCT00000620|10696474|P7|Overall Study|Withdrawal by Subject|32
3130130|NCT00000620|10696475|P6|Overall Study|Withdrawal by Subject|32
3130131|NCT00000620|10696476|P5|Overall Study|Withdrawal by Subject|30
3130132|NCT00000620|10696477|P4|Overall Study|Withdrawal by Subject|27
3130133|NCT00000620|10696478|P3|Overall Study|Withdrawal by Subject|28
3130134|NCT00000620|10696479|P2|Overall Study|Withdrawal by Subject|27
3130135|NCT00000620|10696480|P1|Overall Study|Withdrawal by Subject|40
3130136|NCT00000620|10696473|P8|Overall Study|Lost to Follow-up|14
3130137|NCT00000620|10696474|P7|Overall Study|Lost to Follow-up|13
3130138|NCT00000620|10696475|P6|Overall Study|Lost to Follow-up|15
3130139|NCT00000620|10696476|P5|Overall Study|Lost to Follow-up|15
3130140|NCT00000620|10696477|P4|Overall Study|Lost to Follow-up|14
3130141|NCT00000620|10696478|P3|Overall Study|Lost to Follow-up|14
3130142|NCT00000620|10696479|P2|Overall Study|Lost to Follow-up|14
3130143|NCT00000620|10696480|P1|Overall Study|Lost to Follow-up|14
3130144|NCT00000620|10696473|P8|Overall Study|Death|95
3130145|NCT00000620|10696474|P7|Overall Study|Death|91
3130146|NCT00000620|10696475|P6|Overall Study|Death|77
3130147|NCT00000620|10696476|P5|Overall Study|Death|64
3130148|NCT00000620|10696477|P4|Overall Study|Death|126
3130149|NCT00000620|10696478|P3|Overall Study|Death|112
3130150|NCT00000620|10696479|P2|Overall Study|Death|67
3130151|NCT00000620|10696480|P1|Overall Study|Death|86
3130152|NCT00004445|10696561|P1|Overall Study|Withdrawal by Subject|1
3130153|NCT00004445|10696561|P1|Overall Study|Physician Decision|2
3130154|NCT00004412|10696569|P3|Randomized Period|Moved to Crossover Period|0
3130155|NCT00004412|10696570|P2|Randomized Period|Moved to Crossover Period|0
3130156|NCT00004412|10696571|P1|Randomized Period|Moved to Crossover Period|3
3130157|NCT00000135|10696612|P2|Overall Study|Death|14
3130158|NCT00000135|10696613|P1|Overall Study|Death|27
